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08:30 - 10:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 121  
Emergency radiology I  
A-001 08:30  
A. Acute aortic syndrome  
H. Alkadhi; Zurich/CH (hatem.alkadhi@usz.ch)  
Computed tomography (CT) imaging - often preceded by conventional 
radiography - represents the major imaging modality for the diagnosis of acute 
aortic syndromes. This lecture will review the various underlying diseases of 
acute aortic syndrome, demonstrate typical imaging features enabling the 
diagnosis and discuss management options depending on the type, extent, 
and location of the disease. Clinical examples will be shown.  
Learning Objectives: 
1. To understand the different types of acute aortic syndrome. 
2. To learn about imaging findings and management options. 
A-002 09:15  
B. Abdominal trauma  
R. Basilico; Chieti/IT (rbasilic@unich.it)  
Abdominal traumas can be classified into two categories: penetrating and blunt 
traumas. Abdominal injuries are more often observed in the setting of 
polytrauma; in fact, they are present in about 10% of patients admitted to level 
1 trauma. However, only 11% of patients with abdominal trauma require 
laparotomy when a correct imaging-guide approach is performed. In fact, 
because the management of trauma patients mainly depends on the 
mechanism and severity of the trauma, it is crucial to choose the correct 
imaging modality and/or technique when evaluating a trauma patient on the 
basis of these two parameters. For example, an ultrasound examination, 
possibly integrated by contrast-enhanced ultrasonography, may be adequate 
to image a minor blunt abdominal trauma. This modality, however, is not 
appropriate when evaluating a severe blunt or penetrating abdominal trauma or 
even a polytrauma patient with a minor mechanism of injury. Multidetector CT 
is actually the modality of choice for evaluating severe trauma patients, 
accompanied by an appropriate CT protocol to image these patients so as to 
avoid missed injuries and to correctly detect abdominal solid organ injuries, 
mesenteric and intestinal injuries and abdominal vascular traumatic lesions. 
Moreover, due to the fact that during the past decades there has been a major 
change from operative to increasingly conservative management of abdominal 
traumatic injuries, even in patients with higher grades of injuries or those with 
older age, imaging features together with hemodynamic considerations play an 
essential role in the treatment choice: surgery, conservative management, and 
endovascular treatment.  
Learning Objectives: 
1. To identify the signs of trauma. 
2. To provide an indication of their clinical significance. 
08:30 - 10:00 Room B 
GI Tract  
RC 101  
GI bleeding: how to solve the problem?  
A-003 08:30  
Chairperson's introduction  
S. Wirth; Munich/DE (stefan.wirth@med.uni-muenchen.de)  
Sometimes, things may become more difficult and easier at the same time. On 
one hand advances in imaging allow for very precise and also fast diagnoses 
in a continuous increasing number of cases. Consequently, even the bleeding 
of the GI-tract comes even more into radiological play. On the other hand, 
radiologists have to be more and more aware of clinical entities, pathological 
patterns, and interdisciplinary networks to quickly and precisely provide our 
clinical partners with the information they need. Besides that, more and more 
cases can be managed by minimal-invasive interventional procedures, i.e., by 




1. To define acute, overt and occult GI bleeding. 
2. To learn about different imaging modalities that can be utilised in the work-
up of GI bleeding. 
3. To define the role of the interventional radiologist in the management of the 
GI bleeding. 
A-004 08:35  
A. Acute GI bleeding  
G.H. Mostbeck; Vienna/AT (gerhard.mostbeck@wienkav.at)  
Acute gastrointestinal (GI) bleeding is a common medical problem associated 
with high morbidity and mortality. The clinical presentation of acute GI bleeding 
varies with the location of the bleeding site, the cause, the amount of blood 
loss, and the presence of comorbidities. Anatomically, the ligament of Treitz is 
the border between upper (mouth to Treitz) and lower (Treitz to anus) GI 
bleeding. However, it is not always possible to differentiate between upper and 
lower GI bleeding clinically, despite the fact that clinical presentation is 
different, as is the etiology. In decreasing order, erosions and ulcer, variceal 
bleeding, Mallory-Weiss tears, vascular lesions, and neoplasms are 
responsible for upper GI bleeding. In contrast, lower GI bleeding occurs in the 
elder population, with diverticular disease, angiodysplasia, neoplasms, colitis 
and benign anorectal lesions being the major etiologies. The main diagnostic 
objective is the identification of the etiology and site of bleeding. Endoscopy is 
the initial diagnostic step in upper GI bleeding, but limited in lower GI bleeding 
due to difficulties in colonic cleansing in an emergency situation. Accordingly, 
CT is the imaging method of choice [technique: no positive oral contrast, high 
dose /iodine content/flow of contrast material (e.g.,100-150 ml, 350 mg/ml, 4-6 
ml/sec), plain, arterial and parenchymal phases, dual-energy CT with iodine 
maps if available, multiplanar reformation, high anatomic resolution]. We 
search for high-attenuation (> 80HU) luminal or wall lesions not seen on 
unenhanced CT data. Detection rates vary, and an amount of bleeding > 0.35-
0.5 ml/min is required. As bleeding might be intermittent, CT should be 
performed when active bleeding is present.  
Learning Objectives: 
1. To learn about the common causes of the acute upper and lower GI 
bleeding. 
2. To understand the rationale for different investigative pathways depending 
on the likely site of bleeding. 
3. To appreciate how best to optimise imaging protocols to identify the site and 
cause of bleeding, and assist with treatment planning. 
A-005 08:58  
B. Occult and overt GI bleeding: the role of radiology  
J. Brito; Portimão/PT (jbmbrito@gmail.com)  
The term obscure gastrointestinal bleeding (OGIB) was traditionally used to 
include patients with gastrointestinal bleeding who underwent normal upper 
and lower endoscopic examinations in addition to a small bowel series that did 
not reveal a source of bleeding. This definition was a sign of the difficulties 
experienced in small bowel exploration in the past. Given to recent advances in 
small bowel investigative methods, including endoscopic (video capsule 
endoscopy, deep enteroscopy) and radiological (CT and MR enterography, CT 
angiography) techniques, the cause of bleeding is no longer obscure and can 
now be reached in majority of the patients. For this reason, the term OGIB has 
been reclassified as “small bowel bleeding”, which corresponds to ~5-10% of 
all patients presenting with gastrointestinal bleeding. “OGIB” is now reserved 
for patients in whom a source of bleeding cannot be identified anywhere in the 
gastrointestinal tract after a comprehensive investigation. Small bowel bleeding 
can be overt, if patient presents with melena or hematochezia, or occult for 
patients presenting with iron-deficiency anaemia. Causes of small bowel 
bleeding are varied and the likelihood to be due to a vascular, inflammatory or 
mass lesion is related to the patient’s age. Algorithms for investigation of 
suspected small bowel bleeding include endoscopic and radiological methods, 
frequently with a complementary role, indicating that an adequate interaction is 
required among the elements of a multidisciplinary team.  
Learning Objectives: 
1. To learn about the differences between obscure, occult and overt GI 
bleeding, and the most common causes of each. 
2. To understand when imaging is indicated which tests to perform, and the 
most important diagnoses to look for. 
3. To appreciate the interaction between endoscopic and radiologic 











A-006 09:21  
C. When is the interventional radiologist needed?  
D.K. Tsetis; Iraklion, Crete/GR (tsetis@med.uoc.gr)  
Acute significant gastrointestinal bleeding is generally defined as a bleeding 
requiring transfusion of at least 4 units of blood within 24 hours or showing 
signs of hemodynamic instability (hypotension, tachycardia, signs of 
hypovolemic shock). Most cases are resolved endoscopically, 
pharmacologically, or by correction of coagulation parameters. Due to its 
minimally invasive nature, the endovascular solution is currently in most cases, 
after the previous methods fail, considered the method of choice. The most 
often used access to undergo embolisation is percutaneous access via 
common femoral or brachial artery. After reaching the appropriate visceral 
artery with a diagnostic 4 or 5F catheter, and verification of the source of 
bleeding, microcatheres are introduced coaxially. The most commonly used 
embolic materials are microcoils , PVA microspheres and gelatin foam. In the 
case of more massive bleeding, using of tissue glue (Histoacryl, etc.) may be 
considered . Upper gastrointestinal tract is characterised by a rich network of 
collateral supply with lower risk of ischemia. In the risk of rebleeding via 
collaterals, it is necessary to perform embolisation proximally and distally from 
the site of bleeding (so-called sandwich method). In the lower gastrointestinal 
tract, and in particular in the colon, due to the higher portion of terminal 
branches, ischemia risk is higher and embolisation should be as selective as 
possible. 
Learning Objectives: 
1. To learn about the role of interventional radiology in the management of 
acute and chronic GI bleeding. 
2. To learn about the variety of techniques available to the interventional 
radiologist to evaluate obscure GI bleeding and control acute GI bleeding. 
3. To understand when interventional radiology is clearly indicated, when it 
should be considered, and when it should be avoided if possible. 
09:44  
Panel discussion: Guidelines for management of GI bleeding and real life: 
why are they different?  
08:30 - 10:00 Room C 
Chest  
RC 104  
When and how to use perfusion imaging in 
pulmonary vascular and airway disease?  
Moderator:  
C.J. Herold; Vienna/AT  
A-007 08:30  
A. CT  
M. Rémy-Jardin; Lille/FR (martine.remy@chru-lille.fr)  
Since the introduction of dual-energy CT (DECT) in clinical practice, great 
interest has been directed toward analysis of the distribution of iodine in the 
most distal parts of the pulmonary circulation, often referred to as perfusion 
imaging. Initially only available with dual-source CT, dual-energy CT has 
become accessible to single-source CT, with the introduction of rapid kV 
switching and more recently, dual-layer (sandwich) detectors. Regardless of 
the difference in the technological approach, perfusion images are generated 
from the same data set as that used for morphological evaluation, offering the 
possibility of a simultaneous approach of structure and function in respiratory 
patients. This combined information provided with CT is a major advantage 
over scintigraphy and MRI, not only in the field of primary disorders of the 
pulmonary circulation, like acute pulmonary embolism, but also in the context 
of bronchopulmonary diseases where perfusion alterations can be interpreted 
with precise knowledge of the underlying morphologic changes. More recently, 
this complementarity has also been extended in the field of chronic 
thromboembolic disease and pulmonary hypertension while a growing interest 
is reported in oncologic indications. The purpose of this presentation is to make 
radiologists familiar with the use of CT lung perfusion in clinical practice.  
Learning Objectives: 
1. To learn about the creation of CT perfusion images. 
2. To understand the complementarity between morphological and functional 
information. 
3. To learn the various causes of perfusion defects. 
Author Disclosure: 
  M. Rémy-Jardin: Research/Grant Support; Resaerch grant support from 
Siemens Heathcare. 
A-008 09:00  
B. MRI  
M.O. Wielpütz; Heidelberg/DE (wielpuetz@uni-heidelberg.de)  
Among functional lung magnetic resonance imaging (MRI) techniques, 
dynamic contrast-enhanced (4D) perfusion MRI is probably the most robust 
and widely used method that has entered the clinical arena of routine patient 
management. Because it delivers temporally resolved datasets, perfusion 
parameters such as time-to-peak or pulmonary blood flow may be directly 
quantified by dedicated post-processing. In pulmonary vascular disease it may 
help to identify arterio-venous-malformations, pulmonary shunts or anomalous 
venous return. In combination with contrast-enhanced and non-constrast 
enhanced lung MR angiography, 4D perfusion MRI is now considered an 
alternative for computed tomography angiography for pulmonary embolism. In 
case of airways disease such as cystic fibrosis or chronic obstructive 
pulmonary disease, 4D perfusion imaging exploits the physiological 
mechanism of hypoxic pulmonary vasoconstriction. This effects a 
downregulation of perfusion to functional lung units with reduced ventilation, 
i.e. airway obstruction. Thus, 4D perfusion MRI can directly visualize functional 
lung impairment associated with airways disease, even when small airways are 
affected that cannot be otherwise captured with structural imaging. The lecture 
will summarise technical aspects of performing 4D perfusion imaging with 
clinical MRI scanners, discuss the most important routine indications incl. 
implementation into routine workflow, and discuss most relevant imaging 
findings in vascular and airways disease. Further, future developments and 
non-contrast-dependent techniques will be reviewed.  
Learning Objectives: 
1. To become familiar with the technical aspects of MRI perfusion. 
2. To learn key imaging features. 
3. To discuss the most relevant clinical indications. 
Author Disclosure: 
  M.O. Wielpütz: Advisory Board; Boehringer Ingelheim. Investigator; 
Boehringer Ingelheim, Vertex. 
A-009 09:30  
C. Nuclear medicine and hybrid imaging  
E.J.R. van Beek; Edinburgh/UK (edwin-vanbeek@ed.ac.uk)  
Initial management of pulmonary vascular and lung diseases has consisted of 
lung scintigraphy, enabling the study of both lung perfusion and ventilation. 
The advent of CT and CTPA has replaced many of the acute indications. 
Nevertheless, there remains an important role for the use of both lung 
scintigraphy and the combined use of new hybrid systems (SPECT/CT) to 
study these disease and facilitate in their management. This presentation will 
evaluate the historical and current state-of-the-art capabilities of lung 
scintigraphy to study lung perfusion and ventilation. It will also evaluate the 
potential best applications in the current diagnostic management, as well as 
demonstrate some of the pitfalls of this technology.  
Learning Objectives: 
1. To learn about the specificities of perfusion scintigraphy. 
2. To understand the advantages of hybrid imaging. 
3. To appreciate potential pitfalls of nuclear medicine techniques. 
Author Disclosure: 
  E.J.R. van Beek: Advisory Board; Aidence BV. Equipment Support Recipient; 
Siemens Healthineers. Founder; QCTIS Ltd. Owner; QCTIS Ltd. 
08:30 - 10:00 Room O  
Paediatric  
RC 112  
Paediatric musculoskeletal imaging  
Moderator:  
A.C. Offiah; Sheffield/UK  
A-010 08:30  
A. How to distinguish normal variants from pathology on musculoskeletal 
MRI in children  
D. Avenarius; Tromsø/NO (Derk.Avenarius@unn.no)  
Normal variations of development of the skeleton are well documented when it 
comes to radiographs; with the introduction of MRI there are many more 
features to consider that are often less known. Normal variations are common 
and these can simulate disease. It is important for radiologist to be aware of 
this and an overview of cases will be presented. Protocols for MRI imaging in 
paediatric MSK imaging will be discussed.  
  








1. To discuss MRI protocols for MSK-imaging in children. 
2. To give an overview of normal development and variations in MR anatomy 
and signal patterns. 
3. To provide an understanding of features indicative of pathology. 
A-011 09:00  
B. MRI of the temporomandibular joints: findings that can mimic arthritis  
T. von Kalle; Stuttgart/DE (t.vonkalle@klinikum-stuttgart.de)  
Arthritis of the temporomandibular joint (TMJ) is common in children and 
adolescents with juvenile idiopathic arthritis (JIA). Early treatment is warranted 
to prevent severe growth disturbances and joint deformities. As TMJ arthritis is 
often clinically silent, MRI with contrast-enhancement has been considered to 
be the most reliable method to assess signs of inflammation. To reliably guide 
therapeutic decisions and monitor outcomes, it would be of utmost importance 
to clearly define the MR characteristics of a normal TMJ as a basis for the 
assessment of minor pathologies. However, similar to other small joints in 
children, we are just beginning to understand its developmental, physiological 
and anatomical characteristics as well as its reaction to inflammatory diseases 
and their treatment. Recent studies on normal TMJ in children have revealed 
age dependent changes in shape and angulation of the mandibular condyle as 
well as typical time-intensity curves of contrast-enhancement in the soft joint 
tissue and the condyle. To date, the differentiation between normal synovial 
findings and mild signs of synovitis remains challenging. This lecture presents 
typical MR images of normal and inflamed TMJs in children and adolescents, 
including age dependent anatomical variations. It discusses the available data 
on possible cut-offs between normality and pathology, the impact of the 
temporal dynamics of contrast-enhancement, and presents findings that can 
mimic arthritis. It summarizes the minimum requirements of image quality and 
spatial resolution, the best image orientation, as well as the advantages of fat 
suppression and subtraction analysis in contrast-enhanced imaging. 
Learning Objectives: 
1. To discuss MRI protocols for imaging of the temporomandibular joints (TMJ). 
2. To give an overview of MR imaging finding in arthritis of the TMJ. 
3. To highlight the major differential diagnoses of TMJ arthritis and its MR 
imaging characteristics. 
A-012 09:30  
C. Skeletal trauma in children  
I. Barber; Esplugues de Llobregat/ES (ibarber@hsjdbcn.org)  
Musculoskeletal injuries are common in children. They account for 15-20% of 
admissions to the ED. Children have an immature skeleton with unique 
biomechanical features and a stronger, thicker and richly vascularized 
periosteum. Paediatric fractures may present with unique patterns including 
plastic deformation, buckled fractures, and greenstick fractures. Fractures in 
children include the ones involving the physis (epiphysiolysis) and we will 
review their classification and prognosis after treatment. We will review these 
injuries making special remarks on the imaging techniques used for their 
correct diagnosis and treatment planning.  
Learning Objectives: 
1. To become familiar with the types of injuries seen in children. 
2. To understand the basic mechanisms. 
3. To learn about the diagnostic imaging approach. 
08:30 - 10:00 Room N  
Head and Neck  
RC 108  
Differential diagnoses you don't want to 
miss  
Moderator:  
M.R. Eriksen; Stavanger/NO  
A-013 08:30  
A. Differential diagnoses of orbital masses  
V. Chong; Singapore/SG (vincent_chong@nuhs.edu.sg)  
The approach to orbital mass analysis follows two basic rules. The first rule 
emphasizes the general fact that diseases arise from pre-existing tissues or 
structures unique to different spaces in the orbit. The second rule highlights 
exceptions to the general rule. For example, metastatic or other systemic 
diseases may involve the orbit, while trans-spatial pathological processes such 
as infiltrative lesions may affect multiple compartments simultaneously or 
metachronously. The orbit can be divided (by the muscle cone) into an intra-
conal and an extra-conal compartment. Structures in the intra-conal 
compartment include the optic nerve/sheath complex and the surrounding 
fibro-fatty tissues, small vessels and small nerve branches. The contents of the 
extra-conal space include the lacrimal gland, cranial nerves (V1 and V2) and 
the periosteum of the orbit. Hence, knowledge of the applied anatomy of the 
orbit with a working knowledge of commonly seen diseases is a prerequisite for 
generating lists of differential diagnoses. The analysis of orbital masses should 
always be carried out in the clinical context of the patient. Tentative as well as 
definitive diagnosis can often be made with reference to the clinical 
information. For example, a lesion with unusual morphology or location can be 
tentatively diagnosed as metastatic disease in the presence of a history of 
malignancy elsewhere. In conclusion, the integration of knowledge of orbital 
anatomy, pathology and clinical information provides the basis of sound 
radiological differential diagnoses for further patient management.  
Learning Objectives: 
1. To become familiar with the anatomy of the orbit. 
2. To learn which imaging technique to use. 
3. To understand the typical imaging appearance of orbital masses. 
A-014 09:00  
B. Differential diagnoses of the jaw masses  
C. Czerny; Vienna/AT (christian.czerny@meduniwien.ac.at)  
Cystic and tumorous pathologies of the jaws can be imaged with cone-beam 
CT, CT and MRI. These pathologies include, e.g. in most cases inflammation 
or tumours. PET-CT or PET-MR may also be used. CT may be used without or 
with the i.v. application of iodinated contrast material dependent on the 
pathology. The images can be documented in soft-tissue- and/or bone-window-
level setting. Imaging planes are usually axial, coronal or sagittal depending on 
the pathology. MRI has the advantage of higher soft tissue contrast and the 
possibility of using different sequences. Depending on the pathology, e.g. fat-
suppressed T2-weighted, diffusion-weighted, T1-weighted sequences before 
and after the i.v. use of gadolinium and T1-weighted contrast-enhanced 
sequences with fat suppression are used. The imaging planes may be axial, 
coronal or sagittal. In this refresher course, the normal anatomy of the jaw, 
variants mimicking osteolytic or osteoblastic lesions, and cystic and tumorous 
pathologies of the jaws will be shown, and the imaging characteristics will be 
explained. 
Learning Objectives: 
1. To become familiar with the anatomy of the jaw. 
2. To learn which imaging technique to use. 
3. To understand the typical imaging appearance of jaw lesions. 
A-015 09:30  
C. Differential diagnoses of soft tissue masses  
D. Farina; Brescia/IT (nappaje@yahoo.it)  
Soft tissue masses of the supra and infrahyoid neck are a rather 
heterogeneous group of tumours, classified by WHO in nine categories, based 
on their histologic differentiation: adipocytic, fibroblastic or myofibroblastic, 
fibrohistiocytic, smooth muscle, skeletal muscle, vascular, pericytic, and 
chondro-osseous tumours, and tumours of uncertain differentiation. Based on 
their clinical behavior and history such tumours may be described as benign, 
malignant or intermediate, the latter further subclassified as locally invasive or 
metastatising at distant sites. US is generally the first imaging step in infrahyoid 
neck lesions; MDCT or MRI are mandatory in suprahyoid masses, but are also 
needed to better define the deep extent and anatomic relationships of 
infrahyoid tumours. In many cases, imaging findings are overlapping and 
insufficient for tumour characterisation; nonetheless, some specific clues may 
orient the differential diagnosis. Site of origin of the lesion is probably the first 
brick in the wall; therefore, knowledge of the space-based neck anatomy is 
essential prerequisite. Patient’s age, size and number of lesions, presence and 
pattern of calcifications are useful additional details. Some specific density or 
signal intensity patterns may cut the list of differentials, whereas the potential 
role of the additional information provided by DWI-MRI or dual-energy CT is far 
from being fully elucidated. However, it is clearly assumed that imaging 
diagnosis does not replace pathologic assessment, which in a significant 
number of cases can be accurately obtained with FNA.  
Learning Objectives: 
1. To become familiar with the anatomy. 
2. To learn which imaging technique to use. 











08:30 - 10:00 Room E1  
Special Focus Session  
SF 1  
Hepatocellular carcinoma: diagnosis, 
staging and current guidelines  
A-016 08:30  
Chairperson's introduction  
G. Brancatelli; Palermo/IT (gbranca@yahoo.com)  
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death 
worldwide. In this session, the rationale behind the need for screening for HCC 
will be discussed, and the geographic differences in screening programs will be 
highlighted. The benefits of using LI-RADS terminology, interpretation, and 
reporting for both clinical care and research will be presented. Typical and 
atypical appearance of HCC will be shown, along with common mimickers and 
useful tips of differentiation of focal hepatic nodules in cirrhotic liver. Finally, the 
speakers will be exposed to challenging cases in the form of unknown, will 
share their reasoning with each other, and engage in discussions with the 
chairperson and the audience.  
Session Objectives: 
1. To become familiar with the international guidelines for HCC screening. 
2. To understand why a standardised report facilitates patient management. 
3. To learn about the key concepts of diagnosis of typical and atypical HCC 
with CT and MRI. 
Author Disclosure: 
  G. Brancatelli: Speaker; Bayer, Guerbet. 
A-017 08:35  
Screening for HCC, American, Asian and European guidelines: why are 
they different?  
V. Vilgrain; Clichy/FR (valerie.vilgrain@aphp.fr)  
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, 
accounting for 80-90% of all cases of liver cancer. It is the fifth most common 
cancer and the third leading cause of cancer-related deaths around the world. 
As HCC occurs in 90% of the cases in patients with chronic liver disease, 
screening is indicated in those patients having compensated cirrhosis. Several 
guidelines have been implemented to help the practitioner to manage the 
patients during the screening, when a nodule is detected and to decide the 
optimal treatment in patients with HCC. Among the HCC guidelines which are 
the most used: AASLD, EASL, Japanese, Korean, and Asia-Pacific ones, there 
are common features. All agree : (i) on the noninvasive diagnosis of HCC using 
contrast-enhanced CT or MR imaging with two hallmarks: hypervascularisation 
on arterial-phase and wash-out on portal and/or delayed phase in lesions 
larger than one centimeter; (ii) on the role of liver biopsy when diagnosis 
cannot be achieved with imaging. Yet they differ in many other issues: 
stratification according to lesion size, first-line imaging modality, role of 
hepatobiliary MR contrast agents, and role of contrast-enhanced ultrasound. 
These differences are explained by the different prevalence of HCC worldwide 
and the different goals of diagnostic performance (high specificity or high 
sensitivity).  
Learning Objectives: 
1. To be aware of the different guidelines in HCC screening. 
2. To know the most striking differences. 
3. To understand the consequences in patient management. 
A-018 08:58  
Diagnosis of HCC, LI-RADS 2017: why we need it?  
C.B. Sirlin; San Diego, CA/US (csirlin@ucsd.edu)  
LI-RADS is a comprehensive system for imaging HCC in adults with cirrhosis 
or other risk factors for HCC. It provides standardized terminology with precise 
definitions and illustrations for screening and surveillance using US, diagnosis 
and staging using CT, MRI, and CEUS, and treatment response assessment 
using CT and MRI. It addresses the entire spectrum of lesions and pseudo 
lesions encountered in the cirrhotic liver as well as the full range of malignant 
neoplasms associated with chronic liver disease. This lecture will review LI-
RADS terminology, interpretation, and reporting and explain why 
standardization is needed for clinical care, research, and education.  
Learning Objectives: 
1. To understand the need for standardised terminology, interpretation, and 
reporting for clinical care. 
2. To understand the need for standardised terminology, interpretation, and 
reporting for research. 
3. To become familiar with LI-RADS terminology, interpretation, and reporting. 
Author Disclosure: 
  C.B. Sirlin: Advisory Board; Bayer. Grant Recipient; Bayer, GE, Siemens, 
Philips, ACR. 
A-019 09:21  
Atypical appearance of HCC and mimics: how to solve the challenging 
cases  
J.M. Lee; Seoul/KR (jmsh@snu.ac.kr)  
Hepatocellular carcinoma (HCC) poses a burden on global health. As HCC 
typically has a poor prognosis with a 5-year survival rate of only 28.6%, it is of 
paramount importance to achieve the earliest possible diagnosis of HCC and 
to recommend the most up-to-date optimal treatment strategy in order to 
increase the survival rate of patients who develop this disease. HCC is 
commonly diagnosed using dynamic CT and/or dynamic MRI without 
histological confirmation, on the basis of a characteristic arterial enhancement 
and portal venous or delayed phase washout. Indeed, the noninvasive 
diagnosis of HCC in high-risk patients by typical imaging findings alone is 
widely adopted in major practice guidelines for HCC. HCC usually presents 
with typical imaging characteristics but at times can present with a wide 
spectrum of atypical appearances. Familiarity with unusual presentations and 
their imaging findings is critical to ensuring prompt, accurate diagnosis and 
treatment. Moreover, while imaging techniques have markedly improved in 
detecting small liver lesions, they often detect incidental benign liver lesions 
and non-hepatocellular malignancy that can be misdiagnosed as HCC. The 
common mimickers of HCC in the cirrhotic liver include nontumorous 
arterioportal shunts, rapidly enhancing hemangiomas, intrahepatic mass-
forming type cholangiocarcinoma (CC), angiomyolipomas, focal inflammatory 
liver lesions and focal nodular hyperplasia-like nodules. Among them, it is 
important to recognize the suggestive imaging findings for intrahepatic CC as 
the management of CC is largely different from that of HCC. Recognition of the 
typical imaging findings of common HCC mimickers can reduce false-positive 
HCC diagnosis.  
Learning Objectives: 
1. To demonstrate imaging spectrum of hepatocellular carcinoma including 
typical and atypical appearance. 
2. To illustrate common mimickers of hepatocellular carcinoma in cirrhotic liver. 
3. To provide useful tips of differentiation of focal hepatic nodules in cirrhotic 
liver. 
Author Disclosure: 
  J.M. Lee: Grant Recipient; Bayer, Guerbet, Philips, Samsung Medison, GE 
Helathcare, Starmed, RF medical, Acuzen, Toshiba. Research/Grant Support; 
Siemens, GE Healthcare, Philips, Samsung Medison, Toshiba. Speaker; 
Bayer, GE Healthcare, Siemens, Philips, Samsung Medison, Guerbet. 
09:44  






















08:30 - 10:00 Room E2  
Neuro  
RC 111  
The degenerative cervical spine  
Moderator:  
A. Cianfoni; Lugano/CH  
A-020 08:30  
A. Degenerative uncovertebral and facet disease  
J. Van Goethem; Antwerp/BE (johan.vangoethem@uantwerpen.be)  
Neck pain is a common problem with many possible causes. The facet joint 
and the uncovertebral joint are frequently involved in degenerative cervical 
spine disease. It is important to learn how to differentiate normal and 
asymptomatic changes that occur with age from abnormal findings that are 
causing neck and/or arm pain. I will demonstrate the use of plain film, CT, 
SPECT, and MRI in diagnosing an offending uncovertebral or facet joint. Many 
of these offending joints can be targeted specifically, leading to easy and fast 
pain reduction in many patients with aspecific neck pain.  
Learning Objectives: 
1. To learn about the physiological and pathophysiological degeneration of the 
cervical spine. 
2. To understand the role of imaging in the diagnosis and clinical decision 
making in the degenerative cervical spine. 
3. To appreciate the clinical relevance of imaging findings in the degenerative 
cervical spine. 
A-021 09:00  
B. Cervical spinal stenosis and cervical spondylotic myelopathy  
A.S. Gersing; Munich/DE (alexandra.gersing@ucsf.edu)  
Degenerative changes of the cervical spine occur during the aging process or 
are caused by segmental mechanical overload. Among the degenerative 
processes leading to spinal stenosis are marginal osteophytes of the vertebral 
bodies and joints, intervertebral disc degeneration with herniation and 
hypertrophy of the ligaments. CT, CT-myelography, and MR imaging are 
essential in assessing the extent and severity of spinal canal stenosis, 
especially with a view to guiding conservative or surgical treatment. Next to the 
assessment of the osseous and soft tissue structures of the vertebral column 
as well as spinal canal stenoses, T2-weighted MRI imaging is crucial for the 
assessment of signal changes within the myelon. The differentiation between 
signs of an acute myelopathy and myelomalacia, caused by an irreversible 
damage of the spinal cord, is essential to select the appropriate treatment 
option. Moreover, patients present with a broad spectrum of clinical symptoms 
ranging from neck pain to spastic paraparesis; therefore, it is crucial to put 
imaging findings in context with clinical symptoms to assess the potential 
benefit of different conservative and surgical treatment options.  
Learning Objectives: 
1. To learn about the pathophysiology and imaging findings in spinal stenosis 
and cervical spondylotic myelopathy. 
2. To understand the relation between imaging findings and clinical 
presentation. 
3. To appreciate the importance of imaging findings and the clinical 
presentation with respect to possible treatment options. 
A-022 09:30  
C. The postoperative cervical spine  
I. Herrera; Madrid/ES (isabel.herherrera@gmail.com)  
Cervical spine surgery is common, so it is important for radiologists to know 
what the normal imaging findings are to avoid pitfalls. This is not easy as there 
are substantial imaging overlaps between normal early postoperative findings 
and surgical complications. Because there are a vast variety of surgical 
approaches and hardware that can be applied to the spine, it is a challenge for 
the radiologists to know their anatomical implications and possible 
complications. The use of a particular imaging technique is dictated by multiple 
factors including the underlying pathology, surgical approach, device or 
instrumentation used, and suspected complications. The postoperative imaging 
should be able to assess progression of osseous fusion, confirm correct 
positioning and integrity of instrumentation, and detect suspected 
complications such as new disease or disease progression. Radiographs are 
most commonly used for assessment of fusion. CT is the modality of choice for 
the evaluation of graft position, hardware, bone integrity, and fractures. It also 
provides imaging of bone detail to accurately assess the degree of osseous 
fusion. MRI is the best option for evaluation of endplates, paraspinal soft 
tissues, epidural spaces, and intrathecal structures, making it useful for 
detecting and monitoring infection or postoperative collections.  
Learning Objectives: 
1. To learn about the imaging findings and pitfalls of postoperative cervical 
spine imaging. 
2. To understand the heterogeneity of imaging findings and their clinical 
relevance. 
3. To appreciate the importance of standardised imaging, interpretation and 
reporting of postoperative imaging findings in the cervical spine. 
08:30 - 10:00 Room F1  
E³ - Rising Stars Programme: Basic Session  
BS 1  
Head and neck: inflammation, tumour or 
something else?  
Moderator:  
B. Verbist; Leiden/NL  
A-023 08:30  
Sinuses  
R. Maroldi; Brescia/IT  
"no abstract submitted" 
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe common imaging manifestations of inflammatory diseases. 
3. To review tumour and tumour-like lesions.  
A-024 08:53  
Thyroid and parathyroid  
H. Imhof; Vienna/AT  
The thyroid gland consists of two lobes which are interconnected by the 
isthmus. The gland is directly attached to the larynx and trachea. The standard 
view is axial, visualising the main overlying (strap) muscles, the great vessels 
and lymphnodes and the oesophagus, as well. The main congenital 
abnormalities are thyroglossal duct cyst, lingual thyroid gland and aberrant 
thyroid tissue. Diagnosis of the thyroid masses/nodules is done by sonography 
using the TI-RADS classification and colour-doppler, lesion size suspicion 
grade, and fine needle aspiration biopsy (FNAB) reaching an accuracy of 94%. 
Very important is to differentiate malignancy (papillary / follicular / anaplastic / 
medullary carcinoma) and inflammatory changes (Hashimoto and DeQuervain 
thyroiditis). Standard imaging procedures for the parathyroidea are sonography 
and Sesta-MIBI-SPECT reaching an accuracy of 97%. In unclear cases 4D-CT 
and/or MRI + contrast may be used additionally. 
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe common imaging manifestations of inflammatory diseases. 
3. To identify and describe the imaging appearance of malignant pathologies. 
A-025 09:15  
Salivary glands  
S.J. Golding; Oxford/UK (stephen.golding@nds.ox.ac.uk)  
This presentation offers a clinically orientated approach to imaging salivary 
gland disease in which the alignment between findings and further 
management is defined. Salivary imaging has been changed dramatically by 
the development of cross-sectional imaging. Ultrasound, CT and MRI have 
consigned radiographs and sialograms to a subsidiary role. Scintigraphy offers 
the best measure of global salivary gland function, but currently is not widely 
used in practice. Today investigation is closely related to the underlying 
pathology of salivary disorders and to provide reliable guide to surgical or 
medical treatment. Masses are well detected by cross-sectional imaging, which 
provides accurate guidance on appropriate approaches for surgical 
management. Differential diagnosis cannot always be achieved, but this is 
rarely a clinical problem because biopsy or resection are usually indicated. 
Sialography remains a reliable method of showing calculi and ductal changes 
in sialadenitis, but cross-sectional techniques, especially ultrasound and MRI, 
have advantages in inflammatory disease and complete sensitivity in detecting 
ductal disease may not be necessary in practice because patients may be 
treated symptomatically. A strong case can be made for using MRI as a sole 
investigation as this has been shown to be sensitive to both surgical and 
medical conditions. On this basis, the radiologist may be well placed to offer a 
primary referral service with triage, directing clinical management of patients or 
  







further referral on the basis of findings on MRI. Salivary interventional 
techniques have more recently extended the role of the radiologist.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe common imaging manifestations of inflammatory diseases. 
3. To identify and describe the imaging appearance of malignant pathologies. 
A-026 09:38  
Lymph nodes  
S.S. Özbek; Izmir/TR (sureyya.ozbek@ege.edu.tr)  
In case of a visible or palpated neck mass, lymph node enlargement is 
routinely included in the differential diagnosis list. Medical imaging can be 
effectively used to distinguish other causes of cervical swelling, as well as 
characterizing enlarged lymph nodes. Although commonly used as a criterion, 
nodal size is not reliable in characterization. Imaging parameters including 
internal structure, vascularity pattern, degree of enhancement, and perinodal 
tissue changes may shed light on the etiology of any lymphadenopathy, which 
may be reactive hyperplasia, infection, inflammation or neoplastic infiltration. 
Characteristically, reactive hyperplastic lymph nodes have well-defined 
borders, reniform shape and central fatty hilum contiguous with adjacent 
cervical fat tissue. In children, and in most of the adult cases with a low risk of 
malignancy, ultrasound is the first choice of imaging modality owing to its 
radiation-free nature, and due to practical reasons. However, when further 
characterization of nodal abnormality or evaluation of sonographically 
inaccessible anatomic locations is required, use of other cross-sectional 
techniques, like CT and MRI are mandatory. They provide not only more 
detailed information including anatomic localization, size, number, internal 
structure, and enhancement characteristics of lymph nodes, but also important 
data about perinodal soft tissue and other associated pathologic processes in 
the region. Although the choice of imaging modalities to be used in the 
evaluation of cervical lymph nodes changes according to the means, 
experience, and preferences of institutions, the role of medical imaging 
remains pivotal and decisive in this common indication.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe the imaging features of infectious and inflammatory disorders. 
3. To describe the imaging appearance of neoplastic disorders. 
Author Disclosure: 
  S.S. Özbek: Other; Advisory Panelist -Siemens Healthineers Ultrasound 
Radiology. 
08:30 - 10:00 Room F2  
E³ - ECR Master Class (Oncologic Imaging)  
E³ 126  
Novelties in oncologic imaging  
Moderator:  
C.J. Zech; Basle/CH  
A-027 08:30  
A. Imaging and response assessment of immune-related therapies  
P. Brader; Graz/AT (peter.brader@diagnostikum-graz.at)  
The immune system is capable of preventing the development of tumour 
diseases and stimulation of cytotoxic T-lymphocytes can repress existing 
tumours. A new class of antibody-based medication, the immune checkpoint 
inhibitors, influences the activation of T-lymphocytes. Immune checkpoint 
inhibitors are active against a number of tumours. In some cases, such as 
malignant melanoma and non-small cell lung cancer, the response rates are 
impressive and exceed those achieved with conventional chemotherapies. 
Modern immunotherapies in oncology show tumour response patterns differing 
from conventional chemotherapies including initial pseudo-progression which 
can occur in up to 10% of cases depending on the immunomodulating drug 
and tumour entity. Response Evaluation Criteria in Solid Tumours (RECIST 
1.1) represent the currently most used response criteria for conventional 
chemotherapy of solid tumours. However, atypical response patterns of 
immunotherapies are not correctly classified using RECIST 1.1 so that the 
effectiveness is also incorrectly interpreted. To correctly interpret these atypical 
response patterns, special Immune-Related Response Criteria in Solid 
Tumours (iRECIST) have been published. iRECIST was developed only for 
usage in trials testing modern immunotherapeutics. In contrast to RECIST 1.1, 
according to iRECIST an initially unconfirmed progressive disease (iUPD) 
requires confirmation (iCPD) in clinically stable patients by subsequent control 
imaging after 4-8 weeks. New lesions are separately assessed within iRECIST.  
 
Learning Objectives: 
1. To understand the basic principle of immune related therapies. 
2. To learn how tumour morphology and functional parameters change with 
therapy. 
3. To appreciate the existing evidence for immune therapy follow-up strategies. 
A-028 09:00  
B. Radiomics: the role of imaging  
S. Rizzo; Milan/IT (stefania.rizzo@ieo.it)  
Radiomics is an emerging translational field of research, aiming to extract data 
from clinical images, containing information that may reflect the underlying 
pathophysiology of tumoural tissue. The extracted information may be 
associated with clinical data, and can be used to assess prognosis and to 
support clinical decision. Specific softwares allow the extraction of radiomic 
features, representative of the entire tumors or defined subvolumes within 
tumors, from digital images (CT, MR, PET), and convert them into mineable 
high dimensional data for hypothesis generation, testing, or both. The steps 
necessary for a radiomic approach to digital radiological examinations include: 
acquisition of the images; identification of volumes of interest that may contain 
prognostic value; segmentation of volumes; extraction of radiomic features 
from the volume; clustering of the features; creation of a database; inclusion of 
the extracted data to develop models to predict outcomes, possibly in 
combination with demographic, clinical, comorbidity, or genomic data. Imaging 
is used in routine practice for oncological patients worldwide, at many stages of 
diagnosis and treatment. In the current era of targeted therapies, radiomics 
guarantees a nearly limitless supply of imaging biomarkers over time during 
and after therapy, to quantify and monitor phenotypic changes many times 
during treatment. The power of a predictive classifier model is dependent on 
the amount of data; hence, it is desirable that the radiomic studies will consider 
sharing of data between different centers, with the creation of databases 
including radiomics data and covariates, such as genomic profiles, histology, 
serum markers, patient histories, and biomarkers. 
Learning Objectives: 
1. To learn about the concept of radiomics and individualised medicine. 
2. To learn how radiomics can be extracted from standard clinical 
examinations. 
3. To appreciate the consequences of radiomics for radiologists in the future. 
A-029 09:30  
C. Imaging-guided liver interventions in oncology  
B. Gebauer; Berlin/DE (bernhard.gebauer@charite.de)  
Oncologic liver interventions play an important role in patients management, 
specially in HCC, colorectal cancer, and neuroendocrine tumors. 
Percutaneous, ablative techniques (thermal ablation (RFA, MWA, 
brachytherapy) and transarterial techniques (TACE, TAE, RE/SIRT) are 
available. Precise pre-interventional imaging is essential to select the correct 
patients for these techniques. In transarterial liver interventions enhanced 
intraprocedural imaging with ultrasound and cone-beam-CT increased 
technical opportunities for patients treatment and widened the opportunities for 
interventional oncology.  
Learning Objectives: 
1. To learn about new established treatment options in interventional oncology. 
2. To understand the role of pre- and post-treatment imaging in increasing 
clinical outcome. 
3. To appreciate potential future application of interventional oncology. 
Author Disclosure: 
  B. Gebauer: Speaker; BARD, SIRTex Medical, St. Jude Medical, COOK, 
AngioDynamics, Pharmcept, Roche, Merck, 3M, Siemens, Philips, IPSEN, 
















08:30 - 10:00 Room D  
Musculoskeletal  
RC 110  
MRI of articular cartilage and bone: areas 
of imaging confusion and practical 
solutions  
Moderator:  
O. Papakonstantinou; Athens/GR  
A-030 08:30  
A. Bone oedema syndromes and avascular necrosis  
B. Vande Berg; Brussels/BE (bruno.vandeberg@uclouvain.be)  
Bone marrow edema is a pattern of marrow alteration frequently observed at 
MRI. It is defined by the presence of an ill-delimited area of moderate and 
homogeneous decrease in signal intensity on SE T1 images that converts to 
high signal intensity on fat-saturated proton density or T2-weighted images. It 
is non-specific and may be associated with almost any abnormal marrow, bone 
or joint conditions. Epiphyseal bone marrow edema can be associated with 
self-limited spontaneously resolutive conditions (overuse, stress insufficiency 
fractures, transient osteoporosis), or with evolutive disorders including 
chondropathy or spontaneous osteonecrosis. The main task of the radiologist 
is to assess the cause for bone marrow edema and to highlight imaging 
features that contribute to a specific diagnosis and subsequently a prognosis 
(resolutive versus non-resolutive). The current lecture aims at emphasizing 
imaging features indicative of bone marrow edema to avoid confusion with 
systemic osteonecrosis. We will also highlight imaging features of prognostic 
significance that enable the clinician to tailor the treatment to the patient’s 
condition. 
Learning Objectives: 
1. To understand the aetiologies of bone marrow oedema syndromes. 
2. To learn about the imaging characteristics of avascular necrosis of bone. 
A-031 09:00  
B. Osteochondral injury, subchondral fractures and traumatic bone 
oedema: what is important and how do I describe it  
F.W. Roemer; Erlangen/DE (frank.roemer@uk-erlangen.de)  
Bone marrow contusions are frequently identified at magnetic resonance 
imaging after an injury to the musculoskeletal system. These osseous injuries 
may result from a direct blow to the bone, from compressive forces of adjacent 
bones impacting one another, or from traction forces that occur during an 
avulsion injury. Commonly these injuries resolve without long term sequelae. 
However, they may also involve the cartilaginous surface with or without an 
associated fracture line defining these as osteochondral injuries, which may 
have a different prognostic relevance. Subchondral fractures have been 
implicated in the genesis of some well-known destructive articular conditions 
whose cause was previously undetermined, such as rapidly progressive 
osteoarthritis of the hip or spontaneous osteonecrosis of the knee. 
Subchondral fractures may ultimately lead to bone collapse, secondary 
osteonecrosis, and severe articular damage. It should be suspected in the 
appropriate clinical setting, as in early stages it is usually indistinct on initial 
plain radiographs and magnetic resonance imaging is required for a definitive 
diagnosis. The fracture line usually appears as a band of low signal intensity in 
the subchondral bone plate, adjacent to the articular surface, most often 
surrounded by bone marrow edema. As these injuries may be occult on 
radiographs, the differentiation of bone contusions from osteochondral injuries 
or subchondral fractures is possible only with MRI including fat-suppressed 
and non-fat suppressed sequences. While purely subchondral lesion may have 
a good prognosis if diagnosed early, disruption of the articular surface may 
lead to early degenerative alterations including focal cartilage loss and other 
features of osteoarthritis.  
Learning Objectives: 
1. To understand the pathomechanisms of osteochondral injury and 
subchondral fractures. 
2. To learn about the imaging techniques and prognostic values. 
Author Disclosure: 
  F.W. Roemer: Shareholder; Boston Imaging Core Lab (BICL), LLC. 
 
 
A-032 09:30  
C. Rheumatoid arthritis  
I. Sudoł-Szopiska; Warsaw/PL (sudolszopinska@gmail.com)  
Rheumatoid arthritis is the most common inflammatory rheumatic disease. The 
pathogenesis of RA is subject to ongoing discussion. The traditional concept of 
inflammatory pannus, in which fibroblast-like synoviocytes provoke cartilage 
and bone destruction through direct invasion and indirect triggering of catabolic 
cascades has been termed the outside-in hypothesis. There is also evidence 
supporting the inside-out hypothesis, in which joint inflammation and 
destruction originates from the bone marrow. Next to synovium and 
subchondral bone, another tissue involved in cartilage and bone damage in RA 
is extra- or intraarticular fat tissue which produces ca. 50 adipo(cyto)kines 
which may be involved in degradation of all components of the connective 
tissue, including cartilage. Finally, the hyaline cartilage autoantigens, activated 
by cartilage damage, may activate and maintain synovitis and lead to joint 
damage. In everyday practice, the clinical relevance of synovitis and bone 
marrow inflammation in terms of their role as an erosions precursors is known 
and ultrasound and MRI are used to detect synovitis, BME, inflammatory cysts, 
hyaline cartilage loss, and bone erosions. Less in known about inflammatory 
and destructive potential of intra- and extraarticular fat tissue which may also 
be evaluated in US and MRI. And only research centers use quantitative MR 
applications to cartilage to show glucosaminoglycans loss possibly preceeding 
visible cartilage damage. In this presentation pathomechanisms that result in 
articular cartilage and bone damage in RA will be presented, including the 
clinical relevance of synovitis and BME in terms of their role as an erosion 
precursors, as well as the role of imaging techniques to detect early cartilage 
damage and bone erosions.  
Learning Objectives: 
1. To understand the pathomechanisms that result in articular cartilage and 
bone damage in rheumatoid arthritis, including the clinical relevance of 
synovitis and BME in terms of their role as an erosion precursor. 
2. To learn about the role of imaging techniques to detect early cartilage 
damage and bone erosions. 
08:30 - 10:00 Room G  
Physics in Medical Imaging  
RC 113  
Single-dual-multi-energy CT  
A-033 08:30  
Chairperson's introduction  
A. Torresin; Milan/IT (alberto.torresin@unimi.it)  
CT dual energy publications have heavily increased in the last years. The trend 
seems to be continuing since PubMed has found, from Jan 2015 until Nov 
2017, around 1000 peer review abstracts. Publications on phantom simulation 
(for algorithm verification) and patient's study regarding the most important 
area of diagnostic have been published sourcing from CT imaging and Hybrid 
Imaging (PET CT for examples). Bone and high density tissue evaluation are 
one of the most important application with high density artifact reduction, 
materials analysis based on attenuation spectra observed, tumor analysis and 
no contrast imaging application. A lot of technological solutions have been 
introduced during the last years, but the technique has not yet seen 
widespread implementation in routine protocols. During the course, the basic 
principle of dual energy and some new trend of spectral imaging will be 
introduced both technologically and clinically. To compare image quality and 
radiation dose of single-energy CT and dual energy, it is very important to 
quantify the patient risk with the introduction of these new technologies. 
Quantitative evaluation studies (retrospective and prospective) will be more 
and more important. During the refresh-course, the basic principle of patient 
dose in spectral imaging will be presented and attention is paid to the 
quantitative method of image analysis. 
Session Objectives: 
1. To learn about the basics of dual-energy CT (DECT). 
2. To understand today's photon counting detector technology. 
3. To learn how DECT is applied in clinical practice. 
A-034 08:35  
A. Basics of dual- and multi-energy CT  
K. Perisinakis; Iraklion/GR (Kostas.Perisinakis@med.uoc.gr)  
Dual energy CT (DECT) refers to the use of two CT beams of different photon 
energy spectrum to collect two separate sets of projection data and provide 
two corresponding image datasets of the same anatomical body region to 
  







exploit spectral information regarding attenuation ability of tissues for 
diagnostic purposes. Despite conceived during ‘70s soon after the first clinical 
CT, the clinical endorsement and widespread application of DECT was initiated 
with the advent of dual-source CT systems in 2006. Providing the potential to 
improve CT image quality through artifact suppression and extracting valuable 
information regarding tissue composition and function, DECT is the new 
exciting field for the radiology community and the main driving force for CT 
technology evolution over the last decade. Currently, all CT vendors put 
considerable efforts in developing CT systems capable of performing DECT 
studies, while novel clinical applications of DECT are continuously introduced. 
However, comprehension of the basic physics of DECT and familiarisation with 
the advanced technological features of modern DECT scanners is prerequisite 
to fully exploit the advantages of DECT imaging. 
Learning Objectives: 
1. To learn about the underlying physics and today's technology. 
2. To see potential advantages compared to single-energy CT. 
3. To appreciate the rationale behind clinical applications. 
A-035 08:58  
B. Photon counting detectors in diagnostic CT 
A. Altman; Haifa/IL (ami.altman@philips.com)  
Recent years' advances in room-temperature semi-conductors, especially CZT 
and CdTe, have enabled the transformation from energy-integrated (EI) 
detectors to photon-counting (PC) detectors in diagnostic CT, enhancing 
significantly its clinical benefits. The higher signal per x-ray photon (X10) and 
the short rise time of ~10 nanoseconds enable spectral analysis of each 
counted photon, use of adjustable multi-energy bins, K-edge imaging, and 
increased CNR through different energy weightings, while reducing the dose 
significantly. The continuous sensitivity of a pixelated sensor and the 
elimination of electronic noise through a threshold above it enable using much 
smaller detection pixels than in a conventional EI CT and contribute to further 
lowering of the dose. Consequently, spatial resolution is improved compared to 
EI CT (> 20 lp/cm). Reduction of the detection pixel size is essential also for 
lowering photon rates per pixel to avoid pile-up effects. However, charge 
sharing and K escapes of Te and Cd cause severe distortions to the recorded 
x-ray spectrum. A forward model of the detector response is used to address it 
and restore spectral capability, using a projection domain material 
decomposition. It will be shown that this can be accomplished as long as the 
peak-to-tail ratio is not too large, namely, detection pixel of about 0.5 mm. HW 
and SW methods of pile-up corrections will be shown too. Phantom and pre-
clinical verifications on the PHILIPS Spectral Photon-Counting CT (SPCCT) in 
Lyon demonstrate the capability of such a system achieving spectral results 
superior to dual-energy CT, and the advantage of dual-contrast injection in a 
single scan. 
Learning Objectives: 
1. To learn about the underlying physics and technological solutions. 
2. To understand the potential advantages compared to dual-energy CT. 
3. To appreciate how mature today's photon counting technology is. 
Author Disclosure: 
  A. Altman: Employee; PHILIPS Healthcare. 
A-036 09:21  
C. Clinical need of multi-energy CT  
S.T. Schindera; Aarau/CH (sschindera@aol.com)  
During the last decade, dual-energy CT has gained increasing attention in 
clinical routine due to improved diagnostic performance from the quantitative 
analysis of different tissue composition. Various clinical indications for a dual-
energy CT scan will be reviewed with a focus on the added value. Potential 
future opportunities of dual-energy CT, which still are viewed as research tools, 
will be also discussed. 
Learning Objectives: 
1. To learn about medical applications and potential benefits. 
2. To understand which single-energy applications could be replaced by dual-
energy applications, and why. 
3. To learn which additional multi-energy CT applications could be developed.  
09:44  




08:30 - 10:00 Room K  
Radiographers  
RC 114  
Forensic imaging  
A-037 08:30  
Chairpersons' introduction (part 1)  
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie)  
Radiographers play an essential role in the provision of high quality forensic 
imaging services. This is recognised in many countries and forensic imaging 
has been recognised by the European federation of radiographer societies 
(EFRS) as one of nine specialist areas of advanced practice for radiographers. 
While the concept of optimisation is at the heart of the profession, there 
remains room for improvement in further advancing optimisation for forensic 
applications. As with all specialist areas, or areas of advanced practice, 
appropriate education and training, and continuous professional development 
are fundamental. Through international organisations such as the international 
society for forensic radiology and imaging (ISFRI) and the international 
association of forensic radiographers (IAFR), together with national 
organisations and groups, forensic imaging continues to move in the right 
direction.  
Session Objectives: 
1. To provide insights into the role of imaging, and radiographers, in forensic 
imaging and mass fatality incidents. 
2. To appreciate the key aspects of a quality forensic imaging service. 
3. To understand the challenges associated with forensic imaging. 
A-038 08:33  
Chairpersons' introduction (part 2)  
R.R. van Rijn; Amsterdam/NL (r.r.vanrijn@amc.uva.nl)  
Forensic radiology and imaging is a relatively new field within the realm of 
forensic science and medicine. This introduction provides a short overview of 
the scientific challenges facing the forensic radiological technician radiologist.  
Session Objectives: 
1. To provide insights into the role of imaging, and radiographers, in forensic 
imaging and mass fatality incidents. 
2. To appreciate the key aspects of a quality forensic imaging service. 
3. To understand the challenges associated with forensic imaging. 
Author Disclosure: 
  R.R. van Rijn: Author; Author books published by Thieme and Springer. 
A-039 08:35  
A. Disaster victim identification  
J. Kroll; Maastricht/NL (j.kroll@mumc.nl)  
Forensic radiology, mainly as a tool for forensic odontology, has long been an 
essential discipline in the post-mortem identification of human remains. 
Because forensic radiology is a rapidly developing field due to the fast 
technical developments of CT scanners, the possible applications are 
increasing. A whole body CT contains a wealth of identification information that 
can be used in an identification process. This presentation will highlight the 
contribution of forensic radiology within a DVI process, discussing its 
applications, equipment, advantages and positioning within a DVI-process. It 
will also discuss future developments, opportunities and challenges which 
futures DVI processes will face.  
Learning Objectives: 
1. To appreciate the role of forensic radiology in a disaster victim identification 
process. 
2. To learn about the methods using forensic radiology in a disaster victim 
identification process. 
3. To discuss added value of forensic radiology in a disaster victim 
identification process. 
A-040 08:58  
B. The role of CT angiography in forensic imaging  
A. Dominguez; Lausanne/CH (Alexandre.DOMINGUEZ@hesav.ch)  
Multiphase post-mortem CT angiography (MPMCTA) has been set up almost 
ten years ago at the University Center of Legal Medicine of Lausanne-Geneva, 
Switzerland (CURML). A research project allowed the creation of the 
Virtangio® device: a specific injection system for post-mortem angiography. 
Nowadays, this setting is regularly used as almost a third of the autopsies 
  







benefit of this technique at the CURML. The indication to perform the 
MPMCTA is the suspicion of vascular lesions due to natural or traumatic origin, 
such as traffic accidents, homicides (stab wounds, ballistic), medical 
malpractice (especially in a post-surgery context), or unexpected adults death. 
This procedure allows examining vascular anatomy: analyses of the vascular 
lumen with potential stenosis or dilatation; analyse of the vascular walls with 
potential dissections or ruptures; characterization of the nature of an arterial 
and/or venous leakage. It also permits to obtain morphological information of 
the organs parenchyma. At the CURML, the MPMCTA is fully executed by the 
forensic radiographer. He is in charge of preparing the body, collecting 
samples before the angiography, denudating the arterial and venous vessels 
for the injections and proceeding the CT-scan acquisition. The duration of this 
technique lasting about 30 minutes won’t disturb the investigation work flow. 
The MPMCTA is then interpreted by a team involving forensic pathologist and 
a radiologist. Limitations and pitfalls of this technique should be known to 
identify artefacts and pitfalls.  
Learning Objectives: 
1. To learn about the development of multiphase post-mortem CT angiography 
(MPMCTA). 
2. To appreciate the benefits and limitations of MPMCTA examinations. 
3. To understand the role of the radiographer in the MPMCTA. 
A-041 09:21  
C. The importance of the radiographer's role in forensic imaging  
A.L. Brookes; London/UK (amyleebrookes@outlook.com)  
Forensic imaging is an ever-expanding sub-speciality of both radiology and 
forensic medicine. The overall role of forensic imaging is to obtain evidence 
and answer legal questions associated with either living or deceased 
individuals. Forensic imaging can be utilised in a variety of cases including 
suspected physical abuse, medical negligence, drug trafficking and mass 
fatalities incidents. In forensic pathology, forensic imaging has established a 
role in the assessment of identification and establishment of cause of death, 
particularly in cases of severely decomposed or burnt remains. The role of 
radiographers within forensic imaging contrasts significantly with that of the 
routine clinical environment. Those individuals involved in forensic imaging 
must understand and be aware of the medico-legal features and professional 
guidelines that impact their practice.  
Learning Objectives: 
1. To appreciate the role of the radiographer in forensic imaging. 
2. To learn about the importance of continuity of evidence and record keeping. 
3. To discuss the various situations a radiographer can be exposed to during 
forensic imaging. 
09:44  
Panel discussion: Developing a service/getting involved in forensic 
imaging  
08:30 - 10:00 Room M 1  
Vascular  
RC 115  
Peripheral vascular malformations: what 
every radiologist should know  
A-042 08:30  
Chairperson's introduction  
J.A. Reekers; Amsterdam/NL (j.a.reekers@amc.uva.nl)  
Vascular malformations are rare and therefore the diagnosis is often unknown 
to a general radiologist. It is important to differentiate a congenital vascular 
malformation from an infantile hemangioma. Congential vascular 
malformations a have a specific anamnesis, which is often the major clue to 
the final diagnosis. There are 3 main types of congenital vascular 
malformations. Arterial (high flow with direct fistula), venous (low flow) and 
lymphatic. There are some related vascular tumours like capillary malformation 
and port-wine stains. There are several syndromes in relation to vascular 
malformations. The most known is Klippel-Trenaunay-Weber syndrome. For a 
general radiologists it is important to recognise a vascular malformation. 
Treatment and further work-up diagnosis should only be undertaken in centres 
of expertise. Only malformations that give complaints like pain, bleeding or 
cosmetic issues should be treated. Both embolisation (for high flow) and local 
sclerotherapy (for low flow) are used to treat vascular malformations.  
 
Session Objectives: 
1. To review classification and description. 
2. To identify the role of imaging modalities. 
3. To understand the role of interventional radiologist in management and 
treatment. 
A-043 08:35  
A. The diagnostic assessment  
M. Köcher; Olomouc/CZ (martin.kocher@seznam.cz)  
Vascular malformations are categorised into the low-flow malformations and 
high-flow malformations. From imaging methods is expected to distinguish 
between the low-flow lesions and high-flow lesions, localisation, volume and 
range of lesion and relationship to the surrounding tissues and organs. Color 
doppler ultrasonography (DUS) can offer good differentiation between high-
flow and low-flow lesions. Magnetic resonance (MR) offers good differentiation 
between high-flow and low-flow lesions also, and moreover good evaluation of 
volume and extent of lesion, good interpretation of anatomical relationship to 
the surrounding tissues and organs. On DUS the low-flow malformations are 
demonstrated as hypoechogenic or heterogeneous lesions with minimal flow 
inside, flow during augmentation and normal arterial flow volumes and normal 
high arterial resistance flow. The high-flow malformations are heterogeneous 
lesions with tortuous feeding arteries, high velocity and low-resistance flow in 
feeding arteries, multiple arteriovenous shunts and pulsatile flow in draining 
veins. On MR the low-flow malformations typically have low signal intensity in 
T1 weighted images in abnormal vascular structures and high signal intensity 
in T2 weighted images, whereas the high-flow lesions usually demonstrate a 
signal voids in abnormal vascular structures on most sequences. At follow-up 
DUS demonstrates thrombosis and fibrosis of the low-flow lesion. In the high-
flow lesion the waveform will be normalised and the resistive indexes and the 
flow volumes will become normalised as well. MR demonstrates thrombosis 
and fibrosis of low-flow malformation by the loss of high signal in T2 weighted 
images and loss of signal voids in high-flow lesions.  
Learning Objectives: 
1. To learn about classification and terminology. 
2. To understand the role of US, CT and MRA in diagnostic assessment. 
3. To learn the optimal imaging algorithm for diagnosis and follow-up. 
A-044 08:58  
B. Percutaneous or endovascular treatment: when and how?  
B. Peynircioglu; Ankara/TR (borapeynir@gmail.com)  
Vascular anomalies, are divided in two different categories which carry 
different prognosis and management: "Vascular tumors" and "Vascular 
malformations" (VM). Their precise identification is crucial and involves a good 
knowledge of the biological classification published by Mulliken and Glowacki 
and that has recently been updated by the International Society for the Study 
of Vascular Anomalies (ISSVA). Vascular malformations are always congenital 
and grow with the child. They can involve type of vessels solely or combined 
with others. A rheologic differentiation between low and high flow 
malformations is essential to characterise the seriousness of the lesion. 
Interventional radiology (IR) plays major role in both curative and palliative 
treatments of these VM. Once understanding the nature and high/low flow 
characteristics of VM, transcatheter/endovascular (transarterial or transvenous) 
or direct percutaneous puncture under imaging guidance are the 2 main 
techniques for treating these lesions. Depending on the type, nature, location 
and surroundings of the VM, one should decide the best strategy for treatment. 
Another key point is to decide whether to use embolisation or sclerotherapy. 
Again, the type, location of the VM is vital and the patient based decision is to 
be made carefully by a multidisciplinary team. Operator’s experience is of most 
importance in determining all of the above variables, together with the local 
circumstances. There are many different types of embolic and sclerotherapy 
agents available around the world.  
Learning Objectives: 
1. To recognise the indications and the real need for treatment. 
2. To learn about technical approach and how to plan the intervention. 
3. To understand possible limitations and the final result prediction. 
A-045 09:21  
C. Paediatric vascular malformations: diagnosis and treatment  
A. Barnacle; London/UK (Alex.Barnacle@gosh.nhs.uk)  
Haemangiomas are by far the most common type of vascular anomaly that 
present in childhood. Haemangiomas are benign vascular tumours; several 
subtypes exist. Infantile haemangiomas are the commonest subtype and the 
vast majority of these require no intervention at all, because they involute 
spontaneously over the first few years of childhood. These well defined 
vascular masses have a highly characteristic growth pattern and typical 
  







imaging features. They can be distinguished from the rarer congenital 
haemangiomas by their clinical presentation. Rarer benign childhood vascular 
tumours include kaposiform haemangioendotheliomas (KHEs) and tufted 
angiomas, both of which are associated with thrombocytopaenia and have 
characteristic imaging features to distinguish them from haemangiomas. Unlike 
vascular tumours, vascular malformations are present from birth and grow 
slowly in childhood. Lymphatic malformations (LMs) tend to present earlier and 
are encountered much more commonly in children than adults. Macrocystic 
LMs consist of thin-walled cysts containing lymph or clot and microcystic 
lesions appear more solid. Ultrasound is often sufficient to make a diagnosis 
but MRI may be required to determine the extent of deep-seated lesions. Small 
lesions may not require treatment; larger lesions are usually treated with 
percutaneous image-guided sclerotherapy, though surgery has an important 
adjunctive role in debulking larger lesions. Finally, some children present with 
complex overgrowth, often of just one limb, which is associated with a vascular 
malformation. These patients require expert input from a multidisciplinary team 
and imaging is key.  
Learning Objectives: 
1. To understand the specifics of vascular malformations in children. 
2. To recognise when to observe and when to intervene. 
3. To learn about interventional techniques used and results of treatment. 
09:44  
Panel discussion: How could we improve diagnosis and optimise the 
results of our interventions?  
08:30 - 10:00 Room M 2 
Computer Applications  
RC 105  
Everything you need to know about 3D 
post-processing  
A-046 08:30  
Chairperson's introduction  
E. Sorantin; Graz/AT (erich.sorantin@medunigraz.at)  
Progress in imaging technology equipment enables scanning patients in high 
geometrical and temporal resolution as well as in multidimensional space (e.g. 
4D). The amount of resulting data cannot be read any more in 2D as done in 
the last millennium. Furthermore, advances in computational power enable the 
use of sophisticated processing algorithms in real time. Thus reading in 2D, as 
done in the previous millennium, will be gradually replaced by volumetric 
reading as well as extracting diagnostic information from parametric images. 
Moreover, for personalized medicine, radiology has to deliver more detailed 
information, especially to measure tumour volumes or characterize contrast 
uptake on perfusion imaging. To get familiar with those now really emerging 
techniques, three well-known speakers will cover essential subtopics and 
provide a road map on how to migrate from the reading style in the last 
millennium to that in the current millennium.  
Session Objectives: 
1. To learn about the state of the art in 3D post-processing. 
2. To understand how 3D post-processing can most optimally be used in daily 
clinical practice. 
3. To appreciate how automated 3D post-processing and quantification will 
lead to increased use of 3D visualisations for diagnostics and therapy planning, 
over 2D viewing. 
Author Disclosure: 
  E. Sorantin: Advisory Board; ESPR Represenative at WHO. Author; 
Scientific papers and book contributions. Consultant; Ulrich Medical Inc. 
Germany. 
A-047 08:35  
A. 3D post-processing in 2018  
A. Alberich-Bayarri; Valencia/ES (alberich_ang@gva.es)  
One of the most important developments in radiological interpretation is the 
need for the incorporation of advanced tools to assist the specialist in the study 
evaluation. Automated segmentation of structures based on convolutional 
neural networks (CNN) in the frame of deep learning would allow to 
significantly increase the efficiency of the study evaluation by the radiologist. 
Although the detailed segmentation of organs is still intricate in the field of 
abdomen and modalities like MR, current technology allows for the automated 
detection of the organs' location and identification of most of the tissue using 
bounding boxes. These applications may be used today in clinics for the 
automated assessment of tissue properties. A clear example is the automated 
detection and identification of vertebrae centroids, which allows for the 
acceleration of the radiologist reading process in spine CT examinations while 
it also allows for the automated calculation of trabecular bone quality properties 
in each identified vertebrae, therefore providing a high value to perform 
osteoporosis population studies without the need for a user interaction. These 
algorithms have been recently labelled as zero-click solutions and will provide 
a paradigm shift in 3D post-processing for radiologists, having the results of the 
3D assessment already generated in their PACS even before starting review of 
the study.  
Learning Objectives: 
1. To learn about recent advances in 3D post-processing techniques. 
2. To understand how these techniques can be used in clinical practice now. 
3. To learn new tips and tricks to use in your daily practice. 
Author Disclosure: 
  A. Alberich-Bayarri: CEO; QUIBIM SL. Founder; QUIBIM SL. 
A-048 08:58  
B. Making better use of your 3D package: tips and tricks  
P.M.A. van Ooijen; Groningen/NL (p.m.a.van.ooijen@umcg.nl)  
Advanced visualization, simulation and planning software is increasingly used 
in clinical practice providing a shift from 2D to 3D visualization, processing and 
interpretation. With this ongoing trend the radiological profession should not 
only focus on the diagnosis to be made, but also on the utilization of our 
imaging data in patient simulation, planning, and treatment. Current 
functionality moves in this direction with providing extensive possibilities for 
support of surgical interventions and treatment planning in 3D including the 
advent of Virtual and Augmented Reality. With this 3D is also moving into the 
operating theater. Although these new possibilities are interesting and exiting 
one should be very aware of the pitfalls that come with 3D visualization and 
processing of data. This not only includes the technical but also the procedural 
pitfalls where image acquisition optimal for diagnosis is not always optimized 
for the intended use by the referring physician. To adequately use the new 
techniques and to provide optimal support from radiology to the referring 
physicians training is required and dedicated staff should be involved in this 
process.  
Learning Objectives: 
1. To learn about the functionality of state-of-the-art 3D packages. 
2. To understand the pitfalls in use of 3D post-processing. 
3. To appreciate the need for training in 3D post-processing techniques. 
A-049 09:21  
C. Interpretation of 3D processing results: from image to volume reading  
T. Frauenfelder; Zurich/CH (thomas.frauenfelder@usz.ch)  
The widespread introduction of multidetector computed tomography (MDCT) 
has revolutionized the field of computed tomography (CT). This revolution can 
be attributed to three primary properties of MDCT: its ability to produce a vast 
quantity of volumetric data in a reduced amount of time, the high resolution, 
and the ability to create isotropic voxel data and, consequently, reliable 
multiplanar and three-dimensional (3D) reconstructions. Diagnostic 
approaches that rely solely on axial reconstructions of MDCT data are often 
insufficient for formulating an accurate diagnosis or for documentation of 
clinical cases. Specialized 3D reconstruction techniques permit the 
visualization of anatomical details, which would be difficult to evaluate using 
axial reconstructions alone. Such details may require the use of oblique or 
curved reconstructions, or more complex methods, such as maximum intensity 
projection (MIP), minimum intensity projection (MinIP), surface-shaded volume 
rending (SS-VRT), and virtual endoscopy. For example, small pulmonary 
nodules can only be rapidly and reliably identified through the use of MIP Slab 
slices. The current trend is to merge the routine diagnostic console and 3D 
reconstruction workstation. The integration of 3D reconstruction utilities into the 
standard bi-dimensional diagnostic software has increased the number of 
operations possible on each exam data, greatly increasing the perceived 
complexity of CT diagnosis. Although many of us believe that the use of 3D 
reconstructions greatly increases total exam evaluation time, there are reports 
show how using 3D reconstruction techniques for examining volumetric data 
are effective and also improve the speed of interpretation, recognition, and 
description of specific clinical conditions. Many of these reconstruction 
techniques are of particular importance for the analysis of subspecialty exams, 
as for example the 3D depiction and quantification of lung emphysema. 
Learning Objectives: 
1. To learn about different developments in creating 3D anatomical and 
functional models for diagnostic and therapy planning purposes. 
2. To understand the pros and cons of such technologies. 
3. To appreciate that automated 3D image analysis will lead to new ways in 
which diagnosis and therapy planning will be performed. 
  








  T. Frauenfelder: Other; Bayer. 
09:44  
Panel discussion: Will we still look at 2D images in 10 years' time?  
Image interpretation of 3D results: from image reading to volume reading.  
08:30 - 10:00 Room M 3 
Interventional Radiology  
RC 109  
Portal hypertension and interventional 
radiology (IR)  
A-050 08:30  
Chairperson's introduction  
A. Mizzi; Msida/MT (adrianmizzi@yahoo.co.uk)  
Portal hypertension is characterized by high pressure in the hepatic portal 
venous circulation. Clinically significant portal hypertension is diagnosed when 
the hepatic venous pressure gradient (HVPG) exceeds 10 mmHg. It may be 
caused by hepatic, pre-hepatic or post-hepatic aetiologies. Diagnostic 
radiology plays a crucial role in establishing the aetiology, identifying 
complications and in planning management. Interventional radiology (IR) plays 
a major role in both the diagnostic and therapeutic management of portal 
hypertension. HVPG measurement is a minimally invasive IR technique that 
establishes the diagnosis of portal hypertension. Different therapeutic IR 
procedures may be used in different clinical scenarios and have replaced more 
invasive open surgical techniques. The hepatobiliary radiologist is a key player 
in the multidisciplinary team caring for patients with portal hypertension. The 
imaging findings of portal hypertension and the different IR procedures used in 
this condition will be discussed during this session. Emphasis will be made on 
the practical aspects of interventional radiology procedures, including 
transjugular intrahepatic portosystemic shunt (TIPS), variceal embolization, 
splenic artery embolization and balloon-occluded retrograde transvenous 
obliteration (BRTO) - including their indications, methodology, complications, 
and clinical outcomes.  
Session Objectives: 
1. To appreciate the role of multidisciplinary treatment of portal hypertension. 
2. To learn about imaging and intervention in portal hypertension. 
3. To discuss outcomes of interventions in portal hypertension. 
A-051 08:35  
A. Imaging of portal hypertension  
I. Bargellini; Pisa/IT (irenebargellini@hotmail.com)  
Portal hypertension (PH) represents a fearful complication of several diseases 
(most frequently liver cirrhosis), associated with high morbidity and mortality. 
Definitive diagnosis of PH is based on the measurement of hepatic venous 
pressure gradient (HVPG). PH is diagnosed by measuring a HVPG higher than 
5 mmHg, it is considered clinically significant when HVPG is higher than 10 
mmHg and severe when HVPG is above 12 mmHg. A direct relation has been 
demonstrated between HVPG and risk of variceal bleeding, hepatic 
decompensation and liver related mortality, and HVPG has become a 
surrogate endpoint in the assessment of treatment response and reduction of 
risk of liver-related mortality. However, HVPG measurement is invasive, is not 
routinely available and it is reliably standardized only in expert centers. Thus, 
non-invasive methods, such as elastography, are under investigation, in the 
attempt to diagnose and grade PH, and to predict presence, extent and risk of 
variceal bleeding. Non-invasive imaging, such as ultrasound (US), computed 
tomography (CT) and magnetic resonance imaging (MR) may enable diagnosis 
of PH through the identification of complications (such as varices, 
splenomegaly, ascites). The anatomic information provided by these imaging 
modalities becomes essential to identify the causes of PH and when treatment 
planning is required (such as in patients indicated for TIPS or candidate for 
liver transplantation). Imaging plays a crucial role also to assess response to 
treatment and post-treatment complications.  
Learning Objectives: 
1. To appreciate imaging features of portal hypertension. 
2. To discuss the appropriate choice and timing of imaging technique in 
investigation of portal hypertension 
and its complications. 
3. To learn about relevant findings that influence therapy choice in portal 
hypertension. 
Author Disclosure: 
  I. Bargellini: Advisory Board; Bayer Spa. Speaker; GE Healthcare, BTG, 
Sirtex Medical. 
A-052 08:58  
B. Embolisation of varices and splenic artery in portal hypertension  
I.E. Keussen; Lund/SE (inger.keussen@med.lu.se)  
Portal hypertension is most common secondary to liver cirrhosis, however it 
can also be caused by portal/splenic vein thrombosis or occlusion. A bleeding 
secondary to portal hypertension, usually originates from esophageal or gastric 
varices, other sites may be duodenal, stomal or rectal varices. A bleeding from 
esophageal varices is primarily most often treated endoscopically with 
sclerotherapy or rubber banding. Gastric varices are less prevalent, but more 
difficult to treat endoscopically. If medical and endoscopic treatment methods 
fail, interventional treatment is the next option, which includes embolisation of 
varices, TIPS, BRTO and partial splenic arterial embolisation. Embolisation of 
varices may be performed by percutaneous or transjugular-transhepatic 
approach, but transsplenic route or direct puncture of the stomal varices are 
also reported. A BRTO may be applied in patients with a splenorenal shunt and 
secondary gastric varices. Partial splenic embolisation may decrease inflow of 
blood to the portal vein and secondary decrease the portal hypertension. In 
most cases a combination of different techniques is necessary to achieve good 
results.  
Learning Objectives: 
1. To discuss the rationale for embolisation. 
2. To learn about the selection of technique and choice of material. 
3. To understand outcomes from embolisation techniques. 
A-053 09:21  
C. Transjugular intrahepatic portosystemic shunt (TIPS): critical appraisal 
of techniques and guidelines for treatment  
A. Krajina; Hradec Králové/CZ (antonin.krajina@fnhk.cz)  
TIPS is a minimally invasive method of creating a portosystemic shunt for 
decompression of portal hypertension (PH). A side-to-side shunt of determined 
diameter is created to shunt blood flow from the portal vein (PV) to hepatic vein 
or inferior vena cava above the liver using transjugular approach, long needle, 
balloon angioplasty, and stent-graft. The most often indication for TIPS is 
cirrhotic ascites, which is sometimes combined with severe hydrothorax. 
However, TIPS is used in those patients who are intolerant of repeated large-
volume paracenthesis. TIPS has been used as a rescue treatment in rare 
cases of endoscopically uncontrollable variceal bleeding, especially from 
gastric fundal varices. Emergent TIPS (in 72 hours) performed in patients with 
severe PH and high risk of early rebleeding, has been proved to have better 
bleeding control and survival in 1 year. Partial or complete PV thrombosis does 
not change usual technique of TIPS. TIPS is technically difficult in chronic 
extrahepatic PV obstruction, in children, and in patients with massive hepatic 
veins thrombosis (Budd-Chiari Syndrome - BCS). The absence of hepatic veins 
and distorted anatomy due to the caudate lobe hypertrophy requires 
sometimes direct transcaval approach to the PV in patients with BCS. 
Moreover, these patients must be anticoagulated life long due to underlying 
hypercoagulopathy. TIPS demonstrated good control of ascites and reversal of 
liver failure in large series of patients with BCS. All patients with TIPS must be 
followed regularly in specialized multidisciplinary center, and the surveillance of 
TIPS function is mandatory.  
Learning Objectives: 
1. To discuss the selection of patients for TIPS. 
2. To learn about the techniques for TIPS formation. 
3. To discuss outcomes of TIPS and role of imaging surveillance. 
09:44  
Panel discussion: Appropriate selection of patients for IR including the 
role of balloon-occluded retrograde transvenous obliteration (BRTO) for 














08:30 - 10:00 Room M 4 
E³ - ECR Academies: Chest Imaging  
E³ 118  
Lung cancer in the era of molecular 
oncology and immune therapy  
A-054 08:30  
Chairperson's introduction  
H. Prosch; Vienna/AT (helmut.prosch@meduniwien.ac.at)  
Lung cancer is the most common cause of cancer-related death in Western 
countries. In the last several years, a number of new drugs have revolutionized 
systemic therapy in lung cancer. These new therapies can be divided into two 
major groups, the targeted therapies and the immunotherapies. Targeted 
therapies, such as EGFR tyrosine kinase inhibitors, or ALK inhibitors, are a 
class of drugs that specifically target a well-defined molecular pathway. They 
have been shown to be more effective than classic chemotherapies in patients 
who harbor the specific mutation and are associated with fewer toxicities. As 
these drugs target molecules with a specific mutation, patients who harbor this 
specific mutation need to be identified. In addition to bronchoscopy, image-
guided biopsies are the main modality for obtaining tissue for molecular 
analysis. Imaging may have a potential role in identifying tumors that harbor a 
specific mutation, and thus, in guiding further pathologic and genetic work-up. 
Immunotherapy, however, targets immunological pathways to induce an 
immunological response against tumors. Immunotherapy has been shown to 
be a very effective treatment in a subset of patients with non-small cell cancer. 
Imaging plays a major role in the follow-up evaluation of patients undergoing 
immunotherapy, as immune reactions must be differentiated from disease 
progression.  
A-055 08:35  
A. Lung adenocarcinomas with EGFR mutations  
M. Lederlin; Rennes/FR (Mathieu.LEDERLIN@chu-rennes.fr)  
Adenocarcinoma is the most prevalent type of lung cancer, showing a large 
spectrum of genetics, histologic subtype, CT appearance, clinical behavior and 
prognosis. Activating mutations of EGFR are found in 30%-50% of lung 
adenocarcinomas in East Asian patients and approximately 15% in Caucasian 
patients. EGFR mutation status is correlated with nonsmoking status, female 
sex, lepidic subtype, and high response rate to EGFR tyrosine kinase inhibitors 
(TKI). Some CT findings have shown to be associated with EGFR mutation 
such as nonsolid or mixed ground-glass opacity, air bronchogram, smaller and 
peripheral tumors, and pleural retraction. Furthermore, non-smoking patients 
presenting with diffuse miliary metastatic disease at diagnosis may be 
diagnosed with adenocarcinoma harboring EFGR mutation and may show 
dramatic response to EGFR-TKI. The most common resistance mechanism to 
EGFR-TKI is the T790M mutation, against which new irreversible TKIs have 
been found to be clinically effective, thus increasing demand for rebiopsy in 
progressive NSCLC to analyze mutational status. Rebiopsies are feasible and 
informative in most of patients with acceptable rates of complications. 
Furthermore, continued EGFR-TKI therapy may be indicated beyond RECIST 
progression, because these tumors grow slowly and some tumor cells remain 
sensitive to EGFR-TKI. Radiologists should also be aware of the risk of class-
effect toxicity of EGFR-TKI, in particular pneumonitis with an incidence rate of 
4-5% in the Japanese population. Finally, European radiologists should keep in 
mind that a majority of studies dealing with EGFR mutations in 
adenocarcinomas arise from Asian countries with results that might not be 
transposable to Caucasian populations. 
Learning Objectives: 
1. To be aware of the importance of detecting EFGR mutation. 
2. To learn about demographic and CT features suggestive of EGFR mutation. 
3. To learn about the various initial and follow-up CT features. 
A-056 09:03  
B. ALK-rearranged lung adenocarcinomas  
M. Silva; Parma/IT (mariosilvamed@gmail.com)  
The 2-7% of non-small cell lung cancers (NSCLC) harbor the rearrangement of 
anaplastic lymphoma kinase (ALK) - an oncogene related to a tyrosine kinase 
pathway - notably in adenocarcinoma histology and in non-smokers (about 
60% of all ALK-rearranged NSCLC). Target therapy by tyrosine kinase 
inhibitors (TKI) is clinically available for ALK-positive advanced NSCLC and 
improves progression-free survival (PFS) compared with previous reference 
chemotherapy. Hence, testing for mutations is paramount for optimal planning 
of medical treatment of advanced NSCLC. In the face of a better disease 
control by TKI, however, it happens that ALK-positive tumors are prone to 
driver mutation with resistance to first-line TKI, in the first months of therapy. In 
clinical practice, diagnostic imaging, notably computed tomography (CT), has 
high yield in the management of patients under target therapy. The CT 
evidence of disease progression, either local or systemic (note: brain 
metastases are relatively common because first-line TKIs have low trespassing 
coefficient through emato-encephalic barrier) is paramount for timely 
adaptation of therapy. Rapid radiologic progression demands prompt TKI swap 
towards second-line (e.g., ceritinib, brigatinib, or alectinib) or third-line target 
therapy (e.g., lorlatinib) or otherwise. Re-biopsy is suggested to pitch the 
optimal second (or further) line therapy by continuous molecular testing. In 
clinical trials, again, diagnostic imaging has high yield in the assessment of 
target therapies, namely for definition of PFS. Adverse events occur in a 
minority of patients under TKI (1% incidence of lung toxicity). Therapy 
discontinuation is usually sufficient to reduce toxic effects, with only 3-6% of 
cases lingering after therapy withdrawal.  
Learning Objectives: 
1. To learn about clinicopathologic features characterising ALK-rearrangement. 
2. To understand the impact of ALK rearrangement on the prognosis of non-
small cell lung cancer. 
3. To see some illustrative cases. 
A-057 09:31  
C. PD-L1 positive lung tumours  
O.L. Sedlacek; Heidelberg/DE (sedlaczek@web.de)  
Immune checkpoint inhibitors (ICI) are effective in the treatment of many 
cancers, blocking immunosuppressive pathways; they play a increasing role in 
the first-line treatment of lung-cancers. This is particularly true when there is 
evidence for a significant pretreatment tumor lymphocytic infiltration and/or 
tumors exhibit a positive staining for PD-L1. As ICIs work through a different 
mode of action there is good reason to use therapy response criteria other than 
RECIST. In contrast to cytotoxic agents anti-tumour response in 
immunotherapy may take longer and in the initial phase the response to 
immune therapies can manifest in a morphologic “progressive disease”, 
therefore, called “pseudoprogression”. In this situation a early discontinuation 
of the treatment would not be appropriate, unless PD is confirmed. “Clinically 
insignificant” PD may even include the detection of new lesions ("unconfirmed 
progression") that may not lead immediately to a discontinuation of the 
oncologic regiment and has to be reevaluated. As ICIs act through a different 
mechanism than cytotoxic agents or tyrosine inhibitors, deblocking the immune 
system a broad spectrum of auto immune diseases can be triggered. Imaging 
characteristics of frequent and serious immune-related adverse events (irAEs) 
will be discussed.  
Learning Objectives: 
1. To know about the impact of PD-L1 positivity. 
2. To know how to evaluate the tumour response after immunotherapeutics. 
3. To be aware of the imaging features of immune therapy complications.  
08:30 - 10:00 Room M 5 
Molecular Imaging  
RC 106  
Merging the best: hybrid imaging  
Moderator:  
G. Antoch; Düsseldorf/DE  
A-058 08:30  
A. Hybrid imaging with SPECT/CT  
A. Scarsbrook; Leeds/UK (a.scarsbrook@nhs.net)  
Latest generation SPECT/CT cameras incorporate multi-detector CT and state-
of-the-art gamma camera technology in tandem. These scanners improve the 
efficacy of a wide variety of nuclear medicine tests by providing more accurate 
localisation of lesions, exclusion of potentially misleading physiological uptake, 
characterisation of equivocal or indeterminate activity and detection of 
additional lesions. In addition, they offer the potential for a more efficient "one-
stop-shop" imaging approach. Iterative reconstruction algorithms and faster 
processing power facilitate radiation dose reduction and increased image 
resolution. The clinical utility of SPECT/CT is diverse and a cross-spectrum of 
applications in musculoskeletal, oncological, cardiological, endocrine, hepato-
biliary and GI tract imaging will be presented.  
Learning Objectives: 
1. To learn the basic principles of hybrid SPECT/CT imaging. 
2. To understand what complementary information can be given by 
SPECT/CT. 
3. To learn about clinical applications of SPECT/CT. 
  







A-059 09:00  
B. Hybrid imaging with MR/PET  
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de)  
In this talk an overview on the technological state of the art in PET-MRI as well 
as an outlook on emerging new technologies will be provided. Concerning the 
latter in particular new PET-insert solutions will be highlighted that are tailored 
to specific medical applications and body parts. Besides this, there will be a 
brief overview on new detector setups providing higher sensitivity and spatial 
resolution as well as on the methods to improve absorption correction and 
quantification. In the final part of the talk the focus will be set on the medical 
applications of PET-MRI. In this context, it will be discussed, which applications 
inevitably demand for PET-MRI hybrid imaging. Thus, with this talk I will try to 
convince the audience of the high development potential and clinical value of 
PET-MRI and its future role in patient management.  
Learning Objectives: 
1. To learn the basic principles of hybrid MR/PET imaging. 
2. To understand what new information can be given by MR/PET. 
3. To learn about emerging clinical applications of MR/PET. 
A-060 09:30  
C. Hyperpolarised MRI  
F.A. Gallagher; Cambridge/UK (fag1000@cam.ac.uk)  
There is increasing evidence to support a role for metabolism in many 
diseases; for example, deregulation of cellular energetics is now considered to 
be one of the key hallmarks of cancer. There are a number of imaging methods 
that have been used to probe this metabolism: the most widely available is 
18F-fluorodeoxyglucose (FDG), an analogue of glucose, used in PET. 
Hyperpolarised carbon-13 MRI (13C-MRI) is an emerging molecular imaging 
technique for studying cellular metabolism, particularly in the fields of oncology 
and cardiology. This method allows non-invasive measurements of tissue 
metabolism in real-time. To date, the most promising probe used in conjunction 
with hyperpolarised MRI has been 13C-labelled pyruvate: pyruvate is 
metabolised into lactate in normal tissue in the absence of oxygen, but in 
tumours this occurs very rapidly even in the presence of oxygen. Results from 
many animal models have shown that there is a reduction in the metabolism of 
pyruvate to lactate following successful treatment with chemotherapy. In the 
heart, pyruvate is also metabolised to carbon dioxide in addition to lactate and 
this balance between anaerobic and aerobic metabolism alters in many 
disease states. There are now a small number of sites performing human 
hyperpolarised carbon-13 MRI imaging. This talk will discuss the progress that 
has been made in this field within the areas of oncology and cardiology and 
potential clinical applications.  
Learning Objectives: 
1. To learn the basic principles of hyperpolarisation. 
2. To understand what new information can be given by hyperpolarised MRI. 
3. To learn about oncological and non-oncological applications of 
hyperpolarised MRI. 
Author Disclosure: 
  F.A. Gallagher: Research/Grant Support; GE Healthcare, GSK. 
10:30 - 12:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 221  
Musculoskeletal radiology: inflammation  
A-061 10:30  
A. Inflammatory and infections in the soft tissues  
S. Martin; Palma de Mallorca/ES (silvia.m.martin@gmail.com)  
The diagnosis of infections is based on the presence of clinical symptoms like 
erythema, swelling, and pain. Also the diagnosis is based on the presence of 
clinical signs such as fever, tachycardia, shock, and hypotension and 
laboratory test such as leukocytosis, C protein reactive and Erythrocyte 
sedimentation rate. However, the clinical symptoms and signs of infection may 
not be specific, especially in the early stages of the disease. In these cases, 
imaging tests play a fundamental role in the early diagnosis of infections and in 
the differential diagnosis. The most important radiological findings for 
inflammatory and infections soft tissue are: (1) intramuscular fluid collections; 
(2) soft tissue air; (3) fascial fluid collections; and (4) muscle edema. Potential 
causes of these radiological findings are diverse, including, infectious, 
autoimmune, inflammatory, neoplastic, neurologic, traumatic and iatrogenic 
conditions. Some of these conditions require prompt medical or surgical 
management, whereas others do not benefit from medical intervention. 
Necrotizing fasciitis is a rare, life-threatening soft-tissue infection and a medical 
and surgical emergency that radiologist must know. The presence of gas within 
the necrotized fascia is characteristic, but may be lacking. The main finding is 
thickening of the deep fascia due to fluid accumulation and reactive hyperemia. 
All these findings may be seen in other different conditions. The ability to 
accurately diagnose these conditions is therefore necessary, and biopsy may 
be required to establish the correct diagnosis. Clues to the correct diagnosis 
and whether biopsy is necessary or appropriate are often present on the 
images techniques, especially when they are correlated with clinical features.  
Learning Objectives: 
1. To learn the key signs for differential diagnosis. 
2. To learn about imaging findings and management options. 
A-062 11:15  
B. Arthropathies  
U. Aydingoz; Ankara/TR (uaydingo@hacettepe.edu.tr)  
Arthritis is a common problem involving the joints in the axial and/or 
appendicular skeleton across all age groups. Imaging plays a key role in the 
diagnosis and management of arthropathies, which are generally divided into 
degenerative, inflammatory, and metabolic categories. Digital radiography is 
the main imaging tool for joint diseases. Magnetic resonance imaging (MRI), 
computed tomography and ultrasonography are also used along with digital 
radiographs in the initial diagnosis and follow-up of joint diseases. The 
multiplicity and distribution of the involved joints, the pattern of joint space 
narrowing, and periarticular bone and soft tissue changes are important 
considerations for radiological diagnosis. The involvement of a single joint with 
inflammatory arthritis requires the exclusion of infection, whereas c 
involvement with degenerative arthritis may be due to an identifiable remote 
trauma. Septic arthritis does not have a pathognomonic radiological finding 
and, in the presence of clinical suspicion for infection, imaging should not delay 
joint fluid aspiration for microbiological investigation. This interactive session 
will cover the radiographic clues of arthropathies and the use of cross-sectional 
imaging methods, especially MRI, for suggesting the likely diagnosis. Some 
conditions, such as rotator cuff arthropathy and degenerative disease of the 
medial compartment of the knee secondary to medial meniscus posterior root 
avulsion, that have typical MRI findings shedding light on the pathophysiology 
of arthropathies will also be addressed.  
Learning Objectives: 
1. To explain the key points in the differential diagnosis of common 
arthropathies. 
2. To describe the imaging findings of common arthropathies as they relate to 
pathophysiology. 
10:30 - 12:00 Room F1  
E³ - Rising Stars Programme: Basic Sessions  
BS 2  
Gastrointestinal: 'the gut'  
Moderator:  
B. Marincek; Kilchberg/CH  
A-063 10:30  
Oesophagus  
S. Romano; Naples/IT (stefromano@libero.it)  
In this presentation focused on the first segment of the alimentary tract, current 
imaging techniques for evaluation of normal anatomy will be considered and 
described. From conventional radiography to modern hybrid imaging, essential 
information regarding the methods will be included. The second part of the 
lecture will describe the imaging features in most common benign pathologies, 
to give the attending useful informations for the daily clinical practise. Elective 
and Emergency conditions for the evaluation of the oesophagus will be 
considered. Finally, a pictorial guided review of the imaging features of 
malignant pathologies will be done.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe the imaging features in most common benign pathologies. 











A-064 10:53  
Stomach  
M. Laniado; Dresden/DE (michael.laniado@uniklinikum-dresden.de)  
Today, the stomach is well accessible for endoscopic evaluation. Therefore, 
double-contrast barium studies of the stomach have almost completely 
disappeared from the armamentarium of imaging studies in radiology. 
However, abdominal computed tomography (CT) - not so much magnetic 
resonance imaging (MRI) - has become the number one procedure in many 
scenarios if ultrasonography fails to provide a conclusive diagnosis. As the 
stomach is always imaged when abdominal CT is performed knowledge of 
normal anatomy, incidental findings, and the most often benign and malignant 
gastric pathologies is mandatory. Depending on the clinical request, imaging 
techniques are slightly different. If the main focus is on a lesion of the stomach, 
maximum wall distention should be achieved by oral administration of up to 2 L 
of water shortly before the study and i.v. administration of a hypotonic agent. In 
addition, i.v. administration of iodinated contrast material is mandatory. The 
presentation will cover normal anatomy of the stomach including locoregional 
lymph nodes. Examples of common and uncommon gastric lesions (e.g., 
carcinoma, lymphoma, GIST, NET, metastases, ulcer, portal gastropathy, 
pneumatosis, ischemia, pseudocysts) will be shown and discussed. Also 
examples of postoperative anatomy and potential complications will be part of 
the presentation.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe the imaging features in most common benign pathologies. 
3. To review and illustrate the imaging features of malignant pathologies.  
A-065 11:15  
Small bowel  
N. Papanikolaou; Lisbon/PT 
(nickolas.papanikolaou@research.fchampalimaud.org)  
Magnetic resonance imaging (MRI) provides excellent soft-tissue contrast 
without radiation exposure and three-dimensional imaging capabilities, which 
are important when studying the small intestine. Various sequences and 
contrast agents have been proposed for MRI examination of the small bowel. 
The development of high performance gradient systems improved the 
performance of ultra fast sequences and allowed comfortable breath-hold 
acquisition times. For a more detailed evaluation of small bowel diseases, MRI 
examination should be performed in conjunction with duodenal intubation and 
administration of a suitable contrast agent, i.e., iso-osmotic water solution 
(PEG) for homogeneous lumen opacification and adequate distention. A 
comprehensive MR enteroclysis imaging protocol should comprise single shot 
turbo spin echo (SSTSE), diffusion weighted imaging, true FISP, HASTE and 
fat suppressed T1 FLASH sequences. SSTSE is utilized for monitoring the 
infusion process and performing MR fluoroscopy while true FISP and HASTE, 
classified as sequential ultra fast techniques insensitive to motion, are mainly 
used for anatomic demonstration and detection of the pathology. T1 FLASH 
sequences after intravenous gadolinium injection may aid tissue 
characterization. For the assessment of Crohn’s disease activity other 
alternative techniques may be used including perfusion and calculation of the 
magnetization transfer ratio of the bowel wall. These techniques may be useful 
for differentiating edematous or inflammatory bowel thickening from fibrotic 
thickening, but a more extensive evaluation is required to determine the clinical 
utility of these methods.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe the imaging features in most common benign pathologies. 
3. To review and illustrate the imaging features of malignant pathologies. 
Author Disclosure: 
  N. Papanikolaou: Advisory Board; Advantis. CEO; MRIcons. 
A-066 11:38  
Colon  
R.G.H. Beets-Tan; Amsterdam/NL (r.beetstan@nki.nl)  
Ultrasound, CT and MRI has a role in the workup of diseases of the large 
bowel. Transabdominal US is accurate to detect appendicitis. Contrast 
enhanced CT identifies the causes of bowel obstruction and dilatation. CT 
shows postoperative complications such as leakage of surgical anastomosis, 
internal herniation, bowel strangulations ,and bowel ischemia. Inflammation of 
the bowel, diverticulitis, epiploic appendagitis are well detected on CT. While 
endorectal US and MRI have been widely adopted in the staging work up of 
rectal tumors, the role of imaging in Colon cancer is limited to preoperatively 
roadmap the extent of the tumor into surrounding structures and to identify 
distant disease. Nevertheless this role may increase in the near future. This 
lecture will deal with various diseases of the colon and its imaging features and 
highlights future direction in imaging of colon cancer.  
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal anatomy. 
2. To describe the imaging features in most common benign pathologies. 
3. To review and illustrate the imaging features of malignant pathologies.  
10:30 - 12:00 Room M 4 
E³ - ECR Academies: Chest Imaging  
E³ 218  
CT of vascular pulmonary diseases  
A-067 10:30  
Chairperson's introduction  
J.D. Dodd; Dublin/IE  
Pulmonary vascular disease includes a wide spectrum of disease entities, 
many of which have overlapping clinical and imaging features. CT of the 
pulmonary vasculature has become an integral part of the investigation of such 
entities. In this session we are going to evaluate three distinct disease sub-
categories of pulmonary vascular disease: pulmonary arterial hypertension, 
pulmonary vasculitis and Rendu-Osler disease. The first talk will cover 
pulmonary hypertension, the current clinical classification of pulmonary 
vasculitis, CT signs suggestive of the diagnosis, and CT signs that help 
discriminate between different causes. The comprehensive nature of CTPA in 
evaluating the mediastinum, vasculature and lung parenchyma will be shown. 
The second talk covering pulmonary vasculitis will emphasise the importance 
of combining CT signs with the clinical features and laboratory results since 
vasculitis may mimic other disorders and sometimes the clinical features are 
the major clue. CT findings in granulomatosis with polyangiitis and eosinophilic 
granulomatosis with polyangiitis will be shown, particularly emphasising the 
imaging differences between the two entities. The imaging findings of 
pulmonary hemorrhage will also be shown alongside the commonest causes. 
Finally the association between interstitial lung disease and the ANCA 
associated vasculitis will be discussed. The third talk covering Rendu-Osler 
disease will show the typical imaging features of this disease with a particular 
emphasis on those imaging aspects that determine outcome and treatment 
strategies. The talk will also cover contemporary aspects of endovascular 
treatment modalities and their complications.  
A-068 10:35  
A. CT imaging of pulmonary hypertension  
N.J. Screaton; Cambridge/UK (Nicholas.Screaton@papworth.nhs.uk)  
Pulmonary hypertension (PH) typically presents insidiously with non-specific 
symptoms and is usually progressive with poor outcome independent of 
aetiology. CT plays a vital role both in suggesting the possibility of pulmonary 
hypertension, whether initially clinically suspected or not, and in identifying a 
specific cause of pulmonary hypertension. The causes of pulmonary 
hypertension can be broadly divided into those affecting primarily the small 
vessels, PH secondary to left heart disease or chronic lung disease / hypoxia 
(the most common causes), chronic thromboembolic PH, and multifactorial 
causes. CT is widely available, inexpensive, and permits comprehensive 
assessment of the heart, pulmonary vasculature and lung parenchyma. CT 
signs such as dilatation of the proximal pulmonary arteries and right heart 
chambers can be considered as generic features associated with PH of any 
cause. Signs of a specific cause may lie in the mediastinum (left heart disease, 
shunt, oesophageal varices, oesophageal dilatation), vasculature (signs of 
CTEPH, tumour, large vessel vasculitis, fibrosing mediastinitis) or lungs 
(parenchymal lung disease, mosaic perfusion in CTEPH, signs of a small 
vessel vasculopathy). CTEPH is a not uncommon sequela of previous acute 
embolism. If the distribution is proximal it is potentially cured by surgical 
pulmonary endarterectomy or by balloon pulmonary angioplasty. Imaging in 
general and CT in particular play fundamental roles in both identification of 
CTEPH, its differentiation from acute PE, and in characterising its distribution. 
Imaging signs in CTEPH can be subtle and systematic evaluation of a CTPA is 
essential.  
Learning Objectives: 
1. To learn about the CT signs of pulmonary hypertension (PHT). 
2. To become familiar with the current classification of PHT. 











A-069 11:03  
B. Evaluating the pulmonary vasculitis  
E. Castañer; Sabadell/ES (ecastaner@tauli.cat)  
We will emphasize the importance of combine CT signs with the clinical 
features and laboratory results as vasculitis may mimic other disorders and 
sometimes the clinical features rate the clue. We will describe the findings in 
granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with 
polyangiitis, highlighting the differences. Diffuse alveolar hemorrhage (DAH) is 
one of the manifestations of primary pulmonary vasculitis, among other entities 
(idiopathic alveolar hemorrhage, collagen vascular diseases, drug reactions, 
anticoagulation disorders). GPA and microscopic polyangiitis are the most 
common causes of DAH. Radiologic signs of DAH are nonspecific and 
variable, but must be considered in patients with otherwise unexplained 
alveolar infiltrates, particularly when seen with new onset renal insufficiency or 
a connective tissue disease. Finally we will mention the association between 
interstitial lung disease and ANCA associated vasculitis.  
Learning Objectives: 
1. To learn the common imaging features of granulomatosis with polyangitis 
(GPA). 
2. To learn how to differentiate between GPA and eosinophilic granulomatosis 
with polyangiitis (Churg-Strauss). 
3. To learn about the imaging features and differential diagnosis of pulmonary 
haemorrhage. 
A-070 11:31  
C. Rendu-Osler disease  
S.D. Qanadli; Lausanne/CH (Salah.Qanadli@chuv.ch)  
Rendu Osler disease (ROD) is an autosomal dominant genetic disorders 
characterized by the presence of telangiectasias and/or arteriovenous 
malformations. Pulmonary arteriovenous malformations (PAVM) are observed 
in up to 80% in ROD patients and it is believed that up to 30% of ROD patients 
will develop PAVM. During the last decade CT became the standard of 
reference in assessing pulmonary and associated subphrenic anomalies in 
patients with ROD. This lecture will focus on current protocols and 
recommendations for CT depending on the objective of the examination 
(screening, diagnostic or follow-up). Typically, PAVM is a well circumscribed 
rounded lesion that is connected to an afferent feeding artery and an enlarged 
efferent vein. PAVMs can be focal, multiple or diffuse. Imaging features as well 
as a comprehensive classification is provided. In asymptomatic patients, the 
risk of complications was reported to be high in PAVMs with an afferent artery 
diameter of 3 mm or more. The role of CT is then not only crucial in diagnosis, 
but also in therapeutic decision making process even if the 3 mm threshold 
concept in matter of debate and controversies. Principles of endovascular 
management of PVAM are reviewed. The transarterial access is the most 
common procedure. The modern approach includes the use of coils and/or 
plugs. CT flow up studies aim diagnosis of early complications, PAVM 
reperfusion detection, surveillance of small PAVMs, and diagnosis of new 
PAVMs. 
Learning Objectives: 
1. To become familiar with the CT manifestations of this disease. 
2. To identify imaging features determining outcome and treatment strategies. 
3. To learn about endovascular treatment modalities and complications. 
12:30 - 13:30 Room C 
E³ - The Beauty of Basic Knowledge: Cardiovascular and 
Interventional Radiology  
E³ 24A  
No time to lose: aortic dissection - 
revisited  
Moderator:  
M. Krokidis; Cambridge/UK  
A-077 12:30  
Acute diagnosis and imaging in aortic dissection  
R. Iezzi; Rome/IT (roberto.iezzi.md@gmail.com)  
Aortic dissection is the most common acute emergency condition of the aorta, 
often resulting in the death of the patient. The overall outcome is determined 
by the type and extent of dissection and the presence of associated 
complications; therefore, evaluation of the entire aorta, branch vessels, and 
iliac and proximal femoral arteries is recommended to aid in treatment 
planning. Early diagnosis and treatment are essential for improving the 
prognosis. Patients may present with the classic history of acute onset of 
tearing central chest pain that radiates to the back. Stanford type A dissection 
involves the ascending thoracic aorta, and the dissection flap may extend into 
the descending aorta. Type A dissections account for 60%-70% of cases, 
requiring urgent surgical intervention to prevent extension into the aortic root, 
pericardium, or coronary arteries. If untreated, type A dissections are 
associated with a mortality rate of over 50% within 48 hours. Stanford type B 
dissection involves the descending thoracic aorta distal to the left subclavian 
artery and accounts for 30%-40% of cases. Management takes the form of 
medical treatment of hypertension, unless there are complicazioni due to 
extension of the dissection. CT imaging of the aorta is fast and widely 
available, which are the important features in making an accurate diagnosis 
quickly in unstable patients. Multidetector CT allows imaging of the entire aorta 
with rapid acquisition and data reconstruction to provide prompt and accurate 
diagnosis and to help identify relevant complications that may have an impact 
on treatment and management.  
Learning Objectives: 
1. To learn about definition and classification of aortic dissections and 
subtypes. 
2. To understand the importance of accurate diagnosis for appropriate 
treatment planning. 
3. To appreciate the need for acute diagnosis and treatment indication. 
A-078 13:00  
Endovascular treatment in aortic dissection  
J.P. Schäfer; Kiel/DE 
Acute aortic dissection represents a life-threatening condition, which must be 
diagnosed immediately. CTA is considered the imaging modality of choice, 
offering all relevant information on the pathoanatomy with highest spatial 
resolution. Stanford classification is used to distinguish between type A- and B-
dissections, whereas the left subclavian artery represents the border in 
between the two types. Actually, surgical repair is the method of choice and 
indicated in type Adissection, and endovascular repair is the method of choice 
in type B-dissection, if indicated. Type Bdissection may be uncomplicated or 
complicated. For uncomplicated type B, best medical treatment is the method 
of choice, and it is defined by no further symptoms, relief of symptoms and 
absence of additional dissection associated findings. For complicated type B, 
endovascular repair including a variety of interventions is the method of choice, 
and it is defined by mesenterial, renal, peripheral and spinal malperfusion, 
progressive dissection, aneurysm forming, uncontrollable hypertension, 
rupture, progressive periaortic and pleural haemorrhage, severe hypotension 
and shock. Regarding symptom onset and imaging based diagnosis, type B-
dissection is classified as acute (<2 weeks), subacute (2-8 weeks), and chronic 
(>8 weeks). Endovascular repair usually includes prosthesis placement in the 
descending aorta, in order to seal the proximal entry tear. This excludes the 
perfusion of the false lumen along the covered aortic segment and restores the 
blood flow into the true lumen, maintaining and improving the visceral and 
peripheral perfusion. Additionally, target visceral artery stenting, membrane 
fenestrating or embolising may be indicated. Protocolled CTA follow-up is 
mandatory.  
Learning Objectives: 
1. To learn about endovascular treatment possibilities for aortic dissections. 
2. To understand the role of radiology in modern treatment of aortic 
dissections. 
3. To appreciate the need to combine the radiological information with the 
clinical situation. 
12:30 - 13:30 Room D  
E³ - The Beauty of Basic Knowledge: A Survival Guide to 
Musculoskeletal Imaging  
E³ 25A  
Degenerative disorders  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK  
A-079 12:30  
Degenerative disorders  
A. Cotten; Lille/FR (anne.cotten@chru-lille.fr)  
Osteoarthritis is the most common joint disease worldwide. It is a major source 
of pain, disability, and socioeconomic cost. The epidemiology of the disorder is 
complex and multifactorial, with genetic, biological, and biomechanical 
components. Conventional X-ray is the standard diagnostic method to confirm 
the clinical diagnosis, to evaluate the degree of severity of osteoarthritis and to 
look for predisposing conditions. CT can be performed for the assessment of 
  







bone stock, anatomic conditions and bone deformation. MRI can be used to 
confirm early forms and to clarify possible damage and/or wear and tear, which 
cannot be seen on X-rays. Finally, intraarticular administration of contrast will 
be performed in selected cases, when a precise assessment of the cartilage or 
fibrocartilage is required. This lecture will focus on the role of imaging in clinical 
practice, the typical and atypical imaging features of OA, the radiological 
features which should not be read as OA, and the main predisposing factors 
that have to be known and searched.  
Learning Objectives: 
1. To appreciate the musculoskeletal imaging manifestations of degenerative 
disorders. 
2. To understand the underlying pathomechanisms involved in these imaging 
abnormalities. 
3. To appreciate the strengths and weaknesses of imaging modalities in 
assessing these disorders. 
14:00 - 15:30 Room F1  
E³ - Rising Stars Programme: Basic Sessions  
BS 3  
Neurologic emergencies  
Moderator:  
N. Chidambaranathan; Chennai/IN  
A-080 14:00  
Brain injury  
J. Walecki; Warsaw/PL  
Head injuries are one of the most frequent causes of death and disability. The 
following presentation will discuss the indications for imaging in patients with 
traumatic brain injury(TBI), review the role of X-ray examination, computed 
tomography (CT) and magnetic resonance imaging (MRI) in the management 
of TBI. CT still remains the method of choice in brain injury diagnosis and 
allows rapid assessment of the extent and type of brain pathology which 
ensures us which patients require urgent surgical intervention. There are many 
CT structural modalities such as MPR, volume rendering and CT angiography 
important in particular cases of traumatic patients. In addition to above, author 
will also discuss TBI diagnosis in MRI applications which are newly applied to 
clinical practice like TDI, fMRI and analyse potential applications of these 
imaging modalities. Using a complex variety of MR sequences, we can provide 
data concerning both structural and pathophysiological derangements. Future 
developments with such imaging techniques could improve understanding of 
the pathophysiology of brain injury and provide data that improve management 
and prediction of functional outcome. In this presentation all type of brain injury 
and its imaging features will be presented. Goals and objectives - to 
understand the mechanisms of traumatic brain injury - to learn about CT and 
MR imaging findings in different traumatic lesions of the brain - to be familiar 
with advantages and disadvantages of different imaging techniques in 
traumatic brain injury  
Learning Objectives: 
1. To review mechanisms of brain injury. 
2. To present current imaging techniques for evaluation of brain injury. 
3. To illustrate different types of traumatic intracranial lesions. 
A-081 14:30  
Subarachnoid haemorrhage  
C. Calli; Izmir/TR (cem.calli@gmail.com)  
Subarachnid hemorrhage (SAH) is a very common and life-threatining disease. 
It occurs most commonly secondary to trauma and intracranial vascular 
abnormalities. The early diagnosis is very important and imaging modalities 
have an important role. Non-contrast CT (NCCT) should be the first choice for 
imaging. It can provide the visualisation of hyperdense blood products in the 
cisterns and sulci. In cases of negative NCCT scan, MRI may be a choice, 
especially in patients in the subacute phase using FLAIR and SWI sequences. 
However, every case with non-traumatic SAH should be examined with digital 
substraction angiography (DSA) in order to exclude a vascular abnormality, 
particularly aneurysm. In this lecture both common and uncommon causes of 
SAH will be discussed and a multi-modality approach to the diagnosis will be 
reviewed. 
Learning Objectives: 
1. To review the most common pathologies leading to SAH. 
2. To present current imaging techniques for evaluation of SAH. 
3. To describe the radiological findings of SAH. 
 
A-082 15:00  
Ischaemic stroke  
Z. Merhemic; Sarajevo/BA (merhemic.zulejha@gmail.com)  
CT is primary imaging modality in patients with acute stroke. The early signs of 
brain infarction on non contrast CT are insular ribbon sign reflect cytotoxic 
edema and relates to specificity of of arterial anatomy.Disappearing basal 
ganglia sign is caused my MCA occlusion proximally to lenticulostriate artery. 
Early mass effect includes narrowing of Sylvian fissure or loss of cortical sulci. 
Hyperdense artery sign represent stasis of flow due to arterial thrombus and 
correlates positively with angiographic finding of occlusion. CTA is essential for 
evaluation of intra- and extracranial vessels and intravascular thrombi. 
Conventional MRI finding in acute stroke are hyperintense zones on T2 and 
FLAIR, mass effect, sulcal effacement, loss of arterial flow voids, and abnormal 
blooming and parenchymal black dots due to the hemorrhage on T2*GE and 
SWI. DWI with ADC maps is most sensitive for detection of hyperaute stroke at 
first 6 hours. In ischemic stroke, reduction of perfusion occurs, typically in an 
affected vascular territory. Regions with hypoperfusion are shown as 
decreased CBF, decreased CBV, prolonged MTT, and prolonged measures of 
contrast transit such as TTP, Tmax or DT. Since these parametric changes are 
detectable minutes after stroke onset, they are of great use for early diagnosis 
of ischemic stroke and to differentiate ischemic penumbra from infarct core. 
There are two perfusion approaches with good application in acute stroke, MR 
perfusion and CT perfusion. Compared the two methods, CT perfusion (CTP) 
has the advantage of rapidity and wide accessibility in emergency room 
together with CTA which may be used to guide thrombolytic treatment and may 
guide predictions of functional outcome and hemorrhagic complications.  
Learning Objectives: 
1. To become familiar with the most common aetiologies of stroke. 
2. To present current imaging techniques for evaluation of stroke. 
3. To recognise the imaging signs of stroke. 
14:00 - 15:30 Room M 4 
E³ - ECR Academies: Chest Imaging  
E³ 318  
MR imaging of the lungs  
A-083 14:00  
Chairperson's introduction  
E.J.R. van Beek; Edinburgh/UK (edwin-vanbeek@ed.ac.uk)  
MRI of the lungs is increasingly used for a variety of reasons. In some 
diseases, it can be used as an escape from harmful radiation, such as in young 
or pregnant patients with suspected pulmonary embolism. This is being 
extended by short, focused protocols as a first line test in some centres. In 
other diseases, it is the "go to" modality; for instance, in patients with superior 
sulcus tumours or where difficult anatomical structures need to be evaluated 
before treatment decisions can be made. Lastly, airway imaging and evaluation 
of dynamics of breathing can be assessed using novel methods. This session 
will go into detail for the three areas described.  
Author Disclosure: 
  E.J.R. van Beek: Advisory Board; Aidence BV. Equipment Support Recipient; 
Siemens Healthineers. Founder; QCTIS Ltd. Owner; QCTIS Ltd. 
A-084 14:05  
A. Diagnosing pulmonary embolism  
B. Ghaye; Brussels/BE (benoit.ghaye@uclouvain.be)  
Twenty-five% of patients suspected of PE may present with contraindication to 
iodinated CM which indicates a potential role for MR. Recent MR technical 
refinements have been substantial in this field with faster sequences, larger 
coverage, lung perfusion imaging and high-resolution pulmonary MR 
angiography (MRA). Basic sequences for PE include unenhanced SSFP and 
3D GRE pulmonary MRA. Technically inadequate examinations are reported in 
25-30%, mainly due to poor vascular opacification and artifacts. MR direct 
signs of acute PE are similar to those of CT, including partially occluding 
endoluminal filling defects and complete arterial obstruction showing a 
meniscus termination outlining the clot. Reported sensitivity and specificity of 
MRA in large series were around 80% and 95-100%, respectively. Sensitivity 
decreases from central to lobar level (close to 100%), segmental level (70-
90%) and subsegmental level (30%). Unenhanced MRA has 82% sensitivity 
and 90% specificity in the 50% interpretable examinations, showing a similar 
decrease of sensitivity from proximal to distal level. Perfusion also showed 
75% sensitivity and 90% specificity in the 50% interpretable examinations. 
Similar to CT, MR can provide alternative diagnoses or ancillary findings 
  







altering the management of the patient. A comprehensive assessment of the 
venous thromboembolic disease may be achieved by the addition of a MR 
venous phase without further injection of Gadolinium CM. The sensitivity of the 
combined test may however be increased at the expense of a higher rate of 
technically inadequate examinations. It is expected that newer 3D MR 
angiography sequences will increase yield in the field of venous 
thromboembolism.  
Learning Objectives: 
1. To learn about the various MR sequences for pulmonary arteries imaging. 
2. To become familiar with the MR signs of pulmonary embolism. 
3. To understand the current limitations of MR for PE diagnosis. 
A-085 14:33  
B. Evaluating lung neoplasms  
J. Dinkel; Munich/DE  
The purpose of this presentation is to review the currently available MR 
techniques useful in thoracic oncology and to provide an overview of present 
and emerging clinical applications of oncologic thoracic MRI. Although many 
studies have advocated a valuable role for thoracic MRI, it has currently limited 
clinical utilization with the exception of cardiovascular imaging. However, new 
technical developments and MRI sequences have continuously improved the 
quality and broadened the clinical indications for thoracic MRI, especially in 
thoracic oncology. Furthermore, due to its high soft tissue contrast and the lack 
of radiation exposure, MRI allows for repeated measurements of the lung 
structures and, therefore, appears to be appropriate for functional investigation 
of lung.  
Learning Objectives: 
1. To review the role of MR for assessing the T status. 
2. To learn about MR diffusion sequence performance for N staging. 
3. To review the persisting limitations. 
A-086 15:01  
C. Evaluating the airways  
G. Dournes; Bordeaux/FR (gael.dournes@chu-bordeaux.fr)  
Due technical difficulties related to motions and susceptibility artifacts, MR 
imaging has long been considered out of the scope of routine application in the 
field of imaging of airways, except in a few expert centers. However, recent 
improve and simplification in MR acquisition techniques have enabled MRI to 
reach high resolution imaging for morphological evaluation of both large and 
small airways. In addition, acute and chronic airway diseases are largely 
misunderstood by far, so that the ability of MRI to combine both morphology 
and functional information in a single radiation-free examination will eventually 
make MRI a modality of choice for better understanding, improving patient care 
and long term follow up requiring iterative examinations. Finally, recent 
advances in treatment are also prone to make radiologist reconsider the role 
and place of imaging in chronic diseases (cystic fibrosis, idiopathic pulmonary 
fibrosis, etc) to assess sensitively and specifically response to treatment. 
Learning Objectives: 
1. To review the role of MR for evaluating the large and small airways. 
2. To learn about the current state-of-the-art MR sequences. 
3. To learn about the current role of MR in cystic fibrosis.  
14:00 - 15:30 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 320  
Diffuse liver disease  
A-087 14:00  
Chairperson's introduction  
C. Triantopoulou; Athens/GR (ctriantopoulou@gmail.com)  
The session is focused on the different aspects of diffuse liver disease. An 
update in non-invasive imaging will be offered in detail, pointing mainly to fat, 
iron, and fibrosis deposition and the accuracy of quantitative methods in 
disease grading and severity assessment. Non-alcoholic fatty liver disease is 
the most common cause of chronic liver disease in Western countries. US, CT 
and MRI are used to evaluate the disease, to assess severity, and quantify the 
amount of fat deposition. Despite advances in imaging techniques accurate 
measurements are still challenging, and new evolving methods are applied on 
US and MRI. MRI remains the gold standard and the method of choice, 
answering the clinically important questions. Congenital diffuse liver diseases 
comprise some rather uncommon conditions, while iron overload is related to a 
variety of congenital and hereditary conditions. Differential diagnosis is of 
outmost importance for patients’ management. MRI is the method of choice to 
evaluate and quantify iron overload provided that specific imaging protocols 
are used and the standardized techniques together with validated acquisitions 
are applied. Diagnosis and staging of liver fibrosis is one of the most 
challenging aspects of non-invasive imaging. Current application of US and 
MRI are nowadays able to provide accurate measurements based on US and 
MRI elasticity tools. “Virtual biopsy” refers to the possibility of imaging 
techniques to depict, map and measure fibrosis minimizing the need for liver 
biopsies in chronic diffuse liver diseases. MR allows an accurate determination 
of steatosis, iron overload and fibrosis, even if they coexist.  
A-088 14:05  
A. Assessment and quantification of fat in NAFLD  
M. Ronot; Clichy/FR (maxime.ronot@bjn.aphp.fr)  
The diagnosis of steatosis in patients with NAFLD is historically based on 
histological examination of a tissue specimen obtained by liver biopsy. 
However, liver biopsy has well-known limitations (invasiveness and sampling 
variability) and cannot be proposed for all patients, especially given the high 
prevalence of NAFLD worldwide. Several imaging techniques can be used for 
the non-invasive diagnosis and quantification of steatosis. Ultrasonography 
and computed tomography are useful for the detection of marked steatosis, but 
of limited use for precise quantification of mild to moderate fat deposition. MR 
proton spectroscopy (MRS) is the most accurate technique, but it is not 
feasible in routine use and is time consuming. Chemical shift sequences offer 
now an accurate alternative and have been shown to be very well correlated to 
MRS and liver biopsy. As a consequence, they are progressively accepted as 
a reference technique for detection and quantification of hepatic fat deposition. 
Recently, novel parameters, such as the controlled attenuation parameter 
(CAP), or the speed of sound estimation have been proposed and offer 
promising results. As for liver fibrosis, the diagnostic strategy should rely on the 
combination of several non-invasive techniques.  
Learning Objectives: 
1. To be familiar with the pathogenesis of NAFLD. 
2. To recognise current non-invasive imaging methods used to evaluate 
hepatic steatosis. 
3. To realise the clinical applications, diagnostic accuracy and limitations of 
each method. 
A-089 14:33  
B. Congenital diffuse liver diseases and iron overload  
M.M. França; Porto/PT (mariamanuela.franca@gmail.com)  
Congenital and inherited hepatic diseases, like congenital hepatic fibrosis, 
Wilson disease or hereditary hemochromatosis, are rare diffuse liver diseases 
that may progress to cirrhosis. Liver imaging, particularly magnetic resonance 
(MR) imaging, provides important information on diffuse parenchymal 
abnormalities, but may also reveal focal liver lesions. Iron overload is found in 
hereditary hemochromatosis, but also in transfusional hemosiderosis and iron 
loading anemias, and chronic liver diseases. Quantification of liver iron 
concentration by MR imaging is crucial for the diagnosis and treatment 
monitoring of iron overload diseases. MR quantification of liver iron can be 
performed with signal intensity ratio (SIR) methods or relaxometry techniques. 
Both R2 and R2* values are increasingly being used for quantification of liver 
iron concentration, but they must be performed with validated acquisition and 
analysis protocols. Hereditary hemochromatosis will be presented as an 
example of a clinical scenario, to emphasize the relevance of MR for detection 
and quantification of liver iron deposits and its role in patients’ management 
and treatment monitoring.  
Learning Objectives: 
1. To recognise specific imaging findings in patients with congenital hepatic 
diseases such as Wilson's disease and congenital hepatic fibrosis. 
2. To be able to determine iron content in liver by MRI. 
3. To be able to differentiate common focal lesions found in storage disease of 
the liver. 
A-090 15:01  
C. Diagnosis and staging of liver fibrosis  
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es)  
Chronic liver disease is a major public health problem with an increasing 
prevalence and an emergence clinical interest. Fat, inflammation and iron 
deposits induce an oxidative stress on the liver with synergistic effects in the 
progression of fibrosis and cirrhosis. In this sense, it is well known that around 
7% of the adult population without known liver disease have liver fibrosis, 
mostly associated with NAFLD. The up-till-now gold standard biopsy is limited 
by sample size (1/50.000); sample quality; sampling variability errors (30-
40%); inter- and intraobserver variability (>30%); morbidity (1%); and not being 
  







feasible for follow-up and research studies. Therefore, radiologists need to 
understand the hallmarks and therapeutic implications of liver fibrosis. 
However, correlation with pathology is troublesome, unless digital pathological 
quantitation is achieved. In this way, radiologists need to depict, map and 
measure fibrosis in chronic liver disorders to initiate treatment and evaluate 
response. The fat-suppressed T2w, STIR, and equilibrium phase DCE T1w 
images show fine hyperintense reticular septa. These changes are late in the 
course of disease. Although diagnostic accuracy by texture analysis might be 
earlier (skewness, GLGM categories). T1 MR imaging is also able to detect 
early liver fibrosis as correlates with collagen content. Elasticity can be 
measured with US and MR elastography. IVIM elasticity measures can be also 
incorporated into the imaging armamentarium. All this radiomic and imaging 
biomarkers features have different reproducibility and accuracy, but can be 
excellent tools for the non-invasive diagnosis, follow-up, and treatment 
evaluation metrics in liver fibrosis.  
Learning Objectives: 
1. To be able to understand the clinical relevance of detection, characterisation 
and grading of liver fibrosis. 
2. To recognise the imaging techniques that have an emerging role in non-
invasive assessment of liver fibrosis. 
3. To be able to detect portal hypertension. 
16:00 - 17:30 Room B 
Abdominal Viscera  
RC 401  
Imaging of the complicated postoperative 
abdomen  
A-095 16:00  
Chairperson's introduction  
C.J. Zech; Basle/CH (christoph.zech@usb.ch)  
Imaging of the postoperative abdomen is a crucial part in the evaluation of 
postoperative complications and will lead the clinician in the decision for 
treatment of postoperative complications with either re-laparotomy, 
interventional-radiology treatment or conservative/medical treatment. 
Knowledge of the performed surgical techniques and procedures, the normal 
imaging appearance postoperative and typical findings of frequent 
complications are inevitable to successfully treat patients with complications. A 
good interaction between the surgeon and the abdominal radiologist is needed. 
Nowadays, radiology should be able to diagnose most complications and 
minimise the number of mere diagnostic laparoscopies to evaluate a 
complicated postoperative clinical course.  
Session Objectives: 
1. To learn about the most common indications for abdominal surgery. 
2. To understand the normal imaging findings in postoperative abdomen. 
3. To describe and identify the most common postoperative complications. 
Author Disclosure: 
  C.J. Zech: Speaker; Bayer HealthCare. 
A-096 16:05  
A. Liver  
C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es)  
Liver resection is proven to achieve long term survival in selected patients with 
primary or secondary focal liver lesions. Advances in surgical techniques 
including robotic liver surgeries, systemic adjuvant chemotherapy and 
postoperative intensive care improved the outcome of liver resection. Adequate 
liver remnant is crucial to guarantee the correct liver function after radical 
potentially curative liver resection. In borderline cases, portal vein embolisation 
(PVE), or associating liver partition and portal vein ligation for staged 
hepatectomy (ALPPS) has been proposed before surgery to increase the liver 
remnant. Preoperative volumetric analysis of the liver based on imaging plays 
an essential role in the preoperative work-up previous to liver resection. Also 
the knowledge of the vascular hepatic anatomy and possible variants of the 
biliary system are also key aspects to avoid postoperative complications. 
Imaging tools based on multidetector computed tomography (MDCT) and 
magnetic resonance (MR) influencing preoperative decisions and surgical 
approaches will be discussed. The role of different imaging techniques as plain 
ultrasonography (US), contrast enhanced ultrasonound (CEUS), MDCT and 
MR for the detection and management of hepatic complications after liver 
resection or transplantation (infectious, vascular, biliar, parenchymatous (liver 
rejection) will be analysed. 
 
Learning Objectives: 
1. To learn about indications for liver interventions and different surgical 
approaches to focal liver lesions. 
2. To understand the role for the different imaging techniques (US, CEUS, CT 
and MRI) in assessing different types of complications. 
3. To appreciate the spectrum of parenchymal, biliary and vascular 
complications occurring after liver resection or transplantation. 
A-097 16:28  
B. Pancreas  
R.M. Gore; Evanston, IL/US (rgore@uchicago.edu)  
Both benign and malignant pancreatic disease carry significant morbidity and 
mortality. Because of the fastidious nature of the pancreas and its local and 
regional anatomy, treatment of these disorders also carries significant 
morbidity. Indeed, perioperative morbidity of pancreaticoduodenectomy is 
approximately 30-40%. Due to the diversity of pathology, detection, and 
characterisation of postoperative complications can be challenging. Familiarity 
with the normal imaging appearances of the spectrum of surgical procedures 
and their complications is vital. In this presentation the common pancreatic 
surgical procedures performed for tumour resection (i.e., the Whipple’s 
operation, enucleation, central and distal pancreatectomy, spleen preserving 
distal pancreatectomy) and chronic pancreatitis (i.e., Puestow procedure, 
Beger procedure, Frey procedure) and their normal postoperative appearances 
are discussed. The common postsurgical complications including pancreatic 
fistulas and leaks, abscess formation, haemorrhage, and delayed gastric 
emptying are then described in detail.  
Learning Objectives: 
1. To learn about the various surgical approaches for acute and chronic 
pancreatitis, benign and malignant pancreatic neoplasms. 
2. To understand profound impact that the partial and complete 
pancreatectomy have on the adjacent abdominal organs. 
3. To appreciate the common postoperative complications of pancreatic 
surgery. 
A-098 16:51  
C. Bowel  
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk)  
Post operative assessment of the luminal GI tract is very complex and relies 
heavily on CT. It presents a major challenge for interpretation and detection of 
abnormalities in the context of a very broad range of normal post operative 
appearances. In judging whether the imaging appearances are normal or not it 
is essential to consider the time that has elapsed since the operation and the 
complexity of the procedure that was performed, since a straight forward 
procedure or one performed laparosscopically with carbon dioxide insufflation 
should have very little residual fluid or gas, compared with a complex open 
surgical procedure. Anastomotic leak is the most important complication to 
detect, and in this regard positive luminal contrast is the most sensitive for 
evaluation and this can be administered orally or rectally depending on the 
position of the anastomosis. An 8% concentration of 300mg/ml concentration 
non ionic contrast is used by the author. Other complications such as abscess 
can be detected by CT but this must be differentiated from haemostatic 
surgical material which is left in situ deliberately.  
Learning Objectives: 
1. To learn about the most common types of major oesophago-gastric, small 
bowel and colorectal surgical procedures and the expected postoperative 
anatomy and imaging findings. 
2. To understand how to optimise imaging protocols to maximise the 
opportunity to detect postoperative complications after enteric surgery. 
3. To appreciate and identify early and late complications after bowel surgery. 
17:14  














16:00 - 17:30 Room C 
Chest  
RC 404  
CT - patterns in chest radiology: back to 
basics and beyond  
A-099 16:00  
Chairperson's introduction  
M.A. Mazzei; Siena/IT (mmazzei@sirm.org)  
Today the majority of diagnosis in chest radiology is accomplished by high-
resolution computerised tomography (HRCT) and advanced HRCT imaging 
interpretation which have improved a lot the accuracy in diagnosing diffuse 
lung diseases, such as interstitial pneumonia, thus avoiding the need for a 
surgical biopsy in many patients. All this can be possible because of the 
anatomical distribution of the lesions often suggests the diagnosis in 
pulmonary diseases, owing to the close relationship between HRCT pattern 
and some diseases and also because of the exact depiction of pulmonary 
anatomy at HRCT imaging. For this reason the knowledge of anatomy in 
reading CT is essential for radiologists: recognising the anatomical distribution 
of lesions or a typical pattern at HRCT imaging is the key to a successfully 
correct diagnosis.  
Session Objectives: 
1. To emphasise the importance of anatomy in reading CT. 
2. To appreciate the necessity of defining patterns to improve CT diagnoses. 
A-100 16:05  
A. Secondary pulmonary lobule anatomy: essential to tackle with the 
nodular pattern  
T. Frauenfelder; Zurich/CH (thomas.frauenfelder@usz.ch)  
The goal of this lecture is to provide information about the anatomy of the lung 
and to provide a structured approach to nodular pattern. High-resolution CT 
gives detailed morphologic information about lung structures. This allows 
distinguishing findings by their typical predominance in certain anatomical 
compartments. The secondary pulmonary lobule is the functional unit of the 
lung and is the key to HRCT terminology. The anatomy of secondary lobule, 
therefore, plays a key role. Based on the distribution of nodular lesions in 
relation to the bronchial, vascular and lymphatic structure of the secondary 
lobule the number of possible pathologies can be narrowed down. For 
example, centrilobular predominance of nodules is a frequent sign of 
bronchiolitis. Perilymphatic predominance in the periphery of the lobules is 
associated with sarcoidosis or lymphangitic spread of cancer. Random 
distribution of nodules is interpreted as a sign of haematogenic spread of 
disease. Therefore, a subtle interpretation can contribute substantially to 
clinical decision making. Nevertheless, these signs may not always replace 
biopsy and histologic workup. Sometimes is it can be difficult to determine the 
pattern of lung nodules within the secondary pulmonary lobule. By following a 
consistent approach it will minimise the difficulty in interpretation. During this 
lecture, a stepwise algorithm for differentiating nodular pattern will be provided 
that allows a pragmatic approach for a successful reading of HRCT. 
Learning Objectives: 
1. To become confident in recognising the anatomical compartments of the 
lung. 
2. To describe typical nodular imaging patterns of lung disease using 
appropriate terminology. 
Author Disclosure: 
  T. Frauenfelder: Other; Bayer. 
A-101 16:28  
B. Linear and reticular pattern  
F. Molinari; Lille/FR (francescomolinari.dr@gmail.com)  
The reticular pattern is one of the imaging findings that may suggest the 
presence of a diffuse parenchymal lung disease at HRCT. Reticulations are 
typically formed by a collection of innumerable small linear opacities that by 
summation produce an appearance resembling a "net". Lines may vary from 
smooth to nodular and irregular. The resulting "net" may alter the normal HRCT 
appearance of the lung and become suspected for an underling lung disease. 
Chest radiologists typically use a structured approach to interpret this finding 
and eventually to propose a diagnosis. The radiologic approach consists in 
identifying the dominant types of lines, in establishing what portion of the lung 
interstitium is predominantly involved, and in correctly classifying the type of 
reticulation (namely inter-lobular, peri-lobular, intra-lobular). When all the 
radiologic features are correctly interpreted, the radiologist can differentiate 
reticulations that represent an acute disease from those that indicate a chronic 
inflammatory or fibrotic change in the lung. In addition, by integrating clinical 
and laboratory data, it is possible to significantly narrow the final differential 
diagnosis.  
Learning Objectives: 
1. To recognise and interpret typical reticular imaging patterns. 
2. To differentiate acute and chronic diseases which cause septal patterns. 
A-102 16:51  
C. Ground glass opacities (GGO) and consolidation  
J. Vogel-Claussen; Hannover/DE (vogel-claussen.jens@mh-hannover.de)  
Ground glass opacity (GGO) is a nonspecific finding on computed tomography 
(CT) scans of the chest that indicates a partial filling of air spaces in the lungs 
by exudate or transudate, as well as interstitial thickening or partial collapse of 
lung alveoli. The term derives from the similarity in appearance of the small 
objects to small chips of glass that are a by-product of glass grinding. The 
differential diagnosis of the many causes of GGO includes pulmonary oedema, 
infections (including cytomegalovirus and Pneumocystis jirovecii pneumonia), 
various noninfectious interstitial lung diseases (such as hypersensitivity 
pneumonitis, Hamman-Rich syndrome), diffuse alveolar haemorrhage, and 
cryptogenic organising pneumonia. Thus, clinical correlation and disease 
dynamics are important to narrow down the differential diagnosis. The aim of 
this refresher course is to distinguish ground glass opacities from 
consolidations on chest CT and give practical instructions for daily clinical 
routine.  
Learning Objectives: 
1. To appreciate different conditions which cause GGO pattern and 
consolidation. 
2. To learn how to interpret GGO and consolidation in different clinical settings. 
Author Disclosure: 
  J. Vogel-Claussen: Advisory Board; Bayer. Board Member; IWPFI. 
Consultant; Novartis, Boehringer Ingelheim. Grant Recipient; Siemens. 
17:14  
Panel discussion: Is it always easy to detect a pattern? Tips for success  
16:00 - 17:30 Room X  
Joint Session of the ESR Working Group on Ultrasound with 
EFSUMB  
WG/EFSUMB 1  
Elastography of superficial structures: 
where are we now?  
Moderators:  
M. Claudon; Vandoeuvre-les-Nancy/FR  
P.S. Sidhu; London/UK  
A-103 16:00  
Thyroid US elastography: indications and limitations  
V. Cantisani; Rome/IT (vito.cantisani@uniroma1.it)  
Thyroid gland examination by palpation is a basic method in the assessment of 
thyroid nodules as firm and anelastic lesions should be suspected being of 
malignant nature. On the other hand, US, despite its high sensitivity for the 
detection of thyroid lesion, has limited accuracy to differentiate benign and 
malignant lesions. Indeed, to date, FNAC is still considered the gold standard 
for optimal characterisation of thyroid lesions, but still in 15% to 25% of cases 
FNAC findings can be suspicious and in 5% to 15% of cases inconclusive. 
Elastography is a new imaging modality where elastic tissue parameters 
related to the structural organisation of normal and pathological tissues are 
imaged. The relationship of tissue elasticity and hardness to Cy follows the 
basic principle that to be palpable, the object must be harder than the 
surrounding tissue. The evaluation of stiffness can be qualitative with a color 
coding system or semiquantitatively by means of strain ratio or ECI or 
quantitatively (sp-SWE or 2D-SWE) . Elastography has showed good 
diagnostic values both with qualitative and quantitative modalities. However, to 
date, still some issues may be answered. The main features,the diagnostic 
accuracy and the main recognised limitations of the different elastographic 
techniques, suggesting how we can improve accuracy, and reduce 
interobserver variability will be presented. Personal experience and review of 
the literature will be provided.  
Learning Objectives: 
1. To learn about updated status on thyroid nodule evaluation by using 
TIRADS and US-elastography. 
  







2. To provide tips and tricks, guidelines established indications and limitation of 
thyroid US-elastography. 
Author Disclosure: 
  V. Cantisani: Speaker; bracco, samsung, toshiba. 
A-104 16:20  
Elastography of the breast: when should we assess tumour stiffness?  
J. Carlsen; Copenhagen/DK (jonathan.carlsen@gmail.com)  
Elastography is an adjunct to B-mode imaging in breast tumour evaluation and 
has been included in the latest BIRADS atlas of 2013. Both quantitative and 
qualitative elastography methods can be used to assess breast tumour 
stiffness, which correlates with the risk of malignancy. Elastography is easily 
performed, and is implemented in most new ultrasound systems, but 
depending on the elastography method used, different diagnostic cut-offs or 
visual scoring systems are used. As a stand-alone examination elastography is 
inferior to B-mode imaging, but in combination with B-mode imaging, 
elastography may be used to determine weather or not to perform biopsies or 
do follow-up examinations in low-suspicion tumours. Different ways of 
combining the two diagnostic methods have been proposed, and the diagnostic 
algorithms will vary depending on the clinical practice and setting used. It is 
therefore important, to understand the different elastography methods, their pit-
falls and limitations.  
Learning Objectives: 
1. To learn how to perform elastography of the breast with different US 
techniques. 
2. To learn when breast elastography is a useful adjunct to the standard breast 
ultrasound examination. 
3. To understand the potentials and limitations of breast elastography. 
A-105 16:40  
Is there any value in tendon and nerve assessment?  
A. Klauser; Innsbruck/AT  
The Achilles tendon has been the most studied musculoskeletal structure with 
strain and shear wave elastography (SWT). Alterations in strain elastograms of 
asymptomatic Achilles tendons mainly occur in the mid-portion, they do not 
always correspond to changes on conventional US. This has been correlated 
with histology, where the sensitivity of strain elastography was better than B-
mode US in Achilles tendons, flexor and extensor tendon insertions of the 
elbow for the detection of tendinotic changes. SWT confirmed and quantified 
softening within the Achilles tendon in patients and in lateral epicondylosis 
significantly lower strain ratios in the common extensor tendon origins in terms 
of tendon softening can be observed. For peripheral nerves strain elastography 
has shown, that the diagnostic accuracy of ultrasonographic assessment can 
be improved. Furthermore the stiffness of the intracarpal tunnel contents in 
untreated CTS patients is higher than that of healthy volunteers but decreases 
after corticosteroid injection. Shear-wave elastography provides a further 
exciting tool for examining nerve biomechanics; however, longitudinal studies 
are needed to elucidate clinical relevance before they can be adopted into 
routine clinical practice. To summarize, elastography can be used as a 
supplementary tool to conventional US scanning to increase the diagnostic 
confidence in diagnosing tendinopathies.  
Learning Objectives: 
1. To learn about the value of sonoelastography in musculoskeletal disorders. 
2. To understand the impact of sonoelastography in tendon and nerves. 
3. To appreciate the meaning of sonoelastographic findings in tendon and 
nerve disorders. 
4. To become familiar with sonoelastographic techniques used in tendons and 
nerves. 
A-106 17:00  
Scrotal elastography: hype or real?  
M. Bertolotto; Trieste/IT (bertolot@units.it)  
The testis is readily palpable, allowing a direct examination of masses. Hard 
lesions at palpation are considered likely malignant, until proved differently. 
Compared to palpation elastography provides a more objective evaluation of 
tissue consistency, but the information provided is basically the same. As a 
consequence, benign pathologies that are hard at palpation will display 
increased consistency at elastography as well. On contrary, malignant tumours 
may display soft areas, or appear globally soft. Correlation with histologic 
features helps explain these discrepancies, and changes in time of 
elastographic appearance of evolving lesions. Use of elastography in 
evaluation of diffuse testicular pathologies affecting endocrine function and 
spermatogenesis is undergoing investigation in an attempt to find new clinically 
useful independent parameters. A quantitative evaluation of testicular stiffness 
is feasible using shear-wave modes. In preliminary experience, the elasticity 
pattern of the testis seems to be related to the volume and function. 
Elastography, in particular, seems promising to differentiate azoospermia from 
different causes. The clinical impact of these findings in the current practice is, 
however, questionable and technical optimization is necessary.  
Learning Objectives: 
1. To learn about how to perform elastography of the testis with the different 
US equipment. 
2. To become familiar with the appearance of normal testis at strain and at 
shear wave elastography. 




16:00 - 17:30 Room O  
Paediatric  
RC 412  
Vascular and interventional radiology in 
children  
Moderator:  
E. Alexopoulou; Athens/GR  
A-107 16:00  
A. Common IR procedures in children: state-of-the-art  
A. Barnacle; London/UK (Alex.Barnacle@gosh.nhs.uk)  
Interventional radiology (IR) procedures are now a vital part of paediatric care 
for most complex diseases, providing reliable intravenous access and feeding 
tube support during intensive therapy such as chemotherapy and delivering 
innovative minimally invasive therapies for other conditions to avoid surgery. 
Central venous access in children can be technically challenging, but is quicker 
and less invasive than open surgical techniques and there is evidence to 
suggest that the central veins are preserved for longer, which is key in children 
with chronic disease. Looking beyond central venous access, paediatric IR 
delivers therapies such as sclerotherapy for vascular malformations, 
percutaneous nephrolithotomy (PCNL) for renal stone extraction, oesophageal 
dilatations to manage oesophageal structures and biopsy to safely and 
accurately stage childhood tumours.  
Learning Objectives: 
1. To learn about the most common causes for image-guided intervention in 
children. 
2. To understand how the practical and technical approach to intervention in a 
child differs from that in adults. 
3. To appreciate tips, tricks and pitfalls in the paediatric intervention. 
A-108 16:30  
B. Vascular malformations: diagnosis and interventions  
N.N. 
Learning Objectives: 
1. To learn about the classification of paediatric vascular malformations. 
2. To understand the diagnostic work-up and the indications for percutaneous 
treatment of paediatric vascular malformations. 
3. To appreciate the treatment options for different vascular malformations. 
A-109 17:00  
C. Percutaneous treatment of osteoid osteoma  
D. Filippiadis; Athens/GR (dfilippiadis@yahoo.gr)  
Percutaneous treatment of osteoid osteoma. Osteoid osteoma is a benign 
inflammatory bone tumor encompassing 2-3% of all bone tumors and 10% of 
benign bone tumors; it is most common in males < 25 years of age with 
patients typically complaining of pain that worsens at night and is promptly 
relieved by salicylates. The tumor was first reported by Jaffe in 1953; osteoid 
osteoma is composed of the nidus which is bone at various maturity stages 
surrounded by highly vascular connective tissue stroma. Depending on the 
location and axial imaging findings, osteoid osteoma can be classified into 
subperiosteal, intracortical, endosteal or intramedullary, and intra-articular with 
the latter being the least common type and refers to lesions located within or 
near a joint. In the literature there are scarce studies with limited patient 
number reporting disappearance of the pain post conservative therapy even if 
the imaging findings remain with no change; however, the long term use of 
  







NSAIDs can result in potential complications and additionally there is a chance 
of muscular atrophy and bone deformity in ages<5 years. The application of 
radiofrequency ablation (RFA) was introduced in clinical practice by Rosenthal 
in 1992 performing a percutaneous approach for the treatment of osteoid 
osteoma. Nowadays thermal ablation of osteoid osteoma constitutes a first line 
therapy. Numerous studies upon all ablation techniques, others with lesser and 
others with higher numbers of patients report high pain reduction rates (up to 
96%) and low recurrence rates (~7% at 2 years). Comparing percutaneous 
ablation to the traditional surgical techniques for osteoid osteoma (wide 
excision removing a bone block, marginal resection of the entire nidus, 
curettage or high speed burr techniques) favors percutaneous approach in 
terms of minimum trauma, minimum functional restriction and significantly 
lower cost.  
Learning Objectives: 
1. To learn about the treatment options for osteoid osteomas. 
2. To understand the techniques for percutaneous treatment of osteoid 
osteoma: preparations, procedure and follow-up. 
3. To appreciate advantages and potential complications in percutaneous 
treatment of osteoid osteoma in children. 
16:00 - 17:30 Room N  
Head and Neck  
RC 408  
Pathways for tumour spread  
Moderator:  
J. Huyskens; Antwerp/BE  
A-110 16:00  
A. Pathways for oral cavity and oropharynx tumour spread  
A. Borges; Lisbon/PT (borgalexandra@gmail.com)  
90% of oral cavity and oropharyngeal malignancies originate from the epithelial 
lining and spread superficially along the mucosa and deeply into the 
submucosa, adjacent muscles, bone, and along cranial nerves. As local 
tumour staging is based on size, depth of invasion and involvement of adjacent 
structures, imaging is crucial in this regard. There are 8 tumour subsites in the 
oral cavity each with different patterns of spread and different implications on 
management. Those with direct impact on surgical management are the 
midline raphe, extrinsic tongue muscles, bone and oropharyngeal spread. 
Tumours of the retromolar trigone disseminate in a complex pattern as they lay 
in the crossroad between the oral cavity, masticator space and oropharynx. 
Patients tend to present in late stages, often with trismus. Whereas tumours of 
the superior alveolar ridge can invade the maxilla and spread along the 
superior alveolar nerves and V2, tumours of the inferior alveolar ridge can 
invade the mandible, the inferior alveolar nerve and spread along V3. Invasion 
of the neurovascular tongue bundle prone tumours to spread along the lingual 
or hypoglossal nerves. There are 4 different oropharyngeal subsites. The 
palatine tonsil has the highest association with lymph node metastases. Local 
spread is through the palatoglossus muscle and transgression of the 
constrictor muscles and pterygomandibular raphe lead to tumour extent into 
the retromolar trigone and pterygoid plates. Tongue base tumours can spread 
anteriorly to the tongue root and floor of the mouth and posteriorly into the 
supraglottic larynx. Palatal tumours spread inferiorly into the palatine fossa, 
laterally into the parapharyngeal space and are prone to perineural spread 
along the greater and lesser palatine nerves.  
Learning Objectives: 
1. To become familiar with the anatomy of the oral cavity and oropharynx. 
2. To learn which imaging technique to use. 
3. To understand the typical local and remote spread of oral cavity and 
oropharynx tumours. 
A-111 16:30  
B. Pathways for nasopharyngeal tumour spread including perineural 
spread  
M. Lell; Nuremberg/DE  
The nasopharynx is the uppermost portion of the pharynx, extending from the 
skull base to the the soft palate. Its main connections are the nasal cavity 
anteriorly and the oropharynx inferiorly. The nasopharynx is best imaged by 
MRI to detect the primary tumour, lymph node metastases as well as 
intracranial and bone invasion and perineural tumour spread (PNS). 
Nasopharyngeal cancer (NPC) frequently arises in the fossa of Rosenmuller, 
invades or displaces the parapharyngeal fat laterally and can cause obstruction 
of the Eustachian tube, leading to fluid retention in the tympanon and mastoid 
cells. Often subtle and therefore more difficult to detect than direct invasion is 
PNS. PNS most commonly occurs in a contiguous retrograde fashion from the 
primary tumour toward the intracranial compartment. PNS in NPC most 
commonly involves branches of the trigeminal and facial nerves. These 2 
nerves are responsible for most of the sensory and motor innervation of the 
face. The trigeminal nerve provides sensory information from the face and 
motor innervation to the muscles of mastication. Understanding the CN 
anatomy is critical in identifying PNS.  
Learning Objectives: 
1. To become familiar with the anatomy of the nasopharynx. 
2. To learn which imaging technique to use. 
3. To understand the typical local and remote spread of nasopharyngeal 
tumours, including perineural spread. 
A-112 17:00  
C. Pathway for laryngeal and hypopharyngeal tumour spread  
R. Kohler; Sion/CH (romain.kohler@hopitalvs.ch)  
Squamous cell carcinoma is by far the most frequent malignant neoplasm of 
the larynx and hypopharynx and imaging plays a critical role in its diagnosis 
and management as only its superficial part is accessible to endoscopic 
evaluation. The larynx and hypopharynx are both divided into three subsites 
(supraglottis, glottis, subglottis and piriform sinus, retro cricoarytenoid region 
and posterior wall, respectively). Other important landmarks are the cartilages 
(especially the thyroid and cricoid cartilages) and the paraglottic and 
preepiglottic spaces. After a short overview of the imaging techniques, we will 
discuss in detail the most important pathways of tumour dissemination of 
supraglottic, glottic, subglottic, piriform sinus, retro cricoarytenoid, and posterior 
wall cancer. Endolaryngea dissemination is from one anatomical structure to 
another in the same subsite, from one subsite to another, to the 
prepiglottic/paraglottic spaces or to the cartilages. Extralaryngeal dissemination 
means extension through the cartilages or laryngeal membranes into the soft 
parts of the neck. Criteria for cartilage invasion, dissemination to lymph nodes 
and distant metastases will also be discussed. The description of all invaded 
structures is of greatest importance for the planification of surgery or radiation 
therapy as invasion of some specific structures upstages the tumour. Finally, 
two non-epithelial malignancies with particular appearance and neoplastic 
extension are presented: lymphoma and chondrosarcoma.  
Learning Objectives: 
1. To become familiar with the anatomy of the larynx and hypopharynx. 
2. To learn which imaging technique to use. 
3. To understand the typical local and remote spread of laryngeal and 
hypopharyngeal tumours. 
16:00 - 17:30 Room L 8  
Joint Session of the ESR and ESMRMB  
ESR/ESMRMB 1  
Exploring the microscopic from 
macroscopic: the strengths of 
multiparametric MRI  
Moderators:  
D. Sappey-Marinier; Lyon/FR  
T. Leiner; Utrecht/NL  
A-113 16:00  
Modelling brain multicompartment microscopic diffusion  
C. Poupon; Gif-sur-Yvette/FR (cyril.poupon@cea.fr)  
Diffusion-weighted magnetic resonance imaging (dMRI), sensitised to the 
diffusive motion of water along the direction of an applied magnetic field 
gradient, has become a well established technique to non-invasively probe the 
cellular organisation of tissues, providing access, for instance, to the human 
brain structural connectivity in vivo. Because the contrast of results from 
restrictions of water molecule trajectories by cell membranes populating the 
tissue, it also embeds key information about the tissue at cellular scales than 
can be deciphered using advanced models. Such models rely on the use of 
several compartments corresponding to the numerous cell populations 
composing the tissue that can be modeled using analytical equations involving 
the key characteristics of the various populations, like their volume fraction or 
statistics of cell dimensions (eg axon diameter, size of neuron bodies, ...). The 
presentation will address the various models proposed in the literature to 
characterise brain white matter microstructure, including CHARMED, 
AxCaliber, ActiveAx, and how they are about to revolutionise the in vivo 
mapping of the human brain cytoarchitecture. The NODDI model also able to 
characterise the dendrite arborisation within the cortical ribbon will be 
presented too, as well as the Intra-Voxel-Incoherent-Motion model providing 
  







insights about the microvascular compartment irrigating the brain parenchyma. 
Case studies will be presented during the whole presentation to illustrate the 
strengths and weaknesses of these novel tools that progressively turns 
diffusion MRI into a virtual microscope able to perform virtual biopsies in vivo.  
Learning Objectives: 
1. To learn about the basic principles of diffusion MRI used to turn MRI into a 
virtual microscope. 
2. To understand the potential of diffusion MR microscopy to map in vivo the 
organisations of brain tissues at cellular scales. 
3. To appreciate the potential of brain microstructure maps to provide more 
specific imaging biomarkers of brain disorders. 
A-114 16:30  
How quantitative MRI reveals brain microstructure  
C. Granziera; Basle/CH (cristina.granziera@usb.ch;)  
This lecture will first introduce the difference between quantitative and 
conventional MRI, underlying the advantages and disadvantages of both. 
Then, we will focus on the biological and pathological significance of 
quantitative and semi-quantitative MRI contrasts (q/sqMRI) such as T1,T2,T2* 
relaxometry, magnetization transfer imaging, quantitative susceptibility 
mapping, and diffusion MRI. In the second part of the lecture, several 
examples will be presented related to studies where multiple q/sq MRI metrics 
were applied to answer specific pathophysiological or clinical questions in 
patients affected by neurological diseases (i.e., multiple sclerosis, stroke, 
migraine and neurodegenerative diseases). Through these exemplary studies, 
we will present the advantages and disadvantages of q/sqMRI in clinical 
research and the potential perspectives for clinical routine applications. As well 
as, we will illustrate the potential gain derived by the combination of multiple 
q/sqMRI contrasts in comparison to single contrasts approaches. Finally, on-
going developments will be presented in the field of quantitative MRI, 
especially regarding fast and robust qMRI acquisition schemes, multi-
parametric qMRI protocols as well as personalized ways of quantifying brain 
damage and repair using multiple q/sq MRI metrics.  
Learning Objectives: 
1. To learn about the biological and pathological significance of quantitative 
and semi-quantitative MRI contrasts (q/sqMRI). 
2. To understand the on-going methodological developments in the field of 
q/sqMRI. 
3. To appreciate the potential perspectives of multiple q/sqMRI contrasts for 
clinical routine applications. 
Author Disclosure: 
  C. Granziera: Patent Holder; Patent #16171060.3-1501 (07-29-2016): 
“Apparatus and method for visualizing tissue macro- and microstructure for 
pathology evaluation in magnetic resonance imaging”.. Other; Ongoing 
scientific collaborations with the ACIT Siemens-Radiology team in Lausanne 
(CH). 
A-115 17:00  
MRI of cardiac muscle microstructure  
M. Froeling; Utrecht/NL (M.froeling@umcutrecht.nl)  
Investigating microstructural changes in the heart using DWI is mostly done 
using the DTI model. However, other models are being explored, e.g. IVIM and 
DKI. DWI of the can be challenging due to its low T2 relaxation time of only 30 
to 50 ms. DWI imaging is typically done using a spin echo - echo planar 
imaging sequence (SE-EPI). The diffusion of water in the heart is fast (MD  
1.6 to 1.8 mm2/s) and the diffusion anisotropy is low (FA  0.20 to 0.4). DWI of 
the beating heart is challenging due to that the heart is always moving. 
Measuring the microscopic motion of water in the presence of macroscopic 
motion needs a different diffusion sequence design. To overcome this two 
different approaches are possible: (1) using a stimulated echo acquisition 
(STEAM) which applies the diffusion weighting over two consecutive 
heartbeats and (2) Designing the diffusion weighting wave form to become 
insensitive for macroscopic motion. Diffusion tensor imaging in the heart is of 
great interest since it allows to, next to diffusion parameters, obtain detailed 
information about the cardiac myocardial architecture. Myocytes are aligned in 
a left-handed helix in the epicardium, to circumferential in the mid wall, to a 
right handed-helix in the endocardium. The heart muscle fibers are arranged in 
a laminar structure, called sheetlets. Changes of myocardial architecture over 
the cardiac cycle during development and in pathology have been studied and 
can potentially give new insights in cardiac function and disease and monitory 
of cardiac therapy.  
Learning Objectives: 
1. To learn about the state-of-the-art quantitative diffusion MRI acquisition 
strategies to investigate cardiac and skeletal muscle. 
2. To understand the limitations of such methods and cofounding factors, such 
as noise, inflammation, fat and other artefacts. 
3. To appreciate the potential perspectives in a clinical setting. 
16:00 - 17:30 Room E1  
Breast  
RC 402  
Screening for breast cancer  
A-116 16:00  
Chairperson's introduction  
F.J. Gilbert; Cambridge/UK (fjg28@cam.ac.uk)  
In 2003 the European Council recommended implementation of screening 
according to best practice guidelines and that mammography is offered every 
two years to women between the ages of 50-70 years. Apart from the three 
yearly programme in the UK all countries offer two yearly mammography or 
digital breast tomosynthesis (DBT). Nine countries start at age 40 or 45 years 
with 18 at age 50 years. Three countries stop at 64 years, with the majority at 
stopping at age 69 years although 3 countries continue until age 74 years. 
Uptake varies between 37-85% with Latvia and Poland having the lowest 
uptakes and Finland, Ireland and Holland having the highest acceptance rates. 
Some countries offer supplemental screening with ultrasound to women with 
increased breast density. It is known that high breast density increases the 
likelihood of developing breast cancer by twofold in the over 50 year age group 
and that increased breast density increases the chance of a cancer being 
missed or not being detected until the tumour is of a larger size. Digital breast 
tomosynthesis has been shown to have increased cancer detection together 
with reduced recall rates. Some countries have adopted this technology while 
others are conducting large randomised controlled trials to establish the 
impact, costs and benefits of this more complex examination. It is important to 
ascertain that when changing an established population screening programme 
this will result in a survival benefit and not merely increase over diagnosis.  
Session Objectives: 
1. To learn about mammography screening and how it should be monitored. 
2. To understand the value of supplementary techniques and how it should be 
used in practice. 
3. To recognise that tomosynthesis presents significant advantages and 
disadvantages when used in a screening setting. 
Author Disclosure: 
  F.J. Gilbert: Equipment Support Recipient; GE Healthcare. Grant Recipient; 
GE Healthcare. Research/Grant Support; Hologic. 
A-117 16:05  
A. Screening with mammography only  
R.M. Pijnappel; Utrecht/NL (r.m.pijnappel@umcutrecht.nl)  
Screening with mammography has proven to save lives. The reduction in 
mortality is substantial. In Netherlands, woman who attend all biannual offered 
screening rounds from 50-75 years reduce their change of dying from breast 
cancer before the age of 80 with 50%. The basis for this positive effect from 
screening with mammography only is training and auditing. The shift from 
analogue form to digital between 2005-2010 has improved these results and 
showed that more high risk tumors were detected by mammography. The cost 
effectiveness of screening with mammography only is acceptable. The 
drawbacks of screening with mammography only, i.e., false positive and 
overdiagnosis will be discussed. So far, no other modality has proven to save 
lives and no information is available regarding the aggressiveness of the breast 
cancers detected by other modalities like ultrasound MRI and tomosynthesis. 
The positive predictive value of ultrasound is substantially lower and quality 
control (operator dependent) is difficult. Tomosynthesis is very promising, but 
at this moment there is very little information regarding detection in subsequent 
rounds and interval cancers. For these reasons screening with mammography 
only still is the gold standard for population based screening with an average 
risk.  
Learning Objectives: 
1. To learn about benefits and limitations of mammography screening. 
2. To become familiar with common findings, recall rates and assessment 
outcomes. 
3. To appreciate errors. 
A-118 16:30  
B. Screening with mammography and ultrasound  
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at)  
The sensitivity and specificity of mammography are limited in highly 
fibroglandular /dense breasts. Digital mammography provides increased 
sensitivity in young women and those with moderately dense breasts, and 
digital three-dimensional mammography (tomosynthesis) promises further 
  







improvement. For women with the densest breasts, however, radiography is 
unlikely to be the optimum solution. MRI, although not affected by breast 
density, is expensive and access is often limited. Ultrasonography is attractive 
for breast cancer screening because, likewise, it is not impaired by breast 
density, and it avoids the use of ionizing radiation and the need for breast 
compression. Nevertheless, enthusiasm for the use of ultrasonography has 
been limited because its specificity has been much lower than that of 
mammography, but technical developments have given rise to sharper, more 
informative images. These improvements foster the use of ultrasound 
particular in those women with higher breast density. Different trials have been 
preformed and promising results have been reported. This talk will focus on 
benefits, harms, and cost-effectiveness of supplemental ultrasonography 
screening for women with dense breasts.  
Learning Objectives: 
1. To learn about the added value of US in screening and its indication. 
2. To become familiar with the common level of evidence. 
3. To appreciate its role in clinical practice. 
A-119 16:55  
C. Screening with tomosynthesis  
U. Bick; Berlin/DE (Ulrich.Bick@charite.de)  
By eliminating ambiguity from superposition of normal breast parenchymal 
structures, digital breast tomosynthesis (DBT) holds the potential to improve 
cancer detection rates while at the same time reducing call-backs related to 
false-positive findings. The magnitude of these two effects will depend on the 
clinical setting. In European population-based screening programs, where 
recall rates are kept low, DBT will primarily increase detection rates. On the 
other hand, in screening practices with high recall rates such as North 
America, the main effect of DBT will be to lower recall rates by improving 
specificity. In screening, the advantages of DBT must be weighed against the 
potential disadvantages of DBT such as higher costs (higher equipment and 
image storage costs, longer reading times) and possible increases in radiation 
exposure, especially if DBT is used as an adjunct to 2D mammography. 
However, synthetic 2D views reconstructed from the DBT dataset can be used 
to replace 2D mammography in screening. Although depiction of subtle 
microcalcifications may be slightly inferior on synthetic 2D views, studies have 
shown no significant difference in terms of detection rates or recall frequency 
between 2D mammography and synthetic 2D views. Despite the very 
promising data from the available first DBT screening trials, which all showed a 
significant increase in detection rates with DBT, further studies are needed 
before DBT can replace 2D mammography in population-based screening 
programs. The key question still unanswered up to now is whether the 
additional cancers found by DBT are in the majority clinically relevant and 
contribute to a reduction in advanced-stage interval cancers. 
Learning Objectives: 
1. To learn about the role of tomosynthesis in the screening setting. 
2. To become familiar with the different protocols. 
3. To appreciate potential advantages of tomosynthesis in screening. 
Author Disclosure: 
  U. Bick: Patent Holder; Hologic, Inc. 
17:20  
Panel discussion: What is the best modality approach to screen for 
breast cancer?  
16:00 - 17:30 Room E2  
Professional Challenges Session  
PC 4  
Mass casualties  
A-120 16:00  
Chairperson's introduction  
M. Scaglione; Castel Volturno/IT  
Recent mass casualty incidents have raised many problems in the western 
world, requiring a wide revision of many aspects of the civil life, ranging from 
the public order to medical facilities. More specifically, this “new” emergency 
needs planning, governance, education and specifically, a new team work 
mentality. In this Session, not only the strength and limits of imaging in 
massive attacks from Paris to Brussels, Thai tsunami and migrant victims 
drowned in the Mediterranean sea will be discussed, but also the need for a 
plan and areas of improvements will be illustrated. Finally, the new roles and 
challenges for the radiologists in A&E will be pointed out.  
Session Objectives: 
1. To understand about the need of a new plan for emergency hospitals. 
2. To became familiar with the range of imaging findings related to MCI. 
3. To learn about new roles and challenges for radiologists in Europe. 
A-121 16:05  
Mass casualty incidents: the London framework for planning  
S. Vaidya; London/UK (Sujit.Vaidya@bartshealth.nhs.uk)  
Mass casualty events challenge and have a capacity to rapidly overwhelm 
healthcare systems. Over recent years, we have felt the need to have an 
organized response to major events, to effect better patient care and flow. 
Collaboration, co-operation, and meticulous planning eventually helps save 
lives and limbs. This talk will outline some of the guiding principles of this 
collaboration. There is a need for the imaging department to adapt to the 
altered demands in such situations. Our experiences, successes and 
inefficiencies will be shared with a view to understand the challenges.  
Learning Objectives: 
1. To understand the objectives of the plan. 
2. To appreciate the role of imaging in mass casualty. 
3. To provide an overview of the major incident planning in London. 
A-122 16:23  
Lesson learned from the Paris attacks  
P.A. Grenier; Paris/FR (philippe.grenier@aphp.fr)  
Following the multiple mass casualty terrorist attacks on November 13th, 2015 
in Paris, several measures have been taken in France to improve our medical 
capacity to face the unexpected. French Military Medical Service was asked to 
transfer their expertise into the civilian setting, favouring the concept of 
prehospital damage control to the civilian prehospital phase. A teaching of 
civilian surgeons, anesthesiologists, and emergency physicians by their military 
colleagues about damage control resuscitation and surgery, triage and care 
“under fire” was organized at national and regional levels. An online course is 
now accessible on demand. Dedicated teaching for all medical students and 
dedicated course in trauma management during residency have been 
implemented. Mobilization of the other regions seems to be essential to 
activate rapidly distant additional means and to identify quickly additional 
preserved resources, according to a medical strategy coordinated by 
experience health care professionals. Hospital trauma teams have improved 
their ability to triage between absolute and relative emergencies. Some 
multidisciplinary simulation exercises particularly focused on triage were 
performed. Identification of the victims was clearly a deficiency during the Paris 
and Nice attacks particularly those left dead on scene. Priority is given to 
identification process with the collection of primary identifiers combined with 
external examinations of deceased victims. During and after the attacks, a 
large number of individuals required psychological care. It requires a large 
mobilization of psychiatrists and psychologists able to cope with acute stress 
and to take on a continuous flow of patients over weeks or months.  
Learning Objectives: 
1. To learn from the terrorist attacks in Paris and Nice. 
2. To understand the planning for pre-hospital damage control, medical 
strategy for quick mobilisation of resources, training and multidisciplinary 
simulation exercises, and post-trauma psychological care. 
3. To appreciate the role of imaging in case of massive attack. 
A-123 16:41  
Postmortem imaging of migrant victims drowned in the Mediterranean 
Sea  
G. Lo Re; Palermo/IT (giuseppe.lore12@gmail.com)  
Europe is involved in a large-scale migratory flow coming from Africa and 
Middle East, and Italy is often the first step towards European countries for 
migrants. This high number of people may determine some issues related to 
public security, financial aspects, and ethical issues. In the last years, and until 
now, we have assisted to numerous shipwrecks in the Sicilian Sea, and 
sometimes we had the opportunity to study, with radiological images, the dead 
corps recovered at sea. For example, in 2016, a large number of corpses, 
more than 150, were studied using a multislice CT scanner; the bodies came 
from a shipwreck of an overcrowded boat drowned off the Libyan coasts in 
April 2015. Other corpses were recovered at sea, and in particular near 
Trapani we recovered two child corpses drowned during transhipment 
operations. Radiology in these cases could be essential in helping forensic 
pathologists and police activities, speeding up and making more secure 
identification of people and diagnosis of eventual pathological events. Study of 
number, type, congruency, calluses, fractures and anthropometric 
measurements of bones, teeth, growth-cartilages and of internal/external 
genitals helped to identify sea victims. Furthermore, study of foreign objects 
  







was useful for bodies identification and for a better knowledge of the travel 
conditions of migrants. Radiology has a pivotal role in mass disasters, 
especially in migrant victims, and can help in determining age of people died 
and alive.  
Learning Objectives: 
1. To describe typical findings and pitfalls of virtopsy in mass casualty 
emergency. 
2. To understand the strength and limits of forensic radiological examination. 
3. To become familiar with postmortem imaging. 
A-124 16:59  
High-end CT imaging in forensic medicine: experience after recent 
Brussels terror attacks  
W. Develter; Leuven/BE (wim.develter@uzleuven.be)  
The importance of radiology in the evolution of the ID-process. Experiences 
from former mass disasters revealed an evolution in the identification process. 
Digitalisation boosted logistics and the ongoing technical revolution made of 
radiology an indispensable versatile instrument. Radiology that was used for 
individual diagnostics is now applied for screening - triage and diverse 
documentation (identification, legal inquiry and reconciliation). 
Learning Objectives: 
1. To illustrate MC findings from the Thai Tsunami over the MH-17 to the 
Brussel attacks. 
2. To became familiar with the imaging findings related to unidentified people 
and its medico-legal related issues. 
3. To understand the importance of imaging in the reconciliation process with 
the relatives of the victims. 
17:17  
Panel discussion: How to be prepared accordingly?  
16:00 - 17:30 Room F1 
E³ - Rising Stars Programme: Basic Sessions  
BS 4  
Thoracic emergencies  
Moderator:  
K. Malagari; Athens/GR  
A-125 16:00  
Acute aortic syndrome  
T. Jargiello; Lublin/PL (tojarg@interia.pl)  
Acute aortic syndrome (AAS) describes symptoms relevant to severe chest or 
back pain caused by several aortic pathologies which can be potentially life 
threatening. The most common aetiology, compromises the majority of AAS is 
aortic dissection. Other causes of AAS with similar presentation include 
intramural haematoma, penetrating aortic ulcer (atherosclerotic), aneurysm 
formation (rupture, enlargement), and traumatic transection 
(pseudoaneurysm). Imaging plays a vital role in diagnosing AAS. The role of 
the plain chest radiograph is nowadays historic. Echocardiography (plain or 
transoesophageal) is an effective portable tool, but does not visualise the 
whole thoracic aorta. It may only suggest a certain AAS aetiology. Contrast 
enhanced CT is now considered as the diagnostic method of choice. It 
provides accurate aortic assessment as well as detailed evaluation of other 
thoracic structures. CT permits 3D reconstructions, essential for intervention 
planning and it is widely available. Its sensitivity for aortic disorders reaches 
100%. MRI is another imaging modality to diagnose AAS. Although it provides 
greater anatomical detail than CT, it is seriously limited. The limitation involve 
procedure time, lesser availability, and the expense.  
Learning Objectives: 
1. To become familiar with the most common aetiologies of acute aortic 
diseases. 
2. To present current imaging techniques for evaluation of acute aortic 
diseases. 
3. To demonstrate the most important imaging findings. 
A-126 16:30  
Pulmonary embolism  
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at)  
Pulmonary embolism (PE) represent a daily clinical challenge at the 
emergency department: out of the patients admitted to an emergency room 
because of the very unspecific clinical symptom of chest pain and/or dyspnea, 
the early identification of patients with an high clinical likelihood for PE is a 
difficult task. The D-Dimer test is very sensitive, but unspecific for pulmonary 
embolism, and using this test without clinical assessment, a high number of 
false positive patients will result. On the other hand, PE is potentially life 
threatening; and early and safe diagnosis of this relevant disease is important 
to improve patient’s outcome. CT angiography of the pulmonary arteries has 
been established as the first method of choice to accurately detect PE with an 
high PPV and PPV. This presentation will provide an overview about the 
diagnostic challenges in the chest pain unit will explain the need for accurate 
clinical assessment to select the right patient for the appropriate diagnostic 
test. Furthermore, the risks due to overdiagnosis or false-positive diagnosis will 
be exemplified. In the second part, this presentation will focus on the 
radiological view on this picture by explaining an optimized imaging technique 
and possible pitfalls and problems. Challenging situations in the daily clinical 
practice will be discussed by addressing the role of imaging in suspected PE in 
pregnancy and in the oncologic patients. Finally typical findings in acute and 
chronic pulmonary embolism will be reviewed.  
Learning Objectives: 
1. To review the most common pathologies leading to pulmonary embolism. 
2. To present current imaging techniques for evaluation of pulmonary 
embolism. 
3. To become familiar with the typical findings in acute and chronic pulmonary 
embolism. 
Author Disclosure: 
  C. Loewe: Speaker; GE Healthcare, Bracco, Siemens. 
A-127 17:00  
Acute coronary syndrome  
R.M.M. Hinzpeter; Zurich/CH (Ricarda.Hinzpeter@usz.ch)  
Normal anatomic conditions of the coronary arteries consists of two main 
coronary arteries, a left coronary artery and a right coronary artery arising from 
the coronary sinuses in the proximal ascending aorta immediately distal of the 
aortic valve. The right coronary artery descends in the right atrioventricular 
groove to the inferior surface of the heart, continuing as the posterior 
descending artery representing a right dominant circulation. After a short 
common stem the left coronary artery bifurcates into the left anterior 
descending, coursing in the anterior interventricular groove and the left 
circumflex artery coursing in the left atrioventricular groove. After the initial 
work-up of acute coronary syndrome in the emergency department, including 
laboratory values and ECG changes, coronary CT angiography (CCTA) as a 
non-invasive examination plays an important role besides invasive techniques. 
Especially in patients with low to intermediate risk CCTA is a quick and reliable 
method for ruling out coronary artery disease with a very high negative 
predictive value in the absence of coronary artery calcifications. Besides the 
detection of significant coronary artery stenosis, the presence, amount and 
composition of non-calcified plaques and the degree of coronary remodelling is 
substantial. In addition, information about structural changes of the 
myocardium and myocardial perfusion can be obtained by CCTA.  
Learning Objectives: 
1. To become familiar with segmental coronary anatomy. 
2. To present different techniques for assessment of acute coronary syndrome. 
3. To become familiar with the typical findings of acute coronary syndrome. 
16:00 - 17:30 Room F2  
Multidisciplinary Session  
MS 4  
The heart team: coronary imaging and 
treatment  
A-128 16:00  
Chairperson's introduction  
E. Mershina; Moscow/RU (elena_mershina@mail.ru)  
Due to the rapid technological progress of non-invasive methods of cardiac 
visualisation frequent updates on the clinical indications to perform coronary 
CT angiography (cCTA) and cardiac magnetic resonance (CMR) are required. 
The role of each method including invasive coronary angiography in diagnostic 
algorithm in the patients with different degree of coronary artery disease (CAD) 
probability will be underlined. Various challenges still exist in acquiring high-
quality imaging in cardiac CT, such as artifacts due to calcification and metallic 
densities, motion, noise and poor contrast enhancement. Nevertheless cCTA is 
the first-line diagnostic tool for low-to-intermediate risk CAD patients. On the 
other hand an invasive angiography supported by FFR is the method of choice 
for the patients with high probability of CAD. CMR myocardial perfusion 
imaging produces accurate information on the presence of myocardial 
  







ischemia. As a means of guiding the initial management of patients with stable 
angina and an intermediate-to-high risk of CAD, noninvasive CMR perfusion 
imaging is comparable to a strategy with invasive angiography supported by 
FFR. The implementation of different methods for coronary imaging will be 
illustrated by clinical examples.  
Session Objectives: 
1. To recognise the possibilities of modern coronary imaging modalities. 
2. To explain possible discrepancies in the results of different diagnostic 
investigations and clinical picture. 
3. To understand how to translate the results of coronary imaging into clinical 
practice. 
A-129 16:05  
Non-invasive cardiac imaging  
V.E. Sinitsyn; Moscow/RU (vsini@mail.ru)  
Major indications for cardiac CT angiography are imaging of coronary arteries 
in suspected coronary artery disease, visualization of pulmonary veins and 
planning of endovascular surgical procedures (such as TAVI). Modern types of 
CT scanners open up the opportunity to reach significant improvements of 
image quality of coronary arteries and heart structures even in "difficult" 
patients and to get high quality diagnostic images with very low radiation 
exposure and less volume of contrast media. The contemporary standard of 
coronary CTA (CCTA) is prospective-gated or high pitch wide detector or dual 
source acquisition with iterative image reconstruction. There are some new 
technologies for assessment of coronary or myocardial blood flow with the help 
of CCTA such as perfusion CT, CT-FFR, dual-energy CT. Major indications for 
cardiac MR (CMR) are cardiomyopathies, myocarditis or coronary artery 
disease (imaging of scars and perfusion). Selection of cardiac MR protocols is 
dependent on the main indication for examination. Cine-MR, black-blood 
sequences, perfusion and late gadolinium enhancement modules together with 
blood flow analysis are the most used ones. Today the tissue characterization 
modules (T1, T2 mapping) have become the essential part of CMR protocols. 
Recent changes in cardiological paradigms about approaches to diagnosis, 
treatment, and assessment of prognosis in patients with coronary artery 
disease (CAD ) together with the technical development of CCTA and CMR 
and accumulation of scientific data proving the high diagnostic value of both 
imaging modalities have shown their high value in assessment of prognosis 
and selection of the optimal therapy.  
Learning Objectives: 
1. To get knowledge about modern technology and protocols used in 
coronary/cardiac CT and MRI in coronary artery disease (CAD). 
2. To learn about scientific evidence (including results of major clinical trials) 
supporting use of these technologies in CAD. 
3. To be aware about new developments in non-invasive cardiac imaging 
including studies of coronary flow, myocardial perfusion and hybrid imaging. 
4. To understand the role of co-operation between radiologists and 
cardiologists in non-invasive cardiac imaging for benefit of CAD patients. 
A-130 16:25  
Interventional treatment/percutaneous  
A. Osiev; Moscow/RU (osiev_ag@mail.ru)  
The strategy of diagnosis of coronary artery disease (CAD) was changed since 
non-invasive multi-detector computed tomography (MDCT) had been 
introduced into the common clinical practice. However, in case of high 
coronary calcium score the invasive coronary angiography remains the “Gold 
standard” in CAD diagnostics. Randomised clinical studies demonstrated that 
primary PCI significantly improve the outcomes in pts with ACS especially 
presenting with STEMI, but influence of PCI on long-term prognosis in pts with 
stable CAD is still unclear. Today the most controversial issues are the 
management of the Left Main CAD and strategy selection of myocardial 
revascularisation in pts with multivessel disease (MVD). According to recent 
research data in these cases, we shouldn’t make a decision if not to consider 
SYNTAX Score and SYNTAX score II. As well, the questions of chronic total 
occlusion revascularisation remain unresolved and require meticulous 
preliminary non-invasive assessment of myocardial viability. The innovative 
methods of visualisation are helpful in decision-making in the presence of 
complex cases. Fractional flow reserve (FFR) measurement provides important 
information about lesion severity especially in the presence of MVD. 
Indications for stenting and result assessment can be evaluated by 
intravascular ultrasound imaging (IVUS) and optical coherent tomography 
(OCT). MDCT allows the physicians to verify the anatomical features of culprit 






1. To learn about the current indications for diagnostic coronary catheterisation 
and transluminal interventions. 
2. To know about the latest innovations in percutaneous coronary 
revascularisation technique. 
3. To understand difficulties in assessment of stenosis and occlusions during 
coronary interventions. 
4. To be aware how combined analysis of coronary CTA and invasive coronary 
angiography could help in planning of interventional treatment of coronary 
lesions. 
A-131 16:45  
The role of coronary imaging in the coronary artery bypass and valve 
surgery  
K. Mershin; Moscow/RU 
Learning Objectives: 
1. To learn about surgeon's opinion and the possibilities of different methods of 
coronary imaging. 
2. To understand which coronary imaging modality should be the best in 
complicated cases. 
3. To be aware of CT coronary angiography benefits in the redo procedures. 
A-132 17:05  
Multidisciplinary case presentation and discussion  
Y. Ashikhmin; Moscow/RU (ya.ashikhmin@gmail.com)  
At present time, non-invasive cardiac imaging tools intensively penetrate 
clinical guidelines. Nevertheless, use of modern imaging devices capabilities 
by majority of cardiologists are still scanty. On the other hand, some physicians 
have many footless expectations about potential of conventional scanners. The 
rational diagnostics pathways in typical clinical situations and difficult 
diagnostic cases will be highlighted within multidisciplinary discussion. An 
important place will be given to the discussion of implementation of the current 
guidelines in the real world clinical practice, mentioning the areas of 
uncertainty and discrepancies in the guidelines as well as evidence-based 
personalized diagnostic strategies. Furthermore, attention will be paid to 
cardiovascular prophylaxis, in particular, the usefulness of the coronary 
calcium scoring will be highlighted. It will be explained how to switch clinicians 
from invasive procedures to cardiac MRI and CT when it is the best bet. At last, 
the future of imaging technologies will be discussed, including the present 
transition from the technology-driven model to the unmet clinical need-driven 
progress in imagine tools.  
Learning Objectives: 
1. To outline the rational diagnostics pathways in typical situations: following 
the guidelines. 
2. To learn how to manage the difficult diagnostic cases: beyond the 
guidelines. 
3. To explain how to switch clinicians from invasive procedures to cardiac MRI 
and CT when it is the best bet. 
4. To discuss the future in imaging technologies translation: from the 
technology-driven to the unmet clinical need-driven progress in imagine tools. 
16:00 - 17:30 Room D  
Musculoskeletal  
RC 410  
Bone, joint and soft tissue infection  
Moderator:  
T. Kaya; Eskisehir/TR  
A-133 16:00  
A. Osteomyelitis  
K. Verstraete; Ghent/BE (koenraad.verstraete@ugent.be)  
Osteomyelitis (OM) is an infection of the bone, and can present clinically in an 
acute, subacute or chronic form. Acute OM affects mostly children, just like 
subacute OM which predominantly presents as a Brodie’s abscess. Chronic 
OM is more prevalent in adults (vascular insufficiency, diabetes mellitus). 
Routes of contamination are hematogenous (predominantly in children), 
spread from a contiguous source (cutaneous, dental), or direct implantation 
(bites, open fractures, postoperative). One to 2 weeks after onset, when >50 % 
of trabecular bone is destroyed, radiography can detect OM as ill-defined 
radiolucencies; later findings include extensive osteolysis, periosteal reaction, 
sequestra, involucrum, sinus (cloaca) through the cortex, and permeative bone 
destruction, which may resemble a malignant bone tumor. Bone scintigraphy is 
  







highly sensitive for OM and within 48 hours a focus of increased activity in the 
affected bone can be seen. Specificity is low however, as tumors, trauma, and 
neuropathic osteoarthropathy can result in hot spots. CT has a limited role in 
acute OM, but is useful to evaluate complex findings in chronic OM (e.g., 
sequestra). MRI is the modality of choice to detect acute OM in an early stage: 
it is highly sensitive and specific demonstrating bone marrow edema, 
periosteal reaction, soft-tissue edema, abscess formation and sequestra. 
Gadolinium administration demonstrates enhancement of granulation tissue in 
the abscess wall, along sinus tracts and around sequestra. Special 
manifestations are Garré’s sclerosing OM, tuberculous OM, diabetic foot (may 
resemble neuropathic osteoarthropathy), spondylodiscitis, CRMO (chronic 
recurrent multifocal OM) and SAPHO.  
Learning Objectives: 
1. To understand the pathophysiology and disease spectrum of osteomyelitis. 
2. To learn about the basic imaging criteria for diagnosis of acute and chronic 
osteomyelitis in children and adults. 
A-134 16:30  
B. Septic arthritis  
M. Zanetti; Zurich/CH (marco.zanetti@hirslanden.ch)  
Septic arthritis is often a clinical diagnosis based on physical examination and 
prompt arthrocentesis. Sampling at arthrocentesis can usually be achieved 
with needle aspiration imaging guided, such as fluoroscopy, ultrasound, MRI, 
or CT. Plain radiography and ultrasound have been suggested to be the 
preferred initial imaging method. If further imaging is required, MRI is the most 
accurate technique. FDG-PET is also used less commonly. Staphylococcus 
aureus infection is most commonly seen in acute bacterial arthritis in adults 
and in children older than 2 years. Most septic joints develop hematogenously. 
Rarely, acute septic arthritis may also occur as a result of joint aspiration or 
local corticosteroid joint injection. In addition, bacterial arthritis may arise 
secondary to trauma even without an obvious break in the skin. Bacterial 
arthritis, in association with arthroplasties is commonly seen in our areas. In 
infants, small capillaries cross the epiphyseal growth plate and permit 
extension of infection into the epiphysis and joint space. In children older than 
1 year, osteomyelitis infection presumably starts in the metaphyseal sinusoidal 
veins and is usually contained by the growth plate. The joint is spared unless 
the metaphysis is intracapsular. In adults, the growth plate has resorbed and 
the infection may again extend to the joint spaces. Based on these 
considerations the basic imaging criteria for diagnosis of septic arthritis in 
adults will be shown.  
Learning Objectives: 
1. To understand the pathophysiology and disease spectrum of septic arthritis. 
2. To learn about the basic imaging criteria for diagnosis of septic arthritis in 
children and adults. 
A-135 17:00  
C. Pyomyositis and other soft tissue infections  
D.J. Wilson; Oxford/UK (davidwilson.stlukes@btconnect.com)  
Soft tissue infection can range from a minor wound infection through cellulitis 
to pyomyositis and necrotising fasciitis. At one end of the spectrum the 
treatment may be limited to anti-sepsis and oral antibiotics whilst at the other 
many months of intravenous antibiotics and radical surgery may be necessary. 
Severe infection may be rapidly fatal. Imaging plays a crucial role in the 
detection of the extent of infection, the detection of abscesses and the planning 
of surgical procedures. It is also very useful in determining response to 
therapy. Ultrasound and MRI are the principal techniques. The strength of 
ultrasound has its rapid availability and discrimination of free fluid from 
oedematous solid tissue. It is also critically helpful in detecting foreign material 
which could be a source and irritant causing persisting infection. MRI gives us 
a much better overview showing bone involvement and extent of tissue 
damage or destruction. There is a role for both techniques and their often 
complementary. The first and perhaps most important lesson is to recognise 
the risk of infection. This is particularly true for patients who are 
immunosuppressed or diabetic. The symptoms may be relatively minor and 
these immune compromised individuals should be a low threshold for 
performing imaging investigations. Imaging may be used to guide aspiration of 
cavities and biopsy of tissue to identify organisms. On rare occasions the 
primary treatment of abscesses may be via sump drainage catheter is placed 
using ultrasound guidance. Normally these patients are treated with surgery to 
include excision of necrotic tissue, but there are occasions when patients are 
unfit for anaesthetic and ultrasound guided techniques assist.  
Learning Objectives: 
1. To understand the pathophysiology and disease spectrum of pyomyositis 
and other soft-tissue infections. 
2. To learn about the basic imaging criteria for diagnosis of these conditions. 
16:00 - 17:30 Room G  
Special Focus Session  
SF 4  
Gadolinium deposition: is it harmful?  
A-136 16:00  
Chairperson's introduction  
P.M. Parizel; Antwerp/BE (paul.parizel@uantwerpen.be) 
Since the initial introduction of gadolinium-based contrast agents (GBCAs) in 
the late 1980’s, this class of products has historically been considered safe and 
well tolerated. In a landmark article published in 2014, authors from Japan 
demonstrated that gadolinium is deposited in the brain, as evidenced by T1-
shortening in the dentate nucleus, globus pallidus, and pulvinar of patients who 
had received repeated administrations of gadodiamide and/or gadopentetate 
dimeglumine. Subsequently, many other investigators have confirmed the 
finding that gadolinium deposition occurs, even in patients with normal renal 
function. In the brain, residual gadolinium is mostly discovered in the 
endothelial walls, although small quantities apparently cross the blood-brain 
barrier and accumulate within the neuronal interstitium. Moreover, we now 
know that residual gadolinium is not only deposited certain brain regions, but 
also in tissues such as liver, skin and bone. Today, although gadolinium 
accumulation in tissues is well documented, there is very limited clinical 
information regarding the potential risks and mechanisms of toxicity. In this 
special focus session, 3 of the world leading experts on this topic will explore 
WHERE gadolinium is deposited in the brain, HOW it gets there, what are the 
RISKS and COMPLICATIONS of possible gadolinium toxicity, WHICH 
AGENTS are associated with greater amounts of gadolinum deposition, and 
WHAT are the recommendations of the European Medicines Agency (EMA). 
The special focus session will conclude with a discussion about the future 
strategy to be adopted by the radiological community regarding GBCAs. 
Session Objectives: 
1. To review the evidence of intracranial gadolinium deposits after intravenous 
administration of gadolinium-based contrast agents (GBCAs). 
2. To summarise current theories about why, how, and where gadolinium is 
deposited in the brain and other tissues. 
3. To assess the clinical relevance of this finding for daily radiological practice. 
Author Disclosure: 
  P.M. Parizel: Advisory Board; Bracco. Research/Grant Support; Bayer, 
Bracco, General Electric. Speaker; Bracco. 
A-137 16:05  
Gadolinium deposition in the brain: from preclinical studies to clinical 
implications  
R.J. McDonald; Rochester, MN/US  
"no abstract submitted" 
Learning Objectives: 
1. To understand how gadolinium is deposited in the brain (chemistry and 
pathophysiology). 
2. To demonstrate where gadolinium is deposited in the brain (and other 
tissues) (neuropathology). 
3. To assess the potential clinical implications of gadolinium deposition in the 
human body. 
A-138 16:30  
Assessing tissue integrity in the presence of gadolinium deposition in 
the brain  
C. Olchowy; Wroclaw/PL (cyprian.olchowy@gmail.com)  
A growing evidence of the accumulation of small amounts of gadolinium in the 
cerebellum structures after repeated administrations of selected gadolinium-
based contrast agents (GBCAs) dictates the search for sensitive markers of 
brain tissue damage. Sodium (23Na) MRI can detect possible tissue 
abnormalities. It enables measuring intracellular sodium concentration, which 
is considered a useful marker of tissue viability and has been proved to be 
elevated in many brain disorders. In patients with multiple sclerosis, elevated 
sodium levels were detected in contrast-enhancing lesions to much greater 
extent than in non-enhancing T1 hypointense lesions. These findings may be 
linked to the increase in the blood -brain barrier permeability and signs of 
edema. Multiple sclerosis patients often present with signal hyperintensity 
within the dentate nucleus and globus pallidus as a possible result of multiple 
applications of GBCAs. However, the total sodium concentration within the 
hyperintense dentate nucleus of MS patients did not significantly differ from 
that of the dentate nucleus of MS patients without increased signal intensity 
and healthy controls. Gadolinium deposits have been detected in tissues from 
  







autopsy samples of patients who had been exposed to GBCAs; however, until 
today, there has been no evidence of the direct harmful effect of GBCAs on 
brain tissues. One of the possible reasons is the lack of precise diagnostic 
methods and, the other, the lack of the knowledge of the type of damage 
resulting on using improper diagnostic methods. The hypotheses about the 
possible mechanism and signs of damage will be discussed. 
Learning Objectives: 
1. To detect possible tissue abnormalities with sodium (23Na) MRI in the brain 
of MS patients. 
2. To measure total sodium concentrations in the brains of patients exposed to 
repeated gadolinium administrations. 
3. To predict possible harmful effects of gadolinium deposition in the brain in 
view of the presence or absence of tissue abnormalities. 
Author Disclosure: 
  C. Olchowy: Advisory Board; none. Author; none. Board Member; none. 
CEO; none. Consultant; none. Employee; none. Equipment Support Recipient; 
none. Founder; none. Grant Recipient; none. Investigator; none. Owner; none. 
Patent Holder; none. Research/Grant Support; none. Shareholder; none. 
Speaker; none. Other; none. 
A-139 16:55  
Clinical recommendations in consideration of the EMA's 
pharmacovigilance and risk assessment committee recommendation for 
suspension of linear agents  
V. Runge; Berne/CH (val.runge@mac.com)  
After a two year long consideration of the latest issue (gadolinium deposition in 
the brain and body), including many meetings, rounds of questions from the 
EMA to industry with responses, and two ad hoc expert group meetings, the 
pharmacovigilance and risk assessment committee (PRAC) concluded it's 
assessment of the gadolinium based agents and, on March 10, 2017, 
recommended the following regulatory action (further confirmed by the PRAC 
on July 7, 2017): suspension of the marketing authorization for body imaging of 
4 linear GBCAs (gadodiamide - omniscan, gadoversetamide - optimark, 
gadopentetate dimeglumine - magnevist, and gadobenate dimeglumine - 
multiHance), which would leave—of the linear agents—only gadoxetic acid 
(primovist) and gadobenate dimeglumine on the market (for liver scans only) 
and a formulation of gadopentetic acid for joint injections. Approval for the 
macrocyclic agents was left unchanged; this recommendation was confirmed 
by the committee for medicinal products for human use of the EMA on July 21. 
The final stage of review is the adoption by the European Commission of a 
decision, applicable and legally binding, for all European Union Member 
States.  
Learning Objectives: 
1. To review the in vivo distribution, possible dechelation, and subsequent 
deposition of gadolinium. 
2. To clarify this phenomenon and to stratify gadolinium-based contrast agents 
on this basis. 
3. To provide clinical recommendations to radiologists on how to deal with 
gadolinium deposition in the brain and body. 
Author Disclosure: 
  V. Runge: Grant Recipient; Bayer, Bracco, Guerbet, Siemens. Speaker; 
Bayer, Guerbet, Siemens. 
17:20  
Panel discussion: Strategies for the future  
16:00 - 17:30 Room K 
Radiographers  
RC 414  
Maximising outputs from research  
A-140 16:00  
Chairpersons' introduction (part 1)  
F. Zarb; Msida/MT (francis.zarb@um.edu.mt)  
The radiography profession has gone through numerous developments over 
the past decades. It is also important that we acknowledge these 
developments and the educational requirements to fulfill the developing roles 
of the radiographer. The radiography profession has been required to use and 
also generate quality research on which to develop evidence-based practice. 
The presenters of this session are active researchers within the field of 
radiography and we will be benefitting from their knowledge and experience of 
radiographic research.  
Session Objectives: 
1. To appreciate the importance of study design in enhancing research 
outcomes. 
2. To become familiar with the benefits of collaboration in designing and 
disseminating research. 
3. To understand current funding opportunities and strategies for success. 
A-141 16:03  
Chairpersons' introduction (part 2)  
M. Raissaki; Iraklion/GR  
The cornerstone of academic medicine has always been balanced on the 
concepts of teaching, research and clinical practice. The same concepts are 
interacting with each other in academic radiography. In the era of innovation 
and advancing technology, imaging biomarkers, evidence-based medicine and 
ALARA, radiographers have the opportunity to perceive research on a local, 
National and International level, as their opportunity to make a visible 
difference as health specialists, to better appreciate and understand aspects of 
their craft, to reduce dose and improve or maintain image quality in all imaging 
modalities. Radiographers can and should be aware of the role of research in 
optimization of clinical practice. Familiarization and a positive and attitude 
towards research are important for implementing the paradigm shift from the 
traditional model of practice to evidence-based practice. Research is a learning 
process both on an undergraduate and on a postgraduate level. Research can 
only be mastered through team work, careful design, trial and error, dedication, 
and appropriate funding. Collaboration among institutions can lead to 
enormous benefits for local, National, and International evidence and 
guidelines.  
Session Objectives: 
1. To appreciate the importance of study design in enhancing research 
outcomes. 
2. To become familiar with the benefits of collaboration in designing and 
disseminating research. 
3. To understand current funding opportunities and strategies for success. 
A-142 16:05  
A. Designing robust research projects  
L.A. Rainford; Dublin/IE (louise.rainford@ucd.ie)  
The presenter will provide the audience with a detailed discussion of the key 
steps required to be fulfilled in the design of research projects. The principles 
discussed will bear relevance to a range of research project types from local 
studies to research activity involving international collaborators. The 
information provided will be based on the presenter’s personal experience and 
from referenced literature. The presentation will outline details of support 
mechanisms available to radiography researchers active or those interested in 
becoming research active. The scope of information will range from local 
academic institutions support, professional society support, national and 
international research agencies and European groups, in particular the 
European Federation of Radiography Societies (EFRS). The importance of 
understanding how careful project design is critical to a research project 
success and core considerations in the design process will be provided to the 
audience. Matters such as appropriate supervisory teams, understanding roles, 
maintenance of progress, meeting deadlines, appropriate ethical oversight, 
preparing for unforeseen issues, ensuring novel and innovative approaches, 
ensuring standards are maintained, and positive student development. 
Considerations required if planning multi-site studies either within one 
jurisdiction or internationally will be included in the presentation.  
Learning Objectives: 
1. To learn about the research design process. 
2. To understand the mechanisms available to support the successful design of 
research studies in radiography. 
3. To appreciate the importance of careful research design for successful 
projects. 
A-143 16:28  
B. Collaborating across Europe  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt)  
Radiography profession is evolving in an exponential way, driven mostly by the 
technological development and the new models of delivering care to the 
patient. It’s because these two main drivers that is essential to promote 
research, as a tool to develop the radiographer profession field of knowledge. 
Radiographers, as the guardians of the profession, have the obligation to 
improve the knowledge basis of professional work through research, which is 
only accepted and adopted by the peers, if published: “It doesn’t exist if it isn’t 
written down”. The number of publications in one year is higher than all the 
publications until 1970, and this has a tremendous impact on our daily life. 
According to the European Research Area, Europe must increase the 
  







efficiency and effectiveness of its public research system. This requires more 
cooperation so that the brightest minds work together to make greater impact 
on grand challenges. We have to bear in mind that research paradigm has 
changed. Changes came from a lonely scientist closed in his laboratory to a 
whole worldwide network of knowledge (as the common maxim states: “it’s not 
what you know, it’s who you know.”), reason why networking and integrating a 
multidisciplinary approach into research is essential, not only to avoid 
unnecessary duplication of research and infrastructure investment, but also to 
create knowledge and increase the visibility of radiographers in the patient 
clinical pathway.  
Learning Objectives: 
1. To learn about the importance of networking to promote research activities. 
2. To understand the potential of research collaborations in a multinational 
approach. 
3. To be aware about the importance of research in developing the professions' 
field of knowledge. 
A-144 16:51  
C. Winning research grants  
C. Malamateniou; London/UK (christina.malamateniou@kcl.ac.uk)  
Research in healthcare professions allied to Medicine has been traditionally 
seen as the "difficult to achieve", "challenging" and often "an additional, 
different to clinical practice" task, that was demanding more time from an 
already overloaded clinical schedule of the healthcare practitioners. Recent 
work has shown that research can increase quality of practice, improve patient 
outcomes and job satisfaction and make the service more efficient. 
Radiography research capacity and quality building has been identified as one 
of the key areas for development under the 2016-2021 Research strategy 
agenda of the Society and College of Radiographers. Research capacity 
building involves enhancing research awareness, facilitating research 
involvement but also and most importantly ensuring high quality research 
leadership. There are many different methods one can employ to achieve 
these outcomes, but in order to cement a research leadership role for 
Radiography, one needs to consider how to increase the research income and 
how to succeed in Research grant applications. There is not sadly a cookbook 
on how this can be achieved and it is recognised that one needs to travel 
through rough waters and often learn from constructive feedback and through 
failure, in order to become better in successful grant writing. This talk is about 
the challenges in securing grant funding in Radiography in the UK, some tips to 
help people increase their chances of securing a grant as well as to present 
the currently available research funding opportunities for radiographers.  
Learning Objectives: 
1. To learn about potential research funders for radiographers. 
2. To understand challenges and opportunities in research grant applications. 
3. To appreciate strategies for successful research bids. 
17:14  
Panel discussion: How to avoid strategic mistakes in research?  
16:00 - 17:30 Room M 1 
EuroSafe Imaging Session 
EU 1  
Euratom Basic Safety Standards Directive: 
a comprehensive approach for radiation 
protection  
Moderator:  
G. Frija; Paris/FR  
A-145 16:00  
Chairperson's introduction  
S. Ebdon-Jackson; Didcot/UK (steve.ebdon-jackson@phe.gov.uk)  
EC Directive 2013/59/Euratom lays down basic safety standards for protection 
against the dangers arising from exposure to ionising radiation. Previously, 
such directives have addressed occupational and public exposure and a 
separate directive considered medical exposures (EC Directive 
97/43/Euratom). In contrast, this latest "Basic Safety Standards Directive" 
includes medical exposures and therefore, provides a comprehensive EC 
approach to radiation protection for radiology and other activities in medicine 
that utilise ionising radiation. For occupational exposure, new dose limits are 
introduced for the lens of the eye. For medical exposures, the directive extends 
requirements for justification, at generic and individual levels, and optimisation 
and gives greater detail regarding equipment and the role of the medical 
physics expert. It includes new requirements for non-medical imaging using 
medical radiological equipment and accidental and unintended medical 
exposures. 
Session Objectives: 
1. To become familiar with the new Basic Safety Standards Directive (Council 
Directive 2013/59/EURATOM). 
2. To learn about the most important changes compared to the previous 
directive. 
3. To understand the implications of the new directive for medical imaging. 
A-146 16:05  
The technical approach: achievements and future of dose reduction  
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni-erlangen.de)  
The introduction of spiral-CT in the 1990s followed by the development of 
multi-slice detector technology led to substantial increases in CT performance 
and in its use. In consequence, the cumulative patient exposure also 
increased. Fortunately, new efforts of developing intelligent dose reduction 
approaches, meanwhile helped reducing patient dose significantly. These 
comprise the following innovative approaches: Tube current modulation (TCM), 
automated exposure control (AEC), application-dependent optimal choice of X-
ray spectra, elimination of z-overscanning effects, dose-efficient iterative image 
reconstruction, advanced detector technology. They all have in common that 
dose will be reduced, but not combined with compromising image quality, i.e., 
not by reducing the mAs product. The underlying principles and the resulting 
reduction of dose will be explained. The total effect has actually been very 
successful during the last two decades allowing for a reduction by a factor of 
10 or higher and for sub-mSv CT imaging in many CT-applications. 
Learning Objectives: 
1. To learn about the technical perspective from the BSS. 
2. To become familiar with dose reduction. 
3. To become familiar with the achievements and future of dose reduction. 
Author Disclosure: 
  W.A. Kalender: Consultant; Bayer Schering AG, Advanced Breast-CT 
GmbH. Shareholder; Advanced Breast-CT GmbH. 
A-147 16:17  
The clinical approach: the gap to be closed  
G. Frija; Paris/FR (guy.frija@aphp.fr)  
Several aspects of optimisation and justification are clearly relating to a clinical 
task and this will be introduced. The talk will focus for example on optimisation 
driven by the clinical indication and patient characteristics, and the report, 
which should include dose metrics. Examples will be taken for illustrating the 
importance of considering an integration of radiation protection into the clinical 
work, and thus increasing healthcare professionals’ awareness. 
Learning Objectives: 
1. To learn about the clinical perspective. 
2. To become familiar with the concept of clinical DRLs. 
3. To understand the need for DRLs based on clinical indications. 
A-148 16:29  
The clinical audit: the missing link  
E.J. Adam; London/UK (drjaneadam@gmail.com)  
Translating legislation into routine practice can be challenging. European 
legislation deadlines relating to radiation protection are looming. Regulatory 
agencies across Europe may take different approaches to assessing 
compliance, but there is no need to wait. Self audit within departments is easy 
to carry out, and will mean that departments will have evidence to show that 
they have high standards of safe practice in line with the legislation. The ESR 
audit system makes it straightforward to start, and bridges the gap between 
regulation and routine practice. It should be a continuous, multidisciplinary 
process which is professionally led and aims to improve the performance 
rather than be a pass or fail assessment. Ultimately, it can expand to cover all 
areas of practice and all parts of the patient journey.  
Learning Objectives: 
1. To understand what clinical audit is. 
2. To learn how to implement clinical audit in practice. 
3. To become familiar with the ESR audit pack. 
A-149 16:41  
The regulatory approach  
S. Ebdon-Jackson; Didcot/UK (steve.ebdon-jackson@phe.gov.uk)  
EC Directive 2013/59/Euratom is intended to provide basic safety standards for 
protection against the dangers arising from exposure to ionising radiation. 
  







Member States are expected to transpose the Directive into national law. The 
Directive requires member states to have in place a competent authority which 
will undertake a range of activities including regulatory control through a 
graded approach, which includes notification, registration and licensing. 
Justification of new types or classes of practices provides a particular 
challenge for medical exposures and member states will be required to put in 
place meaningful and responsive processes. The principle of justification is 
extended to individual justification and the justification process will be subject 
to scrutiny. Member states are required to have in place inspection 
programmes that may be proactive. In addition, new requirements relating to 
accidental and unintended medical exposures mean reactive inspection 
processes must be available. The heads of the European Radiation protection 
Competent Authorities (HERCA) working group on medical applications has 
undertaken a range of activities to enhance common understanding of 
Directive requirements, including Multi-Stakeholder Meetings and Workshops 
which have informed position papers and statements on a range of topics 
included within 2013/59/Euratom. Regulators and professionals have the 
common goal of ensuring safe practice and common understanding of 
regulatory approaches and good medical practice will enable increased safety 
for patients, workers and the public. 
Learning Objectives: 
1. To understand the regulator's perspective on the BSS. 
2. To learn about the regulator's role and tasks. 
3. To become familiar with inspection. 
A-150 16:53  
The European Commission's perspective and update on the 
transposition in the European Member States  
G. Simeonov; Luxembourg/LU (georgi.simeonov@ec.europa.eu)  
The "Basic Safety Standards" (BSS) Directive 2013/59/Euratom was published 
in 2014 and has to be implemented in the EU Member States by 6 February 
2018. The BSS Directive updates and consolidates previous pieces of 
European legislation and introduces some important changes, including in 
relation to protection of patients. The European Commission is empowered to 
monitor the implementation of the European BSS in the Member States and 
take corrective action, wherever necessary. The Commission implements also 
a series of 'soft measures' to support the implementation of the BSS Directive 
into practice, with recent examples on paediatric DRLs, MPE qualification 
framework and education and training of medical professionals. The main 
focus in the next years will be on ensuring full implementation of the BSS 
Directive. One specific area, where the Commission will focus further efforts, is 
the development and use of DRLs, where a European survey on clinically-
specified DRLs has been recently launched.  
Learning Objectives: 
1. To learn about the Euratom Basic Safety Standards Directive. 
2. To understand the European Commission's perspective. 
3. To understand how the European Commission ensures implementation of 
the BSS Directive. 
A-151 17:05  
The industry's perspective and work needed to comply with the Basic 
Safety Standards  
N. Denjoy; Brussels/BE (denjoy@cocir.org)  
The medical technology sector in Europe represented by COCIR is highly 
technological and innovative, with around 28 billion € total turnover and 7-8% 
of annual revenues invested in research and development. COCIR Companies 
are working already to implement the new requirements, in particular article 60 
and 78. Nonetheless companies have a few concerns in particular regarding a 
non-harmonized transposition with different requirements at national and local 
level regarding important topics such as justification and information on 
equipment. Manufacturers provide to undertakings manuals and accompanying 
documentation when selling a medical device, containing all the information 
required for safe use. The additional requirements on information in the BSS 
Directive, e.g., article 78, may end requiring a duplication of documentation, 
adding a significant burden on manufacturers and on undertakings as well.  
Learning Objectives: 
1. To learn about industry's perspective on the BSS. 
2. To understand the work needed to comply with the BSS. 
3. To identify regulatory hurdles for industry. 
17:17  
Panel discussion: Is the Basic Safety Standards Directive a step forward 
for patients, clinical professionals and regulators?  
G. Frija1, S. Ebdon-Jackson2, W.A. Kalender3, E.J. Adam4, N. Denjoy5, 





16:00 - 17:30 Room M 2 
E³ - ECR Master Class (Paediatric)  
E³ 426  
Juvenile idiopathic arthritis (JIA)  
Moderator:  
K. Rosendahl; Bergen/NO  
A-152 16:00  
A. Conventional radiography, still a helpful method?  
S.C. Shelmerdine; London/UK  
Juvenile idiopathic arthritis (JIA) is a chronic, rheumatic illness that is 
associated with a high risk of long-term physical disabilities. Radiography can 
help identify changes related to JIA, which are primarily those of chronic, 
destructive changes seen in late disease, but it can also provide indirect 
information on soft tissue inflammation (such as peri-articular increased soft 
tissue density or the presence of a joint effusion). In the initial assessment of a 
child with joint pain, radiography is also useful to rule out other differential 
diagnoses such as neoplasms, posttraumatic changes and developmental 
defects. In this lecture, we will focus on the typical findings of joint inflammation 
and destruction seen in a variety of commonly affected joints and review the 
literature regarding the specificity and sensitivity of such radiographic signs. 
We will also touch upon common pitfalls and how such features may overlap 
with normal findings of a skeletal maturation. We conclude by reviewing the 
benefits and drawbacks of using radiography as a follow-up imaging tool and 
how this modality compares with other radiology techniques for JIA imaging. 
Learning Objectives: 
1. To learn about the features of joint inflammation on plain radiographs. 
2. To understand the role of this technique in the diagnosis and follow-up of 
children with JIA. 
3. To appreciate the strengths and limitations of conventional radiography 
compared to other modalities in JIA. 
A-153 16:30  
B. Ultrasound for detecting and grading of inflammation in JIA  
L. Tanturri De Horatio; Rome/IT (laura.tanturri@opbg.net)  
Musculoskeletal ultrasound (MSUS) is an attractive imaging technique in 
children; particularly, it is a useful tool for joint assessment and guidance of 
steroid injection therapy in JIA. The method is radiation free without any need 
for sedation and allows for a dynamic evaluation of several joints per session 
including assessment of the vasculature with Doppler. Moreover, the new high-
resolution probes provide exquisite image quality. Caution should be taken 
when translating adult musculoskeletal sonographic findings to the paediatric 
joints, as age-related variations in thickness of cartilage and appearances of 
ossification centres can mimic pathology. Moreover in children it may be 
challenging to distinguish between synovial hypertrophy and the adjacent 
cartilage or joint fluid because all these structures may have a similar, 
hypoechoic appearance. Furthermore, the interpretation of intra-articular 
Doppler signals as a marker for synovitis is difficult due to physiologically 
enhanced blood flow which should not be misinterpreted as pathology. Over 
the past decades a great deal of effort has been done by the Outcome 
Measures in Rheumatology Clinical Trials (OMERACT) Ultrasound Task 
Forces to provide a definition of the normal age-dependent sonographic 
anatomy and to standardise an approach to MSUS scanning in children. The 
results from these studies provide the basis to develop definitions for pathology 
and to support the standardised use of MSUS in paediatric rheumatology. 
However, at present, very few studies have addressed the 
repeatability/reproducibility of MSUS finding. Moreover, validated definitions 
and scoring systems for ultrasound pathology in children with JIA are lacking. 
Learning Objectives: 
1. To learn about normal features vs pathology on ultrasound of joints in 
children. 
2. To understand the role of ultrasound in diagnosing and grading of joint 
inflammation. 
3. To appreciate the research-based evidence of ultrasound. 
A-154 17:00  
C. MRI and role of contrast in the assessment of synovitis  
L.-S. Ording Müller; Oslo/NO (lilsofie.ording@googlemail.com)  
MRI scanning is the current gold standard modality for imaging synovitis and 
tenosynovitis in patients with Juvenile idiopathic arthritis. Enhancement of the 
synovium after gadolinium injection is traditionally regarded as mandatory in 
the assessment of synovitis, both for diagnosis and grading, and to distinguish 
  







between active and inactive disease. There have been huge advances in 
medical treatment of JIA over the last two decades and disease remission is 
now the ultimate goal for all patients. This increases the role of imaging to 
detect early signs of disease or relapse and to monitor subtle response to 
treatment. Several research groups work on establishing scoring systems to 
create objective imaging measures for disease activity in JIA. However it is 
challenging to reliably differentiate between normal synovial enhancement and 
inflammation and to grading contrast enhancement in early disease. Timing of 
imaging post contrast injection has shown to play an important role in the 
assessment and grading of synovitis and dynamic contrast-assessment might 
be a better method to improve quantification of synovitis. Focus on potential 
harmful effects of Gd-injection forces us to search for alternative methods in 
synovitis imaging. The diffusion weighted imaging (DWI)-derived apparent 
diffusion coefficient (ADC) seems to be higher in active JIA and may serve as a 
non-invasive imaging biomarker for JIA in the future. In this lecture current 
knowledge on the role of contrast in synovitis assessment, challenges in 
standardisation of imaging, and potential alternative methods for detection and 
grading of synovitis in JIA will be presented.  
Learning Objectives: 
1. To learn about the definition of synovitis on MRI. 
2. To understand the appearances of synovitis and potential pitfalls on MRI. 
3. To appreciate new techniques that may replace contrast-enhanced MRI in 
the assessment of synovitis. 
16:00 - 17:30 Room M 3 
Molecular Imaging  
RC 406  
Molecular imaging in oncology  
A-155 16:00  
Chairperson's introduction  
K. Nikolaou; Tübingen/DE (Konstantin.Nikolaou@med.uni-tuebingen.de)  
Radiology is playing a central role in the set-up of multidisciplinary cancer 
centers and in the comprehensive work-up of oncologic patients, integrating an 
ever increasing amount of qualitative and quantitative diagnostic information. 
Still, radiology is facing significant challenges, as “precision medicine” 
develops and matures. Integrating functional and molecular information in a 
quantitative fashion and adding complementary multimodality information is 
crucial. In detail, molecular imaging is regarded as the direct or indirect 
noninvasive monitoring and recording of the spatial and temporal distribution of 
in vivo molecular, genetic, and/or cellular processes for biochemical, biological, 
diagnostic, or therapeutic applications. Molecular and functional image 
information that indicate the presence of malignancy can be acquired using an 
abundance of modalities, including optical, ultrasonic, radiologic, radionuclide, 
and magnetic resonance techniques. In this session, multimodality imaging of 
oncologic processes will be reviewed with respect to their physical basics and 
imaging characteristics, including attributes of hypoxia, proliferation, and 
metabolism. Also, the role of prognostic, predictive and therapy response 
oncologic imaging biomarkers will be discussed and current and future clinical 
applications in oncologic diagnosis will be reviewed. 
Session Objectives: 
1. To understand the basics of molecular imaging. 
2. To appreciate the unmet needs of oncological imaging. 
3. To learn the role of molecular imaging in oncology. 
A-156 16:05  
A. Imaging of hypoxia  
V.J. Goh; London/UK (vicky.goh@kcl.ac.uk)  
Tumour hypoxia is present in up to 60% of locally advanced solid tumours. 
Tumour hypoxia is a significant challenge to successful therapy, contributing to 
treatment resistance and a poor prognosis. Intra-tumoural hypoxia may be 
assessed by molecular markers including hypoxia inducible factor 1 (HIF-1) 
and carbonic anhydrase isoenzyme IX (CA-IX). However, hypoxia is a dynamic 
process and alters depending on perfusion and oxygenation status. 
Noninvasive imaging of intra-tumoral hypoxia provides an opportunity to better 
stratify patients to improve local control. Tumour hypoxia may be assessed in 
vivo by direct and indirect imaging techniques. Positron emission tomography 
(PET) imaging targets hypoxic cells with tracers including 18F 
fluoromisonidazole (18F-MISO), 18F-fluoroazomycin arabinofuranoside 
(18FFAZA) and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone (64Cu-ATSM). 
Hypoxia imaging may also be undertaken by magnetic resonance imaging 
(MRI) with techniques such as blood oxygenation level-dependent (BOLD) MRI 
and oxygen enhanced MRI measuring R2* and R1 changes, respectively. This 
lecture will review the biological basis and fundamentals of hypoxia imaging 
and potential clinical applications including radiotherapy. 
Learning Objectives: 
1. To review the fundamentals of hypoxia imaging. 
2. To review the advantages and disadvantages of hypoxia imaging and its 
relation to perfusion. 
3. To learn about hypoxia imaging in radiation treatment. 
Author Disclosure: 
  V.J. Goh: Research/Grant Support; Siemens Healthineers. Speaker; Bayer, 
Siemens Healthineers. 
A-157 16:23  
B. Imaging of proliferation  
A. Kjaer; Copenhagen/DK (akjaer@sund.ku.dk)  
Uncontrolled proliferation is a hallmark of cancer and may be imaged both at 
the DNA level with 18F-FLT and at the protein level through amino acid PET 
tracers, e.g., 18F-FET. The value of proliferation imaging with PET in oncology 
will be reviewed with particular focus on use for tumor delineation, 
prognostication and therapy monitoring. Additionally, the relative value 
compared to that of 18F-FDG for the same applications will critically be 
discussed.  
Learning Objectives: 
1. To understand basic principles of proliferation imaging. 
2. To become familiar with imaging of proliferation. 
3. To learn about difficulties in liver proliferation imaging. 
A-158 16:41  
C. Imaging of metabolism  
C. Nanni; Bologna/IT (cristina.nanni@aosp.bo.it)  
18F-FDG PET/CT is an imaging technique that is aimed to evaluate glucose 
metabolism of tissues and organs. PET/CT scanners consist of a combination 
of a PET scanner and a CT scanner providing both morphological and 
functional images that can be fused to accurately localize any pathological 
finding. The procedure is standard and includes several steps. Patients are not 
allowed to consume any food or sugar for at least 6 h prior to the start of the 
PET study. Injection should be fully intravenous. Optimal uptake time is 60 min. 
In general, for a 3D system and 3 MBq/Kg of FDG, 2 min/bed position is 
enough, leading to an average overall acquisition time of 14 minutes. Low dose 
CT (120 kV, 80 mA) is necessary both for attenuation correction and for image 
interpretation. Once reconstructed, images must be interpreted on a dedicated 
workstation. SUV max based on body weight is the standard semi-quantitative 
index. FDG PET/CT was proved to be accurate for several malignancies for the 
definition of TNM at staging and in the suspect of relapse. Furthermore, 
changing in SUV max are related to the response to systemic therapies, both 
during and after treatment. This parameter is considered a non invasive 
surrogate for therapy assessment. Some particular kinds of malignant tumors 
are not detectable at FDG PET. In particular mucinous ca, transitional cell 
cancers, clear cell cancers, indolent HCC and some adenocarcinomas fail to 
significantly concentrate FDG. Low accuracy can also be found in some 
particular areas of the body where FDG is physiologically concentrated such 
the brain and the urinary tract.  
Learning Objectives: 
1. To learn the clinical indications for FDG imaging. 
2. To become familiar with imaging protocol. 
3. To learn about difficulties in FDG imaging. 
A-159 16:59  
D. Biomarker imaging with MR  
M.E. Mayerhöfer; Vienna/AT (marius.mayerhoefer@meduniwien.ac.at)  
Originally regarded as a purely morphological imaging technique with excellent 
soft-tissue contrast, MRI today is recognised as a technique that can also 
provide functional biomarkers through different approaches. For treatment 
response assessment, diffusion-weighted imaging (DWI), which indirectly 
provides information on cell density in tumours, is already well-established, and 
for some tumors (e.g., lymphoma), is has even been proposed as a radiation-
free alternative to [18F]FDG-PET for staging and treatment response 
assessment. Nevertheless, limitations for DWI include artefacts and 
standardisation of apparent diffusion coefficients between different DWI pulse 
sequences, and between MR scanners of different vendors. Perfusion-
weighted imaging (PWI) is another technique that is increasingly being used in 
the response evaluation of hypervascular tumours, such as hepatocellular 
carcinoma. In the body, PWI is most commonly performed on the basis of 
dynamic contrast-enhanced sequences, with k-trans, a measure of capillary 
permeability, being the best-known parameter. Alternatively, PWI may be 
performed using arterial spin labeling, without contrast media. MR 
  







spectroscopy (MRS), which today is most frequently based on protons, is 
another technique that can be used to assess biomarkers in the form of 
metabolites, such as lactate and choline. While several studies reported 
encouraging data, for instance, in breast cancer and prostate cancer, 
limitations such as, long acquisition times and difficulties in terms of 
standardisation and quantification have prevented MRS from being introduced 
into routine clinical imaging. Cutting-edge techniques, such as chemical 
exchange saturation transfer (CEST) imaging, may overcome the limitations of 
MRS.  
Learning Objectives: 
1. To learn the clinical indications for biomarker imaging. 
2. To become familiar with quantification. 
3. To learn about difficulties in quantification. 
17:17  
Panel discussion: The pros and cons of molecular imaging in oncology  
16:00 - 17:30 Room M 4 
E³ - ECR Academies: Chest Imaging  
E³ 418  
Cavitary and cystic diseases of the lung  
A-160 16:00  
Chairperson's introduction  
N. Howarth; Chêne-Bougeries/CH (nigel.howarth@grangettes.ch)  
The session will provide an overview of cavitary and cystic diseases of the 
lung. Diagnostic criteria for cavitary lesions and cysts will be explained and the 
differential diagnosis will be explored in a variety of clinical situations. The 
pathogenesis of different forms of cavitary and cystic lesions will be explained. 
Key CT features will be reviewed. Attendees will learn a practical and logical 
approach for CT interpretation based on clinical setting, of value in everyday 
work.  
A-161 16:05  
A. Cavitary lung lesions  
A.P. Parkar; Bergen/NO (apparkar@gmail.com)  
A cavity is defined as “a gas-filled space, seen as a lucency or low-attenuation 
area, within pulmonary consolidation, a mass, or a nodule”. The wall thickness 
may vary considerably. There is a continuous transition from cavities to cysts. 
Cysts are usually thin walled (i.e., < 2 mm). A wall thickness < 7 mm is highly 
specific for benign disease, a thickness >24 mm is highly specific for malignant 
disease. However, this is not absolute, as thin-walled carcinomas do exist. An 
additional indicator for malignancy is the lack of perilesional centrilobular 
nodules around a cavity. The cavity content is unhelpful in differentiating 
benign and malignant lesions. Wall rim enhancement on contrast-enhanced CT 
is common in abscesses. A connecting pulmonary artery may be seen in 
smaller metastases, but not in larger ones, as the larger nodules tend to 
compress the vessels, so no feeding artery does not always imply benign 
nodules. The acute onset of symptoms is sometimes helpful to distinguish 
malignant and non-malignant disease. Hemoptysis is not a useful symptom to 
differentiate between benign and malignant cavities. Benign diseases may also 
cause fatigue and weight loss similar to malignancies. Acute onset of fever is 
usually helpful to distinguish benign disorders from malignant, but a pulmonary 
cancer may cause a super-infection secondary to the tumor. However, the 
combination of symptoms, laboratory results, past clinical history, and imaging 
findings leads to recognition of the correct diagnosis. This presentation will 
guide you through the most commonly encountered cavitary lung in adults.  
Learning Objectives: 
1. To review the diagnostic criteria and differentials of cavitary lung lesions. 
2. To learn about the most common causes. 
3. To learn about an algorithmic approach to narrow the differential diagnosis. 
A-162 16:33  
B. Langerhans cell histiocytosis (LCH)  
A. Devaraj; London/UK  
This presentation will review the characteristic and atypical CT appearances of 
Langerhans. The challenges in establishing a confirmed diagnosis in atypical 
cases will be reviewed as well as a discussion of the differential diagnoses 
when faced with cystic lung disease. The role of CT beyond diagnosis will be 
highlighted, including a review of complications and outcomes of the disease.  
Learning Objectives: 
1. To understand the pathophysiology of LCH. 
2. To review key features on CT. 
3. To learn about the various stages of the disease. 
A-163 17:01  
C. Lymphangioleiomyomatosis  
A. Oikonomou; Toronto, ON/CA (anastasia.oikonomou@sunnybrook.ca)  
Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease caused by 
infiltration of the lung with smooth muscle cells. It occurs in patients with 
tuberous sclerosis complex (TSC-LAM) and in a “sporadic” form in patients 
without tuberous sclerosis (S-LAM). S-LAM is seen exclusively in women of 
reproductive age while TSC-LAM may also be seen in men. Parenchymal 
lesions in LAM mainly include cysts, which are thin-walled, well-defined, 
rounded, usually small in size up to 2 cm and may reach large numbers. They 
have no zonal lung predominance. Nodules are extremely rare in S-LAM and 
are more commonly seen in TSC-LAM. They may either be solid or ground-
glass and usually tiny. They represent multifocal micronodular pneumocyte 
hyperplasia. Pleural manifestations include chylothorax and pneumothorax. 
Chylous pericardial effusions may be seen. Recent guidelines for the diagnosis 
of LAM from the European Respiratory Society LAM task force classify LAM as 
definite, probable and possible. LAM is differentiated by other cystic lung 
diseases such as Langerhans histiocytocis (PLCH), Birt-Hogg-Dube (BHD), 
lymphocytic interstitial pneumonia (LIP) and amyloidosis. In PLCH the cysts 
have a bizarre shape, are variable in number and are upper and middle lobe 
predominant. In LIP the cysts are round and variable in size but usually small 
and random in distribution surrounded by ground glass opacity. In BHD the 
cysts are elliptical in shape and have a subpleural, lower zone predominance 
adjacent to vessels. In amyloid the cysts are variable in size but usually large 
and diffusely distributed. Nodules are seen in PLCH and amyloid.  
Learning Objectives: 
1. To learn about the current concepts on pathogenesis. 
2. To review the typical and atypical CT features. 
3. To learn about the tuberous sclerosis complex. 
16:00 - 17:30 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 420  
Advanced MR techniques and imaging 
biomarkers  
A-164 16:00  
Chairperson's introduction  
D.-M. Koh; Sutton/UK (dowmu.koh@icr.ac.uk)  
Advanced MR imaging is being applied to the hepatobiliary system to improve 
disease diagnosis and patient management. These include diffusion-weighted 
MRI, MR and US elastography, as well as liver selective contrast media. These 
techniques enhance the diagnostic potential of MR imaging for focal and liver 
diseases, and have impacted on imaging pathways and patient management. 
This session will demonstrate the application of these techniques for patient 
care.  
A-165 16:05  
A. Diffusion-weighted imaging  
N. Papanikolaou; Lisbon/PT 
(nickolas.papanikolaou@research.fchampalimaud.org)  
Diffusion-weighted MR imaging (DWI), based on the thermally driven random 
motion of water molecules (otherwise called Brownian motion) has been 
increasingly applied in the evaluation of a wide variety of oncological diseases 
not only in the brain, but in the body during recent years. Promising results for 
improved detection and treatment evaluation, in terms of prediction and early 
response assessment, have been reported. DWI is probing water mobility 
propelled by thermal energy, and since water molecules are interacting with 
cellular membranes or other structures, DWI has the potential to provide us 
with information regarding the cellular architecture in a non-invasive manner. 
The apparent diffusion coefficient (ADC) is a property of tissue that reflects 
local water mobility. In the presence of pathology, ADC, has been correlated 
with important histologic properties, including the tumor proliferation index, 
tumor grade, the presence of necrosis, and tumor cell apoptosis. The model 
that is used to calculate the ADC value is based on a mono-exponential 
function that generally works well. However, in the presence of increased 
  







vascularity, there is a second component that is called microperfusion and 
needs to be taken into consideration. In that case the use of a bi-exponential 
function where ADC is decomposed into D and D*, the true diffusion coefficient 
and the microperfusion coefficient is providing more accurate modeling of 
diffusion signals. In the presence of increased tissue heterogeneity a non-
Gaussian diffusion model should be considered to take into account the 
interactions between water molecules and local tissue architecture 
components.  
Learning Objectives: 
1. To recognise the general principles of liver DW MRI. 
2. To be familiar with the clinical applications of DW imaging in diffuse and 
focal liver diseases. 
3. To be aware of the evolving developments in liver DW imaging. 
Author Disclosure: 
  N. Papanikolaou: Advisory Board; Advantis. Founder; MRIcons. 
A-166 16:33  
B. MR and US elastography  
D.J. Lomas; Cambridge/UK  
Elastography is the measurement of tissue stiffness which is routinely 
assessed by subjective clinical palpation. Non-invasive in vivo imaging 
methods for quantitative elastography have been developed over the last few 
decades using ultrasound and MRI. These involve vibrating the tissue of 
interest and measuring the speed of the generated acoustic waves as they 
pass through the tissue. Essentially waves travel faster in stiffer tissues. This 
information, with some important assumptions, can be used to estimate 
absolute tissue stiffness. Multiple ultrasound methods are available which use 
different wave generation techniques, frequencies and which vary by the 
volume of tissue sampled and their ability to image simultaneously. Two MRI 
based methods have been developed both using relatively similar techniques 
for wave generation and image processing. MRI methods report liver stiffness 
using the “Shear” modulus, whereas US methods use “Elastic” or “Young’s” 
Modulus (typically 3X larger). The MRI methods are probably more accurate for 
the detection of early and moderate liver fibrosis and sample larger volumes 
than the US methods, but are more expensive and less widely available. Both 
approaches have the potential to replace some liver biopsies in clinical practice 
and have particular screening value in diagnosing the “normal” liver when 
patients are referred with mild liver function test abnormalities. All these 
elastography methods are now being applied directly to clinical outcome 
studies, rather than just comparison studies with liver biopsy and other fibrosis 
measures, and these may demonstrate additional clinical prognostic and 
therapeutic applications for the management of liver disease.  
Learning Objectives: 
1. To recognise the clinical applications and diagnostic performance of MR and 
US elastography. 
2. To be able to compare both techniques. 
3. To be familiar with the factors confounding the accuracy of elastography. 
A-167 17:01  
C. MR contrast agents in liver imaging  
M. Karcaaltincaba; Ankara/TR (musturayk@yahoo.com)  
Contrast choice for liver MR imaging is important for correct diagnosis. 
Extracellular contrast agents should be preferred for diagnosis of hemangioma. 
Dynamic contrast-enhanced imaging phases are early and late arterial, portal 
venous, equilibrium phases. These phases can demonstrate perfusion 
characteristics of common liver lesions. Hepatocyte specific agents should be 
preferred for differentiation of focal nodular hyperplasia (FNH) from hepatic 
adenoma and preoperative planning for metastatic colorectal cancer. Recent 
evidence suggests use of Gd-EOB-DTPA for diagnosis of early HCC. A 
hypervascular lesion appearing as focal hyperintensity on hepatobiliary phase 
images is consistent with FNH in patients without risk factor for HCC and 
cancer. Oxaliplatin (mostly used for colorectal cancer) can induce focal nodular 
hyperlasia like lesions. Gd-EOB-DTPA may also be helpful in the assessment 
of liver function in patients with steatohepatitis, fibrosis and segmental 
dysfunction.  
Learning Objectives: 
1. To understand the dynamic contrast-enhanced imaging and liver perfusion. 
2. To recognise the role of hepatocyte specific contrast agents in liver function 
and lesion characterisation. 
3. To learn the weaknesses of extracellular and hepatospecific contrast agents. 
Author Disclosure: 






















08:30 - 10:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 521  
Imaging of the skull base  
A-168 08:30  
A. Non-tumoural pathology of the temporal bone  
B. Ozgen Mocan; Ankara/TR (burce@hacettepe.edu.tr)  
The temporal bone has a complex anatomy, but the pathologies involving the 
temporal bone structures are somewhat limited with specific and diagnostic 
imaging findings. During this lecture, the most common non-tumoural causes 
of conductive and sensorineural hearing loss will be reviewed in an interactive 
manner with emphasis on the clinical and imaging findings that are helpful for 
the differential diagnosis.  
Learning Objectives: 
1. To learn the most common inflammatory lesions of the temporal bone. 
2. To become familiar with the most common malformations and non-tumoural 
pathologies. 
A-169 09:15  
B. Tumours of the skull base  
T. Beale; London/UK (timothy.beale@uclh.nhs.uk)  
The lecture will describe a classification system for tumours of the skull base 
that will aid in the differential diagnosis. Using clinical cases the imaging 
features of the common skull base tumours will be highlighted. The important 
review areas for the individual tumours will be discussed including those 
features that may alter the clinical management and help in the differential 
diagnosis. The common pitfalls and non-neoplastic differential diagnosis will be 
highlighted and an imaging technique for assessing the skull base will be 
discussed.  
Learning Objectives: 
1. To become familiar with the imaging technique of the skull base. 
2. To identify imaging criteria for improved differential diagnosis. 
08:30 - 10:00 Room B 
New Horizons Session  
NH 5  
The machines are coming: how will they 
change our future?  
A-170 08:30  
Chairperson's introduction  
H.-U. Kauczor; Heidelberg/DE (Hans-Ulrich.Kauczor@med.uni-heidelberg.de)  
Novel developments in computer science and performance have prepared the 
ground for the implementation of so-called artificial intelligence algorithms and 
have computers learn “deeply” from the analysis of big data. This session will 
provide an introduction into machine based learning algorithms touching 
reflecting opportunities, but also limitations. Obviously, quantitative image 
analysis will be a promising field for machine learning and the integration of the 
“machines” in the workflow of radiology will lead to major challenges to 
generate benefits for patients, the health care system and their economics as 
well as our profession. Done properly, machines will help us to cope with the 
ever increasing volume of imaging exams and scans, increase quality and 
safety, while radiologists will generate the value from imaging and the added 
value provided by the machines to strengthen our role as physicians.  
Session Objectives: 
1. To understand the basics of machine learning. 
2. To appreciate the opportunities to improve quality in radiology. 
3. To redefine the professional role of the radiologist. 
Author Disclosure: 
  H.-U. Kauczor: Research/Grant Support; Siemens, Bayer. Speaker; 




A-171 08:35  
Deep learning: current performance  
B. van Ginneken; Nijmegen/NL (bram.vanginneken@radboudumc.nl)  
The application of deep learning to medical image analysis has resulted in 
much-improved performance for many algorithms. There is early evidence that 
for many specific, narrowly defined detection and interpretation tasks, 
computers perform on par with or even better than radiologists. A requirement 
is that these deep learning algorithms are trained on a sufficiently large amount 
of high-quality annotated data. Larger multi-center validation studies are still 
needed to demonstrate that these algorithms work correctly on the variety of 
real-world data, obtained with different scanners and protocols. In this talk, I 
will showcase several examples of high-performing deep learning algorithms 
and argue that the radiological community should play a more active role in (1) 
identifying which tasks should be automated; (2) evaluating and validating 
automated systems in a fair and comparative manner; (3) collecting the high-
quality annotated training and evaluation data; (4) clearly defining the role of 
human readers together with automated systems.  
Learning Objectives: 
1. To learn about the principles of machine learning. 
2. To appreciate the current performance of deep learning in radiology and 
beyond. 
3. To learn about the limitations due to the complexity of radiology. 
Author Disclosure: 
  B. van Ginneken: Founder; Thirona. Owner; Thirona. Research/Grant 
Support; MeVis Medical Solutions, Delft Imaging Systems. Shareholder; 
Thirona. 
A-172 08:58  
Artificial intelligence applications in radiology  
J.B. Seo; Seoul/US (seojb@amc.seoul.kr)  
The recent advances in artificial intelligence, particularly deep learning 
algorithm, have shown performances superior to those of human in image 
recognition of non-medical fields. Accordingly, many researchers and 
companies have tried to apply artificial intelligence in radiology. Artificial 
intelligence can be applied in various aspects of medical imaging such as 
noise reduction, artefact reduction, lesion segmentation, detection, 
classification, and differential diagnosis. Early studies have shown promising 
results in several applications such as detecting nodule or tuberculosis on 
chest radiograph. Furthermore, this technique can applied in finding similar 
cases from the database, predicting disease outcome and so on. In this talk, 
general concept of artificial intelligence and early results of various applications 
of artificial intelligence in medial image will be introduced.  
Learning Objectives: 
1. To become familiar with first clinical applications. 
2. To consolidate knowledge about the integration in the clinical workflow. 
3. To appreciate the future roadmap and its impact on training of young 
radiologists. 
Author Disclosure: 
  J.B. Seo: Shareholder; Coreline Soft Co. Speaker; Siemens / Guerbet. 
A-173 09:21  
Big data for deep learning  
C.L. Schlett; Heidelberg/DE (christopher.schlett@med.uni-heidelberg.de)  
Deep learning is currently an extremely active research area and has the 
potential to be the biggest game changer in medical imaging since the advent 
of digital imaging. It requires massive amount of training dataset with accurate 
annotation; however, annotation of medical images is particular difficult and 
resource consuming as compared to other examples outside of medicine. 
Potentially induced error and bias due to imperfect annotation and/or 
inconsistency increase further the needed sample size. Several sources of 
medical images can be considered. While clinically acquired data are broadly 
available, they are often not interlinked with other data and face the issue of a 
high variability. A potentially more suitable source for big data could be large, 
population-based cohort studies such as the Rotterdam Study, the UK BioBank 
or the German National Cohort, since they have a high level of data quality and 
consistency regarding imaging, and they further frequently linked with clinical 
outcomes and annotations. However, deep learning in medical imaging 
remains a great challenge, not only because of the necessity for big data.  
Learning Objectives: 
1. To become familiar with the opportunities of big data analysis. 
2. To understand that quality of big data is pivotal. 
3. To learn how to generate "evidence" from big data analysis in radiology. 
 
  








Panel discussion: Machines in radiology: do we still need the 
radiologist?  
08:30 - 10:00 Room C 
Breast  
RC 502  
New mammography: tomosynthesis and 
future techniques  
A-174 08:30  
Chairperson's introduction  
E.M. Fallenberg; Berlin/DE (eva.fallenberg@charite.de)  
Early detection of breast cancer through X-ray mammography (MG) has been 
shown to reduce mortality; however, the method is limited by a decreased 
sensitivity and specificity particularly in young patients and women with 
radiographically dense breasts due to tissue overlying and masking tumours or 
architectural distorsions. The introduction of full field digital mammography 
gave the possibility to develop further technical methods, to overcome these 
limitations. Some of these are tomosynthesis, contrast enhanced 
mammography and contrast enhanced tomosynthesis as well as most recently 
also breast CT. In this talk will be presented the background of 2D-
mammography, tomosynthesis and contrast enhanced mammography 
techniques and breast CT. Potential advantages and disadvantages will be 
indicated and a sample of clinical cases will be presented to illustrate how the 
different techniques contribute to the detection of lesions.  
Session Objectives: 
1. To learn about 2D mammography and digital breast tomosynthesis. 
2. To recognise the advantages and disadvantages of tomosynthesis 
compared to 2D mammography. 
3. To look into the future and hear about the potential of new breast imaging 
techniques in lesion assessment. 
Author Disclosure: 
  E.M. Fallenberg: Board Member; EUSOBI. Research/Grant Support; GE 
Healthcare, Guerbet. Speaker; GE Healthcare, Bayer Healthcare, Gurbet. 
A-175 08:35  
A. Should we abandon 2D mammography?  
S. Zackrisson; Malmö/SE (sophia.zackrisson@med.lu.se)  
Full-field digital mammography (FFDM), also called 2D mammography, with flat 
panel detectors has been broadly used in clinical routine for about a decade. 
Even if there has been advances in the technical development of the digital 
detectors, the detectors are not the main limiting factor in breast cancer 
detection; the challenge is the anatomical noise, i.e., dense breast tissue. 
FFDM is a two-dimensional modality and inherent in that is that dense breast 
tissue may cause overprojection and hide or simulate the presence of a tumour 
on these images even if several views are acquired. Digital breast 
tomosynthesis, DBT is a 3D mammography technique that, to a large extent, 
can suppress the confounding effect of the overlapping tissue. DBT is a strong 
competitor to 2D mammography both for screening and clinical examinations. 
This presentation will cover 2D mammography in terms of technical 
background and optimisation of image quality. Furthermore, it will discuss the 
advantages and disadvantages of 2D mammography compared to DBT and 
evaluate if there are situations where 2D mammography still could be the 
preferred method if DBT is transitioned into screening and clinical practice.  
Learning Objectives: 
1. To understand the technique of 2D mammography and what the limits could 
be. 
2. To learn if there are ways to improve image quality of 2D mammography. 
3. To understand when 2D mammography is better than DBT. 
Author Disclosure: 
  S. Zackrisson: Speaker; Speaker's fees and travel support from Siemens 
Healthineers. 
A-176 09:00  
B. Clinical validation of tomosynthesis and results in the last 10 years: 
where do we stand?  
P. Skaane; Oslo/NO (per.skaane@outlook.com)  
Digital breast tomosynthesis (DBT), an advanced mammographic technique, 
has the potential to improve two inherent limitations of conventional 
mammography, FFDM: poor sensitivity in women with dense breasts (caused 
by superimposed parenchyma, “masking effect”) and low specificity (caused by 
parenchyma simulating a mass, “pseudotumor”). In diagnostic setting, DBT can 
replace conventional supplemental views for evaluation of indeterminate 
noncalcified lesions, “downgrade” some indeterminate (BI-RADS 3) lesions, 
and “upgrade” other equivocal masses indicating the need for biopsy. Thus, 
fewer lesions need to have follow-up. Evaluation of extent and multifocality of 
cancer is better demonstrated at DBT, and consequently preoperative cancer 
staging is improved. All the retrospective US screening studies comparing 
FFDM versus FFDM+DBT have shown a significantly lower recall rate for DBT, 
and most studies also an increased cancer detection rate. Lack of significant 
increase in cancer detection in other US studies might have been caused by 
study design and lack of power. The four prospective European trials 
comparing FFDM vs. FFDM+DBT in screening published so far have all 
demonstrated a significantly higher cancer detection rates for DBT, but variable 
recall rates. Challenges regarding implementation of DBT in screening include 
number of projections, reading time, and women with very dense breasts (BI-
RADS d). The radiation dose problem is solved by synthetic 2D images. 
Studies on cost-effectiveness, harm-benefit analyses, overdiagnosis, and 
subsequent interval cancer rates and potential reduction of advanced stage 
cancers would be of importance. Overall, DBT has clearly shown a higher 
accuracy than FFDM in diagnostic as well as screening settings.  
Learning Objectives: 
1. To become familiar with the technique of DBT. 
2. To understand the results of DBT in the screening and diagnostics settings. 
3. To know the evolution of tomosynthesis in screening organisation. 
Author Disclosure: 
  P. Skaane: Equipment Support Recipient; Tomosynthesis equipment for the 
Oslo Tomosynthesis Screening Trial was provided by Hologic.. 
A-177 09:25  
C. The future of mammography: my predictions  
E. Giannotti; Nottingham/UK (Elisabetta.Giannotti@nuh.nhs.uk)  
Breast screening aims to diagnose breast cancer at the earliest opportunity, 
maximize treatment success and reduce breast cancer-related mortality. 
Mammography is the mainstay of screening but it is less sensitive for some 
women, particularly those with dense breasts. Supplemental imaging leads to 
the detection of additional cancers, but this approach increases unnecessary 
recalls and healthcare costs and screening tools by definition should be 
feasible and affordable. In the future, tailored screening based on different 
(personal) risk factors is expected to replace the current standard (one size fits 
all) mammography screening programs, in order to reduce the potential harm 
and costs of screening and increase cancer detection. To achieve this it is 
crucial to develop more accurate risk assessment models that can be easily 
adopted in routine clinical practice. Innovative diagnostic techniques (such as 
digital mammography, quantitative breast density analysis, texture analysis 
and deep learning) could have a crucial role not only in the early diagnosis, but 
also being an active part of the risk assessment for developing breast cancer. 
Lately new digital techniques have been implemented, for example, digital 
breast tomosynthesis and contrast enhanced spectral mammography, 
improving mammographic sensitivity and offering new opportunities that will 
assist in the risk stratification of the patient. In order to increase cancer 
detection rate and reduce breast cancer related mortality we have the potential 
to improve mammographic sensitivity and utilization, and use these techniques 
not only for diagnosis but for stratifying breast cancer risk in order to tailor 
breast cancer screening for “individual women”.  
Learning Objectives: 
1. To understand the role of mammography in analysing and characterising 
breast lesions. 
2. To become familiar with new developments in digital mammography such as 
contrast mammography, tomosynthesis and 3D contrast mammography. 
3. To learn about the new potential of combining mammography with molecular 
imaging, optical imaging and texture analysis. 
09:50  
Panel discussion: Mammography and/or tomosynthesis: where will we 














08:30 - 10:00  Room Z 
Joint Session of the ESR and UEMS  
ESR/UEMS 1  
ESR and UEMS: a united European voice  
A-178/A-179 08:30  
Chairpersons' introduction  






The UEMS - European Union of Medical Specialists is the oldest European 
medical organisation representing the interests of more than 50 different 
medical specialities and involving more than 1.6 million of healthcare 
professionals. The ESR - European Society of Radiology is the world’s biggest 
radiological society, encompassing 67.500 members from 155 different 
countries. It was founded in 2005 by merging the European Congress of 
Radiology and the European Association of Radiology, aiming at establishing a 
single, powerful and unified voice for European radiologists. Through the 
section of radiology of the UEMS, UEMS and ESR share the same ambitious 
objective of promoting the highest quality of care and medical practice in 
radiology, by serving the needs of patients and general public, harmonizing 
radiological training and defending free movement and professional interests of 
European radiologists. This Joint session will focus on the concept and 
importance of advocacy at the level of the European Union, with specific 
emphasis on clinical audit in radiology and the impact of the European BSS 
Directive. With regard to the harmonisation of radiological training, the history 
and the future of the assessment programme of European training centers will 
be discussed. Finally, particular attention will be dedicated to the working 
methodologies of EACCME (European Accreditation Council for Continuing 
Medical Education) and ACI (Accreditation Council in Imaging) in the 
framework of CME - Continuing Medical Education and CPD - Continuing 
Professional Development programmes. 
Session Objectives: 
1. To describe the role of the UEMS within the EU. 
2. To understand the difference between ESR and UEMS. 
3. To understand the importance of cooperation between ESR and UEMS. 
Author Disclosure: 
  M. Adriaensen: Other; Board Member; UEMS SECTION of RADIOLOGY; 
member, Standards Committee of the European Board of Radiology; member, 
EBR-UEMS ETAP 2.0 working group. 
A-180 08:35  
Differences and similarities between ESR and UEMS (part 1) 
P.M. Parizel; Antwerp/BE  
The UEMS and the ESR share a common ideal of serving the healthcare 
needs of the general public through the support of science, teaching and 
research and improving the quality of service. However, UEMS and ESR have 
a different structure: whereas the UEMS is the representative organisation of 
the National Associations of Medical Specialists in the European Union and its 
associated countries, the ESR is foremost a society of individual members. The 
UEMS was founded in 1958 and it is the oldest European medical 
organisation. With a current membership of 39 National Member Associations, 
it comprises 43 different Specialist Sections and Boards, 14 Multidisciplinary 
Joint Committees and over 20 Divisions, involving more than 1.6 million 
healthcare professionals. As the representative organisation of National 
Medical Associations (NMAs) in the EU and its associated countries, the 
UEMS sets standards for high quality healthcare practice, which are 
transmitted to authorities and institutions of the EU and the NMAs, stimulating 
and encouraging them to implement its recommendations. With more than 
75,500 members from 157 different countries, the ESR, an apolitical, non-
profit-organisation, is the world’s biggest radiological society. Founded in 2005 
by merging the European Congress of Radiology (ECR) and the European 
Association of Radiology (EAR), the ESR aims to offer a single, powerful and 
unified voice for European radiologists, thus providing a single house of 
radiology in Europe. In this session, the speakers will highlight the intense and 
positive collaboration between ESR and UEMS.  
Learning Objectives: 
1. To understand the structure of the UEMS and ESR. 
2. To understand the differences between ESR and UEMS. 
3. To understand the importance of UEMS/ESR political involvement in EU 
affairs. 
 
A-181 08:40  
Differences and similarities between ESR and UEMS (part 2) 
B. Maillet; Brussels/BE (bernie.mail@skynet.be) 
European legislation has three levels, from the highest level to the lowest level 
the Regulation, the Directive to the Recommendation. The strongest, the 
Regulation has immediate effect at National level while the Directive has to be 
transposed into National legislation and here derogations can be included 
while Recommendations are not really binding. The European Commission 
drafts those pieces of legislation that have to be then approved both by the 
European Parliament and by the European Council of Ministers jointly. This is 
the so-called EU institutional triangle. And the lobbying can be organised, first, 
at the level of the Drafting of the legislation, contacting the European 
Commission and trying to explain why we as Medical Specialists have some 
positions on some issues but also by contacting the individual Members of the 
European Parliament. There are some MEP’s who are physicians and so they 
are the first “target” of our Lobbying activity at the European Parliament. As 
both the ESR as well as the UEMS Section of Radiology as an integral part of 
the UEMS have both as aim the defense of Radiology and the Radiologists for 
the benefit of better diagnosis for the European citizen and patient, they should 
lobby together in order to avoid duplication and be much more efficient. In the 
recent past such a common action has proven to be effective with for instance 
the derogation for MRI in field of the European Directive on Magnetic Fields. 
Learning Objectives: 
1. To understand the structure of the UEMS and ESR. 
2. To understand the differences between ESR and UEMS. 
3. To understand the importance of UEMS/ESR political involvement in EU 
affairs. 
A-182 08:45  
The European Perspective (part 1): advocacy at the EU Level (part 1) 
V.E. Sinitsyn; Moscow/RU 
Advocacy in medicine and radiology could be defined as a coordinated 
combination of problem identification, solution creation, strategy development, 
and actions taken by all participants in order to achieve the positive changes. 
Today the European radiological community has been facing a serious 
problem: the role of our specialty in modern healthcare is undervalued. This 
situation urgently needs to be corrected with help of large-scale advocacy 
campaign organised both by UEMS and ESR. Through advocacy, rights and 
needs of radiologists could be expressed and represented. So far radiologists 
and national radiological societies have the insufficient political influence to 
change a view of EU, national governments and health authorities on the new 
role of radiologists in the value-based system of healthcare. UEMS has 
contacts with the Authorities and Institutions of the EU, representing multiple 
organisations of the National Associations of Medical Specialists in the EU. 
From another side, ESR has vast professional expertise in all fields of 
radiology, including training of radiologists, setting of standards and guidelines, 
organisation of quality control, patient safety, information management and 
value-based imaging. Advocacy and political lobbying of European radiology 
from multiple combined actions from UEMS and ESR will stimulate and 
encourage EU and national authorities to implement recommendations from 
both professional organisations. Digital technologies and social media make 
such advocacy campaign more visible and effective. Advocacy campaign 
supporting European radiologists will results also in recognition of UEMS and 
ESR as trusted and effective organisations providing added value to the 
healthcare system of EU. 
Learning Objectives: 
1. To understand the concept of advocacy. 
2. To understand the importance of advocacy in the EU. 
3. To learn how the advocacy can improve the role of UEMS and the ESR in 
Europe. 
A-183 08:50 
The European Perspective (part 1): advocacy at the EU Level (part 2) 
B. Maillet; Brussels/BE (bernie.mail@skynet.be) 
The Union Européenne des Médecins Spécialistes is an umbrella organisation 
representing the Professional Medical Associations of the European Union and 
even broader, the European Area. The members are the National Medical 
Associations (NMA) representing medical specialists in the different Member 
States (MS) and was created by the NMA’s of the six countries that created the 
European Economic Community (EEC, as was the name of the EU at that 
time) by the signing of the Rome Treaty in 1957 so the UEMS is the largest 
and oldest European Medical Organization (EMO) and will celebrate in 2018 its 
60th anniversary. Aside the NMA’s the UEMS also has 43 specialist Sections 
one of those being the UEMS Section of Radiology. The aims and objectives of 
the UEMS are the highest level of training of medical specialists and works 
also on the harmonisation of CME-CPD in Europe through the European 
  







Council for CME (EACCME) that has an agreement on mutual recognition of 
Credits with the American Medical Association (AMA) and with the Royal 
College of Physicians and Surgeons of Canada (RCPSC) as well as 
harmonisation of training through European Examinations and the Council for 
European Specialist Medical Assessment (CESMA) that is part of the UEMS 
European Council for Accreditation of Medical Specialist Qualification 
(ECAMSQ). 
Learning Objectives: 
1. To understand the concept of advocacy. 
2. To understand the importance of advocacy in the EU. 
3. To learn how the advocacy can improve the role of UEMS and the ESR in 
Europe. 
A-184 08:55  
The European Perspective (part 2): clinical audit and its implementation 
in view of the European BSS Directive  
B.E. Kelly; Belfast/UK  
In 2018, Euratom Directive 2013/59 will come into effect. This will mandate the 
regular use of clinical audit as a tool for measuring, among other parameters, 
patient safety and radiation protection. In 2017, the audit subcommittee 
produced a booklet (Esperanto) designed to guide the user through the 
principles of clinical audit. A pilot study, performed during the summer of 2017, 
tested the efficacy of the templates within the booklet. The results of this 
indicated that respondents found the algorithm straightforward, the templates 
navigable and the subjects audited, relevant.  
Learning Objectives: 
1. To understand the definition of clinical audit. 
2. To learn about the existence and the legal consequences of the current 
European directive addressing clinical audit in radiology. 
3. To hear about best practices with regard to the implementation of clinical 
audit in radiology 
A-185 09:05  
ETAP 2.0 (part 1): history of ETAP  
H. Aronen; Turku/FI (hannu.aronen@utu.fi)  
The European Training Assessment Programme (ETAP) is a subcommittee of 
the education committee of the European Society of Radiology (ESR). It was 
established in 2001 as a joint initiative between the EAR (European 
Association of Radiology) and the UEMS (European Union of Medical 
Specialists). It has been funded equally by the ESR and the UEMS. ETAP is 
one of the oldest collaboration forms between ESR and UEMS radiology 
section. The aims of ETAP are to improve and harmonise the standards of 
radiology training in Europe, provide institutions that offer postgraduate 
radiology education with objective assessment of their training programmes by 
external assessors nominated by ESR and UEMS and develop assessment 
systems and guidelines for use by postgraduate education authorities at the 
national level. The program has been voluntary, and visits have been made on 
requests from the individual training centers. ETAP has also developed a self 
assessment tool for training centres. ETAP programmes encourage self 
regulation of the specialist training in radiology, further increasing the 
autonomy of European radiologists. The recommendations in the guidelines 
are compatible with the European Training Curriculum for Radiology and 
modern international educational references. ETAP has offered an objective 
method based on external systematic evaluation and self assessment to 
develop radiological specialist programs in Europe. It is necessary that we 
radiologists evaluate our specialist training ourselves. 
Learning Objectives: 
1. To understand the importance of ETAP in the past years. 
2. To know about the structure of ETAP. 
3. To learn about facts and figures of ETAP.  
A-186 09:15  
ETAP 2.0 (part 2): modernisation of ETAP  
L. Oleaga Zufiría; Barcelona/ES (lauraoleaga@gmail.com)  
The European Training Assessment Programme (ETAP) was established in 
2001 as a joint initiative of the European Society of Radiology (ESR) with the 
UEMS (European Union of Medical Specialists) radiology section. The aims of 
the programme were to improve and harmonise the standards of radiology 
training in Europe based on the ESR European Training Curriculum for 
Radiology (ETC) and provide institutions that offer postgraduate radiology 
education with an objective assessment of their training programmes by 
external assessors nominated by the ESR. The main limitation of the 
programme was the limited availability due to the necessity to displace 
advisors. This constraint made the program inefficient since it could not reach 
a large number of institutions. Another limitation was the lack of official 
certification. The new ETAP 2.0 configuration changes from onsite assessment 
to virtual assessment. The assessment programme is divided into 4 phases: 
1st phase: application and completion of the documents. 2nd phase video 
report of the facilities of the centre. 3rd phase online interviews in a structured 
manner with the trainees, tutors and head of the department. 4th phase 
certification by the accreditation council in Imaging (ACI). There are three 
levels of certification: basic, intermediate and excellence, based on the score 
reached by the centre after the evaluation of the three phases. A report with 
recommendations for improvement is sent to the centre that has to report back 
within the established time frame as it was done in the prior ETAP programme. 
It is foreseen a reaccreditation every 5 years.  
Learning Objectives: 
1. To understand the limits of ETAP 1.0. 
2. To learn about the new configuration of ETAP. 
3. To learn about the "starring system". 
A-187 09:25  
CME/CPD in Europe (part 1): EACCME 2.0  
P. Ricci; Rome/IT (paolo.ricci@uniroma1.it)  
The European Accreditation Council for Continuing Medical Education 
(EACCME) has been created by the European Union of Medical Specialists 
(UEMS) in 1999 and started operating in January 2000 with the aim of 
encouraging high standards in development, delivery, and harmonisation of 
Continuing Medical Education (CME) through the international accreditation of 
CME events, and the establishment of a system for the international 
acceptance of CME credits (ECMEC). EACCME can validate and grant the 
official number of ECMEC after professional evaluation has been performed by 
a CME National Accreditation Authority or UEMS Specialty Board. To facilitate 
the transfer of credits and allow the free movement of healthcare professionals 
within Europe, 1 ECMEC equates to 1 hour of CME, with a maximum of 6 
ECMECs for a day and 3 ECMECs for half a day. Beyond European member 
states, mutual recognition agreements have been signed with the American 
Medical Association and the Royal College of Physicians and Surgeons of 
Canada, thus enhancing the international status of EACCME. To comply with 
the growing scopes of CPD-Continuing Professional Development, broader 
than CME, EACCME currently recognises the review and publication of 
scientific and educational material, e-learning by teaching and the participation 
in UEMS examinations as an examiner. As of January 2017, EACCME 2.0 
version has become applicable, resulting in a new interactive platform for 
providers and users, a faster and more efficient accreditation process and in 
the recognition of e-learning materials (e-platform, e-library, apps).  
Learning Objectives: 
1. To learn about the European Accreditation Council for Continuing Medical 
Education (EACCME®). 
2. To know about the existence of European CME and CPD credits. 
3. To learn about the new EACCME 2.0. 
Author Disclosure: 
  P. Ricci: Other; ACI, Scientific Director; UEMS Section of Radiology, 
President; UEMS EEC, Member. 
A-188 09:30  
CME/CPD in Europe (part 2): the Accreditation Council in Imaging  
P. Ricci; Rome/IT (paolo.ricci@uniroma1.it)  
Educational events sent to UEMS/EACCME for European Accreditation have 
to be evaluated by two distinct structures: the National Accreditation Authority 
of the country where the activity is to take place, and the related UEMS Section 
or European Specialty Accreditation Board (ESAB). Based on the mutual 
agreement between the Accreditation Authorities, the Sections and ESABs, the 
process is recognised throughout Europe and the different specialties of the 
UEMS. Recent steps have been taken by the EACCME in order to harmonise 
the whole system in Europe independently from the specialty or the country 
where the activity has taken place. The Section of Radiology keeps the role of 
back-up reviewer for those countries not yet enlisted in EACCME accreditation 
agreements. In 2015, the Section started a fruitful cooperation with the 
Accreditation Council in Imaging (ACI), the body established by the European 
Board of Radiology - an initiative of the European Society of Radiology - in 
Barcelona to reach homogenisation of radiology education across Europe. 
Following an amended agreement in 2016, representatives of the Section hold 
the chair of Scientific Director on alternate basis and sit permanently in ACI 
Policy and Reviewing Committees, each guided by a chairperson. The 
necessary adaptation of ACI Terms & Conditions to the revised criteria for the 
accreditation of Live Educational Events (LEE) and of E-learning materials 
(ELM) has been recently conducted November 2016 - January 2017. ACI team 
is offering constructive feedback on the successful implementation of the 
EACCME 2.0 online platform.  
Learning Objectives: 
1. To learn about the ESABs under the EACCME umbrella. 
  







2. To learn about the structure of the Accreditation Council in Imaging (ACI). 
3. To understand the importance of cooperation with and recognition by the 
EACCME®. 
Author Disclosure: 
  P. Ricci: Other; ACI, Scientific Director; UEMS Section of Radiology, 
President; UEMS EEC, Member. 
A-189 09:35  
CME/CPD in Europe (part 3): the many ways to gain European CME/CPD 
credits  
M.A. Lucic; Sremska Kamenica/RS (milos.a.lucic@gmail.com)  
Recognising the tendency of continuing-medical-education (CME) shift from 
voluntary to mandatory within Europe, the European Union of Medical 
Specialists (UEMS) and its European Accreditation Council for CME 
(EACCME®) introduced European Continuing Medical Education Credits® 
(ECMECs), as CME "tokens" reflecting objectively the CME activity that 
facilitates the exchange of CME credits between European countries and 
comparable systems outside Europe. Considering CME as educational 
activities which serve to maintain, develop or increase the knowledge, skills, 
professional performance and relationships that physician/radiologist uses to 
provide services for patients or profession, ECMECs are awarded for both live 
educational events, and e-learning materials, but from recently also for 
continuing professional development (CPD), defined as the educative means 
of updating, developing and enhancing how physicians apply the knowledge, 
skills and attitudes required in their working lives (Basle Declaration, 2001). As 
CPD incorporates and goes beyond CME, EACCME 2.0, adopted in 2016, 
enabled EACCME® recognition of the several CPD/CME activities that include 
reviewing and/or publishing scientific and educational material, learning by 
teaching, and examining in UEMS exams, including EDiR exam. Being aware 
that CME/CPD systems in Europe differ between countries, the Accreditation 
Council in Imaging (ACI) has recently conducted two surveys, addressed to 
ESR Institutional Member Societies and individual ESR members, which 
provided valuable information on differences in accreditation systems in 
European countries, but also reflected several important standpoints, including 
the recognition of ECMECs as universal European CME "tokens", and 
unification of CME/CPD systems within Europe, which shall be acknowledged 
as the "voice of European radiologists" in future considerations.  
Learning Objectives: 
1. To know about the existence of European CME Credit (ECMEC®). 
2. To learn about the concept of CPD. 
3. To learn about the importance of credits in different European countries. 
Author Disclosure: 
  M.A. Lucic: Board Member; EBR ACI Policy Committee Chairman. 
Consultant; Affidea Serbia. Research/Grant Support; Secretariat for Higher 




08:30 - 10:00  Room O  
Paediatric  
RC 512  
Imaging in abdominal emergencies: an 
(evidence-based) update  
Moderator:  
C.E. de Lange; Oslo/NO  
A-190 08:30  
A. The acute abdomen in neonates  
S. Stafrace; Doha/QA (samstafrace@yahoo.com)  
Common causes of neonatal abdominal emergencies are reviewed focusing on 
congenital intestinal obstruction, malrotation and necrotising enterocolitis 
(NEC). Radiologists play a pivotal part in the management of neonates with 
suspected obstruction and are often asked for an opinion on the presence or 
not of obstruction, the level of obstruction and the cause. The standard choice 
of radiological modalities includes plain film, ultrasound (US) and fluoroscopy. 
Neonatal intestinal obstruction is classified as upper/high versus low 
obstruction done through presenting symptoms and plain film appearances. 
High obstruction presents with vomiting or increased aspirates. Main 
differential diagnoses include congenital obstructions of the duodenum/jejunum 
and malrotation. High obstruction often leads to surgical exploration with some 
radiographic patterns being diagnostic enough to recommend surgery including 
the ‘double bubble’ and ‘triple bubble’ signs. Bilious vomiting and/or the start of 
symptoms in the immediate postnatal period increases the clinical suspicion for 
malrotation. In such cases an urgent upper GI study is indicated. Operators 
should be comfortable with the fluoroscopic technique, normal duodenal 
landmarks and with the less common duodenal anatomical variants. Low 
obstruction presents with distention, vomiting and failure to pass meconium. 
Multiple dilated loops are seen on radiography. Differential diagnoses include 
Hirschsprung disease (HD), small left colon, meconium ileus and atresias. 
Outside HD (when rectal biopsy is diagnostic), suspected low obstruction 
warrants a contrast enema; providing high diagnostic specificity. NEC is the 
leading gastrointestinal emergency of the premature neonate. Imaging mainly 
involves plain films and ultrasound; guided by the clinical course of the 
neonate.  
Learning Objectives: 
1. To learn about typical neonatal abdominal emergencies. 
2. To understand the choice of modalities in acute abdomen in neonates. 
3. To appreciate typical findings and 'red flag' features. 
A-191 09:00  
B. The acute abdomen in young children  
A.D. Calder; London/UK (Alistair.Calder@gosh.nhs.uk)  
Common causes of the acute abdomen in children beyond the neonatal period 
are reviewed, with a focus on three conditions with major roles for imaging: 
hypertrophic pyloric stenosis, intussusception, and acute appendicitis. The 
evidence base underlying the roles imaging plays is evaluated for each 
condition. 
The role of ultrasound in pyloric stenosis is well established and is generally 
highly sensitive and specific. Pyloric length and muscle thickness parameters 
remain robust measures for correct diagnosis, but may need to be adjusted for 
age and size. Additional signs which may be useful, such as pyloric shape and 
colour doppler findings are discussed. Surgical management remains the 
mainstay of treatment, despite evidence of effectiveness of medical therapy in 
some children. The role of ultrasound in the diagnosis of intussusception is 
similarly well supported and is highly accurate even in relatively inexperienced 
hands. Radiologists also typically play the leading role in initial attempts to 
reduce intussusception, and are mostly successful. Various techniques for 
reduction are available, each with their own advocates and evidence base. 
Acute appendicitis is the most common abdominal emergency requiring 
surgery. Pre-operative imaging diagnosis is now the norm. Ultrasound is 
recommended as the primary imaging tool in children, but can lack sensitivity 
and in most centres, equivocal sonography is followed by cross sectional 
imaging. CT has a strong evidence base for accurate diagnosis of appendicitis, 
but confers significant radiation burden. Low dose protocol CT and MRI offer 
alternatives with potentially similar levels of accuracy. Differential diagnoses for 
appendicitis including adnexal torsion and mesenteric adenitis are briefly 
explored. 
Learning Objectives: 
1. To learn about the causes of acute abdominal pain in children. 
2. To understand the choice of imaging techniques and their limitations. 
3. To appreciate typical radiological features of abdominal emergencies. 
A-192 09:30  
C. Polytrauma: differences between adult and paediatric protocols  
M. Raissaki; Iraklion/GR  
Trauma is still the most frequent cause of mortality and disability in childhood 
and adolescence. Emergency physicians have to thoroughly assess injured 
children following high-energy trauma. Traumatized children differ from adults: 
haemodynamically stable children may be actively bleeding. Conversely, 
children have smaller caliber vessels, stronger vasoconstriction, stronger solid 
organ capsules; bleedings may stop spontaneously, organ rupture is more 
difficult and delayed rupture rare. This is why children are imaged aggressively 
although few will undergo surgery or trans-arterial embolisation. Imaging is 
mandatory for diagnosis and management especially during the primary 
survey. Its goal is to exclude life-threatening injuries, identify children that may 
rapidly deteriorate because of clinically silent active bleeding, increase the 
surgeon’s confidence level by clarifying injuries that need to be treated and 
ultimately determine short and long-term management. Radiographs and 
ultrasonography play a basic role in haemodynamically unstable patients. 
Contrast-enhanced ultrasound is an emerging diagnostic tool in low-energy 
trauma and in suspected isolated abdominal injuries. In stabilized patients CT 
scanning has been considered a sensitive, specific, and accurate test for 
identification and grading of multi-organ injuries. Due to children’ increased 
radiosensitivity, CT scans should be indicated based on appropriate early 
clinical evaluation of the closely monitored child and assessment of risk factors 
for CNS, chest, MSK and abdominal injuries. ALARA includes avoiding non-
contrast scans, avoiding multiple phases and applying age/weight-dependent 
  







exposure parameters and radiation-saving reconstruction algorithms. CT 
should not be performed for follow-up unless there is clinical deterioration. 
Objective documentation of injuries is extremely important in suspected child 
abuse.  
Learning Objectives: 
1. To learn how paediatric trauma differs from adult trauma. 
2. To understand how examination techniques and protocols must be tailored 
accordingly. 
3. To appreciate the importance of multidisciplinary team collaboration in 
planning and conducting radiological investigations in a trauma setting. 
08:30 - 10:00 Room N  
Cardiac  
RC 503  
From diagnosis to prognosis: how does 
cardiac imaging affect patient outcome?  
Moderator:  
U. Reiter; Graz/AT  
A-193 08:30  
A. In myocarditis  
M. Francone; Rome/IT (marco.francone@uniroma1.it)  
Natural history of acute and chronic myocarditis is often unpredictable being 
independent on the clinical onset of disease and even poorly correlated with 
more traditional clinical predictors like end-distolic volume or ejection fraction. 
In most cases, patients typically improve within weeks to months, but an 
unfavourable clinical evolution may be observed in a minority of individuals 
consisting with the development of chronic ventricular dysfunction progressing 
leading to transplantation or death in 25% of cases. CMR has emerged as a 
central prognostic indicator in inflammatory cardiomyopathies, mainly because 
of its ability to detect tissue fibrosis in vivo. This has been demonstrated with a 
growing and consistent scientific evidence, derived from late enhancement 
imaging and more recently from native T1 mapping and ECV. Present lecture 
will aim to illustrate of CMR capabilities as prognostic indicator in acute and 
chronic myocarditis, providing an overview of most important published studies 
and ongoing clinical trials. Particular emphasis will given to the importance of 
T1 and T2 mapping techniques, being a new standard of reference for CMR 
diagnosis and patient’s prognostic stratification.  
Learning Objectives: 
1. To learn about the link between clinical presentation and imaging signs. 
2. To understand the current state-of-the-art MRI method for the diagnosis of 
myocarditis. 
3. To learn how MRI could be used to assess prognosis in myocarditis. 
A-194 09:00  
B. In non-ischaemic cardiomyopathy  
A. Jacquier; Marseille/FR (alexis.jacquier@ap-hm.fr)  
Non-ischaemic cardiomyopathy is one of the major indications of cardiac MR 
worldwide. MRI is now included in all European guidelines for diagnosis and 
prognosis assessment in cardiomyopathy. During that talk we will focus on 
dilated cardiomyopathy, hypertrophic cardiomyopathy and arrythmogenic right 
ventricular dysplasia. MRI is a potent tool to assess phenotype of the 
myocardium and characterise tissue in both patients and proband. New 
sequences or post treatment tools could be helpful to better characterise 
myocardial tissue such as parametric maps and feature tracking.  
Learning Objectives: 
1. To recognise the tell-tale signs of early ARVC, HCM and dilated 
cardiomyopathy that affect progression or prognosis. 
2. To understand what should be measured and reported. 
3. To appreciate the role of MRI in early diagnosis and prognosis assessment 
in these cardiomyopathies. 
Author Disclosure: 
  A. Jacquier: Research/Grant Support; Guerbet. 
A-195 09:30  
C. In coronary artery disease  
R. Salgado; Antwerp/BE (rodrigo.salgado@uza.be)  
Non-invasive imaging of the coronary arteries using CT has in the past decade 
reached worldwide clinical implementation. This is the consequence of both 
technical advances of CT imaging, as well as the validation of this technique in 
multiple clinical trials and randomised studies. One of the main strengths of 
non-invasive coronary artery imaging is the ability to exclude obstructive 
disease, as such eliminating the need for further invasive examinations. 
Furthermore, the quantification of coronary calcium provides a quantitative 
measure of the degree of arteriosclerosis, further helping in the risk 
stratification of patients. During this lecture, we will review the scientific 
evidence regarding the use CT-angiography of the coronary arteries in different 
populations, their impact on actual clinical management and their significance 
for mid- and long-term prognosis. Additionally, new technologies aimed at 
improving triage for further testing in patients with intermediate stenosis 
(including CT-derived fractional flow reserve) and their potential role will be 
discussed. Finally, a structured reporting scheme will be provided to streamline 
the communication of findings to referring physicians.  
Learning Objectives: 
1. To understand which patients will benefit from anatomic assessment or 
functional assessment of the coronary arteries. 
2. To learn about how to report on anatomic and functional assessment of 
coronary arteries. 
3. To appreciate the role of non-invasive imaging in prognosis assessment. 
08:30 - 10:00 Studio 2018  
State of the Art Symposium  
SA 5a  
Whole-body MRI: ready for prime time?  
A-196 08:30  
Chairperson's introduction  
F.E. Lecouvet; Brussels/BE (frederic.lecouvet@uclouvain.be)  
WB-MRI is now a commonly applied modality for bone screening for 
“osteophilic” metastatic cancers, lymphomas, and multiple myeloma and can 
also assess visceral and nodal involvement. WB-MRI’s applications have been 
expanded to other fields, mainly in rheumatology; it has shown promise for 
diagnosis and evaluation of treatment response of spondyloarthropathies, and 
many muscle, bone, neurological, and vascular disorders. The diversity of 
indications is reflected by the segmentation of this session: the different 
medical fields where WB-MRI contributes to improvement in patient care will be 
addressed by expert speakers from varied geographical origins who will share 
their respective experience. They will Illustrate imaging findings, provide 
technical recommendations, and describe the place oft he technique amongst 
others in modern management of diseases.  
Session Objectives: 
1. To become aware of the feasibility of whole-body MRI. 
2. To learn about its roles: detect, monitor and provide prognostic information. 
3. To understand the anatomic targets: bone and beyond. 
4. To become familiar with current developments in the technique and their 
implementation. 
A-197 08:35  
The case of metastatic bone disease  
A.R. Padhani; London/UK (anwar.padhani@talk21.com)  
WB-MRI will replace current, ineffective & indirect methods of malignant 
disease detection in the bone marrow with applications in myeloma, breast, 
and prostate cancer. Multiple imaging standards are published including the 
MET-RADS system which will be summarised. WB-MRI has the potential to 
alter diagnostic thinking when assessing bone response: by adding new 
categories that positively assess the success of therapies in bone disease 
(NOT just absence of progression). It is unclear whether this will allow patients 
to live better for longer?. WB-MRI can help deliver the promise of high 
precision medicine for patients with metastatic bone disease.  
Learning Objectives: 
1. To understand the clinical rationale for the use of whole-body MRI when 
evaluating metastatic disease. 
2. To learn about the use of METRADS data acquisition and response 
assessment guidelines. 
3. To become aware of the potential benefits of whole-body tumour load 
quantification. 
4. To review examples of clinical pathway benefits, including precision 
medicine approaches. 
Author Disclosure: 












A-198 08:55  
The case of multiple myeloma  
L.-A. Moulopoulos; Athens/GR (lmoulop@med.uoa.gr)  
WBMRI is more sensitive than WBXR and WBCT for the early detection of 
bone marrow involvement in multiple myeloma and it performs better than 
PET-CT in the diagnosis of small lesions or diffuse bone marrow infiltration. In 
the updated (2014) international myeloma working group (IMWG) criteria for 
the definition of myeloma, MRI is considered a biomarker of malignancy, with 
the presence of more than one focal lesion on MRI establishing the diagnosis 
of symptomatic disease. When MRI of the spine and pelvis is performed, an 
approximately 10% false negative rate may be observed because of focal 
lesions located exclusively in the appendicular skeleton. WBMRI, on the other 
hand, provides a means of bone marrow tumour burden assessment and at the 
same time identifies possible extraskeletal locations of myeloma. Bone marrow 
patterns of involvement and tumour burden on WBMRI have also emerged as 
important tools for prognosis. Regarding assessment of response to therapy, 
even though PET-CT is currently the preferred modality for optimal definition of 
a complete response to treatment in patients with myeloma, ADC values 
extracted from DWI images, have been shown to change early after treatment, 
suggesting a possible role for WBDWI in the evaluation and prediction of 
successful therapy. In the era of novel therapies for multiple myeloma, the role 
of a non-ionizing imaging modality like WBMRI for the search of minimal 
residual disease in the bone marrow and extraskeletal sites of disease at the 
same time, is appealing and warrants further investigation. 
Learning Objectives: 
1. To become aware of the value of whole-body MRI in myeloma. 
2. To learn about its roles: detect, monitor and provide prognostic information. 
3. To understand current imaging protocols. 
A-199 09:10  
The case of lymphoma  
M.E. Mayerhöfer; Vienna/AT (marius.mayerhoefer@meduniwien.ac.at)  
Lymphomas are a heterogeneous group of hematological malignancies that 
can be roughly divided into Hodgkin (HL) and non-Hodgkin (NHL) lymphomas, 
and account for about 5% of all cases of cancer. The NHL group is 
characterized by a high level of heterogeneity between the different subtypes, 
not only with regard to their histological features, but also with regard to growth 
rates and clinical course/prognosis, as well as treatment options. Nevertheless, 
the majority of lymphomas show a high cell density, which makes them an 
attractive target for diffusion-weighted imaging (DWI), because of the 
associated compression of extracellular space. Even though [18F]FDG-
PET/CT is generally regarded as the technique of choice for imaging of 
lymphomas (and in particular, for assessment of treatment response), there are 
several justifications for the use of whole-body DWI in lymphoma patients. For 
instance, the fact that some lymphoma subtypes (such as HL) are common in 
children and adolescents makes DWI attractive due to its lack of exposure to 
ionizing radiation, which is relevant because these patients may require life-
long follow-up. In addition, slowly growing NHL subtypes such MALT 
lymphoma frequently show low, or no, FDG uptake, whereas they still show the 
diffusion restriction pattern on DWI, due to their high cell density. Finally, 
access to MRI, and thus, also to DWI, is far easier than to [18F]FDG-PET/CT 
due to the relative abundance of MR scanners, which may decrease waiting 
intervals and lead to earlier treatment initiation. Nevertheless, while several 
studies have shown that whole-body DWI is only slightly to moderately inferior 
to [18F]FDG-PET/CT, DWI is still limited with regard to the evaluation of small 
lymph nodes, the assessment of diffuse bone marrow involvement, and, mainly 
due to motion artifacts, for lesion assessment in the lower neck and the 
mediastinum.  
Learning Objectives: 
1. To become aware of the role of whole-body MRI for imaging lymphoma 
subtypes. 
2. To learn about its roles: detect, monitor and provide prognostic information. 
3. To understand the current limitations of whole-body DWI. 
A-200 09:25  
Beyond oncology: rheumatology and more  
S. Weckbach; Heidelberg/DE (sabine.weckbach@med.uni-heidelberg.de)  
The high soft tissue contrast and anatomical resolution of whole body MI 
(WBMRI) in combination with an excellent sensitivity and specificity for the 
musculoskeletal system offer many advantages in the diagnostic process of 
rheumatological and neuromuscular disorders. Disease specific adaption of 
different protocol modules allow the replacement of multiple separate exams 
by one whole-body MRI (WB-MRI) examination so that WB-MRI is capable of a 
combined visualisation of the spine and all relevant joints, the vessel system 
and potentially affected organs such as the brain, the kidneys or the heart in 
only one exam. It is able to directly and simultaneously show (even subtle) 
active and chronic inflammation including synovial, cartilaginous and bony 
changes. It is very well suited for the visualisation of enthesitis and arthritis in 
central and peripheral joints at one examination. Moreover, WB-MRI allows the 
early detection of bone marrow changes and muscle pathologies. Therefore, it 
holds the potential to estimate the total disease load and disease activity of 
different rheumatological and neuromuscular disorders as well as follow-up 
patients under therapy. Due to the exact localization of inflammatory processes 
present at multiple sites and visualisation of typical disease pattern, it enables 
us to distinguish between a variety of rheumatological and neuromuscular 
disorders.  
Learning Objectives: 
1. To become aware of the protocols and diagnostic value of whole-body MRI 
in rheumatological and neuromuscular disorders. 
2. To understand the role of whole-body MRI screening for multi-site 
inflammation in one single examination. 
3. To learn about its role in differential diagnosis quantification of disease 
burden and assessment of therapeutic response. 
09:45  
Panel discussion: Whole-body MRI: when, how and why should you do 
it?  
08:30 - 10:00 Room L 8  
Joint Session of the ESR and ESHI  
When to use hybrid imaging  
Moderators:  
K. Riklund; Umea/SE  
T. Beyer; Vienna/AT  
A-201 08:30  
Imaging prostate cancer: MRI or PSMA-PET/CT?  
L. Schimmöller; Düsseldorf/DE (lars.schimmoeller@med.uni-duesseldorf.de)  
The multiparametric magnetic resonance imaging (mp-MRI) of the prostate and 
also imaging with prostate-specific membrane antigen (PSMA-PET) are 
innovative methods that significantly improved the diagnostic of prostate 
cancer. A remarkable change in clinical routine has been the increasing role of 
MRI in prostate cancer detection. Mp-MRI examinations (with T2, DWI, and 
DCE-Images) are already part of international guidelines in secondary 
diagnostics (after previous negative systematic TRUS-GB) and also in active 
surveillance. But in primary diagnostic, staging, and recurrence MRI have got a 
qualification and validly, too. In its updated guidelines 2017 the German 
Society of Radiology notably insists on the importance of mp-MRI and MRI-
guided biopsy for prostate cancer diagnosis. The main significance of the MRI 
is the detection of clinical relevant prostate cancers with its additional 
functional sequences, but nationwide coverage of qualitative mp-MRI 
examinations and qualitative standardized reporting are two of the most 
important challenges. PSMA-PET is the most promising imaging tool primary 
for prostate cancer recurrence and may be currently used for detection in 
unclear cases with high suspicion of prostate cancer, but especially costs and 
availability are liming this promising diagnostic tool. PSMA-PET shows good 
results already in patients with low PSA-values regardless of previous applied 
therapy. As a consequence logically a combination of PSMA-PET and MRI 
might be very nice, but PSMA-PET/MRI is rarely available and its clinical 
benefit remains to be demonstrated. Furthermore, with MRI and PSMA a lot of 
new individual therapeutic opportunities are given. 
Learning Objectives: 
1. To learn about indications of MRI and PSMA-PET in prostate cancer. 
2. To appreciate differences in indications for initial diagnosis and PSA-
recurrence. 
A-202 09:00  
Differentiating radiation necrosis from tumour recurrence: do we need 
hybrid imaging?  
E.-M.B. Larsson; Uppsala/SE (elna-marie.larsson@radiol.uu.se)  
Magnetic resonance imaging (MRI) without and with intravenous contrast 
agent injection is the primary imaging method for the evaluation of treatment 
effects on brain tumours, such as gliomas and metastases. However, the 
method has difficulties to differentiate tumour progression from reactive, 
treatment-related changes after surgery, radiotherapy, chemotherapy or 
immunotherapy. The additional use of positron emission tomography (PET), 
MR perfusion or proton MR spectroscopy (MRS) may improve the diagnostic 
specificity. 18F-FDG-PET is widely used for body imaging, but suboptimal for 
this purpose due to the high glucose uptake in normal brain tissue. 
Radiolabelled amino acid tracers, such as 11C-MET with short half-life or 18F-
FET with longer half-life, show a high tumour-to-background contrast. Amino 
  







acids accumulate in recurrent tumour, but not in reactive or reparative 
processes after treatment. MR perfusion with evaluation of relative cerebral 
blood volume (rCBV) is also helpful, since high rCBV usually indicates tumour 
recurrence. MRS shows the relative concentrations of different metabolites and 
increase of choline (Cho) supports the suspicion of recurrent malignant tumour 
with cell proliferation. However, the areas of increased PET uptake and 
increased rCBV and/or high Cho do not always coincide, which makes the 
interpretation difficult. In addition, a combination of recurrent tumour and 
reactive changes is often present. Since each of the PET and MR techniques 
mentioned above has limitations, hybrid PET/MR combining the information 
from uptake of radiolabelled amino acids, measurement of rCBV and also of 
Cho, may provide improved diagnostic accuracy.  
Learning Objectives: 
1. To learn about different radiopharmaceuticals available for differentiation of 
tumour from radiation necrosis. 
2. To understand typical hybrid imaging findings in radiation necrosis and 
tumour recurrence. 
Author Disclosure: 
  E.-M.B. Larsson: Research/Grant Support; Bayer Pharma AG, Berlin, 
Germany. Speaker; Bayer Pharma AG, Berlin, Germany. 
A-203 09:30  
What can we expect as future targets for new radiopharmaceuticals?  
G. Cook; London/UK  
There are now few hallmarks of cancer that we cannot exploit with imaging. In 
particular, there are several PET and SPECT probes that can measure 
abnormal metabolic processes (e.g., 18F-FDG, 99mTc-sestamibi), proliferation 
(e.g., 18F-FLT, 18F/11C-choline), receptor overexpression (e.g., 68Ga-
dotatate, 68Ga-PSMA, apoptosis (e.g., 18F-ML10), hypoxia (e.g., 18F-MISO, 
64/62Cu-ATSM) and angiogenesis (e.g., 89Zr-bevacizumab, 18F-RGD) 
amongst others. Whilst some of these tracers are useful for diagnosis and 
phenotyping, many are of interest for predicting early treatment response, 
especially in the setting of targeted biologic therapies where an early reduction 
in tumour volume is not expected and where morphologic CT and MRI are 
therefore limited. Of particular current interest is the evaluation of response to 
immunotherapies that may cause pseudoprogression, caused by 
immunocellular infiltration before subsequent tumour shrinkage. In this 
situation early pseudoprogression may also be seen with 18F-FDG PET and 
hence the interest in more specific tracers such as 89Zr-PDL1 antibody. Whilst 
PET and SPECT probes are invaluable in reporting on underlying biological 
tumour characteristics, both CT and MRI provide valuable supportive 
information in hybrid imaging scanners allowing anatomical reference as well 
as some functional measurements, e.g., cellularity with DWI and perfusion with 
DCE MRI / pCT. The ultimate goal of predicting which patients will respond to 
which treatment, or at least to determine non-response as soon as possible, is 
not fully achieved in the clinic with imaging as yet but some areas are now 
contributing to clinical practice, e.g., 18F-FDG PET/CT to guide treatment 
escalation / de-escalation in lymphoma.  
Learning Objectives: 
1. To become familiar with future targets in oncological hybrid imaging. 
2. To learn how hybrid imaging can support the oncologist in diagnosis and 
therapy response assessment. 
Author Disclosure: 
  G. Cook: Research/Grant Support; Siemens, GEHC, Alliance Medical, 
Theragnostics. 
08:30 - 10:00 Room E1  
Pros & Cons Session  
PS 527  
Do we need dynamic contrast 
enhancement (DCE) in prostate mpMRI?  
A-204/A-205 08:30  
Chairpersons' introduction  





Multiparametric MR imaging (mpMRI) is increasingly important for 
individualized decision making in prostate cancer patients. A large number of 
clinical studies have demonstrated that the combination of morphologic and 
functional MR parameters are advantageous for detection and localization of 
significant cancer, for biopsy guidance, for local staging and for active 
surveillance. Various MR-guided or TRUS/MR image fusion biopsy 
technologies are already used in clinical practice for transrectal or a 
transperineal targeted +/- systematic biopsy. High-quality mpMRI including 
standardized image acquisition and image interpretation is crucial and 
recommendations according to PI-RADS are meanwhile widely accepted. But 
there is still controversial discussion about the optimal state-of-the-art mpMRI 
protocol. While meanwhile several studies have shown compelling evidence 
that diffusion-weighted MRI (DWI) is fundamental for prostate cancer detection 
and characterization, the clinical value of dynamic contrast-enhanced MRI 
(DCE) is still under debate. Different views were brought forward weighting 
increased examination time and costs against the clinical benefit. This session 
will point out the controversial discussion to balance pros and cons.  
Session Objectives: 
1. To understand the clinical significance of mpMRI for detection and local-
regional staging of prostate cancer. 
2. To learn about the potential and limits of DCE MRI. 
3. To understand the controversial discussion about the added value of DCE 
as part of mpMRI in clinical routine. 
A-206 08:35  
A. Yes we do!  
G.M. Villeirs; Ghent/BE  
Like many other cancers, prostate cancers can release angiogenic factors that 
cause growth of existing blood vessels and de novo angiogenesis. As these 
new vessels are loosely organized, with varying sizes, leaky endothelium and 
arteriovenous shunts, their permeability is higher than in normal vessels. 
Dynamic contrast-enhanced (DCE) MRI exploits this difference using a series 
of rapid T1-gradient-echo sequences (every 10 seconds over 2 minutes) 
after a 2-3cc/sec bolus administration of 0.1 mmol/kg of gadolinium contrast 
agent. Tumor foci show earlier, faster and more intense enhancement due to 
increased influx of contrast in an expanded vascular space and increased 
extravasation to the extravascular space, followed by marked washout due to 
increased backflow to the vascular compartment. These temporal tissue 
enhancement changes can be evaluated qualitatively (visual analysis of 
enhancing areas), semi-quantitatively (evaluation of enhancement curve 
types), or quantitatively. The latter is based on pharmacokinetic modelling 
techniques that calculate parameters such as Ktrans (leakage to the 
extravascular space), kep backflow to the blood vessels, and ve (size of the 
extracellular extravascular space). DCE can be used to detect prostate cancer 
in the peripheral zone (less in the transition zone due to false positive 
enhancement in benign prostatic hyperplasia), especially in case of doubt on 
DWI or poor DWI quality in multiparametric MRI. It also improves the staging 
accuracy, especially in less-experienced users. Most importantly, it is the best 
technique to assess the location and extent of recurrent disease, both after 
radical prostatectomy, external beam radiotherapy or focal therapy. 
Learning Objectives: 
1. To understand how DCE enables improved cancer detection by revealing 
microvasculature and perfusion. 
2. To become familiar with quantitative analysis of signal intensity-time curves 
after intravenous contrast agent administration in order to reveal cancer 
specific perfusion-related parameters. 
3. To appreciate the diagnostic potential of DCE to detect significant prostate 
cancer. 
A-207 09:00  
B. No we don't!  
H. Hricak; New York, NY/US  
T1-weighted imaging (T1WI) and T2-weighted imaging (T2WI), joined recently 
by DWI, have become the mainstay of prostate evaluation by mpMRI. The 
question is whether, in our clinical protocols, we also need to include dynamic 
contrast-enhanced MRI (DCE-MRI) and/or proton MR spectroscopic imaging 
(MRSI). DCE-MRI improves assessment of tumor aggressiveness, but its value 
in tumor detection remains controversial. Based on studies from the last 5 
years, in the setting of cancer detection, the combination of DCE-MRI+T2WI 
has similar or lower accuracy and is significantly less specific than the 
combination of DWI+T2WI; adding DCE-MRI to DWI+T2WI significantly 
increased sensitivity, but it also significantly lowered specificity. A recent study 
of 542 men with elevated PSA levels found that for tumor detection, T2WI+DWI 
had accuracy comparable to that of T2WI+DWI+DCE-MRI, with diagnosis of 
clinically significant cancer being the endpoint. Overall, the literature suggests 
DCE-MRI adds limited or no value in most scenarios. While MRSI can improve 
tumor characterization, its routine application is not recommended because of 
long scan times, operator dependence and limited spatial resolution. 
Therefore, if we are to advocate the inclusion of mpMRI in a prostate cancer 
screening algorithm, we should recommend a streamlined protocol of 
T1W+T2WI+DWI, as it provides higher accuracy, reduced scan times, greater 
patient comfort and safety, and is less costly than protocols also incorporating 
DCE-MRI or MRSI. However, use of DCE-MRI should be recommended in 
  







searching for recurrence after treatment, in situations where artifacts degrade 
the quality of DWI, or in patients on experimental medical therapy protocols.  
Learning Objectives: 
1. To become familiar with the diagnostic potential of mpMRI including T2w, 
advanced DWI and MRSI. 
2. To understand the diagnostic potential non-contrast-enhanced mpMRI to 
detect significant prostate cancer. 
3. To appreciate the benefits of a shortened mpMRI protocol by omitting DCE. 
Author Disclosure: 
  H. Hricak: Board Member; Ion Beam Application (IBA). 
09:25  
Discussion  
08:30 - 10:00 Room E2  
State of the Art Symposium  
SA 5b  
Current guidelines and diagnostic criteria 
in multiple sclerosis (MS)  
A-208 08:30  
Chairperson's introduction  
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi.gencat.cat)  
In the last few years, techniques and clinical implementation of MR imaging of 
multiple sclerosis (MS) have markedly evolved based on the relative large 
amount of new published data from clinical trials and observational studies, 
which assessed the value of this tool in the early and accurate diagnosis of 
MS. However, the role of MR imaging in MS goes far beyond the diagnostic 
process and differential diagnosis. MR imaging can also provide useful 
prognostic information in terms of long term disability prediction. Moreover, with 
the introduction of the new generation of immunomodulating 
/immunosuppressive drugs for the treatment of MS, MR imaging also plays an 
important role in treatment monitoring. This includes the prediction of treatment 
response, the assessment of treatment efficacy and treatment safety. In this 
state of the art symposium, the speakers will present up to date on the 
diagnostic criteria of MS, and on the value of MR imaging for monitoring and 
predicting treatment response and in the detection of treatment related adverse 
effects. All these information should help radiologists in the standardization and 
optimization of the use of MR imaging in the management of MS in clinical 
practice.  
Session Objectives: 
1. To appreciate the importance of an accurate diagnosis of MS. 
2. To learn about the value of diagnostic criteria for MS. 
3. To understand the relevance of MRI for monitoring and predicting treatment 
response. 
4. To become familiar with treatment-related adverse effects. 
Author Disclosure: 
  A. Rovira-Cañellas: Advisory Board; Novartis, Biogen, Sanofy-Genzyme. 
Speaker; Novartis, Stendhal America, Biogen, Bracco, Bayer, Sanofy-
Genzyme, TEVA. 
A-209 08:40  
Update on new clinical diagnostic criteria  
C. Enzinger; Graz/AT (chris.enzinger@medunigraz.at)  
In the diagnostic process applied to people suspected to have multiple 
sclerosis (MS), MRI of the brain and spinal cord has become an indispensable 
tool to objectively demonstrate lesions disseminated in time and space, which 
are considered as a hallmark of the disease. MRI has been formally integrated 
in the diagnostic criteria first in 2001 by an international panel and - based on 
accumulating scientific evidence - revisions of these criteria have been 
provided in 2005, 2010 and, most recently, in 2017. The presentation will 
briefly review the scientific data underlying the evolution of the current 
diagnostic criteria, highlight the chances (e.g., rapid diagnosis) and 
implications (e.g., establishing early therapy) linked with their use, and raise 
awareness of the challenges (overdiagnosis) and pitfalls (misdiagnosis) 
potentially associated with the application of the new diagnostic criteria. 
Learning Objectives: 
1. To understand the scientific data underlying the evolution of the current 
diagnostic criteria. 
2. To recognise chances and implications linked with the use of the new 
diagnostic criteria. 
3. To become aware of the challenges implicated with the application of the 
new diagnostic criteria. 
Author Disclosure: 
  C. Enzinger: Advisory Board; Bayer Schering, Biogen, Merck Serono, 
Novartis, Roche and Teva Pharmaceutical Industries Ltd./sanofi- aventis. 
Board Member; MAGNIMS; IMSCOGSMS; OHBM Alpine Chapter. Consultant; 
Bayer Schering, Biogen, Merck Serono, Novartis, Roche and Teva 
Pharmaceutical Industries Ltd./sanofi- aventis. Research/Grant Support; 
Unrestricted research support from Merck Serono, Biogen, and Teva 
Pharmaceutical Industries Ltd./sanofi-aventis. Speaker; Funding for travel and 
speaker honoraria from Biogen, Bayer Schering, Merck Serono, Novartis, 
Shire, Genzyme and Teva Pharmaceutical Industries Ltd./sanofi-aventis. 
A-210 09:00  
MRI for MS monitoring: the use of guidelines in clinical practice  
M.P. Wattjes; Hannover/DE (m.wattjes@vumc.nl)  
Magnetic resonance imaging (MRI) plays an important role in the diagnosis of 
multiple sclerosis and has been incorporated into the McDonald diagnostic 
criteria for MS. The role of MRI in MS disease monitoring, particularly for MS 
treatment monitoring purposes, has been less clear defined. The need for 
standardization in terms of MR acquisition, scan intervals and image 
interpretation in MS pharmacovigilance is further stressed by the increasing 
numbers of MS therapeutics in the postmarketing setting. Therefore, MRI in 
MS pharmacovigilance is becoming increasingly important. The main goals of 
the use of MRI for this purpose are treatment efficacy monitoring, prediction of 
treatment response, and safety monitoring. Recent guidelines provided by the 
MAGNIMS collaboration (www.magnims.eu) and the consortium of MS centers 
(CMSC) provide some guidance how to implement MRI in the setting of MS 
pharmacovigilance. The standardized implementation of these guidelines in 
clinical practice will be of great help for (neuro)radiologists, neurologists, and 
patients.  
Learning Objectives: 
1. To understand the importance of standardisation in terms of image 
acquisition and scan intervals in MS monitoring. 
2. To learn about the most relevant and possible future MRI outcome 
measures for MS treatment monitoring purposes. 
3. To appreciate the potential role of MRI in predicting MS treatment response. 
Author Disclosure: 
  M.P. Wattjes: Board Member; European Radiology, Neuroradiology, Journal 
of Neuroimaging, Frontiers in Neurology. Consultant; Biogen, IXICO, Roche. 
Speaker; Biogen, Sanofi-Genzyme, Novartis, Roche, Springer. 
A-211 09:20  
MRI in monitoring treatment complications  
J. Hodel; Créteil/FR (jerome.hodel@gmail.com)  
Several immunosuppressive therapies are available in MS patients with a risk 
of progressive multifocal leukoencephalopathy (PML). MRI is crucial for the 
follow-up of treated patients because recognition of PML before the onset of 
clinical symptoms has important implications for patient care. The diagnosis of 
presymptomatic PML remains highly challenging due to the coexistence of MS 
lesions and the various imaging patterns observed at the early stages of 
disease. Recognition of the most predictive imaging features and comparison 
with previous MRI data may facilitate the detection of presymptomatic PML. 
Hyperintensity on diffusion-weighted images, punctate lesions and involvement 
of U fibers are highly predictive features. Brain magnetic susceptibility changes 
may be explained by the increased iron deposition and could also constitute a 
useful tool for the diagnosis of PML. Such imaging findings may be the first 
imaging feature of PML at the presymptomatic stage. A dedicated MRI protocol 
including optimized diffusion and high-resolution MR sequences may 
potentially improve the sensitivity of MRI for the diagnosis of presymptomatic 
PML.  
Learning Objectives: 
1. To learn about the most important treatment-related adverse events and 
their incidence. 
2. To learn about the imaging pattern of these adverse events. 
3. To become familiar with the algorithms used to monitor these side events 
and the central role of imaging in them. 
09:40  
Panel discussion: Do we need MRI to monitor and predict treatment 











08:30 - 10:00 Room F1  
E³ - Rising Stars Programme: Basic Sessions  
BS 5  
Musculoskeletal: bones and soft tissues  
Moderator: 
D.P. Patkar; Mumbai/IN  
A-212 08:30  
Bone marrow diseases  
K. Verstraete; Ghent/BE (koenraad.verstraete@ugent.be)  
Bone marrow consists of trabecular bone, a stroma of connective tissue, 
haematopoietic cells (red marrow) and fat (yellow marrow). Distribution of red 
and yellow marrow is age dependent, with gradual conversion of red to yellow 
marrow in the limbs during childhood, and patchy heterogeneity in the spine in 
the elderly patient. There are many causes of reconversion from yellow to red 
bone marrow, like smoking, long distance running, obesity, anemia, 
erythropoietin, etc. Depletion may occur in aplastic anaemia and after radiation 
therapy. Gelatinous transformation is seen in anorexia nervosa, cachexia, and 
HIV. Bone infarction and avascular necrosis are well delineated areas of dead 
bone marrow. The value of different imaging techniques, including plain 
radiography, dual-energy CT, bone scintigraphy, PET and the most sensitive 
technique, MRI (conventional T1, T2, fat suppression techniques, in-phase, 
out-phase and diffusion imaging), will be explained. The imaging 
characteristics of many diseases will be reviewed (diffuse bone marrow 
replacement in hematologic diseases, multiple myeloma, metastases; 
treatment related changes of bone marrow, primary bone tumours, and 
multiple causes of bone marrow oedema, like bone contusion, stress fracture, 
insufficiency fracture, Modic changes, spondylodiscitis, osteomyelitis, abscess, 
arthritis and specific bone tumours). 
Learning Objectives: 
1. To describe the typical features of normal bone marrow. 
2. To determine origin of bone marrow changes. 
3. To present the imaging characteristics of a bone marrow disease of the 
different types. 
A-213 09:00  
Soft tissue tumours  
V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk)  
All imaging modalities can play a role in the diagnosis and management of soft 
tissue tumours and pseudotumours with a variable contributory performance to 
both sensitivity and specificity. MRI steals the show with an unparalleled role in 
soft tissue assessment ranging from detection, localisation, characterisation, 
identifying multiple lesions, other syndrome stigmata, probability of 
benignity/malignancy, local staging and recurrence identification. Sonography 
does have a supporting role especially in initial assessment of the likelihood of 
cystic/benign/abnormal malignant Colour Doppler flow patterns. This 
presentation aims to provide a distillation of the knowledge regarding soft 
tissue tumour imaging which can be applied in practice using a stepwise 
analytical approach. Despite an overwhelming spectrum of potential 
histological diagnosis, the radiologist needs to remember that eight benign and 
six malignant lesions account for 80% of all soft tissue tumours.  
Learning Objectives: 
1. To determine the origin of a soft tissue tumour (e.g. fat, neural, vascular, 
etc.). 
2. To present current imaging techniques for evaluation of soft tissue tumours. 
3. To discuss the imaging findings which are important for the diagnosis of soft 
tissue tumours. 
A-214 09:30  
Bone tumours  
J.L. Bloem; Leiden/NL (j.l.bloem@lumc.nl)  
Bone sarcomas are rare (0.2% of all neoplasms, annual incidence in Europe is 
0.8 per 100.000 population), in contrast to benign bone tumors and the so-
called tumor-like lesions. The incidence of these benign entities is relatively 
high, but not known exactly as these are often asymptomatic. The WHO 
(version 2013) classified benign and malignant bone tumors in 13 main 
categories; chondrogenic, osteogenic, fibrogenic, fibrohistiocytic, 
hematopoietic, osteoclastic giant cell rich, notochordal, vascular, myogenic, 
lipogenic, undefined neoplastic nature, and miscellaneous tumors. Each 
category is further subdivided into 1-14 tumor types. Imaging plays an 
important role in diagnosis, monitoring therapy, staging, and detecting 
recurrent disease. Diagnosis is mainly based on conventional radiography 
using morphologic appearance in combination with location, and age. 
Advanced imaging techniques are used for local staging (MR), detection of 
metastases (chest CT), monitoring therapy (MR, ultra-sound, PET-CT), 
detecting recurrence (MR, ultra-sound, PET-CT). Typical imaging features 
based on the WHO classification system will be presented with focus on 
conventional radiography, common tumors, and relevance.  
Learning Objectives: 
1. To review the classification of bone tumours. 
2. To present current imaging techniques for evaluation of bone tumours. 
3. To describe the typical features of common bone tumours. 
08:30 - 10:00 Room F2  
Oncologic Imaging  
RC 516  
Functional imaging in oncology beyond 
morphology: where are we now?  
A-215 08:30  
Chairperson's introduction: What are the problems of morphologic 
evaluation  
C.D. Becker; Geneva/CH  
Morphologic criteria such as size, number or attenuation of solid tumour 
lesions may be used to assess partial or complete treatment response in 
certain clinical situations. However, certain tumours in certain organs cannot 
be reliably assessed without additional biomarkers such as perfusion or 
diffusion or metabolic activity that can be provided by CT, MRI or PET. This is 
especially true in the case of immunotherapy or in situ tumour ablation by 
radio- frequency or chemo-embolisation, where inactivated tumour tissue may 
remain in place. The most recent advances in the field of functional imaging 
biomarkers (also called "radiomics") include imathematical analysis of image 
data (texture analysis) and other quantitative parameters that may correspond 
with histopathologic and even genotypic features. The goal is to develop 
image-based predictive models for tumour treatment in specific neoplasms. 
This course will discuss the most important imaging biomarkers beyond 
morphology. 
Session Objectives: 
1. To briefly address the limitations of mere morphological imaging modalities. 
2. To introduce the basics of the concept of functional imaging in oncology. 
3. To learn about current status of these techniques in daily clinical practice. 
A-216 08:35  
A. Functional MRI techniques  
V.J. Goh; London/UK (vicky.goh@kcl.ac.uk)  
It is recognised that cancer is a biologically heterogeneous disease. Thus, a 
‘one size fits all’ management approach may not bring about the best outcome 
for the individual patient. Oncologic therapies have evolved substantially over 
the last two decades providing cancer patients with a greater opportunity for a 
cure. This personalised approach has also required a paradigm shift in 
oncologic imaging to capture this biological heterogeneity and improve patient 
triage. MRI provides a unique opportunity to combine high contrast and spatial 
resolution imaging of tumour morphology with physiological imaging of water 
diffusion, vascularisation and oxygenation status. At initial diagnosis and 
staging this may allow tumours to be phenotyped better and during therapy for 
tumours to be assessed more comprehensively, particularly where therapy is 
cytostatic and will not result in significant size change. In this lecture the 
different functional imaging techniques that can be applied in clinical practice 
will be discussed and evidence for practice highlighted. The potential of 
integrated PET/MRI will also be considered. 
Learning Objectives: 
1. To learn about the different functional MR techniques (diffusion, perfusion). 
2. To understand the basic principle behind each technique. 
3. To appreciate the clinical usefulness of these techniques in daily clinical 
practice. 
Author Disclosure: 
  V.J. Goh: Research/Grant Support; Siemens Healthineers. Speaker; Bayer, 
Siemens Healthineers. 
A-217 08:58  
B. CT perfusion techniques  
H. Schöllnast; Graz/AT (helmut.schoellnast@medunigraz.at)  
CT-perfusion imaging is a functional imaging tool which enables qualitative and 
quantitative evaluation of tumor perfusion and, therefore, assessment of tumor-
  







related angiogenesis. Clinical applications for CT-perfusion imaging have 
mainly evolved to include lesion characterization, prediction of prognosis, 
prediction of response to therapy and assessment of response to local or 
systemic therapies. Perfusion values have shown significant differences when 
comparing normal tissue with tumors and between benign and malignant 
lesions, although there is overlap between benign and malignant lesions. The 
degree of tumor perfusion is potentially associated with tumor aggressiveness 
as tumor-related angiogenesis determines the ability of tumors to metastasize 
and, therefore, affects prognosis. On the other hand, hypoxia within the tumor 
reflected by restricted perfusion limits the effect of chemotherapy and 
radiotherapy, potentially allowing for prediction of response. Both, conventional 
chemotherapy and targeted therapies such as angiogenesis inhibitors may 
affect tumor vascularization. In contrast to conventional chemotherapy, which 
mainly shows a cytotoxic effect on the tumor, angiogenesis inhibitors show 
rather a cytostatic effect. Traditional tumor size-based response criteria may 
underestimate the response to angiogenesis inhibitors in the early course of 
treatment due to stable tumor size despite effective therapy. In contrary, CT-
perfusion imaging allows detection of decrease in tumor perfusion which 
precedes decrease in size. Use of different models for perfusion calculation 
such as compartmental model and deconvolution model, use of different CT-
perfusion protocols including contrast media injection protocols and inter- and 
intraobserver variability when using perfusion software limit use of CT-
perfusion imaging in clinical routine.  
Learning Objectives: 
1. To learn about current approaches for CR perfusion techniques. 
2. To understand the basic principle behind each technique. 
3. To discuss radiation exposure generated by CT perfusion techniques. 
4. To appreciate the clinical usefulness of these techniques in daily clinical 
practice. 
A-218 09:21  
C. Assessment by molecular imaging  
J. Grimm; New York, NY/US (grimmj@mskcc.org)  
Molecular imaging describes imaging and measurements of biological 
processes at the cellular and molecular level. In a clinical setting this entails 
predominantly PET imaging, measuring increased glycolytic activity. However, 
other radiotracers allow for detecting different and predominantly structural or 
even functional entities, e.g., the imaging of PSMA in prostate cancer to detect 
primary or recurrent or disease; or the imaging with amino acids, reflecting 
increased amino acid metabolism in brain tumors. However, existing tracers 
can also be used to explore new signatures, such as in the case of positron 
lymphography using 18F-FDG to characterize sentinel lymph nodes. Lastly, 
optical imaging of radiotracers has been achieved and utilized both preclinically 
and clinically in novel applications. While most of clinical functional and 
molecular imaging is achieved in the area of nuclear medicine, there are other 
emerging areas: Intraoperative optical imaging is using available as well as 
new targeted fluorescent agents, aiding the surgeon visually during surgery to 
sentinel lymph nodes, remaining tumors and defining the surgical margin. 
Optoacoustic imaging, where novel scanners are listening to the light 
absorption in the body from either intrinsic targets or extrinsic specific contrast 
agents, have reached the clinical realm and have been used to detect specific 
cancers. Metabolic imaging has enjoyed a new boost beyond nuclear imaging 
in the form of hyperpolarized MR imaging, enabling interrogating metabolic key 
pathways to detect and characterize cancers in new ways. All this has been 
supported by the development of new and specific agents, interrogating 
disease signatures.  
Learning Objectives: 
1. To learn about the different concepts in molecular imaging. 
2. To see and understand how molecular imaging might be integrated into 
patient care. 
3. To appreciate clinical examples where molecular imaging is already 
established. 
Author Disclosure: 
  J. Grimm: Board Member; Society of Molecular Imaging. Research/Grant 
Support; NCI (Clinical Cerenkov Imaging). 
09:44  






08:30 - 10:00 Room D  
Special Focus Session  
SF 5  
Cystic pancreatic lesions: how to 
differentiate, how to manage?  
A-219 08:30  
Chairperson's introduction  
C. Matos; Lisbon/PT (celso.matos@fundacaochampalimaud.pt)  
Increased use of cross-sectional imaging has led to increased detection of 
pancreatic cysts. Although the most commonly used management guidelines 
assume knowledge of a specific cyst type, many of detected pancreatic cysts 
are indeterminate. During this multidisciplinary session we will focus on the 
clinical significance of small and large pancreatic cysts, we will review how to 
improve diagnostic accuracy and we will underline shared decision making for 
successful management.  
Session Objectives: 
1. To understand how imaging helps make the differential diagnosis of cystic 
lesions of the pancreas. 
2. To address key questions that should be answered when diagnosing an 
incidental pancreatic cystic lesion. 
3. To discuss how to improve patient management through multidisciplinary 
interaction. 
A-220 08:35  
Diagnostic accuracy of non-invasive imaging modalities for 
characterising cystic pancreatic lesions  
N. Kartalis; Stockholm/SE (nikolaos.kartalis@me.com)  
Pancreatic cystic lesions are increasingly diagnosed due to the widespread 
use of imaging studies (i.e., US, CT and MRI) in the evaluation of abdominal 
pathologies and to the aging population. They encompass a variety of entities 
with different biological behavior, ranging from benign lesios such as 
pseudocysts and serous cystic adenomas (SCA) to premalignant and 
malignant lesions, such as intraductal papillary mucinous neoplasms (IPMN), 
mucinous cystic neoplasms (MCN), cystic neuroendocrine tumours and cystic 
adenocarcinomas. Imaging plays a pivotal role in accurate diagnosis and 
appropriate management of patients with cystic pancreatic lesions. In this talk, 
we will analyze the specific imaging features of pancreatic cystic lesions on 
US, EUS, CT, and MRI. Furthermore, we will discuss the accuracy of cross-
sectional imaging in the diagnosis of cystic pancreatic lesions and, finally, 
comment on the added value of contrast-enhanced US and EUS in the 
characterisation of cystic pancreatic lesions.  
Learning Objectives: 
1. To become familiar with the specific imaging features of pancreatic cystic 
lesions on US, EUS, CT, and MRI. 
2. To learn about the accuracy of cross-sectional imaging in the diagnosis of 
cystic pancreatic lesions. 
3. To understand the added value of contrast-enhanced US and EUS in 
characterising cystic pancreatic lesions. 
A-221 08:58  
The evolving role of pathology: can we improve patient stratification?  
P. Demetter; Brussels/BE (Pieter.Demetter@erasme.ulb.ac.be)  
Distinguishing between the various types of cystic pancreatic lesions has 
important prognostic and therapeutic implications. The sensitivity of cytology 
varies depending on the expertise of the endoscopist and the pathologist. 
Diagnostic accuracy can increase up to 80-90% if cytology is complemented 
with measurements of CEA, amylase levels and mucin staining. Although cyst 
fluid analysis is a tool in preoperative diagnosis, final diagnosis if often 
obtained only after histopathological analysis. Molecular markers in the cyst 
fluid are being increasingly studied in recent years. The four most common 
cystic pancreatic tumours bear tumour-specific genetic alterations, such as 
GNAS mutations in intraductal papillary mucinous neoplasms, -catenin 
mutations in solid pseudopapillary neoplasms and VHL mutations or loss of 
heterozygosity in serous cystadenoma. Molecular tests of the aspirated cystic 
fluid seem particularly useful for detecting the accumulation of genetic 
mutations associated with lesion progression from early dysplasia to 
carcinoma. DNA-based biomarkers have made the most progress and are 
offered clinically, but prospective data are lacking and how DNA testing should 
be integrated into pancreatic cyst evaluation is unclear. In addition to the 
analysis of DNA, there are promising approaches in distinguishing benign and 
premalignant/malignant cystic tumours by evaluating miRNA profiles. At 
  







present, however, molecular analyses cannot replace more conventional tests, 
but should be used in parallel with them and clinical findings.  
Learning Objectives: 
1. To understand the carcinogenic pathway in pancreatic cystic lesions. 
2. To become familiar with the most frequent molecular alterations seen in 
pancreatic cystic lesions. 
3. To learn how the integration of cytohistomorphology, cyst fluid biochemistry 
and molecular testing helps better stratify patients before therapy. 
A-222 09:21  
When not to operate and when to operate an incidental cystic pancreatic 
lesion  
M. Del Chiaro; Stockholm/SE (marco.del.chiaro@ki.se)  
Pancreatic cystic neoplasms (PCNs) are a very common group of diseases 
with a prevalence of 20-30% in the general population. It is today well known 
that some of these lesions (SCN) are benign. In contrast, others, can progress 
from adenoma to cancer (i.e. IPMN or MCN).In front of a so different biological 
behaviour, the differential diagnosis of these lesions still remains a major 
clinical problem. The accuracy in pre-operative diagnosis, independently by the 
diagnostic modality used, remain low and not superior to 70% even in high 
specialized centers. IPMNs are the most common cystic neoplasms of the 
pancreas (50%). Considering the high prevalence of these lesions and the low 
incidence of pancreatic cancer, it is quite logical to understand that only the 
minority of these lesions will progress to cancer. At the moment, no biomarkers 
are available to discriminate the grade of dysplasia and surgery is 
recommended according mostly with radiological signs. When the IPMNs are 
involving the main pancreatic duct, the risk of malignancy is extremely higher. 
MPD dilatation over 5-6 mm represents probably the optimal cut-off for 
resection. More complicated is the management of IPMNs involving the branch 
ducts (BD-IPMN). The large majority of these patients can be managed 
conservatively trough a radiological follow-up. Considering however the risk of 
progression, the surveillance of these patients can´t be discontinued until the 
patient is potentially fit for surgery. Traditionally MCNs should be always 
removed. No surgery is required for SCNs, excluding cases of symptomatic 
lesions or unclear diagnosis.  
Learning Objectives: 
1. To become familiar with surgical options for the management of pancreatic 
cystic lesions. 
2. To understand how information obtained by imaging impact surgical 
management. 
3. To learn how to avoid unnecessary surgery in patients with benign 
pancreatic cystic lesions. 
09:44  
Panel discussion: Are current management recommendations 
appropriate?  
08:30 - 10:00 Room K  
Radiographers  
RC 514  
Successful paediatric imaging  
A-223 08:30  
Chairpersons' introduction: Paediatrics: more than just 'small adults' 
(part 1)  
V. Syrgiamiotis; Athens/GR (syrgiamiotisvasilis@gmail.com)  
From paediatricians usually one listens the very common phrase “children are 
not just small adults”. It is for sure idea for the calculation of drug doses and 
the assessment of physiological parameters, the definition of child medicine in 
such defensive, negative and exclusionary terms deals with some inherent 
dangers and misconceptions as well. In the last decades it is a common 
phrase used in radiology as well. Both children and adults belong to the human 
race. Progress in medicine more often can be applied to and be of benefit to all 
and the transition from childhood to adulthood should be one of continuity 
rather than migration. Indeed we recognise that children, including the embryo, 
fetus, infant and all life stages until the completion of adolescence, are often at 
a different and increased risk from environmental hazards from that of adults. 
Children often have different, and sometimes unique, exposures to 
environmental hazards from those of adults. Due to their dynamic 
developmental physiology children are often subjected to higher exposures to 
pollutants found in air, water, food and radiation. These exposures may be 
handled quite differently by an immature set of systems to the way they are 
dealt with in adults. Children have a longer life expectancy. Therefore, they 
have longer to manifest a disease with a long latency period, and longer to live 
with toxic damage. Finally, children are politically powerless; they are 
defenceless. With no political standing of their own, they must rely on adults to 
protect them.  
Session Objectives: 
1. To appreciate strategies for successful imaging of uncooperative children 
and those with disabilities. 
2. To review current guidelines on imaging in suspected non-accidental injury. 
3. To demonstrate potential techniques to avoid sedation during paediatric 
MRI. 
A-224 08:33  
Chairpersons' introduction: Paediatrics: more than just 'small adults' 
(part 2)  
N. Mitreska; Skopje/MK (mitreska_nadica@hotmail.com)  
Paediatric radiology is a unique subspecialty of diagnostic radiology. 
Radiological findings as well as diagnoses are frequently different in infants 
and children from adults and knowledge and expertise are important for 
evaluation of the images. The child and its parents need special care and 
diagnostic methods must be appropriate selected. Mental development, 
position and structure of organs, increased susceptibility to radiation are 
different from adults. Reduction of radiation dose and radiation protection in 
radiographic examination of children is critical. In paediatric imaging risk- 
benefit dialogue obtain risk control and maximizing the benefit. Radiographers 
working with paediatric patients always are facing unique problems, so they 
must develop competence in knowledge, understanding and skills in paediatric 
imaging. Exposure is reduced by appropriate selection of study, using non-
ionizing examination whenever possible, shielding the gonads and other 
organs. Radiographer have to capture the attention of the child to keep it still, 
response to verbal direction , use immobilization devices , understand the role 
of the family and other modalities for optimization of exposure. For good image 
quality paediatric protocols should be used to prevent repeat examinations and 
sedation or general anesthesia is usually require for MRI in children under 7 
years of age. Radiologist, paediatric radiologist and radiographers must create 
team work, partnership and close cooperation.  
Session Objectives: 
1. To appreciate strategies for successful imaging of uncooperative children 
and those with disabilities. 
2. To review current guidelines on imaging in suspected non-accidental injury. 
3. To demonstrate potential techniques to avoid sedation during paediatric 
MRI. 
A-225 08:35  
A. Imaging the uncooperative child and children with disabilities  
C. Simcock; London/UK (clare.simcock@gosh.nhs.uk)  
Paediatric radiography and imaging requires modification of techniques by the 
radiographer or imaging technologist to ensure that optimal radiographs are 
produced. Following textbook methods, is simply not always possible in 
children and for successful outcomes, adaptation of practice is necessary. 
When faced with imaging children with learning disabilities and challenging 
behaviours, the task can appear daunting. There is limited literature available 
to assist the radiographer to meet the needs of children with disabilities. Over 
40% of children attending our institution have complex needs and it is 
important that we learn strategies that both benefit the patient and result in a 
successful examination across all modalities. Therefore, reasonable 
adjustments should be made, whilst imaging this cohort of patients which will 
ensure that the radiographers actions do not have a negative impact on future 
visits to the imaging department for the patient. 
Learning Objectives: 
1. To learn about behaviours and disabilities that can present a challenge to 
successful imaging. 
2. To understand practical techniques and strategies during projection 
radiography examinations. 
3. To appreciate practical advice for imaging in specialist modality areas such 
as CT, MRI and US. 
A-226 08:58  
B. Suspected non-accidental injury: best practice and advice  
B.R. Mussmann; Odense/DK (bo.mussmann@rsyd.dk)  
Sub optimal imaging in suspected non-accidental injury (NAI) has major 
consequences for the child and family. The procedures must work properly 
each time and the images must be of superior quality to point out the abusers 
and withdraw the suspicion when no abuse has taken place. Furthermore, 
performing NAI imaging is a specialist task and special attention should be 
  







paid to radiation dose, image quality ,and number of projections. The talk will 
focus on current guidelines and legal issues in NAI imaging. 
Learning Objectives: 
1. To appreciate non-accidental injury imaging as a highly specialised 
procedure. 
2. To understand the image quality requirements in non-accidental injury 
imaging. 
3. To be aware of the legal aspects of performing non-accidental injury 
imaging. 
A-227 09:21  
C. Reducing the need for sedation and anaesthesia in MRI: the role of 
play therapy and other techniques  
J. Gårdling; Lund/SE (jenny.gardling@med.lu.se)  
When a child undergo MRI the unfamiliar environment, meeting new 
healthcare professionals and the need to keep still might imply anxiety, fear 
and/or stress. Depending on the child´s age or inability to comply, sedation or 
general anaesthesia may be required, which implies risks and additional 
anxiety and discomfort for the children and their parents. Previous research 
have shown that children needs to have their parents close, play and feel joy, 
participate in care and have good relation with the healthcare professionals. 
Furthermore, children needs to know what to expect as this enables them to 
handle the situation better with increased coping and compliance, and with 
decreased anxiety. Age-appropriate information and preparation procedures 
have shown an impact on the child´s anxiety and their ability to comply during 
different procedures. It have also shown to decrease the need for general 
anaesthesia. Since children learn and understand situations differently 
depending on age and cognitive development combining different information 
and preparation procedures might be considered as an advantage.  
Learning Objectives: 
1. To review the current use of sedation and anaesthesia in paediatric MRI. 
2. To understand how play therapy and other techniques can be used to 
prepare patients for imaging. 
3. To become familiar with practical skills and techniques that might reduce 
sedation rates in paediatric MRI. 
09:44  
Panel discussion: How to avoid mistakes and to learn from working with 
paediatrics?  
08:30 - 10:00 Room M 1  
Joint Session of the ESR and EFOMP  
ESR/EFOMP  
CT screening: benefits, doses and 
associated risks  
Moderators: 
J. Damilakis; Iraklion/GR  
D. Tack; Baudour/BE  
A-228 08:30  
Dose and risk assessment  
M. Brambilla; Novara/IT (marco.brambilla@maggioreosp.novara.it)  
The radiation output of a CT system can be measured in a consistent and 
robust fashion through CT dose indexes (CTDIw for axial scans and CTDIvol 
for spiral scans). The CTDI tells precisely how the machine was operated, and 
it can be used, in conjunction with information regarding patient size and the 
scanned anatomy by mean of the dose length product (DLP), to estimate 
patient dose. The CTDI and DLP values are not, however, patient dose 
estimates. Similarly, the use of effective dose and the application of the 
nominal coefficient of risk, averaged over sex, several populations and all ages 
to calculate the cancer risk is in principle inappropriate. Estimates of individual 
patient risk, and epidemiologic studies assessing potential late effects, must 
use patient size-specific organ dose estimates in conjunction with the BEIR VII 
model. The BEIR VII committee has derived risk models for cancer mortality. 
The models consider the cancer site, sex, age at the exposure and attained 
age. Risks models have been developed for leukaemia, solid cancers in some 
organs and for all solid cancers combined. The cancer risks are non-zero only 
after a latency period (5 years for solid cancer and 2 years for leukaemia). For 
practical purposes, at typical dose levels encountered in X-ray diagnostics, risk 
of exposure-induced death (REID) and lifetime attributable risks (LAR) can be 
interpreted to present the excess radiation-induced cancer risk and their 
numerical values are close enough to be interpreted identical considering the 
uncertainties involved in the models.  
Learning Objectives: 
1. To learn about the correct methodology to assess the stochastic risk 
associated with radiation exposure. 
2. To understand the differences between exposure indexes (CTDI, DLP, etc.), 
organ doses, effective doses and risk. 
3. To appreciate the risks associated with CT screening. 
A-229 08:50  
Quantitative benefit-risk analysis  
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr)  
CT is an important tool for screening such as lung cancer screening and 
colorectal cancer screening in high-risk patients. Can screening reduce 
mortality? Are radiation doses and radiogenic risks associated with the above 
screening methods an important disadvantage for their acceptance as a mass 
screening tool? Studies have found that screening with low-dose CT could 
reduce lung cancer mortality by 20% in comparison with chest radiography. 
Decision for CT screening should be based on careful consideration and 
discussion between patient and health care provider. Low dose CT screening 
for lung cancer has its risks. Thus, individuals screened with low dose CT have 
a high rate of false positive results that may lead to unnecessary follow-up 
invasive testing for example bronchoscopy or biopsy. Another point of concern 
is radiation dose from low dose CT. Patient dose from a low-dose chest CT 
examination is about 1.5 mSv. Little information exists in the literature 
regarding the risk for radiation-induced cancer following low dose CT for lung 
cancer screening. Studies are needed to determine absorbed doses to the 
primarily irradiated radiosensitive organs of female and male patients 
subjected to low-dose CT screening for lung cancer on modern multi-slice CT 
scanners and assess the potential risk of radiation-induced cancer for a typical 
patient cohort subjected to screening. CT colonography (CTC) has been used 
as a method to screen for colorectal tumours as well as for large colorectal 
polyps mainly because of its accuracy, less-invasiveness in comparison with 
colonoscopy and potential for detection of extra-colonic abnormalities. Effective 
dose from CTC ranges from about 3 mSv to about 9 mSv. A single low-dose 
CTC would result in about a 0.01% lifetime cancer risk, i.e., 1 in 10000 for a 
typical patient cohort.  
Learning Objectives: 
1. To learn about medical benefits of CT screening and how they can be 
expressed quantitatively. 
2. To compare the benefits of CT screening with potential radiogenic risks. 
3. To learn the limitations of benefit-risk analyses. 
A-230 09:10  
Breast CT  
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni-erlangen.de)  
Efforts of improving the early detection of breast cancer are a necessity further 
on. Breast screening programs are being criticized frequently because of their 
cancer detection rates considered as too low. X-ray computed tomography 
(CT) has been proposed and evaluated multiple times as a potential alternative 
method for breast imaging. All efforts shown so far suboptimal because of their 
limited spatial resolution and high patient dose when compared to 
mammography. In consequence, we developed a new concept for breast CT 
(BCT) aiming at both high isotropic spatial resolution of about 100 µm and 
average glandular dose levels of 5 mGy or below. For this we chose single 
photon-counting technology, not available in CT so far, combined with spiral 
scanning. The complete scanner concept was evaluated by simulations and 
measurements; the results for dose and technical image quality parameters 
were confirmed. For comparison purposes, lumpectomies and mastectomies 
were imaged with digital mammography, breast tomosynthesis and BCT; these 
tests also confirmed expectations. The direct-conversion photon-counting 
detector technology showed revealed BCT’s unprecedented performance. It 
provided the highest quality in imaging microcalcifications in specimens; 
combined with contrast medium injection as in standard clinical CT use, it 
outperformed the other modalities. Conclusion: CT scanners dedicated to 
breast imaging with photon-counting detectors and spiral scan capability can 
provide superior, unprecedented performance. 
Learning Objectives: 
1. To learn about early efforts at CT imaging of the breast. 
2. To note image quality requirements for improving breast cancer diagnosis. 
3. To understand the importance of advanced detector technology for the low-
dose high-resolution breast CT. 
Author Disclosure: 
  W.A. Kalender: Consultant; Bayer Pharma AG, Advanced Breast-CT GmbH. 
Shareholder; Advanced Breast-CT GmbH. 
 
  







A-231 09:30  
How to communicate  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt)  
Medical imaging departments present an excellent test environment to study 
interventions to enhance patient satisfaction as: (a) the imaging environment is 
highly complex and workflow and time schedule constraints are extensive; (b) 
there is a wide spectrum of patients referred from multiple clinical specialties 
whose conditions vary in acuity, ranging from outpatients undergoing routine 
examinations to critically ill patients undergoing emergency imaging studies. 
Research indicate that training radiologists and radiographers to make simple 
modifications in their language and behavior, during patient, care can 
significantly impact patient satisfaction which can impact quality-of-care. We 
need to incorporate into our daily practice the fact that the 21st century patients 
have higher expectations and are becoming more demanding, as they are 
progressively being part of the process and therefore have access to 
information, allowing them to make better informed choices. Imaging 
departments should adopt communication strategies and policies in the new 
digital environment, explaining the procedure in an understandable manner, 
adapted to patient social and economic characteristics, with the objective to 
give the patient the adequate information for him/her to be able to make a 
proper decision. Radiographers usually are the ones that contact with patients 
and are the only professionals who might notice duplicate or inappropriate 
examinations before they occur and the ones to be asked about the risk. 
Therefore, its crucial to develop guidelines with clearly defined roles and 
responsibilities on how to communicate risks in a harmonized way, to avoid 
patient misinterpretation in their imaging clinical pathway.  
Learning Objectives: 
1. To become familiar with the principals of patient communication strategies. 
2. To be aware of patients' needs and fragilities at the point of care. 
3. To understand the patients' fears and perceptions about risk. 
09:50  
Discussion  
08:30 - 10:00 Room M 2 
E³ - ECR Master Class (Musculoskeletal)  
E³ 526a  
State-of-the-art imaging of postoperative 
joints  
Moderator: 
M.F. Reiser; Munich/DE  
A-232 08:30  
A. Postoperative shoulder  
C.W.A. Pfirrmann; Zurich/CH  
Imaging of the postoperative shoulder is challenging because of various 
surgical techniques, distorted anatomy and the presence of artifacts because 
of metallic implants. The most commonly performed surgical procedures 
include rotator cuff reconstruction, instability surgery, and joint replacements. 
The radiologists should have knowledge of these techniques. In this 
presentation these surgical techniques, the normal imaging findings after these 
procedures and the abnormal findings as well as imaging strategies will be 
discussed.  
Learning Objectives: 
1. To become familiar with the most frequently used surgical techniques for 
glenohumeral instability, subacromial decompression, rotator cuff repair, and 
arthroplasty and their imaging appearance. 
2. To learn about potential postoperative complications. 
A-233 09:00  
B. Postoperative knee  
E.H.G. Oei; Rotterdam/NL (e.oei@erasmusmc.nl)  
In this masterclass we will review the indications for the most commonly 
performed surgical techniques in the field of meniscal repair, knee ligament 
reconstruction, and knee cartilage repair, followed by a brief explanation of the 
surgical procedure. We will also highlight recent advances in joint preserving 
procedures around the knee. Of each discussed technique, the normal 
postoperative appearance on imaging will be presented, with an emphasis on 
MR imaging. This is followed by a discussion on the assessment of potential 
complications. Among the discussed topics will be complications after ACL 
reconstruction (tunnel positions, graft rerupture, impingement, arthrofibrosis, 
cyclops lesions), assessment of meniscus re-tear after surgical repair and 
assessment of the success after cartilage repair procedures.  
Learning Objectives: 
1. To become familiar with the most frequently used surgical techniques for 
meniscal repair, ligament reconstruction and cartilage repair techniques. 
2. To learn about potential postoperative complications. 
A-234 09:30  
C. Postoperative ankle and foot  
M.J. Ereno Ealo; Galdacano/ES (mjereno@gmail.com)  
Foot and ankle traumatic pathologies are frequent conditions, and sometimes 
cause big deformities. Our objectives are to focus on all aspects of diagnosis, 
treatment and subsequent management of these injuries. The most current 
and innovative techniques of internal fixation and their applications will be 
showed. Identifying problems and complications and also talking about 
reconstructive surgery of the lower extremity is important. Very different injuries 
and cases are detailed: surgical management and complications of high-
energy distal tibial and pilon fractures, other fractures like calcaneus, talus, 
lisfranc, toe and forefoot fractures and stress fractures. Other conditions like 
Achilles pathology, bunions, diabetic (Charcot) foot, Morton's neuroma, 
hammer toe, tarsal coalition, and adult acquired flatfoot are also shown. 
Patients with arthroplasty, arthrodesis, triple fusion, ankle replacement should 
be recognised  
Learning Objectives: 
1. To become familiar with the most frequently used surgical techniques for 
osteosynthesis, instability, tendon repair and arthroplasty and their imaging 
appearance. 
2. To learn about potential postoperative complications. 
08:30 - 10:00 Room M 3 
Interventional Radiology  
RC 509  
Musculoskeletal interventions: what every 
radiologist should know  
Moderator: 
A. Gangi; Strasbourg/FR  
A-235 08:30  
A. Musculoskeletal ablation and embolisation  
A. Basile; Catania/IT (basile.antonello73@gmail.com)  
During the past decade we have seen an increasing role of interventional 
radiology (IR) in the treatment of musculoskeletal both benign and malign 
lesions with palliative or curative goal. A common indication for treatment is the 
presence of localized pain, furthermore in some situation the disease 
progression can lead to pathologic fracture, with or without mechanical 
instability. Most frequent malign lesions are spinal and bone metastases. 
Percutaneous tumor ablation is performed under imaging guidance and 
generating cytotoxic temperatures that cause tumor necrosis. Ablation may be 
considered for example for symptomatic spinal metastases, with tumor control 
indication, for uncomplicated painful spinal metastases and stable pathological 
vertebral compression fracture. Ablation can be also performed in association 
to radiation therapy with a better control of local tumor; also vertebral 
augmentation can be performed as fracture prophylaxis at the same time as 
ablation through the same percutaneous access cannula. There are many 
instruments employed for the treatment of the bone lesions: ablation (thermal 
ablation with radiofrequency, microwaves MW, laser ablation and magnetic-
resonance-guided focused ultrasound surgery MRgFUS and cryoablation), 
osteoplasty and vascular procedures. Another indication for percutaneous 
ablation are painful benign tumours such as osteoid osteoma, osteoblastoma, 
chondroblastoma, osteochondroma, giant cell tumour, aneurysmal bone cyst, 
eosinophilic granuloma, vertebral haemangioma and fibrous dysplasia; all 
these lesions can be treated either via ablation and/or embolisation. 
Embolisation can be also performed in the preoperative management of bone 
metastases to reduce perioperative blood loss. Physicians involved in the care 
of patients with oncological musculoskeletal disease should be familiar with 
these treatments and refer patients appropriately based on best available 
evidence. This is challenging, but necessary because of the increasing 
diagnosis of this kind of lesions and the major role that the IR will assume in 













1. To appreciate the indications for ablations and embolisation. 
2. To learn about different techniques and combination of them. 
3. To discuss the results and literature data of interventional radiology 
procedures. 
A-236 09:00  
B. Vertebral augmentation and discectomy techniques: can we challenge 
surgery?  
D. Filippiadis; Athens/GR (dfilippiadis@yahoo.gr)  
Vertebral augmentation and discectomy techniques: can we challenge 
surgery? Vertebral augmentation techniques include standard vertebroplasty or 
vertebral augmentation on terms of balloon kyphoplasty or percutaneous 
implant insertion combined to PMMA injection. Indications include osteoporotic, 
traumatic, pathologic, and cancer-related fractures as well as benign (eg 
symptomatic atypical aggressive hemangiomas) or malignant (e.g., metastatic) 
lesions. Under proper patient selection these techniques provide pain relief and 
functional improvement along with spine alignment height restoration and 
endplate reduction. Additionally, kyphotic angle restoration or maintenance 
seems to prevent future vertebral fracture in the adjacent levels and improved 
sagittal balance. Studies in the literature report that load distribution in patients 
with vertebral fractures post vertebroplasty returns to values of normal 
population. Variety in the morphology, location, and etiology of vertebral 
fractures demands a tailored patient centered approach. Percutaneous 
technique for intervertebral disc herniation and discogenic pain can be either 
decompression or biomaterial implantation techniques. The former can be 
classified into mechanical (discectomy), thermal (RF, laser, coblation, IDET) or 
chemical (Discogel, ozone) methods whilst the later include hydrogel, PRP and 
stem cell therapies. Decompression techniques are indicated for small- to 
medium-sized symptomatic contained hernias. Percutaneous techniques are 
performed as outpatient, low cost procedures and are governed by good 
patient compliance, high success (75-85%) and low complication rates (<1-
2%). In case of treatment failure, percutaneous techniques can be repeated 
without interfering with surgery at a later stage. Percutaneous vertebral 
augmentation and discectomy techniques compared to surgical approaches 
are favored in terms of reduced blood loss and operating time, shorter hospital 
stay, fewer complications, and less postoperative pain.  
Learning Objectives: 
1. To appreciate the rationale for the using of interventional radiology 
procedures. 
2. To learn about different techniques and treatment strategy. 
3. To discuss results and literature data in comparison with other treatments. 
A-237 09:30  
C. Bone biopsy and pain treatment using cone-beam CT (CBCT)  
L. Tselikas; Villejuif/FR (lambros.tselikas@gustaveroussy.fr)  
Oncology has dramatically changed the last decade, and new therapies have 
been proven to be effective in metastatic cancer patients. But bone tumours 
remain difficult to treat, and interventionnal radiology plays a key role in their 
management. Both biopsy, ablation and consolidation techniques are feasible 
and effective with a very good safety profile. Cone beam CT is the guidance 
method of choice because because of its versatility, and comfort of use. 
Guiding softwares are mandatory to improve te technic results and take full 
advantage of this technology. Futur developments including combined guiding 
systems based on optic or electromagnetic needle position estimation and 
dose reduction solutions.  
Learning Objectives: 
1. To appreciate the high imaging quality and guidance accuracy using CBCT 
for biopsy and pain treatment. 
2. To learn about the advantages of CBCT-guided interventions, reconstruction 
algorithms, image enhancement and dose reduction. 







08:30 - 10:00 Room M 4 
E³ - ECR Master Class (Vascular)  
E³ 526b  
TEVAR/EVAR: where we are and where we 
are going  
Moderator: 
F. Fanelli; Rome/IT  
A-238 08:30  
A. TEVAR  
H. Rousseau; Toulouse/FR (rousseau.h@chu-toulouse.fr)  
Thoracic endovascular aneurysm repair (TEVAR) has proven to be a safe and 
effective therapy. In the last 2 decades, TEVAR has been established as first-
line treatment for most descending thoracic aortic pathology due to reductions 
in perioperative morbidity and mortality compared to open surgical repair. 
Improvements in materials, reduction in delivery sheath size, improved 
conformability, tapered grafts, and a wider range of sizes have improved 
TEVAR applicability and outcomes over this initial decade of widespread use, 
for traumatic aortic transection, aneurysms, as well as acute and chronic type 
B aortic dissection. Looking into the future, industry and physicians are working 
together to improve thoracic stent-graft design (branched and fenestrated 
stent-grafts, chimney technique) to further improve safety, effectiveness, and 
applicability to a wider range of patients and aortic pathologies. Treatment of 
the ascending aorta remains less established, but is expected to evolve as 
technology allows integration of ascending, and arch devices. Hybrid ORs 
combining optimal imaging with the ideal environment to perform complex 
open and endovascular operations are available, allowing several features 
such as CTA fusion, CB-CT, and low-dose protocols to reduce the radiation 
exposure to a patient and an operator.This presentation will review the 
indications, technical aspects and results of endovascular TAA repairs. We 
also examine the advantages and limitations of new stent graft treatment of the 
arch and our experience in technological innovation in performing these 
complex procedures. 
Learning Objectives: 
1. To understand the evidence supporting endovascular therapy vs surgery. 
2. To learn what is new for aortic arch disease. 
3. To learn the impact of technological innovation in planning and performing 
the procedure. 
A-239 09:00  
B. EVAR  
E. Brountzos; Athens/GR (ebrountz@med.uoa.gr)  
To understand the evidence supporting endovascular therapy vs surgery 
EVAR is the method of choice because three principal, randomised controlled 
trials have shown better 30-day mortality for EVAR compared to open surgery. 
However, the mortality benefit was lost (catch-up of mortality) after 2 to 5 
years. The main cause of aneurysm-related mortality in the EVAR group was 
secondary aortic sac rupture, caused by late device failures. Careful patient 
selection, diligent adhesion to instructions for use and meticulous life long 
imaging follow up are mandatory for a successful EVAR. Thoracobdominal 
aneurysms are rare and various. Open surgery carries a mortality rate of 2-
12% depending on the aneurysm type. Endovascular treatment includes the 
use of fenestrated and branched devices with high technical success rates and 
significant improvement in perioperative mortality. Additional strategies such as 
hybrid techniques and parallel grafts (chimneys and snorkels) are also 
successful. Standard EVAR requires bilateral or unilateral surgical exposure of 
the common femoral artery. Complications specific for this surgical procedure 
include hematoma (5%), seroma (10%), and femoral nerve damage. Following 
the introduction of the new low profile devices and the development of the 
suture mediated closure devices EVAR can be performed without the need of 
surgical cut down. Recent studies have shown that percutaneous EVAR is 
possible with 96-100% technical success rates, with complication rates less 
than 2%.  
Learning Objectives: 
1. To understand the evidence supporting endovascular therapy vs surgery. 
2. To learn what is new for thoracoabdominal aortic disease and iliac axis. 











A-240 09:30  
C. Post-EVG complication  
R. Uberoi; Oxford/UK (Raman.Uberoi@ouh.nhs.uk)  
Abdominal endovascular repair (EVAR) and thoracic endovascular aortic repair 
(TEVAR) have become an accepted alternative to surgery for the treatment of 
aortic pathologies, particularly aneurysm disease and dissections. Lifelong 
surveillance is obligatory following EVAR and TEVAR to monitor the aortic 
morphology and detect associated complications. The main imaging 
techniques used in evaluating TEVAR follow up are computed tomography 
angiography (CTA), magnetic resonance angiography (MRA) and catheter 
angiography in assessing the technical success, outcome and complications, 
which may necessitate re-intervention. In the abdominal aorta ultrasound 
(duplex) including contrast enhanced ultrasound (CEUS) with plain X-ray may 
also be used as alternative imaging modalities. Of these, computed 
tomography angiography offers a fast, accessible and sensitive imaging 
modality and is established as the default surveillance tool. Long term common 
complications include thrombosis, limb kinking and occlusion, aneurysm sac 
leak which may result in persistent pressurisation of the sac called endoleaks 
type I-V. Device migration, and device failure can contribute to endoleaks and 
need to be closely monitored. Type I and III endoleaks need urgent treatment 
usually with placement of a proximal or distal cuff and or relining of the graft. 
However not all type II endoleaks need treatment, but where there is continued 
sac expansion or aneurysm development his will require embolization of 
feeding vessels. Type IV is less common with the newer devices and usually 
resolve over a period of weeks and months. Type V endoleaks also may 
require relining of the whole device or conversion to an open procedure. 
Learning Objectives: 
1. To learn about individualised post-EVG surveillance programme. 
2. To learn which are the most common complications. 
3. To understand how to select and perform the optimal treatment. 
4. To understand the role of contrast-enhanced US (CEUS). 
Author Disclosure: 
  R. Uberoi: Advisory Board; merit. Grant Recipient; Gore and Bolton. Speaker; 
Spectranetics. 
08:30 - 10:00 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 520  
Imaging of HCC  
A-241 08:30  
Chairperson's introduction  
A. Palkó; Szeged/HU (palkoand@gmail.com)  
Imaging of hepatocellular carcinoma is one of the important tasks of abdominal 
radiology. Early detection and accurate characterisation of this disease is 
challenging, especially in cases of advanced cirrhosis, nevertheless of utmost 
importance since it allows for conducting timely and effective treatment which 
may be curative or palliative, depending on the overall condition of the patient. 
Speakers of this session introduce the state of the art CT and MRI examination 
techniques, the typical morphological characteristics of HCC, the objective 
criteria for establishing the diagnosis and the difficulties of differential 
diagnosis.  
A-242 08:35  
A. CT or MRI for diagnosis and follow-up?  
G. Brancatelli; Palermo/IT (gbranca@yahoo.com)  
Multiphasic CT and MRI allow non-invasive diagnosis of hepatocellular 
carcinoma in cirrhotic patients. Moreover, they are able to stage the tumour 
burden to choose the most appropriate treatment for each patient. 
Furthermore, they have a role in the follow-up of; (1) indeterminate nodules 
such as LI-RADS 3 and (2) treated HCC nodules to confirm the effectiveness 
of treatment or to detect residual tumour or recurrence. LI-RADS is a 
classification system that allows; (1) predicting with CT and MR the likelihood 
that a lesion is HCC in patients with chronic liver disease or cirrhosis and (2) 








1. To understand the CT and MR imaging protocols to identify HCC in cirrhotic 
liver. 
2. To be familiar with LI-RADS . 
3. To review the role of each modality in detecting, staging and follow-up of 
HCC.  
Author Disclosure: 
  G. Brancatelli: Speaker; Bayer. 
A-243 09:03  
B. Early HCC and well-differentiated HCC  
C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es)  
Non invasive criteria for the diagnosis HCC 10 mm in patients with liver 
cirrhosis are based on the developement of neoangiogenesis and on the 
progressive reduction of portal supply within the tumour, leading to the 
characteristic arterial wash-in and portal wash-out pattern detected on dynamic 
CT/ MR studies performed with extracellular contrast agentes (CA). Imaging 
criteria have a sensitivity of 60% and a specificity close to 100% for the 
diagnosis of small HCC. When RM is obtained with gadoxetic acid, the arterial 
and early portal phases demonstrate also the typical wash-in/wash-out pattern 
of HCC. In the transitional and hepatobiliary phases, another key imaging is 
found, the hyposignal intensity of close to 90% of HCCs compared to the 
surrounding liver parenchyma, based on the progressive reduction/absence of 
the expresion of organic anion transporting polypeptides (OATPs) during the 
hepatocarcinogenesis process. LI-RADS can be applied on CT, on MR 
independenly of the CA used, and also on contrast enhanced ultrasound. The 
sensitivity, specificity and interobserved concordance of the stanadardised 
imaging interpretation do not have strong proscpective data availble. Early 
diagnosis is the only way to improve the outcome of patients with HCC. Up to 
now, the active work-up for the diagnosis of HCC is recommended for new liver 
lesion 10 mm detected in the context of surveillance programmes. A confident 
imaging diagnosis of HCC in smaller lesions is limited and treatment of such a 
tiny possible pre-malignant but not confirmed HCC lesions is not 
recommended to avoid overdiagnosis and overtreatment.  
Learning Objectives: 
1. To review key imaging criteria of HCC in a cirrhotic liver. 
2. To be able to differentiate HCC from other lesions in a cirrhotic liver. 
3. To reflect the role of early diagnosis of HCC in the management of the 
patient. 
A-244 09:31  
C. Mimickers and pitfalls  
D. Akata; Ankara/TR (dakata@hacettepe.edu.tr)  
HCC can develop in non-cirrhotic liver and even without identifiable risk 
factors. In this setting it is more likely to manifest as a symptomatic dominant 
lobulated mass. Non-invasive diagnostic criteria such as, arterial enhancement 
and subsequent ‘‘washout’’ during portal venous or equilibrium phases on both 
CT and MR are present in more than 90% of cases. The imaging findings of 
HCC are the same in both cirrhotic or non-cirrhotic liver. However, focal liver 
lesions mimicking HCC in non-cirrhotic liver are different than the ones in 
cirrhotic liver. This presentation describes the typical and atypical imaging 
features of common hypervascular lesions such as hemangiomas, focal 
nodular hyperplasia, metastasis, cholangiocarcinoma and fat containing liver 
lesions such as angiomyolipoma and adenomas. It outlines a general approach 
to distinguishing between benign and malignant hepatic lesions. The role, 
pearls, and pitfalls of the hepatobiliary specific contrast agents as well as 
diffusion weighted imaging in the detection and characterization of the lesions 
will be discussed in detail.  
Learning Objectives: 
1. To review a diagnostic algorithm to detect HCC mimics in non-cirrhotic liver. 
2. To review the imaging characteristics of a wide spectrum of potential pitfalls. 
3. To understand the potential role of extracellular and hepatobiliary contrast 














10:30 - 12:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 621  
Basic breast imaging  
A-245 10:30  
A. Calcifications in mammography  
C.S. Balleyguier; Villejuif/FR (Corinne.BALLEYGUIER@gustaveroussy.fr)  
Breast calcifications are common findings detectable on mammography. 
Breast calcifications are most likely benign; nevertheless irregular 
microcalcifications cluster may be the only imaging findings suggesting a 
ductal carcinoma in situ (DCIS). Analysis of microcalcifications on 
mammography remains on magnification views; size, density, number, 
pleomorphism and distribution within the breast have to be carefully analysed 
to differentiate benign and suspicious microcalcifications clusters. Benign 
calcifications are categorised as BI-RADS 2 and are more likely round, regular, 
with a calcified rim, tea-cup or egg-shell shape. Suspicious microcalcifications 
may be amorphous, irregular, with a linear or segmental distribution. When a 
microcalcifications cluster is categorised as BI-RADS 4, a stereotactic biopsy 
should be performed. Ultrasound may be performed first to detect non-calcified 
mass. Vacuum assisted stereotactic biopsy with at least 6 11 Gauge samples 
must be performed. New technologies such as BLES biopsy, associating 
biopsy and radiofrequency can be performed to remove entirely the cluster. In 
this topic, biopsy techniques and diagnostic strategies to diagnose 
microcalcifications will be presented on a basis of clinical cases.  
Learning Objectives: 
1. To become familiar with different types of calcifications. 
2. To learn the differential diagnosis of different calcifications. 
3. To learn the different tools to biopsy calcification clusters. 
A-246 11:15  
B. Asymmetry and architectural distortion  
L.J. Pina Insausti; Pamplona/ES (ljpina@unav.es)  
Asymmetries and architectural distortions: Asymmetries are unilateral deposits 
of fibroglandular tissue not conforming to the definition of a mass. Four types of 
asymmetries can be considered: (1) Asymmetry as an area of fibroglandular 
tissue visible on only one mammographic projection, mostly caused by 
superimposition of normal breast tissue. (2) Focal asymmetry visible on two 
projections, hence a real finding rather than superposition. (3) Global 
asymmetry consisting of an asymmetry over at least one quarter of the breast 
and is usually a normal variant. (4) Developing asymmetry new, larger and 
more conspicuous than on a previous examination After the detection of one of 
the previous asymmetries, it is mandatory to compare with previous 
mammograms, if available. Palpation and additional techniques can be used to 
study the lesion, such as spot compressions, tomosynthesis, US and in some 
cases MRI. A biopsy is needed if malignancy cannot be excluded. The term 
architectural distortion is used when the normal architecture is distorted with no 
definite mass visible. This includes thin straight lines or speculations radiating 
from a point, and focal retraction, distortion or straightening at the edges of the 
parenchyma. Architectural distortion can also be seen as an associated 
feature. Tomosynthesis is a very sensitive technique to detect architectural 
distortions. Surgery, radial scar and carcinoma are the most common causes 
of distortions. A biopsy is mandatory if a surgical scar is excluded. The 
management of radial scars needs further work-up after a core needle biopsy: 
both surgery or vacuum-assisted biopsy can be used. 
Learning Objectives: 
1. To understand the concept of asymmetry and architectural distortion. 
2. To become familiar with the respective imaging features. 
3. To learn about the diagnostic approach using all breast imaging modalities. 
Author Disclosure: 





10:30 - 12:00 Room X  
EuroSafe Imaging Session  
EU 2  
Strategies for dose reduction in computed 
tomography: from technical concepts to 
clinical practice  
Moderator: 
R.W.R. Loose; Nuremberg/DE  
A-247 10:3s0  
Chairperson's introduction  
W. Stiller; Heidelberg/DE (wolfram.stiller@med.uni-heidelberg.de)  
In the field of computed tomography (CT) technical improvements have 
constantly extended the range of clinical applications and made new 
radiodiagnostic indications accessible. As CT examinations always involve the 
exposure of patients to ionizing radiation, dose reduction is an imperative when 
applying CT in clinical practice and approaches for reducing the dose 
associated with CT are required. To this end, different strategies for dose 
reduction in CT have been developed, spanning technical approaches as well 
as specific examination techniques applied in clinical practice. To date, several 
technical possibilities such as automated tube current modulation and voltage 
selection as well as dynamic beam collimation are available for reducing the 
dose associated with CT examinations. Of late, methods for iterative image 
reconstruction in CT enable noise suppression in image data, which may be 
exploited for enabling further dose reduction. While all scanner technology 
currently available should be exploited for reducing the radiation exposure of 
CT examinations in general, this is especially important in pediatric CT 
imaging. Careful selection and individual adaptation of the CT protocol 
parameters to each specific diagnostic task have the potential to enable 
systematic dose reduction, e.g., for pediatric and chest CT examinations. While 
dose reduction is imperative in CT, excessive reductions will result in a loss of 
diagnostic image quality. In clinical routine, dose reduction of CT examinations 
therefore is limited by the image quality requirements inherent to each specific 
diagnostic task that have to be fulfilled for ensuring confident diagnosis. 
Session Objectives: 
1. To raise awareness of different strategies for dose reduction in computed 
tomography. 
2. To learn about and understand technical concepts facilitating dose reduction 
in CT. 
3. To become familiar with methods for dose reduction in CT applied in clinical 
practice. 
A-248 10:35  
Systems for dose reduction in CT: more than automated exposure 
control  
M. Prokop; Nijmegen/NL  
"no abstract submitted" 
Learning Objectives: 
1. To learn about the technical possibilities available for reducing the dose 
associated with CT examinations. 
2. To become familiar with the functionality of technical systems for dose 
reduction in CT. 
3. To understand the potential and limitations of these dose reduction systems. 
A-249 10:51  
Iterative image reconstruction for dose reduction in CT: technical 
background and concepts for clinical practice  
P.B. Noël; Munich/DE (peter.noel@tum.de)  
After introduction in the 1970s, computed tomography has developed to be a 
major tool in day-to-day clinical routine. A rapid growth in CT examinations can 
be attributed to its wide availability, speed, and diagnostic benefits. In the same 
time, public health concerns have arisen with respect to patient and population 
radiation dose. Industrial and academic CT development teams have, 
therefore, worked on strategies to reduced radiation exposure from CT, for 
example, with concepts like: tube-current modulation, over-beam reduction, or 
organ-specific dose reduction. Over the last decade one promising 
development is the paradigm of advanced reconstruction algorithms. The idea 
of this software solution is to reduce image noise and improve image quality. 
Image noise as well as image quality are directly linked to the radiation 
exposure, and thus the reduction of noise via iterative reconstruction allows a 
reduction in dose. This presentation will give insight into the different flavors of 
  







reconstruction algorithms, including hybrid-, model-based, and full statistical 
iterative algorithms. Furthermore, we will discuss its clinical translation and the 
challenges associated with its introduction into the clinical routine. Additionally, 
the talk will provide an outlook of potential solutions to further reduce CT 
radiation dose.  
Learning Objectives: 
1. To learn about current methods for the iterative image reconstruction in CT. 
2. To raise awareness about the potential of the iterative image reconstruction 
for enabling dose reduction in CT. 
3. To understand technical limitations of the iterative image reconstruction in 
view of image quality at very low doses. 
Author Disclosure: 
  P.B. Noël: Equipment Support Recipient; Philips Healthcare. Research/Grant 
Support; Philips Healthcare. Speaker; Philips Healthcare. 
A-250 11:07  
Dose reduction strategies in paediatric CT  
E. Castellano; London/UK (elly.castellano@rmh.nhs.uk)  
The benchmarking of paediatric CT imaging practice at non-specialist centres 
is likely to show that there is scope for radiation dose reduction because 
general radiologists are not as accustomed to noisy images of small patients 
as their paediatric counterparts. Dose reduction endeavours should first focus 
on reducing local diagnostic reference levels (DRLs) below national or 
European ones, then on adopting specialist centre DRLs as performance 
targets and moving towards them in small steps to permit the radiologists to 
adapt to the image quality. The outcome will be an imaging practice better 
aligned with that of specialist paediatric centres. Scan protocols may need to 
be developed along the way for specific clinical indications and weight 
categories. The slice thickness set for the reporting image set strongly 
influences the radiation dose and must be appropriate for the diagnostic task. 
Particular attention must be given to the choice of tube voltage: lowering the kV 
from 120 kV to 100 kV for body imaging will permit the tube current to 
modulate with patient size; 80 kV is feasible for contrast-enhanced studies of 
the thorax, resulting in increased conspicuity of iodine-perfused vessels and 
tissues. Decreasing the tube voltage will also reduce patient dose if the tube 
current modulation settings are reviewed alongside. Iterative reconstruction 
can be used to improve the appearance of lower-dose images. Good 
radiographic practice must be promoted at all times: careful centering of the 
patient, effective immobilisation and correct positioning of the arms are 
essential.  
Learning Objectives: 
1. To become familiar with dose reduction strategies employed in paediatric 
CT. 
2. To understand how scanner technology can be used for reducing dose of 
paediatric CT examinations. 
3. To raise awareness of the importance of dose reduction in paediatric CT 
examinations. 
A-251 11:23  
Adapting protocols towards dose reduction in chest CT  
D. Tack; Baudour/BE (denis.tack@skynet.be)  
Once a new CT device is installed, it is the responsibility of users to check all 
parameters to fit with the ALARA principle. This is made in a team approach. 
Objectives for dose delivery should not be based on DRLs, but rather on P25 
of national surveys or on best-published practices in agreement with their 
equipment. Default protocols include standard CT, low or ultra-low-dose CT 
(ULD-CT) and CT pulmonary angiography (CTPA). Submillisievert routine CT 
scanning in standard-sized patients is feasible (DLP<70 mGy.cm) in routine as 
standard acquisitions. DLP of ULD-CT could be lower than 15 mGy.cm. CTPA 
can be obtained at DLP lower than 100 mGy.cm in standard patients. 
Subjective image quality should be assessed by radiologists on a five-point 
scale (1=non-diagnostic; 5=excellent). An optimised dose would have a score 
approximating 3,5, whereas a ULD CT would have a sore of 2,5. Inter-observer 
variability in assessing image quality if often observed. Training and consensus 
readings for choosing the final acceptable IQ are mandatory. Adjustments of 
automatic exposure control and tube potential selection for optimising the dose 
are vendor-specific, and include pitfalls that will be detailed. Specific technical 
settings available on some CT devices can also be utilised such as volumetric 
sequential scanning, Sn filtering, and high-pitch acquisitions.  
Learning Objectives: 
1. To become familiar with strategies for dose reduction applied in chest CT. 
2. To learn about the adaptation of acquisition protocol parameters for reducing 
dose of chest CT examinations. 
3. To raise awareness of the potential for dose reduction in chest CT in clinical 
routine. 
A-252 11:39  
Dose reduction and image quality: when low is too low  
S.T. Schindera; Aarau/CH (sschindera@aol.com)  
Dose reduction in CT, according to the ALARA principle is very well known but 
at the same time also very challenging. Depending of the clinical task, different 
magnitudes exist to reduce the dose (e.g., detection of hepatic metastasis vs. 
renal stone detection). Many radiologists are still afraid of losing the diagnostic 
accuracy while reducing the dose. The key question is, how low can we go 
while preserving the diagnostic accuracy. To date, various possibilities (e.g., 
phantom studies, studies with virtual added noise) exists of evaluating the 
possibility of dose reduction in CT. In the future, task specific model observer 
will play an increasing role in the dose optimization process in CT. 
Learning Objectives: 
1. To learn about the implications of dose reduction on the image quality of CT 
examinations. 
2. To become familiar with examples of excessive dose reduction from clinical 
practice. 
3. To understand that dose reduction potential in CT is limited by the image 
quality requirements inherent to each specific diagnostic task. 
10:30 - 12:00 Room F1  
E³ - Rising Stars Programme: Joint Sessions with ESOR  
ESR/ESOR 1  
Radiologic anatomy: lower extremities  
Moderator: 
U. Aydingoz; Ankara/TR  
A-253 10:30  
Hip  
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com)  
The painful hip is a common clinical problem in all age groups. Magnetic 
resonance imaging (MRI) is an invaluable tool to assess the hip joint because 
of its ability to directly visualize bone marrow, cartilage and soft tissues in 
multiple planes. MR arthrography (MRa) using intra-articular contrast material 
is the standard method for imaging labral lesions and cartilage degeneration 
and trauma. Understanding normal hip anatomy and common variants is 
important, in order to accurately detect and localize areas of pathology and to 
prevent misinterpreting normal structures as diseased. Plain radiographs 
should always be available when reporting MRI because basic measurements 
allow assessment of underlying deformities which might explain the clinical and 
MRI findings. The most important to know are: joint space width (JSW), CE 
angle, VCA angle, alpha angle and acetabular retroversion. Among the 
disorders causing hip pain, osteoarthritis (OA) is the most common one. Age is 
a risk factor strongly correlated with OA. Early OA is related to CAM type 
femoroacetabular impingement, developmental dysplasia and previous trauma, 
inflammation or infection. The diagnosis of OA is based on a combination of 
radiographic findings and characteristic symptoms. The progression of OA 
traditionally has been measured using radiographic JSW. Weight-bearing 
radiographs centered on the hip are the most reproducible and reliable ones. 
The sequence of degeneration includes the following radiographic findings: 
joint space narrowing, osteophyte formation, subchondral sclerosis, and cyst 
formation. In cases that radiographs show minor changes and high clinical 
suspicion of early disease, OA can be confirmed with MRI and/or MRa.  
Learning Objectives: 
1. To identify intra- and extra-articular anatomy on MRI. 
2. To learn what we see and what we miss on radiographs. 
3. To understand osteoarthritis and learn its key features on imaging. 
A-254 11:00  
Knee  
M. Klontzas; London/UK (miklontzas@gmail.com)  
Knee pain is one of the most prevalent musculoskeletal symptoms which is 
increasing together with the steady increase in life expectancy and the 
prevalence of obesity. MRI is the imaging modality of choice for the evaluation 
of knee disorders, offering a comprehensive evaluation of the bone marrow, 
the soft tissues and the articular cartilage. As an imaging modality it combines 
high sensitivity and specificity aiding the investigation and differential diagnosis 
of pathology such as cruciate ligament and meniscal tears, which cannot be 
visualized with plain radiographs. This lecture will provide the outlines of the 
normal cross-sectional anatomy of the knee with a special focus on MRI. An 
outline of pathology missed or identified on plain films will be provided before 
focusing on more detail in MR imaging anatomy which is extremely important 
  







for the evaluation of knee pathology and the differential diagnosis between 
anatomical variations and clinically relevant knee lesions. Finally, an outline of 
meniscal lesion evaluation with the use of MRI will be providing since they are 
one of the most commonly injured knee structures. The combination of imaging 
with data provided from the clinical examination and medical history can lead 
to the correct diagnosis and this is why the knowledge on the normal anatomy 
as well as variants can lead to the successful diagnosis and the avoidance of 
unnecessary diagnostic arthroscopic procedures.  
Learning Objectives: 
1. To identify intra- and extra-articular anatomy on MRI. 
2. To learn what we see and what we miss on radiographs. 
3. To understand and learn the key features of meniscal injury. 
A-255 11:30  
Ankle  
F. Smithuis; Amsterdam/NL  
"no abstract submitted" 
Learning Objectives: 
1. To identify intra- and extra-articular anatomy on MRI. 
2. To learn what we see and what we miss on radiographs. 
3. To understand and learn key features of ankle sprain. 
10:30 - 12:00 Room M 4 
E³ - ECR Academies: Chest Imaging  
E³ 618  
The heart between the lungs  
A-256 10:30  
Chairperson's introduction  
J.E. Wildberger; Maastricht/NL (j.wildberger@mumc.nl)  
Modern high end CT scanners with faster scan acquisition times allow for 
routine assessment of cardiac pathologies, even on a standard chest CT. 
Relevant information regarding the heart can be retrieved, incidental cardiac 
findings will play a major role for patient management in the future. Plain CT 
allows for fat distribution as well as for coronary calcium analysis. On contrast-
enhanced scans, coronary arteries and myocardial changes can be assessed. 
During this session, three esteemed speakers will present an overview on the 
diagnostics and the clinical impact of various cardiac pathologies on standard 
thoracic CT scans.  
A-257 10:35  
A. Cardiomyopathies  
D.J. Murphy; London/UK (murphy.84@gmail.com)  
Cardiomyopathies are a heterogeneous, important group of diseases with 
significant morbidity and mortality. They can be broadly classified into five 
major subtypes based on morphology (hypertrophic, dilated, restrictive, 
arrhythmogenic and unclassified). Diagnosis is based on a composite of 
clinical history and examination, laboratory and genetic testing, 
electrocardiography and cardiac imaging. Despite advances in medical 
therapy, overall prognosis remains poor, and early diagnosis is important. 
Echocardiography is the first-line imaging test for the evaluation of cardiac 
structure and function, with cardiac magnetic resonance imaging (CMR) the 
gold standard. Computerised tomography (CT) has a growing role in this area. 
ECG-gated cardiac CT is a well-established test for coronary artery imaging, 
but it also allows an excellent opportunity to assess for structural cardiac 
abnormalities characteristic of an underlying cardiomyopathy, such as septal 
hypertrophy in asymmetric hypertrophic cardiomyopathy, or left ventricular 
dilatation in dilated cardiomyopathy; the CT features of the common 
cardiomyopathies will be reviewed with comparison to CMR, along with a 
revision of normal cardiac chamber anatomy. The improved temporal 
resolution of modern CT scanners has reduced the deleterious effect of cardiac 
motion artefact on routine non-ECG gated chest CT, allowing an opportunity 
for the detection of cardiac structural abnormalities. Standard non-ECG gated 
chest CT has a reported sensitivity of 68% in the detection of cardiomyopathies 
and the most reliable imaging features of cardiomyopathies on standard chest 
CT will also be reviewed.  
Learning Objectives: 
1. To review the normal anatomy on standard chest CT. 
2. To learn about the CT signs of various cardiomyopathies. 
3. To learn about CT performance for the diagnosis of cardiomyopathy. 
A-258 11:03  
B. Coronary artery disease  
M. Williams; Edinburgh/UK (michelle.williams@ed.ac.uk)  
The heart and coronary arteries can be identified on imaging performed 
specifically to assess the heart and also on imaging of the chest performed for 
other reasons. Normal imaging coronary artery anatomy will be reviewed. 
Coronary artery calcification (CAC) is a marker of atherosclerotic plaque 
burden. CAC identified on electrocardiogram gated computed tomography (CT) 
is associated with an increased risk of cardiovascular morbidity and mortality. 
Randomised controlled trials have shown that management guided by CT 
coronary angiography can improve outcomes for patients with suspected 
coronary artery disease. CAC can also be identified on non-gated CT 
performed for other reasons. Calcium scoring or ordinal assessment of CAC on 
non-gated CT correlate with results from gated imaging. CAC on non-gated CT 
is associated with increased mortality in a variety of diseases, including 
patients with respiratory diseases. Evidence of previous myocardial infarction 
can also be identified on non-gated CT with features including mural thinning, 
fatty infiltration, and complications such as aneurysms.  
Learning Objectives: 
1. To review the normal coronary artery anatomy. 
2. To learn about calcium scoring on non-gated CT. 
3. To learn about the CT signs of healed myocardial infarction. 
A-259 11:31  
C. Fat and calcium in the heart  
F. Pontana; Lille/FR (francois.pontana@chru-lille.fr) 
Population ageing and other risk factors are not only associated with 
calcification of coronary arteries but are also likely to induce changes in the 
cardiac structure. These changes can be evaluated by CT and MR. 
Calcifications of the cardiac valves may be a sign of valvulopathy. Aortic valve 
calcium scoring by CT is useful to estimate aortic stenosis severity when 
echocardiography is not feasible or not conclusive. Physiological age-related 
fat deposits within the myocardium or the atrial septum are frequent and must 
not be misreported as pathological. Benign or more rarely malignant cardiac 
tumors may present fatty component. More recently epicardial adipose tissue 
seems to be a new cardiac risk factor quantifiable by imaging. 
Learning Objectives: 
1. To learn about physiologic changes. 
2. To review the main causes of fat and calcium. 
3. To learn how to differentiate pathologic from physiologic images. 
10:30 - 12:00 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 620  
Characterisation of focal liver lesions  
A-260 10:30  
Chairperson's introduction  
C. Stoupis; Männedorf/CH (c.stoupis@spitalmaennedorf.ch)  
One of the most important focus of current liver imaging techniques is the 
potential to characterize liver lesions, facilitating the final diagnosis and 
avoiding unnecessary biopsies. Upon detection of a focal liver lesion on a 
routine imaging study, the question of characterization arises and may times 
the differentiation between a benign and a malignant lesion can be challenging. 
In this session, the important role of current imaging techniques will be 
discussed, reviewing typical imaging appearances of liver lesions, targeting to 
their underlying pathology; the differential diagnosis of hypervascular lesions, 
fat containing or fibrotic lesions, will be discussed, to provide helpful 
information to approach to correct diagnosis.  
A-261 10:35  
A. Hypervascular lesions  
R. Manfredi; Rome/IT (riccardo.manfredi@unicatt.it)  
Liver parenchyma is fed by both the hepatic artery and portal vein; classical 
hepatocellular carcinoma (HCC) is usually fed by the hepatic artery only. 
Therefore, imaging of hepatic blood flow, including arterial and portal venous 
flow, is important for diagnosing liver tumours. Dynamic computed tomography 
(CT) and magnetic resonance imaging (MRI), have been developed to 
evaluate hepatic blood flow. In particular, dynamic CT or MRI are essential for 
diagnosis and characterisation of liver tumours. Moreover, MRI with tissue-
  







specific MR contrast media and enhanced ultrasonography with real-time high-
spatial-resolution imaging are clinically available. Hypervascular liver tumours 
may be both benign and malignant being important to avoid unnecessary 
interventions for benign lesions. There are many types of benign liver tumours 
that may have typical and atypical imaging features, therefore, describe an 
approach to distinguishing between benign and malignant hepatic lesions may 
help in clinical practice. Dynamic imaging is helpful in diagnosing 
hypervascular pseudotumors, such as focal nodular hyperplasia, and nodular 
lesions associated with alcohol-induced hepatitis, from hepatocellular 
carcinoma. There are also some hypervascular malignant tumours, such as 
cholangiocarcinoma, cholangiocellular carcinoma, mixed type tumours, and 
metastatic liver tumours, which also required differentiation from HCC. Imaging 
information enables us to deliver precise diagnoses, but some benign tumours 
are still difficult to differentiate from malignant lesions. In such cases, patients 
require invasive examinations, such as biopsy.  
Learning Objectives: 
1. To understand the imaging techniques to characterise focal liver lesions. 
2. To get familiar with the typical and atypical imaging features of 
hypervascular lesions including haemangioma, focal nodular hyperplasia and 
liver cell adenomas. 
3. To be able to differentiate benign hypervascular lesions from malignant 
ones. 
A-262 11:03  
B. Fat-containing lesions  
O. Benjaminov; Petach Tikva/IL  
"no abstract submitted" 
Learning Objectives: 
1. To list the wide spectrum of fat-containing lesions of the liver. 
2. To be able to identify the imaging features of fat-containing liver lesions. 
3. To describe the patterns of fatty change within hepatic neoplasms, in order 
to use them for differential diagnosis. 
A-263 11:31  
C. Fibrotic lesions  
V. Vilgrain; Clichy/FR (valerie.vilgrain@aphp.fr)  
Fibrotic lesions of the liver are defined by tumours that have a fibrous stroma. 
The most common fibrotic tumours are represented by liver metastases in 
particular of colorectal origin and intrahepatic cholangiocarcinoma. Less 
common fibrotic tumours are fibrolamellar carcinoma, epithelioid 
hemangioendothelioma, and solitary fibrous tumours. On contrast-enhanced 
CT or MR imaging, the fibrotic tumours share common findings such as 
delayed and persistent enhancement, and capsular retraction. Venous 
involvement when present is usually not endoluminal invasion, but 
encasement. On MR imaging during hepatobiliary phase, central enhancement 
may be seen. This lecture will review these imaging features and highlight the 
one enabling specific diagnosis.  
Learning Objectives: 
1. To be aware of the imaging techniques and contrast enhancement patterns 
of the fibrotic lesions. 
2. To get familiar with the spectrum of fibrotic lesions in the liver and their 
imaging features. 
3. To be able to differentiate benign from the malignant conditions. 
12:15 - 12:45 Room A 
Headline Session  
HL 1  
Wilhelm Conrad Röntgen Honorary 
Lecture  
Presiding:  
B. Hamm; Berlin/DE  
A-273 12:15  
Value-based radiology: the future is now!  
M. Dewey; Berlin/DE (marc.dewey@charite.de)  
"no abstract available"  
Learning Objectives: 
1. To get to know why the time for value-based radiology is now. 
2. To appreciate the potential of value-based radiology in the clinical care 
process. 
3. To understand the challenges in implementing value-based radiology. 
12:30 - 13:30 Room C 
E³ - The Beauty of Basic Knowledge: Cardiovascular and 
Interventional Radiology  
E³ 24B  
Every step counts: imaging and treatment 
of peripheral arterial disease  
Moderator:  
C. Loewe; Vienna/AT  
A-278 12:30  
State-of-the-art: non-invasive imaging of peripheral arteries  
T. Leiner; Utrecht/NL (t.leiner@umcutrecht.nl)  
The diagnosis of peripheral arterial disease is made on the basis of the typical 
history and an abnormal ankle/brachial index (ABI). It is important to 
understand that imaging is only indicated when an invasive intervention is 
contemplated. Both CTA and MRA are highly reliable methods for depicting 
vascular anatomy prior to peripheral arterial intervention. Multiple meta-
analyses have reported high sensitivity and specificity for the detection of 
angiographically significant peripheral arterial disease. In my presentation I will 
discuss imaging protocols and strategies to optimise both techniques in daily 
clinical practice.  
Learning Objectives: 
1. To learn about state-of-the-art technique of peripheral MRA and CTA. 
2. To understand the indications for non-invasive peripheral imaging. 
3. To appreciate the importance of radiological diagnosis for treatment decision 
making in pAOD. 
Author Disclosure: 
  T. Leiner: Research/Grant Support; Philips Healthcare; Bayer Healthcare. 
Speaker; Philips Healthcare; Bayer Healthcare. 
A-279 13:00  
Endovascular treatment in peripheral arterial disease  
M. Das; Duisburg/DE (Marco.Das@helios-kliniken.de)  
Endovascular therapies are important treatment options in patients with 
peripheral artery disease. Following regular treatment options like medical 
therapy and exercise training endovascular therapies have become the first 
choice in most clinical stages of the disease. While endovascular treatment 
used to be applied only in limited disease (TASC A/B), endovascular therapies 
nowadays are often seen as first choice option in almost all stages (TASC 
C/D). This is mainly due to the successful evolvement of experience of 
interventional radiologists as well as new developments in endovascular 
material. Percutaneous transluminal angioplasty (PTA) with plain balloons is 
usually the first method of choice, while balloons loaded with anti-proliferative 
drugs such as paclitaxel [drug eluting balloons (DEB)] are often used in 
restenosis. Stents are commonly used as second option or as first choice in 
complex lesions. Evidence has to be found when to use drug eluting stents. 
Stentgrafts are often used in difficult situation when acute bleeding is involved, 
while scaffolds are often used in long lesions in areas with a lot of movement, 
in which regular stents would easily be compressed or kinked. This 
presentation will give an overview about different endovascular techniques 
including indications when to use which material and provide current evidence.  
Learning Objectives: 
1. To learn about different possible access routes in endovascular treatment in 
pAOD. 
2. To understand the meaning of different acronyms and terms used in pAOO 
treatment including PTA, DEB, stents, stentgrafts, scaffolds. 














12:30 - 13:30 Room D 
E³ - The Beauty of Basic Knowledge: A Survival Guide to 
Musculoskeletal Imaging  
E³ 25B 
Chronic trauma: spectrum of bone 
response  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK 
A-280 12:30  
Chronic trauma: spectrum of bone response  
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
Bones are able to develop adaptive mechanisms which are sensitive to their 
mechanical environment. Thus, bone is constantly remodeled, throughout life, 
by the coordinated action of bone-resorbing osteoclasts and bone-forming 
osteoblasts. This remodeling process serves to prevent and heal fatigue-
related microinjuries due to overloading. The balance between the amount of 
bone resorption and formation determines whether the process of bone 
remodeling leads to a net loss or gain of bone mass. Chronic trauma may be 
applied on normal or weakened bone and on the mature or immature skeleton. 
The imaging findings of the resulting painful syndromes cover a wide spectrum. 
Chronic overload ranges from a stress reaction to a stress fracture. The former 
is occult and the latter rarely obvious on radiographs. Fatigue injuries result 
from stress on normal bone and insufficiency injuries from stress on weakened 
bones. Both pathomechanisms may coexist in certain groups of adults. In the 
immature skeleton, the repetitive injury may cause in addition osteochondritis 
dissecans, osteochondral lesions, physiolysis, and chronic apophysitis. 
Abnormal loading matched with various parameters may result in periprosthetic 
fractures. Bisphosphonates may induce suppression on the bone turnover, 
particularly in the jaw and proximal femur, resulting in osteonecrosis and 
insufficiency fractures. Plain films remain the first imaging modality for 
exploring a pain response in chronic trauma. However, very often, plain films 
are normal. MRI is able not only to show even subtle findings, responsible for 
the clinical syndrome, but also to grade lesions and matched with known risk 
factors to guide the treatment.  
Learning Objectives: 
1. To become familiar with the pathomechanisms that can affect the axial and 
peripheral skeleton in chronic trauma. 
2. To understand the radiological manifestation of these pathological
mechanisms. 
3. To appreciate how to best use imaging modalities in diagnosing occult and 
overt injury and monitoring the response to treatment. 
12:30 - 13:30 Sky High Stage 
Special Focus Session 
SF 6 
Artificial intelligence: a strategic view 
A-979 12:30  
Chairperson's introduction 
E. Neri; Pisa/IT  
A-980 12:35  
Keynote lecture  
E.L. Siegel; Baltimore, MD/US 
A variety of difficult challenges in statistics can be solved best with the creation 
of a “machine” which can provide a simulation or model to discern patterns in a 
dataset and make predictions. The rapid adoption of “Deep Learning” in 
Diagnostic Imaging has resulted in the development of algorithms for detection, 
diagnosis, and quantification of medical images at an ever accelerating pace. 
Major successes in the application of “Deep Learning/AI” in speech 
recognition, self-driving cars, translation and strategic games such as Chess, 
Go, and Poker have resulted in major financial investments and bold and 
controversial predictions by “experts” about the rapidity of general adoption in 
Radiology and other medical imaging specialties such as pathology, 
dermatology, and ophthalmology. However, tremendous challenges exist in the 
implementation of machine learning. The current state of the art would require 
thousands of algorithms and many millions of imaging studies to replace more 
than a tiny fraction of the tasks of a diagnostic radiology and would require 
hundreds of thousands or millions of hours of “expert” time to tag these. 
Although algorithm development times have been drastically reduced, the time 
and effort required for testing, verification, and validation of these algorithms in 
clinical practice has not decreased. Regulatory bottlenecks and medico-legal 
issues and constraints will need change substantially for widespread adoption 
within the next several years or decades. Finally, Deep Learning may actually 
have its greatest initial success in solving non-image related challenges such 
as image quality, workflow efficiency, improved communication and patient 
safety. 
Learning Objectives: 
1. Describe the relationship between artificial relationship, machine learning 
and deep learning. 
2. List the challenges associated with the adoption of a general AI programme
that could interpret studies in a manner similar to a radiologist. 
3. Explain the reason for the recent excitement about “AI” in diagnostic imaging 
when the technology has been around for many years. 
4. List applications that are not related to image pixel interpretation that can 
benefit imaging departments that use machine learning. 
A-981 12:45  
Image computing in radiology  
P. Suetens; Leuven/BE  
The 1970s was the decade that “computed imaging” radically changed the field 
of radiology. Today “image computing” has become sufficiently mature to have 
a similar influence on this discipline. In this talk the principles and history of 
image computing will be shortly summarized and its potential will be illustrated 
on clinical examples of computer-assisted detection, screening, quantitative 
measurements, evidence-based diagnosis, early outcome prediction of 
therapy, and imaging biomarkers. Exploiting this new technology is a logical 
evolution in the context of value-based health care and should therefore not be 
postponed or neglected. Instead, it should be considered as an opportunity and 
embraced by radiologists as an indispensable tool for quality assurance. 
Learning Objectives: 
1. To become familiar with the principles and history of image computing 
(automated image analysis, artificial intelligence (AI), artificial neural networks 
(ANN), deep learning). 
2. To learn about the opportunities of image computing in radiology.
3. To have a realistic view of the current and future role and impact of image 
computing to radiology. 
Author Disclosure: 
  P. Suetens: Founder; icometrix. Shareholder; icometrix. 
A-982 13:00  
Deep learning: basic principles  
M. de Bruijne; Rotterdam/NL (marleen.debruijne@erasmusmc.nl) 
With deep learning techniques computers can now solve some image 
interpretation tasks as good as - or even better than - human experts. This 
lecture explains the basic principles of deep learning and its application in 
radiology, discusses technical requirements, and presents examples of 
successful application of deep learning techniques in radiology. 
Learning Objectives: 
1. To become familiar with the basic principles behind deep learning.
2. To understand the requirements and limitations of deep learning.
3. To learn about successful applications of deep learning in radiology.
Author Disclosure: 
  M. de Bruijne: Grant Recipient; NWO, DFF, Vertex. Patent Holder; 
US8126240, US7561727, US7844090, US8811724, US7463758. 
Research/Grant Support; Quantib, Cosmonio. 
A-983 13:15
Machine learning for analysing medical images 
B. Glocker; London/UK  
Due to an ever-increasing complexity, large volume of data and high economic 
pressure the interpretation of medical images pushes human abilities to the 
limit. Machine learning has emerged as a key technology to address some of 
the major challenges in medical imaging. In particular, machine learning-based 
algorithms can be employed to accurately extract quantitative measures such 
as volumes of anatomical and pathological structures from 3D medical scans, 
a task that is very difficult to achieve by a human expert. Additionally, ML has 
potential to discover new patterns of disease, identify abnormalities and extract 
clinically useful information from high-dimensional, multi-modal imaging data 
which otherwise would remain hidden. This presentation will provide an 
overview of the recent successes and challenges of today's machine learning 
approaches when applied to the automatic analysis of brain, cardiac and 
whole-body imaging. Particular focus is put on the interaction between 
  







computational and clinical disciplines and we argue for the need of an even 
closer collaboration between these disciplines and the importance for a 
common language and understanding of the demands of successful 
employment of machine learning in clinical practice. 
Learning Objectives: 
1. To learn how machine learning can help to analyse medical images. 
2. To appreciate the need for close cross-discipline collaboration. 
3. To understand what are the key ingredients for successful use of today's 
machine learning technology. 
Author Disclosure: 
  B. Glocker: Advisory Board; Definiens. Consultant; Kheiron Medical 
Technologies. Grant Recipient; Research Councils UK, European Research 
Council. 
14:00 - 15:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 721  
Gastrointestinal radiology  
A-281 14:00  
A. Inflammatory bowel disease  
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es)  
Cross-sectional imaging has an established role in evaluating patients with 
Crohn’s disease (CD) providing additional information to clinical and 
endoscopic assessment, which is crucial for therapeutic decision-making 
algorithms. Imaging findings are highly predictive of tissue inflammation and 
can be used in clinical practice in evaluating disease activity and identifying 
both stricturing and penetrating complications. Recent evidence demonstrates 
that cross-sectional imaging is useful for the assessment of therapeutic 
response and monitoring the course of the disease. The latter represents a 
clear advantage over endoscopy providing a more global assessment of 
treatment efficacy including luminal activity and disease-related complications 
(i.e., stenosis and fistula). The overall cross-sectional imaging techniques 
characteristics and benefits have driven a rapid increase in their use for CD 
imaging as part as routine practice in many institutions.  
Learning Objectives: 
1. To review the spectrum of imaging findings in inflammatory bowel disease, 
mainly in Crohn's disease. 
2. To learn about the management options. 
Author Disclosure: 
  J. Rimola: Advisory Board; Gilead, TiGenix. Consultant; Robarts Clinical 
Research. Investigator; Abbvie. Speaker; Takeda, BMS. 
A-282 14:45  
B. Rectal cancer staging: key findings  
G. Brown; Sutton/UK (gina.brown@rmh.nhs.uk)  
Report #rectalcancer using the reporting proforma 
https://profginabrown.com/reporting-proformas/ and use a proper high 
resolution MRI scan technique https://profginabrown.com/wp-
content/uploads/2017/04/mri-techniques-for-rectal-cancer.pptx The mrCRM is 
defined as involved if the distance of tumour or EMVI or extranodal tumour 
deposits to mesorectal fascia is 1mm or lessLymph nodes do not cause 
positive CRM but EMVI and Extranodal Vascular Tumour Deposits cause 
pCRM and are a risk for local recurrenceIdentifying patients who require 
surgery beyond TME https://profginabrown.com/wp-
content/uploads/2017/04/beyond-tme-why-the-need-for-pelvic-
exenteration1.pptxMRI defined mucinous tumours have a poor prognosis 
http://www.ejcancer.com/article/S0959-8049%2813%2901101-5/pdfStage low 
rectal cancers using the MERCURY 2 staging system to ensure appropriate 
selection for Low Anterior resection vs intersphincteric APE vs ELAPE vs 
Beyond TME MRI assessment of depth of tumour spread gives the most 
accurate prognostic informationMRI assessment of extramural venous invasion 
identifies more patients at risk of recurrent disease than current pathology 
staging of lymph nodes or venous invasion. https://profginabrown.com/wp-
content/uploads/2017/04/mri-detection-of-emvi-in-rectal-cancer.pptxmrTRG1-2 
represents a population of patients highly likely to have no viable tumour in the 
long term and hence suitable for MRI monitoring and avoiding surgery in the 
TRIGGER trial. No need to biopsy. https://profginabrown.com/trigger/Early 
rectal cancer staging and rectal preservation can be optimised, recurrences 
after TEM avoided by better staging 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891388/.  
Learning Objectives: 
1. To understand the imaging technique. 
2. To identify the key imaging findings. 
Author Disclosure: 
  G. Brown: Advisory Board; EISAI Ltd. Grant Recipient; NIHR BRC Royal 
Marsden, NIHR BRC Senior Investigator Award, Pelican Cancer Foundation. 
14:00 - 15:30 Room M 3 
ESOR Session  
Trends in quality education in radiology  
Moderators:  
B. Brkljai	; Zagreb/HR  
N. Gourtsoyiannis; Athens/GR  
A-283 14:00  
Introduction  
B. Brkljai	; Zagreb/HR (boris@brkljacic.com)  
The European School of Radiology (ESOR) is an institution, fulfilling the 
mission of the European Society of Radiology (ESR) in the field of education. 
One of its main goals is to assist in harmonising radiological education in 
Europe. With its wide range of activities, ESOR additionally aims to raise 
standards in the field of scientific radiology, extend and coordinate teaching 
resources worldwide and help young radiologists achieve the knowledge and 
skills to fulfil tomorrow’s requirements. 
A-284 14:05  
ESOR in action 2018  
N. Gourtsoyiannis; Athens/GR  
A-285 14:15  
The beauty of face-to-face teaching  
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr)  
Today, many ways of teaching are available. In addition to press and books, 
video recorded sessions and webinars play an increasing role in teaching. 
Advantages are many: the offer endlessly increases, access is obtained via 
personal equipment, distances are deleted, availability is defined by the trainee 
who selects recorded sessions. Face to face teaching has none of these 
advantages, but nevertheless remains necessary for three main reasons; (1) It 
is the only manner for the trainer to sample in real time the exact level of the 
trainees and to calibrate his teaching objectives, (2) It is the only way to install 
full and appropriate interactivity, and (3) communication between the teacher 
and the trainees goes through much more tunnels than scientific knowledge, 
including non-verbal communication. All of these cannot be transmitted 
electronically until now.  
A-286 14:30  
Flipped classroom: paradigm shift with pathologists  
V. Vilgrain; Clichy/FR (valerie.vilgrain@aphp.fr)  
Flipped classroom is an instructional strategy and a type of blended learning 
that reverses the traditional learning environment. Residency education in 
radiology is individual and mostly based on image interpretation with faculty 
and conference teaching. Education is completed by reading textbooks and 
online material. Interaction with clinicians is also very important for residents 
and senior radiologists. Yet radiology is close to pathology and radio-
pathologic correlations give many insights to radiology. The purpose of this 
lecture is to show that interaction with pathologists is very helpful for the two 
medical specialties. Examples will be provided showing that both contribute to 
a better understanding of the diseases and increase the diagnostic 
performance.  
A-287 14:45  
Integration of big data in radiological education  
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es)  
Big data are challenging the way radiology is being performed and taught. In a 
big learning data world, rethinking our data sources and adopting a strategic 
approach to presenting data is crucial. Most efforts with big data and radiology 
relate to the discovery on new diagnostic pathways and opportunities to better 
diagnose and treat diseases. Access to data can help residents and 
radiologists define their learning goals and strategies. Medical imaging big data 
analysis and the use of biobanks’ data recently emerged for advancing on the 
  







study of rare diseases, the identification of early surrogate biomarkers and the 
development of population studies. These new aspects will change the way 
radiological science is being taught, as better information on new radiomic 
biomarkers on early disease diagnosis, disease phenotyping, disease grading, 
targeting therapies, and evaluation of disease response to treatment will 
develop. Big data results’ analysis will help radiology providing new model of 
cooperative science to share knowledge within the scientific community; to 
increase production of scientific researcher contribution from radiology; to 
improve healthcare through image quality and radiation dose, technical and 
protocol comparisons and follow-up assessment of clinical guidelines; to 
improve the therapeutic process through the translation of research findings 
into clinical trials with guided imaging, assessment of imaging biomarkers 
endpoints, and early assessment of treatment response; to improve 
epidemiological knowledge of the population through the introduction of 
quantitative diagnostic tests markers; and to create knowledge databases from 
representative cases, semantic, and semiotic advanced searches.  
15:00  
Awards  
14:00 - 15:30 Room M 4 
E³ - ECR Academies: State-of-the-Art and Advanced MR Imaging 
of the Musculoskeletal system  
E³ 719  
Shoulder  
A-288 14:00  
Chairperson's introduction  
A. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
Shoulder pain is a common clinical problem. A painful syndrome may result 
from previous trauma, chronic degeneration or rupture of tendons with or 
without impingement, internal derangement of the glenohumeral joint and 
failure of a previous operation. Imaging methods include plain X-rays, 
ultrasonography, MR imaging and rarely CT. Each modality has its own and 
distinct role depending on the clinical indication. Current indications, as well as 
advantages and limitations of one or more imaging methods for evaluating 
patients with shoulder pain, will be discussed in the following 3 lectures on 
common and uncommon disorders. 
A-289 14:05  
A. Post-traumatic  
K.-F. Kreitner; Mainz/DE (Karl-Friedrich.Kreitner@unimedizin-mainz.de)  
The most common sequelae of shoulder trauma comprise fractures of the 
humeral head, glenohumeral instabilities, SLAP lesions and traumatic ruptures 
of the rotator cuff. Conventional radiography with use of the so-called trauma 
series consisting of true ap, true lateral and axial views of the affected shoulder 
is useful in documentation of dislocations, fractures and fracture dislocations of 
the shoulder, their direction, the result after reduction as well as in first 
assessment of humeral head fractures. CT is mandatory in complex humeral 
head fractures for planning of the operative procedure. In instability, it 
delineates humeral impression fractures and defects of the bony glenoid, and 
thus allows for assessment of on-track and off-track lesions. Direct MR-
arthrography is the imaging modality of choice especially in younger patients 
with glenohumeral instability and SLAP lesions due to its superior resolution of 
soft tissue structures. Furthermore, it enables differentiation of atraumatic and 
microinstabilities of the shoulder, especially when using sequences obtained in 
abduction and external rotation of the shoulder (ABER position). In the acute 
phase after shoulder trauma, unenhanced MR imaging may be sufficient due to 
an existing joint effusion. Precise planning of sequences are the basis for 
assessment of bony defects of the glenoid and humeral head, and thus MR is 
also capable for assessment of on-track/off-track lesions in shoulder instability. 
Direct CT arthrography may be an alternative for assessment of patients with 
glenohumeral instability and SLAP lesions when MR imaging is not available or 
when there contraindications for its use. 
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To know the role of MR imaging, and MR arthrography (direct/indirect) and 
how to optimise MR protocols. 
3. To differentiate post-traumatic changes from typical reasons for chronic 
pain. 
 
A-290 14:33  
B. Chronic pain  
P. Omoumi; Lausanne/CH (patrick.omoumi@chuv.ch)  
Chronic shoulder pain, defined as shoulder pain persisting over six months, is 
frequent, representing about 15% of all musculoskeletal complaints. In the 
work-up of chronic shoulder pain, conventional radiography is the first 
diagnostic modality to perform. Radiographs can reveal a wide range of 
common shoulder pathology that can be source of pain, including 
glenohumeral or acromioclavicular osteoarthritis, calcific tendinitis, indirect 
signs of large rotator cuff tendon tears, as well as sequelae of previous trauma. 
MRI is the diagnostic modality of choice to further clarify the cause of the pain. 
MRI has high diagnostic performance for rotator cuff tears, tendinitis, and 
subacromial bursitis. The diagnosis of adhesive capsulitis is made clinically, 
but signs of capsulitis have been described at MRI, which mostly serves at 
ruling out other diagnoses in case of atypical presentation. In case of chronic 
instability, MR arthrography should be preferred because of its higher 
performance in detecting labra-ligamento-cartilaginous lesions. Findings of 
shoulder pathology at MRI are not necessarily related to symptoms, however. 
For instance, as many as 50% of asymptomatic patients over 60 years old 
have partial or full-thickness rotator cuff tears.  
Learning Objectives: 
1. To identify the most common entities leading to chronic shoulder pain. 
2. To know the role of MR imaging and MR interventions in the shoulder. 
3. To differentiate entities leading to chronic pain from post-traumatic changes. 
A-291 15:01  
C. Postoperative  
S. Waldt; Munich/DE (simone.waldt@tum.de)  
Scope of this course is to discuss technical requirements and strategies 
concerning the interpretation of MR examinations in the postoperative setting. 
The quality of MR images of the shoulder obtained after surgery can be 
significantly impaired by susceptibility artifacts due to metallic implants and 
metal shavings from use of surgical instruments. The use of artefact reduction 
techniques, which will be summarized in this presentation, is a prerequisite for 
a sufficient diagnostic accuracy. Basic knowledge concerning different surgical 
techniques, their common complications and sources of failure are necessary 
to interpret MR examinations. This talk gives an overview on the most 
commonly performed surgical procedures that are used for treatment of 
shoulder instability, impingement syndromes, and rotator cuff lesions. Criteria 
that may be used to differentiate between normal and abnormal postoperative 
findings will be discussed in detail, because findings that indicate pathology in 
non-operated patients are often less significant and unreliable in the 
postoperative situation.  
Learning Objectives: 
1. To identify the most common postoperative changes. 
2. To know the role of MR imaging and MR arthrography (direct/indirect) and 
how to optimise MR protocols for the postoperative patient. 
3. To understand the typical appearances and complications following rotator 
cuff repair. 
14:00 - 15:30 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 720  
Personalised medicine in liver tumours  
A-292 14:00  
Chairperson's introduction  
B.J. Op De Beeck; Antwerp/BE (bart.op.de.beeck@uza.be)  
Metastatic disease to the liver is one of the most common problems 
encountered in patients with cancer. However, not all focal liver lesions in 
oncologic patients are metastases. Although the true prevalence of metastatic 
disease is unknown, some individuals who die of malignancy will have liver 
metastases at autopsy. Autopsy series also reveal the presence of benign 
hepatic lesions in up to 52% of the general population. Imaging protocols and 
findings to differentiate benign lesions from metastases will be presented. 
Management of malignant liver lesions depends on the tumour stage, liver 
function reserve, and patient performance status, and requires a 
multidisciplinary approach for optimal treatment. Treatment options and 
strategies for liver tumours will be discussed including indications of ablation 
techniques and intra-arterial embolisation techniques and their outcome. 
Radiologists must become familiar with the different methods of assessing 
tumour response. Size criteria, including the WHO criteria and RECIST, have 
  







served for years as methods to standardise outcomes of therapy. New evolving 
methods of treatment including antiangiogenic and locoregional therapy do not 
always cause a decrease in size. Therefore, assessment of necrosis will need 
to be incorporated into size-related criteria. Finally, the imaging findings of 
cancer therapy-induced toxicities and their adverse effects will be discussed. 
A-293 14:05  
A. Focal liver lesions in oncology patient  
F. Caseiro Alves; Coimbra/PT (caseiroalves@gmail.com)  
Currently, the widespread use of volumetric cross-sectional imaging methods, 
has led to an increased fortuitous detection of focal liver lesions in all groups 
especially in the oncologic context of extra-hepatic cancer patients. Since 
imaging techniques can now provide high spatial resolution small nodules are 
easily depicted posing the problem of the characterization of the so-called 
incidental liver lesions. The vast majority correspond to cysts, hemangiomas, 
benign hepatocyte-specific-cellular tutors and pseudo lesions such as focal 
fatty infiltration, and focal fatty sparing. Additionally, intra-hepatic vascular 
shunting and vascular variants can be an important source of false positives for 
malignancy in the oncologic setting. A particular sub-set to nodules relates to 
multiacinar regenerative nodules, closely linked to sinusoidal obstruction 
syndrome observed after chemotherapy. The scope of this lecture is to provide 
guidance regarding the imaging aspects that may assist to the differentiation of 
metastases. Emphasis will be put on a multimodality approach generally using 
MR as a problem solver to this important issue in current oncological practice.  
Learning Objectives: 
1. To be aware of the most common incidental liver lesions in patients with 
extrahepatic cancer. 
2. To understand the imaging protocols and findings to differentiate benign 
lesions from metastases. 
3. To be familiar with the strategies for optimising patient management of these 
incidental hepatic lesions. 
A-294 14:33  
B. Treatment options and strategies for liver tumours  
T.K. Helmberger; Munich/DE (Thomas.Helmberger@klinikum-muenchen.de)  
Primary and secondary hepatic malignancies are a common clinical issue. 
Considering the general oncological (isolated hepatic tumor load; prognostic 
benefit), and technical (size, number, location of hepatic metastases; expected 
hepatic functional reserve) framework surgical resection is usually considered 
to be the method of therapeutical choice. However, in clinical reality only 15-30 
% of patients with liver malignancies may qualify for resection. In 
consequence, the majority of patients need other or at least modified 
therapeutical pathways including adjuvant or neoadjuvant chemotherapy and 
more and more image guided local ablative therapies. Interventional oncology 
(IO) provides mainly three image-guided local and loco regional cytoreductive 
therapeutic approaches: (1) percutaneous thermal-ablation (mainly 
radiofrequency and microwave ablation) with current techniques 3 cm tumors 
can safely be coagulated achieving 5-year survival rates of up to 50% 
comparable to surgical results, (2) transarterial chemo-ablation for larger, 
multifocal, or diffuse HCC is established and is currently getting adopted in 
metastatic disease. While classic (Lipiodol) TACE is worldwide still well 
accepted in HCC transarterial chemo-embolization with drug eluting beads 
(DEB-TACE) is gaining promising results with comparable response rates to 
classic TACE in HCC and to systemic chemotherapy in metastases, and (3) 
transarterial radio-embolization (TARE, SIRT) could proof its efficacy in HCC 
patients not suitable for TACE and in chemorefractory patients improving 
hepatic progression free survival. Minimal-invasive, image-guided therapies 
are suitable in a large number of cases and getting implemented increasingly 
in multimodality treatment regimens according to interdisciplinary consensus of 
oncologists, interventional radiologists, and surgeons.  
Learning Objectives: 
1. To understand the main options of tumour treatment and to be able to 
discuss the appropriate method for treatment given the results of imaging. 
2. To recognise the indications of ablation techniques and their outcome. 
3. To know when intra-arterial embolisation techniques are needed and what 
their outcome is. 
Author Disclosure: 
  T.K. Helmberger: Consultant; Boston Scientific. 
A-295 15:01  
C. Assessment of response to treatment  
V.J. Goh; London/UK (vicky.goh@kcl.ac.uk)  
Imaging is essential to the management of cancer patients. Better assessment 
of disease burden, prognostication, treatment triage, and treatment response is 
required to improve patient outcome. For patients with liver tumours 
undergoing systemic or locoregional therapy, imaging provides an objective 
method for assessing response/non-response to therapy, allowing patients to 
transition to alternative therapies when therapy is ineffective. Imaging also 
enables therapy related adverse effects to be depicted and treated. The 
strengths and limitations of the different imaging modalities including CT, MRI, 
PET/CT, and PET/MRI will be discussed for systemic and locoregional 
therapies of liver tumour. The different response criteria will also be highlighted 
and future directions discussed. 
Learning Objectives: 
1. To appreciate the value of different imaging techniques and the criteria for 
assessment of tumour response to systemic therapy. 
2. To become familiar with post-treatment imaging after intra-arterial therapies 
and ablation techniques. 
3. To be aware of imaging findings of cancer therapy-induced toxicities and 
adverse effects. 
Author Disclosure: 
  V.J. Goh: Research/Grant Support; Siemens Healthineers. Speaker; Bayer, 
Siemens Helathineers. 
16:00 - 17:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 821  
Dementia and movement disorders  
A-302 16:00  
A. MR contribution to diagnosis and differential diagnosis in dementia  
M. Sasiadek; Wroclaw/PL (marek.sasiadek@umed.wroc.pl)  
Imaging methods play an increasing role in diagnosing, differentiating, 
prognosing and follow-up of dementia. The most important imaging methods 
are: CT, MR, SPECT, and PET. Among them MR, including MR spectroscopy 
(MRS), perfusion MR (PWI), diffusion tensor imaging (DTI) and functional MRI 
(fMRI), appears to be the most valuable modality. Plain MR might provide 
important contribution to the diagnostics of dementia. The distribution of the 
brain atrophy indicates the specific dementia disease, e.g., hippocampal 
atrophy is highly suggestive of Alzheimer disease and frontotemporal atrophy- 
of frontotemporal dementia. There are also specific MR patterns of progressive 
supranuclear palsy (mesencephalic atrophy) or multiple system atrophy 
(cerebellar/brainstem or putaminal atrophies). Vascular dementia changes 
(e.g., small vessel disease, CADASIL, amyloid angiopathy) could be reliably 
diagnosed with MR, including MR angiography and susceptibility weighted 
sequences. There are also typical MR patterns of many other diseases, which 
may be accompanied by dementia, e.g., normal pressure hydrocephalus, 
multiple sclerosis, Wilson disease, Fahr disease, Creutzfeldt-Jakob disease, 
etc. Advanced MR techniques provide further contribution to diagnosing 
dementia by adding quantitative data. MRS could reveal increase of 
myoinositol level in degenerative diseases or of choline in multiple sclerosis. 
PWI shows decrease of perfusion in vascular dementia, but also in Alzheimer 
disease. DTI detects decrease of fractional anisotropy in white matter tracts 
affected by degenerative, ischaemic or inflammatory process. fMRI provides 
assessment of the impaired cognitive functions in dementia disorders. MR, due 
to the advantages described above, should be a part of routine diagnostic 
protocol in patients with dementia.  
Learning Objectives: 
1. To become familiar with imaging in different types of dementia. 
2. To learn the imaging criteria for differentiation. 
A-303 16:45  
B. Imaging in Parkinsonism and other extrapyramidal disorders  
T. Stosic-Opincal; Belgrade/RS (stosic.tanja@yahoo.com)  
Extrapyramidal disorders can be classified as pathologies that affect basal 
ganglia (caudate, putamen, and globus pallidus), subtalamic nucleus and 
structures that are functionally connected with them (substantia nigra). On 
histological level affected tissues exhibit high level of deposits ofparamagnetic 
ions (presumably iron and copper) and loss of neural tissue. This is manifested 
in loss of volume of brain structures and dysfunction of specific neural tracts. 
Parkinsonism refers to any condition that causes a combination of the 
movement abnormalities such as tremors, slow movement, impaired speech or 
muscle stiffness. Beside idiopathic Parkinson’s disease, a several conditions 
fulfill definition, such as progressive supranuclear palsy, multisystem atrophy, 
and corticobasal degeneration. Role of imaging techniques is assessment of 
structural and physiological changes caused by EPD. Magnetic resonance 
imaging is primary choice since it provides morphological, structural, and 
physiological insight in changes caused by extrapyramidal disorders. Positron 
  







emission tomography gives additional information about physiological changes 
using neurotransmitters labeled with positron emitters. Computerised 
tomography has limited possibilities which are restricted to assessment of 
morphological changes. 
Learning Objectives: 
1. To become familiar with the different imaging modalities. 
2. To learn the imaging criteria. 
16:00 - 17:30 Room C 
Chest  
RC 804  
Chronic obstructive pulmonary disease 
(COPD)  
A-304 16:00  
Chairperson's introduction  
K. Irion; Manchester/UK (klaus.irion@mft.nhs.uk)  
"Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable 
and treatable disease that is characterized by persistent respiratory symptoms 
and airflow limitation that is due to airway and/or alveolar abnormalities usually 
caused by significant exposure to noxious particles or gases”. “The clinical 
diagnosis of COPD requires the presence of a post-bronchodilator FEV1/FVC 
< 0.70 to be established.” Both sentences above are from the 2017 Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) Report. They probably 
represent the biggest challenge to the imaging diagnosis and phenotyping of 
COPD patients. The GOLD statements above imply that COPD cannot be 
diagnosed without persistent respiratory symptoms and a post-bronchodilator 
FEV1/FVC < 0.70: as if a persistent airflow limitation due to airway and/or 
alveolar abnormalities without the two criteria would not be COPD. One of the 
key methodological problems in quantitative CT for the assessment of COPD is 
that the selection of patients is tied up to the above criteria, where correlations 
with pulmonary function tests are taken as the references for the diagnostic 
capability of CT or MRI. To learn how to avoid the progression of emphysema 
and/or chronic airway disease to a symptomatic phase when the FEV1/FVC 
reaches the critical level (< 0.70) for a COPD diagnosis, the medical 
community should first accept that a significant extent of the anatomical 
changes that lead to various degrees of chronic airflow limitation (i.e. COPD) 
will be present much before the current threshold set as a diagnostic criteria of 
COPD is met.  
Session Objectives: 
1. To describe the current challenges of COPD phenotyping. 
2. To learn how to personalise management in COPD. 
3. To understand the methodological problems at the stages of selection of 
patients. 
A-305 16:05  
A. CT phenotyping and visual assessment  
P.A. Grenier; Paris/FR (philippe.grenier@aphp.fr)  
COPD is a slowly progressive obstructive airway disorder resulting from an 
exaggerated inflammatory response to cigarette smoking and air pollution that 
ultimately destroys lung parenchyma and induces irreversible reduction in 
caliber and number of small airways. Both phenomena [emphysema and small 
airway disease (SAD)] are responsible for airflow limitation. Because often 
SAD precedes lung destruction, patients having equal impairment of lung 
function may present different morphologic appearances on CT scans. 
Although quantitative CT is useful for identifying and sequentially evaluating 
the extent of emphysematous lung destruction, changes in airway walls, and 
expiratory air trapping, visual assessment of CT scans is important to describe 
patterns of altered lung structures in COPD. Emphysema is classified as 
centrilobular (subclassified as trace, mild, moderate, confluent, and advanced 
destructive emphysema), panlobular and paraseptal (subclassified as mild of 
substantial). Airway disease is commonly found with all forms of emphysema 
but also commonly occurs in the absence of emphysema as a predominant 
expression of COPD. The CT features of bronchial disease include thickening 
of the walls of segmental and subsegmental airways. CT features of SAD 
include peripheral centrilobular micronodular opacities (inflammatory SAD) and 
gas trapping on expiratory CT (obstructive SAD). Associated features may be 
seen on large airway disease (tracheobronchomalacia, saber sheath trachea, 
tracheobronchial outpouching/diverticula). Interstitial lung abnormalities include 
patchy ground glass abnormality and/or mid subpleural reticular abnormality. 
Other associated features include pulmonary arterial enlargement suggesting 
pulmonary hypertension, and bronchiectasis  
Learning Objectives: 
1. To learn about imaging-based phenotypes. 
2. To understand the strengths and limitations of visual assessment. 
3. To review the phenotypes and comorbidities approachable by CT. 
A-306 16:28  
B. Quantitative imaging biomarkers  
J.B. Seo; Seoul/KR (seojb@amc.seoul.kr)  
With excellent spatial and contrast resolution, CT can be used as an important 
tool to evaluate quantitative imaging biomarkers of COPD. The extent of low 
attenuation area and bronchial wall thickening at segmental and distal level on 
volumetric CT scan acquired at suspended inspiration state are commonly 
used as useful markers for evaluating the severity of emphysema and airway 
wall inflammation, respectively. The clinical values of these two imaging 
biomarkers are as follows: (1) Many studies have proved that the extent of 
emphysema and bronchial wall thickening are independently related with the 
degree of airflow limitation, (2) The extent of emphysema is correlated with 
other clinical parameters such as osteoporosis, exercise capacity, respiratory 
symptoms, and most importantly with BODE index, (3) Both parameters may 
be useful in subgrouping/phenotyping of patients, prediction of treatment 
response, disease progression, and exacerbation. The extent of air trapping 
can be assessed by quantitative volumetric expiratory CT or by comparing the 
density changes on matched inspiratory/expiratory CT. Other potential imaging 
biomarkers on CT include peripheral vascular changes, size and shape 
distribution of emphysema holes, and so on. Despite these advances, several 
important challenges remain before these quantitative imaging biomarkers can 
be used in clinical practice. In patient side, variation in inspiratory and 
expiratory lung volumes is most important issue, which has a major influence 
on lung attenuation values. Technically, variation in measured CT attenuation 
across scanner manufacturers and models, differing reconstruction kernels, 
and varying methods of automatic exposure control should be considered.  
Learning Objectives: 
1. To learn about the COPD biomarkers that may be helpful for managing 
COPD patients. 
2. To understand the potential role for quantitative imaging in identifying 
imaging phenotypes. 
3. To appreciate the recent development of quantitative imaging methods. 
Author Disclosure: 
  J.B. Seo: Shareholder; Coreline Soft Co. Speaker; Siemens / Guerbet. 
A-307 16:51  
C. Is there a role for MRI?  
B.J. Jobst; Heidelberg/DE  
Today, computed tomography (CT) is the imaging modality of choice for the 
assessment of pulmonary diseases, but it requires ionizing radiation. 
Unfortunately, magnetic resonance imaging (MRI) of the lung is complicated by 
low proton density and high magnetic susceptibility of the alveolar structures, 
decreasing the MR-signal obtained from the lungs. Hence, the depiction of the 
pulmonary morphology is hampered by low contrast and spatial resolution. 
Besides, respiratory and cardiac motion artifacts have impact on image quality. 
In the recent years, novel MRI techniques based on parallel imaging and 
advanced gating techniques have been developed and implemented in routine 
MRI protocols, which lead to improved depiction of pulmonary structures. 
Innovative MRI techniques such as ultra-short echo time acquisitions (UTE) 
further improve the structural characterization of airways and parenchyma. 
Although MRI is still inferior to CT concerning the depiction of subtle 
morphological features, MRI offers a broad spectrum of functional acquisitions, 
especially for perfusion, ventilation, and respiratory mechanics. Lacking 
ionizing radiation, MRI can be repeated as often as necessary and represents 
a powerful instrument for longitudinal observations. In this context, MRI 
provides quantitative and semi-quantitative biomarkers which may be helpful in 
the evaluation of the course of lung disease as well as monitoring of the 
therapeutic response.  
Learning Objectives: 
1. To learn about the morpho-functional pulmonary measurements achievable 
with MRI. 
2. To review the various methodological approaches. 
3. To appreciate current and forthcoming developments. 
17:14  











16:00 - 17:30 Room O  
Special Focus Session  
SF 8a  
CT examination of pregnant patients: a 
dilemma for the radiologist and the mother  
A-308 16:00  
Chairperson's introduction  
V. Gershan; Skopje/MK (vesna.gershan@pmf.ukim.mk)  
CT examinations of pregnant patient when the fetus is within the primary beam 
are challenging for radiologist and mother, as well. Two main scenarios in CT 
examination of pregnant patient are possible. The first one is so call 
inadvertent exposure, while patient is scanned and pregnancy is still unknown. 
The second one is when there are strong CT indications due to non-obstetrical 
emergencies like as appendicitis, renal colic, ovarian torsion, hemorrhagic 
ovarian cysts, trauma, and pulmonary embolism. Explanation of benefits vs. 
risks to mother could be challenging and it is good practice to obtain informed 
consent before proceeding with the examination. If CT examination is duly 
justified, then an acquisition protocol that ensures diagnostic image quality at 
lowest possible dose should be applied. There are several dose reduction 
techniques like is decreasing of kV, mA, limit the field of view, increasing of 
pitch, using of iterative reconstruction techniques, etc. There are several 
models for assessment of fetal dose, like is MC simulated whole-body or 
individual organ doses, patient-specific voxel-based computational phantoms 
or dose assessment using of dose conversion factor and exposure parameters. 
Delivered dose to the fetus from a single diagnostic abdominal CT is highly 
unlikely to exceed the estimated threshold dose of 100 mGy for induction of 
malformations. Estimated radiation risk depends on the dose, gestational age 
and applied risk model, and for example, for 50 mGy dose it can be 1 in 909 to 
1 in 334. All these aspects will be addressed under the current session topics.  
Session Objectives: 
1. To give an overview of radiation risk associated with the CT examination of 
pregnant patients. 
2. To learn how to optimise CT imaging of pregnant patients. 
3. To suggest actions for dose management of pregnant patients in CT. 
A-309 16:05  
Radiation risks vs clinical benefits  
M. Prokop; Nijmegen/NL  
"no abstract submitted" 
Learning Objectives: 
1. To give an overview of radiation risks of pregnant patients during CT 
examinations. 
2. To learn about the choice of the modality. 
3. To learn how to manage risk in the CT examination of pregnant patients. 
A-310 16:23  
How to reduce radiation dose and keep CT diagnostics  
M. Kortesniemi; Helsinki/FI (mika.kortesniemi@hus.fi)  
A developing fetus has an increased sensitivity to ionizing radiation exposure. 
Therefore, dose monitoring and optimisation of CT exposures of an expecting 
mother is important. The typical clinical indications related to CT scans during 
pregnancy include pulmonary embolism, appendicitis, and trauma. In these 
situations, the fetus can be fully or partially in the primary CT scan range or in 
its immediate vicinity. In pulmonary embolism scans, increased distance of the 
fetus from the scan range serves as a practical tool for fetal dose optimisation. 
Modern CT scanners have several technical tools for dose reduction. Those 
tools include automatic tube current modulation, automatic tube voltage 
selection, dynamic z-collimation and iterative reconstruction algorithms. When 
used together in a proper way, they may provide tens of percentages of dose 
reduction for the mother and the fetus, depending of the clinical indication and 
individual patient characteristics. The actual purpose is not to use as little 
radiation as possible but to achieve a maximum benefit-to-risk ratio for the 
patient (mother and fetus). Adequate image quality for reliable diagnosis must 
always be reached. Otherwise the dose is unnecessary, however, small it 
could be.  
Learning Objectives: 
1. To give an overview of optimisation methods and techniques in CT. 
2. To describe the method of choice in particular cases. 
3. To learn about examples for different clinical requests. 
A-311 16:41  
Dosimetry methods available  
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr)  
Several methods for the estimation of conceptus dose from CT examination 
have been developed during the last years. Twenty four patient models 
selected to represent a range of gestational ages were created using image 
data from a group of pregnant patients who had previously undergone 
abdominal and pelvic CT examination (Radiology 2008, 249, 220-227). The 
authors provide an equation for the estimation of conceptus dose. 
 
methodology has been created for the accurate estimation of conceptus dose 
from CT examinations performed on pregnant patients during the first weeks of 
gestation (Radiology 2010, 257, 483-489). This period of early pregnancy is 
particularly important because the conceptus is considered to be sensitive to 
radiation in the period of organogenesis. A two-variable equation provided a 
relationship among normalised conceptus dose, body perimeter and skin-to-
conceptus-distance. A general-purpose Monte Carlo simulation code and 
mathematical phantoms simulating pregnancy during all trimesters of gestation 
were used to provide normalised dose data for conceptus dose estimation from 
any CT examination performed in the trunk of the pregnant patient (Medical 
Physics 2010, 37, 6411-6420). CoDE (conceptus dose estimation) online 
software tool allows; (a) calculation of conceptus radiation dose and associated 
risk from X-ray examinations performed on the expectant mother and (b) 
anticipation of conceptus dose for the pregnant employee who participates in 
fluoroscopically-guided interventional procedures. CoDE is available free of 
charge.  
Learning Objectives: 
1. To provide information about the available conceptus dosimetry methods in 
CT. 
2. To understand the accuracy and limitations of the dosimetry methods. 
3. To learn how to estimate radiation dose in pregnant patients during CT 
examinations. 
A-312 16:59  
Dose and risk communication to doctors and patients  
P. Gilligan; Dublin/IE (PGilligan@materprivate.ie)  
Pregnant patients are recognised as a high risk and sensitive group in radiation 
protection. There may be perceived conflict between the benefit of the required 
treatment of the mother and the risk to the foetus. Patient focussed care 
requires open disclosure of any risks. The implications of these risks must be 
well understood by the patient. Radiation risks in the foetus can be complex, 
dependent on the modality, procedure type, radiation dose, and stage of 
pregnancy. The communication of appropriate risks to the mother particularly 
in an emergent context can be challenging. Experience has shown that 
preparation of accurate and well contextualised information assists the patient 
and their care providers to make appropriate health care decisions. The 
environment, context, timing delivery of such information is also important. 
Patients are reassured when good radiation protection culture is evident. The 
use of methods to identify possible pregnancy and minimise the risks in early 
pregnancy have proved divisive and have led to divergent practices and 
opinions even among experts. Inadvertent exposure in pregnancy occurs in 
most hospitals on an occasional basis. Follow up with such patients, 
particularly after systems failures, requires a tailored approach. This talk 
examines the possible risks from diagnostic procedures during pregnancy and 
the contexts and environments in which such information is delivered. It looks 
at both pre planned foetal exposures and inadvertent exposures. The 
multidisciplinary approach involving radiology is essential in providing accurate 
and relevant information on which medical decisions can be based.  
Learning Objectives: 
1. To provide information about the latest scientific knowledge about conceptus 
risk. 
2. To learn how to manage incidents and accidents involving pregnant patients 
in CT. 
3. To learn how to communicate to doctors and patients about dose and risk. 
17:17  
Panel discussion: CT during pregnancy: what are the suggested actions 













16:00 - 17:30 Room N  
Head and Neck  
RC 808  
Pitfalls in interpretation of head and neck 
disease  
Moderator:  
S. Robinson; Vienna/AT  
A-313 16:00  
A. Anatomical variants without clinical consequence  
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl)  
Variant: “Something that is slightly different." Imaging methods can provide an 
extraordinary amount of useful data to specialists treating head and neck 
(cancer) patients. It is crucial that these data are used to full advantage of 
individual patients. The most important factor in this process is mutual 
cooperation between the physicians in charge of patient care and the 
diagnostic imaging specialist. Anatomical variants in the head and neck are 
frequently encountered and may result in interpretation problems for the 
radiologist: usually, anatomical variants are without clinical consequence. 
However, normal variants may simulate disease. If not recognised, normal 
variants (or pseudolesions) may lead to unnecessary interventions. The 
presentation aims to familiarise general radiologists, who have an interest in 
head and neck imaging, with common anatomical variants encountered on 
head and neck CT and MR studies. Many examples from daily practice will be 
discussed. 
Learning Objectives: 
1. To gain insight into the great variability of head and neck anatomy. 
2. To be able to recognise pseudo lesions. 
A-314 16:30  
B. Anatomical variants posing surgical risks  
D. Farina; Brescia/IT (nappaje@yahoo.it)  
Several anatomic variants may pose a threat during surgery. A large part is 
found in the sinonasal region, basically due to the widespread use of 
endoscopy which, inherently, provides the operator with narrow accesses and 
limited exposure of submucosal anatomic structures. Onodi cell is probably the 
most feared anatomic threat, because if not correctly indicated by the 
radiologist and identified by the surgeon, it generates a high risk of disastrous 
intracranial penetration. Similarly, bone dehiscence of the lamina papyracea of 
the ethmoid increases the risk of iatrogenic damage, mainly of intrinsic ocular 
muscles. The inferior alveolar nerve is at high risk of surgical damage during 
molar teeth extraction, particularly when the curved apices of roots embrace 
the inferior wall of the nerve canal. In the neck the main threats are related to 
anomalous course of major vessels: not infrequently the common and/or 
internal carotid artery display a medialized course reaching the lateral aspect 
of the pharyngeal wall or even protruding in the retropharyngeal space towards 
the midline. Simultaneous medial deviation of the arteries on both sides is 
referred to as kissing (common or internal) carotids. The risk in these 
eveniences are mainly related to the possible effects of a deep biopsy 
performed by an unaware surgeon. At the cervico mediastinal junction, 
vascular rings may embrace the trachea or the oesophagus and, consequently, 
pose a threat during intubation or tracheostomy.  
Learning Objectives: 
1. To learn about structures at risk during functional endoscopic sinus surgery 
(FESS). 
2. To become familiar with vascular variants in the head and neck. 
3. To appreciate surgical anatomical landmarks in the head and neck. 
A-315 17:00  
C. Distinct head and neck disease or systemic disease?  
M.G. Mack; Munich/DE (m.mack@radiologie-muenchen.de)  
Head and neck manifestations of systemic disease is characterized by a 
multitude of maladies that have manifestations in the head and neck. This 
lecture relates commonly encountered head and neck symptoms and signs to 
an array of diseases and disorders that should be considered in the differential 
diagnosis. During this lecture, systemic disorders with head and neck 
manifestation (e.g., Sjögren`s syndrome, Adamantiades-Behcet's disease, 
granulomatous disease like Wegener`s granulomatosis), infectious disease 
(e.g., tuberculosis fungal rhinosinusitis and HIV related disease), malignant 
disease (e.g., lymphoma, myeloproliferative disorders and leukemia, malignant 
melanoma, histiocytosis, sickle cell anaemia, and rhabdomyosarcoma) or other 
systemic disorders (e.g., Paget`s disease of bone and fibrous dysplasia) will be 
presented.  
Learning Objectives: 
1. To recognise head and neck manifestations of systemic disease. 
2. To categorise lesions into different pathologic entities. 
16:00 - 17:30 Studio 2018  
Genitourinary  
RC 807  
Imaging of the prostate  
Moderator:  
P. Puech; Lille/FR  
A-316 16:00  
A. MRI diagnosis of prostate cancer  
A.R. Padhani; London/UK (anwar.padhani@talk21.com)  
The PI-RADS v2 analysis system for mpMRI detection of prostate cancer was 
developed by expert opinion, using the observed performance and utilization of 
the PI-RADS v1 system. Test performance of PI-RADS v2 in research and 
clinical practice has been shown to an improvement over v1, maintaining high 
accuracy compared to systematic TRUS biopsies for prostate cancer 
diagnosis. PI-RADS v2 fails to detect all cancers, but does detect the majority 
of tumors capable of causing patient harms; test performance is dependent on 
the definition used to identify clinically significant disease. Good performance 
can be attained in practice provided that the quality of the diagnostic process 
can be assured (including MRI scanner, PI-RADS compliant imaging protocol, 
biopsy procedures, image interpretation, reporting, and communication), 
backed up by the robust training of radiologists and urologists working jointly 
within multidisciplinary teams. This talk summarises the accuracy, strengths, 
and weakness PI-RADS v2, discusses potential pathway implications and 
outlines opportunities for improvements and future developments.  
Learning Objectives: 
1. To become familiar with the different components of mpMRI of the prostate 
(T2, DWI and DCE). 
2. To discuss the role of PI-RADS version 2 in the diagnosis of clinically 
significant prostate cancer. 
3. To understand the correct indications and guidelines on the use of mpMRI. 
Author Disclosure: 
  A.R. Padhani: Speaker; Siemens Healthineers, Janssen, Sanofi. 
A-317 16:30  
B. MRI staging of prostate cancer  
G.M. Villeirs; Ghent/BE  
Staging involves the correct assessment of the local tumour situation (T), 
involvement of lymph nodes (N) and of distant metastases (M). According to 
the European Association of Urology (EAU) Guidelines, assessment of lymph 
nodes is only useful in patients with a PSA >10, Gleason score >7, >cT2b. 
Imaging can be performed using the well known size criteria (round node 
>8mm, short axis of oval node >10mm) on CT or MRI, but this approach clearly 
lacks both sensitivity and specificity. Diffusion-weighted MRI incorporating 
morphologic features, MR-lymphangiography using ultra-small particles of iron 
oxide (USPIO), and nuclear medicine techniques such as choline- and PSMA-
PET/CT offer higher sensitivity and specificity, but cannot (yet) replace the 
current gold standard (pelvic lymphadenectomy). The search for distant 
metastases (T) primarily involves skeletal assessment in patients at increased 
risk (PSA >20, Gleason >8, cT3-cT4). The current gold standard is the bone 
scan, but whole body MRI and new PET tracers seem to be on track to replace 
the bone scan as gold standard. In the absence of N+ or M+ disease, MRI can 
be used to assess the local status (T). High-resolution T2-weighted images are 
used to assess potential extracapsular extension or seminal vesicle invasion. 
Although this is a recommended approach according to the EAU guidelines, 
the accuracy of such T-staging is currently still quite variable. However, 
standardization of scanning techniques for staging and standardization of 
diagnostic criteria may solve this problem. 
Learning Objectives: 
1. To understand the current role of prostate MRI. 
2. To learn how to optimise imaging and reporting. 











A-318 17:00  
C. Imaging of PSA recurrence  
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de)  
Ca. 40% of prostate carcinoma patients develop biochemical recurrence after 
radical prostatectomy and radiotherapy, which are nevertheless in accordance 
to current guidelines first-line treatment options for patients with organ-confined 
prostate cancer. In the situation of PSA recurrence, early detection and precise 
localization of cancer is essential for individualized treatment decision making 
and for prognosis assessment. Early detection of local recurrence after radical 
prostatectomy is particular challenging as salvage radiotherapy is feasible with 
curative intention only in case of very low PSA serum levels. Conventional 
TRUS has limited sensitivity and specificity for detection of local recurrence. 
Multiparametric MRI (mpMRI) has been shown to be superior for detection of 
local recurrence, although early detection of small cancer foci is also 
significantly limited. Concerning early detection of lymphatic cancer spreading 
CT and MRI are significantly limited. Highest sensitivity for cancer detection is 
achieved by PET, although it is important to note that the accuracy significantly 
depends on the used radiotracer. In clinical routine most frequently C-11 or F-
18 choline and Ga-68 or F-18 PSMA PET/CT is performed. PET/MR imaging 
provides additional advantaged by combining the highest sensitivity of PET 
with superior anatomical referencing as well as soft tissue and bone marrow 
assessment by MR. This lecture will provide an overview about the currently 
available imaging methods for detection of recurrence in case of PSA relapse. 
Their clinical relevance will be discussed against the background of the 
potential therapy options.  
Learning Objectives: 
1. To understand the clinical need and indications for imaging in patients with 
PSA recurrence. 
2. To discuss the optimal imaging modalities for detection of local recurrence. 
3. To illustrate the potential of whole-body MRI and new radiotracers for 
detection of distant recurrence. 
16:00 - 17:30 Room L 8  
EIBIR Session  
EIBIR Research Session: European 
imaging researchers united in diversity  
A-319 16:00  
Chairperson's introduction  
G.P. Krestin; Rotterdam/NL  
The European Institute for Biomedical Imaging Research (EIBIR) is an 
organization aiming to coordinate research in, and innovation of, biomedical 
imaging technologies within Europe and support the dissemination of 
knowledge with the ultimate goal of improving prevention, detection, diagnosis, 
and treatment of disease. EIBIR promotes networking activities within Europe 
and ensures the pooling of resources among members to promote a culture of 
cooperation between them. EIBIR also generates publicity concerning new 
opportunities for access, provide dissemination of knowledge, and training 
courses for potential users. In the competitive landscape of European funding, 
EIBIR has enabled numerous consortia to successfully apply and perform large 
collaborative research projects. Recently within the Horizon 2020 framework 
EIBIR is supporting a number of innovative ventures related to cancer 
research. The expertise that the office has built up over the past years did not 
only provide a competitive edge in obtaining funding, but will also guarantee 
the dissemination of the promising results of these projects. This session 
should provide information on how the EIBIR services can help the researchers 
in their endeavors and give an overview of three successfully running projects 
aiming to have an impact in cancer diagnostics and therapy.  
Session Objectives: 
1. To learn about major EU-funded research projects related to cancer imaging 
in which EIBIR is a partner. 
2. To appreciate the impact these projects will have on cancer diagnosis and 
care. 
3. To understand the role of the European Institute for Biomedical Imaging 
Research (EIBIR) in such projects. 
A-320 16:10  
Laser and Ultrasound Co-analyser for Thyroid Nodules (LUCA) Project: 
latest results  
U. Weigel; Barcelona/ES (udo.weigel@hemophotonics.com)  
Near-infrared diffuse optics is receiving increasing interest in cancer 
diagnostics for its capability to measure unique and complementary 
parameters based on hemodynamics (microvascular blood flow, blood oxygen 
saturation and blood volume), tissue structure (cell density, size) as well as 
water and other chromophore concentrations in combination with established 
imaging technologies in a non-invasive, relatively fast and safe procedure. 
After description of the background physics, the basics of the technology, and 
different approaches for probe development, a particular focus will be given to 
hybrid technologies that combine diffuse correlation spectroscopy (DCS) and 
diffuse optical time resolved spectroscopy (TRS) for biomedical applications. 
Finally, I will introduce and report the present status of LUCA (http://www.luca-
project.eu), a European project, aiming at development and validation of a 
combined ultrasound- optical prototype for thyroid cancer diagnostics.  
Learning Objectives: 
1. To learn about the application of diffuse optics to human tissue. 
2. To understand the technology of LUCA. 
3. To learn about the project's status and its initial results. 
Author Disclosure: 
  U. Weigel: CEO; HemoPhotonics S.L.. Founder; HemoPhotonics S.L.. 
Shareholder; HemoPhotonics S.L.. 
A-321 16:30  
Testing hybrid MR/PET (HYPMED) device for enhanced breast diagnosis 
in a multicentre clinical trial  
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at)  
With a consortium of ten partners from across Europe, including major 
universities, research institutes, SMEs and major industry corporations, the 
HYPMED project brings together a wide range of expertise. In this project 
“Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer 
(HYPMED)”, we aim to develop a hybrid system combining MRI and PET that 
facilitates earlier diagnosis of breast cancer and personalized therapy control. 
To achieve this, we are designing and testing a combined PET-radiofrequency 
(RF) insert that can be connected to a conventional clinical MR scanner, 
transforming the device into a high-resolution PET/MRI hybrid system. This 
PET-RF insert can be used to identify even the smallest breast cancer foci and 
better characterize the cancer, as well as its response to therapy. Another key 
benefit of this technology for patients is that the radiation dose of the new 
technology will, unlike other PET-MRI examinations, be comparable to the low 
dose of a regular digital mammogram. Apart from merely diagnosing the 
presence or absence of breast cancer, HYPMED will improve the non-invasive 
biological classification of breast cancers, in other words it will improve the 
assessment of its aggressiveness, therefore facilitate better selection of 
appropriate treatments. In a bench to bedside approach HYPMED includes 
several work packages spanning the spectrum from designing to clinical 
testing.  
Learning Objectives: 
1. To learn about a multicentre clinical trial of the project's hybrid MR/PET 
insert. 
2. To understand how the trial will validate the project's ground-breaking 
MR/PET technology. 
3. To appreciate the complexity of undertaking such a multicentre clinical trial 
at European level. 
Author Disclosure: 
  T.H. Helbich: Board Member; EUSOBI, ESHMIMT. Grant Recipient; EU 
grant. Research/Grant Support; Siemens, Hologic. 
A-322 16:50  
Smart Optical and Ultrasound Diagnostics of Breast Cancer (SOLUS) 
Project: aims and objectives  
P. Taroni; Milan/IT (paola.taroni@polimi.it)  
Due to the high false-positive risk of mammography, there is an unmet clinical 
need for higher specificity in breast cancer imaging following screening. 
Photonics and ultrasound-based imaging are both non-invasive and have, to 
some extent, been proven effective in characterising breast lesions, 
discriminating malignant from benign ones. However, up to now, no individual 
technique proved to be adequate in replacing conventional methods. The EU-
funded research project SOLUS will develop innovative photonic components, 
combining photonics with ultrasound techniques, and clinically validate the 
resulting multi-modal approach in breast cancer patients. To meet the clinical 
need, SOLUS develops novel pulsed laser sources and high dynamic range 
single-photon detectors, providing unprecedented sensitivity and depth 
penetration, making diffuse optical tomography feasible in real clinical settings. 
For the first time, this approach will allow; (1) a comprehensive quantitative 
characterisation of breast tissue, including composition (water, lipid, collagen 
content) and functional blood parameters as provided by diffuse optical 
tomography; (2) morphologic information from B-mode ultrasound imaging; and 
(3) mechanical parameters (stiffness) from shear wave elastography. 
Subsequent multi-parametric data analysis, using new reconstruction 
algorithms, allows high specificity in the discrimination between borderline 
malignant and benign breast lesions. SOLUS is a trans-disciplinary, 48-month 
  







project that brings together 9 partners (industry, academia and hospitals) from 
5 countries. 
Learning Objectives: 
1. To understand how the system developed by the project will combine optical 
methods with ultrasound. 
2. To appreciate how the technology developed by the project will improve the 
ability to differentiate between benign and malignant lesions. 
A-323 17:10  
EIBIR's role in imaging research projects  
P. Zolda; Vienna/AT (pamela.zolda@myesr.org)  
Due to shrinking national research budgets, European researchers more 
frequently apply for EU funding sources. However, navigating through the rules 
and regulations of large EU projects while simultaneously carrying out 
innovative research with partners from across Europe can be challenging. 
Thus, multidisciplinary and multinational consortia require professional project 
management to ensure the successful accomplishment of their project goals. 
The European Institute for Biomedical Imaging Research, EIBIR, is a non-profit 
organisation founded by the European Society of Radiology and supports 
researchers and industry partners in the coordination of biomedical imaging 
research throughout Europe and beyond. EIBIR offers expert advice, 
professional project management and coordination, dissemination and 
exploitation services for dedicated international collaborative research projects. 
The EIBIR services also include advice on funding opportunities, identifying 
consortium partners and proposal writing support by a team of experienced 
writers with knowledge of the European Commission's requirements. Partners 
also benefit from EIBIR`s established, extensive network for dissemination. 
Through the large and diverse landscape of network members, shareholder 
organisations, industry partners and media contacts the conducted research is 
be widely and rapidly communicated. EIBIR is currently partner and/or 
coordinator of seven projects that are funded under Horizon 2020, the biggest 
EU Research and innovation programme. The offered support relieves 
researchers of the administrative burden, allowing them to focus on the 
scientific aspects and thereby ensuring the best possible outcome for the 
project. 
Learning Objectives: 
1. To learn about EIBIR and its services for researchers. 
2. To understand project management and dissemination activities of 
European projects. 
3. To appreciate how EIBIR can support your research project. 
16:00 - 17:30 Room E1  
Special Focus Session  
SF 8b  
My three top tips for breast imaging  
A-324 16:00  
Chairperson's introduction  
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at)  
This session will provide practical information on the fundamental tips and 
tricks of the most renowned European breast radiologists for everyday clinical 
practice with a focus on a tertiary setting. All relevant topics from screening 
with tomosynthesis and automated ultrasound to image-guided interventional 
techniques as well as post-therapy evaluation will be addressed. Attendees will 
be able to learn and experience the most important aspects for successfully 
performing and avoiding common pitfalls at diagnostic and interventional 
breast examinations.  
Session Objectives: 
1. To appreciate fundamental tips and tricks of the most renowned European 
breast radiologists for clinical practice. 
2. To acknowledge the single most important aspects for successfully 
performing breast examinations. 
3. To learn how to avoid common pitfalls in breast radiology. 
A-325 16:05  
Screening with tomosynthesis  
S. Zackrisson; Malmö/SE (sophia.zackrisson@med.lu.se)  
It is well known that digital mammography (DM) has limitations in detecting 
breast cancers, especially in women with dense breasts. Studies show that up 
to 30% of the cancers in screening may not be detectable with DM, mainly due 
to the overlapping tissue effect, i.e., dense breast tissue or the so-called 
anatomical noise obscuring the tumor on the two-dimensional images. Digital 
breast tomosynthesis (DBT) is an emerging pseudo 3D technique in breast 
imaging based on the acquisition of low-dose projections over a limited arc, 
reconstructed into a volume of generally up to 50 images of the breast. This 
reduces the overlapping tissue effect and hence tumors may be more easily 
detected with DBT. The published population based European screening trials 
with DBT (alone or in combination with DM or synthetic DM) show incremental 
breast cancer detection attributed to DBT in the range of 2.2 to 2.7 cancers per 
1000 screens. In other settings, mainly in the US, retrospective studies with the 
combination of DBT and DM has been conducted with large reductions in recall 
rates as the main effect. In this presentation, the use of DBT in screening will 
be presented and discussed in terms of screening performance measures and 
what needs to be further investigated before DBT can fully implemented in 
routine screening.  
Learning Objectives: 
1. To understand why tomosynthesis is better than mammography for breast 
cancer screening. 
2. To appreciate the current scientific evidence of tomosynthesis in screening. 
3. To acknowledge what further steps are needed before implementation in 
screening. 
Author Disclosure: 
  S. Zackrisson: Speaker; Speaker's fees and travel support from Siemens 
Healthineers. 
A-326 16:11  
Automated breast ultrasound  
R.M. Mann; Nijmegen/NL (r.mann@rad.umcn.nl)  
ABUS is a relatively novel automated ultrasound technique that enables 
volume scanning of large portions of the breast. In fact the entire breast can 
usually be imaged in 3 to 5 volumes. The standardised approach for image 
acquisition enables remote interpretation and therefore, the reporting 
radiologist is no longer required to obtain the images him/herself. As such 
specific artefacts such as non-black cysts and wandering shadows (due to a 
suboptimal angle of the transducer to the coopers ligaments) need to be 
understood as these cannot be prevented. A further advantage of ABUS is the 
possibility to perform multilane reconstructions of the image volume. 
Particularly the coronal reconstruction is useful. Not only because it reduces 
the amount of images to be evaluated substantially, but also because in the 
coronal plane often a retraction pattern becomes evident around malignant 
lesions. Therefore, it improves diagnostic accuracy. ABUS has been developed 
as a screening tool and seems to have most benefit as a supplemental 
screening tool in women with dense breasts on mammography. It also 
improves ultrasound staging of breast cancers as the extent of especially 
multifocal and diffuse lesions are easier grasped than with single ultrasound 
shots. A further possibility is the evaluation of lesions treated with me-adjuvant 
chemotherapy, however, data for this indication are limited.  
Learning Objectives: 
1. To recognise artefacts that are specific to ABUS. 
2. To appreciate the value of multiplanar reconstruction and the coronal 
spiculation pattern. 
3. To gain insight into possible indications for ABUS. 
Author Disclosure: 
  R.M. Mann: Advisory Board; Screenpoint Medical, Transonic imaging. Grant 
Recipient; Siemens Healthineers, Bayer Healthcare, Medtronic, Elswood, 
Identification Solutions inc., Seno Medical, Micirima. 
A-327 16:17  
Complex cystic and solid lesions  
P. Kapetas; Vienna/AT (panagiotis.kapetas@meduniwien.ac.at)  
Cysts are the most usual breast pathology and up to one third of all women 
between 30 and 50 years of age are diagnosed with them. According to the BI-
RADS® lexicon, cystic breast lesions are classified into simple cysts, 
complicated cysts and complex cystic and solid lesions. Simple cysts are 
anechoic fluid collections with an imperceptible wall and constitute the biggest 
part of cystic breast lesions. Complicated cysts also have an imperceptible 
wall, but present either with homogeneous hypoechoic content due to the 
presence of debris or with fluid-fluid levels. Complex cystic and solid lesions 
represent either a cystic lesion with a thick (>0.5mm) wall or thick septations or 
a lesion with a combination of cystic and solid components. Several 
complementary sonographic techniques can aid in the correct identification of 
the cyst type. These include compound and harmonic imaging, elastography, 
Doppler, and contrast enhanced ultrasound. A complex cystic and solid lesion 
represents a BI-RADS® 4 or 5 finding and merits histopathological work-up 
with a percutaneous, ultrasound-guided biopsy. In cases of cystic lesions with 
thick walls or thick septations or of predominantly cystic lesions with a small 
solid component a 9-10G vacuum assisted biopsy system should be used, to 
ensure proper sampling and reduce the risk of a false negative result. A post-
  







biopsy marker needs to be introduced after the intervention if the residual mass 
is difficult to identify.  
Learning Objectives: 
1. To understand the difference between complex cystic and solid lesions from 
other cystic lesions of the breast. 
2. To become familiar with complementary sonographic techniques for the 
accurate characterisation of cystic breast lesions. 
3. To be able to properly manage complex cystic and solid lesions of the 
breast. 
16:23  
Questions and discussion  
A-328 16:29  
Imaging the axilla  
F. Kilburn-Toppin; Cambridge/UK (fleur.kilburn-toppin@addenbrookes.nhs.uk)  
Evaluation of regional lymph node status is important for staging, treatment 
planning, and prognosis in breast cancer patients. Pre-operative axillary 
ultrasound and ultrasound-guided biopsy are routinely used to detect nodal 
metastases, allowing patients to proceed directly to axillary lymph node 
dissection thereby avoiding sentinel lymph node biopsy. However, following 
recent clinical trials and with improvement in systemic and radiation therapies, 
the role of staging sonography has been questioned. In this lecture, the current 
role of axillary staging will be reviewed and the future for nodal staging in the 
advent of evolving surgical management of the axilla and a trend towards less 
aggressive surgery will be considered.  
Learning Objectives: 
1. To understand the clinical role of axillary staging. 
2. To learn imaging features of abnormal lymph nodes and criteria for biopsy. 
3. To understand the importance of discriminating minimal vs advanced nodal 
disease. 
A-329 16:35  
Contrast-enhanced spectral mammography  
E.M. Fallenberg; Berlin/DE (eva.fallenberg@charite.de)  
In this talk the technical principles and possible artefacts will be addressed. In 
a couple of example cases the image appearance depending on lesion size 
and 2D images will be explained. The value of CESM in comparison to 
mammography MRI and ultrasound will be demonstrated.  
Learning Objectives: 
1. To understand the technical principles of contrast-enhanced spectral 
mammography. 
2. To understand the added value of information provided by contrast-
enhanced spectral mammography. 
3. To become familiar with the information provided by contrast-enhanced 
spectral mammography and breast MRI regarding lesion morphology and 
enhancement. 
Author Disclosure: 
  E.M. Fallenberg: Board Member; EUSOBI. Research/Grant Support; GE 
Healthcare, Guerbet, Siemens Healthcare. Speaker; GE Healthcare, Guerbet, 
Bayer Healthcare. 
A-330 16:41  
Stereotactic-guided biopsy  
E.J. Cornford; Cheltenham/UK (eleanor.cornford@nhs.net)  
Stereotactic guided breast biopsy has become increasingly sophisticated over 
the past 15 years due mainly to improvements in equipment. It was initially 
used to biopsy mammographic abnormalities not visible on ultrasound, but 
indications have expanded to include diagnostic excision of histopathologically 
indeterminate lesions. Although the underlying principle is the same, the 
technique varies in terms of needle biopsy device, equipment type, and patient 
positioning. More recently the introduction of tomosynthesis guided biopsy has 
facilitated even faster biopsy times. Post procedure placement of marker clips 
is important to confirm accurate biopsy and to facilitate subsequent removal of 
the mammographic abnormality should prove this necessary.  
Learning Objectives: 
1. To understand the indications for stereotactic-guided breast biopsy. 
2. To learn about the technical aspects of stereotactic biopsy. 
3. To understand the importance of marker clip placement post-biopsy. 
16:47  
Questions and discussion  
A-331 16:53  
US-guided biopsy  
A. Athanasiou; Athens/GR (aathanasiou@mitera.gr)  
Ultrasound-guided percutaneous biopsies are nowadays widely used in clinical 
practice. They include FNA (Fine Needle Aspiration, with 19-21 gauge 
needles), core-biopsy (14-gauge or rarely 16-gauge automated or semi-
automated systems) and vacuum-assisted biopsy (11-gauge to 8-gauge 
systems). They are minimally invasive, well tolerated, rapid and cost-effective. 
They can provide histological diagnosis in a safe and accurate way, 
comparable to open surgical biopsies. According to the international 
guidelines, pre-operative diagnosis should preferably be ensured by imaging-
guided procedures; open surgical biopsies should be exceptional and 
performed only when percutaneous procedures are not feasible. BI-RADS 4 
and 5 lesions as well as abnormal lymph nodes represent the main indications 
for performing US-guide biopsies. Simple or complicated cysts are subject to 
FNA when symptomatic or when it is not clear if the lesion is indeed a 
complicated cyst and not a solid nodule. Contraindications include allergies, 
anti-coagulant medications or inability to correctly visualize the target lesion. 
Post-biopsy markers are helpful and should be used, notably in case of small, 
difficult to visualize lesions or in case of complex-cystic lesions. Technique 
should be rigorous and optimized to ensure result accuracy. Radiologic-
pathologic correlation is mandatory and all discordant cases should be 
discussed in MDT. 
Learning Objectives: 
1. To understand current indications, contraindications and possible 
complications of US-guided biopsy. 
2. To be familiar with different available biopsy systems and know which one to 
choose according to the clinical setting. 
3. To learn the most important technical tips for performing a US-guided biopsy 
successfully. 
A-332 16:59  
MRI-guided biopsy  
G. Esen; Istanbul/TR (gulesenicten@gmail.com)  
MRI frequently detects suspicious lesions that cannot be demonstrated on 
other imaging modalities and need to undergo MRI-guided biopsy. Before an 
MRI-guided biopsy is scheduled, we have to make sure that the lesion is real 
and not a benign hormonal change; and then to check again with a second-
look US. If it is not detectable on US, the patient can be scheduled, preferably 
during the second week of the menstrual cycle. On the day of the biopsy, 
patient has to be informed that it is possible to cancel biopsy, because the 
lesion is no longer detected on MRI. During biopsy, patient has to be informed 
that she will be coming in and out of the magnet, and she should not move. 
The sequences that are needed for a biopsy session should be prepared in 
advance, and employed in a standard fashion. MRI-guided biopsy is a team 
work and if everybody involved know what to do, it can be performed efficiently 
and rapidly, before the contrast washes out. CAD or a biopsy software would 
be very helpful in MRI-guided biopsies. Vacuum-assisted biopsy is the 
procedure of choice, because it is fast and accurate. It is possible to achieve 
more tissue from the suspicious region, if the lesion-needle relation is 
determined from the image and more samples are collected from that location. 
A marker should be placed at the biopsy site in each case and radiological-
pathological correlation should always be performed.  
Learning Objectives: 
1. To understand the importance of pre-biopsy preparation including patient 
information. 
2. To be familiar how to relate lesion and needle positions. 
3. To appreciate tricks for targeting lesions in complicated locations 
(superficial, deep, retroareolar). 
A-333 17:05  
Treatment response and therapy monitoring  
C. Van Ongeval; Leuven/BE (chantal.vanongeval@uz.kuleuven.ac.be)  
Neoadjuvant therapy is increasingly been used in the treatment of breast 
cancer. For the monitoring of treatment (chemotherapy or hormonal therapy) 
response, an adequate staging of the breast cancer is needed: marking 
invasion or skin thickening, size of the index tumour, description of multifocal or 
multicentric disease, presence of bilateral breast cancer, and evaluation of 
nodal status (level 1, 2, 3). Besides mammography, ultrasound and biopsy 
procedures, magnetic resonance imaging (MRI) can be added to come to the 
correct staging. During the neoadjuvant treatment, a radiological investigation 
(ultrasound) is performed after 3 to 4 cycles of therapy or earlier in case of a 
tumor growth is suspected (non-responder). In the latter case , MRI will be 
added to the radiological investigation. After the last cycle of treatment, a new 
staging of the tumour is necessary to decide the optimal surgical treatment, 
i.e., mastectomy, breast conserving therapy and or lymphadenectomy or 
  







sentinel node resection. The imaging characteristics of tumour response or 
tumour growth during therapy will be discussed.  
Learning Objectives: 
1. To learn what is important in the reporting of the treatment response. 
2. To understand the accuracy of mammography, ultrasound and magnetic 
resonance in the monitoring of therapy. 
A-334 17:11  
Post-therapy evaluation  
J. Camps Herrero; Valencia/ES (juliacamps@gmail.com)  
To understand the changes that occur in the breast after treatment, one must 
know the different phases of fat necrosis and their translation in 
mammographic, ultrasound or MRI images. In reporting the findings, it is 
important to focus on the ones that have the greatest clinical value for the 
requesting physician. It will also be very important to know how to diagnose 
recurrence and, most of all, how to proceed when mammography or ultrasound 
are equivocal.  
Learning Objectives: 
1. To understand and learn the different phases of fat necrosis and its imaging 
correlates in all modalities. 
2. To know what to report in patients with breast implants and oncoplastic 
reconstructions. 
3. To learn the different appearances of breast cancer recurrence. 
Author Disclosure: 
  J. Camps Herrero: Consultant; Bayer, Bard. Speaker; Bayer. 
17:17  
Questions and discussion  
16:00 - 17:30 Room E2  
Neuro  
RC 811  
State-of-the-art paediatric neuroradiology  
A-335 16:00  
Chairperson's introduction  
C. Amarnath; Chennai/IN (amarrd02@yahoo.co.in)  
This session highlights concepts of myelination and its maturation, role of 
imaging in diagnosing leukodystrophies. The topics focusses on wide spectrum 
of developmental disorders entity and importance of our role in diagnosis and 
add points on some relevant genetic or predisposing factors in pediatric CNS 
tumours. This session review the structural MRI findings in myelination 
disorders, paediatric CNS tumours, with an emphasis on posterior fossa 
tumours. The session emphasizes the contribution of advanced MRI 
techniques in pediatric neuroradiology. This lecture list the spectrum of 
applications and indications for imaging in paediatric neuroradiology. 
Spectators will be able to understand the relevance to apply the appropriate 
image acquisition protocols of disease in the field and appreciate the clinical 
relevance of imaging for the diagnostic process of neurological disorders in 
infants and children.  
Session Objectives: 
1. To learn the spectrum of applications and indications for imaging in 
paediatric neuroradiology. 
2. To understand the relevance to apply the appropriate image acquisition 
protocols of disease in the field. 
3. To appreciate the clinical relevance of imaging for the diagnostic process of 
neurological disorders in infants and children. 
A-336 16:05  
A. Imaging myelin maturation disorders  
N. Wolf; Amsterdam/NL (n.wolf@vumc.nl)  
Hypomyelinating leukodystrophies are frequent and have to fulfill both criteria 
of significant and permanent myelin deficit. Hypomyelination can be diagnosed 
by MRI. Care should be taken that, in children younger than 12 months of age, 
two MRIs at least 6 months apart are needed to make the diagnosis, in order to 
differentiate hypomyelination from the more frequent finding of delayed 
myelination. Severe atrophy in young children usually indicates a primary grey 
matter disorder with secondary myelin deficit and comes with its own 
differential diagnosis. MRI findings in hypomyelination consist of diffuse white 
matter signal hyperintensity on T2-weighted images and, depending on the 
amount of myelin deposited, hypo-, iso- or hyperintensity on T1-weighted 
images. Additional features may be cerebellar atrophy, signal and volume 
changes of deep grey matter structures and signal changes of the pyramidal 
tracts. These findings, when present, help differentiating the diverse 
hypomyelinating conditions. Some entities (e.g., 4H syndrome, H-ABC, HBSL, 
HCC, Salla disease, Pelizaeus-Merzbacher like disease) can be easily 
diagnosed by MRI pattern recognition. This allows direct confirmation of the 
diagnosis by sequencing of the appropriate gene(s). Other hypomyelinating 
disorders do not come with extra features, necessitating a different genetic 
approach.  
Learning Objectives: 
1. To learn about normal and pathological patterns of myelination. 
2. To understand the role of imaging with respect to narrowing the differential 
diagnosis and supporting the clinical diagnosis. 
3. To appreciate the importance of pattern recognition for the diagnosis of 
myelination disorders in children. 
A-337 16:28  
B. Imaging of developmental disorders  
B. Ertl-Wagner; Munich/DE (Birgit.Ertl-Wagner@med.uni-muenchen.de)  
To understand congenital abnormalities of the brain, it is important to be 
familiar with the embryologic development. Neuronal proliferation, migration 
and cortical organization are important steps in the development of the cortex. 
Group I disorders of cortical development are disorders of neuronal and/or glial 
apoptosis or proliferation. Among these are congenital microcephalies (I.A), 
congenital megalencephalies (I.B), and diffuse or focal cortical dysgenesis or 
dysplasia (I.C). Microlissencephaly is characterised by a reduced gyration and 
microcephaly. Hemimegalencephaly is a hamartomatous overgrowth of one 
cerebral hemisphere or parts thereof. Group II disorders are disorders of 
neuronal migration. Among these are periventricular (subependymal) 
heterotopia (II.A), lissencephalies (II.B), focal subcortical heterotopia (II.C), or 
disorders of terminal migration, e.g. cobblestone lissencephalies (II.D). 
Heterotopia are defined as areas of grey matter in an ectopic location; they are 
isointense to cortex. Group III disorders are disorders of postmigrational 
development. Among these are polymicrogyria with schizencephaly (III.A), 
polymicrogyria without clefts or calcifications (III.B), focal cortical dysplasia 
(III.C), or postmigrational microcephaly. In schizencephaly, there is a cleft that 
extends from the ependymal to the cortical surface and that is lined by 
dysplastic grey matter. In polymicrogyria, there are too many too small gyri and 
sulci. Agenesis and dysgenesis of the corpus callosum are common disorders 
with a wide clinical spectrum. They may be associated with other congenital 
abnormalities. Important infratentorial congenital abnormalities include Chiari 
malformations, cystic abnormalities of the posterior fossa/the Dandy Walker 
spectrum, molar tooth malformations/Joubert syndrome and dysplastic 
cerebellar gangliocytoma/Lhermitte-Duclos syndrome.  
Learning Objectives: 
1. To learn about the spectrum of developmental disorders of the brain. 
2. To understand the key imaging features that lead to the correct diagnosis. 
3. To appreciate the importance of making a correct imaging diagnosis. 
A-338 16:51  
C. Imaging in paediatric neuro-oncology  
E. Vázquez; Barcelona/ES (evazquez@vhebron.net)  
Central nervous system tumours are the most common group of solid tumours 
in the paediatric age and the main cause of death from solid tumours in 
childhood. The clinical onset commonly includes signs and symptoms related 
to increased intracranial pressure, gait disorders, or cranial nerve deficits. 
Magnetic resonance (MR) imaging has an important role in characterizing 
these lesions, planning surgery, and follow-up. Advanced MR techniques, 
especially diffusion, help to predict the histological type and degree of 
malignancy, and facilitate the diagnosis of recurrence during follow-up. 
Identification of taurine within the tumour on spectroscopy is typical of 
medulloblastoma. Perfusion imaging, including dynamic susceptibility of 
contrast perfusion and arterial spin-labelling perfusion are particularly useful in 
differentiating recurrence versus radiation necrosis. Specifically referring to 
cerebellar tumours, they may be associated with diverse inherited cancer 
syndromes such as neurofibromatosis type 1 (pilocytic astrocytoma), Von 
Hippel Lindau syndrome (hemangioblastoma), Cowden syndrome 
(gangliocytoma), Li-Fraumeni syndrome (astrocytoma, medulloblastoma) and 
Gorlin and Turcot syndromes (medulloblastoma). In the differential diagnosis, 
conditions that can mimic neoplasms should be included, such as infections 
(e.g., rhombencephalitis), autoimmune processes (e.g., acute disseminated 
encephalomyelitis and multiple sclerosis), and radionecrosis. Proper 
recognition of these entities can help to prevent unnecessary surgery. Of note, 
certain previous histological classifications, such as that of medulloblastoma, 
are being replaced by new classifications based on genetic characteristics, 
which enable better prediction of tumour aggressiveness and help to guide 
  







therapy according to the specific tumour type. Current research focuses not 
only on prolonging survival, but also on improving long-term quality-of-life.  
Learning Objectives: 
1. To learn about the spectrum of neuro-oncological diseases in children. 
2. To understand the role of imaging beyond the diagnostic process. 
3. To appreciate the increasing clinical relevance of advanced imaging 
techniques in paediatric neuro-oncology. 
17:14  
Panel discussion: Ask the expert: what is relevant for my own daily 
clinical practice?  
16:00 - 17:30 Room F1  
E³ - Rising Stars Programme: Joint Sessions with ESOR  
ESR/ESOR 2  
Radiologic anatomy: abdomen  
Moderator:  
S. Gourtsoyianni; Athens/GR  
A-339 16:00  
Liver  
G. Brancatelli; Palermo/IT (gbranca@yahoo.com)  
The liver is the largest organ in the human body. The penetration and 
branching of the hepatic artery, portal vein, and hepatic veins allow dividing the 
organ into the eight traditional segments of the Couinaud scheme. Knowledge 
of vascular and segmental anatomy is important to correctly locate the site of 
disease and to perform increasingly demanding and challenging liver resection 
and transplantation. Anatomy of the liver can be altered by congenital variants, 
diseases causing hepatic dysmorphy and after surgery.  
Learning Objectives: 
1. To locate and identify, using cross sectional medical imaging, superficial and 
internal structures of common liver anatomy. 
2. To learn and understand how the vasculature defines the eight Couinaud 
segments. 
3. To explain how common pathological conditions affect the structure of the 
liver. 
Author Disclosure: 
  G. Brancatelli: Speaker; Bayer. 
A-340 16:30  
Biliary tree  
O. Benjaminov; Petach Tikva/IL  
"no abstract submitted" 
Learning Objectives: 
1. To discuss current imaging techniques for evaluation of normal biliary 
anatomy. 
2. To learn and understand possible anatomical variants that may occur. 
3. To explain how common pathological conditions affect the bile ducts. 
A-341 17:00  
Pancreas  
M. Dioguardi Burgio; Clichy/FR (marco_dioguardi@hotmail.it)  
The pancreas is a retroperitoneal gland, which is anatomically divided in 4 
portions: head, neck, body and tail. Main anatomical relationships of the head 
are duodenal loop, the porta hepatis and the superior mesenteric vessels. 
Body and tail anatomical relationships include left kidney and adrenal gland, 
posterior gastric wall and lesser sac, splenic hilum, celiac region, and 
duodenojejunal junction. Main pancreatic duct (Wirsung) drains into the major 
papilla most of the pancreatic secretions. A common biliopancreatic tract may 
be present. An accessory duct (Santorini) is usually present draining the 
anterior part of the pancreatic head in the minor papilla. Pancreatic gland is the 
results of the fusion of two buds. During the seventh gestational week the 
ventral bud rotate around the duodenum and it locates inferiorly and posteriorly 
to the dorsal bud. The fusion of the two buds leads to anastomosis of the 
ductal systems. Anomalies of this fusion process are at the base of the wide 
spectrum of anatomical variants which pancreatic parenchyma and ductal 
system may present. Most common anatomical variants include pancreas 
divisum, ansa pancreatica and annular pancreas. Knowledge of normal CT and 
MR appearance of the pancreas is crucial to recognize anatomical variants as 
well as to identify pancreatic anomalies. The use of both techniques is often 
necessary for an exhaustive evaluation of the pancreatic gland and to reach a 
proper diagnosis.  
Learning Objectives: 
1. To review and illustrate the imaging features of normal pancreatic anatomy. 
2. To review the possible congenital variants and anomalies of the pancreas 
and pancreatic duct. 
3. To explain how common pathological conditions affect the pancreas. 
16:00 - 17:30 Room F2  
Oncologic Imaging  
RC 816  
Monitoring response: the essential guide 
for all radiologists  
A-342 16:00  
Chairperson's introduction  
P. Brader; Graz/AT (peter@brader.md)  
Imaging-based therapy monitoring is essential to visualise and quantify the 
effect of cancer therapy. Therefore, criteria-based reporting methods were 
established to ensure standardised and reproducible results for response 
evaluation of oncologic patients. Response Evaluation Criteria in Solid Tumors 
(RECIST) as the most widely accepted morphologic, size-based evaluation 
system is based on imaging assessment of change in tumor burden, to 
determine if the tumor has shrunk or grown. However they only evaluate the 
size of the lesion, not its viability, proliferative rate or physiologic state. In 
recent years a broad range of novel molecular cancer therapeutics were 
introduced into clinical use. These new therapy regimes demonstrated 
significant effects on tumor angiogenesis and tumor metabolism, but often only 
subtile effects on tumor morphology. Established methods of monitoring 
cytotoxic tumor therapies, such as RECIST have been shown to be not 
sufficiently sensitive for monitoring the therapeutic effects of molecular anti-
cancer agents to allow for a timely differentiation of responders from non-
responders because such treatments are less likely to result in tumor 
shrinkage. The complementary acquisition of morphological, functional and 
molecular information using advanced imaging methods such as diffusion 
weighted imaging or perfusion imaging as well as hybrid imaging techniques 
(PET/CT, PET/MRI) allows for a higher sensitivity and specificity in the timely 
differentiation of responders from non-responders. The tremendous 
development in oncology and technical innovations in imaging present a 
particular challenge for radiology.  
Session Objectives: 
1. To understand the correlation of functional imaging evaluation with the 
pathophysiological effect of treatment on oncological pathology. 
2. To understand the necessity of functional imaging for an accurate (early) 
evaluation of the therapy regimen on the response (or non-response) of 
oncological disease. 
3. To learn about the added value of functional imaging for evaluating 
treatment (e.g. anti-angiogenic treatment). 
4. To learn about the technical principles of functional imaging in correlation 
with the impact of the therapy on tumour cells and neo-vasculature. 
A-343 16:05  
A. RECIST made easy  
A.G. Rockall; London/UK (a.rockall@imperial.ac.uk)  
A significant part of modern day cancer imaging involves the assessment of 
change in the extent of tumour in the context of a clinical trial or research 
study. The reporting requirements for these imaging studies are documented in 
the research protocol. A standardized response assessment is important to be 
able to collate data between different centres, as well as to evaluate published 
data from different studies. Response evaluation criteria in solid tumours 
(RECIST) were developed and published in 2000. RECIST criteria have been 
widely adopted for the evaluation of treatment response in the clinical trial 
setting. A revised version, RECIST 1.1 was subsequently published in 2009, to 
address several problems that had been encountered with RECIST 1.0. New 
studies frequently use RECIST 1.1 but in some cases, new studies will still use 
RECIST 1.0 to allow direct comparison with a previous similar study. In this 
lecture, the key features of RECIST will be presented with worked examples. 
Selection of appropriate target lesions will be illustrated. Frequently asked 
questions will be addressed and the criteria for response will be illustrated.  
Learning Objectives: 
1. To learn about the basic idea of RECIST. 
2. To understand how to use RECIST in daily clinical practice. 
3. To become familiar with the detailed rules of RECIST. 
  







A-344 16:28  
B. PERCIST: PET response criteria  
C.C. Cyran; Munich/DE (clemens.cyran@med.uni-muenchen.de)  
With the implementation of novel oncologic strategies and prolonged survival 
of cancer patients, early and longitudinal monitoring of therapy response to 
treatment in individual patients has become a key request to imaging. Known 
limitations of morphological size-based criteria (e.g., RECIST) for the 
monitoring of tumor response led to the investigation of additional functional 
and molecular imaging techniques to allow for a reliable and timely distinction 
of responders and non-responders, particularly under novel molecular cancer 
therapies. Particularly hybrid imaging techniques, such as PET/CT or 
PET/MRI, demonstrated significantly improved diagnostic accuracy for the 
evaluation of treatment response in different tumor entities under a variety of 
treatments with a reported change-in-intended management of up to 35% in 
oncologic indications compared to conventional imaging alone. To allow for a 
standardized evaluation of therapy response, criteria-based reporting of target 
and non-target lesions has been established to classify therapy response into 
different categories ranging from complete response to progressive disease 
and has found broad application particularly within clinical studies. Similar to 
the size-based RECIST (response criteria in solid tumors) criteria, PERCIST 
(PET response criteria in solid tumor) criteria were developed to provide a 
systematic, standardized approach for the criteria-based evaluation of 
metabolic tumor response to therapy using 18F-FDG PET. Studies evaluating 
PERCIST criteria suggest, that the inclusion of standardized metabolic criteria 
may allow for an increased sensitivity, specificity and diagnostic accuracy in 
the evaluation of therapy response compared to morphological imaging criteria 
alone. 
Learning Objectives: 
1. To learn about the basic principles of PERCIST. 
2. To understand how to use PERCIST for structured quantitative research and 
clinical reporting. 
3. To appreciate the advantages of PERCIST over mere morphological 
methods. 
Author Disclosure: 
  C.C. Cyran: Research/Grant Support; Novartis AG, iThera. Speaker; 
Siemens Healthineers. 
A-345 16:51  
C. Assessment of response using functional MR and CT imaging: the 
essentials  
L.S. Fournier; Paris/FR (laure.fournier@aphp.fr)  
Key issues in oncology include patient selection based on pre-treatment 
tumour characteristics, and assessment of tumour response in the absence of 
actual shrinkage. There is accumulating evidence that functional imaging using 
advanced techniques such as dynamic contrast enhanced imaging (MRI, CT or 
ultrasound), diffusion weighted-MRI, magnetic resonance spectroscopy, and 
positron emission tomography-CT using various labelled radioactive tracers 
has the potential to address these challenges. New approaches quantifying 
heterogeneity such as texture and radiomics are also emerging.Functional 
imaging allows quantifying physiological or molecular processes, yielding 
information not accessible to morphological imaging. In preclinical animal 
studies, they may give insight into biological mechanisms of efficacy and help 
select best candidate drugs. In human studies, early phase studies can use 
functional imaging to indicate early likelihood of response to a specific therapy, 
and guide the optimal biological dose and drug schedule.Though a very large 
number of studies have been performed using functional imaging, very few are 
used to make clinical decisions. Among the challenges facing functional 
imaging for the past years are standardisation of acquisition and image 
processing, as well as validation of clinical utility.  
Learning Objectives: 
1. To learn about the portfolio of functional imaging response methods in CT 
and MRI. 
2. To understand the current clinical value of each technique. 
3. To appreciate potential advantages compared to PERCIST. 
Author Disclosure: 
  L.S. Fournier: Advisory Board; Keosys. Grant Recipient; Novartis, Invectys. 
Research/Grant Support; Philips, Arian Pharma, Evolucare. Speaker; Novartis, 
Pfizer, Merck, Sanofi. 
17:14  
Panel discussion: When and how will functional imaging overcome 
morphological assessment?  
 
 
16:00 - 17:30 Room D  
Musculoskeletal  
RC 810  
Musculoskeletal ultrasound in the 
management of sports injuries  
Moderator:  
M. Reijnierse; Leiden/NL  
A-346 16:00  
A. Ultrasound of ankle injuries: technique and diagnosis  
C. Martinoli; Genoa/IT (carlo.martinoli@libero.it)  
In sports medicine, the role of ultrasound (US) has become increasingly 
important in the assessment of ligaments, tendons, joints, and other soft-tissue 
injuries about the ankle. Being many structures to be examined, the US 
examination should be focused on clinical findings in an attempt to save time 
and increase the efficacy of the study. In the area around the lateral malleolus, 
that is the most frequently involved in inversion trauma, ligaments and tendons 
can be injured individually or in association. US can assess the status of the 
anterior talofibular and calcaneofibular ligaments with effective results by 
means of static and dynamic scans. Some midtarsal ligaments, such as the 
dorsal calcaneocuboid, the superior talonavicular and the bifurcate, can be 
also evaluated. In high sprains, US can provide evaluation of the anterior 
inferior tibiotalar ligament, including the Bassett fascicle. US can give 
demonstration of peroneal tendon instability based on tendon displacement 
relative to the malleolar groove and is able to recognise retinacular/periosteal 
tears. Dynamic scanning can help to detect cases of intermittent subluxation 
that often go unnoticed at MR imaging. Some predisposing conditions of 
peroneal tendon instability (e.g. convex retromalleolar groove, peroneus 
quartus, low myotendinous junction of the peroneus brevis) may also be 
identified. Longitudinal splits of the peroneus brevis often occur in athletes. US 
can depict early changes with weakening and thinning of the central part of the 
tendon. In more advanced lesions, a complete cleft with formation of two 
distinct hemi-tendons, irregularities of the tendon substance and tenosynovitis 
is observed.  
Learning Objectives: 
1. To become familiar with ultrasound findings seen in ankle instability. 
2. To learn about the ultrasound patterns of tendon abnormalities. 
A-347 16:30  
B. Ultrasound of the hip and knee: what is it good for and what are its 
limitations?  
A. Klauser; Innsbruck/AT  
The hip and knee are anatomically and biomechanically complex joints, often 
causing diagnostic uncertainty for clinicians, therefore, most often MRI is 
requested. But does US have any value in knee and hip sport injuries? In 
cases of intraarticular pathology US can accurately detect effusion and 
synovitis, paralabral and meniscal cysts, however, further imaging assessment 
as by MRI (arthrography) is necessary. Extraarticular pathologies like 
tendinopathy, enthesopathy, tendon strains, different types of bursitis 
(trochanteric, iliopectinea, iliopsoas, prepatellar, infrapatellar, 
semimembranosus ...), muscle strains and ruptures, and collateral knee 
ligament injuries can be assessed and graded by US. US is also great in 
delineation of various neuropathies. The major advantage of US is the 
possibility of dynamic evaluation, for example, in the assessment of iliopsoas 
abnormalities, including snapping iliopsoas tendon and iliotibial band friction 
syndrome. In terms of sport injury management, ultrasound guided punctures 
and injections are highly appreciated by patients and clinicians as well and also 
the ability for therapeutic short terms follow-up is of great importance to better 
understand point of sport return in the athletes.  
Learning Objectives: 
1. To become familiar with examination technique and typical findings of 
ultrasound of the hip and knee. 
2. To understand the limitations of ultrasound of the hip and knee. 
A-348 17:00  
C. Ultrasound-guided intervention in the athlete: indications and 
techniques  
H. Guerini; Paris/FR  
Diagnostic and interventional ultrasound is a rapidly evolving field in sports 
medicine. The use of ultrasound has increased exponentially during the past 
decade. Ultrasound-guided procedure is performed for joint and tendon sheath 
  







injections with PRP or steroid drugs. We will discuss of the the indications, 
technical considerations about interventional ultrasound in sports medicine. 
Learning Objectives: 
1. To become familiar with the indications for ultrasound-guided interventions 
in the athlete. 
2. To learn about the different injection techniques. 
16:00 - 17:30 Room G  
Special Focus Session  
SF 8c  
The ten-minute abdominal MRI: make the 
dream come true!  
A-349 16:00  
Chairperson's introduction  
N. Papanikolaou; Lisbon/PT 
(nickolas.papanikolaou@research.fchampalimaud.org)  
Abdominal MRI images are sensitive to a variety of artifacts related to 
respiratory, cardiac and peristaltic motion, the presence of air in the 
gastrointestinal tract and chemical shift due to abdominal fat. One factor that 
enhances respiration-related artifacts is the level of patient collaboration and 
compliance either to breath-hold commands, or the capability of the patient to 
achieve a steady respiratory pattern during image acquisition. Technical 
advances related to a further reduction of scan times have been applied for 
abdominal imaging purposes, including parallel imaging algorithms, alternative 
ways to fill k-space, radial scanning and compressed sensing. Apart from 
improving the patient experience due to shorter examination times, these 
techniques may result in enhancing the problematic image quality of abdominal 
MRI exams by minimizing the level of artifacts. Additionally, new diagnostic 
information related to the amount of angiogenesis can be obtained by novel 
perfusion sequences that can simultaneously provide very high temporal 
resolution and adequate in-plane resolution and anatomical coverage 
maintaining acceptable image quality. Innovative RF coil designs, taking into 
consideration the patient body habits are also improving the acquired MR 
signal, that can be exploited by further increasing spatial resolution.  
Session Objectives: 
1. To become familiar with technical challenges of MRI examinations in the 
abdomen. 
2. To review current MR examination protocols of the abdominal organs. 
3. To discuss future developments. 
Author Disclosure: 
  N. Papanikolaou: Advisory Board; Advantis Medical Imaging. Owner; 
MRIcons LTD. 
A-350 16:05  
Liver  
T.C. Lauenstein; Essen/DE (thomas.lauenstein@evk-duesseldorf.de)  
MRI has vast potential to non-invasively diagnose and characterize focal liver 
lesions as well as diffuse liver disease. Due to the large extent of different 
sequence types, various information about pathological changes can be 
obtained. Hence, it is sometimes difficult to shorten MRI protocols and to 
withdraw certain MRI sequences without losing relevant information. 
Furthermore, MRI of the upper abdomen can be challenging. Motion and 
breathing artifacts can considerably impede a reliable diagnostic workup. In 
addition, it can be difficult to acquire MR images during the correct contrast 
phases after i.v. gadolinium injection. Hence, it is crucial to choose and apply 
the right contrast delay. Strategies to overcome limitations and to handle the 
outlines challenges will be proposed in this lecture. A comprehensive and 
abbreviated examination protocol for liver MRI will be presented with a special 
focus on diffusion weighted imaging and liver specific contrast agents. 
Eventually, clinical cases and pitfalls will be discussed.  
Learning Objectives: 
1. To briefly review MRI challenges in the liver. 
2. To review techniques and methods to optimise image quality. 
3. To compare comprehensive and abbreviated protocol strategies. 
A-351 16:28  
Pancreas  
N. Kartalis; Stockholm/SE (nikolaos.kartalis@me.com)  
Magnetic resonance imaging/magnetic resonance cholangiopancreatography 
(MRI/MRCP) is increasingly used for the evaluation of patients with pancreatic 
diseases, such as pancreatic cystic neoplasms (PCN), pancreatic cancer and 
pancreatitis as well as for screening purposes, such as in individuals at 
increased risk of developing pancreatic malignancy (i.e. family history of 
pancreatic cancer, genetic factors, etc.). Particularly for the surveillance of 
patients with PCNs, MRI is the suggested imaging modality according to 
various existing clinical practice guidelines due to its exquisite contrast 
resolution, high sensitivity for the detection of lesion communication with the 
pancreatic ductal system and lack of ionizing radiation. However, MRI/MRCP 
protocols are time-consuming, costly and, in the case of serial follow-up 
examinations, the repeated use of gadolinium-based contrast agents raises 
potentially safety concerns. In this presentation, we will discuss various 
strategies for the development of abbreviated protocols useful in everyday 
clinical practice.  
Learning Objectives: 
1. To briefly review MRI challenges in the pancreas. 
2. To review techniques and methods to optimise image quality. 
3. To compare comprehensive and abbreviated protocol strategies. 
A-352 16:51  
Ovaries  
E. Sala; Cambridge/UK (evis.sala@gmail.com)  
Magnetic resonance Imaging (MRI) is recommended as a second line 
investigation for characterisation of complex adnexal masses indeterminate on 
US. MRI gives superb contrast resolution and involves non-ionizing radiation. 
Typical protocols include both T1 and T2 weighted sequences, with imaging 
acquisition performed in 3 planes. Coronal FSE T2WI is very helpful in 
evaluating complex adnexal lesions. Adnexal lesions can be characterised by 
their specific signal characteristics on T1WI and T2WI. Simple fluid has 
homogeneous low signal on T1WI and high signal intensity on T2WI. Fat and 
haemorrhage have high signal intensity on T1WI. Fat suppression (FS) on 
T1W sequences is utilised to differentiate these entities. If the adnexal lesion 
demonstrates low or intermediate signal intensity on T1WI and low signal 
intensity on T2WI, these characteristics suggest fibrotic and/or smooth muscle 
components. Such lesions include pedunculated leiomyoma, fibroma, 
fibrothecoma, cystadenofibroma and Brenner tumours. Multi-phase contrast 
enhanced (CE) MRI after administration of intravenous gadolinium is very 
useful for characterisation of adnexal masses. Solid components will 
demonstrate enhancement, enabling the distinction between debris or 
retracting clot in the cyst wall from papillary projections. Subtraction images are 
essential to evaluate enhancing nodules within a background of hyperintense 
T1W lesion. Gadolinium also improves detection of peritoneal and omental 
implants in case of ovarian carcinoma. Dynamic-CE (DCE)-MRI are not yet 
routinely performed in evaluation of adnexal masses. Diffusion-weighted 
imaging (DWI) is very useful for visualisation of peritoneal implants.  
Learning Objectives: 
1. To briefly review MRI challenges of the adnexa. 
2. To review techniques and methods to optimise image quality. 
3. To compare comprehensive and abbreviated protocol strategies. 
17:14  
Panel discussion: MRI technological advances: impact on radiologist 
routine  
16:00 - 17:30 Room K  
Radiographers  
RC 814  
Contrast media in imaging  
Moderators:  
M.-F. Bellin; Le Kremlin-Bicêtre/FR  
L. Popovic; Belgrade/RS  
A-353 16:00  
A. Contrast-enhanced ultrasound: principles and applications  
G. Johnson; Manchester/UK (gerry.johnson@tgh.nhs.uk)  
The use of contrast enhanced media in medical imaging is well established 
allowing greater visualisation and characterisation of disease 
processes.Ultrasound imaging has been relatively late in creating an specific 
contrast agent, but many contrast agents or micro bubbles exist and are being 
used routinely in clinical practice to aid better diagnoses in a non invasive 
manner. Mircobubbles are the scientific basis for all current developments in 
ultrasound contrast media. The principal characteristic is their backscatter 
effect, simply put when gas filled microbubbles are present in a region of 
interest, a higher proportion of the ultrasound beam is backscattered and 
  







therefore a stronger return echo is received at the transducerThe clinical use of 
contrast media was first used in cardiac imaging in the 1968 by Gramiak and 
Shah (Invest Radiol 3:356-366), their early work found the microbubble 
technology to be "rough and ready", microbubbles were very large and size 
distribution was poorly defined. It was not until the mid 1980's that methods 
were developed to produced smaller more stable microbubbles by means of 
sonication, although the use of this media was limited as they were unable to 
survive passage through the lungs after i.v. injection. Since then there have 
been numerous developments in generating stable and reliable ultrasound 
contrast agents.This presentation will review their basic physical principles, try 
to elaborate on the technical requirements required to perform it, and learn 
about various clinical indications and applications of CEUS. 
Learning Objectives: 
1. To review the basic physical principles of contrast-enhanced ultrasound. 
2. To understand the technical requirements to perform it. 
3. To learn about the various clinical indications and applications of contrast-
enhanced ultrasound. 
A-354 16:30  
B. Radiotracers in PET/RNI  
P. Laverman; Nijmegen/NL (Peter.Laverman@radboudumc.nl)  
Different types of radiopharmaceuticals for both PET and SPECT imaging are 
used for various indications. In this session we will focus on recent 
developments in the field of radiopharmaceuticals. A brief overview of current 
radiotracers for PET and SPECT will be given and - in more general - the 
development and production of these tracers as well as their in vivo behaviour 
will be discussed. The biodistribution and uptake mechanism of a radiotracer 
will be examplified by radiolabeled PSMA-ligands for imaging of prostate 
cancer. The use of these radioatracers have become very popular over the last 
few years and are now an important tool in PET and SPECT imaging. 
Differences in these prostate cancer imaging tracers will be explained and their 
various applications will be discussed. 
Learning Objectives: 
1. To learn about current radiotracers in use in PET/RNI. 
2. To understand the mechanism of distribution and uptake of various 
radiotracers. 
3. To appreciate the most appropriate clinical indications and applications of 
PET/RNI radiotracers. 
A-355 17:00  
C. How safe really are gadolinium agents?  
A. Cradock; Dublin/IE (andrea.cradock@ucd.ie)  
Gadolinium based contrast agents (GdBCA’s) have been used in MRI to aid 
diagnosis since the 1980’s. The gadolinium ion (Gd+3), a heavy metal ion, is 
toxic to within the body and is chelated to prevent deposition of the gadolinium 
ion in tissues. The stability of the chemical bonding between Gd+3 influences 
the tendency for release of free Gd+3 over time. Macrocyclic agents tend to 
have a higher stability than linear agents. Ionic agents tend to have a higher 
stability than non-ionic agents. However, in 2006 the first reports of the 
association between nephrogenic systemic fibrosis (NSF) and GdBCAs were 
described. NSF can progress to a debilitating disease and is potentially fatal. It 
is thought that patients with severe renal insufficiency are more at risk than 
patients with normal renal function. The advent of these reports introduced 
restrictions for the administration of GdBCAs to patients with impaired renal 
function in clinical departments. In recent times, there have been reports of 
accumulation of gadolinium within the brain tissues of patients with normal 
renal function.  
Learning Objectives: 
1. To be aware of the differences between macrocyclic and linear gadolinium-
based contrast agents. 
2. To review current advice regarding the use of gadolinium on patients with 
renal impairment. 
3. To become familiar with our current understanding of gadolinium deposition 






16:00 - 17:30 Room M 1  
Vascular  
RC 815  
Post-treatment evaluation: what every 
radiologist should know  
A-356 16:00  
Chairperson's introduction  
P. Haage; Wuppertal/DE (patrick.haage@helios-kliniken.de)  
Appropriate post-treatment evaluation after any intervention is key for a good 
outcome and superior long term success rates. Accordingly it is necessary to 
supervise the outcomes, define follow-up strategies and to identify potential 
complications and possibly prepare for re-intervention. In this refresher course, 
pathways and most common complications after thoracic aortic interventions, 
abdominal aorta surgical, and endovascular repair and endovascular 
peripheral arterial disease treatment will be presented including imaging 
specifics, i.e., normal and pathological appearances and indications for re-
intervention. Ample information on the selection of modality (ultrasonography, 
CT, MRI), the typical time interval between follow-up examinations plus specific 
suggestions including items to cover in a structured report will be given.  
Session Objectives: 
1. To briefly introduce the distinctive role of proper post-treatment evaluation 
after intervention. 
2. To control the results and to know possible complications in order to be 
prepared for re-intervention. 
A-357 16:05  
A. Thoracic aorta  
T. Leiner; Utrecht/NL (t.leiner@umcutrecht.nl)  
The aorta plays a central role in connecting the heart to various end organs. 
Pathological changes in the aorta have a retrograde effect on the heart, as well 
as affecting perfusion of end-organs. In my presentation I will discuss CT and 
MR imaging protocols optimised for imaging the post-operative aorta and the 
typical appearance of various post-operative conditions. Topics covered will 
include choice of modality, acquisition strategies as well as practical tips on 
how to report important findings. Theoretical considerations will be illustrated 
with case material from clinical practice.  
Learning Objectives: 
1. To learn about the most common complications after thoracic aortic 
interventions. 
2. To understand imaging specifics after thoracic aortic interventions. 
3. To know indications for re-intervention. 
Author Disclosure: 
  T. Leiner: Research/Grant Support; Philips Healthcare; Bayer Healthcare. 
Speaker; Philips Healthcare; Bayer Healthcare. 
A-358 16:28  
B. Abdominal aorta  
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at)  
The endovascular treatment (EVAR) has become a well established treatment 
option for aortic diseases. In contrary to patients after surgical repair, patients 
after EVAR require lifetime follow up imaging since the chronic and progressive 
character of atherosclerosis can cause progression of aortic dilatation leading 
to movement of the prosthesis or insufficient aneurysm exclusion with time. 
Additionally, persistent perfusion of the aneurysm sac (endoleaks) can occur 
even years after stentgraft placement. Finally, the life expectancy of the 
materials used for endovascular treatment might be limited. CT angiography 
was established as the first method of choice for follow up after abdominal 
aortic repair. The advantages of CT angiography are manifold and include 
optimal comparability with the pre-treatment examination (usually done by 
means of CT angiography), high resolution, direct visualisation of the device 
itself and the possibility of multiphasic acquisition to detect even slow flow 
endoleaks. As it is true for all treatment-follow up examinations knowledge 
about primary procedure and typical post-therapeutic findings as well as about 
most common complications is a prerequisite in patient care after abdominal 
aortic repair. Device migration, device fracture and/or persistent sac perfusion - 
in most of the cases related to each other - are the most common procedure 
related complications. In this presentation, different therapeutic means for 
abdominal aortic disease will be presented as well as the typical, normal 
findings after treatment. Furthermore, most common complications will be 
introduced and discussed based on clinical examples. Finally, possible follow 
up strategy depending on disease and procedure should be proposed.  
  








1. To learn about the most common complications after abdominal aortic 
interventions. 
2. To understand imaging specifics after thoracic aortic interventions. 
3. To know indications for re-intervention. 
Author Disclosure: 
  C. Loewe: Speaker; GE Healthcare, Bracco, Siemens. 
A-359 16:51  
C. Peripheral arterial disease  
M. Anzidei; Rome/IT (michele.anzidei@gmail.com)  
CT and MR angiography (CTA and MRA) substantially changed the diagnostic 
approach in planning and follow-up of treatment for peripheral arterial disease 
(PAD), enabling early identification of treatment failure or treatment-related 
complications after endovascular and surgical procedures. Doppler ultrasound 
is the first line imaging modality during follow-up after treatment, but CTA and 
MRA enable more detailed and panoramic imaging that is extremely valuable 
in the assessment of treatment outcome. The aim of this presentation is to 
review the imaging findings in the most common complications after 
endovascular treatment for PAD, to discuss the best imaging modality in the 
various clinical scenarios and to explain when and how to re-intervene on the 
basis of imaging findings.  
Learning Objectives: 
1. To learn about the most common complications after PAD endovascular 
repair. 
2. To understand what imaging technique is preferred (any diagnostic). 
3. To explain when to re-intervene and how to prepare for it. 
17:14  
Panel discussion: How to optimise post-treatment imaging: getting 
proper diagnosis without performing too many examinations  
16:00 - 17:30 Room M 2 
Computer Applications  
RC 805  
Daily use of mobile devices in radiology  
A-360 16:00  
Chairperson's introduction  
O. Ratib; Geneva/CH  
Mobile devices such as tablets and high-resolution smartphones are becoming 
widely available providing convenient mobile solutions for physicians and 
healthcare providers to access imaging data. This is particularly attractive in 
medicine where “nomad” physicians who need to be able access relevant 
patient data and images anywhere-anytime in their daily practice where they 
are rarely a single location. While they may not always be adequate for routine 
diagnostic tasks they provide a convenient mobile solution for on-call and 
remote consultations. There are different types of software architecture that 
can be implemented for such tasks. Two major different design are: (1) online 
web-based applications where the device serves as a “thin-client” to display 
images rendered and manipulated on a remote computer and (2) local 
applications that reside on the mobile device and can run independently after 
images have been downloaded on the device. The first solution requires the 
user to be constantly connected to the network, while the second solution can 
continue to function after disconnecting from the network. Most vendors are 
starting to provide web access to their imaging solutions that can be accessed 
from mobile devices. Web access can however be slow and dependent on 
reliable access to wireless network. 
Session Objectives: 
1. To give an overview of tools available on mobile devices for education and 
exam reporting. 
2. To underline the impact of mobile devices in routine clinical activity. 
3. To learn about the legislative backbone and potential drawbacks of mobile 
technology. 
A-361 16:05  
A. What did mobile devices change in radiology education?  
E. Kotter; Freiburg/DE (elmar.kotter@uniklinik-freiburg.de)  
E-learning has been used in radiology for more than 30 years. The lecture will 
give an introduction to and an overview of e-learning systems for radiology with 
emphasis on e-learning on mobile devices. Advantages and limitations of 
mobile e-learning will be discussed. An outlook to future development of e-
learning will be given.  
Learning Objectives: 
1. To give an overview of tools available for e-learning. 
2. To explore the potential impact of e-learning in the daily radiological 
practice. 
3. To explore future developments and limits of e-learning. 
A-362 16:28  
B. Is it appropriate to read a study on a smartphone or a tablet?  
N.H. Strickland; London/UK (nicola.strickland@nhs.net)  
The portability of tablets and smartphones make them suitable for accessing 
and displaying digital radiological imaging studies particularly in on call or 
remote settings, in wards or clinics and in the emergency setting. The purpose 
of this display can be for primary diagnosis or for review. The portable device 
must be fit for purpose. The small screen size and limited display resolution of 
smartphones limits their appropriateness for primary diagnosis. However 
studies have shown equivalent diagnostic accuracy of tablets compared with 
DICOM-calibrated PACS workstation displays. It is now technically possible to 
satisfy the requirements for viewing large multi-image studies on mobile 
devices: processor and network speeds are fast enough to receive images 
quickly from a PACS; screen resolutions and DICOM conformance can display 
images with appropriate fidelity; memory and graphics processor capacities 
can allow image viewing and manipulation similar to that on a PACS 
workstation; and hospital information technology departments can institute 
appropriate management to ensure functional stability of mobile devices and 
security of the patient data displayed on them. Simultaneous comparative 
viewing of multiple studies is inevitably suboptimal on portable devices due to 
their limited screen real estate. Radiologists should consider exploiting mobile 
devices to raise their profile as clinical doctors, for example, using them to 
interact in person with their clinical colleagues on ward rounds and in out-
patient departments, and with patients to explain their imaging to them.  
Learning Objectives: 
1. To give an overview of available DICOM viewers and software for reporting 
imaging studies. 
2. To discuss technical requirements of mobile devices for use in imaging 
interpretation. 
3. To provide insight on future developments of imaging viewing technology. 
A-363 16:51  
C. Security and ethical issues of mobile device technology  
E.R. Ranschaert; Mol/BE (ranschaert@telenet.be)  
Medical specialists and radiologists are using mobile devices to share and 
exchange medical information and images with other health care professionals. 
Usually they need the advice regarding a diagnosis or treatment, sometimes in 
an acute setting. Popular messaging services such as whatsapp are often 
used for such purpose. Transmission of patient data with mobile devices and 
messaging services, however, does have several ethical and legal limitations, 
mostly related to the security and privacy of patients. Some questions need to 
be answered: is this type of communication unsafe and/or illegal, and if yes, 
why? Are there any regulations and/or guidelines available? Are there any 
secure solutions available? In this refresher course these issues will be 
discussed in more detail.  
Learning Objectives: 
1. To provide an overview of technical solutions for patients' image and data 
mobility. 
2. To provide a risk assessment analysis (data loss, privacy, etc.) of mobile 
technology. 
3. To give an overview of European legislation in relation to patient image and 
data mobility. 
17:14  
Panel discussion: Can mobile technology supplement stationary 
technology in radiology?  
Discussion will address main controversies of the use of mobile technology in a 
clinical environment such as image quality, data mobility, safety and legal 












16:00 - 17:30 Room M 3 
Interventional Radiology  
RC 809  
Percutaneous interventional procedures: a 
practical guide  
A-364 16:00  
Chairperson's introduction  
R. Iezzi; Rome/IT (roberto.iezzi.md@gmail.com)  
Percutaneous imaging-guided interventions are making an increasing 
contribution to the treatment of patients with many non-vascular conditions. 
Minimally invasive techniques enable effective treatment that is followed by 
rapid recovery, with a low morbidity and mortality rate. However, the 
effectiveness of such methods of treatment is enhanced by an accurate 
preprocedural planning, an adequate selection of image guidance technique, 
as well as an optimal intra/periprocedural sedation. In detail, analgesia and 
sedation before, during, and after interventional procedures allow a safe, 
comfortable, and technically successful procedure to be performed. This 
session will explore different imaging-guided methods to define advantages, 
disadvantages, as well as tips and tricks for successful percutaneous 
intervention.  
Session Objectives: 
1. To appreciate the importance of pre-procedure planning and selection of 
image guidance technique. 
2. To learn about intra-procedure patient analgesia and adjunctive techniques 
for access to sites for intervention. 
3. To discuss tips and tricks for successful percutaneous intervention. 
A-365 16:05  
A. How to safely perform US-guided procedures  
D. Akinci; Ankara/TR (akincid@hotmail.com)  
Ultrasound (US) guidance is a frequent modality of choice in percutaneous 
biopsy, drainage, and ablation procedures, because it enables continuous real-
time visualization, is radiation-free, has a lower cost, is better for angled 
access. In most of the abdominal organ biopsies (e.g., liver, kidney, pancreas, 
and spleen) and drainage of fluid collections, local ablation of liver tumors, 
drainage of pleural collections, biopsy of peripheral pleural based thoracal 
lesions, US guidance is utilized. Endocavitary approaches can be used safely 
in pelvic biopsy and drainage procedures with transvaginal or transrectal US 
guidance. Fusion techniques combine US images with CT or MRI images, 
enabling targeted US guided procedures for lesions that are difficult to see on 
US.  
Learning Objectives: 
1. To learn about patient positioning for US-guided percutaneous and 
endocavitary approaches to sites in the body. 
2. To learn about real time guidance advantages of US-guided intervention. 
3. To explain image fusion techniques for US-guided intervention. 
A-366 16:28  
B. How to safely perform CT-guided procedures  
R. García Marcos; Valencia/ES (raulgamar@hotmail.com)  
Percutaneous computed tomography (CT) guided is a minimally invasive 
approach for interventional procedures. Although is a procedure with few 
complications precise planning and knowledge of the indications, technique 
and material. CT-guided interventions may be divided into diagnostic (biopsies) 
and therapeutic interventions (drainages, thermal ablation, vertebroplasty, 
etc.). The main problems of access to lesions depend on the situation due to 
poor imagery, mobility and distance. Therefore, we are obliged to know and 
identify the structures along the established route. Different techniques of CT 
exist. Multidetector CT is commonly used for guiding percutaneous biopsy and 
catheter drainage of fluid collections. CT fluoroscopy has the potential to 
improve the efficacy of CT-guided interventions and to reduce the procedure 
time. C-arm cone-beam CT (CBCT) is a real-time needle guidance technique 
that can be used to visualise the needle trajectory from skin to target lesions. 
The aim of this study is to present the types and advantages of the CT-guided 
interventions, the patient positioning and adjunctive techniques for access to 






1. To learn about patient positioning for CT-guided percutaneous approaches 
to sites in the body. 
2. To learn the types of CT guidance and advantages of CT-guided 
intervention. 
3. To learn about adjunctive techniques for access to sites for intervention. 
A-367 16:51  
C. Post-procedure follow-up and complication management  
M. Seidensticker; Munich/DE (max.seidensticker@med.uni-muenchen.de)  
Biopsy procedures bare - although commonly at a low rate - potentially life 
threating risks. To know about potential complications and proper patient 
monitoring is the key to identify the complications and to react accordingly. The 
lecture will give informations about common and uncommon complications 
after biopsy procedures and help will be given to identify the patient at risk and 
how to avoid/reduce specific complications. Further on, management of 
complications will be addressed. Of note, not all complications are avoidable, 
but proper patient management helps to reduce associated morbidity and 
mortality.  
Learning Objectives: 
1. To appreciate the potential for complications in common biopsy procedures. 
2. To learn about management of post-procedure complications. 
3. To discuss the role of quality improvement. 
Author Disclosure: 
  M. Seidensticker: Advisory Board; BAYER. Grant Recipient; SIRTEX 
Medical, BAYER. Speaker; Cook, Bayer, Sirtex. 
17:14  
Panel discussion: Tips and tricks for choosing your first cases. 
Controversial case-based review of approaches to difficult lesions  
16:00 - 17:30 Room M 4 
E³ - ECR Academies: State-of-the-Art and Advanced MR Imaging 
of the Musculoskeletal system  
E³ 819  
Lower extremity  
A-368 16:00  
Chairperson's introduction  
C.W.A. Pfirrmann; Zurich/CH  
A-369 16:05  
A. Hip and pubic symphysis  
S.J. Eustace; Dublin/IE (eustacesj@gmail.com)  
This presentation will review common causes of groin pain arising from the hip 
and from the symphysis pubis. In relation to hip pain the talk will focus on the 
role of the acetabular labrum in maintaining hip stability in normality, dysplasia 
and in patients with forms of impingement. The talk will outline appearances on 
non contrast MR studies and following arthrographic evaluation. The 
presentation will then review common pathologies in the symphysis pubis that 
can contribute to the development of groin pain contrasting symptoms and 
appearances of micro tearing of the adductor longs attachment (superior cleft 
sign) with appearances of micro tearing at the short adductor attachment 
(secondary cleft sign) with appearances of primary osteitis pubis.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and MR arthrography (direct/indirect) and 
how to optimise imaging protocols for the hip. 
A-370 16:43  
B. Post-traumatic ankle  
M.-A. Weber; Rostock/DE  
MRI is excellent for depicting normal ankle anatomy and it can elegantly 
demonstrate ligamentous injuries of the ankle and associated conditions after 
ankle sprain. In 85% of all ligament ruptures, the lateral ligament complex is 
affected and the anterior talofibular ligament is the most often ruptured 
ligament followed by the calcaneofibular ligament. Additionally, dedicated MRI 
protocols can delineate the cartilage, as well as the appearance of acute and 
chronic osteochondral lesions of the talus. Recent advances in MRI include 3D 
  







isotropic ankle joint imaging. Subchondral microfractures, osteochondral 
fractures and solely chondral fractures are different manifestations of impaction 
injuries, the two last-mentioned affect the articular surface. Since 
osteochondral lesions of the talus may eventually result in post-traumatic 
osteoarthritis, recognition of early cartilage damage and associated lesions 
may help determining the proper treatment of the patient to delay or prevent 
progression to osteoarthritis. Additionally, osteochondral injuries can often 
explain persisting symptoms. MRI, where necessary complemented by CT-
arthrography, has become a decisive tool in diagnosing and characterizing 
cartilage lesions of the ankle. In case of disrupted cartilage layers and fluid 
around undetached fragments as well as in case of a dislodged fragment 
operative treatment may be indicated after consideration of the patient’s 
general clinical condition. The interventional procedures, which have been 
developed for the repair of such lesions, essentially include abrasion, 
microfracture, autologous osteochondral transplantation, allograft 
transplantation, and (matrix-associated) autologous chondrocyte implantation. 
MRI enables the non-invasive assessment of the repair tissue, the success of 
implantation, and the state of cartilage maturation.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To know the role of MR imaging and MR arthrography (direct/indirect) and 
how to optimise imaging protocols for the ankle. 
3. To differentiate post-traumatic changes from typical reasons for chronic 
pain. 
A-371 17:06  
C. Chronic ankle pain  
J. Teh; Oxford/UK (jamesteh1@googlemail.com)  
This lecture will focus on the causes of chronic ankle pain, other than 
osteochondral and ligamentous injuries. The topics covered will include: (1) 
Tendinopathy: The spectrum of tendinopathy in the ankle ranges from 
tendinosis through to complete ruptures. There are specific abnormalities that 
occur in relation to the tibialis posterior tendinopathy such as spring ligament 
disruption and pes planus. On the lateral aspect of the ankle splits of the 
peroneus brevis, the painful os peroneum syndrome (POPS) and peroneal 
dislocation are discussed. (2) Plantar fascia: The plantar fascia is prone 
overuse injury resulting in plantar fasciitis. Acute disruption may also occur. 
Baxter’s neuropathy is discussed. (3) Masses: For many soft tissue masses the 
position of the lesion is often useful for narrowing the differential. For some 
benign soft tissue masses (e.g., Morton’s neuroma, lipomas, hemangiomas, 
cysts, abscesses), the MRI findings may be sufficient to clinch a diagnosis. In 
some cases further imaging and biopsy may be required. (4) Diabetic foot: 
Certain features may help us differentiate between the infected diabetic foot 
from Charcot arthropathy. The key to diagnosing infection is the presence of 
soft tissue ulceration contiguous to the bone abnormality. Ulceration in the foot 
tends to occur in weight bearing areas such as at the heel, the ball of the foot 
and around the toes. Charcot arthropathy is characterized by destruction, 
disorganization, increased density and debris.  
Learning Objectives: 
1. To identify the most common entities leading to chronic pain. 
2. To know the role of MR imaging and MR arthrography (direct/indirect). 
3. To differentiate entities leading to chronic pain from post-traumatic changes. 
16:00 - 17:30 Room M 5 
E³ - ECR Academies: Update on Hepatobiliary Imaging  
E³ 820  
Liver and bile duct pathologies  
A-372 16:00  
Chairperson's introduction  
M. Zins; Paris/FR (mzins@hpsj.fr)  
In this liver and bile duct session we will review, through interactive case 
presentations, challenging cases of liver abscesses, acute cholangitis, intra, 
and extrahepatic cholangiocarcinoma as well as benign and malignant 
conditions of the Gallbladder. The main differentials will be discussed and 
many tips in assessing accurate diagnosis in liver and bile ducts diseases will 
be presented.  
A-373 16:05  
A. Inflammatory and infectious disease  
A. Arora; Worthing/UK (Ankur.Arora@wsht.nhs.uk)  
Infective and inflammatory disorders of the hepatobiliary system are routinely 
encountered in a radiologist’s day to day practice and one ought to be aware of 
their common and uncommon clinico-radiological manifestations. Imaging 
undoubtedly plays a crucial role in their timely detection and characterisation 
and guiding appropriate clinical management. A broad spectrum of 
infective/inflammatory disorders can affect the hepatobiliary system which for 
simplicity can be broadly classified into disorders affecting the liver, 
gallbladder, and the biliary tree, although often these structures are 
concomitantly involved. We shall appraise the common imaging appearances 
of different liver infections (bacterial, viral, parasitic, and fungal) on multimodal 
imaging and discuss relevant differential diagnoses. Whilst in most instances 
US and CT are sufficient to diagnose and characterise hepatic infections MRI 
may be resorted to as a problem solving tool for, e.g., to exclude necrotic liver 
tumours. We shall also review the key imaging manifestation of biliary and 
gallbladder inflammation/infections with a view to familiarise ourselves with 
pertinent diagnostic pointers on cross-sectional imaging.  
Learning Objectives: 
1. To recognise and describe the radiological appearance of the inflammatory-
infectious processes that may involve the liver. 
2. To describe the imaging findings in inflammatory-infectious processes that 
may involve bile ducts. 
3. To assess the role of different imaging modalities in the detection, 
characterisation, and management of patients with inflammatory-infectious 
hepatobiliary disease. 
A-374 16:43  
B. Cholangiocarcinoma: diagnosing and staging  
C. Matos; Lisbon/PT (celso.matos@fundacaochampalimaud.pt)  
The goals of imaging in patients with suspected or known cholangiocarcinoma 
(CCA) are multiple: (a) to show the size and the location of a primary lesion 
and assess the longitudinal and radial extent of bile duct involvement; (b) to 
enable the characterization of a biliary stenosis; (c) to show involvement of the 
hepatic artery main and lobar branches and of the portal vein main and lobar 
branches for the purpose of surgical planning; (d) to depict the presence and 
extent of liver invasion and of lobar atrophy or hypertrophy, and (e) to enable 
the detection of regional lymph nodes and metastases. The lecture will address 
the complementary role of non-invasive and invasive imaging modalities to 
achieve those goals and will illustrate imaging characteristics that may indicate 
a specific diagnosis and may help predict prognosis.  
Learning Objectives: 
1. To be familiar with the multimodality imaging techniques and protocols. 
2. To be aware of the imaging findings of different types of cholangiocarcinoma 
in diagnosing and staging. 
3. To be able to recognise recurrent and metastatic disease in the follow-up. 
A-375 17:06  
C. Gallbladder pathologies  
R. Maksimovi	; Belgrade/RS (ruzica.maksimovic@med.bg.ac.rs)  
Imaging of gallbladder is including variety of diagnostic imaging modalities 
such as ultrasonography (US), multidetector computed tomography (MDCT), 
magnetic resonance imaging (MRI), positron emission tomography (PET), and 
scintigraphy. Wide variety of diagnostic armamentarium provides accuracy of 
noninvasive imaging of benign and malignant gallbladder conditions, and thus 
improves laparoscopic surgery as well as endoscopic and radiologic 
interventional techniques. US has been the first imaging modality for evaluating 
gallbladder disease, due to its high sensitivity and specificity for evaluating not 
only morphology, but also for functional evaluation of the gallbladder. MDCT is 
valuable diagnostic procedure in differential diagnosis, and for preoperative 
assesment of different conditions, including the tumour and its sagting, as well 
as to evaluate therapy response MR is taking place in gall bladder imaging 
preferentially in patients with limited assessment by US. It allows assesement 
of anatomic and physiologic features of not only a gallbladder but also biliary 
tract in preinterventional and postoperative setting. Furthermore, respiratory-
triggered three-dimensional MR cholangiopancreatography (3D-MRCP) is a 
promising new toll for better visualisation of gall bladder lumen, bile duct, and 
pancreatic duct. The utility of 18F-fluorodeoxyglucose positron emission 
tomography-computed tomography (18FDG PET-CT) is to provide optimal pre-
treatment staging of patients and to tailor subsequent treatment. 
Cholescintigraphy is the use of radiotracers to assess the anatomy and 
function of the biliary system, and liver indirectly. Currently this is most 
commonly performed with Tc99m-IDA analogues, for evaluation of different 
conditions including biliary atresia where it could be a problem solving tool.  
Learning Objectives: 
1. To understand the multimodality approach to gallbladder diseases. 
2. To be able to identify gallbladder cancer. 
3. To be able to differentiate benign conditions from the malignant ones. 
 
  
















08:30 - 10:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 921  
Emergency radiology II  
A-379 08:30  
A. Urinary system trauma  
V. Logager; Copenhagen/DK (vibeke.loegager@regionh.dk)  
According to the American Association of Surgeons in Trauma (AAST), 
approximately, 10% of all trauma admissions have kidney injuries. Blunt 
traumas can be graded in a 5-point Renal Injury Scale. On the basis of the 
patient’s clinical findings an imaging algorithm is set. In general, patients that 
are normotensive with microscopic hematuria have less than 0.2% risk of 
serious kidney damage and imaging is unnecessary, whereas patients with 
either: (A) gross hematuria, (B) microscopic haematuria and blood pressure 
less than 90 mmHg or occasionally, (C) microscopic haematuria will require 
imaging. Contrast-enhanced CT is the way to go. Imaging should be in 3 
phases (cortico-medullary, delayed 3-5 min and late phase (more than 10 min). 
Image reading should be by multiplane approach. Most of the findings do not 
require surgical intervention. But the rest do. On the basis of case 
presentations, findings will be analysed, discussed and correlated to the 
patient’s clinical status and treatment possibilities, including where and which 
signs to look for. Which modality could be used to solve the diagnostic problem 
when the clinical picture does not fit with the radiological picture. Relevant 
questions will be asked during this session for the participants to vote and the 
results will be discussed.  
Learning Objectives: 
1. To identify the signs of trauma. 
2. To outline the clinical impact of these findings. 
A-380 09:15  
B. Non-traumatic urinary tract emergencies  
G. Masselli; Rome/IT (gabrielemasselli@libero.it)  
Urinary tract (UT) obstruction secondary to urolithiasis is the most common 
urologic emergency in patients presenting with abdominal pain. Serious 
complications of acute obstruction include ureteral rupture, pyelonephrosis or 
abscesses. Radiologists need to define the extent of obstruction, its likely 
duration and whether an intervention is required, aware that ultrasound (US) is 
usually normal in case of acute onset. In such cases computerised tomography 
(CT) is the gold standard diagnostic tool. UT infection (UTI) is another common 
emergency and it may vary in severity, from ureteral to focal renal infection, 
emphysematous pyelonephritis or pyonephrosis. UTI diagnosis is usually 
clinical, but in case of uncertainty CT provides early diagnosis, outlining the 
extent and severity of the disease. Magnetic resonance diffusion-weighted 
imaging (DWI) is of particular value when differentiating pyonephrosis from 
simple hydronephrosis. DWI of the kidneys is highly sensitive for the detection 
of focal or diffuse infections, reason why is gaining more and more popularity. 
T2-weighted (static fluid) urography is performed in pregnant women to outline 
the ureters in their entirety. A challenge of MR urography is the differentiation 
between physiologic hydronephrosis and pathologic obstruction. Vascular UT 
emergencies include renal infarcts (commonly of thromboembolic origin), renal 
vein thrombosis (typical of hypercoagulable states and neoplastic patients), 
and spontaneous hemorrhage (due to angiomyolipoma rupture). These are 
among the most common non-traumatic UT emergencies and it is fundamental 
for every radiologist to be fully confident in their diagnosis. The role of each 
imaging modality will be interactively discussed in the different clinical 
scenarios. 
Learning Objectives: 
1. To understand the imaging technique. 






08:30 - 10:00 Room B 
Abdominal Viscera  
RC 901  
Imaging of benign liver lesions: still 
difficult?  
A-381 08:30  
Chairperson's introduction  
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es)  
Benign liver tumours are a heterogeneous group of lesions with different 
cellular origins and clinical relevance. In this session there will be an interesting 
discussion on the difficulties and imaging strategies to properly diagnose liver 
cysts, haemangiomas, FNH and adenomas. These benign lesions are 
frequently found incidentally during imaging exams perform for unrelated 
reasons. Most often they do have a benign course, but management difficulties 
might arise. Radiologist have to recognize the best radiological approaches in 
terms of modalities and the use of contrast media, the pearls and pitfalls 
commonly related to these lesions, the main radiological features and 
diagnostic criteria, and the epidemiological data, pathology, pathophysiology, 
and their natural progression. Radiological reports should also include 
recommendations for their management.  
Session Objectives: 
1. To understand the role of different imaging techniques in characterisation of 
focal liver lesions. 
2. To be aware of malignant lesions which may mimic benign liver conditions. 
3. To underline current guidelines for characterisation of equivocal liver lesions. 
A-382 08:35  
A. Hepatic cysts: always simple?  
I. Santiago; Lisboa/PT (ines.santiago@fundacaochampalimaud.pt)  
The differential diagnosis of cystic liver lesions is as broad as their clinical 
significance, which ranges from benign to malignant and/or potentially lethal 
conditions. These lesions include foregut and ductal plate malformations, 
infectious diseases, primary and secondary neoplasms and 
traumatic/iatrogenic fluid collections. The number of lesions, morphology, fluid 
content characteristics, presence/absence of septae and/or solid components 
are the key imaging features for the diagnostic approach and different imaging 
modalities pose different advantages and disadvantages for their 
characterisation. Given imaging characteristics may overlap between distinct 
conditions, patient history and laboratory data should be integrated to allow a 
more definitive diagnosis. 
Learning Objectives: 
1. To learn about different types of cystic lesions in the liver including giant 
biliary hamartomas or foregut cysts. 
2. To understand diagnostic approach to differentiate simple and complex 
cysts/cystic lesions. 
3. To appreciate advantages and limitations of imaging for differentiating 
simple cyst from other cystic lesions. 
A-383 08:58  
B. Liver haemangiomas and mimickers  
P.R. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org)  
Hemangioma is the most common benign tumor-like condition in the liver, with 
a prevalence up to 20% of the general population. Unfortunately its 
demographics (predominance in women, post-menopausal and without 
geographic distribution) is similar to that of other primary benign and malignant 
neoplasms and secondary malignancies. On the other hand, and fortunately, is 
one of the most successful focal liver lesions to be characterized by imaging. 
Particularly if a contrast agent is used. Hemangiomas have a (1) distinct 
morphology, (2) enhancement pattern and (3) signal characteristics by MRI 
scans. These 3 parameters allow the characterization of hemangiomas in 
almost all cases. This ease of characterization obviates in almost all cases the 
use of percutaneous biopsy. Image guided percutaneous biopsy particularly in 
superficial hemangiomas and using a true cut needle can have serious 
complications. Hemangiomas can have an atypical imaging appearance since 
they may contain cystic change, calcification, sclerosis and large central scars, 
particularly when giant (more than 10cm in size). There is overlap with some 
other focal lesions that mimic the imaging findings of hemangioma by all 
imaging modalities: (1) epithelioid hemangioendothelioma (2) angiosarcoma, 
(3) other vascular sarcomas and (4) treated breast cancer metastasis, which 
can present with a pseudohemangioma pattern. We offer throughout the 
presentation imaging/pathologic correlation approach to support the typical and 
  







atypical ultrasound, CT and MRI appearance of hemangioma and its major 
mimickers. 
Learning Objectives: 
1. To learn about typical imaging findings of liver haemangioma. 
2. To understand the atypical imaging findings of liver haemangiomas. 
3. To appreciate the role of multiparametric and liver-specific contrast MRI in 
differentiation between haemangiomas and malignant lesions mimicking 
haemangiomas. 
A-384 09:21  
C. FNH or adenoma?  
A. Ba-Ssalamah; Vienna/AT (ahmed.ba-ssalamah@meduniwien.ac.at)  
FNH and HCA are liver lesions of hepatocellular origin. Whereas FNH 
commonly occurs, HCA is very rare. Distinguishing FNH from HCA is of great 
importance clinically, as FNH is considered a benign lesion and needs no 
further management. In contrast, HCA, according to its subtype, can be 
considered a borderline tumor due to the risk of hemorrhage, growth, and even 
malignant transformation, and requires individualized management. The 
genotype/phenotype classification of HCA is an evolving issue and there is 
now a recent HCA molecular classification by which to stratify patients 
according to the risk of complications. On imaging, HCA is no longer a distinct 
entity and imaging features reflect the tumor subtypes. Contrast-enhanced MRI 
is much more accurate because of its ability to visualize the textural 
composition of the HCA. However, even after the administration of MRI 
hepatobiliary contrast agents, a small proportion of HCA subtypes still show 
either inhomogeneous uptake or inhomogeneous washout in the hepatobiliary 
phase (HBP); therefore, it is difficult to differentiate these subtypes from FNH 
on the basis of imaging presentation alone. This may pose a diagnostic 
dilemma as both FNH and HCA tend to occur in women of child-bearing age. 
Clinical presentation and risk factors, male gender, patient age, presence of 
storage disease, obesity, metabolic syndrome or inflammatory syndrome, 
hepatitis, alcohol abuse and tumour over 5 cms, as well as significant growth 
have been identified as factors associated with an HCA subtype of higher 
malignant potential. In difficult cases histological analysis remains the gold 
standard.  
Learning Objectives: 
1. To learn the imaging features associated with FNH and adenoma on 
contrast-enhanced CT and MRI. 
2. To understand how the imaging characteristics are related to the underlying 
pathological findings. 
3. To appreciate the optimal use of liver-specific contrast media for 
distinguishing between FNH and adenoma, and current classification and 
pathological characteristics and its impact on the management. 
Author Disclosure: 
  A. Ba-Ssalamah: Consultant; Bayer. Speaker; Bayer. 
09:44  
Panel discussion: What imaging strategy for my routine clinical practice?  
08:30 - 10:00 Room C 
New Horizons Session  
NH 9  
Immunotherapy: a revolution in cancer 
care?  
A-385 08:30  
Chairperson's introduction: What the radiologist needs to know  
V.J. Goh; London/UK  
Evasion of the immune system plays an important role in the development and 
progression of cancers. Cancer immunotherapies are a promising class of 
agents that re-engage the immune system in its fight against cancer cells. 
Strategies range from activating innate/adaptive immune effector mechanisms 
to neutralising inhibitory/suppressive mechanisms. For example, treatment with 
interleukin 2 (IL-2) or interferon- (IFN) stimulate effector immune cells; 
conversely antibodies against immune-checkpoint molecules, e.g., cytotoxic T 
lymphocyte-associated protein 4 (CTLA4)-targeted antibodies and 
programmed cell death 1 (PD1)-targeted antibodies neutralise immune 
suppressor mechanisms. Immunotherapies have been shown to be effective in 
a number of advanced cancers including melanoma, renal cancer, and non- 
 
 
small cell lung cancer. As immunotherapies generate anti-tumour effects by 
enhancing tumour-specific T cell responses rather than the direct cell killing, 
response assessment may be challenging. Response may take longer to be 
detectable by imaging and standard methods, such as response evaluation 
criteria in solid tumours (RECIST) may be misleading. In this session the role 
of imaging will be explored and future directions considered. 
Session Objectives: 
1. To be familiar with the concept of immunotherapy. 
2. To be aware of the current imaging methods for assessing 
immunotherapies. 
3. To learn about new methods in development for assessing 
immunotherapies. 
Author Disclosure: 
  V.J. Goh: Research/Grant Support; Siemens Healthineers. Speaker; Bayer, 
Siemens Healthineers. 
A-386 08:40  
CT: looks bigger, but it's better  
C. Dromain; Lausanne/CH (Clarisse.Dromain@chuv.ch)  
A wide range of cancer immunotherapy approaches have been developed 
including non-specific immune-stimulant such as cytokines (Interferon, IL2), 
cancer vaccines (peptide or dendritic cell-based vaccines), adoptive T-cell 
therapy (TILs, CAR, TRC) and immune checkpoint inhibitors (anti CTLA-4, anti 
PD1 and anti PDL1). The most commonly used and intensively studied are the 
immune checkpoint inhibitors (ICIs). Their mechanism of action signifies a true 
shift in oncology where instead of targeting the tumor cells, ICIs target the 
immune system to break the cancer tolerance and stimulate the anti-tumor 
immune response. These new drugs have, since 2011, received marketing 
authorisation for melanoma, lung, bladder, renal, and head and neck cancer 
with remarkable and long-lasting treatment response. The novel mechanism of 
action of these drugs, with immune and T-cell activation, lead to unusual 
patterns of response with presence of flare phenomenon or pseudo-
progression more pronounced and more frequent than previously described 
responses. Pseudo-progression, that has been described in about 3-10% of 
patients treated using ICIs, corresponds to increase of tumor burden and/or 
appearance of new lesions due to Infiltration of the tumor by activated T cells 
before the disease responds to treatment. To overcome the limitation of 
RECIST criteria to assess this specific changes in tumour burden, new criteria 
so-called irRC and then irRECIST were proposed. The major modification 
involved the inclusion of the measurements of new target lesions into disease 
assessments and the need of a 4-week CT re-assessment to confirm 
progression. More recently (2017) a consensus guideline iRECIST was 
developed by the RECIST working group.  
Learning Objectives: 
1. To be aware of the different types of immunotherapies and to understand 
their mode of action. 
2. To understand the limitations of RECIST and be aware of immune response 
criteria. 
3. To understand the limitations of CT for assessment of immunotherapies. 
A-387 09:03  
The MR armoury in follow-up  
D.-M. Koh; Sutton/UK (dowmu.koh@icr.ac.uk)  
Drugs that modulate the body immune responses are being utilised to treat a 
range of cancers, including malignant melanoma, non-small cell lung cancer, 
hepatocellular and bladder carcinomas. In patients receiving immunotherapies, 
CT is still the most widely used imaging technique for assessing tumour 
response to treatment and to identify drug related side-effects. However, 
anatomical MR imaging can also be effectively applied to evaluate tumour 
regression with treatment using size measurement criteria (e.g., iRECIST). Like 
CT, increase in tumour size may be observed on MRI in pseudo-progression, 
which can confound response assessment. Nonetheless, the superior soft 
tissue contrast of MRI helps to depict subtle disease (e.g., intracranial) and 
specific complications (e.g., hypophysitis) that are difficult to visualise on CT. 
There is great interest in applying quantitative MR imaging, including whole 
body MRI techniques, to study functional changes in tumour cellularity 
(diffusion-weighted MRI), vascularity (contrast-enhanced MRI) and 
macromolecules (magnetisation transfer). These are areas of on-going 
research. Whole body MRI can provide information about inter-tumoural 
heterogeneity, thus allowing insights into tumour evolution and differential 
response to treatment. Active research in molecular probes is being 
undertaken to develop PET imaging tracers that can identify and predict 
treatment response, which can be explored alongside multi-parametric MRI 













1. To be aware of the advantages and limitations of MRI for assessment of 
immunotherapies. 
2. To describe the potential role of whole-body MRI and quantitative MRI 
techniques in follow-up. 
3. To consider the potential of integrated MRI/PET for the assessment of 
immunotherapies. 
A-388 09:26  
Systemic and immunologic effects of image-guided interventions in 
oncology  
S.N. Goldberg; Jerusalem/IL (sgoldber@bidmc.harvard.edu)  
Although interventional oncologists have traditionally assumed that our local 
therapies including tumor ablation and chemoembolization have minimal 
systemic effects, there is increasing compelling animal evidence to back up 
anecdotal clinical reports suggesting that these therapies can stimulate distant 
effects and can potentially have more widespread effects than just eliminating 
a focal tumor. On the positive side, several studies have reported that tumor 
ablation can, under poorly defined “favorable” conditions, induce systemic 
immunologic “abscopal” effects that induce distant tumor regression. Thus, 
several groups are pioneering combining interventional oncologic procedures 
with immunotherapies with the express goal of stimulating immune anti-cancer 
responses. Simultaneously and by contrast, we and others have demonstrated 
that radiofrequency and other therapies can in some cases also cause 
increased cancerous effects by inducing tumor initiation and progression in 
non-ablated areas. For liver ablation, this has been linked to an increased 
inflammatory response including cellular recruitment of neutrophils, 
macrophages, and activated myofibroblasts to the peri-ablated zone and 
several pro-tumorigenic cytokines such as IL-6 and HGF that increase 
following ablation. Thus, in all likelihood, there is a balance between pro-
oncogenic and pro-immunogenic effects that differs from patient to patient. 
Thus, our ultimate goal - achievable only through additional mechanistic study - 
should be to alter the post-ablation milieu to prevent any untoward tumorigenic 
effects while simultaneously promoting desired abscopic effects.  
Learning Objectives: 
1. To be aware of abscopal effects with immunotherapy. 
2. To describe how focal therapies can be combined with immunotherapies. 
3. To be aware of the challenges of focal treatments for systemic effects. 
Author Disclosure: 
  S.N. Goldberg: Consultant; Angiodynamics, XACT Robotics, and Cosman 
Instruments. Research/Grant Support; Angiodynamics, XACT Robotics. 
09:49  
Panel discussion: How should radiology improve imaging to support this 
revolutionary care?  
08:30 - 10:00 Room O  
Paediatric  
RC 912  
Dose reduction: tips and tricks  
Moderator:  
C. Granata; Genoa/IT  
A-389 08:30  
A. Dose reduction in paediatric CT  
D. Aadnevik; Bergen/NO (daniel.aadnevik@helse-bergen.no)  
Computed tomography (CT) is an invaluable tool in diagnostics and the use of 
CT has rapidly increased since the 1970s. Ionising radiation can damage 
human tissues, and is associated with an increased risk of cancer. The effect is 
of particular concern in children as they have a higher radiosensitivity and 
longer life expectancy. Modern CT scanners have a high level of 
automatisation regarding acquisition parameters which may leave the imaging 
professionals insecure whether the radiation dose is appropriate for the 
diagnostic task at hand. Studies have shown that in some cases adult 
protocols are directly implemented in paediatric imaging, resulting in 
unnecessary high doses. As radiation professionals, it is our duty to keep the 
radiation dose as low as reasonably achievable (ALARA). It is important to 
have a basic understanding of how technical factors influence image quality 
and how to properly balance the output parameters of the scanner in 
accordance with the ALARA-principle. A review of how the basic imaging 
parameters like tube-current (mA) and tube voltage (kV) affect image quality 
and patient dose will be given. The use of technique charts and size-specific 
dose estimates (SSDE) as a tool to ensure appropriate dose levels and 
consistent image quality for children will be explained. Examples from local 
optimization studies will also be shown, and a brief review of some vendor-
specific solutions for dose reduction will be given.  
Learning Objectives: 
1. To explain the factors that affect patient radiation exposure from CT exams. 
2. To discuss the importance of dose reduction in paediatric CT. 
3. To give an overview of CT dose-reduction strategies and techniques. 
A-390 09:00  
B. Diagnostic reference levels in paediatric imaging: international 
recommendations  
R. Seuri; Helsinki/FI (raija.seuri@hus.fi)  
The small number of paediatric patients is a challenge to the optimization of 
imaging protocols. Optimization of parameters and image quality for children of 
all sizes requires both time and expertise, which might not be easy to find in 
daily practice. Diagnostic reference levels (DRLs) are a tool to help the 
optimization process. DRLs are used by collecting patient dose values and 
comparing the median value to the reference level. In this comparison dose 
should always be considered together with the indication of imaging and image 
quality. Diagnostic reference levels were introduced already in 1990s, but only 
recently have the challenges of paediatric imaging got more attention in the 
international recommendations. The huge variation of sizes of paediatric 
patients has usually been tackled by establishing DRLs for different age-
groups. Now both ICRP and EC recommend the use of weight for grouping of 
paediatric patients. Instead of different groups, also a continuous DRL-curve 
can be used. Detailed advice for the use of DRLs in practice is included in the 
recent international publications. The international guidelines also provide 
recommended dose metrics for each modality to be used in DRL comparison. 
By European recommendation the National DRLs should be based on 
collection of doses from representative institutions in the country, not phantom 
measurements. The European DRLs offer a guidance level for optimization in 
those countries which have not yet established their National DRLs. The most 
recent European guidelines including the paediatric DRLs were published by 
the EC in 2017. 
Learning Objectives: 
1. To discuss the need for establishing diagnostic reference levels (DRLs) in 
paediatric diagnostic imaging. 
2. To give an overview of DRL values for typical paediatric examinations. 
3. To understand the way of implementation and use of DRLs in dose 
reduction and protocol optimisation. 
A-391 09:30  
C. The impact of dose management systems  
L.A. Rainford; Dublin/IE (louise.rainford@ucd.ie)  
It is mandated by European directive that the establishment and use of DRLs is 
fulfilled by all member states. Existing levels of dose information varies across 
imaging sub-specialities, as evidenced by the recent European PiDRL project. 
Specific challenges continue to confound paediatric dose data collections, 
including: reduced frequency of examinations compared to adults, patient 
age/weight/size variations, procedural variability and varied data survey 
methodologies. Increasing numbers of dose tracking software packages, 
including those providing web-based dose data collection, tracking and 
analytics are available. These systems although varied in scope of content 
offer services, including: dose documentation; dose reference levels setting; 
performance benchmarking; imaging protocol management; and outlier 
identification. An overview of products and their management of big data will 
be provided. Furthermore the current clinical reality that substantial amounts of 
both unstructured and structured dose data is routinely being captured, with 
the employment of varied mechanisms of data recording, will be evidenced. 
Why this information is potentially not being used optimally will be discussed, 
as will communication matters relevant to dose management products. 
Practical issues relevant to clinical data required for dose and imaging protocol 
evaluation will be incorporated based on feedback from a number of European 
sites. Finally the role of dose management systems in the review of population 
dose data and protocol optimisation will be discussed and the potential barriers 
to the successful completion of multi-centre surveys will be considered.  
Learning Objectives: 
1. To discuss the importance of dose monitoring in paediatric imaging. 
2. To have an overview of the features and functions of dose-monitoring 
systems. 
3. To understand the role of dose-monitoring systems in the evaluation of 











08:30 - 10:00 Room N  
Cardiac  
RC 903  
Novel ways to characterise myocardial 
tissue: T1 and T2 mapping  
Moderator:  
L.P. Lawler; Dublin/IE  
A-392 08:30  
A. T1 mapping: technical considerations  
M.R. Makowski; Berlin/DE (marcus.makowski@charite.de)  
This lecture will introduce the physical principles of T1 mapping for the 
characterisation of the left ventricular myocardium. Different MR sequence 
types for the acquisition of T1 mapping will be discussed. The technical 
challenges of T1 mapping will be highlighted and strategies to overcome these 
challenges will be introduced. The evaluation of datasets derived from T1 
mapping will be discussed. The clinical relevance of T1 mapping techniques in 
the context the different myocardial diseases will be highlighted.  
Learning Objectives: 
1. To learn about the principles of T1 mapping. 
2. To learn about specific issues of T1 mapping. 
3. To learn how to do and assess T1 mapping. 
A-393 09:00  
B. T2 mapping: technical considerations  
C. Tessa; Lido di Camaiore/IT (ctessa@sirm.org)  
Cardiac T2-mapping is a technique that allows to measure myocardial T2 
relaxation time. To this purpose, T2-prepared steady-state free-precession 
sequences, turbo-spin-echo or gradient-spin-echo sequences with a minimum 
of 3 source images can be employed. T2 mapping sequences can be acquired 
both in breath-hold or during free breathing, utilizing respiratory navigators. 
Cardiac motion is normally avoided by acquiring for a short duration at end 
diastole, but it is also possible to obtain the maps in systole. Motion correction 
algorithms are usually applied to source images to compensate for image-to-
image displacement. T2 maps are often acquired on a short-axis view at basal 
and mid-ventricular level. At apical levels, long-axis views should be preferred 
to avoid partial-volume effects. T2 maps can be analyzed both visually and 
quantitatively, by means of ROIs or automatic thresholds. Small ROIs (<20 
pixels) should be avoided. The reproducibility of T2 mapping sequences is very 
good. However T2 relaxation time is very sensitive to cofactors and it is 
therefore, necessary to generate reference values specific for each site, 
technique and imaging setting. In clinical report, the local reference ranges 
(mean ±2 standard deviations of the normal data) should be quoted. 
Additionally, phantom-based periodic control of the CMR system is 
recommended. Until recently, T2 mapping sequences have not been 
commercially available, and therefore, current recommendations rely mainly on 
single-center studies. Nevertheless, there is now growing evidence on the 
clinical value of T2 mapping, that is expected to become part of a routine 
cardiac MR examination.  
Learning Objectives: 
1. To learn about the principles of T2 mapping. 
2. To learn about specific issues of T2 mapping. 
3. To learn how to do and assess T2 mapping. 
A-394 09:30  
C. Clinical use of T1 and T2 mapping  
J. Bremerich; Basle/CH (jens.bremerich@usb.ch)  
Comprehensive tissue characterisation is a unique feature of cardiac MRI. 
Today, a variety of quantification sequences are available as clinical tools. This 
paper shall illustrate clinical applications of T1- and T2-mapping techniques. 
Late Gadolinium enhanced MRI (LGE-MRI) opened the door to scar imaging, 
today even more refined techniques such as T1- and T2-mapping have 
matured to clinical tools. The combination of pre- and postcontrast T1-mapping 
might even be used to calculate extracellular volume (ECV), when hematocrit 
is measured from blood samples. Contrast enhanced T1-mapping enables 
assessment of structural changes such as in mild inflammation. ECV enables 
detection and quantification of fibrosis such as in treatment with cardiotoxic 
medication or infiltrative diseases such as amyloidosis. It should be 
emphasized, however, that normal T1-values may vary among sequences and 
magnets. This explains the requirement to establish normal values for every 
hardware and sequence system. Moreover, T1-times at 3 Tesla are typically 
longer than at 1.5 Tesla. T2-mapping helps to identify tissue edema as an 
unspecific imaging marker of myocardial injury. Moreover, T2*-mapping is used 
to measure iron overload of the heart in hemosiderosis or haematologic 
diseases. Detailed myocardial tissue characterization with T1- and T2-mapping 
has matured to a robust clinical tool and adds value to cardiac MRI. 
Learning Objectives: 
1. To learn about the main fields of application for T1-T2 mapping. 
2. To learn the specific parameters useful for the clinical implementation of T1-
T2 mapping. 
3. To understand the incremental value of T1-T2 mapping over current 
methodologies. 
08:30 - 10:00 Studio 2018  
Special Focus Session  
SF 9a  
Focal treatment of prostate cancer  
A-395 08:30  
Chairperson's introduction  
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de)  
PSA-screening has led to a higher detection rate of localized, early stage 
prostate cancer. In this situation whole gland treatment by radical 
prostatectomy could bear the risk of overtreatment with side effects that may 
significantly reduce quality of life. To reduce the treatment-related toxicity, 
alternative therapy options causing less damage of prostate tissue and 
adjacent structures are increasingly considered. Hemiablation and focal 
ablation therapies are delivered with intention to cure and are on principle 
achievable for patients with localised PCa. But a lot of open questions still exist 
concerning e.g. eligibility criteria of patients, preinterventional diagnostic 
workup, type of ablation therapy, need for additional treatment, etc. This 
session will provide the current knowledge about opportunities and challenges 
of focal therapy of prostate cancer The role of imaging for diagnosis and 
image-guided interventions by high-intensity ultrasound (HIFU) and irreversible 
electroporation (IRE) will be discussed in detail.  
Session Objectives: 
1. To recognise the demand for minimal invasive therapy of prostate cancer. 
2. To understand the technologies as well as the pros and cons of focal 
therapies. 
3. To be aware of the value of multiparametric MRI for planning and guidance 
of focal therapy. 
A-396 08:35  
Focal treatment of prostate cancer: opportunities, challenges and 
indications  
R. Sanchez-Salas; Paris/FR (rafael.sanchez-salas@imm.fr)  
Focal therapy (FT) has emerged as an alternative to whole-gland radical 
treatments with the objective to reduce treatment-related toxicity by sparing 
prostatic tissue. The FT approach stands on the concept of identifying and 
treating de index lesion. Selection criteria, optimal treatment modalities and 
follow-up strategies remain divergent across published series. A recent 
consensus from field-experts brings guidance to focal treatment strategies in 
PCa while standardizing the selection criteria and follow-up schemes. Efforts 
are being made to improve di agnostic tools to optimize patient selection. 
Multiparametric MRI represents the cornerstone imaging tool for guided 
diagnostic, treatment and follow-up of these patients. With further development 
of image-guided diagnostics and deployment of transperineal prostate mapping 
(TTMB) and MRI-ultrasound fusion biopsies, the histological accuracy at 
diagnosis has increased with optimal risk definitions and patient selection. 
Post-ablation surveillance protocols entail monitoring residual post-ablated and 
preserved tissue. It should be noted that while serum prostate-specific antigen 
(PSA) kinetics is considered a reliable tool for following patients after local 
whole-gland treatment, its role after focal therapy is yet to be defined and the 
thresholds for defining success and failure have not been defined. Key energy 
sources delivering FT for PCa include cryotherapy, high-intensity focused 
ultrasound (HIFU), irreversible electroporation (IRE), photodynamic therapy 
(PDT) and focused laser ablation. In the future, the natural history of non-index 
lesions in the post ablative setting needs to be addressed. Combined 
immunological or hormonal interventions could be considered to further 
improved cancer control of FT.  
Learning Objectives: 
1. To learn the conceptual possibilities and limitations of focal therapy for 
prostate cancer. 
2. To understand indications and patient selection criteria. 
3. To know achievable cure rates, possible causes for failure and treatment-
related toxicity. 
  








  R. Sanchez-Salas: Consultant; EDAP-TMS. Speaker; EDAP-TMS. 
A-397 08:52  
Imaging of prostate cancer: how accurately can prostate cancer be 
localised?  
C. Allen; London/UK (clare.allen@uclh.nhs.uk)  
Successful focal treatment of prostate cancer requires accurate anatomical 
localisation which can only be provided by Mp MR. Exclusion of disease in the 
rest of the prostate is also essential. Mp MRI technique is well established and 
documented in Pirads vs2. However despite this scan quality remains variable. 
The assessment of quality will be discussed along with the current status of 
tumour detection within the gland. The size, position and concordance of the 
MR target with histological target will be discussed. Critical to the success of 
focal ablation is the communication of a well defined target. The various 
techniques available to deliver this are discussed along with contouring 
techniques.  
Learning Objectives: 
1. To know the examination protocol and the required quality standard of 
multiparametric MRI. 
2. To recognise opportunities and limits of prostate MRI for cancer localisation 
and delineation. 
3. To learn about standardised reporting necessary for precise communication 
with urologists. 
A-398 09:09  
Image-guided focal treatment using high-intensity ultrasound (HIFU)  
S. Crouzet; Lyon/FR  
"no abstract submitted" 
Learning Objectives: 
1. To understand the technology of image-guided high-intensity focused 
ultrasound (HIFU). 
2. To recognise the value of MRI for treatment planning and guidance. 
3. To learn about indications, achievable therapeutic results and side effects. 
A-399 09:26  
Image-guided focal treatment using irreversible electroporation (IRE)  
F. Collettini; Berlin/DE (federico.collettini@charite.de)  
In recent years, focal therapy of prostate cancer has gained great interest from 
both health care professionals and patients. Irreversible electroporation (IRE) 
has emerged as a promising technique for tumor ablation and is currently one 
of the most intensively studied technologies. IRE refers to the generation of 
permanent, nanoscale pores in the cell membrane by ultra-short, high voltage 
impulses, resulting in cell death. Features that make this technique particularly 
attractive comprise its negligible thermal effect on tissue and the lack of 
connective tissue destruction distinctive of thermal ablative techniques. 
Available data from clinical studies indicate IRE as a safe and feasible 
technique for treatment of selected patients suffering from localized prostate 
cancer, with limited genitourinary toxicity and promising short-term oncological 
results. Herein we will to review the rationale, as well as the preclinical and 
clinical data supporting the use of IRE for the treatment of prostate cancer. 
Furthermore, we will discuss the importance of patient’s selection and 
pretreatment workup with emphasis on the value of magnetic resonance 
imaging (MRI) for treatment planning.  
Learning Objectives: 
1. To understand the technology of irreversible electroporation (IRE). 
2. To recognise the value of MRI for treatment planning and guidance. 
3. To learn about indications, achievable therapeutic results and side effects. 
Author Disclosure: 
  F. Collettini: Advisory Board; Guerbet. Grant Recipient; Berlin Institute of 
Health (BIH), German–Israeli Foundation for Scientific Research (GIF). 
Research/Grant Support; Boston Scientific, PharmaCept, Guerbet. Speaker; 
PharmaCept, Bayer Helathcare, Siemens, Abbott. 
09:43  
Panel discussion: Can focal therapy already be recommended to prostate 




08:30 - 10:00 Room L 8  
ESR Research Committee Session  
How to foster clinical research in imaging 
departments 
Moderator:  
O. Clément; Paris/FR  
A-400 08:30  
Results of the ESR Survey on European Research  
O. Clément; Paris/FR (olivier.clement@aphp.fr)  
A survey about the imaging research was launched by the European Society of 
Radiology in october 2017. There was questions about: (1) preclinical imaging 
research and small animal imaging platforms. (2) clinical research with the 
radiologist as a provider of imaging for the clinician. (3) imaging research 
performed by the radiologist. The results of the survey will be presented, future 
actions for the development of research in radiology will be discussed.  
Learning Objectives: 
1. To learn about the results the European survey on research. 
2. To understand how preclinical and clinical research in radiology is organised 
in Europe. 
3. To appreciate the differences between countries. 
A-401 08:50  
An overview of the roles of radiographers in research  
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie)  
Research and evidence-based practice (EBP) underpin modern health care 
and can lead to enhanced patient safety, improved patient outcomes, and 
efficiencies in service delivery. The contribution of radiographers, academic 
and clinical, to this evidence through undertaking quality research, on any 
scale, and subsequent dissemination is essential and will also serve to raise 
the profile and standing of radiography beyond our profession. Radiographers 
are much more than facilitators, or data providers, in medical imaging research 
and some of the leading radiography researchers in the world can be found in 
Europe. These individuals lead large research groups, successfully compete 
for national and international research funding, collaborate beyond their 
profession, and publish in high-impact peer-review journals. In 2016, the 
European Federation of Radiographer Societies (EFRS) published a Statement 
on Radiography Research in Europe which clearly sets out the EFRS position 
on encouraging, supporting and developing high-quality radiographer-led 
research to strengthen the knowledge base underpinning our profession. This 
statement, together with the 2015 Statement on Evidence-Based Practice in 
the Undergraduate Curriculum and the European Qualifications Framework 
(EQF) Level 6 (bachelors) and Level 7 (masters) Benchmarking documents for 
radiographers, clearly sets out the importance of a clear research focus on 
educational programmes. Radiographers can add value at all stages of the 
research process and for medical imaging research to have a true impact, and 
to benefit our patients it must be inclusive and multidisciplinary and span the 
academic-clinical divide.  
Learning Objectives: 
1. To learn about radiographer roles in research studies. 
2. To explore the current status of research education and training for 
radiographers across Europe. 
3. To appreciate the added value radiographers can bring to imaging research. 
A-402 09:10  
How to structure a research management unit in an imaging department  
S. Mallard; Bordeaux/FR (Sabine.mallard@chu-bordeaux.fr)  
To structure imaging platforms in our hospitals is a necessity to meet the 
current criteria of quality insurance in clinical research. Strengthening 
optimisation and harmonisation of organisations and practices in our imaging 
departments will increase their attractiveness to pharmaceutical and industrial 
companies and will provide better chances of success in research calls. 
Management of such a research unit requires conciliating perspectives of 
business management, administrative rationalisation and scientific interests. 
The purpose of this presentation is to report the experience of implementing a 
research unit in the imaging department of the University Hospital of Bordeaux 
since 2011.  
Learning Objectives: 
1. To learn about the role of a specific imaging research unit in an imaging 
department. 
2. To understand how to structure a research unit in an imaging department. 
3. To appreciate the results in terms of quality and performance. 
  







A-403 09:30  
Implementing quality imaging in multicentre trials  
Y. Liu; Brussels/BE (yan.liu@eortc.be)  
Imaging is a key component of clinical cancer research and essentially used 
for trial eligibility confirmation and response assessment in most cases. 
Nevertheless, difficulties associated with integrating imaging biomarkers into 
trials have often been ignored, especially for sites that are not familiar with 
imaging biomarker driven studies. The principles of imaging quality assurance 
ad quality control (QA/QC) are therefore critical to be embedded in 
infrastructure to guarantee therapeutic progress, taking into account inherent 
challenges in the complexity of imaging technologies, standardisation of image 
acquisition across multivendor platforms, and various post-processing options 
available with advanced software. Ignorance of these pitfalls has a direct 
negative impact on the quality of the imaging read-out, even leading to trial 
failure. The imaging modality by which QA is applied varies substantially within 
and across the disciplines. The imaging quality requirements should be 
adapted to the role of imaging, disease types, feasibility, and potential 
variability of imaging readout, additionally with full operational support through 
the entire conduct of the trial. In this regard, a risk-based framework is practical 
and recommendations for trials driven by imaging biomarkers will be 
introduced in this presentation, including identification of risks at trial initiation 
to better allocate resources and prioritise key tasks. 
Learning Objectives: 
1. To learn about the role of imaging in clinical trials. 
2. To understand the importance of imaging standardisation in multicentre 
trials. 
3. To appreciate the implementation of quality imaging based on risk 
assessment. 
09:50  
Panel discussion: How to structure imaging departments for clinical 
research?  
08:30 - 10:00 Room E1  
Breast  
RC 902  
Minimally-invasive local treatment of 
breast cancer: the time is now  
A-404 08:30  
Chairperson's introduction  
A. Athanasiou; Athens/GR (aathanasiou@mitera.gr)  
Breast cancer management has been evolving toward minimally invasive 
approaches. Image-guided percutaneous biopsy techniques can provide 
accurate histologic diagnosis thus replacing open surgical biopsies in more 
than 90% of cases. Breast conservation therapy has become the treatment 
standard for early-stage breast cancer. Sentinel lymph node biopsy has 
replaced routine axillary lymph node dissection in selected cases. Is treating 
early breast cancer without surgery the next challenge? For liver metastases, 
treatment by means of ablative techniques has widely replaced surgery. Is 
there any place for minimally invasive treatment of early breast cancer? During 
this course three main procedures will be presented, and current possible 
indications, advantages and disadvantages will be analyzed. These 
procedures include radiofrequency ablation, high intensity focused ultrasound 
ablation, and cryotherapy ablation. They may offer effective tumor 
management in selected cases (small<2cm tumors, elderly patients) and 
provide treatment options that are psychologically and cosmetically more 
acceptable than traditional surgery. By means of excessive local heating or 
freezing under imaging guidance, these procedures can cause cell death and 
tumor destruction. Surgical excision remains the standard local treatment of 
breast cancer. However, these procedures may represent an interesting 
alternative of successful treatment in selected cases. Large prospective trials 
should evaluate the efficacy, cost-effectiveness, cosmetic results and long-
term outcome of minimally invasive, imaging-guided local treatments compared 
with traditional open surgery approach. 
Session Objectives: 
1. To learn about HIFU, radiofrequency ablation and cryotherapy that 
challenge traditional surgical excision in the management of breast cancer. 
2. To become familiar with role of imaging in using these new technologies. 
3. To understand the potential advantages and disadvantages for each of 
these techniques. 
A-405 08:35  
A. High-intensity focused ultrasound (HIFU) therapy  
F. Pediconi; Rome/IT (federica.pediconi@uniroma1.it)  
Surgical treatment of breast cancer has changed overtime, evolving from 
radical mastectomy to more conservative approaches. This has been possible 
thanks to technical advantages in the field of diagnostic imaging that allowed 
early diagnosis of breast cancers with very small dimensions. Mini-invasive 
technologies (radiofrequency ablation, cryoablation, etc.) can preserve the 
original breast volume avoiding glandular resections and surgical scars and 
ensuring at the same time complete tumor ablation. Ablation with high-intensity 
focused ultrasound (HIFU) is based on the use of an extra-corporeal 
ultrasound transducer that selectively destroys target tissue avoiding thermal 
damages to surrounding structures. The technique can be performed under 
ultrasound or magnetic resonance (MR) guidance. MR guidance offers several 
advantages that improve safety and efficacy of the procedure: a visualization of 
the planned US beam during each phase of the procedure, a real-time 
monitoring of the progressive temperature increase within the target tissue and 
surrounding tissues, an accurate treatment planning, an evaluation of the 
treatment efficacy thanks to the use of intravenous gadolinium-based contrast 
agent. HIFU ablation of breast cancer is a new and promising technique that 
deserves large interest in the field of clinical research in order of its potential 
application in the clinical practice.  
Learning Objectives: 
1. To learn about the basics of HIFU therapy. 
2. To become familiar with the different types of imaging guidance. 
3. To appreciate its role in treating benign and malignant lesions. 
A-406 09:00  
B. Radiofrequency ablation therapy  
B. Brkljai	; Zagreb/HR (boris@brkljacic.com)  
Radiofrequency ablation (RFA) is a promising, but quite rarely used minimally 
invasive modality to treat small breast cancer in patients in whom general 
anaesthesia is contraindicated or who refuse surgery. In most studies, cancers 
were surgically excised shortly after RFA. In very few studies, RFA was used 
as the only treatment modality, instead of surgery. The procedure is most 
conveniently performed under ultrasound guidance, in local analgesia, which 
allows constant contact with the patient during the procedure. Precise 
preprocedural imaging is crucial, and should include contrast-enhanced MRI in 
addition to mammography and ultrasound. Preprocedural core biopsy is 
mandatory, with the precise assessment of the tumour type, grade, and 
immunohistochemical features. Typical US findings of hyperechogenicity of 
ablated mass are noted during the procedure. Postprocedural mammographic 
and MRI findings are characteristic and will be presented. The complete 
ablation can be achieved in small T1-2 N0 M0 breast cancers that present as 
masses of maximum 2-3 cm in diameter, with the sufficient distance from the 
skin and pectoral muscle to avoid the thermal lesion of these tissues. In larger 
lesions only partial ablation may be achieved. Only solitary, unicentric, invasive 
ductal cancers, preferably ER/PR positive should be treated. Invasive lobular 
cancers should not be treated with RFA. Our results will be presented in a 
small group of patients who were treated with RFA, and who refused surgery, 
had contraindication to general anaesthesia and opted for RFA. The technique, 
preprocedural, intraprocedural and postprocedural imaging findings, as well as 
long-term result will be presented.  
Learning Objectives: 
1. To learn about how radiofrequency works. 
2. To become familiar with its use in clinical practice. 
3. To appreciate the advantages and disadvantages. 
A-407 09:25  
C. Cryotherapy  
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at)  
Cryotherapy is a new, minimal-invasive image-guided treatment option for 
breast tumours. A specific 12-17G probe is applied into the tumour. Argon gas 
making use of the Joule-Thomson effect cools down the needle tip to minus 
187 degrees centigrade. An ice ball covering lesion and an adequate safety 
margin is formed. Coagulative necrosis of the tumour cells after two freezing 
cycles is the result. Cryoablation for breast tumours can be performed under 
US, CT or MRIguidance. Several studies showed an overall success rate of 
more than 90%. Indications for cryotherapy are small tumours, 
contraindications to general anaesthesia or increased risk of complications, 
support of standard therapies and palliative approach. Cryotherapy can be 
performed under local anaesthesia on out-patient basis with a potential better 
cosmetic outcome than standard surgical therapies. Minimal-invasive therapies 
ask for a paradigm-shift as the eradicated tumour is left in situ and resection 
with clear margins will not be proven histopathologically, but functionally by MR 
imaging. It is important to emphasize that radiology is not aiming to take over 
  







therapy of breast cancer patients but to help with innovative, less invasive 
treatment options as a member of a multidisciplinary team. Close cooperation 
with our clinical partners (surgery, gynaecology, oncology, radiation therapy, 
etc.) is the key to success and avoidance of turf battles. The goal for the future 
should be minimal-invasive ablation therapy for breast cancer as a valid 
therapeutic option.  
Learning Objectives: 
1. To learn about cryotherapy technique. 
2. To become familiar with its use in clinical practice. 
3. To appreciate its role in treating benign and malignant lesions. 
09:50  
Panel discussion: How can we overcome resistance of clinical partner 
specialties to refer eligible women to radiology?  
08:30 - 10:00 Room E2  
Neuro  
RC 911  
Cerebrovascular disease  
Moderator:  
J.-F. Meder; Paris/FR  
A-408 08:30  
A. Vascular distribution territories: arterial and venous  
T. Engelhorn; Erlangen/DE (Tobias.Engelhorn@uk-erlangen.de)  
After a short overview on the vascular anatomy of the brain with a focus on 
vascular distribution territories, the main focus of this talk is to present 
neurovascular pathologies closely associated with arterial and venous vascular 
distribution territories. One focus is also put on the acute stroke and 
subsequent patient selection for interventional stroke therapy. Another aim is to 
provide a better understanding of pathophysiology of different neurovascular 
diseases in an interactive matter. In addition, advantages and limitations of 
CTA, flat-panel CTA and MRA compared to conventional angiography are 
presented.  
Learning Objectives: 
1. To become familiar with the vascular anatomy of the brain. 
2. To understand the advantages and limitations of CTA and MRA. 
3. To recognise the different imaging patterns in stroke and their prognostic 
value. 
A-409 09:00  
B. Arterial dissection and vasculitis  
L. van den Hauwe; Antwerp/BE (lucvdhauwe@mac.com)  
Cerebrovascular disease may arise from diverse vessel wall pathologies such 
as atherosclerosis, dissection, and vasculitis. Careful evaluation of the supra-
aortic vessels from the aortic arch through the intracerebral vessels is 
mandatory in all stroke patients, especially in young stroke patients as the 
second most common cause of stroke in the young is cervicocerebral arterial 
dissection accounting for 10-25% of ischemic strokes. Reversible cerebral 
vasoconstriction syndrome (RCVS) and CNS vasculitis are two distinct disease 
entities with overlapping presenting symptoms. Conventional vascular imaging 
techniques such as DSA, MRA, and CTA fail to distinguish both entities, as a 
result of shared nonspecific luminal findings. More recently, there is a growing 
interest in high-resolution MRI vessel wall imaging that allows direct 
characterization of the vessel wall abnormalities. Distinct spatial characteristics 
of arterial wall thickening and wall enhancement have been described. 
Moreover, differences in the temporal evolution exist with a long period of 
stable persisting arterial wall findings for CNS vasculitis compared with a 
shorter period of resolution of vessel wall abnormalities for RCVS. Also these 
techniques can help to differentiate vasculitis from other causes of 
vasculopathy, such as atherosclerosis.  
Learning Objectives: 
1. To learn how to image dissections of the neck vessels and intracranial 
arteries. 
2. To learn about the imaging features of cerebral vasculitis and how to 
differentiate it from reversible cerebral vasoconstriction syndrome. 
3. To become familiar with the most important causes of secondary vasculitis, 
including infectious causes such as TB and HIV. 
Author Disclosure: 
  L. van den Hauwe: Consultant; icometrix, Leuven/BE. 
 
A-410 09:30  
C. Cerebral perfusion studies in cerebrovascular disease: techniques, 
indications and applications  
H.R. Jäger; London/UK  
"no abstract submitted" 
Learning Objectives: 
1. To understand how advanced imaging can help select patients for treatment 
of acute ischaemic stroke. 
2. To show the importance of collateral flow in ischaemic patients. 
3. To discuss the current evidence-based medicine (EBM) for treatment of 
patients with acute ischaemic stroke. 
08:30 - 10:00 Room F1  
E³ - Rising Stars Programme: Basic Sessions  
BS 6  
Image-guided therapies in oncology  
Moderator:  
V. Bérczi; Budapest/HU  
A-411 08:30  
Kidney  
O. Akhan; Ankara/TR (oakhan@hacettepe.edu.tr)  
Renal Cell Carcinoma (RCC) is the most common malignant renal tumour seen 
for an estimated 2% to 3% of all malignancies in the United States. The 
incidence of renal tumours has reached to a plateau in the developed countries 
in recent period it is still an increasing problem in the developing countries. 
However the incidence of the incidentally detected renal masses has increased 
in the last decade. Therefore, the management of RCC has greatly changed in 
this period from radical nephrectomy to nephron-sparing treatment options 
such as partial nephrectomy or local ablative therapies carried out with RFA, 
Microwave or Cryoablation. Although the guideline of the American Urological 
Association suggests partial nephrectomy as a standart treatment option for T1 
renal masses, local ablative approach with RFA, Microwave or Cryoablation 
are getting to be more applied for the treatment. Relative contraindications for 
the ablative procedures include proximity to the central collecting system, 
bowel or adrenal glands. These limitations are overcome by the fluid injection 
along the margin of the targeted lesion by displacing these anatomical 
structures. The main indications for Renal Artery Embolisation (RAE) include 
preoperative embolisation before nephrectomy, angiographic treatment of 
angiomyolipoma, an adjunctive treatment for RCC ablation and for palliation of 
advanced-stage RCC. RAE is also indicated to reduce blood loss before 
resection of metastatic RCC.  
Learning Objectives: 
1. To have a basic knowledge about indications and limitations of interventional 
radiology procedures in renal malignancies. 
2. To have a basic knowledge about embolisation of renal tumours. 
3. To become familiar with ablation of renal tumours. 
A-412 08:53  
Lungs  
M. Bezzi; Rome/IT (mario.bezzi@uniroma1.it)  
Percutaneous needle biopsy has been a mainstay of oncologic diagnosis for 
more than three decades, since the advent of CT and ultrasound. 
Percutaneous needle biopsy has become the standard of care in the diagnosis 
of most lung tumors and is also used to diagnose non cancerous conditions, 
such as infection. The technique is also beneficial in the staging of patients 
with cancer, particularly when another treatment method may be more 
appropriate than surgical resection. Advantages of percutaneous biopsy over 
surgical excisional biopsy include time and cost savings and reduction in 
morbidity. Aim of this presentation is to discuss the practical aspects of lung 
biopsy, needle selection, and guidance techniques and to show how to 
approach difficult lesions and avoid complications. About 70% of patients with 
lung cancer are not surgical candidates, either due to advanced disease or 
comorbidities. Thermal ablation is a minimally invasive treatment that is 
commonly used in this group of patients, with promising results. Currently, the 
most widely used ablation techniques in the treatment of lung malignancies are 
radiofrequency ablation (RFA), microwave ablation, and cryoablation. This 
presentation reviews the application of thermal ablation in the thorax, including 
patient selection, basics of procedure technique, imaging follow-up, and 
treatment results.  
 
  








1. To have a basic knowledge about indications and limitations of interventional 
radiology procedures in lung malignancies. 
2. To have a basic knowledge about image-guided biopsy. 
3. To become familiar with ablation of lung cancer. 
A-413 09:15  
Bones  
A. Gangi; Strasbourg/FR (gangi@unistra.fr)  
Different image-guided percutaneous techniques can be used for treatment of 
musculoskeletal tumours. The management of patients with bone tumours 
requires consideration of: histology of the tumour with differentiation of benign 
and malignant tumours, careful clinical evaluation of the patient's general 
condition, understanding of the disease process, appreciation of the degree of 
bone destruction (biomechanics and consolidation), thorough working 
knowledge of available treatment options, multidisciplinary decision-making, 
and precision of the treatment goal: curative or palliative. Curative ablation can 
be applied for the treatment of specific benign or in selected cases of 
malignant localized bone tumours. Curative treatment: the therapeutic goal is 
to ablate the tumour completely and definitively. Pain palliation therapy of 
primary and secondary bone tumours can be achieved with safe, fast, 
effective, and tolerable percutaneous methods. Palliative treatment: the 
therapeutic goal is not complete ablation of the tumour, but pain palliation. 
Ablation (chemical, thermal, mechanical), and consolidation (cementoplasty, 
screw fixation), embolisation techniques can be used separately or in 
combination. 
Learning Objectives: 
1. To have a basic knowledge about indications and limitations of interventional 
radiology procedures in bone malignancies. 
2. To understand the basic concepts of embolisation of bone tumours. 
3. To have a basic knowledge about bone tumours ablation. 
Author Disclosure: 
  A. Gangi: Other; proctoring Galil medical. 
A-414 09:38  
Liver  
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es)  
The liver has a dual vascular supply with seventy five percent of the blood 
comes from the portal vein and the rest from the hepatic artery. Small (< 1mm) 
tumors are initially nourished by portal branches; however, when they start 
growing they deliver pro-angiogenic agents which may create an arterial 
network that ensures its vascularization. Thus, liver tumors are almost 
exclusively vascularized by the hepatic artery and can be safely treated by an 
endovascular approach. The angiographic appearance of a liver tumor 
depends on the amount of the arterio-capillary network and hypervascular 
tumors are easily detected and more adequate for receiving endovascular 
treatments. One therapeutic possibility is to occlude the vascular network and 
close the afferent vessels (“embolization”) provoking ischemia that will lead to 
necrosis. However, since the tumor send continuous pro-angiogenic signals, if 
there is a decrease in the blood supply, the ischemic effect will trigger an 
increase in angiogenesis. For abolishing such effect it is possible to add 
chemotherapeutic agents (“chemoembolization”), together with the occluding 
particles, with the aim of obtaining a more complete antineoplastic effect. A 
different approach consists in the use of small particles just as carriers, with no 
occluding effect, that will place an anticancer agent intratumourly. When the 
agent is a radioisotope the procedure is called “radioembolization”, a form of 
brachytherapy. By using a percutaneous access, some tumors (<3cm) can be 
punctured with probes through which energy (heat radiofrequency/microwaves 
or cold cryotherapy) is delivered which will lead to tumoural necrosis 
(“ablation”).  
Learning Objectives: 
1. To understand the basic concepts of chemoembolisation in liver 
malignancies. 
2. To understand the basic concepts of radioembolisation in liver malignancies. 
3. To have a basic knowledge about liver tumours ablation. 
Author Disclosure: 





08:30 - 10:00 Room D  
Musculoskeletal  
RC 910  
Imaging the hip and thigh  
Moderator:  
M. Klontzas; London/UK  
A-415 08:30  
A. Femoroacetabular impingement: what is it, how do I image it and does 
it matter?  
R. Sutter; Zurich/CH  
The last decade has seen a constant rise in the number of patients diagnosed 
and treated for femoroacetabular impingement (FAI). However, there are 
ongoing controversies about the accuracy of measurements for assessing FAI 
and an associated overdiagnosis of FAI. This refresher course covers the 
pathophysiology of FAI, the classic osseous hallmarks, and the characteristic 
damage to the articular cartilage and labrum. It gives an overview of state-of-
the art FAI imaging with different radiological modalities, including the use of 
traction at MR arthrography, and addresses possible pitfalls when evaluating 
the hip joint. Additional anatomical factors are described that contribute to the 
development of FAI, such as abnormal femoral antetorsion and acetabular 
version. And finally, the relevance of the different parts of the diagnostic 
algorithm for evaluating FAI are discussed.  
Learning Objectives: 
1. To understand the mechanism of femoroacetabular impingement. 
2. To learn about the imaging findings in patients with femoroacetabular 
impingement. 
A-416 09:00  
B. Groin pain in the athlete: what causes it and what does imaging 
contribute?  
P. Robinson; Leeds/UK (philip.robinson10@nhs.net) 
Groin pain in the athlete is a complex process with different researchers 
focusing on the symphysis pubis joint, the adductor longus enthesis, pubic 
subchondral stress fractures, lower abdominal muscle abnormalities as well as 
inguinal muscular and aponeurotic tears. There is also confusion over 
terminology with, for example, osteitis pubis and sportsman’s hernia 
encompassing many different potential conditions for different clinicians. In 
reality there is a lot of crossover with many or all of the above regions thought 
to be involved by chronic shearing forces acting through the symphysis pubis 
and surrounding soft tissues. This lecture will review: (1) Biomechanics and 
functional anatomy of the anterior pelvis in relation to athletes especially 
kicking sports. (2) Theories and nomenclature for the pathogenesis of chronic 
groin pain in athletes. (3) Imaging findings in symptomatic and asymptomatic 
athletes focussing on the use of MR imaging. (4) The interpretation of these 
findings and what research shows they relate to in terms of diagnosis, 
prognosis and decision making for treatment. 
Learning Objectives: 
1. To understand the anatomy of the groin region. 
2. To learn about the imaging findings in athletes with groin pain. 
A-417 09:30  
C. Muscle injury of the hip and thigh  
M.-A. Weber; Rostock/DE (marc-andre.weber@med.uni-rostock.de)  
This lecture will focus on MRI for the assessment of muscle injuries at the hip 
and thigh using fluid sensitive sequences. Muscle injuries include a large 
variety of imaging patterns from occasionally subtle changes in muscle strain 
to complete muscle tears. Exercise-related chronic changes such as delayed 
onset muscle soreness, compartment syndrome, and muscle hernias, as well 
as complications of muscle injuries such as myositis ossificans may be 
encountered. The MRI appearance of a muscle contusion may be similar to a 
muscle strain/tear. Mild post exercise oedema can persist for some time and 
can mimic a low grade muscle strain injury. 35% of all soccer injuries are 
muscle injuries and they are the most frequent cause for missing a game. The 
myotendinous junction is the weakest link in the muscle-tendon-bone chain. 
The widely used grading system for muscle injuries divides muscle injuries in 
four grades (grade 0: normal MRI, i.e., functional injury of the muscle, grade 1: 
oedema, grade 2: partial rupture, grade 3: complete tear). However, this 
grading system is only a rough estimate, because grade 2 injuries comprise a 
wide range from tiny fibre discontinuities to subtotal muscle ruptures. Measures 
of the longitudinal length as well as the percentage and volume of the muscle 
injury in MRI have some predictive value with respect to time to return to sports 
  







activities. Moreover, injury to the intramuscular component of the tendon has 
prognostic significance. A complete tear (grade 3) may require surgery.  
Learning Objectives: 
1. To understand the imaging patterns of muscle injury at the hip and thigh. 
2. To learn about grading and prognostic values of muscle injuries. 
08:30 - 10:00 Room G  
EFOMP Workshop: Radiation dose management systems and 
repositories: the present and the future  
EF 1  
Dose management systems and 
repositories: part A  
Moderator:  
A. Trianni; Udine/IT  
A-418 08:30  
Chairperson's introduction  
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr)  
Dose management systems collect dose data from imaging systems that can 
be displayed in a variety of formats for analysis and benchmarking. Reviewing 
practices helps identify areas for improvement. They also play an important 
role in the establishment of local dose reference levels. Dose repositories are 
central places directly accessible to users in which an aggregation of dose data 
is kept in an organised way for benchmarking, research, dose optimisation, 
and patient dose reduction. However, there are challenges in developing these 
systems. Their creation is an expensive process, there are technological 
difficulties, security and legal issues and issues related to coding systems. 
Coding is required in different steps across the imaging workflow, i.e., for 
ordering and performing of imaging procedures, reporting of findings and for 
quality processes such as radiation exposure measurement and reporting. The 
degree of variability in procedure names is a considerable challenge. A tool is 
needed to help facilities map names of procedures, clinical symptoms, 
anatomical locations, findings, etc. to the closest matching of a standardised 
catalogue.  
Session Objectives: 
1. To become familiar with the main features of dose management systems 
and repositories. 
2. To discuss the services provided by these systems. 
3. To understand how dose management systems can optimise medical 
imaging. 
A-419 08:35  
The 'EuroSafe Imaging' campaign's point of view  
G. Frija; Paris/FR (guy.frija@aphp.fr)  
"no abstract submitted" 
Learning Objectives: 
1. To become familiar with the EuroSafe Imaging campaign’s point of view 
regarding dose management systems and repositories. 
2. To understand why collaboration among radiologists, medical physicists and 
radiographers is needed for the optimum use of these systems. 
3. To learn the impact of dose management systems and repositories in the 
clinical practice. 
A-420 09:05  
Strategies for dose management for achieving optimised imaging  
J.N. Vassileva; Vienna/AT (j.n.vassileva@gmail.com)  
International standards and guidelines express the need for medical facilities to 
monitor patient radiation doses for the imaging procedures they perform. The 
monitoring process includes several steps: recording of relevant patient 
exposure and dose-related data at the facility and their collection and analysis. 
The amount of information and the method of recording and collecting depend 
on the purpose, modality, and model. Collected data from different patients, 
modalities, and units are combined and processed to perform relevant dose 
analysis, which might include statistics, trending, tracking, or comparisons. This 
can be done at local, regional, national, or international level. Data quality 
evaluations should be conducted at all steps. Analysis of collected data may be 
at the level of group of patients, or at the level of individual patients. Analysis at 
the level of group includes setting typical doses and diagnostic reference 
levels, procedural optimisation, monitoring operations and trends in the clinical 
practice, and tracking over time. Samples based on specific examination, 
patient group, or acquisition conditions should be well defined. Availability of a 
good coding system of examination and protocol nomenclature is crucial. 
Tracking of exposure history of individuals requires patient identification. It is 
useful to avoid performing redundant radiological examination and optimise the 
overall patient care. A dose data management infrastructure may deploy an 
integrated electronic system, the interface and functionalities of which depend 
on the intentional user groups. Ideally, it should be integrated with the general 
patient information systems. If properly implemented, the patient exposure data 
management contributes to the improvement of radiation protection and patient 
care.  
Learning Objectives: 
1. To learn about the main features of a system for collection and analysis of 
dosimetric data. 
2. To become familiar with different analytical uses of collected dose data. 
3. To understand how patient exposure data management fits into the 
framework of continuous optimisation of medical imaging. 
A-421 09:35  
The benefits of dose management systems in view of the new Euratom 
Directive  
V. Tsapaki; Athens/GR (virginia@otenet.gr)  
The New Council Directive 2013/59/Euratom lays down basic safety standards 
for protection against the dangers arising from exposure to ionising radiation, 
repealing relevant previous directives. It forms a solid pillar for radiation 
protection in Europe and aims to enhance it according to the state of science 
and technology. Dose management systems are sophisticated software with 
friendly interface, that provide a structured way to monitor all data included in 
the digital Imaging and communication in medicine (DICOM) header of digital 
X-ray machines or data recorded in the picture archiving and communication 
system (PACS) of the hospital. They can facilitate in defining diagnostic 
reference levels, in identifying unusual high patient radiation dose, in detecting 
incidents and/or accidents in all imaging X-ray modalities of the radiology 
department. The presentation will go through the articles of the directive and 
show possible ways that these systems can help to comply with the directive. 
Learning Objectives: 
1. o understand how the dose management tools can help in implementation 
of the new European Directive. 
2. To become familiar with the different capabilities of the dose management 
tools and their connection with the European Directive. 
3. To identify the possible limitations of dose management tools in relation with 
the European Directive. 
08:30 - 10:00 Room K  
Special Focus Session  
SF 9b  
Radiographers in preclinical imaging 
research  
A-422 08:30  
Chairpersons' introduction (part 1)  
C. Buissink; Groningen/NL (c.buissink@pl.hanze.nl)  
The role of radiographers in preclinical imaging research - that’s the question? 
There are several methods and opinions to give answers on this question. To 
formulate your own opinion you need background information. Get familiar with 
the preclinical imaging research objectives and constraints and the impact of 
the radiographers in this process. 
Session Objectives: 
1. To learn more about the techniques devoted to preclinical imaging research. 
2. To become familiar with the preclinical image research objectives and 
constraints. 
3. To appreciate the impact of radiographers in preclinical imaging research. 
A-423 08:33  
Chairpersons' introduction (part 2)  
N. Grenier; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr)  
Involvement of radiographers in preclinical imaging remains limited because 
most centres are driven by researchers. Radiographers’ skills covering 
technical, anatomical and clinical fields could be highly beneficial to these 
research centres. On the other hand, involvement of radiographers in new 
preclinical molecular and quantitative imaging methods, which are highly 
growing fields, could be highly beneficial for their own professional 
development and to clinical structures when returning to clinical imaging. This 
  







session will develop these win-win issues as well as, several fields of 
quantitative imaging using MRI and nuclear medicine.  
Session Objectives: 
1. To learn more about the techniques devoted to preclinical imaging research. 
2. To become familiar with the preclinical image research objectives and 
constraints. 
3. To appreciate the impact of radiographers in preclinical imaging research. 
Author Disclosure: 
  N. Grenier: Advisory Board; Supersonic Imagine, Aix-en-Provence, France. 
A-424 08:35  
Radiographers in preclinical research: challenges and chances  
J.-P. Dillenseger; Strasbourg/FR (jpdil@me.com)  
Small animals imaging is a growing field which is appearing as an essential 
step filling the gap between preclinical and clinical research domains; at the 
University Hospital of Strasbourg, a preclinical imaging unit has been identified 
since 2011. This unit is located in the middle of the clinical imaging 
department. Its philosophy is to apply translational imaging research with the 
same modalities that can be found in a clinical imaging department (e.g., 
SPECT, CT and clinical field MRI), but it also aimed at working with a similar 
organisation. We believe that the best way to achieve this goal is to recruit a 
radiographer in such preclinical department. The place of radiographers in 
such a preclinical laboratory seems evident for us to benefit from their clinical 
experience, practical skills as well as general and deep knowledge in medical 
imaging. All the tasks performed are in accordance with the new French 
decree (decree 2016-1672 - Dec. 5, 2016); preparation of the subject before 
any imaging act (e.g., care and registration). - Radiation safety procedures 
implementation (e.g., dosimetry management, laboratory contamination 
controls, management of radioactive waste products) - Quality controls - 
Preparation and administration of contrast agents and radioactive tracers - 
Imaging devices operation (positioning, parameters setting, post-processing 
and data management) - Research and training (e.g., close relationship with 
researchers, physicians and engineers; radiographers trainees). Our 
experience demonstrates that the integration of a radiographer in a preclinical 
imaging department is an added value to scientific projects and provides a 
fluent organisation. Radiographer collaboration with a research team improves 
and facilitates sequence of procedures and consequently increases the 
throughput. We believe that preclinical imaging will offers new opportunities for 
radiographers in the future.  
Learning Objectives: 
1. To learn about the importance of translational imaging research. 
2. To understand the contribution radiographers can play in preclinical 
research. 
3. To appreciate essential skills and knowledge required in preclinical imaging. 
A-425 08:53  
Preclinical evaluation of PET tracers  
M. Zeilinger; Wiener Neustadt/AT (markus.zeilinger@fhwn.ac.at)  
Molecular imaging, especially the field of PET, becomes a vital and versatile 
modality for modern medicine, as well as for applied medicinal research. 
Common indications belong to diagnosis, differential diagnosis, therapy 
control, prevention of diseases and research of pathophysiological processes. 
The potential of molecular imaging and their capabilities strongly depends on 
the presently developed and established imaging probes. Hence the evaluation 
and development of new selective radiopharmaceuticals would be an 
indispensable part to increase the scope of application for molecular imaging. 
The key factor in the evaluation of potential PET radiotracers is the selection of 
substances with high affinity, selectivity and low unspecific binding. Thus, 
several preclinical procedures, such as biodistribution experiments, ex-vivo 
and in-vitro autoradiography, metabolic stability testing, cell binding studies, 
µPET-experiments, and the appropriate data post-processing, as well as 
biomedical imaging quantification procedures are necessary.  
Learning Objectives: 
1. To understand the connection between molecular imaging and the drug 
discovery process. 
2. To become familiar with quantitative molecular imaging approaches. 
3. To review technical and biomedical limitations and future perspectives. 
A-426 09:11  
SPECT/CT  
S. Heskamp; Nijmengen/NL (Sandra.Heskamp@radboudumc.nl)  
MicroSPECT/CT imaging can provide important information regarding the 
biology of tumours and other disease processes. It can be used to measure the 
expression of tumour-associated antigens, for example, to develop a novel 
biomarker for targeted therapies. Furthermore, theranostic agents can be 
developed which combine the potential of diagnosis and radionuclide therapy. 
For example, 111In-PSMA targeting molecules have been used to image 
prostate cancer xenografts and to calculate the maximum tolerable dose 
before kidney toxicity would occur during 177Lu-PSMA-targeted radionuclide 
therapy. Finally, microSPECT/CT imaging can be used to monitor therapy 
induced changes in the tumour microenvironment, such as the expression of 
growth factors, tumour vasculature, and the presence of immune cells. 
Learning Objectives: 
1. To understand the basic principles of preclinical SPECT/CT and the 
differences with clinical SPECT/CT. 
2. To become familiar with the practical aspects which are relevant for 
preclinical SPECT/CT. 
3. To appreciate how preclinical SPECT/CT can help to answer basic 
oncological research questions. 
A-427 09:29  
Small animal imaging studies  
F. Pichler, M. Zeilinger; Wiener Neustadt/AT  
Several topics like species differences, technical limitations, anaesthesia, and 
physiological constraints have to be taken into account for small animal 
imaging studies. Considering that mice are approximately 20 times smaller and 
1500 times lighter compared to humans certain challenges occur. Furthermore, 
nuclear medicine positron emission tomography (PET) systems for humans are 
around 5 times larger in diameter compared to preclinical µPET-systems. 
Besides that, injected activities are increased in small animals to compensate 
for the lack of sensitivity in preclinical systems. In this regard, also the 
substance volume that can be administered is a limiting factor, especially when 
several substances like the radiotracer, inhibitors and possibly contrast media 
have to be applied. Anaesthesia effects are another source of error which have 
to be considered on an individual basis. For instance, intraperitoneal 
administered ketamine/xylocaine leads to increased FDG uptake in peripheral 
regions while inhaled isoflurane decreases FDG uptake in the brain. The origin 
of these effects is not yet fully understood. The choice of anaesthesia can also 
influence the final positioning in the field of view of the scanner. This means 
that with injection anaesthesia a free positioning is possible whereas with gas 
anaesthesia the inhalation mask limits the final position. Lastly, all experiments 
have to be planned in compliance with the 3R principle (replacement, 
reduction, and refinement), which has to be considered for all decisions. 
Learning Objectives: 
1. To understand work-related challenges in preclinical small animal imaging. 
2. To consider limitations in the quantification of preclinical µPET data. 
3. To appreciate the radiographers role in a preclinical environment in contrast 
to clinical work. 
09:47  
Panel discussion: Is there a role for radiographers in preclinical imaging 
research?  
08:30 - 10:00 Room M 1  
Professional Challenges Session  
PC 9  
How can radiologists expand their role in 
peripheral vascular intervention?  
A-428 08:30  
Chairperson's introduction  
R. Iezzi; Rome/IT (roberto.iezzi.md@gmail.com)  
Peripheral arterial disease (PAD) continues to grow in global prevalence, 
consuming an increasing amount of resources in the health care system. 
Overall rates of intervention for PAD have been rising steadily in recent years. 
Changing demographics, evolution of technologies, and an expanding 
database of outcomes studies are primary forces influencing clinical decision 
making in PAD. The management of PAD is multidisciplinary, involving primary 
care physicians and vascular specialists with varying expertise in diagnostic 
and treatment modalities. This approach has the greatest chance of providing 
optimal care for the patients and ensuring ongoing surveillance of the patient’s 
overall health, ultimately resulting in better quality of life and increased 
longevity. Furthermore, it has been recognized that clinical management of 
patients undergoing interventional radiological procedures is an essential 
component of a successful, contemporary interventional radiology practice, 
with several well-respected interventional radiologists emphasizing the 
importance of direct patient management. To effectively participate in patient 
  







management, interventionalists require a clinical knowhow as well as an 
infrastructure within their practice to support these services. All these clinical as 
well as radiological aspects need to be integrated and implemented in 
dedicated vascular intervention training programmes. Main goals of these 
programs should be to provide IR fellows with an organized, comprehensive, 
supervised, full-time educational experience including the ability to provide 
consultation and case selection, perform the full array of vascular and 
interventional procedures, identify and manage potential complications, provide 
appropriate peri-procedure care, and assist in long-term management 
integrated with the clinical management of referring physicians.  
Session Objectives: 
1. To focus on the needs for and challenges in organising a multidisciplinary 
team. 
2. To understand the role of clinical as well as radiological evaluation for 
outpatients consultation and post-procedure visits. 
3. To understand how to implement vascular intervention training programmes. 
A-429 08:35  
How to improve your clinical knowledge  
C.W. Kopp; Vienna/AT (christoph.kopp@meduniwien.ac.at)  
For decision-making within the vascular board, it is important to understand not 
only the anatomy and potential revascularisation strategies, but also to respect 
the patient's clinical status, age and frailty, renal impairment, as well as 
cardiovascular and bleeding risk to impact on both symptom relief and 
prognosis in PAD patients, regarding wound healing and limb salvage. Cutting 
edge studies have recently changed our understanding of how to implement 
the best medical treatment for the underlying disease of atherosclerosis and 
atherothrombosis. This talk will focus on major cardiovascular risk factors and 
their respective best medical treatment, ranging from goals of antihypertensive 
and lipid-lowering treatment and vascular protection from new antidiabetics to 
strategic changes in the treatment of atherothrombosis, including the current 
recommendation of NOACs and antiplatelet therapy in PAD. Finally, caveats of 
age such as frailty, renal impairment and the safe use of contrast media will be 
covered.  
Learning Objectives: 
1. To become familiar with clinical diagnosis and classification of arterial 
occlusive disease. 
2. To understand the disease states being treated and their clinical 
management. 
3. To learn about intraprocedural and postprocedural medical treatment. 
A-430 08:53  
How to improve your diagnostic skills  
T. Leiner; Utrecht/NL (t.leiner@umcutrecht.nl)  
Non-invasive vascular imaging is now considered a cornerstone of the pre-
interventional workup of patients with peripheral arterial disease. Although 
imaging is not needed to establish the diagnosis, imaging provides a roadmap 
for endovascular intervention and it can outline surgical therapeutic options. In 
my lecture I will discuss the strengths and limitations as well as the practical 
implementation of the most commonly used non-invasive imaging tools to 
asses peripheral arterial disease.  
Learning Objectives: 
1. To understand the crucial role of US in the diagnostic assessment and 
patient recruitment. 
2. To learn when is needed to perform a MRA, CTA, or DSA examination. 
3. To learn the optimal imaging algorithm for diagnosis and follow-up. 
Author Disclosure: 
  T. Leiner: Research/Grant Support; Philips Healthcare; Bayer Healthcare. 
Speaker; Philips Healthcare; Bayer Healthcare. 
A-431 09:11  
How to improve your relationship with the vascular surgeon  
C. Ferrer; Rome/IT 
"no abstract submitted" 
Learning Objectives: 
1. To understand the challenges of open surgical treatments. 
2. To learn about hybrid (surgical and endovascular) treatments. 






A-432 09:29  
How to improve your technical/procedural skills  
K. Katsanos; Patras/GR (katsanos@med.upatras.gr)  
Percutaneous endovascular interventions have evolved to the mainstay 
treatment of peripheral arterial disease manifesting as short distance 
claudication or critical limb ischemia (CLI). Several new technologies, such as 
biomimetic metal stents, drug-eluting stents, covered stents, and drug-coated 
balloons, have emerged to address the Achilles heel of neointimal hyperplasia 
and restenosis, and thereby improve long-term patency outcomes. Novel 
techniques of arterial access and recanalisation, like the pedal or transradial 
approach, the pedal-loop techniques, and complex rendezvous strategies may 
help save legs in cases of advanced CLI with severe anatomical complexity. 
Transcatheter atherectomy may achieve atherosclerotic plaque clearance by 
means of directional plaque excision or rotational plaque removal or laser 
plaque ablation. Debulking atherectomy may allow for a more uniform 
angioplasty result at lower pressures with consequently less vessel 
barotrauma, improved luminal gain and potential combination with drug-coated 
balloons without permanent stent implants. Newer functional imaging 
modalities such as perfusion angiography and near infrared spectroscopy to 
monitor deep tissue oxygen levels will be part of multimodality peripheral 
interventions of the future.  
Learning Objectives: 
1. To understand how to perform an accurate treatment planning. 
2. To learn how to select the right endovascular treatment for the right patient. 
3. To understand the challenges and future prospective of endovascular 
devices and treatments. 
09:47  
Panel discussion: Are we ready to be more of a clinician rather than an 
operator?  
08:30 - 10:00 Room M 2 
E³ - ECR Master Class (Head and Neck)  
E³ 926  
Distant metastases of head and neck 
cancer  
A-433 08:30  
Chairperson's introduction  
P.-Y. Marcy; Ollioules/FR (brozpy@gmail.com)  
We aim to understand the impact of distant metastases diagnosis in head and 
neck treatment. Imaging modalities are important in diagnosis and treatment 
planning, post-treatment assessment, and residual mass (DCE MR), local 
failure (early intra-treatment DW MR), and locoregional and distant metastases 
recurrence/second primary/complication assessment. They provide anatomical 
images, but also functional-based MRI/ PET: molecular/metabolic/physiological 
information. Cost-effectiveness studies are mandatory to evaluate the impact 
of imaging on the Qol and overall survival in head and neck cancer patients.  
Session Objective: 
1. To understand impact of the distant metastases in the head and neck 
treatment. 
A-434 08:35  
A. Incidence and prognosis of synchronous cancer or distant metastases 
from head and neck tumours  
A.D. King; Hong Kong/CN (king2015@cuhk.edu.hk)  
Distant metastases: The advance in treatment of head & neck carcinoma 
(HNC) has improved locoregional control and so distant metastases (DM) are 
emerging as a major determinant of survival. Therefore, a more active 
approach is being taken to detect and manage distant site disease, including 
the use of a new generation of immunotherapy agents. Most DM do not 
manifest until after initial treatment, prognosis tends to be poor with patients 
succumbing to disease within a year. However, prognosis is dependent on 
many factors which include histology, site and number of DM. Notably some 
patients survive long term and there is a subgroup of patients with 
oligometastases who have potentially curable disease. In this presentation, 
incidence, risk factors, sites, prognosis, and management will be discussed 
according to the main histological groups of carcinoma that arise in the 
aerodigestive tract including squamous cell carcinoma (SCC), thyroid and 
salivary glands. Second primary tumours: Head & neck cancer has one of the 
highest associations with a second primary tumour (SPT). Risk factors for SCC 
  







include smoking and high alcohol intake, and so these patients are also at risk 
of SPTs in other sites of the head & neck, lungs and oesophagus. Less 
commonly SPTs arise in the colon, pancreas and bladder. SPTs are usually 
metachronous, with synchronous tumours being diagnosed in only ~ 4% of 
patients. SPTs are a leading cause of death in patients with early stage SCC, 
but those SPTs detected early are potentially curable.  
Learning Objectives: 
1. To become familiar with the incidence of the synchronous tumours in the 
head and neck population. 
2. To become familiar with the incidence of the distant metastases in the 
patients with newly diagnosed head and neck cancer. 
3. To understand the consequences in a prognosis. 
A-435 08:58  
B. Is morphologic imaging enough to stage patients with head and neck 
tumours before therapy?  
S. Rohde; Dortmund/DE (stefan.rohde@klinikumdo.de)  
The lecture will focus on the importance of morphologic imaging in the 
management of patients with head and neck malignencies. Imaging features of 
local and distant tumour recurrence will be presented, and the potential and 
limitations of morphologic imaging modalities including diffusion and perfusion 
techniques will be discussed.  
Learning Objectives: 
1. To review current guidelines and clinical practice. 
2. To understand the advantages and disadvantages of the conventional 
imaging modalities. 
3. To appreciate cost-effectiveness of different imaging modalities. 
A-436 09:21  
C. Is functional imaging necessary to detect distant metastases in head 
and neck cancers?  
R. Maroldi; Brescia/IT  
"no abstract submitted" 
Learning Objectives: 
1. To learn about functional imaging (DWI, DECT, PET) in head and neck 
cancer patients. 
2. To understand the advantages and disadvantages of the functional imaging 
modalities. 
3. To review the advanced imaging for detection of distant metastases of head 
and neck cancer.  
09:44  
Panel discussion: Where and how to search for distant metastases in 
head and neck cancer  
08:30 - 10:00 Room M 3 
ESR Working Group on Ultrasound  
WG 2  
Tips and tricks for abdominal ultrasound  
A-437 08:30  
Chairpersons' introduction (part 1)  
M. Claudon; Vandoeuvre-les-Nancy/FR (m.claudon@chu-nancy.fr)  
The evaluation of normal and abnormal abdomen is one of the major clinical 
indications for sonography. Flow imaging, including Doppler techniques and 
contrast-enhanced ultrasound (CEUS), are now commonly used for the liver 
and more and more often for the spleen, pancreas and intestine. Elastography 
of the liver has slowly arisen as a current modality in many institutions. The 
ability to fuse CT, MRI, or PET-CT/MRI with real-time ultrasound has further 
increased the interest of ultrasound as a second- or third-level diagnostic 
modality as well as for interventional purpose. Radiologists, especially juniors, 
should be confident in using these modalities and be aware of the many tips 
and tricks they offer.  
Session Objectives: 
1. To learn about actual indications and applications of ultrasound Doppler 
imaging, CEUS, elastography and ultrasound fusion imaging. 
2. To show better parameter settings for optimal technical results illustrating 
tips and tricks for technical and clinical successful examinations. 
3. To become familiar with the new ultrasound imaging techniques and 
applications. 
Author Disclosure: 
  M. Claudon: Speaker; Philips Ultrasound. 
A-438 08:35  
Chairpersons' introduction (part 2)  
V. Valek; Brno/CZ (vlvalek@med.muni.cz)  
Ultrasound is a non-invasive accessible and versatile diagnostic technique that 
uses high frequency ultrasound waves to outline organs of the human body 
without ionising radiation in real time and with the capacity to visualise several 
planes. The high diagnostic yield of the technique has made it a routine 
method in daily medical practice. CEUS has the ability to characterise 
parenchymal organ lesions and has been proven superior to colour and power 
Doppler ultrasound in the detection of tumour vascularity. Ultrasound Tissue 
Doppler imaging (US-TDI) has been used to diagnose regional wall motion 
(WM) abnormalities in coronary artery disease and other indications. The 
recent development of ultrasound elastography techniques allows a non-
invasive method of estimating organ structure. Transient elastography (TE) is a 
non-imaging elastographic technique, while point shear wave (p-SWE) and 2D-
SWE combine imaging with elastography. The evidence at this time suggests 
that p-SWE is as accurate but more reliable than TE, while 2D-SWE is more 
accurate than TE. Fusion imaging combines the advantages of ultrasound and 
CT/MRI while avoiding their disadvantages. It is often achieved by using an 
external electromagnetic field system with a position sensor mounted on an 
ultrasound transducer. This allows tracking of transducer movements and 
matching ultrasound and CT/MRI image datasets, the real-time ultrasound 
image moves with the CT/MRI image. Once the two images match well, the 
target lesion on ultrasound image can be located according to the CT/MRI 
image. It is important to become familiar with these new ultrasound imaging 
techniques and their applications.  
Session Objectives: 
1. To learn about actual indications and applications of ultrasound Doppler 
imaging, CEUS, elastography and ultrasound fusion imaging. 
2. To show better parameter settings for optimal technical results illustrating 
tips and tricks for technical and clinical successful examinations. 
3. To become familiar with the new ultrasound imaging techniques and 
applications. 
A-439 08:40  
Doppler imaging  
F. Calliada; Pavia/IT (fabrizio.calliada@gmail.com)  
Doppler is surely not a new imaging technique, but an adequate knowledge of 
the basic physics and of the scanner tuning is essential to avoid errors and 
misunderstanding. The first part the presentation will cover the principal 
sources of error that should be avoided during a Doppler examination and the 
major tuning tricks needed for an optimal and successful examination. In the 
second part, we will try to become familiar with new Doppler imaging 
techniques dedicated both to very low velocity microvascular flow and to high 
velocity complex flow representation.  
Learning Objectives: 
1. To learn about actual indications and applications of Doppler imaging. 
2. To show better parameter settings for optimal technical results. 
3. To illustrate tips and tricks for technical and clinical successful examinations. 
4. To become familiar with the new Doppler imaging techniques and 
applications. 
Author Disclosure: 
  F. Calliada: Speaker; Toshiba, Mindray, Hitachi. 
A-440 09:00  
CEUS  
M. D'Onofrio; Verona/IT (mirko.donofrio@univr.it)  
Contrast-enhanced ultrasonography (CEUS) is a safe and accurate imaging 
method to evaluate the vascularity of abdominal organs. CEUS improve the 
ultrasound characterization of tumoural masses. CEUS should be performed 
when possible immediately after the US detection of indeterminate mass in 
abdominal organs. CEUS is accurate in the characterization of neoplastic 
lesions such as liver metastases and pancreatic ductal adenocarcinoma. The 
use of CEUS in studying focal liver and pancreatic lesions found at US, 
especially in the same session of ultrasound examination, is therefore 
recommended to promote faster diagnosis. In particular, liver metastases 
detection could be improved by the use of contrast-enhanced ultrasound with 
respect to basal examination. The actual indications and applications of CEUS 
are presented in official published guidelines. Every CEUS examination should 
be performed with the better parameter settings for optimal technical results.  
 
  








1. To learn about actual indications and applications of CEUS. 
2. To show better parameter settings for optimal technical results. 
3. To illustrate tips and tricks for technical and clinical successful examinations. 
4. To become familiar with the new CEUS techniques and applications. 
Author Disclosure: 
  M. D'Onofrio: Advisory Board; Siemens, BRACCO. Consultant; Bracco, 
Siemens. Speaker; Bracco, Siemens. 
A-441 09:20  
Elastography  
D.A. Clevert; Munich/DE (Dirk.Clevert@med.uni-muenchen.de)  
Elastography has become a standard-of-care supplementary ultrasound 
imaging modality in modern radiological diagnostic in recent years and is an 
ideal tool for the detection and characterization of tissue properties. With 
different elastography techniques, it is possible to quantitatively as well as 
qualitatively assess tissue properties. In daily clinical routine, elastography is 
mostly used in oncological imaging as well as in the quantification of liver 
stiffness for the evaluation of liver fibrosis and cirrhosis. The benefits of 
elastography are the cost-effectiveness of the method, being a non-invasive 
imaging modality and the easy application of the technique. This course 
describes the most common applications of ultrasound elastography in daily 
clinical routine.  
Learning Objectives: 
1. To learn about actual indications and applications of elastography. 
2. To show better parameter settings for optimal technical results. 
3. To illustrate tips and tricks for technical and clinical successful examinations. 
4. To become familiar with the new elastography techniques and applications. 
Author Disclosure: 
  D.A. Clevert: Advisory Board; Siemens, Samsung, Philips, Bracco. Speaker; 
Siemens, Samsung, Philips, Bracco. 
A-442 09:40  
Fusion imaging  
C. Ewertsen; Copenhagen OE/DK (caroline.ewertsen@dadlnet.dk)  
Image fusion software is available on most high-end ultrasound systems and 
several publications for different clinical applications are available. Ultrasound 
images can be fused with images from CT, MRI or PET/CT, which enables the 
user to target biopsies or verify the nature of inconspicuous lesions. In order to 
fuse the images a co-registration or alignment must be made. This can be 
done manually, by choosing common points or planes in the different datasets, 
or automatically by the system by recognition of pixel intensities in the images. 
This applies for some systems, but not for all modalities. The theory behind 
these different co-registration methods will be covered as well as their 
accuracy. Furthermore examples of clinical applications will be demonstrated. 
The technique is more time consuming than conventional B-mode ultrasound 
but time spent decreases with increasing user experience. Depending on the 
body size of the patient and the organ of interest patient positioning should be 
identical to when the previously recorded data set was recorded, but this is not 
mandatory. However, for liver applications accuracy of the co-registration may 
improve if this is taken into account. Also identical in- or expiration may 
improve the accuracy. Real time image fusion enables real-time assessment of 
lesions in several anatomical regions.  
Learning Objectives: 
1. To learn about actual indications and applications of fusion imaging. 
2. To show better parameter settings for optimal technical results. 
3. To illustrate tips and tricks for technical and clinical successful examinations. 









08:30 - 10:00 Room M 4 
E³ - ECR Academies: State-of-the-Art and Advanced MR Imaging 
of the Musculoskeletal system  
E³ 919  
Upper extremity  
A-443 08:30  
Chairperson's introduction  
M.C. De Jonge; Amsterdam/NL (mdjonge@zuwehofpoort.nl)  
DISI and VISI are descriptions of the position of the lunate bone on plain 
radiographs. They are not diagnoses as such but a reflection of underlying 
pathology. It is important to realise that this description is made on standard 
plain radiographs and not on cross sectional imaging. The X-rays have to be 
made in the correct way for ulnar and radial deviation of the hand will result in 
a different position of the lunate and therefore false-positive DISI and VISI 
descriptions. Calling DISI and VISI inappropiately will lead to additional 
imaging to look for the cause of the ‘abnormal’ lunate position. It is important to 
realise this so that patients will not undergo unneccessary imaging. The 
concepts of DISI and VISI will be discussed together with its implications. 
A-444 08:35  
A. Elbow  
A.J. Grainger; Leeds/UK (andrewgrainger@nhs.net)  
The elbow is subject to both acute and chronic trauma, including ligamentous, 
osteochondral and tendon injury. MRI is well suited to demonstrate these 
injuries, but due to the complex anatomy of the elbow joint, optimisation of the 
imaging is required in terms of plane of section, sequence employed and the 
decision of whether to use intravenous or intraarticular contrast medium. The 
talk will address acute injury, looking at mechanisms and appearances of 
ligamentous, tendon and osteochondral injury at the elbow. The anatomy of 
these structures will be discussed along with imaging optimisation. Patterns of 
injury will be highlighted. Causes of chronic elbow pain will also be discussed 
and the relevant appearances on MRI will be illustrated. Patterns of 
impingement at the elbow will be shown and the relationship between chronic 
repetitive injury and pain will be reviewed. Important nerves pass by the elbow 
and the movement of the elbow and muscular structures around the elbow can 
lead to entrapment of nerves - another cause of chronic pain. Common 
patterns of nerve entrapment will also be discussed.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and MR arthrography (direct/indirect) and 
how to optimise imaging protocols for the elbow. 
A-445 09:17  
B. Wrist  
M. Shahabpour, M. De Maeseneer; Brussels/BE 
(maryam.shahabpour@uzbrussel.be)  
The wrist is highly vulnerable to injuries with significant long-term 
consequences if diagnosis is delayed. When initial radiographs are negative in 
presence of strong clinical suspicion, further imaging is appropriate including 
CT and MRI. MRI can accurately show scaphoid fractures or other 
unsuspected fractures of distal radius or carpus as well as soft-tissue injuries. 
CT is recommended preoperatively for displaced fractures where surgery is 
performed to avoid complications. It helps evaluate intra-articular fractures and 
detect fractures of the hook of hamate, subluxations of distal radioulnar joint, 
and fractures-dislocations of metacarpal bases. MRI of hand and wrist requires 
high spatial resolution. The patient is placed in supine position with the hand 
along the body using a dedicated phased-array wrist coil or in prone position 
with the arm overhead. Imaging protocols include 2mm coronal PDFS and T1 
(or PD), sagittal PD and T2, axial PD and PDFS for analysis of ligaments and 
tendons. Using MR arthrography (with double or triple compartment injection), 
2mm thick coronal T1FS and PDFS or 0.5mm 3D PDFS and 3D DESS 
sequences followed by multiplanar reconstructions are performed for the 
detection of ulnar attachments TFCC tears and lesions of extrinsic and intrinsic 
ligaments, especially in (sub)acute trauma to determine if the patient requires 
surgery. In chronic phase, indirect MR arthrography is obtained after addition 
of intravenous contrast prior to the examination to assess ligaments and 
cartilage despite the presence of scarring. For nonunion, SNAC, avascular 
necrosis and SLAC lesions, images are obtained before and after intravenous 
contrast administration.  
  








1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and MR arthrography (direct/indirect) and 
how to optimise imaging protocols for the wrist. 
08:30 - 10:00 Room M 5 
E³ - ECR Academies: Chest Imaging  
E³ 918  
Updates on lung cancer management  
A-446 08:30  
Chairperson's introduction  
A.R. Larici; Rome/IT (annarita.larici@unicatt.it)  
Several studies on lung cancer screening have been performed by low dose 
computed tomography (LDCT) in the last decades. Among these, only the US 
National Lung Screening Trial demonstrated a benefit for the annual LDCT (a 
20% reduction of lung cancer mortality). So far, a major concern in all 
published studies has been the high rate of false positive results leading to an 
increase risk of overdiagnosis whose effects are still not completely known. 
Lung cancer may present as nodule or mass. Mass has a high likelihood of 
being malignant while the majority of lung nodules remains indeterminate at CT 
scans. The most reliable method to characterise lung nodules is to follow them 
over time with CT. In the recently published guidelines for managing solid and 
subsolid nodules by the Fleischner society, the most relevant change is the 
reduction of CT examinations performed during the follow-up period. Once a 
lung lesion is characterised as malignant, the further step is staging the 
disease. The 8TH edition of the TNM classification introduced relevant 
changes regarding the descriptors T (from 1 to 5 cm every centimeter counts; 
T3 if greater than 5 cm; T4 if greater than 7 cm) and M by introducing the 
category M1b and M1c to indicate, respectively, one (oligometastatic disease) 
and more than one extrathoracic lesion. Several limitations still remains, as the 
classification of lymphangitic carcinomatosis and the evaluation of multiple lung 
lesions. Certainties and controversies of each proposed topic will be argued in 
this session.  
A-447 08:35  
A. Lung cancer screening  
M.A. Heuvelmans; Groningen/NL (m.a.heuvelmans@umcg.nl)  
After the largest randomised-controlled lung cancer screening trial, the 
National Lung Screening Trial (NLST), published a 20% decrease in lung 
cancer specific mortality in heavy (ex)-smokers screened by annual low-dose 
chest CT compared to annual chest radiography, lung cancer screening has 
been implemented in clinical practice in the United States. Although in Europe 
the results of the second largest trial, the Dutch-Belgian randomized-controlled 
lung cancer screening trial (NELSON trial) are still awaited, planning for 
implementation of low dose CT screening in high risk individuals is 
recommended by the EU position statement expert group, since lung cancer 
screening can save lives.  
Learning Objectives: 
1. To review the results of the large randomised trials. 
2. To learn about the lung cancer screening modalities. 
3. To understand the overdiagnosis risk. 
A-448 09:03  
B. Lung nodule management  
A.A. Bankier; Boston, MA/US  
This presentation will discuss the background, novel elements, and clinical 
implications of two recently published guidelines on the management and the 
measurement of pulmonary nodules. Participants will learn about the required 
framework for the application of the guidelines, and their potential and 
limitations. The intention of the guidelines, i.e., a more standardised and 
rationale approach to the management of pulmonary nodules will be 
highlighted. 
Learning Objectives: 
1. To review the current guidelines for solid nodule management. 
2. To learn about the subsolid nodule management guidelines. 
3. To review the role of computer-aided tools. 
 
A-449 09:31  
C. Lung cancer staging  
G. Aviram; Tel Aviv/IL (aviramgalit@hotmail.com)  
Lung cancer continues to be the leading cause of cancer-related mortality 
worldwide. Accurate staging is fundamental for estimating prognosis, selecting 
treatment, and conducting and reporting clinical trials internationally. The 
International Association for the Study of Lung Cancer (IASLC) has recently 
published the eighth edition of the tumour, node, and metastasis (TNM-8) 
staging system used for lung cancer. This revised classification is based on 
significant differences in patient survival identified on analysis of a new large 
international database. Key changes include: further modifications to the T 
descriptors based on 1 cm increments in tumour size; grouping of tumours 
resulting in partial or complete lung atelectasis/pneumonitis, and those 
involving a main bronchus regardless of distance from the carina, and 
reassignment of diaphragmatic invasion. In addition, specific new coding for 
adenocarcinoma in situ and minimally invasive adenocarcinoma was 
incorporated as well as their recommended measurements method. The 
clinical N descriptors used are unchanged from the 7th edition; however, the 
description of the number of pathological lymph node stations involved, has 
been added. Further subdivision of metastatic disease into distinct descriptors 
based on the number of extrathoracic metastases and involved organs were 
also added. As a result of the new modifications, several new stage groups 
have been developed, and others have shifted. Although TNM-8 represents 
more advanced understanding of tumour behavior and patient management, 
several limitations, controversies and unaddressed issues persist.  
Learning Objectives: 
1. To learn about the eighth edition of the TNM classification. 
2. To review the main differences with the 2009 edition. 
3. To review the persisting limitations. 
Author Disclosure: 
  G. Aviram: Other; My institution received a research grant from Philips Health 
Care. 
10:30 - 12:00 Room B 
ESR meets Switzerland  
EM 1  
Radiology and Swiss chocolate: a sweet 
combination  
Presiding:  
B. Hamm; Berlin/DE  
D. Weishaupt; Zurich/CH  
A-450 10:30  
Introduction: What Swiss radiology and Swiss chocolate have in common  
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.zuerich.ch)  
The Swiss Society of Radiology, with more than 100 years of history and about 
1,000 members, is a professional medical society dedicated to promoting 
radiology in Switzerland. The aims of the society - among others - are: to 
assure high-quality postgraduate training in radiology by maintaining the 
radiology residency training curriculum as well as conducting the Swiss board 
examinations in radiology, to support education in radiology by organising the 
Swiss Congress of Radiology, offer activities dealing with quality assurance, 
patient safety and radiation protection, improve patient care and the health of 
the population through medical imaging, support the professional and 
economic interests of our members, and serve as a responsible counterpart to 
the Swiss Health authorities and other official bodies. The aim of providing high 
quality radiology and the pursuit of excellence are important characteristics of 
radiology in Switzerland. These characteristics link Swiss radiology with Swiss 
chocolate, which is considered to be one of the highest quality products 
manufactured in our country. Within this session, three educational 
presentations by three renowned Swiss radiologists will underline the broad 
spectrum of cutting edge radiology performed in the country. In addition, you 
will learn about the secret of production and refinement of high-quality 
chocolate made in Switzerland. A representative of a leading family owned 
Swiss chocolate manufacturer will present the fascinating chocolate production 
process and illustrate how high quality chocolate is handmade and how 
innovative chocolate products are designed for the future.  
Session Objectives: 
1. To become familiar with the status of radiology in Switzerland. 
2. To learn how Swiss Society of Radiology supports radiology in Switzerland. 
3. To discuss the link between Swiss radiology and top-quality innovative 
Swiss chocolate culture.  
  







A-451 10:35  
Truffle No. 1: MR-diffusion of the urogenital tract: where it really helps  
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch)  
After its initial application in the brain diffusion-weighted MRI (DWI) is now part 
of most MR exams in the abdomen. In the urogenital tract DWI is particularly 
helpful because it can be applied without contrast medium administration which 
is a major advantage in patients with renal impairment. For daily clinical routine 
image analysis of DWI is performed qualitatively based on visual assessment 
of the high b-value images and the corresponding ADC map. However, image 
interpretation of DWI has always to be performed in combination with 
morphological images to avoid misinterpretation, e.g., a tumour, an abscess 
and a haematoma have the same findings on DWI but can be differentiation in 
combination with anatomical sequences. The ADC value, the quantitative 
parameter of DWI can further provide more detailed information of the 
underlying tissue. DWI in the urogenital tract can be applied for detection, 
characterisation and monitoring of various pathologies. DWI helps to detect 
pyelonephritis in adults and children without contrast medium administration 
and typically normal findings on morphology. It is also routinely applied to 
detect significant prostate cancer and provides even information on tumour 
aggressiveness when the ADC value is taken into account. The differentiation 
between cystic renal cell carcinoma and an abscess is also possible based on 
DWI and even the differentiation of renal cell carcinoma subtypes is possible in 
many cases based on the underlying ADC-value. Several applications and 
examples showing the usefulness of this technique in the urogenital tract will 
be discussed and explained. 
Learning Objectives: 
1. To learn how DWI can be integrated in the acquisitions protocols and 
whether it precludes the need for other sequences. 
2. To learn if DWI can provide useful information for tissue characterisation. 
3. To understand the clinical circumstances in which DWI is most helpful. 
Author Disclosure: 
  H.C. Thoeny: Advisory Board; Guerbet SA. 
Swiss chocolate culture.  
A-452 10:55  
Interlude 1: From cocoa bean to chocolate creations  
A. Trümpler; Ennenda/CH 
A-453 11:05  
Truffle No. 2: hip preservation surgery: a fast evolving field also for 
imaging  
C.W.A. Pfirrmann; Zurich/CH  
Joint-preserving surgery of the hip is one of the most important fields of 
innovation in orthopedics and sports medicine. Before the era of hip 
replacement hip osteotomies were popular to treat osteoarthritis of the hip. Hip 
osteotomies lost a lot of their importance with the introduction of the total hip 
arthroplasty which is considered one of the most successful surgical 
procedures. With the scientific work of Reinhold Ganz and his team at the 
University of Bern in Switzerland joint-preserving surgery of the hip has 
regained importance and has become one of the fastest evolving fields in the 
last two decades. The goal of joint- preserving hip surgery is to prevent 
osteoarthritis in the hip before degeneration becomes evident. Studies on the 
detailed anatomy of the blood supply of the femoral head were the scientific 
bases to develop a new approach for open surgical dislocation of the hip 
without the risk of avascular necrosis. This gave new insights in hip 
biomechanics and the development of the new concept of femoroacetabular 
impingement (FAI). FAI has been identified as the leading cause of the 
premature osteoarthritis of the hip. Imaging of the hip has become increasingly 
important to assess morphology of the hip joint as well as the structural 
damages mainly to the cartilage and the labrum.  
Learning Objectives: 
1. To learn about the history and recent advances in hip preservation surgery. 
2. To understand the biomechanics of the abnormal hip and how to integrate 
biomechanical aspects in the imaging protocol and image interpretation. 
3. To know imaging pitfalls and asymptomatic findings. 
A-454 11:25  
Interlude 2: From cocoa bean to chocolate creations  





A-455 11:35  
Truffle No. 3: multiparametric imaging in head and neck oncology  
M. Becker; Geneva/CH (minerva.becker@hcuge.ch)  
Contrast enhanced CT and MRI with diffusion-weighted imaging (DWI) are 
routinely used for the assessment of submucosal tumour spread in head and 
neck carcinoma, to stage nodal disease, to monitor treatment response and to 
detect recurrent disease. PET/CT is widely used to stage nodal disease, to 
detect distant metastases and synchronous tumours, to identify unknown 
primary tumours in patients with metastatic neck nodes, to assess treatment 
response and prognosis after chemo radiotherapy and for radiotherapy 
planning. Recent data regarding the complementarity of multiparametric 
information derived from hybrid MR/PET systems in clinical settings holds 
promise because it can combine morphologic, functional and molecular 
information and helps to avoid diagnostic pitfalls. This lecture focuses on 
clinical applications of multiparametric imaging in head and neck cancer. 
Current evidence about the complementarity of CT, MRI, DWI, perfusion and 
PET is discussed with particular emphasis on the added value of 
multiparametric information and quantification. The variable appearance of 
functional phenomena mimicking disease as well as diagnostic pitfalls and how 
they can be avoided are discussed. Current research trends regarding texture 
analysis are addressed. Emphasis will be put on ongoing developments in 
head and neck oncology.  
Learning Objectives: 
1. To understand the complementary role of morphologic, functional and 
metabolic imaging techniques in head and neck oncology. 
2. To review the role of diffusion and perfusion imaging for the diagnosis and 
follow-up of head and neck cancers. 
3. To discuss diagnostic pitfalls and how they can be avoided with 
multiparameteric imaging. 
Author Disclosure: 
  M. Becker: Grant Recipient; Swiss National Science Foundation SNSF grant 
No 320030_173091/1 Multiparametric and quantitative imaging in head and 
neck squamous cell carcinoma. 
11:55  
Panel discussion: The way of maintaining and improving quality of Swiss 
radiology  
10:30 - 12:00 Room G  
EFOMP Workshop: Radiation dose management systems and 
repositories: the present and the future  
EF 2  
Dose management systems and 
repositories: part B  
Moderator: 
M. Mahesh; Baltimore, MD/US  
A-456 10:30  
Chairperson's introduction  
M. Brambilla; Novara/IT (marco.brambilla@maggioreosp.novara.it)  
The purposes of this session are to provide an overview of imaging and dose 
repositories, to explain the possibilities and limitations of current 
implementations and standards, to illustrate the technical challenges faced by 
already established dose index registries, such as the ACR dose index 
registry, and to emphasize the role that such systems could have in boosting 
researches on radiation protection. This session will introduce the IHE REM 
profile as one of the potential benchmark standard, explaining its limitations in 
the field of radioprotection and how this standard could be complemented by 
other technologies to cover present and future needs in the domain of 
radioprotection and biomedical research. An overview of the services provided 
by imaging and dose repositories will be provided illustrating how these 
services could be used in the field of radioprotection and biomedical research. 
The issues of security, data protection, privacy and other legal issues 
associated with the implementation of such repositories will be discussed. 
Finally, an existing and well established example of dose repository systems, 
such as the ACR dose index registry, will be introduced and illustrated in its 
past technical development and in its future perspectives.  
Session Objectives: 
1. To provide an overview of imaging and dose repositories. 
2. To understand the main strengths and limitations of these systems. 
3. To understand why dose management systems and repositories are capable 
of supporting research. 
  







A-457 10:35  
Organisation of dose management systems and repositories for radiation 
protection and biomedical research: possibilities and limitations of 
current implementations and standards  
B. Gibaud; Rennes/FR (bernard.gibaud@univ-rennes1.fr)  
Radiation protection and related biomedical research require that dosimetric 
information can be estimated and shared. To meet this objective, the 
integrating HealthCare Enterprise initiative developed an integration profile 
called radiation exposure monitoring (REM). This profile "facilitates the 
collection and distribution of information about estimated patient radiation 
exposure resulting from imaging procedures". This profile specifies the roles of 
the various actors involved, namely: ‘Imaging modality’, that creates and 
transmits the dose information; the ‘Image Manager/Image Archive’ that may 
store and manage dose objects; the dose information consumer (e.g., 
implemented in a RIS or a reporting workstation) that may query/retrieve and 
analyze such dose objects; the ‘Dose Information Reporter’ that may submit 
dose information to national or regional repositories implementing a ‘Dose 
register’ actor. The presentation will introduce this integration profile and 
present in detail the DICOM objects and services involved in the previous 
transactions. The presentation will highlight the possibilities and the limitations 
of this profile, especially regarding the DICOM encoding of the dose reports. It 
will also introduce other complementary technology, based on the semantic 
web technologies, that allow complementing these standards, in a way that is 
compatible with the needs of biomedical research.  
Learning Objectives: 
1. To introduce the IHE REM profile. 
2. To discuss its relevance and limitations regarding radiation protection needs. 
3. To introduce other technology that may complement IHE REM to cover 
future needs of both radiation protection and biomedical research. 
A-458 11:05  
Imaging and dose repositories: tools to boost radiation protection and 
research?  
E. Neri; Pisa/IT (emanuele.neri@med.unipi.it)  
The dose monitoring tools allows a precise internal audit of the dose behaviour 
in the radiological department, tracking the general dosimetric trend, that 
mainly depend on the adopted imaging protocols. Such imaging protocols are 
frequently designed by an anatomical orientation with few concern about the 
specific clinical context in which the exam is performed. In parallel the attention 
of dose reference levels (DRL) is oriented to the anatomical segments, and not 
the clinical context.  
Learning Objectives: 
1. To provide the rationale of imaging and dose repositories. 
2. To describe the services provided by imaging and dose repositories. 
3. To understand the security, legal and other issues associated with the 
implementation of imaging and dose repositories. 
Author Disclosure: 
  E. Neri: Advisory Board; QUIBIM. 
A-459 11:35  
The ACR dose index registry: setting a benchmark  
M. Mahesh; Baltimore, MD/US (mmahesh@jhmi.edu)  
Radiation dose information is essential towards establishing standards, 
reviewing and optimising protocols, to develop safe imaging practices. In this 
regard, Dose Index Registry (DIR) is one of the registry with in National 
Radiology Data Registries (NRDR) hosted by the American College of 
Radiology (ACR). Launched in 2011, the ACR-DIR is a tool for quality 
improvement enabling facilities to review dose indices and optimise protocols. 
The goal of ACR-DIR is to assist in establishing national and regional 
benchmarks and practice patterns and to develop patient size specific 
diagnostic reference levels (DRLs). As of now, ACR-DIR is primarily collects 
CT dose data, however, it has plans to expand registry for interventional 
fluoroscopy, computed and digital radiology ,and nuclear medicine. The 
presentation will discuss what is DIR and how it works, the type of CT dose 
data collected and reported. Presentation will also discuss how certain sites 
are using feedback from DIR reports to plan, implement, and measure the 
success of CT dose reduction program. Technical implementation issues a site 
needs to address upon signing with the registry will be discussed. Finally, the 
presentation will discuss how DIR data were used to establish US national 
dose levels for the most common adult CT examinations based on patient size.  
Learning Objectives: 
1. To give an overview of the ACR dose index registry. 
2. To understand issues related to technical implementation of the registry. 
3. To learn about the new prospects of the ACR dose index registry. 
10:30 - 12:00 Room M 2 
PIER @ ECR Session  
PI 1  
Establishing competence in radiology  
Moderators:  
J. McNulty; Dublin/IE  
P. Valdés Solís; Marbella/ES  
A-460 10:30  
Achieving homogeneity in radiology education: linking content to 
competence through the European training curriculum  
L. Oleaga Zufiría; Barcelona/ES (lauraoleaga@gmail.com)  
There is a great heterogeneity in the training programmes across Europe. The 
curriculum defines the process of training and the competences needed to 
ensure trainees provide a high-quality service after the completion of the 
training programme. The European Training Curriculum (ETC) represents a 
guide to standardised education and harmonise skills and competences among 
radiologists in Europe. Assessment of the competences acquired during the 
training period is not harmonised and there is not a standardised method 
applicable to all European countries. A common e-Portfolio with the individual 
record of each year trainee’s progress, based on the European Training 
Curriculum (ETC) could be a useful tool to standardise education. A final 
examination to assess clinical competence is not mandatory in all countries. 
The European Diploma in Radiology (EDIR) represents a valuable certificate to 
standardise and facilitate the accreditation of radiologists across the EU 
borders. Education is evolving; new technologies and innovative approaches 
are integrated into the radiology field. e-Learning online activities, simulator 
programmes and artificial intelligence are getting incorporated into the clinical 
work and training. Trainees must embrace and participate in value-adding 
activities in radiology using guidelines and appropriateness criteria to lead 
imaging decisions to provide high-value care. Communication skills in 
radiology including the interaction between radiologists, radiographers, 
referring physicians, and patients constitute important aspects of radiology 
education; failure of communication can result in negative results. They have to 
be trained in communication and conflict management. Learning these skills is 
critical for their future.  
Learning Objectives: 
1. To discuss the impact of major inhomogeneities on European radiology. 
2. To describe the European training curriculum's role in achieving 
homogeneity and the importance of linking content to competence. 
3. To evaluate the current status and what must happen next in radiology 
education. 
A-461/A-462 10:45  
Establishing competence in radiology: a UK perspective  






Radiology training in the UK is undertaken in quality assured training 
programmes, over 5 years for clinical radiology, 6 years for subspeciality 
training in interventional radiology and aspires to produce proficient 
radiologists. National systems of assessing competence in the UK are divided 
into summative formal examinations and formative workplace based 
assessments (WPBAs). Allied to these are local evaluations of performance in 
specific techniques such as acute ultrasound and CT. Formal examination 
material is rigorously tested for validity and reliability, and the Royal College of 
Radiologists (RCR) sets national standards. Although examinations address 
knowledge and some elements of competence, they are weaker in assessing 
performance. Passing examinations does not invariably equate to trainees 
performing satisfactorily in the workplace. Although WPBAs occur in clinical 
departments and addresses trainees’ performance of day-to-day tasks, they 
are only used formatively as mandated by national guidance. The RCR is 
improving standardisation, with particular emphasis upon the oral (viva) 
component of the final FRCR examination, to ensure similar material is seen by 
all candidates and it is blueprinted to the curriculum. WPBAs are being revised 
to remove most scoring, allowing greater use of free text comment to help 
trainees’ development. The RCR curricula are being rewritten, and specific 
assessments mapped to individual areas. This ensures that the evaluation of 
competence covers all subjects, both generic and radiology specific. National 
roll-out and training of assessors and examiners are particularly important 













1. To explore the current UK structures for establishing competence in 
radiology. 
2. To discuss the challenges and opportunities arising from these systems. 
3. To consider the key steps to facilitate the successful implementation of a 
competence system in radiology. 
A-463 11:00  
The value of the European Diploma  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se)  
The number of young colleagues in Europe that site for the European Diploma 
in Radiology (EDiR) is constantly increasing and the number of examinations 
performed per year is now 8 with a potential to further increase in the coming 
years. In some countries the EDiR is part of the educational program for 
radiology residents. In some countries the Diploma has been discussed to, in 
part, replace national examination. The curriculum level I and II for residents in 
training is the ground for the EDiR while level III is considered 
subspecialisation and is therefore, not covered in questions and cases at the 
current form of EDiR. By establishing the EDiR and increase the number of 
participants sitting the exam reinforces the homogenization of the radiology 
education and training in Europe which is favourable for the residents 
regardless of country and may in the future open the European market or 
young radiologist to seek work outside their own country - a more flexible 
market.  
Learning Objectives: 
1. To demonstrate the value of the European diploma in overcoming issues 
relating to competence. 
2. To discuss the areas of competence which are currently outside the scope 
of the European diploma. 
3. To propose a route through which the European diploma could form part of a 
European radiology competence structure. 
Author Disclosure: 
  P.C. Maly Sundgren: Board Member; chair written evaluation committee, 
member of the EDiR Scientific Board, member in the ESR Research 
committee. 
A-464 11:15  
Obstacles to establishing competence in radiology  
P. Valdés Solís; Marbella/ES (pabvalsol@gmail.com)  
A competence focused professional system in Radiology is important to 
improve quality and safety. The Spanish Society of Radiology, aware of this, 
began a strategy to develop an advanced system of measuring competence in 
radiology. We had the first experience in interventional radiology and after 
creating a working group and defining the model, a book including the 
competence elements was successfully published. However, when trying to 
adapt the model in other radiology subspecialities, the experience was 
everything but successful: we realized that spanish radiologist did not believe 
in the necessity of going through an exam of their performance and 
competence. Now we are facing a new chance to give life to the project, 
because the Spanish National Medical Association will ask their members to 
apply for a professional validation which, though not compulsory, will probably 
be the standard. The Spanish Medical Association has asked SERAM to define 
the minimum required to radiologist to get the professional validation, so just 
minimal changes in the competence model will be needed. Our experience 
was useful to redesign the way of facing complex projects as this. First of all, 
you have to face the possibility of rejection. Many radiologists in Spain are civil 
servants, and won't get many advantages when passing a competence 
evaluation exam, and personal recruitment is not designed taking into account 
professional competence in many cases. Knowing this, we are now facing a 
new project that we hope will be successful in a few years.  
Learning Objectives: 
1. To show the difficulties that, as a Society, the Spanish Society of Radiology 
has faced in order to establish a national system of competences. 
2. To explain why radiologists are reluctant to join competence programmes, 
especially those that are not proposed by their own health authorities. 
3. To discuss the strategies that should be kept in mind before beginning a 
national competence programme in order to get radiologists compliance and 
participation. 
A-465 11:30  
How to manage the incompetent professional?  
J.K. Bell; Manchester/UK (Jon.Bell@christie.nhs.uk)  
Radiologists must achieve and maintain a certain level of competence to be 
safe and effective. However, the definition of competence is challenging and 
may differ between countries. European accreditation continues to develop to 
define standards of practice in order to ensure that Radiologists perform to an 
acceptable level. There are multiple factors that influence performance in the 
work place and these need to be addressed to ensure a healthy working 
environment. Early signs that a Radiologist is experiencing professional and/or 
personal difficulties should be identified and addressed within a supportive 
management structure. Here we explore clinical competence, optimisation of 
the working environment, identification of colleagues in difficulty and the 
development of a supportive management structure.  
Learning Objectives: 
1 To define competence and how to identify radiologists in difficulty. 
2. To assess factors that lead to poor performance and what can be done to 
promote well-being. 
3. To outline processes for helping incompetent radiologists and managing 
those that cannot be helped. 
11:45  
Panel discussion: Overcoming heterogeneity in radiology competence 
across Europe: a dream or reality?  
10:30 - 12:00 Room M 4 
E³ - ECR Academies: State-of-the-Art and Advanced MR Imaging 
of the Musculoskeletal system  
E³ 1019  
Knee  
A-466 10:30  
Chairperson's introduction  
J. Kramer; Linz/AT (kramer@ctmri.at)  
In this session acute postraumatic as well as chronic disorders leading to 
pain/complaints in the knee region are focussed on. Further more 
postoperative changes including postop. complications are debated. To some 
extent technical considerations for imaging of the cartilage and to avoid 
artifacts are mentioned. At the beginning of the session some cases are 
demonstrated and the final diagnosis is shown after the end of the 3 lectures.  
A-467 10:35  
A. Post-traumatic  
A.P. Parkar; Bergen/NO (apparkar@gmail.com)  
Knee trauma with injury of the menisci, ligaments, cartilage and bone, all 
contribute to the development of osteoarthritis. Acute/traumatic meniscal 
ruptures run obliquely or vertically and affect the articular surface (either 
femoral or tibial). Degenerative ruptures run horizontally and do not affect the 
articular surfaces. Long standing chronic ruptures thin out the meniscus and 
lead to lateral extrusion. Complex ruptures with displaced fragments, be it 
medially/anteriorly/posteriorly, need to be treated swiftly as they cause knee 
locking. Considering isolated injury to the lateral knee stabilisers, a total 
rupture is important to recognise, as this requires surgical reconstruction, while 
partial ruptures are treated conservatively. Chronic injuries may be recognised 
by healed bony avulsion (like Segond or Pellegrini Stieda). MRI findings of 
ruptured ACL with direct and indirect signs is well established. Awareness of 
the reporting “not to be missed” concomitant injuries (posterolateral corner, 
anterolateral ligament, meniscal root avulsions) is on the rise. Chronic post-
traumatic ACL may develop mucoid degneration or ganglion cysts within the 
ligament. The acute PCL injury is recognised when fibres are disrupted, or with 
high signal and when thickened >8mm. An indirect sign is posterior sagging of 
the medial tibia. It is important to know that intact PCL fibres does not exclude 
a chronic PCL injury, as MRI has very low sensitivity and indirect signs may be 
the only clue. Patella luxations may occur due to underlying dysplasia or 
severe trauma. The acute findings are femoral/patellar bone edemas, rupture 
of the medial retinaculum, and cartilage damage.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To know the role of MR imaging and MR arthrography (direct/indirect). 
3. To differentiate post-traumatic changes from typical reasons for chronic 
pain. 
A-468 11:03  
B. Chronic pain  
P. Van Dyck; Antwerp/BE (pieter.van.dyck@uza.be)  
Many conditions can cause or contribute to chronic knee pain, including 
trauma, degenerative disease, infections, connective tissue disorders, 
metabolic disorders, and tumors. Imaging continues to play an important role in 
  







the assessment of these entities to select an appropriate treatment. This 
presentation will give an overview of the most common entities leading to 
chronic knee pain and discuss the basic and advanced imaging methods for 
evaluating the knee joint with particular emphasis on MR imaging techniques 
(including 2D and 3D turbo-spin-echo, 3D gradient-echo, 3D ultrashort echo-
time and quantitative mapping techniques). Degenerative osteoarthritis (OA) is 
the most common form of chronic knee arthritis. It is currently diagnosed using 
clinical and radiographic findings. However, in recent years, MRI has 
increasingly been used to study OA. The diagnostic utility of MRI for diagnosis 
of OA in a clinical setting will be discussed. Chronic anterolateral rotatory laxity, 
typically occurring after injury of the anterior cruciate ligament (ACL) or ACL 
surgery, is a major cause of degenerative OA. A brief update will be provided 
on the anatomy of the anterolateral knee complex (including the superficial and 
deep fibers of the iliotibial tract and the anterolateral ligament) and how to 
assess it on MR images. Finally, clinical case series will illustrate how to 
differentiate entities leading to chronic pain from post-traumatic changes. 
Learning Objectives: 
1. To identify the most common entities leading to chronic pain. 
2. To know the role of MR imaging in evaluating cartilage (including new 
techniques). 
3. To differentiate entities leading to chronic pain from post-traumatic changes. 
A-469 11:31  
C. Postoperative  
P.M. Jungmann; Zurich/CH  
Surgical techniques and MR imaging techniques are undergoing continuous 
developments and optimization. At the knee, frequently a standard MR imaging 
protocol is sufficient to account for most clinical queries; however, cases in 
which dedicated protocols and sequences, intravenous contrast administration 
or intraarticular contrast administration (arthrography) are required will be 
demonstrated as well. Current orthopedic surgical techniques with respect to 
ligament, meniscus and cartilage reconstruction at the knee will be explained 
to allow the radiologist to provide specific information to the demanding 
orthopedic surgeon. Knowledge of the techniques is crucial to fulfill the 
expectations and requirements of the clinicians. This part of the knee session 
discusses normal and pathological postoperative findings on MR imaging of 
the knee during postoperative follow-up after several knee surgeries, such as 
ligament reconstruction (ACL, PCL, MPFL), meniscectomy and meniscus 
repair and after different cartilage repair techniques. Typical and severe 
complications will be pointed out using clinical examples. Particularly, also 
novel metal artifact reduction sequences (MARS) will be explained using 
examples of knee prostheses and other implants. Not only technical 
background knowledge, but also typical postoperative findings at the knee will 
be discussed, that may be depicted using these new sequences. The session 
aims to provide clinically important knowledge on MR techniques and 
postoperative findings at the knee to the interested MSK- or non-MSK 
radiologist.  
Learning Objectives: 
1. To identify the most common postoperative changes. 
2. To know the role of MR imaging and how to optimise protocols for 
postoperative imaging including the use of MR arthrography. 
3. To understand the different techniques of ligament reconstruction and 
meniscal repair and their complications. 
13:00 - 13:30 Room A 
Headline Session  
HL 2  
Marie Curie Honorary Lecture  
Presiding:  
B. Hamm; Berlin/DE  
A-486 13:00  
Hybrid imaging: the story so far and what to expect next  
K. Riklund; Umea/SE (katrine.riklund@umu.se)  
Hybrid imaging, the combination of structural and functional or molecular 
imaging started with visual and software fusion and has developed into new 
scanners with hardware fusion of PET or SPECT together with CT or MRI. 
During the session I will take you on an amazing tour behind the scenes in 
secret chamber; the human body, visualised in structures and biochemistry, 
and molecular medicine. I will present a fascinating story of the development of 
something really astonishing on one hand and on the other hand something 
you cannot be without in daily imaging work.  
 
Learning Objectives: 
1. To learn about the development of hybrid imaging. 
2. To understand the principles for molecular imaging exemplified in PET/CT 
and MR/PET. 
3. To appreciate the combination of molecular and functional imaging. 
4. To become familiar with a few clinical areas with high potential in hybrid 
imaging. 
Author Disclosure: 
  K. Riklund: Advisory Board; cienticit advisory board Swedish Drug authority. 
Speaker; GE, Paris meeting 2016, Nordic Conf in Radiology 2017 Iceland. 
12:30 - 13:30 Room C 
E³ - The Beauty of Basic Knowledge: Cardiovascular and 
Interventional Radiology  
E³ 24C  
Open and closed: the role of radiology in 
treatment of valvular heart disease  
Moderator:  
M. Gardarsdottir; Reykjavik/IS  
A-483 12:30  
How to approach valvular heart disease using MRI  
A. Redheuil; Paris/FR (alban.redheuil@gmail.com)  
Magnetic Resonance Imaging (MRI) has recently evolved as a comprehensive 
modality to provide a reference non-invasive assessment study of cardiac 
remodeling and dysfunction related to valvular disease, but also to quantify 
valvular dysfunction - either stenotic or regurgitant valvular lesions - using 2D 
and 4D phase contrast-based flow imaging. Furthermore, comprehensive 
vascular assessment such as of the thoracic aorta or pulmonary arterial tree is 
feasible within a single exam. If MRI is established for the assessment of 
complex congenital valvular and heart disease it may also be very helpful in 
case of incomplete or non-diagnostic echocardiography to evaluate valvular 
disease mechanism, anatomy and quantify disease severity in the more 
common valvular heart disease settings. Finally, new myocardial mapping tools 
may provide an insight into myocardial tissue changes including diffuse fibrosis 
that may be at play in valvular heart disease and precede heart failure. A 
review of the aforementioned issues and potential value of MRI in valvular 
heart disease will be provided in this lecture.  
Learning Objectives: 
1. To learn about the MR techniques available for functional assessment in 
valvular heart disease. 
2. To understand possibilities and limitations of cardiac MR in valvular heart 
disease. 
3. To appreciate the advantages of cardiac MR in valvular heart disease. 
A-484 13:00  
What to measure prior to transcatheter aortic valve implantation (TAVI)  
R. Salgado; Antwerp/BE (rodrigo.salgado@uza.be)  
Aortic valve stenosis is the most common valvular heart disease in the Western 
World. When symptomatic, aortic valve stenosis is a debilitating disease with a 
dismal short-term prognosis invariably leading to heart failure and death. 
Elective surgical valve replacement is traditionally considered the standard of 
care for symptomatic aortic valve stenosis. However, several studies have 
identified various subgroups of patients who have a significant elevated risk for 
operative complications and death. Accordingly, not every patient is suitable for 
surgery. Recent developments in transcatheter-based therapies have provided 
an alternative therapeutic strategy for the non-surgical patient population, 
replacing the native aortic valve by a bioprosthetic valve brought in place using 
a non-surgical endovascular or trans-apical pathway. This procedure has been 
named transcatheter aortic valve replacement or implantation (TAVR, TAVI), or 
also percutaneous aortic valve replacement (PAVR). Nevertheless, several 
anatomic and technical criteria have to be fulfilled to safeguard procedural 
eligibility and success. Therefore, there is a crucial role for non-invasive 
imaging in both patient selection and subsequent matching to a specific 
transcatheter valve size, to ensure accurate prosthesis deployment and 
minimize peri- and post-procedural complications. In this lecture, the relevant 
anatomy will be reviewed, emphasising anatomic pitfalls, their implications for 
correct reporting of imaging-derived measurements, and highlighting important 
differences between imaging modalities. Furthermore, the evolving role of CT-
imaging and the role of the radiologist in the triage of patients will be 
discussed, reviewing current viewpoints in both patient and proper device size 
selection and the pre-procedural evaluation of the possible access routes.  
  








1. To learn about prerequisites prior to TAVI. 
2. To understand the importance of accurate measurements for TAVI planning. 
3. To appreciate the need for communication with implanting physicians. 
12:30 - 13:30 Room D  
E³ - The Beauty of Basic Knowledge: A Survival Guide to 
Musculoskeletal Imaging  
E³ 25C  
Bone tumours  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK  
A-485 12:30  
Bone tumours  
K. Wörtler; Munich/DE (klaus.woertler@tum.de)  
The diagnosis of a bone tumour is based on clinical findings, the age of the 
patient, the location of the lesion, its radiologic appearance, and if imaging 
does not allow for a specific diagnosis, its histopathologic features. 
Radiography remains the initial imaging modality for evaluation of the 
localisation of the lesion with respect to the longitudinal and axial planes of the 
involved bone, for the depiction of matrix mineralisation, and for estimation of 
biologic activity by analysing the patterns of bone destruction and periosteal 
response. CT is typically used to obtain “radiographic” information in regions of 
complex skeletal anatomy such as the skull, spine, pelvis and shoulder girdle. 
MR imaging is best suited to determine the local extent of a bone tumour (local 
staging), but can also be helpful to narrow the differential diagnosis in specific 
lesions such as cysts and cartilage-forming tumours. With a clear emphasis on 
conventional radiography, this course will review the basic imaging features of 
the most common benign and malignant bone tumours. Important radiographic 
findings, such as bone destruction patterns, types of periosteal reactions and 
matrix mineralisation, will be explained step by step in correlation with 
histopathology as well as advanced imaging techniques. 
Learning Objectives: 
1. To become familiar with the imaging features of benign and malignant bone 
tumours. 
2. To appreciate their imaging characteristic hallmarks on plain film 
radiography. 
3. To learn how best to use imaging modalities in differential diagnosis. 
12:30 - 13:30 Sky High Stage 
Special Focus Session  
SF 10  
Artificial intelligence (AI) applications  
A-990 12:30  
Chairperson's introduction  
A. Brady; Cork/IE (adrianbrady@me.com) 
As artificial intelligence increases its penetration into all aspects of life, 
radiology will change in the future. Radiology reports will become more 
standardised in format and language, and will become rich sources of 
information for teaching, research and machine learning, feeding back into a 
loop of continuing improvement of technological tools. This session will explore 
how these processes will operate, how radiology report data will be mined and 
utilised in the future, and what issues this will highlight in terms of data 
ownership and protection.  
Session Objectives: 
1. To explain the likely future development of structured reporting. 
2. To highlight the opportunities which will arise from availability of radiological 
data in formats which can be searched and used as imaging biobanks. 
3. To discuss the data protection issues which arise from these developments. 
A-991 12:35  
Imaging biobanks  
B. Gibaud; Rennes/FR (bernard.gibaud@univ-rennes1.fr) 
Significant progress in computer-aided or even automated image interpretation 
are expected in the near future. Machine learning and assessment of the 
performances of these new tools will require large quantities of annotated 
image data. The development of imaging biobanks should be able to provide 
such data. The presentation will summerise the challenges of gathering large 
sets of image data, either from past clinical research studies, or from large 
cohorts and population studies. Particular emphasis will be put on the definition 
of consensual ontological models to guarantee a good standardisation of 
semantics borne by image annotations. Indeed, the latter must cover a wide 
scope from general characteristics of the clinical cases (e.g. known pathology, 
patient sex and age) up to quantitative image biomarkers derived from the 
images. The issue of relating image data to other biological data (e.g. genetic / 
genomic) will be underlined, justifying a strategy of designing information 
models for imaging biobanks that are consistent with those used in biobanking 
(e.g. BBMRI-ERIC). 
Learning Objectives: 
1. To discuss the role that the imaging biobanks can play in providing the data 
necessary for machine learning and for the assessment of the performances of 
diagnostic tools. 
2. To understand the role ontologies play in the standardisation of image 
annotations in imaging biobanks. 
3. To understand the need to collaborate with the domain of (specimen) 
biobanking. 
A-992 12:50  
Big data and structured reporting  
D. Pinto dos Santos; Cologne/DE  
There has been a tremendous increase in interest towards artificial intelligence 
and machine learning applications in radiology. In order for such systems and 
algorithms to perform sufficiently well, large amounts of training data are 
required. These data need to be either standardised and of adequate quality or 
available in large enough amounts, that enough relevant information can be 
extracted. However, in current clinical and radiological IT ecosystems access 
to relevant pieces of information is difficult. This is mostly due to the fact, that a 
large portion of information is handled as a collection of narrative texts and 
interoperability is still lacking. This lecture will give an overview on how 
structured reporting can help to facilitate research in artificial intelligence and in 
the context of big data. Potential approaches to implementing structured 
reporting will be discussed, focusing also on interoperability and 
standardisation. 
Learning Objectives: 
1. To discuss the data requirements for artificial intelligence and big data. 
2. To understand how structured reporting can facilitate research in machine 
learning. 
3. To become familiar with informatics standards, relevant to structured 
reporting. 
A-993 13:05  
Data control in the era of AI: man or machine?  
P.M.A. van Ooijen; Groningen/NL (p.m.a.van.ooijen@umcg.nl) 
Recent years has shown an explosive growth in the use of Artificial Intelligence 
(AI) and Deep Learning not in the least for medical applications. These new 
technological developments have started a whole new discussion on privacy of 
data processed by these computerised systems. Especially those applications 
in health care demand a high level of patient privacy and patient data security. 
The actual ownership of medical data is also part of this discussion where we 
can have different situations with original, de-identified, anonymised and 
processed data. Questions like what data is still personal data for an individual 
patient or participant in a clinical trial and who actually owns the data that is 
produced with self-learning computer systems. This educational course will 
discuss these issues with respect to ownership, intellectual property and the 
different aspects that are involved in this when moving towards the era of AI. 
Learning Objectives: 
1. To understand the current and future role of data. 
2. To understand the issues surrounding data control and ownership. 
3. To discuss the role of AI in the future of radiology. 
Author Disclosure: 














14:00 - 15:30 Room K  
EFRS meets Switzerland and Portugal  
EM 4  
EFRS meets Switzerland and Portugal  
Presiding:  
J. McNulty; Dublin/IE  
M. Mordasini; Berne/CH  
J. Santos; Coimbra/PT  
Moderators:  
J. McNulty; Dublin/IE  
I. Gremion; Lausanne/CH  
J. Santos; Coimbra/PT  
A-493 14:00  
Introduction  
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie)  
Introduced for the first time for ECR 2013, the ‘EFRS meets’ sessions follow 
the tradition of the ‘ESR meets’ sessions and give the European Federation of 
Radiographer Societies (EFRS) the opportunity to highlight the contribution of 
one of their member societies to the profession of radiography each year. 
Having met Spain (2013), Russia (2014), Germany (2015), Sweden (2016), 
and Belgium (2017), all of which were the home countries of the congress 
presidents in the respective years, the EFRS will meet both Portugal and 
Switzerland, which are two of the ‘ESR meets’ countries for 2018. Both the 
Portuguese society, Associação Portuguesa dos Técnicos de Radiologia, 
Radioterapia e Medicina Nuclear (ATARP), and the Swiss society, 
Schweizerische Vereinigung der Fachleute für Medizinisch Technische 
Radiologie (SVMTRA) were founding members of the EFRS in 2008. We also 
now count five Portuguese and two Swiss educational institutions among the 
affiliate members that make up our Educational Wing. Portuguese and Swiss 
radiographers alike come from strong organisational and educational 
backgrounds; they contribute to radiography research and continue to 
contribute to the activities of the EFRS.  
Session Objective: 
1. The introductions will give a very short overview of the aim and history of the 
Meets sessions (EFRS president) and the characteristics of Portugal and 
Switzerland (association presidents). 
A-494 14:05  
Introduction: Across Switzerland  
M. Mordasini; Berne/CH (michela.mordasini@insel.ch)  
Although not member of the European Union, Switzerland is closely integrated 
with the EU by bilateral sectoral agreements, known as Bilateral one and 
Bilateral two. By these contracts, free movement of persons between 
Switzerland and EU (and vice versa) is warranted and certifications and 
diplomas in the field of medicine, esp. also in the field of radiological 
technicians are recognised on both sides as long as the training has been 
similar to the equivalent Swiss qualification, which means, that the content and 
duration of training must be comparable. With respect to the four Swiss-
national languages the bilateral exchange of technicians comes to pass mainly 
between Ticino and Italy, Bern/Basle/Zürich with Germany and Austria and 
Lausanne/Geneva with France, whereas the official language of Romance is 
used in the small southeastern Swiss canton Grisons mostly alongside with 
German, French or Italian. The radiographer qualification in Switzerland is 
based on a 3 or 4 year training in an advanced technical college and covers 
special courses in Diagnostic Radiology, Radio-Oncology and Nuclear 
Medicine. Most of the radiographers, working in one of about 630 radiological 
institutes (including radio-oncology and nuclear medicine) of swiss hospitals or 
in one of about 150 private radiological practices have been trained in a 
university of applied medical science or a college of higher education in 
Switzerland, which train and certify about 125 technicians each year. This is 
not enough, thus about one third of the 3,496 technicians, working in 
Switzerland at the moment have been trained abroad. 
Learning Objective: 
1. The introductions will give a very short overview of the aim and history of the 
Meets sessions (EFRS president) and the characteristics of Portugal and 
Switzerland (association presidents). 
 
 
A-495 14:10  
Introduction: Across Portugal  
J. Santos; Coimbra/PT (presidente@atarp.pt)  
Portugal is a European Union country with the 10 millions of habitants. The 
total land area is 91,590 Km2 with 850 Km of splendid beaches bathed by the 
Atlantic Ocean. Per year Portugal has around 3000 hours of sun however 
66.3% of the population is urban. The number of medical imaging equipment’s 
is higher than the Organisation for Economic Co-operation and Development 
(OECD) recommendations. Structurally the supervisory authorities in the area 
of ionising radiation for medical exposures in Portugal are Regional Health 
Administrations, the Nuclear Technological Institute and the Health Authorities. 
The Portuguese health system is divided in five Regional Health 
Administrations (ARS). These government agencies ensure the efficiency of 
health care and manage the human and technical resources. They are 
responsible for the enforcement of the provisions of the Portuguese law 
regarding the facilities to radiology practice. Portugal has three dedicated 
Paediatric Hospitals and three further sites with specialised paediatric services, 
which have a 24 hour service, a large proportion of paediatric medical imaging 
examinations are performed in adult hospitals. The National Health Service 
(Serviço Nacional de Saúde) meets Portuguese healthcare needs. The 
majority of health care institutions are public but the number of private 
institutions had increased on the last decades.  
Learning Objective: 
1. The introductions will give a very short overview of the aim and history of the 
Meets sessions (EFRS president) and the characteristics of Portugal and 
Switzerland (association presidents). 
A-496 14:15  
Radiographers in Switzerland: challenges and chances  
Y. Jaermann; Vevey/CH (yves.jaermann@hopitalrivierachablais.ch)  
Our profession is relatively new in Switzerland. It remains largely unknown by 
the general population as well as by other health professionals. The current 
political and economical context obliges us to explore ways in which to defend 
the position of our profession in the health community. While certain 
professions seek to take over important areas of established radiography skills, 
an update of our training system is absolutely indispensable. At the same time, 
it is vital for us to develop new areas of activity that will allow the profession to 
acquire the recognition that it deserves. 
Learning Objectives: 
1. To understand the curriculum of the Swiss radiographers' education and 
CPD. 
2. To acknowledge the competition with other professions and the need for 
new skills and activities. 
3. To evaluate the next steps to professional independence. 
A-497 14:30  
The Portuguese NHS: the structural pillar that strengthens Portuguese 
democracy  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt)  
Over four decades Portugal has been governed under a dictatorship system, 
leading our country into one of less developed in Europe, specially in the 
education and health system. On the 25th of April of 1974 a military-led coup 
put an end to the 40 years of dictatorship, through what is called the “revolução 
dos cravos”, named to the fact that from one day to another, and without a civil 
war or any kind of deaths, Portuguese went to bed in a dictatorship regime and 
woke up in a Democracy. One of the main pillars on which the Portuguese 
democracy has been raised is the SNS (Serviço Nacional de Saúde): 
Portuguese NHS. The SNS guaranties equal rights and equal access to all 
Portuguese, independently of age, gender, race, religion, with no social or 
economic discrimination. Due to the qualitative and civilisational improvement 
raised from the creation of the Portuguese SNS, Portugal, in the last 38 years, 
has passed from one of the countries with the worse health indicators to one of 
the top 10 WHO ranking. The quality of the education of radiographers and 
radiologists is highly recognised, honouring the Portuguese Nobel prize in 
Medicine, Egas Moniz (1949), that aside from several achievements in the field 
of neurosurgery was the pioneer of the cerebral angiography. Medical imaging 
in Portugal had an important role in the national program against the incidence 
and prevalence of tuberculosis. Portugal was also one of the first European 
countries to successfully implement a national mammography screening 
program.  
Learning Objectives: 
1. To learn about the development of the Portuguese NHS. 
2. To understand the impact of the Portuguese NHS in the social development. 
3. To learn about the role of radiology in improving the Portuguese health 
indicators. 
  







A-498 14:45  
(Helv)ethic: from a project to a new culture  
F. Riondel; Geneva/CH (francois.riondel@hcuge.ch)  
At the University Hospital of Geneva, the radiographers collectively produced a 
document to improve the recognition of their profession within their institution. 
A reflexion spanning several years with the aim of clarifying their autonomy 
and responsabilities, and written as an ethical code, presented as a charter. 
Different elements of this charter reflect themes that are debated in the french 
speaking part of Switzerland or elsewhere in the country. It covers the 
development of a radiographer's expertise and recognition of the necessity for 
access to continuous professional education, centered around the patients 
needs. New ways of positioning the radiographer in the inter-professional 
partnership, increasing their autonomy and their independence for certain 
medicotechnical acts. 
Learning Objectives: 
1. To learn about a team building philosophy able to promote our profession 
and build new career opportunities. 
2. To understand the central role of radiographers within the growth and 
promotion of the professional environment and within the profession itself. 
3. To acknowledge the importance of patient care and human relationships in 
radiography. 
A-499 15:00  
MRI, the image modality for the future: hybrid, diagnostic and therapeutic  
V. Silva; Porto/PT (vitorsoft@gmail.com)  
Magnetic resonance (MR) is a medical imaging modality in permanent 
evolution. Nowadays, MR is becoming a hybrid technique, functioning for 
diagnostic and therapeutic considering the superb soft tissue contrast. 
Dedicated hybrid positron emission tomography (PET) combined with MR - 
PET/MR have been recently introduced and these equipments have the 
potential to combine the molecular and functional information of PET with MR 
excellent soft tissue contrast, perceiving better the localization of pathologies. 
PET/MR offers opportunities for more efficient, accurate and safe diagnoses. 
MR can be used to therapeutic methods when combined to a hybrid linear 
accelerator (linac). MR will provide optimal soft tissue contrast for image 
guidance in multiple sites in human body providing diagnostic quality images 
during treatment delivery, and, consequently, permitting very accurate image 
guided adaptive radiotherapy. Associated to these new paradigms on MR 
hybrid imaging, the knowledge of MR safety issues and considerations are 
fundamental for better practices. Knowing how a MR scanner works and its 
inherent physics is vital. For its functioning, MR has three different types of 
electromagnetic fields: (i) a static magnetic field; (ii) time varying gradient 
fields; and (iii) radiofrequency fields. These have different risks and hazards. 
The MR potential for improving the health care provided to patients is proved 
by the combination with other diagnostic and therapeutic imaging modalities.  
Learning Objectives: 
1. To recognise MRI as an image modality with great clinical potential for 
diagnosis. 
2. To learn about MRI/PET opportunities, challenges and new directions in 
clinical practice. 
3. To understand the MRI potential to improve radiotherapy planning and 
treatment. 
4. To be aware of MRI safety considerations and risks to promote best 
practices. 
15:15  
Panel discussion  
14:00 - 15:30 Room M 1  
EuroSafe Imaging Session  
EU 3  
Clinical diagnostic reference levels for x-
ray medical imaging  
A-500/A-501 14:00  
Chairpersons' introduction and update on the project on clinical DRLs for 
x-ray medical imaging  
J. Damilakis1, G. Frija2; 1Iraklion/GR, 2Paris/FR (damilaki@med.uoc.gr)1, 
(guy.frija@aphp.fr)
2 
Different image quality is needed for different clinical indications of the same 
anatomical area. Kidney stone evaluation, for instance, can be performed 
using lower radiation doses than those used in evaluation of appendicitis 
because detection of high-contrast structures is affected less by high image 
noise than low contrast structures. Clinical indications dictate the main 
parameters that affect patient dose from CT such as scanning length, 
collimation and number of phases. The EC launched the ‘European study on 
clinical diagnostic reference levels for X-ray medical imaging’ (EUCLID) project 
to provide up-to-date clinical DRLs. The main objectives of the project are to; 
(a) conduct a European survey to collect data needed for the establishment of 
DRLs for the most important, from the radiation protection perspective, X-ray 
imaging tasks in Europe; and (b) specify up-to-date DRLs for these clinical 
tasks. This introductory presentation will provide a brief update on EUCLID 
project.  
Session Objectives: 
1. To understand the general concept of diagnostic reference levels (DRLs), in 
particular clinical DRLs and the project on clinical DRLs for x-ray medical 
imaging. 
2. To learn about the current status of DRLs in paediatric imaging. 
3. To become familiar with the concept of local DRLs. 
A-502 14:05  
The concept of diagnostic reference levels (DRLs)  
E. Vaño; Madrid/ES (eliseov@med.ucm.es)  
Diagnostic reference Levels (DRLs) were introduced by the International 
Commission on Radiological Protection (ICRP) as a tool to help optimise 
medical imaging in diagnostic and interventional procedures. ICRP has 
published a new set of recommendations on DRLs (ICRP Publication 135; 
2017). Several issues have been updated: definitions of the terms used in 
previous guidance, determination of the DRLs values (including multimodality 
procedures), the appropriate interval for re-evaluating these values, 
appropriate use of DRLs in clinical practice and application of the DRL concept 
to newer imaging technologies. Weight bands are recommended for 
establishing paediatric DRLs. Concerning medical imaging tasks, the DRL 
values should be tied to defined clinical and technical requirements. The 
assessment of clinical image quality or the proper diagnostic information when 
multiple images are used should be performed as part of the optimisation 
process. ICRP has also included recommendations on establishing regional 
(for several countries) DRL values that can be based on either a representative 
sample of health facilities or on national DRL values. Regional DRL values 
may provide guidance on how to optimise the protection of neighbouring 
countries with no DRL surveys of their own. When relatively few national DRL 
values exist for the countries within a region, regional DRL values may be 
derived through a consensus of the region’s competent authorities. ICRP 
suggested that the problem to combine large and small countries could be 
dealt with by weighting national DRL values according to the population of 
each participating country.  
Learning Objectives: 
1. To understand the concept of DRLs in general. 
2. To learn about the International Commission on Radiological Protection's 
(ICRP) work and perspective. 
A-503 14:20  
The concept of clinical diagnostic reference levels (DRLs)  
G. Frija; Paris/FR (guy.frija@aphp.fr)  
Diagnostic reference levels (DRLs) are an important tool for optimisation. They 
are usually established for specific anatomical locations, although some 
countries established also DRLs based on clinical indications. This talk will 
highlight the advantages of this latter approach, and will briefly introduce the 
EUCLID project (European Study on Clinical DRLs), a European Commission 
tender project aimed at establishing DRLs on clinical indications. 
Learning Objectives: 
1. To become familiar with the concept of clinical DRLs. 
2. To learn about the EUCLID project. 
3. To learn about practical implications and advantages of clinical DRLs. 
A-504 14:30  
An update on current European diagnostic reference levels (DRLs) in 
adult imaging  
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr)  
he clinical indication is the main determinant of patient radiation dose. 
Therefore, DRLs should be specified for a given clinical indication. The 
‘European study on clinical diagnostic reference levels for X-ray medical 
imaging’ (EUCLID) project aims to specify up-to-date DRLs for the most 
important, from the radiation protection perspective, X-ray imaging tasks in 
Europe. A comprehensive review has been carried out to identify the status of 
existing clinical DRLs for CT, interventional radiology and radiography in 
  







Europe and beyond by analysing recent studies, standards and publications. 
Information about existing clinical DRLs has also been collected from national 
competent authorities and other organisations involved in the project. A few 
national radiation protection authorities, only, have defined a limited number of 
DRLs for different clinical indications, so far. Although a large number of 
studies on doses from X-ray imaging are available, there is very limited 
information about clinical-indication specific DRLs.  
Learning Objectives: 
1. To learn about methodological requirements for establishing DRLs. 
2. To learn about the current status of DRLs in adult imaging in Europe and 
beyond. 
3. To understand why clinical DRLs are needed in adult imaging. 
A-505 14:45  
An update on current paediatric diagnostic reference levels (DRLs)  
C. Granata; Genoa/IT (cgranata@sirm.org)  
Particular attention should be paid to using diagnostic reference levels (DRLs) 
in paediatric radiology, as children are at higher risk compared to adults of 
being affected by the detrimental effects of radiations in some organs and body 
areas. However, only a few European countries have established paediatric 
DRLs, mostly for a limited set of examinations. The existing DRLs are often 
derived from old European Commission (EC) recommendations or from 
surveys conducted in other countries with inconsistent methodology and rarely 
updated. Furthermore, DRLs are still largely based on age and not on size, 
which can be very different among children of the same age. Recently, an EC 
project on new European guidelines for DRLs in paediatric Imaging (PiDRL) 
was assigned to a consortium directed by ESR with the involvement of ESPR, 
EFRS, EFOMP, and STUK. This project resulted in a series of 
recommendations concerning the appropriate methods to establish new 
paediatric DRLs. These recommendations define what is intended for local, 
national, and European paediatric DRLs, the set of examinations for which 
paediatric DRLs should be established, patient subdivision into groups, 
dosimetric parameters to be considered, and instructions on how to make good 
use of paediatric DRLs.  
Learning Objectives: 
1. To become familiar with paediatric DRLs. 
2. To learn about the European Guidelines on DRLs for Paediatric Imaging 
(PiDRL). 
3. To learn about recent work undertaken by the ESR to establish paediatric 
DRLs. 
A-506 15:00  
The concept of local diagnostic reference levels (DRLs)  
N. Saltybaeva; Zurich/CH (Natalia.Saltybaeva@usz.ch)  
Diagnostic reference levels (DRLs) are an important dose optimization tool 
endorsed by many professional and regulatory organizations. National DRLs 
(NDRLs) are commonly set by the local health authority at the third quartile 
values (75%) of the dose distribution determined for representative 
examinations conducted across different healthcare facilities. Besides NDRLs, 
local DRLs (LDRLs) can be also established for a single center or group of 
healthcare facilities and used as a baseline for quality control and dose 
optimization. The invited speaker will give an overview of how LDRL should be 
defined; which dose tracking tools can be used for this purpose and how the 
DRLs can be adjusted to the specific needs of the individual healthcare facility. 
Learning Objectives: 
1. To become familiar with the concept of local diagnostic reference levels 
(LDRLs). 
2. To understand the key factors affecting LDRLs. 
3. To learn how the LDRLs can be established and used for dose optimisation; 
what action should be taken if LDRLs are exceeded.  
15:15  
Panel discussion  
J. Damilakis1, G. Frija2, E. Vaño3, J.N. Vassileva4, M. del Rosario Perez5; 
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14:00 - 15:30 Room M 2 
PIER @ ECR Session  
PI 2  
Radiology will survive, but will the 
radiologist still be there?  
Moderators:  
P. Leander; Malmö/SE  
S. Morozov; Moscow/RU  
A-507 14:00  
The landscape in radiology is changing: the radiologists need to adapt  
P. Leander; Malmö/SE (peter.leander@med.lu.se)  
Diagnostic imaging is of great importance and will become even more so with 
addition of new techniques. In the western world, annual growth-rates of 
imaging are around 10%. Not only the number of examinations increase also 
are the studies more complex requiring highly specific reports and more 
quantitative measurements. To respond to the growing demands radiologists 
try to run faster, but may have reached the limit of capacity when working in a 
traditional way. If other strategies not are implemented the increasing workload 
cannot be handled and requests from clinical colleagues may be turned down. 
In many countries, workload is handled partly by external reading from 
teleradiology companies. However, teleradiology is also controversial as it 
shifts radiology from being an interactive specialty to a commodity that can be 
ordered and delivered as a common laboratory service. In radiology, 
traditionally examinations have been performed by technicians and presented 
to a radiologist for reading. Throughout development of new potent modalities 
as CT, MRI and PET-CT and filmless departments using RIS and PACS that 
has not changed. Do we now stand in front of a big paradigm shift? Now the 
radiologist may become a conductor of several systems performing reading, 
i.e., machine learning, artificial intelligence (AI), reading radiographers and 
teleradiology. The technical development may give more opportunities in 
radiology than ever for giving the radiologist help with the right tasks in the right 
time.  
Learning Objectives: 
1. To understand the worldwide trends in workload change. 
2. To appreciate the development of teleradiology and commoditisation of the 
radiology. 
3. To become familiar with the role of information technologies in radiology. 
Author Disclosure: 
  P. Leander: Board Member; Spago Nanomedical MRI contrast media 
research company, Lument, contrast media research in the area of oral CT 
contrast. 
A-508 14:23  
Big-data, artificial intelligence, machine learning, deep learning etc.: what 
radiologists should know  
K.J. Dreyer; Boston, MA/US (kdreyer@partners.org)  
As computers outperform humans at complex cognitive tasks, disruptive 
innovation will increasingly remap the familiar with waves of creative 
destruction. And in healthcare, nowhere is this more apparent or imminent than 
at the crossroads of Radiology and the emerging field of Clinical Data Science. 
As leaders in our field, we must shepherd the innovations of cognitive 
computing by defining its role within diagnostic imaging, while first and 
foremost ensuring the continued safety of our patients. If we are dismissive, 
defensive or self-motivated - industry, payers and provider entities will innovate 
around us achieving different forms of disruption, optimised to serve their own 
needs. To maintain our leadership position, as we enter the era of machine 
learning, it is essential that we serve our patients by directly managing the use 
of clinical data science towards the improvement of care—a position which will 
only strengthen our relevance in the care process as well as in future federal, 
commercial and accountable care discussions. In this session, we will explore 
the state of clinical data science in medical imaging and its potential to improve 
the quality and relevance of radiology as well as the lives of our patients. 
Learning Objectives: 
1. To learn the basic principles of artificial intelligence. 
2. To appreciate the current and future applications of artificial intelligence in 
radiology. 











A-509 14:45  
How to cope with the new IT developments: the developer's perspective  
S. Tolle; Galway/IE (Steven.Tolle1@ibm.com)  
It is humanly impossible for radiologists these days to keep up with the sheer 
volume of medical images generated and the huge reporting workloads, 
complicated by shrinking radiologist workforce in Europe. Thus, radiology 
departments and radiologists need to embrace technology that helps make 
things more efficient and improve their job satisfaction. Through advanced 
image analysis, machine and deep learning as well as a robust knowledge 
base, AI can revolutionise healthcare. The power AI can quickly sort abnormal 
from normal, compare sequential datasets to show changes, detect 
abnormalities, speed up reporting, and increase capacity. Ultimately, AI in 
radiology can bring greater confidence in diagnostic decisions, improved 
workflows, optimised reporting times and better connect people, medical 
images as well as unstructured and structured data.  
Learning Objectives: 
1. To understand the market trends of IT and AI in healthcare. 
2. To appreciate the clinical needs for IT, AI, machine learning and big-data 
analysis tools. 
3. To understand the current business models and future trends of IT/AI 
products in healthcare. 
Author Disclosure: 
  S. Tolle: Employee; IBM Watson Health. 
A-510 15:08  
The value of the radiologist in the evolving digital environment: 
challenges for leadership  
C.D. Becker; Geneva/CH  
The radiologic profession is at the forefront of digitisation in medicine, and had 
to adapt continuously to many disruptive changes over the past few decades. 
Today, images and image processing tools are no longer owned by 
radiologists but readily accessible for all authorised physicians. Patients may 
have direct access to medical information via digital platforms and may wish to 
participate in diagnostic and therapeutic decisions and procedures that are 
based on radiologic images. The diagnostic radiologist must be able to act as 
an imaging consultant, with expert knowledge dedicated to a subspecialty 
area. Although there is a general trend towards a value-based health system, 
the radiologist's role as guarantor of the quality chain of medical imaging is 
often underestimated or even taken for granted. Recent advances in data 
science such as machine-learning algorithms for automated image 
interpretation, quantitative image processing tools for mathematical texture 
analysis in the context of advanced oncology, and automated data extraction 
by means of big data processing tools are on the horizon, heralding new 
disruptive changes for the radiologic profession. The leadership challenges in 
radiology for the next decade include the questions how these new tools can 
best be harnessed and how the clinical relevance of the radiologist can be 
ensured in this rapidly changing digital environment.  
Learning Objectives: 
1. To review the impact of the digital environment on the radiologist's role. 
2. To examine strategies to ensure the clinical relevance of the imaging 
specialist in the future. 
3. To discuss the challenges for leadership in radiology. 
14:00 - 15:30 Room M 4 
E³ - ECR Academies: State-of-the-Art and Advanced MR Imaging 
of the Musculoskeletal system  
E³ 1119  
Small joints  
A-511 14:00  
Chairperson's introduction  
M. Zanetti; Zurich/CH (marco.zanetti@hirslanden.ch)  
This state of the art course will address how MR imaging can be improved in 
the assessment of the small joints in the fingers, forefoot, midfoot, 
temporomandibular joint, and in the pubic symphysis. Optimized MR protocols 
will be suggested. Based on the challenges to assess the anatomical 
structures in the small joints the use of contrast media may be considered by 
some radiologists, but the general use is debated. Thus, this use of contrast 
media in small joints will be specifically discussed.  
 
A-512 14:05  
A. Fingers  
E. Llopis; Valencia/ES (evallopis@gmail.com)  
The purpose of this educational lecture is to become familiar with imaging of 
the fingers. We will review the anatomy based on a compartmental approach: 
flexor, extensor, supportive structures, and bones. We will list the most 
common ligament and tendon traumatic injuries, and the more frequent tumors 
where imaging can be specific and the role of the different modalities. To 
finalize we will give a structured report.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and how to optimise protocols with and 
without contrast administration. 
A-513 14:26  
B. Forefoot and midfoot  
N. Mamisch-Saupe; Zurich/CH (nsaupe@hotmail.com)  
Many disorders produce pain in the forefoot and the metatarsal region. 
Sometimes it is difficult to establish a diagnosis only on the clinical findings. 
MRI with its excellent soft tissue contrast and multiplanar imaging capability 
can often reveal a specific diagnosis. MRI allows a specific diagnosis based on 
the localization, signal intensity characteristics as well as morphologic features 
of the lesion. Commonly present disorders include trauma related lesions such 
as stress fractures or stress reactions of the bone as well as sesamoiditis or 
Freiberg infraction. Traumatic soft tissue lesions include plantar plate tears 
which occurs more often in women with increased weight bearing load and 
hyperextension forces involving the lesser metatarsal joints compared to the 
turf toe involving the greater metatarsal joint after hyperextension arm more 
commonly in men. There are additionally many non-neoplastic soft tissue 
masses to differentiate such as Morton neuroma, ganglia, bursitis or 
pseudobursae leading to chronic pain. Additionally, other chronic diseases 
such as gout and rheumatoid arthritis often affect the metatarsal joints. An 
additional value of contrast-enhanced MRI over standard MRI and STIR 
sequences exists in imaging mid- and forefoot. There is a slightly more added 
value for soft tissue lesions compared to bony lesions. Especially in detection 
of lesser metatarsophalangeal joint plantar plate tears a substantial portion of 
the lesions becoming only visible or after the administration of gadolinium or 
leading to change the diagnosis in many cases.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and how to optimise protocols with and 
without contrast administration. 
A-514 14:47  
C. Temporomandibular joint  
G. Andreisek; Münsterlingen/CH (gustav@andreisek.de)  
The temporomandibular joint (TMJ) is one of the small joint of the body which 
usually gets only little attention by radiologists. It is also often covered clinically 
by dentists. Unfortunately, the interaction between dentists and radiologists is 
usually limited and as such there is also little knowledge among radiologists 
regarding TMJ disorders. However, the incidence of TMJ joint disorders is fairly 
high with subsequent problems for the patients. They typically complain about 
pain or tenderness in the face, jaw joint area, neck and shoulders, and in or 
around the ear when chewing, speaking, or opening the mouth wide. Patients 
also describe jaws that get "stuck" or "lock" in the open- or closed-mouth 
position, clicking, popping, or grating sounds in the jaw joint when opening or 
closing the mouth or chew. Patients may also develop toothaches, headaches, 
neck aches, dizziness, earaches, hearing problems, upper shoulder pain, and 
ringing in the ears (tinnitus). In my lecture, I will review the normal anatomy of 
the TMJ as well as normal appearance on MR imaging. In addition, comments 
on a proper imaging protocol which fulfil both the needs for sufficient image 
quality, but also time-and-cost efficient. Results from own research on ultra-
high filed MR imaging of the TMJ will also be presented. Finally, typical acute 
and chronic TMJ disorders will be discussed.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and how to optimise protocols with and 
without contrast administration. 
 
  







A-515 15:08  
D. Pubic symphysis  
P. Robinson; Leeds/UK (philip.robinson10@nhs.net)  
This lecture will describe the anatomy and function of the symphysis pubis and 
surrounding soft tissues and how this can vary between the sexes and during 
pregnancy. Proposed mechanisms of injury will be presented. Primary stresses 
during athletic activity are thought to be shearing in nature while in pregnancy 
distraction predominates. Post-partum ‘osteitis pubis’ is thought to be due to 
residual instability, but rarely requires surgical intervention. Athletic pubalgia 
has a more controversial aetiology, but more consistent MRI findings involving 
and surrounding the symphysis pubis. However, in both areas imaging 
abnormalities can exist in asymptomatic patients and therefore, clinical context 
and correlation is vital.  
Learning Objectives: 
1. To identify the most common post-traumatic entities. 
2. To identify the most common entities leading to chronic pain. 
3. To know the role of MR imaging and how to optimise protocols with and 
without contrast administration. 
Author Disclosure: 
  P. Robinson: Advisory Board; European PGA. Board Member; seminars in 
musculoskeletal radiology. 
16:00 - 17:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1221  
Imaging of the chest  
A-516 16:00  
A. Fibrosing lung diseases  
F. Molinari; Lille/FR (francescomolinari.dr@gmail.com)  
The diagnostic approach to patients with fibrosing interstitial lung disease 
(FILD) is often complicated even when clinical history and physical findings are 
correctly assessed at presentation. In fact, many disorders of known and 
unknown etiology may result in lung fibrosis and have overlapping clinical and 
radiographic features. Surgical lung biopsy is a viable tool for establishing the 
diagnosis. However, the procedure is associated to morbidity and mortality 
risks. HRCT remains the most important noninvasive modality for the diagnosis 
and management of patients with FILD. HRCT findings such as parenchymal 
reticulation, ground-grass attenuation, traction bronchiectasis and 
bronchiolectasis, architectural distortion, and honeycombing indicate the 
presence of FILD. Honeycombing also indicates that lung fibrosis is irreversible 
and potentially progressive. To differentiate the most commonly encountered 
FILDs, current guidelines recommend to considered the presence of subpleural 
and basilar reticulation associated with honeycombing, altogether as the "UIP 
pattern". In the absence of known causes of lung fibrosis, a "definite" UIP is 
consistent with a diagnosis of idiopathic pulmonary fibrosis and does not 
require lung biopsy. The forms of FILD that manifest at HRCT as "possible" 
UIP and for which an alternative diagnosis of NSIP exists require lung biopsy. 
Finally, if the FILD manifests with HRCT findings that are inconsistent with UIP, 
the potential diagnosis of chronic HP is considered and lung biopsy is usually 
not indicated. This clinical-HRCT interpretative algorithm facilitates the 
assessment of HRCT scans that show the presence of lung fibrosis and 
provides guidance in the management of patients with FILD. 
Learning Objectives: 
1. To become familiar with the differential diagnosis. 
2. To identify the key imaging findings. 
A-517 16:45  
B. Pleural disease  
C. Beigelman; Lausanne/CH  
Diffuse or focal pleural disorders are commonly encountered in routine 
practice, including pleural effusions, pleural thickenings, calcified or not, 
pneumothoraces or masses. Differential diagnosis must be known. In 
particular, focal pleural thickening (PT) may be related to typical pleural 
plaques, but also to normal structures, previous tuberculosis, pleural 
metastasis, silicosis, or other rarer conditions. Furthermore, postero-basal PT 
in supine examination may be reversible on prone position. Any atypical shape, 
location or change of a PT should suggest a pleural metastasis in a context of 
malignancy. In all cases, a careful analysis of other CT findings, previous 
imaging studies and clinical history are determinant for the final diagnosis. 
Parenchymal bands or rounded atelectasis are helpful for the diagnosis of 
benign diffuse pleural thickening. Features suggestive of malignancy include 
circumferential pleural thickening, nodular pleural thickening, parietal pleural 
thickening greater than 1 cm, and mediastinal pleural involvement. Atypical 
aspects such as pleural effusion even without plaque and pleural irregularity 
may be observed in mesothelioma, and slight changes in the mediastinal or 
interlobar pleura should be considered as suspicious of this diagnosis. 
Mistakes may be related to the difficult recognition of features such as in case 
of pneumothorax in supine position or to atypical features such as loculated 
effusions or atypical presentations of malignant pleural involvement, that may 
lead to a delayed diagnosis. 
Learning Objectives: 
1. To identify the key imaging findings. 
2. To become familiar with the differential diagnosis. 
16:00 - 17:30 Room B 
Special Focus Session  
SF 12a  
My three top tips for abdominal imaging  
A-518 16:00  
Chairperson's introduction  
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk)  
A rapid review of the key areas for professional learning and development will 
be provided from a group of expert radiologists for a full range of 
gastrointestinal conditions. This will provide opportunities for both the general 
radiologists and specialists to improve the services they offer patients and 
clinicians dealing with abdominal diseases.  
Session Objectives: 
1. To learn how to avoid common mistakes in abdominal radiology. 
2. To understand how to get over an area of difficulty through the clinical 
expertise of selected abdominal radiologists. 
A-519 16:05  
Postoperative abdomen  
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk)  
Anastomotic leaks on CT are heralded by a number of signs including 
increasing free gas and free fluid in the abdomen, localised fluid around the 
anastomosis and in particular the extravasation of positive contrast from the 
bowel lumen. This is recommended for routine use in the post operative 
evaluation of patients wherever possible. Surgeons utilitise haemostatic agents 
in the intraoperative management of bleeding. These can cause confusion in 
imaging interpretation and can mimic an abscess. Radiologists should have a 
heightened awareness of this appearance and discuss such cases with the 
surgical team for clarification. Similarly retention of surgical swabs remains a 
substantial cause of morbidity for patients in the post operative period. Such 
swabs are readily identifiable by a radiolucent marker and in such cases the 
surgical team needs immediate notification to allow a return to theatre for swab 
retrieval.  
Learning Objectives: 
1. To learn how to optimise detection of anastomotic leaks on CT using 
radiological signs and positive luminal contrast. 
2. To recognise material in the abdomen surgeons may leave deliberately. 
3. To recognise material in the abdomen surgeons may leave by accident. 
A-520 16:11  
Appendicitis  
J.B.C.M. Puylaert; The Hague/NL (dr.jbcmpuylaert@wxs.nl)  
Abdominal ultrasound plays a pivotal role in the imaging workup of patients 
with suspected appendicitis. It should be the primary modality, and only in case 
of a negative or inconclusive examination should it be followed by CT or MR. 
The specific advantages of US over CT are: US has an image definition in the 
close range which is much higher than that of CT. US is more interactive than 
CT. The patient’s history as well as the painful area or palpable mass can 
directly be correlated with the US findings. US is real time and shows 
peristalsis, pulsations and blood flow. US also shows the effects of respiration, 
Valsalva manoeuvre, gravity and compression with the probe, allowing to 
assess whether the appendix or other organs such as the bowel and 
gallbladder are soft or rigid. US allows immediate US-guided puncture of 
intraperitoneal fluid and drainage of pus. US in appendicitis should be 
performed with graded compression. Compression is necessary to displace or 
compress bowel to eliminate the disturbing influence of bowel gas and to 
approach the pathological structure closely. This allows the use of a high-
  







frequency transducer with a better image quality. The final US report should be 
integrated with the clinical findings, laboratory data, CT-scan and possible 
other radiological examinations. It is clear that the US examination, as 
described here, should not be performed by a technician or by a clinician, but 
by an experienced (abdominal) radiologist.  
Learning Objectives: 
1. To learn that US has a pivotal and unique role in appendicitis and should be 
done prior to CT. 
2. To learn that US in acute abdomen allows the radiologist to get closer to the 
patient than CT and MRI. 
3. To learn that US should be performed by abdominal radiologists, and not by 
clinicians or technicians. 
A-521 16:17  
Bile duct stones  
J.A. Guthrie; Leeds/UK (Ashley.Guthrie@nhs.net)  
The first investigations in patients with suspected gallstone disease, especially 
if stones within the common bile duct (CBD) are suspected, are US and liver 
function tests (LFTs). On the basis of this, the risk of CBD stones can be 
estimated and the decision whether or not to perform the next test, MRCP, can 
be made. In the presence of stones in the gallbladder, the risk increases with a 
CBD of > 8 mm and increasing abnormal LFTs. My preference is for 2D T2 
sequences without fat saturation in two planes. Breath-hold when possible is 
preferred in the interests of time, but can be gated in those that struggle. 
HASTE/SS-FSE/FSE-ADA/FASE is the first set of sequences, followed by 
FISP/GRASS/FFE/SARGE if a diagnosis is not made as stones vary in their 
conspicuity between the sequences. The examination can be terminated as 
soon as a positive diagnosis is made. T1-weighted images occasionally help.  
Learning Objectives: 
1. To learn that in patients with a high index of clinical suspicion of bile duct 
stone, MRCP should be employed early. 
2. To know that 2D HASTE/SS-FSE/FSE-ADA/FASE without fat saturation in 
two planes (oblique coronal and axial) will establish a diagnosis in most cases 
and are the "work horse" sequences in most patients. 
3. To understand that FISP/GRASS/FFE/SARGE (which can be gated) are a 
useful adjunct especially in those patients that have difficulty holding their 
breath. 
Author Disclosure: 
  J.A. Guthrie: Speaker; Bayer Healthcare, Siemens AG. Other; Attended a 
symposium organised and at the expense of Bayer Healthcare. 
16:23  
Questions and discussion  
A-522 16:29  
Dilated pancreatic duct  
R. Manfredi; Rome/IT (riccardo.manfredi@unicatt.it)  
The prognosis of pancreatic adenocarcinoma is very poor, and little 
improvement has been reported in the past several decades. Only a low 
percentage of patients in whom pancreatic cancer is detected at an early stage 
without local infiltration have the potential for long-term survival after surgical 
resection. The earliest possible diagnosis may be the most effective way to 
improve the prognosis. Dilatation of the main pancreatic duct may represent a 
secondary sign of pancreatic adenocarcinoma. Therefore, the diagnosis of 
dilated main pancreatic duct may be a predictive sign of pancreatic 
adenocarcinoma; therefore, careful follow-up in people with such signs and 
eventually prompt treatment have been recommended. Pancreatic endocrine 
neoplasms are relatively rare, with an incidence rate of approximately five 
cases per one million person-years. Some pancreatic endocrine neoplasms 
release hormones into the blood stream that cause clinical syndromes, 
whereas others are non-syndromic and present as a mass lesion. At diagnostic 
imaging, pancreatic endocrine neoplasms typically produce hyperenhanced 
well-demarcated lesions that are best seen on arterial phase images. 
Pancreatic endocrine neoplasms may be responsible for pancreatic duct 
stenosis, even when they are small in size (<2 cm) and be responsible for 
marked dilatation of the main pancreatic duct and/or marked atrophy of the 
upstream pancreas. Intraductal papillary mucinous neoplasm (IPMN) originates 
from the ductal epithelium and overproduce mucin which is responsible for the 
dilatation of the main pancreatic duct and/or the side branches. Diagnostic 
imaging is helpful in the diagnosis and follow-up of these patients.  
Learning Objectives: 
1. To learn how to diagnose and manage adenocarcinoma of the pancreas 
mimickers: autoimmune pancreatitis and paraduodenal pancreatitis. 
2. To appraise how to manage incidental cystic lesions of the pancreas. 
3. To learn how to diagnose and manage neuroendocrine neoplasms of the 
pancreas. 
A-523 16:35  
Liver biopsy  
V. Vilgrain; Clichy/FR (valerie.vilgrain@aphp.fr)  
Liver biopsy is the most common invasive procedure of the liver. Indications of 
biopsy in diffuse liver diseases have declined due to improvements in 
noninvasive assessment of fibrosis and steatosis. On the contrary, biopsy of 
liver tumours is still indicated mostly for diagnostic purpose and to a lesser 
extent for assessing the prognosis or the prediction of tumour response. Three 
keys are important. First, check the indication. There are very few 
contraindications (mostly related to coagulation disorders) and the most 
important is to ensure that there is a good indication for liver biopsy. Second, 
use ultrasound guidance, which is faster, easier and more accurate than CT. It 
allows real-time control. Third, if a primary tumour liver is considered, always 
perform a biopsy in the adjacent liver. This will help the pathologist in the 
diagnosis.  
Learning Objectives: 
1. To understand the risk/benefit of liver biopsy. 
2. To know the absolute contraindications. 
3. To be aware of the most important technical tricks. 
A-524 16:41  
Bowel ischaemia  
M. Zins; Paris/FR (mzins@hpsj.fr)  
Acute mesenteric ischaemia (AMI) is defined by inadequate blood supply 
through the mesenteric vessels resulting in intestine injury and carries a high 
mortality rate. A combination of two phenomena is needed to generate AMI: 
vascular insufficiency and intestinal injury. The diagnosis of AMI should be 
made as soon as possible, since early stages of ischaemia are reversible if 
properly treated. The three main messages for the radiologist are: 1) CT 
angiography (CTA) should use a triple-phase protocol (unenhanced, arterial 
and portal venous phase), 2) assessment of bowel wall abnormalities at CTA 
(decreased enhancement, increased attenuation on pre-contrast phase, wall 
thickening, wall thinning) is a major step in the interpretation of CT scans and 
3) always carefully check the mesenteric vessels (for thrombus, embolism, 
dissection) in patients with acute abdominal pain of unknown origin.  
Learning Objectives: 
1. To understand the limited value of isolated mesenteric pneumatosis. 
2. To learn about the added value of unenhanced scan. 
3. To understand the crucial role of vascular assessment at CT angiography. 
16:47  
Questions and discussion  
A-525 16:53  
Colon polyp  
F. Iafrate; Rome/IT (francoiafrate@gmail.com)  
"no abstract submitted" 
Learning Objectives: 
1. To quickly review different morphological aspects and "weapons" in the hand 
of radiologist to detect colonic polyps with CT colonography with small focus on 
correct preparation and the use of CAD. 
2. To define large, small and intermediate polyp size and to review polyp 
pathology including the risk of cancer and high-grade dysplasia moreover in 
small and intermediate polyps. 
3. To summarise the current debate with regard to intermediate polyps 
(conservative management vs polypectomy) and the rational for non-reporting 
of diminutive polyps. 
A-526 16:59  
Acute pancreatitis  
W. Schima; Vienna/AT (wolfgang.schima@khgh.at)  
For diagnosis of acute pancreatitis, at least two of the three following criteria, 
(1) abdominal pain consistent with pancreatitis, (2) increase ( 3-fold) in serum 
amylase or lipase levels and (3) imaging findings of acute pancreatitis, have to 
be fulfilled. According to the Revised Atlanta Classification, the disease is 
categorized as interstitial oedematous or necrotizing pancreatitis. Development 
of necrosis may take some time, so that CT imaging should be performed not 
earlier than 2-3 days after clinical onset. Imaging too early may lead to 
underestimation of disease severity. Necrotizing pancreatitis presents with 
either combined pancreatic and peripancreatic necrosis (most common) or with 
pancreatic necrosis or with peripancreatic necrosis alone. Acute necrotic 
collections (ANC) in the early phase may evolve into walled-off necrosis (WON) 
in the late stage ( 4 weeks). A WON containing chunks of digested fat and 
  







parenchyma must not be confused with a pseudocyst containing enzymatic 
fluid (requiring different therapy). They may appear similarly hypodense at CT, 
but US or MRI will show the predominantly solid nature of a WON. Secondary 
infection of necrotizing pancreatitis usually occurs in the 3rd week after onset 
or later. Diagnosis of infection is difficult based on imaging alone. Infection is 
more likely if collections have broad contact with bowel. Gas within a collection 
is not a sensitive sign, but quite specific. In case of infection, percutaneous 
aspiration is sought, followed by drainage in positive cases. However, necrotic 
collections with large proportions of debris require a more aggressive approach 
for clearance.  
Learning Objectives: 
1. To learn about the proper timing of imaging studies in acute pancreatitis. 
2. To learn about the imaging manifestations of necrotising pancreatitis. 
3. To understand the different nature of fluid collections with regard to further 
therapy. 
A-527 17:05  
Crohn's disease  
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es)  
My three top tips for Crohn's disease. In this session we are going to highlight 
the MUSTs in the assessment of Crohn’s disease using cross-sectional 
imaging techniques: (1) What to look for first: thickness and enhancement, and 
T2 sequences. (2) What to look after: complications- all sequences. (3) Not 
forget to look at: other sequences, and areas other than the bowel.  
Learning Objectives: 
1. To learn about useful signs indicating active Crohn's disease. 
2. To understand the changes which occur after treatment of intestinal 
inflammation. 
3. To become familiar with complications related to Crohn's disease. 
Author Disclosure: 
  J. Rimola: Advisory Board; TiGenix, Gilead. Consultant; Takeda, Robarts 
Clinical Reserach. Research/Grant Support; Abbvie. Speaker; BMS, Takeda. 
A-528 17:11  
Liver metastases follow-up  
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr)  
Follow-up of liver metastases relies mostly on imaging. The need for 
standardisation was initially prompted by clinical trials. Several systems, from 
WHO to RECIST, have been proposed, allowing better intra- and interobserver 
reproducibility and guiding treatment strategy. However, the need for follow-up 
might be different according to clinical situations, like neo-adjuvant, palliative or 
adjuvant therapy. The standard might also be adapted to the type of drug, 
cytotoxic, targeted or immune therapies. Therefore, the radiologist needs to be 
aware of the clinical situation and learn to identify the drug, to perform a 
personalised evaluation.  
Learning Objectives: 
1. To learn how to quickly identify three most common systemic treatments of 
liver metastases (cytotoxic, targeted and immune), and to understand why 
knowledge of the regimen is essential for the radiological report. 
2. To understand the rationale of international standards for the evaluation of 
response to treatment, and how to build accordingly a useful report. 
3. To appraise the respective objectives of neoadjuvant and palliative 
chemotherapy, and to be able to explain the specific endpoints for each clinical 
situation. 
17:17  








16:00 - 17:30 Room C 
Chest  
RC 1204  
Pneumonia  
A-529 16:00  
Chairperson's introduction  
I.E. Tyurin; Moscow/RU (igortyurin@gmail.com)  
Pneumonia is a major health-care and economic problem because of high 
morbidity and mortality rate, and due to direct and indirect costs of its 
management. The most common cause is community-acquired pneumonia, 
caused by common bacteria like S. pneumoniae as well as different viral 
agents. Tuberculosis is one of the most important respiratory infections in 
developing countries and in immune-compromised patients with AIDS 
everywhere. Tuberculosis pneumonia can easily mimic bacterial CAP and 
other pulmonary infections. Viral and mycotic infections represent a common 
course of febrile neutropaenia in immune-compromised patients under 
aggressive therapy. In most of all these patients, a diagnosis is made on the 
basis of a combination of clinical, radiographic, and laboratory findings. High-
resolution CT is usually performed in patients with nonspecific clinical and 
radiologic findings and in patients with progression of disease despite therapy. 
A large number of acute and chronic infectious and noninfectious diseases 
may also result in parenchymal lung disease in both immune-competent and 
immune-compromised patients. Thin-section CT is also performed in patients 
with noninfectious causes of acute parenchymal lung disease such as 
organizing pneumonia, acute interstitial pneumonia, hypersensitivity 
pneumonitis, acute eosinophilic pneumonia, and pulmonary haemorrhage. 
These diseases often have clinical and functional features similar to one 
another, but obviously requiring different treatment. Therefore, the differential 
diagnosis of these entities is important in daily clinical practice.  
Session Objectives: 
1. To review the role of imaging in infectious lung diseases. 
2. To understand the key role of multidisciplinary approach to diagnosis of lung 
infections.  
A-530 16:05  
A. Community-acquired pneumonia  
I. Hartmann; Rotterdam/NL (i.j.c.hartmann@gmail.com)  
Community-acquired pneumonia (CAP) refers to pneumonia acquired outside 
of hospitals or extended-care facilities and is one of the most common 
infectious diseases. CAP is an important cause of mortality and morbidity 
worldwide. According to the IDSA/ATS/AAFP guidelines, a chest radiograph is 
required for the routine evaluation of patients with suspected CAP to exclude 
conditions that mimic CAP (e.g. acute bronchitis) and to confirm the presence 
of an infiltrate compatible with the presentation of CAP. Although chest 
radiography findings usually do not allow identifying the causative organism, 
they may be helpful in narrowing down the differential diagnosis, prognosis, 
and detection of associated conditions. Serial chest radiography can be 
performed to observe the progression of CAP. CT scanning is increasingly 
used in clinical practice. Performing CT should be considered if any of the 
abnormalities at presentation or at follow-up are not consistent with the 
diagnosis of pneumonia, or if concomitant disease is suspected such as an 
underlying bronchogenic carcinoma, for the confirmation of pleural effusion and 
for the detection of pulmonary complications. The aim of the presentation is to 
provide an overview of the imaging findings of the most common aetiologic 
organisms in patients with CAP. In addition, imaging findings that may help in 
the differentiation between pneumonia and other common non-infectious 
causes of abnormal chest radiographs in patients with suspected CAP will be 
discussed.  
Learning Objectives: 
1. To appreciate the role of imaging in the management of community-acquired 
pneumonia. 
2. To consolidate knowledge of how to discriminate from noninfectious 
diseases. 
A-531 16:28  
B. Tuberculosis  
E. Castañer; Sabadell/ES (ecastaner@tauli.cat)  
Pulmonary tuberculosis (TB) remains a common worldwide infection that 
produces high mortality and morbidity, especially in developing countries. In 
2013, an estimated 9.0 million (360 000 of whom were HIV-positive) people 
developed TB and 1.5 million died from the disease. Chest radiographs play a 
  







major role in the screening, diagnosis, and response to treatment of patients 
with TB. However, the radiographs may be normal or show only mild or 
nonspecific findings in patients with active disease. We will review the chest 
radiographs findings of TB, which vary widely in the function of several host 
factors, age, prior exposure to TB, and underlying immune status. CT is useful 
in detecting TB incidentally, in resolving cases with inconclusive findings on 
chest radiographs, and in assessing disease activity. Cavities, centrilobular 
nodules, and tree-in-bud appearance are the most common CT findings of 
active pulmonary tuberculosis. We will discuss the classic, and some not-so-
classic, signs that should suggest the diagnosis of TB.  
Learning Objectives: 
1. To appreciate typical and atypical tuberculosis manifestations on imaging. 
2. To differentiate between acute and chronic tuberculosis infection. 
A-532 16:51  
C. Fungal pneumonia in immunocompromised hosts  
C.P. Heussel; Heidelberg/DE (heussel@uni-heidelberg.de)  
The radiological characterisation of infiltrates gives a first and rapid hint to 
differentiate between different types of infectious (e.g. typical bacterial, atypical 
bacterial, fungal) and non-infectious aetiologies. Follow-up investigations need 
careful interpretation according to disease, recovery, concomitant treatment 
and eventually vessel arrosion requiring contrast-enhanced angio-CT. Due to a 
high incidence of fungal infiltrates in immunicompromised hosts, interpretation 
of the follow-up of an infiltrate must use further parameters besides the lesion 
size. 
Learning Objectives: 
1. To learn the patterns of fungal lung infection depending on the type of 
immune depression. 
2. To become familiar with CT signs suggesting angioinvasive fungal infection. 
Author Disclosure: 
  C.P. Heussel: Consultant; Schering-Plough, Pfizer, Basilea, Boehringer 
Ingelheim, Novartis, Roche, Astellas, Gilead, MSD, Lilly, Intermune, Fresenius. 
Employee; Head of Diagnostic and Interv Radiology with Nuclear Medicine, 
Thoraxklinik Heidelberg, Member of the German Center for Lung Research. 
Patent Holder; Method and Device For Representing the Microstructure of the 
Lungs. IPC8 Class: AA61B5055FI, PAN: 20080208038, Inventors: W 
Schreiber, U Wolf, AW Scholz, CP Heussel. Research/Grant Support; 
Siemens, Pfizer, MeVis, Boehringer Ingelheim, German Center for Lung 
Research. Speaker; Gilead, Essex, Schering-Plough, AstraZeneca, Lilly, 
Roche, MSD, Pfizer, Bracco, MEDA Pharma, Intermune, Chiesi, Siemens, 
Covidien, Pierre Fabre, Boehringer Ingelheim, Grifols, Novartis, Basilea, Bayer. 
Other; Stock ownership in medical industry: GSK, Comitee membership: Chest 
working group of the German Roentgen society: National guidelines: bronchial 
carcinoma, mesothelioma, COPD, screening for bronchial carcinoma, CT and 
MR imaging of the chest,, Comitee membership: Consultant of ECIL-3, 
ECCMID, EORTC/MSG: Guideline for diagnosis of infections in 
immunocompromized hosts, Comitee membership: Founding member of the 
working team in infections in immunocompromized hosts of the German 
society of Hematology/Oncology: Guideline for diagnosis of infections in 
immunocompromize, Comitee membership: Faculty member of European 
Society of Thoracic Radiology (ESTI), European Respiratory Society (ERS), 
and member in EIBALL (European Imaging Biomarkers Alliance) Editor of 
„Medizin. 
17:14  
Panel discussion: What is the role of radiologists in the diagnosis and 
management of lung infections?  
16:00 - 17:30 Room X  
E³ - ECR Master Class (Abdominal Viscera)  
E³ 1226  
Dual-energy CT of the abdomen: the time 
is now  
Moderator:  
P. Vock; Berne/CH  
A-533 16:00  
A. Basic principles and different approaches  
L.S. Guimaraes; Toronto, ON/CA (luis.s.guimaraes@gmail.com)  
Dual-energy CT (DECT) refers to the use of CT data from two different energy 
spectra to differentiating and classifying tissue composition, in addition to 
displaying anatomy and pathology. DECT data can be obtained using various 
hardware solutions (dual-source, fast kilovolt peak-switching, 2-rotation fast kV-
mA switch, dual-layer detector and split filter). An explanation on how each of 
these solutions works, as well as the advantages and disadvantages of each, 
will be presented. Abdominal DECT has as main advantages the ability to 
identify/quantify certain materials (iodine, calcium, urate, etc.), as well as to 
increase the possibility of performing low kV imaging in a wider range of 
patients, which in turn is associated with an increased conspicuity of enhancing 
structures and lesions. The background and reasons for each of these 
advantages will be reviewed. Several challenges remain for full implementation 
of Dual Energy CT in routine clinical abdominal practices. These challenges, 
including absence of standardised post-processing (which may be time-
consuming), lack of well-defined advantageous routine applications and 
limitations in terms of patient size/radiation dose will be discussed.  
Learning Objectives: 
1. To learn about the types of dual-energy scanners and principles of dual-
energy CT. 
2. To understand issues of radiation dose and image quality in comparison with 
single-energy CT. 
3. To appreciate the possible advantages of this technology with its many post-
processing applications. 
Author Disclosure: 
  L.S. Guimaraes: Research/Grant Support; Institutional Research Grant from 
Toshiba Medical Systems. 
A-534 16:30  
B. Applications for genitourinary system  
H. Ringl; Vienna/AT (helmut.ringl@meduniwien.ac.at)  
Dual energy CT is increasingly becoming an important diagnostic tool for the 
non-invasive assessment of the genitourinary system, with a wide range of 
applications and several advantages over conventional single-energy CT, as 
detailed below: (1) The use of dual-energy CT with optimised spit-bolus 
protocols enables considerable dose savings by eliminating two scan phases. 
However, using virtual non-contrast images, this protocol provides the same 
information as an unenhanced, an arterial, a venous, and a urographic phase; 
(2) Virtual non-contrast images and iodine maps enable better characterisation 
of renal cysts with dense content, which often pose a diagnostic dilemma in 
single-energy CT, and which might require MRI or CT follow-up examinations; 
(3) The reconstruction of low kV mono-energetic images results in a higher 
iodine contrast, and, therefore, in better lesion conspicuity in the kidneys and 
the bladder wall; (4) Dual-energy CT enables the quantification of iodine-
uptake, and may, therefore, be used for therapy monitoring of cancer of the 
urinary tract; and (5) The material decomposition algorithms of dual-energy CT 
are able to discriminate urate from non-urate stones in the case of 
nephrolithiasis in the clinical routine, making this method a game-changer in 
therapy.  
Learning Objectives: 
1. To learn about the role of dual-energy CT in the genitourinary system. 
2. To understand the value of determination of renal stone composition with 
dual-energy CT. 
3. To appreciate the ability of dual-energy CT to exactly quantify the iodine 
uptake in renal lesions. 
Author Disclosure: 
  H. Ringl: Research/Grant Support; Siemens. 
A-535 17:00  
C. Applications for abdominal organs  
M. Karcaaltincaba; Ankara/TR (musturayk@yahoo.com)  
Dual-energy CT (DECT) is increasingly used for abdominal applications. DECT 
can be performed by dual-source CT, fast kVp switching and dual-layer 
detector CT. The major advantage of DECT is availability of virtual non-
contrast (water) images in every patient. Spectral CT images can allow the 
diagnosis of a low amount of of fat (normally invisible on CT) within lesions 
similar to in-out of phase T1-weighted MR images. DECT can allow diagnosis 
of calcification or haemorrhage within lesions encountered during routine 
abdominal CT. Low kV images obtained by DECT are more sensitive to 
hepatic and pancreas hypervascular lesions compared to standard kV images. 
DECT can also be helpful in differentiation of colonic polyp/mass from stool 
detected during routine abdominal CT. In the future, all CT scanners will be 
most likely produced with DECT capability.  
Learning Objectives: 
1. To learn about the current applications of dual-energy CT in evaluating the 
abdominal viscera. 
2. To understand the role of dual-energy CT for characterisation of incidental 
lesions discovered during routine abdominal CT. 
3. To appreciate how dual-energy CT increases sensitivity for detecting both 
hypervascular and hypovascular liver and pancreatic lesions. 
  








  M. Karcaaltincaba: Speaker; Bayer, GE Healthcare, Philips Healthcare, 
Pfizer. 
16:00 - 17:30 Room O  
Special Focus Session  
SF 12b  
Imaging of the brain in preterm infants  
A-536 16:00  
Chairperson's introduction  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se)  
In this session, focus will be on ultrasound and MR and their role in 
investigating the brain in preterms, and the use of these techniques for clinical 
outcome prediction and measures as well as for diagnostic decision-making.  
Session Objectives: 
1. To learn about different imaging techniques to study the preterm brain. 
2. To understand the clinical importance of assessing the preterm brain. 
3. To become familiar with novel imaging techniques and their clinical value. 
A-537 16:05  
The role of cerebral ultrasound  
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr)  
Ultrasound (US) represents the imaging modality with which to start the 
evaluation of the neonatal brain in premature babies. A state-of-the-art 
technique should be applied using appropriate transducers (linear and 
sectorial) and different acoustic windows such as the anterior, the posterior 
and the mastoid fontanelle. Familiarisation with the normal US appearance of 
the brain as a function of gestational age is important to detect brain 
abnormalities. In very premature babies peri-occipital hyperechogenicity may 
represent a normal appearance and should be differentiated from 
periventricular leukomalacia. Increased echogenicity of the basal ganglia is a 
normal finding and should be differentiated from severe hypoxia lesions. 
Colour Doppler should be used and offers important additional information not 
only on blood flow, but also on the presence of subarachnoid haemorrhage. In 
the context of intraventricular haemorrhage, the disappearance of the normal 
flow at the level of the terminal vein represents a sign of pending venous 
infarct. Alternating red and blue colour signals at the level of the aqueduct of 
Sylvius represent an early finding of the presence of blood into the CSF 
spaces. The delta resistivity index (RI) evaluated at the anterior cerebral artery 
is calculated from the RI before and after compression of the anterior 
fontanelle and is very useful for treatment decision of post-haemorrhagic 
hydrocephalus.  
Learning Objectives: 
1. To learn about the technique and typical findings of cerebral ultrasound in 
preterm infants. 
2. To understand indications for cranial ultrasound in neonates. 
3. To discuss potential adverse effects and added value of US Doppler. 
A-538 16:30  
The role of cerebral MRI: morphology and beyond  
F.M. Triulzi; Milan/IT (Fabio.triulzi@policlinico.mi.it)  
Preterm birth with subsequent brain injury is an increasing public health 
concern. Advances in neonatal intensive care have significantly improved 
survival rates among very-low-birth-weight infants, but survivors are still at 
considerable risk of developing cognitive, behavioural, neurosensory, and 
motor disabilities. The most common preterm brain injury patterns are white 
matter (WM) injury; germinal matrix-intraventricular haemorrhage and its 
correlates periventricular haemorrhagic venous infarction and post-
haemorrhagic ventricular dilation. Diffuse non-cystic types of WM injury, the so-
called "punctate" WM lesions, are the most frequent lesions seen on MRI and 
the leading cause of disturbed brain growth. Although MR imaging is superior 
to cranial sonography in detecting diffuse WM injury, conventional MR studies 
fail to exactly predict outcome. Advanced MR imaging acquisition sequences 
and post-processing techniques, such as DTI, volumetric MR imaging 
measurements, and proton MR spectroscopy may contribute to a better 
understanding of subtle microstructural, volumetric and metabolic 
abnormalities in preterm newborns, allowing a more precise prognosis at term-
equivalent age. Early MR imaging, though of great interest to obtain very 
precocious biomarkers and enabling an early counselling to the parents, has 
still too many limitations to be considered a standard of care.  
Learning Objectives: 
1. To learn about protocol and typical findings in premature babies. 
2. To understand indications and timing for MR exams in preterm infants. 
3. To discuss the prognostic value of performing advanced MR techniques. 
A-539 16:55  
US screening in preterm infants: prognostsic value from a clinical point 
of view  
J.-P. Schenk; Heidelberg/DE (jens-peter.schenk@med.uni-heidelberg.de)  
Preterm (born before 37 weeks of gestational age) and especially very 
premature infants (gestational age 32 weeks and less) have a great risk for 
intraventricular haemorrhage (IVH) and periventricular leukomalacia (PVL). 
Because of the possibility of a poorer neurodevelopmental outcome, the 
detection of IVH, PVL and subsequent hydrocephalus is mandatory. Due to the 
possibility of an examination inside the incubator with a high resolution, 
transfontanellar ultrasound is the method of choice for routine examination and 
follow-up studies. Typical ultrasound findings and pathology will be presented 
in context to follow-up findings, especially the postheamorrhagic 
hydrocephalus and postischaemic cystic PVL. Therefore, the rationale of a US 
screening will be discussed and the in-Heidelberg-used screening scheme will 
be presented. US findings of blockage of cerebrospinal fluid pathways and 
obliterative arachnoiditis will be demonstrated. In context to the literature, the 
advantages of US screening will be discussed and in case studies the 
extended imaging with MRI will be demonstrated to see the limitations of US 
examinations and screening. The evaluation of periventricular echogenicity in 
PVL typically presents the difficulty of differential diagnosis in single US and 
demonstrates the necessity of repeated examinations in a screening system. 
Imaging at multiple time points improves the detection of cystic PVL. US 
findings in anomalies and tumours complete the range of differential diagnosis. 
Learning Objectives: 
1. To learn about the rationale for routine follow-up of the premature brain. 
2. To understand the clinical impact of US findings in preterm infants. 
3. To discuss the prognostic value of routine ultrasound screening of preterm 
infants. 
17:15  
Panel discussion: Can we afford the extensive screening programmes 
proposed today?  
16:00 - 17:30 Room N  
Special Focus Session  
SF 12c  
Head and neck emergencies  
A-540 16:00  
Chairperson's introduction  
R. Kohler; Sion/CH (romain.kohler@hopitalvs.ch)  
In this session, traumatic, infectious and inflammatory as well as vascular 
emergencies of the head and neck will be discussed. In the head and neck, 
multiple anatomical structures are confined in a small area in which run the 
airway and major vessels. Moreover, the neck is connected with the brain and 
thorax. These anatomical factors and the diversity of pathologies explain why 
emergencies may rapidly lead to potential major complications and disabilities 
or may even be lethal especially when the diagnosis is wrong or delayed. 
Besides the medical history, clinical examination and biological tests, imaging 
therefore plays a crucial role as many pathological processes may extend to 
adjacent structures, deeper structures or even outside of the head and neck 
area. Fractures of orbits, temporal bone, face or larynx may for example lead 
to compromise of the airway or meningitis. All structures of the head and neck 
may contract infection that can propagate to the surrounding spaces or even 
outside the head and neck. More rarely, patients present with bleeding which 
can be secondary to trauma, tumour or vascular malformation. Computed 
tomography and echography are the first techniques used in the emergency 
setting. MRI is rarely the first-line technique and is only reserved for selected 
patients with protected airway that are medically stable. Finally, angiography is 
reserved nowadays only for endovascular treatments. During this session, 
participants will become familiar with the most frequent emergencies of the 
head and neck and learn which imaging technique should be used for a given 
indication.  
Session Objectives: 
1. To become familiar with most emergencies of the head and neck in clinical 
routine. 
2. To understand which imaging technique to use for a given indication. 
  







A-541 16:05  
What is broken?  
E. Loney; Darlington/UK (elizabeth_loney@hotmail.co.uk)  
Radiological assessment is critical in the management of skull base and facial 
trauma. CT is the preferred imaging technique, combining detailed visualization 
of bony and soft tissue injuries with the ability to perform 3D reconstructions 
and aid surgical planning. The scope of this presentation is broad and 
therefore we will concentrate on producing useful reports by differentiating Le 
Fort injuries from naso-orbitoethmoid and zygomaticomaxillary fracture 
patterns. We will consider orbital and temporal bone injuries and briefly touch 
upon laryngeal trauma, which in itself could account for a whole session. If 
attendees feel more comfortable reporting a facial trauma scan by the end of 
the presentation than they did at the start, our aims will have been achieved!  
Learning Objectives: 
1. To know which imaging techniques to use in case of trauma. 
2. To become familiar with base of skull fracture (including temporal bone and 
orbit). 
3. To learn about maxillofacial fractures. 
4. To get acquainted with the traumatic lesions of the larynx. 
A-542 16:28  
It is red and swollen ...  
M. Becker; Geneva/CH (minerva.becker@hcuge.ch)  
Computed tomography (CT), magnetic resonance imaging (MRI) and 
occasionally ultrasonography (US), play a major role for the correct diagnosis 
of a variety of infectious head and neck conditions seen in the emergency 
situation. The purpose of this lecture is to familiarise the radiologist with the 
most common types of infectious emergencies in the head and neck. A 
systematic review will include key radiologic features of these potentially life-
threatening conditions. The following entities are discussed: otomastoiditis, 
complicated sinusitis and sialadenitis, suppurative lymphadenitis, paratonsillar, 
retropharyngeal, parapharyngeal and other neck abscesses, cellulitis, myositis, 
necrotising fasciitis, osteomyelitis, thrombophlebitis and septic deep venous 
thrombosis. Associated complications affecting the mediastinum and lung, 
meninges and brain will be discussed with emphasis on the early detection of 
lesions. Typical spread patterns of infection within the neck will be 
summarised. The detection of foreign bodies as a cause of secondary 
infection, as well as pitfalls and limitations of individual imaging techniques will 
also be addressed. Major emphasis will be put on what is the most appropriate 
imaging modality in which clinical situation, how should imaging be performed 
in an optimal fashion and how to report the findings in a structured and 
comprehensive way.  
Learning Objectives: 
1. To learn which imaging techniques to use in the case of an infection and 
inflammation in the emergency setting. 
2. To become familiar with the infections of the base of skull. 
3. To understand the diversity of infection patterns of soft tissues. 
4. To appreciate the pathologies of the salivary glands that may present in the 
emergency setting. 
A-543 16:51  
It is bleeding ...  
D.-A. Varoquaux; Marseille/FR (arthur@varoquaux.com)  
Arterial embolisation is the preferred treatment for refractory epistaxes and for 
certain hemorrhages of the ENT area. When carried out by trained radiologists, 
it proves to be an efficient method that presents little risk of complications. 
Hemorrhages of the ENT area are of different nature and etiology. Their 
approach should be considered according to specific clinical context. The 
treatment of hemorrhages of venous origin does not fall under the competence 
of interventional radiology; endovascular or percutaneous embolization 
treatment of vascular malformations will not be treated in this article. According 
to circumstances, several types of arterial hemorrhages of the ENT sphere can 
be distinguished: (1) Hsemorrhages of nasal origin (epistaxes). They can be 
essential or symptomatic (2) Life threatening ENT haemorrhages in oncology, 
pre- or postoperative by hemostasis disorders or secondary bleeding 
specifically after a laryngectomy or a tonsillectomy devascularisation of 
hypervascular tumours (paragangliomas and nasopharyngeal fibromas) by 
preoperative embolisation. (3) Carotid blow out, linked to the presence of a 
progressive tumour, or post-radiation, or traumatic. In some cases, these 
haemorrhages are cataclysmic and require extreme emergency care. In all 
cases, close collaboration with the ENT surgery department, the presence of 
an anaesthetist, and at least a sedation are determining factors in the 
improvement of care and therefore in the success of the embolisation. Every 
patient and/or family is to be given true, clear and appropriate information  
 
Learning Objectives: 
1. To learn about the vascular blunt and penetrating traumatic injuries. 
2. To appreciate the role of the interventional radiologist in the treatment of 
epistaxis and tumours (juvenile angiofibroma and squamous cell carcinoma) in 
the emergency setting. 
3. To have notions of vascular malformations and their complications. 
4. To acquire basic notions of endovascular treatments. 
17:14  
Panel discussion: Is the radiologist an essential component of the 
emergency team  
16:00 - 17:30 Studio 2018  
Genitourinary  
RC 1207  
MRI for gynaecologic imaging: how I do it  
A-544 16:00  
Chairperson's introduction  
B. Ahuja; Agra/IN (drbahuja@gmail.com)  
Ultrasound is the imaging modality of choice for the female pelvis. It is widely 
available and is relatively inexpensive. However, there are some shortcomings 
with this modality, such as limited field of view, obscuration of pelvic organs by 
bowel gases, inherent limitations due to patient size and dependence on 
operator skills. With its high contrast resolution, ability to provide good tissue 
characterisation and its multiplanar capabilities, MRI is increasingly used to 
evaluate pelvic pathology. Standard MRI protocol includes coronal single shot 
fast spin echo (FSE), sagittal T2W FSE fat suppressed sequences, axial T2W 
FSE sequence, axial in phase and opposed phase T1W gradient recall echo 
and axial diffusion weighted sequence using a dedicated pelvic phased array 
coil. GRE imaging is done to detect haemorrhagic foci in case of deep 
infiltrative pelvic endometriosis. Diffusion weighted imaging play a pivotal role 
in detection & staging of gynaecological malignancies and to see the response 
of therapy. Fat suppressed T1W sequences following intravenous 
administration of 10 ml of gadolinium contrast are routinely obtained. For pelvic 
floor imaging, dynamic 2D GRE imaging may be performed with and wthout 
the valsalva maeuver. 
Session Objectives: 
1. To learn how to optimise MRI of the female pelvis. 
2. To understand the diagnostic benefit of integration of advanced techniques. 
A-545 16:05  
A. Basics of patient preparation and T2W-imaging  
N.M. deSouza; Sutton/UK (nandita.desouza@icr.ac.uk)  
T2-W MR imaging provides exquisite soft tissue contrast for evaluation of 
pelvic pathology. Maximising contrast and spatial resolution is fundamental to 
achieving a high diagnostic accuracy. Adequate signal-to-noise ratio with 
sufficient T2-weighting requires appropriate consideration of available 
hardware and software. Patient-related factors that result in image degradation 
can be reduced by careful patient preparation. Motion from bowel peristalsis 
may be controlled with antiperistaltic agents (Buscopan [hyoscine 
butylbromide] 20mg or glucagon 1mg); intramuscular administration is crucial 
as intravenous delivery produces a short period of antiperistalsis insufficient to 
last through the scanning period. Bladder filling during the scan also can 
substantially degrade image quality, and therefore an empty bladder at the 
outset is essential. To minimise diuresis during scanning, caffeine-containing 
drinks should be avoided and fluid intake limited for 4 hours prior to scanning. 
Images dedicated to the uterus should be acquired along the long and short 
axis of the organ, with as small a field of view as feasible without compromising 
signal-to-noise ratio. For large field-of-view images, T2-W scans in true 
orthogonal planes to the B0 field are preferred. The sagittal plane is best for 
visualising the uterus, while the transverse plane is ideal for assessing 
parametria, adnexae and pelvic sidewall. For the ovaries, the coronal plane 
may be helpful. 3D acquisitions provide high spatial resolution with the 
flexibility of multiplanar reconstruction. High-quality T2-W images in orthogonal 
planes are usually sufficient for detecting, characterising and staging pelvic 
malignancy, monitoring treatment response and assessing disease recurrence 
in a range of gynaecological pathologies.  
Learning Objectives: 
1. To understand the value of patient preparation. 
2. To learn how to optimise and tailor protocols in female pelvic imaging. 
3. To understand the role of T2WI, and how and when to use 3D techniques. 
  







A-546 16:28  
B. Contrast agents  
R.A. Kubik-Huch; Baden/CH (rahel.kubik@ksb.ch)  
Gadolinium-based contrast material is not usually necessary for evaluating 
benign uterine disease, but is recommended in fibroid evaluation. Gadolinium-
enhanced sequences are performed for staging endometrial carcinoma, being 
useful in the assessment of the depth of myometrial tumour invasion. The 
optimal tumour/myometrial contrast timing was reported between 90 and 150 
seconds. Thus, the utility of dynamic acquisition has been debated. Contrast-
enhanced imaging will not be routinely performed in cervical carcinoma, but 
can be valuable in selected cases. It is recommended in the MR assessment of 
sonographically indeterminate adnexal masses and mandatory for staging 
ovarian carcinoma. Dynamic contrast-enhanced MRI may provide quantitative 
information about tumour perfusion, being useful for monitoring the therapeutic 
effects and predicting the therapeutic outcome. MR angiography should be 
performed in patients scheduled for fibroid embolisation or in suspected pelvic 
congestion syndrome. Gadolinium-based contrast agents will cross the 
placenta and enter the foetal bloodstream. The agents are excreted into the 
amniotic fluid and will not be removed effectively from the foetal environment. 
Contrast agents should be avoided in the pregnant patient. Only a small 
amount of gadolinium is excreted into the breast milk and absorbed by the 
infant, without any adverse effects being reported. Therefore, breast feeding 
can be continued, but it might be the preference of the mother to discard the 
breast milk in the 24 hours after contrast medium. If contrast agents need to be 
administered in these patients, linear gadolinium chelates should be avoided. 
Learning Objectives: 
1. To become familiar with the safety considerations and guidelines for the use 
of gadolinium with a special focus on imaging pregnant and lactating patients. 
2. To learn why, how and when to use IV contrast-enhanced imaging in MRI of 
the female pelvis. 
3. To understand different gadolinium T1W techniques and their clinical value 
in routine imaging, as well as to become familiar with quantification techniques. 
A-547 16:51  
C. Diffusion and ADC  
R. Forstner; Salzburg/AT (r.forstner@salk.at)  
Diffusion-weighted Imaging (DWI) has become a powerful imaging technique in 
the female pelvis providing functional information. It improves tissue 
characterisation and facilitates lesion depiction. This is based on visualisation 
of differences of random motion of water molecules within tissues, changes of 
tissue cellularity, and altered cell membranes. DWI is typically assessed in 
conjunction with findings obtained by conventional MR imaging sequences. 
Although several b values may be used, at least two b values (low <100 and 
high >800-1000mm2/sec) will provide visual information as well as quantitative 
analysis, the apparent diffusion coefficient (ADC). DWI has emerged as an 
available complementary sequence in staging gynaecological cancers, in 
differentiation of benign from malignant masses, and in imaging recurrent 
disease. DWI has also been linked to lesion aggressiveness and emerges as 
an imaging biomarker for tumour response. In pregnancy or in impaired renal 
function, DWI serves also as an alternative to i.v. contrast media. The main 
clinical applications include assessment of depth of myometrial invasion in 
endometrial cancer and identification of local tumour extent in small size or in 
diffusely growing cervical or endometrial cancers difficult to depict on T2WI. It 
also aids in characterisation of adnexal masses and facilitates identification of 
metastatic spread in advanced gynaecologic cancers, particularly to the 
peritoneum or to lymph nodes. The added value of DWI in various applications 
in clinical practice will be highlighted and the pitfalls will be demonstrated. 
Learning Objectives: 
1. To understand the technical principles of DWI. 
2. To learn how to optimise and integrate DWI in pelvic imaging. 
3. To illustrate the added diagnostic value of DWI in female pelvic imaging. 
17:14  
Panel discussion: Multiparametric MRI of the female pelvis: should it 





16:00 - 17:30 Room L 8  
E³ - Rising Stars Programme: EFRS Radiographers' Basic 
Session  
BR 1  
Radiography research: a how to guide  
A-548 16:00  
Chairperson's introduction: Why is radiography research important  
M. Hardy; Bradford/UK (M.L.Hardy1@bradford.ac.uk)  
Increasing the capacity, volume and quality of radiography research is 
essential to professional credibility and standing. Research forms the 
foundation upon which evidence-based decisions are made and enables 
clinical practice and service delivery innovation. As a result, it is imperative that 
we are all comfortable with the research processes and understand the 
sometimes confusing language and terminology adopted, to ensure that our 
practice is relevant and research informed. This starts with being clear about 
what research is and the ethical dilemmas that need to be tackled in designing 
competent and achievable research programmes. A further building block is 
developing the skills of criticality, understanding the limitations of a piece of 
work and, importantly, the gaps in the evidence base that need to be plugged 
to ensure a coherent knowledge base. Finally, it is important to appreciate the 
responsibility of researchers to disseminate their findings to ensure they are 
adopted in practice and the necessary skills required to construct high-quality 
scientific abstracts for conference presentations and posters. This session has 
some exciting speakers who will guide, inform and inspire you to take forward 
your research aspirations, whether as a research user or as a future research 
leader, and I look forward to facilitating this session to enhance your learning. 
Session Objectives: 
1. To become familiar with common ethical issues arising in radiography 
research. 
2. To understand the value of critical appraisal when reading research 
publications. 
3. To identify good practices for constructing quality scientific abstracts and 
posters. 
Author Disclosure: 
  M. Hardy: Board Member; British Institute of Radiology. Employee; University 
of Bradford. Grant Recipient; National Institute of Health Research. 
A-549 16:05  
How to avoid ethical issues  
B.T. Andersson; Lund/SE (bodil-t.andersson@med.lu.se)  
Good research practices. Consent from a research ethics committee. Ethical 
principles: respect, autonomy, non-maleficence, beneficence, justice. 
Fundamental principles of research integrity: reliability, honesty, respect, 
accountability. Research environment: research procedures, documentation, 
data protection and archiving information to participants about the value and 
confidentiality. The right to integrity. The right to decline participation. The right 
to withdraw from the study. Informed consent. Ensuring confidentiality. Risks-
causing harm, violation or suffering to the participant.  
Learning Objectives: 
1. To understand the importance of ethics in medical research and the role of 
research ethics committees. 
2. To become familiar with common ethical pitfalls in research design. 
3. To appreciate strategies for avoiding ethical problems in research. 
A-550 16:23  
How to critically appraise a research article  
B. Kraus; Vienna/AT (barbara.kraus@fh-campuswien.ac.at)  
To appreciate the role of literature reviews in the research process, students 
first of all have to find reading strategies for scientific text and particularly for 
non-native speakers to read an English scientific text. Different methods of 
reading, e.g. the shopping centre strategy or SQ3R technique (Survey, 
Question, Read, Recite, Review), are useful for guiding through research 
articles. Reading the title and abstract of an article is the first selection step 
with "the quick review“, followed by the process of "the detailed review“ to get 
an assessment about not just the quality of the study design, but also the 
quality and applicability of the results. The aim is to find strengths and 
weaknesses in each section of a research report and it is necessary to identify 
the research method (quantitative/qualitative), the methodology with all pros 
and cons and to screen the questions using the PICO (population, intervention, 
comparison and outcome) system. Was the study design appropriate to 
address the research question? How precise are the results and are they 
  







appropriately presented? Also, the relevant expertise of the author(s) should 
be clear. Another important point is to figure out clearly in the discussion or 
conclusion about any conflicts of interest and any acknowledgement of 
limitations. The presence of an ethics committee approval must also be 
declared. Finally, knowledge of and the proper use of guidelines/checklists and 
scoring systems are important key factors that help in the critical appraisal of 
research work.  
Learning Objectives: 
1. To appreciate the role of the literature review in the research process. 
2. To identify strengths and weaknesses in each section of a research report. 
3. To critically appraise the overall value of a research report. 
A-551 16:41  
How to write a good scientific abstract  
R. Decoster; Brussels/BE  
Writing an abstract is the art of delicately luring your reader into exploring your 
research. The abstract, 250 words of carefully selected text, consists of a web 
built from ideas and findings that pinpoint why someone should spend time on 
your article or talk. During this presentation, I will dissect an abstract to 
illustrate the universal backbone of each abstract. We will explore how different 
science branches put other accents in their carefully woven bait. While reading 
between the lines of some examples, we will steal like an artist in the search 
for success.  
Learning Objectives: 
1. To understand general qualities of good scientific abstracts. 
2. To be aware of typical formats of scientific abstracts. 
3. To consider tips for success. 
A-552 16:59  
How to produce a high-quality scientific or educational poster  
L.A. Rainford; Dublin/IE (louise.rainford@ucd.ie)  
This presentation will firstly discuss the many types of posters and the key 
matters a prospective presenter must consider in relation to the variation in 
poster submission processes across national and international conferences. 
The importance of reading the poster submission guidelines will be highlighted. 
Suggestions will be proffered with respect to the poster design under a number 
of key headings. The material covered will include: choosing the correct title, 
institutional identification, author affiliations and ordering of affiliations, 
designing sections of the poster to facilitate the reader with an opportunity to 
logically progress through the material provided in the poster and the 
importance of clear, scientific language, accurate grammar, spell checks and 
appropriate labelling of images and figures. The use of appropriate scientific 
language will be discussed and examples of good practice supplied. Accurate 
formatting cannot be overstressed and the presentation will include examples 
of potentially avoidable poster errors. The overall recommendations and design 
suggestions incorporated in this presentation are aimed at supporting 
radiographers in achieving high-quality scientific poster submissions, and the 
content will be appropriate for both radiography students and radiographers.  
Learning Objectives: 
1. To become familiar with poster formats and layouts. 
2. To consider good practices in poster design. 
3. To appreciate important considerations when designing a poster. 
17:17  
Panel discussion: Ask the experts  
16:00 - 17:30 Room E1  
Breast  
RC 1202  
MRI for early detection, staging and 
management of breast cancer  
A-553 16:00  
Chairperson's introduction  
J. Camps Herrero; Valencia/ES (juliacamps@gmail.com)  
This Masterclass will tackle three issues that are currently at the forefront of the 
breat MRI debate: imaging biomarkers, preoperative staging and the so-called 
“overdiagnosis”. Breast MRI should have already passed the phase of 
diagnostic validation and must now head towards the definition of imaging 
biomarkers that are capable of sampling the whole cancer in its entire 
heterogeneity as well as allowing serial measures in response evaluation. 
Imaging biomarkers must be solid, reproducible and standardised. This lecture 
will define common imaging biomarkers in the clinical setting as well as set the 
path for their further development in the future. Preoperative breast MRI is still 
being questioned as a valid indication and the MIPA study has been designed 
to answer the questions raised by published evidence on the contrary (excess 
mastectomies, no significant difference in mastectomy rates, etc) tainted by 
methodological biases which will be highlighted during this session. The 
number of high-risk (B3) lesions has increased after the use of breast MRI, 
being considered traditionally false-positive diagnoses, when in fact they have 
underlying prognostic implications. This lecture outlines these implications and 
lets us see breast MRI under a different light, when pathology correlates are 
considered.  
Session Objectives: 
1. To understand the contribution of MRI to preoperative staging and the 
context within it should be recommended. 
2. To learn about the different MRI biomarkers and in which clinical setting they 
are of value. 
3. To recognise the steps required to move to abbreviated MRI for high-risk 
screening. 
Author Disclosure: 
  J. Camps Herrero: Consultant; Bayer, Bard. Speaker; Bayer. 
A-554 16:05  
A. Preoperative staging with MRI: did the MIPA trial solve all issues?  
F. Sardanelli; San Donato Milanese/IT (f.sardanelli@grupposandonato.it)  
Preoperative breast MRI is a highly debated modality. New evidence has been 
emerging from the MIPA study, an ongoing prospective observational 
multicentre study, enrolling two concurrent groups with a newly diagnosed first 
breast cancer, not candidate to neoadjuvant therapy, receiving or non-
receiving MRI before surgery. Up to October 2017, over 6,000 patients were 
recruited. The data from 2,425 patients were as follows: 1,201 (49.5%) with 
MRI and 1,224 (50.5%) without. Of these 1,224 MRIs, 210 (17%) were 
performed for screening (4%) and for diagnostic purposes (13%). Of 1,014 
preoperative MRIs, 595 (59%) were ordered by radiologists alone and 321 
(32%) by surgeons alone; radiologists and surgeons were involved in the 
request in 68 and 40% of cases, respectively. Mastectomy rate planned at 
mammography/ultrasound was 185/1201(15.4%) in the non-MRI-group and 
245/1224 (20.0%) in the MRI-group (p<0.001). In the MRI group, 21 additional 
mastectomies (1.7%) were planned after MRI, while 25 patients planned to 
have mastectomy shifted to conservative surgery (CS). Of the 1,004 patients 
planned for CS before MRI, MRI did not indicate a change in performing 
surgery in 733 (73%), while it prompted a wider CS in 143 (12.5%) and a less 
extensive CS in 128 (12.7%). Mastectomy rate was 192/1201(16%) in the non-
MRI-group and 257/1224 (21%) in the MRI-group (p<0.001). Per-patient 
reoperation rates for close/positive margins were 135/1009 (13.4%) and 
80/967 (8%), respectively (p<0.001). Most mastectomies were already planned 
at mammography/ultrasound, using MRI as a confirmation tool. This patient 
selection also contributed in determining a lower reoperation rate in women 
undergoing MRI. Conversely, CS was modified by MRI according to disease 
extent, balancing increased and decreased tissue removal.  
Learning Objectives: 
1. To learn about the evidence for and against the use of MRI in preoperative 
staging. 
2. To understand the background, design and early results of the MIPA trial. 
3. To be able to explain the role of preoperative MRI during multidisciplinary 
tumour board meetings. 
Author Disclosure: 
  F. Sardanelli: Advisory Board; Bracco, General Elecric. Research/Grant 
Support; Bracco, Bayer, Real Imaging. 
A-555 16:28  
B. MR imaging biomarkers for the clinical setting  
E.A. Morris; New York, NY/US (morrise@mskcc.org)  
Background parenchymal enhancement is related to vascular flow and it has 
been proposed that this may represent an imaging biomarker of the underlying 
proliferation of fibroglandular tissue. Investigations have shown that there is an 
extremely strong association between BPE and risk of breast cancer, at least 
as strong as the association between mammographic density and breast 
cancer. It has been observed that background parenchymal enhancement is 
also affected by treatment changes and hormonal manipulation. Radiation 
therapy to the breast causes marked reduction in background parenchymal 
enhancement. MRI can further stratify women at high risk for developing breast 
cancer on the basis of background parenchymal enhancement. Rim 
enhancement MRI phenotypic features can predict the aggressiveness of 
breast cancer. For example, we know that spiculation on MRI is associated 
with a lower histologic grade and lower ki67 expression and is more commonly 
  







seen in ER+ cancer. Rim enhancement has been shown to be associated with 
cancers that are higher in grade and ER-. Rim enhancement is associated with 
a worse distant metastatic survival. It has been shown that triple negative 
tumours without rim enhancement are associated with tumour-infiltrating 
lymphocytes. High TIL levels are associated with pCR, following NAC and 
improved survival in TNBC. Peritumoural oedema is caused by increased 
vascular permeability and release of cytokines. It is seen in <10% of breast 
cancer and is associated with early distant metastases (<2.5 y). In TNBC 
peritumoural oedema was a significant independent predictor of worse 
recurrence-free survival. 
Learning Objectives: 
1. To learn about the different biomarkers that are available and the evidence 
for using them in patients with breast cancer. 
2. To understand in which clinical settings biomarkers might be of value. 
3. To appreciate the newer techniques that are being developed and tested 
clinically. 
Author Disclosure: 
  E.A. Morris: Advisory Board; Delpjinus, Hologic, GE, Avon. Research/Grant 
Support; GRAIL, Hologic, Komen. 
A-556 16:51  
C. Screening with abbreviated protocols  
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de)  
Early diagnosis improves survival of women with breast cancer. 
Mammographic screening improves early diagnosis of breast cancer. Yet, 
there appears to be room for improvement. The major shortcomings of 
mammographic screening are overdiagnosis of prognostically unimportant 
cancer, as well as underdiagnosis of cancers that are indeed relevant. Failure 
to detect biologically relevant breast cancer with mammographic screening is 
driven by host-related factors, i.e. breast tissue density, but also tumour-related 
factors: Biologically relevant cancers may exhibit imaging features that renders 
them indistinguishable from normal or benign breast tissue on mammography. 
These cancers will then progress to become the advanced-stage interval 
cancers observed in women undergoing mammographic screening. Since 
breast cancer continues to represent a major cause of cancer death in women, 
the search for improved breast cancer screening method continues. 
Abbreviated breast MRI has been proposed for this purpose because it will 
greatly reduce the cost associated with this method, due to a greatly reduced 
magnet time (down to 3 minutes), but especially also due to a greatly abridged 
image interpretation time, i.e. radiologist reading time. This lecture will review 
the current evidence and present the EA1141 trial designed to investigate the 
utility of abbreviated breast MRI for screening average-risk women with dense 
breast tissue.  
Learning Objectives: 
1. To learn about the evidence for abbreviated MRI and the comparison with 
standard protocols. 
2. To understand the different protocols for abbreviated MRI and the merits of 
each sequence used. 
3. To appreciate the advantages and limitations for abbreviated MRI. 
17:14  
Panel discussion: Why are some recommendations not adopted and how 
can we change practice?  
16:00 - 17:30 Room E2  
Neuro  
RC 1211  
Inflammatory and infectious CNS 
pathology  
A-557 16:00  
Chairperson's introduction  
E.T. Tali; Ankara/TR (turgut.tali@gmail.com)  
Clinical presentation and imaging features of infectious and noninfectious 
inflammatory diseases of the spinal cord are variable and usually nonspecific. 
Differentiating these conditions from the other spinal cord lesions (neoplasms, 
degenerative disorders, etc.) is still challenging. For both groups, early and 
accurate diagnosis is important because of the different treatment protocols as 
well as to decrease neurologic complications. Spinal cord infections are 
clinically important because of the high rates of morbidity and even mortality. 
The symptoms are usually nonspecific, which can delay the diagnosis. A 
combination of clinical history, neurologic examination, laboratory data, spinal 
fluid analysis, serological studies, and imaging findings are the main tools for 
making a correct diagnosis. Spinal inflammatory diseases can be caused by 
autoimmune, granulomatous, and idiopathic conditions. Demyelinating 
diseases (multiple sclerosis (MS) and neuromyelitis optica (NMO)) are the 
most common inflammatory conditions. Transverse myelitis, acute 
disseminated encephalomyelitis (ADEM) and Guillain-Barré syndrome (GBS) 
should be thought as differential diagnoses. Demyelinating lesions may also be 
seen in autoimmune diseases such as sarcoidosis, systemic lupus 
rrythematosus and Sjögren's syndrome. Vascular malformations, arachnoiditis, 
and even neoplastic diseases may also produce inflammation. For the 
radiologist, it is crucial to be aware of different imaging features of spinal 
infections and inflammatory diseases. Comprehensive evaluation of the 
imaging features associated with the clinical presentation, laboratory data, 
spinal fluid analysis, and serological studies helps to make the final diagnosis.  
Session Objectives: 
1. To understand the role of imaging in the diagnosis and monitoring of 
inflammatory and infectious diseases of the central nervous system. 
2. To learn basic principles of the use of imaging in neuroinfection and 
neuroinflammation. 
3. To appreciate the added value of imaging in addition to the clinical findings 
and laboratory tests including CSF analysis. 
A-558 16:05  
A. Autoimmune encephalitis  
P. Demaerel; Leuven/BE (philippe.demaerel@uzleuven.be)  
Autoimmune encephalitis (AE) is emerging as a more common cause of 
encephalopathy than previously thought. AE is a difficult clinical diagnosis and 
occurs both in adults and in children. The presence of antibodies (Ab) in the 
CSF confirms the diagnosis, but the results can take several weeks to obtain 
and negative results do not exclude AE. Therefore, MR imaging plays an 
important role in these patients, who often present with nonspecific 
neurological symptoms. Subacute encephalopathy, new adult-onset seizures 
or psychiatric symptoms should raise the suspicion of a possible AE. AE 
consists of a large number of Ab-related diseases. They are usually divided 
into three groups: (1) Ab to cell-surface antigens, (2) Ab to intracellular 
synaptic proteins and (3) Ab to intracellular antigens. The imaging-related 
findings will be reviewed in this course. The most common imaging finding 
consists of uni- or bilateral FLAIR hypersignal in the hippocampus, amygdala 
and/or parahippocampal area. It is important to emphasize that these signal 
changes can be very subtle. Extratemporal lesions in the cerebral cortex, the 
grey nuclei, the cerebellum and the brainstem have been reported too and can 
support the clinical suspicion of AE. But Brain MR can also remain normal and 
FDG-PET is certainly recommended in these patients. MR imaging is also used 
to exclude or confirm other autoimmune diseases, e.g. MS, neuromyelitis 
optica, ADEM and lupus. Finally, MR imaging is helpful to exclude other 
diseases that can have a similar clinical presentation, e.g. lymphoma, 
carcinomatous meningitis and Wernicke encephalopathy.  
Learning Objectives: 
1. To learn about the imaging pattern of autoimmune encephalitis. 
2. To understand the limited role of conventional MRI and the need for 
advanced imaging techniques in the diagnostic process and for follow-up 
purposes. 
3. To appreciate the role of imaging in a multidisciplinary and multimodality 
approach. 
A-559 16:28  
B. Infectious encephalitis  
K.D. Kurz; Stavanger/NO (kurk@sus.no)  
Encephalitis is a potentially fatal disease occurring at any age. The most 
common types of encephalitis are caused by viral infections, with herpes 
simplex virus (HSV) encephalitis the most known type. It is critical to make a 
rapid and correct diagnosis to tailor the treatment with the goal of better 
outcome of the disease. MRI is a powerful tool for the fast detection of typical 
imaging patterns in CNS caused by viral infections and helps to grade the 
severity of the disease, especially by using diffusion weighted imaging. In this 
refresher course, we would like to summarize the current understanding of MRI 
findings of viral encephalitis, especially related to HSV, varicella zoster, rabies, 
influenza viruses and haemorrhagic encephalitis. We also discuss the typical 
CNS complications of the infections. In addition, we would also like to discuss 
the imaging features of subacute cerebral infections such as Rasmussen 
encephalitis, HIV, progressive multifocal leukoencephalopathy (PML), and 
Creutzfeldt-Jakobs disease.  
Learning Objectives: 
1. To learn about the correct choice of imaging modalities and image 
acquisition parameters for the detection and monitoring of infectious diseases 
of the central nervous system. 
2. To understand the benefits and challenges of image pattern recognition for 
  








3. To appreciate the heterogeneity of the disease spectrum and challenges to 
interpret imaging findings in the context of the clinical presentation and 
possible comorbidities. 
A-560 16:51  
C. Inflammatory and infectious myelitis  
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at)  
Transverse myelitis (TM) is an “umbrella term” used to describe inflammatory 
disorder of the spinal cord that can be idiopathic or associated with central 
nervous system (CNS) autoimmune inflammatory diseases, connective tissue 
autoimmune diseases, or post-infectious neurological syndromes. Myelitis can 
present either as monophasic or recurrent disease. The most common 
monophasic diseases causing TM are idiopathic transverse myelitis and acute 
disseminated encephalomyelitis (ADEM), whereas recurrent disorders include 
multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), 
vasculitis (Behcet disease, SLE, Sjögren syndrome) and neurosarcoidosis. The 
recent discovery of multiple novel neural-specific autoantibodies accompanying 
autoimmune and demyelinating disease has improved the current 
understanding and classifications. This lecture will provide an overview of 
radiological, clinical, serological, and prognostic differences of inflammatory 
and infectious spinal cord diseases. 
Learning Objectives: 
1. To learn about the spectrum of infectious diseases of the spinal cord level 
and their most characteristic imaging features. 
2. To understand the difficulties in image acquisition and image interpretation. 
3. To appreciate the clinical relevance of early diagnosis and therapeutic 
intervention. 
17:14  
Panel discussion: Ask the expert: Is imaging the key diagnostic modality 
for an early and specific diagnosis of infectious diseases, leading to a 
better functional outcome?  
16:00 - 17:30 Room F1  
E³ - Rising Stars Programme: Joint Sessions with ESOR  
ESR/ESOR 3  
Radiologic anatomy: neuro  
Moderator:  
M.A. Lucic; Sremska Kamenica/RS  
A-561 16:00  
Cortical anatomy and primary functional areas  
T.A. Yousry; London/UK  
The anatomy of the brain is often perceived as being complicated. Especially 
the cortex is seen as an irregular arrangement of variable structures, which are 
difficult to differentiate and to identify. We will review the overall subdivision of 
the brain into lobes and describe their boundaries and their major gyri and 
sulci. We will then describe the location of specific functions. (1) Primary 
sensorimotor cortex: Motor is located in the precentral gyrus, sensory in the 
postcentral gyrus around the central sulcus (CS), hence the importance of 
always correctly identifying the CS. We will present 4 interlocked methods to 
identify the CS in the axial plane a) Knob, b) lateral axial, c) medial axial, d) 
gyral/cortical thickness and 3 to identify it in the sagittal plane a) lateral sagittal, 
b) hook, c) medial sagittal. (2) Primary auditory cortex (A1): Centred at the 
postero-medial part of Heschl’s gyrus (HG), we will present simple landmarks 
in each of the 3 planes: a) axial: adhaesio interthalamica, b) sagittal: 
omega/heart shape of HG, c) coronal: omega shape of HG. (3) Primary visual 
cortex (V1): Centred on the calcarine sulcus, we will discuss the characteristic 
shape that allows the identification of this structure in all 3 planes. At the end of 
this lecture, you will know the subdivision of the cortex; the methods and 
landmarks necessary to identify the primary sensorimotor, speech, auditory, 
and visual areas.  
Learning Objectives: 
1. To understand the basic concepts of cortical subdivision. 
2. To be able to identify critical cortical structures. 
3. To learn to localise primary functional areas. 
 
 
A-562 16:30  
Vascular distribution territories: arterial and venous  
T. Engelhorn; Erlangen/DE (Tobias.Engelhorn@uk-erlangen.de)  
After a short overview on the vascular anatomy of the brain with a focus on 
vascular distribution territories, the main focus of this talk is to present 
neurovascular pathologies closely associated with arterial and venous vascular 
distribution territories. One focus is also put on acute stroke and subsequent 
patient selection for interventional stroke therapy. Another aim is to provide a 
better understanding of the pathophysiology of different neurovascular 
diseases in an interactive matter. In addition, the advantages and limitations of 
CTA, flat-panel CTA and MRA compared to conventional angiography are 
presented.  
Learning Objectives: 
1. To become familiar with a comprehensive vascular anatomy of the brain. 
2. To recognise patterns of various pathologies attributed to vascular 
distribution territories. 
3. To recognise the different imaging patterns in stroke and their prognostic 
value. 
A-563 17:00  
The basal ganglia of the brain revisited  
D. Zlatareva; Sofia/BG (dorazlat@yahoo.com)  
The term “basal ganglia” refers to caudate nucleus, putamen, globus pallidus, 
substantia nigra and subthalamic nucleus. They are paired symmetric 
structures located in the telencephalon, diencephalon and mesencephalon. 
The lenticular nucleus includes putamen and globus pallidus. Together with 
caudate nucleus, these structures are named corpus striatum. Being part of the 
extrapyramidal system, the basal ganglia have wide connections not only with 
each other, but also with the midbrain, thalamus and cerebral cortex. The 
striatum is the main recipient of afferents from the entire cerebral cortex and 
thalamus. The information is then processed and integrated with other inputs 
and transmitted to the globus pallidus internal segment and the substantia 
nigra pars reticulate. Those are major output structures of the basal ganglia 
and make GABAergic, inhibitory connections on their targets. According to 
current concepts in the motor regions of the basal ganglia, there is a motor 
homunculus similar to that in the primary motor cortex. The basal ganglia and 
thalami have five functional divisions that are sensorimotor, supplementary 
motor, premotor, association and limbic territories. Very complex functional 
cortical-basal-ganglial-thalamocortical circuits enable the execution of 
automatic and semi-automatic motor programmes, modulation of muscle tone 
and the harmonisation of movement. If one or more of these regulatory circuits 
are disrupted, the result will be either a net removal of inhibition, leading to 
excessive movement like tremor or dystonia, or a net decrease in motor 
activation causing impaired movement (e.g. rigidity, akinesia).  
Learning Objectives: 
1. To recall the basal ganglia nuclei and their topography. 
2. To identify the classic functional organisation of the basal ganglia and its 
current concepts. 
3. To elucidate the pathophysiology of various movement disorders. 
16:00 - 17:30 Room F2  
Oncologic Imaging  
RC 1216  
Cancer screening  
A-564 16:00  
Chairperson's introduction: Screening for cancer: lessons learned and 
future challenges 
S. Törnberg; Stockholm/SE (Sven.Tornberg@ki.se) 
Cancer is a lethal disease. The purpose of screening is to find cancer in an 
early, still curable, phase. Population based screening is a strategy aiming to, 
in a systematic and organised way, find early cancers in a population at risk, 
related to sex, age, or risk behaviour. The benefit (of not dying) can’t, for 
obvious reasons, be experienced by the individual person, only a confirmation 
of not having a cancer (which is not the purpose of screening). Harms of 
screening are unnecessary exposure to radiation, worry, false negative and 
false positive results, and over-diagnosis leading to unnecessary and invasive 
treatment. The balance between harms and benefit needs to be evaluated 
before recommending population based screening. EU recommends screening 
for breast cancer, colorectal cancer and cervix cancer. EU has also published 
guidelines on how to ensure the quality of the entire screening process by 
using indicators as surrogate measures. If participation rate, cancer detection 
  







rate, interval cancer rate, and stage distribution is equal to the levels 
experienced in the RTC’s, it reflects a similar effect. EU has defined acceptable 
levels of performance. Individual data needs to be recorded in order to 
measure the quality and the effect of the screening. EU’s 2nd screening report 
(2017) compared the extent, and the quality of the recommended cancer 
screening programs between the EU member states. During the session, the 
above mentioned aspects will be discussed for, lung-, colorectal-, and breast 
cancer, all three being leading causes of cancer deaths in Europe. 
Session Objectives: 
1. To understand the basic idea behind cancer screening protocols. 
2. To learn about potential harms and benefits of screening protocols. 
3. To explain why epidemiological data are so important for successful 
screening programmes. 
A-565 16:05  
A. Lung cancer screening: the evidence  
H.-U. Kauczor; Heidelberg/DE  
Lung cancer is the most common and most fatal cancer in Europe and 
worldwide, with a 5-year survival of only 13%. The by far most important risk 
factor for lung cancer is cigarette smoking. In 2011, the results of the largest 
randomized controlled screening trial (NLST) using low-dose CT (LDCT), 
performed in the USA showed a significant 20% reduction of lung cancer 
mortality in elderly (55-74 years) and heavy smokers (> 30 packyears), but has 
not been replicated by any other trial so far. Although lung cancer screening 
(LCS) using LDCT was established in the USA in 2015, the introduction of 
such screening programmes in Europe remains controversial. For a successful 
LCS programme using LDCT the pretest probability has to be high, while the 
numbers of false-positive screens and overdiagnosis are low. Thus, a risk 
model and dedicated nodule management algorithms must be strictly followed. 
The radiation exposure from LDCT should be < 1 mSv if not obese. The whole 
workup of positive screens requires strict SOPs at experienced high-
throughput centres with clinical audits established. A smoking cessation 
programme should be a mandatory component of LCS. Furthermore, LCS in 
the future should tackle the “Big Three” killers associated with cigarette 
smoking, i.e. lung cancer, COPD and cardiovascular diseases, at the same 
time. Cost-benefit analyses should be performed on a national basis. All data 
from comprehensive LCS programmes should be stored in a central registry 
and undergo independent review to confirm the quality and benefits of LCS for 
high-risk smokers.  
Learning Objectives: 
1. To learn about risk populations for lung cancer screening. 
2. To understand the benefits and potential drawbacks of a lung cancer 
screening programme. 
3. To appreciate the already existing clinical evidence for lung cancer 
screening programmes. 
A-566 16:28  
B. Colorectal cancer screening: what is the radiologist's role?  
S. Halligan; London/UK  
The speaker will describe the role of the radiologist in colorectal cancer 
screening. There will be an emphasis on effective and efficient population-
based screening, and on the high-level evidence base for this. Examples of 
current population screening programmes will be given, and the way in which 
radiological techniques intergrate with these will be described.  
Learning Objectives: 
1. To learn about already existing clinical screening tools for CLC. 
2. To understand the concept of radiological screening tools for CLC. 
3. To appreciate the benefit and clinical applications for new imaging-based 
screening tools. 
Author Disclosure: 
  S. Halligan: Research/Grant Support; Holder of multiple competitive peer-
reviewed research grants. 
A-567 16:51  
C. Breast cancer: to screen or not to screen  
P. Skaane; Oslo/NO (per.skaane@outlook.com)  
Screening includes “non-programme screening” (opportunistic) and 
“organised”, with higher degree of management, target groups, defined 
intervals, and specified management procedures. Organised screening is 
“population based” when women in the target group are individually identified 
and personally invited, and all steps adequately coordinated. European 
Guidelines recommend biannual screening for women 50-69 years old. Full-
field digital mammography, the “gold standard” for screening women at 
average risk, has inherent limitations including low specificity and low 
sensitivity in women with dense breasts. Supplementary annual MRI in addition 
to mammography is offered for high-risk women with lifetime risk over 20% and 
BRCA mutation carriers. Supplementary ultrasound is in general not 
recommended when MRI is carried out. To maximise the benefits while 
minimising the harms, there has been much focus on moving from “one-size-fit-
all” to personalised screening. Due to economical and practical reasons, 
reduced screening for women with fatty breast has occasionally been 
suggested. However, caution is necessary since it is problematic to identify 
subgroups of women with nondense breasts with less frequent screening. The 
costs and availability prevent implementation of many new modalities with high 
accuracy in high-volume screening, including molecular breast imaging (MBI), 
contrast-enhanced spectral mammography (CESM), and dedicated breast CT. 
The most promising new technique for population-based screening is digital 
breast tomosynthesis (DBT). The main challenges of DBT include longer 
reading time and overdiagnosis. The problem of radiation dose using 
mammography plus DBT is solved by synthetic 2D images. DBT has reduced 
sensitivity in women with very dense breasts. However, cost-effectiveness 
studies on DBT screening programmes should be carried out.  
Learning Objectives: 
1. To learn about the existing mammography screening programmes. 
2. To understand the potential add-on of MR for breast cancer screening (e.g. 
MR). 
3. To balance harm/cost against benefit for new screening programmes. 
Author Disclosure: 
  P. Skaane: Equipment Support Recipient; Tomosynthesis equipment for the 
Oslo Tomosynthesis Screening Trial was provided by Hologic. 
17:14  
Panel discussion: Cancer screening: a success story?  
16:00 - 17:30 Room D  
Musculoskeletal  
RC 1210  
Shoulder MRI: mastering technique and 
making my report relevant  
A-568 16:00  
Chairperson's introduction  
I. Boric; Zabok/HR (igor.boric1@zg.t-com.hr)  
For a successful MRI of the shoulder, certain conditions should be met. It is 
necessary to perform the examination in a standardised manner using 
generally accepted protocols. The applied protocols should be geared towards 
providing a response to a clear clinical question. Knowledge of the advantages 
and disadvantages of MRI techniques is the guiding node in choosing the 
optimal technique: specific protocol, normal positioning or ABER position of the 
patient, native or contrast-enhanced MR, standard MR examination or MR 
arthrography. Understanding of normal shoulder anatomy: rotator cuff muscle, 
other shoulder muscles and its tendons, labrum and ligaments, shoulder 
bursas, bones and articular cartilage, neurovascular bundles as well as normal 
variants is crucial for a quality finding interpretation and to make the report 
relevant. In the case of postoperative shoulder evaluation, knowledge of the 
applied surgical techniques and the expected anatomical changes is 
necessary. The analysis of shoulder changes should take into consideration 
the specificity of each patient: age, gender, occupation, existence of previous 
injuries and shoulder diseases, and degree of sport activity. Information on the 
mechanism of injury is helpful in assessing the site and extent of lesions. To 
improve the quality and reliability of shoulder MRI evaluation, feedback from 
the clinician and the patient is extremely useful. An experienced MSK 
radiologist is crucial for a good and reliable MRI of the shoulder.  
Session Objectives: 
1. To understand the level of expertise that patients expect for adequate 
performance and reading of shoulder MRI. 
2. To gain insight into differentiating normal age-related changes from clinical 
relevant MR features. 
A-569 16:05  
A. The normal MRI: techniques and anatomy  
E. Llopis; Valencia/ES (evallopis@gmail.com)  
MRI is the primary diagnostic imaging modality when of the shoulder joints is 
suspected. For an accurate evaluation, it is essential to know the normal 
anatomy and the complex biomechanics with a wide range of motions and 
variants, to avoid misdiagnosis and to understand which ones are clinically 
relevant. We will divide shoulder anatomy into static and dynamic structures: 
  







the bone structures, labrum and ligament as static structures, and rotator cuff 
muscles as dynamic ones.  
Learning Objectives: 
1. To become familiar with MRI techniques for imaging the shoulder. 
2. To understand normal MRI shoulder anatomy, and normal variants seen. 
A-570 16:28  
B. Rotator cuff tears: what are they and what do they look like?  
K.-F. Kreitner; Mainz/DE (Karl-Friedrich.Kreitner@unimedizin-mainz.de)  
Rotator cuff (RC) disease is common and maybe a significant cause of 
shoulder pain. The tendons of the rotator muscles are highly organised 
structures with five distinct histologic layers. Over the last decade, the rotator 
cable has received increasing attention, as it acts as a supporting limb of the 
cuff. The cable is adjacent to the crescent zone of the RC and can be seen on 
most MR imaging studies. Pathologically, tendinosis/tendinopathy can be 
differentiated from partial- and full-thickness tears of the cuff. Whereas tears at 
the rotator crescent are often due to ischaemia and degeneration, tears of the 
footprint have obtained increased attention as they affect younger patients and 
have implications on the appropriate operative procedure. Partial-thickness 
tears can be described as articular, bursal or intrasubstance partial tears and 
should be further characterised with regard to the degree of tendon 
involvement. Full-thickness tears allow communication between the 
glenohumeral joint and the subacromial-subdeltoid bursa and can be pinhole in 
size or involve an entire tendon. It is further of utmost importance to assess 
atrophy or fatty infiltration in case of an RC tear, as these findings influence the 
therapy and outcome of the affected patients. Tears of the subscapularis 
tendon typically begin in the cranial part of the tendon and are often associated 
with lesions of the long biceps tendon and the rotator interval. “Novel lesions” 
of the RC most commonly affect the infraspinatus tendon at the 
musculotendinous junction and represent a delamination that may be missed 
at arthroscopy.  
Learning Objectives: 
1. To become familiar with the anatomical basis of rotator cuff tears. 
2. To learn about the MRI findings of rotator cuff pathology. 
A-571 16:51  
C. Patterns of instability: what does the MRI show?  
A.J. Grainger; Leeds/UK (andrewgrainger@nhs.net)  
Two patterns of injury are seen in patients dislocating their shoulder. Younger 
patients will tend to disrupt the labroligamentous complex, whereas the older 
population tends to disrupt the integrity of the rotator cuff. In this latter group, 
tears of supraspinatus are seen along with tears of subscapularis and avulsion 
fractures of the greater tuberosity. Rotator cuff disruption forms the subject of 
other talks and so will not be discussed further here. Anterior dislocation 
leading to avulsion of the anteroinferior labral ligamentous complex from the 
glenoid is termed the Bankart lesion, or bony Bankart if accompanied by a 
fracture. Avulsion occurs due to the pull of the anterior band of the inferior 
glenohumeral ligament (AIGHL) at its attachment to the anteroinferior labrum. 
The AIGHL is the primary restraint to movement when the arm is abducted and 
externally rotated. Avulsion of the labrum is well shown on MR arthrography 
and a number of variants exist which will be discussed. Posterior dislocation 
will produce a reverse pattern of shoulder injury which will also be discussed.  
Learning Objectives: 
1. To become familiar with patterns of abnormality seen in shoulder instability. 
2. To learn about the MRI findings of shoulder instability. 
17:14  
Panel discussion: How are the indications for MR arthrography of the 








16:00 - 17:30 Room G  
New Horizons Session  
NH 12  
Radiomics: what is it and how can we use 
it?  
A-572 16:00  
Chairperson's introduction  
O. Clément; Paris/FR (olivier.clement@aphp.fr)  
The term "Radiomics" has emerged a few years ago and is attracting a lot of 
attention as a tool to extract quantitative information out of the images. Several 
softwares are on the market that provide a large amount of quantitative 
features from medical images using data-characterisation algorithms.These 
features, termed radiomic features, have the potential to uncover disease 
characteristics that fail to be appreciated by the naked eye. The goal of the 
New Horizon session is to review the concepts behind the name and 
appreciate the potential clinical applications in radiology.  
Session Objectives: 
1. To understand what radiomics is. 
2. To appreciate the clinical potential of radiomics in radiology. 
3. To address the professional challenges of radiomics. 
A-573 16:03  
Radiomics: what is it and how does it work?  
L.S. Fournier; Paris/FR (laure.fournier@aphp.fr)  
Radiomics is a new 'data-driven' approach for extracting large sets of complex 
descriptors from routine (or not) clinical images, based on the assumption that 
there is a relationship between the imaging features of tumours and their 
underlying gene expression patterns and biology. The radiomics process aims 
to establish links between the imaging phenotype and genotypic and 
phenotypic characteristics of a tumour governed by its molecular substratum. 
Advanced methods of image processing are applied to images to extract a 
large number of descriptors, such as texture analysis from histograms, co-
occurrence matrices, and fractal analysis. This large set of data can be 
analysed using bioinformatics and biostatitics methods into clusters defining 
metadata sets describing combinations of imaging features, or imaging 
'profiles'. Finally, these data can be correlated to gene expression profiles, 
often called radiogenomics, or to outcomes, such as treatment response or 
survival. 
Learning Objectives: 
1. To learn about new methods of image analysis derived from '-omics' 
methods. 
2. To understand processing of big data derived from images. 
3. To become familiar with new vocabulary such as radiomics, radiogenomics, 
clusters, heat map, etc. 
Author Disclosure: 
  L.S. Fournier: Advisory Board; Keosys. Grant Recipient; Invectys. 
Research/Grant Support; Philips, Ariana Pharma, Evolucare. 
A-574 16:21  
Radiomics: technical validation  
R. Leijenaar; Maastricht/NL (ralph.leijenaar@maastro.nl)  
Radiomics is increasingly more important in cancer research; the high-
throughput mining of quantitative image features from standard-of-care medical 
imaging that enables data to be extracted and applied within clinical decision 
support systems to improve diagnostic, prognostic, and predictive accuracy. 
The field of radiomics is emerging rapidly. However, this field lacks 
standardized evaluation of both the scientific integrity and the clinical 
significance of the numerous published radiomics investigations resulting from 
this growth. With the prospect of multicentre clinical applications, it has 
become clear that variation in, for example, software implementations, feature 
nomenclature, mathematical definitions and methodology, makes 
reproducibility and validation of studies in radiomics a major challenge. For 
radiomics to mature as a discipline, there is a clear need for rigorous 
evaluation criteria, reporting guidelines and tools to facilitate standardization, 
interoperability and advancement of the field.  
Learning Objectives: 
1. To learn about the robustness and reproducibility of radiomics features. 
2. To understand the differences and similarities between radiomics software. 
3. To understand that quality of big data is the key. 
  








  R. Leijenaar: Employee; Health Innovation Ventures / OncoRadiomics. 
Founder; co-founder of OncoRadiomics. Shareholder; OncoRadiomics. 
A-575 16:39  
Radiomics: biological correlation  
E. Sala; Cambridge/UK (evis.sala@gmail.com)  
Tumour heterogeneity in cancers has been observed at the histologic and 
genetic levels, and increased levels of intra-tumour genetic heterogeneity have 
been reported to be associated with adverse clinical outcomes. In oncologic 
imaging, phenotypic heterogeneity between and within tumours of a given 
patient is readily apparent and various imaging features are routinely described 
subjectively in radiology reports. However, recently, imaging research has 
focused increasingly on the newly emergent field of radiomics, which involves 
a high-throughput process in which a large number of shape, edge and texture 
metrics are extracted and quantified objectively and in a reproducible form. 
These quantitative metrics can provide important insights into tumour 
phenotype as well as the interaction of the tumour with its microenvironment, 
referred to as “habitat imaging”. In the effort to delineate the biological and 
clinical implications of these new quantitative metrics, radiomic metrics 
obtained from MRI including diffusion-weighted and dynamic-contrast-
enhanced MRI sequences, computed tomography and FDG-PET/CT have 
been further correlated with genomics data, a process intrinsic to the field 
known as radiogenomics. Radiogenomics and outcome data can be 
meaningfully mined with the goal of developing robust biomarkers that may 
potentially aid cancer diagnosis, improve assessment of treatment response 
and better predict patient outcome.  
Learning Objectives: 
1. To understand how radiomics features relate to the underlying biology. 
2. To learn what information radiomics can give on tumour heterogeneity. 
3. To become familiar with potential added value of radiomics in predicting 
treatment response and outcome. 
A-576 16:57  
Radiomics: clinical challenges  
T. Penzkofer; Berlin/DE (tobias.penzkofer@charite.de)  
Radiomics, either as feature classifiers or in the form of machine intelligence, is 
poised to play an increasing role in clinical imaging. It offers ample potential to 
extend the current practice of oncological and non-oncological imaging: 
currently around the corner are automatic anatomy annotation, next-generation 
CAD systems, lesion tracking and tumour heterogeneity analysis. More 
complex systems with an integrated understanding of a wider range of 
pathologies seem markedly further down the road. Before radiomics can be 
implemented and used to enrich our well-tested and robustly working 
workflows, a number of prerequisites need to be met: it is important to 
understand who wants and accepts semiautomated and/or fully automated 
decision-making systems in radiology. Patients, insurance companies and 
health-care provides are important stakeholders and might or might not be 
drivers of the implementation of radiomics. Additionally, current laws governing 
regulation of medical devices are drafted with monolithic, invariable products in 
mind. This could be impracticable for continuously self-improving machine 
learning systems. Lastly, quality control measures will certainly play an 
important role in tackling these issues, including the liability in case of 
"algorithmic malpractice". Is seems reasonable to assume, that future 
generations of radiologists, instead of being replaced, will have a wider range 
of quantitative information at their disposal. Knowledge in data science to 
better understand, maintain and extend the systems will be a prime skill, just 
as technological understanding of imaging is part of every radiological 
curriculum.  
Learning Objectives: 
1. To understand the potential role in oncological and non-oncological clinical 
settings. 
2. To define prerequisites for the integration into clinical workflows, including: 
patient acceptance, legal challenges and quality control. 
3. To appreciate the future roadmap and its impact on training of young 
radiologists.  
Author Disclosure: 
  T. Penzkofer: Employee; Charité University Hospital, Berlin, Germany. Grant 
Recipient; Berlin Institute of Health, Berlin, Germany. 
17:15  
Panel discussion: Radiomics, the new holy grail in radiology?  
 
16:00 - 17:30 Room K  
Special Focus Session  
SF 12d  
Radiographers' challenge: informing 
patients about radiation risk  
Moderator:  
J.N. Vassileva; Vienna/AT 
A-577 16:00  
Chairperson's introduction: The European BSS (Basic Safety Standards) 
Directive and current legal requirements  
S. Geers-van Gemeren; Utrecht/NL (s.geers@nvmbr.nl)  
It is necessary that patients understand the risks of radiation associated with 
medical imaging examinations. Few studies have been conducted to assess 
patient knowledge of and attitudes towards radiation and only some have 
focused on the general population. Additionally, these studies showed that 
although computed tomography (CT) is estimated to be responsible for more 
than 70% of the collective radiation dose received by patients, most of them 
lack information about the reasons behind the medical imaging examination 
prescribed (the benefits) and the associated radiation dose (the risks). There 
are new requirements in the BSS for informing patients, recording patient 
doses, and recording, reporting and follow-up of accidental and unintended 
exposures. The patient or their representative is provided with adequate 
information relating to the benefits and risks associated with the radiation dose 
from the medical exposure. Similar information as well as relevant guidance 
shall be given to carers and comforters. A collaborative approach between 
referrers, radiologists, medical physicist and radiographers is suggested to 
help explain these risks to patients. Challenges for all professionals involved, 
especially for radiographers. Radiographers are the interface between the 
patient and the technology.  
Session Objectives: 
1. To learn about the requirements within the BSS Directive for the different 
healthcare professionals in informing patients. 
2. To learn about the important role of radiographers in informing patients. 
3. To understand patients' need related to the information about radiation risk. 
A-578 16:05  
So whose role is it? What different professionals can and should do  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt)  
Teamwork is needed wherever multiple individuals with multiple skills are 
required to work interdependently to achieve a favourable outcome. This 
means that teamwork is absolutely critical in the management of patients, 
since health care is a complex activity, which needs many different types of 
professionals, with different knowledge, skills and competences and with 
specific roles. One individual working alone cannot achieve the target of taking 
care of a patient, and from the concept defined in 1926 by Francis Peabody 
that “the secret of the care of a patient is caring for the patient” we have moved 
nowadays to: “the real secret of the care of a patient is teamwork”. An 
increasing volume of medical imaging procedures combined with a demand for 
more rapid access to diagnostic services is putting high pressure on 
radiographers, who, by being the final point of contact for the patient, have the 
responsibility of providing the best and correct procedure to the patient. 
Departments should adopt communication strategies to explain the procedure 
in an understandable manner, adapted to patient social and economic 
characteristics, giving adequate information for him/her to be able to make a 
proper decision. Radiographers are, according to the BSS Directive, 
responsible for the practical aspects of medical imaging procedures, defined 
as: “means the physical conduct of a medical exposure and any supporting 
aspects, including handling and use of medical radiological equipment, the 
assessment of technical and physical parameters (including radiation doses), 
calibration and maintenance of equipment, preparation and administration of 
radio-pharmaceuticals, and image processing”.  
Learning Objectives: 
1. To understand the importance of teamwork to improve communication skills 
when informing about radiation risk. 
2. To learn about the importance of the radiographers' role in the healthcare 
setting. 
3. To become familiar with the European Basic Safety Standards challenges 
for the different health professionals involved in patient clinical pathway. 
 
  







A-579 16:30  
What do patients want to hear and need to be told?  
J. Portelli; Msida/MT (jonathan.portelli@um.edu.mt)  
Recent years have seen an ever-growing movement towards the importance 
for health-care delivery to be more patient centred, particularly since this has 
been associated with improved outcomes and quality of care. In effect, the 
drive towards patient-centred care should compel health professionals to invest 
more time and consideration to reflect upon and amend their practices, as 
necessary, so as to ensure that they are always providing care that is 
respectful of, and responsive to the needs, values and preferences of each 
individual patient, their families and/or representatives. In the context of 
medical imaging and radiotherapy, a patient-centred care approach therefore 
necessitates that radiographers are not only knowledgeable about how to 
identify the different information, emotional and social needs of each individual 
patient, but also need to be able to have and master the necessary skills to 
satisfy such needs in a manner that is meaningful and valuable to each patient. 
In this regard, this lecture will seek to outline and discuss possible information 
and communication needs of different patient groups attending medical 
imaging examinations. Additionally, this lecture will seek to highlight the 
different expectations, perceptions and concerns patients may have when 
attending a medical imaging examination and how such factors need to be 
considered holistically so as to further enhance patients’ experiences in 
medical imaging and radiotherapy departments.  
Learning Objectives: 
1. To learn about the information and communication needs of patients 
attending for a medical imaging examination. 
2. To appreciate that patients may have different expectations, perceptions and 
concerns when attending for a medical imaging examination. 
A-580 16:55  
How to effectively communicate radiation risks  
L.R. O'Hora; Dublin/IE (lohora@mater.ie)  
The quantification of patient dose and communication of associated risk is now 
a legislatively mandated function of radiology departments. The practical 
delivery of this essential service is sometimes lacking in clinical practice. This 
talk aims to suggest simple steps all diagnostic departments can use to 
quantify, interpret and communicate diagnostic doses and associated risks to 
patients.  
Learning Objectives: 
1. To understand dose metrics. 
2. To appreciate the difference between diagnostic dose metrics and effective 
dose. 
3. To understand the concept of “lifetime risks” associated with specific 
effective doses. 
4. To become familiar with relating specific procedure dose to understandable 
concepts such as equivalent periods of environmental radiation. 
17:20  
Panel discussion: Speaking a common language: how best to work 
together to inform patients  
16:00 - 17:30 Room M 1 
ESHI Session  
Non-oncological hybrid imaging: case-
based  
Moderators:  
O. Ratib; Geneva/CH  
K. Riklund; Umea/SE  
A-581 16:00  
Cardiac hybrid imaging indications: case-based  
C. Rischpler; Munich/DE (christoph.rischpler@tum.de) 
Molecular imaging modalities such as positron emission tomography (PET) and 
single photon emission computed tomography (SPECT) are usually combined 
with morphological imaging techniques such as computed tomography (CT) or 
magnetic resonance imaging (MRI). These hybrid cardiac imaging approaches 
allow the beneficial combination of radioactive, molecular imaging probes with 
the detailed assessment of cardiac function and anatomy. As a consequence, 
hybrid cardiac imaging plays an increasing role in the work up in various 
clinical scenarios. Possible indications include the workup of coronary artery 
disease (perfusion and viability), inflammatory diseases and cardiac tumours. 
This case-based talk discusses the application of hybrid imaging in various 
cardiac diseases with a special focus on hybrid PET/MRI. 
Learning Objectives: 
1. To learn about indications of hybrid imaging in cardiology. 
2. To appreciate cardiac indications of different hybrid imaging modalities. 
A-582 16:30  
Non-oncological intracranial indications for hybrid imaging: case-based  
A. Drzezga; Cologne/DE  
"no abstract submitted" 
Learning Objectives: 
1. To understand non-oncological indications of hybrid imaging in the brain. 
2. To become familiar with non-oncological radiopharmaceuticals for brain 
imaging. 
A-583 17:00  
Hybrid imaging in inflammation: case-based  
A. Signore; Rome/IT (alberto.signore@uniroma1.it)  
In the field of infection, early diagnosis of infection extent and severity is 
crucial. In some cases the location of the infection is also unknown. The use of 
hybrid imaging modalities, such as SPECT(CT, PET/CT and PET/MRI has 
enormously increased the possibility to identify and quantify the severity and 
extent of an occult infection. The main role is to be attributes to the choice of 
radiopharmaceutical, followed by the possibility to visualise the anatomy of 
patient by CT or MRI. In this presentation I will show several example about 
how to correctly apply different radiopharmaceuticals and what can be the 
added value of CT and/or MRI in the diagnostic approach. Cases of 
osteomyelitis, diabetic foot, spondylodiscitis and vascular graft infections will 
be presented.  
Learning Objectives: 
1. To learn about indications of hybrid imaging in inflammatory diseases. 
2. To appreciate hybrid imaging for therapy response assessment in 
inflammatory diseases. 
16:00 - 17:30 Room M 2 
PIER @ ECR Session  
PI 3  
Value-based radiology  
Moderators:  
P. Mildenberger; Mainz/DE  
G. McGinty; New York, NY/US  
A-584 16:00  
Basic concepts of value-based radiology: US perspective  
J.A. Brink; Boston, MA/US  
The value of radiology care may be defined from both the patient’s and 
provider’s perspective, including their views about quality and cost. Both 
perspectives demand image-derived information that is simple to understand, 
precise and actionable. Traditional quality metrics are informed well by these 
attributes, providing better pathways to health, risk mitigation and disease 
avoidance. Non-traditional quality metrics centre on patient experience, care 
coordination, and integration in care teams with clinical imaging pathways. 
Both traditional and non-traditional quality systems enable meaningful 
participation in new health-care delivery systems including accountable care 
and population health models. Cost models must consider both tangible and 
intangible costs, from both the patient’s and provider’s perspective. Tangible 
patient costs include out-of-pocket expenses as well as lost wages. Tangible 
provider costs include variable and fixed direct costs as well as indirect costs 
and overhead. Measuring costs can be particularly challenging, as top-down 
approaches may be overly simple while bottom-up approaches may be time 
consuming and difficult to maintain.  
Learning Objectives: 
1. To understand basic concepts of value-based radiology. 
2. To be informed of the current state of value-based radiology in the US. 
3. To explain professional implications of value-based radiology. 
A-585 16:20  
Basic concepts of value-based radiology: European perspective  
L. Donoso; Barcelona/ES (ldonoso@clinic.ub.es)  
Value-based health care (VBH) is a concept that was primarily developed to 
address the challenges resulting from the ever-increasing demand on health-
care systems coupled with financial constraints. These trends also affect the 
  







radiology profession, and the ESR established a working group on value-based 
imaging (VBI WG) in response to these developments and to shape them. The 
ESR’s concept paper on value-based radiology (VBR) sets out the ESR’s 
approach to this topic. At the conceptual level, the ESR argues that the 
diagnostic process should be included in the VBH framework, which focuses 
on outcomes but starting only at the point of treatment. However, an accurate 
and timely diagnosis is the first outcome that matters to patients. In this 
context, VBR should be a concept not only by and for radiologists, and the 
ESR plans to engage in this debate with the wider medical community. The 
focus on outcomes and value also requires organisational changes. The 
organisation of health-care delivery should be centred on the patient, and the 
structure must functionally follow the multidisciplinary management of medical 
conditions. In this new setting, radiologists need to demonstrate the value they 
provide to referrers, treating physicians, administrators and patients. The ESR 
proposes different metrics that can help change the perception of radiology 
from a volume-based cost to a value-driven asset. The metrics focus on five 
key aspects for a high-quality diagnosis: appropriateness of requests, radiation 
protection measures, quality of the radiology report, relationship between 
radiologists and patients, and education, research and innovation.  
Learning Objectives: 
1. To discuss possible concepts of value-based radiology in the European 
environment. 
2. To discuss possible strategies leading from volume-based to value-based 
radiology in Europe. 
3. To explain implications of value-based radiology on quality. 
A-586 16:40  
New metrics are required for value-based radiology  
G. McGinty; New York, NY/US (geraldinemcginty@gmail.com)  
This session will provide participants with an understanding of how quality and 
resource use metrics are currently developed and implemented in the US, both 
for radiology and the health-care system in general. I will discuss how data are 
collected and submitted around these metrics and give an overview of the 
ways in which metrics are used by payers, both governmental and private, in 
the US health-care system. I will also explore the degree to which existing 
metrics have succeeded or failed in shaping value-based imaging care as well 
as the costs associated with demonstrating and reporting compliance.  
Learning Objectives: 
1. To understand the limitations of current metrics. 
2. To understand how to effectively develop metrics around value-based 
radiology. 
3. To understand the connection between metrics and payment. 
17:00  
Panel discussion: A European - US debate on the value of "value-based 
radiology"  











16:00 - 17:30 Room M 3 
Interventional Radiology  
RC 1209  
Pulmonary embolism: a joint challenge for 
diagnostic and interventional radiology!  
A-587 16:00  
Chairperson's introduction  
A.G. Ryan; Waterford City/IE (jackoriain@yahoo.ca)  
Venous thrombo-embolism (VTE) is an enormous health-care issue, resulting 
in more deaths in Western Europe than AIDS, breast cancer, road traffic 
accidents, and prostate cancer, all combined. This session focuses on the 
state of the art in the diagnosis and management of pulmonary embolus (PE). 
All radiologists need to know how to diagnose and interpret the findings in this 
important condition, and Dr. Ghaye will describe in detail the optimal clinical 
and imaging algorithm to diagnose and stratify the condition, and its imaging 
follow-up. Dr. Uberoi will expand on the risk stratification and optimal 
management strategies based on current evidence. Once the diagnosis has 
been established, interventional radiologists have a major role in its treatment 
via aggressive catheter-based therapy and Dr. Spiliopoulos will discuss the 
Interventional techniques, outcomes and evidence supporting their use in the 
treatment of massive and sub-massive pulmonary emboli.  
Session Objectives: 
1. To appreciate the value of imaging in therapy planning and follow-up. 
2. To learn about patient selection and evidence in catheter directed therapies 
for PE. 
3. To learn about recent and ongoing trials in the endovascular treatment of 
PE. 
A-588 16:05  
A. Imaging algorithm for pulmonary embolism  
B. Ghaye; Brussels/BE (benoit.ghaye@uclouvain.be)  
The diagnosis of pulmonary embolism (PE) is difficult, since the clinical signs 
and symptoms are non-specific. Unstable patients usually undergo 
thrombolysis following demonstration of right ventriclular (RV) dysfunction at 
echocardiography. Diagnostic algorithm strategies in stable patients have been 
developed to limit the number of patients requiring an imaging test. The first 
step includes the assessment of the clinical probability of PE and D-dimers 
testing. Patients with either a high clinical probability or a positive D-dimers test 
should undergo further imaging test. Incompliance to such diagnostic 
algorithms has been demonstrated to increase the rate of PE recurrence and 
the rate of false-positive CT pulmonary angiographies. In patients not at high 
risk of mortality (i.e. without clinical findings such as cardiogenic shock or 
persistent arterial hypotension), signs of RV dysfunction (at echocardiography 
or CT pulmonary angiography) are used together with clinical prognostic 
scores, such as the PESI, and cardiac biomarker dosage to discriminate 
patients with intermediate or low risk. This is usually performed by measuring 
the ratio between the diameters of RV and the left ventricle (RV/LV). More 
recent and potentially more powerful predictor CT findings have been reported, 
including among others RV/LV surface and volume ratios, the severity of 
“perfusion” defect and cardiac function parameters as calculated from ECG-
gated acquisition. Evidence concerning the follow-up of unselected patients 
after treatment is still limited in literature. Short-term follow-up after systemic 
thrombolysis or endovascular treatment has been performed using various 
techniques, including RV/LV dimensions, pulmonary arterial obstruction scores 
or pulmonary perfusion comparison.  
Learning Objectives: 
1. To learn how clinical findings influence the selection of the imaging strategy 
in PE. 
2. To learn about the follow-up after treatment. 
3. To learn how imaging may predict the outcome of the patient. 
A-589 16:28  
B. What is new in the recently published guidelines for pulmonary 
embolism treatment?  
R. Uberoi; Oxford/UK (Raman.Uberoi@ouh.nhs.uk)  
PE is a major cause of mortality, morbidity, and hospitalization in Europe. 317 
000 deaths related to VTE were reported in six countries of the European 
Union (with a total population of 454.4 million) in 2004. 34% presented with 
sudden fatal PE and 59% postmortem. Only 7% who died early were correctly 
diagnosed with PE before death. Following diagnosis, patients should undergo 
risk stratification using a scoring system such as the pulmonary embolism 
severity index and patients stratified into high-, intermediate- and low-risk 
groups based on the clinical status of the patient, i.e. shock , hypotension, 
signs of RV dysfunction and cardiac biomarkers. Patients with scores of PESI 
of III-IV will have a 30-day mortality of 24.5%. High-risk and intermediate high-
risk patients should undergo consideration for rapid primary pharmacologic 
treatment or surgery and, where available, interventional treatment to rapidly 
clear thrombus. Acute right ventricular dysfunction is a critical determinant of 
the outcome, and persistent arterial hypotension and cardiogenic shock carry a 
high risk of early death. Primary reperfusion treatment, particularly systemic 
thrombolysis, is currently the treatment of choice. This can result in the early 
reduction of pulmonary resistance and improvement in RV function. The 
maximum benefit is in the first few days , ideally within 48 hours with 90% of 
patients showing improvement, with no benefit at one week. Low-risk patients, 
i.e. with PESI scores I-II or sPESI 0, should be considered for early discharge 
and outpatient treatment with anticoagulation.  
Learning Objectives: 
1. To learn about the recently published guidelines for PE treatment in stable 
patients. 
2. To learn about the recently published guidelines for PE treatment in unstable 
patients. 
3. To learn about recent therapeutic algorithms in PE treatment. 
Author Disclosure: 
  R. Uberoi: Grant Recipient; Gore and Bolton. Speaker; Spectranetics. 
 
  







A-590 16:51  
C. Updates on the endovascular treatment of massive and submassive 
pulmonary embolism  
S.C. Spiliopoulos; Athens/GR (stavspiliop@med.uoa.gr)  
Minimal invasive percutaneous endovascular treatment of massive and 
submassive pulmonary embolism (PE) offers the benefit of low-risk, more 
aggressive management than systemic anticoagulation and has been 
correlated with reduced morbidity and mortality rates. Traditional endovascular 
methods include thrombus dissolution using standard pigtail catheters or 
balloons, presenting reasonable technical success rates of approximately 86%. 
Local low-dose catheter-directed thrombolysis combined with thrombectomy 
(e.g. pharmacomechanical thrombolysis) seems to improve outcomes, without 
increasing the risk of bleeding. The rationale of recent and ongoing trials is 
based on the fact that systemic thrombolysis, although more effective than 
anticoagulation alone, increases by 5-fold the risk of major bleeding and 10-
fold that of haemorrhagic stroke, while it is contraindicated in many patients 
mainly due to recent surgery or intracranial haemorrhage. On the other hand, 
the majority of evidence for catheter-based interventions is based on few 
single-centre case series and prospective trials. Over the past few years, 
several prospective, multi-centre, randomised trials and large registries have 
investigated novel pharmacological and pharmacomechanical thrombectomy 
techniques, such as ultrasound-accelerated thrombolysis, providing a high 
level of evidence regarding the safety and efficacy of endovascular treatment 
options in acute PE. Nonetheless, studies comparing various endovascular 
modalities versus systemic fibrinolysis are missing, while additional large-scale, 
well-designed randomised trials are required to improve the level of evidence 
of currently available interventional radiology techniques. In this lecture, the 
outcomes of all available and ongoing clinical data will be presented and future 
developments will be discussed.  
Learning Objectives: 
1. To learn about the rationale of recent and ongoing trials. 
2. To learn about the level of evidence for interventional radiology techniques 
in PE treatment. 
3. To learn about clinical results and possible further developments. 
17:14  
Panel discussion: Appropriate diagnosis and risk stratification in the 
management of acute massive and acute submassive pulmonary 
embolism  
16:00 - 17:30 Room M 4 
Pros & Cons Session  
PS 1227  
Gadolinium: image wisely  
Moderators:  
P.M. Parizel; Antwerp/BE  
A. Rovira-Cañellas; Barcelona/ES  
A-591 16:00  
A. Intracranial gadolinium deposition: update and perspectives  
H.A. Rowley; Madison, WI/US (hrowley@uwhealth.org)  
Trace quantities of gadolinium are retained in the brain and other body tissues 
after intravenous administration of all gadolinium-based contrast agents 
(GBCAs), even in patients with normal renal function. This phenomenon has 
been known since pre-clinical studies, but only recently ‘rediscovered’ when 
Kanda et al. reported intrinsic T1 hyperintense signal in the dentate and globus 
pallidus on brain MRI in patients who had received multiple doses of certain 
linear agents. Subsequent autopsy studies have shown that gadolinium is 
primarily retained in or near the endothelial walls of these deep grey nuclei. 
Routine histopathology shows no evidence for gliosis or neuronal injury, even 
when there is clear-cut visible signal hyperintensity on MRI. Clinical series and 
population-based studies have not verified any neurologic deficits related to 
this phenomenon. Certain linear agents (e.g. gadodiamide, gadopentate) show 
the greatest visible signal changes on MRI, while the high relaxivity linear 
agent (gadobenate) shows a lower likelihood at similar exposure, perhaps 
accentuated when there is concomitant radiation or chemotherapy. Macrocyclic 
agents show lower propensity for visible changes on T1-weighted images, but 
deposition in brain and other tissues (e.g. bone, spleen, liver) is confirmed for 
these agents when using techniques such as MR relaxometry and direct tissue 
assays. Body tissues show about 10- to 100-fold higher concentrations than in 
brain, in some instances higher for macrocyclic than linear agents. While the 
EU has largely banned linear agents, the USA and most other countries have 
suggested new GBCA label warnings, and all agree that more research is 
needed.  
Learning Objectives: 
1. To evaluate intracranial gadolinium deposition with direct assessment of 
gadolinium accumulation in neuronal tissues of patients previously exposed to 
multiple doses of intravenous gadolinium. 
2. To explore the relationship between intracranial gadolinium deposition, the 
type of contrast agent and renal function. 
Author Disclosure: 
  H.A. Rowley: Consultant; GE Healthcare, Bracco, Bayer, Guerbet, Gore. 
A-592 16:20  
B. Do we need gadolinium in imaging MS? Pros and cons (part 1)  
C. Lukas; Bochum/DE (carsten.lukas@ruhr-uni-bochum.de)  
Magnetic resonance imaging (MRI) plays a key role in the diagnostic setup and 
follow-up of patients with multiple sclerosis (MS). The high sensitivity of the 
MRI enables the detection of focal inflammatory disease involvement in vivo, 
contributing substantially to an early diagnosis of MS. The intravenous 
administration of gadolinium-based contrast agents (GBCAs) in the diagnostic 
workup provides important information for fulfilling the concept of widely 
accepted and established diagnosis criteria. Subclinical MRI activity, e.g. 
detected by enhancing MS lesions, can substitute for a clinical relapse, 
allowing the diagnosis of MS from one single MRI after the first relapse. 
Furthermore, regular brain MRI scans play an essential role in monitoring 
disease progression in treated MS patients. Currently available treatment 
approaches differ in respect to efficacy and associated risks, stressing the 
importance of paraclinical tools to individualize the choice of disease-modifying 
therapy and closely monitor treatment efficacy and drug safety. MR Imaging 
exhibits a higher sensitivity to inflammatory disease activity than clinical 
relapses alone and provides valuable information for guiding escalating 
immunotherapy. Furthermore, its ability to detect early signs of side effects 
such as progressive multifocal leucoencephalopathy (PML) makes it an 
indispensable tool to closely monitor patients at risk. Although gadolinium-
enhanced MRI can increase the confidence of disease activity in the follow-up 
setting in MS patients, referring clinicians and radiologists should be aware of 
certain limitations and consider limiting the amount of serial GBCA 
administration to dedicated situations to reduce the number of unnessessary 
enhanced MRI scans.  
Learning Objectives: 
1. To review the role of Gd-enhanced follow-up MRI for management of 
patients with multiple sclerosis. 
2. To explore alternative imaging techniques for assessment of disease 
progression in order to avoid gadolinium deposition. 
Author Disclosure: 
  C. Lukas: Advisory Board; MerckSerono, Novartis, Sanofi Genzyme, TEVA. 
Board Member; Review Editor: Applied Neuroimaging (Frontiers in Neurology). 
Research/Grant Support; Bayer Schering, MerckSerono, TEVA, German 
Federal Ministry for Education and Research (BMBF). Speaker; Daiichi 
Sankyo, Bayer Vital / Schering, Biogen, Novartis, Sanofi Genzyme, TEVA. 
Other; Endowed professorship supported by the Novartis Foundation. 
A-593 16:35  
B. Do we need gadolinium in imaging MS? Pros and cons (part 2)  
W. Van Hecke; Antwerp/BE (wim.vanhecke@icometrix.com)  
Gadolinium (Gd)-based contrast agents have been used for many years for the 
diagnosis and follow-up of patients with multiple sclerosis (MS). Post-Gd T1-
weighted scans provide the unique ability to assess lesion activity and 
inflammation through the breakdown of the blood-brain barrier. Gd-enhacing 
lesions therefore are part of the standard diagnostic critaria in MS. Recently, 
there have been findings that there might be some Gd retention in the brain for 
some agents. This has led to a discussion on the use of frequent Gd injections 
and comments and recommendations by different bodies (CMSC, FDA, etc.). 
This is especially relevant for patients with MS, as they typically undergo an 
annual MRI scan for therapeutic monitoring. In addition to the possible Gd 
retention in the brain, and the unknown impact on the patient's well-being, the 
clinical need of the use of Gd for follow-up scans can be questioned, as it is 
known that Gd-enhancing lesions only show this Gd enhancement for a few 
weeks. Furthermore, some alternative quantitative measures of MS disease 
activity based on non-contrast MRI scans have been emerging.  
Learning Objectives: 
1. To review the role of Gd-enhanced follow-up MRI for management of 
patients with multiple sclerosis. 
2. To explore alternative imaging techniques for assessment of disease 
progression in order to avoid gadolinium deposition. 
Author Disclosure: 
  W. Van Hecke: Board Member; icometrix. CEO; icometrix. Founder; 
icometrix. Shareholder; icometrix. 
  







A-594/A-595 16:50  
C. Do we need gadolinium in imaging vestibular schwannomas? Pros and 
cons  




Vestibular schwannoma (VS) is a benign nerve sheath tumour that may occur 
in the cerebellopontine angle cistern, internal acoustic meatus and in the inner 
ear. Patients will present with unilateral sensorineural hearing loss (SNHL), 
tinnitus, balance problems and - when tumours become large - cranial nerve 
palsy of the trigeminal and/or facial nerve. According to the most recent 
American College of Radiology (ACR) Appropriateness Guidelines, magnetic 
resonance imaging (MRI) of the head and internal auditory canals with and 
without contrast is the most appropriate imaging modality in patients with 
SNHL to evaluate for a possible VS. However, since the 1990s several studies 
have been conducted to compare the diagnostic accuracy of non-contrast-
enhanced sequences with post-contrast MRI, mainly for reasons of cost-
effectiveness, but more recently also inspired by concerns about the safety of 
MR contrast agent. The use of contrast-enhanced MRI during observation of a 
known VS or surveillance after surgical or radiotherapy treatment has also 
been questioned. In this lecture, the controversies on the use of gadolinium for 
the diagnosis of a VS will be discussed based on current literature and clinical 
experience. The aim of the follow-up studies is to evaluate growth (during a 
wait and scan policy and after irradiation) or to pick up recurrent disease early 
(after surgical removal). A literature review of possible follow-up strategies and 
the results of an own patient review will be presented.  
Learning Objectives: 
1. To determine whether Gd-enhanced MRI offers advantages in the initial 
diagnosis and follow-up of patients with (suspected) vestibular schwannoma. 
2. To assess the diagnostic accuracy of high-resolution T2-weighted scans as 
an alternative to Gd-enhanced T1-weighted scans. 
Author Disclosure: 
  B. Verbist: Research/Grant Support; Nucleus, Advanced Bionics. Speaker; 
Bayer. 
17:10  
Discussion on the pros and con  
16:00 - 17:30 Room M 5 
Special Focus Session  
SF 12e  
Memorable cases in cardiovascular 
imaging: how to avoid common mistakes  
A-596 16:00  
Chairperson's introduction  
K. Nikolaou; Tübingen/DE (Konstantin.Nikolaou@med.uni-tuebingen.de)  
In this session special and memorable cardiovascular cases will be presented 
and discussed by experts in cardiovascular imaging. Cardiac imaging 
modalities covered and discussed will comprise cardiac MRI and cardiac CT 
imaging, and the potential role of multimodality diagnoses, incorporating 
information from several examination techniques. Clinical entities will include 
inflammatory, congenital and ischemic heart disease.  
Session Objectives: 
1. To learn how to avoid common mistakes in cardiac imaging. 
2. To understand how to systematically review complex cardiac cases. 
3. To appreciate the importance of clinical context and clinical knowledge for 
solving differential diagnoses in cardiac imaging. 
A-597 16:06  
Coronary fistula mimicking a cystic paracardial tumour  
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at)  
Coronary fistulas represent a rare type of coronary anomalies. They are 
classified as abnormal coronary drainage (coronary anomaly group C). 
Coronary fistulas show a broad variation in the abnormal anatomical areas 
they could drain into including the atria, the superior vena cava, the pulmonary 
arteries and many more. The changes in haemodynamics could lead to volume 
overload, and huge coronary fistulas might even cause heart failure due to this 
volume overload if they are not treated on time. Additionally, the feeding vessel 
(=coronary artery) can dilate significantly as well, whereas the distal part of the 
feeding coronary artery might become hypoplastic due to steal effect, which 
can cause signs of ischaemic heart diseases and severe problems during 
surgical repair of the fistula. However, most of the coronary fistulas remain 
asymptomatic for a long period of time and are diagnosed usually by chance. 
In such a situation, the diagnosis can be challenging since the coronary fistula 
can mimic other diseases, and non-invasive diagnosis had been difficult in the 
past. With the introduction of non-invasive coronary CT angiography, the 
diagnosis of coronary fistula has become easy and straightforward, since this 
technique can provide a detailed anatomical overview. In case treatment is of 
indicated, coronary CT angiography is able to provide all information for 
treatment planning as well. In the presentation, a memorable case will be 
presented that was initially diagnosed as cystic paricardial tumour, but finally 
confirmed as aneurysmatic coronary fistula.  
Learning Objectives: 
1. To learn how to avoid the most common pitfalls in image interpretation of the 
coronary arteries. 
2. To understand how to systematically review (complex) coronary artery 
anatomy/disease. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses in coronary imaging. 
Author Disclosure: 
  C. Loewe: Speaker; GE Healthcare, Bracco, Siemens. 
A-598 16:20  
Right ventricular myocarditis diagnosed with CMR: the great imitator  
M. Francone; Rome/IT (marco.francone@uniroma1.it)  
Isolated right ventricular (RV) involvement in acute myocarditis is an 
uncommon event, sharing overlapped clinical and morphological 
manifestations with arrhythmogenic right ventricular dysplasia (ARVC). The 
common features associated with both affections may be the presence of RV 
regional wall motion abnormalities and volumetric enlargement, impaired 
ejection fraction and late gadolinium enhancement of the free wall. The 
condition has shown to be misdiagnosed with cardiac magnetic resonance in 
approximately 50% of cases with relevant clinical implications on patient's 
prognosis and therapeutic management, posing a possible source of 
misdiagnosis in clinical pratice.  
Learning Objectives: 
1. To learn how to avoid the most common pitfalls in image interpretation of 
myocarditis and inflammatory heart diseases. 
2. To understand how to systematically review (complex) inflammatory 
myocardial cases. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses in myocardial imaging. 
A-599 16:34  
Congenital elastic band of the aortic valve: a "multimodality" diagnosis  
K. Pagonidis; Iraklion/GR (kpagonidis@yahoo.de)  
Aortic stenosis due to supravalvular membrane (elastic band) usually presents 
in children. It may be associated with fusion of the left coronary leaflet and the 
supravalvular membrane, causing obstruction of the left coronary ostium and 
resulting in myocardial ischaemia. Despite the immobilization of the left 
coronary leaflet, these patients present in childhood with aortic stenosis, with 
or without accompanying myocardial ischaemia. The case is about an adult 
patient with supravalvular aortic membrane presenting with turbulent flow due 
to fusion of the left coronary leaflet with the supravalvular membrane and left 
ventricular hypertrophy with mild obstruction in the LVOT and apical aneurysm.  
Learning Objectives: 
1. To learn how to avoid the most common pitfalls in image interpretation of the 
valves. 
2. To understand how to systematically review (complex) valvular cases. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses in valvular imaging. 
A-600 16:48  
Dyspnea with an abnormal right ventricle: role of MR imaging  
A. Jacquier; Marseille/FR (alexis.jacquier@ap-hm.fr)  
MRI is an accurate and reproducible method to assess right ventricular 
function and characterise phenotype. Specific protocol and methods are used 
to estimate the RV function, volume, segmental abnormality and late 
enhancement. Learning curve for right ventricular assessment is longer than 
for the left side. MRI is increasingly playing a central role in diagnosis, 
prognosis and patient management. MR with its ability to assess cine, flow and 
late enhancement represents the first line exam to assess right ventricular 
pathologies. Pulmonary hypertension, arrythmogenic RV dysplasia, tricuspid 
regurgitation, congenital abnormalities are the main disease that could affect 
the right ventricle but more rare disease could be encountered.  
  








1. To learn how to avoid most common pitfalls in image interpretation of the 
right ventricle. 
2. To understand how to systematically review right heart function and 
morphology. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses in the right heart. 
Author Disclosure: 
  A. Jacquier: Research/Grant Support; Guerbet. 
A-601 17:02  
Misleading CMR LGE artefact in cardiomyopathies  
M. Gutberlet; Leipzig/DE  
"no abstract submitted" 
Learning Objectives: 
1. To learn how to avoid the most common pitfalls in image interpretation of 
LGE images. 
2. To understand how to systematically review (complex) LGE datasets. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses in myocardial and LGE imaging. 
A-602 17:16  
Hypertrabeculation vs non-compaction of the left ventricle: treat or don't 
touch?  
K. Gruszczynska; Katowice/PL (kgruszczynska@poczta.onet.pl)  
Left ventricular non-compaction (LVNC) according to ESC classification 
belongs to unclassified cardiomyopathies. It is defined by the two-layer 
structure of the myocardium with thin compacted subepicardial and thick non-
compacted subendocardial layer with deep recesses and thick trabecula. Two 
forms of LVNC have been reported: non-familial-isolated and familiar-inherited. 
LVNC was thought to develop due to the arrest of coalescence of foetal 
myocardial trabeculae in utero, and was linked to different genetic findings. 
However, hypertrabeculation can also occur in adult life. Clinically, LVNC has 
been linked to LV failure and increased risk of thromboembolic events. 
Radiological diagnostic criteria have defined LVNC as the index of NC/C layer 
>2.3 in LA EDD images or trabecular mass >20% of total LV mass in ED. 
According to recent publications, these criteria could be fulfilled by a 
substantial percentage of the asymptomatic population. Moreover, LV 
hypertrabeculation was not of higher clinical prognostic value than EF, LV 
volume or myocardial fibrosis. So, the question that arises is: what is the 
clinical value of excessive LV trabeculation visible on MRI and CT, both in 
patients with reduced and preserved cardiac function, as the common mistakes 
in diagnosis can have tremendous impact on the patient's life.  
Learning Objectives: 
1. To learn how to avoid most common pitfalls in image interpretation of left 
ventricular function and morphology. 
2. To understand how to systematically review the causes of reduced cardiac 
function. 
3. To appreciate the importance of clinical context for solving differential 
diagnoses of the left ventricle. 
 
  
















08:30 - 10:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1321  
Oncologic imaging  
A-603 08:30  
A. Lung cancer: key signs in the new TNM  
A.R. Larici; Rome/IT (annarita.larici@unicatt.it)  
Lung cancer is a leading cause of cancer-related mortality worldwide. A correct 
staging is the prerequisite for an adequate management of patients with lung 
cancer. Recently, the 8th edition of the TNM classification introduced relevant 
changes to the descriptors T and M. Regarding T, it has been demonstrated by 
survival analyses that from 1 to 5 cm of diameter every centimetre counts, and 
that larger tumours are best aligned with either T3 (tumour size of more than 5 
to 7 cm) or T4 (tumour size of more than 7 cm). This finding further confirms 
the common intuition that the larger the tumour, the worse is the prognosis. 
Regarding M, the category of extrathoracic lesions has been distinguished in 
M1b and M1c to indicate, respectively, one (oligometastatic disease) and more 
than one lesion. In this context, it is advisable that radiologists report the 
number of lesions if only one organ is involved and the number of organs if 
many are involved. This approach has a relevant clinical impact because 
oligometastatic disease nowadays is managed and treated differently with 
respect to an extensive M stage disease. Several limitations still remain, such 
as classification of a tumour adjacent to the chest wall, mediastinum and 
diaphragm, as well as the categorization of lymphangitic carcinomatosis as an 
independent descriptor and the evaluation of multiple lung lesions. Certainties 
and controversies on the topic will be argued in this session, taking into 
account that cancer staging should be always considered a multidisciplinary 
process.  
Learning Objectives: 
1. To learn about the new staging system for lung cancer. 
2. To highlight the differences in the meaning of CT findings between the new 
system and the previous one. 
Author Disclosure: 
  A.R. Larici: Consultant; MSD, Boehringer Ingelheim, Roche. 
A-604 09:15  
B. Incidental findings in oncologic patients  
M.-P. Revel; Paris/FR (marie-pierre.revel@aphp.fr)  
Incidentalomas are frequently found during CT follow-up of oncologic patients. 
Unsuspected pulmonary embolism (UPE) prevalence is reported to be as high 
as 5%. Symptoms, which had been erroneously attributed to cancer, are often 
retrospectively found. UPE more often involves distal arteries. The recurrence 
rate is the same as for suspected PE, around 20%. Up to 30% of UPEs are not 
initially reported. Incidental pulmonary nodules are very frequently found in 
oncologic patients. At the initial staging, it is of major importance to distinguish 
between lung metastasis and other cause of lung nodule. The nature of the 
primary malignancy must be taken into account, and a histologic assessment 
might be required if there are implications on treatment. Adrenal masses are 
also frequently found. An attenuation below 10 UH on unenhanced CT is the 
best criterion for benign adenoma. If not, 40% relative washout on CT or 20% 
drop of signal on out-of-phase MR sequences suggests a benign lesion. In 
case of increased FDG uptake on PET-CT, percutaneous biopsy might be 
performed after having excluded pheochromocytoma by a dosage of 
catecholamine metabolites. 
Learning Objectives: 
1. To recognise the importance of different incidental findings in patients with 
cancer. 






08:30 - 10:00 Room B 
GI Tract  
RC 1301  
Difficult challenges in imaging the acute 
abdomen  
Moderator:  
S.K. Puri; New Delhi/IN  
A-605 08:30  
A. Perforation of the GI tract  
V. Maniatis; Aabenraa/DK (vmaniatis67@gmail.com)  
Perforation of the GI tract represents an emergency and life-threading 
condition. The causes of perforation may be traumatic (endoscopy, blunt 
trauma, ingested foreign body), inflammatory (peptic ulcer disease, 
diverticulitis, appendicitis, Crohn’s disease or other enteritis), bowel schema or 
neoplasms. Clinical diagnosis may be difficult and patients may be first 
radiologically evaluated with plain radiographs or ultrasound, but with limited 
information in cases of perforation. CT scanning is by far the imaging method 
of choice in these patients. CT findings of GI tract perforation can be direct or 
indirect. Direct findings include free air or/and oral contrast either intra- eller 
retroperitoneal. Indirect findings comprise inflammatory mass surrounding an 
appendicolith or a radiopaque foreign body. Non-specific findings include 
bowel wall thickening, mesenteric infiltration, interloop free fluid and abnormal 
bowel wall enhancement. With the use of both direct and indirect findings, the 
sensitivity of CT in diagnosing GI tract perforation is up to 92%. False-positive 
results usually occur in post-operative patients, where free air as a result of 
previous operation can be misdiagnosed as a sign of anastomotic leak or 
iatrogenic bowel trauma. CT is also able to depict the site of perforation with an 
overall accuracy between 82 and 90% and the cause of perforation in up to 
67% of cases. It is well documented that CT plays a crucial role in the 
assessment of patients with GI tract perforation, by offering fast and accurate 
essential information to the clinicians and enabling the most correct therapeutic 
choice.  
Learning Objectives: 
1. To learn about the main causes and clinical symptoms of GI tract 
perforation. 
2. To become familiar with the imaging methods used to detect GI tract 
perforation and with relevant diagnostic algorithms. 
3. To appreciate the important imaging appearances indicative of GI tract 
perforation. What should radiologists not miss? 
A-606 09:00  
B. Bowel obstruction  
A.J.B.S. Madureira; Porto/PT (ajbmadureira@gmail.com)  
Bowel obstruction is responsible for a considerable number of surgical 
admissions for acute abdominal pain in the emergency department. It has a 
high morbidity and mortality if left untreated. The diagnosis can be suggested 
by plain abdominal films, but CT, and particularly contrast-enhanced CT, plays 
a crucial role in the diagnosis and management of these patients. Not only can 
CT confirm the diagnosis, but it can also grade the severity of the obstruction, 
locate it, and provide the aetiology. A dedicated technique is necessary and 
multiplayer reconstructions in the coronal and sagittal planes are mandatory. 
The causes of small bowel obstruction can be divided into intrinsic 
(inflammatory diseases, neoplasia), extrinsic (adhesions, hernias), and 
intraluminal (gallstones, bezoars). The three most frequent causes of large 
bowel obstruction are neoplasm, volvulus, and diverticulitis. The imaging 
findings vary according to the cause, and some are very specific. CT can 
provide a quick diagnosis and allow an early and optimal management of these 
patients, contributing to better patient care and improved survival.  
Learning Objectives: 
1. To learn about the different types and causes of bowel obstruction. 
2. To become familiar with relevant imaging signs in both small and large 
bowel obstruction including complications. 
3. To appreciate the most widely used imaging approach for detection and 
evaluation of bowel obstruction. 
A-607 09:30  
C. Acute biliary conditions  
C.D. Becker; Geneva/CH  
Acute cholangitis is a serious condition which occurs most commonly in the 
context of bile duct obstruction due to stone disease or strictures. Unless 
diagnosed and treated correctly, acute cholangitis may lead to liver abscess 
  







formation, septicaemia and multiorgan failure. The role of noninvasive imaging 
is to determine the presence of obstruction of the biliary tree., as well as its 
level and its cause. Although ultrasonography or computed tomography are 
most commonly used in the emergency situation, magnetic resonance imaging 
offers the most detailed diagnostic results, especially with regard to the cause 
of obstruction. Depending on the level and the cause of bile duct obstruction, 
decompression of the biliary tree may be done by means of minimally invasive 
interventional techniques via the endoscopic- retrograde or the percutaneous - 
transhepatic approach. Acute gallbladder disease is most often associated with 
calculus disease and obstruction of the cystic duct. Depending on the clinical 
situation, a diagnostic workup may be required to exclude the simultaneous 
presence of bile duct stones.  
Learning Objectives: 
1. To learn about the most common pathologies leading to acute biliary 
conditions. 
2. To become familiar with the relevant multimodality imaging appearances in 
this group of patients. 
3. To appreciate the role of interventional radiology in the management of 
these conditions. 
08:30 - 10:00 Room C 
Special Focus Session  
SF 13a  
Chest imaging of cystic fibrosis: from 
infants to adults  
A-608 08:30  
Chairperson's introduction  
M.O. Wielpütz; Heidelberg/DE (wielpuetz@uni-heidelberg.de)  
Chronic progressive lung disease in cystic fibrosis (CF) is the major life-limiting 
factor of this autosomal-recessive genetic disorder. CF newborn screening 
programmes in Western countries allow for an early diagnosis even before 
pulmonary symptoms occur. Imaging provides detailed information on the 
regional distribution of CF lung disease. Chest x-ray (CXR), computed 
tomography (CT) and, most recently, magnetic resonance imaging (MRI) are 
now available as routine modalities, each with individual strengths and 
drawbacks, which need to be considered when choosing the optimal modality 
adapted to the clinical situation of the CF patient. At the same time, novel 
treatment strategies with CFTR modulators have revolutionized treatment in 
CF, starting early to prevent irreversible lung damage. Thus, radiologists are 
now faced with an increasing demand for imaging to monitor the course of CF 
lung disease from birth to adult ages. The hallmarks of the CF lung are 
bronchiectasis as one early sign of lung damage, airway wall thickening, 
consolidations and atelectasis, as well as emphysema in advanced stages of 
lung disease. Mucus plugging as well as air trapping and perfusion impairment 
are linked to basic pathophysiology and potentially reversible under therapy. 
Bronchiectatic destruction of lung lobes, dilatation of bronchial arteries and 
pulmonary haemorrhage are sequelae, which may require invasive treatment 
and lung transplantation. This session aims at teaching the most important 
imaging findings in CF lung disease and how these are depicted by chest x-
ray, CT and MRI.  
Session Objectives: 
1. To learn about the imaging appearance of cystic fibrosis lung disease. 
2. To appreciate the advantages and drawbacks of available imaging 
modalities. 
3. To appreciate the role of repeated surveillance imaging in cystic fibrosis. 
4. To understand the current developments in cystic fibrosis lung imaging. 
Author Disclosure: 
  M.O. Wielpütz: Advisory Board; Boehringer Ingelheim. 
A-609 08:35  
X-ray: is there still a value in CF?  
C. Owens; London/UK (owensc@gosh.nhs.uk)  
The so-called “cutting edge” imaging research in cystic fibrosis suggests the 
use of computed tomography-generated measurements of bronchial wall 
thickness and airway tapering, sometimes using spirometer-guided CT or 
hyperpolarised gas MRI measures of regional ventilation, and even computed 
fluid dynamics based on individual patient airway geometry. But what is the 
real evidence base for this being reliable, reproducible, scientifically specific 
and robust? How does this really influence the patients’ management and well-
being? What of the humble chest radiograph? What other imaging modality 
provides relatively non-invasive, robust, repeatable diagnostic images in 
patients ranging from the neonate to a 40-year-old, and even post-lung 
transplantation? In the presence of good clinical examination and detailed 
pulmonary function tests, for annual follow up, or in the presence of acute 
clinical deterioration, there is no need to provide a potentially "oversensitive' 
view of the anatomy. Subtle (possible transient/ reversible) mucos plugging 
and airway thickening may be overread. Clearly if the patient is on an 
expensive drug trial, CT is more sensitive, but what do we know about how 
reliable (or reversible) the CT images are in reflecting the patients' real clinical 
status. The future of advanced airways imaging is extremely bright, but it is not 
yet time to put the simple chest radiograph to bed.  
Learning Objectives: 
1. To learn about the typical imaging appearance of cystic fibrosis on 
radiography. 
2. To become familiar with semi-quantitative scoring methods. 
3. To appreciate radiography's role in imaging of the cystic fibrosis lung. 
A-610 08:55  
CT: information content vs dose?  
P. Ciet; Rotterdam/NL (p.ciet@erasmusmc.nl)  
Computed tomography (CT) remains the cornerstone of pediatric thoracic 
imaging. This holds true also for Cystic Fibrosis (CF) lung disease. Chest-CT 
has proved to be more sensitive than chest radiographs (CR) and lung function 
to detect disease progression in patients with CF. Chest-CT enables high-
quality and diagnostic images both in non-collaborative and collaborative 
children. In non-collaborative children, fast acquisition CT protocols can be 
used to avoid sedation or anesthesia without compromising image quality. 
Specific CF-CT findings can be assessed with CT to monitor CF lung disease 
progression. The ability to recognize these findings on CT and to summarize 
them in a radiology report is important for the management of the CF patient. 
Nonetheless, the main limitation of Chest-CT remains radiation exposure, 
which always conveys a risk of developing cancer related to its stochastic 
nature. However, dose reduction measures have been introduced to minimize 
this risk and nowadays chest-CT can be performed at the same radiation dose 
of a CR. Further radiation dose reduction might be achieved through Chest-CT 
protocol standardization across vendors, which is still lacking. Finally, chest-CT 
has enabled to shift from qualitative to quantitative radiology. Newly developed 
imaging analysis techniques allows today to extract numbers from CT images 
that can be used to assess treatment’s efficacy or to determine patient’s 
prognosis. This presentation will be a summary of the state of the art of CT 
imaging in CF lung disease, with description of the CT technique, CF-CT 
imaging findings, semi-quantitative and quantitative scoring methods, and 
clinical examples.  
Learning Objectives: 
1. To learn about the typical imaging appearance of cystic fibrosis on CT. 
2. To become familiar with semi-quantitative scoring and quantitative CT. 
3. To appreciate CT's role in imaging of the cystic fibrosis lung. 
Author Disclosure: 
  P. Ciet: Consultant; Vertex Pharmaceutical. 
A-611 09:20  
MRI: value of routine MRI?  
F. Doellinger; Berlin/DE (felix.doellinger@charite.de)  
Substantial technical improvements during the last fifteen years have provided 
a basis for the routine use of chest MRI in the assessment of lung disease in 
cystic fibrosis. Typical pulmonary disease manifestations, such as bronchial 
wall thickening, bronchiectasis, and mucus plugging are easily assessable, as 
they come along with an increase of protons, thereby giving signals. The 
disadvantages of MRI compared to CT, which is the faster technique and still 
offers better spatial resolution, are overwhelmed by the fact that MRI is a 
radiation-free modality and by the possibility of perfusion imaging, which can 
give important additional information. Morphofunctional MRI scores allow for a 
reproducible quantification and surveillance of lung changes. Successful 
response to antibiotic drugs in patients with infectious exacerbations goes 
along with a decrease of MRI scores. Recent studies have shown that MRI 
scores can even be helpful in the detection of cystic fibrosis in asymptomatic 
infants. 
Learning Objectives: 
1. To learn about the typical imaging appearance of cystic fibrosis on MRI. 
2. To become familiar with semi-quantitative scoring and quantitative MRI. 
3. To appreciate MRI's role in imaging of the cystic fibrosis lung. 
09:50  
Panel discussion: X-ray, CT or MRI, or a combination?  
To appreciate the different strengths and weaknesses of each modality.  
 
  







08:30 - 10:00 Room Z 
Joint Session of the ESR and the BBMRI-ERIC (Biobanking and 
BioMolecular resources Research Infrastructure - European 
Research Infrastructure Consortium) 
Linking imaging biobanks to -omics: the 
role of BBMRI and ESR  
Moderators:  
A. Van der Lugt; Rotterdam/NL  
E. Steinfelder; Graz/AT  
A-612 08:30  
Introduction to BBMRI biobanking and biomolecular resources research 
infrastructure  
E. Steinfelder; Graz/AT (erik.steinfelder@bbmri-eric.eu)  
The way biobanks see it, researchers have no alternative than to connect and 
partner up with them when looking for high-quality samples and associated 
data. In other words, researchers cannot go find a better alternative because 
there is none. The researchers themselves, however, are often convinced that 
there are many alternatives to biobanks, which is mainly due to the fact that 
sample collections hosted by biobanks lack visibility, findability and 
accessibility, or simply because researchers have a strong desire to have their 
own collections of specific material. To bridge this gap between biobanks, the 
research community and the different stakeholders, BBMRI-ERIC’s focus will 
be on building and strengthening value-added sustainable biobanking. The set 
of services offered by BBMRI-ERIC to support the various stakeholders will be 
continuously developed and improved. Quality Management will continue to 
expand its self-assessment survey, launch a quality grade and develop a 
concept paper for an audit programme. The Common Service IT will focus on 
improving and supporting the Directory, the Negotiator, the Connector and 
BIBBOX. The Common Service ELSI will centre it efforts around a number of 
services and support, including optimising the recently launched help desk, 
adapting the ethics check and drafting the code of conduct.  
Learning Objectives: 
1. To learn about biobanking and BBMRI. 
2. To understand the diversity of human disease, biological samples and 
corresponding data. 
3. To appreciate the benefits provided by biobanks for personalised medicine. 
A-613 08:40  
Secondary use of existing data: ethical issues, sharing and data 
protection  
M.T. Mayrhofer; Graz/AT (michaela.th.mayrhofer@bbmri-eric.eu)  
In the context of research, the secondary use of data refers to the processing 
of already existing medical data for a purpose different from the originally 
intended and for which it was initially collected. Secondary use of data is a 
common practice in medical research and poses ethical, legal and 
organisational challenges, among others. To seemingly simplify secondary 
use, is often recommended or even required to anonymise the data. Leaving 
aside the fact that anonymisation is a challenged concept in the era of big data, 
it can (a) deprive research projects from producing meaningful results, (b) to 
share incidental findings with research participants and (c) deny research 
participants their right to withdraw. Despite European and international efforts 
on harmonising practices of re-use of data, substantial differences remain 
across countries due to legal frameworks and cultural sensibilities. Moreover, 
appropriate safeguards (e.g., k-anonymity) are only as successful as 
constantly improved and lived as part of organisational culture. This 
presentation provides an overview of the challenges of secondary use of data 
(especially with regard to data sharing and data protection), how our concepts 
of privacy are challenged by scientific progress and discusses potential 
solutions (e.g. the Code of Conduct for Health Research initiative).  
Learning Objectives: 
1. To understand the rationale for patient rights the Code of Conduct for 
responsible use of human biomaterial and data. 
2. To consolidate knowledge about the implementation of anonymization and 
pseudonymisation. 
3. To learn about the sharing data and the General Data Protection Regulation. 
A-614 09:00  
Types of biobanks in the BBMRI network  
P. Holub; Graz/AT (petr.holub@bbmri-eric.eu)  
BBMRI-ERIC is a pan-European research infrastructure facilitating access to 
quality-defined biobanking and biomolecular resources. As such, it comprises 
heterogeneous partner biobanks ranging from clinical biobanks, disease-
specific biobanks, population biobanks or rare diseases biobanks. Recently as 
a part of the collaboration with ESR, BBMRI-ERIC is being extended to 
improve findability of imaging biobanks, too. This presentation provides an 
overview of types of existing biobanks and biological material and data 
collected. Ability to asses quality of the biological material and data, i.e., ability 
to assess fitness for given research purpose and method, has become a 
paramount and resulted in increasing deployment of quality procedures inside 
the biobanks. Different present and upcoming quality standards will be 
discussed, namely CEN and ISO standards, including current standardisation 
work on provenance information management. The presentation will also cover 
basic principles of access procedure as implemented by BBMRI-ERIC and 
showcase how they are practically implemented in a distributed heterogeneous 
research infrastructure.  
Learning Objectives: 
1. To learn about the aims of BBMRI and the existing biobanks. 
2. To understand how to offer and obtain easy access to samples, data and 
images. 
3. To learn about quality assurance in biobanks. 
Author Disclosure: 
  P. Holub: Employee; BBMRI-ERIC. Founder; Comprimato Systems. 
Shareholder; Comprimato Systems. 
A-615 09:20  
Radiomics: enhancing the value of images by standardised feature 
extraction  
S. Trattnig; Vienna/AT (siegfried.trattnig@meduniwien.ac.at)  
The need to improve cancer survival rates continuously motivates scientists to 
uncover the genetic and molecular composition of tumours and use this 
information to develop more effective cancer therapies. Since tumours differ in 
their biological makeup, treatments can now often be tailored towards 
individual patients, in a strategy termed ‘personalised medicine’. Radiomics 
uses computer algorithms to process the data collected by different imaging 
techniques and is becoming increasingly popular in cancer imaging research. 
One of its key characteristics is that radiomics recognises that digital medical 
images are not only pictures, they are also complex data. Radiomic analyses, 
extracts and measures an array of "features" that describe the image texture 
and distributions of individual voxel values, the units that make up a 3D image, 
within a tumour. Features can be descriptive terms derived from radiology 
reports or mathematical quantities. Feature extraction requires several complex 
steps in a defined pipeline: defining the regions of interest and segmenting 
three-dimensional images, extracting features and converting images into 
"mineable" data. Finally, data from imaging techniques, and from biofluids and 
tumour tissue, are combined into models to predict patient prognosis or benefit 
from a specific therapy. One of the main benefits is that medical imaging data 
acquired in routine health care can be used in a new way to inform clinicians 
about the biology of a tumour and provide potential prognostic or predictive 
information. However, several challenges need to be overcome before 
radiomics, such as statistical problems, standardisation of terminology and 
PACS integration.  
Learning Objectives: 
1. To learn how image features can be extracted. 
2. To discuss how radiomics can be integrated in “omics” analysis. 
3. To explore the potential of radiomics analysis in care. 
A-616 09:40  
Integrating an imaging biobank in a BBMRI biobank  
B. Gibaud; Rennes/FR (bernard.gibaud@univ-rennes1.fr)  
Biomedical research related to the development of personalised medicine 
requires more and more imaging data. Moreover, clinical decision in 
personalised medicine involves more and more the use of both biological 
biomarkers and imaging biomarkers, derived from image data through image 
processing. Besides, the ultimate validation of results in medical image 
processing often requires a histopathologic diagnosis, which needs to access 
and analyse the corresponding specimen. In this context, researchers need 
infrastructure and services to search, locate, and retrieve the bioresources they 
need for their research (e.g. images, biospecimen, histopathologic diagnosis, 
genomic data). Such service is being implemented by the BBMRI-ERIC 
infrastructure which coordinates the sharing of biospecimen throughout 
Europe. Such infrastructure does not exist for imaging biobanks yet. The 
presentation will introduce the basic requirements for clinical imaging biobanks. 
It will analyse the main differences between biobanks and imaging biobanks. 
Specifically, it will underline the commonalities and differences between image 
collections and biospecimen collections. It will provide an introduction to the 
Minimum Information About BIobank data Sharing (MIABIS) model, and to its 
ontological version OMIABIS. The presentation will discuss how 
MIABIS/OMIABIS can be extended to facilitate image description and sharing, 
  







in a way that enables native interoperability between biobanks and imaging 
biobanks data infrastructure.  
Learning Objectives: 
1. To understand the requirements for a clinical imaging bank. 
2. To learn about the intra-operability of clinical image biobank and other data 
repositories. 
3. To consolidate knowledge about “Minimum Information About Biobanking 
Sharing” (MIABIS) 2.0. 
08:30 - 10:00 Room O  
E³ - ECR Master Class (Cardiac)  
E³ 1326a  
Cardiac MRI: from sequence to bedside  
A-617 08:30  
Chairperson's introduction  
L. Natale; Rome/IT (luigi.natale@unicatt.it)  
In this session, three main topics will be addressed by speakers: flow, 
metabolism and myocardial deformation. Flow imaging has been recently 
enriched by 4D techniques, that demonstrated to be promising either for 
diagnosis or for prognosis. Metabolic assessment of cardiac diseases has 
been relegated to research field for a long time, due to time consuming 
techniques, costs and relatively low clinical impact. However recent advances 
in metabolic assessment of some cardiomyopathies seems to be promising. 
Finally, myocardial deformation evaluation and strains calculation are actually 
hot topics, due to introduction of a new approach, i.e. feature tracking, that 
allows qualitative and quantitative approach to myocardial function. Differently 
from tagging techniques, feature tracking is applied on cine-MR data sets, 
without any additional time and is more robust.  
Session Objectives: 
1. To understand the current clinical challenge for cardiac MRI in flow, 
metabolism and myocardial deformation. 
2. To understand how the process evolves from method development to 
clinical application for flow, metabolism and myocardial deformation. 
A-618 08:35  
A. 4D flow imaging: how and when can it help?  
A.A. Azarine; Paris/FR  
"no abstract submitted" 
Learning Objectives: 
1. To learn about technical requirements to perform 4D flow imaging. 
2. To understand what the strength and limitations of 4D flow are compared to 
2D flow assessment. 
3. To learn about potential clinical applications of 4D flow imaging. 
A-619 09:00  
B. Spectroscopy: implications of myocardial metabolism?  
H.J. Lamb; Leiden/NL (h.j.lamb@lumc.nl)  
Recently, the concept of the ‘metabolic syndrome’ was introduced, which is a 
constellation of risk factors of metabolic origin that are accompanied by 
increased risk for cardiovascular disease and type 2 diabetes. The two major 
underlying risk factors for the metabolic syndrome are obesity and insulin 
resistance. Metabolic imaging and total body fat distribution may be used to 
determine if obese subjects are at an increased risk for developing type 2 
diabetes. In this situation, more intensive lifestyle intervention can be advised 
and monitored. MR techniques, including MR spectroscopy, offer unique 
possibilities for monitoring the effects of new dietary strategies. Whole-body 
imaging may also allow one to study the interaction between different organs. 
For example, initial results show that high liver triglyceride content in type 2 
diabetes is associated with decreased myocardial perfusion, glucose uptake 
and high-energy phosphate metabolism, in conjunction with impaired whole-
body insulin sensitivity. Multi-organ imaging in a single patient opens 
interesting possibilities to study the interaction between key organs involved in 
the metabolic syndrome, such as liver, pancreas, kidney and heart, in relation 
to vascular morphology and function. In summary, metabolic MR imaging, 
including MR spectroscopy and total body fat distribution, may be used in the 
future for risk assessment and personalized medicine in patients with the 
metabolic syndrome. Furthermore, multi-organ MR imaging and spectroscopy 
are promising for evaluation of the interaction between different organs in 
metabolic syndrome.  
 
Learning Objectives: 
1. To learn about technical requirements and how to perform proton 
spectroscopy and multinuclear spectroscopy. 
2. To understand what has been learned from cardiac spectroscopy. 
3. To learn about potential clinical applications of spectroscopy. 
A-620 09:25  
C. Feature tracking: what to conclude from strain and torsion?  
J. Lotz; Göttingen/DE (Joachim.Lotz@med.uni-goettingen.de)  
Quantification of wall motion has ever been an unresolved issue in cardiac 
imaging. Tagging techniques have been employed by MR-imaging in different 
field strengths and sequence designs to define myocardial features that can be 
tracked by specific software. However most of these techniques fell short of 
adequately defining diastolic myocardial wall motion. Diastolic dysfunction 
however has emerged as a key element in the detection of early stage 
myocardial disease. Myocardial feature tracking based on SSFP-sequence 
images has evolved as a reasonably reliable alternative to the classical 
myocardial tagging techniques in MRI. Similar developments have enriched 
echocardiography imaging for myocardial characterisation. Myocardial strain 
and torsion represent quantitative parameters that allow an in depth 
characterisation of myocardial wall motion. Quantitative myocardial dys-
synchrony is a secondary parameter based on the strain and torsion values of 
left and/or right ventricle. There are numerous reports on the clinical benefit of 
these parameters for early diagnosis of diastolic heart failure and monitoring 
therapeutic interventions in cardiomyopathies. They may be helpful in defining 
the success of electrophysiological interventions in cardiac arrhythmias. This 
talk gives a comprehensive overview on the status and clinical usability of 
quantitative myocardial strain and torsion.  
Learning Objectives: 
1. To learn about a new MRI method to assess myocardial deformation. 
2. To understand the strength of MRI feature tracking compared to other 
methods. 
3. To learn about potential clinical applications of feature tracking. 
09:50  
Panel discussion: Is it time to include these MRI techniques in routine 
practice?  
08:30 - 10:00 Room N  
Head and Neck  
RC 1308  
Post-treatment imaging of the head and 
neck  
A-621 08:30  
Chairperson's introduction  
H.B. Eggesbø; Oslo/NO (h.b.eggesbo@medisin.uio.no)  
Head and neck cancer in the Western countries accounts for 3-4% of all 
cancers. the worldwide incidence is estimated to be 500,000, and in Europe 
250,000. There are three times as many men as women that are affected. 
Squamous cell carcinoma constitutes more than 80% of the cancer. At the time 
of the diagnosis, one-third is in stage I/II, and two-thirds are in stage III/IV. The 
recurrence rates for stage I/II are relatively low, with 5-year-survival of 70-90%. 
Therefore, the risk of a secondary primary cancer after radiation therapy (RT) 
may be higher than the risk of recurrence. For stage III/IV, the local recurrence 
rates vary from 25 to 80%, and metastases from 10 to 30%, and the 5-year-
survival is 10-55%. For stage I/II, the treatment options are surgery and/or RT, 
while for stage III/IV chemo- and RT are the main options. Common for all 
treatments are major alterations to the tissue that challenge the post-treatment 
imaging interpretation, independent of the modality. This session will focus on 
the expected changes after RT and surgery, including the most frequent 
surgical procedures, and when and how to perform post-treatment imaging, to 
depict early cancer recurrence.  
Session Objectives: 
1. To become familiar with different ways of treatment. 
2. To understand post-surgical and post-RT complications. 











A-622 08:35  
A. Normal findings after radiotherapy  
R. Hermans; Leuven/BE (Robert.Hermans@uzleuven.be)  
After radiotherapy, imaging may be used to monitor tumour response and to 
detect recurrent or persistent disease before it becomes clinically evident. 
Early tumour recurrence may be difficult to distinguish from treatment-induced 
tissue changes. Therefore, the expected imaging changes after radiotherapy of 
a head and neck cancer should be well known. These tissue changes depend 
on the radiation dose, the irradiated volume, and the time elapsed since 
treatment. Reticulation of fat layers, retropharyngeal space oedema, 
postirradiation sialadenitis, lymphatic tissue atrophy, and thickening of the 
pharyngeal and laryngeal structures may be seen. These expected tissue 
changes often appear symmetrical, unless asymmetric radiation portals were 
used. However, at the site of a bulky tumour, scar tissue may cause an 
asymmetric appearance also after successful treatment. Therefore, obtaining a 
baseline CT or MR study after therapy for a neoplasm with a high risk for 
recurrence is recommended, best 3-6 months post-treatment. By comparing 
subsequent studies with this baseline study, tumour recurrences or treatment 
complications can be detected with more confidence. Some recommend PET-
CT as the initial baseline study, as this technique has a high negative 
predictive value; the positive predictive value is lower, as therapy-induced 
inflammatory changes may cause false-positive results. Tissue necrosis is a 
rare complication of radiotherapy in the head and neck region, usually 
appearing late after treatment. Both soft tissue, cartilage and bone necrosis 
may be encountered; differentiation from tumour recurrence at an early stage 
may be difficult. Other long-term complications may occur, such as 
development of a secondary tumour.  
Learning Objectives: 
1. To get acquainted with changes in tissues during and after radiotherapy. 
2. To understand expected changes after radiotherapy in CT and MR imaging. 
3. To recognise treatment complications from expected tissue changes after 
radiotherapy. 
A-623 08:58  
B. Normal findings after surgery  
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com)  
Nowadays, the management of head and neck cancer involves 
multidisciplinary evaluation and treatment, which usually includes surgery, 
radiation therapy and chemotherapy. The various approaches to surgical 
resection and tissue reconstruction, the types of neck dissection, different 
radiation therapy techniques and the addition of concurrent and neoadjuvant 
chemotherapy regimens may complicate imaging findings. Differentiating post-
treatment changes from tumour recurrence with the use of different imaging 
modalities is challenging because of the presence of altered anatomy 
secondary to resection, flap reconstructions, oedema, inflammation and the 
presence of scar tissue. Therefore, it is essential to be familiar with normal 
findings after surgery and radiotherapy, to distinguish these characteristics 
from tumour recurrence and treatment-related complications.  
Learning Objectives: 
1. To get acquainted with most frequent surgical procedures in head and neck. 
2. To understand how to evaluate post-surgical patients. 
3. To learn how to assess microvascular flaps. 
A-624 09:21  
C. Treatment monitoring for early detection of recurrence  
A.D. King; Hong Kong/CN (king2015@cuhk.edu.hk)  
Head and neck tumour recurrence occurs in ~ 15-50% (depending on the initial 
stage at diagnosis) of patients with squamous cell carcinoma treated by 
chemoradiotherapy. The majority of recurrences occur in-field and are detected 
either on the post-treatment assessment or within 2-3 years of follow-up. The 
role of MR and CT imaging is not only to identify early recurrence amenable to 
curative salvage surgery, but also to avoid unnecessary biopsy or surgery. 
Reported size criteria for recurrence include  1cm primary focal mass and 
1cm nodal short axis, or for nodes < 75%-90% size reduction. However, size 
criteria have limitations, notably in HPV+ disease which is associated with 
large sterile post-treatment nodes. Extracapsular tumour spread and persistent 
necrosis are also inaccurate signs of persistent nodal disease. The main 
advantages of MRI over CT are the T2-weighted and diffusion-weighted 
images (DWI). Tumour recurrence has similar signal intensity to the pre-
treatment tumour, T2 intermediate signal intensity and restricted diffusion (b-
1000 high + ADC map low signal intensity), compared to inflammation (high 
signal intensity) or mature scar tissue (low signal intensity) on the T2 images 
and ADC maps. Contrast enhancement tends to be moderate in recurrence 
and between that of mature scar tissue (mild/absent) and granulation 
tissue/inflammation (marked), but there is overlap on the conventional T1W 
post-contrast images. DWI is also complementary to FDG-PET, helping to 
reduce the FDG-PET false-positive results for recurrence caused by 
inflammation. False-negative findings arise from microscopic disease such as 
that found at tumour margins or in pre-treatment occult nodal metastases, and 
also from small/infiltrating tumours mixed with benign post-treatment change. 
False-positive findings arise from post-treatment changes, especially 
granulation tissue/inflammation, sterile component of necrotic node (ADC map 
low signal intensity) and complications such as radionecrosis, radiation-
induced tumours and granulomatous polyps. 
Learning Objectives: 
1. To get acquainted with problem of recurrence in imaging studies. 
2. To understand how to estimate signs of recurrence on CT and MRI. 
3. To learn about false positive and false negative findings. 
09:44  
Panel discussion: What are the challenges in differentiating post-
treatment changes from tumour recurrence?  
08:30 - 10:00 Studio 2018  
Genitourinary  
RC 1307  
Management of incidental findings in the 
genitourinary tract  
Moderator:  
R.H. Oyen; Leuven/BE  
A-625 08:30  
A. Adrenals  
L.E. Derchi; Genoa/IT (derchi@unige.it)  
Adrenal gland abnormalities are unexpectedly identified in 5%-8% of 
abdominal imaging studies. Most of them are benign and source of little or no 
concern; others are potentially fatal. Clinical and imaging criteria make 
differentiation between benign and malignant lesions possible in most cases. 
When there is no history of malignancy, adrenal lesions are almost always 
non-malignant (usually an adenoma). On the contrary, in patients with a history 
of malignancy, up to 50% are malignant and mostly metastatic. Imaging criteria 
based on macroscopic appearance of these lesions can easily identify those 
containing mature fat (myelolipomas), the hyperdense haematomas and the 
fluid-filled cysts. However, when lesions have non-specific appearance, it is 
necessary to analyse their structure with lipid-sensitive techniques (density 
measurement on unenhanced CT; chemical shift evaluation at MR), using 
perfusion/washout imaging after contrast injection, or with metabolic imaging 
during PET and CT/PET studies. This presentation will discuss how to behave 
when an unexpected adrenal lesion is encountered and how to perform its 
diagnostic workup.  
Learning Objectives: 
1. To understand the definition of incidental findings in adrenal pathology. 
2. To learn about the imaging characteristics of common adrenal incidental 
masses. 
3. To become familiar with the algorithm approach and evidence-based 
recommendations for management of adrenal incidentalomas. 
A-626 09:00  
B. Kidneys  
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch)  
Cystic and small solid renal masses are frequently detected as incidental renal 
lesions with increasing incidence in the elderly population. Therefore, renal cell 
carcinomas are also increasingly detected as incidental findings on imaging. 
Nephron-sparing surgery has been the method of choice for the treatment of 
small solid renal masses. However, a large percentage of these solid renal 
lesions are benign and most of the incidentally detected malignant renal 
tumours such as renal cell carcinomas (RCCs) are smaller, with lower stage 
and are less aggressive than symptomatic RCCs. In addition, a correlation with 
size of the solid lesion and growth rate has been described ranging from 0.13-
0.31 cm per year. Therefore, active surveillance is now a more frequently 
applied approach to deal with these incidentally detected small solid renal 
lesions (<3-4cm). Whereas in solid enhancing lesions < 1cm in diameter, 
active surveillance is the treatment of choice at any age, in larger lesions, 
management mainly depends on clinical factors including the age and the 
performance state of the patient. The role of the radiologist is to exclude 
benign lesions such as Bosniak I and ll cysts and angiomyolipomas as well as 
non-neoplastic conditions mimicking a tumour (infection, infarct, vascular 
anomalies and aneurysms). In patients with small solid renal lesions stratified 
  







for active surveillance, close follow-up with note of the growth rate has to be 
performed in order not to miss the time point of delayed treatment in case of a 
fast growth rate or clinical progression.  
Learning Objectives: 
1. To understand the definition of incidental findings in renal pathology. 
2. To learn about the imaging characteristics of common renal incidental 
masses, namely cystic. 
3. To become familiar with the algorithm approach and evidence-based 
recommendations for management 
of renal incidentalomas. 
Author Disclosure: 
  H.C. Thoeny: Advisory Board; Guerbet SA. 
A-627 09:30  
C. Adnexa  
C.S. Balleyguier; Villejuif/FR (Corinne.BALLEYGUIER@gustaveroussy.fr)  
Incidental adnexal lesions are non symptomatic lesions diagnosed on 
ultrasound, CT or MRI performed for an unrelated reason. They have 
increased in frequency with increased use of crosssectional imaging. The 
majority are benign, even in patients with known malignancy or 
postmenopausal women. However it is important to reliably differentiate 
malignant from benign lesions to avoid delays in treating ovarian cancer and 
prevent unnecessary interventions in benign lesions. To try to characterise 
these findings, age, menopausal status, previous medical and family history 
and tumour marker such as CA 125 have to be known. Further management 
will depend on whether the lesion is clearly benign or malignant, or 
indeterminate. Specific diagnoses have to be suggested in case of fatty 
content (teratoma, lipoid cell tumour, etc), calcified content (ovarian 
leiomyoma, teratoma, brenner struma, etc), and in extra-gynecological origin 
(lipoleiomyoma, pelvic teratoma, liposarcoma, etc). Diagnostic algorithms in 
cystic and solid incidentaloma will be presented in this session, including 
differential diagnoses. A specific focus will be made on diagnostic strategy in 
post menopausal cystic ovarian lesions. Treatment strategy wil also been 
described.  
Learning Objectives: 
1. To understand the definition of incidental findings in adnexal pathology. 
2. To learn about the imaging characteristics of common adnexal incidental 
masses. 
3. To become familiar with the algorithm approach and evidence-based 
recommendations for management of adnexal incidentalomas. 
08:30 - 10:00 Room L 8  
E³ - Rising Stars Programme: EFRS Radiographers' Basic 
Session  
BR 2  
Radiation protection from A to Z  
A-628 08:30  
Chairperson's introduction: The radiographers' role in radiation 
protection  
D. Catania; Milan/IT (cataniadiego@hotmail.com)  
This EuroSafe Imaging session will incorporate four important aspects of 
radiation protection for consideration by the audience. The session will be 
opened by an update on radiographers’ responsibilities with regard to the EU 
Basic Safety Standards Directive. This is critically important information that all 
professionals with radiation safety responsibilities in clinical practice should be 
aware of. The session will progress to include discussion of justification for 
radiographic examinations, which is an important aspect of all radiographers' 
daily work practice. As the technology used by radiographers advances, so 
must our knowledge of how to best use the technology. It is essential that 
radiographers remain up to date with respect to optimisation techniques in 
radiography practice. The third presentation in this session will provide the 
audience with important updates. The focus will be on conventional 
radiography which remains a core activity in all radiology departments. The 
final presentation will discuss the radiographers’ role in benefit-risk 
communication. Once more, this professional matter is of high importance to all 
radiography professionals. The variety of core radiography matters, as 
included in this EuroSafe session, offers updates to our continuing professional 
development and are aimed at supporting our professional practice.  
Session Objectives: 
1. To understand radiographers' current legal responsibilities regarding 
radiation protection. 
2. To consider the role radiographers play in application of the justification 
principle. 
3. To review recent optimisation techniques for projection radiography. 
4. To appreciate how radiographers can best communicate risk-benefit 
information to patients. 
Author Disclosure: 
  D. Catania: Board Member; EFRS, European Federation of Radiographer 
Societies. Founder; AITRI, Italian Association of Interventional Radiographers. 
A-629 08:35  
The Basic Safety Standards Directive: all you need to know  
S.J. Foley; Dublin/IE (shane.foley@ucd.ie)  
The European Commission issued its most recent radiation protection Directive 
in December 2013 which will repeal five other Directives (including 
97/43/Euratom) and must be transposed by all Member States of the EU by 
February 2018. Therefore, this presentation is timely in coinciding with the 
European-wide adoption of the new Directive, which takes into account new 
recommendations from the ICRP in light of new scientific evidence and is 
hoped to strengthen the culture of radiation safety throughout Europe. While 
the Directive remains faithful to and maintains the already well-accepted pillars 
of radiation protection - justification, optimization and dose limitation - these are 
further strengthened in this Directive. Further new requirements under the 
Directive will also be discussed, including obligations related to recording dose 
information and communicating benefit/risk to patients. Additional 
responsibilities have also been designated to a number of professionals which 
will impact the work of both radiographers and radiologists alike; so, all imaging 
staff need to be aware of its implications. This will ensure that the true ethos of 
the Directive will be effectively implemented into routine clinical practice.  
Learning Objectives: 
1. To familiarise attendees with the European BSS Directive (2013/59). 
2. To discuss the additional responsibilities of radiographers and radiologists 
under the Directive. 
3. To consider how the BSS Directive can improve the culture of radiation 
safety in clinical practice. 
A-630 08:53  
The importance of justification  
D. Katsifarakis; Athens/GR (dikatsifarakis@gmail.com)  
Justification derives from the safety culture. It is a crucial procedure in 
diagnostic radiology, considered as one of the of the cornerstones of radiation 
protection. We currently carry out practices of justification appropriate to an era 
of examinations with minimal radiation dose. The majority of radiological 
examinations are performed by radiographers. They greet the patient and 
receive the medical referral simultaneously. Hence, radiographers can easily 
detect an inappropriate examination, particularly those arising from systems’ 
inconsistencies. Also, according to their education-professional culture and 
expertise, they can recognize whether the prescribed examination will satisfy 
the diagnostic requirements. Radiographers bear the responsibility of 
delivering doses of ionizing radiation to patients and during research 
applications. Therefore, they must have the authority to exercise their 
judgement in accepting a referral for medical exposure. This must include an 
adjusting technique to minimize the exposure to patients, staff and the public 
whilst optimizing a diagnostic or therapeutic outcome. Radiographers must 
engage in effective gatekeeping and clinical audits by: reinforcing knowledge 
and communication skills to facilitate the 3As of justification (awareness, 
appropriateness, audit), complying with referral guidelines and employing 
clinical decision support systems. The ISRRT promotes the scope of practice 
of a team approach to authorization and justification as safe and best practice 
for diagnostic imaging services.  
Learning Objectives: 
1. To appreciate the key role of justification within radiation protection. 
2. To be familiar with the role radiographers can play in justification. 
3. To consider initiatives for improving adherence to the principle of 
justification. 
A-631 09:11  
The latest optimisation techniques in conventional radiography  
P.H. Hogg; Salford/UK (P.Hogg@salford.ac.uk)  
In the clinical routine, demand for medical imaging continues to grow and 
conventional radiography, comprising DR and CR technologies, enjoys 
significant utility. Given the moral and legal requirements to minimise radiation 
dose to patients, optimisation techniques must be used. Methodologically 
speaking, these techniques must evolve constantly because of technological 
and philosophical advances. Overall, optimisation seeks to reduce dose 
without compromising pathology detection/characterisation. Optimisation 
techniques need robust estimates of patient dose and pathology 
detection/characterisation performance to determine which interventions are 
  







fruitful. With relevance to conventional radiography, this review will address 
important philosophical and practical optimisation issues. One philosophical 
issue will consider the merits and limitations of pathology 
detection/characterisation in contrast to assessing image quality; it is worth 
remembering that the latter is often used as a ‘proxy’ for the former. Following 
on from this, a critical review of visual and physical image quality measures will 
be presented. Consideration will also be given to different measures of 
radiation dose, from ‘simple to make’, but relatively unhelpful in optimisation 
(e.g. DAP), to ‘complex to make’, but potentially more helpful (e.g. effective risk 
and effective dose). A proposal will be offered on why dose reference levels 
are of limited value in the absence of pathology detection/characterisation or 
even image quality data. Finally, I will offer some practical suggestions on what 
steps might be taken to reduce dose in the clinical setting while maintaining 
image quality levels fit for pathology detection/characterisation. 
Learning Objectives: 
1. To discuss the limitations of image quality as a parameter for use in 
optimising dose in medical imaging examinations. 
2. To discuss a range of visual and physical techniques that can be used to 
assess medical image quality. 
3. To discuss a range of practical measures which might be implemented to 
minimise radiation dose whilst maintaining a level of image quality that is fit for 
purpose. 
A-632 09:29  
The radiographers' role in benefit-risk communication  
J. Portelli; Msida/MT (jonathan.portelli@um.edu.mt)  
By February 2018, each EU Member State is required to transpose Council 
Directive 2013/59/EURATOM into national legislation, thereby laying down 
revised basic safety standards for the protection against dangers arising from 
exposure to ionising radiation. Amongst the changes noted in these revised 
regulations, apart from the responsibilities relating to the justification and 
optimisation of each medical radiation exposure, referrers and/or practitioners 
will now be legally obliged to provide each patient with adequate information 
relating to the benefits and risks associated with the radiation dose to be 
received from a proposed medical imaging procedure. While many referrers 
and practitioners may already be fulfilling this 'new' responsibility in their daily 
practice, the decision to have such a responsibility well defined within the 
regulations can be interpreted as a way to oblige more health professionals to 
realise their duty in delivering patient-centred care and to duly respect each 
patient's right to information. In this regard, this lecture will seek to highlight the 
importance of radiographers having a sound understanding of radiation-related 
concepts, particularly those relating to the benefits and risks of medical 
imaging procedures they perform. Furthermore, the need for radiographers to 
develop and have effective communication skills will also be highlighted, since 
these are necessary to allow them to convey adequate benefit-risk information 
in accordance to the needs and preferences of different patient groups and 
their families, as well as to other health professionals that may be involved in 
the patient’s care.  
Learning Objectives: 
1. To understand new legislative requirements under the BSS Directive. 
2. To be aware of the key role radiographers play in benefit-risk 
communication. 
3. To understand key principles for appropriate benefit-risk communication. 
09:47  
Panel discussion: Teamwork in radiation protection  
08:30 - 10:00 Room E1  
Breast  
RC 1302  
Rethinking ductal carcinoma in situ (DCIS)  
Moderator:  
C. Van Ongeval; Leuven/BE  
A-633 08:30  
A. New radiologic-pathologic knowledge on DCIS  
A. Frigerio; Turin/IT (alfonso.frigerio@gmail.com)  
A modern rethinking of ductal carcinoma in situ must take off from the 
awareness of the utter inadequacy of the terminology currently in use. Already 
in 1976, Jensen, Rice and Wellings remarked that "ductal carcinoma in situ of 
the human breast is of lobular (acinar) origin". While the latest (2012) WHO 
Classification decided to omit the name 'ductal' from the definition of the most 
common type of invasive breast carcinoma, it still fails to recognize the 
inconsistency of this descriptor for its intra-epithelial counterpart. It is time to 
move to a new inter-disciplinary approach where a mutually respectful 
interaction between radiologists and pathologists should take full advantage of 
new imaging techniques and new pathologic methods to achieve better 
characterization of the different types of breast lesions and their clinico-
biological potential. A new classification and terminology based on the site of 
tumour origin (acinar vs ductal), as best displayed by diagnostic imaging paired 
with modern pathologic techniques as large-format histologic sections, should 
open the way to a better understanding of the lesion biology, eventually 
improving treatment planning decisions. This lecture will include a discussion 
of: different subtypes of in situ lesions; neoductgenesis as an important feature 
that should be recognized and reported; the potential of mammographic 
tumour features as synergistic prognostic factors alongside classical 
pathological and modern molecular patterns. Overcoming long-lasting barriers 
to effective communication would be the prerequisite to a new professional 
setting where all specialists involved mutually enhance the benefits of their 
clinical knowledge.  
Learning Objectives: 
1. To learn about different types of DCIS. 
2. To become familiar with risk of developing cancer. 
3. To appreciate radiologic-pathologic correlations. 
A-634 09:00  
B. Diagnosing DCIS  
S. Schrading; Aachen/DE (sschrading@ukaachen.de)  
The presentation gives an overview over the current role and recent data of 
dynamic contrast-enhanced (DCE) breast MRI for diagnosis ductal carcinoma 
in situ (DCIS). Special attention is paid on the description and illustration of 
typical imaging features as well as pitfalls and difficult differential diagnosis of 
DCIS at MRI. In addition, the impact of DCE MRI on DCIS treatment and 
recent discussion on overdiagnosis and overtreatment of DCIS are discussed.  
Learning Objectives: 
1. To understand the evidence on MRI for evaluating DCIS. 
2. To become familiar with different imaging appearances of DCIS. 
3. To appreciate the value added of MRI for diagnosis. 
A-635 09:30  
C. Reducing overtreatment of DCIS  
M.G. Wallis; Cambridge/UK (matthew.wallis@addenbrookes.nhs.uk)  
Breast screening has led to an inexorable rise in the number of women living 
with a diagnosis of DCIS predominantly but not exclusively as a result of the 
detection of microcalcification. It is clear from long-term follow-up that 
conventional treatment fails the 15 to 20% who develop invasive disease, a 
few of whom then die from breast cancer. There is a larger group that never 
progresses within their life time which means we have either cured them or 
overtreated them. Traditional pathology and genetics suggest that there is a 
low-risk group that either never progress or if they do develop ‘low-risk’ 
invasive disease. I will describe the three international randomised controlled 
trials: LORIS (The LOw RISk DCIS trial), LORD (LOw Risk DCIS), COMET 
(Comparison of Operative versus Medical Endocrine Therapy for Low Risk 
DCIS) and LORETTA a single-arm confirmatory study of endocrine treatment 
only. I will describe PRECISION that aims to identify markers for progression 
from retrospective data sets and then prospectively validated these on the 
three randomised trials. Using LORIS, I will discuss how we have attempted to 
resolve the hurdles of setting up a ‘no treatment trial’ and talk about some of 
the lessons learnt from successfully steering LORIS from feasibility to full trial. 
Anecdotally, patient views have been more entrenched than those of surgeons 
and to my surprise the radiology second opinion service set up to reduce the 
risks of ‘active monitoring’ up by annual VAB has not been overwhelmed.  
Learning Objectives: 
1. To learn about the risk of overdiagnosis and overtreatment. 
2. To become familiar with the risk of avoiding surgery. 














08:30 - 10:00 Room E2  
Neuro  
RC 1311  
Altered mental state  
A-636 08:30  
Chairperson's introduction  
M.A. van Buchem; Leiden/NL  
Session Objectives: 
1. To learn about the complex spectrum disease entities presenting with 
cognitive decline. 
2. To understand the role of standardised imaging and reporting in the context 
of diagnosis and monitoring of patients with neurocognitive disorders. 
3. To appreciate importance of multimodal imaging approaches in the 
diagnosis of neurocognitive disorders. 
A-637 08:35  
A. Patterns of referrals  
N.N. 
Learning Objectives: 
1. To learn about the broad spectrum of clinical presentation of cognitive decline. 
2. To understand the role of imaging in the context of the clinical presentation and 
other biomarkers (e.g. CSF) in the diagnosis of cognitive impairment. 
3. To appreciate the heterogeneity of primary and secondary pathologies 
presenting to the memory clinic. 
A-638 08:58  
B. Imaging in altered mental state  
A.J. Bastos-Leite; Porto/PT (ajbastosleite@gmail.com)  
The most common causes of altered mental state (AMS) encompass 
neurological and psychiatric conditions, as well as pharmacological, toxic, 
infectious, metabolic, or even traumatic disorders. Neuroimaging became a 
very relevant tool for the diagnosis of AMS, especially for the diagnosis of 
dementia (major neurocognitive disorder), a clinical syndrome, rather than a 
single nosological entity, characterised by deficits in one or more cognitive 
domains, and the most serious consequence of pathological brain ageing. 
Over the past decades, the role of neuroimaging has revolutionised the 
diagnosis of neurocognitive disorders by positively predicting the diagnosis 
rather than just excluding disorders that may mimic dementia. This change has 
been possible both by visually assessing the extent, pattern and severity of 
brain volume loss and cerebrovascular pathology, as well as by increasingly 
using computer-aided techniques, potentially advantageous at the very early 
stages of pathology progression. Functional neuroimaging techniques, such as 
arterial spin labelling, represent added value in this setting as well. In addition, 
cerebrospinal fluid biomarkers (Beta-amyloid- and tau-mediated injury markers) 
also support the clinical diagnosis of Alzheimer’s disease. The challenge, 
however, persists in other mental conditions, such as psychiatric disorders. A 
key example here is schizophrenia, in which there are subtle—microscopic—
abnormalities involving functional brain networks. This precludes the diagnosis 
by means of visual inspection, and currently limits the usefulness of 
neuroimaging. Nevertheless, novel techniques and methods for the 
assessment of effective (i.e., directed) brain connectivity seem to provide a 
very promising lead.  
Learning Objectives: 
1. To learn about the role of imaging in the diagnosis of neurocognitive 
diseases: from the exclusionary approach to the inclusionary approach. 
2. To understand the challenges to diagnose neurocognitive disease in a very 
early stage using imaging. 
3. To appreciate the complexity of differential diagnosis of neuroimaging in 
cognitively affected individuals and the crucial need for other biomarkers to 
support the clinical diagnosis. 
A-639 09:21  
C. MRI in the diagnosis of Alzheimer's disease  
A. Krainik; Grenoble/FR (akrainik@chu-grenoble.fr)  
As the most common cause of neurodegenerative dementia, Alzheimer’s 
disease (AD) is a diagnosis and therapeutic challenge. In clinical practice, 
diagnosis remains probabilistic without pathological proofs, relying on clinical 
and neuropsychological examinations, CSF biomarkers, and brain imaging. 
Multidisciplinary collaborations and recent technical advances deliver now 
more accurate and relevant information, to better diagnose AD. Indeed, 
imaging data provide evidence to step forward and to refine AD diagnosis, 
based on homogeneous imaging subgroups of patients, despite similar clinical 
and biological profiles. Additionally, advanced MR techniques investigate new 
tools to demonstrate supplementary abnormalities, that could be used in 
clinical practice and suggest new paths for therapeutic research. Imaging of 
dementia is now far from ruling out neurosurgical aetiologies, only. Clear and 
reproducible cerebral images allow quantitate assessment to estimate severity, 
to discuss differential diagnoses, and to monitor evolution. We, radiologists, 
have to carefully analyse our images to provide the most probable diagnosis 
and to maximise the value of our work. The present lecture gives you tips and 
tricks for your daily practice. 
Learning Objectives: 
1. To learn about the imaging features and possible comorbidities of 
Alzheimer's dementia. 
2. To understand the complexity of differential diagnosis. 
3. To appreciate the crucial and so far unmet medical need to use quantitative 
MRI techniques in the diagnosis of Alzheimer's disease. 
09:44  
Panel discussion: Ask the expert: How can I standardise my image 
reading and reporting in order to support the clinical process in 
cognitively impaired patients?  
08:30 - 10:00 Room F1  
E³ - European Diploma Prep Session  
E³ 1323  
Cardiac and vascular  
A-640 08:30  
Chairperson's introduction  
R. Vliegenthart; Groningen/NL (r.vliegenthart@umcg.nl)  
This European Diploma Prep session covers essential knowledge regarding 
radiological techniques in cardiovascular imaging, cardiovascular anatomy and 
highlights of cardiovascular pathology. Radiologists have an increasingly 
important role in the evaluation of cardiac and vascular diseases, due to the 
fact that CT/MRI can provide a diagnosis in a non-invasive, more detailed, 
more reproducible and/or more tissue-specific way than other modalities. In 
this session, a general basis is provided regarding the technique of 
cardiovascular imaging with CT and MRI, anatomical depiction in CT/MRI, and 
the main disorders of the myocardium, pericardium, valves and aorta.  
Session Objectives: 
1. To understand the basic principles and techniques of cardiovascular imaging 
including CT and MRI of the heart and great vessels. 
2. To become familiar with the imaging presentations of disorders of the 
endocardium, the pericardium and the cardiac valves. 
3. To understand the MR imaging presentation of disorders of the myocardium. 
A-641 08:36  
A. Cardiovascular imaging: the basics  
M. Gutberlet; Leipzig/DE  
"no abstract submitted" 
Learning Objectives: 
1. To understand the anatomy, normal variants and abnormalities of the heart 
and great vessels. 
2. To describe the technical aspects and methodology of cardiac and vascular 
CT. 
3. To describe the technical aspects and methodology of cardiac and vascular 
MRI. 
A-642 09:04  
B. Cardiovascular imaging: valves, endocardium and aorta  
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at)  
The new possibilities provided by means of non-invasive cardiac imaging 
moved the heart back into the interest of radiology, and radiologists play an 
increasing role even in the management of patients suffering from non-
coronary cardiac diseases. Despite the outstanding role of echocardiography in 
the diagnosis and follow-up of valvular diseases in clinical routine, cardiac MR 
plays an important and CT an increasing role in the management of patients 
suffering from valvular diseases. The most common and most important 
valvular diseases including aortic regurgitation and stenosis will be introduced. 
  







The role of imaging for diagnosis, treatment decision-making and treatment 
planning will be discussed as well. After valvular repair, CT evolved as the 
method of choice to assess possible infectious complications providing exact 
information about local and systemic manifestations of endocarditis. The 
importance of early diagnosis and treatment of endocarditis will be clarified and 
the value of modern imaging will be underlined. In the third part of the 
presentation insight into the role of CT angiography in the diagnosis and 
management of acute and chronic aortic diseases will be provided, focusing on 
aortic dissection and aneurysm. Within this presentation, a short overview 
about the most important diseases of valves, endocardium and aorta will be 
provided while defining the most important questions to be answered by 
imaging. Based on this, current and possible future role of CT and MR in these 
fields will be explained and basic tips for optimised imaging will be provided.  
Learning Objectives: 
1. To recognise the imaging presentation of the different forms of valvular 
disease. 
2. To understand the causes and imaging presentations of endocarditis. 
3. To describe the diagnostic evaluation and imaging presentation of common 
diseases of the great vessels, including aortic dissection and aneurysms. 
Author Disclosure: 
  C. Loewe: Speaker; GE Healthcare, Bracco, Siemens. 
A-643 09:32  
C. Cardiovascular imaging: myocardium and pericardium  
J. Bogaert; Leuven/BE (Jan.Bogaert@uz.kuleuven.ac.be)  
Cardiovascular magnetic resonance (CMR) provides substantial, often unique, 
information in the evaluation of myocardial and pericardial diseases. This talk 
summarizes how CMR can be used to comprehensively study the pericardium 
and myocardium including tissue characterization, deep phenotyping, 
assessment of myocardial strain, and ventricular function, as well as the 
interaction between the pathologic pericardium and the remainder of the heart. 
The aim is to make the audience familiar with current use of CMR in daily 
clinical practice to assess this group of cardiac patients.  
Learning Objectives: 
1. To describe the diagnostic evaluation and imaging presentation of ischaemic 
heart disease. 
2. To understand the diagnostic evaluation and imaging presentation of 
myocarditis. 
3. To become familiar with the causes and imaging presentations of pericardial 
effusion. 
08:30 - 10:00 Room F2  
Emergency Imaging  
RC 1317  
Imaging of 'foreign bodies'  
A-644 08:30  
Chairperson's introduction  
M. Pezzullo; Brussels/BE (martina.pezzullo@erasme.ulb.ac.be)  
The presentation starts with an introduction of myself. Foreign bodies could be 
introduced in human body cavities voluntarily or accidentally. All the medical 
devices usually belong to the first category and to be familiar with their names, 
use and radiolgraphic appearance is mandatory to recognise proper 
positioning and prevent displacement or migration. Accidental introduction of 
foreign bodies usually happens due to ingestion of food particles or small 
objects, especially in early childhood or in mentally impaired subjects. These 
objects can cause gastrointestinal tract complications due to impact or 
perforation, and a high level of suspicion is required to look for subtle signs as 
the presence of a foreign body is often unexpected.  
Session Objectives: 
1. To be familiar with names and image characteristics of commonly used 
surgical, and orthopaedic devices and materials. 
2. To learn their proper positioning and early signs of postoperative 
complications. 





A-645 08:35  
A. Surgical and orthopaedic devices: are they really properly positioned?  
E. Dick; London/UK (elizabeth.dick@imperial.nhs.uk)  
This session will address the common surgical and orthopaedic devices that 
we encounter in everyday radiology practice. What do the clinicians consider to 
be optimal placement of each device? How can we assess if positioning is 
suboptimal? What kind of language should we use to describe devices? It will 
cover: (1) Lines and tubes: how to evaluate whether endotracheal tube and 
chest and abdominal drains are correctly placed, including: assessing the 
position of ETT beyond the vocal cords and satisfactory inflation of the ETT 
balloon. (2) Surgicel (surgical packing used in damage control surgery): how to 
evaluate the post-operative trauma abdomen even with Surgicel in place. (3) 
Neurosurgical devices: cervical and thoraco-lumbar spinal fixation: principles of 
stabilisation, how to evaluate whether correctly positioned, what language to 
use, complications including epidural haematoma and collections. (4) 
Orthopaedic devices: rib and pelvic fixation devices: how to assess the stability 
and considerations of neurovascular compromise. 
Learning Objectives: 
1. To become familiar with different types of commonly used surgical, 
neurosurgical and orthopaedic devices in clinical practice. 
2. To understand how to evaluate their proper positioning. 
3. To be familiar with imaging signs of incorrect implementation of 
neurosurgical and orthopaedic devices. 
A-646 09:00  
B. Foreign bodies in the gastrointestinal tract: the role of radiographs, US 
and CT  
J.B.C.M. Puylaert; The Hague/NL (dr.jbcmpuylaert@wxs.nl)  
Did I swallow that?!: US and CT of sharp foreign bodies penetrating stomach 
and bowel. Accidental ingestion of sharp foreign bodies is a potentially life-
threatening event with a reported mortality of 18%. If a sharp foreign body gets 
stuck in the oesophagus, the patient usually will notice its presence and seek 
medical help rapidly. However, when it reaches the stomach or bowel and 
penetrates the wall there, the ensuing symptoms are atypical and treacherous 
and serious delay may ensue. Perforating foreign bodies in the stomach and 
bowel are increasingly recognised by the use of US and spiral CT with 
multiplanar reconstructions and may be of great help in guiding minimal 
invasive treatment. The most frequently encountered penetrating sharp foreign 
bodies are chicken bones, fish bones and wooden sticks such as toothpicks. 
Most patients do not recall having swallowed such an object. Some patients 
wear denture plates rendering their palatum insensitive and the phenomenon is 
reported to be more frequent in mentally retarded patients. However, the 
majority of our patients were otherwise healthy. Over two-thirds have a history 
of a previous operation with kinking of bowel loops caused by adhesions, 
which locally inhibit the foreign body to “take the corner”. Once a sharp object 
penetrates the wall of the stomach or bowel, the omentum and mesentery will 
try to wall-off the ensuing perforation. Often an abscess develops in the 
peritoneal cavity, in the liver or in the abdominal wall. Eventually, significant 
migration of the object may be the result. If the sharp foreign body is beyond 
reach of the endoscope, patients usually undergo laparotomy for removal of 
the foreign body and drainage of the abscess. This presentation will emphasise 
the role of US and CT in the diagnosis and in the minimal invasive treatment of 
these sharp foreign bodies.  
Learning Objectives: 
1. To be familiar with characteristics of commonly ingested abdominal foreign 
bodies. 
2. To understand which imaging modalities are best suited for detection of 
foreign bodies in different clinical scenarios. 
3. To recognise the first signs of early complications resulting from ingested 
abdominal foreign bodies. 
A-647 09:25  
C. Body packing: what to know about imaging and when should we 
suspect early complications?  
M.K. Scherr; Munich/DE (michael.scherr@bgu-murnau.de)  
Body packers, pushers and stuffers incorporate a variable amount of packs 
containing illicit drugs such as heroin and cocaine by ingestion or insertion 
vaginally or rectally. Every pack usually contains a lethal dose of narcotic. Due 
to increased luggage controls and body checks at customs and airports, this 
practice has a steady increase. Radiologists and emergency departments get 
confronted with body packers in two different ways. There is the forensic 
indication when suspects are presented by the authorities or the more familiar 
medical indication in cases of bowel obstruction or mainly severe intoxication. 
In both scenarios, the radiologist should know the legal issues and be prepared 
to perform the adequate examination and proper image interpretation to detect 
the body packs with a high degree of certainty. Already occurred or potential 
  







complications like complete obstruction, package rupture or leakage have to be 
clinically and radiologically perceived. The diagnostic limitation of applied 
conventional x-ray is already known and increasingly replaced by (dose-
reduced) computer tomography with its very high sensitivity. In some cases, 
already the CT scout view gives the clue. It is crucial to know about the CT 
presentation of packages depending on the manufacturing process and 
ingredients, where liquid packs become a diagnostic challenge. Attempts have 
been made to analyse body pack drug content by CT density or dual-energy 
appearance for further treatment planning. The treatment options are 
conservative under surveillance, laparotomy and intensive care with or without 
targeted antidote administration.  
Learning Objectives: 
1. To be familiar with the phenomenon of drug smuggling by body packing and 
its medical/legal issues. 
2. To learn about imaging modalities and their limitations in case of body 
packing and variants. 
3. To recognise potential or manifested complications in body packing.  
09:50  
Panel discussion: Common language with clinicians: how to report 
'foreign bodies' presence  
08:30 - 10:00 Room D  
Special Focus Session  
SF 13b  
Paediatric MRI: can we make gadolinium 
superfluous?  
A-648 08:30  
Chairperson's introduction  
M. Alison; Paris/FR  
Session Objectives: 
1. To learn about the risk of gadolinium injection in paediatric patient. 
2. To learn about the alternative sequences to study vessels or perfusion. 
3. To appreciate the indication of intravenous gadolinium in common paediatric 
diseases. 
A-649 08:35  
Safety issues of intravenous gadolinium in children  
F.E. Avni; Lille/FR (favni@skynet.be)  
A latest report (2017) estimates the adverse drug reaction (AdR) rate between 
0.05 and 0.5%. AdR tends to be more frequent with linear GBCA. AdR is 
mostly mild to moderate and includes nausea, vomiting and urticaria. At 
approved doses, there is no evidence of renal toxicity even in neonates. 23 
cases of nephrogenic systemic fibrosis (NSF) have been reported up to 2012 
in children. All (most) cases were related to linear GBCA. No case has been 
reported in recent years. In the last 3 years, several studies have reported 
evidence of gadolinium deposits after repeated injections in various tissues, 
especially in the brain and bones. Most cases are related to the injection of 
linear GBCA. The rate of AdR and tissue deposits seems influenced by the 
thermodynamic and kinetics stability of GBCA. This rate is further influenced by 
pre-existing renal impairment or immaturity. All these data have generated a 
precautionary approach: (1) The necessity of injection should be evaluated 
case by case. (2) Exceeding the doses advised or repeating examinations with 
injections should be avoided, especially in patients with renal impairment. (3) 
Injecting GBCA in neonates or patients with significant renal impairement 
should be avoided. (4) Many hospitals should shift from linear to macrocyclic 
GBCA. (5) The EMA recommends withdrawing the acceptance of linear GBCA. 
Still, the need to test renal function previous to GBCA injection is presently not 
confirmed. (6) It is recommended to keep a record of cumulative contrast dose. 
(7) In general, it is advised to follow adults' recommendations.  
Learning Objectives: 
1. To learn about the existing literature on potential side effects of intravenous 
contrast in children. 
2. To understand how underlying conditions may influence the risk for side 
effects. 
3. To discuss the implications of the new knowledge for clinical practice in 
paediatric radiology. 
 
A-650 08:53  
The role of intravenous gadolinium in paediatric oncology  
P.D. Humphries; London/UK (humphriespaul@gmail.com)  
Imaging plays a central role in the diagnostic pathway for children with cancer, 
being used to investigate clinically apparent lesions, screen children with 
cancer predisposition syndromes, stage known cancers and monitor treatment 
response. Magnetic resonance imaging has become a mainstay in the imaging 
of children with cancer, not only for CNS malignancies, but also for body 
tumours, owing to a move away from anatomical imaging using ionizing 
radiation. Intravenous MR contrast agent administration is frequently used as 
part of MR imaging protocols in paediatric oncology. With respect to body 
tumour imaging, there is a paucity of literature or systematic investigation of 
the diagnostic benefit of this, with practice being driven largely by expert 
opinion. Lesion characterization, anatomical boundary definition and 
relationships to vascular structures may all benefit from contrast administration, 
and dynamic-enhanced MR may be used to assess the effects of anti-
angiogenic agents. Increasing utility of high-resolution unenhanced MR 
sequences and diffusion-weighted imaging enable MR protocols to be 
optimized such that IV contrast administration can be reduced. Additionally, 
other imaging modalities such as CE-US now provide a broader repertoire of 
imaging modalities to assess the vascular enhancement characteristics of 
lesions.  
Learning Objectives: 
1. To learn about the existing literature on the usefulness of intravenous MRI 
contrast in paediatric oncology. 
2. To understand how protocols can be optimised to avoid the use of 
intravenous gadolinium in the diagnosis and follow-up of children with cancer. 
3. To discuss how non-enhanced MRI sequences could replace gadolinium-
enhanced sequences. 
Author Disclosure: 
  P.D. Humphries: Research/Grant Support; Great Ormond Street Hospital 
Charity. 
A-651 09:11  
Assessment of musculoskeletal disorders: when is intravenous 
gadolinium necessary?  
M. Maas; Amsterdam/NL (m.maas@amc.nl)  
Intravenous use of gadolinium in MSK is mostly seen in the diagnosis of 
oncology, infection and inflammation. It aids in detecting and characterising 
pathology, enhances depicting subtle areas of residual disease, and might 
make a contribution in assessing the response to therapy. Also, dynamic 
biomarkers might be beneficial and can be added to protocols. For some 
pathologies, gadolinium is described to be essential to delineate the diseased 
tissue (i.e. the synovial membrane in juvenile idiopathic arthritis); however for 
other diseases, this need might not be so prudent. Indications will be discussed 
during the lecture and will be illustrated with MR images. Novel techniques that 
might replace intravenous gadolinium-enhanced sequences should at least be 
equal in defining the presence or absence of pathology. In this lecture, special 
focus will be given to DWI as a non-contrast alternative: what is the rationale 
behind using DWI? What are the possible applications of imaging the synovial 
membrane using DWI? can DWI be used in bone tumour assessment? 
Literature regarding non-contrast MRI of synovitis, including DWI and inversion 
recovery techniques, will be addressed and images of our experience as well 
as images of other authors in the field will be shared.  
Learning Objectives: 
1. To discuss what are the indications of gadolinium injection in 
musculoskeletal disorders. 
2. To understand how novel techniques may replace intravenous gadolinium-
enhanced sequences for some indication (i.e. depiction of synovitis or 
ischaemia). 
3. To discuss current knowledge and future potential of non-enhanced MRI 
techniques in detecting and grading of synovitis. 
A-652 09:29  
Brain imaging: when is intravenous gadolinium necessary?  
K. Karli Oguz; Ankara/TR (karlioguz@yahoo.com)  
Since their first availability for clinical use, Gd-based MR contrast agents have 
been widely applied in neuroimaging. Apart from nephrogenic systemic 
fibrosis, there has been an increasing concern about Gd retention in the brain 
and its possible, yet unravelled, clinical effects among the physicians, patients 
and parents. Since we have an obligation not to harm paediatric patients, we 
have to review our contrast material usage policy carefully, present our 
indications strictly and fully take over the responsibility. By doing so, we should 
consider using techniques that do not necessitate administration of contrast 
material (such as arterial spin labelling-ASL instead of T2*EPI perfusion 
studies, non-contrast-enhanced angiography techniques) or supplementing 
  







routine non-enhanced MRI sequences with other techniques to get more 
information on focal lesions such as diffusion-weighted imaging, ASL, SWI and 
MR spectroscopy . Cutting-edge imaging techniques including chemical 
exchange saturation transfer glucose imaging and magnetic particle imaging 
that do not need Gd injection will also be mentioned very briefly in this session. 
The indications such as infections, tumours and vascular diseases will be 
reviewed and contrast material use, especially on demyelinating and 
degenerative diseases, will be discussed.  
Learning Objectives: 
1. To learn about the indications of intravenous gadolinium for brain imaging. 
2. To understand the role of non-enhanced sequences for brain vascular 
imaging. 
3. To understand the role of non-enhanced sequences for brain perfusion 
imaging. 
09:47  
Panel discussion: How can we reduce our use of intravenous gadolinium 
in children?  
08:30 - 10:00 Room G  
Physics in Medical Imaging  
RC 1313  
Motion artefacts and their management in 
medical imaging  
A-653 08:30  
Chairperson's introduction  
T. Beyer; Vienna/AT  
Session Objectives: 
1. To learn about the origins of motion management in medical imaging. 
2. To understand motion-related artefacts in medical imaging. 
3. To learn about solutions and work-arounds. 
A-654 08:35  
A. Managing motion in CT: conventional approaches and motion 
compensating techniques  
M. Kachelrieß; Heidelberg/DE (marc.kachelriess@dkfz.de)  
Diagnostic CT provides highly quantitative images with very high spatial 
resolution (0.3 mm isotropic) for complete anatomical areas in scan times as 
short as about 1 s. CT further routinely achieves an unprecedented temporal 
resolution of 63 ms, which is one-quarter of the rotation time, for complete 
anatomical regions. In many cases, this is sufficient to freeze patient motion. 
For quickly moving organs, even 63 ms may introduce motion blurring. Given 
the spatial resolution of 0.3 mm, objects moving at a speed of about 4 mm/s or 
faster will introduce blurring. Velocities of up to 70 mm/s occur in the heart. 
Typical methods to manage cardiac motion are prospectively or retrospectively 
gated single breath-hold scans. Recently, new algorithms that have the ability 
to compensate for the motion during image reconstruction are being 
developed: they have the potential to significantly increase the temporal 
resolution or to improve the dose usage. For lung imaging, the intrinsic 
temporal resolution of CT is sufficient. However, when 4D images are required, 
as it is the case for radiation therapy planning, the problem arises of how to 
generate moving images with a CT that freezes motion. The solution is to use 
respiratory gated scans with a very low pitch value. These methods, however, 
suffer from artefacts and high patient dose. Although dedicated motion 
compensation techniques for 4D CT could remove the artefacts and decrease 
the dose, the manufacturers provide no implementations. The lecture 
discusses the methods in use and those that are currently being developed. 
Learning Objectives: 
1. To learn about conventional techniques for motion compensation in CT. 
2. To learn about new methods for motion compensation in CT. 





A-655 08:58  
B. Managing motion in cone-beam CT (CBCT): conventional approaches 
and motion compensating techniques  
P. Paysan; Baden−Dättwil/CH (Pascal.Paysan@varian.com)  
Motion management and motion-induced image artefacts in cone-beam CT 
(CBCT) imaging differ from CT due to inherent technical limitations of CBCT 
systems. While CT vendors have the possibility of increasing rotation speed to 
acquire complete slices within one motion state (e.g. breathing phase), the 
rotation speed is limited on CBCT systems. The major limiting factors are the 
readout frequency of a flat panel detector and the design-dependent absence 
of a slip ring (e.g. on C-Arm systems). Understanding the technical differences 
between CBCT and CT explains the different visual appearance of image 
artefacts and how motion management can be addressed on CBCT systems. 
One can distinguish two strategies that are to either reduce (freeze) the motion 
or in case of periodic motion to collect data from subsequent phases. Methods 
for motion reduction (immobilization) are fixations such as head frames, bite 
blocks, abdominal compression and breath-hold acquisitions, and also 
corrective methods for e.g. rigid (global and local) motion often applied on 
head scans. Periodic motion can be dependent on the use case, either 
handled by applying e.g. (prospective) gated CBCT or can be time-resolved 
reconstructed (4D CBCT). Time-resolved 4D CBCT reconstruction implies 
optimized acquisition parameters as well as the different algorithms to obtain 
the 4D reconstruction. Recent research explores new 4D reconstruction 
techniques such as HDTV or motion-compensated reconstruction that show 
very promising results in terms of image quality and dose usage. Knowing the 
technical differences of CBCT over CT helps to understand patient motion-
induced image artefacts and the variety of technical solutions to reduce or 
resolve this motion.  
Learning Objectives: 
1. To learn about conventional techniques for motion compensation in CBCT. 
2. To learn about new methods for motion compensation in CBCT. 
3. To contrast the available and up-and-coming motion compensation methods 
in CBCT. 
Author Disclosure: 
  P. Paysan: Employee; I am Varian Medical Systems employee. 
A-656 09:21  
C. Motion compensation in MR and PET imaging  
C. Kolbitsch; Berlin/DE (christoph.kolbitsch@ptb.de)  
MRI provides images with excellent soft tissue contrast and a wide range of 
diagnostic parameters. Physiological organ motion (e.g. breathing, heartbeat or 
swallowing) can strongly impair image quality and hence diagnostic accuracy. 
Advances in MR hardware, plus novel image acquisition and reconstruction 
approaches, have strongly decreased MR scan times. Nevertheless, still up to 
20% of MR scans experience severe motion artefacts and require repeated 
data acquisition. A wide range of techniques to minimise motion artefacts has 
been developed for different MR applications. In clinical practice, this is 
commonly motion prevention (e.g. asking a patient to hold their breath) and 
motion gating (i.e. restricting data acquisition to a certain motion state). More 
advanced motion correction approaches measure displacement of organs due 
to physiological motion and utilise this information to reduce motion artefacts 
during image reconstruction. PET images are affected by motion in two ways. 
Movement of organs can lead to blurring of the imaged structures and impair 
detectability, particularly of small features. In addition, motion can lead to a 
mismatch between attenuation correction maps and PET image data, resulting 
in severe errors in PET quantification. The recent introduction of simultaneous 
PET-MR now offers us the possibility to improve PET image quality and 
accuracy by utilising MR-based motion information. In addition, PET and MR 
data can also be combined to improve motion estimation and motion 
correction.  
Learning Objectives: 
1. To learn about motion measurement and compensation in MR. 
2. To understand how patient motion affects PET images. 
3. To learn about how MR data can be used to motion-compensate PET 
images, in MR/PET. 
09:44  
Panel discussion: How to optimise motion management in different 












08:30 - 10:00 Room K  
Professional Challenges Session  
PC 13  
Closing the gap between education and 
clinical practice for radiographers  
A-657 08:30  
Chairpersons' introduction (part 1)  
K.G. Vikestad; Oslo/NO (karivi@hioa.no)  
This session, professional changes, focuses on the gap between education 
and clinical practice in radiography. At the end of the session, we will discuss 
the challenges and aim to come up with suggestions to reduce this gap. Three 
speakers are invited; they will present their perspective on the topic to open the 
minds of the audience and provide some new thoughts. The speakers are: 
Anne Bjørnstad, Norway; Eric Wolker Van Der Weij, the Netherlands; and 
Louise Rainford, Ireland. The speakers represent both the clinical and 
educational field of radiography. Anne will present how the clinical field views 
the competence level of the newly graduated radiographers when they start 
working at Oslo University Hospital and what kinds of competence are 
important for the clinical field right now. She will also provide some reflections 
on whether or not specialisation should be part of the bachelor's degree. Eric 
will give a presentation about a new method for preparing students for clinical 
practice. They have starting using this method at his university, and he will 
share his thoughts and experiences in using this method. The title of the 
presentation by Lousie is “Tools for success - academic and clinical practice 
working together”. Her focus will be on how to emphasize variation of 
combined education and training, how to explore collaboration between 
hospitals and universities, and finally how undergraduate research can 
enhance academic/clinical relationships.  
Session Objectives: 
1. To understand the need for updated methods of training radiographers in the 
context of modern technology. 
2. To discuss existing differences and controversies in the education system 
and teaching methods. 
3. To explore possible ways of collaboration between academic institutions and 
hospitals for optimal education. 
A-658 08:33  
Chairpersons' introduction (part 2)  
M. Raissaki; Iraklion/GR (mraissaki@yahoo.gr)  
Competence refers to what a health specialist is capable of doing in his/her 
daily clinical practice. To achieve competence, a health specialist in a radiology 
department should acquire sufficient knowledge of various aspects of anatomy, 
physiology, physics, radiography and medicine. Performance refers to what a 
health specialist actually does. Performance is associated with much more 
than knowledge including ethics, interpersonal relationships, clinical skills, 
empathy for patients and ability to perform diagnostic tests as safely and 
efficiently as possible. Living in the era of evidence-based medicine, 
personalized medicine and ALARA has enhanced the role of the radiographer 
into a highly-skilled health specialist coping with multiple tasks in demanding 
environments. Academic activity composes a triangle formed by research, 
teaching and clinical practice. Teaching is considered one of the most 
challenging and endangered aspects of academic activities because of 
continuous changes in the methods of education, technology and patient 
management. Excellence in performance is the ultimate goal of education 
throughout pre- and postgraduate teaching programmes, and the possibility of 
new learning platforms might prove useful in the effort to close the gap 
between education and clinical practice for radiographers.  
Session Objectives: 
1. To understand the need for updated methods of training radiographers in the 
context of modern technology. 
2. To discuss existing differences and controversies in the education system 
and teaching methods. 
3. To explore possible ways of collaboration between academic institutions and 
hospitals for optimal education. 
A-659 08:35  
Education vs clinical practice  
A. Bjørnstad; Oslo/NO (Anne.Bjornstad@oslo-universitetssykehus.no)  
Newly qualified diagnostic radiographers’ knowledge, skills and competencies 
do not comply with the expectations and demands of the health care sector in 
Norway. Continual developments in technology and the changing role of the 
radiographer create a need for restructuring of radiography education.To 
ensure that newly qualified diagnostic radiographers meet the expectations of 
the clinical site , the Learning outcomes of radiography education should be 
reevaluated. The level of clinical competencies diagnostic radiographers are 
expected to have achieved on completion of their education should be revised. 
This process cannot be initiated without a closer evaluation of the employer´s 
role and responsibility. The employer should consider how the training of both 
students and newly qualified radiographers is organized. The evaluation of the 
required competencies of a clinical diagnostic radiographer should be an 
ongoing and dynamic process. To Ensure satisfactory quality of both the 
academic studies and the clinical training, the collaboration between the 
educational institutions and clinical placement locations should be improved. 
Also, the competence of the clinical practice supervisors should be 
strengthened. Technological advances and the increasing complexity of 
radiographic procedures demand a continuous increase in competencies 
beyond the bachelor education. This raises the question; should the bachelor 
degree include specialization in specific areas within the field of diagnostic 
radiography or should this remain as a mandatory part of continuing 
professional development. 
Learning Objectives: 
1. To understand the different perspectives of theoretical education and 
practical training of radiographers. 
2. To appreciate means of rapid acquisition of clinical skills during education. 
3. To discuss the possibility and potential of sub-specialisation during 
education. 
A-660 08:58  
How can new teaching methods be implemented?  
E. Wolters van der Weij; Groningen/NL (e.m.wolters.van.der.weij@pl.hanze.nl)  
Serious Gaming! Didactics is the scientific discipline that deals with the 
question of how teachers can train knowledge, practical skills and attitude to 
students. Thirty years ago, education was more teacher controlled which is 
often associated with passive learning. Currently, activating or self-directed 
learning are the didactic methods which place the student more in a central 
position. Self-directed learning is a process in which the student himself takes 
the initiative for the learning process: the student plans, tests, evaluates and 
reflects with or without the help of others. Recent scientific literature indicates 
that contemporary or present-day young people (the so-called network 
generation) learn in a different way. Authenticity, multitasking, interactivity and 
gaming are some key concepts. Education does not have to be entirely 
different, but could be better adapted to this generation of students by new 
forms of education like serious gaming. The department of Medical Imaging 
and Radiation Therapy (MIRT) of the Hanze University of Applied Science has 
started implementing serious gaming in their educational programme in 2015. 
How and to what extent can serious gaming be used in the Dutch education 
system for radiographers as a new didactic instrument whose implementation 
may lead to improvement,or complement or replace current traditional 
approaches and methods? 
Learning Objectives: 
1. To understand the different pedagogical methods available for the education 
of radiographers. 
2. To discuss the advantages and disadvantages of expert lectures for 
education. 
3. To demonstrate how EBP can be integrated into the training curriculum. 
A-661 09:21  
Tools for success: academic and clinical practice working together  
L.A. Rainford; Dublin/IE (louise.rainford@ucd.ie)  
This presentation will address the three learning outcomes listed; the principal 
focus of the talk will be on undergraduate radiography education. An overview 
will be provided on how education and clinical training of radiography students 
vary across academic institutions, both within Europe and also internationally, 
and the implications of these variations upon the profession. The presenter will 
explore potential best practice models for collaboration between clinical 
centres and universities in the delivery of radiography training. Reflection upon 
day-to-day considerations required to run local and national training 
programmes will be included. Practical difficulties will be discussed and 
possible mechanisms for enhance into radiography training proffered. A 
discussion of how undergraduate research activity could possibly support and 
enhance academic /clinical relationships will be offered to the audience to 
stimulate further conversation. Reference will be made to initiatives currently 
employed across a number of training programmes with the permission of the 
academic institutions.  
Learning Objectives: 
1. To emphasise variation of combined education and training among different 
academic institutions. 
2. To explore collaboration between hospitals and universities for the 
  







preparation of radiographers. 
3. To discuss how undergraduate research can enhance academic/clinical 
relationships. 
09:44  
Panel discussion: What is the motivation for change?  
08:30 - 10:00 Room M 1  
Vascular  
RC 1315  
US and vascular disease: a perfect match  
A-662 08:30  
Chairperson's introduction  
T. Jargiello; Lublin/PL (tojarg@interia.pl)  
Ultrasound is widely used in the diagnosis of vascular diseases. The technique 
is unique, as it provides not only imaging of vascular structures morphology but 
also haemodynamic information (Doppler technique). Its availability, safety and 
ability to examine real-time blood flow changes makes it very useful in a wide 
range of vascular pathology investigations. Among the disadvantages, high 
dependence on operator’s personal skills and used equipment are the most 
important. Additional technical drawback, coming from limitations of ultrasound 
penetration in tissues (i.e. bones or gas) is also a negative casus. That is why 
the right placing of ultrasound in a diagnostic algorithm is so important. US 
examination usually goes first to make initial diagnosis of vascular pathology 
and to give the information of which modality should be the next. In some 
cases when US study excludes suspected vascular disorder, the diagnostic 
process may be stopped. A similar situation arises with vascular evaluation 
after treatment. US examination is a routine procedure after majority of open 
surgery or endovascular operations. Its outcome determines further diagnosis.  
Session Objectives: 
1. To review advantages and disadvantages of US. 
2. To identify the role of imaging modalities in vascular disease. 
3. To understand the role of US in post-treatment follow-up. 
A-663 08:35  
A. Abdominal aorta  
D.A. Clevert; Munich/DE (Dirk.Clevert@med.uni-muenchen.de)  
Abnormalities of the abdominal aorta and the visceral vessels may represent a 
diagnostic challenge in patients with acute or chronic clinical symptoms. In 
addition to the primary diagnosis in colour-coded duplex ultrasound, contrast-
enhanced ultrasound (CEUS) with low mechanical index (low MI) is a new 
promising method in the diagnosis and follow-up of pathological aortic lesions. 
Colour code duplex ultrasound and CEUS with SonoVue® allows a more rapid 
and noninvasive diagnosis, especially in critical patients because of its bedside 
availability. This course describes the visceral vessels and focuses on the 
aetiology and the meaning of abdominal aortic pathologies. These pathologic 
findings were compared with colour-coded duplex ultrasound, CEUS and multi-
slice computed tomography angiography (MS-CTA).  
Learning Objectives: 
1. To learn how to perform the examination and its role in diagnostic 
assessment. 
2. To learn about US findings in AAA treatment planning and post-treatment 
evaluation. 
3. To appreciate the role of CEUS and technological innovations in routine 
practice. 
Author Disclosure: 
  D.A. Clevert: Advisory Board; Siemens, Samsung, Philips, Bracco. Speaker; 
Siemens, Samsung, Philips, Bracco. 
A-664 08:58  
B. Upper and lower limb: arterial district  
B. Brkljai	; Zagreb/HR (boris@brkljacic.com)  
B-mode ultrasound enables evaluation of arterial anatomy and of the vessel 
wall, detects early atherosclerotic changes, and allows detection of stenosis 
and occlusions, but tends to overestimate the degree of stenosis and should 
not be used for stenosis grading. Colour duplex Doppler ultrasound (CDUS) 
enables fast visualization of the vessel to be examined. It demonstrates 
haemodynamic changes, including velocity increase. Underestimation of 
disease is likely if only colour is used and the precise assessment of 
haemodynamic disturbances is impossible without a spectral analysis. In 
general, CDUS has a high diagnostic accuracy, it is cheap and widely 
available, and there is no exposure to ionizing radiation and no contrast media 
injection. However, the examination is time consuming and requires high 
operator dependence. The thorough understanding of haemodynamics and 
physics is needed for adequate interpretation of Doppler findings. The factors 
influencing spectral morphology will be discussed in the lecture and the 
different types of spectra presented. Waveform changes will be presented in 
stenosis and occlusion. The typical findings of pseudoaneurysms and 
arteriovenous fistulas will be presented. Findings in acute occlusion and 
collateral flow will be discussed, both for native arteries and bypass grafts. The 
role of ultrasound in endovascular recanalizations will be discussed, both in 
planning and performing of the procedure and in the follow-up. Several clinical 
examples will be presented.  
Learning Objectives: 
1. To understand how to perform the examination and its role in diagnostic 
assessment. 
2. To understand US findings for diagnosis and follow-up. 
3. To underline tips and tricks to start your activity. 
A-665 09:21  
C. Upper and lower limb: venous district  
H. Hoppe; Berne/CH (hanno.hoppe@web.de)  
Duplex ultrasound is the initial imaging modality of choice evaluating upper and 
lower extremity veins. For upper extremity veins, most frequent indications are 
evaluation for thrombosis and vessel patency, pre- and postoperative mapping 
of arteriovenous fistula or graft, and venous access procedures. For lower 
extremity veins, duplex ultrasound is an adequate modality diagnosing venous 
valvular incompetence. Usually, this study is performed with the patient in an 
upright position and in addition manual compression manoeuvres are used to 
initiate reflux. Previously, cutoff values for reflux have been defined. Routinely, 
perforating veins are identified and the flow direction during compression is 
recorded. Duplex ultrasound is utilized to examine the extremity veins for 
venous outflow obstruction including chronic changes in deep or superficial 
veins post-venous thrombosis. However, additional imaging studies such as 
magnetic resonance imaging or computed tomography venography are 
increasingly used for reliable noninvasive identification of post-thrombotic 
changes and venous outflow obstruction and for treatment planning. In 
general, anatomic variations in superficial and deep veins are quite frequent 
and should be identified. Reporting should rely on a proper classification of 
venous disease including current anatomic description.  
Learning Objectives: 
1. To understand how to perform the examination and its role in diagnostic 
assessment. 
2. To understand US findings for diagnosis and follow-up. 
3. To underline tips and tricks to start your activity. 
09:44  
Panel discussion: When do we need additional imaging and which 
modality is best suited for the scenario?  
08:30 - 10:00 Room M 2 
E³ - ECR Master Class (Neuro)  
E³ 1326b  
Stroke: emergent large vessel occlusion 
(ELVO)  
Moderator:  
M. Pavia; Brescia/IT  
A-666 08:30  
A. Selecting ELVO patients for endovascular therapy  
T. van der Zijden; Antwerp/BE (thijsvanderzijden@hotmail.com)  
Endovascular treatment of large vessel occlusions in acute ischaemic stroke 
has proven to be effective. In an effort to achieve the best clinical outcome, 
and optimal cost-effectiveness as well, potential candidates for recanalization 
procedures should be triaged correctly. Besides a proper clinical workup, an 
adequate neuroradiological workup should be performed. On the one hand, 
selection of patients with a potential target for endovascular treatment (large 
vessel occlusion) should be done. On the other hand, exclusion of patients, 
who are not eligible for recanalization therapy, should be done as well. Imaging 
should not only be focused on exclusion of haemorrhage and/or stroke 
mimickers and on structural imaging of craniocervical arteries, but also give an 
idea about the extent of potential salvageable brain at risk versus already 
  







infarcted brain. During the last years, in addition to plain CT and CT 
angiography of the brain, CT perfusion techniques and multiphase CT 
angiography have increasingly been used. Implementing these more advanced 
imaging tools in addition to basic neuroradiological workup enables 
theoretically a better prediction of clinical outcome after a potential 
recanalization procedure in a given patient, using qualitative and quantitative 
perfusion-based cutoffs and assessment of collateral vessel status. Advanced 
imaging techniques can also be used in the setting, immediately or early after 
recanalization, in an attempt to predict potential complications and/or clinical 
outcome. 
Learning Objectives: 
1. To learn about the correct indication/patient for endovascular therapy. 
2. To understand the importance of clinical and neuroradiological work-up prior 
to the intervention. 
3. To appreciate clinical relevance in terms of outcome measures applying 
state of the endovascular treatment for the right patient. 
A-667 09:00  
B. Advanced thrombectomy techniques  
O. Jansen; Kiel/DE  
Neurothrombectomy has been shown to be the primarily choice of treatment in 
acute stroke-patients with large intracranial vessel occluison. While the great 
randomised trials were performed mostly with the use of stent-retrievers or 
aspiration devices alone more recent papers have shown better recanalisation 
results in experimental and/or clinical studies. These so called advanced 
thrombectomy techniques mostly combine retrieval and aspiration techniques 
to result in fewer recanalisation maneuvers, shorter recanalisation time and 
less fragmentation of the embolus. While the choice of the best recanalisation 
technique is important for the recanalisation result periprocedural techniques 
(anaesthesia, stenting, medication) also show an important impact on clincal 
outcome. Additonal endovascular or medical treatment is also requested in 
more rare stroke cause like underlying intracranial arterial stenosis or acute 
dissection of the extra- or intracranial arteries. Recent studies and secondary 
analysis have also shown that dedicated patient selection with advanced 
stroke imaging is less important in patients with short time window (<8hrs) but 
may extend the individual treament window up to 24hrs.  
Learning Objectives: 
1. To learn about the spectrum of new and upcoming thrombectomy 
techniques. 
2. To understand the importance of applying correct technique in individual 
patients. 
3. To appreciate the increasing role of thrombectomy in ischaemic stroke 
therapy. 
Author Disclosure: 
  O. Jansen: Consultant; Rapid Medical. Speaker; Stryker, Medtronic. 
A-668 09:30  
C. Is endovascular thrombectomy and medical therapy better than 
medical therapy alone?  
S. Bisdas; London/UK (s.bisdas@ucl.ac.uk)  
A tipping point has been reached in acute stroke management from evidence 
provided in recent clinical trials studying the efficacy of thrombectomy in 
ischaemic stroke. Almost the entire literature has studied anterior proximal 
occlusion, some studies have performed sub-analyses to clarify if the site of 
the clot can be used as outcome predictor. The evidence on the endovascular 
thrombectomy seems still heterogenous in method and underpowered for 
secondary outcomes. Interestingly, endovascular thrombectomy treatment is 
advocated in elderly patients whom will have a higher number of co-
morbidities. Notably, the majority of studies looking at the recanalisation rate in 
patients who had prior IV thrombolysis against those who had direct 
thrombectomy revealed that thrombectomy was more likely to successfully 
recanalise if IV thrombolysis had been administered first. Currently, some of 
the large 2015 trials and subsequent trials patients have often received a 
thrombolysis infusion whilst the thrombectomy is being undertaken. In patients 
with tandem occlusions, any endovascular treatment offered could be the best 
available treatment since IV thrombolysis has showed no significant benefit. 
Recent results have shown excellent long term outcomes, with no evidence of 
delayed complications or restenosis. Additionally, the quality of life score 
measured between the endovascular treatment and conventional therapy 
group showed a significant difference in favour of the treatment arm. This 
advocates the appropriate use of mechanical thrombectomy; however, the 
specific details about best clinical practise in these patients have yet to be 
answered.  
Learning Objectives: 
1. To learn about the current data and medical evidence of the available 
therapies. 
2. To understand the role of individualised therapy concepts. 
3. To appreciate the importance of interdisciplinary approach for ischaemic 
stroke therapy. 
Author Disclosure: 
  S. Bisdas: Advisory Board; Image Analysis Group, Olea Medical, GE 
Healthcare. Consultant; Diagnose me. Founder; Society of Advanced 
NeuroImaging. Grant Recipient; NIHR BRC UK. Research/Grant Support; Olea 
Medical. 
08:30 - 10:00 Room M 3 
Special Focus Session  
SF 13c  
Drug elution or drug illusion in vascular 
disease  
A-669 08:30  
Chairperson's introduction  
R.W. Günther; Berlin/DE  
Advances of coronary artery recanalization have essentially influenced the 
treatment of peripheral artery disease (PAD). Following coronary PTA (1977) 
and bare metal stents (1988), the concept of local drug delivery was realized 
using drug-eluting stents (DES) in 2001 and drug-coated balloons (DCB) in 
2006. The drugs used for local delivery were the cytotoxic paclitaxel and the 
immunosuppressive agent sirolimus and its derivatives, which prevent or inhibit 
vascular restenosis due to suppression of cell proliferation. The 
pharmacokinetics after different drug applications varies and the mechanism of 
cellular inhibition differs. In the treatment of PAD, we saw the stepwise 
development from exclusive mechanical techniques to additional local drug 
delivery using DCB, DES or bare metal stents combined with DCB before or 
after stent placement. Also, debulking procedures like percutaneous 
atherectomy plus DEB have been described. Apart from peripheral artery 
disease, the problem of restenosis can be approached by DEB also in other 
areas such as renal arteries, haemodialysis fistulas and transjugular 
intrahepatic porto-systemic shunts (TIPS). The basic aspects of drug release, 
biological reaction, clinical evidence and practical consequences in different 
vascular areas will be presented in this session, which is dedicated to a critical 
appraisal by showing the clinical evidence of current data as well as the pros 
and cons.  
Session Objectives: 
1. To learn more about drug elution and biological reaction. 
2. To show the pros and cons of drug elution devices in coronaries, 
infrainguinal arteries and haemodialysis fistulas. 
3. To critically analyse the published data and summarise the current evidence 
and indications regarding treatment. 
A-670 08:35  
Drug-eluting balloons and stents, technology and biological interaction: 
lessons learned from the coronaries  
F. Kleber; Berlin/DE (post@fxkleber.de)  
Dilatation of arterial vessels leads to an increase in luminal and overall vessel 
dimensions, only partly counteracted by elastic recoil and dissection. 
Unfortunately, this effect is often short-lived since healing leads to vessel 
shrinkage. Stents, especially drug-eluting stents, can overcome recoil and 
shrinkage, but induce intimal hyperplasia, which in turn leads to late luminal 
loss. Also, late stent malapposition has been found in a sizeable number of 
treated segments promoting vessel thrombosis. Foreign body reaction and a 
persisting small thrombosis rate lead to a 5-year target lesion failure (TLF) rate 
of 13 to 26% . Stents with thinner struts seem to have better long-term results. 
To avoid such high TLF rates, drug-coated balloons (DCBs) were developed 
and clinically used to treat in-stent restenosis as well as de novo lesions. It 
could be shown experimentally and clinically that the most often used drug 
paclitaxel can induce late luminal gain, which after stenting is a untoward side 
effect, but without stenting helps to achieve good long-term results. Therefore 
even in small coronary arteries treated with DCBs, the target lesions 
revascularisation rate is very low (2.5%) and thrombosis is almost absent on 
dual antiplatetet therapy. However, excipients for drug-eluting ballons are 
different and have different efficacy. New drugs are in a late developmental 
stage and compete with paclitaxel. Future trials will shed light on which 
excipients and which drugs show the best results. However, even now, in 
many situations, DCBs are equal or even superior to stents in not jeopardizing 
the further course by foreign body reaction to the implants and thrombosis.  
Learning Objectives: 
1. To learn about the individual components of drug-coated balloon catheters 
and their importance. 
  







2. To summarise key messages from non-clinical studies with coronary 
balloons and stents. 
3. To gain an overview of the key lessons from randomised clinical trials in 
coronary. 
Author Disclosure: 
  F. Kleber: Advisory Board; Corvia Massachusetts. Consultant; BBraun 
Germany, Ancora Heart California, Corvia Massachusetts. 
A-671 08:50  
Drug-eluting balloons and stents in femoropopliteal and crural lesions: 
pro  
F. Fanelli; Rome/IT (fabrizio.fanelli@uniroma1.it)  
Drug-eluting stents-DES and drug-eluting balloons-DEB represent “two sides 
of the same coin” for the ability to deliver locally anti-proliferative drugs. The 
main goal of drug is to inhibit the neo-intimal reaction. DES and DCB have 
been evaluated in different studies, both showing a significant increase in 
primary patency (PP) rate when compared to standard devices. Three 
randomised trials, using different DCBs, were performed to compare DCB vs. 
angioplasty (PTA) in de-novo femoro-popliteal lesions. PP at 1-year ranged 
between 73.5% and 89.0%; the 4-year data of In.Pact SFA trial showed a PP 
of 69.5% (DCB) vs. 45.1% (PTA) p<0.001, and freedom from clinically-driven 
target lesion revascularisation (CD-TLR) of 76.8% (DCB) vs. 70.4% (PTA) 
p=0.039. Many other studies have been performed in different setting such as 
diabetic patients, in-stent restenosis, long lesions, chronic total occlusions and 
all of them showed always a better outcome using DCB. The efficacy of DES, 
in the femoro-popliteal region, was confirmed by the Zilver-PTX trial were PP 
after 5-year is 64.9% compared to a low 19% for PTA. This study showed also 
a superior PP when provisional DES was compared to provisional bre metal 
stent (BMS): 72.4% vs 53.0% respectively. These superior results have been 
also supported from several other studies. In the infrapopliteal region DCB has 
not yet demonstrated their superiority in comparison to the standard PTA, but 
several randomised controlled trials (RCT) are ongoing. DES sowed their 
efficacy in several studies with a PP at 1 year comprised between 75% and 
86%. 
Learning Objectives: 
1. To learn about the difference between the various drug-eluting platforms and 
medication. 
2. To understand the difference between technical success, patency and 
clinical outcome in patients treated with endovascular technologies. 
3. To understand the advantages of drug-eluting balloons and stents in 
femoropopliteal and crural lesions. 
4. To learn which patients and which lesions derive the most benefit from their 
use. 
Author Disclosure: 
  F. Fanelli: Speaker; Medtronic, Cook, WL Gore & Associates, Spectranetics. 
A-672 09:10  
Drug-eluting balloons and stents in femoropopliteal and crural lesions: 
contra  
J.A. Reekers; Amsterdam/NL (j.a.reekers@amc.uva.nl)  
Restenosis after balloon angioplasty or stenting has been a major drawback of 
angioplasty. Depending on the vessel area and length of the lesion, restenosis 
due to intimal hyperplasia is 20%-60% in the first 12 months. Inhibition of 
intimal proliferation with local drug administration, either with a drug-eluting 
stent or a drug-releasing balloon, looks like a promising solution to this 
problem. Paclitaxel and sirolimus have both been shown to be able to inhibit 
local intimal proliferation and thereby to prevent or reduce local intimal 
hyperplasia after angioplasty. Drug elution therefore seems, and is also 
marketed accordingly, the way forward. Unfortunately, there has been no study 
to show the clinical benefit of local drug elution. Prevention of intimal 
hyperplasia is a pseudo end point. The real end points are: improvement of 
walking distance in a patient with intermittent claudication or prevention of 
amputation in a patient with critical limb ischaemia. Until this has been proven 
in a prospective randomised trial, drug elution is still an illusion. 
Learning Objectives: 
1. To understand the limitations of drug-eluting balloons and stents in 
femoropopliteal and crural lesions. 
2. To be familiar with potential complications from their use. 
3. To become familiar with a critical review of the current literature and to 
understand how marketing of new endovascular technologies works. 
 
 
A-673 09:30  
Effect of drug-eluting balloons and stents in haemodialysis access 
lesions: where is the evidence?  
K. Katsanos; Patras/GR (katsanos@med.upatras.gr)  
Creation of hemodialysis access in the form of either an autologous 
arteriovenous fistula or prosthetic arteriovenous graft is one of the commonest 
vascular procedures and serves as the "lifeline" for dialysis patients. 
Percutaneous techniques are widely practised for salvage of failing native or 
synthetic arteriovenous shunts. Nonetheless, balloon angioplasty is frequently 
associated with recurrent, aggressive, vessel restenosis and early failure. The 
pathobiology of arteriovenous stenoses is completely different from arterial 
atherosclerosis, and is typically characterised by aggressive venous neointimal 
hyperplasia associated with adventitial myofibroblast proliferation and striking 
fibrosis on the background of repeated endothelial injury, altered hemodynamic 
shear stress, systemic uremia and oxidative stress. Cutting or high pressure 
balloons, covered stents or stent-grafts, and paclitaxel-coated balloons have 
been extensively tested and investigated with the aim to improve immediate 
anatomical and long-term clinical results. There is high quality of randomised 
evidence that placement of covered stents for the treatment of draining vein 
stenosis may prolong the patency of failing synthetic arteriovenous grafts. 
There is also evidence from mostly proof-of-concept pilot studies that 
paclitaxel-coated balloons may inhibit restenosis and improve mid-term 
patency of failing arteriovenous fistulas and grafts when applied in combination 
with adequate mechanical dilatation of the underlying stenosis. The results of 
different clinical studies for each device category will be reviewed and a good 
practice algorithm for percutaneous salvage of failing arteriovenous shunts will 
be proposed based on anatomical and procedural parameters.  
Learning Objectives: 
1. To understand the pathophysiology of restenosis and mode of failure of 
haemodialysis circuits. 
2. To analyse amassed clinical evidence about drug-coated balloons and 
stents in haemodialysis fistulas. 
3. To learn about the limitations of current drug-coated balloon technologies. 
Author Disclosure: 
  K. Katsanos: Consultant; MEDTRONIC. Speaker; BOSTON SCIENTIFIC. 
09:45  
Panel discussion: Scientific evidence and consequences for daily 
practice  
08:30 - 10:00 Room M 4 
E³ - ECR Academies: Tips and Tricks in Pancreatic and GI Tract 
Imaging  
E³ 1322  
New challenges of pancreatitis  
A-674 08:30  
Chairperson's introduction  
G. Zamboni; Verona/IT (gzamboni@hotmail.com)  
The 2012 Revised Atlanta Classification categorizes acute pancreatitis as 
interstitial oedematous or necrotizing, introducing a uniform terminology for 
describing its imaging features and fluid collections. Collections are defined 
based on their timing (early phase <4 weeks from onset; late phase 4 weeks). 
Interstitial pancreatitis may present with acute pancreatic fluid collections in the 
early phase, which can later either resolve or evolve into pseudocysts. 
Necrotizing pancreatitis presents with necrosis (pancreatic, peripancreatic, or 
combined pancreatic and peripancreatic); the acute necrotic collections may 
later evolve into walled-off necrosis. Autoimmune pancreatitis (AIP) is 
increasingly recognized, accounting for 6% of cases of chronic pancreatitis. 
Type 1 AIP, more common, is a systemic IgG4-associated disease with 
elevated IgG4-positive cells in the serum, pancreas, and other organ. Type 2 
AIP involves primarily the pancreas, without IgG4-positive cells. On MR, the 
affected pancreas appears enlarged, either focally or diffusely, hypointense on 
T1 and hyperintense on T2, with a hypointense capsule-like rim. MPD shows 
diffuse or focal stenosis. The parenchyma has reduced and delayed 
enhancement. Pancreatic cystic lesions include neoplastic and non-neoplastic 
cysts. A combination of imaging findings and demographic, clinical and 
laboratory data is necessary for a correct diagnosis. MR has higher diagnostic 
accuracy than CT in lesion identification, characterization and differentiation 
between benign and malignant lesions. Findings useful for characterization 
include lesion site, cystic pattern, presence of septa, wall thickness, 
calcifications and their morphology, mural nodules, communication with the 
ductal system and dilation of the MPD. Several international guidelines 
address their diagnosis and management.  
  







A-675 08:35  
A. Understanding the Atlanta 2012 classification of acute pancreatitis  
W. Schima; Vienna/AT (wolfgang.schima@khgh.at)  
According to the Revised Atlanta Classification of 2012, acute pancreatitis is 
categorized as interstitial oedematous or necrotizing pancreatitis. In interstitial 
oedematous pancreatitis, approximately 50% of patients develop acute 
peripancreatic fluid collections early (< 4 weeks from onset). In the late phase 
( 4 weeks), these either resolve or evolve into pseudocysts, which are 
hypodense on CT and hyperintense on T2w MRI. Treatment of pseudocysts is 
only indicated in symptomatic patients or if complications (gastric outlet 
obstruction, cholestasis or haemorrhage) develop. Necrotizing pancreatitis may 
present either with combined pancreatic and peripancreatic (most common) or 
with pancreatic necrosis or with peripancreatic necrosis alone. Acute necrotic 
collections may evolve into walled-off necrosis (WON) in the late stage. A 
WON containing digested fat and parenchyma must not be confused with a 
pseudocyst. They are similar on CT, but US/MRI reveals the predominantly 
solid nature of WON. Secondary infection of necrotizing pancreatitis results in 
high mortality. Imaging diagnosis of infection is difficult. Gas within a collection 
is specific, but not sensitive. If feasible, CT-guided abscess drainage is 
recommended. Necrotic collections with debris require a more aggressive 
approach. In general, MDCT for diagnosis of pancreatitis should be performed 
no less than 2-3 days from clinical onset, because development of necrosis 
may take some time. In case of suspected biliary pancreatitis, early MRCP 
guides further treatment (endoscopic stone removal). The Revised Atlanta 
Classification system introduced a uniform terminology for imaging features of 
pancreatitis. Contrast-enhanced CT is the primary tool of diagnostic imaging 
and image-guided therapy. MRCP characterizes fluid collections and 
delineates ductal abnormalities.  
Learning Objectives: 
1. To be aware of the new terminology for the evaluation of acute pancreatitis. 
2. To learn about how to report imaging findings. 
3. To understand the relationship between imaging findings and prognosis. 
A-676 09:03  
B. Autoimmune pancreatitis and its relatives  
G. Morana; Treviso/IT  
"no abstract submitted" 
Learning Objectives: 
1. To understand the various forms of autoimmune pancreatitis, especially 
cases that are associated with extra pancreatic disease. 
2. To learn about the usual and unusual appearance of autoimmune 
pancreatitis. 
3. To understand the principles of the follow-up. 
A-677 09:31  
C. Tough clinical cases of cystic pancreatic lesions  
M.A. Bali; Sutton/UK (mantoniettabali@icr.ac.uk)  
Pancreatic cystic lesions (PCL) include epithelial and non-epithelial neoplasm 
and non-neoplastic cysts and are classified as benign, potentially malignant 
and malignant, according to WHO. Imaging has a key role in detection and 
characterization; however, the final diagnosis is provided by the integration of 
imaging findings with demographic, clinical and laboratory data, including 
cystic fluid analysis obtained by EUS. MR has higher diagnostic accuracy than 
CT for detection and characterization. At imaging, several findings, such as the 
localization, the cystic pattern (unilocular, multilocular), the presence of septa, 
wall thickness, calcifications (central or peripheral, thin or thick), mural nodules, 
communication with the pancreatic ducts and the concomitant dilatation of the 
main pancreatic duct (MPD) may allow the differential diagnosis between PCLs 
and may also be suggestive of malignancy. However, lesions smaller than 3 
cm may lack specific morphological features. Neoplastic cysts such as serous 
cystadenoma (most common with benign behaviour) followed by mucinous 
cystic and intraductal papillary mucinous neoplasms (potentially malignant or 
malignant neoplasm) must be differentiated from non-neoplastic cysts such as 
pancreatitis-associated pseudocysts (most common) to provide the most 
adequate treatment and to avoid unnecessary surgery. For the mucinous 
neoplasm, imaging findings highly suggestive of malignancy are: for brunch-
duct IPMN, mural nodules and dilatation of the MPD; for main duct-IPMN, MPD 
larger than 1cm, mural nodules and symptoms; for mucinous cystic neoplasm, 
large lesion (>4cm), mural nodules, mass-forming lesions and peripheral 
calcifications. Guidelines (Fukuoka Guidelines 2012, European Guidelines 
2013 and American Gastroenterology Association Guidelines 2015) are 





1. To understand how to report a cystic pancreatic lesion, including 
recommendation for imaging strategy. 
2. To become familiar with the most common cystic neoplasms of the 
pancreas. 
3. To learn how to differentiate neoplasms and inflammatory cystic lesions of 
the pancreas. 
08:30 - 10:00 Room M 5 
Transatlantic Course of ESR and RSNA (Radiological Society of 
North America): Sports Imaging  
TC 1328  
Upper extremity sports injuries  
Moderators:  
L.W. Bancroft; Orlando, FL/US  
A.J. Grainger; Leeds/UK  
A-678 08:30  
A. Shoulder injuries in the throwing athlete  
L. Steinbach; San Francisco, CA/US (lynne.steinbach@ucsf.edu)  
Overhead throwing athletes develop significant abnormalities as a result of 
acquired adaptations to the extremes of motion in the dominant shoulder. 
These abnormalities may eventually result in an inability to throw with the same 
velocity, the so-called “dead arm” syndrome. These abnormalities involve 
tendons, ligaments, labrum, muscles, nerves, vessels, and bones. This 
presentation will review the biomechanics of throwing forces as they relate to 
the shoulder. The MR imaging characteristics of the resultant abnormalities in 
the labroligamentous structures and the rotator cuff will also be highlighted. 
This will be followed by a brief discussion of pathologic and normal 
developmental changes in the shoulders of skeletally immature throwing 
athletes.As a prototype, the throwing motion in baseball occurs over a period of 
approximately 2 seconds and is divided into six stages: wind up, cocking, early 
and late acceleration, deceleration, and follow through. The late cocking, 
acceleration, and deceleration phases produce the greatest stress on the 
glenohumeral joint structures. As with other throwing sports, the superior 
labrum and rotator cuff are often affected by these extreme forces.  
Learning Objectives: 
1. To understand the biomechanics of throwing forces as they relate to the 
shoulder. 
2. To become familiar with rotator cuff and labroligamentous injury patterns 
caused by overhead sports. 
3. To appreciate pathologic and normal developmental changes in skeletally 
immature throwing athletes. 
A-679 09:00  
B. Soft tissue wrist injury in the athlete  
C.W.A. Pfirrmann; Zurich/CH  
Wrist injuries account for 5 % of sports injuries. In the young athlete, fractures 
are the most common injuries. The hand and wrist are the most common sites 
for fracture in the young athlete. Physeal injuries are typical overuse injuries in 
gymnasts. Chronic stress reactions with widening of the growth plate are seen 
in the distal radial and less common in the ulnar growth plate. Injuries to the 
TFCC in the athlete occur in acute trauma and with overuse. TFCC injuries are 
an important cause for ulnar-sided wrist pain. The differential diagnosis 
includes ulnar sytloid impaction syndrome, ulnar impingement syndrome and 
tenosynovitis of the extensor carpi ulnaris tendon. Injury to the interosseous 
ligaments may lead to carpal instability. Chronic injury of the intrinsic or 
extrinsic ligaments of the wrist may cause ganglion cyst formation.  
Learning Objectives: 
1. To learn about the patterns of injury seen at the wrist in athletes. 
2. To understand the advantages and disadvantages of different modalities for 
imaging the athlete's wrist. 













A-680/A-681 09:30  
C. Interactive case discussion  






This session will show cases related to upper extremity sports injuries of the 
shoulder.  
Learning Objectives: 
1. To appreciate common patterns of athletic injury in the shoulder and wrist. 
2. To become familiar with the techniques available and imaging appearances 
of shoulder and wrist athletic injury. 
3. To consolidate the knowledge gained from the session with interactive cases 
of upper limb athletic injury. 
10:30 - 12:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1421  
Brain tumours  
A-682 10:30  
A. Paediatric brain tumours  
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr)  
Primary brain tumours in childhood are the second most common malignancy 
after leukaemia. The presenting symptoms depend on age with macrocephaly 
and failure to thrive in infants, and headache, morning vomiting, diplopia, 
ataxia motor and sensory deficits, seizures and endocrinological symptoms in 
older children. Brain tumours may be of glial origin (astrocytomas 
ependymomas), neuronal or neuroglial (gangliogliomas, gangliocytomas, 
DNET), embryonal (PNET, ATRT) and from germ cells (germinomas, 
teratomas). Tumours arising in the sellar and parasellar region 
(craniopharyngiomas, hypothalamic hamartomas and pituitary adenomas) may 
also occur. Neurinomas and meningiomas are rare in children arising mainly in 
the context of neurofibromatosis type II. Secondary brain tumours arise mainly 
from CSF seeding, while haematogenous metastases are rare. MRI is the 
modality of choice for the diagnostic workup of brain tumours. Imaging 
protocols may include T2W, T1W plain and contrast-enhanced images, 
diffusion tensor imaging, dynamic susceptibility-weighted contrast-enhanced 
perfusion imaging (DSC), functional MRI (fMRI) and MR spectroscopy (MRS). 
Brain tumours may be heterogeneous with cystic and solid components. The 
latter appears with low signal on T1W and high signal on T2W images. A low 
signal intensity on T2W images, associated with restricted diffusion and 
increased perfusion indexes on DSC, may be suggestive of a more aggressive 
tumour. Increased choline and lactate and decreased N-acetyl aspartate in 
MRS are also suggestive of malignant tumours. Tractography and f-MRI are 
useful for preoperative evaluation to assess major white matter tracts and 
eloquent areas of the brain related with the tumour.  
Learning Objectives: 
1. To become familiar with different paediatric brain tumours. 
2. To learn the imaging criteria for differentiation. 
A-683 11:15  
B. Adult brain tumours  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se)  
Glioblastomas are the most common malignant neoplasms and together with 
metastatic tumours comprise half of all malignant tumours in the adult 
population. The latest WHO classification is from 2016 and several changes 
have occurred with respect to the classification of brain tumours. The grading 
of tumours presumes biological behaviour or phenotype of a lesion and is of 
high importance clinically by guiding therapy selection: adjuvant radiation, 
chemotherapy, or surgical or palliative treatment of brain tumours. MRI is 
considered the standard modality for the diagnosis and prognosis of brain 
tumours, based primarily on gadolinium (Gd) enhancement. However, this 
concept has become more and more challenging due to the fact that not all 
high-grade gliomas demonstrate Gd enhancement, while low-grade tumours 
might enhance in up to 30% of the cases. This lecture will review the more 
common primary and secondary brain tumours in adults and their imaging 
characteristics on CT and MRI. The use of advanced imaging for diagnosis and 
treatment follow-up will be discussed.  
Learning Objectives: 
1. To become familiar with the different types of brain tumours. 
2. To learn the imaging criteria for differentiation. 
Author Disclosure: 
  P.C. Maly Sundgren: Investigator; I conduct research on advanced MR 
appilcations on brain tumors and brain metastasis. Research/Grant Support; I 
have grants from Swedish Research Council, Swefish Cancer Foundation adn 
reginal Research Funds for Advanced MR imaging techniques in brain tumors 
and ttreatment effects. Speaker; i speak at international meeting on advanced 
imaging brain tumor treatment effects. 
10:30 - 12:00 Room B 
ESR meets Portugal  
EM 2  
Discovering Portuguese radiology: past, 
present, future  
Presiding:  
F. Caseiro Alves; Coimbra/PT  
B. Hamm; Berlin/DE  
A-684 10:30  
Introduction: SPRMN President address  
F. Caseiro Alves; Coimbra/PT (caseiroalves@gmail.com)  
A brief presentation of the past and present history of Portuguese Radiology 
will be made on behalf of SPRMN. Relevant contributions to angiography will 
be highlighted as well as a brief overview of the Portuguese Society and its 
main activities. The future will be presented by the three chosen young 
lecturers on topics of their research domain.  
Session Objectives: 
1. To revisit the major Portuguese contribution for radiological sciences. 
2. To provide a selection of present and future clinical research on imaging. 
3. To explain and display the musical heritage through the Portuguese guitar. 
A-685 10:35  
Imaging biomarkers for diffuse liver disease  
M.M. França; Porto/PT (mariamanuela.franca@gmail.com)  
Fat, iron deposits and fibrosis can be found in different diffuse liver diseases. 
Because liver biopsy has several limitations, MR imaging biomarkers have 
been developed for fat and iron quantification, and to stage liver fibrosis. 
Quantification of proton density fat fraction (PDFF) can be accurately 
performed with multi-echo chemical shift-encoded (MECSE) gradient echo MR 
sequences, corrected for T1 relaxation, T2* decay effect, noise and fat spectral 
complexity. Quantification of liver iron content is needed to detect and stage 
iron overload, and also to monitor iron-reducing treatments. Iron MR 
quantification may be performed with R2/R2* relaxometry techniques. 
Simultaneously, quantification of hepatic fat (PDFF) and iron (R2*) can be 
achieved with MECSE sequences, which are advantageous in diffuse liver 
diseases, as fat and iron frequently coexist in the liver parenchyma. MR 
elastography can detect and stage significant or advanced fibrosis and 
cirrhosis, with high accuracy, in different diffuse liver diseases. All of these MR 
imaging biomarkers are increasingly being used for the non-invasive 
assessment of hepatic steatosis, siderosis and fibrosis for evaluating and 
monitoring diffuse liver diseases.  
Learning Objectives: 
1. To understand the need for non-invasive imaging biomarkers to accurately 
detect and quantify hepatic steatosis, iron overload and fibrosis, in different 
diffuse liver diseases. 
2. To review the different MR imaging techniques to evaluate and to quantify 
imaging biomarkers of liver steatosis, iron overload and fibrosis. 
3. To discuss the role and clinical relevance of MR imaging biomarkers for the 
evaluation of diffuse liver diseases, in different clinical scenarios. 
A-686 10:55  
Prostate artery embolisation (PAE) for benign prostate obstruction 
(BPO): the paradigm shift  
T. Bilhim; Lisbon/PT (tiagobilhim@hotmail.com)  
Prostate artery embolisation (PAE) has been proven to be safe and effective to 
relieve lower urinary tract symptoms (LUTS) related to benign prostate 
obstruction (BPO). Knowledge of the anatomy of the prostate arteries (PAs) is 
cornerstone to PAE. Pre-procedural CT-angiography (CTA) and intra-
procedural cone-beam CT (CBCT) have been proven to be reliable tools to 
study the PAs. Identification of the PAs is generally performed under 
fluoroscopy. Developing alternatives are the use of fusion imaging with the pre-
procedural CTA images, overlay with the intra-procedural CBCT images and 
  







the use of vessel-tracking software that automatically identifies the PAs. Up to 
25% of patients may have clinical failure after PAE. Most of these patients are 
nonresponders, with a minority being relapsers. Thus, it is very important to 
define the predictors of clinical outcome to help exclude those patients less 
likely to respond to PAE. Predictors of better clinical outcome that have been 
identified include: younger age; lower baseline LUTS severity; patients under 
acute urinary retention; and adenomatous-dominant BPO. Bilateral PAE has 
been proven to be better than unilateral PAE. MR-detected ischaemia after 
PAE, PSA values 24 hours after PAE, prostate volume reduction and clinical 
outcome have been shown to be correlated. Prognostic quantification with 
perfusion imaging of the prostate, developing catheters and embolic 
agents/sizes are some of the future directions in the investigative field of PAE 
on the path to inclusion in the guidelines for the management of patients with 
symptomatic BPO.  
Learning Objectives: 
1. To learn about the anatomy of male pelvic arteries relevant for selective 
embolisation of the prostate. 
2. To understand what imaging modalities can be used for guidance inside the 
pelvis to find the prostate arteries. 
3. To become familiar with clinical outcome and predictors of treatment 
response after prostate artery embolisation. 
Author Disclosure: 
  T. Bilhim: Advisory Board; Merit Medical. 
A-687 11:15  
Cardiac CT from anatomy to functional information: comprehensive CAD 
evaluation  
H. Marques; Lisbon/PT (h919741379@gmail.com)  
Coronary CTA has been a fast growing imaging technique to assess the 
coronary arteries non-invasively. Recently, some guidelines consider it to be 
the first-line test in patients with non-acute chest pain of possible cardiac 
origin, regardless of the pre-test probability of CAD. Intense research preceded 
and accompanied its evolution, from a rule-out test to an all-in-one coronary 
disease assessment with prognostic validation. We will follow this route and 
the scientific evidence behind it: from stenosis to plaque presence, segment 
involvement and plaque characteristics; transluminal gradient,"first-pass" 
perfusion CT and dual-energy "perfusion" CT; virtual fraction flow reserve 
(FFR);- evaluation of myocardial viability with CT. Finally, we will focus on 
artificial intelligence and machine learning techniques applied in this context 
and how they will be disruptive. 
Learning Objectives: 
1. To learn and understand the different anatomic information regarding CAD 
derived from coronary CTA and its prognostic relevance. 
2. To review different cardiac CT techniques to access functional relevance 
from anatomic stenosis and its clinical evidence. 
3. To integrate cardiac CT derived data for a comprehensive CAD evaluation. 
Author Disclosure: 
  H. Marques: Employee; Cleerly Inc. 
A-688 11:35  
The soul of Portugal: Facts and sounds of the Portuguese guitar 
F. Caseiro Alves, B. Costa, R. Silva, N. Botelho; Coimbra/PT 
(caseiroalves@gmail.com)  
A historical perspective of the Portuguese guitar will be presented focusing on 
its construction and structure. Emphasis will be put on the differences between 
the Lisbon Guitar and the Coimbra Guitar concerning sound and purposes. 
The explanation will be accompanied by a live performance where players will 
try to show the audience the major sound differences. The session will end 
with a live performance of an instrumental theme for each of the two types of 








10:30 - 12:00 Room O  
RTF - Radiology Trainees Forum 
TF 1  
Highlighted Lectures  
Moderators:  
Z. Snoj; Ljubljana/SI  
T.G. Teneva; Varna/BG  
A-689 10:30  
Routine cartilage evaluation and novel approaches  
V. Salapura; Ljubljana/SI (salapura@siol.net)  
The mechanical properties of cartilage provide repetitive frictionless 
movements across joint surfaces. Cartilage is constituted of chondrocytes and 
extracellular matrix (ECM) mainly composed of water (65-80%), collagen (15-
20%) and negatively charged proteoglycans (PG) (3-10%). The cartilage's four 
layers (superficial, transitional, deep and calcified) differ in the shape and 
orientation of the chondrocytes and the distribution of collagen. The 
biochemical changes of the damaged cartilage include the reduction of 
proteoglycans concentration, the elevation of water content, and degradation of 
matrix macromolecules. Magnetic resonance (MR) imaging is considered to be 
the best noninvasive method for evaluation of cartilage morphology and its 
biochemical changes. Routinely used techniques for morphological evaluation 
are two-dimensional turbo-spin-echo sequences with fat suppression 
(PDW,T2W), and traditional (FLASH, DESS) or novel (SSFP) 3D gradient-echo 
sequences. 3D TSE sequences have been recently developed for 3T scanners 
(SPACE) with capability of contrast properties similar to 2D TSE, allowing 
better tissue contrast. New MR imaging techniques for detection of ECM have 
been developed. The delayed gadolinium-enhanced MR imaging of cartilage 
(dGEMRIC) and Na23 MR imaging use similar principles with Na+ ions 
attraction to the negative glycosaminoglycans chains. The T1 time constant 
displays a relationship between motion-restricted water molecules and the 
macromolecular environment and is most sensitive to the changes of PG 
content. T2 mapping reflects proton movements in the tissue and is affected by 
the density of collagen fibres and free water content. In healthy articular 
cartilage, an increase in T2 values from deep to superficial cartilage layers can 
be observed and therefore zonal evaluation is important in T2 analysis.  
Learning Objectives: 
1. To learn about normal cartilage morphology and structure. 
2. To understand the principles of cartilage imaging. 
3. To learn about standard imaging techniques of cartilage. 
4. To investigate novel approaches to cartilage imaging. 
A-690 11:00  
Non-occlusive mesenteric ischaemia: CT diagnosis and signs of 
reperfusion  
M. Mazzei; Siena/IT (mmazzei@sirm.org)  
Non-occlusive mesenteric ischaemia (NOMI) is an abdominal emergency that 
accounts for 20-30% of all intestinal ischaemic events and is the most lethal 
form of acute mesenteric ischaemia (AMI) (58-70%) because of the delayed 
diagnosis related to the non-specific symptoms and signs at imaging. Among 
various mesenteric ischaemia presentations, the early phase of NOMI is not 
easy to diagnose via CT, because it can reveal a different appearance at 
imaging dependent on the time in which the CT examination is performed and 
on the presence of reperfusion, meaning the re-establishment of normal 
mesenteric blood supply after an ischaemic event is more frequent than in an 
occlusive ischaemic condition. However, the event of reperfusion could be 
further worsened if the initial damage was caused by ischaemia, when it occurs 
in an advanced condition of ischaemia. This entity is known as 
ischaemia/reperfusion injury and in many cases can progress into shock, 
multiple organ failure and death. Drawing a distinction between NOMI with or 
without reperfusion, is necessary to ensure correct treatment (medical or 
surgical). The analysis of not only vessel features, but also of mesenteric, 
bowel and peritoneal CT findings propose a potentially useful method to 
distinguish NOMI with reperfusion (absent or present) and, in addition, any 
possible prognostic value. Therefore, the introduction of CT in the decision tree 
of NOMI treatment may bring the benefit of a prompt diagnosis and 
subsequent early and efficient initiation of therapy in the emergency setting, 
which may improve the mortality rate.  
Learning Objectives: 
1. To investigate imaging/pathological and experimental model correlation in 
NOMI with and without reperfusion. 
2. To gain awareness about the CT findings of NOMI with and without a 
reperfusion event. 
  







3. To learn where to look for reperfusion signs. 
4. To understand the potential clinical impact of imaging in treatment planning. 
A-691 11:30  
Imaging of paediatric gastrointestinal emergencies  
D. Baleva; Mistelbach/AT (dilianabaleva@yahoo.com)  
In the newborn and infant age groups, the gastrointestinal pathology manifests 
often as an emergency condition, which requires a prompt and correct 
diagnosis to be made. In choosing the most appropriate imaging modality, the 
higher radiation sensitivity of the paediatric patients, the inability of voluntary 
follow-of commands and the sparse abdominal fat tissue must be taken into 
consideration. Thus, ultrasound and conventional x-ray modalities are the main 
imaging tools to solve paediatric gastrointestinal emergencies. The imaging 
findings of the most common gastrointestinal emergency entities in the young 
paediatric patient are presented: necrotising enterocolitis, congenital 
diaphragmatic hernia, malrotation and volvulus, proximal and distal congenital 
GI obstructions, intussusception, and hypertrophic pyloric stenosis. Special 
attention has been paid to the specific clinical hallmarks and age predilection of 
each entity.  
Learning Objectives: 
1. To discuss the relevant imaging approach and modalities in the setting of 
acute gastrointestinal pathology. 
2. To review the imaging findings in the most common and important 
emergencies of the paediatric GIT. 
3. To specially emphasise upon the typical clinical setting of the different 
entities. 
10:30 - 12:00 Room L 8  
ESR Patient Advisory Group (ESR-PAG)  
PA 1  
Patient-doctor relationship and 
interdisciplinary communication in the 
radiology department  
A-692/A-693 10:30  
Chairpersons' introduction  
N. Bedlington1, M.H. Fuchsjäger2; 1Vienna/AT, 2Graz/AT 
(michael.fuchsjaeger@medunigraz.at)  
This session will offer insights not only into the patient-radiographer-radiologist 
relationship in general, but specifically into communication between patients 
and health-care professionals (radiographers and radiologists) in the radiology 
department. The impact of good as well as bad communication on patient 
journey and well-being will be reported. Effective communication strategies 
required to avoid miscommunication and misunderstandings will be discussed. 
The radiology report which is another centre piece of communication between 
the patient and radiologist should express and generate confidence, be 
consistent and avoid confusion. Specific focus will be laid on information 
overload, which might be equally detrimental to a safe feeling as no information 
at all, as well as on timely information, which is so critical in radiology. 
Session Objectives: 
1. To understand the patient-doctor relationship and influencing factors, as well 
as how to improve the relationship. 
2. To learn basic principles of communication between the patient and the 
radiologist or radiographer, as well as the impacts of good and bad 
communication. 
A-694 10:40  
A radiologist's point of view  
D.-G. Carrié; Toulouse/FR (dominiquecarrie@wanadoo.fr)  
Only in the practice of a few of our specialities (ultrasound, interventional...) 
does the radiologist enter de facto into a direct relationship expressly with the 
patient. In other domains (CT, MR), patients are informed (or not) about their 
imaging by the doctor who prescribed, our secretaries, information searched 
on the internet, informed consent forms, or even technicians-nurses during 
their stay in the imaging unit. In each European country, the situations are of 
course very disparate, but in most cases the patient cannot see the radiologist 
if the latter decides that it is necessary to consult with the patient (to request 
some elements necessary to an interpretation, or to announce a diagnosis that 
seems necessary, or if he has the time). Our patients endure this existing 
situation. Practical solutions can and must be proposed to facilitate and 
improve patient-radiologist communication (for example, systematically offer 
each patient as much access as possible to the radiologist who will take care 
of his case, physically organise the imaging department: consultation room 
located between interpretation offices and waiting rooms, better understand 
patient expectations by implementing satisfaction questionnaires). Our 
businesses, increasingly technical and standardised, should not distance us 
from the very foundation of medicine: helping our patients better understand 
their disease to better accept treatments that modern medicine is likely to offer 
them. Radiologists are part of this chain of communication, and it is in their 
interest to not remain indifferent and to retain their visibility to their patients. 
Learning Objectives: 
1. To understand the patient-doctor relationship from a radiologist’s view. 
2. To learn about effective communication and how to avoid miscommunication 
and misunderstanding. 
3. To understand the impact of good communication strategies for the patient's 
journey.  
A-695 10:55  
A radiographer's point of view  
B.T. Andersson; Lund/SE (Bodil-T.Andersson@med.lu.se)  
Communication is a vital part of the encounter between the radiologist and the 
patient. Patients require physical and psychological support when undergoing 
a radiographic examination or a complex radiological intervention. The rapid 
growth of technical and scientific knowledge has changed not only the 
environment but also the requirements on competence for all professionals and 
the health care system as whole. High technology has transformed the 
physical appearance of the diagnostic radiology department and influenced its 
social structure. Along with caring for the patient, technology has affected 
radiologists’ as well as radiographers’ everyday life in that it allows less human 
control in the organisation. When a patient attends the hospital to undergo a 
radiographic examination or intervention, he/she expects the encounter to 
involve humane and dignified care, irrespective of how difficult the 
circumstances may be. Provision of information concerning the 
examination/intervention is central, as well as communication to ensure that 
the information provided is accurate and complete and the patient has 
understood. Communication helps the patient to stay involved and participate 
in the examination/intervention, and detailed information about what is going to 
happen next can be of great value to patients experiencing fear and panic. It is 
important to have an understanding of other professions working inside and 
outside a diagnostic radiology department to offer a person-centred care and 
climate, to increase patient safety, including effective communication. 
Learning Objectives: 
1. To understand the patient-doctor relationship from a radiographer’s view. 
2. To learn about effective communication and how to avoid miscommunication 
and misunderstanding. 
3. To understand the impact of good communication strategies for the patient's 
journey.  
A-696 11:10  
Patients' point of view (part 1)  
J. Birch; Poole/UK (judy_b@dsl.pipex.com)  
This presentation will look at: examples of discussion with the radiologist, as 
well as the lack of it, and the implications from the patients’ perspective. 
Avoiding assumptions: what information is helpful and in what form - verbal or 
written? The procedure itself, the report, the follow-up. 
Learning Objectives: 
1. To understand the patient-doctor relationship from patients' view. 
2. To learn about effective communication and useful information for patients. 
3. To learn that an overload of information is equally detrimental to a safe 
feeling as no information. 
A-697 11:20  
Patients' point of view (part 2)  
D. Walsh; Dublin/IE (executivedirector@efna.net)  
This presentation will explore the perspective of the neurology patient in terms 
of what is perceived as useful information and the challenges in 
communicating this effectively. It will also look at how the radiology department 
and the patients it serves, can work together to ensure that these barriers are 
overcome. This will encompass a discussion on the theory of good doctor-
patient communication, but also consideration of the structures of health 
service delivery which may create an environment in which effective 
communication cannot take place.  
Learning Objectives: 
1. To understand the patient-doctor relationship from patients' view. 
2. To learn about effective communication and useful information for patients. 
  







3. To learn that an overload of information is equally detrimental to a safe 
feeling as no information. 
Author Disclosure: 
  D. Walsh: Advisory Board; Pfizer Patient Centricity Board. Grant Recipient; 
The European Federation of Neurological Associations, who I represent as 
Executive Director, is a patient organisation which is funded by unrestricted 
grants from a consortia of industry partners.. 
A-698 11:30  
The radiologist as a patient  
R. Stern Padovan; Zagreb/HR (rpstern@mef.hr)  
I was working the whole career as academic radiologist and I was for almost 
20 years chair of the large academic radiology department. My prinicpal field of 
work was abdominal and urogenital radiology and I was not directly involved in 
breast imaging. Shortly after retirement, I was diagnosed with breast cancer 
and had to undergo complete surgical and oncologic treatment. Imaging is part 
of diagnosis and follow-up. Suddenly, I have seen the medical system from the 
side of the patient and understood more than before the importance of 
communication between patients and physicians. Radiologists often lack 
communication skills which render them invisible to patients. In the case of 
breast cancer patients, radiologists are the first among doctors who should 
very carefully communicate with patients, inform them of all relevant facts and 
further steps and demonstrate compassion. Doctors and radiologists require 
the same as patients from other doctors as non-professional patients. Actually, 
doctors know much more and should be informed in detail, and with great care. 
Being aware of the clinical course and potential complications of my disease, 
which eventually occurred, I was even more vulnerable and needed complete 
information and an even more tailored approach by all managing physicians. 
Radiologists need to communicate with patients much more and the 
importance of that cannot be overemphasized. I strongly believe that 
radiologists should receive training in this area which is largely neglected.  
Learning Objectives: 
1. To understand the patient-doctor relationship from patients' view. 
2. To learn about effective communication and useful information for patients. 
3. To learn that an overload of information is equally detrimental to a safe 
feeling as no information. 
11:40  
Panel discussion: How can we improve communication in the department 
and avoid misunderstanding?  
10:30 - 12:00 Room F1  
E³ - European Diploma Prep Session  
E³ 1423  
Head and neck  
A-699 10:30  
Chairperson's introduction  
M.G. Mack; Munich/DE (m.mack@radiologie-muenchen.de)  
During this session, the participants will learn the most common variants and 
pathologies of the temporal bone, the skull base, the nose, the paranasal 
sinuses and the nasopharynx as well as the oral cavity, the oro- and 
hypopharynx and the larynx. Normal anatomy, variants, inflammatory disease 
as well as benign and malignant tumours will be presented.  
Session Objectives: 
1. To become familiar with the anatomy and imaging presentation of the most 
common disorders of the temporal bone and skull base. 
2. To understand the imaging presentation of common inflammatory and 
neoplastic disorders of the nose, paranasal sinuses and nasopharynx. 
3. To describe the typical imaging features of the most common neoplastic 
disorders of the oral cavity, oropharynx, hypopharynx and larynx. 
A-700 10:36  
A. Temporal bone and skull base  
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com)  
During the lecture we will first discuss the complex anatomy of the temporal 
bone with special regards to conductive and sensorineural hearing loss. Next, 
we will go through most common causes of conductive hearing loss, with 
emphasis on middle ear tumours including cholesteatoma, and chronic 
inflammation. Afterwards we will focus on sensorineural hearing loss, including 
acquired inner ear pathology and developmental anomalies. During second 
part of this lecture we will go through most important tumours of anterior, 
middle and posterior skull base. We will discuss the features of different 
malignancies on CT and MRI images, focusing on providing an informative 
report for the clinician  
Learning Objectives: 
1. To differentiate the anatomy, normal variants and congenital disorders of the 
temporal bone. 
2. To understand the causes and imaging features of hearing and vestibular 
disorders. 
3. To describe the imaging presentation of the most common tumours of the 
skull base. 
A-701 11:04  
B. Nose, paranasal sinuses and nasopharynx  
C. Czerny; Vienna/AT (christian.czerny@meduniwien.ac.at)  
Radiological imaging of the nose, paranasal sinuses and the nasopharynx is 
applied in patients with inflammatory or suspected benign or malignant 
tumours. The knowledge of the normal anatomy and its variants is necessary 
to understand the pathways of inflammatory and tumourous pathologies and to 
establish the correct diagnosis. Multidetector-spiral-CT (MDCT) and MRI are 
the methods of choice for radiological imaging. Additionally, positron emission-
computed tomography (PET-CT) is an extremely valuable imaging tool in 
patients with malignant disease. It is a combination of MDCT and PET. A 
contrast-enhanced CT is performed - in most cases for staging covering the 
whole body - and a PET scan after the intravenous application of a tracer (in 
most cases, fluorodeoxyglucose). Malignant tissues take up the tracer and with 
the CT-scan the pathology can be exactly anatomically localised. In recent 
times, positron emission-magnetic resonance tomography (PET-MR) has been 
introduced. The normal anatomy and its variants as well as the importance of 
close neighbouring anatomical structures, which can be involved in 
inflammatory and tumourous disease, will be described. Pathology consists of 
inflammation and tumours. Inflammation can be differentiated into acute and 
chronic. Tumours can be either benign or malignant. It is important to describe 
the exact localisation and extension of the different pathologies. Imaging 
characteristics and involvement of the surrounding structures may help to 
differentiate between benign and malignant disease. Uptake of contrast 
material and tracer - especially when using PET-CT or PET-MR - may well 
differentiate benign from malignant disease and additionally enable a whole-
body scanning with the exact radiological staging.  
Learning Objectives: 
1. To describe the anatomy and normal variants of the nose, paranasal sinuses 
and nasopharynx. 
2. To differentiate the imaging features of acute and chronic inflammatory 
changes of the nose and paranasal sinuses. 
3. To understand the imaging features of benign and malignant tumours of the 
nose, paranasal sinuses and nasopharynx. 
A-702 11:32  
C. Oral cavity, oro- and hypopharynx and larynx  
M. Becker; Geneva/CH (minerva.becker@hcuge.ch)  
The purpose of this lecture is to review common pathologic conditions of the 
oral cavity, oropharynx, hypopharynx and larynx, to describe the key anatomic 
structures relevant to tumour spread and to discuss the clinical implications of 
CT and MRI in the pre-therapeutic work-up of neoplastic lesions, in particular 
squamous cell carcinoma of the head and neck. A systematic review will 
include key radiologic features and characteristic patterns of submucosal 
tumour spread and implications of cross-sectional imaging for staging and 
treatment. The lecture will also review the characteristic aspect of less common 
tumours and tumour-like conditions affecting this area. Typical radiologic 
features will be discussed with an emphasis on potential pitfalls and on how to 
avoid them. Imaging aspects of Human papilloma Virus (HPV) positive and 
HPV- negative squamous cell cancers will be addressed and the impact of the 
new TNM classification on radiologic reporting will be discussed. Emphasis will 
be put on what the clinician needs to know and how to report the findings in a 
systematic way.  
Learning Objectives: 
1. To describe the normal imaging anatomy of the oral cavity, oropharynx, 
hypopharynx and larynx. 
2. To understand the imaging features of tumours of the oral cavity and 
oropharynx. 
3. To describe the imaging features of tumours of the hypopharynx. 











10:30 - 12:00 Room M 4 
E³ - ECR Academies: Tips and Tricks in Pancreatic and GI Tract 
Imaging  
E³ 1422  
Pancreatic tumours  
A-703 10:30  
Chairperson's introduction  
R. Pozzi-Mucelli; Verona/IT (roberto.pozzimucelli@univr.it)  
Pancreatic tumours represent a major challenge to the radiologist, in detection, 
characterisation and staging. Imaging techniques perform well in the diagnosis 
of typical forms of ductal adenocarcinoma, However, a multimodality imaging 
approach is essential in equivocal and difficult cases. A variety of imaging 
studies, including CT, endoscopic ultrasound (EUS), MRI and positron 
emission tomography with 18F-fluorodeoxyglucose (FDG PET), have important 
roles in the diagnosis, staging and follow-up of pancreatic tumours. Primary 
epithelial neoplasms of the pancreas arise either from the exocrine 
parenchymal tissue or endocrine islet cells. The differential diagnosis among 
these different tumours is essential, since these tumours require different 
therapeutical approches. Although a great improvement has been achieved in 
the diagnosis of pancreatic diseases by modern imaging modalities, a number 
of challenging lesions are still difficult to be characterised. This occurs with 
neoplastic and inflammatory diseases, which, in a limited number of cases, 
may present with similar imaging features that can be misdiagnosed and 
subjected to unnecessary surgical treatment. To make a correct differential 
diagnosis, clinical, morphological and structural (i.e. density and signal 
intensity) findings have to be evaluated at the same time. The value of the 
integration of imaging modalities to reach the correct diagnosis will also be 
discussed in this course. 
A-704 10:35  
A. Staging adenocarcinoma  
N. Kartalis; Stockholm/SE (nikolaos.kartalis@me.com)  
Pancreatic cancer is a disease with very dismal prognosis. The 5-year survival 
is around 5% and has been stable over the last decades. The only potential 
curative treatment is surgical resection combined with adjuvant and/or 
neoadjuvant medical therapy. However, at diagnosis less than 20% of patients 
have a resectable tumour, while the rest have tumours that are locally 
advanced and/or have distant metastases. In order to improve survival, there is 
a need to increase the number of patients that undergo surgery. However, for 
the surgical removal to be meaningful, the goal is to achieve complete 
macroscopic and microscopic removal of tumour (R0-resection). For the 
identification of patients who will benefit from surgery, the so-called 
“resectability status” was developed. It is based on the presence and extent of 
tumour contact with the major peripancreatic vessels such as portomesenteric 
axis (PV/SMV), hepatic artery, celiac artery and superior mesenteric artery. 
Depending on the degree of the circumferential tumour-vessel contact the 
tumours are classified in one of the three categories: resectable, borderline 
resectable and unresectable. The criteria of the various existing classification 
systems will be discussed and their differences outlined. Furthermore, the role 
of CT, MRI and PET-CT in the evaluation of these patients will be analysed 
and, finally, important aspects of the post-operative imaging follow-up will be 
presented.  
Learning Objectives: 
1. To understand the rationale behind local staging of pancreatic 
adenocarcinoma. 
2. To learn about the respective role of CT, MRI and PET/CT. 
3. To become familiar with the principle of postoperative follow-up. 
A-705 11:03  
B. Neuroendocrine tumours  
R. Manfredi; Rome/IT (riccardo.manfredi@unicatt.it)  
Neuroendocrine tumours account for 1.2%-1.5% of all gastrointestinal 
neoplasms, with an incidence of 1.6-2.0 new cases per 100,000 persons per 
year. The majority of neuroendocrine tumours occur sporadically; that is, they 
are non-familial. However, they sometimes occur as part of complex familial 
endocrine cancer syndromes such as type 1 multiple endocrine neoplasia 
(MEN 1) and neurofibromatosis type 1. Immunohistochemical staining has 
played an important role in the diagnosis of neuroendocrine tumours. The 
neuroendocrine cells of the diffuse neuroendocrine system are characterized 
by the expression of certain marker proteins, such as chromogranin, 
synaptophysin, and neuron-specific enolase (NSE). Clinically, neuroendocrine 
tumours of the pancreas are classified into functioning and non-functioning 
tumours, according to the symptoms. Non-functioning, hormonally silent, 
neuroendocrine tumours (NF-NET) represent 68-80% of all NETs, and are 
diagnosed because of the mass effect exerted by the tumour. Abdominal pain 
is the most frequent presenting symptom (35-78%), followed by weight loss 
(20-35%), anorexia and nausea (45%), palpable mass (7-40%), and jaundice 
(17-50%). According to the 2010 WHO classification, neuroendocrine 
neoplasms are classified according to the percentage of Ki67, a protein index 
of cell replication, on the pathologic specimen. There are three categories: G1, 
Ki-67 index 2%; G2, Ki-67 index between 3% and 20%; G3, with Ki-67 index 
>20%. At diagnostic imaging, neuroendocrine neoplasms are hypervascular 
compared to the adjacent pancreas in 74% of the cases. Hyper- or 
isovascularity represents the most suggestive feature of neuroendocrine 
neoplasms that are helpful in the differential diagnosis with adenocarcinoma.  
Learning Objectives: 
1. To understand the basics of histological classification of neuroendocrine 
tumours. 
2. To learn about the natural history of these tumours. 
3. To become familiar with the usual appearance and imaging specificities of 
neuroendocrine tumours. 
A-706 11:31  
C. Tough clinical cases  
T.C. Lauenstein; Essen/DE (thomas.lauenstein@evk-duesseldorf.de)  
The ability to non-invasively diagnose and characterise pancreatic tumours has 
vast therapeutic implications. However, there are several aspects that may 
impede a reliable characterisation of a pancreatic lesion. While some 
pancreatic tumours exhibit typical imaging findings, there is often an overlap of 
imaging findings between different lesions, e.g. pseudotumours due to chronic 
pancreatitis and adenocarcinoma of the pancreas. We often face the same 
dilemma as far as cystic pancreatic lesions are concerned, since some cystic 
tumours have a potential for malignant transformation including IPMN or 
mucinous cystadenomas. Furthermore, there is a large variety of diagnostic 
tools available for the assessment of pancreatic disease, including 
ultrasonography, endosonography, CT, MRI and PET. It is important to 
understand the strengths and weaknesses of these diagnostic modalities, 
particularly in equivocal cases of pancreatic lesions. Eventually, biopsy 
samples are often needed either to establish a diagnosis or to allow for a more 
profound histopathological analysis of tumour tissue. Several challenging 
cases of pancreatic tumours will be presented in this lecture. Differential 
diagnoses will be discussed and a diagnostic algorithm for each case will be 
proposed.  
Learning Objectives: 
1. To be able to define diagnostic probabilities when facing an unknown case 
of solid mass in the pancreas. 
2. To understand the role of multimodality approach, including 
endosonography and biopsy. 
10:30 - 12:00 Room M 5 
Transatlantic Course of ESR and RSNA (Radiological Society of 
North America): Sports Imaging  
TC 1428  
Lower extremity sports injuries  
Moderators:  
L.W. Bancroft; Orlando, FL/US  
A.J. Grainger; Leeds/UK  
A-707 10:30  
A. Sports-related injuries of the knee: what does the orthopaedic surgeon 
need to know?  
T.T. Miller; New York, NY/US (millertt@hss.edu)  
MRI has become the workhorse of musculoskeletal imaging, and in most 
practices the knee is the most commonly imaged joint. We will review 
examples of cruciate ligament and meniscal injuries (with attention to 
diagnostic pitfalls and post operative appearances), patterns of injury, 
osteochondral injuries and repair, and periarticular tendinous and ligamentous 
injuries. We will also discuss features of these injuries that help the surgeon 
decide whether to operate.  
Learning Objectives: 
1. To learn about what to include in knee MRI dictation templates. 
2. To understand the most common sports-related injury patterns in the knee. 
3. To appreciate which specific orthopedic indications should prompt additional 
information in the dictation. 
  







A-708 11:00  
B. Multimodality imaging of foot and ankle injuries in the athlete  
A.J. Grainger; Leeds/UK (andrewgrainger@nhs.net)  
Ankle injuries are common in many sports, and the complicated anatomy of the 
ankle joint can be challenging to the reporting radiologist. The ankle joint itself 
is a synovial hinge joint, but important movement for ankle function also occurs 
at the joints of the hind and midfoot which are also susceptible to injury. In 
addition to conventional radiographs, CT, MRI and ultrasound all have 
important roles to play in the diagnosis of foot and ankle injuries in the athlete. 
The ligamentous and tendon structures about the ankle are generally 
superficial in nature and readily amenable to assessment with ultrasound, 
where assessment can be enhanced due to the dynamic capabilities of the 
technique. While MRI also demonstrates these structures, it has advantages 
for assessing deeper joint structures such as the chondral surfaces and bones. 
The complex 3D anatomy of the foot and ankle means that conventional 
radiographs can struggle to demonstrate bone injury which means CT also has 
an important role to play. This lecture will focus on the use of these imaging 
modalities for the assessment of acute and chronic ligamentous and tendon 
injury. Emphasis will be put on the mechanisms of injury and how they 
determine the resultant patterns of injury and the imaging appearances.  
Learning Objectives: 
1. To appreciate the different and often contributory roles that imaging 
modalities have in the foot and ankle. 
2. To recognise the most common ligamentous and tendon injuries in the 
ankle. 
3. To understand how common patterns of injury relate to the mechanisms 
involved. 
A-709/A-710 11:30  
C. Interactive case discussion  




Several cases of knee MRI will be shown, demonstrating examples of various 
abnormalities such as internal derangement (cruciate ligament and meniscal 
injuries), osteochondral injuries, abnormalities of the extensor mechanism, 
collateral ligamentous injuries, and patterns of injury. These cases will be 
examples of what the orthopedic surgeon wants to know.  
Learning Objectives: 
1. To appreciate common patterns of athletic injury in the knee. 
2. To become familiar with the techniques available and imaging appearances 
of knee, foot and ankle athletic injury. 
3. To consolidate the knowledge gained from the session with interactive cases 
of lower limb athletic injury. 
12:15 - 12:45 Room A 
Headline Session  
HL 3  
Josef Lissner Honorary Lecture  
Presiding:  
B. Hamm; Berlin/DE  
A-714 12:15  
Human papilloma virus and head and neck cancer: the new face of 
malignancy  
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com)  
Head and neck cancer is a commonly encountered pathology. Oropharyngeal 
location of the disease is increasing rapidly, affecting young people and its 
relation with oropharyngeal infection by oncogenic type-16 human 
papillomavirus (HPV) has been proven. The clinical and biologic profile of 
HPV-positive patients is distinct from any other head and neck squamous cell 
cancer patients, however, it is not possible to differentiate the HPV status 
based on imaging studies. HPV-positive patients have a tendency towards 
early lymph nodes metastasis, more frequent distant metastatic disease and 
much better response to non-surgical treatment, comparing to HPV-negative 
ones. Detection of intratumoral oncogenic HPV DNA seems to be mandatory 
now, since it determines prognosis in terms of long-term survival and 
locoregional control. A policy of vaccination for both girls and boys may be the 





1. To describe the behavior of human papilloma virus. 
2. To understand the specific biology and imaging features of HPV - positive 
cancer of the head and neck. 
3. To become familiar with effective diagnostic imaging procedures, treatment 
and follow-up of these tumour. 
12:30 - 13:30 Room C 
E³ - The Beauty of Basic Knowledge: Cardiovascular and 
Interventional Radiology  
E³ 24D  
CT of the heart made easy  
Moderator:  
C. Loewe; Vienna/AT  
A-718 12:30  
Cardiovascular risk estimation made easy: CA-scoring  
R. Vliegenthart; Groningen/NL (r.vliegenthart@umcg.nl)  
Evaluation of the extent of atherosclerotic plaque may improve cardiovascular 
risk stratification in primary prevention. Among the non-invasive measures of 
atherosclerosis, focus has turned to assessment of coronary calcification by 
non-contrast-enhanced computed tomography (CT). The calcium score 
increases with age, and is generally higher for men than for women. The 
calcium score is divided into 4 categories: 0 (none), 1-99 (mild), 100-399 
(moderate), and at least 400 (severe coronary calcification). Another commonly 
used approach is to calculate an age- and gender-matched percentile. The 
calcium score is predictive of coronary events in men and women, and in 
younger and older populations. The relative risks for increasing calcium scores 
are much higher than those reported for cardiovascular risk factors or other 
measures of atherosclerosis. Additionally, the absence of coronary calcification 
indicates a very low risk of cardiovascular disease. According to latest 
guidelines, calcium scoring should be considered in asymptomatic individuals 
at intermediate risk based on risk factors. In this group, calcium scoring leads 
to more appropriate risk classification, into the low- or high-risk group. There is 
increasing interest in a zero calcium score in patients with chest pain. The 
presence of >50% coronary stenosis and coronary events was found to be very 
unlikely in case of a zero calcium score, in both acute and non-acute patients. 
It seems likely that calcium scoring will play a role in the diagnostic algorithm of 
patients with chest pain in the future, especially to exclude coronary artery 
disease. 
Learning Objectives: 
1. To learn about importance of risk estimation in coronary artery disease. 
2. To understand the principle of CA-scoring quantification. 
3. To appreciate the value of “zero calcium” as well as of “high calcium”. 
Author Disclosure: 
  R. Vliegenthart: Research/Grant Support; Institutional grant Siemens. 
A-719 13:00  
Non-invasive coronary (CT) angiography made easy  
F. Bamberg; Tübingen/DE (fabian.bamberg@uni-tuebingen.de)  
Cardiac CT angiography has undergone a tremendous development over the 
last two decades and is diffusing into current medical practice substantially. On 
the one hand, this can be attributed to emerging scientific evidence 
demonstrating the incremental value of implementing cardiac CT angiography 
in diagnostic strategies; on the other hand, the technique itself has become 
very robust and broadly applicable. Still, performing a cardiac CT angiography 
requires some basic understanding of the underlying technical principles, 
physiological circumstances, and the coronary anatomy. The presentation will 
review available protocols and techniques and provide a straightforward 
approach to cardiac CTA acquisitions. Practical tips and tricks as well as 
limitations of the technique will be covered.  
Learning Objectives: 
1. To learn about optimised examination technique of non-invasive coronary 
CT angiography. 
2. To understand the need for structured approach to coronary CT 
angiography. 
3. To appreciate clinical value of non-invasive coronary CT angiography. 
Author Disclosure: 
  F. Bamberg: Research/Grant Support; Siemens Healthineers, Bayer 
Healthcare. Speaker; Siemens Healthineers, Bayer Healthcare. 
 
  







12:30 - 13:30 Room D  
E³ - The Beauty of Basic Knowledge: A Survival Guide to 
Musculoskeletal Imaging  
E³ 25D  
Acute trauma: patterns in the peripheral 
skeleton  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK  
A-720 12:30  
Acute trauma: patterns in the peripheral skeleton  
J. Teh; Oxford/UK (jamesteh1@googlemail.com)  
A systematic approach to analyse trauma imaging of the peripheral skeleton is 
presented. Typically, imaging begins with x-rays. A stepwise approach may 
reveal subtle abnormalities that should prompt further action. For example, the 
presence of a Segond fracture on x-ray suggests an ACL injury and thus 
should lead to an MRI scan. It should be recognized that in trauma, certain 
injuries cannot occur in isolation; therefore, a dislocated radial head on elbow 
x-ray should prompt imaging of the whole forearm, as Monteggia fracture-
dislocation may be present. Understanding the mechanisms of injury allows the 
radiologist to predict the patterns of injury. So if bone bruising is present on 
MRI in the lateral femoral condyle and medial patella, a lateral patellar 
dislocation should be suspected and a specific search for an injury of the 
medial retinaculum should be made. Conversely, recognizing classic patterns 
of injury can allow the mechanism of injury to be deduced. This lecture will 
focus on the classical patterns of acute trauma in the peripheral skeleton.  
Learning Objectives: 
1. To become familiar with the imaging manifestations of common important 
injuries in the upper and lower limb. 
2. To understand the underlying mechanism that result in combination of 
injuries. 
3. To learn how to best employ imaging modalities in their diagnosis. 
12:30 - 13:45 Room M 1  
New Horizons Session  
NH 14  
The new horizon for radiology  
A-721/A-722 12:30  
Chairpersons' introduction  
L. Donoso1, B. Hamm2; 1Barcelona/ES, 2Berlin/DE  
Session Objectives: 
1. To become familiar with the challenge and opportunities of artificial 
intelligence. 
2. To become familiar with the Department of Diagnostics of the future. 
3. To learn from experts how to organise integrated diagnostics. 
4. To learn about integrated diagnostics from the European and American 
experience. 
A-723 12:35  
What will the radiologist’s job look like in 2025?  
W. Kim; Los Angeles, CA/US (woojinrad@gmail.com)  
Today, plenty of fear, hope, and hype encompass the use of artificial 
intelligence (AI) in radiology. Many AI experts have predicted the demise of 
radiology by having AI replace radiologists in the near future. These predictions 
have impacted the career choices of medical students, caused worries for the 
radiology trainees, and brought concerns to many practising radiologists. 
However, much of these so-called expert opinions are based on a very 
simplified view of what we do as radiologists. Furthermore, when it comes to AI 
in radiology, with media attention and many startups focused on using AI to 
identify findings within medical images, it is easy for us in the radiology 
profession to have "tunnel vision" about AI in our field. It is important to widen 
our view to see the many other ways AI can benefit medical imaging. In 2014, 
there was a Journal of the American College of Radiology article on something 
called the “imaging value chain” that described various processes within 
radiology from ordering to reporting and communication. This value chain 
illustrates various areas where AI can augment and improve radiology. 
Throughout history, radiologists have adapted to technological innovations and 
made adjustments to integrate them into our workflow. AI will soon become an 
integral part of our lives and our profession. As we learn to integrate AI into 
radiology, we must have a wider view to take full advantage of this emerging 
technology and maximise our role in patient care.  
Learning Objectives: 
1. To appreciate why some radiologists fear artificial intelligence (AI). 
2. To learn about the role AI can play beyond interpretation of images. 
3. To learn about how AI can augment radiologists and what we can do to 
maximise its positive potential. 
Author Disclosure: 
  W. Kim: Employee; Nuance Communications. 
A-724 12:50  
Transforming the integrated diagnosis (ID) opportunity into the 
Diagnostic Institute (DI) innovative change management  
P. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org)  
In recent years, voices have been calling for tighter integration between 
radiology, pathology, and genomics. This multidisciplinary convergence is 
captured by the term Integrated Diagnostics (ID). Now is the right time for a 
move toward ID, based on current technology advances. One major change is 
that anatomic pathology is transforming from an analogue (slide and 
microscope) approach to a digital workflow at a rapid pace, thanks to whole 
slide imaging scanners and pathology picture archiving and communication 
systems (PACS) for large scale, clinical use. With digital pathology, the cross-
disciplinary IT tools greatly expand. Moreover, there is the strong trend for 
quantification of image contents to enable large-scale computational analysis. 
We discuss three pillars for an effective ID practice The first pillar standardizes 
the pathways through diagnostics that can be quite complex. In our design of 
an ID practice, the diagnosticians would take on a larger responsibility and 
would directly decide on follow-up studies when the next step in the pathway is 
clear. The second pillar is facilitated joint radiology -genomics decision-making. 
The third pillar is dependent on the service level provided and perceived by the 
customers—the referring clinicians, patients, and, ultimately,, society. This is 
essential to ensure the ultimate success of radiology, pathology and genetics. 
The opportunities described sum up a strong call for focusing on ID as one of 
the key forefronts of health-care development forming diagnostic institutes. 
Learning Objectives: 
1. To learn the concept of integrated diagnosis (ID) combining the practices of 
radiology, pathology and genomics into an innovative diagnostic tool. 
2. To understand how the computational resolution provides the technology 
basis for the cross-disciplinary implementation of ID. 
3. To share the early experience of first Diagnostic Institute established in a 
large Academic Health System in the US in 2017. 
A-725 13:05  
Medical imaging and clinical laboratories: a fruitful liaison  
J.E. Wildberger; Maastricht/NL (j.wildberger@mumc.nl)  
Setting up a global diagnostic chain offers new opportunities to optimise patient 
logistics and to become more (cost-)effective. As a first step, all diagnostic 
departments in our center were clustered into the “division of medical imaging 
and clinical laboratories” in 2011. In December 2016, the departments of 
radiology and nuclear medicine were fused. Based on lean principles 
(operational excellence), a framework of breakthrough objectives has been 
established. Achievements are shared and updated on a regular basis. From a 
radiological perspective, the next step to be taken is the implementation of an 
uniform reporting platform for imaging and pathology. In parallel, all diagnostic 
laboratory information systems are to be homogenised and clustered. This set-
up forms the basis for a deep integration of underlying logistics, shared 
infrastructure, as well as for optimisation of current management information 
and reporting. By doing so, bioinformatics can be further developed, not only 
for the clinics but also in the scientific setting. Standardisation throughout the 
entire diagnostic chain will guarantee high quality data sets for new insights on 
a larger scale. Sharing this information openly and cross-disciplinary will help 
to further optimise patient care.  
Learning Objectives: 
1. To understand why we should cluster the entire diagnostic chain. 
2. To learn how “unity in diversity” can be achieved in a clinical setting. 
3. To become familiar with the opportunities of this approach for bioinformatics, 
data sciences and artificial intelligence. 
Author Disclosure: 
  J.E. Wildberger: Research/Grant Support; (Institutional) AGFA, Bayer, GE, 











14:00 - 15:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1521  
Paediatric radiology for the general 
radiologist  
A-731 14:00  
A. Fractures in children  
K.J. Johnson; Birmingham/UK (karl.johnson@bch.nhs.uk)  
Traumatic injury and fracturing are some of the commonest reasons why 
children present to hospital and undergo radiological investigation. The 
anatomy and physiology of the growing skeleton is different from that of adults 
and, as a consequence, some of the fractures and injuries are unique to 
children. This presentation will demonstrate the various types of incomplete 
fracture which occur within the more plastic skeleton of the child. It will detail 
the different types of Salter-Harris fractures which can occur across the 
unfused growth plate. The differences in relative strength of bone and 
ligamental attachments which are seen in children and the consequences of 
the different types of injuries which can occur will be illustrated. The 
importance of recognising the normal variants of growth from pathological 
change will also be highlighted. The importance of understanding the child's 
development and mobility and how this correlates with the injury patterns seen 
in normal childhood will be discussed along with an understanding of the injury 
patterns and fracture types which occur from inflicted physical injury.  
Learning Objectives: 
1. To become familiar with different traumatic fracture types. 
2. To identify possible criteria for child abuse. 
A-732 14:45  
B. Typical MRI applications in paediatric musculoskeletal imaging  
K. Rosendahl; Bergen/NO (karen.rosendahl@helse-bergen.no)  
Magnetic resonance imaging (MRI) has become exceedingly important in the 
diagnosis and follow-up of MSK disease, allowing for targeted therapy. MRI 
uses non-ionising radiation, has a high soft-tissue resolution and discrimination 
and may provide both morphological and functional information. Correct 
interpretation depends on extensive knowledge of physical properties and 
normal appearances of the imaged tissue and of the pathophysiological 
disease processes. Imaging of the paediatric skeleton represents a particular 
challenge as normal appearances change over time, thus mimicking diseases 
such as juvenile idiopathic arthritis (JIA), osteomyelitis, malignancies and 
traumatic changes. All the aforementioned diseases represent typical MRI 
applications in paediatric MSK imaging. During this lecture, I will discuss 
imaging strategies, findings and differentials.  
Learning Objectives: 
1. To learn indications of paediatric MRI. 
2. To become familiar with MR imaging findings in children. 
14:00 - 15:30 Room B 
Professional Challenges Session  
PC 15  
Artificial intelligence and big data in 
medical imaging  
A-733 14:00  
Chairperson's introduction  
W.J. Niessen; Rotterdam/NL (w.niessen@erasmusmc.nl)  
The analysis of big data with artificial intelligence techniques will have an 
enormous impact on disease prevention, cure and care, and by 2030 it will 
have dramatically changed the landscape of the health-care system. This 
session will show examples of possible large benefits of big data analytics in 
health care from the imaging perspective. Specifically, in this introduction I will 
provide examples to show that the use of AI and big data should be embraced, 
as it has a large potential to realizing the potential of precision medicine and 
precision health, both in dementia and oncology.  
 
Session Objectives: 
1. To learn about the disruptive role that big data and artificial intelligence can 
play in medical imaging. 
2. To appreciate that these technologies are key to realise the full potential of 
precision medicine. 
3. To appreciate where the big challenges and opportunities are. 
Author Disclosure: 
  W.J. Niessen: Advisory Board; I am Scientific Advisor to Quantib BV. 
Founder; I am co-founder of Quantib BV. Owner; I have shares in Quantib BV. 
A-734 14:15  
IT infrastructure, data sharing methods and data analysis aspects  
A. Alberich-Bayarri; Valencia/ES (alberich_ang@gva.es)  
Quantitative image analysis solutions and artificial intelligence (AI)-based 
methods usually find interoperability issues when trying to transfer information 
with hospital information systems (HIS) and electronic health records (HER). 
Appropriate quantitative data management would allow for a better 
understanding of the tissue and organ alterations in the disease and their 
relationship with patient characteristics and associated clinical or lab data. The 
image reading process is today in constant improvement, from traditional 
image reading by the naked eye and free text reporting of the findings, towards 
the inclusion of new technologies in the loop such as AI computer-aided 
detection and diagnosis (CAD), imaging biomarker extraction and structured 
reporting. To cover all clinical needs using AI solutions, quantitative imaging 
and structured reporting, a technological framework was engineered. The 
platform is modular and allows the installation both in local and cloud 
environments. The solution also includes a built-in anonymization module and 
allows for the incorporation of AI and image processing plug-ins. After the 
analysis of the images through the different pipelines, a quantitative structured 
report is generated, which can be integrated with hospital information systems. 
The platform allows for the mining of quantitative data extracted from patients, 
a functionality which is not available nowadays in PACS systems and 
workstations.  
Learning Objectives: 
1. To understand the importance of creating IT infrastructures for the 
management of quantitative medical image analysis solutions, both for 
research and clinical applications. 
2. To become familiar with the main storage and computational requirements 
for high performance infrastructures. 
3. To learn about how to move from research to clinical application in the field 
of quantitative imaging and biomarkers. 
Author Disclosure: 
  A. Alberich-Bayarri: CEO; QUIBIM SL. Founder; QUIBIM SL. 
A-735 14:40  
Machine learning in the biomedical domain: challenges and opportunities  
M. de Bruijne; Rotterdam/NL (marleen.debruijne@erasmusmc.nl)  
This lecture introduces the current state-of-the-art techniques in machine 
learning in medical imaging, highlights the potential of these techniques for 
computer-aided diagnosis and quantitative imaging biomarkers, addresses 
challenges related to variations in scan protocols and a requirement of 
annotated data for model training, and presents examples of successful 
applications of machine learning in radiology.  
Learning Objectives: 
1. To learn about machine learning concepts used for diagnosis, prognosis, 
and quantitative analysis of medical imaging data. 
2. To understand the challenges to introduce these techniques in clinical 
practice. 
3. To appreciate the potential of machine learning in radiology. 
Author Disclosure: 
  M. de Bruijne: Grant Recipient; Danish Council for Independent Research 
(DFF), Innovative Medical Devices Initiative (IMDI) of The Netherlands 
Organisation for Health Research and Development, Netherlands Organization 
for Scientific Research (NWO), Vertex, Astra Zeneca. Patent Holder; 
US8811724, US7844090, US8126240, US7561727, US7463758. 
Research/Grant Support; Quantib, COSMONiO Imaging BV. 
A-736 15:05  
How will AI change radiology  
K.J. Dreyer; Boston, MA/US  
"no abstract submitted" 
Learning Objectives: 
1. To learn about the current big data and AI initiatives. 
2. To discuss the current stage and future of AI in radiology. 
3. To discuss the role of the radiologist/radiology department in the AI era. 
  







14:00 - 15:30 Room C 
E³ - ECR Master Class (Chest)  
E³ 1526a  
Patterns of pulmonary toxicity  
Moderator:  
J.E. Roos; Lucerne/CH  
A-737 14:00  
A. Drug-induced lung disease  
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com)  
Drug-induced lung disease is an underreported cause of acute and chronic 
lung disease. It affects up to 10% of patients receiving chemotherapy for 
hematological and solid organ malignancies. Two mechanisms are 
differentiated: lung injury due to direct toxic injury and due to hypersensitivity 
reactions. Numerous CT patterns are seen in the context of drug induced lung 
disease ranging from diffuse alveolar damage (DAD) to all forms of acute and 
chronic interstitial pneumonia but also includes nodules, pleural effusion and 
airways reactions. The presentation will illustrate the most frequent CT patterns 
to be encountered in drug induced lung injury and provide keys how to 
differentiate them from other lung pathology such as infection, edema or 
underlying malignancy. Drugs, known for potential lung injury will be discussed, 
including new immunotherapeutic drugs. Further on, case-based discussion of 
typical clinical scenarios will provide you with practical tools for analysis.  
Learning Objectives: 
1. To learn about the various CT patterns of lung injury. 
2. To understand the role of imaging in their recognition. 
3. To discuss differential diagnoses. 
A-738 14:30  
B. Smoking-related lung disease  
S.R. Desai; London/UK (s.desai@rbht.nhs.uk)  
It is generally accepted that, in addition to the well known consequences of 
COPD and lung cancer, smoking may cause interstitial lung disease (ILD). The 
hypothesis that tobacco smoke can cause ILD - and, specifically, pulmonary 
fibrosis - dates back to the 1960s. The histopathological and radiological 
features of interstitial lung disease caused by smoking are variable and 
frequently overlapping, the latter prompting the introduction of the generic term 
‘smoking-related interstitial lung disease’. The list of interstitial lung disease, in 
which smoking is believed to have an aetiological role, includes Langerhans' 
cell histiocytosis, respiratory bronchiolitis/respiratory bronchiolitis-interstitial 
lung disease and desquamative interstitial pneumonia. There is also evidence 
which indicates that smoking may be associated with other patterns of 
pulmonary fibrosis (e.g. nonspecific interstitial pneumonia and smoking-related 
interstitial fibrosis). In the present session the pathology and imaging of the ILD 
known to be caused by smoking; the typical appearances and the diagnostic 
challenges will be discussed. 
Learning Objectives: 
1. To learn about the classification of smoking-related lung diseases. 
2. To understand the most common CT patterns. 
3. To highlight newly recognised entities. 
Author Disclosure: 
  S.R. Desai: Board Member; Deputy Editor, European Radiology. 
A-739 15:00  
C. Inhalation lung injury beyond smoking  
J.A. Verschakelen; Leuven/BE (johny.verschakelen@uz.kuleuven.ac.be)  
Non-smoking-related inhalation lung injury is usually secondary to chronic or 
repetitive occupational or environmental exposures, but may also result from 
inhalation of smoke or of chemical products of combustion, a condition that is 
mostly associated with significant morbidity and mortality. Every year new 
agents causing pulmonary injury are described, and although many are 
isolated cases others prove to be clustered or repetitive events with more or 
less specific imaging features. The clinical and radiological presentation of 
inhalational lung injury depends, on one hand, on the chronicity of inhalation, 
the amount and phase of the inhaled agent and its toxicity to the lung and, on 
the other, on the reaction of the lung to this injury. This presentation will focus 
on the CT features seen after non-smoking-related lung injury caused by direct 
chemical toxicity to the bronchial tree and lungs and by chronic or repetitive 
inhalation of particulates and organic dusts. Attention will also be given to the 
inflammatory syndrome seen in hypersensitivity pneumonitis.  
 
Learning Objectives: 
1. To learn about the various causes of environmental lung diseases. 
2. To understand the changes related to acute lung injury. 
3. To describe the long-term sequelae of inhalation lung injury. 
14:00 - 15:30 Room O  
Special Focus Session  
SF 15a  
Hybrid imaging in oncology  
A-740 14:00  
Chairperson's introduction  
M.E. Mayerhöfer; Vienna/AT (marius.mayerhoefer@meduniwien.ac.at)  
Hybrid imaging has revolutionized the field of oncologic imaging within the last 
decade. [18F]FDG-PET/CT in particular is now an integral part of the 
management guidelines for different tumours (e.g. lymphoma), with a particular 
emphasis on treatment response assessment. Despite the success of 
[18F]FDG in oncologic imaging, there is a clear trend towards development 
and clinical application of novel, tumour-specific PET tracers, such as 
[68Ga]PSMA for prostate cancer. Since PET/CT is only of limited value for 
local staging of the primary tumour in several malignancies (e.g., rectal cancer 
and gynaecological cancers), hybrid MR/PET scanners were developed and 
are presently being compared to PET/CT in an increasing number of studies. 
Furthermore, the MR component of MR/PET offers additional functional and 
even quantitative information, derived from techniques such as diffusion-
weighted imaging (DWI) and dynamic contrast-enhanced imaging. The 
combination of PET- and MRI-based parameters may not only improve non-
invasive, image-based characterization of tumours (including assessment of 
tumour heterogeneity), but may also enable better assessment of response to 
novel types of immunotherapies that have recently become available. Because 
of this multi-parametric approach, hybrid imaging has the potential to contribute 
significantly to the success of precision medicine.  
Session Objectives: 
1. To identify key clinical applications for hybrid imaging in oncology. 
2. To compare PET/CT and MR/PET for tumour detection, staging and 
restaging. 
3. To discuss the use of established and novel radiotracers and functional MR 
sequences for tumour characterisation and treatment response assessment. 
A-741 14:05  
Role of hybrid imaging in thoracic malignancies  
G. Cook; London/UK (Gary.Cook@kcl.ac.uk)  
18F-FDG PET/CT is now established in the management of solitary pulmonary 
nodules and the staging of lung cancer and mesothelioma when there is 
curative intent. Whilst 18F-FDG PET/CT is of undoubted clinical value, there 
are circumstances when the sensitivity or specificity is limited and therefore 
efforts have been made to evaluate new radiopharmaceuticals to improve 
characterisation, treatment stratification and treatment monitoring. These 
include 18F-FLT for cellular proliferation, 18F-MISO (and other compounds) for 
measuring tumour hypoxia, and angiogenesis-targeting radiopharmaceuticals 
and 68Ga-DOTA-peptides for detection of neuroendocrine tumours. As well as 
the development of new tracers to evaluate underlying buiological 
characteristics of thoracic malignancy, there is growing interest in the 
extraction of additional parameters from PET and CT that describe 
heterogeneity within an image or in a radiomics approach to better characterise 
lung cancers and improve the predictive and prognostic ability.  
Learning Objectives: 
1. To become familiar with the PET tracers used in thoracic malignancies. 
2. To learn the interpretation of PET/CT in lung cancer, mesothelioma, and 
neuroendocrine tumours of the lungs. 
3. To discuss the possible benefits of tumour heterogeneity assessment on 
hybrid imaging. 
A-742 14:23  
Prostate cancer: the "killer application" for MR/PET?  
M.R. Makowski; Berlin/DE (marcus.makowski@charite.de)  
In this lecture, we will give an overview of the potential of MR/PET in the 
context of prostate cancer. The different available MR/PET acquisition 
protocols will be introduced. The evaluation and interpretation of datasets 
acquired during MR/PET acquisitions will be discussed. We will highlight the 
strengths and weaknesses of MR/PET for the evaluation of patients with 
prostate cancer and give an outlook regarding the potential of this technique.  
  








1. To learn pelvic MR/PET acquisition protocols, normal anatomy, and pitfalls. 
2. To become familiar with interpretation of MR/PET in the settings of prostate 
cancer. 
3. To understand strengths and weaknesses of MR/PET applied to prostate 
cancer. 
A-743 14:41  
MR/PET of breast tumours  
K. Pinker-Domenig; Vienna/AT (pinkerdk@mskcc.org)  
Cancer development is characterised by several biological capabilities or so-
called hallmarks, which comprise sustaining proliferative signalling, evading 
growth suppressors, resisting cell death, enabling replicative immortality, 
inducing angiogenesis, and activating invasion and metastasis. With medicine 
entering the genomic era, personalised approaches towards treatment, which 
require a deeper understanding of the hallmarks of cancer, are being explored 
and ultimately will be implemented in patient care. To match advanced 
therapeutic strategies in the era of personalised medicine, diagnostic tests 
must be equally multilayered and complex to identify the relevant underlying 
processes of cancer development and progression. In this context, 
multiparametric magnetic resonance imaging (MRI) and positron emission 
tomography/MRI (PET/MRI), which, in addition to morphologic changes, can 
simultaneously assess a multitude of functional cancer-related processes, 
have emerged as exceptionally powerful, versatile, and precise imaging 
techniques. Multiparametric functional imaging of the breast aims to 
simultaneously quantify and visualise multiple functional processes at the 
cellular and molecular levels to further elucidate the development and 
progression of breast cancer and the response to treatment. There is evidence 
that multiparametric functional imaging, using different MRI and PET 
parameters, provides detailed information about the hallmarks of cancer and, 
thus, improves the diagnostic accuracy and assessment of response to 
neoadjuvant therapy. Multiparametric functional MRI provides a variety of 
techniques to assess functional tumour characteristics such as diffusion-
weighted imaging, dynamic contrast-enhanced imaging and multi-nuclei 
magnetic resonance spectroscopic imaging. PET/(MRI) detects and quantifies 
radiolabelled tracer substances, which allows the measurement of specific 
functional characteristics of breast cancer such as increased glucose uptake, 
tumour hypoxia or hormonal receptor expression. This talk aims to summarize 
the current and emerging applications of PET/MRI in breast tumours.  
Learning Objectives: 
1. To understand the principle of multimodality multiparametric functional 
imaging of breast tumours with MR/PET. 
2. To identify the potential and challenges of multiparametric breast MR/PET 
using different quantitative functional parameters. 
3. To realise the potential of novel tracers for personalised medicine. 
A-744 14:59  
MR/PET of pelvic cancers  
P.R. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org)  
PET/MRI raises the hope of providing a comprehensive TNM staging of pelvic 
malignancies in one single imaging examination. Combining the high 
diagnostic accuracy from PET with the excellent soft tissue contrast of MR 
enables accurate assessment of primary tumours and nodal metastases. In our 
experience, FDG-PET/MR is distinctly helpful in (a) advanced pelvic cancers 
for staging and treatment planning, (b) in a post-treatment setting of recurrence 
and (c) in equivocal cases where other methods failed to determine the exact 
origin and extent of the neoplastic disease. PET/MRI can characterize 
therapeutic fibrosis and tissue scarring after therapy, which significantly 
improves the detection of recurrent diseases. FDG-PET/MR plays an important 
role in ovarian cancer for all stages of disease: (1) the use of DWI in MRI is 
helpful in detecting small peritoneal deposits, which escape detection on FDG-
PET; (2) MRI facilitates the distinction of FDG-avid peritoneal and serosal 
implants from physiological bowel uptake, and 3) MRI can improve lesion 
detection and localisation. Another benefit PET/MR provides is a specific GTV 
(gross tumour volume) which is critical to the treatment of cervical cancer 
patients. The use of PET/MR for prostatic cancer evaluation with Ga-68 PSMA 
is the newest application in pelvic malignancies. Several Ga-68-labelled 
ligands of prostate-specific membrane antigen (PSMA) have recently been 
developed with promising results. Ga-68 PSMA offers a higher tumour-to-
tissue contrast compared to FDG, resulting in an accurate evaluation of the 
prostate gland, highly sensitive loco-regional staging as well as visualising 
distant metastases. 
Learning Objectives: 
1. To learn pelvic MR/PET acquisition protocols, normal anatomy, and pitfalls. 
2. To become familiar with interpretation of MR/PET in the settings of pelvic 
cancers. 
3. To understand strengthens and weaknesses of MR/PET applied to pelvic 
cancers. 
15:17  
Panel discussion: Does the multiparametric approach have a clinical 
benefit?  
14:00 - 15:30 Room N  
Cardiac  
RC 1503  
What a radiologist needs to know about 
imaging of myocardial viability  
A-745 14:00  
Chairperson's introduction  
C. Peebles; Southampton/UK (Charles.Peebles@suht.swest.nhs.uk)  
The concept of myocardial viability is central to the investigation and 
management of ischaemic heart disease (IHD). Viable myocardium is defined 
as ‘dysfunctional myocardium that maintains the potential to return to normal 
function’ e.g. it is alive and not dead. Dysfunctional, but viable myocardium is 
the end result of ischaemic myocardial injury that can either be acute 
(stunning) or chronic (hibernating). In the former, a single acute ischaemic 
injury causes temporary dysfunction that will recover after restoration of 
myocardial blood flow, but there may be a delay of weeks or months for this to 
occur. Hibernation is the end result of chronic or repetitive ischaemia causing 
downregulation of myocyte metabolism and function, which will again recover 
following revascularisation. Accurate identification of viable myocardium is 
critical, as revascularisation of non-viable myocardium confers the risks of 
revascularisation without the benefits of functional recovery. Conversely, failing 
to revascularise viable myocardium that is ischaemic may place the patient at 
increased risk. The two general approaches to identifying viable myocardium 
are functional improvement of a regional wall motion abnormality during low 
dose stress or identification of myocardial scar that involves less than the full 
thickness of a myocardial segment. The first approach is adopted by stress 
echo and dobutamine stress CMR. The second approach requires the use of 
extracellular contrast agent and is usually performed by CMR with late 
gadolinium enhancement or CT with iodinated contrast and delayed imaging. 
This session will compare the standard techniques for viability imaging and 
discuss their pros and cons.  
Session Objectives: 
1. To understand what viability means. 
2. To understand current state-of-the-art knowledge about the principle of 
viability. 
3. To understand shortcomings of echo and SPECT compared to other 
techniques. 
A-746 14:05  
A. MRI  
J. Bogaert; Leuven/BE (Jan.Bogaert@uz.kuleuven.ac.be)  
Ischaemic heart failure is probably the most challenging issue in cardiology 
today, posing an enormous medical and financial burden on our society. 
Conceptually, it represents a maladaptive cardiac remodelling due to acute 
and/or chronic coronary artery disease (CAD) with varying degrees of left 
ventricular (LV) dilatation and dysfunction. Though therapeutic options have 
improved overall survival over the years, mortality rates remain high and in 
daily practice cardiologists not infrequently face the therapeutic dilemma 
whether a revascularization procedure will lead to symptomatic and prognostic 
benefit for the patient. Simple, straightforward guidelines are lacking because 
of the complexity of the disease. Moreover, the issue of viability imaging 
grounded on observational, and retrospective studies has recently been 
challenged by the publication of prospective, randomized trials (e.g. STICH 
and PARR trial) showing no benefit of revascularization or of pre-procedural 
viability assessment in those patients. These contradictory findings have 
obliged us to enquire whether viability imaging still is relevant and what is 
needed to make it more appropriate.  
Learning Objectives: 
1. To learn about how MR should be performed to assess viability. 
2. To understand the strength and weaknesses of MR compared to other 
techniques. 
3. To learn how to report MRI for viability assessment. 
  







A-747 14:28  
B. Hybrid imaging  
O. Ratib; Geneva/CH  
Hybrid imaging combining molecular imaging (PET or SPECT) with anatomical 
and functional imagine (CT and MRI) offers a scope of new clinical 
applications. Traditional myocardial perfusion scans (SPECT) combined with 
advanced CT of coronary arteries anatomy and calcium scoring allows a better 
assessment of the degree of coronary disease and the risk of future events 
and objective determination of the appropriateness of therapeutics 
interventions. The development of new radiotracers for PET imaging of 
myocardial perfusion and viability opens new perspective for more objective 
evaluation of the efficacy of new treatments. The emergence of hybrid PET-MR 
imaging offer new perspectives for cardiac imaging. Functional MR allow 
identifying areas of decreased myocardial perfusion and tissue viability. PET 
provides more quantitative data on true tissue perfusion and metabolism and 
quantitative myocardial flow and coronary flow reserve. The combination of 
both modalities, improve the accuracy and reproducibility of diagnostic 
procedures. But the true potential of hybrid PET-MR may reside in applications 
beyond coronary artery disease. It is shown that the combination of both 
modalities help better characterise atherosclerotic plaques and identify plaques 
with high risks of rupture. Development of new tracers will allow evaluating 
myocardial remodeling and assessment of stem cell therapy in myocardial 
infarction. It will also provide new means for evaluating alterations in cardiac 
innervation and angiogenesis and even in assessment of reporter gene 
technologies. 
Learning Objectives: 
1. To learn about how hybrid imaging should be performed to assess viability. 
2. To understand the strength and weaknesses of hybrid imaging compared to 
other techniques. 
3. To understand how hybrid imaging could be developed in clinical practice. 
A-748 14:51  
C. CT  
F. Bamberg; Tübingen/DE (fabian.bamberg@uni-tuebingen.de)  
Given its high relevance, substantial research efforts have been focused on the 
development of different cardiac CT methods to obtain information on 
myocardial viability. Despite a relatively low level of scientific evidence, these 
approaches are currently initially entering the clinical arena. Analogous to the 
presence of late gadolinium enhancement on MRI, viability imaging using 
cardiac CT may be limited to the detection of delayed iodinated contrast 
enhancement on delayed CT acquisitions. However, from a clinical perspective 
CT myocardia imaging protocols are generally combined with myocardial 
perfusion imaging at rest and stress. In general, such a protocol includes as a 
first step perfusion imaging followed by a second step that includes a low-
radiation scan for the detection of DCE. Of note, perfusion imaging by CT can 
be conducted as a “single-shot” acquisition with or without dual energy or as a 
dynamic acquisition during rest or stress conditions. The talk will provide an 
overview of available approaches and protocols, highlight limitation, and review 
current level of evidence related to the role of CT for assessment of myocardial 
viability.  
Learning Objectives: 
1. To learn about the potential of CT to assess viability. 
2. To understand the strength and weaknesses of CT imaging compared to 
other techniques. 
3. To understand how to report CT for viability assessment. 
Author Disclosure: 
  F. Bamberg: Research/Grant Support; Siemens Healthineers, Bayer 
Healthcare. Speaker; Siemens Healthineers, Bayer Healthcare. 
15:14  







14:00 - 15:30 Studio 2018  
E³ - ECR Master Class (Genitourinary)  
E³ 1526b  
Update on functional genitourinary MRI  
Moderator:  
M. Studniarek; Gdansk/PL  
A-749 14:00  
A. Kidney  
N. Grenier; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr)  
Renal physiology is complex with two compartments functioning under highly 
different conditions. The cortex is highly perfused with a high level of oxygen, 
whereas the medulla shows a poor perfusion level and works under hypoxic 
conditions. Water movements are multiple along the nephrons to maintain 
normal homeostasis. Glomerular filtration rate is a major marker of renal 
function, but its measurement is complex to be obtained in clinics. All these 
parameters can be approached using functional MRI with DCE, DWI, and 
BOLD. However, validation of these tools and their impact on patient 
management still requires further prospective studies. Some of these 
techniques may reflect changes within the extracellular matrix of renal tissue 
during the process of renal scarring.  
Learning Objectives: 
1. To learn about the renal physiology and the pharmacokinetics of contrast 
agents. 
2. To understand the clinical and imaging features of renal disorders. 
3. To appreciate the incremental value of functional imaging in differential 
diagnosis. 
Author Disclosure: 
  N. Grenier: Advisory Board; Supersonic Imagine, Aix-en-Provence, France. 
A-750 14:30  
B. Prostate  
G.M. Villeirs; Ghent/BE  
Multiparametric magnetic resonance imaging (mpMRI) of the prostate 
combines T2-weighted MRI (T2w) with functional techniques such as diffusion-
weighted MRI (DWI) as a marker of cellular density, and dynamic contrast-
enhanced MRI (DCE) to assess neoangiogenesis. The minimal technical 
requirements for these techniques have been described in the Prostate 
Imaging, Reporting and Data System (PI-RADS) by the American College of 
Radiology and the European Society of Urogenital Radiology. T2w MRI detects 
prostate cancer as low signal-intensity (SI) areas in the peripheral zone (PZ) or 
transition zone (TZ). It provides sensitivity up to 85% for overall prostate cancer 
detection, but lacks specificity. DWI primarily detects higher-grade prostate 
cancers as areas of restricted diffusion (high SI on high b-value images; low SI 
on ADC maps) and improves the overall specificity. DCE detects cancers 
because of their early and rapid enhancement after contrast administration, but 
is useful for the PZ only, due to false-positive enhancement of benign prostatic 
hyperplasia in the TZ. Reporting of mpMRI has been standardized using the 
PI-RADS 5-point assessment scale, estimating the likelihood of clinically 
significant prostate cancer. Prostate biopsies directed to mpMRI-detected 
lesions have shown to be able to decrease the overall number of prostate 
biopsies, to increase detection of clinically significant prostate cancer and to 
decrease overdiagnosis of clinically insignificant prostate cancer. mpMRI-
guided biopsies are currently recommended in the setting of rebiopsy after a 
previously negative biopsy, but evidence has been accumulating showing that 
mpMRI-guided biopsies are equally useful in biopsy-naïve men. 
Learning Objectives: 
1. To understand the clinical and imaging features of prostatic disorders. 
2. To appreciate the incremental value of functional imaging in differential 
diagnosis. 
3. To become familiar with MRI-guided prostate biopsies. 
A-751 15:00  
C. Uterus  
E. Sala; Cambridge/UK (evis.sala@gmail.com)  
The standard MRI uterus protocol includes axial SE T1WI with a large FOV to 
evaluate the entire pelvis and upper abdomen for lymphadenopathy as well as 
bone marrow changes and high-resolution FSE T2WI in the sagittal, axial and 
coronal planes. Other extra planes and imaging sequences are specific and 
designed to answer a specific clinical question. Functional MRI sequences 
such as DCE-MRI and DW-MRI are now part of routine protocols. DCE-MRI is 
very useful for assessment of the depth of myometrial invasion in endometrial 
  







cancer. DW-MRI is now part of routine MRI protocol for evaluation of uterine 
malignancies. It should be performed at two or more b-values, which include 
one or more low b-values (50-100 s/mm2), since perfusion contribution to 
diffusion is then eliminated, and a very high b-value (750-1000 s/mm2). Both 
breath-hold and non-breath-hold DW sequences can be used. However, the 
type of DW sequence differs among manufacturers and the radiologist should 
be familiar with the strengths and limitations of their own scanners. A 
combination of DWI with conventional MRI sequences improves lesion 
detection and the radiologist confidence in imaging interpretation. DW-MRI can 
be useful for accurately determining the depth of myometrial invasion in 
endometrial cancer. In addition, ADC values are inversely related to the 
cellularity of tumours which may be useful for distinguishing between benign 
and malignant tissues and for monitoring tumour response to treatment in 
cervical cancer.  
Learning Objectives: 
1. To understand the clinical and imaging features of uterine disorders. 
2. To appreciate the incremental value of functional imaging in differential 
diagnosis. 
3. To learn about the imaging features of the treated uterus. 
14:00 - 15:30 Room E1  
Special Focus Session  
SF 15b  
Contrast-enhanced spectral 
mammography  
A-752 14:00  
Chairperson's introduction  
A. Athanasiou; Athens/GR (aathanasiou@mitera.gr)  
Mammography is the only imaging modality that has been shown to reduce 
mortality from breast cancer. Despite technical advances in full-field digital 
mammography, it is still not a perfect screening tool, especially in women with 
dense breasts. Contrast-enhanced spectral mammography has emerged 
several years ago and has been shown to be superior to FFDM for cancer 
detection. It can depict lesion neovascularity in an analogous manner to breast 
MRI. The dual-energy technique consists of acquisition of low- and high-energy 
images after intravenous iodine contrast agent administration in both CC and 
MLO views. The total acquisition time is about 5 min. Extra radiation dose 
depends on breast thickness, but still it is acceptable and inferior to the 
recommended mammographic dose. Recent studies comparing MG, CESM 
and MRI confirm better lesion detection with CESM and MRI compared to MG 
alone, both in the screening and diagnostic setting. Further possible indications 
include pre-operative local staging in case of multifocality/multicentricity, 
evaluation of response to NACT and possible correlation of enhancement 
pattern with intrinsic tumour biology/molecular subtype. CESM can be 
considered as an alternative to MRI in case of contraindications to MRI (limited 
availability, cost issues, claustrophobia, gadolinium allergic reactions, etc.). 
Further studies will define the future role of this promising technique. 
Session Objectives: 
1. To understand the technical principles of contrast-enhanced spectral 
mammography. 
2. To be familiar with the current indications in clinical practice and current 
published data on overall performance of contrast-enhanced spectral 
mammography. 
3. To appreciate future perspectives in screening and diagnostics setting. 
A-753 14:05  
Technique and comparative approaches  
M.B.I. Lobbes; Maastricht/NL (marc.lobbes@mumc.nl)  
Contrast-enhanced spectral mammography (CESM) or contrast-enhanced 
dual-energy mammography (CEDM) is a novel mammographic technique 
which is superior to full-field digital mammography (FFDM) and matches the 
performance of breast MRI, not only in terms of breast cancer detection but 
also in the assessment of disease extent. In a typical CESM exam, an iodine-
based contrast agent is administered intravenously two minutes prior to image 
acquisition. In general, an iodine contrast concentration higher than 300 mg/mL 
is used, with a dose of 1.5 mL/kg body weight. Preferably, an automated 
injector should be used with a flow rate of 3 mL/s. Next, the patient is 
positioned in the mammography unit like a regular FFDM exam, with image 
acquisition consisting of two views per breast: mediolateral oblique and 
craniocaudal. The exam consists of a low-energy image, which is similar to 
FFDM. However, the CESM exam also acquires a high-energy image to enable 
visualization of the iodine uptake. This image is not for diagnostic purposes, 
but is used to post-process a recombined image, which shows areas of 
contrast captation. On a PACS workstation, only the low-energy and 
recombined images are displayed. The principles behind CESM are similar to 
those used in breast MRI. Hence, several studies have compared the 
diagnostic performance of these two. These have shown that CESM has a 
similar or sometimes even better diagnostic performance than CESM. CESM 
exams tend to have less false-positive findings than breast MRI and are 
generally better tolerated by patients that underwent both exams.  
Learning Objectives: 
1. To understand the technical considerations of contrast-enhanced spectral 
mammography. 
2. To be familiar with the pitfalls and limitations of the technique. 
3. To have an overview of different comparative approaches. 
A-754 14:30  
Evidence for efficacy and implementation  
E.M. Fallenberg; Berlin/DE (eva.fallenberg@charite.de)  
X-ray mammography (MG) has been the gold standard for detection of breast 
cancer so far. However, the method is limited due to a reduced contrast 
difference between breast tumours and surrounding breast tissue, especially in 
dense breasts. In postoperative surveillance exams, scar tissue can 
compromise the detection of local recurrence due to postoperative architectural 
distortions mimicking or masking tumour growth. Also in ultrasound, it can be 
difficult to differentiate scar tissue, postoperative changes or local recurrence. 
To overcome the limits of mammography and ultrasound, especially in these 
conditions, dynamic contrast-enhanced breast MRI is very useful, but is limited 
in availability and reimbursement. The introduction of full-field digital 
mammography has presented the possibility of developing further technical 
methods, which are less expensive and widely available. One of these is 
contrast-enhanced spectral mammography (CESM). CESM is able to increase 
sensitivity without decreasing specificity, due to higher contrast and better 
lesion delineation than mammography alone. In this talk, I will present the 
clinical performance results of CESM versus mammography and ultrasound. I 
will show the additional value of CESM in screening assessment. The potential 
of this technique in imaging the response to neoadjuvant chemotherapy will be 
elaborated. The role in the detection of recurrence during follow-up 
examinations after breast-conserving therapy will be addressed as well. The 
potential advantages and disadvantages will be indicated and a sample of 
clinical cases will be presented to illustrate how CESM contributes to the 
detection of lesions and how it can be used in daily clinical workflow.  
Learning Objectives: 
1. To understand current indications for clinical implementation. 
2. To appreciate the added value of information provided by contrast-enhanced 
spectral mammography as a problem-solving tool in every day diagnostic 
dilemmas. 
3. To become familiar with the results of published studies on overall 
performance of contrast-enhanced spectral mammography comparing to digital 
mammography. 
Author Disclosure: 
  E.M. Fallenberg: Board Member; EUSOBI. Research/Grant Support; 
Siemens Healthcare, Guerbet, GE Healthcare. Speaker; GE Healthcare, 
Guerbet, Bayer Healthcare. 
A-755 14:55  
Finding the killer cancers? Can it replace MRI?  
C. Dromain; Lausanne/CH (Clarisse.Dromain@chuv.ch)  
Contrast-enhanced digital mammography is a relatively recently introduced 
imaging technique that uses an intravascular contrast agent to identify breast 
cancer on the basis of iodine signal enhancement from tumour angiogenesis. 
CESM is generally used in the diagnostic setting with clinical indications similar 
to breast MRI. However, while both CESM and MRI are based on the analysis 
of washing and washout of breast lesions, there are several technical 
differences potentially influencing the clinical performance and image 
interpretation. These major differences include 2D vs 3D images, contrast and 
temporal resolution, type and quantity of contrast agent, acquisition under 
compression vs free of compression, positioning, additional value of LE image 
and limited kinetic analysis for CESM interpretation. If MRI remains the most 
sensitive method for breast cancer detection, published data comparing CESM 
and MRI have shown a similar rate of primary tumour detection and size 
measurement. The largest prospective multicentre study conducted in 178 
patients found the overall sensitivity of MRI to be better than that of CESM 
(76% vs 72%, p <0.05), but the overall specificity of CESM was better than that 
of MRI (94% vs 88%, p <0.001). The difference in sensitivity in favor of MRI 
was explained by a better sensitivity for additional lesion detection (39% for 
CESM vs 49% for MRI), while the sensitivity for index lesion detection was 
identical (95% for CESM versus 94% for MRI). Based on published data 
including one meta-analysis, CESM can be considered as an alternative to 
  







MRI, in particular in the case of contraindications to MRI as well as difficulty in 
MRI availability.  
Learning Objectives: 
1. To understand the association between enhancing pattern information 
provided by contrast-enhanced spectral mammography and tumour biology. 
2. To appreciate the comparison of information provided by contrast-enhanced 
spectral mammography and breast MRI regarding lesion morphology and 
enhancement. 
3. To become familiar with published data comparing sensitivity and positive 
predictive value of the two techniques. 
Author Disclosure: 
  C. Dromain: Research/Grant Support; GE Health Care. 
15:20  
Panel discussion: Is contrast-enhanced spectral mammography the 
"mammography of the future"? Can it provide relevant morphological 
and functional information in everyday practice in a simpler manner? Can 
it replace breast MRI?  
14:00 - 15:30 Room E2  
Special Focus Session  
SF 15c  
My three top tips for neuroimaging  
A-756 14:00  
Chairperson's introduction  
J. Van Goethem; Antwerp/BE (johan.vangoethem@uantwerpen.be)  
Despite the vast amount of knowledge that is available in books, at courses 
and online, sometimes radiologists still miss basic and practical information for 
use in their daily practice. This session will provide easy-to-understand, easy-
to-learn and easy-to-remember tips on neuro-imaging. Each speaker will 
provide his or her top three tips in their field of expertise. The information will 
be presented in short 6-minute lectures focusing on these tips.  
Session Objectives: 
1. To learn practical tips and tricks usable in daily neuroimaging practice. 
2. To avoid common pitfalls in neuroimaging. 
3. To learn how to tackle common diagnostic problems in neuroimaging. 
A-757 14:05  
Leukodystrophies  
B. Ertl-Wagner; Munich/DE (Birgit.Ertl-Wagner@med.uni-muenchen.de)  
Leukodystrophies of the brain can be difficult to diagnose. It is important to be 
familiar with the different imaging patterns of metabolic disorders and with the 
typical clinical presentations. Crucial clinical information needs to include the 
age at presentation, the gender, the family history and the type and evolution 
of symptoms. Symptoms may be progressive or occur in crisis-like 
deteriorations. When interpreting images of patients suspected of suffering 
from a leukodystrophy always remember these three tips: (1) Know as much as 
possible about the clinical symptoms, the onset and time course of the 
symptoms and associated abnormalities. (2) Look for “gradients” in the images, 
e.g. anterior to posterior, inner to outer gradients of the white matter 
abnormalities. (3) Look for imaging patterns, such as zones, tigroid patterns or 
areas of abnormal enhancement.  
Learning Objectives: 
1. To learn about imaging protocols for the diagnostic evaluation of 
leukodystrophies. 
2. To become familiar with typical imaging patterns of the most common 
leukodystrophies. 
3. To gather an understanding of typical pitfalls in imaging leukodystrophies. 
A-758 14:11  
Hydrocephalus  
S. Kumar; Singapore/SG (sumeet.kumar@singhealth.com.sg)  
Hydrocephalus is a disorder of CSF hydrodynamics resulting in dilatation of the 
ventricular system. Imaging plays an important role in establishing the 
presence of hydrocephalus and distinguishing communicating hydrocephalus 
from non-communicating or obstructive hydrocephalus. The cause of 
hydrocephalus and complications arising from it can often be revealed by 
imaging. In this lecture, radiological signs of early hydrocephalus and review 
areas in a patient with hydrocephalus will be discussed. Imaging features 
distinguishing normal pressure hydrocephalus from age-related atrophy will be 
explored and the characteristics of DESH pattern of normal pressure 
hydrocephalus will be explained. 
Learning Objectives: 
1. To learn to distinguish communicating from non-communicating 
hydrocephalus. 
2. To identify the DESH pattern of chronic communicating hydrocephalus. 
3. To discern ventricular dilatation due to atrophy from chronic communicating 
hydrocephalus. 
A-759 14:17  
Acute ischaemic stroke  
P.M. Parizel; Antwerp/BE (paul.parizel@uantwerpen.be) 
Stroke is now a potentially curable disease, if discovered early enough. 
Imaging can help to establish an early diagnosis. Radiologists shoulds be 
familiar with the patient history and understand the neurological signs and 
symptoms; this information tells us WHERE to look and WHAT to look for. My 
“top tips” are focused on CT (still the mainstay for detecting acute stroke in 
most hospitals) and are: (1) Use narrow window-width (high contrast) CT 
review settings to increase detection of subtle stroke signs on CT. Many 
radiologists find it difficult to assess the stroke volume and extent on CT. Other 
tools, such as the ASPECTS score, can also improve sensitivity and specificity, 
especially for less experienced readers, but narrow window width settings are 
the first step. (2) Look for the hyperdense vessel sign, which refers to focal 
increased density in the vessel and reflects the presence of thromboembolic 
material within the lumen. It is most commonly observed in the middle cerebral 
artery, and less frequently in other cerebral vessels, e.g. basilar artery tip. (3) 
Perform CT angiography to look for blocked vessels, in order to decide if the 
patient is a good candidate for referral the the angiography suite for clot 
extraction. (4) Perform CT perfusion, to assess potentially viable brain tissue, 
the so called penumbra. This is the brain tissue at risk, surrounding the infarct 
core. On CT the penumbra is the area surrounding the core infarct with 
delayed arrival of contrast and prolonged MTT, and with preserved CBV 
(reflecting auto-regulation). 
Learning Objectives: 
1. To learn how to recognise acute infarct on NECT. 
2. To know when to use advanced imaging in acute stroke. 
3. To learn the indications for thrombectomy depending on NECT findings. 
A-760 14:23  
Low back pain  
M. Muto; Naples/IT (mutomar2@gmail.com)  
Clinical finding must correlate always with imaging finding before any type of 
minimal invasive or surgical procedure. This is a mandatory rule to avoid 
overtreatment and the development of post-treatment complications that are 
difficult to solve. Low back pain can be related to soft tissue abnormality, DDD 
or neoplastic lesion, and for this reason an appropriate diagnostic approach is 
necessary to exclude or include patients in the treatment. The use of 
multimodality imaging in evaluating low back pain is very important not only in 
the case of degenerative spine disease, but also in patients with clinical and 
imaging findings suspicious of primary or secondary spine neoplasm. 
Integration of MR with CT can have added value in understanding the pain 
source and excluding neoplasm or clarifying the type of neoplasm. In this case, 
never forget Nuclear Medicine study for a complete oncologic balance. Once 
you have excluded or confirmed the presence of a diffuse or solitary oncologic 
disease, it is possible to decide about a mini-invasive treatment or surgical 
treatment. The abscence of neurological deficit leads to a mini-invasive 
approach to disk disease with multiple treatment options.  
Learning Objectives: 
1. To learn how to match clinical and imaging findings. 
2. To understand how to use multimodality imaging in evaluating low back 
pain. 
3. To learn the possibilities of percutaneous treatments in low back pain. 
14:29  
Questions and discussion  
A-761 14:37  
Movement disorders  
T.A. Yousry; London/UK (t.yousry@ucl.ac.uk)  
Disease or degeneration of the basal ganglia, cerebral cortex and sometimes 
the thalamus give rise to disorders of movements (MD) known as dyskinesias 
(Greek: difficult movement), which can be differentiated into hypokinetic and 
hyperkinetic syndromes. We will concentrate on the hypokinetic syndromes, 
which include Idiopathic Parkinson’s disease (IPD), atypical PD (APD): multiple 
system atrophy (MSA), progressive supranuclear palsy (PSP) and cortico basal 
  







degeneration (CBD). These movement disorders (MD) are often difficult to 
diagnose and to treat. Up to now the diagnosis is based on clinical criteria. 
However, despite the fact that imaging plays an increasing role in establishing 
and confirming the diagnosis of MD, many radiologists are not familiar with the 
role of the various imaging techniques, in establishing the diagnosis, 
monitoring disease progression and furthering our understanding of the 
pathophysiology of MD. We will present on the most salient imaging signs that 
will allow the diagnosis of the these disorders.  
Learning Objectives: 
1. To be able to categorise movement disorders. 
2. To know the value of MRI in movement disorders. 
3. To learn how to differentiate different entities causing movement disorders. 
A-762 14:43  
Dementia  
S. Haller; Carouge/CH (Sven.Haller@affidea.ch)  
"no abstract submitted"  
Learning Objectives: 
1. To understand how ASL might improve confidence of diagnosing dementia, 
notably at early stages. 
2. To understand how SWI might contribute to the diagnosis of dementia with 
Lewy bodies. 
3. To understand that in many cases dementia has mixed degenerative and 
vascular pathology. 
A-763 14:49  
Multiple sclerosis  
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi.gencat.cat)  
In the last few years, techniques and clinical implementation of MR imaging of 
multiple sclerosis (MS) have markedly evolved based on the relatively large 
amount of new published data from clinical trials and observational studies, 
which assessed the value of this tool in the diagnosis and for monitoring and 
predicting treatment response of this disease. The aim of this presentation is to 
provide few tips for the clinical implementation of brain and spinal cord MR 
imaging in the diagnostic and monitoring process of patients with MS, based 
on an extensive review of recent literature and personal experience. These 
tips, which include the recommended brain and spinal cord MRI protocol, some 
key radiological features that help in the accurate diagnosis of this disease, 
and the role of MR imaging for monitoring and predicting treatment response, 
should help neuroradiologists in the optimization of the use of MR imaging in 
MS in clinical practice.  
Learning Objectives: 
1. To know the recommended brain and spinal cord MRI protocol in multiple 
sclerosis. 
2. To be familiar with the typical radiological features of multiple sclerosis. 
3. To learn how to use MRI for monitoring and predicting treatment response in 
multiple sclerosis. 
Author Disclosure: 
  A. Rovira-Cañellas: Advisory Board; Biogen, Novartis, Sanofi-Genzyme. 
Speaker; Biogen, Novartis, Roche, Stendhal, Teva. 
14:55  
Questions and discussion  
A-764 15:01  
Non-enhancing brain tumours  
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl)  
A non-enhancing adult brain tumour is commonly a low-grade glioma, but 30% 
of non-enhancing lesions prove to be anaplastic on histopathology. Moreover, 
the current molecular data suggest that 20% of the histologically low-grade 
tumours carry in fact the glioblastoma-like genotype (7+/10- TERT mutated) 
with a dismal clinical course similar to glioblastoma. Given this prognostic 
heterogeneity, the question is even whether tumour grade may retain its 
clinical relevance. Clearly, in patients with non-enhancing tumours mimicking 
relatively benign low-grade glioma, but with a molecular profile indicating 
clinical behaviour and prognosis of glioblastoma, any delay in initiating 
treatment will be detrimental. At the same time, the policy in patients with non-
enhancing tumours is controversial. A watch and wait policy is advocated by 
many physicians, while others recommend immediate surgery. Surgery, 
however, carries a risk for peri-operative morbidity in patients that are generally 
clinically asymptomatic, apart from usually well-controlled seizures. An early 
recognition of specifically patients with glioblastoma-like non-enhancing glioma 
by - advanced - MR imaging and analysis will greatly improve and allow for 
personalised treatment decisions.  
Learning Objectives: 
1. To learn the differential diagnosis of non-enhancing brain tumours. 
2. To learn the added value of advanced imaging techniques in non-enhancing 
brain tumours. 
3. To learn the most important pitfalls in assessing non-enhancing brain 
tumours. 
Author Disclosure: 
  M. Smits: Consultant; independent reviewer for Parexel Ltd. 
A-765 15:07  
Ring-enhancing brain lesions  
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at)  
When ring-like enhancing brain lesion is detected, the following questions 
arise: a) differentiation between an abscess and a neoplasm, b) bacterial or 
fungal origin, c) tuberculous lesion, d) parasitic infection, and finally e) 
demyelinating lesion? Diagnosis will be made using multiparametric MR 
imaging including conventional and advanced MR techniques (DWI, SWI, MR 
perfusion). This lecture will teach you how to create a quick road map and how 
to interpret MR imaging findings on different MR techniques to make a specific 
diagnosis of a ring-like enhancing brain lesion. 
Learning Objectives: 
1. To know the top differential diagnosis of ring-enhancing lesions. 
2. To recognise less common pathology giving rise to ring-enhancing lesions. 
3. To understand the value of advanced imaging in ring-enhancing lesions. 
A-766 15:13  
Assessment of tumour response/progression  
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se)  
Clinical information about primary diagnosis, treatment in the form of surgery, 
chemotherapy and radiotherapy and the time between the treatment and the 
present images are crucial for the correct differentiation between response and 
progression. Images alone can be misleading. In addition to the conventional 
MR sequences pre- and post-contrast administration, additional sequences like 
diffusion-weighted imaging and perfusion-weighted imaging can be valuable to 
differentiate between response and progression as well as these sequences 
can help especially to detect progressive disease before the lesion 
demonstrates contrast enhancement. All imaging shall be analysed together 
with the clinical information and previous MR examinations.  
Learning Objectives: 
1. To understand the importance of appropriate clinical information to be able 
to comment on response or progression. 
2. To understand the indications for diffusion and perfusion imaging in 
assessing response or progression. 
3. To be able to discuss the value of advanced imaging in the assessment of 
response or tumour progression. 
Author Disclosure: 
  P.C. Maly Sundgren: Investigator; I do research on the use of advanced 
imaging in brain tumor treatment effects. Research/Grant Support; I have 
funding from Swedish Research Council, Cancer Foundation and regional 
funding fro advanced MRI in monitoring brain tumor treatment, treatment 
effects and tumor grading. 
15:19  
Questions and discussion  
14:00 - 15:30 Room F1  
E³ - European Diploma Prep Session  
E³ 1523  
Gynaecological and obstetrics  
A-767 14:00  
Chairperson's introduction  
K. Kinkel; Chêne-Bougeries/CH (karen.kinkel@grangettes.ch)  
Imaging of the uterus and the adnexa uses primarly subsequent 
transabdominal AND transvaginal ultrasound with colour Doppler capabilities to 
determine the myometrial, endometrial or adnexal origin of gynaecological 
symptoms. According to the complexity or the size of the anomaly, magnetic 
resonance Imaging is the first problem-solving imaging tool with excellent soft 
tissue capabilities. This session will increase the participants' knowledge in 
learning adequate patient preparation, the appropriate imaging protocol for 
frequent clinical questions and important diagnostic features and rules for the 
  







most common gynaecological problems. Computed tomography of the 
abdomen and pelvis is usually indicated in emergency situations when a 
gynaecological versus urinary or bowel origin of the symptom is unclear. The 
indications, techniques and imaging findings of foetal imaging will be 
presented. 
Session Objectives: 
1. To understand the imaging presentation of the most common benign and 
malignant disorders of the uterus. 
2. To become familiar with inflammatory and neoplastic disorders of the 
adnexa. 
3. To understand the principles of foetal images and the imaging presentation 
of the most common foetal disorders. 
Author Disclosure: 
  K. Kinkel: Consultant; for Bayer in MRI of the uterus. Speaker; Philips 
symposium on Breast Ultrasound. 
A-768 14:06  
A. Imaging of the uterus  
R.A. Kubik-Huch; Baden/CH (rahel.kubik@ksb.ch)  
In this lecture, the current approach to uterine imaging and the advantages and 
limits of the various imaging modalities will be discussed. Ultrasound, usually 
using the high-resolution transvaginal approach, is the imaging modality of 
choice for the uterus. It is widely available and relatively inexpensive. 
Shortcomings with this imaging test are the limited field of view, obscuration of 
pelvic organs by the presence of bowel gas, inherent limitations dependent, 
and its dependence on the experience of the operator. The role of 
hysterosalpingography has become very limited in recent years. CT has an 
inferior soft tissue contrast compared to MRI and the disadvantage of ionising 
irradiation; its role is thus mainly limited to the emergency setting as well as 
oncologic staging of disease. With its high-contrast resolution, its ability to 
provide good tissue characterisation, and its multiplanar imaging capabilities, 
MRI is increasingly used to evaluate pathologies of the uterus. In this lecture, 
indications and contraindications of MRI will be reviewed. Patient’s preparation 
for pelvic MRI and the imaging sequences, tailored to the specific clinical 
questions, will be discussed.The audience will learn about the normal zonal 
anatomy of the uterus, congenital anomalies as well as variations of the uterus 
during the menstrual cycle and in the postmenopausal phase. The spectrum of 
normal and pathologic findings and the most important benign and malignant 
pathologies of the uterus will be reviewed and the role of MRI for staging 
cervical and endometrial cancer will be discussed. 
Learning Objectives: 
1. To comprehend the imaging anatomy of the uterus and its changes 
throughout life and during pregnancy. 
2. To understand typical imaging features and the local imaging-based staging 
of cervical cancer. 
3. To become familiar with the typical imaging features of benign disorders of 
the uterus, especially uterine leiomyomas, adenomyosis and endometriosis. 
A-769 14:34  
B. Disorders of the adnexa  
T.M. Cunha, M. Horta; Lisbon/PT (tmargarida@gmail.com)  
Adnexal disorders are commonly identified in radiologists’ daily practice, mostly 
after minor pelvic complaints or incidentally. The majority of disorders 
correspond to benign ovarian lesions of no concern, but the clinical impact in 
predicting malignancy is crucial for proper patient management. 
Ultrasonography (US) remains the first-line imaging technique to investigate 
adnexal disorders, with about two-thirds being correctly characterized using 
transvaginal US with colour Doppler. Magnetic resonance imaging (MRI) is a 
second-line technique, with higher accuracy than US, and particularly helpful in 
the assessment of complex and sonographically indeterminate adnexal 
masses. An algorithmic MRI approach using basic and problem-solving 
sequences allows to differentiate benign from malignant tumours, and to 
ensure a specific diagnosis in the majority of adnexal masses. Solid tissues 
with intermediate T2 signal, diffusion restriction and time intensity curve type 3 
on dynamic contrast-enhanced MRI, as well as peritoneal implants, are 
important predictors of malignancy. In the emergency setting of acute or 
subacute pelvic pain of women of reproductive age, inflammatory disorders of 
the upper gynaecologic tract should be considered. Computed tomography 
(CT) is often performed to assess gynaecologic disorders and to exclude 
gastrointestinal and urologic diseases. Tubo-ovarian inflammatory diseases 
often cause complex cystic masses and simulate malignant adnexal tumours. 
Bilateral involvement, tubular adnexal masses, perilesional infiltration and 
endometrial thickening in the appropriate clinical and laboratory context 




1. To describe the imaging features of benign tumours of the ovaries. 
2. To understand the diagnostic evaluation and imaging features of malignant 
tumours of the ovaries. 
3. To explain the imaging features of inflammatory disorders of the Fallopian 
tubes. 
A-770 15:02  
C. Fundamentals of foetal imaging  
D. Prayer; Vienna/AT  
Foetal MRI can be done at 1.5T or at 3T. Body or cardiac coils are used and 
ultrafast seqeunces are applied, the duration of which does not exceed 20-30 
seconds on average. The emphasis of foetal MRI lies on providing information 
that cannot be received by ultrasound which is still the mainstay of prenatal 
imaging diagnosis. Cerebral malformations involving cortical development 
and/or infratentorial regions are among the most frequent indications for foetal 
MRI, as information on these structures may alter the prognosis of gross 
malformations considerably and thus change the further management of these 
pregnancies. Acquired pathologies of the brain comprise infection and/or 
haemorrhage. The high sensitivity of MRI to visualize parenchymal damage 
and blood breakdown products allows to give accurate information on such 
processes. in the foetal body, MRI is used in many centres for the assessment 
of lung development in a variety of pathologies such as, for instance, 
congenital diaphragmatic hernia, other lung malformations, or premature 
rupture of membranes which may also be associated with impaired lung 
development. Complex malformations including more tha one organ system 
can be classified , establishing a respective prognosis and sometimes allowing 
a conclusion on a genetic background. Prerequisites of performing foetal MRI 
successfully is a wide knowledge on prenaatl cerebral and extracerebral 
development and deviations thereof. In addition, a training at a foetal MRI 
centre might be useful to learn the methodical details and troubleshooting, as 
foetal MRI differs from other MRI methods.  
Learning Objectives: 
1. To describe the methodology and technical principles of foetal MR imaging. 
2. To understand the imaging presentation of common pathologies of the foetal 
central nervous system. 
3. To understand the imaging presentation of common pathologies of the foetal 
body. 
14:00 - 15:30 Room F2  
Joint Session of the ESR and EU Commission  
ESR/EU  
eHealth in radiology: policies, practices, 
pitfalls, potential  
A-771 14:00  
Chairperson's introduction  
K. Riklund; Umea/SE (katrine.riklund@umu.se)  
eHealth is a priority topic in which the ESR is actively engaged, having been a 
member of the European Commission’s eHealth Stakeholder Group since 
2012. A white paper on teleradiology has been published on insight into 
imaging and an online survey was conducted in 2012. Recently, HIMSS 
Europe and the ESR launched the Digital Imaging Adoption Model (DIAM) as a 
benchmarking programme to guide the adoption of IT supported processes in 
radiology departments. So, radiology is heavily involoved in eHealth and at the 
session we will learn a lot more of policies, practices, pitfalls, and potential.  
Session Objectives: 
1. To learn about the ESR's eHealth policy positions, initiatives and tools. 
2. To understand the European Union's eHealth policies. 
3. To understand the complementarity of and tensions between eHealth policy 
and practice. 
4. To learn about the present status and future outlook for eHealth in radiology 
from the policy makers' and practitioners' perspectives. 
Author Disclosure: 
  K. Riklund: Board Member; Swedish Drug Authority. Speaker; GE, Paris 











A-772 14:05  
ESR eHealth SC and eHealth policy positions  
E. Neri; Pisa/IT (emanuele.neri@med.unipi.it)  
The ESR eHealth and Informatics is a subcommitte of the ESR Quality and 
Safety Committee. The main activities of the subcommittee have been focused 
on the following: (A) Development of the ESR-RSNA joint Structured reporting 
initiative. The initiative is ruled by a memorandum of understanding signed in 
2015 between RSNA and ESR aimed at promoting the development of 
structured reports available on the radreport.org website of RSNA. The 
initiative led to the creation of a Template Library Advisory Board Panel, an 
editorial board that revises and validates the SR Templates. The eHealth 
subcommittee produced a ESR position paper on Structure reporting that is 
under publication in Insight Into Imaging. (B) Impact of the Data Protection 
Regulation on the Radiology profession. In 2016 the EU delivered the General 
Data Protection Regulation (GDPR), that provides rules on how to protect the 
citizens data in the digital era. The eHealth subcommittee has produced a ESR 
position paper on "What the radiology should know about the GDPR", recently 
published in Insight Into Imaging. (C) Proper Use of Mobile Devices in 
Radiology. In the digital single market mobile devices (smartphone, tablets, 
PCs) are used by multiple physicians as a tool for helping their clinical practice. 
In radiology mobile devices are used as DICOM user, as eLearning tool, for 
social media access to improve communication. All these aspects are 
discussed in the ESR Position paper on the "Use of mobile devices in 
radiology" under publication in Insight Into Imaging.  
Learning Objectives: 
1. To learn about the ESR eHealth SC activities. 
2. To understand the role of eHealth tools within radiology. 
3. To learn about the ESR policy positions on eHealth issues. 
Author Disclosure: 
  E. Neri: Advisory Board; QUIBIM. 
A-773 14:20  
EU Strategy for Digital Transformation of Health and Care  
T. Piha; Brussels/EU  
"no abstract submitted" 
Learning Objectives: 
1. To learn about the EU's eHealth policies. 
2. To understand the EU Digital Single Market Strategy. 
3. To understand how EU policies impact radiology. 
A-774 14:35  
Member States Joint Action on eHealth  
C.M. Auer; Vienna/AT  
"no abstract submitted" 
Learning Objectives: 
1. To learn about the EU Member States Joint Action on eHealth. 
2. To understand the links between European Commission and Member State 
eHealth activities. 
A-775 14:45  
ESR eHealth tools  
B. Brkljai	; Zagreb/HR (boris@brkljacic.com)  
The adoption of eHealth systems has already revolutionised radiologists’ daily 
routine and, with big data and artificial intelligence, the next revolution appears 
to be just around the corner. The ESR supports its members caught up in 
these developments by providing a variety of eHealth tools and materials. 
CDS: In cooperation with the American College of Radiology and National 
Decision Support Company, the ESR has developed the clinical decision 
support system, ESR iGuide. Using the ESR’s referral guidelines based on the 
ACR Appropriateness Criteria, ESR iGuide can be integrated into CPOE 
systems to provide actionable, evidence-based guidance to help referrers 
select the most appropriate imaging test at the point of patient care. CDS 
referrals for the first time enable statistical analysis of incoming requests for 
radiology departments, and these data can be used to improve performance or 
be linked with other data sets like dose data or structured reports to 
understand the correlations between the interrelated tasks in the imaging value 
chain. The ESR has been working in cooperation with the Radiological Society 
of North America (RSNA) on a joint structured reporting initiative. The first step 
in this cooperation is the creation of structured reporting templates for a 
template library to cover clinical scenarios suitable for structured reporting. To 
facilitate the adoption of these templates in practice, the ESR is exploring 
cooperation with PACS and voice recognition systems. In addition, the ESR’s 
eHealth and Informatics Subcommittee is publishing a paper on structured 
reporting in radiology, setting out the ESR’s conceptual approach.  
Learning Objectives: 
1. To learn about the ESR's clinical decision support initiative ESR iGuide. 
2. To learn about the ESR-RSNA cooperation regarding structured reporting. 
3. To understand how the ESR views the use of eHealth tools in clinical 
practice. 
A-776 14:55  
ESR-HIMSS Digital Imaging Adoption Model  
J. Studzinski; Leipzig/DE (jstudzinski@himss.org)  
The Digital Imaging Adoption Model (DIAM) has been jointly developed by 
ESR and HIMSS Europe to provide clinical and managerial users of medical 
imaging technology with a tool to assess the maturity of their Imaging-IT 
investments and implementations. The model is designed to identify potential 
gaps in infrastructure and workflow, to monitor technological progress, to 
enable benchmarking with peer organisations and to provide a roadmap for 
strategic and operational planning as well as investment decisions. The DIAM, 
launched in 2016 at ECR, can be used by hospitals with imaging departments 
or external imaging centres collaborating with hospitals across the globe. The 
DIAM associates participating organisations with one of 8 stages. Stage 0 
indicates a low level of imaging IT maturity and Stage 7 represents advanced 
maturity. Participants of the session will learn how the DIAM can be used, 
which organisations have been assessed so far and what benefits they have 
received from participation. An outlook about future developments will also be 
provided.  
Learning Objectives: 
1. To understand the concept of the Digital Imaging Adoption Model (DIAM). 
2. To learn about the benefits in participating in the DIAM. 
3. To learn about the DIAM stages, survey and certification. 
Author Disclosure: 
  J. Studzinski: Employee; HIMSS Europe GmbH. 
A-777 15:05  
Patient perspective on EU eHealth policies  
N. Bedlington; Vienna/AT  
"no abstract submitted" 
Learning Objectives: 
1. To learn about the ESR-PAG view of eHealth policy in the EU. 
2. To understand how patients can benefit from eHealth tools. 
3. To learn about concerns about the adoption of eHealth from the patient's 
view. 
15:15  
Panel discussion: The role of medical societies in implementing EU 
eHealth policy  
14:00 - 15:30 Room D  
Emergency Imaging  
RC 1517  
The latest update in imaging of polytrauma 
patients  
A-778 14:00  
Chairperson's introduction: The role of proper imaging and management 
in patients after severe trauma  
M. Stajgis; Poznan/PL (stajgis@gmail.com)  
The rationale of emergency procedures in severe trauma patients is based on 
the time factor and adequate selection of patients and proper imaging 
modalities. The “Golden Hour” concept describes the need for as-fast-as-
possible management of these patients very well. The present-day diagnostic 
workup of polytrauma patients is mostly based on whole body CT (WBCT); 
however, this method is thought to be overused in some clinical scenarios. 
Therefore, we should look very carefully again at advantages and limitations of 
still evolving all modern diagnostic modalities such as ultrasound, CT and MR. 
All three lectures in this session are dedicated to effective imaging of 
polytrauma patients, management priorities in different clinical situations and 
suggested practical approach. 
Session Objectives: 
1. To understand the role of early and fast diagnostic imaging in patients after 
severe trauma. 
2. To recognise the basic statistics in management of polytrauma patients 
  







which have impact on practical approach regarding selection of proper 
diagnostic modalities and imaging findings. 
3. To be aware of the position and responsibilities of a radiologist in "decision-
making team". 
A-779 14:05  
A. Ultrasound: when, why and by whom?  
P.-A. Poletti; Geneva/CH  
"no abstract submitted" 
Learning Objectives: 
1. To become familiar with the role of modern ultrasound in polytrauma 
patients. 
2. To comprehend the rationale of using FAST protocol in selected patients. 
3. To know the advantages and limitations of ultrasound imaging in emergency 
setting. 
A-780 14:31  
B. CT: is it always whole body?  
F.H. Berger; Toronto, ON/CA (fhberger@gmail.com)  
In the Western world, polytrauma is the major cause of mortality in people 
under 45 years of age. Furthermore, it is a major contributor to loss of quality of 
life and ability to work. The setting of polytrauma is almost always chaotic, not 
a favourable environment to come to timely diagnosis and treatment. To 
decrease morbidity and mortality, time is everything. It is our job as radiologists 
to contribute to the trauma team and help facilitate timely diagnosis - and in 
many cases, also timely treatment by interventional radiology. To reach the 
best treatment strategy for the patient as quickly and accurately as safely 
possible is the goal. In this update on imaging of polytrauma patients, I will 
focus on the role of CT to achieve this goal. With the progress in CT scanner 
development, different protocol options arise. Which CT protocols are being 
used and what factors do they depend upon? In addition, there has been a 
widespread increase in the use of whole-body CT internationally: is this a good 
thing or should we be more selective? What is the current evidence to select 
patients for targeted CT examinations in polytrauma? A lot of these questions 
have not been definitively resolved. This lecture aims to provide an update of 
the current insights into the use of CT for trauma care, with the goal of 
choosing wisely on how to investigate the polytrauma patient in a timely and 
meaningful fashion.  
Learning Objectives: 
1. To be familiar with currently worldwide accepted protocols in polytrauma CT 
imaging. 
2. To know clinical conditions requiring whole-body CT. 
3. To comprehend the selection of trauma patients for targeted CT 
examinations. 
A-781 14:57  
C. Where is the proper place for MRI?  
K. Katulska; Poznan/PL (katarzyna_katulska@op.pl)  
A multimodality of imaging should be involved in the diagnosis and 
management of severely injured multi-trauma patients. The current role of 
magnetic resonance imaging (MRI) of the spinal cord and brain injuries is 
confident. MRI examination is the imaging method of choice in the assessment 
of lesion morphology, extent and severity of trauma. In case of neurological 
symptom not completely explained in CT findings, an MRI must be performed. 
Among all post-traumatic intracranial pathologies, the diagnosis of diffuse axial 
injury remains more complex. In fact, about 30% of negative CTs are already 
positive on MRI. MRI is a powerful diagnostic tool that can detect signs of 
injury such as minute bleeding (microhaemorrhage), small areas of bruising 
(contusion) or scarring (gliosis), which are invisible to the CT scan. Newer, 
specialized types of MRI can assess brain structure at an even finer level or 
measure brain function to detect alterations in brain structure and function due 
to traumatic spinal cord and brain injury (SCI, TBI). The protocol for routine 
MRI of patients with TBI and SCI, which consists of SE and GRE sequences, is 
proposed. MRI techniques such as SWI, DWI and DTI are discussed, as a new 
standard protocol. In the acute setting, MRI can determine the presence and 
extent of injury and guide surgical planning and minimally invasive 
interventions. Neuroimaging also can be important in the chronic therapy of 
injury, identifying chronic sequel, determining prognosis, and guiding 
rehabilitation.  
Learning Objectives: 
1. To learn which patients are the best candidates for post-traumatic MRI. 
2. To be familiar with standard and short MRI examination protocols. 
3. To understand the impact of MR findings on further management of 
polytrauma patients. 
15:23  
Panel discussion: Summarising comprehensive guidelines, how to 
qualify post-traumatic patients for the proper imaging modality  
14:00 - 15:30 Room G  
Physics in Medical Imaging  
RC 1513  
Dose reduction and image quality 
implications of iterative image 
reconstruction in CT  
A-782 14:00  
Chairperson's introduction  
K.N. Bolstad; Bergen/NO (kirsten.bolstad@helse-bergen.no)  
Ever since the development of the first CT, the quest has been to get as much 
information as possible in as short amount of time as possible. In the early 
days of CT, the reconstruction time per image was limited by computer power 
and effective reconstruction algorithms. The filtered back projection algorithms 
(FBP) were a compromise between reconstruction speed and image noise. 
Iterative reconstruction algorithms (IR) takes into account a mathematical 
assumption of the CT system, which results in less image noise but with a 
longer reconstruction time compared to FBP. Today, with more powerful and 
faster computers, IR has become a part of the daily routine. The noise 
reduction can either be used to improve image quality at the same dose or 
maintain similar image quality at a lower dose, typically 25-40% dose reduction 
compared to FBP. Recently, more advanced model-based iterative 
reconstruction algorithms have become commercially available with a 
reconstruction time suitable for the clinical routine. These algorithms take into 
account a mathematical model of the entire system, from the focal spot size 
and x-ray spectrum to the detector system, resulting in a nearly “noise-free” 
image. The dose-saving potential for these newer algorithms is up to 80-90% 
compared to FBP. However, the application of IR does not come without a 
cost. Even though the image noise is reduced, the appearance of the image 
may change. Each vendor's IR has a different appearance and a different 
dose-saving potential. Radiologists need time to get used to the new 
appearance.  
Session Objectives: 
1. To learn about the origins of dose reduction using iterative image 
reconstruction in CT. 
2. To understand dose reduction using iterative image reconstruction in CT. 
3. To learn about solutions and workarounds. 
A-783 14:05  
A. Basics of iterative image reconstruction in CT  
M. Kortesniemi; Helsinki/FI (mika.kortesniemi@hus.fi)  
Computed tomography image reconstruction is a mathematical process where 
the raw data projections (sinogram data) acquired during rotational CT scan 
exposure are transformed into volumetric (3D) image data. As such, 
reconstruction is an inverse problem, with no direct analytical solution. 
Traditional algorithms (filtered back-projection) approximate the true acquisition 
method and are prone to artefacts and noise. Iterative reconstruction methods 
approach the final solution gradually in steps and may take quantum statistics, 
physical properties and limitations of image acquisition more faithfully into 
account. Thus, a more accurate and correct outcome may be achieved. 
However, more detailed modelling of the actual CT acquisition system, physics, 
optics and object also increases the calculation time and related CPU 
requirements. Especially, the forward projection phase (calculation of 
simulated raw data) on each iteration step is computationally intensive. More 
optimised reconstruction techniques with clinically acceptable reconstruction 
times are under active research. As the main diagnostic benefit, higher image 
quality in terms of lower noise and artefacts can be achieved by using iterative 
methods, and/or a lower radiation dose. However, users should be aware that 
current iterative reconstructions potentially alter the image texture in different 
clinically relevant contrast and detail levels. Therefore, sufficient clinical image 
quality should be verified when applying iterative techniques on new exam 
indications and protocol optimization.  
Learning Objectives: 
1. To learn about the basic aspects of iterative reconstruction. 
2. To learn about potential dose reduction via iterative reconstruction. 
3. To compare iterative reconstruction with other techniques. 
  







A-784 14:28  
B. Iterative image reconstruction in clinical practice (dos and don'ts)  
H. Alkadhi; Zurich/CH (hatem.alkadhi@usz.ch)  
The broad use of computed tomography (CT) is paralleled by concerns 
regarding its potential risks. In the past years, these concerns have led to the 
development of a set of strategies for optimising and lowering the radiation 
dose of CT. Of these techniques, iterative reconstruction algorithms represent 
a powerful tool, because they allow lowering the dose at a constant noise level 
and image quality. However, caution must be taken when iterative 
reconstruction algorithms are being used, and radiation dose can be lowered 
only to a level where information in the CT images are not lost. This 
presentation reviews the clinical challenges of using iterative reconstruction 
techniques in CT imaging, with a focus on low radiation dose examinations. 
The different iterative reconstruction techniques are discussed, along with their 
benefits and potential pitfalls.  
Learning Objectives: 
1. To understand the radiologist’s requirements for image reconstruction. 
2. To learn about current best practice in image reconstruction for clinical CT. 
3. To learn about the potential benefits and pitfalls of using iterative 
reconstruction in clinical CT. 
A-785 14:51  
C. Image quality assessment of iterative reconstruction: pitfalls and 
future directions  
E. Samei; Durham, NC/US (samei@duke.edu)  
Enabled by increased computational power of recent years and motivated by a 
desire to reduce CT radiation dose, iterative reconstruction methods have 
become a staple component of modern CT technology. While these methods 
offer a renewed opportunity to optimise dose and image quality, they also 
necessitate a renewed approach towards image quality in CT. Many metrics 
that have traditionally been deployed to characterise and optimise CT 
performance, no longer directly apply to CT images that are iteratively 
reconstructed. The first-order metrics of contrast, resolution, and noise need to 
be extended to second- and third-order metrology of task transfer function 
(TTF), noise power spectrum (NPS), detectability and estimability indices, and 
noise heterogeneity. New methods have been developed to measure these 
new metrics and integrate them in the optimisation process. This presentation 
offers a description of the traditional and new CT image quality metrology, 
outlines the new methods of their assessment, and highlights their utility for 
improved patient care.  
Learning Objectives: 
1. To learn about basic image quality metrics employed in CT. 
2. To understand why image quality assessment is difficult with iterative 
reconstruction. 
3. To learn about up-and-coming methods for image quality assessment. 
Author Disclosure: 
  E. Samei: Advisory Board; medInt Holdings, LLC. Grant Recipient; Siemens, 
GE. 
15:14  
Panel discussion: How low can we go?  
14:00 - 15:30 Room K  
EFRS Workshop  
EFRS WS  
Making the most of social media  
A-786 14:00  
Chairperson's introduction: Social media in healthcare  
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie)  
This is an essential session for any ECR attendees who are active on social 
media. Each year, the European Federation of Radiographer Societies (EFRS) 
delivers a workshop session as part of the main ECR programme with this 
year’s session focusing on the pervasive topic of social media. Facebook, 
Twitter and LinkedIn, which will all be referenced in this session, have a 
combined total of two billion active users worldwide. Social media offer all 
health professionals with new opportunities and new challenges. If used 
appropriately, social media can: enhance peer to peer communication and 
communication with patients and the public; provide educational and 
continuous professional development (CPD) opportunities; allow professional 
societies to more effectively engage with their membership; enhance the reach 
and engagement at international congresses; and facilitate better patient 
engagement with imaging services. For any health professionals using social 
media, they must be aware of the boundaries between personal use and 
professional use, consider confidentiality and data protection, and respect best 
practice guidelines on the appropriate use of social media. For professional 
societies and professional regulators, there is a growing need to implement 
clear policies on appropriate and professional use of social media.  
Session Objectives: 
1. To consider the wide range of use of social media in healthcare, healthcare 
education, and research. 
2. To highlight the importance of all health professionals being aware of best 
practice in professional social media use. 
A-787 14:05  
Enhancing communication and collaboration through social media  
M.J. Díaz Candamio; Ferrol/ES (mjdcandamio@gmail.com)  
Social media (SoMe) that changed our way of getting information and 
communicating is also an incredibly powerful professional networking tool. 
Nevertheless, health-care professionals are using SoMe to a lesser extent than 
specialists from other sectors, probably because it is a highly regulated field, in 
which data privacy is crucial, with many perceived risks and potential threats. 
Radiology is among the health-care fields with lesser presence in SoMe. This 
situation correlates with the fact that radiology professionals perform our work 
“in the dark”, with little recognition on the part of patients. SoMe can end with 
this unawareness of our work. The SoMe-mediated social interactions allow 
many kinds of professional collaboration, including not only sharing information 
and experiences but also discussion on procedures or diagnosis. Personal 
branding of doctors, practices or institutions as well as academic publishing 
promotion are other well-known uses of SoMe publishing. We can utilize SoMe 
in radiology to disseminate knowledge, which is crucial at a time when patient-
centred medicine is practised, in which patients participate in diagnostic and 
imaging-guided procedure decision-making. This collaborative networking is 
global, with fewer language barriers. Nevertheless, the use of English makes 
universal sharing of content easier. SoMe networks have also potential risks, 
including not only false information but even false identities. If you still do not 
use SoMe for professional purposes in radiology, you should be aware of the 
risks, but exploit their advantages as soon as possible. Keep in mind about 
being authentic and professional as well as respecting patient’s data 
confidentiality.  
Learning Objectives: 
1. To explore how social media allows us to enhance communication and 
collaboration between colleagues and patients. 
2. To consider the importance of establishing clear guidance on the use of 
social media for radiologists and radiographers. 
3. To gain some top tips on the dos and don’ts of professional social media 
use. 
A-788 14:20  
#MedRadJClub: a Twitter journal club  
N.H. Woznitza; London/UK (nicholas.woznitza@nhs.net)  
Social media are increasingly being used by health-care professionals, 
including radiographers. #MedRadJclub, a Twitter-based monthly radiographer 
journal club was first held in March 2016. Use of the digital space removes 
barriers to traditional journal club participation, such as geographical 
boundaries, and connects radiographers across the globe. An hour-long chat, 
centred on a key paper chosen from the literature, acts as a forum for 
radiographers to discuss research, share best practice and access continuing 
professional development (CPD). Over 1,000 radiographers have participated 
in the chats, with the website accessed from 101 countries. The impact of 
#MedRadJclub includes accessible CPD, research collaborations and a bi-
annual conference on advanced radiographer practice.  
Learning Objectives: 
1. To understand how Twitter can be used as an alternative to face to face 
journal clubs. 
2. To learn how #MedRadJClub works, what it offers over conventional 
journals clubs, and why radiographers should participate. 
3. To appreciate the impact of #MedRadJClub. 
A-789 14:35  
The value of social media to professional societies  
E. Alfayate Sáez1, M.A. de la Cámara Egea2, N.I. Vega de Andrea3; 
1
Madrid/ES, 2Jaen/ES, 3Girona/ES (ealfayate@fundacioncien.es)  
The aim of this paper is to understand the importance of a digital society and 
the type of knowledge that can be transferred within a digital environment. 
Online presence that lacks activity is not synonym of success. Activity is what 
drives information so that it can be conveyed and create a bigger impact in 
  







digital communities. Use requirements: integrating information related to the 
entity and other new content or links, and to moderate the interaction of 
followers in their comments. Digital marketing (content marketing): variables of 
engagement (encouraging conversation and commitment to the community). 
Effective use of popular digital channels: Facebook, LinkedIn, YouTube and 
Twitter. In the recruitment of key users in a WhatsApp group, the conversation 
has been standardised to: a) improve digital competencies, b) pinpoint interest 
in digital content, and c) create useful conversations for the profession. 
Identifying focus in each channel: the informative content (news from the 
corporate Web or other resources) has been adapted to each type of social 
network. Twitter: corporate information (digital framework), diverse subjects. 
Facebook: corporate information, resources for professionals. LinkedIn: 
corporate information, resources for professionals. YouTube: video reports of 
events that are useful to focus more attention on the congressional activity of 
the entity. External relationship: SEGRA joins health conversations that are not 
related to radiology. Twitter: identifying hashtags related to health. Facebook: 
share content and foster conversations. Value for followers and following 
groups: news about technology, information related to events, moderating 
conversations throughout the social networks, proposals of innovative topics, 
and to find out what the communities’ needs are.  
A-790/A-791 14:50  
Social media at ECR  
S. Lee, K. Friedrich; Vienna/AT, (simon.lee@myesr.org), 
(konrad.friedrich@myesr.org)  
Social media such as Facebook, Twitter and Instagram are frequently a part of 
participants’ experiences at medical meetings, with users’ activity ranging from 
casual photos of their breakfast, to in-depth discussion of scientific content. For 
meeting organisers, engaging with social media users and encouraging 
interaction can be of benefit to both the event and its participants. By 
maintaining an active presence on social media, the organiser gives meeting 
attendees an easy point of contact and a reliable source of information, while 
also being able to monitor and contribute to conversations surrounding the 
event. The European Society of Radiology (ESR) has used social media to 
connect with attendees of its annual meeting, the European Congress of 
Radiology (ECR), for a number of years and has explored ways to stimulate 
the use of those platforms. Many ECR attendees use Facebook and Instagram 
to share their experience of the congress (and the ESR is active on both 
platforms), but it is Twitter that has been the most interesting platform for the 
ESR with regard to the ECR in recent years, especially in terms of feedback 
and discussion of programme content. A steady rise in participation on Twitter 
reached another new high at ECR 2017, with an increase in ECR hashtag 
usage, both in terms of the number of users and the volume of activity. This 
presentation will look at how and why the ESR uses social media in relation to 
its annual meeting and why Twitter is currently our primary focus.  
Learning Objectives: 
1. To learn how social media can be used effectively to enhance engagement 
in a congress. 
2. To explore the scale and impact of social media at ECR 2017. 
3. To consider what more social media can add to ECR. 
A-792 15:05  
Improving patient engagement through social media  
L. Robinson; Salford/UK (l.robinson@salford.ac.uk)  
The presentation will take a case study approach by presenting one particular 
example of social media in imaging: the Word of Mouth Mammogram e-
Network (WoMMeN) developed for UK breast screening clients. Following a 
description of WoMMeN, evaluative data from the WoMMeN project will be 
presented to determine whether social media can lead to improved patient 
engagement. The definition of ‘engagement’ here takes on a broad 
perspective. It will consider not only engagement in the screening programme 
(i.e. attending for the examination), but also engagement in service quality 
improvements. Finally, the lens will be focused more narrowly to explore the 
impact on individual women. This will take the form of illustrative examples, 
online interactions taken directly from our WoMMeN social media hub and 
associated Facebook page. 
Learning Objectives: 
1. To explore how social media can be used to improve patient engagement 
with imaging services. 
2. To learn about social media use in the Word of Mouth Mammogram e-
Network (WoMMeN). 
3. To appreciate the impact of online interactions with patients. 
15:20  
Panel discussion: Making better use of social media: what should we 
consider?  
14:00 - 15:30 Room M 4 
E³ - ECR Academies: Tips and Tricks in Pancreatic and GI Tract 
Imaging  
E³ 1522  
The anal canal: does MRI make it easy?  
A-793 14:00  
Chairperson's introduction  
S. Halligan; London/UK  
As chair of this session, I will introduce the topic of anal MRI, its clinical 
relevance, and how this will be addressed by the speakers. An interactive case 
presentation illustrating the topic will also be presented.  
A-794 14:05  
A. MRI of the anal canal: from normal anatomy to local tumour staging  
C. Hoeffel; Reims/FR  
Although a rare disease, anal cancer is increasingly being diagnosed in 
patients with risk factors, mainly anal infection with the human papilloma virus. 
Magnetic resonance imaging (MRI) with external phased-array coils is 
recommended as the imaging modality of choice to grade anal cancers and to 
evaluate the response assessment after chemoradiotherapy, with a high 
contrast and good anatomic resolution on the anal canal. MRI provides a 
performance evaluation of size, extent and signal characteristics of the anal 
tumour before and after treatment, as well as lymph node involvement and 
extensions to the adjacent organs. MRI is also particularly helpful in the 
assessment of complications after treatment and in diagnosis of disease 
recurrence. We will propose an MRI protocol for imaging of the anal canal, 
explain the MR anatomy of the anal canal and review possibilities of MRI in the 
evaluation of tumour in both the pre- and posttreatment context. 
Learning Objectives: 
1. To learn the relevant sequences for MRI of the anal canal. 
2. To understand the anatomy as demonstrated by MRI. 
3. To become familiar with the staging of primary tumour, before and after 
treatment. 
A-795 14:33  
B. Fistulae-in-ano: detect, stage, classify  
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk)  
MRI is a critical tool for the evaluation of fistulae-in-ano and in particular for the 
surgical management of complex or recurrent cryptoglandular perianal sepsis 
and in patients with fistula from Crohn’s disease who can be treated medically 
or surgically. The MRI sequence selection can target water/oedema (STIR or 
fat saturated T2) or contrast enhancement (post contrast fat saturated T1). 
Correct orientation of MR scan planes to the axis of the anal canal is critical to 
allow correct assessment of fistula anatomy for surgical planning, and Park’s 
Classification is the most commonly accepted by surgeons and should be used 
by radiologists. Reports should follow a uniform structure including the Park’s 
classification type of the fistula, the location of internal opening, course of the 
fistula, position of the external opening and number and position of 
extensions/secondary tracks.  
Learning Objectives: 
1. To learn about the relevant MRI sequences in patients suspected of fistulae-
in-ano. 
2. To understand the most common classification of fistulae. 
3. To become familiar with the questions asked by the clinician before 
treatment. 
A-796 15:01  
C. My tough cases  
F. Maccioni; Rome/IT (francesca.maccioni@uniroma1.it)  
Perianal disease (PD) has a low prevalence in the overall population, 
approximately of 0,01%. It develops more frequently in Crohn's disease (CD) 
and in haematological malignancies (HM). Usually, perianal CD develops in 
association with lesions of the small and large bowel, in 23% to 38% of CD 
patients, including children. In CD, the fistulous tracts are much more complex 
than that in the fistulas of cryptoglandular origin, and are usually associated 
with ramifications and abscess. They are considered as some of the most 
disabling complications of Crohn’s disease (CD), especially in children and 
young adults. Perianal disease is, in fact, frequently associated with aggressive 
intestinal or colorectal disease. The association of anal fistulas with rectal 
  







disease represents a negative prognostic factor due to the higher risk of radical 
proctectomy and definitive ileostomy. Early diagnosis and prompt clinical 
management are fundamental for a positive outcome. High-resolution MRI is 
the gold standard for the first diagnosis and staging of perianal fistulas. MRI 
results are crucial in the therapeutic planning, addressing the patients towards 
pharmacological or surgical treatment. MRI also plays a primary role in the 
assessment of fistula healing after medical or surgical treatment. Perianal 
fistulas, unfortunately, tend to recur in more than 30% of cases, despite 
pharmacological and surgical treatments.  
Learning Objectives: 
1. To learn from clinical experience the unusual presentation of diseases of the 
anal canal. 
2. To understand how to report on MRI after treatment. 
14:00 - 15:30 Room M 5 
Transatlantic Course of ESR and RSNA (Radiological Society of 
North America): Sports Imaging  
TC 1528  
Musculoskeletal interventional procedures  
Moderators:  
L.W. Bancroft; Orlando, FL/US  
A.J. Grainger; Leeds/UK  
A-797 14:00  
A. Diagnostic and therapeutic injections in the athlete: pearls and pitfalls  
P. Peetrons; Brussels/BE (ppeetrons@his-izz.be)  
Before any treatment of tendons and ligaments with any ultrasound-guided 
technique, a correct diagnosis must be achieved. One of the main pitfalls is to 
treat incorrectly diagnosed lesions. This is unfortunately too often the case. 
Patients sometimes come for therapy with a wrong diagnosis or a non-imaged 
documented diagnosis. Some examples are the so-called pes anserine 
bursitis, the so-called trochanteric bursitis, an underestimated rotator cuff tear 
which appears to be a full-thickness instead of a partial thickness tear, and a 
Haglund deformity considered as an Achilles tendinopathy. The examples are 
numerous. A second pitfall is the use of a treatment which is non-adapted to 
the pathology. Using steroids to cure the degenerative changes within a tendon 
may lead to a short-time improvement, but not to a longtime healing of the 
lesion. Depending on the scheduled and importance of sports activity, the 
choice of the treatment can be different. Tendon needling and PRP injections 
are the major actual treatments for long-term regeneration of collagen fibres 
within tendons and ligaments. But they need time and rest. A good post-
therapy rehabilitation must be followed by the sportsman.The quality and 
quantity of the plasma and the platelets are also of very big importance. In 
tendons, in athletes, the plasma must be as poorly cellular as possible, and the 
centrifugation of the blood must give 1.5 to 2.5 the native account of platelets. 
It has been shown that a too heavy concentration may have adverse effects on 
regeneration.  
Learning Objectives: 
1. To become familiar with the most common requests and indications for 
sports-related injections. 
2. To learn about technical considerations for performing MSK injections. 
3. To understand reasons to delay injections or avoid certain injectables. 
Author Disclosure: 
  P. Peetrons: Investigator; GE for evaluation of an Ultrasound Unit. 
A-798 14:30  
B. Injectables, percutaneous tendon fenestration and tenotomy: clinical 
outcomes and current evidence  
J. Jacobson; Ann Arbor, MI/US (jjacobsn@umich.edu)  
For joint abnormalities and tendinopathy, there exists many percutaneous 
treatment options. Anaesthetic agents are used, often combined with 
corticosteroids, to inject joints and bursae for diagnostic and therapeutic 
purposes. With regard to anaesthetic agents, all are cytotoxic to chondrocytes 
and synovial cells to some degree. Corticosteroids may be used to decrease 
inflammation within a synovial space. The use of corticosteroid to treat 
tendinopathy is counterintuitive, as inflammation is not present, injection into 
tendon causes tenocyte death, and the analgesic effect of corticosteroids is 
short lived, and therefore the underlying tendon pathology is not treated. A 
number of ultrasound-guided tendon treatments can be used for tendinopathy. 
One treatment is percutaneous tendon fenestration or tenotomy. With this 
procedure, a needle is passed through the abnormal tendon segment 
repeatedly to break up the degenerative process, induce bleeding and 
inflammation, and initiate the healing of the abnormal tendon. Other 
procedures include the injection of autologous whole blood during the 
fenestration process, as well as the injection of platelet-rich plasma during 
fenestration. With this latter technique, the autologous whole blood is 
centrifuged to concentrate the platelets for injection. All three of these 
percutaneous tendon treatments have been shown to be effective, although it 
is controversial which technique is best. The cost of each procedure should 
also be considered. There exists newer and more controversial percutaneous 
tendon treatment, such as injection of mesenchymal stem cells, human 
amniotic membrane, and deer antler velvet. These procedures are largely 
considered experimental until research studies demonstrate their safety and 
efficacy.  
Learning Objectives: 
1. To be aware of the indications and benefits of available injectables used to 
treat sports-related injuries. 
2. To learn about technical considerations for performing tendon fenestration 
and tenotomy. 
3. To become familiar with the current evidence on results of MSK procedures 
in the literature. 
Author Disclosure: 
  J. Jacobson: Advisory Board; GE, Philips. Author; Elsevier. Consultant; 
Bioclinica. 
A-799 15:00  
C. Interactive case discussion (part 1)  
P. Peetrons; Brussels/BE (ppeetrons@his-izz.be)  
Interactive discussions on cases will be performed with the audience. The 
indication of percutaneous treatment of tendons and muscles will be 
emphazised, compared with indications of steroid injections. The importance of 
a correct diagnosis, prior to any interventional technique, will be stressed out.  
Learning Objectives: 
1. To learn the targeted approach to injecting joints, ligaments, tendons and 
tendon sheaths. 
2. To appreciate pitfalls to avoid in MSK procedures for treatment of sports-
related injuries. 
3. To understand evidence-based data on various MSK procedures in order to 
give patients realistic expectations after treatment. 
Author Disclosure: 
  P. Peetrons: Investigator; GE for evaluation of an Ultrasound Unit platform. 
A-800 15:15  
C. Interactive case discussion (part 2)  
J. Jacobson; Ann Arbor, MI/US (jjacobsn@umich.edu)  
The purpose of the interactive case discussions is to emphasize the teaching 
points made in the prior lecture reviewing injectables, percutaneous 
fenestration, and tenotomy. One topic to be addressed will be the imaging 
findings and potential treatment algorithm for greater trochanteric pain 
syndrome. In this clinical scenario, a true distended and inflamed bursa is not 
common and the primary pathology relates to gluteal tendinopathy. Before 
pursuing an interventional procedure, conservative management such as 
proper eccentric physical therapy should be exhausted. The next consideration 
could be injection of corticosteroid in the subgluteus maximus (or trochanteric 
bursa) for the primary purpose of providing temporary pain relief so that the 
patient can tolerate eccentric physical therapy. The corticosteroid injection is 
not used as an anti-inflammatory agent as true inflammation is not present, 
and the pain relief is typically short lived. If the patient again fails eccentric 
physical therapy, then the patient may be offered percutaneous fenestration, 
autologous whole blood injection, or platelet-rich plasma injection. While all 
three have been shown to be effective, it is still unclear which treatment is best. 
The dramatic differences in cost should be a consideration when selecting the 
tendon treatment.  
Learning Objectives: 
1. To learn the targeted approach to injecting joints, ligaments, tendons and 
tendon sheaths. 
2. To appreciate pitfalls to avoid in MSK procedures for treatment of sports-
related injuries. 
3. To understand evidence-based data on various MSK procedures in order to 
give patients realistic expectations after treatment. 
Author Disclosure: 
  J. Jacobson: Advisory Board; GE, Philips. Consultant; Bioclinica. Other; 












16:00 - 17:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1621  
Errare humanum est  
A-805 16:00  
A. Errors in chest radiograph  
J. Cáceres; Barcelona/ES (josecac@gmail.com)  
Errors in diagnostic imaging are not uncommon and the radiologist is 
responsible for most of them. In this presentation, I intend to analyse the most 
common causes of errors in chest imaging and how to avoid them. Perceptual 
errors are the most common ones, accounting for up to 50% of errors 
committed by radiologists. For a variety of reasons, in this type of error the 
radiologist does not see the abnormality, which may be obvious or subtle. 
Some search findings are missed because we do not search for additional 
abnormalities after the first one is found. Perceptual errors can be avoided if 
we get into the habit of using checklists.  
Learning Objectives: 
1. To learn to recognise ambiguous signs in plain films. 
2. To learn to avoid the most common pitfalls in reading plain chest films. 
A-806 16:45  
B. Errors in CT of the chest  
J. Vilar; Valencia/ES (vilarsamper@gmail.com)  
Observer errors in Chest radiographs and chest CT: The aetiology of error in 
radiology is multi-factorial. In this presentation, I will concentrate on errors 
attributed to the radiologist. Not seeing a lesion (perceptual error) and not 
recognizing a pathology (interpretative error) are by far the most common 
causes. In a study of 500 cases, perceptual errors accounted for 80% and 20% 
were interpretative errors. Perceptual errors occur in CT, as in chest 
radiographs, despite the fact that CT is a tomographic technique. These errors 
may be related to technical factors such as noise, resolution, and use of 
adequate technical protocols including the use and timing of contrast media. 
Vigilance errors are those due to an insufficient time (reading too fast), 
satisfaction of search (interrupting vigilance), or inadequate clinical information 
(ignoring suspicion of pathology). Erroneous interpretation of the findings may 
be related to ignorance and inadequate information. The radiologist could 
avoid these errors by applying simple rules such as using checklists, taking 
enough time to read the studies, comparing with previous examinations, and 
using the clinical data. In this interactive presentation of cases, I will analyze 
some common causes of errors in chest CT and offer simple clues to avoid 
them.  
Learning Objectives: 
1. To learn to interpret ambiguous chest CT signs. 
2. To learn to avoid the most common pitfalls in reading chest CT images. 
16:00 - 17:30 Room B 
Abdominal Viscera  
RC 1601  
Tumour response assessment in 
abdominal imaging  
Moderator:  
S.M. Erturk; Istanbul/TR  
A-807 16:00  
A. Colorectal liver metastases  
S.K. Venkatesh; Rochester, MN/US (venkatesh.sudhakar@mayo.edu)  
Metastatic liver disease occurs in 30-50% of colorectal cancer patients. Neo-
adjuvant chemotherapy (NAC) is the treatment of choice for colorectal liver 
metastases (CRLM). Local control with percutaneous ablation methods and 
surgical resection in those who show response to NAC have evolved as 
treatment options in patients with CRLM only. Accurate definition of number, 
distribution, site and response of CRLM is critical information defining anatomic 
resectability. It is therefore important to assess the response of CRLM to 
chemotherapy and ablation methods for assistance in guidance to further 
management. Standard methods (RECIST) use size criteria to assess 
decrease in size as response; however, there are pitfalls to these methods. 
Viability of CRLM can also be assessed with dynamic contrast-enhanced MRI 
(DCE_MRI), diffusion weighted imaging (DWI), and positron emission 
tomography (PET) after NAC. The chemotherapy also causes liver toxicity 
including sinusoidal obstruction syndrome and fatty change that affect the 
assessment of response of CRLM and define resectability. This presentation 
will review the response of CRLM to treatment, methods of response 
assessment, and limitations and advantages of these methods in the 
management.  
Learning Objectives: 
1. To learn about different methods to assess the tumour response in the 
colorectal metastases. 
2. To understand usefulness and limitation of techniques and the role of 
different contrast media. 
3. To appreciate variable response pattern of colorectal liver metastases. 
A-808 16:30  
B. Rectal carcinoma  
M.J. Lahaye; Amsterdam/NL (MJ.Lahaye@gmail.com)  
MRI is the modality of choice for rectal cancer (re)staging. The high soft-tissue 
contrast of MRI can accurately assess the extramural tumour spread and 
relation to surrounding structures after chemoradiation. This lecture will have 
practical approach in determining the role of MRI in the restaging of rectal 
cancer. The relevant anatomy, MRI techniques, rationale for neoadjuvant 
treatment, and post-chemoradiation therapy imaging (including detection of 
patients with a complete response) will be discussed with special attention to 
how to apply recent advances in knowledge to daily clinical practice.  
Learning Objectives: 
1. To learn about the rationale for neoadjuvant treatment in rectal cancer and 
the impact on subsequent surgery. 
2. To understand why imaging is needed to assess response to neoadjuvant 
therapy, what to look for when judging response, and where the challenges lie. 
3. To appreciate when surgery can be deferred or avoided and how best to 
follow-up these patients. 
A-809 17:00  
C. Pancreatic adenocarcinoma  
M. Zins; Paris/FR (mzins@hpsj.fr)  
Patients with pancreatic ductal adenocarcinoma (PDA) must be selected for 
first-line surgery based on the likelihood of achieving complete curative 
resection with negative margins (R0). In doubtful cases and when the risk of 
incomplete resection (R1 or R2) is high, neoadjuvant chemoradiotherapy 
should be given. Neoadjuvant therapy can convert tumours classified as locally 
advanced by initial imaging studies to resectable tumours. However, the 
imaging study evaluation of the response to neoadjuvant therapy is extremely 
complex. Thus, the diagnostic performance of imaging studies is not sufficient 
to ensure the accurate selection of patients in whom negative-margin resection 
is likely to be achieved. More specifically, standard criteria for predicting 
vascular invasion, based on the amount of tumour-vessel contact, are not valid 
after neoadjuvant therapy. The high risk of underestimating the histological 
response warrants surgery in all patients without indisputable evidence of 
disease progression after chemo(radio)therapy. Patients with even partial 
decreases in tumour size and/or tumour-vessel contact are particularly good 
candidates for surgery. The role for functional imaging techniques can be 
expected to increase in the next few years.  
Learning Objectives: 
1. To understand the rationale for neoadjuvant treatment in pancreatic 
adenocarcinoma. 
2. To learn the limitations of CT in assessing treatment response. 
















16:00 - 17:30 Room N  
Cardiac  
RC 1603  
Coronary CT angiography: how to start 
practice, perform and evaluate the exam?  
Moderator:  
M. Hrabak Paar; Zagreb/HR  
A-810 16:00  
A. Beautiful cases from clinical practice: coronary arteries  
S. Feger; Berlin/DE (sarah.feger@charite.de)  
Coronary computed tomography angiography (CTA) is a non-invasive 
diagnostic test with high diagnostic accuracy in detecting coronary artery 
disease (CAD). Due to its very high negative predictive value, it is especially 
suitable for ruling out CAD in patients with low to intermediate pretest 
probability. For stable chest pain patients in this pretest probability range, the 
current European guidelines already recommend the use of CTA. Additionally, 
in patients with unstable chest pain and a low CAD probability, CTA can be 
considered to detect relevant differential diagnoses. An important advantage of 
CTA compared with invasive coronary angiography is the possibility to perform 
a differentiated plaque analysis including the detection of high-risk plaque 
features besides the stenosis quantification. Different acquisition techniques 
are applied in clinical practice. Initially, retrospective ECG-gated CTA was 
routinely used. While this approach is very robust, especially for high or 
irregular heart rates, radiation exposure is relatively high. Prospective axial 
scanning reduces radiation exposure, since data acquisition is only performed 
in predefined ranges within the RR interval with the tube current entirely being 
turned off outside the acquisition window. Further approaches to reduce 
radiation exposure are the adjustment of scanning parameters, ECG-gated 
tube current modulation (adjusted to the heart rate and variability), automatic 
tube potential selection and, recently, the introduction of iterative 
reconstructions.  
Learning Objectives: 
1. To learn about cardiac CT acquisition techniques, pitfalls, and dose-
reduction strategies. 
2. To summarise current indications and clinical applications of CT coronary 
angiography. 
3. To review the diagnostic performance of CT for the diagnosis of coronary 
artery disease. 
4. To learn how to make a structured report of the coronary CT angiography. 
A-811 16:35  
B. Staff training and technical requirements  
S. Harden; Southampton/UK (stephen.harden@uhs.nhs.uk)  
Imaging the coronary arteries with CT is an increasingly frequent CT 
examination being performed in radiology departments in Europe and across 
the world. It is unusual as a diagnostic CT technique in that it is a procedure, 
involving careful pre-scan drug administration and fine attention to detail such 
that good image quality is obtained at a reasonable radiation dose to the 
patient. As such, this requires a team approach, with every member of the 
team performing a crucial function to ensure the safety of the patient and a 
successful procedure. Staff training is important and this is required for new 
staff, but also for experienced staff where practice review and optimisation 
meetings allow ongoing service improvement. Given that the drugs 
administered change cardiac physiology, staff must be trained in basic life 
support techniques and there must be a process for calling for urgent clinical 
backup even though these situations are rare. As this technique becomes 
more widely used and available, we are seeing an increasing role for CTCA in 
acute chest pain imaging and the team approach to patient care is as important 
if not more important in the acute or emergency setting.  
Learning Objectives: 
1. To become familiar with technical prerequisites and post-processing tools for 
coronary CT angiography. 
2. To discuss a necessary team setup and training modules for radiologists 
and technical staff. 
3. To evaluate the role of coronary CT angiography and requirements for the 
radiological team in routine imaging and in emergencies. 
 
 
A-812 16:55  
C. Beautiful cases from clinical practice: stents and bypasses  
G. Bastarrika; Pamplona/ES (bastarrika@unav.es)  
Advances in cardiac CT and development of new multidetector computed 
tomography (MDCT) scanners have allowed accurate and robust non-invasive 
assessment of coronary artery revascularization procedures. This requires 
development of detailed CT acquisition protocols with specific reconstruction 
parameters and the appropriate use of different post-processing techniques. 
From the clinical perspective, radiologists need to become familiar with diverse 
types of grafts as well as with typical CT findings after coronary artery bypass 
grafts (CABG) surgery and stent placement. In this lecture, the value of 
coronary CT angiography after coronary intervention will be underlined by 
defining MDCT acquisition protocols designed to evaluate coronary artery 
revascularization procedures. Further, the surgical aspects of CABG, 
postoperative graft anatomy, and interpretation of pitfalls when evaluating 
CABG and stent patency will be discussed.  
Learning Objectives: 
1. To emphasise the value of coronary CT angiography after coronary 
interventions. 
2. To outline CT acquisition protocols and contrast administration strategies to 
evaluate coronary stents and coronary artery bypass grafts (CABG) in 
individuals undergoing coronary revascularisation. 
3. To describe usefulness and limitations of different post-processing 
techniques in assessing stent and CABG patency. 
16:00 - 17:30 Studio 2018  
Special Focus Session  
SF 16  
Placental imaging: how, when and why?  
A-813 16:00  
Chairperson's introduction  
M. Weston; Leeds/UK (michael.weston2@nhs.net)  
The high rates of caesarean delivery and the later ages that women are 
choosing to have their children are leading to an increase in the incidence of 
placental problems. Both placenta praevia and abnormal placental attachment 
disorders are commoner the greater the number of prior uterine surgical 
interventions and the older an expectant mother is. Radiologists are finding 
new roles in helping their obstetric colleagues manage these complications. 
Magnetic resonance imaging and interventional procedures are developing 
apace. These three presentations will give us an up-to-date insight into their 
application.  
Session Objectives: 
1. To understand the new imaging modalities available to assess the placenta. 
2. To recognise the signs of abnormal placentation. 
3. To learn about new interventional techniques in the management of 
postpartum haemorrhage. 
A-814 16:05  
Modern MRI of the placenta  
N. Siauve; Colombes/FR (nathalie.siauve@aphp.fr)  
Recent developments in magnetic resonance imaging (MRI) offer new 
perspectives for placental imaging, using fMRI tools to explore vascularisation, 
oxygenation and metabolism. Diffusion weighting imaging (DWI) and intra-
voxel incoherent motion (IVIM) MRI study the movement of water molecules 
within tissues and provide information about vascularisation and tissular 
structure. Quantitative parameters are available: the apparent diffusion 
coefficient (ADC), the perfusion fraction (f), the pseudo-diffusion coefficient (D*) 
and the diffusion coefficient (D). Blood oxygen level-dependent (BOLD) MRI 
uses the hemoglobin (Hb) as an endogenous contrast agent. The oxygen 
saturation of Hb modifies its magnetic properties, and modifications of T2* can 
be depicted when two different statuses of oxygenation are compared. Arterial 
spin labelling (ASL) MRI relies on magnetically labelled water to quantify the 
blood flow (F). Dynamic contrast-enhanced MRI (DCE-MRI) is best able to 
quantify perfusion and permeability. The enhancement of the organ of interest 
after intravenous injection of a gadolinium-based contrast agent is compared to 
the enhancement of the arterial input function, using compartmental model. 
However, the use of gadolinium-based contrast agents during pregnancy is still 
limited to situations when the benefits outweigh the potential risks. Modern 
imaging of the placenta will integrate fMRI techniques in the follow-up of 
pregnancy as numerous biomarkers will become available. The objectives of 
such modern imaging will be to improve the detection of placental insufficiency 
  







and the management of high-risk foetuses. A platform dedicated to human 
foeto-placental research (LUMIERE) will be created soon and will allow further 
research in this area.  
Learning Objectives: 
1. To describe how the vascularisation and the oxygenation of the placenta can 
be explored, using functional MRI. 
2. To list and explain the different parameters of each functional MRI technique 
that is available. 
3. To give an overview of the potential applications in normal and pathologic 
pregnancies. 
A-815 16:30  
Placental abnormalities, timing of imaging, methods and diagnosis  
G. Masselli; Rome/IT (gabrielemasselli@libero.it)  
Placental abnormalities have a profound impact on morbidity and mortality of 
both mother and foetus, underlining the importance of an early diagnosis. The 
placenta may show pathologies in terms of size, adherence, cord insertion, 
cord location and bleeding, and in few cases may also develop trophoblastic 
and non-trophoblastic tumours. Placental adhesive disorders (PADs) are 
characterized by different levels of uterine myometrial invasion that relate to 
different levels of severity and risk of blood loss upon delivery. PADs seem to 
parallel the increase in C-section rate and maternal age, and can be easily 
diagnosed by ultrasound (US); magnetic resonance imaging (MRI) is likewise 
performed either for delivery planning or equivocal cases. Another cause of 
third trimester bleeding is placenta abruption, defined as premature separation 
of the placenta that complicates 1% of pregnancies; US has a sensitivity as low 
as 25% and, when negative, MRI is usually diagnostic. Systematic assessment 
of the placenta by US is the standard imaging examination during pregnancy. 
MRI is used for equivocal cases or when further placental characterization is 
required in view of its multiplanarity, its improved tissue contrast and lack of 
radiation. We will discuss which imaging modalities are used to study the 
placenta, which sequences and planes better delineate this organ, and which 
are the circumstances that require their use, particularly with regard to PADs. 
The advantages of MRI in the diagnosis and management of patients affected 
by these pathologies will be thoroughly discussed along with the most common 
pitfalls. 
Learning Objectives: 
1. To learn about the likelihood and causes of abnormal placental attachment. 
2. To understand the role of US and MR in making the diagnosis. 
3. To appreciate the imaging signs and pitfalls. 
A-816 16:55  
Abnormally invasive placenta: vascular anatomy and interventional 
radiology approaches to management  
C. Hammond; Leeds/UK (christopherhammond@nhs.net)  
Abnormal placentation is increasing in incidence. It now occurs in about 1 in 
500 deliveries in the West. It encompasses a range of pathological entities 
from superficial adherence of placental villi to the myometrium (accreta) to 
penetration through the uterine wall and invasion into surrounding organs 
(percreta). It is associated with massive haemorrhage at delivery in some 
women, though the risks of this are difficult to prospectively determine with any 
certainty, even in women with typical imaging features of abnormal 
placentation. The classical approach to management of abnormal placentation 
has been caesarian hysterectomy, though a number of uterus-conserving 
surgical techniques have been developed. The interventional radiological [IR] 
techniques of balloon occlusion (of various arteries) and embolisation (with 
various agents, and in various vascular territories) have been undertaken to 
either augment or replace open surgery. Evaluation of these techniques is 
complicated by a heterogeneity of approaches between studies and the 
difficulty of accurately assessing haemorrhage risk beforehand. This talk will 
discuss the vascular anatomy of the gravid uterus and its relevance to both IR 
and surgical approaches to the management of actual or potential massive 
obstetric haemorrhage in the presence of abnormal placentation. The evidence 
in support of these techniques will be examined including evidence of safety 
and outcome. The logistical and infrastructural requirements for a truly 
multidisciplinary approach to the management of abnormal placentation will be 
reviewed and then finally the pre-procedural imaging information needed by 
the surgeon or IR will be highlighted.  
Learning Objectives: 
1. To discuss the arterial supply to the uterus and its importance in 
haemorrhage control in abnormal placentation 
2. To discuss the options for haemorrhage control and evidence to support 
each approach 
3. To examine the logistics and infrastructure required to provide an obstetric 
haemorrhage service  
Author Disclosure: 
  C. Hammond: Advisory Board; NICE GDC AAA. Author; Papers on 
haemorrhage control in massive obstetric haemorrhage. 
17:20  
Panel discussion: Is MR scan now a prerequisite for the modern 
management of placental problems?  
16:00 - 17:30 Room L 8  
ESR Patient Advisory Group (ESR-PAG)  
PA 2  
Big data: implications for medical imaging 
and the need for data protection and cyber 
security  
A-817/A-818 16:00  
Chairpersons' introduction  
N. Bedlington1, L.E. Derchi2; 1Vienna/AT, 2Genoa/IT (derchi@unige.it)2 
This session will see different presenters discuss about "big data" in radiology, 
each from his/her perspective. This is a difficult but important topic which will 
have great impact on our discipline (and on the whole healthcare sector). The 
session will specifically address the need for data protection. It is in fact quite 
important to understand the topic of protection of "sensible" data and of cyber 
security. Then, hopefully, it will provide a platform to share opinions and 
decisions on a topic which is getting more and more important in the whole 
healthcare sector and, specifically, in the imaging field.  
Session Objectives: 
1. To understand the importance of big data in medical imaging and related 
implications for patients, radiologists, and radiographers. 
2. To understand the need for data protection and cyber security to combat the 
vulnerability of healthcare. 
3. To learn practical examples. 
A-819 16:10  
Implications of protection of medical imaging data: a European 
perspective  
C.D. Becker; Geneva/CH  
The new general data protection regulation of the European Union will be 
effective in May 2018. Processing and communication of health data including 
images will require explicit consent by the data subject and all patients must 
have access to their personal data. Key elements of the new regulation also 
include the right to obtain rectification of his/her personal data; the right of the 
data subject to transfer personal data to another service provider ("data 
portability"); or the right of the data subject to be informed when his/her data 
have been hacked. The new GDPR implies that all organisations processing 
personal data must be able to prove that they comply with the rules. It also 
proposes a European Data Protection Board and requires institutions which 
process certain types or volumes of data to have a designated data protection 
officer (DPO) who is in contact with the national data protection 
authorities.There is an obvious need to find a reasonable balance between 
protection of individual health data and data use in the interest of public health 
and research projects by means of " big data" analysis. Anonymisation and 
pseudonymisation of digital data are undispensable tools in this context. Codes 
of conduct may be created by specific groups of users to define exceptions 
such as big data analysis or biobanks for scientific purposes. Specific rules 
may also be defined by national law.  
Learning Objectives: 
1. To understand the impact of the new data protection regulation for 
processing and sharing of imaging data. 
2. To understand the need to find a balance between protection of individual 
health data and data use in the interest of public health and research projects 
including “big data". 
3. To discuss safeguards for data processing in the context of research and 
public health projects, including "big data”. 
A-820 16:25  
Cyber security in radiology  
J. Sosna; Jerusalem/IL (jacobs@hadassah.org.il)  
The increase in the number of imaging studies worldwide and especially in 
Europe necessitates the need to secure the integrity of the data. Although 
many organizations have cyber security programmes, many others have not 
  







yet acknowledged the seriousness of the threat. Security breaches occur when 
hackers enter the Internet Protocol (IP) address of medical equipment and data 
centres that appears to be at risk. Hackers can use the device as an entry 
point to access the rest of the facility’s network. The hacker could cause the 
imaging equipment to malfunction or block access to PACS and RIS. This can 
be potentially life threatening, such as in a case of increasing radiation in a CT 
scanner for instance or limiting access to patient studies when necessary. 
Radiologists need to be familiar with such treats and help integrate cyber 
security into the workplace culture. The threats and possible solutions will be 
presented and discussed.  
Learning Objectives: 
1. To understand what cyber security is and its implications for radiology. 
2. To learn a practical example from Israel and lessons learnt. 
Author Disclosure: 
  J. Sosna: Advisory Board; Persimio. Consultant; Xact. 
A-821 16:40  
Importance of data protection from a patient's view  
E. Briers; Hasselt/BE (erikbriers@telenet.be)  
Not all patients are equal, and not all diseases are equal. Some patients have 
illnesses that can be interpreted as benign, such as a common cold. For 
others, the disease is serious and even life threatening. Very often patients 
with serous diseases face long disease journeys with multiple visits to doctors, 
hospitals and even treatments. During this journey, data are generated in every 
step, simple and complex data, but all pertaining to the patient. This 
information, these data, describes the fate of the patient: what has happened, 
is happening and what will happen to this patient. Patients do not like this to be 
read or seen by everybody. If this information is made available to an insurer, 
the patient, after having been pronounced cured, may not be eligible for 
insurance coverage. If the patient looks for a new employment, the information 
on his or her misfortune with the disease may make him unappealing to an 
employer. But, during the journey and even after the journey, the medical 
records contain important data that may speed up future diagnosis, make new 
symptoms understood quickly and help implement correct treatments faster. All 
those from the multi-professional team then need access to the complete data. 
They need to be bound by their professional ethics not to abuse this 
information. In clinical trials, sharing data is from the patient's perspective 
included in the concept and for patients sharing real-world data that could 
improve future applications of treatment is so far an unfulfilled dream.  
Learning Objectives: 
1. To understand the importance of data sharing and protection of patient data. 
2. To learn implications of misuse of patient data. 
3. To understand the necessity of data sharing to improve the patient journey 
through her/his disease. 
A-822 16:55  
Experiences from the US  
J.A. Brink; Boston, MA/US  
Data security in health care is governed in the United States by the Health 
Insurance Portability and Accountability Act (HIPAA) of 1996. The HIPAA 
privacy rule established standards to secure the personal/protected health 
information (PHI) and medical records of US citizens. It applies to all health-
care providers who interact with individual patient’s health records and includes 
all relevant electronic communications and transactions. Moreover, it applies to 
all relevant health-care institutions, insurance companies, and affiliated 
institutions that have access to protected health information. PHI refers 
generally to information that may identify individuals and the care they receive 
through medical history details, imaging and laboratory results, insurance 
information and other demographic information.  
Learning Objectives: 
1. To discuss the status of data protection and cyber security in the US. 
2. To learn a practical example of data misuse, implications and lessons learnt. 
17:10  
Panel discussion: What is the future direction of data protection and 





16:00 - 17:30 Room E1  
ESR Working Group on Ultrasound  
WG 1  
Ultrasound-guided interventional 
procedures: new techniques and 
applications  
Moderators:  
P.L. Pereira; Heilbronn/DE  
D.A. Clevert; Munich/DE  
A-823 16:00  
Liver  
E. Leen; London/UK (edward.leen@imperial.ac.uk)  
The real-time nature of US combined with its low cost and higher availability 
remains the modality of first choice for needle guidance for biopsy, drainage 
and ablation in the liver. Needle guiding device is recommended for deeply 
located lesions, especially for less experienced users. The biopsy technique 
used is dependent on the examiner’s skills and the accessibility of the target. 
Image fusion with CT or MR and navigation systems may be helpful for 
ultrasound guidance in lesions difficult to visualize on ultrasound with or 
without contrast agents (CEUS). Local ablative procedures play a key role in 
the management of patients with malignancies such as hepatocellular 
carcinoma (HCC) or metastases. US and CEUS play an important role before, 
during and after ablation procedures. CEUS enables (a) the assessment of the 
lesions to be treated by ablation (number, size, degree and homogeneity of 
lesion enhancement, presence of feeding vessels, to define the eligibility for 
treatment and the best ablation strategy), (b) the depiction of previously 
undetectable lesions with the support of fusion imaging, enabling needle/probe 
guidance to occult lesions and (c) the detection of viable tumour persistence 
following locoregional treatment.  
Learning Objectives: 
1. To learn about new results and application of ultrasound in guided 
interventional procedures: liver malignancy biopsy, primary liver malignancy 
ablation, secondary liver malignancy ablation. 
2. To understand consolidated and new indications to ultrasound-guided 
interventional procedures: PEI, RFA, MWA, IRE. 
3. To appreciate accuracy of ultrasound-guided interventional procedures from 
consolidated to new applications: analysis of data from personal experiences 
and literature series comparison and discussion. 
4. To become familiar with the new techniques of ultrasound guidance and with 
the new diagnostic and therapeutic indications for ultrasound-guided 
interventional procedures: CEUS imaging, fusion imaging, elastosonographic 
imaging for liver malignancy biopsy and treatment, MWA, IRE, combination 
treatment. 
A-824 16:20  
Pancreas  
M. D'Onofrio; Verona/IT (mirko.donofrio@univr.it)  
Percutaneous interventional diagnostic and therapeutic procedures under 
ultrasound guidance are largely employed in pancreatic diseases. Diagnostic 
procedures include cytologic and/or histologic sampling with fine needles or 
coarse needles to sample pathologic tissue or fluids/collections for 
biochemical, cytologic and microbiologic examinations. Therapeutic 
procedures include the drainage of fluid collections by needle or catheter and 
nowadays the ablation procedures. The advantage of ultrasound guidance is 
strictly linked to the real-time aspect of the examination. Nowadays to amplify 
the view of the image, a method employing CT or MR fusion imaging can be 
used. New results and applications of ultrasound-guided interventional 
procedures such as pancreatic malignancy biopsy or primary pancreatic 
malignancy ablation have been increasingly reported, moving from 
consolidated to new indications to ultrasound-guided interventional procedures. 
The accuracy of ultrasound using new techniques such as CEUS and fusion 
for guiding interventional procedures has improved as reported in literature.  
Learning Objectives: 
1. To learn about new results and application of ultrasound-guided 
interventional procedures: pancreatic malignancy FNA and biopsy, primary 
pancreatic malignancy ablation. 
2. To understand consolidated and new indications to ultrasound-guided 
interventional procedures: FNA and biopsy, RFA. 
3. To appreciate accuracy of ultrasound-guided interventional procedures from 
consolidated to new applications: analysis of data from personal experiences 
and literature series comparison and discussion. 
4. To become familiar with the new techniques of ultrasound guidance and with 
  







the new diagnostic and therapeutic indications for ultrasound-guided 
interventional procedures: CEUS imaging, fusion imaging, elastosonographic 
imaging for panceratic malignancy biopsy and treatment, RFA, MWA, IRE, 
combination treatment. 
Author Disclosure: 
  M. D'Onofrio: Advisory Board; Siemens, bRACCO. Consultant; Bracco, 
Siemens. Speaker; Bracco, Siemens. 
A-825 16:40  
Kidney  
J.-M. Correas; Paris/FR (jean-michel.correas@aphp.fr)  
Ultrasound-guided interventional procedures are playing an increasing role for 
both diagnosis of diffuse and focal diseases and therapeutic applications. 
When the target lesion can be identified using US imaging, it is the modality of 
choice due to the ability to visualize real-time needles, catheter and electrodes. 
New techniques such as contrast-enhanced ultrasound, shear-wave 
elastography and fusion imaging are further improving the capabilities of US-
guided procedures. However, adequate training remains mandatory, 
particularly in the case of difficult procedures.  
Learning Objectives: 
1. To learn about new results and application of ultrasound-guided 
interventional procedures: renal malignancy FNA and biopsy, primary renal 
malignancy ablation. 
2. To understand consolidated and new indications to ultrasound-guided 
interventional procedures: FNA and biopsy, RFA. 
3. To appreciate accuracy of ultrasound-guided interventional procedures from 
consolidated to new applications: analysis of data from personal experiences 
and literature series comparison and discussion. 
4. To become familiar with the new techniques of ultrasound guidance and with 
the new diagnostic and therapeutic indications for ultrasound-guided 
interventional procedures: CEUS imaging, fusion imaging, elastosonographic 
imaging for renal malignancy biopsy and treatment, RFA, crioablation, MWA, 
combination treatment. 
Author Disclosure: 
  J.-M. Correas: Advisory Board; Philips US. Equipment Support Recipient; 
Toshiba MS (Aplio i900), SuperSonic Imagine (AixPlorer). Speaker; Toshiba 
MS, SuperSonic Imagine, Philips US, Bracco, Guerbet. 
A-826 17:00  
Thyroid  
G. Mauri; Milan/IT (vanni.mauri@gmail.com)  
Ultrasound-guided interventional procedures in thyroid disease have shown 
great expansion and are more and more widely applied in the clinical practice 
in a larger spectrum of applications. On the one hand, ultrasound-guided fine 
needle aspiration has become the standard practice for diagnosing the nature 
of thyroid nodules, which are increasingly detected in the population. On the 
other hand, the development of dedicated technique such as laser ablation or 
radiofrequency ablation with specific devices has expanded the role of 
interventional ultrasound in the treatment of both benign and malignant thyroid 
disease. Ultrasound-guided ablation has achieved a more important role in the 
everyday treatment of benign nodules (even hyperfunctioning ones), 
representing a minimally invasive, safe and effective treatment strategy. 
Moreover, the application of thermal ablations to malignant disease, both 
primary and recurrent, seems to represent a promising strategy in order to 
reduce the invasiveness of surgical treatment in such difficult anatomical 
region. In this presentation, consolidated and new applications of interventional 
procedures in the thyroid will be presented and discussed, with particular focus 
on new application of thermal ablations in the setting of both benign and 
malignant disease.  
Learning Objectives: 
1. To learn about new results and application of ultrasound-guided 
interventional procedures: thyroid malignancy FNA, thyroid nodule ablation. 
2. To understand consolidated and new indications to ultrasound-guided 
interventional procedures: FNA, RFA. 
3. To appreciate accuracy of ultrasound-guided interventional procedures from 
consolidated to new applications: analysis of data from personal experiences 
and literature series comparison and discussion. 
4. To become familiar with the new techniques of ultrasound guidance and with 
the new diagnostic and therapeutic indications for ultrasound-guided 
interventional procedures: CEUS imaging, fusion imaging, elastosonographic 
imaging for thyroid malignancy FNA. 
Author Disclosure: 
  G. Mauri: Consultant; Elesta SrL. 
 
16:00 - 17:30 Room E2  
Multidisciplinary Session  
MS 16  
Psychoradiology: a blend of molecular, 
functional and structural imaging with a 
taste of psychology  
A-827 16:00  
Chairperson's introduction  
B. Ertl-Wagner; Munich/DE (Birgit.Ertl-Wagner@med.uni-muenchen.de)  
Psychoradiology is a field of radiology that investigates the brain and mind both 
in health and disease. It usually applies various methods including structural 
and volumetric magnetic resonance (MR) imaging, functional MR imaging, MR 
spectroscopy and diffusion tensor imaging (DTI). A combination of methods 
increases the soundness of the results. Psychoradiology can help to both 
unravel the physiological processes of the mind and to understand pathological 
alterations that lead to disease. In recent years brain stimulation techniques 
have been gaining increasing attention for the treatment of various psychiatric 
disorders. Psychoradiology may become an important tool to guide the target 
of the intervention and to understand the changes in the brain´s networks 
associated with this treatment.  
Session Objectives: 
1. To become familiar with the interdisciplinary aspects of psychoradiology. 
2. To learn about the methodological principles of structural, functional and 
molecular imaging of the brain. 
3. To understand the pathophysiological concepts underlying psychiatric 
disorders. 
A-828 16:05  
A psychiatrist's view on neuroimaging  
F. Padberg; Munich/DE (frank.padberg@med.lmu.de)  
During the last three decades, psychiatrists have developed a comprehensive 
view on brain functions, which underly symptoms and syndroms of psychiatric 
disorders. Different avenues from genetic and molecular research, 
neurophysiology, and multimodal neuroimaging have contributed to this 
development. More recently, parallel to the introduction of the Diagnostic 
Manual DSM-5, the National Institute of Mental Health (NIMH) has challenged 
the diagnostic categories by introducing Research Domain Criteria (RDoC) as 
a new matrix for cognitive and behavioral domains forming human experience 
and behavior. These domains can be addressed from cellular to system 
Levels. Neuroimaging represents a key technology for the investigation of 
these domains and will play a pivotal role in psychiatric research (Bhugra et al. 
2017). This lecture will outline these issues and give examples of the 
diagnostic value of neuroimaging, research on pathophysiology and 
mechanisms of therapeutic action (example: brain stimulation; Padberg et al. 
2017), and finally prediction of individual outcome as well as monitoring 
progress of disease. References: Bhugra D, Tasman A, Pathare S, et al. The 
WPA-Lancet Psychiatry Commission on the Future of Psychiatry. Lancet 
Psychiatry. 2017; 4:775-818. Padberg F, Brem AK, Palm U, et al. Discovering 
the individual brain: brain stimulation in psychiatry: Editorial I to the supplement 
from the 2nd European conference on brain stimulation in psychiatry. Eur Arch 
Psychiatry Clin Neurosci. 2017; Nov 20. doi: 10.1007/s00406-017-0853-3. 
Learning Objectives: 
1. To understand the important role of imaging in the diagnostic evaluation of 
psychiatric patients. 
2. To become familiar with important imaging patterns that may be 
encountered in patients with psychiatric disorders. 
3. To understand future trends in neuroimaging of patients with psychiatric 
disorders. 
Author Disclosure: 
  F. Padberg: Equipment Support Recipient; neuroCare Group Munich, 
Germany; Mag&More GmbH Munich, Germany; Brainsway Inc. Jerusalem, 
Israel. Speaker; neuroCare Group Munich, Germany, Mag&More GmbH 
Munich, Germany. 
A-829 16:23  
Advanced imaging techniques: their role in neuropsychiatric disorders  
S. Stöcklein; Munich/DE (sophia.stoecklein@med.lmu.de)  
Structural MR imaging in neuropsychiatric disorders includes volumetric 
techniques, such as whole-brain voxel-based morphometry and automated 
segmentation of brain structures, as well as assessment of tissue 
  







characteristics such as myelin content. With the advent of advanced data 
mining and machine learning techniques, the results of these approaches can 
be combined to detect disease-specific patterns, as singular volumetric 
measures might lack specificity. For example, hippocampal volume is not only 
reduced in Alzheimer’s disease, but also in depression and schizophrenia. 
Ultrahigh field MRI will further facilitate the detection of disease-specific 
changes, e.g. in the hippocampal subfields in schizophrenia. Functional MRI in 
neuropsychiatric disorders largely relies on resting-state paradigms, as they 
are easily implementable and less dependent on patient cooperation and 
command of language than task-based paradigms. Many fMRI studies have 
investigated differences between patient and control groups and have provided 
valuable insight into alterations of functional brain connections and networks in 
neuropsychiatric diseases. However, applications in the individual patient are 
still sparse. Technical advances such as individualized functional networks, 
reliability correction, and also optimized scan length and the collection of large 
healthy reference populations are currently paving the way towards 
applications of fMRI as an individualized imaging marker for neuropsychiatric 
disorders. Molecular imaging techniques such as PET/SPECT and MR 
spectroscopy have provided insight into alterations in neurotransmission and 
metabolism in neuropsychiatric disorders. Recently, molecular imaging of 
neuroinflammatory markers such as microglia activation has increasingly 
attracted interest, due to increasing evidence suggesting a role for 
inflammation in the pathogenesis of neuropsychiatric disorders.  
Learning Objectives: 
1. To become familiar with the principles and practice of using structural and 
volumetric methods in patients with neuropsychiatric disorders. 
2. To understand methods and applications of task-based and resting-state 
functional MR imaging techniques in neuropsychiatric patients. 
3. To learn about the role of spectroscopy and molecular imaging in patients 
with neuropsychiatric disorders. 
A-830 16:41  
Can images predict psychiatric diagnosis and treatment response?  
N. Koutsouleris; Munich/DE  
"no abstract submitted" 
Learning Objectives: 
1. To become familiar with the principles of imaging-based prediction methods. 
2. To understand the role of neuroimaging in predicting neuropsychiatric 
diagnoses. 
3. To learn about imaging-based methods to predict treatment response in 
psychiatry. 
A-831 16:59  
Neuroimaging and neuromodulation: where are we heading  
D. Keeser; Munich/DE (daniel.keeser@med.lmu.de)  
Non-invasive transcranial brain stimulation (NIBS) methods (e.g. transcranial 
direct current stimulation - tDCS, repetitive transcranial magnetic stimulation - 
rTMS and others) provide a unique in vivo intervention for probing the 
functional role of regions and hubs in human neural systems that play a role in 
the pathophysiology of psychiatric disorders. Recent research has shown that 
the individual human brain functional MRI connectivity (fcMRI) shows distinct 
patterns of within- and between-subject variability. Anatomically targeted 
analyses of NIBS in neuropsychiatric patients and healthy subjects have 
generated promising results. Even combining several neuroimaging methods 
(resting state fcMRI, task-based fMRI, magnetic resonance spectroscopy 
(MRS)) may be useful to detect classifiers that can reliably predict NIBS 
effects. These neuroimaging methods allow individual brain properties as well 
as the evaluation of state dependency. By combining neuroimaging and NIBS 
(term: imaging stimulation), new functional models are expected to be 
developed and compared in different states of health and pathology, e.g. 
during the course of psychiatric disorders from preclinical stages to relapsing-
remitting or chronic disorders.  
Learning Objectives: 
1. To understand the principles of neuromodulation. 
2. To become familiar with methods of imaging-based neuromodulation. 
3. To become familiar with future prospects of neuroimaging and 
neuromodulation. 
17:17  
Interdisciplinary case discussion  
 
 
16:00 - 17:30 Room F1  
E³ - European Diploma Prep Session  
E³ 1623  
Urogenital  
A-832 16:00  
Chairperson's introduction  
R.H. Oyen; Leuven/BE (Raymond.Oyen@uzleuven.be)  
We aim to become familiar with the imaging presentation of common 
neoplastic and infectious disorders of the kidneys, describe the typical imaging 
features of calculus and neoplastic disorders of the ureter and bladder and 
understand the imaging presentation of benign and malignant disorders of the 
prostate. Cross-sectional imaging (ultrasound, CT, MRI) has become the key 
modality for the evaluation of the adrenals, kidneys, upper urinary tract and 
bladder in symptomatic patients. In addition, because of the increased use of 
imaging, abnormalities and disease processes of the urogenital tract are seen 
more frequently in patients not referred for symptoms related to the urogenital 
tract. Such findings can be relevant or not relevant and include anatomical 
variants and inflammatory processes; both may erroneously be interpreted as 
neoplastic lesions (pseudotumours) and benign and malignant tumours. It is 
important to become familiar with some typical imaging features of common 
neoplastic disorders of the kidney and urinary tract, of urolithiasis and of 
inflammatory processes to enable accurate reporting, provide a diagnosis or at 
least a list of suitable differential diagnoses, and suggest appropriate further 
studies (imaging, biopsy,) to eventually refine the diagnosis. The aim is to 
select patients in whom therapy is indicated from those where therapy has to 
be avoided. MRI now is the key modality for the detection of prostate cancer 
and the staging of known prostatic cancer. However other prostatic disease 
processes, including inflammation, benign hyperplasia and cancer may occur 
simultaneously to a variable extent, thus complicating the reading and 
interpretation of MRI. In this respect, structured reporting MRI studies based on 
the PI-RADS system contributes to standardized reporting and communication 
with referring physicians. 
Session Objectives: 
1. To become familiar with the imaging presentation of common neoplastic and 
infectious disorders of the kidneys. 
2. To describe the typical imaging features of calculous and neoplastic 
disorders of the ureter and bladder. 
3. To understand the imaging presentation of benign and malignant disorders 
of the prostate. 
A-833 16:06  
A. Renal and adrenal imaging  
N. Grenier; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr)  
Kidneys and adrenals are retroperitoneal organs contained within a perirenal 
space. Variants of adrenals involve essentially their shape, whereas many 
variants involve kidneys including ectopia, fusion, dystopia and duplication. 
Renal masses are frequent. Most are simple cysts. Cystic masses must be 
classified according to Bosniak classification to guide management. 
Conversely, most of the solid masses are malignant, but diagnosis of benign 
angiomyolipoma can be confirmed by imaging only. Adrenal masses are 
usually solid, and most of them are benign with typical imaging features based 
on evaluation of their lipid content and perfusion level. The role of imaging in 
parenchymal disease remains limited, except for infections, acute or chronic.  
Learning Objectives: 
1. To describe the normal imaging anatomy and variants of the kidney and 
adrenal. 
2. To understand the imaging features of benign and malignant tumours of the 
kidneys. 
3. To describe imaging features of benign and malignant tumours of the 
adrenal glands. 
4. To explain the imaging features of infectious disorders of the kidneys. 
Author Disclosure: 
  N. Grenier: Advisory Board; Supersonic Imagine, Aix-en-Provence, France. 
A-834 16:34  
B. Imaging of the ureter and bladder  
M.N. Özmen; Ankara/TR (mozmen@hacettepe.edu.tr)  
Imaging has a very important role in evaluating the urinary tract. Over the past 
years, computed tomographic urography (CTU) has become the main imaging 
modality for this purpose in various clinical settings. Dose reduction techniques 
have also enabled us to obtain CTUs with very low radiation doses. Several 
  







anomalies of the ureter may be seen, including duplication, muscular 
dysfunction or abnormal termination. An intraluminal disease process in the 
ureter might cause obstruction. Ureteral stone is by far the most frequent with 
high attenuation values on unenhanced CT. Dual-energy CT may contribute to 
the prediction of the chemical composition of the stone. A filling defect seen on 
CTU usually raises the suspicion of urothelial neoplasm. Other entities such as 
clot, metastasis, and tuberculosis might also obstruct the ureter and must be 
considered in the differential diagnosis of selected patients. The prevalence of 
urothelial neoplasms is high in elderly patients with a history of smoking, 
analgesic use or occupational exposure to chemical carcinogens. Urothelial 
cancer has to be considered as a ‘systemic’ disease, with often multiple, 
synchronous or metachronous lesions. CTU not only depicts the neoplastic 
lesion, but also enables the examination of the entire urothelium during staging 
or follow-up. Several treatment options are available and imaging plays an 
important role for tailoring this treatment. In case of haematuria, where CTU is 
the main diagnostic tool for upper urinary tract evaluation, cystoscopy is the 
primary diagnostic tool for screening for bladder neoplasms. CTU is indicated 
for the evaluation of upper urinary tract and staging purposes. 
Learning Objectives: 
1. To explain the imaging anatomy and variants of the ureter and bladder. 
2. To understand the diagnostic evaluation and imaging features of calculi of 
the ureter and bladder. 
3. To describe the imaging features of benign and malignant tumours of the 
ureter and bladder. 
A-835 17:02  
C. Prostate imaging  
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch)  
Prostate imaging is increasingly performed using multiparametric MRI (mpMRI) 
to detect and stage significant prostate cancer as well as for active surveillance 
in patients with a known cancer. The requirements to perform correct mpMRI 
including high-resolution T2w, diffusion-weighted MRI (DW-MRI) and dynamic 
contrast-enhanced MRI (DCE-MRI) are specified in PIRADS vs 2 (Prostate 
Imaging and Reporting Data System). The aim of prostate imaging is to detect 
a significant cancer defined as a tumour with a volume > 0.5 cc or a Gleason 
score of > 7 and/or extraprostatic extension. PIRADS version 2 uses a 5-point 
scale based on the likelihood that a combination of mpMRI findings on T2w, 
DW-MRI and DCE-MRI correlates with the presence or absence of clinically 
significant prostate cancer for each lesion in the prostate gland. PIRADS 1 or 2 
means that clinically significant cancer is unlikely to be present, PIRADS 3 is 
intermediate/equivocal and PIRADS 4 and 5 indicate a high likelihood of 
significant prostate cancer (PIRADS 4: size< 1.5cm, PIRADS 5: size< 1.5 cm). 
Most of the prostate cancers are located in the peripheral zone, where DW-
MRI is the dominant sequence to make the correct diagnosis. In the transition 
zone, T2w is the dominant sequence. In this presentation, typical findings will 
be discussed and also benign diseases such as prostatitis and benign prostatic 
hyperplasia will be demonstrated as potential differential diagnoses.  
Learning Objectives: 
1. To explain the PIRADS system in prostate imaging. 
2. To describe the imaging features of benign prostatic hypertrophy. 
3. To understand the imaging features of prostate cancer. 
4. To describe the imaging features of inflammatory changes of the prostate. 
Author Disclosure: 
  H.C. Thoeny: Advisory Board; Guerbet SA. 
16:00 - 17:30 Room F2  
Emergency Imaging  
RC 1617  
Why do I miss fractures in emergency?  
A-836 16:00  
Chairperson's introduction  
S. Wirth; Munich/DE (stefan.wirth@med.uni-muenchen.de)  
Sometimes, things may become more difficult and easier at the same time. On 
one hand, advances in imaging allow for very precise and also fast diagnoses 
in a continuously increasing number of cases. On the other hand, radiologists 
have to be more and more aware of clinical entities, pathological patterns, and 
interdisciplinary networks to quickly and precisely provide our clinical partners 
with the information they need. Although these changes are apparent, 
overlooked fractures remain a big and also common challenge. Aiming to 
reduce the typical potential problems like arthrosis and pain, this should also 
take into account social dimensions like medical costs and patient's ability to 
work. Which way we should go: More and better education and training? More 
clinical integration? More lowest-dose CT instead of radiographs? More quality 
assurance and management? The three lectures will develop answers to 
theses questions and will also provide high educational value with a focus on 
differences between children and adults, as well as on likelihood and 
complexity of related other injuries. 
Session Objectives: 
1. To learn the typical constellations and findings of missed fractures. 
2. To understand the potential complications resulting from missing fractures. 
3. To appreciate direct and indirect fracture signs with different imaging 
modalities. 
A-837 16:05  
A. Missed fractures in children  
A.C. Offiah; Sheffield/UK (amaka.offiah@nhs.net)  
Fractures in children may be missed in the Emergency Department for several 
reasons. Firstly, a normal variant may be misdiagnosed as a fracture (or vice 
versa). Secondly, normal physiological absence of ossification of the 
epiphyseal centres makes assessment of alignment difficult. Finally, some 
fractures are themselves subtle. This lecture will predominantly focus on 
radiographs, but use cross-sectional imaging to highlight specific points. 
Particular fractures to be covered are accidental (as opposed to inflicted) and 
include skull, vertebral, clavicular, elbow, scaphoid, pelvic (including avulsion 
injuries and slipped capital femoral epiphysis) and tibial fractures.  
Learning Objectives: 
1. To become familiar with the common fractures in childhood. 
2. To understand the choice of the best-suited imaging modality. 
3. To learn about atypical imaging findings in different clinical scenarios. 
Author Disclosure: 
  A.C. Offiah: Advisory Board; Alexion, BioMarin. Consultant; Alexion, 
BioMarin. Grant Recipient; Alexion. Research/Grant Support; Alexion. 
Speaker; Alexion, BioMarin, InfoMed. 
A-838 16:30  
B. Missed fractures in adults  
A. Pinto; Naples/IT (antopin1968@libero.it)  
Falls are the most common cause of injuries among adult patients: advanced 
age substantially increases the likelihood of hospitalization after a fall. The 
most commonly fractured bones in adults are: (1) the hip, femur, pelvis, and 
vertebrae; (2) the humerus, forearm, and hand; (3) the leg and ankle bones. 
Radiography remains the initial modality to detect or exclude the presence of a 
fracture. The main cause of diagnostic error in the Emergency Department is 
the failure to correctly interpret radiographs: the majority of the diagnoses 
missed on radiography are fractures. Some of the fractures are subtle; 
however, the majority are obvious, which suggests inadequate training and/or 
poor technique in radiological interpretation. In other situations, the fractures 
are observed but misinterpreted as normal variants or old injuries. 
Misinterpretation of fractures may determine a delayed treatment and poor 
outcome for patients treated in the Emergency Department. It is also one of the 
most frequent factors leading to medical legal claims. With a high clinical index 
of suspicion, further evaluation with additional imaging is typically required, 
particularly if the results of this imaging will affect clinical management. 
Radiologists should more completely understand the limitations of radiography 
in the diagnosis of subtle fractures and can best indicate the need for more 
advanced imaging, such as CT, for a correct diagnosis in an appropriate time 
frame. Key elements to reduce errors in the diagnosis of fractures on plain 
radiographs are knowledge, experience, and correct application of the imaging 
protocols.  
Learning Objectives: 
1. To become familiar with the most common fractures in adult patients. 
2. To understand which additional data will influence the choice of the correct 
imaging modality. 
3. To learn about atypical imaging findings in adult patients after trauma. 
A-839 16:55  
C. Missed musculoskeletal injuries in whole-body MDCT examinations  
T. Ruder; Whangarei/NZ (Thomas.Ruder@northlanddhb.org.nz)  
Whole-body CT has become the first-line modality in the imaging workup of 
patients with multiple injury trauma in many hospitals across the world. 
Accurate and rapid reporting of whole-body CT in trauma patients is critical for 
patient management. However, reading huge stacks of images under time 
pressure while being frequently interrupted presents great challenges to 
radiologists and carries the risk of missed injuries. The aim of this presentation 
is to provide an overview of common musculoskeletal injuries in multiple injury 
trauma patients, provide insight into the causes of missed injuries, highlight the 
effect of missed injuries on patient care, offer strategies to reduce sources of 
errors, and suggest a systematic approach to reading trauma CT. The first part 
  







of the lecture covers frequently encountered musculoskeletal injuries and their 
relationship to distinct trauma mechanisms. The second part addresses the 
reasons for blindness and bias in diagnostic radiology. The third part focuses 
on a step-by-step approach for reporting whole-body CT in multiple injury 
trauma patients. 
Learning Objectives: 
1. To become familiar with the most common musculoskeletal injuries in 
patients after polytrauma. 
2. To understand the clinical impact of missed subtle injuries on clinical 
outcome of the trauma victims. 
3. To be familiar with less typical imaging findings in musculoskeletal injuries. 
17:20  
Panel discussion: How to reduce the rate of missed fractures most 
effectively and efficiently  
16:00 - 17:30 Room D  
Musculoskeletal  
RC 1610  
The radiological investigation of 
musculoskeletal tumours  
A-840 16:00  
Chairperson's introduction  
F.M.H.M. Vanhoenacker; Antwerp/BE (filip.vanhoenacker@telenet.be)  
Plain films are the initial imaging modality in the detection and characterization 
of bone tumours, as they accurately depict matrix, cortical permeation or 
disruption and periosteal reaction. However, the sensitivity of this technique for 
the detection of small lesions is limited. CT can be used for characterization in 
anatomically complex areas, such as the spine, pelvis and skull. The CT 
appearance is similar to radiography. Due to radiation restraints, CT is not 
recommended in children or for evaluation of the appendicular skeleton in 
adults. Conventional MRI may be of additional help in narrowing the differential 
diagnosis of bone tumours. Soft tissue tumours based on imaging remains 
even more limited and histology is usually required for a definitive diagnosis. 
Ultrasound is mostly nonspecific, but may be used for superficially located 
cystic STT. On MRI, analysis of multiple parameters (shape, presence of signal 
voids, fluid-fluid levels, SI, intratumoural necrosis, multiplicity, pattern/degree of 
enhancement) yields the best results. The highest confidence is reached in 
benign lesions such as lipomas, vascular lesions, benign neural tumours, 
periarticular cysts, haematomas, PVNS, GCTTS, and abscesses. The major 
role of MRI consists of local tumour staging and therapy monitoring. The 
European Society of MusculoSkeletal Radiology (ESSR) has published 
guidelines for the detection, characterization, and referral pathway of 
musculoskeletal tumours based on conventional imaging. The specific aim of 
this session is to discuss the role of recent advances in ultrasound technology, 
advanced CT and MR techniques, and hybrid imaging in imaging evaluation of 
musculoskeletal tumours. 
Session Objectives: 
1. To learn how to differentiate tumours from other non-tumoural pathologies. 
2. To understand the value of imaging modalities in this field. 
3. To appreciate how to determine resectability and extension of the tumour. 
A-841 16:05  
A. Radiographs and ultrasound  
L.M. Sconfienza; Milan/IT (io@lucasconfienza.it)  
Besides advanced techniques, such as computed tomography and magnetic 
resonance imaging which are important in the workup of musculoskeletal 
tumours, plain films and ultrasound still play a crucial role. Plain films still 
represent the cornerstone in the evaluation of bone tumours, as they allow 
detecting the presence of a bone lesion and giving important information about 
characterization of the lesion such as the presence and type of periosteal 
reaction, the pattern of bone destruction, the lytic or sclerotic appearance of 
the lesion, the presence of soft tissue involvement or of associated findings 
such as pathological fractures. However, plain films have limitations in 
particularly complex anatomical locations (e.g. spine and pelvis) and in the 
evaluation of soft tissue tumours not involving the bone. Ultrasound has 
limitations in the evaluation of bone tumours, as the ultrasound beam can only 
minimally cross the bony cortex. However, ultrasound may detect the presence 
of a periosteal reaction in early stages and may be used to assess the 
involvement of surrounding soft tissues and neurovascular bundles by bone 
tumours. On the other hand, ultrasound is accurate in the detection and 
evaluation of soft tissue tumours, being able to correctly evaluate the size and 
the relationship of the mass with the surrounding structures. The use of 
supplementary tools, such as power Doppler, contrast-enhanced ultrasound, 
and elastography has been proved to be useful in increasing the diagnostic 
performance of ultrasound in certain conditions. However, ultrasound may be 
limited by low contrast resolution, small field of view, and deep lesions.  
Learning Objectives: 
1. To learn about the value of radiography and US in the diagnostic work-up of 
MSK tumours. 
2. To be familiar with the most recent advances and trends in the development 
of US technology, including contrast-enhanced US and elastography. 
Author Disclosure: 
  L.M. Sconfienza: Other; Travel grants from Bracco Imaging Srl, Esaote, and 
Abiogen. 
A-842 16:28  
B. MRI and whole-body MRI  
S.L.J. James; Birmingham/UK (stevenjames@nhs.net)  
MR imaging is the modality of choice for local staging of musculoskeletal 
tumours. When dealing with primary bone tumours, MRI enables both the intra- 
and extraosseous extent of the lesion to be delineated so that limb salvage 
surgery can be considered. Soft tissue tumours can be assessed relative to the 
compartmental anatomy and involvement of adjacent neurovascular structures. 
Once again, this facilitates potential curative excision to be planned. A routine 
MR protocol will be presented for primary bone and soft tissue musculoskeletal 
tumours. Additional advanced sequences will be discussed including chemical 
shift imaging, diffusion-weighted imaging, MR spectroscopy and post-contrast 
imaging. Current evidence for the use of these advanced imaging sequences 
will be reviewed. The role of whole-body MRI in staging of musculoskeletal 
tumours will be discussed including current evidence for its use in primary 
musculoskeletal tumours. This talk will not, however, discuss the use of MRI or 
whole-body MRI in the assessment, staging or follow-up of multiple myelomas 
or metastatic disease.  
Learning Objectives: 
1. To learn how to perform an advanced clinical MR protocol for MSK tumours. 
2. To explore the potential of new MR techniques. 
3. To learn the impact of MR imaging and whole-body techniques in MSK 
tumour imaging. 
A-843 16:51  
C. CT and hybrid imaging  
T. Bäuerle; Erlangen/DE (tobias.baeuerle@uk-erlangen.de)  
For imaging of musculoskeletal tumours, CT as well as the hybrid techniques 
PET/CT and PET/MRI offer a broad spectrum of methods for diagnosis, 
staging and follow-up. On the morphologic level, bone destruction ranging from 
osteolytic to blastic lesions and adjacent soft tissue tumours, e.g. in Ewing 
sarcoma or lytic bone metastases, are captured by CT. Beyond morphology, 
PET radiopharmaceuticals including [18]F-fluorodeoxyglucose ([18]F-FDG) or 
[18]F-sodium fluoride ([18]F-NaF) report on tumour and bone metabolism, 
respectively. Whereas the soft tissue tumours of rhabdomyosarcoma or bone 
marrow involvement in multiple myelomas is assessed by [18]F-FDG, 
osteoblastic activity is captured using [18]F-NaF, for example in sclerotic 
metastases. Due to the excellent sensitivity of PET, information on the 
molecular level is available when administering tumour-specific radiotracers 
such as the [68]Ga- or [18]F-labelled prostate-specific membrane antigen 
(PSMA) ligands for prostate cancer bone metastases. In conclusion, this 
lecture will summarize the use of CT and hybrid imaging techniques PET/CT 
and PET/MRI in primary and secondary musculoskeletal tumours. Current 
state-of-the-art techniques on the morphologic, metabolic and molecular level 
will be given as well as an outlook on future developments, particularly in 
hybrid imaging.  
Learning Objectives: 
1. To learn about the role of CT and hybrid imaging in the evaluation of MSK 
tumours. 
2. To understand how hybrid imaging allows the intrinsic combination of 
functional and anatomical image information. 
3. To be aware of the future developments of novel PET tracers and integrated 
PET/CT and MRI/PET in MSK tumours.  
Author Disclosure: 
  T. Bäuerle: Research/Grant Support; Bayer Healthcare. Speaker; Bracco, 
Boehringer Ingelheim. 
17:14  
Panel discussion: Guidelines for and the role of imaging techniques in 
the management of musculoskeletal tumours  
  







16:00 - 17:30 Room G  
Physics in Medical Imaging  
RC 1613  
Demystifying MRI: things you always 
wanted to know  
Moderator:  
I. Seimenis; Alexandropolis/GR  
A-844 16:00  
A. Basic MR: the building blocks of pulse sequences  
D.G. Norris; Nijmegen/NL (david.norris@fcdonders.ru.nl)  
To understand how NMR signals are produced, it is important to realise that 
the hydrogen nucleus has a magnetic moment which causes it to precess 
when placed in a static magnetic field. I shall explain how the presence of 
multiple nuclei gives rise to a bulk magnetisation, and how the orientation of 
the magnetisation vector can be manipulated by the application of 
radiofrequency pulses. Using the example of a bicycle dynamo, I will show how 
rotating transverse magnetisation gives rise to a measurable signal. Following 
excitation, the longitudinal magnetisation recovers (spin-lattice, or T1 
relaxation) and the transverse magnetisation loses phase coherence (spin-
spin, or T2 relaxation). I shall explain the physical basis for these processes 
and the use of inversion-recovery sequences to obtain T1 contrast, and spin-
echo sequences to obtain T2 contrast. Finally, I shall show some modern 
examples of quantitative measurements of T1 and T2. 
Learning Objectives: 
1. To learn about how NMR signals are produced. 
2. To understand the basic concepts of relaxation. 
3. To learn about the operation of inversion-recovery and spin-echo pulse 
sequences. 
Author Disclosure: 
  D.G. Norris: Advisory Board; fMRIB, Oxford. 
A-845 16:30  
B. MR imaging basic concepts: how to turn signals into images  
D.J. Lurie; Aberdeen/UK (d.lurie@abdn.ac.uk)  
To generate images in MRI, NMR signals must be “labelled” with their location. 
Three techniques of spatial encoding are employed, all of which use the 
magnetic field gradient. By sending electrical current (hundreds of amperes) 
through a gradient coil, a magnetic field is produced, whose strength varies 
linearly with position inside the scanner bore. In frequency encoding, the NMR 
signal is recorded while a field gradient is applied. Since the magnetic field 
varies with position along the gradient direction (e.g. X), the NMR resonant 
frequency (Larmor frequency) is a function of position, so the detected signal 
contains a range of frequencies; analysing the frequency content generates a 
one-dimensional projection of the water distribution within the patient. A 
method called phase encoding is employed in the second in-plane dimension 
(e.g. Y); here, the gradient is pulsed on and off prior to measurement of the 
signal, affecting the phase of the NMR signal as a function of position. Finally, 
the slice itself is defined using selective excitation, in which the radiofrequency 
pulse used for NMR excitation is specially shaped and applied in the presence 
of a field gradient perpendicular to the slice plane (e.g. along Z). To generate 
data for an image of NxN pixels, the pulse sequence is usually applied N times, 
varying the phase-encode gradient amplitude with each repetition. A two-
dimensional Fourier transform of the raw data matrix yields the MR image, 
which can be encoded with NMR parameter (T1, T2, diffusion, etc.) information 
to assist in diagnosis. 
Learning Objectives: 
1. To learn how magnetic field gradients encode spatial information. 
2. To understand the main ways in which field gradients are used. 
3. To appreciate the basic concepts of data collection and image 
reconstruction in MRI. 
Author Disclosure: 
  D.J. Lurie: Research/Grant Support; GE Healthcare. 
A-846 17:00  
C. Practical MRI: a toolkit of standard MR pulse sequences  
G. Hagberg; Tübingen/DE (gisela.hagberg@tuebingen.mpg.de)  
The MR sequence is the essential tool to measure MR properties in tissues, 
increase contrast between these and quantify relevant data. Besides furnishing 
the desired tissue-derived MR signal, the sequence must allow spatial 
encoding to take place as efficiently as possible to enable patient compliance, 
and high-quality MRI at the same time. Starting with a brief introduction 
regarding MR tissue properties and spatial encoding in k-space, I will describe 
the fundamental MR toolkit, based on single echo spin-echo (SE) and gradient-
echo (GE) and show how these are extended to different multiple-echo 
regimes. I will describe the basic image contrast and how imaging parameters, 
repetition time, TR; echo time, TE; flip angle, FA; inversion delay, diffusion 
gradients, etc., influence contrast. The possibility to further enhanced imaging 
by adequate spin-preparation, inversion or magnetization transfer pulses, etc., 
will also be discussed. Imaging speed can be achieved while remaining in the 
single echo regime by faster RF pulsing giving valuable information linked with 
magnetic susceptibility as in the GE-based FLASH method, based on spoiling 
of unwanted echoes. Another possibility is to use subsequent (spin) echoes to 
read out different k-space lines, without the cost of greater saturation that 
comes with shorter TRs, as in the SE-based method RARE. An alternative 
possibility that further extends available image contrast is to retain the full 
magnetization in GE-based sequences and acquire images in the different 
steady-state free-precession regimes. The latter techniques have gained 
momentum through the advent of magnetic fingerprinting and are a 
fundamental part of the standard MRI toolkit.  
Learning Objectives: 
1. To learn about common types of MR pulse sequence. 
2. To understand the difference between gradient-echo and spin-echo. 
3. To appreciate the factors influencing choice of pulse sequence. 
16:00 - 17:30 Room K  
Radiographers  
RC 1614  
Optimising computed tomography  
A-847 16:00  
Chairpersons' introduction (part 1)  
U. Nikupaavo; Helsinki/FI  
Computed tomography (CT) is an essential diagnostic tool in many indications. 
New indications for CT imaging and technical development of the CT systems 
have increased the number of elective and emergency CT examinations. This 
has led to an increase in the collective radiation dose. The base of radiation 
safety in CT is a good referral practice. Justified CT examination includes 
adequate information of the patient, so that proper indication-based protocol 
can be used for the best diagnostic result and patient care. The goal of CT 
optimization is to minimize radiation exposure while maintaining diagnostic 
image quality. Technical methods for this purpose include the use of automatic 
exposure control (AEC) (i.e. automatic tube current modulation), bowtie filters, 
lower tube voltage (kVp) settings, adaptive section collimation, partial 
scanning, and iterative reconstruction methods. Correct preparation and 
positioning of the patient and optimized contrast agent protocols have great 
impact on the resulting radiation dose and image quality. Multiprofessional 
team work is essential to achieve justified and optimized CT examinations. 
Traditionally, the radiologist is in charge of adequate image quality level and 
the physicist coordinates the dose management and quality control. The 
radiographer has responsibilities in the following areas: daily workflow, 
preparation of patient, operation of scanner, use of contrast agent, and CT 
optimization, in general. 
Session Objectives: 
1. To review the importance of availability and appropriate CT techniques for 
the diagnosis and treatment of stroke patients. 
2. To appreciate practical measures to optimise both, radiation dose and image 
quality in CT. 
3. To understand how intravenous contrast agent delivery can best be 
optimised in CT to maximise diagnostic capability. 
A-848 16:03  
Chairpersons' introduction (part 2)  
I. Lupescu; Bucharest/RO (ilupescu@gmail.com)  
Worldwide, stroke is the second most common cause of mortality and the third 
most common cause of disability. In most centres, in the hyperacute phase, 
multimodal computed tomography (CT) evaluation is preferred, because of its 
availability and rapid scan times, containing three techniques: a noncontrast 
CT for detecting intracranial haemorrhage, a CT perfusion and a CT 
angiography, allowing the assessment of the site of vascular occlusion, infarct 
core, salvageable brain tissue and degree of collateral circulation. CT is widely 
used to obtain high-quality diagnostic images, with an increase of patient’s 
irradiation. The effective dose for CT examinations can significantly increase, 
in situations when more CT phases are required. Due to the high CT radiation 
doses, it is necessary to track patient dose data and CT protocol scanning 
parameters, and also to apply the system's optimisation and dose reduction 
  







techniques. The dose from the CT examinations can be reduced by controlling 
certain scanning parameters and optimizing the scanning protocols, delivering 
the minimum dose required to ensure the proper diagnosis. Current CTs offer 
reducing dose technologies, such as iterative reconstruction or automatic 
exposure control. With multidetector CT, intravenous contrast material 
administration and CT protocols have become challenging and complex. The 
clinical utility of contrast medium administration and CT scan timing is to 
achieve diagnostically adequate contrast enhancement in a specific organ 
using the lowest radiation exposure and the lowest dose of a non-ionic 
iodinated contrast media injected at the lowest rate in correlation with the renal 
and cardiovascular function of each patient.  
Session Objectives: 
1. To review the importance of availability and appropriate CT techniques for 
the diagnosis and treatment of stroke patients. 
2. To appreciate practical measures to optimise both, radiation dose and image 
quality in CT. 
3. To understand how intravenous contrast agent delivery can best be 
optimised in CT to maximise diagnostic capability. 
A-849 16:05  
A. Optimising access to CT in stroke  
G. Ioannidis; Larissa/GR (i.giorgio@yahoo.gr)  
Purpose: Computed tomography is the method of choice for the diagnosis of 
ischaemic stroke. Early diagnosis is of great importance for early treatment. 
The purpose of this speech is to review the “Golden Hour” of stroke diagnosis 
and therapy. How useful the cooperation of all the specialities involved will be 
noted, so that the patient with suspected stroke will arrive on time at the 
computed tomography department. It is also necessary to indicate the 
usefulness of CT in relation to the corresponding methods in magnetic 
tomography (DWI). Finally, the importance of the image of CT in the 
achievement of thrombolysis is noted. Material and Methods: Protocols that are 
applied for ischaemic stroke imaging as well as methods for the patient’s 
protection against radiation are mentioned. Modification of all these in the last 
few years, comparison of the protocols between CT and MRI, estimation of 
time from the first symptoms up to the initiation of thrombolysis and the 
usefulness of image analysis are reviewed. Conclusion: The optimizing access 
to CT is very important for the immediate treatment of ischaemic stroke. The 
radiographer has a leading role in this process. Therefore, he should be 
perfectly aware of the subject to provide the maximum care for the immediate 
indication of the problem so as to achieve early treatment. 
Learning Objectives: 
1. To review the golden hour of stroke diagnosis and therapy. 
2. To understand strategies for providing timely access to CT for patients with 
suspected stroke. 
3. To appreciate challenges involved in providing timely access to CT and the 
need for multidisciplinary collaboration. 
4. To become familiar with optimal CT protocols for diagnosis and therapy of 
stroke. 
A-850 16:28  
B. Optimising radiation dose and image quality  
R. Booij; Rotterdam/NL (r.booij@erasmusmc.nl)  
The number of computed tomography (CT) scans performed worldwide is 
increasing, which makes radiation dose optimisation of the utmost importance. 
Thereby, continuous technical improvements have been impressive; 
accordingly increasing the number of adjustable scan acquisition and 
reconstruction parameters. Overall, these developments led to improved image 
quality while reducing radiation dose. However, many parameters are 
interrelated and part of automated algorithms, making them less easy to adjust 
individually and more difficult to understand. Consequently, optimisation can be 
a challenge, e.g. patient positioning may seem to be a minor action; however, it 
is not. Patient positioning affects the patient’s shape on a localiser radiograph, 
directly affecting dose modulation settings, as well as the efficacy of a bowtie 
filter. Therefore, a consolidate knowledge of CT scan parameters and their 
effects on radiation dose and image quality is needed to optimise CT exams. 
Learning Objectives: 
1. To enhance our understanding of the challenge of balancing image quality 
and dose reduction. 
2. To review the options available to users for image quality and dose 
optimisation. 
3. To consolidate knowledge to effectively use scan parameters and innovative 
technologies to optimise CT protocols. 
4. To learn how to improve patient positioning and its effect on radiation dose. 
Author Disclosure: 
  R. Booij: Other; Research collaboration, Siemens Healthineers. 
A-851 16:51  
C. Optimising contrast delivery with MDCT  
A. Svensson; Stockholm/SE (anders.svensson@karolinska.se)  
The administration of intravenous contrast media (CM) is essential for 
detecting lesions at most computed tomography (CT) examinations. There are 
several physiological factors that affect the CM-enhancement, where body size 
(defined by body weight and body height) and cardiac output are the most 
important factors. Also, technical factors have great influence on CM-
enhancement, e.g. x-ray tube potential (kVp), injection rate and iodine dose. 
Traditionally, the same amount of CM has been given to all patients. However, 
the volume of distribution, i.e. plasma and extravascular interstitial space into 
which the CM is diluted is related to the body size and, therefore, a more 
individualised dosage of CM is nowadays regarded to be ¨state-of-the-art¨. The 
goal is to achieve a more uniform CM-enhancement independent of body size. 
This will also reduce the amount of CM given to smaller patients, i.e. reducing 
the risk of side effects associated with overdosing of CM. When reducing kVp 
at CT, CM will attenuate a greater number of x-ray photons. Approximately, 
50% higher image contrast can thereby be achieved from the same amount of 
CM when reducing the x-ray tube potential from 120 kVp to 80 or 70 kVp. Vice 
versa, CM dose can be halved if the tube potential is lowered to down to 70 
kVp from 120 kVp.  
Learning Objectives: 
1. To review injection and patient related factors that affect intravenous 
contrast medium (IV CM) enhancement during computer tomography (CT). 
2. To understand the effect of different tube potential settings and its impact on 
IV CM enhancement 
during CT. 
3. To gain knowledge about different aspects of individualised IV CM dosage. 
4. To appreciate practical "tips and tricks" for successful CT angiography 
examinations. 
17:14  
Panel discussion: How to create an optimisation team in CT?  
16:00 - 17:30 Room M 1  
ESR Audit and Standards Session  
Audit across Europe: directive and 
perspective  
A-852/A-853 16:00  
Chairpersons' introduction  




Under the EU 2013/59 Directive, Clinical Audit will be a required activity for all 
radiology departments within the EU from February 2018. Many departments 
already engage in this activity, but for some this will be a new venture. The 
ESR Audit & Standards Subcommittee has developed a package of suggested 
audits, with guidance for their completion, to assist with this new requirement. 
This package (The Esperanto Audit Project) was piloted among Eurosafe 
Imaging Star departments in late 2017 and will be made available widely 
following this pilot. During this session, the principles of Clinical Audit will be 
explained. The distinction between audit and external inspection will be 
explored and the complementarity of the two will be discussed. The Esperanto 
Audit Project pilot will be outlined and the initial results presented. Finally, an 
industry perspective on audit and quality improvement from a commercial 
perspective will be presented, with reference to change management.  
Session Objectives: 
1. To understand the principles of Clinical Audit (CA). 
2. To appreciate the distinction between CA and external inspection. 
A-854 16:05  
The Esperanto Audit Project: results from the pilot project and roll out  
B.E. Kelly; Belfast/UK  
In 2018, Euratom Directive 2013/59 will come into effect. This will mandate the 
regular use of Clinical Audit as a tool for measuring, among other parameters, 
patient safety and radiation protection. In 2017, the Audit subcommittee 
produced a booklet (Esperanto) designed to guide the user through the 
principles of clinical audit. A pilot study, performed during the summer of 2017, 
tested the efficacy of the templates within the booklet. The results of this 
indicated that respondents found the algorithm straightforward, the templates 
navigable and the subjects audited relevant.  
 
  








1. To learn about the nature of the pilot project. 
2. To understand the pilot's significance with regard to the EU 2013/59 
Directive. 
3. To appreciate the necessity of Clinical Audit. 
A-855 16:25  
Engaging in the Pilot: The Eurosafe Imaging Star Perspective  
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt)  
EuroSafe Imaging focuses on promoting appropriateness in medical imaging, 
maintaining doses within diagnostic reference levels, and emphasising the 
importance of using up-to-date equipment to develop a patient safety culture in 
medical imaging. The EuroSafe Imaging Call for Action number 2 focuses on 
developing and promoting a clinical audit tool for imaging to increase the 
quality of patient care and improve justification. Clinical audit is a systematic 
examination or review of medical radiological procedures. It seeks to improve 
the quality and the outcome of patient care through structured review whereby 
radiological practices, procedures, and results are examined against agreed 
standards for good medical radiological procedures. Clinical Audit is required 
under the Euratom Basic Safety Standards Directive and therefore mandatory 
in the EU. The ESR Audit Tool aids departments in carrying out audit in a more 
comprehensive manner and thereby complying with the directive by assuring 
the protection of their patients. Participating in the pilot project gave us the 
opportunity to engage better with the clinical audit process concept, mainly by 
focusing on the specificity of radiology departments, using a comprehensive 
library of templates. A very positive aspect of taking part in this ESR pilot was 
the fact that for the first time, a multidisciplinary team has been created, 
involving radiologists, radiographers, medical physicists, students and 
academic staff. This strategy revealed important aspects, namely, that 
integrating audit concepts into the clinical placements of radiography students 
will contribute to an easy adaptation and understanding to the audit philosophy.  
Learning Objectives: 
1. To learn about participation in the pilot project. 
2. To understand the audit template. 
3. To appreciate the advantage of performing Clinical Audit.  
A-856 16:45  
Quality improvement and change management: Audit in industry  
S. Lee; Amsterdam/NL (steven.lee_1@philips.com)  
Clinical-audit might be likened to the process of ‘continuous improvement’ of 
quality in industry. The latter focuses on improving performance for 
competitiveness by raising the quality (as perceived by the customer) and 
reducing the cost of products and services, while the former focuses on 
improving the quality of patient care by ensuring that clinical practice is 
delivered in line with defined standards. Both face the challenges of engaging 
people, developing supportive cultures and using systematic methods for 
sustaining the improvement process. While industry has deployed quality 
improvement practices extensively over many decades, the practice of clinical 
audit in many health-care organisations is by comparison relatively immature. 
The talk considers the evolution of different industrial management practices 
and paradigms concerned with quality improvement from the middle of the last 
century. During that time, the growing emphasis on the people dimension of 
improvement and change is highlighted, as is the significance of using an 
agreed, common and structured process (e.g. PDSA, DMAIC) for effecting 
quality improvement. The central importance of quality improvement for 
achieving competitiveness in an industrial setting is described, as are the major 
‘trends’ deployed in realising such improvement. Potential areas of symbiosis 
between clinical-audit and management paradigms (Lean, Six Sigma, etc.) are 
proposed, particularly Lean principles, people change management and 
alignment of structured quality improvement processes. Working to align the 
intrinsic motivation of people with the practice of audit and quality 
improvement, by highlighting the benefits offered to customers (patients), is 
emphasised as key to securing staff engagement. 
Learning Objectives: 
1. To learn about the genesis of audit. 
2. To understand the importance of audit in industry. 
3. To appreciate the symbiosis between audit and management paradigms. 
Author Disclosure: 




A-857 17:05  
HERCA and Audit: Inspection vs Clinical Audit. What's the difference?  
S. Ebdon-Jackson; Didcot/UK (steve.ebdon-jackson@phe.gov.uk)  
EC Directive 2013/59/Euratom is intended to provide basic safety standards for 
protection against the dangers arising from exposure to ionising radiation. 
Member States are expected to transpose the Directive into national law. The 
Directive includes provisions for inspections to be carried out by the competent 
authority. In addition, within Chapter VII on Medical Exposures, there is a 
requirement that Member States ensure that clinical audits are carried out in 
accordance with national procedures, recognising that clinical audit extends 
beyond the scope of radiation protection and is normally carried out under 
professional initiatives and not under regulatory frameworks. While there may 
be some overlap between the information gathered as part of these separate 
approaches, the aims and conduct of regulatory inspections and clinical audit 
are different. These differences and the potential for these proceses to be 
complementary are discussed. 
Learning Objectives: 
1. To learn about the duality of the process. 
2. To understand the role of the inspector. 
3. To appreciate the differences between Inspection and Clinical Audit. 
17:25  
Panel discussion: Does Audit make the patient journey safer?  
16:00 - 17:30 Room M 2 
E³ - ECR Master Class (Interventional Radiology)  
E³ 1626a  
Interventional radiology in the venous 
system: vessel and eye opening  
Moderator:  
C. Binkert; Winterthur/CH  
A-858 16:00  
A. Varicose vein  
L. Oguzkurt; Istanbul/TR (loguzkurt@yahoo.com)  
Varicose vein of the leg is a very common disease. Saphenous vein 
insufficiency is the cause in almost 95% of cases. Varicosities are not a sole 
cosmetic problem, as it may induce symptoms such as pain, fatigue, heaviness 
and night cramps which may influence the quality of life of people. Saphenous 
vein insufficiency is also part of chronic venous insufficiency causing leg 
swelling, skin changes and rarely venous ulcers. Surgery with saphenous vein 
stripping and high ligation was the primary treatment for years, but endovenous 
ablation methods are now the first-line treatment. There are several options for 
endovenous treatment of the saphenous vein insufficiency, such as laser, 
radiofrequency and steam (thermal) ablations or mechanicochemical, foam or 
glue (nonthermal) ablations. All these methods proved to be very effective and 
safe to treat truncal vein ablation. Ultrasound-guided foam sclerotherapy is not 
very effective for truncal vein ablation as recurrence rates are high. However, it 
is very effective for ablation of secondary or residual varicosities. Ambulartory 
phlebectomy or sclerotherapy for the secondary varicosities can be performed 
concomitantly or as a staged procedure and the former is preferred in most 
centres. Complications of truncal vein ablation include pain, bruising, 
tenderness, and phlebitis over the treated vein which are usually mild and self-
limited. Deep vein thrombosis, pulmonary embolisms are extremely rare, but 
reported as case reports. Technical and short-/long-term clinical outcomes of 
endovenous ablation of the saphenous veins are very good with improvement 
of both cosmetic problems and clinical complaints.  
Learning Objectives: 
1. To learn about clinical and imaging assessment. 
2. To understand the role of thermal and non-thermal devices. 
3. To review the role of foam sclerotherapy and mini-phlebectomy for ancillary 
therapies. 
A-859 16:30  
B. Lower limb acute deep vein thrombosis  
J. Kettenbach; St. Pölten/AT (joachim.kettenbach@stpoelten.lknoe.at)  
Deep vein thrombosis (DVT) is common and, if left untreated, can lead to life-
threatening conditions. Drug anticoagulation as a standard therapy primarily 
prevents progression of thrombosis and life-threatening pulmonary embolism. 
Long-term consequences with high morbidity, such as the post-thrombotic 
syndrome, cannot be prevented by anticoagulation. Systemic thrombolysis is 
  







no longer indicated because of the high rate of major bleeding complications, 
whereas surgical thrombectomy is increasingly being replaced by 
endovascular procedures. Open surgical thrombectomy may be suitable only in 
selected patients who are candidates for anticoagulation, but in whom 
thrombolytic therapy is contraindicated (2C). In patients with iliofemoral DVT, 
catheter-assisted procedures, in addition to anticoagulation, are very well 
suited to rapidly revascularize extensive thrombosis. Combining local 
thrombolysis and thrombectomy as a pharmaco-mechanical thrombectomy 
(PMT) may be considered over catheter-directed pharmacologic thrombolysis 
(CDT) alone if expertise and resources are available. There is increasing 
evidence that this preserves venous valve function, reduces longer-term 
venous hypertension, and lowers the incidence of postthrombotic syndrome 
(PTS). Pharmaco-mechanical thrombectomy also reduces the required 
thrombolytic dose and allows single-session intervention. Residual stenoses or 
venous obstructions are treated by balloon dilatation and stent implantation. In 
the long term, the severity of a after iliofemoral thrombosis can be significantly 
reduced. Solitary minor deep calf vein thrombosis can be safely treated with 
compression stockings and anticoagulation without the need for urgent 
intervention such as CDT or mechanical thrombectomy, given the associated 
low morbidity and mortality. 
Learning Objectives: 
1. To understand the evidence supporting endovascular therapy. 
2. To learn about clinical and imaging assessment. 
3. To review what is new in terms of techniques and devices. 
A-860 17:00  
C. Lower limb chronic deep vein occlusion  
R. de Graaf; Maastricht/NL (r.de.graaf@mumc.nl)  
Chronic deep venous obstruction is a relatively prevalent condition caused by 
either or a combination of two factors: post-thrombotic vein damage or 
extraluminal venous compression. Post-thrombotic syndrome (PTS) develops 
in up to 50% of patients in the months or years following a deep venous 
thrombosis (DVT). Non-thrombotic iliac vein lesions (NIVL) are usually caused 
by an overriding artery (e.g. May-Thurner), alternatively by any two pelvic 
structures wedging the iliac vein. Both conditions impede venous outflow of the 
lower extremity and are linked to symptoms associated with chronic venous 
disease. Endovascular treatment has been shown to achieve high technical 
and clinical success. Overall, stents to treat NIVL show higher patency rates 
than those implanted for post-thrombotic lesions. The variation in patency rates 
might be dependent on multiple aspects, e.g. diagnostic sensitivity, 
anticoagulation regimens, stents characteristics and venous inflow impairment. 
Stent design might pose a very important variable in long-term patency. With 
increasing awareness and knowledge of deep venous interventions, new 
devices will be introduced which may improve technical success and support 
clinical outcome. The nearest challenge will be to identify a common approach 
in deep venous treatment by appraisal of the current data, moving towards 
international guidelines.  
Learning Objectives: 
1. To understand the evidence supporting endovascular therapy. 
2. To learn about clinical and imaging assessment. 
3. To review what is new in terms of techniques and devices. 
Author Disclosure: 
  R. de Graaf: Consultant; Vesper Medical; Optimed GmbH, Cook Medical, 
Volcano/Philips, Boston Scientific, Bard. 
16:00 - 17:30 Room M 3 
E³ - ECR Master Class (Molecular Imaging)  
E³ 1626b  
Quantitative imaging in oncology  
A-861 16:00  
Chairperson's introduction  
J. O'Connor; Manchester/UK (james.o'connor@manchester.ac.uk)  
Tumours are biologically heterogeneous and this is considered to have 
prognostic significance and may also influence response to therapy. For many 
decades, diagnostic imaging has been used to provide 3D morphological 
assessments of the spatial variation in tumours and quantify overall tumour 
complexity. More recently, there has also been considerable interest in using 
functional imaging techniques derived from CT, MRI, ultrasound and nuclear 
medicine techniques to quantify the spatial variation in tumour 
pathophysiology. In this ECR Masterclass, we will discuss the image analysis 
methods currently used to quantify spatial heterogeneity within tumours. We 
will consider how and when analysis of intratumour heterogeneity can provide 
benefit over more simple biomarkers such as tumour size and average 
function. We will consider how imaging biomarkers of heterogeneity are best 
integrated with genomic and pathology biomarkers into multi-scalar 
assessments of heterogeneity. The Masterclass will also identify the 
challenges for imaging tumour heterogeneity that must be addressed before 
such biomarkers become integrated into guiding patient care.  
Session Objectives: 
1. To understand the impact of tumour heterogeneity on diagnosis and 
treatment. 
2. To learn the basics of quantitative imaging of heterogeneity. 
3. To approach the future impact of quantitative imaging of heterogeneity. 
A-862 16:05  
A. Intra- and interindividual tumour heterogeneity and the impact for 
cancer diagnostics  
M. Eisenblätter; Münster/DE (eisenblaetter@uni-muenster.de) 
Malignant tumours are biologically complex systems with spacially variable 
gene expression patterns, consecutively variable biochemistry, histopathology 
and macroscopically variable structure. In the tumour microenvironment, 
genetic variability of tumour cells meets external stressors and the host 
immune system. The result is a regional heterogeneity of stromal architecture, 
biological activity and expression of e.g. chemokines and growth factors. 
Consecutively, the development of tumour vasculature, nutrient supply, cell 
growth and death etc. exhibit significant, regional variation. This variation 
occurs within a single tumour lesion, between primary tumour and metastasis 
and of course and pronounced between tumour lesions - even of the same 
tumour type - in different individuals. Generally, a high degree of heterogeneity 
is associated with poor prognosis and is at the same time increasingly relevant 
for therapy selection and monitoring, due to ever more specific therapy 
approaches. Various imaging approaches basically allow for visualisation of 
spatial heterogeneity in tumours. However, recorded and documented 
information is often limited to lesion size and macroscopic heterogeneity. In 
this context, relevant information, silently acquired even during clinical 
standard examinations, is ignored and dismissed unused. A rigorous analysis 
of all radiologic imaging data can help discovering this hidden information and 
provide additive information on tumour biology, relevant for tumour therapy. 
This talk is intended as an overview of the different levels of tumour 
heterogeneity, experimental and established imaging approaches to assess 
tumour heterogeneity and the possibility to provide adequate biomarkers for 
state of the art tumour therapy by integrated image data analysis. 
Learning Objectives: 
1. To learn about tumour heterogeneity. 
2. To review current strategies to explore biological heterogeneity. 
3. To understand how this heterogeneity impacts diagnosis and treatment. 
A-863 16:23  
B. Quantitative image biomarkers for targeted tumour therapies  
R. García Figueiras; Santiago de Compostela/ES 
(roberto.garcia.figueiras@sergas.es)  
Clinical imaging systems are a significant source of non-invasive imaging 
biomarkers (IBMs) that may reflect important biological properties of cancers. 
IBMs can provide quantitative information on tumour hallmarks and can be 
used to evaluate tumour heterogeneity. They may also help us to understand 
the mechanism of action of therapies and their effects on the tumour 
microenvironment, offering objective measures of change in response to a 
therapy. This presentation will explain the biologic basis for a number of 
commonly available IBMs obtainable clinically. Besides this, we will illustrate 
how quantification of IBMs is undertaken and provide the validation of such 
measurements. Finally, the role of IBMs for the assessment of therapy 
response will be reviewed.  
Learning Objectives: 
1. To learn how heterogeneity can be quantified from images. 
2. To understand how the main types of heterogeneity features. 
3. To review limits and pitfalls of features extraction. 
A-864 16:41  
C. Requirements for quantitative data extraction and analysis  
H.K. Hahn; Bremen/DE  
We will focus on the question how to extract valuable quantitative information 
from in-vivo imaging data, ultimately leading to clinically relevant imaging 
biomarkers and phenotypes. We enter the topic by discussing the influence of 
image quality and resolution on the accuracy and precision of the derived 
measurements. In addition to signal-to-noise and partial volume effects, which 
always affect image based quantification, image non-uniformity plays a role in 
particular for MRI. A review of the concept of Radiomics will highlight the 
potentials of integrated diagnostics. Radiomics relates imaging based 
quantitative phenotyping to genomics, laboratory medicine, and risk scores 
  







etc., and ultimately to therapy outcomes and further clinically relevant 
parameters. Recently, tremendous advances in machine intelligence were 
demonstrated and successfully applied to medical imaging problems. Deep 
learning and convolutional neural networks will play an important role in next 
generations of automated imaging biomarker extraction and big data analysis 
systems. We will provide a few examples of what is already feasible today and 
also describe additional technological components required for successful 
clinical implementation, such as precise anatomical coregistration of 
multimodal and longitudinal medical images. For instance, the localised 
assessment of disease progress over time will be greatly facilitated by a 
combination of prior-to-current image registration and pattern quantification. 
Not least, we will discuss the requirements regarding infrastructure for the 
validation and interactive exploration of evolving imaging biomarkers. 
Learning Objectives: 
1. To learn how to optimise acquisition of images for quantitative imaging. 
2. To understand image processing which may impact quantification. 
3. To become familiar with the concepts behind quantification. 
A-865 16:59  
D. Imaging heterogeneity and genomic variability in ovarian cancer  
E. Sala; Cambridge/UK (evis.sala@gmail.com)  
Cancer is caused by genetic (DNA) and epigenetic alterations and frequently 
arises as a clonal growth from a founder cell. The subclonal heterogeneity 
provides the basis for inter-metastatic heterogeneity which is of utmost clinical 
importance. New tumour sampling techniques and circulating tumour DNA 
methods may allow for more comprehensive evaluation of clonal composition. 
As both primary tumours and metastatic lesions are spatially and temporally 
heterogeneous, they would require multiple biopsies to extract and analyse 
small portions of tumour tissue, which still does not allow for a complete 
characterisation of the tumour genomic landscape. Therefore, imaging has 
great potential for a comprehensive evaluation of the entire tumour burden in 
ovarian cancer, as it is noninvasive and is already often repeated during 
treatment in routine practice, in contrast to genomics or proteomics, which are 
still challenging to implement into clinical routine. While initial retrospective 
studies linking phenotype with genotype in ovarian cancer have shown high 
prognostic power, they do not provide any spatial information as quantitative 
imaging features are generated and averaged over the entire tumour, 
assuming that tumours are heterogeneous but well mixed. This approach 
ignores spatial heterogeneity readily apparent on imaging. Indeed, recent 
genomics work has highlighted the presence of intratumour variation in gene 
mutation and expression. However, little effort if any has been put into 
integrating imaging, histopathology and genomics and thus there is a clear 
need for well-designed prospective studies focused on meaningful integration 
of phenotype and genotype rather than genomics in isolation.  
Learning Objectives: 
1. To learn about an application of imaging tumour heterogeneity. 
2. To understand how imaging heterogeneity may relate to biological 
heterogeneity. 
3. To become familiar with new imaging concepts such as imaging phenotypes 
and signatures. 
17:17  
Panel discussion: What can we quantify and why is it essential?  
16:00 - 17:30 Room M 4 
E³ - ECR Academies: Tips and Tricks in Pancreatic and GI Tract 
Imaging  
E³ 1622  
Peritoneum and mesentery  
A-866 16:00  
Chairperson's introduction  
A. Ba-Ssalamah; Vienna/AT (ahmed.ba-ssalamah@meduniwien.ac.at)  
The abdominal cavity is subdivided into the peritoneal cavity, lined by the 
parietal peritoneum, and the extraperitoneal space. The visceral peritoneum 
covers the intraperitoneal organs and part of the pelvic organs. The parietal 
and visceral layers of the peritoneum are in sliding contact, the potential space 
between them called the peritoneal cavity which is part of the embryologic 
abdominal cavity or primitive coelomic duct. A thorough understanding of 
peritoneal anatomy is fundamental in determining the cause and recognising 
the extent of peritoneal involvement, as well as in decision-making about the 
appropriate therapeutic approach, whether surgery, conservative treatment, or 
interventional radiology. On imaging, signs of peritoneal involvement include 
fluid collections or solid tumors along the ligaments, mesenteries, and/or within 
the potential spaces of the peritoneal cavity. The spectrum of disorders include 
inflammatory, infectious, and neoplastic diseases, as well as trauma. 
Radiologist, by taking into account the patient’s age, gender, symptoms and 
risk factors, in addition to the key features, including location, textural 
composition of the lesions either cystic or solid and number of lesions come up 
with a list of differential diagnoses. Reports should include measurements, 
pertinent negatives and any other relevant findings that influence patient 
management.  
A-867 16:05  
A. Understanding primary tumours  
C. Dromain; Lausanne/CH (Clarisse.Dromain@chuv.ch)  
Primary tumours arising in the peritoneum and the mesentery are rare. Most 
imaging findings of primary peritoneal and mesenteric tumours are nonspecific 
and very similar to those of peritoneal metastases associating soft-tissue 
masses and ascites. However, several key findings can be helpful for the 
diagnosis and proper management of these patients. Key points to consider 
are the clinical context (sex, age, risk factor such as asbestosis exposition, 
absence of history of cancer, FAP ), the location of the peritoneal implant 
(mesentery vs peritoneum cavity meso and fold), tissular composition of the 
lesions (cystic vs solid, vascularisation), and number of lesions (isolated vs 
multiples). The most common primary mesenteric tumours are cystic tumours, 
such as lymphangiomas and mesothelial cysts, and tissular lesions including 
desmoid tumours (often associated with FAP), GIST, NET (with high fibrous 
content and retraction), primary mesenteric lymphomas, Castleman tumours 
(highly vascularized) and mesenchymal benign and malignant tumours. The 
most common primary peritoneal tumours are mesotheliomas, desmoplastic 
round cell tumours (young male), primary papillary serous carcinomas (PPSC; 
mimicking metastases from ovarian cancer), peritoneal lymphomatosis, and 
leiomyomatosis. Imaging features of mesothelioma depend on the histological 
type. Multicystic mesothelioma has a very typical multiloculated cystic 
appearance with thin septations easily diagnosed on MRI. Benign papillary 
mesothelioma and malignant epitheliod mesothelioma (linked to asbestosis 
exposition) have very similar pattern mimicking peritoneal metastases. 
Sarcomatoid and biphasic mesotheliomas are predominantly solid and 
localized with large masses and no ascites. Differential diagnoses include 
peritoneal metastases, pseudomyxoma peritonei (PMP), splenosis, 
tuberculosis, actinomycosis, and peritoneal endometriosis.  
Learning Objectives: 
1. To become familiar with the spectrum of tumours of the mesentery and 
peritoneum. 
2. To understand how imaging helps in narrowing the differential of mesenteric 
and peritoneal masses. 
3. To learn the role of percutaneous or surgical biopsy. 
A-868 16:33  
B. Peritoneal carcinomatosis  
P.K. Prassopoulos; Alexandroupolis/GR (pprasopo@med.duth.gr)  
Intraperitoneal dissemination of primary GI and gynaecological primary 
tumours - the so-called peritoneal carcinomatosis - is a common process in the 
evolution of these malignancies and has a significant impact on therapeutic 
decisions. The location of implants in peritoneal carcinomatosis is governed 
mostly by peritoneal fluid circulation and by anatomic pathways formed by 
peritoneal reflections, namely ligaments, mesenteries and omenta. The most 
common sites where the peritoneal fluid may be temporarily arrested - 
facilitating implantation of cancer cells - include cul-de-sac, distal small bowel 
mesentery, right paracolic gutter, posterior sub-hepatic space, greater 
omentum and subphrenic spaces. The role of imaging is to disclose the 
presence and extent of the disease - that is fundamental in candidates for 
cytoreductive surgery - to monitor response to treatment and to reveal 
recurrences. MDCT with thin collimation and i.v. contrast material 
supplemented by multiplanar reconstructions remains the primary imaging 
modality for the investigation of peritoneal carcinomatosis, assessment of 
disease distribution and routine post-treatment evaluation. Ascites, contrast-
enhanced smooth, nodular, or plaque-like peritoneal thickening, peritoneal 
nodules, plaques or masses, rounded, ill-defined soft-tissue or cystic 
mesenteric masses, mesenteric fixation with increased attenuation values and 
thickening, irregular soft-tissue permeation of omental fat or confluent solid 
omental masses are the most frequent MDCT findings of peritoneal 
carcinomatosis. MRI-DWI can alternatively be used. Post-gadolinium-
enhanced 3d FLASH sequence with fat saturation is advantageous in cases of 
diffused layered type of peritoneal/mesenteric involvement. PET/CT and DW-












1. To become familiar with the usual origin and spread of peritoneal 
carcinomatosis. 
2. To learn about the role of CT, MRI and PET for the detection and staging of 
peritoneal carcinomatosis. 
3. To understand how imaging helps the clinician for the evaluation of 
response to treatment. 
A-869 17:01  
C. From misty mesentery to mesenteritis  
G.A. Krombach; Giessen/DE (gabriele.krombach@uniklinikum-giessen.de)  
The mesentery can be affected by a variety of entities ranging from spread of 
diseases occurring in adjacent organs, such as necrosis in pancreatitis or 
oedema following thrombosis of the portal or superior mesenteric vein to 
benign or malignant diseases directly arising within the mesentery. Sclerosing 
mesenteritis is an autoimmune disease initiated by an allergic reaction to long-
term expose of allergens regularly contained in food or constantly present in 
the proximity of the patient. IgG4-antigenes are formed against such antigens 
and mesenteritis is a sequel of cross reaction of the IgG4-antigenes to proteins 
contained in the connective tissue of the mesentery. Mesenteritis usually is 
biphasic with a first active phase, marked by cellular infiltration with plasma 
cells and lymphocytes and oedema, and a chronic phase with the hallmark of 
almost acellular storiform fibrosis triggered by the cytokines TNF- and IL-2 
and -4 released by granulocytes. In imaging, in all modalities the mesentery 
appears “misty”, while the tissue immediately surrounding the mesenteric 
vessels is spared from the change, called fat-ring sign. The area of the 
increased density (or altered signal intensity in MRI) in almost all cases and 
phases is sharply surrounded by a pseudocapsule. Contrast enhancement and 
T2 signal intensity vary with the disease phase. The mesenteric lymph nodes 
are often enlarged, which can render differentiation from lymphoma 
challenging in some patients. Symptoms may range from not present to 
abdominal pain, fever, weight loss to severe complications, including stenosis 
of the mesenteric vessels and ischaemia of the bowel, ileus or perforation.  
Learning Objectives: 
1. To become familiar with the differential between incidental mesenteric 
abnormalities, tumour infiltration and true mesenteritis. 
2. To understand how mesenteritis can be associated with other organs lesions 
in case of systemic disease. 
3. To learn which imaging (CT, MRI, PET) is relevant for the detection and 
follow-up of inflammatory diseases. 
16:00 - 17:30 Room M 5 
Transatlantic Course of ESR and RSNA (Radiological Society of 
North America): Sports Imaging  
TC 1628  
Postoperative imaging of sports injuries  
Moderators:  
L.W. Bancroft; Orlando, FL/US  
A.J. Grainger; Leeds/UK  
A-870 16:00  
A. Postoperative shoulder MRI after instability surgery  
L.W. Bancroft; Orlando, FL/US (laura.bancroft.md@flhosp.org)  
Purpose: To become familiar with the expected and abnormal MR imaging 
findings after labral repair, capsular shift/capsulorrhaphy, remplissage and 
Latarjet/Bristow procedures. Methods and Materials: MR imaging will be used 
to demonstrate the various normal and abnormal imaging appearances after 
shoulder instability surgery. Results/Conclusion: Labral re-tear will be evident 
as contrast or joint fluid extension into linear or complex tear cleft, 
absent/truncated/fragmented labrum, or labral displacement from anatomic 
location. Capsular shift results in smaller capacity joint and sometimes irregular 
capsular nodularity. Complications of capsulorrhaphy include capsular tears 
and subluxation of humeral head. Postoperative MR imaging can evaluate 
healing after combined remplissage and Bankart repair for moderate size, 
ngaging Hill-Sachs lesions. Laterjet and Bristow procedures may be performed 
in patients with recurrent dislocations and glenoid deficiency. Incorporated 
bone will yield non-anatomic glenoid configuration, and complications include 
non-union, fatty degeneration of subscapularis muscle, and osteoarthrosis. 
Learning Objectives: 
1. To become familiar with the expected and abnormal MR imaging findings 
after labral repair. 
2. To learn about the postoperative imaging features after capsular 
shift/capsulorrhaphy. 
3. To appreciate normal imaging and complications after remplissage and 
Laterjet/Bristow procedures. 
Author Disclosure: 
  L.W. Bancroft: Author; Lippincott - Book Royalties. 
A-871 16:30  
B. ACL reconstruction and cartilage repair  
C. Weidekamm; Vienna/AT (weidekamm@icloud.com)  
The aim of ACL reconstruction is to stabilize the knee and prevent chondral 
and meniscal injuries, which are the sequelae of anteroposterior translation 
and are associated with early osteoarthritis. The idea of the double-bundle ACL 
graft was to restore normal joint kinematics by anatomic reconstruction of the 
anteromedial and the posterolateral bundle of the original ACL. This was 
expected to improve clinical outcomes and restore anterior and rotational knee 
stability. The single-bundle technique, however, causes less osseous defects 
and is still a popular technique. Complications, such as ACL graft failure, 
impingement, cyclops lesion, arthrofibrosis, and patellar inferior syndrome, are 
discussed. The second part of this presentation will illustrate cartilage repair 
techniques and imaging findings. The radiologist must be familiar with the 
different cartilage repair procedures and characteristics in cartilage imaging to 
evaluate long-term progression or failure. Abnormal postoperative findings 
include hypertrophic filling, incomplete integration of the transplant into the 
surrounding cartilage, or subchondral defects, osteophytes, cysts, and 
persistent bone marrow oedema and joint effusion.  
Learning Objectives: 
1. To review the common and uncommon ACL reconstruction techniques. 
2. To appreciate the expected and abnormal MR imaging findings after ACL 
reconstruction. 
3. To understand common cartilage repair techniques, and corresponding 
normal and abnormal postoperative MRIs.  
A-872 17:00  
C. Interactive case discussion (part 1)  
L.W. Bancroft; Orlando, FL/US  
To engage in interactive case discussions with the expected and abnormal MR 
imaging findings after labral repair, capsular shift/capsulorrhaphy, remplissage 
and Laterjet/Bristow procedures. An interactive case discussion will be used to 
demonstrate the various normal and abnormal imaging appearances after 
shoulder instability surgery. Labral re-tear will be evident as contrast or joint 
fluid extension into linear or complex tear cleft, absent/truncated/fragmented 
labrum, or labral displacement from anatomic location. Capsular shift results in 
smaller capacity joint and sometimes irregular capsular nodularity. 
Complications of capsulorrhaphy include capsular tears and subluxation of 
humeral head. Postoperative MR imaging can evaluate healing after combined 
remplissage and Bankart repair for moderate size, ngaging Hill-Sachs lesions. 
Laterjet and Bristow procedures may be performed in patients with recurrent 
dislocations and glenoid deficiency. Incorporated bone will yield non-anatomic 
glenoid configuration, and complications include non-union, fatty degeneration 
of subscapularis muscle, and osteoarthrosis. 
Learning Objectives: 
1. To learn how to differentiate normal and failed labral repairs with MRI. 
2. To become familiar with the diagnostic features of failed ACL 
reconstructions. 
3. To understand the imaging features of intact and failed cartilage repair. 
Author Disclosure: 
  L.W. Bancroft: Other; Lippincott - Book Royalties. 
A-873 17:15  
C. Interactive case discussion (part 2)  
C. Weidekamm; Vienna/AT  
Postoperative imaging after ACL or cartilage repair is indicated in patients with 
ongoing pain/instability or repetitive injury. Radiography remains the initial 
imaging modality; however, further assessment with CT or MRI is 
recommended. With a clear emphasis on MRI, we will review normal 
postoperative findings and complications after ACL reconstructions and 
cartilage repair. The case discussion will cover the most significant pathologies 
and pitfalls, and normal postoperative findings will be illustrated. 
Learning Objectives: 
1. To learn how to differentiate normal and failed labral repairs with MRI. 
2. To become familiar with the diagnostic features of failed ACL 
reconstructions. 



















08:30 - 10:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1721  
Cardiac imaging  
A-874 08:30  
A. Grown-ups with congenital heart disease  
A.M. Taylor; London/UK  
This session will describe how MRI and CT can be used to image adults with 
congenital heart disease. The common conditions that occur in childhood will 
be described (acyanotic and cyanotic heart disease) and what operations they 
undergo that will be important for imaging them when they become adults. 
Finally, those CHDs that may be diagnosed in adulthood will be described. 
Learning Objectives: 
1. To be familiar with the clinical and radiologic presentations of these patients. 
2. To learn about imaging findings and management options. 
A-875 09:15  
B. Imaging cardiac valves  
R. Salgado; Antwerp/BE (rodrigo.salgado@uza.be)  
Valvular heart disease forms an important part of the workload in every 
cardiology practice. While echocardiography remains a cornerstone in the 
assessment and follow-up of valvular heart disease, an important role is 
reserved for MR and CT imaging, although in different contexts. MR, with its 
ability to investigate the valvular morphology as well as the haemodynamic 
consequences on the cardiac chambers, forms an important complementary 
tool to the echocardiographic findings. It provides a reproducible quantification 
of transvalvular flow and has in recent years gained further importance in 
tissue characterisation with the introduction of T1/T2 mapping techniques for 
the detection and distribution of fibrosis. CT has recently gained a prominent 
place in the non-invasive investigation of the aortic root before transcatheter 
aortic valve replacement and is also becoming a primary imaging modality in 
emerging mitral valve interventions. Furthermore, its role in the evaluation of 
prosthetic heart valves is currently the subject of intense investigation, 
providing valuable additional information not easily acquired through other 
imaging methods. During this lecture, the different advantages and limitations 
of valvular imaging with CT and MR will be discussed, and practical 
recommendations for clinical practice will be given.  
Learning Objectives: 
1. To understand the impact of imaging. 
2. To know the limitations and potential pitfalls of CT and MR techniques. 
3. To learn about the imaging technique. 
08:30 - 10:00 Room B 
Abdominal Viscera  
RC 1701  
Abdominal MRI: from standard to 
advanced protocols  
A-876 08:30  
Chairperson's introduction  
F. Caseiro Alves; Coimbra/PT (caseiroalves@gmail.com)  
Abdominal MR imaging is a continuously evolving technique where 
researchers, vendors and clinical users get together to push it to the next level 
of medical practice. Recent advances in the MR field include the development 
of dedicated DWI sequences, increased spatial resolution and functional 
imaging capabilities, to name a few. Therefore, there is a clear-cut need to use 
and take advantage of the most recent and best suited protocols. In this 
session, we will deal with three important common clinical situations: a) 
suspected pancreatic cancer where MR appears not only as a problem-solving 
tool, but also as a competitive diagnostic modality compared with MDCT, 
ranging from DWI to high-resolution MRCP and time-resolved dynamic 
imaging; b) inflammatory bowel disease, which, as a chronic relapsing disease, 
is one of the cases where MR may contribute to drive patient management, 
exquisitely monitoring the inflammatory activity of the disease; and c) MRI of 
pelvic floor disorders that consists in the use of high-resolution morphological 
data together with functional information under straining conditions. Its 
diagnostic power and contribution to patient management is well 
acknowledged today, but protocol optimisation and proper quantification 
assume vital importance. To enhance the educational value of this session, an 
illustrative clinical case for each clinical problem will be presented exploring the 
benefits and/or MR limits.  
Session Objectives: 
1. To learn the importance of MR protocolling for different abdominal 
conditions. 
2. To become familiar with both dedicated and advanced MR imaging. 
3. To learn through a case-based approach its impact on report quality. 
A-877 08:35  
A. Suspected pancreatic tumour  
R. Manfredi; Rome/IT (riccardo.manfredi@unicatt.it)  
Pancreatic cancer is the fourth leading cause of cancer-related death. Surgical 
resection is the sole curative treatment option; however, only 15%-20% are 
resectable at the time of diagnosis. Furthermore, the prognoses for patients 
with pancreatic cancer remain poor. Although the 5-year survival rate is up to 
20% after complete resection, it is further improved to more than 75% in 
patients with a diagnosis of stage 1 disease. Computed tomography (CT) 
remains the initial imaging modality of choice for pancreatic solid neoplasms, 
because recent improvements in multidetector CT technology, including 
improved temporal and spatial resolution, have facilitated more precise timing 
of multiphasic imaging and increased the accuracy of CT for the detection and 
staging of pancreatic adenocarcinoma. Recently, magnetic resonance (MR) 
imaging has acquired a role in the early diagnosis of adenocarcinoma, 
because of diffusion-weighted (DW) MR imaging. By means of DW imaging, 
MRI is able to depict changes in water mobility caused by interactions with cell 
membranes, macromolecules, and alterations to the tissue environment, and 
thus provides a tissue contrast that is different from that on conventional T1- 
and T2-weighted images. DW imaging plays a role in oncology for tumour 
detection, in general. DW imaging allows detection of pancreatic 
adenocarcinomas with high sensitivity and specificity, because it appears 
hyperintense compared with the rest of the gland. DW-MR imaging is also 
useful in finding small functioning neuroendocrine neoplasms, responsible for a 
clinical syndrome, but difficult to diagnose because of their small size.  
Learning Objectives: 
1. To learn about the role of MRI in the assessment of a patient with suspected 
pancreatic tumour. 
2. To become familiar with the optimal MRI protocols including the role of DWI 
and secretin in this group of patients. 
3. To appreciate the advantages and limitations of MRI in comparison with 
other imaging techniques. 
A-878 08:58  
B. Inflammatory bowel disease  
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk)  
Magnetic resonance enterography (MRE) is increasingly used, particularly for 
Crohn’s disease assessment. It has an evolving role not only in grading 
inflammation and detecting complications, but also for monitoring the course of 
the disease. The diagnostic accuracy of MRE is heavily influenced by the 
technical quality of the examination. Patient preparation, bowel distension, 
sequence selection and scan technique must all be optimised to produce high-
quality examinations. This presentation will review the recommendations of the 
recent ESGAR consensus statement on MRI small bowel imaging and will 
address commonly encountered problems that can arise before and during 
scan acquisition. The utility of novel sequences such as DWI and motility will 
also be discussed. 
Learning Objectives: 
1. To learn about the role of MRI in patients with IBD. 
2. To become familiar with the optimal MRI protocols including bowel 
distension in this group of patients. 
3. To appreciate the role of functional imaging techniques for assessment of 
IBD. 
Author Disclosure: 
  S.A. Taylor: Consultant; Robarts. 
A-879 09:21  
C. Pelvic floor disorder  
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.zuerich.ch)  
Imaging of the female pelvic floor is of rising interest due to an ageing 
population, harbouring an increasing incidence of pelvic floor disorders (PFD), 
and the rising need for comprehensive diagnosis and treatment. Magnetic 
resonance imaging (MRI) of the female pelvic floor combines high-resolution 
imaging with an excellent soft tissue contrast and provides the possibility to 
  







assess noninvasively and objectively a spectrum of possible disorders affecting 
the pelvic floor in one examination. There is general agreement that MRI of the 
pelvic floor should include static and dynamic MR images, whereas dynamic 
means imaging under maximum stress to the pelvic floor and MR 
defecography. Static MR images visualize pelvic floor anatomy and defects of 
the supporting structures, while dynamic MR images visualize pelvic organ 
mobility, pelvic floor weakness, pelvic organ prolapse (POP) and associated 
compartment defects. In this lecture, a standardized approach regarding 
indications, patient preparation, sequence acquisition, interpretation and 
reporting of MRI for diagnosis and grading of PFD is presented. Due to the 
different views of the clinical specialists involved in the treatment of PFD, 
adapting the MRI reporting scheme according to the speciality of the referring 
physician is discussed. Finally, the limitations of the technique are addressed.  
Learning Objectives: 
1. To learn about the clinical relevance of MRI in the management of patients 
with pelvic floor disorders. 
2. To become familiar with the optimal patient preparation and MRI protocols in 
this group of patients. 
3. To appreciate the advantages of MRI relative to other imaging modalities 
including conventional defecography. 
09:44  
Panel discussion: How to create an efficient MR protocol in abdominal 
diseases  
08:30 - 10:00 Room C 
Chest  
RC 1704  
Thoracic manifestations of systemic 
disease  
Moderator:  
A. Chodorowska; Wroclaw/PL  
A-880 08:30  
A. Systemic sclerosis  
N. Sverzellati; Parma/IT (nicolasve@tiscali.it)  
Systemic sclerosis (SSc) is variably associated with pulmonary involvement, 
which is a paramount prognostic factor. Interstitial fibrosis and pulmonary 
vessel abnormalities are the two elementary lung wounds in SSc and can 
occur independently of each other. Chest radiograph has low sensitivity in the 
assessment of early interstitial lung disease (ILD) associated with SSc. 
Oesophageal dilation can be the only apparent finding. High-resolution 
computed tomography (HRCT) is pivotal in baseline staging. HRCT findings of 
SSc-ILD include confluent ground-glass opacities, traction 
bronchiectasis/bronchiolectasis, fine reticulation, and honeycombing. The 
HRCT pattern of non-specific interstitial pneumonia (NSIP) is common, actually 
reflecting more than 75% frequency of histologic NSIP. The combination of 
HRCT and pulmonary function tests (PFTs) has been proposed for 
prognostication of SSc. ILD extent <10% has lower risk compared to >30%, 
with minor influence from PFTs. On the other hand, PFTs can further stratify 
prognosis among subjects with ILD extent 10-30%. Quantitative CT methods 
are being developed to measure the ILD extent. SSc patients are at increased 
risk of lung cancer. Its surgical treatment is mostly prevented by extensive ILD. 
Pulmonary hypertension (PH) can occur independently of ILD, reflected by 
isolated reduction of DLCO at PFTs. In particular, PH is more common in 
limited cutaneous systemic sclerosis, also known under the acronym CREST 
syndrome.  
Learning Objectives: 
1. To learn about the typical radiological appearances. 
2. To be aware of the clinical relevance of scoring. 
3. To know how vascular complications affect patient prognosis. 
A-881 09:00  
B. Granulomatosis and polyangiitis  
S. Bayraktaroglu; Izmir/TR (selenb2000@gmail.com)  
Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s 
granulomatosis, is a chronic granulomatous necrotising vasculitis of small- and 
medium-sized vessels. The classical clinical triad of the disease consists of 
upper and lower airway involvement and glomerulonephritis. The upper 
respiratory tract is affected in almost all patients. The majority of patients with 
GPA will also have pulmonary (90%) and renal (80%) involvement. The most 
common radiologic findings in thoracic involvement are nodules, mass lesions 
and areas of consolidation. Cavitation within these lesions may be seen due to 
the necrotic nature of the disesse. Airway involvement is characterised by 
circumferential tracheal wall thickening. Areas of consolidation, cavitary 
nodules and mass lesions represent active inflammatory disease, whereas 
areas of bronchiectasis and septal-nonseptal lines more often represent 
chronic fibrotic changes. The radiologist must be familiar with the common 
thoracic radiologic manifestations of the disease.  
Learning Objectives: 
1. To learn about the radiological appearances of small-vessels vasculitis. 
2. To learn how clinical and radiological features help in differential diagnosis. 
3. To appreciate the actual role of imaging in assessing disease activity. 
A-882 09:30  
C. Early manifestations in children and young adults  
M.P. García-Peña; Barcelona/ES (plgarciapena@gmail.com)  
Lung disease is common in children with systemic diseases, and the 
radiographic appearance of early-stage pulmonary changes is often subtle. 
Computed tomography (CT) has higher sensitivity and specificity than 
radiography. High-resolution computed tomography (HRCT) is the imaging 
technique of choice for assessing lung involvement in these patients. Even with 
reduction in the peak voltage and tube charge to minimize the exposure of 
paediatric patient to radiation, CT performed with a meticulous acquisition 
technique can provide detailed information. The uses of CT in evaluating 
systemic disease are to detect lung abnormalities, characterize the findings, 
assess the extent of disease, and help establish the differential diagnosis. CT 
also is used for follow-up evaluations, monitor the effects of treatment, and for 
guidance of lung biopsy when that is required. High-resolution CT may depict 
lung lesions in children with no clinical respiratory symptoms and normal 
findings at lung function testing, facilitating early identification of lesions and 
allowing early treatment that can benefit the course of the disease. This lecture 
reviews the findings on high-resolution CT of the chest in children with 
suspected systemic diseases, with emphasis on connective tissue diseases 
(juvenile rheumatoid arthritis, dermatomyositis, systemic sclerosis, systemic 
lupus erythematosus, and mixed connective tissue disease), vasculitis, primary 
and acquired immunodeficiencies, immotile cilia syndrome, cystic fibrosis, and 
Langerhans cell histiocytosis. 
Learning Objectives: 
1. To learn about the radiological manifestations in children. 
2. To review the most adapted scanning protocols. 
3. To appreciate the role of imaging to monitor the effects of treatment. 
08:30 - 10:00 Room X  
Joint Session of the ESR and ESTRO  
New imaging approaches for radiotherapy  
A-883/A-884 08:30  
Chairpersons' introduction  
V. Valentini1, M.H. Fuchsjäger2; 1Rome/IT, 2Graz/AT 
(michael.fuchsjaeger@medunigraz.at)
2 
This session focuses on the importance of imaging for radiation oncology. 
Specific emphasis will be laid not only on current cooperation but also on 
potential future opportunities for radiology and radiation oncology collaboration. 
Furthermore, the latest imaging as a well as radiotherapy technologies will be 
discussed. The understanding of these technologies, ultrasound, dual-energy 
CT, MR-LINAC and MR-PET only forms the basis for clinical applications and 
successful therapy. A panel discussion on how radiation oncology and 
radiology as technological innovation leaders will be able to take advantage of 
each other in the near and distant future will complete this session.  
Session Objectives: 
1. To understand the increasing importance of imaging in radiation oncology 
techniques. 
2. To learn about the cooperation opportunities between radiologists and 
radiation oncologists. 
3. To become familiar with the most modern radiotherapy technologies. 
A-885 08:35  
Dual-energy CT: what are the benefits for radiotherapy?  
P. Wohlfahrt1, C. Richter1, C. Möhler2, S. Greilich2; 1Dresden/DE, 
2
Heidelberg/DE (patrick.wohlfahrt@oncoray.de)  
For about a decade, dual-energy CT (DECT) has been clinically available, 
mainly for radiology applications. In contrast, in the field of radiotherapy DECT 
has gained relevant interest over the last few years and here clinical use is still 
far away from being standard. In this lecture benefits of DECT for radiotherapy 
applications will be discussed. The focus will be on application for treatment 
  







planning in proton therapy, namely the individual prediction of tissue stopping 
power relative to water (SPR) as an alternative to the standard approach using 
a generic look-up table (HLUT). The manifold information gathered by two CT 
scans with different X-ray spectra allow for a patient-specific and direct 
calculation of relative electron density and SPR. This enables the consideration 
of intra- and inter-patient variabilities in CT-based SPR prediction and 
ultimately a more accurate range prediction. The talk will cover the validation of 
the SPR prediction accuracy in realistic ground-truth scenarios, the 
investigation of clinically relevant differences between the DECT-based and 
the standard HLUT-based SPR prediction in clinical patient data as well as the 
status of its clinical implementation. Furthermore, additional applications in 
radiotherapy, e.g. for photon treatment planning, delineating and material 
differentiating will be briefly discussed.  
Learning Objectives: 
1. To learn about technical aspects of dual-energy CT acquisition. 
2. To understand the strengths and limitations of the dual-energy CT 
applications in oncology. 
3. To appreciate the benefits relative to the use of dual-energy CT in the 
radiotherapy workflow. 
A-886 08:55  
Ultrasound imaging in radiotherapy: "old" technology with new 
applications in RT?  
E. Harris; Sutton/UK (Emma.Harris@icr.ac.uk)  
Medical ultrasound was first introduced in the 1940’s and has become a 
powerful diagnostic tool throughout the world. Its real-time, soft-tissue imaging 
capability and non-ionizing nature have contributed to its ubiquitous use in 
disease diagnosis and image guidance in interventional and surgical 
procedures. Ultrasound guidance of radiotherapy is a relatively new field with 
the first commercial systems becoming available in the late 1990’s. Despite 
possessing clear benefits for imaging a variety of tumour sites, challenges 
associated with implementing ultrasound in the radiotherapy clinic initially 
impeded its widespread adoption. The influence of effective training on 
interobserver variation and operator performance was an early barrier. 
Contemporary ultrasound image guidance techniques have done much to 
overcome these problems and modern systems are used clinically for 
interfraction motion estimation in prostate and breast and for intrafraction 
prostate motion monitoring. Other promising clinical applications under 
investigation include intrafraction motion estimation in liver, pancreas and 
kidney, and augmentation of cone beam CT data for the purpose of adaptive 
radiotherapy of the prostate and gynecological cancer. This talk will give an 
overview of the clinical use of ultrasound in radiotherapy, discuss the 
advantages and limitations of ultrasound and present future perspectives for 
ultrasound guided radiotherapy technology and practice. Finally, some exciting 
new applications of ultrasound functional imaging for monitoring of tumour 
response to radiotherapy will be introduced.  
Learning Objectives: 
1. To learn about ultrasounds applications in radiotherapy. 
2. To understand the clinical advantage of using ultrasounds based 
techniques. 
3. To appreciate the modern perspectives of this technique. 
A-887 09:15  
MR-LINAC technological advances and potential usability in clinical 
setting  
O. Jäkel; Heidelberg/DE (o.jaekel@dkfz-heidelberg.de)  
Radiotherapy has reached a point, where dose highly precise dose delivery is 
achieved with various techniques. The next big gain can only be made, when 
dose adaption is achieved not only in 3 dimensions as for static targets, but 
can also be maintained in 4 dimensions, i.e. including temporal changes in the 
patient. Image guided radiotherapy, based mainly on X-ray cone beam CT 
imaging, up to now has mostly been used to improve daily setup accuracy and 
to a lesser extent enabled modest adaption for inter-fractional changes. MRI, 
however, being non-invasive and yielding excellent soft tissue contrast, is an 
optimal tool for continuous monitoring of tumor motion during delivery and for 
allowing intra-fractional adaption of treatment plans. The idea to integrate a 
linear accelerator into an MRI was put forward by the Utrecht group already in 
2000. Due to the technical complexity, it took until 2017 to realize a clinical 
prototype. First patients were treated in 2017 and a commercial product by 
Elekta is expected to be released in 2018. Also in 2017, first patients were 
treated with another commercial system by Viewray, using a 0.35T split bore 
Magnet and a 4MV linac. The latter was modified from the MR-Cobalt unit, 
which is available since 2014. The availability of commercial hybrid systems 
will now enable investigations of the clinical potential of these hybrid systems 
in different tumor sites. In parallel the systems will be continuously developed 
further, in order to exploit their full clinical potential. 
Learning Objectives: 
1. To learn about the technological advances of MRI-LINAC technology. 
2. To understand the physical principles of hybrid treatment units. 
3. To appreciate the clinical advantages of the use of this technology. 
A-888 09:35  
Multiparametric MR-PET for differentiation of residual disease vs 
treatment-induced inflammatory changes  
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to provide a simplified, systematic approach on 
how to detect tumour recurrence on MR-PET examinations of patients treated 
for head and neck squamous cell carcinoma. First, the relevant imaging 
findings of post-therapeutic expected tissue alterations with a special focus on 
their temporal relationship are discussed. Then a brief discussion of common 
complications affecting the soft tissues, vasculature and bony structures will 
follow. A systematic review will include key MRI, diffusion-weighted imaging 
(DWI) and PET features of osteoradionecrosis, soft tissue necrosis, neck 
fibrosis and scar tissue mimicking tumour recurrence. Typical radiologic 
findings of tumour recurrence will be discussed with an emphasis on the early 
detection of lesions, their appearance on MR-PET with DWI and the added 
value and complementarity of multiparametric information extracted from hybrid 
imaging techniques. The potential pitfalls of post-therapeutic image 
interpretation and how to avoid them taking into consideration multiparametric 
data will be addressed. Results of combined MR-PET evaluations for the 
correct staging of recurrent tumours will be presented. Major emphasis will be 
put recently published research results and on quantitative information that can 
be easily extracted in clinical routine. Pitfalls of image interpretation will be 
addressed and how to avoid them. 
Learning Objectives: 
1. To learn about hybrid imaging based tissue characterisation techniques. 
2. To understand the challenges of hybrid imaging use after oncologic 
treatments. 
3. To appreciate the performance of hybrid MR-PET techniques in differential 
diagnosis. 
Author Disclosure: 
  M. Becker: Grant Recipient; SNSF 320030_173091. 
09:55  
Panel discussion: Will radiation oncology and radiology be able to take 
advantage of each other's technological innovation?  
08:30 - 10:00 Room O  
Paediatric  
RC 1712  
Understanding paediatric neuroradiology  
Moderator:  
E. Vázquez; Barcelona/ES  
A-889 08:30  
A. Imaging of the premature brain  
S.M. Aukland; Bergen/NO (stein.magnus.aukland@helse-bergen.no)  
Imaging is essential in detecting and monitoring brain injury in premature 
newborns. Cerebral ultrasonography (CUS) is still the modality of choice in an 
emergency setting, but magnetic resonance imaging (MRI) is a complementary 
modality. The classical findings include haemorrhage and white matter disease 
(WMD)/periventricular leukomalacia (PVL). The haemorrhages are usually part 
of the germinal matrix haemorrhage-intraventricular haemorrhage continuum 
(GM-IVH). Small sub-ependymal haemorrhage and small IVH usually 
disappear in a few weeks, but larger haemorrhages carry a high risk of causing 
hydrocephalus and/or periventricular venous haemorrhagic infarctions, which 
demands close follow-up. CUS is an excellent tool in detecting GMH-IVH and 
cystic WMD, but MRI is more sensitive in detecting non-cystic WMD and 
cerebellar pathology. MRI is also superior to CUS in detecting hypoglycaemic 
parenchymal injury. GMH-IVH and cystic-WMD are associated with major 
disabilities, and the subtle WM and cerebellar lesions seem to be associated 
with behavioural and attention difficulties later in life. MRI at term-equivalent 
age (TEA) is now a routine examination in some institutions, but the value of 
this screening must be evaluated by long-term follow-up studies. In short-term 
studies of extremely preterm, abnormalities detected on late CUS and near-
term MRI are associated with the outcome and TEA may be the best time point 
for scanning. Several studies have compared the value of serial CUS and 
near-term MRI without strong conclusions. Conventional MRI at TEA probably 
  







gives additional prognostic information, and advanced MRI is promising but its 
role is still unclear. 
Learning Objectives: 
1. To discuss the roles of US, (CT) and MRI in preterm imaging. 
2. To give an overview of the different imaging findings in the preterm brain 
related to age. 
3. To discuss the prognostic role preterm brain imaging. 
A-890 09:00  
B. Abusive head trauma: the role of CT and MRI  
R. Van Rijn; Amsterdam/NL (r.r.vanrijn@amc.uva.nl)  
Abusive head trauma (AHT), defined by the American Academy of Pediatrics 
as an inflicted injury to the head and its contents including those injuries 
caused by both shaking and blunt impact, is one of the most severe forms of 
child abuse. Imaging plays an important role in establishing the diagnosis and 
potential outcome of AHT. In this session, the most common neuroradiological 
findings, with their evidence base, in AHT are presented. In short, the 
differential diagnosis and the limitations of CT and MRI will be discussed, as 
well as the imaging strategy as proposed in the newly published guideline ‘The 
radiological investigation of suspected physical abuse in children’ of the Royal 
College of Radiology and the Society and College of Radiographers.  
Learning Objectives: 
1. To discuss the role of CT and MRI in imaging of abusive head trauma (AHT). 
2. To give an overview of common CT and MRI findings in AHT. 
3. To understand the strengths and limitations of CT and MRI in imaging AHT. 
A-891 09:30  
C. Imaging in hypoxic-ischaemic injury and hypothermia: an update  
F.M. Triulzi; Milan/IT (Fabio.triulzi@policlinico.mi.it)  
Hypoxic-ischemic encephalopathy (HIE) is the major recognized perinatal 
cause of neurological morbidity both in premature and full-term newborns. The 
incidence of HIE ranges from 1 to 8 per 1000 live births in developed countries, 
it accounts for approximately 15%-20% of neonatal mortality in full-term 
neonates. Immediately after an acute HIE episode, proton MR spectroscopy is 
often the most useful modality due to the increase of lactate, while diffusion-
weighted imaging (DWI) may be falsely negative in this time frame. However, 
pseudonormalization of lactate levels, which occurs approximately 24 hours 
after birth, may confound interpretation of early MR imaging spectra. Cerebral 
blood flow increases after 24-28 hours in brain areas subsequently exhibiting 
injury, whether or not hypothermia is administered. Consequently, it has been 
suggested to combine a perfusion study using arterial spin labelling technique 
to increase the prognostic value in the acute phase of HIE. After approximately 
24 hours of age, even DWI becomes a sensitive technique, due to the 
presence of cytotoxic oedema and it remains positive for approximately 1-5 
days, after which it may pseudonormalize; at this point, T1- and T2-weighted 
MR images may be most useful to depict brain damage. Due to the reduction 
in the extent of brain injury on conventional T1- and T2-weighted MRI, it is 
mandatory to account for hypothermic treatments when evaluating MR images 
during the acute phase.  
Learning Objectives: 
1. To discuss the role of US, (CT) and MRI in hypoxic-ischaemic injury 
(including advanced MR techniques). 
2. To give an overview of common imaging findings in hypoxic-ischaemic injury 
(HIE). 
3. To understand the importance of timing and prognostic value of imaging in 
HIE. 
08:30 - 10:00 Room N  
Special Focus Session  
SF 17a  
New treatments for musculoskeletal 
tumours  
A-892 08:30  
Chairperson's introduction: What is changing?  
J.L. Bloem; Leiden/NL (j.l.bloem@lumc.nl)  
Biologic tumour behaviour and patient compliance should be primary 
considerations in treating patients with musculoskeletal sarcoma. Diagnostic 
tests in combination with systemic and focal therapy are used to reach curative 
or palliative goals. The progress made in diagnostic tests, treatment strategies, 
and understanding biologic behaviour of tumours increases options to serve 
our patients, but also increases therapy-related morbidity, diagnostic tests-
related anxiety, and costs. The current challenge is to use our diagnostic and 
therapeutic means not only to increase survival chances, but also to preserve 
the quality of remaining life, while involving the patient's opinion in decision-
making. The change of ingredients for this balancing act is explored in this 
introduction.  
Session Objectives: 
1. To understand the demand for new treatment concepts. 
2. To understand how multimodality imaging can influence therapeutic 
balancing between tumour control and quality of life. 
A-893 08:35  
New treatment paradigms in orthopaedic oncology  
M.A.J. van de Sande; Leiden/NL (majvandesande@lumc.nl)  
Knowing if the sarcoma will return remains the basic patient paradigm in 
cancer treatment and follow-up, but going from if to when it returns seems to 
be the next step in follow-up optimisation and stress reduction. All prediction 
models for sarcoma available at present are applicable only at the time of 
baseline, such as the time of diagnosis or surgery. However, updated patient 
information during the follow-up as well as changing covariate effects over time 
may change the prognosis of a patient, which is not accounted for in these 
models. The concept of dynamic prediction allows to include updated 
information; on disease status, patient characteristics and imaging results 
during follow-up. This information can be used to provide better individualised 
treatment and follow-up options that depend on the dynamic assessment of a 
patient’s prognosis. The findings of time-varying effects as well as the 
importance of time-dependent covariates such as LR and DM found in our 
multicentre analysis confirm the inadequacy of the baseline models for 
predictions later on in follow-up. A model designed for dynamic prediction, 
which updates survival probabilities, is needed and it is provided in this work. 
To this end, an APP (PERSARC) was developed to assist in shared decision-
making in clinic. Following up on this, we analysed the timing of LR and DM 
during FU. We concluded that in patients with localised STS after curative 
surgery, the rates of LR and DM are highly non-constant over time and are 
strongly modified by tumour characteristics. These findings contradict a “one-
size-fits-all” aftercare policy, but rather support the concept of a time- and risk-
adapted strategy for personalised post-surgical follow-up.  
Learning Objectives: 
1. To understand the impact of treatment choices on survival chances and 
quality of life. 
2. To learn about the influence of imaging, patient and disease characteristics 
on developing new treatment options. 
Author Disclosure: 
  M.A.J. van de Sande: Grant Recipient; National Cancer Fund. 
A-894 08:58  
Multimodality imaging in treating and monitoring bone sarcoma  
M.-A. Weber; Rostock/DE (marc-andre.weber@med.uni-rostock.de)  
The histopathologic response to chemotherapy and radiation therapy is an 
important prognostic indicator of disease-free survival after the treatment of 
musculoskeletal sarcomas. Several studies report that therapy response 
assessment may rely on functional PET data. Moreover, a decrease in tracer 
uptake indicates early response to neoadjuvant chemotherapy. However, to 
plan surgical resection of the tumour, the surgeon needs reliable information 
on tumour size and extent of infiltration to the adjacent structures. MRI is the 
best additional imaging modality for local staging, as it allows for accurate 
assessment of the extent of the disease and the effect of the tumour on the 
surrounding structures including the joint, neurovascular structures, muscle 
compartments and skin. MRI also gives details of the extent of the 
compartmental involvement to help complete excision of the tumour. Additional 
MRI techniques such as diffusion-weighted imaging (DWI), MR spectroscopy 
(MRS), and dynamic contrast-enhanced (DCE) MR imaging are not routinely 
used for bone tumour assessment. The potential of DWI to reveal tumour 
cellularity, MRS to noninvasively assess metabolic aberrations, and DCE to 
assess treatment response in which traditional size-based assessment criteria 
may underestimate efficacy has been reported. The role of FDG- or NaF-
PET/CT and PET/MRI in the initial diagnostic workup of bone tumours is still 
not established. There is an overlap in the maximum standard uptake value 
between benign and malignant tumours. Therefore, PET/CT does not yet have 
a role in the initial differentiation of benign from malignant bone tumours, but 
may aid in problem-solving in suspected local recurrence. 
Learning Objectives: 
1. To learn how to use multimodality imaging in personalised treatment 
planning aimed at survival and preserving quality of life. 
2. To learn how to use multimodality imaging in monitoring response to neo-
adjuvant therapy. 
  







A-895 09:21  
Multimodality imaging in treatment and surveillance of soft tissue 
sarcoma  
C. Messiou; London/UK (Christina.Messiou@rmh.nhs.uk)  
Limb-sparing surgery is potentially curative for primary non-metastatic 
extremity soft tissue sarcomas. The addition of radiotherapy results in higher 
local control rates. MRI is standard imaging before and after radiotherapy and 
is critical for surveillance of often complex post-treatment appearances. 
However, histopathologic changes that occur after radiotherapy confound 
dimension-based assessments of response. Except for myxoid liposarcoma, 
significant dimensional radiologic responses are rare. Dimension-based 
assessments have been shown to have no correlation with outcome or 
histopathologic response, and alternative assessments are needed. Current 
consensus from the EORTC-STBSG suggests that the addition of functional 
diffusion-weighted MRI to standard anatomic and postcontrast MRI greatly 
facilitates interpretation because the combination of reduced enhancement and 
increasing apparent diffusion coefficient (ADC) may increase confidence for 
response. After radiotherapy, new enhancement alone should be interpreted 
with caution, because this may be a result of vascular disruption rather than 
histologic response. Machine learning is likely to play a crucial role in allowing 
us to fully exploit the quantitative capabilities for use in routine, research and 
adaptive treatment regimens. Alternative methods of assessment are poorly 
understood; however, a small study of 18F FDG PET/CT in high-grade 
sarcomas has shown promise. CT is the mainstay of surveillance and response 
assessment for metastatic disease. However, methods of response 
assessment are evolving beyond dimension-based (RECIST 1.1) 
measurements. Furthermore, patients with the best radiological responses 
often have the worst outcomes, as this reflects high tumour grade. This 
highlights the need for appreciating the significance of imaging responses with 
regard to outcome.  
Learning Objectives: 
1. To learn how to use multimodality imaging in personalised treatment 
planning aimed at survival and preserving quality of life. 
2. To learn how to use multimodality imaging in surveillance strategies. 
09:44  
Panel discussion: Increasing quality of life in sarcoma patients without 
decreasing survival. What is needed from an imaging perspective to 
allow and support this?  
08:30 - 10:00 Studio 2018  
Genitourinary  
RC 1707  
Imaging strategies in renal tumours  
A-896 08:30  
Chairperson's introduction  
C. Nicolau; Barcelona/ES (cnicolau@clinic.ub.es)  
The detection of incidental renal masses has increased due to a large number 
of imaging studies being performed for different clinical indications. The 
characterization and differentiation between benign and malignant renal 
lessions is essential for their management. The objectives of this session are 
to become familiar with the indications and optimal protocols of the current and 
emerging renal imaging modalities as well as to describe the evidence 
regarding renal mass characterization and learn about the capabilities of renal 
imaging to stage renal tumours.  
Session Objectives: 
1. To become familiar with current and emerging renal imaging modalities. 
2. To learn about the capabilities of renal imaging in diagnosis and staging of 
renal tumours. 
A-897 08:35  
A. Imaging methods, CT and MRI: the best out of two  
M.A. Cova; Trieste/IT (cova@gnbts.units.it)  
CT is currently the imaging modality of choice for the evaluation of renal 
masses. The advantages of CT are its widespread availability, high speed of 
acquisition, high spatial resolution and isotropic imaging. MRI can be a 
powerful problem-solving tool in clinical practice for characterisation of renal 
masses, especially for characterisation of lesions with indeterminate 
enhancement at CT and of lesions in which a small amount of fat is suspected. 
Like CT, MRI provides excellent anatomic information on the evaluation of 
renal lesions. Moreover, unlike CT, advanced MRI techniques can provide 
information about tissue structure and function without exposure to ionising 
radiation and without using iodinated contrast. The disadvantage of MRI 
compared to CT is the longer examination time. Optimal MDCT protocol for 
renal masses includes a noncontrast phase followed by postcontrast 
acquisitions with corticomedullary, nephrographic and delayed phases of 
enhancement at approximately 40 seconds, 90 seconds and 7 minutes after 
contrast injection. The nephrographic phase is acquired for assessing the 
presence of a renal lesion and its enhancement, and is therefore sufficient for 
detection and characterisation of renal lesions. Corticomedullary and 
urographic phases are often performed to provide additional information for 
presurgical planning. Optimal MRI protocol for renal mass evaluation includes 
TSE T2-weighted imaging, TSE T1-weighted imaging with and without fat 
suppression, T1-weighted opposed-phase imaging (with in-phase and out-of-
phase sequences) for the detection of microscopic fat, DWI, fat-suppressed 3D 
T1-weighted gradient-echo acquisition before and after administration of 
intravenous gadolinium contrast in corticomedullary, nephrographic and 
urographic phases, and subtraction imaging.  
Learning Objectives: 
1. To become familiar with the optimal CT and MRI protocols for renal imaging. 
2. To understand the best choice of CT or MRI according to the clinical need. 
3. To illustrate the advantages and disadvantages of CT and MRI. 
A-898 08:58  
B. Differential diagnosis of renal masses  
N. Grenier; Bordeaux/FR (nicolas.grenier@chu-bordeaux.fr)  
Imaging is the main source of detection of renal masses. Differenciation 
between complex cystic and solid masses is not always straightforward and 
may require several contrast-enhanced methods, and DCE-MRI and CEUS are 
more sensitive for that purpose. Considering cystic masses, Bosniak 
classification is required. Considering solid masses, characterization of fat-rich 
angiomyolipomas is based on plain CT, but fat-poor AMLs can be 
distinguished from carcinomas by multiparametric MRI only. Multiparametric 
MRI includes chemical shift gradient echo (GRE) sequences, signal intensity 
on T2-weighted images, DCE sequences, diffusion-weighted sequences and 
late contrast-enhanced images. Using different combinations of two or several 
parameters, now makes it possible to clearly distinguish some renal tumours 
such as fat-poor AMLs, papillary carcinomas and clear cell carcinomas, the 
latter being difficult to separate from oncocytoma when a central scar is 
absent. A larger validation of all these combinations is still necessary to define 
those having a clinical significance for routine practice. Percutaneous biopsy 
remains mandatory before such a validation, as soon as pathological result is 
supposed to have an impact on tumour management.  
Learning Objectives: 
1. To learn about the histologic spectrum of renal tumours. 
2. To understand the capabilities of imaging for renal tumour characterisation. 
3. To become familiar with functional techniques applied to characterise renal 
tumours. 
Author Disclosure: 
  N. Grenier: Advisory Board; Supersonic Imagine, Aix-en-Provence, France. 
A-899 09:21  
C. Staging and organ-preserving strategies  
P. Asbach; Berlin/DE (patrick.asbach@charite.de)  
Accurate CT- or MRI-based staging of the two most common malignant 
neoplasms involving the kidneys, renal cell carcinoma (RCC) and transitional 
cell carcinoma (TCC) is an important prerequisite for surgical decision-making, 
especially in the early stages of the disease. The TNM staging system is 
particularly different between RCC and TCC regarding the T-stage. Tumour 
size and invasion of the perirenal fat are important criteria for local staging of 
RCC, whereas invasion of the muscular layer of the renal collecting system 
and invasion into the renal parenchyma are important criteria for staging TCC, 
the latter being more complex based on imaging as compared to RCC. 
Different organ-preserving strategies are evolving, especially for treatment of 
RCC (e.g. local excision versus partial nephrectomy). Also, important additional 
information such as detailed vascular anatomy is needed by the surgeon, 
which has impact on the respective preoperative imaging protocol.  
Learning Objectives: 
1. To understand the TNM-staging system for renal tumours. 
2. To become familiar with optimal staging protocols and imaging findings in 
staging of renal tumours. 
3. To learn about actual organ-preserving strategies. 
09:44  
Panel discussion: How to implement an optimal renal imaging protocol?  
 
  







08:30 - 10:00 Room L 8  
Special Focus Session  
SF 17b  
Abdominal emergencies: friends and 
enemies  
A-900 08:30  
Chairperson's introduction  
I. Arkhipova; Moscow/RU (iarkhipova77@mail.ru)  
Non-traumatic emergencies as well as traumatic ones in the abdomen require 
immediate medical care; however, the absence of a clear reason like trauma or 
a variety of clinical features may often lead to a life-threatening delay of the 
correct diagnosis or of a misdiagnosis. Prompt and qualified imaging with 
either “friendly” or “enemy” pitfalls is a fundamental and crucial part in the 
evaluation of different diseases and conditions, which are to be discussed in 
the five (5) lectures with clinical case presentations. The goal of this session is 
to review current imaging strategies, controversies and reports, corresponding 
to requests of clinicians in the evaluation of common and uncommon acute 
non-traumatic abdominal emergencies. 
Session Objectives: 
1. To learn about the main radiological features of life-threatening non-
traumatic emergencies in abdomen. 
2. To become familiar with the most frequent requests and expectations of 
surgeons. 
3. To be familiar with interpretation of cases in emergency imaging. 
4. To find out possible points that could be useful in daily radiological practice 
in emergency department. 
5. To discuss and understand diagnostic strategy for high-quality and faster 
diagnosis at the end of the session. 
A-901 08:35  
Abdominal vascular emergencies: no time to lose  
V.E. Sinitsyn; Moscow/RU (vsini@mail.ru)  
Acute abdominal vascular emergencies could be traumatic or non-traumatic 
according to their aetiology. Risks of rapid blood loss with development of 
hypovolemic shock and critical organ ischaemia dictate the need for rapid and 
accurate diagnostic assessment. These emergencies could be a result of 
arterial or venous pathology. Major types of vessel injuries are ruptures 
accompanied by active haemorrhage, lacerations or dissections, thrombotic or 
mechanical occlusions with following organ ischaemia, and the formation of 
pseudoaneurysms and fistulae. CT is a most used diagnostic technique in such 
cases. It has several advantages over abdominal US. CT is quick, covers large 
anatomical areas, is widely available, and its results are not dependent on 
patient's preparation. MRI or hybrid imaging is not routinely used in such 
cases. The preferable technique is biphasic CT. In cases of acute vascular 
emergencies, CT is comparable to catheter angiography. CT can show the 
direct signs of vessel injury, intraluminal thrombi or extravascular blood and 
clots, and ischaemia of critical organs (e.g. mesenteric ischaemia). Modern 
systems can be used to see so-called "blush" - a sign of acute extravasation of 
contrast material. It helps to locate the site of continuing acute bleeding. 
Potential pitfalls in CTA interpretation (missed acute bleeding or thrombosis) 
could be related to the low rate of bleeding, stopped bleeding, dilution of blood 
by fluid, and missed signs of organ ischaemia. The use of abdominal MDCT in 
cases of vascular emergencies helps to define and plan the best treatment 
strategy (endoscopic intervention, angiographic embolization, surgery, or 
active surveillance).  
Learning Objectives: 
1. To learn about types and aetiology of non-traumatic abdominal vascular 
emergencies. 
2. To be familiar with the appropriate imaging protocols. 
3. To know about CT findings in various acute life-threatening abdominal 
vascular diseases. 
4. To understand modern approach to diagnostic work-up and reporting in 
vascular emergencies. 
A-902 08:50  
When to call the interventional radiologist and when to call the surgeon?  
K.K. Pyra; Lublin/PL (k.pyra@poczta.fm)  
Vascular abdominal emergencies are not common but, when present, may be 
catastrophic, with significant morbidity and, frequently, mortality. The physical 
examination may not reveal clear abnormalities, making the diagnosis more 
difficult. Due to wide MDCT technology availability, the first-line assessment of 
vascular abdominal emergencies is CTA. The findings of various types of 
vessel injury include laceration, rupture with active haemorrhage, occlusion 
and, for arteries formation of aneurysm, pseudoaneurysm, dissection or fistula. 
Most of them are life-threatening emergencies, since they may cause a heavy 
hypovolemic shock and/or severe organ ischaemia and therefore prompt 
diagnosis and treatment are required. Due to the rapidly growing field of 
endovascular treatment, interventional radiology is increasingly used as a first-
line treatment. This presentation focuses on differences in clinical and 
radiological presentations of vascular emergencies, usual and unusual 
emergencies, endovascular methods of treatment and what is most important 
in choosing appropriate treatment strategy: endovascular or open surgery.  
Learning Objectives: 
1. To learn about differences in clinical and radiological presentations of 
vascular emergencies. 
2. To demonstrate examples of usual and unusual emergencies of the 
abdominal vessels. 
3. To become familiar with the endovascular methods of treatment. 
4. To learn how to choose appropriate treatment strategy. 
A-903 09:02  
Closed loop obstruction: a challenging diagnosis  
M. Zins; Paris/FR (mzins@hpsj.fr)  
Closed-loop small bowel obstruction (CL-SBO) is a form of mechanical 
intestinal obstruction in which a segment of bowel is occluded at two 
contiguous points. Adhesive bands and internal and external hernias are the 
main causes of CL-SBO. CL-SBO is the most common cause of strangulation 
with a rate of intestinal ischaemia ranging from 43 to 84 %. Computed 
tomography (CT) remains actually the best modality to detect ischaemia in 
small bowel obstructions (SBO) with reported sensitivities ranging from 73% to 
100% and specificities from 61% to 100%. In patients with CL-SBO and 
absence of other CT signs of ischaemia, non-surgical management is 
successful in 25% of the cases. Increased unenhanced bowel wall attenuation 
is the only CT finding significantly associated with bowel necrosis in patients 
with adhesive bands or internal hernias CL-SBO. When present, this sign could 
help to differentiate reversible partial mural bowel ischaemia from irreversible 
transmural bowel infarction.  
Learning Objectives: 
1. To be able to differentiate simple mechanical small-bowel obstruction from 
closed loop obstruction (CLO) at CT. 
2. To learn about atypical presentation of CLO at CT. 
3. To become familiar with the most specific CT signs of ischaemia 
complication CLO. 
4. To learn new insights in clinical outcome of CLO related to adhesive bands. 
A-904 09:17  
Expected and unexpected emergencies of abdominal viscera: radiology 
before surgery?  
C. Stoupis; Männedorf/CH (c.stoupis@spitalmaennedorf.ch)  
Evaluation of acute abdominal conditions is sometimes difficult. Various factors 
can obscure the underlying cause, delaying the correct diagnosis with 
subsequent adverse patient outcome. Imaging is one of the most important 
diagnostic tools in acute abdomen and many times radiological examinations 
are done prior to use of other diagnostic tools. This presentation will 
demonstrate the examples of usual and unusual entities of the upper 
abdominal organs that are seen as emergency conditions (imaging on 
demand, not planned) and require timely intervention to limit morbidity and 
mortality. Examples of life-threatening bleeding conditions of the liver and 
spleen, examples of immediate treatment requiring infectious diseases of the 
liver, cases of inflammatory processes of the pancreas and unexpected lesions 
of the adrenals will be shown. The relation of the organ pathology and the 
clinical presentation will be discussed, as a potential guide or even indication of 
danger, to proceed with the correct radiological diagnosis; expected vs 
surprising radiological findings (treat the patient, not the image). Appropriate 
imaging techniques will discussed, with specific emphasis on CT, as a most 
valued tool, demonstrating the advances of imaging in the evaluation of 
emergency pathologies. A short overview of interventional techniques will be 
discussed as well, as an alternative to surgical procedures to treat effectively 
patients with high morbidity, without open or laparoscopic surgery.  
Learning Objectives: 
1. To demonstrate examples of usual and unusual emergencies of the upper 
abdominal organs (liver, pancreas, spleen, adrenal). 
2. To learn about differences in clinical and radiological presentations of those 
entities. 
3. To learn about imaging strategies (time, cost, efficiency, protocols). 
4. To learn about the potential of interventional radiological procedures as 
treatment choice. 
  







A-905 09:32  
Life teaches us case by case  
M.-L. Riibak; Tallinn/EE (mlriibak@gmail.com)  
With a speedy workflow, as is very often necessary at the department of 
emergency radiology, or on the night shift, it might be quite easy to overlook 
some important pathologies. Acquiring some useful habits such as measuring 
densities or comparing and paying attention to 'hints' we see during radiological 
studies could guide us to serious conditions not noticed initially. Good clinical 
and laboratory information are often necessary to come to the right conclusion.  
Learning Objectives: 
1. To recognise the signs of pathology in non-traumatic acute abdomen. 
2. To recognise common finding "as friends" in not so common "unfriendly" 
situations and vice versa. 
3. To become familiar with what the clinician might be interested to know 
besides the diagnosis. 
09:44  
Panel discussion: Every imaging sign could matter!  
08:30 - 10:00 Room E1  
E³ - ECR Master Class (Breast)  
E³ 1726a  
The high-risk patient enigma  
Moderator:  
F. Kilburn-Toppin; Cambridge/UK  
A-906 08:30  
A. Lesions with an elevated risk for breast cancer  
G. Forrai; Budapest/HU (forrai.gabor@t-online.hu)  
The histological, clinical presentation, together with the mammography and US 
appearance of the high-risk lesions, would be demonstrated. They have very 
different probability figures of developing cancer, and this would be detailed for 
each type of lesion. The concept and the global problem of the management of 
these lesions will be explained, together with the conflict of 
over/underdiagnosis/treatment.  
Learning Objectives: 
1. To learn about different types of high-risk lesions. 
2. To become familiar with the risk of developing a cancer. 
3. To appreciate the different imaging modalities for diagnosis. 
A-907 09:00  
B. Value of breast MRI. Rate of underestimation and impact on treatment 
decision: is breast MRI increasing the number of high-risk lesions?  
R.M. Mann; Nijmegen/NL (r.mann@rad.umcn.nl)  
The evaluation of high-risk lesions on biopsy with MRI is commonly performed. 
One of the major ideas is to ascertain that there is not more disease present 
than seen with other techniques. As many high-risk lesions are in fact 
accidental findings on needle biopsy, the absence of enhancement within the 
breast reduces the likelihood of more extensive disease. Nevertheless, the 
underestimation rate with MRI is dependent on the type of high-risk lesion 
initially found and is still substantial for lesions like atypical ductal hyperplasia 
and lobular neoplasia. Moreover, several high-risk lesions may in fact enhance 
strongly in breast MRI, but are not upgraded at subsequent pathological 
assessment. In this lecture, MRI features of common and less common high-
risk lesions will be discussed. In general, MRI cannot preclude the need for 
extensive tissue sampling, but it may be used for guiding of the biopsy and 
may obviate complete surgical excision.  
Learning Objectives: 
1. To learn about the evidence on MRI for evaluating high-risk lesions. 
2. To become familiar with various imaging appearances of high-risk lesions. 
3. To appreciate the added value for diagnosis and treatment decision. 
Author Disclosure: 
  R.M. Mann: Advisory Board; Screenpoint Medical, Transonic imaging. Grant 
Recipient; Siemens Healthineers, Bayer Healthcare, Medtronic, Elswood, 
Identification solutions inc., Seno medical, Micrima. 
 
 
A-908 09:30  
C. Can surgery be avoided?  
S.J. Vinnicombe; Dundee/UK (s.vinnicombe@dundee.ac.uk)  
Within the UK National Health Service Breast Screening Programme 
(NHSBSP), a median of 7% of screen-detected lesions subjected to needle 
core biopsy are categorised as B3, of uncertain malignant potential. These 
lesions comprise a diverse group of pathological entities, with or without 
epithelial atypia, mostly manifest as mammographic microcalcification. B3 
lesions tend to be heterogeneous (such that the area sampled by needle core 
biopsy may not be representative) and are associated with a variable rate of 
upgrade to malignancy, either in situ or invasive, at surgical excision biopsy, 
which has been the treatment of choice until recently. However, the approach 
to B3 lesions is changing. With increasing concerns about overdiagnosis (and 
subsequent overtreatment) in breast screening and the widespread availability 
of large-bore needle biopsy devices, minimally invasive modes of treatment are 
increasingly used for these lesions. Various techniques are available, including 
large-bore vacuum-assisted devices where the lesion is removed in a 
piecemeal fashion, and devices which remove the lesion in its entirety with a 
single pass. These approaches to management of B3 lesions are cost-effective 
and well tolerated, but oncological safety must be the key consideration. In this 
respect, the literature is challenging to synthesise, since there is wide 
variability in the rates of surgical excision in differing series and it seems likely 
that B3 lesions that are surgically excised differ from those treated non-
operatively, introducing a source of bias. Nonetheless, many countries are 
gradually adopting minimally invasive approaches and some consensus has 
been achieved.  
Learning Objectives: 
1. To learn about the different non-invasive modalities to excise high-risk 
lesions. 
2. To become familiar with the risk of avoiding surgery. 
3. To appreciate the standard protocols in different countries. 
08:30 - 10:00 Room E2  
Neuro  
RC 1711  
Diffuse low-grade gliomas: new things you 
should know  
Moderator:  
F.W. Cartes-Zumelzu; Innsbruck/AT  
A-909 08:30  
A. Molecular basis for classification, treatment and predicting outcome in 
low-grade gliomas  
V.C. Keil; Bonn/DE (Vera.Keil@ukbonn.de) 
Low-grade gliomas (LGG) are glial tumours with a high degree of diversity on a 
histological and genetic level. The status of 1p/19q and IDH1/2 genes among 
others has indeed become the tumour type defining criterion in the 2016 WHO 
classification of CNS tumours and has impact on therapy choice. Genetic 
status and protein expression, such as of the oncometabolite 2-HG, are also 
the key to understand why some LGG de-differentiate to high-grade lesions or 
show growth, while other lesions remain stable over decades. Quantitative 
MRI, MRS and PET techniques form the rapidly expanding field of “molecular 
imaging”. Molecular imaging promises to provide the neuroradiologist with non-
invasive tools to predict the genetic and histological status of gliomas. Potential 
applications range from pre-operative assessment of intra-tumoural 
heterogeneity for biopsy targeting to follow-up and therapy monitoring. 
However, the greatest challenge lies in the shortage of direct molecular 
imaging techniques (currently 2-HG MRS is the only one) and the 
establishment of reliable radiological substitute biomarkers with the ability to 
predict patient prognosis. Molecular imaging is not yet at a point where 
unequivocal scientific results rendered watertight imaging biomarkers to rely on 
in LGG assessment. There are conflicts about the additive value of multiple 
imaging techniques, the reproducibility of results and also feasibility in clinical 
practice. In this session we will try to get an overview of the most widely used 
techniques molecular imaging and their current benefits and limitations for a 
non-invasive LGG assessment in contrast to standard, non-quantitative MRI. 
Learning Objectives: 
1. To learn about the role of imaging in the context of histopathology regarding 
the prediction of outcome. 
2. To understand the role of conventional and quantitative beyond diagnosis. 
3. To appreciate the translational approach of diagnosis and monitoring of glial 
tumour based on the histopathological background. 
  







A-910 09:00  
B. Imaging patterns suggestive of different (molecular) subtypes of low-
grade gliomas  
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl)  
Primary brain tumours are histopathologically subtyped into World Health 
Organisation (WHO) grades I to IV, according to - increasing - degrees of 
malignancy. These grades provide prognostic information and guidance on 
management, such as radiotherapy and chemotherapy after surgery. Despite 
the confirmed value of the WHO grading system, a multitude of studies and 
prospective interventional trials indicate that tumours with identical 
morphological criteria, i.e. of the same WHO grade, can have highly different 
outcomes. To personalise brain tumour management, we need additional 
diagnostic markers that can differentiate tumours beyond the current 
morphological WHO grading system. Molecular markers can distinguish 
subtypes of tumours within the same morphological type and WHO grade, and 
are therefore of great interest for personalised medicine. Recent genomic-wide 
studies have resulted in a far more comprehensive understanding of the 
genomic alterations in gliomas, and the suggestions of a new molecularly 
based classification. MR imaging phenotypes can serve as non-invasive 
surrogates for tumour genotypes and as such provide important information on 
diagnosis, prognosis, and, eventually, personalised treatment. The newly 
emerged field of RadioGenomics links specific MR imaging phenotypes with 
gene expression profiles. In this presentation, I will discuss the three best 
known tumoural genotypes with prognostic and - potential - therapeutic 
consequences: 1. isocitrate dehydrogenase (IDH) mutation, 2. 1p19q deletion, 
and 3. methyl guanine methyltransferase (MGMT) promotor methylation. I will 
give an overview of the known and potential MR imaging features of these 
genotypes and their value and validity in a clinical context.  
Learning Objectives: 
1. To learn about whether there is a change of pattern recognition based on 
conventional and quantitative imaging approaches. 
2. To understand the heterogeneity of low-grade gliomas based on 
histopathology and imaging. 
3. To appreciate the perspectives and challenges of diagnostic imaging in 
phenotyping low-grade gliomas. 
Author Disclosure: 
  M. Smits: Consultant; independent reviewer for Parexel Ltd. 
A-911 09:30  
C. Advanced imaging in low-grade gliomas  
N. Bulakbasi; Mersin/TR (nail.bulakbasi@kyrenia.edu.tr)  
Due to the 2016 update of WHO classification, low-grade gliomas (LGGs) are 
typically IDH mutant, diffusely infiltrating, and slow growing having moderately 
increased cellularity, generally without mitosis, necrosis and microvascular 
proliferation. Some Class II and a significant number of Class III series support 
the addition of diffusion and perfusion-weighted MR imaging and MR 
spectroscopy (MRS) in the assessment of suspected LGGs. LGGs have lower 
cellularity (ADC), angiogenesis (rCBV), capillary permeability (Ktrans), and 
mitotic activity (Cho/Cr ratio) than those of high-grade gliomas (HGGs). IDH 
mutation can be indirectly assessed by the identification of 2-hydroxyglutarate 
in MRS with spectral editing. A gradual decrease in minimum ADC values, 
increase in Cho/Cr ratio and maximum rCBV values, and the emergence of 
lactate and free lipid at MRS over time are consistent with tumour progression. 
Quantitative assessment of peritumoural area, indicating the infiltrative nature 
of the tumour, also helps in the differential diagnosis of LGGs from solitary 
metastases and CNS lymphomas. Functional MRI combined with MR 
tractography is widely used for presurgical planning to demonstrate the spatial 
relationship between eloquent brain regions and the tumour. Small tumour 
diameters, artefacts due to bone or air interfaces, vascular structures, 
haemorrhagic, cystic/necrotic and calcific changes in tumoural area can cause 
critical distortions in quantifying parameters. So, the selection of a proper ROI 
avoiding these kinds of areas is critical to obtain proper quantified results. The 
quantitative multiparametric MR imaging of LGGs can either improve the 
diagnostic accuracy of their differential diagnosis or assess their prognosis.  
Learning Objectives: 
1. To learn about the spectrum and diagnostic value of the available advanced 
imaging techniques in neuro-oncology. 
2. To understand the added value and possible pitfalls using quantitative MRI 
techniques in addition to conventional MRI. 
3. To appreciate the importance of standardisation of advanced MR image 




08:30 - 10:00 Room F1  
State of the Art Symposium  
SA 17  
Interventional treatment of stroke: a game 
changer  
A-912 08:30  
Chairperson's introduction  
P. Vilela; Almada/PT (ferrovilela@sapo.pt)  
During the last years acute ischemic stroke (AIS) treatment has been 
revolutionised with the introduction of endovascular treatment - thrombectomy 
(ET). Several randomised controlled trials have clearly shown the clinical 
benefits of this treatment and, recent studies have broadening the inclusion 
criteria, specially concerning the therapeutic time window. Imaging has a 
central role in the acute ischemic stroke management. Diagnostic 
neuroradiology is essential to make the correct diagnosis of AIS and to select 
the appropriate candidates for ET. Imaging provides all the information needed 
for patient selection, excluding stroke mimics, depicting the vessel occlusion 
and defining the potential salvage brain tissue: evaluating the collateral arterial 
circulation status, the extent of irreversible lesion (core) and/or the extension of 
potentially reversible ischemia (penumbra). Interventional neuroradiology has 
achieved tremendous clinical results with the fast and high recanalization rates, 
but further improvements are expected. There are still some technical aspects 
to be improved, such as the tandem lesions, distal occlusions and 
anaesthesiology protocol, which will be discussed in this session. In parallel, 
several organisational processes, from local department/hospital to 
regional/national organisation, must be optimised, in order to fasten the patient 
access to the correct stroke center and increase the number of patients 
treated. The radiology/neuroradiology departments’ organisation and 
professionals are critical for the implementation of AIS national health 
strategies.  
Session Objectives: 
1. To review the current imaging techniques and the individualised patient 
imaging assessment for acute ischaemic stroke. 
2. To overview the current endovascular indications and techniques for acute 
ischaemic stroke. 
3. To discuss the current endovascular treatment challenges, such as tandem 
lesions, distal occlusions and treatment beyond the six-hour time window. 
A-913 08:35  
Stroke, endovascular treatment: current approaches  
T. van der Zijden; Antwerp/BE (thijsvanderzijden@hotmail.com)  
Endovascular thrombectomy has clearly demonstrated its benefit for primary 
treatment of patients with acute ischaemic stroke from large vessel occlusion. 
During the past years, mechanical thrombectomy was mostly done by the use 
of stent retrievers. But, due to ongoing technical developments and 
experiences on the job, other techniques, such as thrombus aspiration and 
mixed techniques, has emerged as effective treatment tools as well. Although 
today very fast procedure times with impressive recanalization rates can be 
achieved using these techniques, it is still of utmost importance to select the 
correct patients for endovascular treatment to avoid futile recanalization and to 
prevent additional harm to ischaemic stroke patients. Besides the proper 
indication setting, optimal clinical circumstances during and after the procedure 
should be pursued as well. In this lecture, current insights into the indication 
setting, different endovascular techniques, choices in supportive care during an 
endovascular procedure and post-thrombectomy medical care will be 
discussed and illustrated. 
Learning Objectives: 
1. To review the current indications for endovascular treatment in acute 
ischaemic stroke. 
2. To overview the endovascular treatment techniques for acute ischaemic 
stroke: stent retriever and aspiration. 
3. To discuss the different options of anaesthesia type, blood pressure control, 












A-914 08:58  
Stroke, endovascular treatment: tandem lesions and acute phase 
stenting  
W. van Zwam; Maastricht/NL (w.van.zwam@mumc.nl)  
In 20 - 30% of patients with acute ischemic stroke due to a large vessel 
occlusion of the anterior circulation, who are eligible for endovascular 
treatment, a concomitant ipsilateral cervical internal carotid artery stenosis or 
(pseud)occlusion is present. These so-called tandem lesions are known to be 
relatively refractory to intravenous rtPA administration and clinical outcome is 
therefore poor if not treated endovascularly. Recent studies have shown a 
large treatment benefit of endovascular treatment in these patients, 
comparable with the treatment effect in patients who have an intracranial 
occlusion without cervical carotid pathology. In current guidelines 
thrombectomy of the intracranial occlusion is therefore recommended for 
patients with these tandem lesions. However, no clear guidelines for the 
management of the extracranial carotid pathology exist, because no evidence 
for the optimal management is yet present. Several options like carotid stenting 
in the acute phase, before or after thrombectomy, PTA only followed by 
delayed stenting or delayed carotid endarteriectomy are available. 
Furthermore, different carotid pathologies like dissections and atherosclerotic 
lesions obviate a uniform treatment recommendation. Various extracranial 
carotid artery pathologies, different treatment options and available evidence 
from published studies will be presented and discussed in this presentation.  
Learning Objectives: 
1. To review the literature data regarding the incidence, natural history and 
treatment of tandem lesions. 
2. To overview the endovascular treatment techniques for the treatment of 
acute ischaemic stroke: stent retriever vs aspiration, and current indications for 
endovascular treatment in acute ischaemic stroke. 
3. To discuss the potential indications for stenting in the setting of acute 
ischaemic stroke and tandem lesions. 
Author Disclosure: 
  W. van Zwam: Grant Recipient; Brain Council, the Netherlands. Speaker; 
Cerenovus, Stryker. 
A-915 09:21  
Stroke, endovascular treatment: beyond proximal occlusion and six-hour 
time window  
J. Macho; Barcelona/ES (jmmacho@clinic.ub.es)  
Most of the guidelines recommend endovascular recanalization in patients with 
acute ischaemic stroke due to large vessel occlusions up until 6 hours after 
symptom onset. Metaanalysis of pooled individual patient data from 1287 
patients in MRCLEAN, ESCAPE, REVASCAT, EXTEND and SWIFTPRIME 
trials suggests that the benefit of thrombectomy rapidly decays over time and 
may no longer exist beyond 7.3 hours from stroke onset. The just published 
DAWN Trial has evaluated late and unwitnessed stroke patients. Eligible 
patients, with clinical and imaging mismatch (defined by age, core, and 
NIHSS), who receive mechanical thrombectomy have better outcomes, 
compared to standard medical therapy. This treatment effect is the highest out 
of any stroke trials to date and suggests that the presence of clinical-core 
mismatch is a critical predictor of treatment effect independent of time to 
presentation. Metaanalysis of randomized trials favoured endovascular 
treatment across all sites of occlussions with better endovascular treatment 
effect in patients with thrombi in ICA and proximal M1 MCA segments than in 
those with thrombi in distal M1 MCA or M2 segments because proximal 
thrombi are larger in volume , less likely to recanalize with intravenous 
alteplase and more easily reached by endovascular thrombectomy. The 
question of benefit with more distally located occlusions in the M2 middle 
cerebral artery segment is only partially addressed, because randomized trials 
had very few patients with more distally located occlusions in the M2 middle 
cerebral artery segment and do not have enough power to fully confirm benefit 
or harm in these patients .  
Learning Objectives: 
1. To review the literature data regarding the incidence, natural history and 
treatment of distal arterial occlusions. 
2. To review the literature data regarding the incidence, natural history and 
treatment of wake-up strokes and arterial ischaemic strokes beyond the six-
hour time window. 
3. To discuss the potential indications for endovascular treatment beyond the 
proximal arterial occlusion and beyond the six-hour time window. 
Author Disclosure: 
  J. Macho: Consultant; stryker neurovascular and Medtronic. Speaker; stryker 
neurovascular. 
09:44  
Panel discussion: Stroke, endovascular treatment: new horizon  
08:30 - 10:00 Room F2  
Oncologic Imaging  
RC 1716  
A multidisciplinary approach to prostate 
cancer: can we make a difference?  
A-916 08:30  
Chairperson's introduction  
A. Baur; Berlin/DE (alexander.baur@charite.de)  
Technical advancements and the introduction of guidelines for magnetic 
resonance imaging (MRI) of the prostate as well as the numerous promising 
study results have laid the foundation for a widespread application of this 
imaging technique in patients with suspected or confirmed prostate cancer. 
Radiological expertise in prostate MRI and standardized image interpretation is 
crucial to maximize the beneficial impact of imaging. Today, radiologists often 
work in a multidisciplinary team with urologists and radiation oncologists. To do 
so proficiently, they have to be familiar with the diagnostic algorithms for 
prostate cancer. Radiologists should also be aware of available treatment 
options including surgery, radiotherapy, local ablative and hormonal treatment 
as well as of the option to put patients under active surveillance. Finally, it is 
important to be aware of what kind of information urologists and radiation 
oncologists require to provide optimal treatment for each patient. All of these 
requirements will be addressed and discussed in this multidisciplinary course 
with experts from the fields of radiology, urology, and radiation oncology.  
Session Objectives: 
1. To understand the pathophysiological properties of prostate cancer and its 
impact on diffusion-weighted imaging and dynamic contrast-enhanced MRI. 
2. To understand the necessity of functional MRI (compared with mere 
morphological MRI) in the assessment of prostate cancer. 
3. To learn about PiRADS classification system. 
4. To learn about the role of MRI in selecting patient-tailored therapy. 
5. To learn about the option of active surveillance vs immediate treatment. 
Author Disclosure: 
  A. Baur: Research/Grant Support; Bayer Pharma. Speaker; Bayer Pharma. 
A-917 08:35  
A. The urologist: evidence-based clinical decision making  
N. Mottet; St. Etienne/FR (nicolas.mottet@chu-st-etienne.fr)  
Prostate cancer is the third most common cause of cancer death in men. While 
systematic screening is not promoted, an individual early diagnosis is the 
standard of care. Based on risk factors (such as family history), PSA and DRE, 
the pathology obtained after sonography-guided biopsies is the only diagnostic 
possibility. A systematic pre-biopsy mpMRI is not yet the standard of care, and 
ongoing RCT are urgently awaited. A quality control of this mpMRI is a major 
prerequisite and potential limiting factor so far. However, a systematic mpMRI 
is the standard of care before rebiopsying. This increases the biopsy reliability 
using a combination of 12 systematic, plus targeted courses. The treatment 
policy is based on individual life expectancy, patient’s wishes and staging. The 
classical risk categories (known as d’Amico’s classification) are more and more 
challenged by information from image results. Apart from biopsy results 
(number of positive cores, Gleason score) and DRE, the local staging (T stage) 
is based on MRI. Its sensitivity is mild (intraprostatic localisation, microscopic 
extracapsular extension), but its specificity is acceptable and it is a must in 
intermediate-/high-risk situtions. It is also mandatory before considering active 
surveillance. N staging is poorly done, even with the PET. As for M staging, 
PSMA represents the future, although its added value regarding improved 
outcome remains unclear. For M staging, bone scan should be replaced by a 
whole-body MRI. Howerer for mCRPC progression characterisation, bone and 
CT scan remain the standard, as no consensus definition of progression with 
MRI exists yet.  
Learning Objectives: 
1. To understand how a diagnosis is established by PSA evaluation and 
biopsy. 
2. To learn about different treatment options: surgery, radiotherapy, local 
ablative and hormonal treatment; as well as active surveillance. 
3. To learn how imaging impacts treatment selection. 











A-918 08:58  
B. The radiologist: evidence-based use of multiparametric MRI  
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de)  
Early detection of prostate cancer with biologic characterization and staging is 
of fundamental importance for individualized decision-making. Localized, early-
stage prostate cancer has been more frequently detected since the 
introduction of PSA screening. Active surveillance and less aggressive focal 
therapy options are accordingly emerging to reduce the side effects that may 
significantly reduce the quality of life. But delayed and unprecise diagnosis as 
well as overtreatment is still feared, because prostate cancer is characterized 
by multifocality with considerable variations of cancer aggressiveness. 
Meanwhile, a body of evidence from clinical studies is available proving that 
multiparametric MR imaging (mpMR) is beneficial for the detection and 
localization of cancer suspicious lesions, for biopsy guidance to finally 
diagnose or rule out significant cancer as well as for T-staging. Different 
transrectal or transperineal TRUS/MR image fusion biopsy methods with 
targeted +/- random biopsies have been developed. During active surveillance, 
the combination of morphologic and functional MR parameters yields important 
objective and reproducible biomarkers for monitoring temporal changes of 
cancer size and aggressiveness. Accordingly, mpMR is of increasing 
importance for individualized decision-making in prostate cancer patients. 
However, the assurance of high-quality imaging is still challenging. The PI-
RADS recommendations have proven very helpful concerning this issue. This 
lecture will provide detailed knowledge of the evidence-based use of “state-of-
the-art” mpMRI in clinical routine. It will demonstrate how the method can be 
integrated in the urological context of diagnosis and treatment to improve the 
complex management of prostate cancer patients.  
Learning Objectives: 
1. To learn how to perform and interpret multiparametric MRI. 
2. To become familiar with the PiRADS classification system. 
3. To become familiar with the role of imaging for patient stratification and 
treatment planning. 
A-919 09:21  
C. The radiation oncologist  
D. Georg; Vienna/AT (dietmar.georg@meduniwien.ac.at)  
Various treatment techniques are successfully used for treating prostate 
cancer (PCa) with irradiation, with an increasing tendency of using higher 
doses per treatment session. In conventional radiation therapy the tumour 
volume is irradiated with a homogeneous dose. Widespread clinical practice 
relies on treatment planning based on computed tomography (CT), often 
combined with MRI. However, recent technology developments and 
achievements made during the last decade enable to focus the high dose 
irradiation very precisely on the tumour, while sparing of the surrounding 
normal tissue. Improved precision of treatment planning and delivery warrant 
equally precise tumour definition, moreover new treatment concepts are 
stimulated by the advancements in imaging to visualise and quantify biological, 
physiological and pathological processes. Positron emission tomography 
(PET), perfusion computed tomography (CT) and especially multiparametric 
magnetic resonance imaging (mp-MRI) are continuously explored for lesion 
characterisation, target definition, and response assessment during and after 
radiotherapy of PCa. To elucidate tumor biology and to identify subvolumes of 
more aggressive behavior, which are often radiotherapy resistant, mp-MRI is 
more frequently used in clinical studies. The concept of inhomogeneous 
tumour irradiation according to its biological behavior, called dose painting, is 
motivated by selective dose escalation based on biological tumour 
characteristics. This approach may lead not only to higher local control but also 
to better sparing of normal surrounding tissue. With the clinical implementation 
of dose painting, improvements in the therapeutic outcome can be expected. 
Due to the existing technical challenges, extensive collaboration between 
radiation oncologists, radiologists, medical physicists and radiation biologists is 
needed.  
Learning Objectives: 
1. To learn the rationale and scientific basis for focal therapies for prostate 
cancer. 
2. To learn how focal therapies are performed in prostate cancer. 
3. To learn through personal experience and from literature how 
multiparametric MRI can guide focal therapies of the prostate. 
09:44  
Panel discussion: Prostate cancer: evidence-based multidisciplinary 
approach to imaging and treatment  
 
 
08:30 - 10:00 Room D  
Musculoskeletal  
RC 1710  
MR imaging of the knee  
Moderator:  
M. Tzalonikou; Athens/GR  
A-920 08:30  
A. Cruciate ligaments: what to know and do  
A. Alcalá-Galiano; Madrid/ES (aalcalagaliano@gmail.com)  
Cruciate ligaments play a key role in knee kinematics and stability. Cruciate-
deficient knees are predisposed to early osteoarthritis due to chronic instability. 
ACL is the most commonly injured major ligament of the knee. PCL lesions are 
far less common, but more frequently associated with multiligamentous 
injuries. MRI is the study of choice to evaluate acutely and chronically injured 
cruciate ligaments, associated injuries and for postoperative imaging following 
ligament reconstruction. Understanding the variations of their anatomy (double 
bundle configuration and insertion sites) is key to performing a tailored 
anatomic reconstruction Accurate description and grading of cruciate tears and 
associated injuries is essential for preoperative planning of ligament 
reconstruction. The primary and secondary signs and indirect imaging findings 
of acute and chronic ligament injury will be reviewed. Atypical findings and 
imaging pitfalls will also be discussed. ACL reconstruction is one of the most 
common orthopaedic procedures, whilst PCL reconstruction is on the rise. 
Knowledge of ligament reconstruction techniques allows differentiation of 
normal postoperative findings from complications, which may be related to 
graft placement, the graft itself or to the donor site. Any standard knee MRI 
protocol must ensure adequate detection of both soft tissue and bony injury, 
including the cruciate ligaments. However, protocols may be tailored for 
specific needs, including oblique acquisitions, 3D or metal artefact reduction 
sequences to better demonstrate the anatomy and facilitate detection of small 
tears.  
Learning Objectives: 
1. To review the normal anatomy and MR imaging appearances of ACL and 
PCL and discuss pitfalls. 
2. To learn about the imaging appearances of ACL and PCL pathology and 
discuss imaging sequences and protocols. 
A-921 09:00  
B. Meniscal tears: obvious and subtle  
P. Omoumi; Lausanne/CH (patrick.omoumi@chuv.ch)  
This lecture will review the basic aspects of MRI of meniscal pathology, 
including some elementary technical and anatomical considerations, as well as 
the description of the basic semiology of meniscal tears and their classification. 
The common pitfalls and errors that need to be avoided will be presented. MRI 
is the modality of choice for the diagnosis of meniscal pathology as well as 
treatment planning. A certain number of technical considerations need to be 
understood by the radiologist. The standard sequence to image the meniscus 
is intermediate-weighted fast spin-echo sequences, in 2D or 3D. Certain 
acquisitions may influence the diagnosis of meniscal tears, including the choice 
of the echo time. Meniscal tears can manifest either as morphological changes 
or intrameniscal signal changes, with specific diagnostic criteria that will be 
reviewed. An appropriate terminology, based on standard arthroscopic 
classification, needs to be used by the radiologist to properly communicate the 
description of the tear to the referring surgeon. Secondary signs of meniscal 
tears, including parameniscal cyst and meniscal extrusion, should be used to 
increase the diagnostic performance for the detection of meniscal tears. 
Common pitfalls include anatomical variants (i.e. intermeniscal meniscal and 
meniscofemoral ligaments, discoid meniscus), as well as other causes for false 
positive findings such as meniscal flounce, chondrocalcinosis and meniscal 
ossicles. Knowledge of common mistakes and patterns of injury helps avoid 
unnecessary mistakes and improve diagnostic accuracy.  
Learning Objectives: 
1. To review the anatomy of the menisci and the classification of meniscal tear. 
2. To familiarise with unusual imaging appearances of meniscal tears and 












A-922 09:30  
C. Looking around the corners: posteromedial and posterolateral  
U. Aydingoz; Ankara/TR (uaydingo@hacettepe.edu.tr)  
Despite their contribution to the stability of the knee and their association with 
multiple ligamentous injuries of this largest joint in the human body, 
posterolateral and posteromedial corners of the knee are hidden from plain 
sight in the daily practice of reporting magnetic resonance imaging (MRI). 
Posterolateral corner (PLC) injuries of the knee are rare, but important 
conditions because of their association with the much more common anterior 
cruciate ligament (ACL) and other ligamentous or meniscal injury. If PLC injury 
is not identified and appropriately addressed, knee instability may persist, ACL 
reconstruction surgery may fail, and osteoarthritis may ensue. Although the 
anatomy of PLC is complex, its three main stabilizers that are targets for 
surgical reconstruction or repair in the presence of high-grade injury are 
identifiable: the lateral collateral ligament, the popliteus tendon, and the 
popliteofibular ligament. Avulsion fractures of the fibular head, where some 
components of the PLC attach, have a characteristic appearance on 
radiographs (the so-called “arcuate sign”) and must alert the radiologist to 
inspect the entire PLC on MRI for injury. Injuries to the posteromedial corner 
(PMC) of the knee are also associated with ACL, as well as the posterior 
cruciate ligament (PCL), tears. Major components of the PMC are the 
semimembranosus tendon (and its expansions), the oblique popliteal ligament, 
the posterior oblique ligament, the posteromedial joint capsule, and posterior 
horn of the medial meniscus. Unrecognized injury to PMC may result in the 
failure of the ACL or PCL reconstruction surgery with sustained anteromedial 
rotational instability.  
Learning Objectives: 
1. To review the relevant anatomical structures of both posteromedial and 
posterolateral corners. 
2. To discuss imaging signs of pathology affecting the aforementioned areas. 
08:30 - 10:00 Room G  
Physics in Medical Imaging  
RC 1713  
Patient-specific dosimetry  
A-923 08:30  
Chairperson's introduction  
E. Samara; Sion/CH (elina.samara@hopitalvs.ch)  
The use of ionizing radiation in medical imaging offers substantial benefits for 
the diagnosis and treatment of numerous medical conditions in children and 
adults. However, exposure to ionizing radiation may be associated with harmful 
risks. Justification and optimization as principles of radiation protection make 
radiation dosimetry fundamental. Physicians need to know the levels of 
exposure and hence the risks from imaging examinations that they have to 
justify, and operators of x-ray equipment need to determine whether their 
techniques are optimized. Special cases such as examinations of children and 
pregnant patients or screening examinations require specific organ dose 
estimations. Moreover, to prevent tissue reactions, patient skin dose needs to 
be estimated during radiological interventional procedures. Patient 
characteristics, such as age, sex and size, should be taken into consideration 
for specific patient dose assessments. Each modality (radiography, 
fluoroscopy, mammography, computed tomography, etc.) has its own 
specificities and demands different methods to calculate the dose. Modern 
imaging modalities usually display conventional dosimetry metrics, such as 
dose-area product, incident air-kerma or computed tomography dose index 
that do not represent individual patient dose. Thus, numerous sophisticated 
concepts and methods have been proposed to estimate patient radiation dose 
that include either physical measurements with dosimeters and 
anthropomorphic phantoms or computational measurements using Monte 
Carlo simulations. All these methods progressively allow more accurate 
estimations of individual patient doses.  
Session Objectives: 
1. To understand the needs for personalised dosimetry. 
2. To learn about existing and new methodologies used for patient dosimetry. 




A-924 08:35  
A. Breast imaging dosimetry  
I. Sechopoulos; Nijmegen/NL (ioannis.sechopoulos@radboudumc.nl)  
Mammographic dosimetry is a subject of intense interest due to the use of this 
imaging modality for population-based screening. Although this topic has been 
studied for the last four decades, advances in the mammography systems, 
introduction of new imaging modalities such as breast tomosynthesis, and new 
insights into breast anatomy have resulted in the need for continued 
development of breast dosimetry methods and models. During this talk, the 
current method and model for breast dosimetry in mammography and 
tomosynthesis will be reviewed and its capabilities and limitations discussed. 
The concept of patient-specific breast dosimetry and its potential applications 
will be introduced. Finally, the upcoming new developments in the field of 
breast dosimetry will be presented.  
Learning Objectives: 
1. To understand the current method to estimate organ dose in mammography 
and its limitations. 
2. To understand breast dosimetry in emerging modalities. 
3. To learn about upcoming approaches in breast dosimetry. 
Author Disclosure: 
  I. Sechopoulos: Advisory Board; Fischer Medical Imaging. Research/Grant 
Support; Siemens Healthcare, Toshiba Medical Systems. Speaker; Siemens 
Healthcare. 
A-925 08:58  
B. Patient dosimetry in CT and CBCT  
S. Edyvean; London/UK (sue.edyvean@phe.gov.uk)  
Conventional CT is a complex imaging device which can utilise narrow or wide 
beams, helical scanning, varying tube current, varying kV, and operating with 
various and dynamic collimations - all of which can affect patient dose. 
Different technology is used in cone beam CT, or flat panel CT, and this term 
usually refers to cross-sectional imaging with digital x-ray systems used in 
dental, digital radiography or radiotherapy. Many of the challenges are similar 
for both conventional CT and cone beam CT; however, there is generally more 
information available for the former. When considering patient-specific 
dosimetry, the technology, scan settings and the patient all need to be 
considered. As with other modalities, the scope to directly measure doses 
using physical dosimeters is limited. Therefore, doses need to be estimated 
using regular-shaped, or anthropomorphic, phantoms, or calculated using 
mathematical modelling techniques. The appropriate application, and the 
limitations, of standard dose indices (such as the computed tomography dose 
index, the size-specific dose index), together with their associated 
methodologies and phantoms, will be addressed. Monte Carlo calculations 
from modelled scanner and patient characteristics give more precise organ 
dose information, and there are a number of applied software packages 
developed to utilise these data. The advantages and limitations of these will be 
discussed.  
Learning Objectives: 
1. To understand what is estimated. 
2. To learn how to measure it. 
Author Disclosure: 
  S. Edyvean: Speaker; Refresher course. 
A-926 09:21  
C. Patient dose in fluoroscopy and interventional  
A. Trianni; Udine/IT (annalisa.trianni@asuiud.sanita.fvg.it)  
Interventional radiology contributes to significant proportion of the collective 
dose of the population from medical exposures. Moreover, when complex 
procedures are performed or procedures are repeated for the same patient, 
high-radiation dose levels can occur because procedures often require long 
fluoroscopy times and require high-quality images. For all of these reasons, 
dosimetric evaluations in interventional radiology are demanding. During this 
talk, patient dosimetry methods currently used in interventional radiology for 
different purposes (risk evaluation, optimisation and quality assurance) will be 
reviewed, together with relevant published dosimetric data. In particular, since 
radiation-induced skin damage might be a complication of interventional 
procedures, the talk will review available real-time patient skin dosimetry 
methods and their possible use.  
Learning Objectives: 
1. To review the fundamental patient dosimetry quantities. 
2. To learn about calculation of patient dose for interventional procedures. 
3. To learn about real time patient dose monitoring strategies. 
09:44  
Panel discussion: The future of patient-specific dosimetry  
  







08:30 - 10:00 Room K  
E³ - Rising Stars Programme: EFRS Radiographers' Basic 
Sessions  
BR 3  
Planning your career  
A-927 08:30  
Chairperson's introduction: What employers are looking for from new 
graduates  
S. Huber; Munich/DE (susanne.huber@med.uni-muenchen.de)  
What employers are looking for from new graduates? It is obvious that new 
graduates are expected to have passed the exam with at least good success. 
They should be interested, motivated and open-minded for their new working 
life. Additionally the graduate should show a character, which can be trusted to 
take care for patients and to be responsible for the own work, especially with 
regard to radiation protection. If the graduate should be from abroad, the 
language skills must be sufficient to fulfill the work requirements. Unfortunately 
many European countries are suffering from a shortage of radiographers. 
While trying to solve this problem, often radiographers are hired from abroad, 
which in consequence may lead to an even higher shortage in those countries. 
Fortunately and thanks to the mostly very good educational curricula there are 
still applicants with the above mentioned qualities available, but in total not 
enough applicants in comparison to the job vacancies. This session is about to 
show graduates ways to meet the expectations of their future employers. E.g. 
how they can prepare their personal presentation in designing their CV and to 
avoid mistakes while doing so. To make them aware of the importance of CPD 
(Continuous professional development), which eventually will lead to more 
competence and future carrier. The graduates will also have the opportunity to 
learn about the experiences of working as a radiographer in another country. 
Session Objectives: 
1. To understand how best to prepare your professional profile using various 
platforms. 
2. To appreciate the potential for radiographers to work in various jurisdictions. 
3. To consider the utility of professional development planning in achieving 
your professional goals. 
Author Disclosure: 
  S. Huber: Author; Susanne Huber. Speaker; Susanne Huber. 
A-928 08:35  
The dos and don'ts of preparing your curriculum vitae  
E. Kelly; Galway/IE (eileenma.kelly@hse.ie)  
A curriculum vitae (CV) is the first impression made by a potential employee to 
an employer. The presentation of one's CV can influence the employer to read 
it or not. Therefore, a well-presented, succinct CV that is tailored to the job is 
essential. Many graduates consider themselves at a disadvantage when 
applying for positions as they lack experience, and consequently make 
attempts to compensate for the lack of experience by unnecessary information 
when constructing their CV. Many employers will research the background and 
experience of potential employees through social media sites such as 
LinkedIn, ResearchGate and EFRS RRN. Such sites can be a valuable 
promotional and networking tool for professionals and can lead to unexpected 
career opportunities. This presentation will consider how to design a CV that 
will grab the immediate attention of an employer. Common mistakes in design 
and content of a CV and how to avoid them will also be discussed. 
Learning Objectives: 
1. To understand qualities of a well-designed curriculum vitae. 
2. To become familiar with common mistakes to avoid when preparing your 
CV. 
3. To be aware of the potential of social media platforms such as LinkedIn, 
ResearchGate, EFRS RRN for your professional profile. 
A-929 08:58  
Radiography: your passport to travel  
R. Caroço; London/UK (caroco.rita@gmail.com)  
At the present moment, there are several countries that have radiographer 
shortages and therefore, welcome overseas professionals. These are mostly 
European countries, that can benefit from the freedom of movement under the 
EU law. The recognition of professional qualifications, particularly within 
Europe makes it highly encouraging to work abroad. Countries like Portugal 
have been affected by the economic and financial crisis, which combined with 
irresponsible coordination between education training and job opportunities, 
reflects very limited career prospects for radiographers. This led and continues 
to cause a rise in emigration for newly qualified/experienced radiographers to 
countries where shortages are high. The aim of this presentation is to talk 
about my personal experience as a radiographer trained in Portugal and 
working in the UK. It will list the requirements and formalities to register as a 
radiographer, the job seeking process, the barriers and benefits I 
encounter(ed). It will also give an overview of the differences in radiography 
career and opportunities, between these two countries.  
Learning Objectives: 
1. To be aware of the potential to use your radiography qualification in various 
jurisdictions. 
2. To consider barriers to practicing as a radiographer abroad. 
3. To appreciate the potential for charitable/voluntary work in developing 
countries. 
A-930 09:21  
Planning your professional development  
A. Wareing; Aberdeen/UK (a.wareing@rgu.ac.uk)  
This session will support radiographers and students in planning their 
professional development. There is a critical need for health-care professionals 
to remain professionally updated regarding continuous changes to the 
evidence base and technological advancements, particularly in radiography, to 
facilitate closure of any gaps between ‘actual practice’ and ‘best practice’. 
Health services across Europe are under increasing stress and a principal 
factor going forwards will be managing increasing demands on health-care 
staff whilst supporting enhancement of the knowledge, skills and competency 
base. A recent body of work completed with individuals in the EFRS network 
has concluded that the primary feature of CPD activity should be the resulting 
impact - to patients, the service, the profession and the individual; with all 
stakeholders working in partnership. CPD activity must be flexible/multi-modal 
to support the changing growth/dynamic workforce. All stakeholders should 
utilise available communication and technology resources and make efforts to 
improve collaboration between the management, regulators and educators. 
Acknowledgement of barriers is required and actions must be taken to reduce 
these over time; financial burden remains a concern, whilst increasing literature 
has identified work pressure and lack of time as the main challenges for 
radiographers. An applied approach to these findings will be discussed in this 
session with an emphasis on realistic practices that delegates can realise and 
share in their own clinical environments. 
Learning Objectives: 
1. To understand the importance of professional development planning for 
radiographers in maintaining, developing and improving radiographer 
competencies. 
2. To be aware of the essential role of CPD and further education for 
radiographers. 
3. To appreciate how best to prepare for promotion opportunities. 
09:44  
Panel discussion: My best career advice  
08:30 - 10:00 Room M 1  
ESR Publications Committee Session  
How to write a scientific paper and how to 
get it published  
Moderators:  
R.G.H. Beets-Tan; Amsterdam/NL  
F. Sardanelli; San Donato Milanese/IT  
A-931 08:30  
The study design and the structure of an original article  
F. Sardanelli; San Donato Milanese/IT (f.sardanelli@grupposandonato.it)  
“Original articles” (ORs), also named “original researches”, are the most 
important category of articles published in medical scientific journals (MSJs): 
they provide new results. Apart from methodologic papers (which explain 
methods to be applied in ORs), all the remaining categories of articles refer to 
ORs as a basis. Particular types of ORs are the “technical notes” (presenting 
new techniques mostly applied to few cases) and “systematic reviews 
with/without meta-analysis”, evaluating all the previous literature on a topic and 
providing, when possible, new “secondary” evidence by pooling data from 
published ORs. In short, ORs are the “core” of MSJs. The typical structure an 
original article (also reflected in the abstract) is composed of four sections: 1. 
Background/Introduction (WHY the authors made that work and study aim[s]); 
2. Methods (HOW the work was done: study design and other related issues 
such as study population and sample size, imaging/interventional methods, 
readings, reference standard, statistics, etc.); 3. Results (WHAT the authors 
  







found); 4. Discussion (interpretation of results, comparison with previous 
works, study limitations, conclusions). Failures in internal/external validity of an 
OR are determined by biases (systematic distortions) that can affect the study. 
The validity of a study is in its Methods. However, the most important part of 
Methods is the study design, sometimes poorly described in radiological 
papers: prospective/retrospective; transversal (cross-sectional) or longitudinal 
(cohort); randomized/non-randomized; patients selection; reading blindness; 
quality and application of the reference standard. Notably, errors in study 
design cannot be solved after study termination. Study design is more 
important than statistics.  
Learning Objectives: 
1. To understand that the core of an original article is the study design. 
2. To understand the structure of an original article and the logics of the blocks 
of the abstract and of the body text. 
3. To learn how systematic reviews and meta-analyses are a particular case of 
original articles. 
4. To learn how to avoid the typical errors that candidate a manuscript for 
rejection. 
A-932 08:50  
The review process in radiology  
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr)  
In single-blind peer reviews, the reviewer is aware of the author's name and 
institution, while authors ignore the name of the reviewer. In double-blind peer 
review, both reviewer and authors are anonymous. Obviously, double blind 
theoretically eliminates the bias of being more prompt to accept papers from 
renowned authors and/or institutions. Conversely, the reviewer feels safer to 
express criticism, avoiding potential professional conflicts. However, double 
blinding may fail. Commonly, manuscripts are prepared immediately after the 
study had been presented in a major meeting. For very focused research, the 
number of potential reviewers is somehow limited. However, in most cases 
double blind is successful in occulting authors' and reviewers' identity. Several 
studies have compared these two methods and the conclusions are still 
unclear. Some studies found that double blind ensured higher quality, while 
others did not find any difference. Some have even questioned the need for 
peer review. European Radiology has decided to go for double-blind review, as 
sources of manuscripts are extremely diverse, while reviewers are from a wide 
range of countries on all continents, therefore diminishing the risk of blinding 
failure.  
Learning Objectives: 
1. To know the variety of the review processes in radiological journals. 
2. To be aware of pros and cons of the double blinded review. 
3. To know how the Editor handles your manuscript. 
4. To learn how to answer to reviewers' criticisms.  
A-933 09:10  
The review process in other clinical journals  
R. Madoff; Minneapolis, MN/US (madoff@umn.edu)  
Scientific publication is more than the road to academic advancement; it is an 
opportunity to contribute to your field and to share your work with others who 
share your interests and expertise. This session will review the principles of 
manuscript preparation and submission with an eye towards optimizing the 
chances of acceptance and publication. The practical aspects of how 
manuscripts are managed on the journal side, peer review, and the editorial 
process will be emphasized, as will various pitfalls to be avoided. In addition, 
the opportunities to publish in journals based on related, but non-radiologic, 
disciplines will be discussed. The goal of this session is to provide practical 
advice that will be of interest to those early in their publication career as well as 
to more experienced authors.  
Learning Objectives: 
1. To know the variety of the review processes in clinical journals. 
2. To be aware of pros and cons of single-blinded or unblinded review. 
3. To know how the Editor handles your manuscript. 
4. To learn how to answer to reviewers' criticisms. 
A-934 09:30  
Important papers other than original articles  
L. Martí-Bonmatí; Valencia/ES (Luis.Marti@uv.es)  
Science is crucial for the advance of a discipline, but so is critically reviewing 
and commenting on hot topics. These are highly cited papers that require 
expertise on the topic and discipline in writing. Review papers focus either on 
educational aspects of imaging, with a pearls and pitfalls approach (Pictorial 
Reviews) or as a critical overview on emerging techniques or state-of-the-art 
topics with an up-to-date and innovational approach (Critical Reviews). Both 
Pictorial and Critical Reviews might serve the radiological community to have 
access to the best evidence-based knowledge and to foresee the impact of 
new approaches within the health-care cycle. Position papers include both 
imaging guidelines on patient’s management aspects and consensus 
statements on imaging-related topics. These papers define the experts' or 
social representatives’ opinions. Reviewing and critiquing the literature requires 
the ability to juggle multiple tasks. The authors have to find and critically 
evaluate relevant material while synthesizing the disperse information with the 
skills of providing new ideas from already known facts. The EQUATOR 
Network and the PRISMA Statement for the reporting of systematic reviews will 
help in some of these items. As general rules, the authors have to define the 
scope of the article, imposing a well-defined structure on the mess that might 
be the scientific literature.  
Learning Objectives: 
1. To know the variety of the review processes in clinical journals. 
2. To be aware of pros and cons of single-blinded or unblinded review. 
3. To know how the Editor handles your manuscript. 
4. To learn how to answer to reviewers' criticisms. 
09:50  
Discussion  
08:30 - 10:00 Room M 4 
Multidisciplinary Session  
MS 17  
The polytrauma patient  
A-935 08:30  
Chairperson's introduction  
M. Brink; Nijmegen/NL (M.Brink@rad.umcn.nl)  
Severe trauma is one of the leading causes of death and disability in the world. 
The outcome of trauma patients improves if the trauma team collaborates 
closely and systematically. In this case-based and interactive session, 
surgeons and radiologists will discuss the multidisciplinary approach to the 
polytrauma patient.  
Session Objectives: 
1. To understand how radiologist can be an active member of the trauma team. 
2. To learn how to communicate effectively in the trauma setting. 
3. To learn how to optimise logistics and to tailor computed tomography (CT) 
imaging for an ideal setting of trauma CT acquisition. 
4. To understand current controversies and recent developments in diagnosing 
injuries in the polytrauma patient. 
5. To be updated on strengths and weaknesses of current resources and 
guidelines on polytrauma trauma imaging. 
Author Disclosure: 
  M. Brink: Research/Grant Support; Toshiba Medical Systems. 
A-936 08:33  
Guidelines and game changers: the radiologist's perspective  
M. Brink; Nijmegen/NL (M.Brink@rad.umcn.nl)  
The outcome of trauma patients improves if the trauma team collaborates 
closely and systematically. As a radiologist, you therefore have to be prepared 
to be an active member of the trauma team. This introduction will discuss the 
three most important issues that radiologists should address prior to image 
evaluation of the polytrauma patient. Which imaging modalities are justified? 
Which modalities should better not be used? And how should you tailor your 
CT protocol?  
Learning Objectives: 
1. To be updated on current, most relevant guidelines on trauma imaging. 
2. To discuss the most relevant CT parameters that can be tailored in the 
setting of polytrauma. 
Author Disclosure: 
  M. Brink: Research/Grant Support; Toshiba Medical Systems. 
A-937 08:40  
The primary survey: talking ABC  
J. Peters; Nijmegen/NL (Joost.Peters@radboudumc.nl)  
The trauma surgeon’s perspective: In the care of the trauma patient, time is of 
essence and prompt focussed action is frequently needed. The most life-
threatening conditions should be diagnosed and addressed first: “Treat first, 
what kills first”. These interventions are prioritised using the simple guidelines 
of the Advanced Trauma Life Support Course (ATLS), using the first letters of 
  







the alphabet. This method provides a solid framework and common language 
for all involved in the care of the trauma patient. Radiologists are an essential 
link in the chain of trauma care. Even more, the role of the radiologist has 
changed in the last years with the widespread use of focussed ultrasound in 
trauma and low-threshold CT scanners available in the emergency department. 
As an active trauma team member, the radiologist needs to be aware of the 
phases in the trauma survey and should provide the proper input needed for 
decision-making. The radiological diagnostics need to be in sync with the 
trauma screening using “ABCDE”. To obtain optimal communication and 
consequently good results, the fundamental guidelines of ATLS must be 
familiar to all involved in the primary trauma care in the emergency department; 
including the radiologist. A team briefing prior to patient arrival is very helpful in 
creating team awareness and a common-team approach. 
Learning Objectives: 
1. To learn how to communicate effectively within the trauma team according 
to ATLS principles. 
2. To understand which traumatic diagnoses can be game changers during the 
primary survey. 
3. To discuss radiology in the trauma room: how to optimise logistics in the 
acute setting. 
A-938 08:55  
The secondary survey: from head to toe  
M. Holla; Nijmegen/NL (Micha.Holla@radboudumc.nl)  
According to the ATLS, after the assessment of vital functions of a trauma 
patient, the secondary survey is performed. In patients with Injury Severity 
Scores (ISS) <16, the treating surgeon often prefers high-quality imaging of the 
extremities . However, in patients with severe injuries of multiple organs 
(ISS>16), a quick imaging procedure is needed. Fast CT scanograms and 
single-direction radiographs can be sufficient to perform damage control 
orthopaedics. High-resolution imaging of extremities must not delay the 
treatment of life-threatening injuries. Quick clearance of the spine can reduce 
the time of unnecessary spinal immobilization and its negative side effects. 
After the secondary survey, effective communication of a resume of all injuries 
highly assists in planning further treatment. A fixed order, reporting on different 
anatomical regions (from brain, face, neck, spine, thorax, abdomen, pelvis, 
right arm, left arm, right leg, left leg), can increase the speed and accuracy of 
this communication to all participating disciplines . This session focuses on 
how to effectively communicate the radiological findings to the orthopaedic 
surgeon and which pitfalls should be avoided.  
Learning Objectives: 
1. To get to know how orthopaedic surgeons approach polytrauma extremity 
trauma. 
2. To understand how to report secondary survey findings to the surgeon. 
3. To learn from diagnostic pitfalls in orthopaedic injuries and how to avoid 
them. 
A-939 09:15  
The neuroradiologist's perspective  
F.J.A. Meijer; Nijmegen/NL (Anton.Meijer@radboudumc.nl)  
Evaluation of vital functions (ABC) precedes neurological evaluation (D) in the 
management of trauma patients, which is also applicable to the diagnostic 
imaging strategy. Nevertheless, adequate and fast neurological evaluation is 
essential to initiate early treatment when indicated, to reduce morbidity and 
mortality. Every radiologist on call should therefore be skilled in the evaluation 
of TBI in the acute stage as part of the polytrauma patient and not consider TBI 
as an area reserved for specialized neuroradiologists. In this lecture, diagnostic 
imaging in head trauma will be discussed focused on the imaging strategy and 
the clinical relevance of imaging findings. Initial diagnostic imaging in the acute 
stage of traumatic brain injury (TBI) mainly concerns non-contrast CT. The 
clinical relevance for differentiating primary from secondary TBI will be 
emphasized. Furthermore, the role of head and neck CTA and the added value 
of brain MR imaging will be discussed. Finally, tips and tricks for choosing an 
appropriate CT angiography and MRI scanning protocol will be provided. 
Learning Objectives: 
1. To learn a structured approach for image interpretation of head trauma. 
2. To learn about the clinical relevance of imaging findings in head trauma. 
3. To give the updated on current knowledge and imaging guidelines, with 
emphasis on blunt cerebrovascular injuries. 
09:35  
Multidisciplinary case presentation and discussion  
 
08:30 - 10:00 Room M 5 
E³ - ECR Master Class (Emergency Imaging)  
E³ 1726b  
Emergencies following tumour therapy  
A-940 08:30  
Chairperson's introduction: The role of imaging in the early detection of 
complications in oncologic treated patients  
D.R. Kool; Amsterdam/NL (dignakool@gmail.com)  
Oncology patients can present with life-threatening conditions. Those 
conditions may be caused by local expansion and complications of the primary 
tumour or metastases, as for example haemorrhage, vena cava superior 
syndrome or spinal cord compression. Furthermore, complications can also be 
caused indirectly by the malignancy, as for instance thromboembolic disease 
or paraneoplastic metabolic or neurological symptoms. Life-threatening 
complications can also be the unwanted consequence of tumour therapy. 
Surgery, radiotherapy, interventional radiology (IR) procedures, chemotherapy 
and immunotherapy, each, have their own set of potential complications that 
can present in the emergency setting. Haematologic and metabolic 
complications are mainly diagnosed with clinical and laboratory findings. For 
other complications, diagnostic imaging is essential for making the correct 
diagnosis and imaging will influence treatment. Complications of surgery, 
radiotherapy and IR procedures will mostly be in the vicinity of the treated area. 
Adverse effects of systemic therapies, chemotherapy and immunotherapy can 
occur at remote sites. Complications of oncological treatment can be life 
threatening. However, when treated on time, they often are reversible. 
Recognizing the imaging findings of complications of tumour therapy timely 
and accurately is of the upmost importance. Immunotherapy is a more recent 
treatment and the adverse effects of immunotherapy differ from the more 
familiar complications of the other tumour therapies. Immunotherapy is 
increasingly used and the radiologist will encounter these complications more 
frequently. In this session, neurological complications and complications in the 
chest and abdomen will be discussed and their imaging findings demonstrated.  
Session Objectives: 
1. To learn about different approaches in tumour therapy. 
2. To understand the radiological appearance of complications. 
3. To appreciate the role of different imaging modalities in further management 
of patients. 
A-941 08:35  
A. Neuro  
C. Calli; Izmir/TR (cem.calli@gmail.com)  
Post-treatment neurooncological emergiencies are usually underdiagnosed by 
imaging methods although the clinical presentation of these conditions are 
obvious in many cases. The aim of this presentation is to create awareness for 
Radiologists who are dealing with follow-up of neurooncology patients. 
Neurooncology patients may suffer emergency situations secondary to either 
surgery, or chemotherapy, or radiotherapy. These emergency conditions 
mostly need the confirmation of imaging techniques to fulfill the diagnosis. 
Thus the radiologists should be familiar of the imaging findings of these 
emergency situations, which will lead the Neurooncologists to decide whether 
to continue the therapy or not, plus to decide further treatment options for 
these conditions. 
Learning Objectives: 
1. To be familiar with different strategies in CNS tumour therapy. 
2. To understand the most common imaging findings in emergent clinical 
scenarios. 
3. To learn how to recognise life-threatening complications. 
A-942 09:00  
B. Chest  
H. Prosch; Vienna/AT (helmut.prosch@meduniwien.ac.at)  
Lung cancer is the most common cause of cancer-related death in Western 
countries. Treatment of lung cancer is based on three pillars: surgery; radiation 
therapy; and systemic therapy. Imaging plays a major role in treatment 
decisions, response evaluation, and last, but not least, also in assessing 
adverse events following therapy. After surgery, acute (early) complications 
include pulmonary oedema (hydrostatic, permeability), atelectasis, 
hemothorax, acute infections, and bronchopleural fistulas. Acute complications 
after radiation therapy include mainly early radiation pneumonitis and 
infections. Following systemic therapy, in addition to infections, non-infectious 
  







pneumonitis and sarcoid-like reactions are important complications that must 
be considered when investigating a patient who presents with acute symptoms.  
Learning Objectives: 
1. To be familiar with modern approach to malignant chest tumour therapy. 
2. To learn how to differentiate clinically important complications. 
3. To understand how to look for the early signs of severe and urgent 
conditions. 
Author Disclosure: 
  H. Prosch: Advisory Board; Boehringer Ingelheim, Roche, MSD. Speaker; 
Boehringer Ingelheim, Roche, MSD, BMS. 
A-943 09:25  
C. Abdomen  
R. Basilico; Chieti/IT (rbasilic@unich.it)  
Despite many improvements in perioperative, post-ionising radiation therapy or 
pharmacological morbidity in abdominal tumour treatments, acute 
complications after tumour therapies in the abdomen are still common. A 
number of different therapies, including surgery, by means of laparoscopic 
approach or minimally invasive robotic surgery, radiotherapy, chemotherapy 
and immunotherapy, may be effectively used to treat abdominal tumours. 
However, these kinds of treatments are not devoid of complications and, last, 
abdominal emergencies may occur after therapies used for extra-abdominal 
tumours. Cross-sectional imaging and particularly CT play a crucial role in the 
diagnosis and management of the most common abdominal emergencies after 
tumour therapies. The main complications following abdominal, urologic or 
gynaecologic surgery include peritonitis, abscesses, haemorrhage, small bowel 
obstruction and anastomotic leaks. Specific complications following 
hepatobiliary surgery include bile leakage and bile duct injuries: US and MRI 
with magnetic resonance cholangiopancreatography (MRCP) sequencers are 
the preferred modalities for assessment of the postoperative biliary tract. Less 
common postoperative emergencies are vascular complications such as 
pseudoaneurysms. Small bowel obstruction caused by radiation enteritis 
represents one of the most frequent abdominal complications after 
radiotherapy of prostate and rectal cancer, whereas a less known disease such 
as pneumatosis cystoides intestinalis may be associated with systemic 
chemotherapy. Due to the increasing use of immunotherapy for different types 
of tumours, new inflammatory and immune-related adverse events occur also 
in the abdomen and need to be managed by a multidisciplinary approach.  
Learning Objectives: 
1. To learn about different techniques used in abdominal tumours therapy. 
2. To be familiar with possible complications. 
3. To understand the effectiveness of imaging modalities in evaluation of 
emergent complications. 
09:50  
Panel discussion: What is the impact of complications findings on the 
further management of oncologic patients?  
10:30 - 12:00 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1821  
Advances in musculoskeletal techniques: 
whole-body MR  
A-944 10:30  
A. Oncologic application  
F.E. Lecouvet; Brussels/BE (frederic.lecouvet@uclouvain.be)  
This interactive session will illustrate the wide range of indications of whole-
body MRI in oncology, the protocols and technical requirements, the 
contribution of anatomic and functional diffusion sequences and their 
respective strengths and pitfalls. Latest technical refinements and efforts to 
decrease examination duration and tailor sequences to the targeted disease 
will be presented. Simple and more complex cases will highlight how the 
technique extends the exploration of the body beyond the musculoskeletal 
system to lymph nodes and visceral metastases screening. Specific cases will 
show how WB-MRI has become a modality of choice for detecting bone 
metastases from many cancers and bone marrow involvement by multiple 
myeloma or lymphoma. The comparison will be provided with bone 
scintigraphy, CT and PET by the time of lesion detection and for assessment of 
the response to treatment. 
 
Learning Objectives: 
1. To become familiar with the technical aspects of whole-body MR. 
2. To learn the role of whole-body MR in the management of oncologic 
patients. 
A-945 11:15  
B. Non-oncologic applications  
M. Faruch; Toulouse/FR (mariefaruch@hotmail.com)  
Thanks to improvement in technique for shortening of examination duration, 
whole-body MR imaging can now be feasible for use in routine clinical practice 
in numerous skeletal and neuromuscular disorders as seronegative 
rheumatologic disease, multifocal ischaemic lesions, multifocal eosinophilic 
granulomas and inflammatory myopathies. Whole-body MR could be helpful for 
early diagnosis, evaluation of the extent and activity of the disease, and 
evaluation of therapeutic response. Current MRI protocols usually include 
anatomic sequences as T1-weighted and water-sensitive sequences as STIR, 
but could also provide functional DWI sequences.  
Learning Objectives: 
1. To become familiar with the indications for whole-body MR in non-oncologic 
patients. 
2. To learn the role of whole-body MR in the management of non-oncologic 
musculoskeletal disorders. 
10:30 - 12:00 Room B 
ESR meets China  
EM 3  
A glance of China through images  
Presiding:  
B. Hamm; Berlin/DE  
Z.Y. Jin; Beijing/CN  
A-946 10:30  
Introduction  
Z.Y. Jin; Beijing/CN (jin_zhengyu@163.com)  
The Chinese radiological system is continuously innovating. Fifteen years 
previously, radiologists were writing reports with pens and watching stacks of 
films from the light box in a dark room. Patients came to the technician with 
handwritten prescriptions and registration information. Now, we have jumped 
into a new era. The workflow is greatly facilitated by automatic machine-
facilitated workflow processes. Patients receive digital imaging. Radiologists sit 
in front of a computer and view images from picture archiving and 
communication sytem (PACS). Quantitative radiology and precision radiology 
have become the pursuit of us in our clinical practice. Data show that CT 
machine possession per million population in China increased from 5.5 in 2007 
to 8.6 in 2010, although still low compared to the developed countries. Health-
care PACS informational process market survey in 2015 showed that about 
50% general public hospitals and 33% community hospitals have PACS. To 
improve the radiological service in China, multiple factors should be taken care 
of, not only the equipment, but also the education of radiologists/technicians, 
the facilitation and optimization of workflow, and the appropriateness and 
efficiency of patient care. With more than 13.8 billion population and varied 
economical situation in China, we are still facing great challenges. It is our goal 
to improve the quality of medical service, especially in rural areas. We will also 
encourage private health centres, imaging centres and Web-based consulting 
services in addition to established public health centres. We would like to 
stretch our arms towards globalization and welcome international 
communication and collaboration.  
Session Objectives: 
1. To give an overview of the current situation and trend of radiology in the 
mainland of China. 
2. To show a few examples of the diversity of clinical radiological researches in 
China. 
3. To introduce the special focuses of Chinese radiological society. 
10:39  











A-947 10:42  
Multiparameteric analysis in imaging liver disease  
F.-H. Yan; Shanghai/CN (ruijin665727@qq.com)  
China has a serious chronic liver disease burden, especially HBV/HCV-related 
cirrhosis and hepatocellular carcinoma (HCC). According to the population-
based cancer registration data of Chinese National Central Cancer Registry, 
HCC is the third most common cancer and the second most cause of cancer-
related deaths. Over 80% of HCC cases develop in cirrhotic liver by a process 
of multistep hepatocarcinogenesis, from regenerative nodule (RN), to 
dysplastic nodule (DN), and finally to overt HCC. Multiparametric imaging plays 
an important role for HCC surveillance, characterization with benign cirrhosis-
associated nodules and noninvasively diagnostic algorithm in these extremely 
high-risk patients. To date, the diagnosis of HCC is mainly based on its 
haemodynamic hallmarks, i.e. arterial hyperenhancement followed by 
venous/delayed washout on multiphasic CT and MRI. It forms the foundation of 
current Western and Eastern HCC practice guidelines. Ancillary features, 
especially the presence of restricted diffusion on diffusion-weighted imaging 
(DWI), are preferred for early detection of HCC and to increase diagnostic 
confidence. MR imaging with hepatocyte-specific contrast agents has shown 
great promise in identifying high-grade DN and early HCC prior to neo-
arterialization and progression to overt HCC. It is gradually changing the 
standard of diagnosis of HCC and may well be endorsed in future guidelines. 
Additionally, quantitative imaging techniques, including dual-energy CT, US- or 
MRI-based elastography, have demonstrated increasing roles for the 
evaluation of diffuse liver disease such as liver fibrosis, siderosis and 
nonalcoholic steatohepatitis.  
Learning Objectives: 
1. To give an introduction to the imaging features of common liver diseases in 
China. 
2. To understand the advantages of multiparameteric analysis of liver imaging. 
3. To show some interesting cases. 
4. To discuss the clinical application of multiparametric analysis in abdominal 
pathologies. 
A-948 10:57  
Multimodality imaging for insulinoma detection  
H.-D. Xue; Beijing/CN (bjdanna95@163.com)  
Insulinomas are the most common hyper-functioning pancreatic endocrine 
tumours. Clinically, patients with insulinomas are characterized by 
hypoglycaemic symptoms caused by insulin overproduction. Insulinomas are 
generally benign and curable with surgery. Recurrence after resection is rare. 
Multiple lesions can be seen in patients with multiple endocrine neoplasia 
(MEN) syndrome. For patients with clinically suspected insulinomas, 
determining the location and number of tumours accurately with imaging 
workup allows for less invasive surgeries. Historically, detection of insulinomas 
by cross-sectional imaging has been difficult. Nowadays, a greater sensitivity 
for insulinoma detection has been reported with state-of-the-art CT and MR 
scanners. Routine dual-phase enhanced CT has relatively low sensitivity for 
insulinoma detection because of the presence of isoattenuating tumours, which 
account for around 25% of all tumours. Volume perfusion CT (VPCT) of the 
pancreas reveals increased blood flow of the tumour, as most ‘isoattenuating 
tumours’ show transient hyperenhancement, which may not be captured by 
traditional scanning protocols. Intra-individual comparative study shows that 
VPCT and mp-MR had similar high accuracy in insulinoma detection, and both 
were significantly more accurate than biphasic CECT. The intrinsic superior 
soft-tissue contrast with MRI helps to identify the tumour more easily without 
using contrast agents. Since insulinomas are quite small, the improved signal 
to noise of 3T MR compared to 1.5T and the introduction of high-resolution 
DWI are key factors for the improved diagnostic performance compared to the 
earlier reports.  
Learning Objectives: 
1. To give a review of "insulinoma imaging" in the past. 
2. To understand the advantages of perfusion CT, multiparametric MR and 
PET/CT with special tracers. 
3. To discuss the potential clinical workflow and decision tree for imaging 
patients with suspected insulinomas and other functional pancreatic endocrine 
tumours. 
A-949 11:12  
Interventional therapy for hepatocellular carcinoma: Chinese experiences  
X.-G. Li; Beijing/CN (xglee88@126.com)  
In China, due to the high prevalence of HBV infection, the incidence rate of 
hepatocellular carcinoma is still very high. According to the 2017 Chinese 
cancer statistics report, HCC ranks 3rd and 6th in the incidence of cancer of 
men and women in urban areas, and it ranks 3rd in the mortality rate. The 
features of Chinese HCC patients include background of liver cirrhosis, 
relatively late stage, large tumor size and high rate of portal vein thrombus. 
Less than 20% of patients are candidates for liver resection or transplantation, 
so interventional treatment plays an important role in the management of HCC. 
Y90 microspheres are not available in the Mainland of China, so TARE is not 
routinely performed except for those in Hong Kong or Taiwan. In recent several 
years, DEB-TACE is accepted as an alternative for cTACE in selected patients. 
Thermal ablation including RFA, MWA and cryoablation is usually performed in 
combination with TACE. For lesions located at high-risk sites, PEI or 125I seed 
implantation is a good option and has achieved satisfactory results. Portal vein 
recanalization with 125I seed loading stent or endovascular RFA is attempted 
in some tertiary centres.  
Learning Objectives: 
1. To learn the epidemiology and special features of hepatocellular carcinoma 
in China. 
2. To review the various interventional procedures and compare their efficacies 
in treating patients with hepatocellular carcinoma. 
3. To understand the indications and clinical applications of interventional 
procedures to treat hepatocellular carcinoma. 
11:27  
Interlude 2: Experience of Chinese tea culture  
A-950 11:30  
Application of artificial intelligence in prostate imaging  
X.-Y. Wang; Beijing/CN (cjr.wangxiaoying@vip.163.com)  
A prostate mpMRI-CAD system has been developed. It can be used for 
identification of clinically significant prostate cancer with high prediction 
efficacy. It was validated by a multicentre clinical trial. After integrating the CAD 
system into the diagnostic process as a second reader, the performance of 
less experienced readers can be significantly improved.  
Learning Objectives: 
1. To learn about the basics and feasibility of applications of artificial 
intelligence. 
2. To understand the clinical value of applying artificial intelligence in detection, 
prognosis and treatment evaluation of prostate cancer. 
3. To learn the technique and clinical application of artificial intelligence in 
abdominal pelvic imaging. 
A-951 11:45  
Radiomics nomogram to predict lymph node metastasis in colorectal 
cancer  
Z. Liu; Guangzhou/CN (zyliu@163.com)  
To develop and validate a radiomics nomogram for preoperative predicting of 
lymph node (LN) metastasis in colorectal cancer (CRC). The prediction model 
was developed in a primary cohort consisting of 326 clinicopathologically 
confirmed CRC patients from January 2007 to April 2010. Radiomics features 
were extracted from portal venous-phase computed tomography (CT) of CRC. 
Lasso regression model was used for data dimension reduction, feature 
selection and radiomics signature building. Then, multivariable logistic 
regression analysis was used to develop the predicting model, with radiomics 
signature, CT-reported LN status and independent clinicopathological risk 
factors incorporated, which was presented with a radiomics nomogram. The 
performance of the nomogram was assessed with respect to its calibration, 
discrimination and clinical usefulness. Internal validation was assessed. An 
independent validation cohort contained 200 consecutive patients from May 
2010 to December 2011. The radiomics signature consisting of 24 selected 
features was significantly associated with LN status (p<0.0001 for both the 
primary and validation cohorts). The predictors contained in the individualized 
prediction nomogram included the radiomics signature, CT-reported LN status 
and carcinoembryonic antigen (CEA) level. The addition of histological grade 
into the nomogram failed to show incremental prognostic value. The model 
showed good discrimination with a C-index of 0.736 (0.759 and 0.766 through 
internal validation), as well as a good calibration. Application of the nomogram 
in the validation cohort still gave good discrimination (C index=0.778 [95%CI: 
0.769-0.787]) and good calibration. Decision curve analysis demonstrated that 
the radiomics nomogram had clinical usefulness. This study presents a 
radiomics nomogram incorporating the radiomics signature, CT-reported LN 
status and clinical risk factors, which can be conveniently used to facilitate the 
preoperative individualized prediction of LN metastasis in CRC.  
Learning Objectives: 
1. To learn about the basics of radiomics and feasibility of clinical applications. 
2. To understand the clinical value of radiomics nomogram in predicting lymph 
node metastasis in colorectal cancer. 
3. To learn the potential applications of radiomics in various oncological 
studies.  
  







10:30 - 12:00 Room F1  
E³ - European Diploma Prep Session  
E³ 1823  
Paediatric  
A-952 10:30  
Chairperson's introduction  
V. Donoghue; Dublin/IE  
The aim of this session is to outline the imaging findings seen in congenital and 
acquired conditions encountered in the brain, chest and abdomen in the 
paediatric and adolescent population. With improvements in ultrasound and 
MR imaging techniques, many congenital abnormalities have now been 
detected antenatally. However, imaging after birth is usually requested to 
confirm the diagnosis and it may also provide additional information to the 
clinician. Acquired disorders such as small bowel volvulus and intussusception 
are true clinical emergencies requiring urgent treatment. Therefore, detailed 
knowledge of the imaging features in these conditions is mandatory. In children 
with respiratory distress, the chest radiograph is often invaluable in suggesting 
a diagnosis. CT, however, is frequently required and knowledge of good 
technique using the appropriate CT dose is required to get the most 
information possible. In children with tumours, recognition of detailed imaging 
findings is important in aiding the correct tumour grading and therefore in 
guiding appropriate therapy.  
Session Objectives: 
1. To understand the imaging features of the most common congenital and 
neoplastic disorders of the brain in children and adolescents. 
2. To describe the imaging presentations of the most common disorders of the 
lung and mediastinum in the paediatric age group. 
3. To become familiar with the imaging features of important acute disorders of 
the abdomen in children and adolescents. 
A-953 10:36  
A. Paediatric neuro imaging  
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr)  
Age-related changes depending on neuronal migration, gyration and 
myelination have been described in the paediatric brain. These changes are 
responsible for the different imaging patterns as the paediatric brain matures. 
Conventional MR sequences along with diffusion tensor imaging (DTI) and 
functional MRI (f-MRI) offer important information regarding the structural and 
functional maturation of the brain. Congenital malformations of the brain can be 
assessed with conventional sequences, but DTI using ADC, FA maps and 
tractography and f-MRI offer valuable structural and functional information and 
help in the detection of additional malformations. The incidence and 
localization of different brain tumours depend on the age. Conventional MRI 
offers useful information, but further evaluation with DTI, susceptibility contrast-
enhanced perfusion imaging, spectroscopy and f-MRI is very important in the 
diagnostic workup and before the application of any therapeutic scheme. A 
number of brain tumours may metastasize through CSF and additional imaging 
of the spinal canal to look for seeding metastases is necessary. MRI is the 
modality of choice for imaging the paediatric brain; nevertheless, in neonates 
and infants, brain ultrasound with colour Doppler should be the first imaging 
approach. Brain ultrasound offers valuable information provided that a state-of-
the-art technique is applied.  
Learning Objectives: 
1. To describe the normal development of the brain. 
2. To explain the most common congenital disorders of the brain. 
3. To understand the most common brain tumours in children and adolescents. 
A-954 11:04  
B. Paediatric chest imaging  
C. Owens; London/UK (owensc@gosh.nhs.uk)  
Normal pulmonary and cardiovascular development will be reviewed leading 
on to a comprehensive overview of congenital disorders of the lung and 
mediastinum and their imaging features. This will include bronchopulmonary 
sequestration, congenital pulmonary adenomatoid malformations and thoracic 
duplication cysts along with an overview of congenital cardiac disorders. The 
role of imaging in neonatal respiratory distress syndrome will be reviewed 
along with a discussion of when and how to use CT in particular cases. Lastly, 




1. To describe the normal development of the lung and mediastinum. 
2. To explain imaging features of congenital disorders of the lung and 
mediastinum. 
3. To understand the imaging manifestations of respiratory distress and 
bronchopulmonary dysplasia in infants. 
4. To describe the most common tumours of the chest in children. 
A-955 11:32  
C. Paediatric abdominal imaging  
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl)  
Paediatric abdominal diseases are highly age dependent. Newborn infants 
may have congenital diseases as Hirschsprung's disease or meconium ileus or 
may develop necrotising enterocolitis, incarcerated inguinal herniation and 
midgut volvulus. Infants and preschool children have intussusceptions, urinary 
tract infections and (rare) haemolytic uraemic syndrome. Children and 
adolescents have appendicitis, genito-urinary infections, ovarian torsion and 
Henoch Schonlein purpura. Abdominal neoplasms can occur at any age, even 
at birth. Considering radiation dose in children and the excess value of 
ultrasonography (US) in small individuals, US plays an important role as initial 
diagnostic modality in paediatric abdominal emergencies. Sensitivity and 
specificity for US in diagnosing intussusception, midgut volvulus, urinary tract 
abnormalities and appendicitis is over 90%. Conventional abdominal 
radiographs or fluoroscopy are valuable in Hirschsprung's disease, meconium 
ileus, malrotation and necrotising enterocolitis. I consider CT as an additional 
technique when the initial techniques (US and conventional radiography) are 
inconclusive. MRI is seldom indicated in paediatric patients with abdominal 
emergencies because of motion artefacts in anxious children and sometimes 
limited MR capacity. However, in children with abdominal neoplasms it is the 
modality of choice. 
Learning Objectives: 
1. To understand the imaging features of congenital disorders of the abdomen. 
2. To describe the diagnostic evaluation and imaging presentation of 
appendicitis in children. 
3. To describe the diagnostic evaluation and imaging presentation of volvulus 
and intussusception in children. 
4. To understand the imaging presentation of the most common oncologic  
12:30 - 13:30 Room C 
E³ - The Beauty of Basic Knowledge: Cardiovascular and 
Interventional Radiology  
E³ 24E  
The heart of the matter: imaging the 
myocardium  
Moderator:  
T. Yalynska; Kiev/UA  
A-959 12:30  
MR in ischaemic cardiomyopathies  
F. Cademartiri; Monastier di Treviso/IT (filippocademartiri@gmail.com)  
Ischaemic cardiomyopathy is the leading cause of morbidity and mortality in 
the western world. Over the years, several improvements in terms of 
knowledge, diagnostic capabilities and treatment options have been developed 
in such a way that today we are in a constant update of our technologies and 
treatments. Cardiovascular Magnetic Resonance (CMR) is by far the most 
flexible and complete imaging modality that can be applied to the evaluation of 
ischaemic cardiomyopathies. It can provide anatomy, function, flow, ischemia 
and tissue characterisation. CMR is considered the reference standard for the 
assessment of inducible ischemia and myocardial viability. Modern MR 
equipment can deliver a huge amount of information that require wide technical 
and clinical knowledge to be handled correctly. Especially the newer 
approaches with quantitative tissue mapping that are being introduced in the 
clinical field. With the advancement of technology also 3T CMR have become 
mainstream and able to add some value in certain specific fields. With the 
rapid growth of Cardiac Computed Tomography as the elective non invasive 
anatomical tool for the assessment of the coronary arteries CMR becomes the 















1. To learn about the MR derived imaging biomarkers in ischaemic 
cardiomyopathy. 
2. To understand the value of cardiac MR to indicate and guide 
revascularisation in ischaemic cardiomyopathy. 
3. To appreciate the potential of cardiac MR to predict the outcome of 
revascularisation. 
A-960 13:00  
MR in non-ischaemic cardiomyopathies  
C. Peebles; Southampton/UK (Charles.Peebles@suht.swest.nhs.uk)  
Non-ischaemic cardiomyopathies are a heterogenous group of inherited and 
acquired diseases affecting myocardial function. Cardiac MR is unsurpassed in 
its ability to quantify myocardial function, identify the pattern and extent of 
myocardial scar, and access myocardial oedema and diffuse fibrosis. 
Established techniques such as late gadolinium enhancement are critical to 
establishing a diagnosis, particularly in differentiation from ischaemic 
cardiomyopathy. Newer techniques such as tissue mapping are still finding 
their role in clinical practice, but seem to be promising tools for both diagnosis 
and prognosis of cardiomyopathies. This lecture will use predominantly case-
based discussion to understand the established and evolving imaging 
biomarkers for non-ischaemic cardiomyopathy and how these are applied in 
clinical practice. The focus will be on establishing an accurate diagnosis in the 
major non-ischaemic cardiomyopathies, whilst highlighting areas of diagnostic 
challenge and uncertainty. The potential of CMR to provide prognostic 
information and the associated evidence base will also be explored.  
Learning Objectives: 
1. To learn about the MR derived imaging biomarkers in non-ischaemic 
cardiomyopathies. 
2. To understand the role of cardiac MR in primary and secondary 
cardiomyopathies. 
3. To appreciate the discriminatory power of cardiac MR in cardiomyopathies. 
12:30 - 13:30 Room D  
E³ - The Beauty of Basic Knowledge: A Survival Guide to 
Musculoskeletal Imaging  
E³ 25E  
Infective/inflammatory disorders  
Moderator:  
V.N. Cassar-Pullicino; Oswestry/UK  
A-961 12:30  
Infective/inflammatory disorders  
F.M.H.M. Vanhoenacker; Antwerp/BE (filip.vanhoenacker@telenet.be)  
Osteomyelitis is divided into acute, subacute and chronic osteomyelitis. 
Pathophysiological factors that determines imaging are patient’s age, route of 
contamination, virulence of the causative micro-organism and the immune 
status of the patient. In haematogenous spread, the site and extent of the 
infection depends primarily on the vascularisation. The metaphysis is the 
common site for haematogenous osteomyelitis in children over 18 months, due 
to stasis of slow-flowing blood. In infants and adults, the presence of 
transphyseal vessels may cause spread of the infection to the epiphysis. 
Imaging plays a pivotal role in confirming the diagnosis of musculoskeletal 
infection, determining the disease extent and guiding early treatment. Plain 
radiography is not very sensitive for early diagnosis. Ultrasound is a reliable 
tool to detect subperiosteal spread in children, but its use in adults is restricted 
to evaluation of soft tissue infection and for aspiration of infected joints. In 
adults, MRI is the preferred modality, although CT may detect sequestrum 
formation in chronic osteomyelitis. SpA consists of a spectrum of chronic 
inflammatory disorders that are distinct from RA. Ultrasound is useful for 
grading of synovitis and early detection of erosions of peripheral joints in RA. 
SpA has a predilection for the axial skeleton. MRI is the preferred technique for 
early diagnosis and detection of active inflammatory lesions by demonstrating 
bone marrow oedema at the sacro-iliac joints. Two or more areas of BME or 
one focus of BME on at least two consecutive 3-mm slices is needed to reliably 
diagnose axial SpA. 
Learning Objectives: 
1. To learn about the pathomechanisms involved in inflammatory and 
infections disorders. 
2. To understand the imaging appearances and their differential diagnosis in 
the acute, sub-acute and chronic phases of infection. 
3. To become familiar with the spectrum of imaging features of inflammatory 
disorders in the axial and peripheral skeleton. 
14:00 - 15:30 Room A 
E³ - ECR Academies: Interactive Teaching Sessions for Young 
(and not so Young) Radiologists  
E³ 1921  
Imaging of abdominal tumours  
A-967 14:00  
A. Liver tumours  
T. Denecke; Berlin/DE (timm.denecke@charite.de)  
Besides the top three malignant (HCC, CCC, metastases) and the top three 
benign liver tumours (haemangioma, FNH, adenoma), there is a large variety 
of rare entities and subtypes, which can be demanding regarding their imaging 
diagnostics. In this session, a number of cases will be presented to illustrate 
the typical and also some challenging findings of focal liver lesions, which the 
radiologist should know, always keeping in view the potentially severe 
consequences of the radiologist’s judgement for patient management.  
Learning Objectives: 
1. To become familiar with the differential diagnosis. 
2. To identify the key imaging findings. 
Author Disclosure: 
  T. Denecke: Grant Recipient; Siemens. Speaker; Siemens, Bayer, Toshiba. 
A-968 14:45  
B. Pancreatic tumours  
C. Matos; Lisbon/PT (celso.matos@fundacaochampalimaud.pt)  
Differential diagnosis and management decisions of pancreatic tumours are 
based on a mixture of clinical and laboratory information and imaging findings 
involving multiple modalities. The lecture will familiarize the delegates with the 
main challenges and future trends in the diagnosis of pancreas tumours, 
differential diagnosis with pancreas inflammation, and in identifying features 
that may help to select surgical candidates.  
Learning Objectives: 
1. To become familiar with the differential diagnosis. 
2. To identify the key imaging findings. 
14:00 - 15:30 Room F1  
E³ - European Diploma Prep Session  
E³ 1923  
Interventional  
A-970 14:00  
Chairperson's introduction  
T. Struffert; Erlangen/DE  
"no abstract submitted" 
Session Objectives: 
1. To understand the principles and techniques of angiography and image-
guided interventions. 
2. To become familiar with the different methods of hepatobiliary interventions. 
3. To describe the most common vascular interventions. 
A-971 14:06  
A. Basic principles of angiography and image-guided interventions  
T.K. Helmberger; Munich/DE (Thomas.Helmberger@klinikum-muenchen.de)  
Basic knowledge of the indications and contraindications, patient preparation, 
typical interventional techniques, outcome and complications in vascular and 
non-vascular interventions is essential for every radiologist. Knowledge of the 
typical arterial and venous anatomy and potential variants is of ample 
importance both from a diagnostic perspective and with respect to planning 
optimal access routes, puncture site/technique, and pathways for transvascular 
and percutaneous procedures. These procedures include (1) a broad spectrum 
of transvascular interventional techniques such as vascular recanalization (e.g. 
balloon and stent angioplasty), occlusion (e.g. bleeding, vascular 
malformations), and perfusion (e.g. trans-arterial oncological interventions) in a 
wide variety of diseases; and also (2) basic percutaneous diagnostic (i.e. 
biopsy, fluid evacuation) and therapeutic procedures (i.e. drainage of e.g. 
abscess, haemorrhage). The understanding of the comprehensive options and 
benefits of these interventional techniques, together with the proper use of 
  







image guidance makes the radiologist a valuable companion to almost all 
clinical specialities in solving diagnostic and therapeutic tasks.  
Learning Objectives: 
1. To describe the normal anatomy and normal variants of the arterial and 
venous vascular system. 
2. To understand diagnostic and interventional angiographic techniques. 
3. To explain basic percutaneous image-guided techniques including abscess 
drainage and biopsy taking. 
Author Disclosure: 
  T.K. Helmberger: Consultant; Boston Scientific. 
A-972 14:34  
B. Image-guided interventions in oncology  
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es)  
Interventional oncology (IO) is an established pillar in the management of 
oncologic patients. Endovascular access allows (almost) any kind of therapies. 
By using devices it is possible to permeabilize, occlude, obtain material, infuse 
chemotherapy, administer brachytherapy, implant devices or genes, among 
others. IO within the multidisciplinary management could offer curative 
procedures such as percutaneous or endovascular ablations using physical or 
pharmacological methods; thus, radiologists are in the front line of patients´ 
care which carries clinical responsabilities. IO is crucial in the 
downstaging/bridging towards a curative treatment such as surgery; these 
adjunctive procedures, are fundamental in allowing patients to be cured and 
should be actively promoted by radiologists. IO procedures can participate in 
the palliation of symptoms, offering to bring them within the established 
treatment protocols; as happens with any bleeding related directly with the 
tumour or indirectly with its treatment. IO offer other procedures essential to 
cancer care, but not considered primarily therapeutic such as venous access. 
Liver´s almost exclusive characteristic of having a dual vascularisation offers 
performing aggressive treatments targeting the tumour while preserving the 
healthy parenchyma. Particularly in the case of hepatocellular carcinoma, 
chemoembolization (particles with chemotherapy) and radioembolization 
(particles with a radioisotope) are included in the therapeutic protocol for this 
devastating disease. Non-vascular procedures, such as percutaneous ablation, 
have proved their efficacy, with improvement in overall survival in a certain 
group of liver tumours and are basic in the management of a wide range of 
lung and renal tumours.  
Learning Objectives: 
1. To describe the basic technical and methodological principles of imaging-
guided interventions in oncological disorders. 
2. To understand the principles of and indications for vascular interventions in 
cancer, e.g. transarterial (chemo)embolisation techniques of the liver. 
3. To become familiar with the principles of and indications for percutaneous 
image-guided interventions in oncological disorders including thermal ablation 
techniques. 
Author Disclosure: 
  J.I. Bilbao: Advisory Board; Sirtex Medical, Terumo. 
A-973 15:02  
C. Vascular interventions  
J.A. Reekers; Amsterdam/NL (j.a.reekers@amc.uva.nl)  
In the exam preparation talk, a variety of different vascular techniques will be 
discussed. Endovascular treatment options of atherosclerotic diseases will be 
explained, and common angioplasty procedures, such as renal, iliac and 
femoral angioplasties, understood. The indications and techniques for arterial 
stenting procedures will be described, and techniques of arterial embolisation 
and coiling explained. All techniques will be illustrated with related patient 
cases.  
Learning Objectives: 
1. To explain endovascular treatment options of atherosclerotic diseases. 
2. To understand common angioplasty procedures, such as renal, iliac and 
femoral angioplasties. 
3. To describe indications and techniques for arterial stenting procedures. 
4. To explain techniques of arterial embolisation and coiling. 
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10:30 - 12:00 Room B  
Abdominal Viscera  
SS 201a  
Multiparametric liver imaging  
Moderators:  
A. Filippone; Chieti/IT 
S. Ichikawa; Chuo-shi, Yamanashi/JP  
K-01 10:30  
Keynote lecture  
D. Regge; Turin/IT  
B-0001 10:39  
Long-term follow-up magnetic resonance elastography after novel direct 
antiviral therapy in chronic hepatitis C virus induced liver fibrosis  
S.R. Marticorena Garcia, J. Guo, H. Tzschätzsch, C.E. Althoff, M. Dürr, 
F. Halleck, B. Hamm, T. Fischer, I. Sack; Berlin/DE 
(stephan.marticorena-garcia@charite.de)  
Purpose: Chronic hepatitis C virus (HCV) infection predisposes to liver 
fibrosis. The purpose of this study is to non-invasively monitor elastic 
properties of the liver and kidney transplants (KTX) using multifrequency 
magnetic resonance elastography (MRE) after direct antiviral therapy. 
Methods and Materials: In this prospective and longitudinal study 13 patients 
with chronic HCV infection and biopsy proven liver fibrosis were treated with 
direct-acting antivirals (Daclatasvir/Sofosbuvir). Shear wave speed (SWS) of 
liver and KTX was measured by multifrequency MRE at baseline (before 
therapy) and during a follow-up period after therapy at 3, 6 and 15 months. The 
results were compared to a healthy control group (CTR, n=7). Laboratory 
results were obtained at each time point. 
Results: Mean time point to reach undetectable viral RNA was 22±13 days 
and remained stable during the entire follow-up period in all responders to 
treatment. Compared to baseline (1.67±0.33 m/s), analysis of repeated 
measurements showed a significant decrease in liver SWS at 6 months 
(1.56±0.27 m/s; p<0.01), being stable at 15 months (1.55±0.26 m/s; p<0.05). 
Viral relapse occurred in one subject and liver SWS remained unchanged after 
treatment, despite of serological marker response. No changes of renal 
stiffness were observed in KTX. 
Conclusion: Direct antiviral therapy is associated with an early decrease of 
liver stiffness and being stable until 1 year after the end of treatment. MRE 
could be used as biomarker for non-invasive therapy monitoring based on liver 
stiffness which is a potential early predictor of the treatment response.  
Author Disclosures: 
 B. Hamm: Grant Recipient; Siemens. 
B-0002 10:47  
Repeatability and reproducibility of multiparametric magnetic resonance 
imaging of the liver  
H.R. Wilman1,2, V. Bachitar1, J. Jacobs1, R. Newbould2, M. Gyngell1, 
C.J. Kelly1, M.D. Kelly1, R. Banerjee1; 1Oxford/UK, 2London/UK 
(henry.wilman@perspectum-diagnostics.com)  
Purpose: LiverMultiScan™ (LMS) is a multiparametric MRI-based technology 
for quantitative analysis of hepatic fat, T2*, and iron corrected T1 (cT1). Here 
we test the robustness of LMS-derived metrics by systematically examining 
reproducibility of measurements across different MRI scanner manufacturers, 
models, software versions and field strengths. 
Methods and Materials: cT1, T2* and Proton Density Fat Fraction (PDFF) 
maps were acquired from 61 participants on combinations of three Siemens 
and two Philips scanners at both 1.5T and 3T. Participants were scanned on at 
least two different scanner models and field strengths in pseudorandomised 
order with up to 1 week between scans and two acquisition repeats on each 
scanner. Standardisation of T1 maps across scanners were based on 
phantom-derived mappings from 90 acquisitions. 
Results: Bland-Altman analysis of the T1 phantom measurements showed a 
clear reduction in bias (from -20ms to -4.7ms), tightening of the 95% Limits of 
Agreement (LoA: from -59.2ms - 19ms, to -25.3ms - 15.9ms) and reduction in 
mean coefficient of variation (CoV: 2.5% to 1.0%) after standardisation. 
Following T1-standardisation, cT1 in participants demonstrated high 
reproducibility (CoV, 3.3%, bias, 6.5 ms, 95% LoA of -76.3 ms to 89.2 ms). 
Both T2* and PDFF measurements also showed excellent reproducibility at 
both field strengths and across different scanners models. 
Conclusion: We demonstrate that following T1 standardization, cT1 is 
reproducible across scanner manufacturer, model, software version and field 
strength. Combined with the excellent reproducibility of T2* and PDFF, LMS 
represents a robust and reliable non-invasive tool for the characterisation of 
liver tissue.  
Author Disclosures: 
  H.R. Wilman: Shareholder; Perspectum Diagnostics Ltd. V. Bachitar: 
Employee; Perspectum Diagnostics Ltd. J. Jacobs: Employee; Perspectum 
Diagnostics Ltd.. Shareholder; Perspectum Diagnostics Ltd. R. Newbould: 
Employee; Perspectum Diagnostics Ltd. M. Gyngell: Employee; Perspectum 
Diagnostics Ltd.. Shareholder; Perspectum Diagnostics Ltd. C.J. Kelly: 
Employee; Perspectum Diagnostics Ltd.. Shareholder; Perspectum 
Diagnostics Ltd. M.D. Kelly: Employee; Perspectum Diagnostsics Ltd.. 
Shareholder; Perspectum Diagnostsics Ltd. R. Banerjee: Board Member; 
Perspectum Diagnostics Ltd.. CEO; Perspectum Diagnostics Ltd.. Shareholder; 
Perspectum Diagnostics Ltd.. 
B-0003 10:55  
Molecular features, histological parameters and enhancement 
measurements in NASH patients using gadoxetic acid-enhanced MR 
imaging  
D.S. Feier1,2, N. Bastati-Huber2, A. Beer2, R.M. Fragner2, H. Einspieler2, 
A. Ba-Ssalamah2; 1Cluj-Napoca/RO, 2Vienna/AT (diana.feier@gmail.com)  
Purpose: To assess the relationship of organic anion transporting polypeptide 
(OATP1B1/3) expression with histological parameters and relative 
enhancement ratio in patients with nonalcoholic fatty liver disease (NAFLD), 
defined according to the steatosis activity and fibrosis (SAF) scoring system, 
which is based on the semi quantitative scoring of steatosis activity and liver 
fibrosis. 
Methods and Materials: The local institutional review committee approved this 
study and waived written informed consent. This was a retrospective study of 
gadoxetic acid-enhanced 3-T MR imaging performed in 52 patients with 
NAFLD, mean age (SD) 50.46 (16.52) years. The MR images were analyzed 
by using the relative enhancement (RLE) (the ratio of signal intensities of the 
liver parenchyma before and 20 minutes after intravenous administration of 
gadoxetic acid). Univariate and multiple regression analyses were applied to 
identify variables associated with OATP1B1/3 expression. 
Results: OATP1B1/3 expression correlated with RLE (r=0.49, p=0.0002), the 
degree of liver fibrosis (r =-0.27, p=0.04) but not with steatosis (r = -0.16, p= 
0.23), ballooning (r=-0.22, p=0.1) or inflammation (r=-0.07, p=0.57). According 
to multivariate analysis both RLE and liver fibrosis are independent predictors 
of OATP1B1/3 expression (coefficient of determination R2=0.32, p=0.01). 
Conclusion: The degree of OATP1B1/3 expression correlated statistically with 
gadoxetic acid relative enhancement and the degree of liver fibrosis in patients 
with NAFLD.  
B-0004 11:03  
Application of T1rho in evaluating liver fibrosis and correlation with liver 
function  
Q. Yang, T. Yu, J. Huang, Y. Su, J. Li, B. Liang; Guangzhou/CN 
(yangqih2@mail.sysu.edu.cn)  
Purpose: To verify the value of T1rho in evaluating liver fibrosis, find out the 
diagnosis threshold of T1rho and correlation coefficient between T1rho value 
and laboratory test results. 
Methods and Materials: The study was approved by the local Institutional 
Review Board and informed consent was obtained from all participants. 
Patients suspected liver fibrosis were enrolled. Clinical data including 
laboratory test results were collected within 7 days before or after MRI scan for 
patients. All patients underwent MR scan including T1rho. Pathology results, 
laboratory test results were compared with T1rho and correlation test were 
done among them. 
Results: 77 patients were enrolled and T1rho values for F0~F4 were 
40.36±4.40ms, 41.99±1.63ms, 44.24±4.40ms, 47.16±2.66ms and 
47.87±4.73ms. One-way ANOVA showed statistical difference among T1rho 
values of F0~F4 groups ( P<0.001) and among T1rho values of Child A~C 
groups in liver cirrhosis(F4) patients. Area below ROC curve of T1rho 
diagnosing liver fibrosis severer than F2 was 0.87. When 42.86ms was chosen 
as diagnosis threshold, sensitivity was 0.91 and specificity was 0.76. Among all 
laboratory tests, PT, PT-INR, Bile acids, TBIL, DBIL, IBIL and APRI were 
positively correlated with bothT1rho and fibrosis stages,while T-CHO, ALB and 
A/G were negatively correlated with both T1rho and fibrosis stage. 
Conclusion: T1rho could be used in early diagnosis of liver fibrosis, in 
differential diagnosis of mild liver fibrosis and liver cirrhosis. Correlation 
between laboratory test results and T1rho may be caused by liver dysfunction 















B-0005 11:11  
Quantitative evaluation of liver function using coefficient of variation 
value and contrast enhancement index (CEI) on gadoxetic acid-enhanced 
MR imaging in preoperative evaluation  
S.W. Kim, H. Ryu, Y.R. Kim, Y.H. Lee, K.-H. Yoon; Iksan/KR  
Purpose: The aim of this study was to evaluate whether coefficient of variation 
value and contrast enhancement index of gadoxetic acid-enhanced MR 
imaging can be used for preoperative evaluation of liver function and diagnosis 
of cirrhosis. 
Methods and Materials: From July 2011 to January 2017, we included 22 
patients who underwent various hepatic resections due to hepatic tumours. 
Gadoxetic acid-enhanced 3T MR imaging was performed before hepatic 
resection within 2 weeks. Heterogeneity and degree of liver parenchymal 
enhancement on MR imaging were analysed by measuring coefficient of 
variation (CV) value and contrast enhancement index (CEI). Relationship 
between these parameters and laboratory findings for liver function such as 
indocyanine green (ICG) R15 test and prothrombin time (INR) were evaluated. 
Results: Among the 22 patients included in our study, 13 patients were proven 
presence of liver cirrhosis and 9 patients were proven absence of liver cirrhosis 
on histopathologic examination. CV value was linearly correlated with ICG R15 
test (p=0.018) and PT INR (p=0.015). Also CV value was significantly higher in 
cirrhosis group than normal liver parenchyma group (3.9±0.73 vs 6.18±2.03, 
p=0.004). On the contrary, CEI was not correlated with laboratory findings 
(p=0.143, p=0.816) and was not significantly different between pathologic 
proven cirrhosis and normal liver parenchymal group (1.68±0.24 vs 1.74±0.29, 
p=0.616). 
Conclusion: CV value on gadoxetic acid-enhanced MR Imaging showed well 
correlated with laboratory tests for liver function and presence of cirrhosis. So, 
quantitative evaluation of liver function using CV value on MR imaging can be 
used in preoperative evaluation for hepatic surgery.  
B-0006 11:19  
Liver volumetry: a useful tool to predict functional improvement after 
antiviral treatment in cirrhotic chronic hepatitis C patients  
T. Di Maira, A. Torregrosa Andres, V. Navarro Aguilar, D. Sánchez Mateos, 
V. Fornes, M. Berenguer Haym; Valencia/ES (asunsuso@gmail.com)  
Purpose: To asses if liver volume measured by CT-MR is a predictor of liver 
function in patients with sustained viral response (SVR). 
Methods and Materials: Consecutive cirrhotic HVC patients assessed for liver 
transplantation and treated with antivirals between September 2014-
September 2015 who achieved SVR were included. Pre-treatment liver volume 
adjusted by Body Surface Area (BSA) were calculated from CT-MR studies 
acquired within 360 days of the start of treatment. The liver delineation was 
performed by two radiologists. Two different semiautomatic software were used 
for volumetric quantification (one for CT and one for MR). Liver function was 
assessed by Child-Turcotte-Pugh and MELD scores collected at baseline, 12, 
24, 52 weeks and at the end of the follow-up period. Multivariate mixed 
regression model was used to identify baseline factors associated with 
improvement of liver function overtime. Follow-up period was up to December 
2016. 
Results: 42 patients were included, median age 58.6 years (Q1-Q3: 52.7-
68.8); MELD 14 (11-17); Child-Turcotte-Pugh 9 (8-10); Liver volume 1400.9 mL 
(1183.2-1601.4); BSA 1.8 m2 (1.7-2). 
MELD scores at baseline and at last control were 14 (11-17) and 10 (8-12), 
respectively (p&It;0,001); Child-Turcotte-Pugh scores were 9 (8-10) and 6 (5-
7), respectively (p&It;0,001). 
In the multivariate mixed regression model, higher liver volume adjusted by 
BSA was associated with an improvement of MELD and Child-Turcotte-Pugh 
over time 95% CI (-12.14, -0.97), p=0.028 and 95% CI (-4.67, -0.65), p=0.014, 
respectively. 
Conclusion: Liver volume adjusted by BSA is a non-invasive radiological tool 
that can predict functional improvement in cirrhotic patients undergoing 
antiviral treatment.  
Author Disclosures: 
  T. Di Maira: Grant Recipient; Rio Hortega Research Grant n.15/00133, 
supported by Instituto Carlos III.  
B-0007 11:27  
GD-EOB-DTPA-enhanced MRI T1 relaxometry as an imaging-based liver 
function test compared with 13C-methacetin LiMAx test  
D. Theilig1, P. Raabe1, L. Lüdemann2, J. Pratschke1, B. Hamm1, T. Denecke1, 
D. Geisel1; 1Berlin/DE, 2Essen/DE (dorothea.theilig@charite.de)  
Purpose: To compare gadolinium ethoxybenzyl diethylenetriaminepentaacetic 
acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) as an 
imaging-based liver function test with the 13C-methacetin LiMAx (maximum 
liver function capacity) test. 
Methods and Materials: Fifty-three patients who underwent both Gd-EOB-
DTPA-enhanced MRI T1 relaxometry before and 20 min after intravenous (IV) 
Gd-EOB-DTPA administration at our institution as well as a 13C-methacetin 
LiMAx test within 30 days of the MRI examination were retrospectively 
analysed. In these patients, T1 relaxation times of liver parenchyma, total liver 
volume and hepatic tumour volume were determined. Patients' laboratory 
parameters including bilirubin were retrieved from routine laboratory tests. 
Pearson correlations, multiple linear regression analysis, and receiver-
operating characteristic (ROC) curve analysis were performed with indices 
derived from T1 relaxometry, liver volumetry, and laboratory parameters to 
identify the best predictor of global liver function as determined by the LiMAx 
test. 
Results: Relaxometry-derived indices, i.e. T1 reduction rate (T1 RR), T1 RR x 
total liver volume (TLV), T1 RR x functional liver volume (FLV), and T1 
relaxation time 20 minutes after IV Gd-EOB administration (T1 post) showed a 
statistically significant correlation with LiMAx and a statistically significant 
discriminatory capacity between patients with LiMAx of > and < 315 µg/kg/h. Of 
the indices investigated, T1 RR showed the best discriminatory capacity and 
proved to be the only statistically significant parameter in multiple linear 
regression analysis. 
Conclusion: The T1 reduction rate (T1 RR) of the liver on Gd-EOB-DTPA-
enhanced MRI allows prediction of liver function as determined by the LiMAx 
test.  
Author Disclosures: 
  D. Theilig: Author; Dr. Theilig is participant in the Charité Junior Clinical 
Scientist Program funded by Charité - Universitätsmedizin Berlin and the Berlin 
Institute of Health. B. Hamm: Author; Prof. Hamm has received travel support 
and honoraria from Bayer AG. T. Denecke: Author; Dr. Denecke has received 
travel support and honoraria from Bayer AG. D. Geisel: Author; Dr. Geiesel 
has received travel support and honoraria from Bayer AG.. 
B-0008 11:35  
Comparison of two liver specific contrast agents in patients with different 
degrees of liver cirrhosis  
C. Khouri Chalouhi1, F. Vernuccio2, B. Tuscano1, P. Duca1, G. Brancatelli2, 
A. Vanzulli1; 1Milan/IT, 2Palermo/IT  
Purpose: Compare the performance of gadobenate dimeglumine (Gd-BOPTA) 
and gadoxetic acid (Gd-EOB-DTPA) in giving an useful hepatobiliary phase 
(HBP) in cirrhotic patients with different degrees of liver dysfunction expressed 
by Model-of-End-Stage-Liver-Disease (MELD) score. 
Methods and Materials: We reviewed a total of 258 liver MRI of 258 cirrhotic 
patients: 131 Gd-BOPTA-enhanced MRI (BOPTA-group) and 127 Gd-EOB-
DTPA-enhanced MRI (EOB-group). For each MRI we calculated the contrast 
enhancement index (CEI) of liver parenchyma. We correlated the MELD score 
and the CEI in both the groups (multiple linear regression analysis). We made 
a qualitative analysis of HBP as adequate/inadequate for both the groups and 
we investigated the difference between the two contrast agents adjusting for 
MELD score (logistic regression analysis). 
Results: In both the groups there was significant reverse correlation between 
MELD score and the CEI (r=-0.013). At the same MELD score value the CEI in 
EOB-group is increased by 0.23 (p<0.001) more than the BOPTA-group. 
Regarding the qualitative analysis at the same value of MELD score the mean 
odds ratio to have an adequate HBP was 3.64 (p<0.001) in the EOB-group 
compared to BOPTA-group, the adequacy of HBP is increasing in favour of 
Gd-EOB-DTPA at the increase of MELD score (exp(b)interaction= 
1.233;p=0.011). 
Conclusion: The HBP is negatively affected by the severity of cirrhosis for 
both the contrast agents. At the same MELD score value parenchymal 
enhancement in HBP is higher for Gd-EOB-DTPA. In cirrhotic patients the use 
of Gd-EOB-DTPA is preferable to have an adequate HBP, especially in 
patients with advanced disease.  
B-0009 11:43  
Correlation between Gd-EOB-DTPA-enhanced MRI and T1rho in patients 
with and without liver cirrhosis  
J.D. Stief1, L. Lüdemann2, T. Denecke1, B. Hamm1, D. Geisel1; 1Berlin/DE, 
2
Essen/DE (jonas.stief@gmail.com)  
Purpose: The aim of this study is to find out whether there is a correlation 
between the functional parameter of the relative enhancement (RE) using Gd-
EOB-DTPA-enhanced MRI and the fibrosis parameter using T1rho-mapping. In 
addition, it will be investigated which of the parameters is better able to 
distinguish between liver cirrhosis and the healthy liver. 
Methods and Materials: A retrospective analysis was performed in patients 
(n=124) who received both Gd-EOB-DTPA-enhanced MRI and the T1rho-
sequence. MRI was performed at 1.5 Tesla. RE was calculated for the entire 
liver. A T1rho-sequence with acquisition of 6 spin lock times (TSLs: 0, 10, 30, 
40, 60 msec) and spin-lock frequency of 500 Hz was applied. T1rho-maps 
were created. T1rho value was calculated on two different levels with 3 ROIs 
each. 
  






Results: There was a significant correlation between RE and T1rho time 
(p=0.013). The correlation coefficient according to pearson was R = -0.22. In 
the ROC analysis for differentiation between liver cirrhosis and normal liver, an 
AUC for RE of 0.755 and an AUC for T1rho of 0.717 were found. The cut-off 
value for RE is 0.645 and for T1rho 50.29 (sensitivity 74.0% and specificity 
74.3%, respectively, 74.0% and 67.6%). 
Conclusion: The MRI liver fibrosis parameter T1rho and the MRI liver function 
parameter RE of Gd-EOB-DTPA show a weak but significant correlation. Both 
parameters are able to distinguish between cirrhosis and normal liver 
parenchyma.  
Author Disclosures: 
  T. Denecke: Speaker; Speaker fee from Bayer AG and Siemens AG. 
B. Hamm: Investigator; Elbit Imaging Ltd. Research/Grant Support; Electric 
Company, Toshiba Medical Services Corporation, Koninklijke Philips NV, 
Siemens AG, General Electric Company,Elbit Imaging Ltd, Bayer AG, Guerbet 
SA, Bracco Group, Braun Melsungen, KRAUTH medi. Shareholder; Toshiba 
Medical Services Corporation,. Speaker; Speaker fee from Bayer AG and 
Siemens AG. D. Geisel: Speaker; Speaker fee from Bayer AG and Siemens 
AG. 
B-0010 11:51  
Perfusion quantification and hepatic function with Gd-EOB-DTPA: 
hepatic fibrosis and hepatocellular transport  
S. Schmidt Kobbe1, J.-L. Daire2, A. Sciarra1, B. Leporq3, B. Van Beers2, 
C. Sempoux1, C. Pastor4; 1Lausanne/CH, 2Clichy/FR, 3Villeurbanne/FR, 
4
Geneva/CH (sabine.schmidt@chuv.ch)  
Purpose: To evaluate the hepatocellular expression of the biliary transporters 
responsible for the uptake of hepatospecific contrast medium Gd-EOB-DTPA 
in patients with different stages of liver fibrosis undergoing dynamic 
gadoxetate-enhanced MRI. 
Methods and Materials: We prospectively included 50 patients with suspected 
chronic liver disease that underwent dynamic gadoxetate-enhanced MRI and 
liver biopsy. After pharmacokinetic modelling we extracted the following MR-
parameters: arterial and portal perfusion, Gd-EOB-DTPA hepatocytic uptake 
rate, biliary efflux, sinusoidal back flux (ml/min/100g for all), and the 
extracellular volume (%). Histologically, two pathologists classified fibrosis 
according to METAVIR and assessed the collagen proportionate area (CPA) 
with automated imaging analysis. The expression of the biliary transporters 
OATP2/8, MRP2 and MRP3 was investigated by immunohistochemistry and 
semiquantitatively scored according to the distribution within the lobule. 
Results: The final cohort included 42 patients (32 men) with different stages of 
fibrosis (F0=5/F1=8/F2=11/F3=10/F4=8). Pharmacokinetic modelling was able 
to distinguish the different stages of fibrosis and correlated with CPA (p<0.01). 
At MRI, increasing fibrosis was associated with a progressive change from 
portal to arterial perfusion, a decrease in hepatocytic Gd-EOB-DTAP uptake 
rate, biliary efflux, sinusoidal back flux, and increased extracellular volume 
(p<0.05). At immunohistochemistry, increasing fibrosis was associated with 
more diffuse expression of OATP2/8 and MRP3 to the whole lobule and 
progressively irregular MRP2 expression (p<0.05). 
Conclusion: At advanced stages of liver fibrosis, the decrease in Gd-EOP-
DTPA hepatocytic uptake could reflect either lower interstitial bioavailability of 
the contrast agent or altered transporter functions. The modified 
immunohistochemical expression of the transporters could mean adaptive 
response to progressive intracellular cholestasis.  
Author Disclosures: 
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B-0011 10:39  
Optimisation of MRI screening in hereditary pancreatic adenocarcinoma  
B. Boekestijn, M. Wasser; Leiden/NL (B.Boekestijn@lumc.nl)  
Purpose: In CDKN2A/p16-mutation carriers with a 15-20% lifetime risk of 
developing pancreatic ductal adenocarcinoma (PDAC), annual surveillance 
using MRI has shown to successfully detect PDAC in an early stage, resulting 
in increased resectability and survival. In a retrospective study we assessed 
the value of different MRI-techniques in early detection of PDAC. 
Methods and Materials: The MRI protocol consisted of axial and coronal T2 
TSE, T1 dynamic contrast enhanced GRE with fat suppression and combined 
2D/3D MRCP. In 2012 T1-weighted turbo field echo (TFE) was added to the 
protocol, followed by DWI in 2015. Three readers independently analysed the 
different MRI sequences of subjects with a proven PDAC for presence and 
location of the tumours. 
Results: Since 2000, 18 pancreatic cancers were found in 205 screened 
subjects (9%). In 4 cases a tumour was detected at the first MRI. In 14 patients 
previous examinations were available for comparison. In 9 of these patients 
pancreatic abnormalities were retrospectively visible on previous examinations. 
T1 TFE was positive in 12 out of 13 cases when the sequence was available, 
DWI was positive in 6 of 8, T1 DCE in 18 of 22 and T2 in 15 of 22. In two 
patients a lesion was detected only on T1 TFE by all readers and not on other 
sequences. 
Conclusion: Annual MRI surveillance in asymptomatic individuals at high risk 
of developing PDAC results in detection of tumours in a potentially resectable 
stage. T1 TFE especially seems to be a promising sequence for detection of 
pancreatic lesions.  
B-0012 10:47  
CT volumetry of the pancreas: gland size in a normal population and its 
relation to age, gender and body composition  
J. Frøkjær, J. Kipp, E. Mark, A. Drewes, S. Olesen; Aalborg/DK (jebf@rn.dk)  
Purpose: The pancreas volume is affected by different diseases, such as 
chronic pancreatitis, and is also known to be related to age and gender. To 
distinguish between normal and pathological pancreas volume, the aims were 
to establish a normal reference material of pancreatic size based on CT, and to 
explore the influence of age, gender and body composition. 
Methods and Materials: 240 trauma patients, 20 in each gender and decade 
(20-80 years) group, were evaluated. 221 CT scans without pancreatic 
pathology were analysed: semiautomatic Hounsfield unit based segmentation 
of pancreas volume, 7 different two-point pancreatic measurements, and a 
calculated volume (formula with 6 two-point measurements). Body composition 
with cross-sectional area (CSA) of visceral and subcutaneous fat at L4 level, 
and body size as L1 vertebral dimensions (height, width, depth) were 
measured. 
Results: Segmented pancreas volume was higher for men (84.1±22.6cm3) 
than for women (72.4±19.7cm3, P<0.001), with correlation to both the 
calculated volume (r=0.73, P<0.001) and all the two-point measurements (two 
best: transverse-head: r=0.50, P<0.001; AP-head: r=0.48, P<0.001). In a 
multivariate regression model only age, L1 width and CSA of visceral fat (all 
P<0.001) were explaining the volume, whereas gender was without influence 
(P=0.42). 
Conclusion: A gender- and age-specific normal reference material of 
pancreas volume was established. Several two-point measurement-based 
parameters are well correlated to pancreas volume. Pancreas volume 
decrease with age, but body size and visceral fat, which could be the true 
explanation behind the gender difference, should be taken into consideration 












B-0013 10:55  
Quantitative MRI of the pancreas: a feasibility study  
N. Vietti Violi1, T. Hilbert1, J. Bastiaansen1, J.-B. Ledoux1, A. Stemmer2, 
A. Stemmer2, R. Meuli1, T. Kober1, S. Schmidt Kobbe1; 1Lausanne/CH, 
2
Erlangen/DE (sabine.schmidt@chuv.ch)  
Purpose: To show the feasibility of quantitative T2 assessment in the 
pancreas. 
Methods and Materials: T2 mapping of the pancreas was performed using an 
accelerated multi-echo-spin-echo prototype sequence with respiratory trigger 
on 10 healthy volunteers. The experiment was repeated with repositioning to 
study intra-subject variability. Quantitative maps were reconstructed by 
employing a combination of generalised auto-calibrating partially parallel 
acquisition (GRAPPA) and model-based accelerated relaxometry by iterative 
non-linear inversion (MARTINI), dubbed “GRAPPATINI”. Two radiologists 
independently delineated 3 regions of interest inside the head, body and tail of 
pancreas in each acquisition to measure mean T2 and standard deviation 
(SD). Inter- and intra-subject comparisons were conducted to estimate the 
range of normal pancreatic T2 values. Robustness of the method was 
assessed by evaluating the variation between scan and rescan measurements. 
In addition, T2 values of each liver lobe were measured to compare the 
obtained T2 value to existing literature. 
Results: The respiratory-triggered accelerated T2-mapping GRAPPATINI 
sequence was successfully performed on all subjects with a mean acquisition 
time of 2:48±0:43min. T2 values were similar across all subjects (inter-subject) 
with low SD (head: 52.8±2.8ms, body: 52.8±4.9ms, tail: 55±3.3ms). An intra-
subject comparison showed low variability between the different acquisitions 
(SD<3.7ms). The measured hepatic T2 values (right lobe: 50.6±4.1ms, left 
lobe: 50.4±4.1ms) showed good agreement with reported in the literature 
(51±5.4ms). 
Conclusion: The feasibility of free-breathing quantitative T2 measurements 
with GRAPPATINI at 3T in moving abdominal organs was demonstrated in the 
example of the pancreas. Furthermore, the obtained T2 values of healthy 
volunteers exhibited good reproducibility and showed low SD between healthy 
subjects.  
Author Disclosures: 
 A. Stemmer: Employee; Siemens Healthcare GmbH.  T. Kober: Employee; 
Siemens Healthcare GmbH. 
B-0014 11:03  
Is MRCP necessary to diagnose pancreas divisum?  
N. Bogveradze1,2, P. Mayer2, M. Klauss2, K. Lashkhi1, H.-U. Kauczor2, 
T.F. Weber2; 1Tbilisi/GE, 2Heidelberg/DE (bogveradze.nino@gmail.com)  
Purpose: To compare the performance of magnetic resonance 
cholangiopancreaticography (MRCP) with non-MRCP T2-weighted magnetic 
resonance imaging (MRI) sequences for diagnosis of pancreas divisum (PD). 
Methods and Materials: Retrospective study of 342 consecutive patients with 
abdominal MRI including MRCP. MRCP was a coronal respiration navigated 
T2-weighted sequence with 1.6mm slice thickness. Non-MRCP T2-weighted 
sequences were (1) a coronal inversion recovery sequence (TIRM) with 6mm 
slice thickness and (2) a transverse single shot turbo spin echo sequence 
(HASTE) with 4mm slice thickness. For MRCP, TIRM, and HASTE, presence 
of PD and assessment of image evaluability were determined in a randomized 
fashion. A consensus read by two radiologists using MRCP, non-MRCP T2-
weighted sequences, and other available imaging served as reference 
standard for diagnosis of PD. Statistical analysis included performance 
analysis of MRCP, TIRM, and HASTE and testing for non-inferiority of non-
MRCP T2-weighted sequences compared with MRCP. 
Results: 33 of 342 patients (9.7%) were diagnosed with PD in the reference 
standard read. Sensitivity/specificity of MRCP for detecting PD was 
81.2%/69.7% (p<0.001). Sensitivity/specificity of TIRM and HASTE was 
92.5%/93.9% and 98.1%/97.0%, respectively (p<0.001 each). Grouped 
sensitivity/specificity of non-MRCP T2-weighted sequences was 99.8%/91.0%. 
Non-MRCP T2-weighted sequences were non-inferior to MRCP alone for 
diagnosis of PD. 20,2%, 7,3%, and 2,3% of MRCP, TIRM, and HASTE, 
respectively, were not evaluable due to motion artifacts or insufficient duct 
depiction. 
Conclusion: Non-MRCP T2-weighted MRI sequences have high performance 
for diagnosis of PD and are non-inferior to MRCP alone. MRCP may not be 
necessary for diagnosis of PD.  
B-0015 11:11  
Predicting the relapse of acute pancreatitis based on radiomics signature 
of contrast-enhanced computed tomography  
Y. Chen, X. Zhang; Nanchong/CN (shaoer.cy@gmail.com)  
Purpose: To predict the relapse of acute pancreatitis (AP) by analysing first-
time AP based on radiomics signature of contrast-enhanced computed 
tomography (CECT). 
Methods and Materials: The radiomics signature was modeled by a primary 
cohort consisting of 271 first-time AP patients from January 2010 to June 2015, 
among whom 124 patients endured recurrent attacks afterwards. Clinical data 
were gathered from medical records of three tertiary referral centers. The 
performance of radiomics signature was assessed by an independent cohort 
containing 118 first-time AP patients including 57 recurrent patients. We 
adopted resampling as the preprocessing method before 740 radiomic features 
were extracted from CECT. Repeatability of the radiomic features was 
evaluated by test-retest reliability. The radiomics signature was performed by 
logistic regression after dimensionality reduction and feature selection by lasso 
regression. Decision curve was used to evaluate the performance of radiomics 
signature, clinical risk factors and the combination of the both. 
Results: There were 23 radiomic features remaining after test-retest reliability 
and lasso regression. The accuracy of radiomics signature to predict the 
relapse of AP was 83.0%. The AUC of radiomics signature of the validation 
group was remarkably higher than clinical risk factors (0.909 vs. 0.688, p < 
0.001). Decision curve showed the performance of radiomics signature was 
better than clinical risk factors, and was similar to the combination of both. 
Conclusion: Radiomics signature based on CECT performed well to predict 
the relapse of AP. As a quantitative method, radiomics shows a promising 
future for recurrent patients to potential precaution.  
B-0016 11:19  
Use of CT texture analysis as a predictive biomarker of response to 
neoadjuvant FOLFIRINOX chemotherapy and chemoRT in pancreatic 
ductal adenocarcinoma  
K.S. Burk, M. Patino, R. Canellas, M.J. Patel, D.V. Sahani; Boston, MA/US 
(ksburk@partners.org)  
Purpose: To investigate the role of CT texture analysis (CTTA) in assessing 
histologic response of pancreatic ductal adenocarcinoma (PDAC) to 
neoadjuvant FOLFIRINOX (folinic acid, 5-FU, irinotecan, oxaliplatin) 
chemotherapy +/- radiation. 
Methods and Materials: In this IRB-approved retrospective study, 39 patients 
with PDAC treated with neoadjuvant FOLFIRINOX chemotherapy +/- radiation 
(neoadj) were identified. Post-neoadj CT exams were analysed using the 
CTTA TexRAD Ltd software. Unfiltered and filtered images were evaluated and 
heterogeneity was quantified using histogram-based texture parameters: 
mean, standard deviation (SD), mean positive pixels (MPP), skewness, 
kurtosis, and entropy. Histologic response was collected from surgical 
resection pathology reports: response = CAP grade 0-1, no response = CAP 
grade 2-3. Logistic regression analysis was used to assess for correlation 
between CTTA features and histologic response. 
Results: 17 patients (average age 61.9 yrs) achieved histologic response after 
neoadjuvant treatment, while 22 (average age 59.4 yrs) did not. Analysis of 
unfiltered images showed that mean (1.05, p=0.035) and MPP (1.052, 
p=0.039) correlated with histologic response to treatment. Analysis using five 
spatial scale filters (SSF) showed a significant correlation between entropy and 
histologic response, which persisted across all filters: SSF2 7.84, p=0.042; 
SSF3 8.19, p=0.035; SSF4 8.82, p=0.037; SSF5 9.40, p=0.035; SSF6 8.45, 
p=0.034. There was no correlation between histologic response and mean, SD, 
MPP, skewness, or kurtosis using any of the filters. 
Conclusion: CTTA, particularly entropy, can be used as a predictive 
biomarker in PDAC to differentiate patients who achieved histologic response 
to neoadjuvant FOLFIRINOX chemo +/- radiation from those who did not.  
B-0017 11:27  
Intravoxel incoherent motion diffusion-weighted MR imaging of solid 
pancreatic masses: reproducibility and usefulness for characterisation  
R. De Robertis1, N. Cardobi1, P. Martini Tinazzi1, R. Grimm2, A. Stemmer2, 
M. Zanirato3, G. Tortora4, M. D'Onofrio4; 1Peschiera del Garda/IT, 
2
Erlangen/DE, 3Milan/IT, 4Verona/IT (riccardo.derobertis@hotmail.it)  
Purpose: To evaluate measurement reproducibility and diagnostic potential of 
apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM)-
derived parameters of solid pancreatic masses including ductal 
adenocarcinoma (PDAC), neuroendocrine neoplasm (panNEN), mass-forming 
pancreatitis (MFP), and normal pancreas. 
Methods and Materials: 48 patients with pathologically confirmed pancreatic 
tumours (31 PDACs, 17 panNENs), 4 patients with mass-forming pancreatitis 
(MFP), and 30 subjects with a normal pancreas were included in this study. All 
patients underwent 1.5-T MR imaging, including IVIM diffusion-weighted 
imaging with 11 b values (from 0 to 800 sec/mm2). ADC, true diffusion (D), 
pseudodiffusion (D*), and perfusion fraction (f) were calculated by placing 
regions of interest (ROIs) within each lesion and normal pancreas. 
Intraobserver reliability of the measurements was assessed using the 
intraclass correlation coefficient (ICC). Kruskal-Wallis H test with pairwise 
comparisons using Dunn’s procedure with a Bonferroni adjustment was used 
for comparison. The diagnostic performance was evaluated using receiver 
operating characteristic (ROC) analysis. 
  






Results: Intraobserver agreement was excellent (ICC= .996, .991, .995, .993, 
and .981 for ROI size, ADC, f, D and D*, respectively). D* and f values of 
PADCs were significantly lower than those of normal pancreas and panNENs 
(P< .05). For differentiation of PDACs from panNENs, perfusion-related 
parameters (f and D*) had the highest AUC (.981 and .829) in ROC analysis. 
No significant differences were found between ADC- and IVIM-derived 
parameters of MFP and PDACs. 
Conclusion: The measurement of ADC- and IVIM-related parameters has 
excellent reproducibility. Perfusion-related parameters could be helpful in 
distinguishing PDACs from panNENs.  
Author Disclosures: 
 R. Grimm: Employee; Siemens Healthcare. A. Stemmer: Employee; Siemens 
Healthcare. M. Zanirato: Employee; Siemens Healthcare. 
B-0018 11:35  
MRI follow-up of IPMN: can we limit the use of gadolinium 
administration?  
L. Bertuzzo, G. Zamboni, R. Pozzi Mucelli; Verona/IT  
Purpose: To assess the feasibility of using a non-Gadolinium enhanced MRI 
protocol to follow-up patients with intraductal papillary mucinous neoplasia 
(IPMN). 
Methods and Materials: In this retrospective study, we evaluated 138 patients 
(48M, 90F, average age 64.5 years) with an initial diagnosis of IPMN without 
malignant features (128 branch-duct IPMN, 10 combined IPMN) who 
underwent at least two consecutive MRI/MRCP with Gadolinium in our centre 
(average follow-up 12.04 months). For each patient one reader evaluated, in 
separate sessions, in the non-contrast and post-contrast scans: cyst size, 
walls/septa thickening, mural nodules, dilation of the main pancreatic duct 
(MPD) and contrast enhancement. 
Results: We detected 376 cysts with a mean size of 10.9mm (5-29mm). 
Patients had a median of 2 cysts each (range 1-20; mean 2.7). The MPD was 
dilated in 22 patients, with a mean caliber of 4.9mm (4-9mm). At the first 
examination available, in the non-contrast scans 356 (94.7%) lesions did not 
show suspicious signs. We detected walls/septa thickening in 4 cysts and 
endoluminal defects in 16: 15 were classified as debris in relation to their 
dependent position, 1 as mural nodule. After contrast administration, none of 
these showed enhancement. At the next follow-up MRI, in the non-contrast 
scans 360 (95.7%) lesions did not show any changes, 11 (3%) showed a slight 
increase in size and 5 (1.3%) showed signs of progression. This was confirmed 
in the post-contrast scans. 
Conclusion: At follow-up, non-contrast MRI would have been enough to 
exclude signs of malignancy in 96.4% patients (98.7% cysts).  
B-0019 11:43  
Multiparametric PET/MR imaging biomarkers are associated with overall 
survival in patients with pancreatic cancer  
B.-B. Chen, T.T. Shih, Y.-W. Tien, M.-C. Chang, M.-F. Cheng; Taipei/TW 
(bangbin@gmail.com)  
Purpose: To correlate the overall survival (OS) with the imaging biomarkers of 
dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), 
diffusion-weighted imaging (DWI), magnetic resonance spectroscopy, and 
glucose metabolic activity derived from integrated positron emission 
tomography (PET)/MRI in patients with pancreatic cancer. 
Methods and Materials: This prospective study was approved by the 
institutional review board and informed consent was obtained from all 
participants. Sixty-three consecutive patients (mean age, 62.7±12 y; 
men/women, 40/23) with pancreatic cancer underwent PET/MRI before 
treatment. The imaging biomarkers were comprised of DCE-MRI parameters 
(peak, IAUC60, K
trans, kep, ve), the minimal apparent diffusion coefficient 
(ADCmin), choline level, standard uptake values, metabolic tumour volume, and 
total lesion glycolysis (TLG) of the tumours. The relationships between these 
imaging biomarkers with OS were evaluated with the Kaplan-Meier and Cox 
proportional hazard models. 
Results: Seventeen (27%) patients received curative surgery, with the median 
follow-up duration being 638 days. Univariate analysis showed that patients at 
a low TNM stage (3, P=0.041), high peak (P=0.006), high ADCmin (P=0.002) 
and low TLG (P=0.01) had better OS. Moreover, high TLG/peak ratio was 
associated with poor OS (P=0.016). Multivariate analysis indicated that ADCmin 
(P=0.011) and TLG/peak ratio (P=0.006) were independent predictors of OS 
after adjustment for age, gender, tumour size, and TNM stage. The TLG/peak 
ratio was an independent predictor of OS in a subgroup of patient who did not 
receive curative surgery (P=0.013). 
Conclusion: The flow-metabolism mismatch reflected by the TLG/peak ratio 
may better predict OS than other imaging biomarkers from PET/MRI in 
pancreatic cancer patients.  
 
 
B-0020 11:51  
Tumour heterogeneity of pancreas head cancer assessed by CT texture 
analysis: association with survival outcomes after curative resection  
G. Yun1, Y. Kim2, Y. Lee1; 1Seongnam-si/KR, 2Gyeonggi-do/KR 
(gabinyun@gmail.com)  
Purpose: To evaluate the association of texture features of CT images with 
survival outcomes in patients with pancreas head cancer. 
Methods and Materials: From January 2006 to December 2014, 88 patients 
with pancreas head cancer who underwent preoperative CT and curative 
resection were included. CT texture features (average, standard deviation, 
kurtosis, skewness, angular second moment, contrast, correlation and entropy) 
were obtained without filtration and with various filter values (fine, medium and 
coarse). After dichotomizing patients into recurred and non-recurred groups, 
clinical, pathological and texture features were compared. Based on the 
optimal cutoff values from ROC analysis, univariate Kaplan-Meier method and 
multivariate Cox regression analysis were used for the prediction of disease-
free survival (DFS). 
Results: The presence of nodal metastasis, texture features of average, 
contrast, correlation, and standard deviation without filtration and with fine and 
medium filter values, and average, contrast with coarse filter value showed the 
significant difference between recurred (n=70, 79.5%) and non-recurred group 
(n=18, 20.5%). In Kaplan Meier analysis, average in all filter values, contrast, 
correlation, and standard deviation without filtration and with fine and medium 
filter values showed poorer DFS. In Cox regression analysis, lower average 
values with homogeneous texture features (lower standard deviation and 
contrast, and higher correlation) were associated with poorer DFS. 
Conclusion: In conclusion, CT texture features of lower average and standard 
deviation values are associated with poorer outcome after curative resection in 
pancreas head cancer. Texture features from pre-operative CT may serve as 
an independent prognostic marker in such patients.  
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B-0021 10:30  
Contrast volume reduction for aortic CT angiography using a volume 
calculator and a spiral flow device: a prospective randomised study  
D. Raymakers, W. Coudyzer, S.A. Cornelissen, G. Maleux; Leuven/BE 
(dominic.raymakers@uzleuven.be)  
Purpose: To assess a method for reducing iodised contrast volume in aortic 
computed tomography angiography (CTA) using a contrast volume calculator 
and a spiral flow device. 
Methods and Materials: Sixty patients undergoing aortic CTA were randomly 
assigned to four groups. Group 1 received a patient-specific calculated 
contrast volume based on weight, length and heart rate; group 2 a 20% 
dilution; and groups 3 and 4 a 50% dilution of the calculated volumes. A spiral 
flow device was used to mix contrast agent and saline. The first three groups 
were scanned on a Siemens Somatom Flash and group 4 on a Somatom 
Force with improved tube voltage modulation. Aortic contrast density was 
measured and image quality was evaluated using visual grading analysis 
(VGA). 
Results: Mean contrast volumes for groups 1 to 4 were, respectively, 93, 78, 
52 and 44 ml. The mean tube voltage was 27% lower in group 4 compared to 
the other groups (P < 0,0001). Contrast densities between groups 1, 2 and 4 
were not significantly different (P > 0.05). The mean density in group 3 was 
42% lower than that in group 1 (P < 0.001) and 31% lower than in group 2 (P < 
0.01). The mean density in group 4 was 52% higher than that in group 3 (P < 
0.001). The VGA score for group 3 was significantly lower than that for the 
other groups. 
Conclusion: Low patient tailored contrast volumes can yield good image 
quality in aortic CTA using scan protocols combining contrast dilution up to 
















B-0022 10:38  
Non-contrast MR angiography for aortic monitoring in Marfan patients 
after aortic root surgery  
S. Veldhoen1, C. Behzadi2, A. Lenz2, F. Henes2, M. Rybczinsky2, 
Y. von Kodolitsch2, T.A. Bley1, G. Adam2, P. Bannas2; 1Würzburg/DE, 
2
Hamburg/DE (veldhoen_s@ukw.de)  
Purpose: Contrast-enhanced magnetic resonance angiography (CE-MRA) is 
the established imaging modality for patients with Marfan syndrome (MFS) 
requiring annual imaging before and after aortic root replacement. Contrast-
free MRA techniques have not been evaluated in the postoperative setup. 
Purpose of the study was to assess the feasibility of non-contrast steady-state 
free precession (SSFP) MR imaging for aortic monitoring of postoperative MFS 
patients. 
Methods and Materials: Sixty-four adult patients after aortic root replacement 
were included. Fourteen patients (22%) had a residual aortic dissection after 
surgical treatment of type A dissection. SSFP imaging and CE-MRA were 
performed at 1.5 Tesla. Two radiologists evaluated the images regarding 
image quality, artefacts and aortic pathologies. Readers measured aortic 
diameters at defined levels. Statistics included observer agreement for image 
scoring and diameter measurements and ROC analyses for comparison of 
diagnostic performance of SSFP and CE-MRA. 
Results: Both readers observed no significant differences in image quality for 
both techniques (all p>.05). No significant differences were found regarding the 
frequency of image artefacts (all p>.05). Sensitivity and specificity for detection 
of aortic dissections was 100% for both readers and techniques. Compared to 
SSFP imaging, CE-MRA resulted in higher diameters (mean bias, 0.9 mm; 
p<.05). The inter-observer biases of diameter measurements were not 
significantly different (all p>.05), except for the distal graft anastomosis 
(p=.001). Using both techniques, the readers correctly identified a graft suture 
dehiscence with aneurysm requiring surgery. 
Conclusion: Unenhanced SSFP MR imaging allows for riskless aortic 
monitoring with high diagnostic accuracy in MFS patients after aortic root 
surgery.  
B-0023 10:46  
Two novel methods for an objective quantification of iliac artery 
tortuosity derived from CT-angiography datasets in patients prior to 
transcatheter aortic valve implantation (TAVI)  
F. Braun, T. Hadlich, H. Ruhnke, B. Jehs, C. Thilo, C. Scheurig-Muenkler, 
T.J. Kroencke, F. Schwarz; Augsburg/DE 
(franziska.braun@klinikum-augsburg.de)  
Purpose: To develop parameters for an objective quantification of iliac-artery-
tortuosity on the basis of CT-angiography datasets. 
Methods and Materials: 150 patients who had undergone wide-range CT-
angiography prior to TAVI were included. In a joint reading-session, a 
cardiologist and interventional radiologist used Volume-Rendering-Technique-
Reconstructions to assign a semiquantitative grade for iliac-artery-tortuosity on 
a 4-point Likert-scale for each side. 
As a precise measure for tortuosity('Tortuosity-Ratio'=TR), the length of the 
iliac arteries was measured on Curved-Planar-Reformations for each side and 
related to the straight distance between the start- and end-point of CPR-
segmentations. 
A second parameter('Simplified-Tortuosity-Ratio'=STR) was derived from axial 
reconstructions only by calculating the ratio between the average distance of 
the aortic bifurcation and femoral artery from a plane tangential to the iliac 
spine and the shortest distance of the iliac artery from this plane for each side. 
ANOVA statistics were applied to test for differences in TR and STR in the four 
tortuosity-grade subgroups. 
Results: The four semiquantitative tortuosity grades were assigned in 42, 174, 
48 and 36 vessels(n=300). Differences in TR and STR between the four 
subgroups were highly significant with TR's of 1.08±0.02, 1.17±0.06, 1.34±0.09 
and 1.49±0.16 and STR's of 1.27±0.08, 1.33±0.09, 1.46±0.1 and 1.54±0.13, 
respectively, for grade 1-4, all p's< 0.01. However, TR had significantly higher 
predictive value for tortuosity grade than STR. 
Conclusion: We describe two novel parameters for an objective quantification 
of iliac-artery-tortuosity which can easily be derived from CT-angiography 
datasets. We demonstrate high validity of these parameters in comparison with 










B-0024 10:54  
Image quality and radiation dose sparing of CT angiography for TAVI 
planning with low-kV, low contrast medium volume and model-based 
iterative reconstruction compared to standard CTA  
L. Riva1, D. Ippolito1, C. Talei Franzesi1, A. de Vito1, C. Maino1, C. Cangiotti1, 
A. Santalco1, S. Sironi2; 1Monza/IT, 2Bergamo/IT (lr-doc@hotmail.com)  
Purpose: To evaluate image quality and radiation dose exposure of low-kV 
setting and low contrast medium volume(CM) CTA protocol in patients 
candidates for TAVI, in comparison with standard CTA protocol. 
Methods and Materials: Eighty-nine patients, candidates for TAVI, were 
prospectively enrolled and examined with 256-MDCT (iCT elite,Philips): 46 
patients (study-group) were evaluated using 80kV retrospective ECG-gated 
protocol, with tube-current modulation and 60mL of CM volume (350mgI/mL); 
while 43patients (control-group) underwent a standard CTA retrospective ECG-
gated protocol (120kV;automated tube-current modulation;100mL of CM). 
Subjective image quality was evaluated using a 4-point-scale (4-excellent,1-
low). Vascular enhancement(HU), SNR and CNR were assessed in each 
patient with multiple regions of interest (ROIs) in lumen of aorta and iliac-
femoral axis at different levels (using the infra-scapular and psoas muscles for 
CNR). The radiation dose exposure of both groups, in terms of CTDIvol and 
DLP, was calculated and all data were compared and statistically analysed. 
Results: In low-kV protocol significantly higher(p<0.01) mean intravascular 
attenuation values were achieved in all the measurements compared to the 
standard protocol(aortic root 367.4HU vs 314HU; external-iliac arteries 
390.2HU vs 289HU). Mean DLP of study-group was significantly lower 
(524.5±243.8mGy*cm) than in control-group (2044±130mGy*cm), with an 
overall radiation dose reduction of about 74.3%, while no significant differences 
were observed in the image quality evaluation in both groups. 
Conclusion: Low-kV with low-CM volume and IMR reconstruction CTA 
protocol allows to correctly perform TAVI-planning study offering high quality 
images and significant radiation dose exposure reduction(49%), as compared 
to standard CTA protocol.  
B-0025 11:02  
Variability of MRI-derived aortic diameters in Marfan patients: 
comparison of inner vs outer vessel wall measurements  
J.M. Weinrich, M. Avanesov, F. Henes, A. Lenz, G. Adam, P. Bannas; 
Hamburg/DE (m.avanesov@uke.de)  
Purpose: To compare the reliability and validity of inner-inner and outer-outer-
edge measurements derived from non-contrast steady-state free precession 
(SSFP) MRI in Marfan patients. 
Methods and Materials: ECG-gated 2D-SSFP at 1.5 T were retrospectively 
evaluated in 40 patients with Marfan syndrome. Two readers rated the 
delineation of both inner and outer vessel walls on a three-point Likert scale 
(excellent-poor) at the sinuses of Valsalva, sinotubular junction, ascending 
aorta, aortic arch and descending aorta. Both readers independently measured 
aortic diameters by assessing both inner-inner and outer-outer edge 
measurements at all levels. Aortic root diameters acquired by 
echocardiography served as reference. Results were compared using 
Wilcoxon test, f test, t test, and Bland-Altman analysis. 
Results: Image quality and vessel wall delineation was significantly better at 
all levels for inner vessels walls than for outer vessels walls (all p<0.001). Inter- 
and intraobserver variances of aortic measurements were significantly smaller 
for inner-inner measurements at the sinuses of Valsalva, sinotubular junction 
and ascending aorta (all p<0.03). Echocardiographic measurements at the 
level of sinus of Valsalva were not significantly different from MRI-derived 
inner-inner measurements (median and interquartile range: 37 [34-40 vs. 
36(32-38) mm; p=0.14], but significantly smaller when compared to MRI-
derived outer-outer measurements [43(40-46) vs. 36(32-38) mm; p<0.001]. 
Conclusion: Non-contrast SSFP results in sharper delineation of inner vessel 
walls compared to outer vessel walls. Inner vessels wall measurements of the 
aortic root are more reliable and valid than outer vessel wall measurements. 
Therefore, we propose to monitor aortic root dimensions in Marfan patients 
using of inner-inner edge measurements in ECG-gated non-contrast MRI.  
B-0026 11:10  
Aortomitral calcification is an independent predictor of mortality in TAVR 
patients  
M.J. Willemink, E. Maret, K.J. Moneghetti, J.B. Kim, F. Haddad, Y. Kobayashi, 
K. Higashigaito, W. Fearon, D. Fleischmann; Stanford, CA/US 
(m.j.willemink@gmail.com)  
Purpose: Aortic valve calcification predicts mortality in patients with aortic 
stenosis; however, it is just one manifestation of left-sided valvular and annular 
calcification, which has been associated with systemic atherosclerosis, 
inflammation and cardiovascular events. We sought to evaluate whether the 
volume of aortomitral calcifications (AMC) as quantified by CT is an 
  






independent predictor of mortality in patients undergoing transcatheter aortic 
valve replacement (TAVR). 
Methods and Materials: 317 consecutive patients undergoing TAVR between 
October 2013 and March 2016 were included. All patients underwent pre-
procedural CT angiography. AMC-volume was quantified on non-contrast thin-
section CT images using commercially available software. Patients were 
followed for all-cause mortality. Baseline characteristics were evaluated with 
Mann-Whitney U and Chi-square tests. A multivariable prediction model was 
derived using Cox proportional hazards regression analysis. 
Results: Median follow-up time of 317 patients was 367 (interquartiles 178-
678) days. In total 63/317 (19.9%) patients died. AMC volume (P<0.001) and 
the clinically used STS score (P=0.001) were significantly different between 
survivors (N=254) and non-survivors (N=63). Age and gender showed no 
significant predictive value in the Cox analyses (P=0.159 and 0.163, 
respectively), whereas AMC volume (HR 1.06 (1.01-1.10) per cm3, P=0.019) 
and STS score>8 (HR 1.89 (1.06-3.37), P=0.032) were independently 
associated with mortality after 18 months. Area under the curve 18 months 
after TAVR was similar (P=0.910) for AMC volume (AUC=0.638 [95%CI 0.575-
0.684]) compared to STS score (AUC=0.631 [95%CI 0.582-0.691]). 
Conclusion: AMC volume measured by CT is independently associated with 
mortality in TAVR patients and may, therefore, improve risk stratification after 
TAVR.  
Author Disclosures: 
  M.J. Willemink: Grant Recipient; Niels Stensen Fellowship. Speaker; Philips 
Healthcare. 
B-0027 11:18  
Magnetic resonance assessment of thrombus remodeling after 
endovascularaortic sealing of abdominal aortic aneurysms using the 
Nellix endosystem  
N. Galea, M. Francone, S. Coco, G. Mancuso, O. Martinelli, C. Belli, 
I. Carbone, B. Gossetti, C. Catalano; Rome/IT (nicogale2000@yahoo.it)  
Purpose: Novel endovascular aortic sealing(EVAS) technique with the Nellix 
endosystem is a valid option for the treatment of infrarenal abdominal aortic 
aneurysms(AAAs).The positive pressure exerted by the endobags in 
aneurismal sac reduces endoleak rate and compacts the thrombus,however 
the impact on sac remodeling is still unclear. Our aim was to elucidate the 
changes in aneurismal sac in patients treated by EVAS for AAAs in terms of 
morphology and thrombus characteristics using MRI. 
Methods and Materials: We consecutively enrolled 10 patients EVAS 
candidates for AAA. All patients underwent MRI before,1-week and 1-year after 
treatment.Specific morphological features of AAA(diameter,proximal neck 
lenght,AAA sectional areas,sac volume,endoleak presence and lumen volume) 
and thrombus characteristics(thrombus volume and maximal thickness,T1 and 
T2 signal) were determined and compared preprocedural and at follow-up. 
Results: No early or late endoleaks were observed in all patients after EVAS.A 
significant reduction of sac and thrombus volume was observed(mean 
value:44.5mL Vs 40.9mL and 7.5mL Vs 3.5mL,respectively,p:0.01-0.23),as 
well as AAA diameter and thrombus thickness did not change significantly at 1-
year follow-up after EVAS(48.5mm vs 47.3mm, 12.4 vs 11.3mm, respectively, 
p >.05 for both).Analysis of thrombus MR signal showed a reduction of T1 and 
T2 values(mean difference:-45% and -30%,respectively,p:0.01-0.03) at the 
1year follow-up,likely reflecting tissue organizing and fibrous replacement 
phenomena. 
Conclusion: Filling the endobags inside the aneurysmal sac leads to the 
progressive reduction of thrombus volume and lowering of T1/T2 
values,probably due to thrombus organization and squeezing of fluid content 
into collateral vessels.EVAS could be associated to an acceleration of 
thrombus remodeling after AAAs treatment  
B-0028 11:26  
4D flow analysis of abnormal haemodynamics within saccular aneurysm 
in contrast to fusiform aneurysm in abdominal aorta  
M. Sugiyama1, Y. Takehara2, M. Alley3, N. Unno1, K. Katahashi1, 
T. Wakayama4, A. Nozaki4, S. Naganawa2, H. Sakahara1; 1Hamamatsu/JP, 
2
Nagoya/JP, 3Stanford, CA/US, 4Hino/JP (m-sugi@hama-med.ac.jp)  
Purpose: Most vascular surgeons believe that saccular aortic aneurysms have 
more ominous natural history than fusiform aneurysm. Majorities of 
physiological evidences indicate that the decline of wall shear stress (WSS) 
produces an expression of pro-atherogenic genes. The purpose of our study is 
to characterise the abnormal flow dynamics within the saccular aneurysm of 
the abdominal aorta as compared to the fusiform aneurysm. 
Methods and Materials: Ten patients with saccular, thirteen patients with 
fusiform abdominal aneurysm underwent 3D cine PC MR imaging (4DFlow) 
covering whole abdominal aorta. The MR imagings were conducted on a 1.5T 
or a 3.0T MR scanner with torso-array coil. Time resolved contrast-enhanced 
3D MR angiography was performed for determination of aortic boundary. The 
acquired data was post-processed with flow analysis software (flova II, R’Tech, 
Japan). Streamlines of the abdominal aorta were depicted for streamline 
analysis. The peak systolic and diastolic WSS within saccular and fusiform 
aneurysm was calculated and compared using Mann-Whitney's U-test. 
Results: The peak systolic WSS of saccular aneurysm was significantly lower 
than that of fusiform aneurysm (p=0.013). The streamline showed vortex flow 
within the saccular aneurysm which is isolated from the mainstream of the 
aorta. This trend was not observed within the fusiform aneurysm. The 
separated turbulent flow within the saccular aneurysm may be the reason for 
even lower WSS. 
Conclusion: The separated vortex flow within the saccular aneurysm and 
consequent low WSS of its wall may be reflecting the continuing risk of 
atherogenic changes of the saccular aortic aneurysm compared to fusiform 
aneurysm.  
Author Disclosures: 
 T. Wakayama: Employee; GE Healthcare Japan. A. Nozaki: Employee; GE 
Healthcare Japan. 
B-0029 11:34  
Fully automated segmentation of ascending aorta on phase-contrast 
cardiac MR images: application in healthy and aneurysmatic patients  
M. Codari1, M. Scarabello2, F. Secchi1, C. Sforza2, G. Baselli2, F. Sardanelli1; 
1
San Donato Milanese/IT, 2Milan/IT (marina.codari@grupposandonato.it)  
Purpose: To develop a fully automated method for segmenting the ascending 
aorta lumen on 2D+t phase-contrast magnetic resonance (MR) images. 
Methods and Materials: We randomly selected, out of a large population 
dataset, 25 subjects with negative cardiac MR and 9 subjects with diagnosed 
ascending aorta aneurysm. All exams were performed from September 2008 to 
October 2013. The local Ethics Committee approved this retrospective study. 
The ascending aorta was automatically identified on all cardiac cycle phases 
using a priori knowledge on aortic geometry. The frame maximising the area, 
eccentricity, and solidity parameters was chosen for unsupervised initialisation. 
Aortic segmentation was then performed on each frame using active 
contouring without edges techniques. For each frame the aortic lumen was 
segmented using the previously segmented frame as initialisation mask. The 
manual segmentation performed by a highly experienced operator was used as 
a reference standard. Dice similarity coefficient (DSC), Bland-Altman analysis 
and Pearson’s correlation coefficient were used as performance metrics. 
Results: Bland-Altman analysis on healthy subjects showed a bias of -6.68 
mm2, a coefficient of repeatability of 91.22 mm2, an average measurement of 
581.40 mm2, and a corresponding reproducibility of 85%; on aneurysmatic 
patients, -3.09 mm2, 159.64 mm2, 1741.42 mm2 , and 91%, respectively. High 
correlation coefficients as well as DSC values (mean±standard deviation) were 
recorded in both healthy (R=0.98; 94.6±2.1%) and aneurysmatic (R=0.99; 
96.4±1.9%) dataset. 
Conclusion: A fully automated and robust method for ascending aorta 
segmentation on both healthy and pathological phase-contrast MR images was 
developed. Further studies on larger samples are warranted.  
B-0030 11:42  
MR angiography in small animals using hyperpolarised water  
S. Fischer1, R. Maeder1, V. Denysenkov1, M. Terekhov2, S. Zangos1, 
T. Prisner1, T.J. Vogl1; 1Frankfurt a. Main/DE, 2Würzburg/DE 
(sebastian.fischer@kgu.de)  
Purpose: Gadolinium based contrast agents are associated with the risk of 
allergic reactions, systemic nephrogenic fibrosis and potential remnants in the 
brain. Purpose is to examine dynamic nuclear polarisation (DNP) as an 
alternative method for MR angiography. 
Methods and Materials: Liquid-state Overhauser DNP achieves 
hyperpolarisation by microwave irradiation of electron spins in TEMPOL 
radicals, which are coupled with the nuclear spins of water molecules. Our 
setup comprises a 42GHz microwave source and an 1.5T in-bore polariser, 
equipped with a multimode resonator. Continuously hyperpolarised water was 
administered with 1.2ml/min into the aorta of five C57BL/6 mice via 
catheterisation (0.15mm ID) of iliac vessels. The aorta and its branches were 
visualised with GRE-sequences (TR 110s, TE 3.8s, FoV 78x58x2mm, Matrix 
256x192px) and intravascular DNP signal intensities, SNR and CNR values 
were measured and compared to its native values. 
Results: Hyperpolarised water features high T1 signal enhancements in MR 
imaging and a short relaxation time. Maximum intravascular signal intensities 
were increased 4.3-fold from 231±47 to 994±194. Thus better SNR and CNR 
values were measured for hyperpolarised vessels with an SNR increased 5.3-
fold from 24±2 to 126±62 and CNR increased 26.3-fold from 3±2 to 79±49. 
Conclusion: The strong enhancement and its high CNR made a visualisation 
of the aorta and its branches possible in mice - even using a standard clinical 
1.5T scanner. Thus hyperpolarised water might be a promising future 
alternative to Gadolinium based contrast agents in MR angiographies without 
risking the potential adverse effects or intracorporal remnants of Gadolinium 
based contrast agents.  
Author Disclosures: 
  S. Fischer: Grant Recipient; Deutsche Forschungsgemeinschaft.  S. Zangos: 
  






Grant Recipient; Deutsche Forschungsgemeinschaft. T. Prisner: Grant 
Recipient; Deutsche Forschungsgemeinschaft. T.J. Vogl: Grant Recipient; 
Deutsche Forschungsgemeinschaft. 
B-0031 11:50  
Low-dose CT angiography for thoracicaorta: optimal combination 
between 80kV and last generation iterative reconstruction algorithm 
levels  
A.D. Annoni, A. Formenti, D. Andreini, M. Guglielmo, G. Muscogiuri, 
G. Pontone, E. Consiglio, E. Conte, M. Pepi; Milan/IT (andrea.annoni@ccfm.it)  
Purpose: To evaluate feasibility and optimization of a low dose CT protocol for 
thoracic aorta by investigating the best combination of last generation iterative 
algorithm level and use of 80 kV in comparison with 50% level suggested for 
standard 100 kV protocols. 
Methods and Materials: We enrolled 60 pts scheduled for thoracic aorta CT 
angiography (48 men) with BMI up to 37 kg/m2 (mean 26.3±4.9 kg/m2). All CT 
examinations were performed with axial ECG-gated acquisition with new 
generation wide array CT scanner using 80kV, mA modulated on patient’s BMI 
and 50 ml of contrast agent. Aortic values, noise, signal to noise and contrast 
noise - ratios were evaluated at different aortic locations for FBP images and 
for images reconstructed at different percentages of adaptive statistical 
iterative reconstruction algorithm - V (ASIR V) (20%, 40%, 50%, 60%, 80%, 
100%). All exams were evaluated for subjective image quality by two 
independent readers. 
Results: No exams were classified as not diagnostic. Overall mean aortic 
attenuation for all aortic segments was over 600 HU. The best balance 
between image quality (subjective and objective) and ASIR-V level was found 
at 60% in the overall population and at 80% in a subgroup of patients with 
BMI30 kg/m2 . The K coefficient for interobserver agreement was 0.87. Mean 
effective dose was 0.98±0.26 mSv. 
Conclusion: Scanning protocol for CTA of the thoracic aorta using wide 
detector coverage, 80 kV and ASIR-V allow good balance between dose 
reduction and image quality also in patients with high BMI.  
Author Disclosures: 
  A.D. Annoni: Speaker; GE healthcare.  D. Andreini: Speaker; GE 
healthcare.  G. Pontone: Board Member; ESCR, SCCT. Speaker; GE 
healthcare, MEDTRONIC, BRACCO.  
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B-0032 10:30  
Percutaneous treatment of postoperative benign hepaticojejunostomy 
strictures: temporary placement of covered metallic stents versus 
balloon dilation  
G. Yun, C. Yoon, N. Seong, J. Byeon, H. Lee, Y. Kim; Seongnam/KR 
(gabinyun@gmail.com)  
Purpose: To compare percutaneous temporary placement of covered metallic 
stent with balloon dilatation for the treatment of postoperative benign 
hepaticojejunostomy strictures. 
Methods and Materials: From November 2004 to August 2017, 56 patients 
with postoperative benign hepaticojejunostomy strictures underwent 
percutaneous transhepatic treatments. A covered stent designed for 
spontaneous migration after temporary indwelling was placed in 23 patients 
(stent group). Balloon dilation was performed in multiple sessions to achieve 
<30% residual stricture in 33 patients (balloon group). The technical success, 
complications, the indwelling duration of percutaneous transhepatic biliary 
drainage (PTBD), and patency rates were compared between the two groups. 
Results: The technical success was achieved in all patients of stent group and 
96.8% (32/33) of balloon group after 1-6 sessions of dilation. There was no 
major complication in both groups. All covered stents spontaneously migrated 
into jejunum and passed out through the anus 2-12 months after placement 
(median 5 months). The indwelling duration of PTBD was shorter in stent group 
(median 9 vs 33 days; p=.001). Recurrent strictures requiring re-intervention 
occurred more frequently in balloon group (51.5% vs 8.7%; p=.001). The 1- 
and 2-year primary patency rates were 95.0% and 89.1% in stent group and 
74.2% and 49.8% in balloon group, respectively (p=0.032). 
Conclusion: In patients with postoperative benign hepaticojejunostomy 
stricture, percutaneous temporary placement of a covered stent provides 
longer patency and shorter PTBD indwelling compared with balloon dilatation. 
A covered stent designed for temporary placement seems to be a feasible 
strategy to prevent stent-related complications in postoperative benign biliary 
strictures.  
B-0033 10:38  
Preliminary experience of TIPS creation using the new controlled 
expansion e-PTFE covered stent  
R. Miraglia, L. Maruzzelli, I. Petridis, G. Marrone, A. Luca; Palermo/IT 
(gmarrone@ismett.edu)  
Purpose: To prospectively evaluate short-term outcome of TIPS creation using 
the new controlled-expansion e-PTFE covered stent (CES), in adult patients 
with portal hypertension complications. 
Methods and Materials: Between 7/2016 and 9/2017, 45 consecutive patients 
received TIPS using CES. 38 /45 patients have a follow up longer than 3 
months and represent our study group. Clinical data were obtained at baseline, 
4 and 12 weeks after the TIPS. 
Results: TIPS indications were: refractory ascites (n=29), variceal bleeding 
(n=5), other (n=4). Mean age 60.5 yrs (±10.38), mean follow-up 4.0 months 
(±3.18). 16 patients had partial/subtotal portal vein thrombosis. In 37 patients 
TIPS was dilated to 8 mm of diameter with a significant reduction of the porto-
caval pressure gradient (PPG) ( 10 mmHg). In 1 patient, not reaching the 
haemodynamic target, the stent was dilated to 10 mm of diameter during the 
same session. Mean PPG pre-TIPS was 16.05 mmHg (±4.82), post-TIPS was 
6.61 mmHg (±2.79). Grade I-II encephalopathy was registered in 10 patients 
(26%). Portal vein thrombosis partially/completely resolved in 13/16 patients . 
No recurrence of bleeding episodes were registered. Disappearance of ascites 
was observed in 22 cases (75.86%). In 2 patients with ascites persistence the 
stent was dilated to 10 mm in a further procedure. 4 patients died because of 
septic episodes (not related to TIPS, 2 to 7 months after TIPS). 
Conclusion: CES for TIPS creation can be safely used in patients with severe 
portal hypertension and seems to be associated with a good short-term 
outcome.  
B-0034 10:46  
Outcomes of transjugular intrahepatic portosystemic shunt using 12-mm-
diameter stent for portal hypertension with refractory ascites  
A.M.K. Abdel Aal1,2, K. Mahmoud1, S. Kim1, B. Heeke1, S. Moawad1, 
M. Massoud1, S. Saddekni1, N. A. Aboueldahab1, A. Gunn1; 
1
Birmingham, AL/US, 2Cairo/EG (akamel@uabmc.edu)  
Purpose: The objective of this study is to evaluate the efficacy, complications 
and survival outcomes of transjugular intrahepatic portosystemic shunt (TIPS) 
creation performed using a 12-mm-diameter stents (Viatorr, Gore) in patients 
with refractory ascites. 
Methods and Materials: We retrospectively reviewed the medical records of 
187 patients who underwent TIPS from January 2004 to January 2017, using 
12-mm Viatorr stents for refractory ascites. Patients' demographics, 
comorbidities, need for paracentesis, model for end-stage liver disease 
(MELD) score, and incidence or worsening of hepatic encephalopathy (HE). 
Survival outcomes were also calculated. 
Results: The study included 115 (61.5%) males with a mean age of 57.1 years 
(SD=9.2 years). The mean Charlson comorbidity index was 3.9 (SD= 1.1). The 
mean portosystemic gradient significantly decreased from 15.79 to 4.98 after 
TIPS (p<0.0001). Ascites was resolved at 3, 6 and 12 months after TIPS in 
59.5%, 69.8% and 81.7% of the patients, respectively. Freedom from 
paracentesis was seen in 93.3% of the patients at 12 months after TIPS. Mean 
MELD score increased significantly after TIPS from 13.2 to 16.9 (p<0.0001). 
HE was seen in 6.5% and 38.2% before and 3 months after TIPS, respectively, 
with 17.5% of the patients medically uncontrolled. The overall survival at 3, 6, 
12 and 60 months was 79.2%, 73.5%, 66.3% and 46.5%, respectively. 
Conclusion: The 12-mm-diameter Viatorr stent used for TIPS in patients with 
refractory ascites appears more efficacious and without increased complication 
rate compared to published literature on the 8- and 10-mm-diameter similar 
stents.  
B-0035 10:54  
Non-invasive pressure monitoring after transjugular intrahepatic 
portosystemic shunt implantation with integrated sensors  
C. Spink1, B. John1, D. Schröder1, W. Krautschneider1, R. Fischbach2, 
M. Braunschweig2, J.-H. Buhk1, G. Adam1, A. Koops1; 1Hamburg/DE, 
2
Dresden/DE (c.spink@uke.de)  
Purpose: In vitro and ex vivo testing of a novel stent-graft with integrated 
pressure sensors capable of wireless digital data transmission for non-invasive 
pressure monitoring after TIPS. 
Methods and Materials: Ten stent-grafts for TIPS-implantation (100x10 mm) 
were designed including integrated pressure sensors at both ends within layers 
of polytetrafluorethylen (PTFE). Digital data conversion was performed by 
integrated microcontrollers within the PTFE-membrane providing energy and 
data transfer by inductive coupling. The stent-grafts were placed in a silicone 
  






liver phantom and in four explanted porcine livers via 16F applicators for 
intraluminal air pressure measurement. 
Results: First in vitro and ex vivo testing demonstrated a capable TIPS stent-
graft design with integrated sensors in a stable PTFE-covering after crimping 
and application into a liver phantom and the explanted porcine livers. In both 
setups measurements were simultaneously taken from both sensors with an 
accuracy of ±1.2 mmHg up to a distance of 10.2±0.9 cm in a liver phantom and 
a distance of 8.3±0.5 cm in the porcine livers. The minimum power input for 
successful data transfer had to be increased from 10±1 W in the liver phantom 
and to 18±2 W in the porcine livers. There was no significant difference in 
intraluminal air pressure measured at both setups (p=0.46). 
Conclusion: First in vitro and ex vivo results demonstrate a successful 
approach for non-invasive pressure monitoring after TIPS implantation using 
integrated sensors. Further in vivo tests are scheduled before the potential 
implementation into a product.  
B-0036 11:02  
Risk factors of survival after TIPS using ePTFE covered stentgrafts in 
refractory ascites  
M. Pitton, M. Moddemann, T. Zimmermann, S. Schotten, P. Galle, C. Düber; 
Mainz/DE (michael.pitton@unimedizin-mainz.de)  
Purpose: To analyse the risk factors of overall survival TIPS with ePTFE-
stentgrafts in patients with liver cirrhosis and refractory ascites. 
Methods and Materials: 213 patients with liver cirrhosis and refractory ascites 
(129 male, 84 female) were treated with ePTFE covered TIPS. Patients with 
portal vein thrombosis, acute and subacute bleeding with need for treatment, 
and Budd-Chiari-syndrome were excluded from analysis. Overall survival was 
analysed depending on 1. the baseline clinical characteristics before TIPS 
(age, sex, etiology of cirrhosis, additional diagnoses, former history of variceal 
bleeding, former endoscopic ligation (EBL), Child-Pugh-stage, number of 
paracentesis needed, history of SBP or hepatic encephalopathy (HE), 
hemodialysis, INR, Bilirubin, Albumin, Creatinin), 2. procedural complications 
during TIPS, and 3. hemodynamic outcome (portosystemic pressure gradient, 
PSG) after TIPS, and hemodialysis within 4 weeks after TIPS. 
Results: Overall survival was 49.4 +/- 4.7 months. Technical success was 
100%, with 97.2% primary sucsess rate. 3d-mortality was 0.9%, 30d-mortality 
8.0%. The reintervention rate was 26.8% (25.8% dilatation/recanalisation, 
8.9% TIPS reduction during follow-up). Significant risk factors for survival were 
age>70y, male gender, etiology (hepatits vs. alcoholic), additional diagnosis 
(cardiac diseases and others), creatinin, bilirubin >2mg/dl, Child-C-stage, and 
need for hemodialyis within 4 weeks after TIPS. Prior history of bleeding, EBL, 
SBP, HE, and hemodialysis before TIPS were not significant. Procedural 
complications, and PSG after TIPS, was also not statistically significant. 
Conclusion: Survival after TIPS depends on clinical baseline characteristics. 
Beside clinical measures of liver function and etiology of liver disease, 
independent co-factors like additional diagnoses and personal characteristics 
should be realised.  
B-0037 11:10  
VesOpen procedure: the new percutaneous image-guided treatment 
option of HCC-induced portal vein thrombosis  
M. Mizandari1,1, T. Azrumelashvili1, N. Habib2; 1Tbilisi/GE, 2London/UK 
(mgmizandari@gmail.com)  
Purpose: The novel technique of PV malignant thrombus recanalisation is 
presented. 
Methods and Materials: 18 patients underwent percutaneous endoportal RF 
treatment attempt. PV tributary is accessed under US guidance; manipulation 
by 5 Fr diameter guiding catheter is used to conduct the guidewire across the 
blocked segment and portography is performed. 15 Watts power was applied 
for 2 minutes using bipolar endoluminal RF device (Habib™ EndoHPB, 
EMcision Ltd., London, UK), placed in PV-blocked segment according the 
guidewire. The number of RF application sessions depends on tumour 
thrombus extent as shown on portography. After RF application, self-
expanding 14-mm-diameter vascular stent is positioned and PV patency 
restoration is documented by final portography. Procedure is completed by 
procedure track RF ablation and/or coil embolisation. 
Results: The procedure was completed in 13 (72.2%) cases; in 3 (16.7%) 
cases we could not conduct the wire across the thrombus; in 2 (1.1%) cases 
we failed to conduct the RF device and procedure was completed by stenting. 
Portal vein obstructed segment showed the restored blood flow in all 
completed cases as documented by postprocedure portography, follow-up 
Doppler and CT studies; this resulted in liver function improvement in 8 
(61.5%) of procedure technical success cases. Recanalised PV patency varied 
from 3 weeks to 22 months; in 4 cases patients underwent successful TACE 
procedure after PV recanalisation. 
Conclusion: PV thrombus percutaneous recanalisation by endoportal RFA 
with subsequent stenting is an effective technique and should be suggested as 
a possible treatment option for HCC patients with PVT.  
B-0038 11:18  
Percutaneous treatment of biliary lithiasis: personal experience  
S. Zanardi, A. Cappelli, C. Mosconi, M. Renzulli, F. Modestino, R. Golfieri; 
Bologna/IT (sara.zanardi10@gmail.com)  
Purpose: to determine the efficacy of percutaneous procedures to remove 
intrahepatic bile duct stones and to treat underlying biliary strictures (BSs). 
Methods and Materials: we retrospectively analysed the outcome of 91 
patients with intrahepatic lithiasis percutaneously treated. Patients were 
divided into two groups: Group A (n= 50) and Group B (n= 41), without or with 
intrahepatic stenosis respectively. We also divided patients according to the 
ethiology of the lithiasis. Stones removal was facilitated with an occlusion 
balloon after sphincteroplasty and mechanical fragmentation. 
Results: 1-year-primary patency was 76% and 51.2% [Group A and B 
respectively (p= 0.014)]; 2-year-primary patency was 72% and 39.1 [Group A 
and B respectively (p= 0.001)]. Secondary patency was 84% (Group A) and 
63.4% (Group B) (p= 0.025). We found a statistically significant difference in 
the outcome of patients with or without intrahepatic stenosis and a significantly 
lower success rate in patients with chronic diseases [Caroli's disease and 
primary sclerosing cholangitis (PSC)]. Patients with post-operative anastomotic 
strictures tend to recur in the 21.9% at 1 year and 28.1% at 2 years. 
Conclusion: percutaneous anterograde biliary stones removal and stenosis 
treatment resulted effective procedures with an high success rate and low 
complications. The procedure is a technically feasible approach when 
endoscopic stones removal failed. The presence of stenosis or underlying 
chronic diseases affect the clinical and the radiological outcome.  
B-0039 11:26  
Parenchymal blood volume (PBV) measurement using C-arm-Dyna-CT as 
a prognostic marker for the response of HCC after repetitive transarterial 
chemoembolisation (TACE)  
T.J. Vogl, K. Graef, L. Alizadeh, R. Hammerstingl, N.-E. Nour Eldin; 
Frankfurt a. Main/DE (t.vogl@em.uni-frankfurt.de)  
Purpose: To evaluate the prognostic value of intraprocedural parenchymal 
blood volume (PBV) parameters using C-arm-CT for the response in 
hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). 
Methods and Materials: 80 patients with HCC underwent at least 2 sessions 
of TACE. On average the patients had four PBV measurements in 4-6-week 
intervals. C-arm-CT scan was created with a rotation speed of 2cm. The 
images were post-processed and reconstructed at a workstation to build a PBV 
map. Then they were overlapped with MRI to measure tumour diameter and 
PBV. 
Results: Results demonstrate significant correlations between PBV alteration 
and downsizing of HCC nodules. Initial blood volume of patients was 
x=111.39ml/1000ml (SD=66.88) with an average size of HCC lesions of 
54.24mm. After first TACE, blood volume decreased on average to 
69.84ml/1000ml (SD=47.29) and lesions were reduced to 49.14 mm in 
diameter. After repeated TACE average blood volume decreased to 
73.03ml/1000ml (SD=47.82) showing a significant reduction of the lesion to 
48.85cm in diameter documented in MRI. In the course of the study a 
considerable reduction in volume (-34.44%) and diameter (-9.94%) was 
documented. In patients with initial PBV>100ml/1000ml lesions decreased 
10.27% in size and 52.78% in blood volume, in patients with a PBV of 50-
100ml/1000ml lesions decreased 6.88% in size and increased 5.70% in blood 
volume, in patients with <50ml/1000ml lesions decreased 8.48% in size and 
increased 57.54% in blood volume. 
Conclusion: PBV measurements can determine TACE effectiveness as 
patients with high initial PBV respond better to TACE regarding diameter and 
volume reduction.  
B-0040 11:34  
Image-guided percutaneous drainage of pancreatic duct: what for and 
how  
M. Mizandari1,1, T. Azrumelashvili1, N. Habib2; 1Tbilisi/GE, 2London/UK 
(mgmizandari@gmail.com)  
Purpose: To present the percutaneous image-guided pancreatic duct (PD) 
drainage. 
Methods and Materials: 45 patients underwent PD percutaneous image-
guided drainage. In 44 of them, the indication was PD obstruction-related 
clinical symptoms (pancreatic irritation, recently revealed diabetes); in one 
case of pancreatic fistula non-dilated PD was drained. PD drainage was 
performed under combined image guidance - US and fluoroscopy (23) or CT 
and fluoroscopy (22 cases). After US or CT-guided PD puncture using 22 to 
18G needles, drainage catheter was placed under the real-time fluoroscopy 
guidance over the wire. 
Results: Drainage was successful in all cases including the case of non-
dilated PD in post-biopsy pancreatic fistula. Clinical improvement was 
documented, pancreatic fluid discharge varied between 300 and 900 ml/day. 
  






Five patients with recent onset of diabetes showed a dramatic improvement in 
glycaemic control. 
Conclusion: The percutaneous PD drainage appears to be a safe and 
effective procedure and should be considered in patients with obstructed PD, 
especially in cases of failed endoscopic retrograde cannulation or where 
impracticable.  
B-0041 11:42  
Fluoroscopy-guided percutaneous interventions via pancreatic duct 
percutaneous drainage track for diagnosis and treatment: feasibility and 
technique  
M. Mizandari1,1, T. Azrumelashvili1, N. Habib2; 1Tbilisi/GE, 2London/UK 
(mgmizandari@gmail.com)  
Purpose: To present the percutaneous procedures, which might be performed 
after pancreatic duct (PD) percutaneous drainage. 
Methods and Materials: 21 patients underwent percutaneous image-guided 
procedures using PD drainage track; among them - endoluminal RFA with 
subsequent stenting - 9, balloon-assisted percutaneous descending litholapaxy 
(BAPDL) - 6, endoluminal biopsy - 3, balloon dilatation - 2, stenting -1. The 
obligatory first step of all procedures was the wire conduction into the 
duodenum performed using 5 Fr diameter advantage catheter. RFA was 
performed by 5 Fr diameter novel bipolar RF device (15 watts of energy 
applied for 2 minutes), positioned in the strictured segment over the wire; 
BAPDL was performed applying the pushing-down efforts by partially inflated 
balloon after papilla dilatation. Endoluminal biopsy was performed by 
endobiliary forceps biopsy set. Balloon dilatation and stenting was performed 
using conventional technique. 
Results: In 18 (85.7%) of 21 cases the procedures were completed, achieving 
either PD patency restoration or adequate tissue sample obtaining; in 3 
(14.3%) cases (all pancreatic head cancers) the procedure completion was 
impossible due to failure of guidewire conduction across the strictured segment 
of PD. All patients tolerated the procedure well, there was no 30-day or 
hospital mortality; no technique-specific complications were observed. 
Conclusion: Percutaneous fluoroscopy-guided percutaneous diagnostic and 
treatment procedures via pancreatic duct percutaneous drainage track are safe 
and effective; this procedures should be routinely suggested as treatment 
options for selected patients.  
B-0042 11:50  
Interstitial transpedal MR lymphangiography in pre-interventional work-
up for lymphatic interventions in patients with chylous effusions  
C.C. Pieper, H. Schild; Bonn/DE (Claus.Christian.Pieper@ukb.uni-bonn.de)  
Purpose: To evaluate the clinical usefulness of transpedal MR 
lymphangiography (tMRL) for pre-interventional work-up for lymphatic 
interventions in patients with chylous effusions. 
Methods and Materials: tMRL was performed in 25 patients (m/f: 13/12, mean 
age 54 years) with chylous effusions scheduled for lymphatic intervention. 
Indications were: traumatic/iatrogenic chylothorax n=6, non-traumatic 
chylothorax n=8, traumatic/iatrogenic chyle ascites n=3, non-traumatic chyle 
ascites n=3, combined chylothorax/chyle ascites n=5. Patients underwent 
tMRL at 1.5T with T1-weighted imaging after pedal/interdigital injection of 
gadolinium contrast-medium under local anaesthesia. Contrast-enhanced 
images were evaluated regarding depiction of leakage, a possible access site 
for lymph-vessel-embolisation and anatomical variations. 
Results: Contrast injection was well tolerated in all patients without 
complications. Sedation was necessary in one case. In 20/25 patients 
enhancing central lymphatics were detectable (cause of failure: restlessness 
despite sedation n=1, lymphoma with lymphoedema n=1, technical reasons 
n=3). Leakage was identified in 13/20 patients. In 5 patients with chyle ascites, 
contrast medium leaked intraabdominally and did not reach the cisterna chyli. 
In the remaining 15 patients (thoracic/cervical pathologies) a possible access 
site for thoracic-duct embolisation was identified in 14/15 patients (cisterna 
chyli in 12/15, thoracic-duct (TD) in 14/15). 8/14 patients had a single TD and 
6/14 a duplicated TD. In one patient, the TD terminated in the right venous 
angle. Overall 20/25 tMRL exams provided useful information to guide 
interventions. 
Conclusion: Transpedal MR lymphangiography is a new and valuable 
diagnostic tool in patients with chylous effusions scheduled for lymphatic 
interventions, providing information on the anatomy of central lymphatics. The 
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B-0043 10:30  
Inspiratory/expiratory xenon-enhanced area-detector CT (ADCT): 
capability for pulmonary functional loss and clinical stage evaluations in 
smokers  
Y. Ohno1, Y. Fujisawa2, Y. Kishida1, S. Seki1, N. Sugihara2, T. Yoshikawa1; 
1
Kobe/JP, 2Otawara/JP (yosirad@kobe-u.ac.jp)  
Purpose: To evaluate the capability of inspiratory/expiratory xenon (Xe)-
enhanced area-detector CT (ADCT) for pulmonary functional loss and clinical 
stage evaluations in smokers. 
Methods and Materials: Forty consecutive smokers prospectively underwent 
inspiratory/expiratory xenon-enhanced ADCT as well as pulmonary function 
tests. Then, all smokers were classified by GOLD classification-based 
pulmonary function test results. Each CT data were transferred to our 
proprietary software to generate Xe wash-in (WI), wash-in/wash-out (=WI/WO) 
ratio and ventilation (=[WI-WO]/WI) ratio maps between inspiratory/expiratory 
CT scans. According to the previous study, each pixel within the lung was 
divided into three lesion groups as follows: normal lung, functional small airway 
disease (fSAD) and emphysema. To determine regional ventilation differences, 
each Xe ventilation index was compared between three groups by Tukey’s 
HSD test. To evaluate the capability for pulmonary function loss assessment, 
step-wise regression analyses were performed among all Xe ventilation 
indexes and pulmonary function test results such as %FEV1 and FEV1/FVC%. 
Finally, discrimination analysis was performed to determine the concordance 
capability for GOLD stage classification was also determined. 
Results: WI and ventilation ratio had significant difference among three lesion 
groups (p<0.05) and WI/WO ratio of emphysema had significant difference with 
that of others (p<0.05). %FEV1 (r
2=0.71, p<0.05) and FEV1/FVC% (r
2=0.71, 
p<0.05) were significantly affected by ventilation ratio as 1st step and WI as 2nd 
step. With all Xe ventilation indexes, the concordance capability for GOLD 
classification was determined as 85.0 (32/40)%. 
Conclusion: Inspiratory/expiratory xenon-enhanced ADCT was useful for 
pulmonary functional loss and clinical stage evaluations in smokers.  
Author Disclosures: 
  Y. Ohno: Research/Grant Support; Toshiba Medical Systems Corporation.  
Y. Fujisawa: Employee; Toshiba Medical Systems Corporation.  S. Seki: 
Research/Grant Support; Toshiba Medical Systems Corporation. N. Sugihara: 
Employee; Toshiba Medical Systems Corporation. T. Yoshikawa: 
Research/Grant Support; Toshiba Medical Systems Corporation. 
B-0044 10:38  
A meta-analysis of a UIP pattern on CT: is surgical lung biopsy necessary 
in patients with a possible UIP pattern?  
H. Kim, S.H. Yoon, H. Hong, S. Hahn, J.M. Goo; Seoul/KR 
(heekyung0363@gmail.com)  
Purpose: With the recent introduction of anti-fibrotic agents for idiopathic 
pulmonary fibrosis (IPF) treatment, accurate diagnosis of IPF has become 
more important. According to the ATS/ERS/JRS/ALAT statement in 2011, 
surgical lung biopsy is required to make a diagnosis of IPF for patients with a 
possible usual interstitial pneumonia (UIP) pattern on HRCT, while not required 
for those with UIP pattern. We performed a meta-analysis of whether the 
surgical lung biopsy is essential for IPF diagnosis with the possible UIP 
pattern. 
Methods and Materials: We performed literature searches of the MEDLINE 
and EMBASE databases and included studies which conducted a radiologic-
pathologic evaluation of IPF according to the 2011 guidelines. Outcomes were 
pooled using a random-effects model. 
Results: Twelve studies were included. Pooled proportions of IPF were 99% 
(95%CI, 93% to 100%; I2=51.7%) for a UIP pattern and 94% (95%CI, 87% to 
99%; I2=82.9%) for a possible UIP pattern. The proportion of IPF for an 
inconsistent UIP pattern was substantially heterogeneous ranging from 0% to 
100% (median, 49%). Pooled percentage difference in proportions of IPF 
between UIP and possible UIP patterns was -1% (95%CI, -4% to 1 %; 
I2=0.0%). Proportions of IPF in possible and inconsistent UIP patterns were 
correlated with the prevalence of IPF (Spearman correlation coefficient, 
0.605[95%CI, 0.055-0.860] for possible UIP; 0.769 [95%CI, 0.319-0.928] for 
inconsistent UIP). 
  






Conclusion: Proportions of IPF diagnosis when biopsied were comparable 
between UIP and possible UIP pattern, indicating that IPF diagnosis can be 
made with a possible UIP pattern without biopsy as a UIP pattern.  
B-0045 10:46  
Follow-up of idiopathic pulmonary fibrosis: computed tomography vs 
functional metrics  
G. Milanese1, M. Silva1, V. Seletti1, C. Galeone2, B. Bartholmai3, S. Palmucci4, 
S. Piciucchi5, R. Karwoski3, N. Sverzellati1; 1Parma/IT, 2Milan/IT, 
3
Rochester, MN/US, 4Catania/IT, 5Forli/IT (gianluca.milanese@studenti.unipr.it)  
Purpose: To test the prognostic value of HRCT with either visual or 
quantitative analysis in both short-term and long-term follow-up of idiopathic 
pulmonary fibrosis (IPF), and to compare it with pulmonary function test (PFT). 
Methods and Materials: Consecutive patients with a multidisciplinary 
diagnosis of IPF were retrospectively selected from two referral hospitals. 
Selection criteria included: availability of baseline, 8-12 months, and 18-30 
months volumetric HRCT (hereafter HRCT0, HRCT1, HRCT2, respectively); 
absence of exacerbation within the defined follow-up period. Visual score was 
performed by two radiologists for the total extent of interstitial lung disease 
(ILD) and its individual patterns; nominal category of longitudinal disease 
behavior was defined as follows: improvement, stability, or progression. 
Quantitative analysis included global histogram descriptors of lung density 
(mean density, skewness, kurtosis) and textural analysis (CALIPER). 
Prognostic value of both visual and quantitative measures and their deltas 
were evaluated by adjusted stepwise multivariate analysis, at HRCT0, HRCT1, 
and HRCT2. The reference standard for pulmonary function trend was defined 
by decline in forced vital capacity (FVC), as per official guidelines. 
Results: Fifty-eight consecutive patients were followed for 43.8 months. At 
HRCT1, either a relative increase in ILD extent greater than 20% with 
CALIPER or visual categorical assessment of disease behavior improved the 
prognostic value of FVC decline >10% (HR 38.8; 95%CI:6.82-232.2). Likewise, 
combining either PVRV changes or visual categorical assessment of disease 
behavior at HRCT2 increased the prognostic value of the HRCT0-HRCT2 FVC 
trend (HR 10.96; 95%CI:2.31-51.99). 
Conclusion: HRCT changes by visual or textural analysis can be added with 
benefit to the current spirometric reference standard to improve prediction of 
mortality in IPF. Annual combined HRCT-functional changes showed the 
greatest prognostic value.  
Author Disclosures: 
 M. Silva: Grant Recipient; ESTI 2016 Experienced Chest Radiology 
Researchers Grant.  
B-0046 10:54  
Chest HRCT findings in adult patients with different subtypes of humoral 
primary immunodeficiencies and correlation with lung function test 
results  
L. Cereser, F. Greco, E. Zanelli, P. D'Angelo, M. De Carli, C. Zuiani, 
R. Girometti; Udine/IT (elisazanelli@hotmail.it)  
Purpose: To assess HRCT findings in different subtypes of patients with 
humoral primary immunodeficiencies (h-PIDs), and whether they predict 
pulmonary function test (PFT) results. 
Methods and Materials: We retrospectively identified fifty-two consecutive 
adult patients with h-PIDs who performed HRCT (64-raw multidetector 
equipment) and PFT at the time of diagnosis. On a per-patient basis, one 
experienced radiologist recorded airway (bronchiectasis, airway wall 
thickening, mucus plugging, tree-in-bud and air-trapping) and parenchymal-
interstitial abnormalities (consolidations, ground-glass opacities, septal 
thickening/linear opacities, parenchymal nodules and bullae/cysts) on HRCT. 
We used the chi-square test to compare the prevalence of each of the above 
abnormalities between different subtypes of h-PIDs included in the study. On 
the overall population, we also performed logistic regression analysis to assess 
whether HRCT findings predicted either obstructive or restrictive PFT results 
(absent-to-mild vs moderate-to-severe). 
Results: Patients showed common variable immunodeficiency (CVID) in 38/52 
cases, and CVID-like condition in 14/52 cases (11 IgG subclass deficiencies + 
3 selective IgA deficiencies), respectively. We observed no significant 
difference in the prevalence of airway or parenchymal-interstitial HRCT 
abnormalities between CVID and CVID-like patients (p>0.05), with bronchial 
wall thickening being the most frequent finding in both groups (71%). On 
multivariate analysis, tree-in-bud and septal thickening-linear opacities were 
found as independent predictors (p<0.05) of significant obstructive defect (OR, 
18.75%) and restrictive defect (OR, 13.95%), respectively. 
Conclusion: There was no significant difference in HRCT findings between h-
PIDs subtypes. Tree-in-bud and septal thickening-linear opacities were found 
to be predictors of higher risk of ventilatory obstructive and restrictive defects 
on PFT, respectively.  
 
B-0047 11:02  
Effect of different radiation doses and reconstruction kernels of HRCT on 
texture analysis-based artificial neural network classification of patients 
with systemic sclerosis  
G. Milanese1,2, M. Mannil2, K. Martini2, B. Maurer2, H. Alkadhi2, 
T. Frauenfelder2; 1Parma/IT, 2Zurich/CH (gianluca.milanese@studenti.unipr.it)  
Purpose: Texture analysis (TA) uses quantitative, statistical metrics to 
evaluate image characteristics reflecting microstructural changes. We used TA 
in high-resolution Computed Tomography (HRCT) with different radiation dose 
(RD) and reconstruction kernels (RK) to discriminate between Systemic 
Sclerosis (SSc) patients and non-SSc controls by use of an artificial neural 
network (ANN). 
Methods and Materials: Eighty-five HRCT with different RD (36 low-dose, 
LDCT and 49 standard dose, SDCT) were retrospectively selected. Each CT 
was reconstructed with filtered-back projection - FBP - and iterative - SAFIRE 3 
and 5 - algorithms. Sixty-one individuals were SSc patients. 304 TA metrics 
were extracted at six levels through manually-drawn regions of interest. Each 
metric was averaged between the six levels and acted as input in an ANN with 
backpropagation (MultilayerPerceptron) for classification of SSc and non-SSc 
patients. Results were compared regarding correctly/incorrectly classified 
instances and Receiver-Operating Characteristics - Area under the curve 
(ROC-AUC). Results were compared between CT with different RK, 
independently from RD, and between CT with different RK and RD. 
Results: The highest discriminatory power for TA-based diagnosis was on 
FPB-CT: the ANN correctly classified patients in the 84.9% of cases (ROC-
AUC=0.904). For CT with different RD, the highest discriminatory power for 
TA-based diagnosis was for LDCT, and among RK, for FBP-CT. With FBP-
LDCT, the ANN correctly classified patients in the 93.8% of cases (ROC-
AUC=0.981). 
Conclusion: TA metrics extracted from six LDCT images reconstructed with 
FPB show the highest discriminatory power for the TA-based diagnosis of SSc 
patients.  
B-0048 11:10  
Description of interstitial findings in patients with diverse severity of 
telomere shortening  
H. Jofré, L. Planas, P. Luburich, A. Conejero, M. Molina; Barcelona/ES 
(hector.jofre.g@gmail.com)  
Purpose: It is known that telomere shortening (TS) is a poor predictor factor 
for pulmonary fibrosis. This disorder presents in a majority of patients with 
familial pulmonary fibrosis (FPF) and in 30% of patients with idiopathic 
pulmonary fibrosis (IPF). A description of radiological findings and the pattern 
of progression are performed in patients with TS. 
Methods and Materials: Descriptive retrospective study including 50 patients 
with TS. Telomere length was calculated through quantitative polymerase 
chain reaction and Z-score (mean length +/- SD) for age matched healthy 
controls, obtained from DNA of mouth epithelial cells. Thoracic CT of included 
patients were analysed. The radiological findings and their pattern of 
progression were characterised by comparing subgroups of different severity of 
TS (p<1%, p<10% and p<25%). 
Results: 90% of patients with TS had interstitial fibrosing changes in thoracic 
CT. 84% of patients in the subgroup p<1% were <60 years old at diagnosis 
CT, while in the less severe TS subgroups (p<10% and p<25%), 78% of 
patients were >60 years old at diagnosis CT. The UIP pattern was seen in 7% 
of patients in the subgroup p<1%, in 46% p<10% and 52% p<25%. 
Inconsistent UIP pattern was seen in 84% of patients in the subgroup p<1%, 
20% in p<10% and 11% in p<25%. 77% of patients showed progression, with 
an average of 1.3 years in the p<1% subgroup, 3.8 years in p<10% and 3.6 in 
p<25%. 
Conclusion: Patients with severe telomere shortening (p<1%) presents earlier 
and heterogeneous changes at thoracic CT, with faster progression.  
B-0049 11:18  
Correlation between pulmonary function tests and HRCT indexes in 
idiopathic pulmonary fibrosis (IPF) patients  
S. Palmucci1, S.E. Torrisi1, D. Falsaperla1, A. Torcitto1, A. Basile1, R. Rosso1, 
A. Stefano2, G. Russo2, C. Vancheri1; 1Catania/IT, 2Cefalù/IT 
(spalmucci@sirm.org)  
Purpose: The aim of this study is to investigate the correlation between 
pulmonary function tests (FVC and DLCO) and HRCT quantification indexes in 
a cohort of patients with idiopathic pulmonary fibrosis (IPF). 
Methods and Materials: The analysis was carried out on 39 IPF patients 
having at least two HRCT (baseline and follow-up) and two spirometry tests 
available - collected no more than 3 months from HRCT evaluation. The extent 
of fibrotic disease was quantified on HRCT examinations calculating Kurtosis, 
High attenuation area (HAA) and fibrotic area (FA) indexes. Pearson’s 
  






correlation coefficient was performed to assess the strength of association 
between pulmonary function tests and HRCT indexes. 
Results: Considering baseline HRCT and pulmonary function tests, Pearson 
correlation analysis revealed moderate correlations between Kurtosis and FVC 
(r=0.58 with p=0.0001), Kurtosis and DLCO (r=0.52 with p=0.0005), HAA and 
FVC (r=-0.56 with p=0.0001), HAA and DLCO (r=-0.48 with p=0.0017), FA and 
FVC (r=-0.56 with p=0.0002), and FA and DLCO (r=-0.49 with p=0.0013). On 
follow-up, analysing HRCT and pulmonary function tests, Kurtosis and FVC 
shower a positive strong correlation (r=0.62 with p<0.0001), whereas Kurtosis 
and DLCO maintained a moderate positive correlation (r=0.55 with p=0.0002); 
negative correlations were found for HAA and FVC (r=-0.62 with p<0.0001), 
HAA and DLCO (r=-0.50 with p=0.0011), FA and FVC (r=-0.57 with p=0.0001) 
and FA and DLCO (r=-0.45 with p=0.0039). 
Conclusion: HRCT quantification indexes showed a moderate or good 
strength of association with pulmonary function tests; therefore, these indexes 
may be useful for radiologists in the monitoring of IPF disease.  
B-0050 11:26  
Performance of a software prototype for ILD patterns recognition: how 
does it compare to chest radiologists?  
J. Cohen1, S. Kritter1, P. Hirt1, J. Ghelfi2, E. Reymond1, G.R. Ferretti1; 
1
Grenoble/FR, 2Meylan/FR (jcohen@chu-grenoble.fr)  
Purpose: To evaluate the performance of a deep-learning software prototype 
in the recognition of various patterns of interstitial lung diseases (ILDs) 
compared to 2 chest radiologists. 
Methods and Materials: This retrospective study included 20 consecutive 
patients diagnosed with ILDs. 2 Radiologists retrospectively reviewed each CT 
and defined region of interests on 5 predefined slices for each of the following 
patterns : honeycombing, intralobular reticulation, traction bronchectasis, 
ground-glass, consolidation and healthy lung. The scans were subsequently 
processed by a locally designed deep-learning software which analyzed each 
patch of 16x16 voxels in the designed slices and attributed for each a 
predominant pattern. We then compared the results of the 2 radiologists and 
radiologist 1 and 2 versus software. 
Results: Among the 20 included patients, the following diagnosis were 
proposed after multidisciplinary concertation: IPF (n=9), NSIP (n=2), Churg 
Strauss ILD (n=1), lymphangitic interstitial pneumonia (n=1), antisynthethasis 
syndrome (n=1), amiodarone-induced ILD (n=1), undetermined (n=5). When 
comparing radiologist 1 versus software, values of 
sensitivity/specificity/PPV/NPV were 28/97/19/98%, 30/93/25/94%, 
14/96/1/100%, 46/85/26/93%, 32/99/13/100%, 52/90/95/34% for 
honeycombing, intralobular reticulation, traction bronchectasis, ground-glass, 
consolidation and healthy lung, respectively. For radiologist 2 versus software, 
those values were of 24/97/21/98%, 18/93/22/91%, 16/96/7/99%, 
39/87/46/84%, 39/99/23/99% and 59/81/84/54% for the same patterns. 
Comparatively, when comparing radiologists 2 versus 1, values were of 
77/98/33/96%, 35/91/24/94%, 42/98/5/100%, 67/84/33/96%, 61/99/41/100%, 
and 75/88/96/50%. 
Conclusion: At this early stage of development, although sensitivity of 
detection of ILD patterns by the software remained lower than chest 
radiologists, its specificity was high for most pathologic patterns with very high 
NPVs.  
B-0051 11:34  
Computed tomography in primary ciliary dyskinesia: typical imaging 
findings in the cohort of adult patients with bronchiectasis  
S. Dettmer, F. Ringshausen, J. Vogel-Claussen, J. Fuge, A. Faschkami, 
H.-.O. Shin, T. Welte, F. Wacker, J. Rademacher; Hannover/DE 
(dettmer.sabine@mh-hannover.de)  
Purpose: Aim of this study was to evaluate specific features of Primary Ciliary 
Dyskinesia in computed tomography in the cohort of bronchiectasis to facilitate 
diagnosis. 
Methods and Materials: 121 CT in patients with bronchiectasis were scored 
for involvement, type, and lobar distribution of bronchiectasis, bronchial 
dilatation, and bronchial wall thickening. Further-on, associated findings like 
tree in bud, mucus plugging, consolidations, ground glass opacities, 
interlobular thickening, intralobular lines, situs inversus, emphysema, and 
atelectasis were registered. Patients with PCD (n=46) were compared to 
patients with other underlying diseases (n=75). 
Results: In patients with PCD, the extent and severity of bronchiectasis were 
significantly lower in the upper lobes (p<0.001-p=0.011). The lobar distribution 
was significantly different (<0.001) with predominance in the middle and lower 
lobes in patients with PCD. Significantly more common in patients with PCD 
were mucous plugging (p=0.001), tree in bud (p <0.001), atelectasis (p=0.009), 
and history of resection of a middle or lower lobe (p=0.047); less common were 
emphysematous (p=0.003) and fibrotic (p<0.001) changes. A situs inversus 
(Kartagener’s Syndrome) was only seen in patients with PCD (17%, p <0.001). 
 
Conclusion: Typical imaging features in PCD are a predominance of 
bronchiectasis in the middle and lower lobes, severe tree in bud pattern, 
mucous plugging and atelectasis. These findings may help practitioners to 
identify patients with bronchiectasis in which further work-up for PCD is 
warranted.  
B-0052 11:42  
CT quantitative and semi-quantitative thoracic and extra-thoracic 
biomarkers in COPD patients: how reliably can they predict patients’ 
outcomes?  
J. Cohen, G. Ferretti, M. Benmerad, S. Bailly, C. Ozcelik, E. Reymond, 
A. Jankowski, S. Bayat, J.-L. Pepin; Grenoble/FR (jcohen@chu-grenoble.fr)  
Purpose: To evaluate the performance of CT biomarkers for predicting 5-year 
survival, number of pulmonary infections, hospitalisations and cardiovascular 
events in COPD patients. 
Methods and Materials: This retrospective preliminary study included 30 
COPD patients from a prospective cohort, with at least one unenhanced chest 
CT-scan. A chest radiologist retrospectively assessed the following 
parameters: inspiration %LAA-950, expiration %LAA-856, pre-pectoral 
subcutaneous adipose tissue (PSAT), anterior mediastinal fat surface, 
epicardial fat surface, mean liver attenuation, mean liver/spleen attenuation 
ratio (LSAR), coronary calcifications using Weston score, presence of 
bronchiectasis and bronchial thickenings, density of vertebral bodies in 
T4,7,10. PSAT, anterior mediastinal and epicardial fat were subsequently 
normalised by the patients’ body surface area. These parameters were then 
compared using univariate analyses with the 5-year survival, number of 
hospitalisations, pulmonary infections and cardiovascular events. 
Results: Median follow up time for the investigated outcomes was 7 years 
(interquartile range (IQR)=3 years). Median patient age was 65 (IQR=11 
years). Mortality was significantly higher in patients who had a higher mean 
liver attenuation (p=0.02) and a lower mean vertebral density in T4-7-10 
(p=0.01). Patients with more lung infections had a significantly lower PSAT 
area (p=0.02), mean attenuation in T4-7-10 (p=0.001) and a higher LSAR 
(p=0.001). A higher number of hospitalisations was associated with a lower 
PSAT area (p=0.02), a higher LSAR ratio (p=0.01) and %LAA-950 (p=0.01). 
Conclusion: Simple CT-biomarkers show the potential to predict the 5-year 
survival, the risk of intercurrent infections and hospitalisations and in COPD 
patients. Further analyses, particularly multivariable, are needed to confirm 
these results.  
B-0053 11:50  
Solid indeterminate pulmonary nodules less than 300 mm³: application of 
the British Thoracic Society guidelines in clinical practice  
S. Pezzotti, A. Borghesi, G. Nocivelli, A. Scrimieri, R. Maroldi; Brescia/IT 
(stefy.pezzotti@gmail.com)  
Purpose: To evaluate the performance of the British Thoracic Society (BTS) 
recommendations for the management of solid indeterminate pulmonary 
nodules (SIPNs) <300 mm³. 
Methods and Materials: During a 7-year period we retrospectively reviewed 
the chest CT of 672 consecutive patients with one or more SIPNs. The study 
sample was selected according to the following inclusion criteria: solitary SIPN; 
volume <300 mm³; 2 or more CT scans performed with the same scanner and 
acquisition/reconstruction protocol; thin-section 1-mm images in DICOM 
format; histologic diagnosis or follow-up >2 years. Patients with previous 
oncology history were excluded. Applying such criteria a total of 29 patients 
with 29 SIPNs were enrolled. For each SIPN, the volume and doubling time 
(DT) were calculated using a semiautomatic software throughout the follow-up 
period. For each SIPN, we retrospectively applied the BTS guidelines and this 
management was compared to what was actually done. 
Results: A significant volumetric increase (more than 20% with DT <600 days) 
has been observed in 6/29 SIPNs. In these SIPNs a histologic diagnosis of 
malignancy was obtained. Applying the BTS recommendations all 6 malignant 
nodules would have been identified. None of the SIPNs with volume <300 mm³ 
and DT >600 days showed a significant growth during the follow-up period. 
The application of the BTS guidelines would have led to a reduction in CT 
examinations (1.5 CT scan for patients). 
Conclusion: The application of BTS guidelines has proven to be effective in 
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B-0054 10:30  
Contrast-enhanced ultrasound in evaluation of renal masses: a 
preliminary experience  
M. Altamash, S.B. Grover, S. Suman, A. Katyan, A. Kumar, A.K. Mandal; 
New Delhi/IN (md.altamash20@gmail.com)  
Purpose: Although grey scale ultrasound (US) and colour doppler are fairly 
efficient in evaluation of renal masses, characterizing complex renal masses 
remains a limitation. CECT is associated with significant risk for patients with 
hyperthyroidism, impaired renal function and allergic reactions because of 
iodinated contrast agents. Our study was therefore, aimed to evaluate the role 
of contrast-enhanced ultrasound in characterization of renal masses and to 
correlate it with contrast-enhanced CT and histopathology. 
Methods and Materials: Twenty three patients with clinically or 
sonographically detected renal masses were included in this IRB approved 
study. Renal masses were evaluated using gray sale ultrasound and contrast-
enhanced ultrasound for location, morphology and enhancement pattern. The 
mass lesions were categorized in benign and malignant varieties. The criteria 
for malignant mass lesion on contrast-enhanced ultrasound were centripetal 
enhancement along-with early contrast wash-in and wash out. Results were 
compared with contrast-enhanced computed tomography scan and 
histopathology. 
Results: Using histopathology as gold standard, the sensitivity and specificity 
of contrast enhanced ultrasound in characterization of benign and malignant 
masses were found to be 95% and 88% respectively. 
Conclusion: Currently, renal lesions are characterized by contrast-enhanced 
computed tomography (CECT). Our study showed that contrast-enhanced 
ultrasound has almost similar sensitivity and specificity to that of CECT in 
characterization of renal masses.Thus, contrast-enhanced ultrasound can be 
used as noninvasive procedure for characterization of renal masses and 
should be further exploited for its role in characterization of renal masses.  
B-0055 10:38  
Value of contrast enhanced ultrasound in evaluation of cystic renal 
lesions compared to computed tomography and magnetic resonance 
Imaging  
M.H. Lerchbaumer1, J. Rübenthaler2, F.J. Putz3, T. Slowinski1, D.A. Clevert2, 
E.-M. Jung3, T. Fischer1; 1Berlin/DE, 2Munich/DE, 3Regensburg/DE 
(markus.lerchbaumer@charite.de)  
Purpose: To assess the value of contrast-enhanced ultrasound (CEUS) in the 
evaluation of cystic renal lesions using the Bosniak classification compared 
with computed tomography (CT), magnetic resonance imaging (MRI) and 
histopathologic findings (HP). 
Methods and Materials: We performed a multicentre, retrospective analysis of 
340 CEUS examinations in high volume ultrasound centres in Germany. 
Bosniak classification of cystic renal lesions is compared to further diagnostic 
up imaging (CT or MRI) and HP. 
Results: Median age was 64 years (IQR: 56-72) and 69 % were male patients. 
CEUS showed an overall moderate correlation when compared to CT and MRI 
(r²=0.55; 95% CI 0.40-0.67, p<0.001). Lesions classified by CEUS were 
significantly higher correlated with CT than MRI with a correlation coefficient of 
0.92 (95% CI 0.91-0.98, p<0.001) and 0.42 (95% CI 0.23-0.59, p<0.001), 
respectively. Most frequent misclassified renal lesions in CEUS compared to 
MRI were Bosniak IIF (n= 14/28) and Bosniak III cysts (n= 11/21). Of 252 
lesions which were classified as Bosniak IV in CEUS and therefore identified 
as suspect for an active malignancy 84.1% (n= 212) were identified as renal 
cell carcinoma through histopathologic examination (Sensitivity 99%, 
Specificity 0%, PPV 84%, NPV 0%). 
Conclusion: Renal lesions classified by CEUS using the Bosniak classification 
have a high correlation when compared to current gold standard CT. MRI 
seems to downgrade especially Bosniak IIF and III lesions compared to CEUS. 
CEUS showed excellent sensitivity in detection of malignancy compared to 





B-0056 10:46  
Contrast-enhanced ultrasonography (CEUS) and time/intensity curves for 
the active surveillance of small renal masses  
E. Bertelli, S. Agostini, G. Addeo, S. Verna, F. Parretti, C. Raspanti, 
A. Minervini, A. Mari, V. Miele; Florence/IT (elena.bertelli3@gmail.com)  
Purpose: To assess the prognostic efficacy of contrast-enhanced 
ultrasonography (CEUS) and time/intensity (T/IS) curves for the active 
surveillance of small renal masses (SRM). 
Methods and Materials: We performed CEUS in 288 patients to evaluate 312 
renal lesions. All the lesions were confirmed by Contrast-enhanced CT or 
Contrast-enhanced MR. 66 patients were operated (group A), 246 (group B) 
are nowadays at least in a 3 years follow up. We performed a quantitative 
evaluation of the lesions enhancement (QE) by T/IS curves. We identify 4 type 
of curves: I “quick wash in (WI) and wash out (WO)”, II “quick WI and slow 
WO”, III “WI and WO synchronous to the surrounding parenchyma” IV “slow WI 
and WO”. 
Results: In the group A we performed the QE in 56 cases, 3 patients were not 
evaluated by time/intensity curves and 7 had cystic lesions; in the group B we 
performed the QE in 85 cases, 139 patients have cystic lesions and 22 were 
not evaluated. Patients with type I curves (16) had aggressive lesions in 96% 
of cases, patients with type II (40) in 57%, patients with type IV (49) in 18%; no 
aggressive lesions showed a type III pattern. The limits of our study are the 
small number of cases and the duration of follow up. 
Conclusion: CEUS is a safe, cost-effective procedure, suitable for patients 
with impaired renal function. T/IS curves are a useful tools for active 
surveillance because they could provide information about the aggressiveness 
of renal lesions.  
B-0057 10:54  
Contrast-enhanced ultrasound (CEUS) as a new technique to 
characterise suspected malignancies in renal transplants in comparison 
to standard imaging modalities  
K. Mueller-Peltzer, J. Rübenthaler, D.A. Clevert; Munich/DE 
(katharina.muellerpeltzer@med.uni-muenchen.de)  
Purpose: Renal transplant patients have a higher risk for malignancies of the 
renal transplant. In most cases suspected renal malignancies will be detected 
during the regular ultrasound follow-up and will require cross-sectional imaging 
to rule out a malignant aetiology. But it is well known that contrast agents for 
crossectional imaging are critical in patients with limited renal 
function.Therefore, this study aims to compare the sensitivity and specificity of 
contrast-enhanced ultrasound (CEUS) and gold standard imaging in 
characterizing suspected renal transplant malignancies in renal transplant 
patients. 
Methods and Materials: A total of 22 renal transplant patients with a 
suspected renal transplant malignancy with at least one CEUS and at least one 
crossectional imaging study performed between 2005 and 2017 were included. 
Patient ages ranged from 28.2 years to 74.6 (mean age 55.7 years; SD ± 13.0 
years). CEUS of 22 patients was correlated with a standard imaging modality, 
CT (15 out of 22) or MRI (7 out of 22), serving as gold standard. 
Results: All 22 lesions of the renal transplants described in CT or MRI could 
be detected using CEUS. CEUS showed a sensitivity of 100%, a specificity of 
94.4%, a positive predictive value (PPV) of 80%, and a negative predictive 
value (NPV) of 100%. 
Conclusion: CEUS is an eligible method to help characterizing suspected 
renal malignancies in renal transplant patients compared to the well-
established imaging modalities CT and MRI. As an imaging modality with no 
nephrotoxic effects CEUS can be used repeatedly even in patients with limited 
renal function.  
B-0058 11:02  
Percutaneous cryoablation for renal cell carcinoma using US-guided 
targeting and CT-guided ice-ball monitoring: procedure time, radiation 
dose and mid-term outcomes  
D. Kim, S. Park; Seoul/KR (kdk7118@yuhs.ac)  
Purpose: To assess procedure time, radiation dose and mid-term outcomes of 
percutaneous cryoablation (PCA) for renal cell carcinoma (RCC) using US-
guided targeting and CT-guided ice-ball monitoring. 
Methods and Materials: A consecutive series of 39 patients (mean age, 
60.6±15.3 years) who underwent PCA for biopsy-proven RCC were included. 
The mass targeting was performed with US guidance and a radiographic ice-
ball was monitored with CT. The procedure time was defined by the interval of 
image acquisition between the first US and last CT images. The effective 
radiation dose of CT examination during PCA was recorded. The follow-up was 
conducted with contrast-enhanced CT or MRI (mean follow-up time, 10.1±7.0 
months; range, 1-23 months). The local tumour progression was defined by the 
presence of focal enhancing areas at the ablation zone (CT, 20 or greater 
  






Hounsfield unit, MRI, presence of focal enhancement on subtraction contrast-
enhanced image). 
Results: The mean procedure time was 110.3±22.8 minutes (range, 79-183 
minutes). The mean effective radiation dose in association with PCA was 
13.7±5.2 mSV (range, 8.0-28.6 mSV). The local tumour progression occurred 
in a single patient (2.6%, 1/39). The local tumour progression-free survival rate 
was 95.7%. 
Conclusion: PCA using US-guided targeting and CT-guided ice-ball 
monitoring may allow acceptable tumour control for RCC, as reducing radiation 
dose.  
B-0059 11:10  
Is multiparametric MRI useful for differentiating oncocytomas from 
chromophobe renal cell carcinomas  
C. Galmiche; Bordeaux/FR (chloe.g1412@gmail.com)  
Purpose: The purpose of this study was to retrospectively evaluate the 
diagnostic accuracy of multiparametric MRI to differentiate oncocytoma from 
chromophobe renal cell carcinoma. 
Methods and Materials: In this retrospective study, 26 histologically confirmed 
oncocytomas and 16 chromophobe RCCs that underwent full MRI examination 
were identified in 42 patients (25 men and 17 women) over a 6-year period. 
Demographic data were recorded. Double-echo chemical-shift, dynamic 
contrast-enhanced T1-and T2-weighted images, and apparent diffusion 
coefficient maps were reviewed independently by two radiologists blinded to 
pathologic results. Signal-intensity index (SII), tumor-to-spleen signal-intensity 
ratio, ADC ratio, three wash-in indexes, and two washout indexes were 
calculated and compared using univariate and ROC analyses. Sensitivity and 
specificity analyses were performed to calculate diagnostic accuracy. 
Results: All carcinomas and nine oncocytomas were resected; the remaining 
17 oncocytomas were biopsied. Patient age (for oncocytomas: mean, 68.2 
years; range, 43-84 years; for RCCs: mean, 60.8 years; range, 20-79 years) 
and tumor size (for oncocytomas: mean, 35.5 mm; range, 12-98 mm; for 
RCCs: mean, 37.2 mm; range, 9-101 mm) did not differ significantly across 
groups (p = 0.132 and 0.265, respectively). Good interobserver agreement was 
observed for all measurements but four. Oncocytomas presented significantly 
higher ADC (p = 0.002) and faster enhancement (p = 0.007-0.012) but lower 
SII (p = 0.03) than carcinomas. This combination provided sensitivity of 92.3% 
(24/26), specificity of 93.8% (15/16), and accuracy of 92.9% (39/42) for the 
detection of oncocytomas. 
Conclusion: Multiparametric MRI helps to accurately differentiate 
oncocytomas from chromophobe RCCs with high sensitivity and specificity.  
B-0060 11:18  
CT texture analysis in clear cell renal cell carcinoma: a radiogenomics 
prospective  
S. Badia1, D. Bellini1, C. Marigliano2, M. Rengo1, M. Osimani1, S. Picchia1, 
V. Petrozza1, A. Laghi1; 1Latina/IT, 2Milan/IT (stefano.badia@gmail.com)  
Purpose: The aim of this study was to investigate whether quantitative 
parameters obtained from CT texture analysis (CTTA) correlate with 
expression of miRNA in clear cell renal cell carcinoma (ccRCC). 
Methods and Materials: In a retrospective single-centre study, multiphasic CT 
examination (with arterial, portal and urographic phases) was performed on 64 
patients with ccRCC (28 women and 36 men; mean age 65 years ± 6). 
Measures of heterogeneity were obtained in post-processing by placing a ROI 
on the entire tumour and CTTA parameters such as entropy, kurtosis, 
skewness, mean, mean of positive pixels and SD of pixel distribution histogram 
were measured using multiple filter settings. Quantitative data were correlated 
with miRNAs obtained from histopathological analysis (miR-21-5p, miR-210-3p, 
miR-185-5p, miR-221-3p, miR-145-5p). Both evaluations (miRNAs and CTTA) 
were done on normal corticomedullar and tumour tissue for comparison. 
Analysis of variance with linear multiple regression model methods were 
obtained with SPSS statistic software. For all comparisons, statistical 
significance was assumed p<0.05. 
Results: The expression of miR-21-5p, miR-210-3p and miR-221-3p resulted 
up-regulated in tumour samples. Among all miRNAs, normal tissue entropy 
was not related to miR-21-5p (R2= 0.06), while a trend of positive correlation 
was found with tumour tissues (R2=0.27). Excluding some patients with 
extreme over-expression of miR-21-5 (10%), excellent relation of entropy in 
tumour with miR21-5p was found (R2= 0.64; p<0.05). 
Conclusion: Entropy and miRNA 21-5p show positive correlation in ccRCC; in 
addition CTTA features, in particular, mean and entropy show a statistically 






B-0061 11:26  
Assessing venous thrombus in renal cell carcinoma: preliminary results 
for non-contrast enhanced magnetic-resonance 3D-SSFP  
L. Adams, B. Ralla, G. Engel, G. Diederichs, J. Busch, F. Fuller, B. Hamm, 
M.R. Makowski; Berlin/DE  
Purpose: To test the potential of non-contrast-enhanced cardiac- and 
respiratory-motion-corrected three-dimensional-steady-state-free-precession 
(3D-SSFP) MR imaging for the assessment of inferior vena cava (IVC) 
thrombus in patients with renal cell carcinoma (RCC), compared to standard 
contrast enhanced MRI. 
Methods and Materials: 14 patients with RCC and suspected IVC thrombus, 
who received a contrast-enhanced abdominal MRI and 3D-SSFP at 1.5T as a 
standard preoperative work-up procedure between June 2015 and September 
2017, could be included in this retrospective study. Contrast-to-noise-ratios 
(CNR), image quality and diagnostic performance of 3D-SSFP and standard 
MRI were compared. Additionally, in vivo- findings were validated against 
intraoperative results and histopathological examinations. 
Results: Both 3D-SSFP and contrast-enhanced MRI correctly identified the 
extent and approximate volume of all IVC thrombi, confirmed by surgery and 
histopathology. 3D-SSFP reached a significantly higher CNR in the supra- and 
infrarenal IVC compared to morphologic imaging (T2-HASTE), the 
unenhanced, the portal venous, nephrogenic and delayed phase. 3D-SSFP 
showed a significantly higher CNR in the infrarenal IVC (mean CNR of 
8.61±3.90 vs. 3.84±1.54 in the delayed phase, p=0.005) and a slightly higher 
CNR in the suprarenal IVC (mean CNR of 8.66±3.76 vs. 5.00±6.31 in the late 
arterial phase, p=0.055). The thrombus delineation score for 3D-SSFP 
(4.38±0.76) was higher compared to standard MRI (3.76±0.71, p=0.016). 
Conclusion: This preliminary study indicates that cardiac- and respiratory-
motion-corrected 3D-SSFP can achieve an accurate delineation of IVC 
thrombus in RCC patients without the need for contrast administration. 3D-
SSFP may thus offer a valid alternative for patients with contraindications to 
gadolinium-based contrast agents.  
Author Disclosures: 
  L. Adams: Grant Recipient; LA is participant in the BIH Charité - Junior 
Clinician Scientist Program funded by the Charité - Universitaetsmedizin Berlin 
and the Berlin Institute of Health. B. Ralla: Grant Recipient; BR is participant in 
the BIH Charité - Junior Clinician Scientist Program funded by the Charité - 
Universitaetsmedizin Berlin and the Berlin Institute of Health.. J. Busch: Grant 
Recipient; JB is participant in the BIH – Twinning Grant Program funded by the 
Charité - Universitaetsmedizin Berlin and the Berlin Institute of Health. 
M.R. Makowski: Grant Recipient; MRM is grateful for the financial support 
from the Deutsche Forschungsgemeinschaft (DFG, 5943/31/41/91).. 
B-0062 11:34  
Can we diagnose T1 stage UB (urinary bladder) cancer from T2 stage with 
an inchworm/stalk sign on 3T-MRI?  
D. Kim, B. Kang, Y. Ko; Seoul/KR (kangbc@ewha.ac.kr)  
Purpose: To evaluate diagnostic performance of an inchworm sign/ stalk sign 
on MRI for T1 stage UB cancer. 
Methods and Materials: Among 261 consecutive UB cancer patients 
underwent radical cystectomy with neobladder. We described the tumorous 
high signal intensity curve on DWI as an ‘inchworm sign’ and the fibrovascular 
stalk on T2WI as a ‘stalk sign’. If the inchworm sign(DWI) or stalk sign(T2WI) 
was shown, it was grouped as T1 staging. If not shown, it was grouped as over 
T2 staging. If there was hydronephrosis associated with UB tumour, even 
having that signs, it was grouped as over T2 staging. We compared the 
preoperative MR T-stage and postoperative pathological T-stage in all enrolled 
patients. We evaluated the diagnostic significance an inchworm sign (DWI) and 
a stalk sign (T2WI) statistically by 2 -Test and McNemar test/Fisher’s exact 
test. 
Results: For diagnosing T1 stage UB cancer, the “inchworm sign(DWI)” and 
the “stalk sign(T2WI)” showed high specificity (94%, 95%), high positive 
predictive value (81%, 77%), and high accuracy (80%, 76%). And we found 
their diagnostic accuracy to increase (86%, 79%) with hydronephrosis. So, 
even inchworm sign or stalk sign were seen, with associated hydronephrosis, 
we can preoperatively indicate over T1 staging urinary bladder cancer with 
more higher prediction. 
Conclusion: We can easily diagnose T1 UB cancer from T2 by detecting an 
inchworm sign(DWI), or a stalk sign(T2WI) on MRI. If there is associated with 
hydronephrosis, suggesting UVJ muscle layer invasion by UB cancer, its 














B-0063 11:42  
Investigation of intravoxel incoherent motion diffusion-weighted imaging 
for assessing bladder cancer invasiveness  
F. Wang, G. Wu, W. Chen; Shanghai/CN  
Purpose: To investigate whether intravoxel incoherent motion (IVIM) diffusion-
weighted imaging (DWI) could differentiate non-muscle-invasive bladder 
cancer (NMIBC) from muscle-invasive bladder cancer (MIBC) and to assess 
whether there were correlations between IVIM parameters and the Ki-67 
labelling index (LI). 
Methods and Materials: Thirty-six patients diagnosed with bladder cancer 
confirmed by histopathological findings underwent magnetic resonance 
imaging including DWI with 8 b-values ranging from 0 to 1000 s/mm2 before 
transurethral resection (TUR). Molecular diffusion coefficient (D), perfusion-
related diffusion coefficient (D*), perfusion fraction (f), and apparent diffusion 
coefficient (ADC) were calculated by bi-exponential and mono-exponential 
model fits, respectively. Comparisons were made between the MIBC and 
NMIBC group. Differences in these values were analysed by comparing the 
areas under the receiver operating characteristic curves (AUC). The 
correlations between these parameters and Ki-67 LI were also analysed. 
Results: ADC and D values were significantly lower in patients with MIBC 
compared to those suffering NMIBC (p<0.01). The AUC of D value (0.894) was 
significantly (p<0.05) larger than those of ADC value (0.786). The sensitivities 
and specificities of D and ADC values were 95% and 87.5% and 80% and 
68.7%, respectively. In addition, there was a negative correlation between D 
value and Ki-67 LI (r=-0.785, p<0.01). 
Conclusion: D value obtained from IVIM could provide better performance 
than conventional DWI in distinguishing NMIBC from MIBC and serve as an 
imaging biomarker reflecting the invasive and proliferative potential of bladder 
cancer.  
Author Disclosures: 
  F. Wang: Speaker; Fang Wang. 
B-0064 11:50  
Predictionof treatment response after immunotherapy in metastatic or 
recurrent urothelialcarcinoma: potential imaging biomarker using CT 
texture analysis-a preliminary study  
K. Park; Seoul/KR (kyejin629@gmail.com)  
Purpose: To evaluate the relationship between tumour heterogeneity 
assessed by computed tomography (CT) texture analysis and treatment 
response after immunotherapy in patients with metastatic or recurrent 
urothelial carcinoma. 
Methods and Materials: From January and April 2017, ten consecutive 
patients who had recurrent/metastatic urothelial carcinoma and underwent 
immunotherapy (Durvalumab, pembrolizumab or atezolizumab) were 
retrospectively evaluated. Texture analysis of all metastatic lesions (42 lesions) 
were performed with CT imaging for immunotherapy planning using in-house 
software. Histogram-based uniformity, entropy and kurtosis as well as 11 run-
length matrix (RLM) and 25 gray level co-occurrence matrix (GLCM) features 
were obtained with manual delineation of a region of interest on metastatic 
lesion. Determination of responder and non-responder was done with 
clinicoradiologic follow-up after at least two consecutive CT reviews. The 
statistical analysis was done using Mann-Whitney U test. 
Results: Six patients were classified as responder and four as non-responder. 
There was statistically significant difference of all three histogram-based 
features, seven RLM and ten GLCM features between responder and non-
responder (p<0.05). Higher kurtosis (1.25 vs. 0.13, p=0.01) lower entropy (6.80 
vs. 7.09, p=0.006), and higher uniformity (0.011 vs. 0.008, p=0.010) were 
observed in responder group. 
Conclusion: In patients with recurrent or metastatic urothelial carcinoma, non-
responders appeared to be more heterogeneous on CT texture analysis 
(higher entropy and lower uniformity) than responders. This preliminary result 
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B-0065 10:30  
The value of readout-segmented diffusion-weighted imaging in the 
evaluation of parotid gland tumours  
Z. Zhang, J. Cheng; Zhengzhou/CN (yinierzhang@sina.com)  
Purpose: The purpose was to investigate the role of readout-segmented echo-
planar imaging using parallel imaging and a two-dimensional navigator-based 
reacquisition (RESOLVE) in differentiating various types of common parotid 
gland tumours. 
Methods and Materials: Sixty-five patients with parotid gland tumours 
confirmed by pathology received preoperative conventional MRI and 
RESOLVE DWI (b-values of 0 and 1000 s/mm2). The apparent diffusion 
coefficient (ADC) values of the lesions were calculated and the receiver 
operating characteristic curves was drawn to obtain the cut-off value for 
differentiating benign and malignant parotid gland tumours. 
Results: The mean ADC value of pleomorphic adenomas were significantly 
higher than that of all other examined subtypes. ADC values of warthin 
tumours were significantly lower than pleomorphic adenoma (p=0.000), basal 
cell adenoma (p=0.000) and malignant tumours (p=0.001). ADC cut-off values 
were 1.22×10﹣3mm2/s between pleomorphic adenomas and malignant tumours 
and 0.90×10﹣3mm2/s between Warthin tumours and malignant tumours; using 
0.90×10-3mm2/sADC values<1.22×10-3mm2/s to make a diagnosis of 
malignant tumour, the sensitivity, specificity, and accuracy were 93.8%, 81.4%, 
84.7%, respectively. 
Conclusion: RESOLVE has high accuracy in differing benign and malignant 
lesions of the parotid gland by producing high-resolution DWI.  
B-0066 10:38  
Sensorineural hearing loss in vestibular schwannoma relies on the 
presence of utricular hydrops, as diagnosed with heavily weighted T2 
sequences  
M. Eliezer1, G. Poillon2, A. Gillibert2, C. Maquet2, J. Horion2, E. Gerardin2, 
A. Trintignac2, N. Magne2, A. Attye3; 1Paris/FR, 2Rouen/FR, 3Meylan/FR 
(mcheliezer@gmail.com)  
Purpose: Due to the increased protein concentration in the perilymph liquid, 
FIESTA-C has recently been proposed to assess endolymphatic spaces 
without administration of contrast media in patients with vestibular 
schwannoma. The aim of this study was to assess whether vestibular 
endolymphatic space dilatation, as evaluated with 3D-FIESTA-C sequences, is 
related to the degree of hearing loss in patients with schwannoma. 
Methods and Materials: In this retrospective study (IRB E2017-23), we 
performed 3D-FIESTA-C sequences in 32 patients with schwannoma, as 
diagnosed on the basis of typical image findings. Two radiologists 
independently checked the visualization and evaluated the volume of the 
utricle and saccule. Pearson and Spearman tests were used to explore the 
correlation between the volume of the tumor, the volume of the vestibular 
endolymphatic space and the degree of hearing loss - as evaluated with the 
levels of pure-tone average (PTA) and speech recognition threshold (SRT). 
Results: The endolymphatic space can be evaluated in 72% (23 out of 32 
patients) of patients with schwannoma on non-contrast 3D-FIESTA-C 
sequences. The mean saccular, utricular and tumor volume were 3.17 mm3, 
14.55 mm3 and 1.74 cm3 respectively. There was a significant correlation 
between the volume of the utricle and the degree of hearing loss as evaluated 
with the levels of PTA (p=0.015) and SRT (p=0.004). There was no significant 
correlation between the saccular and tumour volumes and the degree of 
hearing loss. 
Conclusion: The volume of the utricle in schwannoma patients is related to 
















B-0067 10:46  
Imaging of facial neuritis using T2-weighted gradient-echo fast imaging 
employing steady-state acquisition after gadolinium injection  
A. Venkatasamy, A. Al Najdi, M. Abu Eid, A. Charpiot, C. Debry, F. Veillon; 
Strasbourg/FR (aina.vnkt@gmail.com)  
Purpose: MRI is the modality of choice for the imaging of facial neuritis. 
Previously, gadolinium-enhanced T1WI of the petrous bone was thought to be 
the most informative sequence in the evaluation of facial neuritis. The goal of 
this study is to evaluate the value of gadolinium-enhanced T2WI steady-state 
free precession sequences for the diagnosis of facial neuritis. 
Methods and Materials: We performed an MRI of the petrous bones in 38 
patients with unilateral peripheral facial palsy, using T2WI steady-state-free 
precession sequences and T1WI after intravenous gadolinium injection, and 
compared these to 60 normal patients (control group) imaged with the same 
MRI protocol and to 32 healthy volunteers (volunteers control group) imaged 
by T2WI steady-state free precession sequence without gadolinium injection. 
Results: All patients presenting with a facial neuritis presented with a 
pathological enhancement of the facial nerve on the pathological side on T2W 
steady-state free-precession sequences (FIESTA-C and CISS) acquired after 
gadolinium injection. 94.7% of patients presented with a strong enhancement 
(Grade 2), which had a specificity of 100%, a sensitivity 94.7% and an 
accuracy of 97.9%. T1WI sequences following IV gadolinium injection were 
positive in 79% of the patients with facial neuritis and enhancement was also 
observed in the control group. 
Conclusion: Enhancement of the facial nerve canal on T2WI steady-state free 
precession sequences (FIESTA-C) is a sensitive and specific sign of 
homolateral facial neuritis and is superior to T1WI images for the positive 
imaging diagnosis of facial neuritis.  
B-0068 10:54  
D-prep magnetic resonance imaging for the visualisation of the facial 
nerve  
P. Bos1, B. Jasperse1, A.J.M. Balm1, L.C. ter Beek1, F.W. van Leeuwen2, 
M.W.M. van den Brekel1, R.G.H. Beets-Tan1, T. Buckle2; 1Amsterdam/NL, 
2
Leiden/NL (pa.bos@nki.nl)  
Purpose: Facial nerve damage can be a serious complication of parotid 
surgery. Pre- or peroperative localization of the facial nerve may help the 
surgeon to avoid this complication. Diffusion-prepared MRI (D-prep MRI) is a 
novel technique designed to specifically visualize nerve structures. This study 
evaluates the ability and extent D-prep MRI to detect the Facial nerve. 
Methods and Materials: D-prep MRI was performed in 24 patients (13 
male/11 female, mean age 60 ± 11 years) that underwent a MRI for 
(suspected) head and neck cancer between December 2016 and August 2017. 
The visibility, length and thickness of the different branches of the Facial nerve 
were assessed by one neuro/head and neck radiologist based on the course of 
the nerve. 
Results: Two patients were excluded because of poor MRI quality. For the 
remaining 22 patients the main trunk (from the mastoid foramen to the 
bifurcation of zygomaticofacial and oromandibular branches) was visible in 15 
patients (length between 4 and 26 mm, median thickness: 1.3 mm), the 
posterior auricular nerve in 4 patients (6-11 mm; 0.9 mm), the zygomaticofacial 
branch in 6 patients (2-12 mm; 1.1 mm), the oromandibular branch in 6 
patients (1-23 mm; 1.0 mm) and temporal in 1 patient (6 mm; 1.6 mm). In 7 
patients the Facial nerve could not be identified. 
Conclusion: The facial nerve can be identified and its course delineated with 
D-prep MRI in most cases. Further optimization of this sequence will hopefully 
result in more detailed visualization and delineation of Facial nerve branches.  
B-0069 11:02  
Is gadolinium really necessary for intralabyrinthine schwannomas MRI 
examination?  
A. Venkatasamy, A. Karol, T. Huynh, A. Charpiot, C. Debry, F. Veillon; 
Strasbourg/FR (aina.vnkt@gmail.com)  
Purpose: Our aim was to confirm the usefulness of T2-weighted (T2W) 
gradient-echo sequence for detection and topographic diagnosis of 
intralabyrinthine schwannomas (ILS) compared to T1W contrast-enhanced 
sequence as gold standard to evaluate the necessity of intravenous gadolinium 
injection in ILS imaging. 
Methods and Materials: 30 patients with ILS were retrospectively enrolled and 
compared to a control group of 30 patients with no inner ear pathology. All 
patients underwent a T2W gradient-echo steady-state free precession (SSFP) 
acquisition at 3T, which was visually analysed by two radiologists and 
compared to contrast-enhanced T1W sequence. A quantitative analysis was 
also performed, with the measurement of the tumour and inner ear signal on 
T2W images and the measurement of the tumour length in cochlear 
schwannomas. 
Results: T2W FIESTA-C sequence correctly diagnosed ILS with a sensitivity 
(Se) of 95% and a specificity (Sp) of 100%, with matching results for their 
topographic evaluation (Se 92%, Sp 98%) compared to the gold standard. The 
error rate was only 2.5%, with excellent interobserver agreement. The tumour 
signal on T2W images was significantly lower than the normal bright signal of 
the normal inner ear fluids (mean signal ratio = 0.42 vs 0.98). 
Conclusion: The positive and topographic diagnostic accuracy of T2W 
FIESTA-C sequence was excellent compared to the T1W contrast-enhanced 
sequence, even though the latter remains easier and faster to analyse for an 
untrained radiologist. The performances of T2W gradient-echo sequence at 3T 
renders it sufficient for the imaging of ILS, especially for follow-up imaging.  
B-0070 11:10  
Is post-contrast MRI imaging necessary in the investigation of 
cholesteatoma recurrence when non-echo planar diffusion-weighted 
imaging is available? A diagnostic accuracy study  
R. Kavanagh, A. Carroll, Y.M. Purcell, A.E. Smyth, S.G. Khoo, G. McNeill, 
D.E. Malone, R.P. Killeen; Dublin/IE (richkavanagh@rcsi.ie)  
Purpose: The diagnosis of recurrent cholesteatoma is important in order to 
avoid the associated complications. This has traditionally been done through 
second-look surgery and more recently with contrast-enhanced MRI. Non-echo 
planar (EP) diffusion-weighted imaging (DWI) has been shown to be useful in 
the diagnosis of cholesteatoma. The aim of this study is to assess the 
diagnostic accuracy of a shortened imaging protocol for cholesteatoma 
recurrence, without the use of gadolinium, compared to our standard contrast 
enhanced protocol, used as the gold standard. 
Methods and Materials: This is a retrospective study of 100 consecutive MRIs 
performed for suspected cholesteatoma recurrence in a single institution from 
Jan 2012 to May 2016. Our standard MRI protocol includes T2, PROPELLER 
DWI and pre and post-contrast T1-weighted sequences of the temporal bone. 
Using the standard protocol as the gold standard we assessed the sensitivity 
and specificity of a shortened protocol, which did not include the post-contrast 
sequence, for the detection of cholesteatoma recurrence. 
Results: Using the standard protocol, including post-contrast imaging, as the 
gold-standard, the sensitivity and specificity of the shortened protocol is 100% 
and 95.3%, respectively. The accuracy of the shortened protocol is 98%. The 
calculated positive predictive value is 96.6% and the negative predictive value 
is 100%. Using McNemar’s Test, no statistical difference was found between 
the two diagnostic tests (p=0.16). 
Conclusion: MRI imaging in patients with suspected cholesteatoma 
recurrence can be performed using a shortened protocol without the need for 
further contrast-enhanced sequences.  
B-0071 11:18  
Role of magnetic resonance neurography [MRN] for the diagnosis of 
peripheral trigeminal nerve injuries in patients with prior molar tooth 
extraction  
R.A.K. Dessouky1,2, Y. Xi2, J.R. Zuniga2, A. Chhabra2; 1Zagazig/EG, 
2
Dallas, TX/US (rihamdessouky@gmail.com)  
Purpose: Evaluate the role of magnetic resonance neurography [MRN] for the 
diagnosis of peripheral trigeminal nerve [PTN] injuries in patients with prior 
molar tooth extraction. 
Methods and Materials: In this retrospective study, nerve caliber, T2 signal 
intensity ratio [T2SIR] and contrast to noise ratios [CNR] were recorded by two 
observers for bilateral PTN branches, the inferior alveolar [IAN] and lingual 
nerve [LN]. Subject demographics and correlation of the MRN findings with 
Sunderland classification of nerve injury and intraoperative findings of surgical 
patients were obtained. 
Results: Among 42 subjects, mean ± SD age for cases and controls was 35.8 
± 10.2 and 43.2 ± 11.5. Male to female ratios were 1:1.4 and 1:5, respectively. 
Cases had significantly larger differences in nerve thickness, T2SIR and CNR 
than controls for IAN and LN [p values = 0.01 & 0.0001, 0.012 & 0.005 and 
0.01 & 0.01, respectively]. ROC analysis showed significant association among 
differences in nerve thickness, T2SIR and CNR and nerve injury [AUC = 0.83-
0.84 for IAN and 0.77-0.78 for LN]. Interobserver agreement was good for IAN 
[ICC = 0.70 - 0.79] and good to excellent for LN [ICC = 0.75 - 0.85]. MRN 
correlations with NST and surgical classifications were moderate to good. 
Kappa of 0.60 and 0.77 and Pearson’s correlation coefficients of 0.68 and 0.81 
were observed for differences in nerve thickness. 
Conclusion: MRN can be reliably used in diagnosis of PTN injuries related to 
molar tooth extractions with good to excellent correlation of imaging with 
clinical findings and surgical results.  
Author Disclosures: 
 J.R. Zuniga: Consultant; AxoGen Inc., Merz USA., Daiichi Sankyo. 
A. Chhabra: Consultant; ICON Medical, unrelated to this presentation. Other; 
Book Royalities; Jaypee, Wolters, unrelated to presentation. 
 
  






B-0073 11:26  
DKI can early differentiate radio-insensitive human nasopharyngeal 
carcinoma xenograft in nude mice  
X. Zheng, Y.Y. Chen, Y. Xiao, D. Zheng; Fuzhou/CN  
Purpose: To explore the feasibility of DKI sequence in early differentiating 
radio-insensitivity of nasopharyngeal carcinoma xenografts in nude mice. 
Methods and Materials: Seventy-two nude mice were implanted with CNE-1 
(low radiosensitivity) and CNE-2 (high radiosensitivity) nasopharyngeal 
carcinoma cells, and the xenografts were obtained. Then, the mice were 
underwent fraction irradiation separately. Nude mice of each cell line were 
randomly divided into non-irradiated group (G0), 10Gy group (G1), 20Gy group 
(G2), 30Gy group (G3) and 3 and 5 days after the whole dose irradiation group 
(G4, G5). DKI sequence was performed on each group. Volumes, parameters 
D and K were measured by two experienced radiologists double blindly. 
Student's t test and receiver operating characteristic (ROC) curve analyses 
were included in our study. Significant level  was chosen as 0.05. 
Results: The difference of volumes’ shrink rate between CNE-1 and 2 were 
first found in G2, with the shrink rate of 5.954% and 27.716% (p=0.032). D 
value decreased first (DG1, p=0.001) and then increased, K value increased 
first (KG1, p=0.001) and then decreased after irradiation in CNE-2, but not in 
CNE-1 xenografts (p>0.05). The AUC of DG1 and KG1 were 0.875 and 0.917, 
with sensitivity of 0.667 and 0.833, specificity of 1.000 and 1.000, respectively, 
in the cutoff values 1.27×10-3mm2/s of parameter D and 0.88 of parameter K. 
Conclusion: Both D and K can early (before volumes changed) distinguish 
radio-insensitive NPC xenografts from others. DG1 and KG1 may be the most 
useful parameters.  
B-0074 11:34  
Application of dynamic contrast-enhanced MRI and diffusion-weighted 
imaging in differentiating nasopharyngeal carcinoma and 
nasopharyngeal lymphoma  
C. Song, C. Jingliang; Zhengzhou/CN (songchengru@126.com)  
Purpose: To evaluate the utility of DCE-MRI and DWI in the differentiation of 
nasopharyngeal carcinoma (NPC) and nasopharyngeal lymphoma (NPL). 
Methods and Materials: 42 NPC patients and 27 NPL patients were recruited 
and underwent conventional MRI and DCE-MRI. The MR signals, time signal-
intensity curves(TIC) types, time to peak(TTP), enhancement peak(EP), 
maximum contrast enhancement ratio(MCER), mean ADC value, and relative 
ADC value of all the subjects were calculated and analyzed, thereafter, inter-
group comparison was performed. The threshold values of ADC and rADC for 
differentiating NPC from NPL were determined using a ROC analysis. 
Results: For NPC group, 32 cases (76.19%) demonstrated obvious 
heterogeneous enhancement. The mean TTP, EP, MCER and WR were 
48.29s, 1475.38, 136.89% and 16.81, respectively. For NPL group, 24 cases 
(88.89%) demonstrated obvious homogeneous enhancement. The mean TTP, 
EP, MCER and WR were 63.21s, 1161.82, 113.47% and 7.39, respectively. 
The ADC and rADC value were 842.34×10-6 mm2/s and 0.74 in NPC, whereas 
652.15×10-6 mm2/s and 0.56 in NPL. The differences of above parameters 
between NPC and NPL were statistically significant (P<0.05). The TTP of NPC 
was lower than that of NPL, whereas the opposite for the remaining 
parameters. The best differentiate threshold value of ADC and rADC were 
736.5×10-6 mm2/s, 634.0×10-6 mm2/s, respectively. While the AUC, sensitivity, 
specificity and Youden index of ADC and rADC were 0.943, 0.909, 0.852, 
0.761, and 0.951, 0.955, 0.852, 0.77, respectively. rADC value was slightlly 
superior to ADC value in differentiation. 
Conclusion: DCE-MRI and DWI are effective in differentiating NPC from NPL.  
B-0075 11:42  
Shape-based and quantitative MRI radiomic features in the assessment of 
non-metastatic nasopharyngeal carcinoma  
R. Du, P.-L. Khong, H. Yuan, D.L. Kwong, V.H. Lee, V. Vardhanabhuti; 
Hong Kong/HK (du94@hku.hk)  
Purpose: To investigate the association between MRI radiomic features and 
progression-free survival (PFS) of patients with nasopharyngeal carcinoma 
(NPC) after treatment. 
Methods and Materials: A cohort of 100 patients with histologically confirmed 
NPC that underwent standard treatment was retrospectively obtained. A total 
of 102 radiomic features were extracted from contrast-enhanced T1-weighted 
(CE-T1W) scans acquired at diagnosis. Univariate and multivariate analysis 
was conducted to assess the association between radiomic features and PFS. 
Mann-Whitney U test and log-rank test of Kaplan-Meier estimate was 
conducted for univariate analysis. Minimum redundancy and maximum 
relevance feature selection was used to select the most optimum subset of 
features for multivariate analysis. Logistic regression and support vector 
machine were trained with the selected features and validated using 5x8 
repeated k-fold cross validation. The performance of the models was assessed 
by receiver operator characteristic analysis. 
Results: Both univariate and multivariate analysis has identified the shape 
feature tumour sphericity to be significantly associated with 3-year PFS (Mann-
Whitney U test: p < 0.0001; log rank: p < 0.0001; logistic regression: 
AUC=0.765; SVM: AUC=0.799). No significant separation in PFS was seen 
with clinical staging. No increase in performance was found with multivariate 
models. 
Conclusion: There is a significant association between MRI radiomic features 
and PFS of NPC patients after standard treatment. Tumour sphericity has been 
identified to be most correlated to 3-year PFS. Radiomic models could 
potentially offer a non-invasive method of predicting treatment outcomes.  
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B-0076 10:39  
Digital breast tomosynthesis vs digital mammography: early performance 
measures in a population-based screening programme  
T. Hovda1, Å.S. Holen2, H. Bjørndal1, S. Sebuødegård2, S. Hofvind2; 
1
Drammen/NO, 2Oslo/NO (tone.hovda@vestreviken.no)  
Purpose: Screening with digital breast tomosynthesis (DBT) in combination 
with digital mammography (DM) has demonstrated a higher rate of recalls and 
screen-detected breast cancer compared with DM alone. We aimed at 
comparing results of early performance measures when screening with 
synthetic mammography (SM) and DBT vs DM alone in BreastScreen Norway. 
Methods and Materials: The study group consisted of 37,185 women 
screened with SM+DBT at the screening unit in Oslo, 2014-2015. Data on DM 
were acquired from two comparable screening units (Vestfold and Vestre 
Viken) in the same period (n=61,743), comprising the control group. We 
calculated recall rates and cancer detection rates and performed descriptive 
analyses comparing the two groups. Two-proportion Z-tests were used to test 
for statistical significance (p<0.05). 
Results: The recall rate due to abnormal mammographic findings was 3.4% 
(1253/37,185) and 3.3% (2038/61,743), p=0.56, for SM+DBT and DM, 
respectively. The rate of screen-detected breast cancer was 9.4 per 1000 
screened with SM+DBT and 6.1 per 1000 screened with DM (p<0.01). Both the 
rates of screen-detected ductal carcinoma in situ and invasive breast cancer 
were statistically significantly higher for SM+DBT compared with DM (p<0.01 
for both). 
Conclusion: The rate of screen-detected breast cancer was about 50% higher 
for women screened with SM+DBT compared with women screened with DM. 
This represents one of the largest increases in breast cancer detection 
between SM+DBT vs DM reported in the literature. Further studies are needed 
to investigate the benefits and potential harms by detecting additional cancers 
with DBT.  
B-0077 10:47  
Digital breast tomosynthesis (DBT) as a primary screening test in a 
population-based screening programme: interim results of the Trento 
DBT pilot study  
D. Bernardi1, M. Gentilini1, M. De NIsi1, M. Pellegrini1, C. Fantò1, M. Valentini1, 
V. Sabatino1, N. Houssami2; 1Trento/IT, 2Sydney/AU (dnlbernardi@gmail.com)  
Purpose: To report interim results of a pilot screening study implementing DBT 
(instead of standard mammography, MX) for all women who prospectively 
attended an invitation to screening, and to compare screen-detection 
measures with those obtained two years earlier for a historical cohort screened 
with MX alone 
Methods and Materials: From January to December 2015, according to a 
study protocol approved by local health authorities, a prospective cohort of 
24.060 women presenting for screening had DBT screening. Synthetic 2D 
images were reconstructed and read in integration with DBT. Cancer detection 
rate (CDR), recall rate (RR) and positive predictive value for recall (PPV) were 
calculated, and compared with those measured for a historical cohort of 20.815 
women screened with MX, by calculating the rate ratio (rr). Results were then 
analysed for prevalent and incident screens 
Results: CDR per 1000 screens for DBT-screened and MX-screened cohorts 
were 9.68 versus 5.77, respectively (rr 1.68, 95% CI 1.35-2.09). Recall rates 
  






were 2.76% for DBT and 3.42% for MX (rr 0.81, 95% CI 0.73-0.9). DBT 
implementation increased the PPV for recall from 16.71 to 35.09 (rr 2.10, 95% 
CI 1.68-2.62). The results have been confirmed both for prevalent and incident 
examinations, although the reduction of RR and the increase of PPV have 
been superior in the prevalent 
Conclusion: Population-based implementation of DBT screening was 
associated with increase in cancer detection, reduction in recall with 
significantly increase PPV for recall. Our results indicate that DBT screening 
improves screening-detection metrics however further research needs to 
assess health benefits  
B-0078 10:55  
A prospective study on sensitivity and reading time of different reading 
strategies with DBT + synthetic 2D in breast cancer screening  
F. Caumo1, G. Romanucci2, M. Zorzi1, S. Brunelli2; 1Padua/IT, 2Verona/IT 
(francesca.caumo@iov.veneto.it)  
Purpose: To compare detection rates (DR) and reading time (RT) of five 
reading strategies within the DBT+synthetic2D-based mammographic 
screening program of Verona (Italy). 
Methods and Materials: From April 2015 to March 2017, 34.071 50-69-year-
old asymptomatic women were screened for breast cancer with 
DBT+synthetic2D. We compared the sensitivity for invasive cancer (IC) and 
ductal carcinoma in situ (DCIS) and RT of five reading strategies: (1) double 
reading, (2) single reading, (3) double reading of synthetic2D plus mediolateral 
oblique (MLO) or (4) craniocaudal (CC) DBT view, and (5) double reading of 
synthetic2D plus DBT for suspicious findings (BIRADS 3). We report the 
relative sensitivities (RS) vs strategy (1) with 95% confidence intervals 
(95%CI). 
Results: Strategy (1) detected 315 cancers (271 IC, 44 DCIS; DR 9.26‰); 
mean RT 180 seconds. Strategy (2) detected 276 cancers (238 IC, 38 DCIS; 
DR 8.11‰). RS 0.88 (95%CI 0.70-1.10, p=0.25); mean RT 90 seconds. 
Strategy (3) detected 307 cancers (264 IC, 43 DCIS; DR 9.02‰). RS 0.97 
(95%CI 0.78-1.22, p=0.82); RT 102 seconds. Strategy (4) detected 309 
cancers (266 IC, 43 DCIS; DR 9.03‰). RS 0.98 (95%CI 0.78-1.23, p=0.86); 
RT 102 seconds. Strategy (5) detected 245 cancers (213 IC, 32 DCIS; DR 
7.49‰). RS 0.78 (95%CI 0.61-0.98, p=0.03); RT 66 seconds. 
Conclusion: Compared with double reading synthetic2D+DBT, double reading 
of synthetic2D plus a single DBT view reduces RT by 43% without affecting 
sensitivity for cancer. DBT+synthetic2D single reading is affected by a clinically 
(although not statistically) significant loss in sensitivity.  
B-0079 11:03  
Synthetic 2D mammography can replace digital mammography as an 
adjunct to digital breast tomosynthesis: experience with a wide angle 
DBT system  
P. Clauser1, P.A.T. Baltzer1, P. Kapetas1, R.A. Woitek1, M. Weber1, F. Leone2, 
M. Bernathova1, T.H. Helbich1; 1Vienna/AT, 2Milan/IT 
(paola.clauser@meduniwien.ac.at)  
Purpose: To evaluate the diagnostic performance of synthetic mammography 
(SM) with wide-angle-digital-breast-tomosynthesis (WA-DBT) compared to 
digital mammography (DM) alone and with WA-DBT using one view (1v, 
medio-lateral oblique) and two-view (2v) protocols. 
Methods and Materials: Included in this retrospective, IRB-approved, study 
were 205 patients with 179 lesions (89 malignant, 90 benign) who underwent 
bilateral 2v DM and WA-DBT at our institution. Standard of reference was 
histology and/or one year stability. Four blinded readers randomly evaluated 
images according to BIRADS using five protocols: 2vDM alone 2vDM with 
2vWA-DBT 2vSM with 2vWA-DBT 1vDM with 1vWA-DBT and 1vSM with 
1vWA-DBT. Lesion detection, sensitivity, specificity, and accuracy were 
calculated and compared using multivariate analysis. Readers` confidence and 
image quality were evaluated. 
Results: Average detection rate was 75.4% for 2vDM, 80.2% for 2vDM with 
WA-DBT, 78.5% for 2vSM with WA-DBT, 77.4% 1vDM with WA-DBT, and 
75.0% 1vSM with WA-DBT. 2vDM with 2vWA-DBT achieved a higher detection 
compared to 2vDM alone (P=0.004). No significant differences in detection 
were found between 2vDM with WA-DBT and 2vSM with WA-DBT (P>0.110). 
Detection was higher when two-views were available, for both SM and DM 
(P<0.034). Sensitivity and accuracy were lower with DM alone compared to all 
other reading protocols (P<0.001). Readers’ confidence and image quality 
were good to very good for all protocols. 
Conclusion: WA-DBT combined with DM or SM increases lesion detection, 
sensitivity and accuracy without reducing specificity, with no differences 
between SM or DM. Two-view protocols allow a higher detection rate than 1-
view protocols using DM or SM.  
Author Disclosures: 
 T.H. Helbich: Grant Recipient; The current study (PI T.H.H.) was supported 
by Siemens Healthineers, Erlangen, Germany. 
B-0081 11:11  
Microcalcifications in breast tomosynthesis including synthesised 
mammography, multiple angulated reconstructions and standard stack 
reconstructions  
C. Neubauer, J. Neubauer, M. Windfuhr-Blum, M. Langer; Freiburg/DE 
(claudia.neubauer@uniklinik-freiburg.de)  
Purpose: Our aim was to compare ratings on depiction, diagnostic accuracy 
and lesion characterisation of conventional synthesized mammography (SM), 
multiple angulated mammography reconstructions (INSIGHT3D) and standard 
stack reconstructions in digital breast tomosynthesis (DBT) for 
microcalcifications. 
Methods and Materials: In our retrospective study we included patients with 
microcalcifications, who had received a DBT and histology over a period of four 
months and the same number of normal cases without microcalcifications. 
Patient’s data were deidentified and the images randomised and independently 
analysed by 3 radiologists regarding the depiction, distribution, morphology 
and BI-RADS score of microcalcifications in SM, INSIGHT3D and standard 
stack reconstructions. In addition, the reading time was measured. Friedman 
and post hoc Nemenyi tests, Cochrane´s Q and post hoc Wilcoxon sign tests, 
Fleiss´ kappa and receiver operating characteristics were used for statistical 
analysis. 
Results: We included 41 histopathologically proven and 41 normal cases. 
Depiction of microcalcifications was rated best in stack reconstructions and 
better in INSIGHT3D than in SM (P<0.001). Reading time was lower in both 
SM and INSIGHT3D compared to stack reconstructions (P<0.001). Diagnostic 
accuracy and inter-rater correlation were comparable for all analyses. 
Conclusion: Although depiction of microcalcifications was best in stack 
reconstructions, INSIGHT3D depicts microcalcifications better than SM while 
maintaining a lower reading time compared to stack reconstructions. Our 
preliminary assessment suggests INSIGHT3D as a potential successor to SM.  
B-0082 11:19  
Breast screening with synthetic 2D and digital breast tomosynthesis 
(DBT): is it really more expensive?  
F. Caumo1, G. Romanucci1, M. Zorzi2, S. Brunelli1; 1Verona/IT, 2Padua/IT 
(francesca.caumo@aulss9.veneto.it)  
Purpose: To compare the costs of a breast screening program with 
synthetic2D + DBT versus full-field digital mammography (FFDM). 
Methods and Materials: costs of an organized screening program in Verona 
using FFDM are known. The same analysis was retrospectively carried out for 
two consecutive years of breast screening using FFDM (and synthetic2D + 
DBT only on second level assessment) from 1st April 2014 to 31 march 2015 
and synthetic2D + DBT from 1st April 2015 to 31 march 2016. The cost of the 
entire screening process for single screened woman was calculated by adding: 
the cost of technology (mammograms, ecotomographs, workstations, PACS 
space); the cost of staff (radiographers, radiologists, nurses, secretarial staff); 
the cost of material for invasive assessment. 
Results: the cost of the screening program with FFDM (14374 screened 
women with 76 cancers detected; DR 5.29 per 1,000 screens) was 53.8 euros 
for single screened woman. The cost of the screening program with FFDM 
(DBT performed only on second level assessment; 14423 screened women 
with 78 cancers detected; DR 5.41 per 1,000 screens) was 66.8 euros for 
single screened woman. The cost of the screening program with synthetic 2D + 
DBT (16666 screened women with 155 cancers detected; DR 9.30 per 1,000 
screens) was 64.2 euros for single screened woman. 
Conclusion: the implementation of an organized DBT breast screening has a 
minimal additional cost compared to FFDM-organized screening, especially if 
additional cancers are found.  
B-0083 11:27  
Comparing two visualisation protocols for tomosyntesis in screening: 
specificity and sensitivity of slabs vs planes plus slabs  
V. Iotti, P. Giorgi Rossi, S. Ravaioli, A. Nitrosi, M. Bertolini, E. Bacchini, 
R. Vacondio, M. Pescarolo, P. Pattacini; Reggio Emilia/IT 
(valentina.iotti@ausl.re.it)  
Purpose: Tomosynthesis (DBT) showed to be more sensitive than digital 
mammography (DM), but it needs longer reading time, limiting its introduction 
as primary screening test. Simplified visualisation protocols have been 
designed. We compared accuracy of a simplified protocol with slab only vs. a 
standard protocol of slab plus planes, both integrated with synthetic 2D. 
Methods and Materials: All DBTs were acquired in RETomo trial experimental 
arm. The first set, to estimate specificity, included 894 randomly selected DBT 
(including 12 cancers), and was read by two radiologists(CAM-RV). The 
second set included 273 screening DBTs enriched with 24 cancers, 8 of which 
present in the first set; it was read by one of the first radiologists and another 
radiologist(RV-SR); 28 cancers with 64 independent readings were used to 
estimate sensitivity. DBTs were read by both radiologists with both protocols 
  






separated by 3 months wash out. The order of protocol reading was randomly 
assigned 1:1. Only women that were positive at the screening reading were 
assessed, to date follow up data for negatives are still not available. 
Results: Sensitivity was 82.8% (53/64, 95% confidence interval (95%CI) 71.3-
91.1) and 90.6% (95%CI 80.7-96.5) with simplified and standard protocol, 
respectively (p=0.19). In the random screening setting specificity was 97.9% 
(1727/1764, 95%CI 97.1-98.5) and 96.3% (95%CI 95.3-97.1)(p0.005). Inter-
reader agreement was 0.70 and 0.57 with simplified and standard protocol, 
respectively. Median reading time decreased by 20%. 
Conclusion: A simplified protocol without the presentation of planes, 
increased DBT specificity and reproducibility, but may have a negative impact 
on sensitivity.  
B-0084 11:35  
Overview of early clinical implementation of digital breast tomosynthesis: 
a single-centre experience  
S. Soo, K. Rahmat; Kuala Lumpur/MY (suetwoonsoo@gmail.com)  
Purpose: To evaluate the impact of performance of mammographic study 
before and after the introduction of digital breast tomosynthesis (DBT) into the 
clinical practice in University of Malaya Medical Centre (UMMC). 
Methods and Materials: A retrospective study was conducted on patients who 
underwent breast biopsy in UMMC from October 2013 to February 2015. The 
biopsy rate, cancer detection rate, sensitivity and positive predictive values 
(PPV) were calculated and compared between the groups. Analysis was done 
using SPSS version 22.0 and a p-value <0.05 was considered as statistical 
significant different. 
Results: The patients were divided into two groups: Full Field Digital 
Mammography (FFDM) (n = 1250) and FFDM + DBT (n = 2174). 
Histopathological examination results were the gold standard of the study. The 
combination of FFDM and DBT resulted in significant reduction of biopsy rate 
from 57.5% to 37.0% (p = 0.03). The cancer detection rates were statistically 
significant different between FFDM and FFDM + DBT groups from 30.1% to 
44.5% (p<0.03). The sensitivity and positive predictive value (PPV) were 90% 
and 36% for FFDM group; and 92% and 38% for FFDM + DBT group, 
respectively. 
Conclusion: The combination of FFDM and DBT significantly reduced biopsy 
rate and increased the cancer detection rate compared to FFDM alone. The 
sensitivity and PPV were also increased from 90% to 92% and 36% to 38%, 
respectively, indicating that incorporation of DBT in mammographic 
examinations increased the number of true positive cases. A larger cohort 
study is needed to validate these findings.  
B-0085 11:43  
Breast screening 2D-mammography or breast tomosynthesis: 
comparison in terms of cancer detection and recalls  
F. Fernandez Valverde, S. Romero Martin, J.L. Raya Povedano, 
J.E. Gordillo Arnaud; Cordoba/ES (sararomero@hotmail.com)  
Purpose: To evaluate tomosynthesis compared with 2D-mammography in 
terms of cancer detection and recalls in a screening program. To assess 
positive predictive value (PPV) of recalls. 
Methods and Materials: Prospective study included women (age 50-69) who 
participated in the breast screening program between January 2015 and 
December 2016. Three digital mammographs and one tomosynthesis were 
available, being women appointed for different devices randomly. Blind and 
independent double reading was the standard practice and five radiologists 
participated. The study was approved by a regional ethics committee. The 
comparisons between qualitative variables were performed using the Chi-
squared test and p value of less than 0.05 was considered statistically 
significant. 
Results: 39851 women participated. 2180 women were recalled (5.5%) and 
214 cancers were detected (5.3/1000 screens). 23783 women were appointed 
for digital mammographs and 16068 women for tomosynthesis. 1471 recalls 
occurred with digital mammographs (6.2%) compared with 709 recalls with 
tomosynthesis (4.4%). It meant a significant decreased of 29% (95%IC: 7.8%-
66.2%, p<0.001). 122 cancers were detected with digital mammographs 
(5.1/1000 screens), compared with 92 cancers with tomosynthesis (5.7/1000 
screens), showing an increase in cancers detection of 10.5% (95%IC: 1.3%-
51.5%, p=0.425). PPV of recalls was 8.3% with digital mammographs (122 
cancers/1471 recalls) and 13.0% with tomosynthesis (92 cancers/709 recalls), 
which showed an increase of 36.2% (95%IC: 16.1%-62.4%, p=0.001). 
Conclusion: The use of tomosynthesis in a breast screening program results 
in an increase in cancer detection rate and significant decreases in recall rate. 
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B-0086 10:30  
Noncontrast ASL-perfusion in pre-surgical glioma diagnostics  
A. Batalov, N. Zakharova, I. Pronin, E. Pogosbekyan; Moscow/RU 
(batalov89@gmail.com)  
Purpose: To study the tumor blood flow (TBF) in the supratentorial brain 
gliomas by ASL-perfusion in comparison with the histolpathological 
characteristics of the tumors. 
Methods and Materials: The study group included 126 patients with primary 
supratentorial gliomas of varying degrees of malignancy. Of them, 35 low-
grade gliomas (I-II grade WHO) and 91 high-grade gliomas (41-III grade WHO, 
50 - IV grade WHO). 64 female and 62 male aged from 12 and 75(median-44, 
interquartile range 30-54). Patients were examined on a 3.0 T MR-tomograph. 
The pseudo-continuous ASL (pcASL) technique was used to determine tumor 
blood flow,. Post-processing of data was carried out in the ReadyView (GE) 
program. Tumor blood flow was normalized regarding intact white matter of the 
semiovalicular center of the contralateral hemisphere was performed.All 
diagnoses were confirmed histopathologically. 
Results: Mean tumor blood flow in the group of low-grade gliomas was 28.85 ± 
14.99 ml/ 100 g/ min. Normalized TBF was 1.52±0.77. In the group of high-
grade gliomas, the tumor blood flow was 152.75±92.82 ml/100 g/min. 
Normalized TBF was 8.09±5.24. The sensitivity and the specificity of this 
technique in the differential diagnosis of low-grade and high-grade gliomas was 
88.6% and 91.2%, accordingly, AUC 0.958. Cutoff-51 ml/100 g/min or 2.3 
(normal blood flow). 
Conclusion: ASL-perfusion is a reliable quantitative technique that allows 
estimating blood flow in gliomas. ASL can be used in differential diagnosis of 
low-grade and high-grade gliomas at the pre-operative stage. This technique 
has a high sensitivity (88.6%) and specificity (91.2%).  
B-0087 10:38  
Building an apparent diffusion coefficient radiomics to yield high 
diagnostic performance in identifying atypical primary CNS lymphoma 
mimicking glioblastoma  
M. Kim, J. Park, H. Kim; Seoul/KR (manzae.kim@gmail.com)  
Purpose: To test the technical feasibility, diagnostic performance, and 
generalizability of a radiomics model utilizing apparent diffusion coefficient 
(ADC) for identifying atypical primary central nervous lymphoma (PCNSL) 
mimicking glioblastoma. 
Methods and Materials: This retrospective study was approved by our 
institutional review board. We used a training set of 112 patients (70 
glioblastomas, 42 PCNSLs) and extracted 1618 radiomic features (17 first 
order, 7 volume and shape, 162 texture, and 1432 wavelet) from their ADC 
maps and contrast-enhanced T1-weighted images (CE-T1WI). Different 
combinations of 12 feature selection and 8 classification methods were 
optimized using 10-fold cross-validation. The model was validated internally 
and externally, in a set of 42 patients (21 glioblastomas, 21 PCNSLs) and 42 
patients (28 glioblastomas, 14 PCNSLs) with atypical PCNSL and compared to 
the histogram parameters of cerebral blood volume (90% cutoff, CBV90) and 
ADC (10% cutoff, ADC10) using the area under the ROC curve (AUC). 
Results: The ADC radiomics model was optimized with the combination of 
recursive feature elimination and a random forest classifier (mean AUC= 0.983, 
stability 2.52%). In internal validation, the ADC model (AUC = 0.984) showed 
similar performance with CE-T1WI radiomics (AUC = 0.968) and was better 
than CBV90 (AUC= 0.905) or ADC10 (AUC= 0.787) in atypical PCNSL 
diagnosis. The ADC radiomics model showed robustness (AUC = 0.944) in 
external validation. 
Conclusion: The ADC radiomics model had good generalizability and yields a 
better diagnostic performance than single-parameter measurements in 













B-0088 10:46  
Wavelet-based reconstructions of dynamic susceptibility MR perfusion: a 
new method to visualize hypervascular brain tumours  
T. Huber, L. Rotkopf, W.G. Kunz, S. Bette, B. Wiestler, J. Gempt, C. Zimmer, 
W.H. Sommer, K. Thierfelder; Munich/DE (h-thomas@gmx.de)  
Purpose: Wavelet-based reconstructions of dynamic perfusion datasets offer 
an innovative and elegant way of vascular visualization. This novel technique 
has shown benefits in dynamic CT-perfusion datasets, but it has not been 
applied to MRI yet. The aim of this study was to demonstrate if wavelet-based 
reconstructions can be transferred to dynamic MR-perfusion datasets (wavelet-
MRP) to visualize hypervascular tumours, like glioblastoma. 
Methods and Materials: Consecutive preoperative 3T dynamic susceptibility 
MR perfusion datasets of 46 subjects with glioblastoma (mean age: 63±13.1 
years, 18f) were included in this IRB-approved feasibility study. Wavelet-MRP 
was calculated after initial motion correction using the wavelet transform (Paul 
wavelet, order 1) of each voxel time course. Five different aspects of image 
quality were each rated on a 5-point Likert scale and compared to cerebral 
blood volume (CBV) maps. Quantitative analysis included Weber-contrast and 
signal-to-noise ratio. Wilcoxon signed-rank test was applied. 
Results: Generation of wavelet-MRP was successful in 46/46 subjects (mean 
time 2.45±.12 min). Wavelet-MRP achieved higher scores in all qualitative 
ratings: tumour depiction (4.02 vs 2.33), contrast enhancement (3.93 vs 2.23), 
central necrosis (3.86 vs 2.40), morphologic correlation (3.87 vs 2.24), and 
overall impression (4.00 vs 2.41), all p<.0001. Quantitative image analysis 
showed a higher Weber-contrast (8.08±5.14 vs 2.58±.843; p<.0001) and a 
higher signal-to-noise ratio (3.66±1.67 vs 1.80±.887; p<.0001) for wavelet-
MRP. 
Conclusion: Our study demonstrates the feasibility of wavelet reconstructions 
in MR perfusion datasets. This method allows a fast and reproducible 
evaluation of MR-perfusion data and generates maps with a clearer tumour 
depiction compared to standard CBV maps.  
Author Disclosures: 
  T. Huber: Consultant; Smart Reporting GmbH (not related). L. Rotkopf: 
Consultant; Smart Reporting GmbH (not related).  J. Gempt: Consultant; 
Brainlab AG (not related). C. Zimmer: Advisory Board; Philips, Bayer Schering, 
Clinical Neuroradiology (not related). Research/Grant Support; Biogen Idec, 
Quintiles, MSD Sharp & Dome, Boehringer Ingelheim, Inventive Health Clinical 
UK Ltd., Advance Cor, Brainsgate, Pfizer, Bayer-Schering, Novartis, Roche, 
Servier, Penumbra, WCT GmbH, WCT GmbH, Syngis, SSS Internartional 
Clinical Research, PPD Germany GmbH, Worldwide Clinical Trials Ltd., 
Phenox, Covidien, Actelion, Medivation, Medtronic, Harrison Clinical Research, 
Concentric, Pharmtrace, Reverse Medical Corp., Premier Research Germany 
Ltd., Surpass Medical Ltd. and GlaxoSmithKline (all not related). Speaker; 
Philips, Bayer Schering (not related). W.H. Sommer: Founder; Smart 
Reporting GmbH, Planerio GmbH.  
B-0089 10:54  
Differentiation of glioblastoma multiforme and single brain metastasis by 
the distribution pattern of intratumoral susceptibility sign derived from 
susceptibility-weighted imaging  
H. Kang, S. Jang; Seoul/KR (knroo@hanmail.net)  
Purpose: The aim of this study is to determine whether the distribution pattern 
of intratumoural susceptibility sign (ITSS) derived from susceptibility-weighted 
imaging (SWI) could differentiate glioblastoma multiforme (GBM) and single 
brain metastasis. 
Methods and Materials: 58 intracranial brain neoplasm patients (55 male and 
3 female, age 69.8 ± 8.2 years (mean ± SD), 42 brain metastases and 16 with 
GBM) were enrolled in this study. These patients underwent examinations that 
included SWI in addition to conventional magnetic resonance (MR) sequences 
on a 3T. Two radiologists investigated the distribution patterns of ITSS of the 
tumours and applied an ITSS grading system based on the degree of the ITSS. 
Then, we compared the grade of the visibility of ITSS in the central portion of 
tumours; the inner three-quarter area of tumour volume (CITSS) and in the 
tumour capsular area; the outside one-quarter area of tumour volume (PITSS) 
on SWI. 
Results: Wilcoxon rank sum test showed that the grades of the CITSS in GBM 
were statistically higher than brain metastasis (p < 0.0001) and the PITSS in 
GBM was statistically lower than brain metastasis (p < 0.0001). 
Conclusion: Our findings suggest that there were different characteristics of 
ITSS between GBM and brain metastasis on SWI due to the profound 
difference in histologic feature of capillary between the two tumour types. The 
CITSS within the GBM represents the complex immature neovascularity and 
blood leakage, and PITSS in the metastasis represents the mechanical 




B-0090 11:02  
In vivo assessment of tumour heterogeneity in WHO 2016 glioma grades 
using diffusion kurtosis imaging  
J.-M. Hempel, J. Schittenhelm, C. Brendle, M. Skardelly, B. Bender, 
G. Tabatabai, S. Castaneda Vega, U. Ernemann, U. Klose; Tübingen/DE 
(johann-martin.hempel@uni-tuebingen.de)  
Purpose: To assess the diagnostic performance of normalized and non-
normalized diffusion kurtosis imaging (DKI) metrics extracted from different 
tumour volume data for grading glioma according to the integrated approach of 
the revised 2016 WHO classification. 
Methods and Materials: Sixty patients with histopathologically confirmed 
glioma were retrospectively assessed between 01/2013 and 08/2016 from a 
prospective trial approved by the local institutional review board. Mean kurtosis 
(MK) and mean diffusivity (MD) metrics from DKI were assessed by two 
blinded physicians from four different volumes of interest (VOI): whole solid 
tumour including (VOItu-ed) and excluding perifocal oedema (VOItu), infiltrative 
zone (VOIed), and single slice of solid tumour core (VOIslice). Intra-class 
correlation coefficient (ICC) was calculated to assess inter-rater agreement. 
One-way ANOVA was used to compare MK between 2016 CNS WHO tumour 
grades. Friedman's test compared MK and MD of each VOI. Spearman’s 
correlation coefficient was used to correlate MK with 2016 CNS WHO tumour 
grades. ROC analysis was performed on MK for significant results. 
Results: The MK assessment showed excellent inter-rater agreement for each 
VOI (ICC, 0.906-0.955). MK was significantly lower in IDHmutant astrocytoma 
(0.40±0.07) than in 1p/19q-confirmed oligodendroglioma (0.54±0.10, p=0.001) 
or IDHwild-type glioblastoma (0.68±0.13, p &lt; 0.001). MK and 2016 WHO tumour 
grades were strongly and positively correlated (VOItu-ed, r=0.684; VOItu, 
r=0.734; VOIed, r=0.625; VOIslice, r=0.698; p &lt; 0.001). 
Conclusion: Non-normalized MK values obtained from VOItu and VOIslice 
showed the best reproducibility and highest diagnostic performance for 
stratifying glioma according to the integrated approach of the recent 2016 
WHO classification.  
Author Disclosures: 
 J. Schittenhelm: Grant Recipient; Else Übelmesser Foundation (30.19845).  
B-0091 11:10  
Lipid mapping for grading of gliomas  
P. Seow, N. Ramli, A.T. Hernowo, V. Narayanan, J.H. Wong; 
Kuala Lumpur/MY (norlisahramli@gmail.com)  
Purpose: To evaluate the potential of lipid map generated from magnetic 
resonance imaging (MRI) chemical shift gradient echo in-and opposed-phase 
(IOP) sequence for characterisation lipid landscape and as a tool in grading of 
gliomas. 
Methods and Materials: Forty histologically proven glioma patients underwent 
a standard MRI tumour protocol with the addition of IOP sequence. The 
subregions of tumour (solid enhancing, solid non-enhancing, cystic and tumour 
core) were delineated using snake model (ITK-snap) with reference to 
structural MRI images (T1, T2, FLAIR, ADC & DWI). The lipid maps were 
computed based on signal loss ratio (SLR) obtained from IOP imaging. The 
mean SLR values of the subregions were obtained from the lipid maps after 
post-processing of the MRI images using SPM12. 
Results: The mean SLR of solid non-enhancing portion of tumour (mean SLRII 
= 0.047, mean SLRIII = 0.061, mean SLRIV = 0.079, & p= 0.003) and tumour 
core (mean SLRII = 0.057, mean SLRIII =0.059, mean SLRIV =0.073, & p=0.013) 
demonstrated statistically significant differences between the WHO grades 
(grades II, III & IV). The classification probabilities for solid non-enhancing 
(grade II (SII=0.77), grade III (SIII=0.25) and grade IV (SIV=0.67)) and tumour 
core (grade II (SII=0.60), grade III (SIII=0.38) and grade IV (SIV=0.59)) were 
higher than the other tumour subregions. Moderate positive correlations were 
seen between WHO grades with mean SLR on lipid map of solid non-
enhancing (=0.579, p<0.001) and tumour core (=0.461, p=0.003). 
Conclusion: Lipid quantification via lipid mapping provides useful information 
on lipid landscape in tumour heterogeneity characterisation of glioma.  
B-0092 11:18  
Arterial spin labelling and diffusion tensor magnetic resonance imaging-
derived metrics for differentiation of post-treatment brain tumour 
recurrence from tissue necrosis  
M. Talaat1, A. Abdel Razek2, L. Elserougy2, G. Gaballa2; 1Kafr Elsheikh/EG, 
2
Mansoura/EG (dr_MonaTalaat@hotmail.com)  
Purpose: Differentiating post-treatment brain tumour recurrence from tissue 
necrosis using arterial spin labelling (ASL) perfusion and diffusion tensor 
imaging (DTI)-derived metrics in the enhancing and oedema regions. 
Methods and Materials: The study was done on 42 treated brain tumour 
patients with post-treatment enhancing lesions on MRI. Conventional MRI, 
ASL, and DTI imaging were done. Tumour blood flow (TBF), fractional 
anisotropy (FA), and mean diffusivity (MD) were measured at the enhancing 
  






and oedema regions and the values were recorded for each case. Lesions 
were categorised as recurrence or necrosis by histopathology. 
Results: Comparing recurrence to necrosis, there was high significant 
differences in TBF measured in the enhancing and oedema regions (both P < 
0.001), accuracy (92.5%, 90%), sensitivity (93.8%, 81.2%), and specificity 
(91.7%, 95.8%), respectively. FA values revealed significant differences (P< 
0.001, P<0.04), accuracy (80%, 67.6%), sensitivity (81.2%, 68.8%), and 
specificity (79.2%, 66.7%), respectively. MD values revealed significant 
difference (both p< 0.001), accuracy (92.5%, 80%), sensitivity (93.8%, 81.2%), 
and specificity (91.7%, 79.2%), respectively. Combined ASL and DTI metrics of 
the enhanced lesion revealed AUC of 0.98, accuracy of 95%, sensitivity of 
93.8%, and specificity of 95.8%. Combined ASL and DTI metrics values in the 
peri-lesion oedema revealed AUC of 0.97, accuracy of 92.5%, sensitivity of 
93.8%, and specificity of 91.7%. 
Conclusion: ASL and DTI metrics in enhancing and oedema regions are 
valuable non-invasive tools in differentiating post-treatment recurrent brain 
tumour from tissue necrosis using individual and combined metrics.  
B-0093 11:26  
Histogram analysis of diffusion kurtosis imaging estimates for in vivo 
assessment of 2016 WHO glioma grades  
J.-M. Hempel, J. Schittenhelm, C. Brendle, B. Bender, M. Skardelly, 
G. Tabatabai, S. Castaneda Vega, U. Ernemann, U. Klose; Tübingen/DE 
(johann-martin.hempel@uni-tuebingen.de)  
Purpose: To assess the diagnostic performance of histogram analysis of 
diffusion kurtosis imaging (DKI) maps for in vivo assessment of the 2016 World 
Health Organization Classification of Tumours of the Central Nervous System 
(2016 CNS WHO) integrated glioma grades. 
Methods and Materials: Seventy-seven patients with histopathologically 
confirmed glioma who provided written informed consent were retrospectively 
assessed between 01/2014 and 03/2017 from a prospective trial approved by 
the local institutional review board. Ten histogram parameters of mean kurtosis 
(MK) and mean diffusivity (MD) metrics from DKI were independently assessed 
by two blinded physicians from a volume of interest around the entire solid 
tumour. One-way ANOVA was used to compare MK and MD histogram 
parameter values between 2016 CNS WHO-based tumour grades. Receiver 
operating characteristic analysis was performed on MK and MD histogram 
parameters for significant results. 
Results: The 25th, 50th, 75th, and 90th percentiles of MK and average MK 
showed significant differences between IDH1/2wild-type gliomas, IDH1/2mutated 
gliomas, and oligodendrogliomas with chromosome 1p/19q loss of 
heterozygosity and IDH1/2mutation (p &lt; 0.001). The 50
th, 75th, and 90th 
percentiles showed a slightly higher diagnostic performance (area under the 
curve (AUC) range; 0.868-0.991) than average MK (AUC range; 0.855-0.988) 
in classifying glioma according to the integrated approach of 2016 CNS WHO. 
Conclusion: Histogram analysis of DKI can stratify gliomas according to the 
integrated approach of 2016 CNS WHO. The 50th (median), 75th, and the 90
th 
percentiles showed the highest diagnostic performance. However, the average 
MK is also robust and feasible in routine clinical practice.  
Author Disclosures: 
 J. Schittenhelm: Grant Recipient; Else Übelmesser Foundation (30.19845).  
B-0094 11:34  
Differentiating primary CNS lymphomas from glioblastomas and 
inflammatory demyelinating pseudotumour using relative minimum 
apparent diffusion coefficients  
J. Wen; Shanghai/CN (wen123jianbo@163.com)  
Purpose: Our purpose was to evaluate the diagnostic performance of 
diffusion-weighted imaging (DWI), the relative ADCmin (rADCmin) in 
differentiating primary central nervous system lymphomas (PCNSL) from 
glioblastomas (GBM) and inflammatory demyelinating pseudotumours (IDP). 
Methods and Materials: MRI images were reviewed retrospectively in 82 
patients including 39 PCNSLs, 35 GBMs, and 8 IDPs. Regions of interest 
(ROI) were drawn around the tumour on contrast-enhanced images, these 
images were transferred onto coregistered ADC maps to obtain the minimum 
ADC (ADCmin) and the normalized ADCmin ratios (rADCmin) were calculated 
using the formula rADCmin = ADCmin of the lesion/ADCmin of the normal 
white matter. The rADCmin values were compared between PCNSLs, GBMs 
and IDPs using the ANOVA test. ROC curves were constructed to evaluate the 
diagnostic performance of rADCmin values and to determine the optimum 
thresholds. Simple logistic regression was analysed to evaluate the 
relationship between ADCs and tumour cellularity. 
Results: The rADCmin value was significantly lower in PCNSLs (0.675±0.113) 
than GBMs (0.765±0.059) and IDPs (0.834±0.067 ) (PCNSL vs GBM, p<0.001; 
PCNSL vs IDP, p<0.001). rADCmin was a significant assessor for 
differentiating PCNSLs from non-PCNCLs (p<0.001). The optimal cut-off value 
was 0.722 (sensitivity: 74.5%; specificity: 74.1%; AUC: 0.803) on ROC 
analysis. A stronger negative correlation (r = -0.755, p = 0.000) was obtained 
between the cytoplasm and rADCmin. 
Conclusion: rADCmin value is helpful in differentiating PCNSL from GBM and 
IDP. Thus, ADC values may provide a useful supplement to the information 
obtained from conventional contrast-enhanced MR imaging, and assist in 
future treatment planning.  
B-0095 11:42  
Percentage signal recovery (PSR) calculated from dynamic susceptibility 
contrast perfusion MRI: accuracy in differentiating various enhancing 
intracranial mass lesions  
J.P. Sharma, T. Singh, K. Singh, I. Mohapatra, M. Singh; Gurgaon/IN 
(doc.sharmajai24@gmail.com)  
Purpose: To determine whether percentage signal recovery (PSR) derived 
from dynamic susceptibility-weighted contrast (DSC)-enhanced perfusion MR 
imaging is accurate in differentiating various enhancing intracranial mass 
lesions like GBM, metastasis, lymphoma and tuberculoma. 
Methods and Materials: This prospective study included 65 patients who 
underwent DSC perfusion MRI. T2* mean signal intensity recovery curves were 
drawn to calculate minimum, maximum, mean and relative PSR (rPSR). 
Accuracy of these parameters was assessed using ROC curves, one-way 
ANOVA, Student's t test and Chi-square test. 
Results: Minimum, maximum, mean, rPSR were much higher in lymphoma 
(149.6, 216.6, 198.2, 2.16 ± SD) as compared to GBM (65.0, 86.7, 78.2, 0.91), 
tuberculoma (85.5, 122.3, 131.5, 1.54) and metastasis (52.9, 74.3, 63.9, 0.75). 
Mean curve in all cases of lymphoma crossed above the baseline. ROC curves 
of minimum, maximum, mean, rPSR for differentiating lymphoma from others 
(GBM, tuberculoma, metastasis) yield high AUC values of 0.987, 0.988, 0.963 
and 0.961, respectively (p <0.0001) and sensitivity of 100%, specificity of 
93.0%, 96.5%, 94.7% and 94.7% with optimum cut-off of 108, 147.5, 136.0 and 
1.55, respectively. ROC curves of minimum, maximum, mean, rPSR for 
differentiating metastasis from others (GBM, lymphoma, tuberculoma) yield 
AUC values of 0.800, 0.803, 0.804, 0.839, respectively, with p<0.001. Similar 
ROC curves for differentiating tuberculoma from GBM, lymphoma and 
metastasis yield AUC values of 0.627, 0.722, 0.748 and 0.744 with p<0.05 for 
mean PSR and rPSR. 
Conclusion: PSR is a practical and simplified perfusion MRI parameter which 
is effective in differentiating lymphoma and metastasis from other enhancing 
lesions with high sensitivity and specificity.  
B-0096 11:50  
qMRI using relaxometry detects non-visible peritumoural contrast 
enhancement in malignant gliomas  
I. Blystad1,1, J.B. Warntjes1,1, Ö. Smedby2,1, P. Lundberg1,1, E.-M.B. Larsson3,1, 
A. Tisell1,1; 1Linköping/SE, 2Huddinge/SE, 3Uppsala/SE 
(ida.blystad@regionostergotland.se)  
Purpose: Malignant gliomas are diffusely growing, infiltrative tumours. This 
study was performed to investigate if there is non-visible contrast enhancement 
in the peritumoural area of malignant gliomas using relaxometry with synthetic 
magnetic resonance imaging (syMRI). 
Methods and Materials: 25 patients with a radiological appearance of 
malignant glioma were included. The quantitative MR-sequence (MAGIC), 
measuring longitudinal relaxation (R1), transverse relaxation (R2) and proton 
density (PD), was added to the standard MRI protocol before surgery. 
Diagnosis was confirmed by histopathology. Five patients were excluded, three 
due to another diagnosis and two due to motion during MR examination. In 20 
patients, synthetic MR images were created from the quantitative scan. Manual 
regions of interest (ROIs) outlined the visibly contrast-enhancing border of the 
tumours and the peritumoural area in conventional and synthetic images. 
Contrast enhancement was quantified by subtraction of native images from 
post-Gd-images, creating T1- and R1-difference maps, where the ROIs were 
used to analyse the tissue of interest. Peritumoural T1- and R1-differences 
were normalized to the normal appearing white matter in the contralateral 
hemisphere. A one-sided T test was performed on the peritumoural- and the 
NAWM-ROIs. 
Results: The malignant gliomas have heterogeneous relaxometry values. After 
normalization to normal appearing white matter, the quantitative R1-difference 
maps showed significant, non-visible contrast enhancement in the peritumoural 
area (p<0.001), whereas conventional spin echo images did not. 
Conclusion: Relaxometry detects non-visible contrast enhancement in the 
peritumoural area of malignant gliomas. This could represent infiltrative tumour 
growth.  
Author Disclosures: 
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B-0097 10:30  
Vascular calcification on mammography and coronary artery disease 
identified by computed tomography  
S.L. McLenachan, M. Williams, F. Camilleri, D.E. Newby; Edinburgh/UK 
(suzannemclenachan@gmail.com)  
Purpose: This sub-study of the SCOT-HEART randomised controlled trial of 
computed tomography coronary angiography (CTCA) in patients with 
suspected stable angina aimed to assess the prevalence of breast arterial 
calcification (BAC) and associations with cardiovascular risk factors, coronary 
artery calcification, coronary artery disease on CTCA and subsequent 
outcomes. 
Methods and Materials: 405 female participants underwent CTCA and 
subsequent mammography. Mammograms were assessed for the presence of 
BAC. 
Results: BAC was identified in 92 (23%) patients who were slightly older 
(62.9±6.6 versus 58.6±8.0 years; p<0.001), had higher cardiovascular risk 
scores (19.0±17 versus 16.7±10.5; p=0.018) and were more likely to be non-
smokers (73% versus 51%; p<0.001). Age and non-smoking status were the 
only independent risk factors for BAC. Coronary artery calcification was 
present in 57 (62%) patients with BAC (relative risk 1.26 (95% confidence 
intervals 1.04-1.53, p=0.02). In patients with BAC, non-obstructive coronary 
artery disease was identified in 38 (14%) and obstructive coronary artery 
disease in 19 (21%). Patients with BAC were more likely to have obstructive 
coronary artery disease (relative risk 1.66 (95% confidence intervals 1.01-2.73; 
p=0.046), but this had poor discrimination (AUC 0.560, p=0.149) and was not 
independent of age or cardiovascular risk factors. Fatal or non-fatal myocardial 
infarction at 3 years occurred in one patient with BAC (1.1%) and three without 
BAC (1.0%, p=0.649). 
Conclusion: BAC occurs in one-fifth of the patients referred for assessment of 
suspected coronary artery disease, but is not associated with traditional 
cardiovascular risk factors and is a poor discriminator for obstructive coronary 
artery disease.  
Author Disclosures: 
 D.E. Newby: Speaker; Toshiba Medical Systems. 
B-0098 10:38  
Should breast artery calcifications be graded?  
Ç.M. Altay1, E. Düsünceli Atman2, C. Uzun2, M.F. Arslan2; 1Karabük/TR, 
2
Ankara/TR (cetinmurataltay@gmail.com)  
Purpose: The aim of this study was to determine the relationship between the 
severity of mammographically detected breast arterial calcifications (BACs) 
and severity of coronary artery calcium (CAC) score on ECG gating coronary 
artery computed tomography angiography(CA-CTA). 
Methods and Materials: Between July 2011- September 2016, 112 women 
(age 40-72 years, mean 55,3±8,8) who underwent both mammography and 
ECG gating CA-CTA were reviewed to determine BACs and CAC score, 
retrospectively. The exclusion criteria were determined a. malignant 
microcalcification on mammography, b. previous breast surgery, c. chest 
radiotherapy, d. chemotherapy for any reason, e. coronary bypass and 
stenting. BACs on mammography and CAC score on CA-CTA were identified 
with radiological consensus. BACs were graded in three groups, grade 1: no 
calcification, grade 2: dot like calcifications and grade 3: linear calcifications on 
any artery. The computer software was utilized to calculating CAC score . 
Results: The rate of patients with left BACs was 15.2% (n:17) and right BACs 
was %15,2 (n:17). Patients with BACs were older than patients without BACs 
(p<0,001). The presence of right or left BACs predicted with 47.2% sensitivity 
and 96.1% specificity in patients with CAC 1. Positive correlation was 
detected between BACs severity grading and CAC score (p<0,001). CAC 
score was higher in patients with high BACs grade. 
Conclusion: BACs are an indicator of presence of CAC. The relationship 
between BACs and CAC was evaluated from a different point of view in the 





B-0099 10:46  
Breast arterial calcification on screening mammography can predict 
significant coronary artery disease in women  
B.S. Kelly, E. Heffernan, S. McNally; Dublin/IE (brendanskelly@me.com)  
Purpose: Breast arterial calcification (BAC) on digital mammography has been 
associated with an increased risk of coronary artery disease (CAD). We aimed 
to investigate the association of BAC with findings on coronary computed 
tomography angiography (CCTA) within a symptomatic cohort of women from 
the national breast screening programme (BreastCheck). 
Methods and Materials: Data of symptomatic women (chest pain) aged 
between 50 and 65 years who underwent a CCTA and who also had a 
screening mammography between 2014 and 2015 were recorded. BAC and 
CAD-RADS™: Coronary Artery Disease-Reporting and Data System were 
scored by separate blinded specialist radiologists. Cardiac risk factors were 
recorded. Patients’ cardiac follow-up (with exercise stress test, percutaneous 
coronary intervention or echocardiography) and cardio-protective medications 
were also documented. 
Results: 219 eligible women underwent a CCTA. Of these, 104 patients also 
underwent digital mammography. Using standard linear regression, BAC was 
identified as the only significant predictor of CAD-RADs 3 disease. Using 
binomial logistic regression, BAC remained independently associated with 
CAD-RADs 3 (p=0.023). A significantly higher proportion of patients with BAC 
>1 were on cardio-protective medications (p=0.041) and had medications 
initiated or changed, or had further cardiac investigation (p=0.037 and p=0.019, 
respectively) than those with no BAC, after a mean follow-up of 20.6 (range 15-
27) months. 
Conclusion: BAC diagnosed on 2 yearly screening mammography predicts 
CAD-RADs 3 disease in symptomatic patients.  
B-0100 10:54  
Comparing computer-aided diagnosis (CAD) system with manual method 
for detecting breast arterial calcification (BAC)  
A.N. Kamble, M. Popli; New Delhi/IN (akshaykumar.kamble92@gmail.com)  
Purpose: Cardiovascular disease parthenogenesis starts from vessel changes 
due to chronic conditions like diabetes and hypertension. Breast arterial 
calcification (BAC) provides the unique opportunity to screen women for these 
vascular changes, but unfortunately, they are often ignored in the final report. 
Methods and Materials: 299 women were screened with mammography. BAC 
was evaluated first by manual method followed by CAD method to prevent bias 
from CAD results. Grading of BAC was done from grade 1 to grade 3. The 
manual method of detecting BAC, after being confirmed by two readers, was 
taken as gold standard. 299 women were screened with mammography. 
Manual method of detecting BAC, after being confirmed by two readers, was 
taken as gold standard. 
Results: There was the statistically significant difference between BAC 
detected by CAD method and manual method (chi-squared 116.4, p<0.0001). 
Sensitivity of detecting BAC by CAD method was only 56.10%, though it had 
good specificity 97.67%. Area under curve (AUC) was 0.77, positive predictive 
value being only 78.83%. CAD detected grade 2 and 3 calcifications with more 
accuracy than grade 1 calcifications (p<0.0001). 
Conclusion: CAD has still a long way to go before it could match the 
sensitivity of manual method of BAC detection. Even though specificity of CAD 
is good, it cannot replace manual method for detection of breast arterial 
calcifications.  
B-0101 11:02  
Do we diagnose it better? - new BI-RADS classification for 
microcalcifications  
J. Vucetic, M. Ortega Millán, J. Rivera Mata, J. Palao Errando, 
C. Barber Hueso, R. Garcia Garcia; Valencia/ES (vucetic_jelena@yahoo.com)  
Purpose: To analyze all microcalcification biopsies performed after the 
publication of new edition of BI-RADS and compare it to our previous 
approach. 
Methods and Materials: A retrospective review was performed for all 
microcalcification biopsies carried on in our center between June 2013 and 
May 2017. The cutpoint for two groups was the implementation of the new BI-
RADS classification (May 2015), where low suspicion microcalcifications 
previously classified as BI-RADS 3 (no biopsy), passed to BI-RADS 4a 
(biopsy). Histology results were reviewed. Fisher's exact test was performed 
and p-values less than 0.05 were considered statistically significant. 
Results: There were 19,086 mammograms performed in the cited period. A 
total of 269 patients with diagnosed microcalcifications were biopsied. In the 
period previous to the cut-point there were 86 biopsies and 23 cancers were 
detected (26.74%). After the new BI-RADS recommendations were 
implemented in our screening units, we experienced over two fold increase in 
biopsies performed, 183 biopsies, yet only 37 cancers diagnosed (20.22%). 
This increase in cancer diagnosis was not significant, p=0.271. The increase in 
  






diagnosis of carcinoma in situ (CIS) was also not significant (21 vs 34, 
p=0.259). 
Conclusion: Change in management of microcalcifications led to increase in 
number of biopsies performed as well as cancers diagnosed, especially CIS, 
although this increase is not significant in our series. It is yet to be seen if 
diagnosing more CIS reduces the rate of finding infiltrative cancers in years to 
come.  
B-0102 11:10  
Incidental breast lesions on chest computed tomography: prevalence, 
clinical significance, and differential features for referral  
Y. Choi, C.H. Park, G. Hye Mi, T.H. Kim, E. Son; Seoul/KR  
Purpose: With increasing use of chest CT, incidental breast lesions are 
increasingly being encountered. It is important that clinicians be familiar with 
CT characteristics of breast lesions. The aims of this study were to evaluate 
the CT features of incidental breast lesions on chest CT and to suggest useful 
criteria for referral to specialist breast units. 
Methods and Materials: Between May 2009 and April 2014, 12268 chest CT 
reports containing the keyword ‘‘breast’’ were reviewed retrospectively. 
Patients with known breast disease or who had undergone non-enhanced CT 
examination were excluded. Patients who were referred to specialist breast 
units and then underwent pathological confirmation or follow-up over a 1-year 
period were included. Finally, 86 patients were enrolled. Two chest radiologists 
evaluated lesion characteristics, including size, location, shape, margins, and 
enhancement ratio. The correlations between the CT features and breast 
pathologies were evaluated, and overall diagnostic accuracy of CT features in 
various combinations was assessed to diagnose breast cancer. 
Results: Overall, the malignancy rate of incidental breast masses on chest CT 
was 16.3%. Among the CT features, irregular shape, non-circumscribed 
margin, and enhancement ratio > 1 were significantly different between 
malignant and benign lesions. The combination of non-circumscribed margin 
and high contrast enhancement had the highest accuracy (97.7%). 
Conclusion: Reliable CT features for incidental malignant breast masses are 
irregular shape, non-circumscribed margin, and high contrast enhancement. 
The combination of non-circumscribed margin and high contrast enhancement 
could help distinguish incidental malignant breast lesions on chest CT and 
indicate referral to specialized breast units.  
B-0103 11:18  
Breast MRI: internal thoracic artery lymph node assessment in patients 
with invasive breast carcinoma  
M. Nadrljanski, Z. Milosevic; Belgrade/RS (dr.m.nadrljanski@gmail.com)  
Purpose: To assess MRI features of physiological and metastatic internal 
thoracic artery (ITA) lymph nodes (LNs). 
Methods and Materials: Thirty-four patients with T2 category histologically 
confirmed invasive breast carcinoma (n1=18 physiological LNs; n2=16 
metastatic LNs), were assessed with DCE-MRI (1.5T) and DWI-ADC (b 0, 
1000) for the morpho-functional features of LNs: short axis, long axis, short-to-
long axis ratio, DWI-ADC and positive enhancement integral (PEI) values. 
Results: Difference in morphologic features (short axis, long axis) between 
physiologic and metastatic LNs was considered highly statistically significant 
(short axis: 7.68+/-0.87 mm vs. 4.50+/-0.86 mm, p<0.0001; 13.0+/-1.75 mm vs. 
8.62+/-1.61 mm, p<0.0001). The same applied for DWI-ADC value (0.58+/-
0.06 vs. 0.80+/-0.05, p<0.0001). However, the difference in the short-to-long 
axis ratio and PEI values between the two subgroups was not considered 
highly statistically significant (0.59+/-0.08 vs. 0.53+/-0.09 mm, p=0.002; 
636.97+/-74.50 vs. 530.44+/-68.85, p=0.002). No significant correlation was 
detected in the subgroup of metastatic LNs between the selected morphologic 
and functional parameters. 
Conclusion: Morphologic LN features like short and long axis, and DWI-ADC 
values may contribute to better discrimination between physiological and 
metastatic ITA LNs in patients with invasive breast carcinoma.  
B-0104 11:26  
Comparison of invasive lobular and invasive ductal carcinomas of the 
breast using 3T DCE-MRI  
T. Torheim, R. Woitek, A.J. Patterson, R. Bedair, I.A. Mendichovszky, 
C. Caldas, F. Markowetz, F.J. Gilbert; Cambridge/UK 
(Turid.Torheim@cruk.cam.ac.uk)  
Purpose: To compare the dynamic contrast-enhanced (DCE) magnetic 
resonance imaging (MRI) characteristics of invasive lobular carcinomas (ILC) 
and invasive ductal carcinomas (IDC) of the breast. 
Methods and Materials: In this prospective study, 48 patients with biopsy-
proven IDC (n = 30, mean age 59 years, range 32 - 83) or ILC (n = 18, mean 
age 58 years, range 38 - 81) underwent 3T DCE-MRI prior to surgery. 
Following motion correction, pharmacokinetic maps (Ktrans, ve, kep) were 
calculated using the standard Tofts model with T1 mapping and B1 
inhomogeneity correction. Distribution measures of mean, median, skewness 
and kurtosis for each parameter within the lesions were calculated and 
compared between the two subtypes using Wilcoxon’s signed-rank test. 
Results: The kep parameter was most sensitive to differentiate between IDC 
and ILC, showing significant differences in all distributional measures (p values 
< 0.05). ILC had lower kep values, with a more skewed parameter distribution 
compared to IDC cases. Apart from Ktrans being skewed towards lower values 
in ILC (p value 0.04), there were no significant differences between the two 
subtypes regarding ve and K
trans. 
Conclusion: Our results show that the kep parameter, which is representative 
of contrast agent washout, is more sensitive to the difference between ILC and 
IDC than the more commonly reported Ktrans and ve parameters. This highlights 
a difference in uptake curve shape between these two subtypes of breast 
cancer.  
B-0105 11:34  
Role of diffusion-weighted MRI (DWI) and intravoxel incoherent motion 
(IVIM) in monitoring treatment response to neoadjuvant chemotherapy in 
locally advanced breast cancer  
M.F.A. Kamis1, K. Rahmat1, M.T. Ramli Hamid2; 1Kuala Lumpur/MY, 
2
Selangor/MY (fandi_mohd@yahoo.com)  
Purpose: This study is to investigate diffusion weighted MRI (DWI) and 
changes in IVIM parameters [Random diffusion(D) and functional fraction(f)] of 
invasive breast carcinoma in patients undergoing neoadjuvant chemotherapy 
(NACT). We also aim to evaluate baseline MRI imaging phenotypes of breast 
carcinoma versus normal breast tissue (using ADC and IVIM parameters). 
Methods and Materials: A prospective study involving women with invasive 
breast carcinoma (n= 15) between the age of 29 to 66 years (mean age=43.4) 
who are planned for 6 cycles of NACT. DCE MRI were performed at 3 different 
intervals (Pre-NACT, post-first and third cycles of NACT). DWI data of the 
target lesions were obtained using ROI measurements. The IVIM parameters 
(from multiple b-values) were calculated. 
Results: Mean ADC values for malignant breast lesion is (0.74 x 10-3 mm2/s) 
compared to normal breast tissue (1.90 x 10-3 mm2/s). Following the three 
cycles of NACT, quantitative findings showed increase in mean ADC values 
(1.29 x 10-3 mm2/s). IVIM parameters showed increase in D-value and 
reduction of f-value which reflects reduce in microcapillaries density post 
NACT. 
Conclusion: DWI is useful to characterize breast tumour cellularity. ADC 
values showed significant increase as early as the first cycle of NACT. IVIM 
parameters provides noninvasive indicator to microperfusion properties of 
malignant breast lesion, thus may be used as alternatives to monitor the 
response to NACT for patients with contraindication to gadolinium These tools 
are expected to enhance the role of MRI in monitoring treatment response of 
cancerous lesions in the breast.  
B-0106 11:42  
The diagnostic performance of automated breast ultrasound (ABUS) 
compared with handheld ultrasound (HHUS)  
M. Yoshida1, K. Enokido2, T. Nishiyama1; 1Tokyo/JP, 2Kanagawa/JP 
(ymiwa2000@gmail.com)  
Purpose: For women with dense breasts, the combination of mammographic 
and ultrasound screening was reported to detect more invasive cancers. 
However, handheld ultrasound (HHUS) has also some limitations, such as 
operator dependent and insufficient reproducibility. Automated breast 
ultrasound (ABUS) which acquires 3-D volume images of whole breast can 
potentially overcome these limitations of HHUS. The aim of this study was to 
evaluate the diagnostic performance of ABUS compared to HHUS in terms of 
the detection and characterization of breast lesions. 
Methods and Materials: From January 2016 to May 2017, 390 breasts of 195 
women (Median age 43) examined by both HHUS and ABUS: using Invenia 
ABUS (GE Healthcare Inc.) scanner. Of them, 135 women concurrently 
underwent mammography. The images were interpreted by more than two 
physicians who has sufficient experience of breast ultrasound. 
Results: BI-RADS assessment categories in ABUS coincided with those in 
HHUS of 92% (357/390 breasts). Twenty-three lesions, which were diagnosed 
as cancers, were all classified as BI-RADS 4/5 both in ABUS and in HHUS. 
Three cancers of them were undetectable by mammography. In 7 cases where 
the lesions were classified as BI-RADS 4 in ABUS but as BI-RADS 1 in HHUS, 
those were considered as image artifacts. In most cases with disagreements 
between ABUS and HHUS, there were mismatches of BI-RADS 2 and BI-
RADS 3. 
Conclusion: The capability of ABUS for detection and characterization of 
breast lesions was nearly equivalent to HHUS. It can be further improved by 











B-0107 11:50  
Primary tumour location predicts the site of local relapse after nipple-
areola complex (NAC)-sparing mastectomy  
L. Vassallo1, N. Tomasi Cont1, V. Doronzio1, R. Panzone1, D. Regge2, 
L. Martincich1; 1Candiolo/IT, 2Candiolo-Torino/IT 
(lorenzo.vassallo1987@libero.it)  
Purpose: To evaluate if primary tumour location can predict the site of local 
relapse after nipple-areola complex (NAC)-sparing mastectomy. 
Methods and Materials: 518 consecutive women submitted to NAC-sparing 
mastectomy in the period between 2010 and 2015 were enrolled in the study. 
All the patients underwent pre-surgical breast MRI (1.5T magnet) following the 
recommended technical requirements and intraoperative assessment of NAC 
status. Subsequently, subjects underwent routine clinical and imaging follow-
up. For each local recurrence identified, location and imaging and biological 
characteristics were evaluated. 
Results: Fourteen subcutaneous local relapses (2,7%) occurred over a mean 
follow-up of 33 months. Mean time to recurrence was 38 months. In all the 
cases, relapse was observed in patients with highly proliferative primary 
tumour. Recurrences were identified by clinical examination in eight cases, 
MRI in five and ultrasound in one. A comparison of clinical-pathological 
characteristics revealed that primary tumours and local recurrences were 
located in the same breast quadrant in most of the patients (12/14; 85,7%). No 
local relapses occurred in women who received radiotherapy. A single case of 
NAC recurrence developed as a Paget’s disease in patient without sub-areolar 
and proximal nipple duct involvement at mastectomy. MRI findings of local 
recurrences were represented by small mass lesion with regular margin and 
rapid early homogeneous enhancement. All of them were located in the same 
breast quadrant of the primary tumour. 
Conclusion: Our study shows that local recurrences after NAC-sparing 
mastectomy almost invariably develop in the same quadrant where the primary 
tumour was located.  
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B-0108 10:30  
The performances of radiographic criteria for bone malignancy when 
applied to computed tomography and magnetic resonance imaging  
T. Onal1, G.O. Afacan1, G. Akansel2, A.S. Arslan2, Y. Anık2, N. Inan1, 
B. Muezzinoglu2, F. Corapcioglu2; 1Istanbul/TR, 2Kocaeli/TR 
(tugayonalx@gmail.com)  
Purpose: The conventional radiological features to differentiate benign from 
malignant bone lesions were originally described using radiography (XR). 
When evaluating sectional imaging studies such as MRI and CT one may tend 
to apply these principles to identify malignant bone lesions. The aim of this 
study is to evaluate the performances of these radiographic features for 
detecting malignity when applied to CT and MRI. 
Methods and Materials: Thirty-nine patients with histopathological proof of a 
high-grade bone malignancy and preoperative imaging data obtained at least 
with two different modalities were included in the study. Four radiologists 
reviewed the images and scored the lesions for the distinctness of margins, 
presence and type of periosteal reaction, matrix mineralisation, and presence 
of soft tissue mass. The average score for each modality was then tested for 
accuracy with regard to the histopathology. 
Results: When lesion margins were considered, XR was the best modality to 
detect a high-grade malignancy. MRI, especially post-contrast T1-weighted 
sequence was the least helpful in this regard. There was no significant 
difference between CT and XR, nor between CT and MRI. When the periosteal 
reaction was considered, XR was the best modality to detect the malignant 
type periosteal reaction. In this regard, MRI and CT were misleading either by 
not detecting or under-grading periosteal reaction. 
Conclusion: Conventional imaging criteria for bone malignancy can be 
misleading when applied to MRI, or CT. When cross-sectional imaging features 






B-0109 10:38  
Can quantitative diffusion weighted imaging segregate malignant from 
benign bone lesions? A 3-T MRI feasibility study  
A.A.A. Doweidar1, M.R. Nouh2, A.M. Khalil1, K. Dashti1; 1Kuwait/KW, 
2
Alexandria/EG (ahmeddoweidar1@yahoo.com)  
Purpose: The study aims to probe the potential of apparent diffusion 
coefficient (ADC) in differentiating malignant from benign bone tumours and 
tumour-like lesions on magnetic resonance imaging (MRI) using multiple b 
values. 
Methods and Materials: We included 50 patients (26 males and 24 females) 
with 56 primary or secondary malignant bone tumours, benign bone tumours or 
tumour-like lesions in this study. The diagnosis of all lesions was 
histopathologically confirmed. The MRI studies were conducted using a 3-T 
scanner. MRI protocol included diffusion weighted (DW) images using multiple 
b values. ADC maps were derived from DW-MR imaging data and analysed by 
two radiologists who were blind to the histopathological results. The mean ADC 
values were obtained for statistical analyses. 
Results: The histopathological results revealed that 39/56 (69.6%) lesions 
were malignant, 11/56 (19.6%) were benign tumours, 3/56 (5.4%) were 
tumour-like solid, and 3/56 (5.4%) were tumour-like cystic lesions. The mean 
ADC values were significantly different in the malignant tumours ([0.92±0.35] 
×103 mm2/s) versus benign tumours ([1.25±0.37] ×103 mm2/s) (p<0.009), 
tumour-like solid lesions ([1.24±0.11] ×103 mm2/s) (p<0.026) and all non-
malignant lesions ([1.36±0.46] ×103 mm2/s) (p<0.001). Applying a mean ADC 
cutoff value of  1.185×103 mm2/s for detecting malignancy resulted in a 
sensitivity of 87.2%, a specificity of 64.7%, and an accuracy of 81.5% (95% 
confidence interval [CI] 70.1%-93%). The inter-rater reliability was nearly 
perfect (ICC = 0.969; 95% CI = 0.947-0.982). 
Conclusion: Although there was some overlap, DWI proved highly useful in 
differentiating malignant from benign tumours and tumour-like bony lesions.  
B-0110 10:46  
mDixon is superior to frequency-selective fat suppression in 
musculoskeletal tumour imaging  
W. Huijgen1,2, C.S. van Rijswijk1, J.L. Bloem1; 1Leiden/NL, 2Den Haag/NL  
Purpose: The modified Dixon technique (mDixon) allows reduction of 
acquisition times relative to conventional Dixon, while reducing sensitivity to 
B0-inhomogeneity and maintaining the advantages of FSE frequency selective 
fat saturation techniques. The purpose was to determine the value of mDixon 
relative to conventional FSE (FSE) in musculoskeletal tumour imaging. 
Methods and Materials: In a HIPAA-compliant prospective study, 265 patients 
who required a musculoskeletal tumour MR scan were included. mDixon and 
FSE sequences with similar acquisition times were compared in fluid sensitive 
(T2) and non-fat Gd (Gd) images. Two radiologists, blinded to protocols, 
scored 9 parameters (5-point scale, paired samples t test) including fat 
suppression homogeneity, motion artefacts, and overall preference. 
Results: Overall, reviewers preferred mDixon in 20% (T2) and 27% (Gd) of 
cases, preferred FSE in 17%(T2) and 10% (Gd) and had no preference in 63% 
(T2) and 63% (Gd). The mean score for fat suppression homogeneity in 
mDixon was superior to FSE by 0.56 points in T2 and 0.65 points in Gd 
(p<0.01). Highest differences in scores in favour of mDixon were found in 
cases with susceptibility and magnet inhomogeneity problems. In only 2 cases 
with motion artefacts FSE performed considerably better. 
Conclusion: mDixon showed similar image quality to FSE images, without 
time penalty, but was superior to FSE when susceptibility artefacts were 
present. Thus, replacing FSE by mDixon water reconstructions in T2 and Gd-
enhanced MSK tumour imaging yields superior image quality without 
disadvantages. The advantage of Dixon to reconstruct multiple water-fat 
balanced images was not evaluated.  
B-0111 10:54  
Feasibility study of intra-voxel incoherent motion MR imaging for the 
differentiation of benign and malignant soft tissue tumours  
Y. Li, C. Ren, J. Cheng; Zhengzhou/CN  
Purpose: The purpose is to investigate the application of IVIM and furtherly 
evaluate the ability of IVIM parameters to differentiate benign and malignant 
soft tissue tumours. 
Methods and Materials: Thirty-five patients with tissue tumours (diagnosed 
according to biopsy) were included in this study. 21 for benign tumours and 14 
for malignancies. All the patients were scanned by IVIM sequence based on a 
3T MR scanner. The IVIM scanning was performed with 10 b-values. All the 
above parameters were measured by drawing ROIs within the periphery of the 
lesions(P_D, P_Dstar, P_f short for periphery D, periphery Dstar, periphery f) 
and the center of the lesions(C_D, C_Dstar, C_f short for center D, center 
Dstar, center f). And the all the parameters were compared by using Mann-
Whitney U test with SPSS software (version 16.0). And ROC analysis was 
performed to assess the sensitivity and specificity of every parameter. The 
  






parameters which showed a significant difference were selected and combined 
as the feature vectors for the classification by using SVM classifier. 
Results: The results revealed that P_D and C_D value is significantly different 
(P <0.05). The ROC analysis results showed the ability of the above 
parameters to differentiate lesions. The AUCs (area under the curve) of P_D 
and C_D are 0.776 and 0.752 respectively. And the SVM classifier showed a 
high classification accuracy (82.73%), sensitivity (87%) and specificity 
(76.45%) for differentiating malignant from the benign lesions. 
Conclusion: The IVIM related parameters of tissue diffusivity (D) increases 
diagnostic confidence of soft tissue tumours.  
B-0112 11:02  
An artificial intelligence approach for the automatic diagnosis of lipoma 
and liposarcoma: a pilot radiomics study  
L. Malinauskaite, J. Hofmeister, S. Burgermeister, S. Martin, X. Montet, 
S. Boudabbous; Geneva/CH (sana.boudabbous@hcuge.ch)  
Purpose: To assess the contribution of MRI-based radiomics in the automatic 
diagnosis of lipoma and liposarcoma using artificial intelligence (AI).  
Methods and Materials: Lipoma (n=20) and lipocarcoma (n=17) were 
retrospectively identified on histopathological analyses of percutaneous or 
surgical resection specimen, and their respective pre-operative MRI images 
were retrieved from our institutional PACS. Two senior radiologists manually 
segmented these lesions on Spin Echo T1-weighted images. An open-source 
python library was then used to extract a large number of radiomics features 
(n=123063) from each lesion. Benign (i.e. lipoma) and malignant (i.e. 
liposarcoma) discrimination based on radiomics data was achieved through 
features selection, dimension reduction (using principal component analysis) 
and classification (using a support vector machine classifier). A Leave-One-Out 
Cross-Validation approach was used to estimate the prediction error of our 
model due to the medium sample-size. 
Results: Our approach achieved an overall classification accuracy of 83,8% in 
identifying lipoma (versus liposarcoma), with a sensitivity of 100%, specificity of 
64,7%, positive predicting value of 76,9% and negative predictive value of 
100%. 
Conclusion: Our radiomics-based method for classification of lipomatous soft 
tissue tumor yielded promising results, notably with very high accuracy in 
identifying benign lesions.  
B-0113 11:10  
Tumour load in patients with multiple myeloma: -microglobulin levels 
vs low-dose whole-body CT  
V. Pfahler, M. D'Anastasi, H. Duerr, J. Ricke, A. Baur-Melnyk; Munich/DE 
(vanessa.pfahler@med.uni-muenchen.de)  
Purpose: Beta-2-microglobulin is a serum marker of tumour burden in multiple 
myeloma (MM). Our aim was to correlate serum ß2-microglobulin levels in 
patients with MM to tumour mass determined by low-dose whole-body CT. 
Methods and Materials: 54 patients with newly diagnosed, untreated MM who 
underwent low-dose whole-body CT at our department between 2003 and 
2014 were included retrospectively. The low-dose whole-body CT scans were 
assessed by two musculoskeletal radiologists in consensus for focal lesions. 
The Durie and Salmon PLUS staging System was used for staging patients in 
stage I-III. ß2-microglobulin was also subdivided into stage I-III (stage I: < 3,5 
mg/L; stage II: 3,5-5,5 mg/L; stage III: > 5,5 mg/L) according to R-ISS. 
Results: Using the Durie and Salmon PLUS staging system criteria for image 
evaluation we were able to identify stage I (low grade) MM in 19 patients, stage 
II (intermediate) MM in nine patients and stage III (high grade) MM in 26 
patients. As expected most patients with stage I disease had normal ß2-
microglobulin levels. However eight of nine patients with stage II MM and 16 of 
26 patients with stage III MM had normal ß2-microglobulin levels. Thus, 24 of 
35 patients (68,6%) had 5 or more focal lesions and false-negative ß2-
microglobulin levels. 
Conclusion: ß2-microglobulin may not indicate the full extension of bony 
disease in a significant subset of myeloma patients.  
B-0114 11:18  
MRgFUS treatment for painful bone metastases, analysis of non-
responders: are there imaging features associated with poor clinical 
response?  
S. Guerri1, D. Mercatelli1, C. Gasperini1, M. Aparisi Gomez2, E. Rimondi1, 
U. Albisinni1, A. Napoli3, G. Battista1, A. Bazzocchi1; 1Bologna/IT, 2Valencia/ES, 
3
Rome/IT (guerri.sara@gmail.com)  
Purpose: Magnetic resonance guided focused ultrasound (MRgFUS) proved 
to be effective and safe in the treatment of painful bone metastases. However, 
a few patients experience poor response. The purpose of this study was to 
evaluate the existence of imaging features at pre-operative examination 
predictive of poor outcome. 
Methods and Materials: We retrospectively reviewed 19 non-responders 
(patients with no improvement in VAS score, or pain increase after treatment; 
group-A: 20 lesions) and compared them to 20 responders (group-B: 25 
lesions), out of more than 150 treatments performed at our Institute. The 
following quantitative imaging features were analysed: size and type of the 
lesion (osteolytic/non-osteolytic), extent of anterior/posterior cortex destruction 
(graded 0-5 on pre-treatment-CT), soft-tissue involvement, pretreatment bone 
and soft-tissue oedema (graded 0-3 on T2-fat-sat sequences), post-treatment 
bone oedema, degree of vascularisation, minimum/maximum distance of the 
skin from the lesion, skin and subcutaneous tissue thickness and the presence 
of vessels/nerves/synovial structures in the proximity of the lesion. The Chi-
Square statistic was used to test frequencies in the two groups. This work has 
been supported by the “Programma di ricerca Regione-Università, Regione 
Emilia-Romagna, bando Giovani Ricercatori “Alessandro Liberati” 2013 to AB 
“Magnetic Resonance guided High Intensity Focused Ultrasound treatment of 
bone metastases: pain palliation, and local tumor control?”. 
Results: 55% and 75% of lesions in the group-A showed a bone oedema and 
a soft tissue oedema, respectively, 2 (vs. 16% and 32% in the group-B); 70% 
of lesions in the group-A showed an extent of posterior cortical destruction 3 
(vs. 36% in the group-B). 
Conclusion: Larger pre-treatment bone and soft tissue oedema areas and 
greater posterior cortex destruction are associated with poor outcome in terms 
of VAS reduction after MRgFUS.  
B-0115 11:26  
Percutaneous image-guided cryoablation of musculoskeletal metastases 
to the chest wall: a single-centre experience  
C. Lord, L. King; Southampton/UK  
Purpose: A single-centre experience describing the efficacy and safety of 
percutaneous image-guided cryoablation for local tumour control in the 
treatment of musculoskeletal metastases to the chest wall. 
Methods and Materials: A retrospective review of consecutive patients treated 
from October 2011 to October 2017 for the indication of oligometastatic cancer 
to the chest wall was performed. 9 lesions were treated in 9 patients during the 
time period. The mean age of the cohort was 67 years (range 56-78), 44% 
female (4/9) and 56% male (5/9). Serial follow-up imaging was assessed for 
local tumour control against RECIST 1.1 and MDA criteria. 
Results: The 9 lesions (5 renal, 1 lung, 1 colon, 1 breast, 1 ocular melanoma) 
were followed up for a mean of 1 year 3 months (range 3-35 months). Of the 
patients with available follow up, local tumour control rates were 89% (8/9) at 3 
months and 85% (6/7) at 6 months and 83% at (5/6) at 12 months. 3 patients 
who had stable disease at 6 month follow up had not yet been imaged beyond 
12 months. 3 of the patients who had follow up beyond 20 months showed long 
term local control. Procedural complication rates were low with 1 patient 
sustaining a haemothorax requiring drainage without long term sequelae. 
Conclusion: Percutaneous image guided cryoablation is a safe and effective 
treatment for oligometastatic disease to the chest wall and in certain patients 
can provide long-term disease control.  
B-0116 11:34  
Radiological changes of giant cell tumour of bone in treatment with 
Denosumab  
S. Bonilla, J. Llauger Rossello, C. Nuñez Peralta, S. Valverde Lavirgen, 
J. Palmer Sancho; Barcelona/ES (santibonilla22@gmail.com)  
Purpose: To describe the clinical and radiological progressive changes on 
giant cell tumour of bone (GCT) on patients in treatment with Denosumab. 
Methods and Materials: Retrospective study of 20 patients with GCT 
confirmed histopathologically with an unresectable tumour, post surgical 
recurrence or disseminated tumour. The follow up was made with MRI and CT. 
We analysed the treatment response and the radiological changes of tumoural 
size, the enhancement, tumoural matrix changes, tumoural margin and the 
changes of signal in the different MRI sequences. 
Results: None of the patients in our study demonstrated a progression of the 
basal disease and the 55% showed a partial response with the treatment. The 
radiological changes were diverse but the most important and frequent were 
the decrease of the tumour size, tumoural enhancement, the changes on the 
tumoural matrix like peripheral sclerosis and central necrosis and/or 
quistification. The radiological features were confirmed histopathologically. A 
clinical improvement observed in all the patients was most frequently the pain 
improvement. Only one patient showed a complication with osteonecrosis of 
the jaw due to the treatment. 
Conclusion: The most important radiological changes were the decrease on 
tumoural size, tumoural enhancement and the changes on tumoural matrix in 
patients with partial response. None of all the patients showed a progression of 
the basal disease and more than a half showed a partial response. The 
treatment with Denosumab on GCT seems to be useful in the clinical and 










B-0117 11:42  
MRI characteristics of 26 onychomatricomas  
L. Lassalle1, S. Eminian2, A. Buisson1, E. Pessis3, R. Campagna1, 
N.E. Regnard1, W. Khaled1, L. Moya1, J.L. Drape1; 1Paris/FR, 2Clarens/CH, 
3
Saint Denis/FR (louis.lassalle@gmail.com)  
Purpose: Onychomatricomas are rare benign fibroépithélial tumours of the nail 
matrix. We describe the MRI characteristics of onychomatricomas, and identify 
subgroups with different imaging features. 
Methods and Materials: MRI studies of 26 fingers or toes with 
histopathologically proven onychomatricomas were retrospectively reviewed by 
two MSK-radiologists. MRI protocol included T1w, T2w and gadolinium-
enhanced T1w sequences. MRI characteristics were noted (size, T1 and T2 
signal, enhancement, topography, morphology). 
Results: 26 MRI were reviewed: 19 (73.1%) fingers and 7 (26.9%) toes. 18 
patients (69.2%) were females, and mean patient age was 52.8yrs (range: 31-
76). All tumours presented a proximal head in the matrix cul-de-sac (mean 
diameter 5.9mm) and distal filamentous expansions included inside the nail 
plate. The proximal head showed an hyposignal in T1w (69.2%) and T2w 
sequences (69.2%), and enhancement was present in 55.6%. Lesions had a 
“hairy” pattern (regular filamentous expansions) in 9 cases and a “cryptic” 
pattern (irregular filamentous expansions) in 17 cases. “Central” (n= 17) and 
“lateral” (n = 9) subgroups showed significant differences in location (p = 0.01), 
in T2 signal (p = 0.03) and height (p = 0.01) of the proximal component, in 
demarcation with the surrounding dermis (p = 0.02), in the deformity of the nail 
matrix (“glove finger” invagination) (p = 0.0006), and in the length of the 
filamentous extensions (p = 0.01). 
Conclusion: MRI findings of onychomatricomas are specific and allow 
differentiating two subgroups according to the “central” or “lateral” location in 
relation to the nail matrix.  
B-0118 11:50  
Follow-up of incidental cartilaginous tumours in the knee of middle-aged 
women  
S. Breda, B.A. De Vries, G. Bessems, D. Schiphof, J. Heeringa, G.P. Krestin, 
M.W. Vernooij, S.M. Bierma-Zeinstra, E. Oei; Rotterdam/NL 
(s.breda@erasmusmc.nl)  
Purpose: Enchondromas are benign cartilaginous tumours frequently found 
incidentally on MRI of the knee and should be differentiated from low-grade 
chondrosarcoma. Information on natural course is essential to help clinical 
decision making regarding need to follow-up. We provide follow-up data of 
incidental cartilaginous tumours on knee MRI in the large population-based 
Rotterdam Study. 
Methods and Materials: 891 females aged 45-60 (mean 55) years underwent 
non-contrast bilateral knee MRI (1.5T) at baseline. 700 (79%) participants were 
re-scanned at 5 years follow-up. We analysed growth by comparing the largest 
dimension (of three directions) between baseline and follow-up. Measurements 
were obtained independently by two trained researchers. Lesions >1 cm and/or 
those with endosteal scalloping or cortical disruption were referred for dynamic 
contrast-enhanced MRI (DCE-MRI). 
Results: In 1782 MR scans, we identified 54 incidental cartilaginous tumours 
in 46 patients at baseline (5.2%), of which 16 were referred (32.6%). In the 
absence of malignant features on DCE-MRI, none of referred lesions were 
treated. Mean follow-up duration was 4.6 years (SD 0.6, range 4-6). Mean 
largest dimensions were 12.1 mm at baseline (range 4.1-40.6) and 12.5 mm 
(4.1-44.1) after follow-up for observer 1 and 12.1 mm (4.4-41.3) and 12.8 mm 
(4.1-44.1) for observer 2, with an intraclass correlation coefficient of 0.99 
between both observers for all lesions. 
Conclusion: In middle-aged women, incidental cartilaginous tumours are 
present on 5.2% of knee MRI scans, and show only minor progression after 5 
years. No features of low-grade chondrosarcoma were found on additional 

















10:30 - 12:00 Room G  
Physics in Medical Imaging  
SS 213  
Optimisation in clinical radiology practice  
Moderators:  
E. Samara; Sion/CH  
W. Stiller; Heidelberg/DE  
B-0119 10:30  
Teaching radiation safety intuitively with a head-mounted display  
N. Loy Rodas1, P. Ghimire2, M. de Mathelin1, A. Gangi1, N. Padoy1; 
1
Strasbourg/FR, 2Dijon/FR (nloyrodas@unistra.fr)  
Purpose: A considerable amount of unnecessary exposure and risk 
underestimation results from a lack of awareness and poor knowledge of the 
behavior of ionizing radiation during x-ray guided procedures. While current 
radiation safety training is usually based on courses, lectures and 
presentations of theoretical aspects, we propose to use a head-mounted 
display (HMD) to teach intuitively about radiation behavior. 
Methods and Materials: A virtual interventional room (C-arm, table, clinicians, 
and patient) is displayed through an HMD (Microsoft’s HoloLens). The user 
interacts with the scene to set the C-arm angulation and imaging parameters. 
Virtual color-coded radiation safety information corresponding to the current 
scene configuration is overlaid in the user’s view. The displayed radiation-
related data is accurately pre-computed with Monte Carlo simulations. 
Results: Through an HMD, the trainee can visualize patient and clinicians’ 
models colored according to their ongoing exposure levels or the 3D 
propagation of scattered radiation for the current scene configuration. First 
feedback from users has been promising since the system provides an 
engaging, game-like and risk-free learning environment. Additionally, it 
provides an immediate feedback to maximize learning about the effects that 
altering simultaneously interacting parameters can have on radiation exposure. 
Conclusion: Reducing medical radiation exposure requires to increase staff’s 
awareness and knowledge about radiation. We propose to make radiation 
safety training more intuitive and engaging with HMDs. The trainee can 
visualize the effect of different C-arm configurations on the patient/staff dose 
and on the scattered radiation diffusion. This allows to learn the best safety 
practices intuitively, safely and anywhere.  
B-0120 10:38  
National audit on the appropriateness of CT and MRI examinations in 
Luxembourg  
A. Bouëtté1, A. Karoussou-Schreiner1, H. Ducou Le Pointe2, M. Grieten3, 
E. de Kerviler2, L. Rausin4, J.-C. Bouëtté5, P. Majerus1; 1Luxembourg/LU, 
2
Paris/FR, 3Genk/BE, 4Liège/BE, 5Montreal, QC/CA 
(aurelien.bouette@ms.etat.lu)  
Purpose: In Luxembourg, the frequency of CT and MRI examinations per 
inhabitant is among the highest in Europe. A national audit was conducted to 
evaluate the appropriateness of CT and MRI examinations according to the 
national referral guidelines for medical imaging. 
Methods and Materials: 388 CT and 330 MRI requests forms corresponding 
to already-performed examinations were provided by all radiology departments 
in Luxembourg. Four external radiologists analysed the clinical elements for 
justification present in each request. They consensually assessed the 
appropriateness of each requested examination with regard to the national 
referral guidelines and their clinical experience. 
Results: The appropriateness rate was higher for MRI requests than for CT 
requests (79% vs 61%; p <0.001). For CT, the appropriateness rates were 
better when the requests concerned paediatric rather than adult patients (82% 
vs 68%; p<0.001), when the requests concerned head (79%) and chest (81%) 
areas rather than spinal (28%), extremity (51%) and abdominal-pelvic (60%) 
areas (p<0.001), and when the requests were referred by medical specialists 
rather than by general practitioners (70% vs 37%; p<0.001). The 
appropriateness rates also varied significantly depending on the radiology 
department for both CT requests ([46%-86%]; p<0.001) and MRI requests 
([57%-92%]; p=0.001). 
Conclusion: A high proportion of CT and MRI examinations requested were 
found to be inappropriate. Inappropriate requests of CT examinations could 
potentially lead to unnecessary patient exposures, but the results observed for 
paediatric imaging requests and for two radiology departments suggest 












B-0121 10:46  
Combination of environment recognition sensors and conventional x-ray 
settings  
A. Corbi Bellot1, F. Albiol1, A. Albiol2; 1Paterna/ES, 2Valencia/ES 
(alberto.corbi@ific.uv.es)  
Purpose: Combination of radiographic information (generated in ordinary x-ray 
settings) with the patient's volume and/or visible markers to derive 3D 
anatomical information and density images. These images highlight soft 
tissues or bony regions, separately. 
Methods and Materials: We measure and track the patient's volume/location 
with scene recognition sensors. This allows the derivation of 3D information 
from pairs of radiographs generated at different patient positions. Also, using 
the same tracking equipment, we can derive the traversed lengths (through 
ray-casting) within the patient's skin isosurface. These lengths are pixel-wise 
associated to the original radiograph and used to derive densitometric data. To 
obtain all this information, both the x-ray tube and the tracking sensors have to 
be optically registered and the captured geometry needs to be translated to the 
point-of-view of the x-ray system. 
Results: Resolution of anatomical lengths with millimetric precision. Besides, 
the obtention of density-based images that can be used to enhance soft 
tissues or bone structures, alongside. In the first type, the dynamic range is 
shrunk, improving the visibility of high gradient areas, extending contrast 
manipulations, and correcting underexposed X-ray images. This images also 
contain more information, according to modern pattern recognition algorithms 
and the concept of mutual information. In the bone-enhancement type, a single 
radiograph emphasises the skeletal structure just like a DEXA setup (impact in 
dose reduction). 
Conclusion: The interplay of affordable contour assessment and motion 
detection equipment with plain x-ray settings can be used to add valuable 
information to plain radiographs: 3D real positions/lengths and density-based 
images.  
Author Disclosures: 
  A. Corbi Bellot: Patent Holder; IST Storage (Valencia). Research/Grant 
Support; CPI-15-170, CPAN-13TR01, TSI1001012013019. Other; Hospital La 
Fe (Valencia).  
B-0122 10:54  
Radiation dose optimisation in intraoperative computed tomography of 
the brain  
R. Forbrig, M. Patzig, C.G. Trumm, R. Stahl, F. Dorn; Munich/DE 
(robert.forbrig@gmx.de)  
Purpose: Intraoperative computed tomography (CT) with stereotactic head 
frames is an integral part of navigated neurosurgery. CT scanners must offer 
both a maximal diagnostic accuracy with reduced metal artefacts and a 
reasonable radiation dose. We report on our experience. 
Methods and Materials: 200 patients (84 female, mean age 63) received an 
intraoperative contrast-enhanced CT of the brain on a 128 slice CT scanner 
(SIEMENS SOMATOM Definition AS+). For metal artefact reduction, the same 
iterative reconstruction algorithm (ASIR) was used in each patient. Regarding 
dose optimization, in 100 patients the CT protocol comprised automated tube 
current (CARE Dose4D) and voltage (CARE kV) modulation, in 100 patients 
fixed parameters (300 mAs, 120 kV). Radiation doses and image quality of 
both groups were compared. 
Results: In the automated modulation group, tube current ranged between 475 
and 1065 mAs (mean, 658 mAS), and tube voltage between 100 and 140 kV 
(mean, 118 kV). Mean dose length product (DLP) was 1524 mGy*cm (range, 
692-2140 mGy*cm), mean CTDIvol 89 mGy (range, 43-135 mGy), and mean 
effective dose 2.90 mSv (range, 1.31-4.01 mSv). In the group with fixed 
parameters, mean values of DLP, CTDIvol, and effective dose were 753 
mGy*cm (range, 683-896 mGy*cm), 43 mGy (range, 42-43 mGy), and 1.43 
mSv (range, 1.30-1.70 mSv). All parameters were significantly lower in the 
latter group (p<0.01, each). Image quality was sufficient in both groups. 
Conclusion: In stereotactic brain CT, automated dose modulation results in an 
unnecessary boost of radiation dose and should therefore be replaced by a 
low-dose protocol.  
B-0123 11:02  
Overranging dose reduction by dynamic collimators: evidence from 
clinical practice  
N. Saltybaeva, H. Alkadhi; Zurich/CH (Natalia.Saltybaeva@usz.ch)  
Purpose: Evaluation of dynamic collimators used in spiral CT has been 
performed so far only on cylindrical phantoms with a limited scan length. The 
purpose of this study was to assess the efficacy of dynamic collimators in daily 
clinical routine. 
Methods and Materials: The overranging dose was assessed for 1690 CT 
examinations performed on a third-generation dual-source CT scanner 
(Somatom Force, Siemens Healthineers, Germany). The data for three 
standard clinical protocols (abdomen, chest and heart) with pitch values of 0.6, 
1.2 and 3.2, respectively, were collected by dose tracking software (tqmDose, 
Qaelum, Belgium). The overranging length was defined as the difference 
between the actual scan length and length of the reconstructed volume. The 
exposed range was calculated as the ratio of reported DLP to the CTDIvol. The 
collimator efficiency for each of the exams was defined as percentage of 
overranging dose in terms of DLP which was blocked by the dynamic 
collimator relative to the total dose of the CT scan. 
Results: The number of overranging rotations was inversely proportional to the 
pitch factor, while the absolute overranging length increases with the increase 
of pitch from 30 mm for abdomen CT to 50 mm for heart examinations. We 
found a strong correlation between relative dose reduction and pitch factor 
(p<0.005). The average efficiency of dynamic collimators was 6%, 11% and 
20% for spiral CT examinations with pitch values of 0.6, 1.2 and 3.2, 
respectively. 
Conclusion: In spiral CT, the dynamic collimator is highly efficient for radiation 
dose reduction, especially in high pitch scan modes.  
B-0124 11:10  
Evaluating the effect of image truncation in the calculation of water 
equivalent diameter  
A. Dedulle1,1, P. Moussalli1,2, J. Jacobs1, N. Fytousi1; 1Leuven/BE, 2Lodz/PL 
(an.dedulle@qaelum.com)  
Purpose: To evaluate the necessity of correcting the Water Equivalent 
Diameter (WED) that is calculated from truncated axial images. 
Methods and Materials: A set of 191 non-truncated chest CT examinations 
were analyzed and the WED was calculated using the dose management 
system DOSE by Qaelum (Leuven, Belgium). The middle axial image of each 
case was manually truncated symmetrically and non-symmetrically at different 
Truncation Percentages (TP) up to 50%. The TP (ratio of patient border 
touching image edges to the total patient border) and the truncated WED 
(WEDtrunc) were automatically calculated. Correction factors proposed in the 
literature were applied on WEDtrunc resulting in WEDcorr. Percentage difference 
(Dtrunc) between the initial WED and WEDtrun and percentage difference (Dcorr) 
between WED and WEDcorr were evaluated. 
Results: The application of correction factors worked well, especially for 
symmetrical truncation with TP of 30-50%, where the correction factor 
improved the WED calculation to a Dcorr of -0.4% ± 3.7% while Dtrunc was -6.7% 
± 3.1%. For TP up to 20%, the error due to truncation was small (0.6% ± 
0.6%), thus the gain from correction is small but nevertheless significant 
(p<0.0001). In non-symmetrical truncation, the curve fit was significantly 
different (p<0.0001) than the symmetrical one. When TP increases, the curves 
deviate more from each other. 
Conclusion: A small symmetrical truncation underestimates the WED only by 
a small percentage. For truncation up to 50%, WED needs to be corrected to 
reduce the error in the calculation. In non-symmetrical truncation, results 
deviate more, especially for increased truncation percentages.  
Author Disclosures: 
  A. Dedulle: Research/Grant Support; PhD project supported by the Flanders 
Innovation & Entrepreneurship agency [grant number HBC.2016.0233]. The 
research is conducted in cooperation with Qaelum and the University of 
Leuven.  J. Jacobs: Board Member; Qaelum. CEO; Qaelum. Founder; Co-
founder of Qaelum. Shareholder; Qaelum. N. Fytousi: Employee; Qaelum. 
B-0125 11:18  
Impact of patient size and radiation dose on spectral accuracy in spectral 
detector CT: a phantom study  
S. van Hedent, C. Tatsuoka, S. Carr, B. Eck, R. Kessner, N. Grosse Hokamp, 
P. Ros, D.W. Jordan; Cleveland, OH/US (svhedent@vub.ac.be)  
Purpose: Iodine quantification (IQ) and Virtual Non-Contrast (VNC) images 
produced by Spectral Detector CT (SDCT) can be used for various clinical 
applications. We investigate the performance of SDCT in different phantom 
sizes and varying radiation doses, including a low-dose pediatric setting. 
Methods and Materials: Three phantom sizes (simulating a 10-year old child, 
an average and a large sized adult) were scanned with iodine solution inserts 
with concentrations ranging 0-32 mg/ml, using the SDCT. Each phantom size 
was scanned with CTDIvol 2-15 mGy. The smallest phantom underwent 
additional scans with CTDIvol 0.9-1.8 mGy. All scans were repeated 5 times. 
We determined the accuracy and precision of VNC attenuation and IQ, by 
comparison to the known iodine concentrations. 
Results: For scans from 2-15 mGy, mean VNC attenuation and IQ error in the 
iodine inserts in the small, medium and large phantom were +1.15 HU ± 3.19, -
1.18 HU ± 14.92, +2.59 HU ± 23.58; and +0.12 mg/cc ± 0.41, -0.88 mg/cc ± 
0.88 and -1.81 mg/cc ± 1.76 respectively. Scans with CTDIvol 0.9-1.8 mGy in 
the small phantom showed very limited, but statistically significant lower VNC 
attenuation precision and IQ accuracy (-0.4778 HU ± 5.265 and -0.333 mg/cc ± 
0.454 respectively) compared to higher dose scans in the same phantom size. 
  






Conclusion: Performance of iodine quantification and subtraction in SDCT is 
largely dose independent, with the primary factor being patient size. Low dose 
pediatric scan protocols do not clinically impact IQ or VNC attenuation values.  
B-0126 11:26  
Validation of a task based automatic dose rate control (ADRC) method for 
interventional cardiology and radiology x-ray systems  
M. Dehairs, N. Marshall; Leuven/BE (michiel.dehairs@uzleuven.be)  
Purpose: To propose and validate an ADRC control method for specific tasks 
and requested image quality levels in interventional cardiology and radiology. 
Methods and Materials: The new ADRC sets exposure parameters that 
maximize a figure of merit (FOM) for a specified object material, object velocity 
and image quality level. To achieve this, three quantities must be accurately 
predicted: reference air kerma (Kref), detector dose and SDNR. The predicted 
values were empirically verified on a Siemens Artis Q interventional cardiology 
system as a function of field size and phantom thickness and a wide range of 
exposure parameters. SDNR was measured using an iron insert centered in 
the phantom and afterwards multiplied by MTF based correction factors for 
focal spot and motion blurring to give SDNR(u): the FOM was SDNR²(u)/Kref. 
The optimized ADRC settings were then applied and SDNR(u) was measured 
versus phantom thickness to examine whether the ADRC held image quality at 
the requested level. Measurements were repeated for tantalum, bismuth, 
platinum and gadolinium inserts. 
Results: Average differences of measured data from the predicted values 
were 5±4%, 5±4% and 13±7%, for reference air kerma, detector dose and 
SDNR respectively. Compared to conventional ADRC methods, the new 
approach increased the FOM (i.e. efficiency) and held SDNR(u) constant to 
within 3±3% and 5±4% for the different materials, for fluoroscopy and 
acquisition respectively. 
Conclusion: Measurements in this study validated the calculations required to 
design a FOM based ADRC enabling optimized task-specific control of x-ray 
parameters and leading to potential increases in imaging efficiency.  
Author Disclosures: 
  M. Dehairs: Research/Grant Support; Siemens.  
B-0127 11:34  
Model observer techniques and an innovative statistical method for 
detectability evaluation in digital angiography: comparison with a 2AFC 
experiment  
R. Villa, N. Paruccini, C. Spadavecchia, A. Baglivi, R. Corso, A. Crespi; 
Monza/IT (raffaele.vill@gmail.com)  
Purpose: Interventional radiology procedures are characterised by high dose 
level for patients and physicians; thus dose management and protocols 
optimisation are mandatory.We evaluate the feasibility of different less time 
consuming approaches for protocol optimisation in interventional radiology. 
Methods and Materials: CDRAD Phantom has been acquired with a Flat 
Panel Angiography equipment. Different protocols have been considered: three 
fluoroscopy modes and cine-coronary angiography. 3 different insert 
dimensions (1.3, 2, 3.2 mm of diameter) have been selected to characterise 
low contrast detectability. A 2AFC experiment has been performed by two 
observers with “Recommended Display Frame Rate”. Furthermore, Low 
Contrast Detectability has been evaluated with a statistical method using 
uniform images. This analysis has been performed using an average of 3, 6, 
12 images of different runs was calculated, considering 200 ms as the time of 
noise integration by human eye-brain system. Two different Model Observers 
has been considered: Non-PreWhitening Eye filter (NPWE) with spatio-
temporal contrast sensitivity function and Channelized Hotelling Observer 
(CHO) with spatio-temporal Gabor filters. 
Results: Analysis with both Model Observers and 2AFC experiments suffered 
from the general low quality of the protocols considered. Nevertheless, a good 
agreement (within 20%) can be found considering the effects of internal eye 
noise.Results with the Statistical Method show different degree of accordance 
related to insert dimension; thus, a single correction factor can be used to 
obtain an agreement within 30% for every protocols considered. 
Conclusion: Every methods show both advantages and disadvantages. 
Nevertheless, numerical approaches are useful in protocol optimisation 













B-0128 11:42  
Low-dose protocol in prostatic artery embolisation (PAE): dose 
assessment  
F. Rottoli, C. De Mattia, M. Sutto, P.E. Colombo, A. Rampoldi, A. Torresin; 
Milan/IT (frottoli26@gmail.com)  
Purpose: To implement a low dose angiographic protocol for guidance of 
prostatic artery embolization (PAE) and analyse it in terms of dose, compared 
with a standard protocol. 
Methods and Materials: In our institution, the PAE angiographic procedure 
showed high Kerma Area Product (KAP) compared to other interventional 
protocols, associated with high risk of skin lesions. After a retrospective 
analysis of the exposure values (KAP, entrance dose, Peak Skin Dose (PSD)) 
using RDIM NEXO[DOSE]® (Bracco, Italy), for 84 patients, a new protocol was 
introduced with low entrance detector acquisition dose. In this protocol, images 
are taken at 2 frames per second (fps) (previously 3) with an additional X-ray 
filtration of 1mmAl+0.1mmCu (previously no filtration) in acquisition mode; in 
fluoroscopy, frame rate is reduced from 15 to 7.5 fps. 
Before introducing the low-dose protocol into clinical practice, it was analysed 
in terms of entrance dose on a 20cm PMMA phantom.Image quality was 
assessed quantitatively as low contrast detectability, using a home-made 
phantom. After optimisation, patient dose was monitored using KAP, entrance 
dose and PSD. 
Results: Protocol optimisation provides a 60% reduction of KAP (from 686 to 
276 Gycm2), 49% of entrance dose (from 3829 to 1904 mGy), 50% of PSD 
(from 3.2 to 1.6 Gy), without any relevant loss of image quality as determined 
on the phantom. 
Conclusion: Optimisation of the PAE procedure led to a significant reduction 
of patient dose and without relevant degradation of image quality. This was the 
result of a multidisciplinary team work (physicians, technicians and medical 
physicists).  
B-0129 11:50  
Standardisation and optimisation of MRI examination protocols  
E. Karavasilis1, A. Karatopis1, P. Szatmari2, R. Illing2, N. Papanikolaou2; 
1
Nicosia/CY, 2Budapest/HU (peter.szatmari@affidea.com)  
Purpose: To present a methodology for standardising and optimising 
heterogeneous MRI systems improving quality and patient experience. 
Methods and Materials: The MRI protocol standardisation project was applied 
in 5 European countries in 33 MRI sites. A total number of 74 standardised 
protocols were developed in consensus between 6 experienced radiologists. 
More than 1500 pulse sequences were included in the standardised protocols 
and optimised in 8 MRI systems from 3 different MRI vendors by a group of 3 
MR application consultants. 8 standardisation workshops were organised with 
a mean duration of 3 hours and 14 min, where all radiologists by consensus 
decided which sequences should be included on each different protocol 
dividing them into four categories. The optimisation part was conducted by a 
combination of site visits of the MR application consultants and remote access 
to a protocol exchange platform that was developed to easily transfer 
optimised protocols to those sites where no site visit was performed. The 
duration of the whole project was 14 months. 
Results: The average examination time reduction after optimisation was up to 
42.2% for Philips MRI scanners, 17.1% for Siemens scanners and 22.3% for 
GE scanners. Image quality of the optimised protocols was graded equal or 
superior to the old protocols in all cases. 
Conclusion: Protocol standardisation although a challenging process is 
necessary to achieve workflow optimisation and, therefore, improve quality of 
services. A lot of effort needs to be invested and different stakeholders need to 
be actively involved for such a project to succeed.  
Author Disclosures: 
  E. Karavasilis: Consultant; MRICONS. A. Karatopis: Consultant; 
MRICONS. P. Szatmari: Employee; Affidea. R. Illing: Board Member; Affidea. 
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Optimising mammography  
Moderators:  
M. Marolt Music; Ljubljana/SI  
D. O'Leary; Newcastle/UK  
B-0130 10:30  
Mammography performance and quality assurance practice among five 
European countries  
A. Henner1, N. Richli Meystre2, C. Sá dos Reis3, B. Strøm4, J. Pires Jorge2, 
T. Kukkes5, E. Metsälä6; 1Oulu/FI, 2Lausanne/CH, 3Perth/AU, 4Bergen/NO, 
5
Tartu/EE, 6Helsinki/FI (anja.henner@oamk.fi)  
Purpose: The purpose of this study was to identify variability in mammography 
practice focused on approach to select exposure parameters, breast 
compression, quality control procedures, image quality assessment and 
guidelines in use in five European countries. 
Methods and Materials: This study was cross sectional survey based on an 
online questionnaire addressed to clinical radiographers in five European 
countries. Questions were mostly closed-ended with the possibility to add 
comments. The answers were dichotomous, multiple choice or with a five point 
Likert Scale. The data collected was analysed and redundant data was 
disregarded. Statistical data analysis was performed using the software 
packages SPSS (version 21, IBM) by using descriptive methods, Chi square 
and independent samples t-test. 
Results: Computed Mammography (CR) was used by 10% of the participant 
institutions and Full Field Digital Mammography (FFDM) by 89%. 
Recommendations on exposure parameter selection were based mainly on 
National (23%), EUREF (9 %), ACR (7 %), local (5 %) and IAEA guidelines (4 
%). The main techniques selected by radiographers were use of automatic 
exposure control, molybdenum/rhodium (Mo/Rh) as target/filter combination, 
compression force from 8 kg to 11 kg and standard mediolateral oblique (MLO) 
projection angle of 45 degrees. Technical quality control was implemented in 
99% of the departments involved in this study. 
Conclusion: Practice in mammography varies considering the participant 
institutions. That reveals the need of further studies to identify if the cause is 
due to the population characteristics or if it is due to the use of different 
guidelines.  
B-0131 10:38  
Validation of applied pressures after clinical introduction of pressure-
standardised compression mammography  
D.d. Boer, L.A. Dam-Vervloet, M.F. Boomsma, J. van Dalen, L. Poot; 
Zwolle/NL (d.den.boer@isala.nl)  
Purpose: Validation of the compression pressure of a pressure-standardized 
compression mammography (PSCM) system, which aims to reduce discomfort 
and pain by applying the same force per unit of area to every breast, 
independent of breast size. 
Methods and Materials: We retrospectively studied mammograms of 50 
patients acquired with the conventional force-standardized compression 
mammography (FSCM) technique and intra-individually compared them to 
mammograms acquired on checkup visits with PSCM technique. Patients 
received one craniocaudal (CC) and one mediolateral oblique (MLO) 
compression for both breasts. The contact area between breast and 
compression paddle enabled the calculation of compression pressures. 
Results: A total of 193 FSCM and 193 PSCM images were analysed. The 
mean compression pressure decreased significantly from 16.6 ± 6.8 to 12.8 ± 
3.4 kPa, while also drastically reducing the relative standard deviation of the 
compression pressure with PSCM. The applied compression pressure is 
depends very slightly on breast contact area; however, this was likely to be 
clinically irrelevant. Furthermore, the relative number of compressions of more 
than 20 kPa reduced significantly from 22.8% 1.6%, benefiting patients with 
smaller breasts. 
Conclusion: The introduction of the PSCM system led to a nearly constant 
applied compression pressure for different contact areas and a significant 
reduction in compression pressures. Especially for higher pressures, which are 
generally applied to smaller breasts and are generally associated with 
discomfort and pain. This suggests that using PSCM can reduce patient 
discomfort and pain during mammographic compression and provide a more 




B-0132 10:46  
Breast compression between women imaged using digital mammography 
and breast tomosynthesis in a population-based breast cancer screening 
programme  
G.G. Waade1, Å.S. Holen1, B. Hanestad2, S. Sebuodegaard1, N. Moshina1, 
K. Pedersen1, S. Hofvind1; 1Oslo/NO, 2Bergen/NO 
(Gunvor-Gipling.Wade@hioa.no)  
Purpose: Digital breast tomosynthesis (DBT) leads to longer image recording 
time. We compared breast compression when screening with digital 
mammography (DM) or DBT. 
Methods and Materials: The study included information about 16,832 women 
participating in the Bergen Tomosynthesis Trial, as a part of BreastScreen 
Norway, January 2016 to April 2017. We compared mean values of applied 
compression force (N) and pressure (kPa), for DM and DBT, by view 
(craniocaudal, CC, and mediolateral-oblique, MLO). Two-sample t tests were 
used to test statistical significance. 
Results: Half the women were screened with DM (n=8354) and the other half 
with DBT (n=8478). Mean compression force was statistically significantly 
higher for DM compared to DBT (CC: 108.6N vs 102.7N; MLO: 122.4N vs 
120.8N, p<0.01). Mean compression pressure was statistically significantly 
higher for DM compared to DBT for CC view (13.9kPa vs 13.0kPa, p<0.01). 
There was no difference in compression pressure between the screening 
techniques for MLO view (DM and DBT: 9.7kPa, p=0.55). 
Conclusion: Radiographers applied less compression when performing 
screening with DBT compared to DM. However, the observed differences in 
breast compression between the screening techniques were negligible. Further 
research is needed to investigate the clinical implications of these findings.  
B-0133 10:54  
Breast compression and experience of pain: comparing two compression 
paddles  
S. Hofvind, N. Moshina, G.G. Waade, S. Sebuødegård; Oslo/NO 
(solveig.hofvind@kreftregisteret.no)  
Purpose: Women’s experience of pain during screening mammography may 
be related to breast compression and result in non-attendance of the next 
screening examination. We aimed to compare the pain experienced among 
women screened using an ordinary flexible paddle and women screened using 
a fixed paddle, standardizing compression pressure to 10 kilopascal (kPa). 
Methods and Materials: Data on experienced pain, compression force 
(newton, N) and pressure, and related factors (age, breast volume, contact 
breast area, pain in shoulders and/or neck prior to mammography), were 
collected via a questionnaire from 1,444 women screened using fixed (n=950) 
or flexible (n=494) paddle, May-June 2017. Experienced pain was evaluated 
using a scale from 0 to 10 and presented as no/mild (<3.5) and 
moderate/severe (3.5). We used logistic regression to estimate the odds ratio 
(OR) with 95% confidence interval (95%CI) for moderate/severe pain 
associated with type of compression paddle, adjusting for compression force or 
pressure and related factors. 
Results: No difference in experienced pain was observed for women screened 
using the flexible paddle compared to the study paddle (OR 1.15; 95%CI 0.89-
1.49 for compression force; and OR 1.25; 95%CI 0.94-1.65 for compression 
pressure). Pain in shoulders and/or neck prior to mammography coupled with 
increasing compression force or pressure during mammography was 
associated with moderate/severe pain during mammography. 
Conclusion: The ordinary flexible paddle and the fixed paddle standardizing 
compression pressure perform similarly with respect to pain experienced 
during mammography. Future research on comparing the performance of the 
paddles should explore the association between breast compression and 
image quality.  
B-0134 11:02  
The influence of breast compression on re-attendance in a population-
based screening programme  
S. Sebuødegård, N. Moshina, G.G. Waade, S. Hofvind; Oslo/NO 
(solveig.hofvind@kreftregisteret.no)  
Purpose: A high attendance rate in organized breast cancer screening 
programs is a prerequisite to achieve a reduction in breast cancer mortality. 
We aimed to investigate whether breast compression at prior screening was 
associated with re-attendance among subsequently screened women in 
BreastScreen Norway. 
Methods and Materials: Information about re-attendance were available for 
77,674 women aged 52-69 with at least two prior screening exams, 2007-2013. 
Data on compression force (kg) and pressure (kPa) were available from 
automated density assessment software. Two-sample unpaired t-tests were 
used to identify differences in re-attendance. Logistic regression was used to 
estimate the odds of re-attendance, adjusting for age, county of residence, 
prior false positive result, breast volume, breast density, and year of screening. 
  






Results: Overall, 71,241 (91.7%) women re-attended. For compression force, 
re-attendance was highest for women who received <11.3 kg (92.0%) and 
lowest for women who received >13.3kg (91.5%) (p=0.082). For compression 
pressure, re-attendance was highest for those who received 11.3-14.3 kPa 
(92.5%) and lowest for <9 kPa (90.7%) (p<0.001). The adjusted odds of re-
attendance did not differ statistically significantly by compression force. The 
odds for re-attendance was 33% higher for women who received pressure 9 
kPa relative to <9 kPa (95% CI: 23%-42%). 
Conclusion: Compression force did not show any statistically significant 
influence on re-attendance, while compression pressure 9 kPa was 
associated with a higher odds. Future research focusing on compression 
variables, experienced pain and image quality is needed to understand this 
issue.  
B-0135 11:10  
Impact of contralateral breast shielding on the risk of developing 
radiation-induced cancer from full field digital mammography (FFDM) 
screening  
R.M.K.M. Ali1,2, A. England2, C.E. Mercer2, A.K. Tootell2, P.H.Hogg2; 1Najaf/IQ, 
2
Manchester/UK (p.hogg@salford.ac.uk)  
Purpose: To investigate the impact of contralateral breast shielding on the risk 
of developing radiation-induced cancer from 4-view FFDM screening. 
Methods and Materials: A breast phantom and adult ATOM dosimetry 
phantom were used to measure organ dose on 4 FFDM machines using 
cranio-caudal and medio-lateral oblique projections for each breast. A lead 
rubber shield was used to protect the contralateral breast. Organ dose, 
effective dose and effective risk were calculated; for effective risk estimations, 
the impact of the shield was considered for all known screening programmes 
worldwide. 
Results: The shield can reduce the contralateral breast dose by more than 
95%. For each FFDM machine the figures in µGy were (35.20 reduced to 
1.93), (41.40 reduced to 0.01), (22.85 reduced to 1.24) and (22.76 reduced to 
1.66). A small reduction was identified in sternum bone marrow dose due to 
the use of contralateral breast shield. The contralateral breast shield can 
significantly reduce the total effective risk of worldwide screening programme 
(p<0.05). However, the reduction percent in total effective risk is different for 
the 4 FFDM machines, ranging between 0.95% and 1.44% with minor 
differences amongst different worldwide screening programmes. 
Conclusion: This novel work demonstrates the value of a contralateral breast 
shield. More research is required to determine whether such as shield has 
clinical utility.  
B-0136 11:18  
Outpointing breasts and hallux valgus: correlation and implications in 
mammography quality  
S. Pacifici, D. Giudice; Rome/IT (s_pacifici@virgilio.it)  
Purpose: In mammography, the position of the woman and her feet is critical 
for positioning the breast correctly and, consequently, regarding quality criteria 
such as the nipple in profile, the PNL perpendicular to the pectoral muscle 
edge on MLO view and on the breast midline on CC view. These criteria are 
hard to meet when non-standard breast shapes are in evidence, such as those 
which are outpointing. In these cases, positioning could require feet intra-
rotation. From our working experience, we have observed a consistent co-
existence of outpointing breasts and hallux valgus. For this reason, we began 
to investigate the correlation. 
Methods and Materials: 54 women with at least one outpointing breast were 
selected and asked about the existence of a hallux valgus condition, assigning 
a 0-2 value to the variables and analysing the data by concordance tests. 
Results: The results showed a 99,7% of concordance which called for a 
PubMed search to find out any scientific evidence in Western medicine, with 
negative results. In change, in osteopathy and traditional Chinese medicine 
concepts, we found links between the big toe and the breast-related muscles 
explained by the biomechanics of the muscle chains and some energy 
meridians. 
Conclusion: The study seems to offer sufficient data to confirm a correlation, 
the knowledge of which can facilitate the positioning of outpointing breasts, 
respecting the quality criteria and thus avoiding technical errors which could 
influence recalls and repeats, comparative evaluations with previous 
mammograms and congruence between the PNLs. However, a clinical study 
with postural evaluation and activation points is required.  
B-0137 11:26  
Learner’s perception, knowledge and behavior assessment within a 
breast imaging eLearning course for radiographers  
I.C. Moreira, S.R. Ventura, I. Ramos, P.P. Rodrigues; Porto/PT 
(icm@ess.ipp.pt)  
Purpose: ELearning has been revealed to be a useful tool to specific training 
and continuing education within health professionals, namely by radiographers. 
This education method needs continuous evaluation in order to validate its 
effectiveness. One method for this evaluation is Kirkpatrick’s framework which 
consists of four categories: learner perception, knowledge, behavior, and 
impact on organization. Our aim was to assess an eLearning course on breast 
imaging for radiographers according to the first three categories. 
Methods and Materials: An asynchronous eLearning system was developed 
for radiographers in order to promote a better knowledge about breast imaging, 
namely mammography technique and interpretation. The contents of this 
eLearning course were based on the guidelines proposed by the European 
Society of Breast Cancer Specialists (EUSOMA). Learner satisfaction was 
assessed through a questionnaire. Knowledge gain was assessed by using 
pre- and post-testing. After 6 months finishing the course, learners were 
contacted through a questionnaire in order to give feedback whether behaviour 
changed in their profession. Statistical analysis is under progress. 
Results: Two editions of the course were performed, totalling 64 learners. In 
general, learners reported being very satisfied with the experience (above 
90%), improved their knowledge, and also changed some attitudes and 
behaviours (such as communication, positioning, image analysis and 
processing) within their work routine. These and other results are still being 
thoroughly analysed. 
Conclusion: This course represents an important contribution for the 
improvement of radiographers’ performance in mammography clinical setting, 
enhancing continuous education models in health professions.  
B-0138 11:34  
The customised training for radiographers and its importance for image 
quality improvement and an accurate diagnosis of breast cancer  
T.B. Silva, E.C. Mauad, S. Sabino; Barretos/BR (tbuosi@gmail.com)  
Purpose: To evaluate the impact of a customized training for radiographers on 
clinical quality of mammography. 
Methods and Materials: Radiographers selected for 80 hours training course 
submitted 15 days before the course starts a portfolio containing 50 
examinations conducted by them for review. Through the evaluation of 18 
mammographic positioning quality items stipulated by the European Guidelines 
it is produced a customized practice-oriented training, based on their most 
frequent positioning failures. Students in these classes were grouped 
according to their failures and a personalized training program was established 
for each one of the students, which spends 80% of their time in hands-on 
training. Subsequently, we evaluate each exam performed by the students 
during the course and itens in “non-conformity” were counted. The data pre 
and post-course were tabulated and the performance of the training was 
assessed. 
Results: Since 2012 it was trained 396 radiographers from Brazil. The mean of 
failures reported per exam was 3.7 at the beginning of the course (portfolio 
analysis) and 1.1 at the end. The average rate of decrease of failures per exam 
was 68% (p=0.001). The most common positioning-related failures reported 
were absence of the pectoral muscle at cranio-caudal incidence (89%) and 
pectoral muscle to nipple level (49.1%) and non-visualization of infra-mammary 
angle (43.9%) at Medio-lateral oblique. 
Conclusion: The trained professionals become able to perform mammography 
with higher diagnostic quality, reversing the current national framework, where 
the majority of mammograms performed have errors that make it difficult to 
provide an accurate diagnosis.  
B-0139 11:42  
Dose analytics over large DICOM datasets: a case study in 
mammography and a quest for meta data quality  
M. Rodrigues dos Santos, N. Rocha, A. Silva; Aveiro/PT (mrs@ua.pt)  
Purpose: The DICOM metadata of the mammographic studies, can contribute 
to a better knowledge of the exposure to which a population is exposed. The 
objective of this work was to identify the extent to which the quality of the 
DICOM metadata stored may contribute to the characterization of the exposure 
and dose used to perform mammography studies. 
Methods and Materials: The studies carried out during the first 12 months of 
equipment activity were analyzed. The work was carried out in 5 phases: 
Indexing and extraction of DICOM metadata from PACS archive, image IOD 
characterization (e.g, Patient Age, Organ Dose), data quality analysis and 
sample normalization, population and exposure characterization. 
Results: An initial sample of 1569 images from 379 studies of 351 patients 
was obtained. After the normalization process in which 8.55% of patients, 
9.76% of the studies and 16.54% of the images were excluded, a final sample 
consisted of 1302 images, 342 studies performed on 321 patients was 
obtained. It was possible to characterize the population as well as ESAK (CC = 
7.85 ± 4.48 mGy and MLO = 8.86 ± 4.96 mGy) and AGD (CC = 1.67 ± 0.73 
mGy and MLO = 2.37 ± 0.14 mGy) as well as the mean compression force and 
mean breast thickness per age group 
Conclusion: It is possible to characterize the exposure to which the population 
is subject in mammography studies based on the data stored in the PACS file. 
However, it is pertinent to consider the quality of the stored metadata.  
  






B-0140 11:50  
Tomosynthesis-guided vacuum-assisted breast biopsy: a survey of the 
patient’s experience  
R. Gullien, A. Haakull, T. Nyborg, B. Sollid, M. Stensvoll, S.M. Ali, 
J.-G. Andersen; Oslo/NO (uxraul@ous-hf.no)  
Purpose: To evaluate and measure the patient experience and satisfaction 
following tomosynthesis-guided breast biopsy. 
Methods and Materials: The survey study period was February 3rd-December 
21st, 2016. 90 patients were scheduled for tomosynthesis-guided breast 
biopsy. Of these, 23 patients did not participate in the survey due to cancelled 
examination, language barriers or they refused. The remaining 67 patients 
were asked to fill out two questionnaires: part one immediately after the 
procedure and part two at home two weeks after the examination. Of the 67 
participants, 56 participants answered both questionnaires, 11 participants did 
not answer part two despite reminders. All participants underwent standard 
procedure for local anaesthesia immediately before the procedure. 
Results: 84% (56/67) of the participants answered both surveys. Results part 
one: 24% (16/67) were much or very much anxious before the examination; 
58% (39/67) were a little anxious; 18% (12/67) were not. 69% (46/67) felt the 
examination uncomfortable; 22% (15/67) did not; 9% neutral. 45% (30/67) felt 
the examination painful; 42% (28/67) did not; 13% (9/67) neutral. Results from 
part two: 39% (22/56) no pain five days after; 61% (34/56) had pain or some 
pain; none had severe pain. 9% (5/56) contacted healthcare (pain, bleeding, 
infection, discolouration), 91% did not need. 96% (54/56) answered “yes” they 
received adequate information before, during and after the procedure, 4% 
(2/56) answered “no”. 73% (41/56) was very satisfied with the overall 
experience of how they were taken care of; 25% (14/56) were satisfied; 2% 
(1/56) was not satisfied. 
Conclusion: Most patients were anxious before examination. They got 
adequate information, were satisfied and felt they were very well taken care of 
during the examination.  
10:30 - 12:00 Room M 1  
Cardiac  
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B-0141 10:39  
Paradoxical low-flow, low-gradient severe aortic stenosis: cardiac 
magnetic resonance (CMR) evaluation  
S. Pradella, C. Vignoli, M. Acquafresca, F. Grossi, I. Fusi, V. Miele; Florence/IT 
(pradella3@yahoo.it)  
Purpose: Paradoxical low-flow, low-gradient (LFLG) severe aortic stenosis 
(AS) despite preserved left ventricular ejection fraction (LVEF) is one of the 
most challenging entities in valvular heart disease. The outcome is not clear. 
Aortic valve replacement (AVR) may be indicated in these patients. 
Methods and Materials: A year (2016) patient’s whit LFLG were assessed by 
clinical data and 2D-3D echocardiography. CMR imaging was performed on a 
1.5 T in LFLG AS patient’s. The LV outflow tract (OT) minimal and maximal 
diameters, to calculate the ellipticity index, and area were measured. LV 
volumes, stroke volume (SV), and LVEF was calculated on short axis cine 
images. The aortic valve area (AVA) was measured by direct planimetry of the 
maximal opening of the aortic valve. Late gadolinium enhancement (LGE) was 
evaluated to exclude focal replacement fibrosis, and T1 mapping for assessing 
of diffuse patterns of interstitial fibrosis presence (not in all patients). 
Results: 72 patients with severe AS, 13 (18%) paradoxical LFLG, mean age: 
78.3±9.5 years; male 4-30%, BMI 24.5+2.6, BMI 24.5+2.6, NYHA 1.8+0.6 
BNP 487.8+299.0. The ellipticity index was 1.21+0.3. 48% patients were re-
classified as moderate AS with CMR. No LGE was found. T1 values were 
higher than normal. 
Conclusion: Assessment of AS severity can be complex because standard 
resting echocardiography may not reflect the true severity of stenosis. There 
may be errors and inaccuracies in the calculation of AVA by the continuity 
equation, which could erroneously suggest the paradoxical phenotype. 
Information from CMR may be complementary to provides an accurate 
diagnosis.  
B-0142 10:47  
The role of topography of valve calcification in degenerative aortic 
stenosis: a new marker in CT evaluation  
J.A.B. Araújo-Filho1, A. de Santis1, C.H. Nomura1, F. Tarasoutchi,1, 
M.C. Vieira1, M. Katz1, J. Brown2, E.R. Edelman3, P.A. Lemos1; 1São Paulo/BR, 
2
Cambridge, MA/US, 3Boston, MA/US (ariaraujocg@hotmail.com)  
Purpose: The relationship between calcium location and the severity of aortic 
valve stenosis (AS) remains poorly understood. The present study aimed at 
evaluating whether the location of calcium influences the functional severity of 
AS. 
Methods and Materials: Prospective, single-arm study including 97 patients 
with diagnosed moderate or severe AS. Aortic valve calcium score was 
calculated from no-contrast multidetector computed tomography (MDCT). 
“Low-contrast-dose” MDCT images were acquired for segmentation of the 
cardiac anatomy, with the attenuation at the aortic valve zone used to quantify 
its calcium content. 
Results: The calcium score was higher among patients with severe AS 
compared to patients without severe AS (3131±1828 Agatston units [AU] vs. 
1302±846 AU respectively; p<0.001). Patients with severe AS had significantly 
higher attenuations at the center of the valve than at its periphery (507.4±181.7 
Hounsfield units [HU] vs. 449.8±114.5 HU; p=0.001). Conversely, patients 
without severe AS had lower attenuation at the center than at the periphery of 
the valve (308.7±92.9 HU vs. 347.6±84.2 HU; p<0.001). The center/periphery 
attenuation ratio was significantly higher for patients with severe AS than for 
those without severe disease (1.14±0.32 vs. 0.89±0.13; p<0.001), and 
remained significantly associated with the presence of severe AS even after 
adjusting for the underlying degree of valve calcification. 
Conclusion: The severity of degenerative aortic valve stenosis appears to 
result not only from the degree of calcification but also from the localization of 
the calcific deposits within the valve.  
B-0143 10:55  
Dynamic morphological changes of the aortic annulus in patients with 
bicuspid aortic valves  
S. Boccalini, L.R. Bons, A.T. van den Hoven, G.P. Krestin, 
A.E. van den Bosch, J. Roos-Hesselink, R.P. Budde; Rotterdam/NL  
Purpose: Bicuspid aortic valve (BAV) consists of a malformation of the aortic 
valve. Transcatheter aortic valve implantation is increasingly practiced to treat 
the associated precocious valvular dysfunction. Precise pre-interventional 
measurements of the annulus are fundamental to avoid potentially lethal 
complications. However, in the general population the annulus has an elliptic 
shape that undergoes shape changes during the cardiac cycle. The aim of our 
study was to investigate dynamic changes of the annulus in BAV patients. 
Methods and Materials: BAV patients who underwent an ECG-gated CTA of 
the aorta between January 2015-March 2016 were included. The annulus 
plane was manually identified on reconstructions obtained at 5% intervals of 
the cardiac cycle. Based on semi-automatically defined contours, maximum 
and minimum diameter, area, perimeter and asymmetry ratio (maximum 
diameter/minimum diameter) were calculated. Paired samples Student’s t test 
was used to assess differences. 
Results: In 55 BAV patients (age: 38.4±13.3 years; 58% males) 38 had BAV 
type 1, 10 type 0 and 7 type 2. Minimum diameter, perimeter and area were 
significantly higher in systole than in diastole (relative changes: 14%, 6%, 17% 
respectively), while maximum diameter was significantly higher in diastole (all 
p<0.001). The asymmetry ratio was >1 in all phases, indicating an elliptic 
shape, with more pronounced flattening in diastole (p<0.001). When examined 
separately, the different BAV types showed analogous dynamic changes. 
Conclusion: The annulus of BAV patients undergoes significant changes in 
shape during the cardiac cycle with a wider area in systole and a more elliptic 
conformation in diastole, affecting pre-interventional measurements.  
Author Disclosures: 
 L.R. Bons: Research/Grant Support; Dutch Heart Foundation; Contract grant 
number: 2013T093. A.T. van den Hoven: Research/Grant Support; Dutch 
Heart Foundation; Contract grant number: 2013T093.  A.E. van den Bosch: 
Research/Grant Support; Dutch Heart Foundation; Contract grant number: 
2013T093. J. Roos-Hesselink: Research/Grant Support; Dutch Heart 
Foundation; Contract grant number: 2013T093. 
B-0144 11:03  
Does the heart cycle fase of cardiac-MSCT influence the measurement of 
the aortic root in patients undergoing TAVI placement?  
A. Drago, V. Alberotanza, C. Massarelli, L. Mappa, M. Carbone, M. de Ceglie, 
E. Ventrella, A.A. Stabile Ianora, A. Scardapane; Bari/IT 
(angelicadrago87@gmail.com)  
Purpose: To assess the differences between systolic and diastolic dimensions 
of the aortic root in patients undergoing MSCT before TAVI placement. 
  






Methods and Materials: Coronary-CT examinations of 70 patients, 29 females 
and 41 males with an average age of 66.2 years were evaluated. Modulated 
ECG-gated cardiac CTA was performed after the injection of 60-80 ml of 
iodinate contrast at a flow rate between 4 and 5 ml / sec. Systolic (20% of RR 
interval) and diastolic (75% RR interval) images were obtained and aortic 
annulus was measured just below the insertion of the valve leaflets after true 
axial cuts were obtained aligning the three perpendicular imaging planes. 
Distances of the coronary ostia were also measured. The differences between 
systolic and diastolic measure were compared using the T-Test. 
Results: The mean diastolic and systolic size of the aortic annulus were 
respectively 22.28 mm and 22.5 mm in short axis and 27.25 mm and 27.8 in 
long axis. The distance of the right coronary artery from the aortic valve had a 
mean diastolic value of 14.37 mm and a mean systolic value of 14.15 mm; The 
distance of the left coronary artery from the aortic valve had a mean diastolic 
value of mm 14.21 mm and a mean systolic value of 14.4 mm. No statistically 
significant differences (p>0.05) were found among these measures. 
Conclusion: There was no statistically significant difference between systolic 
and diastolic measurements, so we believe that measurement should be 
performed during the best phase of each patient's heart cycle.  
B-0145 11:11  
Angio-CT: key for landing zone reconstruction in TAVI  
D. Araujo Martins, R. Ruiz Salmeron, A. Rivera, C. Caparros Escudero, 
L. Cueto Álvarez, F. Mateo Carballo; Sevilla/ES (danielamromeo@gmail.com)  
Purpose: AngioCT has become gold standard for planning TAVI. AngioCT 
evaluation of aortic annulus is key to define the prosthesis to be implanted. 
However, anatomical characteristics of TAVI landing zone, the portion between 
the left ventricle outflow tract and the aortic root receiving prosthesis 
deployment, have not been fully described. Aim: To describe the anatomical 
characteristics of the landing zone evaluated by angioCT, and to generate a 
3D model to support TAVI procedure strategy. 
Methods and Materials: In 83 consecutive patients ( 56 females) undergoing 
TAVI, angioCT study of landing zone analysed the values of area (mm2) and 
eccentricity (1- (Minor Diameter / Major Diameter)) in 5 cut-off points separated 
by 5mm: lower cut-point located below the aortic ring, next on the aortic 
annulus, and the remaining three cut-points above, at the aortic root. With 
those data, SolidWork graphics software generated a 3D geometric model. 
Results: Landing zone showed, at each cut-point, inverse relationship 
between area and eccentricity: ascending from the left ventricular outflow tract 
towards the aorta, area increased and eccentricity decreased significantly (p 
0.001). We found significant differences between male and female gender 
regarding the dimensions and degree of eccentricity of the landing zone: men 
showed larger area and a lower eccentricity (p 0.001). For each patient, 
SolidWork was able to generate and print a 3D landing zone model. 
Conclusion: AngioCT allows an accurate description of the landing zone 
anatomy of TAVI procedures, and its 3D printing model is an attractive tool for 
the success of the intervention.  
B-0146 11:19  
One-stop high definition 64-row CT coronary angiography in patients with 
severe aortic stenosis candidate to transcatheter aortic valve 
implantation (TAVI): a pilot feasibility study  
L. Faggioni, M. Gabelloni, M. Bianchi, G. Costa, M. De Carlo, A.S. Petronio, 
D. Caramella; Pisa/IT (lfaggioni@sirm.org)  
Purpose: To assess the diagnostic performance of high definition 64-row CT 
coronary angiography (CTCA) integrated in a one-stop-shop CT protocol for 
TAVI planning. 
Methods and Materials: A retrospectively ECG-gated CTCA examination was 
performed in 57 nonobese patients with severe aortic stenosis as part of a 
comprehensive CT protocol for TAVI planning. All studies were carried out on a 
high definition 64-row CT scanner using 100kV tube voltage and an iterative 
reconstruction algorithm. Patients with inconclusive or positive CTCA findings 
(defined as presence of stenosis >50% of the left main artery and/or proximal 
or mid left anterior descendent, circumflex, or right coronary arteries) 
underwent invasive coronary angiography (ICA) prior to TAVI, whereas in a 
subset of patients with negative CTCA findings (7/30, 23.3%) ICA had 
previously been performed before CTCA. Per-patient sensitivity, specificity, 
positive and negative predictive value of CTCA compared to ICA as gold 
standard were calculated. The association between image quality (graded 
visually as good, adequate or nondiagnostic), coronary calcium score (CCS) 
and heart rate (HR) was also evaluated. 
Results: A total of 47/57 CTCA examinations (82.5%) were of diagnostic 
quality. Sensitivity, specificity, positive and negative predictive value of CTCA 
were 100%, 87.5%, 90.9% and 100%, respectively. Image quality was 
inversely correlated with CCS and HR (p<0.05), and in particular, adequate or 
good image quality was associated with CCS<350 and HR<74bpm. 
Conclusion: One-stop CTCA allows accurate detection of critical coronary 
artery stenoses and can play a role as a gatekeeper to ICA in selected patients 
candidate to TAVI.  
B-0147 11:27  
Comparison of aortic annulus dimensions by multimodal measurement 
before transcatheter aortic valve replacement  
R. Qi; Hangzhou/CN (tsirea@163.com)  
Purpose: We sought to compare 3 methods of measurements of the aortic 
root in patients of severe aortic stenosis (AS), transthoracic echocardiography 
(TTE), transesophageal echocardiography (TEE), and multislice computed 
tomography (MSCT), and to evaluate their potential clinical impact on 
transcatheter aortic valve implantation (TAVI) strategy. 
Methods and Materials: Aortic root dimensions were measured using TTE, 
TEE, and MSCT in 138 consecutive patients with severe AS referred for TAVI 
in our institution. The differences among measurements of aortic annulus 
diameter were compared. The accuracy of the multimodal measurements 
before TAVI was evaluated with postoperative follow-up. 
Results: Mean aortic annulus diameter was 23.37±2.22mm using TTE and 
23.52±1.70mm using TEE (p=0.12) and correlation between TTE and TEE was 
excellent (r=0.87). The mean of long- and short-axis diameters according to 
MSCT multiplanar reconstruction did not differ from the diameter derived from 
cross-sectional area (p=0.08). However, the diameter derived from 
circumference was larger than the others, and the difference is 0.43±0.62mm, 
0.51±0.62mm (p<0.01, respectively). Measurements of the aortic annulus 
diameter by MSCT were larger than the measurement by TTE and TTE 
significantly (p<0.01). Implantation was successful in all, but 3 patients with 
worse than moderate paravalvular leakage and 1 patient with valve-in-valve 
implantation because of prosthetic valve restenosis. 
Conclusion: In patients referred for TAVI, measurements of the aortic root 
using TTE or TEE were smaller than measurements by MSCT. In the absence 
of a gold standard, a strategy based on comprehensive consideration would 
provide good clinical results.  
B-0148 11:35  
Comparison of cardiovascular magnetic resonance imaging and 
computed tomography to guide transcatheter aortic valve replacement: a 
pilot study  
A. Mayr, C. Kranewitter, G. Klug, C. Kremser, G. Feuchtner, W. Jaschke, 
B. Metzler; Innsbruck/AT (a.mayr@i-med.ac.at)  
Purpose: To compare a comprehensive cardiovascular magnetic resonance 
(CMR) imaging protocol with contrast-enhanced computed tomography 
angiography (CTA) for guidance in TAVR evaluation. 
Methods and Materials: Non-contrast three-dimensional (3D) “whole heart” 
CMR imaging for aortic annulus sizing and measurements of coronary ostia 
heights, contrast-enhanced CMR angiography (MRA) for evaluation of 
transfemoral routes as well as aortoiliofemoral-CTA were performed in 16 
patients referred for evaluation of TAVR. 
Results: Aortic annulus measurements by CMR and CTA showed a very 
strong correlation (r=0.956, p<0.0001; effective annulus area for CMR 430±74 
vs. 428±78 mm² for CTA, p=0.629). Regarding decision for valve size there 
was an excellent agreement between CMR and CTA. Moreover, vessel luminal 
diameters and angulations of aortoiliofemoral access as measured by MRA 
and CTA showed overall very strong correlations (r= 0.819 to 0.996, all 
p<0.001), the agreement of minimal vessel diameter between the two 
modalities revealed a bias of 0.02 mm (upper and lower limit of agreement: 
1.02 mm and -0.98 mm). 
Conclusion: In patients referred for TAVR, CMR measurements of aortic 
annulus and minimal aortoiliofemoral diameters showed good to excellent 
agreement. Decisions based on CMR measurements regrading prosthesis 
sizing and transfemoral access would not have modified TAVR-strategy as 
compared to a CTA-based choice.  
B-0149 11:43  
Value of left ventricular fibrosis volume as a parameter for long-term 
survival after TAVI  
A.S. Sträter, A. Huber, J. Nadjiri, M. Rasper, M.T. Berndt, E.J. Rummeny, 
J. Rieber; Munich/DE (alexandra.straeter@gmail.com)  
Purpose: Patients with severe aortic stenosis develop left ventricular 
hypertrophy and reduced left ventricular function. Insufficient vascularisation of 
hypertrophic myocardium may cause development of left ventricular fibrosis. 
Transcatheter aortic valve implantation (TAVI) is an upcoming procedure to 
reduce workload and improve left ventricular function. Long-term survival 
shows huge inter-individual difference. NYHA class 30 days after TAVI has 
shown to be a strong and independent parameter for long-term survival. This 
study assesses the value of left ventricular fibrosis volume as a predictive 
parameter for clinical outcome. 
Methods and Materials: The study enrolled 35 consecutive patients for TAVI. 
The mean characteristics were 81±7 years, NYHA Class 3.2±1.4, EF 48±9.3%. 
In each patient pre-interventional contrast-enhanced cardiac MRI was 
performed in a Philips Ingenia 3T. Left ventricular fibrosis volume was 
  






quantified. Functional recovery was assessed using NYHA class 30 days after 
the procedure. 
Results: NYHA class after TAVI was reduced significantly (1.7±1.3; p<0.001). 
22 (63%) patients revealed 2 class reduction whereas 12 (34%) patients 
showed reduction of 1 class and 1 patient remained (this patient had good pre-
interventional function: EF 74%). Left ventricular fibrosis volume was inversely 
related to the reduction of NYHA class (left ventricular fibrosis volume 
720.75±43 [NYHA reduction 2 grades] vs 1501.6±74 [NYHA reduction <2 
grade]; p<0.05). 
Conclusion: The left ventricular fibrosis volume shows a strong correlation to 
the reduction of NYHA class 30 days after successful TAVI implantation. Thus, 
the quantification of left ventricular volume might possibly be used as a 
prognostic parameter for long-term survival in TAVI patients.  
B-0150 11:51  
Left ventricular reverse remodeling after transcatheter aortic valve 
implantation as assessed by CT angiography  
B. Szilveszter, D. Oren, M. Kolossvary, M. Vecsey-Nagy, J. Karady, F. Suhai, 
A. Apor, B. Merkely, P. Maurovich- Horvat; Budapest/HU  
Purpose: Transcatheter aortic valve implantation (TAVI) has rapidly emerged 
as a safe and effective treatment option for high risk patients with severe aortic 
stenosis. CT imaging provides accurate assessment of left ventricular (LV) 
dimensions. Therefore, we aimed to assess the impact of TAVI procedure on 
LV remodeling as assessed by CT angiography. 
Methods and Materials: We performed retrospectively gated CT angiography 
for the planning and follow-up of TAVI procedure in 48 patients. We measured 
LV mass on serial CT images using a dedicated semi-automated software. Epi- 
and endocardial contours were manually adjusted. Pre- and post-procedural 
left ventricular mass and volumes were compared using Wilcoxon signed rank 
test. Multivariate linear regression analysis was used to establish independent 
factors related to LV reverse remodeling. 
Results: Mean age was 77.1 ± 15.1 years, 58.3% were male. We found 
significant reduction in LV mass after TAVI procedure: 166.3 [139.2-225.5] 
grams for pre- and 128.2 [106.2-151.6] grams for post-TAVI, respectively, 
p<0.001. Mean change in LV mass was 48.9 ± 31.4 grams. On multivariate 
analysis, baseline LV mass is independently associated with LV reverse 
remodeling (ß=0.63, p<0.001) above traditional risk factors, age, gender and 
BMI. 
Conclusion: Significant regression of LV mass was observed in almost all 
cases after TAVI procedure that is presumably associated with the reverse 
remodeling of the left ventricular structure. In line with previous data larger 
baseline LV mass was associated with more pronounced remodeling.  
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B-0151 10:30  
Apparent diffusion coefficient (ADC) and its correlation with gestational 
age (GA) in normal developing foetal brain: preliminary results of a 
prenatal MRI study  
A. Antonelli, S. Capuani, M. Guerreri, S. Bernardo, R. Petrillo, V. Vinci, 
L. Manganaro, C. Catalano; Rome/IT (amanda.antonelli@hotmail.it)  
Purpose: To provide a normal comparison base of ADC values in the 
developing non-pathological foetal brain parenchyma, investigating the 
potential of ADC as a function of gestational age (GA). 
Methods and Materials: Diffusion-weighted imaging (DWI) was performed in 
35 pregnancies (GA range: 19-38 weeks) at 1.5T (Siemens Avanto, Erlangen, 
Germany). A DW-Spin Echo EPI with TR/TE=4000/79; bandwidth=1628 Hz/px; 
matrix=192x192; FOV 379mm2 was obtained. Eight regions of interest (ROIs) 
were manually placed in the frontal white matter (FWM), cccipital WM (OWM), 
thalamus (THAL), caudate (CD), basal ganglia (BG) cerebellum (CH), pons 
and lateral ventricle cerebral spinal fluid (CSF). ADC values of each ROI were 
measured and mean values for second and third trimester of gestation were 
obtained. One-way ANOVA was used to calculate the differences between the 
mean values and Pearson analysis with Bonferroni correction was used to 
evaluate the linear correlation between ADC values and GA. 
Results: ADC values of CH and pons show significant negative correlations 
with GA (R =-0.87, -0.80, respectively, all p<0.0001); a positive correlation was 
found between ADC and GA in FWM (R=0.56, p<0.01). In FWM, the ADC 
increases in parallel to GA during the second trimester; conversely, ADC 
decreases with the increasing of GA in the third trimester. ADC mean values of 
CH, Pons, FWM and BG are significantly different between second and third 
trimester. 
Conclusion: ADC parameters reflect the physiological microstructural changes 
of myelination, occurring during foetal brain maturation; these ADC results may 
be useful in the assessment of suspected fetal CNS abnormalities.  
B-0152 10:38  
A pain in the neck: imaging of the paediatric cervical spine (c-spine) in 
isolated neck trauma  
M. McGill, A. Paterson; Belfast/UK  
Purpose: To the authors' knowledge there are currently no internationally 
recognised guidelines which consider the radiological management of focal 
cervical spine tenderness (FCST) following isolated paediatric c-spine trauma. 
Our aim was to develop regional guidelines for imaging children with FCST. 
Methods and Materials: A retrospective review of 1,000 children (<14yrs) 
presenting to both tertiary and district general hospitals between 2011 and 16, 
with isolated c-spine trauma was undertaken to establish current practice with 
respect to imaging. Guidelines were developed utilising best evidence-based 
practice in consultation with paediatric spinal and orthopaedic surgeons. 
Results: All children evaluated had plain radiograph(s), 39% underwent c-
spine CT and 2% c-spine MRI for persistent focal tenderness. Regional 
differences in local guidelines and practice were identified. Retrospective 
application of the proposed regional guidelines did not result in the ‘miss’ of 
clinically significant c-spine injuries within this study population and would have 
resulted in a 22% reduction in utilisation of CT and a 45% increase in the 
utilisation of MRI. 
Conclusion: It is possible to decrease the number of CT c-spine exams 
undertaken in children with FCST. Proposed imaging guidelines are presented 
for discussion: initially, analgesia is prescribed and consideration of cervical 
collar placement undertaken by the assessing team. C-spine plain films are 
obtained and if abnormal, or inadequate, CT is discussed with the radiology 
team. If pain persists and plain films are normal, referral to the orthopaedic 
team is undertaken, and a c-spine MRI is organised within 72 hours. Children 
with focal neurology are all referred for MRI.  
B-0153 10:46  
Diffusion kurtosis imaging (DKI) can efficiently differentiate low- and 
high-grade gliomas in paediatric patients  
I.P. Voicu, A. Napolitano, L. Lattavo, C. Carducci, M.C. Rossi Espagnet, 
A. Mastronuzzi, P. Toma, G.S. Colafati; Rome/IT (paul.voicu@hotmail.it)  
Purpose: To investigate whether diffusion kurtosis imaging (DKI) can be 
helpful in differentiating low- and high-grade gliomas (LGG and HGG 
respectively) in paediatric patients. 
Methods and Materials: After obtaining informed consent, thirty-two 
consecutive children (median age 8.5 years, 17 M) affected by histologically 
confirmed brain gliomas were prospectively studied on a 3T magnet with a 32-
channel head coil. Conventional sequences and DKI sequences (30 directions, 
3 b values: 0, 1000, 2000) acquired with the simultaneous multislice (SMS) 
technique were obtained. Mean kurtosis (MK), axial kurtosis (AK), radial 
kurtosis (RK) and fractional anisotropy (FA) values were calculated and the 
corresponding maps were obtained. The enhancing and nonenhancing tumour 
volumes (VOIs) were segmented semiautomatically. Mean and highest 20 
percentile (H20%) DKI values in tumour VOIs were calculated for each metric. 
Differences among DKI values in the enhancing and nonenhancing VOIs of low 
and high-grade gliomas (LGG and HGG respectively) were assessed with an 
independent sample t test. 
Results: After excluding three patients for motion artefacts, the scans of 
twenty-nine children (20 LGG and 9 HGG) were analysed. Significantly 
different mean RK, H20% RK and mean MK values were found in the 
enhancing tumour VOI between LGG and HGG (p<0.029, p<0.015 and p<0.05 
respectively). 
Conclusion: DKI can be helpful in differentiating low and high-grade gliomas 
in paediatric patients.  
B-0159 10:54  
Grading of hemispheric gliomas in pediatric patients by using Diffusion 
Kurtosis MR imaging  
I.P. Voicu, A. Napolitano, L. Lattavo, C. Carducci, M.C. Rossi Espagnet, 
A. Mastronuzzi, P. Toma, G. Colafati; Rome/IT (paul.voicu@hotmail.it)  
Purpose: To investigate whether diffusion kurtosis imaging (DKI) can help 
differentiate low- and high-grade hemispheric gliomas (hLGG and hHGG 
respectively) in paediatric patients. 
Methods and Materials: After obtaining informed consent, eighteen 
consecutive children (median age 9.6 years, 9 males) affected by histologically 
confirmed hemispheric gliomas were prospectively studied on a 3T magnet 
with a 32-channel head coil. Conventional sequences and DKI sequences (30 
directions, 3 b values: 0, 1000, 2000) acquired with simultaneous multislice 
  






technique (SMS) were obtained. Mean kurtosis (MK), axial kurtosis (AK), radial 
kurtosis (RK) and fractional anisotropy (FA) values were calculated and the 
corresponding maps were obtained. The enhancing and nonenhancing tumour 
volumes (VOIs) were segmented semiautomatically. Mean and highest 20 
percentile (H20%) DKI values in tumour VOIs were calculated for each metric. 
Differences among DKI values in the enhancing and nonenhancing VOIs of low 
and high-grade hemispheric gliomas (hLGG and hHGG respectively) were 
assessed with an independent sample t test. 
Results: After excluding one patient for motion artifacts, the scans of 
seventeen children (12 LGG and 5 HGG) were analysed. Significantly different 
mean RK, H20%RK, mean MK and H20% MK values were found in the 
enhancing tumour VOI between hLGG and hHGG (p<0.003, p<0.007, p<0.004 
and p<0.001 respectively). No significant differences in DKI values were found 
between nonenhancing tumour VOIs in hLGG and hHGG. 
Conclusion: DKI can help differentiate low and high-grade hemispheric 
gliomas in paediatric patients.  
B-0157 11:02  
Diffusion kurtosis imaging (DKI) can help differentiate low- and high-
grade brainstem gliomas in pediatric patients: a pilot study  
I. Voicu, A. Napolitano, L. Lattavo, M. Rossi Espagnet, C. Carducci, 
A. Mastronuzzi, P. Toma, G. Colafati; Rome/IT (paul.voicu@hotmail.it)  
Purpose: To investigate whether diffusion kurtosis imaging (DKI) can help 
differentiate low- and high-grade brainstem gliomas (bLGG and bHGG 
respectively) in paediatric patients. 
Methods and Materials: After obtaining informed consent, fourteen 
consecutive children (median age 7.4 years, 8 males) affected by histologically 
confirmed brainstem gliomas were prospectively studied on a 3T magnet with a 
32-channel head coil. Conventional sequences and DKI sequences (30 
directions, 3 b values: 0, 1000, 2000) acquired with simultaneous multislice 
technique (SMS) were obtained. Mean kurtosis (MK), axial kurtosis (AK), radial 
kurtosis (RK) and fractional anisotropy (FA) values were calculated and the 
corresponding maps were obtained. The enhancing and nonenhancing tumor 
volumes (VOIs) were segmented semiautomatically. Mean and highest 20 
percentile (H20%) DKI values in tumor VOIs were calculated for each metric. 
Differences among DKI values in the enhancing and nonenhancing VOIs of low 
and high-grade brainstem gliomas (bLGG and bHGG respectively) were 
assessed with an independent sample t test. 
Results: After excluding two patients for motion artifacts, the scans of twelve 
children (8 LGG and 4 HGG) were analyzed. Significantly different H20% FA, 
mean MK, H20% MK, mean AK and H20% AK values were found in the 
nonenhancing tumor VOI between LGG and HGG (p<0.05, p<0.008, p<0.007, 
p<0.045 and p<0.001 respectively). No significant differences in DKI values 
were found between enhancing tumor VOIs in bLGG and bHGG. 
Conclusion: DKI can help differentiate low and high-grade brainstem gliomas 
in paediatric patients.  
B-0154 11:10  
High predictive value of MRI imaging in mitochondrial disease  
I. De Beaurepaire, D. Grevent, R. Levy, V. Dangouloff-Ros, A. Munnich,  
A. Rötig, N. Boddaert; Paris/FR (isaure.debeaurepaire@orange.fr)  
Purpose: Because the mitochondrial respiratory chain is ubiquitous, its 
deficiency can theoretically give rise to any symptom in any organ or tissue at 
any age with any mode of inheritance, owing to the twofold genetic origin of 
respiratory enzyme machinery, i.e. nuclear and mitochondrial. Yet, not all 
respiratory enzyme deficiencies are primary. Indeed, secondary deficiency is 
frequently observed, leading to a number of fake conclusions and inappropriate 
investigations in clinical practice. 
Methods and Materials: Starting from a large series of 189 patients at risk of 
respiratory chain deficiency, for whom both brain MRIs and disease-causing 
mutations were available, we retrospectively studied the predictive value of 
brain MRI imaging and its ability to discriminate between two groups: primary 
deficiency of the mitochondrial respiratory chain machinery (n=152) and 
phenocopies (n=37). 
Results: Although no anomaly was specific, detection of i) brainstem hyper-
intensity with basal ganglia involvement (p0.001) and ii) lactate peak with 
either brainstem or basal ganglia hyper-intensity were highly suggestive of 
primary respiratory chain deficiency (p 0.01). Fourteen items had a positive 
predictive value > 95% and biallelic SLC19A3 mutations represented the main 
differential diagnosis. Non-significant differences between the two groups were 
found for cortical/subcortical atrophy, leukoencephalopathy, and involvement of 
caudate nuclei and corpus callosum. 
Conclusion: Based on these results and owing to invasiveness of skeletal 
muscle biopsies and cost of high-throughput DNA sequencing, we suggest 
giving consideration to brain MRI imaging as a strong predictive marker and 
the first investigation to be performed in patients at risk of respiratory chain 
deficiency.  
B-0155 11:18  
SMI ultrasound of the neonatal brain: comparison with MRI (1.5 T) in a 
clinical case series  
A. Hojreh, G. Kasprian, K.A. Göral, K. Klebermass-Schrehof, 
K. Vergesslich Rothschild, M. Weber, J.M. Patsch; Vienna/AT 
(azadeh.hojreh@meduniwien.ac.at)  
Purpose: Superb microvascular imaging (SMI) is a novel ultrasound 
application capable of depicting micro-vasculature. Previously, we have 
reported feasibility and features of brain SMI in healthy neonates. The purpose 
of this study was to compare SMI ultrasound and MRI in a clinical case series. 
Methods and Materials: Following ethical approval and written informed 
consent, we performed transcranial ultrasound in thirteen neonates with 
suspected brain pathologies. Routine examinations were performed and 
documented according to national standards. SMI ultrasound was performed 
using linear (18mHz and 14mHz) and curved array transducers (4mHz). 
Superficial and deep scans were acquired in the coronal and parasagittal 
plane, using the left and right superior frontal gyrus as anatomical landmarks. 
All subjects underwent 1.5 T MRI. Regarding visibility of microvessels, T2-
weighted turbo-spin-echo sequences and susceptibility-weighted sequences 
were compared with SMI ultrasound. 
Results: In all cases (n=13;100%), cortical and medullary were visible on SMI 
ultrasound and invisible on MRI. In 23 % of cases (3/13), intraparenchymal 
striatal microvessels were visible on SMI, but invisible on MRI (100%). In a 
case with mitochondrial disease, medullary micro-vessels were pathologically 
elongated/tortuous, which was confirmed by histology. Post-ischemic cortical 
hyperperfusion was detected in an area of cortical infarction/diffusion 
restriction. SMI detected tortous subarachnoid vessels in a case of 
osteogenesis imperfecta, which could be confirmed by MRI. 
Conclusion: SMI ultrasound opens a new diagnostic window in the 
assessment of vascular pathologies of the neonatal brain. Abnormalities of 
cortical, medullary, and striatal micro-vessels that are invisible on 1.5T MRI can 
be readily detected.  
B-0156 11:26  
Simultaneous decrease of aspartate and NAA levels in the brain after 
severe TBI: 1H MRS study  
P.E. Menshchikov, M. Ublinskiy, A. Manzhurtsev, T. Akhadov, N. Semenova; 
Moscow/RU (peeterem@gmail.com)  
Purpose: N-acetylaspartate (NAA) is a neuronal marker in the brain. Severe 
TBI is associated with decrease of NAA level. Disturbances in the NAA 
synthesis from aspartate (Asp) may be the reason of NAA decrease. Thus, the 
main objective of this study was to estimate simultaneously cerebral Asp and 
NAA levels in vivo using proton magnetic resonance spectroscopy (1H MRS). 
Methods and Materials: Eight children (mean age: 14±2 years) were 
examined with quantitative 1H MRS after closed severe head injury (5-6 
months after TBI). Control group consisted of 11 healthy children (mean age: 
15±1 years) without history of any TBIs. MRS protocol included MEGA PRESS 
(aspartate and pure glutamate signals) and conventional PRESS spectra with 
TE=115 ms. Voxels in size of 25×25×30 mm were located in the frontal lobe. 
All investigations were performed on Philips 3.0T Achieva TX MRI scanner. 
Results: NAA/tCr as well as Asp/tCr ratios were significantly reduced (P < 
.001) in patients by 34% and 44%, respectively. Cho/tCr was significantly 
increased (by 36%) in patients. GLX and pure glutamate levels were 
unchanged. 
Conclusion: This study for the first time revealed simultaneously reduced 
cerebral Asp and NAA levels. This result can be a significant confirmation of 
NAA synthesis disturbances after TBI. Further investigations on Asp/NAA 
balance in the acute severe TBI will certainly help in understanding of 
biochemical changes in injured brain.  
B-0158 11:34  
Assessment of a 33-point software programme for the identification of 
vertebral fractures in children  
F. Alqahtani, F. Messina, A.C. Offiah; Sheffield/UK 
(ffmalqahtani1@sheffield.ac.uk)  
Purpose: To measure observer reliability and diagnostic accuracy in children, 
of a semi-automated programme using a 33-point technique (Avert™) 
developed for vertebral fracture (VF) diagnosis in adults, which records 
percentage loss of vertebral body height and to compare Avert with previous 
results of a 6-point technique (SpineAnalyzer™). 
Methods and Materials: Lateral spine radiographs (RA) and dual-energy 
lateral vertebral assessment (VFA) images of 50 children were analysed using 
two different programmes (SpineAnalyzer™ and Avert™; 50 RA analysed with 
SpineAnalyzer (Group 1), 50 RA analysed with Avert (Group 2) 50 VFA 
analysed with Avert (Group 3). Diagnostic accuracy (sensitivity, specificity) was 
calculated by comparing with a previously established consensus arrived at by 
three experienced paediatric radiologists, using a simplified algorithm based 
  






qualitative scoring system. Levels of agreement were calculated using Cohen’s 
kappa. 
Results: Overall sensitivity of Groups 1, 2 and 3 was 26%, 37% and 35% and 
specificity was 98%, 94% and 92% respectively. Fair agreement was found 
between different modalities/different software; between Groups 2 and 3 kappa 
0.29 (95% CI, 0.06 - 0.53), between Groups 1 and 3 kappa 0.35 (95% CI, 0.12 
- 0.59). Moderate agreement was noted between identical modalities; Groups 1 
and 2 kappa 0.55 (95% CI, 0.28 - 0.82). 
Conclusion: The 33-point technique has slightly higher accuracy for the 
representation of vertebral morphometry in children when compared to the 6-
point technique. However, neither Avert nor SpineAnalyzer are satisfactorily 
reliable for VF diagnosis in children. Therefore, training of either or both 
software programmes on paediatric images is required.  
B-0160 11:42  
Systematic approach to the congenital abnormalities of the posterior 
fossa: a tertiary paediatric referral hospital experience in last five years 
(2012-2016)  
J. Smiechowicz1, M. Rebollo Polo2, M. Gómez Chiari3, J. Muchart Lopez3, 
C. Fons Estupiña2; 1Girona/ES, 2Esplugues de Llobregat/ES, 3Barcelona/ES 
(jareksmie@wp.pl)  
Purpose: Congenital abnormalities of the posterior fossa present a wide 
spectrum of radiological features including normal anatomic variations and 
severe malformations. MRI permits systematic evaluation of cerebellum and its 
pathology and employment of the biometric parameters. 
Methods and Materials: We reviewed MRI scans of the group of 351 
newborns (age: 1-28 days) performed in the tertiary referral hospital in years 
2012-2016. 1.5T Signa Excite GE MRI T1 T1 FLAIR, PDT2, DWI , T2 , T2* y 
T1 3D-SPGR. We have taken measurements of cerebellum transversal 
diameter, craniocaudal and anteroposterior diameter of the vermis, tegmento-
vermian angle and analysed the cerebellar fissures. Moreover, the presence of 
the supratentorial pathology was also recorded. 
Results: The range of the tegmento-vermian angle in a group of control is 3 - 
14,5 degrees, meanwhile, a significant number of patients with malformation 
present an angle value higher than 15 degrees. In addition, the differences of 
the values of cerebellum craniocaudal diameter of the vermis between both 
groups has drawn our attention. Abnormalities of posterior fossa such as 
arachnoid cyst, Blake cyst, cerebellar dysplasia, rhomboencephalosynapsis, 
Chudley-McCullough syndrome, Joubert syndrome, Dandy-Walker 
malformation, pontocerebellar hypoplasia or congenital muscular dystrophy 
with cerebellar affectation were analysed. Anatomic variations such as mega 
cisterna magna was also recorded. 
Conclusion: The systematic revision of the posterior fossa structures 
increases the sensibility in diagnosing possible congenital malformations. 
These abnormalities can be classified in order to criteria based in biometric 
parameters which facilitate suggesting differential diagnosis, genetic disorder 
orientation and prognostic factors of neurological outcomes.  
B-0161 11:50  
Dentate and basal ganglia T1-hyperintensity in pediatric patients who had 
received both linear and macrocyclic Gadolinium-based MRI contrast 
agents; evidence of a "carry-over" effect  
P. Gulino1, A. Bianchi1, A. Scionti2, S. Diciotti3, E. Bartolini1, P. Papadopulos1, 
C. Defilippi1, M. Mascalchi1; 1Florence/IT, 2Pisa/IT, 3Bologna/IT 
(pietrogulino@yahoo.it)  
Purpose: The capability of macrocyclic Gadolinium-Based Contrast 
Agents(GBCAs) to determine hyperintensity of dentate nucleus and basal 
ganglia in pre-contrast T1-weighted images (T1wH) is controversial. Our study 
intend to demonstrate the “carry over" effect. 
Methods and Materials: Two radiologists visually assessed in consensus 
sagittal T1-weighted SE or TSE images of 140 index-MRI examinations in 
pediatric patients with at least one prior contrast-enhanced (CE)-MRI and of 
123 control-MRI examinations in pediatric patients without prior CE-MRI. 
Results: T1wH was identified in 9 (4 "definite" and 5 "faint": 6.4%) of 140 
index-MRI and in none of 123 control-MRI (p=0.004). All of them belonged to 
the group of 86 patients who had received both linear (gadopentetate 
dimeglumine) and macrocyclic (gadoterate meglumine) GBCAs, whereas none 
of the 54 patients who had received only the macrocyclic GBCA showed T1wH 
(p=0.01). Age, number of prior CE-MRI and the cumulative dose of GBCAs 
were significantly (p<0.01) higher in patients with T1wH as compared to 
patients without. Region-of-interest (ROI) analysis showed a progressive 
increase of pallidal/middle cerebellar peduncle (MCP) signal intensity (SI) ratio 
in the 4 patients with "definite" T1wH and of dentate/MCP SI ratio in 3. 
Conclusion: Dentate and basal ganglia T1wH occurs in pediatric patients after 
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B-0162 10:30  
MRI texture analysis of rectal cancer with mono- and multivariate 
analysis using machine learning artificial intelligence  
R. Ferrari1, C. Voena1, C. Mancini1, M. Zerunian2, F. Rivosecchi2, V. Marè1, 
R. Paramatti1, R. Faccini1, A. Laghi2; 1Rome/IT, 2Latina/IT 
(ferraririccardo@gmail.com)  
Purpose: To perform texture analysis (TA) of first and second order of T2 
weighted images of the entire volume of rectal cancer acquired pre, 
intermediate and after the treatment. To perform mono and multivariate 
analysis of texture parameters using AI by means of machine learning. 
Methods and Materials: 55 patients. T2 weighted images were analysed 
using TA:first order(gray-level histogram) in 2D and 3D 
dimensions,mean,standard deviation, skewness and kurtosis. Local 
entropy.The grey level co-occurrence matrix(horizontal direction, 1pixel 
displacement).The homogeneity, the energy, the contrast and the 
dissimilarity.Time evolution of these parameters has been studied between the 
different time-control.The most effective parameters have been combined in a 
multivariate analysis with the use of the machine learning algorithms. 
Results: The most significant parameters are: the ratio of the minimum of the 
local entropy computed after and before the treatment and some of the 
parameters extracted from the gray-level co-occurrence matrix computed in the 
slice where the tumour has maximum area. We also found that the area of the 
tumour before the treatment, is quite sensitive and it has been included in the 
multivariate analysis. A cut on the output of the random forest classificator can 
be placed to separate CR and PR+NR with the performances summarised in 
the ROC curve. 
Conclusion: The use of a automatic multivariate analysis algorithm for 
analysing values of TA of T2 weighted images in patient with rectal tumour, 
using 2D and 3D segmentation of the tumour could differentiate Complete 
responder patients and partial responder/non responder patients to 
Radiotherapy and chemiotherapy.  
B-0163 10:38  
Radiomic features from pretreatment MRI are associated with prognosis 
in rectal cancer patients: preliminary findings  
S. Yiqun, T.T. Tong, Y.J. Gu; Shanghai/CN (12211230032@fudan.edu.cn)  
Purpose: Our goal was to investigate the correlation between histopathology 
and diffusion parameters by utilizing the most repeatable strategy for ROI- and 
slice-based diffusion parameters in rectal cancer. 
Methods and Materials: Sixty-six patients underwent DKI-MR. Two readers 
independently measured the parameters using three slice protocols including 
single slice, three slices and whole tumour slice (WTS), combined with one of 
two ROIs, including outline and round ROI. Kruskal-Wallis, a paired sample t 
test, interclass correlation coefficient (ICC), Bland and Altman, Student's t 
tests, and receiver operating characteristic curves were used for statistical 
analysis. 
Results: There were no significant differences among three slice protocols 
with regard to diffusion parameters (p > 0.05). The ADC and D derived from 
outline ROI were higher than those from round ROI (p < 0.05), while the 
opposite trend was apparent for K (p < 0.05). The WTS-outline ROI method 
resulted in the most excellent intra- and interobserver ICC. Utilizing the WTS-
outline ROI, the AUC for assessment of well-differentiated tumours is greater 
by K (0.871), compared to ADC (0.809), and AUC for T2 is 0.768 by K. 
Conclusion: The most repeatable strategy was the WTS-outline ROI method. 
In addition to ADC, K correlated with histopathology utilizing the WTS-outline 
ROI.  
B-0164 10:46  
Performance of texture analysis in predicting tumoural response to 
neoadjuvant chemoradiotherapy inrectal cancer patients studied with 3T 
MR   
M. Zerunian, D.M. Bellini, D. Caruso, D. De Santis, T. Biondi, A. Laghi; 
Latina/IT (marta.zerunian@gmail.com)  
Purpose: To determine the performance of texture analysis(TA) in predicting 
tumoural response in colon rectal cancer (CRC). 
  






Methods and Materials: 40 consecutive CRC patients were prospectively 
enrolled and underwent 3T MRI before, during and after 
chemoradiotherapy(CRT). A region of interest was manually drawn around the 
tumour on axial oblique T2 images and analysed using first order statistical 
texture parameters (Skewness, Kurtosis, Entropy and mean value of positive 
pixels (MPP)). Receiver operating characteristic (ROC) curve analysis was 
performed to assess the diagnostic yield of TA parameters to predict complete 
response (CR). 
Results: Thirteen patients showed histological CR, Twenty-two patients partial 
response(PR) and five patients were non-responders (NRs). Entropy, Kurtosis 
and MPP showed significant differences before and after CRT in CR’s; PR/NR 
Entropy and Skewness showed significant differences before and after CRT 
(p<0.05). Absolute changes among different texture parameters in CR and 
PR/NR patients before and after CRT showed significant differences in 
Entropy, Kurtosis and MPP(0.31±0.35, in CR,-0.02 ± 1.28 in PR/NR, (p=0.04); 
1.87 ± 2.19, in CR, -0.06 ± 3.78 in PR/NR(p=0.0005); (107.91 ± 274.40, in CR, 
-28.33 ± 202.91 in PR/NR, (p=0.004), respectively). Kurtosis, evaluated on pre-
treatment images, showed significant results in predicting CR (p=0.04; optimal 
cutoff value  6.68, Se 76.92% and Sp 38.46%). 
Conclusion: TA from T2 images potentially play an important role as imaging 
biomarkers of tumoural response to neoadjuvant-CRT in CRC. Kurtosis is 
accurate in predicting complete responders.  
B-0165 10:54  
Evaluation of diagnostic accuracy of diffusion weighted (DW) MRI in 
mesorectal lymph node staging of rectal carcinoma (ReNoRis)  
C.G. Monaco1, G. Parker2, R. Little2, Y. Watson2, S. Cheung2, J. O'Connor2, 
A.V. Marchianò1, D. Scaramuzza1; 1Milan/IT, 2Manchester/UK 
(cristianmonaco87@gmail.com)  
Purpose: To assess the pre-operative DW MRI accuracy in detecting 
mesorectal lymph-node metastasis. 
Methods and Materials: 34 patients prospectively enrolled April 2012-May 
2014 with newly diagnosed, histologically proven, rectal cancer. T4 and 
mucinous tumors were excluded. 1.5T MRI Avanto, Siemens, Erlangen, 
Germany was used with this sequences protocol: pelvis T1 (5mm), T2 sagittal 
and coronal (3mm), T1 and T2 perpendicular to the rectum (3mm), DWI echo-
planar (5mm, b-values 0, 400, 800 mm/s2), T1 gradient-echo dynamic contrast-
enhanced (5mm), T1 VIBE (1mm) and TSE (3mm) post contrast. ADC was 
evaluated from DWI with ROI’s on tumours and mesorectal lymph-nodes. All 
patients underwent total mesorectal excision within 1 week after MRI, without 
neoadjuvant-therapy. Surgical specimens were cut at 5mm thickness, TNM 
classified. The pathologist and the radiologist identified the lymph-nodes 
location. For predicting mesorectal nodal metastasis we assessed these 
characteristics using Wilcoxon and Fisher’s tests: T stage; lymph-node size, 
margins, internal homogeneity and location with respect to the upper tumoral 
border, lymph-node ADC and node to primary tumour (N/T) ADC ratio. 
Results: TNM staging: 1 T1, 3 T2, 30 T3 tumours, and 22 N0, 6 N1, 6 N2. 
Only irregular lymph-node margins (p=0.002), lymph-nodes located at least 
1cm above the upper tumoral border (p=0.0004) and N/T ADC ratio (p=0.0007) 
were significantly associated with metastasis. 
Conclusion: Similar cellularity between primary tumour and lymph-nodes is 
significantly associated to the presence of mesorectum lymph node 
metastasis, as irregular lymph-node margins. The lymph-node 
location/distance from tumoral margin is possibly related to the anatomic 
drainage of rectal tumours.  
B-0166 11:02  
Prognostic value of bodycomposition parameters assessed at the 
preoperative CT in patients withcolorectal carcinoma  
M. Martinelli, M. Chincarini, G. Zamboni, C. Fabris, C. Conti, C. Pedrazzani, 
R. Pozzi Mucelli; Verona/IT (marco.chincarini@gmail.com)  
Purpose: To assess the effects of Body Composition Parametrs (BCPs), 
measured on the preoperative CT in patients with colorectal cancer (CRC), on 
overall survival and surgical complications. 
Methods and Materials: We reviewed the preoperative CTs of 288 patients 
who were resected for CRC, and measured the BPCs on the L3-L4 transverse 
sections using a free software (ImageJ, National Institutes of Health, USA). 
Total Fat Area (TFA), Subcutaneous Fat Area (SFA), Visceral Fat Area (VFA), 
Retroperitoneal Fat Area (RFA) and Total Muscle Area (erector spinae + psoas 
+ abdominal wall muscles), were measured. The Skeletal Muscle Index (SMi= 
TMA/height2) was calculated to assess for sarcopenia. The clinical features 
assessed included gender, age, BMI, tumor location, TNM stage, overall 
survival and surgical complications. Kaplan-Meier curves for survival were 
calculated. Chi-square was used to assess the association of the parameters 
with complications. 
Results: 194/288 patients (67,4%) were sarcopenic. 3-year survival and 5-
year survival were significantly lower for sarcopenic patients than for the non-
sarcopenic (83.2% vs 93.7%, and 78.2% vs 90.1%, respectively; p=0.03). No 
significant difference was observed regarding surgical complications. BMI and 
fat measures did not appear to influence patient survival or surgical 
complications. 
Conclusion: Sarcopenia appears to be significantly associated with a lower 
overall survival. Amount of visceral, subcutaneous or total fat and obesity did 
not show any significant correlation with patient prognosis. Assessment of 
sarcopenia can provide additional prognostic information from the preoperative 
CT.  
B-0167 11:10  
Pelvic MRI after induction chemotherapy and before long-course 
chemoradiation therapy: what are the imaging findings?  
I. Blazic, N.M. Campbell, A. Knezevic, M. Gonen, P. Lynn, M. Weiser, 
J. Garcia-Aguilar, L. Saltz, M.J. Gollub; New York, NY/US 
(ivanablazic@yahoo.com)  
Purpose: To assess the ability of MRI after FOLFOX-based induction 
chemotherapy (ICT) to predict rectal cancer response to total neoadjuvant 
treatment (TNT). 
Methods and Materials: In this IRB-approved retrospective study, pre- and 
post-ICT tumour T2 volume and relative T2 signal intensity (rT2SI; 
tumour/obturator internus muscle) were assessed in 63 patients with 65 
tumours by two readers. Node size, signal intensity and border characteristics 
were recorded. Correlations were made between the reference standard of 
histopathologic percent tumour response in the primary tumour with tumour 
volume change, rT2SI and baseline and post-ICT lymph node characteristics. 
Results: Post-ICT MRI was obtained within 30 days of completion of ICT. 9/63 
(14.3%) patients had a complete response after TNT. Change in T2 volume 
was not associated with TNT response. Change in rT2SI showed no 
correlation with TNT response. There was a significant negative correlation 
between baseline and post-ICT node size and TNT response (r=-0.25, p=0.05; 
r=-0.35, p=0.005, readers 1 and 2, respectively). Both baseline and post-
induction median node size were significantly smaller in complete responders 
and 95% responders (p=0.03, 0.001; readers 1, 2, respectively). Median 
change in largest baseline node size and decrease in post-ICT node signal 
heterogeneity were associated with 100% tumour response (p=0.04). 
Conclusion: In this cohort of patients receiving post-ICT MRI, tumour volume 
and signal intensity did not correlate with TNT response. Lymph node sizes 
decreased after ICT and were significantly associated with complete response 
to TNT. This potentially useful prognostic information will require validation in a 
prospective study.  
B-0168 11:18  
Tumour volume vs RECIST criteria in re-staging rectal cancer  
E. Guidi, C. Giaconi, C. Arena, E. Neri; Pisa/IT 
(radiodiagnostica3.aoup@gmail.com)  
Purpose: To compare MRI tumour volume regression grade vs RECIST 
criteria in the re-staging of rectal cancer. 
Methods and Materials: Thirty-three patients with locally advanced rectal 
cancer (T3-T4 stage or any N+) underwent MRI for staging and re-staging. MRI 
acquisition was performed on 1.5T and 3T scanners, with a protocol compliant 
with the ESGAR guidelines. MR tumour volume was calculated by a semi-
automatic tool.All patients underwent neo-adiuvant chemo-radiotherapy, 
followed by total mesorectal excission. Each rectal specimen, analysed by the 
pathologist, was classified on the basis of the Dworak tumour regression 
grade. 
Results: In 24/33 patients a complete downstaging from T3 to T-T2 was 
obtained. Among these 7 patients showed a tumour volume reduction grade > 
80%. A statistically significant correlation between tumour regression grade 
and volume reduction was observed (Spearman rank = 0.3626, p = 0.0189). 
According to the RECIST criteria 19/33 (57,6%) patients had partial response 
and only 3 had complete response. 
Conclusion: Tumour volume reduction grade showed the best correlation with 
pathological grading and should be considered as one indicator/biomarker of 
response to chemo-radiotherapy in restaging locally advanced rectal cancer.  
B-0169 11:26  
MRI of rectal cancer response to therapy: comparison of T2, DWI and 
ADC between 3Tand 1.5T  
M. Zerunian, D. Caruso, D.M. Bellini, D. De Santis, F. Rivosecchi, A. Laghi; 
Latina/IT (marta.zerunian@gmail.com)  
Purpose: To compare signal intensity (SI) on T2, DWI and ADCmaps between 
3T and 1.5T MRI of rectal cancer pre, during and post-neoadjuvant-
chemoradiotherapy (CRT). 
Methods and Materials: Twenty-two consecutive rectal cancer patients were 
prospectively analyzed on both 3T and 1.5T MRI. All patients underwent to 
dedicated axial-oblique T2, DWI and ADC performed pre, during and post-
CRT. Two expert radiologists selected in agreement the best qualitative single 
slice where the tumor was detectable for all three chosen sequences of each 
examination, for a total of 396 slices. Another radiologist, blinded for 
  






histological results, drawn a region of interest of the tumor on the selected slice 
and registered the corresponding SI of T2, DWI and ADC. 
Results: Significant differences were observed for DWI on 3T compared to 
1.5T for pre-CRT (324.37±172.21 vs. 70.72±20.83), during CRT 
(199.86±128.08 vs. 52.59±17.16) and post-CRT (135.53±68.03 vs. 
43.17±14.47), and for T2 values between 3T and 1.5T for pre-CRT 
(599.57±144.83 vs. 339.57±117.87), during CRT (527.24±178.92 vs. 
344.76±119.89) and post-CRT (526.19±136.30 vs. 318.91±99.77) (all p<0.05), 
whereas no significant differences were reported for ADC values between 3T 
and 1.5 T for pre-CRT (0.85±0.21 vs. 0.83±0.19), during CRT (1.11±0.25 vs. 
1.18±0.33) and post-CRT (1.24±0.36 vs. 1.27±0.35) (all p>0.05). A progressive 
decreasing trend for DWI and T2 was observed during the three controls, while 
an increasing trend was noticed for ADC in the three examinations, for both 
fields strength. 
Conclusion: DWI and T2 values were significantly higher on 3T than 1.5T 
while no significant differences were observed on ADC pre, during and post-
CRT.  
B-0170 11:34  
Correlations between the iodine concentrations from dual-energy 
computed tomography and molecular markers Ki-67 and HIF-1 in rectal 
cancer: a preliminary study  
S. Fan, X. Li, Z. Ye; Tianjin/CN (303533681@qq.com)  
Purpose: To investigate whether dual-energy computed tomography (CT) with 
iodine quantification is correlated with molecular markers Ki-67and hypoxia-
inducible factor 1 (HIF-1) in rectal cancer (RC). 
Methods and Materials: Eighty patients (43 males and 37 females) diagnosed 
with rectal cancer got pelvic contrast-enhanced CT scan with dual-energy 
computed tomography before any anticancer treatment. The normalized iodine 
concentration (NIC) values and CT values at each energy level (40-140 keV) 
from the virtual monochromatic image of the primary lesions were analysed. 
The postoperative specimens of all 80 patients underwent Ki-67 and HIF-1 
immunohistochemistry staining. By SPSS17.0 software package, we analysed 
the correlations of NIC values and CT values at each energy level (40-140 
keV) with Ki-67 and HIF-1 expression. The receiver operating characteristic 
(ROC) curves of these dual-energy computed tomography parameters were 
calculated and the diagnostic value were assessed . 
Results: There was a weak positive correlation between NIC values and 
carcinoembryonic antigen level (r=0.246, P=0.028) in RC. Both the value and 
the level of Ki-67 expression were correlated positively with the NIC values 
(r=0.344, P=0.002 and r=0.248, P=0.026). HIF-1 expression was correlated 
positively with the NIC values of the RC (r=0.598, P<0.001). The best threshold 
value of NIC values in diagnosing the expression of HIF-1 was 0.5839. The 
sensitivity was 78%; specificity, 87%; PPV, 86%; NPV, 79%; accuracy, 83%. 
Conclusion: The NIC values on dual-energy computed tomography may be 
used as a measurement of hypoxia in RC and determining the ability of tumour 
invasion noninvasively.  
B-0171 11:42  
Utility of CT histogram parameters in discriminating between metastasis 
and non metastases among colorectal cancer patients with pulmonary 
lesions  
S. Wang, T. Tong, T. Hu, W. Peng, J. Wang, L. Huang; Shanghai/CN 
(shengpingwang2007@126.com)  
Purpose: To determine whether whole-lesion histogram parameters of 
pulmonary nodules based on computed tomography (CT) images can 
distinguish between lung metastasis (LMs) and non metastases (NMs) in 
patients with colorectal cancer (CRC). 
Methods and Materials: From January 2012 to December 2014, 276 CRC 
patients with pulmonary lesions were divided into two groups: LM group and 
NM group which were confirmed by pathology. Whole-tumour texture analysis 
was performed on CT images, and histogram parameters were derived from 
the pixel distribution histogram. Potential predictive parameters to differentiate 
LM from NM were identified by univariate regression analysis and 
subsequently tested in multivariable logistic regression analysis. 
Results: Of 276 nodules, pathologic analysis confirmed 171 LMs,105 NMs(13 
PLCs and 92 benign lesions).Kurtosis and sphere value were significantly 
higher (0.73 versus -0.79, P<0.0001; 1.59 versus 0.65, P<0.0001, respectively) 
while skewness was significantly lower (-1.03 versus 0.13, P<0.0001) in LM 
group compared to the group. Multivariate analysis revealed that smaller 
sphere value (adjusted odds ratio, 0.092) and higher kurtosis (adjusted odds 
ratio, 3.319) are significant differentiators of LM from NM (P < .001). With mean 
attenuation, the standard deviation of attenuation, volume, kurtosis, and sphere 
value, the logistic regression model showed excellent accuracy (area under the 
curve, 0.91) in the differentiation of LM from NM. 
Conclusion: In patients with CRC, higher kurtosis and sphere value are 
significant differentiators of LM from NM, and LM can be accurately 
differentiated from NM by using CT histogram analysis.  
B-0172 11:50  
Staging of colon cancer, best technique/modality, a PhD thesis  
E. Nerad1,2, M.J. Lahaye2, R.G.H. Beets-Tan2; 1Worcester/UK, 2Amsterdam/NL 
(nerad19@hotmail.com)  
Purpose: Paradigm shift in the treatment for colon cancer is on the horizon 
with neo-adjuvant therapy possibly becoming available for operable colon 
cancer patients (FOXTROT study). Staging will become crucial; the focus of 
this thesis is to determine what technique/modality has the highest accuracy. 
Methods and Materials: Two meta-analyses, computed tomography (CT) and 
CT colonography (CTC) and an original study using magnetic resonance 
imaging (MRI) to determine the accuracy in the detection of tumour invasion 
through the bowel wall and nodal involvement of colon cancer were performed. 
Results: The sensitivity, specificity for detection of tumour invasion beyond the 
bowel wall were 90% (95%CI: 83-95%); 69% (95%CI: 62-75%) for CT, 90% 
(95% CI: 88-92%); 87% (95% CI: 83-90%) for CTC; 91% (76-98%); 84% (60-
96%) for MRI respectively. For nodal involvement the estimates were 71% 
(95%CI: 59-81%); 67% (95%CI: 46-83%) for CT, 84% (95% CI: 80-88%); 66% 
(95% CI: 59-72%) for CTC, 91% (76-98%); 84% (60-96%) for MRI respectively. 
Conclusion: It appears regular CTC and MRI have a better accuracy in the 
local staging of colon cancer compared with regular CT techniques.  
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B-0173 10:30  
Early treatment for PE diagnosed on CTPA: does electronic critical report 
labelling make a difference?  
S.L. Dluzewski, N. Patel, S.R. Tincey, S. Hare; London/UK 
(sophia_tincey@hotmail.com)  
Purpose: Recent guidance for reporting radiologists emphasises the 
importance of highlighting studies with significant or abnormal findings to 
requesting clinicians. Pulmonary embolism (PE) represents a significant cause 
of morbidity and mortality in the hospital setting. The aim of this study was to 
assess whether electronic critical report labelling has an impact on the rapidity 
of initiating anticoagulation treatment for PE diagnosed on CTPA. 
Methods and Materials: A retrospective observational study was conducted 
with regard to CTPA studies performed between August 2015 and May 2016 at 
a District General Hospital, in the UK. All CTPA studies that identified PE were 
identified. These reports were grouped into those critically labelled and those 
that were not. Time to therapeutic anticoagulation was compared between the 
labelled and unlabelled groups. 
Results: 410 CTPAs were performed, 85 of which were positive for PE. 8 out 
of 85 of these were highlighted as critical (9.4%). Patients with critical report 
labelling were anticoagulated significantly more quickly than those that were 
not (p=0.0249, u=24). Pre-scan clinical suspicion, pulmonary embolism 
severity, ward location, time of day and staffing levels were not statistically 
significant. 
Conclusion: This research forms the first UK study in standard clinical practice 
that provides evidence that labelling reports as critical is associated with 
significantly shorter delay to treatment.  
B-0174 10:38  
Appropriateness and pattern of imaging modality choice amongst 
radiologists from different countries  
V. Pozdniakova1, J. Froehlich2, A. Gutzeit3; 1Stavanger/NO, 2Zurich/CH, 
3
Lucerne/CH (v.a.pozdnyakova@gmail.com)  
Purpose: Appropriate use of medical imaging is a key to the effective 
diagnostic decision making. Heterogeneity of existing radiological standards 
yields a big number of improper examinations and leads to unnecessary 
radiation exposure and high health care costs. In this study we investigated an 
agreement between radiologists from different countries on imaging modality 
choice and an appropriateness of selected procedures. 
Methods and Materials: A web-based questionnaire with 15 clinical cases 
was sent to radiologists from 11 European and 3 non-European countries. 
Responders had to choose the most relevant imaging modality for the 
suggested clinical situation. Responses appropriateness was ranked according 
to American College of Radiology (ACR) Appropriateness Criteria from 1 to 9. 
  






The agreement between responders was analyzed using graphical statistics 
made in R software program. Descriptive statistics were realized in SPSS. 
Results: There were significant discrepancies in ACR scores amongst 183 
responders who completed the survey. The questions with the worst 
agreement were related to imaging in blunt abdominal trauma, stroke, physical 
child abuse and microscopic hematuria. The best agreement was achieved on 
imaging of lung nodules, cervical spine injury, pyelorostenosis and deep vein 
thrombosis. 56% (n=1247) of responses were ranked as usually appropriate, 
13% (n=684) as may be appropriate and 31% (n=295) as not appropriate. 
Conclusion: There is a low agreement between radiologists from different 
countries on preferred imaging modality. It emphasizes a need for an active 
development and implementation of common radiological guidelines.  
B-0175 10:46  
Preliminary analysis of a computer tool to avoid repetition of radiological 
tests  
P. Fraga Rivas1, L. Garcia del Salto1, J. de Miguel Criado2, 
F. Aguilera del Hoyo1, C. Benito Vicente1, A. Marco Sanz1; 1Madrid/ES, 
2
Coslada/ES (fragarivas@gmail.com)  
Purpose: To submit a computer tool implanted in the electronic medical history 
of the notification of repetition of the request of radiological test to analyse the 
results obtained in the first 10 months after its implantation. 
Methods and Materials: In November 2016, this tool was established in the 
electronic history of our hospital. When a physician requests a radiological test, 
which was already requested in the previous 180 days, the tool generates a 
test repetition warning alert. The faculty decides if he continues with the 
creation of that request, or if he considers that this test should not be repeated. 
Results: In these 10 months there have been 8646 notices of repeated 
radiological request, representing 6.5% of the total of 131593 requests 
generated. In 3197 notices (36.9%) the physician decided not to request the 
test again (1273 cases of ultrasound scan, followed by 1109 cases of simple x-
ray ) and in 5449 (63.02%) he made a new request (3572 were simple 
radiographs, and 801 cases of ultrasound. 78.2% of simple RX corresponded 
to trauma). 
Conclusion: A large number of unnecessary tests are consequences of 
ignorance that the patient has a previous and recent one. The tool has proven 
useful since it has managed to avoid a large number of unnecessary 
repetitions. The simple x-ray and the traumatology service are the scenes of 
the greatest number of repetitions of the test. Ultrasonography has been the 
modality in which more repetitions have been avoided.  
B-0176 10:54  
Making the best of clinical radiology: a single-institution review of 
imaging referral appropriateness including cumulative monetary and 
dose estimates for inappropriate scans  
J. Ryan, A. Hollywood, A. Stirling, L. O' Hora, M. Glynn, A. Brady, A. Dolan, 
L. Lawler, F. Bolster; Dublin/IE (jamesryannchd@gmail.com)  
Purpose: There has been a dramatic year on year increase in imaging 
requests at our academic institution. The iRefer guidelines are produced by the 
Royal College of Radiologists (RCR) in the UK and are designed to prevent 
inappropriate imaging and radiation exposure. These guidelines have been 
available to general practitioners and hospital physicians in Ireland since June 
2015. We performed a large retrospective review of radiographs performed in 
2015 and 2017 to determine the proportion of inappropriate referrals before 
and after guideline availability. 
Methods and Materials: 1173 radiographs were reviewed. A validated RCR 
audit template was used for data collection. Emergency department, in-patient 
and general practitioner referrals were reviewed. Cost and cumulative effective 
dose estimates were calculated. 
Results: The inappropriate abdominal radiograph referral rate was 37% in 
January 2015 and 47% in January 2017. The inappropriate spinal radiograph 
referral rate was 48% in 2015 and 39% in 2017. The predicted cost of 
inappropriate abdominal and spinal radiographs for 2017 was 12,720 euros, 
the predicted cumulative dose was 927mSv. Paranasal sinus and nasal bone 
radiographs are considered inappropriate. Over the past 4 years, 573 such 
scans were performed with an estimated cost of 2,868 euros and a cumulative 
dose of 8.6 mSv. 
Conclusion: Despite the availability of the iRefer guidelines there remains a 
significant proportion of inappropriate imaging requests. The cost of these 
scans is significant, as are dose estimates. Interventions are needed to 
decrease inappropriate referrals. Clinical decision support software may help 






B-0177 11:02  
Metformin and intravenous contrast medium: a systematic review of 
international radiological societal guidelines  
A. Weir1, B.S. Kelly1, A. Liew2, P. McCarthy2; 1Dublin 4/IE, 2Galway/IE 
(arleneweir88@gmail.com)  
Purpose: A systematic review was performed to assess the current 
international radiological societal guidelines on metformin and the risk of lactic 
acidosis in patients receiving IV contrast media. The quality of supporting 
evidence was also assessed. 
Methods and Materials: Evidence-based guidelines created by established 
international radiological societies were searched using search terms relating 
to metformin, contrast media and lactic acidosis in PubMed, Cochrane Library, 
Embase and Google Scholar databases. Two reviewers assessed the quality 
of the guidelines using the AGREE collaboration instrument and relevant 
supporting evidence. 
Results: Five international radiological societal guidelines met the inclusion 
criteria. All guidelines have low scores on many criteria assessed using the 
AGREE collaboration instrument. Four of the five guidelines had revised their 
recommendations recently, despite the absence of high-quality evidence. All 
guidelines, except that of the Royal College of Radiologists, had lowered their 
threshold for withholding metformin. Despite a lack of agreement between the 
guidelines in regard to the exact threshold to stop metformin, an improvement 
in clarity and consistency was noted in relation to the type of renal function 
assessment, duration for withholding metformin and timing of renal function re-
assessment. The data used to support these recently revised guidelines was 
derived from observational studies alone. 
Conclusion: This systematic review showed a significant change in current 
recommendations for metformin use and IV contrast media, with specific focus 
on lower renal thresholds for withholding metformin, despite absence of high-
quality evidence. Furthermore, there are substantial inconsistencies in the 
recommendations from various international guidelines.  
B-0178 11:10  
Study of the current situation of patient information in the example of a 
CT scan: what are improvement options?  
D. Kildal1, S. Schmidt1, M. Beer1, O. Schöffski2, T. Blasenbrey1; 1Ulm/DE, 
2
Nürnberg/DE  
Purpose: The yearly number of CT shows a steady increase in Germany. 
Patient information is a significant part of radiologists’ daily work. Additionally, 
in 14% of the legal issues patients complain are focused on the information 
given by the doctor before the radiological examination. That shows the special 
importance of correct information and documentation prior to the CT 
examinations. This study explores the quality, patient satisfaction, doctor 
satisfaction and spent efforts. 
Methods and Materials: 1438 questionnaires from 4 hospitals with different 
care levels were analysed. Additionally, 512 patients and 106 physicians 
throughout Germany were asked regarding quality, satisfaction, spent efforts 
and opportunities for improvement with regard to the patient knowledge 
concerning CT examination and the acceptance of a computer-assisted 
Information. 
Results: Up to 40% of the patients declared that they received no radiological 
information by a physician. Patients and physicians rate current situation only 
as “moderately content”. 22% of the patients wish extended information. 85.3% 
of the doctors said that medical information is heavily impacting their daily 
workflow. Patient information given by radiologists was better than those given 
by non-radiologist doctors. Finally, the quality of the patient information seems 
to depend on the size of the staff. 
Conclusion: The study shows, that patient information for radiological services 
is time consuming and currently not very effective. New media (like video-
based information and computer-assisted methods) might be promising to set 
new quality standards and to reduce needed efforts for medical staff.  
B-0179 11:18  
Patient-adapted communication between radiologist and patient: should 
radiologists rethink their patient care?  
A. Gutzeit; Lucerne/CH (agutzeit2000@gmail.com)  
Purpose: The aim of this study was to investigate how patients’ perception 
changes when the radiologist communicates the findings after an examination. 
Methods and Materials: After a routine MRT patient group 1 (101 patients) 
was given the opportunity to discuss the findings with the radiologist. Patient 
group 2 (101 patients) left the radiological institute without any personal 
communication. By means of a questionnaire both groups could be compared 
in terms of stress level, emotional attachment to the institute, and the feeling of 
competence regarding the radiologist. 
Results: 77 % of all patients were concerned about the findings without any 
difference between the two groups (p>0.05). Significant more patients in group 
1 (81%) appreciated that a discussion of these findings represents a good 
  






radiological consultation service in comparison to group 2 (14%)(p<0.005). 
Patients in group 1 had a significantly higher binding rate and wanted to be 
examined in department with communication only (p<0.05)(93.1% group, 
1/75% group 2). After the interview significantly more patients in group 1 
considered the radiology department as being a competent department than in 
group 2 without a discussion (p <0.001). 
Conclusion: Communication and reporting between radiologists and patients 
after an examination leads to a much better perception of patient well-being, 
feeling of competence and binding factor between patient and radiologist.  
B-0180 11:26  
Significant quality improvement of results and patient satisfaction in 
medical information for radiological examinations applying video 
information techniques  
D. Kildal1, S. Schmidt1, M. Beer1, O. Schöffski2, T. Blasenbrey1; 1Ulm/DE, 
2
Nürnberg/DE  
Purpose: Correct medical information for radiological examinations is very 
important and simultaneously expensive and time consuming. Additionally, 
14% of legal issues are associated with an incorrect medical-information 
process. Legal requirements and wishes of patient representatives increase 
steadily, on the other side, yearly CT examinations in Germany strongly 
increase. Actually German doctors spend on average 17.7 years only for the 
CT information procedures. Despite this time effort, patients and physicians are 
only moderately satisfied with the current situation. This study explores the 
acceptance of patients and doctors regarding the implementation of using 
information videos and computer-assisted anamnesis methods for the patient 
information. 
Methods and Materials: 512 patients and 106 doctors throughout Germany 
were asked regarding the current situation, satisfaction and acceptance of 
technical innovation. Another survey relating an information video was 
conducted for validation. It was analysed how many risks and side effects were 
remembered by the patients depending on the method information was given. 
Results: Patients and doctors showed a great acceptance for technical 
innovation. The second survey (information video) showed a significant rise in 
all test areas. Patients could better remember the radiation risk, side effects of 
contrast agents or risk in general after video-based information. The 
satisfaction after the video information was significantly higher than after a 
conventional given medical Information. 
Conclusion: The video-information is future oriented. Patients could be 
enlightened with higher quality and more satisfactory medical learnings. It is to 
be expected that the medical-information conversation will be more well 
prepared, more focused and at least shorter - the last point is also important for 
cost savings.  
B-0181 11:34  
Radiologists as co-author in case reports containing radiological images: 
does their presence influence quality?  
E. Luyckx1, J.M.L. Bosmans2,1, B. Broeckx3, S. Ceyssens1, P.M. Parizel1, 
A. Snoeckx1; 1Antwerp/BE, 2Ghent/BE, 3Merelbeke/BE 
(elisaluyckx1@gmail.com)  
Purpose: Imaging plays a crucial role in many diagnostic processes. It is, 
therefore, not surprising that medical case reports often include radiological 
images. Cui honorem, honorem deberi (“honour to whom honour is due”) 
seems straightforward, but such is not always the case where it concerns 
including radiologists as co-authors. Clinical specialists often see radiologists 
as ‘image providers’, not as clinical colleagues. The purpose of our study was 
to investigate how often radiologists are mentioned as co-authors in case 
reports containing radiological images, and to assess if their involvement 
influences quality. 
Methods and Materials: We searched PubMed using “Case report” as search 
term. Criteria for inclusion were: publication in a non-radiological journal and 
availability of full text in English. We included 400 case reports, 218 of which 
contained medical images. The images and figure legends of these 218 case 
reports were scored by two radiologists and a nuclear medicine physician in 
consensus, using a self-defined scoring system. 
Results: In 21% (45/218) of case reports a radiologist was included as a co-
author. In 79% (173/218) of case reports there was no radiologist as co-author. 
In 7 of those, a radiologist was mentioned in the acknowledgements. The 
median quality score in case reports with and without a radiologist as co-author 
was 74% and 51%, respectively; this difference was statistically significant 
(p<0.05).  
Conclusion: In a minority of non-radiological case reports containing 
radiological images, a radiologist was listed as co-author. The participation of a 




B-0182 11:42  
Remote radiological audit: a regional quality assurance system  
E. Guseva, S. Morozov, D.V. Burenchev, I. Trofimenko, N. Ledikhova, 
T. Rostovtseva; Moscow/RU (e.guseva@npcmr.ru)  
Purpose: To evaluate the effectiveness of electronic quality assurance system 
in radiology departments. 
Methods and Materials: Currently, 75 outpatient clinics are connected to the 
Unified Radiological Information Service (URIS). The service comprises 130 
CT and MRI units, 422 radiologists, and 321 technicians. In 2016, we 
developed remote quality assurance system and discrepancy detection module 
(DDM). The software is designed to review studies, provide feedback and 
accumulate “big data”. We have compared the number of discrepancies before 
and after DDM implementation (4473 anonymized CT and MRI studies). 
P&lt;<0.05 was considered statistically significant. 
Results: We observed a decrease in significant and non-significant 
discrepancies from 6.4±2.9% (64) to 2.8±0.8% (104) and from 19.6±3.0% (197) 
to 9.5±0.7% (352). The number of reports without any discrepancies increased 
from 51.7±2.9% (520) to 69.1±0.7% (2560). The number of general remarks 
(terminology, scan protocol) remained roughly the same, 22.4±3.0% (226) vs 
18.6±1.59% (691). We have conducted 2622 consultations. Clinics received 
daily updates and 804 monthly reports. Radiologists with high discrepancy 
rates were personally notified. 67 training courses and 89 webinars were 
conducted with 1955 and 10244 participants. 
Conclusion: Regional remote quality assurance system improved department 
effectiveness. In 12 months, the number of discrepancies decreased by more 
than a half.  
B-0183 11:50  
Affidea imaging metrics platform: a comprehensive dashboard providing 
key performance indicators for optimisation of image quality and 
throughput  
N. Papanikolaou1, G. Papaioannou2, A. Iliopoulos2, P. Szatmari1, R. Illing1; 
1
Budapest/HU, 2Nicosia/CY (rowland.illing@affidea.com)  
Purpose: To present a web-based imaging analytics platform that can 
calculate several metrics, the so-called key performance indicators (KPIs) to 
assess both quality of MRI exams and patient throughput. 
Methods and Materials: The Affidea imaging metrics is a web-based system 
comprised of agents and a central server communicating with the agents to 
collect, process, quantify and present metrics on an interactive dashboard. 
Agents were installed in14 MRI departments in 3 European countries. 18 MRI 
scanners were connected to the agents through local network and all MRI 
examinations were sent to the agents through setting an auto-transfer dicom 
service in the background of the MR scanners. Agents extracted metadata 
from the dicom headers of each image and transmitted them through secure 
FTP to a central server. Meta data were compared with a reference database 
and compliance to standardised protocols was calculated. In addition, deviation 
was defined as the percentage of sequences not included in the standardised 
protocols. Other KPIs including number of exams, voxel size, examination time 
and waste time were also quantified. 
Results: All KPIs were presented as info tablets including the name of the KPI, 
the average value over a user-defined time interval, its percent change 
comparing to a user-defined time interval in the past. In addition, each KPI was 
presented on a chart for different countries, sites, MRI models and types of 
exams. 
Conclusion: A comprehensive web-based platform monitoring the 
performance of MRI scanners by means of several KPIs is presented.  
Author Disclosures: 
  N. Papanikolaou: Owner; MRIcons. G. Papaioannou: Consultant; MRIcons. 
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B-0190 14:00  
Differences in liver imaging reporting and data system categorisation 
between MRI with hepatobiliary-specific vs primary-extracellular agents  
V. Bura1, H. Nguyen2, S. Lee2, T. Tirkes3, C. Lall2; 1Cluj-Napoca/RO, 
2
Orange, CA/US, 3Indianapolis, IN/US (vlad.t.bura@gmail.com)  
Purpose: The purpose was to assess whether liver lesions are categorised 
differently using Liver Imaging Reporting and Data System (LI-RADS), in 
chronic-hepatitis patients at risk for hepatocellular carcinoma (HCC), when 
undergoing liver-MRI with two different contrast agents: primary-extracellular 
(ECa) versus hepatobiliary-specific (HBa). 
Methods and Materials: We retrospectively selected patients, provided they 
underwent liver-MRI with both agents within a three-month time interval. The 
cases were reviewed by two radiologists. The images were downloaded and 
anonymised, for blinding the radiologists to patient demographics/agents used 
and further remove any implicit bias. Multiple enhancement and wash-out 
characteristics, as well as capsule visualisation, were studied throughout 
arterial, venous and equilibrium MRI-phases. A final category was assigned 
using LI-RADS-v2014-guidelines. 
Results: We reviewed 22 patients, and a total of 36 lesions. For 44% of the 
lesions, the ECa-MRI upgraded LI-RADS by one or even two categories (5 
lesions), based on better wash-out visualisation and/or the presence of a 
partial/full capsule. Arterial enhancement was assessed as more robust with 
ECa-MRI in 42% cases. Seven lesions not seen with HBa-MRI were LI-RADS 
3 (5/7) or 4 (2/7) category on ECa-MRI. 
Conclusion: Although performed on a small number of patients, the present 
study reveals superiority of EC-agents in a more precise LIRADS 
categorisation of liver lesions for patients at risk for HCC. There is an 
improvement in the visualisation of arterial-enhancement, venous wash-out 
and capsule with an EC-agent. Pertinent negative of the study was the smaller 
number of patients which showed better characterisation and LI-RADS with the 
HB-agent MRI (5%).  
B-0191 14:08  
Prospective evaluation of dynamic MR with gadoxetic acid for the non-
invasive diagnosis of HCC in newly detected nodules smaller than two 
centimetres on US in cirrhotic patients  
C. Ayuso, A. Darnell, J. Rimola, Á. García-Criado, R. Vilana Puig, A. Forner, 
J. Bruix; Barcelona/ES (cayuso@clinic.cat)  
Purpose: To evaluate the diagnostic accuracy of gadoxetic acid-enhanced MR 
(GA-MR) for non-invasive hepatocellular carcinoma (HCC) diagnosis in 
nodules <2cm detected by US screening programme. 
Methods and Materials: Cirrhotic patients with newly detected solitary 
nodules <2cm by screening US were included. Extracellular contrast-MR (EC-
MR) and GA-MR were performed in less than 1 month. Final diagnosis was 
based on the EASL/AASLD guidelines criteria (specific vascular profile on EC-
MR or biopsy). Blind, double reading was performed in all GA-MR studies. The 
criterion for HCC diagnosis using GA was arterial contrast uptake and washout 
in the portal phase or hypointensity in the hepatobiliary phase (HBp). 
Results: 62 consecutive cirrhotic patients Child-Pugh A (53) or B (9) were 
included. Final diagnosis was: 41 (66.1%) HCC, 2 intrahepatic 
cholangiocarcinoma (ICC), 1 colo-rectal cancer metastasis, and 18 benign 
lesions. Benign lesions were followed up during a median of 23 months to 
discard malignancy. The EC-MR diagnosed 26 out of 41 HCC nodules 
(sensitivity 63.4%, CI95%: 46.9-77.9). Sensitivity and specificity for GA-MR 
were 56.1% (CI95%: 39.7-71.5) and 90.5% (CI95%: 69.8-98.8), respectively, 
with a PPV of 92 (CI95%: 74-99) and NPV of 51.4 (CI95%: 34.4-68.1). False 
positives were observed in the two ICC. In GA-MR, wash-in was present in 
82.9% and portal wash-out in 42%. Low signal intensity in the 20 minutes HBp 
was observed in 63.4% of HCC nodules, whereas the remaining 15 HCCs 
were iso- or hyperintense. 
Conclusion: GA-MR is not superior than EC-MR for non-invasive diagnosis of 
HCC in nodules <2cm in cirrhotic patients.  
Author Disclosures: 
  C. Ayuso: Research/Grant Support; Bayer.  J. Bruix: Advisory Board; Bayer. 
 
 
B-0192 14:16  
Diagnostic accuracy of LR-M criteria for differentiating combined 
hepatocellular cholangiocarcinoma on gadoxetate-enhanced MRI  
H. Lee, C. An, M.-J. Kim; Seoul/KR (iitrue9hsii@yuhs.ac)  
Purpose: To determine the diagnostic accuracy of LR-M criteria of LI-RADS 
version 2017 for differentiating combined hepatocellular cholangiocarcinoma 
(cHCC-CC) on gadoxetate-enhanced MRI. 
Methods and Materials: Preoperative gadoxetate-enhanced MRI of 33 cHCC-
CC and 66 hepatocellular carcinoma (HCC) were reviewed by two radiologists, 
who assessed the presence of nine imaging features favoring other 
malignancy (LR-M features) and 10 favoring HCC. The sensitivity and 
specificity of LR-M features for differentiating cHCC-CC from HCC were 
calculated from consensus opinions.. 
Results: At least one LR-M feature was seen in 31 (93.9%) of 33 cHCC-CC 
and 34 (51.5%) of 66 HCC. The sensitivity and specificity for the diagnosis of 
cHCC-CC using any of LR-M features were 93.9% and 48.5%. Among the LR-
M features, the rim arterial phase hyperenhancement (APHE), progressive 
concentric enhancement, peripheral washout, adjacent biliary obstruction, 
mixed pattern, and infiltrative margin were significantly more common in cHCC-
CC (p<0.05). Three or more LR-M features were seen in 18 (54.5%) cHCC-
CC, while two or less were seen in 62 (93.9%) of HCCs. For lesions 2 cm or 
larger, the presence of all three major features of HCC including non-rim 
APHE, washout, and distinct rim showed sensitivity of 46.7% and specificity of 
100% for the diagnosis of HCC, regardless of LR-M features. 
Conclusion: Current LR-M criteria showed high sensitivity and moderate 
specificity for the diagnosis of cHCC-CC. Presence of all three major HCC 
features including distinct rim showed moderate sensitivity and perfect 
specificity for the diagnosis HCC for tumours of 2 cm or larger.  
B-0193 14:24  
An imaging and clinical scoring system to predict early mortality in 
spontaneous ruptured hepatocellular carcinoma treated with transarterial 
embolisation  
K.H. Lee, M.L.D. Tse, A.K.C. Cheng, H.Y.F. Wong, M.L. Yu, Y.L. Li, 
P.Y.C. Chien, Y.C. Ho, F. Chu; Hong Kong/HK (viclkh88@gmail.com)  
Purpose: Spontaneous ruptured hepatocellular carcinoma (rHCC) is an 
emergency associated with significant mortality, and treatment includes 
transarterial embolisation (TAE). We aim to develop a scoring system using a 
combination of clinical and imaging parameters to predict 30-day mortality. 
Methods and Materials: Retrospective review was performed of all patients 
with rHCC who underwent abdominal computed tomography (CT) and 
subsequent TAE between January 2007 and December 2016. CT features 
were reviewed by two radiologists blinded to patient outcome. Clinical 
parameters included serum bilirubin, albumin, INR and scores of individual 
measures according to Child-Pugh score. Independent risk factors for 30-day 
mortality after TAE were identified using multivariate binary logistic regression, 
for development of a scoring system. 
Results: 98 patients with mean age 65.1 years were included. 30-day mortality 
rate was 40.8%. Bilobar distribution (p<0.001), maximum tumour size (p=0.03), 
bilirubin score (p=0.01) and albumin score (p=0.02) were independently 
associated with 30-day mortality. A 12-point score, based on 1-3 points for 
each of the four factors, was derived to predict 30-day mortality, and yielded 
area under receiver operating characteristic curve of 0.905 (95%CI: 0.843, 
0.964). A score 7 was associated with 30-day mortality with sensitivity 100% 
and specificity 60%; a score 10 showed sensitivity 55% and specificity 92%. 
This stratified patients into low-, intermediate- and high-risk groups, with 0%, 
45% and 92% 30-day mortality, respectively. 
Conclusion: Clinical and imaging parameters can be combined into a scoring 
system to accurately predict 30-day mortality after TAE in rHCC patients. This 
may help identify and counsel high-risk patients.  
B-0194 14:32  
Can gadoxetic acid-enhanced MRI predict that a solitary HCC (cT1) is pT1 
or pT2?  
I.C. Chou, Y.-T. Kuo, I.H.W. Lao, P.-L. Hsieh, Y.-Y. Su, C.-W. Mak, D.-P. Sun, 
M.-J. Sheu, H.-T. Kuo; Tainan/TW (yichenchou@hotmail.com)  
Purpose: To determine which imaging findings can predict pathology T2 stage 
of a single hepatocellular carcinoma (HCC, cT1) on gadoxetic acid-enhanced 
MRI. 
Methods and Materials: Pre-operative gadoxetic acid-enhanced MRI were 
reviewed in a retrospective cohort of patients with solitary HCC. The reference 
standard of tumour staging was surgical pathology. Univariate and multivariate 
analyses were performed to identify predictors of microvascular invasion or 
satellite nodules in patients with HCC. Diagnostic performance of different MR 
findings was investigated. 
Results: There were 39 (34.2%; 39 of 114) pathologically staged T2 HCCs 
(either with microvascular invasion, satellite nodules or combination of both). 
  






75 HCCs (65.8%; 75 of 114) were staged T1. Large tumour size (>=2.3cm) 
had higher risk of pT2. In multivariate analysis, two MR findings, i.e. corona 
enhancement (odds ratio: 2.67; 95% CI: 1.101-6.480), and peritumoural 
hypointensity on hepatobiliary phase (odds ratio: 2.203; 95% CI: 0.961-5.049), 
were associated with high risk of pT2 HCCs. Positive likelihood ratio was 6.25 
(95% CI: 1.788-21.845) and sensitivity to diagnose pT2 HCC on EOB MRI was 
86.2% when a HCC was met with two or three of these MR findings. On the 
other hand, small tumour size and hypointense rim on hepatobiliary phase 
were ‘protective’ findings. When small HCCs were with hypointense rim and 
without aggressive findings, most of them were pT1 lesions (specificity was 
100%). 
Conclusion: There are ‘protective’ and ‘aggressive’ imaging findings of solitary 
HCCs on MRI. When combining size and imaging findings, gadoxetic acid-
enhanced MRI could predict solitary HCC (cT1) as pT1 or pT2.  
B-0195 14:40  
Liver imaging reporting and data system (LI-RADS) version 2017 with 
gadoxetic acid-enhanced MRI: utility of ancillary features in diagnosis of 
hepatocellular carcinoma  
H. Chang, H. Park, Y. Kim, M. Yu, S. Jung, H. Jeon; Seoul/KR 
(20150113@kuh.ac.kr)  
Purpose: To investigate the utility of ancillary features of liver imaging 
reporting and data system (LI-RADS) version 2017 using gadoxetic acid-
enhanced MRI in the diagnosis of hepatocellular carcinoma (HCC). 
Methods and Materials: Our institutional review board approved this 
retrospective study and informed consent requirement was waived. Between 
August 2008 and May 2017, 154 high-risk patients with 180 pathologically 
confirmed HCC nodules who underwent gadoxetic acid-enhanced MRI were 
included. Two radiologists retrospectively assigned a LI-RADS category for all 
pathologically proven HCC observations in consensus, before and after 
considering ancillary features on MRI. For the cases in which category change 
was observed, ancillary features that caused category upgrade or downgrade 
were assessed. 
Results: Based on major HCC features without considering ancillary features, 
13.3% (24/180), 21.7% (39/180), and 65% (117/180) of nodules were 
categorized as LR-3, LR-4, and LR-5, respectively. After considering ancillary 
features, 11.1% (20/180) of nodules underwent category change, with all 
nodules upgraded from LR-3 to LR-4. No cases were downgraded after 
considering ancillary features. Mild-moderate T2 hyperintensity and 
hepatobiliary phase hypointensity were the most frequently found ancillary 
features in nodules with upgraded category (60%, n=12), followed by the 
restricted diffusion (50%, n=10). 
Conclusion: In the diagnosis of HCC on gadoxetic acid-enhanced MRI using 
LI-RADS version 2017, ancillary features increased the confidence of HCC 
diagnosis in approximately 10% of the cases. The presence of mild-moderate 
T2 hyperintensity, hepatobiliary phase hypointensity, or restricted diffusion 
were found to be useful ancillary features favouring HCC in nodules with 
intermediate probability for HCC (LR-3).  
B-0196 14:48  
Liver vein infiltration in patients with hepatocellular carcinoma: impact on 
survival  
S. Schotten, F.-I. Meyer, A. Mähringer-Kunz, A. Weinmann, C. Düber, 
R. Kloeckner; Mainz/DE (sebastian.schotten@gmail.com)  
Purpose: Portal vein tumour thrombosis (PVTT) significantly impairs the 
prognosis of patients with hepatocellular carcinoma (HCC) and classifies them 
as advanced stage (BCLC-C). However, the relevance of liver vein infiltration 
(LVI) remains unclear. The aim of this study is to compare the prognosis of 
patients with different forms of macrovascular infiltration as this might influence 
the choice of treatment. 
Methods and Materials: 1378 HCC patients were extracted from the clinical 
registry of our tertiary referral centre treated between 01/2005 and 01/2017. 
Macrovascular infiltration was diagnosed by re-evaluation of all available CT or 
MRI studies by two experienced radiologists in consensus reading. Overall 
survival (OS) was calculated from the date of initial diagnosis for all subgroups 
(no infiltration, PVTT, and LVI). In case of macrovascular infiltration, OS was 
additionally calculated from the date of its first appearance. 
Results: 1341 patients could finally be included. 807 patients had no 
infiltration, 491 showed PVTT, and 43 an isolated LVI. OS from initial diagnosis 
was 37.29, 6.53, and 16.03 months, respectively (p<0.001). The OS calculated 
from the first appearance of macrovascular invasion was 4.9 months for PVTT 
and 7.33 month for isolated LVI (p=0.018). 
Conclusion: Isolated LVI showed significantly better survival compared to 
patients with PVTT. This renders the question if patients with isolated LVI 
should be classified and treated like patients with portal vein infiltration (BCLC-
C, mainly systemic therapy), or if a local approach is justified in selected 
patients.  
B-0197 14:56  
Diagnostic efficacy of conventional gadolinium-enhanced MRI in the 
detection of recurrent hepatocellular carcinoma: intra-individual 
comparison with gadoxetic acid-enhanced MRI  
J.-H. Yim, Y. Kim; Seoul/KR (jh111.yim@samsung.com)  
Purpose: To compare the efficacy of extracellular contrast media (ECCM) MRI 
to gadoxetic acid-enhanced MRI for detection of recurrent hepatocellular 
carcinoma (HCC) in patients previously treated. 
Methods and Materials: One hundred and sixty patients who were suspected 
of having tumour recurrence after multiple treatments for HCCs (surgery, 
transarterial chemoembolization, and radiofrequency ablation) underwent 
ECCM MRI and gadoxetic acid-enhanced MRI with 10- to 30-day interval. A 
total of 105 liver lesions were diagnosed as HCC recurrence. The ECCM MRI 
and the gadoxetic acid-enhanced MRI were retrospectively analysed by two 
observers for detection of HCCs using receiver operating characteristic 
analysis. The diagnostic accuracy and sensitivity were calculated. 
Results: For both observers, the ECCM set showed superior sensitivity and 
accuracy than the gadoxetic acid set (p<0.005, both). In addition, observer 2 
represented higher negative predictive value with the ECCM set (52.3%) than 
the gadoxetic set (33.3%) (p=0.031). Pooled data for two observers also 
showed higher sensitivity, accuracy, and negative predictive value with the 
ECCM set (90%, 90.9%, and 51.1%, respectively) than the gadoxetic set 
(77.6%, 79.7%, and 31.8%, respectively) (p<0.003). We achieved excellent 
degree of interobserver agreement for both MRIs (k=0.804 and 0.891). 
Conclusion: In detection of recurrent HCC in patients with history of multiple 
treatments, conventional ECCM MRI showed superior diagnostic efficacy in 
sensitivity, accuracy, and negative predictive value than gadoxetic acid-
enhanced MRI.  
B-0198 15:04  
Differentiation between hepatocellular carcinoma showing uptake of 
gadoxetic acid and focal nodular hyperplasia  
A. Kitao1, O. Matsui1, N. Yoneda1, R. Kita2, K. Kozaka1, S. Kobayashi1, 
T. Minami1, W. Koda1, T. Gabata1; 1Kanazawa/JP, 2Osaka/JP  
Purpose: To clarify the imaging differentiation points between hepatocellular 
carcinoma (HCC) showing uptake of gadoxetic acid enhanced MRI and focal 
nodular hyperplasia (FNH)/FNH like nodule. 
Methods and Materials: We enrolled the pathologically diagnosed 49 HCC 
with hypreintense area constituting more than two thirds of the nodule on 
hepatobiliary phase and 15 FNH/FNH like nodule, and compared findings of 
dynamic CT and gadoxetic acid enhanced MRI between them using Mann-
Whitney test, Chi square test and univariate logistic regression analysis 
Results: The enhancement pattern of dynamic CT was significantly different 
between HCC and FNH (P<0.0001): arterial enhancement/washout pattern 
(89.8% vs 13.3%) and arterial enhancement/no-washout pattern (4.1% vs 
86.7%), respectively. Enhancement ratio on arterial phase of dynamic CT was 
higher in FNH than in HCC (P<0.0001). The frequency of corona like 
enhancement on portal to equilibrium phase (83.7% vs 13.3%, P<0.0001) and 
arterial phase enhancement of adjacent hepatic vein (6.5% vs 46.7%, 
P=0.001) were significantly different between HCC and FNH. Apparent 
diffusion coefficient (ADC) value was lower in HCC than in FNH (P=0.002). The 
signal distribution on hepatobiliary phase were significantly different between 
HCC and FNH (P=0.0002): homogenous hyperintensity (59.2% vs 73.3%), 
hyperintensity mixed with hypointensity (26.5% vs 0%), hyperintensity with 
peripheral hypointensity(14.3% vs 0%) and hyperintensity with central 
hypointensity (0% vs 26.7%). 
Conclusion: For the differentiation between HCC with uptake of gadoxetic 
acid and FNH/FNH like nodule, presence of washout on dynamic CT, corona 
enhancement, ADC value, distribution of signal intensity on hepatobiliary 
phase would be important.  
B-0199 15:12  
T2 mapping and diffusion-weighted imaging of hepatocellular carcinoma: 
prediction of tumour histological grades  
L. Cao, B. Song; Chengdu/CN (clk2089@icloud.com)  
Purpose: To investigate and compare the diagnostic performance of T2 
relaxation time value and apparent diffusion coefficient (ADC) for non-invasive 
preoperative prediction of the histological grade of hepatocellular carcinoma 
(HCC). 
Methods and Materials: The study consisted of 30 patients with surgically 
resected HCCs who underwent preoperative MRI exams including DWI and T2 
mapping which was acquired using T2-prepared TrueFISP sequence. T2 
values and ADC were measured and averaged over ROIs placed in HCC solid 
regions on T2 mapping and ADC map, respectively. ANOVA was used to 
evaluate the statistical difference of the mean T2 value and ADC among three 
histological grades, and the diagnostic performance of T2 value and ADC was 
  






also evaluated and compared using receiver operating characteristic-based 
positive test. The sensitivity, specificity, and accuracy were calculated. 
Results: The mean T2 values of poorly differentiated (Edmondson grade III 
and IV), moderately differentiated (Edmondson grade II) and well-differentiated 
HCC (Edmondson grade I) were (38.4±2.40) ms, (44.4±3.0) ms and (49.6±3.9) 
ms, respectively, and there were differences in statistical meaning among 
them. The sensitivity, specificity, and accuracy, when an ADC of 0.972 or 
higher was considered as an indicator of well-differentiated tumours, were 
73.1%, 72.9%, and 0.729, respectively, while when T2 = 41.85ms, the 
sensitivity, specificity, and accuracy were 81.3%, 68.4%, and 0.706. Using both 
methods, the AUC was elevated to 89.6%. 
Conclusion: Higher tumour T2 in combination with higher ADC is a potential 
biomarker in the prediction of histological grades before treatment.  
B-0200 15:20  
Prediction of pathological differentiation for hepatocellular carcinoma: 
preoperative Gd-EOB-DTPA-enhanced MRI and histopathological 
correlation  
K. Huang; Guiyang/CN  
Purpose: Our aim of the study is to investigate the feasibility of prediction for 
pathological differentiation of hepatocellular carcinoma (HCC) using 
preoperative Gd-EOB-DTPA enhanced magnetic resonance imaging (MRI). 
Methods and Materials: 91 patients with solitary HCC who underwent 
preoperative Gd-EOB-DTPA enhanced MRI were prospectively analyzed. 
Features including tumor size, signal homogeneity, tumor capsule, tumor 
margin, intratumoral vessels, peritumor enhancement in mid-arterial phase, 
peritumor hypointensity during hepatobiliary phase, apparent diffusion 
coefficient (ADC), T1 relaxation times and the reduction rate between pre- and 
post-contrast enhancement images were assessed. HCC pathological 
differentiation in excision specimens were evaluated using Edmanson 
criterions. Correlation between these MRI features and HCC pathological 
differentiation were analyzed by chi-square test and multivariate logistic 
regression so as to establish a prediction model. Receiver operating 
characteristic (ROC) curve was used to assess the predictive effectiveness for 
the model. 
Results: Univariate analysis showed that tumor margin (p=0.007), intratumoral 
vessels (p=0.041), peritumoral low signal (p=0.017), maximum tumor diameter 
(p=0.014) significantly correlated with pathological differentiation. Those HCC 
lesions with the greater size, the more irregular margin, presence of 
intratumoral vessels and peritumoral low signal indicated high degree 
pathological differentiation. There was no relationship between venous 
thrombosis, tumor signal, tumor capsule, peritumoral enhancement, ADC 
value, T1 reduction ratio and pathological differentiation. Multivariate logistic 
regression analysis demonstrated that the maximum tumor diameter (p=0.007, 
OR=1.0019, 95% CI: 1.005~1.032) was an independent risk factor of HCC with 
poor differentiation. 
Conclusion: Gd-EOB-DTPA contrast-enhanced MRI could noninvasively 
predict pathological differentiation of HCC before surgery.  
14:00 - 15:30 Room C  
Abdominal Viscera  
SS 301b  
Modern imaging techniques of the liver  
Moderators:  
A. Agostini; Ancona/IT  
G.H. Mostbeck; Vienna/AT  
B-0201 14:00  
Evaluation of hepatic warm ischaemia-reperfusion injury and intervention 
effect of Lipo-PGE1 in rabbit models: 3.0T BOLD MRI study  
Q. Ji1,2, Z.-Q. Chu2, J.Y. Li2; 1Nanjing/CN, 2Tianjin/CN (jiqianq@aliyun.com)  
Purpose: To investigate the diagnostic value of blood oxygen level-dependent 
(BOLD) MRI in the grade of hepatic warm ischaemia-reperfusion injury, and to 
evaluate the intervention effect of liposome-carried prostaglandins E1 (Lipo-
PGE1) in rabbit models. 
Methods and Materials: Seventy rabbits were randomly divided into sham-
operation group, three test groups and three corresponding intervention groups 
(n=10 for each group) according to different hepatic warm ischaemia time. 
BOLD MRI was performed on a 3.0 T MR scanner with 9 TE (2.57 to 24.25 
ms). Rabbits were sacrificed for biochemical and histomorphological analysis. 
In vivo R2* values of hepatic parenchyma were compared between different 
groups and matched with biochemical parameters. 
Results: R2* values had excellent interobserver agreement with ICC of 0.805. 
There were significant differences of R2* values between all of groups, 
between sham-operation group and test groups, between sham-operation 
group and intervention groups, between test groups and corresponding 
intervention groups (P<0.05). With the prolonged of warm ischaemia time, R2* 
values showed a gradual increasing tendency; after the intervention of Lipo-
PGE1, the reduction of R2* values was increasingly obvious. R2* values 
corresponded well with biochemical parameters (r>0.5, P<0.05). 
Conclusion: BOLD MRI is a non-invasive and valuable technique in assessing 
the pathophysiologic changes of hepatic WIRI and relieved degree of Lipo-
PGE1 in a rabbit model.  
B-0202 14:08  
Ultrasonic adaptive sound speed estimation for the diagnosis and 
quantification of hepatic steatosis  
M. Dioguardi Burgio1, M. Imbault2, M. Ronot1, A. Faccinetto1, B. Van Beers1, 
P.E. Rautou1, L. Castera1, M. Tanter2, V. Vilgrain1; 1Clichy/FR, 2Paris/FR 
(marco_dioguardi@hotmail.it)  
Purpose: to evaluate the ability of a new ultrasound (US) method based on 
Sound Speed Estimation (SSE) in detection, quantification, and grading of 
hepatic steatosis using magnetic resonance (MR) proton density fat fraction 
(PDFF) as reference standard and to calculate one US fat index based on the 
patient’s SSE. 
Methods and Materials: we consecutively included N=50 patients as study 
cohort and further N=50 as validation cohort who underwent both SSE and 
abdominal MR. Hepatic steatosis was classified according to MR-PDFF cutoffs 
as: S0 6.5%, S1 from 6.5 to 16.5%, S2 from 16.5 to 22% and S3 22%. 
Receiver operating curve analysis was performed to evaluate the diagnostic 
performance of SSE in diagnosis of steatosis. Based on the optimal data fit 
derived from our study, we proposed a correspondence between the MR-PDFF 
and an US fat index. Coefficient of determination R2 was used to evaluate fit 
quality, and was considered as robust when R2 >0.6. 
Results: study and validation cohort presented mean SSE value of 
1.570±0.026 and 1.568±0.023 mm/µs for S0 and 1.521±0.031 and 
1.514±0.019 mm/µs for S1-S3 (p<0.01) patients respectively. SSE threshold of 
1.537 mm/µs had 80% sensitivity and 85.7% specificity in diagnosis of 
steatosis in the study cohort. Robust correspondence between MR-PDFF and 
the US fat index was found both for the study cohort (R2= 0.73) and the 
validation cohort (R2= 0.76). 
Conclusion: SSE can be used to detect, quantify and grade liver steatosis and 
to calculate an US fat index.  
B-0203 14:16  
Performance of a 2D-SWE method for predicting different stages of liver 
fibrosis, using transient elastography as the reference method  
I. Sporea, F.B. Bende, A.S. Popescu, R. Sirli, M. Danila, S. Nistorescu, 
R. Fofiu, V. Baldea; Timisoara/RO (isporea@umft.ro)  
Purpose: To evaluate the performance of 2D shear-wave elastography from 
General Electric(2D-SWE-GE), implemented on the LOGIQ S8 system, for the 
noninvasive assessment of liver fibrosis and to identify liver stiffness(LS) cut-off 
values for predicting different stages of fibrosis using Transient 
Elastography(TE) as reference. 
Methods and Materials: We included 179 consecutive subjects with or without 
chronic hepatopathies in whom LS was evaluated in the same session by 2 
elastographic techniques: TE(FibroScan, EchoSens) and 2D-SWE-GE(LOGIQ 
S8, GE Healthcare). Reliable LS measurements were defined for TE as the 
median value of 10 measurements with a success rate of 60% and an 
interquartile range/median ratio(IQR/M)<0.30 and for 2D-SWE-GE as the 
median value of 10 measurements acquired in a homogenous area and an 
IQR/M<0.30. To discriminate between TE fibrosis stages we used the following 
cut-offs: F2-7; F3-9.5 and F4-12 kPa. 
Results: Reliable LS measurements were obtained in 97.2% subjects by 2D-
SWE-GE, and 98.3% by TE(p=0.72). 171 subjects were included in the final 
analysis. Based on TE cut-off values we divided our cohort into four groups: 
F<2: 51(29.8%); F=2: 40(23.4%); F=3: 31(18.1%); F=4: 49(26.7%). A good 
positive correlation was found between the LS values obtained by the 2 
methods: r=0.72, p<0.0001. The best 2D-SWE-GE cut-off value for F2 was 
6.9 kPa(AUC 0.93, Sensitivity 85.8. Specificity 90.2), for F3 it was 8.2 
kPa(AUC 0.93, Sensitivity 87.5, Specificity 86.8) and for F=4 it was 9.3 
kPa(AUC 0.91, Sensitivity 85.7, Specificity 81.2). 
Conclusion: The best 2D-SWE-GE(S8) cut-off values for predicting F2,F3 
and F=4 were 6.9, 8.2 and 9.3 kPa.  
Author Disclosures: 
  I. Sporea: Consultant; General Electric, Philips. Speaker; Siemens, Philips, 













B-0204 14:24  
Associations between liver fat, visceral fat and microalbuminuria in the 
general population  
I. Dekkers, A. de Vries, A. de Roos, T. Rabelink, F.D. Rosendaal, H.J. Lamb, 
R. de Mutsert; Leiden/NL (I.A.Dekkers@lumc.nl)  
Purpose: Abdominal obesity is an established risk factor for metabolic 
disorders. Our objective was to investigate the relative contributions of visceral 
adipose tissue (VAT) and hepatic triglyceride content (HTGC) to 
microalbuminuria in a middle-aged population. 
Methods and Materials: In this cross-sectional analysis, VAT was assessed 
by magnetic resonance imaging, and HTGC by proton spectroscopy. 
Microalbuminuria was defined as urinary albumin-creatinine ratio 2.5/3.5 
mg/mmol in men/women. With logistic regression we calculated odds ratios 
(OR) of microalbuminuria, adjusted for age, sex, ethnicity, education, smoking, 
alcohol consumption, total body fat, hormonal status in women, and stratified 
by sex and the patatin-like phospholipase domain-containing (PNPLA3) gene. 
Results: Of the 2,023 participants 53% were women, 39% carried a PNPLA3-
risk allele, 29% had fatty liver (HTGC>5.56%), and 2% microalbuminuria. In 
adjusted models, VAT was associated with a two-fold increased risk of 
microalbuminuria (per SD=55.4 cm2, OR: 2.16, 95% CI: 1.29, 3.62). Per SD 
HTGC (7.9%) the OR of microalbuminuria was 1.34 (95% CI: 1.02, 1.77). In 
joint models, the OR of microalbuminuria per SD VAT was 2.02 (1.18, 3.47), 
and per SD HTGC it was 1.20 (0.85, 1.70). Associations of VAT, but not 
HTGC, were stronger in women and in non-carriers of the PNPLA3-risk allele. 
Conclusion: Both liver fat and visceral fat were associated with 
microalbuminuria. In joint models VAT was more strongly associated with 
microalbuminuria than HTGC fat and may, therefore, be more important in the 
development of microalbuminuria. Prospective analyses need to study 
associations of VAT, fatty liver and the development of chronic kidney disease.  
B-0205 14:32  
Use of 2D shear-wave elastography in predicting different stages of liver 
fibrosis according to METAVIR scoring system: a histopathological 
correlation study  
M. Aksakal, S. Ozhan Oktar, G. Esendaglı Yılmaz, S. Özenirler, M. Cindoruk, 
K. Hızel, F.N. Baran Aksakal, C. Yucel; Ankara/TR 
(mehmetaksakalmd@gmail.com)  
Purpose: In this study, we investigated accuracy of 2D shear-wave 
elastography (2D SWE) in detecting liver fibrosis by using histopathological 
analysis as the reference method. 
Methods and Materials: Our single-center prospective study included 53 
consecutive adult patients who had liver biopsy within 14 months of 
elastographic examination. A real time SD SWE evaluation was performed 
using LOGIQ E9 system (GE Medical Systems, Wisconsin, USA). The median 
of 10 valid liver stiffness measurements in kPa for each patient were obtained 
and were compared with the METAVIR scores obtained from the liver biopsy, 
using Kendall’s rank correlation test. The diagnostic performance of real time 
2D SWE was assessed and cut-off values were set by ROC curve analysis. 
Results: A significant correlation was found between liver stiffness kPa values 
and degree of liver fibrosis (Kendall's tau=0.53, p=0.0001). AUROCs were 0.97 
(95% confidence interval:0.93-1; SD: 0.02) (p= 0.0001) and 0.98 (95% 
confidence interval:0.95-1, SD: 0.14) ( p= 0.0001) when comparing F0-1 
versus F2-3-4 and F0-1-2 versus F 3-4, respectively. When we compare F0-1 
versus F2-3-4 and F0-1-2 versus F 3-4 groups, optimal cut-off values were 
determined as 6.5 kPa (sensitivity:%100, specificity %84) and 8.8 kPa 
(sensitivity:%83, specificity %92), respectively. 
Conclusion: Our findings suggest that 2D-SWE can be used for the 
assessment of liver fibrosis, especially in identifying patients with no or 
minimum/mild fibrosis and those with severe fibrosis. Studies on larger groups 
of biopsied patients are required in order to establish the most appropriate cut-
off values for each particular stage of liver fibrosis.  
B-0206 14:40  
Preliminary exploration of the application of super microvascular imaging 
in focal liver lesions  
H. Meng-Na, T.-A. Jiang; Hangzhou/CN (monahe@163.com)  
Purpose: To explore the ability of super microvascular imaging (SMI) to 
differentiate diagnose focal liver lesions. 
Methods and Materials: 31 FLLs consisted of haemangioma (HE) (n = 17), 
hepatocellular carcinoma (HCC) (n = 5), metastatic lesions (n = 5), primary 
hepatic lymphoma (n = 1), focal nodular hyperplasia (FNH) (n = 2) and 
adenoma (n = 1). 9 lesions were pathologically diagnosed and 22 lesions were 
radiological confirmed. All patients had been done SMI. The patients were 
divided into subgroups based on the diagnostic results to analyse the SMI 
manifestations. We also compared the SMI manifestations between the most 
common FLLs of HCCs, metastatic lesions and HEs. 
Results: The HEs were described as three SMI subgroups: diffuse dot-like 
type (n = 6); strip rim type (n = 8); nodular rim type (n = 3), the size of the three 
groups were obviously different (P=0.00,<0.05); The HCCs were described as 
two subgroup: diffuse honeycomb type (n = 2); non-specific type (n = 3). Four 
of the metastatic lesions were like strip rim type of HE; the other one shared 
the same type of thick rim type with lymphoma. The FNH was described as 
spoke-wheel type and the adenoma was diffuse honeycomb type. The SMI 
types were significantly different between HCCs and metastatic lesions with 
HEs (P=0.048, <0.05). 
Conclusion: SMI technology made the evaluation of micro-vascular of focal 
liver lesions possible without any enhanced agents. SMI had the potential to 
add useful information to differential diagnosis between HCCs and metastatic 
lesions with HEs.  
B-0207 14:48  
Intraoperative shear wave elastography for assessment and staging of 
liver fibrosis and cirrhosis during open liver tumour surgery in 
correlation with histopathology: first results  
N. Platz Batista da Silva, L.P. Beyer, M. Hornung, S. Brunner, H.J. Schlitt, 
P. Wiggermann, E.-M. Jung; Regensburg/DE 
(natascha.platz-batista-da-silva@klinik.uni-regensburg.de)  
Purpose: Evaluation of feasibilty of intraoperative shear wave elastography 
(SWE) for quantitative assessment and staging of liver fibrosis/cirrhosis during 
liver tumour surgery in correlation with histopathology after partial liver 
resection. 
Methods and Materials: Retrospective analysis of intraoperative ultrasound 
(IOUS) data of 103 patients was performed who underwent liver tumour 
surgery between 08/2015-07/2017. IOUS was performed by one experienced 
examiner using multifrequency linear/T-shaped probes from 6-9MHz on the 
freely mobilized liver. SWE images of parenchyma were stored for assessment 
of shear wave speed (SWS,m/s) and stiffness (kPa). Five ROIs were placed 
each to measure SWS/stiffness out of which a mean value was calculated. 
Findings were correlated to histopathology after partial liver resection. For 
histopathological staging of liver fibrosis/cirrhosis Ishak score (F0-F6) was 
used. Statistical analysis was performed using ROC analysis. 
Results: 103 patients (M:66, F:37) aged 29-87 years (mean 60y, sd±11,8) 
were included. Postoperative histopathology showed no fibrosis in 52, F1-4 
fibrosis in 30, (in)complete cirrhosis (F5-6) in 21 cases. Patients without fibrosis 
showed a mean of 2.69m/s(1.5-3.8m/s)/19.9kPa(4.6-45.9kPa). In patients with 
fibrosis (F1-F4) mean was 2.85m/s(1.8-3.96m/s)/ 26.91kPa(3.7-53.1kPa). 
Patients with cirrhosis presented a mean of 3m/s(1.8-4.3m/s)/29.03kPa(11.7-
66.7kPa). By ROC analysis a cut-off of 2.46m/s/20.4kPa was calculated for 
diagnosis of relevant fibrosis/cirrhosis (F3). SensitivitySWS was 94%, specificity 
54.3%, accuracy 67%, NPV95%, PPV49.2% (AUC 0.745,95%CI:0.6482-
0.8419). SensitivityStiffness was 94%, specificity 57.4%, accuracy 69.3%, 
NPV95.1%, PPV51.7% (AUC 0.7643,95%CI:0.6706-0.8579). 
Conclusion: Intraoperative SWE enables staging of liver fibrosis/cirrhosis 
during liver surgery. Stiffness measurements were superior to SWS. Thereby 
surgical extent could be adapted individually to prevent postoperative hepatic 
insufficiency.  
B-0208 14:56  
Intraoperative CEUS for localisation and characterisation of liver lesions 
during open liver tumour surgery: a single centre's 7 years experience  
N. Platz Batista da Silva, M. Hornung, S. Brunner, C. Hackl, H.J. Schlitt, 
C. Stroszczynski, E.-M. Jung; Regensburg/DE 
(natascha.platz-batista-da-silva@klinik.uni-regensburg.de)  
Purpose: To evaluate the accuracy of intraoperative contrast-enhanced 
ultrasound (IoCEUS) for localization, characterization and differentation of focal 
liver lesions (FLL) during liver tumor surgery in correlation with postoperative 
histopathological results. 
Methods and Materials: A retrospective analysis of IoCEUS of 166 patients 
with 202 liver lesions was performed who underwent liver tumor surgery 
between 10/2010-07/2017. IoCEUS was conducted by one experienced 
examiner on the freely mobilized liver using multifrequency linear/T-shaped 
probes (6-9 MHz) after i.v.-application of 2.4-10 ml sulphurhexaflouride 
microbubbles. FLL were characterized dynamically during arterial (15-45s), 
portal venous (45-90s) and late venous phase (2-5min). An irregular 
hypervascularization during arterial phase and/or increasing wash out from 
portal venous to late phase were considered signs of malignancy. Findings of 
IoCEUS were correlated to postoperative histopathological findings after partial 
liver resection or biopsy. Statistical analysis was performed using cross-tables, 
chi-square- and fisher’s exact test with p<0.05 as level of significance. 
Results: IoCEUS data of 166 patients with 202 FLL (m:104, f:62) aged 
between 2-81 years (mean 60.5y, sd±12.2y) were retrospectively analyzed. 
FLLs’ size ranged from 0.1-8.88cm (mean 2.51cm, sd±1.44cm). Postoperative 
histopathology showed 183 malignant and 19 benign FLL. IoCEUS could 
correctly characterize 180/183 malignant and 15/19 benign FLL. Four benign 
lesions were mistaken for malignant by IoCEUS, 3 malignant lesions for 
  






benign. Sensitivity was 98.4%, specificity 79%, accuracy 96.5%, PPV 97.8%, 
NPV 83.3% (p<0.0001). 
Conclusion: Intraoperative CEUS is a highly valuable tool for localization and 
characterization of preoperatively known or unknown FLL during open liver 
surgery and should be used routinely.  
B-0209 15:04  
How safe are percutanous liver biopsy procedures? Complication rate 
and seeding risk in an oncological setting  
K.N. De Paepe1, L. Bonne2, E. Raimondi3, N. Fotiadis1, D.-M. Koh1, 
N. Starling1, I. Chau1, G. Brown4, D. Cunningham1; 1London/UK, 2Leuven/BE, 
3
Ferrara/IT, 4Sutton/UK (katjadepaepe@gmail.com)  
Purpose: Percutaneous biopsy of liver metastases is common practice in the 
setting of oncological clinical trials, where it serves as a relatively non-invasive 
method to obtain sufficient tissue for genetic analyses. Complications can 
occur, including seeding of the tumour along the biopsy track; however, 
literature on the incidence of seeding is scarce. The aim of this study was to 
evaluate the technique’s safety. 
Methods and Materials: Patients with ultrasound or CT-guided liver biopsy 
between 2012 and 2016 were included. Medical records were reviewed 
retrospectively for post-biopsy complications and all follow-up imaging was re-
assessed for the presence of seeding, defined as tumoural deposits in the 
biopsy needle track. 
Results: In 550 patients (282 women, 268 men; mean age of 61y), 782 
biopsies were performed, 43.9% (343/782) for trials and 56.1% (439/782) for 
diagnostic purposes. 93.7% (733/782) were diagnostic, revealing malignancy 
in 96.9% (710/733). Patients had 1 (n=387) to 7 (n=1) biopsies; a co-axial 
system was used in 70.6% (552/782) and multiple passes in 29.4% (230/782). 
Complication rate was 8.8% (69/782), namely pain (4.7%) and vasovagal 
reaction (2.3%). Less frequent severe complications were bleeding (1.0%), 
sepsis/fever (1.1%), pulmonary embolism (0.3%) and pneumothorax (0.4%). 
Seeding rate was 1.1% (8/782) [2/44 melanoma, 1/9 GIST, 1/39 
cholangiocarcinoma, 1/248 colorectal, 1/14 oesophagus, 1/97 breast, 1/31 
prostate], mean seeding time was 208 days, mean post-biopsy survival time 
was 495 days and 349 days in the seeding and non-seeding groups, 
respectively. 
Conclusion: Percutaneous liver biopsy is an effective and safe method for 
tissue collection, with a minimal risk of seeding.  
B-0210 15:12  
Role of interventional radiology in the scope of liver transplantation  
M. Pitton, F. Becker, S. Schotten, R. Kloeckner, T. Zimmermann, J. Mittler, 
P.R. Galle, G. Otto, C. Düber; Mainz/DE 
(michael.pitton@unimedizin-mainz.de)  
Purpose: To analyse the role of interventional radiology (IR) in the complex 
scenario of liver transplantation (LTx). 
Methods and Materials: Patients with history of liver transplantation (LTx) 
were analysed for number and type of interventional procedures in the scope 
of liver transplantation. The institutional data base was searched for all 
interventional procedures during the time on waiting list, in the perioperative 
phase, and during follow-up after LTx. All interventional procedures were 
categorised in image-guided punctures (e.g. biopsies, drainages), local tumour 
treatment (e.g. ablations, TACE, SIRT), biliary interventions (e.g. in ischaemic 
or ischaemic type biliary lesions [IBL/ITBL]), vascular interventions (portal, 
venous, arterial recanalisation or embolisation), TIPS, and others. The 
numbers and time point during the patient´s course were analysed. 
Results: 815 patients who received liver transplantation between 1996 and 
2016 were included. 24.4% of patients had no interventions at all. 44.7% of 
patients received interventions during time on the waiting-list (in 20.4% <=3 
procedures per patient, in 24.3% >3 procedures per patient, e.g. TACE etc). 23 
patients (2.8%) received procedures within the perioperative phase (<= 3 days 
after LTx). During 30d-Follow-up, a total of 60% of patients received some IR-
procedures: 56.4% <= 3 per patient (28.7% only one per patient). However, 
3.6% of patients received >3 procedures per patient (range 4-8). 
Conclusion: Interventional procedures are an integral part in the scenario of 
liver transplantation and cover the whole scope of IR, particularly TIPS and 
local tumour treatment before LTx, peri-/postoperative vascular issues, as well 
as biliary interventions in IBL/ITBL during follow-up.  
B-0211 15:20  
Transient elastography (TE), shear wave elastography (SWE) and 
magnetic resonance elastography (MRE) for fibrosis assessment in 
chronic viral hepatitis: preliminary data  
L. Cevasco, S. Perugin Bernardi, L. Bacigalupo, F. Paparo, M. De Cesari, 
G. Siri, G. Cenderello, V.M. Pinto, G.A. Rollandi; Genoa/IT 
(dott.luca.cevasco@gmail.com)  
Purpose: Verify if TE, SWE and MRE obtain comparable results in the 
measurement of fibrosis in patients affected by chronic viral hepatitis. 
Methods and Materials: We have evaluated 30 consecutive patients (of 100 
expected) affected by HCV or co-infected by HCV+HIV. Acquisition of TE, 
SWE and MRE was performed the same day. Interdisciplinary consensus 
reference, performed by a panel of experts, determined the real fibrosis stage 
of each patient, taking into consideration clinical and laboratory features, 
serum biomarkers of fibrosis and a comprehensive assessment of all non-
invasive stiffness imaging methods. Weighted kappa (with Landis & Koch 
categorization), Bland-Altman plot and Pearson correlation were adopted. 
Results: All the techniques, compared independently with the interdisciplinary 
consensus reference, showed substantial agreement (at least 64%). In 
particular the agreement resulted almost perfect (93%) in case of MRE. 
Comparing the techniques with each other the agreement resulted at least 
moderate (46%) and, in the case of TE vs. MRE, substantial (66%). BMI 
(Pearson: 38.3%, p=0.028) and Dual-Dixon-Fat-Fraction (48.6%, 0.008) were 
positively correlated with a higher difference among values. Bland-Altman plot 
showed that the mean difference between obtained METAVIR scores ranged 
from a minimum of 0.0, 95%CI (-1.0; 1.0) MRE vs SWE, to a maximum of 0.1, 
95%CI (-0.7; 0.8) fibroscan vs. MRE. 
Conclusion: The preliminary data showed that TE, MRE and SWE obtain 
comparable results in the measurement of fibrosis in patients affected by 
chronic viral hepatitis. MRE showed the best agreement with our consensus 
reference. These data must be confirmed at completion of enrollment.  
Author Disclosures: 
  L. Cevasco: Research/Grant Support; The study received a grant from 
General Electric. 
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B-0212 14:00  
Association of non-alcoholic fatty liver disease with increased carotid 
intima-media thickness considering other cardiovascular risk factors  
A. Mohammadzadeh, M. Mohammadzadeh, V. Shahkarami, M. Shakiba, 
P. Sabetrasekh; Tehran/IR (psrpsr82@gmail.com)  
Purpose: Non alcoholic fatty liver disease (NAFLD) is the most common liver 
disease (%6-35) while associated with cardiovascular risk factors and 
metabolic syndrome (age, diabetes, hyperlipidemia , hypertension and 
smoking). Here, we want to evaluate association of increased carotid intima-
media thickness with NAFLD considering other cardiovascular risk factors to 
see if NAFLD is independently associated with increased carotid IMT. 
Methods and Materials: Totally 300 patients [150 NAFLD - 150 normal] 
referred to 4 academic hospitals were enrolled. Patients with history of alcohol 
use, hepatitis, HIV, chemotherapy and other organ failures were excluded. A 
single radiologist performed abdominal sonographies[3-5MHz probe] and 
carotid sonography[7.5 MHz probe](measuring posterior wall of both common 
carotids and calculating mean value). NAFLD was diagnosed based on 
sonographic findings in absence of acute or chronic liver and kidney diseases 
and malignancies. 
Results: Mean age was 51.2±14.8[20-97] and 184[%61.3] were male. Mean 
IMT was greater in patients with diabetes, hypertension, hyperlipidemia and 
NAFLD[all Ps<0.001] and these variables with age were statistically significant 
in univariate models for estimating IMT. Among NAFLD patients, 38[%25.3] 
had increased IMT [unilateral or bilateral;considering 0.8 as cutoff point] while 
this frequency was 8 [%5.3] among normal subjects [P<0.001, odds ratio=6, 
95%CI=2.7-13.4].In multivariate regression models[IMT as dependent 
variable], NAFLD, age and HLP were independent significant variables in linear 
model[R2=0.41] and NAFLD showed highest odds ratio[16.4] among significant 
variables[age, BMI,NAFLD and HLP] in logistic model 
Conclusion: Increase carotid IMT is highly associated with NAFLD 
independent of other cardiovascular risk factors and should be considered in 
these patients.  
B-0213 14:08  
Carotid intima-media thickness (CIMT) as a window to atherosclerosis  
D.J. Petrovic; Belgrade/RS (dusanpetrovic736@gmail.com)  
Purpose: The objective of the survey was to establish the relation between the 
carotid intima-media thickening (CIMT) and the coronary artery disease (CAD) 
among the patients tested by coronary angiography due to suspecting the 
coronary artery disease. 
  






Methods and Materials: Eighty respondents with angiography-diagnosed 
coronary disease (40 men and 40 women varying between the age of 30 and 
80) were tested by the ultra-sound Doppler angiography and compared to the 
identical number of healthy respondents of the same gender and age structure 
and without risk factors in terms of the coronary disease. 
Results: Statistically, the thickness of CIMT is significantly higher for the 
respondents of both sexes with the presence of CAD (p< 0.01). The 
respondents with the multi-vessel coronary disease have significantly higher 
CIMT than the respondents with the one-vessel or two-vessel coronary disease 
(p< 0.05). Statistically, the cross-sectional surface area of the a. carotis 
communis (CSA) is significantly larger among the respondents with CAD in 
comparison with the control group. 
Conclusion: The evaluation of CIMT is a reliable parameter for detecting the 
degree of vascular remodelling in the process of arteriosclerosis (pre-
atherosclerosis or subclinical atherosclerosis) while changes on coronary and 
carotid arteries correlate to a high degree. Carotid duplex ultrasonography can 
be used as an important screening method owing to several advantages such 
as ease of use, reproducibility, no radiation exposure, and high correlation with 
atherosclerosis. Early diagnosis of carotid artery disease is of utmost 
importance, and ultrasound plays a pivotal role therein.  
B-0214 14:16  
Development and validation of a pathlength calculation for carotid-
femoral pulse wave velocity  
M. Bonnici-Mallia, J. Weir-McCall, L. Brown, J. Summersgill, P. Talarczyk, 
S. Chin, F. khan, A.D. Struthers, G. Houston; Dundee/UK 
(mbonnicimallia@nhs.net)  
Purpose: Carotid-femoral Pulse Wave Velocity (PWV) is the gold standard for 
measuring arterial stiffness and is predictive of future cardiovascular events. 
The purpose of this study was to generate a formula from easily obtainable 
clinical metrics in order to determine the carotid-femoral pathlength component 
of PWV calculation. 
Methods and Materials: 1183 participants, free from cardiovascular disease, 
underwent whole-body MRI (WBMRI) as part of the TASCFORCE study. 
Distance between carotid and femoral vessels was obtained by tracing the 
arterial centreline from the bifurcation of the common carotid to that of the 
common femoral artery. A backward linear regression model was used to 
generate a formula for calculating pathlengths based on age, sex, heart rate, 
height and weight. This calculation was then validated in an external cohort of 
128 participants from the SUMMIT study who had also undergone WBMRI. 
Results: Applied within the TASCFORCE cohort, the formula provided 
moderate agreement with true distance (r=0.59, p<0.001), with a mean 
difference of 0.04mm (limits of agreement=-55.5-56.3mm, p=0.96 for 
difference). Compared with the measured arterial pathlength on MRI in the 
SUMMIT cohort, there was a small underestimation of the pathlength distance 
by the formula with a mean difference of 10.1mm (limits of agreement=-39-
59mm), p<0.001, and a moderate correlation between the two measures 
(r=0.61, p<0.001). 
Conclusion: Using simple allometric measures, arterial pathlength for PWV 
can be calculated with less variability and greater accuracy than current body 
surface techniques, holding promise for improving interstudy and intercentre 
reproducibility, thus expanding the utility of PWV calculation in clinical practice.  
Author Disclosures: 
 J. Weir-McCall: Research/Grant Support; Guerbert Laboratories.  
G. Houston: Research/Grant Support; Guerbet Laboratories, Cook Medical, 
Medtronic. 
B-0215 14:24  
Lumen dynamics of spontaneous arteries dissection  
M. Dreval, L. Kalashnikova, M. Krotenkova, L. Dobrynina; Moscow/RU 
(dreval-marina83@yandex.ru)  
Purpose: To estimate the possibility of recanalization of internal carotid (ICA) 
and vertebral arteries (VA) with spontaneous dissection treated with 
conservative management 
Methods and Materials: The study included 46 patients (46% males, mean 
age 36,83±7,61 years) with artery dissection manifested by ischaemic stroke or 
isolated head or neck pain. MRI was performed on 1.5 T scanner. Data of 3D-
TOFMRA of the cervical arteries and T1fat-sat of the neck were obtained. The 
examinations were carried out twice: in the course of the first two weeks and 
after two months. The size of an internal lumen at the level of dissection and at 
the level of unchanged artery were measured, degree of the stenosis was 
evaluated 
Results: At the 1st study lumen stenosis of ICA was revealed in 60% of cases, 
lumen stenosis of VA in 90% (35), occlusion in 40% (10) and 5% (2), 
respectively. The mean stenosis degree was 45% for ICAD and 50% for VA. 
MRI Follow-up study showed that in patients with initial stenosis lumen 
diameter of dissected arteries increased with the time in all cases. In patients 
with initial luminal occlusion due to dissection recanalization of VA occurred in 
50%, spontaneous recanalization of ICA - in 40%. Residual stenosis in all 
cases was haemodynamically insignificant (20-25%). 
Conclusion: Cervical arteries dissection is a dynamic process, stenosis is 
completely or partially resolved in all cases in two months. In contrast, 
occlusions are resolved in less than a half of cases and the residual stenosis is 
considered haemodynamically insignificant.  
B-0216 14:32  
Relationship between ICA geometry and plaque composition  
G. Corrias1, M. Porcu2, M. Laino3, L. Saba1, A. Mereu1; 1Monserrato/IT, 
2
Cagliari/IT, 3Rome/IT (ale.mereu7@studenti.unica.it)  
Purpose: The aim of our study is to demonstrate whether there is a 
relationship between the geometry of the ICA and atherosclerotic plaque 
composition in terms of fat, mixed, calcific plaque and volume. 
Methods and Materials: This is a prospective single institution pilot study 
enrolling 55 patients, for a total of 110 carotids, who were scheduled to perform 
a MDCTA of the supra-aortic vessels. The institutional review board approval 
for this study was obtained. Plaque composition was quantified either as 
absolute volume or as percentage of each different component to the total 
plaque. Associations between ICA curvature and plaque development were 
statistically investigated. The variables relationship was calculated using 
correlation coefficient r. 
Results: There is a strong correlation between ICA curvature and the volume 
of each plaque component in absolute values. Fat plaque volume and 
curvature correlation coefficient r: 0.3390 (significance level p: 0.0006). Fibrous 
plaque volume and curvature correlation coefficient r: 0.2295 (significance level 
p: 0.0217). Calcium plaque volume and curvature correlation coefficient r: 
0.2820 (significance level p: 0.0045). 
Conclusion: We have found a strong correlation between the ICA curvature 
and the presence of a plaque in the proximal tract of ICA, of any composition. 
The bigger the curvature value, the highest is the probability to find a plaque, in 
terms of absolute volume representation. In particular, analysing the 
percentage of the plaque composition we have found that the higher the 
curvature value, the bigger the probability to find a plaque composed with 
mostly fat (with a significancy level p= 0.0027).  
B-0217 14:40  
Are there any differences in radiation-induced and non-radiation-induced 
carotid atherosclerosis?  
T.-C.M. Ying1, Y. Li1, W.C.V. Wu1, C. Yuan2, L.W.D. Kwong1, S.P. Yip1, 
K.W.H. Law1, W.Y.S. Lee1; 1Hong Kong/HK, 2Hunan/CN 
(htmying@polyu.edu.hk)  
Purpose: Carotid atherosclerosis is common in both post-radiotherapy (RT) 
nasopharyngeal carcinoma (NPC) patients and individuals with cardiovascular 
risk factors (CVRF). This study aimed to use ultrasound to investigate the 
differences in radiation-induced and non-radiation-induced carotid 
atherosclerosis with focus on the number of carotid plaque, carotid intima-
media thickness (IMT) and plaque echogenicity. 
Methods and Materials: Carotid ultrasound was performed on 20 post-RT 
NPC patients and 20 CVRF subjects. In each patient/subject, the IMT of 
common carotid arteries was measured. The common, internal and external 
carotid arteries were examined, and the number of carotid plaque detected 
was recorded. Ultrasound images of carotid plaques were analysed with a 
computer software to quantify the plaque echogenicity which was expressed as 
grey scale median (GSMedian) and mean (GSMean). 
Results: Post-RT NPC patients (0.78±0.24mm) had significantly larger carotid 
IMT than CVRF subjects (0.69±0.16mm) (p<0.05). Carotid plaques were more 
commonly found in post-RT NPC patients (n=48) than CVRF subjects (n=36). 
Carotid plaques in post-RT NPC patients (31.1±11.8 and 35.3±12.5 
respectively) had significantly lower GSMedian and GSMean than those in 
CVRF subjects (39.5±16.2 and 43.6±17.2 respectively) (p<0.05). 
Conclusion: Radiation-induced carotid atherosclerosis tended to be more 
severe than non-radiation-induced carotid atherosclerosis as evidenced by 
larger carotid IMT and higher incidence of plaque formation in post-RT NPC 
patients. When compared to CVRF subjects, carotid plaques in post-RT NPC 
patients were more hypoechoic as evidenced by the lower GSMedian and 
GSMean, and thus were relatively more unstable leading to higher risk of 
cerebrovascular diseases.  
B-0218 14:48  
Carotid IMT and haemodynamic indices in evaluation of atherosclerosis 
in hypertensives  
S.F. Kenis; Zaria/NG (shedrackkenis@yahoo.com)  
Purpose: To evaluate carotid intima media thickness and haemodynamic 
indices as sonographic markers of atherosclerosis in a resource limited 
environment. 
Methods and Materials: The study involved 130 hypertensive patients and 
130 age-matched controls. All underwent carotid Doppler examination using 
  






Mindray DC-8 ultrasound machine. Blood samples were taken after an 
overnight fast for lipid profile and blood sugar (FBS). The Framingham risk 
score (FRS) was calculated from patients’ information. The data was analysed 
using SPSS version 20.0, and T-test was used to assess the difference 
between variables. Pearson correlation was used to determine correlation 
between duplex finding and FRS. p<0.05 was considered statistically 
significant. 
Results: The mean age of the hypertensive patients was 50.20 ± 10.30years, 
and the mean age for control is 49.39 ± 9.89 years. The mean carotid intima-
media thickness (CIMT) was significantly higher in hypertensives compared to 
control. Common carotidartery (CCA) pulsatility index (PI), CCA resistive index 
(RI), internal carotid (ICA) PI and ICARI were not significantly different between 
hypertensive patients and control. It was observed that the value of carotid 
haemodynamic indices increases with increasing age in the hypertensive, but 
the relationship of increasing age and haemodynamic indices was less clearly 
demonstrated in the control. There was a strong correlation between CIMT and 
FRS in the hypertensives and only in the ICA was there a moderate to weak 
correlation between haemodynamic parameters and FRS. 
Conclusion: CIMT appears to be the best sonographic marker of 
atherosclerosis. Though carotid haemodynamic indices correlate less clearly 
than CIMT, there appears to be a gradual increase in the carotid 
haemodynamics with age, particularly in the hypertensives. 
 
B-0219 14:56  
Magnetic resonance imaging-based assessment of carotid atheroma: a 
comparative study of patients with and without coronary artery disease  
A. Usman, U. Sadat, Z. Teng, M. Graves, J. Boyle, J. Gillard; Cambridge/UK 
(ammara.usman2013@gmail.com)  
Purpose: Functional magnetic resonance (MR) imaging of atheroma using 
contrast media enables assessment of the systemic severity of atherosclerosis 
in different arterial beds. Whether black-blood imaging has similar ability 
remains widely unexplored. In this study, we evaluate whether black-blood 
imaging can differentiate carotid plaques of patients with and without coronary 
artery disease (CAD) in terms of morphological and biomechanical features of 
plaque vulnerability, thereby allowing assessment of the systemic severity 
nature of atherosclerosis in different arterial beds. 
Methods and Materials: Forty-one patients with CAD and 59 patients without 
CAD underwent carotid black-blood MR imaging. Plaque components were 
segmented to identify large lipid core (LC), ruptured fibrous cap (FC), and 
plaque haemorrhage (PH). These segmented contours of plaque components 
were used to quantify maximum structural biomechanical stress. 
Results: Patients with CAD and without CAD had comparable demographics 
and comorbidities. Both groups had comparable prevalence of morphological 
features of plaque vulnerability (FC rupture, 44% versus 41%, P = .90; PH, 
58% versus 47%, P = .78; large LC, 32% versus 47%, P = .17), respectively. 
The maximum biomechanical stress was not significantly different for both 
groups (241 versus 278 kPa, P = .14) respectively. 
Conclusion: Black-blood imaging does not appear to have the ability to 
differentiate between the morphological and biomechanical features of plaque 
vulnerability when comparing patients with and without symptomatic 
atherosclerotic disease in a distant arterial territory such as coronary artery.  
B-0220 15:04  
DCE-MRI demonstrates less microvasculature in symptomatic carotid 
atherosclerosis  
G.A.J.C. Crombag1, R. van Hoof1, F.H. Schreuder2, R.J. van der Geest3, 
W.H. Mess1, R. van Oostenbrugge1, P.A. Hofman1, J.E. Wildberger1, M. Kooi1; 
1
Maastricht/NL, 2Nijmegen/NL, 3Leiden/NL 
(g.crombag@maastrichtuniversity.nl)  
Purpose: Rupture of a vulnerable carotid atherosclerotic plaque is an 
important underlying cause of stroke. Increased leaky plaque microvasculature 
may contribute to plaque vulnerability. These immature microvessels may 
facilitate the entrance of inflammatory cells into the plaque. As dynamic 
contrast-enhanced (DCE) magnetic resonance (MR) imaging is a non-invasive 
method to study leaky plaque microvasculature, we investigated the difference 
in plaque microvasculature between the symptomatic and contralateral 
asymptomatic carotid plaque. 
Methods and Materials: 88 symptomatic patients with >2mm carotid plaque 
underwent 3T MRI (including DCE-MRI) to identify the presence of a lipid-rich 
necrotic core (LRNC) and to assess plaque microvasculature. Ktrans was 
calculated for the entire symptomatic and contralateral asymptomatic plaque, 
using a pharmacokinetic model (Patlak model). Ktrans represents the contrast 
medium transfer rate from the microvasculature to the extracellular space. The 
presence of an LRNC was assessed on the post-contrast black-blood T1W MR 
images. Differences in Ktrans between the symptomatic and asymptomatic side 
were assessed using a paired samples T test. Independent samples T test was 
used to compare the means between plaques with and without LRNC. 
Results: A significantly lower Ktrans was found in the symptomatic carotid 
plaque compared to the asymptomatic side (0.062±0.0017 min-1 versus 
0.057±0.0020 min-1, p=0.033). Furthermore, there was a significant lower Ktrans 
in plaques with an LRNC (0.061±0.017 min-1 versus 0.054±0.014 min-1, 
p=0.041). 
Conclusion: Unexpectedly, the symptomatic carotid plaques had a 
significantly lower Ktrans, indicative of a decrease of leaky plaque 
microvasculature in symptomatic plaques. This may be related to a larger 
amount of necrotic tissue in symptomatic plaques.  
B-0221 15:12  
New 3D-arterial analysis software to evaluate carotid atherosclerotic 
plaque in comparison with CEUS, CTA and histological examination  
V. De Soccio1, V. Cantisani1, M. Di Segni1,2, N. Di Leo1, A. Rubini1, V. Forte1, 
D. Fresilli1, F. D'Ambrosio1, C. Catalano1; 1Rome/IT, 2Civitavecchia/IT 
(valerio.forte@gmail.com)  
Purpose: To assess the accuracy of ultrasonographic 3D-Arterial Analysis in 
characterizing stenosis percentage and vulnerability of carotid plaques. 
Methods and Materials: Sixty seven patients were enrolled with the following 
criteria: (1) asymptomatic stenosis of carotid artery &gt70% but &lt100%; or (2) 
recent transient ischemic attack or ischemic stroke, and ipsilateral carotid 
stenosis &gt50%. Eventually all patients underwent endarterectomy and 
samples were histologically assessed for instability features. 3D-Arterial 
Analysis provided a colour map to evaluate plaque vulnerability and a 3D 
volumetric stenosis evaluation. Its diagnostic performance has been compared 
to histological examination for plaque’s vulnerability and to CEUS and CTA for 
stenosis’ grading. 
Results: Histological examination identified 47 vulnerable plaques with at least 
one of the following criteria: fibrous cap &lt200 m, presence of lipid core, intra-
plaque haemorrhage, leukocyte recruitment or angiogenesis. 3D-Arterial 
Analysis software, CEUS and CTA were able to detect 42, 41 and 41 of these 
47 vulnerable plaques respectively, with 89%, 87% and 87% sensitivity and 
100% specificity. 3D-Arterial Analysis software and CEUS were able to 
evaluate stenosis percentage with 88% sensitivity and 100% specificity 
compared to CTA, identifying 59/60 severe stenosis. 
Conclusion: 3D-Arterial Analysis software and CEUS seem effective tools to 
assess plaque’s vulnerability and stenosis severity, providing useful 
information for surgery planning.  
Author Disclosures: 
 V. Cantisani: Speaker; Bracco, Toshiba Medical Systems, Samsung 
Healthcare.  
B-0222 15:20  
MR imaging shows an inverse association between the microvasculature 
and intraplaque haemorrhage in atherosclerotic carotid lesions  
G.A.J.C. Crombag1, R. van Hoof1, S. Heeneman1, P. Nederkoorn2, 
W.H. Mess1, R. van Oostenbrugge1, M.J. Daemen2, J.E. Wildberger1, M. Kooi1; 
1
Maastricht/NL, 2Amsterdam/NL (g.crombag@maastrichtuniversity.nl)  
Purpose: Rupture of a vulnerable atherosclerotic plaque is an important cause 
of clinical ischaemic events. The presence of intraplaque haemorrhage (IPH) is 
associated with plaque rupture and plaque progression, and predicts 
cerebrovascular events. However, the underlying mechanisms contributing to 
IPH are not fully understood. The dominant view is that IPH is caused by 
leakage of erythrocytes from immature microvessels. Alternatively, it has been 
suggested that plaque rupture/fissures are important in the development of 
IPH. The goal of this study was to investigate the association between leaky 
atherosclerotic plaque microvasculature and the presence of IPH in a large 
prospective cohort study of patients with symptomatic carotid plaques. 
Methods and Materials: 101 symptomatic patients underwent MRI of the 
symptomatic carotid plaque for detection of IPH and dynamic contrast-
enhanced (DCE)-MRI for assessment of plaque microvasculature. Ktrans, an 
indicator of microvascular flow, density and leakiness, was estimated using 
pharmacokinetic modeling. Statistical analysis was performed using an 
independent samples T test and logistic regression, correcting for clinical risk 
factors. 
Results: A decreased vessel wall Ktrans was found for IPH-positive patients 
(0.033±0.001 min-1 versus 0.040±0.001, p=0.001), which remained significant 
after correction for confounding factors. No difference in adventitial Ktrans was 
found in patients with and without IPH (0.040±0.002 min-1 versus 0.039±0.001). 
Conclusion: We identified an inverse association between IPH and the 
microvasculature in symptomatic carotid plaques. Alternative and additional 
factors, such as disrupted plaque surface and fissures, may contribute to the 
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B-0223 14:09  
Hybrid repair of aortic pathology involving aortic arch  
Y. Xue, L. Huang; Beijing/CN (xueyuguo2006@163.com)  
Purpose: To evaluate the safety and efficacy of hybrid repair for aortic lesions 
involving aortic arch. 
Methods and Materials: From February 2009 to September 2016, 81 
consecutive patients (70 men; mean age 63.4±7.9 years, range 32-79) 
underwent brachiocephalic bypass combined with stent-graft implantation 
(“hybrid”) and were enrolled in the study. Aortic pathologies included Stanford 
type B aortic dissection (n=22), aortic arch aneurysm (n=26), aortic arch 
pseudoaneurysm (n=14), aortic arch penetrating ulcer (n=11) and proximal 
endoleak (n=5) or pseudoaneurysm formation (n=3) after TEVAR. Hybrid 
repair comprised 3 landing in zone 0, 44 landing in zone 1 and 34 landing in 
zone 2. Simultaneous procedures included left subclavian artery embolization 
(n=57), endovascular abdominal aortic repair (n=1), coronary artery bypass 
(n=1), left common carotid endarterectomy (n=1) and renal stenting (n=4). 
Follow-up was performed at 1 month, 3 months, 6 months, 1 year and annually 
thereafter to investigate endoleak, patency of vascular graft and exclusion of 
aortic pathology. 
Results: Technical success was 100%. Instant endoleak was observed in 9 
(11.1%, 7 type I, 2 type II) cases on postoperative angiography. Early morbidity 
was 8.6% (7/81). Early death occurred in 5 cases (6.2%). Follow-up was 
complete in 100% for 39.4±14.5 months (range 1 -81 months). During follow-
up, all the vascular grafts were patent. Late mortality was 6.2% (5/81) and 
morbidity was 14.5% (8/81). 
Conclusion: Hybrid repair of aortic pathologies involving aortic arch is safe 
and effective with good short- and mid-term results, greatly expanding the 
indication of endovascular aortic repair.  
B-0224 14:17  
Overall survival and factors predicting long-term outcome after thoracic 
aortic endovascular repair  
B. De Coster, S. Houthoofd, A. Laenen, I. Fourneau, G. Maleux; Leuven/BE 
(bruno.decoster@uzleuven.be)  
Purpose: To assess overall survival and to determine factors predicting 
outcome after thoracic endovascular aortic repair. 
Methods and Materials: This is a retrospective analysis including a cohort of 
212 consecutive patients (165 males and 47 females; mean age 64 years) who 
underwent thoracic endovascular aortic repair (TEVAR) in a tertiary referral 
centre for aortic disease. Main indications were true thoracic aortic aneurysm 
(TTAA) (n=58; 27.6%), traumatic aortic rupture (n=33; 15.7%), anastomotic 
pseudoaneurysms (n=23; 10.9%), dissecting thoracoabdominal aneurysm 
(n=22; 10.5%) and symptomatic, acute type B dissection (n=21; 10.0%). In 79 
patients (37.3%), a hybrid procedure, including supra-aortic rerouting, was 
performed. Kaplan-Meier estimates are used for overall survival and Cox 
regressions models are used for univariable analysis of the association 
between risk factors and survival. 
Results: Proximal landing zone were predominantly zone 3 (n=66; 31.3%), 
zone 2 (n=63; 29.9%) and zone 1 (n=38; 18%). In-hospital mortality was n=18 
(8.5%). Overall survival was 79.6%, 65.9% and 51.1% at 2, 5 and 10 years, 
respectively; better overall survival was revealed for traumatic aortic rupture, 
chronic posttraumatic pseudoaneurysms and anastomotic pseudoaneurysms 
(P<0.05). Clinical risk factors influencing overall survival include prior coronary 
bypass surgery, atrial flutter, arterial hypertension, renal failure, chronic 
obstructive pulmonary disease and associated abdominal aortic aneurysm 
(P<0.05). 
Conclusion: TEVAR is an effective treatment option for various thoracic aortic 
diseases with highest survival rates for traumatic aortic rupture and 
anastomotic pseudoaneurysms. Several clinical parameters are identified as 
risk factors for overall survival.  
 
B-0225 14:25  
Analysis of remodeling in abdomial aortic branch perfusion patterns 
complicated by type B aortic dissection after thoracic endovascular 
aortic repair  
T. Li, X. Han; Beijing/CN (litiezhengaz@163.com) 
Purpose: To evaluate the efficiency of thoracic endovascular aortic repair in 
dealing with visceral malperfusion based on the image-analysis of type B aortic 
dissection. 
Methods and Materials: Retrospective analysis to 32 patients from 
September 2015 to March 2016 in our department, who were diagnosed type B 
aortic dissection with visceral malperfusion, the information of clinic and image, 
as well as the following-up were collected. By observing the image of 
computed tomography angiography of aortic dissection in preoperative, we 
analyzed the type of branch perfusion patterns in four abdominal branches 
(celiac trunk, superior mesenteric artery, bilateral renal artery) in statistical. 
Results: Four abdominal branches (total 128 branches), 78 branches (67%) 
expressed with Class I patterns, in which Class I-b presented with 1%, Class I-
c presented with 5%; 14 branches (11%) expressed with Class II patterns, in 
which Class II-b-1 presented with 4%, Class II-b-2 presented with 3%; 16 
branches (13%) expressed with Class III patterns, in which Class III-a 
presented with 13%, without Class III-b and III-c presentation; the remaining 12 
branches with normal. Successful rate of TEVAR was 100%. The mean 
following-up was 4 months. Postoperative CTA showed that among 14 high-
risk abdominal branches, 13 branches (92.9%) preserved improvement, the 
remaining one branch (7.1%) with I-b showed ischemic malperfusion in 
progress to I-c. 
Conclusion: In comparison to the perfusion of ischemic branches complicated 
by aortic dissection in pre- and post- operative, there was profound benefit in 
the reconstruction of abdominal branches to extend the redefined branch type 
by Nagamine.  
B-0226 14:33  
Evaluating aortic endograft (EVAR) fate according to anatomical 
instruction (IFU) compliance: which anatomical feature has the most 
impact on graft fate?  
N. Güner, A. Gulcu; Izmir/TR (baturalpguner@gmail.com)  
Purpose: In today's practice, abdominal aortic aneurysms (AAA) are 
prevalently repaired endovascularly (EVAR). Because of its applicability on 
high-morbidity patients, a large group of EVAR patients have anatomic 
features that do not comply with endograft device specifications. Our research 
evaluates the follow-up complication rates of EVAR patients with device-
compliant and device-non-compliant anatomical features. 
Methods and Materials: Patients treated with EVAR between 2009 and 2015, 
and having follow-up studies in our institution are included in our study (50 
patients). Patients were grouped according to their IFU (instructions for use) 
compliance, and later each of the seven IFU anatomic criteria individually. 
Treatment efficiency were observed by aortic/iliac enlargement, type 1 and 3 
endoleaks and reintervention obligations during follow-up. 
Results: Of patients, 48% had IFU compliant and 52% had non-compliant 
anatomy. Mean follow-up time was 23 months. There were not any differences 
between compliant and non-compliant groups in complication rates and 
treatment efficiency. When each of the IFU anatomic criterias was used for 
grouping, proximal properties and iliac diameter did not yield any statistical 
difference. In patients with inadequate iliac fixation (<15mm), endoleak and 
reintervention rates were statistically higher (P 0.002 and 0.008). 
Conclusion: Proximal aneurysmal features were for long considered the most 
important factor in endograft fate. New design features in endografts may have 
changed this. Our study claims that distal fixation properties represent a very 
important and possibly strongest factor on the fate of an endograft. Small 
number of studies found on distal fixation properties had similar outcomes with 
our study.  
B-0227 14:41  
Role of intra-vascular ultrasound (IVUS) in EVAR planning  
G. Falcone, C. Raspanti, G. Gabbani, E. Casamassima, F. Mondaini, 
M. Citone, F. Fanelli; Florence/IT (gianmarcofalcone@gmail.com)  
Purpose: To evaluate accuracy and safety profile of Intravascular Ultrasound 
(IVUS - PhilipsVolcano) in pre-treatment EVAR planning for Aortic Abdominal 
Aneurysm(AAA) 
Methods and Materials: In 36 consecutive patients( mean age 70.1 +/- 5.9; 15 
male) with AAA pre-procedural EVAR evaluation was performed with CT 
angiography ( CTA). IVUS intra-operative evaluation of proximal neck 
diameter, sac diameter , distal neck and iliac artery diameter was performed. 
Endoprosthesis sizing was grounded on CTA data in 18 pts and on IVUS data 
in 18. IVUS evaluation of endoprosthesis apposition was performed at the end 
of the procedure. A comparison between IVUS and CTA data was performed. 
  






Results: IVUS was technically feasible in all cases. Mean proximal aortic neck 
diameter was 28mm (range 21-34mm) on CTA evaluation while on IVUS 
evaluation was 26mm ( range 20-31); Mean Iliac artery diameter on CTA was 
12mm (range 11-15mm) and 12mm on IVUS (10-13mm). In 5 cases a 
mismatch >2.5mm between CT and IVUS measurement of the proximal neck 
was observed. Technical success was achieved in all EVAR cases. No type I 
endoleaks were observed in the IVUS group. In the CTA group one type I 
endoleak was observed due to infolding of the fabric. In this case proximal 
aortic neck diameter was 26 on CTA and 21mm on IVUS evaluation. No IVUS 
related complication were reported. 
Conclusion: IVUS is a safe evaluation tool and allows a better measurement 
of aortic diameters in the EVAR planning, reducing the complication rate.  
B-0228 14:49  
Interventional treatment of visceral artery aneurysms: single centre 
experience over 16 years  
P. Reidler, M. Lerchenberger, M. Rentsch, C.G. Trumm; Munich/DE 
(Paul.Reidler@med.uni-muenchen.de)  
Purpose: To evaluate treatment efficacy, complications and short-term 
mortality after primary interventional treatment of visceral artery aneurysms 
(VAAs). 
Methods and Materials: From 71 consecutive cases of treated VAAs during 
the years 1999-2015 we selected all patients who had undergone primary 
endovascular treatment in elective or emergency settings. Aneurysm location 
and size were assessed by CTA with multiplanar reconstructions. 
Complications were classified according to Clavien-Dindo (CD) from Grade 0 to 
V. Mortality was assessed at follow-up after 30 days. 
Results: Thirty-two patients (mean age: 57.5 years, female/male: 12/20) who 
received primary emergency (12) or elective (19) endovascular treatment for 
single VAA were included. VAAs occurred at the coeliac trunk (1), splenic (8), 
gastroduodenal (8), hepatic (7), superior mesenteric (3), gastric (3), pancreatic 
(1) and pancreaticoduodenal artery (1). Aneurysm size varied between 7 and 
116mm (Median: 23mm). Primary intervention was successful in 29 patients 
(91%). 25 patients (78%) did not show any or only insignificant 
postinterventional complications (CD 0 and I). Pharmacologically treatable 
complications (CD II) were found in 1 patient (3%). 6 patients (19%) needed 
further interventional (4) or surgical (2) treatment (CD III) due to residual 
aneurysm perfusion (1), re-bleeding (2), splenic infarction (2), hepatic abscess 
(1), stent dislocation (1) or complications due to severe pancreatitis (1). 30-day 
mortality was 0%. 
Conclusion: Interventional therapy of VAA presented a high rate of primary 
therapeutic success and no to minor complications in a majority of cases. As 
more severe complications might require interventional or surgical approach, 
management should include both specialties.  
B-0230 14:57  
Endovascular repair of 40 Visceral Artery Aneurysms (VAAs) and 
Pseudoaneurysms(VAPAs) with the Viabahn Stent-Graft: technical 
aspsects, clinical outcome and mid-term patency  
P. Marra, M. Venturini, M. Colombo, G. Brembilla, M.M. Panzeri, M. Salvioni, 
S. Gusmini, F. De Cobelli, A. Del Maschio; Milan/IT (marra.paolo@hsr.it)  
Purpose: Endovascular repair of VAAs and VAPAs with Stent-Grafting (SG) 
can simultaneously allow aneurysm exclusion and vessel preservation, 
minimizing the risk of ischemic complications. We report a single-center 
experience on SG of visceral aneurysms, focusing on technical aspects, 
clinical outcome and mid-term patency. 
Methods and Materials: Patients affected by VAAs or VAPAs and treated 
between 2003 and 2017 with SG using a self-expandable peripheral Viabahn 
stent-graft were retrospectively reviewed. Aneurysm type, patient number, SG 
clinical setting, procedural data, peri-procedural complications, technical 
success, clinical success, 30-day mortality, and follow up (aneurysm exclusion, 
stent-graft patency, ischemic complications) were analysed. 
Results: SG was performed in 40 patients (22 VAPAs/18 VAAs) with 44 
procedures (25 in emergency, 19 in election), via transfemoral approach in 37 
cases and transaxillary in 7. SG was associated with coil-embolization in 6 
cases. One peri-procedural complication was recorded (a splenic artery 
dissection successfully converted to transcatheter embolization). The overall 
technical and clinical success rates were respectively 96% and 84%, with 
excellent trend in election procedures (both 100%). Overall 30-day mortality 
was 12.5% always due to septic shock after pancreatic surgery. Stent-graft 
thrombosis occurred in 2 patients within 3 months, with aneurysm exclusion 
and without ischemic complications. Stent-graft patency and aneurysm 
exclusion were confirmed at 6, 12 and 36 months in 18, 12 and 7 patients, 
respectively. 
Conclusion: SG of VAAs and VAPAs was safe and effective, particularly in 
election setting. The Viabahn stent-graft, flexible and without shape memory, is 
suitable for endovascular repair of tortuous visceral arteries.  
B-0231 15:05  
Endovascular treatment of visceral artery aneurysms and 
pseudoaneurysms: extravascular stent graft migration as a possible 
long-term complication  
L. Mascagni1, M. Tipaldi1, M. Pignatelli1, M. Cappucci1, M. Krokidis2, 
G. Orgera1, M. Rossi1; 1Rome/IT, 2Cambridge/UK (luca.nero@hotmail.it)  
Purpose: Immediate- and long-term result analysis of endovascular visceral 
aneurysm and pseudoaneurysm treatment with stent grafts. 
Methods and Materials: From February 2006 to Octuber 2011, we deployed 
23 stent grafts in 21 patients (12 males and 9 females, mean age 58,2 years) 
affected by aneurysm or pseudoaneurysm of the splenic artery (n=13), hepatic 
artery (n=5), gastroduodenal artery (n=1) and renal artery (n=2). The 
aneurysmal sack dimensions ranged from 9 to 60 mm. We evaluated the 
technical success, stent patency, possible migration, breakage and 
aneurysmal reperfusion. The follow-up, performed with CECT, was repeated at 
1, 6 and 12 months, then yearly (range 12-72 months). 
Results: We achieved complete aneurysmal exclusion in 20/21 patients 
(95%). In one case, we had incomplete sealing and splenic artery's hilar 
branch fissuration during the procedure and thus treated with coils and ruled 
out of the follow-up. We reported complete aneurysmal exclusion in 20/20 
patients in follow-up. In 4 cases, we observed stent occlusion, although without 
organ-related ischemia; in 3 of these 4 cases, stent occlusion was associated 
with stent graft migration: one inside the gastric antrum at the 36th month 
during follow-up (confirmed with endoscopy) and two in the lesser omentum at 
the 12th and 60th month follow-up. 
Conclusion: Endovascular treatment of aneurysmal and pseudoaneurysmal 
pathology of visceral arteries with stent grafts is a safe and effective technique 
with good immediate- and long-term results. Extravascular migration of the 
stent graft after its occlusion is a rare, yet possible late complication. According 
to our evidence, we recommend follow-up even in case the stent is occluded.  
B-0232 15:13  
Multicentre experience in endovascular treatment of aorto-iliac-femoral 
anastomotic pseudoaneurysms: evaluation of long-term follow-up  
G. Guzzardi1, B. Del Sette1, P. Cerini1, G. Carrafiello2, F. Fusaro1, D. Laganà3, 
C. Stanca1, A. Carriero1; 1Novara/IT, 2Milan/IT, 3Catanzaro/IT (guz@libero.it)  
Purpose: The purpose of this study is to assess the effectiveness of 
anastomotic pseudoaneurysms (APAs) endovascular treatment following 
aorto-iliac-femoral surgical reconstruction confronting technical and clinical 
success in patients with aortic lesions versus iliac-femoral lesions. 
Methods and Materials: Were retrospectively evaluated 54 patients that had 
underwent aorto-iliac-femoral by-pass (72APAs). All patients were evaluated 
before treatment with CTA to assess the characteristics of the lesions. Follow 
up was performed with Eco-color-Doppler and/or CTA at 1, 3, 6 months after 
theprocedure and than yearly. Patients were divided in two groups if they 
presented pseudoaneurysms in aorta or only in iliac-femoral district. 
Results: Immediate technical success was 100%. No periprocedural 
complications occurred. Six patientsdied during follow-up due to APA-non 
related causes and 5 for sepsis 3 months after the procedure.During a mean 
follow up of 25,5 months (range: 3-72), 3/47 occlusions of stent-graft leg 
occurred respectively 7days, 3 days and 24 months after the procedure, 2 type 
I endoleak and 1 type III endoleak. Primary clinical success rate was 87.2% 
and secondary clinical success was 95.7%. We witnessed a higher mortality in 
patients with aortic pseudoaneurysms even though it did not reach statistical 
significance (P>0.05). 
Conclusion: Endovascular treatment of APAs is a valid alternative to open 
surgery and could be proposed as treatment of choice especially in patients 
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B-0233 14:00  
Correlation analysis of quantitative CT parameters and pulmonary 
function in COPD patients  
Q. Yu1, X. Quan1, X. Lu2; 1Guangzhou/CN, 2Shenyang/CN  
Purpose: To explore the correlation between quantitative CT parameters and 
clinical pulmonary function in COPD patients using a new COPD automatic 
analysis software. 
Methods and Materials: There were 60 patients with COPD (male 51, median 
age: 65.9y) who underwent thin-slice chest CT scans both at end-inspiratory 
and end-expiratory. Airway measurement was provided average values along 
center line between start and end in the bronchiole of right upper apica lobes 
by software.  Indirect indicators of air trapping were measured (end-
inspiratory/end-expiratory), which included relative volume change (RVC)-860 to -
950, the expiration to inspiration ratio of mean lung density (MLDE/I);  Direct 
indicators of airway were measured (end-inspiratory,filter D), which included 
the following parameters: wall thickness (WT), lumen diameter (LD), Pi10, wall 
area (WA), lumen area (LA), wall area ratio (WA%), lumen area ratio (Ai%), 
WA/LA. Spearman rank correlation test and multiple variable analysis were 
used to evaluate the relationship between the above quantitative CT 
parameters and pulmonary function (airflow limitation: FEV1%, FEV1/FVC; 
airway resistance: Z5, R5, R20, Fres; diffusion capacity: DLCOSB). 
Results:  The correlation between indirect index of air trapping (RVC-860 to -
950, MLDE/I) and airflow limitation (r=-0.898 to -0.906, P<0.001), diffusing 
capacity (r=-0.830, -0.802, P<0.001),airway resistance (r=0.725-0.815, 
P<0.001) was statistically significant.  The correlation between direct 
indicators and airflow limitation (r=-0.305 to -0.623, <0.01), diffusing capacity 
(r=-0.325 to -0.482, P<0.01), airway resistance (r=0.280 to 0.591, P<0.01) also 
was significant. Obviously, the correlation between the indirect index and 
pulmonary function is good (r²>0.5), which was better than the direct index 
(r²<0.5), the best of those was -0.906 (between RVC-860 to -950 and FEV1/FVC). 
Conclusion: COPD software provides accurate and reproducible 
measurement of quantitative CT parameters, in which the correlation between 
indirect indicators of air trapping (RVC-860 to -950, MLDE/I) and pulmonary function 
is good.  
B-0234 14:08  
Using a neuronal network-based software to predict lung function values 
from qCT parameters in patients with COPD  
J.F.M. Gawlitza, T. Sturm, K. Spohrer, T. Henzler; Mannheim/DE 
(joshua_gawlitza@yahoo.de)  
Purpose: Quantitative computed tomography (qCT) is an emerging technique 
for diagnostics and research in patients with COPD. qCT parameters show 
strong correlation with lung function tests and symptoms. Nevertheless, it is 
often criticised that qCT only provides anatomical and not functional 
information. We evaluated a neuronal network-based tool to predict lung 
function parameters from qCT values against actual lung function tests. 
Methods and Materials: 75 patients with diagnosed COPD underwent body 
plethysmography and a dose-optimised qCT examination on a third-generation 
dual-source CT (Somatom Force, Healthineers, Forchheim, Germany) in 
inspiration and expiration. Four qCT parameters were acquired and used within 
a neuronal-network based dashboard software (PrediCT, Mannheim, 
Germany) to predict FEV1, FEV1/VC and RV/TLC. The predicted lung function 
values were then evaluated against the actual tested lung function parameters 
from body plethysmography. 
Results: The mean relative error of the predicted values compared to the lung 
function tests was 9% for FEV1/VC, 10% for RV/TLC and 17% for FEV1. The 
root mean squared error was 9.3 for FEV1/VC, 10.5 for RV/TLC and 16.9 for 
FEV1, respectively. 
Conclusion: Novel neuronal-network based software allows the prediction of 
lung function values from static qCT parameters within a reasonable margin of 
error. Therefore, qCT parameters may contain more information than we 
currently utilise and can potentially augment standard functional lung testing.  
 
 
B-0235 14:16  
Quantitive assessment of lung volume and lung density distribution in 
lung transplant patients: progression pattern in chronic lung allograft 
dysfunction  
S. Dettmer1, H. Suhling1, T. Kaireit1, J.-M. Kuhnigk2, J. Gottlieb1, 
J. Vogel-Claussen1, F. Wacker1, H.-o. Shin1; 1Hannover/DE, 2Bremen/DE 
(dettmer.sabine@mh-hannover.de)  
Purpose: To evaluate lung volume and density distribution as quantitative CT 
parameters for progression of chronic lung allograft dysfunction (CLAD) 
following lung transplantation. 
Methods and Materials: 120 lung transplant patients with 327 CT (baseline 6 
months after transplantation and during follow up) were evaluated. Following 
calculation of lung volume and density histogram features (mean lung density, 
peak, full-width-at-half-maximum, percentiles) skewness und kurtosis were 
calculated. Longitudinal analysis was performed using the difference of 
measurements between baseline and follow-up examinations. Patients with 
and without CLAD (matched 1:3) were compared with independent t-test. 
Three different time points in regard to CLAD diagnosis were evaluated: the 
last examination (<1year) before CLAD onset, the first examination after CLAD 
onset (<1year), and the first examination with severe CLAD / BOS stage 3. 
Results: Of these 120 lung transplant patients 16 patients developed CLAD 
during the follow-up period. Measurements were significantly different between 
patients with and without CLAD and increase with disease progression. Major 
differences are the expiratory and inspiratory lung volume (p<0.001-p=0.014), 
the ratio of expiratory and inspiratory lung density (p=0.001-p=0.236) and the 
percentiles on expiration (p<0.001-p0.36). Measurements reveal a progressive 
hyperinflation of the lung and a reduced respiratory dynamic. 
Conclusion: Longitudinal changes of lung volume and density distribution 
measured on CT were significantly different between patients with and without 
CLAD and reveal a progressive hyperinflation of the lung which begins in the 
lower lobes and expands to the whole lung with disease progression.  
B-0236 14:24  
Quantitative CT and machine learning methods can predict eventual 
development of bronchiolitis obliterans syndrome after lung 
transplantation  
E.J.M. Barbosa Jr.1, M. Lanclus2, W. Vos2, C. Van Holsbeke2, W. De Backer3, 
J. De Backer3, J.C. Lee1; 1Philadelphia, PA/US, 2Kontich/BE, 3Antwerp/BE 
(eduardo.mortani@gmail.com)  
Purpose: Long term survival after lung transplantation (LTx) is limited by 
bronchiolitis obliterans syndrome (BOS), defined as sustained decline in FEV1 
not explained by other causes. Machine learning (Support Vector Machine - 
SVM) applied to baseline quantitative CT metrics (qCT) and pulmonary 
function testing (PFT) was used to predict eventual development of BOS. 
Methods and Materials: Paired inspiratory-expiratory CT scans of 41 patients 
who underwent LTx were analysed retrospectively. All were disease free at 
initial CT; 15 patients developed BOS at follow up, whereas 26 patients 
remained BOS free (BOS was defined as sustained reduction in FEV1>10% 
compared to baseline FEV1 after LTx). SVM was applied to baseline qCT 
features and PFT, to predict LTx patients’ probability of eventual development 
of BOS. 
Results: A total of 23 baseline FRI parameters could significantly distinguish 
between non-BOS patients and eventual BOS developers (p < 0.05), whereas 
no PFT parameters could. Using machine learning methods (SVM), LTx 
patients with smaller lung volumes (p<0.001), smaller airway volumes (p=0.01) 
and surface (p=0.04) and higher airway resistance (p=0.03) had greater 
probability of developing BOS. A combination of lobar resistance, surface area 
of the central airways and regional lobar volumes could predict BOS 
development with an accuracy of 85%. 
Conclusion: Baseline qCT biomarkers may allow, via machine learning 
methods, accurate prediction of eventual onset of BOS from baseline qCT 
features, whereas baseline PFT metrics cannot. This may optimise the 
management paradigm of LTx patients.  
B-0237 14:32  
Temporal subtraction of serial-computed tomography images for 
visualisation and quantification of disease progression in idiopathic 
pulmonary fibrosis  
H.-O. Shin, M. Minkler, L. Jaeger, C. Caliskan, S. Dettmer, J. Vogel-Claussen, 
F. Wacker, A. Prasse; Hannover/DE (shin.hoen-oh@mh-hannover.de)  
Purpose: To evaluate temporal subtraction (TS) as an imaging biomarker for 
monitoring disease in idiopathic pulmonary fibrosis (IPF). 
Methods and Materials: In 54 paired volumetric computed tomography scans 
(CT) of 27 patients with IPF, a semi-automatic lobe-based segmentation and a 
non-linear registration were performed warping the follow-up CT scan to the 
baseline CT scan. A TS image was calculated by subtracting the baseline CT 
from the warped follow-up CT. A colour look-up table was used for visualisation 
  






of the TS image showing areas of decreased/increased density in shades of 
blue and red, respectively. CT-quantification was performed calculating the 
percentage volume change (PVC) of areas with decreased/increased density 
using a threshold of ± 150 HU in the TS images together with density 
histogram measures (changes in skewness and kurtosis). CT measurements 
were correlated with changes in pulmonary function test (PFT): FVC%, 
FEV1%, and KCO. 
Results: In TS images, even subtle changes in parenchymal patterns could be 
visualised. Considering the complementary nature of CT features and PFT, a 
good correlation was found between PVC (increased/decreased/ total density 
change) and KCO (-0.36/-0.56 /-0.5, p<0.1 ). No significant correlation was 
found for FVC% and FEV1% . Density histogram features (skewness / kurtosis) 
showed no significant correlation with PFT for KCO, FEV1% and FVC%. 
Conclusion: TS facilitates visual assessment of longitudinal CT scans 
displaying morphological changes in the colour-coded TS image. PVC may 
allow for objective quantification of regional morphological changes in IPF 
patients.  
B-0238 14:40  
Subtraction CT of the lungs: accuracy of motion correction software  
D. Grob1, L.J. Oostveen1, J. Rühaak2, S. Heldmann2, B. Mohr3, M.M. Prokop1, 
M. Brink1, I. Sechopoulos1; 1Nijmegen/NL, 2Lübeck/DE, 3Edinburgh/UK 
(Dagmar.Grob@radboudumc.nl)  
Purpose: To compare the performance in registration between pre- and post-
contrast computed tomography (CT) chest images of two algorithms using an 
anthropomorphic digital phantom to evaluate the potential accuracy of temporal 
subtraction to generate pulmonary iodine maps. 
Methods and Materials: We used a recent version of the XCAT phantom, with 
enhanced airway and pulmonary vessel structures, to simulate pre- and post-
contrast CT images (voxel size: 0.6x0.6x1.0 mm3) at different inspiration levels 
with realistic system noise. We varied the difference in diaphragm position 
between the two scans from 0 to 20 mm because this value exceeded the 95th 
percentile found in 100 clinical subtraction CT datasets. Registration was 
performed using two different lung algorithms (SURE Subtraction Lung, 
Toshiba Medical Systems and NLR, Fraunhofer MEVIS). For each registration, 
we calculated the voxel-by-voxel difference between the true deformation and 
the algorithm-estimated deformation. 
Results: Between respiratory phases, the median displacement in the 
phantom was 5.2mm (interquartile range: 2.3mm - 11.6mm). At 20 mm 
difference in diaphragm position, the median residual error in registration was 
0.93mm (0.52mm - 1.58mm) with SURE Subtraction Lung, and 0.97mm (0.50 
mm - 1.84 mm) with the NLR algorithm. The largest errors were seen in the 
paracardiac regions. 
Conclusion: Both tested registration algorithms can compensate for 
respiratory motion with a median residual error below 1 mm. This level of 
accuracy opens up new applications such as direct detection of emboli in 
segmental arteries or evaluation of pulmonary nodule enhancement.  
Author Disclosures: 
  D. Grob: Research/Grant Support; Toshiba medical systems. L.J. Oostveen: 
Research/Grant Support; Toshiba Medical Systems.  S. Heldmann: Employee; 
Fraunhofer-Gesellschaft zur Förderung. B. Mohr: Employee; Toshiba Medical 
Visualization Systems. M.M. Prokop: Research/Grant Support; Toshiba 
Medical Systems. Speaker; Bracco, Bayer, Toshiba Medical Systems. Other; 
Thirona (Spinoff), Veolity. M. Brink: Research/Grant Support; Toshiba Medical 
Systems. I. Sechopoulos: Research/Grant Support; Toshiba Medical systems, 
Siemens. Speaker; Siemens. 
B-0239 14:48  
Quantitative CT assessment in patients with desquamative interstitial 
pneumonia: correlations with pulmonary function parameters  
S. Hong, S. Lee, N. Kim, S. Lee, J. Seo; Seoul/KR 
(sanghyeop.hong@gmail.com)  
Purpose: To evaluate the correlations between quantitative CT parameters 
and pulmonary function parameters in patients with desquamative interstitial 
pneumonia (DIP). 
Methods and Materials: From April 2002 to April 2014, 40 patients with DIP 
were included in our study (39 men and 1 woman; mean age 58.5 years). For 
quantitative assessment on CT, a texture-based in-house software was used to 
quantify six regional CT patterns: normal, ground-glass opacity (GGO), 
reticular opacity (RO), honeycombing, emphysema, and consolidation. The 
total abnormal opacity was defined as the sum of extents of GGO, 
honeycombing, and emphysema. Correlations between the quantified CT 
parameters and the physiologic parameters were evaluated using the Pearson 
correlation coefficient. 
Results: The mean values of FEV1, FVC, FEV1/FVC ratio, FEF25-75%, and DLco 
were 85.0%, 86.7%, 74.9 %, 79.2%, and 65.6%. The mean 6-minute walking 
distance and lowest SpO2 during the 6-minute walking test were 514.2 m and 
92.7%. The mean extents of GGO, consolidation, emphysema, RO, 
honeycombing, and total abnormal opacity were 14.3%, 3.0%, 3.6%, 8.9%, 
2.6%, and 20.5%. The total abnormal opacity showed significant correlations 
with DLco (r = -0.466; P = 0.002) and SpO2 (r = -0.534; P = 0.001), but no 
correlations with FEV1, FVC, FEV1/FVC ratio, and FEF25-75% (P = 0.391, 0.366, 
0.281, and 0.681, respectively). 
Conclusion: Quantitative assessment of regional disease patterns in DIP 
patients showed significant correlations with DLco and SpO2.  
B-0240 14:56  
Use of quantitative computed tomography to assess post-interventional 
long-term changes after bronchial thermoplasty in patients with severe 
asthma  
P. Konietzke, O. Weinheimer, M. Wielpütz, W. Wagner, P. Heussel, 
C. Heussel, H.-U. Kauczor, F.J. Herth, M. Schuhmann; Heidelberg/DE 
(p.konietzke@gmx.de)  
Purpose: Bronchial thermoplasty (BT) can be considered in the treatment of 
severe asthma. By reducing smooth muscle mass, and thus reducing bronchial 
wall thickening and bronchoconstriction, asthmatic symptoms may be 
controlled. We hypothesized that quantitative computed tomography (QCT) is 
an appropriate tool to measure long-term effects of BT on airway dimensions 
and air-trapping. 
Methods and Materials: 32 paired inspiratory and expiratory CT scans of 16 
patients were acquired before and after BT. The fully automatic YACTA 
software calculated wall thickness (WT), wall percentage (WP), lumen area 
(LA) and total diameter (TD) in a generation-based as well as total lung volume 
(TLV) and air-trapping parameters (E/I, RVC856-950, A1-A3) in a lobe-based 
approach, respectively. 
Results: WT decreased after performing BT significantly by 3.75% (p=0.035) 
with a subsequent significant increase in LA by 5.39% (p=0.046) and a 
decrease of 3.67% in WP (p<0.001) for the combined airways generations 2nd-
7th. TD increased by 0.69% on average (p=0.706). After BT media TLV 
decreased by 68 cm³ (p=0.459), air-trapping had a significant reduction for the 
parameter IE (p=<0.001), RVC856-950 (p=<0.001), and A1-A3 (p=<0.003, 
p=<0.001 and p=<0.001), respectively. 
Conclusion: QCT was able to show long-term post-interventional changes in 
patients treated with BT. Significantly reduced WT and WP with an increase in 
the lumen can be interpreted as direct therapeutic effects caused by a 
reduction in airway-smooth muscle mass and changes in neuronal innervation. 
QCT also showed a significant reduction in air-trapping. QCT parameters may 
be used in therapy guidance and monitoring.  
B-0241 15:04  
Accuracy of emphysema volume and airway measurements according to 
FBP, HIR, MIR, and virtual monoenergetic reconstruction images at both 
low- and standard-dose settings  
M. Ha1, C. Kim1, K.Y. Lee1, C. Shin1, E.-Y. Kang2, Y.-W. Oh2, C. Ko1, J. Cha1; 
1
Ansan/KR, 2Seoul/KR (gkahdls89@gmail.com)  
Purpose: To evaluate the accuracy of emphysema volume (EV) and airway 
measurements (AMs) produced by various iterative reconstruction (IR) and 
virtual monoenergetic images (VME) at both low- and standard-dose settings. 
Methods and Materials: CT images were obtained on phantom at both low 
and standard doses (30mAs vs 100mAs at 120kVp). Each CT scan was 
reconstructed using filtered back-projection (FBP), hybrid IR (iDose4), model-
based IR (IMR-R1, IMR-ST1, IMR-SP1), and VME at 70 keV (VME70). The EV 
of each air column and wall area percentage of each airway tube were 
measured in all algorithms. Absolute percentage measurement errors of EV 
(APEvol) and AM (APEWA%) were then calculated. Repeated measures analysis 
of variance (ANOVA) was performed on repeated measured data. 
Results: EV was most accurately measured in IMR-R1, and AM was the most 
accurate in IMR-SP1 on both low- and standard-dose CT (all P<0.05). There 
were no significant differences in the APEvol of IMR-R1 between low and 
standard doses (all P>0.05). VME70 showed a significantly higher APEvol than 
iDose4, IMR-R1, and IMR-ST1 (all P<0.004). VME70 also showed a 
significantly higher APEWA% compared with the other algorithms (all P<0.001). 
Conclusion: The measurement of EV and AM via application of IMR on both 
low- and standard-dose CT showed reliable accuracy in a phantom study. 
However, VME did not result in any improvement of measurement accuracy. 
Among these algorithms, IMR was the most accurate modality for 
measurement of both emphysema volume and airway wall thickness.  
B-0242 15:12  
Qualitative and quantitative comparison of lung nodules in an ex-vivo 
system on a high-pitch dual source CT and a standard CT in free 
breathing  
C.A. Burgard; Munich/DE (caroline.burgard@med.uni-muenchen.de)  
Purpose: To analyse the image quality of lung nodules using two different CT 
protocols (high pitch dualsource or standard CT) in free breathing and in full 
inspiration and expiration stimulating a non-compliant patient. 
  






Methods and Materials: Three porcine lungs were prepared with 28 artificial 
nodules (mean diameter 10.4 mm) and subsequently placed into a dedicated 
CT compatible chest phantom (PROdesign artiCHEST). Images were obtained 
in static full inspiration and expiration breath hold, and as well as in free 
breathing, with two different CT protocols. Quantitative analysis was carried out 
with a semiautomatic volumetric program (LungCARE, Syngo.via, Siemens, 
Erlangen, Germany). The reproducibility of nodule volumetry was calculated. 
Motion artifacts were semi quantitatively assessed by two readers (from 0 or 
absent to 3 or relevant and non-diagnostic). 
Results: In the qualitative analysis, the artefacts in the examinations 
performed with standard CT intensified with increasing number of respiratory 
acts per minute, whereas they were negligible in the highpitch dualsource CT 
examinations. These differences were statistically significant (P <0.005). In 
quantitative analysis, the relative differences (∆ between the value of the 
volume calculated with standard and high pitch minus the inspiration value 
divided by the inspiration value) in the volumetric volume measured in standard 
CT were statistically significant in the 9, 15 and 18 breaths per minute scans. 
Conclusion: While a standard CT examination for nodule volumetry relies on a 
steady breath-hold of the subject, the presented study demonstrated the 
feasibility of a high-pitch, dualsource CT acquisition in free breathing i.e in non-
compliant patients.  
B-0243 15:20  
Quantitative CT as a one-stop shop to describe status and outcome of 
patients with acute respiratory distress syndrome (ARDS)  
P. Leiser, J. Schoettler, F.S. Centner, T. Kirschning, J. Krebs, M. Hagmann, 
C. Weiß, S.O. Schönberg, H. Haubenreisser; Mannheim/DE 
(p.leiser@stud.uni-heidelberg.de)  
Purpose: The aim of this study was to establish quantitative CT (qCT) 
parameters for pathophysiological understanding and clinical use in patients 
with ARDS. The most promising parameter is introduced. 
Methods and Materials: 28 intubated patients with ARDS obtained a 
conventional and dual-energy CT scan in end expiratory breathhold. Following 
manual segmentation, 138 volume-, perfusion- and lung weight-related qCT 
parameters were correlated with 71 anaesthesiological parameters such as 
applied ventilation pressures (PEEP, Pdrive) and established status and 
prognosis scores (SOFA, SAPS II). Multiple regression analysis was then 
performed to enable the prediction of these scores by a single CT scan. 
Results: Of all examined qCT parameters, excess lung weight (ELW) 
displayed the most significant results. ELW correlates positively with the 
amount of extravascular lung water (r=0.72), atelectatic lung volume (r=0.92), 
applied PEEP (r=0.37) and negatively with the lung’s mean CM enhancement 
(r=-0.65; all p<0.05). More significantly than any other anaesthesiological 
parameter it correlates with the patient’s SOFA- (p<0.0001, r=0.69) and SAPS 
II-Score (p=0.0005, r=0.62). A combination of ELW, mean CM and Pdrive can 
predict SOFA up to r2=87.95%. 
Conclusion: ELW constitutes the best parameter to assess pathophysiology, 
status and outcome of patients with ARDS and should be considered a first-
range diagnostic tool during the first hours of ICU treatment, providing better 
correlation to relevant clinical parameters than the current standard Horovitz 
index (PaO2/FiO2).  
14:00 - 15:30 Room N  
Genitourinary  
SS 307  
Prostate cancer diagnosis  
Moderators:  
A. Guerra; Lisbon/PT 
N.N. 
B-0244 14:00  
Analysis of clinical and economic management optimisation of 
multiparametric-MRI as the first line tool in men with high clinical 
suspicion of prostate cancer  
M. Pecoraro1, A. Padhani2, R. Campa1, M.C. Valerio1, C. Catalano1, 
V. Panebianco1; 1Rome/IT, 2Middlesex/UK (pecoraro.martina1@gmail.com)  
Purpose: Determine diagnostic and treatment costs, and effectiveness of the 
pathways incorporating multiparametric MRI biopsy (mp-MRI/Bx), compared 
with transrectal ultrasound-guided biopsy (TRUS/Bx), in men at high risk of 
prostate cancer (PCa). 
Methods and Materials: A cost and time analysis, based on data from a 
published randomized, single centre study. 1140 patients with total PSA > 4 
ng/mL divided in 2 groups: 570 patients underwent a TRUS/Bx, while 570 
patients underwent a mp-MRI/Bx. 
Results: Mp-MRI/Bx diagnosis costs were 14.6% greater than TRUS strategy 
(228,946 € vs 199,750 €), and 5.2-6.0% higher for therapy (1,912,000 € vs 
1,802,800 €). Mp-MRI/Bx strategy was highly effective for excluding clinically 
significant disease (Gleason 7); sensitivity and NPV both 100% (95% CI 98-
100%). If verification of negative mp-MRI was not undertaken, differential 
cumulative therapy costs for mp-MRI/Bx strategy remained higher (8.4%), 
despite potential savings in active surveillance costs, because of increased 
radical therapies (mp-MRI/Bx =409; TRUS/Bx = 373). Time-to-diagnosis was 
shorter for the mp-MRI/Bx strategy (median 4.0 months (IQR 3-6); TRUS/Bx 
(median 6 months (IQR 4-12): p < 0.001). 
Conclusion: Our analyses suggest mp-MRI/Bx strategy is effective for 
diagnosing patients with suspected PCa, providing faster and more accurate 
diagnoses.  
B-0245 14:08  
Impact of upfront risk stratification on the negative predictive value of 
multiparametric MRI in patients with no history of prostate cancer  
M. Abihanna1, C. Melodelima2, P.-C. Moldovan1, R. Souchon1, A. Ruffion3, 
M. Colombel1, S. Crouzet1, O. Rouviere1; 1Lyon/FR, 2Grenoble/FR, 
3
Pierre Benite/FR (m_abihanna@hotmail.fr)  
Purpose: To assess the impact of upfront risk stratification on the negative 
predictive value (NVP) of multiparametric MRI (mpMRI) with patients without 
history of prostate cancer. 
Methods and Materials: We retrospectively analysed a prospective database 
of 646 patients (456 biopsy naïve, 189 referred for repeat biopsy) who 
underwent mpMRI before biopsy. The prediction of clinically significant 
prostate cancer (csPCa) at biopsy by clinical (age, digital rectal examination, 
PSA density [PSAd], history of prior negative biopsy) and imaging (Likert 
score, extracapsular extension [ECE], magnetic field strength, experience of 
radiologist and presence of a concordant hypoechoic lesion [Concord-Echo]) 
variables was assessed by multivariate analysis. Significant clinical variables 
were included in a ‘clinical model’. Three definitions for csPCa were used 
(csPCa1: USIP grade group 3; csPCa2: USIP grade group 2; csPCa3: 
csPCa2 and USIP grade group 1 with cancer invasion length 5 mm). 
Results: Age, PSAd, history of prior negative biopsy, Likert score, ECE and 
Concord-Echo significantly predicted the presence of csPCa1-3. Adding the 
Likert score to the clinical models significantly increased the models’ 
performance. Omitting biopsy in patients with negative mpMRI would have 
avoided 28.9% (Likert 3/5) or 45.7% (Likert 4/5) of biopsies while missing 
9.2-11.5% of csPCa1, 11.9-18.5% of csPCa2 and 19.5-28% of csPCa3. 
mpMRI NPV decreased when the csPCa probability given by the clinical 
models increased. Therefore, considering clinical models’ output allowed 
defining scenarios missing <5% of csPCa and omitting biopsies in 24.1-39.8% 
(csPCa1), 20.4-26.2% (csPCa2), and 10.2-12.8% (csPCa3) patients. 
Conclusion: Upfront risk stratification of patients allows rational use of mpMRI 
NPV.  
B-0246 14:16  
Diagnostic performance of biparametric MR imaging for detection of 
prostate cancer: a systematic review and meta-analysis  
X. Niu; Chengdu/CN (niu19850519@163.com)  
Purpose: To perform a systematic review and meta-analysis to estimate the 
diagnostic performance of biparametric MR imaging (bp-MRI) for the detection 
of prostate cancer (PCa). 
Methods and Materials: Two independent reviewers performed a systematic 
review of the literature published as of June 1, 2017, using predefined search 
terms. The standard of pathological reference was established at 
prostatectomy or prostate biopsy. The number of true- and false-positive, true- 
and false-negative results were extracted. The quality assessment of 
diagnostic accuracy studies tool was used to assess the quality of the selected 
studies. Statistical analysis included pooling of diagnostic accuracy, meta-
regression, subgroup analysis, head-to-head comparison and identification of 
publication bias. 
Results: Thirty-three studies were used for general data pooling. Overall 
sensitivity was 81% (95% confidence interval [CI]: 76%, 85%), and overall 
specificity was 77% (95% CI: 69%, 84%). As for clinically relevant prostate 
cancer (cr-PCa), multiparametric MRI (mp-MRI) maintained high diagnostic 
value [AUC=0.85 (95% CI: 0.82, 0.88)]. There was no evidence of publication 
bias (P=0.673). From head to head comparison, mp-MRI demonstrated 
significantly higher pooled sensitivity of 0.85 (95% CI: 0.78, 0.93) compared 
with 0.80 (95% CI: 0.71, 0.90) for bp-MRI (P=0.01). However, the pooled 
specificity was not significantly different [0.77 (95%CI: 0.58, 0.95) vs 0.80 
(95%CI: 0.64, 0.96), respectively; P = 0.82]. 
Conclusion: Results of this meta-analysis suggest that bp-MRI has high 
diagnostic accuracy in detection of PCa, and maintained high detection rate for 
crPCa. However, owing to high heterogeneity among the included studies, 
caution is needed in applying our results.  
  






B-0247 14:24  
Diffusion-weighted MRI in prostatic lesions: diagnostic performance of 
normalised ADC using normal peripheral prostatic zone as a reference  
T.F.T. Ali; Zagazig/EG (tamerfathi2008@yahoo.com)  
Purpose: To evaluate the potential value of using the normal peripheral 
prostatic zone (PZ) as a reference site to improve the performance of DWI in 
the evaluation of prostatic lesions. 
Methods and Materials: 38 patients with clinical suspicion of cancer prostate 
and who are scheduled to undergo a TRUS-guided biopsy were subjected to 
DW-MRI with ADC calculation. The normalised ADC (nADC) value was 
calculated by dividing the ADC of lesion by ADC of reference site (healthy 
peripheral zone). DWI-MRI results were compared to that of biopsy. Data were 
analysed and ROC was used to evaluate the performance of ADCs and 
nADCs. 
Results: The patients were classified histopathologically into non-malignant 
group (16 patients) and malignant group (22 patients). Significant negative 
correlation between each of ADC and nADC and malignancy was detected. 
There was no significant difference between the mean ADC of peripheral 
healthy PZ in benign and malignant cases. There was significant difference 
between the mean ADC and mean nADC in benign and malignant lesions 
(1.049±0.217 versus 0.659±0.221x10-3mm2/sec, p<0.001) and (0.475±0.055 
versus 0.328±0.044, p<0.001), respectively. There was a significant higher 
diagnostic performance of nADC than ADC with ADC cut-off value 0.75×10-
3mm2/sec and nADC cut-off value 0.39 could significantly differentiate between 
benign and malignant lesion with sensitivity, specificity, PPV, NPV of 86.36, 75, 
82.61 and 80%, respectively, p<0.0001 for ADC and 95.45, 93.75, 95.45 and 
93.75%, p<0.0001 for nADC. 
Conclusion: The diagnostic performance of nADC using normal peripheral 
zone is higher than ADC in the discrimination between cancerous and non-
cancerous lesions of the prostate.  
B-0248 14:32  
Dynamic contrast-enhanced MRI (DCE) for prostate cancer detection: are 
qualitative and quantitative analyses the key to success?  
F. Ziayee, T. Ullrich, R. Rabenalt, P. Albers, G. Antoch, L. Schimmöller; 
Düsseldorf/DE (farid.ziayee@med.uni-duesseldorf.de)  
Purpose: DCE remains an integral part of the multi-parametric MRI of the 
prostate. The aim of this study was to evaluate the importance of qualitative 
and quantitative analyses of dynamic contrast-enhanced MRI (DCE) with 
regard to prostate cancer (PCa) detection. 
Methods and Materials: DCE data of 103 consecutive patients with multi-
parametric MRI (T2WI, DWI, DCE) and subsequent MRI-(in-bore)-biopsy of the 
prostate were retrospectively analysed. Qualitative (curve type, PI-RADS v2) 
and quantitative (Ktrans, Kep) analyses of in total 206 lesions (87 cancer positive 
and 119 benign lesions) were performed. Cancer detection, discrimination of 
significant cancer, and localization was assessed and compared to 
histopathologic findings. 
Results: Regarding discrimination between PCa and benign lesions, 
differences between Ktrans, Kep, and curve types were not statistically significant 
(p=0.2-0.9). Subdivided in peripheral zone (PZ) and transition zone (TZ) Ktrans 
(p<0.01; p=0.04) and Kep (p=0.04, p<0.01) were significantly different between 
PCa and benign lesions. The PI-RADS v2 overall score could discriminate PCa 
and benign lesions in both, PZ and TZ (p<0.01), whereas PI-RADS single 
scores of DCE could differentiate PCa better in PZ (p<0.01) than in TZ (p=0.5). 
All perfusion parameters could not differentiate between insignificant and 
significant (4+3=7b) prostate cancer (p=0.5-0.8).  
Conclusion: PI-RADS v2 criteria for DCE discriminate well between benign 
lesions and PCa in the peripheral zone. Qualitative (curve type) and 
quantitative parameters (Ktrans, Kep) provide no additional improvement in PCa 
detection compared to PI-RADS scoring alone. DCE-MRI alone did not allow 
differentiation between significant and insignificant PCa.  
B-0249 14:40  
Prostate tumour volume analysis on MRI as a predictor for aggressive 
disease  
N.M. Hughes, C. O'Neill, F.M. O'Brein, N. Mayer, P. Kelly, J.G. Buckley, 
K. O'Regan; Cork/IE (nicolahughes@rcsi.ie)  
Purpose: Patients with high Gleason grade (GG) prostate cancer have been 
shown to have radiological indicators of increased tumour aggressiveness on 
MRI. The aim of this study was to evaluate tumour volume on MRI as a 
potential predictor of aggressive disease by correlating with Gleason grade. 
Methods and Materials: We performed a retrospective review of prostate MRI 
in patients with HG-PCa (GG8-10) over a three year period. An age-matched 
and PSA-matched number of patients with GG7 Pca (GG 3+4 and 4+3) was 
also reviewed. Volumetric tumour analysis was performed on T2-weighted 
(T2W) sequences and on diffusion-weighted MRI using Osirix® software. 
Results: Seventy-five (n=38 GG7, n=17 GG8, n=17 GG9, n=3 GG10) MR 
studies were included in total. Average tumour volume for GG 7 disease was 
1.96 cc on T2W sequences (range: 0.14-21.0159 cc) and 1.81 cc on ADC 
maps (range: 0.0763-17.1745 cc). HG-PCa (GG 8 and above) had an average 
tumour volume of 6.95 cc (3.29 cc GG8, 9.31 cc GG9, 14.39 cc GG10) on T2W 
sequences (range: 0.0891-54.3883) and 7.83 cc (3.27 cc GG8, 11.04 cc GG9, 
15.47 cc GG10) on diffusion MRI (range: 0.0778-72.7619). There was a 
positive correlation between tumour volume and GG using both T2W 
sequences (p<0.001) and ADC maps (p<0.001). 
Conclusion: This study has shown a positive correlation between tumour 
volume and Gleason grade. Volumetric analysis of prostate cancer on MRI 
may have a role in predicting more aggressive disease.  
B-0250 14:48  
Prostate volume estimation at MRI: reproducibility and limits  
M. Bonatti1, F. Lombardo1, M. Simioni2, G. Avesani1, G. Bonatti1; 1Bolzano/IT, 
2
Verona/IT (matteobonatti@hotmail.com)  
Purpose: To evaluate reproducibility of prostate volume estimated with the 
ellipsoid formula and to show its correlation with PSA density risk class. 
Methods and Materials: We included in our IRB-approved retrospective study 
60 consecutive patients who underwent prostate MRI for the detection of 
cancer at our Institution between July and September 2017. Two readers 
independently estimated prostate volume by means of the ellipsoid formula 
using axial and sagittal T2-weighted images. A third reader measured prostate 
volume by means of manual segmentation on axial T2-weighted images using 
commercially available software (iTK-SNAP). PSA density was calculated for 
each patient according both to the measured and estimated prostate volumes. 
Data were compared using paired t-test. 
Results: Mean prostate volume calculated with manual segmentation was 
54+-20 cc. Mean prostate volume estimated with ellipsoid formula was 50+-19 
cc for reader 1 and 52+-20 cc for reader 2. Prostate volume estimated with the 
ellipsoid formula was significantly different between the two readers (p=0.015). 
Prostate volume estimated with the ellipsoid formula was significantly different 
from prostate volume calculated with segmentation for reader 1 (p=0.0016) and 
not significantly different for reader 2 (p=n.s.); the mean volume difference was 
14% for reader 1 and 13% for reader 2. For both readers, 5/60 (8.3%) patients 
would have changed their PSA density risk class (<or0.15) when comparing 
data obtained from estimation with those obtained from measurement. 
Conclusion: Prostate volume estimated with the ellipsoid formula shows poor 
reproducibility and might lead to errors in PSA density evaluation.  
B-0251 14:56  
Prevalence and significance of incidental extraprostatic findings in 
patients undergoing magnetic resonance imaging of the prostate for 
detection of prostate cancer  
F.M. Schäfer, P. Asbach, M. Haas, B. Hamm, A. Baur; Berlin/DE 
(Frederik.Schaefer@charite.de)  
Purpose: Multiparametric magnetic resonance imaging (mpMRI) of the 
prostate can detect prostate cancer with high accuracy. Imaging depicts a wide 
array of pelvic and abdominal tissues in addition to the prostate. In this study 
we evaluated the prevalence as well as the clinical significance of incidental 
extraprostatic findings that can be detected on mpMRI. 
Methods and Materials: We retrospectively identified 300 patients (median 
age, 64 years; range, 46-76 years) who had undergone mpMRI of the prostate 
at 3 Tesla as a first-line test before prostate biopsy between October 2016 and 
August 2017 using a standardized examination protocol in accordance with the 
current Prostate Imaging - Reporting and Data System recommendations. One 
experienced reader blinded to clinical data analyzed imaging with a focus on 
incidental extraprostatic findings. Findings that necessitated further work-up 
were rated as clinically significant. 
Results: Of all extraprostatic findings diverticulosis (n=103; 34.3%) and 
inguinal herniation of fat (n=85; 28.3%) were most common. In 13 patients 
(4.3%) extraprostatic findings were rated as clinically significant including 
suspicion for a neoplasm of the bladder (n=1), neoplasms of the sigmoid and 
rectum (n=3), femoral head necrosis (n=1), chronic diverticulitis of the sigmoid 
(n=5), and subacute inflammation of an aortic aneurysm (n=1). 
Conclusion: Whilst incidental extraprostatic findings were commonly detected 
on mpMRI, findings rated as clinically significant were only found in a small 
number of patients. However, awareness of these findings as well as their 
correct description in imaging reports is important in order to initiate further 
work-up.  
Author Disclosures: 
 B. Hamm: Research/Grant Support; Siemens AG, Bayer AG. Shareholder; 











B-0252 15:04  
Mp-MRI of the prostate: anti-peristaltic hyoscine butylbromide 
significantly decreases motion artefacts and allows better delineation of 
anatomic structures  
T. Ullrich, L. Schimmöller, M. Quentin, K.A. Schmaltz, C. Rubbert, C. Arsov, 
R. Rabenalt, P. Albers, G. Antoch; Düsseldorf/DE 
(Tim.Ullrich@med.uni-duesseldorf.de)  
Purpose: To prospectively evaluate the effect of hyoscine butylbromide (HBB) 
on visualisation of anatomical details and motion-related artefacts in mp-MRI of 
the prostate at 3.0 Tesla. 
Methods and Materials: One hundred and three consecutive patients 
(65±10years) received high-spatial resolution axial T2-weighted TSE 
sequences at 3.0T without a spasmolytic agent, repeated after application of 
40mg HBB and followed by routine mp-MRI. Secondary endpoints were (1) 
susceptibility to side effects assessed on 5-point Likert scales by two blinded 
readers, (2) dependence of spasmolytic effect on patients' weight, and (3) 
prostate volume. 
Results: In 68% of the patients, HBB significantly improved the anatomic 
score (mean 3.4±0.9 before and 4.4±0.7 after HBB for both readers, 
p=<0.001). In 67% HBB significantly enhanced the artefact score (mean 3.2±1 
before and 4.2±0.8 after HBB for reader 1, p=<0.001; 3.2±1 and 4.1±0.8 for 
reader 2, p=<0.001). Subgroup analyses revealed no statistically significant 
difference between patients with different bodyweight or prostate volume. Inter-
reader agreement was excellent (k=0.95-0.98). 
Conclusion: Administration of anti-peristaltic medication (hyoscine 
butylbromide) significantly improved image quality and relevantly reduced 
motion-related artefacts in mp-MRI of the prostate in over 2/3 of the patients. 
The anti-spasmolytic effect is independent of body weight and prostate volume. 
No side effects of HBB were reported.  
B-0253 15:12  
Texture analysis of prostate MRI: utility for differentiating patients 
combined intraductal carcinoma of the prostate from prostate 
adenocarcinoma  
L. Chu, R. Liu; Chengdu/CN (710341139@qq.com)  
Purpose: To investigate texture analysis of prostate MRI for cancer 
differentiation between patients combined intraductal carcinoma of the prostate 
(IDC-P) and prostate adenocarcinoma. 
Methods and Materials: 3.0T multi-parametric MRI was performed on 41 
significant prostate cancer patients prior to prostatectomy. Twenty-one patients 
had prostate adenocarcinoma and twenty patients combined intraductal 
carcinoma of the prostate. Histogram-based parameters and textural features 
were extracted from the region of interests delineated around tumor outline on 
T2 and the T1-TSE DCE sequence based on pathological information and 
diffusion weighted imaging(DWI). The resulting data were processed with 
Mann-Whitney U test and binary logistic regression models. Diagnostic 
accuracy was assessed by area under the receiver operating characteristic 
curves (ROC-AUC). 
Results: Texture features have no significant difference on T2WI between two 
groups. IDC-P showed lower Skewness(p=0.016) with ROC-AUC 0.724, 
Cluster Shade(p=0.013) with ROC-AUC 0.732 and higher 
HaraEntroy(p=0.015) with ROC-AUC 0.726 compared to prostate 
adenocarcinoma. Combining Cluster Shade and HaraEntroy yielded ROC-AUC 
0.803. 
Conclusion: Several texture features on DCE series appear useful for 
differentiating intraductal carcinoma of the prostate from prostate carcinoma 
and GS assessment. The role of DCE in prostate MRI diagnosis may be 
underestimated for various DCE features in distinct pathology types of prostate 
cancer.  
B-0254 15:20  
Cell cycle progression genomics and MRI features of prostate cancer: 
radiogenomic correlation and prognostic synergism  
A.G. Wibmer1, N.L. Robertson1, B. Ehdaie1, S. Stone2, M. Brawer3, H. Hricak1, 
H. Vargas1; 1New York, NY/US, 2Salt Lake City, UT/US, 3Irvine, CA/US 
(wibmera@mskcc.org)  
Purpose: To explore correlations of the Prolaris© genetic test with magnetic 
resonance imaging (MRI) features of prostate cancer; and to assess both tests’ 
capabilities to predict adverse features on prostatectomy histopathology. 
Methods and Materials: 122 patients undergoing prostate biopsy, Prolaris© 
test, and MRI from 08/2013-11/2015 were included. The Prolaris© test 
encompasses 46 genes associated with cell cycle progression (CCP). MRI 
features included PI-RADSv2 scores, extracapsular extension (ECE), and 
quantitative metrics (i.e. tumour length, volume, apparent diffusion coefficient). 
In a sub-group analysis of 42 patients (34.4%) undergoing prostatectomy, 
results of both tests were correlated with adverse histopathologic features, i.e. 
Gleason Group 3, ECE, and lymph node metastases. 
Results: According to the American Urologic Association guidelines, 54 
(44.3%) were ‘low risk’, 64 (52.5%) ‘intermediate risk’, and 4 (3.3%) ‘high risk’ 
patients. Tumour volume (p=0.032) and ECE (p= 0.015) on MRI were 
associated with higher CCP scores, while PI-RADSv2 scores were not. In the 
subgroup analysis, ECE on MRI (p=0.009) and Prolaris© CCP scores 
(p=0.017) were independently associated with Gleason group 3 on surgical 
specimen. ECE on MRI was the only independent predictor of histopathologic 
ECE (p=0.003) and nodal metastases (p=0.025). 
Conclusion: We found a radiogenomic association of cell cycle progression 
genes with tumour volume and ECE on MRI. Gene expression levels and ECE 
on MRI were independent predictors of adverse histopathologic tumour 
features. Both tests may therefore provide synergistic prognostic information.  
Author Disclosures: 
 S. Stone: Employee; Myriad Genetics, Inc. M. Brawer: Employee; 
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B-0255 14:00  
The diagnostic value of ultrasonography in assessing 
temporomandibular joint disc position  
D. Talmaceanu1, L.M. Lenghel1, G. Baciut1, M. Baciut1, H. Rotar1, N. Bolog2, 
S. Buduru1, L. Daniel1, S. Dudea1; 1Cluj-Napoca/RO, 2Munchenstein/CH 
(manu_2416@yahoo.com)  
Purpose: The purpose of this study was to assess the diagnostic value of 
high-resolution ultrasound (US) in temporomandibular joint (TMJ) disc 
displacements, compared to magnetic resonance imaging (MRI). 
Methods and Materials: 74 patients (with 148 TMJs) with signs and 
symptoms of TMJ disorders were included in this study. All patients underwent 
US and MRI of both TMJs 1 to 5 days after the clinical exam. MRI 
examinations were performed using 1.5 T equipment. Ultrasonographic 
examination was performed using a high-resolution (13 MHz) linear transducer. 
The diagnostic characteristics of the tests (sensitivity, specificity, positive and 
negative predictive values, accuracy and Youden Index) were computed along 
with 95% confidence intervals. 
Results: MRI depicted 68 (45.95%) normal joints, 47 (31.76%) with disc 
displacement with reduction, 33 (22.3%) with disc displacement without 
reduction and 34 (22.97%) with degenerative changes. US detected 78 
(52.7%) normal joints, 37 (25%) with disc displacement with reduction, 33 
(22.3%) with disc displacement without reduction and 21 (14.19%) with 
degenerative changes. Compared to MRI, US showed a sensitivity of 93.1%, 
specificity of 87.88%, accuracy of 90.32%, a positive predictive value of 87.1% 
and a negative predictive value of 93.55% for overall diagnosis of disc 
displacement. The Youden Index was 0.81. 
Conclusion: Based on the results of the study, high-resolution 
ultrasonography showed high sensitivity, specificity and accuracy in the 
diagnosis of TMJ disc displacement, being a valuable imaging technique in 
assessing TMJ disc position.  
B-0256 14:08  
Is condyle morphology a factor for anterior temporomandibular disc 
displacement?  
I. Camlidag, A.T. Sayıt, M. Elmali; Samsun/TR (ilkayozaydin@hotmail.com)  
Purpose: To investigate morphological features of the mandibular condyle and 
its association with anterior temporomandibular disk displacement. 
Methods and Materials: 133 patients who underwent temporomandibular MRI 
examination with presumed diagnosis of temporomandibular dysfunction 
between January 2015 and December 2016 were retrospectively involved. 
Patients with marked osteoarthritis, posterior disk dislocation, tumour, abscess 
and motion artefacts that would hamper evaluation were excluded. Three 
radiologists evaluated all MR images in consensus. Temporomandibular disc 
locations were classified as normal, anteriorly displaced with reduction (ADr) 
and anteriorly displaced without reduction (ADwr). Condylar shapes were 
classified as flat, rounded and angled on sagittal oblique images. Condyle 
anteroposterior width (c-APW) was measured on sagittal oblique T1-weighted 
images in closed-mouth positions. 
Results: 106 discs were in normal position, 80 discs were ADr, 80 discs were 
ADwr. 93 discs were flat, 109 were rounded and 64 were angled. Mean cAPW 
  






was 6.9 mm in normal cases, 5.9 mm in ADr and 5.8 mm in ADwr patients. c-
APW were significantly smaller than normal cases in patients with ADr and 
ADwr (p=0.00); however, no significant difference was found between ADr and 
ADwr patients. Flat and rounded type condylar shape was equally common 
among normal discs; however, rounded type was common among ADr and 
angled type was common among ADnr. ADr cases were significantly younger 
from normal cases; however, no age difference was found between normal and 
ADwr patients and ADr-ADwr patients. ADr and ADwr were more common 
among female gender. 
Conclusion: Mandibular condyle shape and its anteroposterior width is 
associated with anterior disc displacement.  
B-0257 14:16  
Fast and accurate diagnosis of oval or round window perilymphatic 
fistula on CT and MRI without contrast injection on 101 patients with 
surgical confirmation  
A. Venkatasamy, Z. Al Ohraini, A. Charpiot, C. Debry, F. Veillon; 
Strasbourg/FR (aina.vnkt@gmail.com)  
Purpose: We evaluated the usefulness of temporal bone CT and/or T2W 
steady-state free precession sequence (SSFP) MR images for the positive 
diagnosis of perilymphatic fistula (PFL) of the round (RW) and/or oval windows 
(OW), with surgery as gold standard. 
Methods and Materials: We enrolled patients who presented for a suspicion 
of PLF after a barotrauma, imaged by either a temporal bone CT and/or a high-
resolution T2W SSFP MR sequence. All patients underwent exploratory 
surgery and surgical findings served as gold standard. Two radiologists, 
analysed the RW and OW on the side of the clinical symptoms on CT and MR. 
Results: A fluid filling of the RW and OW on non-contrast CT or T2W MR was 
a good sign of PFL with high sensitivity and specificity. For the OW, if a fluid 
filling was the best sign of PFF, indirect CT signs were also helpful. The 
combination of CT and MR had the best sensitivity (95.6%) and specificity 
(100%) for the diagnosis of PFL. 
Conclusion: Non-injected CT or MRI is highly reliable for the fast and accurate 
diagnosis of PLF. Sensitivity and specificity increased when both techniques 
are combined, thus we recommend starting the explorations with CT, followed 
by a T2W sequence on MRI.  
B-0258 14:24  
Effect of varying tube potentials for the assessment of cochlear implants 
using advanced cone-beam CT  
I. Burck, I. Yel, M.H. Albrecht, S.S. Martin, J.L. Wichmann, S. Balster, 
T. Stöver, B. Kaltenbach, T.J. Vogl; Frankfurt a. Main/DE (iris.burck@gmx.de)  
Purpose: To evaluate the diagnostic value of 120 kilovolt (kV) compared to 96 
kV acquired cone-beam CT images in patients after cochlear implantation (CI). 
Methods and Materials: In this retrospective study, 75 postoperative cone-
beam CT examinations obtained with 120 kV versus standard 96 kV were 
independently reviewed by four radiologists. Depiction of bone structures of the 
otocapsule were rated including the ossear spiral lamina, inner and outer wall 
of the cochlea, vestibule and semicircular canals. Furthermore, metal and 
motion artefacts, visualisation of single electrode contacts on the CI array, as 
well as overall image quality were assessed. Criteria were analysed using 5-
point Likert-scales. Radiation dose was measured. 
Results: Visualisation of bone structures of the otocapsule (mean score, 2.2 
vs 3.1; P<0.01), and motion artefacts (mean score, 1.7 vs 2.4; P<0.01) were 
both rated higher using 120 vs 96 kV images. In addition, overall image quality 
showed higher scores for 120 kV settings (mean score, 2.1 vs 2.8; P<0.01). No 
significant differences were found for subjective evaluation of metal artefacts 
(mean score, 2.6 vs 2.7; P=0.33). Radiation dose of 96 kV images was 
significantly lower compared to 120 KV images (0.082 mSv vs 0.141 mSv, 
P<0.01). 
Conclusion: Most recent cone-beam CT at 120 kV significantly improves the 
depiction of temporal bone structures and single electrode contacts compared 
to standard kV settings.  
Author Disclosures: 
 J.L. Wichmann: Speaker; GE Healthcare; Siemens Healthcare.  
B-0259 14:32  
Radiation exposure imparted during multidetector and cone-beam CT 
scans for the perioperative cochlear implant evaluation  
N. Guberina, U. Dietrich, D. Arweiler-Harbeck, M. Forsting, A. Ringelstein; 
Essen/DE  
Purpose: To examine radiation doses imparted during 128-, 256-, 384-
multislice CT-scanners (MSCT) and cone-beam computed tomography (CBCT) 
for the perioperative cochlear implant insertion. 
Methods and Materials: Radiation doses were evaluated during standardized 
petrous bone CT protocols at different MSCTs ((I) single-source CT-scanner 
Somatom Definition AS+, (II) 2nd generation of dual-source CT-scanner 
Somatom Definition Flash, (III) 3rd generation of dual-source CT-scanner 
Somatom Force (all Siemens Healthcare GmbH, Erlangen, Germany)) and at 
the CBCT Ziehm Vision RFD 3D (Ziehm Imaging GmbH, Nuremberg, 
Germany) ((IV) (a) RFD 3D (standard modifier) and (b) RFD 3D (low-dose 
modifier)). Image quality was independently examined by two experienced 
radiologists appraising various important parameters (electrode array 
placement, quality control of cochlear implant surgery and evaluation of the 
temporal bone in case of complications) based on real patients’ examinations 
(n=78). Wilcoxon signed rank test was used to determine statistically significant 
differences (p<0.05). Interrater reliability was determined by calculating k 
values. 
Results: In MSCT setting, the following radiation doses were assessed 
(CTDIw; DLPmean of different positions, top, center, bottom, right and left): (I) 
21.5mGy; 216mGycm; (II) 19.7mGy; 195mGycm; (III) 12.7mGy; 127mGycm; in 
the CBCT setting, radiation doses were distributed as follows: (IV) (a) 1.9mGy; 
19.4 mGycm; (b) 1.2mGy; 12.9mGycm. Overall, image quality was evaluated 
as good for both, MSCT- and CBCT-examinations, with a good interrater 
reliability (r = 0.81). 
Conclusion: For the perioperative examination of cochlear implant insertion 
CBCT bears considerable dose-saving potential. Radiation doses are 
considerably lower during petrous bone CT protocols in the CBCT setting 
compared to MSCT setting while maintaining adequate image quality.  
B-0260 14:40  
Diagnostic performance of digital tomosynthesis as compared to 
conventional radiography in evaluation of craniovertebral junction  
P. Kala, R. Avantsa, G. Gowda; Bangalore/IN (prachi_kala@yahoo.com)  
Purpose: Overlying bony structures limit the assessment of CVJ anatomy. CT 
provides more precise information but with potential radiation hazards and high 
costs. Digital tomosynthesis (DTS) improves visualization by removing visual 
clutter of overlying anatomy. Purpose of the study is to assess the diagnostic 
performance of DTS in evaluation of CVJ. 
Methods and Materials: In an approved prospective study, CT, conventional 
radiography and DTS were performed in 30 controls and 26 patients with CVJ 
pathology. Standard radiographs and DTS were performed on GE Discovery 
XR650 system with "VolumeRAD™. An automatic exposure control technique 
was used. Image quality was scored for conspicuity and pathology detection by 
two independent radiologists with experience of more than 3yrs in DT. 
Radiation dose of the all exams was compared. 
Results: DTS was superior to radiography with sharper delineation of anatomy 
and detection of pathology of occipital condyles ( 89.6%), odontoid process 
(95%), C1 ( 86%) and C2 (100%) vertebrae in the coronal and atlanto-axial 
junction (92.4%) and dento-axial distance( 92.4%) in sagittal slices. The results 
were found comparable to CT for the same. There was gross reduction in the 
radiation dose compared to CT (from 28 mGy to 3 mGy), and no significant rise 
compared to plain radiographs (from <2 mGY to 4 mGy). 
Conclusion: DTS improved evaluation of CVJ anatomy. It has the potential to 
cut in number of views required, providing rapid diagnosis and savings on 
further imaging, radiation exposure, imaging costs that could mean reducing 
anxiety and discomfort for the patient.  
Author Disclosures: 
  P. Kala: Research/Grant Support; GE Healthcare.  G. Gowda: Research/ 
Grant Support; GE Healthcare. 
B-0261 14:48  
Thesphenoid ostium and its relationship to other endoscopic landmarks 
inacromegaly: a CT-based morphological study  
V. Hegde1, N. Rajgopalan2, S. Thakar2; 1Chennai/IN, 2Bangalore/IN 
(verahegde@gmail.com)  
Purpose: Acromegalic pituitary adenomas are known to cause 
disproportionate enlargement of the craniofacial and skull base structures (both 
soft tissue and bony) and thus complicate the trans-sphenoidal surgical 
approach. Morphological assessment of various landmarks, relevant to the 
endoscopic pituitary surgeon was done on thin section CT-PNS in operated 
cases of pituitary adenoma. The data was analysed with respect to growth 
hormone (GH) levels. 
Methods and Materials: The medical records, thin section (1mm) CT-PNS 
images and their 2D reformations of 15 acromegalic patients (GH) were 
compared with 15 non-acromegalic patients (n-GH). Various morphological 
data (size of sphenoid ostium (SO), displacement of SO, depth of sphenoid 
and sella from piriform aperture, turbinates, sella and inter-carotid distance) 
and anatomical variations (middle turbinate, sphenoid sinus) were documented 
and compared between the two groups and in correlation with serum growth 
hormone levels. Image analysis was done using ImageJ software (ver 1.49). 
Results: The ostium size in GH group was significantly larger than n-GH group 
(p=0.005). A moderate trend for an upward (r=-0.45) and lateral (r=0.34) 
displacement of the SO in the sphenoid face was observed in patients with 
increasing GH values. The width of the sellar floor, sphenoid rostrum and inter-
carotid distance positively correlated with GH levels (r = 0.40, 0.43, 0.35 
respectively). 
  






Conclusion: The anatomical distortion in acromegalic pituitary adenoma 
poses a challenge to endoscopic pituitary surgeon. Prior knowledge and 
anticipation may prevent failures and complications.  
B-0262 14:56  
Comparing subjective and objective image quality at two different 
radiation exposure ranges of the paranasal sinus CT examinations using 
a volumetric 320-row detector CT system  
M. Kantarci, A. Levent, S. Eren, B. Pirimoglu; Erzurum/TR 
(akkanrad@hotmail.com) 
Purpose: To evaluate image quality of protocol including 135 kVp, 5 mAs and 
80 kVp, 5 mAs in the paranasal sinus CT examinations using single volumetric 
320-row multidetector CT technique. 
Methods and Materials: From September to December 2016, both of our 
control group including 135 kVp and 5 mAs and our study group including 80 
kVp and 5 mAs paranasal CT protocols were simultaneously performed on 40 
patients using single volumetric 320-row multidetector CT device. Image 
quality for bony structures, air-filled structures and soft tissues were 
independently assessed for each group by three blinded observers using a 3-
point grading scale. 
Results: The effective radiation dose calculated for the control group scans 
was 0.037 ± 0.003mSv. But, it was 0.0099 ± 0.001mSv for the study group 
scans. The effective radiation dose of study group was statistically significantly 
lower than control group (p < 0.001). Despite significant lowering of the 
radiation doses, image qualities were sufficient for evaluating all the bony 
structures, air-filled structures and soft tissues except for eye muscle, 
retrobulbar fat and eye bulb. 
Conclusion: Our results present that our protocols for study and control group 
provide significant dose reduction without the loss of diagnostic image quality 
for paranasal sinus CT. Paranasal sinus CT imaging can be performed at very 
low radiation exposure maintaining high image quality using a single volume 
320-row detector CT device using 135 kVp and 5 mAs.  
B-0263 15:04  
“How much radiation do my baby get sick?” Answering to worried moms 
about dental radiology in childhood  
F. Testa, N. Angaramo, M. Marchisio, R. Olivero, D. Fraire, V. Verna; Bra/IT 
(frates@gmail.com)  
Purpose: To evaluate the impact on the pediatric population of radiological 
examinations such as OPT and cephalometry and to provide practical answers 
to parents often in trouble about radiation risk. 
Methods and Materials: We considered a series of 345 OPTs and 165 
cephalometries on children 4-12 yo, calculating the effective dose using an 
anthropomorphic phantom, according to MonteCarlo algorithms. We estimated 
the exposure rate of the pediatric population of our country. For each 
procedure, we optimized parameters in order to dose and image quality. 
Results: OPTs not rightly optimized administered a cumulative effective dose 
of 34.368 mSv, that could be reduced of an amount of 4.096 mSv, (-11.9%); 
unoptimized cephalometries administered a cumulative dose of 14.15 mSv, 
that could be reduced of 0.49 mSv, (-3.46%). We calculated an Odds Ratio to 
undergo OPTs between children 0-12 and adults as 2.24 (p<0.0000) ad to 
undergo to cephalometries as 15.08 (p<0.0000). We estimated 31.5% of the 
children of our country undergo to an OPT during their childhood in public 
health service; nowadays it is impossible to estimate how many children are 
studied at private dental practice. 
Conclusion: Empirically, considering an average annual Italian environmental 
dose of 3.3 mSv, an optimized cephalometry is estimated equal to about one 
week of environmental exposure, but it can reach the three months if not 
optimized; an OPT equals one month if optimized but until one year if 
unoptimized. Therefore, optimization is a must and, if implemented, the parents 
can be quietly relaxed. 
B-0264 15:12  
High-resolution dental MRI for planning palatal graft surgery: a clinical 
pilot study  
T. Hilgenfeld, T. Kästel, A. Heil, P. Rammelsberg, S. Heiland, M. Bendszus, 
F.S. Schwindling; Heidelberg/DE (tim.hilgenfeld@med.uni-heidelberg.de)  
Purpose: Because previous studies have revealed high variability of palatal 
masticatory mucosa thickness, preoperative evaluation before tissue graft 
harvesting is recommended e.g. by cone beam computed tomography. To 
evaluate whether high-resolution, non-contrast-enhanced dental MRI can be 
used for accurate determination of palatal masticatory mucosa thickness 
(PMMT) and to locate the greater palatal artery (GPA). 
Methods and Materials: Two independent raters measured PMMT by use of 
dental MRI in 180 positions for five human volunteers. For comparison, clinical 
bone sounding was performed. To ensure identical measurement positions in 
MRI and bone sounding, tooth-supported resin splints were fabricated. 
The GPA was identified in two MRI sequences. Intra- and inter-observer 
agreement for MRI measurements and agreement between MRI and bone 
sounding were calculated by using the intra-class correlation coefficient (ICC) 
and Cohen’s kappa (). 
Results: Reliability of dental MRI measurements was high (intra-observer ICC 
0.962; inter-observer ICC 0.959). Agreement of MRI measurements with bone 
sounding was moderate (ICC 0.744) and the GPA could be identified in 85% of 
measurement points. Good intra-observer agreement was observed for GPA 
identification ( 0.778). 
Conclusion: PMMT thickness measured by high-resolution, non-contrast-
enhanced dental MRI is comparable with that obtained by bone sounding. 
Dental MRI enables reliable, non-invasive, and radiation-free planning of 
palatal tissue harvesting and can also be used for precise location of the GPA, 
which might help reduce complications during surgery.  
B-0265 15:20  
MRI profile of sinonasal mucosal melanoma: analysis of 46 cases  
E. Tononcelli, L. Calabretta, M. Ravanelli, D. Lombardi, D. Farina, R. Maroldi; 
Brescia/IT (tononcelli.elena@gmail.com)  
Purpose: To assess the MR imaging profile of sinonasal mucosal melanoma 
(SMM) and to compare it with intestinal-type adenocarcinoma (ITAC) and 
squamous cell carcinoma (SCC). 
Methods and Materials: Retrospective analysis of MRI signal pattern was 
performed in 46 patients affected by SMM, correlating with histology on 
surgical specimen in 41/46. In all lesions, quantitative assessment was 
performed on T1 sequences -normalising tumour signal to a pterygoid muscle- 
and on the ADC map, comparing findings with 28 ITAC and 9 SCC. 
Enhancement homogeneity and bone changes in SMM were qualitatively 
assessed. Statistical analysis was performed applying Student’s T-test, exact-
Fischer test and ANOVA-test. 
Results: Statistically significant difference was seen between normalised T1 
signal of amelanotic (avg.0,88) and melanotic (avg.1,23) SMM and between 
each subtype and SCC (avg.1,05) and ITAC (avg.1,06) (p<0.05). No significant 
difference was seen between normalised T1-signal of ITAC and SCC. ANOVA 
with pairwise comparison showed significant difference between the ADC 
value of SMM (avg.0,875 mm2/s), ITAC (avg.1,125 mm2/s) and SCC 
(avg.0,941 mm2/s). Inhomogenous enhancement was significantly more 
frequent in larger SMM (p<0,05). Bone remodelling was significantly more 
frequent in primary than in recurrent SMM (p<0,05), associated with focal 
erosion in primary and extensive erosion in recurrent SMM. 
Conclusion: SMM is a rare and highly aggressive histotype displaying some 
specific MR signs that may differentiate it from the most common ITAC and 
SCC. MRI pattern is related to histology, particularly in the melanotic type.  
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B-0266 14:00  
Breast lesions characterisation: prospective comparison of strain and 
shear wave elastography as additional tool to BIRADS classification  
V. De Soccio, V. Cantisani, G. Alagna, M. Di Segni, V. Forte, N. Di Leo, 
S. La Morte, F. D'Ambrosio; Rome/IT  
Purpose: To evaluate the diagnostic performance of strain elastography (SE) 
and shear-wave elastography (SWE), in combination with US, to improve the 
differentiation of benign and malignant breast lesions 
Methods and Materials: 130 histopathologically proven breast lesions were 
prospectively evaluated by using US, SE and SWE. Each lesion was classified 
according to the BIRADS lexicon and SE semi-quantitative dynamic features 
(strain ratio), and SWE through quantitative techniques (expressed in k/Pa). 
Histology was used as reference standard. 2x2 contingency tables and ROC 
curve analysis were used to assess the diagnostic performance and Pearson’s 
² test was used to assess the significance of differences, with p=0.05 
significance threshold 
Results: Histological examination revealed 83 benign and 47 malignant breast 
lesions. US showed 80% sensitivity and 70% specificity. SWE kPa yielded a 
sensitivity of 72%, a specificity of 66% and ROC area of 0.691. US plus SR 
showed a sensitivity of 88%, a specificity of 76.6% and ROC area of 0.823. US 
plus SWE m/s had a sensitivity of 74%, a specificity of 76% and ROC AUC of 
0.750. 
  






Conclusion: Our experience suggests that SE and SWE in combination with 
B-mode US, are valid tools to improve BIRADS category assessment and the 
differentiation of benign from malignant breast lesions. According to our 
results, SE was more accurate than SWE.  
Author Disclosures: 
 V. Cantisani: Speaker; Toshiba, Samsung and Bracco.  
B-0267 14:08  
Meta-analysis of 3 methods to analyse breast strain elastography  
R.G. Barr1, A. DeSilvestri2, V. Scotti2, F. Manzoni2, C. Tinelli2; 
1
Rootstown, OH/US, 2Pavia/IT (rgbarr@zoominternet.net)  
Purpose: There are 3 methods of interpreting strain breast elastography; E/B 
ratio, 5-point color scale and strain ratio. This meta-analysis was performed to 
determine if one methods was superior. 
Methods and Materials: A systematic search of the medical literature was 
performed on July 2017. The following terms were used for the bibliographic 
strategy: Breast Neoplasm, Ultrasonography, mammary, elastic imaging 
techniques, strain elastography, real-time elastography, strain imaging, 
sensitivity, and specificity. Studies eligible for inclusion had biopsy proven 
results, utilised either E/B, 5-P, or SR and had at least 50 cases. 
Results: 505 records were retrieved (220 after duplicates removal); of them 60 
full-text were carefully examined and 46 papers were included in the 
metanalysis, publication year ranged from 2007 and 2017 (median year 2012). 
Quality of studies was generally high. Mean age of woman was 48 years; 
12398 lesions (4242 malignant) were analysed. For the 5p methods the sens 
was 77%, spec 87%, LRP 5.3, LRN 0.24. For the strain ratio the sens was 
87%, spec 81%, LRP 4.8, and LRN 0.16. For the E/B the sens was 96%, spec 
87%, LRP 7.6 and LRN 0.03. 
Conclusion: Of the three methods the E/B ratio has the highest sensitivity and 
E/B and 5P have the highest spec. With a LRN of 0.03 the E/B ratio can 
conclusively exclude a malignancy.  
Author Disclosures: 
  R.G. Barr: Advisory Board; Bracco Diagnostic; Lantheus Medical. Equipment 
Support Recipient; Philips Ultrasound; Siemens Ultrasound; GE Ultrasound; 
SuperSonic Imagine. Speaker; Philips Ultrasound;Bracco Diagnostic.  
B-0268 14:16  
Anatomic factors affecting shear wave elastography of malignant and 
benign breast lesions  
L. Plonski, E. Carmon, E. Chernovsky, G. Zeltzer, T. Sella; Jerusalem/IL 
(tamarse@hadassah.org.il)  
Purpose: Shearwave elastography (SWE) characterizes breast lesion stiffness 
by measuring waves propagating through the surrounding tissue. The purpose 
of this study was to evaluate how anatomic factors of the breast affect the 
performance of SWE. 
Methods and Materials: SWE was measured in 349 breast masses 
undergoing biopsy. Variables analyzed were density of the surrounding breast 
tissue (fatty n=130 or dense n=219) and depth of the lesion (superficial n=79, 
mid-breast n=137 or deep n=117). Data analysis evaluated the ability of SWE 
to differentiate benign from malignant as compared to histology. Statistical 
analysis included ROC curves, student's T test and the Kruskal-Wallis test. 
Results: The optimal cutoff point to distinguish benign from malignant was 
58.5kPa (AUC= 0.923) in dense tissue and 60.2kPa (AUC =0.932) in fatty 
tissue. Average Emax was higher for malignant masses: 144.4 kPa vs 34.8 
kPa in dense tissue and 134.3 kPa vs 34.2 kPa in fatty tissue (p<0.001). There 
was no difference in PPV and NPV of SWE for dense vs fatty tissue (70.7% 
and 94.9% vs 87% and 90.2%). In all three depth groups ave Emax was higher 
for malignant compared to benign lesions (superficial 152.1 kPa vs 31.8 kPa, 
mid 129.1 kPa vs 30.6 kPa, deep 143.4 kPa vs 43kPa; p<0.001). PPV and 
NPV of SWE in superficial lesions were 72.4% and 93.9%, at mid-depth 81% 
and 92.4% and for deep lesions 78.1% and 94.3%. 
Conclusion: SWE is not significantly affected by anatomic factors of the 
breast, differentiating malignant from benign lesions with high accuracy.  
B-0269 14:24  
Breast sonoelastography: comparison of the accuracy of the computer 
assisted diagnosis (CAD) classifier system using two values of different 
cut-off values with the visual classifier  
E.F. Fleury1, A.C. Gianini1, V.J. Ayres2, L. Ramalho1, J. Sousa Neto1, 
K.D. Marcomini3; 1São Paulo/BR, 2Santo André/BR, 3São Carlos/BR 
(edufleury@hotmail.com)  
Purpose: To evaluate the diagnostic accuracy of a CAD system to classify 
breast masses by elastography, using cut-off values for 75% and 80% stiffness 
areas, comparing with the results of the visual analysis. 
Methods and Materials: Prospective evaluations were performed in 
accordance to local ethical committee. It was included 85 consecutive breast 
masses evaluated by strain elastography, of which 33 were malignant and 52 
were benign. The masses were classified according to stiffness: 1. Soft; 2. 
Intermediate; 3. Rigid. The rigid lesions (3) were considered suspicious. First, 
the visual classification was performed. To evaluate the CAD system, the 
radiologist needs to delimit the edges of the lesion so that the computer 
automatically classifies the lesion. For classification with the CAD system the 
radiologist needs to delineate the mass margins so that the computer 
automatically classifies the lesion. For classification, the CAD system values 
the percentage of rigid area of the mass. Cutting values of 75% rigidity 
(CAD75) and 80% rigidity (CAD80) were compared. The ROC curves for the 3 
classifiers were determined. 
Results: The sensitivity and specificity obtained for each classifier were as 
follows: CAD75 90.9% and 67.3% respectively, CAD80 90.9% and 65.4%, and 
VISUAL 87.9% and 63.5%. The ROC curves were as follows: 0.837, 0.832, 
0.817. There was no statistically significant difference for the ROC curves, 
however the CAD75 was the classifier that presented the best ROC curve. 
Conclusion: Our results show that CAD using 75% cutoff for rigid area is the 
classifier with the best diagnostic accuracy.  
B-0270 14:32  
Role of elastography in the characterisation of subcentimeter breast 
lesions  
S. Sampangi, S. Shivalingappa, M. Ashok Kumar, I. Desai, A. Kesari, 
D. Basavalingu, A. Verma, K. Kallur, P. Asokan; Bangalore/IN 
(dr_sudhakar79@yahoo.com)  
Purpose: To characterize subcentimeter breast lesions on elastography and to 
determine it's utility for differentiating benign from malignant lesions. 
Methods and Materials: 60 patients aged between 25 to 60 years and a total 
of 65 subcentimeter isoechoic or hypoechoic breast lesions were evaluated 
with elastography ( Siemens Acuson S2000) between 2014 to 2016. 
Elastography was performed using Virtual Touch imaging (VTI) and Virtual 
Touch quantification (VTQ) applications. E/B ratio (Elastography/B-mode size 
ratio) was recorded from the VTI image and an average VTQ value (average of 
5 measurements in m/s) were obtained. All the lesions underwent 
percutaneous ultrasound guided core biopsy. 
Results: Of the 65 lesions biopsied, 41 lesions were malignant and 24 lesions 
were benign. The mean E/B ratio of malignant masses (1.28± 0.21) was 
significantly higher than that of benign masses (1.07 ± 0.09), with p value less 
than 0.001.There was no statistically significant difference between the mean 
VTQ value of malignant masses (2.71 ± 0.75) and benign masses (2.79 ± 
1.03), with p value more than 0.05. With the use of ROC curve, the cut off E/B 
ratio was estimated to be 1.2 with sensitivity of 73.2%, specificity of 82.7%, and 
accuracy of 79.2 %. 
Conclusion: Ultrasound elastography (VTI and VTQ) is a noninvasive 
technique to characterize tissue stiffness. E/B ratio of subcentimeter breast 
lesions can be used for differentiating between benign and malignant breast 
lesions and for potentially correlating with tumor desmoplastic reaction.  
B-0271 14:40  
Chemoresponse assessment in locally advanced breast cancer patients: 
comparison of grey scale ultrasound and ultrasound elastography  
A. Katyan, M.K. Mittal, C. Mani, A.K. Mandal, S.B. Grover; New Delhi/IN 
(amitkatyan@icloud.com)  
Purpose: The study was conducted to compare the role of grey scale 
ultrasound and strain wave elastography in evaluating the response to neo-
adjuvant chemotherapy (NACT) in patients with locally advanced breast cancer 
(LABC). 
Methods and Materials: In this IRB approved study, eighty three patients of 
LABC were investigated with greyscale ultrasound and strain wave 
elastography. Women receiving NACT had the affected breast scanned by 
greyscale ultrasound and elastography before each cycle of chemotherapy and 
immediately before surgery. Changes in ultrasound size and elastographic 
parameters (size ratio, strain ratio) were documented and then compared to 
clinical and pathologic tumour response as evaluated after mastectomy. 
Results: Mean strain ratio and mean size ratio for responders was significantly 
lower in responders in comparison to non-responders. Elastographic strain 
ratio parameters demonstrated high sensitivity and specificity for determining 
response even after the first cycle of chemotherapy. Strain wave elastography 
was found to detect treatment response earlier as compared to greyscale 
ultrasound in patients of LABC receiving NACT. 
Conclusion: Tumour strain ratio was found to be the best predictor of 
treatment response in patients of LABC. Elastographic parameters showed 
significant change in its parameters earlier as compared to change in 
greyscale ultrasound size measurements. Serial imaging with elastography has 
the potential to predict treatment response early during the course of NACT, 











B-0272 14:48  
Can a hyperechogenic breast lesion be malignant?  
E. Horvath, E.H. Castillo Balladarez, M.F. Pizzolon, C. Silva, M. Gallegos, 
M.A. Pinochet, M. Galleguillos, M. Uchida, P. Gonzalez; Santiago/CL 
(eliette88@hotmail.com)  
Purpose: Hyperechogenic breast lesions have been described as generally 
benign and are rarely biopsied. The aim of this work was to evaluate the 
frequency of malignant hyperechogenic breast lesions, describe their imaging 
findings and histopathological characteristics. 
Methods and Materials: IRB approved, retrospective, descriptive case series. 
Biopsied hyperechogenic lesions were selected from a database of 3.394 
consecutive US-guided breast Core biopsies (1,020 malignant, 299 high-risk 
and 2,075 benign lesions) performed between 2006 and 2016. Any lesion that 
presented greater echogenicity than subcutaneous cellular tissue of more than 
90% of its volume, was considered hyperechogenic. Demographical data, US 
and histopathological characteristics were recorded. 
Results: In total 27 (1,08%) lesions biopsied were hyperechogenic: 21 (57%) 
of them had benign results. Sixteen patients (mean age: 52 years; range: 26-
80) had hyperechogenic cancers, representing 1,5% (16/1,020) of all 
malignancies: 1 CDIS and 15 invasive carcinomas (81% ductal and 19% 
lobular histology). Mean size = 2 cm, range: 7-30 mm. All of them exhibited a 
small central hypoechoic foci and were partially or completely surrounded by 
fatty tissue. Shape, margins, orientation and vascular architecture were highly 
suggestive of malignancy on US, mammogram and MRI (features BI-RADS 4 
and 5). In histopathological exam these cancers were surrounded by adipose 
tissue (not by fibroglandular tissue); also, they presented a hypocellular 
collagenous center and were hypercellular on its periphery, intermixing with 
fatty tissue, fibrous tracts and collagen. 
Conclusion: Hyperechogenic cancers are very rare (less than 2% of breast 
cancers), but it is important to recognise them to avoid misdiagnosis.  
B-0273 14:56  
Texture feature analysis can support breast lesions identification and 
characterisation in images acquired by automated breast ultrasound 
systems  
M. Marcon, A. Becker, N. Berger, M. Wurnig, M. Wagner, T. Frauenfelder, 
A. Boss; Zurich/CH (Magda.Marcon@usz.ch)  
Purpose: To demonstrate how texture feature analysis(TA) can support the 
management of breast imaging findings in automated breast ultrasound 
imaging. 
Methods and Materials: In this prospective IRB-approved study 644 images 
acquired with an automated breast ultrasound system(ABUS) in 24 
consecutive patients with biopsy-proved malignancy(230 images from cancer, 
53 glandular tissue, 53 fat) and in 21 with fibroadenoma with follow-up longer 
than 18 months or biopsy(211 images from fibroadenoma, 49 glandular tissue, 
48 fat) were evaluated. After ROI placement, TA was performed applying 19 
features computed from histogram and higher-order features for differentiation 
of cancer, fibroadenoma, glandular tissue and fat.ANOVA was used for the 
evaluation of differences among the four categories. In case of significant 
differences, ROC curve calculation and logistic regression analysis were 
performed to determine sensitivity and specificity. Bonferroni correction was 
applied using a p-value<0.05. 
Results: Entropy values were different among the four categories(mean+/-sd, 
cancer 5.27+/-0.40, fibroadenoma 5.67+/-0.15, glandular tissue 5.73+/-0.30, fat 
5.56+/-0.23, p<0.00001) and the ROC curve obtained comparing malignant 
lesions versus other findings had AUC=0.84(C.I. 0.81-0.88); using a cut-off 
value of 5.48 a sensitivity of 86% and specificity of 70% was obtained. Using 
contrast and energy_mean to differentiate lesions (cancer and fibroadenoma) 
from normal tissue (fat and glandular tissue) AUC=0.86(C.I.0.83-0.89) und 
AUC=0.88(C.I.0.85-0.91) were obtained, respectively, and binary logistic 
regression of the two variables results in AUC=0.92(C.I.0.89-0.94). 
Conclusion: Texture feature analysis has the potential to support the 
differentiation between breast lesions and normal tissue as well as to 
distinguish cancer from fibroadenoma in automated breast ultrasound imaging.  
B-0274 15:04  
Does breast cancer subtype affect the diagnostic performance of axillary 
ultrasound for nodal staging in breast cancer patients  
M.L.G. Vane1, T. van Nijnatten1, P.J. Nelemans1, M.B. Lobbes1, 
L. van Roozendaal2, L. Kooreman1, K. Keymeulen1, M. Smidt1, R. Schipper1; 
1
Maastricht/NL, 2Heerlen/NL (thiemovn@gmail.com)  
Purpose: Physical examination followed by axillary ultrasound is routinely 
performed to assess preoperative axillary lymph node status in breast cancer 
patients. However, the accuracy of axillary ultrasound to assess nodal status 
for different subtypes of breast cancer is unknown. The aim of this study was to 
determine whether the diagnostic performance of axillary ultrasound is affected 
by breast cancer subtype. 
Methods and Materials: All newly diagnosed breast cancer patients between 
2008 and 2016 in MUMC+ with axillary ultrasound prior to axillary surgery were 
retrospectively included. Diagnostic performance of the axillary ultrasound 
(sensitivity, specificity, positive predictive value (PPV), negative predictive 
value (NPV), false-negative rate (FNR) and accuracy) was determined for each 
of the following subtypes:ER+PR+HER2-, HER2+, and ER-PR-HER2-. 
Histopathology of axillary surgery specimens served as gold standard. 
Differences in diagnostic performance between breast cancer subtypes were 
calculated using Chi-squared test. 
Results: A total of 1,129 breast cancer cases were included. Most common 
subtype was ER+PR+HER2- with 76.0% (858), followed by 13.3% in HER2+ 
(150) and 10.7% in ER-PR-HER2- tumors (121). The difference in NPV was 
significant between ER-PR-HER2- and HER2+ tumors (90.2% versus 80.6%, 
p=0.048) and HER2+ and ER+PR+HER2- tumors (90.2% versus 87.2%, 
p=0.04). Sensitivity, specificity, NPV, FNR and accuracy did not significantly 
differ per breast cancer subtype. 
Conclusion: The NPV of axillary ultrasound differed per molecular subtype, 
and was highest in ER-PR-HER2- tumors. The clinical consequence of the 
difference in NPV between breast cancer subtypes is unknown. Other 
parameters of diagnostic performance did not significantly differ per breast 
cancer subtype.  
B-0275 15:12  
Can documenting the number of abnormal nodes at axillary ultrasound 
accurately predict axillary nodal burden  
N. Sharma1, M. Wallis2, R.G. Newcombe3, S. Puri4, M. Al-Attar5, S. Pascaline6, 
M. Hajaj5, B. Elsberger7, A. Goyal4; 1Leeds/UK, 2Cambridge/UK, 3Cardiff/UK, 
4
Derby/UK, 5Leicester/UK, 6Kettering/UK, 7Dundee/UK 
(Nisha.sharma2@nhs.net)  
Purpose: The aim was to determine if for women with needle biopsy-proven 
positive node on preoperative axillary ultrasound (AUS), the number of 
abnormal nodes seen on AUS is a predictor of number of positive nodes at 
histology. 
Methods and Materials: This prospective multicentre cohort study included 
consecutive patients with early breast cancer who had needle biopsy-proven 
positive node on AUS and underwent axillary lymph node clearance (ALND) 
between October2015 and July 2016. The number of abnormal nodes at 
preoperative AUS was recorded by the scanning radiologist/radiographer. 
Results: 123 patients were included in the study. Median age of the women 
was 62 (range 30 to 93) years. 54/123 (44%) women had one abnormal node 
while 69 (56%) had multiple abnormal nodes on AUS. 40/123 (33%) women 
had two or less nodes with metastases at histology after ALND. Tumours 20 
mm or less (P < 0.001) and one abnormal node on AUS (P < 0.001) were 
associated with two or less nodes with metastases at ALND. Both remained 
significant in logistic regression analysis. The likelihood of at least three 
metastases based on the combination of these two factors had 95% sensitivity 
(79 of 83), 35% specificity (14 of 40), negative predictive value of 78% (14 of 
18) and positive predictive value of 75% (79 of 105). 
Conclusion: Women with needle biopsy-proven positive nodes, around 3 in 4 
women (78%) with invasive tumour size 2cm or less and one abnormal node 
on AUS have 2 or less positive nodes at ALND. These women are overtreated 
by upfront ALND and can be offered SNB.  
B-0276 15:20  
Specification of breast masses according to BI-RADS classification 
enforced with contrast-enhanced ultrasound  
E. Peniaeva1, A. Sencha2, Y. Patrunov1, E. Sencha2; 1Yaroslavl/RU, 
2
Moscow/RU (Ellapenyaeva@mail.ru)  
Purpose: To define the diagnostic value of contrast-enhanced ultrasound 
(CEUS) in specification of BI-RADS category of breast lesions. 
Methods and Materials: CEUS with intravenous bolus administration of 2.4ml 
of Sonovue® was performed in 67 patients of the age 28-67 years. Linear 7-
15MHz probes with specialised “contrast” option were used for CEUS. Core 
needle biopsy after CEUS diagnosed 28 carcinomas and 39 benign lesions. 
Results: The following patterns were registered. CEUS BI-RADS 1 - no 
change. CEUS BI-RADS 2 (conferred 30 benign lesions) - slow or synchronous 
isoenhancement without perfusion defects and feeding vessels, slow or 
synchronous hypoenhancement with distinct regular margins without feeding 
vessels, absence of contrast enhancement of the lesion with distinct regular 
margins. CEUS BI-RADS 3 (6 benign lesions and 2 carcinomas) - synchronous 
hyperenhancement without perfusion defects and feeding vessels that does 
not exceed the grayscale size of the lesion. CEUS BI-RADS 4 (3 benign 
lesions and 12 carcinomas) - fast hyperenhancement of irregular shape that 
exceeds the grayscale size. CEUS BI-RADS 5 (14 breast carcinomas) - fast 
hyperenhancement of regular/irregular shape with perfusion defects that does 
not exceed or exceeds the grayscale size, or hyper/isoenhancement 
with/without perfusion defects with feeding vessels. US BI-RADS scale had the 
sensitivity of 75%, specificity 82.4%, diagnostic accuracy 79.1% in diagnosis of 
  






breast carcinoma. CEUS BI-RADS scale improved the sensitivity up to 92.8%, 
specificity - 92.3%, diagnostic accuracy - 92.5%. 
Conclusion: CEUS improves the diagnostic value of ultrasound in 
differentiation of breast lesions.  
14:00 - 15:30 Room E2  
Neuro  
SS 311  
Neuroinflammation and neuroinfection  
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A. Rovira-Cañellas; Barcelona/ES  
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B-0277 14:00  
Histogram analysis of ADC maps and FLAIR MR imaging can predict 
active demyelination in multiple sclerosis  
K.Y. Wang, J. Carlton, D. Guffey, F.E. Moron; Houston, TX/US 
(femoron@gmail.com)  
Purpose: The aim is to evaluate the discriminatory power of apparent diffusion 
coefficient (ADC) values and FLAIR signal intensity histogram analysis in 
differentiating new acute demyelinating lesions (ADLs) and new non-acutely 
demyelinating lesions (N-ADLs) in multiple sclerosis (MS). 
Methods and Materials: A total of 64 lesions from 32 MRIs of patients with 
clinically definite MS were analyzed. A new ADL was defined as an enhancing 
lesion. A new N-ADL was defined as a new non-enhancing lesion not present 
on a prior comparison MRI performed <1 year. Discrete lesions were selected 
for optimal region-of-interest (ROI) placement. Manual ROIs were drawn on 
FLAIR and ADC map by maximizing lesion coverage while avoiding volume 
averaging. Mean, max, min, 10th, 25th, 50th, 75th, and 90th percentile values 
were calculated. A second ROI was drawn in the contralateral normal-
appearing white matter (WM). A ratio was obtained by dividing lesion value by 
contralateral WM value. Wilcoxon rank-sum test was used to compare ratios 
between ADL and N-ADL. Logistic regression was used to assess associations 
between FLAIR ratios and new ADLs. Receiver operating curve analysis 
evaluated discriminatory power of ADC map and FLAIR ratios. A p<0.05 was 
considered statistically significant. 
Results: The data skewness ranged from 1.11 (ratio of 10th percentile 
diffusivity) to -0.34 (ratio of min FLAIR value). The FLAIR ratios of all 
descriptive statistics (mean, max, min, and percentiles) were significantly 
higher for ADLs compared to N-ADLs (p=0.0002 to <0.0001). No significant 
associations between FLAIR ratios and ADLs were noted for all descriptive 
statistics with logistic regression. The diffusivity ratios of all descriptive 
statistics (mean, max, min, and percentiles) were also significantly higher for 
ADLs compared to N-ADLs (p=0.0309 to 0.0117). ROC analysis of FLAIR 
demonstrated an area under the curve ranging from 0.792 (max ratio) to 0.833 
(25th percentile ratio). A cutoff of 1.471 for the 25th percentile FLAIR ratio 
provides a 0.86 sensitivity, 0.70 specificity, and 0.81 accuracy. ROC analysis 
of ADC demonstrated an area under the curve ranging from 0.669 (min ratio) 
to 0.698 (90th percentile ratio). A cutoff of 1.543 for the 90th percentile ADC 
ratio provides a 0.75 sensitivity, 0.70 specificity, and 0.73 accuracy. 
Conclusion: The signal intensity of FLAIR and diffusivity on ADC maps may 
have the potential to discriminate between new ADL and N-ADL in MS.  
B-0278 14:08  
Proton magnetic resonance spectroscopy (1H-MRS) of the brain in 
patients with tick-borne encephalitis  
R. Zawadzki1, B. Kubas1, M. Hładu
ski1, J. Zajkowska1, O. Zajkowska2, 
D. Jurgilewicz1, A. Garkowski1, S. Pancewicz1, U. Lebkowska1; 1Bialystok/PL, 
2
Warsaw/PL (zaw.radoslaw@gmail.com)  
Purpose: To study the metabolic changes of the brain by 1H-magnetic 
resonance spectroscopy (1H-MRS) in patients with tick-borne encephalitis 
(TBE). 
Methods and Materials: 22 patients diagnosed with TBE and 24 healthy 
controls have been enrolled. All of them underwent routine magnetic 
resonance imaging (MRI) protocol using 3.0 T MRI scanner, which included 
T1-weighted images, T2-weighted images, fluid-attenuated inversion recovery 
(FLAIR), and diffusion weighted images (DWI). 1H-MRS examinations were 
performed with the following acquisition parameters: repetition time (TR), 2000 
ms; echo time (TE), 135 ms; number of excitations, 128. Single voxels were 
manually located bilaterally in the basal ganglia, thalami and in the 
hemispheres of cerebellum. Metabolites to creatine (Cr) ratios were analysed. 
The following peaks were assessed: N-acetylaspartate (NAA), choline-
containing compounds (Cho), and glutamate/glutamine/-aminobutyric acid 
complex (Glx). 
Results: Compared to controls we found statistically significant decrease of 
the NAA/Cr ratio bilaterally in the right and left thalamus (p = 0.0002 and p = 
0.0017, respectively) and statistically significant increase of the Cho/Cr ratio in 
the right and left thalamus (p = 0.03 and p = 0,0065, respectively). We also 
observed statistically significant increase of the Cho/Cr ratio in the left 
hemisphere of cerebellum (p=0.04). There were no statistically significant brain 
metabolite alterations within other evaluated areas. 
Conclusion: A significant reduction in NAA/Cr ratio and statistically significant 
increase of the Cho/Cr ratio in comparison with the control group suggests the 
presence of neuronal damage in patients with TBE.  
B-0279 14:16  
Altered hippocampal GABA and glutamate levels and functional 
connectivity in multiple sclerosis  
X. Yin1, F. Gao2, G. Wang2; 1Chongqing/CN, 2Jinan/CN 
(xuntaoyin@gmail.com)  
Purpose: There is growing evidence for dysfunctional glutamatergic excitation 
and/or gamma-aminobutyric acid (GABA)ergic inhibition in patients with 
multiple sclerosis (MS). Cognitive impairment may occur during the early 
stages of MS and hippocampal abnormalities have been suggested as 
biomarkers. However, researchers have not clearly determined whether 
changes in hippocampal GABA and glutamate (Glu) levels are associated with 
cognitive impairment and aberrant neural activity in patients with MS. 
Methods and Materials: We used magnetic resonance spectroscopy to 
measure GABA and Glu levels in the left hippocampal region of 29 patients 
with relapsing-remitting MS and 29 healthy controls (HCs). Resting-state 
functional connectivity (FC) with the hippocampus was also examined. Partial 
correlation analyses of the cognitive performance, hippocampal GABA+ and 
Glu levels and FC strengths, were performed separately for patients with MS 
and HCs, while controlling for age and gender. 
Results: Compared to HCs, patients exhibited significantly lower GABA+ and 
Glu levels, which were associated with verbal and visuospatial memory deficits, 
respectively. Patients also showed decreased FC strengths between the 
hippocampus and several cortical regions, which are located within the default 
mode network. Moreover, hippocampal GABA+ levels correlated with the FC 
strengths in HCs but not in patients with MS. 
Conclusion: This study describes a novel method for investigating the 
complex relationships among excitatory/inhibitory neurotransmitters, brain 
connectivity and cognition in health and disease. Strategies that modulate Glu 
and GABA neurotransmission may represent new therapeutic treatments for 
patients with MS.  
B-0281 14:24  
Advanced MRI assessment during dendritic cell immunotherapy  
A. Gioppo, M. Eoli, D. Aquino, G. Finocchiaro, M.G. Bruzzone, V. Cuccarini; 
Milan/IT (andrea.gioppo@istituto-besta.it)  
Purpose: To examine advanced MRI findings encountered in first diagnosis 
glioblastoma patients treated with dendritic cell immunotherapy. 
Methods and Materials: A retrospective analysis was performed on 
longitudinal MRIs obtained before the first vaccination and every two months, 
by 22 patients enrolled in the EUDRACT N°2008-005035-15 trial. Tumor 
volume, mean normalized tumoral CBV (rCBV), mean normalized tumoral ADC 
(rADCmean), ADC mode (ADCmode), ADC skewness (ADCskew) were 
collected. 
Results: We identified 10 responders and 12 not-responders. In responders, 
basal rADCmean was significantly higher than in non-responder patients 
(1.34±0.17 vs 1.14±0.34;p=0.03). After the first four vaccinations, responders 
showed a significant decrease in rADCmean (1.34±0.17 vs 1.23±0.23;p=0.028) 
and not statistically differences in ADCskew, when compared to non-
responders. A decrease in rADCmean value 0.13 and a change in ADCskew 
-0.14 were significant predictor of longer progression-free survival (PFS) (17.2 
vs 10.2;p=0.04/ 15.4 vs 9.3;p=0.02) and overall survival (OS) (33 vs 
19.9;p=0.003/ 29 vs 12.4;p=0.002). Regarding follow-up, MRI performed at 
progression demonstrated a significant increase of rCBV (4.25 vs 5.38;p=0.04) 
and a significant decrease in rADCmean (1.17 vs 1.01;p=0.004) when 
compared to basal MRI. MRI performed at pseudo-progression showed no 
modification of rCBV and rADCmean. A significant decrease in ADCmode was 
observed comparing value obtained at pseudo-progression time with those 
obtained at the following exams (0.0012 vs 0.0010;p=0.008). 
Conclusion: An early decrease in rADCmean and no significant changes in 
ADCskew are related to a better survival in GBM patients treated with DC 
immunotherapy. Modification of rCBV and rADCmean can be useful in 












B-0282 14:32  
Cortical vs juxtacortical lesions in multiple sclerosis: an analysis of PSIR 
performance in comparison to FLAIR  
M.R. Lima1, G. Furlin1, A. Kupske1, J.S. Muller1, M.C.A. de Vecino1, 
M.G. Longo2, K.R.S.B. Nunes1, B.B. Valentini1, M.A.G. de Caneda1; 
1
Porto Alegre/BR, 2Boston, MA/US (Gabifurlin@gmail.com)  
Purpose: Multiple sclerosis (MS) affects white and grey matter. Imaging 
differentiation between juxtacortical and cortical lesions can be challenging 
with the standard magnetic resonance (MRI) sequences. New sequences have 
demonstrated better performance, like phase-sensitive inversion recovery 
(PSIR). This study evaluates the performance of PSIR to detect and 
differentiate cortical plaques in patients with MS, in comparison to FLAIR. 
Methods and Materials: Patients with MS confirmed by McDonald criteria 
(2010) who underwent MRI examination in our service between March 2016 
and April 2017 were retrospectively evaluated by two radiologists that 
quantified the number of lesions detected first by FLAIR and then by PSIR. 
Later, they estimated how many lesions were reclassified using PSIR. 
Results: 71 patients were included with an average of 12.7 years of disease. 
52 patients (73.2%) presented juxtacortical lesions in FLAIR. Of these, 43 
(82.7%) had lesions reclassified using PSIR, with a median number of 2.55 
lesions per patient. 38 (54.3%) presented supratentorial lesions identified only 
in PSIR, with a median number of 1.44 lesions per patient. 23 (32.9%) 
presented infratentorial lesions identified only in PSIR, with a median number 
of 1.43 lesions per patient. PSIR showed better performance than FLAIR in 
identifying MS lesions in supratentorial and infratentorial compartments 
(p<0.001 for both), detecting an average of 1.5 more lesions in supratentorial 
and 0.42 more in infratentorial compartment. 
Conclusion: The evaluation of MS lesions with PSIR showed greater 
performance for diagnosis and classification in comparison to FLAIR and its 
use should be encouraged in the clinical practice.  
B-0283 14:40  
Neuroimaging manifestations of HIV-AIDS at a reference center in south 
of Brazil  
G.F.D. Castanho, P. Yokoo, J. Geske, G. Michelis, A. Cremoneze, 
B.C. Teixeira; Curitiba/BR (gabrielle.castanho@gmail.com)  
Purpose: The nervous system is among the most frequent and serious targets 
of human immunodeficiency virus (HIV) infection, mainly in patients with 
profound immunosuppression. This group of patients presents particular 
aspects of neuroimaging that must be known and recognised by radiologists. 
We want to present illustrative magnetic resonance imaging (MRI) findings in 
HIV positive patients. 
Methods and Materials: This was a retrospective observational study. We 
reviewed all orders of Brain MRI at our service, in a two year period (March 
2015 to March 2017) with a total of 2089 exams. We included patients with a 
known HIV diagnosis described in the medical application or summary of 
hospital discharge. We identified 123 HIV patients (154 Brain MRI) and we 
studied and correlated with anatomopathological and clinical-laboratory 
findings. 
Results: The majority of patients in our sample were hospitalised (61%). In this 
group 52% had CD4<200 and 14% was not available, also we observed some 
overlapping findings, infection was found in 56% (39% toxoplasmosis, 16% 
PML, 11% syphilis, 11% tuberculosis and 9% HIV encephalopathy), neoplasm 
in 10% (62% lymphoma and 25% metastasis), 26% had others lesions (45% 
microangiopathy, 20% infarcts and 5% IRIS) and 17% of patients evolved to 
death.In the outpatients only 8% had CD4<200 and 8% was not available, we 
found 6.3% with signs of active infections and 23% with chronic alterations 
(vascular and infectious), the remainder presented nonspecific or normal 
findings. 
Conclusion: The hospitalised patients presented a more aggressive pattern 
than outpatients, as expected, because of the larger immunosuppression.  
B-0284 14:48  
Acute optic neuritis (ON): can magnetic resonance (MRI) in the acute 
setting help in determining the aetiology?  
C. Rosti, M. Cellina, V. Fetoni, M. Pirovano, M. Ciocca, G. Oliva; Milan/IT 
(cristina.rosti@gmail.com)  
Purpose: ON is an inflammatory disease of the optic nerve which can be 
idiopathic or associated with demyelinating or autoimmune diseases. Our aim 
was to investigate if MRI in the acute setting may help in establishing ON 
aetiology. 
Methods and Materials: 60 previously healthy subjects presented to our 
emergency department with a first episode of ON, clinically diagnosed. 
Patients underwent ophthalmologic, neurologic examinations, blood tests and 
by brain and orbit basal CT. A 1.5T MRI of the orbit, brain and cervical spine 
was executed within 48 hours from the onset. The protocol included a 3D 
FLAIR, DWI, T1 and T2 weighted sequences, with fat saturation (FS) on the 
orbit and, after contrast injection, a T1 3D MPRAGE on the brain, FS T1 SE on 
the orbit and cervical spine. Neuroradiologists, unaware of clinical data, made 
an ON aetiological diagnosis based on the MRI datasets. ON were classified 
as idiopathic or clinically isolated syndrome (CIS), multiple sclerosis (MS) or 
optic neuromyelitis (NMO) in case of T2 lesions, according to location, 
morphology, contrast enhancement (CE). 
Results: All CT were negative. According to MRI, 22 ON were classified as 
idiopathic (19 negative MRI, 3 swelling of the optic nerve); 7 as MS (spatio-
temporal disseminated T2 lesions); 29 as CIS (T2 lesions without CE 
with/without cervical and optic nerve involvement), 2 as NMO (brain and 
cervical lesions with typical characteristics). MRI results confirmed 
neuroradiologists’ diagnosis. NMO was confirmed by the antiaquaporin-4. 
Conclusion: MRI findings perfectly matched neurologists’ diagnosis confirming 
ON aetiological diagnosis.  
B-0285 14:56  
Evaluation of chronic MS lesions with T1 magnetic resonance 
fingerprinting  
E. Springer1, W. Bogner1, P. Cardoso1, M. Nittka2, J. Pfeuffer2, 
G. Koerzdoerfer2,2, R. Kirsch2, S. Trattnig1; 1Vienna/AT, 2Erlangen/DE 
(elisabeth.springer@meduniwien.ac.at)  
Purpose: MR Fingerprinting(MRF) is a novel approach in data acquisition, 
post-processing and visualization[1]. Non-enhancing T1-hypointense 
lesions(black holes) in multiple sclerosis(MS) are chronic lesions characterized 
by severe axonal damage[2, 3], and with a persistent iron ring are considered 
slowly progressive lesions[4, 5]. Iron rings are in most cases only visible at 7T 
due to higher spatial resolution and stronger susceptibility effects[6, 7]. To 
investigate whether MRF T1 relaxation times may be used to differentiate 
chronic T1-hypointense lesions with iron ring-deposits from chronic T1-
hypointense lesions without iron-deposits. 
Methods and Materials: Ten relapsing remitting MS(RRMS) patients were 
measured on a 3T MAGNETOM-PRISMA MR-scanner with a 64-channel 
head/neck coil, and on a 7T-MAGNETOM MR-scanner(both Siemens 
Healthcare, Germany) with a 32-channel head coil (Nova Medical). The 
comprehensive routine MS protocol, including FLAIR, 3D-FLAIR, T2-TSE, 
MP2RAGE, diffusion-weighted imaging, post-contrast T1-weighted images, as 
well as a prototype MRF sequence[8] were performed at 3T, susceptibility-
weighted imaging at 7T. MRF T1 relaxation times were measured in regions of 
interest in FLAIR-hyperintense, T1-hypointense lesions without contrast media 
uptake, containing iron ring-deposits on SWI, and non-containing iron-deposits, 
using Syngo Via. Multi-Level Analysis(MLA) was assessed to take clustered 
multiple measures per patient into account when comparing different regions. 
Results: MRF T1 relaxation times were significantly higher in chronic T1-
hypointense MS lesions containing iron ring-deposits than in non-iron-
containing chronic T1-hypointense MS lesions (p=0.002). 
Conclusion: MRF T1 relaxation times may be used to differentiate iron-
containing from non-iron-containing chronic MS lesions, and thus may facilitate 
the depiction of a more progressive form of RRMS at 3T.  
Author Disclosures: 
 M. Nittka: Employee; Siemens Healthcare GmbH. J. Pfeuffer: Employee; 
Siemens Healthcare GmbH. G. Koerzdoerfer: Grant Recipient; from Siemens 
Healthcare GmbH. R. Kirsch: Employee; Siemens Healthcare GmbH.  
B-0286 15:04  
Brain damage in early adult paediatric-onset MS with no or minimal 
disability  
L. Nichelli1, A. Giorgio2, J. Zhang2, M. Stromillo2, F. Rossi2, M. Battaglini2, 
M. Mortilla3, M.P. Amato3, N. De Stefano2; 1Modena/IT, 2Siena/IT, 3Florence/IT 
(lucianichelli@gmail.com)  
Purpose: Paediatric-onset MS (POMS) patients seem to benefit from brain 
adaptive mechanisms in the short-medium term, although they reach clinical 
disability at a significantly younger age than adult-onset MS (AOMS) patients. 
To investigate such unfavourable long-term clinical outcome, we measured 
structural and functional brain damage in early adult POMS patients with no or 
minimal clinical disability. 
Methods and Materials: 15 POMS patients (age=24.8±7 years; median 
EDSS=1), 14 age- and disability-matched AOMS patients and 20 normal 
controls (NC) underwent a 3T MRI examination. We obtained WM-lesion 
volume (LV) and probability maps (LPM), brain volumes (whole brain, WM, 
GM, neocortical, deep GM) with SIENAx and performed a voxelwise DTI and 
resting fMRI analyses with FSL tools, using the statistics of non-parametric 
permutation testing. 
Results: No differences in LV and in brain volumes were found between 
POMS and AOMS. However, in comparison with AOMS patients, early adult 
POMS showed (i) at the level of posterior corona radiata (PCR), an eloquent 
area for motor disability, higher probability of lesion occurrence (p=0.002) and 
higher axial and radial diffusivity (p<0.001); and (ii) a reduced long-range 
functional connectivity between default mode network and secondary visual 
  






network (p=0.0016), whose interaction supports important cognitive functions 
such as spatial attention and visual learning. 
Conclusion: This pattern of structural damage and altered functional 
connectivity in early adulthood may give insight into long-term outcome of 
POMS.  
B-0287 15:12  
Comparison between grey matter-only and white matter-only imaging in 
the detection of brain multiple sclerosis lesions  
Z. Abidi1, F. Faeghi2, Z. Mardanshahi3, J. Abdolmohammadi4, 
M. Haghighikaboudkola5; 1Qaemshahr/IR, 2Tehran/IR, 3Sari/IR, 4Sanandaj/IR, 
5
Babolsar/IR (abidi4805@sbmu.ac.ir)  
Purpose: We aimed to evaluate two different types of double inversion 
recovery sequence including grey matter-only (GM only) and white matter-only 
(WM only) imaging and routine brain MRI sequences in detection of multiple 
sclerosis (MS) lesions. 
Methods and Materials: In this study, 30 patients including 19 patients with 
RRMS and 11 with SPMS were examined on a 1.5T Philips MRI scanner, 
using GM only, WM-only imaging and routine brain MRI sequences with same 
parameters, including field of view, matrix, slice thickness, voxel size and 
number of signal averaging (NSA). In GM-only imaging two inversion pulses 
with inversion delay times (TI1=3400 and TI2=325 ms) optimized to suppress 
signal of WM and cerebrospinal fluid (CSF) to image cortex alone and in WM-
only imaging two different TI (TI1=3700 and TI2=525 ms) are used to suppress 
signal of GM and CSF to image the WM lonely. 
Results: More total number of lesions were displayed on GM-only sequence 
compared with WM-only imaging (p=0.0001 ) and FLAIR (p=0.014) and 
T2W_TSE (p=0.0001). Higher contrast ratio has been observed between the 
white matter lesions and the normal-appearing white matter (NAWM) in most 
anatomical regions. 
Conclusion: GM-only and WM-only imaging provide additional information 
compared to routine brain MRI sequences. Although GM-only imaging was 
superior to routine sequences, but WM-only imaging had a poor detection of 
MS lesions in brain. So, we highly recommend routine use of GM-only imaging 
for early detection of MS lesions.  
14:00 - 15:30 Room F2  
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B-0288 14:00  
Improved image quality and reduced radiation dose in trauma CT using a 
custom arm rest pillow  
V. Larsen, C.T. Traply, B.R. Mussmann; Odense/DK (brz9ak@gmail.com)  
Purpose: In multi-trauma CT, assessment of the liver is crucial for the 
diagnosis, but with current scan procedures the patients are often scanned 
with the arms down causing artifacts in the abdominal region. We developed a 
custom arm rest pillow allowing for scans with arms in overhead position. We 
hypothesized that the arms-over-head position would affect image quality in 
the parenchymal organs positively, while moderate image quality decrease in 
the cervical spine was expected. The purpose was to assess dose and image 
quality implications of the custom pillow in emergency CT. 
Methods and Materials: We included 24 multi-trauma patients referred for 
chest-abdomen scans. Using the trauma pillow 12 patients were scanned feet 
first, arms over head and 12 were scanned head first, arms down (standard 
procedure). Subjective image quality was assessed in the parenchymal organs 
and cervical spine using a five-point scale. Image quality scores < 3 were 
considered unacceptable. Image scores and dose length products were 
compared using the two-sided unpaired t test. 
Results: Mean DLP decreased from 2360 to 1800 mGy*cm (p=0.06) using the 
pillow. Mean image quality score in the parenchymal organs increased from 
2.4 to 4.3 (p<0.00001). All patients with insufficient image quality were scanned 
with arms down. Cervical spine image quality decreased from 4.7 to 3.6 
(p<0.0001) with no scores below cut-off. 
Conclusion: Image quality can potentially be improved in the parenchymal 
organs and radiation dose can be reduced using the trauma pillow while image 




B-0289 14:08  
Evaluation of the diagnostic potential of the GCS for the indication of 
whole-body CT in paediatric polytrauma  
C. Frellesen, J. Wichmann, P. Tischendorf, T.J. Vogl, K. Eichler; 
Frankfurt a. Main/DE (c.frellesen@gmail.com)  
Purpose: To evaluate the diagnostic potential of the Glasgow Coma Scale 
(GCS) for the indication of whole-body CT (WBCT) in paediatric polytrauma. 
Methods and Materials: 100 paediatric polytrauma patients with WBCT were 
compared according to age, gender, mechanism of injury (MOI), GCS, 
detected injury and injury severity score (ISS). Correlation between GCS and 
patient groups with (p+) and without (p-) injury was assessed using Mann-
Whitney U Test and ROC analysis to evaluate its predictive potential. 
Results: Average age was 9.13 years with predominance of male patients (72 
vs 28%). Traffic accidents were the most frequent MOI (63%). Injury was 
detected in 71% of the patients, most commonly of the head (43%). There was 
no significant correlation between MOI and ISS. P+ and p- showed significant 
differences regarding GCS (p<0.001). ROC analysis revealed an optimum 
discrimination threshold of the GCS at 12.5 with an inaccuracy rate of 21% 
relating to craniocerebral injuries and 30% to whole-body injuries, respectively. 
Conclusion: The indication of WBCT in paediatric polytrauma patients should 
not be based on the GCS alone. Focused CT of individual body regions is to 
be preferred. Cranial CT is recommended at a GCS less than or equal to 13.  
Author Disclosures: 
 J. Wichmann: Speaker; Siemens Healthcare; GE Healthcare.  
B-0290 14:16  
Who needs a CT scan? Incorporating S100B into existing guidelines in 
the management of mild traumatic brain injury  
L. van den Hauwe, M. Landen, F. Vandereyken, R. Vael, P. Bracke; 
Brasschaat/BE (lucvdhauwe@mac.com)  
Purpose: To determine whether S100B, a protein biomarker of brain injury, 
can predict intracranial abnormalities CT in patients with mild traumatic brain 
injury (mTBI). 
Methods and Materials: Consecutive adult patients with mTBI (GCS 14-15) 
were included in this study. Patients were managed according to existing 
guidelines for CT selection based on patient history and clinical examination. 
S100B was analysed within 4 hours after the traumatic event; results were 
available within 1 hour. Non-contrast CT was subsequently performed when 
elevated S100B levels were found. 
Results: One hundred seven patients were included during a 12-month period 
(October 2016-September 2017). Thirteen patients (12%) showed traumatic 
abnormalities on CT, including skull/facial fractures (n=9), subarachnoid 
haemorrhage (n=6), cortical contusions (n=4), subdural haematoma (n=3), 
intracerebral haematoma (n=2), and epidural haematoma (n=1). No patients 
needed neurosurgical intervention; none died as a result of the TBI. Thirty-
three patients (31%) had normal S100B levels and 74 patients (69%) showed 
elevated S100B levels ( 0.105µg/L). Compliance to the new guidelines was 
not always perfect. As a result over-triage occurred in 4 patients (4%) and 
under-triage occurred in 11 patients (10%). A false-negative test was observed 
in 1 demented patient who had a subarachnoid haemorrhage and a subdural 
haematoma on CT. A false-positive test was observed in a multitrauma patient 
(liver laceration and rib fractures) without head injury. 
Conclusion: Used in combination with clinical decision rules, S100B may 
reduce the need for CT and as such reduce radiation exposure to the patient 
and save costs to the society.  
B-0291 14:24  
Can computed tomography (CT) help in predicting diplopia in orbital 
blowout fractures (BOFs)?  
M. Cellina1, M. Orsi1, C. Floridi2, G. Oliva1; 1Milan/IT, 2Perugia/IT 
(m.cellina@yahoo.it)  
Purpose: The management of BOFs is controversial and the assessment of 
diplopia is the most important criterion for planning surgical repair. Our aim was 
to determine CT findings that can be used to predict diplopia in patients with 
BOFs. 
Methods and Materials: We retrospectively evaluated orbital CT of all patients 
presented for blunt craniofacial trauma (N=3500) from January 2014 to June 
2016, selecting patients with CT-proven BOFs. For each CT we assessed the 
following variables: fracture site, bone fragments displacement, extraocular 
muscle (EOM) swelling, EOM dislocation, EOM entrapment, EOM hooking, 
intraconal and extraconal emphysema, intraconal and extraconal hematoma, 
orbital fat herniation. All patients underwent Hess-Lancaster test to establish 
the presence of diplopia. After performing group comparison with Pearson 2 
test, we derived our prediction model using logistic regression, with diplopia as 
the prediction and CT variables as predictors. 
Results: We observed 299 patients with BOFs, 46 (15.4%) with diplopia. CT 
variables with statistically significant difference between the group with diplopia 
  






and the group without diplopia were as follows: floor fracture (p=.014), bone 
fragments displacement (p=.001), EOM swelling (p=.001), EOM displacement 
(p<.001), EOM entrapment (p<.001), orbital fat herniation (p=.003). CT 
variables with significance as predictors of diplopia at multivariate analysis 
were only: floor location (odds ratio [OR], 2.87; 95% confidence interval [CI]: 
1.22, 6.73; p=.01), muscle entrapment (OR, 10.69; 95% CI: 3.76, 30.4; p<.001) 
and muscle displacement (OR, 11.51; 95% CI: 3.05, 43.3; p<.001). 
Conclusion: Diplopia can be predicted on CT findings after an orbital trauma.  
B-0292 14:32  
Multi-energy CT in patients with thoraco-abdominal bleeding: new 
techniques to facilitate image reading and to help save dose  
J. Kahn1, G. Böning1, U. Fehrenbach1, F. Feldhaus1, D. Kaul1, M.H. Maurer2, 
D.M. Renz3, F. Streitparth1; 1Berlin/DE, 2Berne/CH, 3Jena/DE  
Purpose: CT protocols for the detection of bleeding sources often include 
native CT series to distinguish between calcifications and contrast-agent 
extravasation. The study evaluates whether virtual native imaging (VNI) can 
replace real native imaging (RNI) in the reading of acute thoraco-abdominal 
bleeding and whether monoenergetic imaging can improve the detection of the 
bleeding's origin. 
Methods and Materials: Out of a total of 107 data sets from patients with 
clinically suspected bleeding, 20 patients (14 men; age 65.4±14.1 years) 
showed active visceral or soft-tissue bleeding in multi-energy CT angiography. 
After acquisition of an RNI series, the multi-energy protocol included VNI, 
monoenergetic images at 40 and 140keV and iodine mapping. CT numbers of 
ROIs in liver, pancreas, aorta, kidney, muscle and the bleeding jet were 
measured for quantitative image analysis (contrast-to-noise ratios, CNR). Two 
radiologists rated detectability of the bleeding source in different series. 
Wilcoxon rank test was used to compare related samples. 
Results: VNI series showed sufficient, but not complete suppression of iodine 
(CT number aorta RNI: 33.2±12.3, VNI: 44.8±9.5, p<0.01; bleeding jet RNI: 
43.1±16.9, VNI: 56.2±16.7, p<0.05). VNI showed significantly higher CNR than 
RNI in all measured organ regions. 40keV images showed a CNR in bleeding 
jets 4 times higher than standard 140keV images and were the best series to 
detect bleeding sources in qualitative rating. 
Conclusion: VNI can safely replace RNI in a CT protocol looking for bleeding 
sources with a potential dose reduction of 30%. Low keV series may improve 
detection of the bleeding’s origin.  
B-0293 14:40  
Evaluation of CT and clinical features of bowel and/or mesenteric injury 
in blunt abdominal trauma: a case-control study  
A. Lansier, C. Bourillon, R. Jantzen, E. Ragot, A. Follin, A. Berger, O. Clement, 
P. Halimi, C.A. Cuenod; Paris/FR (alexandre.lansier@gmail.com)  
Purpose: To evaluate the multidetector CT and clinical features of bowel 
and/or mesenteric injuries in blunt abdominal trauma and evaluate the 
interobserver agreement according to the experience of the radiologist. 
Methods and Materials: This retrospective case-control study included 30 
cases with surgically confirmed bowel and/or mesentery requiering surgical 
repair and 52 consecutive controls with blunt abdominal or chest trauma and 
no surgically important bowel and/or mesenteric injury. CT findings were 
screened by two radiologists: an 8-year-experimented in abdominal imaging 
radiologist and a second-year resident blinded to the patients’ outcome. 
Clinical outcomes were analysed by consulting the medical file. Sensitivity and 
specificity were calculated for each sign and a kappa coefficient were used to 
establish the interobserver variability. 
Results: The CT signs with best positive likelihood ratio were extra luminal air 
(infinity), bowel wall defect (infinity) and thickening (38.13), decreased bowel 
wall enhancement (10.4) and mesenteric vessels abnormalities (9.01). The 
specificity of clinical seat belt sign associated with anterior abdominal wall 
injury on CT was 98%. The sensitivity of free intraperitoneal fluid was 100% 
and its density was higher in cases. More than 50% of patients with missed 
diagnosis on first CT had a visceral injury associated. Diagnosis of mesenteric 
and/or bowel injury depends on the experience of the radiologist (kappa = 0,6). 
Conclusion: Multidetector CT is accurate for the diagnosis of bowel and/or 
mesenteric injuries in blunt abdominal trauma depending on the experience of 
the radiologist. The association of clinical seat belt sign and anterior abdominal 
wall injury on CT is highly specific.  
B-0294 14:48  
Prognostic and diagnostic value of hyperattenuating adrenal glands on 
contrast-enhanced computed tomography scans of polytraumatised 
patients  
D. Kildal, T. Erben, M. Beer; Ulm/DE  
Purpose: The adrenal gland with its endocrinal hormones relates to several 
reactions due to traumatic injury of the human body. Purpose of this study was 
to seek possible connections between hyperattenuating adrenal glands on 
contrast-enhanced CT scans of polytraumatised patients and potentially lethal 
injuries. 
Methods and Materials: This retrospective study includes 379 
polytraumatised patients which had a biphasic contrast-enhanced CT. Two 
radiologists assessed the general pathologies, Hounsfield units (HU) 
measurements of the adrenal gland [AG], the V. cava inferior [VCI] and the 
erector spinae muscle [ESM] were registered. Patients were sorted into 2 
groups [group 1: HU(AG)  HU (VCI); group 2: HU (AG)  HU (VCI)]. 
Results: 31 patients exhibited hyperattenuated AGs and were sorted into 
group 1. 348 patients were sorted into group 2 due to non-hyperattenuated 
AGs. Density in group 1 was 106.77 ± 29.29 HU, in group 2 density was 83.80 
± 26.50 HU. 11 patients of group 1 suffered from intracranial bleeding [ICB] 
(group 1: 11/31 ICB, 35.48%) whilst 54 patients of group 2 showed ICB (group 
2: 54/348 ICB, 15.52%). Intracranial bleeding and hyperattenuating AGs were 
noticed in 11 out of 65 cases (11/65, 16.92%). A comparison between group 1 
and 2 showed that it is significantly more likely to express/suffer from ICB while 
expressing hyperattenuated ADs (Fisher’s exact test p value: 0.0104, Chi-
square test p value: 0.0047). 
Conclusion: Hyperattenuating AGs of polytraumatised patients are frequently 
linked to intracranial bleeding and, therefore, might function as a red flag in 
contrast-enhanced abdominal examinations of polytraumatised patients.  
B-0295 14:56  
Dual-phase CT protocol in the assessment of traumatic liver injuries  
F. Iacobellis1, I. Iadevito2, A. Sorbo2, M.G. Scuderi1, S. Daniele1, A. Sparano1, 
G. Russo1, L. Romano1, M. Scaglione2; 1Naples/IT, 2Castel Volturno/IT 
(iacobellisf@gmail.com)  
Purpose: To examine the role of dual-phase CT protocol in the assessment of 
traumatic injuries of liver, evaluating the prevalence of parenchymal contusion, 
active bleeding, and contained vascular injuries between arterial and portal 
venous phase. 
Methods and Materials: Dual-phase CT examinations of 175 patients 
diagnosed with traumatic liver injury performed were retrospectively reviewed. 
For each examination, arterial and portal venous phase were compared in the 
identification of liver parenchymal injuries, active bleeding, and contained 
vascular injuries. 
Results: Of 175 patient, 154 (88%) had parenchymal lesions and 21 (12%) 
showed associated vascular injuries. Out of these, 16/21 (76.2%) had active 
bleeding and 5/21 (23.8%) contained vascular injuries. Parenchymal lesions 
were evident in all the patients in the portal venous phase. In 5/16 patients with 
active bleeding (30%), the arterial phase was crucial to correctly identify the 
arterial origin of the bleeding. In 3/5 patients with contained vascular injuries 
(60%), the detection of vascular lesion was possible only in the arterial phase. 
Conclusion: Dual-phase CT examinations increase the possibility, in the 
arterial phase, to detect contained arterial injuries and to identify the arterial 
origin of active bleeding, whereas the venous phase is essential to identify the 
parenchymal injuries, venous vascular injuries, to differentiate contained 
vascular injuries from active bleeding and to evaluate the bleeding entity.  
B-0296 15:04  
Correlation between CT-based liver injury scoring and subsequent 
management  
M. Reim1, A. Lomp1, V. Mihnovits1, P. Ilves1, S. Saar2, U. Lepner1, P. Talving1,2; 
1
Tartu/EE, 2Tallinn/EE (Reimmartin@gmail.com)  
Purpose: The liver is the second most commonly injured abdominal solid 
organ. The aim of the study was to determine correlation between CT scoring 
of liver injuries and subsequent operative management. 
Methods and Materials: The data for consecutive trauma admissions to major 
trauma facilities with liver injuries between 1/2009 and 12/2013 were 
retrospectively included using ICD 10 codes (S36.10) and the images reviewed 
from the All-Estonian Picture Archive (PACS). CT scoring per American 
Association for the Surgery of Trauma organ injury scale stratified liver injuries 
into minor/moderate (grades I-III) vs. severe (grades IV-V) injuries. The primary 
outcomes were operative management and in-hospital mortality. 
Results: Overall, 81 cases were included. The mean age of the cohort was 
31.5 ± 12,2 years and 73.1% were male. Overall, grades I-III injuries 86.4% 
(n=70) and grades IV-V injuries 13.6% (n=11) were examined. The most 
common associated injuries involved chest wall (n=44; 54.4%), lung (n=42; 
51.8%), lower ribs (n=32; 39.5%), and small bowel at (n=11; 13.6%), spleen 
(n=9; 11.1%), kidneys (n=7; 8.6 %). Nonoperative management was used in 
82.7% (n=67), 84.3% (n=59) of the cases for grades I-III and in 72.7% (n=8) of 
the cases for grades IV-V. There was no correlation between CT scoring of 
liver injuries and surgical management (p=0.196). The mortality of the patients 
with CT scoring was 2.5% (n=2), including one grade V injury. 
Conclusion: The majority of the liver injuries were minor or moderate and CT-
scoring of liver injuries did not determine subsequent surgical management. 
Further prospective studies are warranted.  
  






B-0297 15:12  
Comparison of the inter-observer reliability of injury severity recording 
between unstructured and structured CT reports of blunt abdominal 
trauma  
Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan/TW (ycwong@cgmh.org.tw)  
Purpose: To compare between unstructured and structured CT reports for the 
inter-observer reliability of injury severity recording in blunt abdominal trauma 
(BAT) among different readers. 
Methods and Materials: In this IRB-approved study, we randomly selected 30 
contrast-enhanced CT examinations of BAT from January 2013 to December 
2013. All images were anonymised for viewing by six readers (two attending 
radiologists, two senior residents, two junior residents) who were blinded to 
clinical outcome. They recorded CT findings independently on unstructured 
and structured templates six months apart. We compared injury severity of 
each item on a 6-point Likert scale and intraclass correlation coefficient (ICC) 
of all readers between unstructured and structured reports. 
Results: Active bleeders were recorded more critical on structured reports by 4 
(4/6, 66.7%) readers. Solid organ injuries were recorded more critical on 
structured reports by 2 (2/6, 33.3%) junior residents. Pelvic and spine injuries 
were recorded more critical on structured reports by 1 (1/6, 16.7%) junior 
resident. In contrast, hollow organ injuries were recorded less critical on 
structured report by 1 (1/6, 16.7%) attending radiologist. The ICC values for 
hollow organ injuries on unstructured and structured reports were 0.837 and 
0.821, respectively. The ICC values for active bleeders, solid organ injuries, 
pelvic and spine injuries on unstructured and structured reports were all > 
0.900. 
Conclusion: Structured reports could alter the injury severity recording of 
active bleeders and solid organ injuries from less to more critical especially 
among junior residents.  
Author Disclosures: 
  Y. Wong: Grant Recipient; MOST104-2314-B-182A-090. L. Wang: Grant 
Recipient; MOST104-2314-B-182A-090. C. Wu: Grant Recipient; MOST104-
2314-B-182A-090. 
B-0298 15:20  
Whole-body multidetector CT in polytrauma patients: incidence and 
clinical significance of missed diagnoses  
F. Ruschi; Bolzano/IT (francesco.ruschi@gmail.com)  
Purpose: To evaluate the incidence and significance of missed diagnoses at 
whole body MDCT in polytrauma patients. 
Methods and Materials: Whole body (head to symphysis) MDCT reports of 
169 polytrauma patients (study group) were retrospectively evaluated and 
compared with clinical/surgical management. The study group was divided into 
three subgroups: no missed injuries, missed injuries of no clinical significance, 
clinically significant missed injuries (requiring medical or surgical treatment). 
The MDCT exams of second and third subgroups were re-evaluated in order to 
determine whether the missed lesions were recognisable or truly non-
detectable. 
Results: The commonest types of injuries were intracranial bleeding (23%), rib 
fractures (32%), pneumothorax (17%), lung contusions (15%), spine fractures 
(23%) and midface-skull fractures (11%). In 94.1% of patients all injuries were 
diagnosed correctly. Eight patients (4.7%) had missed injuries that required no 
further treatment (non-displaced fractures, spleen/liver/cerebral contusions). 
Two patients (1.2%) had relevant missed injuries such as carotico-cavernous 
fistula and diaphragmatic rupture. With secondary interpretation the 80% of 
these lesions could be diagnosed. The carotico-cavernous fistula was missed 
probably because during the second survey (MDCT) there were concomitant 
life-threatening injuries (diffuse subarachnoid hemorrhage, internal carotid 
artery dissection) to focus on. On the other hand, as the diaphragmatic lesion 
was detected at laparotomy in a patient with CT diagnosis of complete spleen 
rupture, this had no additional therapeutic consequence (there was already an 
indication for an emergent laparotomy). 
Conclusion: Missed injuries in CT reports of polytrauma patients have rarely 
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B-0299 14:00  
Dose optimisation in digital radiography of the hands: evaluation of the 
GC85A low-dose technology  
S. Siepmann, K. Ziegeler, A. Beck, T. Diekhoff, A. Bach, B. Hamm, 
K.-G. Hermann; Berlin/DE (stefan.siepmann@charite.de)  
Purpose: Patients with rheumatic conditions are frequently required to 
undergo follow-up X-ray examinations to measure disease progression. Thus, 
reduced dose digital radiography may play a role to keep long-time exposure 
minimal. The aim of this study was to evaluate the GC85A low-dose 
technology in patients with suspected rheumatoid arthritis. 
Methods and Materials: Fixed low-dose (LD) digital radiography protocols at 
51.6 kVp were defined with 1.7 mAs and 1.2 mAs, that equal 80% and 64%, 
respectively, of the standard exposure (SE). LD images were processed further 
using the feature preserving noise reduction algorithm (S-Vue 3.02) 
implemented into the GC85A X-ray device (Samsung, Seoul, South Korea). 
Patients were consecutively enrolled. Randomly, one hand was X-rayed with 
one of the LD protocols while the opposite hand received the SE protocol. 
Images were scored independently by two readers blinded to X-ray protocol. 
Standardised scoring included evaluations of bony contours, spongious bone, 
joint spaces, soft tissues, image noise and contrast on 0-5 numeric weighting 
scales. 
Results: X-ray images of both hands were acquired in 116 patients. Mean 
image quality scores were 29.1±2.8 for SE and 28.9±3.1 for LD (no significant 
difference) for the total population. This result remained when analysing only 
80% and 64% LD images, respectively. No major artefacts occurred in any of 
the X-rays acquired. 
Conclusion: Low-dose GC85A digital radiography down to 64% of the 
standard exposure is a suitable approach to reduce the lifetime X-ray radiation 
dose in patients with rheumatic conditions, that need to undergo follow-up X-
ray examinations every other year.  
B-0300 14:08  
Heels: the higher, the better? Weight-bearing MRI evaluation of the 
forefoot in women during heeled-shoes wearing  
C. Gianneramo, F. Bruno, S. Quarchioni, E. Cannizzaro, P. Palumbo, 
S. Mariani, F. Arrigoni, A. Barile, C. Masciocchi; L'Aquila/IT 
(camillagianneramo@gmail.com)  
Purpose: To evaluate the possible physiological changes of the forefoot in 
women wearing heels using weight-bearing MRI. 
Methods and Materials: We evaluated 22 healthy volunteers (mean age 32.3 
years, range 28-36). All women were submitted to MRI examination of the foot 
in orthostatic weight-bearing position using a dedicated low-field scanner 
(0.3T). Each examination consisted of 3 acquisitions, respectively without heel 
(position1, P1), with a 2.3in (6cm)-heel (position2, P2) and with a 4.7in (12cm)-
heel (position3, P3). We acquired a sagittal SSFP 3D sequences, with 
reconstructions on coronal and axial planes. 
Results: For each position we measured, on the axial plane, the distance 
between the centre of the first and the centre of the fifth metatarsal heads (M1-
M5D), the transverse arch height (TAL), the distance from the centre of the 
third metatarsal head to the plane passing from the base of the medial sesmoid 
to the base of the fifth metatarsal head, and the angle between the first and 
fifth metatarsal (M1-M5) measured on the coronal plane.Mean values of M1-
M5D were 63.4mm (P1), 69.4mm (P2) and 74.8mm (P3) (p<0.005).Mean 
values of TAL were 12.7mm (P1), 10.8mm (P2) and 8.1mm (P3) 
(p<0.005).Mean values of M1-M5 were 21.68° (P1), 28° (P2) and 31° (P3) 
(p<0.005).These alterations resulted into evident modifications of the 
anatomical relations of the forefoot structures. 
Conclusion: Our MRI findings defined the physiological changes of the 
forefoot structures in women wearing heeled-shoes; these results could 
represent an important background to evaluate symptomatic subjects with foot 













B-0301 14:16  
MDCT arthrography assessment of the severity of cartilage damage and 
scapholunate dissociation in regard to specific component tears of the 
scapholunate ligament  
J.-B. Quere, C. Phan, A. Miquel, L. Arrive, Y. Menu, M. Crema; Paris/FR 
(quere.jb@gmail.com)  
Purpose: To evaluate the severity of cartilage damage assessed on MDCT 
arthrography in a sample of patients with scapholunate interosseous ligament 
(SLIL) tear, in regard to specific dorsal or volar component involvement. The 
relationships with assessment of scapholunate dissociation were also 
evaluated. 
Methods and Materials: We retrospectively included 43 patients who 
underwent MDCT arthrography with SLIL tears. Dorsal and volar components 
of the SLIL were separately assessed for tears and graded as: normal, partial 
tear, or complete tear. Cartilage damage was assessed in 14 regions of the 
wrist using a modified WORMS system (grades 0-6). Cartilage damage score 
was obtained by summing WORMS grades from regions of the radial side. 
Staging of SLAC (0-3) was performed. Scapholunate dissociation was 
measured at the tenth of a millimeter. The Student's T and the Wilcoxon rank-
sum tests were used to evaluate the differences in cartilage damage scores 
and scapholunate dissociation when assessing tears of dorsal and volar 
components of the SLIL. 
Results: Cartilage damage scores were greater in patients with complete tears 
of the dorsal component (12.67; 95%CI 7.63, 17.72) than in patients with no or 
partial tears (2.83; 95%CI 1.25, 4.41); p values<0.001. Scapholunate 
dissociation values were also greater in these patients (p values<0.0001). 
Scapholunate dissociation was more severe in SLAC1 than in SLAC 0 (p 
values<0.0001), with a cut-off value of 3.9 mm for diagnosing SLAC1 
(sensitivity 79.2%, specificity 94.7%). 
Conclusion: The severity of cartilage damage and scapholunate dissociation 
is greater when the dorsal component of the SLIL is completely ruptured.  
Author Disclosures: 
 M. Crema: Shareholder; Boston Imaging Core Lab, LLC. 
B-0302 14:24  
MRI patterns of locked metacarpophalangeal joints of the long fingers  
L. Lassalle1, F. Lapegue2, H. Guerini1, R. Campagna1, V. Vuillemin1, 
N.E. Regnard1, A. Buisson1, J.L. Drape1; 1Paris/FR, 2Narbonne/FR 
(louis.lassalle@gmail.com)  
Purpose: Locked metacarpophalangeal (MCP) joints of long fingers may be 
clinically misdiagnosed with more common trigger fingers. The goal is to 
describe the MR patterns of locked fingers 
Methods and Materials: MRI studies of 13 patients (12-65 yo) : 9 females 
(69%) and 4 males (31%), with clinical presentation of locked finger (loss of 
active and passive extension of the MCP joint with preserved interphalangeal 
joint mobility) were retrospectively reviewed by two MSK radiologists. MRI 
patterns were described according to the type of the lesion (dorsal or volar 
locking) and clinical presentation (further flexion possible: type 1 of impossible: 
type 2). Surgical correlation was available in 6 cases. 
Results: In type 1 lesions MR demonstrated osseous prominences or 
osteophytes of the radial condyle of the MC head and entrapment of the 
accessory collateral ligament. In type 2 lesions MR depicted intra-articular 
entrapment of a torn volar plate following an acute trauma. In dorsal locking 
MRI highlighted an entrapment of either a dorsal interosseous tendon or a torn 
collateral ligament between the sagittal band and the dorsal interosseous 
expansion (“stener like” lesion). 
Conclusion: MRI allows an accurate evaluation of the anatomical lesions in 
locked MCP joints. Several different lesions may have the same clinical 
presentation.  
B-0303 14:32  
Cartilage damage assessed with dGEMRIC occurs at the zone of 3D CT-
based impingement simulation: a pilot study  
F. Schmaranzer, T. Lerch, I. Todorski, P. Haefeli, M. Hanke, S. Werlen, 
K. Siebenrock, M. Tannast; Bern/CH  
Purpose: For complex cases of femoroacetabular impingement (FAI), CT-
based 3D impingement simulation is the current gold standard to determine the 
impingement location. Delayed gadolinium-enhanced MRI of cartilage 
(dGEMRIC) allows a noninvasive estimation of cartilage composition. (1) To 
compare T1 indices between clock-face positions with versus without 
simulated impingement; (2) to assess whether the clock-face position of lowest 
T1 index is located at the zone with highest prevalence of impingement. 
Methods and Materials: This is a retrospective IRB-approved study. Twenty-
one patients (mean age 30 years) with symptomatic FAI and preoperative 
indirect MR arthrography at 3.0 T (0.2 mmol/kg, Gd-DTPA2-) for dGEMRIC (3D 
T1 maps, dual-flip angle technique) and 3D CT scans of the pelvis with distal 
femoral condyles were included. Radial T1 images were reformatted. Regions 
of interest were placed manually. CT-based 3D models of the bony hip were 
generated and impingement simulation was performed with in-house 
developed software. This served as the gold standard. (1) Mean T1 indices 
between clock-face positions with versus without impingement were compared. 
(2) Overlap between the clock-face position with lowest mean T1 indices with 
the zone of highest prevalence of impingement (% of hips) was assessed. 
Results: (1) Mean T1 indices for clock-face positions with impingement 
(482±146 ms) were significantly (p<0.001) lower compared to those without 
impingement (594±180 ms). (2) Lowest mean T1 indices (472±140 ms) were at 
the zone of highest prevalence of impingement (2 o'clock position; 21/21 hips, 
100%) . 
Conclusion: DGEMRIC may be used for impingement detection instead of CT 
scans in young patients with FAI.  
B-0304 14:40  
Diagnostic efficacy of a 3D sequence in the standard MR protocol among 
high risk patients for knee cartilage lesions  
M. Vlychou1, I. Kyriakis2, K. Vassiou1, I. Tsougos1, S. Michalitsis1, M. Hantes1; 
1
Larissa/GR, 2Milton Keynes/UK (mvlychou@med.uth.gr)  
Purpose: Articular cartilage lesions is a common injury among patients 
between 20 and 40 years of age. 3T MR imaging is the method of choice for 
detecting traumatic knee lesions; however, its performance remains 
challenging especially for grade I and II cartilage defects. The purpose of the 
present study is to assess the diagnostic efficacy of a 3D sequence among 
high risk patients for knee cartilage lesions. 
Methods and Materials: One hundred eleven patients (78 males, 33 females, 
mean age 34.8 years) were included in the study. All patients underwent the 
same MR protocol at a 3T MR scanner including T1-weighted and 2D proton 
density-weighted sequences in three planes and a 3D spoiled gradient-recalled 
echo (SPGR) sequence. Subsequently all patients underwent arthroscopy. 
Each articular surface was graded initially at the 2D sequences and 
subsequently at the 3D sequence and was graded accordingly by two 
independent radiologists blind to arthroscopic findings. Arthroscopic grading 
was used as the gold standard. The McNemar test was used to compare 
sensitivity, specificity, positive and negative predictive values. 
Results: There was a statistically significant improvement in both specificity 
and sensitivity for detecting cartilage lesions by adding the 3D SPGR 
sequence and also a statistically significant (p < 0.05) improvement in the 
proportion of correctly graded cartilage lesions, especially in cartilage defects 
located in the femoral trochlea. 
Conclusion: The routine protocol of knee may benefit from adding a 3D 
sequence since it may improve the diagnostic efficacy for detecting and 
grading cartilage lesions in high risk patients.  
B-0305 14:48  
Comparison of T2*-weighted gradient-echo sequence with magnetisation 
transfer contrast, to other MRI sequences in the diagnosis of 
gonarthrosis  
Ü.Y. Ayaz1, M.H. Ozturk2, A. Dilli3, B. Hekimoglu3; 1Mersin/TR, 2Trabzon/TR, 
3
Ankara/TR (umityasarayaz@yahoo.com)  
Purpose: We compared the efficacy of T2*-weighted (W) gradient-echo (GE) 
sequence with magnetisation transfer contrast (MTC), to those of other MRI 
sequences in diagnosis of osteoarthritic chondral defects of the knee. 
Methods and Materials: In this prospective study, 30 patients with 
gonarthrosis who would undergo total knee prosthesis operations were 
included. 1.5-T knee MRI was performed before surgery. T2*W GE with and 
without MTC, fat-saturated (FS) T1W GE and FS proton density (PD) 
sequences were obtained. Before surgery, images were evaluated by two 
radiologists together, in consensus. For verification of MRI, osteoarthritic 
chondral defects were evaluated and documented both intraoperatively (in 
vivo) and after their excision by two orthopedic surgeons, together in 
consensus. T2*W GE sequence with MTC was compared to other MRI 
sequences in distinguishing the lesioned cartilage. Statistical analysis was 
made. 
Results: In distinguishing lesioned cartilage from the intact one, the 
sensitivities of FS PD FSE, T2*W GE with MTC, FS T1W GE and T2*W GE 
without MTC were 82%, 82%, 78% and 78%, respectively. There was no 
significant difference between FS PD FSE and T2*W GE with MTC (P> 0.05), 
while there were significant differences between these two sequences (FS PD 
FSE and T2*W GE with MTC) and the other two sequences (FS T1W GE and 
T2*W GE without MTC) (P <0.05). 
Conclusion: The use of MTC with T2*W GE seems to increase the sensitivity 
of the sequence in diagnosis of osteoarthritic chondral defects. The contrast 











B-0306 14:56  
Knee derangement in the era of total knee replacement epidemic  
M. Abd El Bagi, O. Alshehre, H. Alfaleh, S. Ahmed, F. Alorfi, N. Ashraf, 
A. Thomas, M. Reutener; Riyadh/SA (othmanzayed@googlemail.com)  
Purpose: To determine the current causes of internal knee derangement that 
might lead to total knee replacement if not treated at an earlier stage. 
Methods and Materials: A retrospective review of consecutive knee MRI 
scans performed at a tertiary care hospital.The reports and all images were 
reviewed. Indications were tabulated. Where plain films were performed, their 
results were registered. 
Results: 404 consecutive knee MRI scans were reviewed. Age range was 41 
to 81 with a mean age of 39.3 years. 247(61.1) were males. 157(38.8%) were 
females. Commonest age group was 21-40 (46.6%)of the 404 patients. The 
commonest abnormality was osteoarthritis in 182 (45%) of the 404 patients 
with equal number of affected males and females. Osteoarthritis was mild in 
126(69.2%), moderate in 44(24.1%) and severe in 12 (6.5%) of the 182 cases. 
The second commonest abnormality was menisci derangement in 160(39.6%). 
93(58.1%) of these 160 patients were males and 67(41.8% were females. 
Anterior cruciate ligament abnormalities were detected in 146(36.1%), other 
ligaments injuries in only 34(8.4%). Joint effusion was seen in 110(27.2%). 
Cartilage lesions detected in 67(16.5%). Trochlear dysplasia was seen in 91 
(22.5%) by groove depth. Lateral patellar tilt indicated a higher incidence of 
114(28.2 %) possibly exaggerated by collateral ligaments degenerative laxity. 
Conclusion: The common findings of current internal derangement are 
surgically or arthroscopically correctable by simpler and less expensive 
procedures than total knee replacement. MRI alone or in correlation with plain 
radiographs, can demonstrate these lesions at an earlier stage.  
B-0307 15:04  
Diagnostic imaging of haemophilic arthropathy in children: 3T MRI 
HAMRIS staging scale  
K. Bokwa-Dabrowska, P. Łaguna, M. Brzewski; Warsaw/PL 
(katarzyna.bokwa@gmail.com)  
Purpose: Haemophilia is a genetic bleeding disorder which leads to many 
complications including arthropathy. Precise MRI assessment provides valid 
clinical information and may lead to complementation of primary prophylaxis. 
Methods and Materials: The study group included 16 boys (25 large joints) 
aged 5-19 years with haemophilia who were examined with 3T MRI within 
HAMRIS programme (haemophilic arthropathy in magnetic resonance imaging-
staging programme). Each patient had had an episode of haemarthrosis 
affecting the examined joint and was supplemented with factor VIII or IX. Some 
examinations were performed in forced positions due to limited mobility. The 
HAMRIS protocol included basic sequences in three planes: T1 fse, T2-
weighted fse, TIRM, PD, T2 mapping. T2 me2d and T2 fl2d gradient 
sequences were obtained in 3D. Each examination was complemented with 
DWI to reassess the osseous oedema. 
Results: The HAMRIS scale includes 5 grades which gives a detailed 
classification of post-haemorrhagic complications. It classifies an injury 
according to the location and concerns the scope of endosteal oedema. The 
exacerbation of pathologies may be easily determined with the HAMRIS scale 
and make it possible to implement early orthopaedic prophylactic treatment. 
Conclusion: The implementation of the HAMRIS programme may be a chance 
to avoid surgery and permanent disability. As MRI diagnostics is becoming 
more accessible, it is thought that it should be performed on a routine basis in 
patients with haemophilia.  
B-0308 15:12  
Fat saturated 3D-flash sequence improves erosion detection on the 
sacroiliac joints: results from the SIMACT study  
T. Diekhoff, J. Greese, J. Sieper, D. Poddubnyy, B. Hamm, K.-G. Hermann; 
Berlin/DE (kghermann@gmail.com)  
Purpose: Detection of structural lesions of the sacroiliac joint improves the 
specificity of magnetic resonance imaging (MRI). Our study applies a three-
dimensional 3D-flash sequence (volumetric interpolated breath hold 
examination; VIBE) for erosion detection to patients with suspicion of axial 
Spondyloarthritis (axSpA). 
Methods and Materials: Low-dose computed tomography (ldCT) and MRI 
with T1 and VIBE of 110 prospectively included patients with low back pain 
were acquired and scored for erosions and joint space alterations by three 
readers. A contingency table analysis using ldCT as standard of reference, a 
comparison of sum scores using repeated measurements ANOVA with multiple 
comparisons and the calculation of interrater-reliability using Cohen’s kappa 
was performed. 
Results: The erosion sum score was higher for MR-VIBE (8.1 ± 9.3) as 
compared to MR-T1 (6.7 ± 8.4), p = 0.003, similarly, the total number of 
erosions (15.5 ± 21.8 vs 9.2 ± 12.1, p < 0.001). The joint space sum score was 
1.8 ± 2.2 for MR-VIBE and 0.8 ± 1.0 for MR-T1, p < 0.001. MR-VIBE showed a 
higher sensitivity for erosions as compared to MT-T1 (95 % vs 79%, 
respectively) and joint space alterations (88 % vs 76%) without a decrease in 
the specificity for erosions (93 % each) and only a small decrease for joint 
space alterations (93% vs 99 %, respectively). 
Conclusion: MR-VIBE detected erosions at the sacroiliac joints with higher 
sensitivity and similar specificity compared to a standard MR-T1 sequence. 
Therefore, MR-VIBE may be a valuable supplement to standard MR protocols.  
B-0309 15:20  
Prevalence of fat metaplasia and other structural changes of sacroiliac 
joints in patients without axial spondyloarthritis: a cross-sectional MRI 
study  
K. Ziegeler, H. Eshkal, C. Schorr, J. Sieper, T. Diekhoff, M.R. Makowski, 
B. Hamm, K.-G. Hermann; Berlin/DE (katharina.ziegeler@charite.de)  
Purpose: To determine the prevalence of fat metaplasia and other structural 
lesions of the sacroiliac joints associated with axial spondyloarthritis in a non-
rheumatological patient population. 
Methods and Materials: MRI examinations that included the pelvis of patients 
without known rheumatological disease were used for this retrospective cross-
sectional study. These images were evaluated for sacroiliac fat deposition, 
sclerosis, osteophytes and joint space alterations such as erosions or 
ankylosis. Patients were divided into 7 age groups (from 15-24 to 75). 
Prevalence of lesions across age groups were calculated. Possible clinical 
confounders (e.g. status post-radiation, suspected inflammatory bowel 
disease) were investigated with regard to their impact on lesion prevalence and 
extent to exclude bias. 
Results: A total of 485 patients were enrolled in this study. Fat deposition, was 
very common, showing a prevalence of 50.6% in the age group <45 which 
increased with age to 94.4% in patients 75 years. Erosions were uncommon: 
0.6% of patients <45 and 2.6% of the entire study population exhibited this 
feature, with no detectable age-dependent increase. Sclerosis and osteophytes 
were detected in 13.7% and 37.0% of patients, respectively. None of the 
investigated clinical confounders showed a significant impact on lesion 
prevalence. 
Conclusion: Our study shows a very high prevalence of periarticular fat 
deposition adjacent to the sacroiliac joint in asymptomatic patients, while 
erosions are extremely uncommon.  
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B-0310 14:09  
Online platform for fast and accurate calculation of fetus dose in CT  
N. Saltybaeva, H. Alkadhi; Zurich/CH (Natalia.Saltybaeva@usz.ch)  
Purpose: CT examination of pregnant patients is always a challenging task 
because of the concern about the radiation risk to the fetus (embryo). The 
methods estimating radiation dose to the fetus are either limited in their 
accuracy or require complicated measurements and calculations. The purpose 
of our study was to create online platform for fast and accurate fetal dose 
assessment. 
Methods and Materials: The online tool for fetal dose assessment was based 
on precalculated data from Monte Carlo simulations (MSC). These simulations 
were performed on standard phantoms, representing 3-, 6- and 9-month of 
pregnancy, using generic x-ray spectrum, filtration and scanner geometry. To 
validate the tool we compared the dose values calculated by the algorithm on 
standard phantoms against those calculated for the real patients. For this 
purpose MCS were also performed on 11 pregnant patient (gestational ages 7- 
35 weeks) previously underwent clinically indicated abdominal CT, using 
individual kVp, mAs curves, collimation, and scanner geometry. 
Results: The algorithm proposed in the study allows estimating dose to the 
fetus with an accuracy of 32 (STD~17%). The study has shown strong 
correlation (p<0.05) between the accuracy of calculated dose and patients 
size. The algorithm tends to overestimate fetus dose by 41% in overweight 
  






patients, however, this effect can be corrected (23±11% of accuracy) if patient 
effective diameter is used as an input parameter. 
Conclusion: The proposed algorithm allows for fast and sufficiently accurate 
assessment of radiation dose to the fetus in CT. The prototype is available 
online.  
B-0311 14:17  
Radiation dose for digital breast tomosynthesis: influence of breast 
composition and breast thickness  
N. van der Werf1, E.-.J. van Dijk2, D. Dickerscheid1, M.C. Kock1; 1Dordrecht/NL, 
2
The Hague/NL (n.r.vanderwerf@asz.nl)  
Purpose: Compared to digital mammography (DM), average glandular dose 
(AGD) increases for digital breast tomosynthesis (DBT). However, the 
contribution of breast composition and compression thickness (CT) to the 
increase in AGD remains unknown. Therefore, the objective of this study was 
to evaluate the influence of breast composition and CT on differences in AGD 
between DM and DBT. 
Methods and Materials: A total of 2,368 out-patients with low (n=479), 
medium (n=1689) and high (n=200) glandular fraction (GF) were scanned with 
the Selenia Dimensions as part of routine clinical practice. Each scan 
consisted of both DM and DBT acquisition within the same compression. ACR 
composition A and D correspond with the categories low GF and high GF, 
respectively. ACR composition B and C were combined and correspond with 
medium GF. Each GF was subdivided based on the CT into >40, 40-50, 50-60 
or <60mm. Statistical significance was analysed using paired T tests between 
DM and DBT scans, where p<0.05 was deemed significant. 
Results: For cranio-caudal (CC) views, overall AGD increased significantly 
(p<0.0005) by 0.99, 0.40 and 0.12 mGy for low, medium and high GF, 
respectively. Low and medium GF showed significant increased (p<0.0005) 
AGD for all CT. For high GF, AGD increased (p<0.0005) for 35 and 45 mm, 
whereas AGD decreased significantly (p<0.05) for 55 and 65mm. 
Conclusion: Differences in AGD between DM and DBT depends on both GF 
and CT. AGD for high GF breast of 50-60 or >60mm CT was significantly lower 
for DBT than for DM.  
B-0312 14:25  
A national web-based tool for optimisation of radiological protocols  
S.J. Thunberg, H. Båvenäs, T. Cederlund; Stockholm/SE 
(stefan.thunberg@ssm.se)  
Purpose: All medical examinations using radiation for imaging must be 
optimized for both adult and paedriatric patients. The purpose of this project 
was to develop a web-based national support for the optimization process for 
medical exposures. 
Methods and Materials: Swedish Radiation Safety Authority has developed 
and launched DosReg, a web-based tool for registration of imaging protocols 
and local diagnostic reference levels (LDRL). The user receives a histogram in 
real-time illustrating other clinics’ results as well as the national DRLs for each 
modality and procedure. DosReg has been developed for six different 
modalities: computef tomography, nuclear medicine, mammography, 
interventional procedures, conventional radiology, and dental CBCT. 
Results: Five out of DosReg’s six modalities were released in 2017. CT was 
released in September 2016. All the modalities contain registered LDRLs. CT 
has the most registrations, with 351 (as of October 2017), as this modality has 
been available for the longest period of time. Several clinics in Sweden have 
used DosReg in their optimization work in cases where their initially reported 
LDRLs were higher than those of other clinics. There have been several cases 
where DosReg’s optimization tool has resulted in a dose reduction in the range 
of 50-80 per cent. 
Conclusion: Immediate implementation of this tool by radiological 
departments needing to optimize some of their protocols will lead to 
substantially improved optimization of radiological protocols in Sweden, which 
in turn will result in less variation nationally in doses received by patients from 
the same kind of examination.  
B-0313 14:33  
Validation of the DACS-integrated radiation dose monitor skin dose 
mapping software using XR-RV3 Gafchromic films for fluoroscopically 
guided procedures  
L. Hadid-Beurrier1, B. Habib Geryes1, M.-J. Waryn2, A. Jean-Pierre1, J. Farah3; 
1
Paris/FR, 2Bondy/FR, 3Le Kremlin-Bicêtre/FR 
(bouchra.habib-geryes@aphp.fr)  
Purpose: To determine the accuracy of a DACS-integrated patient skin dose 
mapping solution for fluoroscopically guided procedures using on-phantom and 
on-patient Gafchromic film measurements. 
Methods and Materials: The DACS-integrated radiation dose monitor® (RDM, 
Medsquare) software uses radiation dose structured report (RDSR) to calculate 
cumulative patient skin dose distribution in 1 cm² area taking into account 
backscattered radiation, table and mattress attenuations. To determine their 
accuracy, RDM skin dose maps were compared against measurements 
performed with XR-RV3 Gafchromic films on IGS530 and 540 (GEMS) and 
ArtisZee-VC21 (Siemens) systems. To validate RDM peak-skin-dose (PSD) 
calculations and 2D-skin-dose distributions, measurements were first 
performed considering a PMMA phantom and then in clinical settings for 
patients undergoing pulmonary angioplasties and AVM/aneurysm neuro-
embolizations. 
Results: Thanks to a careful calibration of XR-RV3 films using a clinical beam 
quality, a 11.4% overall measurement uncertainty was achieved. RDM PSD 
calculations and Gafchromic film measurements performed on the PMMA 
phantom agreed within 23% for all considered beam projections (PA, 
R/LAO20°-60°, RAO30°CAU20°, etc.), radiation qualities (60-85 kV), fields-of-
view (16-30 cm), collimations and lateral/vertical table positions (-30 to +30 cm 
from isocenter). Skin dose distributions measured on patients show a 25% 
agreement with RDM mapping proving its accuracy in complex clinical settings. 
Conclusion: This benchmarking study proves the accuracy of RDM skin dose 
mapping software as a key tool for interventional procedures with high risk of 
skin reactions. The software is being tested in clinical settings for cardiac and 
abdominal procedures extending the tests to Philips and Toshiba vascular 
equipment.  
B-0314 14:41  
Radiation dose impact of indication- and BMI-based CT protocols vs 
anatomy-based protocols: prospective multicentre study  
H. Brat1, F. Zanca2, S. Imsand1, B. Rizk3, S. Montandon4, H. Pasquier5, 
D. Fournier1; 1Sion/CH, 2Leuven/BE, 3Villars-sur-Glane/CH, 4Gland/CH, 
5
Creteil/FR (hugobene@gmail.com)  
Purpose: To assess impact on dose metrics of indication- and BMI-based CT 
protocols vs anatomy-based protocols in a prospective multicentre dose 
optimisation study. 
Methods and Materials: A protocol optimisation based on clinical indication 
and BMI with stepwise dose reduction was implemented on 5 CT scanners 
(Philips Healthcare, NL). 3215 abdomen CT examinations (mean BMI 26 (13-
86)) were prospectively assessed for diagnostic image quality. All data were 
collected using a dose management software (DoseWatch, GE) after 
parameter uniformisation and protocol Radlex mapping. Anatomy- and 
indication-based institutional DRLs (median CTDIvol) were compared to each 
other as well as to national DRLs, according to BMI. Mann-Whitney tests were 
used to assess statistical significant differences (p<0.05). 
Results: (1) All examinations were significantly lower than national P75 DRLs. 
(2) Per clinical indication, institutional DRLs were significantly lower than 
national abdomen P25 DRL (10 mGy) for BMI<25 patients. (3) BMI 
stratification enabled a significant dose impact (BMI<25/BMI>25): appendicitis 
5.8/9mGy, colonography 4.1/9.5mGy, diverticulitis 5.9/9.5mGy, kidney stones 
5.6/8.6mGy, liver 7.3/13mGy, pancreas 5.6/8.5mGy, renal infection 
6.5/8.9mGy, renal tumour 5.8/9.4mGy. (4) Indication: compared to anatomy-
based protocols were significantly lower for specific indications: CT 
colonography, kidney stones and pancreas for BMI<25 and pancreas, kidney 
stones, renal infection and renal tumour for BMI>25 patients. 
Conclusion: This multicentre prospective study showed: (1) a statistically 
significant reduction in patient X-ray exposure when considering BMI and 
indication-based abdomen CT protocols compared to anatomical region 
protocols and national DRLs. (2) A p25 DRL target for BMI<25 abdomen CT 
achievable in all patients.  
Author Disclosures: 
 F. Zanca: Employee; GE Healthcare.  S. Montandon: Employee; Philips 
Healthcare. 
B-0315 14:49  
CT scan radiation dose evaluation by clinical indication: a multi-centric 
French study  
A. Hornbeck1, B. Habib Geryes2, N. Pierrat2, V. Jarrige3, S. Dreuil4, 
H. Ducou le Pointe2; 1Strasbourg/FR, 2Paris/FR, 3Bourges/FR, 
4
Fontenay-aux-Roses/FR (amauryhornbeck@gmail.com)  
Purpose: To propose dosimetric indicators representing French national 
practices for current adult CT-scan clinical indications. 
Methods and Materials: 22 groups of clinical indications (GCI) for diagnostic 
CT-scan in adult patients were defined jointly by the French Society of Medical 
Physics (SFPM) and the French Society of Radiology (SFR), based on their 
frequency and their requirements in terms of image quality. A national call for 
participation was sent to the medical physicists’ community and a data sheet 
was emailed to the volunteers. Data collection took place from March to June 
2017. For each scanner and each GCI, 15 to 30 consecutive exams performed 
between 2015 and 2017 were required. Collected data included scanner 
characteristics (model, year, maximum collimation), patient morphological data 
(age, gender, weight, height), technical settings (kV, scan length, contrast 
media, tube current modulation, reconstruction algorithm) and dosimetric data 
(CTDIvol, DLP) for each phase of the CT exam. A two-step validation was 
  






performed: the global coherence of the collected data was checked and the 
pertinence of the selection method of the examinations was reviewed. 
Results: 10753 CT-scan acquisitions, representing 7490 examinations, were 
collected from 53 public and private French radiology departments. Dosimetric 
indicators are proposed as examination DLP and acquisition CTDI and DLP for 
each GCI. Influence of patient morphology or examination technical settings is 
studied for selected GCIs. 
Conclusion: CT-scan dosimetric indicators by clinical indication represent an 
attempt to provide a tool for CT dose optimization that is better adapted to the 
everyday clinical practices.  
B-0316 14:57  
Multicentre CT scanner dose excellence programme: strategies and 
results  
H. Brat1, C. Dias2, S. Behzad Imsand3, C. Thouly1, S. Montandon4, B. Rizk5, 
D. Fournier1, F. Zanca6; 1Sion/CH, 2Buc/FR, 3Epalinges/CH, 4Gland/CH, 
5
Villars-sur-Glane/CH, 6Leuven/BE (hugobene@gmail.com)  
Purpose: To comply to the revised European Basic Safety Standards Directive 
to present a radiation dose optimisation and education programme through CT 
protocol harmonisation and optimisation in a multicentre setting. 
Methods and Materials: A dose team was set up with one radiologist and one 
technologist in each center, a CT field engineer, a physicist and team leader. 
Data were collected in a dose management software (Dosewatch™, GE). Two-
step strategy: 1. harmonisation by designing a clinical indication-based 
protocol map with 2 categories of patients according to body mass index (BMI 
< 25 and BMI > 25), after CT parameters uniformisation and protocol Radlex 
mapping. 2. Optimisation using a 12% step-wise mA reduction for all protocols. 
Low-contrast resolution was quantified by phantom analysis (QRM™ 401 
abdomen phantom, Germany) to guarantee 5mm liver lesion detectability. 
Image quality was assessed using adapted European image quality guidelines 
and an electronic voting tool in the dose tracking software. 
Results: Protocol harmonisation eliminated redundant protocols and reduced 
dose globally by 6% for chest and 7% for abdomen at institutional level. 
Protocol optimisation additionally reduced dose by 26% on average before 
hitting the low-contrast resolution limit (phantom measurements). Clinical 
indication- and BMI-based protocols allowed significantly lower dose levels 
than existing DRLs. 
Conclusion: Homogenising CT protocols and optimising radiation doses 
without compromising image quality can be achieved with a clear road map, 
leadership, team work, education, regular communication, commitment, 
continuous dose monitoring and partnership with stakeholders. The use of 
automatic dose data collection and phantom tests during optimisation are key.  
B-0317 15:05  
Evaluation of diagnostic reference levels for conventional radiography in 
Austria  
D. Wachabauer, F. Röthlin, P. Homolka, H.M. Moshammer, H. Ostermann; 
Vienna/AT (david.wachabauer@goeg.at)  
Purpose: Evaluation of Austrian National Diagnostic Reference Levels 
(NDRLs). 
Methods and Materials: A nationwide survey on common conventional 
radiography examinations was conducted. In line with Austrian radiation 
protection standards, all relevant Austrian hospitals and radiology practices 
were asked to report a minimum sample of 10 representative dose-area 
products (DAP) together with patient weight. Participants were invited via e-
mail, followed up by reminders to increase participation rates. 59% of invited 
institutions (67% hospitals, 51% radiology practices) submitted DAP data 
(n=15305), 31% submitted additional data on patient weight. Case numbers 
presented varied from 1005 to 2121. Plausibility checks were performed to 
increase data quality. Third quartiles (Q75) of median DAP of participating 
institutions were calculated and compared to NDRLs. 
Results: DAP values and interquartile ranges (IQR) are given in cGy*cm2. 
Third quartiles (Q75) were considerably lower than existing NDRLs. Highest 
discrepancies (50%) were observed for skull AP/PA (Q75: 49, IQR:21, 
NDRL:100), skull LAT (Q75:49, IQR:21, NDRL:100), chest PA (Q75:13, IQR:6, 
NDRL:28) and LAT (Q75:42, IQR:21, NDRL:100). Discrepancies of 20% 
occurred for abdomen AP/PA (Q75:184, IQR:92, NDRL:300), pelvis AP 
(Q75:194, IQR:96, NDRL:300) and lumbar spine LAT (Q75:310, IQR:149, 
NDRL:400). For lumbar spine AP (Q75:176, IQR:90, NDRL:200) discrepancy 
was 12%. Q75 for bedside chest X-ray (Q75:20, IQR:10) was significantly 
(p0.01) higher than thorax PA. Average patient weight was 74kg. 
Conclusion: Q75 derived from the survey are on average 40% lower than 
Austrian NDRLs suggesting an update of NDRLs. Since Q75 correspond nicely 
to German and Swiss NDRLs, an update would be in accordance with 




B-0318 15:13  
Diagnostic reference levels for interventional radiology: quantifying 
diagnostic cerebral angiography complexity  
T. De Bondt1, F. Zanca2, X. Lopez Rendon2, L. Brouhon1, T. Van der Zijden1, 
M. Voormolen1, O. D'Archambeau1, P.M. Parizel1; 1Antwerp/BE, 2Buc/FR 
(timo.debondt@gmail.com)  
Purpose: To comply with the 2013/59/Euratom guidelines, diagnostic 
reference levels (DRL) for interventional radiology procedures need to be 
established. The complexity of procedures influences the delivered radiation 
dose; hence, a quantitative measure for complexity needs to be defined to 
stratify dose levels. 
Methods and Materials: A complexity form was drafted through a 
collaboration of 3 interventionalists, a radiographer and a medical physicist. 
This form contains factors, with grading scale, that contribute to delivered 
radiation dose in diagnostic cerebral angiography. Complexity data from 27 
interventions were acquired, along with automatically collected dosimetric data 
from a dose-tracking software system (DoseWatch, GE Healthcare). A multiple 
linear regression model was built to predict air kerma (Kair) and dose area 
product (DAP), which are the quantities in which DRLs are expressed. 
Results: Statistically significant factors to predict Kair and DAP are fluoroscopy 
time (p=0.007; p<0.001) and presence of anatomical variant (p<0.001; 
p=0.002). Additional parameters are of significant value to predict DAP: weight 
(p=0.002), ease of catheterization (p<0.001) and peripheral vessel disease 
(p<0.001). A complexity index based on the regression coefficients was not 
able to categorize procedures as being easy, medium or difficult with a 
statistically significant difference. 
Conclusion: Adding a complexity factor to define DRLs for interventional 
procedures poses a significant challenge. Our pilot study shows that relevant 
complexity factors differ between models for Kair and DAP, which is 
problematic. Larger datasets with standardized complexity forms need to be 
acquired to establish robust models to define DRLs for interventional radiology 
procedures.  
Author Disclosures: 
  T. De Bondt: Consultant; GE Healthcare. F. Zanca: Employee; GE 
Healthcare. X. Lopez Rendon: Employee; GE Healthcare.  
B-0319 15:21  
Implementation of updated ACR size-specific CT diagnostic reference 
levels based on water-equivalent diameter and SSDE using automated 
dose monitoring software  
P. Kröpil, C. Thomas, O.T. Bethge, Y. Klosterkemper, J. Aissa, E. Appel, 
C. Schleich, G. Antoch, J. Boos; Düsseldorf/DE  
Purpose: To use automatic dose monitoring software to analyse institutional 
CT dose data regarding the updated American College of Radiology (ACR) 
diagnostic reference levels (DRLs) based on water-equivalent diameter (Dw) 
and size-specific dose estimates (SSDE) to detect patient-size subgroups in 
which dose can be optimised. 
Methods and Materials: This retrospective study included all institutional 
chest CT, pulmonary CT-angiography and abdominopelvic CT from 06/2016 to 
03/2017. Dw and SSDE were automatically calculated using in-house-
developed Matlab software (The Mathsworks, Natick) and stored into our dose 
monitoring system (DoseIntelligence®, Pulmokard). SSDE as CT dose 
parameter was analysed regarding updated ACR DRLs using Dw to group 
patients (size groups: 21-25cm, 25-29cm, 29-33cm, 33-37cm, 37-41cm). 
Results: 30002 CTs were performed during the study period, n=4541 were 
included in the analysis (age 62.2±16.1 years, Dw 29.0±3.6cm). Mean SSDE 
relative to updated DRLs were 43.9±21.7% for non-contrast (n=655) and 
51.2±24.5% for contrast-enhanced (n=719) chest CT, 66.9±30.6% for 
pulmonary CTA (n=371), 41.8±28.5% for non-contrast (n=635) and 
55.1±21.7% for contrast-enhanced (n=2161) abdominopelvic CT. Lowest dose 
compared to ACR DRLs was found for Dw-group 21-25cm in non-contrast 
abdominopelvic CT (31.8±21.3%). The only transgression of ACR DRLs was 
found for Dw-group 37-41cm in non-contrast abdominopelvic CT 
(100.3±60.0%). 
Conclusion: Mean SSDE of institutional CT protocols were lower than 
updated ACR DRLs. However, size-specific subgroup analysis revealed slight 
transgression of DRLs in non-contrast abdominopelvic CT of large patients. 
Updated ACR size-specific DRLs allow for a comprehensive analysis of CT 
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B-0320 14:09  
Image comparison of virtual non-contrast images and true non-contrast 
images obtained from dual-energy CT in latest generation dual-source 
and dual-layer CT for liver  
B. Na, S.-J. Lee, H.-J. Jeong, D.-S. Kim; Seoul/KR (passion3744@gmail.com)  
Purpose: To evaluate the reliability of virtual non-contrast (VNC) images 
obtained from two different dual-energy CT (DECT) which have different 
mechanism to produce VNC image. 
Methods and Materials: Sixty patients underwent liver CT examination, using 
both dual-layer detector CT and third-generation dual source CT. Mean 
attenuation and contrast to noise ratio (CNR) for the relevant tissues were 
compared between true non-contrast (TNC) and VNC images. Paired student t 
tests were used for statistical analysis. Under same CT scan parameter, using 
the both DECT, performance phantom was scanned to evaluate background 
noise which could influence CNR. 
Results: Mean attenuation difference between TNC and VNC image with dual-
source CT and dual-layer CT were as follows, respectively: right liver lobe -
0.22 and -1.02, left liver lobe -0.99 and 2.12, psoas muscle -0.8 and 1.01, aorta 
5.63 and 14.47, spleen 3.92 and 3.9, right kidney 5.17 and 6.59, left kidney 
6.35 and 6.23. There was no significant difference in mean attenuation value of 
liver and psoas muscle from the both DECT scanner (p>0.05). CNR on TNC 
image was higher than on VNC image because background noise of VNC was 
almost twice of higher than TNC. However, under same CT scan parameter, in 
the phantom experiment, same background noise values were shown between 
TNC and VNC from the both CT scanner. 
Conclusion: VNC image obtained from both dual-source and dual-layer CT 
could potentially be an alternative to TNC image for liver examination.  
B-0321 14:17  
Acceptable noise levels in abdominal CT examinations of obese 
paediatric patients  
M. O'Connor, J.G. Stowe, S.J. Foley; Dublin/IE (michelle.oconnor@ucd.ie)  
Purpose: This research investigated acceptable noise levels in abdominal CT 
scans of obese paediatric patients 
Methods and Materials: A MATLAB-based low dose simulation software was 
developed and validated in-house which enabled simulation of 50mAs 
stepwise increases in mAs. With ethical permission, a sample of 21 obese 
abdominal CT datasets, stratified by age (5-, 10- and 15-year olds) was 
retrospectively collected from Irish paediatric hospitals. Scans were performed 
on Philips 64 slice Brilliance scanners using weight-based protocols (80-
120kVp, AEC, 64x0.625mm collimation, pitch0.891, iDose level 4). A single 
axial slice at the level of L1 from each scan was modified using the low dose 
simulation software to imitate scans obtained at lower mAs i.e. higher noise 
levels. This resulted in a total of 76 scans for review. Objective noise 
measurements were performed by the lead researcher using identical sized 
ROI’s in three homogeneous locations; (1) liver, (2) subcutaneous adipose 
tissue, (3) air 2cm anterior to skin. Subjective image quality analysis was 
carried out by four experienced paediatric radiologists. Diagnostic acceptability, 
subjective image noise, contrast resolution, spatial resolution and visibility of 
anatomical structures were scored using a grading system devised from the 
European Guidelines on quality criteria for CT. 
Results: The amount of noise considered acceptable in abdominal scans of 
obese paediatric patients by all four viewers was; 18.6HU in the 5-year-old 
group, 16.24HU in the 10-year-old group and 15.91HU in the 15-year-old 
group. 
Conclusion: This research is the first to establish the maximum noise level 





B-0322 14:25  
Does body mass index affects radiation dose reduction in prospective 
electrocardiographic gating cardiac computed tomography?  
B. Kara, M. Onur, A. Toker, S. Horoz, D. Akata; Ankara/TR 
(tomografi@hotmail.com)  
Purpose: To evaluate the effect of body mass index (BMI) in radiation dose 
reduction in different cardiac computed tomography (CT) protocols. 
Methods and Materials: We retrospectively evaluated cardiac CT 
examinations of 172 patients (79 female, 93 male; mean age: 64, ranging 
between 37-81) presented with cardiac symptoms. Patients were grouped 
according to BMI as group I (BMI < 30) and group II (BMI > 30). Cardiac CT 
examinations were performed with two different methods as conventional 
cardiac and prospective ECG gating (PECT) method. Radiation dose levels of 
patients were recorded as dose length product (DLP) values. We compared 
the DLP values of two cardiac CT protocols in group I and group II. 
Results: PECT and conventional cardiac CT were performed in 32 and 56 
patients, respectively in group I. Group II was consisted of 28 and 56 patients, 
respectively. There were statistically significant differences between mean DLP 
values of patients underwent PECT (DLP:111.88; DLP: 188.50) and 
conventional cardiac CT (DLP: 376.54; DLP: 858.54) in group I (P < 0.0001) 
and group II (P < 0.0001), respectively. Radiation dose reduction was more 
significant in group II. 
Conclusion: Prospective ECG gated cardiac CT yields significant radiation 
dose reduction in patients with BMI < 30 and BMI > 30. Reduction of radiation 
dose is more prominent in patients with BMI > 30.  
B-0323 14:33  
Metal artefact reduction in the musculoskeletal system with dual-energy 
CT and spectral imaging  
C. Fraga Piñeiro1, M. González Vázquez1, M. Monteiro2; 1Vigo/ES, 
2
Coimbra/PT (carlosfrapi@gmail.com)  
Purpose: Metal artefacts have been an important limitation in musculoskeletal 
CT, but with the advent of dual-energy equipment new strategies to reduce 
metal artefact have been provided. We intended to compare metal artefact 
reduction and image quality in dual-energy computed tomography (DECT) 
using polychromatic and high-energy monochromatic images. 
Methods and Materials: We collect data from 39 patients with metallic 
implants in extremities who underwent DECT polychromatic images with 80, 
120 and 140kV and post-processing high-energy monochromatic images at 
110, 130 and 150KeV were used. Qualitative evaluation of the artefact and 
image quality was performed by two musculoskeletal radiologists using Likert 
scale. We use Spearman's Rho for inter-observer correlation. Artefact severity 
was assessed quantitatively. 
Results: The best results were obtained at 140kV as well as in monochromatic 
series. The inter-observer agreement was (artefact rs=0.73- 0.95 and quality 
image rs=0.77-0.93). Artefact severity (artefact index): 14.16 (80kV), 11.01 
(120kV), 7.74 (140kV), 6.36 (110keV), 5.5 (130keV) and 4.94 (150keV). All 
results presented statistical significant differences (p<0.05), except for 130 and 
150keV which had comparable results. 
Conclusion: Metal artefact reduction and image quality were rated superior in 
monochromatic high energies, compared with polychromatic images and, 
within these, those with 140kV were considered better than with energies of 80 
and 120kV.  
B-0324 14:41  
Effective dose calculations of trunk CT scans in single-energy CT (SECT) 
and fast kVp switching dual-energy CT (FKS-CT)  
K. Yagami1, T. Miyoshi1, S. Shigeyama1, H. Okada1, S. Suzuki2, S.J. Foley3; 
1
Gifu/JP, 2Toyoake/JP, 3Dublin/IE (yagami@gifu-u.ac.jp)  
Purpose: To compare effective dose calculations based on dose-length 
product (DLP), size-specific dose estimate (SSDE) and measured organ doses 
in SECT and FKS-CT using an anthropomorphic phantom. 
Methods and Materials: Two 64-detector row CT systems (Discovery 
CT750HD; GE and Brilliance 64; Philips) were used for dose measurement. An 
anthropomorphic phantom (Alderson Rando Phantom) with thermo-
luminescent dosimeters (BeO) was positioned inside (n=97) and on the surface 
(n=60) of various anatomical organs as per ICRP 103 for measuring the 
effective dose and calculating SSDE according to AAPM 204. The scanning 
conditions were the same as those used in clinical practice. The scanning 
range of FKS-CT was chest apices to symphysis pubis and SECT were three 
different examinations including chest apices to symphysis pubis (whole body), 
diaphragm to symphysis pubis (abdomen-pelvis) and chest apices to 
diaphragm (chest). 
Results: Measured average effective dose between the two CT systems in 
whole-body CT was 13 mSv, in abdomen-pelvis CT was 9 mSv, chest CT was 
5 mSv, and in FKS-CT was 13 mSv. For both CT systems, the difference 
between effective dose based on measured organ doses and calculations from 
  






SSDE and k-factors was within 10% for all scan ranges and also FKS-CT. 
However, the use of DLP and k-factors resulted in 25% differences in effective 
dose compared to measured organ dose values. 
Conclusion: For both SECT and FKS-CT, effective dose from measured 
organ doses closely approximated effective dose calculated from SSDE but 
DLP conversion to effective dose consistently underestimated both values.  
B-0325 14:49  
Impact of scanner type and acquisition parameters on the accuracy of 
displayed computed tomography dose index  
C. Dionisi, B. Cannillo, R. Matheoud, L. Vigna, G. Fusco, M. Brambilla; 
Novara/IT (clizia.dionisi@gmail.com)  
Purpose: According to the EU directive 2013/59, CT scanners shall be able to 
inform the practitioner of relevant parameters for assessing the patient dose. 
The aim of this study was to measure the accuracy of the displayed CTDI on 
ten different CT scanners of various vendors and to assess the impact of 
acquisition parameters on CTDI accuracy. 
Methods and Materials: CT scanners from 4 vendors (16 slices n=6, 32 slices 
n=1, 64 slices n=3) were included in the study. The accuracy of the displayed 
CTDI was checked using a dosimeter. The impact of the independent 
variables, CT model (16, 32, 64 slices), phantom size (head/body), kVp (80, 
100, 120, 140 kVp) and primary collimation (3mm, 3-10mm, 10-20mm, >20 
mm) on the dependent variable, accuracy of the displayed CTDI (derived from 
user manual), assessed by a four-way factorial ANOVA. 
Results: All the factors had a statistically significant impact on CTDI accuracy 
(p<001). In a head to head comparison, the lower accuracies were found on 
average for 16 slices CT (-10±5%), for HeadPhantom (-8±8%), for 80kV (-
14±11%) and for thick collimation (-9±12%), whereas maximum accuracies 
were found for 64 slices CT (-5±10%; p<0.001), BodyPhantom (-5±9%; 
p=0.05), 140 kV (-5±9%; p<0.01) and thin collimation (-6±7%; p=NS ). 
Conclusion: In the case of 16CTs and acquisition protocols involving the use 
of the HeadPhantom with low kV and a wide primary collimation, the displayed 
CTDI inaccuracies may be higher than 20% (suspension level in the EC RP 
N.162).  
B-0326 14:57  
Dose values in interventional computed tomography procedures: a 
multicentre study  
A.R. Costa1, I. Gomes1, A.S. Pimenta2, C. Oliveira1, C.M. Almeida3, 
G.N. Paulo1, J. Santos1; 1Coimbra/PT, 2Porto/PT, 3Lisbon/PT 
(araquel.costa@hotmail.com)  
Purpose: The number of computed tomography (CT)-guided interventions had 
increased exponentially on the last decade. The aim of this study was to 
analyse the frequency of examinations, protocols and patient dose values. 
Methods and Materials: The study was carried out in three Portuguese 
centres of reference of excellence. Retrospective analysis of the frequency of 
interventional CT procedures, patient data (age, gender and examination body 
region), exposure parameters and dose values, in terms of CT dose index 
(CTDIvol) and dose length product (DLP) were directly collected from picture 
archiving and communication system (PACS). 
Results: Local DRLs were obtained for the most common interventional CT 
procedures per each centre (76% chest, 10% bone, 8% pelvic and 6% 
abdomen). Lung biopsy revealed to be the most frequent procedure. The 
exposure parameters and dose values vary across the centres. The found 
acquisition modes for intervention CT are 2D in (axial and helical mode) and 
CT fluoroscopy. The highest interventional acquisition dose values were found 
for CT fluoroscopy. The majority of the obtained dose values are similar to 
other studies. 
Conclusion: The first national approach of interventional CT dose values was 
performed. Different approaches to these procedures were verified. A lack of 
standardisation of practice was identified justifying further research to protect 
the staff and decrease the risk of patient’s over-exposure and procedure 
complications.  
B-0327 15:05  
One-stop imaging for triple-rule-out CT angiography using 16-cm wide-
detector CT: a preliminary study  
K. Liu, Z. Li; Chengdu, Sichuan/CN (634270986@qq.com)  
Purpose: To investigate the feasibility of one-stop imaging for triple-rule-out 
(TRO) CT angiography (CTA) using 16-cm wide-detector CT in patients with 
acute chest pain. 
Methods and Materials: Totally 23 patients with requests for examinations of 
thoracic vessels underwent TRO CTA on a 256-row, 16-cm wide-detector CT 
using a protocol consisting of an axial, ECG-gated cardiac acquisition followed 
by a spiral chest CT acquisition from the thoracic inlet to the diaphragm bottom 
in a free breathing condition. Heart rate was not controlled. The total volume of 
iodinated contrast medium (370mg/ml) for a biphasic injection protocol was 60-
75ml (30-45ml based on the weight of patients; then another 30ml). 
Attenuation values and standard deviations in pulmonary artery, thoracic aorta, 
coronary artery and muscle were measured to calculate contrast noise ratio 
(CNR) for vessels as objective indicators to evaluate the image quality. The 
subjective image quality was evaluated independently by two readers. Effective 
dose was recorded. 
Results: All patients gained satisfactory image quality for diagnosis. There 
was no statistically significant difference between the scores of two readers 
(P>0.05). Mean attenuation values were adequate at 464.3±146.1HU in the 
pulmonary trunk, 313.1±50.4HU in the aortic arch, 378.5±64.9HU and 
410.3±58.3HU in the right and left coronary artery, respectively. Noise was 
16.6±1.8 and CNR were 27.1±8.6 in the pulmonary trunk, 18.0±3.2 in the aortic 
arch, 22.1±5.1 and 23.8±3.7 in the right and left coronary artery, respectively. 
Effective radiation dose for the entire scan was 4.5±0.9 mSv. 
Conclusion: One-stop imaging for TRO CTA using 16-cm wide-detector CT 
can improve image quality, with low radiation dose and contrast medium 
volume.  
B-0328 15:13  
Optimisation of computed tomography practice: phantom and patient 
approach  
F. Pires, T. Patrão, F. Alves, J. Santos; Coimbra/PT (fspires.11@gmail.com)  
Purpose: Computed tomography examinations are responsible for a large 
proportion of effective collective dose across the countries, and concern about 
potential effects increased in the last years. The aim of this study was to 
analyse the exposure parameters and dose levels of the most common CT 
procedures to audit and implement optimisation measures. 
Methods and Materials: This study was carried out in four phases: (1) 
establishment of local diagnostic reference levels (DRLs) base on the 75th 
percentile dose value of the most common CT examinations; (2) analyse of the 
practice and literature comparison; (3) anthropomorphic phantom experimental 
tests with PBU-60; (4) subjective and objective image quality analysis, based 
on visual grading characteristic (VGC) of the radiologist opinion of the guideline 
criteria and on the standard deviation value of the Hounsfield units in 
homogeneous regions of interest, respectively. 
Results: Local DRLs were obtained for head, chest, abdomen and lumbar 
column. The majority of the values were higher than the recommendation. The 
optimisation experimental tests allowed the definition of new exposure 
parameters with radiologist approval. The optimised local DRLs are according 
to the recommend values in most of the body regions. Image quality analyses 
revealed an expected increase of noise; however, no significant differences 
were founded for the majority of criteria. 
Conclusion: The most common CT procedures were optimised. Dose 
reductions were obtained with diagnostic imaging criteria fulfilment and 
radiologist approval.  
B-0329 15:21  
Assessment of image quality criteria from chest CT examinations  
R. Carrasquinho1, A.M. Ribeiro1, L.P. Ribeiro1, O. Lesyuk2, R.P. Almeida1, 
A.F. Abrantes1; 1Faro/PT, 2São Brás de Alportel/PT 
(oksanalesyuk@gmail.com)  
Purpose: To assess the image quality criteria from chest CT examinations 
based in quality control charts and to demonstrate the importance of 
implementing an image quality control system. 
Methods and Materials: A retrospective study was conducted in a public CT 
unit using a random sample of 750 chest CT examinations grouped into 30 
smaller samples, each one with 25 exams. Using a checklist based on CT 
quality criteria, the conformities and non-conformities found were recorded and 
used to establish three types of quality control: (1) the proportion of 
conformities and non-conformities (p chart); (2) the total number of non-
conformity exams (np chart) and (3) the total number of non-conformities in 
each sample (c chart), in order to suggest corrective actions for improvement. 
Results: Considering all exams, 186 (24,80 %) are non-conformity exams. 265 
non-conformities were identified and the "absence of data relating to 
examination" presented the highest number of non-conformities (55,09%), 
followed by the group "image quality criteria" (17,36 %), “artefacts” (13,96%) 
and the "incorrect positioning" (13,58 %). 
Conclusion: This research allowed the identification of different types of non-
conformities found in chest CT images, which have impact on image quality. 
Therefore, the existence of suitable quality control of the image is essential to 
achieve high quality standards in CT departments. It is recommendable to do 
training courses regularly improving radiographer’s performance and strategies 
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B-0330 14:00  
Obesity and type 2 diabetes: cardiovascular and cerebral aspects  
R.L. Widya; Leiden/NL (R.L.Widya@lumc.nl)  
Purpose: This thesis focuses on cardiovascular and cerebral dimensions and 
function in people with obesity and type 2 diabetes. 
Methods and Materials: Extensive cardiovascular, abdominal and cerebral 
phenotyping by magnetic resonance imaging (MRI), magnetic resonance 
spectroscopy and functional MRI was performed in healthy, overweight and 
obese subjects, and type 2 diabetes patients. Statistical analysis included 
multivariate linear regression models to investigate the complex 
interrelationships between fatty liver, visceral and subcutaneous adiposity, 
metabolic syndrome, and several cardiovascular and cerebral outcome 
measures. 
Results: In a large population-based cohort, hepatic triglyceride content was 
associated with left ventricular diastolic function and aortic pulse wave velocity 
after adjustments for several cardiometabolic risk factors. Studies with type 2 
diabetes patients showed right ventricular remodeling and impaired systolic 
and diastolic function, in a similar manner as changes in left ventricular 
dimensions and function. A 6-month exercise intervention induced tissue-
specific changes in ectopic fat compartments. Short-term caloric restriction 
normalized hypothalamic responsiveness to glucose ingestion in patients with 
type 2 diabetes. Obesity was associated with larger amygdalar and 
hippocampal volumes, and increased abdominal visceral adipose tissue rather 
than subcutaneous adipose tissue was associated with microstructural brain 
tissue damage. 
Conclusion: Cardiovascular and cerebral impairments in obesity and type 2 
diabetes are influenced by several metabolic abnormalities. Fatty liver itself 
could pose a risk of myocardial dysfunction and subclinical vascular 
impairment above and beyond known cardiovascular risk factors that are 
clustered within the metabolic syndrome. Exercise and caloric restriction show 
beneficial effects on ectopic fat deposition and hypothalamic glucose response.  
B-0331 14:08  
CT dose reduction for epicardial fat measurement in obese patients: 
effects of low-dose cardiac CT and adaptive statistical iterative 
reconstruction  
S. Mirafzal, C. Lahaye, A. Mulliez, P. Morin, M.A. Vaz Touret, Y. Boirie, 
L. Boyer, L. Cassagnes; Clermont-Ferrand/FR (sonia_mirafzal@hotmail.fr)  
Purpose: To evaluate the effects of radiation dose reduction—120 kV versus 
100 kV—and the reconstruction algorithm used—adaptive statistical iterative 
reconstruction (ASIR)—on the variability and reproducibility of EFV (epicardial 
fat volume) in obese patients. 
Methods and Materials: Standard dose CT (120 kV) and low-dose (100kV) 
calcium artery scoring CT (CAS-CT) examination were performed in 80 obese 
patients. The standard dose CT images were reconstructed using ASIR 30% 
(reference standard in our center); the low-dose CT images were reconstructed 
using ASIR 30%, 50% and 100%. In the 320 images series obtained, the EFV 
was measured using a semi-automatic software. Two observers independently 
quantified EFV and inter-observer agreement was evaluated. 
Results: Radiation dose of the low-dose CAS-CT examinations was 67% 
(mean) lower than standard dose CT examinations. The mean noise on 
standard dose CT, ASIR 30 low-dose CT, ASIR 50 low-dose CT, ASIR 100 
low-dose CT were 22.5, 35.5, 30.3, and 22.8, respectively. Excellent 
correlations were observed between the EFV measured on standard dose CT 
and EFV measured on low-dose CT ASIR 50/EFV measured on low-dose CT 
ASIR 100 (r=0.96, p<0.01 and r=0.97, p<0.01, respectively). Inter-observer 
agreement was excellent too: r=0.97, p<0.01. 
Conclusion: A 67.0% reduction of the radiation dose would be possible in CT 
for the measurement of EFV in obese patients using low-dose CT and the 







B-0332 14:16  
Computer-aided semi-automatic quantification of epicardial fat volume on 
angio-CT images  
M. Codari1, C. De Angelis2, M. Scarabello2, F. Secchi1, F. Sardanelli1; 
1
San Donato Milanese/IT, 2Milan/IT (marina.codari@grupposandonato.it)  
Purpose: The quantification of epicardial adipose tissue (EAT) on angio-CT 
images is still limited in clinical routine due to the post-processing time. To this 
aim, we proposed a semi-automated method for EAT quantification and 
evaluated its reproducibility. 
Methods and Materials: Twenty-one consecutive angio-CT, performed from 
February 2017 to May 2017, were retrospectively selected. Our local Ethics 
Committee approved this study. A semi-automatic approach was developed to 
detect the pericardial sac through the 3D interpolation of contours manually 
identified on different views and segment the EAT contained therein. Two 
operators segmented all images using a double-blinded approach. One 
operator performed it twice. The number of contours and EAT volume (cm3) 
were recorded for all images. Data are presented as median and interquartile 
range. Wilcoxon signed rank test was used for comparisons while Bland-
Altman analysis was used to assess operator reproducibility. 
Results: Intra- and inter-operator analysis showed: a bias of 1.0 cm3, a 
coefficient of repeatability of 14.0 cm3, an average measurement of 90.2 cm3, 
and a reproducibility of 84%; 1.1 cm3, 21.0 cm3, 90.9 cm3, and 77% 
respectively. The median number of drawn contours was 12 (10-14), with 
statistically significant difference between the number of segmented contours 
by each operator (p=0.018), but not between the corresponding volume values 
(p=0.875). 
Conclusion: The proposed method allows segmenting a whole angio-CT 
images, with submillimetric resolution, using few contours with an acceptable 
level of reproducibility. The significant difference in contours number seems to 
not affect volume segmentation accuracy, allowing to further reduce them.  
B-0333 14:24  
Epicardial fat volume as a potential imaging biomarker for coronary 
artery disease in symptomatic patients  
G. Milanese1, M. Silva1, L. Bruno2, M. Goldoni1, E. Maffei3, F. Cademartiri4, 
N. Sverzellati1; 1Parma/IT, 2Palermo/IT, 3Urbino/IT, 4Rotterdam/NL 
(gianluca.milanese@studenti.unipr.it)  
Purpose: Epicardial adipose tissue is a visceral fat depot with paracrine 
activity that may associate with increased coronary artery disease (CAD). We 
tested if individuals with increased epicardial fat volume (EFV) - as quantified 
by cardiac CT angiography (CCTA) - show a higher amount of coronary artery 
calcifications (CAC) and a higher prevalence of CAD. 
Methods and Materials: Patients with clinical indication to CCTA were 
retrospectively selected. EFV was quantified as the sum of voxels with density 
between -190 and -30 HU, within the volume outlined by the epicardial sheet. 
CAC was quantified according to the Agatston score (AS) and patients were 
stratified in four groups: AS=0; 1AS<100; 100AS<400 and AS400. CAD 
was classified as absent, non-obstructive, and obstructive (lumen 
reduction50%). Parameters were reported as median and interquartile range 
(IQR). Correlation was tested by Spearman test. Multivariable analysis tested 
association between CAD and morpho-clinical metrics. 
Results: In 1,351 patients, median EFV was 90.92 ml (IQR=66,2); median 
CAC was 58 (IQR=452). CAD was absent in 848, non-obstructive in 325 and 
obstructive in 170 patients. EFV and CAC were moderately correlated (rs 
=0.34;p<0.001). EFV was significantly higher in patients with higher CAC 
(p<0.001) and in patients with obstructive CAD (p<0.001). CAC (p<0.001), but 
not EFV (p>0.05), was a significant predictor of CAD category. When adjusting 
for traditional clinical cardiovascular risk factors, EFV was not a significant 
predictor of CAC. 
Conclusion: EFV is higher in patients with obstructive CAD, its role in the 
development of CAD is probably due to shared risk factors.  
B-0334 14:32  
Intra- and interobserver variability of MR-based assessment of 
myosteatosis as a biomarker for metabolic diseases in subjects from the 
general population  
L.S. Kiefer1, J. Fabian1, R. Lorbeer2, J. Machann1, C.L. Schlett3, S. Rosplecz4, 
A. Peters5, F. Bamberg1; 1Tübingen/DE, 2Munich/DE, 3Heidelberg/DE, 
4
Oberschleißheim/DE, 5Neuherberg/DE (lena.kiefer@med.uni-tuebingen.de)  
Purpose: To determine the reproducibility of skeletal muscle adipose content 
quantification by magnetic resonance imaging (MRI) as a metabolic biomarker 
in subjects from the general population. 
Methods and Materials: Subjects without cardiovascular disease from a 
population-based cohort study underwent a whole-body 3T MRI protocol, 
including a T2*-corrected, multi-echo 3D-gradient-echo Dixon (TR 8.90 ms, six 
echo times, flip angle 4°). Skeletal muscle adipose content was quantified as 
mean proton-density fat fraction in % in M. psoas major (MPM), M. quadratus 
  






lumborum (MQL), autochthonous back muscles (ABM) and M. rectus 
abdominis (MRA) on the right (R) and left (L) side at level L3 by two 
independent readers. Variability was assessed using Bland-Altman plot 
analysis of absolute differences and intra-class-correlation coefficients (ICC) 
from two-way random-effects ANOVA. 
Results: Among 40 subjects (mean age 54.8±8 years, 62.5% males, mean 
BMI 28.7±5.3) a total of 320 measurements were performed. Inter-reader 
agreement was excellent for all muscle compartments (MPMR: ICC 0.91, 
MPML: ICC 0.98, MQLR: ICC 0.98, MQLL: ICC 0.91, ABMR ICC 0.97, ABML: 
ICC 0.98, MRAR: ICC 1.00, MRAL: ICC 0.98) with only minor absolute 
differences (-0.3±1.0%, -0.1±0.5%, 0.2±0.7%, -0.2±0.8%, -0.9±1.5%, -
0.4±1.3%, -0.3±1.5% and -0.3±1.5%; respectively). Similarly, intra-reader 
reproducibility was excellent for all included muscle compartments (ICC 0.95 to 
1.00, absolute differences -0.2 to 0.3%). All agreement was independent of 
BMI and body height (ICC 0.90 to 0.99). 
Conclusion: Skeletal muscle adipose content by MRI is highly reproducible 
and may therefore serve as a robust metabolic biomarker in larger cohort 
studies to determine its prognostic role.  
B-0335 14:40  
Cardiovascular function in relation to abdominal adipose tissue 
distribution  
E.H.M. Paiman, R. de Mutsert, R.L. Widya, J.W. Jukema, F.R. Rosendaal, 
H.J. Lamb; Leiden/NL (e.h.m.paiman@lumc.nl)  
Purpose: To assess the relation of abdominal subcutaneous (SAT) and 
visceral adipose tissue (VAT) with left ventricular (LV) remodeling, cardiac 
function and aorta stiffness. 
Methods and Materials: This is a cross-sectional analysis of 1076 participants 
of the Netherlands Epidemiology of Obesity study, who underwent abdominal 
and cardiovascular MRI. We used linear regression to examine the 
associations of SAT and VAT area with LV ejection fraction (EF), LV mass/end-
diastolic volume (concentricity), the ratio of mitral early and late filling rate (E/A) 
and aorta pulse wave velocity (PWV), adjusted for sex, age, ethnicity, 
education, smoking, menopausal status, use of hormone therapy and either 
VAT or SAT. 
Results: Participants (47% men) had a mean (SD) age of 56 (6) years, SAT: 
237 (97) cm2, VAT: 91 (56) cm2, LVEF: 64 (6)%, LV concentricity: 0.66 (0.13) 
g/ml, E/A ratio: 1.32 (0.50), PWV: 6.7 (1.4) m/s. Per SD of SAT, LV 
concentricity was 0.02 (95%CI: 0.01, 0.03) g/ml lower, and LVEF was 0.79 
(0.30, 1.29)% lower. Per SD of VAT, LV concentricity was 0.02 (0.01, 0.03) 
g/ml higher, and E/A ratio was 0.07 (0.03, 0.11) lower. SAT and VAT were not 
associated with PWV (beta: 0.00 (-0.11, 0.11) m/s per SD SAT and 0.06 (-0.07, 
0.19) m/s per SD VAT). 
Conclusion: In this middle-aged population-based cohort, SAT was 
associated with LV eccentric remodeling and lower systolic function. In 
contrast, VAT was associated with LV concentric remodeling and lower 
diastolic function. For cardiovascular risk assessment, it is essential to 
differentiate between abdominal subcutaneous and visceral adiposity.  
B-0336 14:48  
MRI-based epi- and para-cardial fat depots in a cohort of prediabetics, 
diabetics and healthy controls from a general population without 
cardiovascular disease  
S.D. Heber1, R. Lorbeer2, S. Gatidis1, J. Machann1, S. Auweter2, S. Sellner2, 
A. Peters3, F. Bamberg1, C.L. Schlett4; 1Tübingen/DE, 2Munich/DE, 
3
Neuherberg/DE, 4Heidelberg/DE (sophiaheber@web.de)  
Purpose: The quantification of the pericardial fat depots by MRI in a cohort of 
prediabetics, diabetics and healthy controls from a population without 
cardiovascular disease and relation to different fat depots and cardiovascular 
risk factors. 
Methods and Materials: Assessment of the cardial fat depots was conducted 
in the MR cine steady-state free precession (SSFP) sequence (TR 29.97 ms, 
TE 1.46 ms) in 400 subjects from the KORA FF4 cohort. Epi- and pericardial 
fat were segmented manually in a single slice at end-systole and end-diastole. 
Median regression was conducted to examine the relationship of epi- and 
paracardial fat to impaired glucose metabolism. 
Results: Of 400 subjects, 372 (93%) were included in the analysis (median 
age 57 years; 59.4% male), including 220 healthy controls, 100 prediabetics, 
and 52 diabetics. Fat measurements correlated strongly between end-systolic 
and end-diastolic slices while measurements were on average slightly larger 
when derived from systolic (+11.3% for epicardial- and +10.8% for paracardial 
fat). Both, epi- and para-cardial fat increased stepwise from healthy controls to 
subjects with prediabetes and diabetes (7.7 vs. 9.2 vs. 10.3 cm2 for epicardial- 
and 14.3 vs. 20.3 vs. 27.4 cm2 for paracardial fat, retrospectively; both 
p<0.001). While paracardial fat is independent of BMI (p=0.03) or SAT 
(p=0.048) in diabetics, none of the cardial fat depots are associated to the 
diabetic status independent of VAT. 
Conclusion: There is an increase for epi- and paracardial fat from healthy 
controls to subjects with prediabetes and diabetes, which is only partially 
independent of other, abdominal MR-based fat depots.  
B-0337 14:56  
Coronary CT angiography-based fractional flow reserve in diabetic 
patients: results from the MACHINE consortium  
F. Nous1, A. Coenen1, M. Kruk2, J. De Geer3, U.J. Schoepf4, D. Yang5, 
A. Kurata6, R.P. Budde1, K. Nieman1; 1Rotterdam/NL, 2Warsaw/PL, 
3
Linköping/SE, 4Charleston, SC/US, 5Seoul/KR, 6Ehime/JP 
(f.nous@erasmusmc.nl)  
Purpose: Coronary CT angiography (CCTA)-derived fractional flow reserve 
(FFR) (CT-FFR) simulates the hyperaemic state to evaluate the 
haemodynamic impact of coronary artery disease (CAD), assuming a normal 
coronary microvascular response. Coronary microvascular dysfunction, 
however, is frequently present in diabetic patients. We assess the diagnostic 
performance of a machine learning (ML) application for on-site computation of 
CT-FFR in diabetic patients. 
Methods and Materials: The diagnostic performance (sensitivity, specificity, 
negative predictive value, positive predictive value, accuracy) of ML-based CT-
FFR was analysed per patient and per vessel in patients with and without 
diabetes, who were enrolled in the MACHINE consortium. Invasive FFR was 
used as a reference and FFR 0.8 was considered haemodynamically 
significant for CAD. Per-patient and per-vessel discrimination of lesion-specific 
ischaemia by CT-FFR were assessed by the area under receiver operating 
characteristic (ROC) curves. 
Results: 75 out of 351 patients had diabetes (21%), involving 110 of the 525 
vessels (21%). Per-vessel diagnostic accuracy of ML-based FFR in diabetic 
patients was 85% (95% CI: 72-91%) and 76% (72-80%) in non-diabetic 
patients (p=0.136). On a per-patient level, the accuracy of ML-based FFR in 
diabetic patients was 86% (77-94%) and in non-diabetic patients 85% (80-
89%) (p=0.884). The area under curve of per-vessel and per-patient ROC 
curves of diabetic and non-diabetic patients was comparable (per-vessel: 0.88 
(0.82-0.95) vs 0.82 (0.78-0.86); per-patient: 0.88 (0.80-0.96) vs 0.82 (0.77-
0.87)). 
Conclusion: The diagnostic performance and the discrimination of ischaemia 
by on-site ML-based CT-FFR analysis are similar in diabetic patients and non-
diabetic patients.  
Author Disclosures: 
 U.J. Schoepf: Consultant; Bayer Healthcare and Guerbet Inc.. 
Research/Grant Support; Astellas, Bayer Healthcare, GE Healthcare, Siemens 
Healthineers.  K. Nieman: Research/Grant Support; Bayer Healthcare, GE 
Healthcare, Siemens Medical Solutions, HeartFlow. 
B-0338 15:04  
The right ventricular strain assessment in type 2 diabetes mellitus 
patients: insights from cardiac magnetic resonance feature tracking  
B.-Y. Hu, Z.-G. Yang, X. Liu, K. Shi, H.-Y. Xu, Y.-K. Guo; Chengdu/CN 
(237772342@qq.com)  
Purpose: To investigate the feasibility of cardiac magnetic resonance (CMR)-
derived feature tracking for assessing right ventricle (RV) myocardial 
deformation in type 2 diabetes mellitus (T2DM), and to determine if these 
parameters are correlated to biochemical markers. 
Methods and Materials: A total of 57 T2DM patients, including 14 with 
impaired right ventricle ejection fraction (RVEF), 43 with preserved RVEF and 
22 healthy controls were studied. Cardiac volumes and function, right 
ventricular feature tracking parameters [the global longitudinal, circumferential, 
and radial peak strain (PS), peak diastolic strain rate (PDSR), and peak 
systolic strain rate (PSSR)] were determined by CMR. The intraclass 
correlation coefficient (ICC) was used to evaluate the inter- and intra-observer 
variabilities. 
Results: Compared with controls, significantly lower values of longitudinal PS 
in the T2DM with impaired RVEF (-23.90±4.06% vs -27.22±2.37%, p=0.009) 
and preserved RVEF groups (-25.27±3.37% vs -27.22±2.37%, p=0.009) 
indicates impairment of RV function. Furthermore, the circumferential and 
radial PDSR in the impaired RVEF group decreased significantly compared 
with controls (both P<0.05). In the T2DM cohort, longitudinal PS correlated with 
HbA1c (r=0.470, P=0.001) and low-density lipoprotein (r=0.355, P=0.027), and 
had weak correlation with RV end-diastolic volume (r=0.279, P=0.013), RV 
end-systolic volume (r=0.262, P=0.020), and RV myocardial mass (r=0.226, 
P=0.045). The ICCs for intra- and inter-observer variabilities were 0.798-0.905 
and 0.701-0.897. 
Conclusion: In adults with T2DM, abnormal RV myocardial deformation can 
be monitored using CMR feature tracking, even in those with preserved RVEF; 










B-0339 15:12  
Assessment of the left ventricular myocardial strain in type 2 diabetes 
mellitus patients with hypertension using MR tissue tracking  
L. Xie, Y. Guo, Z. Yang; Chengdu/CN (xielinjun2016@163.com)  
Purpose: To investigate the left ventricular myocardial strain in type 2 diabetes 
mellitus (T2DM) patients with hypertension using cardiac magnetic resonance 
tissue tracking. 
Methods and Materials: Thirty-six T2DM patients with hypertension (Group 
1), 39 cases of T2DM without hypertension (Group 2) and 26 normal control 
individuals were enrolled. All patients underwent cardiovascular magnetic 
resonance (CMR), including cardiac cine sequence (short-axis, long-axis two-
chamber and four-chamber image). Cardiac function indexes and tissue 
tracking parameters were all measured by CVI42 and compared statistical. 
Pearson’s correlation between the left ventricular ejection fraction (LVEF) and 
the left cardiac strain parameters were also investigated. 
Results: All the patients recruited finished CMR and the baseline 
characteristics were recorded. The Group 1 presented lower LVEF than Group 
2 and normal group (LVEF: Group 1: 57.17±9.30%, Group 2: 61.11±5.73%, 
normal group: 62.22±3.44%; P=0.032, 0.004). Compared with the normal 
group, the global radial, circumferential and longitudinal peak strain (PS) of the 
Group 1 were significantly reduced (all P<0.05). Group 2 presented with lower 
longitudinal PS value than control group (Group2: -16.50±2.27% control group: 
-18.10±1.85%, P=0.004). Pearson correlation analysis indicated a significant 
and positive correlation between the LVEF and radial PS (r = 0.746, P<0.001) 
and circumferential PS (r = 0.786, P<0.001). A positive correlation existed 
between the longitudinal PS and LVEF (r = 0.587, P<0.001). 
Conclusion: The myocardial strain decreased in T2DM patients with 
hypertension were more obvious than control group. The myocardial strain 
appears to be more sensitive than LVEF for assessing LV dysfunction in T2DM 
patients without hypertension.  
B-0340 15:20  
Phenotypic multi-component involvement of subclinical disease as 
quantified by MRI in subjects with prediabetes, diabetes and normal 
glucose tolerance  
C. Storz1, S. Rosplecz2, R. Lorbeer3, W. Rathmann4, M.F. Reiser3, 
U. Hoffmann MD MPH5, A. Peters2, C.L. Schlett6, F. Bamberg1; 1Tübingen/DE, 
2
Neuherberg/DE, 3Munich/DE, 4Düsseldorf/DE, 5, Boston, MA/US, 
6
Heidelberg/DE (corinna.storz@med.uni-tuebingen.de)  
Purpose: To compare whole-body subclinical disease phenotypes by 
magnetic resonance (MR) imaging to study differences between subjects with 
prediabetes, diabetes, and controls with normal glucose tolerance. 
Methods and Materials: Overall, 400 subjects from a western general 
population without prior cardiovascular disease were enrolled in a prospective 
case-control study and underwent whole-body MR between June 2013 and 
September 2014. The MR protocol was tailored to the assessment of metabolic 
and arteriosclerotic alterations, including age-related white matter changes, 
hepatic proton-density-fat-fraction, visceral adipose tissue volume, left 
ventricular remodeling index, carotid plaque, and late-gadolinium 
enhancement. MR features were summarized in an ordinal phenotypic-based 
metric (score range: 0-6). Univariate, multivariate correlation, and unsupervised 
clustering were performed. 
Results: 243 subjects with complete multi-component MR datasets were 
included in the analysis (55.6±8.9 years, 62% males), 48 were classified as 
subjects with prediabetes and 38 as subjects with diabetes. The MR 
phenotypic score was significantly higher in subjects with diabetes and 
prediabetes as compared to controls (mean score, 3.00±1.04 and 2.69±0.98 vs 
1.22±0.98, p<0.001, respectively), also after adjustment for potential 
confounders. Clustering analysis identified two clusters of MR phenotype 
patterns associated with glycaemic status (p<0.001), independent of the MR 
phenotypic score (Cluster II: odds ratio: 2.49; 95%-CI: [1.00, 6.17], p=0.049). 
Conclusion: Subjects with prediabetes and diabetes have significantly higher 
phenotypic-based metric as compared to subjects with normal glucose 
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B-0341 14:00  
Detection of bridging vein thrombosis at computed tomography: a 
specific sign of shaken baby syndrom?  
S. Nahmani, D. Grevent, K. Beccaria, N. Boddaert; Paris/FR 
(sarah.nahmani@gmail.com)  
Purpose: Shaken baby syndrom (SBS) also known as abusive head trauma 
(AHT) is a major cause of head trauma in infants. Bridging vein rupture caused 
by anterio-posterior movements has proofed to be responsible of subdural 
hematoma (SDH). The resulting thrombosis, following the rupture can be seen 
in CT and MRI. The objective is to evaluate the specificity of bridging vein 
thrombosis (BVT) seen in cranial CT (cCT) in SBS compared to a cohort of 
infants victims of accidental head trauma. 
Methods and Materials: A total of 173 cCT of children under 36 months of 
age, performed between 2010 and 2016 in Necker hospital (92 who were 
diagnosed AHT and 81 with accidental head trauma) were analyzed 
retrospectively and independently by two radiologists who were blinded to the 
diagnosis. 
Results: BVT were found in 69/92 AHT, sensitivity = 75%, (95% CI : 64.8- 
83.4%)) and 6/81 accidental head trauma, specificity =93% (95% CI : 84.6-
97.2%) by the senior reader (and respectively 65, sensitivity =71%, (95% CI : 
60.2-79.6) and 11, specificity = 86% (95% CI : 76.9 - 93) by the junior reader), 
p&lt0.05. Further analysis showed that the 6 BVT in the accidental group were 
consecutive to 2 road traffic accidents, 1 defenestration, 1 polytraumatism, and 
2 traumatisms eventually reclassified as AHT. 
Conclusion: BVT, seen in cCT, is a very sensitive and specific sign of AHT. 
This finding is not compatible with a minor alleged trauma and should suggest 
AHT in infants brought spontaneously to emergency room without polytrauma.  
B-0342 14:08  
The estimation of radiation dose in suspected child abuse imaging  
H. Niiniviita, E. Saukko, J. Saunavaara; Turku/FI (hannele.niiniviita@tyks.fi)  
Purpose: To assess the radiation doses related to imaging in suspected child 
abuse with patients under the age of 2 years and to estimate the additional 
radiation dose, if follow-up images are taken according to the new guidance of 
the Royal College of Radiologists. 
Methods and Materials: There were 60 suspected child abuse patients, who 
were imaged between the years 2013 and 2016. The number of studies, 
radiation doses and image parameters for calculating effective dose (voltage, 
tube current-time product, image area, additional filtration) were collected from 
PACS. The radiation dose was recorded as DAP-value (dose area product, 
mGycm2) and the effective dose of skeletal survey was estimated by PCXMC-
software for nine patients. The effective dose of suggested follow-up images 
were estimated from these calculations. 
Results: We reviewed 154 x-rays studies, where the main protocols used were 
skeletal survey (22%), femur (17%) and thorax (10 %). In skeletal survey there 
were at mean 19 exposures and the mean DAP was 261mGycm2. The highest 
DAP-values were observed in skull (AP+LAT, 102.7mGycm2), spine (LAT, 
34.8mGycm2), thorax (oblique, 17.1mGycm2) and pelvis (AP, 15.4mGycm2). 
The mean effective dose in skeletal survey was 61µSv and the effective dose 
of follow-up images including extremities, thorax AP and two obliques was 
estimated to be approximately 25µSv. The effective dose of extremities 
contribute 25% of total dose in control images. 
Conclusion: The highest radiation doses related to suspected child abuse 
imaging are generated from skull and spine. The additional radiation dose of 
follow-up images is low.  
B-0343 14:16  
Optimising imaging in suspected child abuse: a five-year prospective 
study in a tertiary referral children’s service  
I. Moorthy, K. Iliadis, T. Diacon, L. Moon, L. Vitta; Brighton/UK 
(kyriakos.iliadis@bsuh.nhs.uk)  
Purpose: Imaging teams are crucial in assisting paediatric and social service 
professionals when child abuse is suspected. This study aims to consolidate 
guidance on best practice in imaging these vulnerable children, while 
remaining sensitive to the rights of their carers. 
  






Methods and Materials: Prospective data were collated for every skeletal 
survey performed over a five-year period (April 1, 2012 to March 31, 2017) as 
part of an ongoing audit, using a pre-designed data collection form. Accuracy 
of reporting of bony injury, and bony density and morphology were studied 
(audit standard: 100% compliance). As double reporting and timely follow-up 
imaging contribute to diagnostic accuracy, this was also studied (audit 
standard: 100% compliance). Our neuroimaging practice was also audited. 
Results: Total number of children studied = 88 (100%); number of positive 
initial skeletal surveys = 48 (55%); number where bone morphology and 
density were commented on = 80 (91%); number of double reports of initial 
skeletal surveys = 80 (91%); number where second reporter disagreed with 
first reporter = 3 (3%); interval to follow-up imaging = 11 to 33 days (mode 14 
days); number of follow-up surveys = 72 (82%); number of follow-up surveys 
with new findings = 4 ( 5%). 
Conclusion: Multidisciplinary teamwork and clear imaging protocols (including 
double-reporting, follow-up imaging, and relevant neuroimaging) are crucial to 
making the correct diagnosis in suspected child abuse. Ongoing audit of 
imaging practice optimises diagnostic accuracy.  
B-0345 14:24  
Quantitative bone ultrasound: low sound wave propagation in cortical 
bone as a novel, non-invasive imaging biomarker in children and 
adolescents with hypophosphatemic rickets  
J. Schneider1, A. Raimann2, A. Boni-Mikats2, M. Krssak2, R. Klepochová2, 
G. Häusler2, K. Raum1, J.M. Patsch2; 1Berlin/DE, 2Vienna/AT 
(janina.patsch@meduniwien.ac.at)  
Purpose: The assessment of ultrasound wave propagation in cortical bone is a 
novel, non-invasive quantitative imaging tool in bone research. The purpose of 
this study was to determine sound wave propagation properties in the distal 
extremities of paediatric patients with hypophosphatemic rickets and healthy 
controls. 
Methods and Materials: Following study approval by institutional review and 
written informed consent, we performed quantitative bone ultrasound in 
children, adolescents and young adults with xlh (n=8), and healthy controls 
(n=13). The majority of patients and controls also underwent high-resolution 
peripheral quantitative computed tomography (HR-pQCT) of the radius and 
tibia as a standard of reference. Bone ultrasound was performed at the distal 
radius and the distal tibia according to a structured examination protocol, using 
a dedicated 1MHz transducer with one receiver arrays and two transmitter 
array. Based on bidirectional axial transmission and propagation of ultrasound 
waves, the ‘first arriving signal velocity’ (vFAS) was measured and post-
processed. HR-pQCT images were reviewed by a board-certified radiologist, 
data were evaluated by the manufacturer’s quantification software. 
Results: Quantitative bone ultrasound of wave propagation was feasible in all 
study participants. At the distal radius, we found vFAS to be significantly lower 
in in XLH patients than in healthy controls (-6.8%; ANOVA: p = 0.0013). A 
similar reduction of vFAS was observed in the distal tibia (-6.5%; ANOVA: p = 
0.0009). HR-pQCT scans revealed microstructural deficits in both cortical and 
trabecular bone. 
Conclusion: Sound wave propagation in cortical bone is a promising imaging 
biomarker in children and adolescents with hypophosphatemic rickets.  
B-0346 14:32  
Evaluation of a new computer-aided diagnosis system for automated 
bone age assessment in comparison to the Greulich Pyle atlas method: 
advanced results of a multireader study  
C. Booz, J.L. Wichmann, S. Böttger, A. Al Kamali, S.S. Martin, D. Leithner, 
L. Lenga, T.J. Vogl, B. Bodelle; Frankfurt a. Main/DE 
(boozchristian@gmail.com)  
Purpose: To investigate a novel computer-aided diagnosis (CAD) software for 
bone age (BA) assessment in comparison to the Greulich Pyle (GP) method 
regarding its accuracy and precision. In addition, we evaluated the influence of 
carpals on bone age assessment. 
Methods and Materials: Data from clinically indicated left hand and wrist 
radiographs of 305 children were included. Total BA, BA of the distal radius 
and BA of the carpals were determined by three radiologists using the GP 
method and additionally assessed by the CAD software (BoneXpert). Pearson 
product-moment correlation, Bland-Altman plot, root-mean-square (rms) 
deviation and further agreement analyses were calculated. 
Results: Mean total BA was 9.76 years (CAD) and 9.81 years (GP) showing 
very high correlation between both approaches (r=0.985; rms deviation 0.49 
years). Mean BA of the distal radius was 9.50 years (CAD) and 9.82 years 
(GP) (r=0.963). Mean BA of the carpals was 9.94 years (GP). Statistical 
analysis demonstrated a significantly higher correlation between total BA and 
BA of the distal radius (r=0.969) than between total BA and BA of the carpals 
(r=0.923). Assessment of the carpals showed only good inter-reader 
agreement (=0.79), while the agreement in analysing the distal radius was 
excellent ( =0.98). 
Conclusion: The evaluated CAD system allows for precise BA assessment 
compared with the GP method. Assessment of the carpals is challenging and 
leads to comparatively lower precision and inter-reader agreement. Methods 
assessing BA without analysing the carpals should be more accurate than 
methods including the carpals in analysis like the GP method.  
Author Disclosures: 
 J.L. Wichmann: Speaker; GE Healthcare, Siemens Healthineers.  
B-0347 14:40  
Role of imaging in the diagnosis of glenohumeral deformity following 
obstetric brachial plexus injury  
A.N. Parimalai1, A. Chelladurai1, K. Damodaran2, P. Muthayan1; 1Chennai/IN, 
2
Coimbatore/IN (anand7687@gmail.com)  
Purpose: To study the use of imaging in the assessment of glenohumeral 
deformity following obstetric brachial plexus injury. To study the usefulness of 
CT in the measurement of glenoid version angle and humeral head dislocation 
and to propose a grading for the severity of glenohumeral deformity. 
Methods and Materials: This was a prospective study, conducted in the 
Department of Radiodiagnosis at Stanley Medical College between August 
2015 and July 2016. The study group included 21 children below the age of 10 
years presenting with posterior dislocation of the shoulder, with a past history 
of obstetric brachial plexus palsy. The children were examined with modified 
Mallet score and Naraka’s neurological grading. CT of both shoulders using 
GE Optima 128 slice scanner and MRI using 1.5 Tesla Siemens unit were 
done. MR myelogram of the cervical spine was done. 
Results: In our study, glenoscapular angle, percentage of humeral head 
anterior to the scapular line, scapular height and scapular width were analysed 
by paired Student's t test and were statistically significant [p<0.05]. We 
classified the children according to Waters and proposed radiological grading. 
We also classified according to the joint’s stability. 3 affected joints were 
stable, 9 were subluxated and 9 dislocated. The higher the grade of deformity, 
the more difficult will be the shoulder movements and the scores worse in the 
Modified Mallet scale. 
Conclusion: CT clearly identifies glenohumeral deformities such as increased 
glenoid retroversion, posterior subluxation or dislocation of the humeral head, 
smaller humeral head size and smaller size of the scapula as deviations from 
the normal status.  
B-0348 14:48  
Relationship between cranio-orbital volume changes and the severity of 
skull base dysmorphology in infants with anterior synostotic 
plagiocephaly: a quantitative analysis  
M. Panfili, R. Calandrelli, L. Massimi, S. Gaudino, C. Colosimo; Rome/IT 
(panfilimarco@gmail.com)  
Purpose: The premature fusion of one coronal suture causes skull and orbital 
alterations in terms of side-to-side asymmetry. This study aimed to quantify the 
relationship between cranio-orbital complex changes and the severity of skull-
base dysmorphology in patients with unicoronal synostosis. 
Methods and Materials: We analysed CT images of 21 infants (mean age 156 
days) with unicoronal synostosis, subdividing them into three subgroups 
according to severity of skull-base dysmorphology. Cranial fossae lengths, 
intracranial volume (ICV), each half-skull ICV (synostotic and non synostotic 
side), whole brain volume (WBV), orbital volumes (OV) were measured. 
ICV/WBV, ICVaffected/ICVunaffected side and OVaffected/OVunaffected side ratios were 
evaluated. Our results were compared with those of 21 age-matched healthy 
subjects. 
Results: In all subgroups: reduced lengths and asymmetry of the anterior (CX) 
and the middle (XM) cranial fossae and asymmetry between 
ICVaffected/ICVunaffected and between OVaffected/OVunaffected were significant (p<0,05); 
ICV, WBV and ratio ICV/WBV were not significantly altered (p>0,05); OV on the 
affected side resulted significantly reduced only in group III (p<0,05). OV on the 
synostotic side were found to correlate with CX and XM lengths. 
Conclusion: Skull and orbital changes revealed a side-to-side asymmetry but 
only the OV of the affected side, in group III, was found significantly reduced. It 
implies a relationship between the major severity of skull base dysmorphology 
and orbital alterations on affected side probably related to earlier timing of 
synostotic process; the lack of reduced ICV on synostotic side, in group III, 
suggests a different plasticity of skull cavity respect to orbital one.  
B-0349 14:56  
Detailed evaluation of a completely automatic, computer-assisted (CAD) 
analysis of hand X-ray examinations by including four different paediatric 
collectives  
D.M. Renz1, A. Schröder1, J. Böttcher2, A. Pfeil1, F. Streitparth3, 
U.K. Teichgräber1, H.-J. Mentzel1; 1Jena/DE, 2Gera/DE, 3Berlin/DE 
(diane.renz@med.uni-jena.de)  
Purpose: The CAD system BoneXpert (Visiana) determines the bone age of 
children and adolescents on hand X-ray examinations. Furthermore, the CAD 
  






method calculates bone parameters of the metacarpals, among others the 
,,bone health index“ (BHI). The study purpose was a detailed evaluation of the 
CAD method, focusing on bone parameters, by including paediatric collectives 
with the following disorders: obesity, underweight, hypothyroidism, or chronic 
inflammatory bowel disease. 
Methods and Materials: In the investigation, 325 children and adolescents 
(151 boys, 174 girls) between 3 and 18 years were included. All X-ray 
examinations were analysed visually and with the CAD system. The bone 
parameters of the CAD analysis were compared with age- and gender-
matched normative values by using Z-scores; these Z-scores were calculated 
for the calendar as well as the skeletal age. 
Results: High correlations were achieved between the visual determination of 
bone age and the CAD analysis, ranging between 0.848 and 0.956 (p<0.001) 
for the different paediatric collectives. The Z-scores of the BHI were 
significantly reduced in all four cohorts (Student´s t-tests, p<0.01), if the bone 
age was the reference. In the case of using the calendar age, the BHI Z-scores 
were also significantly lower compared to the normative collective (p<0.01), 
with one exception of female obese patients. 
Conclusion: One major benefit of the CAD method is the calculation of 
parameters of bone health without using any additional radiation exposure. To 
early identify paediatric patients with osteopenia can induce prevention 
strategies to reduce the risk of developing osteoporosis, also in later life.  
B-0350 15:04  
Movie projection systems for paediatric CT examinations: effects on 
examination time, motion artefacts, and the need for restraints  
N. Nagasawa, K. Kitagawa, K. Hashizume, A. Yamazaki, H. Maki, H. Sakuma; 
Tsu/JP (nagasawa@clin.medic.mie-u.ac.jp)  
Purpose: It is important to reduce the anxiety of children for successful 
diagnostic and therapeutic procedures. The purpose of this study was to 
develop and assess the usefulness of a handy movie projection system for CT 
examinations. 
Methods and Materials: We designed a handy movie projection system 
consisting of a mobile projector (MP-CL1; Sony, Tokyo, Japan) connected with 
a tablet device (iPad; Apple, Cupertino, USA) that was placed on the patient 
couch near the child’s head. Movies were projected onto the upper wall of the 
CT gantry aperture with a projection size of 35 x 26 cm at 32 lumens. The 
system was implemented for head CTs in 54 paediatric patients aged 3-10 
years (projection system group, 6.5±2.6 y.o.) and animated movies were 
projected during the CT examination. Examination time, motion artefact, and 
the need for restraint were compared with 46 paediatric head CTs scanned 
without the system (conventional group, 6.6±1.8 y.o., p=ns). 
Results: Examination time (from topogram to end of scan) of the projection 
system group was significantly shorter compared to the conventional group 
(63.0±37.1 sec vs 92.4±42.4 sec, p<0.001). The projection system group had 
no motion artefacts, while 15.2% (7/46 cases) of the conventional group had 
motion artefacts (p<0.001). The projection system group less frequently 
required restraint to complete the examination, compared to the conventional 
group (3.8% (2/52) vs 15.2% (7/46), p<0.05). 
Conclusion: We developed a handy movie projection system that can shorten 
examination time, decrease motion artefacts, and reduce the need for restraint 
in paediatric CT.  
B-0351 15:12  
Parents wish more information on radiation exposure of their children  
H. Oikarinen, H. Mahajan, A. Perttu, L. Ukkola, A.-.L. Jussila, A. Henner; 
Oulu/FI (helja.oikarinen@ppshp.fi)  
Purpose: To find out parents’ experience and wishes for information in 
connection with their child’s examination exposing to radiation. 
Methods and Materials: A questionnaire was prepared and provided to 
parents of paediatric patients up to 12 years in a university hospital. 
Information received from the referring physician prior to their child’s x-ray 
examination as well as wishes for future communication were enquired. Forty-
one parents responded to the survey. Twenty-five children were referred for 
plain radiography of extremities, the others for dental, body or skull area 
examinations. 
Results: Twenty-one patients had been referred from primary care and 17 
from the hospital. Altogether 34/41 parents had received enough information 
on the purpose of the examination, 3/41 on the dose of radiation and 8/35 on 
other possible options. In all, 11/41 parents were aware of radiation use, and 
previous examinations were discussed in 7/41 of the cases. The parents 
scored the overall communication as 6.5 (mean) on a Likert scale from 4 (poor) 
to 10 (excellent). Altogether 38 out of 40 parents wish to receive information on 
the purpose, 35 on the dose and 31 on other possible options. Symbols of 
radiation and corresponding period of natural background radiation are 
preferred to reveal the dose. In all, 32 out of 38 parents would like to receive 
the information from the referring physician, 19 from a radiographer. 
Conclusion: Parents wish to receive more information on radiation exposure 
prior to their child’s radiography examination.  
B-0344 15:20  
Ultrasound of the limping child  
D. Grant, E. Quinn, R. Gordon Boyd, C. Lee, K.A. Platt, K. Partington; 
Oxford/UK (davidjamesgrant@live.co.uk)  
Purpose: Septic arthritis (SA) is an emergency with potential long-term 
sequelae if diagnosis/treatment is delayed. Kocher determined four predictors 
which help distinguish between SA and transient synovitis: nonweight-bearing 
(non-WB), fever, raised white cells (WC), and Erythrocyte Sedimentation Rate 
(ESR). Singhal showed that C-Reactive Protein (CRP) may also be predictive. 
Ultrasound with aspiration and microscopy remains the gold standard. 
Although not irradiating, ultrasound represents a time, resource and 
opportunity cost. Aspiration may prove upsetting for a child and poses its own 
risks. This study assesses whether clinical predictors may help determine the 
need for US. 
Methods and Materials: Retrospective analysis of all paediatric lower limb 
ultrasound performed over 12 months at a Tertiary Hospital. Studies were 
manually filtered for clinical concern of SA. Data obtained from Electronic 
Patient Records and Radiology Information Systems. 
Results: Of 142 cases, joint effusion was present in 46 (32.4%). 14 aspirations 
performed. There were 6 cases of SA. Pre-determined risk factors were as 
follows: ‘non-WB’ (6/6 in SA, 84/136 in non-SA); fever (SA 5/6, non-SA 54/136, 
p=0.035*); CRP>20mg/L (SA 5/6, non-SA 35/128, p=0.004*); ESR>40mm/hr 
(SA 3/5, non-SA 25/112); and WC>12x109/L (SA 4/6, non-SA 31/130, 
p=0.019*). All cases of septic arthritis demonstrated at least 2 risk factors. 68 
(50%) of non-SA cases demonstrated fewer than 2 risk factors. 
Conclusion: Requiring at least 2 SA clinical risk factors would have obviated 
the need for 68 ultrasounds, including 3 aspirations, whilst maintaining 100% 
sensitivity. We propose that this represents a resource-efficient addition to the 
diagnostic algorithm in a limping child.  
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B-0352 14:09  
Radiomics as a novel tool for primary nodal staging in rectal cancer  
J.J.M. van Griethuysen1,2, D.M. Lambregts1, S. Trebeschi1, M. Maas1, 
M.J. Lahaye1, G.L. Beets1,2, F.C. Bakers2, R.G.H. Beets-Tan1,2, H.J. Aerts3; 
1
Amsterdam/NL, 2Maastricht/NL, 3Boston, MA/US (j.v.griethuysen@nki.nl)  
Purpose: To assess the potential of quantitative MR-imaging analysis using 
radiomics for nodal characterization in primary rectal cancer staging. 
Methods and Materials: 226 lymph nodes (from 34 rectal cancer patients who 
underwent MRI followed by surgical resection) were analyzed and matched 
node by node with histopathology. The short axis was measured for each node 
(on T2W-MRI) and nodes were manually segmented on T1W and T2W-MRI to 
extract 748 radiomic features (using PyRadiomics). Using principal feature 
selection, we selected the 25 features providing the best complementary 
information to routine nodal size measurements. Performance to distinguish 
between malignant and benign nodes was assessed with areas under the 
curve (AUC) per feature using a binomial mixed effects logistic regression 
model, correcting for patient number. False detection rate correction set at 
10% was applied to correct for multiple testing. 
Results: 17/226 nodes were malignant. The selected features were compared 
to (and combined with) nodal size measurements using a bootstrap method 
with 100 iterations; the model was trained on a random subset of patients and 
tested on the remaining patients (train:test ratio 80:20). The average 
performance for nodal size measurements was AUC 0.82. The best performing 
radiomic feature after FDR correction (GLCM-difference average; a measure of 
heterogeneity) resulted in an AUC of 0.83; the combination of this feature with 
nodal size resulted in an AUC of 0.85. 
Conclusion: Radiomics may provide valuable quantitative information to 
characterize rectal cancer lymph nodes, particularly features reflecting nodal 
heterogeneity are promising. Although radiomics slightly improves staging 
performance, the added benefit compared to routine size-based staging 
appears to be limited. 
  






B-0353 14:17  
CT radiomics signarure for preoperative esophageal cancer patients 
lymph node metastasis prediction  
J. Qu1, C. Shen2; 1Zhengzhou/CN, 2Xi'an/CN (qjryq@126.com)  
Purpose: To build and validate a radiomics signature for the prediction of pre-
operation lymph node (LN) metastasis in esophageal cancer (EC). 
Methods and Materials: A total of 189 EC patients were enrolled in this study, 
and their LN metastases have been pathologically confirmed. The data was 
collected from January 2016 to April 2016, patients in the first three months 
were set in the training cohort, and patients in April 2016 were set in the 
validation cohort. 789 radiomics features were extracted from CT images of 
patients. The lasso approach was exploited for dimension reduction and 
selection of the feature space. The multivariable logistic regression analysis 
was adopted to build the radimics signature. The area under receiver operating 
characteristic curve (AUC) were adopted to estimate the signatures’ 
discrimination power. 
Results: Thirteen radiomics features were selected to build the radiomics 
signature. The radiomics signature was significantly associated with the LN 
metastasis (P<0.001). The area under the curve (AUC) of radiomics signature 
performance in the training cohort is 0.763 (95% CI: 0.680-0.847), and in the 
validation cohort is 0.738 (95% CI: 0.677-0.793). The model showed good 
discrimination, with a C-index of 0.754 (95% CI: 0.686 to 0.822) in training 
cohort and 0.741 (95% CI: 0.663 to 0.819) in the validation cohort. Decision 
curve analysis showed the threshold probability is larger than 0.15, our model 
will receive benefit. 
Conclusion: The present study proposed a radiomics signature, which can be 
potentially applied in the individual preoperative prediction of LN metastasis 
status in EC patients.  
B-0354 14:25  
CT texture features of adrenal tumours: the answer to indeterminate 
adrenal lesions?  
J. Gariani, M.M. Siddique, G. Cook, V.J. Goh; London/UK 
(Joanna.Gariani@hcuge.ch)  
Purpose: To identify the potential discriminating global and locoregional CT 
texture features of adrenal tumours. 
Methods and Materials: Following an institutional review board waiver, portal-
phase enhanced CT scans (120kV, variable mAs, soft tissue reconstruction, 
matrix 512, FOV 350mm, 2/5mm slice thickness) of 58 consecutive incidentally 
discovered adrenal lesions (>2.0cm, 21 benign adenomas and 37 malignant 
tumours) in 48 patients (28 male-20 female, mean age 66.35 years) were 
assessed with the final diagnosis based on imaging follow-up (>6months) or 
adrenal CT/MRI. Manual segmentation of each lesion was performed, using an 
in-house software, by a radiologist (>8 years experience) who was blinded to 
the final diagnosis, and 92 features encompassing histogram, fractal, second 
and high-order features were recorded. 
Results: Significant differences were found for 46 features including histogram 
mean, median and skewness (p=0.004, p=0.029 and p=0.013); fractal 
dimension standard deviation and Hurst exponent (p=0.014, p=<0.001); GLCM 
(grey-level co-occurrence matrices) autocorrelation and cluster shade 
(p=0.003, p=0.003); and NGTDM (neighbourhood grey tone difference 
matrices) coarseness, contrast, busyness and complexity (p<0.001, p=0.001, 
p<0.001, p=0.03). There was a significant difference in volume between 
malignant and benign lesions (48.5cm3 vs 13.3cm3, p=<0.001). 
Conclusion: CT texture differs between benign and malignant adrenal lesions. 
Texture analysis may be a useful adjunct for the characterisation of 
indeterminate adrenal lesions.  
B-0355 14:33  
Machine learning and radiomics analysis of multi-parametric PET/MRI: 
characterisation of primary cervical cancers  
J. Grueneisen, F. Nensa, A. Demircioglu, M. Forsting, K. Herrmann, L. Umutlu; 
Essen/DE (johannes.grueneisen@uk-essen.de)  
Purpose: To investigate the prediction potential of PET/MR-derived 
parameters of patients with cervical cancer assessed with radiomics and 
machine-learning algorithms. 
Methods and Materials: A total of 30 patients with previously untreated 
cervical cancers underwent a simultaneous 18F-FDG PET/MR examination. 
The study protocol comprised the acquisition of morphological (T1w-, T2w-
images), functional (DWI, DCE-MRI) and metabolic (18F-FDG PET) 
parameters. After tumour segmentation, quantitative imaging features (n=631) 
were extracted using the Radiomic Image Processing Toolbox. Statistical 
analysis and modeling were performed using Python 3.5 and the scikit-learn 
software machine learning library for the Python programming language. 
Results: Correlation analysis of the full set of 631 image features revealed 
strong correlations between image features, representing redundant 
information. Therefore, feature selection methods were applied to identify the 
20 highest ranking features, which were used for further analysis. For the 
determination of N-stage, receiver operating characteristic (ROC) analysis 
revealed an area under the curve (AUC) of 0.85 with a sensitivity and 
specificity of 79% and 75%. Furthermore, statistical analysis revealed a higher 
performance for the determination of the M-stage with a 94% sensitivity and 
90% specificity and an AUC of 0.97. 
Conclusion: The present data show strong correlations between certain PET 
and MRI-derived quantitative features and major prognostic factors of cervical 
cancers assessed with radiomics and machine learning algorithms. Therefore, 
radiomics analysis based on multiparametric PET/MR data offers a large 
number of non-invasive biomarkers, potentially facilitating a new platform for 
improved cancer detection, prediction of prognosis and determination of 
treatment response.  
B-0356 14:41  
Radiomics as a predictive biomarker of metastatic response to 
immunotherapy  
S. Trebeschi1, S.G. Drago2,1, I. Kurilova1, F. Lalezari1, D.M. Lambregts1, 
E. Smit1, C.U. Blank1, H.J. Aerts3,1, R.G.H. Beets-Tan1; 1Amsterdam/NL, 
2
Monza/IT, 3Boston, MA/US (s.trebeschi@nki.nl)  
Purpose: Immunotherapy represents a major breakthrough in cancer 
treatment. Various predictive biomarkers are currently under investigation, but 
none with conclusive results yet. With this study, we aim to evaluate the 
performance of radiomics imaging biomarkers to predict response to 
immunotherapy (PD-1 blockade) in specific to discriminate non-responders. 
Methods and Materials: We retrospectively retrieved baseline and follow-up 
CE-CTs of 213 metastasized patients (131 NSCLC, 82 melanoma) undergoing 
immunotherapy at our institution. Patients were divided in a discovery (n=143) 
and independent validation set (n=70). Target lesions (1-43 lesions/patient, 
median 3, 1055 total) were delineated on baseline and first follow-up. 
Radiomics features were extracted from each lesion. Evolution in lesion 
diameter on FU-CT was the main response outcome (non-response>20% 
increase). A random forest with wrapper feature selection was trained on the 
discovery set and optimized via sequential model-based optimization. 
Results: The radiomic classifier revealed coarse texture features (GLCM), 
compactness, elongation and sphericity to be the best predictive features. 
When tested in the independent validation set, AUCs up to 0.83 were reached 
to predict non-response in the NSCLC group, with results better compared to 
predicting response based on routine pre-treatment lesion volume 
measurements (AUCs<64). In the melanoma group, results were considerably 
poorer with similar results for radiomics features (AUCs<0.65) and lesion 
volume (AUC<0.65). 
Conclusion: (1) Radiomics analysis of routine clinical CE-CT-imaging could 
provide viable biomarkers to predict non-response to immunotherapies in 
melanoma and NSCLC before treatment; (2) the differences in performance 
between melanoma and NSCLC suggest that both immune-generic and 
cancer-specific models are required.  
B-0357 14:49  
CT-derived texture analysis in predicting tumoral response to 
immunotherapy in patients with lung cancer and correlation with iRECIST  
F. Rivosecchi, D. Caruso, D. De Santis, D.M. Bellini, N. Panvini, M. Rengo, 
A. Laghi; Latina/IT (flaminiarivosecchi@gmail.com)  
Purpose: To investigate whether CT-derived texture features (TFs) correlate 
with tumoral response in patients with lung cancer (LC) undergoing 
immunotherapy. 
Methods and Materials: Twelve patients with lung adenocarcinoma who 
underwent contrast-enhanced CT before and after immunotherapy with 
Nivolumab were retrospectively analysed. Tumoral first-order TFs (mean, 
attenuation, standard deviation, mean value of positive pixels [MPP], entropy, 
skewness, and kurtosis) were assessed with TexRAD software using 5 scale 
filter (SF) as 0, 1, 1.5, 1.8, and 2. Response assessment was obtained by 
using Response Evaluation Criteria in Solid Tumours in Immunotherapeutic 
Trials (iRECIST) using appropriate software (mint lesionTM). Paired t-student 
test was performed to compare the texture results and Pearson correlation with 
iRecist was performed as well. 
Results: Seven patients showed progressive disease (PD) and 5 patients 
showed stable disease (SD) with iRECIST. Kurtosis was significantly higher for 
all the SFs in patients with PD compared to SD (P=0.007). Mean attenuation at 
SF0 was higher in PD compared to SD (12.1 ± 12.2 and -67.7 ± 60.0, 
P<0.001). Standard deviation at SF1 and SF1.5 in PD (139.2 ± 1.9 and 192.8 ± 
2.5) was lower than SD (387.8 ± 180.7 and 501.8 ± 214.1). MPP at SF1.5 in 
PD was lower than SD (121.5 ± 3.9 vs 457.1 ± 260.2) (all P <0.05). No 
significant differences were found among the other TFs. A positive correlation 
was observed between kurtosis and PD using iRecist (r=0.56, P<0.05). 
Conclusion: CT-derived TFs could serve as imaging biomarkers of tumoral 
response to immunotherapy in patients with LC.  
  






B-0358 14:57  
Evaluating response to chemotherapy in colorectal liver metastases: 
correlation between CT texture analysis and RECIST criteria  
N. Panvini, D. Caruso, D. De Santis, D.M. Bellini, F. Rivosecchi, M. Rengo, 
A. Laghi; Latina/IT (npanvini88@gmail.com)  
Purpose: To evaluate potential role of CT texture analysis (TA) based 
quantitative imaging biomarkers in predicting response of colorectal liver 
metastases (CRLM) to chemotherapy in comparison to response evaluation 
criteria in solid tumours 1.1 (RECIST 1.1). 
Methods and Materials: This preliminary study evaluated eleven patients who 
underwent MDCT before and after chemotherapy (FOLFIRI or FOLFOX). 
According to RECIST 1.1 criteria computer-aided response assessment of 
target lesions was performed as reference standard using appropriate software 
(mint lesionTM). For each measured target lesion the software automatically 
derived statistical texture parameters (mean value of positive pixel (MPP), 
uniformity of distribution of positive pixel (UPP), skewness, kurtosis, uniformity 
and entropy). TA parameters were compared between patients with partial 
response (PR) and progressive disease (PD). Correlation analysis between % 
change in TA parameters and in sum of diameters (SOD) of target lesions was 
performed. 
Results: Four patients were classified as PR based on RECIST 1.1 while 
seven patients showed PD at follow-up. Mean follow-up time was 63.4 ± 6.6 
days. Kurtosis and skewness significantly increased in patients who showed 
PD and were reduced in those who responded to treatment (p<0.05). No 
correlation was observed between response to therapy and MPP, UPP, 
uniformity and entropy. 
Conclusion: Kurtosis and skewness significantly correlated with variation of 
target lesions’ largest diameters. These TA parameters may play a relevant 
role in predicting response to therapy of CRLM.  
B-0359 15:05  
Histogram analysis of T1-weighted, T2-weighted, and postcontrast T1-
weighted images in primary CNS lymphoma: correlations with 
histopathological findings  
H.-J. Meyer, S. Schob, B. Münch, C. Frydrychowicz, U. Quäschling, 
K.-T. Hoffmann, A. Surov; Leipzig/DE (jonas90.meyer@web.de)  
Purpose: Previously, some reports mentioned that magnetic resonance 
imaging (MRI) can predict histopathological features in primary CNS lymphoma 
(PCNSL). The reported data analysed diffusion-weighted imaging findings. The 
aim of this study was to investigate possible associations between 
histopathological findings, such as tumour cellularity, nucleic areas and 
proliferation index Ki-67, and signal intensity on T1-weighted and T2-weighted 
images in PCNSL. 
Methods and Materials: For this study, 18 patients with PCNSL were 
retrospectively investigated by histogram analysis on precontrast and 
postcontrast T1-weighted and fluid-attenuated inversion recovery (FLAIR) 
images. For every patient, histopathology parameters, nucleic count, total 
nucleic area, and average nucleic area, as well as Ki-67 index, were estimated. 
Results: Correlation analysis identified several statistically significant 
associations. Skewness derived from precontrast T1-weighted images 
correlated with Ki-67 index (p=- 0.55, P=0.028). Furthermore, entropy derived 
from precontrast T1-weighted images correlated with average nucleic area 
(p=0.53, P=0.04). Several parameters from postcontrast T1-weighted images 
correlated with nucleic count: maximum signal intensity (p=0.59, P=0.017), P75 
(p=0.56, P=0.02), and P90 (p=0.52, P=0.04) as well as SD (p=0.58, P=0.02). 
Maximum signal intensity derived from FLAIR sequence correlated with nucleic 
count (p=0.50, P=0.03). 
Conclusion: Histogram-derived parameters of conventional MRI sequences 
can reflect different histopathological features in PSNCL.  
B-0360 15:13  
Added value of radiomics signature to predict pulmonary metastasis in 
colo-rectal cancer patients with lung nodules  
T. Hu, T. Tong, S. Wang; Shanghai/CN (h16211230001@163.com)  
Purpose: To evaluate the added value of radiomics signature in the 
development and validation of nomograms to predict pulmonary metastases in 
colorectal cancer (CRC) patients with lung nodules. 
Methods and Materials: A total of 266 CRC patients with pulmonary nodules 
were identified between January 2010 and October 2016 to analyze the clinical 
characteristics and texture parameters from chest CT images. Clinical features 
identified by the logistic regression analysis were used to construct a clinical 
nomogram, radiomics signature built by a LASSO regression model were 
added to the selected clinical features to develop the clinical-radiomics 
nomogram. The nomograms performance was assessed through 
discrimination and calibration. Decision curve analyses were applied to 
compare the clinical usefulness. 
Results: The logistic regression analysis identified the primary tumor site, 
chronicity, and carcinoembryonic antigen as independent predictors. The 
LASSO model built the radiomics signature with four predictive texture 
parameters. The clinical nomogram was developed with good discrimination (c-
index of 0.808 in the primary set and 0.776 in the validation set) and poor 
calibration. The clinical-radiomics nomogram showed an incremental 
prognostic value with superior discrimination (c-index of 0.944 in the primary 
set and 0.922 in the validation set) and calibration. The decision curve 
analyses demonstrated that the clinical-radiomics nomogram showed clinical 
usefulness. 
Conclusion: In CRC patients with pulmonary nodules, the clinical-radiomics 
nomogram which was created by the clinical features and radiomics signature 
had exhibited superior discriminatory ability and accuracy for a metastases 
prediction. The clinical-radiomics nomogram is a reliable clinical treatment tool 
to predict pulmonary metastases.  
B-0361 15:21  
Personalised radigenomic medicine: prostate cancer gene 3 and PI-
RADSv2 team up to predict clinically significant prostate cancer  
M. Nguyentat1, V. Bura2, A. Ushinsky1, S. Fardin1, C. Green1, E. Uchio1, 
T.K. Lee1, C. Lall1, R. Houshyar1; 1Orange, CA/US, 2Cluj-Napoca/RO 
(vlad.t.bura@gmail.com)  
Purpose: Multiparametric-MRI (mpMRI) utilizing PI-RADSv2 has been shown 
to detect prostate cancer (PCa) with high diagnostic accuracy. Genomic data, 
such as prostate cancer Gene 3 (PCA3) is known to be overexpressed in PCa. 
However, studies combining the two are lacking. We propose a radiogenomic 
model combining prostate imaging and PCA3 data for detecting clinically 
significant PCa (csPCa). 
Methods and Materials: We retrospectively reviewed patient charts of those 
who underwent urinary PCA3 testing, mpMRI, and MRI/TRUS fusion-biopsy 
from 09/2014-12/2016. PI-RADSv2 was utilized for mpMRI. csPCa was defined 
as Gleason Score  7. PCA3 data were recorded as both qualitative 
(positive/negative) and quantitative (absolute number) results. Logistic 
regression and ROC analysis were performed to assess correlation and 
diagnostic accuracy of our radiogenomic model for detecting csPCa. 
Results: A binomial logistic regression of 62 men with 96 prostate lesions was 
performed to ascertain the effects of PCA3 and PI-RADSv2 scores on the 
likelihood that subjects have csPCa. The logistic regression model was 
statistically significant, 2(3) = 33.029, p < .0005. Sensitivity of our model was 
53.3%, specificity was 95.1%, positive predictive value (PPV) was 66.7% and 
negative predictive value (NPV) was 91.7%. The AUC of quantitative-PCA3 
was 0.720 (95% CI 0.585-0.855, p = 0.009), while for PI-RADSv2 was 0.818 
(95% CI 0.705-0.931, p < 0.001). Combining the two into one multivariate 
model produced an AUC of 0.920 (95% CI 0.860-0.979, p < 0.001). 
Conclusion: Combining PI-RADSv2 and quantitative-PCA3 into one 
radiogenomic model achieves an excellent specificity, NPV, and a larger AUC 
for detecting csPCa.  
14:00 - 15:30 Sky High Stage  
Oncologic Imaging  
MY 3  
Oncologic Imaging  
Moderators:  
G. Brancatelli; Palermo/IT  
S. Gourtsoyianni; Athens/GR  
B-0362 14:00  
Whole-body diffusion-weighted MRI in Hodgkin Lymphoma: 3D texture 
analysis for early treatment response assessment  
K.N. De Paepe1, I.F. Vieira2, F. De Keyzer2, P. Wolter3, O. Bechter2, 
D. Dierickx2, R. Oyen2, G. Verhoef2, V. Vandecaveye2; 1London/UK, 
2
Leuven/BE, 3Verviers/BE (katjadepaepe@gmail.com)  
Purpose: To evaluate feasibility and predictive utility of early treatment 
response assessment n Hodgkin lymphoma (HL) using 3D texture analysis of 
whole-body diffusion-weighted MRI (WB-DWI/MRI). 
Methods and Materials: Twenty-six patients with HL underwent 3-T whole 
body (WB) DWI/MRI before and 4 weeks after start of chemotherapy (1 
treatment cycle). Responses after 1 treatment cycle, were assessed by the 
apparent diffusion coefficient change relative to baseline (ADCavg), change of 
first-order-statistics (FOS) ADC histogram features (ADChist) and change of 
second-order-statistics (SOS) textures (ADCtext), generated by grey-level co-
occurrence matrices. The discriminative capability of ADCavg, ADChist and 
ADCtext to identify refractory/recurrent lesions versus responding lesions was 
determined using Mann-Whitney U tests, supplemented by Monte Carlo (MC) 
permutation tests for statistical robustness. Correlation of the response 
  






variables with progression-free survival (PFS) was assessed with Kaplan-Meier 
and log rank tests. 
Results: At a median follow-up time of 43 months (range 3-79 m), 21/26 
patients had complete remission and 5 patients persistent/ recurrent disease (8 
non-responding and 47 responding lesions). The ADCavg (p=0.84) and 
ADChist (p>0.05) didn't correlate significantly with lesion response. The 
ADCtext showed significant differences for energy (ADCE; p=0.001), local 
homogeneity (ADCLH; p=0.002), and entropy (ADCH; p=0.001), which also 
correlated significantly with PFS (ADCLH,p=0.031; ADCE,p=0.013; 
ADCH,p=0.002). 
Conclusion: Early response assessment after 1 cycle of chemotherapy by 
WB-DWI/MRI texture analysis (ADCtext) correlates significantly with PFS, 
showing substantially stronger association with tumor response than ADCavg 
or ADChist.  
B-0363 14:04  
Dynamic glucose-enhanced MRI: clinical perspectives and challenges  
D. Paech1, P. Schuenke1, C. Köhler1, P. Bachert1, M. Ladd1, M. Bendszus1, 
H.-P. Schlemmer1, M. Zaiss2, A. Radbruch1; 1Heidelberg/DE, 2Tübingen/DE 
(d.paech@dkfz.de)  
Purpose: To investigate dynamic glucose-enhanced (DGE) magnetic 
resonance imaging (MRI) at 7 Tesla (7T) in the healthy human brain and newly 
diagnosed untreated glioblastoma patients. 
Methods and Materials: Eleven newly diagnosed glioblastoma patients and 
eight healthy volunteers were included in this prospective ethic approved 
study. DGE MRI was performed at a 7T whole-body scanner 
(Siemens,Healthcare,Erlangen,Germany) using an in-house developed 
adiabatically-prepared chemical exchange sensitive spin-lock (CESL) 
sequence (temporal resolution = 7 sec). 100ml of 20% D-glucose were injected 
intravenously during DGE MRI. Gadolinium contrast-enhanced T1-w images 
were obtained along the clinical standard MRI protocol at 3T. Mean signal 
intensities of (1)the tumor regions vs. normal appearing white matter, and 
(2)gray matter vs. white matter, were compared by using the Student's t-test. 
Results: No adverse effects were observed in patients and volunteers related 
to glucose injections. The DGE contrast allowed for the identification of 
pathophysiologically increased glucose uptake in the tumor area in all patients. 
The mean signal intensity of the glucose enhancing tumor region over all 
patients (DGE=3.57±1.79%) was significantly higher than in contralateral 
normal appearing white matter (DGE=0.22±0.80%) (p<0.01). Futher, DGE 
MRI revealed an increased glucose uptake in gray matter regions compared to 
white matter of the normal human brain (p<0.001). 
Conclusion: DGE MRI may provide complementary information about the 
metabolic heterogeneity of tumors, with implications for biopsy targeting, 
patient therapy and response monitoring. Furthermore, glucose enhanced MRI 
could open up the field of metabolic imaging without the limitations set by 
ionizing radiation and high expenses associated with radioisotopes.  
B-0364 14:08  
Compressed sensing accelerated 3D magnetic resonance 
cholangiopancreatography: application in pancreatic diseases  
L. Zhu, Z.-y. Sun, H.-d. Xue, T.-y. Qian, Z.-y. Jin; Beijing/CN 
(zhuliang_pumc@163.com)  
Purpose: To prospectively evaluate image quality, duct visibility and diagnostic 
performance in duct-related pathologies of compressed-sensing (CS) 
accelerated 3D MRCP, and compare to conventional 3D MRCP in patients with 
suspected pancreatic diseases. 
Methods and Materials: Eighty patients (47 men and 33 women, median age, 
57 years, range, 24-87 years) underwent 3D MRCP at 3.0T. Three protocols 
were performed in each patient: CS breath-hold (BH) protocol, CS navigator-
triggered (NT) protocol, and conventional NT protocol. Acquisition time of each 
protocol was recorded. Image quality and duct visibility were independently 
rated in random order on a 5-point scale by two radiologists, who were blinded 
to the protocols. Receiver operating characteristic curves were generated, and 
area under the curve (Az value) was used to compare the diagnostic 
performance of each protocol in duct-related pathologies. 
Results: Acquisition time was 17 seconds for CS-BH protocol and 134.1±33.5 
seconds for CS-NT protocol, both being significantly shorter than the 
conventional NT protocol (364.7±78.4 seconds, both p<0.01). CS-BH protocol 
showed significantly less artefacts compared to both NT protocols (both 
p<0.01). Visualization of bile ducts was comparable with all three protocols, 
whereas CS-NT and conventional NT protocol depicted pancreatic duct better 
than CS-BH protocol (for proximal, middle and distal segment, all p<0.05). CS-
NT MRCP had highest diagnostic performance for detecting ductal anomalies, 
long-segment duct stenosis, abnormal branch ducts, and communication 
between cystic lesion and pancreatic duct (mean Az value 0.943-0.983). 
Conclusion: CS-MRCP is feasible in patients with suspected pancreatic 
diseases. CS-NT MRCP demonstrated superior diagnostic accuracy for duct-
related pathologies.  
B-0365 14:12  
Multiparametric MRI to predict response to external beam radiotherapy in 
locally advanced cervical cancer: comparison of MRI volumetry, 
diffusion-weighted MRI and MR texture analysis  
L.A. Min1,2, L.L.G.C. Ackermans1, M.E. Nowee1, J.J. van Griethuysen1,2, 
S. Trebeschi1, W. Vogel1,1, M. Maas1, R.G.H. Beets-Tan1,2, D.M. Lambregts1; 
1
Amsterdam/NL, 2Maastricht/NL (lisaannamin@gmail.com)  
Purpose: Locally advanced cervical cancer (LACC) patients who respond very 
well to external beam radiotherapy (EBRT), i.e. with near-complete tumour 
regression, might be candidates for early start of subsequent brachytherapy 
and dose de-escalation in the future. Goal was to investigate if we can predict 
upfront which patients will achieve a near-complete response using 
multiparametric MRI. 
Methods and Materials: N=41 LACC patients were retrospectively included. 
Two readers in consensus analysed the pre-treatment MRIs (3.0T) and 
delineated whole-tumour volumes on T2-weighted and high b-value diffusion-
weighted imaging (DWI). The following parameters were calculated: T2W-
volume, DWI-volume, apparent diffusion coefficient (ADC), and texture 
parameters mean, SD, entropy and uniformity (LoG-filter 1.5). Areas under the 
ROC curve (AUC) to predict a near-complete response (tumour volume 
reduction >90% on T2W-MRI after EBRT) were calculated. 
Results: AUC to predict a near-complete response was 0.58 for T2W-volume 
and 0.54 for DWI-volume. ADC rendered an AUC of 0.66. Texture 
measurements resulted in AUCs of 0.53 (mean), 0.69 (SD), 0.65 (entropy) and 
0.63 (uniformity). The improvement in AUCs for the ADC and texture measures 
compared to T2W-volumetry were not statistically significant. Combining 
volume with ADC and/or texture parameters did not improve performance. 
Conclusion: Pre-treatment tumour volumetry (T2W- or DWI-based) is not 
useful to predict a near-complete response. Quantitative diffusion and texture 
parameters may help to improve predictive performance, although results were 
not statistically significant and remained suboptimal in this small cohort. For 
future research it would be worthwhile to see if combining quantitative MRI with 
FDG-PET/CT can further improve results.  
B-0366 14:16  
Is there rationale for the routine inclusion of chest CT in gastric cancer 
staging? Evidence from a single-institution cancer registry  
A.-H. Chen1, C.-M. Chen2; 1Taoyuan/TW, 2Taipei/TW 
(angel08141@gmail.com)  
Purpose: ESMO 2016 and AJCC 8th edition guidelines recommend routine 
inclusion of chest CT in gastric cancer staging. We assessed the necessity and 
clinical value for such routine inclusion. 
Methods and Materials: This is a retrospective review of Chang Gung 
Memorial Hospital, Linkou, Taiwan gastric cancer registry (between 2008 and 
2014). We evaluated the inclusion of chest CT at initial staging, patterns of 
metastases at initial presentation and at recurrence following surgery. Overall 
survival was calculated from Kaplan-Meier estimates. 
Results: A total of 1675 cases were reviewed. Between the review period, 
there was a doubling trend in the inclusion of chest CT (18.0% - 32.0%); 
however, the incidence of pulmonary metastases (0.8% - 2.6%) is rare. 478 
patients (28.5%) had metastatic disease at presentation. The most common 
metastases was intra-abdominal (90.0%). 27 (3.2%) and 20 (2.4%) patients 
had pulmonary and cytologic-proven pleural metastases, respectively. Of all 
pulmonary metastases, 11 patients (40.7%) had primary lesions located at 
cardia/fundus. There was no solitary metastasis to lung or pleura and all the 
lesions could be identified in lower lung fields. Of the 203 patients (16.2%) 
recurrence, 15 (4.4%) pulmonary and 7 (2.1%) pleural metastases were found. 
There was no isolated pulmonary metastasis. No demonstrated significant 
difference in the median overall survival with or without lung metastases at 
initial presentation (p=0.78) and at recurrence (p=0.85). 
Conclusion: Our findings do not support routine inclusion of chest CT in 
gastric cancer staging because of the rarity of pulmonary metastasis, absence 
of solitary metastasis and lack of survival difference.  
B-0367 14:20  
MR texture analysis: potential imaging biomarker for prediction of 
chemotherapy response in patients with colorectal liver metastases  
H. Zhang, T.T. Tong; Shanghai/CN (17081376182@163.com)  
Purpose: The purpose of the study was to determine if pre-treated MR texture 
features of colorectal liver metastases (CRLMs) are predictive of chemotherapy 
response after the first-line chemotherapy. 
Methods and Materials: The study included 26 consecutive patients (a total of 
193 liver metastasis) with unresectable CRLMs at our institution from August 
2014 to February 2016. All patients underwent baseline MRI within 3 weeks 
before chemotherapy. Lesions were classified as either responding group or 
non-responding group according to changes in size. Texture analysis was 
quantified on T2-weighted images by two radiologists with an agreement on 
  






regions of interest which were manually drawn on the largest cross-sectional 
area of the lesions. Five histogram features (mean, variance, skewness, 
kurtosis, entropy1) and five grey level co-occurrence matrix features (GLCM; 
angular second moment (ASM), entropy2, contrast, correlation, inverse 
difference moment (IDM)) were extracted. The texture parameters were 
analysed statistically to find the differences between the two groups and 
receiver operating characteristic curves were depicted to characterize each 
parameter value for evaluating treatment outcome. 
Results: 107 responding and 86 non-responding lesions were evaluated. 
Higher variance, entropy1, contrast, entropy2 and lower ASM, correlation and 
IDM were independently (P<0.05) associated with good response to 
chemotherapy with area under the ROC curve (AUCs) of 0.602-0.784. 
However, mean (P=0.186), skewness (P=0.311) and kurtosis (P=0.763) did not 
show a significant difference. 
Conclusion: MR texture features on pre-treated T2 images seem to be a 
promising tool for predicting the chemotherapy response of patients with 
colorectal liver metastases.  
B-0368 14:24  
Patterns of responses in metastatic NSCLC during immunotherapy: 
comparison of RECIST 1.1, irRECIST and iRECIST criteria  
M. Tazdait, F. Bidault, S. Ammari, C.S. Balleyguier, D. Planchard, J.-C. Soria, 
A. Marabelle, B. Besse, C. Caramella; Villejuif/FR (melodie.tazdait@orange.fr)  
Purpose: Immune checkpoint inhibitors are an important tool in the therapeutic 
strategy against metastatic non-small cell lung cancer (NSCLC), however 
radiological evaluation is challenging due to the emergence of atypical patterns 
of responses. Several evaluation criteria have been proposed, RECIST 1.1, 
irRECIST and iRECIST, but have not been systematically compared in a 
homogeneous population. 
Methods and Materials: We conducted a monocentric retrospective analysis 
of consecutive advanced NSCLC patients treated with an anti-PD1 or anti-PD-
L1. Response patterns and the discordance between RECIST1.1, irRECIST 
and iRECIST guidelines were described, and associations of response 
patterns and clinical outcome were explored. 
Results: Overall 160 patients treated between February 2013 and October 
2016 were included. Atypical responses were observed in 20 patients (13%), 
including 8 pseudoprogressions (5%) and 12 dissociated responses (8%). 
Thirteen of the 20 patients demonstrated clinical benefit. Per RECIST 1.1, 37 
patients (23%) showed an objective response or stable disease and 123 
patients (77%) exhibited progression. Eighty progressive patients were 
assessable for irRECIST and iRECIST: 15 patients were assessed differently 
however only three (3.8%) mismatches with a theoretical impact on the 
therapeutic decision were identified. Patients with pseudoprogression or 
dissociated response had higher overall survival than patients with true 
progression. 
Conclusion: Atypical responses (pseudoprogression/dissociated response) 
occurred in 13% of NSCLC patients under immune checkpoint inhibitors. 
Based on survival analyses, RECIST 1.1 evaluation underestimated the benefit 
of immune checkpoint inhibitors in 11% of progressive patients. irRECIST and 
iRECIST identified these unconventional responses, with a 3.8% discrepancy 
rate.  
B-0369 14:28  
Diagnostic value of automated breast volume sonography (ABVS) in 
breast cancer detection in women with different ACR types  
M. Efremova, V.E. Gazhonova; Moscow/RU (frem13@mail.ru)  
Purpose: To evaluate ABVS diagnostic performance in comparison with hand-
held ultrasound (HH-US) and X-ray mammography MMG for breast cancer 
detecting depending on ACR breast type. 
Methods and Materials: 171 women with 251 morphologically verified lesions 
were examined. For each woman ABVS, HH-US, MMG were performed. Two 
independent examiners evaluated the ABVS data separately on different 
workstations without any prior knowledge of patients’ history. Bi-RADS 
classification for ABVS examination was used. 
Results: In patients with ACR III, ACR IV the sensitivity (SE) of ABVS was 
significantly higher among all the methods and amounted to 96.5%, specificity 
(SP) was 84.1%, the area under the curve (AUC) had the highest value of 0.9 
which indicated an excellent quality of the method. For ACR III, ACR IV breast 
type patients MMG had significantly greater SE 92% and SP 84,6% versus 
ABVS diagnostic performance (SE-76%, SP-40%, AUC-0,58). Cohen's kappa 
for inter-rater agreement for BI-RADS evaluation for ABVS in total was  = 0.62 
± 0.05 - good. For malignant tumours  = 0.82 ± 0.07 - very good, for benign  
= 0.39 ± 0.05 - satisfactory. Thus, the possibility of missing malignant tumour 
by ABVS is extremely low but the chance of getting false-positive result is high. 
Conclusion: ABVS can be recommended as a reliable imaging method for 
breast cancer detecting in patients with dense breasts (ACR III, ACR IV). 
Second look follow-ups may be required in cases of benign findings.  
B-0370 14:32  
Prognostic significance of different MRI modalities for evaluation of 
neoadjuvant chemoradiation treatment of locally advanced rectal cancer  
O. Ganych; Kyiv/UA (ganich1@gmail.com)  
Purpose: In a current study we assess the prognostic significance of a widely 
used tumor regression grade (mrTRG) and the approach that uses grey-scale 
evaluation of T2 WI aided by the software developed by us (EmrTRG). 
Methods and Materials: During the years 2016-2017, 74 patients with primary 
diagnosed locally advanced rectal cancer (LARC) (mrT3mrf+-4N1-2M0) had 
been enrolled. All patients completed a course of neoadjuvant chemoradiation 
therapy (NCRT) with a total dose of 50,4 Gy with capecitabin and underwent 
curative surgery. 8-10 weeks after completion of the NCRT course an MRI 
examination with mrTRG and EmrTRG for evaluation of NCRT response was 
performed. MRI data had been compared with pathological TRG (pTRG), 
calculated by Dworak grading system. 
Results: We observed no cases of tumor progression. Pathologic complete 
response (pTRG-5) was observed in 6 (7%) of patients, pTRG-4 - 10 (13%), 
pTRG-3 - 20 (26%), pTRG-2 - 24 (37%), pTRG-1 - 10 (13%), pTRG0 - 4 (4%). 
There were 12 (16%) patients with complete radiologic response according to 
mrTRG and 8 (11%) according to EmrTRG, 20 (27%) and 12 (16%) (p<0.05) 
with mrTRG and EmrTRG grade 4 , 12 (15%) and 18 (24%) (p<0.05) with 
grade 3, 10 (13%) and 22 (31%) (p<0.05) - grade 2, 14 (22%) and 10 (14%) - 
grade 1, 6 (7%) and 4 (4%) - grade 0 respectively. 
Conclusion: EmrTRG demonstrated superior accuracy in detecting pTRG-2-4 
grade of response to NCRT comparing to mrTRG. Both mrTRG and EmrTRG 
showed insignificant accuracy level in detecting pathological complete 
response.  
B-0371 14:36  
Prediction of response to transarterial radioembolisation by means of 
MRI-based texture analysis as a potential radiomics tool  
R. Reimer1, P. Reimer2, A. Mahnken1; 1Marburg/DE, 2Karlsruhe/DE 
(robertpeterreimer@gmail.com)  
Purpose: To evaluate whether assessment of tumor heterogeneity by means 
of MRI based texture analysis in patients with liver metastases may predict 
progress to transarterial radioembolization (TARE) earlier than by morphologic 
criteria. 
Methods and Materials: 37 patients with liver metastases treated by TARE 
underwent dynamic contrast enhanced and hepatocellular phase MRI with 
gadoxetic acid after TARE (mean 2.2 days). Response was evaluated on 
follow-up imaging scheduled in intervals of 3 months (median follow-up, 221 
days) based on Response Evaluation Criteria in Solid Tumors 1.1 (RECIST 
1.1). Results of texture analysis (mean (m), standard deviation (sd), skewness 
(s), kurtosis (k), entropy (e), uniformity (u)) of the ROI were compared between 
patients with and without progressive disease. Receiver operating 
characteristics including the area under the curve (AUC) were calculated. 
Results: According to RECIST 1.1, 24 patients (64.9%) had progressive 
disease and 13 (35.1%) stable disease or partial response. Median k 
(2.88vs.2.33) in arterial phase MRI and median s (0.48 vs.0.3) and median k 
(2.85vs.2.45) (p<0.05) in venous phase MRI derived from texture analysis 
showed earlier significant differentiation (p<0.05) than RECIST 1.1 between 
patients with and without progressive disease. The AUC for k in arterial phase 
was 0.77 (p<0.05) and for s and k in venous phase 0.71 (p>0.05) and 0.72 
(p<0.05). 
Conclusion: Texture analysis indicating tumor heterogeneity of liver 
metastases after TARE has the potential to predict progressive disease earlier 
than by morphologic criteria. Earlier prediction of response to TARE may 
optimize individual therapy in clinical medical and interventional oncology.  
B-0373 14:40  
Comparison of whole-body MRI (wbMRI) and bone scintigraphy in 
oncologic follow-up  
A. Malich1, I. Papageorgiou1, D. Kovacevic1, A. Kott1, D. Wiech1, 
U.K. Teichgräber2; 1Nordhausen/DE, 2Jena/DE (ansgar.malich@shk-ndh.de)  
Purpose: Scintigraphy is still first line method in the detection of osseous 
metastases. Whole body MRI, however, is increasingly more available at 
various MR-scanners and thus could fill the gap of reduced availability of 
nuclear medicine departements. Only few data compare both technologies. 
Methods and Materials: 1633 whole body MRI were retrospectively evaluated 
using a double blinded setting. An unsusipicious MRI was scored true in case 
of continued unsuspicious follow up, true positive results were accepted in 
case of histopathology, or initiazation of treatment due to proven metastases 
with related clinical signs. All cases were evaluated regarding the existence 
and report of scintigraphic analyses within 1 year after MRI. 
Results: 285/1633 wbMRI-cases had a bone scintigraphy; 264/285 had a 
verification of the imaging modalities. In 208/264 cases scintigraphy and wb-
MRI revealed same results (86tp, 122tn). In total WbMRI vs scintigraphy had 
  






the following results: tp: n=102/n=88; tn: n=136/n=146; Fp: n=25/n=14; fn: 
n=1/n=16. Sensitivity, specificity, PPV, NPV, accuracy are (wbMRI/scinti): 
99.0%/84.6%; 84.5%/91.3%; 80.3%/86.3%; 99.3%/ 90.1%; 91.8%/88.0%. 
Other then bone metastases were found in 18.3%, other incidentally detected 
tumor like structures were reported in 11.3%. Additional findings in scintigraphy 
were reported in 1.5%. 
Conclusion: Whole body MRI is valuable in oncologic follow up and can 
replace bone scintigraphy in case of availability. Significant number of 
additional metastatic findings and incidental tumor like lesions could be found 
by wbMRI compared to scintigraphic analysis.  
B-0374 14:44  
Does second reader opinion affect pancreatic adenocarcinoma 
management?  
G. Corrias1, S. Huicochea Castellanos1, V. Balachandran1, L. Saba2, 
L. Mannelli1; 1New York, NY/US, 2Monserrato/IT (corriasgmd@gmail.com)  
Purpose: Patients with pancreatic cancer frequently present to tertiary referral 
centers with imaging studies that have been performed and interpreted 
elsewhere. At our institution, these outside studies undergo formal second 
opinion reporting by a fellowship-trained oncologic radiologist with expertise in 
abdominal imaging. The purpose of this study was to determine the impact of 
this practice on cancer staging and patient management 
Methods and Materials: Randomised original and second opinion reports for 
65 consecutive cases of biopsy proven pancreatic adenocarcinomas in a 4 
years period from 2009 to 2013 were considered. Discrepancy rates for 
recommended patient management, as recommended by two experienced 
abdominal surgeons, were calculated. For the 10,8% (7/65) of cases that 
subsequently went to surgery, the accuracies of the reports were determined 
relative to the pathologic staging gold standard. For all other patients, 
performed management, checked with clinical and imaging standard of 
reference at 6 months, was considered. 
Results: Following oncologic radiologists second opinion review, the cancer 
stage changed in 13% (9/65) for surgeon 1 and in 18,4% (12/65) for surgeon 2. 
The recommended management changed in 38,4% (25/65) for surgeon 1 and 
in 20% (13/65) for surgeon 2. When compared to the pathologic staging gold 
standard, the second opinion was correct 85,7% (6/7) of the time for both 
surgeons’ interpretation. 
Conclusion: Specialist second opinion review of outside imaging studies 
resulted in an accurate change in cancer stage and this frequently led to a 
change in their management plan.  
B-0375 14:48  
Prognostic impact of body composition in patients with metastasised 
malignant melanoma with checkpoint-inhibitor therapy  
J. Nattenmüller, L. Eller, S. Lücke, A. Lonsdorf, H.-P. Schlemmer, 
H.-U. Kauczor, O.L. Sedlaczek; Heidelberg/DE (johannawelzel@gmail.com)  
Purpose: Checkpoint-inhibitors (CI) are a major breakthrough in the treatment 
of a variety of human malignancies and led to significant improvements in 
response and survival rates in metastatic melanoma patients. However, 
prognostic markers to select for patients that will respond to CI-therapy remain 
vastly elusive. As a close link between body composition (esp. fat distribution) 
and immune competence has been suggested, the aim of this study is to 
evaluate the prognostic impact of body composition on therapy response. 
Methods and Materials: 82 stage IV malignant melanoma patients (41 female, 
mean age 66ys, mean BMI 26.2kg/m2) treated with CI (Ipilimumab, Nivolumab, 
Pembrolizumab) underwent staging-CT with densitometric quantification of 
total (TFA), visceral (VFA) and subcutaneous fat area (SFA) and skeletal 
muscle index (SMI) at the spinal level L3/4 to evaluate their impact on 
progression-free (PFS) and overall survival (OS). 
Results: Median PFS and OS time were 293 and 913 days, respectively. On 
OS, a significant univariate negative impact of male gender (HR=2.88; 
p=0.018) and a beneficial multivariate impact of SFA (HR=0.64, p=0.044) was 
found. On PFS, a significant beneficial effect was found for SFA in univariate 
(HR=0.69, p=0.01) and multivariate (HR=0.49, p<0.001) analyses. These 
effects of SFA were independent of gender. No significant impact of BMI, VFA, 
TAT and SMI was detected. 
Conclusion: SFA had a significant beneficial prognostic value on both PFS 
and OS in stage IV melanoma patients undergoing CI-therapy. Further studies 
are needed to validate body composition and SFA as candidate biomarkers of 








B-0376 14:52  
Influence of Trigger-PSA and molecularactive tumour volume evaluated 
with 68Ga-PSMA PET/CT on detection rate and localisation of recurrence 
in patients with prostate cancer  
S.S. Medina-Ornelas, F. Garcia-Perez; Mexico City/MX 
(dr.sevastian@outlook.com)  
Purpose: Investigate the association between molecular active tumour volume 
(MATV) evaluate with 68Ga-PSMA-PET/CT and levels of Trigger-PSA for 
patients with Prostate cancer (PC). 
Methods and Materials: Eighty-four patients who underwent to evaluation of 
PSA levels on the same week of the 68Ga-PSMA-PET/CT (Trigger-PSA) were 
studied. were included. Sixty patients had received ADT at last 6 months 
before the examination. The median of the Trigger-PSA was 8.9 ng/mL (range 
0.2-127 ng/ml). 
Results: The median MATV of bone metastatic disease was significantly 
higher than that in metastatic lymph nodes (LN) and prostate bed (139.5 
versus 17.7; p<0.05). Respect to Trigger-PSA values, the median Trigger-PSA 
levels of patients with tumours that were limited to the prostate bed (median 
Tigger-PSA 2.8ng/ml); loco-regional and/or distant lymph node disease 
(median Tigger-PSA 6.8ng/ml) and metastatic bone disease (median 
46.8ng/ml (p<0.05). Positive patients had a mean Trigger-PSA of 4.3ng/mL vs 
1.5ng/mL in negative patients (p <0.05). We established several threshold 
points for Trigger-PSA level and studied the detection rate for each one: 
Trigger-PSA 1ng/mL, detection rate 47.3%; Trigger-PSA 1-4ng/mL, 68.4%; 
Trigger-PSA 4ng/mL, 96.7%. When analyzing the best association between 
Trigger-PSA and MATV, we found that when Trigger-PSA was >4ng/mL, was 
greater for patients with a higher MATV (p<0.001). 
Conclusion: The correlation of a low MATV evaluate with 68Ga-PSMA-PET/CT 
has greater influence than the level of Trigger-PSA, which may have an impact 
on the timely change of the therapeutics used. A detection of the site of 
metastatic disease could lead to an appropriate therapeutic strategy.  
B-0377 14:56  
Improved detection of skeletal muscle metastases in iodine-density 
overlay maps and virtual monoenergetic reconstructions provided by 
spectral detector CT  
S. Lennartz1, M. Le Blanc1, N. Abdullayev1, N. Grosse Hokamp1,2, D. Maintz1, 
J. Borggrefe1, T. Persigehl1; 1Cologne/DE, 2Cleveland, OH/US 
(simon.lennartz@uk-koeln.de)  
Purpose: To investigate if iodine density overlay maps (IDM) and/or virtual 
monoenergetic images at 40 keV (VMI40keV) acquired with dual layer spectral 
detector computed tomography (SDCT) can improve detection of skeletal 
muscle metastases (SMM) compared to conventional polyenergetic images 
(PI). 
Methods and Materials: In total, 36 oncologic patients, 12 patients with 
confirmed SMM proven by prior or follow-up CT, FDG-PET or histopathology, 
and 24 patients without SMM who received SDCT staging examinations were 
included in this retrospective, IRB-approved study. Detection rate was 
determined in a blinded, randomised multi-reader analysis of PI, IDM and 
VMI40keV. Quantitatively, iodine density and contrast-to-noise-ratio (CNR) were 
determined using the following ROIs: metastasis, adjacent skeletal muscle, 
subcutaneous fat, and air. Size and localisation of ROIs were kept constant 
between IDM, VMI40keV and PI. Standard deviation within the fat was 
considered to be representative of image noise. Statistical analysis was 
performed using Wilcoxon test and ROC-analysis. 
Results: Both, IDM (69.1%) and VMI40keV (49.2%) yielded a significantly 
increased sensitivity for SMM compared to PI (24.2%). Specificity slightly 
dropped by 3.1% in IDM (78.0%) compared to PI (81.4%), while in VMI40keV, it 
decreased to 68.4%. Quantitative image analysis revealed a significant higher 
CNR (14.3±8,0) of SMM in VMI40keV compared to PI (5.5±6,2, p0.0001). Iodine 
density in SMM was significantly enhanced compared to adjacent muscle 
tissue (1.83±1,1 mg/ml vs. 0.28±0,22 mg/ml, p0.0001). 
Conclusion: Iodine density maps (IDM) provided by SDCT significantly 
improve detection rate of SMM in oncologic patients while maintaining an 
equivalent level of specificity.  
B-0378 15:00  
Comparison of biopsy and pathological Gleason score in patients with 
biopsy-proven prostate cancer  
V. Romano1, V. Doronzio1, S. Pedalino1, V. Giannini1, S. Mazzetti1, 
A. Giacobbe2, G. Muto2, F. Russo1, D. Regge1; 1Candiolo/IT, 2Milan/IT 
(vittorio.romano@ircc.it)  
Purpose: To compare biopsy Gleason Score (bGS) with pathological Gleason 
score (pGS) after prostatectomy in patients with positive MRI finding and 
biopsy-proven PCa. 
Methods and Materials: Men with biopsy-proven PCa from either MR-targeted 
biopsy or saturation TRUS-guided biopsy were included in this study and 
  






underwent radical prostatectomy within 3 months from diagnosis. Overall, 24 
men with positive MR-targeted biopsy, and 30 subjects with positive saturation 
biopsy were considered. Whole-mount histological sections resected from 
radical prostatectomy were used as the reference standard, and 
biopsy/pathological Gleason score (GS) were compared, assessing the 
proportion of correctly classified PCa, upgrading and downgrading rates. 
Results: After surgery, biopsy GS was correctly identified in 67% and 43% of 
cases, in MR-targeted biopsy and saturation biopsy, respectively (p=0.08). 
Biopsy GS was upgraded in 29% of MR-targeted and 30% of saturation biopsy 
, respectively (p=0.94). Downgrading was registered in 4% and 27% of cases 
in MR-targeted biopsy and saturation biopsy, respectively (p=0.03). Stratifying 
patients according to bGS, a higher number of 4+4 PCa were detected in the 
saturation than in the MR-targeted biposy (16% vs 2%, p=0.13), while 
considering the pGS, the two sampling techniques (MR-targeted or saturation) 
reported no statistical difference when men were stratified by pGS (p>0.27). 
Conclusion: MR-targeted and saturation biopsy reported a similar rate of 
correctly classified bGS, while in-bore MR-targeted biopsy showed a significant 
lower rate of downgrading with respect to saturation biopsy.  
B-0379 15:04  
Efficacy of intravoxel incoherent motion MRI in discrimination of 
metastatic vs non-metastatic abdominal lymph nodes in hepatobiliary 
malignancies: a correlation study with PET-CT  
S. Sabet, S. Server, I. Karalok, E.K. Namal, N. Inan, Y. Tokat; Istanbul/TR 
(soheyl_61@yahoo.com)  
Purpose: The aim of this study was to evaluate the diagnostic performance of 
IVIM MR parametres in differentiating metastatic from non-metastatic 
abdominal lymph nodes in hepatobiliary malignancies. 
Methods and Materials: MR images of 34 consecutive patients harbouring 83 
upper abdominal lymph nodes with diagnosis of hepatobiliary malignant tumor 
were evaluated retrospectively. IVIM parameters were calculated for each 
lymph node form MR images obtained with 16 different b factors (0, 50, 100, 
150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300 s/mm2) 
by a 1.5 Tesla MR scanner (Siemens, Magnetom Symphony, Erlangen, 
Germany). These parameters were compared with SUV max. values of target 
lesions in FDG PET-CT studies. 
Results: The mean value of D was lower, and mean value of f was higher 
significantly for metastatic group than those of non-metastatic group (p0,001), 
while D* and ADC did not show significant difference. D and f had largest area 
under curve in the ROC analysis ( 0,649 and 0,984 respectively) compared to 
other individual IVIM parameters leading to sensitivity and specifity of %96 and 
%86 for f in identification of metastatic lymph nodes. 
Conclusion: IVIM parameters, specially D and f, reflect the metabolic activity 
of lymph nodes, providing a reliable diagnostic tool in distinguishing metastatic 
from non-metastatic lymph nodes with a lower price, shorter scan time and 
radiation free modality instead of PET-CT and may be applicable not just in 
cervical and thoracic tumors but also in abdominal lymphadenopathies caused 
by hepatobiliary malignancies.  
B-0380 15:08  
T2 hyperintense myometrial tumours: can MRI features differentiate 
leiomyomas from leiomyosarcomas?  
G. Rio1, M. Lima2, R. Gil2, M. Horta2, T.M. Cunha2; 1Braga/PT, 2Lisbon/PT 
(giselario_123@hotmail.com)  
Purpose: To establish MRI features that help differentiate atypical and 
degenerated leiomyomas that show hyperintensity on T2WI from 
leiomyosarcomas (LMS). 
Methods and Materials: This retrospective study evaluated 51 women who 
performed MRI and had T2 hyperintense myometrial tumours, proved by 
histology as atypical or degenerated leiomyomas or leiomyosarcomas (21 
leiomyomas; 20 leiomyosarcomas), before they underwent hysterectomy. The 
association between MRI features (contours; free pelvic fluid, intra-tumoural 
haemorrhagic areas, T2 heterogeneity; T2 dark areas; flow voids; signal 
intensity and heterogeneity after contrast administration; unenhanced areas, 
localization of unenhanced areas; necrosis; cystic areas) and the histology 
(leiomyoma vs leiomyosarcoma) were calculated using Fisher’s exact test. For 
those features that showed a significant association, a multivariate linear 
regression was performed. 
Results: Five MRI features demonstrated a significant correlation with 
malignant histology: lobulated borders (p= 0,002); T2 dark areas (p=0,02); 
necrosis (p=0,001); hyperintensity relative to the myometrium after contrast 
administration (p=0,007) and central unenhanced areas (p=0,016). Three of 
these features demonstrated a significant result predicting a malignant 
histology: lobulated contours, central unenhanced areas and necrosis (F 




Conclusion: The presence of lobulated borders, T2 dark areas, necrosis, 
hyperintensity relative to the myometrium after contrast administration and 
central unenhanced areas can help distinguish between leiomyoma and 
leiomyosarcoma. The association of lobulated borders, necrosis and central 
unenhanced areas can help predict a malignant histology.  
B-0381 15:12  
3D imaging biomarkers for the prediction of survival in patients with non-
small cell lung cancer or melanoma brain metastases treated with 
stereotactic body radiation therapy  
M. Della Seta, F. Collettini, D. Kaul; Berlin/DE (marta.della-seta@charite.de)  
Purpose: To investigate the value of 3D-quantitative tissue enhancement as 
an early imaging biomarker for survival in patients with singular non-small cell 
lung cancer (NSCLC) and melanoma brain metastases (BM) treated with 
stereotactic body radiation therapy (SBRT). 
Methods and Materials: 48 patients with a singular BM were treated with 
SBRT (27 NSCLC- and 21 melanoma patients). Baseline contrast-enhanced 
MRI (ceMRI) was used for image analysis using the qEASL tool (Philips 
Healthcare). A segmentation-based 3D-quantification was performed to 
measure the relative tumour enhancement. Survival was evaluated using 
univariable and multivariable cox regression models. 
Results: Median overall survival (OS) of the cohort was 8.9 months. The 
stratification of the cohort according to a 65% cutoff for the relative enhancing 
tumour volume achieved statistical significance in univariable and multivariable 
analysis for OS (univarible regression: p=0.005, HR= 0.375 [95% CI, 0.168-
0.744], multivariable regression: p=0.006, HR= 0.376 [95% CI, 0.186-0.757]). 
Patients with >65% enhancing lesion volume survived significantly longer than 
patients with less-enhancing tumour lesions (4.9 months vs 10.2 months). In 
subgroup analysis of NSCLC-patients adenocarcinoma showed significantly 
longer median OS than non-adenocarcinoma NSCLC patients in univariable 
and multivariable analysis (3.5 months vs 10.2 months). 
Conclusion: Enhancement on baseline ceMRI in patients with singular 
NSCLC and melanoma BM is strongly associated with patient survival after 
SBRT. Specifically, patients with hyper-enhancing lesions demonstrated 
improved survival as compared to those with mainly hypo-enhancing lesions. 
Lesion enhancement may be a potential factor in future prognostic indices for 
the prediction of survival of patients with BM.  
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B-0382 16:00  
Radiomics of high-grade serous ovarian cancer: association between 
quantitative CT features and prognosis  
F. De Piano, V. Buscarino, M. Femia, L. Tofanelli, S. Raimondi, D. Origgi, 
F. Botta, S. Rizzo; Milan/IT (fran.depi@gmail.com)  
Purpose: To determine if radiomic features, alone or combined with clinical 
data, are associated with residual tumour (RT) at surgery, and predict the risk 
of disease progression within 12 months (PD12) in ovarian cancer (OC) 
patients. 
Methods and Materials: This retrospective study enrolled 101 patients 
according to the following inclusion parameters: cytoreductive surgery 
performed at our Institution (05/09/2007-23/02/2016), assessment of BRCA 
mutational status, pre-operative CT available. Radiomic features of the ovarian 
masses were extracted from 3D structures drawn on CT images. A phantom 
experiment was performed to assess the reproducibility of radiomic features. 
The final radiomic features included in the analysis (516) were grouped into 
clusters using a hierarchical clustering procedure. The association of each 
radiomic feature with RT and PD12 was assessed by Chi-Square test. 
Multivariate analysis was performed using logistic regression models. P-values 
< 0.05 were considered significant. 
Results: Patients with values of F2-Shape/Compactness1 below the median, 
values of F1- GrayLevelCooccurenceMatrix25/0-1InformationMeasureCorr2 
below the median, and values of F1-GrayLevelCooccurenceMatrix25/-333-
1InverseVariance above the median showed a higher risk of RT (36%, 36% 
and 35%, respectively, as opposed to 18%, 18% and 18%). Patients with 
values of F4-GrayLevelRunLengthMatrix25/-333RunPercentage above the 
median, values of F2 shape/Max3DDiameter below the median, and F1-
GrayLevelCooccurenceMatrix25/45-1InverseVariance above the median 
showed a higher risk of PD12 (22%, 24% and 23%, respectively, as opposed 
  






to 6%, 5% and 6%). At multivariate analysis F2-Shape/Max3DDiameter 
remained significant (HR (95%CI)=11.86 (1.41-99.88)). 
Conclusion: This study demonstrated significant associations between 
radiomic features and prognostic factors such as RT and PD12.  
B-0383 16:04  
Prostate cancer detection rate in patients with negative multi parametric 
(mp) MRI or negative biopsy after 2 years of follow up  
E. Appendino1, S. Pedalino1, E. Tabone1, V. Romano1, S. Mazzetti1, 
A. Giacobbe2, G. Muto2, F. Russo1, D. Regge1; 1Candiolo-Turin/IT, 2Milan/IT 
(elena.appendino@gmail.com)  
Purpose: To assess prostate cancer (PCa) detection rate among patients in 
follow-up after a negative mp-MRI or biopsy, and to assess the negative 
predictive value (NPV) of mpMRI in the detection of PCa. 
Methods and Materials: 140 men with negative prostate mp-MRI (PI-RADS 1, 
2 or 3 with lesion diameter <7 mm), and 10 men with positive mp-MRI (PI-
RADS>3 or =3 with diameter >7 mm) but a negative biopsy (TRUS or RM-
guided) were monitored periodically with PSA values and urological visit. In 
case of PSA doubling time < to 3 years or following urological indication, 
subjects underwent a second mpMRI (2nd-MRI).After 2-year follow-up, we 
defined as negative patients with: a) no increase of PSA, or b) patients with 
negative 2nd-MRI, or c) patients with negative biopsy after a 2nd-MRI. 
Results: During follow-up 44/150 patients underwent a 2nd-MRI. In 10/44 
patients a prostate lesion was found, triggering a biopsy. Presence of PCa was 
biopsy-confirmed in 8/10 patients (6 men with GS=3+4, 1 with GS=4+3 and 1 
with GS=3+3). Among the 8 biopsy-proven PCa after the 2nd-MRI, 2 were 
already reported on the first MRI, although not confirmed by biopsy. No clinical 
or laboratory changes were observed in the remaining 106/150 patients (102 
men with negative mpMRI and 4 men with negative biopsy) during the 2-year 
follow-up period (70,6%). Overall 142/150 patients were considered negative 
(NPV of 94,7%). 
Conclusion: Biopsy can be safely avoided in subjects with a negative mp-MRI 
if follow-up is performed with clinical examination and PSA assessment.  
B-0384 16:08  
Which cancer-related factors are associated with prostate cancer missing 
when evaluating mpMRI with PI-RADS v2?  
R. Girometti1, F. Greco1, L. Cereser1, G. Como1, V. Ficarra2, G. Giannarini1, 
A. Crestani1, C. Zuiani1; 1Udine/IT, 2Messina/IT (rgirometti@sirm.org)  
Purpose: To assess which prostate cancer (PCa)-related factors are 
associated with cancer missing (CM) on multiparametric magnetic resonance 
imaging when using prostate imaging reporting and data system version 2 (PI-
RADS v2). 
Methods and Materials: Between May 2016-February 2017 we prospectively 
enrolled patients with biopsy-proven prostate cancer who underwent staging 
3.0T Multiparametric magnetic resonance imaging (mpMRI) before radical 
prostatectomy. Two readers with 6 and 8 years of experience, respectively, 
detected and scored mpMRI findings according to PI-RADS v2 criteria in a 
blinded fashion compared to final whole-mount pathology. Using PI-RADS 4 
score as threshold, we calculated the per-lesion cancer detection rate (CDR) of 
each radiologist. We then performed multiple logistic regression to assess 
whether PCa-related factors (clinical significance according to Epstein criteria, 
Gleason score, prostate specific antigen (PSA) level, histological lesion size, 
extraprostatic extension and prostatic location) were predictors of CM. 
Results: Included were forty-eight patients (median iPSA 7.2 ng/ml) with 71 
cancers (median size 16 mm, median Gleason score 6, stage T3 in 19/48 
cases, 51/70 clinically significant cancers (csPCa)). CDR ranged 0.48-0.60 for 
all cancers and 0.61-0.72 for csPCa. On univariate analysis, the model of both 
readers showed significant association (p<0.01) between CM and non-csPCa, 
Gleason score <7, size <1.4-1.5 cm, and absence of extraprostatic extension. 
On multivariate analysis, lower lesion size was the only independent predictor 
of CM (p<0.01) for both radiologist 1 (OR 0.12) and 2 (OR 0.18). 
Conclusion: Smaller cancer size is the most impacting factor in CM when 
assessing PCa with PI-RADS v2.  
B-0385 16:12  
Role of ureteric jet angle as measured by colour Doppler ultrasound in 
evaluating severity (grading) of VUR in patients presenting with urinary 
complaints  
P. Maravi; Bhopal/IN (maravipoornima@gmail.com)  
Purpose: To correlate ureteral jet angles (UJA), measured by colour Doppler 
USG with VUR grades on micturating cystourethrogram (MCU) and establish 
ureteral jet angle (UJA), as non-invasive screening tool for detecting high 
grade vesioureteral reflux (VUR). 
Methods and Materials: Symptomatic children referred in Dept. of Imaging for 
MCU were examined by colour Doppler USG in order to get the bilateral 
ureteric jet angles (UJA). UJA was measured as angle between the direction of 
the ureteral jet and inter-ureteral ridge. Patients, who showed VUR in MCU, 
UJA were then correlated to grades of VUR using excel data tool. 
Results: In total 34 children (8 mon- 12 yrs) including 20 males (M) and 14 
females (F) were examined. Mean age was 4.96 yrs {4.60 yrs (M) and 5.47 yrs 
in (F)}. 21 patients, (10 (F) and 11 (M) showed VUR on MCU. 8 patients 
showed higher grade (grade 4 -5) including 7 M, 1 F. Range of UJA in VUR 
negative patients was 27-59° on right side (R) and 23-60° on left side (L). VUR 
positive patients showed angle range 42-84°(R) and 40-84° (L). Mean ureteric 
jet angle was 62.61°(R) and 61.80° (L). Grade IV/V VUR seen above >70°. 
Positive correlation {r=0.88 on R and 0.73 on L} was noted between UJA and 
VUR grading. 
Conclusion: Colour Doppler USG measurement of UJA can be used as 
simple and non-invasive screening tool to detect the grade of VUR in 
symptomatic children therefore minimising the need for MCU, which is invasive 
and imposes risks related to radiation/contrast media administration.  
B-0386 16:16  
Accuracy of multiparametric MRI of prostate cancer recurrence after 
high-intensity focused ultrasound (HIFU): is dynamic contrast 
enhancement still needed?  
R. Lotte, A. Lafourcade, M. Ezziane, P.-H. Jouve de Guibert, S. Tavolaro, 
P. Mozer, F. Boudghene, O. Lucidarme, R. Renard Penna; Paris/FR 
(raissalotte@hotmail.com)  
Purpose: To assess the added value of dynamic contrast-enhanced (DCE) 
imaging to the combination T2-weighted imaging (T2w) + diffusion-weighted 
imaging (Dw) in detecting recurrence of prostate cancer (PCa) after HIFU using 
multiparametric magnetic resonance imaging (mpMRI). 
Methods and Materials: We retrospectively selected 45 patients with clinical 
and biological suspicion of recurrence of PCa after focal HIFU. All patients 
underwent mpMRI at 1.5 and 3 Tesla (T2w, Dw and DCE) before biopsies. 
Two readers independently assigned a Likert score (from 1 to 5) of cancer 
likelihood for each prostatic sector (divided on 6 sextants) on T2w + Dw + DCE 
and T2w + Dw images. Prostatic biopsies were taken as the gold standard. 
Results: Recurrent PCa was identified at biopsy in 37 (82%) of 45 patients. 
Area under the receiver operating curve of T2w + Dw and T2w + Dw + DCE 
imaging were not significantly different for both readers, at patient level and at 
lobe level. Using a Likert score 3 for PCa diagnosis threshold, sensitivity at 
lobe level for (a) senior and (b) junior reader for T2w +Dw +DCE was (a) 0.97 
(b) 0.94 vs (a) 0.94 (b) 0.97 for T2w + Dw, specificity was (a) 0.27 (b) 0.09 vs 
(a) 0.27 (b) 0.27, respectively. 
Conclusion: Accuracy of mpMRI was not significantly improved with added 
DCE to T2w + Dw imaging. Sensitivity was high for T2w + Dw + DCE and T2w 
+ Dw with no significant difference, either for the junior or the senior reader.  
B-0387 16:20  
Development of preoperative prediction of high Fuhrman grade in the 
patient with clear cell renal cell carcinoma  
J. Ding, J. Chen, J. Sun, W. Xing; Changzhou/CN (dingjiule@163.com)  
Purpose: To develop and validate a nomogram for the preoperative prediction 
of high Fuhrman grade ccRCC (III-IV). 
Methods and Materials: The prediction model was developed in a training 
cohort that consisted of 114 patients with ccRCC. The pseudocapsule, 
intratumoural artery, morphological feature and tumour size were assess by a 
radiologist. Radiomic features were extracted from the CT images of ccRCC at 
both arterial and portal venous phases. The least absolute shrinkage and 
selection operator was used for data dimension reduction and radiomics score 
calculation. A multivariate logistic regression model was used in training cohort 
to predict the high Fuhrman grade at nephrectomy. The predictors included 
pseudocapsule, intratumoural artery, morphological feature, tumour size and 
texture analysis of renal mass, and a nomogram was generated. The 
performance of the nomogram was assessed in an independent validation 
cohort contained 92 consecutive patients. 
Results: The radiomics score, which consisted of 2 selected features, was 
significantly associated with Fuhrman grade (P < 0.05). Predictor contained in 
the individualized prediction nomogram included the features of radiomics 
score and morphological feature. The model showed the good discrimination 
with a concordance index of 0.859 (concordance index = 0.861 through the 80 
samples in training cohort) and good calibration. Application of the nomogram 
in the validation cohort still gave good discrimination [concordance index = 
0.782 (75%CI, 0.575 to 0.987)] and good calibration. 
Conclusion: The nomogram that incorporated the radiomics and 
morphological features can be conveniently used to facilitate the preoperative 












B-0388 16:24  
Prognostic value of diffusion-weighted imaging for clinical outcome 
prediction in uterine cervical cancer treated with radiotherapy  
K. Gu, C.K. Kim, J. Lee; Seoul/KR (kyowon.gu@gmail.com)  
Purpose: To investigate the prognostic value of diffusion-weighted imaging 
(DWI) in predicting clinical outcome in patients with cervical cancer after 
radiotherapy (RT). 
Methods and Materials: Enrolled 124 patients with stage IB-IVB cervical 
cancer who received definitive RT with (n=117) or without (n=7) concurrent 
chemotherapy underwent MRI at 3T including DWI before and during (at 1 
month) treatment. The mean apparent diffusion coefficient (ADC) value was 
measured on the tumour and the percentage change (∆ADCmean) between 2 
time points was calculated. Cox proportion hazard model was performed to 
evaluate the association of imaging and clinical variables with progression-free 
survival (PFS) and cancer-specific survival (CSS). 
Results: During a median follow-up of 3.6 years, disease progression was 
found in 40 patients (32.2%) and 19 patients (15.3%) died of their disease. On 
multivariate analysis, ∆ADCmean (hazard ratio [HR]=0.98, P=0.015) and 
histologic type (HR= 2.66, P= 0.020) were significantly independent factors for 
PFS, and ∆ADCmean (HR=0.97, P=0.015) and parametrial invasion on MRI 
(HR=0.22, P=0.024) were significantly independent factors for CSS. 
Pretreatment ADC values were not associated with PFS and CSS (P>0.05). 
Using the optimal cutoff values of ∆ADCmean, the 3-year PFS was significantly 
lower for ∆ADCmean <38.7% than for ∆ADCmean ≥38.7% (P<0.001). The 3-year 
CSS was significantly lower for ∆ADCmean <15.7% than for ∆ADCmean ≥15.7% 
(P<0.001). 
Conclusion: The percentage change of tumour ADC after RT may be a useful 
predictor of tumour progression and survival in patients with cervical cancer.  
B-0389 16:28  
Intravoxel incoherent motion and blood oxygen level-dependent of early 
iodinated contrast-induced acute kidney injury induced in a rabbit model  
Y. Wang1, K. Ren1, L. Xie2; 1Shenyang/CN, 2Beijing/CN 
(wangyongfang1219@163.com)  
Purpose: To assess if parameters in intravoxel incoherent motion (IVIM) and 
Blood oxygen level-dependent (BOLD) can be used to evaluate early Iodinated 
Contrast-Induced Acute Kidney Injury (CIAKI) in a Rabbit model. 
Methods and Materials: 21 zealand white rabbits weighing 2.5-3.0 kg were 
choosen and received iohexol at the dosage of 5.0gI/kg. IVIM and BOLD were 
performed longitudinally at 24 h prior to and 1 h,1 d, 2 d, 3 d and 4 d 
postinjection of iohexol. The parameters D, f, D* and ADC and R2* values 
were obtained.The expression of hypoxia inducible factor (HIF-1α) in renal 
tissue was detected by immunohistochemistry. Repeated measure One-way 
analysis of variance was used for data analyses. 
Results: BOLD and IVIM demonstrated distinct signals in all of the four renal 
regions, and inner stripes of the renal outer medulla showed the most 
pronounced modifications. For the measurements, an increased R2* value and 
strong attenuation of D and ADC were observed at 1-2 d after iohexol injection 
(p<0.05). As perfusion measurement, a significant decrease was shown for D* 
and f in 1 h-2 d (p<0.05) and an increase in 3-4 d. Compared with baseline 
levels, distinct elevation of R2* value were observed in all the anatomical 
compartments at 1 hour (p<0.05), to the maximum levels at 1 d (p<0.05), this 
observed trends were consistent with the expression of hypoxia inducible 
factor HIF-1α. 
Conclusion: The IVIM and BOLD techniques can be used as noninvasive 
tools to perform a time course study of the pathogenesis associated with 
CIAKI.  
B-0390 16:32  
Comparison of MRI and transvaginal ultrasonography in the diagnosis of 
retrocervical septum endometriosis  
M. Wang, J. Lu, Y. Dai, Y. Xia; Beijing/CN (wmd328@126.com)  
Purpose: To explore the clinical value of MRI and transvaginal 
ultrasonography (TVS) in the identification of retrocervical septum 
endometriosis. 
Methods and Materials: Thirty-five patients with histologically confirmed 
endometriosis in retrocervical septum were retrospectively studied. All the 
patients underwent both MRI and TVS before laparoscopic surgery. Mapping 
of deep infiltrating endometriosis(DIE) in retrocervical septum was performed. 
MRI and TVS results were compared with surgical and pathological findings. 
Results: The accuracy for MRI in the identification of endometriosis in 
retrocervical septum was 62.9% (22/35) and for TVS was 28.6% (10/35). 
Among 35 patients, the sensitivity, specificity and accuracy for MRI in the 
detection of posterior cul-de-sac obliteration and adhesion was 71.4% (10/14), 
61.9% (13/21), 65.7% (23/35). The sensitivity, specificity and accuracy for MRI 
in the detection of DIE in uterosacral ligment was 47.6% (10/21), 87.8% 
(43/49), 75.7% (53/70). 
Conclusion: MRI was superior to TVS for the diagnosis of DIE in retrocervical 
septum. MRI can demonstrate high sensitivity in the detection of cul-de-sac 
obliteration and adhesion, as well as evaluation the locations and extension of 
DIE. The information offered by MRI is helpful in determining surgical options 
and planning appropriate treatment.  
B-0391 16:36  
Clinical complications in percutaneous renal biopsy guided by 
ultrasound: 16 vs 18-gauge needles  
P. Ramos Botelho Antunes1, M.C. Barbosa Álvares1, 
F. Franco Monteiro Prado1, F. Tinôco Alvim de Souza1, 
M. Álvares de Campos1, E. Carvalho de Siqueira1, R. Berindoague Neto1, 
B. Carvalho Silva Rabelo2; 1Belo Horizonte/BR, 2Itauna/BR 
(brenorabelomed@gmail.com)  
Purpose: Compare complications of percutaneous renal biopsy using two 
gauge(G) needles, 16G and 18G. 
Methods and Materials: 238 individuals with renal biopsy(RB) indication were 
randomly separated into two groups according to the gauge of needle used. 
134 patients(110 non-transplanted, and 24 renal transplanted) were biopsied 
with a 16G needle and 104(64 non-transplanted, and 40 renal transplanted) 
were biopsied with a 18G needle. Major and minor complications were 
analyzed immediately, and at 3 different times after procedure(4 hours, 12 
hours and 7 days). 
Results: The study presented a general index of 11.3% major complications. 
Patients who underwent RB with a 16G needle were more likely to complicate 
than 18G needle biopsies(17% vs. 3.8%; OR 5.1; 95% CI, 1,7-15.4; p=0.001). 
Although renal transplant patients submitted to 16G needle biopsies also 
presented higher complication rates when compared to patients submitted to 
18G needle biopsies(OR 5.5; CI 95%, 0,5-56,9), there was no statistically 
significant association(p=0.14). On the other hand, non-transplanted renal 
patients had higher rates of complications in patients submitted to 16G needle 
biopsy in relation to patients submitted to 18G needle biopsy(OR 4.5; 95% CI, 
1,3-15,8; p=0.01). The mean number of complete glomeruli harvested per 
biopsy for 16G and 18G needles was 22.1 and 17.5, respectively. 
Conclusion: Our study findings suggest that there is a need to carefully weigh 
the potential risks for using a larger biopsy needle against the desire for more 
diagnostic tissue. Kidney biopsies taken by 18G needles resulted in lower 
frequency of complications compared to 16G.  
B-0392 16:40  
Developing a new PI-RADS v2-based nomogram for forecasting high-
grade prostate cancer  
X. Niu; Chengdu/CN (niu19850519@163.com)  
Purpose: To establish a predictive nomogram for high-grade prostate cancer 
(HGPCa) in biopsy-naive patients based on the prostate imaging reporting and 
data system version 2, magnetic resonance imaging (MRI)-based prostate 
volume, MRI-based PV-adjusted prostate-specific antigen density, and other 
classical parameters. 
Methods and Materials: Between August 2014 and August 2015, 158 men 
who were eligible for analysis were included as the training cohort. A prediction 
model for HGPCa was built using backward logistic regression and was 
presented on a nomogram. The prediction model was evaluated by a validation 
cohort between September 2015 and March 2016 (n=89). Histology of all 
lesions was obtained with MRI-directed transrectal ultrasound (TRUS)-guided 
targeted and sectoral biopsy. 
Results: The multivariate analysis revealed that patient age, PI-RADS v2 
score, and adjusted PSAD were independent predictors for HGPCa. The most 
discriminative cut-off value for the logistic regression model was 0.33; the 
sensitivity, specificity, positive predictive value, and negative predictive value 
were 83.3%, 87.4%, 88.4%, and 81.2%, respectively. The diagnostic 
performance measures retained similar values in the validation cohort 
(AUC=0.83). 
Conclusion: The nomogram for forecasting HGPCa is effective and potentially 
reducing harm from unnecessary prostate biopsy and over-diagnosis.  
B-0393 16:44  
Diffusion-weighted MRI as a prognostic and response biomarker in 
patients with castration-resistant prostate cancer and bone metastases  
R. Perez Lopez1,2, N. Tunariu1, D.-M. Koh1, J.S. de Bono1; 1London/UK, 
2
Barcelona/ES (rperez@vhio.net)  
Purpose: To correlate diffusion-weighted imaging (DWI) MRI features of bone 
metastases from castration-resistant prostate cancer (CRPC) with pathology 
(1), and evaluate whole-body DWI as prognostic (2) and response biomarker 
(3) in CRPC. 
Methods and Materials: 1. 43 consecutive bone metastasis biopsies (33 
patients) with DWI performed <12 weeks before bone biopsy and a reference 
cohort of 10 patients with no bone metastases were reviewed. DWI differences 
in bone biopsy positive/negative for tumour cells (Mann-Whitney) and DWI 
  






cellularity correlations (Spearman’s correlation “r”) were assessed. 2. 
Prognostic value was evaluated in 43 consecutive patients. Total volume of 
bone metastases by DWI (tDV) was correlated with survival (Kaplan-Meier) 
and prognostic factors (r). 3. Utility as response biomarker was assessed in a 
clinical trial of olaparib in CRPC (n=21), comparing whole-body DWI at 
baseline and after 12 weeks of treatment. Regression analysis between tDV 
and median apparent diffusion coefficient (mADC) changes and treatment 
response were pursued. 
Results: 1. mADC in bone metastases and non-metastatic bone was 993x10-
6mm2/s vs 601.8x10-6mm2/s, median normalized (n) nDWI signal was 4AU vs 
1.6AU; p<0.001. ADC and nDWI signal correlated with tumour cellularity; 
p<0.001. 2. tDV correlated with all evaluated prognostic factors (haemoglobin; 
prostate-specific antigen; lactate dehydrogenase; alkaline phosphate; all 
p<0.001) and CTC count (p=0.004). tDV associated with overall survival 
(hazard ratio: 1.74; p=0.035). 3. Change in tDV and mADC at 12 weeks 
associated with response to therapy (p<0.01, p=0.04, respectively). 
Conclusion: DWI of bone metastases informs on prognosis and response to 
treatment in CRPC. DWI findings correlate with pathology. These data 
contribute towards DWI implementation in prostate cancer care.  
B-0394 16:48  
Tumour size at MRI association with lymph node metastasis and 
lymphovascular space invasion in resectable cervical cancer: a 
multicentre evaluation of surgical specimens  
X.-l. Chen, P. Zhou, H. Li; Chengdu/CN (penghyzhou@126.com)  
Purpose: To determine whether the gross tumour volume (GTV) and the 
maximum diameter of resectable cervical cancer at MRI could predict the 
presence of lymph node metastasis (LNM) and lymphovascular space invasion 
(LVSI). 
Methods and Materials: 315 consecutive patients with cervical cancer who 
underwent surgery in 1 week after contrast-enhanced MRI were retrospectively 
identified from multiple hospitals. The tumour size including GTV and the 
maximum diameter of tumour were evaluated on MRI. Statistical analysis was 
performed to determine whether tumour size could predict LNM and LVSI. 
Cutoffs of GTV and the maximum diameter of tumour were first investigated in 
a cohort of 255 patients (group A) and then validated in an independent cohort 
of 60 patients (group B) using area under the receiver operating characteristic 
curve (AUC) analysis for predicting LNM and LVSI. 
Results: Univariate analysis showed GTV and the maximum diameter of 
tumour could predict the presence of LNM and LVSI (all P<0.0001). 
Multivariate analyses indicated GTV as an independent risk factor of LNM and 
LVSI (all P<0.0001). In the group A, GTV and the maximum diameter of tumour 
could help identify the presence of LNM (AUC, 0.813 and 0.741, respectively) 
and LVSI (AUC, 0.806 and 0.751, respectively). In the group B, GTV and the 
maximum diameter of tumour could help identify the presence of LNM (AUC, 
0.902 and 0.825, respectively) and LVSI (AUC, 0.771 and 0.748, respectively). 
Conclusion: GTV and the maximum diameter of resectable cervical cancer at 
MRI demonstrated capability in predicting the presence of LNM and LVSI.  
B-0395 16:52  
NSsaFe: observational study on the incidence of nephrogenic systemic 
fibrosis in patients with renal impairment following gadoteric acid 
administration  
A. Gottschalk, B. Kress; Frankfurt a. Main/DE (andreas.gottschalk@gmx.net)  
Purpose: To prospectively determine the incidence of nephrogenic systemic 
fibrosis (NSF) in patients with renal impairment after administration of gadoteric 
acid (Dotarem, Guerbet, France). 
Methods and Materials: Worldwide post-marketing study including 540 
patients with moderate, severe or end-stage renal impairment, scheduled to 
undergo a routine contrast-enhanced MRI with gadoteric acid. Medical history, 
MRI indication(s) and adverse events (AEs) were recorded for each patient. 
Patients were followed up over 2 years after gadoteric acid administration with 
three visits to detect any signs/symptoms suggestive of NSF. 
Results: Included patients had a mean age of 69.6±12.7 years [range: 21-95], 
with a ratio male/female of 58.5%/41.5%. Renal impairment was graded as 
moderate for 69.3% of patients, severe for 16.1% and end-stage for 12.0%; 
2.6% had undergone a kidney transplant. The mean (±SD) estimated 
glomerular filtration rate was 37.6 ± 15.7 ml/min/1.73 m2 [range: 4.0-74.2]. 
Central nervous system exploration was the main MRI indication (34.6%). The 
follow-up period was completed: 434 patients (80.4%) attended the first follow-
up visit, 390 (72.2%) attended the second, and 354 (65.6%) attended the third. 
At the third follow-up visit, renal impairment was moderate for 40.1% of the 
patients, severe for 9.3% and end-stage for 14.4%. Overall, neither AEs 
related to the administration of gadoteric acid, nor signs of NSF were reported. 
Conclusion: At the end of the 2-year follow-up period, the study shows no 
signs of NSF after gadoteric acid administration, confirming its good safety 
profile in this high-risk population.  
B-0396 16:56  
Staging of endometrial carcinoma with MRI: does the fusion T2-weighted 
and high b-value diffusion-weighted images improve diagnosis? An 
agreement study with histopathology  
M. Correia1, M.A. Serrado2, M. Horta1, T.M. Cunha1, D. Virella1; 1Lisbon/PT, 
2
Funchal/PT (marianatomecorreia@gmail.com)  
Purpose: To assess diagnostic accuracy of staging of endometrial carcinoma 
using MRI and evaluate the utility of fused T2-weighted (T2WI) and high b-
value diffusion-weighted images (DWI). 
Methods and Materials: This single-centre study includes 94 patients with 
endometrial carcinoma who underwent pretreatment MRI and subsequent 
surgery. One experienced radiologist assessed the grade of tumor invasion, 
according to FIGO system. The first evaluation was based on the T2WI, 
dynamic contrast enhance-MRI and DWI, afterwards the DWI and Fused T2-
DWI images were considered for staging. These data were compared with the 
histopathologic findings as gold standard. The agreement was assessed by 
Cronbach Alpha test (kappa value) and interclass correlation coefficient (ICC). 
Results: The diagnostic agreement of MRI without the fusion T2-DWI images 
was 85.7%, 50%, 22.2%, 30.8%, 50%, 40%, 28.6% and 25% for staging IA, IB, 
II, IIIA, IIIB, IIIC1, IIIC2 and IVB respectively (kappa=0.405±0.058; ICC=0.556, 
95%CI 0.399-0.681). When fused T2-DWI images were considered, the 
agreement was instead 97.1%, 50%, 22.2%, 38.5%, 50%, 70%, 28.6% and 
50% for IA, IB, II, IIIA, IIIB, IIIC1, IIIC2 and IVB respectively 
(kappa=0.537±0.057; ICC=0.695, 95%CI 0.574-0.786). The fused T2-DWI 
images improved the diagnostic agreement when evaluating tumor invasion of 
more than one-half of the myometrial thickness (kappa=0.787±0.063 vs. 
0.617±0.063), the pelvic lymph node involvement (kappa=0.480±0.141 vs. 
0.217±0.155) and the distant metastatic spread (kappa=0.569±0.166 vs. 
0.378±0.192). 
Conclusion: The use of fused T2-DWI images seems to improve the 
diagnostic performance for staging of endometrial carcinoma, particularly for 
assessing myometrial invasion, pelvic lymph node involvement and distant 
metastatic spread.  
B-0397 17:00  
Testicular microlithiasis: clinic-radiologic-pathologic correlation in 289 
patients with germ cell tumour  
M. De la Mora Malváez1, A. Garza Gangemi1, D.A. Sánchez Nava1, M. Licano2, 
O.C. Rico Rodríguez1, C. Kauffman Ortega1, R. Castillejos Molina1; 
1
Mexico City/MX, 2Tlalpan/MX (mariannedlm27@gmail.com)  
Purpose: Testicular microlithiasis (TML) has been reported in 5.6% of 
asymptomatic patients in ultrasound examinations. Its association with primary 
testicular cancer (PTC) and extragonadal cell tumours (EGCT) is still 
controversial. 
Methods and Materials: This is a retrospective observational study of 
prospectively collected data of 289 consecutive patients with germ cell tumours 
from a tertiary care centre between 2008 and 2017. Baseline characteristics 
(the presence of comorbidities, hypogonadism, primary tumour site, tumour 
histology, and clinical stage) and testicular ultrasonographic characteristics 
(testicular volume, tumour characteristics, and the presence of microlithiasis) 
were recorded for every patient. Imaging characteristics were analysed 
between groups according to primary tumour site and tumour histology. 
Results: The median age at diagnosis was 27 ± 9 years and 12.7% of the 
patients had a history of cryptorchidia. Non-seminomatous tumours were more 
frequent (60.6%) than seminomas. Twenty two patients (7.6%) had EGCT and 
267 had PTC. Unilateral TML was observed in 20.8% of the patients and 
bilateral microlithiasis was detected in 11.8% of the patients. Bilateral TML was 
more frequent in non-seminomatous tumours, 16.8% v.s. 6.5%, p = 0.04. 
Furthermore, the presence of bilateral TML was more common in patients with 
EGCT when compared with PCT patients 31.8% v.s. 10.1%, p = 0.01. 
Testicular atrophy (volume <12cc) was also associated with the presence of 
microlithiasis (p<0.01). 
Conclusion: TML is more common in non seminomatous histology and it is 
associated with testicular atrophy. Bilateral testicular microlithiasis is more 
common in EGCT.  
B-0399 17:04  
Differentiation and diagnosis of benign and malignant testicular lesions 
using 18F-FDG PET/CT  
D. Shao; Guangzhou/CN (312368517@qq.com)  
Purpose: The purpose of this study was to evaluate the differential diagnostic 
value of 18F-fluorodeoxy glucose positron emission tomography/computed 
tomography (18F-FDG PET/CT) for benign and malignant testicular lesions. 
Methods and Materials: The PET/CT scans of 53 patients with testicular 
lesions confirmed by biopsy or surgical pathology were retrospectively 
analysed. There were 32 cases of malignant tumours and 21 cases of benign 
lesions. Differences in the maximum standardised uptake value (SUVmax) 
  






measurements and the SUVmax lesion/background ratios between benign and 
malignant lesions were analysed. The diagnostic value of this PET/CT modality 
for the differential diagnosis of benign versus malignant testicular lesions was 
calculated. 
Results: The differences in the SUVmax measurements and the SUVmax 
lesion/background ratios between benign and malignant lesions were 
statistically significant (SUVmax: Z=-4.295, p=0.000; SUVmax 
lesion/background ratio: Z=-5.219, p=0.000); specifically, both of these 
indicators were higher in malignant lesions compared to benign lesions. An 
SUVmax of 3.75 was the optimal cutoff value to differentiate between benign 
and malignant testicular lesions. The diagnostic sensitivity, specificity, 
accuracy, positive predictive value, and negative predictive value of this 
PET/CT modality in the differential diagnosis of benign versus malignant 
testicular lesions were 90.6%, 80.9%, 86.8%, 87.9%, and 85.0%, respectively. 
Conclusion: 18F-FDG PET/CT can accurately identify benign and malignant 
testicular lesions.  
B-0400 17:08  
Ectopic pregnancies in caesarean section scars: five-years' experience  
H.S. Darwish1, Y. Habash1, M. Habsah2; 1Ismailia/EG, 2Cairo/EG 
(darwish.hoda@yahoo.com)  
Purpose: To evaluate our 5 years experience in diagnosis and treatment of 
ectopic pregnancy developing in a caesarean section scar. 
Methods and Materials: The study included twenty one women who were 
diagnosed with a cesarean scar ectopic pregnancy (CSEP) in the first 
trimester, which was confirmed by ultrasound and treated in our hospital during 
5 years between 2012 and 2016. The clinical presentations, imaging findings, 
and treatment outcomes of all these pregnancies were recorded. 
Results: All our 21 cases underwent successful early first trimester diagnosis 
with trans-vaginal colour Doppler ultrasonography and termination by a 
systemic methotrexate administration, or with aspiration of the gestational sac. 
Fourteen of them underwent systemic methotrexate treatment; and seven 
patients underwent trans-cervical aspiration of the gestational sac. 
Intraoperative bleeding occur in all 7 cases that treated with aspiration of the 
gestational sac, one of them end with hysterectomy. Uterine rupture occurs in 
one patient and treated conservatively. No complications occur in cases 
treated with systemic methotrexate injection. The cesarean scar mass followed 
with trans-vaginal ultrasound and regressed from 2 months to about 1 year 
after treatment. 
Conclusion: Early imaging recognition, diagnosis of CSEP and effective 
treatment is critically important to improve outcome, minimise the need for 
emergency extended surgery, minimise maternal complications, maintain 
treatment options, and potentially preserve future fertility.  
B-0401 17:12  
Role of ultrasound and MR imaging in evaluation of patients at high risk 
of morbidly adherent placenta  
G. Khatri, N. Antil, R. Misra, S.K. Bajaj; New Delhi/IN 
(garvit_khatri@hotmail.com)  
Purpose: To study the spectrum of ultrasound Doppler and MR Imaging 
findings in patients at high risk for adherent placenta; to compare the efficacy 
of ultrasound Doppler and MR Imaging in diagnosis of adherent placenta. 
Methods and Materials: A total of 50 high risk pregnant patients (at least one 
caesarean section and low lying placenta) were included in the study. 
Ultrasound and MR imaging was performed. Specific Ultrasound and MR 
Imging features were evaluated. All patients were followed up to delivery for 
confirmation of diagnosis.Categorical variables were presented in number and 
percentage (%) and continuous variables were presented as mean ± SD and 
median. Normality of data was tested by Kolmogorov-Smirnov test. If the 
normality was rejected then non parametric test was used. A p value of <0.05 
was considered statistically significant. 
Results: Diagnostic accuracy of MR imaging was 94 % compared to 78 % for 
ultrasound Doppler. Both the modalities have similar high sensitivity (92.3 %). 
However MR imaging has better specificity (97%) compared to ultrasound 
Doppler (82 %). Most sensitive MR imaging feature is dark intraplacental band 
on T2 images. Most sensitive ultrasound Doppler imaging feature is 
intraplacental lacunae with turbulent flow. 
Conclusion: All pregnant patients with previous caesarean section should be 
screened for low lying placenta in the first trimester. Ultrasound Doppler should 
be the initial modality for choice to diagnose adherent placenta. In equivocal 
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B-0402 08:30  
Fully automated assessment of HRCT images for follow-up of IPF  
R. Rubtsov, L. Kehler, A. Giannakis, M. Kreuter, M. Eichinger, O. Weinheimer, 
K. Maier-Hein, H.-U. Kauczor, C.P. Heussel; Heidelberg/DE 
(roman.rubtsov.med@gmail.com)  
Purpose: To quantify CT data using computer-aided diagnostic tool compared 
to pulmonary functional tests (PFT) longitudinally in patients with idiopathic 
pulmonary fibrosis (IPF). 
Methods and Materials: 112 patients (M:F; 92:20) with IPF diagnosed through 
interdisciplinary approach, with either stable disease (n=73) or acute 
exacerbation (n =39) underwent 2 consecutive HRCT (6 months interval)."In-
house" software, Lung Fibrosis Quantification Tool (LUFIT), based on a 3D-
metamodel algorithm was used for fully automated lung segmentation and 
histograms analysis. Percentiles of lung histogram analysis, reflecting the 
amount of end-stage fibrosis (80th) and “ground-glass” (40th), derived from 
baseline HRCT and follow-up, were correlated to PFT and analysed according 
to Mann-Whitney. 
Results: The strongest correlation was found between TLC measured by 
LUFIT and with body plethysmography (R2=0.95). Moderate negative 
correlations were observed between 80th and VCIN (-0.696) and DLCO SB (- 
0.649) in the "exacerbation-group"at baseline. In the stable group no relevant 
change of PFT or histogram parameters was found. In the "exacerbation" 
group 80th/40th percentile rise by 42/14 HU (p=0.0008/0.0047). 
Conclusion: LUFIT proved to be accurate in quantifying the lung volume. In 
patients with exacerbation it detects the acute end-stage changes, developing 
in the course of the disease. Fully automated assessment of fibrosis extent and 
can be helpful as an additional tool in quantitative analysis of CT data in 
patients suffering from IPF.  
B-0403 08:34  
Quantitative prediction of malignancy on newly developed 3D computer-
aided volumetry (CADv) with pulmonary nodule component evaluation on 
thin-section CT  
Y. Ohno1, A. Yaguchi2, K. Aoyagi3, S. Kaminaga3, Y. Kishida1, S. Seki1, 
T. Yoshikawa1; 1Kobe/JP, 2Kawasaki/JP, 3Otawara/JP (yosirad@kobe-u.ac.jp)  
Purpose: To evaluate the quantitative capability of newly developed 3D 
computer-aided volumetry (CADv) with pulmonary nodule component 
assessment for predicting malignancy and postoperative recurrence on thin-
section CT. 
Methods and Materials: 59 consecutive patients with 101 pulmonary nodules 
underwent repeated thin-section CT, pathological examination, surgical 
resection and/or follow-up examination. Then, all nodules were divided into 
malignant (n=64) and benign (n=37) nodule groups. In this study, CADv 
automatically assessed solid, ground-glass opacity, cavity and total nodule 
volumes from two serial CT data. Then, total volume change per day (TV/day), 
solid to total volume change ratio per day (S/T ratio/day) and doubling time 
(DT) were determined. Student’s t test was performed to compare all indexes 
between malignant and benign groups. Then, ROC analyses were performed 
to compare differentiation capabilities of indexes as having significant 
differences between malignant and benign groups. Finally, each diagnostic 
performance was compared by McNemar’s test. 
Results: TV/day and DT had significant differences between malignant and 
benign nodule groups (p<0.05), although TV/day and S/T ratio/day had 
significant difference between recurrence and non-recurrence groups (p<0.05). 
On distinguishing malignant from benign groups, area under the curves (Azs) 
of TV/day (Az=0.94) was significantly larger than that of DT (Az=0.62, 
p<0.001). In addition, specificity (SP) and accuracy (AC) of TV/day were 
significantly higher than those of DT (p<0.001). 
Conclusion: Newly developed 3D CADv system has quantitative capability for 
prediction of malignancy and postoperative recurrence on thin-section CT.  
Author Disclosures: 
  Y. Ohno: Research/Grant Support; Toshiba Medical Systems Corporation. 
A. Yaguchi: Employee; Toshiba Corporation. K. Aoyagi: Employee; Toshiba 
Medical Systems corporation. S. Kaminaga: Employee; Toshiba Medical 
Systems Corporation.  S. Seki: Research/Grant Support; Toshiba Medical 
Systems Corporation. T. Yoshikawa: Research/Grant Support; Toshiba 
Medical Systems Corporation. 
B-0404 08:38  
Logistic regression analysis and a risk prediction model of tumour 
spread through air spaces (STAS) in patients with stage I lung 
adenocarcinoma  
X. Wang; Beijing/CN (oliverwxy_zz@sina.com)  
Purpose: Tumour spread through air spaces (STAS) is an important pattern of 
invasion and impacts the frequency and location of recurrence. The objective 
was to assess the correlation between STAS and metabolic tumour burden 
measured by PET/CT, and to establish a risk prediction model of STAS in 
patients with stage I lung adenocarcinoma. 
Methods and Materials: We reviewed 121 consecutive patients. The 
standardised uptake value (SUVmax, SUVmean and SUVpeak), metabolic tumour 
volume (MTV), total lesion glycolysis (TLG), diameter and computed 
tomography volume (CTV) were measured. All risk factors were analysed by 
multivariate logistic regression analysis; regression coefficients and odds ratios 
were calculated for independent risk factors. A STAS risk prediction model was 
created using the regression coefficients to determine the predictive probability 
(PP). 
Results: There was significant difference of STAS distribution among different 
nodule types (P = 0.001). In the correlation analysis of STAS with the 
metabolic tumour burden parameters, SUVmax (P=0.020), SUVmean 
(P=0.002), SUVpeak (P=0.002) and TLG (P=0.004) were significantly 
correlated with STAS. MTV (P=0.721), diameter (P=0.480) and CTV (P=0.651) 
showed no significant correlation with STAS. The predictive probability of 
STAS and the incidence of STAS were analysed using the ROC curve (AUC = 
0.749, P = 0.000). The sensitivity, specificity, and accuracy of the predictive 
model for STAS were 67.3%, 70.8% and 69.4%, respectively. 
Conclusion: The predictive model developed was accurate in predicting the 
incidence of STAS. SUV and TLG were valuable predictive indices in the 
prediction of STAS.  
B-0405 08:42  
Quantitative MRI assessment of interstitial lung disease  
M.T.A. Buzan1, A. Wetscherek2, C. Heussel2, M. Kreuter2, J. Dinkel3; 
1
Cambridge/UK, 2Heidelberg/DE, 3Munich/DE  
Purpose: To evaluate the contribution of advanced quantitative magnetic 
resonance imaging (MRI) in the assessment of interstitial lung disease (ILD). 
Methods and Materials: We prospectively included 34 patients (mean age: 68 
years; M:F, 1:1) with pathologically proven usual interstitial pneumonia (UIP) 
and nonspecific interstitial pneumonia (NSIP). All patients underwent thin-
section multislice computed tomography (CT) and MRI of the lung at 1.5T. The 
MRI protocol included entire lung T2 mapping based on ECG-gated multi-echo 
single shot turbo spin-echo sequence (TE: 20, 40, 79, 140, 179 ms), and a 
contrast-enhanced radial-VIBE sequence with golden-angle spacing acquired 
during 5 minutes of free-breathing, followed by 5D reconstructions of the data. 
For this study, we used the end-expiratory phase. The CT images were used to 
assess the patterns and severity of lung fibrosis. 
Results: The T2 relaxation of normal lung showed significant difference to 
pathological areas (p<0.001). The T2 relaxation time increased with the 
increase in fibrotic tissue density. UIP and NSIP regional patterns could not be 
differentiated by T2 relaxation times. T2 relaxation showed a significant 
statistical difference between active-inflammatory and stable-fibrotic NSIP. 
Both in severe and non-severe disease, there is later peak enhancement in 
idiopathic pulmonary fibrosis (IPF) compared to non-IPF, p<0.01. In non-IPF, 
the more severe lesions had longer time to peak and slower washout rate as 
compared to non-severe lesions, p<0.05. 
Conclusion: MRI is a non-invasive, non-irradiating method that allows 
advanced, quantitative tissue characterization in ILD both in chronic and active 
states.  
B-0406 08:46  
Primary and metastatic lung tumours treated with stereotactic body 
radiation therapy (SBRT): own experience  
N. Martynova, N. Vorobyov, A. Mikhailov, J. Gutsalo, E. Smirnova, A. Kalesnik, 
G. Andreev, A. Kubasov, A. Lyubinskij; St. Petersburg/RU 
(natlmartynova@gmail.com)  
Purpose: Assessing SBRT efficiency and toxicity for primary lung cancer and 
lung metastases. 
Methods and Materials: In a period from 12.2011 to 02.2017, 71 patients with 
primary and metastatic lung tumours were treated. SBRT was applied to 103 
tumours: 33 primary tumours and 70 metastases of different tumour sites. Two 
linear accelerators with different respiratory motion tracking systems (RMTS) 
were used: CyberKnife (CK) with Synchrony RMTS and TrueBeam STx (TB) 
with gating. 
Results: Clinical observation group includes 52 patients with 81 lung tumours. 
Average tumour volume was 44.7 cc (0.2-496.5 cc). Observation median was 7 
months. Local control (LC) was achieved in all cases, median of LC was 6 
  






months. For 19 (23.5%) tumours complete response was achieved, median 
was 5 months. There was a local relapse in 17 (21%) cases, 15 of which were 
squamous cell relapse. There was discovered a negative linear dependence of 
local relapse probability from BED10 for squamous cell tumours. Disease 
progression was observed among 29 patients, 93% of them had a local control 
preserved during the whole observation period. TB demonstrated higher early 
toxicity rate than CK (19% vs 8%, p=0.01), grade 1-2 for most patients; 5 
patients had grade 3 early toxicity. None of the patients had grade 4 early 
toxicity. Late toxicity did not exceed grade 2 for all the patients. 
Conclusion: SBRT appears to be safe and effective treatment option for 
patients with lung lesions, including huge and central tumours. Potentially, 
higher radiation doses are needed to achieve better LC for squamous cell 
tumours.  
B-0407 08:50  
Diagnostic value of radiologic signs of pulmonary hypertension: 
pulmonary artery aortic ratio, pulmonary artery vertebral ratio and 
contrast regurgitation in hepatic veins  
G. Zanirato Rambaldi, F. Niro, N. Galiè, M. Zompatori; Bologna/IT 
(giuseppe.zanirato@gmail.com)  
Purpose: To assess the diagnostic value of pulmonary artery (PA) aortic ratio 
(PAr), PA vertebral ratio (VR) and regurgitation of intravenous contrast medium 
(CM) into hepatic veins (HVR) as predictors of pulmonary hypertension (PH). 
Methods and Materials: We retrospectively reviewed clinical characteristics, 
CT scans, echocardiograms, and right-sided heart catheterization of patients 
with suspected PH undergoing angio-CT scan of PA between 2005 and 2013. 
The PA, aortic and anteroposterior vertebral diameter from the same CT image 
were measured. HVR was evaluated based on reflux of CM into hepatic veins. 
Linear and logistic regression were used to examine the relationships between 
CT studied parameters and PA systolic (PASP), diastolic (PADP), mean 
pressure (mPAP) and PA resistances (PAR) by invasive haemodynamics. 
Results: 359 patients (96 with primary PH, 77 and 98 with, respectively, 
connective tissue diseases and congenital heart diseases: Eisenmenger 
syndrome associated PH and 88 without PH) were enrolled. PAr and VR 
correlated linearly with PASP, PADP, mPAP and PAR (p<0.0001). PAr > 1 is 
63.3% sensitive and 85.4% specific (area under the ROC curve (AUC)=0.83) 
for PH. VR > 1.33 is 71.53% sensitive and 80.9% specific (AUC=0.84) for PH. 
In younger subjects (<58 years), AUC for PAr and VR was 0.91 (respectively, 
p=0.0020 and p=0.0004). HVR was 89.6% specific for tricuspid regurgitation 
and correlated with increased PAP and PAR. 
Conclusion: PAr, VR and HVR correlate with haemodynamic dysfunctions in 
PH, PAr > 1.07 and VR > 1.33 are valid predictors of possible PH, especially in 
subjects < 58 years old.  
B-0408 08:54  
Application of high-pitch scanning mode in low-dose lung-computed 
tomography screening for patients with chronic obstructive pulmonary 
disease: a pilot study  
C. Li, M. Li, L. Jin; Shanghai/CN (licheng3456@sohu.com)  
Purpose: This study was performed to evaluate the performance of high-pitch 
scanning mode in computed tomography (CT) examination of chronic 
obstructive pulmonary disease (COPD). 
Methods and Materials: Chest CT scans were performed in 300 patients 
clinically diagnosed with COPD before which the subjects were divided into 3 
experimental groups and 2 control groups; Siemens sensation 16 was 
employed to perform spiral CT scanning for experimental group 1, a GE 
lightspeed VCT was used for experimental group 2, a Siemens definition flash 
was used for experimental group 3, with the parameters of 100kV and 
automatic mAs and different pitch. 
Results: The average of lung parenchyma CT in experimental group 3 was -
918.18±6.57, which was significantly different from the other 4 groups 
(P<0.001). There was no significant difference between control groups 1, 2 and 
experimental groups 1, 2 (P>0.05), but the experimental group 3 was 
significantly different from those of the remaining groups (P<0.001). 
Conclusion: The application of a high-pitch scanning mode for patients with 
COPD can effectively reduce their breath holding time, prevent complications, 
and reduce motion artefacts. As such, the approach has great scanning 
performance and is promising for clinical applications.  
B-0409 08:58  
Morphological study of blood vessels near lung tumour by the 3D 
quantitative CT technique  
Y. Li, Y.-l. Dai, Y.-m. Guo; Xi’an/CN (yuyanyan_zi@126.com)  
Purpose: The effect of non-enhanced CT on the changes of vascular 
morphology in lung cancer is investigated. A 3D quantitative CT measurement 
method based on differential geometry algorithm was found to be suitable for 
the morphological study of blood vessels adjacent to lung tumour. 
Methods and Materials: Lung cancer ipsilateral and contralateral pulmonary 
vascular changes were assessed by the routine visual examination and FACT-
digital lung TM quantitative CT measurement software. This study included 162 
patients with lung cancer and 178 healthy subjects. All cases of lung cancer 
were confirmed by pathology. The number of blood vessels and area of blood 
vessels normal to cross sections of 5/6-generation bronchioles were selected 
as pulmonary vascular morphological parameters. 
Results: The visual method has revealed the ratio of ipsilateral pulmonary 
vascular abnormalities in lung cancer (151/162 ) to be less than that of 
quantitative CT (162/162). The visualization time required to determine 
pulmonary vascular abnormalities (3.2 ± 1.5 min) exceeded that of quantitative 
CT measurements (2.5 ± 1.3 min) for P <0.05. According to quantitative CT 
measurements, the number and area of pulmonary blood vessels in the 
ipsilateral lung cancer exceeded those in the contralateral side and in the 
control group (P = 0.00, 0.00). 
Conclusion: A fully automated quantitative CT measurement method was 
successfully applied to the identification of pulmonary blood vessels and 
quantitative measurements of morphological changes of blood vessels near 
lung tumour.  
B-0410 09:02  
IPF: diagnosis and follow-up using CT fibrosis score, correlation with 
clinical and functional data in a cohort of patients in therapy with 
pirfenidone or nintedanib  
S. Riva, G. Guzzardi, M. Barini, M. Valenti, A. Carriero, M. Pelle; Novara/IT 
(silviariva.riva@gmail.com)  
Purpose: The aim of this study was to evaluate the utility of a VISUAL CT-
FIBROSIS SCORE in evaluation of extension of usual interstitial pneumonia 
(UIP) and in the 12-month follow-up after the start of antifibrotic therapy with 
pirfenidone or nintedanib. 
Methods and Materials: Since 2015, in our institute 15 patients have received 
IPF diagnosis on the basis of clinical and radiological data. The inclusion 
criteria was only the radiological diagnosis of UIP DEFINITE. For each patient 
a CT-FIBROSIS SCORE (as suggested by previous experiences in the 
literature as those of Ichikado, Ley and Sverzellati) was calculated and the 
value of diffusing capacity of the lungs for carbon monoxide (DLCO) was 
collected, which correlates with the progression of the disease, at diagnosis 
and follow-up. We used McNemar's test for the correlation between CT-
FIBROSIS SCORE and DLCO. 
Results: The assigned FIBROSIS SCORE score was measured in absolute 
terms within the sample a minimum value of 123.3 and a maximum of 238.3. 
The mean DLCO value at diagnosis was 46.24 and at the follow-up of 40.75. 
McNemar's test showed a statistically significant difference between evolution 
over time of the FIBROSIS SCORE parameter and the clinical-instrumental 
parameter of the DLCO. The value of p, returned by the application of this test, 
was in fact above 0.05, resulting in 0.7. 
Conclusion: The interpretation of the statistical result allows us to assert that 
there is a correlation between the score of fibrosis and the performance of the 
DLCO.  
B-0411 09:06  
Pulmonary embolism-induced perfusion defects on iodine maps: 
quantitative comparison of dual-energy CT and subtraction CT  
D. Grob1, L.J. Oostveen1, M.M. Prokop1, C. Schaefer-Prokop2, I. Sechopoulos1, 
M. Brink1; 1Nijmegen/NL, 2Amersfoort/NL (Dagmar.Grob@radboudumc.nl)  
Purpose: To compare signal-to-noise ratios for pulmonary embolism-induced 
perfusion defects on iodine maps derived from dual-energy CT (DECT) and 
subtraction CT (SCT). 
Methods and Materials: We recruited 27 consecutive patients diagnosed with 
acute PE from a prospective trial for comparison of DECT and SCT, in which 
100 kV unenhanced scans and 140/100 kV DECT pulmonary angiography had 
been performed in patients with suspected PE. We included all perfusion 
defects seen on DECT in which there was an acute segmental PE with 75% 
vascular obstruction but no emphysema or consolidation present. Noise was 
measured on the iodine maps as the standard deviation in normal 
parenchyma. Signal was defined as the enhancement difference between the 
perfusion defect and the surrounding normal parenchyma in a triangular region 
of interest. Signal-to-noise ratios (SNRs) were compared for iodine maps 
derived from DECT and SCT using a Wilcoxon signed test. 
Results: Median dose-length product was 154 mGycm for SCT and 162 
mGycm for DECT. Noise was not significantly different between the two 
(p=0.86). Seventy perfusion defects in 45 lungs were included. The average 
SNR was 18.5 for SCT and 16.9 for DECT (p=0.09). Significant differences in 
SNR were only found in perfusion defects in the upper lobes, with an average 
SNR of 22.0 for SCT and 18.1 for DECT (p<0.05). 
Conclusion: At similar radiation dose, perfusion defects on subtraction CT 
show similar or higher SNR than those on dual-energy CT. This implies that 
SCT is a viable alternative to DECT for depicting perfusion defects.  
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B-0412 09:10  
Advantages of spectral CT in staging of patients with non-small cell lung 
cancer (NSCLC)  
U. Fehrenbach1, K. Merz1, G. Böning1, J. Kahn1, F. Feldhaus1, M.H. Maurer2, 
D. Renz3, B. Hamm1, F. Streitparth1; 1Berlin/DE, 2Berne/CH, 3Jena/DE 
(uli.fehrenbach@charite.de)  
Purpose: Imaging of NSCLC is based on morphological criteria in contrast-
enhanced CT studies. Spectral CT(SCT) offers additional information by 
specific SCT values. We evaluated the SCT values’ usefulness in staging of 
lung cancer patients. 
Methods and Materials: 116 patients with confirmed NSCLC were included in 
a prospective cohort study. All patients received a single-phase contrast-
enhanced SCT (80kV/140kV). SCT values (iodine content(IC), spectral slope 
pitch(k) and quantitative HU increase) of tumor tissue (primaries and 
metastases) and lymph nodes(LN) were acquired. Adrenal masses(AM) were 
evaluated in virtual native series(VNS). Additional lung structure changes were 
analyzed as secondary findings. 
Results: 52 non-treated NSCLC primary tumors were sufficiently measurable. 
Adenocarcinoma showed significantly higher normalized IC than squamous 
cell carcinoma (18,8vs12,0;p=0,035). 126 LN were analyzed and metastases 
showed significantly lower IC and k than benign LN 
(20,8vs25,8;p=0,023;1,6vs2,5;p=0,000). Tumors in local control after 
radiochemotherapy showed significant lower IC in hot spot analysis than 
tumors in progressive disease (4,27vs2,06;p=0,000). In 34 AM, VNS identified 
adenomas with high sensitivity and specificity (96%,100%). Pulmonary 
metastases showed no significant differences to benign lung nodules (p=0,18-
0,76). Secondary findings of atelectasis, pneumonia, scar tissue and pleural 
effusion showed heterogeneous IC. In 2 patients a perfusion defect through 
pulmonary embolism could be visualized. 
Conclusion: SCT and its specific values may support the differentiation 
between histological NSCLC subtypes and may improve the identification of 
LN metastases. It can also improve evaluation of tumor response after 
radiochemotherapy. With VNS, adrenal adenomas can be differentiated to 
metastases. Pulmonary perfusion defects can be visualized in iodine maps.  
B-0413 09:14  
Longitudinal airway remodeling in active and past smokers in a lung 
cancer screening population  
T.D. Buschulte, M.O. Wielpütz, B.J. Jobst, M. Trauth, J. Tremper, 
O. Weinheimer, S. Delorme, N. Becker, H.-U. Kauczor; Heidelberg/DE 
(T.Buschulte@gmx.de)  
Purpose: Little is known on the longitudinal changes of airways on computed 
tomography (CT) depending on smoking status. Thus, we assessed CT-based 
airway metrics by quantitative post-processing repeatedly over a period of 4y in 
a group of heavy smokers. 
Methods and Materials: CT scans in a lung cancer screening program were 
performed for 4y at 12mon intervals in 284 long-term ex-smokers (ES), 405 
continuously active smokers (CS), and 31 subjects who quitted smoking during 
2y after baseline CT (recent quitters, RQ). CT were evaluated by airway 
analysis software, computing the total diameter (TD), luminal area (LA) and 
wall percentage (WP) from 5th-8th airway generation. 
Results: At all time points, TD and LA were significantly higher in ES 
compared to CS, for example at baseline with 6.24mm vs. 5.93mm (p<0.001) 
and 15.23mm² vs. 13.51mm² (p<0.001), respectively. RQ also showed a 
tendency towards higher TD (6.15mm vs. 5.93mm, n.s.) and significantly 
higher LA (14.77mm² vs. 13.51mm², p<0.001) than CS after 3y, and also after 
4y. Smoking status independently predicted TD, LA, and WP at baseline as 
well as at 3y and 4y follow-up (p<0.01-0.001) in a multivariate analyses, with a 
stronger impact than pack years. 
Conclusion: Bronchial narrowing and wall thickening depend on the smoking 
status. Smoking-induced airway wall inflammation may partially be reversible 
after smoking cessation even in heavy smokers at risk of COPD. Therefore 
quantitative CT-based airway metrics within clinical trials should consider the 






B-0414 09:18  
Bronchial wall changes after thermoplasty in the treatment of severe 
asthma: CT scan assessment at 3 months  
Y.W. Kim1, M.P. Debray2, C. Fetita3, O. Fouque1, M. Aubier2, P.-Y. Brillet1; 
1
Bobigny/FR, 2Paris/FR, 3Evry/FR (wouk1805@gmail.com)  
Purpose: Our goal is to assess by CT scan bronchial wall changes induced by 
thermoplasty, an endoscopic technique aiming at reducing airway smooth 
muscle mass. 
Methods and Materials: This prospective study included 24 patients with 
severe asthma. For each bronchus, airway lumen area (LA), wall area (WA) 
and WA as a percentage of total bronchial area (WA%) were automatically 
generated from CT acquisitions by the software BronCare, before (M0) and 
after (M3) treatment. The measures were confronted to functional data and 
asthma control. 
Results: After treatment, LA remained unchanged. By contrast, WA and WA% 
increased at M3 (M0/M3: 16.7/19.0 mm² for WA and 63.7/66.7% for WA%; 
p<0.0001). These variations were correlated to pre-thermoplasty values, with a 
negative linear correlation (r>0.7, p<0.0001). The less thick bronchi tended to 
thicken more. The importance of this effect differed between patients 
(p=0.0004 for WA%). Thereby, the patients could be split into two clusters in 
relation to WA and WA% pre-thermoplasty values, their modifications after 
treatment and patient's height (p<0.0046). The clusters did not differ according 
to other initial clinical data or follow-up events. 
Conclusion: Bronchial thermoplasty results in bronchial structural changes, 
reflecting a residual inflammation and might be adjusted to patient's 
morphotype.  
B-0415 09:22  
Optimisation of a chest CT protocol for the detection of ground glass 
opacity nodules: feasibility study with a computer-assisted detection 
system and a lung cancer screening phantom  
S. Kang, T.H. Kim, I.K. Park, C.H. Park; Seoul/KR (smkang13@gmail.com)  
Purpose: To optimise computed tomography (CT) parameters for the detection 
of ground glass opacity nodules (GGNs) using a computer-assisted detection 
(CAD) system and a lung cancer screening phantom. 
Methods and Materials: A phantom containing GGNs (−600 HU) was 
examined with a 256-row multi-detector CT scanner. Three tube voltages (120, 
100, 80kVp) were used in combination with five tube currents (400, 200, 100, 
50, 25mA); three slice thickness (0.625, 1.25, 2.5mm); and four different 
reconstruction algorithms (ASIR-V) of 0, 30, 60, 90. For each protocol, the 
accuracy of the CAD system was evaluated for the 6 target GGNs that were 8, 
10, or 12mm in size. 
Results: Among the 180 combinations of CT parameters, 80kVp, 200mA, and 
1.25mm had the best performance with 6 true positives (TP) and no false 
positives (FP). For 80kVp, 400mA, 1.25mm, there were 5TP, 1FP; and 
100kVp, 100mA, 1.25mm had 4TP and 1FP; while 100kVp, 50mA, 1.25mm 
had 4TP and 1FP; and 120kVp, 25mA, 1.25mm had 4TP and 3FP. (All above 
combinations were with ASIR-V of 90.) Other combinations had fewer than 
3TP and especially any combinations with a 0.625mm had 0TP and at least 
1FP result. 
Conclusion: Chest CT at low voltage with thin slice thickness and high 
iterative reconstruction algorithm might improve the detection rate of a CAD 
system for small GGNs in lung cancer screening.  
B-0416 09:26  
Diagnostic ability of the primary lung cancer by radiologists with chest x-
ray  
R. Nishino1, H. Numasaki2, N. Minamoto1, S. Nakai1, T. Uchigashima1, 
A. Takahashi1, S. Ehara1, M. Sakai1, S. Takashima1; 1Suita/JP, 2Osaka/JP 
(u686321c@ecs.osaka-u.ac.jp)  
Purpose: The purpose of this study was to determine the factors that influence 
the diagnostic ability of pulmonary nodules with chest x-ray (CXR) and to 
assess the factors that influence the confidence on the diagnosis of the 
nodules that were correctly detected. 
Methods and Materials: Five chest radiologists interpreted chest radiographs 
(non-nodule images: 200 and nodule images; 200 (subsolid nodule: 95 and 
solid nodule; 105)), and diagnostic ability was assessed using localized 
receiver operating characteristics (LROC) analysis. For nodule group, we 
studied statistical differences between the correctly diagnosed group and 
incorrectly diagnosed group in 9 factors, and assessed the factors that 
influence the diagnostic ability using logistic regression analysis. For the 
correctly diagnosed group, we performed statistical tests in 9 factors, and 
assessed the factors that influence the confidence on the diagnosis using 
multiple regression analysis. 
Results: The mean area under the LROC curves was 0.73 ± 0.015 (accuracy: 
70.3%, sensitivity: 48.7% and specificity: 91.9%). On logistic modeling, CT 
value of the nodule, diameter of the nodule and the overlap with other 
  






structures were common significant factors for 5 radiologists. On multiple 
regression analysis, the overlap with other structures was common significant 
factor for 5 radiologists. 
Conclusion: The significant factors that influence the diagnostic ability of CXR 
for primary lung cancer were CT value of the nodule, diameter of the nodule 
and the overlap with other structures. The significant factor that influences the 
confidence on the diagnosis of the nodules that were correctly detected was 
the overlap with other structures.  
B-0417 09:30  
Salivary gland tumours in the central airway: the comparison of CT 
features between adenoid cystic carcinoma and mucoepidermoid 
carcinoma  
Y. Deng, Q. Zeng, X. Wu, X. Li, W. Luo; Guangzhou/CN 
(hotden_1@hotmail.com)  
Purpose: To compare the CT features between adenoid cystic carcinoma 
(ACC) and mucoepidermoid carcinoma (MEC) in the central airways. 
Methods and Materials: This retrospectively study complying with HIPAA was 
approved by Institutional Review Board. A total of 10 patients with ACC (7 
females, 3 males; median age, 33 years; age range, 21 to 59 years) and 9 
patients with MEC (7 females, 2 males; median age, 21 years; age range, 15 
to 37 years), who underwent contrast-enhanced CT before surgery or biopsy, 
were identified and included. The CT features of the tumour including location, 
maximum diameter, growth pattern, and enhancement were evaluated . The 
difference of tumour location and growth pattern between ACC and MEC was 
compared using Chi-squared test. The difference of maximum tumour 
diameter, enhancement between ACC and MEC were compared using Mann-
Whitney U test. 
Results: 8 of 10 ACC (80%) origin from trachea, while 2 of 9 MEC (22%) origin 
from trachea (p=0.04). 9 of 10 ACC (90%) and 3 of 9 MEC (33%) exhibited 
infiltrative growth pattern, while 1 of 10 ACC (10%) and 6 of MEC (67%) 
exhibited expansile growth pattern (p=0.04). There was no difference of 
maximum tumour diameter between two subtypes (p=0.762). The MEC 
showed significant greater enhancement than ACC (MEC: median, 62 HU; 
25th-75th percentile, 55-67 HU; ACC: median, 30 HU; 25th-75th percentile, 26-37 
HU; p=0.002). 
Conclusion: ACC and MEC in the central airways has distinct CT features 
including the location, growth pattern and enhancement.  
B-0418 09:34  
Early residual tumour differentiation from benign periablational thermal 
injury after radiofrequency ablation by spectral analysis with dual-energy 
computed tomography  
L. Yuekao; Shi Jiazhuang/CN (64502240@qq.com)  
Purpose: To investigate the applicative value of dual-energy computed 
tomography (DECT) spectral analysis on the quantitative assessment of 
residual tumour after radiofrequency ablation. 
Methods and Materials: With CT-guided percutaneous tumour tissue 
inoculation, we established rabbit VX2 tumour model and incomplete tumour 
ablation model. Triple-phase contrast-enhanced DECT data on 24 rabbits with 
VX2 carcinoma then were assessed at day 3 (n=6), 1 week (n=6), 2 weeks 
(n=6) and 3 weeks (n=6) after incomplete RFA independently by two readers. 
Under different KeV values, we determined the average CT value of the area 
of interest and the plot of spectra and compared the differences between the 
residual tumour and inflammation. The pathologic specimens were sectioned in 
the same plane as DECT imaging. 
Results: With CT-guided percutaneous tumour tissue inoculation, we 
established a rabbit VX2 tumour model and an incomplete tumour ablation 
model. Triple-phase contrast-enhanced DECT data on 24 rabbits with VX2 
carcinoma then were assessed at day 3 (n=6), 1 week (n=6), 2 weeks (n=6) 
and 3 weeks (n=6) after incomplete RFA independently by two readers. Under 
different KeV values, we determined the average CT value of the area of 
interest and the plot of spectra and compared the differences between the 
residual tumour and inflammation. The pathologic specimens were sectioned in 
the same plane as DECT imaging. 
Conclusion: Spectral curve with DECT might help in differentiating benign 
periablational reactive tissue from residual tumour in VX2 carcinoma in rabbits 










B-0420 09:38  
Assessment of survival in patients with idiopathic pulmonary fibrosis 
using Kurtosis and mean lung density HRCT indexes  
A.G. Torcitto1, D. Falsaperla1, S.E. Torrisi1, L.A. Mauro1, M. Pavone1, 
G. Russo2, A. Stefano2, C. Vancheri1, S. Palmucci1; 1Catania/IT, 2Cefalù/IT 
(alfre.84@katamail.com)  
Purpose: To investigate the diagnostic accuracy of Kurtosis and Mean Lung 
Density (MLD) in the assessment of survival in a cohort of patients with 
Idiopathic Pulmonary Fibrosis (IPF). 
Methods and Materials: 42 patients with IPF diagnosis and a minimum follow-
up time of 3 years were retrospectively collected; HRCT and pulmonary 
function tests (FVC and DLCO) performed at diagnosis time were analysed; 
the extent of fibrotic disease was quantified on HRCT using Kurtosis, MLD, 
percentage of HAA and Fibrotic areas. Patients were divided into 3 groups 
according to Kurtosis value (kurtosis index <3, 3-4 and >4) and according to 
MLD (MLD <-800, between -800 and -750, >-750). Survival analysis was 
performed according to these variables. Correlations between kurtosis and 
MLD indices and pulmonary function tests were also performed using 
Spearman’s Rank correlation. 
Results: Significant survival differences were found according to the kurtosis 
values (p=0.002) and MLD value (p=0.003) obtained from HRCT quantitative 
evaluation at the diagnosis time. Spearman’s Rank correlation analysis 
showed also a positive correlation between kurtosis value and FVC (r=0.57, 
p=0.0001); a positive correlation between kurtosis value and DLCO (r=0.52, 
p=0.0004); a negative correlation between MLD value and FVC (r=-0.53, 
p=0.0003); a negative correlation between MLD value and DLCO (r=-0.41, 
p=0.0069). 
Conclusion: Kurtosis index and MLD value may provide an accurate 
estimation of survival in a population of IPF patients from the time of diagnosis. 
These HRCT-derived indices demonstrate also a correlation with common 
pulmonary function values (FVC and DLCO) pointing out their possible use in 
clinical practice.  
B-0421 09:42  
Volumetric analysis of intravoxel incoherent motion diffusion-weighted 
MRI in predicting the invasiveness of non-small cell lung cancer  
J. Jiang1, L. Cui2, Y. Fu1, G. Xu1; 1Yancheng/CN, 2Nantong/CN 
(1021809719@qq.com)  
Purpose: To investigate the value of intravoxel incoherent motion (IVIM) 
parameters D, D*, f and apparent diffusion coefficient (ADC) in preoperative 
prediction of tumour grade, lymph node metastasis and pleural invasion in non-
small cell lung cancer (NSCLC) patients. 
Methods and Materials: 39 surgically-diagnosed NSCLC patients (39 lesions) 
were enrolled in this study and underwent free-breathing DWI and IVIM (10 b-
values, 0-1000 s/mm2) scans one week before the operation on a Siemens 3T 
MRI. ADCmean, ADCmin, D, D* and f values were independently calculated by 
volumetric region of interest (ROI) by 2 observers. Inter-observer reproducibility 
was assessed. Differences of these parameters in tumors with different 
differentiation degree, with or without lymph node metastasis, and with or 
without pleural invasion were compared. Receiver operating characteristic 
(ROC) curves were generated to determine the diagnostic performance. 
Results: Good inter-observer reproducibility was seen in all parameters except 
D*. D and ADCmin were significantly lower in poorly differentiated lung cancer 
(P<0.001 and 0.001, respectively) and so was D in patients with lymph node 
metastasis (P=0.010). While in patients with pleural invasion, D was 
significantly lower and f was significantly higher (P=0.017 and 0.005, 
respectively). According to ROC curve analysis, highest values of area under 
the curve (AUC) appeared when predicting tumor grade and lymph node 
metastasis with D (0.858, 0.761) and predicting pleural invasion with f (0.766). 
Conclusion: IVIM diffusion parameter D can better predict tumor grade and 
lymph node metastasis whereas IVIM perfusion fraction f can better predict 
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B-0422 10:30  
Potential ketamine-related cholangitis in severely ill burn patients: liver 
imaging features  
M. Hajji, C. De Tymowski, P. Bourrier, V. Mallet, A.M. Zagdanski, M. Legrand, 
E. De Kerviller; Paris/FR (hajjimaha1989@gmail.com)  
Purpose: The French national drug agency (ASM) has recently issued a 
warning regarding potential ketamine-related liver toxicity in burn patients, with 
cases of severe liver cholestasis. Our aim was to describe the radiological 
pattern of biliary tract abnormalities in this setting. 
Methods and Materials: We included patients admitted in the St-Louis burn 
unit between 2012 and 2017 with liver cholestasis (Alkaline phosphatase and 
Gamma-glutamyltransferase more than 1.5N) and treated with intravenous 
ketamine. Liver imaging was analyzed for potential signs of bile duct 
abnormalities. Among 154 patients with liver imaging,116 had scanner, 45 had 
US, and 10 had liver MRI. 
Results: Liver imaging was most of times found normal except for 
hepatomegaly (n=15). Seven patients had cholangitis images with diffuse 
enlargement of intra and extra-hepatic bile ducts and abnormal heterogeneous 
intra-luminal material in bile ducts (fig). . In 3 cases, small satellite abscesses 
were noticed. They received cumulative high doses of ketamine (mean 122 g 
[min 62-max 221g] during their hospitalization. They had a severe biological 
cholestatsis = 5time N . Liver biopsies showed an aspect of cholangitis with 
overloaded bile without ischemic lesions in one patient and portal-lobular fibro-
inflammatory lesions in another. 
Conclusion: In severely ill burn patients receiving very high doses of 
ketamine, we observed bile duct images featuring cholangitis together with 
intra-luminal heterogeneous abnormal material. Imputability and mechanisms 
of liver toxicity of ketamine still requires further exploration. In the meantime, 
radiologist should specifically search for such features in patients exposed to 
high doses of ketamine.  
B-0423 10:38  
Gd-BOPTA excretion MRI analysis in patients with compromised and 
non-compromised bile ducts  
M. Shorikov, M. Lapteva, P. Polyakov, D. Frantsev, O.N. Sergeeva, 
B. Dolgushin; Moscow/RU (mglapteva@inbox.ru)  
Purpose: Magnetic resonance contrast agent (MRCA) Gd-BOPTA 
demonstrated dual excretion either by liver or kidneys. As it was previously 
shown in obstructive jaundice models, a bile duct ligation in the rodents 
significantly reduced the liver-to-kidneys excretion ratio compared to that in the 
animals after sham procedure. MRI assessment of the hepatic function based 
on Gd-BOPTA excretion shift is attempted in the study. 
Methods and Materials: 25 patients that had MRI-examination with Gd-
BOPTA in period 2015-2016 showing normal total serum bilirubin level were 
included in the study: 15 patients with cholestatic liver diseases (14-Klatskin 
tumour,1-primary sclerosing cholangitis) after biliary decompression (group 1) 
and 10 patients without cholestasis(10-metastatic neuroendocrine tumours, 
group 2). They were studied on 1.5T MRI system. MRCP was also done in all 
the cases. T1VIBE-images were acquired before/after (arterial, portal, venous, 
delayed (1, 20, 40 minutes) phases) 10ml Gd-BOPTA i.v.injection. One patient 
from group 1 had an additional study with 7.5ml of Gd-DTPA a month later; 
T2WI, DWI+ADC-maps were also evaluated in this patient for liver fibrosis 
detection. 
Results: Endobiliary Gd-BOPTA was registered in 3/10 patients in group 1 and 
in all group 2. Maximal diameter of bile duct correlated to SI (liver) at 20, 40min 
(r2=0.9, p<0.002). SI(liver)/SI(kidney) was significantly lower in group 1 
compared to group 2 (p<0.02) at 20, 40min phase. Additionally in patient who 
had two studies with different MRCAs: 1)Gd-BOPTA: SI(liver)/SI(kidney) for 
segment with signs of liver fibrosis was lower than SI(liver)/SI(kidney) for 
segment without fibrosis (p<0.05); 2) Gd-DRPA: the ratio for segments was not 
significantly different (p>0.05) and higher than in case of the Gd-BOPTA 
injection (p<0.05). 
Conclusion: Patients with cholestatic liver diseases demonstrated Gd-BOPTA 
excretion shift even after biliary decompression and serum bilirubin 
normalisation.  
 
B-0424 10:46  
Spectral CT and cholesterol content in gallbladder stone  
E. Danse1, N. Joudiou1, G. Muccioli1, N. Michoux1, J. Collart1, C. Hubert1, 
A. Vlassenbroeck2, B. Gallez1, E. Coche1; 1Brussels/BE, 2Eindhoven/NL 
(etienne.danse@uclouvain.be)  
Purpose: To assess whether dual energy CT measurements can predict the 
percentage of cholesterol in gallstones taking spectro-MR as reference. 
Methods and Materials: In 18 patients operated for symptomatic gallbladder 
stone, the removed stones were evaluated in vitro using a spectral MDCT 
(IQon, Philips Healthcare, Cleveland, OH). These specimens were evaluated in 
the Biomedical MRI research lab with a Spectro-MR system, to assess the 
presence and the amount of cholesterol and Calcium respectively. Correlation 
between spectro-MR measurements and CT data was assessed using 
Spearman rank correlation coefficient. Relationship between CT attenuation 
(HU) and MR measurements was investigated for different voltages (40kVp, 
70kVp, 80kVp and 200kVp) using linear regression. The correlation between 
effective atomic number (Zeff) and MR measurements was also investigated. 
Results: The proportion of the variation in the dependent variable (%cholesterol) 
explained by the regression model was found to be high at 40kVp (Equation: 
%cholesterol = 56.4 - 0.15*HU, pintercept < 0.0001, pslope = 0.0001, coefficient of 
determination R240kVp = 0.76). A linear model was found to describe well the 
relationship between Zeff and the cholesterol content determined by RMN 
(Equation: %cholesterol = 192 - 21.0*Zeff, p
intercept < 0.0001, pslope < 0.0001, 
coefficient of determination R2 = 0.73). 
Conclusion: At 40kVp, a linear model explains the relationship between the 
density of the stones measured in Hounsfield unit and the % of cholesterol in 
the stones measured in MR. Additionally, the Z number allows predicting the 
content in cholesterol within the stones.  
Author Disclosures: 
 A. Vlassenbroeck: Employee; Philips HealthCare. 
B-0425 10:54  
Is cross-sectional imaging predictive of difficult hepatectomy in patients 
undergoing liver transplantation?  
R. Girometti, D. lorenzin, L. Montaldo, G. Como, A. Risaliti, C. Zuiani; Udine/IT 
(rgirometti@sirm.org)  
Purpose: Dissecting the inferior vena cava (IVC) from the dorsal sector (DS) of 
the recipient’s liver is a major cause of difficult hepatectomy (DH) in orthotopic 
liver transplantation (OLT). We investigated whether DS morphology is 
associated with DH (primary end point) or early postoperative complications 
(EPOC). 
Methods and Materials: We retrospectively included 67 patients who 
underwent preoperative 64-raw multidetector (CT) (n=57) or 1.5T magnetic 
resonance imaging (MRI) (n=10) before OLT. Two radiologists in consensus 
calculated the volume of the liver dorsal sector (V-LDS, including Couinaud 
segments I and IX), volume of caudate lobe (V-CL), degree of IVC 
encirclement (E-IVC), length of IVC-DS contact (L-IVC-DS), and caudate lobe-
to-right lobe ratio (CL/RL). Imaging findings, clinical and operative features 
(including sex, age, aetiology of cirrhosis, model end-stage liver disease 
(MELD), IVC-related operative times, packed red blood cells and fresh frozen 
plasma) were entered into a logistic regression model to identify predictors of 
the study end points. 
Results: DH and EPOC occurred in 19/67 (28.4%) and 15/67 patients 
(19.7%), respectively. On multivariate analysis, no imaging, clinical or operative 
features were predictors of DH (p>0.05), while a V-LDS <33.6 cm3, V-CL <15.0 
cm3, and CL/RL <0.75 were found to be significant (p<0.05) protectors from 
EPOC (OR 0.08, 0.03 and 0.13, respectively). On receiving operating 
characteristic (ROC) analysis, the sensitivity/specificity for DH and POC of V-
DLS, V-CL and CL/RL were 0.65/0.63, 0.70/0.51 and 0.70/0.4 for DH, and 
0.46/0.71, 0.73/0.56 and 0.86/0.57 for EPOC. 
Conclusion: While having no role in predicting DH, liver DS morphology can 
help in the preoperative stratification of the risk of EPOC.  
B-0426 11:02  
Improved visualisation of hepatic metastases in gadoxetate disodium-
enhanced MRI: potential of contrast-optimised (phase-sensitive) 
inversion recovery imaging  
U.L. Fahlenkamp, L.C. Adams, S.M. Böker, G. Engel, M. Huynh Anh, 
M. Wagner, B. Hamm, M.R. Makowski; Berlin/DE (ute.fahlenkamp@charite.de)  
Purpose: To investigate the potential of a contrast-optimised (phase-sensitive) 
inversion recovery (IR) MR imaging technique in gadoxetate disodium-
enhanced scans for detection of hepatic metastases. 
Methods and Materials: The institutional review board approved this 
prospective study. After written informed consent, 31 patients (16 male, 15 
female) with suspected or known hepatic metastases were examined on a 1.5 
T MR system 20 minutes after administration of 10 ml gadoxetate disodium. A 
single-breath-hold T1-weighted gradient-echo volumetric-interpolated-breath-
  






hold (VIBE) sequence was acquired as part of the standard clinical imaging 
protocol. In addition, a contrast-optimised (phase-sensitive) IR sequence was 
acquired with an inversion time (TI) adjusted for optimal suppression of signal 
from metastases compared to surrounding liver parenchyma. In both 
sequences, number of metastases and lesion-to-liver contrast (LLC) was 
assessed. 
Results: Overall, 302 liver metastases were identified in the investigated 
patient collective (n=31). A significantly (p  0.05) higher LLC was measured 
on contrast-optimised (phase-sensitive) IR sequences (0.79 ± 0.13) compared 
to VIBE sequences (0.40 ± 0.17). Detection rate for metastases  0.5 cm was 
significantly higher (p  0.05) based on (phase-sensitive) IR (n=106/117) 
compared to standard VIBE sequence (n=88/117). Detection rate for 
metastases > 0.5 cm was comparable (p > 0.05) between both sequences. 
Size measurement revealed a slightly larger lesion size (1.14 ± 0.80, p  0.05) 
of the metastases on (phase-sensitive) IR images compared to T1 VIBE. 
Conclusion: Contrast-optimised (phase-sensitive) IR MR imaging improves 
the detection of small hepatic metastases in gadoxetate disodium-enhanced 
scans compared to a conventional T1 gradient-echo VIBE sequence.  
B-0427 11:10  
CT-based liver surface nodularity quantification for the detection of 
clinically significant portal hypertension in cirrhotic patients  
R. Sartoris1, V. Vilgrain2, P.-E. Rautou2, M. Ronot2; 1Genoa/IT, 2Clichy/FR 
(riccardo.sartoris@hotmail.it)  
Purpose: To evaluate the diagnostic performance of non-invasive liver surface 
nodularity (LSN) quantification derived from CT images for the diagnosis of 
clinically significant portal hypertension (CSPH), with respect to hepatic venous 
pressure gradient (HVPG) and to compare it with other non-invasive measures 
and derived scores. 
Methods and Materials: 203 cirrhotic patients [(mean 58±10 years, women: 
119); 102 of them with CSPH] with valid HVPG measurement and abdominal 
CT within 60 days were selected. Transient elastography (fibroscan) was 
performed in 91 patients. LSN was measured by drawing a ROI over the liver 
edge and the software calculated the margin irregularity. LSN and derived 
scores (LSN x spleen diameter and LSN/platelet count) were compared with 
other common non-invasive measures including liver-to-spleen volume, platelet 
count/spleen diameter, liver stiffness, PH-risk score and LSPS score. 
Results: LSN valid measures were obtained in 189 patients (93.1%). LSN was 
significantly correlated with HVPG (r=0.75; p< 0.001). Patients with CSPH had 
a significantly higher LSN score (3.22±0.59 vs 2.44±0.34; p<0.001), with 
AUROC of 0.884±0.03. Cut-off value of 2.76 allowed identifying CSPH with 
sensitivity, specificity, PPV and NPV of 80%, 87%, 88% and 79%. AUROC of 
LSN was significantly higher than that of all other non-invasive tests (all 
p<0.001). 
Conclusion: CT-based non-invasive LSN quantification is effective for the 
detection of patients with CSPH, with higher diagnostic performance than other 
non-invasive measurements and could improve the detection of CSPH.  
B-0428 11:18  
Improvement of diagnostic image quality of abdominal CT using a deep 
learning-based reconstruction: initial clinical trial targeting hepatic 
metastases  
Y. Nakamura1, T. Higaki1, F. Tatsugami1, J. Zhou2, Z. Yu2, N. Akino3, Y. Ito3, 
M. Iida1, K. Awai1; 1Hiroshima/JP, 2Vernon Hills, IL/US, 3tawara/JP  
Purpose: We developed a new reconstruction method which could generate 
better image quality CT image using a deep learning-based reconstruction 
(DLR) trained by teaching dataset of higher dose CT image reconstructed with 
model-based iterative reconstruction. The purpose of this study was to confirm 
clinical feasibility of our method compared with conventional hepatic CT 
images targeting hepatic metastases. 
Methods and Materials: We evaluated 51 hepatic metastases from colorectal 
cancer in 17 patients. A radiologist measured standard deviation of the 
attenuation measured in the paraspinal muscle as image noise, and calculated 
contrast-to-noise ratio (CNR) = (ROIL-ROIT)/N, where ROIL is the mean 
attenuation of the liver parenchyma, ROIT is the mean attenuation of the 
tumour, and N is noise. Each liver lesion was reviewed independently by other 
two radiologists and graded on a 5-point confidence scale ranging from 1 = 
cannot identify to 5 = can detect lesion without diagnostic compromise. The 
difference between conventional CT processed with hybrid iterative 
reconstruction (hybrid-IR) and CT processed with our new method using DLR 
was determined. 
Results: Image noise was significantly lower on images with DLR compared to 
hybrid-IR (p&lt;0.01). In addition, CNR on images with DLR was significantly 
higher than those with hybrid-IR (p&lt;0.01). Confidence score for liver lesions 
was significantly higher with images with DLR compared to those with hybrid-
IR (p&lt;0.01 for both radiologists). 
Conclusion: DLR improved quantitatively and qualitatively image quality of 
abdominal CT for evaluation of hepatic metastases.  
Author Disclosures: 
 J. Zhou: Employee; Toshiba Medical Research Institute USA, Inc. Z. Yu: 
Employee; Toshiba Medical Research Institute USA, Inc. N. Akino: Employee; 
Toshiba Medical Systems Corporation. Y. Ito: Employee; Toshiba Medical 
Systems Corporation.  K. Awai: Advisory Board; GE Healthcare. 
Research/Grant Support; Toshiba Medical Systems Co., LTd, Hitachi, Ltd, 
Bayer AG, Daiichi Sankyo, Ltd, Eisai, Ltd, Fujitsu, Ltd. 
B-0429 11:26  
Up to seven criteria for liver transplantation: a single-centre experience  
K. Koryukova, M. Bezzi, M. Di Martino, S.G. Ginanni Corradini, M. Rossi, 
C. Catalano; Rome/IT (micdimartino@hotmail.it)  
Purpose: To test "up to seven" criteria for HCC in liver transplant candidates, 
with emphasis on imaging role and patients outcome. 
Methods and Materials: The study was approved by the Institutional Review 
Boards. In this prospective study were analysed patients who underwent liver 
transplantation (LT) between January 2012 and December 2015. Of 79 
transplant procedures 31 patients reported HCC nodules (69 lesions of which 
43 were treated before). Diagnosis of HCC was taken by two expert 
radiologists in liver imaging according to LI-RADS classification in MR or CT 
examinations. Radiological staging correlated with histological result 
(Pearson). One-year survival was also take into account. 
Results: Of 31 patients with HCC, 10 exceed Milan criteria for imaging 
analysis but were considered within "up-to-seven". On a patient-per-patient 
analysis, imaging reported a sensitivity of 60% (in explanted liver four patients 
were out of "up to seven" criteria). One-year after liver transplantation, four 
patients developed recurrence of HCC, of these 2 patients were out of Milan 
criteria. 
Conclusion: "Up-to-seven" criteria for LT should replace Milan criteria and 
allow more patients with HCC to be candidates of this treatment.  
B-0430 11:34  
A deep-learning approach to the significant liver fibrosis binary 
classification problem using gender, morphologic and haemodynamic 
measurements derived from B-mode ultrasound images  
A. Angelakis, I. Gatos, A. Soultatos, A. Kanavaki, E. Panteleakou, 
I. Theotokas, I. Vafiadis, E. Manesis, P. Zoumpoulis; Athens/GR 
(ath.angelakis@gmail.com)  
Purpose: Traditional methods such as haematologic tests, e.g. 
FIBROMETER®, strain, shear wave elastographic (SWE) stiffness cut-off 
values, e.g. FIBROSCANTM, SuperSonic Imagine SWE, and parameters 
derived from image analysis, e.g. color clustering of SWE, are used for the 
significant liver fibrosis binary classification (SLFBC) problem. The AUC of the 
above methods is: 0.82, 0.82, 0.84 and 0.87 accordingly. The purpose of this 
study was to design and tune a deep neural network (DNN) to automate 
classification of a patient’s liver fibrosis stage (FF1, FF2) with high accuracy, 
sensitivity, specificity and AUC. 
Methods and Materials: Our data set consisted of 103 liver biopsy validated 
patients with chronic liver disease from which 62 were FF1 and 41 were 
FF2. Input parameters for our model were: {patient gender}, four B-mode 
morphologic longitudinal diameter (LD) measurements: {right lobe, caudate 
lobe, left lobe, spleen} and one haemodynamic parameter {portal vein LD}. We 
normalized the values of these features and designed a DNN with two hidden 
layers. A 10-fold cross validation (CV) technique was used to overcome 
underfitting, overfitting, bias and variance issues. 
Results: 10-fold CV provided the following results: accuracy: 0.9364 +/- 
0.0582, F1: 0.9136, sensitivity: 0.9024, specificity: 0.9365, AUC: 0.927 with 
95% CI [0.817 - 1.000]. 
Conclusion: In this study, we proposed a different approach to solve SLFBC 
problem using deep learning. Our preliminary results demonstrate improved 
accuracy, sensitivity, specificity, and AUC (all > 0.90) compared to traditional 
diagnostic methods. Larger data sets are required to further validate our 
algorithm.  
B-0431 11:42  
Three-dimensional texture analysis technology in computed tomography: 
a new radiological marker in the pathology of liver cancer  
H. Xu, Y. Gao; Chengdu/CN (xuhuisophia@163.com)  
Purpose: Texture analysis is a new technology with many advantages such as 
non-invasive, quantized and economical. This research is performed to 
explored the relationship with the parameters of TA(texture analysis) and the 
pathological grade of liver cancer. 
Methods and Materials: Patients were involved in the retrospective research 
from march of 2011 to November of 2014 who have primary liver cancer. 
According to the radiology and pathology, 47 patients who have contrast-
enhanced CT imaging were involved in the study. Analysis software is CT 
Kinetics APP, in which includes GLH, grey-level histogram, GLCM, grey-level 
co-occurrence matrix and GLRLM, grey-level run-length matrix. CT imaging 
  






(Siemens 128 multislice spiral CT,slice thickness=1mm;scan protocol:plain 
scan,arterial phase and venous phase). Region of interest(ROI) was drawn by 
2 radiologists with at least 2 years of experience. ROI was drawn in three 
phases and merge to 3d imaging for texture analysis. 
Results: All parameters were divided into 2 groups by high differentiation and 
poor differentiation in pathology, which calculated by Mann-Whitney U test 
from SPSS23.0. The area under curve (AUC) of inverse difference moment 
(arterial phase) in GLCM is 0.762(cutoff=0.60097) , which is tested by receiver 
operating characteristic. The AUC of correlation (arterial phase) in GLCM is 
0.755(cut off=0.3021). The AUC of energy and skewness in GLCM are 0.731 
(cutoff=0.0679) and 0.672 (cutoff=-0.2186) respectively. 
Conclusion: Texture analysis could predict the pathological grade of liver 
cancer from pre-treatment CT imaging. As a non-invasive and post-processing 
computer-aided diagnosis, TA could provide more information for clinic.  
B-0432 11:50  
Analysis of the relationship between imaging patterns of calcification and 
response to chemotherapy in patients with colorectal metastases  
J. Zhang, B. Wu, Y. Zhou; Chengdu/CN (396297113@qq.com)  
Purpose: The purpose of our study was to determine the relationship between 
the CT features (morphology ,distribution and density) of colorectal cancer 
metastases calcification and response to chemotherapy(cetuximab combined). 
Methods and Materials: A retrospective review of CT of 111 patients who 
were treated with cetuximab-combined chemotherapy between 2011 and 2016 
revealed 27 cases of tumor calcifications .The Response evaluation was 
performed according to the standard of Response Evaluation Criteria in Solid 
Tumors1.1(RECIST1.1). And the patients with metastases calcification was 
divided into two groups according to the response to the therapy. Analysis 
included the survival time between the two groups; the morphology and 
distribution of calcifications; and changes in number, density,morphology. 
Results: The common site of metastatic calcification is the liver (70.4%), 
followed by lymph nodes (29.6%). The overall prognosis of patients with 
metastases calcification is better than those without calcification,279 ± 37 VS 
186± 18 days(P=0.022)respectively. In all patients with metastases 
calcification, the overall outcome of the effective group was better than that in 
the ineffective group, 385 ± 17 VS244 ±38 days(P =0.042)respectively. The 
density increases with time, the effective group compare to the ineffective 
group slope are 11.9±4.0 VS 7.9±1.6, P =0.025. The calcification number 
changes between the two groups is significantly different. But the differences of 
morphology and distribution between the two groups are not significantly. 
Conclusion: Metastasis of colorectal cancer with calcification predicts a 
favorable prognosis. Calcification density growth rate and increased 
calcification number, which correlated with the response to the chemotherapy.  
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B-0433 10:39  
Role of iliac crest tangent sign in correct numbering of lumbosacral 
transitional vertebrae  
N. Gunduz, G. Durukan, M.B. Eser, A. Aslan, A. Kabaalioglu; Istanbul/TR 
(gulcin_dr_kan@hotmail.com)  
Purpose: Iliac crest tangent (ICT) sign has recently emerged as a reliable 
landmark to correctly number the lumbosacral transitional vertebrae (LSTV) in 
patients with degenerated intervertebral disc disease. We retrospectively 
evaluated the usefulness of ICT in subjects without disc degeneration. 
Methods and Materials: Fifty-eight patients with LSTV [19 (32.8%) female, 
42±18 years] and 55 control subjects without LSTV [23 (41.8%) female, 42±19 
years] who had undergone vertebral computed tomography in the emergency 
service for evaluation of suspected trauma were included. The ICT was drawn 
on the coronal images, with the cursor in the sagittal view set to the posterior 
one third of the vertebral body located one level above the LSTV. The last 
lumbar vertebra was used instead of LSTV in control group. When more than 
1.25 vertebral body was counted below the ICT, the LSTV was considered as 
S1, otherwise as L5. The gold standard numbering was determined by 
counting the vertebrae craniocaudally. Two readers blinded to the correct 
LSTV numbers analysed the images. Interobserver agreement and accuracy of 
ICT sign were assessed. 
Results: The interobserver agreement was good for determining ICT level 
(Cohen’s kappa=0.78, p<0.001). The rate of correct numbering by ICT sign in 
LSTV group was significantly lesser than controls (43.1% vs 96.4%, 
respectively, p<0.001). Moreover, patients with sacralisation had significantly 
less rate of correct numbering than those with lumbarisation (33.3% vs 63.2%, 
respectively, p=0.03). 
Conclusion: The ICT does not seem as a reliable landmark for correct 
numbering of LSTV in patients with no intervertebral disc degeneration.  
B-0434 10:47  
The termination level of dural sac relevant to caudal epidural block in 
lumbosacral transitional vertebrae: comparison between sacralisation 
and lumbarisation groups  
J.Y. Jeon; Incheon/KR (mdjeonjy@gmail.com)  
Purpose: Back and buttock pain can be associated with lumbosacral 
transitional vertebrae (LSTV). Appreciation of anatomical variations due to 
LSTV may impact safe performance of caudal epidural block (CEB). We 
investigated the termination level of the dural sac (DS) and anatomical features 
of lumbosacral region in patients with LSTV, and compared these findings 
between sacralisation and lumbarisation groups. 
Methods and Materials: 494 LSTV were included and categorised into 
sacralisation (n=201) or lumbarisation groups (n=293). MRI of the all LSTV 
patients were reviewed to determine the termination level of DS, the presence 
and the caudal level of sacral perineural cyst. MRI findings in the both groups 
were compared and analysed. 
Results: The distribution frequency of termination levels of DS demonstrated 
significant difference between the two groups. The mean caudal DS level in the 
lumbarisation group was significantly lower than the sacralisation group (lower 
third of S2 [131 {44.7%} of 293 patients] vs. lower third of S1 [78 {38.8%} of 
201 patients]). The DS terminated at S3 in more than 19% of lumbarisation 
group, whereas in only one case of sacralisation group. The incidence of 
perineural cyst was not significantly different between two groups. 
Conclusion: When planning CEB for patients with LSTV, especially in the 
lumbarisation cases, pre-procedural MR imaging to check the termination level 
of DS, presence of perineural cysts would be of great use for lowering the risk 
of unexpected dural puncture during the procedure.  
B-0435 10:55  
Modic changes: the association with low back pain and activity limitation 
- a systematic literature review and meta-analysis  
C. Herlin1, P. Kjaer1, A. Espeland2, J. Skouen2, C. Leboeuf-Yde1, 
J. Karppinen3, J. Niinimaki3, J.S. Sørensen4, T.S. Jensen5; 1Odense/DK, 
2
Bergen/NO, 3Oulu/FI, 4Svendborg/DK, 5Silkeborg/DK (tuejen@rm.dk)  
Purpose: To investigate if Modic Changes (MC) are associated with non-
specific low back pain (LBP) and/or activity limitation and if such an association 
is modified by other factors. 
Methods and Materials: The MEDLINE, CINAHL and EMBASE databases 
were searched for relevant cross-sectional and case-control studies including 
people of all ages from general, working or clinical study populations were 
eligible for inclusion. Data extraction for risk of bias assessment, associations 
and potential modifiers were completed independently by pairs of reviewers. 
Data were used to calculate odds ratio (OR) with for dichotomous outcomes or 
to perform t-tests for continuous outcomes. Meta-analysis was performed for 
homogeneous studies. 
Results: In all, 5210 citations were identified and 31 studies were included. 
One study had low risk of bias. Fifteen studies (48%) reported statistically 
significant positive associations between MC and LBP. Meta-analysis resulted 
in an OR of 4.01 (1.52-10.61). Both pooled and individual study data showed 
no difference in the strength of association of MC1 and MC2 with LBP. One of 
seven studies reported a statistically significant positive association between 
activity limitation and MC. Lumbar disc level and disc degeneration were found 
to reduce the estimates of association between MC and LBP. 
Conclusion: The results from this comprehensive systematic review indicate 
that the associations between MC and LBP related outcomes are inconsistent. 
This finding should call for caution when using “Modic changes” as a specific 
diagnosis, explanation for LBP, and indication for specific treatment in patients 
















B-0436 11:03  
Weight-bearing MRI evaluation of Modic changes: uncovering the 
“biomechanical stress” and “active discopathy” therories in low back 
pain  
F. Bruno, C. Marsecano, M. Micelli, A. Splendiani, C. Masciocchi; L'Aquila/IT 
(federico.bruno.1988@gmail.com)  
Purpose: To evaluate the MRI modifications of Modic 1 endplate changes 
under loading and the possible clinical correlation in patients with low back 
pain 
Methods and Materials: We evaluated 38 patients (20 females, 16 males, 
mean age 48.3 years) with low back pain and MRI evidence of Modic 1 
vertebral changes. Patients were examined on a low field MR scanner in 
standard supine and upright position. Patients with history of trauma, 
malformations, infectious-inflammatory diseases, spine tumours were 
excluded. For each patient, in each scan, two observers evaluated the 
endplate involvement by Modic changes (as percentage of vertebral body 
extension) , the intervertebral disc height at the level of the endplate changes 
and the degree of intervertebral disc hydration (according to Pfirmann). Pain 
evaluation in both supine and upright position was assessed by means of VAS 
score. 
Results: In upright position Modic 1 changes increased in 24 patients (63.1%, 
p<0.001). A reduction of disc height (89.5% of patients) and disc hydration 
(68.4%), respectively with negative (r=-0.12) and positive (r=0.46, p<0.005) 
correlation with Modic 1 changes was observed. 30 patients (78.9%) reported 
increase of pain in the upright position, and positive correlation with Modic 1 
increase 
Conclusion: Our imaging results suggest an instrumental evidence of the 
biomechanical stress theory for the development of Modic 1 changes. 
Moreover, upright scans under physiological loading represent an added value 
to standard sequences, being able to provide diagnostic information for 
answering clinical questions, such as pain due to “active discopathy” in 
patients with Modic 1 changes  
B-0437 11:11  
Oblique sagittal images prevent underestimation of neuroforaminal 
stenosis grade caused by disc herniation in cervical spine MRI  
L. Kintzelé1, C. Rehnitz1, H.-U. Kauczor1, M.-A. Weber2,1; 1Heidelberg/DE, 
2
Rostock/DE (laurent.kintzele@med.uni-heidelberg.de)  
Purpose: Identify whether sagittal MRI images (SMI) result in underestimation 
of neuroforaminal stenosis grade (NSG) compared to oblique sagittal MRI 
images (OSMI) in patients with cervical spine disc herniation. 
Methods and Materials: 74 patients with 104 cervical disc herniations 
compromising the corresponding nerve root were evaluated. NSGs were 
evaluated in SMI and OSMI by one senior and one resident radiologist. OSMI 
were angled 30° towards the standard sagittal plane. NSGs were classified 
from 0 (no stenosis) to 3 (high-grade stenosis). 
Results: Average NSG of both readers was significantly lower in SMI 
compared to OSMI (2.41 ± 0.65 and 2.92 ± 0.27). For 49 of 104 disc 
herniations (47,1%), one or both readers found a NSG which was at least 1 
grade lower in SMI compared to OSMI. Significant difference maintained 
looking at patients who had neurological symptoms (2.50 ± 0.55 and 2.88 ± 
0.32) or underwent cervical spine surgery subsequently (2.58 ± 0.49 and 2.90 
± 0.31). Based on location a significant difference between SMI and OSMI was 
found for foraminal herniations (2.36 ± 0.67 and 2.91 ± 0.27). In contrast, no 
significant difference was observed for recessal herniations (2.68 ± 0.46 and 
2.91 ± 0.30) or herniations which caused myelopathy (2.74 ± 0.45 and 2.91 ± 
0.29). Kappa values showed a very good interreader reliability for SMI (0,88) 
and OSMI (0,94). 
Conclusion: SMI tends to underestimate NSG compared to OSMI for disc 
herniations in cervical spine MRI. OSMI should, therefore, be considered as a 
valuable option for selected patients.  
B-0438 11:19  
Disc and vertebral changes after spinal fusion at serial CT imaging: 
correlation with discstability  
N. Amini, E. Fomekong, C. Raftopoulos, B. Vande Berg; Brussels/BE 
(nadia.amini@uclouvain.be)  
Purpose: To assess disc and vertebral changes after translaminar interbody 
fusion (TLIF) of lumbar discs by comparing MDCT examinations of the lumbar 
spine obtained immediately after surgery and 6 months later with comparison 
between stable and unstable discs. 
Methods and Materials: Two radiologists independently analyzed 36 discs 
after TLIF (Peek cage and bone grafting) by comparing CT examinations 
obtained immediately after surgery and 6 months later. They assessed 
changes in disc height and they scored bone formation and graft resorption (0 : 
no bone formation/graft resorption, 1 : bone formation without bridging bone/ 
partial graft resorption, 2 : bridging bone/complete graft resorption). Disc 
stability was determined by consensus reading on follow-up CT (unstable disc: 
intradiscal vacuum or bone resorption around the pedicle screws). 
Results: There were 19 stable and 17 unstable discs at 6 months follow-up. 
For both readers, the frequency of complete bony fusion was statistically 
significantly higher in stable than in unstable discs (p=0.003/0.02 for reader 
1/2). The frequency of trabecular bone thickening was statistically significantly 
higher in stable than in unstable discs (p=0.005 for reader 1 only). For both 
readers, the frequency of bone graft resorption, of trabecular bone atrophy and 
of disc space narrowing was not statistically significantly different between 
stable and unstable discs. 
Conclusion: Appearance of bridging bone and of trabecular bone thickening 
near the cages are associated with disc stability. Disc space narrowing, 
vertebral bone resorption and bone graft resorption are seen in similar 
frequency in stable and unstable disc.  
B-0439 11:27  
Evaluation of colour-coded virtual non-calcium images reconstructed 
from dual-energy CT for detection of lumbar disc herniation in 
comparison to MRI: initial results  
C. Booz, J. Noeske, S.S. Martin, L. Lenga, D. Leithner, T. Gruber-Rouh, 
K. Eichler, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main/DE 
(boozchristian@gmail.com)  
Purpose: Detection of lumbar disc herniation in standard grey-scale computed 
tomography (CT) is challenging. The aim of this feasibility study was to 
evaluate the diagnostic accuracy of two dual-energy computed tomography 
(DECT)-based colour-coded virtual non-calcium (VNCa) image reconstruction 
algorithms for detection of lumbar disc herniation in comparison to magnetic 
resonance imaging (MRI) as standard of reference. 
Methods and Materials: In this retrospective study, thirty-seven patients 
underwent clinically indicated third-generation dual-source DECT and MRI of 
the lumbar spine. Conventional linear-blended CT scans were obtained and 
two different corresponding colour-coded VNCa reconstructions were 
generated. First, three radiologists independently evaluated standard VNCa 
images for presence and degree of lumbar disc herniation and spinal nerve 
root affection. After 4 weeks, VNCa images optimized for analysis of 
intervertebral discs were examined by the same observers. Findings were 
compared with MRI evaluated by two separate observers serving as reference 
standard. 
Results: A total of 222 intervertebral discs were analysed. VNCa images 
optimized for analysis of intervertebral discs showed a higher overall sensitivity 
(94.7% vs 78.0%), specificity (97.0% vs 92.3%), positive predictive value 
(96.3% vs 89.3%) and negative predictive value (95.7% vs 83.5%) for 
detection of lumbar disc herniation compared with standard VNCa images 
(P<0.001). Receiver-operating characteristic analysis revealed areas under the 
curve of 0.958 (optimized VNCa) and 0.851 (standard VNCa). 
Conclusion: Initial results showed that a novel DECT-based colour-coded 
VNCa image algorithm specifically optimized for analysis of intervertebral discs 
can substantially improve diagnostic accuracy for detection of lumbar disc 
herniation. Inexperienced observers showed the most benefit.  
Author Disclosures: 
 J.L. Wichmann: Speaker; GE Healthcare, Siemens Healthineers. 
B-0440 11:35  
The effect of radiographically detected vertebral osteoarthrosis (VO) on 
bone mineral density (BMD) and trabecular bone score (TBS)  
A. Corazza1, D. Albano2, S. Rapisarda1, V. Chianca3, C. Messina1, 
L.M. Sconfienza1; 1Milan/IT, 2Palermo/IT, 3Naples/IT (angelcoraz@libero.it)  
Purpose: TBS is a recently developed textural score that provides an indirect 
index of vertebral trabecular microarchitecture from lumbar spine (LS) dual 
energy x-ray absorptiometry (DXA) scan. Our aim was to evaluate the effect of 
radiographically detected VO on BMD and TBS. 
Methods and Materials: We retrospectively identified all patients who 
performed a LS DXA during the first six months of 2015, together with a LS x-
ray (maximum interval between x-ray and DXA=4 months). Among them, we 
only included patients with VO visible on DXA and confirmed on LS x-ray 
(maximum two vertebrae involved). We calculate: 1. BMD/TBS difference 
between the vertebrae affected by VO and the adjacent vertebrae (AV) with the 
greater BMD/TBS value; 2. BMD/TBS difference between the vertebrae 
affected by VO and the average L1-L4 BMD/TBS (average value included the 
vertebrae with VO). 
Results: Out of 542, we included 42 females (mean age=75±10y) with VO. 
Mean BMD (g/cm2): vertebrae with VO=1.120±0.160; AV=0.976±0.152; L1-
L4=0.988±0.127. Mean TBS: vertebrae with VO/VF=1.379±0.138; 
AV=1.298±0.144; L1-L4=1.310±0.104. BMD difference between VO and 
VA=+14,8%; between VO and L1-L4=+13,4%. TBS difference between VO 
and VA= +6,2%; between VO and L1-L4=+5,3%. All differences were 
significant (p<0.05). We found a positive correlation between BMD and TBS for 
vertebrae with VO (R=0.6194, p<0.05). 
  






Conclusion: Compared to adjacent-vertebrae and L1-L4, VO significantly 
impacts both on BMD and TBS, despite the variation in terms of TBS was 
lower was lower compared to BMD. BMD and TBS values are positively 
correlated.  
B-0441 11:43  
Vertebral bone marrow composition: assessment of age and gender 
dependency using chemical shift encoding-based water-fat MRI  
A. Rohrmeier, J. Syväri, M. Diefenbach, D. Franz, S. Ruschke, M. Dieckmeyer, 
J.S. Kirschke, D. Karampinos, T. Baum; Munich/DE 
(Alexander.Rohrmeier@t-online.de)  
Purpose: Assessment of vertebral bone marrow composition has been 
recently proposed as an advanced imaging biomarker for osteoporosis-
associated fracture risk prediction. We investigated the age and gender 
dependency of vertebral proton density fat fraction (PDFF) using chemical shift 
encoding-based water-fat MRI. 
Methods and Materials: 156 subjects with no history of pathological bone 
changes were recruited (age range 20-29 years:12/30 males/females; 30-
39:15/9; 40-49:4/14; 50-59:9/27; 60-69:5/19; 70-79:4/8). All subjects underwent 
3T MRI with a sagittal spoiled gradient echo sequence for chemical shift 
encoding-based water-fat separation at the lumbar spine (pixel spacing: 
0.98x0.98 mm²; slice thickness:4 mm). Vertebral bodies of L1-4 were manually 
segmented in the PDFF maps to extract PDFF values at each vertebral level. 
Results: PDFF increased from L1 to L4 in all subjects (L1: 35.9±11.7%; L2: 
36.2±10.9%; L3: 37.2±10.7%; L4: 39.5±11.2%; p<0.05). Mean PDFF was 
significantly (p<0.05) greater in males than females in their twenties 
(32.0±8.0% vs 27.2±6.0%) and thirties (35.3±6.7% vs 27.3±6.2%). With 
increasing age, females showed an accelerated fatty conversion of the bone 
marrow compared to men with no significant (p>0.05) PDFF differences in their 
forties (males: 32.4±8.4%; females: 34.5±6.8%) and fifties (males: 42.0±6.1%; 
women: 40.5±9.7%). The accelerated conversion process continued resulting 
in greater PDFF values in females than males in their sixties (males: 
40.2±6.9%; females: 48.8±7.7%; p=0.033) and seventies (males: 43.9±7.6%; 
females: 50.5±8.2%; p=0.208). 
Conclusion: Vertebral bone marrow composition is dependent on age and 
gender. An accelerated fatty conversion of the bone marrow was observed in 
females with increasing age. The results allow insights into physiological 
changes of the vertebral bone marrow and may serve as reference data.  
B-0442 11:51  
A preliminary study of dual-energy CT spectral curve equation for the 
diagnosis of osteoporosis  
L. Wang, S. Gong; Nantong/CN (wanglin_nt@126.com)  
Purpose: To investigate the diagnostic value of dual-energy CT (DECT) 
spectral curve equation for osteoporosis (OP). 
Methods and Materials: The prospective study was approved by the 
institutional ethics committee. Informed consent was obtained from all patients. 
Sixty-seven patients with lumbago underwent both DECT and dual-energy x-
ray absorptiometry (DXA) examinations. DECT images were reconstructed 
using iterative algorithm (ADMIRE) with strength level 3. Spectral curves were 
generated through measuring CT values from photon energy 40 keV to 190 
keV with commercially available software (virtual monoenergetic plus, Syngo 
Via, version VB10A, Siemens Healthcare). Curve estimation was implemented 
for analysing correlations between photon energies and CT values under 
functions of linear, quadratic, cubic, inverse and power. In addition, degree of 
fittings was recorded to determine the optimal curve equation. Bone mineral 
density (BMD) and T-score of patient measured by DXA were set as the 
reference standard. Diagnostic value of curve equation was assessed by ROC 
analysis. 
Results: 16 patients were diagnosed as OP and 51 patients were diagnosed 
as non-osteoporosis (NOP) under DXA. R2 of cubic and inverse curve equation 
was significantly higher than linear, quadratic, and power (all P < 0.01). The 
average coefficients of inverse curve equation (ai-average) were correlated with 
BMD and T-score (r were 0.56 and 0.55, respectively. All P < 0.01). The 
sensitivity and specificity of ai-average for diagnosing OP were 93.75% and 
83.39% with a cut-off value of 10760.97. 
Conclusion: The DECT spectral curve equation is clinically applicable for 
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B-0443 10:30  
CT-guided transgluteal drainage of deep pelvic abscess  
S.F. Murphy, C.J. Sullivan, P. McCormick, B.J. Mehigan, D. Kevans, 
I.M. Brennan, M.J. Guiney, N. Sheehy, J.F.M. Meaney; Dublin/IE 
(stephenmurphy@rcsi.ie)  
Purpose: Deep pelvic abscesses can be challenging to drain percutaneously. 
Transabdominal drainage, the simplest approach, may be precluded by 
overlying structures including bowel loops, bladder and iliac vessels. The 
greater sciatic foramen, an oval space in the posterolateral aspect of the pelvis 
lying inferior to the sacroiliac articulation, offers an effective alternative access 
route, but requires detailed anatomical knowledge of the region to avoid vessel 
and nerve injury. We describe a consecutive case series of CT-guided 
transgluteal drainages from our institution. 
Methods and Materials: We retrospectively reviewed all cases from January 
2007 to August 2017 identified on our RISPACS database. Data collected 
included patient demographics, cause/size of abscess, catheter size, 
microbiology, inflammatory markers, follow-up scans and complications. 
Results: 100 patients (65 female, 35 male) underwent CT-guided transgluteal 
drainage. The mean age was 57.4 (range 20-89) years. Causes included post-
operative anastomotic leak, perforated malignancy, inflammatory bowel 
disease, diverticulitis and appendicitis. The mean collection diameter was 7.6 
cm (range 1.2-16). 78 patients had complete resolution following single (71) or 
2 drainages (7), 9 failed to resolve and required surgical intervention and the 
remainder (13) had a partial resolution that was managed conservatively. 
Conclusion: CT-guided transgluteal drainage is a safe and effective technique 
and is the procedure of choice for deep pelvic abscesses when a 
transabdominal approach is not possible.  
B-0444 10:38  
Virtual guidance of percutaneous transthoracic needle biopsy with c-arm 
cone-beam CT: diagnostic accuracy, risk factors and effective radiation 
dose  
D. Fior1, D. Leni1, F. Vacirca1, D. Ippolito1, S. Sironi2, R. Corso1; 1Monza/IT, 
2
Bergamo/IT (davidefior85@gmail.com)  
Purpose: C-arm cone-beam computed tomography (CT)-guided transthoracic 
lung core-needle biopsy (CNB) is a safe and accurate procedure for the 
evaluation of patients with pulmonary nodules. The purpose of our study was 
to retrospectively evaluate the diagnostic performance, complication rates and 
effective radiation dose of C-arm cone-beam CT-guided core-needle biopsy in 
a large monocentric XperCT-guided lung CNB series. 
Methods and Materials: We retrospectively collected data regarding 514 C-
arm cone-beam CT-guided CNBs from January 2010 to June 2017. Diagnostic 
performance, complication rate and effective radiation dose were investigated. 
Variables influencing diagnostic performance and complications were 
assessed using univariate logistic regression analyses. 
Results: The sensitivity, specificity, positive and negative predictive value and 
accuracy for patients subjected to CNBs were, respectively, of 96.8%, 100%, 
100%, 100% and 97.2%. Considering risk factors for pneumothorax, no 
significant differences were found regarding patient and lesion characteristics. 
Perilesional haemorrhage occurred more frequently in older patients (P=.046) 
and in smaller lesions (P=.001). Haemoptysis was more frequent in patients 
with perilesional haemorrhage, with a statistically significant P value (P=.01). 
Mean effective dose through CBCT-guided biopsies and CT-guided biopsies 
was 7.12 ± 8.78 mSv and 20.91 ± 8.12 mSv, respectively, with a statistically 
significant difference (p=0.024). 
Conclusion: Our results demonstrate that C-arm cone beam CT biopsy 
combined with Xper-CT virtual guidance is a reliable and accurate technique 
that allows exact localisation of pulmonary lesions, effective preprocedural 
planning and real-time fluoroscopy altogether, potentially improving the 














B-0446 10:46  
Real-time 3D-guidance based on C-arm-acquired cone-beam CT (CBCT) 
in transjugular intrahepatic portosystemic stent shunt (TIPSS) placement  
G. Böning1, W. Lüdemann1, J. Chapiro2, M. Jonczyk1, B. Gebauer1, 
R.W. Günther1, F. Streitparth1; 1Berlin/DE, 2New Haven, CT/US  
Purpose: Placement of TIPSS is a technically challenging intervention. The 
aim of this study was to evaluate the feasibility of CBCT-based real-time 3-D 
guidance and its potential benefits compared to standard guiding methods. 
Methods and Materials: 21 patients were prospectively included. We used 
real-time, 3-D guidance based on a C-arm-acquired CBCT. Feasibility, 
technical success, procedure/puncture time, applied dose of the intervention 
and the relative dose share of CBCT were determined. As control groups, we 
prospectively analyzed 15 TIPSS interventions with ultrasound (US) guidance, 
retrospectively 23 cases with US guidance and 23 cases with puncture utilizing 
anatomical landmarks. 
Results: CBCT guidance was feasible in all patients. Additional US guidance 
was necessary in 7 cases, and in 2 of these cases TIPSS implantation was not 
successful (9,5%). TIPSS placement failure in the prospective US-guided 
group was 20% and 13% in both retrospective control groups. All failures were 
excluded from analysis. In the CBCT only group a median of 2 attempts and a 
mean of 11±14 minutes were needed for portal vein puncture. The mean 
procedure time in this group was 91±38 minutes with an applied dose of 
426±208 Gy*cm and 4% mean dose share of CBCT in the intervention. 
Regarding to our results CBCT guidance is not significantly inferior to current 
standard guiding techniques. 
Conclusion: CBCT-based guidance for TIPSS placement was feasible and 
comparable to standard guidance procedures regarding to puncture attempts, 
time and dose. The relative dose of CBCT is low compared to total dose of 
intervention.  
B-0447 10:54  
Impact of personality and experience of interventional radiologists in 
outcome of CT-guided percutaneous lung biopsies  
M.-L. Kromrey1, S. Schäfer1, T. Ittermann1, B. Mensel1, J.-P. Kühn1,2; 
1
Greifswald/DE, 2Dresden/DE (marie-luise.kromrey@uni-greifswald.de)  
Purpose: To investigate the influence of personality and experience of 
interventional radiologist itself on technical success and rate of complication in 
computer tomography-guided percutaneous transthoracic needle biopsies 
(PTNB) of suspicious pulmonary nodules. 
Methods and Materials: Between 2006-2014, 38 interventional radiologists 
performed 1,056 PTNB. Technical success, rate of complications and 
interventional-related predictors of PTNB were determined. PTNB of 
radiologists with less than 20 interventions, lack of consent, and PTNB with 
missing variables were excluded, leaving 445 interventions performed by 14 
radiologists. Interventionalists underwent a Big-Five personality trait and State-
Trait Anxiety Inventory to quantitatively assess personality and psyche. 
Adjusted for predictors, factors to describe personality such as openness to 
experience, conscientiousness, extroversion, agreeableness, neuroticism 
(range 0-20), and anxiety (range 20-80) as well as experiences of 
interventional radiologists were compared to outcome of PTNB for each 
interventionalist. 
Results: There was no significant difference in technical success of 
interventional radiologists, which ranged between 75.8-95.7%, P=0.428. Rate 
of complications ranged between 56.1-85.7%, P=0.12 (major complications: 
15.0-24.1%, P=0.57; minor complications: 31.6-67.5%, P<0.05). Personality 
traits of interventionalists did not differ in technical success and rate of 
complications. Experience of interventional radiologists had no significant 
impact on technical success (P=0.132) or rate of complications (P=0.459). 
Conclusion: Using a standard operation procedure for CT-guided lung 
biopsies, technical success and rate of complications are unaffected by the 
interventional radiologists itself, as well as their years of experience and 
personality traits such as openness to experience, conscientiousness, 
extroversion, agreeableness, neuroticism and anxiety.  
B-0448 11:02  
MR-guided transrectal prostate biopsy with robotic assistance: initial 
experience  
F. Cornud1, A. Lefevre1, P. Camparo2, P. Soyer1; 1Paris/FR, 2Amiens/FR 
(francois.cornud@imagerietourville.com)  
Purpose: To show our preliminary results of MR-guided transrectal biopsies 
(MRGB) with a robotic assistance (Soteria, the Netherlands) for the diagnosis 
of prostate cancer. 
Methods and Materials: 33 patients (67±33y/o, PSA level: 10±6ng/ml), with a 
single PI-RADS lesion score equal to or greater than 2, underwent MRGB. In 
18 patients, MRGB was a repeat biopsy session following one to three series 
of systematic biopsies (15 patients) or three targeted biopsies (3 patients) with 
a software-based image fusion system, all showing no cancer or a microCa, 
Gleason score 3+3. The remaining 15 patients had no prior biopsy. The 
success rate to sample the lesion, the cancer-detection-rate (CDR) and the 
occupation time of the MR-room were evaluated. 
Results: The PI-RADS score was 2, 3, 4 and 5 in 3, 8, 13 and 9 cases, 
respectively. Sixteen lesions originated in the peripheral zone and 17 in the 
transition zone (one in the anterior stroma). Software-based adjustments of the 
robot allowed to align the needle guide with the target in all lesions. Two cores 
were obtained in 31 patients and 3 cores in 2 patients. The MR-room 
occupation time dropped from approximately 45-50mn to 20-30mn after 20 
cases. The overall CDR was 64.7% and, according to the PI-RADS score, 0, 
50, 64 and 100% for PI-RADS score 2, 3, 4 and 5 lesions, respectively. No 
complication was observed. 
Conclusion: Robotic-assisted MRGB can be performed with a short MR-room 
occupation time. Sampling is possible whatever the lesion location, with two 
cores in the vast majority of cases.  
B-0449 11:10  
Volumetric magnetic resonance-guided high-intensity focused 
ultrasound ablation of adenomyosis: the influence of T1 perfusion in 
predicting treatment outcome  
N.M. Duc1, B. Keserci1, H.Q. Huy1, P.N. Hoa1, P.M. Thong2; 1Ho Chi Minh/VN, 
2
Ha Noi/VN (bsnguyenminhduc@pnt.edu.vn)  
Purpose: We investigated the role of magnetic resonance (MR) T1 perfusion-
based time-signal intensity (SI) curves of adenomyosis tissue compared to the 
myometrium in predicting the treatment outcome of MR-guided high-intensity 
focused ultrasound (HIFU) ablation of adenomyosis. 
Methods and Materials: 30 adenomyosis patients (39.2 ± 5.1 years with a 
range of 30-56 years) who underwent MR-guided HIFU ablation were divided 
into 2 groups based on dynamic contrast-enhanced (DCE) MR images at 
screening: group A (n = 15) if the time-intensity curves of adenomyosis are 
lower than that of myometrium and group B (n = 15) if the time-intensity curves 
of adenomyosis are equal or higher than that of myometrium. The immediate 
post-HIFU non-perfused volume (NPV) ratio and adenomyosis volume 
reduction ratio at 6-month follow-up were assessed. 
Results: The volume of adenomyosis was 101.2 ml ± 59.0 (32-189.0 ml) for 
group A and 98.3 ml ± 53.5 (27.0-186.0 ml) for group B. Immediate post-HIFU 
NPV ratio of adenomyosis was 84.5± 6.9 (80-100%) for group A and 42.7% ± 
17.2 (11.3-59.6%) for group B (p<0.001). Adenomyosis volume reduction ratio 
at 6-month follow-up was 26.8% ± 15.2 (21.2-42.6%) for group A and 7.5% ± 
8.2 (-8.9-21.6%) for group B (p<0.001). 
Conclusion: Our findings suggest that T1 perfusion-based classification could 
be served as the MRI classification parameter before MR-guided HIFU ablation 
for predicting the treatment outcome of HIFU ablation.  
B-0450 11:18  
Transjugularrenal biopsy in patients with impaired coagulation status  
P. Heil, B. Tyczynski, M. Reinboldt, Y. Li, J. Theysohn, S. Suntharalingam, 
J. Grüneisen, A. Kribben, A. Wetter; Essen/DE (axel.wetter@uk-essen.de)  
Purpose: To evaluate transjugular renal biopsy (TJRB) in patients with acute 
nephritic or nephrotic syndrome and impaired coagulation status. 
Methods and Materials: 99 TJRB were performed in 42 patients (median age 
58y, range 18-83y; 31 male/11 female) from August 2008 to September 2017. 
After ultrasound-guided puncture of the right jugular vein, a 9F-sheath was 
inserted in Seldinger technique and the lower branch of the right kidney vein 
was probed with a 5f multipurpose-catheter. Biopsies were performed under 
fluoroscopic control with a curved 9F-renal biopsy set and a 19G-Tru-Cut 
needle. The obtained samples were visually checked by an experienced 
nephrologist. 
Results: Tissue of the renal cortex was extracted in 97 of 99 biopsies. The 
mean number of glomeruli obtained was eight per procedure. Two specimens 
contained renal medulla without glomeruli, however, one of those specimens 
was sufficient for histopathological diagnosis. Main diagnoses were IgA 
nephritis and glomerulosclerosis. We observed two complications: One patient 
developed haematuria and urinary bladder tamponade. Another patient 
suffered from a retroperitoneal haematoma. 
Conclusion: In our large unicenter experience, TJRB enabled 
histopathological diagnosis in 41 of 42 Patients (98%). TJRB proofs to be an 
effective procedure in patients at risk for bleeding complications.  
B-0451 11:26  
Development of a new image display system for angiography based on 
detection of electroencephalogram signals from operator’s brain  
M. Sato1, T. OGURA1, S. Yamanouchi1, N. Hayashi1, H. Watanabe1, K. Doi2; 
1
Maebashi/JP, 2Willowbrook, IL/US (mitubati.mitu.mitu@gmail.com)  
Purpose: Various radiographic images obtained during interventional radiology 
are commonly used. Although radiographic images may be displayed by 
physicians, they could not use the console of the image display system to 
  






avoid their unsanitary hands. Therefore, we developed an image display 
system with use of an electroencephalogram (EEG) without use of hands. 
Methods and Materials: We used Mindwave MOBILE (Neurosky Ltd., CA, 
US) as an EEG sensor. We programmed proper algorithms to provide suitable 
commands such as paging and zooming by use of EEG signal obtained. For 
observer study, we investigated the average response time required for paging 
due to observer’ s eye blink and the correct detection rate. We also 
investigated the average response time required for zooming due to the 
observer’s concentration and the correct detection rate. 
Results: The average response time required for paging which can be 
controlled by operator’s eye blink was 0.43±0.02 s. The correct detection rate 
of 100% was achieved by 28 observers, whereas three observers provided 
80%. The average response time required for zooming which can be controlled 
by operator’s concentration on his/her mind was 5.85±0.56 s. The correct 
zooming rate of 100% was achieved by 27 observers, whereas three observers 
provided 90%, and one observer provided 80%. The correct detection rate of 
100% was achieved by approximately 90% observers. The results seem to 
indicate that the image display system could be utilized for physicians properly. 
Conclusion: Radiographic images can be displayed by use of EEG signals 
without use of physician’s hands for angiography.  
B-0452 11:34  
Contrast enhancement improves PET-US fusion navigation for tumour 
ablation targeting  
N. Gennaro1, G. Mauri1, S. de Beni2, T. Ierace1, D. Poretti1, V. Pedicini1, 
A. Chiti1, L. Solbiati1; 1Milan/IT, 2Genoa/IT (nicolo.gennaro@humanitas.it)  
Purpose: To assess if tumour targeting improves when US/18FDG-PET/CT 
image fusion-guided percutaneous ablations of liver metastases 
inconspicuously seen or undetectable with US are performed using contrast 
enhanced PET-CT (PET-CECT) vs conventional unenhanced PET-CT. 
Methods and Materials: Fifty-eight metastases mostly from colorectal cancer 
(38/58, 65.5%) in 23 patients (13 males/10 females, mean age 62.8±9 years) 
underwent percutaneous microwave ablation (MWA) guided by US/18FDG-
PET/CT image fusion, either with PET-CECT (28/58, 48.3%) (group 1) or with 
unenhanced PET-CT (30/58, 51.7%) (group 2). Lesion size (1.0-4.0 cm, mean 
2.0 in group 1 and 0.6-4.5 cm, mean 1.9 in group 2) was comparable in the two 
groups. Time needed for co-registration and rates of technical success and 
complete ablation were evaluated in both groups. 
Results: Time needed for co-registration was significantly shorter in group 1 
(mean 4.5 vs 6.0-14.0 min, mean 10.9 in group 2). All lesions were targeted in 
group 1, while 5/30 were missed in group 2 (technical success 100% vs 
83.3%)(p= 0.0237). Complete ablation was achieved in one session for 23/28 
(82.1%) metastases of group 1 and for 17/30 (56.7%) of group 2 (p=0.03). 
Conclusion: Percutaneous ablation of liver metastases inconspicuously visible 
of totally undetectable with US, guided by US/18FDG-PET/CT image fusion is 
feasible and effective. If PET-CECT is performed and used for co-registration 
with US, time needed for co-registration, technical success and completeness 
of ablation are significantly improved, since the visualisation of hepatic 
vascularity on CECT allows to achieve more accurate spatial registration and 
therefore more precise lesion targeting.  
B-0453 11:42  
Prospective comparison US vs. CEUS guided percutaneousbiopsy in the 
diagnosis of large intra-and retroperitoneal tumors  
Z. Spirchez, P. Radu, N. Al Hajjar, G. Kacso, T. Mocan; Cluj-Napoca/RO 
(zsparchez@yahoo.co.uk)  
Purpose: Due to the presence of necrosis the accuracy of echoguided 
percutaneous biopsy (US-PB) in the diagnosis of large retro (RPT) and intra 
peritoneal tumors (IPT) is around 70-80%. CEUS is able to deliniate necrotic 
from well perfused areas inside the tumors. The aim of this prospective study is 
to compare the sensitivity of US and CEUS guided PB in the diagnosis of these 
tumors. 
Methods and Materials: 60 patients with 24 IPT and 36 RPT (mean diameter 
7.5 cm, range 4-22 cm) were referred for PB. In 32 patients (11 IPT, 21 RPT) 
PB was performed using US guidance. 28 patients ( 13 IPT, RPT) were 
biopsied using real time CEUS guidance The lesions in the CEUS -PB group 
were larger than those in US-PB group (mean diameter 8.1 cm vs. 6.8 cm) 
(P>0.05). PB was performed with an 18G Bard needle coupled on Biopty Gun. 
Results: Real time CEUS-PB was technically successful in all procedures 
(100% technical success rate). The sensitivity of PB was significantly higher in 
CEUS -PB group than in conventional US -PB group for all lesions (96.4% vs. 
78.1%, p< 0.05) and RPT (100% vs. 78.9%, p<0.05). For IPT the sensitivity 
was also higher for CEUS-PB ( 90.9% vs. 76.9%) but without statistical 
significance (p=0.36). No major complication occurred in both groups. 
Conclusion: Percutaneous CEUS guided PB in intra and retroperitoneal 
tumors is a feasible and safe technique. It significantly improves the overall 
sensitivity of the procedure in patients with large lesions.  
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B-0454 10:30  
Oligaemia of tumour-involved lung displayed by Z-effect of dual-detector 
spectral CT  
Y. Yue, X. Lu, Q. Guo; Shenyang/CN (ghostaa2000@aliyun.com)  
Purpose: Tumour destruction of pulmonary vessels may result in reduced 
blood flow of distal or proximal lung tissue. Our purpose is to display blood flow 
change by Z-effect of dual-layer detector CT. Z-effect is an image in which the 
pixel values represent the effective atomic number of the displayed tissue. 
Methods and Materials: We reviewed 29 cases with enhanced dual-detector 
spectral CT scan. In them, 23 were proved to have malignancy, with 5 cases of 
squamous cell carcinoma, 16 cases of adenocarcinoma and 2 cases of small 
cell carcinoma. Ten of these cases are central type tumour while other 19 
cases are solid solitary nodules (SPN) or mass, including all 6 inflammatory 
cases. Conventional unenhanced lung window, virtual monoenergetic at 70keV 
and 40keV, Z-effect slices were saved for evaluation. Abnormal attenuation at 
distal or proximal part of the tumour in artery or delay phase were identified as 
positive for oligaemia. 
Results: According to morphological type, all ten central type cases are 
positive for oligaemia in Z-effect images in both artery and delay phase. While 
4 positive in monoenergetic slice. In the 13 malignant SPN or mass cases, 8 
(72.7%) show oligaemia in artery phase and 4 in delay phase in Z-effect 
images. Two (33.3%) in the 6 inflammatory cases show oligaemia in Z-effect 
images in artery and delay phase. 
Conclusion: Z-effect image is sensitive in detecting blood flow changes of 
lung caused by tumour invasion. These changes take places in most central 
type and peripheral type carcinomas but less likely to appear in inflammatory 
cases.  
B-0455 10:38  
Application value of dual-detector spectral CT in evaluation of metastatic 
lymph nodes in lung cancer  
L. Gao, Y. Hou, Y. Ma, X. Lu, Z. Jia; Shenyang/CN  
Purpose: To investigate the application value of dual-detector spectral CT in 
the evaluation of metastatic lymph nodes in lung cancer. 
Methods and Materials: 24 patients with lung cancer undergoing dual-phase 
enhanced scan with dual-detector spectral CT were selected. Short diameter of 
lymph nodes, spectral curve, and iodine uptake were measured. According to 
pathological findings, lymph nodes were divided into metastatic group and non-
metastatic group. The slope of the spectral Hounsfield unit curve (Hu), arterial 
enhancement fraction (AEF) and short diameter were calculated (AEF = iodine 
uptake in arterial phase/iodine uptake in venous phase × 100%) and 
compared. Additionally, receiver operating characteristic (ROC) curves were 
drawn to confirm the optimum threshold and diagnostic efficiency. 
Results: A total of 50 lymph nodes were included, with 24 metastatic lymph 
nodes and 26 non-metastatic lymph nodes. Short diameter of lymph nodes, 
Hu and AEF in the 2 groups all showed significant differences (1.49 ± 0.69 vs 
0.87 ± 0.22, 2.77 ± 0.24 vs 2.40 ± 0.17, 98.54 ± 15.83 vs 70.14 ± 16.38, 
respectively; P < 0.05). The optimum diagnostic efficiency of AEF was the 
largest (AUCAEF = 0.928, AUC short diameter = 0.809 and AUCHu = 0.889), and its 
threshold was 76.84%. The sensitivity, specificity, negative predictive value 
and positive predictive value were 88.00%, 76.00%, 90.48% and 75.00%, 
respectively. 
Conclusion: Multiple quantitative parameters of dual-detector spectral CT 
provide an effective noninvasive method for accurate evaluation of metastatic 
lymph nodes in lung cancer, especially, AEF has the higher diagnostic efficacy 
in differentiating metastatic and non-metastatic lymph nodes.  
B-0456 10:46  
Evaluation of diagnostic value of iodine base material of dual-detector 
spectral CT for pulmonary aspergillosis invasion by ROC  
B. Yuan, W. Zhang, X. Lu, Z. Jia; Shenyang/CN (zhw65321@sina.com)  
Purpose: To explore the diagnostic value of iodine base material of dual-
detector spectral CT for pulmonary aspergillosis invasion by receiver operating 
characteristic curve (ROC curve). 
  






Methods and Materials: The patients who underwent chest contrast-
enhanced scanning by dual-detector CT and confirmed with pathology results 
were enrolled (20 cases with pulmonary aspergillosis invasion and 30 cases 
with lung neoplasm). The normalised iodine concentrations (NIC-ROI iodine 
concentration/thoracic aorta iodine concentration) of all lesions on both arterial 
and venous phases were measured and calculated and the results were 
compared between the two groups. ROC curve was used to determine the best 
cut- off points of NIC on arterial and venous phases for pulmonary aspergillosis 
invasion group. Pathological diagnosis as gold standard, the diagnostic values 
of NIC on arterial and venous phases for pulmonary aspergillosis invasion 
were analysed. 
Results: The differences of NICs on arterial and venous phases between the 
two groups were statistically significant (both P <0.01). The areas under ROC 
of NICs on arterial and venous phases were 0.901 and 0.900, respectively, and 
the best cut-off points of NIC on arterial and venous phases obtained via 
analysis of the ROC were 0.90 and 0.85, respectively. Their sensitivities for the 
diagnosis of NPC were 88% and 86%, while the specificities were 85% and 
83%, respectively. 
Conclusion: With high values in the diagnosis of pulmonary aspergillosis 
invasion, the NICs on arterial and venous phases can be used as effective 
indicators for diagnosis of pulmonary aspergillosis invasion by dual-detector 
spectral CT.  
B-0457 10:54  
Are there suboptimal CTPE studies in the DECT era: low mono-energetic 
images for pulmonary artery assessment  
N. Lev Cohain, I. Leichter, J. Sosna; Jerusalem/IL 
(NAAMAL@HADASSAH.ORG.IL)  
Purpose: Low mono-energetic images (MEI) of dual-energy CT (DECT) 
enable greater contrast density. We hypothesized that low-energy MEI could 
salvage suboptimal pulmonary emboli CT (CTPE) studies. Hence, the contrast 
enhancement of the pulmonary arteries (PA) on conventional CTPE and low 
MEI was compared. 
Methods and Materials: 49 patients who underwent CTPE using DECT at 
120kV and 90mAS (IQon, Philips Healthcare, Eindhoven, Netherlands) 
between 1 and 4/2017 were retrospectively reviewed. Early arterial enhanced 
series were evaluated using conventional images and MEI at 50-keV. Regions 
of interest (ROI) were marked in four locations: the main, left, right and right 
lower lobe PA. Any HU value below 220 was considered suboptimal. Paired t 
test determined the significance of difference in contrast density. 
Results: Of the conventional images, 32.1% (63/196 ROIs) had HU values 
lower than 220, and considered limited for the evaluation of an emboli. 24.5% 
(12/49) were suboptimal in the main PA, 34.7% (17/49) in the left PA, 32.7% 
(16/49) in the right PA and 36.7% (18/49) in the right lower lobe PA. No low HU 
values were found on the MEI at 50-keV. The mean HU value on the 50-keV 
images was significantly higher (p<0.001) compared to the conventional image 
(536.4 HU vs 257.5HU, respectively). The mean enhancement factor of the 
contrast density on the 50-keV images was 2.08. 
Conclusion: Low mono-energetic DECT images significantly enhance the 
contrast density in the pulmonary vessels. The diagnostic yield of CTPE 
studies can be increased, by salvaging suboptimal studies and turning them 
into diagnostic studies.  
B-0458 11:02  
Transient interruption of contrast (TIC) in CT pulmonary angiography: 
frequency and impact on the diagnostic value of CT examinations using a 
dual-source CT system  
J. Hennicaux, A. Hutt, M. Kyheng, J.-B. Faivre, J. Remy, M. Rémy-Jardin; 
Lille/FR (martine.remy@chru-lille.fr)  
Purpose: To evaluate the incidence of transient interruption of contrast (TIC) 
during dual-source chest CT angiographic (CTA) examinations and its impact 
on the diagnostic value of examinations. 
Methods and Materials: Retrospective review of 449 consecutive chest CTA 
examinations obtained on a 3rd generation DSCT system was undertaken to 
search for TIC on single- (SE) (n=276; 61.5%) and dual-energy (DE) (n=173; 
38.5%) CT examinations. This physiological artifact was recognized on the 
basis of (a) decrease in opacification within pulmonary arteries (PAs); (b) 
concurrent depiction of unopacified blood from the inferior vena cava entering 
the right heart; and (c) adequate opacification of pulmonary veins and left 
cardiac cavities. 
Results: TIC was identified on 19 examinations (19/449; 4%), more frequently 
seen on DE (14/19; 74%) than SE (5/19; 26%) examinations. Four types of TIC 
were depicted: (1) decreased opacification only within central PAs, observed in 
4 patients (Group 1; 4/19; 21%); (2) decreased opacification within central and 




depicted in the middle third of the chest (12/15), the initial (1/15) or late (1/15) 
part of the acquisition, or over the entire thorax (1/15). In both groups, the 
mean level of attenuation within PAs of the TIC zone was 228.7± 69.1 HU in 
central and 223.9 ± 54.8 HU in peripheral PAs, enabling confident analysis of 
PAs down to the segmental (2/19) or subsegmental (15/19) level. 
Conclusion: TIC was identified in 4% of the study population, never 
responsible for indeterminate CTA examinations.  
Author Disclosures: 
 J. Remy: Consultant; Research Consultant, Siemens Healthcare. 
M. Rémy-Jardin: Research/Grant Support; Siemens Healthcare. 
B-0459 11:10  
Incidence of transient interruption of contrast (TIC): a retrospective 
single-centre analysis in 225 consecutive CT pulmonary angiography 
studies  
S. Sudarski1, T. Henzler1, H. Haubenreisser1, S.O. Schönberg1, A. Gutzeit2; 
1
Mannheim/DE, 2Zurich/CH (sonja.sudarski@medma.uni-heidelberg.de)  
Purpose: To assess occurrence of transient interruption of contrast (TIC) 
phenomenon in pulmonary CT angiography (CTPA) studies performed to rule 
out pulmonary embolism. 
Methods and Materials: In this retrospectively designed single-centre study, 
CTPA exams of 225 consecutive patients scanned between 9/1/2016 and 
12/31/2016 on a 16-slice single-source CT scanner system were analysed. 
Exams were screened a priori to measurements and exams with non-adequate 
pulmonary artery contrast due to incorrect bolus tracking or failure of i.v. 
contrast administration were excluded from the analysis. HU values in the 
thoracic aorta and in the pulmonary trunk were assessed in duplicate 
measurements and the aorto-pulmonary ratio was calculated. An aorto-
pulmonary ratio > 1 was defined as presence of TIC. 
Results: 3 patients had to be excluded due to incorrect bolus tracking. Final 
analysis in 222 patients (mean age 65 ± 19 years, range 18 to 99 years) were 
analysed. Mean density in the pulmonary trunk was 275 ± 17 HU, in the aorta 
208 ± 15 HU. Mean aorto-pulmonary ratio was 0.81± 0.29. 48 patients (21.6%) 
had an aorto-pulmonary ratio >1. 
Conclusion: TIC is a common phenomenon in CTPA studies with an 
incidence of 22% in our retrospective cohort.  
B-0460 11:18  
Assessment of optimal window settings for display of traditional and 
noise-optimised virtual monoenergetic imaging in dual-energy CTPA  
J.L. Wichmann1, A.M. Bucher1, L. Lenga1, C. Arendt1, D. Caruso2, 
T. D'Angelo3, A. Blandino3, G. Ascenti3, T.J. Vogl1; 1Frankfurt a. Main/DE, 
2
Rome/IT, 3Messina/IT (docwichmann@gmail.com)  
Purpose: To define optimal window settings for display of virtual 
monoenergetic images (VMI) of dual-energy CT pulmonary angiography (DE-
CTPA) and assess impact on image quality in comparison to standard 
reconstruction and settings. 
Methods and Materials: Data from 45 patients who underwent DE-CTPA 
were retrospectively evaluated. Three image dataset were assessed: standard 
linearly-blended (M_0.6), 70-keV traditional VMI (M70), and 40-keV noise-
optimised VMI (M40+) reconstructions. For M70 and M40+, the subjectively 
best window setting (width and level, B-W/L) was initially assessed 
independently by two blinded observers and subsequently related with 
pulmonary artery attenuation to obtain calculated optimised values (O-W/L) 
using linear regression. Subjective evaluation of image quality between 
different W/L settings were assessed by two additional blinded readers. 
Results: Best (B-W/L) settings for M70 and M40+ were 880/280HU and 
1410/450HU, respectively. Regression analysis resulted in an O-W/L of 
850/270HU for M70 and 1350/430HU for M40+. Significant differences for W/L 
were found between B-W/L and O-W/L for M40+, and between M70 and M40+ 
for both B-W/L and O-W/L (all p<0.001). Subjective image quality was 
significantly increased for M70 and M40+ after application of O-W/L (all 
p<0.001). Highest subjective scores were observed for M40+ regarding 
vascular contrast, embolism demarcation, and overall image quality (all 
p<0.001). 
Conclusion: Application of O-W/L settings is mandatory to optimise subjective 
image quality of VMI reconstructions of DE-CTPA. M40+ showed better 
subjective image quality than M70. A width slightly less than two times the 
pulmonary trunk attenuation and a level approximately of overall pulmonary 
vessel attenuation are recommended.  
Author Disclosures: 















B-0461 11:26  
Optimalmonochromatic energy levels in spectral CT pulmonary 
angiogram for thedetection of pulmonary thromboembolism: using 
detector-based spectral CT  
M. Ha, K.Y. Lee, C. Kim, S.-K. Kim, S.-J. Park, B.-K. Je, S.H. Lee, Y. Lee, 
J. Cha, A. Jeong-Cheon; Ansan/KR (bearksk@gmail.com)  
Purpose: The aim of this study was to investigate the optimal monochromatic 
level, in spectral CT pulmonary angiography, for the detection of pulmonary 
thromboembolism, using detector-based spectral CT. 
Methods and Materials: 103 patients were referred to undergo pulmonary 
CTPA with spectral CT mode in the arterial phase. Images of both conventional 
(120 kVp) and multiple monochromatic energy level (VME) images from 40 keV 
to 100 keV at intervals of 10 keV were generated using Spectral CT viewer. 
Image noise, clot diameter and clot to artery contrast-to noise ratio (CNR), 
signal-to-noise ratio (SNR) at selected monochromatic levels were measured 
and compared. Subjective image quality was also assessed by two radiologists 
and compared. We analyzed data using Kruskal-Wallis test and correlation 
analyses. 
Results: The lowest noise was obtained at VME level of 100 keV. There was 
no difference in the mean noise between the VME images of 50, 60, 70, 80, 90 
and 100 keV. The CNR and SNR values were achieved at the 40 keV level and 
increased as energy decreased. The highest diagnostic confidence for the 
detection of pulmonary thromboembolism was at VME level of 70 keV, 
because two reader's agreement at this level had the highest kappa coefficient 
(k=0.68). The clot diameter decreased with decreasing energy level. 
Conclusion: Virtual monochromatic images at 100 keV yielded the lowest 
image noise. The highest CNR and SNR were obtained at 40 keV VME image. 
An optimal analysis of pulmonary thromboembolism can be achieved on virtual 
monochromatic spectral images at 70 keV.  
B-0462 11:34  
Right heart thrombi and acute pulmonary embolism: analysability of right 
cardiac cavities in the conditions of routine dual-source chest CT 
angiographic examinations  
C. Fantini, J. Hennicaux, J.-B. Faivre, P. Felloni, J. Remy, M. Remy-Jardin; 
Lille/FR (martine.remy@chru-lille.fr)  
Purpose: To evaluate the analysability of right cardiac cavities on dual-source 
chest CT angiographic (CTA) examinations positive for acute pulmonary 
embolism (PE) in the conditions of routine clinical practice. 
Methods and Materials: Among 449 patients referred for suspicion of acute 
PE, chest CTA was found positive in 59 patients (13%). The analysability of the 
right atrium (RA) and right ventricle (RV) was based on the evaluation of (a) 
the homogeneity of contrast attenuation; (b) the presence & severity of beam-
hardening artifacts. A second acquisition during the CT session was at the 
radiologist’s discretion. 
Results: The RA was deemed interpretable in 44 patients (44/59; 74.6%) 
(Group 1a: 31/39; 79%) (Group 2a: 13/20; 65%) with homogeneous or slightly 
heterogeneous opacification and no beam-hardening artifacts (mean 
attenuation: 340.5 ±140.6 HU) while it was rated as not confidently 
interpretable in 15 patients (15/59; 25.4%) (Group 1b: 8/15; Group 2b: 7/15). 
The RV was always interpretable. In Group 1b, the RA became analysable on 
the delayed acquisition, obtained in all but one patient. In group 2b, the use of 
monochromatic images at 90 and 100 keV provided interpretable images 
(absence of beam-hardening artifacts; sufficient level of attenuation to depict 
intracardiac thrombi) in all but 2 patients, leading to a total of analysable 
cavities in 90% of Group 2 patients (18/20). Right intracardiac thrombi were 
depicted in two patients (2/59; 3%). 
Conclusion: Right cardiac cavities were interpretable on a single acquisition in 
79% and 90% of patients scanned with SE and DE, respectively.  
Author Disclosures: 
 J. Remy: Consultant; Research Consultant, Siemens Healthcare. 
M. Remy-Jardin: Research/Grant Support; Siemens Healthcare. 
B-0463 11:42  
Automatic spectral chest CT assist protocol: can the improvement of the 
noise index setting further decrease the radiation dose and optimise the 
image quality?  
R. Wang, J. Gao, Y. Zhou; Zhengzhou/CN (wr807115125@163.com)  
Purpose: To investigate the effect of automatic spectral imaging assist (ASIA) 
on radiation dose and image quality of enhanced chest CT examinations with 
low-dose contrast agent for patients with different body mass index (BMI). 
Methods and Materials: 120 patients with dual-phase enhanced chest CT 
were randomly divided into experimental group (A) and control group (B). In 
each group, patients in three different BMI intervals were scanned at the noise 
index of 13, 18 and 22 respectively. By using 300 mgI/kg contrast agent ,the 
group A used the ASIA combined with 50% adaptive statistical iterative 
reconstruction (ASIR) technique to obtain the spectral monochromatic images 
(40~70 keV). The conventional 120 kVp CT with 450 mgI/kg contrast agent 
was adopt in the group B, and the filtered back-projection (FBP) algorithm was 
used to reconstruct images. Then, the index of radiation dose and image 
quality were calculated and evaluated. 
Results: The images of the group A show better performance in reducing and 
maintaining image noise than that of group B (p < 0.05), especially for patients 
with BMI < 18.5kg/m2 and BMI > 24.9 kg/m2. There are no statistical 
differences of CTDIvol, DLP and ED between two groups at all BMI levels with 
noise index of 13(p>0.05). However, the NI of 18 and 22 in group A were 
higher than that of group B. 
Conclusion: The quality of images obtained by using ASIA combined with 
ASIR technique can meet the requirements of clinical diagnosis. However, its 
ability to reduce radiation doses is not satisfactory.  
B-0464 11:50  
Segmental and sub-segmental pulmonary embolism displayed by dual-
detector spectral CT  
Y. Yue, X. Lu, W. Zhang, Q. Guo; Shenyang/CN (ghostaa2000@aliyun.com)  
Purpose: Pulmonary embolism involving segmental or sub-segmental artery is 
difficult to diagnosis in enhanced CT. Dual-detector spectral CT can promote 
detecting ability by display low perfusion area and small thrombi. We reviewed 
cases of segmental or sub-segmental embolism and correlate with there 
clinical background. 
Methods and Materials: Enhanced dual-detector CT scans of lung were 
performed in 1200 cases. Lung and mediastinum slices along with iodine 
density and Z-effect map were reviewed (Z-effect is an image in which the pixel 
values represent the effective atomic number of the displayed tissue). 
Pulmonary embolism was described as artery thrombi with or without low 
perfusion in corresponding area in iodine density or Z-effect maps. Embolism 
involving pulmonary artery trunk or lobar branches is not included in this study. 
Clinical information including patient history, serum D-dimer level and revised 
Geneva score was recorded for analysis. 
Results: Twenty-three cases were confirmed to have single or multiple 
segmental or sub-segmental embolisms. In them, 16 cases have a history of 
malignancy, including 5 cases of cervical cancer, 4 cases of esophageal 
cancer, 3 cases of lung cancer, 2 cases of liver cancer, 1case of lymphoma 
and 1case of pancreas cancer. In benign cases, 3 patients have brain stroke 
and 4 patients have no special history. Serum D-dimer level varied from 674 to 
5440 (1520±1313) mmol/l and revised Geneva score varied from 4-7 
(5.28±0.83). 
Conclusion: Segmental or sub-segmental embolism is more likely to involve 
patients with malignancy and with mild symptoms or D-dimer levels.  
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B-0465 10:30  
Myometrial infiltration by deep pelvic endometriosis: MRI assessment  
M. Francavilla1, D. Resta1, F. Lorusso2, G. Angelelli1, C. Tartaglia1, 
P. Pignataro1, M. Scioscia3, A.A. Stabile Ianora1, A. Scardapane1; 1Bari/IT, 
2
Castellana Grotte/IT, 3Negrar, Verona/IT (marianto_fra@hotmail.it)  
Purpose: Myometrial infiltration from peritoneal implants is often associated 
with endometriotic lesions in bowel, bladder, and with adenomyosis. Evaluation 
of the correlation between myometrial invasion and severity of deep pelvic 
endometriosis was made. 
Methods and Materials: A retrospective survey of 198 women with previous 
laparoscopic surgery for pelvic endometriosis was carried out. A pelvic MRI 
was performed in all patients: it consisted in T2w-TSE sequences in axial, 
sagittal, and coronal planes and T1w and THRIVE sequences in the axial 
plane.The presence of endometriomas and endometriotic nodules in Douglas 
pouch, rectovaginal septum, torus uterinus and uterosacral ligaments was 
reported. Similarly, intestinal infiltrative nodules, vesical and ureteral implants 
and pelvic adherences were recorded. Results were analysed with 2 test. 
Results: Uterine infiltration was found in 26/198 (13%) patients, adenomyosis 
in 76/198 (38%) of cases, and their coexistence in 19/198 (9%) of women. 
Uterine invasion was detected in 19% of patients with Douglas pouch 
obliteration (vs 3% of women without Douglas involvement), in 24% of patients 
with rectovaginal septum lesions (vs 3% of women without RVS foci), in 28% 
and 38% of patients with bowel nodules and major intestinal resection 
  






respectively (vs 2,5% of women that did not show these two findings). All the 
results demonstrated to be statistically significant, with p<0.05. 
Conclusion: Myometrial infiltration is associated with severe features of deep 
pelvic endometriosis, in particular with colorectal involvement and consequent 
bowel resection.  
B-0466 10:38  
Diffusion tensor imaging (DTI) for evaluation of sacral plexus 
abnormalities in patients with pelvic deep infiltrating pelvic 
endometriosis with pelvic pain: a pilot study  
A.M. Kalovidouri, M.I. Vargas, B. Delattre, N. Pluchino, X. Montet, D. Botsikas; 
Geneva/CH (Anastasie-Marie.Kalovidouri@hcuge.ch)  
Purpose: To prospectively investigate if fractional anisotropy(FA) or apparent 
diffusion coefficient(ADC) of the lumbosacral plexus roots, correlate with 
intensity of pelvic pain in patients with pelvic deep infiltrating 
endometriosis(DIE). A secondary aim was to compare FA and ADC values in 
patients with DPE documented on MRI with those with negative morphologic 
MRI. 
Methods and Materials: A DTI sequence was performed in all patients(mean 
age 33.5±8.9y)referred for pelvic MRI with clinical suspicion or known DIE from 
June 2016 to July 2017.The patients filled in a questionnaire with self-
evaluation of pelvic pain in a scale from 0-10. A radiologist tracked all roots of 
lumbosacral plexus, from L5 to S3. Mean FA and ADC for all roots were 
calculated. Correlation coefficient r between pain scale and FA and ADC was 
calculated. FA and ADC values between patients with MRI documented DIE 
and those without DIE lesions on MRI were compared. 
Results: 149 patients(74 with endometriosis detected on MRI and 75 
without)were included in the study. There was a statistically significant negative 
correlation between overall pain and ADCmean(r=-0.1967, p=0.0181) and a 
weak positive correlation of FA mean and pain, with a statistical 
trend(p=0.0541). There was no statistically significant difference between ADC 
and FA values for patients with and without DPE detected on morphological 
MRI(p>0.05). 
Conclusion: This study showed a negative correlation between ADC and 
positive correlation between FA of the lumbosacral plexus and pain. This could 
be explained by a intramyelinic oedema or microarchitectural abnormalities of 
the neural roots providing innervation to DIE lesions.  
B-0467 10:46  
Ovaries in patients with Mayer-Rokitansky-Küster-Hauser syndrome vs 
normal females: a retrospective cohort study with magnetic resonance 
imaging  
Y. Wang, J. Lu, L. Zhu, R. Chen, B. Jiang, Z. Jin; Beijing/CN 
(wang_yue111@126.com)  
Purpose: To explore the MRI appearances of ovaries in patients with Mayer-
Rokitansky-Küster-Hauser (MRKH) syndrome as compared with a control 
group. 
Methods and Materials: Pelvic MRI of 83 MRKH patients and 60 age-
matched normal females were retrospectively reviewed by two experienced 
gynaecological radiologists in consensus. Characteristics including location of 
ovary, ovarian volume, and follicle counts were assessed. Ectopic ovary was 
established when it was located out of the pelvis, anterolaterally just behind the 
anterior pelvic wall, or far laterally in the paracolic gutter or near the lateral 
pelvic wall. Ovarian volume was calculated using the formula for the volume of 
an ellipsoid. Average numbers of follicle counts determined by two radiologists 
were recorded. The incidence of ectopic ovary was compared between MRKH 
patients and controls. The ovarian volume and follicle counts were compared 
among three groups: ectopic ovaries in MRKH patients, eutopic ovaries in 
MRKH patients, and normal controls. 
Results: In total, 166 ovaries in 83 MRKH patients and 120 ovaries in 60 
control females were evaluated. Thirty-seven ovaries in 23 MRKH patients 
(28%, 23/83) and 3 ovaries in three control females (5%, 3/60) were 
abnormally located (P<0.001). The mean volume was 9.2±6.3ml of the ectopic 
ovaries in MRKH patients, 7.8±4.0ml of the eutopic ovaries in MRKH patients, 
and 8.9±4.8ml in control females (P>0.05). No obvious difference was 
observed with regard to follicle counts. 
Conclusion: MRKH patients associated with increased incidence of ectopic 
ovaries. Ovarian volumes and follicle counts were not differed statistically 









B-0468 10:54  
Invasive placenta: MRI prognosticators for patients' clinical outcome  
C. Bourgioti, K. Zafeiropoulou, E. Panourgias, K. Chatoupis, A. Antoniou, 
M. Nikolaidou, L.A. Moulopoulos; Athens/GR (charisbourgioti@yahoo.com)  
Purpose: To investigate any possible association between MRI features and 
maternal peripartum outcome in patients with abnormal placentation. 
Methods and Materials: Between March 2016 and June 2017, 49 gravid 
patients (mean age: 35.7years, mean gestational age: 32.5weeks) with 
sonographically confirmed placenta previa were referred for dedicated prenatal 
MRI. All MRIs were reviewed prospectively by two radiologists experienced in 
genitourinary imaging. All patients underwent C-section within 6 weeks from 
MRI; perioperative or/and pathological findings were used as standard of 
reference. Logistic regression models were used to investigate which MRI 
features were predictive of adverse peripartum events including increased 
blood loss, prolonged duration of delivery or hysterectomy performance. 
Results: Thirty-eight (77.6%) patients had invasive placenta (percreta, n=26, 
accreta/increta, n=12) on surgery; 22/38 patients had bladder involvement, 
while 11/38 patients had parametrial invasion. Stepwise linear regression 
analysis showed that evidence of bladder invasion on MRI and T2 dark 
intraplacental bands were independently associated with prolonged duration of 
delivery (> 60 min). Additionally, bladder invasion on MRI, serosal 
hypervascularity and T2 dark bands were independently associated with 
massive blood transfusion (> 10 units packed red blood cells) during surgery. 
Serosal hypervascularity (OR=18.34, 95% CI: 1.53-219.0, p=0.021) and T2 
dark bands (OR=11.32, 95% CI: 2.09-61.38, p=0.005) were significantly 
associated with hysterectomy performance. 
Conclusion: MRI evidence of bladder invasion, serosal hypervascularity or T2 
dark intraplacental bands were independently associated with poor maternal 
outcome in patients with abnormal placentation.  
B-0469 11:02  
Colour Doppler unhappy surprise in transvaginal ultrasound evaluation 
of post-abortive vaginal bleeding: uterine arteriovenous malformations  
S.A.H. Hassanein; Shebin el-kom/EG (shaimaahamid@hotmail.com)  
Purpose: To assess the prevalence of uterine arteriovenous malformations 
and emphasize its presence as a cause of post-abortive bleeding. 
Methods and Materials: A retrospective study was conducted reviewing the 
data acquired from transvaginal ultrasound combined with Doppler 
examination to patients presented by post-abortive bleeding at our institute 
during the last two years. The studied group included 548 patients presented 
clinically by post-abortive bleeding. All of them were examined by transvaginal 
ultrasound. Both grey-scale and Doppler examination were conducted in all 
cases. 
Results: Reviewing the transvaginal ultrasound data revealed retained 
products of conception in 412 patients, normal scan in 118 patients and 18 
cases of suspected uterine arteriovenous malformations which constitute the 
study population. Reviewing the patients' clinical data revealed post-abortive 
bleeding with duration ranging from 3 days to 3 weeks post-abortion. The 
mean age was 28.7 years. History of previous curettage was present in 16 
cases. Doppler study showed the intense myometrial hypervascularisation with 
turbulent flow in 18/18 cases of AVM. The size of the intra-myometrial 
component exceeded 5 cm in 12/18 cases (66.7%). The largest vessel 
diameter ranged from 8 to 28 mm with a mean of 16.2 mm. The mean velocity 
detected was 22 cm/sec. 
Conclusion: Uterine arteriovenous malformations are a serious cause for 
post-abortive bleeding and although their incidence is rare, it is very important 
to be identified using transvaginal ultrasound whether grey-scale or Doppler to 
avoid serious life-threatening bleeding.  
B-0470 11:10  
Ovarian ischaemia vs haemorrhagic infarction: differentiation by MRI in 
cases of adnexal torsion  
Y. Ragab1, H. Kheir1, H. Hamza2, S. Maher1; 1Cairo/EG, 2London/UK 
(yragab61@hotmail.com)  
Purpose: To demonstrate the role of magnetic resonance (MR) imaging 
findings, in differentiating between ovarian infarction and ischaemia and 
consequently the rate of ovarian salvage in cases of adnexal torsion. 
Methods and Materials: 25 patients with surgically proven ovarian torsion 
were evaluated by two radiologists regarding the following MR findings: pelvic 
fluid collection, uterine deviation, ovarian enlargement, ovarian parenchymal 
hypointensity on T2-weighted images (WI), hyperintensity on T1 (WI) with fat 
saturation, recognition of twisted pedicle, diffusion restriction and ovarian 
parenchymal enhancement. These MR findings were statistically correlated 
with the operative findings and histopathological results (for cases of ovarian 
infarction). 
Results: Pathologically, ovarian haemorrhagic infarction was confirmed in 6 
out of 25 cases. Ovarian hyposignal on T2 WI was seen in all cases with 
  






infarction 6/6. Ovarian hyperintensity (compared to the contralateral sides) was 
observed in 4/6 and 5/6 cases with infarction on T1WI and DWI, respectively. 
Ovarian enlargement, fluid collections, uterine deviation and twisted pedicle 
were detected in most cases with or without haemorrhagic infarction. Poor 
parenchymal contrast enhancement was observed in all cases without or with 
necrosis. 
Conclusion: Detection of ovarian infarction is of prognostic importance in 
cases of torsion to assess salvageability, and thus may affect the surgical 
decision. Swollen hypointense ovarian parenchyma on T2 WI with lack of 
contrast uptake are the most reliable MRI signs, followed by hypersignal on T1 
WI fat sat and DWI.  
B-0471 11:18  
MRI predictive factors for vaginal stenosis in patients with cervical 
cancer after ChemoRadiation Therapy (CRT)  
M. Sbarra, M. Miccò, B. Gui, E. Rodolfino, A.L. Valentini, R. Manfredi; Rome/IT 
(sba.martina@gmail.com)  
Purpose: Vaginal Stenosis (VS) is a toxicity after radiotherapy. Our purpose 
was to describe radiotherapy induced changes in the vagina after CRT for 
cervical cancer and to find any Magnetic Resonance Imaging (MRI) predictive 
factors for the development of stenosis. 
Methods and Materials: This retrospective study included 43 patients (mean 
age 49,5 y) with FIGO IB2-IIIB cervical cancer treated with CRT administered 
with external beam radiation therapy. They underwent 1.5 T pelvic diffusion 
weighted DW-MRI before (baseline), at 2 weeks from the start (early) and at 
the end of the treatment (late). On all MRIs, tumor volume (TV), the lenght and 
the thickness of the vagina were measured. DWI were analysed qualitatively at 
each time point. VS was clinically graded at each follow-up using Common 
Terminology Criteria for Adverse Effect v.4.03. The statistical analysis were 
made with Mann-Whitney test. ROC curves were generated for statistically 
significant DW-MRI parameters. 
Results: According to CTCAE: Grade1 had 15 pts and Grade2 had 28 pts. 
TV was higher in Grade1 (p= 0,013). The mean vaginal length and thickness 
decreased between baseline and final MRI from 82,0 to 71,6 mm and from 3,3 
to 2,6 mm respectively. DWI had a lower signal intensity at the final MRI in 
Grade2 (p<0,0001). According to ROC analyses the AUC was 0,917 (p< 
0,0001) for DWI and 0,731 (p= 0,013) for TV. 
Conclusion: This is the first study that demonstrates the utility of DW-MRI to 
find predictive factors for VS in cervical cancer after CRT.  
B-0472 11:26  
Female Skene's gland diseases: CT and MR imaging evaluation  
H. Wang, J. Guan, Y. Guo; Guangzhou/CN (usefulkey0077@hotmail.com)  
Purpose: To analyse the imaging characteristics of Skene's gland (periurethral 
gland) diseases on CT and MRI, further to improve the understanding and 
imaging diagnosis. 
Methods and Materials: 15 female cases with Skene's gland disease 
confirmed by pathology were retrospectively analysed. Imaging features of 
Skene's gland disease were summarized. 
Results: Skene's gland cysts (n=3) located in the distal and posterolateral 
urethra or close proximity to the urethra, presenting as cystic lesions with 
teardrop shape on sagittal images, appeared as hypo-attenuation on CT, and 
hypo-intensity on T1WI, hyper-intensity on T2WI, and without enhancement. 
One with infection presented as hyper-intensity on T1WI and gaseous intensity 
inside, and thickened cystic wall. Urethral diverticulums (n=10) located in the 
middle or distal and posterolateral urethra, and presented as a horseshoe-
shaped cystic lesion partially surrounding the urethral (n=3) or spoke wheel-like 
cystic lesion with multiple septum completely surrounding the urethra (n=7). 
They appeared as fluid attenuation/intensity on CT and MRI without 
enhancement. Heterogenous signal or attenuation and enhanced septum or 
cystic wall were found in 6 cases with infection. Malignant tumour of Skene's 
gland (n=2, adenocarcinoma and neuroendocrine carcinoma) presented as 
cystic-solid mass surrounding the urethral, showing heterogeneous low 
attenuation on CT and iso- to hyper-intensity on T2WI and hypo- to iso-
intensity on T1WI with enhancement. A “prostate” sign was specific for 
determining the lesion origin of the Skene's gland. 
Conclusion: According to the lesion location and imaging features, we can 
make an accurate diagnosis and distinguish different types of female Skene's 









B-0473 11:34  
Diagnostic value of MR perfusion in characterisation of complex adnexal 
masses  
H.A.S. Sabet, R.M. El Kady, N.N. Omar, A.M. Abbas; Assiut/EG 
(bobaez1989@gmail.com)  
Purpose: To assess the role of MR perfusion weighted imaging (MR PWI) in 
characterisation of complex adnexal masses. 
Methods and Materials: Twenty-seven patients underwent MR PWI using 
rapid dynamic contrast-enhanced T1-weighted gradient echo. Regions of 
interest (ROIs) were drawn in the solid part of the adnexal lesion and the outer 
myometrium. PWI was analysed using descriptive, time signal intensity curves 
and semiquantitative parameters (relative enhancement (RELENH), maximum 
enhancement (MAXENH), maximum relative enhancement (MAXRELENH), 
time to peak (TTP), and wash-in rate (WASHIN) and wash-out rate 
(WASHOUT). Time intensity curve and semiquantitative parameter results 
were correlated to the histopathological results. 
Results: Curve type 1 was found to be 100% specific for benign ovarian 
tumours (p=0.017). Type III curve showed (76%) sensitivity and (60%) 
specificity for malignant tumours. MAXENH showed accuracy of 73.2%, 
sensitivity of 76.5% and specificity of 70% for malignant tumours. WIR showed 
the highest sensitivity (88.2%) while WOR with a cut-off value of 6.03 showed 
the highest specificity (90%). 
Conclusion: PWI is useful in characterisation of adnexal masses. We can 
depend upon WIR in depicting malignant masses and applying the cut-off of 
WOR to exclude the false-positive cases and avoid radical surgery in 
unnecessary patients especially in women aiming at preserving fertility.  
B-0474 11:42  
MRI in endometriosis: a new platform  
W.R.A. Abdel Hamid; Cairo/EG (w.gforever@yahoo.com)  
Purpose: The aim of this study is to validate the ability of MRI as an accurate 
tool in verifying the endometriotic load in patients with clinically suspected 
endometriosis. Our aim was also to verify the results of non-contrast MRI 
compared to contrast enhanced MRI through laparoscopic correlation. 
Methods and Materials: 60 female patients within an age range of 27 and 44 
years were included in the study. A thin slice high resolution MR study was 
performed for all patients with a protocol including Axial & sagittal T2W, T1W 
(with and without fat suppression), DWI images together with delayed post 
contrast T1W fat suppressed images in the three orthogonal planes. Findings 
were compared to results of laparoscopy. 
Results: Based on our results, IV contrast didn’t add much. The data acquired 
from T1W images with fat suppression and DWI's were sufficient and showed 
high sensitivity and specificity values when compared to laparoscopic findings. 
Each key finding was validated separately including endometriomas, 
adenomyosis, solid endometriotic implants, giving high sensitivity (94.59%, 
100% & 95.35%), specificity (96.15%, 95.65% & 100%), PPV (97.22%, 88.89% 
& 100%) and NPV (92.59%, 100% & 90.48%) respectively. 
Conclusion: Non- contrast MRI can be considered a highly accurate tool in 
screening for endometriotic load. It can be used as a roadmap prior to 
laparoscopic intervention to help guide gynecologists so as not to miss lesions.  
B-0475 11:50  
Utility of histogram analysis of apparent diffusion coefficient maps 
obtained using 3.0T MRI for distinguishing uterine endometrial carcinoma 
from endometrial polyps  
W. Wang, J. Cheng, Y. Zhang; Zhengzhou/CN (weijianwang520@163.com)  
Purpose: We explored the role of histogram analysis of apparent diffusion 
coefficient (ADC) maps for discriminating uterine endometrial carcinoma and 
endometrial polyps. 
Methods and Materials: We retrospectively evaluated findings in 40 patients 
with uterine endometrial polyps and 50 patients with endometrial carcinoma 
who underwent diffusion-weighted imaging (b = 0,800 s/mm(2) ) at 3T with 
acquisition of corresponding ADC maps. We derived histogram data from 
regions of interest drawn on all slices of the ADC maps in which tumour was 
visualised, including areas of necrosis and haemorrhage in the tumour. We 
used the Mann-Whitney test to evaluate the capacity of histogram parameters 
(mean, skewness, kurtosis,50th,90th percentiles) to discriminate uterine 
endometrial carcinoma from endometrial polyps and analysed the receiver 
operating characteristic (ROC) curve to determine the optimum threshold value 
for each parameter and its corresponding sensitivity and specificity. 
Results: Uterine endometrial carcinoma demonstrated significantly higher 
mean vales of ADC, skewness, kurtosis, 50th, 90th percentiles than 
endometrial polyps (P < 0.05). ROC curve analysis of the 90th percentile 
yielded the best area under the ROC curve (AUC; 0.92), sensitivity of 90%, 
and specificity of 95%, with a cutoff value of 198. 
Conclusion: Histogram analysis of ADC maps might be helpful for 
discriminating uterine endometrial carcinoma from endometrial polyps  
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B-0476 10:30  
Radiomics of metastatic clear-cell renal carcinoma: reproducibility and 
correlation for feature reduction  
A. Bouchouicha, J. Deidier, K. Benac, D. Balvay, S. Oudard, R. Pirracchio, 
L.S. Fournier, B. Rance; Paris/FR (afef.bouchouicha@aphp.fr)  
Purpose: To evaluate the robustness and redundancy of radiomics features 
extracted from CT images. 
Methods and Materials: 28 metastatic clear-cell renal carcinoma patients 
were enrolled, before therapy initiation. Tumour was manually delineated by 
three expert physicians. Three categories of features were extracted: shape 
descriptors, intensity histogram statistics and textural features. Impact of filters 
and grey-level scales on features was studied. Concordance correlation 
coefficients (CCC) and inter-class correlation coefficients (ICC) were calculated 
to assess the reproducibility. Spearman correlations were performed to assess 
feature redundancy. 
Results: 1564 radiomics features were extracted from each image. Different 
filters had little effect and grey levels no significant effect on extracted 
radiomics feature values. 231/1564 features showed high reproducibility for 
ICC (ICC0.8), and 198/1564 for CCC (CCC0.9). Features with an ICC0.8 
and CCC0.9 were considered the most robust. This step reduced the number 
of relevant features to 158. Among these, highly correlated features with 
correlation  0.9 were removed. This procedure yielded 23 features both robust 
and independent. 
Conclusion: This study allows understanding feature stability and redundancy, 
and impact of pre-processing filters and grey-scales levels. These steps are 
mandatory to subsequently use radiomics features for prediction of therapy 
response and outcome in oncology.  
B-0477 10:38  
Application of radiomics and artificial intelligence in survival prediction 
of lung cancer patients  
I. Shiri, P. Geramifar, H. Abdollahi, S. Shayesteh, G. Hajianfar, 
H. Pouraliakbar, A. Mohammadzadeh, A. Bitarafan-Rajabi; Tehran/IR 
(Isaac.sh92@gmail.com)  
Purpose: Before initiation of therapy, accurate prediction of tumor’s response 
to treatment enhance clinical care management. The aim of current study was 
to develop a predictive model based on lung cancer survival using artificial 
neural network (ANN) algorithm on image biomarkers. 
Methods and Materials: Lung lesions from archived DICOM images (TCIA) of 
four hundred and sixty cancer patients were segmented using automatic region 
growing algorithm. Image preprocessing steps were performed by wavelet 
decompositions. Following image preprocessing and decompositions, eight 
images based on the wavelet, 632 quantitative 3D textures based on the 
GLRLM, GLCM and GLSZM, and 15 Shape features and 19 first order features 
were extracted from the 3D-tumor volumes segmentation. Supervised back-
propagation ANN classifier was used to predict survival and dead status in lung 
cancer patients using radiomics features. Sixty-six percent of data was 
recruited as test and remained was used as training set. 
Results: ANN was found as an effective method in prediction of survival in 
lung cancer patients. Our results showed this model with 73.4%, sensitivity, 
79.1% specificity and 78.7% area under the curve (AUC) has a strong 
predictive power. 
Conclusion: We discovered a novel prognostic model based on radiomics and 
artificial intelligent which can effectively predict survival in lung cancer patients. 
This study demonstrates that radiomics and artificial intelligent can provide 
valuable clinical information for advance personalized treatment in patients 
with lung cancer.  
B-0478 10:46  
Multimodality radiomics signature analysis improves prediction power 
against Stand-Alone analysis of PET, CT and MRI images  
I. Shiri, P. Geramifar, H. Abdollahi, A. Bitarafan-Rajabi, A. Mohammadzadeh, 
H. Pouraliakbar; Tehran/IR (Isaac.sh92@gmail.com)  
Purpose: Radiomics is a high-throughput computing process convert medical 
tomographic images to high dimensional data sets. These data is subsequently 
mined and can effectively contribute for improving decision support system. 
Although radiomics signature was performed on different image modality 
systems, in this study, we assessed the possible improvement of prediction 
power of multi-modality analysis against stand-alone imaging systems. 
Methods and Materials: Forty two soft tissue sarcoma (STS) patient from the 
Cancer imaging archive with MRI, CT, PET scans and information about lung 
metastases were subjected to current study. Image were preprocessed by 
different methods including image resampling, Laplacian of Gaussian (LOG) 
filtration with different sigma value, and wavelet. Following preprocessing and 
segmentation of GTV, 3D radiomics features based on shape, SUV (for PET) 
and intensity histogram, texture features including NGTDM, GLSZM, GLRLM, 
TFC were extracted. After feature selection and reduction, different supervised 
machine learning methods were used to predict lung metastases from stand 
alone and multimodality systems. 
Results: Improvement in radiomics signature was observed in multimodality 
imaging system. The results of the prediction model using stand-alone analysis 
of CT, MRI and PET shows area under the curve (AUC) values of 0.731, 0.89, 
and 0.95 respectively. The corresponding value is 0.978 in multi-modality 
imaging systems analysis. 
Conclusion: The results of this study indicate that multimodality radiomics 
signature analysis improves prediction power against stand-alone analysis of 
PET, CT and MRI images which lead to better predicting model of lung cancer 
in patients with STS.  
B-0479 10:54  
A new radiomics approach to predict the evolution of PI-RADS score 3/5 
prostate areas in multiparametric MR  
N.C. D'Amico, E. Grossi, G. Valbusa, A. Malasevschi, G. Cardone, S. Papa; 
Milan/IT (damiconatascha@gmail.com)  
Purpose: To characterize, through a radiomic approach, the nature of areas 
classified PI-RADS 3/5, recognized in multiparametric prostate magnetic 
resonance with T2-weighted (T2w), diffusion and perfusion sequences with 
paramagnetic contrast. 
Methods and Materials: 24 cases undergoing multiparametric prostate MR 
and biopsy were admitted to this pilot study. The clinical outcome of the PI-
RADS 3/5 was found through biopsy, which found eight malignant tumours. 
The analysed images were acquired with a Philips achieva 1.5T machine with 
a CE-T2-weighted sequence in the axial plane. Semi-automatic tumour 
segmentation was carried out on MR images using 3DSlicer image analysis 
software. 45 shape-based, intensity-based and texture-based features were 
extracted and represented the input for pre-processing. An evolutionary 
algorithm (a TWIST system based on KNN algorithm) was used to subdivide 
the dataset into training and testing set and select features yielding the 
maximal amount of information. After this pre-processing 20 input variables 
were selected and different machine learning systems were used to develop a 
predictive model based on a training testing crossover procedure. 
Results: The best machine learning system (three-layer feed-forward neural 
network) obtained a global accuracy of 90% ( 80 % sensitivity and 100% 
specificity ) with an ROC of 0.82. 
Conclusion: Machine Learning systems coupled with radiomics show a 
promising potential in distinguishing benign from malignant tumours in PI-
RADS 3/5 areas.  
B-0480 11:02  
Quantitative CT-based radiomics as predictor of local resectability of 
pancreatic ductal adenocarcinoma  
J. Van der Putten1, S. Zinger1, P.H.N. De With1, M.M. Prokop2, J.J. Hermans2; 
1
Eindhoven/NL, 2Nijmegen/NL (jjhermans@gmail.com)  
Purpose: To compare the performance of an expert radiologist to that of 
quantitative radiomics for prediction of local resectability of pancreatic ductal 
adenocarcinoma on routine abdominal CT. 
Methods and Materials: We included 66 patients (m:f=32:34; range 35-82 yrs) 
with histologically proven pancreatic ductal adenocarcinoma who were 
operated within 4 weeks of an initial routine portal-venous phase multidetector-
row CT examination. An expert abdominal radiologists scored CT data for 
tumor resectability. Another expert abdominal radiologist drew tumor contours 
to obtain a volume of interest, from which we computed 90 intensity, shape and 
texture features. During training the feature vector was reduced with a feature 
selection algorithm and combined with several classifiers to predict local 
respectability using radiomics. 
Results: There were 43 hypo- and 23 iso-attenuating tumors, of which 29 were 
resectable and 37 non-resectable. The best classification result was obtained 
with a logistic regression classifier with the feature vector reduced by 
regularized discriminative feature selection. Accuracy for predicting 
resectability was 67% for the radiologist, and 83% for radiomics. Sensitivity, 
specificity, positive and negative predictive value for resectability were 90%, 
49%, 58% and 86%, respectively, for the radiologist and 79%, 86%, 84%, and 
82%, respectively, for radiomics. 
  






Conclusion: Quantitative CT-based radiomics for prediction of resectability of 
pancreatic adenocarcinoma on routine CT may outperform expert radiologists 
with respect to accuracy and positive predictive value but at a lower sensitivity.  
B-0481 11:10  
Radiomics: prediction of acoustic neuroma response to the CyberKnife 
treatment  
N.C. D'Amico, I. Castiglioni, E. Grossi, G. Valbusa, G. D'Anna, F. Rigiroli, 
I. Bossi Zanetti, G. Scotti, S. Papa; Milan/IT (nataschaclaudia.d'Amico@cdi.it)  
Purpose: The objective of the study is to analyse MR images acquired before 
CyberKnife treatment, to predict the response and avoid unnecessary 
radiosurgery for patient. 
Methods and Materials: T1-weighted MR images of 38 patients presenting an 
acoustic neuroma treated with CyberKnife® at the CDI (52.6% responders with 
volume reduction) were selected and analysed. Analysed images were 
acquired on 1.5T machines with contrast-enhanced T1-weighted sequences in 
the axial plane. Semi-automatic tumour segmentation was carried out on MR 
images using the 3DSlicer image analysis software. Shape-based, intensity-
based and texture-based features were extracted. An evolutionary algorithm (a 
TWIST system based on KNN algorithm) was used to subdivide the dataset 
into training and test set and select features yielding the maximal amount of 
information. After this pre-processing, a predictive model based on a training-
testing crossover procedure was developed. The best neural network obtained 
was a 3-layer feed forward back propagation algorithm with 8 input variables 
containing the maximal amount of information. 
Results: The neural network was used twice inverting the training/testing set. 
In the first analysis, the sensitivity was 100%, while the specificity, was 
77.78%. These two results gave a global accuracy of 88.89%. In the second 
analysis the sensitivity was 61.54% and the specificity 100%, with a global 
accuracy of 80.77%. The mean value of the global accuracy was 84.83%. 
Conclusion: The obtained results show that machine learning coupled with 
radiomics has a great potential in distinguishing responders with volume 
reduction from responders without volume reduction to radiosurgery, before the 
treatment.  
B-0482 11:18  
Automated translation of radiologic reports with deep learning-powered 
translation engines: a feasibility study  
T. Weikert1, R. Wyttenbach2, G. Nicolas1, R. Hendel3, C. Glessgen1, 
J. Bremerich1, E.M. Merkle1; 1Basle/CH, 2Bellinzona/CH, 3Würzburg/DE 
(thomasjohannes.weikert@usb.ch)  
Purpose: The quick, accurate and inexpensive translation of medical reports is 
a task of increasing importance in a globalised world with many patients 
crossing language borders during their treatment. Recently, deep learning-
powered translation engines showed impressive results translating prose texts. 
The purpose of our study was to assess the utility of such engines in a 
radiological context. 
Methods and Materials: 20 German radiology reports of oncologic follow-up 
examinations generated between March and September 2017 were randomly 
selected. The impression section was translated into English, French and 
Italian by two deep learning-powered translation engines (DeepL and Google 
Translate). The translations were then evaluated by three bilingual radiologists 
in the respective language (RH: English; NG: French; RW: Italian). Three error 
categories were labeled (stylistic error, content error without significance, 
potentially dangerous error). 
Results: Overall, 79% of all words were translated correctly. However, only 
nine out of 120 translations were free of potentially dangerous errors and 
altogether 806 mistranslations were identified. Overall, the two translation 
engines showed a comparable performance. Of note, the quality of the 
translations into English was noticeably superior with 89% of all words correctly 
translated and 43% less potentially dangerous errors. 
Conclusion: Deep learning-powered translation engines in their current 
version are not suitable for automated translation of complex oncologic 
radiology reports. However, considering the fact that the performance of 
neuronal networks depends heavily on the data they were trained on, training 
on medical texts holds an enormous potential for better results in the near 
future.  
B-0483 11:26  
Automated detection and localisation of skull fractures from CT scans 
using deep learning  
R. Ghosh1, S. Chilamkurthy1, P. Rao1, M. Biviji2; 1Mumbai/IN, 2Nagpur/IN 
(rohit.ghosh@qure.ai)  
Purpose: To develop and validate deep learning-based algorithm pipeline for 
fast detection and localisation of skull fractures from non-contrast CT scans. All 
kinds of skull fractures: undisplaced, depressed, comminuted, etc. were 
included as part of study. 
Methods and Materials: Anonymized and annotated dataset of 350 scans 
(11750 slices) with skull fractures were used for generating candidate 
proposals for fractures. Stacked network pipeline was used for candidate 
generation - a fully convolutional network for ROI generation and another deep 
convolutional network for ROI classification. Final ROI classification model 
(ResNet18) yielded fracture probabilities for candidates generated through the 
fully convolutional (UNet) network. Separate deep learning model was trained 
to detect haemorrhages on scan level which was used as proxy for clinical 
information. Fracture candidate features like size, probabilities, depth for top 5 
most probable fracture candidates along with haemorrhage model confidence 
(phaemorrhage) were combined to train random forest classifier to detect fracture 
on scan level. In case of predicted fracture, most probable candidate(s) were 
used for localization. 
Results: Separate set of 2971 scans, uniformly sampled from database with 
no exclusion criterion, was used for testing scan-level decisions with 108 scans 
reported as skull fracture cases. To evaluate scan-level decisions for fractures, 
area under receiver operating curve (AUC-ROC) was calculated as 0.83 with 
phaemorrhage as feature and 0.72 without. Free receiver operating curve yielded 
0.9 sensitivity at 2.85 false-positives-per-scan. Predictions on each patient 
takes <30s. 
Conclusion: Deep learning-based pipeline can accurately detect and localize 
skull fractures. Pipeline can be used for triaging patients for presence of skull 
fractures.  
Author Disclosures: 
  R. Ghosh: Employee; Qure.ai. S. Chilamkurthy: Employee; Qure.ai. P. Rao: 
Employee; Qure.ai. 
B-0484 11:34  
Fast estimation of kidney volumes and time courses in DCE-MRI using 
convolutional neural networks  
A.S. Lundervold1, K. Sprawka2, A. Lundervold1; 1Bergen/NO, 2Lodz/PL 
(allu@hvl.no)  
Purpose: We create a novel method for fast and accurate estimation of kidney 
volumes and signal intensity time courses in DCE-MRI, aiming at extracting 
both structural and functional quantitative information from the moving kidney. 
Methods and Materials: Two repeated SPGR-DCE-MRI datasets were 
acquired from 20 healthy volunteers, resulting in 40 examinations, each 
consisting of 74 volumes recorded over ~6 min. We trained a 3D convolutional 
neural network (using a single standard NVIDIA GeForce 1080Ti GPU) for 
segmentation of left and right kidneys. The network has a dual-pathway 
architecture, incorporating both local and global information in the volumes. To 
create training data, we manually delineated 10 individual volumes from 10 
different time-series, and extended the delineations to 740 volumes using 
image registration. 
Results: Our implementation is able to segment all 74 volumes in a previously 
unseen, unregistered recording in less than 7 minutes. Mean segmentation 
accuracy (Dice) was 0.843 (SD=0.010). Mean (SD) left and right kidney 
volumes [ml] (incl. renal hilum) in one of the subjects (FF03) examined seven 
days apart (MR1 and MR2) was: MR1 L: 301.6 (15.9), R: 389.8 (16.9); MR2 L: 
307.4 (17.8) R: 395.3 (23.6). 
Conclusion: A CNN is able to quickly and accurately segment the moving 
kidneys in DCE-MRI, providing estimates of kidney volumes and mean signal 
intensity time courses. We are currently working to achieve sub-segmentation 
of the kidney (cortex, medulla, pelvis) and segmentation of the aorta (for AIF), 
enabling automated and fast estimation of GFR directly from the DCE-MRI.  
B-0485 11:42  
Automatic detection of intracranial calcifications in non-contrast CT  
G. Bortsova, G. van Tulder, F. Dubost, A. van der Lugt, D. Bos, M. De Bruijne; 
Rotterdam/NL (gerdabortsova@gmail.com)  
Purpose: Intracranial carotid artery calcification (ICAC) is a major risk factor 
for stroke, and might contribute to dementia and cognitive decline. Further 
research into the relationship between ICAC and neurological diseases is 
much demanded, but hampered by the time-consuming manual annotation of 
ICAC lesions. Therefore, we introduce the first fully automatic ICAC lesion 
detection method. 
Methods and Materials: Non-contrast-enhanced CT scans were performed in 
1882 participants of the Rotterdam Study, a population-based cohort study 
(mean age 69.6(6.8), 51.7% female). Two trained observers annotated the 
scans by indicating regions of interest on the intracranial carotid artery track 
(from the horizontal petrous segment to the circle of Willis) where calcifications 
were visible. ICAC lesion segmentations were obtained from these annotations 
by thresholding at 130 HU. We developed a deep learning based algorithm to 
automatically delineate ICAC lesions in CT scans. The algorithm was trained 
on scans of 882 subjects and validated on 1,000 scans of other subjects. 
Results: The intraclass correlation between ICAC volumes computed from 
manual and automatic ICAC segmentations was 97.7%. This is close to the 
interrater agreement of 99%. The Bland-Altman bias (95% CI) was 197(-384, 
778). (Mean ICAC volume is 1151±1624.) 
  






Conclusion: Our algorithm can be used to automate the time-consuming 
manual annotation of ICAC in large epidemiological studies, whilst maintaining 
a comparable level of accuracy. This can facilitate research into causes and 
consequences of ICAC, which might result in development of new treatments 
and establishment of ICAC volume as a stroke risk estimator in clinical 
practice.  
B-0486 11:50  
Automatic liver metastases detection on CT using multi-class patch 
based convolutional neural networks  
E. Klang1, M. Frid2, I. Diamant2, A. Ben Cohen2, M. Di Segni3, E. Konen1, 
H. Greenspan2, M.M. Amitai1; 1Ramat Gan/IL, 2Tel Aviv/IL, 3Rome/IT  
Purpose: To evaluate a patch based deep learning approach for liver 
metastases detection that models the variability between liver metastases, 
normal liver parenchyma and normal liver boundary. 
Methods and Materials: This research was supported by the ISRAEL 
SCIENCE FOUNDATION (grant No. 1918/16). In this study we evaluate a 
patch based Convolutional Neural Networks (CNN) approach for liver 
metastases detection on portal phase CT studies. Patches (~32X32 
pixels/patch) are extracted from each liver and then fed into a multi-class CNN, 
which classifies the patches into three categories: (1) liver metastases, (2) 
normal liver parenchyma, (3) normal liver boundaries. The networks decisions 
between the three categories are then fused to reach a binary lesion versus 
non-lesion decision. Data augmentation was applied to enrich the number of 
patches (flipping, rotation). A senior radiologist segmented all liver and 
metastases boundaries. True positive rate (TPR) and false positive per case 
(FPC) were compared to a binary patch based CNN classifier (metastases vs. 
liver). 
Results: The entire dataset included CT images of 132 livers with 498 2D 
segmented liver metastases. The CNN was trained using ~140,000 patches for 
each class. Evaluation was performed on the 132 livers with 2-fold cross 
validation. TPR and FPC were 85.9% and 1.9 for the multi-class CNN and 
80.0% and 2.8 for the binary CNN. 
Conclusion: The multi-class deep learning algorithm shows promising results 
in liver metastases detection task. Using prior knowledge of medical data, such 
as differences between interior and boundaries, may enhance CNN results.  
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B-0487 10:39  
In vivo evaluation of optic nerve and periorbital structures' 
biomechanical properties using shear-wave elastography in patients with 
glaucoma  
M. Guazzaroni, S. Marsico, V. Girardi, T. Campagnuolo, S. Altobelli, R. Floris; 
Rome/IT (salvatore.marsico@hotmail.it)  
Purpose: Glaucoma is an eye disease characterised by a slow and 
progressive damage of the optic nerve, retinal ganglion cell and visual field. 
The purpose of this study was to investigate shear-wave elastosonography use 
in the evaluation of the optic nerve and periorbital structures (orbital fat, lateral 
rectus and complex retinal-choroid). 
Methods and Materials: An observational retrospective study, including 20 
patients with glaucoma and 20 volunteers of the control group, was carried out. 
All of the participants had comprehensive ophthalmological exams (tonometry, 
OCT). In vivo evaluations of the biomechanical properties of the optic nerve 
and periorbital structures were performed with shear-wave elastosonography 
using a linear multifrequency probe (10-2 Mhz) in all participants. Differences 
of parameter stiffness of patients with and without glaucoma were evaluated 
using Student's t test. 
Results: The mean stiffness of the optic nerve and periorbital structures (fat 
tissue, complex retinal-choroid) was significantly higher in glaucoma patients 
for each measured region (P<0.05). Statistical significance of these results 
increased by the evaluation of the “Strain Ratio”, which is the relationship 
between the optic nerve and periorbital structure. Indeed, the “Strain Ratio”, 
optic nerve/fat tissue, was significantly higher in patients with glaucoma. 
Conclusion: Shear-wave elastosonography allows to identify stiffness 
variations of the optic nerve and periorbital structures in glaucomatous eyes.  
B-0488 10:47  
Ultrasound elastography of solid thyroid nodules: how far could we get?  
N.F. El Ameen, M.F. Amin; El Minia/EG (nadia.elameen@yahoo.com)  
Purpose: To evaluate the diagnostic accuracy of elastography in differentiation 
between benign and malignant solid thyroid nodules. 
Methods and Materials: A prospective study, included 100 patients having 
120 solid thyroid nodules. All patients were referred from surgery department 
between June 2016 and June 2017. All patient cohorts undergo routine 
ultrasonography and then elastography (USE). All radiological results were 
correlated with surgery and histopathology results. 
Results: Using routine ultrasonography only showed sensitivity and specificity 
of 91% and 94%, respectively. Adding elastography to routine ultrasonography 
examination increases the sensitivity and specificity to 95% and 97.3%, 
respectively. Elastography confirmed that scores 4 and 5 were diagnostic for 
malignant nodules in examination of 40/48 nodules and scores 1 and 2 were 
diagnostic for benign nodules in the examination of 59/72 nodules. 
Conclusion: Elastography is a promising technique if added to routine 
ultrasonography examination. It will improve the diagnostic accuracy of 
ultrasonography in differentiation between malignant and benign solid thyroid 
nodules. It will reduce the need for unnecessary biopsy and surgery.  
B-0489 10:55  
Complementary diagnostic role of shear wave elastography (SWE) in 
assessment of thyroid nodules during ultrasound examination  
M. Schiavone; Monza/IT  
Purpose: To evaluate the feasibility of the application of shear wave 
elastography (SWE) in the routine management of thyroid nodules, as a 
possible additional tool to the standard ultrasonography (US) triage. 
Methods and Materials: A total of consecutive 214 patients, scheduled for 
US-guided thyroid fine-needle aspiration (FNA), were included in the study 
group. The presence of a pure colloid lesion was an exclusion criteria. The 
patients underwent conventional US examination and software 2D-SWE 
measurements. Absolute SWE stiffness measurements on color-coded 
elastograms, expressed in kPa and m/s, were correlated with radiological and 
pathological features and their discriminatory performances have been 
assessed and statistically analysed. 
Results: The SWE values in thyroid nodules were significantly higher than 
normal thyroid tissue (p=0.0001), proving the different elastic properties of the 
pathological tissues. The SWE elasticity was not influenced by the 
characteristics of the bioptic smears, being unrelated to content and haematic 
composition of FNA. Regarding the radiological characteristics of the nodules, 
SWE highest values were associated with largest lesions (p=0.0105) but 
independent from ecographic and Doppler findings. The final correlation 
between the SWE results and the pathological diagnoses showed a trend in 
stiffness from tender tumours (follicular adenoma) to papillary thyroid 
carcinoma (p= =0.0160). 
Conclusion: SWE represents a quick, feasible, reproducible and helpful 
complementary diagnostic tool in routinely clinical practice in identifying the 
presence of thyroid nodules within normal parenchyma.  
Author Disclosures: 
  M. Schiavone: Author; Davide Ippolito, Cammillo Tale-Franzesi, Davide Leni, 
Fabio Pagni. 
B-0490 11:03  
Comparison of shear-wave elastography (SWE) and real-time 
elastography in the same thyroid nodules: which is more accurate?  
Y. Fu; Beijing/CN (13699216067@163.com)  
Purpose: Virtual touch tissue imaging (VTi), conventional US elasticity imaging 
(EI), virtual touch tissue imaging quantification (VTIQ), acoustic radiation force 
impulse (ARFI) are four elastographic forms available in one ultrasound 
machine. The purpose of this research is to establish the diagnostic accuracy 
of VTi, VTIQ, ARFI, EI in differentiating benign from malignant thyroid nodules. 
Methods and Materials: All solid nodules identified on grey-scale imaging 
were subjected to elastography in 2016. Diagnostic performance was 
compared with histological findings as the gold standard. Receiver operating 
characteristics curves were applied to look for any significant differences. 
Univariate and multivariate analyses with potential variables were examined to 
identify independent variables for malignancy prediction. 
Results: There were 85 patients (mean age, 42 years) with 90 pathologically 
proven thyroid nodules included in our research. There were 32 benign 
nodules and 58 malignant nodules. Forty nodules could not be assessed using 
ARFI for the lesion velocity was x.xx m/s. So, ARFI was not included for 
statistics. Four potential factors were found with significant effects on 
malignancy prediction and they were echogenicity, echogenic foci, VTI, VTIQ. 
After multivariate analysis, VTi was the only independent variable for 
  






malignancy prediction (P=0.001). Area under the ROC curve for VTi was 
higher than that with other significant independent variables, and VTi of at least 
grade III was the best cutoff values for malignant thyroid nodules. 
Conclusion: VTi is a useful tool for the differential diagnosis of thyroid nodules 
with higher diagnostic performance than shear-wave elastography and 
traditional EI.  
Author Disclosures: 
  Y. Fu: Author; ligang cui. 
B-0491 11:11  
Comparison between the US vs MRI features of papillary thyroid 
carcinoma  
S. Hu; Zhenjiang/CN (hsd2001054@163.com)  
Purpose: This study aimed to evaluate the magnetic resonance imaging (MRI) 
and ultrasound (US) features of papillary thyroid carcinoma (PTC) and to 
compare the US and MRI features of PTCs. 
Methods and Materials: Between January 2015 and April 2016, 86 
consecutive patients underwent surgery for pathologically confirmed PTCs. All 
patients underwent neck US and MRI examination before thyroid surgery. For 
each case, the US and MRI features emphasised included the 
echogenic/signal, margin, shape, anteroposterior to transverse diameter ratio 
(A/T), microcalcifications and lymph node metastasis. Statistical analysis was 
performed using the 2 test. 
Results: In the comparison of US and MRI features, A/T1 (41.9% in US and 
62.8% in MRI) and lymph node metastasis (88.0% in MRI; 56.0% in US) 
demonstrated a statistically significant difference (P=0.009, P =0.025) and 
there was no significant difference in the margin and shape (P=0.724, 
P=0.316). 
Conclusion: The study results demonstrated that the MRI features of PTCs 
including A/T and lymph node metastasis were inferior to US.  
B-0492 11:19  
Role of ultrasound in management of indeterminate thyroid nodules 
(Bethesda III and IV)  
E. Horvath, C. De la Barra, G. Aguilera, C. Silva, J. Slater, V. Skoknic, 
S. Majlis, M. Garcia, P. Gonzalez; Santiago/CL (camidlb@gmail.com)  
Purpose: To evaluate the role of US in predicting benignity or malignancy of 
lesions Bethesda III and IV, to support medical decisions (follow-up, re-
puncture or surgery). 
Methods and Materials: IRB approved retrospective descriptive study. 
Thyroid fine needle aspirations (FNA) with clot technique, performed between 
2010 and 2015 were reviewed. Nodules classified as Bethesda III (atypia of 
undetermined significance = AUS; follicular lesion of undetermined significance 
= FLUS) and IV (follicular neoplasm = FN and suspicion of follicular neoplasia 
= SFN) were selected. Only patients who underwent thyroidectomy were 
included for this analysis. Nodules were considered low risk on US when 
presenting as TIRADS score 2, 3, 4A and intermediate-high risk with TIRADS 
4, 4B, 5. US risk was compared with the presence of malignancy in the surgical 
specimen. 
Results: In total 3.738 FNAs were performed in the period studied; 269 (7.2%) 
were Bethesda III and 46 (1.2%) Bethesda IV. Ninety patients (65 FLUS, 11 
AUS and 14 FN/SFN) underwent surgery. In TIRADS 4, 4B and 5 nodules 
malignancy was 12.2% (6/49) in FLUS, 100% (10/10) in AUS and 50% (6/12) 
in FN/SFN. Meanwhile, in TIRADS 2, 3 and 4A nodules, no malignancy was 
identified (0/19). 
Conclusion: The high presence of AUS malignancy is highlighted. No 
malignancy was detected for Bethesda III-IV nodules presenting with low risk 
US TIRADS patterns. This information could assist the clinician in making 
therapeutic decisions.  
B-0493 11:27  
Prospective assessment of TIRADS US assessment and strain and Shear 
wave elastography to discriminate benign from malignant thyroid lesions  
V. De Soccio, G. Alagna, V. Forte, M. Di Segni, V. Cantisani, E. Tassone, 
C. Catalano, F. D'Ambrosio; Rome/IT  
Purpose: To determine the diagnostic performance of strain ratio elastography 
(SR) and shear wave elastography (SWE) associated with TIRADS based US 
classification, in order to differentiate benign from malignant thyroid nodules. 
Methods and Materials: 210 consecutive, histopathologically proven nodules 
in 200 patients (55 males, 145 females; mean age: 42.2 years; range: 18-83 
years) and were evaluated through B-mode US with Color-Doppler 
assessment, SR and SWE. Each lesion was classified according to the 
TIRADS lexicon - as proposed by Kwak et al. and evaluated for US features 
(size, B-mode and Color-Doppler features), SR semi-quantitative and SWE 
quantitative data. Imaging and histopathological findings were compared. 
Diagnostic performances of B-mode ultrasound, SR, SWE, and their 
combination were estimated using ROC analysis and 2x2 contingency tables. 
Results: Histological examination identified 136 benign and 74 malignant 
thyroid lesions. US according to TIRADS, SR and SWE showed a sensitivity 
(Se) of 59.6%, 82.7% and 51.9% and a specificity (Spe) of 83.8%, 92.7%, 
85.3%, respectively. SR with B-mode US increased the diagnostic 
performance (Se: 90.4%, Spe: 93%, AUC: 0.9 p<0.004); SWE with B-mode US 
did not improve overall accuracy (Se: 58.3%, Spe: 84.2%), though 
representing a valid tool in selected cases 
Conclusion: SWE and SR are useful additional US techniques. SE was, in 
general, more accurate than SWE - which proved useful only in selected 
cases. The combination of SR with B-mode US increased the diagnostic 
accuracy between benign and malignant nodules.  
Author Disclosures: 
 V. Cantisani: Speaker; Toshiba, Samsung, Bracco.  
B-0494 11:35  
Ultrasonographic diagnosis of salivary gland atrophy after radio-iodine 
treatment for papillary thyroid cancer  
E. Horvath, V.S. Skoknic, C. Silva, H. Tala, N. Sánchez, C. Whittle, 
J.P. Niedmann, S. Majlis, C. Schweinitz; Santiago/CL 
(velimirskoknic@gmail.com)  
Purpose: To describe ultrasonographic (US) findings of mayor salivary glands 
(MSG) atrophy in patients who received radio-iodine (RAI) treatment for 
papillary thyroid cancer (PTC). Determine MSG damage prevalence and 
associated risk factors. 
Methods and Materials: IRB approved, prospective non-concurrent cohort 
study. Patients that had CPT surgery with subsequent RAI between 2005-
2015, were included. All had a preoperative US and at least one follow-up US 
12months after RAI administration. Patients with prior MSG altered findings 
were excluded. Uni and multivariate analysis with logistic regression was 
performed using US gland damage as dependent variable and RAI dose, 
gender and age as independent variables. Statistical significance was defined 
as p<0.05. 
Results: In total 328 patients [average age: 42.47(IQR 34-53), female: 263 
(80.2%)] met inclusion criteria, receiving a median dose of 105mCi (IQR 100-
150). Follow-up period: 12-107months. In 103 patients (31.4%) US detected 
salivary gland atrophy (size reduction, wavy contours, hypoechogenicity and 
heterogenous structure) in at least one MSG. Univariate analysis indicated that 
total RAI dose received was significantly associated with atrophy (p<0.01). No 
actinic injury was present in patients treated with a total dose lower than 
100mCi. Multivariate logistic regression revealed total radiation dose OR of 
2.35 (IC95% 1.80 to 3.06) and women OR of 2.17 (IC 95% 1.07 to 4.42) for 
MSG atrophy. 
Conclusion: Actinic sialoadenitis is common, affecting approximately one-third 
of patients. Cumulative dose is the main factor related to this damage. For the 
first time, US was used to prospectively and systematically evaluate the MSG 
of patients with RAI treatment.  
B-0495 11:43  
Sonographic evaluation of abdominal wall fat index, intima-media 
thickness and plaque score in obstructive sleep apnoea syndrome  
N. Çetin, I. Gunes Tatar, O. Ergun, M. Yüceege; Ankara/TR 
(mdnurcan@hotmail.com)  
Purpose: Visceral obesity is prevalant in obstructive sleep apnoea syndrome 
(OSAS) and it is an independent risk factor for cardiovascular diseases. The 
aim of this study was to investigate whether patients with OSAS have an 
increase in abdominal wall fat index (AFI), a new indicator of visceral fat 
deposition, intima-media thickness (IMT) and plaque score (PS), two indicators 
of cardiovascular risk. 
Methods and Materials: 104 patients (73 females, 31 males) between ages 
23-73 years without known atherosclerotic or metabolic disease were 
evaluated by ultrasonography to calculate AWFI, to measure MTs and to 
determine plaque scores, who underwent polysomnography with suspect of 
OSAS. Maximum thickness of preperitoneal fat (Pmax) and minimum thickness 
of subcutaneous fat (Smin) were measured to calculate AFI (AFI=Pmax/Smin), 
IMTs were measured and carotid arteries were evaluated for the presence of 
atherosclerotic plaques to determine PS. Patients were grouped as no OSAS 
(<5), mild OSAS (5-15), moderate OSAS (15-30) and severe OSAS (>30) 
according to AHI. 
Results: While AHI correlated with AFI (p=0.019), it was not with IMTmean 
(p=0.158) and PS (p=0.345). There was no significant difference between four 
OSAS groups in terms of AFI (P=0.179). 
Conclusion: This study suggests that AFI may reflect and be used in the 
follow-up of OSAS. AFI was correlated with AHI but not with OSAS groups. It 
was thought to be due to low numbers of patients in each group. AHI was also 
not correlated with IMTmean and PS. This could be due to majority of newly 
diagnosed patients.  
 
  






B-0496 11:51  
Transverse and sigmoid sinus stenosis and pressure gradient in patients 
with pulsatile tinnitus  
T. Su, L. Jin, Y. Han; Beijing/CN  
Purpose: To investigate angiographic features in patients with pulsatile tinnitus 
(PT) and assess intravenous pressure gradient in venous sinus stenosis 
associated with PT. 
Methods and Materials: This study retrospectively analyzed cerebral 
angiography in a group of patients with diagnosed PT. Besides conventional 
arterial images, all angiography included indirect 2D and 3D venography 
focusing on related venous sinus. A subgroup of venous stenosis in transverse 
and sigmoid sinus detected by venography was noted. Subsequent direct 
venography and intravenous pressure gradient in venous sinus stenosis was 
acquired. 
Results: Our study included consecutive 37 PT patients with angiography. 
Except for four cases with dural arteriovenous fistula, all had normal arterial 
appearances. There were only two cases showing complete normal arterial 
and venous patterns. Among other 31 PT patients, there were nine with 
sigmoid sinus diverticulum (SSD) and ipsilateral upstream sinus stenosis (SS) 
and ipsilateral dominant venous sinus (DVS), nine with transverse and sigmoid 
SS and ipsilateral DVS, three with SSD and ipsilateral upstream SS, four with 
transverse and sigmoid SS, three with SSD, three with DVS, respectively. 
Besides 15 cases with SSD (48.4%) known as one of the causes for PT, 25 
cases with transverse and sigmoid SS (80.6%) were found, and average 
intravenous pressure gradient in venous sinus stenosis was 906 Pa (130-2170 
Pa). In addition, DVS in PT diseased side (67.7%) may have some relation 
with PT. 
Conclusion: High rates of transverse and sigmoid Sinus abnormalities were 
observed in PT. Related sinus stenosis with pressure gradient may have 
connection with PT.  
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B-0497 10:30  
Histogram analysis of apparent diffusion coefficients for monitoring early 
response in patients with breast cancer undergoing concurrent 
chemotherapy  
W. Wang, J. Cheng, Y. Zhang; Zhengzhou/CN (weijianwang520@163.com)  
Purpose: To explore the role of histogram analysis of apparent diffusion 
coefficient (ADC) related parameters in early assessment of treatment 
response during the concurrent chemotherapy(CCT) course of breast cancer. 
Methods and Materials: We retrospectively evaluated findings in 42 patients 
with breast cancer who underwent diffusion-weighted imaging (b = 0,800 
s/mm2 ) at 3T with acquisition of corresponding ADC maps before CCT, at the 
end of 2nd and 4th week during chemotherapy. Whole lesion ADC histogram 
analysis generated several histogram related parameters including skewness, 
kurtosis, mean, variance and percent. The ADC histograms of 42 patients were 
generated to visually observe dynamic changes of the histogram parameters 
following CCT. 
Results: All parameters except mean and variance showed significant 
changes during CCT (all P<0.05). Skewness and kurtosis both showed high 
early decline rate (25%, 32 %) at the end of 2nd week of CCT. The percent of 
ADC histogram also changed obviously following CCT. 
Conclusion: ADC histogram analysis held the potential in monitoring early 
tumor response in patients with breast cancer undergoing CCT.  
B-0498 10:38  
Imaging of the hypoxic microenvironment in breast cancer using PET/MR  
J.C. Carmona-Bozo, T. Torheim, R. Woitek, A.J. Patterson, O. Abeyakoon, 
C. Carraco, E. Provenzano, M.J. Graves, F.J. Gilbert; Cambridge/UK 
(jcc83@cam.ac.uk)  
Purpose: To investigate relationships between hypoxia (18F-FMISO-PET), 
tumour perfusion (DCE-MRI) and pathology in breast cancer. 
Methods and Materials: Imaging was performed using a GE Signa PET/MR 
scanner on 13 patients with pathologically confirmed breast cancer. A 60-min 
simultaneous PET/MR scan was performed following injection of 300 MBq 18F-
FMISO and a 2-hour uptake period. Hypoxic status was assessed using the 
influx rate constant Ki determined through Patlak-plot analysis. Tumour hypoxic 
fractions were estimated as the percentage of voxels with Ki values >2SD of 
the mean in normoxic muscle. Perfusion was derived from DCE-MRI data 
using the extended Tofts model (Ktrans). Pathological correlates included tumour 
type, grade, size, percentage of tumour-infiltrating lymphocytes, necrosis, 
nodal and receptor status. 
Results: A total of 26 lesions were assessed (ER+: n=25; ER-: n=1). Linear 
mixed effects analysis indicated that tumour grade and necrosis were 
significant predictors of Ki (p=0.014 and 0.027, respectively). Hypoxia was 
identified in 46% of the lesions, with hypoxic fractions ranging between 0-36%. 
Higher median hypoxic fractions were observed in lobular (6.7%) vs ductal 
(3.0%), HER2- (8.4%) vs HER2+ (3.6%), and positive (6.0%) vs negative 
(2.6%) nodal status, although these differences were not significant. A negative 
significant correlation was observed between tumour-infiltrating lymphocytes 
and hypoxic fraction (=-0.45; p=0.023). An inverse, heterogeneous 
relationship was observed between Ki and K
trans (=-0.1; p>0.05). 
Conclusion: Necrosis, tumour grade and lymphocyte infiltration were strong 
predictors of hypoxic status. Hypoxia had a negative, heterogeneous 
relationship with perfusion and may also be influenced by tumour type, HER2 
and nodal status.  
B-0499 10:46  
What is the diagnostic performance of 18-FDG-PET/MR and PET/CT in the 
initial staging of breast cancer?  
D. Botsikas, I. Bagetakos, M. Picarra, S. Boudabbous, X. Montet, G.T. Lam, 
I. Mainta, A.M. Kalovidouri, M. Becker; Geneva/CH 
(diomidis.botsikas@hcuge.ch)  
Purpose: To compare the diagnostic performance of 18-FDG-PET/MR and 
PET/CT for the initial staging of breast cancer. 
Methods and Materials: Two independent readers blinded to clinical/follow-up 
data retrospectively reviewed PET/MR and PET/CT examinations performed 
for initial breast cancer staging in 80 consecutive patients (mean age =55.3+/-
7.7 years). The diagnostic confidence for lesions in the contralateral breast, 
axillary and internal mammary regions, bones and other distant sites were 
recorded. Sensitivity, specificity, positive predictive (PPV) and negative 
predictive values (NPV) were calculated and results were compared with the 
gold standard (pathology and/or follow-up>24months). 
Results: 9/80 patients had bone metastases, 13/80 had other distant 
metastases, 46/80 had axillary, 9/80 had internal mammary metastases and 
3/80 had contralateral breast tumours. Inter-reader agreement for lesions was 
excellent (weighted kappa=0.833 for PET/CT and 0.823 for PET/MR) with 
similar results regarding reader confidence between the two tests (ICC=0.875). 
In the patient-per-patient analysis, sensitivity and specificity of PET/MRI and 
PET/CT were similar (p>0.05). In the lesion-per-lesion analysis, the sensitivity 
of PET/MR and PET/CT for bone metastases, other metastases, axillary and 
internal mammary lymph nodes, and contralateral tumours was 0.924 and 
0.6923 (p=0.034), 0.923 and 0.923 (p=1), 0.854 and 0.812 (p=0.157), 0.9 and 
0.9 (p=1), 1 and 0.25 (p=0.083), respectively. The corresponding specificity 
was 0.953 and 1 (p=0.081), 1 and 1(p=1), 0.893 and 0.92 (p=0.257), 1 and 1 
(p=-1) and 0.987 and 097 (p=1), respectively. 
Conclusion: Diagnostic confidence with both examinations was similar. 
Although PET/MR had a superior sensitivity for bone metastases than PET/CT 
in the lesion-by-lesion assessment, the diagnostic performance in the patient-
per-patient analysis was similar.  
B-0500 10:54  
A proposal diagnostic algorithm for F-18FDG PET/CT-detected breast 
incidental lesion based on BI-RADS and SUVmax criteria  
M. Bakhshayeshkaram, S. Zahirifard, F. Aghahosseini, R. Hashemi Beni; 
Tehran/IR (kfaghahosseini@gmail.com)  
Purpose: To propose a diagnostic algorithm for PET-detected breast 
incidental lesion by applying BI-RADS and SUVmax criteria. 
Methods and Materials: A total of 58 breast incidental lesions from 51 
patients contemporaneously investigated by BI-RADS within 1 month from PET 
study constituted the study cohort and verified by histopathologic results or a 2-
year clinical formal follow up (malignant=10, benign=48). The performance 
characteristics were then calculated for SUVmax2, SUVmax3.7 and BI-
RADS4, separately and conjunctively. 
Results: Diagnostic performance of SUVmax2, SUVMAX3.7 and BI-
RADSt4 were calculated to be 70%, 60% and 80% for sensitivity, 73.2%, 
82.9% and 92.7% for specificity and 72.54%, 88.23% and 90.19% for 
accuracy, respectively. Combined criteria using either SUVmax2 or 
SUVmax3.7 had 100% sensitivity, 73.2% and 87.8% specificity and 78.43% 
and 90.19% accuracy, respectively. The distribution of combined criteria in 
benign and malignant groups were found to be as the following: Benign group: 
double positive: 2 (4.87%), 1 (2.44%), PET-only positive: 9 (21.95%),1 
(2.44%), BI-RADS-only positive: 1 (2.44%), 2 (4.87%), double negative: 28 
(68.29%), 37 (90.24%), respectively, Malignant group: double positive: 7 
(70%), 4 (40%), PET-only positive: 2 (20%), 2 (20%), BI-RADS-only positive: 1 
(10%), 4 (40%), double negative: 0, respectively. 
  







Malignancy can be confidently excluded in double negative lesions. Lesion with 
BI-RADS<4 and SUVmax3.7 and those with BI-RADS 4 and SUVmax <2 
should prompt into histopathologic confirmation. BI-RADS negative lesions with 
2<SUVmax<3.7 may benefit from a short term imaging follow up.  
B-0501 11:02  
Breast MRI and dedicated breast PET (dbPET): friends and foes  
M. Herranz1, S. Argibay-Vazquez1, I. Dominguez-Prado1, P. Ling Ling2, 
L. Graña3, M. Vázquez Caruncho3, A. Ruibal1; 1Santiago de Compostela/ES, 
2
Shanghai/CN, 3Lugo/ES (michel.herranz.carnero@sergas.es)  
Purpose: Breast MRI shows high sensitivity with non-ionizing radiation; 
however, significant disadvantages including its moderate specificity are also 
reported. Recently, dedicated breast PET (dbPET) system has emerged as an 
additional imaging tool for breast cancer diagnosis and follow-up. To compare 
FDG-dbPET with MRI on breast lesion characterization, we analysed 
sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV). 
Methods and Materials: Two hundred women with known or suspected breast 
carcinoma were enrolled in this study. Both a dbPET scan and breast MRI 
scans were performed. Sensitivity and specificity of MRI and dbPET scans 
were calculated on the basis of pathology reports. 
Results: A total of 252 lesions were assessed. Lesion size range was 0.18 to 
7.6 cm. In lesion-by-lesion analysis, specificity and sensitivity of MRI alone 
were 93% and 81%, respectively; meanwhile, the lesion-based sensitivity of 
dbPET was 96% and the breast-based specificity was 98%. The positive 
predictive value and the negative predictive value for MRI alone were 80% and 
89%, respectively; however, for dbPET were 98% and 96%, respectively. In a 
significant number of cases, dbPET helped to disprove positive findings by 
resonance, and in 4% helped to define new positives that had gone unnoticed 
at resonance. 
Conclusion: Dedicated breast PET scans increase the specificity of MRI. 
False positives are reduced. The results of the current study showed that FDG-
dbPET is much more effective than MRI in detecting early breast cancer 
positives.  
B-0502 11:10  
Value of quantitative magnetic resonance imaging T1-relaxation time in 
predicting contrast-enhancement in breast cancer  
X. Zhang, M. Li, L. Mao, C. Wang, S. He, M. Liu; Guangzhou/CN 
(764673239@qq.com)  
Purpose: To evaluate the feasibility of T1 mapping in assessing the tissue 
properties equivalent to contrast-enhancement without the need for contrast 
agent. 
Methods and Materials: Patients with newly-diagnosed breast cancer were 
selected for this study. The subtraction of T1 maps pre and post-conrast 
enhancement lt; ∆T1 mapsgt: was used to determine areas of contrast-
enhancement. With the contrast-enhancement on ∆T1 maps as reference, 
ROC analysis served to detect an optimal T1 cut-off on T1 maps prior contrast 
agent injection to distinguish between contrast-enhancing tissue and its 
surroundings. 
Results: 15 patients were included. A T1 value >2081ms predicted contrast-
enhancing tumor tissue with a sensitivity of 83% and specificity of 71% lt;AUC, 
0.89; p<0.0001gt:. Interestingly, T1 prolongation >2081 ms that did not overlap 
with contrast-enhancing area transformed into contrast-enhancement later on. 
Conclusion: T1- relaxation time may be a useful technique to assess tissue 
properties in breast disease equivalent to contrast-enhancement without the 
need for contrast agent. It may also provide information on sites with future 
tumour progression.  
B-0503 11:18  
MRI of invasive mass breast cancer: correlation of global vascularity and 
ADC with pathological features  
A. Milani, R.M. Trimboli, L.A. Carbonaro, M. Codari, G. Di Leo, F. Sardanelli; 
Milan/IT (angelomilani9296@gmail.com)  
Purpose: To investigate the association between breast global vascularity 
(GV), apparent diffusion coefficient (ADC) and pathological prognostic factors 
in invasive mass lesions. 
Methods and Materials: Thirty invasive mass breast cancers were included: 
27 (89%) ductal, 2 (8%) lobular and 1 (3%) mucinous. Vessels with > 2mm 
diameter and > 30mm length were identified on maximum intensity projections 
from contrast-enhanced subtracted MRI, then lengths of all selected vessels 
were summed and considered as GV, for each of the two breasts. ADC was 
obtained for each lesion placing a region of interest encompassing the mass. 
Grade, Ki67, human epidermal growth factor receptor 2 (HER2), estrogen and 
progesterone receptors, pT and pN were obtained from pathology reports. 
Spearman, Mann-Whitney U, Kruskal-Wallis and Jonckheere-Terpstra statistics 
were used. 
Results: Women were aged 57.9±10.6 (mean ± standard deviation); median 
lesion size was 19.8 mm (interquartile range [IQR] 13-27 mm). A significant 
difference in GV was observed between cancerous and healthy breasts 
(p<0.001). A trend for correlation of GV and ADC was observed (r=0.337, 
p=0.08). A higher GV was associated with HER2 positive tumors (p=0.027) 
and lower ADC values were associated with a higher proliferation of Ki67 
(p=0.017). 
Conclusion: In invasive mass breast cancers, GV is associated with HER2 
overexpression, showing an interplay between receptor status and 
vascularization. The association of ADC with Ki67 proliferation subtends an 
increased cellularity of aggressive cancers. Multiparametric MRI, including GV, 
has a potential for defining the hallmarks of breast cancers.  
B-0504 11:26  
Utility of diffusion in evaluating chest wall invasion of breast tumours  
N. Samreen, C. Lee, K. Adler, A. Bhatt, T. Hieken, S. Zingula, 
K.N. Glazebrook; Rochester, MN/US (samreen.naziya@mayo.edu)  
Purpose: To investigate the sensitivity and specificity of diffusion-weighted 
imaging (DWI) in determining chest wall invasion of breast malignancies. 
Methods and Materials: A retrospective search was performed on keywords 
including “chest wall invasion” in breast MRI reports at our institution over the 
last 12 years. The presence of chest wall invasion based on T2-weighted, DWI, 
and post-contrast acquisitions was evaluated through consensus readings by 
two board-certified breast imagers. Correlations with histopathology and 
neoadjuvant chemotherapy were made. 
Results: Search results yielded 58 patients; 30 had no DWI and were 
excluded. The remaining 28 patients each showed loss of fat plane on T2-
weighted and post-contrast acquisitions. 23/28 (82%) additionally showed 
enhancement within the chest wall, and 20/28 (71%) qualitatively showed 
restricted diffusion within the chest wall. The mean ADC values (automatically 
calculated by CAD software) in the chest wall (-0.4±1.2 mm2/s, [-1.8, 1.5]) were 
similar to those in the breast tumour (-0.2±1.3 mm2/s, [-1.5, 1.4]). Review of 
clinical notes showed 5/28 patients with unavailable follow-up, so 23 patients 
were used in subsequent data analysis. Sensitivity, specificity, and negative 
predictive value (NPV) were 100%, 33%, and 100% for DWI and 100%, 27%, 
and 100% for post-contrast MRI, respectively, in the assessment of chest wall 
invasion. 
Conclusion: DWI when used in conjunction with post-contrast MRI suggests a 
high NPV for assessing chest wall invasion of breast cancers which can 
increase confidence for surgical planning.  
B-0505 11:34  
MR evaluation of fibroglandular tissue (FGT) and background 
parenchymal enhancement (BPE) in breast cancer and its association 
with receptor status  
S.B. Grover1, P. Jain1, S.K. Jain1, A.K. Mandal1, H. Grover2; 1New Delhi/IN, 
2
Bridgeport, CT/US (shabnamgrover@yahoo.com)  
Purpose: Breast cancer encompasses a spectrum of several molecular 
subtypes with distinct epidemiological and pathophysiological profiles, leading 
to significant variations in treatment response. Fibroglandular tissue (FGT) 
proportion and background parenchymal enhancement (BPE) on breast MR 
have been proposed as predictors of tumour molecular subtypes, thereby 
affecting treatment protocol. The aim of our study was to evaluate the 
biomarker role of FGT and BPE in breast cancer, by correlating with oestrogen 
receptor (ER), progesterone receptor (PR) and HER2 receptor status. 
Methods and Materials: 36 patients with newly diagnosed, biopsy-proven 
breast cancer underwent breast MR on 1.5T, in this IRB-approved study. FGT 
proportion and BPE were recorded and classified based on previously 
described criteria. Pathological analysis for receptor status was done. 
Association between the considered variables was evaluated using Pearson’s 
chi-square, continuity correction chi-square, and Fisher's exact test. A p<0.05 
was considered statistically significant. 
Results: Patients with increased FGT proportion were found to have ER- and 
PR-positive tumours (p<0.01 for both). Higher extent of BPE was associated 
with ER positivity (p=0.002); however, no significant association was found with 
PR status (p=0.310). Both FGT and BPE showed no relation with HER2 status 
(p=0.536 and p=0.226, respectively). 
Conclusion: Higher FGT proportions in breast cancer show association with 
both ER and PR positivity, whereas BPE showed association only with ER. Our 
work further substantiates research on the biomarker role of MR-assessed 
FGT and BPE in breast cancer, in predicting molecular subtypes and their 













B-0506 11:42  
Implementation of imaging biomarkers of healthy breast tissue with 
multiparametric [18F]FDG-PET/MRI may aid breast cancer diagnosis  
D. Leithner1,2, G.J. Wengert2, M. Weber2, T.H. Helbich2, P. Kapetas2, 
P.A.T. Baltzer2, E.A. Morris1, G. Karanikas2, K. Pinker1,2; 1New York, NY/US, 
2
Vienna/AT (doris.leithner@googlemail.com)  
Purpose: To assess imaging biomarkers of breast tumors and contralateral 
healthy breast parenchyma with 3T multiparametric (mp) PET/MRI and to 
investigate which can be used for breast cancer diagnosis.  
Methods and Materials: In this IRB-approved prospective study 125 women, 
who underwent fused 3T mpPET/MRI with dynamic contrast-enhanced MRI 
(DCE-MRI), diffusion-weighted imaging (DWI) and [18F]FDG-PET for a BI-
RADS 0,4/5 lesion and histopathological verification were included. BI-RADS 
descriptors with DCE, ADC with DWI, and SUVmax with [18F]FDG-PET of the 
lesion were recorded. SUVmax, ADCmean, BPE (background parenchymal 
enhancement), and FGT (amount of fibroglandular tissue) for the contralateral 
healthy breast were noted. A stepwise logistic regression with forward 
selection to identify the combination of biomarkers for the differentiation of 
benign and malignant tumors and to assess diagnostic parameters was 
performed. 
Results: There were 98 malignant lesions (81 IDC, 8 ILC, 5 DCIS, 4 other; 90 
masses) and 27 benign lesions (16 masses). The biomarkers that were 
different between benign and malignant lesions and included in the equation 
were BI-RADS descriptor DCE margins (P<0.001), and tumor ADCmean 
(P=0.008). Other biomarkers of tumor and normal breast tissue did not reach 
significance. Based on the combination of these two imaging biomarkers, 
diagnostic accuracy was 96.2%, sensitivity was 98.9%, and specificity was 
81.3% for separation of benign and malignant lesions. 
Conclusion: The combination of qualitative and quantitative MRI imaging 
biomarkers (DCE margins, ADCmean tumor) show promise to improve 
differentiation of benign and malignant breast lesions. In this study, other 
mpPET/MRI imaging biomarkers did not add diagnostic accuracy.  
B-0507 11:50  
Are there differences in multiparametric breast [18F]FDG-PET/MR 
imaging biomarkers of contralateral healthy tissue in patients with and 
without breast cancer?  
D. Leithner1,2, T.H. Helbich2, B. Bernard-Davila1, G.J. Wengert2, P. Kapetas2, 
P.A.T. Baltzer2, A. Haug2, E.A. Morris1, K. Pinker1,2; 1New York, NY/US, 
2
Vienna/AT (doris.leithner@googlemail.com)  
Purpose: To evaluate whether there are differences in multiparametric (mp) 
[18F]FDG-PET/MR imaging biomarkers of contralateral healthy breast tissue in 
patients with benign and malignant breast tumours. 
Methods and Materials: In this IRB-approved prospective study, 141 women 
underwent 3T mpPET/MRI with contrast-enhanced MRI, diffusion-weighted 
imaging (DWI), and [18F]FDG-PET for the assessment an abnormality (BI-
RADS 0,4/5). The following imaging biomarkers were recorded for the 
contralateral tumour-free breast: background parenchymal uptake (BPU) with 
[18F]FDG-PET; apparent diffusion coefficients (ADCmean) with DWI; BPE 
(background parenchymal enhancement); and amount of fibroglandular tissue 
(FGT). Appropriate statistical tests were used to assess differences in imaging 
biomarkers between benign and malignant lesions. 
Results: There were 100 malignant and 41 benign lesions. BPE was minimal 
in 61, mild in 56, moderate in 19, and marked in 5 patients. BPE differed 
significantly (P<0.001) between patients with benign and malignant lesions, 
with patients with cancer demonstrating decreased BPE in the contralateral 
breast. A borderline statistically significant difference was observed for FGT 
(P=0.055). BPU for patients with mild BPE was 1.5, for mild BPE 1.9, for 
moderate BPE 2.2, and for marked BPE 1.9. BPU differed significantly 
between patients with benign (mean, 1.9) and malignant lesions (mean, 1.8) 
(P<.001), whereas ADCmean did not differ between groups (P=0.19). 
Conclusion: Differences in mpPET/MR imaging biomarkers, obtained from 
contralateral healthy breast tissue, exist between patients with benign, and 
patients with malignant breast tumours. Contralateral BPE, BPU, and FGT are 
decreased in patients with cancer, and may potentially serve as imaging 
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B-0508 10:30  
Mechanical thrombectomy of M1 and M2 segment occlusions: a single-
center experience with 546 patients  
F. Seker, J. Pfaff, U. Neuberger, S. Nagel, P.A. Ringleb, M. Bendszus, 
M.A. Möhlenbruch; Heidelberg/DE  
Purpose: Considering recent randomized controlled trials on mechanical 
thrombectomy (MT) in ischemic stroke, the American Heart Association 
guidelines state that MT in M2 occlusions may be reasonable, but with 
uncertain benefit. We, therefore, compared safety, angiographic and clinical 
results of M1 and M2 segment occlusions after MT in a retrospective study. 
Methods and Materials: Between 2009 and 2016, patients with an acute 
occlusion of the M1 or M2 segment of the middle cerebral artery were 
retrospectively analyzed. Good outcome was defined as modified Rankin Scale 
score of 0-2 at 90 days. Successful recanalization was defined as a 
Thrombolysis in cerebral infarction score of 2b-3. 
Results: In total, 546 consecutive patients with M1 (n=457) or M2 (n=89) 
occlusion were included. Compared to M1 occlusions, M2 occlusion presented 
with a significant lower baseline NIHSS score (15 vs. 17, p=0.010) and higher 
ASPECTS [9 (IQR 8-10) vs. 9 (IQR 7-9), p=0.004]. Endovascular treatment of 
M2 occlusions had a non-significant lower rate of symptomatic intracranial 
hemorrhages (2.2% vs. 8.1%, p=0.068). Furthermore, M2 occlusions showed a 
trend to higher recanalization rates (82.0% vs. 72.6%, p=0.065) and a 
significantly higher rate of good clinical outcome (49.4% vs. 34.8%, p=0.026). 
Conclusion: This retrospective analysis adds evidence that MT in M2 
occlusions is safe and achieves slightly better recanalization rates and 
significantly better clinical outcome compared to M1 occlusions with a lower 
rate of symptomatic intracranial hemorrhages after MT.  
B-0509 10:38  
Impaired cerebrovascular reactivity is at high risk of stroke in patients 
with intracranial stenosis  
J. Papassin, A. Krainik, O. Heck, E. Condamine, J. Pietras, F. Tahon, 
O. Detante; Grenoble/FR (akrainik@chu-grenoble.fr)  
Purpose: Impaired cerebrovascular reserve is suggested to explain 
haemodynamic stroke in symptomatic patients with intracranial atherosclerotic 
stenosis (IAS) in spite of intensive medical management. We studied 
relationships between baseline characteristics of patients with unilateral 
symptomatic IAS, recurrence of ischaemic events, basal perfusion, and 
cerebrovascular reactivity assessed by BOLD fMRI (CVR BOLD fMRI). 
Methods and Materials: Twenty patients with symptomatic unilateral IAS of 
middle cerebral artery (MCA) or internal carotid artery were selected 
(61.0±11.5yo). We measured basal perfusion using DSC, and CVR elicited by 
hypercapnic challenge (8%CO2) using BOLD contrast (3T AchievaTX, Philips, 
voxel=4x4x4mm, TR/TE/=3000/35ms/90°, 240 dynamics in 12min during a 
block-design hypercapnia). Individual end-tidal CO2 pressure was used as 
physiological regressor to conduct linear regression analysis. Post-processing 
was performed using AMIGOv0.9, an in-house software (Python3.6, Matlab8.6, 
SPM12), giving whole-brain and regional basal CBF, CBV, MTT and CVR. We 
calculated statistical relationships between individual clinical and biological 
baseline characteristics, recurrent ischaemic events, basal perfusion, and CVR 
BOLD fMRI in MCA territories (CVRMCA) reported by laterality indices (LI). 
Results: Nine patients (45%) had an abnormal LI CVRMCA (|LI| CVRMCA0.08). 
During follow-up (m=3.0years), recurrent ischaemic events occurred within the 
first year. They were more frequent in impaired CVRMCA group (n=7/9) than in 
normal CVRMCA group (n=1/11), with different survival curves (log rank, 
p=0.001). Baseline characteristics were similar in both groups. 
Conclusion: Impaired CVR assessed by BOLD hypercapnic fMRI is 
associated with increased risk of stroke in patients with symptomatic IAS. CVR 















B-0510 10:46  
Dual-energy computed tomography for optimised visualisation of early 
cerebral infarctions after endovascular stroke therapy  
A.E. Grams, T. Djurdjevic, T. Schiestl, M. Knoflach, F. Dazinger, 
E.R. Gizewski, B. Glodny; Innsbruck/AT (astrid.grams@i-med.ac.at)  
Purpose: The aim of this study was to investigate if dual-energy computed 
tomography (DECT) series, optimised for edema visualisation, allows an 
advantageous identification of early infarctions after endovascular stroke 
therapy (EST). Therefore, a modified virtual non-contrast (VNC) series, named 
“edema map” (EM), was generated. 
Methods and Materials: Forty-six patients (21 women and 25 men) with a 
mean age of 63 years (24-89 years) were included. Brain window (BW), VNC 
and EM series were evaluated. Density differences between infarctions and 
contralateral areas (CID), final infarct volume predictability, infarction 
identifiability and image noise were assessed with region of interest 
measurements. Follow-up imaging served as standard for comparison. For the 
statistical evaluation, Kruskal-Wallis, Dunn's multiple comparison tests and 
receiver operating curve analyses were performed. 
Results: Highest CIDs were found in the EM (73.3+/-49.3), compared to the 
BW (-1.72+/-13.29) and the VNC (8.30+/-4.74) series (p < 0.0001). The EM 
revealed highest infarction identification rates (area under the curve: 0.97, vs. 
0.54 and 0.90, p < 0.0001) with a cut-off value of < 50.7 HU, despite slightly 
more pronounced image noise. A prediction of the future infarction size 
succeeded best with the EM series (area under the curve: 0.67, vs. 0.50 and 
0.59, cut-off 16.74 HU). 
Conclusion: With the EM series a higher contrast and better early infarct 
identifiability can be achieved than with VNC or BW series. This technique 
could feature the opportunity to modify early therapy decisions.  
B-0511 10:54  
Mechanical thrombectomy in basilar artery occlusion: the presence of 
bilateral posterior communicating arteries is a predictor of favorable 
clinical outcome.  
V. Maus1, A. Kalkan1, C. Kabbasch1, N. Abdullayev1, U.B. Barnikol1, T. Liebig2, 
C. Dohmen1, G.R. Fink1, A. Mpotsaris3; 1Cologne/DE, 2Berlin/DE, 3Aachen/DE 
(volker-maus@gmx.de)  
Purpose: Mechanical thrombectomy (MT) in basilar artery occlusion (BAO) is 
a subject of debate. We investigated clinical outcome of MT in BAO and 
predictors of a favorable outcome. 
Methods and Materials: 104 MTs in BAO (carried out between 2010 and 
2016) were analyzed. Favorable outcome (modified Rankin Scale (mRS) 2) at 
90 days was the primary endpoint; influence of following variables on outcome 
was investigated: number of detectable posterior communicating arteries 
(PcoAs), patency of basilar tip, completeness of BAO, and posterior circulation 
Alberta Stroke Program Early CT Score (PC-ASPECTS). Secondary endpoints 
were technical periprocedural parameters including symptomatic intracranial 
hemorrhage (sICH). 
Results: Favorable clinical outcome at 90 days was 25% and mortality was 
43%. Rate of successful reperfusion (modified Thrombolysis In Cerebral 
Infarction (mTICI) 2b) was 82%. Presence of bilateral PcoAs (AUC: 0.81, 
p<0.0001), low National Institute of Health Stroke Scale (NIHSS) on admission 
(AUC: 0.74, p<0.01), PC-ASPECTS 9 (AUC: 0.72, p<0.01), incomplete BAO 
(AUC: 0.66, p<0.001), and basilar tip patency (AUC: 0.66, p<0.01) were 
associated with favorable outcome. Stepwise logistic regression analysis 
revealed that the strongest predictors of favorable outcome at 90 days were 
bilateral PcoAs, low NIHSS on admission, and incomplete BAO (AUC: 0.923, 
p<0.0001). 
Conclusion: MT in BAO is safe with high rates of successful reperfusion. 
Aside from baseline NIHSS and incomplete vessel occlusion, both known 
predictors of favorable outcome in anterior circulation events, we found 
collateral flow based on the presence or absence of PcoAs had a decisive 
prognostic impact.  
B-0512 11:02  
Intracranial carotid artery calcification and endovascular treatment effect 
in acute stroke patients due to large vessel occlusion  
K. Compagne1, P. Clephas1, C.B. Majoie2, W. Van Zwam3, A. van Es1, 
D.W. Dippel1, A. Van der Lugt1, D. Bos1; 1Rotterdam/NL, 2Amsterdam/NL, 
3
Maastricht/NL (c.compagne@erasmusmc.nl)  
Purpose: Intracranial carotid artery calcification (ICAC) may interfere with the 
safety and efficacy of endovascular treatment (EVT). We assessed the 
influence of ICAC volume and pattern on the effect of EVT in patients with 
acute ischemic stroke. 
Methods and Materials: All 500 patients included in the MRCLEAN trial on the 
effectiveness of EVT were analyzed. The volume (mm3) and pattern (located in 
tunica intima or tunica media) of ICAC were determined on baseline CT. 
Functional outcome at 90 days was assessed with the modified Ranking Scale. 
Next, we investigated the association of ICAC volume and pattern with 
functional outcome using adjusted ordinal logistic regression models with an 
interaction term between treatment allocation and ICAC. 
Results: We found no association of ICAC volume with functional outcome 
(acOR per unit increase ICAC volume 0.94 (95%CI 0.84-1.06). Moreover, we 
found no evidence for effect modification by ICAC volume (p=0.56). 
Predominantly medial ICAC pattern was nearly significant associated with 
poorer functional outcome (acOR 1.63; 95%CI 0.99-2.66). Yet, we found 
evidence for treatment effect modification by ICAC pattern (p=0.02): a better 
functional outcome after EVT in patients with predominantly medial calcification 
(acOR 2.55; 95%CI 1.38-4.72) and no effect of EVT in patients with 
predominantly intimal calcifications (acOR 0.76; 95%CI 0.39-1.50). 
Conclusion: Predominantly medial calcification pattern of ICAC relates to 
poorer functional outcome in ischemic stroke patients, but the benefit of EVT in 
ischemic stroke patients with a medial calcification pattern is larger compared 
to the treatment effect in patients with a intimal calcification pattern.  
Author Disclosures: 
 C.B. Majoie: Research/Grant Support; Stryker. W. Van Zwam: 
Research/Grant Support; Stryker, Codman.  D.W. Dippel: Research/Grant 
Support; Stryker, Bracco Imaging. A. Van der Lugt: Research/Grant Support; 
Stryker. 
B-0513 11:10  
Ipsilateral thalamic diaschisis in acute ischaemic stroke: occurrence, 
perfusion characteristics, and association with morphologic and clinical 
outcome  
P. Reidler, K. Thierfelder, M.P. Fabritius, F. Schuler, W.H. Sommer, 
W.G. Kunz; Munich/DE (Paul.Reidler@med.uni-muenchen.de)  
Purpose: Ipsilateral thalamic diaschisis (ITD) describes the reduction of 
thalamic function, metabolism and perfusion resulting from a distant lesion to 
the ipsilateral hemisphere. Our aim was to evaluate its perfusion characteristics 
and clinical impact in acute ischemic stroke. 
Methods and Materials: Subjects were selected from a cohort of 1,644 
patients who underwent multiparametric CT including CT-perfusion (CTP) for 
suspected stroke. Inclusion criteria were: acute middle cerebral artery (MCA) 
territory ischemia, follow-up-confirmed infarction and absence of posterior 
circulation ischemia. Perfusion-deficit regions were delineated according to the 
Alberta Stroke Program Early CT Score (ASPECTS) regions. ITD was defined 
as reduced perfusion of the ipsilesional thalamus present on 2 CTP maps. 
Morphologic outcome and subacute complications were assessed on follow-
up. Functional outcome was quantified using the modified Rankin Scale 
(mRS). Statistical analysis contained univariate linear and binary logistic 
regression. 
Results: We included 154 patients. ITD was present in 32 subjects (20.8%, 
ITD+). Perfusion deficit regions in ITD+ subjects revealed a more frequent 
involvement of caudate, internal capsule and lentiform nucleus (each with 
p<0.001). We observed larger perfusion-deficit volumes and smaller perfusion-
mismatch (p<0.001) in the ITD+ group. There was no significant independent 
association of ITD with final infarction volume (beta=-0.110, p=0.135) or 
functional outcome (mRS2) after 90 days (OR=1.109, p=0.987). No 
differences in baseline characteristics or subacute complications were present 
(p>0.05). 
Conclusion: ITD is frequently observed in acute MCA stroke associated with a 
marked involvement of subcortical areas. This finding should neither be 
misdiagnosed as posterior circulation ischemia nor considered unfavorable in 
clinical management.  
B-0514 11:18  
Improved assessment and evaluation of arterial occlusion in acute 
ischaemic stroke with contrast-enhanced MR angiography  
S. Dhundass, A. Collin, L. Duron, S. Escalard, M. Obadia, R. Blanc, 
J.-C. Sadik, J. Savatovsky, A. Lecler; Paris/FR (sdhundass@gmail.com)  
Purpose: To compare in acute ischaemic stroke (AIS) patients, the accuracy 
of two techniques of MR angiography: contrast-enhanced magnetic resonance 
angiography (CEMRA) and Time Of Flight MRA (TOF MRA) for the detection of 
the clot and their value in predicting clot location and length. 
Methods and Materials: 131 consecutive adult patients admitted to our center 
for confirmed acute ischaemic stroke from august 2014 to july 2016 were 
assessed. Clot visibility, location and length on CEMRA were compared to 
those on TOF MRA and SWI. It was compared to Digital subtraction 
angiography (DSA) for the subgroup that underwent thrombectomy. Clot 
burden score (CBS) was evaluated on TOF MRA and CEMRA in case of 
anterior arterial occlusion. 
Results: 52 patients showed an occlusion on CEMRA and 63 on TOF MRA. 
CEMRA showed higher correlation to SWI regarding detection of the clot 
(k=0.68 (0.55-0.81)) its length (ICC=0.72 (0.61-0.79)) and location (k= 
0.69(0.57-0.79)), than TOF MRA (k=0.48(0.33-0.61) ;ICC=0.18 (-0.03-
0.38);k=0.5 (0.36-0.62)). CBS was significantly higher on CEMRA (p=7e-06). In 
the thrombectomy sub group (N=28), occlusion was detected on both 
  






techniques for all patients, CEMRA had a higher correlation with DSA (k= 0.73 
(0.47-0.91) vs k= 0.62(0.35-0.85)) for determining clot’s location. 
Conclusion: Our results showed that CEMRA enabled a more accurate 
detection of arterial occlusion in patients with AIS in comparison with TOF 
MRA, as well as the evaluation of clot characteristics such as its length and 
location, adding valuable information to stratify patient’s risk and management.  
B-0515 11:26  
Combined measurements of clot density in unenhanced and enhanced 
CT of acute ischaemic stroke in complete vessel occlusions of the medial 
cerebral artery predict 90 day patient outcome  
J. Kottlors1, C. Kabbasch1, V. Maus1, A. Mpotsaris2, J. Borggrefe1; 
1
Cologne/DE, 2Aachen/DE (Jan.Borggrefe@uk-koeln.de)  
Purpose: Ex-vivo CT-studies of blood thrombi (BT) showed, that contrast-
enhancement (CE) is determined by fibrin-content while unenhanced density is 
associated with the fraction of red blood cells. This study investigates if CE BT 
measurements in CT of acute ischemic stroke (AIS) can enhance prediction of 
patient outcome. 
Methods and Materials: This study includes 137 AIS patients treated with 
mechanical thrombectomy between 2010-2016, including M1 middle cerebral 
artery occlusions only. Outcome was determined with modified Rankin-Scale 
(mRS90). Differentiation of complete and incomplete large vessel occlusion 
(CLVO/ILVO) based on CT and angiography. Two blinded readers classified 
BT based on native CT (NECT); a) hypo-, b) iso-, and c) hyperdense as well as 
in CT angiography (CECT); d) not-enhancing, e) intermediate and f) 
enhancing. 
Results: Twenty-three ILVO patients (16.8%) differed significantly from CLVO 
patients in mRS at admission (median: 4 vs. 5) and after 90 days (median: 1 
vs. 4) (p<.05). Excluding ILVO, classification according NECT did not show 
statistical differences between hypo-, iso- and hyperdense CLVOs. 
Classification of CLVOs according CECT shows significant distinctions 
between the intermediate (median: 3) and enhancing BT-group (median: 4), 
also between the enhancing- and the not-enhancing BT-group (median: 3) 
(both p < .05). This is consistent with a correlation of .291 between CE and 
mRS after 90 days (p<.001). 
Conclusion: As described in literature, NECT BT density is associated with 
good patient outcome. Increased contrast enhancement of the BT in CECT, 
shows a further significant association with unfavorable outcome. ILVO is a 
significant bias of thrombus characterization.  
B-0516 11:34  
The influence of CT perfusion on the selection of stroke patients for 
endovascular therapy  
J.M. Ospel, G. Karwacki, K. Blackham; Basle/CH 
(johannamaria.ospel@usb.ch)  
Purpose: Determine whether CT perfusion changes patient selection for 
interventional therapy in acute stroke patients compared to combined native 
CT and CT angiography data. 
Methods and Materials: 100 consecutive acute stroke CT examinations (non-
contrast CT, CTA, CTP) from patients who received intravenous lysis at our 
hospital were retrospectively evaluated in a blinded fashion. An experienced 
neurointerventionalist reviewed the cases first without and, after a month delay, 
with the CTP data (Syngo.via, Siemens Healthineers). Clinical information such 
as NIHSS, age and side of neurologic deficit was provided to the reader. A 
questionnaire was used, including ASPECTS score, location of vessel 
occlusion and whether or not endovascular intervention was indicated. 
Differences in detection rate of vessel occlusion and interventional decision 
were compared. Criteria for intervention on CTP included <100 ml core infarct 
volume and > 1.2 mismatch ratio. 
Results: ASPECTS score was >= 7 in all cases. Detection rates of proximal 
vessel occlusion (n=33) and the decision to intervene differed between the two 
interpretive sessions in only one case; in this group the average NIHSS was 
16. Within the remaining group (distal or no vessel occlusion), there was 
discordance in 12 patients; average NIHSS was 8. 
Conclusion: In selected acute stroke patients (NIHSS>=10 and 
ASPECTS>=7) presenting within the 4.5 hour intravenous lysis window, CTP is 
unnecessary for the detection rate of proximal vessel occlusion or the decision 
to proceed with endovascular intervention. CTP may be helpful in patients with 
NIHSS<10 where distal occlusions are more common.  
B-0517 11:42  
Classification of CT perfusion infarct core in acute ischaemic stroke 
using automated measurements of tissue density on non-contrast CT  
P. Reidler, K. Thierfelder, M.P. Fabritius, W.H. Sommer, W.G. Kunz; 
Munich/DE (Paul.Reidler@med.uni-muenchen.de)  
Purpose: To determine the diagnostic value of automated quantification of 
tissue density on non-contrast CT (NCCT) to classify CT perfusion (CTP) 
infarct core in acute ischaemic stroke. 
Methods and Materials: Out of 1,644 consecutive cases of suspected 
ischaemic stroke, we selected patients with follow-up-confirmed middle 
cerebral artery infarction, admission NCCT and CTP, and absence of prior 
stroke. NCCT density in Alberta Stroke Program Early CT Score (ASPECTS) 
regions were quantified as average Hounsfield Unit (HU) values using 
automated segmentation and calculation of HU ratios (rHU) between ischaemic 
and non-ischaemic hemispheres (ASPECTS-Tool.v1.2, Siemens, Germany). 
CTP-deficit was rated separately on cerebral blood flow (CBF) and volume 
(CBV) maps per region. Infarct core was defined as coexisting CBF- and CBV-
deficit. Receiver operating characteristic curves (ROC) with Youden's index 
and associated rHU cut-off values with highest discriminative power were 
calculated per region. 
Results: A total of 129 patients were included. ROC analysis demonstrated 
that density measurements enabled a significant discrimination of infarct core 
in the regions Capsula interna (C) (AUC=0.797, p<0.001), Insula (I) 
(AUC=0.663, p=0.002), Lentiform nucleus (L) (AUC=0.726, p<0.001), and M1 
cortex (AUC=0.615, p=0.025). Youden's Index calculations indicating the 
power to discriminate infarct core resulted in cut-off values of rHU=0.963 for C 
(sensitivity/specificity=0.767/0.727), rHU=0.960 for I 
(sensitivity/specificity=0.506/0.886) rHU=0.957 for L 
(sensitivity/specificity=0.706/0.674), and rHU=0.949 for M1 cortex 
(sensitivity/specificity=0.343/0.903). 
Conclusion: Automated NCCT density measurements can identify ASPECTS 
regions with CTP infarct core in C, I, L and M1 cortex. This technique has the 
potential to improve decision support in case CTP is not available.  
B-0518 11:50  
Haemorrhagic transformation and aspirin therapy after thrombectomy: an 
inter- and intra-rater agreement study  
A. Guenego1,2, A. Leclerc1, K. Premat1, C. Ducroux1, M. Roques2, R. Blanc1, 
M. Piotin1, R. Fahed1; 1Paris/FR, 2Toulouse/FR (adrienguenego@gmail.com)  
Purpose: We aimed to systematically review the literature and assess the 
reliability of haemorrhagic transformation (HT) diagnosis and classification on 
brain computed tomography performed 22-36 hours after mechanical 
thrombectomy in acute ischaemic stroke (AIS) patients with anterior circulation 
large vessel occlusion. 
Methods and Materials: Studies assessing the reliability of HT diagnosis 
and/or ECASS classification were reviewed. Eighteen raters independently 
assessed twice 30 brain CT scans realized 22 to 36 hours after mechanical 
thrombectomy in patients included in a multicentric randomized trial. 
Agreement was measured with Fleiss’ and Cohen’s unweighted kappa 
statistics. 
Results: The review yielded 4 studies reporting 19 measures of agreement. 
Populations, methods, analyses, and results were heterogeneous (moderate to 
excellent agreement), precluding a meta-analysis. In our study, interrater 
agreement for HT diagnosis was moderate for all raters (=0.55, 95%CI [0.41-
0.68]) and each subspecialty. The interrater agreement for ECASS 
classification was fair for all raters (=0.37 [0.27-0.50]), but improved to a 
moderate level after dichotomization. Dichotomization of the ECASS 
classification also improved the number of raters to reach a substantial (or 
higher) intrarater agreement (from 7/18 [38.9%] to 14/18 [77.8%]). The 
interrater agreement for aspirin therapy decision was moderate for all raters 
(=0.52 [0.40-0.66]), and substantial among the vascular neurologists (=0.70 
[0.57-0.84]). 
Conclusion: The diagnosis and classification of HT according to ECASS 
criteria on brain CT scans performed 22 hours to 36 hours after thrombectomy 
might not be reliable among untrained physicians. Despite the lack of reliability, 
the interrater agreement for aspirin therapy decision among vascular 
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B-0519 10:39  
Impact of radiologist experience on detection of colorectal neoplasms at 
CT colonography screening  
L. Pusceddu1, V. Vani1, G. Giannetto1, L. Morra2, L. Correale2, S. Delsanto2, 
C. Senore2, D. Regge1,2; 1Candiolo/IT, 2Turin/IT (laura.pscd@gmail.com)  
Purpose: To assess the relationship between radiologist experience and 
adenoma detection rate at CT colonography (CTC) screening.  
Methods and Materials: Post-hoc analysis of a large RCT was performed, 
including 2593 CTCs read by 7 radiologists. Radiologist experience was 
classified according to the total number of CTC performed before the trial (i.e. 
<200, 200-1,000, >1,000). Multilevel logistic regression was used to model the 
influence of reading volumes on the probability to detect adenomas. Analyses 
were performed separately for each of the following lesions: all adenomas 
(ADR), distal adenomas (DADR), proximal adenomas (PADR), advanced 
histology (i.e. 10-mm, villous histology or high grade dysplasia). A 6-mm cut-
off was used for post-CTC referral to colonoscopy. 
Results: 1337 (51.5%), 584 (22.5%), and 672 (26.0%) CTCs were read by 
radiologists with reading volumes<200, 200-1000, and >1000, respectively. 
The average ADR, DADR and PADR were 8.0% (95% CI: 7.0-9.1%; range, 
5.8-8.7%), 5.0% (95% CI: 4.3-5.9%; range, 2.1-8.4%), and 5.1% (95% CI: 4.2-
6.3; range, 4.4-5.4%), respectively. Radiologist experience appeared to be 
related with DADR (OR, >1000 vs 1000: 1.49; 95% CI: 1.04-2.13), but not 
with PADR (OR, >1000 vs 1000: 0.91; 95% CI: 0.64-1.29). The association of 
radiologist experience with distal location appeared to be statistically significant 
also for advanced adenomas (OR, >1000 vs 1000: 1.73; 95% CI: 1.08-2.88). 
Conclusion: High reading volumes, greater than 1000 CTCs, may be required 
to achieve high adenoma detection rates in the distal colon. Reading volume 
may be considered as a new quality indicator for CTC screening.  
B-0520 10:47  
Patients' experience with, and factors for participation in flexible 
sigmoidoscopy and CT colonography screening insight from the Proteus 
Colon Trial  
V. Vani, G. Giannetto, L. Pusceddu, L. Morra, L. Correale, S. Del Santo, 
C. Senore, D. Regge; Turin/IT (vanina.vani87@gmail.com)  
Purpose: To compare the acceptability of CTC and FS screening and the 
factors predicting CTC screening participation, targeting participants in the 
Proteus Trial. 
Methods and Materials: 1984 eligible individuals, were randomly assigned to 
be invited to FS or CTC screening. All attendees and a 50% sample of CTC 
non-attendees were contacted 3-6 months after invitation for a phone 
interview, investigating screening experience and factors affecting 
participation. Odds ratios (OR) were computed by multivariable logistic 
regression. 
Results: 239/264 (90.6%) FS attendees, 237/298 (79.5%) CTC attendees and 
182/299 (60.9%) CTC non-attendees answered the interview. Attendees who 
would recommend the test to friends or relatives were 99.1% among FS and 
93.3% among CTC attendees. Discomfort associated with bowel preparation 
was higher among CTC than FS attendees (OR: 2.77; 95% CI: 1.47-5.24). 
CTC non-attendees were less likely to be men (OR: 0.36; 95% CI: 0.18-0.71), 
retired (OR: 0.31; 95% CI: 0.13-0.75), to report regular physical activity (OR: 
0.37; 95% CI: 0.20-0.70), or having read the information leaflet (OR: 0.18; 95% 
CI: 0.08-0.41); they were more likely to mention screening-related anxiety (mild 
- OR: 6.30; 95% CI: 2.48-15.97; moderate/ severe - OR:3.63; 95%CI:1.87-
7.04), erroneous beliefs about screening (OR: 32.15; 95% CI: 6.26-165.19), or 
a recent FOBT (OR: 13.69; 95% CI: 3.66-51.29). 
Conclusion: CTC and FS screening are well accepted. Further reducing the 
discomfort from bowel preparation may increase CTC screening acceptability. 
Negative attitudes, erroneous beliefs about screening and organizational 
barriers are limiting screening uptake. All these factors are modifiable and 
therefore potentially susceptible to interventions.  
B-0521 10:55  
Patient experience of screening CT colonography with reduced and full 
bowel preparation in a randomised trial  
L. Sali1, L. Ventura1, A. Borgheresi1, S. Delsanto2, P. Mantellini1, 
M. Mascalchi1, M. Zappa1, G. Grazzini1; 1Florence/IT, 2Turin/IT 
(lapo.sali@unifi.it)  
Purpose: To assess patient experience of bowel preparation and procedure 
for screening CT colonography with reduced (r-CTC) and full preparation (f-
CTC) in a randomised trial (SAVE study). 
Methods and Materials: 4825 eligible subjects were randomly invited to 
screening r-CTC or f-CTC. Participants to r-CTC (n=674) and to f-CTC (n=612) 
were asked to complete a pre- and post-procedure questionnaire. Items were 
analysed separately and pooled with chi-square ant t test. 
Results: Pre-procedure questionnaire was returned by 531 (79%) subjects in 
the r-CTC group and by 465 (76%) in the f-CTC group, and post-procedure 
questionnaire by 525 (78%) in the r-CTC group and by 453 (74%) in the f-CTC 
group. In pre-procedure questionnaire 88% of subjects in the r-CTC group 
reported no preparation related disorders compared to 70% of those in the f-
CTC group (p<0.001). In post-procedure questionnaire average scores for 
discomfort of the procedure were not significantly different between r-CTC 
(3.53±0.04) and f-CTC (3.59±0.04) groups (p=0.84). 
Conclusion: Reduced bowel preparation is reported to be more tolerable than 
full preparation for screening CT colonography. Procedure related discomfort is 
not influenced by bowel preparation.  
Author Disclosures: 
 S. Delsanto: Employee; im3D.  
B-0522 11:03  
Neoplasia yield with FIT two years after CTC screening  
G. Giannetto1, L. Pusceddu1, V. Vani1, L. Morra2, L. Correale2, C. Senore2, 
S. Del Santo2, D. Regge1,2; 1Candiolo/IT, 2Turin/IT (ggiannetto27@gmail.com)  
Purpose: We have conducted a trial (Proteus trial) comparing neoplasia yield 
of CTC and sigmoidoscopy in a population based screening setting among 
subjects aged 58-60. Screenees detected with polyps  6 mm at CTC were 
referred for colonoscopy (TC) . We aim to assess the role of FIT screening 
among subject without polyps or with polyps< 6 mm at CTC screening. 
Methods and Materials: According to the FIT screening protocol eligible 
screenees enrolled in the Proteus trial, were invited to undergo FIT screening 
(single sample, with a positivity cut-off at 20 µg/gr. faeces) two years after the 
screening CTC. The outcomes of interest were: participation rate (proportion of 
invitees examined), positivity rate (PR), positive predictive value of TC referral 
and detection rate (DR) of advanced adenomas or CRC (AN). 
Results: Participation was 70.4% (1541/2331); the PR was 4.1% and 89.7% 
(57/64) of those referred for TC actually had the test. The PPV for AN was 
17.5% (10/57, including 1 CRC) and the AN DR was 6.1% . 
Conclusion: Participation in FIT screening among subjects having performed 
a CTC was lower than among subjects who had previous FIT tests. FIT is still 
detecting AN among subjects with diminutive polyps or negative CTC, although 
PR and PPV are lower as compared to subjects with previous negative FIT 
result.  
B-0523 11:11  
Focal colorectal uptake in 18FDG-PET/ CT: maximum standard uptake 
value as a trigger in a semi-automated screening setting  
W. Luboldt; Munich/DE (luboldt@screening.org)  
Purpose: Focal colorectal uptake in 18FDG-PET/CT may be associated with a 
malignancy and can be quantified. This provides the basis for an automatic 
trigger threshold above which cases are flagged for colonoscopic evaluation 
and below which for individual assessment. The purpose is to determine the 
lowest maximum standard uptake (SUVmax) in colorectal cancer that could be 
used as a threshold to trigger endoscopic evaluation and to evaluate whether 
the SUVmax needs to be further normalised to a priori known extrinsic factors. 
Methods and Materials: The SUVmax was measured in 54 colorectal 
carcinomas and correlated with gender, age, blood glucose level, injected 
activity, body mass index and time to scan using t test or correlation 
coefficients (Pearson or Spearman, according to distribution). 
Results: There was no correlation between SUVmax and any of the extrinsic 
factors mentioned above. The lowest SUVmax value was 5 [mean ± SD (range): 
11.1 ± 4.8 (5.0-24.6)]. 
Conclusion: In contrast to most other screening techniques, semi-automation 
in colorectal screening seems possible with PET/CT. This opens the door for 
further study into the feasibility of automated screening. Independent from 
extrinsic factors, an SUVmax 5.0 in a focal colorectal uptake in 
18FDG-PET/CT 
should automatically trigger for endoscopic evaluation, if not contraindicated. 
Cases with SUVmax <5 should be assessed individually before referral for 
endoscopy. Thus, more interpretation time could be spent on those cases with 
a lower uptake and more ambiguous diagnosis.  
  






B-0524 11:19  
MRI T2WI and fat-suppressed-T2WI image fusion technology in improving 
image quality for the evaluation of anal fistulas  
Z. Dong, S.-T. Feng, M. Huang, Y. Jia, H. Cai, Z.-P. Li, B. Shen; 
Guangzhou/CN (asrachel@126.com)  
Purpose: We aimed to develop a novel magnetic resonance (MR) image 
fusion technology (combined T2-weighted imaging [T2WI] and fat-suppressed 
T2WI [T2WI-FS]) to improve image quality for better display of both anal 
fistulas and the anatomical structure of the anus. 
Methods and Materials: A total of 32 patients with proven anal fistula were 
retrospectively studied. All of the patients underwent anal MR imaging, 
including axial fast spin echo (FSE) T2WI and FSE T2WI-FS. T2WI and T2WI-
FS were used to form the fusion image (T2WI-fusion) based on the addition of 
the gray values obtained from each pixel via a MR post-processing 
workstation. The signal intensities of the fistula, the peri-fistula sphincter and 
perianal fat in T2WI, T2WI-FS and T2WI-fusion were measured with the 
algorithm Fisher score=(t-m)/sqrt(t2-m2), where  and  are the mean and 
standard deviation (SD), respectively, of the tissue signal intensity. The 
difference in Fisher scores between T2WI, T2WI-FS and T2WI-fusion were 
compared. 
Results: The mean Fisher scores of the fistula vs sphincters from T2WI-fusion 
(FS Fusion-fistula=6.56) were significantly higher than those from T2WI (FS T2WI-
fistula=3.35) (P=0.001). The mean Fisher scores of sphincter vs fat from T2WI-
fusion (FS Fusion-sphincter=10.84) were also significantly higher than those from 
T2WI-FS (FS fat suppression-sphincter=2.57) (P=0.001). 
Conclusion: The T2WI and T2WI-FS fusion technology integrates the 
advantages of both T2WI and T2WI-FS. The combination has the ability to 
improve image quality and facilitate accurate evaluation of anal fistulas and 
sphincters.  
B-0525 11:27  
Preoperative assessment of simple and complex anorectal fistulas: 
tridimensional endoanal ultrasound? Magnetic resonance or both?  
F. Iacobellis, L. Roberto, L. De Pascale, R. Rella, R. Natella, A. Reginelli, 
R. Grassi; Naples/IT (iacobellisf@gmail.com)  
Purpose: The purpose of this study was to evaluate the diagnostic value of 
3D-EAUS and MR in the preoperative assessment of both simple and complex 
anorectal fistulas. 
Methods and Materials: From Jan-2015 to Jan-2017, 124 patients with 
perianal fistulas underwent anamnestic evaluation, clinical examination, 
unnhanced and H2O2 enhanced 3D-EAUS and MRI. The results of imaging 
evaluation were compared with surgical findings, considered as reference 
standard. 
Results: Perfect agreement between 3D-EAUS and surgery in the anal fistulas 
severity grading was found (K= 1). The fistulas were classified as simple in 
68/126 (53.9%) and complex in 58/126 (46.03%) cases. In both simple and 
complex anal fistulas, 3D-EAUS showed a not significantly higher accuracy in 
the evaluation of internal openings, if compared with MRI (p= 0.47; McNemar 
Chi-Square Test). In the complex anal fistulas, MRI showed a significantly 
higher accuracy in the evaluation of secondary extensions if compared with 
3D-EAUS (p= 0.041; McNemar Chi-Square Test) whereas, in the simple anal 
fistulas, not significantly difference was found. 
Conclusion: In the preoperative work-up of patients with anorectal fistulas, 
3D-EAUS may represent the first-line diagnostic tool. In the cases of fistulas 
classified as complex by 3D-EAUS, the MR may be indicated as adjunctive 
diagnostic imaging examination, to more carefully describe the fistulas 
complete anatomy.  
B-0526 11:35  
Identification of internal opening in perianal fistula: comparison of 3D 
cube vs 2D at 3.0 Tesla  
V. Nyapathi; Rajahmundry/IN (drvinaynyapathy@gmail.com)  
Purpose: The hypothesis was that 3D T2FSE cube in comparison to 2D 
T2FSE sequence would be more accurate in detection of internal opening with 
perianal fistula. 
Methods and Materials: A total of 100 (age 20-60yrs) patients with clinically 
suspected fistula-in-ano (72 men and 28 women) underwent pelvic MR 
examinations on a GE Signa HDxt 3.0 Tesla. All the patients had T2-weighted 
MR imaging at 3T with both 1-mm-thick 3D T2FSE cube and 5-mm-thick axial, 
coronal and sagittal 2D T2FSE sequences. The internal opening, side tracts 
and abscesses were evaluated on both sequences. Statistical analysis of 
detection rate was performed to compare 3D T2FSE with 2D T2FSE images 
using Fisher exact test and Chi-square test. 
Results: Accuracy in detection of internal opening is higher on 3D cube than 
2D images. A p value of 0.0004 in Fisher exact test and p value of 0.00023 in 
Chi-square test are considered to indicate a significant difference. 
Conclusion: The advantage of 3D T2 FSE cube sequence is its accuracy in 
the identification of internal opening in a perianal fistula and secondary lesions 
with multiplane reconstruction in comparison with 2D T2 FSE sequence.  
B-0527 11:43  
Can we reliably identify the appendix on unenhanced ultra-low-dose CT 
in the era of iterative reconstruction?  
D. Ordu, L.-P. Rollandi, K. Rippel, C. Scheurig-Muenkler, T. Kröncke, 
F. Schwarz; Augsburg/DE (deniz.ordu@klinikum-augsburg.de)  
Purpose: To determine factors influencing the accuracy in the identification of 
the appendix on ultra-low-dose CT by residents with on-call experience. 
Methods and Materials: We included 163 patients presenting to the ED over 
a 5-month period who were referred for an unenhanced ultra-low-dose CT of 
the abdomen for urolithiasis. A model-based iterative algorithm was used for 
image reconstruction. As reference standard, two faculty radiologists evaluated 
all datasets and information from the electronic health records. Two residents 
blinded towards this reference standard independently analysed all datasets 
for the presence of the appendix and digitally marked it if identified. 
Results: 35 patients were excluded due to uncertain AE status. Of the 
remaining 128 patients (80 men, median age 47, median DLP 46mGy*cm), 56 
had had prior appendectomy. Interobserver agreement was high (88%, 
=0.75). Readers had a sensitivity, specificity and accuracy of 91%, 88%, 90% 
and 92%, 91%, 91%, respectively. The subgroup of patients with incorrect 
identification of the appendix had lower BMI (23.5±4 vs 28±7kg/m², p=0.02) 
and tendencies towards lower CTDI (0.91±0.3 vs 1.21±0.6mGy, p=0.1) and 
lower DLP (43±13 vs 53±25mGy*cm, p=0.16) but there was no difference in 
image noise (15.9±3.8 vs 15.9±3.6HU, p=1.0). BMI had high predictive value 
for an incorrect identification of the appendix (AUC=0.73, p<0.01), while image 
noise lacked any measurable effect (AUC=0.52, p=0.84). 
Conclusion: The normal appendix or its absence can be correctly identified on 
unenhanced ultra-low-dose CT scans in the vast majority of cases by residents 
with on-call experience. Low BMI is a strong predictor for misclassification, 
while image noise lacked any measurable effect.  
B-0528 11:51  
Use of conventional defecography or dynamic MRI defecography in 
patients with symptomatic pelvic floor dysfunction: a retrospective 
intraindividual trial  
M.C. Langenbach, M. Kaup, M. Beeres, J.-E. Scholz, C. Park, C. Frellesen, 
T.J. Vogl, T. Gruber-Rouh; Frankfurt a. Main/DE 
(marcel.langenbach@me.com)  
Purpose: Conventional defecography [CD] is a standard method in diagnostic 
of pelvic floor dysfunction. Since dynamic magnetic resonance imaging [MRI] 
has become more common, examinations are possible without X-ray and 
iodinated contrast media. Differences of both methods will be compared in this 
retrospective intraindividual trial. 
Methods and Materials: 50 patients (44 females, 6 males; mean age: 57 
years) were evaluated with CD and dynamic MRI defecography [MRD]. 
Iodinated contrast media was used for CD, ultrasound gel for MRD. Two 
radiologist with more than 5 years’ experience evaluated the presence of rectal 
prolapse, rectocele, enterocele, sigma deverticula and Cul de sac [CdS] 
phenomenon/syndrome. 
Results: In CD, rectal prolapse was observed in 45 patients, in MRD only in 8 
patients (p<0.001). CD showed a rectocele in 37, MRD in 41 patients 
(p=0.337). No significant differences were documented for retention of 
rectoceles (p=0.188), but significant for the size (MRD: 2.40cm; CD: 1.91cm; 
p=0.016). For occurrence of enterocele and sigma diverticula (p=0.604; 
p=0.149), no significant differences were found. Identification of elongated 
sigma is more sensitive in CD than MRD (p=0.008). CdS phenomenon and 
syndrome were seen in CD in 8 and 9 cases, in MRD only in one patient, 
respectively (p=0.015; p=0.008). 
Conclusion: MRD instead of CD is a strong alternative option for diagnosis of 
pelvic floor dysfunctions. Additionally, lack of radiation and possibility for direct 
evaluation of anterior and middle compartment puts MRI into a stronger role. 
Despite various advantages of MRD, the choice of the method is depending on 
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B-0529 10:30  
Three-material decomposition with dual-layer spectral detector CT 
compared to MRI for the detection of bone marrow oedema in patients 
with acute vertebral fractures  
B.J. Schwaiger, A. Gersing, J. Hammel, K. Mei, F.K. Kopp, E.J. Rummeny, 
K. Wörtler, T. Baum, P.B. Noel; Munich/DE  
Purpose: To assess whether bone marrow oedema in patients with acute 
vertebral fractures can be accurately diagnosed based on three-material 
decomposition with dual-layer spectral detector CT (SDCT). 
Methods and Materials: Acute (n=41) and chronic (n=19) osteoporotic 
thoracolumbar vertebral fractures in 28 subjects (70±14 years, 18 women) as 
diagnosed by MRI (hyperintense signal in STIR sequences) were assessed on 
a SDCT (Philips IQon). Data were processed using an in-house developed 
algorithm to decompose spectral data into calcium, oedema-equivalent and fat-
equivalent density maps. Two radiologists, blinded to clinical and MR findings, 
assessed the images independently, using a Likert scale (1=no oedema; 
2=likely no oedema; 3=likely oedema; 4=oedema). Accuracy, sensitivity and 
specificity for identifying acute fractures (Likert scale, 3 and 4) were analysed 
using MRI as standard of reference. 
Results: For the identification of acute fractures, conventional CT images 
showed a sensitivity of 63% and specificity of 84%, whereas the sensitivity 
(95%) and specificity (90%) of decomposed SDCT images were substantially 
higher. Accuracy increased from 70% for conventional images to 93% using 
SDCT. Readers considered MRI necessary for fracture age determination in 
60% (based on conventional images) and 28% (based on SDCT images), 
respectively. Interreader agreement was high for the classification of acute 
fractures in conventional (ICC, 0.79 [95% confidence interval, 0.68-0.87]) and 
SDCT images (ICC, 0.95 [0.92-0.97]). 
Conclusion: Material decomposition of SDCT data substantially improved 
accuracy for the diagnosis of acute vertebral fractures, with a high interreader 
agreement. This may spare patients' additional examinations and facilitate the 
diagnosis of vertebral fractures.  
B-0530 10:38  
Single-source dual-energy computed tomography for the assessment of 
bone marrow oedema in vertebral compression fractures: a prospective 
diagnostic accuracy study  
T. Diekhoff1, N. Engelhard1, M. Fuchs1, M. Pumberger1, M. Putzier1, J. Mews2, 
B. Hamm1, K.-G. Hermann1; 1Berlin/DE, 2Neuss/DE 
(torsten.diekhoff@charite.de)  
Purpose: The aim of this study was to evaluate the diagnostic accuracy of 
single-source dual-energy computed tomography (DECT) in patients with 
vertebral compression fractures. 
Methods and Materials: Patients aged 50 or more years were prospectively 
included and underwent both DECT on a single-source machine (80/135 kVp 
sequential volume acquisition) and 1.5 Tesla MRI including T1 and STIR 
sequence that severed as standard of reference. Virtual non-calcium images 
(VNCa) were reconstructed using a three-material decomposition algorithm. 
Only vertebras with loss of height in CT were included in the analysis. Images 
were independently scored for bone marrow oedema by three blinded readers 
using a 0-3 rating scale. A contingency table analysis, test for inter-reader 
reliability using Cohen’s kappa and measurements of signal-to-noise (SNR) 
and contrast-to-noise ratios (CNR) were performed. 
Results: 70 patients and 192 vertebras were included. DECT showed a 
reader-dependent sensitivity of 72% (62 to 80%) and a specificity of 70% (46 to 
71%) for BME. Sensitivity increased with the oedema score in MRI (81% for 
grade 2 and 89% for grade 3). Cohen's kappa was inferior for DECT (0.32 to 
0.48) compared to MRI (0.56 to 0.62). T1 provided a significantly better signal- 
and contrast-to-noise ratio compared to STIR, CT and VNCa (p < 0.0001); 
however, there were no differences between STIR and VNCa. 
Conclusion: DECT is able to detect BME with substantial diagnostic accuracy 
and can be performed utilizing a single-source system. It provides sufficient 
image quality; however, trained readers are needed for image interpretation.  
Author Disclosures: 
 J. Mews: Employee; Toshiba MS. 
 
B-0531 10:46  
Contribution of ultra-low dose CT in lumbar spine trauma  
F. Snene, A. Hamard, J. Greffier, P. Viala, J. Beregi, A. Larbi; Nîmes/FR 
(snenefehmi@gmail.com)  
Purpose: To evaluate the diagnostic power of ultra-low-dose CT (ULD-CT) of 
the lumbar spine compared to the X-ray in emergency room. 
Methods and Materials: A preliminary study on anthropomorphic phantom 
made it possible to determine the level of reference dose and the iterative level 
for the ULD-CT. Then an ULD acquisition without contrast medium injection as 
well as an X-ray of the lumbar spine were performed in 28 patients consulting 
the emergency department of our institution from March to August 2017.Raw 
data were reconstructed with Sinogram-Affirmed-Iterative-Reconstruction 
(SAFIRE, Siemens) with bone (I70f) and soft tissue (I30f) reconstructions 
kernel. 
The subjective analysis (image quality, diagnostic quality, characterization of 
the lesions with confidence level) was performed by double blind reading (1 
senior and 1 junior radiologist).The diagnostic performance of the ULD-CT and 
X-ray were compared. 
Results: Effective dose for ULD-CT were lower than the national X-ray 
Diagnostic Reference Level (DRL). Kappa Cohen test agreement among the 
two observers for the evaluation of traumatic lesions was substantial, ranging 
from 0.9 to 1. The analysis of data showed the absence of inferiority of the 
ULD-CT in the detection of traumatic lesions comparatively to the X-ray. The 
ULD-CT showed its superiority in the detection of disc disease 
(p<0.05)Readers recorded a significantly high score of diagnostic confidence 
level for ULD-CT compared to X-ray (p<0.05) 
Conclusion: ULD-CT with iterative reconstructions allowed a reliable study of 
spine trauma patients with a lower irradiation dose than spine radiography. 
Reproducibility is independent of the level of experience of the readers.  
B-0532 10:54  
Evaluations of outcomes for drop in pain and analgesic use for 
kyphoplasty in the treatment of 249 patients with vertebral compression 
fractures: a single centre results  
R. Marcello, G. Assegnati, A. Di Blasi, F. Cortese, S. Vitale; Rome/IT 
(robermarcello@gmail.com)  
Purpose: Vertebral compression fractures (CF) resulting from osteoporosis, 
cancer and trauma are common and painful. QoL is at high risk and morbidity 
and mortality rates increase following a compression fracture (CF). 
Kyphoplasty is a minimally invasive procedure to stabilise a CF. The 
effectiveness and reliability to reduce pain and drop in pain killers use were 
considered. 
Methods and Materials: 249 patients suffering from CF due to osteoporosis, 
trauma and malignancy receiving percutaneous trans-pedicle fluoro-guided 
balloon kyphoplasty were evaluated. The primary objective was to show 
significant improvement in two end points such as back pain relief (VAS score) 
and analgesic use at one week and three months after treatment. Pre-
procedural workup was carried out on spinal unenhanced multiplanar MRI or 
CT. 
Results: Back pain significantly decreased after treatment: the mean VAS pain 
score before treatment was 16.33 +/- 2.45 (range 13-20) versus 9.25 +/- 4.90 
(range 2-18) one week after treatment and was 7.00+/- 5.25 (range 1-14) three 
months after treatment. Analgesic use dropped after treatment. Device- and 
procedure-related complications were asymptomatic balloon rupture in three 
patients, asymptomatic to the skin cement leakage through monolateral pedicle 
access successfully removed with a clamp in one patient and possibly cement-
related new CF within four weeks post-procedure in five patients. 
Conclusion: Our large single centre evaluation shows that balloon 
kyphoplasty is a very effective and reliable procedure for the treatment of 
vertebral CF due to osteoporosis, trauma and malignancy.  
B-0533 11:02  
Vertebral body insufficiency fractures: detection of vertebrae at risk on 
clinical CT images using texture analysis and machine learning  
U. Mühlematter, M. Mannil, T. Finkenstaedt, A.S. Becker, G. Osterhoff, 
R. Guggenberger, M. Fischer; Zurich/CH (urs.muehlematter@gmail.com)  
Purpose: Osteoporotic insufficiency fractures of the spine are frequent 
complications in elderly patients. We introduce an alternative for bone quality 
measurements based on texture analysis (TA) with machine learning (ML) of 
CT scans of the trunk to identify vertebrae at risk for fracture. 
Methods and Materials: Consecutive standard CT scans of 57 patients with 
insufficiency fractures of the spine were analyzed. Intact vertebrae in the first 
scan that either fractured (‘instable’) or remained intact (‘reference’) in the 
consecutive scan were manually segmented on mid-sagittal reconstructions. If 
available, a third scan was assessed to validate the reference vertebra over a 
longer period. Texture features for all vertebrae were extracted using open 
source software (MaZda). Multiple ML approaches, e.g. random forest and 
  






support vector machines were used to classify instable and reference 
vertebrae as well as cases (instable and reference) and matched (gender, age 
and fracture level) controls from a prior study. 
Results: 60 vertebrae were included. Mean time difference between the first 
and second scan was 237 days (SD ±117.5), between latter and third 548 days 
(SD ± 386). ML based classification of cases vs. controls showed sensitivity, 
specificity and AUC of 0.91, 0.86 and 0.93 and of 0.63, 0.43 and 0.45 for 
instable vs. reference vertebrae, respectively. 
Conclusion: TA combined with ML allows to distinguish healthy and diseased 
bone with a high accuracy. However, within the diseased spine the prediction 
of single vertebrae that will fracture at a future point in time remains 
challenging.  
B-0534 11:10  
Comparing trabecular bone score and serum bone biomarker in 
predicting vertebral fracture for diabetes  
Y.-C. Lin1, A.Y. Cheung2, S.-F. Kuo1, K.-H. Wu1, C.-M. Sung1, C.-M. Fan1, 
F.-P. Chen1; 1Keelung/TW, 2Taoyuan/TW (yuching1221@gmail.com)  
Purpose: Type 2 diabetes patients (T2D) have poor bone quality with 
increased vertebral fracture (VF) risk. There are two available methods for 
predicting fracture risk, trabecular bone score (TBS) and serum bone turnover 
biomarkers. This study compares the diagnostic performance and also studies 
the association between these two methods. 
Methods and Materials: Postmenopausal T2D female patients were 
prospectively enrolled. All received image studies of bone densitometry for 
TBS calculation and lateral lumbar spine radiographs for VF assessment. 
Laboratory studies of vitamin D, intact parathyroid hormone (iPTH), bone-
specific alkaline phosphatase (sBALP, bone resorption biomarker) and beta-C-
terminal telopeptides (sCTX, bone formation biomarker) for bone turnover 
assessment. We compared the performance of each parameters with vertebral 
fracture using Student’s t test, age-adjusted odds ratio (OR) and receiver 
operating characteristic (ROC) curve. Lastly, Pearson for correlation of different 
parameters was calculated. 
Results: A total of 285 T2D patients were analysed with mean age of 61.1 
years and total of 32 patients with VF (11.23%). Significantly lower TBS and 
higher sBALP (p<0.001; p=0.030) were shown in group with VF with OR of 
<0.001 and 1.080 (p<0.001; p=0.029) and area under curve (0.820 and 0.746). 
Vitamin D, iPTH and CTx is not significantly associated with VF. TBS only 
significantly correlated to sBALP (-0.276, p<0.001) but not to sCTX (-0.096, 
p=0.107). 
Conclusion: TBS has a better diagnostic performance than serum bone 
turnover biomarkers in predicting VF in T2D and lower the TBS are 
predisposed to unbalanced rate of bone turnover and resulted in bone fragility.  
B-0535 11:18  
Haemarthrosis of the knee and knee fracture: evaluation with high-
resolution ultrasound  
S.P. Ivanoski1, V. Vasilevska Nikodinovska2; 1Ohrid/MK, 2Skopje/MK 
(slavcoivanoski@gmail.com)  
Purpose: To evaluate the presence of knee fracture in patients with 
sonographic signs of knee haemarthrosis. 
Methods and Materials: 31 patients with acute knee trauma and ultrasound 
signs of knee haemorrhagic effusion were evaluated for presence of bone 
fractures. High-resolution transducer was used for detecting haemorrhagic 
knee effusion within the suprapatellar and parapetellar knee recesses. 
Emergency radiography or CT was performed for establishing diagnosis of 
bone fracture. Control group consisted of 31 patients with acute knee trauma 
and anechoic, non-haemorrhagic knee effusion on ultrasound. Sensitivity, 
specificity, positive and negative predictive value of the method were 
evaluated. 
Results: Radiography and CT findings were positive for bone fracture in 26 of 
31 patients with knee haemarthrosis on ultrasound. In 12 cases patellar 
osteochondral fracture in acute dislocation were found, followed by fracture of 
femoral condyle (6 patients), platotibial fracture (5 cases), and tibial eminence 
fracture (2 patients). Avulsion fracture of the tibial tuberosity was present in 1 
patient. In control group 4 avulsion fractures were detected (2 Pelegrini-Stieda, 
and 2 segond fractures), without any intraarticular fracture. Sensitivity of the 
method for detection of intraarticular fractures was 83.9%. Specificity was 
87.1%, positive and negative predictive value were 86.7% and 84.4%. 
Conclusion: High resolution ultrasound is a good method for detecting even a 
small amounts of fluid within the knee recesses. Sonographic diagnosis of 
knee haemarthrosis can be a good predictor of intraarticular knee fracture. 
Further investigations should be performed for detecting small knee fracture in 




B-0537 11:26  
Anatomy-based MR classification of the iliopsoas muscle complex after 
pertrochanteric femur fracture  
M. Kaniewska1, M. Schenkel1, K. Eid1, T. Bühler1, R. Kubik-Huch1, 
S. Anderson1,2; 1Baden/CH, 2Sydney/AU  
Purpose: Petrochanteric femur fracture (PFF) with a dislocation of the lesser 
trochanter may lead to deterioration of quality of the iliopsoas muscle complex 
(IMC). In this prospective study, an anatomy-based evaluation of the IMC after 
PFF using MRI is proposed. Additionally, the inter-reader reliability of 2 
classifications of fatty muscle degeneration (FMD) was determined. 
Methods and Materials: Adult patients after surgery of PFF with a displaced 
lesser trochanter were included. Muscle quality was evaluated by means of 
MRI using Goutallier and Slabaugh classifications at 3 anatomic levels (L4/L5, 
L5/S1, spina iliaca anterior inferior). Two radiologists independently reviewed 
the images. Force measurement was performed on both hips. Linear mixed-
effect models were used to determine the effect of fracture on muscle quality 
and strength. Cohen’s kappa statistic was used to assess the inter-reader 
agreement. 
Results: 18 patients were included. The IMC showed higher grades of FMD 
(grade 3 and 4 in Goutallier and grade 3 in the Slabaugh classification, 
respectively) on the fractured side (FS) than on the non-fractured side (NFS). 
The mean difference between muscle strength on FS and NFS was -12N (p 
value>0.05). Inter-reader agreement for the Goutallier and Slabaugh 
classifications was good and very good, respectively (weighted K = 0.78 and 
0.85). 
Conclusion: Anatomy-based MR evaluation of the IMC provides a valuable 
tool for the assessment of muscle quality after PFF. FMD of the IMC is evident 
and results in a minimal reduction of muscle strength. In terms of inter-reader 
agreement, the Slabaugh classification is superior to the Goutallier 
classification.  
Author Disclosures: 
  M. Kaniewska: Research/Grant Support; Young Researchers Grant 
European Society of Musculoskeletal Radiology (ESSR). 
B-0538 11:34  
Are fractures of the anterior calcaneal process indicative of a more 
advanced Chopart joint injury?  
A. Hirschmann1,2, W.R. Walter2, E.F. Alaia2, E. Garwood2, Z.S. Rosenberg2; 
1
Basle/CH, 2New York, NY/US (anna.hirschmann@usb.ch)  
Purpose: To assess the co-existence of anterior calcaneal process (ACP) 
fractures with talonavicular joint injury, indicating advanced Chopart joint injury, 
and to correlate our findings with radiologic and clinicians' diagnosis. 
Methods and Materials: Retrospective radiological data search (“avulsion 
fracture”; “anterior calcaneal process fracture”) was performed. Inclusion 
criteria were imaging evidence of injury to ACP on radiographs and MRI within 
8 weeks of ankle injury. Injuries at ACP and talonavicular component of 
Chopart joint, using radiographs and MRI, were assessed by three 
musculoskeletal radiologists. The prospective radiologic and clinical diagnosis 
were documented. McNemar and kappa statistics were used (P<0.005). 
Results: Final cohort had 21 patients. On radiographs, avulsion fractures of 
the ACP and at talonavicular joint were evident in 48% (10/21) and 38% (8/21), 
respectively. Concomitant fractures of both joints, indicating advanced Chopart 
joint injury, were evident in 14% (3/21). On MRI, avulsion fractures of the ACP 
and at the talonavicular joint were evident in 100% (21/21) and 76% (16/21), 
respectively. Thus, concomitant fractures at both joints were present in 76% of 
the cases. Differences between imaging modalities were significant (p<.008). 
Interrater agreement was 0.144-0.538 and 0.976-1 for ACP and 0.488-0.637 
and 0.286-0.364 for talonavicular injuries on radiographs and MRI, 
respectively. 60% of ACP fractures were prospectively missed on radiographs 
(none on MRI), while 38% and 25% of talonavicular findings were prospectively 
missed on radiographs and MRI, respectively. 60% of Chopart joint injuries 
were clinically misdiagnosed as ankle sprains. 
Conclusion: Radiological evidence of injury at either component of Chopart 
joint should draw attention to a more severe Chopart joint sprain.  
Author Disclosures: 
  A. Hirschmann: Research/Grant Support; Stiftung Prof. Dr. Max Cloëtta and 
Uniscientia Foudation, Gottfried und Julia Bangerter-Rhyner-Stiftung, Helmut-
Hartweg-Fonds of the Schweizerischen Akademie der Medizinischen 
















B-0539 11:42  
Comparing dGEMRIC and clinical outcome 6 years after FAI surgery with 
versus without microfracturing: a controlled pilot study  
F. Schmaranzer1, P. Haefeli1, M. Hanke1, T. Lerch1, K. Siebenrock1, 
S. Werlen1, M. Tannast1, L. Büchler2; 1Bern/CH, 2Biel/CH  
Purpose: To compare (1) T1 indices and (2) clinical outcome in patients with a 
minimum 6-year follow-up who had undergone FAI surgery with versus without 
microfracturing. 
Methods and Materials: After IRB approval patients with a minimum 6-year 
follow-up who had undergone surgical hip dislocation with or without 
microfracturing for treatment of FAI and of extensive chondral flaps and defects 
were searched. A total of 46 patients were identified, 17 in the `Mfx group' and 
29 in the `no Mfx group'. All eligible patients underwent indirect MR 
arthrography (Gd-DTPA 2-0.2 mmol/kg) with a dual-flip angle GRE-technique 
for acquisition of 3D T1 maps at latest follow-up. (1) T1 indices of acetabular 
cartilage were assessed on radially reformatted images. Regions of interest 
were manually placed. (2) Patient-reported outcome was evaluated at latest 
follow-up using Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) and Harris Hip Score (HOOS). Unpaired Student's t tests and 
Mann-Whitney U tests were used (p<0.05). 
Results: There was no significant difference (p>0.05) in the overall (438 ± 
150ms versus 434 ± 136ms) and regional (superior [11-1 o'clock], anterior [2-4 
o'clock], posterior [8-10 o'clock]) T1 indices between the two groups. WOMAC 
(52 ± 65 versus 39 ± 46) and HHS (71 ± 27 versus 87 ± 12) did not differ 
significantly (p>0.05) between the two groups. 
Conclusion: The results suggest that treatment of cartilage lesions with 
microfracturing during FAI surgery does not positively or negatively affect 
clinical or radiographic mid-term results compared to patients with no treatment 
of cartilage lesions.  
10:30 - 12:00 Room G  
Physics in Medical Imaging  
SS 613  
Innovations in medical imaging  
Moderators:  
M. Kortesniemi; Helsinki/FI  
G. Sommer; Basle/CH  
B-0540 10:30  
Impact of software parameter settings on image quality of Virtual Grid 
processed radiography images: a contrast-detail study  
T. Gossye, M. Peleman, P. Smeets, E. Achten, K. Bacher; Ghent/BE 
(tim.gossye@ugent.be)  
Purpose: The use of an anti-scatter grid is uncommon in bedside radiography. 
Dedicated software to compensate scatter in the images became recently 
available. The aim was to evaluate the influence of software parameter settings 
on the image quality using a contrast-detail study. 
Methods and Materials: 2400 images of a CDRAD (Artinis) test object were 
acquired with a digital D-EVO II GOS detector accompanied with Virtual Grid 
(VG) post-processing software (Fujifilm Medical Systems). The test object was 
placed between PMMA to mimic patient scatter (total thickness range: 12-26 
cm). For each phantom thickness images were acquired with a kVp range 81-
125. 12 different VG software parameters combinations were investigated (2 
grid ratios, 3 linepairs/cm, 2 types of interstitial material). The acquired images 
were analysed with the CDRAD Analyser software 2.1 and the relative Image 
Quality Figure inverse (IQFinv) was calculated. A linear mixed model statistical 
design was performed for data analysis (IBM SPSS 23). 
Results: VG software significantly (P<0.001) improved the digital images. 
Compared to non-VG images, mean relative IQFinv values significantly 
increased from 26% to 32% for grid ratio 6 and 10 respectively (P<0.001). For 
the other two parameters no statistically significant differences are observed 
(P>0.05). Small but significant interactions are noticed for: ratio*linepairs/cm 
and ratio*PMMA thickness*kV. 
Conclusion: VG software is able to improve bedside radiography imaging 
significantly. The most important factor influencing the image quality 
improvement is the VG grid ratio setting. The other software parameter settings 








B-0541 10:38  
X-ray dark-field and phase-contrast images facilitate the detection of 
wooden and glass foreign bodies on radiographs  
K. Hellbach1, E. Beller1, A. Schindler1, F. Schoeppe1, N. Hesse1, 
A.B. Baumann1, R. Schinner1, C. Hauke2, F. Meinel1; 1Munich/DE, 
2
Forchheim/DE  
Purpose: The purpose of this study was to assess the value of dark-field and 
phase-contrast radiography for the detection of foreign bodies (FB) compared 
to transmission radiographs. 
Methods and Materials: Ex vivo pig paws were prepared with metallic, 
wooden and glass FB (n=10 each). Paws without FB served as controls 
(n=30). Images were acquired with a prototype, preclinical grating-based large 
object radiography system (not commercially available). To investigate the 
diagnostic value of adding dark-field and/or phase-contrast images to 
transmission images a reader study was performed, asking five blinded 
readers to independently assess the images for the presence or absence of 
any FB. 
Results: Sensitivity for the detection of metal FB was 100% for all readers. 
The sensitivity for the detection of wooden FB increased from 2% for 
transmission images to 78% for dark-field images (p<0.0001), and to 16% 
when phase-contrast images were added (p=0.0264). For the detection of 
glass FB, the sensitivity slightly increased from 84% for transmission images to 
96% when adding phase-contrast images (p=0.041). The sensitivity for the 
detection of any foreign bodies was highest when transmission, dark-field and 
phase-contrast images were assessed simultaneously: 91%, compared to 62% 
for the sole analysis of transmission images (p<0.0001). 
Conclusion: Detection of glass FB was significantly improved when phase-
contrast images were analysed. Assessment of dark-field images resulted in a 
substantially improved detection of wooden FB compared to the sole analysis 
of transmission images.  
Author Disclosures: 
  C. Hauke: Employee; Siemens Healthcare GmbH. 
B-0542 10:46  
High-fidelity vessel visualisation in diagnostic CT: low-dose dynamic 
CTA via singular value decomposition-guided filter (SVGF)  
F. Pisana1, T. Henzler2, H. Haubenreisser2, E. Klotz3, B. Schmidt3, 
M. Kachelrieß1; 1Heidelberg/DE, 2Mannheim/DE, 3Forchheim/DE  
Purpose: To provide high-fidelity images of vessels in low-dose dynamic CT 
angiography (CTA). 
Methods and Materials: Dynamic CTA provides additional unique information 
compared to conventional CTA. Low-dose acquisitions, however, typically 
result in noise and artefacts and small vessels may be hard to be visualised, 
particularly in the temporal MIP volume. We developed a non-linear filter to 
significantly improve image quality. After subtracting the baseline, the temporal 
redundancy of the dataset is enforced via singular value thresholding, which 
has the effect of reducing the temporal noise while preserving the temporal 
signal. The temporal MIP of the such-filtered volume is used to guide a spatial 
bilateral filter. Additionally, to preserve temporal coherence, we introduced a 
weight depending on the similarity of the smoothed temporal profiles. The 
SVGF was retrospectively tested on several low-dose dynamic CTA cases, 
acquired at 70 kV, with a Somatom Force CT scanner (Siemens, Forchheim, 
Germany). 
Results: The CNR of small vessels was evaluated on the temporal MIP of both 
the unfiltered and filtered cases. The SVGF improved the CNR by 80% on 
average, resulting in a potential dose reduction of a factor of 3. Also, each 
temporal phase was significantly improved, allowing for higher details in the 
dynamic MPR, MIP and VRT visualisations. 
Conclusion: Dynamic CTA could potentially replace conventional CTA given 
the significance of the additional information provided. Our new SVGF 
approach could allow for dynamic CTA at very low doses, roughly 1.5 mSv 
instead of 4.5 mSv, and restore detailed dynamic visualisation of the vessels.  
Author Disclosures: 
 E. Klotz: Employee; Siemens Healthcare GmbH. B. Schmidt: Employee; 
Siemens Healthcare GmbH.  
B-0543 10:54  
Potential of spectral photon-counting CT for the differentiation between 
blood and iodine in a bovine brain  
I. Riederer1, D. Bar-Ness2, F. Pfeiffer3, P. Douek2, S.A. Si-mohamed2, 
A.A. Fingerle1,3, E.J. Rummeny1, P.B. Noel1,3, D. Muenzel1,3; 1Munich/DE, 
2
Bron/FR, 3Garching/DE (isabelle.riederer@tum.de)  
Purpose: To evaluate the potential of Spectral Photon-Counting CT (SPCCT) 
for the differentiation between blood and iodine in a bovine brain. 
Methods and Materials: Tubes with blood and a concentration series of 
iodine-based contrast agents were scanned with a preclinical SPCCT system 
(both in-vitro and in an ex-vivo bovine brain tissue sample) to obtain spectral 
  






and conventional data. Iodine density maps and virtual non-contrast images 
were generated using the multibin spectral information to perform material 
decomposition. Region-of-interest (ROI) analyses were performed within the 
tubes to quantitatively determine the absolute content of iodine. 
Results: In conventional CT images, ROI analysis showed similar HU density 
values for the tubes with blood and iodine (59.9 +/- 1.8 versus 59.2 +/- 1.5). 
Iodine density maps enabled clear differentation between blood and iodine in-
vitro, as well as in the bovine brain. Quantitative measurements of the different 
iodine concentrations matched well with those of actual prepared mixtures 
(measured: 0.57 +/- 0.09 mg/cm³, actual: 0.5 mg/cm³; measured: 0.77 +/- 0.16 
mg/cm³, actual: 0.75 mg/cm³; measured: 0.93 +/- 0.15 mg/cm³, actual: 1 
mg/cm³; measured: 2.11 +/- 0.21 mg/cm³, actual: 2mg/cm³; measured: 5.06 +/- 
0.06 mg/cm³, actual: 5 gm/cm³; measured: 10.33 +/- 0.18 mg/cm³, actual: 10 
mg/cm³; measured: 16.08 +/- 0.13 mg/cm³, actual: 15 mg/cm³). 
Conclusion: Spectral Photon-Counting CT allows for multi-material 
decomposition and differentiation between blood and iodine in-vitro and within 
a bovine brain, providing reliable quantification of the iodine concentration.  
B-0544 11:02  
An automated alignment correction algorithm for CT imaging: evaluation 
based on a CT image quality phantom and application to sediment cores 
from cold-water coral mounds  
S. Skornitzke1, G. Pahn1, A. Bahr1, J. Raddatz2, H.-U. Kauczor1, W. Stiller1; 
1
Heidelberg/DE, 2Frankfurt a. Main/DE 
(Stephan.Skornitzke@med.uni-heidelberg.de)  
Purpose: Alignment of objects during computed tomography (CT) acquisition 
can be crucial for evaluation, e.g. for image quality assurance. An algorithm for 
automated alignment correction of scanned objects was developed, evaluated 
in a phantom, and applied to acquisitions of sediment cores, enabling 
extraction of geological samples. 
Methods and Materials: A phantom (ConeBeam Phantom; QRM, Germany) 
was scanned at 120kVp/150mAs (SOMATOM Definition Flash; Siemens 
Healthineers, Germany). Image series were randomly rotated (up to ±2.86°) 
and translated (up to ±15mm) 1000 times and alignment was automatically 
corrected using the developed algorithm. Alignment parameters determined by 
the algorithm were compared to randomised parameters, and four regions of 
interest (ROIs) were placed in the low-contrast phantom segment, comparing 
mean values before and after correction. After validation, CT series of six 
sediment cores from cold-water coral mounds acquired at 140kVp/570mAs 
were corrected for alignment. 
Results: Average absolute differences between detected and randomized 
parameters were 0.15±0.07° around x-axis, 0.02±0.02° around y-axis, 
0.01±0.06mm in x, and 0.11±0.08mm in y. Mean values for ROI measurements 
averaged for corrected datasets were -148.54±1.40HU, -76.78±0.90HU, -
48.16±0.86HU and -16.64±0.48HU, compared to original measurements of -
149.76HU, -77.54HU, -48.61HU and -17.00HU. Alignment could be corrected 
for all six CT series of sediment cores. Average absolute rotation was 
0.37±0.33° around x-axis, 0.21±0.22° around y-axis, and average absolute 
translation was 3.93±2.89mm in x and 7.21±2.37mm in y. 
Conclusion: The algorithm allows to automatically correct alignment of imaged 
objects, e.g. in CT series of standard quality assurance phantoms as well as 
general cylindrical objects, enabling further evaluation.  
Author Disclosures: 
 G. Pahn: Employee; Philips GmbH Market DACH.  
B-0545 11:10  
Correcting for acoustic and optical inaccuracies in photoacoustic 
imaging using multimodal priors  
S. Mandal, D. Komljenovic; Heidelberg/DE (s.mandal@dkfz.de)  
Purpose: Photoacoustic (PA) imaging depends on the principle of optical 
generation and acoustic detection of signals from tissue sample. However, 
biological tissue suffer from significant depth dependent optical fluence losses 
and acoustic attenuations. We aim to correct for these inaccuracies aided by 
extrinsic imaging priors obtained through concurrent high-frequency ultrasound 
(US) imaging of tissue samples. 
Methods and Materials: A hybrid PA-US system (Vevo LAZR-X, 
VisualSonics) was employed for acquisition of fused multimodal data in real 
time. The temperature was monitored continuously using built-in temperature 
sensor, it was used as an initial estimate for speed-of-sound (SoS) calibration. 
We corrected for the small variations in SoS by incorporating multiple SoS in 
tissue and coupling medium, which was modelled using skin-line detection 
from the US image. The optical fluence correction was achieved through Monte 
Carlo modeling of light transport in multi-layered tissues (MCLM). The 
information regarding the different tissue layers were obtained through multi-
label segmentation of US images. Finally, anisotropic diffusion was used for 
noise reduction in the images without loss of edge information. 
Results: The corrected beamformed PA image showed an improvement of 
PSNR (43.289) and MSE (3.049). Further, fluence correction offers improved 
resolution at greater depths in the PA images. Results were verified using 
phantom studies and in vivo kidney images of small animal (rat) models. 
Conclusion: These experimental results demonstrate that mutual information 
from US and PA can significantly improve the imaging performance of the 
beamformed PA image, and reduce errors introduced by optical and acoustic 
attenuations.  
B-0546 11:18  
Improved contrast-enhanced time-resolved MR angiography on a small 
bore 3T MRI system  
S. Riederer, E. Stinson, M. Bernstein, N. Campeau, J. Huston, J. Trzasko; 
Rochester, MN/US (riederer@mayo.edu)  
Purpose: To describe the implementation of an improved time-resolved 
contrast-enhanced MR angiography sequence on a compact 3T MRI scanner. 
Methods and Materials: Recently a 37-cm bore “compact” 3T MRI system has 
been developed, specifically targeted to imaging the head and extremities, with 
smaller bore size enabling improved-performance gradient hardware. 
Compared to typical gradient amplitude and slew rates (50 mT/m, 200 T/m/sec) 
of a 70 cm whole body MRI, the compact 3T system has specifications (80 
mT/m, 700 T/m/sec). The smaller gradient diameter reduces peripheral nerve 
stimulation at higher switching limits than conventional diameter gradients. For 
this work, a reference time-resolved CE-MRA sequence was adapted to benefit 
from the compact 3T scanner’s increased gradient performance. This enabled 
reduction of the TR/TE of the SPGR T1-weighted sequence from 4.2/1.9 msec 
to 2.9/1.3 msec. This technique was evaluated in five human volunteers under 
an IRB-approved protocol. 
Results: Acceleration techniques enabled 1 mm isotropic resolution with 2.5 
sec update time on the compact 3T. The improved CE-MRA technique was 
able to resolve multiple phases of the arterial-venous passage of blood through 
brain vasculature of the volunteers. Benefits of shorter TE imaging include 
increased SNR and fewer flow-related artefacts. None of the volunteers 
experienced peripheral nerve stimulation. 
Conclusion: The enhanced gradient performance of the compact 3T MRI 
scanner permits 30% reduction in TR and TE parameters for contrast-
enhanced MRA, affording increased SNR and improved spatial/temporal 
resolution compared to that achievable using a whole body MRI scanner.  
B-0547 11:26  
Fast field-cycling MRI for medical applications  
L.M. Broche, J. Ross, G.R. Davies, D.J. Lurie; Aberdeen/UK 
(l.broche@abdn.ac.uk)  
Purpose: The relationship between T1-relaxation time and field strength in MRI 
is known to be very informative on molecular dynamics but is not accessible by 
conventional MRI systems. Here we introduce a new technology that measures 
T1 as a function of field strength, accessing that rich source of information to 
provide novel contrast. 
Methods and Materials: Our prototype human-scale Fast Field-Cycling (FFC) 
measures T1-dispersion by rapidly switching the main magnetic field (B0) during 
the pulse sequence to reach any field strength between 25 uT and 0.2 T within 
20 ms. Its resistive magnet is driven by power amplifiers giving full control of B0 
with a 15 ms stabilisation time. Additional coils outside the main magnet 
provide local cancellation of the Earth's field. 
Results: The system has been fully commissioned and is capable of in vivo 
imaging using its full field range. Images of the head and knees were obtained 
from normal volunteers and patients within 40 minutes for a resolution of 4x4x8 
mm over 250 mm field of view. T1-dispersion images were obtained that 
agreed with measurements on excised tissues from a benchtop FFC 
instrument. 
Conclusion: FFC-MRI allows us to explore and take advantage of the unique 
T1-dispersion contrast. The use of a purely resistive magnet allows us to 
access ultra-low magnetic fields, providing information on slow molecular 
dynamics. Our work currently concentrates on demonstrating how this newly 
accessible region of the T1 dispersion curve can be exploited for clinical 
diagnosis in stroke, osteoarthritis and Alzheimer's disease.  
Author Disclosures: 
 D.J. Lurie: Grant Recipient; GE Healthcare. 
B-0548 11:34  
Radiopaque 3D printing of patient individual phantoms for computed 
tomography and radiation therapy  
P. Jahnke, F.B. Schwarz, M. Ziegert, B. Hamm, M. Scheel; Berlin/DE 
(paul.jahnke@charite.de)  
Purpose: To develop a method for 3D printing realistic anthropomorphic 
phantoms of individual patients. 
Methods and Materials: Conventional inkjet technology is used together with 
radiopaque ink to print CT images of individual patients on standard paper. 
Stacking of the printed sheets results in 3D objects that are examined in the 
CT scanner. Calibration of the printer and a gray scale correction procedure of 
  






the CT images are necessary to achieve realistic Hounsfield units. Processing 
of the printed stack with a paper based 3D printer creates stable phantoms 
with the attenuation properties and the shape of the original patient. 
Results: Radiopaque 3D printing allows transfer of patient anatomy and 
pathology into a detailed individual phantom. Gray scale analysis with ink 
containing potassium iodide solutions (0.6 g/mL) on a HP Deskjet 6940 inkjet 
printer (Hewlett Packard, Palo Alto, Calif) yields an exponential correlation 
between template gray scales and printer deposition. Correction of the print 
template allows to achieve a linear correlation (r = 0.9946; 95% CI: 0.9916, 
0.9966). Application of the gray scale correction procedure to the CT image 
data set results in linear correlation of phantom and patient Hounsfield units (r 
= 0.9925; 95% CI: 0.9635, 0.9985). 
Conclusion: Radiopaque 3D printing realizes detailed anthropomorphic 
phantoms of individual patients. Applications are in training, device and 
protocol optimization, quality assurance and dosimetric investigations.  
Author Disclosures: 
  P. Jahnke: Patent Holder; DE202015104282U1, EP000003135199A1, 
US020170042501A1. Research/Grant Support; BIH TTF, BMWi EXIST. 
F.B. Schwarz: Research/Grant Support; BMWi EXIST. M. Ziegert: 
Research/Grant Support; BMWi EXIST.  M. Scheel: Patent Holder; 
DE202015104282U1, EP000003135199A1, US020170042501A1. 
B-0549 11:42  
Gallium Arsenide hybrid photon counting x-ray detectors: towards large 
area single-shot spectral mammography  
S. Gkoumas, M. Habl, V. Radicci, M. Rissi, T. Thuering, S. Traut, P. Trueb, 
P. Zambon, C. Broennimann; Baden-Daettwil/CH 
(spyridon.gkoumas@dectris.com)  
Purpose: This study presents the latest developments of two dimensional 
GaAs hybrid photon counting (HPC) detectors with respect to breast imaging 
applications. We discuss why direct conversion GaAs sensors combined with 
HPC technology is an optimum choice for fast exposure, single-shot and large 
area spectral mammography. 
Methods and Materials: The two prototype HPC X-ray imaging detectors used 
for this study are based on the DECTRIS SANTIS 0804 HR design using IBEX 
technology. They employ GaAs and CdTe as direct conversion sensor 
materials. Each detector has an active area of 8 x 4 cm2, a pixel size of 75 m2 
and two fully calibrated and independently adjustable energy selective 
thresholds. The detectors’ performance is assessed using mammography 
phantoms such as the ACR 156 and also imaging performance characteristics 
such as quantum efficiency (QE), modulation transfer function (MTF) and the 
newly introduced spectral efficiency (SE). 
Results: Both GaAs and CdTe show an excellent 5/4/5 score when imaging 
the ACR 156 phantom. For the relevant energy range of screening and 
diagnostic mammography, or digital breast tomosynthesis, GaAs exhibits QE 
higher than 80%. Moreover, GaAs shows higher QE than CdTe for the 30-50 
keV energy range which is significant in terms of dose efficiency for spectral 
mammography. Spectral efficiency in combination with preliminary material 
decomposition results are discussed. 
Conclusion: GaAs HPC X-ray imaging detectors present very attractive 
characteristics optimally suited for large area, low dose single-shot spectral 
mammography. They exhibit excellent image quality and optimum QE for the 
energy range of breast imaging applications.  
B-0550 11:50  
Development of algorithms to degrade the image quality of mammograms 
for lesion detectability studies  
J. Boita1,1, A. Mackenzie2, R. Van Engen1, M.J. Broeders1,1, I. Sechopoulos1,1; 
1
Nijmegen/NL, 2Guildford/UK (joana.dossantosboita@radboudumc.nl)  
Purpose: To develop algorithms to degrade mammographic image quality for 
future studies of how varying image quality affects lesion detectability. 
Methods and Materials: Algorithms were developed to reduce the contrast in 
specific image areas, decrease spatial resolution, and add correlated noise in 
digital mammograms: problems sometimes observed in processed images of 
several systems. First, an algorithm was developed to segment dark and bright 
areas on mammograms, reducing their contrast using a sigmoid function. To 
decrease resolution, images were multiplied by the difference between the 
standard and the desired, lower modulation transfer function (MTF). Correlated 
noise was created by enhancing the high spatial frequencies content in the 
image. The low contrast algorithm was tested by comparing mammograms to 
low-quality mammograms. Validation of resolution reduction was performed 
comparing the image of a 3D printed breast phantom placed on the support 
table corrupted by the MTF obtained 7 cm above the table, to an image of the 
phantom when placed there, using the Universal Quality Index (UQI). Addition 
of correlated noise was tested with breast phantom images using the 
Normalized Noise Power Spectrum (NNPS). 
Results: Changes in contrast appeared realistic comparing to real low-quality 
mammograms. Comparison of phantom images and the simulated reduced 
resolution images resulted, as expected, in a UQI of 1. Breast phantom images 
with added correlated noise showed, as expected, a higher NNPS. 
Conclusion: The three algorithms appear to result in realistic images with 
degraded quality, allowing for flexible paired comparisons with high-quality 
mammograms when evaluating image quality and detectability.  
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B-0551 10:30  
MRI of children aged 4-9 without anaesthesia using communication at the 
children's cognitive level  
S. Scheffmann Olloni, N. Villadsen; Odense/DK 
(signe_scheffmann@hotmail.com)  
Purpose: The primary purpose was to assess if MRI can be performed without 
anaesthesia on children aged 4-9 using communication at their cognitive level. 
The secondary purpose was to evaluate the parents’ perception of the 
children’s confidence using an app to inform about the scan. 
Methods and Materials: During a 3-month period, we asked 52 children aged 
4-9 to show up 30 minutes before their MRI scan. 11 of the children were 
scheduled for MRI under general anaesthesia (GA). We welcomed each child 
in the waiting room and established a good relation with the child to provide the 
necessary information before the MRI scan. We used an app called ‘HC And’ 
with animated characters showing how MRI and other examinations are 
performed. Furthermore, we asked the parents to answer a questionnaire to 
assess if they thought their children were better informed and more confident 
after using the app. 
Results: All children scheduled for GA completed the scan without GA. All 
parents rated the app either overall good or very good. All parents felt their 
child got more information about the scan using the app. All parents felt that 
their child was more confident before and during the scan using the app. 
Conclusion: Using communication at the children's cognitive level, more 
children can complete MRI scan without GA. At the same time, the use of the 
app markedly improves the parents’ perception of the children’s confidence.  
B-0552 10:38  
Development of an fMRI linguistic paradigm to monitor PPA patients: a 
pilot study  
C. Ferreira1, I. Cadório2, A. Barbosa2, A. Freixo2, B. Silva2, D. Figueiredo2, 
M. Lousada2, M. Castelo-Branco1, P.M. Martins2; 1Coimbra/PT, 2Aveiro/PT 
(pmartins@ua.pt)  
Purpose: Functional magnetic resonance Imaging (fMRI) is an emerging 
technique used to report therapy induced changes in primary progressive 
aphasia (PPA). However, there are no well-defined protocols and most studies 
only use picture naming tasks. This study aimed to develop and test an 
adequate fMRI paradigm for future use in PPA patients. 
Methods and Materials: Five right-handed healthy volunteers were enrolled in 
this study. Three lists of stimuli were visually presented, one for each task. The 
naming task consisted of 40 black and white line drawings. Semantic task 
included 15 related word-pairs and 15 unrelated word-pairs. A total of 36 non-
word pairs were specifically tailored to the phonological task, considering 
European-Portuguese syllabic structure. Image acquisition was carried out in a 
3T scanner and general linear model analysis was performed using 
BrainVoyagerQx. Statistical findings were thresholded at the voxelwise level 
p<.05 and corrected for multiple comparisons. 
Results: The naming task induced a left-sided activation of frontotemporal 
cortices accompanied by a bilateral activation of occipital regions. In the 
semantic task, participants recruited semantic processing areas located in the 
left frontotemporal and parietal lobes, as well as occipital lobe bilaterally. The 
phonological task revealed cortical activity in the left frontal lobe, right 
cerebellar areas, and bilateral occipital lobe. In general, cerebral activation 
patterns found in this study are supported by the literature. 
Conclusion: This protocol can be used in future studies targeting PPA 
population. Diagnosis and treatment monitoring can be facilitated by comparing 












B-0553 10:46  
1.5T vs 7T in determining changes of white matter in multiple sclerosis: 
preliminary studies  
A. Pankowska, K. Kochalska, K. Dyndor, A. Łazorczyk, R. Pietura; Lublin/PL 
(zubianna@gmail.com)  
Purpose: Multiple sclerosis is a chronic, progressive neurological disease 
which causes disablement and cognitive impairment. The aim of this work is to 
reveal main advantages of examinations performed in the ultra-high magnetic 
field. More precise and detailed imaging may help in better understanding of 
mechanisms responsible for origination and progression of this disease. 
Methods and Materials: MRI examinations were performed on 1.5 T Optima 
MR GE using 8-channel NV Head Array Coil and Discovery 950 GE 7T 
scanner with Nova Head 32-channel head coil. At 1,5 T we performed a 3D 
CUBE T2 FLAIR and 3D T1 SPGR sequence with inversion time of 1000ms. At 
7 T we acquired 3D CUBE T2, 3D T1 BRAVO sequence with an inversion time 
of 1000ms and SWAN. All ten patients with a demyelinating disease with age 
in a range of 22 to 58 and EDSS scale in the range of 1 to 6 were imaged on 
the both MRI systems. Images of all patients group were analyzed by two 
radiologists working in consensus. 
Results: Studies performed in 7T showed higher sensitivity and specificity in 
detecting the presence of demyelinating plaques in the subcortical white matter 
and changes in the cerebral cortex. SWAN sequence presented the 
characteristic course of the blood vessels through a demyelination plaque. 
Conclusion: Ultra-high 7T field MR imaging contributes to the better detection 
and characterisation of MS lesions due to an increased signal to noise ratio 
(SNR) and improved contrast what allows clinician for better visualisation of 
white matter lesions.  
B-0554 10:54  
A multi-centre study: qualitative and quantitative comparison of liver MR 
image quality  
S. Al Dahery, L.A. Rainford, A. McGee; Dublin/IE (shrooq_talal@hotmail.com)  
Purpose: Quality evaluation of axial liver MR images acquired at 1.5T using 
two-dimensional (2D) breath-hold T2-weighted (T2W) fast spin-echo (FSE) and 
three-dimensional (3D) T1-weighted (T1W) gradient echo sequences, focusing 
on the clarity of visualisation of normal liver anatomy. 
Methods and Materials: Axial 2D T2W FSE and T1W 3D GRE pre-contrast 
liver MR images from (n=96 cases) acquired at Irish (n=10) and Kingdom of 
Saudi Arabia (n=9) hospitals were analysed. SNR and CNR values were 
calculated for normal liver parenchyma, spleen and background noise. Images 
were evaluated qualitatively for the presence of motion artefacts, visualisation 
of liver parenchyma and vascular pattern and spleen parenchyma. Optimal 
sequence parameters were independently agreed by expert readers (n=8) and 
applied to 10 volunteers. Radiologists (n=3) and radiographers (n=2) 
qualitatively evaluated optimised liver MR images and indicated their preferred 
sequence (original/optimised). 
Results: Differences in motion artefact within original T2W FSE images was 
noted between countries. Differences in 3D T1W GRE image quality criteria 
scores for spleen parenchyma visualisation, SNR and spatial resolution from 
protocol 1 using a slice thickness 3 mm compared to protocol 2 using slice 
thickness of 4 mm were noted (p <0.05). SNR and CNR findings elicited 
significant differences following optimisation compared the original protocols (p 
= 0.004). Qualitative descriptive statistics were higher for the optimised 
protocols compared to the original protocols for all sequences. 
Conclusion: Radiographers require appropriate knowledge of MR physics to 
fully optimise MR image quality. Quantitative and qualitative evaluation of MR 
images can usefully guide sequence parameter optimisation.  
B-0555 11:02  
Performance of single-use syringe versus multi-use MR contrast 
injectors: a prospective comparative study  
F. Struik, J.J. Futterer, M. van der Graaf, M.M. Prokop; Nijmegen/NL 
(femkestruik@gmail.com)  
Purpose: To compare performance parameters of a single-use syringe and a 
multi-use MR contrast injector. 
Methods and Materials: We compared preparation time, cost for disposables 
and volumes of contrast material used for a single-use syringe (A; Mallinckrodt 
Optistar LE, Liebel-Flarsheim, USA) and a multi-use MR contrast injector (B; 
Max 3, ulrich medical, Germany) in a prospective cross-over trial. All 
consecutive patients eligible for dynamic MRI on two MR systems were 
included during a period of 20 working days. After 10 days, the injector was 
switched. Technician satisfaction was evaluated using a questionnaire. 
Results: We could include 111 and 95 patients for systems A and B, 
respectively. Average preparation time was 4:55 min for A and 2:24 min for B 
(p< 0.05). Total injected volume was 752 ml for A and 695 ml for B (N.S.). 
Contrast waste for A was 10.7% using 7.5-ml syringes. Contrast waste for B 
was 4.5% for 7.5-ml containers. Costs for disposables were lower for B if more 
than 5 patients per days were injected. Technicians satisfaction was higher for 
B (4.7 versus 2.8 on a 5-point scale; p< 0.05). 
Conclusion: The multi-use MR contrast injector led to higher technician 
satisfaction, shorter preparation time, and lower cost if more than 5 patients 
were injected per day. In addition, cheaper contrast containers of 15 or 30 ml 
could be used for the first patients if more than 2 or more than 4 injections are 
performed per day.  
Author Disclosures: 
  F. Struik: Research/Grant Support; Ulrich Medical. J.J. Futterer: 
Research/Grant Support; Ulrich Medical. M. van der Graaf: Research/Grant 
Support; Ulrich Medical. M.M. Prokop: Research/Grant Support; Ulrich 
Medical. 
B-0556 11:10  
Ambient experience in MRI  
P. Pedersen1, L. Fremmelevholm1, S.H. Jørgensen2, S. Moerup1; 1Odense/DK, 
2
Svendborg/DK (curly64@gmail.com)  
Purpose: To investigate if radiographers can contribute to reduced anxiety 
during MRI scans for adults with the use of new developed Ambient 
Experience system. 
Methods and Materials: In total, 102 patients were included in this study and 
randomized into two groups, 61 patients (61.8%) were scanned with the 
Ambient Experience system turned on and 41 (40.1%) were scanned with 
white light. Two validated questionnaires “The Magnetic Resonance Imaging-
Anxiety Questionnaire” and “The Claustrophobia Questionnaire” were used to 
illustrate whether Ambient Experience (Philips Healthcare, Amsterdam) could 
reduce anxiety for adults during an MRI scan. Patients included in this study 
were all scanned with head first to get the perfect effect of the Ambient 
Experience system. 
Results: Results showed that 83 of the 102 patients had a degree of 
claustrophobia. 29 patients had a mild degree, 33% of these patients scanned 
with Ambient Experience were more relaxed during the MRI scan, than 
patients scanned without the system (9%). Furthermore, six patients scanned 
with Ambient Experience described that previous scans were horrible or 
uncomfortable, but the use of Ambient Experience made it a better experience 
with reduced anxiety. 
Conclusion: The questionnaire indicated that patients preferred to be scanned 
with Ambient Experience. It is difficult to conclude that Ambient Experience 
alone can reduce anxiety. Communication, time and previous experiences can 
also affect the patient; however, all 61 patients scanned with Ambient 
Experience had a better experience during the scan and felt less anxious than 
those who have been scanned with white light.  
B-0557 11:18  
Evaluation of occupational exposure from electromagnetic field radiation 
on mobile magnetic resonance imaging units  
A.F.C. Sousa, J. Santos, A. Ferreira; Coimbra/PT (a.filipa.c.sousa@gmail.com)  
Purpose: The health staff exposure to electromagnetic fields in Magnetic 
Resonance Imaging (MRI) has been increasing and no evidence is found 
regarding the mobile MRI units and their exposure measurement. This study 
intends to measure the staff exposure to static magnetic fields on these units to 
assess compliance with exposure limits. 
Methods and Materials: This investigation was performed in the United 
Kingdom, in 5 mobile MRI units, Siemens Symphony 1.5T and was divided in 
three phases: analyses of the examinations frequency; Measurement of the 
first operator exposure using a TAOMA TS/001/UB combined with a 
TS/002/BLF probe during routine protocols (n=98); Quantification of the 
exposure variation in different locations using a homogenous phantom. 
Results: The lumbar spine, knee and brain are the three most common 
anatomic regions examined. On the second phase, no significant differences 
were found between the anatomic region selected and the amplitude or 
frequency (p>0.05). However, significant differences were found (p=0.001) 
between the anatomic regions and the maximum value detected on the lumbar 
spine. On the third phase, the amplitude values shown significant differences 
between the amplitude value and the probe's position (p=0.015). 
Conclusion: The obtained results are in compliance with the Electromagnetic 
Field Directive. However, it would be interesting to promote training for MRI 
mobile workers, in order to present methods for their exposure reduction during 
patients attending. Further research on this subject would be helpful and 
interesting, not just on the mobile units but also at other facilities.  
B-0558 11:26  
Detection of colorectal cancer liver metastases with MRI: is diffusion-
weighted imaging (DWI) solely as good as DWI + dynamic T1-weighted 
sequences after extracellular Gd?  
M.N. Tettero; Alkmaar/NL (mereltettero@gmail.com)  
Purpose: To compare the diagnostic performance of unenhanced liver 
magnetic resonance imaging (MRI) with diffusion-weighted MR (DWI) and Gd-
  






based enhanced liver MRI with DWI in patients with colorectal liver metastases 
(CRLM) on per-patient basis. 
Methods and Materials: A query of our image database was performed 
between 2014 and 2016, identifying patients with histologically proven 
colorectal cancer, who were submitted to MRI for suspicion of CRLM. 24 
patients were found with CRLM, and 24 patients without liver metastases were 
found to form the control group. All patients underwent dedicated liver MR 
protocol among others with DWI and T1-weighted GRE sequences after 
extracellular Gd. Comparison was performed between the entire dataset 
(extended protocol) and reduced dataset in which the post-contrast T1 GRE 
had been removed (reduced protocol). Three abdominal radiologists evaluated 
both datasets independently of each other, with a minimum time between the 
reading of 2 weeks. Images were correlated with the reference standard 
(consisting of histopathology/comparison imaging/follow-up). 
Results: The diagnostic performance for the detection of CRLM, on per-patient 
basis is as follows. Reduced protocol: sensitivity 92% ( CI 80.6-100), specificity 
100%. Extended protocol: sensitivity 100%, specificity 100%. 
Conclusion: DW-MRI is an excellent imaging tool for screening and 
surveillance of patients at risk of CRLM (sensitivity 92%, specificity 100%) with 
a short scan time of 10-15 minutes. The combination of DWI with enhanced 
T1-weighted MRI is the best screening modality for CRLM with 100% 
sensitivity and 100% specificity, however, with long scan times, 40-45 minutes 
and with the administration of intravenous contrast agent.  
B-0559 11:34  
A data mining approach to the SAR values over large MR image 
repositories  
A.C.C. Murraças1, P.M. Martins1, C. Ferreira2, T.M. Godinho1, 
M. Castelo-Branco2, A. Silva1; 1Aveiro/PT, 2Coimbra/PT (accm@ua.pt)  
Purpose: In magnetic resonance imaging, the radiofrequency energy 
absorption arises as one of the main safety concerns, being mainly related with 
increased body temperature. Monitoring radiofrequency absorption is achieved 
by the estimation of specific absorption rate (SAR), whose implementation lies 
on equipment manufacturers, which in turn are not totally enlightening about its 
calculus. This work presents an exploratory approach of whole-body SAR 
values stored in DICOM metadata aiming to find correlation with body weight, 
body mass index (BMI), gender and pulse sequences for abdominal/pelvic 
(17.812 series) and head (29.907 series) studies. 
Methods and Materials: All studies were acquired in a 3 Tesla scanner with 
high-performance gradients. Data were extracted using Dicoogle, a DICOM 
metadata mining tool. Several DICOM tags were analysed (e.g. patient weight, 
height, gender, sequence name). For each study type, specifically weighted 
pulse sequences were related with weight, BMI and gender through boxplot 
diagrams, statistical and effect size analysis. 
Results: SAR limits were never exceeded. Generally, SAR values tended to 
decrease with increasing body weight and BMI values for abdominal/pelvic 
studies. On the other hand, head studies showed different trends regarding 
distinct pulse sequences. SAR values tend to be higher in male individuals 
(p<0,05). As expected, turbo spin echo sequences present the highest SAR 
values. The values found for echo gradient spoiled sequence (FLASH) were 
also high. 
Conclusion: It is confirmed that SAR estimates are related with the analysed 
variables. An individual examination of pulse sequences is recommended to 
observe trends regarding weight, BMI or gender.  
B-0560 11:42  
Optimisation of the Blade technique in the cervical spine MRI  
R.M. Lopes1, D. Carvalho2; 1Vila Nova de Gaia/PT, 2Coimbra/PT 
(rogeriolopes87@gmail.com)  
Purpose: The Blade technique for MRI imaging of the cervical spine has 
proven to be a reliable tool for reducing artifacts typically for this anatomic 
region. The objective of the study is to evaluate the image quality, the contrast 
and diagnostic acuity between T2 TSE conventional and T2 Blade in the axial 
and sagittal planes. 
Methods and Materials: The sample is composed of 14 patients in the sagittal 
plane and 12 patients in the axial, being acquired with similar acquisition 
parameters and evaluated by two neuroradiologist. Statistical evaluations were 
achieved using the X2 test. 
Results: The neuroradiologist A considered the images of the sagittal Blade 
excellent in 42.9% of the cases and only 14.3% in the TSE that relates the 
characterization of bone lesions. The neuroradiologist B considered the sagittal 
Blade technique excellent in 78.6% of the cases and only 35.7% in the TSE in 
the representation of herniated disc. In the axial plane, in the representation of 
bone lesions, the neuroradiologist A, considers the Blade technique excellent 
in 41.7% of the cases and only 25% in the TSE. The neuroradiologist A, select 
the Sagittal Blade technique in 42.86% and the TSE in 7.14% of the cases. 
The neuroradiologist B, in the axial plane prefers the Blade in 41.67% and only 
8.33% in the TSE. 
Conclusion: The quality of the images belonging to the T2 Blade sequences 
on the sagittal and axial plans were considered superior to the T2 TSE 
conventional.  
B-0561 11:50  
Comparing the detection rate of melanoma metastases on gadolinium-
based contrast-enhanced MRI brain scan compared to a non-enhanced 
scan.  
K. Thakor, V. Major, S. Patel, H.R. Bergman, W. McGuire, A. Lakhani; 
Northwood/UK (kirti_tailor@yahoo.co.uk)  
Purpose: Malignant melanoma is the 3rd most common malignancy to 
metastasise to the brain. At our institution, patients with high-risk melanoma 
undergo surveillance with regular MRI brain scans with intravenous 
gadolinium-based contrast agents (GBCA). Research has recently shown that 
recurrent administration of GBCA can result in gadolinium deposition within the 
brain although the effects of this is yet unknown. The purpose of this study was 
to identify if intracranial metastatic melanoma deposits can be visualised on the 
pre-contrast scans to evaluate if these patients can undergo surveillance with 
unenhanced brain MRI scans. 
Methods and Materials: A retrospective study was conducted. Consecutive 
patients attending for MRI brain scans with intravenous GBCA for metastatic 
melanoma were reviewed for the period of January 2016 to December 2016. 
The pre-contrast T1 coronal sequence was compared to the post-contrast 3D 
sequence. 
Results: 195 patients were evaluated. An intracranial metastatic deposit was 
reported in 13.9% of the scans, out of which only 25.9% of the scans showed 
identifiable metastasis on the pre-contrast scan. 
Conclusion: The results demonstrate that the use of GBCA is essential in 
brain scans for metastasis detection in patients with melanoma as the majority 
of lesions are not identifiable without contrast enhancement. However, at our 
institution the pre- and post-contrast sequences are not identical, this 
difference could account for some of the number of lesions detected. Using the 
same sequence for pre- and post-contrast scans for further investigation would 
help in a more accurate comparison.  
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B-0562 10:30  
Correlation of a new formula measuring carotid-femoral pulse wave 
velocity with cardiovascular risk factors, major adverse events and 
mortality  
S. Chin, J. Weir-McCall, L. Brown, J. Summersgill, P. Talarczyk, 
M. Bonnici-Mallia, F. khan, A.D. Struthers, G. Houston; Dundee/UK 
(sookcheng@doctors.org.uk)  
Purpose: Carotid femoral pulse wave velocity (PWV) is a strong predictor of 
cardiovascular mortality and methods using external distance measurements 
are not reliable as they are prone to confounding factors. A new formula for 
PWV calculation was derived from whole-body magnetic resonance 
angiograms (WB-MRA) and we aim to examine if this formula correlates better 
with cardiovascular risk factors, major cardiovascular adverse event (MACE) 
and mortality. 
Methods and Materials: Arterial pathlengths were measured from WB-MRA 
from the TASCFORCE study group and backwards linear regression was 
applied to derive the formula: carotid femoral pathlength=100.36+(0.70 
×age[years] )+(137.81×height[m] )+(0.51×weight[kg] )-(0.18×pulse)+(46.25 [if 
female],53.89 [if male]). This was then applied to two population study groups. 
From this, correlation between the new PWV calculations (PWVNEW) versus 
external measurements (PWVCAER and PWVSUM) and cardiovascular risk 
factors were calculated using Pearson and Spearman correlation co-efficients. 
Significant difference was assumed when p<0.05. 
Results: There were 1242 SUMMIT study participants and 825 Caerphilly 
study participants. There were no loss of correlation between PWVNEW with 
age, blood pressure or creatinine levels (p<0.01). In both the SUMMIT and 
Caerphilly cohort, the PWVNEW showed a loss correlation with obesity and waist 
circumference. The hazard ratio was 1.11 and 1.17, respectively, for 
cardiovascular mortality and MACE and is unchanged for all PWV 
measurements. 
  






Conclusion: The new formula based on the patient’s height, weight, sex and 
pulse measurements demonstrates less variability and is more accurate 
compared to measurements using external distances without losing its 
association with cardiovascular risk factors, MACE and mortality.  
Author Disclosures: 
 J. Weir-McCall: Grant Recipient; Guerbet Laboratories. G. Houston: Grant 
Recipient; Guerbet Laboratories, Cook Medical, Medtronic. 
B-0563 10:38  
Acute adverse events in cardiac MR imaging with gadolinium-based 
contrast agents: results from the European Society of Cardiovascular 
Radiology (ESCR) MRCT registry in 72,839 patients  
J. Uhlig1, C. Lücke2, R. Vliegenthart3, C. Loewe4, M. Grothoff2, A. Jacquier5, 
M. Francone6, J. Lotz1, M. Gutberlet2; 1Göttingen/DE, 2Leipzig/DE, 
3
Groningen/NL, 4Vienna/AT, 5Marseille/FR, 6Rome/IT (cluecke@gmx.de)  
Purpose: To assess the incidence of acute adverse events (AAE) in 
gadolinium-enhanced cardiac magnetic resonance (CMR) imaging with 
statistical adjustment for potential confounders. 
Methods and Materials: Gadolinium-based contrast agents (GBCA) enhanced 
CMR from the ESCR MR/CT registry were included. AAEs were classified 
according to the ACR manual on contrast media. Multivariable logistic 
regression was used to model the likelihood of AAEs in various GBCA, 
adjusting for pharmacological stressor, main indications, age and sex. 
Results: In 72,839 CMR, 260 AAE occurred (0.36%), with a minority of severe 
adverse events (SAE) (n=24, 0.033%). Patients without pharmacological stress 
(PS) imaging had a lower AAE rate (n=120/54,285, 0.22%) than patients 
receiving PS (n=140/18,554, 0.75%). Highest AAE rates were reported for 
regadenoson (n=34/1,151, 2.95%), and dobutamine (n=7/482, 1.45%), mainly 
dyspnoea (n=24). Compared to the most frequently used gadobutrol [56%], 
AAE were more likely for gadoteridol [4%] (OR=3.16, 95% CI: 2.10-4.74, 
p<0.001), and less likely for gadoter acid [20%] (OR=0.64, 95% CI: 0.44-0.93, 
p=0.018). There was multiplicative interaction between GBCA and PS 
(p<0.01). Comparing adenosine to regadenoson, the AAE rate differed by the 
factor 9 for gadobutrol (0.52% vs 4.56%), while rates were comparable for 
gadoter acid (0.3% vs 0.47%), independent of PS. However, no significant 
difference in the frequency of AAEs depending on the molecular structure, 
ionicity or chelate stability of GBCAs was found. 
Conclusion: GBCA-enhanced CMR is generally safe with event rates 
comparable to those of other body regions. The likelihood of AAE increases 
with stress imaging and depends on the pharmacological stressor and main 
indication.  
B-0564 10:46  
Prevalence and clinical relevance of extra-cardiac findings in CMR 
imaging  
D. Mastrodicasa1, C. Mantini2, F. Bianco2, F. Ricci2, S. Gallina2, G. Messalli3, 
F. Cademartiri4, A.R. Cotroneo2; 1Charleston, SC/US, 2Chieti/IT, 3Naples/IT, 
4
Rotterdam/NL (domenico.mastrodicasa@gmail.com)  
Purpose: To estimate the prevalence of ECF detected from clinically indicated 
CMR scans, and to determine the associated downstream effect on clinical 
management and resource utilisation. 
Methods and Materials: ECF were retrospectively evaluated in 500 
consecutive patients undergoing CMR for different cardiovascular diseases. 
Two independent radiologists retrospectively reviewed transaxial bSSFP multi-
slice images acquired with a field of view including thorax and upper abdomen. 
The ECF were classified as clinically non-significant (benign), clinically 
significant (potentially or absolutely considered to be of clinical significance, 
mandatory to be reported and monitored), and major (remarkable pathology, 
mandatory to be reported, further investigated and treated). A 15-month clinical 
follow-up was obtained from hospital records and referring physicians. 
Results: Of 500 patients, 108 patients (21.6% of study population) had a total 
of 153 ECF, 59 (38.8%) non-significant, 76 (50%) significant and 18 (11.7%) 
major. Of 94 significant and major ECF, 46 (36 clinically significant and 10 
major) were previously unknown and more common in older patients. The 10 
newly diagnosed major ECF (2% of study population and 6.5% of all IEFs), 
including tumours in 5 patients (1% of study population), were confirmed by 
downstream evaluations and required specific treatment.Patients with major 
ECF were older than patients without. Significant and major newly diagnosed 
ECF both required additional diagnostic tests respectively in 44% and 100% of 
cases. 
Conclusion: ECF are increasingly being spotted by radiologists and 
cardiologists on CMR scans. The detection of previously unknown major ECF 





B-0565 10:54  
Results from the Italian Registry of Contrast Material use in Cardiac 
Computed Tomography (IRCM-CCT)  
L. La Grutta1, A. Clemente2, E. Maffei3, G. Privitera4, M. Rengo5, P. Toia1, 
M. Francone6, M. Midiri1, F. Cademartiri7,8; 1Palermo/IT, 2Massa (MS)/IT, 
3
Urbino/IT, 4Catania (CT)/IT, 5Latina/IT, 6Rome/IT, 7Rotterdam/NL, 8Naples/IT 
(ludovicolagrutta@hotmail.it)  
Purpose: The Italian Registry of Contrast Material use in Cardiac Computed 
Tomography (IRCM-CCT) is a retrospective, multicenter, multivendor, 
observational study on the use of contrast media (CM) in patients undergoing 
CCT. The aim of IRCM-CCT is to assess safety profile and influence on image 
quality of CM use. 
Methods and Materials: IRCM-CCT enrolled 1894 consecutive patients (50 
per site; CCT indicated for suspected coronary artery disease) at 20 cluster 
sites. Demographic characteristics, CT and CM protocols, clinical indications, 
safety markers, radiation dose reports, qualitative (i.e. poor vascular 
enhancement) and quantitative (i.e. HU attenuation values) image parameters 
were recorded. A core lab assessed all image parameters. 
Results: The cohort includes 1117 men and 777 women (mean age 61±14 
years, mean body mass index 26±4) studied with 64 detector rows CT 
scanners and several iodine contrast media protocols and molecules 
(iodixanol, iopamidol, iobitridol, iopromide, and iomeprol). The following 
adverse reactions to CM were recorded: 6 extravasations and 17 reactions (11 
mild, 4 moderate, 2 severe). The core lab reading reported the following 
vascular attenuation: 537±160HU in the aorta, 472±160HU in the right 
coronary artery, 502±158HU in the left main, 475±156HU in the left anterior 
descending artery, and 458±158HU in the circumflex artery. In 4% of cases the 
image quality was not satisfactory due to poor enhancement. 
Conclusion: In a multicenter registry on CM use during CCT the prevalence of 
CM-related adverse effects was very low. The appropriate use of CM is a major 
determinant of image quality.  
B-0566 11:02  
Frequency and spectrum of incidental findings in cardiovascular disease 
CT screening trial  
M. Vonder1, C.M. van der Aalst2, R. Vliegenthart1, M. Kaatee1, J. Gratama3, 
D. Kuijpers4, H. de Koning2, M. Oudkerk1; 1Groningen/NL, 2Rotterdam/NL, 
3
Apeldoorn/NL, 4The Hague/NL (marleenvonder@gmail.com)  
Purpose: To determine the frequency, spectrum, and potential clinical 
relevance of incidental findings found on computed tomography coronary 
artery calcium scans (CT-CAC) of screenees. 
Methods and Materials: Incidental findings on CT-CAC scans of screenees 
from the ROBINSCA trial were recorded from January 2015 through 
September 2017. Informed consent for the ROBINSCA trial was obtained from 
all participants. Incidental findings were described individually and grouped 
based on potential clinical relevance and organ level. Incidental findings with a 
high potential of being clinically relevant were reported to the screenee’s 
general practitioner. 
Results: In total, 10,129 screenees underwent a CT-CAC scan, mean age was 
61.6 (SD: 7.3) years and 52.1% were male. One or more incidental findings 
were recorded on 603 (6.0%) CT-CAC scans, the mean of age of screenees 
with an incidental finding was 64.1 (SD: 6.5) year and 40.7% were male. Of the 
incidental findings found, 46.1% was hepatic, 24.5% cardiovascular, 13.5% 
pulmonary, 12.0% gastrointestinal, 3.0% lymphatic and 0.7% splenic. Of all 
incidental findings, 9.0% were potentially clinically relevant and were reported 
to the general practitioner. 
Conclusion: In 1:16 screenees one or more incidental findings are found on 
CT-CAC scans for cardiovascular screening, and 1:200 is potentially clinically 
relevant and reported to the general practitioner.  
B-0567 11:10  
Correlation between haptoglobin phenotypes and myocardial reperfusion 
injury in consecutive ST-elevation myocardial infarction as detected by 
cardiac magnetic resonance  
M. Guglielmo1, C. Banfi1, E. Giannazza1, A. Guaricci2, A. Baggiano1, 
D. Andreini1, S. Mushtaq1, M. Pepi1, G. Pontone1; 1Milan/IT, 2Bari/IT 
(marco.guglielmo@ccfm.it)  
Purpose: Primary percutaneous coronary intervention (pPCI) has significantly 
reduced cardiovascular mortality of ST segment elevation myocardial infarction 
(STEMI) patients. Cardiac magnetic resonance (CMR) has emerged as the 
gold standard technique for the measurement of the myocardial salvage index 
(MSI) and microvascular obstruction (MVO). We sought to evaluate the 
correlation between variants of haptoglobin and myocardial reperfusion injury.  
Methods and Materials: Consecutive STEMI patients reperfused by primary 
PCI were enrolled in this study with characterization of phenotypes of 
haptoglobin. A CMR was performed by 1 week after STEMI evaluating the 
following parameters: left ventricle ejection fraction (LVEF), MSI and 
  






prevalence and amount of MVO. Primary endpoint of study was to evaluate the 
correlation between different phenotypes of haptoglobin and myocardial 
reperfusion injury as detected by CMR. 
Results: 124 consecutive STEMI were enrolled.Three different phenotypes Hp 
1-1, Hp 1-2, Hp 2-2 were observed in 10 (8%), 55(44%) and 59(48%) patients, 
respectively. CMR showed a LVEF and MSI of 49±10% and 0.38±0.9, 
respectively.The MVO was observed in 33 patients (27%) with a mean value of 
2±4% of left ventricle myocardial mass. The patients with phenotype Hp 1-1 or 
Hp 1-2 showed no differences in terms of LVEF (p:0.18) and MSI (p:0.3) but 
higher prevalence(37% vs 17%, p<0.01) and amount (2.7±0.4% vs 1.3±0.4% 
of left ventricle mass, p<0.05) of MVO as compared to phenotype Hp 2-2. Hp 
2-2 was an independent predictor of MVO [HR:1.28 (1.08-2.4), p:0.20]. 
Conclusion: Different variants of haptoglobin may play a crucial role in cardiac 
repair responses. Further studies might evaluate if different therapeutic 
strategies should be developed based on phenotypes of haptoglobin of 
patients.  
B-0568 11:18  
Basic haematological biomarkers are associated with coronary 
calcification  
A.M. den Harder1, J.M. Wolterink1, P.A. de Jong1, M.C.H. de Groot1, 
R.P. Budde2, I. Isgum1, S. Haitjema1, I.E. Höfer1, T. Leiner1; 1Utrecht/NL, 
2
Rotterdam/NL (t.leiner@umcutrecht.nl)  
Purpose: Improved understanding of potential associations between basic 
haematological biomarkers and the coronary artery calcification (CAC) score 
may help unravel the pathophysiology of CAC and subclinical coronary artery 
disease. Therefore we investigated the association between basic 
haematological biomarkers and the CAC score. 
Methods and Materials: A retrospective cross-sectional study was performed 
within the Utrecht Patient Oriented Database. Patients with suspected/known 
coronary artery disease who underwent CT CAC scoring and standard 
haematology analysis that was part of routine clinical care (within 3 months of 
CT acquisition) were included. Complete haematology datasets were extracted 
from haematology analyzers. Linear regression adjusted for clinical 
confounders was used to assess if haematological biomarkers were related to 
the CAC score. 
Results: In total, 1,507 patients were included of which 43% (n=648) had a 
CAC score of 0. Mean age (±SD) was 53±13 years, and 34% of patients were 
female. Red blood cell count (=-0.16 [-0.25 - -0.04], p=0.011), red blood cell 
distribution width (RDW, =0.24 [0.10 - 0.40], p=0.001), coefficient of variation 
of neutrophil lobularity (=0.13 [0.01 - 0.26], p=0.028) and mean lymphocyte 
cell size (=0.24 [0.11 - 0.38], p<0.001) were independently associated with 
the CAC score after adjustment. 
Conclusion: RDW, coefficient of variation of neutrophil lobularity, and mean 
lymphocyte cell size are associated with a higher CAC score. While increased 
red blood cell count is associated with a lower CAC score. These biomarkers 
may further contribute to our understanding of the pathophysiology of CAC. 
Future studies should determine the pathophysiological significance of these 
associations.  
Author Disclosures: 
  A.M. den Harder: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
J.M. Wolterink: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
P.A. de Jong: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
M.C.H. de Groot: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
R.P. Budde: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
I. Isgum: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
S. Haitjema: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
I.E. Höfer: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
T. Leiner: Research/Grant Support; Abbott Diagnostics, BBMRI-NL. 
B-0569 11:26  
Accuracy of an artificial intelligence deep learning algorithm for the 
detection of calcified plaques at coronary CT angiography  
M. Eid1, C.N. De Cecco1, D. De Santis2, A. Varga-Szemes1, M.H. Albrecht3, 
D. Mastrodicasa1, P. von Knebel Doeberitz1, P. Sahbee4, U.J. Schoepf1; 
1
Charleston, SC/US, 2Rome/IT, 3Frankfurt a. Main/DE, 4Malvern, PA/US 
(eidmarwen.md@gmail.com)  
Purpose: Evaluate the accuracy of an artificial intelligence deep learning 
algorithm for the detection of coronary artery calcium in coronary CT 
angiography (CCTA) studies. 
Methods and Materials: 194 patients who had undergone clinically indicated 
CCTA were retrospectively selected. Two readers independently evaluated the 
contrast-enhanced images noting the presence of calcified plaques in the right 
coronary artery (RCA), left anterior descending artery (LAD) and left circumflex 
coronary artery (LCx). In this analysis, the left main coronary artery (LM) was 
merged with the LAD. Evaluation discrepancies were solved by a third reader. 
For the automated analysis, the heart detection, coronary artery centreline 
detection, centreline labeling, and plaque detection was performed fully 
automatically. The presence of coronary calcified plaques was assessed by a 
recurrent neural network with long short-term memory, previously trained for 
coronary artery calcium detection. Per-vessel and overall sensitivity, specificity 
and diagnostic accuracy of the algorithm were calculated. 
Results: A total of 194 patients were analysed for a total of 565 vessels. No 
patient was excluded. On a per-vessel analysis, the algorithm achieved a 
sensitivity (Se), specificity (Sp), and diagnostic accuracy (DA) of 92.96% (CI 
84.33%-96.67%), 82.76% (CI 74.64%-89.14%), and 86.63%, respectively, for 
the RCA, 93.07% (CI 86.24%-97.17%), 95.45% (CI 88.77%-98.75%), and 
94.17%, respectively, for the LM/LAD, 89.86% (CI 80.21%-95.82%), 90.00% 
(CI 83.18%-94.73%), and 89.95%, respectively, for the LCx. The overall Se, Sp 
and DA were 92.12 (CI92.12%-95.19%), 88.89% (CI 84.95%-92.10%), and 
90.26%, respectively. 
Conclusion: The proposed deep learning algorithm performs with high 
diagnostic accuracy for the automated detection of calcified plaques at CCTA.  
Author Disclosures: 
 C.N. De Cecco: Research/Grant Support; Siemens Healthineers. 
A. Varga-Szemes: Research/Grant Support; Siemens Healthineers. 
U.J. Schoepf: Research/Grant Support; Astellas, Bayer, GE, Siemens 
Healthineers. 
B-0570 11:34  
Computer-aided detection of coronary plaques in cardiac CTA  
L. Liu, J. Yang; Beijing/CN (tjdxdxxy@qq.com)  
Purpose: Computed Tomography Angiography (CTA) is a widely used non-
invasive imaging modality to diagnose and treat Cardiovascular diseases 
(CVD). Detection of coronary plaques(CP), especially non-calcified plaques 
with lower intensity values, from CTA data is a time-consuming and challenge 
task. In this work, we proposed and evaluated an automated segmentation 
system for plaques detection in CTA imagery. 
Methods and Materials: We developed a machine-learning framework for 
plaque detection using 3D convolutional neural network (3D CNN). The system 
combined both a priori knowledge of CPs and data-driven learning method. CP 
candidates were generated using intensity, geometric features. The CP 
candidates in the form of 3D cubes are fed into a 3D CNN to classify plaque 
and non-plaque inputs. Due to the limited amount of CTA data, transfer 
learning was utilized to obtain highly discriminative features. The performance 
of the system on 52 CTA volumes with manually labeled plaques was 
investigated. 
Results: The total detection accuracy was 90.4% with respect to the manual 
expert. Specifically, 86.3% of non-calcified and 92.4 of calcified plaques were 
achieved. The mean accuracy of plaque localization was 91.2% in term of the 
Dice similarity coefficient. 
Conclusion: Using a priori knowledge in our computer-aided framework 
improved the accuracy of coronary detection. The overall performance of the 
proposed computer-aided frameworks demonstrates a good agreement with 
manual expert annotations.  
Author Disclosures: 
  L. Liu: Employee; MedPai LLC. J. Yang: Employee; MedPai LLC. 
B-0571 11:42  
Comparison of coronary calcium distribution in large population-based 
screening trials: Dutch (ROBINSCA) vs multi-ethnic (MESA) population  
M. Vonder1, C.M. van der Aalst2, R. Vliegenthart1, M. Kaatee1, J. Gratama3, 
D. Kuijpers4, H. de Koning2, M. Oudkerk1; 1Groningen/NL, 2Rotterdam/NL, 
3
Apeldoorn/NL, 4The Hague/NL (marleenvonder@gmail.com)  
Purpose: To compare coronary artery calcium (CAC) distribution of the Dutch 
ROBINSCA trial and with the multi-ethnic MESA trial. 
Methods and Materials: ROBINSCA participants screened with CAC 
computed tomography (CT) were included in this study, and informed consent 
was obtained from all participants. The Agatston score was determined and 
CAC distribution based on the number of affected coronary arteries and 
diffusivity index was calculated. Diffusivity index (%) was defined as: 1-(CAC in 
most affected vessel/total CAC). Agatston score-based risk categorization (1-
100, 101-300, >300) was performed, and CAC distribution was analysed per 
risk category. The CAC score and distribution were compared for the Dutch 
ROBINSCA trial and multi-ethnic MESA trial as published by Blaha et al. 
(JACC Cardiovascular Imaging 2016). 
Results: In total 59.8% of the 7,516 ROBINSCA participants (mean age 62.9 
(SD 7.1)) had a positive Agatston score, being higher than in MESA (49.9%). 
The number of affected arteries increased for increasing age, calcium score 
and diffusivity index (p<0.001). The CAC distribution tended to be less diffuse 
for a similar number of affected arteries (2, 3, 4 arteries with CAC) in 
ROBINSCA (19.7%, 33.1%, 44.1%) compared to MESA (24.3%, 38.2%, 
46.0%). On the contrary, a comparable distribution pattern for number of 
affected arteries over the risk groups was found for the two populations. 
Conclusion: The amount of CAC tends to be less diffuse for similar number of 
affected arteries, while the distribution of the number of affected arteries over 
the risk categories is comparable for ROBINSCA compared to the multi-ethnic 
MESA population.  
  






B-0572 11:50  
Mitral annular plane systolic excursion assessed by cardiovascular 
magnetic resonance is an independent predictor of major adverse 
cardiac events after STEMI  
M. Pamminger, T. Nalbach, M. Reindl, G. Klug, S.J. Reinstadler, W. Jaschke, 
B. Metzler, A. Mayr; Innsbruck/AT (Mathias.Pamminger@tirol-kliniken.at)  
Purpose: We aimed to assess whether mitral annular plane systolic excursion 
(MAPSE) as assessed by cardiac magnetic resonance (CMR) imaging is a 
predictor of major adverse cardiac events (MACE) after ST-elevation 
myocardial infarction (STEMI). 
Methods and Materials: CMR was performed in 322 consecutive patients 
within 3 days (IQR 2-4 days) after reperfused first acute STEMI. MAPSE was 
determined in a 4-chamber CINE view by measuring the distance of mitral 
annulus position between the end diastole and the aortic valve closure. 
Patients were followed for major adverse cardiac events (MACE) - death, non-
fatal myocardial re-infarction, stroke and congestive heart failure. Cox 
proportional hazards regression modelling was used to identify factors 
independently associated with MACE. 
Results: Thirty-eight MACE (12%) occurred during a median follow-up of 18 
months [IQR 12-19 months]. In ROC analysis, the AUC of MAPSE for the 
prediction of MACE was 0.72 (95%CI 0.64 - 0.80, p<0.0001) with an optimal 
cut-off value of 8.6 mm. Univariate Cox regression analysis revealed a hazard 
ratio (HR) for reduced MAPSE of 4.45 (95%CI 2.21 - 9.15, p<0.0001). After 
adjustment for age, left ventricular (LV) ejection fraction and infarct size the 
association between reduced MAPSE and MACE remained significant (HR: 
3.74, 95%CI 1.51 - 9.22, p=0.004). By Kaplan-Meier analysis, patients with 
MAPSE < 8.6 mm experienced significantly higher incidence of MACE than 
patients with a MAPSE  8.6 mm (p <0.0001). 
Conclusion: CMR assessed MAPSE represents an easily determinable 
parameter and is an independent predictor of MACE after acute STEMI.  
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B-0573 10:30  
Magnetic resonance enterography (MRE) surveillance of asymptomatic 
paediatric Crohn's disease patients  
K. Wu, M. Gee, J. Kaplan; Boston, MA/US (kwu4@partners.org)  
Purpose: Magnetic resonance enterography (MRE) has become the primary 
modality for the evaluation of symptomatic paediatric Crohn’s disease (CD) 
patients. The role of MRE for surveillance in asymptomatic patients is not clear. 
We seek to analyse MRE studies performed on asymptomatic CD patients and 
to identify imaging features associated with clinical recurrence. 
Methods and Materials: Retrospective search was performed to identify 
patients <18 years of age with known CD and MRE performed while 
asymptomatic on therapy. Studies were reviewed by an experienced paediatric 
radiologist blinded to clinical data for the presence or absence of four imaging 
features: wall thickening, T2 hyperintensity, mural hyperenhancement, and 
vasa recta engorgement, as well as overall assessment of the presence or 
absence of active disease. Two paediatric gastroenterologists reviewed the 
electronic records to evaluate for clinical recurrence within six months of MRE. 
Results: 37 MRE studies performed in 36 asymptomatic patients were 
identified. 10 patients demonstrated clinical recurrence within 6 months of 
MRE. Overall assessment of disease activity by MRE was observed in a higher 
proportion of patients with clinical recurrence (80%) compared to patients 
without recurrence (29.6%) (p=0.01). Among individual imaging features, mural 
hyperenhancement demonstrated the highest accuracy (76%) and was 
observed in 80% of patients with 6-month clinical recurrence vs 26% without 
(p<0.01). 
Conclusion: MRE evidence of active inflammation in asymptomatic CD 
patients is associated with future clinical recurrence, with mural 
hyperenhancement having a statistically significant association with recurrence 
within 6 months. These suggest a role for imaging in surveillance of 






B-0574 10:38  
Fast acquisition abdominal MRI study for the investigation of suspected 
acute appendicitis in paediatric patients: prospective assessment of 
diagnostic accuracy and clinical efficacy  
K. James, P. Duffy, R. Kavanagh, A. Feeley, D. Ryan, P. Murphy, C. Bogue, 
M. Maher, O.J. O'Connor; Cork/IE (richkavanagh@rcsi.ie)  
Purpose: The purpose of this study was to investigate if a short duration, fast 
acquisition MRI scan of the lower abdomen is diagnostically superior and faster 
than ultrasound when investigating paediatric patients who present with 
suspected acute appendicitis. 
Methods and Materials: After obtaining clinical research ethics committee 
approval, 17 patients aged between 7 and 16 were included in the study. All 
patients underwent US and MRI scanning. MRI protocol: Axial and coronal 
gradient echo T2 scans (SSFSE) from the renal hilum to the femoral heads 
followed by axial and coronal fat saturated SSFSE. Diffusion weighted imaging 
was also performed. Diagnostic accuracy, radiologist diagnostic confidence, 
and patient satisfaction were measured. 
Results: Three males and fourteen females were included in the study. Mean 
age was 11.3 +/- 2.6 yrs. Mean BMI was 20.9 +/- 7 kg/m2. The appendix was 
seen on only 12% of US scans but was seen on 88% of MRI scans (p<0.0005). 
Appendicitis was diagnosed on 12% of US and on 41% of MRI (p=0.05). 
Diagnosis remained uncertain after US in 88% of cases and after MRI in 12% 
(p<0.0005). No difference was found between the mean time for US 16.8+/-10 
mins [95% CI: 11.6-22] and MRI 18.2+/-4.1 mins [95% CI: 16.1-20] (p=0.6). No 
significant difference was found in patient satisfaction between the modalities 
(p=0.87). 
Conclusion: This fast acquisition MRI abdomen protocol was superior to US in 
the investigation of paediatric patients with suspected appendicitis with 
superior diagnostic performance and diagnostic confidence and similar patient 
satisfaction.  
B-0575 10:46  
Comparison of image quality of the abdominopelvic computed 
tomography in paediatric patients: low-osmolar contrast media vs less 
iodine-containing iso-osmolar contrast media  
M. Kim1, J.-Y. Hwang1, K. Choo1, H. Ryu2, Y.-W. Kim1; 1Yangsan/KR, 
2
Seoul/KR (maeran.kim@gmail.com)  
Purpose: The aim of this study was to evaluate the effect of iso-osmolar 
contrast media (CM) containing a low iodine dose on image quality for 
abdominal computed tomography in paediatrics. 
Methods and Materials: The low-osmolar CM group and iso-osmolar CM 
group consisted of 101 and 102 CT scans, respectively, with patients less than 
18 years old. Patient age, weight, radiation dose, peak tube voltage, and 
volume of CM were retrospectively reviewed. Objective measurement of the 
contrast enhancement and noise were analysed and contrast-to-noise ratios 
(CNRs) of the abdominal aorta, portal vein and liver were calculated. Four 
radiologists participated in subjective analysis. Regarding subjective 
measurement, a four-point scale system was devised to evaluate degrees of 
contrast enhancement, image noise, beam hardening artefact, and overall 
image quality. Reader performance for correctly differentiating the groups was 
evaluated. 
Results: Regarding the objective measurement, contrast enhancement and 
noise were significantly higher in the low-osmolar CM group (P<.02). In 
subjective analysis, there was no significant difference in contrast 
enhancement, and overall image quality between groups. Image noise, 
however, was worse in the low-osmolar CM group (P=.003). Overall sensitivity 
and specificity for correctly differentiating iso-osmolar CM were 58.3% and 
51.7%, respectively. Especially, among subjects that used 120kVp, contrast 
enhancement was significantly stronger in the low-osmolar CM group (P=.008), 
and sensitivity to differentiate the iso-osmolar CM was as high as 75%. 
Conclusion: Application of iso-osmolar CM was found to be feasible for 
performing paediatric abdominopelvic CTs. Subjective contrast enhancement 
and image quality assessments were not statistically different between groups.  
B-0576 10:54  
CT colonography in the diagnostic algorithm of examination of children 
with defaecation dysfunction  
V. Ermolaeva, N. Marochko, A. Pinigin; Khabarovsk/RU 
(ermolaeva.valent@gmail.com)  
Purpose: The goal of the research was to analyse the anatomical features of 
the distal colon, pelvic muscle diaphragm by CT colonography in children with 
defecation dysfunction. 
Methods and Materials: We examined 121 patients, including 13 children 
after surgical correction of the anal atresia. CT colonography was performed 
using a CT Toshiba Aquilion64 . Children were divided into three age groups: 
0-4 years (young), 5-10 years (middle) and 11-17 years (older). 
  






Results: The research showed a significant increase in anorectal angle in the 
group of children with encopresis: 115 ± 8° and in the group of operated 
children: 122 ± 9°, as a sign of puborectalis muscle dysfunction. Anorectal 
angle was 94 ± 2.5° in the young and the middle-age groups and 86 ± 5° in the 
older group with constipation. External anal sphincter was considerably thicker 
in children with constipation, than in children with encopresis. The research 
revealed a significant shortening of the puborectal muscle in patients with 
constipation and its lengthening in patients with encopresis. We offered to use 
the ratio of the length to width of the puborectalis muscle (PR coefficient) that 
was 10 ± 2 in the patients with encopresis and 19 ± 5.5 in operated patients, 
which was significantly different from the control group: 7.5 ± 0.6. 
Conclusion: CT colonography allows to determine the role of pelvic 
diaphragm and distal colon in the development of defecation disorders in 
children, including in patients after surgical correction of the anal atresia.  
B-0577 11:02  
Value of structured report form for appendix ultrasound in paediatric 
patients: can we reduce negative appendectomy and additional CT?  
H. Kim, H. Kim, S. Jang; Seongnam-si/KR (rabafrap@naver.com)  
Purpose: To evaluate the rate of negative (unnecessary) appendectomy and 
additional CT exams after structured report (SR) versus free text report (FTR) 
for ultrasound (US) exams in paediatric patients with suspected appendicitis. 
Methods and Materials: Between January 2009 and June 2016, 1150 
paediatric patients with suspected appendicitis who underwent appendix US 
were included. On November 2012, we deployed a SR form delivering the 
likelihood of appendicitis in a 5-point Likert scale for appendix US. The patients 
were classified into two groups according to the US report form (SR and FTR). 
The patients of each groups were categorised into three grades according to 
the likelihood of appendicitis (1=not appendicitis, 2=equivocal appendix, and 
3= acute appendicitis) based on described US report. Primary outcome 
(negative appendectomy rate) and secondary outcome (percentage of 
additional CT exam following US to diagnose appendicitis) were compared 
between two groups. 
Results: We identified 550 patients in the FTR group and 600 patients in the 
SR group. Negative appendectomy rates was decreased by 8.4% between two 
groups: 16.2% (19 of 117 patients) in FTR and 7.8% (8 of 102 patients) in SR 
(p = 0.028). And there was also decrease in the proportion of additional CT 
exam by 5.3% between two groups: 13.5% (74 of 550 patients) in FTR and 
8.2% (49 of 600 patients) in SR (p = 0.003). 
Conclusion: Using the SR based on the likelihood of appendicitis for 
paediatric appendix US can decrease the rate of negative appendectomy and 
additional CT exam.  
B-0578 11:10  
Liver regenerative nodules in paediatric patients: diagnostic value of Gd-
EOB-DTPA  
E. Petrash, E.V. Mikhaylova, D. Sevrjukov, A. Nikulina; Moscow/RU 
(cherkun.ekaterina@gmail.com)  
Purpose: To describe radiological patterns of multiple liver lesions in 
hepatospecific phase in children after cytostatic and immunosuppressive 
therapy to analyse their nature. 
 
Methods and Materials: Nine children aged 10 to 17 with multiple liver lesions 
were included in retrospective study with the following diagnoses: Ewing's 
sarcoma (n=1), vaginal rhabdomyosarcoma (n=1), neuroblastoma (n=1), 
nephroblastoma (n=1), dermatofibrosarcoma (n=1), Li-Fraumeni syndrome 
(n=1), glomerulonephritis (n=2), juvenile rheumatoid arthritis (n=1). 6 patients 
underwent chemotherapy, 2 high-dose chemotherapy, 1 radiation therapy on 
abdominal area, 3 immunosuppressive therapy. All children underwent MRI at 
3T using body coil. Contrast agent Gd-EOB-DTPA was used at dose of 
0.1ml/kg. 
Results: Liver lesions appeared in the interval 2 to 14 years after special 
treatment for oncology patients, 2 to 9 years from the beginning of treatment 
for patients continuously receiving immunosuppressive therapy. Most of the 
nodules accumulated contrast agent in hepatospecific phase (i.e. have 
hepatocyte nature). Among multiple hepatocyte-nature lesions in patient with 
Li-Fraumeni syndrome the 3rd tumour (PEComa) has been revealed. It had 
different pattern of contrast enhancement compared to other lesions in 
hepatospecific phase. Diagnoses were confirmed histologically for non-
hepatocyte lesions, by dynamic control for hepatocyte lesions. 
Conclusion: Multiple liver hepatocyte nature lesions in children may be 
assigned to hepatotoxic therapy and were described as regenerative nodules. 
However, we should not forget about the possibility of appearance of new 
primary tumours in these patients. Hepatospecific contrast agent can explain 
nature of the liver lesions and provide the possibility to avoid biopsies in some 
cases.  
 
B-0579 11:18  
Simplified cystography protocol for dose exposure reduction in 
paediatric patients for the diagnosis of vescicoureteral reflux  
G. Zanirato Rambaldi, M. Baldazzi, L. Pierotti, F. Carfagnini, M. Zompatori; 
Bologna/IT (giuseppe.zanirato@gmail.com)  
Purpose: Vesicoureteral reflux (VUR) is the most common indication for 
voiding cystourethrography (VCUG) in paediatric patients. The aim of this 
study was to evaluate whether a simplified cystography (SC) protocol, 
consisting of only two images, can lead to the correct diagnosis of presence 
and degree of VUR, to save dose exposure. 
Methods and Materials: We retrospectively reviewed VCUG from 243 patients 
(164 male, 79 female; aged between 2 days and 24 years, median 7 months) 
performed in our centre over a period of two years, from July 2015 to June 
2017. The SC consisted of two images acquired at maximum filling and post-
urination. The first image to reveal passive VUR and the second for active 
VUR. VUR was graded in the SC unaware of the result of the traditional 
VCUG. K Cohen and Chi-square tests were applied to analyse the agreement 
between the SC and traditional VCUG. 
Results: The agreement between SC and VCUG was “very good” with k value 
of 0.952 (95%CI 0.91-0.99). SC, moreover, confirmed the exact degree of VUR 
in almost all cases (p <0.001 at Chi-square test). Only 7 cases of grade 1 VUR 
were not diagnosed at SC. SC was 93.7% sensitive (95%CI 88.7-98.7) and 
100% specific. 
Conclusion: The SC protocol revealed to be accurate in the diagnosis of VUR 
in paediatric population. Acquiring only two images instead of a traditional 
VCUG can lead to a drastic reduction in dose exposure to paediatric patients, 
when the clinical indication is VUR.  
B-0580 11:26  
Non-contrast-enhanced MR angiography for detecting crossing renal 
vessels in infants and young children (< 6 years old): comparison with 
CE angiography and surgery  
F. Sertorio1, M. Damasio1, V. Incarbone2, M. Wong1, A. Pistorio1, G. Mattioli1, 
G. Magnano1; 1Genova/IT, 2Varese/IT (fiammetta.sertorio@gmail.com)  
Purpose: Evaluate a new non-contrast-enhanced MR sequence, the 
bTRANCE (balanced-SSFP-triggered angiography non-CE), for the 
identification of crossing renal vessels (CRVs) in children under 6 years of age, 
comparing with data obtained from contrast-enhanced MR angiography (CE-
MRA) and surgery. 
Methods and Materials: A retrospective review of pre-operative MR 
urography (MRU) of 29 children (1 month to 6 years old) with monolateral 
hydronephrosis was conducted by two independent readers. Presence or 
absence of CRVs at the ureteropelvic junction (UPJ) was identified with T2w, 
BTFE, bTRANCE sequences and 3D CE-MRA and compared with surgical 
findings. Intra- and inter-reader agreement was calculated using Cohen’s 
kappa coefficient. Image quality, sensitivity, specificity, positive predictive value 
(PPV), negative predictive value (NPV), positive likelihood ratio (LR+) and 
negative likelihood ratio (LR-) were evaluated. 
Results: Image quality was fair/good in more than 85% of cases for the 
bTRANCE, 95% for the CE-MRA. The agreement with surgical findings 
resulted 83% for the bTRANCE and 75% for the CE-MRA. The bTRANCE had 
a sensitivity, specificity, NPV, PPV, LR+, LR- of 70%, 92.9%, 81.3%, 87.5%, 
9.8, 0.32, respectively, vs 55.6%, 90.9%, 71.4%, 88.3%, 6.11, 0.49 of the CE-
MRA. Inter- and intra-reader agreements for the identification of CRVs were 
both 100% for the bTRANCE, and 88% and 90.9%, respectively, for CE-MRA. 
Conclusion: The bTRANCE has proven to be superior to the contrast-
enhanced sequences compared with the surgical gold standard in infants and 
young children under 6 years of age, with UPJ obstruction. Thus, it is a 
reliable, valid and safe alternative to CE-MRA for identifying CRVs.  
B-0581 11:34  
Coexistence and relation of congenital and acquired urinary tract 
pathologies in Jarcho Levin syndrome: comparison to spina bifida aperta  
I. Karalok, I. Alatas, H. Canaz, S. Sabet, C. Sever, A. Gayef, N.I. Gurcan; 
Istanbul/TR (dr.igulcan@hotmail.com)  
Purpose: Our aim was to evaluate the coexistance and relation of congenital 
and acquired urinary tract pathologies in Jarcho Levin Syndrome with 
comparison to spina bifida aperta. 
Methods and Materials: 60 Jarcho Levin Syndrome and 55 spina bifida 
aperta patients, between 2013-2017, were evaluated and compared for 
congenital and acquired urinary tract pathologies by ultrasonography. 
Results: There was a significant increased incidence of position anomaly 
secondary to rotoscolyosis(p<0,005), horseshoe kidney(p=0,007) and 
congenital anomaly(p<0,005) in Jarcho Levin Syndrome compared to spina 
bifida aperta. We also depicted a significant correlation between renal scar and 
parenchymal thinning(p=0,001), increased renal parenchymal echo(p=0,028), 
atrophy(p=0,006) and pelviectasis(p=0,049). Increased echogenity of renal 
  






parenchyma was positively related with existance of parenchymal 
thinning(p<0,001), scar(p=0,028), atrophy(p<0,001), hydronephrosis(p<0,001) 
and bladder wall thickening(p=0,014). Ectopic kidney anomaly was found to be 
related with renal hypogenesia(p<0,001). Horseshoe kidney anomaly 
demonstrated a significant correlation with hydronephrosis(p=0,024) and 
acquired renal pathologies(p<0,001). 
Conclusion: Position anomaly secondary to rotoscolyosis, horseshoe kidney 
and congenital anomaly are more frequent in Jarcho-Levin syndrome 
compared with spina bifida aperta. Renal scar and increased renal 
parenchaymal echogenity are the most important predictors of subsequent 
renal parenchymal disease. Horseshoe kidney is the only congenital anomaly 
which increases the risk of acquired renal pathologies. Congenital and 
acquired urinary tract pathologies are more frequent in Jarcho Levin Syndrome 
than normal population. Long term and carefull follow-up is essential in order to 
o reduce the risk of probable renal insufficiency in this group especially in 
cases with increased echogenity of renal paranchyma and renal parenchymal 
scar.  
B-0582 11:42  
Quantitative evaluation of testicular stiffness with shear-wave 
elastography  
Z. Bayramoglu, E. Çaliskan, R. Yilmaz, I. Adaletli; Istanbul/TR 
(incezuhal@yahoo.com)  
Purpose: We aimed to evaluate the testicular parenchyma in terms of stiffness 
in paediatric patients with testicular microlithiasis by shear-wave elastography 
and compare the values with normal control subjects. 
Methods and Materials: Nineteen patients previously diagnosed with 
testicular microlithiasis under follow-up for 18±10 months were included in 
study group. In control group, 21 patients with no medical history that could 
affect testicular tissue were prospectively included. 38 testes in the study group 
and 42 testes in the control group were evaluated with grey-scale ultrasound 
and shear-wave ultrasonography. 
Results: There were no differences in ages and testis volumes between the 
study and control groups. The mean SWE values of all testes based on 
elasticity and speed parameters in the study group were 8.24 ± 2.36 kPa and 
1.56 ± 0.16 m/s, respectively; while in the control group mean SWE values 
were 4.66 ± 1.07 kPa and 1.21 ± 0.12 m/s, respectively. Elasticity values were 
significantly higher in testes with microlithiasis compared to the control group 
(p<0,001). 
Conclusion: Shear-wave elastography evaluation demonstrate effects of 
ultrastructural changes in elasticity that are not detected on grey-scale 
ultrasound. Shear-wave elastography is a further reliable method in follow-up 
examination of paediatric testicular microlithiasis.  
B-0583 11:50  
Application of ADC Value of MR DWI in the evaluation of children’s renal 
function  
W. Bai, G. Ning, X. Li; Chengdu/CN (huaxi_bwj@163.com)  
Purpose: To discuss the application of ADC value of MR DWI in the evaluation 
of children’s renal function. 
Methods and Materials: 9 patients of 1 stage purpura nephritis (group A: 5 
male and 4 female, 7~15 years old) and 6 healthy volunteers (group B: 3 male 
and 3 female, 6~11 years old) were underwent routine MRI and coronal DWI 
(b=600s/mm2). For every child, the ADC values of cortex and medulla in the 
two kidneys were measured in ADC images, with setting the region of interest 
(ROI) of about 20mm2 to the upper, the middle, the lower regions and 
calculating the average values. Independent-samples t test was made in the 
ADC values of cortex and medulla from the two groups. And paired-samples t 
test was made in the ADC values of cortex and medulla from the same group. 
Results: (1) the mean ADC value of cortex in group A (178.73×10-
5m2/s±14.04) was lower than that in group B (202.78×10-5m2/s±11.11), with 
statistically significant differences (P=0.004).(2) the mean ADC value of 
medulla in group A (161.48×10-5m2/s±20.33) was lower than that in group B 
(193.56×10-5m2/s±17.67), with statistically significant differences (P=0.008). (3) 
In group A and B, the ADC value of cortex was higher than that of medulla, 
without statistically significant differences (p=0.114 in group A and p=0.265 in 
group B). 
Conclusion: MR DWI is a noninvasive method to evaluate children’s renal 
function. The ADC value can early detected the abnormality of renal function in 









10:30 - 12:00 Room M 3  
Oncologic Imaging  
SS 616  
Lung cancer: what's next?  
Moderators:  
M. Sánchez; Barcelona/ES  
M. Simic; Zagreb/HR  
B-0584 10:30  
Comparison of 18FDG PET/CT and 18FDG PET/MRI for thoracic staging in 
lung cancer patients  
J. Kirchner1, L.M. Sawicki1, A.F. Tschischka1, L. Umutlu2, K. Herrmann2, 
B.M. Schaarschmidt1, G. Antoch1, P. Heusch1; 1Düsseldorf/DE, 2Essen/DE 
(Julian.Kirchner@med.uni-duesseldorf.de)  
Purpose: To compare the diagnostic potential of 18F-FDG PET/MRI and 18F-
FDG PET/CT for primary and locoregional lymph node staging in lung cancer 
patients. 
Methods and Materials: A total of 101 patients (64 men, 37 women, mean 
age 62.5±9 years) with histopathologically confirmed NSCLC were included. All 
patients underwent 18F-FDG PET/CT and subsequently 18F-FDG PET/MRI. 
Two readers performed T and N staging in separate sessions according to the 
eighth edition of the American Joint Committee on Cancer Staging manual for 
18F-FDG PET/CT and PET/MRI, respectively. Histopathology served as the 
reference standard. The mean and maximum standardised uptake value 
(SUVmean and SUVmax) and the maximum diameter of the primary tumour 
were measured and compared in PET/CT and PET/MRI. 
Results: PET/MRI and PET/CT agreed on T stages in 55 of 56 (98.2 %) 
patients. Compared with histopathology, PET/CT determined correct T-stage in 
89.3% and PET/MRI in 87.5%, respectively. For definition of thoracic N stages, 
PET/MRI and PET/CT were concordant in 100 of 101 patients (99%). PET/CT 
determined the N stage correctly in 91 of 101 patients (90.1 %). PET/MRI 
determined the N stage correctly in 90 of 101 patients (89.1%). No statistically 
significant difference between PET/CT and PET/MRI for primary tumour or 
lymph node metastases detection was seen. The tumour size and SUVmax 
measurements derived from PET/CT and PET/MR imaging exhibited an 
excellent correlation (r=0.968 and r =0.817, respectively; p<0.01). 
Conclusion: 18F-FDG PET/CT and 18F-FDG PET/MRI perform equally well for 
T and N staging in patients suffering from NSCLC.  
B-0585 10:38  
Impact of waiting times on tumour growth and pathological upstaging at 
surgery  
I.H. Bhat; London/UK (insha.bhat24@gmail.com)  
Purpose: There is no objective data on tumour growth or pathological 
upstaging in early lung cancers awaiting surgery. Our study aims to evaluate if 
the current waiting times under ‘62-day’ lung cancer pathway are associated 
with tumour growth or pathological upstaging. 
Methods and Materials: 121 consecutive patients with early stage NonSmall 
Cell lung cancer who underwent resection were analysed. The difference 
between maximum diameters at diagnostic & preoperative CTscans was 
calculated to obtain diameter change. Increase in size of  5 mm or  20% was 
considered significant. Time interval between baseline & repeat CT (CT-int), & 
between baseline CT and surgery (Surg-int) were calculated. CT-int & Surg-int 
were compared between upstaged & non-upstaged patients. Other potential 
prognostic indices (SUVmax, smoking status etc.) were also evaluated as 
categorical variables, p value <0.05 considered significant. 
Results: Median CT-int and Surg-int were 2.6 and 2.4 months respectively. 
44.6% patients had a tumour growth  5 mm, 22% had tumour growth  20%. 
36% patients were upstaged at surgery due to nodal/pleural invasion, satellite 
nodules or increase in tumour diameter. There was no significant difference 
between median CT-intervals in patients who had a tumour growth <20% or  
20%: 2.4 months vs 2.6 (p=0.06). Surg-int was not correlated with growth  
20% either (p=0.24). 
Conclusion: Current cancer pathway waiting time practices are not associated 
with significant tumour growth or pathological upstaging in this cohort. 
Adenocarcinomas have an increased risk of pathological upstaging, however 















B-0586 10:46  
The 8th edition IASLC staging system for lung cancer, a step beyond 
current imaging accuracy?  
M. Murphy, C. Barry, C. Cronin, D. Healy; Dublin/IE 
(markmurphy1608@gmail.com)  
Purpose: The International Association for the Study of Lung Cancer (IASLC) 
has recently developed an 8th edition of its lung cancer staging. This further 
sub divides the T-status component into ever smaller size ranges. This was 
developed on pathology specimen measurements from a large population 
database. Many clinical decisions are made in the pre-operative domain 
however, with the T status dependent on radiology measurement. We wanted 
to determine if contemporary clinical staging based on radiology would 
accurately predict the proposed T-status from post-operative specimens. 
Methods and Materials: We performed a retrospective analysis of 150 
primary lung cancer cases that proceeded to surgical resection. Determination 
of size on the diagnostic CT scan was compared with the post-operative 
pathological size. Factors such as interval between imaging and surgery were 
also assessed. 
Results: There was a discrepancy between the pre-operative CT tumour size 
and the post-operative pathology. The average difference was 0.567cm. This 
had consequences on staging accuracy. Based on size alone, CT accurately 
assessed T status in 65.3% of patients using the 7th edition IASLC, whereas 
only 54% of patients were accurately staged with the 8th edition. There was no 
correlation between time to surgery and tumour size. 
Conclusion: We conclude that although the 8th edition of the IASLC TNM lung 
cancer staging system is an evolution at a population level, in lung cancer 
management, implementing the 8th edition as proposed may reduce the staging 
accuracy to as low as 54%. This evolution may prove an obstacle to utilisation 
of neoadjuvant strategies  
B-0587 10:54  
Iodine density obtained with spectral detector CT is a predictor for lesion 
dignity of pleural thickening  
S. Lennartz1, M. Le Blanc1, N. Grosse Hokamp1,2, D. Maintz1, T. Persigehl1; 
1
Cologne/DE, 2Cleveland, OH/US (simon.lennartz@uk-koeln.de)  
Purpose: To examine whether iodine density (ID) provided by spectral 
detector computed tomography (SDCT) is a valid parameter for differentiation 
between benign pleural thickening (BPT) and pleural carcinomatosis (PC). 
Methods and Materials: In total, 30 contrast-enhanced SDCT scans of the 
chest were included at this retrospective, IRB-approved study. In detail, 15 
SDCT scans of oncologic patients with PC confirmed by histopathology, FDG-
PET or change during treatment, as well as 15 SDCT scans of patients with 
BPT confirmed by prior or follow-up CT (6 months). ROI-based quantitative 
image analysis was performed by two radiologists that determined attenuation 
(HU) and standard deviation (SD) in conventional polyenergetic images (PI). 
ROIs were than copied to identical position in iodine density reconstructions to 
determine the iodine density (mg/ml). The following ROIs were used: pleural 
lesion, adjacent skeletal muscle (thoracic wall, diaphragm, myocardium), 
subcutaneous fat, air, aorta, lung, pleural effusion. Statistical analysis was 
performed using student’s t-test and multivariate linear modelling. 
Results: Iodine density was significantly higher in PC (2.26±0,83 mg/l) 
compared to BPT (0.58±0,49 mg/ml, p0.0001). Although attenuation in PI 
differed significantly between PC and BPT as well, multivariate linear modelling 
showed that ID was the more powerful predictor for lesion dignity (p0.05). 
Both contrast-to-noise ratio (CNR) and difference in ID of PC in relation to the 
adjacent skeletal muscle of the thoracic wall were significantly increased 
compared to BPT (p0.0001). 
Conclusion: Iodine density reconstructions provided by SDCT are a powerful 
predictor for differentiation between benign pleural thickenings and pleural 
carcinomatosis in oncologic patients.  
B-0588 11:02  
Comparison of overall-survival in squamocellular-NSCLC patients treated 
with Nivolumab assessed with RECIST1.1 and iRECIST  
E. Raimondi, L. Belluomini, A. Cartuan, M. Bassi, R. Rizzati, M. Tilli, 
A. Frassoldati, M. Giganti, G. Benea; Ferrara/IT (edoardo.raimondi@unife.it)  
Purpose: To compare the survival data, consisting of overall-survival (OS), for 
squamocellular-NSCLC patients treated with Nivolumab with RECIST1.1 and 
iRECIST criteria response categorisation. 
Methods and Materials: After IRB approval, the CT-images of 15 
squamocellular-NSCLC patients treated with Nivolumab were retrospectively 
evaluated at baseline, 3-months and 6-months by RECIST1.1 and iRECIST 
criteria. Patients were categorised as responders and non-responders as per 
RECIST1.1. For iRECIST, patients showing complete-response, partial-
response or 6-months ongoing stable-disease were considered responders, 
while those showing progressive-disease were considered non-responders. 
Unconfirmed progressive-disease by iRECIST was considered as stable-
disease for categorisation purposes. Kaplan-Meier analysis for these response 
categories was performed for OS. 
Results: According to RECIST1.1, 5/15 (33.3%) patients were categorised as 
responders and 10/15 (66.6%) patients as non-responders. According to 
iRECIST, 11/15 (73.3%) patients were categorised as responders and 4/15 
(26.6%) patients were categorised as non responders. Significant differences 
between responders and non-responders for OS were observed for both 
radiological response criteria (Log-rank test: p<0.05). Median OS following 
RECIST1.1 was 22 months for responders and 10 months for non-responders 
(HRs: 0.5796; 0.2101-1.5991). Median OS following iRECIST was 21 months 
for responders and 7 months for non-responders (HRs: 0.1774; 0.02127-
1.4795). 
Conclusion: The OS curves for RECIST1.1 were similar to the one observed 
in iRECIST. For non-responders, the OS observed in RECIST1.1 was longer 
than the one observed in iRECIST; this difference may suggest that iRECIST 
better identifies progression of disease.  
B-0589 11:10  
Can perfusion heterogeneity in CT perfusion maps of NSCLC flaw clinical 
considerations based on global mean blood flow values?  
S. Malavasi1, D. Barone2, G. Gavelli1, A. Bevilacqua1; 1Bologna/IT, 2Forli/IT 
(s.malavasi@unibo.it)  
Purpose: Tumour heterogeneity is one of the key features regarding 
progression disease, diagnosis, and therapeutic response. CT perfusion (CTp) 
studies are usually based on mean perfusion values, computed on a single 
slice or the whole tumour. The aim of this work is to determine to what extent 
the heterogeneity pouring out from single slices can flaw studies using global 
mean values only. 
Methods and Materials: 10 patients with single NSCLC lesions (26 
examinations) were enrolled and underwent CTp. ROIs were drawn on aorta 
and on five central slices of each lesion. Mean global BF values were 
calculated on each slice (mSBF) and for the whole tumour (mWBF). The 
entropy E (i.e., a direct measure of data information content) was computed on 
BF values to assess the hemodynamic heterogeneity. For each lesion, the 
equivalence between each mSBF and mWBF was checked to assess whether 
mWBF of a lesion could represent the perfusion characteristics of a slice. 
Results: Five slices only, all pertaining to different lesions, were represented 
by the mWBF, none of them bringing the highest information content in its 
tumour (i.e., the maximum E). 11 couples of lesions having the same mWBF 
were found, but with slices with very different perfusion patterns, mSBF and E 
values. 
Conclusion: While global perfusion values computed on whole tumours may 
improve reproducibility, they cannot allow for tumour haemodynamic 
heterogeneity. Tumours with same mWBF could have very different response 
to therapies. Accordingly, additional parameters like BF entropy are needed to 
support mWBF in clinical considerations.  
B-0590 11:18  
Single-source dual-energy CT as part of 18F-FDG PET/CT: direct 
comparison of iodine-related and metabolic parameters in lung cancer  
J. Baxa1, T. Matouskova1, J. Ludvík1, B. Schmidt2, M. Sedlmair2, J. Ferda1; 
1
Plzen/CZ, 2Forchheim/DE (baxaj@fnplzen.cz)  
Purpose: To assess possible correlation of FDG uptake and iodine-related 
attenuation values derived from PET/CT using single-source dual-energy CT 
scan (DE-CT) in non-small cell lung cancer (NSCLC). 
Methods and Materials: 48 patients with histologically proven NSCLC 
underwent 18F-FDG-PET/CT within the staging. PET/CT included single-
source DE-CT in late post-contrast phase. Direct comparison of FDG uptake 
and DE-related values was performed. Sub-study regarding different 
histological types and various thresholds for volume metabolic values 
quantification was also performed. 
Results: A strong correlation was found between volumetric FDG parameters 
(MTV - metabolic tumour volume and TLG - total lesion glycolysis) and total 
iodine content using Pearson correlation analysis with various thresholds for 
FDG lesion segmentation (r=0.965-0.983; p<0.0001). The strongest correlation 
of MTV and TLG with iodine content was reached using 10% threshold for 
segmentation. Only weak correlation was found between iodine content and 
SUVmax. Significant difference between adenocarcinomas and other 
histological subtypes was proved in selected parameters of metabolic and DE 
data. 
Conclusion: Our study demonstrated the strong correlation of the iodine 
content calculated from single-source DE-CT with volumetric FDG parameters 
in NSCLC without a significant effect of the threshold value for FDG lesion 
segmentation. This fact indicates the possible prognostic value of iodine 
content that could be used as another parameter for therapy-response 
monitoring.  
Author Disclosures: 
 B. Schmidt: Employee; Siemens Healthineers. M. Sedlmair: Employee; 
Siemens Healthineers. 
  






B-0592 11:26  
Value of the first day PET/CT in post thermal ablation of lung tumours  
W. Tantawy, A. Zarea, A.S. Ibrahim, M. Abdel Kawi, Y. Hussein, M. Nasr, 
M. Barsoum; Cairo/EG (oyehiaomar@gmail.com)  
Purpose: to evaluate the role of the first day PET/CT imaging done 
immediately post CT guided microwave thermal ablation (TA) of lung tumors. 
Methods and Materials: Thermal Ablation of lung tumors by using microwave 
technique guided by CT was performed for all 26 patients followed by post 
ablation PET/CT that was done immediately within the first day. Twenty-six 
patients were included in the study (16 females, 10 males) including 32 
lesions, two lesions were ablated in 6 cases and single lesion in 20 cases. 
Results: PET/CT examination done within the first day post ablation for all 
cases following microwave ablation (MWA), showed complete loss of metabolic 
activity of whole ablated lesions (i.e. SUV= equal or lesser than the 
physiological background lung activity). Sensitivity and specificity of first day 
PET/CT following adequate ablation was 100%. 
Conclusion: First day PET/CT examination is an excellent and accurate 
imaging modality for the evaluation of adequacy of microwave ablation of lung 
tumors and should be considered the modality of choice with a sensitivity and 
specificity of 100%.  
B-0593 11:34  
Predicting nodal activity and clinical outcome of non-small cell lung 
cancer using 18-FDG PET-CT in the age of EBUS-FNA: initial results  
G. Chambers, S. Vaidyanathan, F.U. Chowdhury; Leeds/UK 
(g.chambers@nhs.net)  
Purpose: 18F-FDG PET-CT has an established role in the staging of lung 
cancer and helps guide Endobronchial ultrasound-guided fine needle 
aspiration (EBUS-FNA), increasing the positive yield and informing 
management. This study aims to correlate FDG PET-CT with EBUS-FNA to 
assess patient outcomes in discordant cases. 
Methods and Materials: Images of 177 patients who underwent both EBUS-
FNA and 18-FDG PET-CT, between 2010 and 2012, were analysed for nodal 
disease status using maximum standardised uptake values (SUVmax) above 
mediastinal background as a marker for positivity. Assessors were blind to the 
EBUS-FNA outcomes during this analysis. 354 EBUS-FNA sampled nodes 
were then correlated with the PET-CT findings and categorised as concordant 
or discordant. Survival analysis was performed comparing the patients with 
concordant and discordant results to determine if discordant results (FDG PET-
CT false positive) conferred a survival benefit over a 5 year follow-up period. 
Results: FDG-positive nodal disease and EBUS-FNA were concordant in 91 
patients (51%) and discordant in 86 (49%) patients (6 up-staged by EBUS, 80 
down-staged by EBUS). Survival analysis showed that there was no significant 
survival benefit when EBUS-FNA down-staged nodal disease, compared to 
those with concordant findings (p=0.91). Overall sensitivity, specificity, positive 
predictive value and negative predictive value for PET-CT were 0.88, 0.60, 
0.56 and 0.88 respectively, compared to EBUS-FNA. 
Conclusion: Initial results suggest that even when EBUS-FNA downstages 
FDG PET avid disease, no statistically significant survival benefit is conferred 
over a 5 year follow up period. The reasons for this are likely to be 
multifactorial.  
B-0594 11:42  
DWI-based radiomics for prediction of chemotherapy outcomes in lung 
cancer: a pilot study  
Z. Li; Kunming/CN (lizhenhui621@qq.com)  
Purpose: To investigate the wealth of radiomics for pretreatment DWI in 
prediction of treatment response of lung cancer with chemotherapy.  
Methods and Materials: Thirty patients with lung cancer confirmed by 
pathology were enrolled. According to the RECIST, all patients were divided 
into good response group (GR) and non-good response group (non-GR) after 
the second cycle of chemotherapy. ADC imaging (b=600, 800 and 1000 
s/mm2) were collected. Totally, 19 985 radiomics features were extracted in the 
ADC imaging. The lasso was adopted in feature selection and used in classifier 
model. ROC was used to evaluate the capability of the three models to predict 
GR. 
Results: 16 patients were divided into GR, while 14 patients were divided into 
non-GR. The AUC, sensitivity and specificity of the radiomics based on the 
ADC imaging (b=600, 800 and 1000 s/mm2) for GR prediction were 0.875, 
0.895 and 0.750, 0.924, 0.947and 0.938, 0.918, 0.895 and 0.875, respectively. 
The AUC among the three groups had no difference (P>0.05). 
Conclusion: It is possible to predict GR after chemotherapy in lung cancers 




14:00 - 15:30 Room B  
Abdominal Viscera  
SS 701a  
New developments in MRI of the liver  
Moderators:  
T. Bader; Vienna/AT  
I.L. Gubskiy; Moscow/RU  
B-0601 14:00  
Added value of diffusion-weighted imaging in hepatic tumours and its 
impact on patient management  
J. Taron, J. Johannink, M. Bitzer, K. Nikolaou, M. Notohamiprodjo, 
R. Hoffmann; Tübingen/DE (taronjana@yahoo.com)  
Purpose: To investigate the diagnostic value of additional diffusion-weighted 
imaging (DWI) of the liver and its impact on therapy decisions in patients with 
hepatic malignancy. 
Methods and Materials: Interdisciplinary gastrointestinal tumour board cases 
concerning patients with hepatic malignancies discussed between 11/2015 and 
06/2016 were included in this retrospective, single-center study. Two 
radiologists independently reviewed the respective liver MR examination first 
without, then with DWI. The readers were blinded regarding number, position 
and size of hepatic malignancies. Cases in which DWI revealed further findings 
to conventional sequences on hepatic tumour status were presented to the 
members of the interdisciplinary tumour board. In this setting, the changes in 
treatment decisions based on these additional findings in the DWI sequences 
were recorded. 
Results: A total of 87 patients were included. DWI revealed additional findings 
in 12 patients (13.8%) which had a direct effect on the therapy in 8 patients 
(9.2%): in 6 patients (6.9%) the surgical/interventional treatment was adapted 
(n=5: extended resection, n=1: with transarterial chemoembolization of a single 
hepatocellular carcinoma only detectable in DWI); 2 patients (2.3%) received 
systemic therapy (n=1: neo-adjuvant, n=1: palliative) based on the additional 
findings in DWI. In 4 patients (4.6%) additional findings did not affect the 
therapeutic decision. Definite confirmation of malignancy was not possible in 
two cases during follow-up. 
Conclusion: DWI is a relevant diagnostic tool in oncologic imaging of the liver. 
By providing further information regarding tumour load in hepatic malignancies 
it can lead to a significant change in treatment.  
B-0602 14:08  
MRI liver surface nodularity score: optimising spline stiffness to non-
invasively stage fibrosis  
K. Cox1, S. Nandwana1, B. Olaiya2, P. Mittal1, O. Ibraheem1, A. Smith3; 
1
Atlanta, GA/US, 2Marshfield, WI/US, 3Birmingham, AL/US 
(klcox2@emory.edu)  
Purpose: Determine ideal preprogrammed liver surface nodularity (LSN) spline 
stiffness (SS) for differentiating fibrosis stages in viral chronic liver disease 
(vCLD). 
Methods and Materials: vCLD patients with 2009-2015 MRI were cross-
referenced for liver biopsy within 6 months or prior to cirrhosis biopsy. LSN 
score was obtained on post-contrast MRI with increasing preprogrammed SS 
(S15, S18, S21, S24). Patients excluded for slice thickness >3mm, frequency 
matrix <256. Median LSN score calculated for fibrosis stages and splines. 
ANOVA and receiver operator characteristic curve (AUC) analysis for accuracy 
of LSN score per SS for differentiating fibrosis stages. Wilcoxon rank-sum test 
explored associations between LSN scores and Scheuer staging. Exploratory 
cutoff values were investigated. 
Results: 244 patients (153 male); mean age 53.8 (range 24-79). Patients per 
fibrosis stage: F0=41, F1=16, F2=24, F3=29, F4=134. LSN scores increased 
with increasing SS (p<0.001). AUC increased with increasing fibrosis. S21 had 
the highest AUC for F0-1 versus F2-4 (AUC=0.794), F0-2 versus F3-4 
(AUC=0.807), and F0-3 versus F4 (AUC = 0.855). Using S21, median LSN 
scores were higher in advanced versus early fibrosis (4.06 versus 3.54), and 
cirrhosis versus non-cirrhosis (4.26 versus 3.54), p <0.001. S21 advanced 
fibrosis cutoff LSN score 3.83 had 67% sensitivity and 88% specificity. 
Cirrhosis cutoff LSN score 3.99 had 66% sensitivity and 92% specificity. 
Conclusion: LSN scores increase with increasing SS. S21 LSN score 
demonstrated highest AUC for most fibrosis stages and can differentiate early 
from advanced fibrosis; cirrhosis from non-cirrhosis. Optimizing SS may 
differentiate early stages of fibrosis with improved accuracy, potentially 
eliminating the need for liver biopsy.  
Author Disclosures: 
  K. Cox: Grant Recipient; RSNA Seed Grant.  A. Smith: Owner; Liver 
Nodularity LLC. Patent Holder; patent pending. 
  






B-0603 14:16  
Association between multi-phasic MRI radiomic features and treatment 
response after stereotactic body radiation therapy  
R. Du, M.S. Alam, V.H. Lee, V. Vardhanabhuti; Hong Kong/HK (du94@hku.hk)  
Purpose: In this study, we analyse the association of radiomic features 
extracted from multi-phasic MRI scans and treatment response of patients who 
underwent stereotactic body radiation therapy (SBRT) and overall survival 
(OS). 
Methods and Materials: A prospective cohort of 24 patients diagnosed with 
hepatocellular carcinoma (HCC) who underwent SBRT was analysed. Each 
patient received multi-phasic MRI scans at pre-treatment and 3-months post-
treatment using gadoxetic acid (gadoxetate) contrast agent. Several 
sequences were analysed including pre-contrast, dynamic phases, 10 minutes 
and 20 minutes post-contrast, and T2W for radiomic features (103 extracted 
features). Volumetric ADC values were also extracted for each lesion. 
Univariate logistic regression model was used to analyse the association 
between pre- and post-treatment radiomic features/ADC and treatment 
response (infield recurrence and overall survival). The performance of the 
features was assessed by ROC analysis using leave-one-out cross-validation. 
Results: Radiomic features from GLCM texture features were found to be 
most associated with treatment response. Features extracted from 10-minute 
delayed phase scans were found to be highly associated with infield 
recurrence (AUC = 0.7-0.85). For OS, GLCM features extracted from arterial 
phase scans and portal venous phase scans were found to the most 
associated (AUC = 0.65-0.76). No significant association was found with 
features extracted from pre-contrast, T2W and 20-minute delayed phases. No 
association was found between SBRT dose and changes in ADC values. 
Conclusion: We have found a strong association in radiomic features 
extracted from different MRI phases and infield recurrence in HCC patients 
treated with SBRT and overall survival. No association was found between 
ADC values and treatment parameters.  
B-0604 14:24  
Liver fibrosis vs cholangiocarcinoma MRI appearance and distinguishing 
features based on the DWI and ADC map  
A. Sciuk1, R. Kidzinski2, E. Frankowska2; 1Houston, TX/US, 2Warsaw/PL 
(adam.sciuk@bcm.edu)  
Purpose: Benign confluent hepatic fibrosis and cholangiocarcinoma can have 
a similar morphologic appearance at CT and MRI. DWI offers a new method for 
making this distinction more reliable. 
Methods and Materials: We retrospectively reviewed 18 abdominal MRI done 
with conventional T2, T1-precontrast, and dynamic postcontrast as well as DWI 
performed using b values of 0 and 500 sec/mm2. Diagnoses: 12 
cholangiocarcinomas, 3 primary sclerosing cholangitis and 3 diffuse liver 
cirrhosis. Both quantitative (ADC values) and qualitative reviews of DWI data 
(comparing SI of lesion to liver and spleen) were performed. 
Results: All 12 cases with cholangiocarcinoma demonstrated increased 
relative signal intensity (SI) of the lesion relative to liver on the b-500 DWI in 
comparison to the b-0; nine cases had SI equal or higher than the SI of the 
spleen. Three cholangiocarcinomas despite a relative increase in SI on the b-
500 images were slightly darker than the spleen. All benign cases showed 
decrease in relative signal intensity on the b-500 images in relation to the b-0, 
and were similar to the spleen. Quantitative assessment demonstrated a 
significant overlap. 
Conclusion: Preliminary work indicates that cholangiocarcinoma displays a 
“relative brightening” of SI on b-500 in relation to b-0, whereas the benign 
cases showed a “relative darkening”. Furthermore, the SI of nine out of twelve 
malignant cases was equal or higher the SI of the spleen; three potential false 
positives can occur with PSC. A SI equal to liver on b-500 image has a high 
negative predictive value despite positive T2 and contrast-enhanced imaging 
results.  
B-0605 14:32  
Initial experience with magnetic resonance elastography of liver  
I. Csemez, M. Ujlaki, M. Gödeny; Budapest/HU (imcsemez@gmail.com)  
Purpose: Mechanical tissue properties of the liver can be quantitatively 
assessed using magnetic resonance elastography (MRE). These parameters 
change in pathological conditions of the liver. We aimed to investigate the 
potential benefits of MRE with focal liver lesions, post-treatment changes and 
cirrhosis in focus. 
Methods and Materials: Scans were performed on a 3 Tesla GE Discovery 
MR750w MRI scanner using the MR Touch Standard sequence. The system 
produces elastograms, i.e. liver maps indicating tissue stiffness. MRE was 
performed on 43 patients: 20 patients with histologically confirmed malignant 
liver tumors, 7 patients undergoing intervention (5 metastasectomies and 2 
radiofrequency ablations), 3 patients with hemangioma, 2 patients with 
cirrhosis, and 11 patients with chemotherapy followup. 
Results: In 13 cases of malignant liver lesions, tissue stiffness was 
significantly higher compared to the surrounding liver parenchyma (> 4.5 kPa). 
No abnormal stiffness was measured in the case of benign lesions or post-
treatment changes except one patient. In both cases of cirrhosis, significant 
increase in liver stiffness was observed. In 10 cases, the study was not 
interpretable, due to small lesion size (< 2 cm) or motion artifacts. 
Conclusion: Areas of high tissue stiffness can be easily distinguished from 
soft tissue on elastograms. Unlike ultrasound-based elastography techniques, 
MRE provides quantitative information on tissue stiffness of nearly the whole 
liver. It may provide additional information to conventional MR sequences on 
focal liver lesions greater than 2 cm. By decreasing motion artifacts MRE may 
be used to estimate hepatic functional reserve in patients scheduled for major 
hepatectomy.  
B-0606 14:40  
Improved DWI of the liver at 3T using respiratory triggering with 
simultaneous multi-slice acceleration  
A.A. Tavakoli, U. Attenberger, J. Budjan, S.O. Schönberg, P. Riffel; 
Mannheim/DE (s.tavakoli@gmx.de)  
Purpose: To compare respiratory triggered diffusion weighted imaging with 
simultaneous multi-slice acceleration (SMS-RT-DWI) of the liver with a 
standard free-breathing echoplanar-DWI (s-DWI) protocol regarding a 
reduction of imaging artefacts associated with diffusion weighted imaging at 
3T. 
Methods and Materials: 23 patients who underwent an MRI study of the liver 
were included in this retrospective study. Examinations were performed on a 
3T whole-body MR system (Magnetom Skyra, Siemens). In all patients both s-
DWI and SMS-RT-DWI of the liver were obtained. Images were qualitatively 
evaluated by two independent radiologist with regard to overall image quality, 
liver edge sharpness, sequence related artefacts and overall scan preference. 
For quantitative evaluation signal-to-noise ratio (SNR) and apparent diffusion 
coefficient (ADC) values were measured in different areas of the liver. We 
performed the Chi2-test for statistical analysis of qualitative parameters and the 
paired students t-test for analysis of quantitative parameters. 
Results: Overall image quality, liver edge sharpness and sequence related 
artefacts of SMS-RT-DWI were rated significantly better compared to s-DWI 
(for all p < 0.05). For 82.6% of the examinations (19/23), both readers 
preferred SMS-RT-DWI overall to s-DWI with excellent inter-reader agreement 
(kappa=0.83). SNR values were significantly higher for SMS-RT-DWI than for 
s-DWI (151±122 vs. 69±46, p=0.0006), while mean ADC values did not differ 
significantly between the two sequences (994±129x106mm2/s vs. 1002±123 
x106mm2/s, p=0.75). 
Conclusion: By exploiting a simultaneous multi-slice technique at 3T, 
respiratory triggered DWI of the liver could be acquired with substantial image 
quality improvements compared to s-DWI while maintaining acquisition time.  
B-0607 14:48  
How to avoid gadoxetic acid-related artefacts? Prospective multi-
institutional study in 1994 patients  
U. Motosugi1, M. Hori2, S. Goshima3, K. Kozaka4, T. Hyodo5, Y. Nakamura6, 
A. Nishie7, T. Tamada8, A. Kanki8; 1Yamanashi/JP, 2Suita/JP, 3Gifu/JP, 
4
Kanazawa/JP, 5sakasayama/JP, 6Hiroshima/JP, 7Fukuoka/JP, 8Kurashiki/JP 
(umotosugi@nifty.com)  
Purpose: To prospectively investigate the potential solution of gadoxetate 
disodium-induced imaging artefacts using the data from multi-institutional study 
in Japan. 
Methods and Materials: This prospective observational study was performed 
in eight institutions in Japan. In total, 1,994 dynamic contrast-enhanced MR 
examinations of the abdomen were performed either with gadoxetate disodium 
(gadoxetate group, n = 1,647) or with other gadolinium-based contrast agents 
(other GBCA group, n = 347). MR technologists recorded breath-hold fidelity 
using a respiratory monitor on MR scanners. Breath-holding during the scan 
was classified as either a success or a failure based on the shape of the 
monitored respiratory motion. Any adverse effects (self-report) were also 
recorded. The severity of respiratory motion-related artefacts in the liver on the 
pre-contrast and arterial phase images were evaluated: substantial artefact or 
not. The risk of gadoxetate-induced substantial artefacts was evaluated with 
multivariate logistic analysis. 
Results: Substantial artefacts in the arterial phase were more frequently 
observed in the gadoxetate group (8.3% [136/1647]) compared with the “other 
GBCA” group (3.2% [11/347], p=0.001). Gadoxetate-induced substantial 
artefacts in patients who successfully held their breath in pre-contrast scans 
were independently related to older age (odds ratio [OR]=1.04, p<0.001), 
female (OR=0.57, p=0.032), longer acquisition time (OR=2, p=0.009), and 
multiple arterial phase acquisitions (OR=0.47, p=0.048). 
Conclusion: Gadoxetate induces breath-hold failure and substantial artefacts 
in arterial phase scans. Gadoxetate-induced substantial artefacts can be 
avoided using a shorter acquisition time sequence and multiple arterial phase 
acquisitions.  
  






B-0608 14:56  
High-field-strength MR imaging of the liver at 3.0T: comparative study 
with 1.5 T in cirrhotic population  
K. Koryukova1, M. Rossi1, M. Di Martino1, L. Saba2, S.G. Ginanni Corradini1, 
C. Catalano1; 1Rome/IT, 2Cagliari/IT (micdimartino@hotmail.it)  
Purpose: To prospectively evaluate whether magnetic resonance (MR) 
imaging of the liver at 3.0 T is comparable to that at 1.5 T in terms of detection 
and characterization of focal liver lesions in cirrhotic patients. 
Methods and Materials: This prospective study was approved by the 
institutional review board. A comparative study between two groups of cirrhotic 
patients, composed, respectively, with 58 and 56 elements with 109 and 97 
lesions, was conducted. Patients were examined at 1.5- and 3.0-T MR 
imaging. The imaging protocol consisted of T2-weighted turbo spin-echo (SE) 
sequences with or without fat suppression, as well as T1-weighted gradient-
echo (GRE) sequences with or without gadoxetic acid contrast agent. All 
images were rated independently by two radiologists. 
Results: Excellent interobserver agreement was found (=0.86 1.5T and 0.81 
3T). The mean sensitivity of MR was similar between 1.5T and 3T (85% vs 
86.2%) as well as the mean positive predictive value (98% vs 97.8%). The 
diagnostic accuracy was significantly greater at 3T (0.88 vs 0.995). 
Conclusion: MR imaging of the liver at 3.0 T, compared with that at 1.5 T, is 
feasible with equivalent diagnostic utility in terms of detection and 
characterization of focal liver lesions in cirrhotic patients.  
B-0609 15:04  
The influence of intravenous non-specific gadolinium-based contrast 
media application on image quality of T2-weighted MRC in preoperative 
evaluation of living liver donors  
A. Jarczewski, I. Reimers, D. Geisel, T. Denecke; Berlin/DE 
(anne.frisch@charite.de)  
Purpose: To investigate the influence of gadobutrol (Gd-DO3A-butrol, 
Gadovist®, Bayer-Schering Pharma AG, Germany), gadoterate dimeglumine 
(Gd-DOTA, Dotarem®, Guerbet GmbH, Germany) and gadofosveset trisodium 
(Vasovist®, Bayer-Schering Pharma AG) on image quality of heavily T2-
weighted single-shot thick-slab and multisection-thin-slice MRC in preoperative 
evaluation of living liver donors. 
Methods and Materials: In this retrospective study, 58 patients (30 female, 28 
male, mean age 35 years) underwent MRC before and after intravenous 
injection of non-specific contrast agents at 1.5 and 3 Tesla (T). Assessment 
included the evaluation of signal to noise ratio (SNR) and contrast to noise 
ratio (CNR) performance of the left and right bile duct, hepatic hilum as well as 
common bile duct (CBD). The assessment of image quality and duct 
visualization (each 5-point Likert scale) was analysed independently by three 
blinded readers. Reasons for impairment of image quality (e.g. movement 
artefacts and superimposing signals) were noted, if applicable. 
Results: SNR, CNR, image quality and degree of duct visualization do not 
differ significantly before and after intravenous injection of non-specific 
gadolinium-based contrast agents. Overlapping signals caused by intrahepatic 
vessels that diminish the image quality of MRC were reduced by 8% in single-
shot thick-slab MRC and by 3% in multisection MRC, respectively. 
Conclusion: T2-weighted MRC in preoperative evaluation of living liver donors 
should be acquired after an intravenous application of non-specific gadolinium-
based agents since the pre-contrast MRC does not bring any benefit in image 
quality and the incidence of superimposing intrahepatic vessel signals are 
lower in post-contrast MRC.  
B-0610 15:12  
Transient arterial phase respiratory motion-related artefact in liver MR 
imaging gadoxetic acid vs extracellular gadolinium. A within-patient 
cohort comparative study  
A. Darnell, J. Rimola, E. Belmonte, A. Forner, V. Sapena, C. Ayuso, J. Bruix; 
Barcelona/ES (ANDARNEL@clinic.cat)  
Purpose: To compare the frequency and severity of transient arterial phase 
(TAP) respiratory motion-related artifact following gadoxetic acid (EOB) and 
extracellular gadolinium [(EC-Gd), Gadobutrol] in a cohort of cirrhotic patients. 
Methods and Materials: Eighty-two cirrhotic patients from prospective series 
underwent liver MR with EC-Gd and EOB within 1 month. Two readers, blinded 
to all data assigned a respiratory motion-related artifact score (0 [none], 1 
[mild, no impact on reader confidence interpretation], 2 [moderate, causing 
decrease in reader confidence interpretation], and 3 [severe, non-diagnostic]) 
for non-enhanced, arterial and portal-venous phase. Scores for each phase 
were averaged and definitions for TAP, severe TAP and post-contrast motion-
related artifacts were established. The frequency of motion-related artifacts 
was compared for each pair of examinations. 
Results: The mean motion scores for EC-Gd and EOB for non-enhanced 
phase were 0.68 vs. 0.73 (p=0.3), for arterial phase 0.91 vs. 1.26 (p<0.0001), 
and for portal-venous phase 0.73 vs. 0.87 (p=0.04). The frequency of TAP 
observed on EOB was superior to EC-Gd (19.5% vs. 6%; p=0.013), but there 
were no differences in frequencies for severe TAP (p>0.99) between both 
contrast agents. EOB was associated to a higher frequency of post contrast 
motion-related artifacts (7.3% vs. 0%; p=0.03). 
Conclusion: TAP respiratory motion-related artifact is more frequently 
observed on liver MRI with EOB than with EC-Gd and it may affect 19.5% of 
the patients. However, the rate of severe TAP was very low and similar for both 
contrast agents.  
Author Disclosures: 
 J. Bruix: Consultant; Bayer HealthCare, BTG, Daichi, Bristol-Myers Squibb, 
Novartis, Gilead, AbbVie, Arquile, Sytex and Roche. Speaker; Bayer 
HealthCare, BTG. 
B-0611 15:20  
Respiratory motion artefact affecting hepatic arterial phase MR imaging: 
comparison between gadoxetate disodium and gadobenate dimeglumine  
K. Koryukova1, L. Saba2, M. Di Martino1, C. Catalano1; 1Rome/IT, 2Cagliari/IT 
(micdimartino@hotmail.it)  
Purpose: To compare frequency and severity of arterial phase respiratory 
motion-related artefact following gadoxetate disodium and gadobenate 
dimeglumine in patients with cirrhosis. 
Methods and Materials: This prospective study was approved by the 
institutional review board and was compliant with HIPAA. The requirement to 
obtain informed consent was waived. One-hundred and six consecutive MR 
examinations were evaluated, 48 performed with gadoxetate disodium and 58 
performed with gadobenate dimeglumine. All examinations were performed 
with the same magnet (1.5 T) and acquisition protocol. Two radiologists 
blinded to the contrast material rated motion artefacts on a scale of 1 (no 
motion) to 5 (non-diagnostic images) for the pre-contrast, the arterial, the 
venous and the late dynamic phases. Mean motion scores were compared 
using the Wilcoxon signed rank test. The number of patients with TSM, as well 
as the number of those with “adequate” arterial phases, was compared with the 
² or Fisher's exact test, as appropriate. 
Results: The arterial phase reported significantly more MTS compared to the 
other acquired sequences with both contrast agents. Mean motion scores in 
the arterial phases in the gadoxetate disodium cohort were significantly worse 
than those in the gadobenate dimeglumine cohort (P =0.029). TSM occurred at 
a higher rate with gadoxetate disodium than with gadobenate dimeglumine 
(20.8% [10 of 48 examinations] vs 3.4% [two of 58 examinations], P<.001). 
Conclusion: Motion-related artefact occurs significantly more often than after 
gadobenate dimeglumine in patients with cirrhosis.  
14:00 - 15:30 Room C  
Musculoskeletal  
SS 710a  
Muscle and nerve  
Moderators:  
H. Gruber; Innsbruck/AT  
H. Platzgummer; Vienna/AT  
K-12 14:00  
Keynote lecture  
M. Reijnierse; Leiden/NL  
B-0612 14:09  
Diffusion tensor imaging (DTI) in the evaluation of peripheral nerve 
sheath tumours: is it valuable for surgeons?  
I. Capretti1, F. Bruno1, S. Quarchioni2, E. Cannizzaro1, C. Gianneramo1, 
S. Mariani1, F. Arrigoni1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2Teramo/IT 
(ilaria_capretti@hotmail.it)  
Purpose: To demonstrate the preoperative role of MR in the localization and 
characterization of tumoral peripheral nerve sheath lesions and the 
identification of nervous fibers and the relationship with adjacent structures. 
Methods and Materials: Twenty-six patients, suspected of having tumoral 
lesions, underwent contrast enhanced MR (3Tesla). They were evaluated with 
morphological sequences such as PD, FSE T1, FSE T2, FSE T2-weighted fat-
saturated and postcontrast T1- weighted fat-saturated, but also with Spin-echo-
single-shot EPI sequences (b-value 1000 s/mm2; 25 diffusion gradient 
orientations). We used quantitative parameters derived from DTI : apparent 
diffusion coefficient (ADC) and fractional anisotropy (FA) and reconstructed the 
nervous fibers involved in the lesion. All patients were subjected to surgical 
treatment and we studied the correlation between MR imaging and surgical 
findings. 
Results: In all the patients, morphological sequences showed that lesions 
involved peripheral nerves and they appeared hyperintense in T2-weighted 
  






sequences with enhancement in postcontrast T1- weighted fat-saturated 
sequences. DTI techniques allowed the visualization and relationship between 
tumour and normal axons of peripheral nerves with high sensitivity (78.9%), 
specificity (71.4%) and positive predictive value (88.2%). During surgery, a 
good correlation between MR images and intraoperative aspects was observed 
with sensitivity of 90%, specificity of 83% and positive predictive value of 95%. 
Conclusion: According to our experience, preoperative DTI techniques are 
useful to plan the safest surgical resection in order to minimize post-operative 
neurological deficits.  
B-0614 14:17  
Feasibility of shear wave elastography (SWE) in diagnosing carpal tunnel 
syndrome (CTS)  
S. Rauch; Innsbruck/AT (stefanrauch@gmx.at)  
Purpose: To evaluate longitudinal and axial plane measurements of shear 
wave elastography (SWE) at a proximal and distal Level in determining median 
nerve (MN) elasticity and diagnosing carpal tunnel syndrome (CTS). 
Methods and Materials: 27 healthy volunteers (three male, mean 37 yrs., 
range 24-37; 24 female, mean 54 yrs., range 43-78) and one hand of 27 CTS 
patients (twelve male, mean 72.0 yrs., range 43-82; 15 female, mean 65 yrs., 
range 29-82) were examined by using a 18-5 MHz transducer. Cross sectional 
(CSA) area of MN was determined at the level of pronator quadratus muscle 
(CSAp) and at the level of the maximum CSA in the carpal tunnel (CSAd). ∆-
CSA was determined as the difference between both measures. SWE 
measurements were performed for MN both at proximal and distal levels in 
axial and longitudinal orientations. Measures were compared between CTS 
patients and controls at both levels in both orientations (axial and longitudinal). 
Results: Both the SWE values and CSA in CTS patients were significantly 
higher than that of healthy volunteers (P <0.001). Longitudinal SWE was 
superior to axial SWE measurements (P=<0,001). The presence of CTS was 
predicted by a share wave velocity of 10,41 cm/s (mean) (P=<0,001) with a 
cut-off value of 9,85 (sensitivity 0.93, specificity 0.63) and an area under the 
curve (ROC) of 0.85. 
Conclusion: SWE proved to be sensitive in CTS patients and a single 
longitudinal SWE measurement at the carpal tunnel is sufficient for the 
diagnoses of CTS.  
B-0615 14:25  
Ultrasound of the Thenar Motor branch in Carpal Tunnel Syndrome  
F. Zaottini, R. Picasso, S. Airaldi; Genova/IT (federico.zaottini.fz@gmail.com)  
Purpose: This study was aimed to investigate the ultrasound (US) appearance 
of the thenar motor branch (TMB) of the median nerve (MN) in patients with 
carpal tunnel syndrome (CTS) and thenar muscle weakness at physical 
examination and electrophysiology. 
Methods and Materials: Twenty-two consecutive wrists from n=15 patients 
(mean age 61±5) who had clinical and electrophysiological diagnosis of CTS 
and signs of thenar muscle weakness were included. In each patient, the CSA 
of the MN and the caliber of the vertical segment of the TMB were measured 
with 17-5MHz US. In addition, the thenar muscles echotexture and the 
appearance of the intermuscular segment of the TMB were recorded. 
Electrophysiology included standard needle technique and sampling of motor 
and sensory conduction velocities of the MN. Correlation between US findings 
and electrophysiologicy was then obtained. 
Results: US was able to identify the TMBs in all but one wrists. The mean 
TMB diameter was 0.9±0,28mm (95% CI). In 43% of cases, the vertical 
segment of the TMB resulted to be larger than normal, ranging between 0.7mm 
to 2mm. The intramuscular segment of the TMB appeared swollen in 9% of 
cases. Overall, the mean CSA of the MN at wrist was 16,1mm2. No correlation 
was observed between TMB caliber and either CSA of the MN or 
electrophysiologic signs of denervation of thenar muscles. 
Conclusion: The TMBs often appear swollen in patients with CTS and signs of 
thenar muscle weakness. There is no significant correlation, however, between 
thenar muscle weakness and abnomal appearance of the TMB.  
B-0616 14:33  
High resolution Ultrasound of the Motor Branch of the Ulnar Nerve 
beyond the Guyon tunnel  
R. Picasso1, F. Zaottini1, S. Airaldi2; 1Genova/IT, 2Savona/IT 
(riccardo.picasso@gmail.com)  
Purpose: To illustrate the ultrasound (US) findings of distal entrapment 
neuropathy of the motor branch of the ulnar nerve (UNMB) beyond the Guyon 
tunnel. 
Methods and Materials: A dissection study was performed on n=3 cadaveric 
hands to assess the regional anatomy of the UNMB beyond the pisiform. US 
was perfomed in a group of n=10 healthy subjects to examine the nerve at the 
hamate hook, pisohamate ligament and within the palm. A series of n=10 
consecutive patients with motor symptoms in the territory of innervation of the 
UNMB in the hand (zone 2) were examined with US using a linear 17-5MHz 
transducer. These patients had neurophysiologic, 1.5T MR imaging and 
surgical correlations. 
Results: US was reliable to depict the UNMB from its origin to the midpalm. 
Two levels of entrapment were identified. In five patients, the UNMB was 
compressed on the outside slope of the hamate hook by ganglion cysts. Four 
other patients had more distal compression in the palm by fibrous bands (n=1) 
and ganglion cysts (n=3). One had multiple neurofibromas affecting the nerve 
and its divisional branches. In midpalmar entrapments, there was selective 
denervation of the III/IV dorsal interosseous muscles. Overall, US gave useful 
preoperative information on the level of injury. 
Conclusion: US may help the diagnostic work-up of distal ulnar neuropathies 
giving information on the level and nature of constricting findings. In patients 
with suspected zone II syndrome, US should include a through evaluation of 
the UNMB at the level of the hamate hook and the midpalm.  
B-0617 14:41  
MRI assessment of the microstructural integrity of the peripheral nerves 
in Charcot-Marie-Tooth disease  
F.I. Rozalli, F. Fadzli, T. Krisnan, K. Rahmat, L.K. Tan, N. Shahrizaila, 
N. Ramli; Kuala Lumpur/MY (farhana.fadzli@yahoo.com)  
Purpose: Charcot-Marie-Tooth (CMT) is one of the most common inherited 
causes of peripheral neuropathy. Our goal was to investigate the 
microstructural integrity of sciatic and peroneal nerves in CMT using diffusion 
tensor imaging (DTI), and evaluate muscle atrophy. 
Methods and Materials: A total of 9 CMT patients and 9 age- and gender-
matched healthy controls were recruited. DTI using 3-tesla MRI machine was 
performed to evaluate the sciatic and peroneal nerves. Post-processing 
produced DTI values for each nerve. Axial in-out phase of the calf was used to 
classify muscle atrophy (tibialis anterior) using Goutallier classification. 
Results: The FA values were significantly reduced (0.330±0.036 vs 
0.408±0.023, p<0.001, for sciatic nerve; 0.3575±0.107 vs 0.5484±0.107, 
p<0.001, for peroneal nerve) and RD values were significantly increased 
(1.149±0.102 vs 0.852±0.472, p=0.04 for sciatic nerve; 2.291±0.6417 vs 
1.103±0.329, p<0.001 for peroneal nerve) in CMT patients. The mean muscle 
atrophy value was significantly increased in CMT patients (0.78±0.833 vs 
3.33±0.707, p<0.001). We also found correlation between DTI values (FA and 
RD) and muscle atrophy grading. 
Conclusion: DTI was able to detect degenerative and demyelination changes 
in CMT, which corresponds to the nature of the disease. MRI also supports 
that there was significant muscle atrophy in CMT patients. MRI-DTI could 
emerge as a useful screening tool for asymptomatic high-risk patients with 
family history of CMT for early detection of neuropathy and as an adjunct to 
EMG in the prognostication of CMT.  
B-0619 14:49  
Core muscle composition and fat distribution in Parkinson's disease  
C.-K. Wang, H.-L. Chen, W.-C. Lin; Kaohsiung/TW (moonrbt@gmail.com)  
Purpose: Sarcopenia and alteration of fat distribution were known in PD 
patients, but the intramuscular fat distribution has not yet been well 
established. The aim of this study was to investigate fat distribution in core and 
extremity muscle and its relationship with clinical severity and frailty. 
Methods and Materials: Twenty-five patients with PD and 20 age- and sex-
matched healthy volunteers were recruited. All subjects underwent MRI study 
using IDEAL sequence to determinate the fat distribution in core and extremity 
muscles (including psoas muscles and the thigh). PD patients received clinical 
survey to evaluate disease severity and frailty. The alternation in the fat 
content in core and extremity muscles, frailty and clinical severity were 
correlated. 
Results: The fat content in measured muscles exhibited higher in PD patients 
(psoas muscles: p=0.014, anterior compartment of thigh: p=0.006, medial 
compartment of thigh: p<0.001, posterior compartment of thigh: p=0.003 ). The 
fat infiltration of measured muscle was significantly correlated with clinical 
severity and items of frailty. The average percentage of fat content of bilateral 
medial compartment of thigh showed correlation with UPDRS-1 (r=0.707, 
p<0.001) and average percentage of fat content of bilateral anterior 
compartment of thigh showed correlation with weakness and exhaustion 
(r=0.519, p=0.019). 
Conclusion: Higher percentage of fat content in core and extremity muscles is 
a significant phenomenon in PD patients. The pathophysiology of sarcopenia 
and frailty in PD might be a consequent process of neuromuscular 
degenerative changes and, therefore, PD patients were limited their daily 













B-0620 14:57  
Ultrahigh field (7T) diffusion tensor imaging of healthy skeletal muscles: 
a quantitative comparison with 3T  
C. Giraudo1, S. Motyka1, M. Weber1, T. Feiweier2, S. Trattnig1, W. Bogner1; 
1
Vienna/AT, 2Erlangen/DE (chiara_giraudo@hotmail.it)  
Purpose: To compare diffusion tensor imaging (DTI) with 7T and 3T of the 
human calf muscles. 
Methods and Materials: Ten volunteers (5 males; mean age 29.1±4.7 years), 
without any history of muscle disease, were examined twice (i.e. during the 
same day, without repositioning) at 3T (MAGNETOM Prisma, Siemens 
Healthcare) and 7T (research scanner, Siemens Healthcare), using a STEAM-
DTI sequence. SNR, DTI metrics (tracks’ number (tracksn), length (tracksl), 
volume (tracksv), fractional anisotropy (FA), and mean (MD), axial (AD) and 
radial diffusivity (RD)) of the entire datasets (entire_calf), of tibialis anterior 
(TA), gastrocnemius medialis (GM) and lateralis (GL) were collected. Student’s 
T test was used to compare SNR and DTI metrics obtained at 3T and 7T. 
Intraclass-correlation coefficients (ICC) were derived to assess the reliability of 
DTI measurements at 3T and 7T. 
Results: The SNR was higher at 7T (+105.11%; p<.001). At 7T, tracksn, 
tracksv,and tracksl were higher for entire_calf, GM and GL (tracksn: +5.5%, 
+3.1%, +8.5%; tracksv: +12.1%, +12.2%, +14.7%; tracksl: +13.3%, +16.4%, 
+19.2%; p<.05, each); TA showed only higher tracksn and tracksv (+6.3%, 
+16.4%; p<.05 each). MD and RD were higher at 7T for the entire_calf (+1.3%; 
+1.8%; p<.05, each) and for TA (+7.3%, 8.9%; p<.05, each). TA showed higher 
FA at 3T (+3.1%; p=.001) and higher AD at 7T (+5.6%; p<.001). GM 
demonstrated lower MD and RD at 7T (-2.8%; -3.4%; p<.05). ICC was 
excellent (>.750) for both 7T and 3T regarding GM’s and GL’s tracksn, tracksv, 
RD, entire_calf’s RD, TA’s RD and FA. Excellent ICC values were obtained 
only at 3T for the entire_calf’s and GL’s MD and AD, and GL’s FA and GM’s 
AD. GM’s tracksl and TA’s tracksv had excellent ICC only at 7T. 
Conclusion: Ultrahigh field demonstrated higher SNR and an overall 
improvement in fibre tracking metrics. Further studies are necessary to better 
characterize the advantages and the challenges in specific muscles.  
Author Disclosures: 
 T. Feiweier: Employee; Siemens Healthcare GmbH. 
B-0621 15:05  
Compression garments in delayed-onset muscle soreness (DOMS): 
randomised controlled trial with acoustic radiation force impulse (ARFI), 
contrast-enhanced ultrasound (CEUS) and MRI  
R. Heiß1, M. Kellermann1, B. Swoboda1, C. Grim2, A.M. Nagel1, M. Uder1, 
T. Hotfiel1; 1Erlangen/DE, 2Osnabrück/DE (Rafael.Heiss@uk-erlangen.de)  
Purpose: To investigate the influence of compression garments on changes in 
muscle perfusion, stiffness and oedema in DOMS. 
Methods and Materials: DOMS was induced in fifteen healthy participants 
using an eccentric exercise protocol. After exercise, a conventional sports 
compression garment (class I) was worn on one randomized calf for 60h. ARFI 
(shear wave velocities (SWV)), CEUS (peak enhancement (PE) and wash-in 
area under the curve (WIAUC)) and MRI (normalized T2 signal intensity and T2 
time) of the gastrocnemius muscle (GM) were assessed at baseline and 60 h 
after exercise at both calves. 
Results: After exercise the normalized T2 signal intensity (1.0±0.30 vs 
1.94±1.05, p=0.008) and the T2 time (37.52±9.67 vs 55.64±12.72 ms, p=0.015) 
were significantly higher in the GM in the compressed calf; but no change for 
WIAUC (p=0.88), PE (p=0.51) and ARFI SWV (p=0.60) were observed. For the 
non-compressed calf all assessed parameters changed significantly: T2: 
1.0±0.16 vs 2.20±1.16, p=0.001; T2 time: 37.75±9.28 vs 55.67±14.78 ms, 
p=0.005, WIAUC: 2461±660 vs 5297±743, p=0.01, PE: 328±45 vs 753±31, 
p=0.005, ARFI SWV: 2.2±0.26 vs 1.78±0.24m/s, p=0.008. No significant 
difference was observed in normalized T2 signal intensity (p=0.397), T2 time 
value (p=0.953), WIAUC (p=0.93) and PE (p=0.730) in the GM comparing the 
compressed and non-compressed lower leg after exercise. Only ARFI SWV 
values in the same comparison revealed a statistically significant difference 
(p=0.001). 
Conclusion: Wearing conventional compression garments after inducing 
DOMS may shorten the normalization of muscle stiffness, but have no 
significant effect on the degree of intramuscular oedema or perfusion of the 
gastrocnemius muscle.  
Author Disclosures: 








14:00 - 15:30 Room Z  
Interventional Radiology  
SS 709  
Non-liver ablation 
Moderators: 
D. Ilic; Novi Sad/RS 
N.N.  
B-0622 14:00  
Feasibility study of microwave ablation system: localisation and 
eradication of tumourous lesions  
T.J. Vogl1, C. Reimann2, M. Puentes-Damm2, F. Hübner1, B. Bazrafshan1; 
1
Frankfurt a. Main/DE, 2Darmstadt/DE (t.vogl@em.uni-frankfurt.de)  
Purpose: To investigate the difference between the dielectric properties of 
normal and malignant liver tissue by measuring the permittivity of freshly 
excised samples from liver resection. 
Methods and Materials: A microwave ablation system is proposed with a 
microwave sensor at the tip of the applicator as an additional information 
source for accurate localization of the targeted tumour during the intervention. 
A measurement procedure was developed to evaluate the broadband dielectric 
properties of a liver sample containing healthy and tumour tissue. In total, 22 
measurements were performed by touching the surface under test with a 
dielectric probe (2.1 mm in diameter) connected to a network analyser. 
Measurement points were recorded on normal (8), tumour (8), and tumour 
boundary (6) locations. 
Results: At 12GHz, the permittivity mean value ± standard deviation of normal 
tissue was n=33.8±0.86 and of tumour tissue t=44.33±5.49, which results in a 
relative difference of =31.15%. The proposed applicator is able to distinguish 
between healthy and tumour tissue exhibiting a sensitivity of 10%. During 
thermal ablation measurements, a lesion zone of approximately 3 cm3 was 
obtained with an input power of 20W for 4 minutes when the functional model 
was inserted into the liver sample. By detecting tumour tissue, an additional 
source of information is provided for the interventional radiologist and could 
lead to a reduced number of insertions and readjustments. Moreover, the high 
operation frequency leads to an efficient heat generation for thermal ablation 
treatment. 
Conclusion: The new microwave system possibly allows simultaneous 
diagnostic and therapeutic microwave application.  
B-0623 14:08  
Microwave ablation (MWA) of pulmonary neoplasms: clinical 
performance of MWA with spatial energy control vs conventional low-
frequency MWA  
T.J. Vogl, L. Basten, N.N.N. Naguib, N.-E.A. Nour-Eldin; Frankfurt a. Main/DE 
(t.vogl@em.uni-frankfurt.de)  
Purpose: To evaluate the clinical performance of a new microwave ablation 
(MWA) technology with spatial energy control (SEC) for treatment of lung 
malignancies in comparison to a conventional low-frequency (LF) MWA 
technology. 
Methods and Materials: In this retrospective study, 59 consecutive patients 
(mean: 58.9±12.7 years) were treated in 71 sessions using SEC-MWA. 
Parameters collected were technical success and efficacy, tumour diameter, 
tumour and ablation volume, time, energy, complication rate, 90-day mortality, 
local tumour progression (LTP) at 3-month follow-up, ablative margin size and 
ablation zone sphericity. Results were compared with the same parameters 
retrospectively collected from the last 71 conventional LF-MWA sessions (n=56 
patients; mean 60.3±10.8 years). Statistical comparison was done using 
Wilcoxon-Mann-Whitney test. 
Results: Technical success was 98.6% for both technologies; efficacy was 
97.2% (SEC-MWA) and 95.8% (LF-MWA). The 90-day mortality rate was 4.2% 
(3/71) in both groups without any intraprocedural death. Complications were 
recorded in 21.1% (15/71) of SEC-MWA and in 31% (22/71) of LF-MWA, of 
which 4.2% (3/71) and 9.9% (7/71) were major (all p>0.182). The median 
deviation from ideal sphericity (1.0) was 0.195 (SEC-MWA) vs 0.376 (LF-MWA) 
(p<0.001). Absolute minimal ablative margins per ablation were on average 
7.5±3.6 (SEC-MWA) vs 4.2±3.0 mm (LF-MWA) 8p<0.001). LTP until 3-month 
follow-up occurred in 5.6% (4/71) and 7.0% (5/71), respectively (p>0.7). 
Conclusion: SEC-MWA of lung malignancies and conventional LF-MWA 
technology are safe and effective independent of the used system. However, 
SEC-MWA achieves more spherical ablation zones with larger ablative margins 











B-0624 14:16  
Renal tumour cryoablation beyond T1a: outcomes for 56 T1b biopsy-
proven RCC lesions  
T.A. Gibson, N. Patel, N. McGill, A. King, D. Breen; Southampton/UK 
(tagibson0@gmail.com)  
Purpose: Percutaneous image-guided renal cryoablation (CRA) represents an 
alternative nephron-sparing technique for renal tumours. The majority of 
published data has focused on its application specifically to T1a disease. 
Hence, our purposes are to: a) provide results of a single-centre prospective 
study of the technical and oncological outcomes of CRA for T1b (<7cm) lesions 
and b) compare these results with our equivalent data for T1a (</= 4cm) renal 
masses. 
Methods and Materials: 433 patients with 486 T1 renal lesions treated 
between 2008 and 2016 were identified from a prospectively maintained 
tumour registry. A subset of 56 patients with stage T1b (4-6.9cm) sporadic 
biopsy-proven RCC were selected for further analysis. Exclusion criteria: 
previous history of RCC or heritable disease; <3 months follow-up. 
Results: a) Demographics: 39 male, 17 female; average age = 70yrs; average 
tumour size = 4.8cm. b) Technical outcomes: technical success i) primary 
ablation rate = 51/56 (91.1%), ii) secondary ablation rate (where performed) = 
2/2 (100%); complications (Clavien-Dindo grade III+) = 3/56 (5.4%). c) 
Oncological outcomes: mean length of follow-up = 26 months. No significant 
difference between T1a and T1b cohorts in overall survival (p= 0.43), late local 
recurrence-free survival (p = 0.45), or metastasis-free survival (p = 0.50). 
Conclusion: Our findings of no statistical difference for CRA in the treatment 
of T1a or T1b renal masses concur with those of other studies in the literature. 
CRA, therefore, seems a reasonable treatment option for sporadic RCC 
tumours of <7cm. Further (follow-up) data are needed for comparison with 
partial nephrectomy.  
B-0625 14:24  
CT-guided percutaneous cryoablation treatment of renal cancer: an 
outcome analysis from our experience  
S. Gitto, G. Calareso, T. Cascella, G. Greco, G. Greco, M. Vaiani, S. Stagni, 
R. Salvioni, C. Spreafico; Milan/IT (sal.gitto@gmail.com)  
Purpose: To perform an outcome analysis from our experience in CT-guided 
percutaneous cryoablation(PCA) treatment of renal cancer(RC). 
Methods and Materials: We evaluated patients with a minimum follow-up of 
one year after PCA of RC or extrarenal metastasis from RC performed 
between 10/2007 and 10/2016. All patients were inoperable or refused surgery 
and cases were discussed multidisciplinary. A biopsy was performed in 
patients without a previous diagnosis of RC. Post-operative monitoring 
included biochemistry 4, 8, 24 hours and a non-contrast CT scan 24 hours 
after PCA. Follow-up consisted of contrast CT scans 1, 3, 6, 9, 12 months after 
PCA and then every 6 months for 3 years. Absent/persistent mass contrast-
enhancement indicated response/recurrence, respectively. 
Results: Eighty-five patients were included (27F; mean age 68[35-86] years; 
25 with a solitary kidney): 80 with RC and 5 with an extrarenal metastasis. 
Mean follow-up was 51(12-116) months. Mean mass diameter was 30(10-100) 
mm. Biochemical parameters were normal after PCA. Major early 
complications included: 1 sepsis, 1 ureteral fistula, 1 duodenal fistula, 1 
arteriovenous fistula, 1 active arterial bleeding. No patients died for these 
complications. 93% of patients (79/85) showed complete response after PCA. 
Six patients had recurrent disease: 3 were successfully retreated with PCA, 1 
underwent nephrectomy, 2 were not further treated and died for other causes. 
No significant difference in age (P=0.113;95%CI) and mass diameter 
(P=0.668;95%CI) was found between responsive and recurrent patients. 
Conclusion: PCA is effective in the treatment of RC in patients ineligible for 
surgery and can be repeated in recurrent cases.  
B-0626 14:32  
Technical success and local control after image-guided microwave 
ablation (MWA) of T1a renal tumours with a new high-power generation 
system  
M. Colombo, M.M. Panzeri, P. Marra, G. Brembilla, M. Venturini, U. Capitanio, 
F. Montorsi, A. Del Maschio, F. De Cobelli; Milan/IT (colombo.michele@hsr.it)  
Purpose: MWA is a novel thermal ablation technique which allows larger and 
more uniform ablation zones (AZ) with shorter procedure time compared to 
other ablative techniques. High-power MWA may present advantages in term 
of local renal tumor control. In the present study we evaluated safety, technical 
success, local control, and survival after MWA of RCC with a new high-power 
generation system. 
Methods and Materials: From October 2014 to March 2017 twenty-three 
patients (mean age 65 y; range 45-86 y) with 26 renal cancers (clear cell RCC 
= 21; papillary RCC = 10; chromophobe RCC = 3, oncocytoma=1) not eligible 
for surgical treatment were treated with MWA procedures (US/CT guided 
percutaneous = 23 lesions; laparotomic = 1; laparoscopic = 2), with a 2450 
MHz/100 W generator with Thermosphere™ Technology (Emprint™, 
Medtronic). At follow up (FU), contrast-enhanced CT or MR was performed 
after one, six and twelve months. Technical success, AZ, complete ablation 
(CA) and clinical success were assessed. 
Results: Mean diameter of the lesions was 2.3 cm ± 1.1; (range, 0.9-4.2 cm). 
Technical success was achieved in 100% of cases and mean AZ was 28.7 mm 
at 1 month FU. CA at 1 year was 96%. No severe complications and 6 mild 
complications (19%, all perirenal haematoma) were observed. One year 
morbidity and mortality were both 0%. 
Conclusion: In our experience, MWA with Thermosphere™ Technology is 
effective and safe to treat RCC.  
B-0627 14:40  
Our experience in percutaneous ablative treatment of renal T1a e T1b 
lesions: results from 90 patients treated with MWA, RFA and CRA  
E. Faiella, D. Santucci, A. Alfonsi, G. Pacella, C. Altomare, C. Bernetti, 
C. Rollo, R.F. Grasso, B. Beomonte Zobel; Rome/IT (a.alfonsi@unicampus.it)  
Purpose: To evaluate efficacy and safety of ablation procedures for the 
treatment of kidney lesions <7cm. 
Methods and Materials: 90 patients with single T1a and T1b lesions of the 
kidney, susceptible to ablative procedure, were retrospectively analyzed: 30 
treated with Radiofrequency (RFA), 30 with Cryoablation (CA) and 30 with 
Microwave (MWA).Biopsy was perfomormed for all the lesions. Complications 
rate, local control in terms of Disease Free Survival (DFS) and renal function, 
and survival in terms of Cancer Specific Survival (CSS) and Overall Survival 
(OS), were evaluated. 
Results: Mean age of patients was 68.8 years (29-94 years); mean tumor size 
was 26.51mm (6-102mm). Eighty-two lesions (91%) were T1a and 8 (9%) T1b. 
In 19 cases artificial dissection was performed. The treatment was effective in 
96% of cases, with peri-procedural complications in 6 patients (5 
haemorrhages and 1 hydro-ureteronephrosis). Ten patients (11.1%) reported a 
recurrence of disease (9 T1a and 1 T1b) (p> 0.05) in a mean time of 3 months: 
6 (20%) underwent MWA, 2 (6.7%) RFA and 2 (6.7%) CA (p <0.05). 1 case of 
renal failure in mono-kidney patient. The only significant predictor of DFS in the 
multivariate analysis, was the histotype, with a higher recurrence rate in RCC 
(p <0.05). Nine (10%) patients died for other causes. 
Conclusion: Safety and efficacy in short and long-term control of the three 
procedures are comparable. However, long-term surveillance is required, 
especially after MWA. Patient selection, based on tumor characteristics (size 
and location), and patient comorbidities remain crucial.  
B-0628 14:48  
Percutaneous ablative treatment of pelvic rectal cancer recurrence  
C. Pusceddu; Cagliari/IT (clapusceddu@gmail.com)  
Purpose: To retrospectively evaluate the technical feasibility, safety and 
efficacy of percutaneous ablative treatment of painful pelvic rectal cancer 
recurrent in patients unfit for surgery and no longer susceptible to radiotherapy 
or chemotherapy. 
Methods and Materials: Fourteen patients, mean age 61 years, with pelvic 
recurrence of rectal carcinoma, mean size 4.7 (2.5-9cm) underwent RFA (11 
cases) and cryoablation (2 cases) to reduce pain and to limit local progression 
of disease. All the procedures were performed under CT guidance using local 
anaesthesia and conscious sedation. The therapeutic outcomes were 
evaluated by CT or MRI at 1-, 3-, 6- and 12-month intervals. Complete lack of 
tumour enhancement images after injection of contrast media was considered 
an indication of complete tumour necrosis. 
Results: Total necrosis of the tumour was observed in 7 patients, partial in the 
remaining 7. Complete pain relief was obtained in eight patients and a 
significant reduction of pain in the remaining patients (mean VAS score from 
7.8 before treatment to 1.4 after treatment). In two patients an abscess in pre-
sacral space and a bladder-rectal fistula after RFA was observed. During the 
mean follow-up of 40 months (7-55 months) 10 patients died due to local or 
distant tumour progression whereas four patients are still alive and 2 of them 
disease free. 
Conclusion: In selected cases, percutaneous ablative treatment of pelvic 
rectal cancer recurrence can be considered a safe and effective treatment 
capable of obtaining satisfactory control of pain and stabilization of the relapse.  
B-0629 14:56  
Microwaveablation (MWA) of liver metastases from pancreatic 
neuroendocrine tumour (pNET): preliminary results with a new 
generation system  
P. Marra, P. Diana, F. Ratti, S. Partelli, M. Salvioni, S. Gusmini, M. Venturini, 
L. Aldrighetti, F. De Cobelli; Milan/IT (marra.paolo@hsr.it)  
Purpose: MWA is in the panel of treatment for pNET liver metastases in 
symptomatic oligometastatic patients. Many case series in the literature, most 
based on radiofrequency ablation, report variable rates of efficacy with 
  






relatively high rates of local tumor progression (LTP). We aimed to report our 
preliminary results, using a new generation high-power MWA system. 
Methods and Materials: In the last two years, seven patients underwent liver 
MWA in our institution for the treatment of synchronous (n=4) or metachronous 
(n=11) pNET metastases (total nodules=15). MWA procedures were performed 
either percutaneously (n=5) or during surgery (n=10), using a 100W/2450MHz 
Microwave Generator (Emprint, Medtronic). Resection of the pancreatic 
neoplasm was performed synchronously to MWA treatment in 2 patients. DCE-
CT or MRI were used to assess 1-month complete ablation (CA) and LTP at 
follow up. 
Results: CA was achieved in 100% of cases. No complications occurred. 
Overall LTP was 0% at a mean observation time of 11.8 months (9-18). One 
patient developed liver disease progression after 15 months, however without 
recurrence at ablation site. 
Conclusion: In our preliminary experience, MWA performed with a new 
generation system provided excellent results for the treatment of pNET liver 
metastases. During follow up, although limited, no LTP was observed. Even if 
the utility of loco-regional treatment of pNET liver metastases is still debated, 
we believe that MWA with a new generation system provide good cost-benefit 
ratio in oligo-metastatic patients.  
B-0630 15:04  
MR-guided focused ultrasound (MRgFUS) ablation of painful osteoid 
osteoma: perfusion imaging as predictors of clinical outcomes 
associated with complete bone integrity restoration  
S. Bednarova, A. Napoli, R. Scipione, S. Dababou, C. Marrocchio, 
H.-P. Erasmus, C. Catalano; Rome/IT (sandra.bednarova@gmail.com)  
Purpose: To correlate quantitative and semi-quantitative perfusion parameters 
of post-ablation osteoid osteoma (OO) nidus with treatment outcome and bone 
remodelling. 
Methods and Materials: Thirty-nine subjects with radiologically confirmed 
symptomatic OO were treated with MRgFUS in an institutional review board-
approved clinical trial, according to the intention-to-treat principle. Bone-
forming changes were evaluated before and after MRgFUS procedure; annual 
CT and dynamic contrast-enhanced MRI (DCE-MRI) scans were performed 
over a period of 3 years. Quantitative and semi-quantitative parameters of OO 
nidus perfusion were analysed for significance with regard to post-procedural 
complete/partial bone restoration. Multivariate analysis was conducted to 
investigate imaging and demographic (age, sex, BMI) variables in relationship 
with clinical outcomes (VAS for pain). 
Results: 31 of 36 patients underwent MRgFUS ablation of OO nidus; 29 
encountered a complete clinical response (VAS score 0 during follow-up); 2 
patients with residual pain at 1-month follow-up (VAS 1-3) required re-
treatment using RFA. At 36-month follow-up, MRI showed no residual nidus 
perfusion in 76.7% of cases, with bone restitution-ad-integrum in 30% of cases. 
Multivariate statistical analyses demonstrate that both patients' age (<18 years) 
and no residual perfusion of nidus on post-procedural DCE-MRI are significant 
favorable prognostic factors in terms of clinical outcome and complete bone 
restoration. Variable relationship between clinical outcome and bone 
remodelling was found in older patients (>18 years). 
Conclusion: MRgFUS is an effective and safe treatment for painful non-spinal 
osteoid osteoma; patients' age shows significant impact on clinical outcome as 
well as on bone integrity restoration when total nidus ablation is achieved.  
B-0632 15:12  
Percutaneous US- and CT-guided thermal ablation of 20 adrenal 
metastases: treatment effectiveness in short- and intermediate-term 
imaging follow-up with CT and MRI  
G. Frauenfelder, E. Faiella, D. Santucci, B.B. Beomonte Zobel, R. Grasso; 
Rome/IT (giulia.frauenfelder@gmail.com)  
Purpose: To retrospectively evaluate efficacy and safety of adrenal metastasis 
percutaneous ablation, in terms of clinical outcomes and imaging follow-up. To 
evaluate additional contribution of DWI and subtracted MR sequences during 
radiological follow-up. 
Methods and Materials: A total of 20 adrenal metastases were treated 
through RTA, CA or MWA. Probes were inserted under US-/CT-guidance. 
Type of ablation and treatments parameters were influenced by lesion size and 
location. Each patient was evaluated with a short-term (3 months) and 
intermediate-term (after 6 months) imaging follow-up through contrast-
enhanced CT and/or MRI. Technical success, complications, local tumour 
progression and overall survival were analysed on a per-patient basis. 
Sensitivity, specificity, positive predictive value (PPV), negative predictive value 
(NPP) and accuracy of CT and MR enhancement, DWI and subtraction 
sequences were separately evaluated during short- and intermediate-term 
intervals. 
Results: Technical success (within 24 hours) was obtained in 100% of cases. 
Complications were recorded in 20% of patients (15% hypertensive peak; 5% 
sub-glissonian haematoma). There were 15% cases of short-term progression 
(recidive): all these patients had undergone RTA (62,5% of efficacy). In short-
term follow-up, accuracy for CT enhancement, MR enhancement, DWI and 
subtraction was, respectively, 83.3%, 80%, 75% and 90% while in 
intermediate-term was 84.2%, 89.5%, 94.7% and 94.7%. Overall survival was 
92% after 12 months. 
Conclusion: Percutaneous US- and CT-guided thermal ablation may be a safe 
and effective procedure in metastatic adrenal lesion treatment. Short- and 
intermediate-term imaging follow-up could be performed with both CT and MR; 
DWI and subtracted sequences are essential to increase MR accuracy.  
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B-0633 14:09  
Individual and specific dose-level selection using dual-source computed 
tomography of the chest and its impact on image quality and radiation 
dose  
A. Wressnegger1, C. Schestak1, H. Prosch1, G. Apfaltrer2, H. Ringl1, 
P. Apfaltrer1; 1Vienna/AT, 2Graz/AT 
(alexander.wressnegger@meduniwien.ac.at)  
Purpose: The purpose of this study was to evaluate the value of individual and 
specific dose-level selection in dual-source computed tomography (DSCT) of 
the chest and its impact on image quality and radiation dose. 
Methods and Materials: This retrospective study included 105 patients 
(57.1% male, 52.5±13.3 years). All patients had received routine unenhanced 
chest CT for follow-up examination reasons on both, a 2nd-generation DSCT 
(2nd DSCT) (Somatom Definition Flash, Siemens Healthineers) and a latest 
generation DSCT (Somatom Drive, Siemens Healthineers). 2nd DSCT scans 
were performed with 120kV and 100-150ref mAs, Care dose enabled, and 
FBP. Latest generation DSCT were performed with variable kV (Care kV 
enabled) and 50-70ref mAs, Care dose enabled, and iterative reconstruction 
(Admire). Signal/noise (SNR) was assessed in 6 thoracic regions. Subjective 
image quality (IQsub) was graded on a 5-point Likert scale. Group comparisons 
were performed using t test or Wilcoxon-rank-sum-test as appropriate. 
Results: Dose length product (DLP) and effective dose (ED) were 
208.5±63.3mGy*cm and 3.8±1.1mSv versus 112.2±34.7mGy*cm and 
2.0±0.6mSv for 2ndDSCT and latest generation DSCT, respectively (P<.001), 
corresponding to a radiation dose reduction of 54%. SNR was 5.4±3.5 versus 
6.5±3.4 for 2nd DSCT and latest generation DSCT, respectively (P=0.01), 
indicating a superior IQ for the latest generation scanner despite significantly 
less dose. IQsub was excellent for both scanners with a median score of 1[1-1] 
[25th-75th percentile] (P=0.7). 
Conclusion: Use of latest generation DSCT enables personalized and specific 
dose level selection with an overall consequent radiation dose reduction of 
54% while maintaining or exceeding image quality of former CT hardware.  
B-0634 14:17  
Model-based iterative reconstruction algorithm in low-dose CT 
pulmonary angiography in emergency setting: dose reduction and 
diagnostic quality images  
L. Riva1, D. Ippolito1, C. Talei Franzesi1, A. de Vito1, C. Cangiotti1, C. Maino1, 
S. Sironi2; 1Monza/IT, 2Bergamo/IT (luca.riva89@gmail.com)  
Purpose: To compare radiation dose and image quality of low-dose CT 
pulmonary angiography(CTPA) combined with Model-Based Iterative 
Reconstruction (IMR), with a standard dose CTPA-study, in patients with 
suspect of pulmonary embolism(PE). 
Methods and Materials: Eighty-seven patients investigated for PE in 
emergency setting were enrolled. The study-group was evaluated using a 256-
MDCT (iCT elite,Philips) with 80-kV, dose right index and automated tube-
current modulation, low volume of CM (50mL;350mgI/mL) and IMR algorithm to 
reconstruct raw data. Control-group underwent a standard CTPA-study on 16-
MDCT scanner, with the same volume of CM(120kV;150-250mAs;FBP-
reconstruction).Two radiologists performed quantitative evaluation measuring 
vessels contrast-enhancement and calculating SNR and CNR. A 4-point scale 
  






was used to perform qualitative evaluation. Radiation dose exposure data was 
recorded as DLP and CTDIvol. 
Results: The intra-vessel density, SNR and CNR were significantly higher in 
study-group than in control-group (i.e.CNR: IMR 43.56±21.81 vs FBP-CTPA 
23.21±12.11;p<0.05),while background noise was significantly lower(p<0.05) in 
study-group in comparison with control-group. DLP and CDTIvol in IMR-CTPA 
were significantly lower than those in FBP-CTPA (p<0.05),with a 56% 
reduction of CTDIvol (IMR-CTPA 6.41±1.41mGy vs FBP-CTPA 
14.68±3.42mGy) for study-group. Raw data reconstruction time of the IMR was 
higher than FBP with a mean value of 2.08 minutes, otherwise acceptable for 
emergency setting. Moreover, the overall image quality rating score was higher 
for IMR-CTPA than FBP-CTPA both for the two readers 
(p<0.05;C.Alpha=0.91). 
Conclusion: Low-kV setting combined with IMR can improve diagnostic image 
quality of CTPA in pulmonary embolism, compared to a standard CTPA 
reconstructed with FBP, allowing to reduce the radiation dose to patients.  
B-0635 14:25  
The impact of ASiR-V in different noise index in thorax CT imaging: 
comparison between normal dose and low dose  
L. Jin, M. Li, Y. Sun; Shanghai/CN (BrightDK@126.com)  
Purpose: To evaluate the impact of adaptive statistical iterative reconstruction-
veo (ASiR-V) technique in thorax CT imaging between normal dose and low 
dose. 
Methods and Materials: Randomly selected 42 patients sent to do thorax CT 
by clinical doctors from April-July 2017 were divided into three groups: 
(NI=14,120KV) group A, (NI=28,120KV) group B, (NI=28,80KV) group C. All 
groups were reconstructed by ASiR-V technique: weight from 0%-100%, 
interval was 10%, image slice and reconstruction interval was 0.625mm. Signal 
intensity was measured by placing a region of interest in 3cm upon the corner 
of the sternum, noise was measured in the thoracic aorta. Image quality was 
visually assessed by two radiologists over 15 experience using a 5-point scale. 
The inter-observer differences were determined by kappa statistics. 
Results: The image noise of each group decreases with the increase of ASiR-
V weight, and the contrast noise increases with the increase of ASiR-V weight. 
The image quality of all sequences in image analysis was above 3 points and 
above which was satisfied with diagnosis, 40% weight ASiR-V got the highest 
image quality. The ED of each group was (3.03±1.63)mSv, (3.86±0.74)mSv, 
(3.62±0.63)mSv; the ED of low-dose group (B&C) was decreased by 75% 
compared with normal group (A). There was perfect inter-observer 
concordance in terms of image quality (kappa=0.912). 
Conclusion: ASiR-V technique for image reconstruction was obviously better 
than FBP, 40% weight was the best choice, specially under low-dose scanning; 
the effect of noise on image quality could be well compensated, so images met 
the diagnosis in lower radiation dose.  
B-0636 14:33  
Study of image quality in chest CT using prospective ASIR-V  
Q.Q. Yuan; Zhengzhou/CN (yuanqian10@163.com)  
Purpose: To explore the optimal prospective ASIR-V percentage in chest CT 
with good image quality and low radiation dose. 
Methods and Materials: A phantom containing solid pulmonary nodule 
examined on GE revolution CT was randomly divided into six groups using 
prospective ASiR-V technique (0%, 20%, 40%, 60%, 80%, 100%). The 
quantitative analyses included objective noise and CNR. The subjective image 
quality was graded on a scale from 1 (worst) to 5 (best). CTDIVol, CNR, noise 
and image score were compared with ANOVA. 
Results: CTDIVol had statistically significant differences of all groups 
(P<0.05). CNR, noise and image score of 40%, 60%, 80% and 100% ASiR-V 
were statistical difference between each group (P<0.05). However, the image 
score of 60%, 80% and 100% ASiR-V could not meet the diagnostic 
requirement with 3.40±0.51 vs 2.40±0.51 vs 1.20±0.41. 40% ASiR-V image 
score basically met the diagnostic requirement with 4.40±0.51, meanwhile 
mean dose reduction relative to 0% ASIR-V was 44%. There was no significant 
difference in CNR and image score between 20% and 0% ASiR-V, CNR was 
1.36±0.16 vs 1.22±0.22 (P =0.17) and subjective image score was 4.80±0.41 
vs 5.00±0.00 (P = 0.21), meanwhile mean dose reduction relative to 0% ASIR-
V was 26%. 
Conclusion: Images of prospective 60%, 80%, 100% ASiR-V provided the 
lower CTDIvol and noise, but the poor image quality could not meet the 
diagnostic requirement. Images obtained from 20% and 40% ASiR-V had the 
similar image quality with 0% ASiR-V producing lower radiation dose. 20% and 





B-0637 14:41  
Comparison of ultra-low-dose computed tomography (ULDCT) and 
standard-dose computed tomography (SDCT) for the detection of 
interstitial lung disease  
S. Takehara1, T. Iwasawa1, T. Baba1, T. Ogura1, M.S. Oba2; 1Yokohama/JP, 
2
Tokyo/JP (takehara198963@gmail.com)  
Purpose: To compare the ability of ultra-low-dose computed tomography 
(ULDCT) and standard-dose computed tomography (SDCT) for detecting 
interstitial lung disease (ILD). 
Methods and Materials: Fifty-one patients were recruited prospectively. Each 
patient underwent computed tomography (CT) examinations at standard dose 
(auto electric current; below 350 mA, 120 kV) and ultra-low-dose (20 mA, 120 
kV). The average effective doses were 5.8 and 0.37 mSV, respectively. Three 
board-certified radiologists diagnosed ILD based on SDCT images.The volume 
of a normal lung (N-pattern) and fibrosis (F-pattern) were measured using a 
Gaussian histogram normalized correlation (GHNC) system; volume ratios to 
the whole lung volumes were calculated. Receiver operating characteristic 
(ROC) curve analysis of the F-pattern volume ratio was used to examine the 
ability of ULDCT and SDCT to detect ILD. 
Results: Out of 51 patients, 30 were diagnosed with ILD. The GHNC was used 
to analyse the ULDCT results of all patients.In the GHNC analysis, the N-
pattern volume ratio on ULDCT was significantly larger than that on SDCT 
[median, 86.19% in ULDCT and 83.58% in SDCT (p<0.001)]. The F-pattern 
volume on ULDCT was significantly smaller than that on SDCT [median, 5.59% 
in ULDCT and 7.33% in SDCT (p<0.001)]. The areas under the ROC curve for 
F-pattern were 0.946 (95% confidence interval, 0.89-1.0) in ULDCT and 0.927 
(95% confidence interval, 0.87-1.0) in SDCT. 
Conclusion: The area of fibrosis might be underestimated when ULDCT is 
used. However, the F-pattern volume ratio measured using ULDCT is similar to 
that by SDCT in its ability to detect ILD.  
B-0638 14:49  
Ultra-low-dose CT with tin filtration for lung densitometry and 
emphysema detection  
Y. Gao, X. Zhai, L. Zhang, K. Huang; Beijing/CN (gaoyanli1997@msn.com)  
Purpose: The purpose of this study was to determine whether ultralow-dose 
CT with tin filtration can be used for quantification of lung density and for 
emphysema detection. 
Methods and Materials: Fifty-two patients were prospectively enrolled and 
underwent both low-dose CT (120 kV, 50 effective mAs) and ultralow-dose CT. 
Ultralow-dose CT was performed with single-energy at 100kV using tin filtration 
(Sn100 kV, 100 effective mAs). Images were reconstructed by filtered back 
projection (FBP) for low-dose CT and FBP and advanced modelled iterative 
reconstruction (ADMIRE, strength level 3 and 5) for ultralow-dose CT. 
Radiation dose was recorded. Emphysema index, 15th percentile of lung 
attenuation, mean lung attenuation, total lung volume and image noise were 
measured in each image series and compared. 
Results: The effective dose of low-dose CT was 2.0 ± 0.6 mSv, and that of 
ultralow-dose CT was 0.2 ± 0.1 mSv. Compared with the findings for low-dose 
CT, emphysema index was significantly overestimated by 4% on ultralow-dose 
CT FBP images, 2% on ADMIRE step 3 images, but no significant difference 
was observed on ADMIRE step 5 images. The 15th percentile of lung 
attenuation was significantly underestimated by 6 HU on ultralow-dose FBP 
images, while no significant differences were exhibited on ADMIRE images 
compared with low-dose CT. No significant differences were observed in mean 
lung attenuation and total lung volume. Image noise was significantly reduced 
using ADMIRE compared to FBP. 
Conclusion: Ultralow-dose CT with tin filtration is feasible for lung density 
quantification and emphysema detection. ADMIRE improves the accuracy of 
ultralow-dose CT.  
B-0639 14:57  
Impact of iterative model reconstruction on the correlation between CT 
quantification of emphysema and airway measurements and pulmonary 
function test in the normal study cohort  
D. Kim1, C. Kim2, K. Lee1, J.-Y. Choo2, E.-Y. Kang2, Y.-W. Oh2; 1Ansan/KR, 
2
Seoul/KR (dj8827@naver.com)  
Purpose: To compare the correlation between PFT and different 
reconstruction algorithms and to suggest useful guidance to optimize the 
reconstruction protocol in the CT quantification of the lung and airways in the 
normal study subjects. 
Methods and Materials: Chest CT from 223 subjects were reconstructed 
using variable reconstruction algorithms including FBP, hybrid IR(HIR), and 
model-based IR(MIR) to determine the scan protocol best correlated with PFT. 
Measurements of each dataset were compared: emphysema index (EI) and 
wall area percentage (WA%). We compared the CT parameters between FBP, 
HIR and MIR with PFT parameters. Pearson correlation and linear regression 
  






analysis were conducted to evaluate between different algorithms and PFT in 
the whole study subjects and subgroups according to smoking history. 
Results: In the whole study subjects, EIs of all the reconstruction algorithms 
involving FBP, HIR, IMR-R1, and IMR-ST1 showed significant correlations with 
FEV1/FVC. Among these, EI of IMR-R1 showed the highest correlation with 
FEV1/FVC. WA% in IMR-SP1 showed significant correlation with both FEV1 
and FEV1/FVC. In the subgroup analysis, EIs of all the reconstruction 
algorithms involving FBP, HIR, IMR-R1, and IMR-ST1 showed significant 
correlations with FEV1/FVC in both ever- and never-smokers. Among these, EI 
of IMR-R1 showed the highest correlation with FEV1/FVC in both ever- and 
never-smokers. WA% in IMR-SP1 showed also significant correlation with both 
FEV1 and FEV1/FVC in both ever- and never-smokers. 
Conclusion: CT quantification of emphysema and airway using MIR showed 
best correlation with PFT compared to using HIR and FBP in the normal study 
cohort.  
B-0640 15:05  
Performance and radiation dose comparison of the recently introduced 
ultralow-dose chest computed tomography (CT), standard-dose CT and 
digital chest radiography  
T. Svahn1, T. Sjöberg2, K. Shahgeldi1, J. Nordström1; 1Gävle/SE, 
2
Hudiksvall/SE (tony.svahn@regiongavleborg.se)  
Purpose: To evaluate diagnostic performance and absorbed radiation dose of 
ultra-low-dose CT (ULD-CT) in comparison to that of standard CT (SD-CT) and 
digital chest radiography (DR). 
Methods and Materials: Pulmonary nodules were simulated in an 
anthropomorphic phantom (LungMan; Kyoto Kagaku). Thirty cases, 18 with 
lesions (45 lesions in total of 3-12 mm) and 12 without, were acquired at each 
imaging technique. Two radiologists interpreted the cases in a blinded 
detection study. Performance was assessed using the JAFROC figure-of-merit 
(FOM). Radiation absorbed dose to the lungs were measured using TLD-
dosimeters. A systematic search was performed to identify patients examined 
by both ULD-CT and SD-CT for extraction and evaluation of radiation dose 
metrics. 
Results: Performance was not significantly different between ULD-CT and SD-
CT (FOMs: 0.824 vs 0.857; ∆FOM: 0.03). Significantly more lesions were 
detected with the two CT techniques in comparison to DR (FOM: 0.541; ∆FOM: 
0.31 and 0.28). Depending on patient size, ULD-CT was found to yield two to 
twelve times higher dose to the lungs than DR (PA + lateral views), but only 
~4-11% the dose from SD-CT. Paired radiation dose data was eligible for forty 
patients, which correlated with the measured dose differences, but with a wider 
dose range. 
Conclusion: ULD-CT may serve as an alternative to both SD-CT and DR, 
considerably reducing dose in the first case and improving diagnostic accuracy 
in the second. Raised awareness of ULD-CT may lead to increased usage in 
the appropriate clinical setting at the local radiology department.  
B-0641 15:13  
Low-dose digital radiography in diagnosis of COPD’s phenotypes  
N. Gorbounov, A. Dergilev, V. Kochura, Y. Manakova, A. Sudarkina; 
Novosibirsk/RU (a.sudarkina@mail.ru)  
Purpose: Determination of the features of low-dose digital radiography in the 
diagnosis of phenotypic variants of COPD. 
Methods and Materials: 107 patients with COPD of varying severity were 
examined. The average age of the patients was 51.8 ± 1.5 years (46 - 59 
years). All patients underwent low-dose digital radiography of the chest in the 
frontal projection in different phases of respiration. The electron optical density 
of the lungs was determined in the upper, middle and lower zones of both 
lungs. 
Results: In patients with a predominance of emphysematous variant of COPD 
(n = 15) the most characteristic radiological symptom was lung emphysema 
(14% of 107 patients) and inspiratory electron optical density value was 748.18 
± 4.72 optical density units (ODU). In patients with a predominance of 
bronchitic variant of COPD (n = 43) the most common radiological symptom 
was the presence of amplification and deformation of lung pattern (40% of 107 
patients) and inspiratory electron optical density value was 668.04 ± 12.26 
ODU. For patients with mixed phenotypic variant of COPD (n = 49) it was 
characterized by a combination of X-ray symptom of amplification and 
deformation of lung pattern with lung emphysema (46% of 107 patients); the 
average value of inspiratory electron optical density value was 815.24 ± 17.25 
ODU. 
Conclusion: The technique of low-dose digital radiography can detect X-ray 
symptoms and determine electron optical density of the lungs in patients with 
COPD that allows optimizing the diagnosis of phenotypic variants of chronic 
obstructive pulmonary disease.  
 
 
B-0642 15:21  
Radiation protection: factors influencing compliance to referral 
guidelines in minor chest trauma  
F. Louagé1, A. Van Muylem2, N. Howarth3, P. Gevenois2, D. Tack4; 1Ath/BE, 
2
Brussels/BE, 3Chênes-Bougeries/CH, 4Braine-L'Alleud/BE 
(fabian.louage@ulb.ac.be)  
Purpose: To test the hypothesis that referral guidelines are not sufficiently 
known by prescribers and that medico-legal concerns could influence the 
prescription of radiographs in minor chest trauma. 
Methods and Materials: We submitted a questionnaire including a typical 
clinical history and questions on reasons for prescribing radiographs of the ribs 
in minor chest trauma to 112 prescriptors (33 residents, 18 surgeons, 7 
internists, 24 general practitioners and 30 ER physicians). All accepted to 
participate. Comparisons were performed by exact Fisher tests followed by a 
post hoc analysis and by a McNemar test. 
Results: Fifty-eight percent of prescriptors proposed rib radiographs, most 
(89%) being unaware of the guidelines. Only 11% of them changed their 
intention to order radiographs after information on referral guidelines and 
radiation dose (P=0.057). The mean dose delivered by rib radiographs was 38 
times higher than that of a chest X-ray. Legal and medico-legal concerns 
(requirements from insurance policies and avoidance of lawsuits) were the 
main reasons for requesting radiographs. 
Conclusion: Unsharpness of guidelines in addition to social and medico-legal 
issues, rather than medical reasons or the lack of knowledge of the guidelines, 
strongly influence the prescription of radiographs of the ribs in minor chest 
trauma. As stated by the 2013/59 Euratom Directive, legal issues should be 
addressed specifically in future versions of referral guidelines.  
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B-0643 14:09  
Newly categorised seromucinous tumours of ovary: computed 
tomographic and magnetic resonance imaging features with pathological 
correlation  
J. Han, K.A. Kim, C. Hyeyoon, J.W. Kim, Y. Park, J. Lee, J.W. Choi, C.H. Lee, 
C.M. Park; Seoul/KR (seryjooin@hanmail.net)  
Purpose: To describe computed tomographic (CT) and magnetic resonance 
imaging (MRI) findings of newly established seromucinous ovarian tumors in 
the revised 2014 WHO classification, according to tumor type with pathological 
correlation. 
Methods and Materials: We retrospectively reviewed the CT and MR images 
of 29 patients with seromucinous tumors of ovary for the following factors: size, 
configuration, signal intensity (SI), staging, and accompanying ovarian 
endometriosis. 
Results: The mean age was 45.2 years (range, 20-84 years). 32 
seromucinous tumors were found on CT or MRI (17 adenoma (A), 7 borderline 
(B), and 8 carcinoma (C)), and the mean size was 11.4 cm (A: 12.6 cm, B: 6.8 
cm, C: 13.3 cm). Adenomas appeared as unilocular (n=10) or multilocular 
(n=7) cystic mass. Borderline tumors (n=6, 86%) and carcinomas (n=8, 100%) 
showed complex cystic and solid mass. The SI of solid portion on T2-weighted 
images (T2WI) was hyperintense in borderline and hypointense in carcinoma. 
The seromucinous carcinomas were FIGO stage IA (n=7, 88%) and stage IC 
(n=1). Endometriosis was accompanied with 18 tumors (A: 8; 46%, B: 5; 71%, 
C: 5; 63%). 
Conclusion: The CT and MRI appearance of seromucinous tumors varied 
according to tumor type. T2WI high SI solid portion was useful for 
differentiating borderline tumor from carcinoma. Seromucinous tumors were 













B-0645 14:17  
Clinical value of low-kiloelectron volt monoenergetic images of dual 
energy computed tomography for evaluation of peritoneal seeding of 
ovarian cancer  
T.M. Kim, S. Kim, J. Cho, S. Kim; Seoul/KR (kjambong@gmail.com)  
Purpose: The purpose of this study was to compare the image quality of 
virtual low-kiloelectron volt (keV) monoenergetic (monoE) images with 
conventional images reconstructed from enhanced spectral computed 
tomography (CT) in detection of peritoneal implants. 
Methods and Materials: Thirty patients who underwent serial pelvis CT scans 
due to ovarian cancer were included in this retrospective study. From spectral 
data, the two virtual low-keV monoE (40-keV and 50-keV) images were 
reconstructed. The conventional images using filtered back projection (FBP) 
and iterative reconstruction (IR) protocols were also evaluated. Two 
radiologists measured the attenuation and standard deviation of peritoneal 
implants, adjacent bowels and ascites. The mean attenuation, signal-to-noise 
ratio (SNR) and contrast-to-noise ratio (CNR) were calculated and compared 
using paired t-test. 
Results: The 201 peritoneal implants were measured and evaluated. The 
virtual low-keV monoE (40-keV and 50-keV monoE) images showed 
significantly higher mean attenuation values of peritoneal implants than 
conventional images. The all SNR and CNR values showed significantly higher 
in the virtual 40-keV monoE images. The virtual 50-keV monoE images 
showed the similar SNR and CNR values to IR images. In terms of contrast 
between peritoneal implants and adjacent bowels, the virtual 40-keV monoE 
images showed significantly higher image quality than virtual 50-keV monoE 
images. 
Conclusion: The virtual 40-keV monoE images significantly increase the 
contrast of peritoneal implants. The low-keV monoE reconstructions from 
spectral CT can demonstrate excellent clinical value for detection and 
management of peritoneal seeding in ovarian cancer patients.  
B-0646 14:25  
Prediction of histological grade of endometrial cancer by means of MRI  
M. Bonatti, B. Pedrinolla, F. Lombardo, G. Avesani, G. Bonatti; Bolzano/IT 
(matteobonatti@hotmail.com)  
Purpose: To evaluate the capability of MRI in predicting histological grade of 
endometrial cancer (EC). 
Methods and Materials: IRB-approved retrospective study; requirement for 
informed consent was waived. 90 patients with histologically proven EC who 
underwent preoperative MRI and surgery at our Institution between Sept2011 
and Nov2016 were included. Myometrial invasion (</>50%) was assessed on 
T2-weighted images in association with diffusion-weighted images. Neoplasm 
and uterus volumes were estimated according to the ellipsoid formula using 
sagittal and para-axial images. Neoplasm/uterus volume ratio (N/U) was 
calculated. ADC maps were generated and histogram analysis was performed 
using commercially available software. MRI parameters were compared with 
the definitive histological grade (G1=28 patients, G2=29, G3=33) using ANOVA 
and Tukey-Kramer tests. 
Results: Deep myometrial invasion was significantly more frequent in G2-G3 
lesions than in G1 ones (p<0,005). N/U ratio was significantly higher for high-
grade neoplasms (mean 0,08 for G1, 0,16 for G2 and 0,21 for G3; P=0,002 for 
G1 vs. G2-G3); a cut off value of 0,13 enabled to distinguish G1 from G2-G3 
lesions with 50% sensibility and 89% specificity. ADC values didn’t show any 
statistically significant correlation with tumour grade. 
Conclusion: N/U ratio >0.13 and deep myometrial invasion are significantly 
correlated with high grade EC, whereas ADC values are not useful for 
predicting EC grade.  
B-0647 14:33  
Prediction of pathologic upgrading in biopsy-proven low-grade 
endometrial cancer: utility of diffusion-weighted imaging  
J. Park1, C. Kim2; 1Daejeon/KR, 2Seoul/KR (jjskku@naver.com)  
Purpose: To investigate the utility of diffusion-weighted imaging (DWI) for 
predicting pathologic upgrading in endometrial cancer. 
Methods and Materials: A total of 221 patients who underwent MRI before 
surgery for biopsy-proven grade I endometrial cancer were enrolled. The 
minimum apparent diffusion coefficient (ADCmin) was calculated using 
histogram analysis of the entire tumour. Clinical and imaging variables were 
compared between patients with and those without postoperative pathologic 
upgrading. The independent predictors of pathologic upgrading were 
determined using logistic regression analysis. 
Results: Pathologic upgrading was identified in 42 patients (19.0%). Patients 
with pathologic upgrading had larger tumours, more frequently showed deep 
myometrial invasion on MRI, and had lower ADCmin values than those without 
pathologic upgrading (all P<0.001). The area under the receiver operating 
characteristic curve of ADCmin and tumour size was 0.812 (cut-off, 0.600×10
-
3mm2/s) and 0.758 (cut-off, 3cm), respectively. On multivariate analysis, tumour 
ADCmin0.600×10
-3mm2/s (odds ratio [OR], 11.8; P<0.001) and tumour size on 
MRI>3 cm (OR, 3.24; P=0.009) were independently associated with pathologic 
upgrading. Upgrading occurred in 23 of 31 patients (74.2%) with ADCmin 
0.600×10-3mm2/s and tumour size>3cm, and in 7 of 114 patients (6.1%) with 
ADCmin > 0.600×10
-3mm2/s and tumour size 3cm. 
Conclusion: Tumour ADC and tumour size on MRI may be useful parameters 
for predicting pathologic upgrading in biopsy-proven grade I endometrial 
cancer.  
B-0648 14:41  
Utility of histogram analysis of apparent diffusion coefficient maps in 
differential diagnosis of uterine sarcoma and degenerated uterine 
leiomyoma  
M. Huang; Zhengzhou/CN (huangmengna1127@163.com)  
Purpose: To investigate the value of histogram analysis of apparent diffusion 
coefficient (ADC) maps for discriminating uterine sarcoma and degenerated 
uterine leiomyoma. 
Methods and Materials: 43 patients with uterine sarcoma and 46 patients with 
degenerated uterine leiomyoma who underwent MRI and DWI scanning were 
retrospectively evaluated. Histogram data from regions of interest drawn on all 
slices of the ADC maps of parenchyma of different tumours were derived and 
statistically analysed by independent samples t test. The receiver operating 
characteristic (ROC) curve was analysed to determine the optimum threshold 
value for each parameter and its corresponding sensitivity and specificity. 
Results: Uterine sarcoma demonstrated significantly lower mean values of 
ADC: 5%, 10%, 25%, 50%, 75%, 90% and 95% than degenerated uterine 
leiomyoma (P < 0.05). ROC curve analysis of the 90% yielded the best area 
under the ROC curve (AUC; 0.941), sensitivity of 91.3%, and specificity of 
90.2%, with a cutoff value of 1.155×10-3mm2/s. 
Conclusion: Histogram analysis of apparent diffusion coefficient maps is 
beneficial in differential diagnosis of uterine sarcoma and degenerated uterine 
leiomyoma.  
B-0649 14:49  
Diagnostic performance of MRI for assessing parametrial invasion in 
cervical cancer: a head-to-head comparison between oblique and true 
axial T2-weighted images  
S. Woo1,2, S. Kim1, J. Cho1, S. Kim1; 1Seoul/KR, 2Daejeon/KR 
(j_crew7@hotmail.com)  
Purpose: To investigate whether oblique axial T2-weighted images (T2WI) 
provide added value compared with true axial T2WI for assessing parametrial 
invasion (PMI) in cervical cancer. 
Methods and Materials: This retrospective study included 71 women with 
treatment-naive cervical cancer who underwent MRI (including oblique and 
true axial T2WIs) followed by radical hysterectomy. Two blinded radiologists 
(R1 and R2) independently assessed PMI on both sequences using a 5-point 
Likert scale. Receiver operative characteristic (ROC) curve analysis was 
performed. Subgroup analysis was done for tumours sized >2.5 and 2.5 cm. 
Inter-reader agreement was assessed with kappa (k) statistics. 
Results: There were 15 patients (21.1%) with PMI at hysterectomy. Oblique 
axial T2WI showed significantly greater area under the curve (AUC) than true 
axial T2WI by R1 (0.941 [95%CI=0.858-0.983] vs 0.917 [95%CI=0.827-0.969], 
p=0.027) but not R2 (0.879 [95%CI=0.779-0.944] vs 0.827 [95%CI=0.719-
0.906], p=0.153). In tumours >2.5 cm, AUC was greater using oblique than true 
axial T2WI (0.906 vs 0.860, p=0.046 and 0.839 vs 0.765, p=0.086). Agreement 
was almost perfect for oblique axial T2WI (k=0.810) and substantial for true 
axial T2WI (k=0.704). 
Conclusion: Oblique axial T2WI may provide potentially greater diagnostic 
performance than true axial T2WI for determining PMI, especially in tumours 
>2.5 cm. The inter-reader agreement was greater when using oblique axial 
T2WI than when using true axial T2WI.  
B-0650 14:57  
Blood oxygenation level-dependent MRI for prediction of clinical outcome 
in uterine cervical cancer treated with radiotherapy  
J. Lee, C. Kim, K. Gu; Seoul/KR (jiyeong25.lee@samsung.com)  
Purpose: To investigate the value of blood oxygenation level-dependent 
(BOLD) magnetic resonance imaging (MRI) as a predictor of clinical outcome 
in cervical cancer patients treated with radiotherapy (RT). 
Methods and Materials: Between October 2009 and August 2017, 98 patients 
with stage IB-IVB cervical cancer who received definitive RT with (n= 92) or 
without (n= 6) concurrent chemotherapy underwent BOLD MRI before 
treatment. BOLD MRI was obtained at 3T using a multiple fast field echo 
sequence to acquire 12 T2*-weighted images. The R2* value (rate of spin 
dephasing, sec-1) was measured in the tumour. Cox proportion hazard model 
was used to evaluate the association of imaging and clinical variables with 
  






progression-free survival (PFS), cancer-specific survival (CSS), and overall 
survival (OS). 
Results: During a median follow-up of 3.8 years, disease progression was 
identified in 33 patients (33.7%) and 14 patients (14.3%) died of their disease. 
Tumour R2* value had a significant difference between with and without 
progression (P< 0.001). On multivariate analysis, tumour R2* value was 
significantly independent factor for PFS (hazard ratio [HR]= 1.18, P= 0.001), 
CSS (HR= 1.25, P= 0.003) and OS (HR= 1.22, P= 0.009), respectively. Of 
clinical variables, histologic type was significantly independent factor for PFS 
(HR= 1.02, P= 0.013). For predicting tumour progression, the area under 
receiver operating characteristic curve of R2* value was 0.724, which was 
significantly different with other variables (P< 0.001). 
Conclusion: As an imaging marker, pretreatment BOLD MRI may be useful for 
predicting clinical outcome in patients with cervical cancer treated with RT.  
B-0651 15:05  
Primary vaginal malignancies: a single oncology centre experience  
M. Lima1, G. Rio2, M. Horta1, T.M. Cunha1; 1Lisbon/PT, 2Braga/PT 
(mariana_talina@hotmail.com)  
Purpose: Review the clinical and imaging features of primary vaginal 
neoplasms of a large oncologic referral centre. 
Methods and Materials: Retrospective analysis of clinical and MR findings of 
primary vaginal cancers over a 11-year period (Feb/2006-Sep/2017). 
Results: 35 cases were found. The most common histological type was 
squamous cell carcinoma (SCC) (77,1%), followed by adenocarcinoma 
(14,3%). Glassy cell carcinoma, melanoma and botryoid sarcoma occurred as 
single cases. There was no statistically significant difference (p=0,550) in the 
mean age at diagnosis between SCC (63y) and adenocarcinoma (58y), as well 
as in the mean size of the tumor (p=0,998; SCC:41.5mm; adenocarcinoma: 
41.3mm). SCCs were homogeneous on T2-weighted images, while 
adenocarcinomas were heterogeneous (one also showed hyperintense areas 
on T1-weighted imaging). Regarding the location, both SCC(59%) and 
adenocarcinomas (80%) were predominantly confined to the upper third, while 
melanoma occurred in the lower third. All adenocarcinomas originated on the 
anterior vaginal wall, while the majority of SCC originated on the posterior wall 
(62.5%). The remaining SCCs preferentially involved the right (16.7%)/left 
vaginal wall (16.7%), however one case showed circumferential involvement. 
54% of patients had previous hysterectomy. In the adenocarcinomas group, all 
were performed for benign pathology; in the SCCs group, 73% were 
associated with cervical dysplasia (83%CIN III). 
Conclusion: The imaging distinction of histological subtypes of vaginal cancer 
is not possible, although their location and MR signal can provide some clues. 
Many patients with vaginal SCC had a previous hysterectomy with cervical 
dysplasia, probably because they may share HPV infection as a risk factor.  
B-0652 15:13  
Comparison of 18F-FDG PET/MRI and MRI alone for whole-body staging 
of 71 women with suspected recurrent pelvic cancer: a follow-up study  
L.M. Sawicki1, J. Kirchner1, J. Grueneisen2, V. Ruhlmann2, 
B.M. Schaarschmidt1, M. Forsting2, K. Herrmann2, G. Antoch2, L. Umutlu2; 
1
Düsseldorf/DE, 2Essen/DE (Linomorris.sawicki@med.uni-duesseldorf.de)  
Purpose: To evaluate the diagnostic performance of 18F-FDG PET/MRI for 
whole-body staging of women with suspected recurrent pelvic cancers in 
comparison with MRI alone. 
Methods and Materials: Seventy-one consecutive women (54±13 years) with 
suspected recurrence of cervical (32), ovarian (26), endometrial (7), vulvar (4), 
and vaginal (2) cancer underwent PET/MRI including a diagnostic contrast-
enhanced MRI protocol. PET/MRI and MRI were separately evaluated 
regarding lesion count, localisation, categorisation (benign/malignant), and 
diagnostic confidence (3-point scale; 1-3) by two physicians. Reference 
standard was histopathology and follow-up imaging. Diagnostic accuracy and 
proportions of lesions rated correctly were retrospectively compared using 
McNemar's Chi2 test. Differences in diagnostic confidence were assessed by 
Wilcoxon test. 
Results: Fifty-five patients showed cancer recurrence. PET/MRI correctly 
identified more patients with cancer recurrence than MRI alone (100% vs 
83.6%, p<0.01). Based on the reference standard, 241 lesions were detected 
in the study cohort (181 malignant, 60 benign). While PET/MRI provided 
correct identification of 181/181 (100%) malignant lesions, MRI alone correctly 
identified 135/181 (74.6%) malignant lesions, which was significantly less 
compared to PET/MRI (p<0.001). PET/MRI offered superior diagnostic 
accuracy (99.2% vs 79.3%, p<0.001) and diagnostic confidence in the 
categorisation of malignant lesions compared with MRI alone (2.7±0.5 vs 
2.4±0.7, p<0.001). 
Conclusion: PET/MRI demonstrates excellent diagnostic performance and 
outperforms MRI alone for whole-body staging of women with suspected 
recurrent pelvic cancer.  
Author Disclosures: 
 L. Umutlu: Consultant; Bayer AG. 
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B-0653 14:00  
Investigating direction of effective connectivity in obsessive compulsive 
disorder with resting state fMRI  
H. Li, X. Hu, L. Zhang, L. Lu, X. Bu, S. Tang, X. Huang; Chengdu/CN 
(979280614@qq.com)  
Purpose: Obsessive-compulsive disorder(OCD) is a common psychiatric 
disorder characterized by disruption in functional connectivity of certain brain 
networks. This study aimed to investigate direction of effective connectivity(EC) 
in OCD by estimating anomalous cross-structure causal effects and to further 
investigate whether those connectivities would correlate with the severity of 
clinical symptoms. 
Methods and Materials: A total of 88 OCD patients and 88 sex and age 
matched healthy control(HC) were recruited. We performed bivariate voxel-
wise and multivariate ROI-wise Granger Causality(GC) Analysis using the 
REST-GCA in the REST toolbox. The multivariate GC analysis incorporating 
regions identified in the bivariate GC analysis. The comparison of group 
difference were performed using a linear mixed-effects model and the 
correlations between effective connectivity and clinical variables were 
performed by Pearson correlation analysis. 
Results: Compared with HC, OCD patients showed excitatory EC from 
pallidum and cerebellum to dorsolateral prefrontal cortex(DLPFC), and from 
DLPFC to posterior cingulate cortex(PCC), from superior parietal lobule(SPL) 
to PCC. While inhibitory EC start from middle temporal gyrus(MTG) point to 
DLPFC. In addition, there is a positive correlation between inhibitory EC from 
MTG to DLPFC and Hamilton Score for Anxiety in OCD patients. 
Conclusion: Our findings for the first time demonstrated the either excitatory 
or inhibitory effects among these structures implicated in OCD brain network 
alterations and its correlation with clinical symptom. These findings shed light 
on our understanding of the OCD pathology from a cerebral network point of 
view.  
B-0654 14:08  
Structural magnetic resonance imaging study on schizophrenic patients 
with violence risk  
Y. Li, F. Fan, Z. Feng, W. Liang, S. Tan, F. Yang; Beijing/CN 
(867840617@qq.com)  
Purpose: This study utilized structural MRI with FreeSurfer to assess different 
brain cortical morphology changes (brain cortical thickness, surface area, 
volume and mean curvature) in schizophrenic patients with violence risk and to 
elucidate the correlation between the obtained brain characteristics and clinical 
parameters. 
Methods and Materials: Sixty-six patients were classified into 2 groups 
(violence: nonviolence group =49:17) based on the MOAS to analyse the brain 
structure differences. Individuals in each group underwent structural MRI, then, 
FreeSurfer was used to carry out subsequent brain structure analysis. The 
statistical software used was SPSS22.0. 
Results: There were no statistical differences in gender, age and other clinical 
information between two groups (P>0.05). Compared with nonviolence group, 
the violence group showed increased cortical mean curvature in left cingulate 
sulcus (0.0104±0.0132 vs 0.1131±0.0107, P=0.006), reduced cortical thickness 
in right postdorsal cingulate gyrus (3.2771±0.2993 vs 2.999±0.2637, P=0.001) 
and left occipital pole (2.2471±0.2237 vs 2.0971±0.1856, P=0.008). Brain 
volume showed reductions in left temporal middle gyrus (8734.12±1091.164 vs 
7562.33±1195.055, P=0.001), left transverse temporal sulcus (567.71±143.795 
vs 466.57±117.752, P=0.005) and right superior frontal sulcus 
(4503.53±737.935 vs 3856.24±799.814, P=0.005) in violence risk brains. The 
ROC demonstrated left cingulate and superior precentral sulcus mean 
curvature can diagnose the schizophrenic violence risk, the AUC is 0.715 
(95%CI: 0.566-0.865, P=0.008) and 0.726 (95%CI: 0.578-0.875, P=0.006), 
respectively. The multinomial logistic regression model adjusting the general 
clinical information the right postdorsal cingulate gyrus cortical thickness is 
shown to be an independent factor predicting the violence risk of schizophrenia 
(OR: 0.003[0.000,0.174], P=0.005). 
Conclusion: A reduction in the brain cortex thickness and volume and an 
increase in the cortical mean curvature may be associated with schizophrenia 
with violence risk. The right postdorsal cingulate gyrus cortex thickness could 
predict violence of schizophrenia as an independent factor.  
  






B-0655 14:16  
Meta-analysis of resting-state functional connectivity of major depressive 
disorder in youth  
S. Tang, X. Hu, Q. Gong, X. Huang; Chengdu/CN (731781233@qq.com)  
Purpose: To investigate neural dysfunction in youth with major depressive 
disorder (MDD) reported in existing resting-state functional connectivity (rsFC) 
studies. 
Methods and Materials: Seed-based rsFC studies comparing youth with MDD 
with healthy controls (HCs) (published before September 30.2017) were 
retrieved from electronic databases (PubMed, Web of Science, and EMBASE). 
Articles that conducted a comparison of youth with MDD aged under 25 and 
HCs using seed-based rsFC were retained and coordinates of brain regions 
exhibiting different rsFC in youth with MDD compared with HCs were extracted. 
Anisotropic effect size-signed differential mapping (AES-SDM) meta-analysis 
was performed to assess rsFC alterations in 375 youth with MDD compared to 
313 HCs. 
Results: Compared with HCs, youth with MDD showed hyperconnectivity in 
the right postcentral gyrus(the main sensory receptive area), left superior 
frontal gyrus(in coordination with the action of the sensory system), and right 
heschl gyrus(processing incoming auditory information) and hypoconnectivity 
in the left middle orbital-frontal gyrus(referring to emotion and reward in 
decision making). 
Conclusion: Increased connectivity in the right postcentral gyrus, left superior 
frontal gyrus and right heschl gyrus which all involve in sensory perception 
such as vision, hearing and touch may reflect the biased external to internal 
sense and cognition processing.Meanwhile,reduced connectivity in the left 
middle orbital-frontal gyrus implicated in emotion and reward in decision 
making may give an index to the deficits in internal to external emotion and 
salience executing. These findings paralleled to the core feature of MDD 
patients may underlie the cognitive and affective abnormalities in depressive 
disorder.  
B-0656 14:24  
Relationship between peripheral Interleukin 10 and white matter integrity 
in stable medicated schizophrenia  
G. Fu1, W. Zhang1, J. Liu1, Y. Xiao1, L. Yao1, J.A. Sweeney1,2, S. Lui1; 
1
Chengdu/CN, 2Cincinnati, OH/US (guifu08011991@163.com)  
Purpose: Deficits of white matter integrity have been widely reported in 
patients with schizophrenia, while the cause of such changes remains unclear. 
Interleukin 10 (IL-10) was reported to be associated with white matter integrity 
in animal model. However, it is unknown whether there is any change of IL-10 
and related white matter integrity in schizophrenia patients. We aimed to 
investigate the relationship between peripheral IL-10 level and fractional 
anisotropy (FA) in stable medicated schizophrenia patients. 
Methods and Materials: Diffusion tensor data scanned with 3T SKYRA and 
IL-10 data tested via quantitative chemiluminescent assay were acquired from 
47 stable medicated schizophrenia outpatients and 49 healthy subjects. FA 
map was processed using FSL 5.0.6 and Tract-Based Spatial Statistics. 
Correlation analyses controlling for age and gender were conducted to explore 
the relationships between FA values and IL-10 levels. 
Results: There was no significant difference in age and sex between the two 
groups. Decreased FA was found diffusively distributed, mainly including 
corpus callosum, bilateral posterior thalamic radiation, right longitudinal 
fasciculus and left inferior fronto-occipital fasciculus in schizophrenia compared 
with healthy controls (TFCE p<0.05). IL-10 level was higher in schizophrenia 
than healthy group (p<0.001). Interestingly, IL-10 level was negatively 
correlated with FA among all subjects mainly involving corpus callosum, right 
posterior thalamic radiation, right superior longitudinal fasciculus, and left 
inferior fronto-occipital fasciculus (p<0.05). 
Conclusion: This study shows that dysregulation of IL-10 relates to the 
changes of white matter integrity in schizophrenia patients, which supports the 
role of the inflammatory processes in the pathogenesis of schizophrenia.  
B-0657 14:32  
Support vector machine-based classification of first-episode drug-naïve 
schizophrenia patients and healthy controls using structural MRI  
Y. Xiao1, Z. Yan2, Y. Zhao3, B. Tao1, Q. Gong1, S. Lui1; 1Chengdu/CN, 
2
Wenzhou/CN, 3Cheng Du/CN (xiaoyuancq@163.com)  
Purpose: Although regional brain deficits have been demonstrated in 
schizophrenia patients by structural MRI studies, one important question that 
remains largely unanswered is whether the complex and subtle deficits 
revealed by MRI could be used as objective biomarkers to discriminate 
patients from healthy controls individually. 
Methods and Materials: To address this question, a total of 326 right-handed 
participants were recruited, including 163 drug-naïve first-episode 
schizophrenia (FES) patients and 163 demographically matched healthy 
controls. High-resolution anatomic data were acquired from all subjects and 
processed via Freesurfer software to obtain cortical thickness and surface area 
measurements. Subsequently, the support vector machine (SVM) was used to 
explore the potential utility for cortical thickness and surface area 
measurements in the differentiation of individual patients and healthy controls. 
Results: The accuracy of correct classification of patients and controls was 
85.0% (specificity 87.0%, sensitivity 83.0%) for surface area and 81.8% 
(specificity 75.0%, sensitivity 88.2%) for cortical thickness (p < 0.001 after 
permutation testing). Regions contributing to classification accuracy mainly 
included the grey matter in default mode, central executive, salience, and 
visual networks. 
Conclusion: Current findings, in a sample of never-treated FES patients, 
suggest that the patterns of ill-related grey matter changes has potential as a 
biomarker for identifying structural brain alterations in individuals with 
schizophrenia. Future prospective studies are needed to evaluate the utility of 
imaging biomarkers for research and potentially for clinical purpose.  
B-0658 14:40  
LHPP gene polymorphism affects spontaneous brain activity in major 
depressive disorder  
L. Cui1, F. Wang1, X. Gong2, M. Chang1, Z. Yin1, G. Fan1, Y. Tang1, K. Xu1; 
1
Shenyang/CN, 2Shanghai/CN (cmu00ring@163.com)  
Purpose: A single-nucleotide polymorphism at the LHPP gene (rs35936514) 
has been reported in genome-wide association studies to be associated with 
major depressive disorder (MDD). However, the neural system effects of 
rs35936514 that mediate the association are unknown. The present work 
conducts a neuroimaging analysis to explore whether and which brain neural 
systems are affected by the LHPP rs35936514 polymorphism. 
Methods and Materials: A total of 160 subjects were studied: a CC group 
homozygous for the C allele (23 individuals with MDD and 57 controls) and a 
T-carrier group carrying the high-risk T allele (CT/TT genotypes; 22 MDD and 
58 controls). All participants underwent resting-state functional magnetic 
resonance imaging (rs-fMRI) scanning. Brain activity was assessed using the 
amplitudes of low-frequency fluctuations (ALFF). 
Results: MDD patients showed a significant increased ALFF in the left middle 
temporal gyrus and occipital cortex. The T-carrier group showed increased 
ALFF in the left superior temporal gyrus. Significant diagnosis × genotype 
interaction was noted in the bilateral lingual gyri, bilateral dorsal lateral 
prefrontal cortex (dlPFC) and left medial prefrontal cortex (mPFC) (P < 0.05, 
corrected). 
Conclusion: MDD patients with LHPP rs35936514 CT/TT genotype may 
influence the regional brain activity. These findings implicate the effects of the 
rs35936514 variation on the neural system in MDD.  
B-0659 14:48  
Impaired mixed emotion processing in the right ventrolateral cortex in 
schizophrenia  
A.G. Szabo, L.R. Kozák, K. Farkas, G. Rudas, G. Csukly; Budapest/HU 
(szabadam@gmail.com)  
Purpose: My thesis is about the differences of brain activity between 
schizophrenic patients and healthy controls, when they are about to recognize 
mixed emotions. Schizophrenia has negative effect on the processing of 
emotional facial expressions, as proved by multiple previous studies. While 
most of these research used the standard Ekman dataset, we aimed to reflect 
on everyday life situations a more complex way than the limited set of facial 
expressions presented by Ekman’s actors. 
Methods and Materials: Age- and education-matched healthy controls (18) 
and patients with schizophrenia (19) were enrolled in an fMRI experiment, 
using a set of 10 fearful, 10 happy, 10 mixed fear (70% fear and 30% happy) 
and 10 mixed happy (70% happy and 30% fear) facial expressions, the mixed 
expressions created by the software Morph from Ekman images. The images 
were presented in a randomized order and subjects had to categorize 
expressions by button presses. Data analysis was performed in SPM, and 
resulting maps further analysed using ICN_Atlasing toolbox. 
Results: The patient group showed decreased fMRI activation during fear, 
mixed fear and mixed happy conditions in the right ventrolateral prefrontal 
cortex (VLPFC) and the right anterior insula (RAI) at the voxel and cluster level 
after family-wise error correction. No difference was found between study 
groups in activations for happy faces. 
Conclusion: Using mixed emotions opens a new avenue in schizophrenia 
research, pointing out the importance of VLPFC in emotion recognition and 














B-0661 14:56  
A fMRI comparison of paediatric patients with obsessive-compulsive 
disorder and controls during a Stroop task  
I. Duman, G. Ekinci, A.R. Arman, H. Aslan, E.B. Usta, G.O. Bilim, M. Kavus; 
Istanbul/TR (edda_ikram@hotmail.com)  
Purpose: It has been suggested that abnormal inhibitory networks may be 
implicated in the pathophysiology of obsessive-compulsive disorder (OCD) and 
could account for the disorder's core symptom. The study aimed to investigate 
abnormalities in brain regions mediating cognitive response inhibition and 
attention allocation (basic demanding task) during the performance of 
coloured-card Stroop task using functional magnetic resonance imaging (fMRI) 
in children and adolescent with OCD compared to healthy controls. 
Methods and Materials: Block-design fMRI was used to compare brain 
activation in 7 children and adolescents with OCD with that of 8 matched 
controls during a Stroop task of response inhibition and basic demanding 
conditions. 
Results: No patient had comorbidity besides OCD. During the basic 
demanding task, participants with OCD showed reduced activation in the 
bilateral frontal, insular, parietotemporal regions (p<0.05, uncorrected). During 
response inhibition task, OCD group showed reduced activation in the left 
middle frontal gyrus (dlPFC), right frontal medial cortex (FMC), left anterior 
cingulate cortex (ACC), bilateral inferior frontal gyri, orbitofrontal cortices 
(OFC), insular, parietotemporal regions, basal ganglia, and thalamus (p<0.05, 
uncorrected). When we compared the basic demanding status with the 
response inhibition condition, the OCD group showed decreased activation 
only during the response inhibition task in the right FMC, left ACC, bilateral 
OFC, basal ganglia and thalamus. 
Conclusion: The results of the present study support the hypothesis that 
frontostriatothalamic regions and ACC play effective role in response inhibition 
in childhood OCD, and also demonstrate dysfunction of left dlPFC, 
temporoparietal regions, and insular cortices during attention allocation.  
B-0662 15:04  
Posttraumatic stress disorder-related alterations in modular 
characteristic and white matter connectivity of brain structural networks  
X. Suo1, D. Lei2, Q. Gong1; 1Chengdu/CN, 2London/UK (1107229715@qq.com)  
Purpose: Although previous studies reported altered topology of brain network 
in posttraumatic stress disorder (PTSD), the modular organization of brain 
network remains largely unknown. This study aims to examine the topologic 
alterations of brain white matter structural network in PTSD at global, modular 
and nodal levels. 
Methods and Materials: Diffusion tensor imaging and graph theory 
approaches were used to investigate the topologic organization of the brain 
structural network in 76 PTSD patients and 76 age-, gender-, and years of 
education-matched trauma-exposed non-PTSD controls. Individual white 
matter networks were constructed for each participant, and the global, modular 
and nodal measurements of the networks between two groups were compared 
with nonparametric permutation tests. 
Results: At global level, the PTSD showed lower clustering coefficient (P = 
0.0156) and normalized characteristic path length (P = 0.0348) compared with 
non-PTSD controls. At modular level, the patients demonstrated significantly 
increased between-module connections between fronto-parietal module, 
fronto-striatal-temporal module and default mode network. At node level, 
increased nodal centralities in the common frontal, temporal and occipital 
regions were found (P < 0.05, FDR corrected). The clinician-administered 
PTSD scale score was positively correlated with the nodal efficiency of left 
inferior temporal gyrus (r = 0.354, P = 0.002). 
Conclusion: The structural brain network showed a shift toward 
'randomization' in the PTSD group, indicated by increased between-modular 
connections with increased nodal centralities involving frontal-temporal-
occipital regions. The disassociation between the current structural and 
previous functional connectome studies suggests that the neural activity is 
shaped, but not limited by the underlying anatomy.  
B-0663 15:12  
Structural and functional brain abnormalities in schizophrenia: a cross-
sectional study at different stages of the disease  
C. Zhao; Beijing/CN (zhaochaoxy@163.com)  
Purpose: To investigate the grey matter volume (GMV) and neural activity 
alterations in subjects at 4 different stages of schizophrenia. 
Methods and Materials: The subjects comprised 53 genetic high-risk (HR) 
individuals, 26 ultrahigh-risk (UHR) individuals, 58 first-episode schizophrenia 
(FES) patients, 41 chronic schizophrenia (ChSz) patients and 39 healthy 
controls (HC). They underwent structural and resting-state functional MRI 
scanning. GMV, amplitude of low-frequency fluctuations (ALFF) and regional 
homogeneity (ReHo) values were compared among the 5 groups using voxel-
based morphometry and the software REST. Relationships between these 
alterations and symptoms in FES group were evaluated by partial correlation 
analysis. 
Results: GMV decline was observed in the bilateral occipital lobe, left orbital 
frontal cortex, bilateral superior parietal lobule (SPL), right middle temporal 
gyrus (MTG), gyrus rectus and medial superior frontal gyrus (SFG) in FES 
group and in the bilateral occipital lobe in HR group. FES group showed 
increased ALFF in the caudate and decreased ReHo in the bilateral inferior 
parietal lobule (IPL) and precuneus. ChSz group showed increased ALFF in 
the right hippocampus. GMV of the right MTG and SPL and ReHo of the 
precuneus were negatively correlated with the general score, while GMV of the 
right MTG was negatively correlated with the total score on the positive and 
negative syndrome scale. 
Conclusion: Structural and functional deficits are prior to symptoms and are 
more prominent at the onset of illness than other phases. The prefrontal cortex, 
right MTG, striatum and default mode network play important roles in the 
pathogenesis of schizophrenia.  
14:00 - 15:30 Room L 8  
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B-0664 14:00  
Sonographic features of medullary thyroid carcinoma: application of 
Thyroid Imaging Reporting and Data System (TIRADS) classification  
G. Yun, Y. Kim, S. Choi; Seongnam-Si/KR (gabinyun@gmail.com)  
Purpose: To evaluate the performance of the Korean Thyroid Imaging 
Reporting and Data System (K-TIRADS) for medullary thyroid carcinoma 
(MTC) and to report the sonographic characteristics of MTC. 
Methods and Materials: The ultrasound (US) images and medical records of 
MTC patients diagnosed on the basis of cytopathologic results from June 2003 
to November 2016 were retrospectively reviewed. Four independent reviewers 
(two experienced radiologists and two 1st year residents) reviewed fifty-seven 
pre-operative US images of MTC patients for shape, composition, 
echogenicity, margin and calcification of the MTC nodules and categorized the 
nodules using K-TIRADS classification. The metastatic lymph nodes were 
assessed for cystic change, echogenicity, the presence of fatty hilum and 
microcalcification. Inter-observer agreement for K-TIRADS was assessed with 
weighted kappa statistics. 
Results: Ninety-five percent of nodules were classified as having either high 
suspicion (68.4%) or intermediate suspicion (26.3%). K-TIRADS score was 
significantly higher in MTCs with lymph node metastasis (p=.003). The 
predominant sonographic findings of MTCs were solid content (87.7%) and 
hypoechogenicity (99.5%). Suspicious lymph nodes were present in 28% of 
MTCs, which showed solid component (81.3%), heterogeneous echogenicity 
(50%), loss of fatty hilum (93.7%), microcalcification (68.8%) and 
hypervascularity (86%). MTCs showing irregular shape, microcalcification and 
presence of ETE were associated with lymph node metastases (p = .008, .001, 
021, respectively). The inter-rater agreement was good (weighted kappa 0.82) 
between the two experienced reviewers, and the inexperienced reviewers also 
showed good agreement with the most experienced reviewer (weighted kappa 
0.73 and 0.81). 
Conclusion: The K-TIRADS classification performed well in MTC nodules with 
good inter-observer agreement.  
B-0666 14:08  
Can valuable information be derived from the exploitation of quality maps 
along elasticity maps in SWE of thyroid nodules?  
L. Chami1,1, G. Bera1, M. Lefort1, J. Griffon1, O. Lucidarme1,1, 
C. Pellot-Barakat2; 1Paris/FR, 2Orsay/FR (linda.chami@yahoo.com)  
Purpose: Quality maps are now provided together with elasticity maps on 
Shear wave elastography (SWE) Aixplorer systems (Supersonic Imagine, 
France). The purpose was to evaluate how to improve reliability and 
reproducibility of SWE measurements in thyroid nodules. 
Methods and Materials: 50 thyroid nodules from 46 patients (33 w, 9 m, 
56±15 yrs) scheduled for fine needle biopsy were prospectively included. 4 
nodules with non- diagnostic cytology were excluded. 3 SWE measurements 
were obtained repetively in longitudinal and transversal plane resulting in 300 
measurements. Mean elasticity values (ME), mean quality coefficients (MQC), 
ratio ME nodule/thyroïd and ME long/trans were computed. Coefficients of 
variation of elasticity values (CV_E) were computed for reproducibility study. 
Spearmans coefficients and Student T-tests were used for statistical analysis. 
  






Results: Neither ME values nor the ratio ME nodule/thyroid were significantly 
different for benign (N= 34/50) and malignant (N=12/50) nodules (ME values: 
18.4±9.7 kPa vs 21.1±8.6 kPa and 12.8±6.1 vs 8.5±3.5 kPa in the longitudinal 
and transversal plane respectively; ratio : 1.23+/-0.61 vs 1.25+/-0.72 (NS)). 
The ratio ME long/trans was significantly lower for benign nodules (1.55±0.91 
vs 2.67±1.29 (p=0.05)). MQC values were significantly higher in the 
longitudinal plane than in the transversal one (0.73±0.11 vs 0.63±0.10, p < 
0.001). A significant correlation was found between MQC and CV_E (r=0.46, p 
= 0.0015). 
Conclusion: The ratio ME longitudinal/transversal was the only parameter that 
allowed to discriminate benign from malignant thyroid nodules. Quality maps 
were higher in longitudinal plane and SWE reproducibility was improved for the 
measurements with the highest quality.  
B-0667 14:16  
Atypical ultrasonographic patterns of papillary thyroid carcinoma: how to 
recognise them  
E. Horvath, G. Aguilera, C. Silva, M. Droguett, V.S. Skoknic, H. Tala, S. Majlis, 
J. Slater, C. Whittle; Santiago/CL (velimir.skoknic@gmail.com)  
Purpose: To analyse the atypical papillary thyroid carcinoma (PTC) US 
patterns, comparing them with typical cases, and to describe their main 
characteristics. 
Methods and Materials: A retrospective review of thyroidectomies between 
2013 and 2016 with PTC was conducted. Classical PTCs (Group A) were 
separated from those that showed atypical patterns (Group B). These were 
compared according to age, gender, size, histological subtype and association 
with Hashimoto's thyroiditis (HT). Shapiro-Wilk, chi-squared, Student’s t tests 
or Mann-Whitney-Wilcoxon tests were used. 
Results: A total of 453 PTC met inclusion criteria. In 51 cases (11.2%) [19 
men (38%), median age 41 years (14-68)], an atypical pattern was observed. 
Median size: 14 mm (5-50 mm), 32 (63%)> 10 mm. 27% were associated with 
HT. A significant difference was found between Groups A and B in terms of 
gender (p <0.025), size (p <0.001) and histological subgroup (p <0.01), with 
more men, larger lesions and more follicular variant of PTC with atypical 
pattern. The dominant characteristics observed in Group B were: solid-cystic 
mixed structure, similar to colloid nodule but without hyperechoic foci in 23 
(45%), isoechogenicity in 19 (37%) and presence of capsule in 20 (40%), 
findings that were shared in the majority of the cases, with or without 
association with calcifications. In addition, pooled microcalcifications without 
associated nodule were detected in 6 cases (12%). 
Conclusion: One in every 10 PTCs has an atypical ultrasound appearance. It 
is important to recognise the characteristics described as concerning for 
malignancy to recommend FNAs in a timely manner, since 63% are 
macrocarcinomas.  
B-0668 14:24  
Can S-detect provide accurate differentiation of thyroid nodules? - 
assessing the impact on the assessment made by operators with 
different experience  
G. Alagna, V. Cantisani, V. Forte, V. De Soccio, N. Di Leo, A. Rubini, 
M. Di Segni, F. D'Ambrosio, C. Catalano; Rome/IT (gralagna@gmail.com)  
Purpose: To assess whether automatic TI-RADS assessment with S-Detect 
could be reliable in the differentiation of thyroid nodules. 
Methods and Materials: One hundred seventy eight FNAB proven nodules in 
106 patients (77 females, 29 males, aged 13-85 years, mean 55.3), were 
evaluated by a radiologist and a radiology resident. Operators assessed and 
categorized lesions without and with S-detect, using Kwak’s TI-RADS. 
Sensitivity (SE), specificity (SPE), positive and negative predictive values 
(PPV, NPV), diagnostic accuracy through McNemar’s test were calculated. 
Differences significance was assessed with Pearson’s ² test, with a p= 0.05 
threshold. 
Results: At FNAB, 13 nodules on 178 (7.3%) were malignant, 27 out of 178 
(15.1%) at high risk, 110 on 178 (61.8%) probably benign and 28 out of 178 
(15.7%) were certainly benign.Nodules categorization according to S-detect, 
radiologist and resident was as follows: TIRADS 2: 27, 26, 26; TIRADS 3: 112, 
112, 105; TIRADS 4: 29, 30, 39; TIRADS 5: 10, 10, 8. When S-detect was not 
employed, SE, SPE, PPV and NPV were 83.5%, 93.5%, 85.2%, 89.6% for the 
experienced radiologist and 75.6%, 86.4%%, 70.4% and 96.9% for the 
radiology resident, respectively. When S-detect was employed, SE, SPE, PPV 
and NPV 84.8%, 97.1%, 90.7%, 95.1%, for the experienced radiologist and 
84.8%, 97.1%, 90.7%, 95.1% for the resident. No statistically significant 
difference in diagnostic performance was noted for the radiologist, whereas it 
resulted significant for the resident. 
Conclusion: According to these results, S-Detect is a useful tool since it 
improves thyroid nodule differentiation accuracy of the non-experienced 
operator.  
Author Disclosures: 
 V. Cantisani: Speaker; Bracco, Toshiba Medical Systems, Samsung 
Healthcare.  
B-0669 14:32  
Quantitative analysis of ADC values in differentiating papillary thyroid 
carcinoma and thyroid adenoma  
S. Hu; Zhenjiang/CN (hsd2001054@163.com)  
Purpose: To explore the differential diagnosis value of ADC value of PTC and 
thyroid adenoma (TA). 
Methods and Materials: Routine MRI sequences and axial diffusion weighted 
sequences of neck with different b values (300,500,800 s/mm2) were 
performed in 34 patients with 43 nodules (including 37 PTCs and 6 TAs) 
confirmed by pathology. The ADC value of the solid component of each lesion 
was measured respectively. Independent samples t test was used to evaluate 
whether the ADC values had significant differences between the two lesions. 
Receiver operating characteristic (ROC) curves were drawn and used to 
evaluate the diagnosis value of ADC values in PTC and TA. 
Results: The ADC value of PTC is lower than the one of TA with a significant 
difference statistically in all different b values. The average ADC values of PTC 
and TA were 1.791±0.544×10−3 mm2/s and 2.528±0.642×10−3 mm2/s (b-value 
300 s/mm2), 1.510±0.453×10−3 mm2/s and 2.138±0.656×10−3 mm2/s (b-value 
500 s/mm2), and 1.305±0.419×10−3 mm2/s and 1.906±0.643×10−3 mm2/s (b-
value 800 s/mm2), respectively. The highest diagnostic accuracy can be 
obtained with a b-value of 300 s/mm2 with the area under the curve of 0.815. 
When the b-value was selected as 300 s/mm2 and the diagnostic threshold 
was 1.786×10−3 mm2/s according to the ROC curve, the sensitivity, specificity, 
positive predictive value, negative predictive value and Youden Index were 
62.6%, 100%, 100%, 30.0% and 62.6, respectively. 
Conclusion: The ADC value is helpful in the differentiation of PTC and TA, 
and a better result can be achieved by using a DWI with a b-value of 300 
s/mm2.  
B-0670 14:40  
A novel mobile phone app to minimise bias and aid the FNAC decision-
making process  
A. McDermott, P. Navin, T. Tarmey, A. Weir, D. Bergin, J.F. Bruzzi, B. Voisin, 
D. Sheppard; Galway/IE (ailbhemcdermott@gmail.com)  
Purpose: Ultrasound is the modality of choice to help differentiate between 
benign and malignant thyroid nodules. The investigation algorithm on whether 
or not to perform FNAC takes into account several sonographic features of 
different weighting, and is not clear-cut. The decision is facilitated by a number 
of international guidelines. This study aims to address the sensitivity of the 
available guidelines in recommending FNAC. We then present and assess the 
clinical utility of a novel user-friendly mobile-phone ‘app’ to facilitate decision-
making. 
Methods and Materials: 200 consecutive thyroid FNAC cases between 2013 
and 2014 were retrieved. Imaging was blindly reviewed by 4 subjects. The 
decision regarding FNAC was determined: 1. using guidelines (AACE, ASRU, 
ATA, BTA, Korean) in read-only format; 2. using an interactive locally derived 
‘app’ incorporating sonographic features and presenting various guideline 
recommendations, including TI-RADS. Statistical analysis was performed using 
‘R’ and SPSS. 
Results: In read-only format, the highest sensitivity was achieved with ATA 
(88.2%) and Korean (88.3%) guidelines. However, there was inter-user 
variability. The incorporation of specific sonographic features into an app 
(yes/no format) provides an overall sensitivity of 80% (new TI-RADS), 91% 
(AACE) and 96% (Korean), thus increasing the appropriateness of FNAC. In 
addition, the app significantly reduced inter-user variability (p<0.001), thus 
minimising discrepancy. 
Conclusion: Even when presented with international guidelines there are 
inconsistencies in the decision on when to perform FNAC. We describe the 
performance of widely-applied international guidelines in clinical practice, and 
present a novel ‘app’ to standardise the decision-making process and minimise 
the potential for human bias.  
B-0671 14:48  
Comparison of the clinical utility of international guidelines to aid the 
decision on when to perform FNAC for thyroid nodules  
A. McDermott, P. Navin, A. Weir, T. Tarmey, J.F. Bruzzi, B. Voisin, 
D. Sheppard; Galway/IE (ailbhemcdermott@gmail.com)  
Purpose: Thyroid nodules are a common finding. The decision on whether to 
perform fine-needle aspiration cytology to dissociate benign from malignant 
nodules is complex. A number of international guidelines, including the recent 
ACR TIRADS, incorporate sonographic features of different weighting to 
facilitate the decision-making process. This study compares commonly used 
international guidelines and their clinical utility for appropriate nodule FNAC. 
Methods and Materials: Consecutive thyroid FNAC cases between 2013 and 
2014 were retrieved. Sonographic features were reviewed and the 
recommendation on whether to perform FNAC or not based on international 
  






guidelines (ACR TIRADS, AACE, ASRU, ATA, Kim and Korean) was analysed. 
Data were analysed using R statistical software package. 
Results: 200 patients who underwent thyroid nodule FNAC during the study 
time period were included. The mean age was 55.1±15.6 years, with 83% 
women. The new ACR TIRADS guidelines provided a sensitivity of 81% and a 
specificity of 32%. The best sensitivity (appropriate sampling of cancer cases) 
was achieved from the application of the Korean guidelines (96%, specificity 
0.075%). However, the best specificity (true-negative rate) was achieved from 
the ASRU guidelines (49%, sensitivity 64%). 
Conclusion: Despite numerous internationally available guidelines, no 
guideline satisfactorily achieves a combination of high sensitivity and 
specificity. The new ACR TI-RADS guidelines provide a sensitivity and 
specificity of 81 and 32%, respectively.  
B-0672 14:56  
Diagnostic performance of US-based fine-needle aspiration criteria for 
thyroid malignancy: comparison of three international society thyroid 
imaging reporting and data systems  
S. Yoon, D. Na, H. Gwon; Gangneung/KR (ysj-626@hanmail.net)  
Purpose: Thyroid imaging reporting and data system (TIRADS) is the 
quantitative scoring system for malignancy risk stratification of thyroid nodules. 
The aim was to compare the diagnostic performance of US-based FNA criteria 
for the detection of thyroid malignancy among recently proposed three 
international society TIRADS including Korean-TIRADS, ACR-TIRADS, and 
EU-TIRADS. 
Methods and Materials: This study included a total of 1081 consecutive 
thyroid nodules ( 1 cm) in 898 patients with final diagnoses from January 
2013 to December 2015. US features of thyroid nodules were retrospectively 
reviewed and classified according to the categories defined by the three 
international society TIRADS. The diagnostic performance of US-based FNA 
criteria for the detection of thyroid malignancy and unnecessary FNA rates 
were calculated and compared among the three TIRADS. 
Results: Of the 1081 thyroid nodules, 940 (87%) were benign and 141 (13%) 
were malignant, with papillary carcinoma comprising 93.6% of all malignancies. 
The Korean-TIRADS (96.5%) and EU-TIRADS (92.9%) were more sensitive for 
the detection of malignancy than ACR-TIRADS (79.4%) (p < 0.001), while the 
ACR-TIRADS (67.4%) had a higher specificity than Korean-TIRADS (22.6%) or 
EU-TIRADS (23.2%) (p < 0.001). The unnecessary FNA rate was lower in the 
ACR-TIRADS (28.3%) than that in Korean-TIRADS (67.3%) or EU-TIRADS 
(66.8%). There was no significant difference in sensitivity, specificity, and the 
unnecessary FNA rate between Korean-TIRADS and EU-TIRADS (p  0.125). 
Conclusion: Korean-TIRADS and EU-TIRADS had a similarly higher 
sensitivity for malignancy than ACR-TIRADS; however, those had a lower 
specificity and higher unnecessary FNA rates than ACR-TIRADS.  
B-0673 15:04  
Ectopic parathyroids: incidence, localisation trends and diagnostic 
evaluation: retrospective study from a single tertiary institute  
A.A. Singhal, S.S. Baijal, D. Sarin, S.K. Arora, A. Mithal, S. Mishra; Gurgaon/IN 
(DR.ALKAASINGHAL@GMAIL.COM)  
Purpose: Aim is to evaluate the incidence of ectopic parathyroids, their 
localisation, diagnostic evaluation and surgical confirmation. 
Methods and Materials: Retrospective study conducted at a tertiary 
institution, where 400 patients operated for hyperparathyroidism from 2012 to 
2017 was analysed. Diagnostic findings of Sestamibi and ultrasound were 
compared with surgical findings. SPECT CT was used in select cases. 
Results: Of 400 patients single adenoma was seen in 350 patients (87.5%), 
two or more nodules in 41 patients (10.2%), and carcinoma in 3 cases. Of the 
350 solitary adenomas, 291 were juxtaposed to thyroid (83.1%), and ectopic in 
59 (16.8%) cases. Ectopic along the thymic tract in 38 cases (10.8%), upper 
mediastinum 8 cases (2.2%), angle of jaw in 2 cases (0.5%), carotid sheath 2 
cases (0.5 %),retroesophageal 2 cases (0.5%) and intrathyroidal in 7 cases 
(2%). Sestamibi was positive in localising parathyroid nodule in 297 (84.8%) 
cases, and ultrasound in 339 (96.8%) cases. Of the localised sestamibi 
nodules 82% were true and 3% were false localisation at surgery. Nodules 
localised by Ultrasound were true in 99 % and false in 1% cases. Ultrasound 
localised the nodules in sestamibi negative cases in 12% patients. 
Conclusion: Identification of ectopic parathyroids and differentiation from 
thyroid nodules and other neck lesions is the key role of imaging. Ultrasound is 
complimentary to MIBI and offers significant value addition by precision 
anatomical localisation, characterisation and finding additional nodules. Using 
two imaging modalities of MIBI and ultrasound, the diagnostic sensitivity is 





B-0674 15:12  
The diagnostic value of 4D MRI for the localisation of parathyroid 
adenomas  
M. Ozturk, A.V. Polat, C. Celenk, M. Elmali, C. Polat; Samsun/TR 
(dr.mesutozturk@gmail.com)  
Purpose: The aim of this study was to assess the feasibility of 4-dimensional 
magnetic resonance imaging (4D MRI) for the localisation of parathyroid 
adenomas in patients with primary hyperparathyroidism. 
Methods and Materials: Preoperative 4D MRI including dynamic contrast-
enhanced (DCE) sequence and T2-weighted multipoint Dixon (T2-mDixon) 
sequence with in-phase, out-phase and, fat-suppressed images in 31 patients 
with surgically proved parathyroid adenomas were evaluated retrospectively. 
Two readers blinded to surgical findings independently reviewed the images in 
two sessions (T2-mDixon sequence alone and T2-mDixon + DCE sequence). 
MRI localisation of the suspected adenoma in each session was compared 
with the surgical results and interobserver variability (weighted kappa []) was 
assessed. 
Results: By interpreting the T2-mDixon images alone, reader 1 correctly 
detected 26 parathyroid adenomas (sensitivity: 84%, positive predictive value: 
90%) and reader 2 correctly detected 24 parathyroid adenomas (sensitivity: 
77%, positive predictive value: 92%). With the addition of DCE sequence, 
reader 1 correctly identified 27 parathyroid adenomas (sensitivity: 87%, 
positive predictive value: 90%) while reader 2 correctly identified 26 
parathyroid adenomas (sensitivity: 84%, positive predictive value: 93%). 
Interobserver agreement was also superior in T2-mDixon + DCE sequence 
compared to T2-mDixon sequence alone ( = 0.81 and 0.74, respectively). 
Conclusion: 4D MRI with T2-mDixon and DCE sequence is a reliable method 
for identification of parathyroid adenomas.  
14:00 - 15:30 Room E1  
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Moderators:  
C. Colin; Pierre-Bénite/FR  
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B-0675 14:00  
Incidence and tumour characteristics of bilateral and unilateral interval 
breast cancers at screening mammography  
R.M.G. van Bommel; Eindhoven/NL (rob_van_bommel@hotmail.com)  
Purpose: Detected by screening mammography, bilateral breast cancer has a 
different pathological profile compared to unilateral breast cancer. We 
investigated the incidence of bilateral interval breast cancers and compared 
their characteristics with those of unilateral interval breast cancers. 
Methods and Materials: We included all screening mammograms of women 
who underwent biennial screening mammography in the South of the 
Netherlands between January 2005 and January 2015. We collected breast 
imaging reports, biopsy results and surgical reports of all referred women and 
of all women who presented with interval breast cancer. The tumour with the 
highest tumour stage (index cancer) was used for comparison with unilateral 
interval cancers. 
Results: A total of 753 interval cancers were detected, of which 24 (3.2%) 
were bilateral. Among the invasive interval cancers, bilateral cancers more 
frequently showed a lobular histology than unilateral cancers (37.5% (9/24) vs. 
16.1 % (111/691), P=0.01). There is a trend towards a larger proportion of 
bilateral than unilateral interval cancers graded 1 (45.8% (11/24) vs. 27.8% 
(192/691), P=0.08). There were no other statistically significant differences in 
tumour characteristics. Also, the proportion of missed cancers on the latest 
screen was comparable for unilateral and bilateral interval cancers (23.0% vs. 
25.0%, P=0.9). 
Conclusion: Bilateral interval cancers comprise a small proportion of all 
interval cancers. Except of a higher proportion of invasive lobular cancers and 
a more favourable histological grade of invasive cancers, tumour 

















B-0676 14:08  
Missed and true screen-detected and interval breast cancers in a 
population-based breast cancer screening programme  
T. Hovda1, Å.S. Holen2, H. Bjørndal1, S. Sebuødegård2, S. Hofvind2; 
1
Drammen/NO, 2Oslo/NO (tone.hovda@vestreviken.no)  
Purpose: To describe the distribution of missed and true screen-detected 
(SDC) and interval (IC) breast cancer after a retrospective informed consensus 
review in a biennial population-based breast cancer screening programme. 
Methods and Materials: We performed a consensus-based informed review 
of randomly selected cases of SDC and IC detected at eight breast centers in 
BreastScreen Norway. Prior screening and diagnostic digital mammograms 
were used. A panel of five breast radiologists (minimum 1 year experience with 
high volume screen-reading), reviewed and classified 648 SDC and 532 IC 
cases according to visibility of the breast tumor at prior screening 
mammograms (missed, minimal sign actionable, minimal sign non-actionable, 
true, and occult), and mammographic density (BI-RADS 5th edition, a-d). We 
used descriptive statistics to describe the distributions of classification, 
stratified by detection mode (SDC and IC). 
Results: Among the SDC, 163 (25%) were classified as missed, 95 (15%) 
minimal sign actionable, 108 (17%) minimal sign non-actionable, 281 (43%) 
true, and one case as occult. For the IC: 133 (25%) were missed, 79 (15%) 
minimal sign actionable, 77 (15%) minimal sign non-actionable, 178 (34%) 
true, and 65 (12%) occult. 67% of the SDC were classified as BI-RADS a or b 
and 33% as c or d. For IC, 50% were BI-RADS a or b and 50 % c or d. 
Conclusion: In this retrospective informed review, 40% of cancers were visible 
at prior screening (missed or minimal sign actionable), regardless of detection 
mode. A higher mammographic density was observed among IC compared to 
SDC.  
B-0677 14:16  
Interval breast cancer rates and histopathologic tumour characteristics 
after false-positive screening result in a population-based screening 
programme  
S. Sebuødegård, S. Hofvind; Oslo/NO (solveig.hofvind@kreftregisteret.no)  
Purpose: To compare rates and tumour characteristics of interval breast 
cancers (IBC) detected after a prior screening negative versus false-positive 
result among women who participated in BreastScreen Norway. 
Methods and Materials: The study included 497,694 women aged 49-71 
years who underwent 1,179,645 mammographic screening examinations 
during 2004-2014. Rates and odds ratio (OR) of IBC among women with a 
prior negative (reference group) versus false-positive result were estimated 
using logistic regression models, adjusting for age at diagnosis, year of 
screening and county of residence. 
Results: Among 1,999 IBC, 32 (2%) and 86 (4%) were detected in women 
with a false-positive result with and without needle biopsy, respectively. The 
rate of IBC was 16.4 (95%CI: 15.7-17.2) for women with a prior negative result, 
and 45.6 (95%CI: 32.3-64.5) and 43.0 (95%CI: 34.8-53.0) for women with a 
prior false-positive result with and without needle biopsy, respectively. Adjusted 
ORs of IBC were 2.9 (95% CI: 2.1-4.2) and 2.8 (95% CI: 2.2-3.4) for women 
with a false-positive result with and without needle biopsy, respectively, relative 
to women with a negative result. Women with a prior negative result had a 
lower proportion of tumours 10 mm and Grade I tumours compared to women 
with a prior false-positive result with benign biopsy (15% [248/1,634] versus 
40% [8/20], p<0.01, and 14% [243/1,725] versus 45% [9/20], p<0.01). 
Conclusion: Women with a false-positive screening result had a higher odds 
of IBC, but more favorable tumour characteristics of IBC compared to women 
with a prior negative screening result.  
B-0678 14:24  
Comparison between interval breast cancer (IBC) and screen detected 
cancer (SDC) in a single centre  
F. Currò, M. Tonutti, F. Giudici, F. Zanconati, M. Bortul, M.A. Cova; Trieste/IT 
(francescacurro86@gmail.com)  
Purpose: The introduction of the breast screening program (BSP) raised the 
problematic of interval breast cancer (IBC). The aim of this study was to 
evaluate the performance of BSP and the prognostic features of screen 
detected cancer (SDC) compared to IBC. 
Methods and Materials: Women diagnosed with breast cancer (SDC and IBC) 
between January 2008 and December 2014 at a single unit of the BSP in 
Trieste (Italy) were included. We retrospectively collected data concerning 
patient’s demographics, radiological patterns, tumour size, lymph node 
involvement, grading, and molecular biology. The proportional incidence of IBC 
was determined considering the incidence of expected breast cancers without 
BSP. 
Results: There were 640 breast cancers included (626 women, 14 bilateral): 
520 (81%) were SDC and 120 were IBC (19%). The proportional incidence of 
IBC was 15.3% and the sensitivity of the BSP was 83%. IBC presented more 
aggressive features compared to SDC, such as tumor invasion (95% vs 85%; 
p=0.005), tumor size (pT2 36% vs 20%; p=0.0003), grading (G3 38% vs 19%; 
p<0.001) and St.Gallen molecular subtype (triple negative 12% vs 6%; 
p<0.001). IBC were mostly diagnosed in women with dense breasts (density c 
and d: 45% vs. 24%; p<0.001) and were hardly detectable with mammography 
(R1 14% vs. 1%, p<0.001). There were no significant differences in lymph 
node involvement (p=0.4). 
Conclusion: The proportional incidence of IBC and the sensitivity of the BSP, 
indicators of efficacy, were aligned to European standard. IBC had more 
adverse prognostic markers for overall survival when compared to SDC  
B-0680 14:32  
Detection of multiple cancers in a large UK screening population  
S. Dumonteil, L.S. Wilkinson, S. Mohammadi, V. Scott; London/UK 
(scott.victoria@gmail.com)  
Purpose: Imaging protocols at assessment of women recalled based on their 
screening mammograms are inconsistent across UK screening units. At our 
institution we carry out bilateral whole breast ultrasound on all women with a 
suspicious ultrasound lesion. The purpose of this study was to quantify the 
number of multiple cancers detected and how many of these were identified as 
a result of completion ultrasound imaging or further review of the screening 
mammogram. 
Methods and Materials: The assessment results of 16,244 consecutive 
women assessed in screening clinic at the South West London Breast 
Screening Service between 2008 and 2016 were retrospectively analysed. 
Cancer detection rate and number of multiple cancers were calculated. 
Imaging from the multiple cancers was reviewed to assess how many extra 
cancers were detected due to local practice. 
Results: From 2008 to 2016, 16,244 individual women were assessed in 
screening clinic and 8,136 (50%) women had at least 1 biopsy. 34% of 
assessment episodes (2,821 of 8,284) resulted in the detection of cancer. 351 
(12%) were multiple cancers, 288 (10%) being ipsilateral and 63 (2%) being 
contralateral. A review of the imaging from the multiple cancers revealed that 
approximately one third of the extra cancers were identified as a result of our 
local protocols for women with a suspicious lesion on initial targeted 
ultrasound. 
Conclusion: Bilateral whole-breast ultrasound and careful review of the 
screening mammograms in women with a suspicious lesion leads to significant 
increased detection rate of multiple breast cancers.  
B-0681 14:40  
Attendance in BreastScreen Norway by proportion of immigrants in a 
county  
S. Bhargava, G. Mangerud, S. Hofvind; Oslo/NO 
(sameer.bhargava@kreftregisteret.no)  
Purpose: To examine whether the attendance rate among immigrants and 
non-immigrants in BreastScreen Norway was associated with the proportion of 
immigrants residing in the counties. 
Methods and Materials: We selected invitations sent to women living in 
counties with a low (<5% of invitations sent to immigrants) or a high proportion 
of immigrants (>10% of invitations sent to immigrants), hereafter referred to as 
low- and high-density counties, respectively. We merged data about birth 
country and socio-demographic factors from Statistics Norway with screening 
data from the Cancer Registry of Norway. The study period was 2005-2015. 
For both immigrants and non-immigrants, unadjusted and adjusted rate ratios 
(RR) with 95% confidence intervals (95% CI) compared attendance rates in 
low- and high-density counties. 
Results: Women in the six low-density counties received 852,193 invitations, 
and women in Oslo, the capital city and the only high-density county, received 
277,229 invitations. Attendance rates were 76.9% in low-density counties and 
63.1% in Oslo. Using Oslo as reference, RR of attendance was 1.26 (95% CI 
1.24-1.28) for immigrants and 1.16 (95% CI 1.16-1.16) for non-immigrants in 
low-density counties. Adjusted RR was 1.16 (95% CI 1.14-1.17) for immigrants 
and 1.14 (95% CI 1.14-1.14) for non-immigrants. 
Conclusion: Immigrants and non-immigrants in Oslo had lower attendance 
than the same groups of women living in low-density counties. Efforts to 
increase attendance in urban areas should target both immigrants and other 
low-attending groups.  
B-0682 14:48  
Comparison of phantom target detectability for digital mammograms, 
tomosynthesis and synthetic mammograms  
L. Vancoillie, L. Cockmartin, N. Marshall, H. Bosmans; Leuven/BE 
(liesbeth.vancoillie@uzleuven.be)  
Purpose: To compare target detectability in digital mammography (FFDM), 
digital breast tomosynthesis (DBT) and synthetic mammograms (SM) using two 
contrast detail phantoms: CDMAM (homogeneous background) and a 3D 
  






phantom developed in-house with calcification and mass lesion-like inserts 
(‘L1’) in a structured background. 
Methods and Materials: Detectability was measured for FFDM, DBT and SM 
acquisitions of the phantoms on a Siemens Inspiration Prime. Dose settings 
were derived from automatic exposure control (AEC), and then manually set at 
three levels: AEC/2, AEC and 2xAEC, with 10 acquisitions per dose level. Both 
phantoms were read manually using the 4 alternative forced choice (4-AFC) 
method. Threshold thickness (TT) was established for CDMAM while threshold 
diameter (dT) was found for L1, both calculated for a 62.5% correct score. 
Software (CDCOM-based) scoring of the CDMAM images was also performed. 
Results: CDCOM followed human reading and ranked threshold thickness as 
a function of dose the same way as did the human readers. Both the CDMAM 
TT results for 0.1 mm diameter discs and the L1 dT results showed small detail 
(~microcalcification) detectability was greatest for FFDM, followed by DBT and 
then SM (p<0.0001). The L1 phantom (i.e. with structured background relevant 
to mass lesion detection) showed better mass-like lesion detection for DBT, 
followed by SM, with FFDM having the worst performance (p<0.0001). 
Conclusion: For detection of microcalcification-like details, both phantoms 
ranked imaging modality detectability as FFDM>DBT>SM. For detection of 
mass-like lesions in a structured background, the L1 phantom ranked 
detectability as DBT>SM>FFDM.  
Author Disclosures: 
 H. Bosmans: Research/Grant Support; The medical physics team has a 
research agreement with Siemens-Healthineers. 
B-0683 14:56  
Screening mammography’s pitfalls: a retrospective review of false 
positive recall  
F. Leone, M. Orsi, A. Presazzi, D. Mariani, M. Cellina, G. Oliva; Milan/IT 
(federica-leone@live.it)  
Purpose: To analyse the most common feature in false positive recall in order 
to suggest a strategy for assessment of challenging screening mammogram. 
Methods and Materials: We reviewed a retrospective cohort of 6830 patients 
involved in screening program for breast cancer between November 2015 and 
September 2017. We included the false positive recall which at second level 
exam have been classified as BIRADS 1 or 2. We evaluated two different 
groups according to agreement recall(AR) or disagreement recall(DR).We 
compared the differences among tumoural imaging features between the two 
groups and considering also the overall findings prevalence in screening 
recall(SR). 
Results: we obtained a final cohort of 1157 suspicious findings whose 
416(35,9%) have been in AR group and 741(64,1%) in DR group. In the AR 
group we found, as single or one of multiple features in suspicious lesion, 
287(69%) mass, 26(6,25%) calcifications, 78(18,75%) architectural distortion 
and 25(6%) asymmetric density; in the DR group we detected 578(78%) mass, 
89(12%) architectural distortion, 43(6%) asymmetric density, 31(4%) 
calcifications. Differences in tumour imaging features between the two groups 
were statistically significant (p<0.05). 
Conclusion: Our results show how mass is the most common feature in false 
positive recall with no changes between one or two readers. Calcification, 
when classifided as BIRADS 2, is a rare challenging feature, mostly due to the 
expertise of breast radiologist. Our study proves how screening program is a 
good tool to avoid false positive recall for architectural distortion and 
asymmetric density, condsidering the higher prevalence of these findings in 
recall group.  
B-0684 15:04  
The impact of image quality and mammographic breast density on 
missed cancers in organised screening  
M. Abdolell, P. Brown, J. Caines, J.I. Payne, K. Tsuruda, P. Barnes, 
M. Rivers-Bowerman, S.E. Iles; Halifax, NS/CA (Sian.Iles@nshealth.ca)  
Purpose: The aim of this study was to explore the relationship between image 
quality and breast density with the risk of missing cancers in a breast screening 
practice. 
Methods and Materials: The study sample included women diagnosed with 
missed interval cancers (n=45) and non-cancer controls (n=2475) identified 
from a 3:1 age- and screen-matched case-control study that included all breast 
cancer cases diagnosed between 2009-2015 in a provincial breast screening 
program offering digital mammography to women aged 40-75 (n=9388).Image 
quality and breast density were determined for each mammogram using fully 
automated algorithms (Densitas Inc.). Data were partitioned into training (two-
thirds) and test (one-third) datasets. Women with inadequate (versus 
adequate) image quality were compared on their status of true missed cancers 
vs non-cancers, controlling for breast density. Logistic regression analysis was 
conducted, modeling cancer status as the dependent variable with image 
quality and percent mammographic density as independent variables. Odds 
ratios were estimated for risk of missed cancers using the test dataset. 
Results: Women with mammograms of inadequate quality are 1.56 times more 
likely (OR=1.56, 95% CI(0.97,2.46), adjusted for breast density) to have a 
missed cancer; including an interaction term of quality*density generates an 
OR=0.92, 95% CI(0.29,2.75). 
Conclusion: Image quality affects risk of missing cancers in mammographic 
breast exams differentially by breast density. The results of this study indicate 
that it may be clinically important to evaluate both image quality and breast 
density routinely during mammographic screening.  
Author Disclosures: 
  M. Abdolell: CEO; Densitas Inc. Founder; Densitas Inc.  K. Tsuruda: 
Employee; Densitas Inc.  
B-0685 15:12  
Piloting an international self-test: assessment of international 
mammography screening skills (AIMSS)  
M. Broeders1, B. Yankaskas2, J. Timmers1, D.L. Miglioretti3, R.A. Smith4; 
1
Nijmegen/NL, 2Chapel Hill, NC/US, 3Davis, CA/US, 4Atlanta, GA/US 
(m.broeders@lrcb.nl)  
Purpose: To pilot a mammography self-test, developed to measure 
radiologists’ screening performance and provide feedback, in different 
translations and international settings and evaluate the logistical challenges of 
implementing a self-test. 
Methods and Materials: Nine countries varying in language and organisation, 
participated: USA, Canada, Norway, Italy, Spain, Mexico, Brazil, Taiwan and 
Japan. For each country, a local coordinator targeted recruiting 30 radiologists. 
A web-based system was developed to support the self-test and pre- and post-
test questionnaires to gather information on radiologists, practice 
characteristics, feedback on experience and performance. Each site received 
IRB exemption or approval. 
Results: To date, 133 radiologists have consented, 71 completed the self-test, 
114 completed the pre-test questionnaire and 54 completed the post-test 
questionnaire. Early recruitment was good, however, currently, only 41 of 133 
(31%) participants completed all pilot items, despite multiple reminders. The 
self-test, including teaching points, was well-received with 95% rating it a good 
tool for evaluating performance and 88% saying they would recommend it to 
others; 54% thought they performed better than the results indicated; 27% 
expected worse results. Main problems reported were downloading the images 
to the workstations, delays from IRBs, and in some countries, delay due to the 
technical testing and translation of the self-test. Performance was generally 
good with mean women-level sensitivity 85%, breast-level sensitivity 80% and 
specificity 82%. 
Conclusion: The self-test was well-received, was considered a good teaching 
tool, and translations worked well. We experienced logistical and technical 
problems which resulted in inability for some radiologists to complete the self-
test.  
Author Disclosures: 
  M. Broeders: Research/Grant Support; American Cancer Society.  
B. Yankaskas: Research/Grant Support; American Cancer Society.  
J. Timmers: Research/Grant Support; American Cancer Society.  
D.L. Miglioretti: Advisory Board; Hologic. Research/Grant Support; American 
Cancer Society. R.A. Smith: Research/Grant Support; American Cancer 
Society. 
14:00 - 15:30 Room E2  
Neuro  
SS 711b  
Vascular imaging  
Moderators:  
S.A.C. Squarza; Milan/IT  
P. Vilela; Almada/PT  
B-0686 14:00  
Effect of carotid endarterectomy on the distribution and value of cerebral 
blood flow: evaluation by territorial arterial spin labelling  
H. Xu, Y. Liu, H. Yuan; Beijing/CN (84498843@qq.com)  
Purpose: To evaluate the cerebral blood flow(CBF) changes on distribution 
and value of brain feeding arteries after carotid endarterectomy(CEA) using 
territorial arterial spin labelling(t-ASL). 
Methods and Materials: 1. Twelve patients diagnosed with carotid artery 
stenosis scheduled for CEA were recruited (mean age 60±7;8 males, 4 
females). 2. MR imaging was performed with a 3.0T MR system 1 week before 
and after CEA. Cerebral perfusion territory maps were obtained by labelling 
bilateral internal carotid arteries and basilar artery using super-selective ASL. 
These images were then combined into a 3-colored territorial CBF maps. 3. 
The CBF values were obtained from the same size ROI (70mm2))respectively 
in the same position of different individual vascular perfusion images before 
  






and after surgery. To assess the changes in CBF after CEA(∆CBF), we 
calculated the following difference: ∆CBF=CBFpostoperative-CBFpreoperative. 
Results: 1. The contribution to perfusion in the hemisphere via the collateral 
circulation is reduced after CEA. 2. The CBF values of both the lesion carotid 
artery perfusion sides and contralateral sides were increased after 
CEA(P<0.5). 
Conclusion: 1. CEA improves cerebral perfusion in patients with carotid artery 
stenosis, and patients with greater perfusion deficits prior to CAS have greater 
improvement in perfusion after CEA. 2. tASL has potential as a noninvasive 
imaging tool for the quantitative evaluation of hemodynamic changes after 
CEA, as well as demonstrate the relative role of collateral pathways before 
surgery and redistribution of blood flow after surgery.  
B-0687 14:08  
Added value of c-arm contrast-enhanced cone-beam CT to routine 
contrast-enhanced MRI in evaluation of sporadic intracranial cavernous 
malformations for detecting associated DVAs  
B. Kocak, A. Zeynalova, O. Kizilkilic, N. Kocer, C. Islak; Istanbul/TR 
(drburakkocak@gmail.com)  
Purpose: Association of intracranial cavernous malformations (CMs) and 
developmental venous anomalies (DVAs) has a significant impact on 
preoperative planning and postoperative prognosis. In routine clinical practice, 
T1-weighted contrast-enhanced MRI (CE-MRI) is generally considered the gold 
standard. C-arm contrast-enhanced cone-beam computed tomography (CE-
CBCT) is a relatively new technique and increasingly used to investigate 
vascular pathologies. Our purpose was to explore the added value of CE-
CBCT to CE-MRI in detecting associated DVAs. 
Methods and Materials: Between July 2011 and September 2017, one 
hundred and fifty patients with intracranial CMs were evaluated with CE-CBCT 
in our department. Applying the inclusion and exclusion criteria, retrospective 
review revealed 56 patients with sporadic intracranial CMs (53 with single; 3 
with double CMs) who had both CE-MRI and CE-CBCT studies. DVAs were 
evaluated first on CE-MRI,and then along with CE-CBCT. The diagnosis was 
made by consensus. McNemar’s test was used in statistical analysis. 
Results: Of 56 patients, 37 (66%) had associated DVAs on CE-MRI. On the 
other hand, 19 (33%) patients had no DVA. Of 19 patients with no DVA on CE-
MRI, 10 (52.6%) had DVA on CE-CBCT as a new diagnosis. The remaining 9 
patients had no DVA on CE-CBCT either. Differences in the proportions of 
associated DVAs on CE-MRI and CE-CBCT was statistically significant, p<.05. 
Conclusion: C-arm CE-CBCT evaluation may be a useful imaging technique 
especially in patients with negative routine CE-MRI in terms of detecting 
associated DVA. Nearly in half of those particular patients, CE-CBCT can 
reveal an associated DVA as a new diagnosis.  
B-0688 14:16  
MRI agreement of SVS of thrombi  
R. Bourcier1, L. Détraz1, J.-.M. Serfaty1, B. Guyomarc'h Delassale1, M. Mirza2, 
I. Derraz1, F. Toulgoat1, O. Naggara3, H. Desal1; 1Nantes/FR, 2Dublin/IE, 
3
Paris/FR (lili.detraz@gmail.com)  
Purpose: The susceptibility vessel sign (SVS) on MRI is related to thrombus 
location, composition and size, in acute stroke. No study has questioned its 
inter-MRI agreement. We aimed to compare in vitro the diagnostic accuracy of 
4 different MRI for thrombus histological characterisation. 
Methods and Materials: 35 thrombi analogs of different composition that was 
histologically categorised as fibrin-dominant, mixed, or red blood cell (RBC)-
dominant. We scanned these manufactured thrombi on four different MRI with 
T2* sequence constructor’s parameters. Nine radiologists, blinded to thrombus 
compo sition and MRI scanner model, classified twice, in a two-week interval, 
the SVS of each thrombus as absent, questionable, or present. We calculated 
weighted kappa with 95% confident interval (CI), the sensitivity, specificity and 
accuracy of the SVS on each MRI scanner to detect RBC dominant thrombi 
and compared it between MRI scanners. 
Results: The SVS was present in 42%, absent in 33%, and questionable in 
25%. The inter-scanner agreements were moderate to good, ranging from 0.45 
(CI : 0.37-0.52) to 0.67 (CI : 0.61 - 0.74). The correlation between the SVS and 
the thrombus composition was moderate  : 0.50 (CI: 0.44 - 0.55) to good : 
0.76 (CI: 0.72-0.80). Sensitivities, specificities and accuracy to identify RBC-
dominant clots were significantly different between MRI (p<0.001). 
Conclusion: The diagnostic accuracy of the SVS to determine thrombus 
composition varies significantly among MRI scanners. Normalization of 
T2*sequences between scanners may be needed to better predict thrombus 






B-0689 14:24  
Dynamic evaluation of notch signaling-mediated angiogenesis in 
ischemic rat using magnetic resonance imaging  
J. Tian, Y. Yang; Shanghai/CN (tjqhehe@126.com)  
Purpose: Notch signaling pathway is involved in angiogenesis induced by 
brain ischemia and can be efficiently inhibited by the -secretase inhibitor 
DAPT. The aim of the present study was to non-invasively investigate the 
effect of DAPT treatment on angiogenesis in brain repair after stroke using 
MRI. 
Methods and Materials: Sprague-Dawley rats were subjected to 90 minutes 
of transient middle cerebral artery (MCA) occlusion and treated with saline 
(n=20) or with DAPT (n=20) at 72 hours after onset of ischemia. MRI 
measurements including T2-weighted imaging (T2WI), susceptibility-weighted 
imaging (SWI) and cerebral blood flow (CBF) were performed at 24 hours after 
reperfusion and weekly up to 4 weeks using a 3-Tesla system. Histological 
measurements were obtained at each time point after MRI scans. 
Results: Brain edema and ischemic lesions was significantly reduced in the 
DAPT-treated rats, as demonstrated by T2WI. SWI showed that DAPT 
treatment significantly enhanced angiogenesis in the ischemic boundary zone 
(IBZ) especially in the ipsilateral striatum compared to control group, with local 
cerebral blood flow in the angiogenic area elevated, along with increases in 
vascular density confirmed by histology. 
Conclusion: Treatment of ischemic stroke with DAPT significantly augments 
angiogenesis, which promotes post-stroke brain remodeling by elevating CBF 
level, and these processes can be dynamically monitored and evaluated by 
MRI.  
B-0690 14:32  
Delayed postoperative changes after intracranial aneurysm surgery  
E. Grigorieva, V. Krylov, V. Dashyan, V. Lukyanchikov; Moscow/RU 
(iara333@yahoo.com)  
Purpose: Main strategies of intracranial aneurysm treatment are microsurgical 
clipping or coiling complicated by angiospasm and ischaemia with 
microcirculation deficits. Our purpose was to estimate the long-term changes 
after treatment both non-rupted aneurysms and after angiospasm. 
Methods and Materials: 69 patients (40 women, 29 men, 19-71y.o.) were 
examined more than 12 months after surgery with native brain CT, CT 
angiography and whole brain CT perfusion followed by estimating of cerebral 
blood flow, cerebral blood volume and mean transite time in similar areas of 
the cortex. 
Results: 56 patients underwent surgical clipping, including 10 patients (14,5%) 
with rupted aneurysms. In 13 cases (18,8%) aneurysms were coiled, in 1 
patient with stent assisting. In 43 of 56 cases native CT revealed postoperative 
brain changes, in 90,7% at the access level with 36 cases (83,7%) of the 
perfusion deficits. The deformities of the parent artery was determined in 22 
patients (31,9%) with hypoperfusion in 68,2% of cases. 11 patients 
demostrated the residual aneurysm sac with hypoperfusion of temporal lobe in 
54,5% (p< 0,005). 10 patients were treated after aneurysm rupture and 
angiospasm. In 50% of patients perfusion deficits were revealed with arteries 
deformity, independent of the aneurysm size, localization or treatment strategy. 
No residual sac was found. 
Conclusion: The parent vessel postoperative deformity was more common 
after the ruptured aneurysm closure while the residual aneurysmal sac was 
revealed after non-rupted aneurysms. Perfusion disturbances correlated with 
post-ischaemic changes and vessel deformity (p<0,001) but not with residual 
aneurysm or method of treatment.  
B-0691 14:40  
Epidemiology of intracranial vertebral artery calcification observed on 
computed tomography in a cohort of trauma patients  
C. Lucci1, R. Kockelkoren1, D. Bos2, A. Van der Lugt2, M. Geerlings1, 
J. Hendrikse1, P.A. de Jong1; 1Utrecht/NL, 2Rotterdam/NL 
(carlo.lucci@hotmail.com)  
Purpose: Intracranial vascular disease is the leading cause of ischemic stroke 
worldwide. In this light, substantial research has been performed on 
calcification in the carotid artery while data available on vertebral artery 
calcification (VAC) are limited. Considering its possible role in the development 
of symptomatic cerebrovascular disease, we examined VAC prevalence and 
distribution according to sex and age in a cohort of trauma patients. 
Methods and Materials: Unenhanced head CT scans of patients admitted 
from July 2007 to August 2016 to the University Medical Center Utrecht for 
trauma were examined. We randomly selected 1016 patients (49.2% men) 
aged 0-99 years (mean±SD, 47.8±28.6; approximately 50 men/women per age 
decile). Calcifications were assessed visually (Modified Woodcock) and 
volumetrically (mm3) from the foramen magnum till the basilar artery 
bifurcation. 
  






Results: The overall prevalence of VAC was 16% and the mean volume (±SD) 
was 11.27±57.06 mm3. At logistic regression, increasing age was significantly 
associated with the presence of VAC (p<0.001). Age was also related to VAC 
volume (Spearman’s rho= 0.212, p=0.007). There was a statistically significant 
association between female sex and VAC prevalence (18.6% in women and 
13.4% in men; Chi-Square=5.107, p=0.024). 
Conclusion: Prevalence of VAC in our cohort is high and increments 
proportionally with ageing. It also seems to affect women more than men but 
further studies must investigate the aetiology behind this finding. VAC 
evaluation is easy on non-contrast head CT scans and could be implemented 
in clinical radiology in behalf of the creation of a stroke risk assessment scale.  
B-0692 14:48  
Standard diffusion-weighted imaging on the brain detects cervical 
internal carotid artery dissections  
G.G.A. Adam, C. Cognard, F. Bonneville; Toulouse/FR 
(gilles.adam31@gmail.com)  
Purpose: To assess the capacity of a standard diffusion-weighted sequence 
performed on the brain and to detect dissecting haematoma related to cervical 
internal carotid artery (ICA) dissections. 
Methods and Materials: Retrospective study of a cohort of 110 patients under 
55 years of age (40 women, mean age: 46.79 years) admitted at the acute 
phase of a neurological deficit, headache or neck pain, and investigated by at 
least a standard 3 Tesla diffusion-weighted sequence on the brain. Among 
them were included 50 patients (14 women, mean age: 46.72) who 
subsequently had an internal carotid artery dissection, as confirmed by 
ultrasound, MRI or DSA. In the whole anonymized cohort, a senior and a junior 
radiologist separately assessed on the diffusion-weighted sequence only, the 
presence of a crescent-shaped or circular hypersignal projecting on the 
subpetrosal segments of the ICA arteries, assuming that it would correspond to 
a dissecting haematoma related to ICA dissection. 
Results: The senior radiologist found 46 subpetrosal hyperintensities in 43/50 
patients with ICA dissection, none in patients without dissection (sensitivity 
86%, specificity 100%). The junior radiologist found 48 subpetrosal 
hyperintensities in 45/50 patients with dissection, none in patients without 
dissection (sensitivity 90%, specificity 100%). The interobserver kappa, 
calculated at 0.99, was excellent. 
Conclusion: In our cohort, a standard diffusion-weighted sequence performed 
on the brain, at the acute phase of a stroke or a clinical suspicion of dissection 
detected nearly 90% of the ICA dissections.  
B-0693 14:56  
Diagnosticperformance of three-dimensional high resolution magnetic 
resonanceimaging for intracranial aneurysms: comparison with digital 
subtractionangiography  
Y. Yim, J.Y. Kim, S.C. Jung, B.E. Lee, S.J. Kim, H.S. Kim, D.H. Lee, C.G. Choi, 
J.E. Park; Seoul/KR (youngheeyim@gmail.com)  
Purpose: To evaluate diagnostic performance of three-dimensional high-
resolution magnetic resonance imaging (3D HR-MRI) for intracranial 
aneurysms compared to digital subtraction angiography (DSA). 
Methods and Materials: A total of 299 patients (M:F= 37:262; age range, 27-
79) who underwent 3D HR-MRI, DSA, TOF-MRA from January 2012 to 
December 2016 were retrospectively enrolled. Two neuroradiologists 
independently evaluated TOF-MRA (3D MIP and axial source), CTA, 3D HR-
MRI, and DSA for the determination of intracranial aneurysms or infundibula 
which were suspected of having on TOF-MRA within circle of Willis, bilateral 
ophthalmic arteries, bilateral posterior communicating arteries, bilateral anterior 
choroidal arteries, basilar artery and bilateral superior cerebellar arteries. 
Diagnostic performances for TOF-MRA, CTA, and 3D HR-MRI were assessed 
with DSA as the reference standard. Inter-observer agreements are calculated. 
Results: Of 452 lesions on TOF MRA, aneurysms of 173 (38%) and 
infundibula of 276 (61%) , and no aneurysm of 3 (1%) were diagnosed on 
DSA. Sensitivity, specificity, positive predictive value, and negative predictive 
value were 61%, 81.3%, 73.8%, 76% for TOF 3D MIP, 73.7%, 89.4%, 81.5%, 
84.3% for TOF-MRA source, 65.9%, 99%, 97.7%, 82.7% for CTA, and 70.2%, 
97.6%, 94.9%, 83.8% for 3D HR-MRI, and with the exception of ophthalmic 
arterial lesions, 53.7%, 87.3%, 60.9%, 83.6% for TOF 3D MIP, 65.1%, 92.5%, 
76.2%, 87.7% for TOF-MRA source, 64.6%, 100%, 100%, 83.7% for CTA, and 
90.6%, 98.5%, 95.6%, 96.6% for 3D HR-MIR. Readers showed good inter-
observer agreement (K=0.637). 
Conclusion: 3D HR-MRI shows superior diagnostic performance for 
intracranial aneurysms except ophthalmic arterial lesions compared to TOF-





B-0694 15:04  
Scannographic density of intracranial venous sinuses in healthly patients 
and diagnosed with venous thrombosis at 2600 meters above sea level 
from 2008 to 2016  
S. Andrade, S. Velasco, S. Bermúdez, N. Useche, A.J. Morillo; Bogota/CO 
(santiandrade_1985@hotmail.com)  
Purpose: Intracranial venous sinus thrombosis is a rare pathology in which 
diagnostic imaging plays a crucial role. Simple brain scanning is the initial 
choice imaging study because it is a rapid method to evaluate the morphology 
and quantification of venous sinus density. Actually, only quantitative reference 
values of attenuation of sinus have been documented at geographic altitudes 
below 500 meters above sea level. According to the correlation between 
hematocrit and vascular density, the available values may be inaccurate for 
populations living at higher altitudes. The purpose of this research is to 
document the attenuation of venous sinuses in healthy patients and the 
intracranial venous thrombosis in Bogotá-Colombia (located at 2600 mts above 
sea level), to obtain quantitative information that allows an objective analysis in 
patients with suspicion of this pathology, values that could be used as 
reference in similar geographic altitude at world-wide level. 
Methods and Materials: Cross-sectional, retrospective and analytical studies 
performed from January 2008 to June 2016. Accessible population were 
patients with a simple brain scannography with diagnosis of venous sinus 
thrombosis and healthy patients in Bogota-Colombia. 
Results: Hematocrit and intravascular scanographic attenuation has been 
demonstrated again. There were higher densities in healthy patients as 
previously reported in the literature (70 HU). 
Conclusion: Reference values for patients living at higher altitudes than those 
already reported have a direct impact on diagnosis of intracranial venous 
thrombosis, decreasing neurological sequelae secondary to late diagnosis; 
these values also help to define which patients should be subjected to 
confirmatory studies.  
B-0695 15:12  
Virtual non-contrast CT derived from dynamic CTA in acute stroke  
E.J. Smit, F.J.A. Meijer, M.M. Prokop; Nijmegen/NL (ewoudsmit@gmail.com)  
Purpose: To assess if virtual non-contrast CT derived from dynamic CTA may 
obviate separately performed non-contrast CT images for acute stroke 
assessment. 
Methods and Materials: In our hospital, all patients with suspected stroke 
undergo non-contrast CT and dynamic CTA/CT perfusion imaging if they 1) are 
eligible for i.v. thrombolysis or 2) have evidence of intracerebral hemorrhage 
on non-contrast CT (clinical trial). We selected 27 consecutive patients from 
this database. Virtual non-contrast images were reconstructed as the 
precontrast images of dynamic CTA after applying a 4D-similarity noise 
reduction filter. An experienced observer scored all images in a blinded 
manner for the presence and location of hemorrhage, midline shift, loss of gray 
white-matter differentiation, dens-vessel sign, old infarcts and hydrocephalus. 
Standard non-contrast images served as the reference standard. 
Results: Virtual non-contrast images could not be derived in one case 
because of severe motion artefacts. Five patients had an intracranial 
hemorrhage which were all detected on virtual non-contrast CT. Also midline 
shift (four cases), loss of gray white-matter differentiation (one case), old 
infarcts (two cases) and hydrocephalus (none) were scored equal on both 
techniques. Dens vessel signs could not be reliably assessed on the virtual 
non-contrast images because of occasional artefacts or early contrast arrival. 
Conclusion: It seems feasible to replace non-contrast CT by virtual non-
contrast CT images for acute stroke assessment, allowing for a single-
acquisition dynamic CTA stroke protocol from which haemorrhage, artery 
occlusion, and tissue perfusion can be evaluated.  
Author Disclosures: 
  E.J. Smit: Research/Grant Support; Toshiba Medical Systems. Speaker; 
Toshiba Medical Systems. M.M. Prokop: Research/Grant Support; Toshiba 
Medical Systems. Speaker; Toshiba Medical Systems. 
B-0696 15:20  
Neuroimaging signs and features of brain lesions in patients with 
CADASIL  
N. Kurochkina, A. Moroz, R. Konovalov, M. Krotenkova, S. Illarioshkin; 
Moscow/RU (nadia_sk@mail.ru)  
Purpose: To evaluate specific changes in MRI of the human brain, associated 
with either cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) or hypertensive microangiopathy (HM). 
Methods and Materials: We enrolled 24 patients with genetically confirmed 
CADASIL (19-81 y.o.) and 25 patients with HM (46-79 y.o.). The following MRI 
sequences were performed for every subject: T1 MPR, T2, FLAIR, DTI with 
calculation of fractional anisotropy (FA), mean, axial and radial diffusivity maps. 
Brain tissue lesions were assessed using STandards for ReportIng Vascular 
  






changes on nEuroimaging (STRIVE). Voxel-wise group analysis was carried 
out using SPM12 software to study the white matter microstructure. 
Results: In the CADASIL group the following changes were observed (in % of 
patients): recent small subcortical infarcts - none; lacunes - 54%; white matter 
hyperintensities (WMH) by Fazekas 1 - 12%, Fazekas 2 - 17%, Fazekas 3 - 
71% (sites of predilection: anterior temporal lobe and external capsule); 
cerebral microbleeds - 42%; enlarged perivascular spaces - 88%; brain atrophy 
- 27%. Morphometry analysis revealed differences in diffusivity maps and FA 
as well as volumes of brain structures in patients with moderate and severe 
WMH (Fazekas 2 and 3) between CADASIL and HM groups. 
Conclusion: Neuroimaging signs of brain lesions are common for all types of 
cerebral small vessel disease, including CADASIL. However, the distribution of 
WMH and patterns of microstructural alterations specify the differences 
observed in CADASIL in comparison with HM, that reflects their various 
morphopathology.  
14:00 - 15:30 Room F1  
Oncologic Imaging  
SS 716  
Advances in oncologic imaging  
Moderators:  
E.G. Klompenhouwer; Eindhoven/NL 
N.N.  
B-0697 14:00  
Can conventional MRI help to rectify grading of soft-tissue sarcomas 
(STS) on needle-core microbiospy (NCB)?  
A. Crombe1, P.-J. Marcelin2, F. Le Loarer1, E. Stoeckle1, A. Italiano1, 
J.-M. Coindre1, M. Kind1; 1Bordeaux/FR, 2Saint-Pierre/FR 
(amandine.crombe@ens-lyon.fr)  
Purpose: Prognosis and management of STS strongly rely on 
histopathological grading. The European Society for Medical Oncology 
recommends NCB to assess grading, despite the risk of underestimation due 
to sampling. Our aim was to identify combination of MRI features associated 
with high-grade (III) and how it reclassified grade I-II STS on NCB into true 
high-grade STS on surgical specimen. 
Methods and Materials: Of the 498 patients diagnosed with a STS in the 
Conticabase (CONnective Tissue in Cancer NETwork database) and followed-
up in our sarcoma reference center between 2008 and 2015, we 
retrospectively included 130 patients with: available MRI with gadolinium-
chelates injection, pathological grade on final surgical specimen, no 
neoadjuvant treatment. 66 had NCB. Visceral sarcomas, well-differentiated 
liposarcomas, angiosarcomas were excluded. Two radiologists evaluated: 
location, size, heterogeneity, margins, architecture, surrounding tissue and 
bone-vessel-nerve invasion. 
Results: Final pathological grade was 69 grade III, 47 grade II, 14 grade I. On 
multivariate analysis, 3 criteria were associated with true grade III: ill-defined 
margins >10% of tumor surface on post-contrast T1-WI (p=0.026, OR=2.93, 
IC95%=(1.14-7.56)), necrotic signal (p=0.013, OR=2.28, IC95%=(1.24-6.43)), 
enhancement of surrounding oedema (p=0.004, OR=3.55, IC95%=(1.51-
8.32)). Inter-observer agreements were 0.66(0.52-0.79), 0.78(0.65-0.90) and 
1(1.00-1.00), respectively. Among the 43 patient with grade I-II on NCB, 
presence of at least 2 of these 3 criteria would correctly reclassify 12/14 
(85.7%) true grade III but would ill-classify 15/29 (51.7%) true grade I-II 
(p=0.047). 
Conclusion: Conventional MRI can help evaluate STS grading but additional 
features from other imaging modalities are required to improve reclassification 
after NCB.  
B-0698 14:08  
Machine learning approach on semantic and texture MRI features for 
early response evaluation in patients with high-grade soft-tissue 
sarcomas undergoing neoadjuvant chemotherapy  
A. Crombe1, C. Perier2, O. Saut2, B. Denis de Senneville1, F. Le Loarer1, 
E. Stoeckle1, S. Cousin1, A. Italiano1, M. Kind1; 1Bordeaux/FR, 2Talence/FR 
(amandine.crombe@ens-lyon.fr)  
Purpose: To evaluate the feasibility and added value of machine learning and 
radiomics approaches to early predict the response after 2 cycles of 
anthracycline-based neoadjuvant chemotherapy (NAC) in soft-tissue sarcomas 
(STS) 
Methods and Materials: This retrospective single-center study included 52 
uniformly patients (4-6 cycles NAC) with locally advanced high-grade STS, 
between 2008 and 2015. Good histological response (GHR) was defined as 
10% stainable cells on final surgical specimen. All benefited from baseline (t0) 
and post-2 cycles 1.5T-MRI (t1) with gadolinium-chelates injection. MRI post-
processing consisted in histogram-based intensity normalisation and voxel 
standardisation. Random forest classifier was applied on: initial clinico-
biological data, features from radiologist’s visual assessment (semantic 
features: tumour architecture, margins, periphery), shape, histogram and 
textural features from T2-weighted-imaging at t1 and their changes (absolute 
or relative from t0 to t1). Areas under the receiver operating curve (AUC) and 
diagnostic performance of tested classifiers were compared. 
Results: 17 GHR and 35 poor-responders (PHR) were analysed. According to 
RECIST1.1, 3/35 (8.6%) PHR showed progressive disease and 0/17 (0%) 
GHR showed partial or complete response at early evaluation. 77 features 
were assessed. The best classification performance was obtained using 
absolute changes of radiomics features giving: accuracy=75%, 
sensibility=91%, specificity=48%, positive predictive value=77%, negative 
predictive value=69%, AUC=0.67 (0.60-0.74). 
Conclusion: Machine learning and radiomics approaches can substantially 
improve the NAC response prediction in high grade locally advanced STS and 
should be evaluated in prospective studies on additional imaging modalities.  
B-0699 14:16  
Calcium suppression in spectral detector computed tomography 
improves visualization of bone metastasis  
N. Grosse Hokamp1,2, N. Abdullayev1, V. Neuhaus1, J. Holz1, D. Maintz1, 
J. Borggrefe1; 1Cologne/DE, 2Cleveland, OH/US 
(nils.grosse-hokamp@uk-koeln.de)  
Purpose: To investigate a benefit from calcium suppression images (VNCa) in 
spectral detector computed tomography (SDCT) for assessment of bone 
metastases using MRI as a gold standard. 
Methods and Materials: 24 patients with vertebral metastases that underwent 
SDCT for oncologic staging purpose and MRI examination of the spine were 
included in this retrospective, IRB-approved study. Images were reconstructed 
as conventional images (CI) and using a prototype algorithm for calcium 
suppression (Philips Healthcare) with 3 different presets (VNCa1, VNCa2 and 
VNCa3). In each patient, normal bone (as determined by MRI) served as intra-
individual standard-of-reference. Circular regions of interest were drawn in 
metastatic bone, normal bone and subcutaneous fat in CI and copied to 
identical positions in VNCa1-3, attenuation and standard deviation were 
recorded. Attenuation was compared using t test and receiver operator 
characteristics (ROC) were analysed to assess performance of the different 
VNCa algorithms. 
Results: In conventional images attenuation in normal bone was higher than in 
metastatic bone (140.9±65.7 vs 86.1±33.6; p0.05), after subtraction of 
calcium attenuation in metastatic bone was higher (e.g. VNCa1: -240.0±60.6 vs 
-80.5±70.5, p0.05); the absolute difference between normal and metastatic 
bone increased from 54.8 in CI to 159.5 (p0.05), while noise remained 
constant (p0.05). This resulted in a significant increase of the area under the 
curves as depicted by ROC analysis in VNCa1+2 as compared to CI and VNCa3 
(0.95/0.98 vs 0.74/0.73, respectively, p0.05). 
Conclusion: Virtual non-calcium images provided by SDCT can be helpful in 
differentiating bone metastasis and non-metastatic bone if calcium suppression 
is adjusted to an appropriate level.  
B-0700 14:24  
A deep learning-based radiomics model for classification of 
mammography mass lesions in breast cancer patient  
I. Shiri, P. Geramifar, A. Bitarafan-Rajabi, A. Mohammadzadeh, 
H. Pouraliakbar, S.P. Shayesteh; Tehran/IR (Shayeste_sajad@yahoo.com)  
Purpose: Breast cancer is the most commonly diagnosed cancer with high 
mortality and morbidity. There are different biomarkers which can be obtained 
from breast tissue to classify mass lesions. The main aim of this study was to 
classify malignant and benign breast cancer using convolutional neural 
network (CNN). 
Methods and Materials: In this study, we used 315 mammography images of 
breast cases (148 benign and 167 malignant) from CBIS-DDSM database. 
Image patches are extracted around each lesion and used as train and test 
data set. The neural network consists of convolutional blocks composed of 
Convolutions, Batch Norm, ReLU, and Max Pooling Blocks followed by FC 
layers. The final layer is a soft-max layer for binary classification. We evaluate 
the CNN performance using free response receiver operating characteristic 
(FROC) analysis. 
Results: CNN performance evaluation and accuracy of the model was 
performed using free response receiver operating characteristic (FROC) 
analysis. The analysis shows the deep learning approach achieves FROC 
value of 82.3% with accuracy of 85.3%. 
Conclusion: CNN in hierarchically way uses a set of nonlinear 
transformations, to represent the visual content of an image automatically from 
scratch. Deep learning takes advantage of no need for segmentation, feature 
extraction, feature reduction and classification manually against conventional 
radiomics methods. Thus, deep learning-based radiomics model can be used 
instead of hand crafted texture feature analysis in radiomics processing.  
  






B-0701 14:32  
IVIM MRI of oestrogen-receptor-positive breast cancer: association with 
quantitative IVIM parameters and Ki-67 proliferation status  
R. Balaji; Chennai/IN (ravikanthbalaji@gmail.com)  
Purpose: Investigate association of IVIM MRI-derived quantitative parameters 
with Ki-67 proliferation index in patients with oestrogen receptor (ER)-positive 
breast cancers. 
Methods and Materials: 67 patients with ER-positive breast cancer were 
included in the study. All patients underwent IVIM MR imaging along with 
regular diffusion and DCE MRI on 1.5 Tesla scanner. IVIM-derived parameters: 
f the perfusion fraction, D the pure diffusion coefficient, D * perfusion-related 
pseudo-diffusion and IVIM-derived ADC were analysed and correlated with Ki-
67 status. High (gt14%) and low Ki-67 (lt14%) proliferation indices were 
obtained. 
Results: f values (perfusion fraction) were significantly elevated in high Ki-67 
index group (Plt0.001). D and ADC values were lower in high Ki-67 group (P 
&lt0.001). Low Ki-67 index tumours had lower f values but not statistically 
significant high D or ADC values. High f values (14%) were seen in grade 3 
tumours which were larger (gt2cm) and had greater propensity for axillary 
nodal metastases and were associated with high Ki-67 proliferation index. f 
fraction had greater confidence interval 1.756-42.24 for correlation with Ki-67 
index. 
Conclusion: f and true diffusion coefficient values can be used as 
independent biomarkers to correlate Ki-67 proliferation status in oestrogen 
receptor-positive breast cancers.  
B-0702 14:40  
Metastatic axillary lymph nodes in patients withbreast cancer: value of 
quantitative shear wave elastography  
Y. Kabin, O. Kostash, V. Kapustin, A. Gromov; Moscow/RU 
(wwkapustin@yandex.ru)  
Purpose: To evaluate the usefulness of LN tissue elasticity quantitative 
assessment by shear wave elastography (SWE) for detection of axillary lymph 
node (LN) metastatic involvement in women with breast cancer (BC). 
Methods and Materials: 172 women with verified BC were included in this 
study. In every case the most suspicious LN was chosen, using B-mode 
ultrasonography (BUS) for the further elasticity parameters assessment. Tissue 
elasticity (kPa) was measured at the most suspicious hypoechoic portion of 
LNs, detected by BUS. LN tissue changes type (benign or malignant) were 
subsequently proved by ultrasound-guided fine-needle aspiration biopsy or 
postoperative histological evaluation in all cases. These data were 
retrospectively compared for two groups of patients (with benign and 
metastatic LN) using Mann-Whitney test. Statistical measures of performances 
(Se, Sp) of SWE elasticity for LN metastases detection were calculated using 
receiver operating curve (ROC) analysis. 
Results: “Tissue elasticity” value in metastatic LNs was significantly higher 
comparing to benign LN changes (p= 0.000). This quantitative SWE parameter 
showed high diagnostic efficacy for axillary LN metastases detection [area 
under curve (AUC) - 0.924]. The best diagnostic performance (Se=0,87, 
Sp=0,81) was received at 31,5 kPa cut-off value. 
Conclusion: Tissue elasticity parameter (kPa), assessed by SWE, gives 
valuable diagnostic information (adjunctive to the diagnostic performance of 
BUS) for the axillary LN metastasis detection in patients with BC.  
B-0703 14:48  
Quantitative PET parameters in predicting event free survival in patients 
with hodgkin lymphoma  
I. Kriachok1, O. Novovsad1, T. Skrypets1, A. Gorbach1, Y. Kmetyuk1, 
O. Kozlova1, M. Novikov1, L. Mikhalska1, V. Kozlov2; 1Kiev/UA, 2Odessa/UA 
(nicknovi@gmail.com)  
Purpose: To analyse whether quantitative metabolic PET parameters, their 
negative predictive value (negative PET scan and no treatment failure, NPV) 
and positive predictive value (positive PET scan and treatment failure, PPV) 
were associated with EFS. 
Methods and Materials: SUVmean, MTV (computed with 41% threshold 
algorithm) and TLG were retrospectively calculated at baseline (PET-1), interim 
(PET-2) and end of treatment (PET-3) metabolic PET/CT studies of 45 patients 
with Hodgkin lymphoma. 53% of patients had stage I-II disease and 47% - 
stage III-IV disease. All patients were treated with ABVD or BEACOPP-14/esc 
chemotherapy regimens. 
Results: The ORR in the group was 95.5%. There were 73% patients with 
negative and 27% with positive PET-2 studies, which yielded an NPV of 82% 
and PPV of 18%, p< 0.05.Multivariate analysis showed PPV to be the only 
variable significantly influencing EFS with HRs of 1.07 [95% confidence 
interval(CI) 1.0-1.15, p = 0.00008].According to Cox regression, MTV and 
SUVmean at PET-3 were the variables significantly influencing EFS with HRs 
of 1.07 [95% confidence interval(CI) 1.0-1.13, p = 0.005] and 2.0 [95% (CI)1.4-
2.82, p = 0.0001), respectively. Unfortunately, quantitative parameters at PET-
1 and PET-2 were not statistically significant in predicting clinical outcome in 
this study. 
Conclusion: Quantitative PET parameters may play a predictive role in 
identifying patients at high risk of treatment failure. Further studies will be 
conducted to investigate PET quantitative data predictive value.  
B-0704 14:56  
Diagnosis of diffuse spleen involvement in haematological malignancies 
using a spleen to liver attenuation ratio in CECT  
C.P. Reinert, C. Hinterleitner, K. Nikolaou, M. Horger; Tübingen/DE 
(christian.reinert@med.uni-tuebingen.de)  
Purpose: To assess the mean attenuation values of the normal spleens vs. 
involved spleens in haematological malignancies and to try to discriminate the 
two groups by using attenuation ratios to the normal liver parenchyma in the 
potal-venous enhancement phase on CECT. 
Methods and Materials: Included were 60 (27 male; mean age 55.0y) 
consecutive patients with known malignant haematologic diseases who 
underwent CECTs for staging before and after chemotherapy and 60 controls 
(31 male; mean age 62.2y). We calculated in all patients the spleen index 
(LxBxDx0.5) and measured the attenuations of the spleen and liver in the 
portal-venous enhancement phase calculating the spleen-to-liver ratios. 
Standard-of-reference was the significant reduction (>20%) of the spleen index 
following successful chemotherapy or normalization of FDG-uptake in a 
subgroup undergoing 18F-FDG-PET/CT for staging. 
Results: The spleen-to-liver attenuation ratios in involved spleens were 
significantly lower over the controls, respectively (0.94 vs. 0.98, p<0.0045). The 
pre- to posttreatment attenuations in the spleen in the involved group were 
significant lower (93.70 HU vs. 113.15 HU, p<0.0001) as well as the pre- to 
posttreatment spleen to liver attenuation ratios (0.94 vs. 1.17, p<0.0001). Using 
a cut-off-value of 100.9 HU the positive predictive value was 0.81 (95% 
confidence interval). The spleen index significantly dropped down after 
successful treatment (574.87 cm3 to 287.64 cm3, p<0.0001). 
Conclusion: Spleen-to-liver attenuation ratios in haematological malignancies 
with diffuse involvement of spleen are significantly lower as in controls and 
could therefore be used complementary to the spleen index as an indicator of 
spleen involvement at staging.  
B-0705 15:04  
Is whole body 18FDG-PET/CT including the extremities routinely 
warranted in melanoma patients?  
C. Riedl1, H. Schoder1, G.A. Ulaner1, T. Saidon1, K. Juluru1, W. Weber1, 
K. Pinker2; 1New York, NY/US, 2Vienna/AT (riedlc@mskcc.org)  
Purpose: 18FDG-PET/CT of melanoma patients is often performed as a whole 
body (WB) study including the upper and lower extremities. This causes 
increased examination time and radiation dose and is of questionable clinical 
value. The aim of this study was to investigate the value of 18FDG-PET/CT 
imaging of the extremities in melanoma patients. 
Methods and Materials: The hospital database was searched for melanoma 
patients who underwent WB 18FDG-PET/CT between 2012-2016. Imaging 
reports were searched for findings in the extremities that would not have been 
included in a scan ranging from the skull base to mid thighs, the range 
routinely used in most other malignancies. Findings in the extremities 
considered less likely to be malignant (<25%) were considered clinically 
irrelevant. Findings in an extremity related to the primary tumour were also 
considered clinically irrelevant. 
Results: 1975 18FDG-PET/CT scans in melanoma patients were identified. 
There were 276 (14%) findings in the extremities that were classified as a 
malignant (primary/recurrence, local or distant metastases). In 1.6% (32/1975) 
patients we identified metastases in an extremity that would not have been 
covered by an “eyes-to-thighs” scan or a scan of the extremity afflicted by the 
primary tumour. In 93.8% (30/32) of these patients there was disseminated 
disease. Thus WB 18FDG-PET/CT detected clinically relevant metastases in 
the extremities in only 0.1% (2/1975) of melanoma patients. 
Conclusion: WB 18FDG-PET/CT almost exclusively detected metastases in 
the extremities in patients with disseminated disease or in the extremity 
afflicted by the primary tumour.  
B-0706 15:12  
Integrated 18F-FDG PET/MR for the initial detection of lymph node 
metastases in malignant melanoma: is sentinel lymph node biopsy still 
necessary?  
B.M. Schaarschmidt1, J. Grueneisen2, V. Stebner2, L.M. Sawicki1, 
C. Buchbender1, P. Heusch1, L. Umutlu2, G. Antoch1, T. Poeppel2; 
1
Düsseldorf/DE, 2Essen/DE  
Purpose: To evaluate the performance of 18F-FDG PET/CT, 18F-FDG 
PET/MR and 18F-FDG PET/MR including diffusion-weighted imaging (DWI) in 
  






sentinel lymph node metastasis detection after primary tumour resection in 
malignant melanoma patients. 
Methods and Materials: In this retrospective analysis, 52 patients (female: 
n=30, male: n=22) that underwent 18F-FDG PET/CT and subsequent PET/MR 
including DWI 18F-FDG prior to radioguided SPECT/CT sentinel lymph node 
mapping and resection were included. In separate sessions, 87 sentinel lymph 
nodes were identified using SPECT/CT in PET/CT, PET/MR PET/MR+DWI 
datasets and their dignity (benign/malignant) was determined by increased 
tracer uptake (PET/CT), increased tracer uptake and suspicious morphological 
appearance (PET/MR) as well as reduced apparent diffusion coefficients in 
DWI (PET/MR+DWI). Histopathological results served as reference standard. 
Results: Of 136 resected lymph nodes, 87 could be identified in SPECT/CT. 
Seventeen metastatic lymph nodes were detected by histopathology (size: 
<0.1mm: n=4, 0.1-1mm: n=7, >1mm: n=6). Sensitivity, specificity, positive 
predictive value and negative predictive value were 17.7%, 95.6%, 50.0% and 
82.3% for PET/CT, 23.5%, 96.9%, 66.7% and 82.3% for PET/MR and 0%, 
93.3%, 0%, 82.4% for PET/MR+DWI. PET/MR+DWI performed worse than the 
other methods as contradictory information between PET and DWI reduced the 
number of true-positive findings. 
Conclusion: 18F-FDG PET/MR is unable to improve initial lymph node 
metastasis detection in malignant melanoma patients in comparison to PET/CT 
and will not be able to replace sentinel lymph node resection for diagnostic 
purposes in malignant melanoma patients. The additional analysis of DWI even 
worsen the performance of PET/MR due to contradictory Information.  
B-0707 15:20  
Usefulness of spleen size and volume measured by computed 
tomography for predicting clinical outcome in chronic myeloid leukemia  
M. Seo, S.-E. Lee, J.-I. Choi, D.-W. Kim; Seoul/KR (minkook.seo@gmail.com)  
Purpose: Spleen size is one of well-known prognostic factors for chronic 
myeloid leukemia (CML) patients and many scoring systems include the spleen 
size as a parameter. The purpose of this study is to evaluate whether spleen 
diameter on axial (ASD) and coronal (CSD) CT imaging and spleen volume 
(SV) measured using CT images would accurately predict the prognosis of 
initially diagnosed CML patients. 
Methods and Materials: A total of 89 CML patients who were initially 
diagnosed and treated by imatinib were enrolled. ASD and CSD were 
measured on axial and coronal CT imaging by measuring the longest diameter 
of spleen. SV was quantitated by the semi-automatic volume measurement 
software. Conventional measurement of spleen by palpation, ASD, CSD and 
SV were analyzed for cumulative incidence (CI) of complete cytogenetic 
response (CCyR), major molecular response (MMR), failure-free survival 
(FFS), progression-free survival (PFS) and overall survival (OS) using the 
Kaplan-Meier methods and the log rank test. 
Results: Measurements by palpation and ASD were statistically significant for 
CI of CCyR and MMR (p<0.001 for all parameters). However, they were not 
significant for FFS, PFS and OS. On the other hand, CSD was significant for CI 
of CCyR (p=0.003), MMR (p<0.001) and PFS (p=0.038). SV was significant for 
CI of CCyR (p<0.001), MMR (p<0.001), FFS (p=0.040) and PFS (p=0.033). 
However, no measurement was significant for OS. 
Conclusion: Spleen volume measurement using CT images is superior to 
conventional palpation or 2-dimensional measurement of spleen size for 
predicting the prognosis of CML patients treated by imatinib.  
14:00 - 15:30 Room F2  
GI Tract  
SS 701b  
Solving challenges in upper GI imaging  
Moderators:  
M. Radzina; Riga/LV  
S. Schmidt Kobbe; Lausanne/CH  
B-0708 14:00  
Intravoxel incoherent motion diffusion-weighted MR imaging in gastro-
esophageal cancer: correlation with 18F-FDG-PET and histopathology  
K. Schawkat1, B.-R. Sah1,2, G. Delso3, E. Ter Voert1, P. Schneider1, 
C.S. Reiner1, M. Huellner1, P. Veit-Haibach4; 1Zurich/CH, 2London/UK, 
3
Waukesha, WI/US, 4Toronto, ON/CA (khoschy.schawkat@usz.ch)  
Purpose: To evaluate the relationship of multimodality parameters derived 
from intravoxel incoherent motion (IVIM) diffusion-weighted MR imaging and 
18F-FDG-PET in patients with gastro-esophageal cancer and to investigate 
their histopathological correlation. 
Methods and Materials: Twenty-two consecutive patients (19 male; mean age 
64.9±11.7 years; range 37-84 years) with adenocarcinoma (n=15) and 
esophageal squamous cell carcinoma (n=7) were analyzed prospectively. PET-
parameters (SUVmax, mean tumor volume (MTV), total lesion glycolysis 
(TLG)) and IVIM parameters (pseudodiffusion (D*), perfusion fraction (fp), true 
diffusion (D), b-value (bval)) were determined, correlated to each other and to 
histopathology (staging, grading, regression). The relationship of these 
parameters was evaluated using Spearman’s correlation with Bonferroni 
correction to exclude false positive results under multiple testing. 
Results: IVIM and PET-parameters showed significant negative correlation for: 
MTV  bval (rs= -0.643, p=0.002), TLG  bval (rs=-.699, p=0.000) and TLG  fp 
(rs=-0.577, p=0.006). Negative correlation was also found for bval  staging 
(rs=0.590, p=0.005). TLG  Dt showed positive correlation (rs=0.705, p=0.000). 
After Bonferroni correction no significant correlation was found for MTV  fp 
(rs=-0.527, p=0.014) and for MTV  Dt (rs= 0.487, p=0.025). 
Conclusion: IVIM parameters (fp, Dt) provide useful quantitative information 
and correlate with the PET-parameter total lesion glycolysis (TLG). In addition, 
bval significantly correlates with staging. IVIM might be a valuable tool for non-
invasive pre-therapeutic characterization of gastro-esophageal cancer.  
B-0709 14:08  
The concentration of iodine in perigastric adipose tissue: a novel index 
for assessment of serosal invasion in patients with gastric cancer after 
neoadjuvant chemotherapy  
L. Yang; Shijiazhuang/CN (64502240@qq.com)  
Purpose: This study aims to explore the association between iodine 
concentration (IC) in perigastric adipose tissue (PAT), quantified by dual-
energy computed tomography (DECT), and serosal invasion (SI) in patients 
with gastric cancer after neoadjuvant chemotherapy (NAC) 
Methods and Materials: 43 patients with T4-staged gastric cancer (with SI) 
were enrolled in the 4th Hospital of Hebei between January 2015 and 
December 2016. IC and standard IC in PAT (ICPAT and SICPAT) were quantified 
by DECT pre- and post-NAC. Postoperative pathologic examination was 
performed to stage gastric cancer. ICPAT and SICPAT between patients at T1-T3 
stages (group A, without SI) and patients at T4 stage (group B, with SI) were 
compared subsequently, with receiver operating characteristic (ROC) curve 
applied for evaluating the accuracy of the SICPAT in identifying post-NAC SI. 
Results: The accuracy of conventional computed tomography (CT) in 
identifying SI was 72.09%. Differences of variations between pre- and post-
NAC ICPAT, SICPAT, ICPAT and SICPAT were observed, respectively (P<0.05). 
Intragroup ICPAT and SICPAT also changed significantly after NAC (P<0.05), 
except the SICPAT in group B (P>0.05). The area under the ROC curve (AUC) 
was 0.929, with the threshold of SICPAT reaching 0.095. The sensitivity, 
specificity and accuracy of SICPAT in identifying post-NAC SI were 92.30 %, 
86.70 %, and 88.37%, respectively. 
Conclusion: These results showed that SICPAT is an accuracy index for 
identifying post-NAC SI, by which it might be used to assess the effectiveness 
of neoadjuvant chemotherapy and the optimal timing for the operation.  
B-0710 14:16  
Use of CT perfusion parameters in assessment of early response of 
gastric cancer to neoadjuvant chemotherapy  
P. Pilius, I. Shrainer, A. Klimenko, V.E. Sinitsyn; Moscow/RU 
(polishka1903@gmail.com)  
Purpose: To assess whether the changes of CT Perfusion (CTP) parameters 
of gastric cancer could be used as biomarkers for evaluation of early response 
of gastric cancer to neoadjuvant chemotherapy. 
Methods and Materials: 21 patients with local advanced adenocarcinoma of 
stomach were analyzed. The patients received 2-5 courses of neoadjuvant 
chemotherapy (EOX or XELOX schemes) before surgery. CTP scans were 
performed prior and after the first course of chemotherapy. CTP parameters 
(blood flow (BF), blood volume (BV) and permeability surface (PS)) of the 
tumor were computed on a dedicated workstation with a consensus between 
two radiologists. 
Results: 7 patients (33.3%) with good pathological response to treatment 
(grade 1-2 accordingly to Mandard score) consisted the 1st group. Other 14 
patients (66.6%) with poor response (grade 3-5) made the 2nd group. All 
studied CTP parameters decreased in the both groups after treatment, but all 
these changes were not significant. CTP values before and after chemotherapy 
In the 1st group: BV 5.5 and 5.2 (p=0.83), BF 68.5 and 56.8 (p=0.21), PS 39.5 
and 31.3 (p=0.3); in the 2nd group: BV - 7.3 and 5.9 (p=0.83), BF - 73.2 and 
68.6 (p=0.58), PS - 35.0 and 30.7 (p=0.24), corr. 
Conclusion: CTP parameters of the gastric cancer decreased after the first 
course of chemotherapy both in patients with good and poor response. Further 
improvements in CTP protocols and analysis are needed in order to make it a 












B-0712 14:24  
The CTP for detection of primary oesophageal carcinoma  
M. Kantarci, A. Levent, R. Sade, S. Eren, H. Ogul, F. Guven, G. Bayraktutan; 
Erzurum/TR (akkanrad@hotmail.com)  
Purpose: The purpose of this study was to investigate the efficiency of 
computed tomographic perfusion (CTP), contrast-enhanced computed 
tomography (CECT) and 18F- fluorodeoxyglucose positron emission 
tomography (PET/CT) in the diagnosis of oesophageal cancer. 
Methods and Materials: This prospective study consisted of 33 patients with 
pathologically confirmed oesophageal cancer of which 2 had oesophageal 
abscess. All the patients underwent CTP, CECT and PET/CT imaging and the 
imaging findings were evaluated. Sensitivity, specificity, positive predictive and 
negative predictive values were calculated for each of the three imaging 
modalities relative to the histological diagnosis. 
Results: Thirty three tumours were visualized on CTP; on CECT:29, on 
PET/CT:27. Six tumours were stage 1 and the two and four tumours were 
missed by CECT and PET/CT, respectively. The significant differences were 
between the CTP and CECT (p:0.02), and CTP and PET/CT (p:0.04), for stage 
1 tumours were found. Sensitivity, specificity, positive predictive. 
Corresponding values for and negative predictive value of CTP were 100%, 
100%, 100% and 100%, respectively. Corresponding values for CECT were 
93.94%, 0%, 93.94% and 0%, respectively, and those of PET/CT were 
87.88%, 0%, 93.55% and 0%, respectively. Hence, the sensitivity, specificity, 
positive predictive and negative predictive values of CTP were better than 
those of CECT and PET/CT. 
Conclusion: The CTP had an advantage over CECT and PET/CT in detecting 
small lesions. The CTP was valuable especially in stage 1 tumours.  
B-0713 14:32  
The value of dual-detector spectral CT imaging in the identification of 
gastric carcinoma and gastric lymphoma  
S. Jiang, Y. Ren, H. Yan, X. Lu; Shenyang/CN (1904451977@qq.com)  
Purpose: To explore the value dual-detector spectral CT scan in the 
differential diagnosis of gastric cancer (GC) and gastric lymphoma (GL). 
Methods and Materials: 32 patients with gastric cancer and 12 patients with 
gastric lymphoma were retrospectively analysed. All patients were performed 
enhanced abdominal CT scanning with spectral CT. The attenuation values of 
virtual monochromatic energy 40 ~ 140 keV, iodine concentration and effective 
atomic number (Zeff) of the two groups were measured. The normalized iodine 
concentration (NIC, lesion iodine concentration / aorta abdominalis iodine 
concentration) and the slope of the spectral curve (HU)were calculated in 
arterial phases and venous phases. 
Results: In arterial phase, attenuation values of 40 ~ 70 keV of GL group were 
lower than that in GC group, the difference was significant at 40 keV, 
attenuation values of GC group was statistically higher than that in GL group 
(131.3 ± 67.6 HU vs 81.3 ± 40.4 HU; t = 2.56, P<0.05). HU on 40 ~ 100 keV 
monochromatic images was higher in GC group than that in GL group 
(1.37±0.98 vs 0.65 ± 0.59; t=2.64, P<0.05). The NIC in GC group was higher 
than GL group (0.125±0.1 vs 0.061±0.06; t=2.34, P<0.05). The Zeff in GC group 
was higher than GL group (8.1±0.47 vs 7.6±0.51; t=3.39, P<0.05). 
Conclusion: Gastric cancer and gastric lymphoma have different energy 
spectrum CT characteristic parameters that can provide the reference value for 
clinical imaging to identify.  
B-0714 14:40  
Prognostic significance of systemic inflammation and FDG-PET bone 
marrow uptake in patients with oesophageal cancer  
R.J. Pallas, K.G. Foley, T. Crosby, P.A. Fielding; Cardiff/UK 
(robbyfromtherock-2@yahoo.co.uk)  
Purpose: Systemic inflammation is regarded as a poor prognostic indicator in 
cancer patients. FDG uptake is increased in areas of inflammation. Early 
research suggests novel immunotherapy techniques may be beneficial in 
selected cancer patients and treatment decisions could be guided by PET/CT. 
The aim of the study is to investigate the prognostic significance of bone 
marrow (BM) uptake in patients with oesophageal cancer (EC) and correlate 
serum haematological results with recorded standardised uptake values (SUV). 
Methods and Materials: Consecutive patients with biopsy-proven esophageal 
cancer staged with PET/CT between October 2010 and July 2015 were 
considered. All patients underwent definitive chemoradiotherapy. Patients with 
haematological disorders and BM metastases were excluded. Mean BM SUV 
was calculated from regions of interest placed in 5 adjacent vertebral bodies. 
Cox regression models assessed the prognostic significance of clinical, 
metabolic and haematological variables. P values <0.05 were considered 
statistically significant. Primary outcome was overall survival (OS). 
Results: Seventy-eight patients (median age 71 (range 35-81), 54 males, 38 
adenocarcinomas, 35 squamous cell carcinomas) were included. Median OS 
was 25.0 months (95% confidence intervals 13.6-36.4). Radiological stage was 
significantly associated with OS (X2 14.735, df 6, p=0.022). Age, tumour 
location, SUVmax of primary tumour, mean SUV of vertebrae, Hb, WCC, 
neutrophils, lymphocytes, platelets and albumin were not associated with OS 
(p=0.561, 0.971, 0.656, 0.869, 0.584, 0.216, 0.344, 0.324, 0.165, 0.378, 
respectively). 
Conclusion: Radiological stage was significantly associated with OS. 
However, metabolic and haematological variables were not statistically 
significant. A larger cohort of EC patients is required to test this hypothesis.  
B-0715 14:48  
MRI of the gastric antrum for the quantification of gastric motility: 
comparison between obese and normal weight patients  
S. Picchia, M. Rengo, D. De Santis, D.M. Bellini, S. Badia, A. Laghi; Latina/IT 
(simona.picchia87@gmail.com)  
Purpose: To compare gastric motility in obese and normal weight patients with 
magnetic resonance imaging (MRI). 
Methods and Materials: This is a non-randomized single-centre study. 
CineMRI for motility analysis was obtained by 1.5T MRI using 2DtrueFISP 
(coronal and axial planes) after 650-ml liquid meal (Nutridrink) plus 2 yolks, 1 
albumen and 150 ml of water over 10 minutes. This 525-kcal meal was 
composed of 25% fat, 25% protein, and 50% carbohydrate. Images were 
acquired before and immediately after the meal and every 20 minutes, for a 
total exam time of 100 minutes. Each gastric motility scan lasted 60 seconds, 
with 100 images acquired in free breathing. Antral length, maximal contraction 
amplitude and contraction frequency were evaluated on a dedicated software. 
Results obtained in obese and normal weight patients were compared. 
Results: Twenty patients (10 obese and 10 normal weight) were included in 
the study. Motility antral scans showed that during fasting and postprandial 
period, in obese patients the three parameters evaluated were significantly 
lower (mean basal antral length in obese patients: 6.75±0.8cm/in normal 
weight patients: 8.12±0.43cm, p value<0.05; mean postprandial antrum length 
in obese patients: 7.56±1.03cm/in normal weight patients: 9.4±0.12mm, p 
value<0.05; mean basal maximal contraction amplitude in obese patients: 
7.1±0.72mm/in normal weight patients: 8.97±0.43, p value<0.05; mean 
postprandial maximal contraction amplitude in obese patients: 8.3±1.5mm/in 
normal weight patients: 9.76±0.76mm, p value<0.05; mean basal contraction 
frequency in obese patients 8.7±0.98cpm/in normal weight patients: 10.3±0.9, 
p value<0.05; mean postprandial contraction frequency in obese patients: 
9.8±1.4cpm/in normal weight patients: 11.2±1.2cpm, p value<0.05). 
Conclusion: MRI is able to identify differences in antral motility between obese 
and normal weight patients.  
B-0716 15:56  
Prediction of gastric cancer with synchronous hepatic metastasis by 
enhancement pattern of primary lesion using multiphasic contrast-
enhanced computed tomography  
D. Tsurumaru, Y. Nishimuta, T. Muraki, Y. Asayama, H. Honda; Fukuoka/JP 
(tsuru-d@radiol.med.kyushu-u.ac.jp)  
Purpose: To examine contrast-enhanced computed tomography (CECT) 
features of primary site of gastric cancers with synchronous hepatic 
metastasis. 
Methods and Materials: One hundred and eleven consecutive patients with 
pathologically proven advanced gastric cancers who were evaluated with 
CECT were enrolled. CT images were obtained 40s (arterial phase), 70s 
(portal phase) and 240s (delayed phase) after injection of nonionic contrast 
material. Eleven patients were diagnosed having hepatic metastasis at the time 
of diagnosis. Two radiologists in consensus determined the “peak 
enhancement phase” in which the lesion showed the highest attenuation value 
among the three phases for each case. The readers traced the entire tumour 
as the region of interest (ROI) of the gastric lesion, and measured the CT 
attenuation value for each phase. We compared the peak enhancement phase 
of positive hepatic metastasis group (n=11) and negative hepatic metastasis 
group (n=100) using Chi-square tests, and compared the CT attenuation 
values of the two groups in each phase using analysis of variance (ANOVA). 
Results: The peak enhancement was significantly different between the two 
groups (p=0.0007); most of the positive hepatic metastasis cases had peak 
enhancement in the arterial phase. The CT attenuation values of positive 
hepatic metastasis cases were significantly lower than those of negative 
hepatic metastasis cases in the delayed phase. 
Conclusion: Hepatic metastasis of gastric cancer may be predictable 














B-0717 15:04  
MRI for response assessment after neoadjuvant chemoradiotherapy in 
oesophageal cancer: added value of diffusion-weighted imaging  
S.E. Vollenbrock, F.E. Voncken, D.M. Lambregts, M. Maas, L.C. ter Beek, 
B.M. Aleman, R.G.H. Beets-Tan, A. Bartels-Rutten; Amsterdam/NL 
(s.vollenbrock@nki.nl)  
Purpose: High accuracy is needed to select oesophageal cancer patients with 
a complete response (CR) after neoadjuvant chemoradiation (nCRT) for organ-
preserving treatment instead of oesophagectomy. Performance of T2-weighted 
MRI (T2W-MRI) without and with diffusion-weighted MRI (DW-MRI) for 
response assessment after nCRT was determined. 
Methods and Materials: Thirty-two patients with locally advanced 
oesophageal cancer underwent MRI (1.5T; T2W-MRI and DW-MRI(b-
values=0,200,800 s/mm2)) before and after nCRT with a maximum of 21 days 
between MRI and surgery. Three radiologists first scored only T2W-MRI. 
Secondly they rescored with DW-MRI. A 5-point score was used (1=definite 
CR, 3=inconclusive, 5=definite residual tumour). Histopathology after 
oesophagectomy represented the reference standard (Mandard tumour 
regression grade 1=CR, 2-5=residual tumour). Area under the ROC (AUROC), 
sensitivity and specificity were calculated considering MRI scores 3-5 as 
tumour-positive. 
Results: Two out of 32 patients were excluded due to poor image quality. 
Seven (23%) of 30 patients achieved a CR. AUROCs for the 3 radiologists 
individually were 0.57, 0.67, 0.64 for T2W-MRI only and 0.76, 0.69, 0.72 with 
DW-MRI (p=0.06, 0.57, 0.60). Sensitivity for detecting residual tumour was 
100%, 91%, 87% on T2W-MRI and 96%, 96%, 87% with DW-MRI. Specificity 
was 14%, 43%, 43% on T2W-MRI and 57%, 43%, 57% with DW-MRI. 
Conclusion: T2W-MRI with DW-MRI shows fair accuracy of response 
assessment after nCRT in oesophageal cancer patients while T2W-MRI only 
performs poorly. Sensitivity of the combination is high, indicating that the risk of 
missing residual tumour is minimal. However, specificity is lacking. Future 
studies investigate if addition of (echo-)endoscopy improves response 
assessment.  
B-0718 15:12  
Perivascular infiltration and histologic difference: is it helpful to 
determine T stage of advanced gastric cancer in CT?  
J. Kim, W.S. Chung, H.Y. Jang, H.C. Kim, T.S. Kang, H.J. Lee, J.S. Sohn; 
Daejeon/KR (apple17171@naver.com)  
Purpose: This study aims to determine whether morphologic and histologic 
features are useful for CT T stage of advanced gastric cancer. 
Methods and Materials: A review of medical records yielded the 160 patients 
with advanced gastric cancer, who had available preoperative stomach CT 
scans for review and were pathologically confirmed. Individual review of 
stomach CT scans was subsequently performed by two radiologists, who were 
blinded to pathologic stage. Using CT, they were classified according to 
standard T stage, perivascular T stage, and histologic T stage. Diagnostic 
accuracy of each T stage and time to progression (TTP) between positive and 
negative perivascular infiltration group were analyzed. 
Results: Diagnostic accuracy of standard T stage, perivascular T stage, and 
histologic T stage was respectively 65%, 68.75%, and 77.5%. There was 
significantly different between diagnostic accuracy of standard T stage and 
histologic T stage. There was no significantly different between standard T 
stage and perivascular T stage. However, in the subgroup analysis that was 
pathologically confirmed as T3 and T4a, there was significantly different 
between standard T stage and perivascular T stage. In pathologically 
confirmed T3 and T4a group, TTP of negative perivascular group was longer 
than positive perivascular group. 
Conclusion: Considering histologic differentiation and perivascular infiltration 
could be useful option for pre-operative CT T staging of AGC. Especially, 
perivascular infiltration is more useful option for differentiation of T3 and T4a 
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B-0719 14:00  
Posterior tibial tendon dysfunction: clinical and magnetic resonance 
imaging findings having histology as reference standard  
C. Messina1, D. Albano2, A. Corazza1, S. Rapisarda1, N. Martinelli1, 
A. Bianchi1, L.M. Sconfienza1; 1Milan/IT, 2Palermo/IT 
(carmelomessina.md@gmail.com)  
Purpose: To investigate the correlation between MRI, clinical tests, 
histopathologic features of posterior tibial tendon (PTT) dysfunction in patients 
with acquired adult flatfoot deformity surgically treated with medializing 
calcaneal osteotomy and flexor digitorum longus tendon transposition. 
Methods and Materials: Nineteen patients (11 females; age: 46years, range: 
18-75) were pre-operatively evaluated using the single heel rise (HR) and the 
first metatarsal rise (FMR) sign tests. Two reviewers graded the PTT tears on a 
I-III scale and measured the hindfoot valgus angle on the pre-operative ankle 
MRI. The specimens of the removed portion of PTT were histologically 
analysed by two pathologists using the Bonar and Movin score. Linear 
regression, Spearman's rank order, and intraclass correlation coefficient (ICC) 
statistics were used. 
Results: ICC for MRI was excellent (0.952). Correlation between FMR and HR 
tests was at limit of significance (r=0.454; P=0.051). HR and FMR significantly 
correlated to the Movin score (r=0.581; P=0.009 and r=0.538; P=0.018, 
respectively), not to the Bonar score (both with r=0.424; P=0.070). PTT 
tendinopathy grading at MRI significantly correlated to the FMR (p=0.041), but 
not to the hindfoot valgus angle (p=0.496), the HR (p=0.943), the Bonar 
(p=0.937) and Movin score (p=0.436). The hindfoot angle did not correlate to 
any of the other variables (p>0.264). 
Conclusion: For PTT dysfunction, HR and FMR tests showed high correlation 
with histology evaluated using the Movin score, without correlation with the 
Bonar score. Semiquantitative grading of PTT dysfunction at MRI only 
correlates to the FMR and not to histology. The hindfoot valgus angle is not 
correlated to any of the considered variables.  
B-0720 14:08  
Factors related to bone marrow oedema of accessory navicular bone in 
the evaluation with MR imaging  
M. Tsuchiya, T. Masui, M. Katayama, M. Sasaki, K. Kawamura, Y. Hayashi, 
T. Yamada, H. Sakahara; Hamamatsu/JP (D16018@hama-med.ac.jp)  
Purpose: A symptomatic accessory navicular bone was reported to show bone 
marrow oedema pattern (BMEP) in magnetic resonance imaging (MRI), but the 
relationship between BMEP and the characteristics of the accessory navicular 
bone and feet might not be clear. This study examined the relationship 
between accessory navicular-related BMEP and MRI-based measurements. 
Methods and Materials: Patients with accessory navicular bone were enrolled 
from January 2004 to September 2017, including 20 patients with BMEP (8 
females; mean age ± SD, 22.2 ± 15.1 years) and 29 control subjects without 
BMEP (14 females; mean age ± SD, 32.9 ± 19.6 years). The maximum length 
of the accessory navicular bone, protrusion percent, and arch height index 
(AHI), an indicator of flat feet, were obtained from MRI. Two observers 
independently conducted these measurements. Uni-/multivariate analyses 
were performed. 
Results: Univariate analysis revealed that patients with BMEP showed longer 
maximum length (p<0.001), higher protrusion percent (p<0.001), and lower AHI 
(p<0.001) than those without BMEP. Multivariate logistic regression analysis 
revealed that patients with BMEP were more likely to show larger accessory 
navicular bones (odds ratio, 1.695; 95% confidence interval [CI]: 1.130, 2.544; 
p=0.011) and lower AHI (odds ratio, 0.759; 95% CI: 0.619, 0.930; p=0.008) 
than those without BMEP. The area under the receiver operating characteristic 
curve was 0.922. 
Conclusion: Patients with accessory navicular bone with BMEP have larger 
accessory navicular bones and are more likely to have flat feet than those 
without BMEP. This information can be an objective basis for therapeutic 
strategy.  
Author Disclosures: 
 H. Sakahara: Grant Recipient; Bayer Yakuhin, Ltd, DAIICHI SANKYO 
COMPANY, LIMITED, Eisai Co., Ltd, FUJIFILM RI Phrma Co., Ltd, Nihon 
Medi-Pysics Co., Ltd, KONICA MINOLTA JAPAN. INc, Hamamatsu Photonics 
k.k.. 
  






B-0721 14:16  
Detection of kinematic changes induced by sequential lateral ankle 
ligament section: a dynamic 4D-CT scan study  
L. Buzzatti, B. Keelson, J. Apperloo, N. Buls, T. Scheerlinck, G. Van Gompel, 
J.P. Baeyens, J. De Mey, E. Cattrysse; Brussels/BE 
(Luca.Buzzatti@vub.ac.be)  
Purpose: To investigate the potential of 4D-CT to detect kinematic changes 
induced by sequential lateral ankle ligament section. 
Methods and Materials: The tibia of two fresh frozen specimens were fixed on 
a custom-made device and the ankle joint was moved at a pace of 25 
cycles/minute. The anterior talo-fibular ligament, the calcaneo-fibular ligament 
and the posterior talo-fibular ligament were cut sequentially. Dynamic-CT scan 
image datasets of the intact ankle and after each ligament cut were acquired 
with a 256-slice GE Revolution CT-Scanner (80kV, 25mA, tube rotation time 
0.28s, z-axis coverage 120mm, scanning time 3.92s). Rigid registrations of 
single bones (tibia, talus and calcaneus) were performed and transformation 
matrixes were derived. Using the global reference frame of the CT (x, y, z), the 
talo-crural (motion of talus relative to the tibia) and sub-talar (motion of 
calcaneus relative to the talus) joint kinematics were described as 
displacement of the centroid of the talus and calcaneus, respectively. Radiation 
dose was also recorded. 
Results: The difference between the displacement of the intact ankle and the 
cut scenarios was up to 2.90mm, 1.19mm, 1.37mm (sub-talar joint) and up to 
2.63mm, 2.58mm, 5.46mm (talo-crural joint) for the x-, y-, z-axes, respectively. 
Comparing the intact and injured ankle, deflections in the centroid 
displacement curves occurred at different time points. Each acquisition 
required a radiation dose (CTDIvol) of 1.9mGy. 
Conclusion: The present study showed that low-dose 4D-CT may allow to 
detect motion changes of the talo-crural and sub-talar joint induced by lateral 
ankle ligament lesions. This highlights the potential of 4D-CT to investigate 
dynamic functional joint laxity.  
B-0722 14:24  
Value of b-mode ultrasonography and real time sonoelastography for 
detecting injury of the lateral ligaments of the ankle joints  
A. Karadayi, T. Ozer, N. Voyvoda, B. Fariz; Kocaeli/TR 
(aysegulkaradayi@hotmail.com)  
Purpose: We aimed to demonstrate the effectiveness of Ultrasound 
Elastography(USE) in lateral collateral ligament (LCL) injury due to recurrent 
ankle sprain, to compare with LCL elastography findings of healthy individuals. 
Methods and Materials: A total of 108 ankles in 54 patients with a clinical 
suspicion of ankle ligament injury and total of 60 ankles in 30 healthy 
volunteers were included. The LCL including ATFL, CFL, PTFL were divided 
into the following thirds for images evaluation: proximal, middle and distal. 
Longitudinal images of each tendon were obtained using ultrasonography (US) 
and USE. Each tendon were evaluated in four grades and measured for length 
and thickness in US images. USE images were evaluated in four grades for 
elasticity pattern, strain ratios(SR). 
Results: The ATFL lengths were shorter in the patient group than the control 
group (p<0.05). The grades of ATFL, CFL, PTFL were found to increase in the 
patient group than the control group based on US findings (p<0,05). The 
elastogram types of ATFL and CFL were different from the control group 
(p<0.001). In the patient group, the values of SR and mean SR values for 
ATFL and CFL were found to be significantly lower than the control group 
(p<0.001) 
Conclusion: US can be used as an effective non-invasive diagnostic method 
to demonstrate LCL injuries resulting from recurrent sprains of the ankle in 
active athletes. The USE examination is also a valuable US-based diagnostic 
method which can show alterations in the ligament structures during recurrent 
traumas of LCL in the asymptomatic period  
B-0724 14:32  
Subtalar instability and lateral ankle instability: the difference with 
emphasis on subtalar ligaments using 3-D isotropic MRI  
D. Yoon, S. Moon; Seoul/KR (ydy0222@gmail.com)  
Purpose: To investigate, using 3-D isotropic MRI, the difference between 
subtalar instability (STI) and lateral ankle instability (LAI) with emphasis on 
subtalar ligaments. 
Methods and Materials: Preoperative MRIs of 10 patients with STI treated 
with arthroscopic subtalar reconstruction were compared with MRIs of 23 
patients with LAI only. The thickness and width of the anterior capsular 
ligament (ACL), interosseous talocalcaneal ligament (ITCL), thickness of 
calcaneofibular ligament (CFL) and anterior talofibular ligament (ATFL) were 
measured (Mann-Whitney test). Abnormalities in the ACL, ITCL, CFL, ATFL, 
cervical ligament and inferior extensor retinaculum were analysed by two 
radiologists. 
Results: Patients with STI had a significantly smaller ACL thickness (1.48mm 
vs 2.12mm in LAI; p=0.012) and smaller ACL width (7.30mm vs 8.64mm in LAI; 
p=0.007) compared with those with LAI. The ACL thickness of 1.8 mm had 
sensitivity of 80.0% and specificity of 75.0% and the ACL width of 8 mm had a 
sensitivity of 80.0% and a specificity of 85.0% for discriminating STI from LAI. 
The thickness of ATFL was significantly larger in patients with LAI (p=0.001). 
Absence or complete tear of ACL was more common in patients with STI 
(60.0% vs 13.0% in LAI; p=0.010). Complete tear of ATFL was more common 
in patients with LAI (60.9% vs 10.0% in STI; p=0.008). 
Conclusion: Thin or narrow ACL in the tarsal sinus are suggestive of STI 
rather than LAI. Absence or complete tear of ACL was more common in 
patients with STI. Complete tear of ATFL is more common in patient with LAI.  
B-0725 14:40  
Usefulness of T2 mapping sequences for the evaluation of Achilles 
tendinopathy with 3T MRI  
E. Cannizzaro, S. Quarchioni, F. Bruno, C. Gianneramo, S. Mariani, 
F. Arrigoni, L. Zugaro, A. Barile, C. Masciocchi; L'Aquila/IT 
(estercannizzaro@hotmail.it)  
Purpose: To investigate the capability of T2 mapping sequences on a 3T 
scanner in evaluating quantitatively Achilles tendon (AT) composition. 
Methods and Materials: 13 patients (8 male, 5 female, mean age 34.7 years, 
range 24-61) with clinical and instrumental evidence of tendinopathy of the AT 
and 13 healthy volunteers (9 male, 4 female, mean age 36.4 years, range 26-
59) were examined on a 3T MR scanner with standard morphological and T2 
mapping sequences. The AT was divided into 3 clinically relevant subregions: 
insertion (INS), midportion (MID) and muscle-tendon junction (MTJ).Regions of 
interest (ROI) were used for quantitative assessment and mean values of T2 
relaxation times were recorded. 
Results: In asymptomatic volunteers, we obtained mean T2 values of 42.27ms 
at the insertional area, 36.24ms in the midportion and 45.91ms at the muscle-
tendon junction. In patients with low-grade tendinopathy the mean T2 values 
were: 45.8 at the MTJ, 54.86 at the MID, 44.90 at the INS, with statistically 
significant higher values in the midportion compared to the matched healty 
controls (p<0.05). In patients with high grade tendinopathy mean T2 values 
were significantly lower than the control group in all subregions: 25.90 at the 
MTJ, 16.56 at the MID, 23.85 at the INS (p<0.05). 
Conclusion: Our study provides normal T2 values for asymptomatic AT and 
T2 values changes in degenerated tendons. These reference values can be 
used for comparison in order to diagnose subtle degeneration and can be a 
reliable tool to monitor treatment related tendon healing.  
B-0726 14:48  
Importance of sonoelastographic assessment of ruptured and 
contralateral achilles tendons - prevention of further injuries  
I. Dumic Cule, G. Ivanac, D. Lemac, B. Brkljacic; Zagreb/HR 
(ivodc1@gmail.com)  
Purpose: The concept of assessing the mechanical properties of the Achilles 
tendon after reconstruction using ultrasound shear wave elastography (SWE) 
and its positive correlation with standardised questionnaires has been recently 
introduced in the clinical practice. Since it was demonstrated that about 6% of 
patients with ruptured Achilles tendon experience the rupture of contralateral 
tendon in the future, the aim of this study was to estimate the risk for rupture of 
contralateral tendon in patients who underwent surgical reconstruction of 
ruptured Achilles tendon by using subjective questionnaires and ultrasound 
SWE. 
Methods and Materials: Twenty-four patients who underwent surgical repair 
of the ruptured achilles tendon and twelve aged matched healthy controls were 
examined with ultrasound SWE. Functional outcomes were assessed with 
American Orthopedic Foot and Ankle Society (AOFAS) scoring system and 
subjective rating system which we introduced and validated. 
Results: The elasticity of injured tendon was markedly decreased (by 42%) 
compared to contralateral tendon of the patient, as expected. Both AOFAS 
score and our novel subjective assessment scale positively correlate with 
ultrasound SWE values in ruptured Achilles tendons. The elasticity of 
contralateral Achilles tendons in patients is 23% lower than among healthy 
individuals. 
Conclusion: Irrespective of the lack of difference in the subjective feeling 
assessed by AOFAS, the contralateral tendon in the patients with 
reconstructed Achilles tendon has significantly lower elasticity than healthy 
individuals. Therefore, contralateral tendons in patients who suffered from 














MRI T2 mapping: a sensitive and reliable approach to examine changes in 
muscle metabolism of extrinsic foot muscles  
G. Bratke, S. Willwacher, K. Weiss, D. Maintz, G.-P. Brüggemann; Cologne/DE 
(grischa.bratke@uk-koeln.de)  
Purpose: The aim of the study was to examine the sensitivity and reliability of 
T2 mapping demonstrating changes in metabolism of the extrinsic foot muscles 
through experimentally varied foot and ankle biomechanics in running. 
Methods and Materials: Twelve volunteers completed three 75-min treadmill 
running sessions at constant speed in a neutral shoe (NS) and two 
experimental shoes. Experimental shoe 1 (ESm) has posts on the medial 
aspect of the midsole increasing the stiffness to control the foot eversion and 
moves the point of ground reaction force application (PFA) medially. Shoe 2 
has posts on the lateral border and shifts the PFA laterally. T2 mapping was 
taken with a Carr-Purcell-Meiboom-Gill-sequence on a 3T Philips Ingenia 
Scanner before the run, after 2.5, 45 and 75 minutes. ANOVA was applied to 
identify differences related to the biomechanical intervention and the duration 
of exercise. 
Results: For all muscles, T2 mapping identified a significant increase in T2 
times after 2.5 min (p<0.001) and a decrease after 45 and 75 min (p<0.001). 
ANOVA showed a significant smaller increase in T2 times for the NS compared 
to ESm in the lateral and medial (MG) head of the gastrocnemius muscle, 
soleus, extensor digitorum longus and peroneus (e.g. MG: NS +13.17%; ESm 
+15.27% (P<0.001)). 
Conclusion: T2 mapping documents sensitively experimentally induced 
changes in foot and ankle biomechanics during running and related muscle 
activation with higher spatial resolution than surface electromyography. The 
decrease of T2 times might be a correlate of an earlier described intramuscular 
lactate decrease during prolonged exercise.  
Author Disclosures: 
 K. Weiss: Employee; Philips. 
B-0728 15:04  
Diabetic foot complicated by osteomyelitis: the role of multiparametric 
magnetic resonance tomography  
M. Zamyshevskaya, V. Zavadovskaia, M. Zorkaltsev, V. Udodov, E. Grigoriev; 
Tomsk/RU (Zamyshevskayamari@mail.ru)  
Purpose: To evaluate the possibilities of multiparametric magnetic resonance 
imaging for the identification of osteomyelitis (OM) in the diabetic foot (DF). 
Methods and Materials: 90 patients (51 male (56.7%), 39 female (43.3%); 
mean age 56.43±13.20) with suspected diabetic foot bone infections were 
studied. MRI was performed by using the Siemens MAGNETOM Essenza MRI-
scanner (1.5T) in the T1, T2, FSat. After native images, MR angiography with 
contrast enhance was performed (Gadobutrol, 15ml). Delayed post-contrast 
MR study was performed in T1-SE. 
Results: Pyoinflammatory processes in patients with diabetic foot syndrome 
according to CE MRA were associated not only with accelerated contrast travel 
time (26.04±8.03s), but in ischemic form of complicated DF - with delayed 
contrast travel time (38.20±6.47s), other features were early venous 
visualisation because of arteriovenous shunting, long-time local increase of the 
contrast accumulation in the area of interest. Osteomyelitis in patients with 
diabetic foot syndrome characterised by junction ulcer/fistula to the bone with 
increased marrow signal in T2 and FSat for native MRI followed by the 
appearance of constant local increased contrast accumulation in the soft tissue 
area of interest in conjunction with the long-term increase of bone marrow 
signal for postcontrast MRI. 
Conclusion: Multiparametric MRI is informative diagnostic method in 
diagnostics of osteomyelitis in the diabetic foot, because complex 
morphofunctional vascular assessment in combination with bone inflammatory 
process detection should help to decrease amputations and volume of the 
resected fragment.  
B-0729 15:12  
T2 mapping of Achilles tendinopathy: our experience using T2 mapping 
sequences in the diagnosis and evaluation of treatment response after 
PRP therapy  
I. Capretti1, F. Bruno1, S. Quarchioni2, P. Palumbo1, S. Mariani1, F. Arrigoni1, 
L. Zugaro1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2Teramo/IT 
(ilaria_capretti@hotmail.it)  
Purpose: To evaluate the capability of T2 mapping in evaluating 
semiquantitatively changes in Achilles tendon after PRP treatment. 
Methods and Materials: We evaluated 15 patients (10 males and 5 females 
with mean age of 35.2 years, range 26-51) with Achilles tendinopathy at 
different degrees (mild-intermediate, 7 patients, group A ; moderate-severe 8 
patients, group B). All patients were treated with US-guided intratendinous 
injection of Platelet-Rich Plasma (PRP). They were examined on a 3T MR 
scanner with standard morphological and T2 mapping sequences before and 
after six months from treatment. 
Results: In patients with mild-intermediate grade tendinopathy the mean T2 
values before treatment were: 46.2 at the muscle-tendon junction(MTJ), 53.70 
at the midportion(MID), 42.70 at the insertion(INS), with statistically significant 
higher values in the midportion compared to the matched healty controls 
(p<0.05). After six months to treatment with PRP they showed an improvement 
of T2 values in midportions similar to normal values (36,24 ms). In patients with 
moderate-severe grade tendinopathy mean T2 values were significantly lower 
than the control group in all subregions: 23.94 at the MTJ, 15.10 at the MID, 
20.50 at the INS (p<0.05) and after six months they didn’t show significant 
variations of T2 values. 
Conclusion: According to our preliminary results, T2 mapping shows an high 
capability to assess and follow-up Achilles tendon pathologies togheter with 
other standard morphologic sequences and is usefullness in predict Achilles 
tendon changes after PRP therapy.  
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B-0730 14:00  
Automatic computation of liver and lung perfusion parameters through 
the analysis of CT image sequences  
S. Malavasi1, G. Gavelli2, V. Vilgrain3, A. Bevilacqua1; 1Bologna/IT, 2Meldola/IT, 
3
Clichy/FR (s.malavasi@unibo.it)  
Purpose: The goal of this PhD thesis work is contributing to advance 
Computed Tomography perfusion (CTp) towards standardization by improving 
the accuracy of perfusion results(1), the clinical relevance of studies where 
global perfusion parameters are commonly utilised(2) and the reproducibility of 
results in multicentre studies(3). 
Methods and Materials: 315 liver CTp examinations from 14 Centres and 34 
lung CTp studies were considered. First, through a voxel-based analysis of the 
time-concentration curves, an error index capable to measure the quality of 
perfusion results was set up and validated. Thereafter, an adaptive algorithm 
exploiting that error index was developed to automatically detect on CTp maps 
misleading perfusion values (1). Then, a measure of tumour functional 
heterogeneity was conceived(2). Finally, data pertaining to a large multicentre 
study on liver CTp (PIXEL) were analysed to also investigate the effects of the 
sources of protocol heterogeneity(3). 
Results: The algorithm developed was correctly able to identify and exclude 
from the analysis vessels, bronchi, and artefacts, allowing to improve perfusion 
results reliability(1). Global values cannot take into account haemodynamic 
heterogeneity proving to even mislead clinical considerations(2). Tentative 
guidelines were provided to help planning protocols(3). 
Conclusion: Reliability of results improved by detecting and removing 
unreliable CTp values. A measure of functional heterogeneity must be provided 
together with mean perfusion values to improve the clinical representativeness 
of the studies. In conclusion, the automatic methods implemented and the 
tentative guidelines for multicentre studies represent a clear step forwards to 
CTp translation in the standard clinic.  
B-0731 14:08  
Use of calcium chloride as a calibration phantom material to aid 
identification of clinically significant compounds with spectral CT  
T.E. Kirkbride, N. Anderson, A.Y. Raja; Christchurch/NZ 
(tracy.kirkbride@ara.ac.nz)  
Purpose: Material identification using spectral CT relies on scanning known 
concentrations of compounds of interest to enable calibration of the material 
decomposition software for spectral photon-counting CT (SPCCT). Clinically 
significant compounds, such as calcium hydroxyapatite (HAP), do not dissolve 
well and preparation requires creating a suspension, which may not be 
spatially stable. We show that calcium chloride can be used as a substitute for 
such compounds during this procedure, by comparing these solutions with 
commercial solid HAP rods, the advantage of the rods being the stable and 
uniform distribution of HAP. 
Methods and Materials: A range of serially diluted concentrations of calcium 
chloride and commercially available solid inserts of HAP, with CT water as 
base material, were used. High-resolution images of the samples were 
generated using a preclinical MARS SPCCT scanner equipped with the 
Medipix3RX photon processing detector bonded to cadmium-zinc-telluride. 
  






Images of the calibration phantom were obtained using energy thresholds 20, 
30, 40 and 50 keV at 80 kVp. Theoretical attenuation coefficients of HAP and 
calcium chloride were used to determine the effective HAP concentration of the 
calcium chloride samples. This information, along with the MARS SPCCT 
signals from the calcium chloride, was used to calibrate the system. 
Results: Concentrations of calcium chloride whose attenuation profile matches 
that of HAP have been determined. MARS SPCCT data from HAP rods shows 
calcium chloride can be used to substitute HAP. 
Conclusion: Substitution of soluble compounds for insoluble compounds 
within a calibration phantom for spectral CT is possible, potentially improving 
material identification.  
Author Disclosures: 
 N. Anderson: Research/Grant Support; Supported in part by project grant 
PROJ-13860-NMTS-UOC from the New Zealand Foundation for Research, 
Science, and Technology.. Shareholder; N. G. Anderson holds shares of 
MARS Bioimaging Ltd. A.Y. Raja: Research/Grant Support; Supported in part 
by project grant PROJ-13860-NMTS-UOC from the New Zealand Foundation 
for Research, Science, and Technology.. 
B-0732 14:16  
The effect of motion blur and noise on the precision and accuracy of 
wrist joint kinematics detection from 4D-CT scans  
G.J. Streekstra, M. de Roo, S.D. Strackee, I. Dobbe; Amsterdam/NL 
(g.j.streekstra@amc.uva.nl)  
Purpose: Recent developments in 4D CT acquisition techniques enable 
detection of kinematics of carpal bones in the wrist joint. Detection of carpal 
kinematics requires the patient to move the wrist, while multiple 3D CT scans 
are acquired. If the wrist motion is too fast, time frames in the 4D image 
sequence will become blurry and therefore, may become unusable for 
kinematics detection. We investigated the impact of motion blur and noise on 
kinematics estimates from 4D-CT images. 
Methods and Materials: 4D CT images were acquired of a phantom 
representing a wrist joint, while moving with known rotational speed. For this 
purpose we used a dedicated 4D scan protocol on a regular Philips Brilliance 
64 slice CT scanner. The wrist phantom was created by segmenting a wrists' 
anatomy from a CT-scan and subsequent 3D printing by additive 
manufacturing. Joint kinematics was estimated by 4D image analysis methods 
involving segmentation of wrist bones from a static CT scan and image 
registration of the segmented bones to the time frames in the 4D scan. 
Results: The experiments reveal that, within a physiological range of carpal 
bone velocities, the accuracy of joint kinematics estimation are in the order of 1 
degree for rotational and 0.2 mm for translational parameters. Systematic 
errors in kinematical parameters increase slightly with rotational speed. 
 
Conclusion: The limited influence of wrist joint motion on kinematic 
parameters ensures sufficiently accurate estimation of carpal bone kinematics 
with regular 64 slice 4D CT scanners in patients.  
B-0733 14:24  
Context-sensitive organ-specific evaluation and analysis of dual-energy 
computed tomography (DECT)  
S. Dorn1, S. Chen2, F. Pisana1, M. Özdemir1, J. Maier1, S. Sawall1, M. Knaup1, 
A. Maier2, M. Lell3, M. Kachelrieß1; 1Heidelberg/DE, 2Erlangen/DE, 
3
Nürnberg/DE (marc.kachelriess@dkfz.de)  
Purpose: To combine various organ-dependent dual energy evaluation 
methods into an automatic and standardized analysis tool to facilitate 
radiologists' workflow. 
Methods and Materials: There are many commercial DECT applications, 
which provide a multitude of information about the tissue type, material 
composition or function. However, all applications automatically process the 
entire dataset and the user needs to invoke each one separately. The 
proposed method automates and standardizes the DE applications using prior 
anatomical information. By means of a 3D convolutional neural network, the 
DECT data are classified into different organs. The ROIs that are required for 
patient-specific calibration of the algorithms can now be placed automatically 
into the corresponding anatomical structures and the applications are 
automatically selected and only applied to the specific organs. This context-
sensitive analysis allows to simultaneously evaluate multiple organs and to 
show organ-specific dual energy overlays wherever appropriate. 
Results: Ten contrast-enhanced DECT patient datasets are processed. The 
data are acquired with a dual source CT system. We are able to automate and 
standardize the spectral analysis of the DE data using prior anatomical 
information. Each tissue type is evaluated with its corresponding DE 
application simultaneously. The results are identical with those obtained by a 
user who manually calibrated, selected and applied the applications to various 
organs. 
Conclusion: The proposed method is an important step towards the 
presentation of evermore increasingly complex information in spectral CT and 
towards improving the radiologists' workflow significantly. The method can 
readily be generalized to the automatic evaluation of multi energy CT data.  
B-0734 14:32  
Deep convolutional neural network (D-CNN) for efficient and automatic 
lung cancer detection  
I. Shiri, P. Geramifar, A. Bitarafan-Rajabi, A. Mohammadzadeh, 
H. Pouraliakbar; Tehran/IR (Isaac.sh92@gmail.com)  
Purpose: Lung cancer is one of the most widely cause of cancer death in the 
world. One of the most challenging task is the early detection of lung cancer in 
full 3D CT-Scans. In this study we present a deep learning framework for 
efficient and fully automated lung cancer detection in 3D CT-Scan images. 
Methods and Materials: 750 CT scan of patients (430 non-cancers and 320 
cancerous) from KDSB17 were used in this study. Image preprocessing such 
as variance reduction image re-sampling to an isomorphic resolution , Lung 
segmentation, Normalization, and Zero centering in order to reduce the 
problem of space were performed. The 3D Convolution layers perform 3×3×3 
convolutions with stride 1×1×1 and no padding, and of 3D Pool layers perform 
with 2×2×2 max pooling with stride 2×2×2 (and no padding). ReLU function 
was used as activation functions, and soft-max layer was applied for binary 
classification of cancerous and noncancerous patient. 
Results: The 3D deep convolutional neural network were performed on 
different iterations and epochs and the best accuracy of D-CNN was reached 
to 69.7 percent. 
Conclusion: Accuracy of model was acceptable at CAD study, however the 
radiologist needs more detailed information than just one single series of CT 
scan for diagnosis (e.g., time series of CT scan over a few month, biopsy 
information, and metabolic imaging). Deep learning model need to use more 
data-set and also more information than just one single series of CT scan to 
improve its performance and reaching human observer level.  
B-0735 14:40  
A noise-robust and accurate measurement method for the wall thickness 
of small airways in low-dose CT scans  
Z. Yang1, H. Jin1, J. Kim1,2; 1Suwon/KR, 2Seoul/KR (yangzepa@snu.ac.kr)  
Purpose: Small airway dimensions are important biomarkers for evaluation of 
pulmonary diseases, such as asthma, COPD, etc. We present a novel method, 
attenuation profile matching (APM) technique, which provides accurate 
determination of small airway dimension as well as robustness to CT scan 
parameters. 
Methods and Materials: The point spread functions of a CT were acquired 
and employed for generating synthetic attenuation profiles of an airway by 
taking convolution with the numerical airway models of varying wall thickness. 
Dimensions of a given airway were determined as those of the numerical 
model yielding minimum error between the measured and synthetic attenuation 
profiles across the airway. 
Results: In a phantom study with airway tubes, proposed method was shown 
to be highly accurate in determining airway dimension. The measurement error 
for the 0.6 mm thick tube with 3 mm diameter was as small as 0.02 mm (3.3%) 
in wall thickness and 0.17 mm (5.6%) in lumen diameter. And for the wall 
thickness, error for the smallest (0.6 mm thick) tube was 0.02 mm (3.3%). In a 
pilot patient study, the proposed method could distinguish the airway thickness 
of COPD cases (1.16 ± 0.23 mm) from that of normal subjects (0.6 ± 0.18 mm) 
while the measurements with FWHM substantially overlapped (1.45 ± 0.32 mm 
vs. 1.28 ± 0.30 mm) and thus hardly be distinguished each other. 
Conclusion: Our proposed APM technique has a potential to overcome the 
resolution limitations of current CT systems and determine the small airway 
dimensions of COPD patients accurately.  
B-0736 14:48  
Real-time x-ray scatter estimation for CT and CBCT using a deep 
convolutional neural network  
J. Maier, S. Sawall, M. Kachelrieß; Heidelberg/DE (marc.kachelriess@dkfz.de)  
Purpose: Scatter correction is crucial to maintain the diagnostic value and to 
obtain quantitative images in CT and CBCT. Current scatter correction 
approaches are either too inaccurate or too slow. Therefore, we developed the 
deep scatter estimation (DSE) algorithm: a deep convolutional neural network 
to derive accurate scatter estimates in real-time. 
Methods and Materials: The gold standard of scatter correction is to subtract 
a scatter estimate derived by a Monte Carlo (MC) photon transport code. 
However, being computationally expensive, MC simulations cannot be used 
routinely. To combine high accuracy and real-time applicability, DSE uses a 
modified U-net that is trained to reproduce the outcome of MC simulations 
based on the acquired projection data. This study demonstrates the potential of 
DSE using simulations and measurements of an experimental CBCT system. 
Two conventional computationally efficient scatter estimation approaches were 
implemented as reference: A kernel based scatter estimation (KSE) and the 
hybrid scatter estimation (HSE). 
  






Results: The mean absolute error (MAE) between MC and KSE, HSE and 
DSE was used as a performance measure. Considering the simulated data, we 
observe a MAE of 14.1 % (KSE), 7.2 % (HSE) and 1.1 % (DSE). Similar results 
are obtained for measured data with a MEA of 16.7 % (KSE), 7.8 % (HSE) and 
2.8 % (DSE). 
Conclusion: DSE clearly outperforms conventional scatter estimation 
approaches in terms of accuracy while requiring similar processing time. DSE 
performs nearly as accurate as Monte Carlo simulations but is superior in 
terms of speed by orders of magnitude.  
B-0737 14:56  
An innovative MRI harmonization method for multicentre radiomic 
analysis in glioblastoma  
S. Reuzé1, A.-S. Dirand1, R. Sun1, F. Orlhac2, G. Louvel1, S. Ammari1, 
E. Deutsch1, c. robert1; 1Villejuif/FR, 2Orsay/FR 
(sylvain.reuze@gustaveroussy.fr)  
Purpose: MR-based radiomic features show a great correlation with tumour 
heterogeneity and treatment outcome, but also a strong dependence on 
acquisition parameters. 
Methods and Materials: 190 glioblastoma patients with multicentre T1-Gd 
MRI were retrospectively included. Two spheres were delineated in the white 
matter (WM). Tumour (GTV) was manually segmented. Post-processing was 
performed as follows: an intensity rescaling to [0−32767] to erase inter-patient 
differences in intensity range, then a resampling on a 0.5x0.5x0.5mm3 grid. 39 
radiomic features were extracted using LIFEx freeware. Wilcoxon analysis was 
performed between sets of feature values in WM to assess the robustness of 
features among different scanners. Different methods of discretization were 
investigated in GTV: relative (RD) or absolute (AD) with 32−256 levels. 
Spearman correlation coefficients  were computed in GTV between all 
features, and between each feature and tumour volume. 
Results: Histogram characteristics extracted from WM highlighted a large 
scanner dependence (p<0.05). RD (32 or 64 bins) limited this dependence for 
textural features. Only two histogram features were robust among all devices, 
whereas 7 histogram and 7 textural features were robust depending on 
magnetic field strength (p>0.05). After postprocessing, RD highlighted 
correlations between features and tumour volume (||>0.5, 8 features). AD 
decreased these correlations and reduced the dependence of features 
between devices. For 25 couples of devices, there were at least 25 robust 
features, and 11 textural features were robust among magnetic field strength 
(p>0.05). 
Conclusion: We proposed a simple and innovative MRI harmonization method 
which showed promising results on a large multicentre cohort.  
B-0738 15:04  
ROI-based phase analysis for neuronal current MRI  
T. Yoneda, M. Iwata, H. Indo, N. Kurehana, S. Yoshinaga, M. Takeda, 
H. Terasawa; Kumamoto/JP (tyoneda@kumamoto-u.ac.jp)  
Purpose: Functional MRI (fMRI) using BOLD effect is noninvasive tool for 
study of neuro activation in various areas. In this twenty years, alternative 
principle of BOLD was suggested so called Neuronal Current MRI (ncMRI). 
The ncMRI is designed so as to directly detect neuronal current on MRI. This 
study suggested an ROI-based analysis approach to sensitively detect 
neuronal current via MR-phase information. 
Methods and Materials: We prepared axon imitated phantom in which 
cellophane tube with 1 mm diameter as axon was located. Potassium and 
Sodium were doped in the 20 %/w gelatin and it was filled in the phantom to 
realise source of neuronal current. The neuronal current (5 uA) was induced by 
alternative voltage with 40 Hz. MRI scan were carried out on 7T-MRI (BioSpec 
20/70 USR, Bruker BioSpin, Germany) with FLASH sequence with solenoid 
transmit-receiver coil. All MR-images were acquired a plane perpendicular to 
long axis of axon. Phase image was derived in DICOM format and unwrapped 
by high-pass filter to remove unwanted phase bias. Phase around the axon 
was measured by setting circular ring ROI and phase signal was statistically 
evaluated by student’s-t test between current on and off. 
Results: Statistics showed significant difference (p < 0.05) when the charge 
carried by current during scan was larger than 100 nC, but no significant 
difference less than 50 nC. 
Conclusion: The ncMRI with phase information could detect very small but 
biologically reasonable current. Our study showed limit of sensitivity depended 








B-0739 15:12  
MRI delta-radiomics feature robustness and reproducibility: the impact of 
image registration and day-to-day repeat-ability in GBM cancer patient  
I. Shiri, G. Hajianfar, H. Abdollahi, S. Shayesteh, h. pouraliakbar, 
A. Bitarafan-Rajabi, A. Mohammadzadeh, P. Geramifar; Tehran/IR 
(Isaac.sh92@gmail.com)  
Purpose: Delta-radiomics features can be used as prognostic models during 
therapy courses and time series data analysis. As the image registration is one 
of the main process in time series and multi-modality image analysis, the 
purpose of this study is investigate the impact of image registration on delta 
radiomics features. 
Methods and Materials: Ten patients’ data with recurrent GBM who 
underwent brain MRI were used in this study. T2w, T1w Images were 
registered by different methods including, Full affine (12 DOF), Full scale (9 
DOF), Global scale (7 DOF) and Rigid body (6 DOF). Following image 
registration, GBM lesions were segmented and delineated using semi-
automatic 3D region growing algorithms. 94 quantitative 3D features were 
extracted from each lesion, corresponding to size, shape, Intensity histogram 
and textural feature. All radiomics features were categorised into 3 groups 
based on coefficient of variation (COV) including a small (COV 10%), 
intermediate (10 % < COV 25%) and large (COV >25%) range of variation 
with respect to the mean. 
Results: All shape features such as compactness, elongation and spherical 
disproportion and 71 (73%) features have good reproducibility. Eleven 
intermediate reproducibility and 14 remain features including difference 
entropy, entropy, difference variance, cluster shade, cluster prominence, 
inverse variance from GLCM and GLV from GLRLM, and Entropy from 
intensity have low reproducibility. 
Conclusion: Delta-radiomics feature robustness and reproducibility in brain 
MRI due to image registration is feature-dependent. Delta-radiomics features 
with low COV are better candidates for robust tumour quantification in time 
series data analysis and clinical practice.  
B-0740 15:20  
Wavelet-based radiomics texture features stability in MRI of GBM 
patients: a test-retest study  
I. Shiri, G. Hajianfar, S. Shayesteh, H. Abdollahi, H.R. Pouraliakbar, 
A. Bitarafan-Rajabi, A. Mohammadzadeh, P. Geramifar, A. Sanaat; Tehran/IR 
(amir.sanaat@gmail.com)  
Purpose: Radiomics texture features have been recently introduced as 
quantitative image bio-markers which can be used potentially for diagnosis, 
prognosis and prediction of response to therapy in cancer patient. One of 
major challenges in this era is validity of this quantitative parameters. The main 
aim of current study was to evaluate stability of radiomics features in test retest 
study. 
Methods and Materials: Fifteen patients with recurrent GBM who underwent 
repeated MR imaging with approximately two day interval were included to 
current study. All lesions were segmented to whole tumor, necrosis area and 
active tumor area. Following wavelet decompositions of image, eight images 
were derived. Following segmentation and decompositions of images, 632 
quantitative 3D textures based on GLRLM, GLCM and GLSZM, were extracted 
from the 3D-tumor volumes of each segmentation. For every radiomics feature, 
test-retest was assessed with the intra-class correlation coefficient (ICC) and 
the concordance correlation coefficient (CCC) and finally the most reproducible 
and robust radiomics features were selected. 
Results: 455 texture feature (71%) such as GLNUN from HHH_glrlm and 
Entropy from HHH_glcm had good reproducibility. 114 texture features (18%) 
had intermediate reproducibility and remain (11% ) such as Autocorrelation 
from LLH_glcm, from LLH_glszm and Cluster Shade from LLL_glcm. 
Conclusion: Test-retest and correlation analyses have identified redundant 
radiomics wavelet based textures which would be prone to errors if they 
employed as quantitative biomarker for GBM image analysis. Using 
reproducible texture warranted more advanced applications of this quantitative 
parameters as being used for treatment monitoring, outcome prediction or 
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B-0741 14:00  
Relationships between image quality and radiation dose during paediatric 
pelvis radiography: a factorial phantom study  
A.H. Mohammed Ali1, P.H. Hogg1, A. England2; 1Salford/UK, 2Manchester/UK 
(p.hogg.@salford.ac.uk)  
Purpose: Paediatric pelvic radiography exposure factor selection is difficult 
due to age/size variations; this study evaluates image quality and dose for a 
range of acquisition parameters. 
Methods and Materials: 2,016 DR images were acquired using a 5-year-old 
pelvis phantom. Acquisition parameters included: KVp (56-89, 3 kVp 
increments), mAs (1-16, 1 or 2 mAs increments), SID (100, 115, 130 and 145 
cm) and filtration (0, 2 mm Al and 1mm Al + 0.1 mm Cu). Image quality (IQ) 
was assessed using physical and visual methods. Physical included SNR and 
CNR. Visual involved observers scoring sharpness and noise. Entrance 
surface dose was measured. Regression and main effect plots were 
conducted. 
Results: Adjusted (R2) was 0.76 for radiation dose; range = 0.31-0.78 for IQ. 
Increasing additional filtration had the greatest impact decreasing IQ (physical 
=-6.72 and visual =-1.13) and radiation dose (=-50.0). mAs increased 
radiation dose (=17.32) and IQ (physical =0.63, visual =17.32). Elevating 
KVp increases radiation dose (=4.92); initially it increases IQ, then it reduces 
(physical =-0.15, visual =0.49). As SID increases dose reduces (=-2.60) 
and IQ remained unchanged (physical =-0.80, visual =-0.09). Main effect 
plots for each exposure parameter showed different relationships when 
compared to others: either linear, or non-linear, with plateauing. SID=115cm 
produced the highest levels of image sharpness. 
Conclusion: Paediatric optimisation studies should consider a full factorial 
design to identify the impact of all acquisition parameters. Increasing KVp 
whilst reducing mAs produces lower dose and maintains IQ, but only for 
specific levels of filtration and SID.  
B-0742 14:08  
PA vs AP positioning in digital radiography of lumbar spine: the impact 
of kVp in large-sized patient image quality  
E.Y. Boateng1,2, H.K. Shariati1, R.K. Sharma2, A. Sanderud2; 1Kongsvinger/NO, 
2
Oslo/NO (emmboa@ous-hf.no)  
Purpose: Investigate differences in lumbar spine radiography when changing 
from AP to PA projection and impact of a large patient size and kVp. 
Methods and Materials: The radiography was performed at a Canon Triathlon 
T3 with CXDI 401C detector using AEC with 100mAs cut-off, 50-100kVp to 
image a RS-113 pelvis phantom. Without modifications, the phantom had a 32-
inch waistline. By adding 4 kg ox fat at the stomach region, and 1 kg on the 
back and buttock of the phantom, a large patient with a 44-inch waistline was 
simulated. With 10 observers, an absolute visual grading analysis (VGA) study 
using a 5-point Likert scale was performed to assess the images in sharpness, 
noise, and overall diagnostic quality. Effective dose was calculated using 
PCXMC. 
Results: The VGA-study showed no significant difference between the image 
quality in AP and PA (p = 0.084). The best average VGA scores, AP=4.6 and 
PA=4.4, were at 70 kVp for the standard-sized images while effective dose was 
calculated to be reduced by 64% when changing from AP to PA projection. 
With the large-sized phantom the 80kVp had the best VGA scores, AP=3.8 and 
PA=3.7, and effective dose was reduced 44% in the PA projection. The PA 
projection magnification of the spine give a slight reduction in sharpness. 
Conclusion: The result of the study shows that PA projection provides a lower 
effective dose to the patient compared with AP projection with no significant 
reduction in visible image quality. This is seen in both standard- and large-
sized patient.  
B-0743 14:16  
Indexing DICOM metadata from medical imaging repositories: 
opportunities and challenges  
M. Rodrigues dos Santos; Aveiro/PT (mrs@ua.pt)  
Purpose: DICOM metadata, stored in medical image repositories, can be a 
very valuable source of information for the professional practice 
characterization. The enormous amount of data, as well as the diversity of 
informational environments, can make very problematic the DICOM metadata 
access and usage. It is therefore very relevant to identify the potentialities 
associated with indexing DICOM metadata as well as the main challenges that 
arise from the acquisition and management of huge volumes of data. 
Methods and Materials: A meta-analysis was performed on the results of 
works supported in the indexing of DICOM metadata from different hospitals 
PACS archives using the Dicoogle application as a DICOM metadata indexing 
tool. 
Results: Work supported by the indexation of metadata from several PACS of 
7 health units was analyzed. The volume of data analyzed ranged from 85757 
to 36562284 images, corresponding for the latter to more than 1324000 
imaging studies performed on more than 438000 patients. The articles 
analyzed revealled the potential for the use of DICOM metadata, but also 
challenges associated with indexing and managing large volumes of metadata, 
namely the identification of medical imaging stakeholders, computational 
needs and information management, the quality of DICOM metadata, the 
analysis of individual and population exposure and the use of human and 
material resources. 
Conclusion: It is possible to aggregate and consolidate huge amounts of 
DICOM metadata as a means to characterize professional practice. However, 
the success of its use depends on access and information management 
strategies as well as of the metadata quality.  
B-0744 14:24  
Patient radiation dose and fluoroscopy time during ERCP: a single-centre 
retrospective study of influencing factors  
E. Saukko1, J.M. Grönroos1,1, P. Salminen1,1, A. Henner2, M.T. Nieminen2,2; 
1
Turku/FI, 2Oulu/FI (ekaterina.saukko@tyks.fi)  
Purpose: The number and complexity with associated increased technical 
difficulty of therapeutic ERCP procedures have significantly increased resulting 
in longer procedural and fluoroscopy times. During ERCP, the patient is 
exposed to ionizing radiation and the consequent radiation dose depends on 
multiple factors. The aim of this study was to identify factors affecting 
fluoroscopy time and radiation dose in patients undergoing ERCP. 
Methods and Materials: Data related to patient demographics, procedural 
characteristics and radiation exposure in ERCP procedures (n=638) performed 
between August 2013 and August 2015 were retrospectively reviewed and 
analysed. Statistically significant factors identified by univariate analyses were 
included in multivariate analysis with fluoroscopy time (FT) and dose area 
product (DAP) as dependent variables. Effective dose (ED) was estimated from 
DAP using conversion coefficient. 
Results: The factors independently associated with increased DAP during 
ERCP were age, gender, radiographer, complexity level of ERCP, cannulation 
difficulty grade, bile duct injury and biliary stent placement. In multivariate 
analysis, the endoscopist, the complexity level of ERCP, cannulation difficulty 
grade, pancreatic duct leakage, bile duct dilatation and brushing were identified 
as predictors for a longer FT. The mean DAP, FT, number of acquired images 
and ED for all ERCP procedures were 2.33 Gy·cm2, 1.84 min, 3 and 0.61 mSv, 
respectively. 
Conclusion: Multiple factors had an effect on DAP and FT in ERCP. The 
awareness of these factors may help to predict possible prolonged procedures 
causing a higher radiation dose to the patient and thus facilitate the use of 
appropriate precautions.  
Author Disclosures: 
 P. Salminen: Speaker; Lecture fees from Merck and Lilly.  
B-0745 14:32  
Dose reduction with PA projection in lumbar spine radiography  
E. Alukic, D. Škrk, N. Mekis; Ljubljana/SI  
Purpose: The aim of the research was to determine the effect on radiation 
dose to the patient in lumbar spine radiography when using the PA projection 
instead of the conventional AP projection and how does that effect the image 
quality. 
Methods and Materials: The research was conducted both, on an 
anthropomorphic phantom and on 100 patients, randomly divided into two 
equal groups of 50. In the first group the lumbar spine imaging was conducted 
in the AP projection, whereas in the second group the imaging was conducted 
in the PA projection. The dose was measured with dose area product (DAP) 
meter. The level of tissue displacement and patient height and weight was 
measured and image size was obtained. The image quality assessment was 
performed by three experienced radiologists with the use of ViewDEX imaging 
software and the effective dose was calculated using PCXMC2.0. Prior to the 
study the National medical ethic committee approval was obtained. 
Results: When using PA projection, the average thickness of abdomen was 
reduced by 2.4 cm (p < 10-3) in the PA projection, as did DAP by 16.3 Gy m2 
(p = 0.009) and the effective dose by 0.09 mSv (p <10-3). We did not find any 
significant difference in image quality between AP and PA projection of lumbar 
spine radiography (p = 0.690). 
  






Conclusion: The results showed that the use of PA projection of lumbar spine 
reduces DAP (26.7 %) and effective dose (53.3 %) while preserving the image 
quality.  
B-0746 14:40  
Construction of obese phantoms for dose optimisation and image quality 
purposes  
S.J.M. Alqahtani1,2, K. Knapp1, R.M. Palfrey1, J.R. Meakin1; 1Exeter/UK, 
2
Najran/SA (salbeshri@hotmail.com)  
Purpose: To build obese phantoms that can be used in dose optimisation and 
image quality research. 
Methods and Materials: Two sets of urethane based materials, along with 
other additives, priorly verified to be identical to fat and lean in terms of density, 
Hounsfield unit (HU) and linear attenuation coefficient, were used . Moulds 
were constructed using polystyrene design based on a 3D scan of a KYOTO 
phantom (PBU-50). The fat and lean mass in the abdominal region was 
calculated from DXA scans of 264 healthy female subjects. Two BMI groups, 
38 and 46 kg/m2, were constructed and tested for HU across different regions. 
Results: The constructed phantom consisted of two layers of fat tissue-
equivalent substitutes (FTES) which enscorned the abdominal region of the 
KYOTO phantom anteriorly and posteriorly each weighed 9.3 kg. Additionally, 
two thin layers of lean tissue-equivalent substitutes (LTES), each 1.9 kg, were 
added anteriorly and posteriorly to the previous FTES layers. This represented 
a BMI group of 38 kg/cm2. Another two layers of FTES, total weight of 7.5 kg, 
along with two LTES layers, total weight 3.9kg, represent a 46 kg/m2 BMI 
group. Across 4 levels of kvp (70,80,100 and 120 kvp) the HUfor FTES was -
77.87 ± -16.7, in 9 different regions for each slab, while for the LTES, the HU 
was 23.25 ± 7.14, in 3 different regions for each slab. 
Conclusion: Two obese phantoms were constructed. When used along with 
the KOYOTO phantom, dose optimisation work and image quality assessment 
can be conducted.  
B-0747 14:48  
Personalised patient protocol for radiostereometric analysis  
O. Muharemovic, A. Troelsen, M.G. Thomsen, T. Kallemose, K.K. Gosvig; 
Hvidovre/DK (omarradiograf@hotmail.com)  
Purpose: Increasing pressure in the clinic requires a more standardised 
approach to radiostereometric analysis (RSA) imaging. The aim of this study 
was to investigate whether implementation of personalised RSA patient 
protocols could increase image quality and decrease examination time and the 
number of exposure repetitions. 
Methods and Materials: Forty patients undergoing primary total hip 
arthroplasty (THA) were equally randomised to either a case or a control 
group. Radiographers in the case group were assisted by personalised patient 
protocols containing information about each patient’s post-operative RSA X-
ray. Radiographers in the control group used a standard RSA protocol. 
Results: At 3 months, radiographers in the case group significantly reduced 
(p<0.001) the number of exposures (NE) by 1.6, examination time (ET) with 
19.2 minutes, and distance between centrum of prosthesis (CP) and centrum 
of calibration field (CCF) with 34.1 mm when compared to post-operative 
(baseline) results. At 12 months, the case group significantly reduced 
(p<0.001) NE by 2.0, ET with 22.5 minutes, and CP to CCF distance with 43.1 
mm when compared to baseline results. No significant improvements were 
found in the control group at any time point. 
Conclusion: There is strong evidence that personalised RSA patient protocols 
have a positive effect on image quality and radiation dose savings. 
Implementation of personal patient protocols as a RSA standard will contribute 
to the reduction of examination time, thus ensuring a cost-benefit for 
department and patient safety.  
B-0748 14:56  
Large-sized patient chest radiography: a relative visual grading analysis 
study  
F.P. Soares1, E. Aymon2, A.M. Burke3, S. Dijkstra4, J. Fosskaug5, 
S.N. Sanders4, A.F.N. Silva6, A. Sanderud5; 1Florianopolis/BR, 2Lausanne/CH, 
3
Dublin/IE, 4Groningen/NL, 5Oslo/NO, 6Lisbon/PT (s.n.sanders@st.hanze.nl)  
Purpose: To investigate the impact of different kVp and mAs values on image 
quality and effective dose in large-sized patient chest radiography. 
Methods and Materials: A chest phantom (Kyoto) with simulated lesions and 
additional 30mm plates to simulate a large-size patient was imaged at various 
kept and mass values using a Canon CXDI digital detector. With 20 observers, 
a relative visual grading analysis (VGA) study was performed to assess image 
quality and nodule visibility in five chest radiographs asking worse, equal or 
better on eight image criteria adapted from the EU guidelines. The VGA study 
reference image was of the phantom at standard size without the chest plates 
using 125kVp, 2.4mAs by AEC and 24Sv. Effective dose was calculated 
using PCXMC. VGA scores were compared against signal-to-noise ratio (SNR) 
and contrast-to-noise ratio (CNR). 
Results: An image obtained with 125kVp/4.0mAs/43Sv had the highest SNR, 
and the 125kVp/2.0mAs/21Sv had the highest CNR. In the VGA study, the 
125kVp/4.0mAs/43Sv was seen as the most optimal image with 51% of 
scores from the observers being equal or better than the reference image. The 
image using AEC 125kVp/6.88mAs/74Sv was given the lowest score in VGA 
study with 23% score of equal or better. The scores with different kVp, 
117kVp/2.5mAs/22µSv and 133kVp/2.5mAs/31µSv were 41% and 34%. 
Conclusion: It is possible to get higher SNR, CNR and VGA scores in large-
sized patient chest radiography at lower mAs than that given using standard 
AEC, due to post-processing. Changing the kVp did not improve the image 
quality.  
B-0749 15:04  
Radiation dose reduction on thyroid in mammography  
D.C. Entradas, S. Rodrigues, R.P.P. Almeida, L.P. Ribeiro, A.F. Abrantes, 
M.V.C. Reis; Faro/PT (monica14@live.com.pt)  
Purpose: To evaluate the entrance skin dose reduction in the thyroid using 
radiation protection in mammography exams. 
Methods and Materials: In this experimental research, two anthropomorphic 
phantoms (full body and breast phantoms) were placed in the mammography 
equipment according with the standard positioning criteria. Optically stimulated 
luminescence (OSL) dosimeters were placed over the phantom thyroid region 
and a total of 40 radiation exposures were made for entrance skin dose 
measurements. The measurements were made on both standard projections 
for the breast study (cranio-caudal and medio-lateral oblique) with and without 
the use of the thyroid lead protection (0.5 mm). 
Results: The entrance skin dose received by the thyroid was superior in 
medio-lateral oblique projection (44 µGy) compared to the cranio-caudal 
projection (36 µGy) without lead protection. With the lead protection there is a 
dose reduction of 83,3 % in the cranio-caudal projection (6 µGy ) and 93,2% in 
the medio-lateral oblique projection (3 µGy). Therefore, in the mammography 
examination (total of four projections), the use of the lead protection reduces 
the entrance skin dose on thyroid by 89%. 
Conclusion: The use of thyroid lead protection is highly recommended since it 
can reduce the radiation dose in this radiosensitive organ during 
mammography exams, attending the ALARA principle. However, we should 
also consider that the use of the shield might provide artefacts, making difficult 
the correct analysis of the breast tissue and leading to the examination 
repetition increasing the dose received in the mammary gland, as well as the 
other organs.  
B-0750 15:12  
Correlation measurements between positron emission tomography 18F-
FDG dose and external exposure  
Ž.R. Janulcikas; Vilnius/LT  
Purpose: To evaluate correlation between administered 18F - FDG dose and 
measured patient‘s emitted external exposure at different time. 
Methods and Materials: In this study was analysed data of 101 adult patients: 
weight, administered 18F - FDG dose, external exposure. Patient's emitted 
external exposure was measured at distance of 0,3 m and 1 m, also at different 
time. Pearson correlation coefficient was used to determine correlation 
strength. 
Results: 101 Patient's weight was from 42 kg to 109 kg and injected 18F - FDG 
was from 290 MBq to 438 MBq. Correlation between weight and dose was 
strong (r = 0,88) and statistically significant (p<0,00). Unfortunately, it is 
estimated that the correlation between the injected 18F - FDG dose and 
external exposure (immediately after the injection) is very weak (r = 0,17) and 
statistically insignificant (p = 0,07) Also, correlation between the administered 
dose and the emitted external exposure before patients being released to 
home is very weak (r = 0,03) and statistically insignificant (p=0,731), and more 
weaker than correlation immediately after injection. 
Conclusion: Correlation between injected 18F - FDG dose and external 
exposure is estimated to be very weak and statistically insignificant. Radiation 
safety specialists and nuclear medicine radiographers should always gather 
external exposure data from patient at exactly same distance and body part. 
To testify this study results, there should be more further tests and data.  
B-0751 15:20  
Fabrication of fat tissue-equivalent substitutes (FTES) and lean tissue-
equivalent substitute (LTES) to underpin obese phantom construction  
S.J.M. Alqahtani1,2, K. Knapp1, R.M. Palfrey1, J.R. Meakin1; 1Exeter/UK, 
2
Najran/SA (salbeshri@hotmail.com)  
Purpose: The literature reports high doses delivered to obese patients in 
projection radiography. This suggests more dose optimisation work is required 
for this group of patients. However, to date, there is no commercially available 
phantom representing obese patients. Therefore, this study outlines a 
fabrication method to build an obese phantom. 
  






Methods and Materials: A urethane-based material, PMC 121/30 dry, was 
used for fat and lean tissue-equivalent substitutes (FTES and LTES). For the 
LTES, a 2.8% by weight of calcium carbonate was added to the PMC and 
mixed by hand for 25 minutes, while 2% of phenolic microspheres by weight 
was used instead for the FTES. Both FTES and LTES were tested for density 
and Hounsfield unit and compared to the ICRU 44. For linear attenuation 
coefficient, they were compared to slabs of lard and Perspex with identical 
thickness across a wide range of kVp (40 to 120 kVp). 
Results: The density was 1.04 and 0.90 g/cm 3 for LTES and FTES, 
respectively. The Hounsfield unit for the FTES was -66.75 ± -4.26, and 30.08 ± 
6.03 for LTES, both agreed with ICRU 44. The mass attenuation coefficient for 
the FTES against the lard and for the LTES against the Perspex was identical 
across the range of kvp. 
Conclusion: The current study illustrates a method of constructing LTES and 
FTES that can be used in building different sizes of phantom for dose 
optimisation and image quality purposes.  
14:00 - 15:30 Room M 1  
Cardiac  
SS 703  
New CT protocols to assess coronary 
artery and myocardium  
Moderators:  
M. Francone; Rome/IT  
C.L. Schlett; Heidelberg/DE  
B-0752 14:00  
Diagnostic accuracy between low and high tube voltage third-generation 
dual-source coronary CT angiography using tailored contrast medium 
injection protocols  
M. Albrecht1, C.N. De Cecco2, K. Otani3, J.W. Nance2, A. Varga-Szemes2, 
D. De Santis4, P. von Knebel Doeberitz2, T.J. Vogl1, U.J. Schoepf2; 
1
Frankfurt a. Main/DE, 2Charleston, SC/US, 3Tokyo/JP, 4Roma/IT 
(MoritzAlbrecht@gmx.net)  
Purpose: To compare the diagnostic accuracy between coronary CT 
angiography (CCTA) using 100 vs >100 kV peak (kVp) settings and a kVp-
tailored contrast medium injection protocol with catheter angiography as the 
reference standard. 
Methods and Materials: One hundred-twenty patients were retrospectively 
enrolled in this study (mean age=62.6 years, mean BMI=29.0 kg/m2). Patients 
underwent CCTA and were separated into two cohorts (each n=60) based on 
the tube voltage (mean kVp=84.3 and 116.5, respectively). The contrast media 
was tailored to the kVp level: 70=40mL, 80=50mL, 90=60mL, 100=70mL, 
110=80mL, and 120=90mL. Quantitative contrast-to-noise ratio (CNR) was 
measured. Two radiologists evaluated image quality and reported the presence 
of significant coronary stenosis (>50% luminal narrowing) in a segment-based 
fashion. 
Results: Sensitivity/specificity for 100 vs >100 kVp CCTA were: per-
patient=93.9/92.6% vs 90.9/92.6%, per-vessel=91.5/97.8% vs 94.0/96.8%, and 
per-segment=90.0/96.7% vs 90.7/95.2%, respectively, without significant 
differences (all P>0.64). Quantitative image quality was slightly higher (P>0.18) 
using lower kVp settings (mean CNR=12.0 and SNR=9.8) vs higher kVp CCTA 
(mean CNR=11.1 and SNR=8.9). No significant differences were found for 
subjective image quality among the cohorts (P=0.38). Contrast media 
requirements were reduced by 38.1% using low vs high kVp (53.6 vs 86.6mL, 
P<0.001). Radiation dose in 100 kVp was 59.6% less than >100 kVp 
examinations (4.3 vs 10.6 mSv, P<0.001). 
Conclusion: Third-generation dual-source CCTA using a kVp-tailored contrast 
injection protocol can be robustly performed at 100 kVp in an overweight 
population while maintaining diagnostic accuracy for coronary stenosis 
detection compared to >100 kVp image acquisition, substantially reducing 
radiation and contrast dose.  
Author Disclosures: 
 C.N. De Cecco: Consultant; Consultant for and/or receives research support 
from Guerbet and Siemens. K. Otani: Employee; Siemens. 
A. Varga-Szemes: Consultant; Consultant for Guerbet.  U.J. Schoepf: 
Consultant; Consultant for and/or receives research support from Astellas, 







B-0753 14:08  
Dual-energy coronary CT angiography: improved vascular contrast using 
noise-optimised virtual monoenergetic imaging  
C. Arendt, D. Leithner, L. Lenga, S.S. Martin, T.J. Vogl, J.L. Wichmann; 
Frankfurt a. Main/DE (crt.arendt@gmail.com)  
Purpose: To evaluate the impact of different energy levels on image quality 
regarding visualization of coronary arteries and evaluation of coronary 
stenoses in traditional (VMI) and noise-optimized virtual monoenergetic 
imaging (VMI+). 
Methods and Materials: Spectral DE-CCTA evaluation was performed in 50 
cases by using standard linearly-blended (F_0.6), VMI and VMI+ algorithms at 
different energy levels (40-100 keV,10 keV-increments). SNR and CNR of main 
coronary arteries were assessed for objective image quality analysis. 
Diagnostic confidence was determined by 4 observers using a 5-point Likert 
scale. Diagnostic accuracy for the detection of >50% stenoses was performed 
by the same observers, taking into consideration invasive coronary 
angiography. 
Results: Objective image parameters peaked at 40-keV VMI+ reconstructions 
(SNR: 46.3 [29.6]; CNR: 36.2 [20.3]), significantly superior (all p<0.001) 
compared with highest results at 70-keV VMI series (29.0 [15.8]; 18.4 [14.8]) 
and with F_0.6 images (23.7 [14.0]; 15.7 [10.2]). Diagnostic confidence (all p-
values < 0.05) was highest at 40-keV VMI+ series with good subjective image 
quality (median: 4; ICC: 0.81), low noise (4; 0.82) and optimal plaque 
delineation (5; 0.85). 16 patients (32%) underwent additional ICA. Sensitivity 
and specificity for the detection of >50% stenoses were highest in 40-keV 
VMI+ reconstructions (98% and 96%) compared with 70-keV VMI (95% and 
94%) and standard F_0.6 (94% and 94%) image series. 
Conclusion: DE-CCTA with VMI+ reconstructions at 40 keV significantly 
increases objective image quality of coronary arteries, leading to improvement 
of plaque delineation compared with VMI-technique and standard linearly-
blended image series. Consequently, diagnostic accuracy and confidence were 
increased.  
Author Disclosures: 
 J.L. Wichmann: Speaker; GE and Siemens. 
B-0754 14:16  
Napkin-ring plaques can be identified on coronary CT angiography 
images using radiomic analysis  
M. Kolossvary1, J. Karady1, B. Szilveszter1, P. Kitslaar2, B. Merkely1, 
P. Maurovich- Horvat1; 1Budapest/HU, 2Leiden/NL 
(marton.kolossvary@cirg.hu)  
Purpose: Napkin-ring sign (NRS) is an independent prognostic imaging 
marker of major adverse cardiac events. However, identification of NRS is 
challenging due to its qualitative nature and, therefore, depends on reader 
experience. A more quantitative and reproducible approach is desirable. 
Therefore, our purpose was to assess whether radiomic parameters can 
differentiate between NRS and non-NRS plaques. 
Methods and Materials: From symptomatic patients' coronary CT 
angiography images we identified 30 NRS plaques. We matched these with 30 
non-NRS plaques with similar degree of calcification and stenosis, localization, 
tube voltage and image reconstruction settings. All plaques were segmented 
manually. 8 conventional (lesion length and volume, mean plaque burden, 
vessel wall remodeling index, lumen area stenosis, mean, minimum and 
maximum plaque attenuation) and 4440 radiomic parameters were calculated. 
We used permutation test of symmetry to assess differences between NRS 
and non-NRS plaques, while we calculated receiver operating characteristics' 
area under the curve (AUC) values to evaluate diagnostic accuracy. 
Bonferroni-corrected p<0.0012 was considered significant. 
Results: None of the conventional quantitative parameters, while 20.6% 
(916/4440) of radiomic parameters showed a significant difference between 
NRS vs. non-NRS plaques. Almost half of these (418/916) reached an AUC 
value greater than 0.80. Short- and long-run low-grey-level emphasis and 
surface ratio of high-attenuation voxels to total surface had the highest AUC 
values (0.918, 0.894 and 0.890, respectively). 
Conclusion: Radiomics can identify NRS plaques with excellent diagnostic 
accuracy. Radiomics could increase the reproducibility and accuracy of 
diagnostic image interpretation in the future.  
Author Disclosures: 
  M. Kolossvary: Author; Márton Kolossváry is the software developer of 
Radiomics Image Analysis (RIA) program which was used for radiomic 
calculations.  P. Kitslaar: Employee; Pieter Kitslaar is employed by Medis 
medical imaging systems bv. This software was utilized for the coronary 












B-0755 14:24  
Diagnostic accuracy of coronary CT angiography performed with a novel 
whole-heart coverage high-definition CT scanner in patients with 
coronary artery bypass graft  
D. Andreini, S. Mushtaq, G. Pontone, A.D. Annoni, A. Formenti, M.E. Mancini, 
M. Guglielmo, A.L. Bartorelli, M. Pepi; Milan/IT (daniele.andreini@ccfm.it)  
Purpose: To evaluate interpretability, radiation exposure and diagnostic 
accuracy of CCTA compared to invasive coronary angiography (ICA) in the 
assessment of grafts and non grafted or distal runoff coronary arteries 
performed with the latest generation of cardiac-CT scanner. 
Methods and Materials: We enrolled 100 consecutive patients with CABG 
who underwent ICA and CCTA (16-cm z-axis coverage with 256 detector 
rows,0.28 sec gantry rotation time). We assessed coronary segment 
interpretability, effective dose (ED) and diagnostic accuracy vs. ICA. 
Results: Mean HR during the scan was 70±11 bpm. 26 patients were in atrial 
fibrillation and 74 in sinus rhythm. Among the latter, 27 patients had a 
HR>75bpm. CCTA CABG interpretability was 100%, independently from the 
type of graft (arterial or venous). After comparison with ICA, CCTA was able to 
correctly detect the occlusion or significant stenosis of all CABG. The overall 
interpretability of non-grafted and distal runoff coronary arteries was high 
(95.5%). Sensitivity, specificity, positive predictive value, negative predictive 
value and accuracy of native coronary arteries were 98.3%, 98.6%, 96.2%, 
99.4%, and 98.5%, respectively. Mean effective dose was 2.5±0.8mSv. 
Conclusion: The novel whole-heart coverage CT scanner allows to evaluate 
CABG and native coronary arteries with excellent diagnostic accuracy and low 
radiation exposure also in the presence of atrial fibrillation and high heart rate.  
B-0756 14:32  
Cardiac CT for demonstrating non-calcified coronary atherosclerotic 
plaque: effect of knowledge-based iterative model reconstruction on 
image quality  
T. Li, L. Yang; Beijing/CN (litaofeivip@163.com)  
Purpose: The purpose of this study was to assess image quality of 
demonstrating coronary plaques using iterative model reconstrucion (IMR), a 
knowledge-based iterative reconstruction algorithm, the latest reconstruction 
technique. 
Methods and Materials: Sixty-six patients (53 male and 13 female) with 
single-vessel disease with non-calcified plaques or non-calcified predominant 
plaques and significant coronary stenosis (50% ) using prospective 
electrocardiogram-gated coronary 256-slice CT angiography were selected. 
Paired image sets were created using two types of reconstruction: hybrid 
iterative reconstruction (HIR) (iDose4; Philips Healthcare) and IMR. Signal-to-
noise ratio (SNR) of image was calculated and contrast-to-noise ratio (CNR) 
between plaque and adjacent fat tissue was measured on a cross-sectional 
multi-planar reconstruction image of the plaque. 
Results: Seventy-seven non-calcified plaques or non-calcified predominant 
plaques with significant coronary stenosis were detected. Two plaques were 
located on LM, 51 plaques on LAD, 23 on RCA and 1 on LCX. x2 test showed 
there was no significantly statistical difference to present positive remodeling, 
low density plaque and spotty calcification with HIR and IMR reconstructed 
method, still there was significantly statistical difference to discern napkin-ring 
sign between two algorithms (x212.12,p<0.001). The image noise of IMR was 
lower than that of HIR (10±2 versus 13±2) (p<0.01),and SNR of image and 
CNR between plaques and surrounding fat tissue on IMR were better than that 
on HIR (SNR: 46±15 versus 37±11) (CNR: 16.0±4.6 versus 12.0±3.6) (p<0.01). 
Conclusion: IMR can significantly decrease the image noise and improve 
image quality compared with HIR for the coronary atherosclerotic plaques 
demonstration on coronary 256-slice CT angiography.  
B-0757 14:40  
Iodine quantification at rest and stress to differentiate ischaemic, 
infarcted and normal myocardium using dual-energy CT  
M. van Assen1, C.N. De Cecco1, R. Vliegenthart2, M. Oudkerk2, U.J. Schoepf1; 
1
Charleston, SC/US, 2Groningen/NL (m.van.assen@umcg.nl)  
Purpose: The aim of this study was to evaluate the potential of rest-stress 
dual-energy CT (DECT) iodine quantification to discriminate between normal, 
ischemic, and infarcted myocardium. 
Methods and Materials: Patients underwent rest-stress DECT on a second-
generation dual-source scanner. Rest-stress perfusion single photon emission 
CT (SPECT) and rest-stress cardiac magnetic resonance (CMR) imaging with 
late gadolinium enhancement (LGE) were performed to identify ischemic and 
infarcted myocardium. Patients were categorized into an ischemic, infarcted, 
and control group based on SPECT and CMR results. Regions of interest 
(ROI) were placed in the septal area of the iodine maps to assess iodine 
concentrations in normal/remote myocardium. ROIs were sampled in ischemic 
and infarcted areas detected on perfusion and LGE-images. In addition, 
variations in iodine concentration were analyzed on a per-segment basis 
according to the AHA-16-segment model in the control group. 
Results: 42 patients were included: 10 ischemic, 17 infarcted, and 15 controls. 
There were no significant differences in iodine concentrations between 
segments. Iodine concentrations in both ischemic and infarcted myocardium 
were significantly lower than in normal myocardium (p value 0.005 and 
<0.001), ranging from 1.3 mg/mL (0.9-1.8) and 0.6 mg/mL (0.4-0.8) at rest and 
stress in ischemic myocardium, and 0.3 mg/mL (0.3-0.5) and 0.5 mg/mL (0.5-
0.7) at rest and stress in the infarcted myocardium, respectively. At rest, iodine 
concentration of ischemic myocardium was significantly higher compared to 
infarcted myocardium (p value<0.001). 
Conclusion: DECT quantification of iodine concentration from rest-stress 
imaging is able to distinguish between normal, ischemic, and infarcted 
myocardium and holds potential as an imaging biomarker for tissue 
characterization.  
Author Disclosures: 
 C.N. De Cecco: Research/Grant Support; Siemens Healthineers.  
U.J. Schoepf: Research/Grant Support; Siemens Healthineers, Bracco, GE, 
Bayer. 
B-0758 14:48  
The value of wide-detector helical CT combined with adaptive statistical 
iterative reconstruction-V in patients with high heart rate during coronary 
CT angiography  
H. Zhao; Zhengzhou/CN (kindergirl@sina.cn)  
Purpose: To compare the radiation dose and image quality of wide-detector 
helical CT combined with ASIR-V with stand-detector helical CT with ASIR in 
patients with high heart rate (HR) during coronary CT angiography (CCTA). 
Methods and Materials: Eighty high heart rate patients (HR-during the CT 
scans80bpm) underwent CCTA were randomly divided into two scan groups 
(n=30 each;the study group: detector coverage of 160mm,100 kVp,50% pre-
ASIR-V; the control group, detector coverage of 40mm,120 kVp,50% 
ASIR).Quantitative parameters [image noise (SD of AA),SNR,CNR,CT values 
of ascending aorta (AA),left main coronary artery (LM),proximal segment of left 
anterior descending (LAD-p ),circumflex proximal segment (LCX-p),right 
coronary artery(RCA-p) ] and effective dose (ED) were compared with two 
sample t tests.The image quality of coronary artery was evaluated using a four-
point scale based on the 15-segment model after using SSF technique 
reconstructions when necessary and then compared with 2 test. 
Results: The study group and control group showed no significant differences 
in image noise, SNR, CNR and CT values of AA, LM, LAD-p, LCX-p, RCA-
p.No significant differences were found for the diagnostic image quality of 
coronary artery segments(546/551 VS 552/559) and the ratio of SSF technique 
reconstructions(27/40 VS 31/40) among the two groups.The ED for the study 
group and the control was (2.16±0.79)mSv and (9.74±3.89)mSv, respectively. 
There was significant difference in ED among this two groups. 
Conclusion: Comparing with stand-detector helical CT in patients with high 
HR, the wide-detector helical CT combined with 50% pre-ASIR-V could reduce 
78% radiation dose while maintain overall image quality.  
B-0759 14:56  
Study on the optimum keV and different contrast agent concentration in 
coronary stent imaging using spectral CT: in vitro study  
L. Yang, Y. Hou, Y. Ma, Z. Jia, X. Lu; Shenyang/CN (8609469@qq.com)  
Purpose: To investigate optimally visual combination of different keV and 
concentration of contrast agent (CT) in the coronary artery stent using sprctral 
CT in vitro study. 
Methods and Materials: Fifteen coronary artery stents (internal diameter of 
2.5 - 4.0 mm) were randomly divided into artificial coronary artery, respectively 
filled six different concentrations of contrast agent(12.85, 6.59,5.29,4.43,3.80 
and 3.33 mgI/ml).All artificial coronary artery scanned with dual-detector CT, 
obtain images from 40 to 200 keV (interval of 10 keV) .Subjective image quality 
was evaluated by two doctors using Likert 5 method. Objective image quality 
assessment including artificial lumen narrowing(ALN), signal to noise ratio 
(SNR), contrast to noise ratio( CNR) . 
Results: The image quality of 6.59mgI/ml+60 keV group was the highest total 
score(P<0.05). The ALN value was (21.33 ± 12.48)% in 6.59mgI / ml + 60 keV 
group, which was significantly lower than that in other groups (P <0.05). In 
6.59mgI / ml + 60 keV group ,the SNR of stent lumen was 26.08 ± 3.74, which 
was significantly higher than that of 3.93 ~ 12.85mgI / ml + 70 ~ 200keV group 
(P <0.05). The CNR of 6.59mgI / ml + 60 keV group was significantly higher 
than that of 3.33 ~ 12.85mgI / ml + 70 ~ 200keV group (P <0.05). 
Conclusion: In vitro scans, at concentration of 6.59 mgI / ml with 60 keV, 
image quality was better, stent diameter measurement results closer to real 










B-0760 15:04  
Assessment of image quality of coronary artery and left ventricular 
function and volume using low kVp, mA modulation and advanced model 
based iterative reconstruction  
K. Choo, Y.-J. Jeong, M. Kim; Busan/KR (jyj107@hanmail.net)  
Purpose: To compare 3rd generation dual source CT (DSCT, Somatom force, 
Siemens Medical Solution, Forchheim, Germany) using 70 or 80 kVp and 
ECG-based maximum tube current modulation and advanced modeled 
iterative reconstruction with echocardiography (ECHO) for the determination of 
left ventricular ejection fraction (LVEF), end-diastolic volume (EDV), end-
systolic volume (ESV) as well as assessing coronary artery image quality and 
patient radiation dose. 
Methods and Materials: Forty consecutive patients (M:F = 32:8, mean age, 
57.1 ± 6.4 years) with chest pain were enrolled in this study. EF, EDV and ESV 
were measured by both DSCT and ECHO, and the correlation coefficients 
were assessed. In addition, subjective image quality of coronary artery 
segment (1, excellent; 4, poor) and radiation dose were recorded. 
Results: Comparison of LVEF, EDV, and ESV between DSCT and ECHO 
showed a significant correlation (p < 0.01) and the LVEFs measured by DSCT 
and ECHO were not statistically different. However, LV, EDV and ESV from 
DSCT were statistically higher than those from ECHO (p < 0.05). The average 
subjective image quality score of the coronary artery segment was 1.10 and 
the mean patient radiation dose was 2.07 ± 0.4 mSv. 
Conclusion: DSCT with low kVp, mA modulation and advanced model based 
iterative reconstruction offers comparable results to ECHO for LVEF and LVV 
and good image quality of coronary artery with a low radiation dose.  
B-0761 15:12  
Effect of image reconstruction algorithms on cardiovascular radiomic 
features using coronary CT angiography  
M. Kolossvary, B. Szilveszter, J. Karady, B. Merkely, P. Maurovich-Horvat; 
Budapest/HU (martonandko@gmail.com)  
Purpose: Radiomic analysis is an emerging analytical approach to identify 
new imaging biomarkers of specific phenotypes and outcomes. Little is known 
how novel image reconstruction algorithms might affect radiomic 
characteristics. Therefore, our objective was to assess the effect of image 
reconstruction settings on radiomic features of coronary atherosclerotic 
lesions. 
Methods and Materials: 60 coronary atherosclerotic lesions were 
reconstructed using filtered-back projection (FBP), hybrid iterative 
reconstruction (HIR) and model-based iterative reconstruction (MIR). Images 
were segmented using a semi-automated software. Segmentations were 
manually adjusted if needed. Voxels containing plaque tissue were exported as 
an original DICOM dataset. Overall, 114 grey level co-occurrence matrix 
(GLCM) and 11 grey level run length matrix (GLRLM) statistics were calculated 
using the Radiomics Image Analysis (RIA) software package. Using linear 
regression analysis, the effect of FBP and MIR as compared to the reference 
HIR technique corrected for additional imaging settings was investigated. A p 
value smaller than 0.05 was considered significant. 
Results: Among GLCM statistics 14.0% (16/114) was differed between FBP-
HIR, while 19.3% (22/114) showed a significant difference between HIR-MIR. 
However, among GLRLM statistics only short run emphasis, and run 
percentage was significantly different between HIR and MIR reconstructions. 
Conclusion: Image reconstruction algorithms affect several radiomic statistics, 
therefore standardization of imaging protocols is needed to achieve robust and 
reproducible results.  
Author Disclosures: 
  M. Kolossvary: Author; Márton Kolossváry is the software developer of 
Radiomics Image Analysis (RIA) program which was used for radiomic 
calculations.  
B-0762 15:20  
Motion elimination in low-dose 4D myocardial computed tomography 
perfusion (CTP) using the automated smooth temporal registration for 
analysis of 4D image data (ASTRA) algorithm  
S. Lukas, S. Feger, M. Rief, E. Zimmermann, M. Dewey; Berlin/DE  
Purpose: We propose a four-dimensional (4D) motion elimination algorithm for 
joint temporal alignment and denoising of a 4D CTP sequence to provide 
physiologically meaningful local time attenuation curves (TACs) for subsequent 
myocardial perfusion quantification. 
Methods and Materials: Dynamic contrast-enhanced 320-row CTP was 
performed in 31 patients with suspected or confirmed coronary artery disease 
(CAD). In a unified approach we decouple cardiac deformation from temporal 
intensity changes due to contrast enhancement by iteratively performing a local 
polynomial kernel regression temporally and a 4D principal component 
analysis (PCA) spatially. A multi-resolution two-stage rigid and deformable B-
spline registration model was applied by minimizing the temporal misalignment 
measured by the weighted sum of the eigenvalues of the inter-volume 
correlation matrix. Registration performance was assessed by measuring 
temporal smoothness, spatial noise, and degree of local volumetric 
deformation (determinant of the spatial Jacobian) at four distinct regions at the 
left-ventricular wall for each patient. Solely PCA-based registration without 
temporal regression served as the reference standard. 
Results: The proposed ASTRA registration algorithm provided superior 
registration performance when compared to the benchmark. The algorithm 
consistently improved temporal smoothness (32.5±12.4 vs. 185.1±103.8, 
p<0.001) and spatial noise (21.8±13.2 vs. 27.6±12.4, p<0.001) at the 
myocardial target regions at comparable local deformation behaviour 
(0.997×/1.073 vs. 0.999×/1.055, p=0.169, geometric average) and improved 
overall temporal alignment of the registered sequence (20.93±2.60 vs. 
21.86±2.94, p<0.001). 
Conclusion: The novel ASTRA registration algorithm for a 4D CTP sequence 
outperforms the benchmark with 80% temporal and 20% spatial noise 
reduction without introducing strong volumetric deformations.  
Author Disclosures: 
 M. Dewey: Grant Recipient; Toshiba Medical Systems, Guerbet, Cardiac MR 
Academy Berlin, and Bayer (Schering-Berlex), Siemens Medical Solutions, 
Philips Medical Systems. Research/Grant Support; DE 1361/14-1, 603266-2, 
HEALTH-2012.2.4.-2, 20072013 2/05, 20072013 2/48, F/23/08, F/27/10, DFG, 
BMBF, 01KG1013, 01KG1110, 01KG1210,. Speaker; Toshiba Medical 
Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer (Schering-Berlex). 
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B-0763 14:00  
Fast magnetic resonance imaging (MRI) of invasive lung aspergillosis in 
immunocompromised children: comparison with HRCT  
T. Akbas1, S. Ulus2, B.S. Karagun1, T. Arpaci1; 1Adana/TR, 2Istanbul/TR 
(tugana.akbas@acibadem.edu.tr)  
Purpose: To compare the diagnostic accuracy of fast lung MRI with high 
resolution computed tomography (HRCT) in immunocompromised children with 
invasive pulmonary aspergillosis. 
Methods and Materials: Twenty seven children (14 boy, 13 girl, mean age= 
12.8; range age 5-17 years) with suspected invasive pulmonary aspergillosis 
after chemotherapy and hematopoietic stem cell transplantation underwent 1.5 
Tesla MRI and HRCT. Pulmonary MRI study protocol included T2 weighted 
half-Fourier single-shot turbo spin echo (HASTE) and T1 weighted volumetric 
interpolated breath hold examination (VIBE) sequences. The average MRI 
scanning time was three minutes. Both the location and the type of lesion (halo 
sign, air crescent sign, peribronchial consolidation, bronchopneumonia, 
centrilobular and tree in bud nodules) were assessed on MRI and HRCT 
blinded to patient’s data by two radiologists. Kappa test, sensitivity, specificity, 
accuracy, positive and negative predictive values were used to determine the 
compliance. 
Results: The location of the lesion in HRCT were concordant with T2 HASTE 
sequence (w:0,550 p=0,0001) and T1 VIBE sequence (w:0,550 p=0,0001) 
corresponding to a negative predictive value of 100%, positive predictive value 
of 95%, sensitivity of 100%, specificity of 40%, accuracy 95%. The type of 
lesion in HRCT were concordant with T2 HASTE sequence (w:0,447 
p=0,0001) and T1 VIBE sequence (w:0,442 p=0,0001) corresponding to a 
negative predictive value of 33%, positive predictive value of 100%, specificity 
of 100% and accuracy 93%. 
Conclusion: According to our study; MRI is a fast, radiation free examination 
for detecting of pulmonary invasive aspergillosis lesions with high accuracy 
rate in immunocompromised children.  
B-0764 14:08  
Pulmonary MRI: diagnostic performance and detection of structural 
abnormality using ultrashort echo time in cystic fibrosis patients  
M.S. Kraus, M. Esser, M. Teufel, S. Fleischer, J. Riethmueller, C. Ruff, 
I. Tsiflikas, J.F. Schäfer; Tübingen/DE (mareen.kraus@med.uni-tuebingen.de)  
Purpose: To evaluate the diagnostic performance of a coronal 3D Ultra Short 
Echo time sequence (UTE) in pulmonary magnetic resonance imaging in cystic 
fibrosis patients in comparison to the in-house standard; a morphological axial 
PDw Flash 3D in breath-hold, coronal T2w TSE with double tiggering and 
functional sagittal PDw Flash 2D in submaximal in- and expiration. 
  






Methods and Materials: Twenty five CF patients who underwent pulmonary 
MRI (1.5 Tesla scanner) were included. Coronal UTE sequences were 
acquired in submaximal in- and expiration as well as the standard pulmonary 
protocol. Two independent readers assessed overall image quality, cardiac 
respiratory motion artifacts (using a 3-point Likert scale), bronchiectasis 
abnormality and the degree to which airways and vessels were visible. For 
both MR protocols typical cystic fibrosis pathologies were semi-quantitatively 
assessed using the 
`MRI-CF-Score`including bronchiectasis, mucus plugging, centrilobular opacity, 
consolidation, saccualtion and air trapping. 
Results: Diagnostic performance based on overall image qualtiy, motion 
artifacts and airway/vessel visibility was rated higher by the independent 
readers for the UTE sequence. There were no significant differences in total 
MR-CF-Scores considering the different protocols. Significant (p<0.001) 
reduction of acquisition time was noted for the singular plane UTE in 
submaximal breathing conditions. 
Conclusion: Pulmonary MRI with UTE offers increased depiction and 
delineation of peripheral pathologic lung manifestations in patients with cystic 
fibrosis with improved image qualtiy compared to the conventional standard 
protocol, whilst significantly reducing the acquisition time, which is particularly 
relevant in the pediatric patient group.  
B-0765 14:16  
World Health Organization guidelines for achieving high-quality 
paediatric chest radiographs for use in epidemiological studies  
S. Lacey1,1, K. Mulholland1, N. Fancourt1, K. O'Brien2, J. de Campo1, 
M. de Campo1; 1Parkville/AU, 2Baltimore, MD/US (stephen.lacey@rch.org.au)  
Purpose: Consistent high-quality chest radiographs are essential for reliable 
case definitions in epidemiological studies of childhood respiratory disease. 
However, there is no centralised resource on chest radiograph acquisition 
relevant to study investigators and site staff. Previous experience suggests that 
suboptimal quality radiographs can be minimised through early collaboration 
between radiology departments and research staff. 
Methods and Materials: The World Health Organisation Chest Radiography in 
Epidemiological Studies or "WHO-CRES" project was formed in 2015. A major 
objective of the project was to develop appropriate resources for investigators 
and facility staff in remote and under-resourced regions to enable them to 
safely obtain high-quality paediatric chest radiographs. These resources were 
developed by the Quality and Safety co-investigator and finalised by a 
technical working group consisting of radiologists and investigators. 
Results: The technical guidelines are divided into three sections: 1. The Pre-
Study Survey evaluates the current technical parameters, capabilities and 
processes of individual radiology facilities and their suitability for participation in 
paediatric epidemiological studies. 2. The Study Guidelines review the major 
factors contributing to quality paediatric chest radiographs, identifying issues 
that are most important and/or require adjustment by a research team. 
Recommendations for achieving quality chest radiographs in studies involving 
children aged 0-59 months are provided. 3. The Quality Control Guidelines 
include the recommended performance and documentation of quality control 
measures for continual optimisation of equipment and facility processes. 
Conclusion: These WHO-CRES guidelines provide an easily accessible and 
unique resource to better facilitate the acquisition of consistent, high-quality 
chest radiographs in epidemiological studies.  
B-0766 14:24  
Value of paediatric chest CT in a representative patient cohort of 2019 
examinations  
M. Esser, S. Hess, M. Teufel, S. Gatidis, I. Tsiflikas, J.F. Schäfer; Tübingen/DE  
Purpose: To test if chest CT delivers useful results according to the clinical 
question and which examinations are possibly dispensable. 
Methods and Materials: In this retrospective study at a clinic with maximum 
care facilities, 2019 chest CT examinations in 973 patients (median age, 10.5 
years; range, 2 days to 17.9 years) were analysed over 7 years with regard to 
the application of contrast agents and information about the referring 
department including the clinical question and CT findings. For this purpose 
electronically stored documents were evaluated. For each examination it was 
identified if the clinical question was answered and if additional findings 
relevant for therapy were detected. 
Results: Most CT scans were performed without contrast enhancement 
(n=1251; 62%). Most examinations (n=987) were requested from the 
Department of Haematooncology. The most frequent indication was a 
suspected pneumonia (n=380; 19%). In 1411 CT scans (70%) anomalies 
according to the suspected diagnosis were found, 608 examinations (30%) 
gave a negative reply to the question. There were predominantly negative 
results (62%) when the question was for an infection process prior to bone 
marrow transplant. In 81 scans without relevant findings concerning the 
primary question, an additional finding relevant for therapy was detected (19% 
of all additional findings). Overall, CT provided findings with a conclusive result 
and clinical relevance in 97.6% of all scans. 
Conclusion: Based on an appropriate clinical question, paediatric chest CT in 
specialised centres has a high informative clinical value. The strict indication 
and clinical evaluation appears crucial for the prevention of dispensable CT 
examinations.  
B-0767 14:32  
Influence of reconstruction algorithms to chest CT examination in 
children: comparison of image quality among standard-, reduced- and 
ultra-low-dose CTs in chest phantom study  
E. Suehiro1, T. Sekitani1, W. Tani1, N. Negi1, K. Fujii2, T. Yoshikawa1, Y. Ohno1; 
1
Kobe/JP, 2Tokyo/JP  
Purpose: To determine the influence of reconstruction algorithm to image 
quality and radiation dose reduction capability on chest CT in chest children 
phantom study. 
Methods and Materials: A commercially available chest CT phantom was 
simulated as 5-year-old children were scanned with a 320-detector row CT with 
automatic exposure control (AEC). Performance of 3D AEC was performed by 
targeted SDs, which were tested from 10 (CTDIvol: 16.6mGy) to 110 (CTDIvol: 
0.5mGy) at every 20 intervals, although other scan parameters were constant. 
Then, each SD data was reconstructed as 1mm and 5mm contiguous section 
thickness with filtered back projection (FBP), commercially available hybrid-
type iterative reconstruction (IR) (i.e. AIDR 3D), and model-based IR (FIRST) 
methods. Then, actual image noise determined by ROI measurement was 
compared at each targeted SD data by Tukey's HSD test. Finally, mean 
visualization scores were compared between CT obtained at targeted SD as 
10 and reconstructed by FBP (i.e. standard CT) and all other CT data by 
Wilcoxon signed-rank test. 
Results: On both section thickness CT images at each targeted SD, image 
noise of FBP was significantly higher than that of AIDR 3D and FIRST 
(p<0.05). When compared lung parenchyma visualization capability, both 
section thickness CT data obtained at targeted SD as 70, 90 and 110 and 
reconstructed by FBP had significant difference with standard CT (p<0.05). 
Conclusion: This phantom study shows reconstruction algorithm had 
significantly affected the radiation dose reduction at chest CT examination 
using 3D AEC in children.  
B-0768 14:40  
Technical challenges of quantitative chest MRI data analysis in a large 
cohort paediatric study  
A. Nguyen1, A. Perez-Rovira1, L. Duijts1, M. De Bruijne1, A. Aliverti2, 
F. Pennati2, T. Ivanovska3, H.A. Tiddens1, P. Ciet1; 1Rotterdam/NL, 2Milan/IT, 
3
Göttingen/DE (354271an@student.eur.nl)  
Purpose: To evaluate the effect of geometric distortion on MRI lung volume 
quantification and evaluate available manual, semi- and fully automated 
methods for lung segmentation. 
Methods and Materials: A phantom was scanned with MRI and CT. GD was 
quantified as difference in phantom’s volume between MRI and CT, with CT as 
gold standard. Dice scores were used to measure overlap in shapes. 
Furthermore, a subset of 11 subjects with MRI measurements from a large 
prospective population-based cohort study was used to test lung segmentation 
methods on 2D and 3D Gradwarp corrected scans. Intra-Class Correlation 
coefficient, Bland-Altman plots, Wilcoxon, Mann-Whitney U and paired t-tests 
were used for statistics. 
Results: Using phantoms, volume differences between CT and MRI varied 
according to MRI positions and 2D and 3D Gradwarp correction. With the 
phantom located at isocenter, MRI overestimated the volume relative to CT by 
5.56±1.16% to 6.99±0.22% with body and torso coils, respectively. Higher Dice 
scores and smaller intra-object volume differences were found for 3D 
Gradwarp corrected MR images. In subjects, semi- and fully automated 
segmentation tools had high agreement with manual segmentations 
(ICC=0.971-0.993 for end-inspiratory scans; ICC=0.992-0.995 for end-
expiratory scans). Manual segmentation time per scan was approximately 4 
hours and 2-3 minutes for automated methods. 
Conclusion: Volume overestimation of MRI due to GD can be quantified. 
Existing semi- and fully automated segmentation methods allow accurate, 
reproducible and fast lung volume quantification. Chest-MRI can be a valid 
radiation-free imaging modality for lung segmentation and volume 
quantification in large cohort studies.  
Author Disclosures: 















B-0769 14:48  
Imaging findings of Loeys-Dietz syndrome in paediatric population  
H.O. Özdemir, A. Sanchez-Montanez Garcia-Carpintero, A. Sabate Rotes, 
I. Delgado Alvarez, L. Riaza Martin, A. Coma, L. Riera Soler, A. Castellote, 
E. Vazquez Mendez; Barcelona/ES (onurkont88@gmail.com)  
Purpose: Loeys-Dietz syndrome is a rare autosomal-dominant connective 
tissue disorder with multisystemic radiological manifestations. The purpose of 
our study was to describe radiological findings of LDS in 3 groups; 
cardiovascular, neuroradiological and musculoskeletal findings which can help 
to correct diagnosis and follow-up. 
Methods and Materials: Three paediatric radiologists retrospectively reviewed 
cardiovascular MRI, cranial MRI/MRA, cervical MRA/CTA and plain film studies 
of 12 patients all of whom had positive genetic testing and clinical 
characteristic of LDS. All patients were under 18 years old at diagnosis. All of 
them had cardiovascular MRI and nine had neurovascular imaging modalities. 
Results: Eleven patients had aortic root dilatation which is the most common 
cardiovascular finding of the syndrome. 6 patients had also dilatation of the 
other parts of thoracic aorta, 2 had main pulmonary artery dilatation, 2 had 
coronary artery dilatation, 1 had abdominal aortic dilatation and 1 had bicuspid 
aortic valve. 2 patients had aortic dissection (cause of death). One patient had 
normal cardiovascular MRI. In between 9 patients who had cranial imaging, all 
patients had tortuosity of vertebrobasillary and carotid arteries, hypertelorism 
and microretrognathia. Other neuroradiological findings: craniosynostosis (5 
patients), upper cervical spine abnormalities (3), gliotic foci (2), 
ventriculomegaly (1), intracranial aneurysms and intracranial haemorrhage (1, 
cause of death). As musculoskeletal findings, 10 patients had scoliosis, 7 had 
pectus deformities and 1 had joint contractures. 
Conclusion: Aortic root dilatation, neurovascular tortuosity, hypertelorism, 
microretrognathia are the most common imaging findings associated with LDS. 
Aortic dissection and intracranial haemorrhage are the most common causes 
of mortality.  
B-0770 14:56  
Aortic & carotid intima-media thickness in term small for gestational age 
newborns and term normal newborns  
S.M.s.a. Revanna, V. Kenchanahalli Rangaswamy, V. Devappa, 
V.K. Shamachar; Bangalore/IN (sinumr25@gmail.com)  
Purpose: To compare the intima media thickness of abdominal aorta (aIMT) & 
carotid arteries (cIMT) in small for gestational age (SGA) term newborns with 
appropriate for gestation age term newborns 
Methods and Materials: In our study the newborns are divided into 2 groups: 
Group I included 50 AGA normal term newborns with birth weight between 50-
90th centile (control group) and group II included 50 SGA term newborns with 
birth weight less then 10th centile (patient group). All measurements are 
performed by a single observer by using high resolution ultrasonography. 
Results: Mean abdominal aIMT and cIMT values of normal term newborns 
(AGA) were 0.40 ± 0.042 mm (n = 50) and 0.32 ± 0.031 mm (n = 50), 
respectively. Maximum and minimum aIMT and cIMT values of term newborns 
were 0.45 and 0.35 mm and 0.35 and 0.25 mm, respectively. The mean aIMT 
and cIMT were higher in SGA group (0.45 ± 0.058 mm) and 0.40 ± 0.047 
compared with the control group. 
Conclusion: Small for gestational age fetuses have a thicker aortic and carotid 
wall than AGA fetuses, which possibly represents preclinical atherosclerosis 
and a predisposition to later cardiovascular disease.  
B-0771 15:04  
What is the underestimation of radiation dose to the paediatric thyroid 
from contrast-enhanced CT, if contrast medium uptake is not taken into 
account?  
K. Perisinakis, S. Pouli, A. Tzedakis, K. Spanakis, A.A. Hatzidakis, M. Raissaki, 
J. Damilakis; Iraklion/GR (stellapouli@gmail.com)  
Purpose: Administration of iodine-based contrast in CT has been shown to 
increase radiation dose in enhanced organs. The current dose calculation 
methods ignore contrast administration. The aim of our study was to assess 
the underestimation of radiation dose to the thyroid of children undergoing 
contrast-enhanced CT if contrast medium uptake is not taken into account. 
Methods and Materials: Paediatric head/neck or chest CT examinations 
involving pre- and post-contrast imaging were retrospectively selected from our 
department database to identify those CT image series where the thyroid was 
visible. CT density of thyroid tissue in HU was measured in pre- and post- 
contrast images at the corresponding positions. The resulting ∆HU was 
recorded for each patient. Utilizing recently published data, ∆HU corresponded 
to % w/w iodine concentration and subsequently to % dose increase induced 
by contrast uptake. 
Results: The thyroid gland was visible in 11 chest and 3 neck CT scans. The 
estimated increase in radiation dose absorbed by thyroid tissue due to contrast 
accumulation ranged from 12% to 46%, with a mean value of 23%. 
Conclusion: The radiation dose to the paediatric thyroid gland due to contrast 
enhancement may be underestimated by up to 46% if contrast medium uptake 
is not taken into account. Scanning of the upper lung fields should be avoided 
during paediatric chest CT whenever possible to prevent thyroid exposure. 
Whenever this is unavoidable, estimation of radiation dose to the gland should 
take into consideration contrast medium uptake.  
B-0772 15:12  
Dose distribution to radiosensitive organs using advanced thoracic CT 
imaging techniques  
A.F. Halaweish1, M. Siegel2, I. Duba1, K. Grant1, B. Schmidt3; 1Malvern, PA/US, 
2
St. Louis, MO/US, 3Forchheim/DE  
Purpose: To examine how various Thoracic CT techniques affect radiation 
dose distribution in pediatric-sized phantoms, with particular focus on 
especially radiosensitive organs like the lungs and breasts. 
Methods and Materials: In two anthropomorphic phantoms (1- and 5-year-old 
equivalents), radiation doses in 38 sites (six organs) were measured using 
metal oxide semiconductor field effect transistors (MOSFETs) paired with a 
mobileMOSFET measurement system (model TN-RD-70-W, Best Medical 
Canada Ltd.). The phantoms were scanned using routine single-energy, dual-
energy, ultra-fast pitch spiral and ultra-low dose tin-filtered CT imaging 
protocols. Organ dose distribution was calculated as a percentage of the dose 
length product, facilitating inter- and intra-protocol comparisons. 
Results: Compared with single-energy scans, dual energy CT demonstrated 
lower relative organ doses for both phantoms. Dual-energy scanning reduced 
lung dose by 27.3% and 21.9% and breast dose by 37.8% and 31.3 % in the 1- 
and 5-year-old phantoms respectively. Ultra-low dose Sn100kV scans reduced 
lung dose by 31.63% (1-year-old phantom) and 14.74% (5-year-old phantom) 
when compared to 70kV scans, and 13.79% (1-year-old phantom) and 1.89% 
(5-year-old phantom) when compared to 80kV scans. Ultra-low dose Sn100kV 
imaging in combination with ultra-fast pitch spiral produced the largest dose 
reduction for lung and breast compared to single-energy CT at 70 kV in the 5-
year-old phantom (25.66% and 48.44% for lung and breast respectively). 
Conclusion: Dual-Energy CT, ultra-low dose tin-filtered and ultra-fast pitch 
spiral scanning demonstrated a decreased dose to the lungs and breasts of 
pediatric size phantoms when compared with routine single-energy scans, 
while providing clinically diagnostic image quality.  
Author Disclosures: 
  A.F. Halaweish: Employee; Siemens Healthineers. I. Duba: Employee; 
Siemens Healthineers. K. Grant: Employee; Siemens Healthineers. 
B. Schmidt: Employee; Siemens Healthineers. 
B-0773 15:20  
Study of the feasibility of DAP-to-body-weight ratio as diagnostic 
reference level in paediatric interventional cardiology  
F. De Monte, L. Riccardi, A. Boschini, B. Castaldi, L. Baffoni, O. Milanesi, 
M. Paiusco; Padova/IT 
Purpose: To investigate the feasibility of the dose-area product to body weight 
ratio (DAP/BW) as dose index for Diagnostic Reference Level (DRL) in 
paediatric Interventional Cardiology (IC) procedures. 
Methods and Materials: IC procedures (91 diagnostic,166 therapeutic) 
performed on patients <18 years old were stratified into BW classes every 10 
kg. DAP values were extracted from the Structured Dose Report using a dose-
tracking software. Mean, median,  and 75th values of DAP and DAP/BW were 
calculated. ANOVA was used to determine whether there were any statistically 
significant differences between DAP corresponding to BW classes both for 
diagnostic and interventions. Correlations DAP vs. BW were investigated for 
diagnostic and therapeutic procedures and also for homogeneous subgroups 
of interventions. DAP/BW ratios were compared between procedure groups 
(Mann-Whitney test). 
Results: When diagnostic and therapeutic procedures are considered as a 
whole, DAP differences among BW classes were not statistically significant 
and, in addition, a low correlation DAP vs. BW was found (R=0.533 and 
R=0.265, respectively). Strong correlations did appear when procedures were 
stratified by type: R coefficient varied from 0.730 (angioplasty) to 0.859 (PDA 
closures). Highest DAP values resulted for highly complex interventions 
(angioplasty) performed on <10 kg babies. DAP/BW values derived from ASD 
closures were statistically different from all the other investigated interventions. 
Conclusion: When a robust correlation between DAP and BW exists, the 
DAP/BW ratio is a reliable DRL in IC procedures overcoming BW stratification 
method. An effort is necessary in order to define appropriate criteria of 
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B-0774 14:00  
The image quality of turbo high-pitch dual-source CT coronary 
angiography in patients with free-breathing, free heart rate and any BMI  
K. Sun, B. Lu; Beijing/CN (Henrysk@163.com)  
Purpose: To evaluate the image quality and effective radiation dose of turbo 
high-pitch dual-source CCTA in patients with free-breathing, free heart rate and 
any body mass index. 
Methods and Materials: Between July 2015 and December 2015, 1179 
consecutive patients (body mass index (BMI) range: 14.53-37.65 kg/m2) (597 
female, mean age: 58±10 years) undergoing clinically indicated CCTA were 
included. No -blockers were administered for all patients before the 
examinations. CCTA was performed with a 3rd-generation dual-source CT 
system. The image acquisition phase was manually set at 60% of the RR 
interval for patients with HR70 beats per minute (bpm) and at 30% of the RR 
interval for the patients with HR>70bpm. The image noise, contrast-to-noise 
ratio (CNR), image quality scores and effective radiation dose were assessed. 
Results: The average heart rate was 76±12 bpm (range: 40-133 bpm). A total 
of 3537 coronary arteries were evaluated in 1179 patients. The mean image 
quality scores was 1.21±0.72 for all coronary arteries. Based on patient 
analysis, the proportion of non-diagnostic coronary artery segments was 
8.54%. The average image noise and CNR of aortic root were 24.6±6.7 HU 
(range:7-52 HU) and 30.8±9.8 (range 8.3-110.8), respectively. The effective 
radiation dose was 0.61±0.16 mSv (range: 0.14-1.41 mSv). 
Conclusion: In conclusion, in patients with free-breathing, free heart rate and 
any body mass index, the turbo high-pitch dual-source CT coronary 
angiography provides a good image quality and low rate of non-diagnostic 
coronary segments, while being associated with significant reduction of 
radiation exposure.  
Author Disclosures: 
  K. Sun: Author; Bin lu. 
B-0776 14:04  
Machine-learning on-site CT-derived fractional flow reserve (FFR) 
compared to invasive FFR: influence of myocardial mass on accuracy  
M. Albrecht1, S. Baumann2, J.W. Nance3, C.N. De Cecco3, A. Varga-Szemes3, 
R. Vliegenthart4, C. Schwemmer5, T.J. Vogl1, U.J. Schoepf3, S.S. Martin1; 
1
Frankfurt a. Main/DE, 2Mannheim/DE, 3Charleston, SC/US, 4Groningen/NL, 
5
Erlangen/DE (simartin@outlook.com)  
Purpose: To investigate the impact of myocardial mass on accuracy of on-site 
machine-learning CT-derived fractional flow reserve (CT-FFRml) for the 
determination of lesion-specific ischaemia using invasive FFR as the reference 
standard. 
Methods and Materials: In total, 458 vessels from 301 patients were 
evaluated. The correlation of myocardial mass was correlated to the 
discrepancy of CT-FFRml and FFR. Diagnostic accuracy of CT-FFRml for the 
detection of lesion-specific ischaemia (FFR < 0.8) was analysed according to 
the amount of myocardial mass. 
Results: Greater myocardial mass was associated with an underestimation of 
CT-FFRml values (r = 0.307, P < 0.001). The incremental value of CT-FFRml 
in diagnostic accuracy compared to visual CCTA assessment was greater (P = 
0.04) in the cohort with higher myocardial mass (increase in accuracy, 18.0 %) 
in comparison with lower myocardial mass values (increase in accuracy, 16.8 
%). 
Conclusion: Machine-learning on-site CT-FFRml has greater incremental 
value for the detection of lesion-specific ischaemia compared to CCTA 
evaluation in patients with higher myocardial mass. Simultaneously, higher 
myocardial mass is correlated to a slight underestimation of CT-FFRml values.  
Author Disclosures: 
 C.N. De Cecco: Consultant; Guerbet and Siemens. A. Varga-Szemes: 
Consultant; Guerbet.  C. Schwemmer: Employee; Siemens.  U.J. Schoepf: 






B-0777 14:08  
Extra-cardiac findings at cardiac MR imaging: a single-center 
retrospective study over 14 years  
F.C. Sokolowski, P. Karius, A. Lembcke, P.M. Wagner, A. Rodríguez Sánchez, 
M. Dewey; Berlin/DE (felix.sokolowski@gmail.com)  
Purpose: To determine the prevalence and significance of extra-cardiac 
findings (ECF) in a large set of cardiac magnetic resonance (MR) imaging-
examinations. 
Methods and Materials: The institutional review board approved this 
retrospective, single-center study. A total of 4376 cardiac MR imaging reports 
of 3553 patients (age 37.4 ± 20 years, 60.8 % male) from 2000 to 2014 were 
included. Findings with a recommendation for follow-up were considered 
“major ECF”. To analyze the association of indication, age and gender of 
patients with ECF, Poisson regression and computed incidence rates ratios 
(IRR) were evaluated. 
Results: The overall prevalence of ECF was 34% (95% confidence interval 
(CI) 32.5-35.6). Major ECF were present in 3.4% (95% CI 2.9-4.1) while 
findings that changed patient management were found in 0.9% (95% CI 0.7-
1.3). In the cases of congenital heart disease (CHD), the prevalence of ECF 
was higher as compared to myocarditis (IRR 6.0, p<0.001) while the 
prevalence for major ECF was lower (IRR 0.2, p<0.05). Increased patients’ age 
was associated with more non-vascular ECF (p<0.001). Female patients had 
the same probability of having an ECF as male patients (IRR 1.04 (95% CI 
0.95 - 1.14)). 
Conclusion: ECF in cardiac MR are present in about every third examination 
while relevant ECF that change patients’ management can be found in about 
one in hundred patients. Our data suggest that it is important to involve well-
trained radiologists in reading cardiac MR images, which often contain ECF if 
congenital heart disease is the clinical indication.  
Author Disclosures: 
 M. Dewey: Author; Dewey is the editor of Coronary CT Angiography and 
Cardiac CT, both published by Springer, and offers hands-on workshops on 
cardiovascular imaging (www.ct-kurs.de), Associate editor of Radiology and 
European Radiology. Consultant; He is a consultant to Guerbet and one of the 
principal investigators of multi-center studies (CORE-64 and 320) on coronary 
CT angiography sponsored by Toshiba Medical Systems.. Patent Holder; 
PCT/EP2016/071551. Research/Grant Support; Heisenberg Program of the 
DFG for a professorship (DE 1361/14-1), the FP7 Programme of the European 
Commission for the randomized multicenter DISCHARGE trial (603266, 
HEALTH-2012.2.4.-2), The European Regional Development Fund (20072013 
2/05, 20072013 2/48), the German Heart Foundation/German Foundation of 
Heart Research (F/23/08, F/27/10), The Joint Program from the German 
Research Foundation (DFG) and the German Federal Ministry of Education 
and Research (BMBF) for meta-analyses (01KG1013, 01KG1110, 01KG1110), 
GE Healthcare, Bracco, Guerbet, and Toshiba Medical Systems. Speaker; 
Lecture fees from Toshiba Medical Systems, Guerbet, Cardiac MR Academy 
Berlin, and Bayer (Schering-Berlex). Other; Institutional master research 
agreements exist with Siemens Medical Solutions, Philips Medical Systems, 
and Toshiba Medical Systems.. 
B-0778 14:12  
Incremental diagnostic value of myocardial perfusion stress testing for 
intermediate obstructive lesions on coronary CT angiography in acute 
chest pain  
E. Feldman, J. Bai, E. van Staalduinen; Stony Brook, NY/US 
(eric.Feldmann@stonybrookmedicine.edu)  
Purpose: The purpose of our study is to evaluate the diagnostic yield of 
nuclear medicine stress testing in acute chest pain patients deemed to have 
borderline obstructive (50-69%) stenosis by coronary CT angiography (CCTA). 
Methods and Materials: We retrospectively reviewed 4769 patients who 
presented to our emergency department (ED) with acute chest pain and had a 
CCTA. All patients had normal initial troponin levels, EKG and no prior history 
of obstructive coronary artery disease. The interpreting physicians' 
recommendations and any subsequent testing such as myocardial stress/rest 
perfusion imaging and coronary artery catheterization were recorded. 
Results: Patient demographics included a mean age of 53.3 years and 53.3% 
(N= 2544) were female. The interpreting CCTA physicians recommended 
stress testing 8% (385/4769) of the time with 54% (209/385) of these patients 
receiving nuclear medicine myocardial perfusion imaging (MPI) within 30 days 
of the coronary CT. Of the patients receiving MPI, 93.8% (N=196) were 
interpreted as normal and 6.2% (N=13) abnormal. Of the patients with an 
abnormal MPI 62% (N=8) had a coronary catheterization with 37.5% (N=3) of 
these requiring percutaneous coronary intervention (PCI). 
Conclusion: The vast majority of acute chest pain patients (93.8%) with 
intermediate (50-69%) obstructive lesions on CCTA will have normal findings 
on contemporaneous MPI.  
 
  






B-0779 14:16  
Subclinical coronary and carotid atherosclerosis in asymptomatic high-
risk patients  
M. Guglielmo1, A. Guaricci2, V. Lorenzoni1, S. Mushtaq1, G. Muscogiuri1, 
E. Maffei3, F. Cademartiri4, R. Mark5, G. Pontone1; 1Milan/IT, 2Bari/IT, 
3
Monastier di Treviso/IT, 4Montreal, ON/CA, 5Maywood, IL/US 
(marco.guglielmo@ccfm.it)  
Purpose: The aim of the study was to evaluate the incremental prognostic 
benefit of carotid artery disease and subclinical coronary artery disease (CAD) 
features in addition to conventional clinical evaluation in asymptomatic 
population. 
Methods and Materials: Over a six-year period, 10-year-Framingham risk 
score (FRS) together with carotid ultrasound (CUS) and coronary computed 
tomography angiography (CCTA) were evaluated for the prediction of coronary 
heart disease (CHD) events. 
Results: We enrolled 517 consecutive asymptomatic patients (63% male, 
64±10 years of age). Median CACS was 34 [0-100]. Over a median follow-up 
of 4.4 [3.4-5.1] years there were a total of 53 CHD events (10%). Patients 
experiencing CHD had higher CACS, higher incidence of carotid disease, 
presence of CAD50%, and remodeled plaque as compared to patients without 
CHD events. At multivariable analyses, presence of CAD50% (HR=5.14, 
95%CI: 2.1-12.4) and percentage of segment with remodeled plaque 
(HR=1.04, 95%CI: 1.03-1.06) independently predict CHD risk (P<0.001). The 
models adding CAD50% or percentage of segments with remodeled plaque 
resulted in higher discrimination and reclassification ability compared to a 
model based on 10-year FRS, carotid disease and CACS. Specifically, the C-
statistic improved up to 0.75 with the addition of CAD and 0.84 when adding 
percentage of segments with remodeled plaque, while net reclassification 
improvement index was 0.86 and 0.92, respectively. 
Conclusion: In an asymptomatic population, carotid disease assessment and 
CACS provide incremental prognostic value as compared to FRS. CAD- and 
plaque-positive remodeling further increase the CHD events prediction as 
compared to a model based on 10-year-FRS, carotid disease, and CACS 
estimation.  
B-0780 14:20  
Comparison of sports activity between ambitious triathletes with and 
without myocardial late gadolinium enhancement  
J. Stáreková, B. Scherz, E. Tahir, M. Avanesov, M. Patten, J.M. Weinrich, 
K. Müllerleile, G. Adam, G.K. Lund; Hamburg/DE (j.starekova@uke.de)  
Purpose: Long-term intensive training leads to functional and morphological 
adaptation of the heart. Incidence of myocardial fibrosis detected by cardiac 
MRI (CMR) is variable in competitive athletes. The purpose of this study was to 
analyse the differences in sports activity between triathletes with and without 
LGE. 
Methods and Materials: 54 competitive healthy male triathletes (44±10 years) 
underwent a CMR performed on 1.5T Achieva (Philips), including LGE 
imaging. Image analysis was performed on cvi42 (Circle). CMR parameters are 
given as the mean of two independent observers. Physical fitness was 
determined by an exercise test. Competition history was reported using a 
standardised questionnaire with information about the number, distance and 
duration of completed events. 
Results: In 9 out of 54 triathletes (17%) a non-ischaemic focal myocardial 
fibrosis of the left ventricle (LGE+) was detected. LGE+ triathletes had higher 
peak exercise systolic blood pressure (213±24 vs 194±26mmHg, p<0.05) and 
higher LV mass index (93±7 vs 84±11g/m2, p<0.05) compared to LGE- 
triathletes. They participated more often in middle- and long-distance 
competitions and completed longer cumulative race distances at cycling 
(4418±3094 vs 1490±1114km, p<0.0001) and swimming (64±32 vs 31±25km, 
p<0.01). 
Conclusion: There is high prevalence (17%) of focal non-ischaemic 
myocardial fibrosis among male triathletes. An increased systolic blood 
pressure during exercise, the amount and extent of race distances as well as 
unapparent myocarditis might be cofactors in the genesis of myocardial 
fibrosis. The clinical relevance of myocardial fibrosis in triathletes is currently 
unclear; however, it might be a foundation for future heart failure and 
arrhythmia leading to sudden cardiac death.  
B-0781 14:24  
Evaluation of dark blood LGE in assessing sub-endocardial MI and 
papillary muscle scar  
L. Song1, X. Ma1, X. Zhao2, L. Zhao1, Y. Fan1, B. Wu1, Z. Wang1, H. Chen1; 
1
Beijing/CN, 2Kunming/CN (linsheng.s1992@yahoo.com)  
Purpose: To investigate whether modified dark blood late gadolinium 
enhancement (DB-LGE) technique can provide complementary diagnostic 
information in patients with subendocardial myocardial infarction (MI) and 
papillary muscle scars. 
Methods and Materials: 37 patients (52±10 years, 34 male) with definitely 
diagnosed MI, were prospectively included. All patients underwent 3.0 T-
cardiac-MR (Discovery MR 750W, GE, WI) with conventional LGE and DB-
LGE acquisition. The image quality and infarcted size quantitative 
measurement were compared using paired T test and Bland-Altman analysis. 
The level of agreement between reviewers was assessed using intraclass 
correlation coefficients. 
Results: Modified DB-LGE performed better on a visual assessment of the 
ability to differentiate MI from the blood pool. The images provided significantly 
higher contrast to noise ratio (6.3±2.3 vs 2.1±1.4, P<0.001) and a 4-fold higher 
signal intensity ratio (4.9±1.8 vs 1.3±0.3, P<0.001) between MI and blood pool 
signals. DB-LGE detected more subendocardial MI (26 segments, 263 vs 237) 
and papillary muscle with scars (21 vs 7). Combined with echocardiography, 
papillary muscle with scars was associated with potential mitral valve 
insufficiency. Infarcted size compared between conventional LGE and DB-LGE 
showed no statistically significant difference (18.7±10.1 vs 19.4±10.5, 
P=0.096). The interobserver agreement was good to excellent for MI detection. 
Conclusion: DB-LGE improves the contrast between the MI and blood pool 
and helps in the identification of subendocardial MI and papillary muscle scars. 
The quantitative and qualitative comparison in this study revealed that DB-LGE 
may be an alternative method to LGE in clinical use.  
Author Disclosures: 
  L. Song: Author; First author. X. Ma: Author; Corresponding Author. X. Zhao: 
Author; First author.  
B-0782 14:28  
Stress-rest CMR for the assessment of myocardial perfusion reserve 
index modification after coronary sinus stent implantation  
A. Palmisano, G. Benedetti, F. Giannini, L. Baldetti, A. Del Maschio, 
F. De Cobelli, A. Esposito; Milan/IT (palmisano.anna@hsr.it)  
Purpose: The management of patients with angina refractory to 
revascularisation procedures and medical therapy is a challenge. The 
implantation of a hourglass-shaped coronary sinus stent named "Reducer" 
seems to improve patients’ symptoms. However, the physiopathological 
mechanism underlying clinical benefit is not clear. Aim of the study was to 
evaluate the modification in myocardial perfusion reserve occurring after 
"Reducer" implantation using a stress-rest CMR study. 
Methods and Materials: 11 patients eligible for implantation of the "Reducer" 
underwent clinical evaluation (CCS Angina Class and 6minutesWT) and a 
stress-rest CMR study with dipyridamole before the implantation and after 3 
months. Segmental and transmural distribution of inducibile hypoperfusion and 
LGE was visually assessed. Myocardial perfusion reserve index (MPRI) of 
each segment and each myocardial layer (endocardium, midwall and 
epicardium) was measured using stress-rest CMR. 
Results: All patients reported an improvement of 2CCS (p <0.0001) and a 
60% increase in the average distance during the 6 minutes WT (p=0.004). 
MPRI significantly increased after "Reducer" implantation (1.29 vs 1.48; 
p<0.05). The analysis per cardiac segments showed an increase of MPRI in 
the ischemic territories (p=0.02334 for subendocardial ischaemia, and 
p=0.0001 for transmural ischaemia) while post-infarction necrotic area and 
healthy myocardial did not show significant changes (p=0.14 and p=0.12, 
respectively). 
Conclusion: These preliminary data provide a new insight about the 
physiopathological mechanism of action of coronary sinus stent, suggesting its 
ability to determine a reduction of the inducible ischaemia of viable myocardial 
segments, associated to an improvement of angina symptoms and exercise 
tolerance.  
B-0783 14:32  
Myocardial fibrosis imaging based on T1-mapping and ECV measurement 
in diabetes: diagostic value compared with LGE imaging  
Y. Gao, Z. Yang, X. Liu; Chengdu/CN (304789161@qq.com)  
Purpose: The objects of this study were: (i) evaluate the sensitivity and extent 
of myocardial fibrosis by extracellular volume fraction (ECV) and late 
gadolinium enhancement (LGE) in diabetes mellitus (DM) patients; (ii) ECV in 
diabetic individuals would be associated with the level of glycosylated 
hemoglobin (HbAlc) and duration of diabetes. 
Methods and Materials: Thirty-six DM patients and 15 health controls who 
underwent cardiovascular magnetic resonance (CMR) including ECV 
measurement and LGE imaging were included. The 36 DM patients were 
classified in two group: a higher HbAlc group (HbA1c (%) 7.0; n=15) and a 
lower HbAlc group (HbA1c (%) <7.0; n=21). The independent-samples T test 
and Spearman rank correlation test were used for comparison and evaluated 
the relation. 
Results: CMR measured ECV value was significantly higher in DM group 
compared with control group (36.1±3.8% vs. 31.1±1.7%, p<0.05), while the 
LGE percent was no difference in the two group (p=0.234). Between the higher 
HbAlc group and lower HbAlc group, the value of ECV was higher in the higher 
group (36.2±4.72 vs. 32.67±2.61, p<0.05). The spearman test showed a 
  






moderate relationship between ECV and high HbAlc (r=0.331, p<0.05) and the 
same between ECV and duration of diabetes (r=0.348, p<0.05). 
Conclusion: For DM patients, ECV might be more sensitive to early detect 
myocardial fibrosis than LGE. In addition, ECV was associated with HBALC 
and duration disease time, which could help to early heart condition monitoring.  
B-0785 14:36  
Prevalence of subclinical coronary artery disease by coronary computed 
tomography among low risk women after preeclampsia  
G.A. Zoet1, L. Benschop2, R.P. Budde2, C.J.M. de Groot3, A.H.E.M. Maas4, 
J.E. Roeters van Lennep2, B.B. van Rijn1, B.K. Velthuis1, A. Franx1; 
1
Utrecht/NL, 2Rotterdam/NL, 3Amsterdam/NL, 4Nijmegen/NL 
(gzoet@umcutrecht.nl)  
Purpose: The risk of coronary artery disease (CAD) is increased after 
preeclampsia, although traditional cardiovascular risk models often classify 
these women as low risk. This study compared prevalence of coronary artery 
atherosclerosis in low risk women with a history of preeclampsia to a 
population-based reference cohort. 
Methods and Materials: Formerly preeclamptic women aged 45-55 years and 
low risk according to National Cholesterol Education Program (NCEP) were 
included in this analysis of a multicenter, prospective cohort study. Data were 
compared with women of similar age and ethnicity in the Multi-Ethnic Study of 
Atherosclerosis (MESA). Coronary artery calcium score (CACS) was calculated 
and contrast-enhanced coronary computed tomography angiography (CCTA) 
was performed in addition to routine cardiovascular risk assessment. Primary 
outcome was prevalence of CACS &gt;0 Agatston Units (AU) and/or any 
coronary atherosclerotic plaques on CCTA. CACS were converted to adjusted 
MESA percentiles. Increased cardiovascular risk was defined according to the 
2016 European guideline definition as CACS &gt;300AU or &gt;75th MESA 
percentile. 
Results: Of 131 asymptomatic low risk women (mean age 48.3+/-2.8 years) 
with prior preeclampsia; 28% had CACS &gt;0, 46% had coronary 
atherosclerotic plaques on CCTA, and 3.9% showed &gt;50% luminal stenosis. 
Compared with the reference group, women after preeclampsia showed 
increased prevalence of CACS &gt;0AU (OR 2.3; 95% CI 1.4-3.8), any plaque 
on CCTA and increased cardiovascular risk (28% versus 15%; OR 2.2, 95% CI 
1.4-3.7). 
Conclusion: Asymptomatic women after preeclampsia aged 45-55 years 
commonly show subclinical CAD with increased cardiovascular risk compared 
with women from a population-based reference cohort.  
B-0786 14:40  
Quantitative oedema and late gadolinium enhancement thresholds for the 
diagnosis of myocarditis in suspect cases  
M. Alì, C.B. Monti, F.S. Carbone, F. Secchi, P.M. Cannao', F. Sardanelli; 
Milan/IT (marco.ali90@gmail.com)  
Purpose: To quantify and evaluate left ventricle oedema and late gadolinium 
enhancement (LGE) percentages in patients with acute myocarditis in order to 
establish thresholds for Lake Louise Criteria in cardiac magnetic resonance 
(CMR). 
Methods and Materials: A total of 96 patients, 48 of which having a diagnosis 
of myocarditis and two CMR examinations from acute phase and follow-up (at 
least 3 months apart), and 48 age- and sex- matched healthy subject as 
control group with one CMR examination, were retrospectively analyzed. For 
both groups left ventricle oedema and LGE percentages were quantified after 
manual contouring using the semi-automated Medis Suite MR Software. After 
the assessment of data distributions’ normality, parametric and non-parametric 
tests were used for comparison among groups. Thresholds were established 
using ROC curves formed comparing data from acute phase and controls. 
Results: Comparison between oedema in acute phase (12.76%, IQR 8.73%
19.10%) and follow-up (6.69%, IQR 5.41%9.00%), or with controls (6.41%, 
IQR 5.27%7.67%), showing significant differences with both p<0.001. The 
comparison between LGE in acute phase (6.30%, IQR 4.51%9.08%) and 
follow-up (4.29%, IQR 3.22%7.19%), or with controls (4.27%, IQR 3.00%
5.09%), showed significant differences with a p-value of 0.001 and <0.001, 
respectively. Thresholds were established for oedema at 7.9% with 93% 
sensitivity and 73% specificity, and for LGE at 4.30% with a sensitivity of 80% 
and specificity of 55%. 
Conclusion: Quantitative thresholds of oedema and LEG may be used as 









B-0787 14:44  
Correlation between liver density and epicardial fat volume: biomarkers 
of coronary artery disease  
C. Ferrari1, G. Milanese1, M. Silva1, N. Giovanardi1, M. Goldoni1, E. Maffei2, 
F. Cademartiri3, N. Sverzellati1; 1Parma/IT, 2Urbino/IT, 3Rotterdam/NL 
(cate.ferr@gmail.com)  
Purpose: To test correlation between liver density and metabolic visceral 
adipose depot of epicardial fat, and whether it can act as biomarker of coronary 
artery disease (CAD) in patients undergoing cardiac computed tomographic 
angiography (CCTA). 
Methods and Materials: The mean liver density (MLD) was quantified 
averaging density of three manual regions of interest (ROI; one in the left and 
two in the right lobe) on non-contrast computed tomography (CT) scans. 
Patients were stratified in steatotic (MLD 40 HU) and non-steatotic (MLD >40 
HU). Epicardial fat volume (EFV) was quantified as the sum of voxels with 
density between -190 and -30 HU, within the volume outlined by the epicardial 
sheet. CAD was qualitatively evaluated and stratified in three groups: no CAD, 
non-obstructive CAD, and obstructive CAD. Continuous variables were 
reported as median and its interquartile range (IQR). 
Results: In 1.181 patients, median MLD was 51.71 HU (IQR=13); median EFV 
was 87.19 ml (IQR=63.36). No CAD, non-obstructive CAD, and obstructive 
CAD were defined in 721 (61%), 296 (25.1%) and 164 (13.9%) patients, 
respectively. MLD and EFV were negatively correlated (rs=-0.364; p<0.001); 
EFV was significantly higher in steatotic (114.21, IQR=84.02) compared with 
non-steatotic patients (82.03, IQR=58.23) (p<0.001). MLD was lowest in 
patients with obstructive CAD (p<0.001). In multivariate analysis, after 
adjustment for traditional clinical cardiovascular risk factors, MLD was 
associated with EFV (p<0.001) and with the presence of CAD (p<0.001). 
Conclusion: MLD correlates with EFV and it can act as a potential biomarker 
for the stratification of CAD risk.  
B-0788 14:48  
Semi-quantitative evaluation of coronary microvascular dysfunction in 
paediatric patients with leukaemia using magnetic resonance first-pass 
perfusion imaging  
Q. Zhao, X. Rong, Z. Yang, K. Diao, Y. Gao, Y. Guo; Chengdu/CN 
(zhaoqin626@foxmail.com)  
Purpose: To evaluate the regional coronary microvascular dysfunction 
discrepancies in paediatric leukaemia patients with or without daunorubicin 
therapy by cardiac magnetic resonance (CMR) first-pass perfusion imaging. 
Methods and Materials: Twenty-six paediatric patients with leukaemia, 
including 13 with daunorubicin therapy (treatment group) and 13 without 
daunorubicin therapy (non-treatment group) underwent CMR at rest. Imaging 
protocols included short axis cine, first-pass myocardial perfusion and late 
gadolinium enhancement (LGE). Left ventricular ejection fraction (LVEF), 
degree of LGE, perfusion parameters including maximal slope (Slopemax), 
time to peak (Tpeak) and peak signal intensity were all measured and 
compared by independent-sample t-test. The Spearman correlation test was 
used to calculate the relationships between LVEF, LGE, cumulative dose of 
daunorubicin and perfusion parameters. 
Results: A total of 416 myocardial segments were analysed. Compared with 
non-treatment group, Slopemax decreased in treatment group (12.62±4.80 vs. 
8.53±2.64, p < 0.05), while Tpeak increased (30.85 ±12.89 vs. 116.78±38.95, p 
< 0.001) in apical segments alone. LVEF and peak signal intensity were not 
shown significant difference in two groups. LGE was identified in 6 patients 
with daunorubicin therapy. In mid-ventricular segments, the cumulative dose of 
daunorubicin (mean 165.13±54.43 mg) was moderately associated with the 
degree of LGE (r = 0.682, p < 0.05). 
Conclusion: Combined with LGE, CMR resting first-pass myocardial perfusion 
may help to achieve early diagnosis and clinical intervention of coronary 
microvascular dysfunction in paediatric patients with leukaemia, especially 
after the daunorubicin therapy.  
B-0789 14:52  
Cardiac magnetic resonance in prognostic stratification of patients with 
acute myocardial infarction and preserved ejection fraction  
G. Dacquino, I. Carbone, N. Galea, L. Agati, G. De Rubeis, C. Catalano, 
M. Francone; Rome/IT (gianmarcodacquino@gmail.com)  
Purpose: This study was designed to investigate the prognostic role of early 
post-infarction CMR on long-term risk stratification of STEMI patients with 
preserved ejection fraction (LVEF > 50%). 
Methods and Materials: 55 PCI-reperfused STEMI patients were included. 
The median time between STEMI and CMR was 5 days (IQR 3 - 7). LV 
volumes and function, infarct size, early and late microvascular obstruction 
(MVO), and haemorrhage were measured. The primary endpoints were the 
incidence and CMR determinants of MACE at 5-year follow-up. 
  






Results: During median follow-up of 2.5 years (range 1 to 5 years), 7 patients 
experienced MACE, yielding an annualized event rate of 2.71%. All CMR-
based prognostic markers were no significantly different between MACE and 
no MACE patients, except for late MVO extent (0.9 ± 1.0 g vs. 0.07 ± 0.10 g; p 
= 0.003). Late MVO extent and the incidence of MACE at 5 years correlated 
moderately (r = 0.411; p = 0.003). ROC analysis identified late MVO extent > 
1.4 g (AUC 0.647; 95% CI, 0.374 - 0.920; p = 0.036) as the best cut-off value 
for predicting the primary endpoint. Late MVO cut-off value > 1.4 g was a 
strong independent predictor of MACE at long-term follow-up (HR = 8.31; 95% 
CI, 1.52 -45.65; p = 0.015). 
Conclusion: CMR-based late MVO extent after primary PCI is a strong 
predictor of MACE at 5-year follow-up in patients with LVEF > 50%. 
Remarkably, late MVO extent > 1.4 g provided prognostic insights leading to 
improved long-term risk stratification.  
B-0790 14:56  
4D flow MRI for the analysis of celiac trunk and mesenteric artery 
stenoses  
F. Siedek, D. Giese, K. Weiss, S. Ekdawi, S. Brinkmann, W. Schröder, 
C. Bruns, D. Maintz, S. Haneder; Cologne/DE (f.siedek@gmail.com)  
Purpose: This study aims to assess the feasibility of 4D-flow-MRI 
measurements in complex vascular territories; namely, the celiac artery(CA) 
and superior mesenteric artery(SMA). 
Methods and Materials: In this prospective study, 22 healthy volunteers(HV) 
and 10 patients(PAT) were scanned at 3T. Blood flow parameters were 
compared between HV and PAT with stenosis of the CA and/or SMA as a 
function of stenosis grade characterised by prior contrast-enhanced computed 
tomography(CE-CT). 4D-flow-MRI acquisition covered the CA, SMA and 
adjusting parts of the aorta(AO). Measurements of velocity- (peak 
velocity[PV],average velocity[AV]) and volume-related parameters (peak 
flow[PF],stroke volume[SV]) were conducted. Further, stenosis grade and wall 
shear stress(WSS) in the CA, SMA and AO were evaluated. 
Results: In PAT, prior evaluation by CE-CT revealed 11 low- and 5 mid-grade 
stenoses of the CA and/or SMA. PV and AV were significantly higher in PAT 
than in HV [PV:p<0.0001;AV:p=0.03,p<0.001]. PF and SV did not differ 
significantly between HV and PAT; however, a trend towards lower PF and SV 
could be detected in PAT with mid-grade stenoses. Comparison of 4D-flow-
MRI with CE-CT revealed a strong positive correlation in estimated degree of 
stenosis (CA:r=0.86;SMA:r=0.98). PAT with mid-grade stenoses had a 
significantly higher average WSS magnitude than HV (p=0.02). 
Conclusion: This study suggests that 4D-flow-MRI is a robust technique for 
the evaluation of complex flow characteristics in small vessels such as the 
CA/SMA. It approves comparable to the morphologic assessment of complex 
vascular territories using CE-CT but in addition offers the functional evaluation 
of flow parameters that goes beyond the morphology.  
Author Disclosures: 
 K. Weiss: Employee; Philips Healthcare, Germany.  
B-0791 15:00  
Comparison of biphasic DE-CT with virtual unenhanced dual energy 
reconstruction and triphasic CT with true unenhanced images in patients 
with suspected acute bleeding  
S. Walter, S. Schneeweiß, M. Maurer, M. Lescan, F. Bamberg, K. Nikolaou, 
A.E. Othman; Tübingen/DE (sven.walter@uni-tuebingen.de)  
Purpose: The comparison of biphasic DE-CT with arterial and venous phase 
and conventional triphasic CT in patients with suspected active hemorrhaging. 
Methods and Materials: With suspected active bleeding, ninety-seven 
consecutive patients underwent routine triphasic CT with true unenhanced 
(TNE), arterial and venous dual-energy phase. For simulation of virtual 
unenhanced images (VNE), which were generated using dual-energy venous 
phase, we used commercially available software. Both noncontrast datasets 
were assessed on image quality, noise, artifacts, sharpness and diagnostic 
confidence on a 5-point-scale (5 = best possible outcome) by two blinded 
readers, individually. Furthermore, datasets with conventional triphasic CT and 
biphasic DE-CT with VNE were compared in respect to presence/absence of 
active bleeding and type of bleeding. 
Results: Acute hemorrhage was diagnosed in 37.1% (75% arterial) of the 
included subjects (mean age: 66.3±14.5 years, 62% male). VNE images 
showed significantly lower overall image quality (p<.001) while compensation 
for artifacts was superior (p<.001) compared to TNE. No significant difference 
was seen in diagnostic confidence, both rated highly (p.012). Hematoma was 
found in 48.6% in virtual and true unenhanced scans with no discordant 
findings by the radiologists (Kappa=1.0). Regarding presence and type of 
hemorrhage, triphasic and biphasic CT datasets showed almost perfect 




Conclusion: VNE images showed comparable diagnostic confidence and an 
almost perfect agreement regarding presence and type of acute hemorrhage 
as TNE images. This indicates that biphasic DE-CT with VNE could replace 
triphasic CT for suspected acute bleeding, thus reducing scan time and 
radiation dose.  
B-0792 15:04  
Virtual monochromatic imaging improves the stent visualisation in lower 
extremity run-off CT angiography by dual-layer spectral detector CT  
D. Zhang, Z. Jin, H. Xue, S. Yu, R. Wu; Beijing/CN (cadina1984@163.com)  
Purpose: To evaluate the image quality and optimise keV level of VMI on stent 
visualisation in lower extremity CT angiography (CTA) compared with 
conventional 120 kVp image. 
Methods and Materials: 24 patients undergoing run-off CTA on a dual-layer 
spectral detector CT were enrolled. All images were acquired at 120-kVp and 
monochromatic images from 40 to 150 keV with 10 keV increment and 
conventional 120 kVp images were reconstructed from the same scan due to 
the nature of spectral detector CT. The image quality was analysed on 12 
monochromatic and conventional image sets. In-stent luminal diameter was 
measured twice using a calibre by 2 radiologists. The attenuation, noise, SNRs 
and CNRs were measured. Image quality was determined using a five-point 
scale. 
Results: 30 stents were present. CNR and SNR were significantly higher with 
70 keV-VMI (CNR: 16.0 ± 5.9-61.1 ± 27.5; SNR: 23.2 ± 11.7-48.6 ± 29.6) 
compared to conventional CT (CNR: 21.0 ± 8.6; all p = 0.000; SNR: 8.9 ± 10.4; 
all p < 0.003); there was no significant difference between 80keV-VMI (CNR: 
16.0±6.4, p= 0.197; SNR: 17.4±6.0, p=0.417) and conventional CT on CNR 
and SNR. Luminal stent diameters were increased at 70 keV (5.26 ± 1.27-
5.43 ± 1.32 vs. 5.09 ± 1.34, all p < 0.001). The score of image quality was 
highest at 80-90 keV-VMI (3.94 ± 0.25-4.00 ± 0.03 vs. 3.31 ± 0.48, both p = 
0.000). 
Conclusion: 80 keV-VMI improves image quality and accuracy for stent 
evaluation at run-off CT angiography by dual-layer spectral detector CT.  
B-0793 15:08  
Magnetic particle imaging: safe use of endovascular stents  
F. Wegner, T. Friedrich, N. Panagiotopoulos, J.P. Goltz, F.M. Vogt, M.A. Koch, 
T.M. Buzug, J. Barkhausen, J. Haegele; Lübeck/DE (franz.wegner@uksh.de)  
Purpose: Magnetic particle imaging (MPI) is a new three-dimensional imaging 
method. Cardiovascular imaging is seen as a promising future application of 
MPI. The purpose of this study was to evaluate the heating behaviour of 
endovascular stents as a safety aspect of cardiovascular MPI. 
Methods and Materials: 21 commercially available endovascular stents of 
different sizes (diameter: 3-10mm, length: 11-99mm) and materials (stainless 
steel, nitinol, platinum-chromium, cobalt-chromium) were evaluated. They were 
implanted in silicone tubes matching the stent diameter and placed into a 
preclinical MPI scanner. The temperature change was measured with fiber 
optic thermometers over a period of 431 seconds of a standard imaging 
protocol. 
Results: An increase of temperature of 0.1K (absolute accuracy of the 
temperature measurement) or more in relation to the reference temperature 
was defined as heating of the material. 12 stents showed heating of at least 
0.1K or more. Four stents showed heating of more than 3.0K. The biggest 
temperature difference was 12.4K. The only significant predictor for the heating 
behaviour of the stents was their diameter. Pearson’s correlation coefficient 
between the stent diameter and the square root of the temperature difference 
was r=0.96. 
Conclusion: In principle, MPI in the presence of endovascular stents is safely 
possible as most of the stents showed no or mild increase in temperature. If 
the increase of temperature of stents with a larger diameter is still measurable 
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B-0794 16:00  
Trajectories of imaging markers of the ageing brain: the Rotterdam study  
E.J. Vinke, M. de Groot, V. Venkatraghavan, S. Klein, W.J. Niessen, 
M.A. Ikram, M.W. Vernooij; Rotterdam/NL (e.vinke@erasmusmc.nl)  
Purpose: Brain changes in ageing may aid in better understanding of the 
ageing process and to distinguish normal ageing from age-related pathology. 
Longitudinal data in a broad age range are scarce, whereas these can provide 
important information on the rate of change. We estimated trajectories of 
several MRI markers based on longitudinal data and determined the sequence 
of these changing markers in ageing. 
Methods and Materials: On 11,020 MRI scans (1.5T) from 5,428 persons 
aged 45 years and older from the population-based Rotterdam study, the 
following imaging markers were assessed: volumetric measures (total brain 
volume (TBV), grey matter (GM), white matter (WM), normal appearing white 
matter (NAWM), white matter lesion (WML), hippocampus), diffusion measures 
(fractional anisotropy (FA), mean diffusivity (MD)) and focal vascular lesions. 
Linear mixed models were used to estimate trajectories of change, for males 
and females separately. The sequence of changing MRI markers in ageing 
was determined by comparing these trajectories. 
Results: Most markers show an exponential change with advancing age in the 
whole brain and per lobe, except for GM, which showed a more linear 
decrease with age. In general, females showed lower rates of change 
compared to males. The sequence in ageing markers was: TBV-MD-NAWM-
WML-WM-hippocampus-GM-FA. The presence of vascular lesions shows an 
exponential increase with age, where males have a higher probability of having 
cortical and lacunar infarcts. 
Conclusion: These data provide insight into the normal ageing process in the 
brain and its variability. Future studies can use this as a background to study 
pathology.  
B-0795 16:04  
The neural substrate of retinal neurodegeneration: the Rotterdam study  
U. Mutlu, M. Ikram, G.V. Roshchupkin, P.W.M. Bonnemaijer, J.M. Colijn, 
W.J. Niessen, M. Ikram, C.C.W. Klaver, M.W. Vernooij; Rotterdam/NL 
(u.mutlu@erasmusmc.nl)  
Purpose: There is a growing evidence that markers of retinal 
neurodegeneration such as thinner retinal nerve fiber layer (RNFL) and 
ganglion cell layer (GCL), assessed on optical coherence tomography (OCT), 
are reflective of global brain atrophy. Yet, little is known on the relation of these 
layers with specific brain regions. Using voxel-based analyses (VBA) of both 
grey matter density and white matter microstructure, we aimed to unravel 
which specific brain regions are associated with these retinal layers. 
Methods and Materials: We included 2235 persons (mean age: 67.3 years, 
55% women) from the Rotterdam Study (2007-2012), who had gradable retinal 
OCT images and brain magnetic resonance (MRI) scans. Thickness of RNFL 
and GCL were measured on OCT images. Voxel-based morphometry protocols 
were applied to process MRI data. We investigated the association of retinal 
sublayers with voxels in brain MRI by performing linear regression models 
adjusted for age, sex, subcohort, education, axial length of the eye, intracranial 
volume, and cardiovascular risk factors. 
Results: We found that thinner RNFL and GCL were associated with lower 
grey matter density of the visual cortex, and with lower fractional anisotropy 
and higher mean diffusivity in white matter tracts that are part of the optic 
radiation. Furthermore, thinner GCL was associated with lower grey matter 
density of the thalamus. 
Conclusion: Thinner RNFL and GCL are associated with grey and white 
matter changes in the visual pathway suggesting that retinal degeneration on 









B-0796 16:08  
Multi-parametric 11C-methionine-MR/PET for brain tumour imaging 
utilising MR fingerprinting  
L. Umutlu1, M. Nittka2, R. Kirsch2, H. Quick1, K. Herrmann1, M. Gratz1, 
M. Forsting1, M. Forsting1; 1Essen/DE, 2Erlangen/DE  
(Lale.Umutlu@uk-essen.de)  
Purpose: To investigate a novel approach of multiparametric tissue 
characterization of brain tumours based on morphologic, functional, metabolic 
and relaxometric properties utilizing integrated MR/PET and MR fingerprinting. 
. 
Methods and Materials: 25 patients with suspected brain tumours were 
enrolled in this trial. Examinations were performed on an integrated 3-tesla 
PET/MR system (Biograph mMR). PET and MR imaging was obtained 
simultaneously in one bed position after injection of 18F-FET. The (PET)MRI 
protocol included the following sequences: (1) TIRM, (2) FLAIR, (3) DWI, (4) 
SWI, (5) post-contrast MPRAGE imaging, (6) single-voxel spectroscopy and (7) 
MR fingerprinting. Histopathology served as the reference standard. 
Results: An increase in malignancy from low-grade (grade 1-2) to high-grade 
glioma (grades 3, 4) was associated with increasing/positive PET uptake, 
contrast enhancement, increasing values in choline and choline/creatine as 
well as increasing T1 and T2 values. While low-grade astrocytoma did not 
show any pathologic tracer uptake or contrast enhancement, grade 3 gliomas 
showed increasing tracer uptake and increasing T1 and T2 values in MRF, 
respectively (mean values, grade 3 tumours: SUVmax:1.8 T/N: 1.3; T1: 1442/ 
T2: 122.9; mean values, grade 4 tumours: SUVmax: 3.4 T/N: 2.1; T1: 1752/ T2: 
93.8). 
Conclusion: The results of this novel approach of multi-parametric PET/MR 
imaging of brain tumours including MR fingerprinting demonstrate 
corresponding changes in tissue property based on the combined assessment 
of morphologic, functional, metabolic and relaxometric properties, indicating a 
correlation to the grading of brain tumours and leveraging tissue 
characterization to a unique level of multi-parametric assessment.  
Author Disclosures: 
 M. Nittka: Employee; Siemens Healthineers. R. Kirsch: Employee; Siemens 
Healthineers.  
B-0797 16:12  
Sum score of cerebral small vessel disease relates to risk of stroke, 
dementia and mortality in the Rotterdam study  
P. Yilmaz, M. Ikram, W.J. Niessen, M. Ikram, M.W. Vernooij; Rotterdam/NL 
(p.yilmaz@erasmusmc.nl)  
Purpose: Cerebral small vessel disease (CSVD) is a major cause for brain 
damage leading to disability, morbidity and mortality. Markers of CSVD on 
magnetic resonance imaging (MRI) include white matter hyperintensities, 
lacunes, cerebral microbleeds and perivascular spaces. These have been 
separately associated with stroke, cognitive decline and dementia. However, 
combining the individual CSVD markers into a sum score might better capture 
the global CSVD burden. We investigated the association of CSVD sum scores 
with stroke, dementia and mortality. 
Methods and Materials: 1655 stroke-free and non-demented participants 
(mean age 73.3 years, 54.4% women) of the prospective population-based 
Rotterdam Study underwent brain MRI (1.5 T) in 2005-2011 and were followed 
for major outcomes until 2015-2017. The CSVD sum score was composed by 
counting presence of each CSVD MRI marker (range 0-4). We determined the 
association of CSVD sum scores with risk of stroke, dementia and mortality 
using Cox models, adjusting for age, sex and also the Framingham Stroke Risk 
Profile (FSRP). 
Results: During mean follow-up of 7.0 years, 66 participants developed stroke, 
67 dementia and 308 died. CSVD sum scores 2 were associated with a 
higher risk of stroke and mortality (FSRP-adjusted hazard ratios (HR) 3.3, 95% 
CI 1.5-7.2; HR 1.5, 95% CI 1.0-2.0, respectively). A CSVD sum score of 3 
showed an increased risk of dementia (FSRP-adjusted HR 2.8, 95% CI 1.1-
7.3). 
Conclusion: Higher CSVD sum scores on MRI are associated with a higher 
risk of stroke, dementia and mortality. Future steps are optimising the CSVD 
score including advanced imaging biomarkers.  
B-0798 16:16  
MRI brain atrophy can predict dementia in cognitively normal Parkinson’s 
patients: a 7 year follow-up study  
V. Pozdniakova1, R. Zivadinov2, T.O. Dalaker1, I. Dalen1, N. Bergsland2, 
K. Oppedal1, K. Pedersen1, O. Tysnes3, G. Alves1; 1Stavanger/NO, 
2
Buffalo, NY/US, 3Bergeb/NO  
Purpose: Dementia has a significant impact on mortality and prognosis in 
patients with Parkinson’s disease (PD). Previous magnetic resonance imaging 
(MRI) studies have demonstrated cross-sectional associations of hippocampal 
atrophy and lateral ventricle enlargement with cognitive impairment in PD. In 
  






this 7-year population-based prospective longitudinal study of an incident PD 
cohort, we explored whether early volume loss in these anatomic areas can 
predict future dementia development in cognitively normal Parkinson’s 
patients. 
Methods and Materials: This MRI study enrolled 123 newly-diagnosed and 
drug-naïve PD patients without mild cognitive impairment according to 
Movement Disorder Society (MDS) level 1 criteria. All underwent standardised 
3D-T1 weighted brain MRI on a 1.5T or 1.0T scanners at baseline. MRI images 
were segmented using SIENAX and FIRST software. Patients were followed 
prospectively over a 7-year period. Dementia was diagnosed according to 
MDS criteria. Multiple logistic regression analysis with adjustment for age, sex 
and education was performed to calculate odds ratios (ORs) with 95% 
confidence intervals (CIs) for incident dementia during follow-up. 
Results: We found that total hippocampal volume (OR 0.54 [CI 0.32-0.91], 
p=0.02), right hippocampal volume (OR 0.29 [CI 0.11-0.78], p=0.01) and lateral 
ventricle volume (OR 1.03 [CI 1.00-1.05], p=0.04) at time of diagnosis were 
significant predictors of dementia development during follow-up, independently 
of age, sex and education. 
Conclusion: Hippocampal atrophy and lateral ventricular enlargement in 
patients with PD are early signs of evolving cognitive decline. Volumetric MRI 
may be helpful in the prediction of dementia associated with PD.  
B-0799 16:20  
Quantitative study of noninvasive prediction of glioma IDH1 gene status 
by APT combined with ASL imaging  
J. Wen; Shanghai/CN (wen123jianbo@163.com)  
Purpose: The purpose of the study was to explore whether amide proton 
transfer (APT) and arterial spin labeling imaging (ASL) helped to noninvasively 
predict isocitrate dehydrogenase 1 (IDH1) gene status of glioma. 
Methods and Materials: MTRasym (3.5 ppm) values (APT values) and CBF 
values were measured in the tumour parenchyma region. Normalised CBF was 
calculated according to the formula nCBF = CBF tumour/CBF cerebellum. 
Independent samples t-test and ROC analysis were used in this study. 
Logistics regression analysis was combined with the effective parameters of 
APT and ASL to calculate the overall correct prediction rate. 
Results: 90 patients with both APT and ASL data. In LGG, the APT and nCBF 
values of wild-type IDH1 gene were higher than those of IDH1 mutant group (p 
= 0.027, p<0.001). AUC= 0.802, 0.844, APT cutoff = 1.35 (%) and nCBF cutoff 
= 1.74, the sensitivity was 97% and 81.80%, the specificity was 60.2% and 
62.2%. In HGG, the APT and CBF have statistical significance (p = 0.004, p = 
0.005); AUC=0.695, 0.712, respectively. APT cutoff= 3.24 (%), the sensitivity 
and specificity were 67.4% and 72.2%, respectively. When CBF = 76.83 × 
ml/100 g/min, sensitivity and specificity were 64.2% and 69.4%, respectively. 
Logistics regression combined with APT values and nCBF values to obtain the 
overall correct prediction rate is 78.7% and 86.8%, respectively. 
Conclusion: APT and ASL provide a valuable new method for the noninvasive 
diagnosis of the IDH1 gene state of brain glioma. Combination of APT and ASL 
can improve the overall IDH1 gene prediction rate of glioma.  
B-0800 16:24  
Sex differences in resting-state cerebral activity alterations in internet 
gaming disorder  
Y. Sun, Y. Zhou, Y. Wang, X. Han, W. Ding, J. Xu; Shanghai/CN 
(cjs1119@hotmail.com)  
Purpose: Although there is evidence that the prevalence rates of internet 
gaming disorder (IGD) differs between males and females, no studies have 
examined whether such sex differences extend to brain function. This study 
was to explore the sex differences in resting-state cerebral activity alterations 
in IGD. 
Methods and Materials: Thirty male participants with IGD (IGDm), 23 female 
participants with IGD (IGDf), and 30 male and 22 female age-matched healthy 
controls (HC) were recruited and underwent resting-state functional MR 
imaging. Maps of amplitude of low-frequency fluctuation (ALFF) and seed-
based functional connectivity (FC) were constructed. A two-factor ANCOVA 
model was specified using SPM8, with sex (male, female) and diagnosis (IGD, 
HC) as the between-subject factors. When interaction effects occurred, post 
hoc pair-wise comparisons were performed using two-sample t tests within the 
interaction masks. We used Barratt impulsiveness scale-11 (BIS-11) to assess 
the behavioral inhibition function and Chen internet addiction scale (CIAS) to 
evaluate the severity of IGD. The correlations between the values of ALFF/FC 
and clinical scores were assessed using partial correlation analysis, 
respectively. 
Results: The amount of ALFF in the orbit part of left superior frontal gyrus 
(SFG) significantly decreased selectively in IGDm, which was negatively 
correlated with BIS-11 score. Furthermore, orbit part of left SFG also showed 
decreased connectivity with posterior cingulate cortex, right angular gyrus, and 
right dorsolateral prefrontal cortex in IGDm. 
Conclusion: Our findings suggest that sex-specific cerebral activity alterations 
existed in IGD, and these alterations have clinical relevance as a biomarker for 
the behavioral inhibition function of IGD.  
B-0801 16:28  
3D neuromelanin imaging for differential diagnosis between Parkinson 
disease and essential tremor: a multicenter retrospective study  
Y. Kwon1, W.-J. Moon1, M. Park1, H. Kim1, J. Choi2; 1Seoul/KR, 2Suwon/KR 
(quan01@gmail.com)  
Purpose: Differentiation between Parkinson disease (PD) and essential tremor 
(ET) can be difficult. As neuromelanin-containing SN can be visualised on 3D-
neuromelanin-sensitive imaging, we aimed to evaluate SN T1 hyperintensity 
and its diagnostic accuracy in patients with PD and ET. 
Methods and Materials: This retrospective study enrolled 36 patients with PD 
and 22 patients with ET from two hospitals, between August 2016 and 
February 2017. 3D neuromelanin-sensitive T1-weighted sequence was 
obtained using two 3-T scanners. Two observers evaluated the SN T1 
hyperintensity of each side of SN using a seven-point scale (with 0.5 
increments from 0 to 3) according to the extent and degree of signal reduction 
of neuromelanin. Diagnostic performance of visual assessment was 
investigated using receiver operating characteristic analyses. Intra-rater and 
inter-rater agreement were calculated by weighted kappa. 
Results: Reduction of SN T1 hyperintensity was significantly more prominent 
in PD than in ET (p<0.001). The sum of neuromelanin scale from both sides 
provided AUC of 0.924 (95% CI, 0.823-0.977; sensitivity of 80.6% and 
specificity of 90.9%) with a threshold of at least 1.0. Inter-rater and intra-rater 
agreement was 0.902 and 0.900, respectively. 
Conclusion: Visual assessment of SN T1 hyperintensity by expert reviewers 
provides high diagnostic accuracy in differential diagnosis between PD and 
ETs. We suggest that 3D neuromelanin imaging with a simple visual grading 
system can be helpful in clinically challenging cases.  
B-0802 16:32  
Ischaemic optic neuropathy: using track-weighted imaging to detect 
changes in the neuroretina  
A. Attye1, C. Jean1, P. Remond1, A. Lecler2, F. Aptel1, C. Chiquet1, L. Lamalle1, 
A. Krainik1; 1Grenoble/FR, 2Paris/FR (aattye@chu-grenoble.fr)  
Purpose: Track-Weighted Imaging (TWI) was recently introduced as a 
tractography-based method with high anatomical contrast. We report the use of 
this method to explore the human retina in healthy volunteers and patients with 
anterior ischemic optic neuropathy (AION). 
Methods and Materials: Twenty patients who had undergone MRI were 
included, and compared with 20 healthy volunteers. For the diffusion-weighted 
acquisition, we used a b-value of 1000 s/mm2 and 60 directions distributed 
over four scans. We performed a constrained spherical deconvolution-based 
volumetric tractography method, whereby 10 million streamlines are initiated 
from seed points randomly distributed throughout the orbital area. We then 
reconstructed TWI maps with isotropic voxel size of 300 µm. We tested the 
effect of number of diffusion-weighted directions, ocular laterality, ocular 
dominance on healthy retinal fascicles distribution and the effect of the 
presence/absence of the fascicles on the visual field defect in patients with 
factorial analysis of variance. 
Results: We found influence of ocular laterality, ocular dominance and number 
of diffusion-weighted directions on the neuroretinal healthy fascicle distribution. 
8 out of 20 AION patients presented with complete absence of neuroretinal 
fascicle, side of the disease, which was correlated with visual field mean 
deviation at the 6 month-visit [F (1, 17) = 6.97, p= 0.016]. 7 patients presented 
with a temporal fascicle in the injured eye, this fascicle presence was linked to 
visual field mean deviation at the 6 month-visit [F (1, 17) = 8.43, p= 0.009]. 
Conclusion: The initial distribution of neuroretinal fascicle correlated with 
AION patients’ visual outcome.  
B-0804 16:36  
Intracranial atherosclerotic plaque enhancement associated with 
ischaemic stroke: a study with three-dimensional high-resolution 
magnetic resonance vessel wall imaging  
X. Bai, J. Lin; Shanghai/CN (baixueqin1@126.com)  
Purpose: To evaluate the reproducibility of three-dimensional high-resolution 
magnetic resonance vessel wall imaging(HR-MRI)for demonstration of 
intracranial atherosclerotic plaque enhancement and to explore the relationship 
between plaque enhancement and ischemic stroke. 
Methods and Materials: 52 patients with ischemic stroke underwent traditional 
head MRI, 3 dimensional -time of flight magnetic resonance angiography and 
HR-MRI on a 3.0T MRI scanner. Each identified intracranial plaque was 
classified as either culpritor non-culprit. The degree of plaque enhancement 
was graded by two independent radiologists,the degree of plaque 
enhancement and luminal stenosis were compared between culprit and non-
culprit groups by using Mann-Whitney U test. Binary logistic regression 
  






analysis was performed to assess the relation between the degree of plaque 
enhancement and culprit plaques. 
Results: 118 plaques were identified in 52 patients with ischemic stroke(52 
culprit and 66 non-culprit plaques). The degree of enhancement was rated as 
strong, moderate and none in 40,9 and 3 culprit plaques, and in 4,24 and 38 
non-culprit plaques. Both intra-observer and inter-observer agreement were 
high for identification of plaque enhancement(kappa>0.75). For the group of 
culprit plaques, the degree of plaque enhancement(Z=-7.787,P<0.01) and 
luminal stenosis (Z=-5.327,P<0.01)were significantly higher than those in non-
culprit group. Binary logistic regression analysis revealed that strong 
enhancement of plaques was independently associated with culprit 
plaques(OR:74.3, 95%CI:15.0-367.1, P<0.01). 
Conclusion: Three-dimensional HR-MRI detects enhancement of intracranial 
plaques with high reproducibility. Enhancement is more common in culprit 
plaques and is associated with the likelihood of ischemic stroke.  
B-0805 16:40  
Quantitative measurement of brain iron deposition in patients with 
peritoneal dialysis using susceptibility mapping  
A.-N. Lin; Kaohsiung/TW (miracoli1126.al@gmail.com)  
Purpose: To evaluate different susceptibility of brain structures between 
patients with chronic kidney disease who underwent peritoneal dialysis & 
healthy controls using quantitative susceptibility mapping (QSM) & their 
correlations with clinical data. 
Methods and Materials: For twenty-six patients (13 men & 13 women, mean 
age 54.46 year old) with peritoneal dialysis and twenty-six age & sex matched 
controls (12 men & 14 women, mean age 55.65 year old) were included in this 
prospective study. Magnitude image & phase image were reconstructed for 
susceptibility mapping to quantitate difference of iron deposition between 
patients & healthy controls. Partial correlation & stepwise multiple regression 
analysis between susceptibility & clinical parameters were calculated. 
Results: The result confirmed that increased brain iron deposition in bilateral 
caudate nucleus, putamen, substantia nigra, red nucleus & right dentate 
nucleus in the patient group. There is no significant correlation between brain 
susceptibility & serum iron profile or dialysis efficiency. Also, negative 
correlation were found between susceptibility of basal ganglia and excecutive 
function, speech and language function and visuospatial function but positive 
correlation with Beck depression inventory which indicates increased iron 
deposition leads to cognitive impairment. 
Conclusion: It is concluded that increased brain iron deposition in peritoneal 
dialysis patient was associated with cognitive dysfunction.  
B-0806 16:44  
Increased cerebral GABA concentration measured using 1H MRS in the 
acute paediatric mTBI  
P.E. Menshchikov, N. Semenova, I. Melnikov, M. Ublinskiy, T. Akhadov; 
Moscow/RU (peeterem@gmail.com)  
Purpose: The vast majority of mild traumatic brain injury (mTBI) cases do not 
lead to abnormalities of brain structures. The correlation between early 
structural neuroimaging findings and long-term clinical outcomes is weak. The 
main aim of this work was to estimate changes in in vivo cerebral GABA and 
glutamate concentrations after acute mTBI using 1H MRS. 
Methods and Materials: Two groups of participants were included in the 
study: patients (n=11, mean age - 16±2 years, Glasgow Coma Score (GCS) - 
15) with acute mTBI (mean time between trauma and MRI examination 40±20 
hours); 8 healthy children (mean age - 16±1 years) without history of any TBIs. 
1H MR spectra were acquired on scanner Philips 3.0T Achieva TX using 
PRESS (NAA, creatine, choline signals) and MEGA PRESS (GABA and 
glutamate signals) pulse sequences. All voxels in size of 25×25×30 mm were 
located in the frontal lobe. 
Results: The main effect on the [GABA] was found (Z=2.03, p<0.05), with the 
patients having higher [GABA] as compared to the control group (36%) (Fig. 2). 
Absolute concentrations of NAA, tCho, tCr and glutamate were unchanged. 
Conclusion: This study for the first time revealed increased cerebral [GABA] 
as well as disorders in the [GABA]/[GLX] balance in the paediatric acute mTBI. 
The most likely cause of [GABA] increase is growth of free pool of GABA (non-
related to GABA receptors). Postconcussion changes of neurotransmitter 
revealed in the present study could be promising for understanding of 
functional consequences of MRI-negative TBI.  
B-0807 16:48  
A preliminary study on non-invasive prediction of IDH1 gene status in 
glioblastoma by intravoxel incoherent motion MR imaging  
J. Wen; Shanghai/CN (wen123jianbo@163.com)  
Purpose: To investigate the value of intravoxel incoherent motion MR imaging 
(IVIM) in non-invasive judgment of IDH1 gene status of diffuse glioblastoma. 
Methods and Materials: Prospective collection of diffuse glioma patients in 95 
cases, the tumour real area of the IVIM imaging parameters: (F), average 
apparent diffusion coefficient (ADCmean), fast apparent diffusion coefficient 
(fastADC), diffusion coefficient (DDC), and pseudo-diffusion coefficient (D*). 
Calculate the parameters of the contralateral white matter area after the 
parameters: (NrF, nrD, nrD*nrADC). The effective parameters were used to 
plot the ROC curve. The correct predictive rate of IDH1 gene was calculated by 
logistic regression analysis. 
Results: The values of F, ADCmean, nrADCmean and DDC were significantly 
higher in the low-level group than in the wild-type low-grade group (P 
<0.05).The F value and fastADC values of the mutant high-level group were 
significantly lower than those of the wild-type high-level group (P<0.05). The 
sensitivity and specificity of ROC AUC were 0.125, 0.67, 0.65 and 0.780; 
ADCmean were 1.182, 0.750, 0.875 and 0.842, respectively, and nrADCmean 
were 1.481, 0.762, 0.875 and 0.899, respectively, DDC were 1.193, 0.792, 
0.750, 0.774, respectively. High-grade glioma combined with F and fastADC 
concluded that the correct predictive rate of IDH1 gene was 82.5% and the 
likelihood ratio was 46.07. 
Conclusion: IVIM examination provides a new method for non-invasive 
diagnosis of diffuse glioblastoma IDH1 gene status before surgery.  
B-0808 16:52  
In vivo molecular profiling of human glioma using dynamic susceptibility 
contrast magnetic resonance perfusion imaging  
J.-M. Hempel, J. Schittenhelm, B. Bender, M. Skardelly, G. Tabatabai, 
S. Castaneda Vega, U. Ernemann, U. Klose, C. Brendle; Tübingen/DE 
(johann-martin.hempel@uni-tuebingen.de)  
Purpose: To assess the diagnostic performance of dynamic susceptibility 
contrast perfusion magnetic resonance perfusion imaging (DSC-MRI) for in 
vivo human glioma molecular profiling. 
Methods and Materials: One hundred patients with histopathologically 
confirmed glioma who provided written informed consent were retrospectively 
assessed between 01/2016 and 02/2017 in two prospective trials that were 
approved by the local institutional review board. Cerebral blood volume (CBV) 
metrics from DSC-MRI were assessed, and histogram parameters of rCBV 
results were compared among WHO 2016-based histological findings and 
molecular characteristics. A classification and regression tree (CART) 
algorithm with 10-fold cross-validation was used to calculate the diagnostic 
accuracy. 
Results: The 90th percentile (C90) of rCBV was significantly lower in patients 
with the isocitrate-dehydrogenase 1/2 (IDH1/2) mutation (2.86±1.21; p &lt; 
0.001) and loss of alpha-thalassemia/mental retardation syndrome X-linked 
(ATRX) expression (2.23±0.91; p &lt; 0.001) than in those with the IDH1/2 wild 
type (4.78±2.34) and who maintained ATRX expression (4.30±2.02), 
respectively. The C90 of rCBV correctly predicted ATRX expression in 86.4% 
and the IDH1/2 mutation in 70.4% of patients. The standard deviation (SD) of 
rCBV was significantly higher in glioblastoma with methylated O6-
methylguanine DNA methyltransferase (MGMT; 1.99±0.73; p = 0.001) than in 
those with unmethylated MGMT (1.20±0.45). The SD of rCBV correctly 
predicted MGMT methylation status in 81.8% of all primary glioblastomas. 
Conclusion: DSC-MRI may provide insight into the human glioma molecular 
profile regarding IDH1/2 mutation status, ATRX expression, and the MGMT 
methylation profile. Thus, rCBV is a promising potential biomarker for glioma.  
Author Disclosures: 
 J. Schittenhelm: Grant Recipient; Else Übelmesser Foundation (30.19845).  
B-0810 16:56  
Prediction of postoperative cerebral hyperperfusion: a study using 
territory arterial spin labelling (tASL)  
T. Lin, Y. Lyu, Z. Zuo, H. You, J. Qu, B. Hou, F. Feng; Beijing/CN 
(jasminelty@163.com)  
Purpose: Cerebral hyperperfusion (CH) or hyperperfusion syndrome (CHS) is 
a rare complication after revascularisation, but may lead to intracranial 
haemorrhage. The objective of this study was to investigate the relationship 
between postoperative hyperperfusion and perfusion territories change. 
Methods and Materials: We retrospectively reviewed 22 patients with severe 
unilateral or bilateral carotid stenosis. The perfusion volume and cerebral blood 
flow of each brain feeding vascular (left/right internal carotid artery and 
vertebrobasilar artery) before and within 3 days after carotid endarterectomy 
(CEA) were measured using tASL and ASL, respectively. Volume fraction 
(perfusion volume/brain volume) of each territory was calculated. Patients were 
classified into three groups: only with postoperative CBF increase100% (CH 
group, n=7), CBF increase with headache right after surgery on the ipsilateral 
side and/or with deteriorated consciousness, focal neurological deficits or 
seizure (CHS group, n=2) and normal perfusion group (n=13), both CH and 
CHS group were considered as hyperperfusion group (n=9). 
Results: Perfusion volume fraction before CEA was significantly smaller in the 
hyperperfusion group compared to normal perfusion group (14.05%±11.51% vs 
31.55%±11.45%, P=0.02). And perfusion fraction significantly increased after 
surgery in the hyperperfusion group compared to normal perfusion group 
(19.53%±9.76% vs 4.75%±7.65%, P=0.001). 
  






Conclusion: Postoperative markedly increased CBF is associated with smaller 
perfusion volume before surgery and large perfusion volume increase after 
surgery in the stenosis side, which may be predictors for postoperative 
hyperperfusion.  
B-0811 17:00  
Characterists of plaques and lenticulostriate arteries in stroke patients by 
whole-brain vessel wall  
F. Wu, Q. Yang, C. Zhang; Beijing/CN (chaozhang0328@hotmail.com)  
Purpose: The aim of the present study was to evaluate atherosclerotic plaque 
characteristics and lenticulostriate arteries (LSA) together by novel whole-brain 
high-resolution magnetic resonance imaging (WB-HRMRI) and to establish 
their relationship with different infarction patterns. 
Methods and Materials: Stroke patients with artery-to-artery (A-to-A) 
embolism or branch atheromatous disease (BAD) were prospectively enrolled 
and WB-HRMRI was performed. The characteristics of the intracranial 
atherosclerotic plaques and distribution of LSA branches were compared 
between the two groups. 
Results: Fifty-eight first-time stroke patients were finally enrolled including 32 
A-to-A embolism and 26 BAD. Hyperintensity plaques (HIP) and plaque 
surface irregularity were more frequently observed in A-to-A embolism group 
than in the BAD group (P < 0.001 and P = 0.028, respectively). Patients with A-
to-A embolism infarction had severer stenosis degree than patients with BAD 
infarction (P = 0.001). The average number and length of visualized LSA 
branches significantly reduced in patients with BAD compared with A-to-A 
embolism (P = 0.025 and P = 0.029). Logistic regression analysis showed that 
HIP was independently associated with A-to-A embolism infarction, while 
reduction in the numbers of LSA branches was independently associated with 
BAD infarction. Odds ratios for HIP and the numbers of LSA branches were 
12.21 and 2.07 (95% confidence interval 2.41 - 61.83 and 1.06 - 4.07; P = 
0.002 and 0.034) respectively. 
Conclusion: A-to-A embolism infarction has distinct vascular 
pathophysiologies in terms of plaque and LSA characteristics compared with 
BAD. WB-HRMRI enables the combination of vessel wall and LSA imaging 
which can predict future stroke.  
B-0813 17:04  
MRI assessment of brain grey matter structural changes in severe 
nicotine dependency  
A. Dong; Zhengzhou/CN (845516273@qq.com)  
Purpose: To evaluate brain structure changes in mild nicotine dependency by 
voxel-based morphological method. 
Methods and Materials: In this study, 77 severe nicotine-dependent (FTND<6 
score) and 37 non-smoking healthy volunteers were scanned with Siemens 
Skyro 3.0T magnetic resonance scanner. Subjects were routinely MRI (to 
exclude intracranial lesions) sequence and 3D-MPRAGE sequence. SPM8 
pretreatment based on Matlab was used to analyse the data. The SPM8 
software was used to analyse the independent sample t test (FWE correction, 
P<0.001) with the smoking group and the control group. The spearman 
correlation analysis was used to analyse the difference between severe 
nicotine-dependent group and smoking data with SPSS 17.0. 
Results: Compared with the control group, the mild nicotine-dependent group 
exhibited decreased GMV in bilateral thalamus, bilateral supramarginal gyrus 
(right supramarginal gyrus, left supramarginal gyrus), and the area with 
elevated GMV was not found (FWE corrected, P<0.05, cluster size>318 
voxels). Bilateral thalamus, right supramarginal gyrus GMV were significant 
negatively correlated with smoking index and tobacco years, and right 
thalamus was negatively correlated with daily smoking ( = 0.05, P<0.05). 
Conclusion: The changes of brain structure among smokers mainly focused 
on reward-related pathways and marginal systems, and part of the grey matter 
volume of brain regions is related to smoking behaviour data. The results 


































08:30 - 10:00 Sky High Stage  
Interventional Radiology  
MY 9  
Interventional Radiology  
Moderators:  
R.F. Dondelinger; Liège/BE  
P.M. Kitrou; Patras/GR  
B-0814 08:30  
Two year follow-up: results after acute stroke endovascular 
thrombectomy  
A. Balodis, M. Radzina, K. Kupcs, E. Milglane, J. Savlovskis, H. Kidikas, 
A. Veiss; Riga/LV (arturs.balodis7@gmail.com)  
Purpose: Endovascular thrombectomy(ET) in acute ischemic stroke treatment 
with large artery occlusion after 3 months has shown a good neurological 
result, however there are only few long term results available. The aim of our 
study was to analyze ET functional outcome after 2-years from initial treatment, 
in patients with acute ischemic stroke due to large artery occlusion. 
Methods and Materials: The prospective study included 91 patients 
hospitalized within time window of 8 hours with middle cerebral artery M1 or 
internal carotid artery occlusion. Sixty-one (67%) of them received thrombolysis 
followed by ET, 30(33%) - thrombectomy solely. Modified Rankin scale (mRS) 
was used to evaluate early therapy results and late results at 3 months and 2 
years. 
Results: There were 44(48%) women and 47(52%) men analyzed with mean 
age 67.66±11,9(SD) years. Successful recanalization rate after ET was 90% 
(TICI-2b,3). Median mRS (0-2): after discharge was 29(32%), 3 months mRS 
was 36(40%), p=0.01 and 2 years mRS (0-2) was 34(37%), respectively. No 
statistical difference between 3mo and 2y, p=0.32. Two years follow up 
mortality was 32(35%) compared to 13(15%) in 3 months, difference was 
statistically significant. 44% of patients with severe disability mRS 4-5 at 3 
months were with the same status after 2 years (3mo vs 2y: 23(25%) and 
10(11%), respectively). 
Conclusion: Our results show that after 2 years ET can show high number of 
good long term functional outcome. The majority of high mortality rates after 2 
years resulted from patient group with severe neurological deficit mRS(4-5) at 
3 months.  
B-0815 08:34  
Comparison between not-stent retriever and stent retriever mechanical 
thrombectomy for the intra-arterial acute ischemic stroke treatment  
E. Puglielli, R. Lattanzi, V. Di Mizio, S. Roiati, F. Navarra, V. Di Egidio; 
Teramo/IT (edopug@hotmail.com)  
Purpose: The objective of this work is to compare the ability to remove of the 
thrombus, the final TICI and outcomes for non-stent retriever nST and stent 
retriever ST thrombectomy for the AIS treatment. 
Methods and Materials: between April 2009 and September 2017, 220 
patients (mean age 62,7y) were treated for AIS with mechanical 
thromebctomy, fulfilled the classic inclusion criteria of EST, using retrievable 
stents or aspiration. NCCT, CTP-CTA and DSA were used for imaging. Primary 
outcomes were: the 90 days  2 mRS, the TICI recanalization rate, the 
incidence of symptomatic intracranial hemorrhages (ICHs). Patient’s age, sex, 
etiology of occlusion, time of treatment, median NIHSS at presentation, mRS at 
discharge were correlated using univariate analysis and multivariate 
regression. 
Results: mNIHSS at presentation was 24 (ranged 9-33). Sites of arterial 
occlusion before treatment were: M1-M2 156/220 (70.90%), intracranial carotid 
8/220 (0.03%), M2-M3 14/220 (6.36%), tandem occlusion 6/220 (2.72%), 
extracranial internal carotid isolated occlusion 5/220 (2,27%), P1 7/220 
(3.18%), basilar trunk 24/220 (10.90%). Statistical significant differences were 
observed between ST group 123/220 patients (55.90%) and nST 97/220 
(44.09%) one in terms of  2 mRS at discharge (21.24% [nST] vs 64.73% [ST]; 
p<0.005) and high TICI Score 2b-3 recanalization rates (77.32% [NSR] vs 
98.51% [SR]; p < 0.005). 
Conclusion: clot composition and anatomic factors could explain the 
difference on nST vs ST outcomes. A combined multimodal approach for AIS 
treatment using the two different methods could lead to very high 







B-0816 08:38  
Endoscopic ultrasound-guided hybrid therm ablation in patients with 
stage III pancreatic adenocarcinoma: a clinical study with radiological 
perspectives  
M. Barbera, S. Testoni, E. Dabizzi, S. Gusmini, M. Petrone, A. Esposito, 
A. Del Maschio, P. Arcidiacono, F. De Cobelli; Milan/IT 
(barbera.maurizio@hsr.it)  
Purpose: A third of cases of pancreatic cancer is locally advanced and 
unresectable (LAPC) at diagnosis. Endoscopic ultrasound-guided hybrid 
cryotherm ablation (EUS-HTP) combines radiofrequency with cryogenic 
cooling, reaching the pancreas also when inaccessible through percutaneous 
approaches. Aim of this ongoing study was to evaluate the feasibility, safety 
and post-procedural imaging findings of this novel therapy. 
Methods and Materials: 35 consecutive patients with LAPC were 
prospectively enrolled at the Gastrointestinal Endoscopy Unit of our tertiary 
referral Center for a singular or repeated EUS-HTP session. The absolute 
tumor volume (ATV) and ablation necrotic volume (ANV) were measured in 
timely close follow-up CECT scans and, if suitable, MR images by an advanced 
visualisation tool. Data were analysed by descriptive and non-parametric 
statistics. 
Results: EUS-HTP resulted feasible in 26 patients (74.3%), except in 9 cases 
due to tumor stiffness or vessel interposition. CT identified the ANV in 25 
patients (96%), whereas MR in all cases when performed; no statistical 
difference was found in the ANV measure between CT and MRI (P = 0.664). 
The mean ANV was 12.44 mm3 (range 1.3-56) with an average ablation 
percentage of 34.9% (range 3-65). The median post-HTP overall survival (OS) 
time was 6 months (range 1-22), increasing from 5 to 9 months with more than 
one session (P = 0.066). Early complications occurred in 11 patients (37%), all 
mild except one moderate, conservatively treated. 
Conclusion: EUS-HTP is a safe and feasible therapy for patients with LAPC; 
both CT and MRI result useful for follow-up after treatment.  
B-0817 08:42  
Impacts of related risk factors on the efficacy of interventional treatment 
towards intractable postpartum haemorrhage  
C. Zhao; Beijing/CN (zhaochaoxy@163.com)  
Purpose: To investigate the risk factors that impact the efficacy of 
interventional treatment of intractable postpartum haemorrhage (IPH). 
Methods and Materials: A total of 64 IPH patients were admitted and received 
interventional treatment, among whom 57 cases were successfully treated 
(bleeding stopped), while 7 cases failed. The clinical data of the success group 
and the failure group were observed for the multivariate analysis of the 
possible reasons that might cause haemostatic failure. 
Results: The univariate analysis of each suspected factor of haemostatic 
failure showed that history of uterine scar, combined use of uterotonics, uterine 
inertia, and placenta exhibited statistically significant differences between the 2 
groups (p<0.05); the multivariate logistic regression analysis showed that 
history of uterine scar and combined use of uterotonics were the risk factors for 
the interventional treatment failure of IPH, with OR values of 11.23 (95% CI 
1.26~100.22) and 12.83 (95% CI 1.05-156.34), respectively. 
Conclusion: History of uterine scar and combined use of uterotonics were the 
risk factors for interventional treatment failure of IPH.  
B-0818 08:46  
Is portal vein embolisation of liver segment IV mandatory before 
extended right hemihepatectomy?  
C. Loberg, S. Keil, F. Goerg, C.K. Kuhl, P.L. Bruners; Aachen/DE 
(cloberg@ukaachen.de)  
Purpose: Portal vein embolisation (PVE) is an established procedure to 
introduce hypertrophy of the future liver remnant (FLR) in patients scheduled 
for extended right hemihepatectomy (ERH). There is uncertainty as to whether 
PVE needs to include the branches to the left medial segment (S4), or whether 
induction of hypertrophy is sufficiently achieved if right PV branches (S5-8) are 
occluded. We analysed hypertrophy rates of patients undergoing PVE of S5-8 
branches only. 
Methods and Materials: PVE was done prior to ERH when the anticipated 
volume of FLR was < 30% of the total liver volume in patients with 
compromised, or < 25% of the total liver volume in patients with normal liver 
function. PVE of the right portal venous system (S5-8) was performed. Liver 
volumetry was done on contrast-enhanced CT acquired within 1 week before 
and 3-4 weeks after PVE. 
Results: 140 patients were included. Technical success was achieved in 
(99%) of patients. At follow-up CT volumetry showed sufficient hypertrophy by 
an average of 36% (range, 25-39%) in (97%) . A total 98 of the 135 patients 
with sufficient hypertrophy (73%) went on to ERH. In 37/135 patients (27%), 
hepatectomy was ultimately not performed because of extrahepatic tumour 
spread. A total 8/135 patients (6%) had new lesions in the left liver (FLR) at 
  






post-PVE-CT; these patients underwent ERH with additional percutaneous 
local ablation. 
Conclusion: PVE of portal vein branches to segments 5-8 is sufficient to 
induce satisfactory hypertrophy of the FLR to allow extended right 
hepatectomy.  
B-0820 08:50  
Combined antegrade and retrograde approach in iatrogenic ureteral 
injuries: the rendez-vous technique  
G. Pacella, E. Faiella, D. Santucci, A. Alfonsi, C. Altomare, B. Beomonte Zobel, 
R.F. Grasso; Rome/IT (giuseppina.pacella23@gmail.com)  
Purpose: Ureteral injuries are the most common urologic complications 
occurring during abdominal and pelvic surgery, with an incidence ranging from 
1% to 10%. The choice treatment is generally open surgery, but the rendez-
vous technique represents an alternative strategy. Our study evaluates the 
feasibility and effectiveness of the rendez-vous technique in case of complete 
iatrogenic ureteral injuries. 
Methods and Materials: From 2012 to 2017 we treated 20 patients with the 
rendez-vous technique for complete iatrogenic ureteral injuries: 12 patients 
underwent to radical hysterectomy, 3 to radical cistectomy, 5 to rectal anterior 
resection. The diagnosis was supported by CT-urography and antegrade 
pielography.The rendez-vous technique was performed by the introduction of a 
gooseneck snare through the nephrostomic access to capture the end of the 
retrograde ureteral wire, which was retrieved from the percutaneous sheath to 
gain a through-and-through access. A double J stent was antegradely inserted 
and a nephrostomy tube was kept in place. 
Results: The rendez-vous technique was successful in all cases with 
resolution of the ureteral leak. In all patients the nephrostomy tube was 
removed after 30 days. After performing CT-urography the stent was removed 
permanently in 16 patients after 6 months and in 4 after 9 months. Only three 
cases showed a locale post-treatment stenosis treated with surgical ureteral 
reimplantation. In the other cases there was no ureteric stricture at the site of 
the previous injury. 
Conclusion: The rendez-vous technique is an effective minimally invasive 
procedure that can be used to restore the continuity of the ureter avoiding open 
surgical.  
B-0821 08:54  
MR-guided focused ultrasound (MRgFUS) thalamotomy for the treatment 
of medically refractory essential tremor  
S. Dababou1, C. Marrocchio1, C. Halpern2, J. Henderson2, A. Napoli1, 
C. Catalano1, K. Butts Pauly2, V. Santini2P. Ghanouni2; 1Rome/IT, 
2
Stanford, CA/US (susy150791@gmail.com)  
Purpose: Clinical outcome assessment of MRgFUS thalamotomy for the 
treatment of medically-refractory essential tremor. 
Methods and Materials: 8 patients underwent unilateral transcranial 
MRgFUS(ExAblate-InSightec)ablation within the ventral intermediate nucleus 
of the thalamus for the treatment of medically refractory essential tremor. The 
primary endpoint was the reduction in the dominant hand tremor score, 
evaluated by Part A and Part B of the Clinical Rating Scale for Tremor(CRST) 
at 3 months. The secondary endpoints were the changes at 3 months in the 
quality of life(Questionnaire for Essential Tremor(QUEST)), and in the subject 
daily functionalities(Part C of the CRST); and in the durability of these changes 
at 6 and 12-month follow-up visits. 
Results: At 3-month follow-up 8 patients were assessable. The dominant hand 
tremor decreased by 57% from a mean baseline score of 20.5+/-3.4 to 8.8+/-
4.6(P=0.01). Quality of life scores improved by 25% from a pre-treatment value 
of 57.1+/-17.7 to 42.9+/-14.1(P=0.01), and disability scores also reduced by 
65% from a baseline value of 18.9+/-4.4 to 6.6+/-4.0(P=0.01). Symptom 
improvement was durable with 9.0+/-3.6(P=0.01) and 9.3+/-5.0(P=0.01) 
dominant hand tremor score at 6 and 12 months respectively. The most 
common immediate adverse events were related to frame placement. At 12 
months, 2 patients reported a mild sense of imbalance. 
Conclusion: MRgFUS thalamotomy has shown positive and promising results 
in reducing dominant hand tremor in medication-refractory essential tremor.  
B-0822 08:58  
CT-guided percutaneous synovial cyst rupture using a 11G Jamshidi 
needle: early experience and results of a novel technique  
S. Islam, D. Johnson; London/UK (s.islam@imperial.ac.uk)  
Purpose: Lumbar synovial cysts are an increasingly reported cause of 
radiculopathy and back pain. Percutaneous treatment offers a minimally 
invasive alternative to high-risk surgery. Percutaneous techniques involve 
imaging to guide a small calibre needle into the facet joint. In our experience 
this leads to a high rate of recurrence requiring future surgery. We trialled a 
novel approach using a large bore needle under CT guidance in the hope of 
achieving increased disruption of the fibrocartilaginous wall and reducing 
recurrence. The purpose of the study was to review the early results of 
percutaneous synovial cyst treatment using a 11G Jamshidi needle. 
Methods and Materials: 9 sedated patients underwent percutaneous synovial 
cyst rupture through a translaminar approach, using a 11G Jamshidi needle 
under CT guidance. Following rupture as demonstrated by contrast injection, 
80mg depomedrone + 1ml bupivacaine was injected into the rupture bed. 
Patients were followed up from 6 weeks to 4.5 years post-procedure. 
Results: At 6-week follow-up there were no significant complications and only 
1 patient had required surgery for persistent symptoms. At long-term follow-up, 
5 patients remained asymptomatic, with 3 patients requiring a repeat 
intervention. 
Conclusion: There is currently no standardised technique for percutaneous 
synovial cyst treatment and the previously published outcome data are based 
on using small 20/22G needles. The number of patients requiring future 
surgery in these studies varies from 10 to 55%. This is the first time a large 
bore needle has been used to achieve cyst rupture, demonstrating its safety 
and efficacy.  
B-0823 09:02  
Performance and safety of pancreas biopsy: are there more 
complications made by routes of risk?  
J.M. Sastoque G, S. Lombardo, J.J. Espejo Herrero, I. Domínguez Paillacho, 
M. Perez Montilla, L.J. Zurera Tendero; Cordoba/ES 
(jorgem4402@hotmail.com)  
Purpose: Retrospective analysis of pancreas CNB performance and overall 
safety assessment comparing biopsies performed through risk routes (liver, 
gastrointestinal tract) in relation to a direct route (peritoneal or retroperitoneal). 
Methods and Materials: Biopsies of pancreatic lesions performed between 
April 2010 and September 2017 were retrospectively analysed. Biopsies were 
performed with 16 and 18G needles. The CT images, histopathological results 
and details of the procedure as route of approach and the associated 
complications were evaluated. If the biopsy was negative for malignancy, the 
clinical history was reviewed to evaluate the final etiology of the pancreatic 
lesion. 
Results: CNB was performed on 83 patients (50 men, 33 women) with mean 
age of 62.65 years through different routes with 16G (n = 35) and 18G (n = 48) 
needles. The sensitivity, specificity, positive and negative predictive value of 
the total study were 82.53%, 100%, 100% and 64.51%, respectively. A total of 
24 biopsies were performed with transperitoneal approach, 1 retroperitoneal 
and 58 with risk routes (colon (n = 3), stomach (n = 34), duodenum (n = 1), 
jejunum = 8), pleura (n = 1) and the remainder combining these routes (n = 
10). The rate of major complications was 4.81% (n = 4) and minor 3.61% (n = 
3); without finding a significant difference between the direct peritoneal 
approach (n = 3) and through risk routes (n = 4), neither with the needle size. 
Conclusion: Pancreatic percutaneous CNB using the trans-organ approach is 
a safe and effective technique to diagnose malignant pancreatic lesions.  
B-0824 09:06  
TACE using mitomycin with or without irinotecan for HCC in European 
patients  
T. Gruber-Rouh, K. Eichler, N.-E. Nour Eldin, N.N.N. Naguib, 
M.C. Langenbach, T.J. Vogl; Frankfurt a. Main/DE  
Purpose: To evaluate survival data and local tumour control in two groups with 
different chemotherapeutic agents in TACE treatment of HCC patients. 
Methods and Materials: A total of 28 patients (mean age: 67.3 years) with 
HCC were repeatedly treated with chemoembolisation in four-week intervals. 
Twenty patients suffered of BCLC-stage-B, while eight patients obtained 
chemoembolisation for bridging purpose (BCLC-Stage-A). In total, 98 
chemoembolisations were performed (mean 3.4 treatments/patient). The 
administered chemotherapeutic agent included either mitomycin only (n=14; 
50%) or mitomycin in combination with irinotecan (n=14; 50%). Lipiodol plus 
DSM was used for all embolisations. Local tumour response was assessed by 
MRI using mRECIST criteria. Progression-free survival (PFS) was evaluated. 
Results: In the mitomycin-irinotecan group, the CR was encountered in 21.4%, 
PR in 42.9% and SD in 28.6%, and PD in 7.1%. The local tumour control in the 
mitomycin group was: PR in 57.2%, SD in 21.4%, and PD in 21.4% (p=0.043). 
The PFS of patients after chemoembolisation with mitomycin was four months 
compared to the significantly higher PFS of twelve months in the mitomycin-
irinotecan group (p=0.003). 
Conclusion: Chemoembolisation of HCC with mitomycin and irinotecan is the 














B-0825 09:10  
Randomised controlled trial of free-hand vs robotic-guided needle 
positioning in CT-guided thermoablation of liver tumours  
W.J. Heerink1, S.J.S. Ruiter1, M. Arnolli2, J. Pennings1, B. Lansdorp2, 
R. Vliegenthart1, M. Oudkerk1, K.P. de Jong1; 1Groningen/NL, 2Enschede/NL 
(w.j.heerink@umcg.nl)  
Purpose: Accurate needle placement and minimal needle manipulation is 
critical in microwave ablation (MWA) of liver tumours. In this randomized 
controlled trial, a novel robotic-guided needle positioning system (NPS) is 
compared to free-hand positioning. 
Methods and Materials: 42 liver tumours were randomized in a free-hand 
group and a robotic-guided NPS (DEMCON Advanced Mechatronics, 
Enschede, the Netherlands) group. Primary endpoint was the number of 
needle repositionings before start of ablation. Secondary endpoints included 
Euclidian and lateral positioning error. Stratification between in-plane and out-
of-plane (needle angle from axial plane 10 degrees) procedures was 
performed. 
Results: For in-plane procedures, the median number of needle repositionings 
in the free-hand (n=13) and NPS group (n=10) was 1 (0-5) and 0 (0-0, 
p=0.012), the mean Euclidian error was 12.7±6.8mm and 11.0±4.7mm 
(p=0.514), and the mean lateral error was 6.1±2.9mm and 7.2±5.3mm 
(p=0.518), respectively. For out-of-plane procedures, the median number of 
needle repositionings in the free-hand (n=8) and NPS (n=11) group was 1 (0-7) 
and 0 (0-1, p=0.011), the mean Euclidean error was 15.7±5.7mm and 8.4±3.3 
(p=0.003), and mean the lateral error was 11.6±2.8mm and 6.0±3.2mm 
(p=0.001), respectively. Tumour size and depth were comparable in all groups. 
Conclusion: For all procedures, robotic-guided needle positioning required no 
needle repositioning before start of ablation. It is associated with a higher 
positioning accuracy, though only in out-of-plane approaches. Especially in 
these cases, the use of the novel robotic-guided NPS is advantageous.  
Author Disclosures: 
 M. Arnolli: Employee; DEMCON Advanced Mechatronics.  B. Lansdorp: 
Employee; DEMCON Advanced Mechatronics.  
B-0826 09:14  
Vertebroplasty with trajectory planning and 3D road map applications: 
first experiences  
M. Inecikli; Rize/TR (drinecikli@yahoo.com)  
Purpose: Trajectory planning and 3-dimensional road map (TP&3D-RM) 
advanced applications are two important software programmes installed in 
new-generation angio devices. The purpose of this study is to show that the x-
ray exposure in vertebroplasty (VP) cases is reduced by the TP&3D-RM 
technique. 
Methods and Materials: All VP operations were performed using a biplane 
angiography device. 52 patients were included in the study and divided into 
two groups. The TP&3D-RM technique of the angio device was used at 26 VP. 
In 26 VP cases, conventional VP operation was performed. The amount of 
dose used during the procedure was recorded. Complications during the 
procedure were noted. The data were analysed statistically. P <0.05 was 
determined to be statistically significant. 
Results: The age of 22 female and 30 male patients was on average 67.5 
years. In 39 cases left transpedicular, in 4 cases right transpedicular and in 9 
cases bipedicular approach was used. VP treatment was performed between 
thoracic 5 and lumbar 5 vertebras. VP operation was performed mostly in the 
L3 vertebra (%17,3). The decrease in x-ray exposure in VP cases made with 
TP&3D-RM technique was statistically determined (p<0.001). There was no 
statistically significant difference in complication rates during the procedure (p> 
0.05). 
Conclusion: VP processing with TP&3D-RM technique increases the reliability 
of the process, reduces radiation exposure, and provides profit in terms of time 
and cost. Especially in cases with rotoscoliosis, for L5 vertebra and thoracic 
vertebrae on T8 and above, and traumatic vertebral fractures, this technique 
can contribute to a more controlled treatment.  
B-0827 09:18  
Stent retriever single shot study (4S): multivariable analysis for first-pass 
recanalization in acute stroke  
F.J. Melendez1,1, S. Rosati2,2, S. Aixut Lorenzo1,1, S. Remollo Friedemann3,1, 
M.F. Werner Reyes1,1, M. Ribó Jacobí1,1, D. Hernández Morales1,1, 
M. Martínez1,1, A. Tomasello Weitz1,1; 1Barcelona/ES, 2Madrid/ES, 
3
Riells I Viabrea/ES (fernandomelendezun@gmail.com)  
Purpose: First-pass recanalization have been described as a predictor factor 
for the clinical outcome and mortality in acute stroke. It is necessary to identify 
optimal techniques that maximise recanalization in the first-pass. A 
multivariable analysis of technical aspects in thrombectomy is introduced. 
Methods and Materials: 228 patients were treated by thrombectomy. A 
multivariable analysis was carried out in order to achieve recanalization in the 
first-pass. Stent-retriever, aspiration catheter, balloon catheter, adapt 
technique, combined techniques, diameter and length of devices were 
considered. TICI 2B-3 was the aim. A statistical analysis was done to find the 
best possible combination to get first-pass recanalization. 
Results: We found statistically significant difference in the diameter of the 
stent but not the length, diameter less than 4 mm (,772 U.Mann-Whitney) when 
compared to more than 4 mm (,49 U.Mann-Whitney). Distal aspiration catheter 
(48.6%) vs without distal aspiration catheter (62.2%) (X2= 3,884 p=,049). 
Bypass effect (61.1%) vs without bypass effect (52.4%) (X2= 7,057 p= ,029) 
and thrombus protrusion into cell stent (65.3%) vs without protrusion (34.8%) 
(X2= 10,477 p= ,005) also showed difference statistically significant. 
Conclusion: In our study, we found that smaller diameters of stent, protrusion 
of thrombus into the cell stent with bypass effect and without aspiration 
catheter have better first-pass effect. Further manoeuvers may be helpful as 
the balloon catheter. This combination should increase the accuracy and 
successful recanalization after the first-pass.  
B-0828 09:22  
US-guided percutaneous renal biopsy: a 10 year retrospective analysis  
J.A. Sheehan, R. Durganaudu, T. Tarmey, G.J. O'Sullivan, D. Sheppard; 
Galway/IE (sheehan24@gmail.com)  
Purpose: To evaluate the indication and safety of US-guided percutaneous 
renal biopsy at our institution over a 10 year period. 
Methods and Materials: A retrospective analysis was performed of 749 
patients whom underwent renal biopsy between March 2006 and September 
2016. All US-guided biopsies were performed with free hand technique, using 
a 5mhz curvilinear probe, and an 18-gauge core biopsy needle. Patient’s vital 
signs were monitored during the procedure and 6 hours post biopsy to 
evaluate for signs of haemodynamic instability. All patients underwent a post 
procedure full blood count to ensure stable haemoglobin levels. In the case of 
ongoing pain or a drop in haemoglobin levels, further investigation with 
Ultrasound or Computed Tomography(CT) was performed to evaluate for the 
presence of acute haemorrhage. 
Results: 749 patients underwent biopsy with a mean age of 53 and a range of 
15 to 90. 443(59%) were male. 785 total biopsies were performed on both 
native(n=737) and allograft(n=48) kidneys. The majority (54.4%) of biopsies 
were indicated for renal impairment(n=408) followed by proteinuria(n=204), 
Haematuria(n=74), and renal mass (n=64). 11(1.4%) patients had a major 
complication requiring blood transfusion. 53(7%) patients had minor 
complications requiring subsequent imaging, but were managed conservatively 
without further intervention. 
Conclusion: US guided renal biopsy is indicated for multiple reasons the 
majority of which are renal impairment. The procedure is safe with an 
acceptable low risk of both major and minor complications.  
B-0829 09:26  
Treatment of intramural and submucosal uterine fibroids (UFs) using 
MRgFUS (magnetic resonance-guided focused ultrasound surgery)  
S. Iafrate, I. Capretti, E. Cannizzaro, F. Arrigoni, M. Di Luzio, A.V. Giordano, 
S. Mascaretti, G. Mascaretti, C. Masciocchi; L'Aquila/IT 
(sonia.iafrate87@gmail.com)  
Purpose: To evaluate the reduction of volume of submucosal and intramural 
uterine fibroids (UFs) by MRgFUS treatment and subsequent possible 
reduction of symptoms, during 1 years of follow-up. 
Methods and Materials: Twenty-six women,(mean age 42), affected by 
symptomatic UF underwent MRgFUS between July 2015 and July 2016.All the 
patients were assessed by MRI and UFs were classified according to FIGO 
staging system.Twelve/26 patients showed submucosal UFs(GROUP 1,5 of 
type 0,4 of type 1 and 3 of type 2) experiencing reproductive problems, 
dismenoerrea.Fourteen/26 patients showed intramural fibroid (GROUP 2, 5 of 
type 3, 3 of type 4 and 6 of type 5)experiencing "bulk symptoms".We analysed 
non-perfused-volume (NPV) that represent the treated area after treatment; 
reduction of UFs volume,Symptoms severity score questionnaire (UFS-
QOL),clinical symptomatology improvement. 
Results: A good outcome was observed in all patients underwent MRgFUS, 
the mean initial value of the NPV was about 80-90 %. At the end of follow-up (1 
year), in the GROUP 1,7/12 displayed a decrease of the UFs volume 
associated with a recovery of uterine wall morphology. A disappearance of the 
UF was observed in 5/12. In the GROUP 2 we observed a decreased in UFs 
volume, (5/14 about 70%, and 9/14 about 50%).All the patients showed a 
reduction of UFS-QOL with an improvement around 90%.No severe adverse 
events were recorded during the follow-up. 
Conclusion: Patients affected by both submucosal and intramural UFs may 
benefit from MRgFUS, during follow-up of 1 year. A progressive reduction of 










B-0830 09:30  
Evaluation of a 3D printed anthropomorphic phantom for simulation of 
CT-guided procedures  
P. Jahnke, F.B. Schwarz, M. Ziegert, O. Abdelhadi, T. Almasi, M. Nunninger, 
B. Hamm, M. Scheel; Berlin/DE (paul.jahnke@charite.de)  
Purpose: Radiopaque 3D printing realizes detailed anthropomorphic 
phantoms of individual patients. We further developed this method to allow CT-
guided needle placement. The aim was to evaluate such a phantom for 
realistic simulation of CT-guided procedures. 
Methods and Materials: Experienced interventional radiologists (n = 10) 
performed periradicular infiltration on a radiopaque 3D printed phantom and 
rated different aspects regarding suitability of the phantom to simulate CT-
guided procedures in a questionnaire. Additionally, quantitative parameters of 
their simulation procedures (number of images acquired, procedure time, 
needle tip visibility, and needle corrections) were compared with a 
retrospective cohort of 50 clinical cases performed by the same 
interventionalists. Descriptive statistics and Mann-Whitney U test were used for 
data analysis. 
Results: Simulation procedures on the phantom were rated highly realistic for 
anatomic detail, needle navigation, and overall course of the procedure. 
Phantom haptics were characterized as most comparable to tight muscle 
tissue. All participants found the phantom suitable for training and learning 
purposes. Strong similarity of the simulation procedures to clinical procedures 
was supported by the comparative analysis of quantitative procedure 
parameters, with no significant differences in overall number of images 
acquired (p > 0.5), procedure time (p > 0.5) and needle corrections (p > 0.05) 
between procedures on the phantom and on patients. 
Conclusion: A radiopaque 3D printed anthropomorphic phantom allows highly 
realistic simulation of CT-guided procedures and can be used for training, 
procedure optimization, and development of interventional techniques.  
Author Disclosures: 
  P. Jahnke: Patent Holder; DE202015104282U1, EP000003135199A1, 
US020170042501A1. Research/Grant Support; BIH TTF, BMWi EXIST. 
F.B. Schwarz: Research/Grant Support; BMWi EXIST. M. Ziegert: 
Research/Grant Support; BMWi EXIST. M. Scheel: Patent Holder; 
DE202015104282U1, EP000003135199A1, US020170042501A1. 
B-0831 09:34  
Recurrence and survival following image-guided percutaneous 
microwave ablation in primary lung malignancy  
M. Tsakok, M. Little, R. Millington, G. Hynes, F. Gleeson, M. Anderson; 
Oxford/UK (mariatsakok1@gmail.com)  
Purpose: Microwave ablation (MWA) is a relatively new alternative to 
radiofrequency ablation (RFA), that has been shown to produce larger ablation 
zones within a shorter time compared to RFA. There is a paucity of literature 
regarding recurrence and survival for this technique in primary lung cancer 
(LC). 
Methods and Materials: Retrospective review yielded 53 patients with LC 
treated with MWA over a 6-year period at our tertiary referral centre. We 
defined LC on the basis of biopsy sample (45%) or imaging features (PET 
avidity/size increase, 55%). Patients were unsuitable for surgical resection or 
stereotactic body radiation therapy (SBRT) due to medical co-morbidities or 
tumour characteristics, and MWA was recommended by the MDT. The median 
age of patients was 76.3 (55-91), mean size of ablated lesion 25mm (12-
50mm) and mean follow-up was 14 months (1-33 months). 
Results: Local recurrence was identified in 11% (6/53), however in three 
patients, local control was subsequently achieved by re-ablation. Local 
recurrence was significantly more likely for larger tumour size >25mm 
(p=0.002). 78% patients demonstrated no evidence of recurrence at follow-up 
imaging (mean 14 months; 1-33). There were six cases of distant recurrences: 
three occurring to liver, one intrapulmonary recurrence, one nodal recurrence 
and two mixed recurrence (lung+liver, lung+peritoneum). 32/53 patients have 
deceased, median survival was 13 months (1-32) - cause of death was not 
cancer in 60% of cases. 
Conclusion: MWA of primary LC is able to achieve local control rates that are 
equivalent to SBRT and superior to the literature using RFA.  
B-0832 09:38  
Sampling errors in image-guided liver biopsies: depiction of the biopsy 
site on immediate post-interventional CE MRI  
G. Schneider, A. Bücker, L. Fenzl; Homburg/DE 
(Lisa.Fenzl@uniklinikum-saarland.de)  
Purpose: Sampling errors in image-guided biopsies of focal liver lesions are a 
common problem in clinical routine. The purpose of our study was to evaluate 
if MRI may detect the exact location where a liver biopsy was taken and 
confirm sampling of representative tissue. 
Methods and Materials: MRI-guided liver biopsy was performed in a total of 
35 patients. Immediately post-biopsy unenhanced and CE-MRI (0.05 mmol/kg 
MultiHance) was performed in order to depict the exact biopsy site. Imaging 
included T1- and T2-weighted unenhanced sequences (T2-TSE, HASTE, T1w-
flash-2D and 3D-VIBE-DIXON Sequences) as well as dynamic 3D-VIBE-
DIXON imaging post-bolus CM injection. Furthermore a T1w-flash-2D 
sequence and a 3D-VIBE-DIXON sequence in the equilibrium phase and in the 
hepatobiliary phase (hb-phase) were acquired. 
Results: In all patients the biopsy tract could be detected on post-biopsy 
imaging. On unenhanced imaging the biopsy tract was best detected on the 
T1w flash-2D sequences (30/35) followed by the 3D-VIBE-DIXON sequence 
(27/35). T2w-TSE and HASTE images could not delineate the biopsy tract 
sufficiently. On CE images the biopsy tract was depicted best in the equilibrium 
phase both on the T1w flash 2D and 3D-VIBE-DIXON sequence (34/35). In the 
biliary phase depiction of the sampling area (33/35) together with a more 
adequate depiction of the lesion that underwent biopsy was noted. 
Conclusion: Immediate post-liver biopsy MRI allows for depiction of the biopsy 
tract both on unenhanced and CE MRI with advantages seen for CE images. 
T2w imaging does not reliably depict the biopsy tract.  
Author Disclosures: 
  G. Schneider: Advisory Board; Bracco. Research/Grant Support; Bracco, 
Siemens, Guerbet. Speaker; Bracco, Siemens, Guerbet. A. Bücker: 
Research/Grant Support; Bracco, Siemens. 
B-0833 09:42  
Contrast-enhanced ultrasound (CEUS) as guidance system for ablative 
treatments of primary and secondary liver tumours: a multicenter study  
G. Francica1, F. Meloni2, M. Pompili3, F. Terracciano4, E. Caturelli5, I. de Sio6; 
1
Castel Volturno/IT, 2Milan/IT, 3Rome/IT, 4San Giovanni Rotondo/IT, 
5
Viterbo/IT, 6Naples/IT (giampierofrancica@gmail.com)  
Purpose: To retrospectively characterise the prevalence of CEUS-guided 
ablation (CEUS-ABL) of liver tumours at six interventional ultrasound centres. 
Methods and Materials: The six participating centres retrospectively selected 
all patients in whom therapeutic needles for percutaneous ethanol injection 
(PEI), radiofrequency (RF), microwave (MW) have been positioned into target 
lesions during CEUS. The prevalence of CEUS-ABL of each centre between 
2008 and 2016, contrast agent consumption and safety, procedure indications, 
ablation effectiveness and complication rate were assessed. 
Results: CEUS-ABL was carried out in 148 patients (103 M/45 F, median age 
74 yrs.) with 151 liver targets (median size 15 mm) of which 86.7% were HCC 
tumours. PEI, RF and MW were performed in 35.2%, 46.3% and 18.5% of 
cases, respectively. CEUS-ABL represented 7.4% (range 2.5%-13.8%) of 2015 
ablative sessions performed at the participating centres. Indications to the 
procedure were: improvement of conspicuity of the target (28.5%), target 
undetectable on non-enhanced ultrasound (29.8%), detection of vital area/s in 
nodules with either incomplete ablation or recurrent tumour (41.7%). A single 
dose (2.4 ml) of contrast agent was used in 72.2% of cases. No major 
complications or death occurred after CEUS-ABL. Complete ablation was 
obtained in 113 nodules (74.8%). Altogether hyperthermic techniques (RF and 
MW) performed better than PEI (86.7% vs. 51% of complete ablation). 
Conclusion: The indications for CEUS-ABL for liver tumours are limited, but 
this procedure can be useful in challenging clinical scenarios, e.g. poorly 
visualised or invisible lesions, choice of vital area/s in nodules with previous 


































10:30 - 12:00 Room A  
Abdominal Viscera  
SS 1001a  
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B-0834 10:30  
MRI imaging of branch-duct IPMN: evaluation of agreement between 
observers with different degrees of experience  
L. Bertuzzo, G. Zamboni, R. Negrelli, R. Pozzi Mucelli; Verona/IT  
Purpose: The Sendai and Fukuoka consensus guidelines have defined the 
characteristics of high-risk mucinous lesions. Purpose of our study was to 
assess the agreement between an experienced and a non-experienced reader 
in recognising the main features defined by the guidelines in a series of IPMN. 
Methods and Materials: IRB approval was waived for this retrospective study. 
We included 118 patients (45 M, 73 F, average age 68 years) affected by 
IPMN who underwent MRI and MRCP in our institution. Two readers, 
respectively with 10 and 4 years of experience in abdominal imaging, reviewed 
independently the scans assessing all cysts >5 mm for wall/internal septa 
thickening, solid mural nodules, dilation of the main pancreatic duct (MPD) and 
contrast enhancement. The readers were blinded to clinical and laboratory 
information. Kappa statistics was calculated. 
Results: 10 patients had mixed-type IPMN and 108 branch-duct IPMN. 
Patients had a median of 2 cysts >5 mm each (range 1-20; mean 2.6). A total 
of 307 cystic lesions were reviewed, with a mean size of 11.8 mm (5-50 mm). 
The two readers showed very good agreement regarding MPD dilation 
(k=0.908), wall thickening (k=0.893), and presence of mural nodules (k=0.856). 
The agreement was good for presence of filling defects (k=0.721), wall 
enhancement (k=0.725) and presence of mural nodules (k=0.663). 
Conclusion: Readers with different experience in abdominal imaging, when 
assessing IPMN at MRI-MRCP, show an interobserver agreement ranging 
between good (0.663) and very good (0.908) when applying the Fukuoka 
criteria, confirming their usefulness for lesion evaluation standardisation.  
B-0835 10:38  
Intraindividual interscanner variation of virtual unenhanced attenuation 
values derived from twin-beam dual-energy CT in comparison to dual-
source dual-energy CT in 126 patients  
A. Cosentino1, M. Obmann2, J. Gehweiler2, V. Kelsch2, V. Hofmann2, T.J. Re2, 
D. Boll2, M. Benz2; 1Turin/IT, 2Basle/CH (aurelio.cosentino@gmail.com)  
Purpose: The purpose of this study was to evaluate the comparability of virtual 
unenhanced (VUE) attenuation values derived from a novel technique for 
single-source twin-beam dual-energy CT using a split-filter (tbDECT; two equal 
parts of gold and tin) and a dual-source dual-energy CT (dsDECT). 
Methods and Materials: A total of 126 patients were retrospectively analysed. 
Each patient underwent an abdomino-pelvic CT on a tbDECT and a second-
generation dsDECT scanner (SOMATOM Definition Edge and Flash, Siemens, 
Germany). Virtual unenhanced images were reconstructed off of venous phase 
series using commercially available software (Syngo.via, Siemens, Germany). 
Attenuation values of the liver, spleen, kidneys, blood, fat and muscle were 
recorded. Disagreement of VUE attenuation values >10HU between the two 
scans was defined as inadequate. 
Results: The intrapatient interscanner analysis showed significant differences 
between VUE attenuation values derived from tbDECT and dsDECT (p<0.01) 
in 6 of 7 organs. The percentage of patients with differences in VUE 
attenuation values >10HU between tbDECT and dsDECT ranged between 
15% (left kidney) and 62% (spleen). 
Conclusion: This study showed significant differences in VUE attenuation 
values derived from different dual-energy techniques (tbDECT vs dsDECT) in 
the same patient. Thus, to ensure reliable VUE attenuation measurements, it is 
advisable to perform patient follow-up studies using the same dual-energy 
technology.  
B-0836 10:46  
Diffusion-weighted magnetic resonance imaging in uveal melanomas: 
validation of early chemotherapeutic monitoring of targeted therapy  
N. Guberina, S. Bauer, H. Richly, M. Scheulen, A. Wetter; Essen/DE 
(nika.guberina@uk-essen.de)  
Purpose: The aim of this study was to explore the feasibility of diffusion-
weighted magnetic resonance imaging (MRI) sequences (DW-MRI) as a non-
invasive technique for monitoring of therapeutic response to targeted therapy 
in patients with metastatic uveal melanoma. 
Methods and Materials: In retrospective analysis the chemotherapeutic 
response to targeted therapy was evaluated in 47 patients with metastatic 
uveal melanoma using diffusion-weighted MRI (DW-MRI) and ADC maps at 
1.5T MRI [b=100,500,1000s/mm2]. The apparent diffusion coefficient (ADC) 
was assessed in metastatic liver lesions prior to therapy [w0] as well as two 
[w2] and eight weeks [w8] after therapy initiation. The examination protocol 
included fat-saturated, dynamic T1- and T2-weighted sequences. Correlation 
with clinical response was performed. Responders were defined as stable-
disease. The results were analysed using the analysis of variance (ANOVA) 
and the paired-sample t-test. 
Results: The apparent diffusion coefficient measured by DW-MRI increased in 
hepatic lesions which showed no tumour progress under targeted therapy (w8 
p8<0.05). Lesions with no therapeutic response revealed a decrease of ADC 
within w8 (w8 p8<0.02). Furthermore, ratio of ADC0/ADC2 and ADC0/ADC8 
between patients with stable-disease and non-responders proved to be 
significant (w2 p2<0.05; w8 p8=0.006). Baseline ADC values showed no 
significant relationship to therapeutic response. 
Conclusion: Notably, the results illustrate that DW-MRI allows a non-invasive 
monitoring of therapeutic response to targeted therapy in patients with 
metastatic uveal melanoma at an early stage of therapy. An early monitoring of 
therapeutic response is crucial to determine whether the therapy benefits 
outweigh the risks associated to treatment toxicity of targeted therapy.  
B-0837 10:54  
MRI liver adenoma subtyping in animal models of glycogenosis type Ia  
F. Rosa, L. Basso, R. Resaz, L. Secondini, I. Verardo, F. Grillo, V. Prono, 
A. Eva, C. Neumaier; Genoa/IT (francescarosa892@gmail.com)  
Purpose: Hepatocellular adenomas (HCA) are benign tumours and their major 
complication is malignant transformation to hepatocellular carcinoma (HCC). 
Among various subtypes of HCA, -catenin-activated (HCA) have a greater 
risk of malignant transformation. In preclinical studies dedicated MRI protocols 
suitable to characterize and monitor liver lesions are requested to allow 
research on their oncogenesis and progression. The aim of this study is to 
validate a new MRI protocol for HCA subtyping to distinguish low-risk from 
high-risk tumours. 
Methods and Materials: An experimental animal model of glycogen storage 
disease 1a in which HCC and different types of HCA represent late and severe 
complications has been previously designed. The experiments were carried out 
on a 3T scanner performing T2-weighted imaging and T1 spoiled gradient 
echo-weighted imaging before and after administration of gadobenate 
dimeglumine. A total of 40 mice were studied for focal lesions detection and a 
group of 15 was monitored every 4 weeks for 3 months to evaluate lesion 
growth. Mice were sacrificed after last MRI and lesions were classified using 
immunohistochemistry. 
Results: Our protocol was able to detect liver lesions with a minimum diameter 
of 1 mm. MRI identified 4 different patterns after contrast administration 
(isointense, hyperintense, hypointense lesions and lesions with a peripheral 
contrast enhancement) which corresponded to different HCA subtypes. 
Conclusion: HCA displayed MRI features (hyperintensity on T2WI and 
hypointensity after contrast administration) clearly distinguishable from those 
exhibited by other subtypes, indicating that MRI is a reliable method to identify 
high-risk HCA.  
B-0838 11:02  
The role of visceral and subcutaneous adipose tissue measurements and 
their ratio by MRI in subjects with prediabetes, diabetes and healthy 
controls from a general population  
C. Storz1, S.D. Heber1, S. Rosplecz2, J. Machann1, K. Nikolaou1, R. Lorbeer3, 
A. Peters2, C.L. Schlett4, F. Bamberg1; 1Tübingen/DE, 2Neuherberg/DE, 
3
Munich/DE, 4Heidelberg/DE (corinna.storz@med.uni-tuebingen.de)  
Purpose: Different adipose tissue compartments are associated with metabolic 
risk. The aim of this study was to study the relationship of visceral and 
subcutaneous adipose tissue (VAT and SAT, respectively) by magnetic 
resonance imaging (MRI) and their ratio in subjects with impaired glucose 
metabolism from the general population. 
Methods and Materials: Subjects from a population-based cohort with 
established prediabetes, diabetes and healthy controls without prior 
cardiovascular diseases underwent 3 Tesla MRI. VAT and SAT were quantified 
from isotropic VIBE-Dixon as total volume and area on a single slice, and their 
ratio was calculated. Clinical covariates and cardiovascular risk factors were 
assessed in a standardized fashion. Univariate and adjusted analyses were 
carried out to determine group differences. 
Results: Among 384 subjects (age: 56.2 ± 9.2 years, 58.1% male), volumetric 
and single-slice VAT, SAT and VAT/SAT ratio measurements were strongly 
correlated (all >r=0.89). Similarly, VAT/SATvolume ratio was strongly correlated 
with VATvolume but not with SATvolume (r=0.72 and r=-0.21, respectively). 
Significant higher levels of VATvolume, SATvolume and VAT/SATvolume ratio were 
found in subjects with impaired glucose metabolism (all p0.01). After 
adjustment for potential cardiovascular confounders, VATvolume and 
  






VAT/SATvolume ratio remained significantly higher in subjects with impaired 
glucose metabolism (all <0.02), whereas the association for SATvolume 
attenuated. In addition, there was a decreasing effect of glycemic status on 
VAT/SATvolume ratio with increasing body mass index and waist circumference. 
Conclusion: VATvolume and VAT/SATvolume ratio are associated with impaired 
glucose metabolism, independent of cardiovascular risk factors, with a 
decreasing effect of VAT/SATvolume ratio in obese subjects.  
B-0839 11:10  
Non-invasive preoperative quantification of pancreatic fibrosis and 
lipomatosis: correlation of magnetisation transfer imaging and multi-
gradient echo MRI with histopathology  
K. Schawkat, D. Eshmuminov, D. Lenggenhager, K. Endhardt, B. Vrugt, 
A. Boss, H. Petrowsky, P.-.A. Clavien, C.S. Reiner; Zurich/CH 
(khoschy.schawkat@usz.ch)  
Purpose: To investigate the correlation of magnetization transfer (MT) imaging 
and multi-gradient-echo magnetic resonance imaging (MRI) with 
histopathology to quantify pancreatic fibrosis and lipomatosis in patients prior 
to pancreatoduodenectomy. 
Methods and Materials: 24 patients (age, 68±8ys, 16 males) prospectively 
underwent quantitative MT imaging with a 2D gradient-echo sequence and 
multi-gradient-echo imaging on a 3T MRI one day prior to 
pancreatoduodenectomy due to pancreatic adenocarcinoma (n=14), duodenal 
adenocarcinoma (n=6), neuroendocrine tumor (n=3) or IPMN (n=1). MT-ratio 
(MTR) and proton density fat fraction (PDFF) were measured in pancreatic tail 
(PT) and at the resection margin (RM). Pancreatic fibrosis was graded as mild, 
moderate or severe (F1-3), lipomatosis was graded as 0-10%, 11-30%, and 
>30% fat deposition (L1-3) on histopathology. Mann-Whitney-U-test and 
Spearman’s correlation was used. 
Results: Patients with advanced pancreatic fibrosis (F3) showed a significant 
higher MTR compared to the F1-group at the RM and PT (38±4 vs. 32.3±1.6, 
p=.018 and 39.7±5.5 vs.31.2±1.7, p=.001). Spearman’s correlation coefficient 
of MTR and fibrosis grade was r=.532 for RM (p=.011) and r=.554 for PT 
(p=.008). Pancreatic parenchyma with advanced fat deposition (L2-3) showed 
significantly higher PDFF compared to lipomatosis grade L1 (RM: p=.002 and 
PT: p=.001). PDFF of pancreatic parenchyma showed a moderate and 
significant correlation with histopathological lipomatosis grade (RM: r=.668 and 
PT: r=.707, p=.000). MTR was significantly higher in pancreatic tumor 
compared to pancreatic parenchyma (44±5.5 vs. 37.4±5.4, p=.000). 
Conclusion: Multiparameteric MRI of the pancreas including MTR and PDFF 
maps may yield quantitative information to preoperatively quantify pancreatic 
fibrosis and lipomatosis noninvasively.  
B-0840 11:18  
Conventional liver fat quantification MRI vs complex chemical shift-
encoded MRI in an oncologic population  
G. Corrias1, S. Eskreis-Winkler1, S. Krebs1, J. Zheng1, L. Saba2, L. Mannelli1; 
1
New York, NY/US, 2Monserrato/IT (corriasgmd@gmail.com)  
Purpose: MRI is the most accurate imaging technique in diagnosing steatosis. 
It can also be used to quantify hepatic fat content. There are two main ways in 
which steatosis can be quantified with MRI: conventional IOP and proton 
density fat fraction (PDFF). The aim of this study is to compare IOP with an 
innovative type of PDFF, called IDEAL-IQ, in quantifying fat fraction in an 
oncological population. 
Methods and Materials: A total of 50 consecutive patients were included in 
the study. Two radiologists reviewed the images and placed 3 elliptic ROIs of 
10 mm of diameter in the liver. Intraclass correlation coefficient (ICC) was 
estimated to evaluate agreement on fat fraction between conventional MRI and 
IDEAL, as well as between 2 readers. Exact Wilcoxon signed rank test was 
used to compare iron level and fat fraction between conventional MRI and 
IDEAL, in all patients, patients with normal iron level, and patients with above 
normal iron level. 
Results: The agreement on fat fraction using conventional MRI was poor 
(ICC=0.372). The agreement on iron level and IDEAL IQ fat fraction was 
excellent (ICC=0.935). A statistical difference was demonstrated in fat fraction 
estimation in low iron group between the fat fractions calculated by IDEAL-IQ 
and IOP (p<0,001 for reader 1 and 2). 
Conclusion: Our results show that fat fraction calculated from IDEAL-IQ maps 
and from T1-weightened-in-and-out-of-phase (IOP) imaging are significantly 
different in a population without pathologic liver iron levels. IDEAL IQ had an 







B-0841 11:26  
Ability to diagnose disorders of liver haemodynamics in conditions of 
biliary hypertension with perfusion computed tomography  
V. Malakhanov, P.V. Seliverstov; Irkutsk/RU (malakhanow@mail.ru)  
Purpose: The possibility of detection of haemodynamic disorders of the liver in 
patients with obstructive jaundice syndrome. 
Methods and Materials: The study included 37 patients (median 59 years). 
Duration of jaundice from 3 days to 1 month from the onset of the disease. 
Patients according to the classification by V. D. Fedorov (2000) were divided 
into three groups: mild(n = 14), moderate(n = 12) and severe (n = 11). Used 
Ultravist-370 (50 ml), the infusion rate 5.5 ml/s. Evaluated: arterial liver 
perfusion (ALP), portal liver perfusion (PLP) . The total liver perfusion (TLP) 
were calculated by summing up blood (ALP) and portal perfusion (PLP). 
Results: In patients with mild, decrease PLP to 15.0%, increase ALP up to 
10.0%, TLP is not reduced. In patients with a medium degree of reduced PLP 
to 40.0%, ALP is increased to 80.0% of TLP is reduced from 15 to 30.0%. In 
patients with a severe degree there is a decrease in PLP to of 73.0%, with an 
increase in ALP to 26.0%, TLP was reduced by more than 50.0%. 
Conclusion: CT perfusion can be used as a method of assessing 
haemodynamic instability in the liver in patients with biliary hypertension to 
assess the severity of liver failure. The obtained information will allow you to 
properly optimise the treatment of patients.  
B-0842 11:34  
Comparison of stiffness values of peripheral and central liver tissues 
with MR elastography in patients with primary sclerosing cholangitis  
D. Kuru Öz, E. Peker, M. Kul, A. Erden; Ankara/TR (digdem_k@hotmail.com)  
Purpose: In primary sclerosing cholangitis (PSC), peripheral vascular and / or 
lymphatic drainage disturbances resulting from periductal inflammation of 
peripheral bile ducts are seen as peripheral subcapsular triangular 
hyperintense areas in T2-weighted images. In the progressive phase, fibrosis 
may develop in this tissue of impaired perfusion. This study aims to compare 
the tissue stiffness values of liver peripheral and central segments with MR 
elastography based on T2 signal differences in liver parenchyma in patients 
with PSC. 
Methods and Materials: A total of 10 patients with PSC were included in this 
study (5 males, 5 females, mean age 50.6 years, median age 49 years (range 
38-59)). The stiffness values of the 1/3 peripheral section and the remaining 
central section of the liver were measured on confidence map of MR 
elastography (1.5 Tesla MR system). The 'Wilcoxon signed rank test' was used 
to compare the peripheral and central measurements determined as mean 
kPa. 
Results: The median stiffness values were 4.3 kPa and 3.35 kPa in peripheral 
and central sections, respectively. Significant difference between the peripheral 
and central tissue stiffness values was detected (p=0.008). 
Conclusion: In PSC, tissue stiffness in the periphery of the liver is greater than 
in the central. This finding is consistent with the observation that ductal 
dilatation, periductal inflammation and fibrosis are predominantly seen at the 
periphery.  
B-0843 11:42  
Portal hypertension associated with oxaliplatin administration: incidence 
and natural history  
M. Di Martino, K. Koryukova, C. Catalano; Rome/IT (micdimartino@hotmail.it)  
Purpose: To establish incidence and clinical manifestations of non-cirrhotic 
portal hypertension in patients affected by gastrointestinal neoplasm treated 
with oxaliplatin. 
Methods and Materials: This is a retrospective single-center study. From a 
database of 570 patients we considered eligible for the study 94 patients with 
GI tract neoplasm (57 colon, 28 rectum, 5 stomach, 4 other) who underwent 
chemotherapy (mean duration therapy 5.7 months) according to specific 
selective criteria. Two expert radiologists in liver imaging reviewed in 
consensus three computed tomography examinations (baseline, at the end of 
therapy and 6 months after the end of therapy) looking for features of portal 
hypertension (ascites and varices) and measuring portal vein and spleen 
parameters (long axis, area and volume). T Student's test and ² Person were 
used for statistical analysis. 
Results: Mean long-axis diameter of portal vein and spleen and spleen volume 
were significantly higher at the end of therapy (p=.0009; p < .0001; p < .0001, 
respectively). At the end of therapy, two patients developed varices (2.1%), ten 
cases of portal vein increase in size (10.6%) and 26 cases of splenomegaly 
(28%) were reported. Seven patients reported both splenomegaly and portal 
vein enlargement. After six months the end of therapy, in 4 patients signs of 
portal hypertension disappeared. 
Conclusion: Patients who undergo chemotherapy with oxaliplatin should be 
also observed for portal hypertension and its evolution.  
  






B-0844 11:50  
Learning from our errors: what are the common clinically important 
errors that radiologists repeatedly make in the UK’s largest teaching 
hospital and how can we best address them?  
A. Koo, J.T. Smith; Leeds/UK (andrew.koo@doctors.org.uk)  
Purpose: To review the attendance, activity and outcomes of 5 years of 
Radiology departmental educational/discrepancy meetings in our hospital. This 
is a meeting attended by sub-speciality radiologists, radiographers, nurses, 
support staff and managers. 
To review the clinically important cases and categorise them in an attempt to 
identify recurring patterns of errors (or educational themes). To identify how 
many of these themes could be addressed by a more positive and less 
pejorative method of presenting cases rather than simply reviewing people’s 
“errors”. 
Methods and Materials: All the attendance records and cases discussed in 
the 30 consecutive meetings from November 2011 under a single chairman 
were reviewed retrospectively. Cases had been selected by team members 
who had noticed a discrepancy / educational case and were presented 
anonymously. 
Results: Mean consultant attendance per meeting was 29 and 69% attended 
at least 3 meetings per year (Royal College of Radiology recommendation). 
628 cases were reviewed. 98% consultants in the department had contributed 
at least one case over 5 years. 7 common themes were identified; missed lung 
cancers, missed fractures and their mimics, missed incidental cancers, 
incorrect cancer staging, incorrect characterisation of disease, missed clinically 
significant non-cancer diagnoses and uncommon but clinically important 
disease processes with image-specific signs. Good spots could be identified to 
illustrate each of these seven common themes. 
Conclusion: The fact that many errors in our department fell into several 
common themes could facilitate rolling audits and targeted teaching. “Good 
spots” address these themes in a more positive way than “errors”.  
Author Disclosures: 
 J.T. Smith: Author; The authors would like to acknowledge Catherine 
Parchment Smith in helping write and edit our abstract. 
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B-0846 10:30  
Diffusion-weighted MR-volumetry and high-resolution MR-volumetry 
association with lymphovascular invasion and N-stages in resectable 
rectal cancer  
H. Li, G.W. Chen, X.-.L. Chen; Chengdu/CN (522696619@qq.com)  
Purpose: To determine whether diffusion-weighted imaging (DWI)-volumetry 
and high-resolution T2-weighted imaging (T2WI) MR-volumetry could predict 
lymphovascular invasion (LVI) and N-stages in resectable rectal cancer. 
Methods and Materials: 50 consecutive patients with rectal cancer who 
underwent radical surgery in 1 week after DWI and high-resolution T2WI were 
retrospectively identified. Gross tumour volume (GTV) was evaluated on DWI 
and high-resolution T2WI. Univariate and multivariate analyses were 
performed to determine whether GTV could predict LVI and lymph node 
metastasis (LNM). Mann-Whitney U test was performed to compare GTV 
among N-stages. Cut-offs of GTV were investigated using area under the 
receiver operating characteristic curve (AUC) analysis for predicting LVI and N-
stages. 
Results: DWI-GTV and T2WI-GTV increased with LVI (r=0.750 and 0.710, 
P<0.0001, respectively) and increasing of N stage (r=0.780 and 0.755, 
P<0.0001, respectively). Univariate analysis showed DWI-GTV and T2WI-GTV 
could predict LVI (P<0.0001). Multivariate analyses indicated only DWI-GTV as 
an independent risk factor of LVI (P=0.005, odds ratio=1.207) and LNM 
(P=0.005, odds ratio=1.420). The Mann-Whitney U test showed DWI-GTV and 
T2WI-GTV could distinguish N0 from N1, N0 from N1-2, N0-1 from N2 
(P<0.0001). DWI-GTV could predict LVI (cut-off 11.05cm3; AUC 0.899), and 
distinguish N0 from N1 (cut-off 10.86cm3; AUC 0.865), N0 from N1-2 (cut-off 
10.46cm3; AUC 0.934), N0-1 from N2 (cut-off 17.7cm3; AUC 0.932). T2WI-GTV 
could predict LVI (cut-off 13.74cm3; AUC 0.877), and distinguish N0 from N1 
(cut-off 12.25cm3; AUC 0.827), N0 from N1-2 (cut-off 13.36cm3; AUC 0.911), 
N0-1 from N2 (cut-off 20.43cm3; AUC 0.927). 
 
Conclusion: High-resolution T2WI-GTV and DWI-GTV of resectable rectal 
cancer were correlated well with the LVI and LNM, but the latter is a potentially 
more promising non-invasive technique that can help predict the preoperative 
LVI and distinguishing N-stages.  
B-0847 10:38  
Could perfusion heterogeneity assessed at DCE-MRI predict rectal cancer 
sensitivity to chemoradiotherapy?  
A. Di Chiara, A. Palmisano, A. Esposito, P. Rancoita, P. Passoni, 
A. Del Maschio, F. De Cobelli; Milan/IT  
Purpose: To evaluate whether the rectal cancer’s perfusion heterogeneity 
prior to chemoradioterapy (CRT) evaluated using histogram analysis of DCE-
MRI quantitative parameters can predict response to treatment. 
Methods and Materials: Twenty-one patients with histologically proven rectal 
adenocarcinoma underwent DCE-MRI before CRT. Tumour volumes were 
drawn on Ktrans and Ve maps using T2W-images as reference and 25th, 50th, 
75th percentile, mean, standard deviation, skewness and kurtosis calculated. 
After CRT, all patients underwent surgery and, according with histopatological 
Rödel's tumour regression grade (TRG), patients were classified in poor 
responder “non-GR” (TRG 0,1,2) and good responders “GR” (TRG3-4). Mann-
Whitney's test was used to compared measurement between GR and non-GR 
and ROC curves to identify parameters predictive of response. All p-values 
were adjusted for multiple comparisons using the Bonferroni’s correction. 
Results: 16 (76%) patients resulted GR and 5 (24%) non-GR. Skewness and 
kurtosis of Ve resulted significantly higher in non-GR (4.886±1.320 and 
36.402±24.486, respectively) than in GR (1.809±1.280, p=0.003 and 
6.268±8.130, p= 0.011). Ve skewness < 3.635 was able to predict GR with an 
AUC of 0.988, sensitivity 93.8%, specificity 80% and accuracy 90.5%. Ve 
kurtosis < 21.095 was able to predict response with an AUC of 0.963, 
sensitivity 93.8%, specificity 80% and accuracy 90.5%.Other parameters 
showed no significant differences, and were not predictive of response. 
Conclusion: Ve skewness and kurtosis seem promising in the prediction of 
rectal cancer’s response to CRT.  
B-0848 10:46  
Radiomics analysis for preoperative prediction of lymph node metastasis 
in patients with rectal cancer  
H. Liu, C. Zhang, J. Li, D. Wang; Shanghai/CN (liuhuanhuan0117@163.com)  
Purpose: To investigate the value of radiomics analysis for preoperative 
prediction of lymph node metastasis in patients with rectal cancer. 
Methods and Materials: A total of 183 patients with histopathologically 
confirmed rectal cancer who underwent high-resolution MR imaging without 
chemoradiotherapy were divided into the primary cohort (n=128) and the 
validation cohort (n=55). Radiomics features were extracted from oblique axial 
T2-weighted images of each patient. The independent two-sample t test, 
Kruskal-Wallis test, and Pearson correlation analysis were used for feature 
selection. A radiomics signature was built and multivariable logistic regression 
analysis was used to develop the radiomics model including radiomics features 
and independent clinico-radiologic risk factors. The performance of the 
radiomics model was assessed by its calibration, discrimination, and clinical 
usefulness. 
Results: A total of 385 radiomic features were extracted from each patient, 
and 6 radiomics features were selected for the radiomics signature. The 
radiomics model included radiomics signature, MR-reported lymph node status, 
and carcinoembryonic antigen (CEA) level. The model showed good 
discrimination and moderate calibration in the primary cohort and validation 
cohort, with a C-index of 0.842 (95% confidence interval (CI), 0.770-0.914) and 
0.722 (95% CI, 0.643-0.884), respectively. Decision curve analysis confirmed 
the clinical utility of the radiomics model. 
Conclusion: We developed a radiomics model based on the MR radiomics 
features in combination with independent clinico-radiologic risk factors. The 
model could be helpful for predicting the lymph node metastasis in patients 
with rectal cancer.  
B-0849 10:54  
Locally advanced rectal cancer: the value of whole-tumour histogram-
based texture analysis of baseline ADC map in predicting tumour 
response to neoadjuvant chemoradiotherapy  
l. Yang, B. Wu; Chengdu/CN (lqyang95@163.com)  
Purpose: To determine the diagnostic performance of ADC map before 
treatment in predicting pathological complete response (pCR) after 
neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced 
rectal cancer (LARC) using whole-tumour histogram-based texture analysis. 
Methods and Materials: 26 patients with LARC who completed nCRT and 
surgery were enrolled retrospectively. Histopathologic tumour regression grade 
was the reference standard. Whole-tumour ROIs were manually drawn twice 
(two weeks interval) on pre-CRT ADC maps performed with the same imaging 
unit (b=0, 600, 1000 s/mm2) by one radiologist. Intraclass correlation coefficient 
  






(ICC) was calculated to evaluate intraobserver variability. Independent t test 
was used to compare histogram-based texture parameters between two 
groups. Receiver operating characteristic (ROC) analysis was performed to 
evaluate their diagnostic performance.. 
Results: For both measurements the standard deviation, variance, entropy, 
quantile 75%, 90% and 95% of whole-tumour pre-CRT ADC values were 
significantly lower in pCR group (P=0.001-0.046). And the uniformity and 
energy were higher (P=0.007-0.027). Since the intraobserver agreement was 
good between two measurements (ICC, 0.850-0.957), the first-time data were 
used to following analyses. Respective AUCs of quantile 75%, 90% and 95% 
values when determining pCR were 0.739, 0.770, and 0.806, with the optimal 
cut-off point of 1.04×10-3 (sensitivity=86.7%, specificity=63.6%), 1.204×10-3 
(sensitivity=86.7%, specificity=63.6%), and 1.339×10-
3mm2/s(sensitivity=86.7%, specificity=72.7%), respectively. 
Conclusion: The pCR group appeared less heterogeneous on pre-CRT ADC 
map and had lower high percentile ADC values than non-pCR group. Whole-
tumour histogram-based texture analysis of pre-CRT ADC map could 
effectively predict pCR after neoadjuvant CRT in LARC patients.  
B-0850 11:02  
T2-weighted signal intensity to predict complete and good response after 
neoadjuvant chemoradiation therapy in patients with rectal cancer  
R.A.P. Dijkhoff; Maastricht/NL (rebeccadijkhoff@hotmail.com)  
Purpose: To determine whether T2-weighted signal intensity (T2W-SI) can 
predict complete and good response after neoadjuvant chemoradiation(CRT) 
in patients with rectal cancer. 
Methods and Materials: 171 consecutive patients with rectal cancer treated 
with neoadjuvant CRT underwent MRI before and 8-10 weeks post-CRT. The 
primary tumour and remnant after CRT were manually delineated on T2W-MRI. 
Histogram analyses were performed on these volumes of interest with 
pyradiomics. Extracted parameters were mean, median, SD, range, minimum, 
maximum T2W-SI before and after CRT. Change between pre- and post-CRT 
T2W-SI parameters was calculated. Heterogeneity of T2W-SI was assessed by 
the coefficient of variance (CoV=SD/mean). T2W-SI parameters were 
compared between complete (CR; ypT0), good responders (GR; ypT0-1) and 
non-responders (NR; ypT2-4). Reference standard was either surgery or a 
wait-and-see programme with at least 2years of recurrence-free follow-up. 
Results: 36/135 patients had a CR and 49/171 a GR. Maximum SI (941.62 vs 
1149.63, p=0.028), heterogeneity of the SI (0.265 vs 0.291, p=0.017) and SI 
range (828.56 vs 1074.52, p=0.009) at primary staging were significantly lower 
in CR than in NR. Minimum SI at primary staging was significantly higher in 
both CR (113.06 vs 75.10, p=0.017) and GR (117.02 vs 69.46, p=0.001) 
compared to NR. The mean difference in SI between primary and restaging 
was larger in both CR and GR compared to NR, although not statistically 
significant in the CR patients (CR: -14257 vs NR: -105.44, p=0.114 and GR: 
176.83 vs NR: -87.72, p=0.001). 
Conclusion: The pre-CRT T2W-SI is significantly higher in CR and GR with a 
larger decrease in mean SI after CRT. These parameters could be a potential 
non-invasive marker for predicting complete/good response in patients with 
rectal cancer before and after CRT.  
B-0851 11:10  
Predictive value of functional imaging markers derived from PET/CT and 
diffusion-weighted MRI in response assessment of rectal cancer 
treatment  
S. Drago, C. Talei Franzesi, S. Lombardi, A. Casiraghi, L. Guerra, S. Sironi, 
D. Ippolito; Monza/IT (silvia.drago@hotmail.it)  
Purpose: To assess the clinical diagnostic value of functional imaging for 
tumor response prediction in rectal cancer, combining quantitative parameters 
of ADC and SUV max before and after chemo-radiation therapy, with tumor 
regression grade at histology 
Methods and Materials: Forty-five patients with biopsy rectal adenocarcinoma 
were enrolled in this study. All patients underwent whole body 18-FDG-PET/CT 
scan and pelvic MRI examination before (PET1, MR1) and after neoadjuvant 
chemo-radiation therapy(PET2, MR2). MRI was performed on 1,5T 
magnet(Philips,Achieva), adding DWI sequences (b-value 0 and 1000 
mm²/sec)to the standard protocol. On PET/CT the SUVmax of rectal lesions 
was calculated in PET1 and PET2.The different SUVmax(∆SUV) and 
ADC(∆ADC) values, between baseline and pre-surgical scan, were assessed 
and correlated with pathologic tumor regression grade (Mandard’s criteria;TRG 
1=complete regression,TRG5=no regression) 
Results: Twenty-nine tumors (68%) showed complete or subtotal regression 
(TRG1-2) at histology and classified as responders; 16 tumors (32%) were 
classified as non-responders (TRG3-5). The mean values of SUV max in PET1 
were higher than in PET2 (p<0.001), whereas mean ADC values were lower in 
MR1 than MR2 (p<0.001). The best predictors for TRG response were SUV2 
(threshold 4.4) and ADC2 (1.28x10-3mm2/s). Moreover, combining the median 
quantitative values in a single analysis, the PPV for different response groups 
related to TRG system, showed an overall AUC of 96%, higher than 
DWI(88.2%) or SUVmax(93.3%) 
Conclusion: In era of PET/MRI scanner, combining DWI value and PET/CT 
could be the most feasible method to evaluate tumor response in rectal cancer, 
with accuracy values higher than other imaging techniques  
B-0852 11:18  
Texture analysis of magnetic resonance imaging in differential diagnosis 
of rectal tumours  
M. Huang; Zhengzhou/CN (huangmengna1127@163.com)  
Purpose: To analyse magnetic resonance images of rectal villous tubular 
adenoma and T1-T2 rectal adenocarcinoma, and evaluate the texture 
characteristics of two kinds of rectal tumours by "nearest neighbour algorithm". 
Methods and Materials: From March 2014 to January 2017, 30 patients with 
rectal villous tubular adenoma and 43 patients with T1-T2 rectal 
adenocarcinoma in our hospital were retrospectively analysed; texture analysis 
was performed on the ROIs of two types of tumours. 
Results: Totally 24 texture parameters were extracted based on statistical 
methods, of which 14 parameters had statistically significant difference 
between the two kinds of data sets (P<0.05). The sensitivity, specificity and 
accuracy of "nearest neighbour algorithm" of texture parameters of rectal 
villous tubular adenoma and T1-T2 rectal adenocarcinoma were 79.87±7.55%, 
53.89±10.16% and 69.24±5.52%, respectively. 
Conclusion: Texture analysis can extract more features for the differential 
diagnosis of rectal villous tubular adenoma and T1-T2 rectal adenocarcinoma, 
which would be conducive to the development of clinical treatment and provide 
a new method for the differential diagnosis of rectal tumours.  
B-0853 11:26  
Whole tumour texture analysis based on ADC maps as quantitative 
imaging biomarker in patients with locally advanced rectal cancer 
"responders" to neoadjuvant chemoradiotherapy  
A. Grassi, A. Cirigliano, S. Carbone, M. Biondi, V. Nardone, L. Pirtoli, 
L. Volterrani; Siena/IT (andrea.grassi14@alice.it)  
Purpose: To evaluate the predictivity of Texture Analysis (TA) parameters 
extrapolated by the whole tumour analysis on ADC maps in tumoural response 
and recurrence in patients whit locally advanced rectal cancer (LARC) treated 
with neoadjuvant chemoradiotherapy (CRT). 
Methods and Materials: We retrospectively analysed 35 pre-CRT MR imaging 
examinations. After complete surgical resection, only 23 patients with tumour 
regression grade (TRG) 1-2, considered “responders” according to Mandard 
TRG, were finally enrolled. Texture features (mean, standard deviation, 
skewness, kurtosis, entropy and uniformity) were assessed using a filtration-
histogram tecnique and were independently correlated, by univariate and 
multivariate analysis, with TRG and the onset of metastasis. ROC curve 
analysis was performed and DFS was assessed with Kaplan-Meier method. 
Results: Nine patients showed TRG1 (pathological complete response: pCR) 
and fourteen TRG2 whereas six patients (one TRG1, five TRG2) developed 
metastatic disease. Kurtosis was significantly lower in TRG1 in comparison 
with TRG2 (p= 0,016) and significantly higher in patient who had recurrence 
from those who did not have metastasis (p=0,013). The optimal cut off values 
were 3,5 (78% sensitivity, 86% specificity in predicting pCR) and 4,6 (67% 
sensitivity, 100% specificity in predicting metastatic disease) respectively. 
Conclusion: Texture ADC Kurtosis is seems to be a promising parameter in 
discriminating both rectal cancer responsiveness to CRT and tumoural 
aggressiveness (metastatic risk). Further investigations are needed to confirm 
usefulness TA kurtosis in custumised menagement of patients with LARC.  
B-0854 11:34  
Accurate localization of rectal cancer on preoperative magnetic 
resonance imaging: a prospective study using an anal verge marker  
Y. Han, B. Park, M. Kim, D. Sung, N. Han, K. Sim, S. Cho; Seoul/KR 
(yeonny0714@naver.com)  
Purpose: To determine an approach for rectal cancer localization using MRI, 
with the anal verge as a landmark. 
Methods and Materials: Fifty patients scheduled for MRI evaluation of rectal 
cancer were evaluated. Two markers were attached to the anal verge at 6 and 
12 o’clock positions. On sagittal T2WI, the distance between the lowest margin 
of cancer and upper tangent of the two markers was measured by two 
radiologists in 6 different ways, and compared with that obtained using rigid 
sigmoidoscopy. The intraclass correlation coefficient (ICC) was used for the 
correlation verification. Precise localization of the anal verge was evaluated 
based on the anal verge markers. 
Results: Among 6 different measurment methods, the “direct centre” method 
showed the highest correlation with rigid sigmoidoscopy (ICC = 0.81) and good 
interobserver correlation (ICC = 0.98). This method measures the linear 
distance between the centre of the line segment abutting the lowest margin of 
the tumour and perpendicular to the longitudinal axis of the rectum, and the 
  






upper tangent of the anal verge markers, on mid-sagittal T2WI. The anal verge 
identified by the marker was located within a range of -1.4 ~1.5 cm (mean -
0.24 cm) from the lowest margin of the external sphincter. 
Conclusion: The “direct centre” method is an accurate and relatively easy way 
for tumour localization using preoperative rectal MRI. The anal verge is located 
between 1.4 cm above and 1.5 cm below the lowest margin of the external 
sphincter and is usually in the upper portion of the lowest margin of the 
external sphincter.  
B-0855 11:42  
Predictive factors of recurrence at MR examination performed before and 
after preoperative chemoradiotherapy in patients with rectal cancer: a 
retrospective study  
F. Prampolini, S. Taschini, A. Pecchi, F. Sani, F. Gelsomino, A. Spallanzani, 
S. Kaleci, P. Torricelli; Modena/IT (prampolini.francesco@tiscali.it)  
Purpose: To evaluate whether MRI performed before and after neoadjuvant 
chemoradiotherapy (NACRT) could predict the risk of recurrence in patients 
with rectal cancer. 
Methods and Materials: This study included 87 patients with rectal cancer 
who had undergone pre- and post-NACRT local staging MRI, with dedicated 
protocol, between 2005 and 2016. Two radiologists independently reviewed all 
MR examinations retrospectively and assessed the T-stage, nodal involvement 
(>5 mm), distance from mesorectal fascia and extramural venous invasion 
(EMVI scoring system 0-4). Correlation between these parameters and 
patients’ risk of recurrence was evaluated with statistical analysis. 
Results: In our analysis all four assessed parameters correlated significantly 
with the risk of recurrence (P value range 0.002-0.026) when evaluated in MRI 
performed after NACRT, but not in MRI performed before NACRT. The specific 
analysis of EMVI score (0-4) showed a statistically significant correlation with 
recurrence only when evaluated at MRI post-NACRT, while extramural venous 
invasion, if considered as present or absent, regardless of its score, correlated 
significantly with the risk of recurrence also in pre-NACRT MR examination (P= 
0.011). 
Conclusion: MRI performed after NACRT has a significant value in predicting 
the risk of recurrence in patients with rectal cancer. EMVI strongly correlated 
with the risk of recurrence and its presence in pre-NACRT MRI should be 
considered as an early predictive factor of disease relapse.  
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B-0856 10:30  
Outcomes of endovascular treatment for acute large vessel ischaemic 
stroke more than 6 hours after symptom onset  
R. Motyer1,1, H. Kok2, H. Asadi3, A. O'Hare1, P. Brennan1, P. Sarah1, S. Looby1, 
P. Nicholson1, J. Thornton1; 1Dublin/IE, 2London/UK, 3Melbourne, Victoria/AU 
(ronanmotyer@gmail.com)  
Purpose: Benefit from endovascular thrombectomy (EVT) for large vessel 
occlusion (LVO) acute ischaemic stroke (AIS) is well demonstrated. 
Furthermore, emerging evidence supports efficacy in appropriately selected 
patients treated beyond current recommendations of 6 hours. We evaluated 
clinical outcomes in patients undergoing late EVT at our institution. 
Methods and Materials: Retrospective review of prospectively collected 
clinical database on 355 patients who underwent EVT for LVO AIS. Data 
collected consisted of patient demographics, radiological findings and outcome 
details. Outcomes, including 90-day functional status, recanalisation, 
symptomatic intracranial haemorrhage (sICH) and 90-day mortality, for patients 
undergoing EVT <6 hours, >6 hours and >7.3 hours were compared. 
Results: 355 patients underwent EVT for LVO AIS at our institution during the 
review period, with 74 (21%) patients treated >6 hours from symptom onset. 
Successful recanalisation was achieved in 285 (80%) patients, with 228 (81%) 
achieving a mTICI 2b in <6 hour group, and 57 (77%) in >6 hour group 
(p=0.429). 90-day functional independence (mRS 0-2) was achieved in 162 
(46%) patients, with 130 (46%) achieving a mRS of 0-2 in <6 hour group, and 
32 (43%) in >6 hour group (p=0.643). No significant differences were found in 
rates of sICH or 90-day mortality. No significant differences in functional 
independence, recanalisation rates, sICH, or mortality were identified in 
patients treated with EVT >7.3 hours compared to <7.3 hours. 
Conclusion: In appropriately selected patients, EVT >6 hours was associated 
with comparable outcomes to those treated <6 hours. These data support a 
physiological approach to patient selection.  
B-0857 10:38  
Endovascular thrombectomy beyond 12 hours of stroke onset: a stroke 
network's experience of late intervention  
R. Motyer, J. Thornton, S. Power, P. Brennan, A. O'Hare, S. Looby, 
D. Williams, B. Moynihan, S. Murphy; Dublin/IE (ronanmotyer@gmail.com)  
Purpose: The benefit of late endovascular thrombectomy (EVT) in correctly 
selected patients presenting with large vessel occlusion acute ischaemic stroke 
has been demonstrated, with positive outcomes achieved up to 24 hours from 
symptom onset. As a tertiary stroke service, we reviewed our outcomes in 
cases of EVT performed >12 hours from symptom onset. 
Methods and Materials: Retrospective review of prospectively maintained 
database of all EVT cases performed for management of AIS with LVO of the 
anterior circulation at our institution. Patients were evaluated using ASPECTS 
on non-contrast CT brain and collateral grade on multiphase CT angiogram 
(mCTA) to aid selection for intervention. Data, including patient demographics, 
neuroimaging findings, procedural details, recanalization rates and 90-day 
functional outcomes, from all EVT cases performed >12 hours was collected. 
Results: Of the 542 consecutive EVT cases reviewed, 25 (4.6%) were 
performed >12 hours from symptom onset. Median age was 69 (IQR, 55-80), 
median NIHSS on presentation 14 (IQR, 11-18.5), median ASPECTS was 8 
(IQR, 8-9) and moderate-good cerebral collateral status in 96% of patients 
(n=24). Median time to groin puncture was 880 minutes (IQR, 753.5-977.5), 
with a rate of successful recanalization (mTICI 2b-3) of 88% (n=22). The rate of 
90-day functional independence (mRS 0-2) was 52% (n=13). There were no 
cases of symptomatic intracranial haemorrhage and 90-day mortality rate was 
12% (n=3). 
Conclusion: With careful patient selection, guided by ASPECTS and collateral 
status, EVT may be performed safely and effectively, with good functional 
outcomes achieved in patients with delayed presentation acute ischaemic 
stroke.  
B-0858 10:46  
Acute ischaemic stroke due to tandem occlusions of the internal carotid 
artery: results of endovascular recanalisation and clinical outcome  
M. Voormolen, T. Van der Zijden, O. D'Archambeau, L. Yperzeele, 
P. Vanacker, I. Baar, M. Muto, T. Menovsky, P.M. Parizel; Antwerp/BE 
(maurits.voormolen@uza.be)  
Purpose: Tandem occlusion of internal carotid artery (ICA) is defined as 
proximal ICA (near) occlusion combined with distal (embolic) occlusion of ICA 
and/or middle cerebral artery (MCA). We assessed endovascular 
recanalisations and clinical outcome in acute ischaemic stroke (AIS) patients 
due to ICA tandem occlusions. 
Methods and Materials: We evaluated immediate angiographic results and 
prospective clinical outcomes of 19 consecutive patients with tandem ICA 
occlusions, treated with mechanical thrombectomy (MT) between January 
2014 and July 2017, involving 15 men and 4 women, with a median age of 69 
years (range 52-87). They comprised 15% of total anterior circulation stroke 
recanalisations in this period. Thirteen patients had left ICA occlusion (68%). 
Fifteen patients (79%) received intravenous thrombolysis before endovascular 
recanalisation. 
Results: Successful recanalisation (TICI 2b/3) was seen in 14 patients (74%) 
and no recanalisation (TICI 0) in three patients (16%). Median procedure time 
was 65 minutes (range 20-120). Median number of passages was one (range 
0-5). In 7 patients (37%) balloon angioplasty of ICA was performed; 1 carotid 
stent was placed (5%). Median NIHSS was 19 (range 9-29) at admission and 
13 (range 2-30) at discharge. Only six patients (32%) had favorable clinical 
outcome at 3 months (mRS2); 9 patients (47%) had major cerebral infarcts, 6 
patients died (32%). 
Conclusion: In our series, endovascular recanalisation of tandem ICA 
occlusions in patients with acute ischaemic stroke showed high rates of 
successful recanalisation, but unfavorable clinical outcomes. Further studies 
are needed to determine which patients might benefit from endovascular 
recanalisation.  
B-0859 10:54  
Bronchial artery embolisation: tuberculosis patients with haemoptysis  
K. Muhammad, I.A. Lutfi; Karachi/PK (dr.khairmuhammad@gmail.com)  
Purpose: The goal of this study is to present our experience of bronchial artery 
embolization for the treatment of life threatening haemoptysis in patients with 
pulmonary tuberculosis. This study focuses on overall clinical success rate of 
this procedure and its cost effectiveness. 
Methods and Materials: Our study is based on four year retrospective cross-
sectional data from March 2013 to Feb 2017. In our study, fifty patients 
underwent bronchial artery embolization for the treatment of life threatening 
  






haemoptysis secondary to pulmonary tuberculosis. These patients were 
referred to radiology department from pulmonary clinics/ emergency. As a part 
of our departmental protocol, CT aortogram/pulmonary angiogram was 
performed on almost every patient to evaluate the bleeding bronchial artery for 
embolization. 
Results: We found out in our study bronchial artery embolization was 
successful in forty eight patients (96 %) and followed up till six months. 
Recurrence occurred in four (8%) patients after six months in whom there 
developed new lung cavity or recanalization of artery in previous lesion. In two 
patients (4%) embolization procedure was abandoned due to tortuous course 
of bronchial artery. Out of total fifty patients, some of our patient developed 
complications such as chest pain in fifteen patients (30%) and one patient (2%) 
developed lower limb weakness (spinal cord related complication). However, 
there was no mortality due to this procedure in our study. 
Conclusion: Bronchial artery embolization is life saving procedure for patient 
with haemoptysis with no procedure related mortality in our study and cost 
effective compared to surgery.  
B-0860 11:02  
Pulmonary arterial occlusion treatment in patients with haemoptysis: a 
32-case single-centre study  
Z.C. Charline, M. Jaffro; Toulouse/FR (charline.zadro@gmail.com)  
Purpose: Pulmonary arterial bleeding is a rare cause of haemoptysis, which 
requires a specific endovascular treatment. Herein, we report the feasibility and 
effectiveness of pulmonary artery occlusion treatment (PAOT) in our centre. 
Methods and Materials: Thirty-two patients treated by PAOT between 
January 2010 and May 2017 in Toulouse Rangueil University Hospital were 
retrospectively included. We performed a thoracic angio scan for each patient 
looking for an argument pointing to a pulmonary arterial origin (PAO) of the 
bleeding. 
Results: Nineteen patients (59 %) had a neoplasia and seven (22%) an active 
infectious disease. Signs contradicting to a PAO were irregularities (88%) and 
occlusion (31%) of the pulmonary artery, a lung parenchyma necrosis (59%) 
and pseudoaneurysms (44%). We used steel coils in 23 cases (72%) and 
plugs in 12 (38%). The feasibility of PAOT was 100% and the clinical efficacy, 
defined by early and sustained interruption of bleeding for 1 month, was 78% 
with a recurrence rate at the last follow-up of 31%. Seven patients had 
recurrence in the first month, and three later with additional embolisations (5) 
or surgeries (2). Only one patient with active infection experienced recurrence. 
Twenty-five patients (78%) had received an exclusive PAOT and 7 (22%) a 
combined occlusion of pulmonary and bronchial or systemic non-bronchial 
arteries. There was no significant difference between the two interventions 
concerning recurrence or survival. 
Conclusion: PAOT by steel coils or/and plug is feasible and efficacious with 
little recurrence in the long term.  
B-0861 11:10  
Renal artery embolisation for vascular lesions following Nephron-sparing 
surgery: a five-year experience  
E. Amodeo, A. Contegiacomo, N. Attempati, A. Paladini, C. Di Stasi, 
R. Manfredi; Rome/IT (enriamo@gmail.com)  
Purpose: Indications to Nephron-Sparing Surgery (NSS) are extending 
overtime, resulting in improved renal function and parenchymal preservation. 
On the other hand, NSS is burdened by potentially life-threatening vascular 
lesions (NSS-VL). Renal Artery Embolization (RAE) is emerging as a mini-
invasive alternative to surgery for NSS-VL management. This observational 
retrospective study describes our experience in the treatment of NSS-VL. 
Methods and Materials: Thirty-six patients, from January 2012 to December 
2016, with a NSS-VL diagnosed on Computed Tomography Angiography 
(CTA) before RAE were retrospectively enrolled. Type (pseudo-aneurysm; 
arteriovenous fistulas; active bleeding) and site (proximal; segmental; distal) of 
NSS-VL were assessed on CTA images and confirmed during RAE procedure. 
Technical (intra-procedural VL exclusion) and clinical (patient clinical stability 
>5 days) success, type of embolic agents (Coils; Glue; Polyvinyl-alcohol 
particles, PVA; Absorbable Gelatine Sponge, AGS) and intra/ peri-procedural 
complications were assessed by clinical charts and radiological reports 
analysis. 
Results: Patients had 24/36 (66,6%) pseudo-aneurysms, 6/36 (16,7%) 
arteriovenous fistulas and 6/36 (16,7%) active bleeding. RAE was performed 
with Glue (25/3; 69,4%), PVA (6/36; 16,7%), Coils (5/36; 13,9%), AGS (3/36; 
8,3%) or a combination of materials (7/36; 19,4%). Technical and clinical 
success was achieved in 36/36 (100%) and 33/36 (91,7%) patients, 
respectively. Glue migration occurred in 1/36 (2,8%) patient and was managed 
with intra-procedural fragmentation with angioplasty balloon. 3/36 (8,3%) 
patients encountered post-procedural bleeding successfully re-treated with 
RAE. 
Conclusion: RAE is a feasible, effective and safe, mini-invasive alternative to 
surgery in NSS-VL management.  
B-0862 11:18  
Alternative techniques in splenic artery embolisation in blunt splenic 
trauma  
M. Citone, F. Mondaini, C. Raspanti, G. Gabbani, E. Casamassima, 
G. Falcone, F. Fanelli; Florence/IT (michele.citone@gmail.com)  
Purpose: Splenic artery embolisation( SAE) has been increasingly employed 
as adjunctive tool in non operative management (NOM) in blunt splenic 
trauma( BST). Despite high technical success, controversies still exist on 
technique and materials employed, being coils the most utilised tool. We report 
our experience with Amplatzer Vascular Plug (AVP) and Onyx in splenic artery 
embolisation for trauma. 
Methods and Materials: Between 2015 and 2017, 11 patients, 7 male,( mean 
age 47yo range 16-67) received SAE treatment as part of NOM for isolated 
BST with embolic agent different from coils. Indication to treatment was 
grounded on contrast blush or active bleeding (AB) or AAST injury score >3 on 
CECT In 6 patient proximal embolisation with AVP (20-30%oversized) for injury 
grade >III without active bleeding (AB) was performed while in 5 patients distal 
SAE with Onyx 34 was performed for AB and (4pts) or extensive laceration( 
1pt). All procedures were performed under local anesthesia while deep 
sedation was required for the onyx group. 
Results: Technical success (intended as bleeding cessation or splenic artery 
occlusion) was achieved in 100%. Embolisation was achieved in less than 
1min. No migration of embolic agent was observed. None of the patients 
required splenectomy. No major complication or re-bleeding were reported. No 
evidence of abscess or major infarction was observed at CT scan performed 
within 48h. 
Conclusion: SAE with AVP or Onyx is a safe and effective procedure in 
splenic artery embolisation for blunt splenic trauma alternative to traditional 
coils.  
B-0863 11:26  
Management of acute occlusion of the superior mesenteric artery by local 
thrombolysis (multidisciplinary approach)  
M.M.A.H. ElShafey, A. Elgendi; Alexandria/EG 
(mohamedeshafei@yahoo.com)  
Purpose: To evaluate the effectiveness of endovascular local thrombolysis 
management in acute superior mesenteric artery (SMA) occlusion as 
alternative or neo-adjunctive treatment modality to surgery in a multidisciplinary 
approach strategy. 
Methods and Materials: The study was conducted on 12 patients presented 
by acute abdomen in the emergency department and diagnosed by CT as 
acute superior mesenteric artery occlusion. In all cases the main stem of the 
SMA was involved. The median time from admission to attempted 
endovascular revascularisation was 6-12 hours except for one case (36h). 
Superselective catheterisation of the SMA was done using Cobra 5fr catheter 
for control angiogram and a hydrophilic guidewire was introduced passing the 
occlusive thrombus or embolus and an initial bolus dose of rt-PA or 
streptokinase was injected, after that exchanged the Cobra catheter by 
Simmond' catheter for infusion over 12-24 hours. Re-checking the flow after 
the infusion period was done before removal of the catheter. Close monitoring 
of the patient was done by multidisciplinary team. 
Results: Successful revascularisation of the SMA was achieved in all patients. 
Only one patient needed further open laparotomy and bowel resection. No 
significant post-procedure bleeding was reported in any of the cases. One 
month follow up was done. 
Conclusion: Local thrombolysis for acute SMA occlusion is a minimally 
invasive procedure that can be effective as alternative treatment in selected 
group of patients without peritonitis. Early intervention (golden time) is the key 
for better results.  
B-0864 11:34  
Endovascular treatment of haemodialysis arteriovenous fistula with 
vessel preparation and drug-coated balloon angioplasty: a single-centre 
study  
J. Lucev, S. Breznik, D. Dinevski, R. Ekart, M. Rupreht; Maribor/SI 
(jernej.lucev@gmail.com)  
Purpose: To evaluate the effect of PTA of haemodialysis fistulas utilizing drug-
coated balloons with plain balloon vessel preparation (VP DCB). 
Methods and Materials: From 2012 to 2015, 31 patients (16 men; mean age 
62.81+/-17.2 years) with failing arteriovenous fistula were treated. All stenoses 
were dilated with regular high-pressure PTA balloons. After achieving 
angiographic success (<10% residual stenosis), drug-coated balloons were 
used for drug administration. Observation period was 6, 12 and 24 months. 
Results were compared with plain balloon PTA performed from 2006 to 2011 
(31 patients; 15 men; mean age 67.03+/-8.44 years). Target lesion primary 
patency, primary-assisted patency and secondary patency were compared. T 
test, Mann-Whitney U test, Fisher's exact test, Kaplan-Meier survival curve and 
  






log-rank test were used for statistical analysis. The significance was set at 
0.05. 
Results: Target lesion primary patency for VP DCB and plain balloon group 
was significantly different at 6 months (90.3% vs 61.3%; p=0.016), 12 (77.4% 
vs 29%; p=0.000) as well as 24 months (45.2% vs 16.1%; p=0.026). Kaplan-
Meier survival curve also showed significant difference for target lesion primary 
patency (534.2 vs 315.7 days; p=0.000). Target lesion primary assisted 
patency could not be compared because both groups were too different. 
However, only 38.7% of patients in VP DCB group were treated twice or more 
vs 80.6% in plain balloon group (p=0.002). There were no significant 
differences in target lesion secondary patency. 
Conclusion: VP DCB PTA decreases the rate of reinterventions and increases 
target lesion primary patency during the first 24 months.  
B-0865 11:42  
Lysis-assisted balloon (LAB) thrombectomy - a method for declotting 
thrombosed arteriovenous dialysis grafts: results from a retrospective 
analysis of 241 endovascular procedures  
P. Kitrou1, P. Papadimatos1, K. Katsanos1, S.C. Spiliopoulos2, N. Christeas1, 
D. Karnabatidis1; 1Patras/GR, 2Athens/GR (panoskitrou@gmail.com)  
Purpose: To retrospectively investigate the results of a percutaneous lysis-
assisted balloon (LAB) thrombectomy procedure for the treatment of 
thrombosed arteriovenous dialysis grafts (AVGs). 
Methods and Materials: Within 5 years (January 2012 to Decmber 2016), 291 
declotting procedures were performed for the treatment of thrombosed dialysis 
arteriovenous fistulas and grafts. Data were available for 129 patients (75 men, 
58.1%) with an AVG, undergoing 241 procedures [1.87procedures/patient (1-
10)]. Procedure includes initial lysis with 5mg recombinant tissue plasminogen 
activator followed by thrombectomy with a high pressure balloon for thrombus 
maceration using “facing sheaths” technique. 61 patients had 2 declotting 
procedures. In 80 cases (80/241; 33.2%) a stent graft (SG) was used for 
treatment of persistent stenosis. Main primary outcome measures were clinical 
success and postintervention assisted primary patency (PAPP). Secondary 
outcome measures included procedural complications and investigation of 
independent factors that could influence circuit survival. 
Results: Median PAPP was 434 days according to Kaplan Meier survival 
analysis. Clinical success was 96.26%. In 6 cases (6/241, 2.49%) declotting 
failed and a catheter was placed. There were 16 minor (16/241, 6.64%) and no 
major complications. There was no significant difference in circuit survival 
regardless of SG use (No SG 406 days vs. SG 349 days; p=0.24). There was a 
significant difference in favor of the 2nd declotting compared to the 1st in 61 
patients (1st: 162 days vs. 2nd: 447 days; p<0.0001). 
Conclusion: LAB thrombectomy resulted in high circuit survival rates with 
increased technical success and minimum complications without the use of 
thrombectomy devices.  
B-0866 11:50  
Cumulative patency rate of forearm vs upper arm arteriovenous dialysis 
fistulae  
A. Almehmi, V. Narasimha Krishna, A.M. Abdel Aal; Birmingham, AL/US 
(aalmehmi@uabmc.edu)  
Purpose: Both upper arm (UA) and forearm (FA) arteriovenous fistulas (AVF) 
are utilised as a permanent hemodialysis access. The aim of this study was to 
compare the cumulative patency rate of FA-AVFs and UA-AVFs and to explore 
the predictors of access survival. 
Methods and Materials: We retrospectively analysed 286 hemodialysis 
patients who underwent AVF creation at our institution between January 2005 
and December 2015. Cumulative access patency was defined as the time from 
access creation to permanent failure, regardless of the number of interventions 
required to maintain long-term patency for dialysis. The cumulative patency 
rate was calculated in UA-AVF and FA-AVF groups using Kaplan- Meier 
survival methods and log-rank tests. Backward stepwise Cox regression model 
was utilised to determine predictors of hemodialysis access survival. 
Results: The total number of patients included in the UA-AVF and FA-AVF 
groups were 121 and 165 cases, respectively. Baseline characteristics 
included: 39% were females; 88% were blacks; 50% were diabetics; 96% and 
28% of patients had hypertension and congestive heart failure, respectively. 
Cumulative patency rate of UA-AVF and FA-AVF during the follow up time was 
74% and 59%, respectively (p=0.008). In multivariate analysis of AVF survival, 
we found that hemodialysis access failure was higher in FA-AVF than UA-AVF 
( HR: 1.97 [1.28-3.06]; p=0.002). Further, female gender was associated with 
increased AVF failure (HR: 1.58 [1.05-2.37]; p=0.03). 
Conclusion: FA-AVFs have a lower cumulative patency rate as compared to 
UA-AVFs. Further, UA-AVFs and male gender are associated with a better 
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B-0867 10:39  
Artificial intelligence applied on the national lung screening trial dataset: 
a radiomics study  
S. Martin, J. Hofmeister, S. Burgermeister, C.D. Becker, X. Montet; Geneva/CH 
(steve.martin@hcuge.ch)  
Purpose: To investigate the added value of radiomics applied on the National 
Lung Screening Trial (NLST) dataset in estimating solitary pulmonary nodule 
malignancy risk compared to the PanCan model. 
Methods and Materials: Lung adenocarcinoma (n=227) and squamous cell 
carcinoma (n=94) with a long axis greater than 8 mm obtained from the NLST 
dataset were included and matched with benign lung nodules (n=299). 
Features extraction (n=124671) was performed using an open-source python 
package after automatic segmentation of the 620 lung nodules from low-dose 
unenhanced computer tomography (CT). Benign versus malignant 
classification based on radiomics and clinical data was achieved via features 
selection, dimension reduction (using principal component analysis), and 
classification (using a support vector machine classifier). The demographic 
data, part of the NLST dataset and combined to the extracted features from the 
CT images for the radiomics analysis, were also evaluated solely according to 
the PanCan model. Sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) of the radiomics were calculated based on the 
histological diagnostic given in the NLST dataset. The diagnostic performances 
of the two models were compared on their area under the receiver operating 
characteristic curve (AUC) analysis. 
Results: Radiomics model: sensitivity 96.9%, specificity 93.3%, PPV 93.9%, 
NPV 96.6%, AUC: 0.983. PanCan model: AUC: 0.797. 
Conclusion: Artificial intelligence and data mining in chest CT raise the 
diagnostic confidence higher than any other models in the field of non-invasive 
characterisation of lung nodules.  
B-0868 10:47  
Lung nodule risk stratification using Deep Learning on the complete US 
National Lung Screening Trial dataset  
C. Arteta, L. Pickup, P. Novotny, Z. Sandford, J. Brabec, D. Dufek, J. Kunst, 
J. Declerck, T. Kadir; Oxford/UK  
Purpose: Correct classification of screen or incidentally detected indeterminate 
pulmonary nodules is essential to avoid excessive follow-up. Prior work on 
limited datasets has shown the potential of computer aided risk stratification 
but validation on large datasets is required prior to use as a rule-out test. For 
the first time, we demonstrate validation of a Deep Learning risk stratification 
system on the complete US National Lung Screening Trial (NLST) dataset. 
Methods and Materials: The NLST dataset was manually curated such that 
each reported nodule and cancer was located and diagnostically characterised. 
Training and testing sets were built from the full set of patients with solid/mixed 
nodules of 6mm and above (6132). A Convolutional Neural Network (CNN) 
was trained with four-fold cross-validation, withholding approximately 370 
nodules (class-balanced) in each test set. Performance was evaluated using 
Area-Under-the-ROC analysis and also the fraction of benign nodules correctly 
rejected at 0%, 1% and 2% of misclassified malignant nodules (FNR). Similar 
analysis was performed using nodule size as a classifier. 
Results: Using the CNN, Benign Rejection Fraction (min, variance) at 0%, 1%, 
2% FNR was 19% (14%, 8%), 32% (16%, 12%), 37% (18%, 13%) respectively. 
Using size, benign rejection fraction values were 0% at all threshold. AUC for 
the CNN and size was 0.87 and 0.82 respectively. 
Conclusion: Using the CNN, a significant proportion of patients with benign 
nodules can be correctly identified while keeping the rate of missed cancers at 
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B-0870 11:55  
Automatic prediction of emphysema extent in low-dose CT by deep 
learning  
G. Bortsova1, S.N. Ørting2, F. Dubost1, I. Katramados3, L. Hogeweg3, 
M.M. Wille4, L.H. Thomsen4, M. De Bruijne1; 1Rotterdam/NL, 2Copenhagen/DK, 
3
Groningen/NL, 4Hellerup/DK (gerdabortsova@gmail.com)  
Purpose: Emphysema is commonly quantified using CT densitometry 
measures, which however correlate only moderately with visual assessment of 
emphysema extent according to trained observers. We propose a deep 
learning approach to automatically quantify emphysema extent based on its CT 
patterns rather than on density alone, mimicking visual assessment. 
Methods and Materials: Two low-dose CT scans (baseline and 5th annual 
follow-up) were acquired at full inspiration from 1934 participants of the Danish 
Lung Cancer Screening Trial (inclusion criteria: age 50-70, at least 20 pack-
years of smoking and FEV1 of at least 30% of predicted). Two observers 
independently scored emphysema extent from 0 (no emphysema) to 5 (75-
100% of lung affected) in the upper, middle and lower lung regions. We trained 
our algorithm on scans of 993 subjects and evaluated it on 941 subjects. 
Results: Agreement between automated and expert’s assessment of 
emphysema presence was good (area under the ROC curve 0.89, accuracy 
90.4% - similar to interobserver agreement of 91%). The intraclass correlation 
coefficient was 0.757 (Pearson: 0.823) for emphysema extent scoring and 
0.835 (Pearson: 0.852) between the observers. The Pearson correlation of the 
expert’s scores and densitometry based on -950HU threshold was 0.436. Only 
in 1.5% of the scans the predicted score was more than one category off. 
Conclusion: Our emphysema quantification method’s performance is 
promising. This method may replace time-consuming visual assessment in 
large-scale studies and, eventually, in clinical practice.  
Author Disclosures: 
 I. Katramados: Founder; COSMONiO. L. Hogeweg: Employee; COSMONiO. 
B-0871 11:03  
Fully automated segmentation of pulmonary fibrosis using different 
software tools  
A. Giannakis1, T. Norajitra1, L. Kehler1, J. Dinkel2, O. Weinheimer1, 
C. van Lunteren1, M. Kreuter1, K. Maier-Hein1, C. Heussel1; 1Heidelberg/DE, 
2
Munich/DE (a-giannakis@hotmail.com)  
Purpose: Evaluation of software tools for segmentation of fibrotic pulmonary 
parenchyma will strengthen the role of multidetector CT as biomarker of 
disease extent, evolution, and response to therapy in patients with pulmonary 
fibrosis. 
Methods and Materials: 418 non-enhanced thin section MDCT of 127 
patients with idiopathic pulmonary fibrosis and 78 MDCT of 78 healthy 
individuals were analysed through three fully automated, completely different 
software tools: YACTA, LUFIT, and IMBIO. The agreement between YACTA 
and LUFIT on segmented lung volume, 80th (reflecting fibrosis) and 40th 
(reflecting ground glass opacity) percentile of lung density histogram was 
analysed using Bland-Altman plots. The fibrosis and ground glass opacity 
segmented by IMBIO (lung texture analysis software tool) were included in 
specific regression analyses. 
Results: In the IPF-group, LUFIT performed better than YACTA by segmenting 
more lung volume (mean difference 242 ml, 95% limits of agreement -54 to 
539 ml), as well as quantifying higher 80th (76 HU, -6 to 158 HU) and 40th 
percentile (9 HU, -73 to 90 HU). No relevant differences were revealed in the 
control group. The 80th/40th percentile as quantified by LUFIT showed positive 
correlation with the percentage of fibrosis/ground glass opacity calculated by 
IMBIO (r= 0.784/r=0.918). 
Conclusion: In terms of segmentation of pulmonary fibrosis, LUFIT as shape 
model-based segmentation software tool is superior to YACTA, which works 
based on threshold, because the density of severe fibrosis is similar to that of 
the surrounding soft tissues. Therefore, LUFIT may serve as a valid tool in the 
quantification of pulmonary fibrosis, since this disease mainly affects the 
subpleural space.  
Author Disclosures: 
 L. Kehler: Advisory Board; LK received compensation for advisory boards 
from Roche.  C. Heussel: Consultant; Consultation or other fees Schering-
Plough 2009, 2010 Pfizer 2008-2014 Basilea 2008, 2009, 2010 Boehringer 
Ingelheim 2010-2014 Novartis 2010, 2012, 2014 Roche 2010 Astellas 2011, 
2012 Gilead 2011-2015. Employee; •Head of Diagnostic and Interv Radiology 
with Nuclear Medicine, Thoraxklinik Heidelberg •Member of the German Center 
for Lung Research. Owner; Stock ownership in medical industry: GSK. Patent 
Holder; Method and Device For Representing the Microstructure of the Lungs. 
IPC8 Class: AA61B5055FI, PAN: 20080208038, Inventors: W Schreiber, U 
Wolf, AW Scholz, CP Heussel. Research/Grant Support; Research funding: 
Siemens 2012-2014 Pfizer 2012-2014 MeVis 2012, 2013 Boehringer Ingelheim 
2014 German Center for Lung Research. Speaker; Lecture Fees: Gilead 2008-
2014 Essex 2008, 2009, 2010 Schering-Plough 2008, 2009, 2010 AstraZeneca 
2008-2012 Lilly 2008, 2009, 2012 Roche 2008, 2009 MSD 2009-2014 Pfizer 
2010-2014 Bracco 2010, 2011 ME. Other; Comitee membership, Chest 
working group of the German Roentgen society, National guidelines: bronchial 
carcinoma, mesothelioma, COPD, screening for bronchial carcinoma, CT and 
MR imaging of the chest. 
B-0872 11:11  
Clinical validation of a deep learning algorithm for quantification of the 
idiopathic pulmonary fibrosis pattern  
T.R. Nimmada1, P. Rao1, P.S. Sanghavi1, V. Venugopal2, P. Warier1, 
Z. Udwadia1, B. Jankharia1; 1Mumbai/IN, 2New Delhi/IN (pooja.rao@qure.ai)  
Purpose: Radiologists are currently ill equipped to precisely estimate disease 
burden and track the progression of idiopathic pulmonary fibrosis (IPF). 
Development of an automated method for IPF segmentation is challenging, 
due to the complexity of the fibrosis pattern and degree of variation between 
patients. Deep neural networks are machine learning algorithms that overcome 
these challenges. We describe the development and validation of a novel deep 
learning method to quantify the IPF pattern. 
Methods and Materials: We used high-resolution chest CT scans from 23 
patients with IPF as training data. The fibrosis pattern was marked out on 60 
slices per scan. Annotated scans, with 6 additional normal scans were used to 
train a convolutional neural network to outline the IPF disease pattern. 
Segmentation accuracy was measured using Dice score. For each patient, 
percentage of lungs affected by IPF was calculated. An independent set of 50 
scans was used for clinical validation. Disease volume was independently 
estimated by 2 thoracic radiologists blinded to the algorithm estimate. 
Algorithm-derived estimates were correlated with radiologist estimates of 
disease volume. 
Results: A 3-dimensional neural network architecture coupled with 2-
dimensional post-processing of each slice produced the most accurate 
segmentation, with a Dice score of 0.77. The correlation between algorithm-
derived disease volume estimate and average radiologist estimates was 0.92. 
Inter-radiologist correlation was 0.89. Radiologist estimates of disease volume 
varied by 5.5% (range 0-15%). 
Conclusion: We demonstrate that a deep neural network, trained using 
expert-annotated images, can accurately quantify the percentage of lung 
volume affected by IPF.  
Author Disclosures: 
  T.R. Nimmada: Employee; Qure.ai. P. Rao: Employee; Qure.ai.  P. Warier: 
Employee; Qure.ai. 
B-0873 11:19  
Risk assessment of lung cancer development in Idiopathic Pulmonary 
Fibrosis (IPF) patients using quantitative HRCT analysis  
D. Falsaperla1, S.E. Torrisi1, A. Torcitto1, G. Russo2, A. Stefano2, A. Vancheri1, 
A. Basile1, C. Vancheri1, S. Palmucci1; 1Catania/IT, 2Cefalù/IT 
(danielefalsaperla@gmail.com)  
Purpose: To investigate the diagnostic accuracy of Kurtosis, High Attenuation 
Area (HAA) and Fibrotic Area (FA) HRCT indexes in risk assessment of lung 
cancer development in patients with Idiopathic Pulmonary Fibrosis (IPF). 
Methods and Materials: 42 IPF patients were retrospectively analysed; 
patients were divided into subjects that developed lung cancer (Group A n=9) 
and patients without lung cancer development (Group B n=33). HRCT and 
pulmonary function tests were reviewed; the extent of fibrotic disease was 
quantified on HRCT using Kurtosis, HAA and FA. For group A, measurements 
were obtained from HRCT acquired before cancer development - medially 
performed 26 months after IPF diagnosis; for group B, we analysed HRCT 
acquired medially 18 months from IPF diagnosis. HRCT indexes, FVC and 
DLCO values were compared between groups using Mann-Whitney U-test. 
Results: No difference was recorded for FVC and DLCO values. No statistical 
difference was found among groups for median values of Kurtosis (3.76 versus 
4.26), HAA (27.85 versus 23.16) and FA (15.77 versus 13.89). ROC analysis 
for prediction of lung cancer development using a threshold value of Kurtosis 
index 5.31 showed sensibility of 100% and specificity of 24.2%; for FA index, 
using a threshold value >26.375, ROC analysis obtained sensibility of 66.7% 
and specificity of 69.7%. For HAA index, a threshold value >14.59 reported 
sensitivity and specificity of 77.8% and 60.6%. 
Conclusion: Kurtosis, FA and HAA provide limited diagnostic accuracy in risk 
assessment of cancer development in IPF patients; FA and HAA showed the 










B-0874 11:27  
Radiomics signature for non-small cell lung cancer recurrence risk 
prediction after surgery: quantitative analysis of the tumour and 
peritumoural lung parenchyma on presurgical MDCT  
T. Akinci D'Antonoli, A. Farchione, J. Lenkowicz, M. Chiappetta, G. Cicchetti, 
A.R. Larici, V. Valentini, L. Bonomo, R. Manfredi; Rome/IT 
(drtugba@hotmail.com)  
Purpose: To estimate recurrence risk after surgery in non-small cell lung 
cancer (NSCLC) patients by employing a prediction model with radiomics 
signature (RS) and clinical parameters. 
Methods and Materials: 124 NSCLC patients (stages I to IIIA) who received 
surgery (2008-2013) at our hospital were retrospectively enrolled. Tumour 
recurrence (TR), local recurrence (LR) and distant metastasis (DM) was 
diagnosed on follow-up imaging (3-5 years). The region of interests (ROI) for 
the tumour (GTV), the peritumoural lung parenchyma 2 cm around the tumour 
(PTV) and the involved lobe (LB) were semiautomatically contoured. 90 
features (statistical, morphological, textural) were extracted from each ROI with 
an in-house developed software (Moddicom). RS was computed with the best-
performed radiomics model's coefficients for each outcome (features selection: 
“fscaret” and step-wise selection on the top 10 features; model selection: 
highest AUC in 10-fold cross-validation), then significant clinical features (Cox 
regression analysis: tumour-node-metastasis stage [TNMS], histology, age, 
smoking status and gender) were added. Predictive nomograms were created 
at 1-, 2-, 3-year survival. 
Results: Median time-to-recurrence was 44 months; 25 patients developed 
LR, 31 patients developed DM. For TR and DM outcomes GTV+PTV (AUC 
0.750 for both), for LR outcome GTV (AUC 0.731) were found to be the best 
performed models; adding TNMS improved all models’ performance (TR, DM, 
LR: AUC 0.760, 0.759, 0.750, respectively). The nomogram with RS and 
TNMS discriminated high-risk better than TNMS alone. 
Conclusion: Utilizing radiomics on pre-treatment MDCT images, extracting 
peritumoural and intratumoural radiomics features could be a useful tool to 
stratify NSCLC patients at different recurrence risk and to define a 
personalised treatment.  
Author Disclosures: 
  T. Akinci D'Antonoli: Grant Recipient; ESOR. 
B-0875 11:35  
Lung adenocarcinoma radiogenomics predicts clinical outcome  
A. Leonardi, A. Napoli, R. Scipione, M. Anzidei, S. Dababou, C. Catalano; 
Rome/IT (andrea.leonardi1988@gmail.com)  
Purpose: To statistically correlate CT features, quantitative texture analysis 
(QTA), epidermal growth factor receptor (EGFR) mutations and clinical 
outcome in patients with lung adenocarcinoma. 
Methods and Materials: We retrospectively enrolled eighty-one patients 
affected by lung adenocarcinoma to evaluate conventional CT features and 
assess QT analysis. Correlations between CT features, QTA, EGFR mutations 
and clinical outcome were determined through univariate analysis, unpaired 
Student t test, chi-square and Mann-Whitney tests. A multiple logistic 
regression analysis and Receiver Operating Characteristics (ROC) curve 
analysis versus death and EGFR status was performed for CT features and 
QTA. 
Results: EGFR mutation was detected in 31/81 tumors (38.3%). EGFR 
mutation demonstrated a correlation with emphysema (p<0.0001) and a 
positive association with necrosis (p=0.017). At multivariate analysis air-
bronchogram and locoregional infiltration were proved to be positively and 
negatively associated with EGFR-mutated status (p=0.0304 and p=0.0018 
respectively). No significant correlation was observed between the 
conventional CT features and overall survival. Mean, SD and skewness were 
found to have a significant correlation with EGFR mutation (p=0.0001; 
p=0.0001; p=0.0459). The only parameter correlated with the event of death 
was entropy (r=0.2708; p=0.0329). 
Conclusion: CT and QTA features of lung adenocarcinoma demonstrated a 
significant relationship with EGFR mutations and clinical outcome.  
B-0876 11:43  
Can texture analysis predict non small cell lung cancer recurrence after 
surgery ?  
R.S.R. Lopes do Rosario, N. Michoux, V. Lacroix, B. Ghaye; Brussels/BE 
(ritar1@hotmail.com)  
Purpose: To predict the aggressiveness of NSCLC (in terms of recurrence) 
using morphology and texture analysis on a pre-surgical CT. 
Methods and Materials: This retrospective study included 46 consecutive 
patients with NSCLC (T1 or T2N0M0) treated by surgery. A preoperative 
acquisition obtained using the same reconstruction parameters on the same 
CTscanner was used to extract tumor morphological properties, to assess 
intra-tumoral texture parameters from the Grey Level Co-occurrence and Run-
Length matrices. Eight patients presented with tumor recurrence during a 
mean follow-up of 4.5years after surgery. Different predictive models either 
based on individual parameters or on a small set of parameters embedded in a 
logistic regression were reconstructed. Receiver operating characteristic 
analysis was performed to assess the predictive performance of these 
models.Then, the best multiparametric models were submitted to a leave-one-
patient-out-cross-validation (LOOCV). 
Results: Individual morphological parameters Surface Area and Aspect Ratio 
displayed a good performance in identifying patients with tumor recurrence 
(Area: Se=88%, Sp=88%, AUC=0.86, Aspect Ratio: Se=88%, Sp=60%, 
AUC=0.73). After LOOCV, models based on 4 texture parameters 
(Homogeneity, Sum Variance, Grey-Level Nonuniformity, Run Percentage) or 
on (Sum Average, Grey-Level Nonuniformity, Run Percentage, Short Run Low 
Grey-Level Emphasis) displayed a very good performance in identifying 
patients with tumor recurrence (Se=100%, Sp=91%, Acc=91% for both 
models). 
Conclusion: These preliminary results confirm the growing evidence that lung 
cancers have texture features related to their tumoral aggressiveness. 
Combining morphological and texture parameters may allow improved tumor 
recurrence prediction. Further work is required to understand how to optimally 
implement texture analysis of these CT images.  
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B-0877 10:30  
Diagnostic accuracy of primary macronodular adrenal hyperplasia on CT: 
a quantitative and qualitative study  
S.M. Ando, F.M. Coelho, P.C. Viana, L.G. Gomes, M.B.V. Fragoso, 
F.I. Yamauchi; São Paulo/BR (sabrina.ando78@gmail.com)  
Purpose: To determine the accuracy of computed tomography (CT) in 
diagnosis of primary macronodular adrenal hyperplasia (PMAH). 
Methods and Materials: This retrospective IRB approved study included 122 
patients divided into 4 groups: PMAH (n=9), congenital adrenal hyperplasia 
(CAH) (n=21), primary hyperaldosteronism (PH) (n=52) and control group (CG) 
(n=40). CT images were evaluated by two blinded observers, who subjectively 
classified adrenals as definitive or not for PMAH, based on bilateral adrenal 
enlargement with nodules. Measurements of adrenal body and limbs width and 
length in axial plane were also recorded. 
Results: Sensitivity, specificity, positive and negative predictive values for 
subjective analysis were 89%, 95%, 57% and 99% for observer 1 and 89%, 
91%, 44% and 99% for observer 2. The interobserver agreement was 0.99 by 
kappa statistics. All measurements demonstrated significant difference 
between PMAH and others groups (p<0.05 ANOVA). Mean body, medial and 
lateral limbs width and adrenal length measurements in right and left adrenals 
were respectively on PMAH 1.5, 0.9, 0.8 and 4.9 cm and 1.7, 1.0, 1.3 and 4.9 
cm. On CG, 0.6, 0.3, 0.3 and 3.5 cm and 0.7, 0.5, 0.4 and 3.6 cm. On CAH and 
PH, 0.8, 0.5, 0.5 and 4.0 cm and 0.9, 0.6, 0.5 and 4.1 cm. The cut off  1.5 cm 
of right body width had 100% of specificity and 55.5% of sensitivity for the 
diagnosis of PMAH. 
Conclusion: Qualitative CT features have high accuracy for diagnosis of 
PMAH. Quantitative analysis may also be useful in indeterminate cases with 
high specificity.  
B-0878 10:38  
Hollowed adrenal gland sign in patients of septic shock: prevalence, CT 
appearance and consequence  
Q. Xie, H. Wang, J. Guan; Guangzhou/CN (usefulkey0077@hotmail.com)  
Purpose: To investigate the prevalence, CT appearance and consequences of 
hollowed adrenal gland sign in septic shock patients. 
Methods and Materials: From September 2014 to May 2017, there were 152 
consecutive patients with septic shock in ICU (mean 60.6 years; range 19-89 
years; 95 males, 57 females). All the patients received dual-phase contrast-
enhanced CT scan in one week after diagnosis. CT findings and clinical 
records were reviewed retrospectively. Single factor analysis was performed. 
The hollowed adrenal gland sign was defined as: ⑴ diffuse enlargement of 
bilateral adrenal gland; ⑵ in arterial phase, the central area of adrenal gland 
shows much lower attenuation; ⑶ in venous phase, the central “hollowed” area 
shows further enhancement and is similar to the peripheral area. 
  






Results: All the patients showed various degrees of and diffuse enlargement 
in bilateral adrenal gland. 52 patients (52/152) showed hollowed adrenal gland 
sign (positive group) while the remaining 100 patients were negative. The 
prevalence of hollowed adrenal gland sign in septic shock patients was 34.2% 
and finally 43 patients died from MODS (82.7%, 43/52). In negative group, 50 
patients finally died from MODS (50.0%, 50/102). There was significant 
difference between two groups (P<0.01). The result of single factor analysis 
showed that the hollowed adrenal gland sign was an independent factor to 
predict prognosis (death) for septic shock patients. 
Conclusion: Hollowed adrenal gland sign is common on CT in septic shock 
patients and predicts a dim prognosis.  
B-0879 10:46  
Histogram analysis of adrenal lesions with a single measurement: 
feasibility and incremental value for diagnosing adenomas  
T.O. Rocha1, T.C.V. Albuquerque1, J.C. Nather1, C.S. Garrido1, J. Elias Jr1, 
S. Tucci Jr1, Z. Wang2, A.C. Westphalen2, V.F. Muglia1; 1Ribeirao Preto/BR, 
2
San Francisco, CA/US (talescva@gmail.com)  
Purpose: Our purpose was to assess if histogram analysis of adrenal lesions, 
from a single measurement of mean and standard deviation (SD), using 
threshold of 10% of negative voxels can replace voxel counting while keeping 
diagnostic accuracy. 
Methods and Materials: In a four-year period, 308 consecutive patients had 
325 adrenal lesions diagnosed on CT exams. After exclusions, 91 patients 
(108 lesions), 20 malignant and 88 adenomas (confirmed by histology or 
follow-up) were enrolled. Two observers retrospectively measured size, mean 
attenuation, SD and generate histogram. The voxel distribution was assessed 
for normality. The 10th percentile was calculated from voxel counting (P10obs) 
and estimated from the formula: P10est = mean - (1.282 x SD). Diagnostic 
accuracy of mean attenuation and histogram analysis using P10obs and 
P10est were compared. 
Results: 74 patients had 88 adenomas and 17 patients had 20 malignant 
lesions, 7 adrenocortical carcinomas, 13 metastasis. 93.1% of histograms had 
a normal distribution. The correlation among P10obs and P10est was perfect, 
r=0.9827 (reader 1) and 0.9843 (reader 2) (p<0.00001 for both). For both 
readers, sensitivity, specificity of the mean attenuation analysis was 65.9% 
(55.0-75.7%) and 100.0% (83.2-100%), and for P10obs and P10est was the 
same, for both observers, 87.5% (78.7-93.6%) and 95% (75.1-99.8%), 
respectively. The increment in sensitivity was significant (p<0.0001), while the 
drop of specificity was not (p=0.15). 
Conclusion: The majority of voxels histograms from adrenal lesions follows 
normal distribution allowing an estimation using mean and SD. The accuracy of 
histogram was superior to mean attenuation analysis, either using P10est or 
P10obs.  
B-0880 10:54  
CT numbers of kidneys in virtual noncontrast images acquired from dual-
source dual-energy dynamic CT of kidney: comparison with standard 
noncontrast CT  
Y.-M. Lin; Taipei/TW (garbato@gmail.com)  
Purpose: To compare virtual noncontrast (VNC) images derived from dynamic 
dual-source, dual-energy CT (dsDECT) of kidney with standard noncontrast 
(SNC) images, and determine the optimal phase for generating virtual 
noncontrast images. 
Methods and Materials: Twenty-nine men and sixteen women underwent 
dynamic dsDECT (100/Sn140kVp) of kidney that included noncontrast, 
corticomedullary (CMP), nephrographic (NP), and excretory phases (EP). CT 
numbers were measured in the cortex and medulla. Image noise was 
measured on SNC and VNC images. Expected dose saving by removing the 
SNC phase was calculated. 
Results: The difference in mean attenuation between SNC and VNC images 
was  4 HU. VNC attenuation values of the cortex in the CMP and medulla in 
the NP did not significantly differ from SNC values. VNC attenuation of the 
cortex was higher than that of the medulla in the CMP (p < 0.05), while there 
was no significant difference in NP. In the EP, inadequate iodine subtraction 
was obvious in the urinary collecting system. Image noise was significantly 
greater in SNC images (p < 0.001). Mean radiation dose reduction achievable 
by removing the SNC phase was 12.3% ± 0.9%. 
Conclusion: VNC images from dynamic dsDECT of kidney were similar to 
SNC images, with greater attenuation variability. We recommend the NP as the 







B-0881 11:02  
Optimal energy level for renal lesion detection and characterisation on 
virtual monoenergetic images  
C. Schabel1,2, F. Vernuccio3, J. Ramirez Girlando4, K. Nikolaou1, D. Marin2; 
1
Tübingen/DE, 2Durham, NC/US, 3Palermo/IT, 4Malvern, PA/US 
(christoph.schabel@med.uni-tuebingen.de)  
Purpose: Dual energy-reconstructed virtual monoenergetic images (VMIs) can 
yield more stable CT numbers and improved image quality compared to 
conventional single energy CT imaging. The aim of our study was to 
investigate the best VMI energy for the detection and characterization of renal 
lesions. 
Methods and Materials: This retrospective, HIPAA-compliant study was IRB 
approved, with a waiver of informed consent. Between June 2012 and July 
2016, a total of 194 renal lesions (62 solid, 132 cystic) underwent unenhanced 
single-energy and enhanced dual-energy CT during the nephrographic phase. 
VMI datasets were created from 70 to 100 keV. Lesion enhancement was 
measured by calculating the difference in attenuation (HU) between the 
contrast-enhanced VMI and unenhanced single-energy images. Receiver-
operating-characteristics were determined. 
Results: The area-under-the-curve (AUC) was highest at 70keV (0.96) and 
decreased significantly with higher energies (0.94 at 80keV[P = 0.004]; 0.86 at 
90 keV[P < 0.0001], and 0.79 at 100keV[P < 0.0001]). Number of missed 
minimally-enhancing solid renal lesion was lowest at 70keV(13/62) and 
increased with higher energies (19/62 at 80keV, 25/62 at 90keV, and 29/62 at 
100keV) using a threshold of 15HU lesion enhancement. However, 12 of the 
132 confirmed renal cysts were incorrectly classified at 70 keV VMI due to 
spurious levels of enhancement, compared to 5, 3, and 7 false positive cases 
at 80, 90, and 100keV, respectively. 
Conclusion: Our study demonstrated that VMI at 70 keV may represent the 
optimal energy level for renal lesion detection and characterization.  
Author Disclosures: 
  C. Schabel: Speaker; Siemens Healthcare.  J. Ramirez Girlando: 
Employee; Siemens Medical Solutions USA.  D. Marin: Speaker; Siemens 
Healthcare. 
B-0882 11:10  
Diffusion weighted magnetic resonance imaging in assessment of 
parenchymal damage in chronic kidney disease  
K. Sulkowska, P. Palczewski, A. Furmanczyk-Zawiska, 
A. Perkowska-Ptasinska, W. Szeszkowski, M. Durlik, M. Golebiowski; 
Warsaw/PL (k.sulkowska@outlook.com)  
Purpose: The aim of our study was to evaluate the feasibility of using diffusion 
weighted magnetic resonance imaging (DW-MRI) for noninvasive assessment 
of pathologic changes in CKD. 
Methods and Materials: Thirty-four patients in different stages of CKD were 
examined on a 1.5 T MR unit. The examination consisted of morphologic 
sequences and respiratory triggered multislice diffusion-weighted echo-planar 
sequence with 10 b values. Diffusion parameters were calculated with the use 
of mono- (total apparent diffusion coefficient, ADCT) and biexponential model 
(pure diffusion coefficient-D and perfusion fraction-Fp). In 31 patients, 
ultrasound guided biopsy was performed in less than 30 days from MRI (18 ± 4 
days). Histopathological assessment was performed by an experienced 
nephropathologist who separately scored changes in glomeruli and tubulo-
interstitium. Pearson’s correlation coefficients (PCCs) were calculated by 
bivariate correlation to investigate relationship between diffusion parameters 
and histopathological assessment of renal damage. P-value<0.05 indicated 
statistical significance. 
Results: We observed a moderate negative correlation between D and the 
percentage of glomeruli with focal global sclerosis (PCC -0.52, p=0.003). D 
also reversely correlated with combined parameters reflecting chronic changes 
in glomeruli (PCC -0.48, p=0,006) and tubulo-interstitium (PCC -0.47, 
p=0,007). ADCT showed significant negative correlation only with interstitial 
infiltrations (PCC- 0.44, p=0,013). Fp showed very high standard variation and 
no significant correlation with histopathological assessment. 
Conclusion: DWI-MR allows for a noninvasive assessment of parenchymal 
damage and glomerular loss in CKD. Using biexponential fitting of DW-signal is 
advantageous over monoexponential fitting owing to the elimination of negative 
influence of Fp on obtained results.  
B-0883 11:18  
Towards renal metabolic imaging of fatty kidney  
I. Dekkers1, P. de Heer2, A.P.J. de Vries1, H.J. Lamb1; 1Leiden/NL, 
2
Amsterdam/NL (I.A.Dekkers@lumc.nl)  
Purpose: Elevated renal triglyceride content (fatty kidney) is a potential 
biomarker for obesity-related renal disease. However, non-invasive 
measurement techniques for the assessment of renal triglyceride content (TG) 
are currently limited. Here we report the results of the technical development of 
  






renal metabolic imaging for the quantification of renal TG using proton-
magnetic resonance spectroscopy (1H-MRS). 
Methods and Materials: Renal metabolic imaging was performed in healthy 
human volunteers using a 3T MRI. Quantitative intra- and inter-examination 
single-voxel point resolved spectroscopy (PRESS) spectra were obtained in 
healthy human renal parenchyma using 1H-MRS with respiratory motion 
triggering. In total, 23 healthy participants (mean age 30.1±13.4 years, mean 
BMI 22.8±5.2 kg/m²) underwent 1H-MR spectroscopy, of which 19 participants 
underwent intra-examination reproducibility and 9 participants underwent inter-
examination reproducibility. Renal TG content was calculated via in-house-
developed post-processing script and corresponding reproducibility was 
determined using Pearson’s correlation and Bland-Altman analysis. 
Results: Overall mean renal TG content was 0.19±0.12% (range 0.07 to 
1.02%). There were no significant differences between first TG% and repeated 
measurements (p=0.96 for intra-examination; p=0.75 for inter-examination). 
Both intra-examination (r=0.91) and inter-examination (r=0.73) measurements 
were highly correlated with first TG measurements. Intra-examination and inter-
examination limits of agreement of renal log TG% were, respectively [-1.36%, 
+0.34%] and [-0.77%, +0.62%]. 
Conclusion: Renal proton MR spectroscopy is a reproducible technique for 
measuring renal triglyceride content non-invasively. This technique can be 
applied in future studies to further investigate the development of obesity-
related renal disease.  
B-0884 11:26  
DKI of microstructural alterations in the kidneys of patients with 
hyperuricemia  
X. Cai, Z. Chen; Guangzhou/CN (caixran@jnu.edu.cn)  
Purpose: To evaluate the feasibility of diffusion kurtosis imaging (DKI) for early 
detection of renal microstructural alterations in patients with hyperuricemia. 
Methods and Materials: A total of 75 subjects including 25 asymptomatic 
hyperuricemia (AH) patients, 25 gouty arthritis (GA) patients and 25 age- and 
sex-matched healthy volunteers were enrolled in this study. MR examinations 
were performed on a 3T MR scanner. DKI data were acquired to derive axial, 
radial, and mean kurtosis, as well as fractional anisotropy (FA), axial, radial, 
and mean diffusivity for comparisons among the 3 groups. Also, they were 
correlated with estimated glomerular filtration rate (eGFR). 
Results: Mean MK and Kr values in the renal cortex and medulla significantly 
increased from control subjects to the AH and GA patients (p < 0.05). GA 
patients showed statistically greater cortical and medullary Ka values as 
compared with the other two groups (p < 0.05). Mean medullary FA value 
significantly decreased across the three groups (p < 0.05). The mean MD and 
Da values in the cortex and medulla and Dr value in the medulla were found to 
be significantly different between GA patients and control subjects (p < 0.05). 
No correlation was found between any DKI parameters with eGFR. 
Conclusion: DKI demonstrates comparably stronger potential than diffusion 
tensor imaging in terms of early detection of renal cortex and medulla changes 
in patients with hyperuricemia. MK and Kr may be more sensitive to detect 
early-stage injury.  
B-0885 11:34  
Can renal artery resistive index predict disease activity in lupus 
nephritis?  
S.M. Mehana; Alexandria/EG (sayedmehana9@gmail.com)  
Purpose: To evaluate the predictive value of Doppler renal resistance index 
(RRI) in comparison with disease activity score, serologic and biology 
parameters in lupus nephritis. 
Methods and Materials: The study included 43patients with SLE fulfilling the 
Systematic Lupus International Collaborating Clinics Classification 2012 
Criteria; group I included 33 patients with lupus nephritis, group II included 10 
SLE patients without lupus nephritis and group III included 10 healthy subjects 
as control group.Determination of the activity and chronicity indices performed 
according to the scheme of the International Society of Nephrology/Renal 
Pathology Society (ISN/RPS) 2003 classification of lupus nephritis. 
Results: • The mean value of Doppler-Based RRI in the healthy group is 
significantly lower than the lupus nephritis and SLE patients who showed also 
a significant difference. • The mean age of those who had resistive index of 0.7 
and above was significantly higher than those below 0.7.. The same pattern 
was observed for blood urea, creatinine and renal biopsy chronicity index. • 
The Area under the ROC curve (AUC) of Doppler-Based Renal Resistive index 
as a marker of renal biopsy chronicity index was 0.769 (95% confidence 
interval). • A renal resistive index of 0.70 threshold is better than 0.65 cut-off to 
predict renal biopsy chronicity index • No significant correlation was found 
between renal resistive index and activity index in renal biopsy. 
Conclusion: Renal resistive index can be used as a non invasive reliable 
marker of chronicity in cases of lupus nephritis.  
 
B-0886 11:42  
Deep learning for automated MRI-based cyst load determination in PKD 
patients  
M. Gattoni, A. Hartenstein, E. Siewert, T. Denecke, B. Hamm, D. Geisel, 
T. Penzkofer; Berlin/DE  
Purpose: Quantification and follow-up of cyst load in polycystic kidney disease 
(PKD) patients through radiological imaging can be arduous to perform, 
especially in MRI. We applied deep learning to facilitate this task. 
Methods and Materials: We collected 51 datasets of patients with polycystic 
kidney disease, standardized imaging and good image quality. Manual 
segmentation of the liver and liver cysts was performed on T2 Imaging. The 
data were divided into cases for training, for validation and for independent 
testing. A deep learning network was trained using the DeepMedic 3D-CNN 
platform. The results were compared to manual threshold segmentation of the 
same dataset using the DICE coefficient for segmentation similarity. 
Results: Average cyst load in the datasets was 42.4 ± 21.7 percent in livers 
with a volume of 3404 ± 1705ml. DICE similarity coefficients were 0.84 ± 0.07 
between manual and deep learning segmentations and 0.80 ± 0.10 between 
thresholding and manual segmentation (p=0.038). Typical segmentation times 
in PKD patients are 30+ min for manual segmentation, compared to ~5min for 
threshold segmentation and less than a minute (24.9 ± 14,6s) for the deep 
learning segmentation. 
Conclusion: Automated liver cyst load measurement using a deep learning 
approach can be performed using a 3D-CNN approach on a single MRI 
sequence. Application of this method could lead to markedly reduced 
assessment time enabling consistent follow-up and potentially abbreviated MRI 
protocols for PKD patients.  
Author Disclosures: 
 B. Hamm: Consultant; Toshiba Medical Services Corporation. Equipment 
Support Recipient; Elbit Imaging Ltd. Grant Recipient; Toshiba Medical 
Services, Koninklijke Philips NV, Siemens AG, General Electric Company, Elbit 
Imaging Ltd, Bayer AG, Guerbet SA, Bracco Group, B. Braun Melsungen AG, 
KRAUTH medical KG, Boston Scientific Corporation. Investigator; CMC 
Contrast AB. Shareholder; Siemens AG, General Electric. 
B-0887 11:50  
An integrated CAD system of DWI MRI and laboratory biomarkers in the 
diagnosis of kidney transplant dysfunction  
M. Shehata1, M.E. Abou El-Ghar2, T. El-Diasty2, A. EL-Baz3;  
1
lousivelle, KY/US, 2Mansoura/EG, 3Louisville, KY/US 
(maboelghar@yahoo.com)  
Purpose: Accurate non-invasive assessment of kidney transplant dysfunction 
(KTDF) is crucial for the identification of proper treatment. Therefore, we 
introduce a novel fully automated computer-aided diagnostic (CAD) system for 
KTDF assessment using 4D (3D + b-value) DW-MRI data integrated with 
laboratory-based biomarkers. 
Methods and Materials: The proposed CAD system integrates both clinical- 
(e.g. SPCr and CrCl) and image-based biomarkers. To extract the latter, our 
CAD system aligns the DW-MRI data to handle motion effects and then 
segments kidney from surrounding tissues, after that, estimates ADCs to 
construct the discriminatory features for transplant status classification, finally, 
image and clinical biomarkers are fused together to assess transplant status by 
cascading two stages of deep learning-based classifiers. The first stage 
distinguishes non-rejection (NR) from rejection and its mimics; the second 
stage classifies this rejection and its mimics as early rejection (ER) or other 
kidney diseases (OD) (e.g. acute tubular injury, etc.). 
Results: DW-MRI datasets have been collected from 58 biopsy-proven cohort. 
All subjects, NR (16), ER (37), and OD (5), were assessed with SPCr 
laboratory values. Approximately, 50 coronal DW-MR images were acquired to 
cover the whole kidney before any biopsy procedure using a GE 1.5T scanner 
at different b values. Using leave-one-subject-out experiments, our CAD 
system achieved a 95% accuracy (sensitivity = 95% and specificity = 94%) 
between NR and rejection and its mimics, and a 95% accuracy between ER 
and OD transplants. 
Conclusion: Our initial diagnostic results hold promise of the proposed CAD 
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B-0888 10:30  
A 2 minute, ultra-fast wholebody PET/CT enabled by digital photon 
counting PET detector technology  
M.I. Knopp1, C.L. Wright1, K. Binzel1, F.L. Giesel2, J. Zhang1, P. Maniawski3, 
M.V. Knopp1; 1Columbus, OH/US, 2Heidelberg/DE, 3Cleveland, OH/US 
(knopp.29@osu.edu)  
Purpose: To assess the clinical feasibility of a 10x reduction in whole body 
PET acquisition time with comparable diagnostic and quantitative 
characteristics to current clinical PET acquisition enabled by digital photon 
counting PET (dPET). 
Methods and Materials: Thirty-eight patients scheduled for FDG whole body 
PET/CT were imaged using three separate acquisitions as part of intra-
individual comparison study with a pre-commercial release dPET/CT (Vereos) 
and cPET/CT (Gemini). Standard cPET imaging was performed at ~75 min p.i. 
of ~ 450 MBq FDG with investigational dPET imaged at ~55 min p.i. The first 
dPET acquisition was performed using 90s/bed position, immediately followed 
by a 9s/bed position acquisition lead to average table times of ~15 and ~2 min 
and compared with 90s/bed position cPET. The 9s/bed dPET were 
reconstructed using a previously optimised methodology. All other aspects of 
image acquisition were kept identical. Three blinded reviewers evaluated the 
data sets regarding visual characteristics, diagnostic confidence and semi-
quantitative readouts. 
Results: Visual assessment scores were significant higher for 90s/bed dPET 
whole body (p<.01) with no significant difference between 9s/bed dPET and 
90s/bed cPET. Quantitatively, the 9s/bed dPET presented slightly increased 
background noise, however there was no impact on diagnostic confidence or 
SUV measures. 
Conclusion: Next generation digital photon counting detector technology 
enabled a radical reduction in wholebody acquisition time with comparable 
diagnostic confidence and quantitative precision to current generation cPET 
acquisitions taking 10 times longer. This allows for new PET workflow 
concepts, improved patient comfort, minimised patient motion and whole-body 
pseudo dynamic imaging of tracer uptake.  
Author Disclosures: 
 P. Maniawski: Employee; Philips. 
B-0889 10:38  
Practice-based evidence for clinical benefit of PET/CT - results of the first 
oncologic PET/CT registry in Germany  
C. Pfannenberg, L. Wang, B. Gückel, S. Gatidis, S.-.C. Olthof, M. Reimold, 
C. La Fougère, K. Nikolaou, P. Martus; Tuebingen/DE 
(christina.pfannenberg@med.uni-tuebingen.de)  
Purpose: To evaluate the impact of PET/CT on clinical management based on 
a prospective data registry. The registry was developed to meet the 
requirements for PET/CT coverage by health insurance. 
Methods and Materials: We evaluated a prospective patient cohort having a 
non-investigational PET/CT at one university center from 4/2013 till 08/2016. 
The registry collected questionnaire data from requesting physicians on 
intended patient management before and after PET/CT. 4504 patients with 
5939 PET/CT examinations were enrolled in the registry, including evaluable 
data from 3724 patients with 4754 studies. The impact of PET/CT was 
assessed across various cancers for different indications and categories of 
non-treatment (watching, additional imaging, biopsy) and treatment. 
Results: The most frequent PET/CT indication was cancer staging (60.5%). 
Melanoma, lung, lymphoma, NET and prostate cancers accounted for 70% of 
cases. Overall, PET/CT was associated with a 36.9% change (OR 4.4; 95% CI, 
3.8-5.0) in decision to treat or not to treat, including 30.4% change to treatment 
from non-treatment. The frequencies of changes ranged from 46.0% for 
melanomas to 28.3% for head and neck cancers. The impact of PET/CT was 
highest in reducing demands for additional imaging which decreased from 
50.9% to 5.8%. Pre-PET/CT planned invasive biopsy could be avoided in 
73.3% of cases. When the intended management was treatment, the 
therapeutic goal (curative vs.palliative) changed after PET/CT in 21.6% of 
cases. 
Conclusion: The data of this large representative registry confirmed that 
physicians often change their intended management on the basis of PET/CT 
consistent across different cancer types.  
B-0890 10:46  
Patients' perception of radiologists in a oncologic imaging department  
C. Giaconi, F. Cerimele, A. Bulleri, C. Basile Fasolo, E. Neri; Pisa/IT 
(radiodiagnostica3.aoup@gmail.com)  
Purpose: To analyse the patients' perception of the radiologist role in a 
oncologic imaging Department. 
Methods and Materials: Between June and July 2017, two surveys have been 
addressed to 400 patients admitted to a Oncologic Imaging Department. The 
"Entry" survey was handed out to patients waiting for their turn in the radiology 
unit and included questions related to the environment and reception workflow. 
The “Exit” survey, instead, was given at the end of the examination to patients 
waiting for their report or that were just about to leave the department. It 
included questions related to the visibility of radiologist, to the clarity of medical 
consultation, the perception of the different professional roles (radiologist and 
radiographer). 
Results: Ninety percent (369/400) of patients declared that the Radiologist did 
not clearly introduced himself to the patient, but were satisfied by the quality of 
consultation in the entry and exit phases. Eighty-four patients who had 
ultrasound, that were asked to rate the helpfulness and kindness of the 
radiologist, responded very satisfied in 68 cases (80.25%) satisfied in 10 
(11.9%), somewhat satisfied in 6. Most patients (294/400; 93.04%) recognized 
that the diagnosis was carried out by the radiologist, but 13 patients (4.11%) 
answered “the technician” and 9 (2.85%) “the machine”. 
Conclusion: The survey demonstrate that the vast majority of patients have a 
correct perception of the radiologists' roles in the imaging department. 
However such well recognized value of the radiologist seems to be less 
balanced by an appropriate doctor to patient communication.  
B-0891 10:54  
How to structure the attendance of radiologists to oncologic 
multidisciplinary team meetings  
C. Giaconi, F. Cerri, C. Arena, A. Bulleri, E. Neri; Pisa/IT 
(claudiagiaconi@tiscali.it)  
Purpose: In XX University Hospital there is a strong demand of attendance of 
radiologists to oncologic multidisciplinary teams (MDTs). The aim of the study 
is to analyse the additional workload of radiologists attending MDTs. 
Methods and Materials: The oncologic imaging Unit of the xx University 
Hospital fulfill the imaging requests of the Oncologic Unit with 8 board certified 
radiologists. Each staff member is committed to perform US, CT and MRI on a 
38 hours x week working time.However, in the last 3 years a strong demand of 
attendance of radiologists to MDTs has been raised by the Oncology 
Department, on a weekly basis, for the following cancer types (GI tract, head 
and neck, melanoma, pediatric, lymphoma, prostate, gynecology). Radiology 
staff commitments and workload has been re-scheduled accordingly. 
Results: The mean weekly workload increase by each radiology staff was 7 
hours (+20%). The time allocated by each radiologist to participate MDTs 
included 3 hours for MDTs preparation (prior review of patient's images, and 
clinical information) and 4 hours mean attendance.The workload increase was 
not compensated by a reduction in imaging acquisition and reporting time. 
Conclusion: Attendance of radiologists to MDTs is mandatory for the 
management of oncologic patients, and represents a value-based professional 
role. However, the time allocated to prepare and attend MDTs is not accounted 
as indicator of radiologists workload and performance.  
B-0892 11:02  
Open access prescription in oncologic imaging: one-year trial  
F. Cerri, C. Giaconi, C. Arena, A. Bulleri, E. Neri; Pisa/IT 
(claudiagiaconi@tiscali.it)  
Purpose: To implement an open access prescription system (Pleiade) to allow 
order entries from the Oncologic to the Imaging Unit in a Academic Hospital. 
Methods and Materials: In the last 3-years the oncologic imaging demand in 
XX University Hospital raised rapidly, with specific request of Total Body CT for 
primary staging and follow-up in various cancer groups; the Oncologic Imaging 
Unit could not itself fulfill the entire CT request. Therefore since January 2017 
a so called "open access" hospital information system, called "Pleiade", was 
implemented, allowing the electronic prescription of CT exams from the 
Oncologic to the Imaging Department on a 365 day scheduled agenda, that 
included 54 patients slots per week. A clinical decision support system is not 
yet implemented. 
Results: To date the agenda is fully booked since December 2017, with 218 
patients scheduled per month. A retrospective analysis of a 6 months activity 
that included 1308 patients, showed that the vast majority of CT (1110/1308 
patients; 84%) was performed with the clinical indication of oncologic follow-up. 
Therefore the strong demand of CT exams for the follow-up impacted on the 
availability of primary staging slots. 
 
  






Conclusion: The Pleiade system unburdened the administrative workload of 
the oncologic imaging Department. However the open access to the imaging 
schedule, and the absence of appropriateness criteria, generated a significant 
prescription of follow-up CT, that impacted on the availability of primary staging 
CT.  
B-0893 11:10  
Integrated versus separate reporting of FDG-PET/CT and MRI for 
abdominal malignancies: effect on diagnostic confidence and staging 
outcomes  
L.A. Min1,2, W. Vogel1, M.J. Lahaye1, M. Maas1, M. Donswijk1, E. Vegt1, 
R.G.H. Beets-Tan1,2, D.M. Lambregts1; 1Amsterdam/NL, 2Maastricht/NL 
(l.min@nki.nl)  
Purpose: Increasing numbers of patients receive multimodality imaging (FDG-
PET/CT and MRI) to stage abdominal malignancies, with potential implications 
for optimal image interpretation. This study evaluates effects of integrated 
reporting of FDG-PET/CT and abdominal MRI on diagnostic confidence and 
staging outcomes. 
Methods and Materials: 149 cases where abdominal MRI and FDG-PET/CT 
were performed within a 14-day interval were retrospectively included. Original 
MRI and PET reports were retrieved from the hospital database and reported 
findings (per lesion; total 1228) translated into a 5-point confidence score 
(1=definitely benign to 5=definitely malignant). Teams of 2 readers (radiologist 
+ nuclear physician) together performed integrated re-assessment of the 
images, blinded for the initial reports. 
Results: Integrated re-assessment led to discrepant findings in 1 lesions 
compared with either the original FDG-PET/CT or MRI reports in 62/149 cases, 
which would have had no clinical impact in 26 (17.4%), minor impact in 17 
(11.4%) and potential major impact in 19 (12.8%). On a per lesion basis, the 
integrated approach resulted in increased/decreased diagnostic confidence in 
8.7%/6.2% compared to the initial FDG-PET/CT and 11.5%/11.0% compared 
to the initial MRI reports. Inconclusive (confidence 3) scores were comparable: 
8.3% (FDG-PET/CT) and 8.1% (MRI) for the initial reports vs 6.9% for the 
integrated approach. 
Conclusion: Integrated assessment of FDG-PET/CT and MRI by a nuclear 
physician and radiologist together leads to discrepant findings compared to 
separate imaging assessment in a substantial number of cases, which could 
have potential major clinical impact in 12.8%. Impact on overall diagnostic 
confidence and number of inconclusive outcomes appears to be limited.  
B-0894 11:18  
New insights for spectral CT imaging in staging of patients with 
hypervascularised abdominal tumours  
G. Böning1, S. Adelt1, U. Fehrenbach1, J. Kahn1, F. Feldhaus1, M.H. Maurer2, 
D.M. Renz3, B. Hamm1, F. Streitparth1; 1Berlin/DE, 2Berne/CH, 3Jena/DE  
Purpose: In oncologic imaging, spectral CT based parameters of iodine 
concentration and spectral slope over virtual mono-energetic levels may deliver 
information superior to standard CT. Aim of this study was to analyse potential 
differences of spectral CT parameters in hypervascularised abdominal tumours 
to improve lesion characterisation. 
Methods and Materials: 111 patients with hypervascularised abdominal 
tumours were included. We analysed 77 cases with neuroendocrine tumours/ 
carcinomas (NET/NEC), 18 cases with hepatocellular carcinoma (HCC) and 16 
cases with renal cell carcinoma (RCC). Patients underwent a standardised 
multiphase abdominal CT with spectral mode arterial phase. We analysed 
iodine concentrations of the tumours, the increase slope of mean HU in tumors 
between 40keV and 140keV as well as the applied dose. 
Results: The iodine concentrations of the tumours were 2.5±1.5mg/cm3 
(NET/NEC), 2.2±0.7mg/cm3 (HCC) and 3.8±1.8mg/cm3 (RCC). The increases 
slope of mean HU in tumours between 40keV and 140keV were 2 (NET/NEC), 
1.8 (HCC) and 3 (RCC). In a subgroup of 41 patients (26 NET/NEC, 9 HCC, 6 
RCC) with strong tumour hypervascularisation the mean HU values at 40 keV 
were significantly (p < 0.001) different between RCC (421±167 HU) and 
HCC/NET (245±70 HU/266±140 HU). The mean CTDIvol of the spectral mode 
arterial phase was 9.6±4mGy and 9.9±4.3mGy/9.9±4.6mGy for portal venous 
and hepatic venous phases. 
Conclusion: Spectral CT based parameters are promising to deliver additional 
information for characterisation of hypervascularised abdominal tumours at 
dose levels comparable to standard CT. To determine whether they can be 








B-0896 11:26  
Application of 80-kVp scan and raw data-based iterative reconstruction 
for reduced iodine load PET/CT in an oncological setting: a win-win 
technique  
R. Balaji; Chennai/IN (ravikanthbalaji@gmail.com)  
Purpose: To evaluate the image quality, radiation dose, and renal safety of 
contrast medium (CM)-reduced abdominal-pelvic CT combining 80 kVp and 
advanced Iterative Reconstruction (IR) in patients with renal dysfunction being 
worked up or followed up in an oncological setting. 
Methods and Materials: The study included 30 patients with renal dysfunction 
(estimated glomerular filtration rate [eGFR] It 45 mL/min/1.73 m2) who 
underwent PET/CT with low dose of contrast medium (Iodixanol 320, 360 
mgI/kg, 80 kVp, IR). 30 other patients without renal dysfunction (eGFR gt 60 
mL/min/1.73 m2) who underwent standard PET/CT (120 kVp, filtered-back 
projection) with normal contrast dose (Iodixanol 320, 600 mgI/kg) were 
included as controls. The following image criteria were compared - CT 
attenuation, image noise, and contrast-to-noise ratio (CNR). Size-specific dose 
estimate (SSDE) and renal function 1-3 months after CT were measured. 
Results: The SSDE and iodine load of the 80-kVp protocol were 30% and 
45%, respectively, lower than of the 120-kVp protocol (p lt0.01). CT attenuation 
and CNR of solid viscera and vessels in 80-kVp images were better than those 
of 120-kVp images (plt0.05). There were no significant differences in 
quantitative or qualitative image noise or subjective overall quality (p>0.05). No 
significant contrast induced renal parenchymal injury was observed. 
Conclusion: 80-kVp scans combined with advanced Iterative Reconstruction 
result in 40-50% reduction in radiation dose and 40% iodine load with no 
compromise on diagnostic image quality. At the same time risk of contrast 
induced renal damage was also reduced.  
B-0897 11:34  
Improved image quality of whole body low-dose CT study combined with 
iterative model reconstruction algorithms for follow-up of oncologic 
patients  
I. Salemi1, D. Ippolito1, C.R. Talei Franzesi1, C. Maino1, C. Cangiotti1, 
S. Sironi2; 1Monza/IT, 2Bergamo/IT (i.salemi1@campus.unimib.it)  
Purpose: To compare radiation dose and image quality of low-dose CT 
protocol combined with iterative model reconstruction algorithm (IMR) with 
standard-dose approach combined with hybrid-iterative reconstruction 
algorithm (iDose) for follow-up of oncologic patients. 
Methods and Materials: Seventy-three patients with known oncological 
diseases who underwent, during their clinical follow-up, both low-dose CT, 
performed on 256-row scanner (iCT Elite, Philips) with 100 kV and automated 
mAs modulation (depending on patient weight), and standard-dose CT, 
performed on 256-row scanner with 120 kV and automated mAs modulation, 
were enrolled. Images were reconstructed with IMR algorithm for low-dose CT 
examination and iDose algorithm for standard-dose CT examination. We 
evaluated density values and signal-to-noise ratio (SNR), along with image 
noise, dose parameters and diagnostic quality with 5-point scale. 
Results: Noise of images expressed as SD values, measured in liver and 
spleen, was significantly lower in IMR images (liver 10,98 vs 14,05, p<0,001) 
whereas SNR was statistically higher (9,03 vs 8,47) compared to iDose 
reconstructions. Volumetric-Computed-Tomographic-Dose-Index (CTDIvol) 
and Dose-Length-Product (DLP) were significantly lower in IMR compared to 
iDose reconstructions (DLP 491,48 vs 856,92 mGy*cm, p<0,001), with overall 
dose reduction of 42,6%. Qualitative analysis did not reveal significant 
differences in diagnostic quality (p=0,04). 
Conclusion: Automatic tube-current modulation combined with IMR algorithm 
and low kV setting allows dose reduction (42,6%) in whole body CT imaging 
without loss of diagnostic quality, thus representing a useful diagnostic 
approach in reducing dose exposure in oncologic patients who underwent 
several follow-up studies.  
B-0898 11:42  
Slowly injected unsplited bolus protocol for the reduction of contrast 
medium (CM) and mean radiation dose exposure (SUPREME Protocol)  
A. Contegiacomo, N. Attempati, E. Amodeo, D. Coppolino, A. Cina, 
R. Manfredi; Rome/IT (andrea.contegiacomo@policlinicogemelli.it)  
Purpose: To validate SUPREME protocol in terms of vascular/parenchymal 
enhancement, image quality, contrast medium (CM) administration and 
radiation exposure (RE), in oncological patients. 
Methods and Materials: SUPREME Protocol was adopted for prospective 
examination of 40 consecutive patients with a previous standard protocol CT 
examination, performed in our institution. SUPREME protocol: patient weight: 
>70/<70 kg; CM volume: 130/120; CM injection-rate: 2/1,8 mL/s; Saline 
solution volume: 60/50 mL; Saline solution injection-rate: 3 mL/s; Acquisition 
delay: 80s; body surface: thorax-abdomen. Two radiologists in consensus 
compared SUPREME Protocol examinations with both immediately previous 
  






and next follow-up CT examinations of the same patient performing: images 
qualitative (0/3=poor/excellent) and quantitative (Hounsfield Units sampling at 
aorta, great vessels and liver/spleen parenchyma) assessment; CM 
administration and RE comparison between the two protocols. Statistical 
analysis was performed with T-student test and Cohen's k coefficient. 
Results: The agreement between the two protocols for the images qualitative 
assessment was good (k-Cohen>0.6) for the two radiologists in consensus. No 
quantitative differences were observed between the two protocols with only a 
better enhancement of the inferior mesenteric artery in the standard protocol 
(p<.05). A global 15% of CM volume and 37.8% of dose exposition reduction 
was observed in the SUPREME protocol with respect to standard protocol 
(p<.05). 
Conclusion: SUPREME Protocol is a valid tool in oncological parients, for CM 
administration and RE reduction, providing the same image quality of standard 
protocol.  
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B-0899 10:30  
Metal artefact reduction in computed tomography (Smart MAR): 
improvement of image quality and diagnostic confidence in patients with 
metallic dental implants  
F. Feldhaus1, G. Böning1, U. Fehrenbach1, J. Kahn1, M.H. Maurer2, 
D.M. Renz3, B. Hamm1, F. Streitparth1; 1Berlin/DE, 2Berne/CH, 3Jena/DE 
(felix.feldhaus@charite.de)  
Purpose: To determine whether the metal artefact reduction tool - a three-
stage, projection-based, postprocessing algorithm - improves subjective and 
objective image quality and diagnostic confidence in patients with dental 
artefacts. 
Methods and Materials: 100 consecutive patients with nonremovable oral 
implants or dental fillings were included. Indications were oropharyngeal 
tumours. CT scans were performed on a single-source, 64-row multislice CT 
scanner (MS-CT, Evolution, GE Healthcare). CT raw data were postprocessed 
using Smart MAR. Image quality of Smart MAR-based reconstruction series 
was evaluated both quantitatively (5 ROIs) and qualitatively (two independent 
raters) and compared to standard reconstructions. Dose was analysed in terms 
of dose-length-products (DLP) and computed tomography dose indices 
(CTDIvol). 
Results: In Smart MAR reconstructions, both attenuation and noise were 
significantly reduced in areas adjacent to implants and in more distant areas 
(all p<0.001) compared to standard reconstructions. There was statistically 
significant improvement in signal-to-noise ratio (SNR; p=0.001) and contrast-
to-noise ratio (CNR; p=0.001). Smart MAR significantly improved visualization 
of tumour (detected in 36 of 100 patients, 36%) and representative 
oropharyngeal tissue (p<0.001). In 8 of 36 patients (22%), tumour was only 
detected in reconstructed series using Smart MAR. The mean DLP of the 
entire scan was 506.8mGy*cm; average CTDIvol was 5.5mGy for 
oropharyngeal region. 
Conclusion: Smart MAR significantly improved both objective and subjective 
image quality of oropharyngeal CT scans even in the presence of severe 
artefacts, resulting in higher diagnostic confidence. Allowing automated 
imaging postprocessing without increasing radiation exposure compared to 
standard CT scans, Smart MAR appears to be well suitable for clinical routine.  
B-0900 10:38  
Next generation imaging of head and neck cancer using dual-layer 
spectral CT  
F. Lohöfer, G. Kaissis, F. Köster, M. Rasper, I. Einspieler, C. Gerngross, 
A. Fichter, E.J. Rummeny, R. Braren; Munich/DE  
Purpose: The aim of this study was to evaluate the performance of dual-layer 
spectral CT (DLSCT) in the detection and staging of head and neck cancer 
(HNC) compared to conventional contrast enhanced CT (CECT). 
Methods and Materials: 39 patients with histopathologically proven diagnosis 
of HNC were examined with a DLSCT scanner and retrospectively analyzed. A 
50-patient healthy control group was used. Images were acquired in the portal 
venous phase. Monoenergetic 40kV-equivalent (MonoE40) images and iodine 
maps were compared to CECT images. Diagnostic confidence for tumor 
identification and margin detection was rated independently by 4 experienced 
observers. The steepness of the Hounsfield Unit (HU)-increase at the tumor 
margin was analyzed. External carotid artery branch image reconstructions 
were performed and their contrast compared to conventional arterial phase 
imaging. 
Results: MonoE40 images were superior to CECT images in tumor detection 
and margin delineation. MonoE40 showed significantly higher attenuation 
differences between tumor and healthy tissue compared to conventional CT 
images (p<0.0001) The HU-increase at the boundary of the tumor was 
significantly steeper in MonoE40 images compared to conventional CT images 
(p<0.0001). Iodine uptake in the tumor was significantly higher compared to 
healthy tissue (p<0.0001). MonoE40 images allowed depiction of the external 
carotid artery and its branches in the portal venous phase. 
Conclusion: DLSCT enables improved detection of primary and recurrent 
HNC as well as quantification of tumor iodine uptake. Improved contrast 
between tumor and background compared to CECT provides diagnostic 
confidence concerning tumor margin detection and vessel identification, which 
can facilitate surgical planning.  
B-0901 10:46  
Staging of head and neck cancer by dual energy CT: comparison of dual 
and single source dual energy  
M. Wiesmüller, W. Wüst, M.S. May, M. Uder; Erlangen/DE 
(marco.wiesmueller@uk-erlangen.de)  
Purpose: Aim of this study was to compare image quality of third-generation 
Single-Source Dual-Energy CT (SS-DECT) with third-generation Dual-Source 
dual energy CT (DS-DECT) in staging examinations of head and neck cancer. 
Methods and Materials: 102 patients with histologically proven head and neck 
cancer were prospectively randomized to undergo radiation dose matched SS-
DECT (n=51, 120 kV, split filter technique, 384 ref. mAs) or DS-DECT (n=51, 
80/Sn150 kV, tube A 100/ tube B 67 ref. mAs) for tumor staging. Inline 
weighted average images (WAI) and virtual monoenergetic images (VMI) for 
two different low energies (40 and 60 keV) were reconstructed. Objective 
image quality was evaluated as dose normalized contrast to noise ratio 
(CNRD) and subjective image quality was rated on a 5-point Likert-scale. 
Results: In both groups highest CNRD for vessel and tumor attenuation was 
obtained on 40 keV VMI. CNRD for tumor attenuation was comparable 
between SS-DECT and DS-DECT while CNRD for vessel attenuation was on 
average 1.4 times higher with DS-DECT for low energies (40 and 60 keV). 
Overall subjective image quality in the SS-DECT group was highest on the 
WAI followed by 40 keV and 60 keV. Subjective image quality was significantly 
better with DS-DECT. 
Conclusion: In SS-DECT as well as DS-DECT highest overall image quality in 
head and neck imaging can be obtained with a combination of WAI and low 
keV reconstructions. DS-DECT is superior to SS-DECT in terms of subjective 
image quality and vessel attenuation, but comparable for tumor attenuation.  
B-0902 10:54  
Oral cavity cancer staging by CT for the new TNM-8: using an 
extrapolated measurement to evaluate the depth of invasion  
J.M.M.M. Santos, A. Mourão de Abreu, M.R.T. Garcia, L. Franceschi, 
L.L. Matos, C.J. Silva, E.M.M. Gebrim, R.L.E. Gomes; São Paulo/BR 
(joao_ssa@hotmail.com)  
Purpose: To retrospectively compare computed tomography oral cavity 
primary cancer staging, comparing the 7th and 8th edition of TNM, based on 
an imaging extrapolated measurement of the new pathological depth of 
invasion criteria. 
Methods and Materials: The records of 100 patients with oral cavity primary 
cancer operated in our institution from 2009 to 2015 were reviewed 
retrospectively. Pathological and imaging tumor and nodal staging were 
reclassified according to 8th edition of TNM (TNM-8), and correlated to the 
previous TNM-7. TNM-8 changes implemented extranodal extension and depth 
of invasion (DOI), which was based on the pathological specimen measure 
from the level of outer line of the closest adjacent normal mucosa to the 
deepest point of the tumor. Here, we proposed a post-contrast CT 
extrapolation of the pathological DOI criteria using the measure from the 
transition line between lesion and adjacent normal mucosa to the deepest point 
of the tumor (extrapolated depth). 
Results: Among T1 or T2 patients, there was a discrepancy between 7th and 
8th TNM staging in 70%. Of these, 67 (95.8%) were up-staged (p < 0.0001). 
The nodal factor was up-staged in 10% of the patients. Locoregional 
recurrence-free survival and oral cavity cancer-specific survival prediction of 
TNM-8 was significantly more accurate (p < 0.0001). 
Conclusion: Compared with the 7th edition, TNM-8 provides valuable results 
regarding tumor and nodal staging. Post-contrast CT is a great tool to analyze 
the depth of the lesion and perform the correct staging, provided that the 
measurements are made in the right way.  
 
  






B-0903 11:02  
Does performing staging MRI for lateral tongue tumours after biopsy of 
the primary tumour overestimate tumour dimensions and staging?  
B. Dhillon, D. Pawaroo; Norwich/UK (baljeet.dhillon@doctors.org.uk)  
Purpose: Tumour (T) staging of oral cavity carcinoma is dependent upon the 
maximal dimension of the tumour. The majority of the staging MRIs for lateral 
tongue tumours in our institution are performed after the biopsy of the primary 
tumour. It can be difficult to discern whether the abnormal T2 high signal and 
contrast enhancement at the primary tumour site is due to malignancy or 
whether part of it may be due to the biopsy. This makes T staging of the 
tumour difficult. It is important for the surgeons to have accurate T staging 
particularly the thickness of the tumour to ensure the correct operation is 
carried out for complete excision. 
Methods and Materials: 35 patient who underwent hemiglossectomy for 
lateral tongue carcinoma were identified. Tumour dimensions on T2-weighted 
MRI and contrast-enhanced MRI were measured in AP and lateral planes. 
Corresponding tumour measurements from histology reports of the surgical 
specimen were compiled. Paired t test was used to compare the MRI and 
histological measurements. 
Results: All patients had biopsy before staging MRI. Paired t test showed no 
significant difference between the MRI and histologic measurements (p=0.3978 
for AP dimension, p=0.4364 for lateral dimension). Only 3 cases (of 35) had 
their T-staging downstaged based on histology post-operatively. 6 cases 
actually had their T-staging upstaged based on histology post-operatively. 
Conclusion: Performing MRI post-biopsy does not significantly increase the 
tumour measurements and hence does not affect the tumour staging 
preoperatively.  
B-0904 11:10  
Assessment of mandibular involvement by oral cavity and oropharyngeal 
squamous cell carcinoma: CT scan and MRI evaluation  
R.K.N. Solanki, I.N. Patel; Ahmedabad/IN (solankirn@yahoo.co.in)  
Purpose: To identify CT and MRI findings to predict mandibular involvement 
by oral cavity and oropharyngeal squamous cell carcinoma.To establish MRI 
as a superior modality to CT scan for mandibular involvement. 
Methods and Materials: MR and CT images in 36 patients with SCC of the 
oral cavity(Ca buccal mucosa, retromolar trigone, gingivobuccal sulcus, floor of 
mouth) were evaluated for the presence and extent of mandibular cortex, bone 
marrow invasion and inferior alveolar canal involvement. The results were 
correlated with histopathologic findings. Using a multidetector spiral CT 
scanner & 1.5 T MRI in all patients with T1 WI, T2WI and fat suppressed 
images were obtained 
Results: We analyzed location of tumor on lower alveolus, tumor within 1 cm 
of mandible, sensory distribution of inferior alveolar nerve and identified 
periosteal striping like subperiosteal reaction, cortical expansion and pathologic 
fracture as predictor of bone invasion. CT scan detects mandibular invasion 
grossly, missing it in 27% cases and is also associated with pitfalls of dental 
amalgam artifact. T1 WI, T2 WI and contrast- enhanced T1-weighted images 
are of highest value detection of involvement of bone marrow , inferior alveolar 
canal and soft tissue extent.Detection of tumour signal replacing the 
hypointense cortical rim was considered the main MRI finding 
Conclusion: MRI is now commonly considered the modality of choice for bony 
involvement ,extension to retromolar trigone, alveolar ridge and inferior 
alveolar canal invasion with additional information about recurrent or residual 
disease in oral cavity and oropharyngeal squamous cell carcinoma, even more 
sensitive than CT scan.  
B-0905 11:18  
Automatic adaptive iterative metal artifact reduction  
A.F. Halaweish1, B. Schmidt2, K. Grant1, T. Flohr2, C. Hofmann2; 1Malvern, 
PA/US, 2Forchheim/DE  
Purpose: Current metal artifact reduction (MAR) algorithms either present the 
user with a list of application specific presets, resulting in varying image 
impressions based on usage, or forgo the flexibility for simplicity and provide 
one processing option regardless of scenario. The objective of this work is to 
evaluate the performance of an automatic-adaptive MAR algorithm, aimed at 
automating the metal detection and artifact reduction processing and 
eliminating end result variability. 
Methods and Materials: Building upon the currently implemented iterative 
MAR (IMAR) algorithm, automatic IMAR incorporates an automated online 
adaption of MAR parameters into the post-processing pipeline. This is 
accomplished through slice-by-slice adaption of the parameters based on 
image and sinogram metrics. In addition to the adaptive parameterisation, 
dedicated z-filtering and sinogram mixing improvements facilitate the 
incorporation of a more accurate sinogram restoration, by preserving as much 
of the original information as possible. Finally, an adaptive high-frequency 
streak reduction solution is incorporated into the workflow. To give the user 
additional flexibility, rather than relying on predetermined application specific 
presets, strength of artifact reduction was incorporated as an option for 
processing. 
Results: Automatic IMAR processed images from Head and Neck, Thoracic, 
Abdominal and MSK specific scans demonstrated excellent image quality and 
significantly reduced streak artifacts through the imaged region of interest, 
when compared to their WFBP and traditional IMAR processed equivalents. 
Conclusion: The automation of the metal artifact reduction process, through 
adaptive parameter selection and improved metal artifact reduction efforts, 
facilitates an application which specifically tailors image quality with minimal 
user interaction.  
B-0906 11:26  
Virtual monoenergetic images can reduce metal artefacts caused by 
dental implants in computed tomography  
N. Grosse Hokamp1,2, K.R. Laukamp1, S. Lennartz1, D. Zopfs1, D. Maintz1, 
J. Borggrefe1; 1Cologne/DE, 2Cleveland, OH/US 
(nils.grosse-hokamp@uk-koeln.de)  
Purpose: To compare the extent of metal artefact reduction by use of high-keV 
virtual monoenergetic images (VMI) from spectral detector computed 
tomography (SDCT). 
Methods and Materials: 40 consecutive patients with dental implants were 
included in this retrospective, IRB-approved study. All examinations were 
performed using a SDCT (IQon, Philips Healthcare). Images were 
reconstructed as conventional images (CI) and as VMI in a range of 40-200 
keV (10 keV increment). Quantitative image analysis was performed ROI-
based by measurement of attenuation (HU) and standard deviation (SD) in 
most pronounced hypo- and hyperdense artefact, fat and soft tissue with 
presence of artefacts. Qualitatively, extent of artefact reduction, assessment of 
soft palate and cheeks were rated on 5-point Likert scales by 2 radiologists. 
Statistically data were assessed using ANOVA and Wilcoxon test with 
correction for multiple comparisons; interrater agreement was determined by 
intraclass correlation coefficient (ICC). 
Results: The hypo- and hyperattenuating artefacts showed an increase and 
decrease of HU values in high-keV VMI (CI/ VMI200keV: -218.7/-174.4 HU, 
p=0.1; and 309.8/119.2, p0.05, respectively). Artefacts in the fat, as depicted 
by image noise did also decrease in high-keV VMI (CI/VMI200keV: 23.9/16.4, 
p0.05). Qualitatively, hyperdense artefacts were decreased significantly in 
VMI100keV (e.g. VMI200keV/CI: 3(1-5)/2(1-3), p0.05). Ariefact reduction 
resulted in improved assessment of the soft palate and cheeks (e.g. 
VMI200keV/CI: 3(1-5)/2(1-4) and 3(1-5)/2(1-5), p0.05). Overall interrater 
agreement was good (ICC=0.78). 
Conclusion: VMI as provided by SDCT allow for reduction of artefacts caused 
by dental implants and improves diagnostic assessment of soft tissue.  
B-0907 11:34  
Diagnostic accuracy of FDG-PET and contrast-enhanced CT in patients 
with head and neck cancer of unknown primary origin  
D. de Haan1,2, A. van der Hoorn2, H.E. Westerlaan2; 1Almelo/NL, 
2
Groningen/NL (ddhaan@gmail.com)  
Purpose: To assess the diagnostic accuracy of FDG-PET and contrast-
enhanced CT in patients with a malignant cervical lymph node of unknown 
primary origin. We propose that additional imaging techniques could improve 
the diagnostic accuracy in these patients. 
Methods and Materials: We retrospectively analysed 48 patients who 
presented with a malignant cervical lymph node, without presence of a 
clinically apparent primary tumour. Patients underwent an total body FDG-PET 
scan or total body FDG-PET combined with a contrast-enhanced CT-scan of 
the head and neck. The imaging studies were correlated with biopsy or surgical 
pathology results of the suspected primary tumour if detected in clinical follow-
up. 
Results: FDG-PET detected a primary tumour in 21 out of 48 patients (44%), 
while contrast-enhanced CT detected a primary tumour in 13 patients (29%). 3 
patients had a negative FDG-PET and a positive CT, and 9 patients had a 
positive FDG-PET and a negative CT. The combined sensitivity of FDG-PET 
and CT was 50%. Out of 23 patients with negative imaging (50%), 13 had a 
confirmed site of primary tumour during treatment and follow-up (27%), 
confirming malignancy in 34 patients (71%). In 14 patients, no primary site was 
confirmed (29%). 
Conclusion: Patients with cancer of unknown primary often have negative 
findings on oncologic imaging workup. A primary site may be detected during 
follow-up. We demonstrate the diagnostic accuracy of FDG-PET and contrast-
enhanced CT-scan. Adding other imaging modalities might also improve the 











B-0908 11:42  
Can MR textural analysis improve detection of extracapsular nodal 
spread in patients with oral cavity cancer?  
R. Frood, E.Y.A. Palkhi, M. Barnfield, R. Prestwich, S. Vaidyanathan, 
A. Scarsbrook; Leeds/UK (russell.frood@doctors.org.uk)  
Purpose: To explore the utility of MR texture analysis (MRTA) for detection of 
extracapsular nodal spread (ECS) in oral cavity squamous cell carcinoma 
(SCC). 
Methods and Materials: 115 patients with node-positive oral cavity SCC 
treated surgically between 2008 and 2016 who received radiotherapy in a 
single centre were evaluated; 45 patients (39%) had pathological evidence of 
ECS. Two experienced radiologists independently reviewed baseline MRI 
blinded to histology. Presence/absence of MR features associated with ECS 
were agreed in consensus. Region of interests (ROI) encompassing the largest 
node on T2 and post-contrast T1-weighted images were defined. First-order 
texture parameters (entropy, skewness and kurtosis) were extracted using 
proprietary software (TexRAD) with fine, medium and coarse filters. Sensitivity, 
specificity and positive and negative predictive values (PPV and NPV) of MR 
predictors of ECS were compared with histology as the gold standard. Areas 
under the curve (AUC) calculated by receiver operating characteristics (ROC) 
analysis and optimal threshold was calculated for texture parameters. 
Results: Sensitivity, specificity, PPV and NPV (%) for MR predictors were: 
flare sign (38%, 95%, 86%, 66%); irregular capsular contour (69%, 45%, 42%, 
63%); local infiltration (31%, 92%, 77%, 63%); nodal necrosis (72%, 41%, 
49%, 65%). Nodal entropy had a statistically significant correlation with ECS on 
both MR sequences independent of filtration level; the most significant being 
medium filtration T1 nodal entropy (p =0.001), AUC = 0.70, with a threshold > 
5.26. 
Conclusion: First-order MRTA may improve ECS prediction in oral cavity 
SCC.  
B-0909 11:50  
Comparison of local shim coils and slice-specific integrated shimming in 
EPI-based DWI of the head and neck region  
S. Walter1, M. Notohamiprodjo1, M. Keil2, K. Nikolaou1, P. Martirosian1, 
S. Gatidis1; 1Tübingen/DE, 2Erlangen/DE (sven.walter@uni-tuebingen.de)  
Purpose: Echo-planar (EPI) diffusion weighted imaging is a widely used MR 
method for (non-)oncological diseases because of its short acquisition-time 
and defiance against motion induced phase errors. Nevertheless, static field 
inhomogeneities cause artefacts at higher field strengths in the head/neck 
region. The purpose was to assess the implementation of additional shim coils 
into the head/neck surface coil to homogenize the magnetic field, thus 
improving image quality, compared to single-shot and slice-specific integrated 
dynamic shimming EPI. 
Methods and Materials: sEPI, iEPI and sEPI with additional shim coils (cEPI) 
of the head/neck region was performed in 10 healthy volunteers (6 male, mean 
age: 29±4 years) on a clinical 3 Tesla MR-scanner (MAGNETOM Vida, 
Siemens). Additionally, B0 field maps were acquired using T1w GRE 
sequence. Assessment of image quality, geometric distortions, ghosting 
artefacts and signal loss was performed visually by two radiologists in 
consensus on a 4-point-scale (1 = best possible outcome). Apparent diffusion 
coefficients (ADC) were compared using ROIs in the spinal fluid, spinal cord 
and the trapezius muscle. 
Results: Additional shim coils showed improved homogenization of the static 
field, foremost of the lower, posterior neck. Image quality, geometric 
distortions, signal loss and fat saturation were reduced in iEPI and cEPI. Mean 
ADC values showed no significant differences in all three compartments; sEPI: 
3507, 793 and 1663, iEPI: 3722, 797 and 1765, cEPI: 3597, 839 and 1690. 
Conclusion: Additional shim coils in the surface coils of the head/neck showed 
improved overall image quality compared to sEPI and comparable results to 
iEPI.  
Author Disclosures: 
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B-0910 10:39  
Malignant breast lesions typing with diffusion tensor imaging: could 
fractional anisotropy considered a preoperative 'imaging biomarker'?  
F. Pipan1, P. Clauser2, C. Zuiani1, T.H. Helbich2, P.A.T. Baltzer2; 1Udine/IT, 
2
Vienna/AT (francesca.pipan@gmail.com)  
Purpose: To assess the relationship between apparent diffusion coefficient 
(ADC) and fractional anisotropy (FA) derived from diffusion tensor imaging 
(DTI) and breast cancer biomarkers Estrogen Receptor (ER), proliferation 
index Ki67 and human epidermal growth factor receptor2 (HER-2). 
Methods and Materials: The Ethics Committee approved this retrospective 
study. 359 consecutive patients performed 3T MRI with an additional DTI 
sequence. Included in our analysis were 154 patients (mean age 54 years, 
range 26-87) with 159 new diagnosed histologically verified malignant lesions. 
The ADC and FA values were retrospectively measured using a region of 
interest positioned in the suspicious lesion. Immunohistochemical analysis with 
evaluation of ER (>11% ER+, 11% ER-), Ki67 (>14% Ki67+, 14% Ki67-) and 
HER-2 was performed on the biopsy specimens according to current 
standards. Mann-Whitney U-test and receiver operating characteristics (ROC) 
analysis were applied. 
Results: FA values were higher in ER+ (0.152±0.004; ER- 0.117±0.006 
p<0.05) and lower in Ki67+ (0.138±0.004; Ki67- 0.164±0.009, p<0.05). There 
were no significant differences in ADC in ER+/ER- (p=0.22) and Ki67+/Ki67- 
(p=0.47) or ADC and FA values in HER2+/HER2- (p=0.88 and p=0.36, 
respectively). The area under the ROC curve showed two cut off values: 
FA>0.17 (identification of 34.7% of ER+, specificity 90.9%) and FA<0.10 
(identification of 23.3% of Ki67+, specificity 94.19%). 
Conclusion: FA were significantly higher in ER+ and lower in Ki67+ tumours. 
FA seems to be more reliable than ADC in characterizing malignant breast 
lesions. FA could be used as a preoperative "imaging biomarker" and 
considered an additional tool for therapeutic planning.  
B-0911 10:47  
Breast lesion detection and characterisation with MRI: intra-individual 
comparison of gadoterate meglumine and gadobenate dimeglumine at 3 
Tesla  
P. Clauser1, T.H. Helbich1, P. Kapetas1, K. Pinker2, M. Bernathova1, 
P.A.T. Baltzer1; 1Vienna/AT, 2New York, NY/US 
(paola.clauser@meduniwien.ac.at)  
Purpose: To compare a halved dose of the high-relaxivity contrast agent 
gadobenate dimeglumine, 0.075 mmol/kg, with a two-fold higher dose of 
gadoterate meglumine, 0.15 mmol/kg, for breast lesion detection and 
characterization on contrast-enhanced MRI at 3 Tesla. 
Methods and Materials: Eligible for this IRB-approved prospective, 
randomized, intra-individual comparative study were patients with imaging 
abnormalities (BI-RADS 0, 4 or 5) on conventional imaging. Each patient 
underwent two examinations, 24-72h apart, one with gadobenate and the other 
with gadoterate administered in randomized order. Examinations were 
performed at 3T using identical sequence and timing parameters including high 
spatiotemporal resolution dynamic-CE, T2w-TSE, STIR-T2w and DWI. 
Histopathology was the standard of reference. Three blinded, off-site readers 
evaluated the examinations using BIRADS. Detection, sensitivity, specificity, 
and accuracy were calculated per-lesion and per-region and compared by 
univariate and multivariate analysis. 
Results: 109 patients were recruited. Five were excluded due to technical 
problems or lack of reference standard leaving 104 women with 142 
histologically verified lesions (109 malignant, 33 benign) for evaluation. The 
detection with gadobenate (84.5-88.7%) was not inferior to gadoterate (84.5%-
90.8%), P>0.165. At per-region analysis, gadobenate demonstrated higher 
specificity (96.4%-98.7% vs. 92.6-97.3%, P<0.007) and accuracy (96.3-97.8% 
vs. 93.6-96.1%, P0.001), for all three readers. Gadobenate allowed a 
reduction in false positives of up to 58%. Multivariate analysis demonstrated a 
reader-independent superior accuracy with gadobenate. 
  






Conclusion: Halved dose of gadobenate (0.075, mmol/kg) is not inferior to a 
two-fold higher dose of gadoterate (0.15 mmol/kg) for lesion detection. 
Gadobenate allows improved lesion characterization with an increased 
specificity and accuracy.  
Author Disclosures: 
 T.H. Helbich: Grant Recipient; The current study (PI T.H.H.) was supported 
by Bracco Imaging, Milan, Italy.  
B-0912 10:55  
A formalised clinical decision rule applied to breast MRI: can we rule-out 
malignancy in lesions presenting as suspicious mammographic 
microcalcifications?  
J. Al Mohanna1, F. Pipan2, P. Clauser3, A. Bumberger3, A. Stöttinger3, 
P. Kapetas3, C. Zuiani2, T.H. Helbich3, P.A.T. Baltzer3; 1Riyadh/SA, 2Udine/IT, 
3
Vienna/AT (dr.jalilah@hotmail.com)  
Purpose: To investigate whether a clinical decision rule (the Kaiser score, 
formerly Tree flowchart) applied to breast MRI in patients with lesions 
presenting as suspicious mammographic microcalcifications can rule-out 
malignancy. 
Methods and Materials: IRB-approved retrospective single-center study. 150 
consecutive patients (mean age 52 years, range 24-85) undergoing breast MRI 
(protocol in accordance with EUSOBI/EUSOMA recommendations) for lesions 
presenting as suspicious mammographic microcalcifications (BI-RADS 4) were 
investigated. Breast MRI were interpreted by two independent readers that 
localized the area of microcalcifications in the MRI images and applied the 
Kaiser score. In short, this rule consists of a formalized flow chart that guides 
the reader through a 3-step diagnostic process. A resulting score indicates the 
probability of malignancy ranging from 1 (minimal) to 11 (maximal). A cut-off of 
4 was suggested to avoid unnecessary biopsies. Each reader’s results were 
tested against the reference standard (vacuum-assisted breast biopsy) using 
Receiver Operating Characteristics (ROC) analysis. 
Results: Histopathology revealed 96 malignant and 54 benign lesions 
(malignancy rate 64%). Areas under the ROC curves (AUC) were measured: 
0.810 (95%-CI: 0.738-0.869), R1 and 0.779 (95%-CI: 0.704-0.842), R2. Both 
readers AUC´s did not differ (P=0.479). At a cut-off of >4, sensitivity was 
97.9% (R1) and 100% (R2). Applying this cut-off could have reduced 
unnecessary biopsies by 50% (95%-CI: 36.1-63.9%) for R1 and 22.2% (95%-
CI: 12.0-35.6%). 
Conclusion: The formalized Kaiser score applied to breast MRI in patients 
with lesions presenting as suspicious mammographic microcalcifications can 
rule-out malignancy, allowing a potential reduction of unnecessary biopsies by 
22.2-50%.  
B-0913 11:03  
Selecting treatment options in patients with ductal carcinoma in situ 
(DCIS) using MRI  
A. ter Braak, P.W. Plaisier, M. Menke-Pluijmers, P.J. Westenend; Dordrecht/NL 
(bpmterbraak@yahoo.com)  
Purpose: Ductal carcinoma in situ (DCIS) is diagnosed in a needle biopsy. In 
20-25% of the patients underestimation occurs, i.e. invasive breast cancer is 
detected in the surgical specimen. In patients with invasive cancer, nodal 
staging is performed by sentinel node biopsy. Patients without invasive cancer 
could be candidates for active surveillance. MRI is sensitive in detecting 
invasive cancer and thus could be helpful in selecting patients with a biopsy 
diagnosis DCIS for one of these options. 
Methods and Materials: Prospective observational study in which MRI was 
offered to all subsequent patients with a biopsy DCIS diagnosis in addition to 
standard diagnosis and treatment between april 2012 and march 2017. 
Results: 157 of 228 (69%) subsequent patients with DCIS were included. 
Biopsies were performed using a 9G needle. 71 patients were not included, 
mainly because patients declined participation. Five patients, two of which 
were included, were not operated. The underestimate rate both in included and 
not included patients was 25%, thus excluding selection bias. The positive 
predictive value of MRI for detecting invasion was 0.57 (26 of 46 patients) .The 
negative predictive value of MRI was 0.90 (98 of 109 patients). Sensitivity and 
specificity for detecting invasive cancer on MRI were 0.70 and 0.83. 
Conclusion: In patients with DCIS diagnosed by needle biopsy, negative MRI 
could reliably identify patients without invasive cancer. MRI could be used to 
select patients with DCIS for active surveillance. However, MRI can not reliably 
predict the presence of invasive cancer in patients with DCIS.  
Author Disclosures: 
  A. ter Braak: Research/Grant Support; Supported by a grant from Pink 





B-0914 11:11  
Contribution of preoperative breast MRI study to pure DCIS  
E. Horvath, C. Darrás Ismael, C. Silva, E. Castillo, M.A. Pinochet, 
C. Galleguillos, E. Droguett, M. Villalon, F. Pizzolon; Santiago/CL 
(darrascarla@gmail.com)  
Purpose: To evaluate the usefulness of preoperative MRI study in patients 
with pure ductal carcinoma in situ (DCIS). 
Methods and Materials: IRB approved a retrospective, descriptive 
observational study of a series of cases. Patients with breast cancer operated 
between January 2015 and March 2017 were reviewed and pure DCISs with 
mammography (Mx), ultrasound (US) and preoperative MRI available in PACS 
were selected. Bland-Altman test was used to describe the size concordance 
considering the histopathology of the surgical specimen as the reference 
standard. The MRI contribution was classified into 4 groups. Group 1: MRI 
provided the same information as conventional studies. Group 2: improved the 
description of tumour size without changing the surgical approach. Group 3: 
generated unnecessary procedures. Group 4: correctly changed the surgical 
management. 
Results: Of 467 cancers operated, 77 (16.5%) were DCIS, 41 (53.2%) pure 
and 36 with microinvasion (46.8%). Thirty-three patients met inclusion criteria. 
Thw average age was 52.78 ± 12.55 years. The detectability of the lesions was 
90.9%, 30.3% and 74.2% for the Mx, US and MRI, respectively. Concordance 
index of tumour size: MRI=73.3%, US=70% and Mx=58.1%. MRI contribution 
in preoperative staging: Group 1=18 cases (58%), Group 2= 3 cases (9.7%), 
Group 3=0 and Group 4=2 cases (6.5%). 
Conclusion: Undoubtedly, Mx is the main method of detection of pure DCIS. 
However, MRI proved to be the best technique to evaluate tumour size, 
allowing better preoperative staging than conventional studies in 15% of the 
cases, and even to correctly change surgical management in 6%.  
B-0915 11:19  
Is it worth to perform preoperative MRI after the combination of digital 
mammography, digital breast tomosynthesis and US?  
I. González de la Huebra Rodríguez, A. García Baizán, M. Calvo Imirizaldu, 
A. Ezponda Casajús, P. Bartolomé, A. Quilez, A.M. Elizalde Pérez, 
L.J. Pina Insausti; Pamplona/ES (igonzalez.6@unav.es)  
Purpose: To compare the sensitivity (ST) of preoperative breast MRI and the 
combination digital mammography (DM) + tomosynthesis (DBT) + US in all 
cancers and in specific subtypes. 
Methods and Materials: We reviewed the records of 280 breast cancers in 
192 women, diagnosed between October 2011 and September 2016. All of the 
patients underwent DM, DBT, US and MRI. This was designed as a lesion-by-
lesion study. The lesions were classified according to the BI-RADS categories 
(1-3 were considered negative, while 4-5 positive). The gold standard was the 
surgical specimen. We compared the sensitivities of the different combinations 
DM+DBT+US vs DM+DBT+US+MRI using a McNemar test (SPSS 20.0). 
Results: 280 breast cancers (32 ductal carcinomas in situ, 210 invasive ductal 
carcinomas, 38 invasive lobular carcinomas) were reviewed in 192 patients. 
Among the 248 invasive cancers, 207 were luminal (129 luminal A, 78 luminal 
B) and 41 were non-luminal (32 triple negative and 9 pure Her2). The ST for 
the combination DM+DBT+US was 86.4% while the ST for MRI was 94.3% 
(p<0.001). For DCIS the ST were, respectively, 82.3% vs 85.3% (p=1), for IDC 
the ST were 87.9% vs 96.2% (p<0.001), for ILC the ST were 81.6% vs 92.1% 
(p=0.219). Regarding the immunohistochemical patterns, for luminal cancers 
the ST was 85.8% vs 94.6% (p<0.001) and for non-luminal cancers 92.7% vs 
97.6% (p=0.5). 
Conclusion: According to our data, the addition of breast MRI significantly 
increased the sensitivity of the combination DM+DBT+US for all cancers, 
except for DCIS, invasive lobular cancers and non-luminal cancers.  
B-0916 11:27  
The incremental value of preoperative MRI for evaluation of extent of 
disease in IDC vs ILC  
T. Alster, E. Carmon, B. Maly, T. Sella; Jerusalem/IL 
(tamarse@hadassah.org.il)  
Purpose: ILC is more commonly multifocal/multicentric compared to IDC, with 
a high discordance rate between imaging and pathology. However, most 
studies were conducted before the era of breast MRI. The purpose of this 
study was to assess the incremental value of pre-operative breast MRI over 
mammography (MG) and US in depicting the accurate extent of disease in IDC 
compared to ILC. 
Methods and Materials: Retrospective analysis of pre-operative MG, US and 
MRI was performed in 239 patients with either IDC (n=193) or ILC (n=46). 
Images were evaluated for solitary, multifocal or multicentric disease and 
compared for concordance with post-surgical pathology. Discordance was 
documented as either overestimation or underestimation. Two tailed paired T 
and Fischer’s exact tests were used for analysis. 
  






Results: Multifocality was present on pathology in 35% and 61% of patients 
with IDC and ILC (p<0.05) and multicentricity in 23% and 42% respectively 
(p=0.84). For IDC, concordance with pathology for all modalities was similar 
(65-76%). In ILC, MRI was more commonly concordant than MG and US (89%, 
44%, 49% for multifocality (p<0.05) and 80%, 63%, 71% for multicentricity 
(p=0.3)). Among discordant cases, underestimation was significantly more 
common for MG and US. MRI equally overestimated multifocal and multicentric 
disease in IDC (21 and 22%), but very rarely overestimated multifocal disease 
in ILC (2%). 
Conclusion: The added benefit of MRI for evaluation of extent of disease is 
greater in ILC than IDC. Demonstrating an 80-90% concordance rate with 
pathology, ILC should be regarded as a relative indication for pre-operative 
MRI.  
B-0917 11:35  
The role of MRI in predicting irradical surgery and local recurrence after 
breast conserving surgery in T3 breast cancer patients after neoadjuvant 
chemotherapy  
I. Ioan1,2, J. van Urk2, D.K. Schouten2, M.E. van der Noordaa2, 
M. Vrancken Peeters2, R.G.H. Beets-Tan2, G. Winter-Warnars2, C. Loo2; 
1
San Donato Milanese/IT, 2Amsterdam/NL (ileana.ioan@libero.it)  
Purpose: To investigate the role of MRI in predicting irradical surgery and local 
recurrence (LRR) after breast conserving surgery (BCS) in patients with 
extensive breast cancer (>5 cm) treated with neoadjuvant chemotherapy 
(NAC). 
Methods and Materials: Dynamic Contrast Enhanced MR images of 45 
patients with T3 breast cancer, treated with NAC and BCS were retrospectively 
reviewed. Morphology, size, enhancement kinetics were assessed before and 
after NAC and the accuracy of MRI to predict pathological CR (pCR). Clinical, 
surgical and histological information after NAC and during long term follow up 
was obtained. 
Results: Median follow up was 4.6 years (min 0.8y - max10.2y). Seventeen 
(38%) patients had positive margins after BCS. Of these, only seven (15%) 
had mastectomy, two (4%) had re-excision and eight (18%) had more 
extensive radiotherapy. There were no local recurrences. Two patients died of 
distant metastasis. Clinical Complete Response (cCR) on MRI was achieved in 
24 (53%) patients and pCR in only 14 (31%). Sensitivity, specificity, NPV and 
PPV of MRI to predict pCR was: 55%, 71%, 42% and 81%. The risk of irradical 
surgery was equal for patients with 37% (9/24) and without 38% (8/21) cCR on 
MRI after NAC. The risk of irradical BCS was higher in patients with non mass 
enhancement on MRI before NAC 45% (11/24) or ILC 60% (6/10) than in mass 
enhancement 28% (6/21) or IDC 34% (12/35). 
Conclusion: Non mass enhancement on MRI before neoadjuvant 
chemotherapy is associated with higher risk of irradical breast conserving 
surgery in T3 breast cancer.  
B-0918 11:43  
Accuracy of breast magnetic resonance imaging compared to 
mammography in the preoperative detection and measurement of pure 
ductal carcinoma in situ  
H. Preibsch, J. Beckmann, G. Blumenstock, A. Staebler, B. Wietek, 
K. Nikolaou, B. Wiesinger; Tübingen/DE 
(Heike.Preibsch@med.uni-tuebingen.de)  
Purpose: Ductal carcinoma in situ (DCIS) hinders detection by imaging 
methods due to multifocal appearance and discontinuous growth. Preoperative 
determination of its extent is therefore challenging. Aim of this study was to 
investigate the additional benefit of breast magnetic resonance imaging (MRI) 
to mammography (MG) in the diagnosis of DCIS according to size and grading. 
Methods and Materials: Retrospective analysis of 295 patients with biopsy-
proven, pure DCIS. Mean patient age was 57.0 years (27-87 years). In 41.7% 
(123/295) MRI was performed additional to MG. Mammographic breast density, 
benign breast parenchymal enhancement (BPE), tumour size and grading 
were analyzed. 
Results: Mean tumour size of DCIS was 35.3mm. DCIS was occult on MG in 
14.6% (43/295) and on MRI in 1.6% (2/123). Size was underestimated by 
4.6mm (mean) mammographically. Regarding breast density MG 
overestimated tumour size by 16mm (median) in density a, was exact in 
density b and underestimated by 5.5 and 8mm in density c and d, respectively. 
DCIS was high grade in 46.8% (138/295), intermediate grade in 41.1% 
(122/295) and low grade in 11.9% (35/295). MG was exact regarding tumour 
size in low grade DCIS, underestimated intermediate grade by 1mm (median) 
and high grade by 10.5mm (median). MRI overestimated low grade DCIS by 
1mm (median), was exact regarding intermediate grade and underestimated 
low grade by 1mm (median). BPE did not significantly influence tumour 
detection and measurement. 
Conclusion: MRI outperforms MG in the detection and size estimation of DCIS 
with a benefit for surgical planning and reduction of positive margin rates.  
B-0919 11:51  
Non-mass enhancement in breast-MRI: which BI-RADS descriptors for 
distribution and internal enhancement patterns have the highest 
likelihood of malignancy?  
M. Lunkiewicz1, S. Forte2, B.K. Freiwald1, G. Singer1, R.A. Kubik-Huch1; 
1
Baden/CH, 2Basle/CH (magdalena.lunkiewicz@ksb.ch)  
Purpose: The purpose of this study was to evaluate the positive predictive 
values for malignancy of non mass enhancement (NME) descriptors, using the 
revised BI-RADS Atlas (5th Edition), with focus on clustered ring internal 
enhancement pattern. 
Methods and Materials: We reviewed Breast MRIs of patients on which an 
MRI-guided VAB-Biopsy had been performed between 2012 and 2016. All 
studies were independently reevaluated by two experienced radiologists, 
blinded to the histopathological results. Distribution modifiers and pattern of 
internal enhancement was recorded. Consensus was reached by involving a 
third radiologist. The findings were correlated with the histopathological results. 
Results: 142 women were included. 72 biopsied lesions were assessed as 
NME.Pathology results for NME included 53 (73.6%) benign lesions and 19 
(26.4 %) malignant lesions.Among all internal enhancement patterns, clustered 
ring enhancement (7/14, PPV 50%) and clumped enhancement (7/30, PPV 
23.3 %) had the highest malignancy rate.Among all distribution patterns, 
segmental distribution (5/9, PPV 55.6 %) and linear distribution (5/20, PPV 
25%) had the highest malignancy rate.The combination of segmental 
distribution and clustered ring internal enhancement pattern had the highest 
malignancy rate (4/6, PPV 66,7 %).The overall interobserver agreement rate 
for distribution modifiers was 0.67 and 0.69 (CI 95%) for internal enhancement 
pattern. The biggest discrepancy occurred between focal distribution of non 
mass enhancement vs mass lesions.Interreader agreement was lowest for the 
segmental distribution and clumped internal enhancement pattern. 
Conclusion: Using the revised 5h edition of BI-RADS Atlas, clustered ring 
internal enhancement pattern and segmental distribution had the highest PPV 
for malignancy.  
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B-0920 10:39  
Covert brain ischaemia and its impact on cognition in the Polish 
population: preliminary results of the PURE - mind (Prospective Urban 
and Rural Epidemiological) cohort study  
J. Jacków, A. Zimny, P. Podgórski, M. Sasiadek, D. Szczesniak, 
J. Rymaszewska, K. Połtyn-Zaradna, K. Zato
ska, A. Szuba; Wroclaw/PL 
(jagodajackow@yahoo.pl)  
Purpose: Assessment of incidence of covert brain ischaemia and its impact on 
cognition in the Polish population as a part of Polish and international PURE-
mind (Prospective Urban and Rural Epidemiological) cohort study after one 
year of the project. 
Methods and Materials: The study group consisted of 249 subjects (mean 
age:56.1 yrs range:42-66 yrs, F/M:155/94, urban/rural:197/52). All participants 
were examined using international PURE-mind protocols including 
questionnaires about their life-style, laboratory blood tests and psychological 
assessment measured with Montreal Cognitive Assessment (MOCA) followed 
by structural brain MRI. Axial T2-, PD-weighted, FLAIR and DWI images were 
used to assess the number of white matter hyperintensities (WMHs) and SWI 
for microbleeds. Imaging findings were correlated with cardiovascular risk 
factors and cognitive state. 
Results: WMHs were found in 97/249 (38.9%) subjects (mean number:16.1, 
range:1-89). No large territorial infarcts and microbleeds were found. 176/249 
(70.6%) participants showed normal cognitive state while 73/249 (29.4%) 
revealed mild cognitive impairment (MCI). There was a significant positive 
correlation between WMHs and age (p<0.05). There were no correlations 
among WMHs and gender, weight, urban/rural living environment, contact with 
heavy metals, smoking, alcohol consumption, hypertension, diabetes, 
myocardial ischaemia and cognitive impairment (p>0.05). 61/176 (34.6%) 
normal and 36/73 (49.3%) MCI subjects showed similar amount of WMHs 
(mean number:15.0, range:1-73; mean number:14.0, range:1-89, respectively). 
  






Conclusion: Incidence of WMHs is strongly related to age, less dependent on 
their life-style or accompanying diseases. WMHs have no important impact on 
cognitive state in the relatively young screened population.  
B-0921 10:47  
Clinical and MRI characteristics of patients with pontine hyperintense 
lesions in a series of ischaemic strokes  
M. Majer, S. Colombani, M. Mejdoubi; Fort De France/FR  
Purpose: Pontine hyperintense lesions (PHL) are sometimes detected on 
brain Magnetic Resonance Imaging (MRI) in asymptomatic patients. They are 
therefore considered a form of small vessel disease (SVD) with possibly the 
same pathophysiology as white matter hyperintensities (WMH). Because this 
imaging sign is rarely seen in the general population, the aim of our study was 
to investigate the relationship between PHL and clinical/MRI data in a series of 
stroke patients. 
Methods and Materials: Patients' medical history was obtained regarding age, 
gender, the presence of arterial hypertension, diabetes mellitus, 
hypercholesterolemia, coronary heart disease, atrial fibrillation, peripheral 
arterial obstructive disease, current smoking and alcohol consumption. WMH 
grade, presence of microbleeds, infarcts type and PHL presence were reported 
after MRI analysis. Potential predictors of PHL presence were investigated 
using logistic regression modelling. 
Results: PHL were found in 110 (20.6%) of the 534 prospectively included 
stroke patients. In univariate analysis, a significant association was 
demonstrated between PHL and age (p< 0.0001), female gender (p=0.04), 
microbleeds (p< 0.0001), high WMH grade (Fazekas classification 2-3; p= 
0.0001), hypertension (p = 0.02) and diabetes (p = 0.03). In multivariate 
analysis, only age 60 years (OR [95% CI]: 3.44 [1.17-10.15], p< 0.025), 
female gender (OR [95% CI]: 1.78 [1.11-2.87], p= 0.0175), microbleeds (OR 
[95% CI]: 1.97 [1.18-3.30], p= 0.0098) and high WMH grade (OR [95% CI]: 
7.54 [4.17-13.62], p<0.0001) remained independently associated with PHL. 
Conclusion: Several clinical and imaging factors are independent predictors of 
PHL presence in stroke patients. To our knowledge, significant association 
between PHL occurrence and microbleeds has never been reported before. 
This might suggest that SVD is the principle pathophysiologic process in PHL. 
We suggest that PHL be considered as a subgrade in the Fazekas 
classification. 
B-0922 10:55  
Collateral filling velocity predicts malignant oedema development in 
acute ischaemic stroke  
M.F. Froelich, P. Reidler, M.P. Fabritius, L. Rotkopf, F. Schuler, W.H. Sommer, 
K.M. Thierfelder, W.G. Kunz; Munich/DE  
Purpose: To assess the predictive value of collateral filling velocity on 
malignant edema development (MED) in acute ischemic stroke. 
Methods and Materials: Subjects were selected from a cohort of 1,845 
consecutive patients with suspected ischemic stroke who underwent CT 
including whole-brain CT perfusion. Inclusion criteria were: (1) isolated pre-
bifurcation M1 segment occlusion, and (2) available follow-up imaging within 
72 hours. Time to peak (TTP) enhancement was measured distal to the 
occlusion in the M2 segment branches in the Sylvian fissure. Collateral filling 
velocity was defined as the difference in TTP enhancement between the 
ischemic and non-ischemic hemisphere. MED was defined as development of 
midline shift of 5 mm in follow-up imaging. Multivariable binary logistic 
regression analysis was performed to adjust for clinical and imaging 
parameters. 
Results: Ninety-nine patients (56.6% female, mean age 73 years) were 
included. 18 patients (18.2%) suffered from MED. Longer TTP enhancement 
was significantly associated with MED (odds ratio [OR]=1.627; 95% confidence 
interval [CI], 1.044-2.536; p=0.032). Lower values of the Alberta Stroke 
Program Early CT Score (OR=0.370; 95% CI, 0.152-0.898; p=0,028) were also 
associated with MED. The analysis was further adjusted for intravenous 
thrombolysis treatment, neurological deficit on admission based on the 
National Institutes of Health Stroke Scale, and the volume of cerebral blood 
flow-cerebral blood volume mismatch, which were not associated with MED (all 
p>0.05). 
Conclusion: Slower collateral filling velocity independently predicts malignant 
edema development in acute large-vessel occlusion stroke. As an objective, 
threshold-independent quantitative parameter, it may allow standardized risk 
prediction in acute stroke imaging.  
B-0923 11:03  
Collateral scores and perfusion parameters for outcome prediction in 
acute ischaemic stroke: how many scans are needed?  
K. Schregel, I. Tsogkas, D. Behme, C. Peter, I. Maier, J. Liman, M. Knauth, 
M.-N. Psychogios; Göttingen/DE (katharina.schregel@med.uni-goettingen.de)  
Purpose: Collateral circulation is an important determinant for outcome in 
endovascularly treated patients with acute ischaemic stroke (AIS). Several 
collateral scores to support triage and outcome prediction exist. We applied 
different scoring systems on single- and multi-phase CTA (sp-/mpCTA) and 
compared them to CT perfusion (CTP) to identify the best method for collateral 
evaluation in AIS. 
Methods and Materials: A total of 102 patients with AIS due to large vessel 
occlusion (LVO) in the anterior circulation who underwent multimodal CT 
imaging and who were treated endovascularly were included. Collateral status 
was assessed on spCTA and on mpCTA derived from CTP using four different 
scoring systems and compared to CTP parameters. 
Results: Collateral scores correlated well with each other and with CTP 
(p<0.01 for each). Collateral scores stratified by extent of perfusion deficit were 
significantly different between groups (p<0.01 for each). Stepwise logistic 
regression showed that probability of a favorable outcome was highest, when 
patients were not hypertensive, had high baseline ASPECTS and good 
collaterals on spCTA (OR 5.82, 1.53 and 1.47, respectively; 95% CI 1.83-
18.51, 1.03-2.27 and 1.11-1.94, respectively). In ROC analysis, a spCTA 
collateral score discriminated best between favorable and unfavorable 
outcome and was equal to CTP parameters. 
Conclusion: Collateral status evaluated on spCTA may suffice for outcome 
prediction and decision making in AIS patients, potentially obviating further 
imaging modalities like mpCTA or CTP.  
Author Disclosures: 
 M. Psychogios: Speaker; Speakers' honoraria from Siemens Healthineers. 
B-0924 11:11  
The utility of CAD software in acute stroke protocol workflow for 
automatic evaluation of infarct core size  
D. Juskanic, A. Petrovicova, S. Holly; Nitra/SK (juskanic@gmail.com)  
Purpose: Triaging acute stroke patients for appropriate treatment is often 
carried out in a high-pressure setting, which is a potential source of 
interpretative variability. Use of decision supportive tools appears to be 
promising in reducing interpretation and management errors. Without prior 
systematic use of ASPECTS, we describe the single centre experience while 
implementing the CAD software during night shifts. 
Methods and Materials: During two months study period, all 95 patients with 
suspected stroke referred during night shifts were examined under standard 
CT stroke protocol with subsequent automatic post-processing using the CAD 
tool e-ASPECTS (Brainomix, Oxford, UK). In patients with ICA or MCA strokes, 
logistic regression was used to evaluate the relationship between entry 
variables and treatment decisions. The correlation between ASPECTS with 
mRS on discharge was performed. 
Results: The greatest influence on treatment decision had entry NIHSS (p 
0.01), ASPECTS was not significant (p 0.294). In the treatment group, none of 
the patients had ASPECTS lower than 7, median ASPECTS was 9 
(interquartile range [IQR] 8-9). In patients with no specific treatment, median 
ASPECTS was 10 (interquartile range [IQR] 9-10). Moderate correlation 
between ASPECTS and mRS on discharge was found (r 0.518). 
Conclusion: In the treatment group, where no other contraindications were 
present, ASPECTS played more of an external role in validating decisions 
made during standard routine protocol. Conversely, in the subset of patients 
outside the 4.5-hour window or patients with wake-up stroke, ASPECTS could 
potentially serve as a factor favoring revascularization, or as a quantitative 
alternative for CT perfusion.  
B-0925 11:19  
Voxel-based lesion symptom mapping of NIHSS scores in patients with 
acute media infarction  
J. Jesser1, B. Dinse1, J. Baldo2, A. Arévalo3, M. Bendszus1, K. Schlamp1; 
1
Heidelberg/DE, 2Martinez, CA/US, 3São Paulo/BR 
(Jesser.Jessica@gmail.com)  
Purpose: The aim of this study was to find key areas in the brain that cause a 
severe clinical situation when damaged in patients with an acute infarction of 
the middle cerebral artery. 
Methods and Materials: In retrospect we identified 126 patients with acute 
media infarction. Inclusion criteria: symptom onset <24h before MRI, no 
mismatch between stroke lesion in diffusion- and perfusion-weighted imaging 
(DWI vs. PWI) in the MRI session, accessible NIHSS records ("National 
Institute of Health Stroke Scale"). The NIHSS is used for quantification of 
stroke severity. The stroke lesion was manually traced in the DWI-sequence 
and normalized to standard space. VLSM-analysis ("voxel-based lesion 
symptom mapping"): In the process a t-test is conducted in every voxel using 
the lesioned versus non-lesioned voxel as independent variable and the total 
NIHSS score (at the time of the MRI) as dependent variable. 
Results: We found three highly significant clusters (p<0,001) associated with 
high NIHSS scores in acute media infarction. These clusters are localised in 
the left brain hemisphere: subcortical in the supramarginal gyrus, in the corona 
radiata where the corticospinal tract and the arcuate fascicle cross and below 
the basal ganglia in the inferior frontooccipital fascicle. 
  






Conclusion: The areas associated with high NIHSS scores in acute media 
infarction are involved in functions like language, visual attention and 
movement. We think that these areas are important for integrating several 
functions and therefore cause a dramatic clinical situation even when only a 
small volume of brain tissue is damaged.  
B-0927 11:27  
Clinical outcome after mechanical thrombectomy in diabetic patients with 
major ischaemic stroke of the anterior cerebral circulation  
J. Borggrefe1, B.K. Glück1, C. Kabbasch1, O. Onur1, N. Abdullayev1, V. Maus1, 
G.R. Fink1, A. Mpotsaris2; 1Cologne/DE, 2Aachen/DE 
(Jan.Borggrefe@uk-koeln.de)  
Purpose: Diabetic patients (DP) with acute ischaemic stroke (AIS) show a 
poorer outcome than non-diabetic patients (NDP). This study provides a 
comprehensive analysis of factors associated with unfavourable outcome in 
DP receiving MT for AIS of the anterior circulation. 
Methods and Materials: This monocentric study includes 317 consecutive 
patients receiving MT for AIS in the terminal internal carotid artery and/or 
middle cerebral artery, including 46 DP. The study included pretreatment 
stroke CT with perfusion and collateral status, comprehensive treatment data, 
pre-existing comorbidities, laboratory parameters, and medication. 
Neurological status was assessed at baseline (NIHSS/mRS) and after 90 days 
(mRS 90). 
Results: Compared to NDP, DP showed a significantly poorer outcome 
(mRS90 >2) (p<0.05). Collateralization and infarct core size did not differ 
between groups while the penumbra was significantly smaller in DP than in 
NDP (p<0.05). The poorer mRS 90 outcome (mRS90 > 2) in DP was 
associated with poor collaterals (p=0.01) and hyperglycemia on admission 
(aHG) (p<0.05). Shorter time to recanalization (TTR) was associated with 
favourable mRS 90 in the NDP group (p<0.001) but not in DP (p=0.49). In 
univariate logistic regression, following parameters were significantly 
associated with mRS 90: diabetes, aHG, TTR, and the NIHSS (p<0.05 each). 
In multivariate analyses and partition regression models DP with admission 
hyperglycemia ( 132 mg/dl) and older age ( 66 years) showed a particularly 
poor outcome. 
Conclusion: The main factors for a less favourable outcome of DP after MT 
are admission hyperglycemia, age, NIHSS, and prolonged times to 
recanalization.  
B-0928 11:35  
MRI morphometry of the corpus callosum in patients with small vessel 
diseases of the brain  
D. Bazhenova, V.E. Sinitsyn, R.N. Konovalov; Moscow/RU 
(bazhenova.darya@gmail.com)  
Purpose: The purpose of this study was to compare the area of corpus 
callosum () segments in healthy subjects and patients with small vessel 
disease of the brain (SVDB) using MRI morphometry. 
Methods and Materials: Three groups of subjects (N = 109, 29-83 years, 42 
male) took part in the study: 1st group - hypertensive microangiopathy (n=73), 
2nd - cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) (n=9), 3rd - healthy volunteers (n=27). 
Subjects underwent MRI of the brain and neuropsychological assessment. The 
areas of  and each of 7 segments were calculated using the MultiVox 
software (Fig.1). 
Results: The areas of the 1st, the 6th, the 7th segments, and the total area of 
 in patients with hypertensive microangiopathy were significantly less than 
in the control group and CADASIL (p0.005). The severity of cognitive 
impairment of the examined individuals positively correlated with the area of 
the 1st, the 2nd segments and the total area of  (p0.05). The grade of the 
cerebrospinal space expansion correlated inversely with the areas of the 1st, 
the 2nd, and the 6th CC segments (p0.05). 
Conclusion: The study discovered differences in the area of the CC and some 
of its segments between studied groups. The severity of cognitive impairment 
correlated with a volume decrease in the anterior part of . The expansion of 
cerebrospinal space volume in patients with SVDB was associated with 
decrease of the grey and white matter volume, including . Morphometry of 
CC can be used as a biomarker of SVDB.  
B-0929 11:43  
The aspect of intracranial haemorrhage of cranial CT at the moment of 
admission is useful to predict the clinical and radiological evolution  
S. Bonilla, E. Pascual Goni; Barcelona/ES (santibonilla22@gmail.com)  
Purpose: To determine which neuroradiology signs were able to predict the 
growth (HG), the early neurological impairment and the functional prediction. 
Methods and Materials: Retrospective study of consecutive patients 
diagnosed with spontaneous intracraneal hemorrage [IHC] (2013-2016). The 
study includes the patients with craneal CT < 6 hours and exclution criteria. 
Two blind assessors analyzed the form, density, presence of intralesional 
hipodensities, swirl-sign, blend-sign & black hole in basal CT. Interobserver 
variability for each sign (Cohen’s kappa) was analyzed. Clinical and 
radiological variables associated to growth, DNP (decrease of the scale of 
Glasgow (GCS) of >1p and/or NIHSS 4p increase) and functional prediction 
at 3 months were evaluated through univariate and multivariate analysis. 
Results: 98 out of 313 patients fulfilled criteria. The irregular form frequency, 
heterogeneous density, presence of hipodensities, “swirl-sign”, “blend-sign” 
and “black hole” were 57%, 32%, 51%, 36%, 9% and 34% respectively. 
Interobserver concordancy was good for all of them (K>6). The growth was 
observed in 42% of cases. The growth was associated regardless the form and 
the presence of hopidensities. The DNP was associated regardless the GCS at 
the admission, the form and the swirl-sign. The functional prediction was 
associated regardless the form. 
Conclusion: The morphological characteristics of intracranial haemorrhage 
(IHC) in the craneal CT at the admission predict the risk of growth, the early 
neurological impairment and the functional prediction. The analysis of the form 
of the haemorrhage in our patients was the sign of the best predictive power of 
the clinical & radiological evolution.  
10:30 - 12:00 Room F1  
Oncologic Imaging  
SS 1016b  
Improvements in neuro-oncology imaging  
Moderators:  
L. Hermoye; Brussels/BE  
L. Jacobi-Postma; Maastricht/NL  
B-0930 10:30  
Whole tumour histogram analysis of T2-weighted, diffusion-weighted, 
and postcontrast T1-weighted images in medulloblastoma: assessment 
risk of recurrence  
Q. Lv; Zhengzhou/CN (478071645@qq.com)  
Purpose: To explore the value of MRI whole-tumour histogram in the risk 
assessment of medulloblastoma recurrence. 
Methods and Materials: Retrospective analysis of 32 patients which were 
pathologically confirmed medulloblastoma. These patients were divided into 
two groups, which were defined as the recurrent group and the non-recurrent 
group. Using the software Mazda, whole-tumour regions of interest were drawn 
on all slices of diffusion-weighted, T2-weighted, and postcontrast T1-weighted 
images to obtain histogram parameters, including the average value, variance, 
skewness, kurtosis, perc.01%, perc.10%, perc.50%, perc.90% and perc.99%. 
The histogram parameters were analysed statistically to find out the 
characteristics of the significant differences between the two groups. Next, we 
drew the ROC curve to assess diagnostic efficiency in medulloblastoma 
recurrence. 
Results: The variance, the kurtosis derived from precontrast T1-weighted 
images have the statistical significance (P<0.05). The variance showed the 
sensitivity and the specificity of the risk of medulloblastoma recurrence were 
81.36% and 60.0%, respectively; the kurtosis were 86.7% and 62.5%. The 
variance and the 99th percentiles derived from T2-weighted images have the 
statistical significance (P<0.05). The sensitivity and the specificity were 66.7%, 
87.2% and 66.7%, 76.5%, respectively. However, there is no difference of 
parameters between two groups in the ADC (P>0.5). 
Conclusion: MRI whole-tumour histogram analysis can be used as an 
important supplementary method to assess the risk of medulloblastoma 
recurrence. The variance derived from T2-weighted images has the potential to 
be the most significant parameter for assessing the risk of medulloblastoma 
recurrence.  
B-0932 10:38  
The role of diffusion weighted imaging for the differentiation of malignant 
and benign peripheral nerve sheath tumours  
L. Well1, K.I. Geier1, M. Kaul1, L. Späth1, T. Derlin2, J. Herrmann1, G. Adam1, 
J. Salamon1; 1Hamburg/DE, 2Hannover/DE (l.well@uke.de)  
Purpose: To evaluate the role of diffusion-weighted-imaging (DWI) for the 
differentiation of malignant and benign peripheral nerve sheath tumours 
(MPNST/BPNST) in patients with Neurifibromatosis 1 using intravoxel 
incoherent motion (IVIM) and standard apparent diffusion coefficient (ADC) 
models. 
Methods and Materials: Prospectively, n=26 patients with neurofibromatosis 1 
were subjected to magnetic resonance imaging; n=67 tumours (n=12 MPNST / 
n=55 BPNST). Imaging was performed at 3T, acquired sequences were T2w 
with and without fat-saturation, 3D-T1w and DWI. Eleven b-values (0-800 
s/mm²) were fitted with a biexponential model to extract perfusion fraction f, 
diffusion coefficient D and pseudo-diffusion coefficient D*. Additionally, the 
  






apparent diffusion coefficient (ADC) was calculated. ROIs were manually 
drawn in the center and periphery of tumours to determine signal intensities. 
Seven morphological features were selected for visual differentiation. Mann-
Whitney-U, Fisher’s exact test and receiver operating characteristic (ROC) 
analyses were performed. 
Results: Signal intensities of MPNST were significantly different from BPNST 
in IVIM (mean f: 21022 vs 13608 p=0.0028; mean D*: 971613 vs 1756326 
p<0.0001) and ADC (mean 1232182 vs 2108616; p<0.0001). Signal intensities 
between center and periphery of tumours were significantly different for the 
perfusion fraction in BPNST but not in MPNST (p=0.0171; all other p>0.05). 
ROC showed good levels of sensitivity and specificity for ADC and D* 
(Sensitivity vs specificity: ADC 91.67%vs98.18%, AUC 0.9833; D* 
91.67%vs90.91%, AUC 0.9318). Morphological features were applicable for 
identification of MPNST (all p<0.05). 
Conclusion: Diffusion weighted imaging allows identification of MPNST in 
patients with Neurofibromatosis 1 with high levels of sensitivity and specificity.  
B-0933 10:46  
Relaxation-compensated multi-pool CEST signal at 7T MRI of 
glioblastomas is dependent on the anatomic localisation  
C. Dreher1, J. Windschuh1, F. Sahm1, P. Bachert1, M. Ladd1, M. Zaiss2, 
H.-P. Schlemmer1, A. Radbruch1, D. Paech1; 1Heidelberg/DE, 2Tübingen/DE 
(c.dreher@dkfz-heidelberg.de)  
Purpose: To investigate the localization dependence of relaxation-
compensated multi-pool Chemical-Exchange-Saturation-Transfer (CEST) MRI 
at 7T and histopathological parameters in newly diagnosed untreated WHO IV° 
glioma patients. 
Methods and Materials: Twenty patients with newly diagnosed WHO IV° 
gliomas were prospectively included in this study and investigated at a 7T 
whole-body scanner (Siemens Healthcare, Erlangen, Germany). Mean CEST 
signal intensities (Nuclear-Overhauser-Effect(NOE), Amide-Proton-
Transfer(APT), Downfield_NOE-suppressed APT(DNS_APT)), ADC 
parameters and histopathological parameters of the tumor volumes were 
evaluated with regard to extension, localization (brain hemisphere and lobe) 
and contact to the subventricular zone using non-parametric Mann-Whitney 
tests, ANOVA on ranks test and Spearman correlation. 
Results: Mean CEST APT&DNS_APT signal intensities (0,156±0,118 & 
0,137±0,116) were significantly increased in right vs. left hemisphere 
glioblastomas (0,072±0,014 & 0,048±0,014), (p=0,044 and 0,010). Mean ADC 
parameter were significantly decreased in right vs. left hemisphere 
glioblastomas (1,04*10^7±0,08*10^7 vs. 1,18*10^7±0,12*10^7) (p=0,046). 
Mean CEST NOE signal intensity didn’t differ significantly between both 
hemispheres, but was significantly increased in case of subventricular zone 
contact (0,101±0,015 vs. 0,118±0,015) (p=0,037). The lobe localization and 
extension of the tumor had no significant effect on CEST and ADC signals. 
CEST APT&DNS_APT and ADC signal intensities did significantly correlate (-
0,67 and -0,56) (p<0,01), but not CEST NOE and ADC parameters. 
Histopathological parameters were not significantly different with regard to 
different localizations. 
Conclusion: Relaxation-compensated multi-pool CEST MRI signal depends 
on the anatomic localization. Amide CEST and ADC are positively correlating - 
NOE parameters are solemly different with regard to subventricular zone 
contact, possibly showing complementary information to Amide CEST and 
ADC.  
B-0934 10:54  
Metabolic imaging of tumours employing dynamic 17O MRI: initial results 
in glioma patients  
D. Paech, N. Behl, R. Umathum, M. Ladd, H.-P. Schlemmer, A. Nagel, 
S. Niesporek; Heidelberg/DE (d.paech@dkfz.de)  
Purpose: To investigate cerebral metabolic rate of oxygen consumption 
(CMRO2) in brain tumours employing dynamic 
17O magnetic resonance 
imaging (17O-MRI). 
Methods and Materials: In this ongoing IRB approved study one untreated 
glioma patient (male, 26 y.-o. astrocytoma WHO grade II) was included. 17O 
MRI was conducted at a 7 Tesla whole-body scanner (Siemens Healthcare, 
Erlangen, Germany) with a nominal spatial resolution of (7.5mm)3 employing a 
density-adapted radial sequence with Golden Angle acquisition scheme. 
3.8±0.1L of 70%-enriched 17O gas were administered using a remotely 
controllable closed circuit breathing system. High-resolution T1 MPRAGE 
(0.6mm)3 and T2 TSE (0.4x0.4x0.5mm)3 sequences were additionally acquired 
and used for tumour and normal brain segmentation. Post-procecessing of 17O-
MRI data was conducted with a partial volume correction algorithm to account 
for spilling-effects at low resolution. Signal intensities in the investigated 
volumes were compared using the Wilcoxon rank-sum tests. 
Results: 17O-MRI MRI revealed significantly decreased CMRO2 in tumour 
tissue (0.59-0.66±0.16 mol/g/min) compared to contralateral normal 
appearing brain tissue (1.10-1.22±0.08 mol/g/min) (p<0.01). Further, CMRO2 
was significantly increased in gray matter (2.34-2.58±0.20 mol/g/min) 
compared to white matter tissue (0.56-0.62±0.06 mol/g/min) (p<0.01). 
Conclusion: 17O-MRI may provide new insights into tumour metabolism 
through the localised quantification of the cerebral metabolic rate of oxygen 
consumption. Our results agree with the Warburg-effect describing decreased 
CMRO2 of tumours due to the shift in glucose metabolism from oxidative 
phosphorylation to lactate production for energy generation.  
B-0935 11:02  
Histogram analysis of apparent diffusion coefficient maps for 
distinguishing lateral ventricle central neurocytoma from ependymoma  
W. Wang, J. Cheng, Y. Zhang; Zhengzhou/CN (weijianwang520@163.com)  
Purpose: We explored the role of histogram analysis of apparent diffusion 
coefficient (ADC) maps for discriminating lateral ventricle central neurocytoma 
from ependymoma. 
Methods and Materials: We retrospectively evaluated findings in 35 patients 
with lateral ventricle central neurocytoma and 20 patients with ependymoma 
who underwent diffusion-weighted imaging (b = 0,800 s/mm(2) ) at 3T with 
acquisition of corresponding ADC maps. We derived histogram data from 
regions of interest drawn on all slices of the ADC maps in which tumor was 
visualized, including areas of necrosis and hemorrhage in the tumor. We used 
the t test to evaluate the capacity of histogram parameters (variance, 
kurtosis,1th,10th percentiles) to discriminate central neurocytoma from 
ependymoma and analyzed the receiver operating characteristic (ROC) curve 
to determine the optimum threshold value for each parameter and its 
corresponding sensitivity and specificity. 
Results: Lateral ventricle central neurocytoma demonstrated significantly 
lower variance, kurtosis,1th,10th percentiles than ependymoma(P < 0.05). 
ROC curve analysis of the variance yielded the best area under the ROC curve 
(AUC; 0.83), sensitivity of 80%, and specificity of 82%, with a cutoff value of 
2012. 
Conclusion: Histogram analysis of ADC maps might be helpful for 
discriminating lateral ventricle central neurocytoma from ependymoma.  
B-0936 11:10  
Nedd4-1 expression promotes tumour progession in gliomas and 
relationship between nedd4-1 expressions and DKI features in gliomas  
X. Cheng, J. Cheng; Zhengzhou/CN (chengxiaoyaz@163.com)  
Purpose: The aim of this study was to investigate whether Nedd4-1 is present 
in glioma and to evaluate the correlation of Nedd4-1 expression with the 
progression, prognosis and DKI manifestation of the disease. 
Methods and Materials: 60 patients with gliomas, who underwent 
preoperative DKI at 3 T after written informed consent. Normalized mean 
kurtosis (MKn) and mean diffusivity (MDn) metrics from DKI were assessed in 
these patients. Immunohistochemistry and western blot were used to 
investigate the expression of Nedd4-1 protein in these patients. 
Results: Immunohistochemistry levels and western blotting analysis 
discovered that the expression of Nedd4-1 was increased with WHO 
grade(P<0.05). In addition,a non-parametric analysis revealed that the 
attenuated Nedd4-1 expression was significantly correlated with a large tumour 
diameter (P<0.05),frequent intra-tumour necrosis (P<0.05),and that high 
expression of Nedd4-1 is closely consistent with poor prognosis of glioma. 
MKn was significantly higher(but MDn decreased) in higher glioblastoma(0.56 
± 0.11) than in primary glioblastoma (0.38 ± 0.10, p < 0.05). Significant 
correlations were found between nedd4-1 and MKn (r = 0.623, P < 0.001); as 
well as for MDn (r=-0.418, P < 0.05). In contrast, FA had no obvious correlation 
with nedd4-1 (r = 0.065, P = 0.603). 
Conclusion: Our results provide convincing evidence that the expression of 
Nedd4-1 is up-regulated in human gliomas. The glioma patients with higher 
Nedd4-1 expression have a worse prognosis. Considering the diagnostic and 
prognostic significance of these molecular markers, MK appears to be a 
promising in vivo biomarker for glioma.  
B-0937 11:18  
Visually AcceSAble Rembrandt Image (VASARI) assessment features 
predict GBM recurrence patterns  
D. Xuesong, W. Zhang; Chongqing/CN (duxs1966@126.com)  
Purpose: To estimate Visually AcceSAble Rembrandt Image 
(VASARI)assessment features in predicting GBM recurrence patterns. 
Methods and Materials: Sixty-five patients who suffered from GBM 
recurrence were included. Pre-surgery MRI and survival data were collected 
retrospectively. Semantic features were extracted using the VASARI feature-
set criteria by three experienced neuro-radiologists independently. Recurrence 
patterns defined as “local” and “distant” with enhanced T1WI at the time 
recurrence was proven. Survival analysis was done using the Kaplan-Meier 
analysis. 
Results: Patients' recurrence was proven either by pathology or by the RANO 
criteria. Patient number of “local” was 49 (71.1%), while “distant” was 16 
  






(28.9%). Clinical data such as age, Ki-67 and KPS showed no significant 
differences in the two groups. Semantic feature based on VASARI set 
indicated that tumour necrosis (F7), definition of the non-enhancing (F13), 
cortical involvement (F20), extent of resection of enhancing tumour (F26) and 
extent resection of nCET (F27) showed significant difference in unique 
recurrence patterns. Results revealed PFS was much longer when tumour 
necrosis ratio was low and patients suffered cortical involvement survived a 
shorter PFS and so it did in F26 and F27 subgroups. 
Conclusion: VASARI features could predict GBM recurrence patterns and 
these features were associated with patients’ PFS.  
B-0938 11:26  
Using multiple linear regression to investigate IDH1 gene mutation in 
glioma by joint application of DCE-MRI and DSC-MRI  
W. Xu1, J. Wen2, Y. Li2; 1Shanghai, SH /CN, 2Shanghai/CN 
(xuweixingzi@163.com)  
Purpose: To explore whether quantitative analysis of DCE-MRI and DSC-MRI 
could detect IDH1 gene status in glioma. 
Methods and Materials: Patients (Dec. 2014-Oct. 2016 ) underwent DCE-MRI 
and DSC-MRI. The associations between each parameters and IDH1 gene 
status were analyzed by independent sample t test. The effective parameters 
were analyzed by multiple linear regression to calculate the prediction 
accuracy (PA). 
Results: 57 LGG (43 IDH1 mutation type vs 14 IDH1 wild type) and 71 HGG 
cases (12 IDH1 mutation type vs 43 IDH1 wild type) underwent DCE-MRI. 56 
LGG (45 IDH1 mutant type vs 11 IDH1 wild type) and 74 HGG cases (14 IDH1 
mutant type vs 60 IDH1 wild type) had DSC-MRI. 120 patients took both 
scanning. All cases were pathologically confirmed. In LGG group, the Kep, 
Ktrans, TTP, Ve, rCBV, rCBF had statistical difference between IDH1 mutant and 
wild type (P<0.05). AUC was 0.945, 0.904, 0.934, 0.827, 0.818 and 0.79, 
respectively. Combined rCBV, Kep and K
trans obtained PA as high as 96.4%, 
OR= 9.22. Model: y=19.11-0.89 rCBV - 60.6 Kep + 11.22 K
tran . The Kep, K
trans, 
Ve, MAXSlope, AUC, rCBV and rCBF had significant associations with IDH1 
status in HGG (P<0.05). AUC was 0.838, 0.816, 0.827, 0.832, 0.862, 0.826 
and 0.774, respectively. Combined rCBV, Kep and K
trans obtained 90.5% IDH1 
PA, OR=42.34. Model: y=2.44-0.43 rCBV - 5.05 Kep - 4.93 K
trans. 
Conclusion: Combined use of DCE-MRI and DSC-MRI could benefit the 
judgement of IDH1 gene mutation in glioma.  
B-0939 11:34  
Evaluation of the apparent diffusion coefficient in patients with recurrent 
glioblastoma under treatment with bevacizumab with radiographic 
pseudoresponse  
T.A. Auer, F. Marini, M. Renovanz, M.A. Brockmann, Y. Tanyildizi; Mainz/DE  
Purpose: Response assessment in neuro-oncology criteria (RANO) are used 
to assess response to first-line treatment of glioblastoma (GBM). Differentiation 
between response and pseudoresponse under treatment with bevacizumab 
(BVZ) remains challenging. This study evaluates ADC changes in patients with 
radiographic pseudoresponse under treatment with (BVZ). 
Methods and Materials: Patients (n=40) with recurrent GBM under treatment 
with BVZ underwent MRI before, two and four months after treatment with 
BVZ. In patients with radiological pseudoresponse (n=11), ADC analyses were 
performed. Areas with T1 contrast enhancement (CE) decrease and FLAIR 
signal decrease were manually selected and compared with size and position-
matched healthy contralateral brain parenchyma. 
Results: Histogram-based ADC (10-6 x mm2/s) of these patients decreased 
significantly (p < 0.005) from baseline MRI (T1-CE, FLAIR: 1124.9±160.3, 
1098.4±226.2, respectively) to 2 months (781.3±110.7, 783.3±103.3) and 
remained stable during 4 months (777.0±138.5, 784.4±155.4, all mean±SD), 
despite progressive disease. Mean ADC values of the healthy contralateral 
brain tissue remained stable (p > 0.05) (ADC values: baseline: 786.2±110.7, 2 
months: 781.1±76.2, 4 months: 804.1±86.2). 
Conclusion: Treatment of GBM with BVZ leads to a decrease of ADC values 
in areas of pre-treatment T1-CE/FLAIR signal hyperintensity to levels of 
comparable with normal brain tissue. ADC values remained normal, even when 
progressive tumour growth was reported.  
B-0940 11:42  
The predictive capacity of DWI vs perfusion imaging in response 
assessment of brain metastases following stereotactic radiosurgery  
P. Arcuri1, S. Roccia1, G. Fodero1, R. Mole'1, A. Destito1, C. Bertucci2, D. 
Lagana'1; 1Catanzaro/IT, 2London/UK (arppaolo@alice.it)  
Purpose: The purpose of this study was to compare the predictive capacity of 
the apparent diffusion coefficient (ADC) with perfusion imaging distinguishing 
tumour recurrence or progression from treatment effects in brain metastasis, 
following stereotactic radiosurgery (SRS). 
Methods and Materials: We retrospectively reviewed 32 brain metastases 
from 24 patients treated with SRS (3x10 Gy), imaged at baseline, one month 
and three months post-treatment using DWI and perfusion imaging. At one 
year post-treatment or last available follow-up MRI, volume criteria determined 
final tumour response status. Gd-DTPA was injected intravenously at a rate of 
4 mL/s . To assess differences in tumour blood volume during radiotherapy 
and among patients, all CBV maps were normalized to CBV values in the 
contralateral NAWM (rCBV). Youden’s index test was used for statistical 
analysis to define optimal thresholds that distinguished responders from non-
responders as well as sensitivity and specificity. 
Results: Sensitivity of an increase in the ADC ratio to make an early (1 month) 
prediction of tumour control was 81.7% and specificity was 86.5%. When using 
rADC values of metastases measured in the follow-up of 3 months, sensitivity 
and specificity were 83.5 and 70.7%, respectively. Progressive lesions showed 
a significant reduction in rCBV values at the 1-month follow-up with a 
sensitivity and specificity of 85.3% and 80.0%. At the 3-month follow-up, 
sensitivity and specificity were 83.5 and 70.7%, respectively. 
Conclusion: An increased rADC values and a significant reduction in rCBV 
values at the 1-month follow-up are indicators of good tumour control, and 
reflect the beneficial effect of SRS.  
10:30 - 12:00 Room F2  
Emergency Imaging  
SS 1017  
Non-traumatic emergencies  
Moderators:  
R.M.M. Hinzpeter; Zurich/CH  
D.J.M. Tolan; Leeds/UK  
K-18 10:30  
Keynote lecture  
D.R. Kool; Amsterdam/NL  
B-0941 10:39  
Simulation-based training for radiology professionals in the management 
of acute emergencies following contrast media reactions  
R. Taoussi, Z. Qechchar, M. Fehdi, M. Mouhaoui, N. Touil, O. Kacimi, 
N. Chikhaoui, G. Lembarki; Casablanca/MA  
Purpose: The purpose of our study was to assess the effectiveness of 
simulation-based medical education in the management of radiological 
emergencies among Radiologists and technicians and to compare this 
teaching method to the traditional theoritical clinical education. 
Methods and Materials: Our study was a prospective, observational, single-
centered study including the radiologist and technicians of Casablanca Ibn 
Rochd University Hospital including Professors in Radiology. The study 
undertaken in five phases: First a pre-test followed by a theoritical and practical 
training on emergencies following the administration of iodinating contrast 
medias, then the students were separated in two groups, one undergoing the 
medical simulation training and one that doesn't, and then a post-test 
concerning the two groups. 
Results: 40 professionals were enrolled in the study: 20 (Group 1) benefited 
from the medical simulation and 20 (Group 2) who didn't. The pre-test results 
were comparable between the two groups (6,05/20 ± 2,68 for groupe 1 versus 
5,88/20 ± 2,52 for group 2). The post test results were better for group 1 
(18,83/20 ± 1,27 versus 17,13/20 ± 2,01 for group 2, p<0,0001). The average 
satisfaction rate was 8,79/10 ± 2,17. The results of the satisfaction survey were 
in favor of the effectiveness of simulation-base medical teaching in the 
improvement of the theoritical knowlede (100%) as well as the medical 
reasoning when faced with a Radiological emercency (100%). 
Conclusion: This study emphasis the benefit of simulation-based medical 
teaching and learning as an innovating teaching tool in front of Radiology 
emergencies.  
B-0942 10:47  
Clinical impact of iterative model reconstruction algorithm in a 
department of emergency radiology in a large series of patients  
A. Pecorelli1, D. Ippolito1, A. de Vito1, S. Lombardi1, L. Riva2, 
C. Talei Franzesi1, S. Sironi3; 1Monza/IT, 2Missaglia/IT, 3Bergamo/IT 
(pecorelli.anna@gmail.com)  
Purpose: To compare the radiation dose exposure of low dose Computed 
Tomography (CT) examinations using iterative model reconstruction (IMR) 
algorithm with standard CT equipment in an Emergency Radiology Department 
(ERD), with trauma center. 
Methods and Materials: We reviewed more than 7000 CT scan examinations 
performed wit new 256row CT scan (iCT Elite, Phlips) combined with new IMR 
algorithm, in several anatomical district (i.e.: brain, thorax, abdomen and whole 
body) in patients referred to our ERD with different clinical emergency settings 
  






(trauma, embolism, vascular disease). For each exam we analyzed the CT 
dose index (CTDI, expressed in mGray) and the dose length product (DLP, 
expressed in mGray.cm) and compared with dose of our previously CT scan 
equipment. 
Results: The means values of CTDI were lower with IMR compared with our 
previous CT equipment: brain 59.3 vs 42.4 (-29%), thorax 8.8 vs 5.6 (-36%), 
abdomen 17.7 vs 6.3 (-64%) and whole body 16.8 vs 12.4 (-26%).In the same 
way the totals DLP were lower with IMR compared with standard CT: brain 
949.2 vs 794.7 (-17%), thorax 324.3 vs 242.5 (-25%), abdomen 911.0 vs 361.5 
(-60%) and whole body 1118.0 vs 893.0 (-20%). 
Conclusion: The radiation dose can be significantly reduced using LDCT with 
IMR algorithm instead standard CECT for the diagnostic evaluation of patients 
admitted in an ERD.  
B-0943 10:55  
Age dependency of the Wells Score for pulmonary embolism  
S. Nagel, I. Steffen, T. Elgeti; Berlin/DE (sebastian.nagel@charite.de)  
Purpose: To evaluate a possible age dependency of the classic Wells Score 
(WS) in patients with suspected pulmonary embolism (PE). 
Methods and Materials: 1000 consecutive patients from our emergency 
department were included into this IRB approved retrospective study. WSs 
were re-calculated from electronic patient records. CT-pulmonary angiography 
(CTPA) served as standard of reference for the diagnosis of PE. Logistic 
regression models and receiver operating characteristic (ROC) curves were 
used to analyze the effect of patient age, D-Dimer, WS and INR on PE. Best 
cut-off values in ROC analyses were determined using Youden-Index. 
Results: Pulmonary embolism was present in 25.6% of cases. Univariate ROC 
analysis showed a significant effect of D-Dimer (AUC=0.8; p<0.001) and WS 
(AUC=0.78, p<0.001) . The multivariate logistic regression model showed a 
significant association of PE with D-Dimer (p<0.001), WS (p<0.001) and INR 
(p<0.05) whereas patient age showed a tendency to significance (p=0.070). A 
significant interaction was observed for WS and patient age (p=0.006). ROC 
analysis of the multivariate logistic regression model predictor revealed an 
AUC of 0.84 (p<0.001) with a sensitivity of 79.4% and a specificity of 73.5% for 
the best cut-off value. 
Conclusion: The results of this exploratory study show a significant interaction 
of the patients’ age and the Wells Score for the diagnosis of PE. This may 
indicate the use of age dependent cut-off values for WS to undertake CTPA.  
B-0944 11:03  
Ruling out acute kidney injury (AKI) with “admission” reno-caval 
ultrasound (ARCUS) examination  
N. Attempati, A. Contegiacomo, E. Amodeo, M. Barone, A. Cina, R. Manfredi; 
Rome/IT (nicoatt89@gmail.com)  
Purpose: Acute Kidney Injury (AKI) requires fast and effective diagnostic 
workup, but no tools are available for ruling out all possible aetiologies (pre-
renal/renal/post-renal) at one time. This study aims to evaluate whether 
examination of Inferior Cava Vein (IVC) collapsibility (hydration index) and 
hydronephrosis (obstruction index), with the integration of doppler Resistivity 
Index (RI), as first diagnostic tool (ARCUS), allows AKI aetiology identification. 
Methods and Materials: from January 2016 to July 2017, ARCUS 
examination was prospectively performed on 30 patients with sudden oligo-
anuria or estimated Glomerular Filtration Rate (eGFR) reduction. Maximal 
inspiration IVC collapse >50% was considered suggestive of pre-renal AKI and 
presence of hydronephrosis suggestive of post-renal AKI; in all the other cases 
RI >0.70 was considered diagnostic for renal AKI. ARCUS examination 
outcome was compared with final medical diagnosis to assess tool specificity 
and sensitivity. 
Results: 17/30 patients had IVC collapse >50%, with 85,7% specificity and 
93,7% sensitivity for pre-renal AKI; hydronephrosis was observed in 10/30 
patients, with a 100% specificity and sensitivity for post-renal AKI. In 3/30 
patients RI evaluation was performed: 2 patients had RI >0.70 and 1 <0.70 
(pre-renal AKI), with a sensitivity and specificity of 50% and 100% respectively 
for Renal AKI. 
Conclusion: our pilot study suggests that ARCUS examination is a very good 
tool for AKI initial and rapid evaluation, with excellent specificity and good 
sensitivity.  
B-0945 11:11  
When ultrasound is not enough: predicting downstream utilisation of CT 
after ultrasound in patients with acute abdomen  
K. Rippel, D. Ordu, L.-P. Rollandi, T. Kleffel, C. Scheurig-Muenkler, T. Kröncke, 
F. Schwarz; Augsburg/DE (Katharina.Rippel@klinikum-augsburg.de)  
Purpose: To analyse whether markers of systemic inflammation predict the 
utilisation of additional CT after ultrasound in ED patients presenting with acute 
abdominal pain. 
Methods and Materials: We analyzed 506 patients who presented to the ED 
over a three-month period with acute abdominal pain and were referred for an 
ultrasound examination of the abdomen. We analysed electronic health 
records for prior medical history and laboratory tests of systemic inflammation 
(WBCC and CRP) at the time of presentation. Furthermore, all abdominal CT 
scans performed within a 36-hour window following the ultrasound exam were 
registered. Receiver-Operating-Characteristic(ROC) statistics were used to 
analyse the predictive value of CRP and WBCC for additional utilisation of CT. 
We performed subgroup analyses for patients without recent hospital 
admission and with known malignancy. 
Results: 71 patients were excluded due to various reasons. Of the remaining 
435 patients, 65(15%) underwent additional abdominal CT. Differences in 
WBCC and CRP between patients who underwent CT vs. those who did not 
were highly significant (WBCC: 12.4 [9.2;17.6] vs. 9.6 [7.5;12.9]; CRP: 8.2 
[0.93;20.4] vs. 1.1 [0.28;6.0], both p’s<0.01). On ROC analysis, WBCC and 
CRP had similar moderate predictive values for subsequent utilisation of 
additional CT (AUC:0.69±0.04 vs. 0.66±0.04,p=0.66). Predictive values were 
highest in the subgroup of patients without hospital admission in the preceding 
12 months (AUC:0.89± 0.06 vs. 0.75±0.05, p=0.06). 
Conclusion: Across all patients presenting with acute abdomen, CRP and 
WBCC has moderate predictive value for subsequent CT utilisation after 
ultrasound. However, in patients without recent hospital admission, predictive 
value is excellent.  
B-0946 11:19  
How accurate are we and how can we get better in diagnosing acute 
appendicitis by unenhanced multidetector computed tomography: a large 
meta-analysis and literature review  
A. Mishra, R. AlSaady, S. Patel, S.A. Mahemood, T.S. Abdulla, 
A.A.W. Hussain; Doha/QA (dranujmish@yahoo.com)  
Purpose: To analyse CT criteria and determine best CT parameter(s) for 
diagnosing acute appendicitis. 
Methods and Materials: Retrospective analysis of patients diagnosed with 
acute appendicitis was done. 800 patients underwent unenhanced abdominal 
CT(UACT) within 24-48 hours of onset of acute pain, were analysed (male 563 
(70.4%); female 237 (29.6%); mean age 36 years; range 5-86 years). UACT 
assessment of appendix was based on: appendix diameter, periappendiceal 
inflammatory fat-stranding (PIFS), fluid collection, free air and appendicolith. 
Results: Appendiceal diameter correlated to the inflammation of the appendix 
(p=0.001) with sensitivity (Sn)=94.4%, specificity (Sp)=90.3%, negative 
predictive value (NPV)=93.2% and positive predictive value (PPV)=91.6%. 767 
(95.9%) patients had appendiceal diameter >7 mm, of which 43(5.6%) did not 
have histopathological diagnosis of acute appendicitis. The patients with acute 
appendicitis had a mean appendiceal diameter of 8.5 mm (range 6-16; SD 2.7) 
whereas patients with normal appendix had mean appendix diameter of 4.1 
mm (range 2-6; SD 0.8). There was correlation between CT criteria for 
presence of PIFS, fluid, appendicolith and inflammation of the appendix 
(p=0.01). In patients with normal appendix, mild-to-moderate PIFS was noted 
in 16 (48.5%) and severe PIFS in 10 (30.3%) patients. In patients with acute 
appendicitis, PIFS was observed in 682 (85.3%) patients with Sn=96.2%, 
Sp=87.4%, NPV=92.8% and PPV=89.6%. None of the patients with normal 
appendix had appendicolith whereas 309 (38.6%) with acute appendicitis 
demonstrated appendicolith with Sn=96.1%, Sp=78.2%, NPV=76.7%, 
PPV=74.3%. 17(2.1%) had periappendiceal fluid. 6(0.8%) had extraluminal air 
around the appendix out of which 1 (5.9%) did not have histopathological 
perforation. Combining appendiceal diameter and PIFS yielded Sn=98.4%, 
Sp=99.8%, NPV=94.5% and PPV=99.2%. 
Conclusion: Appendiceal diameter > 7 mm and PIFS have high sensitivity but 
relatively lower specificity individually, but when combined together has almost 
100% specificity with 99.2% positive predictive value.  
B-0947 11:27  
Comparing diagnostic performance of ultra-low-dose CT compared to 
abdominal plain films  
J. Lee1, S. Bruni1, S. Kennedy1, V. Swami1, E. Chen1, R. Menezes1, 
D. Borrego2, C. Lee2, P. Rogalla1; 1Toronto, ON/CA, 2Rockville, MD/US 
(ljhjohn.lee@mail.utoronto.ca)  
Purpose: To determine relative diagnostic performance of ultra-low-dose CT 
(ULD-CT) and abdominal plain films (APF) with regard to sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value (NPV) in the 
emergency setting. 
Methods and Materials: As per new institutional protocol, all patients with 
acute abdominal pain who would be referred to APF were automatically 
converted to ULD-CT. Target exposure values were set to achieve 1 mSv 
equivalent exposure to a standard 75 kg individual. Our study examined 196 
consecutive ULD-CT ordered since initiation of the new protocol and 196 
consecutive APF from the emergency department prior to inception of new 
protocol over a period of 9 weeks. Final diagnosis was compared to the gold 
standard diagnosis comprising of lab values, clinical notes, additional imaging 
tests, endoscopy, and surgery. Each patient was followed up for a minimum of 
one month. 
  






Results: There were no statistical difference between age (63.3 vs 60.8, 
p=0.5) and gender (49% vs 51% male, p=0.7) between ULD-CT and APF 
groups. When comparing ULD-CT to APF, sensitivity (0.86 vs 0.40, p<0.01), 
specificity (0.98 vs 0.81, p=0.02), PPV (0.94 vs 0.50, p<0.01) and NPV (0.92 
vs 0.74, p=0.02) were higher for ULD-CT. 
Conclusion: ULD-CT has statistically higher sensitivity, specificity, PPV and 
NPV compared to APF. ULD-CT has the potential to replace APF by delivering 
significantly better diagnostic information despite a radiation dose profile 
comparable with conventional APF. This is the largest study to date comparing 
the diagnostic performance of ULD-CT compared to APF.  
B-0948 11:35  
CT signs of bowel necrosis in CL-SBO  
C. Rondenet1, I. Millet2, L. Corno1, I. Boulay Coletta1, P. Taourel2, M. Zins1; 
1
Paris/FR, 2Montpellier/FR  
Purpose: To identify computed tomography (CT) findings associated with 
bowel necrosis in patients with surgically confirmed strangulating closed-loop 
small-bowel obstruction (CL-SBO) due to adhesions or internal hernia. 
Methods and Materials: This retrospective study was approved by our 
institutional review board and informed consent was waived. To identify 
specific signs of bowel necrosis, two gastrointestinal radiologists performed 
blinded, independent, retrospective reviews of 41 CT studies from consecutive 
patients who had CL-SBO due to adhesions or internal hernias and who 
underwent surgery within 48 h. Based on surgical and pathological findings, 
patients were classified as having reversible ischaemia or histologically 
documented necrosis. Univariate statistical analyses were performed to assess 
associations between CT signs and bowel necrosis. K statistics were 
computed to assess interobserver agreement. 
Results: We included 25 (61%) women and 16 (39%) men with a median age 
of 79 years. Bowel necrosis was found in 25/41 (61%) patients and ischaemic 
but viable bowel in 16/41 (39%) patients. Increased unenhanced bowel-wall 
attenuation was the only CT finding significantly associated with bowel 
necrosis (P=0.0002). This sign had 58% (95%CI, 37-78) sensitivity and 100% 
(95% CI, 79-100) specificity for necrosis. Interobserver agreement was fair 
(0.59; 95%CI, 0.37-0.82). 
Conclusion: Increased unenhanced bowel-wall attenuation is specific of bowel 
necrosis and should lead to prompt laparotomy for bowel resection.  
B-0949 11:43  
Contribution of ultra low-dose CT in extremities trauma  
F. Snene, T. Addala, J. Greffier, P. Viala, J.P. Beregi, A. Larbi; Nîmes/FR 
(snenefehmi@gmail.com)  
Purpose: To evaluate the diagnostic power of ultra-low-dose CT (ULD-CT) of 
the extremities (wirst/hand or ankle/foot) compared to the X-ray in emergency 
room. 
Methods and Materials: An ULD acquisition without contrast medium injection 
as well as an X-ray of the injured extremitie were performed in 76 patients 
consulting the emergency department of our institution from March to August 
2017.Raw data were reconstructed with Sinogram-Affirmed-Iterative-
Reconstruction (SAFIRE, Siemens) with soft tissue (I30f) and bone (I70f) 
reconstructions kernel. The subjective analysis (image quality, diagnostic 
quality, characterization of the lesions with confidence level) was performed by 
double blind reading (1 senior and 1 junior radiologist). The diagnostic 
performance of the ULD-CT and X-ray were compared. 
Results: Effective dose for ULD-CT were lower than the recommandations of 
the IRSN 2012(National Institute for Radiation Protection and Nuclear 
Safety).Kappa Cohen test agreement among the two observers for the 
evaluation of traumatic lesions was substantial, ranging from 0.8 to 0.95.The 
analysis of data showed the absence of inferiority of the ULD-CT in the 
detection of traumatic lesions comparatively to the X-ray. The ULD-CT showed 
its superiority in the characterization of associated anomalies (p<0.05)Readers 
recorded a significantly high score of diagnostic confidence level for ULD-CT 
compared to X-ray (p<0.05) 
Conclusion: ULD-CT with iterative reconstructions allowed a reliable study of 
extremities trauma patients with an equivalent or lower irradiation dose than 
plain X-ray.Reproducibility is independent of the level of experience of the 
readers.  
B-0950 11:51  
Diagnostic performance of quiescent interval single-shot (QISS) non-
contrast MRA at 3 Tesla for the diagnosis of acute lower limb ischaemia  
Y. Ragab1, A. Al Marakby1, H.M. Hamza2, A. Hasanin1; 1Cairo/EG, 2London/UK 
(yragab61@hotmail.com)  
Purpose: To assess the diagnostic performance and limitations of ECG-gated 
non-contrast-enhanced quiescent interval single-shot (QISS) magnetic 
resonance angiography at a magnetic field strength of 3 Tesla in patients with 
acute peripheral arterial occlusive disease (PAOD).  
Methods and Materials: 29 patients with manifestations of acute lower limb 
ischaemia, referred for lower limb gadolinium-based contrast enhanced 
magnetic resonance angiography (MRA) were included. Imaging was 
performed on a 3T whole-body MR. Non-contrast MRA series using QISS 
technique were initially performed. Image quality and stenoses diameters were 
compared to contrast-enhanced MRA (CE-MRA) as standard of reference. Two 
blinded readers rated the image quality and the degree of stenosis for both 
ECG-gated QISS and CE-MRA in 26 predefined arterial vessel segments on 5-
point Likert scales. 
Results: Compared with CE-MRA, QISS MRA technique showed high 
sensitivity (93%), specificity (95%), positive (95.1%), and negative predictive 
value (96%) for the detection of significant (50%) stenosis or occlusion. 
Interreader agreement for stenosis and occlusion assessment of both QISS 
and CE-MRA was excellent (-values of 0.94 and 0.95, respectively). As 
compared to CR-MRA, image quality of QISS was significantly lower for the 
distal aorta, the femoral and iliac arteries (each with p<0.01), while no 
significant difference was found in the popliteal (p=0.07) and lower leg arteries 
(p=0.9). 
Conclusion: Non-contrast QISS MRA has been shown to be technically 
comparable to CE-MRA in the assessment of femoropoliteal and leg arteries; 
however, it has limitations during evaluation of the lower aorta and iliac 
arteries.  
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B-0951 10:30  
Inferior glenohumeral vertical distance: a novel radiographic marker 
better suited for detection of rotator cuff tears involving the infraspinatus 
tendon  
M. Alfaqih, S. Soni, S. Flacke, Y. Andrabi, D. Elentuck, R. French; 
Burlington, MA/US (mohammad.alfaqih@lahey.org)  
Purpose: Evaluate the association between the radiographically determined 
inferior glenohumeral vertical distance (IGHVD) and rotator cuff tears (RCT) 
involving infraspinatus (IS) tendon and compare the sensitivity and specificity 
of acromiohumeral distance (AHD) and IGHVD for RCT involving IS tendon. 
Methods and Materials: 140 patients with MRI proven full thickness rotator 
cuff tear were included after they met the inclusion and exclusion criteria. 
Patients were divided into two groups, group A: RCT involving full or partial IS 
tears, and group B: RCT not involving IS. Radiographs were analysed blinded 
to MRI findings. IGHVD determined by measuring vertical distance from 
anatomical neck to inferior glenoid level in anteroposterior (AP) view; distance 
of more than 2mm was considered positive. AHD was assessed by measuring 
vertical interval between inferior border of acromion process and humeral head 
in (AP) view; distance less than 7 mm was considered positive. 
Results: Group A included 89 patients and Group B involved 51 patients. A 
strong association was found between IGHVD and rotator cuff tears involving 
infraspinatus tendon (p < 0.001). IGHVD was found to have increased 
sensitivity, PPV and NPV (66%, 92%, 60%, respectively) compared to AHD 
(20%, 85%, 40%, respectively). The specificity of both was comparable (90% 
for IGHVD and 94% for AHD). 
Conclusion: There is a strong association between radiographically 
determined IGHVD and infraspinatus tear and is more sensitive than AHD.  
Author Disclosures: 
 S. Flacke: Consultant; BTG International Ltd, Surefire Medical, Inc, 
Koninklijke Philips BV, XACT Robotics.  
B-0952 10:38  
Imaging of aponeurotic expansion of supraspinatus tendon by 3.0 T MRI 
and its association with biceps brachii long head, supraspinatus and 
subscapularis tendon pathologies  
Z. Akkaya, H. Bas, D. Oztuna, G. sahin; Ankara/TR (zehraakkaya@gmail.com)  
Purpose: The purpose of this study was to identify the prevalence of the 
aponeurotic expansion of the supraspinatus tendon (SSa) by 3.0 T MRI and to 
search for possible associations with the pathologies of the supraspinatus 
(SS), biceps brachii long head (BB) and subscapularis (Sub) tendons. 
Methods and Materials: A total of 154 patients and 157 shoulders (3 cases 
with bilateral examinations) between the ages of 18 and 45 years, examined by 
3.0 T scanner between July 2011 and March 2017, were re-examined for the 
presence of SSa. When present, it was further categorised according to its 
  






size. The exclusion criteria were history of shoulder trauma, surgery, deformity, 
inflammatory arthropathy, end-stage rotator cuff disease, major systemic 
illness, and technically inadequate imaging. The pathologies of BB, SS and 
Sub tendons were evaluated separately and using Mann- Whitney U and 
Kruskall- Wallis tests tendon pathologies were compared to SSa types 
Results: A total of 82 male and 72 female cases with a mean age of 34 (±8.2) 
were included. There were 126 cases (80.3%) without a visible SSa and the 
incidence of BB pathologies in this group was significantly lower than the other 
types where a visible SSa was noted (p<0.05). No significant correlations were 
found between pathologies of SS and Sub and SSa types. For pathologies of 
all three tendons, age was found to be a significant variable (p<0.01). 
Conclusion: BB tendon pathologies were significantly more common in cases 
with SSa which might indicate a risk factor on its own.  
B-0953 10:46  
Reliability of strain elastography in the supraspinatus tendon  
K. Brage; Odense M/DK (kabr2@ucl.dk)  
Purpose: Sonoelastography (SEL) is used to measure tissue elasticity, and 
individual studies show good reliability; however, this study investigates the 
reliability of SEL, when used in the supraspinatus tendon. The aim of this study 
was to test the intra-examiner reliability of a novel SEL protocol for 
supraspinatus tendon elasticity in participants with supraspinatus tendinosis 
diagnosed with MRI and in asymptomatic participants. 
Methods and Materials: Ten participants with no shoulder complaints and 10 
participants with supraspinatus tendinosis were examined independently by the 
project leader (KB). GE LOGIQ S7 fitted with a quasi-static strain imaging 
software was used to create elastograms as ratios between the supraspinatus 
tendon and reference regions of muscle (deltoid), and a gel pad, respectively. 
Elastograms were also evaluated qualitatively according to the structure 
(homogeneous, relatively homogenous, and heterogeneous), the colour (blue, 
blue with 1-25% green, blue with 26-50% green, green with 1-25% blue, and 
green), and the number of lesions was counted. 
Results: The intra-class correlation (ICC 2.3) of measurements with the 
reference of muscle was excellent 0.92 (95%CI: 0.80-0.97), as well as for the 
gel pad 0.87 (95%CI: 0.67-0.95) and number of lesions 0.98 (95%CI: 0.96-
0.99). Moderate kappa (k) was found for estimation of colour (k = 0.58) and 
structure (k = 0.60). 
Conclusion: Intra-rater reliability was moderate to excellent when a 
standardized procedure was applied for measuring tissue stiffness in the 
supraspinatus tendon. Future studies should test inter-rater reliability in 
addition to validation against conventional ultrasound and MRI.  
B-0954 10:54  
Evaluation of tendinopathy of the long head of the biceps tendon by 
strain and shear wave elastography  
M.H. Sahan, M. Inal, V. Burulday, T. Kultur; Kirikkale/TR 
(vedoctor@hotmail.com)  
Purpose: The purpose of this study was to investigate strain (SE) and shear 
wave elastography (SWE) characteristics of the long head of the biceps tendon 
(LHBT) tendinopathies in comparison with magnetic resonance imaging (MRI). 
Methods and Materials: Twenty patients with a diagnosis of tendinopathy and 
twenty healthy subjects with a normal LHBT in MRI were enrolled. A total of 40 
shoulders were examined prospectively by SE and SWE. LHBT SE color 
mapping was divided into four types in accordance with elasticity designs: type 
I predominantly blue (hardest tissue), type II predominantly blue-green (hard 
tissue), type III predominantly green (intermediate tissue), type IV 
predominantly green-yellow-red (soft tissue). Quantitative measurements of 
LHBT hardness with SWE were analyzed in kilopascals (kPa). 
Results: SE images from the tendinopathy group: transverse: type I (24%), 
type II (50%), type III (25%): longitudinal: type I (15%), type II (75%), type III 
(10%); control group images: transverse: type II (10%), type III (55%), type IV 
(35%), longitudinal: type II (10%), type III (55%), type IV (35%). SWE values: 
transverse: 38.32±7.2 kPa, 18.6±3.1 kPa and longitudinal: 39.42±7.4 kPa, 
20.62±4.6. There was a statistically significant difference in terms of elasticity 
patterns between the tendinopathy and control groups (p<0.001). The receiver 
operating characteristic curve analysis was perfect and a cut-off value of 
tranverse, 25.8 kPa, longitudinal, 24.6 kPa shear had very high sensitivity and 
specificity for tendinopathy. 
Conclusion: SE and SWE may be useful diagnostic tools for LHBT 
tendinopathy when considering usability, cost effectiveness and patient 







B-0955 11:02  
How, when, why in magnetic resonance arthrography: an international 
survey by the European Society of Musculoskeletal Radiology  
D. Albano1, C. Messina2, A. Tagliafico3, L.M. Sconfienza2; 1Palermo/IT, 
2
Milan/IT, 3Genoa/IT (albanodomenico@me.com)  
Purpose: To perform an online survey among all members of the European 
Society of Musculoskeletal Radiology (ESSR) to understand how, when, and 
why magnetic resonance arthrography (MRA) is used in clinical practice. 
Methods and Materials: We administered an online survey to all 1,550 
members of the ESSR about the use of MRA in clinical practice asking ten 
different questions. Subgroup analysis was performed between general and 
orthopaedic hospitals. Mann-Whitney U and X2 statistics were used. 
Results: A total of 148 answers were included in our analysis, representing 
9.5% (148/1,550) of ESSR members. A median of 3,000 (25th-75th percentiles: 
1,567.5 - 5,324.5) musculoskeletal MR examinations per single institution were 
performed in 2016 and a mean of 125.5 MRAs (50.75 - 249). Ratio between 
MRA and musculoskeletal MR was 4.7% (1.6%-9.0%). Using MRA, the most 
investigated joint was the shoulder followed by the hip. The most common 
indications were the evaluation of instability, labrum, and rotator cuff. 
Fluoroscopy represented the preferred guidance to inject joints in 61.0% of 
cases. A self-prepared mixture of gadolinium and saline solution is preferred in 
general hospitals, while pre-diluted gadolinium-based syringes are mainly used 
in orthopaedic hospitals (P=.010). The number of MRA performed at 
orthopaedic hospitals (284; 83.75-449.50) was significantly higher (P=.006) 
than that performed at general hospitals (115.50; 44.75-234.25). 
Conclusion: One out of twenty MR examinations is a MRA, with higher 
prevalence in orthopaedic hospitals. The shoulder and the hip are the most 
investigated joints. Instability and labrum are the most common reasons to 
perform MRA.  
B-0956 11:10  
The diagnostic accuracy of diffusion-weighted imaging for the detection 
of partial-thickness rotator cuff tears  
O. Mansour, G. Jafarinosar; Tehran/IR (mansour.omid@yahoo.com)  
Purpose: The aim of our study was to investigate the accuracy of DWI 
sequence in diagnosis of partial thickness tears of rotator cuff tendon in 
compare with routine sequences. 
Methods and Materials: We collected the data of 60 patients who referred to 
our imaging centre for shoulder MRI. Imaging was performed with a 1.5 Tesla 
MRI unit (Ingenia CX , Philips medical systems). The following imaging 
protocol was used: coronal oblique T2W TSE (TR/TE 3200/90ms), thickness 
3.5mm, coronal oblique T1W TSE (TR/TE 460/16ms), thickness 3.5mm, 
coronal, sagittal and axial PD fat suppressed (TR/TE 1800/24ms ), thickness 
3.5mm. All sequences were acquired with a fov 16cm and matrix size 256x228. 
DWI sequence (b factors 0 and 600s/mm2) was performed in coronal oblique 
plane (TR/TE 3200/60ms), thickness 3.5mm, fov 20cm, matrix size 128x128. 
Of 60 patients, 32 patients underwent shoulder arthroscopy within 3 months 
after MR examination. Two radiologists reviewed MRI studies. 
Results: Imaging findings at MRI studies and arthroscopic results were 
compared in 22 of 32 patients were diagnosed with partial thickness tears in 
arthroscopy. The results showed DWI sequence was superior to routine 
sequences in diagnosing partial thickness tears of rotator cuff. 
Conclusion: According to the results of our study, DWI sequence plays a 
effective role to diagnose the partial thickness tears of rotator cuff than routine 
sequences (DWI accuracy 88%, routine sequences accuracy 76%).  
B-0957 11:18  
Ultrasound imaging of muscle contraction of the tibialis anterior in 
patients with facioscapulohumeral dystrophy  
K. Gijsbertse1, R. Goselink1, S. Lassche1, M. Nillesen1, A. Sprengers1, 
N. Verdonschot1,2, N. van Alfen1, C.L. de Korte1; 1Nijmegen/NL, 2Enschede/NL 
(kaj.gijsbertse@radboudumc.nl)  
Purpose: The pathophysiological mechanisms leading to muscle weakness in 
most neuromuscular disorders are not completely understood. Dynamic 
ultrasound imaging in combination with a speckle tracking method is 
introduced to visualize and quantify muscle deformation. 
Methods and Materials: Ultrasound image sequences were acquired from 16 
legs (4 patients with facioscapulohumeral dystrophy (FSHD) and 4 healthy 
controls) during voluntary contractions of the tibialis anterior muscle. A cross 
correlation method was applied to estimate muscle tissue deformation from the 
ultrasound images. The resulting deformation patterns were compared with 
muscle ultrasound echo intensity analysis (a measure of fat infiltration and 
dystrophy) and clinical outcome measures. 
Results: Ultrasound speckle tracking revealed a distinctively different tissue 
motion patterns between patients with peroneal weakness and healthy 
controls. Patients with severe peroneal weakness showed a homogeneous 
displacement pattern of the tibialis anterior with small motion of the central 
  






aponeurosis (2.1 ± 1.0 mm), contrary to healthy subjects that showed a large 
non-uniform displacement (9.7 ± 1.8 mm), increasing form the periphery of the 
muscle to the central aponeurosis. Furthermore, the difference in muscle 
deformation patterns of patients shows good agreement with clinical measures 
(e.g. decrease in force generation) and ultrasound echo intensity analysis. 
Conclusion: This work provides a tool to quantify muscle motion and evidence 
of changing functional behaviour of the affected muscles in FSHD patients. 
The quantitative characterization of muscle contraction provides new insights 
into the way pathologic muscle tissue deforms, leading to a better 
understanding of the underlying mechanisms related to weakness in muscle 
disease.  
B-0958 11:26  
Adhesive capsultis of the shoulder: a new ultrasound-guided and 
rehabilitation multidisciplinary treatment protocol to restore shoulder 
girdle kinesis  
G. Ferrero, V. Amico, F. Lacelli, E. Fabbro, N. Perrone, G. Serafini; 
Pietra Ligure/IT (giulio.ferrero@gmail.com)  
Purpose: To examine the effectiveness in short and medium terms of a new 
multidisciplinary treatment protocol (ultrasound guided and rehabilitative) of 
adhesive capsulitis of the shoulder (AC). 
Methods and Materials: 12 patients with clinical diagnosis of AC were treated 
with a protocol including ultrasound-guided capsular hydrodistension, intra-
articular steroid and hyaluronic acid (HA) injection, suprascapular and axillary 
nerves US-guided block and physiokinesitherapy (PKT) within two hours. 
Intensive PKT was then administered for 20 sessions. Evaluation was made 
before and after the first treatment, at the fifth, tenth and twentieth session 
using Constant-Murley scale and measuring ROM. The results were compared 
with a control group of 15 patients treated without nerve block. T test was used 
to evaluate differences in Constant-Murley scale and ROM before and after 
treatment. 
Results: Prompt ROM improvement (P<0,001) was observed after the first 
treatment session in both groups, with better C-M score and ROM values in 
patients who underwent nerve block. In both groups, a gradual and constant 
ROM recovery was observed. 
Conclusion: The study demonstrates that the proposed treatment can be 
effective, with better results compared to conventional treatment both in terms 
of ROM recovery and pain. AC can be treated with a multidisciplinary approach 
to obtain a shorter recovery time and better clinical results.  
B-0959 11:34  
US-guided percutaneous double needle lavage in the treatment calcific 
tendinopathy of therotator cuff performed with or without US-guided 
block of the suprascapular nerve  
D. Maiettini, R. Torre, S. Mosca, A. Rebonato; Perugia/IT 
(danielemaiettini@gmail.com)  
Purpose: To compare the outcome of ultrasound-guided percutaneous double 
needle irrigation (US-PICT) in the treatment of calcific tendinopathy of the 
rotator cuff performed with or without ultrasound-guided block of the 
suprascapular nerve in terms of pain control and shoulder mobility. 
Methods and Materials: We retrospectively enrolled 47 patients treated with 
US-PICT during 2015 and 2016 diagnosed with calcific tendinitis of the rotator 
cuff. Twenty-seven patients were treated with US-PICT alone while the 
remaining 20 were treated after the ultrasound-guided block of the 
suprascapular nerve of the same shoulder, using Lidocaine. The Visual 
Analogy Scale (VAS) and the Constant score were assessed before and 
immediately after the procedure and at 7 days, one and three months. 
Results: Overall patients the VAS and Costant scores showed a significant 
improvement after the procedure, during the follow-up (p<0.0001). The block 
group showed a significant reduction of the VAS immediately after the 
procedure with respect to the non-block group (mean values 4,4 vs 5,6) 
(p=0.01). At one week, one and three month follow-up there was no significant 
difference between groups considering VAS score (p>0.05). Constant score 
values didn't show any statististical difference during follow up between the 
block and non-block group. No major or minor complication were encountered. 
Conclusion: Ultrasound-guided percutaneous double needle irrigation in the 
treatment calcific tendinopathy confirmed to be effective both considering pain 
control and shoulder recovery. Ultrasound-guided block of the suprascapular 
nerve is effective in peri-procedure pain control while doesn't improve shoulder 








B-0960 11:42  
Another breach in the wall: efficacy of sodium hexametaphosphate 
(SHMP) solution vs simple saline in percutaneous treatment of calcific 
tendonitis of the shoulder: 6-months follow-up  
S. Mariani1, F. Bruno1, S. Quarchioni2, E. Cannizzaro1, C. Gianneramo1, 
F. Arrigoni1, L. Zugaro1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2Teramo/IT 
(mari.silvia@hotmail.it)  
Purpose: Calcific tendinitis of the shoulder is a common cause of pain and 
articular disability. The aim of our study was to evaluate the efficacy of 
percutaneous US-guided lavage in treatment of calcific tendinitis using a 
sodium hexametaphosphate(SHMP) solution(0.5%), in comparison with the 
same technique using simple saline. 
Methods and Materials: We evaluated 32 symptomatic patients with calfic 
tendinitis of the rotator cuff . Patients were randomly divided into 2 groups and 
treated by percutaneous fragmentation and lavage using SHMP (Group1, 16 
patients) or simple saline (Group2, 16 patients). In all patients, clinical and 
instrumental evaluation morphologic changes were assessed before and 2 
weeks, 1 month and 6 months after treatment. Imaging evaluation included 
conventional radiography and ultrasound, while clinical follow-up was 
performed using Constant Shoulder Score for functional improvement and VAS 
Score for pain. 
Results: In Group 1, 11 patients showed almost complete dissolution of 
calcifications (68,75%), while the remaining 5 just partial dissolution (31,25%); 
of these, 3 (60%) showed subtotal dissolution after 1 month. In Group 2, 9 
patients (56,25%) showed almost complete dissolution and partial in the 
remaining 7(43,75%) (p0.05), of these 1 patient (14,29%) showed subtotal 
dissolution after 1 month. VAS and Constant Score showed a significant 
improvement in 100% of patients in both groups (p0.05) after 4 weeks and 6 
months. 
Conclusion: The use of SHMP showed superior results compared to the 
treatment with simple saline solution especially in single session treatment and 
short-term follow-up. After 6 months in fact, both groups showed matched 
results.  
B-0961 11:50  
Improvement of image quality and diagnostic confidence using Smart 
MAR - a projection-based CT protocol in patients with orthopaedic 
metallic implants in hip and shoulder  
F. Feldhaus, G. Böning, U. Fehrenbach, J. Kahn, B. Hamm, F. Streitparth; 
Berlin/DE (felix.feldhaus@charite.de)  
Purpose: To determine whether the metal artifact reduction tool - a three-
stage, projection-based, postprocessing algorithm - improves subjective and 
objective image quality and diagnostic confidence in patients with orthopaedic 
implants. 
Methods and Materials: 20 patients with orthopaedic screws/replacement of 
hip or shoulder were included. CT scans were performed on a single-source, 
64-row multislice CT scanner (MSCT, Evolution, GE Healthcare). CT raw data 
were postprocessed using Smart MAR. Image quality of standard and Smart-
MAR-based reconstruction series was evaluated both quantitatively (in ROIs) 
and qualitatively (two independent raters) and compared to standard 
reconstructions. Dose was analyzed in dose-length products (DLP) and 
computed tomography dose indices (CTDIvol). 
Results: Smart MAR reconstructions of shoulder and hip (each n=10) showed 
significantly reduced attenuation and noise of regions adjacent to metallic 
implants (all p</= 0.005). Smart MAR improved subjective visualization of 
adjacent trabecular and cortical bone and adjacent soft tissue (all p<0.02). 
Subjective diagnostic confidence was also improved in hip (p=0.01) and 
shoulder region (p=0.02). There was no significant improvement in signal-to-
noise ratio (SNR; p<0.72). Mean DLP of hip region was 515,7 SD 192,2 HU 
(shoulder: 295,6 SD 144,0), mean CDTIvol 13,5 SD 4,6 (shoulder 13,7 SD 
6,4). 
Conclusion: Smart MAR significantly improved image quality of hip and 
shoulder CT scans even in the presence of severe artifacts, resulting in higher 
diagnostic confidence. Especially for the evaluation of periprosthetic tissues of 
the hip and shoulder, this automated postprocessing technique appears to be 
well suitable for clinical routine without increasing radiation exposure compared 
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Quality issues in ultrasound and CT  
Moderators:  
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A. England; Salford/UK  
B-0962 11:18  
Reduction of contrast agent using virtual monochrome image in 
haemodynamics aortic phantom  
F. Washizuka, T. Kitamura, T. Hatakeyama, H. Nakano; Tokyo/JP 
(fuyuki.washizuka@med.toho-u.ac.jp)  
Purpose: It is possible to reduce the contrast agent in the fixed type phantom 
using virtual monochrome images (VMI). Consider whether reduction of the 
amount of contrast agent is possible even using haemodynamic aortic 
phantom. 
Methods and Materials: Using the CT scanner (Somatom Definition Flash; 
Siemens Healthcare), haemodynamic phantom was scanned in the dual 
energy scan (80-Sn140kV). The kernel used for image reconstruction is "B30”. 
Injection condition was 24mgI/kg/s (assuming a weight of 60 kg, 370mgI/ml 
syringe, and 10-second injection). After that the contrast agent was reduced by 
10% and scanned. The reconstructed images are 54 keV, 57 keV, 60 keV, 63 
keV, 66 keV, 69 keV, and 72 keV and MIX images. Contrast to noise ratio 
(CNR) and shape reproducibility was calculated, and visual evaluation was 
performed. 
Results: The CNR was highest at around 66 keV, and CT value was increased 
at lower keV. Using VMI (66keV), if the CNR is made equivalent, the contrast 
agent can be reduced by 20% and equivalent images can be obtained. 
Considering the noise of the background and using further low keV, the CT 
value increases, it is possible to reduce 40% of the contrast agent. 
Conclusion: Using VMI in not only fixed phantom but also haemodynamic 
phantom, we could reduce contrast agent by up to 40%.  
B-0963 10:30  
Development and reliability of an ultrasound protocol to evaluate 
quadriceps muscle mass and diaphragm structure: a pilot study  
A. André1, J. Pinto2, D. Oliveira2, C. Aguiar2, S. De Francesco2, A. Oliveira2, 
A. Marques2, P. Martins2; 1Coimbra/PT, 2Aveiro/PT 
(alexandra.andre@estescoimbra.pt)  
Purpose: This study aimed to evaluate the intra and inter-operator reliability of 
an ultrasound (US) protocol, to assess quadriceps muscle mass and 
diaphragm structure in healthy people, for future monitoring of patients with 
respiratory disease. 
Methods and Materials: Twelve volunteers (6  !"# $%&'(
BMI=23.4±3.7 kg/m2) participated. An US equipment (Logiq P6 PRO, GE) with 
a multifrequency linear probe (11L) was used. Three measures of Quadriceps 
(QTK) and Rectus Femoris thickness (RFTK), RF cross sectional area (RFArea), 
bilateral diaphragmatic thickness at maximal inspiration (DTKI) and at end 
expiration (DTKE) were obtained by one operator. Six volunteers were randomly 
evaluated by two operators. Mann Whitney test was used to assess differences 
between inspiration and expiration and the right and left hemi-diaphragm. The 
Intraclass Correlation Coefficient (ICC2,1) was used to explore reliability. 
Results: Mean RFTK were 1.72cm, 8.19cm
2 for RFArea and 3.23cm for QTK. 
Significant differences were found between DTKI and DTKE both at right 
(0.31±0,17cm vs 0.23±0.19cm, p=0.01) and left hemi-diaphragm (0.37±0.18cm 
vs 0.24±0.14cm, p=0.01). No significant differences between the right and left 
hemi-diaphragms were observed during inspiration or expiration. Intra and 
inter-operator reliability were all Excellent: DTKE (intra: ICC2,1=0.977; inter: 
ICC2,1=0.822), DTKI (intra: ICC2,1=,0.903; inter: ICC2,1=0.805), QTK (intra: 
ICC2,1=0.976; inter: ICC2,1=0,940), RFArea (intra: ICC2,1=0.973; inter: 
ICC2,1=0.981) and RFTK (intra: ICC2,1=0.998 ; inter: ICC2,1=0.762). 
Conclusion: Results showed the feasibility and reliability of this US protocol in 
healthy people. One single measurement by one operator seems to be 
adequate. Bilateral diaphragmatic measurements might not be necessary in 
respiratory patient's evaluation  
B-0964 10:38  
Orbital ultrasound evaluation of the optic nerve sheath diameter  
H.I.M.G. Ferraz1, R.A. Santos2; 1Peso da Régua/PT, 2Coimbra/PT 
(helenaimgferraz@gmail.com)  
Purpose: The human eye is one of the most complex organs in our body. The 
fact that the eye is a liquid-filled superficial structure allows an optimal 
appreciation of the ocular structures on ultrasound. There has been an 
increase in the use of this modality in the evaluation of the diameter of the optic 
nerve sheath (ONSD). To purpose of the study is to analyse the reproducibility 
of the ONSD diameter measures, to characterise the ONSD by ultrasound, to 
verify the existence of correlation with body mass index (BMI), blood pressure 
(BP) and glucose values. 
Methods and Materials: 370 ultrasound images of ONSD were collected from 
84 individuals, divided into 2 groups. The ICC was obtained to evaluate the 
reproducibility of the ultrasound measurements. The BMI, BP and glucose 
values were also collected from all subjects. The correlation of data was also 
evaluated with the Pearson test and the Student's T test for independent 
samples. 
Results: The ONSD ICC values showed satisfactory reproducibility (0.73). BMI 
and age showed a positive correlation with BP (p<0.05). No significant 
differences were found between the group with pathology (myopia, 
astigmatism or hypermetropia) and without. 
Conclusion: Ultrasonography showed a satisfactory reproducibility to assess 
the ONSD and could help with new ocular disease evaluation.  
B-0965 10:46  
Effects of smoking on carotid artery structures and haemodynamics: role 
of the radiographer in ultrasound assessment  
D.M.B. Simão, L.P. Ribeiro, A.F. Abrantes, J.P. Pinheiro, R.P. Almeida, 
A.Q. Brito, S. Rodrigues; Faro/PT (diogo_simao93@hotmail.com)  
Purpose: Currently, tobacco is a behaviour associated with the appearance of 
several pathologies, such as atherosclerosis or stroke and qualified 
radiographers in sonography field should be able do detect premature vascular 
changes due to smoking. The goal of this study was to assess and compare 
structural and haemodynamic parameters on carotid arteries in smokers and 
non-smokers by ultrasound. 
Methods and Materials: Several parameters on the carotid artery were 
evaluated by a trained radiographer: intima-media thickness (IMT), peak 
systolic velocity (PSV) and end-diastolic velocity (EDV). Measurements were 
performed using a sample of 103 volunteer participants (52 non-smokers and 
51 smokers) aged between 20 and 40 years. B-mode images were acquired in 
longitudinal and transverse sections of the common carotid arteries. Inclusion 
criteria contains healthy participants with unknown diseases. The smokers 
group was divided into four different categories depending on the number of 
cigarettes smoked by day. 
Results: It were observed higher mean values for all of the structural and 
haemodynamic parameters in the smokers group (IMT=0,706mm; 
PSV=104,94cm/s and DV=30,20cm/s) comparing with non-smokers 
(IMT=0,512mm; PSV=72,47cm/s and DV=19,29cm/s). Also, the female 
smokers group presents higher values when compared with the male smokers 
group (x=0,758 vs x=0,652, respectively). 
Conclusion: The data from this study suggest that smoking has negative 
effects on carotid artery structure and haemodynamics. Therefore, smoking is 
a risk factor for alterations in carotid artery haemodynamics and female 
smokers are more likely to develop vasculares changes. Radiographers can 
play a key role in the detection of pathophysiological changes in a preventive 
perspective.  
B-0966 10:54  
Abdominal and lumbar muscle evaluation by ultrasound  
R.A.M. Santos, R. Barreiro; Coimbra/PT (rutemartinssantos@gmail.com)  
Purpose: The aim of this study is to characterize the muscular ultrasound of 
two postural muscles (rectus abdominis and lumbar multifidus) in healthy 
individuals and in individuals with postural alterations (namely hyperlordosis). 
Methods and Materials: 30 young adults were submitted to an ultrasound 
evaluation of the rectus abdominis and multifidus lumbar muscles in rest and 
contraction and an angle measurement of the lumbar spine through a 
photometry equipment. They were divided into groups: one of control and other 
with non-congenital posture. The sample was composed of 11 participants with 
postural deviations and 19 without. 360 images were analysed with Image J 
software to obtain muscle thickness and echo-intensity values from the two 
muscles in two conditions and the angle of the lumbar spine was calculated 
also for all participants. 
Results: There were significant differences between rest and contraction on 
muscle thickness and echo intensity of both muscles. There were no significant 
differences between the two groups of participants and there was no 
correlation between the angle and the ultrasound measurements. 
Conclusion: The postural deviations do not influence the ultrasound 
characteristics of the studied muscles. However, more studies must be 
performed to analyse the relation between the lumbar and abdominal muscles 











B-0967 11:02  
Vastus lateralis stiffness assessed by SSI elastography  
R.A. Santos1, P. Armada-da-Silva2; 1Coimbra/PT, 2Lisbon/PT 
(rutemartinssantos@gmail.com)  
Purpose: To assess changes in VL’s shear modulus with knee position and 
after a session of maximal isometric and isokinetic Conc and Ecc contraction 
and to analyse the relationship between VL’s shear elasticity and submaximal 
knee extension torque with supersonic shear wave imaging (SSI). 
Methods and Materials: Sixteen subjects were submitted to acute changes in 
VL’s stiffness associated with passive stretching, performance of short but 
intense contractile activity, and muscle isometric contractions that were 
investigated by means of SSI. 
Results: The results demonstrated an acute increase of around 10% in VL’s 
shear modulus as a result of performing maximal isometric, concentric, and 
eccentric contractions. The shear modulus of the VL also increased when the 
knee moved from 10o to 50o and then to 90o flexion. Finally, a linear 
relationship between the shear modulus and the level of isometric muscle 
contraction was observed. 
Conclusion: SSI proved to be a good method to investigate muscle 
mechanical property changes associated with muscle function. These results 
emphasise the value of an objective and quantifiable muscle US evaluation for 
studying muscle adaptation to exercise training and muscle function, in 
general.  
B-0968 11:10  
Use of ultrasound for diagnosis of schistosomiasis mansoni  
H.M.K. Masha; Nairobi/KE (hildakadzo@yahoo.com)  
Purpose: To establish the role of ultrasound in the diagnosis of Schistosoma 
mansoni. 
Methods and Materials: Ultrasound was used to scan a group of 400 
individuals in obtaining sonographic grading.The study was done in an area 
called Nzoila in Kenya and included adults and children both males and 
females.The age range considered for the study was 8-45 years.Characteristic 
sonographic features of schistosoma to be observed were periportal fibrosis 
noted along the long axis of the intrahepatic portal veins. Scanning along 
central and peripheral bifurcation points of the portal veins produced branching 
pattern of high echogenicity. From this sonographic pattern, grading was done 
as follows; A- Normal, B-Early peripheral fibrosis, C-Clear cut pipestems and 
rounded density bands, D-Central fibrosis of main portal vein and gallbladder 
wall thickening, E-Advanced stages of fibrosis forming patches on the liver 
parenchyma, F-extreme advanced fibrosis extending to the liver surface, 
distorting its shape, XYZ other pathology not schisto related.Wall thickness of 
the portal veins was measured. Other sonographic abnormalities were noted 
(splenomegaly, oesophageal and splenic varices and ascites). A portable 
ultrasound machine with curvey linear probe was used. Portable generator, 
warm gel, Pinter with glossy printing paper and recording material. 
Results: The grading observed were as follows; pattern B-65% ,C-5.4%, E- 
1.5%,F-4.6%, X Y Z- 0.7%It was also noted that advanced sonographic 
abnormalities seen in children differed significantly from those of adults. 
Conclusion: Ultrasound is an ideal tool for classification of liver fibrosis in 
schistosomiasis and can also be used in a country control programme.  
B-0969 11:26  
Point of care creatinine testing: a feasibility study in an outpatient CT 
setting  
B. Snaith1,2, M.A. Harris1, B. Shinkins3, M. Jordaan1, A. Lewington3, 
M. Messenger3, N. Spencer1; 1Wakefield/UK, 2Bradford/UK, 3Leeds/UK 
(bev.snaith@midyorks.nhs.uk)  
Purpose: There remains controversy around the relationship between 
iodinated contrast media and contrast-induced acute kidney injury (CI-AKI), but 
international guidance endorses renal function screening. Point of care (PoC) 
testing may reduce inefficiencies, improve patient safety and optimise capacity, 
but evaluation of their implementation within this context is limited. 
Methods and Materials: Following ethical approval, this feasibility study was 
performed across two UK hospital sites. A PoC creatinine analyser was added 
as an adjunct to the standard laboratory blood test. Patients having contrast-
enhanced CT consented to a risk screening questionnaire and two samples of 
blood for PoC and laboratory analysis for evaluation of serum creatinine (SCr) 
and estimated glomerular filtration rate (eGFR). Follow-up testing 48-72 hours 
post-contrast was also offered. The analytical performance and clinical 
concordance of PoC was assessed. 
Results: 300 patients were recruited with a mean age of 65 years (range 23-
91). Pre-scan blood test timing varied (mean 3.7 weeks; range 0- 59.6); 
however, four patients had bloods available despite fail-safe procedures. Three 
patients had an unexpected drop in eGFR; all indicated acute illness. 
Screening questionnaire responses showed a statistically significant 
relationship between reduced eGFR and renal (p=0.010) or cardiac (p=0.032) 
problems. At follow-up, five patients (5/102; 4.9%) registered CI-AKI (25% 
increase in SCr). Positive and negative bias was seen with the PoC device, 
with mean bias close to zero. 
Conclusion: PoC technology exhibits acceptable clinical performance. The 
implementation of a risk screening questionnaire partnered with PoC 
technology may streamline services and enable direct access to imaging; 
however, multi-centre evaluation is required.  
Author Disclosures: 
  B. Snaith: Grant Recipient; NHS England Cancer Diagostic Capacity Fund.  
B-0970 11:34  
Implementation of a multi-phase contrast injection: single-pass 
acquisition trauma CT protocol  
D.J. Biddle, S. Freeman, A. Barker, C. Walker, R. Higgins, S. Upponi; 
Cambridge/UK (david.biddle@nhs.net)  
Purpose: Can the radiation dose for trauma CT be reduced utilising a 
multiphase contrast injection, single-pass acquisition, whilst maintaining the 
overall image quality? 
Methods and Materials: 50 consecutive trauma CTs using the established 
two-pass protocol were retrospectively analysed (arterial thoracoabdominal 
imaging and portal venous abdominopelvic imaging). Retrospective analysis 
was also made of 50 consecutive trauma CTs utilising the new single-pass, 
multiphase injection protocol (mixed arterial and venous phase of chest, 
abdomen and pelvis). Patients were imaged on a Siemens Definition AS+ 128 
slice scanner. Both trauma protocols were triggered using a region-of-interest 
(ROI) placed over the descending thoracic aorta. Hounsfield unit 
measurements were obtained with a ROI drawn over the main pulmonary 
artery, descending thoracic aorta and portal vein. Two consultant radiologists 
assessed the overall quality of the studies, rating the studies as diagnostic or 
non-diagnostic, and evaluating contrast density. Splenic enhancement was 
specifically assessed as a marker of solid organ enhancement. Radiation dose 
was compared. 
Results: The single-pass cohort had significant dose reduction compared with 
the two-pass method (DLP 935.60 vs 1849.58 mGycm; p=0.0000000005506 ), 
and a lower kV (p = 0.0029). Pulmonary artery enhancement was comparable 
(p = 0.401), whilst the aortic and portal vein attenuation was significantly higher 
in the single-pass cohort. Both cohorts had excellent diagnostic quality: 100% 
in two-pass method and 98% in single-pass method. Both cohorts maintained 
diagnostic splenic attenuation (100%). 
Conclusion: The single-pass, multiphase technique significantly reduces the 
radiation dose in trauma patients, compared with the established technique, 
whilst maintaining diagnostic accuracy.  
B-0971 11:42  
CT hepatic contrast enhancement adjusted for body type versus lean 
body weight  
T. von der Fehr, V. Hjelle, J.M. Erdal, T. Helle, A.P. Parkar; Bergen/NO 
(janne.erdal@gmail.com)  
Purpose: The optimal contrast enhancement for detection of liver lesions on 
CT is 50 HU. We aimed to study if switching from administered contrast 
amount based on body type to a lean body weight (LBW) calculator (according 
to Hume) could improve the quality of hepatic contrast enhancement (HCE). 
Methods and Materials: The age, gender, height and weight, contrast 
amount, flow rate and tube voltage (kV) of 200 consecutive patients who 
underwent the same CT protocol were recorded. The first 100 patients (group 
A) were administered contrast amount (80-100-120 ml) according to their body 
type (normal-overweight-muscular). The next 100 patients (group B) were 
administered contrast according to their LBW (0.75 g Iodine/kgLBW). As delay 
was fixed at 70s and all other parametres remained constant, flow rate varied 
in group B. CT density (HU) on the first smart-prep image and post-contrast 
were measured on the same slice and anatomic area. Density increase 49 
HU was considered “inadequate”. 
Results: After image review, 183 patients were included (group A= 95, group 
B=88). Inadequate HCE scans fell between group A (29;31%) and group B 
(16;18%), but not significantly (X2, p=0.053). Age, gender, body weight and 
flow rate did not significantly affect HCE. kV significantly affected HCE, with 
91% adequate scans with 100 kV and 61% with 120 kV (X2, p<0.001). LBW 
>60 kg significantly affected kV (p=0.006) and HCE (p=0.004). 
Conclusion: The LBW calculator only slightly, but not significantly, improved 
HCE. Increasing LBW warrants imaging at 120 kV to achieve acceptable 
image quality, but also reduces the iodine attenuation. Future optimisation 














B-0972 11:50  
Optimisation of contrast delivery using quantitative and qualitative 
analysis in a clinical based CTPA setting  
C. McKay, S. Maguire, P. Gilligan, C. Walsh, J. Matthews, S.J. Eustace; 
Dublin/IE (ce.mckay5@gmail.com)  
Purpose: Current practice in our hospital involves bolus tracking with 
subjective manual cessation of contrast administration for CT Pulmonary 
Angiography. This has implications for contrast usage in certain vulnerable 
patient cohorts. The purpose of the study was to assess the effect of varying 
the volume of contrast administered on the enhancement of the pulmonary 
arteries. 
Methods and Materials: CTPA (n=100) images from a dual tube definition 
scanner ( Siemens, Erlangen) were evaluated using objective and subjective 
parameters. The average Hounsfield units were assessed in the pulmonary 
artery at central, segmental and subsegmental levels. The clinical analysis was 
based on the experienced radiologists' reports which include a commentary on 
image quality including the level of contrast opacification of the pulmonary 
arteries. 
Results: There was a significant variation in the volumes of contrast 
administered for CTPA exams (Range 35-90 ml of Optiray 350 (Guerbet, 
France), Median: 66 ml, Mode :90 ml). Contrast enhancement of the 
pulmonary arteries were maintained above the set threshold of 210 Hounsfield 
units even at low contrast volumes. All exams in the cohort were considered 
sufficient for diagnosis, however 7% were noted as suboptimal in the clinical 
reports. A lower KVp setting was found to improve vascular enhancement. 
Conclusion: It is possible to deliver adequate CTPA images with lower 
contrast volumes in a clinical setting and a protocol of a maximum volume of 
70 ml is proposed.  
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B-0973 10:30  
T1 based myocardial tissue characterisation in healthy volunteers: 
reference values for novel parameters of tissue dispersion  
S. Rueppel, S. Lyschik, M.C. Halfmann, S. Benz, J. Eichstädt, C. Düber, 
K.-F. Kreitner, T. Emrich, F. Hahn; Mainz/DE 
Purpose: Data on reference values of healthy adults concerning novel 
markers of myocardial tissue heterogeneity based on T1 Maps does actually 
not exist. We aim to provide these reference values for analysis of myocardial 
tissue heterogeneity to strengthen this approach for clinical use. 
Methods and Materials: In this study, 55 carefully chosen healthy volunteers, 
matched in age and sex, underwent CMR imaging at 3 Tesla (Magnetom 
Skyra®, Siemens Healthineers). We evaluated Modified Look-Locker inversion 
recovery (MOLLI) based T1 Maps by using a dedicated software (CVI42, 
Circle®) after accurate elimination of artifacts. Beside established parameters 
like mean segmental und global T1 values, parameters of myocardial tissue 
dispersion as maximum and minimum T1 (max and minT1), dynamic range 
(dyn), standard deviation (SD) and mean absolute deviation (MAD) of mean T1 
and SD were calculated. 
Results: The measurements lead to the following values (median and 
interquartile range): Global T1 1190 ms (1148 ms/ 1217 ms), SD 85,2 ms (70.9 
ms/ 98,7 ms), MADT1 25,3 ms (16,7 ms/ 35,5 ms), MADSD 12,8 ms (9,6 ms/ 
21,0 ms), minT1 931 ms (864 ms/ 1013 ms), maxT1 1710 ms (1595 ms/ 1810 
ms) and Dyn 777 ms (696 ms / 928 ms). 
Conclusion: To our knowledge, our study provides first reference values for 
novel markers of myocardial tissue heterogeneity in healthy adults. Further 
studies are needed to establish this approach for clinical use.  
B-0974 10:38  
Novel T1 map parameters of tissue heterogeneity are not influenced by 
age and gender in healthy volunteers  
S. Lyschik, S. Rueppel, S. Benz, M.C. Halfmann, J. Eichstädt, C. Düber, 
K.-F. Kreitner, T. Emrich, F. Hahn; Mainz/DE 
Purpose: Data concerning the influence of gender and age on myocardial T1-
values is controversial or not existing, especially for novel parameters of tissue 
heterogeneity. Our aim is to perform analyses of influencing factors on 
established and novel parameters of myocardial tissue characterization. 
Methods and Materials: 55 cardiovascular magnetic resonance examinations 
were performed at 3T (Magnetom Skyra®, Siemens Healthineers) in carefully 
chosen healthy volunteers. A dedicated software (CVI42, Circle®) analysed the 
produced T1 Maps. Tissue heterogeneity parameters were calculated and 
included analysis of dispersion like mean and standard deviation (SD), 
dynamic range and mean absolute deviation (MAD) of mean T1-values and 
their SD. These values were subsequently tested for influencing factors like 
age, sex and their combination using an analysis of variance (ANOVA). Post-
hoc testing using the Bonferroni correction was performed for subgroup 
analyses. 
Results: Established parameters like median T1 were influenced by gender 
(p=.001), but not by age (p=.777). Myocardial dispersion parameters, e.g. MAD 
or dynamic range showed no statistically significant differences with regard to 
age and gender (p=.559 and .665 respectively p=.416 and .105). The 
combination of both factors did not reveal a significant influence. 
Conclusion: Published data on the influence of age and gender on 
established T1-Map parameters in healthy volunteers is controversial. These 
controversies could be caused by selection bias, differences in sequence types 
or post-processing software. Sophisticated post-processing analysis of 
myocardial tissue heterogeneity are not influenced by age and gender and 
could be beneficial to establish myocardial tissue characterization as a method 
for clinical use.  
B-0975 10:46  
Artefacts in myocardial mapping  
C. Eilers, J. Eichstädt, K.-H. Schmidt, C. Düber, T. Emrich, K.-F. Kreitner; 
Mainz/DE (tilman.emrich@gmail.com)  
Purpose: Cardiac magnetic resonance (CMR) imaging in general and 
myocardial mapping in particular provide valuable insights into the structure of 
myocardial tissue and help in discriminating healthy from diseased 
myocardium. However, artefacts and insufficient motion correction remain an 
existing but rarely addressed problem in CMR mapping imaging. 
Methods and Materials: In this study, 66 patients with miscellaneous heart 
diseases and 80 healthy volunteers underwent T1 and T2 myocardial mapping 
at 3T. All maps were evaluated with regard to frequency of artefacts. The type 
of artefacts and the involved myocardial segments according to American 
Heart Association (AHA) classification were recorded. Furthermore, we 
evaluated in how far the artefact prevented clinical evaluation of the involved 
segment. The artefacts were classified as: chemical shift artefacts, off-
resonance artefacts, susceptibility artefacts, partial volume artefacts and 
artefacts due to insufficient motion correction. 
Results: In native T1- and T2-mapping, artefacts occurred in 7% of the 
myocardial segments, 6% had to be excluded from further analysis. Most 
common artefacts were off-resonance and susceptibility artefacts. Myocardial 
segments most often affected by artefacts were located inferolateral, 
anteroseptal and apical. There was no statistical significant difference in the 
amount, type and distribution of artefacts between T1 and T2 mapping and 
between the mapping of healthy volunteers and patients. 
Conclusion: The frequency of artefacts in T1 and T2 mapping prevented 
further analysis in 6% of segments. The distribution of artefacts among 
segments is not random. Instead, it follows the same recurring pattern in 
patients and healthy volunteers and in both T1 and T2 mapping.  
B-0976 10:54  
Myocardial T1 and T2 mapping in severe aortic stenosis: novel insights 
into the pathophysiology of myocardial remodelling  
A. Fehrmann Efferoth, M. Treutlein, T. Rudolph, V. Rudolph, K. Weiss, 
D. Giese, A. Bunck, D. Maintz, B. Baessler; Cologne/DE 
(anafehrmann@googlemail.com)  
Purpose: Severe aortic stenosis (AS) is known to be associated with 
substantial myocardial remodelling, leading to diffuse myocardial fibrosis 
(DMF). The purpose of the present study was to combine native T1 and T2 
mapping in a comprehensive cardiac magnetic resonance (CMR) examination 
to characterize myocardial tissue changes in the setting of severe AS. 
Methods and Materials: 26 prospectively selected patients with severe AS 
and 17 healthy controls underwent CMR imaging on a clinical 3T scanner. The 
CMR protocol included a native modified Look-Locker T1-mapping and a 
gradient-spin-echo T2-mapping sequence in three short-axis slices and one 
long-axis view. After segmentation, myocardial T1 and T2 values were 
averaged over the entire myocardium. 
Results: Global native myocardial T1 was significantly increased in AS 
patients when compared with controls (1305±39 vs 1272±21 ms, p=.005). 
Similarly, mean myocardial T2 was significantly elevated in AS patients (51±4 
vs 46±2 ms, p<.001) and showed a strong correlation with native T1 (r=.60, 
p<.001). An overlap was observed between T1 values of both groups, whereas 
T2 times discriminated nearly perfectly between the two groups (area under 
the curve: 0.76 for T1, 0.87 for T2). 
  






Conclusion: Patients with severe AS exhibit significantly elevated native 
myocardial T1 times, which has previously been shown to correlate with the 
amount of myocardial collagen. The present study is the first to show that 
native T1 and T2 values are both significantly elevated and correlated in AS 
patients, pointing towards a potential role of oedematous/inflammatory 
processes in the pathophysiology of myocardial remodelling associated with 
AS.  
Author Disclosures: 
 K. Weiss: Employee; Philips Healthcare.  B. Baessler: Research/Grant 
Support; Wilhelm Vaillant-Stiftung. 
B-0977 11:02  
Myocardial tissue characterisation by cardiac magnetic resonance 
imaging in left ventricular non-compaction: new insights with T1 mapping 
and extracellular volume quantification  
J.A.B. Araújo-Filho, A.N. Assuncao-Jr, M.D. Tavares de Melo, R.N. Dantas Jr, 
C.H. Nomura, J.R. Parga Filho; São Paulo/BR (ariaraujocg@hotmail.com)  
Purpose: This study aimed to characterize myocardial T1 mapping and 
extracellular volume (ECV) fraction by cardiovascular magnetic resonance 
(CMR), and investigate how these biomarkers relate to left ventricular ejection 
fraction (LVEF) and ventricular arrhythmias (VA) in patients with left ventricular 
non-compaction (LVNC). 
Methods and Materials: We prospectively recruited 36 patients with LVNC 
and 18 controls to perform a cardiovascular magnetic resonance (CMR) with 
T1 mapping from July 2013 to September 2016. ECV was quantified in LV 
segments without late gadolinium enhancement (LGE) areas to investigate 
diffuse myocardial fibrosis. Differences in CMR parameters between patients 
and controls were assessed using t test or Wilcoxon rank-sum test, and a 
linear regression model was built for LVEF to test the association with ECV 
and clinical characteristics. 
Results: Patients with LVNC had higher native T1 (1024±43ms vs. 995±22ms, 
p=0.01) and expanded ECV (28.0±4.5% vs. 23.5±2.2%, p<0.001) compared to 
controls. ECV was independently associated with LVEF (=-1.3, p=0.003). 
Moreover, among patients without LGE, VA were associated with higher ECV 
(27.7% with VA vs 25.8% without VA, p=0.002). 
Conclusion: In LVNC patients, tissue characterization by T1 mapping 
suggests an extracellular expansion in myocardium without LGE, which was 
associated with myocardial dysfunction and VA, possibly related to diffuse 
myocardial fibrosis. These findings lend support to the potential role of T1 
mapping in refining LVNC risk stratification.  
B-0978 11:10  
ECV mapping without HCT: comparison between two different synthetic 
ECV-calculation methods and clinical applicability  
L. Bottoni1, E. Gavazzi1, M. Ravanelli1, M. Zanirato2, A. Greiser2, D. Farina1, 
R. Maroldi1; 1Brescia/IT, 2Erlangen/DE (luca.bottoni87@hotmail.com)  
Purpose: To assess the accuracy and clinical applicability of two different 
synthetic-ECV mapping methods. 
Methods and Materials: 47 consecutive cardiac MRI scans were performed 
applying three different ECV mapping techniques: 8/47 patients were 
discarded for poor image quality. In 15/39 automated ECV mapping (Siemens, 
Germany), incorporating the Hct measured in lab. This method was set as the 
reference standard. In 24/39 cases was applied automated synthetic ECV 
mapping (with software-calculated Hct) (Siemens, Germany). In all patients in-
house calculated ECV was performed applying the formula [(1-
Hct)(1/myocardium-1/blood)] with Hct=[0,88-(T1blood/3240)]. Image were 
analysed placing ROIs on blood pool and myocardium, rigidly in the same 
position in all cases. 
Results: The software-calculated Hct was compared with the lab-measured 
Hct in 17 cases: software-calculated Hct was significantly higher (p=.0089). 
The in-house calculated Hct was compared with the lab-measured Hct in 29 
cases: no significant difference was seen. However, no statistically relevant 
difference between the ECV measured with automated-ECV, synthetic-ECV 
and in-house calculated ECV was found. 
Conclusion: Synthetic-ECV mapping bases it measurement on a software-
calculated Hct which is significantly different from real, whereas in-house 
calculation offers a more reliable estimate. However, the ECV values 
measured with three techniques show no statistical difference. Synthetic-ECV 
mapping is a clinically applicable alternative in cases when lab-measured Hct 








B-0979 11:18  
Diagnostic potential of texture analysis applied on cardiac magnetic 
resonance T1 and T2 mapping in patients with biopsy-proven chronic 
myocarditis  
B. Baessler1, C. Lücke2, K. Klingel3, R. Kandolf3, G. Schuler2, D. Maintz1, 
M. Gutberlet2, H. Thiele2, P. Lurz2; 1Cologne/DE, 2Leipzig/DE, 3Tubingen/DE 
(bettina.baessler@uk-koeln.de)  
Purpose: To apply texture analysis (TA) for the first time on T1 and T2-maps 
derived from cardiac magnetic resonance (CMR) T1 and T2 mapping and to 
test its diagnostic performance in patients with “DCM-like” chronic myocarditis. 
Methods and Materials: Fourty patients with clinical chronic heart failure 
(EF<50%, symptom duration >14 days) and suspicion for underlying chronic 
myocarditis were prospectively included. Patients underwent biventricular 
endomyocardial biopsy (EMB), cardiac catheterization and CMR imaging at 
1.5T including native T1 and T2-mapping as well as standard Lake Louise 
criteria (LLC). TA was applied on T1 and T2-maps using a freely available 
software package by drawing a region of interest encompassing the entire 
myocardium. Step-wise dimension reduction and texture feature selection was 
performed for selecting texture features enabling the diagnosis of DCM-like 
chronic myocarditis, using EMB as the reference standard. 
Results: Mean symptom duration was 121±164 days and mean EF was 
26±11%. EMB confirmed the presence of myocarditis in 26 patients (EMB+), 
whereas 14 patients had no signs of inflammation (EMB-). Similar to standard 
LLC, mean myocardial T1 and T2 demonstrated poor diagnostic performance 
in receiver operating curve (ROC) analyses (area under the curve [AUC]: 0.52 
for LLC, 0.54 for T1 and T2, respectively). The combination of two texture 
features derived from T2 maps, T2_Kurtosis and T2_SumEntrp, yielded a 
superior diagnostic performance with an AUC of 0.75 and a 
sensitivity/specificity of 77/71%. 
Conclusion: TA is feasible when being applied on myocardial T1 and T2-maps 
and delivers interesting novel parameters for the diagnosis of chronic 
myocarditis.  
B-0980 11:26  
Texture analysis of myocardial infarction of CT: impact of iterative 
reconstruction  
M. Mannil, J. von Spiczak, U. Mühlematter, A. Thanabalasingam, R. Manka, 
H. Alkadhi; Zurich/CH (Manoj.Mannil@usz.ch)  
Purpose: To compare machine learning-based texture analysis (TA) with 
subjective visual diagnosis of myocardial infarction (MI) in CT of the heart, and 
to evaluate the impact of iterative reconstruction (IR) on the results. 
Methods and Materials: Ten patients with confirmed chronic MI and twenty 
controls with no cardiac abnormality underwent the same contrast-enhanced 
ECG-gated cardiac CT protocol. Images were reconstructed with filtered back 
projection (FBP) and advanced modelled IR at strength levels 3-5. Subjective 
diagnosis of MI was made by two independent, blinded readers. Classification 
of MI was performed using machine-learning based decision tree models for 
the entire dataset and after splitting into training and test data to avoid over-
fitting. 
Results: Subjective visual analysis for diagnosis of MI showed excellent 
intrareader (kappa:0.93) and poor interreader agreement (kappa:0.3), with 
variable performance at different reconstruction types. TA showed similarly 
high performances for all image reconstructions (correct classifications 94-
97%, areas-under-the-curve 0.94-0.99). After splitting into training and test 
data, overall lower performances were observed with best results for IR level 5 
(correct classifications 73%, area-under-the-curve 0.65). 
Conclusion: As compared to subjective visual image analysis, machine 
learning-based TA enables objective and reproducible diagnosis of MI in CT 
with high accuracy, showing best results at highest IR levels.  
B-0981 11:34  
Texture analysis and machine learning for detecting myocardial 
infarction in non-contrast low-dose CT  
M. Mannil, J. von Spiczak, R. Manka, H. Alkadhi; Zurich/CH 
(Manoj.Mannil@usz.ch)  
Purpose: To test whether texture analysis (TA) and machine learning enable 
the detection of myocardial infarction (MI) on non-contrast enhanced low 
radiation dose cardiac computed tomography (CCT) images. 
Methods and Materials: In this IRB-approved retrospective study, we included 
non-contrast enhanced electrocardiography-gated low radiation dose CCT 
image data (effective dose 0.5mSv) acquired for the purpose of calcium 
scoring of 27 patients with acute MI, 30 patients with chronic MI, and in 30 
subjects without cardiac abnormality (hereafter termed controls). TA of the left 
ventricle was performed using free-hand regions-of-interest and texture 
features were classified twice. Model I: controls vs. acute MI vs. chronic MI; 
Model II: controls vs. acute and chronic MI. For both classifications, five 
commonly used machine learning classifiers were used: decision tree C4.5 
  






(J48), k-nearest neighbors (k-NN), locally weighted learning (LWL), sequential 
minimal optimization (SMO), and an artificial neural network. Additionally, two 
blinded, independent readers visually assessed non-contrast CCT images for 
the presence or absence of MI. 
Results: In model I, best classification results were obtained using the k-NN 
classifier (sensitivity 69%, specificity 85%). In model II, best classification 
results were found with the LWL classification (sensitivity 86%, specificity 81%) 
with an area-under-the-curve from receiver operating characteristics analysis of 
0.78. In comparison, both readers were not able to identify MI in any of the 
non-contrast, low radiation dose CCT images. 
Conclusion: This study indicates the ability of TA and machine learning for 
detecting MI on non-contrast low radiation dose CCT images, being not visible 
for the radiologists’ eye.  
B-0982 11:42  
Myocardial textural analysis and machine learning for differentiating 
normal myocardium vs chronic infarct on non-contrast CT scan  
A.A. Albweady1, S. Raja2, S. George3, M. Alharbi2, K. Aldossari2; 1Qassim/SA, 
2
Riyadh/SA, 3Houston, TX/US (ALBWEADY88@GMAIL.COM)  
Purpose: Prior sparse literature suggests that a couple of soft findings on plain 
CT such as hypodensity, calcium deposits etc can favor chronic Infarction. 
Recent developments in Radiomics- texture analysis (TA) and machine 
learning (ML) can tease out such occult features on medical imaging including 
CT. We explored if TA and ML can differentiate normal myocardium from prior 
infarcts. 
Methods and Materials: We retrospectively analysed 24 patients(M=18, F=6), 
having both FDG PET-CT and MPI (cardiac perfusion SPECT) for myocardial 
viability from 2015 to 2017. Utilising the ground truth (scar Vs. normal 
myocardium) on the co-registered PET and SPECT transverse slices (matched 
defect-infarct, mismatch-viable myocardium), we flagged 3 to 4 representative 
3D VOI (volume of interest) on each pt. on a dedicated workstation. The voxel 
level data from the flagged VOI were exported to EXCEL and MATLAB for TA 
computation. 
Results: Utilising a Training subset 50% (no=18), Testing subset 50% 
(no=18), for developing the predictive model and testing respectively. A 
prediction classification accuracy of 82%, AUC 0.875 in the training set was 
achieved with C5.1 decision tree algorithm to classify scar vs. normal 
myocardium. Using one way ANOVA the single most important feature had a 
statistically significant p-value of 0.009 in the differentiation of scar Vs normal 
myocardium. 
Conclusion: Texture analysis and machine learning can dissect normal 
myocardium from chronic infarcts, on non-contrast CT. The novel technique 
could potentially be used as a screening tool in patients at high risk for 
unrecognised chronic infarcts.  
B-0983 11:50  
Initial in vitro comparison of a spectral photon counting CT and a 
spectral dual-layer CT system for non-invasive evaluation of soft-plaque-
restenosis in coronary artery stents  
T. Hickethier1, D. Bar-Ness2, A. Bunck1, D. Maintz1, G. Pahn3, P. Coulon4, 
S.A. Si-mohamed2, P. Douek2, M. Sigovan2; 1Cologne/DE, 2Lyon/FR, 
3
Hamburg/DE, 4Suresne/FR (tilman.hickethier@uk-koeln.de)  
Purpose: Even when compared to latest spectral-dual-layer-CT-systems 
(SDLCT) future spectral-photon-counting-detector-CT-systems (SPCCT) 
promise improved spatial resolution and decreased (stent related) blooming 
artifacts. We investigated the influence of conventional (Conv) and 
monoenergetic (MonoE) reconstructions from SDLCT and SPCCT on 
delineation of soft-plaque-restenosis in coronary stents. 
Methods and Materials: Artificial stenosis (~30HU) were implanted into 10 
different coronary stents (~3mm) embedded in plastic tubes filled with contrast 
agent (~400HU). CT data was acquired with a SDLCT (IQon, Philips) and a 
SPCCT (Prototype, Philips). Sharp kernels were used for reconstructions with 
Conv and MonoE at 50, 70, 100 and 140keV. Visibility of the stenosis and the 
remaining lumen was evaluated by 2 readers for each stent and reconstruction 
using a Likert scale reaching from 1 (image quality impedes lumen 
assessment) to 5 (stenosis and remaining lumen are clearly visible). 
Results: Interrater agreement was very good (kappa=0.9). Stenosis 
delineation was best in Conv, 50 and 70keV MonoE SPCCT images (median 
score=5). Differentiation was significantly more difficult in corresponding 
SDLCT images (median score=3;p<0.01). Despite visibly lower blooming 
artifacts, 100 and 140keV MonoE images showed significantly poorer results 
than the corresponding 50keV MonoE images due to reduced contrast 
enhancement resulting in impaired visualisation of the unaltered lumen 
(median score=2 for 100keV and 1 for 140keV on both scanners;p<0.01). 
Conclusion: Evaluation of soft-plaque-restenosis can be significantly improved 
by using conventional and low keV MonoE reconstructions of future SPCCT. 
High keV MonoE reconstructions are not recommended for coronary stent 
assessment with SPCCT or SDLCT due to impeded stenosis delineation.  
Author Disclosures: 
 G. Pahn: Employee; Philips. P. Coulon: Employee; Philips.  
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B-0984 10:30  
To evaluate the role of 68Ga DOTA NOC receptor PET CT in detection of 
unknown primary neuroendocrine tumours  
S.M. Shaikh; Hyderabad/IN (drsikandar_s@yahoo.co.in)  
Purpose: The aim of our study was to evaluate the role of receptor PET/CT 
using 68Ga-DOTA-NOC in the detection of undiagnosed primary sites of 
neuroendocrine tumours (NETs). 
Methods and Materials: Overall 29 patients (M:F 15:14, age 55±9 yr) with 
histopathologically proven NET and unknown primary were included . PET/CT 
was performed after injection of 100 MBq (46-260 MBq) of 68Ga-DOTA-NOC. 
The (SUVmax) was calculated and compared with SUVmax in known 
pancreatic NET (pNET) and ileum/jejunum/duodenum (SI-NET). The results of 
PET/CT were also correlated with CT alone. 
Results: In 17/29 (59%) of patients, 68Ga-DOTA-NOC PET/CT localised the 
site of the primary: ileum/jejunum (7), pancreas (6), rectum (1), lungs (1) and 
paraganglioma (2). CT alone (on retrospective analyses) confirmed the 
findings in 6/29 (20%) patients. The mean SUVmax of identified previously 
unknown pNET and SI-Net were 15.6 ± 9.8 (range 7.8-34.8) and 8.1± 6.0 
(range 4.2-27.8), respectively. SUVmax in patients with previously known 
pNET and SI-NET were 26.1±14.5 (range 8.7-42.4) and 11.3±3.7 (range 5.6-
17.9). The SUVmax of the unknown pNET and SI-NET was significantly lower 
(p< 0.05) as compared with known primary tumour sites. 19% of the patients 
had high-grade and 81% low-grade NET. In 3/29 patients the primary tumour 
was subsequently resected (1 pancretic, one ileal and one rectal tumour). 
Conclusion: 68Ga- DOTA-NOC PET/CT is highly superior to 111In 
Octreoscan (17% detection rate for CUP according to the literature) and plays 
a major role in the management of patients with CUP-NET.  
B-0985 10:38  
PET/MR of biliary tract malignancies: impact on treatment planning  
O.A. Catalano1, U. Mahmood1, C. Ferrone1, L. Blaszkowsky2, L. Goyal1, 
T. Hong1, C. Catana3, D. Gervais1, B.R. Rosen3; 1Boston, MA/US, 
2
Newton, MA/US, 3Charlestown, MA/US (onofriocatalano@yahoo.it)  
Purpose: To compare the impact of PET/MR versus PET/CT on treatment 
planning in biliary malignancies. 
Methods and Materials: 18 consecutive patients with biliary malignancies 
underwent whole-body contrast-enhanced (CE)-FDG-PET/CT, 13 of them 
underwent CE-FDG-PET/MR and 5 non-CE-FDG-PET/MR. Two readers 
evaluated PET/CT and PET/MR for local extension, resectability and 
metastases. Impact of findings on treatment planning was discussed with the 
referring clinicians. 
Results: PET/MR and PET/CT were concordant and correct in 8/18 patients: 
disclosing metastases in 4 and ruling out metastases and confirming 
resectability in 4. However, in 1/4 of resectable cases PET/MR demonstrated 
additional regional lymphadenopathy mandating changes in surgical technique. 
PET/MR and PET/CT were concordant and incorrect in 1/18 patient, missing 
peritoneal disease. PET/MR and PET/CT were discordant in 9/18, with 
PET/MR being correct: PET/MR disclosed metastases missed at PET/CT in 4, 
diaphragmatic infiltration missed on PET/CT in 1, and interpreted benign 
findings, confused with metastases on PET/CT, in 4 (inflammatory enlarged 
non-regional lymph nodes in 1, focal cholangitis in 2, perfusion abnormalities in 
1) making them resectable. 
Conclusion: PET/MR imaging of biliary malignancies is useful in staging and 
assessment for resectability. PET/MR did not mis-stage any patient when 
compared to PET/CT, correctly diagnosed all 9 discordant cases, and 
mandated changes in treatment plan in 10 cases (p<0.05). PET/MR might 












B-0986 10:46  
Implications of 2-hydroxyglutarate in gliomas with IDH1/2 mutations  
L. Wang1,2, Y. Zhang1, Z. Liu3,1, H. Mao2; 1Shenzhen/CN, 2Atlanta, GA/US, 
3
Nanchang/CN (2718377613@qq.com)  
Purpose: Mutated isocitrate dehydrogenase 1 or 2 (mIDH1/2) occur in 80% of 
low grade gliomas. Onco-metabolite, R(-)-2-hydroxyglutarate (2HG) is a 
biomarker for mIDH on molecular classification of tumors and can be detected 
with magnetic resonance spectroscopy (MRS) for predicting prognosis. To 
determine whether MRS measurement of 2HG can provide more prognostic 
and therapeutic information, we investigated the correlations of 2HG level with 
tumour progressions and other metabolites. 
Methods and Materials: 2HG concentrations were measured from tissue 
specimens of 47 gliomas with mIDH by 2D Correlation Spectroscopy using 
solid state NMR. All tumours were categorised into three WHO grades. 
Progression free survival (PFS) of patients with mIDH/wild type (WT) IDH was 
determined. 2HG levels were compared with WHO grades, PFS, and selected 
metabolites, such as lactate (Lac), glutamate (Glu) and glutamine (Gln). Non-
parametric Mann-Whitney correlation for comparison/Spearman was used for 
statistical analysis. 
Results: 2HG level is elevated in tumours of higher grades. mIDH gliomas has 
increased PFS compared to those with WT IDH. However, PFS is negatively 
correlated with 2HG concentration. Metabolite measurements showed that 
increased 2HG level is related to increases of Glu and Gln, indicating that 2HG 
may trigger a metabolic shift since Glu/Gln can be converted to a-
ketoglutarate, the substrate of mIDH. Furthermore, the levels of Lac and 2HG 
are found to be positively correlated, possibly due to increase of glucose 
consumption related to high mutant enzyme activity. 
Conclusion: Imaging methods capable of monitoring 2HG level may enable 
non-invasive and longitudinal assessment of prognosis and treatment 
responses.  
B-0987 10:54  
Magnetic resonance spectroscopy of the placenta: a feasibility study  
C.M.J. Beaumont, E.H. Whitby; Sheffield/UK (charlottiebeaumont@gmail.com)  
Purpose: Placental proton magnetic resonance spectroscopy (1H MRS) is a 
newly emerging technique with the potential to non-invasively assess the 
function of the placenta in vivo. Previous studies utilising this technique have 
been limited. This study aimed to investigate whether this tool could be feasible 
for routine clinical use. 
Methods and Materials: In utero-placental MR spectra were obtained from 
women (n=43) referred for foetal MRI following abnormal ultrasound scans. 
Participants were of varying gestational age (GA) and exhibited a wide range 
of foetal pathologies unrelated to placental function. Spectra quality was 
assessed both qualitatively and quantitatively, with the potential influence of 
GA and placental Grannum grade (GG) also considered. 
Results: Almost 75% of spectra obtained were considered good quality, with 
substantial agreement between assessors (Fleiss Kappa: K=0.646) and were, 
therefore, considered suitable for diagnostic interpretation. Neither GA (Anova: 
P>0.05) nor GG significantly influenced visual spectra quality. Signal-to-noise 
ratio also appeared unaffected by the GA (regression: P>0.05) and GG 
(Anova: P>0.05) of participants. Lipid contamination due to foetal movement 
negatively affected spectra obtained from participants of low GA. No visible 
trend was observed between GA or GG and spectral metabolites. 
Conclusion: In vivo placental 1H MRS is feasible in routine clinical practice 
and warrants further investigation. The spectra obtained do not appear to be 
influenced by either the GA or GG in terms of quality or spectral metabolites. 
Future studies establishing metabolite threshold profiles for conditions, and 
confirming our conclusions regarding the influence of potential confounding 
variables would be beneficial.  
B-0988 11:02  
Imaging glycolytic heterogeneity of HCC in real time using dynamic 
hyperpolarised magnetic resonance spectroscopy: a personalised 
medicine approach  
G. Kaissis, F. Lohöfer, E. Bliemsrieder, G. Topping, F. Schilling, 
E.J. Rummeny, M. Schwaiger, R. Braren; Munich/DE  
Purpose: To demonstrate glycolytic heterogeneity of hepatocellular carcinoma 
in a homograft model using hyperpolarised 13C-Pyruvate dynamic magnetic 
resonance spectroscopy (MRS) and response to PARP14 inhibition therapy as 
in vitro validation. 
Methods and Materials: Cell clones were derived from diethyl nitrosamine 
(DEN)-induced tumors and implanted into the hindquarters of Wistar rats. 
Dynamic hyperpolarised 13C-Pyruvate-MRS was performed. Real-time 
conversion of pyruvate to lactate was measured and modelled using a two-
compartment model. Results were correlated with IC50 values of the 
corresponding cell lines for PARP14 inhibition in vitro. 
Results: Cell clone isolation and reimplantation from DEN-induced HCC was 
successful. Dynamic MRS provided excellent SNR and showed linear kinetic 
characteristics for pyruvate to lactate conversion (R2= 0.98, p<0.001, n=6). 
Kinetic constants correlated inversely with IC50 values of the same cell lines for 
in vitro PARP14 inhibition (R2= -0.9384, p=0.0015, n=6). 
Conclusion: This is the first study to demonstrate successful cell isolation and 
reimplantation in the DEN/Wistar model and the first to demonstrate feasibility 
of dynamic hyperpolarised 13C-Pyruvate-MRS for kinetic modelling of pyruvate-
to-lactate conversion for identification of metabolic subgroups. In vitro results 
correlate with MRS measurements demonstrating higher sensitivity to 
antiglycolytic therapy in tumors with high lactate production from pyruvate (i.e. 
higher glycolytic activity). Our approach can be utilised for imaging metabolic 
heterogeneity of HCC (e.g. differentiating glycolytic vs. nonglycolytic tumors) in 
the setting of personalised medicine applications as well as pharmacodynamic 
studies and novel inhibitor development.  
B-0989 11:10  
The early study of DWI and 1H-MRS in rabbit VX2 transplanted tumours 
after radiation comparison with pathology changes  
Y.-M. Li, D.-D. Lin, Z. Xing, Y. Chuan, X. Xu; Fuzhou/CN (fjmulym@163.com)  
Purpose: To analyse the role of DWI and 1H-MRS in evaluating the sensitivity 
of early radiotherapeutic effects by comparing the features of DWI and 1H-
MRS with pathology changes in VX2 transplanted tumour. 
Methods and Materials: Sixty rabbits were implanted VX2 tumour in unilateral 
thigh muscle to establish the experimental models. 2 weeks later, the rabbits 
were randomly divided into 10 groups according to whether accepting the 
radiation therapy and the different observation time.The groups were 
performed MR scans include T1WI, T2WI, DWI, and 1H-MRS on 3.0T before 
radiotherapy and 1,3,5,7days after radiotherapy, respectively. Tumour 
volume,ADC values, Cho/Cr ratios and Lip/Cr ratios of rabbit VX2 transplanted 
tumour in radiation group and control group at different observed day were 
analysed using a factorial design statistical method. 
Results: 1. After radiation, ADC values in radiation group increased gradually 
(P<0.05). 2. Cho peak tended to descend and the Lip peak tended to climb in 
radiation group. There were statistically changes of Cho/Cr, Lip/Cr ratios in 
different group and times. 3. The expression of the bax gene in radiation group 
tended to increase gradually. 
Conclusion: DWI and 1H-MRS could detect the internal structure changes of 
tumour early after radiation in the level of molecule and biochemistry. There 
were some correlations between the tumour volume, the ADC values, Cho/Cr 
ratios and Lip/Cr ratios and the expression of bax gene after early 
radiotherapy, DWI and 1H-MRS may be valuable means in predicting early 
radiotherapeutic effect.  
B-0990 11:18  
BAT activity in Type I and Type II diabetes mouse models: multimodal 
imaging study using 7T MRI and intravital microscopy  
C.S.L. Jung, M. Heine, N. Mangels, M. Kaul, G. Adam, H. Ittrich, J. Heeren; 
Hamburg/DE  
Purpose: Purpose was to determine metabolic activity of brown adipose tissue 
(BAT) in type I and type II diabetes mouse models using superparamagnetic 
iron oxide nanoparticles (SPIO) or quantum dots (QD - for intravital microscopy 
(IVM)) embedded into triglyceride-rich lipoproteins (TRL). 
Methods and Materials: C57BL/6J wild-type mice were either treated iv with 
Alloxan (Abcam) which is toxic to pancreatic beta cells or received a high fad 
diet to induce diabetes (type I and II). BAT activity was stimulated using 
CL316,243, a 3 receptor agonist. MRI at 7T ClinScan (Bruker) was performed 
before and 20min after iv injection of TRL-SPIOs using a T2*w Multiecho-GRE 
sequence. IVM analysis was performed for real time imaging of TRL-QD 
uptake into BAT. To quantify TRL clearance, the fate of radioactively labelled 
TRLs were analysed under same experimental conditions. 
Results: While control mice show a significant signal drop after CL treatment, 
no signal difference in BAT before and after TRL-SPIO injection was 
detectable neither for type I nor for type II diabetes mouse model. Real time 
IVM analyses showed a reduction of TRL-QD uptake in case of diabetes. MRI 
and IVM results were confirmed quantitative by metabolic studies using 
radioactive TRL. In both setups diabetes disease leads to a reduction of TRL 
uptake into BAT. 
Conclusion: 3-receptor activation via CL with following acute insulin release 
lead to BAT activation, which can be visualised in vivo by MRI. In case of 
diabetic disease, the uptake of TRL into BAT is diminished, indicating a loss of 













B-0991 11:26  
In vivo tracing of superparamagnetic iron oxide-labelled bone marrow 
mesenchymal stem cells transplanted for traumatic brain injury by 
susceptibility weighted imaging in a rat model  
Y. Zhang; Zhengzhou/CN (109496417@qq.com)  
Purpose: To label rat bone marrow mesenchymal stem cells (BMSCs) with 
superparamagnetic iron oxide (SPIO) in vitro, and to monitor the survivorship 
and location of these labelled BMSCs in a rat model of traumatic brain injury 
(TBI) by susceptibility weighted imaging (SWI) sequence. 
Methods and Materials: BMSCs were cultured in vivo and then labeled with 
SPIO. The rat TBI model was developed in the left hemisphere following 
Feeney’s method. Twenty-four hours after TBI, we stereotactically transplanted 
the BMSCs into the region nearby the contusion site. Monitoring of these 
SPIO-marked BMSCs by SWI was performed at one day, one week and three 
weeks after implantation. 
Results: Numerous BMSCs were successfully labeled with SPIO and positive 
for Prussian blue staining. Scattered iron particles were observed in the 
cytoplasm by electron microscopy. MRI of the transplanted sites demonstrated 
a low signal intensity on every image of SWI sequence. 
Conclusion: SWI sequence in vivo can consecutively and noninvasively trace 
and demonstrate the status and distribution of BMSCs labelled with SPIO in 
the brain of TBI model rats.  
B-0992 11:34  
Molecular imaging heterogeneity study of breast tumours as a new 
diagnosis parameter  
M. Herranz1, P. Ling Ling2, P. Aguiar1, W. Liang2, L. Albaina Latorre3, 
M. Juaneda3, A. Ruibal1; 1Santiago de Compostela/ES, 2Shanghai/CN, 
3
A Coruña/ES (michel.herranz.carnero@sergas.es)  
Purpose: The concept of tumour heterogeneity corresponds to different levels 
of expression, cellularity, hypoxia or other parameters interested in being 
measured into a single tumour. We describe relationship between tumour 
heterogeneity concept uses in radiology with PET parameters and if any 
biological characteristics of the breast tumours have a structure-function 
correlation. 
Methods and Materials: 500 consecutive patients with breast cancer were 
analysed in a dedicated breast PET. Different parameters have been defined 
to find a pattern of texture and heterogeneity (TeHe), for this, and following the 
rules of the radiological descriptions we have described a series of structural 
templates. A mathematical pattern has been defined for their correlation. 
Patterns of heterogeneity have been correlated with clinical values of the 
tumours, such as molecular classification, size, type, histology, progression, 
relapses, etc.  
Results: 7 different patterns divided into 5 large groups of values for TeHe are 
described, and classified as: 1: homogeneous diffuse, 2: lobular, 3: annular 
and spindle, 4: eccentric and focused; and 5: speckled. A numerical value has 
been assigned between 1 and 5 for this classification with 1 being the most 
homogeneous and 5 being the most heterogeneous. This value is achieved 
through a mathematical relationship: 
medSUV/maxSU/[(MedSUV/maxSUV)Qmax/(medSUV/maxSUV)Qmin]. 
Conclusion: Studies of tumour heterogeneity based on metabolism show us 
different patterns that correlate with molecular subtypes and predict response 
to treatments.  
B-0993 11:42  
Small animal imaging using a clinical PET/CT system: high throughput 
imaging enabled by next-generation digital PET  
M.V. Knopp, K. Briley-Saebo, M.I. Menendez, A. Siva, K. Binzel, J. Zhang; 
Columbus, OH/US  
Purpose: Preclinical imaging, particularly of rodents, is a key aspect of 
development of new molecular imaging approaches. We sought to develop the 
capability of multi-subject, simultaneous whole-body PET/CT imaging using a 
next generation, digital PET detector based, clinical PET system. 
Methods and Materials: A pre-commercial release, next-generation, digital 
photon counting clinical PET/CT system (Philips Vereos, dPET) was used. 
Enabled by the excellent count sensitivity and time of flight timing resolution 
(325 ps) of the dPET system, we have previously optimized an ultra-high 
definition reconstruction utilizing a 1 mm3 voxel size. CT imaging was 
reconstructed with a 1024x1024 matrix, 0.5 mm voxel length. A mouse hotel 
that can be variably configured to accommodate up to 6 animals at once was 
constructed. 
Results: Both CT and PET imaging was achievable within a single acquisition 
volume achieving excellent image quality with an initial acquisition time of 10 
minutes. We additionally found that imaging for 3 minutes produced adequate 
image quality as well. No cross-interference from the multiple beds was 
observed. While the 6 bed layout appears practical, a higher number of beds is 
feasible without loss of spatial or quantitative quality from the PET perspective. 
The CT field of view is limited to about 6 mice if high resolution imaging is 
required. 
Conclusion: Next-generation clinical PET/CT systems can feasibly be used for 
high throughput, whole-body imaging of rodents, here with 6 animals 
simultaneously. This approach could benefit large rodent population imaging 
with efficient radiotracer management, particularly for short lived isotopes.  
B-0994 11:50  
Preliminary analysis of ultrasound imaging-based thermometry in ex vivo 
biological tissues  
F. Giurazza, G. Frauenfelder, C. Massaroni, G. Galati, A. Picardi, E. Schena, 
B.B. Beomonte Zobel, S. Silvestri; Rome/IT (francescogiurazza@hotmail.it)  
Purpose: Real-time monitoring of tissue temperature during percutaneous 
tumour ablation improves treatment efficacy, leading clinicians to adjustment of 
treatment settings. This study aims at assessing the feasibility of ultrasound-
thermometry during laser ablation of biological tissue using a specific 
ultrasound imaging techniques based on elastography (ARFI). 
Methods and Materials: ARFI uses high-intensity focused ultrasound pulses 
to generate ‘radiation force’ in tissue; this causes tissue displacements 
trackable using correlation-based ultrasound methods: the sensitivity of shear 
waves velocity is able to detect temperature changes. Experiments were 
carried out using a Nd:YAG laser (power: 5W) in three ex vivo pig livers. In 
each organ was placed a thermocouple close to the applicator tip (distance 
range: 1.5-2.5cm) used to record a reference temperature. Positioning of laser 
applicator and thermocouple was eco-guided. The organ was scanned by an 
echography system (Siemens ACUSON-S3000); propagation velocity was 
measured in a region of interest (ROI) of 1x0.5cm located close to 
thermocouple, to investigate the influence of tissue temperature on shear wave 
velocity. 
Results: Shear wave velocity has a very low sensitivity to temperature up to 
55-60°C, and in all cases velocity is <5ms-1; for temperature >55-60°C velocity 
shows a steep increment. The system measures a value “over limit”, meaning 
a velocity >10 ms-1. 
Conclusion: Ultrasound thermometry during laser-ablation of biological tissue 
based on elastography shows an abrupt output change at temperatures >55-
60°C. This issue can have a significant clinical impact, considering tumour 
necrosis when temperature crosses 55°C to define the boundary of the 
damaged volume.  
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B-0995 10:30  
Gd presence in the brain: impact of daytime and anaesthesia  
T. Taoka1, G. Jost2, S. Naganawa1, H. Pietsch2; 1Nagoya/JP, 2Berlin/DE 
(ttaoka@med.nagoya-u.ac.jp)  
Purpose: The purpose of the current study is to investigate the influence of the 
circadian rhythm associated with the glymphatic activity on the presence of 
gadolinium the rat brain after repeated administration of gadolinium-based 
contrast agents (GBCA). 
Methods and Materials: Twenty-four Han-Wistar rats were divided into four 
groups: Group 1; morning injection, Group 2; evening injection, Group 3; 
morning injection under short-duration anaesthesia and Group 4; morning 
injection under long-duration anaesthesia. Every subject received gadodiamide 
(1.8mmol/kg x 8 times over 2 weeks). 5 weeks after the last injection the brains 
were dissected and the Gd concentration in the cerebellum, pons and 
cerebrum was quantified by inductively coupled plasma mass spectrometry. 
Results: In cerebellum, mean Gd concentrations were 3.58, 5.77, 2.95 and 
2.51 (nmol/g tissue) in Groups 1, 2, 3 and 4, respectively. Likewise, mean Gd 
concentrations were 2.86, 5.04, 2.37 and 1.92 (nmol/g) in cerebrum, and 1.63, 
1.76, 1.61 and 1.22 (nmol/g) in pons. 
Conclusion: In the cerebellum and cerebrum, Gd concentration was highest in 
the group with evening injection, followed by morning injection, morning 
injection with short anaesthesia and morning injection with long anaesthesia 
GBCA administration. As rats are nocturnal animals, glymphatic system is 
expected to be more active during daytime. The results of this study might be 
explained by the higher glymphatic clearance following the morning injection, 
while a reduced glymphatic activity is present after the injection in the evening. 
Anaesthesia seemed to facilitate the glymphatic clearance of GBCA especially 
for longer durations.  
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B-0996 10:38  
Quantitative assessment of spatial and temporal gadolinium deposition 
within the deep brain nuclei  
G. Marie, P. Poeg, J. Son Forget, J.P. Maeder, R. Meuli; Lausanne/CH 
(guillaume.marie@chuv.ch)  
Purpose: Gadolinium is known to deposit in the deep brain nuclei, but no 
quantitative study has been done yet. This study aims to quantify the spatial 
and temporal dissemination of gadolinium in deep brain nuclei after repeated 
injections of linear GBCA. 
Methods and Materials: We analysed retrospectively MRIs from a cohort of 
30 patients at CHUV, who received at least 10 injections of non-ionic linear 
gadodiamide (Omniscan, GE healthcare, Piscataway, New Jersey). We 
calculated the difference of native T1 mean SI ratios of DN, GP, posterior 
thalamus, SN, superior colliculus and anterior putamen, to pons, not known to 
accumulate significantly gadolinium. We analysed the change rates in the SI 
ratios over the successive GBCA's administrations, using linear mixed effects 
modelling (Bernal-Rusiel et al., NeuroImage, 2013). 
Results: We observed a significant, gradual and differential increase of SI 
ratios in ROIs after successive injections (P<0.001), suggesting a gradual 
deposition in space and time where faster profiles of deposition in GP, DN and 
SN are demonstrated in comparison to superior colliculus, posterior thalamus 
and anterior putamen. 
Conclusion: The deposit may occur gradually in space and time following the 
first injection of linear GBCAs, as quantitative measures show differential 
profiles of T1 hypersignals in basal ganglia structures. The different slopes 
observed in SI ratios may correlate with respective inner iron content of 
different nuclei and subsequent increased probability of transmetallation 
reactions with the GBCA ligand and of gadolinium unchelation.  
B-0997 10:46  
Gadolinium retention in the brain: an MRI relaxometry study comparing 
linear and macrocyclic types of gadolinium-based agents  
Y. Forslin, J. Martola, S. Shams, S. Fredrikson, M. Kristoffersen Wiberg, 
T. Granberg; Stockholm/SE (yngve.forslin@ki.se)  
Purpose: Gadolinium retention in the brain after administrations of gadolinium-
based contrast agents (GBCA) has recently been demonstrated, predominantly 
in the dentate nucleus (DN) and globus pallidus (GP). This retention is 
associated with lasting high T1-weighted signal and has been consistently 
shown for linear GBCAs. It is debated if the more stable macrocyclic GBCAs 
lead to in vivo-detectable alterations of the T1. We aimed to quantitatively 
investigate T1 in relation to linear and macrocyclic GBCA administrations in DN 
and GP by relaxometry in MS patients. 
Methods and Materials: A multi-parametric MRI sequence was used to obtain 
longitudinal relaxation rates on a 3 T Siemens Magnetom Trio MRI scanner. In 
89 consecutively recruited patients with multiple sclerosis (MS), regions of 
interest were drawn in the DN and GP by a resident in radiology blinded to the 
clinical information. 
Results: Patients without previous exposure to GBCAs and those who had 
only received macrocyclic GBCA had longer T1 relaxation, in DN and GP, in 
comparison with those patients who had received >1 linear GBCA (unpaired t 
test: P=0.036 and P=0.021, respectively). Higher number of administered 
linear (but not macrocyclic) GBCA was associated with faster T1 relaxation in 
DN and GP (multiple regression analysis: =0.32, P=0.006 and =0.24, 
P=0.046). These results remained significant after correction for the MS 
disease duration. 
Conclusion: Multiple GBCA administrations lead to shorter relaxation rates in 
GP and DN. Patients only receiving the macrocyclic type gadoterate 
meglumine have a longer relaxation rates in comparison with patients who 
received linear types of GBCA.  
Author Disclosures: 
 S. Fredrikson: Other; has received honoraria for lectures, educational 
activities or consultancy from Allergan, Bayer, Biogen Idec, Genzyme, Merck 
Serono, Novartis, Sanofi and Teva. 
B-0998 10:54  
Increased signal intensity of dentate nucleus in multiple sclerosis 
patients with history of higher gadolinium-enhanced MRI scans  
H. Naghibi, M. Mohammadzadeh, A. Fallahian, M. Shakiba, P. Sabetrasekh, 
H. Soroush; Tehran/IR (mm1361@yahoo.com)  
Purpose: It has been mentioned that there is an increased probability of 
hyperintensity of dentate nucleus [DN] with more gadolinium [GAD]-enhanced 
MRI exams. Here, we have assessed this event in a group of multiple sclerosis 
[MS] patients with history of multiple GAD-enhanced MRI exams. 
Methods and Materials: Totally 140 MS patients [mean age: 36.1±9.3 years 
(19-64); 86% female] with history of multiple GAD-enhanced MRI scans and 21 
healthy controls were enrolled. DN hyperintensity was assessed visually in 
unenhanced T1-weighted MRI; signal intensity ratio [SIR] was calculated by 
setting region of interests [ROIs] on DN and pons and dividing DN SI into pons 
SI. Two groups of patients and controls and different patient subgroups 
[classified based on total number of MRI scans (more than 4 times versus 
others)] were compared regarding mean SIR and visual hyperintensity. 
Results: Totally, 83 patients received contrast more than 4 times [68%]; 
among them, 26 showed DN hyperintensity [31.3%] while there was not 
hyperintensity in other patients and controls [both Ps<0.02]. Mean SIR in 
patients and controls was 1.10±0.07 and 1.04±0.02, respectively [P<0.001]. 
Mean SIR was 1.14±0.04 in DN hyperintense patients and 1.09±0.07 in other 
patients [P<0.001]. Mean SIR in patients with higher contrast injection (>4) was 
1.12±0.7 while it was 1.06±0.04 in other patients [P<0.001]; after deleting 
patients with DN hyperintensity, these figures were 1.11±0.08 and 1.06±0.04, 
respectively [P<0.001]. Correlation coefficient of SIR with contrast injection 
time was 0.66 [P<0.001]. 
Conclusion: SI and visual DN hyperintensity are increased in more contrast 
injections. This could be due to tissue deposition of GAD. The clinical 
importance of this phenomenon should be assessed in future studies.  
B-0999 11:02  
USPIO-enhanced MRI study on electroacupuncture alleviating 
inflammatory response of permanent focal subacute-stage cerebral 
ischaemia in rats  
S. Yang, F. Lu, S. Zhan; Shanghai/CN 
Purpose: To evaluate the effectiveness of acupuncture on alleviating 
inflammatory response derived by macrophages recruitment during subacute 
period after permanent middle cerebral artery occlusion (pMCAO) in rats on 
enhanced MRI with ultrasmall superparamagnetic particles of iron oxides 
(USPIO). 
Methods and Materials: Thirty-nine SD ischaemia rats with USPIO injection 
were established including sham-operation group (group A), pMCAO group 
without acupuncture (group B) and electroacupuncture pMCAO group (group 
C). Each group was further divided into 3 subgroups on 72h, 5d and 7d after 
ischaemia modeling. The signal intensity of the darkest area of infarction with 
corresponding mirror area was measured on T2W images after MR scanning. 
Then the darkest area of infarction and mirror area on SWI of groups B and C 
were measured and the ratios were calculated. Correlations between signal 
intensity ratios of the darkest area on T2W images and proportion of positive 
iron particles in anti-CD68 macrophages were analysed. 
Results: The ratios of darkest area with 7d on T2W images were significantly 
higher in group C than in group B (P﹤0.05). The ratios of darkest area with 5d 
and 7d subgroups were significantly higher in group C than that in group B on 
SWI (P < 0.05).The signal intensity ratios of the darkest area on T2WI were 
positively correlated with proportion of positive iron particles in anti-CD68 
macrophages of 5d (r = 0.483, P = 0.047) and 7d (r = 0.525,P = 0.033). 
Conclusion: With USPIO-enhanced MRI, we found electroacupuncture could 
alleviate inflammatory response derived by macrophages recruitment at the 
subacute stage in pMCAO rats.  
B-1000 11:10  
MRI perfusion weighted imaging and von Willebrand factor antigen 
plasmatic levels (VWF:Ag) as predictors of prognosis in grade IV gliomas 
(GBM)  
F.M. Doniselli, G. Marfia, S.E. Navone, L. Guarnaccia, R. Campanella, 
P. Summers, A. Costa; Milan/IT (fabio.doniselli@gmail.com)  
Purpose: The prognostic significance of VWF:Ag and dynamic contrast-
enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI parameters in 
brain tumours is unknown. The aim of the study is to investigate the correlation 
of MRI-perfusion parameters and VWF:Ag with patient prognosis in GBM. 
Methods and Materials: We reviewed a series of twenty-six patients with 
biopsy-proven GBM (males/females 18/8; median age 63 years) who 
underwent pre-operative DCE-MRI and DSC-MRI. VWF:Ag was analysed from 
pre-operative collected plasma sample (expressed as IU/dL). We measured 
the mean and maximum values of DSC-derived relative cerebral blood flow 
(rCBF) and volume (rCBV), DCE-derived volume transfer constant (Ktrans), 
plasma volume (Vp) and reflux rate constant between the fractional volume of 
the extravascular space and blood plasma (Kep). Non-parametric Mann-
Whitney test was used. 
Results: The median overall survival was 7 months (interquartile range=5-
12).The distribution of vWF:Ag was bimodal, for which the median value (247 
IU/dl) was used to separate the patients into two equally sized groups: a low 
vWF:Ag group (vWF:Ag<248; median=165, IQR=137-201) and a high vWF:Ag 
group (vWF:Ag>=248; median=410, IQR=329-528). When we compared the 
two groups, the median follow-up duration was 10 (IR=7-15) and 6 months 
(IR=3-7.5), respectively (p=0.02). The median Ktrans values were 0.31 (IR=0.16-
0.50) and 0.53 min-1 (IR=0.34-1.19), respectively (p=0.02). The median Kep 
  






values were 1.79 (IR=1.23-2.70) and 3.89 min-1 (IR=2.42-7.15), respectively 
(p=0.005). No significant differences in overall survival or correlation with 
vWF:Ag were found for other parameters. 
Conclusion: These findings in a small group of patients suggest a role for 
VWF:Ag, Ktrans, and Kep as a prognostic indicator of post-operative survival of 
patients with GBM.  
B-1001 11:18  
3D high-resolution post-contrast imaging at 3T for the delineation of 
enhancing brain tumours: a comparison of three different techniques  
L. Danieli1, D. Distefano1, E. Prodi1, E. Ventura1, G.C. Riccitelli1, M. Reinert1, 
A. Kaelin1, A. Cianfoni1,2, E. Pravatà1; 1Lugano/CH, 2Bern/CH 
(lucia.danieli@eoc.ch)  
Purpose: To prospectively investigate three different post-contrast 3D-T1-MRI 
techniques [Magnetization-Prepared-Rapid-Gradient-Echo (MPRAGE), 
Volumetric-Interpolated-Brain-Examination (VIBE), Sampling-Perfection-with-
Application-optimised-Contrasts-using-different-flip-angle-Evolutions (SPACE)] 
in the assessment of contrast-to-noise-ratio (CNR), total volume (TV) and 
margins extent delineation (MED) of brain primitive tumours (pT) and 
metastases potentially amenable to surgical and/or conformal radiotherapy 
treatment. 
Methods and Materials: Fifty contrast-enhancing lesions (38 pT and 12 
metastases) were detected in 36 patients using 3T MRI with 1-mm MPRAGE, 
VIBE and SPACE sequences randomly acquired 5 minutes after 0.1ml/kg 
administration of gadobutrol. Lesions CNR and TV segmentation were 
performed by an experienced neuroradiologist using a validated semi-
automated tool (SmartBrush, Brainlab) followed by manual refinement. For 
each combination of sequence pairs, MED mismatch was quantified using 
subtraction volumetric maps of the segmented lesions. Mann-Whitney and 
paired-samples Wilcoxon non-parametric tests were used to investigate 
between-sequences discrepancies in CNR, TV and MED subtraction volumes. 
Results: In both pT and metastases, CNR was higher for SPACE compared to 
VIBE and MPRAGE (p-range<0.001-0.045) and for VIBE compared to 
MPRAGE (p-range<0.001-0.004). Larger TVs for pT were obtained with 
SPACE compared to VIBE (p=0.006), and for metastases with SPACE 
compared to MPRAGE (p=0.012). Discrepancy in MED was also found, with 
SPACE exceeding both VIBE (p=0.004) and MPRAGE (p=0.01) in pT, and 
MPRAGE only (p=0.005) in metastases. 
Conclusion: We found technique-related differences in the CNR, TV and MED 
estimates of both brain pT and metastases. The relatively higher CNR seen 
with SPACE may account for the larger TV and MED. These findings may be 
relevant for treatment planning and response assessment.  
Author Disclosures: 
  L. Danieli: Research/Grant Support; Scientific Research Advisory Board of 
the EOC (ABREOC).  
B-1002 11:26  
Comparison of arterial spin-labeling and dynamic susceptibility contrast 
MRI in detecting crossed cerebellar diaschisis in patients after glioma 
resection  
T. Lin, F. Feng, Y. Lv, H. You; Beijing/CN (jasminelty@163.com)  
Purpose: To compare two clinical most common used methods: arterial spin-
labeling (ASL) and dynamic susceptibility contrast (DSC) MRI in detecting CCD 
in patients after glioma resection. 
Methods and Materials: 145 patients with perfusion deficit in one hemisphere 
after glioma resection and radiotherapy were reviewed. Lesion locations were 
recorded. Visual qualitative analysis was performed by two neuroradiologists 
on ASL CBF map. Signal intensity asymmetry of bilateral cerebellar 
hemisphere was classified into three grades: grade I, isointense; grade II, 
slightly hypointense; grade III, markedly hypointense. Quantitative analysis by 
calculating asymmetry index (AI) of bilateral cerebellar hemispheres was 
performed on all 145 patients on ASL CBF, DSC rCBF and rCBV maps. One-
way ANOVA was used to compare differences between the AIs in each 
method. Chi-squared or Fisher exact test was used for finding correlations 
between CCD and the locations of supratentorial lesions. 
Results: The interrater agreement was excellent (kappa value = 0.852) in 
qualitative analysis. Thirty-nine (26.9%) patients were CCD positive (27 in 
grade II and 12 in grade III). Lesions affecting corona radiata (P<0.001), basal 
ganglia (P<0.001), temporal lobe (P=0.038) and insular lobe (P=0.031) were 
significantly associated with CCD. The mean AI of ASL CBF (27.59%±8.60%) 
was significantly larger than that of DSC rCBV (15.27%±12.66%) (P<0.001) 
and DSC rCBF (10.84%±8.56%) (P<0.001). 
Conclusion: ASL is more sensitive than DSC rCBV and rCBF map in 
detecting CCD among patients after glioma resection. CCD is more likely to be 
associated with supratentorial lesion involved with corona radiata, basal 
ganglia, temporal lobe and insular lobe.  
 
B-1003 11:34  
MR-perfusion characteristics and PET/CT comparison in patients with 
gliomas after radiotherapy  
A.V. Smirnova1, O.V. Lukina2, M. Cherkashin2, N. Plakhotina2, A. Tkachev3, 
M. Anishkin1, M. Rukhlenko1; 1St. Petersburg/RU, 2Saint-Petersburg/RU, 
3
Volgograd/RU (smirnova_alina@bk.ru)  
Purpose: To evaluate gliomas perfusion changes after radiotherapy in 
comparison with PET/CT data. 
Methods and Materials: In our study 125 gliomas patients treated by different 
radiation modalities were initially included. 51 were excluded on different 
stages because they did not survive at month 24. All patients were divided into 
two groups: group A - gliomas I-IIG (n=21), group B - gliomas III-IVG (n=53). 
MR-perfusion and PET/CT (methionine) were performed before radiotherapy, 
and after 6, 12, 18 and 24 months. 
Results: In group A initially increase CBV, methionine UI2.0; in follow-up 1 
high CBV in 93%, UI2.2; decrease CBV in 7%, UI1.8; in follow-up 2 high 
CBV in 74%, UI2.7; reduction CBV in 26%, UI1.8; in follow-up 3 high CBV in 
57%, UI3.2; in follow-up 4 reduction CBV in 43%, UI1.8; in follow-up 5 high 
CBV in 31%, UI4.1; reduction CBV in 69%, UI1.6 were detected. In group B 
initially not increased CBV, methionine UI1.5; in follow-up 1 low CBV in 83%, 
UI1.5; in follow-up 2 increase CBV in 17%, UI1.7; in follow-up 3 low CBV in 
91%, UI1.5; increase CBV in 8%, UI1.7; in follow-up low CBV in 98%, 
UI1.5; increase CBV in 2%, UI1.5; in follow-up 5 low CBV in 100%, UI1.5. 
Conclusion: Gliomas metabolism and perfusion in first year after radiotherapy 
characterised by multidirectional changes. Just after 2 years of surveillance we 
have detected strong CBV and UI reduction. We suggest that future 
investigations with strong study power will generate evidence for clear 
differentiation the gliomas relapse and postradiation brain damage.  
B-1004 11:42  
Can unenhanced brain magnetic resonance imaging be used in routine 
follow-up of meningiomas to avoid gadolinium deposition in the brain?  
F. Kural Rahatli, F. Yildirim Donmez, Ç. Kesim, k. Haberal, H. Turnaoglu, 
A. Agildere; Ankara/TR (drkural@hotmail.com)  
Purpose: We speculated that unenhanced brain MRI can be used in routine 
follow-up of patients with intracranial meningioma to avoid gadolinium 
deposition in the brain and allow measurement of meningioma dimensions 
from precontrast T2-weighted images. We investigated whether measurements 
on pre-contrast T2-weighted images and post-contrast T1-weighted images are 
correlated. 
Methods and Materials: Thirty meningiomas with multiple enhanced brain 
MRI using linear non-ionic GDBCA (gadoversetamide) were analysed. The 
dimensions of meningiomas were measured on both axial precontrast T2-
weighted images and axial postcontrast T1-weighted images. Signal intensity 
ratios were calculated for dentate nucleus-to-pons (DN/pons), dentate nucleus-
to-cerebellar white matter (DN/cerebellum) and globus pallidus-to-thalamus 
(GP/thalamus). 
Results: Size of six meningiomas increased, as determined from 
measurements on both axial precontrast T2-weighted images and axial 
postcontrast T1-weighted images. The signal intensity ratios showed a 
significant increase (p<0.005) from the first to last brain MRI. The mean 
DN/pons ratio at first MRI was 1.055±0.38 and 1.149±0.86 at the last MRI. The 
mean DN/cerebellum ratio at first MRI was 1.068±0.42 and 1.156±0.78 at the 
last MRI. The mean GP/thalamus ratio at first MRI was 1.077±0.24 and 
1.136±058 at the last MRI. 
Conclusion: Size of meningiomas in post-contrast axial T1-weighted images 
was correlation with that in pre-contrast axial T2-weighted images, that is, both 
showed tumour growth. DN/pons, DN/cerebellum, and GP/thalamus signal 
intensity ratios increased with multiple administrations of linear non-ionic 
GBCAs in patients with normal renal function. Gadolinium deposition could be 
avoided in patients with meningioma using unenhanced brain MRI for follow-up 
scans.  
B-1005 11:50  
Perfusion abnormality in posterior inferior cerebellar artery termination of 
vertebral artery on arterial spin labelling and dynamic susceptibility 
contrast perfusion MRI  
D. Park, T. Kim; Guri/KR (dwpark@hanyang.ac.kr)  
Purpose: A posterior inferior cerebellar artery (PICA) termination of vertebral 
artery has been regarded as a normal variation of vertebrobasilar circulation. 
However, the perfusion condition of PICA territory in the cerebellum has not 
been evaluated. This study aims to present the perfusion abnormality in PICA 
termination of vertebral artery (PICA-VA) on arterial spin labeling (ASL) and 
dynamic susceptibility contrast (DSC) perfusion MRI. 
Methods and Materials: Sixteen patients (M:F=8:8, 49-90 years old) who 
conducted brain MRI including MR angiography, and ASL and DSC perfusion 
MR studies and are found to have PICA-VA, are evaluated in this study. PICA-
  






VA are associated with ipsilateral hypoplastic vertebral artery in 14 patients, 
and bilateral foetal type posterior cerebral artery in 2 patients. 
Results: Hypoperfusion in PICA territory is detected on both ASL and time to 
peak (TTP) map of DSC perfusion MRI in 11 patients (68.7%), on only TTP 
perfusion MRI in 2 patients (12.5%), on only ASL perfusion MRI in 1 patient 
(6.3%) and not on both perfusion MRI in 2 patients (12.5%). Any clinical 
manifestations of vertebrobasilar insufficiency are not accompanied in 2 
patients (12.5%). 
Conclusion: PICA-VA that is regarded as normal variation, considerably have 
hypoperfusion in PICA territory of cerebellum. PICA-VA could have the clinical 
significance, especially in vertebrobasilar insufficiency, so perfusion study such 
as ASL or DSC perfusion MRI may help to evaluate the clinical status of 
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B-1012 08:30  
Spectral detector-computed tomography iodine density thresholds for 
the detection of vertebral metastases  
N. Abdullayev, V. Neuhaus, M. Le Blanc, N. Grosse Hokamp, V. Maus, 
S. Lennartz, D. Maintz, J. Borggrefe; Cologne/DE 
(Jan.Borggrefe@uk-koeln.de)  
Purpose: To evaluate quantitative iodine density mapping (IDM) from spectral 
detector computed tomography (SDCT) as a quantitative parameter for the 
separation of vertebral trabecular bone metastases (BM) and healthy 
trabecular bone (HTB). 
Methods and Materials: This retrospective study includes portal venous 
SDCT datasets of cancer patients with and without known bone metastasis 
(n=43 and n=40, respectively). Target lesions as well as non-affected control 
vertebrae were defined by two radiologists in consensus using follow-up CT 
imaging, MRI and/or bone scintigraphy. IDM and its standard deviation (SD) 
were determined based on ROI measurements in BM and HTB of patients with 
and in HTB of patients without bone metastasis, and various reference 
tissues/vessels in both. Phantomless bone mineral density (vBMD) 
measurements of the lumbar spine were conducted. 
Results: We found a significant difference between IDM of BM and HTB 
(mean 5.55±0.98 vs. 3.57±0.96) (p<0.0001); however, there was a 
considerable overlap and a vBMD bias. A trivariate analysis including IDM, the 
inhomogeneity of the IDM as determined by the SD, and the normalization to 
the vertebral venous sinus improved the statistical separation of metastasis to 
a specificity of 100.0% and a sensitivity of 95.4% (AUC 0.98, p<0.05 compared 
to univariate models). 
Conclusion: SDCT allows for quantification of iodine in bone lesions which 
appears promising to serve as a parameter for the detection of bone 
metastases.  
B-1013 08:34  
Combining fractal- and entropy-based bone texture analysis for the 
prediction of osteoarthritis: data from the multicentre osteoarthritis study 
(MOST)  
Z. Bertalan1, S. Nehrer2, R. Ljuhar1, A. Fahrleitner-Pammer3, D. Ljuhar1, 
H.-P. Dimai3; 1Vienna/AT, 2Krems/AT, 3Graz/AT (rljuhar@gmail.com)  
Purpose: Osteoarthritis (OA) is the leading cause of long-term pain and 
disabilities associated with musculoskeletal disorders. Effective treatment 
depends on early detection and quantification of risk. Current disease 
parameters, like joint space width (JSW), have proven to be insufficient for the 
prediction of OA. The purpose of the present study was to investigate if 
combining bone texture analyses with JSW and joint space area (JSA) may 
improve prediction of OA. 
Methods and Materials: Conventional posterior-anterior (PA) knee 
radiographs were obtained from the multicentre osteoarthritis study (MOST) 
database. Oriented texture algorithms were developed, using specific machine-
learning algorithms. Selected areas used for textural analyses included 4 
regions of interest (ROI) in the proximal tibia and one on each condyle of the 
distal femur. Furthermore, JSW/JSA were assessed using newly developed 
and fully automated software. 
Results: 1092 radiographs obtained from one study centre were screened. 
230 women, 344 men met the inclusion criteria, i.e. a Kellgren & Lawrence 
(KL) score of 0 at baseline. At month 84, 41 female, 79 male patients had 
developed KL1, and 189 female, 265 male patients remained at KL0. Area 
under the curve (AUC) for incident OA using JSW/JSA/clinical features was 
0.67±0.08 for women, 0.61±0.1 for men. In contrast, combining texture, JSW/A 
and clinical features resulted in significantly improved AUC (0.80±0.07 for 
women and 0.69±0.1 for men, respectively). 
Conclusion: This study provides strong evidence that a combination of 
textural analyses of plain radiographs together with JSW/A and clinical features 






B-1014 08:38  
Delayed gadolinium-enhanced MRI of menisci and cartilage 
(dGEMRIM/dGEMRIC) in overweight patients with knee osteoarthritis  
S. Hangaard1, H. Gudbergsen1, C.L. Daugaard1, H. Bliddal2, J.D. Nybing1, 
V. Casula3, M.T. Nieminen3, C.J. Tiderius4, M. Boesen2; 1Frederiksberg/DK, 
2
Copenhagen/DK, 3Oulu/FI, 4Lund/SE (stine.hangaard.01@regionh.dk)  
Purpose: Changes in the menisci are associated with development of knee 
osteoarthritis (KOA). The aim of this study was to examine the delayed-
gadolinium-enhanced-MRI-of-menisci (dGEMRIM) and its relationship with 
Kellgren-Lawrence grade (KLG) and with articular cartilage dGEMRIC. 
Methods and Materials: 86 overweight patients with KOA (mean KLG 3) from 
the CAROT study had an intra-articular injection of Gd contrast. Four invasion 
times (50, 350, 650, 1410 ms) dGEMRIC and dGEMRIM were performed in 1.5 
T. T1 relaxation time values were calculated for posterior weight-bearing 
femoral cartilage in the lateral knee compartment, and for the posterior horn of 
the lateral and medial menisci. 
Results: For femoral cartilage (N=86) the mean T1 value was 441ms. The 
mean T1 value in the lateral menisci (N=85) was 498ms and for the medial 
menisci (N=62) mean T1 value was 484ms. A positive correlation was found 
between posterior medial and lateral menisci R=0.62 (p<0.0001) and a similar 
trend was seen between lateral femoral cartilage and lateral menisci with R= 
0.26 (p=0.02). Comparing the meniscus from the most affected knee 
compartment to KLG showed trends toward increasing T1 values for KLG 1-3 
and a decreasing T1 value for KLG 4. 
Conclusion: The positive correlation between lateral and medial menisci 
indicates parallel degeneration processes in both knee compartments. The 
correlation between menisci and cartilage suggests concomitant, but different, 
degeneration in the two tissues in OA. The interpretation of inverse U-shaped 
relation between meniscal T1 values and KLG is in accordance with findings 
comparing various degrees of meniscal degeneration with dGEMRIM and 
proteoglycan content.  
B-1015 08:42  
Ultrasound of the posterior interosseous nerve in the arcade of Frohse  
C. Tulay, S. Aubry, A. Podda, J. Behr; Besancon/FR 
(wonder_angel15@hotmail.com)  
Purpose: To accurately assess the diameter of the posterior interosseous 
nerve (PIN) as it passes through the arcade of Frohse and to demonstrate that 
exist a physiological difference in anteroposterior diameter between the 
upstream, the entry point and downstream of the arcade. 
Methods and Materials: Prospective monocentric study of the PIN in 30 
healthy volunteers (sex ratio = 1) which have been examined bilaterally by 
ultrasound with a high frequency probe (18 MHz) in longitudinal section. The 
anteroposterior diameter of the PIN was measured at the entry point in the 
arcade of Frohse, 5mm upstream and 5mm downstream. 
Results: The anteroposterior diameter of the NIP was 0.833 mm +/- 0.208, 
0.6mm +/- 0.173 and 0.486mm +/- 0.131 respectively upstream, at the entry 
and downstream of the Arcade of Frohse. It significantly decreases by 27.2% 
between the upstream and entry point (-0.233mm; p<0.001), by 16.6% 
between the entry point and downstream (-0.114mm; p < 0.001), and by 39% 
between the upstream and downstream (0.357mm; p<0.001). 
Conclusion: There is a physiological decrease in the anteroposterior diameter 
of the PIN as it passes through the arcade of Frohse, not to be wrongly 
considered as a compression of the nerve in the arcade.  
B-1016 08:46  
Safety and efficiency of treatment of partial supraspinatus tendon tear 
with injection of PRP and HA  
C. Lupo1, A. Meli2, V. Incarbone2, N. Casamassima2, L. Callegari2; 1Palermo/IT, 
2
Varese/IT (claudialu@live.it)  
Purpose: Evaluate safety and efficiency of treatment of partial supraspinatus 
tendon tears with intralesionals injection of autologous platelet-rich plasma 
(PRP) associated with low molecular weight hyaluronic acid (HA 0.8%) under 
ultrasound guidance. 
Methods and Materials: Between January and September 2016, we selected 
84 patients, mean age 57, with a ultrasound diagnosis of partial tear of 
supraspinatus tendon; 48/84 confirmed with MRI. Before the treatment (T0), all 
patients were evaluated the pain with the visual analogue scale (VAS). After 
local ultrasound guided anaesthesia with lidocaine, an injection of 
glenohumeral joint with a 22G needle with lateral access was given, followed 
by needling of supraspinatus tendon and subsequent intratendineus injection 
with 2.5cc of (PRP) and 2cc of (HA0.8%), 3 injections, one every three weeks. 
The safety of the procedure was considered by the analysis of complications; 
efficacy was considered by clinical follow-up at six weeks after the procedure 
and imaging follow-up at six months in 84/84 patients with US and in 35/84 
with MRI. 
  






Results: 84/84 patients improved pain with a statistically significant difference 
(p <0.001) of VAS scale before and after treatment without major 
complications. 55/84 patients showed some modification of the ultrasound and 
RM patterns. 
Conclusion: Injection of (PRP) with (HA0.8%) is a well-tolerated procedure in 
treatment of partial the supraspinatus tendon tear with a marked improvement 
on pain.  
B-1017 08:50  
Improving the sensitivity of bone mineral density assessment using 
spectral detector CT  
S. van Hedent, K.-H. Su, F. Liang, J.-W. Kuo, D.W. Jordan, B. Eck, P.R. Ros, 
R. Muzic; Cleveland, OH/US (svhedent@vub.ac.be)  
Purpose: Bone mineral density (BMD) analysis by Dual-Energy x-ray 
Absorptiometry (DEXA) is complicated by false negatives due to overlapping 
densities in the projection area. Spectral Detector CT (SDCT) can overcome 
these limitations, while providing volumetric information. We investigated its 
performance for BMD assessment and compared it to DEXA and phantom-less 
Quantitative CT (QCT). 
Methods and Materials: Ten uniform solutions of bone-like material, K2HPO4 
ranging 0-600 mg/ml, were scanned in an acrylic phantom using the SDCT in 
four varying clinically relevant scan conditions. Images were processed to 
estimate the K2HPO4 concentrations. A model representing a human lumbar 
spine (European spine phantom) was scanned and used as calibration for 
linear regression analysis, so that our method could be retrospectively applied 
to abdominal SDCT scans of 20 patients who also had a QCT and DEXA. 
Performance of QCT, DEXA and our SDCT method were compared. 
Results: There was excellent correlation (R2 >0.99, p = 0.00) between true 
and measured K2HPO4 concentrations for all scan conditions. Overall mean 
measurement error ranged from -11.49 ± 4.70 mg/ml (-2.78 ± 6.01%) to -12.34 
± 6.26 mg/ml (-4.77 ± 3.00%) depending on scan conditions. Using DEXA as 
gold standard, sensitivity and specificity for detecting decreased BMD in the 
scanned patients was 100 and 73.3%, and 100 and 40% for SDCT and QCT 
respectively. 
Conclusion: SCDT has excellent sensitivity and high specificity for detecting 
decreased BMD, allowing its use for opportunistic screening or pre-operative 
planning.  
B-1018 08:54  
Virtual bone mineral density imaging with third-generation dual-energy 
CT for diagnosis of osteoporosis: a preliminary study  
L. Wang, G. Shenchu, B. He, J. Chen; Nantong/CN (wanglin_nt@126.com)  
Purpose: To quantitatively assess the diagnostic value of virtual bone mineral 
density (VBD) imaging at DECT for osteoporosis (OP). 
Methods and Materials: Forty-five patients with vertebral trauma underwent 
DECT and DXA examinations of the lumbar 1-4. VBD images were derived 
from three-material decomposition algorithm using post-processing software 
(‘Liver VNC’, Syngo Via Dual Energy, Siemens), while the default CT values of 
fat, soft tissues, iodine and iodine slope were corrected to the yellow marrow, 
red marrow, calcium and calcium slope which were recommended in another 
software (‘Bone Marrow’, Syngo Via Dual Energy). CT attenuation values 
(VBD_Att), calcium density (VBD_CaD) and fat fraction (VBD_Fat) were 
measured for quantitative analyses. CT numbers on mixed images (LB_0.5) 
reconstructed with a merging coefficient 0.5 at DECT were recorded. Bone 
mineral density and T scores of lumbar measured with DXA served as the gold 
standard. Pearson correlation analysis was performed to compare DECT and 
DXA results. Diagnostic performance of VBD imaging was assessed by ROC 
analysis. 
Results: A total of 166 lumbars were evaluated. LB_0.5 and VBD_Att were 
significantly different between OP and non-OP vertebral bodies (all P<.01). 
VBD_Att and VBD_CaD both had significant correlations with T scores (all 
P<.01). However, no significant correlation existed between VBD_Fat and T 
scores (P=.08). Furthermore, sensitivity and specificity for assessment of OP 
were 86.00%, 80.17% for VBD_Att and 84.00%, 81.03% for VBD_CaD. 
Diagnostic performance was significantly higher in VBD_Att and VBD_CaD 
compared to LB_0.5 (all P<.01). 
Conclusion: Dual-energy VBD imaging shows acceptable diagnostic 
performance for OP in patients with vertebral trauma.  
B-1019 08:58  
Quantitative MRI of knee articular cartilage in hyperuricemia  
X. Cai, X. Liu; Guangzhou/CN (caixran@jnu.edu.cn)  
Purpose: To identify the changes of knee articular cartilage in patients with 
gout and with asymptomatic hyperuricemia. 
Methods and Materials: Forty-three patients with gouty arthritis, 30 with 
asymptomatic hyperuricemia and 30 age- and sex-matched controls were 
included in this study. Multiple-TE FSE sagittal images of the knee were 
acquired using a 3T MRI scanner. T2 values of the superficial and deep zones 
of the tibiofemoral and patellofemoral cartilages were analysed in sub-
compartmental areas and compared among the three groups. Also, they were 
correlated with the serum uric acid level in those gout patients without taking 
any uric-acid-lowering drug. 
Results: Cartilage thinning was observed in 13 out of 57 (22.81%) involved 
knees in patients with the symptomatic gout and 3 out of 36 (8.33%) examined 
knees with asymptomatic hyperuricemia. Significantly higher T2 values were 
observed at the superficial and deep zones of the cartilage in the gout patients 
compared to the normouricemic controls. However, no significant difference 
was found in T2 values of superficial and deep zones of the cartilage between 
the asymptomatic hyperuricemia patients and normouricemic controls. 
Moderate positive correlation was found between the T2 value of superficial 
zone of the cartilage with serum uric acid level. 
Conclusion: Patients with gout demonstrate increased T2 value at the 
superficial and deep zones of the knee cartilage indicative of early change in 
cartilage matrix composition. Cartilage thinning also occurs more frequently in 
those patients. The high serum uric acid level could accelerate the cartilage 
injuries in gouty patients.  
B-1020 09:02  
In vivo quantitative 4D-CT analysis of carpal kinematics with radio-
scaphoid and luno-capitate angles during radio-ulnar deviation: 
feasibility and clinical interest  
A. Rauch; Nancy/FR (aym.rauch@gmail.com)  
Purpose: To study the variation of radioscaphoid (RSA) and lunocapitate 
(LCA) angles during wrist radio-ulnar deviation (RUD) using semi-automatic 
quantitative 4D-CT in patients with and without scapholunate-ligament tears 
(SLT). 
Methods and Materials: 37 patients with suspected scapholunate instability 
were prospectively evaluated with 4D-CT and CT-arthrography of the wrist. 
The study was approved by the local ethics committee and all patients signed 
an informed consent. Various dynamic parameters (mean, amplitude, maximal 
angle, standard deviation (SD), angular coefficient of variation (ACV)) 
describing RSA and LCA variation during wrist RUD were calculated and 
compared in patients with and without SLT by two readers. 
Results: The mean values for RSA and LCA in the control group varied, 
respectively, from 102.98° ± 7.6° to 104.47° ± 8.89° and 85.92° ± 9.37° to 
90.09° ± 10.56° with ACV from 10,78% to 11.03% and 13.49% to 13.52% for 
readers one and two, respectively. The inter-observer variability was excellent 
for RSA (ICC = 0.82) and substantial for LCA (ICC= 0.79). LCA amplitude, SD 
and maximal angle were significantly smaller in SLT group (p varied from 
0.0001 to 0.0026), respectively, from 36% to 44%, 37% to 44% and 13% to 
19%. RSA amplitude tended to be smaller in SLT group (18% to 27%, p varied 
from 0.0295 to 0.1328). LCA yielded the best sensitivity for SLT (71-91%) while 
RSA yielded the best specificity (87-100%). 
Conclusion: 4D-CT can quantitatively assess carpal kinematics during RUD 
which could improve the diagnosis and prognostic evaluation of patients with 
SLT.  
B-1021 09:06  
Detection of osseous metastases using dual-energy CT with material 
decomposition algorithms: phantom development and preliminary 
clinical validation  
H.-C. Huang1, B.M. Yeh2, R. Srinivasan2, Y. Sun2; 1Taipei City/TW, 
2
San Francisco, CA/US (hjround@gmail.com)  
Purpose: Meta-analysis studies have shown that the conventional single-
energy computed tomography (SECT) has limited ability in detecting subtle 
bone metastases. The purpose of this study was to use dual-energy CT 
(DECT) with bone-water material decomposition algorithms to detect nearly 
isodense bone metastases in phantoms, and to validate its use with 
retrospective patient DECT scans which were initially read as negative for 
bone metastases, but later detected by other imaging modalities or at follow-up 
CT. 
Methods and Materials: We constructed 51 semi-anthropomorphic lumbar 
spine phantoms randomly embedded with 75 simulated tumours (25 mild lytic, 
25 isodense, and 25 mild sclerotic). These phantoms were scanned in a rapid-
kilovoltage-switching DECT scanner. Two radiologists independently reviewed 
images from 70 keV virtual monochromatic reconstruction and 4 material 
decomposition algorithms (hydroxyapatite-water, water-hydroxyapatite, cortical 
bone-water, water-cortical bone). We recorded reviewer’s response regarding 
the presence of tumours. The sensitivity and specificity of different 
reconstruction algorithms were evaluated with McNemar test. The tumour 
conspicuity scores were recorded in 3-point Likert scales and then evaluated 
by Wilcoxon signed rank test. Finally, we validated our testing algorithms by 
retrospectively reviewing patients’ images in our institution. 
Results: Hydroxyapatite-water material decomposition algorithm achieved 
higher sensitivity in detecting isodense lesions (38% vs 18%, p=0.013) and 
possessed higher tumour conspicuity score (p<0.0001) as compared to the 70 
  






keV reconstruction in the phantom study. Hydroxyapatite-water algorithm also 
detected more tumours in the retrospective patients’ studies. 
Conclusion: DECT with hydroxyapatite-water material decomposition may 
help detect subtle spine metastases. Further study in prospective clinical scans 
is warranted.  
Author Disclosures: 
 B.M. Yeh: Author; Author with Royalties, Oxford University Press. 
Shareholder; Nextrast, Inc. R. Srinivasan: Grant Recipient; Seed Grant, 
Department of Radiology and Biomedical Imaging, UCSF. 
B-1022 09:10  
High diagnostic accuracy of kep on dynamic contrast-enhanced MRI 
perfusion in identifying vertebral malignancy  
M. Verma, S. Sood, B. Singh, M. Thakur, S. Sharma, S. Sharma; Shimla/IN 
(mansiverma1608@gmail.com)  
Purpose: Vertebral lesions are not easily amenable to biopsy due to inherent 
risks associated with this invasive procedure. There is considerable 
overlapping of radiologic features of benign and malignant lesions on 
conventional MRI. We performed this study to evaluate the role of dynamic 
contrast-enhanced (DCE) MRI perfusion parameters in differentiating 
malignant from benign lesions. 
Methods and Materials: We studied all patients presenting to our hospital with 
a radiologic evidence of vertebral lesions from July 2016 through June 2017. 
We performed DCE-MRI of spine on 1.5 T scanner using 3D VIBE sequence 
after intravenously injecting 0.1mmol/kg body weight of gadopentetate 
dimeglumine. We used Tofts model to calculate DCE parameters that included 
Ktrans, kep, Ve and iAUC. We compared the means of each perfusion 
parameters by type of lesion (benign/malignant) at 0.05 significance level and 
performed ROC curve analysis. 
Results: We could confirm histologic/cytologic diagnosis in 35 of the 45 
patients recruited. Of these 19 were tubercular and 16 malignant lesions. The 
mean (±sd) of kep (min
-1
) was significantly higher (2.89±3.3) in malignant 
compared to benign lesions (0.81±0.19), whereas Ve (ml/g) was significantly 
lower in malignant (0.27±0.13) compared to benign lesions (0.47±0.12) at 0.05 
significance level. kep cut-off of  1.17 min
-1 had a sensitivity of 93.8% and 
specificity of 100% with a diagnostic accuracy of 94.4% in detecting malignant 
disease. 
Conclusion: High kep is highly suggestive of malignant lesions. We 
recommend kep cut-off of  1.17 min
-1 that was found to have high diagnostic 
accuracy in identifying malignant lesions.  
B-1023 09:14  
Complementary metal artefact reduction of total hip replacements by 
monoenergetic and O-MAR reconstructions in spectral-detector 
computed tomography  
K.R. Laukamp, S. Lennartz, V. Neuhaus, N. Grosse Hokamp, R. Rau, 
M. Le Blanc, N. Abdullayev, D. Maintz, J. Borggrefe; Cologne/DE 
(kai.laukamp@uk-koeln.de)  
Purpose: This study compares metal artefact (MA) reduction in imaging of 
total hip replacements (THR) using virtual monoenergetic images (VMI), for MA 
reduction specialised iterative reconstructions (O-MAR) and conventional 
images (CI) from spectral-detector computed tomography (SDCT). 
Methods and Materials: 27 SDCT datasets of patients carrying THR were 
included. CI, O-MAR and VMI with different energy levels (60-200keV) were 
reconstructed from the same scans. MA width was measured. Attenuation 
(HU), noise (SD) and contrast-to-noise ratio (CNR) were determined in: 
extinction artefact, adjacent bone, muscle and bladder. Two radiologists 
assessed artefact reduction and image quality subjectively. 
Results: In comparison to CI, VMI (200keV) and O-MAR showed a strong 
artefact reduction (MA width: CI 29.9±6.8mm, VMI 17.6±13.6mm, p<0.01; O-
MAR 16.5±14.9mm, p<0.001; MA density: CI -412.1±204.5HU, VMI -
279.7±283.7HU; p<0.01; O-MAR -116.74±105.6HU, p<0.001). In strong 
artefacts reduction was superior by O-MAR. In moderate artefacts VMI was 
more effective. O-MAR showed best noise reduction and CNR in bladder and 
muscle (p<0.05), whereas VMI were superior for depiction of bone (p<0.001). 
Subjective assessment confirmed that VMI and O-MAR improve artefact 
reduction and image quality (p<0.001). 
Conclusion: O-MAR and VMI (200keV) yielded significant MA reduction. Each 
showed distinct advantages regarding effectiveness of artefact reduction and 








B-1024 09:18  
Ultra-high field 7 Tesla MRI and biomechanical investigation of vertebral 
bone microarchitecture  
D. Guenoun, A. Foure, M. Pithioux, S. Guis, T. Le Corroller, V. Pauly, 
P. Chabrand, P. Champsaur, D. Bendahan; Marseille/FR 
(daphne.guenoun@ap-hm.fr)  
Purpose: to investigate bone microarchitecture parameters of human ex-vivo 
vertebrae using ultra-high field 7Tesla MRI (7T MRI). 
Methods and Materials: Twenty four vertebrae (L2, L3, and L4) from eight 
cadavers were studied using 7T MRI. Their Bone mineral densities (BMD) were 
investigated using dual energy x-ray absorptiometry. Then, all specimens 
underwent mechanical compression tests to failure. The failure load (in 
Newton) and constraint (in megapascal) were measured. Bone volume fraction 
(BV/TV), trabecular thickness (Tb.Th), and trabecular spacing (Tb.Sp) were 
measured in MRI using a digital topological analysis (Bone J). Measurements 
were recorded by two observators to characterize the interrater reliability. 
Statistical analyses were performed using SPSS. Correlations between 
variables were analyzed using Spearman correlations and stepwise 
regression. A p value of 0.05 was considered as significant. 
Results: the inter-rater reliability for bone microarchitecture parameters 
quantification was very good. The failure load and constraint measured during 
the compression tests were significantly correlated with BV/TV, Tb.Sp and 
BMD while Tb.Th was correlated with constraint only (p<0.05). Stepwise 
regression with backward elimination demonstrated that combining BV/TV and 
BMD improved the relationship with the constraints from an adjusted r² =0.384 
for BMD alone to an adjusted r²=0.414 for BMD+BV/TV. 
Conclusion: we demonstrated for the first time that the variables 
characterizing the vertebral bone microarchitecture in 7T MRI were significantly 
correlated with biomechanical parameters. In addition, we illustrated that 
combining BMD and 7T MR, trabecular bone analysis provided additional 
information regarding vertebral bone strength in comparison with DXA alone.  
B-1025 09:22  
Postoperative evaluation of a arthroscopic coracoid bone block surgery 
with CT-Scan.  
O. Andreani1, P. Gendre2, C. Dekimpe1, A. Rudel1, N. Amoretti1, P. Boileau1; 
1
Nice/FR, 2Cagnes sur Mer/FR (andreani.olivier@gmail.com)  
Purpose: To know and use the criteria of good positioning and bone 
consolidation of a coracoid bone block. To evaluate the results in terms of 
positioning and bone consolidation of an arthroscopic technique of Latarjet 
coracoid bone block. 
Methods and Materials: A retrospective monocentric study of 161 patients 
who underwent a Latarjet coracoid bone block surgery under arthroscopy by a 
senior operator for management of anterior chronic shoulder instability. All 
patients were monitored at 15 days and 6 months by CT-scan. The positioning 
of the stop was evaluated in the horizontal and vertical plane. Bone 
consolidation was evaluated at 6 months. 
Results: The bone block was sub-equatorial in 151 (93%) patients, equatorial 
in 9 (5%) and supra-equatorial in 2 (1%). The bone block was flush in 153 
patients (94%), overflowing in 8 (4.5%) and medial in 1 patient (0.5%). At 6 
months postoperative, complete bone consolidation was obtained in 147 
patients (90.5%). 14 (9%) had a bone block pseudarthrosis, one a fractured of 
the bone block, one a complete lysis and one a bone block migration. The 
clinical prognostic factor of lack of consolidation was smoking. Five patients 
had recurrent instability. 
Conclusion: CT-scan is an easy and reproducible tool for postoperative 
osseous evaluation of Latarjet arthroscopic surgery.This technique gives good 
results in terms of positioning and consolidation of the coracoid bone block.  
B-1026 09:26  
Volumetric bone mineral density assessment of the lumbar spine using a 
novel phantomless dual-energy CT postprocessing algorithm in 
comparison to dual x-ray absorptiometry  
C. Booz1, P.C. Hofmann2, M. Sedlmair2, T. Flohr2, B. Schmidt2, S.S. Martin1, 
D. Leithner1, T.J. Vogl1, J.L. Wichmann1; 1Frankfurt a. Main/DE, 
2
Forchheim/DE (boozchristian@gmail.com)  
Purpose: Current techniques for the evaluation of bone mineral density (BMD) 
commonly require phantom calibration. The purpose of this study was to 
evaluate a novel algorithm for phantomless in vivo dual-energy computed 
tomography (DECT)-based volumetric assessment of BMD of the lumbar spine 
in comparison to dual x-ray absorptiometry (DXA). 
Methods and Materials: This retrospective study was approved by the 
institutional review board. The requirement to obtain informed consent was 
waived. Data from clinically indicated DECT and DXA examinations within 2 
months of 47 patients were evaluated. Using a novel automated dedicated 
postprocessing algorithm for DECT, the trabecular bone of lumbar vertebrae 
L1-L4 was analysed after five volumes of interest on different slices had been 
  






manually defined for each vertebral body. Pearson product-moment 
correlation, Bland-Altman plot and further regression analyses were calculated 
for statistical analysis. 
Results: A total of 186 lumbar vertebrae in 47 patients (24 male, 23 female) 
were analysed. Mean BMD of L1-L4 determined by DXA was 0.986 g/cm², and 
20 patients (42.6%) showed an osteoporotic BMD according to guidelines of 
the World Health Organisation. Average DECT-based BMD of L1-L4 was 88.68 
mg/cm³. According to CT guidelines of the American College of Radiology 
DECT measurements identified seventeen patients (36%) with an osteoporotic 
BMD. Statistical analysis showed a moderate correlation between volumetric 
and areal BMD values based on DECT and DXA with a Pearson's product-
moment correlation coefficient of r=0.421. 
Conclusion: A novel DECT-based postprocessing algorithm allows for 
phantomless volumetric BMD assessment of the trabecular bone of lumbar 
vertebrae.  
Author Disclosures: 
 P.C. Hofmann: Employee; Siemens Healthineers. M. Sedlmair: Employee; 
Siemens Healthineers. T. Flohr: Employee; Siemens Healthineers.  
B. Schmidt: Employee; Siemens Healthineers.  J.L. Wichmann: Speaker; GE 
Healthcare, Siemens Healthineers. 
B-1027 09:30  
Learning curve of an ultrasound-guided percutaneous release of carpal 
tunnel: a cadaveric study  
O. Andreani, C. Dekimpe, C.-P. Raffaelli, N. Amoretti; Nice/FR 
(andreani.olivier@gmail.com)  
Purpose: The aim of our study was to evaluate the feasibility and the learning 
curve of an ultrasound-guided percutaneous carpal tunnel release. 
Methods and Materials: 14 carpal tunnel releases were carried out, on un-
embalmed cadavers, 7 by a senior and 7 by a junior radiologist. Sonographic 
evaluation, with 18 MHz probe, was first performed to detect the anatomical 
variant and length of the retinaculum. After hydrodissection by Xylocaine of the 
carpal tunnel, we used an Acufex knife (2,5 mm; Smith and Nephew®) to cut 
the retinaculum, under ultrasonographic guidance. We evaluated the time 
(from the first injection of Xylocaine until the knife was taken off); success of 
the procedure: complete release of retinaculum and absence of complication 
(lesion of the median nerve and its branch, especially the thenar motor branch, 
or vascular structure, especially the arterial palmar arch), checked by 
dissection after procedure; and size of cutaneous incision. 
Results: The mean time of the procedure was 14 minutes. (11 min senior 
versus 17 min junior). The section was complete at the 4th procedure for the 
senior and at the 5th procedure for the junior radiologist. No lesion of the 
median nerve or vascular structure was observed. The release was incomplete 
in 7 firsts’ wrists, due to an incomplete section of the distal retinaculum (lack of 
10 mm on average). Several passages were associated with more frequent 
complete section. The mean size of the incision was 3 mm. 
Conclusion: We observed a rapid learning curve of carpal tunnel release with 
ultrasound guidance, for a senior or junior radiologist, without difference in the 
term of success. This procedure seems to be safe, reproducible and minimally 
invasive.  
B-1028 09:34  
The accuracy of ultrasound with and without sonoelastography in the 
diagnosis of partial-thickness rotator cuff tears with MDCT arthrography 
and arthroscopic verification  
V.E. Gazhonova, M. Emelianenko, M. Onishchenko; Moscow/RU 
(vx969@yandex.ru)  
Purpose: To compare the diagnostic accuracy of conventional US and 
sonoelastography (SE) for the diagnosis of partial-thickness rotator cuff tears 
(RCTs) with MDCT-arthrography and arthroscopic correlation. 
Methods and Materials: 50 shoulders with suspected partial RCT based on 
MRI or US findings were assessed with conventional US and SE. SE images 
were evaluated by reviewers using experimentally proven colour grading 
system (grade 2, red colour - RCT, grade 1, green - tendonitis, grade 0, blue - 
normal). Strain ratios (SR) in the affected region of the tendon were calculated 
in comparison to the deltoid muscle. MDCT arthrography and arthroscopy were 
used as reference methods for verification. 
Results: Using conventional US, 75% (24 of 32) of the partial RCTs were 
found correctly. Using SE, 28 RC tendons were categorised as grade 2, 15 as 
grade 1, and 7 as grade 0. SR in RCT regions <1.2 was in 30 shoulders, and 
SR >1.2 in 20 patients. Evaluation of interobserver reliability of the SE findings 
showed “almost perfect agreement” with a weighted kappa coefficient of 0.83 
for colour SE grades. By comparing SE with the reference methods, colour 
grading system had a positive correlation (r=0.84, p=<0.001), and SR values 
<1.2 were characteristic for RCT with positive correlation (r=0.93, p=<0.001). In 
diagnosing a partial RCT, SE was more sensitive than conventional US 
(p<0.05). 
Conclusion: SE using colour grading scale and quantification of SR values in 
the affected tendon’s regions is a more sensitive and specific technique for 
diagnosing partial-thickness RCT than conventional US.  
B-1029 09:38  
Iterative reconstruction improves image quality in virtual non-calcium 
images of the spine for the detection of bone marrow edema in patients 
with vertebral compression fractures  
N. Engelhard1, K.-G. Hermann1, M. Fuchs1, M. Pumberger1, M. Putzier1, 
J. Mews2, B. Hamm1, T. Diekhoff1; 1Berlin/DE, 2Neuss/DE 
(nils.engelhard@charite.de)  
Purpose: Dual-energy computed tomography (DECT) allows detection of bone 
marrow edema (BME) after vertebral compression fractures using virtual non-
calcium imaging (VNCa). The aim of this study was to evaluate, which 
reconstruction offers the best image quality. 
Methods and Materials: 18 patients over 50 years of age with available CT 
raw-data were retrospectively included. DECT was performed on a single-
source machine (80/135 kVp sequential volume acquisition) and reconstructed 
using filtered back projection (FBP) and iterative reconstructions (IR) with three 
different iteration levels (IR1-IR3). VNCa images were generated using a raw-
data (RD) and an image-data (ID) based software. Target vertebras (TV) with 
fracture and BME in STIR sequence and normal appearing reference vertebras 
(RV) were defined. Signal-to-noise ratio (SNR) and contrast-to-noise ratio 
(CNR) were calculated. Intervertebral ratio (IVR) served as measurement for 
the detectability of BME. Friedmann-Test with multiple comparisons was 
applied. 
Results: 39 TV and 18 RV were included. RD showed significantly inferior 
SNR (p = 0.0001-0.0003) compared to ID. CNR differences were only 
significant for FBP vs IR3 (p = 0.002). In ID, IR gradually improved SNR 
values, however, differences were only significant for FBP vs IR3 (p = 0.005). 
For CNR there was no significant difference. IVR improved with increasing 
iteration levels, however, differences were only significant for the comparison 
to FBP (p = 0.03-0.0008). We found no differences of IVR comparing RD and 
ID. 
Conclusion: IR improved the image quality and detectability of BME in DECT. 
The ID was superior to the RD based approach.  
Author Disclosures: 
 J. Mews: Employee; Toshiba MS. 
B-1030 09:42  
T2 relaxometry of cartilage and meniscus and semi-quantitative 
assessment of the knee using DESS: a 5-minute MRI scan  
S. Eijgenraam1, A. Chaudhari2, G. Gold2, M. Reijman1, E. Oei1, B. Hargreaves2; 
1
Rotterdam/NL, 2Stanford, CA/US (s.eijgenraam@erasmusmc.nl)  
Purpose: Quantitative MRI measures such as T2 relaxation times of cartilage 
and meniscus, and semi-quantitative assessments such as MRI Osteoarthritis 
(OA) Knee Score (MOAKS), are commonly used to track spatial and temporal 
changes of knee-OA. Acquiring these biomarkers currently requires multiple 
MR sequences, resulting in long acquisition-times. We evaluated the double-
echo steady-state (DESS) sequence with an acquisition-time of only five 
minutes for simultaneous T2 relaxometry of cartilage and meniscus, and 
MOAKS scoring, in patients with no, mild and moderate knee-OA. 
Methods and Materials: 54 patients (20, 18 and 16 with Kellgren-Lawrence 
(KL) grades 0, 2, and 3 resp.) were scanned using DESS and a clinical 
multisequence knee-protocol. MOAKS was performed with only DESS (with 
multiplanar reformatting). Mean T2-values of cartilage and meniscus were 
calculated on single slices. Statistical testing between KL-groups was 
performed using Students T-Tests. Correlation between T2-values and 
MOAKS was assessed using linear regression analysis. 
Results: Mean T2-values in cartilage, obtained with DESS, were 37.7 ± 4.1, 44 
± 8 and 50.8 ± 8.4 ms for KL0, KL2 and KL3 resp. (p < 0.001). In menisci, 
mean T2-values of 15.4 ± 3.3, 18 ± 3.3 and 21 ± 6.4 ms were found for KL0, 
KL2 and KL3 resp. (p < 0.001). T2-values showed a good correlation with 
corresponding MOAKS-cartilage findings (r = 0.61, p = 0.002). 
Conclusion: Simultaneous quantitative T2 and morphological assessment of 
cartilage and meniscus with a 5-minute DESS-sequence show consistent 
outcomes with increasing stages of degeneration, making this sequence a 

















B-1031 09:46  
Correlation of body mass index with paraspinal muscle fatty 
degeneration in non-diabetic patients with lumbar spinal canal stenosis: 
results from 685 patients  
S. Winklhofer1, J. Burgstaller1, U. Held1, T. Finkenstaedt1, F. Del Grande2, 
G. Andreisek3, J. Steurer1, N. Bolog4; 1Zurich/CH, 2Lugano/CH, 
3
Münsterlingen/CH, 4Munchenstein/CH (Sebastian.Winklhofer@usz.ch)  
Purpose: Purpose of this study was to investigate the correlation between 
lumbar muscle fatty degeneration assessed by magnetic resonance imaging 
(MRI) and body mass index (BMI) in a large non-diabetic patient group with 
lumbar spinal stenosis (LSS). 
Methods and Materials: MRI images of 685 patients (52% female, mean age 
74 years, interquartile range 67 - 80 years) with LSS were analysed in this 
institutional review board-approved study. Muscle degeneration was assessed 
by two independent readers on axial T2 weighted images using a modified 5-
grades Goutallier classification. Th correlation between muscle degeneration 
and BMI was calculated using the non-parametric Spearman coefficient test. 
Results: The following distribution of muscle degeneration was found in the 
685 patients: grade 0: 136 (20%), grade 1: 265 (39%), grade 2: 220 (32%), 
grade 3: 41 (6%), grade 4: 23 (3%). The mean BMI was 26.6 kg/m2, 
interquartile range 23.8 to 29.7. Correlation analysis between BMI and the 
muscle stage degeneration in 5 ordinal categories was 0.060 for female 
patients (p = 0.26), 0.148 for male patients (p = 0.007), and 0.067 for all 
patients (p = 0.08). 
Conclusion: The weak correlation between BMI and the degree of muscle 
degeneration indicates that overweight might not be an important potential 
source of paraspinal muscle degeneration in non-diabetic patients with LSS.  
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B-1032 10:39  
Diffusion tensor imaging in idiopathic normal-pressure hydrocephalus: 
clinical and CSF flowmetry correlations  
I. Grazzini, G. Cuneo, F. Redi, C. Caccialupi, K. Sammartano, C. Ciccotosto; 
Arezzo/IT (irene.grazzini@gmail.com)  
Purpose: Diffusion tensor imaging (DTI) is a non-invasive magnetic resonance 
(MR) technique that provides information about the orientation and the 
anisotropy of the white matter tracts, and may delineate microstructural 
changes in cerebral white matter. We analysed DTI quantitative parameters in 
idiopathic normal-pressure hydrocephalus (INPH) patients and investigated the 
relationship between DTI findings and clinical scores and CSF flow velocity. 
Methods and Materials: 15 consecutive patients with INPH and Evans Index 
>0.3 and 15 age-matched controls underwent MR CSF flowmetry and DTI 
using a 1.5T system. Fractional anisotropy (FA), mean diffusivity (MD), axial 
diffusivity (AD) and radial diffusivity (RD) values were calculated using a 
region-of-interest (ROI) atlas-based tract mapping in 9 cerebral areas and 
compared among the two groups. In addition, for INPH patients, DTI 
parameters were correlated to clinical scores (Mini-Mental State Examination 
(MMSE) and Frontal Assessment Battery (FAB)) and CSF flow velocity. 
Results: Mean FA was significantly lower in the INPH group than in the control 
group for the forceps minor; the INPH group had significantly higher mean AD 
for the genu of the corpus callosum (p<0.05). We did not find significant 
correlation between the DTI parameters and CSF flow velocity and MMSE, 
whilst we observed a negative correlation between forceps minor FA and FAB. 
Conclusion: Our findings suggest that DTI will provide a non-invasive 
biomarker of white matter changes in patients with INPH. Moreover, DTI may 
offer a prognostic tool, over CSF flow velocity, to help identify INPH patients 






B-1033 10:47  
A survey for neuroimaging harmonization needs for large-scale 
neurodegenerative biomarker studies  
J. Jovicich1, F. Barkhof2,3, C. Babiloni4, K. Herholz5, B.N. van Berckel2, 
C. Mulert6, G. Frisoni7,8, SRA-NED JPND Working Group1; 1Mattarello/IT, 
2
Amsterdam/NL, 3London/UK, 4Rome/IT, 5Manchester/UK, 6Hamburg/DE, 
7
Brescia/IT, 8Geneva/CH (jorge.jovicich@unitn.it)  
Purpose: The European Joint Programme on Neurodegenerative Disease 
Research committed to our working group SRA-NED (http://www.sraned.org/) 
the survey of the international community for identifying (1) current barriers for 
a harmonized use of MRI/PET/EEG biomarkers of neurodegenerative diseases 
and (2) community-driven solutions to overcome them. 
Methods and Materials: A 10-minute survey was developed to gather 
information from relevant communities (neuroimaging consortia, industry, and 
more than 30 international researcher and medical associations). The survey 
evaluated high-level barriers to participate in multicentric studies, biomarkers to 
be prioritized and current challenges for modality-specific harmonization 
issues. 
Results: 459 participants completed the survey (MRI 53.6%, EEG 30.3%, and 
PETSPECT 16.1%). Participants represented a strong multidisciplinary 
community, dominated by research and academia including industry and 
clinical settings (Europe 75%, North and South America 20%, and Asia, 
Oceania and Africa 5%). In all modalities (MRI/PET/EEG), more than 60% of 
the participants reported significant difficulties for including neuroimaging 
markers in multicentric clinical studies, indicating barriers for each 
neuroimaging modality. Survey participants converged to specific requests 
about support needs for a more productive use of MRI/PET/EEG biomarkers. 
Results allowed making concrete suggestions for potential solutions, inspiring 
a roadmap for the future investments of international sponsors for clinical trials 
in the neurodegenerative diseases. 
Conclusion: To our knowledge, this survey represents the largest in the 
clinical neuroimaging community in the field of neurodegenerative diseases. 
The results support a strategic research agenda of future investments to 
exploit the potential of the MRI/PET/EEG biomarkers in large multicentric 
studies in neurodegenerative diseases.  
B-1034 10:55  
Subcortical nuclei in Alzheimer’s disease: a volumetric and diffusion 
kurtosis imaging study  
M.-L. Wang, W. Li; Shanghai/CN (doctor-mingliang@sjtu.edu.cn)  
Purpose: To investigate the volumetric and DKI parameter changes of 
subcortical nuclei in AD, and their relationship with cognitive function. 
Methods and Materials: A total of 17 mild AD patients, 15 moderate to severe 
AD patients, and 16 controls underwent examinations of neuropsychological 
tests, MRI scans. Volume, mean kurtosis (MK), mean diffusivity (MD), and 
fractional anisotropy (FA) were measured in subcortical nuclei including the 
hippocampus, thalamus, caudate, putamen, pallidum, and amygdala. MRI 
parameters were compared among groups. Correlation analysis was 
performed between subcortical nuclei volume, DKI parameters, and MMSE 
score. 
Results: Significant volume reduction was seen in left hippocampus in mild 
AD, and bilateral hippocampus, thalamus, putamen, left caudate and right 
amygdala in moderate to severe AD (P<0.05). Increased MD values were 
observed in left hippocampus, left amygdala and right caudate in mild AD, and 
bilateral hippocampus and right amygdala in moderate to severe AD (P<0.05). 
Decreased MK values were observed only in bilateral hippocampus in 
moderate to severe AD (P<0.05). No group significances were found in FA 
value. MMSE score was positively correlated with volume of bilateral 
hippocampus, thalamus, and putamen, and MK value of left hippocampus 
(P<0.05). A negative correlation was found between MMSE score and MD 
value of bilateral hippocampus and left amygdala (P<0.05). 
Conclusion: Mild AD mainly has microscopic subcortical changes revealed by 
increased MD value, and moderate to severe AD mainly has macroscopic 
subcortical changes revealed by volume reduction. MK is more sensitive in the 
late AD than mild AD.  
B-1035 11:03  
Structural and functional changes in resting brain activity in 
neurodegeneration according to VBM and rsfMRI comparison  
E. Seliverstova, Y. Seliverstov, M. Krotenkova, R. Konovalov, A.N. Sergeeva, 
S. Illarioshkin, S. Morozova; Moscow/RU  
Purpose: To study structural and functional pattern in resting brain network 
(default mode network) in early stages Parkinson’s disease (PD) comparing to 
healthy controls by voxel-based MRI (VBM) and resting-state fMRI (rsfMRI) 
data analysis. 
Methods and Materials: We have exanimated and compared 3 independent 
groups. Forty patients with PD in early steps in pharmacological treatment and 
  






newly diagnosed and 22 healthy volunteers were investigated and underwent 
1.5 T T1-MPR, rsfMRI scanning for VBMand rsfMRI data acquisition. All 
participants were right-handed. 
Results: In group of newly diagnosed PD patients we observed significant 
(p<0,005) greater volume of right precuneus (part of DMN) comparing to 
patients in pharmacological treatmentand healthy volunteers. We perform the 
ROC-test with estimation of sensitivity and specificity of right precuneus 
changes with receipt of threshold values of this index. Comparing rsfMRI data 
and volume changes in precuneus in group of newly diagnosed PD patients we 
observed direct correlation: than higher volume of precuneus that greater area 
of spontaneous neuronalactivity in left anterior prefrontal cortex. 
Conclusion: Our findings may be part of functional cortical reorganization with 
functional connectivity changes between brain regions and indicate about 
compensatory hypertrophy ofprecuneus as compensatory mechanisms of 
neuroplasticity phenomena in early stages of PD with sensitivity (77,8 %) and 
specificity (76,5%) probably achieve to beginning PD and be anadditional early 
marker of neurodegeneration.  
B-1036 11:11  
Determining leader nodes in dementia networks  
Y. Yazicioglu1, K. Pinker2, A. Tahmassebi3, A. Meyer-Baese3,4; 
1
Boston, MA/US, 2Vienna/AT, 3Tallahassee, FL/US, 4Maastricht/NL 
(ameyerbaese@fsu.edu)  
Purpose: Fusing modern network theory and control strategies yields a novel 
transformational paradigm in dementia research. One research direction is 
determining the leader nodes in disease networks that can be directly 
manipulated via external inputs to influence the overall network trajectory and 
simulate the disease progression. 
Methods and Materials: We examine 249 subjects with FDG-PET and T1-
weighted MRI images consisting of 68 control, 111 mild cognitive impairment 
(MCI) and 70 Alzheimer’s disease (AD). We consider only 42 out of the 116 
from the AAL in the frontal, parietal, occipital and temporal lobes. Different from 
previous work on controllability of disease networks, we determine the disease 
leader nodes by relying only on the network's structure, particularly the graph 
distances between the nodes, and not on the existing connection weights. 
Results: We show that there is a common leader node in structural and 
functional brain networks reflecting the changes from controls over MCI to AD. 
For functional data, we see one leader node in the frontal lobe present in all 
three networks and a decreasing number of leader nodes from controls to AD. 
The same situation is observed for structural data with one node in the 
temporal lobe, however there are more nodes in common between 
controls/MCI and MCI/AD. 
Conclusion: We have established a new method to determine the leader 
nodes that can be directly manipulated to change the trajectory of the dementia 
networks. Implicitly, we can gain an understanding of dementia evolution and 
the subsequent development of therapeutic solutions.  
B-1037 11:19  
Differential functional connectivity changes of subregions of the dorsal 
premotor cortex in healthy ageing  
B. Sigl1, C. Jockwitz2, S. Eickhoff2, F. Hofstaedter2, C. Rubbert1, K. Amunts2, 
S. Caspers2, B. Turowski1, J. Caspers1; 1Düsseldorf/DE, 2Jülich/DE 
(benjamin.sigl@med.uni-duesseldorf.de)  
Purpose: The dorsal premotor cortex (PMd) is the interface between the motor 
and higher cognitive networks and shows several structural and functional 
changes in healthy ageing as well as in various neurodegenerative diseases 
such as Parkinson’s disease. Here, we investigate the resting-state functional 
connectivity (RSFC) and age effects of the PMd with respect to three recently 
identified cytoarchitectonic subregions (6d1-3). 
Methods and Materials: Resting-state fMRI of 848 healthy adults from the 
population-based cohort study 1000BRAINS was analysed (age=55-88 years, 
mean-age=67.22 years; 459 males; 3T-MRI). Cytoarchitectonic maximum 
probability maps of PMd areas served as seed regions for RSFC analyses. 
After preprocessing of fMRI data using SPM, voxel-wise whole-brain RSFC 
was assessed for each seed and correlated with age (p<0.05, cluster-level 
FWE corrected). 
Results: All PMd areas of both sides showed connectivity decline with left 
anterior insula (AI) with increasing age. Area-specific connectivity loss was 
found for the right area 6d1 in the bilateral primary motor cortex , for the left 
area 6d2 in the inferior parietal lobule, for the right area 6d2 in the right 
dorsolateral prefrontal cortex (dlPFC), and for the left area 6d3 in the left 
ventral premotor cortex. An age-dependent increased connectivity was found 
for bilateral area 6d3 in the sensorimotor areas on both sides. 
Conclusion: PMd subregions show divergent RSFC changes during ageing, 
which support their functional diversity. Connectivity loss with the motor cortex, 
dlPFC and AI could explain the decline in sensorimotor and cognitive abilities 
in older age. Increase of area 6d3’s RSFC with sensorimotor areas might hint 
at compensatory mechanisms regarding its interface function within the motor 
system.  
B-1038 11:27  
Automatic quantification of enlarged perivascular spaces on brain MRI  
F. Dubost1, H.H. Adams1, G. Bortsova1, M. Ikram1, W.J. Niessen1,2, 
M.W. Vernooij1, M. De Bruijne1,3; 1Rotterdam/NL, 2Delft/NL, 3Copenhagen/DK 
(floriandubost1@gmail.com)  
Purpose: Enlarged perivascular spaces (EPVS) are an emerging biomarker for 
cerebral small vessel disease. An automatic quantification of EPVS is 
introduced, as manual scoring of EPVS is a tedious and error-prone task. 
Methods and Materials: T2-weighted MR images (voxel size 0.49 x 0.49 x 
0.8mm3) were acquired from 2000 subjects (mean age 74 years, range 60-90) 
from a population-based study. An experienced rater (2 years experience) 
counted the number of EPVS on a single slice in the centrum semiovale and 
basal ganglia and on the whole volume in hippocampi and midbrain. A deep 
learning algorithm, based on convolutional network regression, was developed 
to reproduce the visual scoring. The algorithm was trained on 1600 and 
evaluated on 400 MRI scans. Intraclass correlation coefficients (ICCs) were 
computed to assess agreement between automatic and visual scores and we 
compared to inter-rater (105 scans) and intra-rater (85 scans) reliabilities. 
Results: The ICC between visual and automatic scores was 0.87 (+/- 0.02) for 
centrum semiovale, 0.80 (+/- 0.02) for basal ganglia, 0.81 (+/- 0.03) for 
hippocampi and 0.62 for midbrain (+/- 0.04). Except for the midbrain, these 
values were equal to or higher than inter-rater reliability (ICCs 0.80, 0.62, 0.82 
and 0.75, respectively), and intra-rater reliability (0.88, 0.80, 0.85 and 0.82, 
respectively). 
Conclusion: The automatic scoring of EPVS shows good agreement with 
visual scoring, at the level of intrarater agreement for the centrum semiovale, 
basal ganglia and hippocampi. This method can facilitate quantitative EPVS 
analysis in large clinical studies.  
B-1039 11:35  
Dementia imaging in Europe: results from the European Society for 
Neuroradiology (ESNR) Diagnostic Subcommittee Survey  
M.W. Vernooij1, S. Haller2, G. Frisoni3, F. Pizzini4, T.A. Yousry5, 
N. Bargalló Alabart6, M. Smits1, R. Schmidt7, F. Barkhof8; 1Rotterdam/NL, 
2
Geneva/CH, 3Brescia/IT, 4Verona/IT, 5London/UK, 6Barcelona/ES, 7Graz/AT, 
8
Amsterdam/NL (m.vernooij@erasmusmc.nl)  
Purpose: The purpose of this survey was to assess current practices 
throughout Europe, with respect to standardised imaging, evaluation and 
reporting of brain imaging in clinical practice of patients suspected of dementia. 
Methods and Materials: Survey invitations were emailed to ESNR members 
(n=1662) and known associates (n=6400). The questionnaire featured 45 
individual items, divided into multiple choice, single best choice and free text 
answers. Information was gathered on personal practice, imaging technique 
and protocol, scan rating and reporting and communication with clinicians. 
Results: 193 individuals from unique institutes (28 European countries) had 
responded by 1 July 2017. Of these, 75% were neuroradiologists, 12% general 
radiologists, 11% (neuro)radiologists in training. 38% of responding centres 
perform > 5 scans/week for suspected dementia (48% 1-5 scans). MRI is 
primarily used in 72% of centres, 25% use primarily CT. >90% of centres 
acquire a combination of T2w, FLAIR, non-contrast T1w, DWI and T2*w 
sequences. 75% of centres use visual rating scales in reporting, primarily 
Fazekas and medial temporal atrophy scale. 32% of respondents note they are 
not fully confident in using rating scales. Only 23% of centres extract 
volumetric information from dementia scans. A minority of centres (28%) uses 
structured reports. 
Conclusion: Results show homogeneity in imaging modality and protocol, but 
more heterogeneity in application of volumetric processing and structured 
reporting and communication. Though likely subject to selection bias, this 
survey yields valuable information on current practices in dementia imaging, 
and forms the basis for future recommendations.  
B-1040 11:43  
Sulcal-based morphometry for the diagnosis of normal-pressure 
hydrocephalus in patients with ventriculomegaly  
G. Kuchcinski, C. Jacquiez, M. Baroncini, J. Dumont, C. Delmaire, L. Defebvre, 
J.-P. Pruvo, X. Leclerc; Lille/FR (gregkuch@msn.com)  
Purpose: To determine the diagnostic accuracy of automated sulcal 
morphometry to differentiate patients with idiopathic normal-pressure 
hydrocephalus (iNPH) from patients with ventriculomegaly secondary to other 
conditions in comparison to standard visual rating scales. 
Methods and Materials: The local institutional ethics review board approved 
the study. Written informed consent was obtained from all patients. Thirty-one 
consecutive patients with iNPH, 35 with vascular dementia, 23 with chronic 
noncommunicating hydrocephalus and 24 healthy controls prospectively 
underwent a 3T MR examination. Sulcal opening of ten sulci of interest 
throughout the brain convexity was measured using an automated surface-
based approach from the 3D T1-weighted images. High-convexity tightness 
  






and lateral sulcus dilatation were independently evaluated by 2 observers 
using visual rating scales. The interobserver reliability was calculated with 
linear weighted kappa and intraclass correlation coefficient for visual rating 
scales and sulcal opening, respectively. ROC curve analysis determined the 
best parameter to identify iNPH patients. 
Results: Automated sulcal morphometry achieved a higher reproducibility and 
diagnostic accuracy than visual rating scales (P<0.05). The best parameter to 
discriminate iNPH from other conditions was the ratio between opening lateral 
sulcus opening and intraparietal sulcus opening (AUC=0.85 [95%CI=0.74-0.95] 
and 0.87 [95%CI=0.74-0.96] for the left and right hemisphere, respectively). A 
cut-off value>1.25/1.20 in the left/right hemisphere provided a sensitivity of 
81%/84% and a specificity of 89%/84%. 
Conclusion: Automated sulcal morphometry is a suitable method to analyse 
the modifications of the subarachnoid spaces of iNPH patients and may help 
the radiologist to discriminate iNPH from ventriculomegaly secondary to brain 
atrophy or noncommunicating hydrocephalus.  
B-1041 11:51  
3D detection of cellular neurodegeneration in Alzheimer's disease via 
multi-scale x-ray phase-contrast micro- and nano-CT  
G.E. Barbone1, P. Di Pietro2, M. Eckermann1, A. Mittone3, A. Bravin3, 
P. Romanelli4, G. Battaglia2, P. Coan5; 1Garching/DE, 2Pozzilli/IT, 
3
Grenoble/FR, 4Milan/IT, 5Großhadern/DE 
(Giacomo.Barbone@physik.uni-muenchen.de)  
Purpose: Experimental x-ray phase-contrast CT (PCI-CT) provides soft-tissue 
sensitivity without application of stains or contrast agents. Most interestingly, 
this technique can visualize nervous tissue structure at multiple scales, from 
full-organ anatomy to single cells without the need for sample dissection. We 
thus choose PCI-CT for the analysis of AD pathology in the brain of 3xTgAD 
mice, an experimental model of AD expressing three mutant alleles, Psen1, 
APP and tau, and displaying both amyloid- plaque and tangle pathologies. 
Methods and Materials: Multi-scale 3D images of brain samples extracted 
from wild-type mice (n=6) and 3xTgAD mice (n=6, all at 13 months of age) 
were obtained by synchrotron PCI-CT. We used 17-30 keV x-rays and 
sCMOS-sensor PCO camera, and switched between optics systems with voxel 
sizes from 3³ µm³ to 0.1³ µm³. 
Results: Full-organ 3-micron brain CTs showed the PCI’s sensitivity to 
microscopic amyloid deposits within both hippocampal and cortical cell layers. 
Moreover, localized 0.3 µm CTs detect single neuronal cells, intra-neuronal 
aggregates, and extracellular deposits. We observed both healthy and altered 
pyramidal neurons and recognized them alongside agglomerates. Image 
contrast allows quantification of aggregate load and of cell layers-specific 
plaque size 3D distributions. Last, sub-cellular structures (cone-shaped soma, 
circular high-density nuclei) are visible at 0.1³ µm³. 
Conclusion: PCI-CT detects amyloid plaques in aged healthy and diseased 
3xTgAD mice, and provides unique 3D mappings of neuronal tissues, their 
surrounding angio-structures, and of single neurons down to the nanometer 
scale. PCI-CT thus provides a novel high-resolution 3D virtual histology 
































10:30 - 12:00 Room X  
Vascular  
SS 1415  
Peripheral arteries/arteritis  
Moderators:  
E. Dosa; Budapest/HU  
C. Herzog; Munich/DE  
B-1042 10:30  
Preliminary results of DWI sequences in detecting arterial wall 
inflammation in patients with giant cell arteritis  
A. Napolitano, G. Ironi, E. Tombetti, E. Incerti, S. Leoni, M. Picchio, L. Gianolli, 
L. Dagna, F. De Cobelli; Milan/IT (napolitano.angela@hsr.it)  
Purpose: The usefulness of techniques of vessel wall imaging is still debated 
and novel tools are required. We aimed to verify if MRI diffusion-weighted 
imaging can provide a novel characterisation of vasculitic lesions. 
Methods and Materials: T1 weighted, T2-weighted STIR and DWI (b0 -b600) 
MRI sequences were performed to evaluate the aorta and its primary branches 
in 5 GCA patients with a recent positive FDG-PET examination. From a clinical 
point of view, two patients were classified as “active”, while three as 
“grumbling”. The same sequences were performed in 5 healthy subjects, as 
controls. 
Results: All five patients showed arterial wall hyperintensity in STIR (median 
arterial-to-muscle ratio 4.1, range 3.6-5.1) and DWI b-600 images, with 
restricted arterial wall diffusivity in the ADC maps (median ADC 2.3, range 1.6 - 
3.3). Conversely, in the healthy control group no abnormalities in the aortic wall 
were found with STIR sequences (median T2 ratio 1.8, range 1.1-2.2 , 
p=0.016), as well as no high signal was detectable in DWI. Considering 
individual arteries of the GCA patients, the ADC values correlated both with 
wall thickness (r 0.607, p=0.016) and the arterial-to-muscle ratio at the STIR 
sequences (r 0.709, p=0.015), while did not correlate with SUV (r 0.065, 
p=0.819). 
Conclusion: Vessel wall characterisation by DWI is feasible in GCA and can 
reveal ongoing wall oedema in patients with grumbling disease. DWI might 
thus help define the activity status of patients. Further studies are warranted to 
better define the role of DWI imaging in GCA.  
B-1043 10:38  
Ultrasound biomicroscopy in the diagnosis of giant cell arteritis  
C.-P. Raffaelli, A. Hombreux, N. Tieulie, S. Lassalle, N. Azulay, P. Giordana; 
Nice/FR (raffaelli.c@chu-nice.fr)  
Purpose: The purpose of this study was to evaluate the value of ultrasound 
biomicroscopy (UBM) in the diagnosis of giant cell arteritis (GCA). 
Methods and Materials: 19 patients with classical clinical criterias of GCA 
were included. Both temporal arteries were explored using an ultra-high 
frequency transducer (Vevo MD, Visualsonics, 70 MHz) providing an axial 
resolution of 20 µm. Wall artery analysis relayed on : (i) Wall thickness and 
ratio wall thickness/artery diameter. (ii) Characteristic GCA features as intima 
hyperplasia. All the patients underwent a temporal artery biopsy (TAB) as a 
gold standard with histologic and biomicroscopic correlations. 
Results: The feasibility of UBM was complete in all the patients. 11 patients 
were diagnosed with GCA by TAB. The UBM wall thickness ratio(p = 0,001) 
and intimal hyperplasia (p = 0,001)were highly correlated with GCA. A wall 
thickness cut-off (210 µm) had an accuracy of 100%. 
Conclusion: The UBM seems a new and promising device for early diagnosis 
and monitoring of GCA, requiring further studies.  
B-1044 10:46  
Dynamic 4D CT angiography (DCTA) of the lower extremities with a 256-
slice CT  
N. Buls1, Y. De Brucker1, H. Devos2, D. Aerden3, G. Van Gompel1, 
P.T. Boonen3, K. Nieboer1, J. de Mey3; 1Brussels/BE, 2Wemmel/BE, 3Jette/BE 
(nico.buls@uzbrussel.be)  
Purpose: To investigate the benefit of additional dynamic 4D CT series 
(DCTA) on the lower extremities in the evaluation of patients suspected with 
periphery arterial disease (PAD). 
Methods and Materials: Seventeen patients received a dynamic sequence 
next to their runoff CTA. Acquisition was performed on a 256-slice CT (GE 
Healthcare) with following scan protocol: 18x repeated series at the level of the 
calves at 2s interphase delay and 160mm collimation. The CTA injection 
protocol was: 90mL contrast and 40mL saline, the dynamic sequence used 
50mL contrast and 40mL saline. Two readers rated following items on a four 
point Likert scale: arterial enhancement; stenosis assessment; diagnostic 
confidence; vessel calcification; venous overlay. Enhancement (HU) was 
  






measured in major vessels from time enhancement curves. Effective radiation 
dose was also estimated. 
Results: A total of 102 vessels were analyzed. Enhancement was considered 
better with DCTA (66% of vessels) than CTA (44%) and vessels with 
insufficient enhancement dropped from 24% to 8%. Optimal diagnostic 
confidence increased from 31% to 58% with DCTA. The DCTA information 
changed stenosis assessment in 25% of the cases. Venous overlay was higher 
with DCTA (15%) than CTA (6%). Interreader variability was moderate (kappa 
0.42). Compared to runoff CTA, mean HU values were higher (p < 0.001) with 
DCTA in all arteries: ATA (+48%), APer (+53%), ATP (+42%). The additional 
dose of the DCTA (0.2mSv) was 3.9% of the CTA (5.1mSv). 
Conclusion: The addition of dynamic CT angiography could improve 
diagnostic confidence in the evaluation of patients with PAD.  
B-1045 10:54  
Establishing a new protocol for aortofemoral CT angiography using the 
lowest possible contrast media with the advent of faster scanners  
A. Hatem1, B.K. Hazaimeh1, I. Alhyari1, A. Jalaileh1, S. Salman2, A. Al-Omari1; 
1
Amman/JO, 2Beirut/LB (bhazaimeh@gmail.com)  
Purpose: To establish low-contrast-dose protocol for imaging of lower 
extremity arteries adjusting scan parameters without affecting image quality. 
This is particularly important in diabetics, elderlies and patients with renal 
impairment. 
Methods and Materials: 81 patients have been examined in this study on 64 
slice CT scanners or higher from different vendors. Double test bolus 
technique was used to calculate time to peak (TTP) in descending aorta and in 
popliteal artery using 5 and 8mL of contrast for each patient consequently. 
Scan time was calculated subtracting TTP1 from TTP2. Total scan time and 
delay values were adjusted according to a formula related to scan length and 
TTP-interval. Machine parameters were adjusted to fit with the scan length and 
time needed. CT density was measured in 4 consecutive levels to ensure 
satisfactory enhancement within the aorta, iliac, popliteal and distal posterior 
tibial (PTA) arteries. 
Results: Contrast volume used was 40ml for 72% of case and 50ml for 24% of 
the cases. In two cases, 60mL of contrast was used due to prolonged 
TTP2/TTP1 interval. Average CT densities were 529, 430, 379 and 224HU at 
aorta, iliac, popliteal and PTA levels respectively. 92.5% of cases had density 
values more than 200HU at popliteal level and 97.5% were more than 115HU 
at level of PTA. All studies revealed satisfactory enhancement at all scan 
levels. 
Conclusion: Volume of contrast media needed to do angiography studies can 
be lowered with the advent of faster CT machines.  
B-1046 11:02  
Combined assessment of peripheral artery disease by MRI-based 
vascular calcification visualisation and quiescent interval single-shot 
(QISS) MRA  
A. Varga-Szemes1, T. Duguay1, T. Todoran1, S. Fuller1, C.N. De Cecco1, 
P. Suranyi1, R.R. Edelman2, I. Koktzoglou2, U.J. Schoepf1; 
1
Charleston, SC/US, 2Evanston, IL/US (vargaasz@musc.edu)  
Purpose: To investigate the added value of calcification visualisation on the 
diagnostic confidence and accuracy of detecting peripheral artery disease 
(PAD) and to compare the accuracy of calcium quantification between 
prototype proton density weighted, in-phase 3D stack-of-stars gradient-echo 
(PDIP-GRE) MRI in patients undergoing quiescent interval single shot (QISS)-
MRA and CTA. 
Methods and Materials: Fourteen patients (68±9 years) referred for lower 
extremity CTA prior to digital subtraction angiography (DSA) were 
prospectively enrolled for a same-day 1.5T MRI. PDIP-GRE MRI and QISS-
MRA were acquired covering the iliofemoral region. Two readers rated 
diagnostic confidence (3-point scale) and graded stenosis (< or >50%) on 
QISS-MRA without and with the visualisation of calcification. Sensitivity and 
specificity were calculated using DSA as reference. Intra-arterial calcium was 
quantified using ImageJ (NIH) and compared between MRA and CTA using 
paired t test and Bland-Altman analysis. 
Results: Of the 84 segments available for calcification assessment, >50% 
stenosis was detected in 37 (44%), while calcium was present in 58 (69%). 
The diagnostic confidence (2.1 [1.9-2.3] vs 2.3 [2.1-2.5]; P<0.0001) and the 
sensitivity and specificity of QISS-MRA in the detection of >50% stenosis 
(83.2% and 97.6% vs 86.4% and 98.0%, respectively) were improved when 
calcification data were available. Calcium quantification showed no statistical 
difference between MRI and CTA (121±77mm3 vs 127±84mm3; P=0.0249). 
Bland-Altman analysis revealed excellent agreement with a mean of difference 
at -5.8mm3. 
Conclusion: Based on our initial results, QISS-MRA combined with PDIP-GRE 
MRI seems to be promising for the complex assessment of vascular anatomy 
in PAD, which could be beneficial in interventional procedure planning.  
Author Disclosures: 
  A. Varga-Szemes: Research/Grant Support; Siemens Healthcare.   
C.N. De Cecco: Research/Grant Support; Siemens. U.J. Schoepf: Consultant; 
Bayer, General Electric, Guerbet, Siemens. Research/Grant Support; Astellas, 
Bayer, General Electric, Siemens. Speaker; Bayer, General Electric, Guerbet, 
Siemens. 
B-1047 11:10  
Quiescent-interval single-shot (QISS) MRA for interventional procedure 
planning: a feasibility study in patients with peripheral artery disease  
A. Varga-Szemes1, T. Duguay1, T. Todoran1, M. Penmetsa1, S. Fuller1, 
P. Suranyi1, C.N. De Cecco1, D. Mastrodicasa2, U.J. Schoepf1; 
1
Charleston, SC/US, 2Chieti/IT (vargaasz@musc.edu)  
Purpose: To investigate the feasibility of interventional procedure planning 
using quiescent-interval single-shot (QISS) MRA in patients with peripheral 
artery disease (PAD). 
Methods and Materials: Twenty-one PAD patients (67±8 years) underwent 
lower extremity CTA and QISS-MRA at 1.5T (prototype QISS sequence) prior 
to digital subtraction angiography (DSA). Segmental vascular diameter was 
compared among QISS-MRA, CTA, and DSA using the Friedman test. For 
each significant stenosis observed on QISS-MRA, intravascular stent length 
and diameter needed to reinstate flow in the vessel was estimated. The 
estimated stent size was compared to the stent implanted using the Wilcoxon 
test and Bland-Altman analysis. 
Results: Of the 346 segments analysed with QISS-MRA, significant stenosis 
was detected in 82 (23.6%). Vascular diameters showed good agreement 
among QISS-MRA, CTA, and DSA (overall P>0.05). Based on DSA evaluation, 
25 stents were implanted involving 31 segments. Average estimated stent 
diameter was in good agreement with the average actual diameter (8.4±2.8mm 
vs 8.1±3.7mm, respectively; P=0.0934; Bland-Altman mean of differences 
0.3mm). However, QISS-MRA-based stenosis length measurement 
underestimated the length of the stent necessary to bridge the stenosis 
(35.5±11.9mm vs 40.1±13.9mm, P=0.0215, respectively; Bland-Altman mean 
of differences -4.6mm). 
Conclusion: The prediction of stent diameter required to treat stenosis in 
patients with PAD was feasible using QISS-MRA. QISS-MRA slightly 
underestimated the actual stent length, which is most likely attributed to the 
fact that implanted stents usually extend beyond the proximal and distal ends 
of a stenosis. Based on these preliminary results, QISS-MRA seems promising 
for the non-contrast evaluation of vascular anatomy in PAD patients prior to 
intervention.  
Author Disclosures: 
  A. Varga-Szemes: Research/Grant Support; Siemens.  C.N. De Cecco: 
Research/Grant Support; Siemens.  U.J. Schoepf: Consultant; Bayer, General 
Electric, Guerbet, Siemens. Research/Grant Support; Astellas, Bayer, General 
Electric, Siemens. Speaker; Bayer, General Electric, Guerbet, Siemens. 
B-1048 11:18  
Accuracy of diameter measurement of vascular model: comparison of 
virtual monochromatic imaging in dual-energy CT with conventional 120-
kVp scan  
H. Sugawara, S. Suzuki, Y. Katada, T. Ishikawa, R. Fukui, Y. Yamamoto; 
Tokyo/JP (capy.sugawara@gmail.com)  
Purpose: To compare the performance of virtual monochromatic imaging 
(VMI) in dual-energy CT and conventional 120-kVp scan in measurement of 
the inner diameter of vascular models. 
Methods and Materials: We compared 50-keV VMI, 70-keV VMI, and 
conventional 120-kVp scan using images of an acrylic phantom for MTF 
calculation and another vascular phantom. The vascular phantom contains 12 
vascular models with 4 diameter (1.5, 2.0, 2.5, 3.0 mm) and filled with 3 
densities of contrast material (high, 20-fold dilution; middle, 40-fold dilution; 
low, 60-fold dilution). We evaluated intraluminal peak CT value and full width at 
half maximum (FWHM) for each 3.0-mm vascular model on CT attenuation 
profile. The diameters of all 12 vascular models were measured by software 
automation. Analysis of variance with repeated measures was used for 
statistics. 
Results: Calculated MTF indicated 120-kVp scan has better spatial resolution 
than VMI. Intraluminal peak CT value and FWHM were 50-keV VMI > 120-kVp 
scan > 70-keV VMI. Measurement errors of 70-keV VMI were significantly 
larger or comparable than that of 120-kVp scan in all 12 vascular models. 
Measurement errors of 50-keV VMI were significantly smaller than that of 120-
kVp scan in low-density vascular models, but larger in most of high/middle 
density vascular models. 
Conclusion: In comparison with conventional 120-kVp scan, VMI at low keV 
can improve the accuracy of diameter measurement of poorly enhanced 
vessels. However, in other conditions, VMI can increase the measurement 
errors with decreased spatial resolution, and should be applied carefully in 
evaluating vessel diameter.  
 
  






B-1049 11:26  
Modified calcium subtraction in dual-energy CT angiography of the lower 
extremity runoff: impact on diagnostic accuracy for stenosis detection  
D. De Santis1, C.N. De Cecco1, M.H. Albrecht2, B.A. Thomas1, B.E. Jacobs1, 
U.J. Schoepf1, K. Otani3, K. Grant4, A. Laghi5; 1Charleston, SC/US, 
2
Frankfurt a. Main/DE, 3Tokyo/JP, 4Rochester, MN/US, 5Latina/IT 
(domenico.desantis@hotmail.it)  
Purpose: To investigate the diagnostic accuracy of a modified three-material 
decomposition calcium subtraction (CS) algorithm for arterial stenosis detection 
in dual-energy (DE) computed tomography angiography (CTA) of the lower 
extremity runoff compared to standard images using digital subtraction 
angiography (DSA) as the reference standard. 
Methods and Materials: Eighty-eight patients (53 males; mean age, 65.9±11 
years) with peripheral artery disease (PAD) who had undergone DE-CTA of the 
lower extremity runoff were included in this IRB-approved, HIPAA-compliant 
retrospective study. Linearly blended (M_0.5) and CS datasets were 
reconstructed. Contrast-to-noise ratios (CNR) for both datasets were 
quantified. Two independent readers assessed subjective image quality using 
5-point Likert scales. A subgroup of 45 patients with DSA was used to assess 
the diagnostic accuracy of the two datasets for 50% stenosis detection. 
Diagnostic performance parameters were estimated using random-effects 
logistic regression analysis and compared using generalized estimating 
equations. 
Results: The overall diagnostic accuracy (sensitivity, specificity, positive and 
negative predictive values) for CS reconstructions was 96.5% (97.5%, 95.6%, 
90.9%, and 98.1%) and for M_0.5 images 93.1% (98.8% 90.4%, 82.3%, and 
99.1%). CS datasets showed higher CNR (15.3±7.3) compared to M_0.5 
images (13.5±6.5, P<0.001). Both reconstruction series showed comparable 
subjective image quality scores (CS, 4.64; M_0.5, 4.57; P=0.220). 
Conclusion: The modified three-material decomposition CS algorithm 
provides greater diagnostic accuracy for stenosis detection of the lower 
extremity runoff compared with standard linearly-blended images.  
Author Disclosures: 
 C.N. De Cecco: Research/Grant Support; Siemens.  U.J. Schoepf: 
Consultant; Bayer, Guerbet. Research/Grant Support; Astellas, Bayer, GE, 
Siemens. K. Otani: Employee; Siemens. K. Grant: Employee; Siemens. 
B-1050 11:34  
Quantification of blood velocity from time-resolved CT angiography on a 
256-slice CT  
P.T. Boonen1, N. Buls1, J. Vandemeulebroucke2, G. Van Gompel1, 
Y. De Brucker1, D. Aerden1, J. De Mey1; 1Jette/BE, 2Etterbeek/BE 
(pieter.thomas.boonen@vub.be)  
Purpose: To quantify the blood velocity in the arteries of the lower extremities 
and to investigate the correlation with peripheral arterial disease (PAD). 
Methods and Materials: 7 Patients with suspicion of PAD underwent time-
resolved Computed Tomography Angiography (CTA) in addition to their 
standard run-off CTA, consisting of 18 repeated axial acquisitions at 2s 
interphase delay at the level of the calves with 16cm collimation (Revolution 
CT, GE Healthcare). Image data was processed using in-house developed 
processing tools. Motion during the acquisitions was compensated by applying 
registration, after which the anterior tibial artery, posterior tibial artery and 
peroneal artery were automatically segmented by identifying large intensity 
changes over time. Subsequently, blood velocity was quantified in the arteries 
by creating time attenuation curves (TAC) of the arterial cross-sections in every 
slice and determining the time to peak (TTP). 
Results: The described method led to plausible velocity estimations in all 
arteries (n=18) for patients that were considered healthy (n=3). For 
pathological patients (n=4), only 12 out of 22 arteries could be quantified due to 
suboptimal bolus arrival, severe calcification or occlusions. For arteries of 
healthy patients, blood velocity was normally distributed (p=0.282) with a 
median value of 82.3 mm/s (95% CI= 55.5- 89.9 mm/s). Blood velocity in 
arteries of pathological patients was observed to be significantly lower, 30.7 
mm/s (95% CI= 27.4-45.7 mm/s), p<0.01. 
Conclusion: Time-resolved CT data allows to quantify blood velocity in the 
arteries of the lower extremities. In heavily occluded arteries, the contrast was 
insufficient in order to quantify velocity.  
B-1051 11:42  
Resveratrol treatment does not reduce vascular inflammation in male 
subjects at risk of developing type 2 diabetes: an 18F-FDG PET/CT study  
E. Boswijk, M. de Ligt, M.-F. Habets, W. van Marken Lichtenbelt, 
J.E. Wildberger, F. Mottaghy, P. Schrauwen, J. Bucerius; Maastricht/NL 
(eboswijk@gmail.com)  
Purpose: Resveratrol has shown anti-inflammatory effects in in vitro and 
animal studies. We investigated the effect of resveratrol on vascular 
inflammation and systemic inflammatory activation in the spleen and bone 
marrow in humans. 
Methods and Materials: This was a sub-study of a double-blind randomized 
crossover trial and included eight men with decreased insulin sensitivity 
undergoing an 18F-FDG PET/CT after, respectively, 34 days of placebo and 
resveratrol treatment (150 mg/day) to evaluate its effect on brown adipose 
tissue activity. 18F-FDG uptake was analysed in the carotids, ascending aorta, 
aortic arch, descending and abdominal aorta, as well as in adipose tissue 
regions, spleen and bone marrow to investigate resveratrol’s effect on these 
structures. Mean and maximum target-to-background ratios (TBRs; TBRmean 
and TBRmax) were compared between periods (paired T test or Wilcoxon 
signed-rank test). 
Results: In all arterial territories, TBRmean and TBRmax were slightly higher after 
resveratrol treatment compared to placebo treatment (n.s.). The TBRmax of the 
most diseased segment and the percentage of active segments (TBRmax1.6) 
were also higher after resveratrol treatment (n.s.). A similar trend was seen for 
the spleen (n.s.), bone marrow (n.s.) and visceral adipose tissue (TBRmax 
0.3±0.1 vs. 0.5±0.2, p=0.011), but not for subcutaneous adipose tissue (n.s.). 
Conclusion: Arterial inflammation was not reduced by resveratrol in subjects 
at risk of developing type 2 diabetes as assessed with 18F-FDG PET/CT. In 
addition, systemic inflammatory activation in the spleen, bone marrow and 
adipose tissue was not attenuated by resveratrol. Our results could underline 
findings of recent studies questioning the effects of resveratrol in humans.  
B-1052 11:50  
Automated tube potential selection of the lower extremity runoff: 
comparison to fixed kV with mAs modulation  
M. Beeres, K. Juhee, A.M. Bucher, C. Frellesen, M.H. Albrecht, 
J.L. Wichmann, J.-E. Scholtz, T.J. Vogl, T. Gruber-Rouh; Frankfurt a. Main/DE 
(beeres@gmx.net)  
Purpose: To evaluate the impact of automated attenuation-based tube 
potential selection (ATPS) on image quality and radiation dose exposure 
parameters by a computed tomography angiography (CTA) lower extremity 
runoff. 
Methods and Materials: Two hundred and forty patients (156 men, 84 
women) underwent CTA examinations of the lower extremity runoff on a 
second-generation dual-source CT system: 120 patients at a fixed tube 
potential of 120 kV and a tube current of 180 reference mAs, another 120 
patients using automated attenuation-based tube potential selection (ATPS). 
Volume CT dose index (CTDIvol), dose-length-product (DLP), body diameters, 
noise, signal-to-noise ratio (SNR) and subjective image quality were compared. 
Results: In the ATPS group, 80 kV was automatically selected in 102 patients, 
100 kV in 15 patients and 120 kV in 3 patients. 140 kV was not chosen in any 
of the cases. The median CTDIvol 4.81 (2.2-10.6) mGy and DLP 568 (203 - 
1324) mGy·cm in the ATPS group were significantly lower compared to the 
fixed 120 kV group with CTDIvol 8.1 (4.4-14.4) mGy and DLP 1027.5 (509 - 
1806) mGy·cm; p < 0.01. Image quality was comparable (p>0.05). 
Conclusion: Automated attenuation-based tube potential selection allows for 
significant dose savings in lower extremity runoff CTA while image quality 
remains constant at a high level.  
10:30 - 12:00 Room Z  
Interventional Radiology  
SS 1409  
Embolisation techniques for liver tumours  
Moderators:  
J.I. Bilbao; Pamplona/ES  
M. Dioguardi Burgio; Clichy/FR  
B-1053 10:30  
Treatment of non resectable HCC: SIRT vs TACE liver toxicity 
comparison with MELD score  
J. Delicque, C. Allimant, C. Cassinotto, L. Piron, L. Escal, A.-D. Ilonca, 
E. Assenat, B. Guiu; Montpellier/FR (j-delicque@chu-montpellier.fr)  
Purpose: To evaluate and compare liver toxicity of trans-arterial chemo-
embolization (TACE) and selective internal radiation therapy (SIRT) in non 
resectable hepatocellular carcinoma (HCC). 
Methods and Materials: 158 TACE treatments (80 patients) and 37 SIRT 
treatments (31 patients) performed from August 2012 to July 2015 were 
included and analysed. Pre and post treatment (1month) MELD score were 
calculated and compared. Datas about technical points of TACE and SIRT, 
liver disease and HCC were noted. Post treatment evaluation was about MELD 
score variation (Delta MELD) and post treatment score >15, with calculation 
models that integrated possibility of multiple treatments (Generalized 
Estimating Equations). 
  






Results: SIRT patients had higher tumor burden (AFP score > 2) and portal 
vein thrombosis (PVT) rate than TACE patients (p< 0.005). In univariate 
analysis, there were a trend (p=0.11) to a higher MELD variation with TACE 
than with SIRT and a statistical association with a post treatment MELD >15 
with TACE than with SIRT. In multivariate analysis, factors associated with 
Delta MELD and MELD > 15 were all related to liver disease. 
Conclusion: There is a trend to a lower degradation in liver function with SIRT 
compared with TACE in the treatment of non-resectable HCC, taking into 
account the possibility of multiple treatments. Further investigations should be 
performed due to a higher tumor burden and PVT in our SIRT population.  
B-1054 10:38  
TACE of HCC using mitomycin and lipiodol with or without DSM for HCC: 
comparative study  
T. Gruber-Rouh, K. Eichler, N.N.N. Naguib, M.C. Langenbach, B. Kaltenbach, 
T.J. Vogl; Frankfurt a. Main/DE  
Purpose: Evaluation of survival data and local tumour control after TACE in 
two groups with different embolisation protocols in the treatment of HCC 
patients. 
Methods and Materials: 99 patients (mean age: 63.6 years), 78 male (78.8%) 
and 21 female (21.2%) with HCC were repeatedly treated with 
chemoembolisation in 4-week intervals. Eighty-eight patients had BCLC-stage-
B, in 11 patients chemoembolisation was performed for bridging (BCLC-Stage-
A). In total, 667 chemoembolisation treatments were performed (mean 6.7 
treatments/patient). The administered chemotherapeutic agent included 
mitomycin. For embolisation, lipiodol only (n=51; 51.5%) or lipiodol plus 
degradable starch microspheres (DSM) (n=48; 48.5%) was used. The local 
response of the tumours was assessed by MRI using response evaluation 
criteria in solid tumours 1.1 (RECIST 1.1) Patient survival times were evaluated 
using Kaplan-Meier curves and log-rank tests. 
Results: The local tumour control in the lipiodol group was: PR (partial 
response) in 11 (21.6%), SD (stable disease) in 32 (62.7%) and PD 
(progressive disease) in 8 cases (15.7%). In the lipiodol DSM group, the PR 
was encountered in 14 cases (29.2%), SD in 22 (45.8%) and PD in 12 (25.0%) 
(p=0.211). The median survival of patients after chemoembolisation with 
lipiodol was 25 months and in the lipiodol DSM group 28 months (p=0.845). 
Conclusion: There was no statistical significant benefit reported of using 
lipiodol and DSM in comparison of using lipiodol-only for chemoembolisation of 
HCC in achieving local control and survival data. Only a slight trend for benefit 
of using lipiodol and DSM was shown.  
B-1055 10:46  
Safety and efficacy of transarterial chemoembolization using very small 
drug-eluting beads for advanced stage hepatocellular carcinoma  
A.M.K. Abdel Aal1,2, S. Tatum1, K. Mahmoud1, S. Moawad1, N. Ertel1, R. Oser1, 
S. Saddekni1, N. A. Aboueldahab1, A. Gunn1; 1Birmingham, AL/US, 2Cairo/EG 
(akamel@uabmc.edu)  
Purpose: To evaluate the safety and efficacy of transarterial 
chemoembolization (TACE) in the treatment of advanced stage hepatocellular 
carcinoma (HCC) using very small drug-eluting beads (DEB). 
Methods and Materials: We retrospectively reviewed the medical records of 
47 patients with advanced-stage HCC (BCLC-C) who underwent TACE using 
75um DEB as their first therapy for HCC between November 2013 and March 
2016. Patients were evaluated for median hospital stay, 30-day adverse 
events, 30-day mortality, toxicity profile, radiologic response, progression-free 
survival (PFS) and overall survival (OS). 
Results: The study included 36 (78.2%) males with a mean age of 65.5 
(SD=9.4) years. HCV and alcoholic cirrhosis were present in 56.5% and 30.4% 
of the patients, respectively. Child-Pugh A, ECOG 1 and portal vein invasion 
were seen in 71.7%, 69.7% and 19.6% of the patients, respectively. Segmental 
TACE was performed in 91.3% of the patients. The median hospital stay was 1 
day (range: 1-4). There were no 30-day mortality. There was a single 
occurrence of hepatic abscess. Grades 1 and 2 toxicities were seen in 21.7% 
of the patients. There was no grade 3, 4 or 5 toxicity recorded. Complete 
response, objective response and disease control were 21%, 61% and 79%, 
respectively. The PFS and OS were 7.2 and 14.3 months, respectively. The 6, 
12 and 24 months survival were 93%, 89% and 71%, respectively. 
Conclusion: TACE using very small (75um) DEB is safe and effective in the 
treatment of patients with advanced stage HCC, with OS of 14.3 months and 








B-1056 10:54  
Comparing HCC tumour vascularisation on baseline imaging and after 
Lipiodol cTACE: how do estimations of enhancing tumour volumes differ 
on contrast-enhanced MR and CT?  
W. Lüdemann1, F. Collettini1, D. Geisel1, D. Schnapauff1, G. Wieners1, 
B. Gebauer1, J. Chapiro2, J. Kahn1; 1Berlin/DE, 2New Haven, CT/US  
(willie-magnus.luedemann@charite.de)  
Purpose: Arterial tumour vascularisation and Lipiodol deposition after cTACE 
of HCC are known to be associated. Nature and strength of the correlation 
between enhancing tumour volume on baseline imaging and Lipiodol 
deposition after cTACE were analyzed. Estimations of enhancing tumour 
volumes on contrast enhanced (CE)-CT or MRI were compared using Lipiodol 
deposition as a benchmark for arterial tumour vascularisation. 
Methods and Materials: 78 HCC patients who underwent their first cTACE 
procedure were retrospectively enrolled. A segmentation-based quantification 
of overall and enhancing target lesion volumes (qEASL) was performed on 
baseline arterial phase CE-CT (55 patients) or MR (23 patients), post treatment 
Lipiodol deposition was quantified on native CT imaging. Correlations were 
analyzed using scatter plots, the Pearson correlation coefficient (PCC) and 
linear regression analysis. Subgroup analysis was performed according to 
lobar, segmental and subsegmental execution of cTACE. 
Results: The PCC for each of the baseline imaging modalities and Lipiodol 
deposition as dependent variable was 0.91, after stratification according to 
selectivity of cTACE the PCCs ranged between 0.91 and 0.98. The linear 
regression equations for the non-stratified data sets were y=1.39x+15.44, 
R2=0.83 for CT and y=0.33x+12.58, R2=0.82 for MR imaging, hence, the 
regression coefficient for CT as baseline modality was 4.21 times greater. 
Conclusion: There is a highly linear correlation for both MR and CT baseline 
enhancing tumour volume and Lipiodol deposition after TACE. Using Lipiodol 
deposition as a benchmark, it could be objectified that MR imaging is more 
sensitive for the detection and estimation of arterial tumour vascularisation 
than CT imaging.  
B-1057 11:02  
Tumour targeting and 3D voxel-based dosimetry to predict tumour 
response, toxicity and survival after Y-90 resin microsphere 
radioembolisation in HCC  
C. Allimant, M. Kafrouni, J. Delicque, A.-D. Ilonca, M. Fourcade, 
D. Mariano-Goulard, C. Cassinotto, L. Piron, B. Guiu; Montpellier/FR 
(carole.allimant@gmail.com)  
Purpose: To evaluate the impact of complete targeting and 3D-voxel-based 
dosimetry on post-treatment Y90-PET/CT to predict tumour response, survival 
and toxicity in patients with advanced HCC treated with Y90-resin 
microspheres. 
Methods and Materials: 42 Sir-sphere® treatments administered in our centre 
from February 2012 to December 2015 were retrospectively analysed. 3D-
dosimetry was calculated using a treatment planning system to obtain dose-
volume histogram and the area under the DVH (AUDVH, in Gy) to measure 
Y90 dose deposition in different liver volume (tumour, non-tumoural). Tumour 
control was defined upon mRECIST criteria at 6 months. We documented 
toxicity by radioembolization-induced liver disease (REILD) occurrences. Uni-
and multivariate logistic regressions were used to compute corresponding odds 
ratios [95%CI] according to tumour complete targeting and AUDVHTumour. 
Second endpoints were survival analysis using the Kaplan-Meier method and 
compared using log-rank tests and toxicity analysis comparing mean dose 
deposition in non-tumoural irradiated liver in REILD versus non-REILD patients 
using Mann-Whitney test. 
Results: The 6-month tumour control rate was 40.5%. Complete targeting was 
observed in 60% of cases. By univariate logistic regression, tumour targeting 
and AUDVHTumour were significantly associated with tumour control (p<0.001 
and p=0.008 resp.). By multivariate analysis, both factors independently 
predicted tumour control (OR=36.97[1.83-747] p<0.001 and OR=1.027 [1.002-
1.071], p=0.0325 resp.). Overall survival was significantly higher for both 
factors (p<0.002). We observed 4 REILD (9.5%) with significantly higher dose 
to the normal irradiated liver (p=0.004). 
Conclusion: Complete targeting and Y90-dose to the tumour, for the first time 


















B-1058 11:10  
Transarterial Radio-embolisation with 131I-Lipiodol for Hepatic 
metastases: experience intertiary care oncology centre in India  
V. Bhargavi, I. Subbanna, S.S. Swamy; Bangalore/IN 
(bhargavi_vidya@yahoo.in)  
Purpose: Surgical resection is often not feasible in metastatic hepatic disease 
To analyse the response and survival benefits of Transarterial 
Radioembolization (TARE) with Iodine-131(I131) Lipiodol for hepatic 
metastases. 
Methods and Materials: Prospective study of 65 patients (between May 2011 
to December 2016) with pathologically proven hepatic metastases from varying 
groups of primary carcinomas having poor response to other treatments. All 
patients fulfilling the inclusion/exclusion criteria underwent transarterial 
radioembolization (TARE) with I131 Lipiodol. All patients were isolated for at 
least 5 days for radiation safety purpose. Post procedure the patients were 
reviewed after one month with a follow up PET CT and tumour marker levels to 
evaluate response of treatment. Overall survival for each patient was 
calculated . 
Results: At the end of follow up period, 17 of 65 patients died with 48 
alive.Mean overall survival was 34.415 ± 3.0 months. Mean survival duration 
was 38.88 ± 5 months in NET, 35.118± 3.95 in GI , 27.21 ± 8.3 with 
pancreatico-biliary and 20.685 ± 5.2 with other malignancies( p=0.17).Overall 
survival after 45 months was 70%. 45 months survival in NET was 76% , 75 % 
in GI , 57% in pancreatico-biliary and 50% in other malignancies . Response 
evaluation int 22 patients, 7 (32%) showed partial response , 3 (14%) showed 
stable disease and 12 (54%) showed progressive diseases. All patients 
showed reduction in serum tumour marker levels.. 
Conclusion: TARE with 131I-Lipiodol is highly effective with significant 
survival benefit in patients with hepatic metastases , refractory to other 
treatments.  
B-1059 11:18  
Prospective randomised trial: tumour response of colorectal liver 
metastasis after transarterial chemoembolisation with two different 
protocols using MRI  
T.J. Vogl, M.C. Langenbach, R. Hammerstingl, J. Scholz, T. Gruber-Rouh; 
Frankfurt a. Main/DE (t.vogl@em.uni-frankfurt.de)  
Purpose: To prospectively evaluate therapy response of third-line transarterial 
chemoembolisation (TACE) for colorectal liver metastases with either 
degradable starch microspheres (DSM) or lipiodol using regular and diffusion 
MRI. 
Methods and Materials: In total, 50 patients (35 males, 15 females, mean 62 
years, range 40-79) underwent TACE. They were randomly assigned into two 
groups: group A receiving DSM and group B receiving lipiodol as embolisation 
agents. Chemotherapy consisted of a combination of cisplatin, irinotecan and 
mitomycin. Therapy response was evaluated using MRI with diffusion imaging 
and unenhanced MRI sequences, which were performed before each of the 
three TACE cycles to obtain tumour volume and apparent effusion coefficient 
(ADC). Moreover, contrast-enhanced MRI sequences were performed before 
the first and after the last TACE cycle. Tumour response was evaluated using 
the RECIST criteria. Differences in tumour volume response between the 
lipiodol and DSM group were calculated with BIAS using the Friedman test and 
the Mann-Whitney U test. 
Results: The DSM group showed statistically significant reduction in the 
average tumour volume compared with lipiodol during the course of the 
therapy (mean -59%, p=0.006). Additionally the dynamics of ADC values 
during the therapy correlated significantly with therapy response, stating partial 
response as responders and stable disease with progressive disease as 
nonresponders (p=0.046). No statistically significant difference in tumour 
response was found comparing the lipiodol and DSM group. 
Conclusion: A statistically significant reduction in tumour volume was found in 
the DSM group. No significant difference in tumour response was found 
comparing the Lipiodol and DSM group.  
B-1060 11:26  
Idarubicin-loaded beads for chemoembolisation of HCC: interim analysis 
of IDASPHERE II (FFCD 1307) multicentre single-arm phase II trial  
B. Guiu1, P. Chevallier2, A. Rode3, A. Bouvier4, P.-J. Valette3, C. Cassinotto1, 
L. Piron1, M. Boulin5; 1Montpellier/FR, 2Nice/FR, 3Lyon/FR, 4Angers/FR, 
5
Dijon/FR (b-guiu@chu-montpellier.fr)  
Purpose: The primary end point was to assess the objective response (OR) 
rate at six months after trans-arterial chemoembolisation (TACE) for HCC 
using idarubicin-loaded beads. 
Methods and Materials: TACE sessions (1-4) were performed using 10 mg of 
idarubicin loaded in 100-300 micron DC Bead. Toxicity was assessed 
according to NCI-CTCTAE v4.0. The objective response (primary end point) 
was evaluated (mRECIST) using MRI (centralized review). The study was a 2-
step Fleming design (H0: 25% of OR at 6 months vs H1: 40%, power=90%, 
one sided: =5%). 46 patients were included for the interim analysis. 
Results: 46 patients (median age: 71y; range: 44-89y) were enrolled in seven 
centres at interim analysis. Performance status was 0 in 83%, 1 in 15% and 3 
in 2%. BCLC status was A in 10.9%, B in 76.1% and C in 13%. Bilobar disease 
was reported in 51% with >3 HCC nodules in 53.5% patients. Complete 
response, partial response and stable disease were observed in 6 (13.6%), 16 
(36.4%) and 4 (9.1%) patients, respectively. OR rate at 6 months was 50% 
(90%CI: 36.8-63.2%). The trial was stopped at interim analysis because of its 
efficacy. 
Conclusion: TACE of HCC using idarubicin-loaded beads is well tolerated and 
provides a 50% objective response rate at 6 months. A randomised phase 3 
trial is warranted.  
B-1061 11:34  
Transradial versus transfemoral access for hepatic chemo-embolisation: 
intrapatient prospective single-center study  
A. Posa, R. Iezzi, F. Carchesio, C.A. Barone, A. Gasbarrini, R. Manfredi; 
Rome/IT (alessandro.posa@gmail.com)  
Purpose: To compare transfemoral approach (TFA) and transradial approach 
(TRA) in patients undergoing hepatic chemoembolization in terms of safety, 
feasibility, and procedural variables, including fluoroscopy time, radiation dose 
(reference air kerma [RAK]), and patient preference. 
Methods and Materials: A single-center prospective intrapatient comparative 
study was conducted with 42 consecutive patients with hepatic malignancies 
who received 2 consecutive treatment sessions of unilobar hepatic 
chemoembolization within a 4-week interval over a 6-month period with both 
TRA and TFA. All procedures were performed by 1 interventional radiologist 
who assessed the eligibility of patients for inclusion in the study. The primary 
endpoint was intraprocedural conversion rate. Secondary endpoints were 
access site complications, angiographic and procedural variables, and 
evaluation of patient discomfort and preferences. 
Results: A 100% technical success rate and a crossover rate of 0% were 
recorded. There were no major vascular complications and similar rates of 
minor complications (4.8% for TRA, 7.1% for TFA; P=.095), which were self-
limited and without any clinical sequelae. TRA treatments required a 
significantly longer preparation time for the procedure (P=.008) with no 
significant differences for other procedural variables. Greater discomfort at the 
access route and patient inability to perform basic activities after the procedure 
were recorded for TFA (P<.001). TRA was preferred by 35 patients (35/42) for 
potential future transarterial procedures. 
Conclusion: TRA is safe and feasible for transarterial hepatic 
chemoembolization, with high technical success, low overall complications, 
and improved patient comfort.  
B-1062 11:42  
A comparative study of a new generation robotic angiography system 
based on patient dose and image quality during transarterial 
chemoembolisation  
T.J. Vogl, L. Alizadeh, M.H. Albrecht, P. Tischendorf; Frankfurt a. Main/DE 
(t.vogl@em.uni-frankfurt.de)  
Purpose: Comparison of patient dose and diagnostic image quality between 
two generations of robotic angiographic systems for transarterial 
chemoembolization (TACE) therapy of malignant liver tumours. 
Methods and Materials: 159 patients undergoing TACE treatment were 
divided randomly into three groups: generation one, generation two before and 
generation two after the protocol update. Patient imaging was performed with 
fluoroscopy and digital subtraction angiography (DSA) acquisition protocols. 
Radiation dose was measured using an ionization chamber, measuring dose-
area-product (DAP) in Gy·cm2 and reference-point-air-kerma (RP) in mGy. 
Image quality was analysed by three radiologists through a blinded evaluation, 
considering clinically relevant image parameters. 
Results: The second-generation system provided significantly (p < 0.05) better 
clinical image quality (IQ) of 30% in DSA and 81% before and 76% after digital 
fluoroscopy protocols vs the older generation system. The new generation 
system also showed a lower radiation exposure, by RP -48% and -40% DAP in 
DSA acquisition. In fluoroscopy protocols a decrease of RP -3% and -5% DAP 
before, and RP -50% and -49% DAP after update was found for second-
generation systems, compared to first-generation systems. 
Conclusion: Recent generation angiography systems allow significant dose 














B-1063 11:50  
Generation I vs new-generation cone-beam CT, digital subtraction 
angiography and digital fluoroscopy in patients undergoing TACE: 
comparison of radiation dose and image quality  
T.J. Vogl, L. Alizadeh, K. Graef, N.-E.A. Nour-Eldin; Frankfurt a. Main/DE 
(t.vogl@em.uni-frankfurt.de)  
Purpose: To compare radiation dose, clinical image quality (IQ) and aspects of 
workflow and usability in a clinical environment for patients and radiologists 
during transarterial chemoembolization (TACE) of hepatic malignancies using 
generation I (A.Zeego) C-arm cone-beam CT (CBCT) or the new generation II 
(A.Pheno) CBCT. 
Methods and Materials: 153 patients with liver malignancies underwent 
preprocedural MRI and TACE in a 4- to 6-week interval. During TACE 
generation I and generation II CBCT were both operated by the same 
experienced radiologists and patients were randomized. From 02/17 onwards a 
software patch was applied on the generation II system for reducing the 
radiation dose in fluoroscopy. Radiation dose and image data were collected 
as DICOM (SR,XA) system data from each CBCT. Radiation doses were 
measured with the built-in standardized measuring units of the CBCTs 
(Siemens-Healthineers/Forchheim) measuring DAP and SED. Afterwards 
qualitative image quality was compared in a blinded trial of three individual 
experienced readers through a scale-based evaluation. 
Results: Generation II system provided a significantly better IQ of x) =30% 
before and x) =25% after patch in digital subtraction angiography (DSA) and of 
x) =81% before and x) =76% after patch in digital fluoroscopy protocols vs the 
older generation. Moreover, detectability of guidewire and microcatheters in 
fluoroscopy protocols was improved. It also showed a lower radiation exposure 
after patch fluoroscopy and in DSA acquisitions vs generation I system. 
Conclusion: Generation II vs generation I system provides better IQ and 
workflow with lower radiation dose. Further, it facilitates very low-dose radiation 
spectrum for clinical use.  
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B-1070 10:30  
To evaluate the role of 68Ga-PSMA PET-CT in patients with newly 
diagnosed high-risk prostate cancer  
S.M. Shaikh; Hyderabad/IN (drsikandar_s@yahoo.co.in)  
Purpose: The aim of the current study was to assess the use of 68Ga-PSMA 
(prostate-specific membrane antigen) in patients with prostatic cancer. 
Methods and Materials: 68Ga-PSMA PET-CT was performed after injection 
of radiotracer and scan done after one hour. 27 patients with diagnosed 
prostate cancer, Gleason score of 7or higher were included in inclusion criteria. 
The study is retrospective. 
Results: All 27 patients had increased 68Ga-PSMA uptake in the prostate. In 
8 patients (32%) uptake was localized. In 6 patients PET-CT findings 
suggested capsular involvement, in 3, seminal vesicles involvement and in 2, 
uptake was not separated from the rectum or urinary bladder wall which was 
suggestive of infiltration. Nineteen patients (72%) had increased lymph node 
uptake. In 14 patients nodal uptake was detected only in the pelvis (3 
perirectal, 10 iliac, 1 superior rectal), in 3 also in retroperitoneal nodes and in 2 
in mesenteric nodes. In 6 patients (23%) skeletal increased uptake 
intramedullary=1, cortical and intramedullary=2, and cortical =9. In 2 of the 6 
patients the bone was the only site of uptake other than the primary tumour 
site. There was a single patient with lung nodules suggestive of metastasis. Of 
the 23, 6 had surgery (26%); 5 patients (in 2 with combination of radiation (R) 
and hormonal therapy (H)) and 1 with uptake also in pelvic lymph node 
dissected at surgery. 12 patients (54%) received hormonal therapy and one 
patient received chemotherapy. 







B-1064 10:38  
Prediction of minimal extraprostatic extension with MRI: correlation with 
whole-mount histological sections  
S. Pedalino, E. Appendino, E. Tabone, S. Mazzetti, D. Regge, F. Russo; 
Candiolo/IT (salvatore.pedalino@ircc.it)  
Purpose: To differentiate with MRI organ-confined prostate cancers (PCas) 
that infiltrate the fibrous capsule from PCas with minimal extracapsular 
extension (mECE). 
Methods and Materials: 70 prostatectomized patients with a total of 73 
lesions were enrolled in this study. Of the 73 lesions, 57 were organ confined 
but with infiltration of the fibrous capsule (T2f); 16 had mECE (i.e. 0.7 mm in 
radial extension; T3m). An experienced uroradiologist retrospectively reviewed 
T2w images (axial, coronal, sagittal) of all 73 lesions to assess the 
presence/absence of mECE. For each tumour the contact length with the 
fibrous capsule in mm, the presence/absence of bulging, the 
presence/absence of plaque-like morphology without bulging were recorded. 
Receiver operating characteristic (ROC) curves were used to determine the 
contact length cut-off to differentiate T2f from T3m. 
Results: Presence of bulging was found in 12% (7/57) and 44% (7/16) of T2f 
and T3m, respectively (p<0.01). Plaque-like morphology was present in 14% 
(8/57) T2f and in 19% (3/16) T3m tumours (p=0.70). Both plaque-like 
morphology and bulging were absent in 74% (42/57) of T2f and 37% (6/17) of 
T3m tumours (p=0.02). The median contact between lesion and prostatic 
capsule was 11mm (IQR 7-15) and 14mm (IQR 13-16) for T2f and T3m 
tumours, respectively (p=0.02). With ROC analysis a sensitivity of 75% and a 
specificity of 65% were obtained in the prediction of the T3f at the best cut-off 
value (12mm). 
Conclusion: Presence of bulging and a of broad contact (>12 mm) of the 
tumour with the fibrous capsule are predictive of mECE.  
B-1065 10:46  
Added value of MRI tractography of periprostatic nerve plexus to 
conventional T2-WI in detection of extra-capsular extension of prostatic 
cancer  
A. Cybulski, M. Catania, R. Negrelli, E. Boninsegna, S. Brancato, A. Tafuri, 
G. Zamboni, S. Siracusano, R. Pozzi Mucelli; Verona/IT 
(matteocatania89@gmail.com)  
Purpose: To evaluate the role of MRI in detection the extra-capsular extension 
(ECE) of prostatic tumor through T2-WI, tractography of periprostatic nerve 
plexus and a combination of both. 
Methods and Materials: 36 patients with diagnosis of prostatic neoplasia 
performed MRI and underwent radical prostatectomy. Histopathological 
analysis showed ECE in 15/36 and capsule sparing in 21/36. By means of T2-
WI, ECE was evaluated in a qualitative manner: a score (1 to 4) was assigned 
to each lesion; sensitivity and specificity were calculated for each score group. 
We performed a quantitative analysis on 2 tractographic parameters, fractional 
anisotropy (FA) and apparent diffusion coefficient (ADC), and computed the 
ratio between the lesion quadrant and its controlateral (L/H ratio). We 
compared L/H ratios of patients with and without ECE; ROC analyses were 
performed to determinate ECE cut-off values of tractographic parameters. 
These cut-off values were used in association with T2-WI to reassess patients 
and to evaluate if specificity and sensitivity of ECE detection change. 
Results: T2-WI showed a sensitivity of 80% and a specificity of 71% in 
detection of ECE. Tractography displayed a significant difference in L/H ratio 
for FA and ADC between patients with and without ECE. The simultaneous use 
of T2-WI and tractography revealed high sensitivity (100%) on patients with low 
suspect of ECE (score:1-2) and high specificity (80-100%) on patients with 
medium-high suspect of ECE (score:3-4). 
Conclusion: MRI tractography combined with T2-WI is able to identify tumor 
ECE with higher sensitivity and specificity than conventional T2-WI alone.  
B-1066 10:54  
How to predict anterolateral extracapsular tumour extension in patients 
with prostate cancer  
H. Ahn, S.I. Hwang, H.J. Lee; Seongnam/KR (ahnhyungwoo@naver.com)  
Purpose: To investigate imaging markers indicating anterolateral 
extracapsular extension (ECE) of anteriorly located prostate cancer. 
Methods and Materials: Among 505 anteriorly located prostate cancers on 
histopathological mapping between 2011 and 2016, 221 lesions of category 4 
and 5 in prostate imaging reporting and data system on multiparametric MRI 
were enrolled. Two radiologists independently measured the largest tumour 
dimension, the length of the border where the tumour contacts the anterolateral 
prostate capsule if present and apparent diffusion coefficient value, and 
assessed the capsular morphology in five categories (intact, focal thinning, 
bulging, disrupted, or measurable extracapsular disease). Intraclass correlation 
coefficient (ICC) and Cohen’s  statistics were used to assess inter-reader 
agreement. Logistic regression analysis was done to assess the meaningful 
  






indicator of ECE, along with Gleason score and prostate-specific antigen level 
with each measurement. The cutoff value of measurement in the prediction of 
ECE was obtained using Youden Index. 
Results: Inter-reader agreement was excellent for the largest tumour 
dimension (ICC 0.81, 95% CI 0.76-0.85) and capsulotumoural border length 
(ICC 0.80, 95% CI 0.75-0.85), and was good in the categorisation of capsular 
morphology ( 0.64, 95% CI 0.55-0.74). The capsulotumoural border length 
(odds ratio [OR], 1.1) and the preservation of capsular contour (OR 0.3) were 
found to be statistically significant in the prediction of ECE. A capsulotumoural 
border of 1.0 cm demonstrated a sensitivity and specificity of 82.6% (57/69) 
and 71.1% (108/152), respectively. 
Conclusion: Anterolateral ECE should be suspected when the tumour is in 
contact with the anterolateral capsule with its border measuring 1.0 cm or 
longer, or when the capsular contour is disrupted.  
B-1067 11:02  
T-staging of prostate cancer: prevalence and predictive value of 
frequently used signs of extracapsular extension on prostate MRI  
F. Pesapane, C. Standaert, P. De Visschere, G. Villeirs; Ghent/BE 
(filippopesapane@gmail.com)  
Purpose: To evaluate the staging performance of frequently used signs of 
extracapsular extension (ECE) on prostate magnetic resonance imaging. 
Methods and Materials: The presence of ECE in index lesions visible on 
prebiopsy mpMRI (consisting of T2w images, DWI and DCE on a 3 Tesla 
system) of 46 patients (mean age 63 years, mean PSA 17.2 ng/mL) with 
biopsy-proven prostate cancer, who underwent subsequent radical 
prostatectomy between 11/2011 and 12/2014, was retrospectively assessed by 
two radiologists (15 and 8 years of experience) on the basis of 8 criteria 
selected from literature. For each sign, the prevalence and positive predictive 
value (PPV) for histopathologically proven ECE was calculated as the average 
of both readers. 
Results: Tumour-capsule contact was the most prevalent sign (56.9%), but 
with the lowest PPV (51.9%), although increasing with broader capsular 
contact (57.9% if  10 mm and 81.3% if  20 mm). Prevalence and PPV were 
18.6% and 69.0% for capsular signal-intensity disruption, 14.7% and 75% for 
contour bulging, 11.8% and 75.0% for unsharp margin, 8.8% and 85.7% for 
irregular contour, 6.9% and 87.5% for periprostatic fat infiltration, and 2.9% and 
100% for both rectoprostatic angle obliteration and periprostatic mass, 
respectively. 
Conclusion: Broad tumor-capsular contact length, irregular contour, 
periprostatic fat infiltration, rectoprostatic angle obliteration and periprostatic 
mass are associated with the highest chance of ECE of the index lesion. All 
other signs are more prevalent, but less predictive of ECE. Reporting the 
chance of ECE can add important information to the treatment decision-
making.  
B-1068 11:10  
Development of an extraprostatic extension imaging score based on 
multiparametric MRI and histopathology correlations  
R. Campa, V. Salvo, M. Pecoraro, M. Del Monte, V. Panebianco, C. Catalano; 
Rome/IT (riccardocampa23@gmail.com)  
Purpose: To develop an extraprostatic extension imaging score (EPEIS) 
based on multiparametric magnetic resonance (mpMRI) of prostate cancer 
(PCa). It may give the urologist an easily comprehensible information, either 
alone or embedded into a nomogram, that can be helpful for local staging and 
proper therapeutic planning. 
Methods and Materials: A cohort of 32 consecutive patients with clinically 
localised PCa who underwent preoperative mpMRI and then radical 
prostatectomy (RP) were enrolled in the study from January 2015 to August 
2017. Patients underwent staging 3T MpMRI (T2WI on axial and coronal 
planes, DWI with b values up to 2000 s/mm2, DCE images). Two expert 
radiologists retrospectively evaluated the exams assigning a T-stage, 
according to ESUR MR prostate guidelines, and the EPEIS, ranging from 0 to 
5, based on PIRADSv2 staging criteria. Histopathological prostatectomy data 
were used as standard reference. 
Results: Extraprostatic extension (EPE) was present in 13/32 (41%) patients. 
ROC curves analysis shows How EPEIS proved to be a good indicator in the 
staging (AUC=0.76 [0.65-0.85]); better than the assignment of a T-stage 
(AUC=0.71 [0.60-0.82]). Youden's J statistic was made to select the best 
EPEIS cut-off. EPEIS proved good sensitivity (0.65-0.87) and specificity (0.73-
0.95), especially if compared to the T-stage assignment sensitivity (0.58-0.80) 
and specificity (0.67-0.89). 
Conclusion: EPEIS proved to be a promising mpMRI indicator of PCa micro- 
and macroscopic extracapsular extension. Its usefulness could be increased if 
included within appropriate nomograms.  
 
 
B-1069 11:18  
Whole-body MRI for bone metastasis detection in prostate cancer: the 
roles of static field intensity and contrast media in focus  
D. Kovacevic, I. Papageorgiou, R.L. Chelaru, S. Winzler, A. Malich; 
Nordhausen/DE (ismini.e.papageorgiou@gmail.com)  
Purpose: The purpose of this study is to define whether the static field 
intensity (1.5T vs 3T) and the use of gadolinium enhancer influence the 
diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) for 
osseous metastasis in prostate cancer. 
Methods and Materials: The study was retrospective for 96 patients scanned 
between 05/2007 and 08/2017. 49 patients were imaged at 1.5T and 47 at 3T 
with a T1-w FFE and a STIR or a Dixon at the coronal level. The slice 
thickness was 6 mm at 1.5T and 3 mm at 3T. In 24 (25%) patients, the scan 
was enhanced with gadoteridol (ProHance) 0.2 mmol/kg. Clinical or bioptic 
confirmation served as the gold standard. 
Results: The sensitivity (Se) and specificity (Spe) for 1.5T was 88%/100%, 
and the positive predictive value (PPV)/negative predictive value (NPV) was 
100%/88%. The static field strength of 3T showed Se/Spe 96.15%/90.48% and 
a PPV/NPV of 92.59%/95%. Binary logistic regression with Fisher´s exact test 
revealed no significant difference between 1.5T and 3T WB-MRI (P 1.0). The 
Se/Spe of WM-MRI (merged 1.5T and 3T) without enhancement was 
92.5%/96.87%, with PPV/NPV 97.37%/91.18%. With administration of 
gadoteridol, the Se/Spe was 92.31%/90.91% and the PPV/NPV was 
92.31%/90.91%. Binary logistic regression with Fisher´s exact test returned no 
significant effect for gadoteridol (P 1.0, odds ratio 1.545). 
Conclusion: The diagnostic accuracy of WB-MRI for osseous metastatic 
disease in prostate cancer is equal for the most commonly used static field 
strengths, 1.5T and 3T, and independent of gadolinium enhancer 
administration.  
B-1071 11:26  
Multiparametric magnetic-resonance to confirm eligibility to an active 
surveillance programme for low-risk prostate cancer: intermediate time 
results of a high-volume centre protocol  
S. Luzzago, M. Catellani, A. Russo, E. Di Trapani, F. Mistretta, G. Musi, 
P. Pricolo, G. Petralia, O. De Cobelli; Milan/IT (stefanoluzzago@gmail.com)  
Purpose: To evaluate confirmatory multiparametric magnetic resonance 
imaging (mpMRI) of the prostate at the time of active surveillance (AS) 
enrollment to reduce disease misclassification. 
Methods and Materials: From 2012 to 2016, 383 patients with low-risk 
disease respecting PRIAS criteria underwent confirmatory 1.5-T mpMRI. AS 
was proposed to patients with PI-RADS score3 and no extraprostatic 
extension (EPE) at mpMRI, whereas patients with PI-RADS score4 and/or 
EPE were treated actively. Kaplan-Meier analyses quantified progression-free 
survival (PFS) in patients enrolled in AS program. Logistic regression analyses 
tested the association between confirmatory mpMRI and clinically-significant-
prostate-cancer (csPCa) at radical prostatectomy (RP). Diagnostic 
performance of mpMRI was calculated in patients submitted to immediate RP. 
Results: Median time of persistence in AS protocol was 24 months (IQR 13-
38). Progression-free-survival rate was 99%, 90%, and 86% at 1, 2 and 3 
years, respectively. At multivariable analysis, PI-RADS 3, PI-RADS 4, PI-RADS 
5 and EPE increased the probability of having csPCa at immediate RP (PI-
RADS 3 [OR]: 1.2, p=0.26; PI-RADS 4 [OR]: 5.1, p=0.02; PI-RADS 5 [OR]: 6.7 
p=0.009; EPE [OR]: 11.8, p<0.001). Confirmatory positive mpMRI showed 
sensibility, specificity, PPV and NPV of 85%, 55%, 68% and 76%, respectively. 
Conclusion: Confirmatory mpMRI at the time of AS enrollment reduces 
misclassification rate of csPCa. We suggest to perform target biopsies in 
patients with PI-RADS score 3 and 4 lesions.  
B-1072 11:34  
Evaluation of MRI parameters for prediction of prostate cancer upgrading 
in active surveillance  
D. Portalez, M. Jaffro; Toulouse/FR (jaffro.m@chu-toulouse.fr)  
Purpose: To evaluate MRI parameters for Gleason score progression in 
patients with low-risk prostate cancer managed with active surveillance. 
Methods and Materials: 125 patients enrolled in AS for prostate cancer with a 
PI-RADSv2 score 3 or higher underwent systematic biopsies (SB) and MRI-
TRUS targeted-fusion biopsies (TB). MRI findings (PI-RADS v2 scoring, ADC 
value measurements, quantitative DCE parameters, tumour's volume, tumour's 
visibility on the high b value images) were correlated to pathological results for 
each lesion. The final study population included 111 patients with Gleason 3+3 
on initial biopsies and MRI's target in the peripheral zone (PZ). Statistics 
consisted in Chi-squared or Fisher's exact test for categorical variables and 
Mann-Whitney test for continuous variables with a multivariate logistic 
regression between Gleason 7 and MRI parameters. 
Results: Overall upgrade concerned 50/125 patients with 45/111 in the PZ and 
1/14 in the transitional zone. Disease was upgraded in 23/125 patients on SB 
  






and in 50/125 patients on TB. Sensitivity, specificity, positive and negative 
predictive values of ADC value for confirmatory biopsy upgrade in the PZ of 
111 patients were 82.2%, 81.8%, 75.5% and 87.1% respectively. A higher 
performance of ADC value in the prediction of Gleason score upgrading was 
found compared to other MRI parameters. This upgrading was clearly 
associated with a lower tumour's ADC value and tumour visibility on the high b 
value Images. 
Conclusion: ADC value tumour's measurement and tumour visibility on the 
high b value images provided greater accuracy in predicting upgrading on 
confirmatory biopsies than other MRI parameters.  
B-1073 11:42  
Added value of multiparametric magnetic resonance (mpMR) and 
transrectal ultrasound-MR fusion biopsy in active surveillance for 
prostate cancer  
F. Ciccarese, B. Corcioni, C. Gaudiano, M. Garattoni, F. Busato, R. Golfieri; 
Bologna/IT (ciccarese.f@gmail.com)  
Purpose: Active surveillance is currently reserved for selected low-risk patients 
affected by prostate cancer with a Gleason Score =6; at initial diagnosis, 
mpMR is considered for the high negative predictive value and to reduce 
misclassification. The aim of this study was to evaluate mpMR findings in 
patients in active surveillance, with focus on suspected lesions submitted to 
transrectal ultrasound-MR fusion biopsy. 
Methods and Materials: We retrospectively reviewed mpMR scans performed 
from January 2016-June 2017; on a total of 744 exams, we selected 88 
patients submitted to MR for a previous diagnosis of prostate cancer Gleason 
Score 3+3 suitable for active surveillance. MR data were expressed by using 
PIRADS classification. In case of PIRADS 3, we considered patients that 
underwent adjunctive transrectal ultrasound-MR fusion biopsy and we 
analyzed histological results. 
Results: mpMR documented benign findings (i.e. PIRADS 1-2) in 39/88 
patients (44.3%), while in the others 49/88 (55.7%) the presence of a clinically 
significant cancer was considered to be equivocal (PIRADS 3 in 35/88-39,8%) 
or probable (PIRADS 4-5 in 14/88-15.9%). 20/49 patients were submitted to 
fusion biopsy in our Institute; in 12/20-60.0% a higher Gleason score was 
detected (7-9) 
Conclusion: Almost 50% of patients in active surveillance shows MR 
abnormalities. Prostate mpMR combined with target fusion biopsies reduce 
downstaging and help in correct management.  
B-1074 11:50  
Impact of upfront risk stratification on the negative predictive value of 
multiparametric MRI in patients under active surveillance  
M. Abihanna1, C. Melodelima2, P.-C. Moldovan1, R. Souchon1, A. Ruffion1, 
M. Colombel1, S. Crouzet1, O. Rouviere1; 1Lyon/FR, 2Grenoble/FR 
(m_abihanna@hotmail.fr)  
Purpose: To assess the impact of upfront risk stratification on the negative 
predictive value (NPV) of multiparametric MRI in patients under active 
surveillance (AS). 
Methods and Materials: We retrospectively analysed a prospective database 
of 326 patients under AS who underwent multiparametric MRI before biopsy. 
The prediction of clinically significant prostate cancer (csPCa) at biopsy by 
clinical (age, digital rectal examination, PSA density [PSAd], history of prior 
negative biopsy) and imaging (Likert score, extracapsular extension [ECE], 
magnetic field strength, experience of radiologist and presence of a concordant 
hypoechoic lesion [Concord-Echo]) variables was assessed by multivariate 
analysis. Significant clinical variables were included in a ‘clinical model’. Three 
definitions for csPCa were used (csPCa1: grade group 3; csPCa2: grade 
group 2; csPCa3: csPCa2 and grade group 1 with cancer invasion length 
5mm). 
Results: Age, PSAd and Likert score significantly predicted the presence of 
csPCa1-3. In addition, ECE significantly predicted the presence of csPCa1-2. 
Adding the Likert score to the clinical models significantly increased the 
model’s performance for csPCa1-3. Omitting biopsy in patients with negative 
mpMRI would have avoided 37.4% (Likert 3/5) or 53.1% (Likert 4/5) of 
biopsies while missing csPCa in 7.1% (csPCa1), 20.2-33.7% (csPCa2) and 
35.8-48.9% (csPCa3) patients. mpMRI NPV decreased when the probability of 
csPCa given by the clinical models increased. Therefore, considering clinical 
models’ output allowed defining scenarios missing <5% of csPCa and omitting 
biopsies in 33.4-45.4% (csPCa1), 13.5-16.6% (csPCa2), and 7.1-8.9% 
(csPCa3) patients. 
Conclusion: Upfront risk stratification of patients can allow rational use of 
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B-1075 10:30  
Combined diffusion-weighted MRI with conventional T2 and T1 in-
phase/out-of-phase sequences: a short screening protocol for liver 
metastases  
S. De Vuysere1,2, V. Vandecaveye1, R. Dresen1; 1Leuven/BE, 2Bonheiden/BE 
(sofie.devuysere@gmail.com)  
Purpose: To evaluate whether a short magnetic resonance imaging (MRI) 
protocol consisting of diffusion-weighted imaging (DWI), T1 in-phase/out-of-
phase and T2-weighted sequences can accurately detect liver metastases 
without the need of post-contrast imaging. 
Methods and Materials: Liver MRI was performed in 124 consecutive patients 
with various primary cancers. Three independent readers with different 
experience level (1 year, 10 years and 15 years respectively) retrospectively 
reviewed the DWI, T2 and T1 in-phase/out-of-phase sequences. All observers 
used confidence levels for the prediction of metastases (1 = definitely no 
metastases, 2 = probably no metastases, 3 = inconclusive, 4 = probably 
metastases, and 5 = definitely metastases). Sensitivity, specificity, positive 
predictive value, and negative predictive value were calculated with the cut-off 
level between 2 and 3 (rating 1) and 3 and 4 (rating 2). Histopathology or 2-
years imaging follow-up were the reference standard. 
 
Results: Reader 1 had a sensitivity and NPV of 100% in both ratings. 
Specificity was respectively 72% versus 96%, PPV of 61% versus 92%. 
Reader 2 had a sensitivity of 100%, specificity 98%, PPV 97%; NPV 100% in 
rating 1 ; sensitivity 94%, specificity 100%, PPV 100%, NPV 97% in rating 
2.Reader 3 had no inconclusive results. In both ratings sensitivity was 100%, 
specificity 97%, PPV 97%, NPV 100%. 
Conclusion: DWI, T2 and T1 in-phase/out-of-phase sequences allowed 
accurate detection of liver metastases in an experienced reader. In future, this 
time-efficient protocol could be used for screening of liver metastases, without 
the need for post-contrast imaging.  
B-1076 10:38  
CT attenuation of liver metastases of colorectal cancer is a prognostic 
factor of overall survival  
M.F. Froelich, V. Heinemann, W.H. Sommer, J. Holch, J. Ricke, D. Modest, 
F.O. Hofmann; Munich/DE  
Purpose: To investigate the prognostic value of mean CT-attenuation of liver 
metastases for overall survival (OS) in metastatic colorectal cancer (mCRC). 
Methods and Materials: Patients with histologically confirmed mCRC from a 
clinical phase III trial who received 5-FU, leucovorin and irinotecan with 
cetuximab or bevacizumab were included into the analysis. In a baseline CT in 
portal venous phase the mean attenuation of liver metastases was assessed 
using semi-automated volumetry. ROC analysis was used to determine an 
optimal threshold identifying long-term survivors. Its influence on OS was 
investigated in Kaplan-Meier and Cox proportional hazard regression. 
Results: Of a total of 592 patients, 347 were eligible for volumetric 
segmentation of liver metastases. Mean attenuation was 60.09HU. A higher 
attenuation was associated with longer OS (per 10HU: HR 0.85 (0.75; 0.93), 
p<0.001). 61.62HU was found as optimal threshold to predict longer OS 
(median 21.3 vs 30.6 month; HR 0.61 (0.47; 0.80), p<0.001) and was 
confirmed in multivariate regression (HR 0.61 (0.46; 0.82), p<0.001). 
Conclusion: Increased mean baseline CT attenuation of liver metastases may 
be utilised to identify mCRC patients with longer OS.  
Author Disclosures: 
 V. Heinemann: Advisory Board; Merck KGaA, Roche AG, Amgen, Sanofi, 
Lilly, SIRTEX, Boehringer Ingelheim, Baxalta, Taiho, Merrimack. Consultant; 
Merck KGaA, Roche AG, Amgen, Sanofi, SIRTEX, Baxalta. Other; Merck 
KGaA, Roche AG, Amgen, SIRTEX, Baxalta.  J. Holch: Consultant; Roche. 
Other; Novartis.  D. Modest: Consultant; Merck KGaA, Amgen, Bayer, Servier, 











B-1077 10:46  
Predicting the response of colorectal cancer liver metastases (CRCLM) to 
preoperative chemotherapy using gadoxetic acid-enhanced MRI  
N.V.V.P. Costa1, N. Bastati2, S. Pötter-Lang2, Z. Guengoern2, Y. Bican2, 
A. Ba-Ssalamah2; 1Lisbon/PT, 2Vienna/AT (nunovpc@gmail.com)  
Purpose: The aim of the study was to create a scoring system based upon 
gadoxetic acid-enhanced magnetic resonance imaging (gaMRI) features to 
predict the treatment response (TR) to chemotherapy. 
Methods and Materials: This was a retrospective study of 30 consecutive 
patients (65.2±11.2years) with CRCLM, who underwent gaMRI after 
chemotherapy and before hepatic resection. Metastases were classified 
according to a suggested scoring system (0-6 points) in three groups of 
response: optimal (2 points); partial (2-4 points); and no-response (4 points). 
The scoring system comprised three features: overall homogeneity 
(homogeneous=0, mixed=1, heterogeneous=2); tumour-liver interface 
(sharp=0, mixed=1, ill defined=2); and peripheral rim enhancement (2 mm=0, 
2-4 mm=1, 4 mm=2). Apparent diffusion coefficient (ADC) values were 
measured.The primary outcome was residual vital tumour (RVT). The scoring 
system, response groups, and ADC values were calculated and compared with 
the RVT percentage. Demographic, laboratory, and imaging findings were 
included in a multivariate statistical analysis. The three groups of response 
were correlated with patient survival and the log-rank test was used to 
compare two survival distributions (optimal/partial response vs no-response 
groups). 
Results: Forty-one CRCLM showed good inter-observer agreement (=0.86). 
Multiple regression demonstrated an association between RVT (32.9±11.2) 
and the scoring system (p<0.001), the response group (p<0.001), and the ADC 
values (p<0.021). The survival distributions between optimal/partial response 
and no-response showed a trend to be different (p=0.066). 
Conclusion: gaMRI correlated well with our scoring system, different response 
groups, and ADC values in patients with CRCLM treated with chemotherapy, 
and may be used to assess the RVT percentage.  
B-1078 10:54  
MRI-based treatment response assessment for liver metastasis 
stereotactic radiotherapy  
D.I. Kuplevatskaya, A. Babiy, N. Vorobyov, V.I. Kuplevatsky, N. Berezina, 
M. Cherkashin; St. Petersburg/RU (dkupl@ldc.ru)  
Purpose: To develop MRI criteria for stereotactic body radiation therapy 
(SBRT) treatment response assessment in patients with liver metastases. 
Methods and Materials: In our study 39 patients with liver metastasis, treated 
by SBRT were included. Abdominal MRI (1.5T scanner) was performed before 
radiation and after 1, 4, 6, 12 months. The protocols include: T2 Cor, T2 
CorFS, T2 Sag, T2 tra, T1 tra in a phase-antiphase, DWI (b 50, 400, 1000), T2 
Ax TSE BLADE FS 3 mm on the liver area, dynamic contrast T1tra VIBE FS 
1.5 mm. Analysis included target measurement by RECIST 1.1 criteria, 
necrotic area volume measurement by "Segmentation volume" (OleaSphere 
V2.3 SP1), DWI, dynamic contrast enhancement and parenchymal 
postradiation change assessment. 
Results: Tumour response after SBRT was revealed in 62% in month 1 and in 
49% in month 4. Size decreasing by 30% or more was maximal in 76.9% 
patients (month 1) and maximal tumour necrosis (25 to 50% lesions) was 
detected in month 4. In 6 and 12 months after radiation, stabilization was 
observed in 64% and 71% of cases. Necrotic changes (more than 50% of 
target volume) were revealed in 61.2% of patients. Complete tumour response 
after 12 months of SBRT was detected in 13% of patients. 
Conclusion: Multiparametric MRI allows to assess morphological 
characteristics and functional status of radiated metastases and liver 
parenchyma after SBRT. Complex imaging support radiation oncologist with 
clear treatment response assessment and is a helpful tool for timely treatment 
strategy changing.  
Author Disclosures: 
  D.I. Kuplevatskaya: Speaker; Siemens.  M. Cherkashin: Speaker; Siemens. 
B-1079 11:02  
Multi-parametric MRI assessment of acute response to stereotactic body 
radiation therapy in patients with hepatocellular carcinoma or non-small 
cell lung cancer  
X. Yang, E. Miller, P. Subramanian, T.M. Williams, M.V. Knopp; 
Columbus, OH/US  
Purpose: To study tumour’s acute response to stereotactic body radiation 
therapy (SBRT) with multi-parametric functional MRI. 
Methods and Materials: Patients with unresectable hepatocellular carcinoma 
(HCC) or non-small cell lung cancer (NSCLC) received multi-parametric MRI 
prior to and within 24 hours after a single fraction of SBRT. BOLD, DWI 
(NSCLC: b=0/600; HCC: b=0/50/600), and DCE-MRI (Gadobenate, 0.5mL/s 
infusion) sequences were acquired on a 3T scanner. BOLD response to an 
oxygen challenge (15L/min) was measured with the R2* difference between 
air-breathing and oxygen-breathing cycles. Apparent Diffusion Coefficient 
(ADC) was calculated from the DWI data. DCE-MRI was analyzed with the 
modified Brix’s pharmacokinetic model. Linear mixed effects model was used 
for statistical analysis. 
Results: Sixteen lesions (9 HCC/7 NSCLC) were identified for analysis. 
BOLD/DWI/DCE data were available for 16/15/11 lesions. Statistically 
significant BOLD response to the oxygen challenge was observed in 5 HCCs 
but in only 1 NSCLC. SBRT induced significant decreases in air-breathing R2* 
in both HCC (2.1 s-1, P<0.001) and NSCLC (3.4 s-1, P=0.006). This decrease in 
R2* was positively correlated with an increase in DCE parameter kep 
(r=0.74/0.70 for HCC/NSCLC). The correlation between R2* decrease and 
ADC increase was negative for NSCLC (r=-0.68), and close to zero for HCC 
(r=0.1). 
Conclusion: SBRT induces an acute decrease in R2* within 24 hours post-
treatment in different types of lesions regardless of their BOLD responses. This 
change cannot be explained by radiation-induced vasogenic edema. It is more 
likely to be an indicator of improved tumour oxygenation due to a temporary 
increase in perfusion.  
B-1080 11:10  
Impact of the MRI sequence and observer on the gross tumour volume 
(GTV) in patients with oesophageal and gastro-oesophageal junction 
(GOJ) cancer  
K. Owczarczyk, C. Kelly-Morland, S. Mcelroy, J. Winfield, M.M. Siddique, 
A. Qureshi, G. Cook, V.J. Goh; London/UK (christian.kelly-morland@kcl.ac.uk)  
Purpose: Target volume definition for oesophageal/GOJ cancer is challenging 
and guided by a combination of diagnostic modalities. The high contrast-to-
noise of MRI may be of value for radiotherapy treatment planning (RTP). Our 
aim was to compare the gross tumour volume (GTV) using T2-weighted (T2w) 
and diffusion weighted (DWI) MRI and to evaluate the agreement between a 
radiation oncologist and radiologist. 
Methods and Materials: Following ethics approval and consent, 26 
oesophageal/GOJ cancer patients underwent prospective 1.5T MRI. The GTV 
was delineated on both T2-w and high b-value (b-900s/mm2) DWI images by a 
radiation oncologist and subspeciality radiologist independently. GTV was 
compared for each reader and sequence using the paired t-test (comparing 
means); and Dice Coefficient (DC), and Jaccard Similarity Index (JSI; 
assessing volume congruity). Inter-observer agreement was assessed using 
Bland-Altman statistics. 
Results: DWI GTV was larger by a mean of 14.8% (95% CI -6.7%-36.6%) 
when delineated by the radiation oncologist while T2w GTV was larger by 
18.2% (95%CI -48.2%-4.8%) when delineated by the radiologist, p>0.05. DC 
and JSI were higher for the T2w than DWI GTV (DC: 0.46±0.19 vs. 0.56±0.16; 
JSI: 0.41±0.15 vs 0.31±0.16). Bland-Altman limits of agreement were similar 
(DWI: -137.7to -130.5%; T2-w: -146 to -149.5% respectively ). 
Conclusion: Sequence selection and reader affects GTV measurements. 
These results emphasize the importance of sub-speciality radiologist input in 
RTP of oesophageal cancer as well as combining the information from multiple 
sequences at the time of target volume delineation.  
B-1081 11:18  
Comparison of 4'-[methyl-11C] thiothymidine (4DST) PET/CT and FDG 
PET/CT for predicting response to neoadjuvant therapy in patients with 
oesophageal cancer  
M. Hotta1, R. Minamimoto1, K. Yamada1, K. Yokoyama1, J. Toyohara2; 
1
Shinjyuku-ku, Tokyo/JP, 2Itabashi-ku, Tokyo/JP 
(masatoshihotta@yahoo.co.jp)  
Purpose: Imaging of DNA synthesis can be achieved using 4’-[methyl-11C] 
thiothymidine (4DST) PET/CT, which shows a high correlation with cell 
proliferation. The aim of this study was to evaluate the diagnostic value of 
4DST PET/CT for predicting response to neoadjuvant therapy in patients with 
oesophageal cancer, compared with FDG PET/CT. 
Methods and Materials: Twenty-five patients (23 males, 2 females; mean 
age, 64.8±9.2 years) with histologically diagnosed oesophageal cancer 
underwent 4DST and FDG PET/CT after completion of neoadjuvant 
chemotherapy or chemoradiation therapy. All patients subsequently underwent 
oesophagogastrectomy after neoadjuvant therapy. Based on pathological 
findings, patients were divided into responder and non-responder groups. The 
maximum standardized uptake value (SUVmax) of the primary lesion was 
measured for 4DST and FDG, and compared between responder and non-
responder groups. Receiver operating characteristics (ROC) analysis was used 
to evaluate the diagnostic performance of 4DST and FDG SUVmax for 
predicting response. 
Results: The pathological diagnosis revealed 13 responders and 12 non-
responders. The responder group showed lower 4DST and FDG SUVmax than 
the non-responder group, which was statistically significant for 4DST (4.0±1.6 
vs 6.8±3.1 for 4DST, p=0.01; 4.3±1.2 vs 7.3±4.3 for FDG, p=0.07). Area under 
  






the curve (AUC) was higher for 4DST SUVmax (0.82; CI, 0.66-0.98) than for 
FDG SUVmax (0.72; CI, 0.50-0.93). 
Conclusion: 4DST PET/CT has a potential for predicting response to 
neoadjuvant therapy in patients with oesophageal cancer compared with FDG 
PET/CT. Higher uptake of 4DST after neoadjuvant therapy may indicate 
inadequate response to neoadjuvant therapy.  
Author Disclosures: 
  M. Hotta: Research/Grant Support; Grant-in-Aid for Young Scientists（B）
No. 17K18396 from the Japan Society for the Promotion of Science, Grant of 
the Japan Radiological Society from Bayer.  
B-1082 11:26  
Efficiency of perfusion CT in pancreatic mass characterisation  
S. Aslan, M. Nural, I. Camlidag, M. Danaci; Samsun/TR 
(serdaraslan28@hotmail.com)  
Purpose: To evaluate the efficacy of perfusion CT (PCT) in pancreatic lesion 
detection and characterisation. 
Methods and Materials: 56 patients with tumour or tumour suspicion on 
dynamic MDCT underwent PCT. Perfusion parameters (BV, BF, MTT, PS) of 
the tumour and normal parenchyma was calculated separately by two different 
readers. Lesions were grouped as adenocarcinoma, neuroendocrine tumour 
(NET) and mass-forming chronic pancreatitis (MFCP) according to 
histopathological diagnoses. Isoattenuating lesions were evaluated as a 
subgroup. 
Results: All perfusion parameters in 42 adenocarcinoma cases were 
significantly different from normal pancreatic parenchyma and MFCP cases (p 
< 0.001 and p < 0.001, respectively). 5 MFCP cases had significantly 
prolonged MTT and lower BV, BF, and PS (p < 0.05) whereas 5 NET cases 
had higher BV, BF, and PS compared with normal parenchyma (p < 0.05). 
When BV, BF, PS, and MTT were chosen as 6.84 ml, 64.43 ml, 28.08 ml/100 
ml/min and 7.47 sec, respectively, differentiation between adenocarcinoma and 
MFCP were made with high sensitivity (%100, %100, %97.8 and %100, 
respectively) and specificity (%92.3, %100, %80 and %100, respectively). 11 
isoattenuating lesions also had prolonged MTT and lower BV, BF, and PS 
compared with normal parenchyma (p < 0.05). Of isoattenuating lesions, 6 
adenocarcinomas had significantly lower BV, BF, PS and prolonged MTT 
compared with 5 MFCP cases (p < 0.001). Interreader agreement was high-
very high (ICC = 0.76 - 0.99). 
Conclusion: PCT is a reliable method for diagnosis and characterisation of 
pancreatic masses and in cases of the diagnostic dilemma.  
B-1083 11:34  
Pancreatic ductal adenocarcinoma: association of RECIST1.1 and Choi 
criteria with survival data and clinical outcome  
E. Raimondi1,2, K. Young2, K. Kouvelakis2, D.-M. Koh2, V. Calamai2, 
N. Starling2, M.A. Bali2; 1Ferrara/IT, 2London/UK (edoardo.raimondi@unife.it)  
Purpose: To compare overall survival (OS) and progression-free survival 
(PFS) of pancreatic ductal adenocarcinoma (PDA) patients treated with 
FOLFIRINOX chemotherapy with RECIST1.1 and Choi criteria response 
categorisation. 
Methods and Materials: After IRB approval, 32 patients with locally advanced 
(LAPDA) and 35 patients with metastatic (MPDA) PDA treated with 
FOLFIRINOX were retrospectively included. Pre and post-treatment CT studies 
were analysed using Mint LesionTM. Within each group, patients were 
categorised as responder (R) and non-responder (NR) according to 
RECIST1.1 and Choi criteria. Kaplan-Meier analysis was performed for R and 
NR categories for each radiological criteria for OS and PFS. 
Results: Significant differences between R and NR for OS and PFS were 
observed in both groups for both radiological response criteria (Log-rank test: 
p<0.05). For LAPDA median OS was 34.57 vs 13.82 months by RECIST1.1 
(HRs: 2.62-32.59) and 21.12 vs 12.34 months by Choi (HRs: 1.44-12.12). 
Median PFS was 27.07 vs 11.74 months for RECIST1.1 (HRs: 1.89-13.79) and 
15.10 vs 10.59 by Choi (HRs: 1.16-8.98). For MPDA, median OS was 20.89 vs 
8.88 months by RECIST1.1 (HRs: 1.34-6.66) and 18.49 vs 8.22 months by 
Choi (HRs: 2.47-15.26). Median PFS was 13.82 vs 5.56 months by RECIST1.1 
(HRs: 1.59-7.95) and 13.39 vs 2.76 months by Choi (HRs: 4.95-55.56). 
Conclusion: Response categorisation by RECIST1.1 was superior to Choi 
criteria in LAPDA in stratifying patient outcomes, but Choi criteria better 
associated with OS and PFS in MPDA. These observations may suggest 








B-1084 11:42  
Virtual touch quantification technology in differentiation between benign 
and malignant solid small pancreatic tumors: initial results  
Y. Dong, F. Mao, J. Cao, P. Fan, W. Wang; Shanghai/CN (dr_mimi@163.com)  
Purpose: To evaluate the feasibility of differentiating between pancreatic 
ductal adenocarcinomas (PDA) and other solid benign pancreatic tumors with 
virtual touch quantification (VTQ) shear wave technology. 
Methods and Materials: Over the periods of January 2016 to October 2017, a 
total of 78 patients with unclassified solid small pancreatic lesion  20 mm were 
prospectively evaluated. ACUSON AXONA US system (Siemens Medical 
Solutions, Mountain View, CA, USA), equipped with a C6-1 transducer was 
used. VTQ were performed, shear wave velocity (SWV) and the differences in 
SWV ratio of solid pancreatic lesion to surrounding parenchyma were 
evaluated. In all patients VTQ elastography results were compared with 
cytology or histology findings as the gold standard. 
Results: A total of 78 pancreatic lesions including 58 (74.3 %) PDA, 13 (16.7 
%) solid pseudopapillary tumors (SPT) and 7 (8.9 %) pancreatic 
neuroendocrine tumors (NET) were analysed. The mean SWV values obtained 
were (3.59 ± 0.32) m/s for PDA, (2.61 ± 0.11) m/s for SPT and (2.47 ± 0.54) 
m/s for NET (P < 0.05). The SWV ratios were 2.43 ± 0.22 for PDA and 1.19 ± 
0.21 for benign lesions (P < 0.05). For the diagnosis of PDA, while using the 
cut off value 3.67 m/s for SWV and 2.51 for SWV ratio, good sensitivity (81.3%) 
and specificity (77.5%) were obtained for the characterization of PDA. 
Conclusion: VTQ is a new elastography method that shows promising clinical 
application for the quantification of PDA elasticity. Increasing tissue stiffness of 
PDA is represented by greater SWV values.  
B-1085 11:50  
Dedicated DW-MR imaging as an accurate selection tool for hyperthermic 
intraperitoneal chemotherapy (HIPEC) in patients with peritoneal 
carcinomatosis (PC) from colorectal origin  
I. van't Sant-Jansen, M. Engbersen, S. Chandrasegaram-Shanmuganathan, 
D.M. Lambregts, N.F. Kok, G.L. Beets, R.G.H. Beets-Tan, A.G. Aalbers, 
M.J. Lahaye; Amsterdam/NL (M.Lahaye@nki.nl)  
Purpose: The peritoneal cancer index (PCI) is a surgical scoring system to 
quantify the extent of PC. It is used to select patients who might benefit form 
cytoreductive surgery (CRS)/HIPEC. To prevent unnecessary surgery in 
patients whose peritoneal tumour burden is too extensive, patient selection 
based on preoperative imaging is highly desirable. Computed tomography is 
inaccurate in predicting PCI. In order to assess whether DW-MRI can select 
potentially operable patients we compared PCI estimated preoperatively by 
DW-MRI with PCI found at surgery. 
Methods and Materials: Forty-seven consecutive patients (M/F=21/26) with 
histologically proven colorectal cancer and suspected or confirmed PC were 
included. All patients underwent preoperative dedicated whole-body DW-MRI 
(scantime=35min) before exploratory laparoscopy or CRS/HIPEC. PCI was 
prospectively assessed by two independent radiologists on MR-imaging and 
was compared to PCI at surgery (=reference standard). Based on PCI patients 
were categorised as operable (PCI 0-20) or inoperable (PCI 21-39). 
Results: Mean PCI at surgery was 11.6(range 0-31). Mean radiological PCI for 
reader 1 was 10.8 (range 2-33) and 9.2(range 0-31) for reader 2. Radiologist 1 
and 2 staged respectively 44/47 and 41/47 patients correctly (accuracy 
94%/87%). Both radiologists detected all operable patients with a PCI<21 at 
surgery (sens=100%). Respectively, 3 and 6 patients were understaged by 
DW-MRI. There were no false negatives results. The intraclass correlation 
between the two radiologists was excellent (ICC=0.91, 95%CI:0.765-0.956). 
Conclusion: DW-MRI is an accurate and reproducible selection tool to non-
invasively select patients who could potentially benefit from CRS/HIPEC. DW-
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B-1086 10:30  
Role of one-pass breast lesion excision system in complete excision of 
high-risk breast lesions expressed as clusters of microcalcifications  
A. Christou1, V. Koutoulidis2, D. Koulocheri2, K. Zografos2, G. Zografos2; 
1
Doncaster/UK, 2Athens/GR (alexandrachristou@gmail.com)  
Purpose: To assess the role of the breast lesion excision system (BLES) in 
complete removal of clusters of microcalcifications found on mammogram 
proved histologically to be high-risk lesions. 
Methods and Materials: 394 consecutive women with 400 cases of suspicious 
clusters of microcalcifications underwent stereotactic biopsy using the intact 
BLES device between January 2014 and January 2016. 38/400(9.5%) cases 
proved histologically to be high-risk lesions and were subsequently assessed 
for underestimation and complete removal. 
Results: Mean size was 9.75mm (1.5mm-18mm) which was within the size 
that BLES needle can excise (20 mm). 4 papillomas with atypia (10.5%), 14 
cases with flat epithelial atypia (FEA) (36.8%), 10 cases with lobular neoplasia 
(LN-atypical lobular neoplasia [ALN], lobular carcinoma in situ [LCIS]) (26.3%), 
8 with atypical ductal hyperplasia (ADH) (21.2 %) and 2 cases with mucocele-
like lesions (MLL) with atypia (5.3%) were found. 29/ 38 lesions had 
subsequent surgery and all 38 had a 2-year follow up. Complete excision was 
achieved in 23/29 lesions (79.3%). No underestimation was found. 2-years 
mammographic stability was found in all lesions. Mann Whitney test showed 
that clear BLES specimen margins over 1mm was statistically significant 
predictive factor for complete removal (p=0,041). 
Conclusion: One-pass BLES intact stereotactic technique is a safe and 
accurate biopsy method with high rates of complete removal of small high-risk 
lesions which could be potentially used as an alternative excision method to 
diagnostic surgery and avoid subsequent surgical excision.  
B-1087 10:38  
Prognostic characteristics of B3 lesions detected by mammographic 
screening programmes in the Veneto region  
I. Brilli1, E. Tosi1, M. Zorzi1, A. Rizzo2, C. Fedato3, E. Orvieto1, M. Lo Mele1, 
M. Baracco1, A. Fiore1; 1Padua/IT, 2Treviso/IT, 3Dorsoduro/IT 
(isa.brilli@libero.it)  
Purpose: Breast lesions with uncertain malignant potential (B3) are extremely 
heterogeneous and have a mean predictive value (PPV) for cancer of 31.7%. 
We retrospectively analysed a case series of B3 detected by screening 
programmes of Veneto region to identify selection criteria for surgery. 
Methods and Materials: Among the 2.239.137 women screened from 2003 to 
2015, 7.179 performed a biopsy (VAB or CNB) and 757 had a B3 outcome, 
542 of which confirmed at histological revision. We evaluated the PPV for 
cancer of age, mammographic and/or ultrasound findings, radiological 
suspicion (R), biopsy diagnosis, presence of atypia. 
Results: B3 cases referred to surgery were 447/542 (82%). Out of the 419 
with available outcome, 133 (31.7%) were positive for carcinoma (43 invasive - 
PPV 10.3%, and 90 in situ - PPV 21.5%). At preoperative mammography, 57% 
of B3 lesions showed cluster of microcalcifications, 30% opacity and 13% 
distortions. PPV for invasive lesions was higher for distortions (RR 3.63; 95% 
CI 1.39-9.14) and for R4 radiological classification (RR 2.15; 95% CI 1.06-
4.43). PPV was reduced in the absence of atypia (RR 0.49; 95% CI 0.23-0.99) 
and for the B3 class of papillary lesion (RR 0.12; 95% CI 0.003-0.81). Age was 
not significantly associated with PPV. 
Conclusion: Radiological distortion, R4 classification and the presence of 
epithelial atypia could be considered as valid selection criteria for surgical 
excision. The low risk for malignant neoplasm suggests to select the B3 cases 










B-1088 10:46  
A prospective study on uncertain biological potential lesion (B3) 
overtreatment in tomosynthesis breast screening: role of tomosynthesis-
guided biopsy (DBT-VAB)  
G. Romanucci1, S. Brunelli1, A. Caneva2, S.A. Montemezzi1, F. Caumo3; 
1
Verona/IT, 2San Bonifacio/IT, 3Padua/IT (giovi.romanucci@libero.it)  
Purpose: DBT in screening practice improves the detection of architectural 
distortions, often associated with B3 lesions. B3 category represents a clinical 
dilemma due to the significant risk of associated malignancy with often 
subsequent surgical excision to histologically examine the entire lesion. Aim of 
this study is to assess the accuracy of DBT-VAB in reducing overtreatment of 
B3 lesions , detected with tomosynthesis as architectural distortions. 
Methods and Materials: 265 DBT-VAB were performed from 1st April 2015 to 
31th March 2017, 97 of them on architectural distortions. At least 24 biopsy 
specimens were obtained in each procedure. Radial scars and papillary 
lesions, usually considered B3 lesions, if <20 mm and completely removed 
after DBT-VAB, were downgraded to B2 and sent to yearly follow-up. 
Results: Microhistological result of architectural distortions was malignant in 
22/98 cases (22.4%). According to the new proposed categorization, B3 
lesions lowered from 61/98 (62.2%) to 21/98 (21.4%) with the subsequent 
management: 9 were sent to yearly follow up; the remaining 12 lesions 
underwent surgical excision which revealed 3 malignancies, both seen only on 
DBT. Similarly, B2 lesions raised from 15.3% (15/98) to 56.1% (55/98), all sent 
to yearly follow-up. 
Conclusion: DBT-VAB ensures the patient the most precise diagnostic and 
therapeutic workup for architectural distortion. It accurately characterizes 
architectural distortions and allows a B3 risk stratification to reduce 
overtreatment.  
B-1089 10:54  
Radial scars detected at screening mammography: is surgical excision 
always indicated?  
T. Tarmey, P. McGreal, A. McDermott, M. Sheehan, A. OConnell; Galway/IE 
(tarattarmey@gmail.com)  
Purpose: Radial scars (RS) diagnosed at percutaneous biopsy can be 
associated with ductal carcinoma in situ (DCIS) and invasive carcinoma and 
current management involves surgical excision. The occurrence of DCIS and 
invasion is increased when there is associated atypia at biopsy. We assessed 
any histological features at biopsy that may warrant more conservative 
management. 
Methods and Materials: We retrospectively reviewed all cases from a 
National Breast Cancer Screening Program centre over a ten-year period 
(2007-2016) to identify all patients with a histological diagnosis of a RS made 
by percutaneous biopsy. All women underwent excision. For all cases, the core 
biopsy reports were analysed for the presence of atypia, carcinoma in situ or 
invasive carcinoma. Any progression in histological grade from a lesion on 
initial biopsy to the surgically excised specimen was considered an upgrade. 
Data were statistically analysed with SPSS V.23. 
Results: 185,766 women were screened and 91 pure RS were identified at 
percutaneous biopsy giving an incidence of 0.05%. 9 (10%) cases were 
upgraded to atypia, 8 (9%) cases were upgraded to DCIS and 7 (8%) cases 
were upgraded to invasive carcinoma giving an overall upgrade rate of 26%. 
Therefore, initial core biopsy has a sensitivity of 37% and specificity of 92%. 
Conclusion: In patients with RS, the overall histological upgrade rate of 26% 
from percutaneous biopsy to surgical excision suggests that lack of invasion, 
DCIS or even atypia at biopsy does not help differentiate between RS that 
warrant excision versus those that may be managed more conservatively.  
B-1090 11:02  
Atypical ductal hyperplasia: our experience in the management and long-
term clinical follow-up in 71 patients  
L. Nicosia1, A. Latronico1, A. Faggian2, C. Cannataci3, S. Penco1, E. Cassano1; 
1
Milan/IT, 2Acerra/IT, 3Msida/MT (lucanicosia88@gmail.com)  
Purpose: Atypical ductal hyperplasia (ADH) is a high-risk benign lesion found 
in approximately 1-10% of breast biopsies and associated with a variable 
incidence of carcinoma after surgical excision.The main goal of our study is to 
present our experience in the management and long-term follow-up of 71 
patients with ADH diagnosed on breast biopsy. 
Methods and Materials: Results of 3808 breast biopsy specimens from 1 
January 2000 to 31 December 2005 were analysed to identify all biopsies 
which resulted in a diagnosis of ADH. The histopathological results of the 45 
patients who underwent surgery were analysed. Long-term follow-up for the 
remaining patients was carried out. 
Results: 45 of 71 (63.4%) patients with histological diagnosis of ADH on 
breast biopsy underwent surgery. Definitive histological results revealed 
invasive carcinoma in 7 ftucases (15.6%), high-grade ductal carcinoma in situ 
(DCIS) in 10 (22.2%) patients, lobular carcinoma in situ (LCIS) in 4 cases 
  






(8.9%) and benign findings in 24 cases (53.3%). 12 of 71 (16.9%) patients 
underwent only long-term follow-up; one (8,3%) of these developed invasive 
breast carcinoma after 6 years. 
Conclusion: Atypical ductal hyperplasia diagnosed on breast biopsy is 
associated with a relatively high incidence of invasive carcinoma and high-
grade ductal carcinoma in situ at the time of surgical excision. Certain 
radiological and cytological criteria can be used to help determine which 
patients should forgo surgery and be followed up with good results. Long-term 
follow-up is always crucial for patients who have not undergone surgery.  
B-1091 11:10  
Intraductal papilloma without atypia in breast biopsies: rate of upgrades 
to carcinoma at excision and radiological features predictive of an 
upgrade  
D. Leithner1,2, B. Kaltenbach1, C. Park1, K. Pinker2,3, P. Hoedl1, F. Stephan1, 
V. Moebus1, T.J. Vogl1, M.P. Müller-Schimpfle1; 1Frankfurt a. Main/DE, 
2
New York, NY/US, 3Vienna/AT (doris.leithner@googlemail.com)  
Purpose: While excision of atypical papilloma of the breast is mandatory, the 
management of intraductal papilloma without atypia (IDP) diagnosed with 
biopsy remains controversial. This study sought to investigate the rate of 
upgrade to carcinoma at surgical excision of IDPs, and identify clinical and 
radiological features predictive of an upgrade. 
Methods and Materials: Patients with a core-needle or vacuum-assisted 
biopsy diagnosis of papilloma without atypia and surgical excision of this lesion 
at a breast centre between 2007 and 2017 were enrolled in the study. Cases 
with radiologic-pathologic discordance and history of breast carcinoma were 
excluded. Appropriate statistical tests were performed to correlate clinical 
characteristics and radiologic features with an upgrade to malignancy at 
excision. 
Results: For 60 women with 62 surgically removed IDPs, the upgrade rate to 
malignancy was 16.1% (10 upgrades; 4 IDC, 6 DCIS). Vacuum-assisted biopsy 
was used for 14 IDPs, while 46 were sampled by core-needle biopsy. IDP with 
upgrade to carcinoma showed a significantly greater distance to the nipple 
than benign papilloma after excision (63.5 vs. 36.8, P=0.013). No significant 
associations were found between upgrade to carcinoma and age, menopausal 
status, lesion size, presence of microcalcifications, BI-RADS descriptors, initial 
BI-RADS category, and biopsy modality. 
Conclusion: The upgrade rate at surgical excision for IDPs diagnosed with 
biopsy was 16.1%, suggesting that observation only might not be appropriate 
for all patients with a biopsy diagnosis of IDP. For patients with peripheral IDP, 
excision of the lesion should be considered.  
B-1092 11:18  
Imaging findings of papillary lesions of the breast with histopathologic 
correlation: a five-year study from Instituto Nacional de Ciencias Médicas 
y Nutrición "Salvador Zubirán"  
D. Lara Nuñez, P. Gonzalez Balboa, M. Chapa Ibargüengoitia, 
R.E. Fuentes Corona, F. Candanedo González, M. Licano Zubiate, 
K.P. Castro German; Mexico/MX (dennylaran5@gmail.com)  
Purpose: To establish the radiologic characteristics of benign and malignant 
papillary lesions of the breast. 
Methods and Materials: A descriptive, cross-sectional study was used to 
examine all patients who underwent percutaneous or excisional breast biopsy 
between July 2012 and July 2017 at Instituto Nacional de Ciencias Médicas y 
Nutrición “Salvador Zubirán. All radiologic and histopathological images where 
rechecked for the study. 
Results: Of the 94 papillary lesions, 47.3% were intraductal papilloma, 33.3% 
intraductal papillomatosis, 11.8% micropapillary ductal carcinoma in situ and 
7.5% papillary carcinoma. 24.7% corresponded to BIRADS 4A, 41.5% to 
BIRADS 4B, 16.8% to BIRADS 4C, 9% to BIRADS 5, and 7.8% to BIRADS 6. 
Of these lesions, only 17% were located in a retroareolar region. 66% of the 
lesions corresponded to nodules with an average size of 13 mm(± 7.8 SD) and 
24.5% contained calcifications. 
Conclusion: It is difficult to differentiate between benign and malignant 
papillary lesions by their appearance, this is why the final diagnosis is done 
with radiologic-pathologic correlation.  
B-1093 11:26  
Probably benign findings (BI-RADS 3) at breast MRI: frequency and 
malignancy rate  
M. Iodice1, V. Pittari1, R.M. Trimboli2, N. Berger3, L.A. Carbonaro2, 
F. Sardanelli1; 1Milan/IT, 2San Donato Milanese/IT, 3Zurich/CH 
(maiodice@gmail.com)  
Purpose: Retrospectively evaluate the frequency of BI-RADS3 lesions on 
breast MRI and determine the rate of malignancy in women at average, 
intermediate and high risk of breast cancer. 
Methods and Materials: Consecutive breast MRI examinations performed 
from July 2010 to February 2017 were retrospectively reviewed to identify 
lesions prospectively assigned with BI-RADS3 category. Women with 
histopathology or a minimum 2-year imaging follow-up entered the analysis. 
Findings reported as BI-RADS3 were reviewed. The frequency of BI-RADS3 
assessment, the rate of cancer and negative predictive value (NPV) were 
calculated. 95% confidence interval (CI) were calculated using the binomial 
distribution. 
Results: A total of 682 women underwent breast MRI in the study period. 444 
women who underwent MRI before March 2015 were considered for this study. 
47 lesions in 38 women were assigned with BI-RADS3 category (38/444, 8.5%, 
95% CI 0.1%-2.0%). Outcomes were available for 44 lesions in 36 
women:19/44 (43%, 95%, CI 28.3%-59.0%) were biopsied, 8/44 (18%, 95%, CI 
8.2%-32.7%) were operated, 17/44 (38.6%, 95%, CI 24.4%-54.5%) did not 
have evidence of malignancy at 22-81 months. Malignancy was found in 3/44 
lesions (6.8%, 95% CI 1.4%-18.7%), in 2/36 women (5.5%, 95% CI 0.7%-
18.7%). NPV was 93.2% (41/44 lesions%, 95% CI 81.3%-98.6%) and 94.4% 
(34/36 women, 95%, CI 81.3%-99.3%). There were one invasive ductal 
carcinoma (IDC) and 2 IDC with in situ component; they appeared on MRI as 
masses (n=2) and focus (n=1). 
Conclusion: The rate of women who received a BI-RADS3 assessment at 
breast MRI was 8.5% with a cancer rate higher of 5.5%. Careful adherence to 
lesion criteria is necessary to maintain a low malignancy rate for BI-RADS 
category 3 lesions. The presence of a unique suspicious feature deserves an 
up-graded rating.  
B-1094 11:34  
Optoacoustic imaging increases the sensitivity of mammography and 
specificity of US: implications for practice  
O. Abeyakoon1, R.A. Woitek2, M. Wallis1, P.L. Moyle1, S. Morscher3, 
N. Malchus3, R. Manavaki1, I.A. Mendichovszky1, J. Joseph1, 
I. Quiros-Gonzales1, S. Bohndiek1, F.J. Gilbert1; 1Cambridge/UK, 2Vienna/AT, 
3
Munich/DE (oshi.creativity@googlemail.com)  
Purpose: Optoacoustic (OA) imaging fused with ultrasound (OPUS) can 
provide novel functional and anatomical information on breast tissue 
microenvironment. The aim of our study was to develop a clinically useful OA 
feature set to differentiate benign and malignant breast lesions and investigate 
its usefulness in image interpretation. 
Methods and Materials: Female patients with benign, indeterminate or 
suspicious lesions were recruited from our institution’s symptomatic and breast 
screening clinics and imaged at 800nm (total haemoglobin wavelength) 
mapping vascularity. An OA imaging feature set was developed using the first 
38 lesions. Features for malignancy were (1) irregular high signal lesion cap, 
(2) feeding vessel, (3) high signal rim and (4) claw sign; for benignity (1) 
splayed/displaced vessels sign and (2) absence of OA signal were used, in 
combination with the ultrasound BIRADS lexicon. Two radiologists (5 and 25 
years breast-imaging experience) trained initially on feature set examples. 
They then independently, blindly and randomly scored the mammography, 
ultrasound and OA images of the remaining 44 lesions. 
Results: Of 92 lesions, 10 were excluded due to technical errors. The feature 
set had 12 malignant and 26 benign lesions; the test set included 31 malignant 
and 13 benign lesions. Sensitivity pairs for readers 1 and 2 for mammography, 
US and OPUS were (90.3%, 90.3%), (96.5%, 96.5%) and (96.5%, 96.5%), 
respectively, with specificities of (71.4%, 71.4%), (53.8%, 46.1%) and (84.6%, 
84.6%). The weighted Kappa inter-reader agreement was 0.91, 0.79 and 0.997 
for mammography, US and OPUS. 
Conclusion: Combining OA with US information has the potential to improve 
reader specificity and decrease biopsy rates.  
B-1095 11:42  
Phyllodes tumours of breast: histogram analysis of the apparent 
diffusion coefficient for assessment of tumour grade  
W. Tang, Y. Zhang, J. Cheng; Zhengzhou/CN (597744255@qq.com)  
Purpose: Investigating the value of histogram analyses of apparent diffusion 
coefficient (ADC) values for determining phyllodes tumour grades. 
Methods and Materials: In all, 48 patients with phyllodes tumours (PTs) of 
breast included low-grade (Group 1; n = 30), intermediate-grade (Group 2; n = 
12), and high-grade (Group 2; n = 6) tumours. Diffusion-weighted imaging 
(DWI) was performed in the axial plane. The ADC maps were generated, 
regions of interest were drawn on the middle section of lesion. Calculated 
histographic parameters included mean, 0.1th, 10th, 50th, 90th, and 99th 
percentiles of ADC, skewness, and kurtosis. Histogram parameters were 
correlated with tumour grade. We divided intermediate-grade and high-grade 
tumours into Group 2, low-grade tumours into Group 1. The parameters of two 
groups were calculated and the diagnostic performance for distinguishing 
different pathologic features was assessed. 
Results: The ADC mean, 50th, 90th, and 99th percentiles of ADC, skewness 
showed significant differences among the two groups. The ROC analysis 
between low-grade, intermediate-grade and high-grade tumours showed that 
the 90th percentile ADC achieved the highest area under curve (AUC) at 
0.806. 
  






Conclusion: ADC histogram analyses are able to differentiate histologic 
grades of PTs.  
B-1096 11:50  
Variations in BI-RADS mammographic density classification between 
radiologists at three breast centres  
T. Hovda1, Å.S. Holen2, H. Bjørndal1, S. Sebuødegård2, S. Hofvind2; 
1
Drammen/NO, 2Oslo/NO (tone.hovda@vestreviken.no)  
Purpose: Mammographic density is a risk factor for breast cancer and may 
serve as a basis for implementation of stratified screening. We explored 
variations in mammographic density classification performed by radiologists at 
three breast centres in BreastScreen Norway. 
Methods and Materials: The initial classification of mammographic density 
according to BI-RADS 5th edition (a-d) for a total of 1617 screening 
examinations was performed in consensus at three different breast centres by 
local radiologists. Subsequently, the same examinations were re-viewed and 
re-classified by a consensus panel of two radiologists from each centre. We 
used descriptive statistics to compare the initial and subsequent classifications 
of mammographic density. 
Results: The initial density classification yielded the following distribution: a: 
13%; b: 43%; c: 35%; and d: 9%, while subsequent classification resulted in 
the distribution a:12%; b: 45%; c: 32%; and d:12%. For classification a), the 
percentage of examinations classified in the same density category initially and 
subsequently was 64% (n=132), ranging from 39 to 92% among the three 
centres; for b): 76% (n=523, range 58-82%); for c) 52% (n=359, range 55-
64%); and for d): 67% (n=98, range 59-89%). When grouping the density 
categories a+b and c+d, 88% (range 74-96%) initially classified as category a 
or b remained in category a or b, while 82% (range 80-92%) initially classified 
as c or d remained in category c or d. 
Conclusion: Mammographic density classification is subject to great variability 
among radiologists. This makes comparisons demanding and may complicate 
the use of density as a factor for stratification of mammographic screening.  
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B-1097 10:30  
Preliminary clinical application of high-resolution MRI of the optic nerve 
using a small loop coil combined with head coil  
Q. Dai1,2, Z. Yang2, G. Hong2, L. Rao2, M. He2, P. Geng2; 1Shenzhen/CN, 
2
Guangzhou/CN (dqunyaod@163.com)  
Purpose: To preliminary explore the clinical application of high resolution MRI 
of the optic nerve using a small loop coil combined with head coil. 
Methods and Materials: 102 optic nerves from optic neuritis and optic nerve 
radiation injury patients from October 2015 to February 2017 were 
prospectively collected. Transverse, coronal and sagittal images of optic 
nerves were obtained using a loop coil combined with head coil (group A) and 
single head coil (Group B), respectively. Whole brain 3D enhanced scan and 
optic nerve reconstruction were also performed. Image quality was scored and 
images were analysed by two neuroradiologists. The non-parametric Wilcoxon-
signed rank test was used to compare the difference of quality scores between 
group A and B, and P<0.05 was statistically significant. Compared with the 
gold standard, sensitivity and specificity of displaying optic nerve lesions using 
different coils were calculated. 
Results: The difference of FS-T2W image quality scores between two groups 
was statistically significant (P<0.05) in three planes, and group A was better 
than group B. Sensitivity of displaying optic nerve lesions of group A was 86%, 
and specificity was 100%; while sensitivity of group B was 38.7%, and 
specificity was 88.9%. 
Conclusion: High resolution MRI of the optic nerve using a small loop coil 
combined with head coil is suitable for clinical application and has certain 
clinical application value, with better image quality and higher sensitivity and 
specificity in displaying optic neuritis and optic nerve radiation injury, compared 






B-1098 10:38  
Selection of coil for high-resolution MRI of the optic nerve  
Q. Dai1,2, Z. Yang2, G. Hong2, L. Rao2, P. Geng2; 1Shenzhen/CN, 
2
Guangzhou/CN (dqunyaod@163.com)  
Purpose: To compare MR image quality of the optic nerve using a small loop 
coil combined with head coil, single head coil, and single small loop coil to 
choose the best coil for high-resolution MRI of the optic nerve. 
Methods and Materials: Imaging was performed on 12 healthy volunteers with 
a 3.0T MR scanner using single 7-cm-diameter loop coil (group A), single head 
coil (group B) and a combination of these 2 coils (group C). Transverse, 
coronal and sagittal images of optic nerves were obtained. 3 groups of images 
were independently reviewed and scored according to an image quality scoring 
criterion by 2 neuroradiologists. The Kappa test, paired 2 test and 
nonparametric Wilcoxon signed rank test were used. P<0.05 was statistically 
significant. 
Results: 24 optic nerves were included. Group A can only display part of the 
intraorbital optic nerve and no quality scoring was performed. The Kappa 
values of scores of group B and C between the 2 radiologists were 0.880, 
0.778, 0.600; 1.000, 0.882, 0.619, respectively. There was no significant 
difference between the scores by the 2 radiologists (P>0.05). Scores of 
transverse, coronal and sagittal FS- T2WI of group B and C were 2.250±0.909, 
1.250±0.417, 2.521±0.499; 3.750±0.442, 3.771±0.417, 3.875±0.304. The 
difference between the two groups was statistically significant (P<0.05), with 
group C better than B. 
Conclusion: Optic nerve MRI using a small loop coil combined with head coil 
is better than using single head coil or single small loop coil and can display 
the whole optic nerve with high resolution.  
B-1099 10:46  
The impact of trigeminal nerve atrophy and vascular compression on 
outcomes of trigeminal neuralgia after stereotactic radiosurgery  
Y.-S. Hu, C.-C. Lee, W.-Y. Guo, C.-J. Lin, H.-C. Yang, H.-M. Wu, K.-D. Liu, 
W.-Y. Chung; Taipei/TW (sam6526@hotmail.com)  
Purpose: Trigeminal nerve atrophy and neurovascular compression (NVC) are 
frequently observed in symptomatic nerves of classical trigeminal neuralgia 
(TN). The purpose of this study was to determine whether these nerve 
characteristics on MRI contribute to gamma knife surgery (GKS) outcomes in 
classical TN. 
Methods and Materials: From 2006 to 2012, 67 patients of unilateral classical 
TN without previous surgery received GKS with a maximal dose of 90 Gy 
delivering to the trigeminal nerve proximal to the brainstem. Two evaluators, 
blinded to the side of pain, analysed the MRI before GKS to obtain the 
parameters, including proximal nerve cross-sectional area (CSA), vessel type 
of NVC, and site of NVC along the nerve. Correlations of the parameters with 
pain relief (Barrow Neurologic Institute [BNI] Grades I-IIIb) and pain recurrence 
(BNI Grades VI-V) after GKS were made using Cox regression and Kaplan-
Meier analyses. 
Results: The median CSA of the symptomatic nerves was significantly smaller 
than that of asymptomatic nerves (4.95 mm2 vs 5.9 mm2, p<0.001). After 
adjustment for age and sex, only the nerve CSA was predictive of initial pain 
relief (hazard ratio 0.81, p=0.032) and pain recurrence (hazard ratio 0.58, 
p=0.028) after GKS. Patients with nerve atrophy (defined as CSA4.4 mm2) 
had a lower 5-year probability of maintaining pain relief than those without 
nerve atrophy (65% vs 86%, p=0.044). 
Conclusion: Trigeminal nerve atrophy may predict pain recurrence in classical 
TN after GKS. Future studies are required to determine optimal treatment for 
long-term pain relief in classical TN with nerve atrophy.  
B-1100 10:54  
Measurement of normal optic nerve sheath diameter and nerve diameter 
on high resolution MRI  
Q. Dai1,2, Z. Yang2; 1Shenzhen/CN, 2Guangzhou/CN (dqunyaod@163.com)  
Purpose: To measure normal optic nerve sheath diameter (ONSD) and nerve 
diameter (OND) on high resolution MR images using a small loop coil 
combined with head coil. 
Methods and Materials: 33 normal optic nerves underwent MR scanning 
using a small loop coil combined with head coil. ONSD and OND (transverse 
and superior inferior) at levels 3, 6, 9, 12, 15, 18, 21mm after the eyeball were 
measured on coronal FS-T2W images. Nonparametric Wilcoxon signed rank 
test was used to compare transverse and superior inferior diameters on the 
same level, and Friedman test was used to compare diameters among 
different levels. 
Results: (1)Transverse and superior inferior ONSD and OND on coronal 
images was statistically different (P<0.05) on levels 3, 6, 9mm after the eyeball. 
There was no statistical significance in difference between transverse and 
superior inferior ONSD and OND on levels 12, 15, 18, 21mm (P>0.05). (2) 
Difference of ONSD among levels 3, 6, 9mm was statistically significant 
  






(P<0.001, both transverse and superior inferior). There was no statistical 
significance in difference of OND among levels 3, 6, 9mm (P>0.05), while OND 
among levels 3, 6, 9, 12mm was statistically different (P<0.05). No significant 
difference was in ONSD among levels 12, 15, 18, 21mm (P>0.05), similarly in 
OND (P>0.05). 
Conclusion: Normal optic nerve shows oval on levels 3-9mm after the eyeball 
and nearly circular on levels 12-21mm on coronal plane. Subarachnoid space 
on levels 3-9mm decreases gradually. Consistent results of ONSD and OND 
among different levels can be obtained on levels 12-21mm.  
B-1101 11:02  
Diagnostic efficiency of ultrasonography in case of peripheral nerve 
traumatic injuries  
E. Zhurbin, A. Gayvoronskiy, I. Zheleznyak, V. Dekan; St. Petersburg/RU 
(Zhurbin-90@mail.ru)  
Purpose: To estimate the use and diagnostic efficiency of ultrasonography in 
case of peripheral nerve traumatic injuries. 
Methods and Materials: The research includes 154 patients with post-
traumatic peripheral nerve neuropathy. All patients underwent ultrasonography 
on the expert class machine with the linear transducer with frequency range of 
5 to 15 MHz. For ultrasonography efficiency evaluation, a statistical analysis of 
sensibility, specificity and accuracy was used, by the procedure of a referential 
(surgical interference or positive conservative treatment) and studied method 
(ultrasonography) qualified assessment. 
Results: It was discovered that ultrasonography is an efficient diagnostic 
method for peripheral nerve traumatic injuries. It allows assessesing injury 
localisation and the type to the full extent and to decide on further treatment 
tactics. According to ultrasonography results, 122 patients were operated and 
32 patients treated conservatively. After comparative analysis of pre-operative 
ultrasonography data with the changes detected during the surgical 
interference and the results of conservative treatment, the diagnostic efficiency 
of ultrasonography in case of limb peripheral nerve traumatic injuries was 
estimated. 
Conclusion: Ultrasonography is an efficient diagnostic method for limb 
peripheral nerve traumatic injuries . Ultrasonography with a sensitivity of 93,6% 
and specificity of 68,2% allows to detect injuries which always demand surgical 
interference, or prove the nerve trunk anatomical integrity, which does not 
demand a surgery as the injury appears to be reversible. The accuracy of 
ultrasonography is 86,4%, which makes it one of the leading methods of the 
given pathology diagnostics.  
B-1102 11:10  
Opportunities for the combined use of ultrasonography and 
neuromonitoring during the intra-operative phase of ultrasound guidance 
for the surgical treatment of radial nerve injury  
V. Dekan, E. Zhurbin, A. Grishchenkov; St. Petersburg/RU (dekanvs@mail.ru)  
Purpose: To assess the opportunities for the use of ultrasonography and 
neuromonitoring for ultrasound guidance during radial nerve surgical treatment. 
Methods and Materials: A combination of ultrasound and neuromonitoring 
was applied to 37 patients during surgical treatment of radial nerve injuries. 
The research included patients with post-traumatic neuropathy of varying 
severity levels and duration. 
Results: Intra-operative ultrasonography reduces operational trauma by 25% 
on average in each case, due to application of neurolysis from the nerve trunk 
injury in the direction of native anatomical structures and ending within the 
cicatricial adhesion. In five cases of radial nerve neurotmesis, proved visually 
afterwards, applying neuromonitoring in the nerve proximity test mode led to 
exposure of the safe muscular branches of the brachioradialis muscle, which 
were situated in the cicatricial conglomerate of the modified tissue and did not 
come in sight of the ultrasound detector. In the closing stage of neurolysis, due 
to the use of ultrasonography combined with neuromonitoring, in four cases an 
intrastem neuroma, undiscovered during the pre-operative percutaneous 
diagnostics, was detected. 
Conclusion: The use of ultrasonography and neuromonitoring represents the 
opportunity of nerve trunk direct visualization and simultaneous nerve 
conduction assessment, which leads to a reduction in operational trauma and 
the number of early post-operative complications. It helps to increase the 
patient rehabilitation tempo. Intra-operative ultrasonography and 
neuromonitoring measurements are able to give a qualified failure mode 
assessment of all the nerve trunk structures and allows choosing more efficient 







B-1103 11:18  
Preliminary application study of optic nerve DTI in non-neoplastic lesions  
Q. Dai1,2, Z. Yang2, G. Hong2, L. Rao2; 1Shenzhen/CN, 2Guangzhou/CN 
(dqunyaod@163.com)  
Purpose: To analyze DTI findings of normal optic nerve and measure normal 
ADC and FA values to offer reference for clinical application, and to explore 
clinical application value of DTI in non-neoplastic lesions of the optic nerve. 
Methods and Materials: DTI was prospectively performed on 24 normal optic 
nerves and 73 optic nerves with non-neoplastic lesions from October 2015 to 
February 2017 using 3.0T MR scanner. Signal characteristics were observed 
and ADC, FA values were measured respectively. The difference of values 
between normal and lesion group was compared using independent sample t 
test. Ability of ADC and FA value in displaying non-neoplastic lesions was 
analyzed with ROC curve. 
Results: Normal optic nerves showed slightly low signal on ADC maps and 
high signal on FA maps. Normal ADC value (×10-3mm2/s) was 1.102±0.202, 
and FA value was 0.540±0.073. Signal of lesions slightly increased on ADC 
maps and decreased on FA maps. ADC value of lesion group significantly 
increased (P=0.03), and FA value significantly decreased (P<0.001). Area 
under the ROC curve of ADC was 0.642, and that of FA was 0.768. When the 
cut-off point of FA value was 0.4827, Youden index being the biggest, 
sensitivity was 64.4% and specificity was 87.5%. 
Conclusion: Normal optic nerve shows slightly low signal on ADC maps and 
high signal on FA maps. Signal of non-neoplastic lesions slightly increases on 
ADC maps and decreases on FA maps, with ADC value increasing and FA 
value decreasing. In displaying non-neoplastic lesions of the optic nerve, FA 
value is better.  
B-1104 11:26  
High-resolution MRI findings of the normal optic nerve using a small loop 
coil combined with head coil  
Q. Dai1,2, Z. Yang2, L. Rao2, G. Hong2, P. Geng2; 1Shenzhen/CN, 
2
Guangzhou/CN (dqunyaod@163.com)  
Purpose: To observe the morphology and signal characteristics of normal 
optic nerve on high-resolution MR images and analyse the anatomical and 
histological basis. 
Methods and Materials: 33 normal and 2 cadaveric optic nerves underwent 
MR scanning using a small loop coil combined with head coil. The cadaveric 
optic nerves were separated and pathologically examined. The morphology 
and signal characteristics of the optic nerves were analysed by two 
neuroradiologists, and those of the cadaveric optic nerves were observed and 
compared with the histological findings. 
Results: 31 normal optic nerves (2 were abandoned because of obvious 
artefact) and 2 cadaveric optic nerves were included. The normal optic nerve 
was round and showed mixed isointensity and hypointensity surrounded by 
hyperintense subarachnoid space on coronal FS-T2WI and elongated 
isointensity on transverse and sagittal FS-T2WI, and the optic nerve sheath 
showed hypointensity. MRI findings of the cadaveric optic nerves were similar, 
and histology showed that the optic nerve fibers were separated into bundles 
by connective tissue including vessels. Compared with MRI, the optic nerve 
fibers showed isointensity and septae showed hypointensity. 
Conclusion: High-resolution MRI of the optic nerve using a small loop coil 
combined with head coil can show the anatomical details and signal 
characteristics on coronal images. The normal optic nerve is round and shows 
mixed isointensity and hypointensity similar to a chessboard on high-resolution 
coronal T2WI, which is consistent with cadaveric optic nerve MR findings and 
relative to nerve bundles and connective tissue septae in histology.  
B-1105 11:34  
Automated three-dimensional detection of dural ectasia in Marfan 
syndrome by means of isotropic MRI and shape-based machine learning  
F. Rengier1, O. Naas1, T. Norajitra1, M. Messerli2, K. Kallenbach1, M. Karck1, 
K. Maier-Hein1, H.-U. Kauczor1; 1Heidelberg/DE, 2Zurich/CH 
(fabian.rengier@web.de)  
Purpose: To investigate automated three-dimensional detection of dural 
ectasia in Marfan syndrome using isotropic MRI and shape-based machine 
learning. 
Methods and Materials: 211 patients being evaluated for Marfan syndrome 
during 2012-2016 underwent MRI including single slab 3D T2-weighted TSE 
sequence of the lumbosacral spine with a spatial resolution of 1x1x1mm in 
5:06 min. A random sample of 40 patients (32.5±11.2 years, 22 female) was 
included, thereof 21 patients diagnosed with Marfan syndrome according to the 
2010 Revised Ghent Nosology. A shape-based machine learning algorithm 
was developed for 3D segmentation of dural sac and vertebral bodies L4, L5 
and S1. For comparison with current clinical standard, anteroposterior 
diameters of vertebral bodies and dural sac were assessed at mid-level 
  






between the superior and inferior endplates and dural sac diameter ratios were 
calculated. 
Results: Dural sac volumes for Marfan patients/controls were in ml: at L4 
10.8±2.9/7.5±1.1 (p=0.013), L5 9.2±3.5/5.7±1.2 (p<0.001), and S1 
10.2±8.4/3.3±1.3 (p<0.001). Sensitivity, specificity, positive predictive value 
and negative predictive value for diagnosis of Marfan syndrome were: for 3D 
segmentation using L4 >9.1ml or S1 >5.6ml as cut-off 81%/94%/94%/80%, for 
criteria of Habermann et al. 71%/65%/71%/65%, for criteria of Oosterhof et al. 
57%/88%/86%/63%, and for dural sac diameter ratios with highest AUC 
67%/94%/93%/70%. The false-positive rate was reduced to 6% using 3D 
segmentation compared to 35%/12% using criteria of Habermann/Oosterhof et 
al., respectively. 
Conclusion: Automated three-dimensional detection of dural ectasia using 
isotropic MRI and shape-based machine learning is feasible and potentially 
superior to the current clinical standard of dural sac diameter ratios.  
B-1106 11:42  
The role of diffusion tensor imaging parameters in characterisation and 
differentiation of the spinal cord tumours  
B. Szemplinska1, E. Maj2, W. Szeszkowski2, M. Prokopienko1, 
A. Cieszanowski2, A. Marchel2, O. Rowinski2; 1Warszawa/PL, 2Warsaw/PL 
(bszemplinska@yahoo.com)  
Purpose: The aim of this study was to differentiate between infiltrating and and 
non-infiltrating nature of the intramedullary spinal tumours using diffusion 
tensor imaging (DTI) derived metrics from the enhancing parts of tumour and 
peri-tumoural regions. 
Methods and Materials: 18 patients were included in the study: 6 with 
infiltrating (3 Astrocytomas, 2 Glioblastomas, 1 PNET) and 12 with non-
infiltrating (Ependymomas) spinal cord tumours. Conventional MRI before and 
after IV Gadolinium administration was done followed by DTI. Fractional 
anisotropy (FA), diffusivity (TRACE) and apparent diffusion coefficient (ADC) 
were measured in the enhancing tumour parts, peritumoural margin (oedema 
most adjacent to the tumour), peritumoural oedema and normal-appearing 
spinal cord (24 DTI values per patient). ROI of a fixed size of 0.15 cm2 was 
used in all measurements. The results were compared between the two groups 
of tumours. 
Results: FA values measured in the peritumoural margin were significantly 
higher in the non-infiltrating compared to the infiltrating tumours (p<0,007), 
whereas TRACE values were significantly lower (p<0,009). The differences 
were smaller in peritumoural oedema (p<0,03 and p<0,04 respectively). FA 
values measured in the enhancing tumour parts and in normal-appearing 
spinal cord showed no significant differences between the two groups of 
tumours. 
Conclusion: The information provided by DTI may be used to help 
differentiate between infiltrating and non-infiltrating intramedullary spinal 
tumours by characterisation of surrounding spinal cord tissue. Our preliminary 
results showed that this technique, applied previously for the imaging of brain 
tumours, could also improve the preoperative assessment of spinal cord 
lesions.  
B-1107 11:50  
Three years of experience with magnetic resonance spectroscopy in 
spinal cord  
P. Wawrzyniak, A. Hebda, B. Bobek-Billewicz; Gliwice/PL 
(pawel.wawrzyniak@io.gliwice.pl)  
Purpose: Usefulness of MRS of spinal cord-own experience. 
Methods and Materials: 1H MRS of spinal cord was performed in 44 patients 
with spinal cord lesion between 09.2014 and 09.2017 (total of 55 studies). 
Spinal cord lesions were localized: 42/55 in C spine, 3/55 in C-Th ,10/55 in Th. 
Mean lesion volume was 1.75 cm3. 8 patients had resection done with 5 cases 
of ependymoma 2 cases of pilocytic astrocytoma and one case of 
hemangioblastoma. Patients were divided into groups: presumed neoplastic 
lesion (n=28, 36 studies), proven tumours (n=8, 11 studies) and presumed 
non-neoplastic lesion (n=8, 8 studies). All spectra were analyzed in LCModel 
(version 6.1-4F) software. Spectra was deemed good quality when LCModel 
calculated SNR was above 1. Metabolite ratios were calculated as follows: 
Cho/Cr, NAA/Cr, Cho/NAA for long echo time and mI/Cr for short echo. 1H 
MRS study of spinal cord was performed on Siemens 3T MAGNETOM Prisma 
as a part of standard spinal cord imaging protocol. Sequence parameters: SVS 
PRESS; TE 30 and 135 ms; NEX, respectively, 256 and 320, FA 90°; water 
signal saturation; TR 1700 ms ;total acquisition window: 2000 ms. 
Results: There was no statistically significant difference between these 
groups. From total of 110 spectra 57 were of good quality. 
Conclusion: Spinal cord spectroscopy is very demanding technique for both 
patient and operator. No reference spectra was taken into account in this study 
which might help with proper evaluation, however, it is too time consuming for 
standard protocol  
 
10:30 - 12:00 Room F2  
Breast  
SS 1402b  
DWI of the breast  
Moderators:  
P.A.T. Baltzer; Vienna/AT  
I. Thomassin-Naggara; Paris/FR  
B-1108 10:30  
Apparent diffusion coefficient at 3T MRI in differentiating benign and 
malignant breast lesions: a quantitative analysis  
P. Gupta, M. Popli, K. Diwan; New Delhi/IN (dr.pranavg@gmail.com)  
Purpose: The purpose of this research work was to establish role of 
quantitative assessment of apparent diffusion coefficient (ADC) in 
distinguishing benign breast lesions (BBL) from malignant breast lesions 
(MBL). 
Methods and Materials: In a cross sectional study from September 2013 to 
August 2016, 200 patients with palpable or mammographically detected breast 
lesions underwent 3T MRI. Of these, 120 patients with 126 lesions underwent 
specimen histologic examination and were included in the study for 
retrospective analysis. ADC values were calculated at b values of 0, 400 and 
800 s/mm² after identification of maximally enhancing component on dynamic 
contrast enhanced images. ADC value and histopathology correlation was then 
done using appropriate statistical tools. 
Results: Of the 126 lesions, 84 lesions were malignant and 42 were benign on 
histopathology. The mean ADC value varied significantly (p value < 0.01) 
between BBL (1.52 ± 0.45 × 10−3 mm2/s) and MBL (0.98 ± 0.21 × 10−3 mm2/s). 
An ADC cut-off value of 1.2 × 10−3 mm2/s for MBL was calculated by drawing 
ROC curve and it achieved a sensitivity of 92.9% and specificity of 81%. The 
study showed a sensitivity of 94%, specificity of 83.3%, positive predictive 
value (PPV) of 91.8% and negative predictive value (NPV) of 87.5% upon 
using ADC cut off value 1.2 x 10-3 mm2/s. 
Conclusion: Diffusion weighted imaging (DWI) along with quantitative ADC 
value proves to be an effective complimentary parameter in differentiating MBL 
from BBL and needs to be integrated into the diagnostic algorithm of breast 
lesions.  
B-1109 10:38  
High reproducibility of breast lesion ADC values based on fixed size and 
shape region of interest in diffusion-weighted imaging  
M. Wielema, M. Dorrius, H. Dijkstra, E. Langius, G. De Bock, M. Oudkerk, 
P. Sijens; Groningen/NL (m.wielema@umcg.nl)  
Purpose: To evaluate three fixed-size region of interest (ROI) methods and 
the largest oval ROI positioned within breast lesions, in apparent diffusion 
coefficient (ADC) analysis of diffusion-weighted imaging (DWI) data. 
Methods and Materials: Included were 98 consecutive women with 110 
lesions (95 malignant) undergoing breast DWI between 11/2008 and 06/2014. 
Reproducibility of three smaller fixed-size circular ROIs in the middle of each 
lesion (ROI2, 0.3 cm
2) and at lowest ADC (ROI3, 0.3 cm
2; ROI4, 0.6 cm
2) was 
compared with maximum oval ROI positioned within the lesion contours (ROI1). 
ROIs were positioned by three independent observers at the largest cross 
section on the T1-weighted image and copied to the DW images, using b 
values 0 and 1000 s/mm2 to obtain ADC maps. Intraclass-correlation 
coefficients (ICCs) were calculated to evaluate intra-and inter-observer 
agreement for each ROI method. ROC analysis was performed. 
Results: Inter- and intra-observer ICCs were strong (0.80-0.94) in ROIs 2-4, 
and similar to ROI1 (0.82-0.90). Highest agreement between observers (0.84-
0.94) and highest accuracy (0.80) was reported for ROI4. 
Conclusion: Breast lesion ADCs derived from fixed-size subregion ROIs are 
highly reproducible. The proposed user-friendly methodology is equal or better 
in clinical performance as compared with whole lesion assessment, as 
assessed by ROC analysis and false-positive outcomes.  
B-1110 10:46  
A comparative study of the DKI model and the traditional DWI model in 
the diagnosis of breast cancer  
T. Li, K. Li, Y. Xiong; Shanghai/CN (kanganli@sina.com)  
Purpose: To compare the value of the diffusion kurtosis imaging model with 
the traditional single-index diffusion-weighted imaging model parameters in the 
differential diagnosis of breast lesions. 
Methods and Materials: 64 cases of breast lesions were examined by DKI (b 
= 0,500, 1000, 1500, 2000, 2500, 3000 s/mm2 ) and traditional DWI (b = 0, 
1000 s/mm2). The diagnostic efficacy of the DKI parameters (MK and MD) and 
the traditional DWI parameters (ADC) in benign and malignant breast lesions 
  






was compared, and the correlation between MK, MD and ADC values and the 
prognostic factors of breast cancer was analysed. 
Results: The difference of MK, MD and ADC between the benign and 
malignant groups was statistically significant (P <0.05).The area under the 
ROC curve of MK, MD and ADC was 0.897, 0.827 and 0.776, respectively. 
According to the Youden index, the sensitivity, specificity and accuracy of the 
MK were 83.3%, 85.3% and 84.4%, respectively. The combination of the three 
parameters could increase the AUC to 0.935. The MK of ER-positive lesions 
was higher than negative (P = 0.024). The correlation analysis showed that ER 
was low positively correlated with MK (r = 0.417, P = 0.022), and there was no 
significant correlation between the other prognostic factors and the parameters 
(P> 0.05). 
Conclusion: The parameters of the DKI model and the traditional DWI model 
can be used to differentiate benign from malignant breast lesions. The 
diagnostic value of MK in the DKI model is the largest. There is a certain 
correlation between the DKI model parameters and the prognostic factors.  
B-1111 10:54  
Preoperative diagnostic value of DKI combined with quantitative dynamic 
contrast-enhanced MRI in breast lesions  
T. Li, Y. Xiong, K. Li; Shanghai/CN (kanganli@sina.com)  
Purpose: To evaluate the diagnostic efficacy of MRI diffusion kurtosis imaging 
and quantitative dynamic contrast enhancement in benign and malignant 
breast lesions. 
Methods and Materials: Sixty-four females were enrolled in the study of MRI 
diffusion kurtosis imaging and quantitative dynamic contrast enhancement 
between November 20 and 2017 in May, respectively. All of them were 
confirmed benign and malignant after surgical resection or puncture. The MK 
and MD values were calculated by the DKI model, and the hemodynamic 
parameters were obtained by quantitative dynamic contrast enhancement, 
including Ktrans, Kep, Ve and Vp. 
Results: The MK and MD values of breast cancer were 0.879±0.176 and 
1.248±0.380*10-3mm2/s respectively in the DKI model. The MK and MD values 
of benign lesions were 0.577±0.142 and 1.792±0.505*10-3mm2/s , the 
difference was statistically significant (P <0.05). In the DCE model, the Ktrans 
and Kep mean values of breast cancer were 0.101 ± 0.039min-1 and 0.398 ± 
0.194 min-1, respectively. The mean values of Ktrans and Kep of benign 
lesions were 0.062 ± 0.067 min-1 and 0.210 ± 0.121 min-1, respectively. The 
difference was statistically significant (p <0.05), and the other DCE parameters 
were not statistically significant. The highest sensitivity, specificity and 
accuracy of MK in all parameters were 91.3%, 80.5% and 84.4% respectively. 
Conclusion: MRI diffusion kurtosis imaging and dynamic contrast-enhanced 
quantitative hemodynamic parameters are of great value in the differential 
diagnosis of benign and malignant breast lesions. The combination of both can 
significantly improve the diagnostic efficiency.  
B-1112 11:02  
Non-mass-like enhancement in MR imaging of the breast: lesion 
characterisation with morphologic criteria and diffusion-weighted 
imaging  
W. Buchberger, K. Gautsch, W. Oberaigner; Innsbruck/AT 
(wolfgang.buchberger@tirol-kliniken.at)  
Purpose: The purpose of this study was to assess the accuracy of contrast-
enhanced magnetic resonance imaging and diffusion weigthed imaging in 
distinguishing benign from malignant non-mass-like breast lesions. 
Methods and Materials: 76 lesions showing non-mass-like enhancement in 
74 consecutive patients were analyzed. Distribution, internal enhancement 
patterns, and contrast kinetic curve patterns were classified according to the 
BI-RADS lexicon. Apparent diffusion coefficient (ADC) values were obtained 
from manually placed ROIs on diffusion weighted images. Univariate and 
multivariate analysis was performed to find indicators for malignancy. The 
probabibiliy of malignancy was calculated for various combinations of findings. 
Histological diagnosis obtained by means of vacuum-assisted core biopsy was 
used as gold standard. 
Results: Clumped enhancement (p= < 0.001), heterogeneous or clustered ring 
enhancement (p=0.031), and ADC less than 1.3 x 10-3mm2/s (p=0.028) were 
the strongest indicators of malignancy. Non-mass lesions with homogeneous 
internal enhancement and ADC values more than 1.3 x 10-3mm2/s had a 
probability of malignancy of 5%, while all other combinations of findings had a 
probability of malignancy of 31- 85%. 
Conclusion: The combination of internal enhancement characteristics and 
ADC showed a high accuracy in the characterization of non-mass-like lesions 





B-1113 11:10  
DTI of the breast: is it worth the hassle?  
W.R.A. Abdel Hamid; Cairo/EG (w.gforever@yahoo.com)  
Purpose: The aim of this study is to assess the role of diffusion tensor imaging 
in characterization of equivocal breast lesions. 
Methods and Materials: 30 female patients with 36 equivocal breast lesions 
were subjected to an MR study including T2W, STIR, DTI and dynamic post 
contrast study. DTI maps including direction, ADC and FA maps were 
assessed both qualitatively and quantitatively. All lesions were biopsied and 
verified histopathologically. 
Results: The mean acquisition time of DTI was 14 min and its mean post 
processing time was 22 minutes. Based on histopathology the 36 lesions were 
21 benign and 15 malignant. Based on time/intensity curves, 20 were 
considered suspicious with types IIb and III curves, while 16 were considered 
benign with types I and IIa curves with 7 false positive lesions and 2 false 
negative. Addition of DTI significantly improved the accuracy of 
characterization with only 2 false positive lesions and only 1 false negative with 
a sensitivity of 94.12% and specificity of 89.47%. Direction map proved 
beneficial in overcoming the pitfalls of ADC and FA value overlaps between 
benign and malignant entities. 
Conclusion: Although DTI requires long acquisition and post processing 
times, yet our initial results are promising warranting further research over a 
larger scale of patients to confidently establish it as a diagnostic tool that can 
replace contrast and reduce the need for unwanted biopsies.  
B-1114 11:18  
Comparison of FOCUS (field-of-view optimised and constrained 
undistorted single-shot)-DWI with standard DWI-MRI and DCE-MRI in the 
qualitative assessment of breast lesions  
L. Vassallo, V. Doronzio, G. Cappello, E. Tabone, D. Regge, L. Martincich; 
Candiolo/IT (lorenzo.vassallo1987@libero.it)  
Purpose: To compare the performance of FOCUS-DWI with standard DWI-
MRI and DCE-MRI in detecting breast lesions. 
Methods and Materials: 50 consecutive women undergoing pre-surgical 
breast MRI from January to December 2016 were enrolled in the study. Exams 
were carried out with 1.5T magnet and dedicated 8-channel coil following the 
recommended technical requirements. FOCUS-DWI was performed on the 
axial plane with limited shimming to the rectangular area target. DCE-MRI was 
considered as the standard reference. The type (mass and non-mass) of each 
suspicious lesion detected at DCE-MRI was evaluated and then compared to 
similar findings identified at both standard DWI-MRI and FOCUS-DWI. The 
diagnostic confidence of FOCUS-DWI and DCE-MRI was compared by the 
following point scale: +1 (FOCUS-DWI > DCE-MRI), 0 (equal) and -1 (FOCUS-
DWI < DCE-MRI). The same evaluation was performed between FOCUS DWI 
and standard DWI. 
Results: DCE-MRI identified 59 malignant pathologically proven lesions, 48 
mass and 11 non-mass (size range 6-90mm). All the lesions were correctly 
detected at standard DWI. 5 lesions (all mass; size range 7-15 mm) were not 
identified at FOCUS-DWI. In no case, diagnostic confidence with FOCUS-DWI 
was higher than that with DCE-MRI, while it was comparable in only 10/54 
cases (18%). The diagnostic confidence between FOCUS-DWI and standard 
DWI was higher in 37% of cases (20/54), similar in 28% (15/54) and worse in 
35% (19/54). 
Conclusion: Our series shows that FOCUS-DWI has potential clinical utility 
since it can identify 85% of suspicious breast lesions. Because of better spatial 
resolution, FOCUS-DWI reached higher diagnostic confidence when compared 
with standard DWI-MRI.  
B-1115 11:26  
Breast MRI: circularity metrics in mass shape assessment of benign and 
malignant breast tumours  
M. Nadrljanski, Z. Milosevic; Belgrade/RS (dr.m.nadrljanski@gmail.com)  
Purpose: Mass shape metrics on breast MRI include parameters of tumour 
geometry reflecting the lesion growth pattern. Differences between benign and 
malignant breast masses in terms of circularity metrics (tumour ellipticity, linear 
eccentricity, tumour area surface, tumour volume, circulatory ratio, 
compactness, circularity, Cmax value) were tested in order to define the 
significance and potential use for better mass shape characterisation and 
differentiation between benign and malignant lesions. 
Methods and Materials: Thirty histologically confirmed mass lesions were 
evaluated with MRI (1.5T) - benign tumours (n1=15) and carcinoma (n2=15) for 
the circularity parameters, which were computed and visualised in 3D, based 
on the mathematical expressions (volume, ellipticity, linear eccentricity, 
circulatory ratio, compactness, Cmax value) and (in)complete elliptic integrals 
(circumference assessment, surface area definition). 
Results: Difference in linear eccentricity proved to be highly statistically 
significant between benign and malignant lesions (6.91+/-1.81 vs. 12.39+/-
  






3.75, p=0.0001). The same applied to tumour compactness (0.42+/-0.08 vs. 
0.27+/-0.07, p=0.001) and Cmax value (0.96+/-0.02 vs. 0.82+/-0.12, p=0.001). 
Ellipticity was not considered highly significant in differentiation between 
benign and malignant mass lesions (0.65+/-0.09 vs. 0.56+/-0.18, p=0.04). 
Expectedly, linear eccentricity and compactness were considered correlated 
only in benign lesions (r=0.79, p=0.0004) and ellipticity and compactness only 
in malignant lesions (r=0.54, p=0.038). 
Conclusion: Computed parameters of circularity metrics in mass shape 
assessment on breast MRI (tumour compactness, Cmax value and linear 
eccentricity), enabled binary classification: benign vs. malignant mass lesion. 
Possible compound mass-shape-score may be of help in better mass shape 
assessment, should the results of larger trials support these preliminary data.  
B-1116 11:34  
Background parenchymal enhancement at breast magnetic resonance 
imaging: association with tumour response to neoadjuvant 
chemotherapy  
E. Horvath, E.H. Castillo Balladarez, C. Silva, C. Darrás, M. Uchida, 
M.A. Pinochet, A. Altamirano, E. Droguett, C. Galleguillos; Santiago/CL 
(eliette88@hotmail.com)  
Purpose: Analyse neoadjuvant chemotherapy (NAC) effect on breast MRI 
background parenchymal enhancement (BPE). Determine association between 
BPE changes and tumour response. 
Methods and Materials: IRB-approved, analytic retrospective study. All breast 
cancer patients who underwent NAC and had pre-treatment and follow-up 3T 
MRI studies between December 2013 and September 2017 were included. 
BPE was analysed on subtraction images and axial and sagittal MIP images, 
and categorised with BI-RADS lexicon. Tumours were classified according to 
histology as invasive ductal carcinoma (IDC) or invasive lobular carcinoma 
(ILC) and grouped by immunohistochemical (IHC) subtype: Luminal A, Luminal 
B, HER-Luminal (HL), HER2-enriched and Triple negative (TN). Imaging 
response was evaluated using RECIST 1.1 criteria. 
Results: 40 patients were included, mean age of 47 ± 9.9 years, 67,5 % were 
premenopausal. Histopathological analysis revealed 37 cases of IDC, two ILC 
and one IDC+ILC. IHC assessment showed 12 TN, 10 Luminal A, 10 Luminal 
B and 8 (HL). There was a global reduction of BPE after NAC in all subgroups, 
larger in premenopausal women (Pv= 0.01). TN and HL had higher initial BPE, 
and postmenopausal patients had an OR of 6.4 for having a mild BPE prior to 
NAC. 32,5% of patients had complete imaging response. A prior absent-mild 
BPE, IDC tumour or Luminal A/B IHC subtype were associated with higher OR 
for partial tumour response (OR 1.8, 2 y 5.7, respectively), although only IHC 
subtype reached statistical significance. 
Conclusion: Decrease in BPE signal after NAC may be used as a predictive 
factor of tumour response.  
B-1117 11:42  
Ultra-high field dynamic contrast-enhanced MRI (DCE-MRI) of the breast 
at 7T with pharmacokinetic (PK) modeling accurately differentiates 
between benign and malignant breast tumours  
R.E. Ochoa Albíztegui1, J.V. Horvat1, S. Thakur1, B. Bernard-Davila1, 
S. Trattnig2, T.H. Helbich2, E.A. Morris1, K. Pinker1; 1New York, NY/US, 
2
Vienna/AT (eochoa.albiztegui@gmail.com)  
Purpose: To investigate whether ultra-high field dynamic contrast-enhanced 
magnetic resonance imaging (DCE-MRI) of the breast at 7T with 
pharmacokinetic (PK) modeling using the quantitative biomarkers can be used 
for differentiation of benign and malignant tumors. 
Methods and Materials: Thirty-seven patients with 43 lesions with a 
suspicious imaging finding on mammography or sonography were included in 
this IRB-approved study and underwent DCE-MRI of the breast at 7T using a 
high spatial and temporal resolution sequence (spatial resolution of 0.7 mm3 
voxel size, temporal resolution of 14 s). Quantitative PK imaging biomarkers 
(KTrans & kep) were assessed using the DCE-Tool OsiriX plugin 
(http://kyungs.bol.ucla.edu/software/DCE_tool/DCE_tool.html). A whole tumor 
2D-ROI (wtROI) and a 10mm standardized 2D-ROI (sROI) were manually 
drawn by two readers independently in the slice with the maximum lesion 
diameter and the most enhancing part of the lesion. Appropriate statistics were 
used to assess inter-rater agreement. 
Results: Mean () and standard deviation (x ) for KTrans of malignant lesions 
for wtROI and sROI were =0.322 (x =0.14), =0.379 (x =0.126) respectively. 
Kep of malignant wtROI and sROI was =0.553 (x =0.508), =0.613 (x=0.50) 
respectively. KTrans for malignant and benign lesions were significantly 
different in the wtROI (p=0.0070) and sROI (p=0.0023). Kep for malignant and 
benign lesions were also significantly different in the wtROI (p=0.0050) and 
sROI (p=0.0149). There was excellent inter-reader correlation between the 2 
readers, with a (91%, 88%, 84%, 76%) p=<0.01. 
Conclusion: DCE-MRI at 7T using PK modeling can differentiate between 
benign and malignant breast tumors using both wtROI or sROI.  
B-1118 11:50  
Characterisation of breast lesions by whole lesion texture analysis of 
high b value diffusion-weighted imaging (DWI)  
A. Christou1, A. Ghiatas2, K. Veliou3, D. Priovolos2, H. Bougias3; 
1
Doncaster/UK, 2Athens/GR, 3Ioannina/GR (alexandrachristou@gmail.com)  
Purpose: To retrospectively investigate texture parameters in distinguishing 
breast lesions using high b-value DWI. 
Methods and Materials: 30 women with 34 breast lesions underwent breast 
MRI in 1.5T MRI unit. DWI was applied as part of the standard protocol. The b-
value 800 images were analysed and classified by whole lesion texture 
analysis(TA). 21 features derived from the histogram, grey-level-co-occurrence 
matrix (GLCM) and grey-level-run-length-matrix (GLRLM) were analysed and 
compared between benign and malignant lesions with Mann-Whitney U test 
(p=0.05). ROC analysis was used to evaluate the most effective cut-off values. 
Results: 19 cases were malignant and 15 benign. Statistically significant 
difference between malignant and benign lesions was found in contrast, 
correlation, dissimilarity and homogeneity regarding GLCM texture metrics. No 
significant difference found in entropy and energy metrics. Short-run low grey-
level emphasis (SRLGE) regarding the GLRLM metrics showed significant 
difference. No statistical difference found in any feature from histogram 
metrics. Univariate logistic regression showed that contrast and dissimilarity 
yielded the highest area under curve (AUC) 0.836 and 0.845, respectively, 
whereas energy and entropy yielded the lowest AUC 0.576 and 0.561, 
respectively. 
Conclusion: High b-value DWI whole lesion texture analysis is able to 
differentiate breast pathologies with contrast and dissimilarity from GLCM 
texture metrics being the most effective discriminators.  
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B-1119 10:39  
Reduction of metal artefacts in patients with spinal fusions: metal 
artefact reduction algorithms and virtual monoenergetic images from 
spectral detector computed tomography  
N. Grosse Hokamp1,2, N. Abdullayev1, V. Neuhaus1, A. Mpotsaris1, D. Maintz1, 
J. Borggrefe1; 1Cologne/DE, 2Cleveland, OH/US 
(nils.grosse-hokamp@uk-koeln.de)  
Purpose: To compare the extent of metal artefact reduction by use of 
dedicated metal artefact reduction algorithms (MAR) and high keV virtual 
monoenergetic images (VMI) from spectral detector computed tomography 
(SDCT). 
Methods and Materials: 25 patients with spinal fusion were included in this 
IRB-approved study. All examinations were performed using a SDCT (IQon, 
Philips Healthcare). Images were reconstructed as conventional images (CI), 
with a MAR algorithm and as VMI in range of 40-200keV (10keV increment). 
Quantitative image analysis was performed ROI-based by measurements of 
attenuation (HU) and standard deviation in most pronounced hypo- and 
hyperdense artefacts and posterior subcutaneous fat. Qualitatively, 
assessment of metal-bone interface, spinal canal and soft tissue were rated on 
5-point Likert scales. Further, extent of artefact reduction was evaluated by two 
radiologists. Statistical analysis was performed using ANOVA and Wilcoxon 
test with correction for multiple comparisons. 
Results: The hypo- and hyperattenuating artefacts showed a significant 
increase and decrease of HU values in both high keV VMI and MAR 
reconstructions (CI/MAR/VMI200 keV: -397/-115/-48 HU and 470/211/74 HU, 
respectively; p0.05). Artefacts in the subcutaneous fat, as depicted by image 
noise, did decrease in high keV VMI (p=0.09) and MAR (p0.05; 
CI/MAR/VMI200keV: 27.0/20.2/17.6). Qualitatively, metal-bone interface was 
better assessable in high keV VMI (p0.05), while soft tissue was better 










Conclusion: SDCT allows for metal artefact reduction through MAR algorithms 
and computation of virtual monoenergetic images in patients with spinal fusion. 
Thus, the combination of both techniques is promising to yield further artefact 
reduction.  
B-1120 10:47  
MR imaging with metal artefact reduction for the differentiation between 
patients with and without infected total hip arthroplasty  
B.J. Schwaiger, A. Gersing, D. Münzel, J. Dangelmaier, P.M. Prodinger, 
C. Suren, E.J. Rummeny, K. Wörtler; Munich/DE  
Purpose: To evaluate imaging parameters obtained from MRI with metal 
artefact reduction to differentiate between patients with and without infected 
total hip arthroplasty (THA). 
Methods and Materials: In 46 patients (65±11 years; 25 women) with THA, 
1.5T MRI was acquired with view angle tilting (VAT) and slice-encoding metal 
artefact correction (SEMAC). Parameters describing changes of metal/bone 
interface, surrounding bone and soft tissue including synovial response 
patterns were assessed independently by three radiologists. All patients 
underwent revision surgery, and signs of infection and loosening were 
assessed according to AAOS criteria. Chi-squared tests and 
sensitivity/specificity analyses were performed with intraoperative findings as 
standard of reference. 
Results: At surgery, an infection was confirmed in 12 patients, 21 patients 
showed an implant loosening and 13 showed conditions not related to 
infection/loosening. Presence of the following findings was significantly more 
common in patients with infection compared to those without: T2-hyperintense 
lining at the metal/bone interface (p=0.037; sensitivity, 92%; specificity, 41%), 
periostitis (p=0.027; 58%; 77%), an oedema (p=0.001; 75%; 77%), contrast 
enhancement (p=0.030; 75%; 70%) or an abscess (p=0.026; 38%; 95%) in the 
surrounding soft tissue, enlarged lymph nodes (p=0.020; 25%; 97%) and 
lamellated synovial response (p=0.020; 25%; 97%). 
Conclusion: The differentiation between patients with and without infected 
total hip arthroplasty may be possible using a set of parameters derived from 
MR with metal artefact reduction. The most sensitive parameter was a T2-
hyperintense lining at the metal/bone interface, while the most specific findings 
were presence of an abscess, enlarged lymph nodes and lamellated synovial 
response.  
B-1121 10:55  
Comparison of metal artifact reduction by OMAR, MonoE or combined 
techniques derived from dual-layer spectral CT  
J. Dangelmaier, B.J. Schwaiger, A.S. Gersing, A. Sauter, I. Riederer, 
D. Muenzel, A.A. Fingerle, E.J. Rummeny, P.B. Noel; Munich/DE  
Purpose: To compare image quality using virtual monoenergetic images 
(MonoE), the orthopedic metal artifact reduction (OMAR) algorithm and a 
combination of both techniques in patients with arthroplasty or spondylodesis. 
Methods and Materials: 30 patients (70±12 years; 19 women) with total 
hip/shoulder arthroplasty (n=20) or spondylodesis (n=10) were examined on a 
dual-layer spectral CT. Axial reconstructions (0.9 mm) of standard CT images, 
MonoE (160keV and 200keV), OMAR and combined techniques 
(MonoE+OMAR) were calculated in soft and hard convolution kernels. Image 
quality in all reconstructions was rated by four radiologists, blinded for the type 
of artifact reduction technique, using a 5-point Likert scale. Hounsfield units 
(HU) were measured within the most pronounced hypodense streak artifact as 
well as in the reference tissue. Friedman´s analyses and Wilcoxon-signed rank 
test were performed for each observer separately and the mean of all 
observers for each reconstruction. Inter-reader agreement was calculated with 
ICCs. 
Results: Image quality was rated significantly higher in all artifact-reduced 
images, compared to standard CT (p<0.001; MonoE160 soft tissue kernel 
p=0.001). Images reconstructed with MonoE+OMAR were rated significantly 
better than MonoE or OMAR alone (p<0.001). HU measurements within 
artifacts were significantly closer to reference values in all artifact-reduced 
images, with a superior artifact reduction obtained with MonoE+OMAR (88 % 
vs. 80% for OMAR or 45% for MonoE). Inter-reader agreement was good to 
excellent (ICCs). 
Conclusion: Both, the qualitative assessment and quantitative measurements, 
demonstrated superior artifact reduction using virtual monoenergetic images in 
combination with OMAR, suggesting a clinical advantage in patients with 








B-1122 11:03  
Bone marrow adiposity assessed by 3T MR-spectroscopy in the hip of 
women with anorexia nervosa  
S. Badr1, V.M. Pansini1, I. Legroux-Gérot1, J. Vignau1, R. Stefan2, 
D.C. Karampinos2, C. Chauveau3, B. Cortet1, A. Cotten1; 1Lille/FR, 2Munich/DE, 
3
Boulogne-sur-Mer/FR (sammy@badr.fr)  
Purpose: Bone marrow adiposity (BMA) in women with anorexia nervosa is 
paradoxically increased, contrasting with a reduction of the subcutaneous and 
visceral fat compartment volumes. As BMA may contribute to bone fragility in 
anorexic patients, we studied its relationship with bone mineral density and 
body composition. 
Methods and Materials: 82 anorexic patients were included between January 
2014 and June 2017. BMA of the hip was quantified using 3 tesla MR 
spectroscopy, by calculating signal-weighted bone marrow fat fraction (BMFF) 
in 4 different locations: the acetabulum, greater trochanter, femoral neck and 
proximal femoral diaphysis. Bone mineral density of the hip and body 
composition (body mass index, percentage of lean body mass and body fat 
percentage) were determined using dual-energy x-ray absorptiometry. 
Results: With the exception of the greater trochanter, correlations were 
significant between BMFF and bone mineral density in the different locations of 
the hip (Spearman’s rank correlation coefficients: femoral neck=-0.24, 
acetabulum=-0.28, diaphysis=-0.28; p<0.05). Regarding body composition, 
BMFF was significantly correlated with the percentage of lean body mass and 
the body fat percentage only in the femoral neck (fat=0.29 and lean=-0.27; 
p<0.05). No significant correlation was found between body mass index and 
BMFF in the hip. 
Conclusion: BMFF is negatively correlated with bone mineral density in the 
acetabulum, femoral neck and proximal femoral diaphysis of the hip of women 
with anorexia nervosa. However, correlations between BMFF and body 
composition were only found in the femoral neck, suggesting location-
dependent relationships with the other fat compartments.  
Author Disclosures: 
 D.C. Karampinos: Research/Grant Support; Philips Healthcare. 
B-1123 11:11  
Augmented reality-guided lumbar facet joint injections  
C.A. Agten, C. Dennler, A.B. Rosskopf, L. Jaberg, C.W. Pfirrmann, M. Farshad; 
Zurich/CH (christoph.agten@balgrist.ch)  
Purpose: To assess accuracy of augmented reality-guided lumbar facet joint 
injections. 
Methods and Materials: A spine phantom completely embedded in hardened 
opaque agar with three ring markers was built. A 3-D model of the phantom 
was uploaded to an augmented reality headset (Microsoft HoloLens). Two 
radiologists, independently performed twenty augmented reality-guided and 20 
CT-guided facet joint injections each: for each augmented reality-guided 
injection, the hologram was manually aligned with the phantom container using 
the ring markers. The radiologists targeted the virtual facet joint and tried to 
place the needle tip in the holographic joint space. CT was performed after 
each needle placement to document final needle tip position. Time needed 
from grabbing the needle to final needle placement was measured for each 
simulated injection. An independent radiologist rated images of all needle 
placements in a randomized order blinded to modality (augmented reality vs 
CT) and performer as: perfect, acceptable, incorrect, unsafe. Accuracy and 
time to place needles were compared between augmented reality-guided and 
CT-guided facet joint injections. 
Results: In total, 39/40 (97.5%) of augmented reality-guided needle 
placements were either perfect or acceptable compared to 40/40 (100%) CT-
guided needle placements (P=.5). One augmented reality-guided injection 
missed the facet joint space by 2 mm. No unsafe needle placements occurred. 
Time to final needle placement was substantially faster with augmented reality 
guidance (mean 14 ± 6 s vs 39 ± 15 s, P<.001 for both readers). 
Conclusion: Augmented reality-guided facet joint injections are safe and 
accurate in an experimental setting.  
B-1124 11:19  
3D MR-based simulation of hip impingement is as accurate as 3D CT-
based impingement simulation  
F. Schmaranzer, C. Degonda, T. Lerch, I. Todorski, K. Siebenrock, 
J.L. Cullmann, M. Tannast, G. Zheng; Bern/CH  
Purpose: For complex cases of femoroacetabular impingement (FAI), CT-
based 3D impingement simulation is the current gold standard for impingement 
detection. 3D MRI-based impingement simulation would offer a radiation-free 
alternative. We asked: (1) How many surface points of 3D models derived from 
3D CT versus 3D MRI differ by <1mm? (2) Do impingement-free range of 
motion values correlate between 3D models derived from CT/MRI? 
Methods and Materials: IRB-approved comparative, retrospective study of 20 
symptomatic hips with FAI. 3D CT scans (isovoxel: 1mm3) of the entire pelvis 
  






and the distal femoral condyles were obtained. Preoperative MR arthrograms 
of the hip were obtained including 0.8mm3 isovoxel T1 3D VIBE- and 1mm3 
isovoxel 3D T1 VIBE DIXON sequences of the entire pelvis and the distal 
femoral condyles. Threshold-based manual segmentation was performed using 
commercial software (AMIRA). Both 3D models were compared with in-house 
developed software to calculate (1) percentage of the surface points with < 
1mm difference between the CT-/MR-based 3D models and to assess (2) the 
correlation in impingement-free range of motion (in: flexion; extension; internal 
rotation 90° of flexion; external rotation in 90° of flexion; abduction; adduction) 
and location of impingement on CT/MRI. 
Results: (1) 83%/79% of the surface points of the proximal femur, respectively, 
of the acetabulum differed by <1mm between the CT-based and MRI-based 3D 
models. (2) Correlation for the range of motion values was excellent 
(Spearman rho=0.993, p<0.05) between CT/MRI. 
Conclusion: MR-based 3D models of the hip joint can replace CT-based 3D 
models for impingement simulation in young FAI patients.  
B-1125 11:27  
Performance of an automated vs manual MR scanner workflow of whole-
body MRI  
D. Stocker1, T. Finkenstaed1, B. Kuehn2, D. Nanz1, M. Klarhöfer1, B. Kiefer2, 
C.S. Reiner1; 1Zurich/CH, 2Erlangen/DE (daniel.stocker@usz.ch)  
Purpose: To evaluate the performance of an automated magnetic resonance 
imaging (MRI) scanner workflow reducing user interactions compared to the 
manual MRI workflow for whole-body (WB) MRI. 
Methods and Materials: This prospective study was approved by the local 
ethics committee. 20 patients underwent WB-MRI for myopathy evaluation on 
a 3T MRI-scanner. 10 patients (7 females; age, 52±13ys; body mass index 
[BMI], 23.2±3.0) were examined with a prototypical automated scanner 
workflow (automated whole-body segmentation) and 10 patients (6 females; 
age, 35.9±12.4ys; BMI, 24.9±5.6) with a manual scan. For each sequence 
(coronal T2-weighted turbo inversion recovery magnitude [TIRM] and axial T1-
weighted contrast-enhanced sequence with volume interpolated breath-hold 
examination [VIBE]) overall image quality (IQ; 5, excellent; 1, poor) and 
completeness of examination volume were assessed by two readers. 
Examination time, number of user interactions and the MR-technicians’ 
planning effort (1, highest; 10, lowest) were compared. 
Results: Overall IQ was similar between automated and manual MRI (TIRM: 
4.00±.94 vs 3.45±1.19, p=.264; VIBE: 4.20±.88 vs 4.55±.55, p=.423). Total 
examination time was significantly shorter for automated MRI (30.0±4.2min vs 
41.5±3.4min, p<.0001) with significantly shorter planning time (2.5±.79min vs 
14.0±7.0min, p<.0001). Planning time was 8% vs 34% of total examination 
time for automated vs manual workflow (p<.0001). The number of user 
interactions and rated planning efforts with automated MRI were significantly 
lower compared to manual MRI (10.2±4.4 vs 48.2±17.2, p<.0001 and 2.20±.92 
vs 4.80±2.39; p=.005, respectively). 
Conclusion: The automated MRI workflow significantly reduced examination 
time and user interactions while producing comparable IQ in WB-MRI for 
evaluation of myopathies.  
Author Disclosures: 
 B. Kuehn: Employee; Siemens Healthcare.  M. Klarhöfer: Employee; 
Siemens Healthcare. B. Kiefer: Employee; Siemens Healthcare. 
B-1126 11:35  
CAM type femoroacetabular impingement: correlations between alpha 
angle vs volumetric measurements and surgical findings  
R.A.K. Dessouky1,2, J. Wells2, L. Zhang3, A. Gleason2, R. Chopra2, 
Y. Chatzinoff2, N.P. Fey2, Y. Xi2, A. Chhabra2; 1Zagazig/EG, 2Dallas, TX/US, 
3
Beijing/CN (rihamdessouky@gmail.com)  
Purpose: To determine the correlation of 3DCT measurements of CAM type 
femoro-acetabular impingement [FAI] with surgical findings of labral tear and 
cartilage loss. 
Methods and Materials: Digital search of symptomatic FAI patients who 
underwent hip surgery for a CAM-type FAI from July 2013 to August 2016 
yielded 43 patients. Demographic data, clinical and surgical findings were 
recorded. Two readers evaluated 3DCT images to calculate volumes of the 
femoral head and bump as well as alpha angles. Correlations between CT and 
surgical findings were obtained. Inter-reader reliability was determined using 
intraclass correlation [ICC]. 
Results: Thirteen men and fourteen women were included with a mean age of 
37.3 ± 10.4 years. The most common clinical finding was positive FADIR 
[19/27, 70.4%]. Twenty-seven labral tears and twenty cartilage defects were 
found on surgery. Significant correlations between the femoral bump and head 
volumes with the extent of the labral tear [p values = 0.008 and 0.003, 
respectively] existed. No significant correlations were found between alpha 
angles at 1 and 2 O’clock and extent of the labral tear [p values >0.05] or any 
measurement with cartilage loss [p>0.05]. Inter-reader reliability was excellent 
to moderate [ICC= 0.85 and 0.52] for femoral head and bump volumes, and fair 
to poor [ICC = 0.40 and 0.05] for alpha angles at 1 and 2 o’clock, respectively. 
Conclusion: Volumetric measurements of CAM type FAI significantly correlate 
with the extent of the labral tear with superior inter-reader reliability than alpha 
angle, rendering it a more clinically relevant method to quantify CAM 
morphology.  
Author Disclosures: 
 A. Chhabra: Consultant; ICON Medical, unrelated to this presentation. Other; 
Book Royalities; Jaypee, Wolters, unrelated to presentation. 
B-1128 11:43  
FDG-PET/CT for diagnosis of infection in post-traumatic non-unions  
L. Antunovic, M. Catalano, L. Di Mento, E. Malagoli, L. Balzarini, A. Chiti, A. 
Kirienko, M. Berlusconi, N. Trenti; Rozzano/IT (lidija.antunovic@humanitas.it)  
Purpose: To assess the diagnostic performance of FDG-PET/CT in the 
evaluation of infection causing post-traumatic bone non-unions. 
Methods and Materials: 47 patients treated in our trauma center, who 
underwent pre-operative FDG-PET/CT for suspected infection, were 
retrospectively reviewed. Clinical history, diagnostic examinations, laboratory 
and microbiology results, patient outcome, were collected and analyzed. FDG 
PET/CT images were evaluated with the addition of semi-quantitative analysis 
using SUVmax. Imaging findings, as assessed by an experienced nuclear 
medicine physician and a musculoskeletal radiologist, were correlated with 
microbiological examination of the intraoperative specimens. Finally, diagnostic 
performance of FDG-PET/CT was assessed. 
Results: 22 patients were not infected, while remaining 25 had positive 
intraoperative microbiological results. Infection was correctly detected on FDG-
PET/CT images in 23 cases, while 2/25 infected patients had no significant 
FDG uptake and were considered as false negatives. In 6 cases FDG-PET/CT 
showed false positive results; 16/22 disease-free patients were correctly 
diagnosed. The diagnostic accuracy of FDG-PET/CT in the final diagnose of 
infection was 83% (39/47). Sensitivity, specificity, positive predictive value and 
negative predictive value of FDG-PET/CT were 92%, 73%, 79% and 88% 
respectively. Likelihood ratio for a positive test(LR+) 3.41. Likelihood ratio for a 
negative test resulted 0.11. Pre-test probability of disease was 53%. Post-test 
probability based on LR+ resulted 79%, while post-test probability based on 
LR- was 11%. 
Conclusion: Our data indicate FDG-PET/CT is a valuable diagnostic tool in 
the evaluation of post-traumatic infection.  
10:30 - 12:00 Room G  
Physics in Medical Imaging  
SS 1413  
Image quality evaluation and optimisation 
in CT  
Moderators:  
I. Hernandez-Giron; Leiden/NL  
O. Rampado; Turin/IT  
B-1129 10:30  
Iterative reconstruction algorithms in computed tomography: is it 
possible to go beyond Fourier metrics for image quality assessment?  
N. Paruccini, R. Villa, S. Morzenti, C. Spadavecchia, M. Signoriello, D. Ippolito, 
A. Crespi; Monza/IT (n.paruccini@asst-monza.it)  
Purpose: Iterative reconstruction algorithms (IR) have been introduced in 
clinical practice. In this condition, the Fourier analysis requirements are not 
completely satisfied because of the effects of non-linearity and non-stationarity 
produced by the iterative reconstruction process.Alternative metrics, not based 
on Fourier transform, have been used to evaluate image quality. 
Methods and Materials: A cylindrical water filled phantom was equipped with 
central cylindrical inserts of various densities and then scanned changing 
CTDIvol, reconstruction algorithm, filter and slice thickness. Blur was 
investigated with a simple metric based on the comparison of the original 
images with the same images after a low pass filter application. A statistical 
method was employed to evaluate low contrast detectability (LCD) in a 
homogeneous region. Results were then used to characterise noise amount 
and texture. Furthermore, the relationship between Noise Power Spectrum 
(NPS) and LCD was investigated. 
Results: The image quality improvement obtained with IR is underline with 
both metrics. Blur metric is able to detect the different sharpness degree. The 
relationship between noise and Blur underlines a different behaviour for IR; 
Blur increases with lower dose levels or with higher reconstruction thickness. 
LCD curves underline an averaged improvement of 35-45%. Through 
evaluation of the LCD curves, information regarding colour and texture of noise 
are obtained. Furthermore, the shapes of LCD and NPS curves are in 
accordance. 
  






Conclusion: The metrics proposed can be applied to any kind of 
reconstruction algorithms and with few requirements. Results are in 
accordance with metrics based on Fourier analysis.  
B-1130 10:38  
Image quality of conventional images of dual-layer spectral CT: a 
phantom study  
F. van Ommen1, E. Bennink1, A. Vlassenbroek2, J.W. Dankbaar1, A. Schilham1, 
M.A. Viergever1, H.W. De Jong1; 1Utrecht/NL, 2Brussels/BE 
(f.vanommen@umcutrecht.nl)  
Purpose: As dual-layer spectral CT scanners are mainly used for routine non-
spectral imaging, these images should not come with a dose or image quality 
penalty as compared to a conventional CT scanner. The influence of a dual-
layer detector on the image quality of conventional CT images is evaluated by 
comparison with a conventional CT scanner. 
Methods and Materials: A CATPHAN600 phantom was scanned on an IQon 
Spectral CT and a Brilliance iCT scanner (Philips Healthcare, Best, The 
Netherlands). Four protocols, and three tube voltages were used to assess 
image quality at equalized dose levels. Noise and spatial resolution were 
characterized. Furthermore, contrast-to-noise-ratio, image uniformity, CT 
number linearity, slice thickness, slice spacing, and spatial linearity were 
evaluated. 
Results: Noise levels were equivalent for both scanners. Resolution levels 
showed small but significant differences up to 0.3 lp/cm in favour of the dual 
layer. Contrast-to-noise ratio was equivalent at 80 and 120 kVp, but at 140 kVp 
significant differences up to 0.4 in favour of the dual-layer detector were found. 
Both scanners showed perfect CT linearity for body scans, but both showed an 
underestimation of the CT numbers for high-opacity materials for head scans. 
Slice thickness was slightly overestimated, but slice spacing was reconstructed 
correctly. In addition, spatial linearity was excellent with a maximum error of 0.1 
mm. 
Conclusion: The performance of the IQon in routine non-spectral imaging is 
comparable to the performance of the iCT. The similar performance suggests 
that the introduction of a dual-layer detector does not compromise image 
quality of conventional CT images.  
Author Disclosures: 
  F. van Ommen: Research/Grant Support; Dutch heart foundation, 
Netherlands Organization for Scientific Research (NWO), Philips 
Healthcare.  A. Vlassenbroek: Employee; Philips Healthcare. J.W. Dankbaar: 
Grant Recipient; TTW grant: 14732.  M.A. Viergever: Grant Recipient; TTW 
grant: 14732. H.W. De Jong: Grant Recipient; TTW grant: 14732. 
B-1131 10:46  
Evaluation of the effect of image noise on CT perfusion measurements 
using digital perfusion phantoms  
S. Skornitzke, H.-U. Kauczor, W. Stiller; Heidelberg/DE 
(Stephan.Skornitzke@med.uni-heidelberg.de)  
Purpose: Models used for computed tomography (CT) perfusion studies might 
react differently to image noise present in CT acquisitions. Different algorithms 
from one commercially available CT perfusion software were evaluated for 
susceptibility to image noise. 
Methods and Materials: Digital perfusion phantoms were generated using a 
deconvolution model for simulating time-attenuation curves (TACs) for 16 
different combinations of the perfusion parameter blood flow (BF: 30/60/90/120 
ml/100 ml/min) and flow extraction product (FEP: 10/20/30/40 ml/100 ml/min) 
corresponding to values encountered in clinical studies. TACs were distorted 
with additive Gaussian noise at 50 different strengths to approximate various 
levels of image noise, performing 200 repetitions for each noise level. 160000 
TACs were evaluated in total by measuring BF and FEP, and comparing 
results for the maximum-slope and Patlak model to those obtained with a 
deconvolution model (syngo.via Body Perfusion; Siemens Healthineers, 
Germany). 
Results: All evaluated perfusion models show a dependence on image noise: 
means and standard deviations of BF and FEP over repetitions increase with 
increasing image noise. The increase in means is larger for low values of BF 
and FEP and nearly vanishes for high values. Deviations are below 50% under 
all conditions only for noise levels below 20 HU (BF) or 10 HU (FEP). BF 
measurements performed with the deconvolution model show a larger 
standard deviation than those performed with the maximum-slope model. 
Conclusion: Measurements of perfusion parameters depend heavily on the 
magnitude of image noise, which has to be taken into account during the 
interpretation of results, e.g. as a quantitative imaging biomarker.  
Author Disclosures: 





B-1132 10:54  
The optimal energy level of virtual monochromatic images from spectral 
CT for reducing beam-hardening artefacts due to contrast media in the 
thorax  
D. Kim1, C. Kim2, K. Lee1, E.-Y. Kang3, Y.-W. Oh3, H. Kim1, J. Cha1; 
1
Ansan/KR, 2Ulsan/KR, 3Seoul/KR (dj8827@naver.com)  
Purpose: To determine the optimal energy level of virtual monoenergetic 
images (VME) from spectral CT compared to that of conventional 
polychromatic images (COV) for reducing beam-hardening artefacts caused by 
contrast media in the thorax. 
Methods and Materials: A total of 101 consecutive patients who underwent 
chest CT were retrospectively included in this study. The same contrast media 
and injection protocols were applied to the whole study population. VME image 
data sets ranging from 70 to 200 keV and COV were obtained. Readers’ 
subjective image quality scores were recorded in COV and VME at 70 keV 
(VME70), 100 keV (VME100), 130 keV (VME130), and 200 keV (VME200). 
Image noise, CT number difference, contrast-to-noise ratio (CNR), and signal-
to-noise ratio (SNR) were also obtained in each algorithm. The Kruskal-Wallis 
test with Bonferroni correction was used compared to the differences in 
subjective image scores, CT numbers, image noise, SNR values, and CNR 
values between the reconstruction techniques. 
Results: The best subjective image quality score and the lowest image noise 
were observed in VME130 compared to COV (all P&lt0.001). CT number 
differences were significantly lower in both VME100 and VME130 than in COV 
(all P&lt0.001). SNR was similar between VME130 and COV, although both 
SNR and CNR decreased as the energy level increased. 
Conclusion: Optimal evaluation of chest CT was best achieved at 100-130 
keV. VME130 offered the best image quality score and image noise. VME100 
and VME130 showed significantly lower CT number differences than in COV.  
B-1133 11:02  
Sub-millisievertmultiphasic acquisitions for coronary CT angiography of 
congenital coronaryanomalies in paediatric patients  
J. Le Roy, H. Vernhet Kovacsik, H. Zarqane, M. Vincenti, A. Lacampagne, 
P. Amedro; Montpellier/FR (le.roy-julien@hotmail.com)  
Purpose: To assess feasibility and performance of selective multiphasic 
coronary CT angiography (CCTA) at very low dose for paediatric patients with 
coronary artery anomaly 
Methods and Materials: 50 paediatric patients with coronary artery anomalies 
underwent a cardiac CT between December 2015 and October 2017. Several 
parameters were recorded, including age (6.1y± 4.9), BMI (15.8kg.m-2±2.5), 
heart rate (89bpm±26) and heart rate variability (14bpm±11). Depending on 
these parameter combinations, specific protocols were designed to target the 
best theoretical cardiac phase in every situation; giving best compromise 
between image quality and reduced radiation dose. Acquisitions were realized 
on last generation single-source CT (Revolution CT, GEHC). Image quality was 
assessed qualitatively on a four point scale by two radiologists. 
Results: All acquisitions fully answered the diagnostic question (100% - 
50/50). Image quality was considered as “good” or “excellent” in ninety percent 
of cases (90%-45/50). Ten percent (10%-5/50) were scored as “adequate” 
while no exam were “not assessable”. Looking at these five patients, 
movement artefacts were principal causes of average -but still diagnostic- 
image quality. No significant visualisation differences were reported between 
the different coronary segments with a global score of 3.5±0.6 on a 4 point 
scale (200 segments analysed in total). No correlation between image quality 
and cardiac parameters were reported (r=-0.17 and r=-0.10 respectively for 
Heart rate and HR variability). Mean effective dose was 0.98 mSv. 
Conclusion: Infra-milliSievert multiphasic CCTA acquisitions could be 
performed with diagnostic quality for a dose equivalent to only 20% of a 
paediatric chest CT dose.  
B-1134 11:10  
A preliminary study about the robustness of quantitative CT features of 
pancreatic NEN: inter-observer variability assessment in delineation of 
lesions contours on CT images  
G. Benedetti1, M. Panzeri1, M. Mori1, C. Sini2, M. Barbera1, S. Partelli1, 
M. Falconi1, C. Fiorino1, F. De Cobelli1; 1Milan/IT, 2Potenza/IT 
(benedetti.giulia@hsr.it)  
Purpose: Radiomic is a promising field to build predictive models relating 
imaging features to clinical outcomes, especially for neoplasms. Nevertheless, 
its robustness is still under investigation. Especially, a reliable delineation of 
the lesions is of fundamental importance for Radiomic Features(RF) extraction. 
Our aim was to assess interobserver variability in delineating pancreatic 
neuroendocrine neoplasms (NEN) on CT images, and its impact on RF. 
Methods and Materials: 10 histologically confirmed pancreatic NEN were 
contoured on CT images by 3 blinded observers. Contours were delineated on 
arterial or venous phase, depending on where the tumour was best seen, and 
  






then projected onto the pre-contrast acquisition and adjusted to correct small 
anatomical discrepancies. Interobserver contouring variability was assessed by 
DICE-index and volume distribution among contours; significance of 
differences between observers was tested with Wilcoxon. Paired analysis 
between observers was performed. 72 RF were extracted from each observer’s 
contours; their robustness was investigated against contour variability with 
Spearman-R and Intra-Class Correlation (ICC). 
Results: Volume mean and median were 7.6cc and 1.5cc. A satisfactory 
agreement was found, with mean DICE=0.77±0.075 and no significant 
differences between observers. 50/72 RF were very robust (ICC>0.9); 10/72 
showed an ICC<0.8, mostly in the ‘Neighbourhood intensity-difference’ RF 
family. Average R-values were 0.89 for RF with ICC>0.9 and 0.84 for the 
others RF. Only ‘sphericity’ (i.e. external shape of the lesion) R-value was<0.6. 
Conclusion: Results show a relatively small inter-observer variability in 
delineating pancreatic NEN with little impact on RF, suggesting the possibility 
of a robust CT-based RF extraction on larger population.  
B-1135 11:18  
Comparison of clinical and phantom image quality for low-contrast liver 
lesions in a prospective multicentre dose optimisation protocol  
H. Brat1, D. Racine2, S. Montandon3, S. Behzad Imsand4, B. Rizk5, 
D. Fournier1; 1Sion/CH, 2Lausanne/CH, 3Gland/CH, 4Epalinges/CH, 
5
Villars-sur-Glane/CH (hugobene@gmail.com)  
Purpose: To compare diagnostic performance for low-contrast liver lesions on 
patient and phantom images in a prospective multicentre CT scanner dose 
optimisation protocol. 
Methods and Materials: A protocol optimisation based on clinical indication 
and BMI with stepwise dose reduction was implemented on 5 CT scanners 
(PhilipsTM). 3035 abdomen CT examinations were prospectively assessed for 
diagnostic image quality (radiologist vote). 33 patients who underwent a CT 
examination for liver tumour or cancer staging before and after optimization 
were evaluated for image quality (European guidelines). In parallel, phantom 
(QRM™ 401 abdomen) acquisition with 2.5 (size M) and 5cm (size L) soft-
tissue ring was performed before and after dose reduction using the liver 
tumour follow-up protocol. A channelized Hotelling (CHO) model observer was 
used to assess lesion detectability using the ROC paradigm with the area 
under the ROC curve (AUC) as figure of merit. 
Results: Median patient CTDIvol value decreased from 6.8 to 5.2mGy (-24%) 
and from 10.8 to 8.5mGy (-22%), respectively, for BMI<25 and >25. For 
phantom images, mean CTDIvol value decreased from 8.8 to 6.3mGy (-28%) for 
M-sized and from 15.9 to 11.8mGy (-26%) for L-sized phantom. No negative 
vote was registered and no loss of image quality was observed in the 33 paired 
patients' subgroup. Phantom analysis showed constant low-contrast lesion 
detectability until 26% dose reduction. However, additional dose reduction 
impaired detectability of 5mm lesions. 
Conclusion: Combining clinical and phantom diagnostic image quality enabled 
dose reduction according to the ALARA principle without impairing low-contrast 
liver lesion detectability.  
B-1136 11:26  
Endoleak detection with ultra-low radiation exposure CT based on sparse 
sampling and reduced tube current  
F.K. Kopp1, R.-D. Bippus2, K. Mei1, A. Sauter1, B.J. Schwaiger1, A. Gersing1, 
J. Dangelmaier1, E.J. Rummeny1, P.B. Noel1; 1Munich/DE, 2Hamburg/DE 
(felix.kopp@tum.de)  
Purpose: To assess the diagnostic performance of sparse sampling computed 
tomography with significantly reduced radiation dose regarding the detection of 
endoleaks after endovascular aortic repair (EVAR). 
Methods and Materials: 11 patients (seven positive and four negative for the 
diagnosis of an endoleak after EVAR) were examined using a 256-slice CT 
scanner and were retrospectively included in this study. A reduced radiation 
exposure was simulated by combining tube current reduction and sparse 
sampling. Three datasets were calculated, hereby each dataset showed the 
same radiation dose (20% of clinical radiation dose): dataset A with continuous 
sampling, dataset B with 2-times sparse sampling (keeping every 2nd view) 
and dataset C with 4-times sparse sampling. Four blinded radiologists, 
evaluated each dataset for the presence of an endoleak, with at least seven 
days between the consecutive readings. Sensitivity, specificity, negative 
predictive value (NPV), positive predictive value (PPV) and the area under the 
ROC curve (AUC) were calculated with the clinical diagnosis as standard of 
reference. 
Results: Sensitivity, specificity, NPV and PPV were 71%, 69%, 81% and 58% 
for dataset A; 75%, 81%, 88% and 65% for dataset B; and 82%, 75%, 87% 
and 75% for dataset C. AUC values, averaged over the four readers, were 
0.80, 0.82 and 0.86 for dataset A, B and C, respectively. 
Conclusion: Using sparse sampling, sensitivity, specificity, NPV, PPV and 
AUC is increased compared to continuous sampling at the investigated dose 
level (dose reduction of 80%), suggesting that sparse sampling may allow 
significant radiation dose reduction for follow-up examinations.  
Author Disclosures: 
 R. Bippus: Employee; Philips Research.  
B-1137 11:34  
Optimisation of abdominal CT examinations across different scanners in 
one hospital using a new liver phantom  
S.F. Svensson1, H. Heier-Baardson2, B.E. Nielssen2, E.B. Herud2, 
L.O. Holmen2, H.K. Andersen1, A.C.T. Martinsen1; 1Oslo/NO, 2Grålum/NO 
(sirifl@ous-hf.no)  
Purpose: To optimize a CT abdomen protocol using a newly developed liver 
phantom. 
Methods and Materials: An anthropomorphic liver phantom with hyperdense 
lesions, designed for receiver operating characteristic (ROC) analysis, was 
scanned using three CT scanners, each with its own iterative reconstruction 
method: a Philips Ingenuity Elite with IMR, a Philips Brilliance with iDose4 and 
a GE Revolution Evo with ASiR-V. The phantom was scanned at CTDIw 5, 10, 
15 and 20 mGy, and the images were reconstructed using levels 3 and 5 of 
iDose4, IMR 1 routine, IMR 2 routine and IMR 1 soft tissue, and ASiR-V 20%, 
40%, 60% and 80%. Three radiologists interpreted the images independently, 
and a ROC analysis was performed. 
Results: Generally, the area under curve (AUC) increased and the confidence 
interval (CI) narrowed with higher dose levels for all scanners. All 
reconstructions at 15 and 20 mGy had AUC values > 0.8. IMR scans at 10 
mGy or higher had AUC > 0.9. At 10 mGy, IMR 2 routine had the highest 
score, 0.96 (CI 95%: 0.911-1.0). At 5 mGy, only IMR scored better than AUC 
0.5. The interpreters are most familiar with Philips CT images, and preferences 
may have influenced image quality scoring. 
Conclusion: In general, IMR had higher score than iDose4 and ASiR-V for all 
dose levels. This was a phantom study, so a future clinical validation of the 
results is necessary.  
B-1138 11:42  
Feasibility of whole-body low-dose CT using spectral shaping for 
detection of osteolytic lesion in patients with multiple myeloma  
S. Suntharalingam, C. Mikat, A. Wetter, N. Guberina, A. Salem, P. Heil, 
M. Forsting, K. Nassenstein; Essen/DE 
(Saravanabavaan.Suntharalingam@uk-essen.de)  
Purpose: The aim of this study was to investigate radiation dose and image 
quality of a whole-body low-dose CT (WBLDCT) with tin filtration at 100 kV 
(Sn100 kV) for the assessment of osteolytic lesions in patients with multiple 
myeloma. 
Methods and Materials: Thirty consecutive patients were retrospectively 
selected, who underwent a WBLDCT on a third generation DSCT (Sn100 kV, 
ref. mAs: 130). They were matched with patients, who were examined on a 
second generation DSCT with a standard low-dose protocol (100 kV, ref. mAs: 
111). Objective and subjective image quality, radiation exposure as well as the 
frequency of osteolytic lesions were evaluated. 
Results: All scans were of diagnostic image quality. Subjective overall image 
quality was significantly higher in the study group (p=0.0003). Objective image 
analysis revealed that signal intensities, signal-to-noise and contrast-to-noise 
of the bony structures were equal or significantly higher in the control group. 
There was no significant difference in the frequency of osteolytic lesions 
(p=0.259). The median effective dose of the study protocol was significantly 
lower (1.45 mSv vs. 5.65 mSv; p < 0.0001). 
Conclusion: WBLDCT with Sn100 kV can obtain sufficient image quality for 
the depiction of osteolytic lesions while reducing radiation dose by 
approximately 74%.  
B-1139 11:50  
A procedure towards optimised prenatal CT scan protocols for low dose 
imaging of suspected skeletal dypsplasia  
I. Indesteege, L. Cockmartin, J. Binst, W. Coudyzer, H. Bosmans, M. Aertsen; 
Leuven/BE (ingeindesteege@gmail.com)  
Purpose: To work out a procedure for low dose computed tomography (CT) 
protocols allowing diagnosis and evaluation of prenatal skeletal dysplasia. 
Methods and Materials: Three antropomorphic phantoms were constructed 
with a fresh-frozen female lumbar spine and pelvis, in combination with the 
(Leeds Test Objects) sedentexCT phantom at the theoretical position of the 
fetus, and water and fat slabs to simulate different sizes of mother and fetus. 
Scans were performed on a Somatom Force CT (Siemens) under tube current 
and kV modulation to verify with which patients the 3 phantoms would match 
(dose data collection with DOSE by Qaelum). The phantoms were also 
compared to patients in perimeter and size-specific dose estimate (SSDE). 
Scans were acquired for 5 kV settings at 5 dose levels each to find threshold 
detectability of hydroxyl-apathite inserts in the phantom and subsequently 
graded for several criteria by 2 readers. 
Results: Perimeters, kV, CT Dose Index (CTDI) and SSDE confirmed that the 
phantoms covered the complete range of patients, with the perimeter being a 
  






practical criterium for future patient categorisation. The following dose settings 
guaranteed proper quality (visual grading minimally 4 on a scale of 5) and 
lowest CTDI: perimeter 100.4 cm: 80 kVp, 18 mAs, CTDI 0.34mGy; perimeter 
119.7 cm: 110kV, 34 mAs, CTDI 1.76 mGy, and perimeter 126.6 cm: 140 kVp, 
18 mAs, CTDI 1.75mGy. The procedure worked out well in a first patient case. 
Conclusion: A procedure for low dose prenatal CT scans with satisfactory 
image quality for skeletal evaluation was successfully established.  
Author Disclosures: 
 H. Bosmans: Other; co-founder of Qaelum. 
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B-1140 10:30  
Development of a radiological anatomy free software as a teaching tool  
M.V.L. Oliveira, P. Geambastiani, G.A. Lopez, M. Cambuí; Salvador/BR 
(marcusradiology@gmail.com)  
Purpose: To develop a learning environment for radiologic anatomy education 
to assist radiographers/radiologic technologists students and professionals. 
Methods and Materials: This study was divided into two phases: 1) image 
acquisition and 2) software development. The first step was to perform a 
tomographic scan and radiographic images from a tissue-equivalent phantom 
of the head and neck, containing the same density and atomic number as bone 
tissue. In addition, an anthropomorphic phantom of the chest was used for 
radiographic imaging. The radiographs were held using a computed 
radiography (CR) digitizer system. The second step consisted in the 
development of a macro using the imageJ free software. In this digital 
environment, radiologic anatomy reference points were inserted and multiple 
questions were applied. 
Results: The software presented radiologic anatomy from 1) skull projections: 
Waters view, Caldwell view, Towne view, lateral, submentovertex, PA view, 2) 
thoracic spine projections: AP view and lateral view, and 3) chest ( PA view, 
lateral and oblique). Tomographic imaging presented hundred anatomic points 
of the skull. Multiple choice questions and a report containing the number of 
correct answers, as well as the user ID and date of the test were presented. 
The tests were applied in three languages (Portuguese, Spanish, and English). 
Conclusion: An user-friendly and inexpensive software was presented. 
Radiographers/radiologic technologists, students and professionals from 
several countries are able to practice, repeatedly, the identification of radiologic 
anatomic points. This method can be applied as a feasible technological tool 
for enhancing learning by interactive learning environment.  
B-1141 10:38  
Pregnancy and radiation: video as a tool for health professionals 
communicating knowledge and risks  
A.F. Reitan1, H.M. Olerud2, A. Borthne3; 1Oslo/NO, 2Kongsberg/NO, 
3
Lørenskog/NO (anita.reitan@hioa.no)  
Purpose: To ensure that health care professional have the necessary basic 
knowledge of radiation protection recommendations by producing the 
information film “Pregnancy and radiation”. Pregnancy and radiation is a 
subject that can cause concern to both healthcare professionals and pregnant 
women. There is a lot of uncertainty about how much radiation a foetus is 
capable of taking and the risk of foetal damage after an x-ray examination. 
Methods and Materials: Qualitative survey: semi-structured interviews of two 
general practitioners (GPs) to map which topics were relevant in an information 
film and how these should be conveyed in film. Video production: produce a 
short, research-based film with the aim of making existing knowledge more 
accessible and easier to understand. 
Results: The information video is based on recommendations and available 
knowledge. The take-home message is delivered through dialogue, narration 
and text. The film consists of five cases that show examples of how x-ray 
examinations of pregnant women can be justified. Using focused, research-
based knowledge, in a video as a tool, we can raise the knowledge of GPs on 
the subject of pregnancy and radiation. 
Conclusion: Using focused, research-based knowledge, in a film as a tool, we 
are most likely to raise the knowledge of GPs on the subject of pregnancy and 
radiation. A quantitative survey showed that knowledge among GPs increased 
after them seeing the video.  
 
B-1142 10:46  
Application of the cognitive load theory in simulation experiences to 
stimulate critical thinking in 2nd year radiography students  
A. Louw; University of Johannesburg/ZA (amandal@uj.ac.za)  
Purpose: To explore the significance of the cognitive load theory as 
pedagogical strategy to enhance critical thinking in radiography students who 
participate in a high-fidelity simulation experience. 
Methods and Materials: An inter-professional, high-fidelity simulation scenario 
was specifically designed to stimulate students’ higher cognitive skills such as 
critical thinking, multi-level communication, teamwork and prioritisation in a 
stress loaded scenario involving chest and elbow imaging. An authentic 
scenario setting, various role players, life-like sound effects and the demand of 
multiple cases realistically increased the cognitive load of students and 
exposed them to the pressures often encountered in casualty settings in South 
African hospitals. In line with the cognitive load theory, essential basic 
knowledge and skills were revised and layered well in advance of the 
simulation experience to be stored in students’ long-term memory for easy 
retrieval when immersed in a non-routine scenario. 
Results: Students managed the demands of the scenario fairly well, performed 
up to the standard expected at their level of training and came to new insights 
not previously addressed in a classroom context. During the reflective 
debriefing session steered by student observers, four themes, namely 
prioritisation, communication, team roles and situational and mental 
preparedness emerged. 
Conclusion: Students who were given explicit guidance regarding supportive 
knowledge and skills prior to being involved in a multi-case stress-loaded 
simulation experience achieved the targeted learning outcomes when allowed 
to reflect on their actions and decisions immediately after the simulation 
experience.  
B-1143 10:54  
Enhancing radiographer threshold CT competencies through simulation  
M. Hardy1, M.A. Harris2; 1Bradford/UK, 2Wakefield/UK 
(M.L.Hardy1@bradford.ac.uk)  
Purpose: The last decade has seen extensive growth of computed 
tomography (CT) placing greater expectations on radiographers to participate 
in CT image acquisition early in their careers. Pre-qualification technical skills 
development is achieved through the integration of academic and clinical 
learning but pressures on service capacity limit opportunities for students to 
obtain practical experience. Practice simulation has been shown to be 
beneficial to learning but limited opportunities exist in relation to CT skills 
development. This proof of concept study explored whether a bespoke CT 
simulation web platform could increase student confidence and competence in 
non-contrast head acquisition. 
Methods and Materials: Supported by funding from Health Education 
England, an integrated CT simulation programme distributed through the 
internet was developed. This programme reflected current clinical CT practice 
taking student from patient registration through to discharge and requiring 
decision-making on image acquisition and reconstruction processes. Both 
practice and assessment modes were incorporated for monitoring student CT 
skills development and errors in decision-making. 
Results: The CT simulation programme enabled students to practice their 
clinical skills and see the consequence of errors in parameter choice on image 
quality. Students reported greater confidence in CT processes prior to clinical 
placement and ability to question clinical radiographers from a wider 
knowledge base. 
Conclusion: CT simulation technologies that enable errors in judgement to be 
made, and consequences appreciated, increase fundamental knowledge and 
understanding of the technology. Expansion of the CT simulation programme 
to include chest imaging is being explored.  
B-1144 11:02  
A systematic methodology for the development and validation of 
inventories of biomedical imaging physics learning outcomes for 
radiography and radiology specialities  
J. Castillo1, C. Caruana2, A. Mizzi3, P.S. Morgan4, C. Westbrook5; 
1
San Gwann/MT, 2Msida/MT, 3Attard/MT, 4Nottingham/UK, 5Cambridge/UK 
(josecast@melita.com)  
Purpose: To develop a research methodology for developing local CPD 
learning outcomes in imaging physics for radiographers and radiologists. 
Methods and Materials: An extensive literature review on learning outcomes 
development and multi-stakeholder consensus validation approaches was 
carried out and best practices were identified. A methodology was developed 
and tested by application to the development of a physics learning outcomes 
(LO) for local MRI radiographers. 
Results: The method follows: (a) a multi-stakeholder Delphi process was used 
to forecast the MRI service portfolio for the year 2020; (b) a multi-stakeholder 
  






nominal group technique was used to optimise the MRI care pathway/service 
quality criteria; (c) a survey of MRI competence profiles (CP) from the major 
English-speaking countries was used to identify good practices in CP design; 
(d) an MRI CP was set up based on the results of steps (a)-(c) and validated 
with a multi-stakeholder group; (e) an inventory of biomedical imaging physics 
LO required to deliver the CP was developed via an analysis of textbooks and 
research literature and validated by a multi-stakeholder expert group. The 
multi-stakeholder group agreed that the current MRI service catalogue should 
be maintained, whilst proposing new specific services. The care 
pathway/associated quality criteria were optimised. CP from 6 countries were 
studied. A CP consisting of 43 competence statements was developed and 
validated. An inventory of physics LO closely integrated with the CP was 
developed and validated. 
Conclusion: The process is sufficiently generic to be applicable to the 
development of physics learning outcomes for all radiography and radiology 
specialities.  
B-1145 11:10  
Periodic refresher course for the radiographers of multimodal radiology 
department: the role of IT technologies  
A. Fedorov, M. Cherkashin; St. Petersburg/RU (fedorov@ldc.ru)  
Purpose: To assess electronic-based educational programs' effectiveness in 
radiographers' professional development plan. 
Methods and Materials: 18 MRI radiographers were included in study. We 
have used electronic testing system with ID binding, MR examination simulator. 
Electronic platform was created by IT specialist under MR technologist 
overview. On the first step, initial experience was evaluated by testing and 
interview and staff was divided in 3 groups (by knowledge level). Educational 
course was 2 days (12 hours in total) and includes lectures, MR simulator 
practice with case studies and final examination. After 6 months we have 
performed interim review (interview) and after 12 months final review with 
electronic testing and interview with feedback form. 
Results: Based on 3 groups' scoring, radiographers were divided into 
qualification classes. 2 technicians were assigned to the highest qualification 
group. Moderate group was assigned to 11 employees. 5 radiographers were 
assigned to the lowest group of qualifications. All employees have passed re-
certification in months 12 and the strong positive dynamic was revealed. 5 
technicians from the lowest group increased their knowledge level and 
upgraded into group 2. 2 employees, received the highest qualification, were 
transferred to an expert multimodal centre for working with advanced 
technologies and to act as coaches. Personal satisfaction rate was revealed in 
89%. 
Conclusion: Electronic platform with face-to-face interviews, regular follow-
ups and employees' motivation is the effective tool for staff development. For 
high-quality and full-fledged training of healthcare personnel it is obvious to use 
educational and development plans based on electronic technologies.  
B-1146 11:18  
Eyes on the future of mammography education and training: what needs 
to be focused to match the demands of the clinical practice?  
A. Henner1, E. Metsälä2, N. Richli Meystre3, C. Sá dos Reis1, B. Strøm4, 
J. Pires Jorge3, T. Kukkes5; 1Oulu/FI, 2Helsinki/FI, 3Lausanne/CH, 4Bergen/NO, 
5
Tartu/EE (eija.metsala@metropolia.fi)  
Purpose: The purpose of this study was to identify areas that require update 
on specific knowledge to allow the progression of radiographers' practice in 
mammography. 
Methods and Materials: This study was a cross sectional online survey based 
on online questionnaire addressed to clinical radiographers in five European 
countries about training including perceived challenges and continuous 
professional development (CPD). The questions were closed-ended with 
possibility to add comments. Answers were dichotomous, multiple choice or 
with a five point Likert Scale. The data collected (N= 140) was analysed and 
redundant data was disregarded. Statistical data analysis was performed using 
the software packages SPSS (version 21, IBM) by using descriptive methods, 
Chi square and independent samples t-test. 
Results: Regardless of country, radiographers considered positioning (86%) 
and coping with pain (88%), anxiety (83%) and imaging breast implants (71%) 
as the most challenging tasks. Respondents participated on CPD training 
about mammography (88%). However, 62% had less than 10 hours CPD per 
year. Congresses (70%) and conferences (41%) were the most common 
sources to update knowledge. 
Conclusion: The majority of the radiographers reported the need of more 
training in mammography. The lack of evidence-based knowledge especially 
related to clinical image quality appropriateness criteria and related to optimal 
breast compression suggest the importance of well-designed studies on these 
topics. Variability found could encourage radiographers and teachers to 
question their own practice and to revise the training programs.  
B-1147 11:26  
Comparison of curricula, clinical experiences and attributes of 
radiography programmes delivered by four European educational 
institutions  
C.S. Reis1, S. Mæhle2, J.A. Pires Jorge3, H. York4, L. Flaction3, S. Johansen2; 
1
Perth/AU, 2Oslo/NO, 3Lausanne/CH, 4Herts/UK (Jose.JORGE@hesav.ch)  
Purpose: To compare the curricula, teaching/learning strategies, skills, clinical 
practice outcomes and research of radiography programmes delivered by four 
different European educational institutions. 
Methods and Materials: This study was developed in two phases: one 
focused on curricula analysis using an observation grid and another involving a 
survey performed on students and teaching staff. Questionnaires were design 
to explore teaching and learning strategies, skills and outcomes of clinical 
practice. 
Results: ECTS dedicated per core area (natural sciences, clinical practice, 
research, imaging technology, humanities) differed between institutions. 
Research practice was similar for three institutions out of four. Students 
classified technical, practical and communication skills as the most important, 
while teaching staff highlighted critical thinking. The majority of students 
defined as “very good” their experience in radiography (58.5%) and computed 
tomography (45%). Magnetic resonance imaging training was considered 
“average” by 53% of the UK students and “good” by the others (40%). 
Mammography, nuclear medicine and radiotherapy were not always available 
for some students. For 71% (55/78) of the students, the research work 
contributed to the development of critical/reflective thinking. 
Conclusion: The four radiography programmes analysed in this study 
presented variations on curricula, contact hours and clinical experiences with 
impact on the outcomes. The critical thinking was emphasised as one of the 
most important skills that a radiographer should develop and, for that reason, 
research should be considered as a core unit in radiography/medical imaging 
education. Further work is needed to assess the real impact of different 
programmes on professional and academic mobility across Europe.  
B-1148 11:34  
The development of a CAD tool employing TELTA, designed to support 
the training of radiographers in chest pattern recognition  
S. Mdletshe1, A. Nel1, L. Rainford2, H.A. Lawrence1; 1Johannesburg/ZA, 
2
Dublin/IE (sibusisom@uj.ac.za)  
Purpose: Radiography is a dynamic profession that has undergone rapid 
technological advancements in recent years. The use of technology-enhanced 
learning, teaching and assessment (TELTA) to support innovative training 
options for radiographers to enhance their radiographic image evaluation and 
pattern recognition skills is warranted. However, a gap in current practice exists 
in the availability of custom designed computer-aided detection (CAD) tools to 
augment TELTA use in radiography. 
Methods and Materials: A CAD tool for teaching pattern recognition in chest 
imaging was designed as a collaborative project between the Mechanical 
Engineering Science and Medical Imaging and Radiation Sciences 
Departments, the University of Johannesburg. A Design Science Research 
(DSR) paradigm was used. An initial needs analysis was performed involving a 
focus group interview of eight practising radiography educators. The findings of 
a systematic literature review coupled with the needs analysis outcomes were 
used to compile a software requirements specification document to guide the 
CAD tool development process. 
Results: A CAD prototype was designed to function as a live tool for LTA 
purposes. The CAD tool design facilitates the collection of data on student tool 
usage, performance in automated assessments and managed progress based 
on user-tracked data. Important to the tool was that the students should be 
able to apply standard pattern recognition tools to manipulate the image 
without altering the original. 
Conclusion: Details of how the prototype was developed will be given; the 
development base provides an evidence based mechanism for further 
prototype innovations. Initial data from prototype testing will be provided.  
B-1149 11:42  
Internship supervisors' perception of the radiography students in clinical 
environment  
A.F. Abrantes1, V.L. Gaspar1, L.P. Ribeiro1, O. Lesyuk2, A.M. Ribeiro1, 
R.P. Almeida1, C.A. da Silva3; 1Faro/PT, 2São Brás de Alportel/PT, 3Evora/PT 
(oksanalesyuk@gmail.com)  
Purpose: To identify and describe the perception of internship supervisors of 
the radiography students in clinical environment about their competencies, 
skills and characteristics. 
Methods and Materials: A quantitative descriptive, correlational design was 
used. Data were collected through an adapted version of the Clinical Learning 
Assessment Inventory-Mentor (CLASI-M) questionnaire with a final sample of 
  






34 radiographer supervisors of the last year undergraduated radiography 
students from a public university. 
Results: The training and education provided to the undergraduated 
radiography students prior to their internship is sufficient to assure the gradual 
development of the competencies and characteristics of the future 
radiorgaphers. Additionally, the effective integration into the multidisciplinary 
team and a relationship of trust with the supervisor are also fundamental for 
the student’s development. The majority of the supervisores are very satisfied 
with the students’ availability (93,6%) and the levels of supervision (96,7%) 
throughout the radiography clinical internship. 
Conclusion: The pedagogical atmosphere is considered pivotal, with 
reference to students’ learning activities and competent development within the 
clinical setting. The most desired competencies in a student by supervisors are 
communication skills with both patients and other team members, a high level 
of theoretical knowledge and performance in practice, fast learning and the 
overall motivation exhibited throughout the internship. Furthermore, 
supervisores are satisfied with both their own and students’ availability, 
showing great expectations for the future radiographers.  
B-1150 11:50  
The use of moulage to prepare first year diagnostic radiography students 
for the sight of open wounds: initial findings of a doctoral pilot study  
N. Shiner; Derby/UK (N.shiner@derby.ac.uk)  
Purpose: Transitioning to clinical placement is challenging for first year 
diagnostic radiography students; specifically working with ill patients. Focus 
groups held with students following their first clinical placements indicated 
issues comprehending the sight of open wounds. Witnessing the result of 
trauma is linked with anxiety and psychological trauma. Simulated practice 
offers experiential learning to students in a safe environment. Active 
participation and the debrief stage offers opportunity for analysis, problem 
solving and reflection. The use of moulage (make-up) increases fidelity and 
immersion of participants in simulated practice. A gap in the literature was 
identified and led to this pilot study for a doctoral thesis; preparing students for 
open wounds prior to clinical placement. 
Methods and Materials: Ethical approval was gained. A mixed method quasi-
experimental study was designed. Twelve first year radiography students were 
randomly assigned to control and experimental groups. The experimental 
group attended a simulation of a patient suffering open wounds (moulage). 
Quantitative data was gathered from both groups at the same time points using 
visual analogue scales. Focus groups will be held post clinical placement to 
gather qualitative data. 
Results: It is hypothesised that the experimental group will value the 
opportunity to explore and discuss experiencing patients with open wounds. 
The control group will have similar experiences to previous cohorts indicating 
difficulties in this area. 
Conclusion: As work is in progress the findings of this study will be reported. 
This is an innovative use of moulage in this context, contributing to the 
































10:30 - 12:00 Room M 1  
Cardiac  
SS 1403  
Myocardial MRI: perfusion, tissue tracking 
and fibrosis  
Moderators:  
F. Secchi; Milan/IT  
E.J.R. van Beek; Edinburgh/UK  
K-21 10:30  
Keynote lecture  
R. Vliegenthart; Groningen/NL  
B-1151 10:39  
Impact of local native T1 times on pixel-wise quantification of myocardial 
blood flow  
C. Kräuter, U. Reiter, C. Reiter, A. Schmidt, M.H. Fuchsjäger, R. Stollberger, 
G. Reiter; Graz/AT (corina.kraeuter@medunigraz.at)  
Purpose: To investigate the impact of local native T1 time variations on pixel-
wise quantification of myocardial blood flow (MBF) from dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI). 
Methods and Materials: 15 patients with coronary heart disease underwent 
3T pre-contrast T1 mapping and cardiac DCE-MRI at rest using a saturation 
recovery fast low angle shot sequence. Gadolinium-based contrast agent was 
administered as bolus at a dose of 0.05 mmol/kg. After coil sensitivity and 
motion correction of DCE series, signal intensity was converted to contrast 
agent concentration employing a signal intensity model and incorporating 
measured native T1 times. MBF was calculated pixel-wise using Fermi 
modelling. Segmental mean MBF values calculated with global and local native 
myocardial T1 times, respectively, were compared using paired t-test. 
Myocardial segments exhibiting perfusion deficits were identified by visual 
analysis of DCE series. 
Results: Segmental mean MBF values calculated with global and local native 
T1 times, respectively, did not yield a significant difference (MBF global T1, 
0.61±0.16 ml/min/g; MBF local T1, 0.62±0.16 ml/min/g; p=0.4354). However, 
considering segments with and without perfusion deficits individually revealed 
a decrease in MBF for segments with perfusion deficits if local instead of global 
native T1 times were employed (MBF global T1, 0.47±0.17 ml/min/g; MBF local 
T1, 0.43±0.16 ml/min/g; p=0.0016); segments without perfusion deficits 
showed the opposite behavior (MBF global T1, 0.64±0.14 ml/min/g; MBF local 
T1, 0.65±0.14 ml/min/g; p=0.0083). 
Conclusion: Local instead of global native T1 times should be used in pixel-
wise MBF quantification to avoid overestimation of MBF in myocardial regions 
with perfusion deficits.  
Author Disclosures: 
 G. Reiter: Employee; Siemens Healthineers. 
B-1152 10:47  
Cardiac magnetic resonance T1 reactivity in coronary artery disease  
M. van Assen, R. van Dijk, D. Kuijpers, R. Vliegenthart, M. Oudkerk; 
Groningen/NL (m.van.assen@umcg.nl)  
Purpose: To assess the potential of rest and stress T1-mapping for 
differentiating normal and diseased myocardium without Gadolinium in patients 
with suspected coronary artery disease (CAD). 
Methods and Materials: Patients underwent 1.5T magnetic resonance 
imaging (MRI) as part of clinical work-up due to suspicion of CAD. To identify 
ischemic and infarcted myocardium adenosine stress perfusion and late 
gadolinium enhancement (LGE) MRI were performed. Patients were 
categorized into an ischemic, infarct, and control group based on perfusion and 
LGE images. Patients were excluded if they had both ischemic and infarcted 
myocardium. At rest and stress, a native Modified Look-Locker Inversion 
Recovery (MOLLI) T1-mapping acquisition was performed. Short-axis pixel-
wise myocardial T1-maps were acquired with inline motion-correction. Regions 
of interest (ROI) were placed in the septal (normal myocardium), ischemic and 
infarcted areas. 
Results: 64 patients were included: 10 with myocardial ischemia, 15 with 
myocardial infarction, and 39 controls. Rest and stress native T1-values were 
significantly higher in infarcted myocardium (median 1044ms [interquartile 
range (IQR) 985-1076] and 1053ms [IQR 989-1088]) compared to ischemic 
myocardium (median 961ms [IQR, 939-988] and 958ms [IQR, 945-988]). T1-
reactivity was significantly lower in ischemic and infarcted myocardium (median 
0.00% [IQR,-0.18-0.16] and 0.41% [IQR, 0.09-0.86]) compared to remote 
myocardium (median 3.54% [IQR, 1.48-5.78] and 3.21% [IQR, 1.95-4.79]). 
  






Conclusion: T1-mapping in rest and stress is able to distinguish between 
normal, ischemic, infarcted and remote myocardium using native T1-values 
and T1-reactivity, and holds potential as an imaging biomarker for tissue 
characterization using MRI.  
B-1153 10:55  
Myocardial microvascular dysfunction in patients with end-stage renal 
disease: assessment with 3.0T cardiac magnetic resonance  
R. Xu, H. Xu, Z. Yang, Y. Guo; Chengdu/CN (Xrongdoctor@163.com)  
Purpose: To quantitatively evaluate the left ventricular regional myocardial 
microvascular function in patients with end-stage renal disease (ESRD), and to 
clarify the feasibility of first-pass perfusion imaging for detection myocardial 
microvascular dysfunction in patients with ERSD. 
Methods and Materials: In total, 67 patients with ERSD and 19 healthy 
subjects were enrolled and the first-pass perfusion was analysed. The ERSD 
patients were divided into two groups including 16 patients with systolic 
dysfunction (EF<50%) and 51 patients with preserved systolic function 
(EF50%). The LV myocardial perfusion parameters included Upslope, time to 
maximum signal intensity (TTM) and max signal intensity (MaxSI) which were 
compared among the patient groups and controls. Continuous variables were 
compared using independent one-way analysis of variance (ANOVA). 
Results: The ERSD patients with impaired LVEF had significantly lower SV 
than that of the normal subjects, and the LV mass was markedly increased (all 
P < 0.001). The patients with ERSD had significantly reduced first-pass 
perfusion MaxSI in the all segment compared with the normal subjects (all P < 
0.001). For the Upslope and TTM, the patients with ERSD (impaired EF) had 
lower Upslope in the basal segment (2.53±1.21 vs 2.04±0.81, P < 0.05) than 
the patients with ERSD (preserved EF); all patients had lower Upslope in the 
mid-segment and shorter TTM in the apical segment than the controls P < 
0.05). 
Conclusion: The first-pass perfusion CMR can discover and monitor the 
myocardial microvascular dysfunction in ERSD patients.  
B-1154 11:03  
Impaired segmental myocardial microvascular dysfunction in chronic 
kidney diseases patients: assessed by cardiac magnetic resonance first-
pass perfusion imaging  
H. Xu, Z. Yang, Y. Guo, W. Peng, W. Peng; Chengdu/CN 
(xuhuayan89@sina.com)  
Purpose: This research is aimed to access the myocardial microvascular 
dysfunction in chronic kidney disease(CKD) patients by using cardiac magnetic 
resonance (CMR) first-pass perfusion imaging, and investigate its association 
with left ventricular (LV) dysfunction. 
Methods and Materials: Seventy-five CKD patients and 29 normal controls 
were enrolled. All subjects were underwent 3.0T CMR examination. First-pass 
perfusion imaging in three standard short-axis slices (apical, middle, and basal) 
and one the 4-chamber view were obtained immediately after intravenous 
injecting gadobenate dimeglumine. All imaging were calculated on the offline 
dedicated software (cvi42).Perfusion slope, time to peak(TTP) and max signal 
intensity(mSI) were obtained. LV dysfunction were defined as LV ejection 
fraction(EF) <50%. 
Results: The slope and mSI of basal, middle and apical segment in CKD 
patients with LV dysfunction was lower than those without LV dysfunction and 
normal controls; and those preceding slope of CKD patients without LV 
dysfunction were also reduced comparing with normal controls(all P0.05). For 
the TTP, only basal segment of patients with LV dysfunction were elongated 
comparing with those without LV dysfunction and normal 
controls(37.52±16.10s vs.26.92±14.02s and 28.30±8.29s). LVEF were 
positively correlated with basal and middle slope(r=0.293 and 0.129, P0.05).In 
addition, LVEF is significantly related to basal mSI(r=0.301, P0.05). Logistic 
regression analysis demonstrated that myocardial perfusion slope is the 
independent risk factor of LV dysfunction. 
Conclusion: Segmental myocardial microvascular dysfunction was found in 
CKD patients without LV dysfunction. Segmental slope and basal mSI were 
significantly associated with LVEF. Perfusion slope was demonstrated the 
independent risk factor of LV dysfunction.  
B-1155 11:11  
Semi-quantitative and quantitative magnetic resonance perfusion 
analysis: a meta-analysis  
R. van Dijk1, M. van Assen2, R. Vliegenthart1, G. de Bock1, P. van der Harst1, 
M. Oudkerk1; 1Groningen/NL, 2Charleston, SC/US (r.van.dijk02@umcg.nl)  
Purpose: To assess the diagnostic accuracy of semi-quantitative and 
quantitative magnetic resonance perfusion (MR) analysis. 
Methods and Materials: Pubmed, WebOfScience, and Embase were 
systematically searched using the following eligibility criteria: study domain - 
patients with known or suspected CAD. Index test - quantitative or semi-
quantitative MR perfusion. Reference standard - ICA+/-FFR or QCA. Outcome 
- diagnostic accuracy of index test compared to reference standard. Study 
design - observational. The summary measures used to assess diagnostic 
accuracy were sensitivity, specificity, and area under the receiver operating 
curve (AUC). Data were pooled according to analysis territory, reference 
standard and perfusion parameter. Significant heterogeneity was defined as Q-
statistic <0.10 and/or I2 of >50%. 
Results: After removal of duplicates 1967 articles were screened based on 
title and abstract. 137 articles were selected for full text assessment and 22 
studies were included in the final analysis. Pooled diagnostic accuracy for 
segment-, territory- and patient-based analyses showed good diagnostic 
performance with sensitivity of 0.88, 0.82, and 0.83, specificity of 0.72, 0.83, 
and 0.76 and AUC of 0.90, 0.84, and 0.87, respectively. Only per territory 
analysis pooled sensitivity, per territory anatomical reference standard 
sensitivity and per territory semi-quantitative specificity did not show significant 
heterogeneity. 
Conclusion: Overall, the diagnostic performance of both semi-quantitative and 
quantitative MR perfusion analysis is quite good. However, the real clinical 
value of semi-quantitative and quantitative MR perfusion analysis remains 
uncertain due to extensive inter-study heterogeneity and large differences in 
MR perfusion acquisition protocols, reference standards, and methods of 
assessment of myocardial perfusion parameters.  
B-1156 11:19  
Compressed sensing real-time cine imaging in patients with cardiac 
arrhythmia: does it help to reduce mistriggering artefacts?  
P.-E. Allard1, A. Bridoux1, B. Longere1, V. Silvestri1, M. Schmidt2, C. Forman2, 
F. Pontana1; 1Lille/FR, 2Erlangen/DE (pauledouardallard@hotmail.fr)  
Purpose: To evaluate the impact of a compressed sensing (CS) real-time 
prototype cine sequence (sparse 2D cine, Siemens Healthineers) on 
mistriggering artefacts in patients with arrhythmia, in comparison with the 
reference cine-imaging technique. 
Methods and Materials: 71 consecutive patients (41 males; mean 
age=59±20.6 years), referred for cardiac magnetic resonance (CMR) 
examination with concomitant irregular heart rate (defined by R-R interval 
variation >10%), were prospectively enrolled. For each patient, a standard 
segmented multi-breath-hold steady-state free precession (bSSFP) sequence 
(Group 1) and a real-time CS single-breath-hold prototype sequence (Group 2) 
were systematically acquired. Two radiologists independently assessed 
mistriggering artefacts, objective and subjective image quality for both 
acquisition techniques. 
Results: The mean heart rate variation was 38% ±22.6 (range: 12-122). A total 
of 599 cine slices were evaluated in each Group (mean number of slices per 
patient=8.4 ±1.9). The number of slices with mistriggering artefacts per patient 
was higher in Group 1 than in Group 2 (7.2 ±2.4 vs 0.03 ±0.08, p<0.0001). The 
European CMR registry standardised artefact score was lower in Group 2 than 
in Group 1 (1.6 ±1.5 vs 2.9 ±0.5, respectively, p<0,0001). Subjective image 
quality score was improved in Group 2 compared to Group 1 (2.6 ±0.7 vs 1.9 
±0.8, respectively, p<0.0001). 
Conclusion: Compressed sensing real-time cine imaging drastically reduces 
mistriggering artefacts and improves image quality of CMR cine acquisition in 
patients with arrhythmia.  
Author Disclosures: 
 M. Schmidt: Employee; Siemens Healthcare. C. Forman: Employee; 
Siemens Healthcare. 
B-1157 11:27  
Strain parameters for the right ventricle in cardiac MRI: the forgotten 
child?  
S. Benz, M.C. Halfmann, J. Eichstädt, A. Lollert, C. Düber, K.-F. Kreitner, 
T. Emrich; Mainz/DE (sbenz@students.uni-mainz.de)  
Purpose: Since the original work from Zerhouni et al. in 1988, strain analysis 
in cardiac magnetic resonance (CMR) imaging has been dwelling under the 
surface of clinical routine. Recently, through the development of post-
processing approaches such as feature tracking, strain analysis is in the focus 
of interest. In a meta-analysis by Vo et al., only 9 out of the 17 publications 
included the right ventricle by just measuring global longitudinal strain (GLSRV). 
The purpose of our study was to establish the reference values of the RV in 
healthy volunteers. 
Methods and Materials: In this study, 62 healthy volunteers underwent CMR 
imaging at 3T (Magnetom Skyra®, Siemens Healthineers). We manually traced 
the endocardial and epicardial contours for both late systolic and diastolic 
phases in both ventricles on the short- and long-axis cine images. The 
software (CVI42 Circle®) then subsequently tracked the movement of these 
contours. 
Results: We measured all three strains for both ventricles, leading to the 
following values for right ventricle: global radial strain (GRSRV) 13.47% (± 6.46), 
global circumferential strain (GCSRV) -7.61% (± 3.92) and median global 
longitudinal strain (GLSRV) -24.35% (± 5.22). There was a significant difference 
  






between GLSRV in the present study from the pooled mean value of meta-
analysis. 
Conclusion: The amount of variance between our and the published data 
might be explained by the use of different tracking softwares and the absence 
of standardized protocols. However, there is a need for establishment of those 
as a basis for assessment of RV strains in cardiac diseases in future studies.  
B-1158 11:35  
Global and segmental cardiac magnetic resonance tissue tracking of 
hypertrophic cardiomyopathy: how do hypertrophy and fibrosis 
contribute to myocardial deformation?  
R.-Y. Shi, R. Wu, D. An, B. Chen, L. WU, J.-R. Xu; Shanghai/CN 
(ryshicn@hotmail.com)  
Purpose: In hypertrophic cardiomyopathy (HCM), both heterogeneous left 
ventricular hypertrophy and focal fibrosis influence regional deformation. The 
goal of this study was to assess global strain, native T1 and extracellular 
volume (ECV) changes to differentiate the extent of hypertrophy, and to 
measure the contribution of hypertrophy and fibrosis in segmental strain 
deformation. 
Methods and Materials: Forty early-stage HCM patients were examined by a 
3.0 Tesla magnetic resonance scanner. We analysed circumferential, 
longitudinal and radial strain, systolic and diastolic strain rates using 2D and 
3D modes. Native T1, ECV values and focal fibrosis were assessed. The 
generalised equation estimating (GEE) module was applied to evaluate in 
segmental levels. 
Results: At the global level, ECV significantly correlated with conventional LV 
function and strain parameters, but not native T1 values. Global strain 
parameters in 3 directions were found to correlate best with the extent of 
hypertrophy (LV mass/ BSA). At the segmental level, LGE presence 
significantly correlated with segmental hypertrophy (P < 0.0001). The GEE 
module suggested that LGE presence and segmental hypertrophy (thickness  
15mm) were observed antagonistic in 2D radial strain (beta = 12.756, P = 
0.006) and diastolic radial strain rate (beta = 1.314, P = 0.005). 
Conclusion: Subtle LV deformations can be observed and measured by strain 
before the manifestation of LV functional changes. Our study demonstrated 2D 
CS is a stable global parameter correlated with LV functional and ECV 
changes. At the segmental level, hypertrophy and LGE presence are 
antagonistic in 2D RS and diastolic RSR.  
B-1159 11:43  
Taking CMR strain into the next dimension  
S. Benz, M.C. Halfmann, J. Eichstädt, A. Lollert, C. Düber, K.-F. Kreitner, 
T. Emrich; Mainz/DE (sbenz@students.uni-mainz.de)  
Purpose: Cardiac magnetic resonance (CMR) imaging and post-processed 
tissue tracking are evolving for characterisation of a wide variety of 
pathologies. Though the images are captured two-dimensionally, tissue 
tracking algorithms allow for accurately visualised and measured 3D 
movements. We therefore analysed similarities and differences between 2D 
and 3D strain analysis. 
Methods and Materials: CMR was performed on 62 healthy volunteers at 3T 
(Magnetom Skyra®, Siemens Healthineers). Based on cine images, 
endocardial and epicardial contours were manually traced on late systolic and 
diastolic images in both ventricles. This comprised multiple slices in the short 
axis and four chamber views for both ventricles, respectively two chamber view 
for the left ventricle. The tissue tracking software (CVI42 Circle®) then 
subsequently tracked the movement of the drawn contours and calculated 2D 
and 3D strain parameters. 
Results: We found significant differences between 2D and 3D in global values 
concerning radial and longitudinal strains (p < .0001, respectively), while the 
circumferential strain was not significantly different. After adjusting for gender 
and age we were not able to explain the differences. 
Conclusion: Due to the complex myocardial architecture and the three-
dimensional movements of the heart, it appears plausible that the 3D strain 
comes closer to measuring the physiological motion. Therefore we suggest 
adding it to standard protocol, especially as long as superiority of either 2D or 
3D strains has not been proven. Furthermore, there is a need for general 
standardisation in CMR tissue tracking.  
B-1160 11:51  
Age and sex dependency of myocardial strain in CMR: an urgent need to 
standardise  
M.C. Halfmann, S. Benz, J. Eichstädt, A. Lollert, C. Düber, K.-F. Kreitner, 
T. Emrich; Mainz/DE (Moritz.Halfmann@gmx.de)  
Purpose: Data concerning feature tracking strain analyses are still rare. 
Therefore, it is difficult to perform reliable analyses of influencing factors. We 
aim at providing additional data to consolidate feature tracking cardiac 
magnetic resonance imaging (FT-CMR) as a method eligible for clinical use. 
Methods and Materials: We performed 62 FT-CMR examinations for the left 
and right ventricles in healthy volunteers using semi-automatic tracking 
software (CVI42 Circle®). The calculated global strain values were 
subsequently tested for influencing factors like age, sex and their combination 
using an analysis of variance (ANOVA). Post-hoc testing using the Bonferroni 
correction was performed for the various subgroup analyses. 
Results: The left ventricular global strains (radial, circumferential and 
longitudinal) both in 2D and 3D showed statistically significant differences with 
regard to sex but not with regard to age. The combination of both factors did 
not reveal a significant influence. Interestingly, in the right ventricle we found 
statistically significant differences of strain values between old and young 
individuals, while sex had a smaller impact. Again, the combination of the 
subgroups did not yield any significant results. 
Conclusion: Our results contrast those of a recently published meta-analysis 
of Vo et al., where sex or age did not have a significant influence. These 
differences might be explained by use of different software, number of slices 
used for tracking and measured strain parameters. This shows the urgent need 
of standardisation for feature tracking algorithms before we can effectively 
employ FT-CMR in clinical routine.  
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B-1161 10:39  
Establishing age-specific reference values of lung volume in preterm 
born infants using MR-based volumetry  
G. Negrao de Figueiredo, F. Schöppe, A. Pomschar, K. Förster, A. Hilgendorff, 
S. Stöcklein, B. Ertl-Wagner; Munich/DE (giofigueiredo@yahoo.de)  
Purpose: Although reference values of total lung volume (TLV) exist for foetal 
MRI, age-specific normal values of TLV in preterm infants based on MRI are 
not yet available. We aimed to evaluate the influence of gestational age (GA) 
at birth, and severity of bronchopulmonary (BPD) on TLV in preterm infants 
establishing age-specific values of TLV. 
Methods and Materials: 38 preterm neonates with no (n=20) and mild (n=18) 
BPD (grades 0 and 1, respectively) were evaluated. GA at scan ranged 
between 34 and 38 gestational weeks (GW) and GA at birth from 24 to 31 
weeks. The whole lung was segmented manually on axial T2w images. TLV 
across BPD grades was compared using the t-test. Multivariate linear 
regression was used to evaluate the influence of GW at birth, at scan and BPD 
grade on TLV. 
Results: The median (IQR) TLV was 56.76cm3 (47.07-68.12). There was no 
significant difference in TLV between BPD 0 vs. 1 (P=0.987). Neither GW at 
birth, nor BPD grade had a significant influence on TLV (P=0.637 and 
P=0.958). Only GW at scan was significantly associated with TLV (P=0.015). 
Therefore, reference values for GA at scan around term (36±2 weeks) were 
established. The TLV increased with GW at scan, with the median TLV ranging 
from 48.71cm3 at 34 GW to 78.11cm3 at 38 GW. 
Conclusion: We demonstrated that manual MR-based volumetry of TLV in 
preterm neonates is a feasible approach. The established age-specific 
reference values of TLV may provide an important basis to detect alterations of 
TLV.  
B-1162 10:47  
Towards an elastographic atlas of the neonatal brain  
E.F. Garces Iñigo, L. Marti-Bonmati, R. Llorens, M. Vento Torres; Valencia/ES 
(engari@alumni.uv.es)  
Purpose: To define the normal elasticity values of the grey and white matter in 
the neonate. 
Methods and Materials: Randomised healthy term new born neonates were 
recruited from our maternity ward between their 2nd and 3rd day of live. A total 
of 57 cerebral ultrasound elastography were archived. All examinations were 
performed using a Siemens Acuson S2000 ultrasound system with a 
multifrequency 4-9 MHz probe. In all cases, a quantitative shear wave imaging 
method (Virtual Touch TM Imaging Quantification) was applied. Protocol 
included bilateral sagittal planes of the thalamus and of the corona radiata. 
  






Elastograms with at least 5 non-overlapping quantitative measurements were 
obtained from each anatomic location. 
Results: Statistical analysis was made from a total of 1.885 quantitative 
measurements of the shear wave velocity (493 from right thalamus, 513 from 
left thalamus, 434 from right corona radiata and 445 from left corona radiata). 
The estimated mean value of the velocity in the thalamus is 1,184 m/s with a 
IC95% [1,147 - 1,221] and that of the corona radiata is 1,608 m/s with a IC95% 
[1,573 - 1,642]. No significant association was found with laterality, gestational 
age, cephalic perimeter, sex, height, or type of delivery. 
Conclusion: There is a clear difference in the elasticity of the grey and white 
matter in healthy term neonates. Knowledge of the normal values is essential 
since changes from normal elasticity are expected in pathological tissues.  
B-1163 10:55  
Respiratory distress syndrome in neonates-comparison between lung 
ultrasound and chest x-ray  
I. Sefic-Pasic, A. Džananovic, M. Bukvic, S. Terzic, M. Agovic, 
S. Vegar-Zubovic; Sarajevo/BA (irmina.sefic@gmail.com)  
Purpose: The aim of this paper is to introduce basic principles of lung 
ultrasonound, technique and ultrasound findings in neonatal respiratory 
distress syndrome and to compare it with chest X-ray. 
Methods and Materials: Lung ultrasound examinations were performed 
prospectively in 49 neonates (25 boys, 24 girls) with positive clinical and 
laboratory signs of respiratory distress syndrome and ultrasound findings were 
compared with chest X-ray. All ultrasound examinations were performed with a 
high frequency linear-array probes of 7,5 and 10 MHz. Interpretation of findings 
have been done by two radiologists. Interpretation of chest x -ray was based 
on 4-grade scale and ultrasound findings were classified into 3-stage profiles. 
Results were compared with statistical analysis. 
Results: In the cohort of 49 patients we calculated Pearson Correlation 
Coefficient and the value of R was -0.5161. This is a moderate negative 
correlation , but these results correlate with grading system of RDS (respiratory 
distress syndrome) - high x-ray score and low ultrasound score refers to most 
severe grade of RDS and vice versa. Sensitivity of ultrasound was 98,4% and 
PPV 93%. We have found pathological findings on ultrasound presented with 
confluent B-lines-white lungs, subpleural consolidation of lung parenchyma, 
pneumothorax, abnormalities of pleural line and A lines in resolution of 
disease. 
Conclusion: Lung ultrasonound is a reliable tool for diagnosing and follow up 
of respiratory distress syndrome in neonates. Introducing lung ultrasound in 
diagnostic algorithm, number of x-ray examinations can be decreased and 
exposure of neonates to ionizing radiation.  
B-1164 11:03  
The role of lung ultrasound in the differential diagnosis of respiratory 
distress syndrome and transient tachypnoea in preterm and newborn 
infants  
M. Mughetti1, G. Gardelli1, E. Giampalma1, M. Zompatori2; 1Cesena/IT, 
2
Bologna/IT (martinamughetti@gmail.com)  
Purpose: Respiratory distress syndrome (RDS) and transient tachypnoea 
(TTN) are the most common causes of respiratory distress in premature and 
newborn infants. The diagnosis of RDS and TTN is based on clinical diagnosis 
and chest x-ray, but sometimes these entities show overlapping radiographic 
patterns. For this reason, pulmonary ultrasound is emerging as a reliable 
diagnostic tool to integrate radiography. The aim of our study was to evaluate 
the role of pulmonary ultrasonography in the differential diagnosis of RDS and 
TTN in the newborn. 
Methods and Materials: From September 2016 to June 2017, 62 preterm or 
newborn infants with respiratory distress admitted to the Neonatal Intensive 
Care Unit were studied with chest x-ray and lung ultrasound. 
Results: The white lung was demonstrated exclusively in patients with RDS (p 
= 0,000) and the simultaneous presence of a white lung and pleural 
irregularities and absence of spared areas showed high specificity (100%) and 
discrete sensitivity (76%) in identifying RDS. The double lung point was 
detected in both lung fields in 16 out of 21 TTN patients and in no patients with 
RDS (p = 0,000), exhibiting 100% sensitivity, 76% sensitivity, 100% positive 
predictive value and 88% negative predictive value. 
Conclusion: The results of this study show that pulmonary ultrasound is a 
reliable and accurate tool for the differential diagnosis of RDS and TTN. 
However, chest RX remains the first-level diagnostic tool and can be integrated 







B-1165 11:11  
Italian guidelines for diagnostic exposure in neonatal intensive care units  
A. del Vecchio1,1, S. Salerno1,2, M. Barbagallo3,1, M. Campoleoni1,1, 
V. Cannatà4,1, G. Chirico1,5, C. Granata1,6, A. Loria1,1, A. Magistrelli1,4; 1Milan/IT, 
2
Palermo/IT, 3Catania/IT, 4Rome/IT, 5Brescia/IT, 6Genoa/IT 
(loria.alessandro@hsr.it)  
Purpose: In the recent years, clinical progress and better medical assistance 
for pregnant women, together with the introduction of sophisticated 
technologies, have improved the survival of preterm infants. However, this 
result requires frequent radiological investigations mostly represented by 
thoracic and abdominal radiographs in incubators.The aim of this document is 
to help public and private health-care operators in taking choices involving 
radiation exposures of newborns. 
Methods and Materials: The guideline has been written and shared by four 
scientific societies: AIFM (Italian Association of Physics in Medicine), SIN 
(Italian Neonatology Society), SIP (Italian Paediatric Society), and SIRM 
(Italian Medical Radiology Society) to guarantee good standard practices for 
every professional involved in neonatal intensive care units (NICUs). The 
report is divided into clinical and physical dosimetric sections as follows: clinical 
indications (thorax x-ray indications; abdominal x-ray indications); good 
practice in radiological exposures (devices; exposure parameters and 
modalities; x-ray field collimation; patient positioning and immobilisation; 
diagnostic reference levels); radiation protection (patient, operators and 
environmental protection; shieldings); incubators (commercial incubators and 
their characteristics; the results of attenuation measurements). 
Results: Taking into account the experience and expertise of 10 Italian 
centres, the guideline set out the criteria to ensure a high standard of neonatal 
care in NICU about procedures, facilities, recommended equipment, quality 
assurance, radiation protection measures for children and staff members and 
communication on radiation risk. 
Conclusion: This document will allow a standardisation of the approach to the 
exposures in NICU.  
B-1166 11:19  
Magnetic resonance imaging of congenital lung lesions  
C. Amaxopoulou1, J. Geiger1, P. Grehten1, R. Gnannt2, P. Bode1, U. Moehrlen1; 
1
Zurich/CH, 2Zollikerberg/CH (camaxopulu@hotmail.com)  
Purpose: To evaluate the performance of magnetic resonance imaging (MRI) 
for assessment of congenital pulmonary malformations. 
Methods and Materials: Retrospective review of consecutive lung MRI 
performed (2013-2017) in 29 children (median age 0.4y, range 2d-15y) for 
suspected congenital lung anomalies with detection of 31 lesions: congenital 
pulmonary airway malformation (n=15), sequestration (n=3), hybrid lesion 
(n=3), hypogenetic lung syndrome (n=3), congenital lobar hyperinflation (n=3), 
bronchogenic cyst (n=1), and bronchial atresia (n=3). Respiratory-gated fast-
spin-echo and dynamic contrast-enhanced images obtained at 1.5 T (free-
breathing) were assessed for parenchymal, vascular and perfusion 
abnormalities. MRI findings were compared to results obtained from computed 
tomography (CT) and pathology following surgery. 
Results: Lung parenchyma was delineated as normal (n=5; 16%), solid (n=8; 
26%), cystic (n=13; 42%), hyperinflated (n=6; 19%), or mixed (n=7; 23%). 
Mucus plugs were seen in 5 cases. Systemic arterial supply was evident in 10 
cases, systemic or anomalous venous drainage in 7 cases. All parenchymal 
lesions showed altered perfusion, either defects (n=22;71%), delayed systemic 
perfusion (n=8;26%) or both (n=2;7%). Perfusion was helpful for lesion 
characterization in 18 cases (58%). Parenchymal findings were confirmed by 
CT in 11/11 cases. The type of congenital lesion was verified by pathological 
findings in 17/17 cases. No correlation is available in 13 patients managed 
conservatively and in 2 patients awaiting surgery. 
Conclusion: A dedicated MRI lung protocol is able to reliably delineate not 
only vascular but also parenchymal abnormalities. As characterization of 
congenital lung lesions has become feasible, lung MRI should be considered 
as radiation-free alternative to CT for evaluation of these lesions.  
B-1167 11:27  
The meconium sign in foetal MRI performed for the diagnosis of 
diaphragmatic hernia  
C. Sofia1, M. Tropea1, L. Di Grazia1, P. Spillare1, N. Boscolo Bariga1, 
M. Marino2, A. Tregnaghi1; 1Venice/IT, 2Messina/IT (carm.sofia@tiscali.it)  
Purpose: To assess the presence of T1 hyperintensity due to meconium in the 
herniated bowel of foetuses with diaphragmatic hernia.Background: Meconium 
is the material retained in the intestine of foetus from the 13 weeks gestation. It 
is composed of paramagnetic substances as minerals (Fe, Mn and Mg) and of 
free fatty acids, carbohydrates and minerals that explain its hyperintense signal 
on T1 sequences. Meconium slowly migrates from the small bowel to the colon 
and rectum, increasing in T1 brightness and amount throughout the gestation. 
  






Methods and Materials: 56 foetal MRI examinations were reviewed by two 
different readers, with different expertise in foetal MRI, in consensus. All the 
examinations were performed using both T1 and T2 weighted acquisitions. 
Among the studies 9 diaphragmatic hernias were found. Intestine filled with 
meconium was considered present in the thorax when a bowel-shaped T1 
hyperintensity was seen. The final diagnosis was made by surgical or 
pathological follow-up. Sensitivity and specificity of the “meconium” sign as 
diagnostic feature for diaphragmatic hernia were calculated. 
Results: 8 foetuses showed the meconium sign. In one case of diaphragmatic 
hernia no bowel-shaped T1 hyperintensity was seen in the thorax. The 
sensitivity and specificity of meconium sign alone in the diagnosis of 
diaphragmatic hernia were 88.89 and 100 %. 
Conclusion: Meconium sign can reliably detect diaphragmatic hernia in foetal 
mri examinations. However, the evaluation of all the other MRI diagnostic 
criteria and features is mandatory.  
B-1168 11:35  
Fetal-MRI based segmentation of the diaphragm in fetuses with 
congenital diaphragmatic hernia: a retrospective pilot study  
F. Prayer, W. Krois, M. Metzelder, G. Kasprian, P. Brugger, G.M. Gruber, 
M. Weber, D. Prayer, J.M. Patsch; Vienna/AT (florian.prayer@gmail.com)  
Purpose: Characterization of congenital diaphragmatic hernia (CDH) type and 
extent during fetal development may provide an opportunity for personalised 
therapy planning. This pilot study investigates the feasibility of fetal MRI-based 
manual diaphragmatic segmentation in fetuses with CDH. 
Methods and Materials: Routine fetal MRI data of 22 fetuses with CDH (GW 
22-36), who later underwent diaphragmatic repair surgery, were utilised to 
perform manual segmentation of the diaphragm and diaphragmatic defect 
using ITK-SNAP. Three-dimensional visualisation and surface area 
measurements of the normal diaphragm and diaphragmatic defect were 
obtained. Ratios of diaphragmatic and diaphragmatic defect surface areas, as 
well as diaphragmatic defect surface area and lung volume were calculated. 
Three-dimensional visualistions and surface area measurements were used to 
determine type and size of the diaphragmatic defect, and findings were 
compared with information extracted from diaphragmatic repair surgery reports 
regarding diaphragmatic defect location, size, and possible use of a patch. 
Results: Diaphragmatic segmentation, subsequent three-dimensional 
visualisation and diaphragmatic (defect) surface area measurements were 
feasible in 20 of 22 (90.91%) fetuses with CDH. In two cases diaphragmatic 
segmentation was not possible due to excessive fetal movement. Findings 
regarding diaphragmatic defect type and size showed good accordance with 
information extracted from diaphragmatic repair surgery reports. 
Conclusion: Fetal MRI-based diaphragmatic segmentation is feasible in a 
majority of CDH cases. Three-dimensional visualisation and surface area 
measurements of the diaphragm and diaphragmatic defect may support 
therapeutic decision-making and promote a personalised approach in CDH.  
B-1169 11:43  
Post-mortem magnetic resonance imaging appearances of foeticide in 
perinatal deaths  
S.C. Shelmerdine, M. Hickson, N.J. Sebire, O.J. Arthurs; London/UK 
(susie_c_s@yahoo.co.uk)  
Purpose: Determine the imaging features of foeticide at post-mortem MRI 
findings to eliminate confusion at post-mortem where mode of death is 
unknown. 
Methods and Materials: A retrospective review over a 5.5-year period was 
performed comparing two groups of post-mortem foetal cases, cases which 
underwent termination of pregnancy matched to a group of controls which had 
undergone spontaneous miscarriage or stillbirth. The groups were matched 
according to gestational ages, weight and time since death. Two readers 
blinded to the patient’s antenatal history recorded the presence of gas, blood 
and fluid in different body compartments. Statistical analysis was conducted 
using a Fisher's exact test. 
Results: 26 cases of foeticide (mean age 25wks (range: 20 - 36)) and 75 non-
terminated foetuses (mean GA 26.7wks (19 - 36)) were compared. A higher 
proportion of foeticide cases had pneumothoraces (23.1% vs 1.3%, p= 0.001), 
haemothoraces (42.3% vs 4%, p = 0.001), pneumopericardium (30.8% vs 
5.3%, p = 0.002) and haemopericardium (34.6% vs 0%, p = 0.0001) compared 
to controls. The presence of intracardiac gas and abdominal findings (ascites, 
haemoperitoneum and free gas) were higher in the foeticide group but did not 
reach statistical significance. Pericardial and pleural effusions and soft tissue 
oedematous changes were not statistically different and are likely to represent 
post-mortem change. 
Conclusion: Characteristic imaging features of foeticide can help the reporting 
radiologist differentiate iatrogenic from physiological and pathological causes 
of body fluid and gas disturbance on post-mortem perinatal MRI.  
 
B-1170 11:51  
High-resolution isotropic diffusion-weighted imaging in neonatal death 
investigation  
S.C. Shelmerdine, A. Mcdowell, D. Carmichael, O.J. Arthurs; London/UK 
(susie_c_s@yahoo.co.uk)  
Purpose: To develop/assess a new multi-band diffusion imaging at 3T for 
perinatal post-mortem MRI (PMMR). 
Methods and Materials: We acquired PMMR brain and body imaging in 7 
neonates, mean gestational age 33 weeks (range 30-37 weeks) at 3T. Whole-
body 3T quantitative DWI imaging scan parameters were TE 53.4ms; TR 
5600ms; voxel size 1.8mm isotropic; multi-band factor 2. One unweighted 
image and four diffusion-weighted images at b=250, 750, 1250 and 1750smm-2 
with gradients applied in 12 uniformly distributed directions, and a reversed 
phase encoding scan were acquired and corrected for distortion. Image quality 
was scored by one radiologist blinded to acquisition technique on a visual 
analogue scale (1 to 5, unacceptable to excellent, respectively) at individual b 
values and on combined b-score mean diffusivity (MD) map. 
Results: There was good image quality for the multiband, multislice DWI 
PMMR, attributable to increased resolution and signal-to-noise ratio. The 
average mean quality score increased with increasing b values with score of 
2.7 for b=250, 3.6 for b=750, 4.1 for b=1250, 4.7 for b=1750 and 4.9 for 
combined b-value map. This improved quality allowed separation between 
average MD and fractional anisotropy signal values in all major body organs at 
3T. 
Conclusion: Multi-slice multi-band quantitative DWI is feasible for whole-body 
perinatal post-mortem imaging. Our optimised sequence utilising higher field 
strength and gradient performance gave improved whole-body isotropic high-
resolution imaging compared to the current clinical approach, reducing partial 
volume effects and allowing detailed future PMMR investigation.  
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B-1171 10:39  
Orthotopic lung cancer: molecular imaging-monitored intratumoural 
radiofrequency heat-enhanced HSV-TK gene therapy  
Q. Weng1,2, F. Zhang1, F. Xiong1, Y. Jin1, J. Song2, M. Chen2, J. Hui2, J. Ji2, 
X. Yang1; 1Seattle, WA/US, 2Lishui/CN (wengqy99@gmail.com)  
Purpose: To validate the feasibility and efficacy of intratumoural 
radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus thymidine 
kinase (HSV-TK)/ganciclovir (GCV) gene therapy for non-small cell lung cancer 
(NSCLC). 
Methods and Materials: Animal protocols were approved by the Institutional 
Animal Care and Use Committee. The study included: (1) in vitro experiments 
using human NSCLC cells to establish the “proof of principle” of the new RFH-
enhanced HSV-TK/GCV gene therapy; (2) in vivo experiments using mouse 
models with NSCLC to further demonstrate the principle; and (3) in vivo 
experiments using rat models with orthotopic NSCLC to validate feasibility of 
the new technique. Cells and animals were divided into four groups 
(n=6/group): (i) combination therapy (HSV-TK/GCV gene therapy plus RFH); 
(ii) RFH alone; (iii) HSV-TK/GCV gene therapy; and (iv) PBS. Molecular 
imaging findings were confirmed by subsequent pathology. 
Results: For the in vitro experiments, the confocal microscopy, MTS assay, 
and bioluminescent imaging demonstrated significantly diminished viable cells 
and cell proliferation with the combination therapy, compared to the other three 
treatments (P<0.05). For the in vivo experiments, the optical and/or ultrasound 
imaging demonstrated significantly decreased relative bioluminescence signals 
and sizes of tumours, respectively, with the combination therapy, compared to 
other treatments (P<0.05). These results were confirmed with pathology. 
Conclusion: This study demonstrates the feasibility and efficacy of 
intratumoural RFH-enhanced HSV-TK/GCV gene therapy for NSCLC, as 
guided and monitored by molecular imaging. This technical development may 
introduce a new paradigm for effective management of unresectable lung 
cancer by integrating the advantages of interventional molecular imaging, RF 
technology, and direct intratumoural gene therapy.  
  






B-1172 10:47  
Radiofrequency hyperthermia-enhanced intratumoral herpes simplex 
virus-thymidine kinase (HSV-TK) gene therapy of ovarian cancer: 
monitored by ultrasound and optical imaging  
Y. Li1, F. Zhang2, S. Zhao2, G. Jin3, L. Zhao4, Y. Zhou2, P. Li2, X. Yang2; 
1
Guiyang/CN, 2Seattle, WA/US, 3Shanghai/CN, 4Wenzhou/CN 
(Liyaying1120@163.com)  
Purpose: To investigate the feasibility of using imaging-guided RF 
hyperthermia (RFH) to enhance intratumoural HSV-TK/ganciclovir (GCV) 
suicide gene therapy of ovarian cancers, monitored by optical and ultrasound 
imaging. 
Methods and Materials: Human ovarian cancer cells (SK-OV-3) labelled with 
luciferase/lentivirus and rats with luciferase-positive orthotopic ovarian cancers 
in four groups received different treatments: (i) combination treatment with 
HSV-TK/GCV-mediated gene therapy plus RFH; (ii) gene therapy; (iii)RFH and 
(iv) control. MTS assay and confocal microscopy were used to evaluate the cell 
viability. Bioluminescence optical and ultrasound imaging were used to monitor 
the changes of tumour size and bioluminescence signal intensities at different 
time points. The imaging findings were correlated with subsequent pathology 
confirmation. 
Results: MTS assay demonstrated the lowest cell proliferation in the group 
with combination therapy, compared with three control treatments (41.0% vs 
47.8% vs 97.3% vs 100%), as corresponded to the smallest number of 
survived cells by confocal microscopy and the lowest bioluminescence signal 
by optical imaging. Ultrasound imaging showed the smallest relative tumour 
volume with combination therapy, compared with the other three groups (0.23 
vs 1.26 vs 5.43 vs 6.74). Bioluminescent optical imaging demonstrated a 
significantly decreased relative bioluminescence signal in combination therapy, 
compared with the other three treatments (0.35 vs 1.26 vs 3.43 vs 3.90). Both 
imaging findings were confirmed by pathology, demonstrated as the 
significantly increased apoptotic cells in the combination therapy group. 
Conclusion: Image-guided intratumoural RFH could enhance HSV-TK/GCV 
gene therapy of rat ovarian cancers, which provides a new opportunity for 
effectively managing ovarian cancers.  
B-1173 10:55  
In vivo tracking of the tropism of mesenchymal stem cells to malignant 
gliomas using reporter gene-based MR imaging  
M. Cao; Guangzhou/CN (caominghui1019@163.com)  
Purpose: Mesenchymal stem cells (MSCs) have emerged as a promising 
cellular vehicle for gene therapy of malignant gliomas due to their property of 
tumour tropism. However, MSCs may show bidirectional and divergent effects 
on tumour growth. Therefore, a robust surveillance system with a capacity for 
noninvasive monitoring of the homing, distribution and fate of stem cells in vivo 
is highly desired for developing stem cell-based gene therapies for tumours. 
Methods and Materials: In this study, we used ferritin gene-based magnetic 
resonance imaging (MRI) to track the tumour tropism of MSCs in a rat 
orthotopic xenograft model of glioma. MSCs were transduced with lentiviral 
vectors expressing ferritin heavy chain (FTH) and enhanced green fluorescent 
protein (eGFP). Intra-arterial, intravenous and intertumoural injections of these 
FTH transgenic MSCs (FTH-MSCs) were performed in rats bearing intracranial 
C6 gliomas. 
Results: The FTH-MSCs were detected as hypointense signals on T2- and 
T2*-weighted images on a 3.0 T clinical MRI. After intra-arterial injection, 17% 
of FTH-MSCs migrated toward the tumour and gradually diffused throughout 
the orthotopic glioma. This dynamic process could be tracked in vivo by MRI 
up to 10 days of follow-up, as confirmed by histology. Moreover, the tumour 
tropism of MSCs showed no appreciable impact on the progression of the 
tumour. 
Conclusion: These results suggest that FTH gene-based MRI can be used to 
reliably track the tropism and fate of MSCs after their systemic transplantation 
in orthotopic gliomas. This in vivo tracking system will facilitate the 
development of stem cell-based therapies for malignant gliomas.  
B-1174 11:03  
Tumour microenvironment-responsive intelligent nanocomposites for 
efficient theranostics of glioma  
H. Liu, W. Zhang; Chongqing/CN (303609940@qq.com)  
Purpose: To evaluate the applicability of an intelligent nanocomposite for 
tumour microenvironment (TME)-responsive multi-modality imaging and 
enhanced photodynamic therapy of glioma in vivo. 
Methods and Materials: Bovine serum albumin (BSA)-stabilized manganese 
dioxide (MnO2) and gold nanoclusters (AuNCs) hybrid nanocomposites (BSA-
MnO2-AuNCs, BMANCs) were synthesized via a facile and environmentally 
friendly one-pot biomineralization approach. The response of BMANCs to 
acidic hydrogen peroxide (H2O2) was evaluated in vitro. The applicability of 
BMANCs for MRI/NIRF/CT multi-modality imaging was performed in glioma-
bearing nude mice. The efficacy of BMANCs on TME regulation tumour and 
photodynamic therapy were also investigated. 
Results: BMANCs with suitable size, desirable water dispersibility and 
excellent biocompatibility were prepared. The AuNCs exhibited an intense red 
fluorescence (Ex/Em=520/720 nm) and a satisfactory CT contrast ability. The 
high reactivity of MnO2 towards endogenous H2O2 within the acidic TME could 
release Mn2+ ions and realize TME-responsive MR imaging. Owing to the 
efficient tumour accumulation of BMANCs and generated O2 in situ resulting 
from the reaction between MnO2 and H2O2, tumour hypoxia, acidification and 
tumour angiogenesis were effectively alleviated. Furthermore, the BMANCs 
exhibited remarkably enhanced photodynamic therapy than that of BSA-
AuNCs, due to the improved oxygenation at the tumour site. 
Conclusion: The as-prepared BMANCs hold great potential for 
comprehensive TME regulation and enhanced theranostics against hypoxic 
solid tumours.  
B-1175 11:11  
Fluorescence molecular imaging of infection and inflammation utilizing a 
novel probe specific for myeloperoxidase  
B. Pulli, C. Wang, G.R. Wojtkiewicz, J. Chen; Boston, MA/US 
(pulli.benjamin@mgh.harvard.edu)  
Purpose: Myeloperoxidase (MPO) is an important oxidative enzyme that is 
crucial for defence against pathogens, but also contributes to tissue damage in 
inflammation. We sought to develop a molecular imaging probe sensitive and 
specific to MPO that is suitable for fluorescence imaging applications. 
Methods and Materials: Sixteen female C57BL/6J (wild-type) mice and 6 
MPO-knockout mice were either injected subcutaneously with purified MPO, 
treated topically with PMA to induce irritant contact dermatitis, injected 
intracerebrally with Salmonella to induce brain abscess, or injected 
subcutaneously with Streptococcus pneumoniae to induce bacterial cellulitis. 6 
hours after induction, mice were injected with the MPO sensor or a non-
specific control analogue. Mice underwent fluorescence reflectance imaging. 
Brains were cut into sections on a cryotome, and immunohistochemistry for 
MPO was performed. 
Results: A linear increase in signal is observed with increasing concentrations 
of purified MPO (R2=0.991). In irritant contact dermatitis and bacterial cellulitis, 
increased fluorescence signal was detected in wild-type mice injected with 
MPO sensor (P<0.01). In MPO-knockout mice injected with MPO sensor and in 
wild-type mice injected with control analogue, no signal increase was 
detectable (P>0.05). In cerebral abscess, MPO activity (MPO sensor) was only 
observed within the abscess, whereas MPO protein (immunohistochemistry) 
was detected in adjacent brain areas as well. 
Conclusion: The fluorescent MPO sensor can specifically detect MPO activity 
in vivo at relevant biological concentrations. This was validated in mouse 
models of infection and inflammation. Importantly, we found that MPO activity 
does not always colocalize with MPO protein, differentiating between active 
and latent inflammation.  
B-1176 11:19  
Integrin-targeted multispectral optoacoustic tomography with MRI 
correlation for monitoring a BRAF/MEK inhibitor combination therapy in a 
murine model of human melanoma  
P.M. Kazmierczak, N.C. Burton, G. Keinrath, H. Hirner-Eppeneder, 
M. Schneider, R.S. Eschbach, M.F. Reiser, J. Ricke, C.C. Cyran; Munich/DE 
(Philipp.Kazmierczak@med.uni-muenchen.de)  
Purpose: To investigate v3-integrin-targeted multispectral optoacoustic 
tomography (MSOT) and MRI for monitoring a BRAF/MEK inhibitor 
combination therapy in a murine model of human melanoma. 
Methods and Materials: Human BRAF V600E-positive melanoma xenograft 
(A375)-bearing Balb/c nude mice (n=10) were imaged before (day 0) and after 
(day 7) a BRAF/MEK inhibitor combination therapy (encorafenib, 1.3 mg/kg/d; 
binimetinib, 0.6 mg/kg/d, Array BioPharma Inc.; n=5) or placebo (n=5), 
respectively. MSOT was performed on a preclinical system (inVision 256-TF, 
iThera Medical GmbH) unenhanced and 5 h after i. v. injection of an v3-
integrin-targeted fluorescent probe (IntegriSense 750, Perkin Elmer; 4 nmol). 
The v3-integrin-specific tumor signal was derived by spectral unmixing. T2w 
MRI data sets were acquired on a clinical 3 Tesla scanner (MAGNETOM 
Skyra, Siemens Healthineers). The imaging results were validated by 
multiparametric immunohistochemistry (ß3-integrin expression, CD31-
microvascular density, Ki-67-proliferation). 
Results: The v3-integrin-specific tumour signal was significantly reduced 
under therapy showing a unidirectional decline in all animals (from 7.98±2.22 to 
1.67±1.30; p=0.043). No significant signal change was observed in the control 
group (from 6.60±6.51 to 3.69±1.93; p=0.155). Immunohistochemistry revealed 
a significantly lower integrin expression (ß3: 0.20±0.02 vs. 0.39±0.05; p=0.008) 
and microvascular density (CD31; 119±15 vs. 292±49; p=0.008) in the therapy 
group. Tumour volumes increased with no significant intergroup difference 
(therapy: +107±42 mm3; control +112±44mm3, p=0.841). In vivo blocking 
  






studies using the v3-integrin antagonist cilengitide (Selleck Chemicals) 
confirmed the target specificity of the fluorescent probe. 
Conclusion: v3-integrin-targeted MSOT allowed for the early non-invasive 
monitoring of a BRAF/MEK inhibitor combination therapy in a murine model of 
human melanoma.  
Author Disclosures: 
  P.M. Kazmierczak: Grant Recipient; Förderprogramm für Forschung und 
Lehre, LMU. N.C. Burton: Employee; iThera Medical GmbH.  C.C. Cyran: 
Speaker; Speakers bureau Siemens Healthineers. 
B-1178 11:27  
Molecular MR imaging of myeloperoxidase reveals a new myeloid cell 
treatment effect of interferon-beta in experimental multiple sclerosis  
B. Pulli1, R. Forghani2, C. Wang1, G.R. Wojtkiewicz1, J. Chen1; 
1
Boston, MA/US, 2Montreal, QC/CA (pulli.benjamin@mgh.harvard.edu)  
Purpose: Treatment effects of interferon-beta (IFN) and glatiramer acetate 
(GA), two first-line agents used in multiple sclerosis (MS), are similar as 
evaluated by conventional MRI. We investigated the effects of these two drugs 
on myeloid cells with MPO-Gd, an activable molecular MR probe specific to the 
pro-inflammatory enzyme myeloperoxidase (MPO). 
Methods and Materials: Fifty female wild-type or MPO knockout mice were 
induced with EAE, a mouse model of MS, and treated with IFN (1 g/day), GA 
(150 g/day), MPO inhibitor ABAH (0.8 mg/day), or saline. The mice 
underwent MRI at 4.7T with MPO-Gd at disease peak (day 12). Lesion volume, 
number, contrast-to-noise ratio (CNR), and total MPO-Gd enhancement were 
quantified, and mechanistic in vitro experiments were performed. 
Results: MPO-Gd CNR (representing MPO activity in vivo) decreased after 
ABAH and IFN administration, but not with GA. Lesion volume, lesion number, 
and total MPO-Gd enhancement decreased with all three agents. These 
findings suggest that IFN may have the imaging signature of an MPO inhibitor. 
However, direct enzymatic inhibition was only found with ABAH. When isolated 
myeloid cells were stimulated to secrete MPO, IFN decreased MPO activity, 
similar to ABAH. Inhibition of superoxide anion production resulted in the 
restoration of MPO activity from stimulated cells. Spectrophotometry revealed 
that IFN destroys the iron-containing prosthetic group of MPO and thus 
inactivates the enzyme. 
Conclusion: Molecular imaging profiling revealed a novel myeloid cell-specific 
treatment effect of IFN, a first-line treatment of MS. IFN irreversibly inactivates 
MPO via a superoxide-dependent pathway, which improves clinical disease.  
B-1179 11:35  
Naluf4 for spectral CT in the diagnosis of osteoscarcoma  
Y. Jin, L. Gao, F. Han, Y. Lv, J. Zhang; Shanghai/CN (yingyingjin@yahoo.com)  
Purpose: To investigate the potential of spectral computed tomography (CT), 
used in combination with a Lutecium-based upconversion nanoparticles 
(UCNPs), for characterization of osteosarcoma and bone. 
Methods and Materials: Spectral CT which can enrich conventional CT 
images with the capability to image and quantify certain elements based on 
their distinctive Kedge energies was chosen as a powerful tool. Lutecium-
based upconversion nanoparticle (UCNPs) had higher spectral CT 
performance compared with clinically used iohexol. Spectral CT performance 
was investigated by testing gradient concentration of these contrast agents 
(CAs) in vitro. Balb/c nude mice were used as model for imaging osteosarcoma 
in vivo. Cellular uptake of Lutecium-based UCNPs was further evaluated by 
using confocal microscopy. Toxicity tests were also carried out including 
cellular toxicity tests, blood routine examinations, hepatorenal function, body 
weight and some other indexes. 
Results: Spectral CT enabled differentiation of Lutecium-based UCNPs, 
iohexol and bone. Different materials were presented as colorized voxels 
against the normal grayscale X-ray background, distinguishing the high 
attenuation of calcium from the osteosarcoma tumor tissues that contained the 
Lutecium-based CAs. The results of in vivo and in vitro experiments 
demonstrated that Lutecium-based CAs had higher spectral CT performance 
and could still be obviously observed at higher KeV (120-140 KeV) images 
while the signals of iohexol and bone were relatively weak. The toxicity was 
proven to be low which made it potential for clinical application in the future. 
Conclusion: Spectral CT imaging, combined with Lutecium-based CAs, 
provided a promising opportunity for effectively distinguishing bone and 
osteosarcoma in vivo.  
B-1180 11:43  
Ultrasound molecular imaging of breast cancer in mcf-7 orthotopic mice 
model using a novel dual-targeted ultrasound contrast agent  
L. Xu, F. Li, J. Du; Shanghai/CN (ly230502@163.com)  
Purpose: To prospectively evaluate ultrasound molecular imaging with dual-
targeted gold nanoshelled poly(lactide-co-glycolic acid) nanocapsules carrying 
p53 and vascular endothelial growth factor receptor type 2 (VEGFR2) 
antibodies (V&p53-PLGA@Au NCs) in MCF-7 orthotopic mice model. 
Methods and Materials: V&p53-PLGA@Au NCs were fabricated with an inner 
PLGA and outer gold nanoshell spherical structure. Its targeting capabilities 
were evaluated in targeted cells (HUVEC, MCF-7 cells) and control cells (4T1, 
MDA-MB-231 cells). Contrast-enhanced ultrasound imaging with V&p53-
PLGA@Au NCs was evaluated qualitatively and quantitatively in vitro and in 
MCF-7 orthotopic mice model by two different systems. The biodistribution of 
NCs in mouse was preliminarily investigated. Differences were calculated using 
analysis of variance. Expression of p53 and VEGFR2 in mice tumour tissues 
were tested with immunofluorescence. 
Results: The V&p53-PLGA@Au NCs showed well-defined spherical shape 
with the average diameter of 276.90±110.50 nm. In cell culture, targeted cells 
showed higher fluorescence signals and targeting rate than control cells 
(79.01±5.63% vs 2.11±1.07%, P<0.01; 75.54±6.58% vs 5.21±3.12%, P<0.01). 
In vivo, contrast-enhanced ultrasound imaging showed significantly higher 
video intensity when using V&p53-PLGA@Au NCs compared with non-
targeted NCs. There were more V&p53-PLGA@Au NCs in tumours in mice 
than non-targeted NCs (P<0.05). 
Conclusion: V&p53-PLGA@Au NCs are demonstrated to be novel dual-
targeted ultrasound molecular contrast agents and may have potential 
applications in early noninvasive visualization of breast cancer.  
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B-1181 10:30  
Evaluation of the differentiation in head and neck squamous cell 
carcinoma with PET/MR  
H. Dang, Y. Chen, Z. Jin, H. Xue, B. Hou, F. Li; Beijing/CN 
(shengdai23@126.com)  
Purpose: To preoperatively evaluate the performance of discrimination with 
integrated positron emission tomography/magnetic resonance imaging 
(PET/MR) in the tumour differentiation of head and neck squamous cell 
carcinoma(HNSCC). 
Methods and Materials: 18F-FDG PET imaging was performed with ToF 
method. MR imaging included the anatomic and functional sequences of T1-
weighted and T2-weighted imaging , diffusion-weighted imaging and dynamic 
contrast enhanced imaging. The values of standardise uptake value(SUVmean ) 
which was measured based on 42% contour lines, apparent diffusion 
coefficients(ADCmean), and the volume transfer coefficient (K
trans) were used as 
the qualitative analysis measurements. Pearson correlation coefficients were 
calculated between each pair of the three parameters. One-way ANOVA was 
used to evaluate the discrimination of each parameter among different 
differentiation groups. The PET/MR multi parameters were combined with 
Logistic Regression. ROC was used to evaluate the diagnostic efficiency of 
tumour differentiation with individual parameters and the combination of 
PET/MR. 
Results: Finally, a total of 23 subjects included in this study. The correlations 
between each of the three individual parameters are weak. The statistic 
differences are significant in different degrees of tumour differentiation for all 
three individual parameters, and the value of ADCmean is the best one. The 
accuracy of SUVmean , ADCmean and K
trans are 74.3%, 77.1%, 57.1%. The 
combination of PET/MR demonstrated an improved diagnostic efficiency with 
an accuracy of 85.7%. 
Conclusion: This preliminary integrated PET/MR study demonstrated that 
compared with the individual parameters of PET/MR, the combination of 
PET/MR can improve the diagnostic efficiency of tumour differentiation in 
HNSCC.  
B-1182 10:34  
Is it benign or malignant? Assessing isolated lymphadenopathy of the 
head and neck using textural analysis  
S. Chin, A. Kamalasanan, S. Henderson, T.A. Sudarshan; Dundee/UK 
(sookcheng@doctors.org.uk)  
Purpose: Isolated lymphadenopathy can be the only initial presentation of 
squamous cell cancer (SCC) of the head and neck. Accurate identification of 
benign lymphadenopathy from malignant nodal disease and lymphoma is 
difficult. Due to this, patients are subjected to invasive nodal biopsies, majority 
of which will be benign disease and a small proportion will be non-diagnostic. 
We aim to analyse if the use of textural analysis can help identify malignant 
disease and aid differentiation between lymphoma and metastatic disease. 
  






Methods and Materials: Twenty patients each with normal lymph nodes, 
histology-proven lymphoma and SCC with nodal involvement were 
restrospectively selected. Lymph node textural analysis on computed 
tomography (CT) images was analysed using MaZda software (Technical 
University of Lodz, Poland). Statistical differences were assessed using the 
Mann-Whitney U test. 
Results: From the eleven textural features analysed, there were significant 
differences in entropy, contrast, correlation, difference entropy and inverse 
difference moment between metastatic nodes, lymphoma nodes and normal 
nodes (all p < 0.001). Entropy has been shown to be a good differentiator 
between pathology; entropy of normal nodes was 1.448, metastatic nodes 
2.163 and lymphoma nodes 0.143. 
Conclusion: Significant differences in the various textural features between 
lymphoma, metastatic and normal lymph nodes exist. This suggests an avenue 
for the use of lymph node textural analysis to aid diagnosis and reduce the 
number of benign nodal biopsies.  
B-1183 10:38  
Head and neck cancer heterogeneity assessed by CT texture analysis: 
can it predict the human papilloma virus status?  
F. Mungai, M. Pietragalla, L. Bonasera, M. Bartolucci, V. Berti, V. Miele; 
Florence/IT (f.mungai@gmail.com)  
Purpose: Human papillomavirus-positive (HPV+) head and neck (HN) 
squamous cell carcinoma represents a different molecular, clinical and 
prognostic entity from HPV-negative (HPV-) disease. The purpose of this study 
was to determine if analysis of texture features of primary lesion on contrast-
enhanced CT (CECT) images can be useful in predicting the HPV status. 
Methods and Materials: Pre-treatment CECT images of 50 patients with 
primary HN carcinoma and known HPV status were retrospectively reviewed. 
The primary tumour was delineated within a manually drawn volume of interest 
(VOI). Six first-order and 34 higher order textural features were extracted from 
each VOI; the latter parameters were derived from analysis of: grey-level co-
occurrence matrix (GLCM), neighbourhood grey-level different matrix 
(NGLDM), grey-level run length matrix (GLRLM) and grey-level zone length 
matrix (GLZLM). T test was used to evaluate differences in textural features 
between HPV+ and HPV- lesions. Logistic regression was performed to 
ascertain the effects of different textural features on the likelihood that a lesion 
is related or not to HPV. 
Results: Of the 50 examined lesions, there were 30 HPV+ and 20 HPV-. 
Statistically significant (p<0.05) differences were seen in, respectively, 5 
GLRLM, 2 NGLDM and 4 GLZLM extracted parameters. The logistic 
regression model was statistically significant for these parameters and correctly 
classified lesions with accuracies of 77-95%. 
Conclusion: HPV+ HN cancers have different textural characteristics than 
HPV- lesions and are correlated with higher textural coarseness. CT texture 
analysis of the primary HN carcinoma may be used as a tool for predicting the 
HPV status.  
B-1184 10:42  
Estimation of the irradiation dose of children exposed to CBCT for 
various dental pathologies  
M. Marcu, M. Hedesiu; Cluj-Napoca/RO (marcumaria88@gmail.com)  
Purpose: The aim was to estimate the effective, cumulative and organ doses 
in children exposed to CBCT. 
Methods and Materials: A prospective study was conducted in 561 children 
aged between 0 and 18 years exposed to CBCT in two European centres, over 
two years. The radiation doses were estimated for the following dental 
pathologies: orofacial cleft, impacted teeth, bone pathology, dental anomalies, 
dentoalveolar trauma, orthognathic surgery, and endodontics. The effective 
and organ doses were calculated by Monte Carlo simulation in paediatric voxel 
phantoms. The doses obtained were extrapolated and normalized to age and 
for the CBCT exposure protocol. 
Results: The median of the effective dose was 137.9 µSv and median of 
cumulative dose was 231.4 µSv. Children with dental anomalies had 
statistically significant higher radiation doses compared to other pathologies 
(p<0.05). The effective dose was influenced by the field of view (FOV) and age 
at exposure. The highest doses were found for salivary glands (Q3 was 4.5 
mGy) followed by brain (2.4 mGy), thyroid (1.0 mGy) and bone marrow (0.2 
mGy). Organ doses were significantly influenced by dental pathology with a 
lower exposure for brain, thyroid and bone marrow (RBM) in clinical cases that 
used a small FOV (impacted teeth, endodontic evaluation) compared to cases 
that required a large FOV (dental anomalies, orofacial cleft and orthognathic 
surgery). The radiation exposure of salivary glands does not vary with dental 
pathology. 
Conclusion: The results revealed the influence of dental pathology, FOV 
dimension and age on CBCT doses of children.  
 
B-1185 10:46  
Disrupted brain functional network architecture in long-term 
sensorineural hearing loss patients  
X.-M. Xu, G. Teng; Nanjing/CN (xmxu15@163.com)  
Purpose: Resting-state functional magnetic resonance imaging (fMRI) studies 
have demonstrated the disruptions of multiple brain networks in sensorineural 
hearing loss (SHL) patients. Nonetheless, several studies found no differences 
in network processing between HL patients and healthy controls (HCs). Its 
neural bases are poorly understood. To identify aberrant brain network 
architecture involved in long-term hearing loss, we compared the resting-state 
fMRI (rs-fMRI) patterns of SHL patients and HCs. 
Methods and Materials: Long-term SHL patients (n = 22) with abnormal 
hearing abilities and age-, sex-, education-matched HCs (n = 21) participated 
in the current study and underwent the rs-fMRI scanning. We used degree 
centrality (DC) to investigate functional connectivity (FC) strength of the whole-
brain network and functional connectivity analysis to explore aspects involved 
in sensorineural HL. 
Results: Compared to HCs, we found significantly increased network centrality 
in left angular gyrus and left precuneus (GFR corrected, P<0.025 for voxel 
level; P<0.05 for cluster level). What’s more, the left angular gyrus revealed 
increased connectivity to the right parietal lobe while the precuneus exhibited 
enhanced connectivity to the right angular gyrus (GFR corrected, P<0.025/2). 
Conclusion: Rs-fMRI provides a new and novel method for identifying 
aberrant brain network architecture. Long-term HL patients have disrupted FC 
in visual and non-auditory areas. The current findings will provide a new 
perspective for understanding the neuropathophysiological mechanisms and 
neural plasticity in long-term SHL.  
B-1186 10:50  
Elastography shear wave contribution when evaluating thyroid follicular 
nodules comparing to histological findings  
P.H.D. Moraes, M. Chammas, M. Schelini; São Paulo/BR 
(pedrohenrique.mmoraes@gmail.com)  
Purpose: Follicular lesion is found in about 10-30% of all FNAB of thyroid 
nodules. 20% have a diagnosis of follicular carcinoma in the final histological 
analysis, although 80% of them are benign. Motivated by unnecessary 
surgeries performed, we studied with shear-wave elastography (SWE) to 
distinguish benign from malignant nodules (BETHESDA III and IV) before the 
histological analysis. 
Methods and Materials: We included nodules with Bethesda III or IV on 
cytological analysis. The equipment used was Logic E9, GE, with SWE 
elastography. We classified follicular nodules according to strain pattern (1-5) - 
1: high deformity, lower risk for malignancy and 5: low strain, high risk for 
malignancy. SWE deformation indexes (SWE index) were defined by two ROIs: 
one including most of the nodule and the other at pre-thyroid muscles. The 
arithmetic average of three different SWE indexes of each nodule was 
calculated. A deformation ratio (RDM) was calculated by dividing the SWE 
index of the pre-thyroid musculature (sternocleidomastoid) by the SWE index 
of the nodule, both using Kpa. All patients were submitted to surgical removal, 
with histological analysis. 
Results: 16 patients were studied. 11/16 had histological diagnosis of 
carcinoma. 7/11 had an elastogram pattern>2. Statistical analysis, however, 
failed to show a significant association between carcinoma diagnosis and the 
elastogram pattern (p=0.611). RDM>1.32 suggest an increased risk for the 
diagnosis of carcinoma (sensitivity 81.8% and specificity 80%) (p=0.015). 
Conclusion: RDM>1.32 is related to increased risk for the histological 
diagnosis of carcinoma in nodules with follicular pattern at cytology 
(BETHESDA III and IV).  
B-1187 10:54  
Metrics and textural features of MRI diffusion to improve classification of 
common parotid gland tumours  
Z. Zhang, J. Cheng; Zhengzhou/CN (yinierzhang@sina.com)  
Purpose: This study aimed to improve the identification ability of benign and 
malignant parotid gland tumours using support vector machine classifiers on 
quantitative MR imaging features. 
Methods and Materials: 52 patients with parotid gland tumours (28 
pleomorphic adenoma, 16 mucoepidermoid carcinoma, and 8 Warthin tumour) 
were included in this retrospective study without previous biopsy or surgery. 
Shape, histogram, and textural features were computed from T2WI and 
contrast-enhanced T1WI and the apparent diffusion coefficient (ADC) map. 
Combinations of features were used to train tumour-type-specific classifiers for 
pleomorphic adenoma, Warthin tumour, and mucoepidermoid carcinoma types 
in separation and as a joint classifier. The performance of different classifiers 
was assessed and compared using randomly selected subsets of training and 
test data. 
  






Results: ADC histogram features (50th and 90th percentiles and skewness) 
yielded the best classification of tumour type (on average >92.3% of 
pleomorphic adenoma, >96.1% of Warthin tumour, and >84.7% of 
mucoepidermoid carcinoma). The resulting joint classifier correctly assigned 
>90.3% of the parotid gland tumours. 
Conclusion: Support vector machine-based classifiers using ADC histogram 
features yielded very good discrimination among common parotid gland tumour 
types, and ADC textural features show promise for further subtype 
discrimination.  
B-1188 10:58  
The diagnostic value of combination of US < MRI preoperative prediction 
for the extrathyroidal extension of papillary thyroid carcinoma  
S. Hu; Zhenjiang/CN (hsd2001054@163.com)  
Purpose: The purpose of the present study was to evaluate the diagnostic 
performance of preoperative ultrasonography (US), magnetic resonance 
imaging (MRI) and US combined with MRI for the prediction of extrathyroidal 
extension (ETE) in patients with papillary thyroid carcinoma (PTC). 
Methods and Materials: Between January 2013 and December 2016, 83 
consecutive patients underwent surgery for pathologically confirmed PTCs with 
ETE. We analysed all patients with PTC with ETE preoperative combination of 
US and MRI scan to evaluate ETE. 
Results: For T3 (minimal ETE), the accuracy was 92.2% (47/51) for US, 
74.5% (38/51) for MRI, and their combination was 98.0% (50/51). The 
difference in the three methods for T3 was statistically significant (P=0.000). 
For T4 (extensive ETE), the accuracy was 62.5% (20/32) for US, 87.5% 
(28/32) for MRI, and their combination was 93.8% (30/32). The difference in 
the three methods for T4 was statistically significant (P=0.000). For the total 
accuracy of ETE, US was 80.7% (67/83), MRI was 79.5% (66/83), and their 
combination was 96.4% (80/83). The difference of the three methods for ETE 
was statistically significant (P=0.001). 
Conclusion: The combination of US and MRI can improve the accuracy of 
ETE for PTC.  
B-1189 11:02  
Use of the previously proposed (2013) ultrasound total malignancy score 
(TMS) in the management of thyroid nodules  
S. Zannoni1, G. Pompili1, S. Tresoldi1, G. Di Leo1, A. Ravelli1, A. Primolevo2,  
G. Spadarella1, G. Carrafiello1; 1Milan/IT, 2Altamura/IT 
(stefaniazannoni@hotmail.com)  
Purpose: To validate the role of the Total Malignancy Score (TMS) previously 
proposed (Pompili et al.2013) in identifying thyroid nodules suspicious for 
malignancy by means of the sum of their ultrasound features. 
Methods and Materials: The local ethical committee approved this 
prospective observational study. We examined 231 nodules in 231 consecutive 
patients (164 females; age range 20-87 years; median age 59 years; IQR 48-
70 years) who underwent ultrasound followed by fine needle aspiration 
cytology (FNAC). Nodules had been further classified using the TMS 
considering ultrasound features (number, echogenicity, structure, halo, 
margins, Doppler-signal, calcifications, growth) and the Bethesda System for 
Reporting Thyroid Cytopathology (TBSRTC) considering cytological features. 
Patients with nodules considered non-negative (categories III-VI TBSRTC) 
underwent histological analysis, repeated FNAC or 2 years strict ultrasound 
follow-up. Association between final diagnosis, each of the ultrasound features 
and TMS was estimated using the Chi-square test, the Mann Whitney U test 
and a multivariate logistic regression. A ROC curve was obtained for TMS 
diagnostic accuracy. 
Results: At ultrasound 47%(108/231) of the nodules had TMS<3, 18%(42/231) 
TMS=3 and 35%(81/231) TMS>3. At FNAC 85%(196/231) of the nodules 
resulted benign and 15%(35/231) non-negative. Hypoechogenicity, solid 
structure, presence of microcalcifications and nodule’s number resulted 
independent predictors of the final diagnosis and TMS diagnostic accuracy was 
good (area under the ROC curve: 0.82). 
Conclusion: The TMS system is simple to use, reliable, easy reproducible and 
strongly relates to malignancy risk. According to our results, FNAC could be 
limited to nodules with TMS >=3, without missing any carcinoma.  
B-1190 11:06  
A multivariate analysis combining DCE and IVIM derived parameters to 
improve parotid tumours differential diagnosis  
F. Patella1, G. Franceschelli1, M. Petrillo2, M. Sansone2, R. Fusco2, 
G. Carrafiello1; 1Milan/IT, 2Naples/IT (battellina@gmail.com)  
Purpose: To evaluate the diagnostic value of a MRI protocol combining 
dynamic contrast-enhanced(DCE-MRI) and diffusion-weighted imaging (DW-
MRI) in patients with parotid tumours. 
Methods and Materials: 14 histopathological proven parotid tumours(7 
Warthin tumours,WT, and 7 Pleomorphic Adenomas, PA) in 11 patients were 
included. For both DCE-MRI and DW-MRI model free and model based 
parameters were computed pixel by pixel on manually segmented regions of 
interest(ROIs) drawn on entire lesion's volume. Extracted parameters were: 
Ktrans, kep, vp, MRE, TTP, WIS, WOS, f, D, D*. For each parameter median 
and standard deviation values on segmented ROIs were calculated for each 
lesion with a Matlab environment. Statistical evaluations included univariate 
and multivariate analysis using conventional linear analysis and advanced 
techniques to separate PA by WT. Furthermore,for the 153 possible couples of 
parameters specificity, sensibility,PPV and NPV were computed. 
Results: No single variable could differentiate WT by PA. Only 4 couples 
presented AUC = 1: 1) Ktrans(std) and f(std); 2) Ktrans(std) and D(std); 3) 
Kep(std) and D(std); 4) MRE(av) and TTP(av). The linear combination of these 
coupled variables provided 4 new parameters: Y1 = 46.0* Ktrans(std) + 34.7* 
f(std) ;Y2 = 34.8* Ktrans(std) + 8368* D(std);Y3 = 0.525* kep(std) + 7223* 
D(std); Y4 = 0.0361 *MRE(av) + 1.5*TTP(av)-Optimal cut-off resulted 7.2973; 
6.8202; 1.0210; 6.0205 respectively.In all cases sensitivity, specificity, PPV e 
NPV were 100% (misclassification error rate = 0%). 
Conclusion: New coupled variables provided by a linear combination of DCE-
MRI and IVIM derived parameters potentially could help in differential 
diagnosis between WT and PA.  
B-1191 11:10  
Does RFA induce neoplastic change of benign thyroid nodules  
S. Ha, J. Shin, J. Baek, D. Song, S. Chung, Y. Choi, J. Lee; Seoul/KR 
(su3ha5@hanmail.net)  
Purpose: With increase in detection of thyroid nodules, radiofrequency 
ablation (RFA) has been investigated for the treatment of symptomatic thyroid 
nodules, and has been shown to represent acceptable alternative to surgery. 
Currently, there has been no data whether RFA promote neoplastic 
transformation of undertreated peripheral portion of the benign nodules through 
biopsy. The aim of our study was to evaluate during 5-year follow-up, whether 
RFA treated benign thyroid nodules is associated with malignancy through 
biopsy, along with clinical efficacy and cytomorphological alteration after 
treatment. 
Methods and Materials: The data were retrospectively collected between April 
2008 and June 2013 and core needle biopsy (CNB) was performed on 16 
benign thyroid nodules who were treated using RFA . Parameters were 
compared between the time of each patient’s enrollment and the last follow-up 
examination using a linear mixed model statistical analysis. The slides were 
reviewed again by two pathologists. 
Results: No atypical cells or neoplastic transformation were detected in 
undertreated peripheral portion of treated benign nodules on CNB specimen. 
RFA neither altered thyroid capsule nor changed the thyroid tissue adjacent to 
the treated area. In the histopathological examinations, we observed 82.3% 
acellular hyalinization, which was the most common finding. After mean follow-
up period of more than 5 years, mean volume had decreased to 6.4±4.2 ml, 
with volume reduction rate of 81.3%±5.8% (p< 0.0001). 
Conclusion: RFA is effective for treatment of benign nodules without 
carcinogenic effect or tissue damage in the normal thyroid tissue adjacent to 
the RFA treated zone.  
B-1192 11:14  
Prognostic significance of PET-based radiomic image features in locally 
advanced laryngeal and hypo-pharyngeal squamous cell carcinoma  
H.L. Nelstrop, R. Prestwich, M. Barnfield, G.M. McDermott, A. Scarsbrook; 
Leeds/UK (hannah.nelstrop@nhs.net)  
Purpose: To determine whether radiomic features derived from 18F-FDG 
positron emission tomography (PET) are prognostic predictors in patients with 
locally advanced laryngeal and hypo-pharyngeal squamous cell carcinoma 
(SCC) and explore the relationship between radiomic features and tumour 
volume. 
Methods and Materials: Retrospective analysis of 43 consecutive patients 
with laryngeal and hypo-pharyngeal squamous cell carcinoma (SCC) treated at 
a single institution was performed. Tumours were segmented using specialised 
software: RTx Advanced (Mirada Medical) and Advantage workstation (GE 
Healthcare). Radiomic analysis was performed on tumour and background 
volumes using Chang-Gung Image Texture Analysis toolbox (CGITA). Entropy 
derived from the grey-level histogram (Entropyhist), entropy and dissimilarity 
derived from the grey-level co-occurrence matrix and zone percentage derived 
from the grey-level size zone matrix were assessed. Univariate Cox regression 
was performed on the results with respect to disease-specific survival (DSS) 
and progression-free survival (PFS) with significance taken as P<0.05. 
Spearman’s rank correlation was used to assess the correlation between 
parameters. 
Results: None of the radiomic features were prognostic predictors of DSS or 
PFS following correction for multi-hypothesis testing; however, all texture 
features were significantly correlated with tumour volume (p<0.002). This 
correlation reduced for Entropyhist and zone percentage when only the larger 
tumours (10-15cm³) were included in the analysis. 
  






Conclusion: Patients with laryngeal/hypopharyngeal tumour sizes greater 
than 10-15cm³ are more suited for radiomic analysis due to the reduced 
correlation between texture features and tumour size.  
B-1193 11:18  
Lateralisation effects on functional connectivity of the auditory network 
in patients with unilateral pulsatile tinnitus as detected by functional MRI  
H. Lv, P. Zhao, Z. Liu, X. Liu, H. Ding, S. Gong, Z. Wang; Beijing/CN 
(chrislvhan@126.com)  
Purpose: Unilateral pulsatile tinnitus (PT) was proved to be a kind of disease 
with brain functional abnormalities within and beyond the auditory network 
(AN). However, changes in patterns of the lateralisation effects of PT are yet to 
be established. 
Methods and Materials: We recruited 23 left-sided, 23 right-sided PT (LSPT, 
RSPT) patients and 23 normal controls (NC). We combined applied 
independent component analysis and seed-based functional connectivity (FC) 
analysis to investigate alteration feature of the FC of the AN using resting-state 
functional magnetic resonance imaging (rs-fMRI). 
Results: Compared with NC, LSPT patients demonstrated disconnected FC 
within the AN in both sides. Disrupted network integrity between AN and 
executive control network, self-perceptual network and limbic network was also 
demonstrated bilaterally. In contrast, RSPT demonstrated decreased FC within 
the AN on the left side, but significant increased FC within the AN in the right 
side (symptomatic side). Enhanced FC between AN and executive control 
network, self-perceptual network and limbic network was also found mainly on 
the right side. Positive FC between the auditory network and the limbic network 
may be a reason to explain why RSPT patients are willing to be in clinic. 
Conclusion: LSPT exhibits disrupted network integrity in brain functional 
networks. But RSPT are featured by enhanced FC within AN and between 
networks, especially on the right (symptomatic) side. Corroboration of featured 
FC helps to reveal the pathophysiological changing process of the brain in 
patients with PT, providing imaging-based biomarker to distinguish PT from 
other kind of tinnitus.  
B-1194 11:22  
Shear wave elastography in the evaluation of level VI lymph nodes in 
papillary thyroid carcinoma  
W. Chang, M. Chen; Shanghai/CN (cwy_jiayou@126.com)  
Purpose: This study aimed at exploring the value of shear wave elastography 
(SWE) in ultrasound evaluation for level VI lymph nodes in papillary thyroid 
carcinoma (PTC). 
Methods and Materials: 87 level VI lymph nodes from 22 consecutive patients 
with PTC were evaluated by grey-scale ultrasound and SWE in condition of ex 
vivo before rapid frozen section. Grey-scale ultrasound and SWE indexes of 
metastatic and non-metastatic lymph nodes were evaluated by statistical 
analysis separately in all patients and in patients without Hashimoto’s 
thyroiditis (HT). Indexes included transverse diameter, longitudinal diameter, 
longitudinal-to-transverse diameter ratio (L/T ratio), Emean, Emin, Emax and ESD. 
The rapid frozen section result of each lymph node was used as gold standard 
to evaluate the diagnostic performance of grey-scale ultrasound and 
combination method which combined grey-scale ultrasound and SWE. 
Results: In all patients, significant indexes included longitudinal diameter 
(p=0.009), L/T ratio (p=0.003), Emax (p=0.016) and ESD (p=0.006). In patients 
without HT, significant indexes included longitudinal diameter (p=0.002), L/T 
ratio (p=0.003), Emean (p=0.030), Emax (p<0.001) and ESD (p=0.001). Combining 
grey-scale ultrasound with SWE, combination method had higher AUC than 
grey-scale ultrasound both in all patients (0.887 vs 0.841) and patients without 
HT (0.925 vs 0.866). Grey-scale ultrasound had higher AUC in patients without 
HT than in all patients (0.866 vs 0.841), which was the same with combination 
method (0.925 vs 0.887). 
Conclusion: Shear wave elastography can provide additional information for 
ultrasound evaluation of level VI lymph nodes in papillary thyroid carcinoma, 
especially in papillary thyroid carcinoma without Hashimoto’s thyroiditis.  
B-1195 11:26  
Diagnostic value of dual-energy CT imaging for cervical lymph node 
metastasis in patients with papillary thyroid cancer  
M. He; Fuzhou/CN (hemuzhen@sina.com)  
Purpose: To quantitatively assess the diagnostic value of dual-energy 
computed tomography(CT) imaging for cervical lymph nodes metastasis in 
patients with papillary thyroid cancer. 
Methods and Materials: Fifty-five consecutive patients with suspected of 
thyroid cancer were prospectively enrolled and underwent enhanced dual-
energy spectral CT scan. The normalised iodine concentration (NIC) and the 
slope of the spectral Hounsfield unit curve (HU) during both arterial and venous 
phases were measured, respectively, from iodine overlay images and spectral 
curves. Two-sample t test was performed to compare quantitative parameters 
at dual-energy CT between the histopathologically proven benign and 
metastatic lymph nodes. Receiver operating characteristic curves were 
generated for sensitivity and specificity analyses as well as evaluating the 
diagnostic value of dual-energy CT imaging and conventional CT features. 
Results: Using the conventional CT features for detection of metastatic lymph 
nodes, sensitivity, specificity and accuracy were 4%-79.0%, 63.6%-100% and 
43.9%-72.6%, respectively. Both arterial and venous phase NIC and HU were 
significantly higher in metastatic than in benign lymph nodes (all p<0.001). The 
best quantitative parameter for detection of lymph nodes metastasis was 
arterial phase NIC with optimal threshold value of 25.8%, sensitivity, specificity 
were 90.3% and 96.6%. The area under curve (AUC) of arterial phase NIC and 
HU was significantly higher than those of venous phases (all P<0.001). 
Conclusion: Compared with qualitative conventional CT features, quantitative 
parameters associated with NIC and HU at dual-energy CT showed higher 
accuracy and better diagnostic performance for cervical lymph node 
metastasis in patients with papillary thyroid cancer.  
B-1196 11:30  
Multiphasic CT vs dynamic contrast-enhanced MRI in the 
characterisation of parotid gland tumours  
N. Tharwat Mohammed El-Sayed; Mansoura/EG (nehaltharwat83@gmail.com)  
Purpose: Salivary gland tumours are challenging with regard to preoperative 
diagnosis. The aim of our study was to highlight the value of multiphasic CT 
and contrast-enhanced dynamic MRI in characterisation of benign and 
malignant parotid tumours as well as to compare the diagnostic accuracy of 
both modalities. 
Methods and Materials: The study group included 45 patients (54 lesions), 26 
males and 19 females, and their age ranged from 24 to 78 years. All patients 
underwent both CT and MRI examinations. The time intensity (or attenuation) 
curve for each lesion was analysed and compared with the final post-operative 
pathology. 
Results: The type of the curve on dynamic contrast-enhanced MRI had high 
sensitivity, specificity, positive predictive and negative predictive values, and 
accuracy in characterisation of benign and malignant parotid tumours (94.4%, 
97.2%, 94.4%, 97.2%, and 96.3%, respectively). Also, curve analysis on 
multiphasic CT revealed similar high sensitivity, specificity, positive predictive 
and negative predictive values, and accuracy as compared to DCE-MRI 
(92.6%, 96.3%, 92.6%, 96.3%, and 95.1%, respectively). 
Conclusion: Both dynamic contrast-enhanced MRI and multiphasic CT have 
comparable high accuracy in characterising the different histological types of 
parotid gland tumours.  
B-1197 11:34  
An innovative 3D-3D superimposition for assessing anatomical 
uniqueness of frontal sinuses (FS) through segmentation on CT scans  
M. Cellina, D. Gibelli, C. Sforza, G. Oliva; Milan/IT (m.cellina@yahoo.it)  
Purpose: Uniqueness in shape and size is the most relevant anatomical 
characteristic of FS and finds a prominent application in personal identification 
of skeletons and human remains. This study aims at assessing anatomical 
uniqueness of FS through 3D registration and automatic calculation of point-to-
point distances between 2 models. 
Methods and Materials: We selected 30 subjects who underwent 2 maxilla 
CT scans (interval time: 1-5 months; acquisition parameters: kV: 120, mAs: 
320, collimation: 40 × 0.6 mm, tube rotation: 1 s; reconstruction thickness: 3 
mm; reconstruction filter: H60 sharp). FS were automatically segmented 
through ITK-SNAP software; the 3D models belonging to the same patient 
were automatically superimposed according to the least point-to-point 
difference between the 2 surfaces. Then, we executed the same procedure on 
200 randomly selected maxilla CT of other patients to perform 100 
superimpositions of FS belonging to different individuals (mismatches). 
Average root mean square (RMS) point-to-point distances observed in the 
group of matches and mismatches were assessed through Student’s t test. 
Logistic regression was calculated to provide a diagnostic tool for the 
recognition of FS. 
Results: In the group of matches, RMS value was on average 0.35 mm (SD: 
0.25), and 2.90 mm (SD: 1.63) in the group of mismatches, with a statistically 
significant difference (p<0.0001). A logistic formula was developed according 
to the RMS values from matches and mismatches and was applied to a novel 
set of 100 superimpositions, with an accuracy of 100%. 
Conclusion: This approach to the assessment of anatomical uniqueness 
provides reliable morphological and quantitative evaluation.  
B-1198 11:38  
Diagnostic efficacy of dynamic manoeuvres in computed tomographic 
evaluation of oral cavity lesions  
R.V. Mathilakath; Davangere Karnataka/IN (rajesh.venunath@gmail.com)  
Purpose: To evaluate the diagnostic efficacy of dynamic manoeuvres in CT for 
better delineation of oral cavity lesions as compared to conventional scans to 
assess the origin and extent of oral cavity lesions. 
  






Methods and Materials: 52 patients with histologically proven diagnosis of 
various oral cavity lesions referred for CT evaluation were included in this 
hospital-based prospective cross-sectional study conducted over a period of 
two years from December 2013 to November 2015. The consented subjects 
were subjected to a preliminary conventional plain and contrast study followed 
by puffed cheek CT scans as described by Weissman and Carrau . The 
images were compared simultaneously by an experienced radiologist for 
evaluation of origin and extent of the lesion. 
Results: Puffed cheek manoeuvre was highly useful in 71.2% of cases and 
was not much helpful in 28.8% in evaluation of oral lesions. Puffed cheek CT 
has a sensitivity of 69% and a specificity of 43% in accurately staging oral 
malignancies. Puffed cheek CT had a positive predictive value of 36% and a 
negative predictive value of 81% and an accuracy rate of 51% compared to 
conventional CT in staging oral malignancies. 
Conclusion: Puffed cheek CT scans provide a clearer and more detailed 
evaluation of mucosal surfaces of the oral cavity than do conventional (non-
puffed) images. In selected patients, like those with lesions of retromolar 
trigone, the puffed cheek technique may serve as a worthy supplement to 
conventional CT in the evaluation of bony invasion and proper delineation of 
tumour extent.  
B-1199 11:42  
Diagnostic value of contrast-enhanced 3D FLAIR sequence in acute optic 
neuritis  
P. Tunlayadechanont, T. Panyaping, P. Cheecharoen, P. Jindahra; 
Bangkok/TH (fangpt123@gmail.com)  
Purpose: Contrast enhancement and hypersignal T2W of the optic nerve are 
abnormal findings in acute optic neuritis. Contrast-enhanced FLAIR sequence 
has both T2W and T1W effects. We aimed to study the diagnostic accuracy of 
whole-brain CE 3D FLAIR sequence in our routine brain protocol in detecting 
acute optic neuritis compared with clinical diagnosis. 
Methods and Materials: This was retrospective cross-sectional study 
including optic nerves from twenty-two patients who first-time diagnosis of 
acute optic neuritis from clinical data and neuro-ophthalmological examination. 
All patients underwent brain MRI imaging with CE 3D FLAIR imaging at 3T. 
The hypersignal CE-FLAIR of optic nerve was assessed independently by 2 
neuroradiologists. The optic nerve to white matter of the frontal lobe signal 
intensity ratio was also calculated as maximum SIR and mean SIR. 
Results: 30 pathologic nerves of acute optic neuritis from twenty-two patients 
were diagnosed by neuroophthalologist. 23 hypersignal of optic nerves were 
found on CE-FLAIR. Interrater agreement was substantial (K=0.73). The 
consensus optic nerve signal abnormality on CE-FLAIR has 82% accuracy, 
77% sensitivity, 93% specificity, 96% positive predictive value and 65% 
negative predictive value. Optic nerve to frontal white matter SIR of the 
affected optic nerves showed statistically significant higher than those normal 
optic nerves. Using a cut-off maximum SIR of 1.24 and cut-off mean SIR of 
1.16 with 93% sensitivity and 86% specificity have 89% and 91% accuracy, 
respectively. 
Conclusion: Hypersignal of optic nerve on whole-brain CE 3D FLAIR 
sequence has diagnostic potential in acute optic neuritis.  
B-1200 11:46  
Radiological diagnosis of desomorphine-associated osteonecrosis  
A. Babkova, N.S. Serova, S.P. Pasha, M. Shariya; Moscow/RU (an4i1@ya.ru)  
Purpose: Atypical osteonecrosis cases have been noted from 2003 in Russia 
due to abuse of synthetic drugs, such as desomorphine, which is one of the 
most widespread drug because of it low cost, quick production process from 
codeine pills with red phosphorus and other toxic substances. 
Methods and Materials: From 2010 to 2017, 165 desomorphine addicts were 
evaluated at the Sechenov University. Patients underwent skull X-ray, 
panoramic radiography, multispiral computed (MSCT) and cone-bean 
computed tomographies (CBCT), radionuclide diagnostics. As a result of this 
evaluation, 165 patients were diagnosed with “Toxic phosphorus necrosis” of 
skull bones. Patients underwent different surgical interventions. 
Results: Conventional radiography, MSCT, CBCT revealed empty tooth 
sockets in 165 patients, sclerotic end plates in 76 patients (46%). Massive 
diffuse periosteal deposits in the lower jaw region were in 97 patients (59%). 
Alterations in the upper jaw were in 39 subjects (24%). A pathological mandible 
fracture was observed in 38 cases (23%). Bone scintigraphy and SPECT 
showed excessive accumulation of the 99mTc-Pyrphotech in the skull bones in 
30 cases (100%): in the maxilla, mandible, in the eye-pits (n=11;31%), in the 
cheekbones (n=8;26%), in the sternum (n=11;31%), in the clavicles and 
humeral heads (n=7;23%), in the crests of the ilium (n=6;20%), in the knee 
areas (n=5;17%). 
Conclusion: Complex radiological diagnostic technologies used to evaluate 
the skeletal system in patients taking desomorphine allow full identification of 
the nature of this disorder, presence of concomitant complications, help in the 
determination of the surgical strategy and planning of further reconstructive 
treatments.  
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B-1201 14:00  
Microwave ablation (MWA) in the treatment of colorectal liver metastases 
(CRLM): an eight-year follow-up study  
T.J. Vogl, M. Zitsch, W. Bechstein, J. Trojan; Frankfurt a. Main/DE 
(t.vogl@em.uni-frankfurt.de)  
Purpose: To evaluate survival time and the progression-free survival of 
patients with colorectal liver metastases (CRLM) in curative and palliative 
intention depending on different parameters. 
Methods and Materials: In this retrospective study, 132 patients (59 women, 
73 men; mean 61.86; range 35-88) were treated with microwave ablation 
(MWA) for CRLM between 2010 and 2017. A total of 257 lesions were 
investigated regarding location of the metastases, technical success, used 
power, diameter, volume and ablation zone volume. Pre-treatment and follow-
up were also documented. Moreover, patients were divided into two different 
groups based on the indication of the treatment (palliative or curative). 
Results: The mean diameter and volume of the intrahepatic metastases were 
18.6 mm±10.1 mm and 4.54 cm3±3.4 cm3. MWA was performed with an 
average power of 45 kJ. The follow-up MR images showed a mean post-
ablation volume of 38.0 cm3. Three patients had a local recurrence (3/132; 
2.2%) and 13 patients had new intrahepatic metastases (13/132; 9.8%). The 
average survival was 520 days (1.42 years). In the curative group, mean 
survival was 637 days (1.74 years) and in the palliative group 250 days (0.68 
years), respectively. All MWAs were without any serious complications. Mild 
side effects were local haematoma and pain symptoms. 
Conclusion: MWA for treatment of CRLM is an effective therapeutic treatment 
procedure with excellent local control rates and improved survival in the 
curative group.  
B-1202 14:08  
Comparison between microwave and radiofrequency ablation in local 
control of colorectal liver metastases  
E. Raimondi1,2, K.N. De Paepe2, D.-.M. Koh2, J. McCall2, N. Fotiadis2; 
1
Ferrara/IT, 2London/UK (edoardo.raimondi@unife.it)  
Purpose: To retrospectively analyse the safety and efficacy of radiofrequency 
ablation (RFA) and microwave ablations (MWA) in the treatment of colorectal 
cancer liver metastases (CRC-LM). 
Methods and Materials: 193 patients with unresectable CRC-LM treated with 
RFA or MWA in a single centre between March 2006 and December 2016 
were retrospectively evaluated. Medical records and imaging studies were 
reviewed for demographic data, technical deployment, associated 
complications, tumour recurrence and overall survival. Rate of tumour 
recurrence, complication rates and patient survival were compared between 
RFA and MWA treatments. 
Results: 456 procedures were performed in 193 patients (123 male, 70 
female) with a median age of 66 years (range 32-91 years). Of these, 343/456 
(75.2%) were RFA and 113/456 (24.8%) were MWA. The median number of 
procedures per patient was 2 (range 1-10). Median lesion size was 17mm 
(range 3-80mm). The local tumour recurrence rate was 45% for RFA and 28% 
for MWA, with a hazard ratio of 0.6 in favour of MWA (95%CI 0.4-0.9). Two and 
five year overall survival for RFA vs MWA were 88% vs 89% (p>0.05) and 35% 
vs 66% (p<0.05) respectively. Complications were reported in 43/456 
procedures (9.4%); in 28/343 (8.1%) of RFA and 15/113 (13.3%) of MWA. One 
patient died due to multi-organ failure post RFA. 
Conclusion: MWA achieved better local tumour control compared with RFA in 
the treatment of CRC-LM, with a slightly higher complication rate.  
B-1203 14:16  
Risk factor-based prediction algorithm for liver function damage in 
patients with hepatocellular carcinoma after microwave ablation  
Y. Zhou, X. Jing, J. Ding; Tianjin/CN (dr.jingxiang@aliyun.com)  
Purpose: To investigate the influence of liver function damage in patients with 
hepatocellular carcinoma (HCC) after microwave ablation (MWA) on prognosis 
and establish a risk factor-based algorithm to predict liver function damage. 
Methods and Materials: A total of 745 patients with HCC undergoing MWA 
were enrolled in this study and were classified into modelling and validation 
group. The progression-free survival (PFS) and overall survival (OS) were 
  






analysed using Kaplan-Meier and log-rank tests. The -coefficients derived 
from a logistic regression model were used to calculate the risk score. 
Results: 69 of 498 patients in modelling group suffered from liver function 
damage. The 1-, 2- and 3-year OS were 93.7%, 88.0%, 79.8% and 89.2%, 
79.6%, 57.8% for patients without and with liver function damage (p=0.043), 
respectively. A total of five risk factors were filtrated by logistic regression 
model, namely Child-Pugh classification before treatment, tumour numbers, 
ablation volumes, relative position between the tumour and portal vein (PV) 
and APRI. These factors were used to calculate the risk score to predict liver 
function damage. The AUC of the risk score for predicting liver function 
damage was 0.798 in modelling group and 0.832 for validation group. The 
sensitivity and specificity to identify liver function damage were 65.22%, 
84.38% in modelling group and 60.61%, 88.32% in validation group, 
respectively. 
Conclusion: Liver function damage after MWA is an unfavourable factor for 
prognosis. The algorithm based on risk factors is a stabilized assessment 
model to predict liver function damage in patients with HCC after MWA.  
B-1204 14:24  
CT texture parameters to evaluate outcome after thermal ablation for 
colorectal liver metastases  
E. Klompenhouwer, R.G.H. Beets-Tan, M. De Boer, S. Trebeschi, W. Prevoo, 
D.M. Lambregts, G.L. Beets, M. Maas; Amsterdam/NL 
(l.klompenhouwer@nki.nl)  
Purpose: Early detection of incomplete ablation or local tumour progression 
(LTP) after thermal ablation is challenging. Aim of this retrospective pilot study 
is to determine whether liver CT texture is valuable to evaluate the 
completeness of ablation and to early detect LTP after thermal ablation in 
patients with colorectal liver metastases. 
Methods and Materials: Texture parameters were extracted from CT scans of 
27 patients (38 lesions; 23 RFA and15 MWA) 1 month post-ablation. Ablation 
zones were delineated in 3D-slicer and texture parameters were calculated 
with an internal tool programmed in Python for the total lesion and for the 
ablation margin. This ablation margin of 3 mm inwards and outwards was 
added by the Python tool after delineating the total lesion. Evaluated texture 
parameters were mean, median, entropy, skewness and kurtosis, which were 
compared with outcome post-ablation: no LTP, LTP during follow-up or 
incomplete ablation. Median follow-up was 12 (5-48) months. 
Results: 25 lesions were completely ablated, 4 were incompletely ablated and 
9 showed LTP during follow-up. In lesions that were incompletely ablated or 
showed LTP (N=13), the median and mean texture density were significantly 
higher than in patients without LTP, both for the total lesion texture (p=0.032 
and p=0.036, respectively) and the texture of the ablation margin (p=0.026 and 
p=0.034, respectively). 
Conclusion: The mean and median texture density of the total lesion and 
ablation margin 1 month post-ablation might be valuable non-invasive markers 
to evaluate incomplete ablation and detect early LTP after thermal ablation for 
colorectal liver metastasis before they are visible on CT during follow-up.  
B-1205 14:32  
Microwave ablation (MWA) of liver malignancies: outcomes and 
prognostic factors of local tumour progression (LTP) with a new 
generation system  
P. Marra, P. Diana, F. Ratti, F. Cipriani, M. Salvioni, S. Gusmini, M. Venturini, 
L. Aldrighetti, F. De Cobelli; Milan/IT (marra.paolo@hsr.it)  
Purpose: High-power MWA may present advantages in term of local tumor 
control, compared with other ablative techniques, but data in the literature are 
conflictual. We analyzed the outcomes and investigated potential prognostic 
factors of LTP in the treatment of hepatocellular carcinoma (HCC) and 
colorectal cancer liver metastases (CRLM), using a new generation MWA 
system. 
Methods and Materials: From November 2014 to June 2017, 50 patients 
(HCC=30; CRLM=20) underwent percutaneous, laparoscopic or open surgical 
MWA of 61 liver nodules with a 100W/2450MHz Microwave Generator 
(Emprint, Medtronic). DCE-CT or MRI were used to assess 1-month complete 
ablation (CA) and LTP at follow up. 
Results: Overall CA rate was 97.3%. Overall LTP in HCC and CRLM 
metastases was respectively 18% (mean observation time, 15.3 months, 
interval 6-31 months) and 10% (mean observation time 10.8 months, interval 
6-21). For HCC, BCLC-stage >0, multiple nodules, viral etiology and relapsing 
disease were associated to LTP without statistical significance; LTP was not 
influenced by age, nodule size and vessels/capsule proximity. For CRLM, a 
lesion size >20mm was associated to higher LTP (p=0.027). Nodule number 
>5 showed increased LTP without statistical significance. LTP was not 
influenced by age, KRAS mutation, synchronous/metachronous metastases 
and vessels/capsule proximity. LTP did not differ among percutaneous and 
surgical approaches. 
 
Conclusion: LTP rates after liver MWA for HCC and CRLM are comparable 
with the literature. CRC mets >20mm are associated with higher LTP. Our 
initial experience with high-power MWA is promising and further development 
of this technique will probably provide even better results.  
B-1206 14:40  
Microwave ablation therapy of giant hepatic cavernous haemangiomas  
S. Çakir, M. Baykara Ulusan, I.N. Mutlu, N. Kiliçkesmez, C. Turan Bektas, 
A. Yardimci; Istanbul/TR (mehmetsemihcakir@gmail.com)  
Purpose: Endovascular embolisation therapy used as a classical method in 
the treatment of hepatic giant cavernous haemangiomas does not yield the 
desired results like dimensional diminution and a decrease in symptoms. It is 
aimed to demonstrate the effectiveness of treatment with microwave ablation 
(MWA) therapy. 
Methods and Materials: Between October 2016 and April 2017, patients 
(n=10; 5 female, 5 male) with liver giant cavernous haemangioma underwent 
MWA therapy and followed for a mean of 6 months. 3 patients presented with 
gastric complaints, 5 patients had abdominal pain and 2 patients had 
thrombocytopenia. Patient pain scoring was noted according to the 10-point 
visual analog scale. MWA therapies were performed by using an 18-gauge 
electrode (Accu2i pMTA Applicator, AngioDynamics, Inc. Hampshire, UK) 
under ultrasound guidance in the presence of analgesia and sedation. Mean 
ablation time was 8.5 minutes. 
Results: All ablations were terminated with technical success and there were 
no major complication. Abdominal pain, especially localised at right upper 
quadrant, developed after procedure due to ablation therapy and additional 
analgesia support was given. Average pain score decreased from 5.1 to 1.3 
after the first month. Mean tumour volume decreased 66.1% after sixth 
months. 
Conclusion: Therapy of microwave ablation for hepatic haemangiomas with a 
high-powered microwave device appears to be safe and effective in providing 
tumour shrinkage, devascularisation and pain relief. While transarterial 
chemoembolisation alone cannot cause significant tumour shrinkage, the effect 
of MWA is excellent for haemangioma destruction. Therefore MWA can be 
used for the treatment of large hepatic haemangiomas.  
B-1207 14:48  
The effect of oesophageal varices on the outcome of RF ablation in 
patients with HCC  
M. Ahmad; Sohag/EG (mandw20022002@hotmail.com)  
Purpose: To determine the therapeutic efficacy of radiofrequency ablation and 
the impact of oesophageal varices on the survival final results. 
Methods and Materials: 121 of 168 patients with portal hypertension had 
oesophgeal varices, underwent RF ablation as a treatment for a single HCC ( 
5cm). Therapeutic efficacy was evaluated. Logistic regression analyses of risk 
factors for occurrence of complication and multivariate cox-regression analyses 
for overall survival were detected. 
Results: Patients with HCC and oesophageal varices had a complete ablation 
rate of 88.4%. Portal vein thrombosis was the most type of complication. By 
univariate analysis, thrombocytopenia (P= 0.032) was an independent risk 
factor of complications. By multivariate analysis , left lobe location of HCC (P = 
0.015) was an independent risk factor of complications and subcapsular 
location of HCC (P = 0.019) was an independent prognostic factor for survival . 
Conclusion: This current study has proven that patients with portal 
hypertension and oesophageal varices can tolerate RF ablation of HCC. 
Dealing caution as regards correction of thrombocytopenia and professionally 
as regards location of HCC, we can improve the outcome of RF ablation.  
B-1208 14:56  
Feasibility, effectiveness and safety of percutaneous MR-guided ablation 
of small hepatic malignancies  
J. Weiß, R. Hoffmann, E. Kessler, H. Rempp, K. Nikolaou, S. Clasen; 
Tübingen/DE (jakob.weiss@med.uni-tuebingen.de)  
Purpose: To investigate the feasibility, effectiveness and safety of 
percutaneous MR-guided ablation of small hepatic malignancies. 
Methods and Materials: Between January 2012 and December 2016, 45 
patients were included in this IRB-approved retrospective study. All patients 
were scheduled for percutaneous MR-guided tumour ablation (radiofrequency 
n=27; microwave n=16) due to primary (HCC n=11; CCC n=2) or secondary 
hepatic malignancies with a lesion diameter of 12mm. A 1.5T MR system was 
used for planning, targeting and therapy monitoring. Technical success and 
long-term effectiveness were assessed by dynamic contrast-enhanced MR 
imaging. Mean follow-up was 17.1±11.6 months (range: 4-42 months). 
Results: Tumour ablation was successfully completed in 43 patients. In six 
patients (13%), planning imaging revealed new, unexpected lesions, which 
were either treated in the same session (n=4) or changed therapy 
management (n=2) due to diffuse tumour progress. Thus, incomplete treatment 
or non-indicated local ablation could be avoided. Planning imaging was 
  






conducted without contrast agent administration in 82% (n=37) of the ablation 
procedures. In 66% (n=30), target tumours were visible in real-time MR-
fluoroscopy during the intervention. Post-procedural imaging revealed a 
technical success of 100% with no major complications. During follow-up, no 
local tumour recurrence was observed although twelve patients presented with 
new tumours distant to the ablation zone. 
Conclusion: MR-guided ablation is a feasible approach for effective and safe 
treatment of small hepatic malignancies. In addition, MR planning imaging is 
helpful to account for unexpected changes of the oncological situation to avoid 
inappropriate treatment in favor of patient safety.  
B-1209 15:04  
A new software for immediate volumetric assessment of tumour ablation 
completeness: could it allow to spare local retreatments?  
R. Muglia1, M. Solbiati2, L. Solbiati3; 1Pieve Emanuele/IT, 2Milano/IT, 
3
Rozzano (Milano)/IT  
Purpose: To retrospectively evaluate accuracy of a software (AblationFit®, 
R.A.W. Endosight, Milan, Italy) in assessing complete ablation of tumours with 
percutaneous thermal ablation. 
Methods and Materials: Out of 320 HCCs treated with microwave ablation 
(AMICA, HS, Aprilia, Italy) from 2010 to 2016, 90 patients in which ablations 
were technically successful were selected. Imaging follow-up of at least one 
year was performed. With AblationFit® the ceCT volumes of the 90 HCCs 
before ablation and the corresponding achieved volumes of necrosis were 
segmented, co-registered and superimposed, to estimate complete target 
inclusion into the necrosis volume. Predictions of complete vs partial ablation 
provided by the software were verified analysing presence or absence of local 
tumour progression (LTP) on 1-yr follow-up ceCT. 
Results: Two experienced radiologists confirmed the ablation in 90/90 cases. 
With AblationFit® reconstructions, only 73/90 HCCs were entirely included into 
the volumes of necrosis, while 17/90 were partially included. At 1-yr follow-up, 
ceCT showed no-LTP in 69/90 and LTP in 21/90. With AblationFit® no-LTP 
and LTP were correctly predicted, respectively, in 65/73 and 13/17. 8/73 cases 
of complete ablation according to AblationFit® developed LTP and in 4/17 of 
partial ablation according to AblationFit® LTP did not develop. Sensitivity of 
AblationFit® was 62% and specificity 94%. In 13/13 cases of correct prediction 
of LTP, tumour regrowth in the location where AblationFit® showed residual 
tumour. 
Conclusion: AblationFit® used at the time of ablations, in 13/90 HCCs local 
re-treatment could have been spared thanks to the immediate detection of non-
ablated tumour.  
Author Disclosures: 
 M. Solbiati: Founder; R.A.W., Endosight, Milan, Italy. Shareholder; R.A.W., 
Endosight, Milan, Italy. 
B-1210 15:12  
Ablation therapy of non-colorectal cancer lung metastases: retrospective 
analysis of tumour response post LITT, RFA and MWA  
N.-E.A.N. Mohammed, N.N.N. Naguib, T. Gruber-Rouh, I. Burck, T.J. Vogl; 
Frankfurt a. Main/DE (nour410@hotmail.com)  
Purpose: To retrospectively compare the local tumour response and survival 
rates in patients with non-colorectal-cancer-lung-metastases post-ablation-
therapy using laser-induced thermotherapy-(LITT), radiofrequency ablation-
(RFA) and microwave ablation-(MWA). 
Methods and Materials: Retrospective analysis of 175 CT-guided ablation 
sessions performed on 109 patients (43 males and 66 females,mean age: 
56.6years). 17 patients with 22 lesions underwent LITT treatment (tumour 
size:1.2-4.8 cm),29 patients with 49 lesions underwent RFA (tumour size:0.8-
4.5 cm) and 63 patients with 104 lesions underwent MWA treatment (tumour 
size:0.6-5 cm). CT-scans were performed 24-hours post-therapy and on follow-
up at 3,6,12,18 and 24months. 
Results: The overall-survival rates at 1-,2-,3- and 4-year were 
93.8%,56.3%,50.0% and 31.3% for patients treated with 
LITT,81.5%,50.0%,45.5% and 24.2% for patients treated with RFA and 97.6%, 
79.9%,62.3% and 45.4% for patients treated with MWA respectively. The mean 
survival-time was 34.14 months for MWA, 34.79 months for RFA and 35.32 
months for LITT. In paired comparison a significant difference could be 
detected between MWA versus RFA (p=0.032). The progression-free survival 
showed a median of 23.49 ± 0.62 months for MWA,19.88 months ±2.17 
months for LITT and 16.66 ± 0.66 months for RFA(p=0.048). The lowest 
recurrence rate was detected in lesions ablated with MWA (7.7%; 8 of 104 
lesions) followed by RFA (20.4%; 10 of 49 lesions) and LITT (27.3%;6 of 22 
lesions) p- value of 0.012. Pneumothorax was detected in 22.16% of MWA 
ablations, 22.73% of LITT ablations and 14.23% of RFA ablations. 
Conclusion: LITT, RFA and MWA may provide an effective therapeutic option 
for non-colorectal cancer lung metastases with an advantage for MWA 
regarding local tumour control and progression-free survival rate.  
B-1211 15:20  
Application of contrast-enhanced ultrasound during microwave ablation 
for large benign thyroid nodules  
W. Wang, F. Mao, J.Y. Cao, P. Fan, Y. Dong; Shanghai/CN 
(puguang61@126.com)  
Purpose: We aimed to evaluate the value of contrast-enhanced ultrasound 
(CEUS) during both pre- and post-treatment evaluation of microwave ablation 
(MWA) for large benign thyroid nodules. 
Methods and Materials: Between Jan 2017 and Oct 2017, 65 patients with a 
total of 65 large benign thyroid nodules admitted to our hospital for MWA 
treatment were included. Mean diameter of nodules is 54 ± 14 (mm). The 
generator of microwave system is designed with a frequency of 2450 MHZ and 
a maximum output power of 100W. The ablation procedures were monitored 
by real-time ultrasound. Before MWA, dynamic CEUS examinations were 
performed to make pre-treatment assessment, including blood perfusion of 
nodules and their relationship with surrounding large vessels. One day and six 
month after ablation, the post-treatment CEUS were conducted to evaluate 
whether the original nodules were completely ablated. 
Results: During pre-ablation CEUS evaluation, peripheral hyperenhanced 
rings were detected during arterial phase of all nodules, with mean thickness 
1.3 ± 0.5 mm. MWA were conducted successfully in all 65 thyroid nodules. 
Post-ablation CEUS showed that 62 (95.4%) nodules with complete ablation 
had no enhancement. The peripheral hyperenhanced ring disappeared in all 
nodules. The volume reduction of 63 ± 3.1 % was achieved with benign thyroid 
nodules after six months follow-up. No major complications occurred. 
Conclusion: Microwave ablation with real time ultrasound guidance is an 
effective and safe method in treatment of large benign thyroid nodules. CEUS 
is a sensitive and effective method to make both pre-treatment evaluation and 
post-treatment efficacy of MWA.  
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B-1212 14:09  
Proposal of imaging reporting and data system for cervical lymph node 
based on computed tomography  
K. Lee1, J. Baik2; 1Ras Al Khaima/AE, 2Busan/KR (lkh770429@naver.com)  
Purpose: To compare computed tomography (CT) features of benign and 
malignant cervical lymphadenopathy and to propose a CT-based, structural 
reporting system for cervical lymph node: lymph node reporting and data 
system on CT (LNRADS-CT). 
Methods and Materials: The Institutional Review Board approved and 
informed patient consent was waived. Between January 2014 and August 
2016, a total of 1337 subjects underwent neck CT examination at a single 
institution. The study included consecutive 407 (malignant lymphadenopathy: 
170, benign lymphadenopathy: 237) cases with pathologic diagnosis or 
sufficient follow-up. CT features of cervical lymph nodes were retrospectively 
analysed: longest diameter, shortest diameter, shape, necrosis, perinodal fat 
infiltration, conglomeration, invasion of adjacent structures and enhancement 
pattern. Regression equation was utilized, and a score was assigned for each 
significant factor. Risk of malignancy was determined according to the number 
of suspicious CT features. 
Results: Malignant lymphadenopathy revealed larger shortest diameter, round 
shape, necrosis, conglomeration and well enhancement more frequently (P < 
.05). As the number of suspicious features increased, fitted probability of 
malignancy increased. Risk stratification of LNRADS-CT was 12.2% in 
category I (no suspicious features), 38.2% in category II (one suspicious 
feature), 80.6% in category III (two suspicious features), and 92.4-99.3% in 
category IV (more than three suspicious features). 
Conclusion: LNRADS-CT was proposed based on a 4-point category and can 











B-1213 14:17  
Diagnostic value of real-time ultrasound image fusion compared to 
ultrasound-only-guided lymph node fine-needle aspiration in head and 
neck cancer patients  
P. De Koekkoek-Doll, M. van den Brekel, W. Vogel, L. Smit, 
J.J. van Griethuysen, M. Maas; Amsterdam/NL (p.doll@nki.nl)  
Purpose: Aim was to evaluate the feasibility of real-time fusion of ultrasound 
(US) with available tomographic image data for the assessment and guidance 
of fine-needle aspiration (fused-FNA) for nodal staging in head and neck 
cancer. 
Methods and Materials: 55 patients were prospectively included. Fused-FNA 
was performed after routine US-FNA, using the electromagnetic navigation 
system Percunav on a Philips EPIQ-US machine. Live US was fused with 
PET/CT, MRI, or CT-data. FNA was performed on additional suspicious nodes 
identified by image fusion. Reference standard consisted of cytological 
evaluation of the FNAs and histology from node dissection if performed. 
Results: Fusion was performed with PET/CT (n=53, 96%), MRI (n=1, 2%) and 
CT (n=1, 2%). In 6 patients (11%) without suspicious lymph nodes fused-FNA 
was not performed. On the remaining 49 patients (89%), FNA was performed 
in 120 nodes. For 97 nodes, FNA was performed based on routine US. Their 
location was confirmed with accurate image fusion in 88 cases, for the 
remaining 9 nodes adequate image fusion was not achieved. After US-FNA, 23 
additional nodes were identified based on image fusion and fused-FNA was 
performed. Of all nodes undergoing FNA 46/111 (41%) had malignant 
cytology, and of the 23 additional fused-FNA nodes 7 were proven malignant 
(30%). In total, 42% of all PET-positive nodes were malignant. 
Conclusion: Real-time US image fusion with FNA is feasible in head and neck 
cancer, leads to an increased detection of malignant nodes, and allows for 
more accurate identification of the location of PET-positive nodes.  
Author Disclosures: 
  P. De Koekkoek-Doll: Author; M. van den Brekel, MD PhD, W. Vogel, MD 
PhD, L. Smit, MD PhD, J. van Griethuysen, MD, M. Maas, MD PhD.  
B-1214 14:25  
Computer-aided quantification of intranodal vascularity enhanced the 
accuracy of ultrasound in distinguishing metastatic and tuberculous 
cervical lymph nodes  
T.-C.M. Ying, S. Cheng, A. Ahuja; Hong Kong/HK (htmying@polyu.edu.hk)  
Purpose: Ultrasound features of tuberculous nodes are varied and simulated 
metastatic nodes. This study presents a novel computer-aided method that can 
quantify intranodal vascularity and enhance the accuracy of ultrasound in 
distinguishing metastatic and tuberculous cervical lymph nodes. 
Methods and Materials: Grey scale and power Doppler sonograms of 100 
patients with palpable cervical nodes were reviewed (60 metastases, 40 
tuberculous lymphadenitis). Ultrasound images of cervical nodes were 
evaluated for the shape, echogenic hilus, necrosis and vascular distribution of 
lymph nodes (conventional assessment). Intranodal vascularity index (VI) was 
quantified using a customised computer program. The diagnostic accuracy of 
using conventional assessment and its combination with intranodal VI was 
evaluated. 
Results: Metastatic and tuberculous nodes tended to be round (75% vs 50%), 
without echogenic hilus (90% vs 72.5%) and have peripheral vascularity 
(73.3% vs 85%). Intranodal neceosis is more common in tuberculous nodes 
(27.5%) than metastatic nodes (8.3%). The diagnostic accuracy of 
conventional assessment in distinguishing metastatic and tuberculous nodes 
was 59% with sensitivity, specificity, positive predictive value (PPV) and 
negative predicative value (NPV) of 87%, 18%, 61% and 47% respectively. 
Results showed that metastatic nodes (23.4±2.1%) tended to have higher VI 
than tuberculous nodes (12±1.6%) (p<0.05). The optimal cut-off of VI was 
20%. By combining conventional assessment and intranodal VI quantification, 
the diagnostic accuracy was 69% with sensitivity, specificity, PPV and NPV of 
72%, 65%, 75% and 60% respectively. 
Conclusion: Combining intranodal VI quantification and conventional 
assessment enhances the diagnostic accuracy of ultrasound in distinguishing 
metastatic and tuberculous cervical lymph nodes.  
B-1215 14:33  
Cervical adenopathies: diagnostic efficacy of DCMR  
L. Aghaghazvini, F. Hashemi, H. Sharifian, B. Rasuli, N. Yazdani; Tehran/IR 
(aghaghazvini.leila@gmail.com)  
Purpose: Pre-operative differentiation of benign from malignant cervical 
adenopathies (CN) remains a challenge. We assessed the efficacy of dynamic 
contrast MRI (DCEMR) for differentiation between benign and malignant CN. 
Methods and Materials: DCEMR were performed in patients with CN who 
were candidates for surgical resection, before radiotherapy or chemotherapy. 
In all patients we used 3 Tesla MRI with fast spin echo T2- and T1-weighted 
images in axial and coronal planes and T1 weighted after contrast medium 
administration. We recorded dynamic curves and values every 30 seconds up 
to 10-15 minutes after contrast injection. Data were evaluated in a mixed 
model analysis and findings were compared with postoperative histopathologic 
results. 
Results: 49 cervical lymph nodes (17 benign and 32 malignant) were included 
in this study. In time-intensity curves there were significant differences between 
benign and malignant groups in two parameters: 5-minute washout slope (p 
value: 0.008) and 5-minute washout ratio (p value: 0.013). For 5-minute 
washout slope there were 96% sensitivity and 27% specificity at cut-off point: 
1.7, 100% specificity and 40% sensitivity at cut-off point: 7.4, 70% sensitivity 
and 70% specificity at cut-off point: 3. Other DCEMR parameters, lymph nodes 
sizes and T2w heterogeneity were different but not significant statistically. Also 
necrosis only was present in malignant lymph nodes. 
Conclusion: DCEMR only for washout ratio and slope at 5 minutes after 
contrast injection could be helpful in differentiation between benign and 
malignant CN in this study but larger studies are necessary.  
B-1216 14:41  
Role of RI (resistive index) value as imaging bio marker in differentiating 
benign and malignant cervical lymphnodes  
K.A. Bhagwat; Davangere/IN (bhagwatkishan@gmail.com)  
Purpose: To assess the role of resistive index , RI value as imaging bio 
marker in differentiating benign and malignant cervical lymph nodes. To 
correlate routine ultrasonography features of enlarged nodes with resistive 
index on Doppler and cytological correlation. 
Methods and Materials: Type of study: prospective study. Sample size: 50; 
Inclusion criteria: patients presenting with clinically palpable cervical 
lymphadenopathy referred for Ultrasonography. Exclusion criteria: patients who 
have been treated earlier for cervical lymphadenopathy. Method: all patients 
underwent high resolution sonography of neck with Colour Doppler and 
following results were recorded. Only the largest node in each patient was 
included for study. Morphology: 1. shape of node; 2. size; 3. echotexture; 4. 
roundness index; 5. necrosis; 6. loss of hilar architecture. Doppler: Hilar flow 
pattern. Resistivity index of vascularity. The above findings were recorded. 
Morphologically the nodes were classified as benign and malignant and their 
RI values were studied. FNAC results were correlated wherever possible. 
Results: Out of 50 patients , about 30 patients had benign lymph nodes and 
20 patients had malignant secondary nodes. Most of the lymph nodes which 
were benign on morphological criteria had RI value less than 0.7. All malignant 
nodes had RI value of 0.8 and above.The unequivocal cases had RI value 
between 0.7 and 0.8. In these cases FNAC finally concluded that nodes with RI 
value of 0.75 are malignant. 
Conclusion: Thus resistivity index of vascularity of lymph nodes is a reliable 
cost effective imaging bio marker in differentiating benign and malignant 
cervical lymphadenopathy.  
B-1217 14:49  
The use of micro-flow imaging (MFI, Philips Medical Systems) in 
ultrasound guided tissue sampling of head and neck masses  
H. Toghyan, A. Al-Khatib, B. Stenberg, A. McQueen; Newcastle upon Tyne/UK 
(hamid.toghyan101@gmail.com)  
Purpose: Ultrasound (US) guided tissue sampling of neck masses is an 
essential component of a head & neck imaging service. One reason for non-
diagnostic US guided lymph node sampling is necrosis of the target lesion 
(particularly in head & neck squamous cell carcinoma and lymphoma) and this 
can lead to additional samples being required via repeat percutaneous 
procedures or surgical excision. Standard Doppler flow is primarily used for 
diagnostic assessment of vascular architecture within neck masses, but a more 
detailed perfusion map could enable the ultrasound practitioner to identify and 
target viable, non-necrotic tissue and reduce the number of samples required 
to achieve diagnostic sample quality for pathological interpretation. 
Methods and Materials: Patients presenting with a neck mass requiring tissue 
sampling were assessed with MFI, a new technology designed to detect small 
vessel blood flow with high resolution and minimal artifact, facilitating 
assessment of lesion perfusion. Samples were obtained from each target 
lesion, under direct ultrasound guidance using an el18-4 linear US probe and 
Epiq 7 US machine (Philips Medical Systems). Pathology results, including the 
pathologist’s comments about the adequacy and quality of the samples were 
obtained from our hospital’s intranet. 
Results: In this case series/technical evaluation, we present our early 
experience in utilising MFI and its superiority to standard Doppler flow imaging 
in depicting vascularity in head and neck masses. 
Conclusion: We propose that increased diagnostic confidence in detecting 
viable regions within abnormal cervical nodes guides tissue sampling, with the 










B-1218 14:57  
Higher definition head and neck imaging enabled with digital photon 
counting PET/CT: an intra-individual comparison with conventional 
photomultiplier PET/CT  
C.L. Wright1, K. Binzel1, J. Zhang1, P. Maniawski2, M.V. Knopp1; 
1
Columbus, OH/US, 2Cleveland, OH/US  
Purpose: To assess the clinical impact and potential clinical benefit of digital 
photon counting PET (dPET) for higher definition PET/CT imaging in 
head/neck by intra-individual comparison to conventional photomultipler tube 
detector (cPET) PET. 
Methods and Materials: Thirty oncology patients participated in an intra-
individual comparison of FDG PET using pre-commercial release dPET/CT 
(Vereos) and cPET/CT (Gemini). Standard cPET imaging was performed at 
~75 min p.i. of 481 MBq FDG, investigational dPET imaging either at ~55 min 
or ~95 min p.i. All other aspects of image acquisition were kept identical. Digital 
PET images were reconstructed using Time-of-Flight with 4mm3 (standard 
definition/SD), 2mm3 (high definition/HD), and 1mm3 (ultra-high 
definition/UHD) voxel volumes and compared with SD cPET images. Blinded 
readers evaluated image sets in regard to overall quality, lesion/tissue 
characterization, and quality of background in head/neck region. 
Results: All cPET/dPET data sets were evaluable. When compared with 
cPET, higher definition dPET demonstrated improved image quality for 
qualitative assessment and detection of small FDG-avid head/neck lesions. 
There was also improved image quality for normal structures/tissues without an 
appreciable effect on the background FDG activity. FDG activity in lesions and 
normal tissues/structures were better characterized with HD/UHD dPET. 
Kappa scores were consistenly higher. 
Conclusion: Higher definition dPET improved visualization and 
characterization of FDG-avid lesions and normal tissues/structures in the 
head/neck including higher kappa scores for agreement. The improved image 
quality and lesion/tissue characterization appears to be enabled by the faster 
timing resolution of dPET (~325ps) compared with cPET (~550ps) and higher 
definition reconstruction reducing partial volume.  
Author Disclosures: 
 P. Maniawski: Employee; Philips Healthcare. 
B-1219 15:05  
Correlation between apparent diffusion coefficient and standardised 
uptake values in head and neck carcinomas  
S. Türk, S. Bayraktaro+lu, E. Ramo, Ö. Akagündüz, R. Sava,; Izmir/TR 
(sevcanturk.ege@hotmail.com)  
Purpose: Head and neck carcinoma may cause a decreased apparent 
diffusion coefficient (ADC) on diffusion-weighted magnetic resonance imaging 
(DW MRI) and an increased standardised uptake value (SUV) on 
fluorodeoxyglucose (FDG) positron emission tomography (PET/CT). We 
analysed the reproducibility and treatment-related changes of ADC and SUV 
measurements in head and neck carcinoma and evaluated whether these 
biomarkers are correlated or independent. 
Methods and Materials: This retrospective analysis of DW MRI and FDG 
PET/CT data series included 36 head and neck carcinoma. Kruskal-Wallis, 
one-way ANOVA and Mann-Whitney U methods were used to detect any 
statistical correlation and prognostic significance of ADC and SUV values in 
responders and non-responders to radiotherapy. 
Results: Mean ADCmin, ADCmean and ADCmin/mean in head and neck 
carcinoma were 0.68±0.17×10−3mm2/s, 0.82±0.17x10−3 mm2/s and 0.83 ± 
0.10 mm²/s, respectively. Mean SUVmean and SUVlbm were 14.65±5.5 and 
10.96±5.1, respectively. Spearman’s correlation analysis showed no significant 
correlation between ADC and SUV measurements. Although statistically not 
significant, a trend towards higher SUV and lower ADC was observed in head 
and neck tumours. Statistically, not significant, a trend towards higher SUV and 
higher ADC was observed in non-responders to radiotherapy. 
Conclusion: Our data suggest that ADC and SUV values are reproducible and 
independent biomarkers in head and neck carcinomas.  
B-1220 15:13  
MRI-based surveillance for patients with recurrent head and neck cancer 
after hypofractionated stereotactic (SBRT) re-irradiation  
N. Plakhotina, A. Mikhailov, A.V. Smirnova, D.I. Kuplevatskaya, N. Vorobyov; 
St. Petersburg/RU (plahotinadezhda@gmail.com)  
Purpose: To assess MRI value for SBRT treatment response evaluation in 
patients with recurrent head and neck cancer. 
Methods and Materials: 23 patients with head and neck cancer relapse 
primarily treated by SBRT were enrolled (age range: 33-79 years). Patients 
were re-radiated with SBRT (35 Gy in 5 fractions). MRI protocol included T2 
and T1 WI, with/without FS, axial DWI, T1FS after gadolinium enhancement, 
with slice thickness 1-3 mm. MRI were performed before initiating SBRT and 
then each 3 months. 
Results: In 86.9% (20 patients) we have found disease stabilization (by 
RECIST criteria) and the absence of progression during the 24 months. After 
3-9 months tumour contours became more uneven, structure became 
heterogeneous, signs of the necrosis appeared, which were replaced by 
fibrous tissue after 9-12 months. In all patients in months 3-9 significant 
oedema at 1 cm margin around tumour focus was revealed. However, after 6 
months, the distant oedema signs (mucositis, muscles and fat swelling) were 
decreasing. In 3 patients (13.1%) we could not assess the long-term results 
due to death from disease progression. 
Conclusion: MRI-based treatment response assessment in head and neck 
cancer relapse provides adequate information for clinical decision but 
characterized by some features, demanding multidisciplinary evaluation. Local 
tissues swelling after SBRT in first months do not allow accurate tumour 
evaluation and simulate disease increase. To exclude false errors radiologist 
needs to know RT method, compare MR results with treatment plans and 
review images in close collaboration with radiation oncologist.  
B-1221 15:21  
Perineural spread of fungal sinonasal infections: CT scan and MRI 
findings  
M. Mohammadzadeh1, A. Mohammadzadeh1, Z. Haghighi1, H. Sharifian1, 
V. Mohammadzadeh1, S. Kadivar2; 1Tehran/IR, 2Rasht/IR 
(mralimohammadzadeh@yahoo.com)  
Purpose: To study imaging features and anatomic pathways of perineural 
spread(PNS) in head and neck fungal infections. 
Methods and Materials: Imaging findings of 25 patients diagnosed with 
sinonasal fungal infection evaluated. Perineural tumour spread was defined as 
foraminal enlargement, foraminal destruction, nerve enlargement, abnormal 
enhancement of the evaluated nerves and obliteration of the perineural fat pad. 
Results: 52% of patients revealed definitive signs of perineural spread. All of 
patients with PNS had Infra Orbital Fissure and pterygopalathine obliteration. 
Maxillay branch of trigeminal nerve was involved in 100% of PNS cases. Sinus 
covernous involvement in 69% and Meckels cave in 30% of these cases were 
identified. 
Conclusion: Perineural spread is a common mechanism of extension in 
sinonasal fungal infections and the most common pathway is spread along 
mandibular division of trigeminal nerve.  
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B-1222 14:00  
3D-assessment of RVOT dimensions prior to percutaneous pulmonary 
valve implantation  
S. Ebel1, S. Gottschling2, M.T.A. Buzan3, M. Grothoff1, I. Dähnert1, R. Wagner1, 
D. Gräfe1, M. Gutberlet1, C. Lücke1; 1Leipzig/DE, 2Halle/DE, 3Cluj-Napoca/RO 
(sebastian.ebel@icloud.com) 
Purpose: To evaluate which cardiacMRI technique allows for better 
assessment of the RVOT in patients with pulmonary valve disease after 
tetralogy of Fallot (TOF) repair: contrast-enhanced MR-angiography (ceMRA) 
or 3D steady-state free precession (SSFP) during systole and/or diastole. 
Methods and Materials: We retrospectively evaluated 89 patients 
(male:female:45:44 mean age 19 ± 8 years), who underwent cardiac-MRI (1.5 
T) after surgical TOF repair. Data sets covering the whole heart in systole and 
diastole were obtained using a ECG-gated 3D SSFP and a non-gated ceMRA. 
Measurements were performed in the narrowest diameter of the RVOT and 
MPA to obtain the mean minimal, maximal and effective diameter. 
Results: The mean minimal diameters in diastolic SSFP, systolic SSFP and 
ceMRA were 21.4 mm (± 6.1 mm), 22.6 mm (± 6.2 mm) and 22.6 mm (± 5.96 
mm), respectively. The mean maximal diameters were 29.9 mm (± 9.5 mm), 
29.98 mm (± 6.98 mm) and 28. mm (± 8.1 mm) respectively. The mean 
effective diameter was 23.2 mm (± 5.7 mm), 27.4 mm (± 6.7 mm) and 24.4 mm 
(± 6.2 mm), with a significant difference between diastole and systole 
(p<0.0001). Measurements in ECG-gated SSFP showed a better inter- and 
intraobserver variability compared to measurements in ungated ceMRA 
sequences. 
Conclusion: Patients with TOF repair who could benefit from PPVI should 
undergo non-invasive CMR for preprocedural assessment. There are 
significant differences regarding the size of the RVOT and pulmonary trunk 
between systole and diastole; therefore, it is essential to obtain ECG-gated 
  






sequences for precise measurements. We show that 3D SSFP sequences 
acquired during systole are best to identify a potential landing zone for PPVI.  
Author Disclosures: 
  S. Ebel: Author; Sebastian Gottschling, Maria TA Buzan, Matthias Grothoff, 
Ingo Dähnert, Robert Wagner, Daniel Gräfe, Matthias Gutberlet, Christian 
Lücke. 
B-1223 14:08  
3D-printed heart model to guide LAA closure: preliminary results  
A.-L. Hachulla, S. Noble, G. Guglielmi, D. Agulleiro, H. Muller, J.-P. Vallee; 
Geneva/CH (anne-lise.hachullalemaire@hcuge.ch)  
Purpose: Percutaneous left atrial appendage (LAA) occlusion is as an 
alternative therapeutic approach to medical therapy for stroke prevention in 
patients with atrial fibrillation. The correct sizing of the occluding device 
remains challenging due to the variable LAA shape. We investigated the use of 
personalised 3D-printed model to guide the selection of the device size. 
Methods and Materials: Fifteen patients scheduled for an occlusion of the 
LAA underwent a cardiac CT. The left atrium was segmented by semiautomatic 
algorithms and a 1.5 mm thick shell of the left atrium was exported in STL 
format and printed using a flexible material. A new CT scan of the 3D-printed 
model with and without inserted Amplazer® Amulet cardiac plugs was 
acquired. The size of the Amulet predicted with CT, transechocardiography 
(TEE) and 3D-printed model was compared to the size of the device implanted 
in the patient. 
Results: The segmentation process was fast (less than 15 min). The device 
size was correctly predicted in 8/15 cases with TEE, in 10/15 cases with 
Cardiac CT, in all of the 15 cases with 3D-model. On the 3D-printed model CT, 
the proximal disc sealing the ostium of the LAA and the close contact of the 
distal lobe with the LAA wall could be seen very well. In case of incorrect 
sizing, absence of contact with the LAA wall or device deformation was easily 
identified. 
Conclusion: We introduced a fast and robust protocol using personalized 3D-
printed LAA model to select the correct size of the occluding device.  
B-1224 14:16  
Left atrial appendage closure guided by 3D-printed patient-specific 
models  
M. Guglielmo1, A. Guaricci2, D. Andreini1, M. Conti1, S. Marconi1, F. Auricchio3, 
M. Pepi1, C. Tondo1, G. Pontone1; 1Milan/IT, 2Bari/IT, 3Pavia/IT 
(marco.guglielmo@ccfm.it)  
Purpose: Percutaneous left atrial appendage (LAA) occlusion has been 
proposed as an alternative therapeutic approach for stroke prevention in 
patients affected by atrial fibrillation. 3D printing allows reconstruction of 
patient-specific models of the heart using computed tomography angiography 
(CTA). We sought to assess whether the sizing of the implanted occluder 
device is in accordance with the sizing obtained using the 3D printing models. 
Methods and Materials: We used 3D printing to create patient-specific LAA 
models, reconstructed by CTA, as supporting tool of the pre-operative stage of 
the LAA occlusion procedure with endovascular devices, such as the Wave 
Crest device (Coherex Medical, Inc, USA) and the Amplatzer Amulet device (St 
Jude Medical, St Paul, MN). 
Results: 13 patients, undergoing percutaneous LAA occlusion, were 
retrospectively analysed; for each of them a patient-specific 3D LAA-printed 
model was manufactured using pre-operative CTA images. We observed that: 
i) in 54% of the cases (n=7) the actual sizing was underestimated when 
compared to the 3D-printed model; ii)in 38% of the cases (n=5) the two sizing 
approaches matched; iii) only in 1 case (8%) an overestimation of the actual 
size compared to the 3D-printed model was detected. In all underestimated 
cases a drawback, such as leakage or device migration was observed. 
Conclusion: This report demonstrates that 3D printing LAA model may 
contribute in sizing the device, finding its correct position and guiding the 
choice of the device, providing additional data to angiography and TEE.  
B-1225 14:24  
3D printing of the aortic root based on cardiac computed tomography 
and cardiac magnetic resonance imaging: preliminary experience on pre-
procedural planning for aortic valve sizing  
M. Gatti, R. Faletti, A. Cosentino, G. Pennisi, A. De Paoli, A. Di Chio, S. Fiore, 
L. Pavan, P. Fonio; Turin/IT (marcogatti17@hotmail.it)  
Purpose: To determine the feasibility of using CCT and CMRI to print 
individual models of the aortic root complex for aortic annulus measurement. 
Methods and Materials: Retrospective study on 20 patients who underwent 
aortic valve replacement with available records of pre-surgery annulus 
assessment by CCT and CMRI and of intra-operative assessment by Hegar 
dilators. The imaging DICOM data were loaded into an imaging processing 
software (OsirixMD) to obtain Standard Tessellation Language (STL) files that 
were exported to a model-editing software (Meshmixer®) and edited to retain 
only the aortic root from the left ventricular outflow tract to the sinotubular 
junction. 40 aortic annuli were printed using a fusion deposition modelling 
printer (Ultimaker 2 Extended+®) with flexible polylactic acid filaments. The 
same cardiac surgeon performed both the intra-operative and the 3D model 
measurements. A time-cost analysis was performed. Data were analysed using 
Wilcoxon signed-rank test. 
Results: There were no significant differences when compared the annulus 
dimensions measured by 3D models derived from CCT (p=0.33) and CMRI 
(p=0.44) to the surgical reference of intra-operative sizing. Valve sizing for 
CoreValve® by intra-operative measurement had the same good agreement 
with 3D model-based measurement, with a 95% match rate; for SAPIEN XT® 
the agreement was slightly better (95%) for CMR-derived model than for CCT 
(90%). Time and cost per model were: STL creation ~30min; printing time 
~30min; post-processing ~5min; material cost <1€. 
Conclusion: The 3D models performed well when compared to the surgical 
reference of intraoperative sizing. This approach may be a reliable, not 
expensive, patient-specific pre-operative planning opportunity.  
B-1226 14:32  
Fusion of coronary CT angiography and whole-heart 3D CMR myocardial 
perfusion: building a framework for comprehensive 3D cardiac imaging  
J. von Spiczak, R. Manka, A. Gotschy, S. Oebel, S. Hamada, H. Alkadhi; 
Zurich/CH  
Purpose: To develop a high-quality framework for hybrid three-dimensional 
imaging of coronary CT angiography (CCTA) and dynamic whole-heart 3D 
cardiovascular magnetic resonance stress perfusion (CMR-Perf) image data to 
correlate coronary artery stenoses to stress-induced myocardial perfusion 
deficits. 
Methods and Materials: 23 patients underwent CCTA and CMR-Perf. For 
CCTA, image quality and stenoses >50% were documented. For CMR-Perf, 
image quality and stress-induced perfusion deficits were noted. A new software 
framework was developed to allow for three-dimensional image fusion of 
patient data revealing relevant stenoses and corresponding perfusion deficits. 
Computation steps included: 1) automated segmentation of CT coronary 
arteries and heart contours; 2) manual segmentation of the left ventricle in 
CMR-Perf images; 3) automatic co-registration of CT and CMR datasets; 4) 
projection of the CMR-Perf values on the CT left ventricle. A dedicated 
algorithm for high-quality interpolation and co-registration was developed to 
avoid frequently occurring image artefacts. Results of the hybrid 3D analysis 
were compared to separate readouts from CCTA and CMR-Perf data. 
Results: CT and CMR image quality was rated as good to excellent (scores 
3.5±0.5 and 3.7±0.4, respectively, scale 1-4, 1=poor, 4=excellent). Multimodal 
three-dimensional image fusion was feasible in all patients. Perfusion deficits 
could be correlated to culprit coronary lesions in all cases. 
Conclusion: Three-dimensional fusion of morphological high-resolution CCTA 
and functional CMR-Perf image data is feasible using the imaging framework 
presented in this work. Hybrid imaging can ease the anatomic correlation of 
stress induced myocardial perfusion deficits and their culprit lesions.  
B-1227 14:40  
3D image fusion of whole-heart dynamic cardiac MR perfusion and late 
gadolinium enhancement: identifying areas for revascularisation  
J. von Spiczak, M. Mannil, H. Alkadhi, R. Manka; Zurich/CH  
Purpose: To develop a framework for three-dimensional image fusion of 
whole-heart dynamic 3D cardiac MR perfusion (3D-PERF) and 3D late 
gadolinium enhancement (3D-SCAR) to delineate stress-induced myocardial 
perfusion deficits and areas of scar. 
Methods and Materials: Five patients with coronary artery disease (54±20 
years) undergoing cardiac MR were included. A software framework was 
developed for 3D fusion of 3D-PERF and 3D-SCAR data revealing perfusion 
deficits along with myocardial scar. Computation steps included: 1) manual 
segmentation of the left ventricle in 3D-PERF and 3D-SCAR images; 2) semi-
automatic thresholding of perfusion and scar data; 3) automatic calculation of 
ischaemic and scar burden; 4) projection of perfusion and scar values on an 
artificial template of the left ventricle; 5) semi-automatic co-registration to an 
exemplary heart contour easing 3D orientation; 6) 3D rendering of the 
combined datasets using automatically defined color tables. All tasks were 
performed by two independent, blinded readers. Interreader agreement was 
determined by calculating intraclass correlation coefficients. 
Results: Image acquisition, post-processing, and 3D fusion was feasible in all 
cases. All patients showed stress-induced perfusion deficits in 3D-PERF; three 
patients showed late gadolinium enhancement in 3D-SCAR. Average 
ischaemic burden was 16% and average scar burden was 8%. Interreader 
agreement was excellent for both 3D-PERF (ICC=0.95) and 3D-SCAR 
(ICC=0.99). 3D fusion allowed intuitive visual assessment of perfusion deficits, 
scar, their overlap, and areas possibly accessible to revascularisation. 
Conclusion: 3D fusion of 3D-PERF and 3D-SCAR facilitates anatomic 
correlation of stress-induced myocardial perfusion deficits and scar tissue for 
identifying areas for potential revascularisation.  
  






B-1228 14:48  
Prognostic impact of myocardial perfusion single-photon-emission 
computed tomography in patients with major extracardiac findings by 
computed tomography for attenuation correction  
Z.C. Charline; Toulouse/FR (charline.zadro@gmail.com)  
Purpose: Attenuation correction computed tomography (CT) contributes to an 
improvement in the diagnostic accuracy of myocardial perfusion imaging (MPI) 
by single-photon-emission tomography (SPECT). The aim of this study was to 
explore the prognosis of patients with major findings by CT according to the 
results of MPI. 
Methods and Materials: 1506 patients who underwent MPI by SPECT 
between January 2010 and June 2011 in the CHU of Toulouse Rangueil were 
retrospectively included. Attenuation correction CT images were systematically 
analysed for major and minor abnormalities. 
Results: 830 (55.1%) and 212 (14.1%) patients had minor and major 
extracardiac findings, respectively. Among patients with major extracardiac 
findings, the abnormality was previously unknown in 113 (53.3%) patients. 90 
(41.9%) had abnormal MPI, 73 (34.4%) had a myocardial infarction scar, 55 
(25.9%) had myocardial ischaemia, and 38 (17.7%) patients had both 
myocardial infarction scar and myocardial ischaemia. Among the 201 patients 
available for survival analysis, there were 67 (31.2%) deaths over a follow-up 
period of 3.2±1.3 years. There was no significant impact on survival arising 
from MPI, whatever the result. The results were the same among the 103 
patients with previously unknown major extracardiac findings. 
Conclusion: Extracardiac findings by CT during MPI are frequent. Patients 
with major extracardiac findings have a poor mid-term outcome, whatever the 
results of the myocardial perfusion imaging. Extracardiac findings should be 
systematically checked when attenuation correction CT is performed.  
B-1229 14:56  
3D analysis and planning of septal reduction therapy basedon CT 
coronary angiography in patient with hypertrophic cardiomyopathy  
B. Batsak; Kiev/UA (dr.batsak@gmail.com)  
Purpose: The aim of our study was to develop non-invasive method for 
preoperative 3D analysis and planning of septal reduction therapy . 
Methods and Materials: Were performed CT coronary angiography with 320-
MDCT (Aquilion ONE ) in 45 patients with obstructive form of hypertrophic 
cardiomyopathy (mean age- 41±7,3, mean weight-70±13,2). We performed 
reconstruction of the 3D anatomy of coronary artery and myocardium of 
interventricular septum with the help of a post processing software package. 
For alcohol septal ablation we define the area of blood supply by septal branch 
of LCA. For planning surgical myectomy we perform 3d anatomical 
reconstruction of LV myocardium and zone of obstruction for determine level 
and amount of myocardium resection. Obtained data was analyzed. 
Results: We found that septal branch supply the hypertrophic region of 
interventricular septum which caused obstruction in 21 patients. In 15 patient, 
no septal branches larger than 1 mm. In 9 patient, the 1st septal branch 
supplies area below site of obstruction. In patients with an appropriate anatomy 
of septal branches we performed alcohol ablation. During procedure we 
confirm area of blood supply by contrast echocardiography with perftoran. In 
patients with a non-appropriate anatomy of septal branches we performed 
myectomy after preoperative 3D planning 
Conclusion: 3D analysis and planning of septal reduction therapy based on 
CT coronary angiography helps in choosing optimal methods of treatment in 
patient with obstructive form of hypertrophic cardiomyopathy.  
B-1230 15:04  
Assessment of post-operative pulmonary regurigitation by pre-operative 
RV and pulmonart artery imaging characteristics in pediatric TOF 
repaired with trans-valve surgert  
Y. Gao, Z. Yang, K. Shi, K. Diao; Chengdu/CN (304789161@qq.com)  
Purpose: Pulmonary regurgitation (PR) is most common complications after 
tetralogy of Fallot (TOF) surgical repair, the long-term PR might result in 
cardiovascular events. The aim of this study was to assess the influence of 
pre-operative right ventricle(RV) and pulmonary artery(PA) parameters on 
post-operative PR by dual-source computed tomography(DSCT). 
Methods and Materials: A total of 41 patients had TOF repaired with trans-
valve surgery were retrospectively recruited. All diameters were measured 
using the computer caliper during systole. The RV and PA parameters 
evaluated by pre-operative DSCT were compared between the PR and non-PR 
groups used non-parametric test and Spearman test. 
Results: The result showed that the PA parameters (McGoon ratio, Nakata 
index and LPA diameter) and RV parameters (RV length diameter and RV 
short diameter) all had significant differences between the two groups (all 
p<0.05). There was a significant correlation between PR and LPA diameter (r = 
0.35), McGoon ratio (r = 0.32), and Nakata index (r = 0.43), and the same as 
PR between RV length diameter (r =-0.46) and RV short diameter (r =-0.34). 
ROC analysis also revealed that moderate sensitivity and specificity were 
obtained for predicting the occurrence of PR with LPA (66.33%; 82.60%), 
McGoon ratio (83.33%,56.52%), Nakata index (83.33%; 60.87%), RV length 
diameter 66.67%; 82.61%)and RV short diameter (77.78%; 60.87%). 
Conclusion: This study indicated that these pre-operative indexes by DSCT 
are associated with post-operative PR, and these pre-operative PA and RV 
parameters could be new predictive factors for the occurrence of PR.  
B-1231 15:12  
Modified myocardial performance index for evaluation of foetal cardiac 
function in small for gestational age foetuses  
A. Taori; Indore/IN (abhijittaori@gmail.com)  
Purpose: To test the validity of modified myocardial performance index for 
foetal cardiac function assessment and explore the sequence of changes in 
modified MPI, umbilical artery and ductus venosus flow in SGA foetuses. 
Methods and Materials: Singleton pregnancies between 24 and 36 weeks 
gestation with ‘small for gestational age foetuses’ as assessed by foetal 
biometry were included. Umbilical artery and ductus venosus waveforms were 
obtained. Myocardial performance index was calculated as MPI = 
(ICT+IRT)/ET with appropriate placement of Doppler gate to include both the 
lateral wall of the ascending aorta and the mitral valve, where the clicks 
corresponding to the opening and closing of the two valves could be clearly 
visualised. 
Results: All foetuses with early-onset IUGR and abnormal umbilical artery 
indices had abnormal MPI values. Significant percentage of foetuses with late-
onset IUGR and normal umbilical artery PI also had an elevated MPI. In IUGR 
foetuses, MPI is one of the earliest parameters affected and remains elevated 
throughout the different stages of IUGR. MPI is a direct measurement of 
myocardial performance while DV flow patterns are an indirect reflection, thus 
abnormal myocardial function becomes evident in DV only in advanced stage 
of deterioration. 
Conclusion: Modified MPI is the earliest and reliable marker for global cardiac 
dysfunction in response to hypoxia. It can detect true growth-restricted 
foetuses amongst SGA foetuses with normal UA flow velocities. It has 
immense potential in late-onset IUGR foetuses where even a short period of 
hypoxia can cause severe morbidity.  
B-1232 15:20  
Diagnostic accuracy of non-contrast self-navigated free-breathing MRA in 
paediatric patients with coronary anomalies using CTA as reference 
standard  
M. Albrecht1, A. Varga-Szemes2, C.N. De Cecco2, T.J. Vogl1, J.W. Nance2, 
D. De Santis3, M. Eid2, D. Piccini4, U.J. Schoepf2; 1Frankfurt a. Main/DE, 
2
Charleston, SC/US, 3Rome/IT, 4Lausanne/CH (MoritzAlbrecht@gmx.net)  
Purpose: To evaluate the diagnostic accuracy of a non-contrast, free-
breathing, self-navigated 3D (SN3D) coronary MR angiography (cMRA) 
technique for coronary artery (CA) anatomy assessment in children with 
coronary abnormalities, using coronary CT angiography (cCTA) as the 
reference standard. 
Methods and Materials: We prospectively enrolled 21 pediatric patients (15 
male, 12.3±2.6 years) undergoing same-day unenhanced SN3D cMRA and 
contrast-enhanced cCTA. Two radiologists scored the depiction of CA 
segments and reader confidence using a 3-point scale: 1=insufficient, 
2=moderate, and 3=excellent. Readers assessed CAs for anomalies, high CA 
origin, and both inter-arterial and intra-mural CA course. Sensitivity, specificity, 
positive and negative predictive values (PPV, NPV) were calculated to 
evaluate diagnostic accuracy. Inter-observer agreement was assessed using 
Intra-class Correlation Coefficients (ICC). 
Results: Fourteen children showed CA anomalies or pathologies on cCTA 
images. Depiction of CA segments was scored higher for cCTA compared to 
cMRA (P<0.015), except regarding the left main CA (P=0.301), with good 
(ICC=0.62) to excellent (ICC=0.94) inter-observer agreement. Diagnostic 
confidence was higher for cCTA evaluation (P=0.046). Sensitivity, specificity, 
PPV and NPV of cMRA were 92%, 92%, 96% and 87% for the detection of CA 
anomalies, 85%, 85%, 74% and 92% for high CA origin, 71%, 92%, 82% and 
87% for inter-arterial course, and 41%, 96%, 87% and 80% for intra-mural 
course. 
Conclusion: SN3D cMRA is highly accurate for the detection of CA anomalies 
and inter-arterial course in children without radiation exposure, contrast 
administration, or need for breathing commands. Diagnostic confidence and 
CA visualisation, however, are still inferior in comparison with cCTA.  
Author Disclosures: 
 A. Varga-Szemes: Consultant; Akos Varga-Szemes is a consultant for 
Guerbet. C.N. De Cecco: Consultant; Carlo N. De Cecco is a consultant for 
and/or receives research support from Guerbet and Siemens.  D. Piccini: 
Employee; Siemens. U.J. Schoepf: Consultant; U. Joseph Schoepf is a 
consultant for and/or receives research support from Astellas, Bayer, Bracco, 
GE, and Siemens. 
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B-1233 14:00  
MR imaging of the Parkinson's syndrome: a pictorial essay  
E.D. Alves, C.d.F. Zorzenon, G.H.A.A. Bienes, H.B. Ferraz, H. Carrete Jr; 
Sao Paulo/BR (ealves23@hotmail.com)  
Purpose: The Parkinson syndrome is a worldwide condition that affects 
millions of people. This syndrome has a broad aetiology, but mostly are caused 
by unknown neurodegenerative process. Some of these diseases, including 
the most common one, the Parkinson disease, have been a usual challenge 
diagnosis to radiologist around the world. We intend to show that this situation 
can change under the new MRI sequences that have been developed and 
applied to the diagnosis of these conditions. 
Methods and Materials: 40 patients suffering from Parkinson's syndromes 
underwent brain MRI non-contrast studies in a 3 Tesla system. We have 
applied the usual T1 and T2 images associated with a T1-weighted 
neuromelanin-sensitive image and to a multiecho susceptibility image to 
evaluate the substantia nigra and nigrosome-1. These patients all have already 
a clinical diagnosis, with a diverse aetiology. Among these group of aetiologies 
are Parkinson disease, Parkinson plus syndromes, vascular diseases, 
medicament-related conditions and Parkinson-like processes (essential 
tremor). It was also done studies of 15 voluntary healthy control patients. 
Results: Some of the diseases that cause Parkinson syndrome have 
presented typical findings in regular MRI studies. Others, like Parkinson 
disease, that a few years ago would have presented no conclusive MRI signs, 
have showed reliable findings in the T1 neuromelanin-sensitive images and in 
multiecho susceptibility images. 
Conclusion: The use of the new developed sequences to evaluate the 
morphology and signal of the substantia nigra can provide reliable information 
for the differential diagnosis of the conditions that causes the Parkinson 
syndromes.  
B-1234 14:08  
Phase value assessment reveals iron accumulatin in Parkinson disease  
A.N. Sirin Özcan, E.B. Dirik; Ankara/TR (aysenursirinozcan@gmail.com)  
Purpose: As a progressive neurodegenerative disorder Parkinson disease 
demonstrated iron accumulation in substantia nigra. n daily neuroradiology 
practice neuroimaging still have supplied limited information and used 
particularly only to exclude parkinson plus sydromes. ron accumulation 
prediction was made with different methods and phase value assesment from 
susceptibility weighted imaging phase data is one of them. 
Methods and Materials: 20 parkinson and 21 healty control group patient 
included in the prospective study. MRI examination consisted Susceptibility 
weighted imaging with phase and magnitude imaging. Phase value quantified 
via SPIN software. Phase value evaulated from substantia nigra from three 
level at axial section for each side as right and left. Parkinson disease clinically 
effected and non efected side analyzed individually .Both side of Parkinson 
group compared with control group and also with each other. Statistical 
analysis was performed on SPSS with ANOVA test. 
Results: Phase values were statically different in Parkinson and control group. 
But inside the Parkinson group although clinically effected side demonstrated 
higher phase values than non effected side it didn’t showed statically 
significant difference. 
Conclusion: Phase value asesment is useful to demonstrate iron 
accumulation effect at substantia nigra in Parkinson disease.  
B-1235 14:16  
Within- and across-network alterations of the sensorimotor network in 
Parkinson's disease  
J. Caspers1, S.B. Eickhoff2, F. Hoffstaedter2, C. Rubbert1, J. Aissa1, 
M. Südmeyer3, B. Turowski1, A. Schnitzler1, C. Mathys4; 1Düsseldorf/DE, 
2
Jülich/DE, 3Potsdam/DE, 4Oldenburg/DE 
(Julian.Caspers@med.uni-duesseldorf.de)  
Purpose: Neuroimaging studies repeatedly demonstrated alterations in 
sensorimotor areas related to Parkinson’s disease (PD). As a systematic 
evaluation of the sensorimotor network (SMN) in PD is yet missing, we 
investigate the within- and across-network functional connectivity (FC) of the 
SMN in PD based on independent component analysis (ICA) of resting-state 
fMRI. 
Methods and Materials: Resting-state fMRI (3T, EPI, TR=2.2s, TE=30ms, flip-
angle=90°, resolution=3.1x3.1x3.1mm, acquisition time=11min) was evaluated 
in 38 PD patients, acquired under regular medication (ON) and after withdrawal 
of dopaminergic drugs (OFF), and 43 age-, gender-, and movement-matched 
healthy controls. Preprocessed fMRI time series were decomposed into 20 
intrinsic connectivity networks using ICA in FSL. We tested for group 
differences in FC between patients and controls within the SMN using dual 
regression (p<0.05, FWE corrected), and between SMN and the remaining 19 
networks using FSLNets (p<0.05, FDR corrected). 
Results: Within the SMN, PD patients (OFF) showed decreased connectivity in 
left inferior parietal lobule compared to controls and, additionally, in left 
postcentral gyrus compared to their ON scan. There were no group differences 
between patients (ON) and controls. Across networks, SMN was decoupled 
from (primary) motor and visual networks in PD OFF, which partially 
normalized in medical ON. 
Conclusion: PD is associated with SMN connectivity impairments, both, within 
and across networks. These dysfunctions in short- and long-range 
sensorimotor connections are at least partially alleviated by dopaminergic 
treatment. Connectivity decrease within the network and to primary motor 
networks is directly linked to PD-related motor symptoms. Decoupling from 
visual networks hints to deficits in visuospatial integration for motor planning.  
B-1236 14:24  
Peculiarities of brain activation during dominant-hand tactile perception 
in lateralised Parkinson’s disease  
O. Omelchenko, Z. Rozhkova, M. Makarchuk, I. Karaban; Kiev/UA 
(Ol.Omelchenko@Gmail.Com)  
Purpose: We propose brain activation and connectivity analysis during the 
unilateral tactile stimulation in primary and non-primary hand motor symptom 
lateralised Parkinson’s disease (PD) patients for the motor PD symptom 
asymmetry impact study on the somatosensory processing in PD. 
Methods and Materials: Three groups of right-handed subjects (G1/G2/G3) 
were studied with 1.5T Signa MR scanner (GE, USA). G1 consisted of 7 
healthy subjects (4F, 51-83y.o.). G2 consisted of 6 PD patients with left-side 
(non-primary hand) motor symptoms (2F, 53-74y.o.). G3 consisted of 6 PD 
patients with right-side (primary hand) motor symptoms (2F, 56-74y.o.). Index 
finger tactile stimulation successively alternating for right and left hand was 
used for somatosensory fMRI activation. Data processing was made by FSL. 
Results: For G1/G2/G3 activation of contralateral postcentral gyrus was 
shown. In G2/G3 primary (right) hand stimulation evoked more activation in 
bilateral postcentral gyri, contralateral superior parietal lobule, supramarginal 
gyrus, inferior part of pre/postcentral gyri. In G3 activation of contralateral 
ventral premotor area was found. Increased functional connectivity was shown 
for left globus pallidus, right dorsal premotor cortex, right dorsolateral prefrontal 
cortex in G2 and bilateral premotor, right prefrontal, bilateral superior parietal 
lobule in G3. 
Conclusion: Primary somatosensory cortex remains steadily active during 
tactile stimulation in PD, while primary hand tactile stimulation in primary hand 
lateralised PD patients also evoke activation of primary and associative 
sensory, motor and executive nodes of the cortex. Tactile stimuli processing 
evokes increased connectivity of globus pallidus, premotor, prefrontal and 
parietal cortex, which might reveal tactile-evoked motion suppression in PD.  
B-1237 14:32  
Detection of Parkinson's disease based on resting-state inter-network 
functional connectivity using machine learning  
C. Rubbert1, C. Mathys1,2, S.B. Eickhoff3,1, F. Hoffstaedter3,1, M. Südmeyer4, 
C.J. Hartmann1,1, B. Turowski1, A. Schnitzler1,1, J. Caspers1,3; 1Düsseldorf/DE, 
2
Oldenburg/DE, 3Jülich/DE, 4Potsdam/DE 
(christian.rubbert@med.uni-duesseldorf.de)  
Purpose: Parkinson’s disease (PD) is a clinical diagnosis, which may be 
challenging in certain cases. Resting-state functional connectivity has been 
reported to show alterations in PD and may prove to be a valuable biomarker 
in those cases. We evaluated an unsupervised, data-driven classification 
approach to identify PD patients based on between-network connectivity in 
whole-brain resting-state fMRI (rs-fMRI). 
Methods and Materials: Whole-brain rs-fMRI (Siemens Trio 3T, 
EPI/TR=2.2s/TE=30ms/flip angle=90°/resolution=3.1x3.1x3.1mm/acquisition 
time=11min) was assessed in 42 PD patients (medical OFF) and 47 healthy 
controls (HC) matched for age and gender. Between-network connectivity 
based on full and partial correlation measures were computed for each subject 
based on a canonical functional network architecture at different levels of 
granularity (Human Connectome Project, “recon2” subjects, 03/2017 dataset). 
A boosted logistic regression model was trained on the correlation matrices 
using 20 repeats of 10-fold cross-validation. The number of iterations was fixed 
  






at 100, then optimized for the best set of components. Accuracy was averaged 
over the validation folds to evaluate model performance. 
Results: The median accuracy over the different granularities was as 
following: 15 components = 61.9% (full correlations)/66.4% (partial 
correlations), 25=75.8%/73.1%, 50=71.4%/65.6%, 100=66.0%/62.5%, and 
200=67.0%/52.5%. 160 iterations were found to be optimal for the best model 
(25 components), yielding a median accuracy of 75.9% (SD=3.5) for full 
correlations and 74.5% (SD=3.9) for partial correlations. 
Conclusion: The accuracy for predicting PD in rs-fMRI is overall acceptable. It 
is varying with the number of components and better at a lower number of 
components, which should be explored in more detail.  
B-1238 14:40  
Volumetric analysis of the pattern of brain atrophy in Wilson’s disease  
J.P. Chu, Y. Song, X. Tang, L. Zou; Guangzhou/CN (15692009037@163.com)  
Purpose: To quantitatively evaluate brain atrophy pattern in Wilson’s disease 
(WD) using a novel and validated fully automated whole brain segmentation 
method. 
Methods and Materials: 3D-T1-weighted MRI scans were obtained from 27 
WD patients (M: 17, F: 10, median: 31.3y) with neurological manifestations and 
25 health controls (M: 8, F: 17, median: 25.1y). The volumetric segmentations 
of each structure were obtained automatically by using a multi-atlas processing 
pipeline to segment T1-weighted images into 289 anatomical regions of 
interest (ROI). In the volumetric group difference analyses, multiple comparison 
correction was carried out by controlling the family-wise error rate (FWER) at 
0.05. 
Results: In WD patients, significant volumetric decrease was found in 59 
ROIs. Deep nuclei including bilateral putamen, substantia nigra, red nucleus, 
globus pallidus, caudate nucleus and thalamus showed obvious atrophy. For 
neuroanatomically defined white matter, we found significant atrophy of 
bilateral superior fronto-occipital fasciculus, external capsule in the claustrum, 
subcortical white matter of the subgenual anterior cingulate cortex, 
corticospinal tract, then followed by anterior corona radiate and cerebral 
peduncle (P<0.001). More notably, volumetric reduction detected in deep 
nuclei was more severe than white matter. Among basal ganglia, the putamen 
showed the most obvious atrophy. Moreover, eight ROIs including lateral and 
third ventricles had volumetric increase, which indicated a larger ventricular 
system secondary to brain atrophy. 
Conclusion: Volumetric data obtained with automated segmentation of 
cerebral regions showed a significant atrophy of different brain structures in 
WD. Our study demonstrated that the atrophy of deep nuclei was more obvious 
than whiter matter.  
B-1239 14:48  
A 3 Tesla MRI brain atlas for Parkinson's disease as diagnostic and 
interventional tool  
I. Papageorgiou1,2, L. Angelidakis3, C. Damianou3, M.-N. Psychogios2,  
P. Lingor2, K. von Eckardstein2, A. Malich1, S. Hadjidemetriou3; 
1
Nordhausen/DE, 2Goettingen/DE, 3Limassol/CY 
(ismini.e.papageorgiou@gmail.com)  
Purpose: Parkinson's disease (PD) is a chronic degenerative disorder of the 
central nervous system. The aim of this work is to develop an MRI-based brain 
atlas representative of the PD-brain alterations for diagnostic and interventional 
medical applications. 
Methods and Materials: The data were 3.0 T MRI brain images from 16 PD 
patients and 10 matched controls. The brain atlases with multiple contrasts 
have been computed with the open platform 3D Slicer® using T1-weighted 
(T1w), T2-weighted (T2w) images, as well as susceptibility weighted images 
(SWI). Anatomic co-registration with a labeled atlas in BrainSuite® was done, 
refined with the level-set segmentation method by ITK-Snap®. Target 
structures were analysed for their volume and signal intensity. 
Results: Comparison with the control group unravels a significant PD-related 
T1w signal loss in the caudate nucleus (CN) and putamen (Put) compared to 
age-matched controls (CTL). The T1w signal intensity is significantly reduced 
in PD patients in the CN/Put by approximately 8%/4% on the average CTL 
value (p < 0.001, rank-sum test), albeit without associated volume loss. The 
diagnostic efficacy of the T1w signal intensity is high according to the ROC 
analysis with an AUC 0.93/0.88. T1w, T2w and SWI atlas data, as well as 
average 3D volume rendering reconstructions for the substantia nigra, red 
nucleus, subthalamic nucleus and thalamus, are provided in detail. 
Conclusion: We establish a disease-specific, PD MRI brain atlas for the 
midbrain structures and the striatum using the 3D Slicer®. T1w signal loss in 







B-1240 14:56  
Asymptomatic T1 pallidal hyper intensity in patients with chronic liver 
disease  
F. Costa, J.P. Filipe, C. Reis; Porto/PT  
Purpose: T1 pallidal hyperintensity is believed to be caused by the deposits of 
neuroactive substances in the brain, particularly manganese. These changes 
may precipitate Acquired Hepatocerebral Degeneration (AHD), a rare chronic 
encephalopathy that may follow any form of chronic liver disease (CLD). Its 
clinical spectrum comprises motor signs, cognitive impairment, short term 
memory loss and in some cases mielopathy. It is believed that its prevalence is 
approximately from 1 to 2% in patients with CLD. Little is known about the 
prevalence of T1 pallidal hyperintensity in chronic liver patients population that 
bare no symptoms and may therefore be wrongfully labeled as AHD. 
Methods and Materials: We retrospectively analyzed the medical records and 
imaging studies of CLD patients, for whom brain MRI data was available. The 
presence of T1 hyperintensity, its location and signal intensity was registered. 
We used non-parametric tests and Fisher’s exact test to evaluate the 
association between symptomatic and asymptomatic patient and T1 signal 
intensity, hyperintensity location and Child-Pugh scores. 
Results: We identified 250 patients, of which 16 (6,4%) had T1 pallidal 
hyperintensity, and among them only 7 (2,8%) presented with AHD clinical 
spectrum symptoms, meaning that 56% of patients with T1 pallidal 
hyperintensity showed no symptomatology whatsoever. Comparing 
symptomatic and asymptomatic patients, we observed no significant univariate 
association between the two groups and Child-Pugh score, signal intensity or 
location. 
Conclusion: The T1 hyperintense pallidal signal is not predictive of AHD in 
this exploratory study, raising the question of its exact role in the clinical 
diagnosis of AHD.  
B-1242 15:04  
T2* hypointensity of the bulbar segment of the primary motor cortex in 
ALS patients with bulbar impairment  
G. Donatelli, E. Caldarazzo Ienco, G. Migaleddu, P. Cecchi, G. Aringhieri, 
G. Siciliano, M. Cosottini; Pisa/IT  
Purpose: In amyotrophic lateral sclerosis (ALS) the disruption of bulbar 
function as speech and swallowing is a possible clinical manifestation and to 
distinguish between the contribution of UMN and LMN degeneration to bulbar 
impairment is difficult. Recent 7T-MR studies suggested T2*-hypointensity as a 
possible marker of UMN impairment in ALS patients. We assessed the cortical 
T2* signal intensity of the bulbar segment of the primary motor cortex (fM1) in 
ALS patients, and its relationship with bulbar impairment. 
Methods and Materials: Forty-seven ALS patients underwent 3D multi-echo 
T2*-weighted sequence at 3T-MR. Two neuro-radiologists visually assessed 
fM1 signal intensity using a score system (0=signal intensity similar to that of 
the postcentral gyrus; 1=mild hypointensity; 2=marked hypointensity). The 
bulbar impairment was evaluated using the items I-III of ALSFRS-R. 
Results: Thirteen patients had bulbar impairment. In 15 patients fM1 was rated 
bilaterally hypointense: 10 patients received score=2 and had bulbar 
impairment; 5 patients received score=1 and have not bulbar impairment. fM1 
of two patients without bulbar symptoms had score=1 only in one side. Thirty 
patients received score=0; three of them had bulbar impairment. Considering 
score=2 as pathological, sensitivity, specificity, PPV, NPV and accuracy of fM1 
hypointensity were 0.77, 1, 1, 0.92 and 0.94. Considering bilateral score>0 as 
pathological, they were 0.77, 0.85, 0.67, 0.90 and 0.83. The interobserver 
agreement was 0.78. 
Conclusion: The marked bilateral fM1 hypointensity seems the typical finding 
in ALS patients with bulbar impairment. The follow-up of patients without bulbar 
symptoms could provide information about the prognostic role of fM1 
hypointensity.  
B-1243 15:12  
Role of qualitative and quantitative parameters in differentiation of PSA 
from other atypical parkinsonian syndromes in MRI  
P. Hota1, T. Dhibar2, A. Biswas2; 1Bangalore/IN, 2Kolkata/IN 
(meparamitahota@gmail.com)  
Purpose: Overlapping atrophic features without specific radiological signs 
complicate the diagnosis of various atypical parkinsonian syndromes. A 
method of differentiating progressive supranuclear palsy from other atypical 
Parkinsonian syndromes with qualitative and quantitative measurement of 
midbrain volume loss is introduced. 
Methods and Materials: T1 mid-sagittal MRI image of 35 patients with 
clinically diagnosed PSP (n=6), MSA (n=4), DLB (n=2), CBD (n=3) and IPD 
(n=20) were acquired and measurements were taken as depicted below. 
Elliptical region of interest was placed over the pons and the midbrain in mid-
sagittal slice. Two lines were drawn to define the major axes of the ellipses, 
corresponding to superior - inferior axis . The maximum measurement 
  






perpendicular to the major axis was taken as the absolute pons and midbrain 
diameter for calculation. 
Results: The absolute midbrain diameter and the midbrain to pons ratio were 
measured. Statistical significance of midbrain measurement < 9.35mm 
calculated from two columns and rows contingency table by Fisher's exact 
probability test gives the P value that is <0.001. 100% of clinically diagnosed 
MSA and PSP cases had a midbrain diameter measured as previously shown 
<9.35mm. 100% of clinically diagnosed PSP cases showed midbrain to pons 
ratio as described before < or =0.52. 
Conclusion: Midbrain to pons ratio < or =0.52 is 100% specific for detection 
and differentiation of PSP from other atypical parkinsonian syndromes. This 
sign is reproducible, simple and correlates with other previously published 
results.  
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Prostate cancer: what's next?  
Moderators:  
I. Blazic; Belgrade/RS  
U.G. Mueller-Lisse; Munich/DE  
B-1244 14:00  
Radiological Wheeler staging system: a valid tool to improve the local 
staging of organ-confined prostate cancer with mp-MRI  
E. Tabone1, V.M. Doronzio1, E. Appendino1, V. Romano1, S. Pedalino1, 
M. Manfredi2, S. Mazzetti1, D. Regge1, F. Russo1; 1Candiolo/IT, 2Orbassano/IT 
(emanuele.tabone@gmail.com)  
Purpose: To determine a new multiparametric-MRI staging system based on 
pathology for the assessment of capsular invasion in PCa. 
Methods and Materials: This retrospective single center multi-reader study 
included consecutive patients with preoperative mp-MRI who underwent non 
nerve-sparing radical prostatectomy. Three radiologists with different 
experience and blinded to pathology, reported all examinations, classifying 
lesions according to a 5-point score based on radiological Wheeler (rW), 
derived from the pathological Wheeler (pW). Whole-mount histological sections 
were used as the reference standard and the pathologist defined the extent of 
capsular invasion using pW. PCa classified as L0,L1,L2 (respectively without 
contact, with contact or with infiltration of fibrous capsule) were grouped in the 
T2 stage class, while L3F and L3E (respectively with radial extracapsular 
infiltration 0.7mm and >0.7mm) in the T3 stage class. The accuracy of mp-
MRI in predicting the pathological group T2 or T3 was assessed and AUC 
analysis was performed for each and overall readers. 
Results: 105 patients were included for a total of 130 PCas. Sensitivity of the 
most experienced reader was 49% (17/35 T3 PCas), specificity 95.8% (91/95 
T2 PCas), PPV 81% (17/21), and NPV 83% (91/109). Overall sensitivity was 
60%, specificity 77%, PPV 50%, and NPV 84%. The AUC of the two most 
experienced readers in the detection of capsular invasion was 0.72-0.74. 
Conclusion: In experienced hands organ-confined PCa is well recognized by 
mp-MRI and allows pre-treatment decision to tailor surgical approach (i.e., 
nerve-sparing radical prostatectomy). The understaging of T3 tumours remains 
a limitation, independently of radiologist expertise.  
B-1246 14:08  
Comparison of prostate cancer detection rates between MR-targeted and 
saturation TRUS-guided biopsy  
V. Romano1, E. Tabone1, E. Appendino1, S. Mazzetti1, V. Giannini1, 
A. Giacobbe2, G. Muto2, F. Russo1, D. Regge1; 1Candiolo/IT, 2Milan/IT 
(vittorio.romano@ircc.it)  
Purpose: To compare PCa detection rate of in-bore MR-targeted biopsy and 
of saturation TRUS-guided biopsy in men with clinical suspicion of PCa and a 
positive MRI finding. 
Methods and Materials: Diagnostic mp-MRI was performed using a 1.5T 
magnet and a phased-array coil combined with an endorectal coil. Acquisition 
protocol included T1- and T2-weighted, diffusion-weighted, and dynamic 
contrast-enhanced imaging. Subjects with at least one region with suspicion of 
PCa were considered positive at MRI, and randomly allocated (ratio 1:1) to 
MR-targeted biopsy (arm A) or saturation TRUS-guided biopsy (arm B). In MR-
targeted biopsy only index lesions were sampled, using at least 2 cores, while 
in saturation TRUS-guided biopsy at least 28 cores were retrieved. Biopsy 
Gleason score (bGS) was used as the reference standard. 
Results: PCa detection rate was 71% and 76% in arm A and arm B, 
respectively. No statistical significant difference was observed between the 
detection rates of the two study arms (p=0.58). In arm B, we observed higher 
overall PCa detection rate in the biopsy-naïve group than in patients with at 
least one previous negative biopsy (88% vs 62%, p=0.03). Sampling efficiency 
was in favour of arm A with 59.7% of core detecting PCa versus 22.3% of the 
arm B (p < 0.0001). 
Conclusion: In-bore MR-targeted biopsy has a comparable PCa detection rate 
to TRUS-guided saturation biopsy, but reached a significant higher positivity 
rate of biopsy cores. Using a lower number of sampling cores could reduce 
pain perceived by patients, increasing acceptance and tolerability of the 
targeted procedure.  
B-1247 14:16  
Targeted MRI/TRUS fusion-guided biopsy in patients with suspicious 
pararectal lymph nodes after radical prostatectomy  
V. Kapustin, A. Gromov, V. Shirokorad, Y. Subbotin; Moscow/RU 
(wwkapustin@yandex.ru)  
Purpose: To determine a possibility of simultaneous transrectal ultrasound 
and MR imaging technique (sensor-based MR-TRUS Fusion) for biopsy 
guidance in patients with biochemical recurrence (BR) after radical 
prostatectomy when metastatic involvement of pararectal LN is suspected. 
Methods and Materials: 18 patients with BR after radical prostatectomy (RP) 
and suspicious pararectal LN were included in this study. Multiparametric 1.5T 
MRI with a surface coil were performed. Initial MR examinations showed 
suspicious prararectal LN in 16 cases. In 2 cases pararectal LN-mts were 
primarily suspected by PET-CT findings and subsequent retrospective MRI 
data review. Simultaneous MR and TRUS image formations were performed. 
High accuracy level (0.3-0.4 cm) of ”Fusion” images superposition was 
achieved in 11 cases. In these cases core-needle targeted biopsies (TB) of 
suspicious LN were performed. In 3 cases achieved accuracy level was too 
low, however areas of suspicious LN localization for further TRUS-guided TB 
were detected. Eventually, in 2 cases LN-mts were localized at the level of 
rectosigmoid junction, thus they were unachievable for TRUS approach. In 
these cases fine-needle aspiration biopsies (FNAB) were performed with 
cognitive Fusion navigation under endosonoscopic control. 
Results: Use of MRI/TRUS-Fusion technique allowed us to verify metastatic 
involvement of pararectal LN in 13 out of 18 cases. In the remaining 5 cases 
fragments of pelvic fat with no evidence of tumor growth or LN tissue were 
histologically revealed. 
Conclusion: MRI/TRUS-Fusion proves to be a promising technique for 
targeted core-needle biopsies in patients after RP when a pararectal lymph 
nodes mts-involvement is suspected.  
B-1248 14:24  
Could mpMRI really improve the detection of clinical recurrence of 
prostate cancer with low PSA value and efficacy of radiation treatment?  
F. Kossov, P. Bulychkin, D. Romanov, M.A. Shorikov, E. Tarachkova, 
V. Panov, S. Tkachev, B. Dolgushin, G. Hagverdiyeva; Moscow/RU  
(fil-doc@yandex.ru)  
Purpose: Salvage radiation therapy (SRT) is the main treatment modality for 
patients with prostate cancer recurrence (PCaR) after radical prostatectomy 
(RP). Clinical PCaR (tumour substrate appearance at area of prostate bed or 
regional lymph nodes metastasis) early detection improves SRT efficiency. 
Medical imaging plays minor role in clinical PCaR diagnostic due to low 
accuracy of routine radiological approaches (TRUS-CT-MRI). Multiparametric 
MRI (mpMRI) would significantly improve clinical PCaR detection even in 
patients with low PSA values and small sizes of tumour substrate. 
Methods and Materials: 142 men (54-71 years, median - 62) with biochemical 
recurrence (PSA>0.2 ng/ml) after RP were examined by mpMRI before and 6 
months after SRT with every 3 months PSA control. There were 2 groups of 
patients with clinical PCaR: 1) PCaR size>5 mm (PSA 0.9 ng/ml); 2) PCaR 
size<5 mm (PSA 0.5 ng/ml). Prescribed dose of SRT to regional lymphatic 
nodes was 44 Gy, to prostate bed - 66 Gy (72 Gy - if region of clinical PCaR 
was identified). 
Results: Clinical PCaR was found in 121 cases. 8 patients had distant 
metastasis. 13 patients had no significant mpMRI data of clinical PCaR. 
mpMRI sensitivity/specificity for clinical PCaR at I group were 89%/96%; at II 
group - 78%/87%, respectively. In all cases, PSA progression decreases after 
SRT was evaluated. Size of clinical PCaR significantly correlated with PSA 
level (p<0.001). Higher SRT doses to PCaR areas associated with fast PSA 
level decrease (p<0.004). 
Conclusion: mpMRI showed high sensitivity and specificity in clinical PCaR 
detection. SRT escalation dose to area of clinical PCaR effected to more 














B-1249 14:32  
11C-Choline PET/CT in the detection of oligometastatic prostate cancer 
recurrence  
D. Pursanova, I. Aslanidis, O. Mukhortova, I. Ekaeva, T.A. Trifonova, 
V.I. Shirokorad, D.A. Roshchin; Moscow/RU (dipoursanidou@gmail.com)  
Purpose: To investigate the diagnostic value of 11C-Choline PET/CT in the 
detection of oligometastatic prostate cancer (PCa) recurrence, which is 
essential in determining the personalized therapeutic approach. 
Methods and Materials: This retrospective analysis included results of 11C-
Choline PET/CT examinations performed in 217 PCa patients with rising PSA 
after radical treatment. The mean PSA value in the group was 2.1±2.5 (0.2-9.7) 
ng/ml. Examinations were done on PET/CT scanner (Biograph-64, Siemens) 
10 min after 11C-Choline injection (400-550Mbq). 
Results: Overall, PET/CT detected PCa relapse in 56% (121/217) patients, of 
which 68% (82/121) had oligometastatic process (1-3 lesions). Local relapse 
was revealed in 62% (51/82) patients, distant oligometastatic lesions were 
identified in 33% (27/82), both local and distant metastases in 5% (4/82) cases. 
Oligometastases to lymph nodes were diagnosed in 35 patients, of which 71% 
(25/35) had single foci, and of these 57% (20/35) were presented by normal-
size lymph nodes (median 6 mm). Oligometastases to skeleton were revealed 
in 23 patients, of which 78% (18/23) had single foci, and the rest had several - 
two (n=4) and three (n=1) foci. Importantly, that 5 of 23 PET-positive patients 
with bone metastases had no structural abnormalities on CT images, 
corresponding to isolated involvement of bone marrow. 
Conclusion: 11C-Choline PET/CT has been shown to be a noninvasive 
accurate technique for detection of recurrent PCa in patients with rising PSA 
after radical treatment, which allows to differentiate patients with local and 
distant metastases in one study, as well as identify oligometastatic process 
and, therefore, is useful in determining the further personalized therapeutic 
approach.  
B-1250 14:40  
Comparisons of imaging biomarkers on simultaneous choline PET and 
multiparametric MRI between TNM staging in high-risk prostate cancer 
patients  
L.-J. Wang, J.-R. Tseng, Y.-C. Lin; Taoyuan/TW (lijenwang0918@gmail.com)  
Purpose: To compare imaging biomarkers between TNM staging on 
simultaneous C11 choline PET (chPET) and multiparametric prostate MRI 
(mpMRI) in high-risk prostate cancer (PCA) patients. 
Methods and Materials: From January 2015 to December 2016, we 
prospectively enrolled 31 PCA patients undergoing simultaneous chPET and 
mpMRI. Of each patient, total lesion glycolysis and metabolic tumour volume of 
standardized uptake values (SUVTLG and SUVMTV), maximum values of 
perfusion parameters (ktransmax and kepmax), and minimum value of apparent 
diffusion coefficient (ADCmin) of PCA were recorded. The presence or absence 
of extra-prostate or adjacent organ extension (T3-4), regional lymph node 
metastasis (N1) and distant metastasis (M1) of each patient was determined by 
histological results, imaging findings, clinical examinations and follow-up. 
Imaging biomarkers between patients with and without T3-4, N1 and M1 were 
compared using Mann-Whitney U test. 
Results: Of the 31 patients, there were 27 patients (87.1%) with T3-4, 13 
patients (41.9%) with N1, and 17 patients (54.8%) with M1 diseases. 
Significant differences of SUVTLG, SUVMTV, ktransmax, kepmax and ADCmin 
between patients without and with T3-4 as well as of SUVTLG and SUVMTV 
between patients without and with M1 were shown (all p < 0.05). Nonetheless, 
there were no significant differences of all 5 imaging biomarkers between 
patients without and with N1 as well as of ktransmax, Kepmax and ADCmin 
between patients without and with M1 diseases. 
Conclusion: Imaging biomarkers on chPET and mpMRI are good indicators of 
primary tumour status of PCA.  
B-1251 14:48  
Prospective evaluation of extent of disease in prostate cancer 
biochemical relapse by [68Ga]PSMA-HBED-CC PET/CT  
G. Chong, D. Barahona Z., A. Balcells, D. Hasson, G. Schiappacasse, 
A. Labra Weitzler; Santiago de Chile/CL (danibarahona@gmail.com)  
Purpose: Accurately determining the extent of disease on biochemical relapse 
of prostate cancer (PCa) can have important therapeutic implications. The 
lesion detection rate of [68Ga]PSMA-HBED-CC-PET/CT and its relation to 
prostate-specific antigen (PSA) level and Gleason score is evaluated. 
Methods and Materials: All patients subjected to [68Ga]PSMA-HBED-CC-
PET/CT with PCa biochemical relapse, from November 2014 to December 
2016 were included. Laboratory exams performed prior to PSMA-PET-CT were 
retrieved from electronic medical records, and histopathology results were 
extracted from surgical specimens. All high-uptake regions were identified by 
two experienced readers. Regional involvement was defined as urethrovesical 
anastomosis lesions or pelvic lymphadenopathies. 
Results: 102 patients were recruited. Mean age was 70.3 years (SD: 9.2), and 
median PSA Score was 2.52 ng/ml (IQR: 7.1), with a minimum value of 0.04 
ng/ml, and 35% of PSA values under 1 ng/ml. PSMA-PET/CT was positive for 
70% of patients. Among PSMA-PET/CT positive cases, 55% had regional 
involvement and 2.5% had suprapelvic lymphadenopathies without regional 
involvement. PSMA-PET/CT was positive in 43% of studies with PSA levels of 
<1 ng/ml. The lowest PSA level related to a positive finding was 0.11 ng/ml. 
16% of lymphadenopathies detected were under 0.5 cm, and 69% were under 
1 cm. 28% of studies showed bone metastases. A high Gleason score (9-10) 
was non-significatively associated with a higher number of pelvic metastases. 
Conclusion: [68Ga]PSMA-HBED-CC-PET/CT can identify secondary lesions in 
PCa biochemical relapse even in patients with very low PSA levels and can 
accurately identify small intra- and extra-pelvic lymphadenopathies, which can 
substantially influence treatment planning.  
B-1252 14:56  
The impact of [68Ga]PSMA I&T PET/CT on radiotherapy planning in 
patients with biochemical cancer relapse after radical prostatectomy in 
prostate cancer.  
C. Berliner, T. Frenzel, M. Tienken, M. Abdel, S. Klutmann, D. Beyersdorff,  
G. Adam, A. Krüll, P. Bannas; Hamburg/DE (caberliner@gmail.com)  
Purpose: To determine the impact of [68Ga]PSMA I&T PET/CT on 
radiotherapy planning of biochemical cancer relapse of prostate cancer. 
Methods and Materials: We performed a retrospective analysis of 75 patients 
who underwent [68Ga]PSMA I&T PET/CT scans prior to scheduled 
radiotherapy treatment. All patients had a documented biochemical relapse 
after radical prostatectomy. The age distribution was median 69 (range 52-86) 
years. The PSA level was median 0.2 (range 0.02-653.2) ng/ml. We compared 
the impact of [68Ga]PSMA I&T PET/CT on lesion detection and treatment 
decision. 
Results: [68Ga]PSMA I&T PET/CT revealed a total of 47 positive lesions, 
whereas CT detected 18 lesions. The therapeutic regimen was changed in 32 
of 75 cases (43%) based on the [68Ga]PSMA I&T PET/CT. In 31 cases (41%) it 
upstaged to an enhanced tumour extension. Twenty-five cases (33%) received 
an additional boost to the [68Ga]PSMA I&T PET/CT-positive findings. 
Conclusion: [68Ga]PSMA I&T PET/CT is an advanced hybrid imaging 
technique prior radiotherapy treatment for prostate cancer patients with proven 
biochemical relapse. It is significantly impacting the radiotherapy planning and 
enables individualized therapy for prostate cancer patients.  
B-1253 15:04  
Clinical utility of 18F-NaFand 68Ga-PSMA PET-CT as prognostic marker in 
patients with metastatic prostate cancer treated with Radium-223  
S.S. Medina-Ornelas, F. Garcia-Perez; Mexico City/MX 
(dr.sevastian@outlook.com)  
Purpose: Determine if 18F-NaF and 68Ga-PSMA PET/CT can predict response 
to 223Ra treatment in patients with metastatic prostate cancer (mPC). 
Methods and Materials: Twenty patients with metastatic castration-resistant 
PC (mCRPC), and seven patients with high-grade PC (hgPC), were evaluated 
with 18F-NaF and 68Ga-PSMA PET-CT prior to receipt 223Ra therapy a standard 
dose (55kBq/kg), and 4-6 weeks after the last dose, with simultaneous 
measurements of PSA and alkaline phosphatase (AP). A semiquantitative 
bayesian analysis of each patient allowed to establish 3 study groups based on 
the molecularly active volume: low-burden (<1000 cm³), medium-burden (1001-
3000 cm³); and high burden (>3001 cm³). Ten patients were classified as high-
burden, 7 patients as medium-burden and 10 patients as low-burden. 
Results: Fifteen patients completed 6 cycles (7-hgPC, 8-mCRPC). Nine were 
of low burden and six of medium-burden, which showed a decrease in PSA 
and AP levels (p <0.05); the rest of patients according to the number of doses 
variable results was obteined; the value of 18F-NaF and 68Ga-PSMA as a 
predictive tool in response therapy according to the degree of tumour burden. 
Patients with low-burden treated with 223Ra showed to be a predictor of good 
prognosis in response to treatment (p <0.05); while patients with high-burden 
have a high probability of do not complete 6 cycles. 
Conclusion: The PET-CT in the evaluation of response to 223Ra is useful tool 
in the selection of those patients who are likely to improve according to their 
degree of overall tumour burden, in addition to timely evaluation of therapeutic 
efficacy.  
B-1254 15:12  
Assessment of response to therapy in bone metastases from prostatic 
malignancy beyond mono-exponential diffusion imaging  
R. Balaji; Chennai/IN (ravikanthbalaji@gmail.com)  
Purpose: To evaluate performance of intra-voxel incoherent motion model of 
diffusion imaging in monitoring treatment response in bone metastases from 
prostatic malignancy and possible identification of early androgen resistance. 
Methods and Materials: 36 patients with histologically proven prostatic 
malignancy with bone metastases on whole body diffusion imaging (using 
  






DWIBS sequence) with no prior treatment with anti-androgens were included in 
the study. Imaging was performed on Achieva 1.5 Tesla scanner (Philips 
Healthcare, Best, The Netherlands) the day after commencement of 
antiandrogen therapy and thereafter at 3 time points: 2 weeks, 3 months and 6 
months. Lesions in iliac bones or sacrum were analysed. Images were 
acquired in an axial plane with 11 b values. IVIM parameters (perfusion fraction 
[f], molecular diffusion coefficient [D], and perfusion-related D [D*]) and 
apparent diffusion coefficient (ADC) were obtained. 
Results: D values (P 0.001) were the most sensitive, robust and reproducible 
indicator for response. D values increased in the first 2 weeks of therapy and 
continued to rise and plateaued off after 3 months. f values increased after one 
month and remained stable till 3 months but showed further increase at 6 
months. ADC values derived from mono-exponential equation also showed 
elevation after therapy. 
Conclusion: D values derived from IVIM model demonstrated very good 
measurement repeatability and sensitive to treatment response. f values 
provide complimentary data to identify tumour response. Thus, a combination 
of ADC, D and f values would provide non-invasive monitoring of therapy and 
possibly predict early resistance to treatment.  
14:00 - 15:30 Sky High Stage  
Abdominal Viscera  
MY 15  
Abdominal and Gastrointestinal  
Moderators:  
M. Dewey; Berlin/DE  
M. Zins; Paris/FR  
B-1255 14:00  
The efficacy of MRI in the diagnostic work-up of cystic fibrosis-
associated liver disease  
S. Pötter-Lang, K. Staufer, P.A.T. Baltzer, D. Tamandl, D. Muin, 
N. Bastati-Huber, E. Halilbasic, L. Kazemi-Shirazi, A. Ba-Ssalamah; Vienna/AT 
(sarah.poetter-lang@meduniwien.ac.at)  
Purpose: To identify independent imaging features and establish a diagnostic 
algorithm for early diagnosis of cystic fibrosis-associated liver disease (CFLD) 
in CF patients as compared with a control group (CG) on gadoxetic acid-
enhanced MRI. 
Methods and Materials: 90 adult patients were enrolled, 50 with CF and 40 of 
the CG. The CF group was divided in two subgroups, the retrospective or test 
subgroup (n = 33) and the prospective or validation subgroup (n = 17). The CG 
(patients with normal liver enzymes, but no more than benign focal liver 
lesions) was divided also accordingly (27:13). MRI variables including 
quantitative and qualitative parameters were used to distinguish those with 
CFLD from the CG using the clinical criteria by Debray. Fifteen qualitative 
single-lesion CF descriptors were defined. Two readers independently 
evaluated the images. Univariate statistical analysis was performed to obtain 
the significant imaging features that differentiate CF patients from the CG. 
Subsequently, a multivariate classification analysis using the chi-squared 
automatic interaction detector (CHAID) methodology was performed to identify 
the most important descriptors. Diagnostic performance was assessed by 
receiver-operating characteristic (ROC) analysis. 
Results: Three independent imaging descriptors distinguished CFLD from CG: 
a) the presence of altered gallbladder morphology (GBAM); b) periportal 
tracking (PPT) and c) periportal fat deposition (PPFD). Prospective validation 
of the classification algorithm demonstrated a sensitivity of 94.1 % and 
specificity of 84.6 % for discriminating CFLD from the control cohort. 
Conclusion: We identified 3 independent imaging features that could 
potentially diagnose early-stage CFLD on unenhanced MRI.  
B-1256 14:04  
T1 mapping on gadoxetic acid-enhanced MR imaging potentially predicts 
recurrence of HCC after hepatectomy  
W.T. Wang, S. Zhu, Y. Ding, L. Yang, C.-Z. Chen, Q.-H. Ye, M.-S. Zeng, 
S.-X. Rao; Shanghai/CN (787356268@qq.com)  
Purpose: The enhancement on hepatobiliary phase on gadoxetic acid-
enhanced magnetic resonance imaging (MRI) could reflect biological 
properties of hepatocellular carcinoma (HCC). The retrospective study aimed 
to evaluate the prognostic significance of T1 mapping on gadoxetic acid-
enhanced MRI in prediction of recurrence of single nodular HCC ( 3cm) after 
hepatectomy. 
Methods and Materials: A total of 107 patients with single nodular HCC ( 
3cm) who underwent preoperative gadoxetic acid-enhanced MRI followed by 
hepatectomy was included retrospectively. Independent prognostic MR 
imaging findings were identified on multivariate analysis. Based on the optimal 
cut-off value of the receiver operating characteristic (ROC) curve analysis, 
cumulative recurrence rates were compared between groups of low and high 
reduction rate of T1 relaxation time. 
Results: Reduction rate of T1 relaxation time (P =0.001; hazard ratio = 0.08; 
95% confidence interval [CI]: 0.02-0.38) and non-hypervascular hypointense 
nodules (P =0.042; hazard ratio = 2.21; 95% CI: 1.03-4.77) in preoperative 
gadoxetic acid-enhanced MRI were independently related to recurrence of 
HCC after hepatectomy. The area under ROC curve analysis of reduction rate 
of T1 relaxation time was 0.802. Patients with lower reduction rates ( 44.8%) 
group had higher cumulative recurrence rates. A combination of these two risk 
factors in patients with single HCC had significantly higher recurrence rates 
compared to those with either or none of the two risk factors during the years 
of follow-up. 
Conclusion: Reduction rate of T1 relaxation time in combination with the 
presence of non-hypervascular hypointense nodules can potentially predict 
recurrence of HCC after hepatectomy.  
B-1257 14:08  
Magnetic resonance imaging of hepatitis B virus-related hepatocellular 
carcinoma: correlations with imaging features and molecular marker 
glypican-3  
S. Wang, J.H. Li; Beijing/CN (wangsudan815@163.com)  
Purpose: To investigate whether imaging features from dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI) could aid in the prediction 
of pathological grading of hepatocellular carcinoma (HCC) related to hepatitis 
B virus (HBV) cirrhosis, by correlation analysis between lesion signal intensity 
variation in MRI and glypican (GPC)-3 immunohistochemistry. 
Methods and Materials: Seventy-four patients with HBV-related HCC (22 
cases well-differentiated HCC, 33 cases moderately differentiated, and 19 
poorly differentiated) underwent DCE-MRI and biopsy before any targeted 
therapy. Signal intensity variance ratio was used to assess the image contrast 
between the region of interest (ROI) of tumours and liver parenchyma, by two 
radiologists who independently drew the ROI and calculated signal variance 
ratio on MRI images. GPC-3 expression grading was evaluated with 
immunohistochemistry. 
Results: Low GPC-3 expression level was observed predominantly in well-
differentiated HCC, whereas high GPC-3 expression level was observed 
predominantly in poorly and moderately differentiated HCC (p<0.05). We 
observed a significant correlation between GPC-3 expression and lesion signal 
intensity variance ratio in the arterial enhancement phase (r=0.323, p=0.005), 
as well as between GPC-3 expression and lesion signal intensity variance ratio 
from T2-weighted images (r=0.276, p=0.017). However, no correlation was 
found between GPC-3 grade and signal variance ratio in hepatic portal venous 
and late phases. 
Conclusion: GPC-3 expression level of HCC showed a favorable diagnostic 
performance in differentiating well-differentiated from poorly differentiated 
HCC. Signal intensities in arterial phase and T2WI were well correlated with 
the degree of GPC-3 expression in HBV-cirrhosis-related HCC. Consequently, 
some MRI parameters are expected to non-invasively predict differentiation 
stages of HCC before biopsy or surgery.  
B-1258 14:12  
Differentiation of inflammatory pseudo-tumour from colorectal liver 
metastases on gadoxetic acid-enhanced magnetic resonance imaging  
S. Ichikawa, U. Motosugi, T. Suzuki, T. Shimizu, H. Onishi; Chuo-shi/JP  
Purpose: To determine the differential features of inflammatory pseudo-tumour 
(IPT) from colorectal liver metastases (CLM) on gadoxetic acid-enhanced 
magnetic resonance imaging (MRI). 
Methods and Materials: This retrospective study was approved by the 
institutional review board, and waived informed patient consent. One hundred 
and thirty-four patients with pathologically proven or clinically diagnosed IPT (n 
= 25) and CLM (n = 109) who had undergone gadoxetic acid-enhanced MRI 
were enrolled. Images were analysed for the shape, enhancement pattern on 
hepatic arterial phase (HAP), persistent rim-enhancement during HAP to late 
phase, blood vessel penetration, peri-tumoural enhancement on HAP, peri-
tumoural hypointensity on hepatobiliary phase (HBP), peri-tumoural 
hyperintensity on T2-weighted imaging (T2WI), biliary dilatation, target 
appearance (central hypointense area with peripheral hyperintense rim) on 
HBP, signal pattern of diffusion-weighted imaging (DWI) and T2WI, and lesion-
to-liver signal intensity ratio (LLR) on HBP and DWI. Univariate and 
multivariate analyses were performed to identify relevant differentiating 
features between ITP and CLM. 
Results: Univariate analysis revealed that the following significant parameters 
favour IPT over CLM: irregular shape, hyperenhancement on HAP, blood 
vessel penetration, target appearance on HBP, peri-tumoural hyperintensity on 
T2WI, absence of persistent rim-enhancement, high LLR on HBP, and low LLR 
on DWI (P < 0.0001-0.0361). Multivariate analysis revealed that target 
appearance on HBP, high LLR on HBP, and low LLR on DWI were predictive 
of IPT (P = 0.0220-0.0330). 
  






Conclusion: Target appearance on HBP and LLR on HBP and DWI were the 
reliable imaging features for distinguishing IPT from CLM on gadoxetic acid-
enhanced MRI.  
B-1259 14:16  
Dynamic-enhanced CT of multiple solid pancreatic lesions: prevalence 
and features of non-malignancies  
L. Zhu, J. Li, Z.-y. Sun, H.-d. Xue, Z.-y. Jin; Beijing/CN 
(zhuliang_pumc@163.com)  
Purpose: To determine the prevalence of multiple solid pancreatic lesions on 
dynamic enhanced CT in a large cohort of patients with suspected pancreatic 
diseases, and to describe CT features of non-malignant disease entities. 
Methods and Materials: We investigated 8096 consecutive patients who 
underwent dynamic enhanced CT pancreas protocol at a tertiary pancreatic 
disease center (June 2014 to August 2017). The final clinical diagnosis was 
used to determine the prevalence of malignant and non-malignant courses. 
The diagnostic accuracy of dynamic enhanced CT for non-malignancies was 
calculated. Univariate and multivariate analyses were conducted to identify 
clinical and CT findings (age, gender, symptoms, serum biomarkers and CT 
morphological and enhancement features) that predict non-malignancy. 
Results: Multiple solid pancreatic lesions were seen in 1.5% of patients with 
suspected pancreatic diseases (121/8096). The prevalence of non-
malignancies was 19.8%(24/121). The most common non-malignancy was 
autoimmune pancreatitis (17.4%, 21/121). The most common malignancies 
were neuroendocrine tumours (51.2%, 62/121), pancreatic adenocarcinoma 
(as the dominant lesion, 12.4%, 15/121), metastases (7.4%, 9/121) and 
lymphoma (5.8%, 7/121). In patients with multiple solid pancreatic lesions, 
dynamic enhanced CT had a sensitivity of 79.2% and a specificity of 92.8% for 
diagnosing non-malignancies. Elevated serum IgG4 level (p<0.001), 
hypoenhancement in arterial phase (p=0.001), non-hypoenhancement in later 
phases (p=0.009) and location in both proximal and distal pancreas (p=0.036) 
were found to be predictors of non-malignancies. 
Conclusion: Multiple solid pancreatic lesions were rare, with a wide disease 
spectrum. Dynamic enhanced CT provides clues for determining disease 
nature.  
B-1260 14:20  
Diagnostic accuracy and interobserver agreement: CEUS-LI-RADS vs 
MRI-LI-RADS  
B. Schellhaas, M. Hammon, D. Strobel, R. Görtz, A. Cavallaro, R. Janka, 
M.F. Neurath, M. Uder, H. Seuss; Erlangen/DE 
(hannes.seuss@uk-erlangen.de)  
Purpose: We compared diagnostic accuracy and interobserver-agreement for 
the recently introduced contrast-enhanced ultrasound (CEUS)-based algorithm 
CEUS-LI-RADS (liver imaging reporting and data system) versus the well-
established magnetic resonance imaging (MRI)-LI-RADS for non-invasive 
diagnosis of hepatocellular carcinoma (HCC) in high-risk patients. 
Methods and Materials: Focal liver lesions in 50 high-risk patients (mean age 
66.2 ±11.8 years; 39 male) were assessed retrospectively with CEUS and MRI. 
Two independent observers reviewed CEUS and MRI examinations, 
respectively, classifying observations according to CEUS-LI-RADSv.2016 and 
MRI-LI-RADSv.2014. Interobserver agreement was assessed with Cohen’s 
Kappa. Diagnostic accuracy for histologically proven lesions (n=36) was 
compared between CEUS-LI-RADS and MRI-LI-RADS. 
Results: 43 lesions were HCCs; two were ICCs; five were benign lesions. 
Diagnostic accuracy was 64%/50% (observer 1/2) for CEUS-LI-RADS and 
81%/75% (observer 1/2) for MRI-LI-RADS. Washout was observed more 
frequently with MRI. Interobserver-agreement for arterial hyperenhancement 
was -=0.511/0.565 (CEUS/MRI), for washout it was -=0.490/0.582 
(CEUS/MRI), and for CEUS-LI-RADS category it was 0.309/0.609 
(CEUS/MRI). 
Conclusion: CEUS-LI-RADS in its current form is inferior to MRI-LI-RADS for 
definite diagnosis of HCC (LR-5). Arterial hyperenhancement is the key feature 
for diagnosis of HCC with CEUS. Combining the LR-4 and LR-5 categories in 
CEUS-LI-RADS would improve diagnostic accuracy, sensitivity and interreader 
agreement.  
B-1261 14:24  
Evaluating autoimmune pancreatitis under corticosteroid treatment with 
T1 mapping  
L. Zhu1, H.-D. Xue1, Z.-Y. Sun1, D. Nickel2, T.-Y. Qian1, Z.-Y. Jin1; 1Beijing/CN, 
2
Erlangen/DE (zhuliang_pumc@163.com)  
Purpose: To evaluate the T1 relaxation time of autoimmune pancreatitis (AIP) 
in the native state and its change after corticosteroid treatment (CST). 
Methods and Materials: The institutional review board approved this 
prospective study and all patients provided written informed consent. Twelve 
patients with focal AIP and 22 patients with diffuse AIP received pancreatic MR 
including T1 mapping on a 3T scanner, both before and after steroid treatment. 
Twenty patients without pancreatic diseases who received T1 mapping of the 
pancreas served as control. In each patient, T1 relaxation time of pancreatic 
parenchyma in the head, body and tail was measured. 
Results: The T1 relaxation time of normal pancreatic parenchyma was 
785.4±49.5 msec. For both focal and diffuse AIP, the T1 relaxation time was 
significantly elongated compared to the control (both p<0.001). After 4-12 
weeks of CST, the T1 relaxation time of the pancreas shortened significantly 
towards normalization, compared to the baseline value (for focal AIP: from 
1220.7±139.3 msec to 931.7±86.4 msec; and for diffuse AIP: from 
1104.5±121.8 msec to 893.8.4±108.4 msec, both p<0.01). The visually 
uninvolved parenchyma in focal AIP had longer T1 relaxation time compared to 
normal pancreas (p<0.01), which also shortened significantly after steroid 
treatment (from 918.7±128.9 msec to 831.1±94.3 msec, p<0.01). 
Conclusion: T1 mapping could accurately depict the inflammatory state and 
extent in patients with AIP, and monitor parenchyma change with treatment. T1 
mapping detects more extensive parenchyma involvement in focal AIP, 
compared to visual inspection.  
B-1262 14:28  
Non-hypervascular pancreatic neuroendocrine tumours: spectrum of 
MDCT imaging findings and differentiation from pancreaticductal 
adenocarcinoma  
E. Belousova, G. Karmazanovsky; Moscow/RU (mestre@inbox.ru)  
Purpose: To determine contrast-enhanced MDCT features to differentiate 
nonhypervascular pancreatic neuroendocrine tumors (PNETs) from pancreatic 
ductal adenocarcinomas (PDACs). 
Methods and Materials: We included 74 patients with PNETs and 80 patients 
with PDACs who underwent preoperative MDCT. Two radiologists evaluated 
the morphologic characteristic and enhancement patterns of the tumors. 
Tumor-to-pancreas enhancement ratio was defined as the HU value of the 
tumor divided by the HU value of the pancreas. The possibilities of PNET or 
PDAC were estimated for nonhypervascular PNETs. 
Results: On the basis of arterial enhancement, 43 PNETs were hypervascular 
and 31 were nonhypervascular. When compared to PDAC, nonhypervascular 
PNETs more frequently had well-defined tumor margins, intratumoral cystic 
components, calcifications and blood vessels and less frequently had main 
pancreatic duct dilatation, peripancreatic infiltration and vascular invasion 
(p<0.01 for all). Nonhypervascular PNETs had higher tumor-to-pancreas 
enhancement ratio in venous phase (1.02vs.0.78,p<0.05). Nonhypervascular 
PNETs more often had portal-venous hyperenhancement or persistent 
isoenhancement, while PDAC more often had persistent hypoenhancement or 
gradual delayed enhancement (p<0.001). The most accurate MDCT-findings to 
predict nonhypervascular PNET were the absence of MPD dilatation and 
peripancreatic infiltration (79% and 92% accuracy), portal-venous phase 
hyperenhancement or persistent isoenhancement (77%), the presence of 
intratumoral blood vessels (77%) and relative enhancement intensity in venous 
phase >0.9(76%). Using these criteria, the area under curve for differentiation 
of PNET from PDAC was 0.906-0.846. 
Conclusion: Combined assessment of the enhancement and morphologic 
characteristics can improve the diagnosing of nonhypervascular PNETs at 
contrast-enhanced MDCT, reducing the rate of false diagnoses of 
nonhypervascular PNETs as PDAC.  
B-1264 14:32  
Application of CT texture analysis in evaluating histologic grade of 
pancreatic neuroendocrine tumours  
S.-h. Cheng1,2, L. Zhu1, H. Xue1, Z. Jin1; 1Beijing/CN, 2Chengdu/CN 
(1025518057@qq.com)  
Purpose: To explore the application of CT texture analysis (CTTA) to 
differentiate between G1 versus G2 and G3 pancreatic neuroendocrine 
tumours (PanNETs).  
Methods and Materials: A total of 36 patients with G1 PanNETs (n = 18) and 
G2+G3 PanNETs (n = 18) were included in this retrospective study. Both 
unenhanced and enhanced CT images were chosen for CTTA. Texture 
parameters including mean grey-level intensity (mean), standard deviation 
(SD), entropy, mean of positive pixels (MPP), skewness, and kurtosis were 
compared between G1 and G2+3 PanNETs. Receiver operating characteristic 
(ROC) analysis was performed and the area under the ROC curve (AUC) was 
calculated. Sensitivity (Se), specificity (Sp), positive predictive value (PPV), 
negative predictive value (NPV), and accuracy were calculated using the cut-
off value of texture parameter with the highest AUC. 
Results: Compared to G2+G3 PanNETs, G1 PanNETs had significantly lower 
skewness (P = 0.031) on unenhanced images and lower skewness (P < 0.05), 
higher mean (P = 0.047) and MPP (P < 0.05) on enhanced images. A 
skewness <0.23 at medium texture scale on enhanced images identified G1 
PanNETs from G2+G3 PanNETs with the highest AUC of 0.724 ± 0.091 (Se = 
61.1%, Sp = 94.4%, PPV = 91.6%, NPV = 70.8%, and accuracy = 77.8%). 
 
  






Conclusion: CTTA proved to be a feasible tool for differentiating G1 PanNETs 
from G2+G3 PanNETs. Skewness quantified from medium texture scale on 
enhanced images was the optimal diagnostic parameter for estimating 
histologic grade of PanNETs.  
B-1265 14:36  
The efficacy of superb microvascular imaging for diagnosing acute 
cholecystitis: comparison with conventional ultrasonography  
J. Ra, E. Lee, H. Park, J. Lee, S. Park, B. Choi; Seoul/KR 
(joonbi89@naver.com)  
Purpose: To evaluate the diagnostic performance of ultrasonography (US) 
plus superb microvascular imaging (SMI) compared to conventional US alone 
for diagnosing acute cholecystitis. 
Methods and Materials: We retrospectively investigated 54 patients with right 
upper quadrant abdominal pain who underwent US with SMI. The pixel count 
of SMI showing flow signal was measured in the region of interest of the 
gallbladder bed of the liver. Two radiologists independently evaluated the 
imaging features and rated the five-point diagnostic likelihood level before 
versus after the addition of SMI using the optimal cut-off SMI pixel count 
obtained by the receiver operating characteristic (ROC) curve. Multivariate 
logistic regression analysis identified predictive factors for acute cholecystitis. 
Pairwise comparison of ROC was performed to compare the diagnostic 
performance of US before versus after the addition of SMI. 
Results: Of the 54 patients, 29 had acute cholecystitis confirmed by 
cholecystectomy or percutaneous cholecystostomy. The SMI pixel count was 
significantly higher in acute than in non-acute cholecystitis (169.84 versus 
27.48, p < 0.001). The optimal SMI cut-off pixel count for predicting acute 
cholecystitis was 56.67 with 82.8% sensitivity and 92.0% specificity. In 
multivariate analysis, SMI pixel count and gallbladder wall thickening were 
significant predictive factors (p < 0.05). Area under the curve values were 
significantly higher after the addition of SMI than before (0.850 versus 0.729, p 
= 0.022). 
Conclusion: Quantitative SMI values were significantly higher in acute than in 
non-acute cholecystitis. US plus SMI could objectively improve diagnostic 
performance compared with conventional US alone for acute cholecystitis.  
B-1266 14:40  
MR T2 mapping of hepatocellular carcinoma: sequence parameters 
optimisation and its correlation with Ki-67 proliferation status, 
histological grades and microvascular density  
L. Cao, B. Song; Chengdu/CN (clk2089@icloud.com)  
Purpose: To optimise T2 mapping imaging parameters in liver and explore the 
relationship between T2 relaxation time of HCC and histological results. 
Methods and Materials: (I) Ten healthy volunteers were examined to optimise 
T2-prepared TrueFISP parameters to acquire the best quality of T2 map. (II) 
Thirty-five HCC patients were included. T2 map was acquired through T2-
prepared TrueFISP on a 3T scanner. Freehand ROI was placed in HCC solid 
regions to measure T2 value. The relationship between Ki67 indices, 
microvascular density (MVD) and T2 was determined by correlation analysis. 
ANOVA was used to evaluate the statistical differences of T2 among 
histopathological groups. ROC analysis of discriminating well-differentiated 
(grade I) from moderately-(grade II) and poorly-differentiated (grade III and IV) 
HCC was performed for T2. 
Results: (I) Three T2-prepared images with length of 0, 25 ms, 55 ms could 
provide the best quality of T2 map and meanwhile the shortest breath-holding 
time. (II) T2 value of poorly-, moderately- and well-differentiated HCC were 
(40.6±3.2) ms, (42.9±2.8) ms and (49.6±3.9) ms, respectively, and there were 
significant differences among them (p < 0.001). T2 value demonstrated good 
diagnostic performance (AUC = 0.94) for discriminating well-differentiated HCC 
from the others, with sensitivity of 83.3% and specificity of 72.4% respectively. 
T2 value were significant negatively correlated with Ki67 indices (rho = -0.546 
,p=0.037 ) and MVD (rho = -0.679 ,p= 0.009). 
Conclusion: T2 value demonstrated moderate correlations with tumour 
proliferation status and neovascularisation. Quantitative measurement of T2 
value offers a potential way for non-invasive evaluation of HCC malignancy.  
B-1267 14:44  
Readout-segmented echo-planar diffusion-weighted MR for the 
evaluation of aggressive characteristics of rectal cancer  
X. Chunchao, Z.-L. Li; Chengdu/CN (xiachunchao@126.com)  
Purpose: To evaluate whether aggressive characteristics of rectal cancer can 
be predicted by the apparent diffusion coefficient (ADC) obtained using 
readout-segmented echo-planar imaging (rs-EPI) diffusion-weighted magnetic 
resonance. 
Methods and Materials: One hundred and fifteen patients were enrolled. The 
image quality of ADC maps obtained using rs-EPI was compared with that 
using traditional single-shot echo-planar imaging (ss-EPI), and ADC 
measurement was performed on the rs-EPI based ADC maps. Differences in 
ADC values of tumors grouped according to differentiation grade, clinical T 
stage and plasmatic carcinoembryonic antigen (CEA) level were tested. The 
correlation between each aggressive characteristic and the corresponding 
ADC values was evaluated. 
Results: The image quality of ADC maps obtained by rs-EPI was superior to 
that of ss-EPI (P <0.05). The ADC values of tumor were categorized based on 
the following differentiation grades: poor (0.89 ± 0.12 × 10-3 mm2/s), moderate 
(1.13 ± 0.25 × 10-3 mm2/s), and good (1.31 ± 0.19 × 10-3 mm2/s); P <0.001. 
Tumors with lower differentiation grades corresponded to lower ADC values (r 
= 0.59, P <0.001). However, significant differences were not observed in 
different clinical T stage (1.16 ± 0.19 × 10-3 mm2/s vs. 1.15 ± 0.28 × 10-3 mm2/s 
vs. 1.08 ± 0.21 × 10-3 mm2/s vs. 1.15 ± 0.20; P = 0.47) and plasmatic CEA level 
(1.14 ± 0.26 × 10-3 mm2/s, vs. 1.03 ± 0.35 × 10-3 mm2/s, P = 0.06). 
Conclusion: rs-EPI sequence-based ADC values represent a potential 
imaging marker for the assessment of aggressive rectal cancer characteristics.  
B-1269 14:48  
Comparison of liver stiffness measurements between point shear wave 
elastography (ElastPQ) and two-dimensional shear wave elastography 
(ElastQ Imaging) equipped on a same machine  
W. Hong1, S.M. Lee1, M.J. Kim1, H. Ha1, K. Lee1, D. Lee2, S. Lee1; 
1
Anyang/KR, 2Seoul/KR (wj.jenny29@gmail.com)  
Purpose: To prospectively compare applicability rate between point shear 
wave elastography (pSWE, ElastPQ) and a new two-dimensional shear wave 
imaging (2D-SWE, ElastQ Imaging) and to correlate liver stiffness (LS) values 
measured by the two elastographic techniques equipped on a same machine 
in the same population. 
Methods and Materials: We prospectively enrolled 152 patients (82 men, 70 
women; age 20-83 years) , 62 of whom were previously diagnosed with chronic 
liver disease. LS values were measured in the same session using two 
techniques equipped on a same ultrasound machine (EPIQ7G). The 
applicability rates of the two techniques were compared by Chi square test. LS 
values obtained by the two techniques were correlated and compared using 
Spearman correlation coefficient and Wilcoxon signed-rank test. For the 
assessment of agreement of LS value measurement, we used 95% Bland-
Altman limit of agreement. 
Results: The applicability rate of ElastQ Imaging (139/152, 91.4%) was 
significantly higher than that of ElastPQ (115/152, 75.7%) (P=0.001). The LS 
values obtained by the two techniques showed strong correlation (r=0.866, 
P<0.001). The 95% limit of agreement of the two techniques was ranged from -
53.7% to 36.2%. The mean LS value of ElastQ Imaging (6.49 ± 3.95 kPa) was 
significantly higher than that of ElastPQ (5.88 ± 3.29 kPa) (P<0.001). 
Conclusion: ElastQ Imaging showed better applicability rate than ElastPQ. 
However, LS values obtained by ElastQ Imaging was significantly higher than 
those obtained by ElastPQ. In addition, the two techniques are not 
interchangeable due to the large limit of agreement.  
B-1270 14:52  
MRI-detected extramural vascular invasion is one of the strongest risk 
factors in predicting distant metastasis in rectal cancer  
P. Tripathi1, S. Rao1, W. Guo1, B. Rai2, M.-S. Zeng1; 1Shanghai/CN, 
2
Wuhan/CN (pratik9_band@hotmail.com)  
Purpose: Extramural vascular invasion (EMVI) has been recommended as an 
independent prognostic factor for poor overall survival rate in rectal cancer. We 
aimed to evaluate the MRI-detected extramural vascular invasion (mrEMVI) in 
predicting distant metastasis in T3 rectal cancer. 
Methods and Materials: Post-operative histopathologically confirmed T3 
rectal cancer patients without previous treatment from July 2014 to December 
2016 were enrolled for this study. Two blinded radiologists evaluated location 
of the tumour, the degree of mesorectal extension and MRI detected 
extramural vascular invasion (mrEMVI). mrEMVI was further categorized into 
EMVI positive and EMVI negative in T2-weighted image using mrEMVI scoring 
system. The results along with other clinical characteristics (age, sex, tumour 
location, MRI detected distance of mesorectal extension, lymphatic invasion, 
perineural invasion, mrEMVI score and CEA) were then correlated with 
synchronous metastases to determine the risk factors using univariate and 
multivariate analyses. 
Results: In 180 patients, 38 patients were confirmed to be mrEMVI positive, 
142 patients mrEMVI negative. There were totally 34 patients with 
synchronous metastasis in which 25 were mrEMVI positive and 9 were 
mrEMVI negative. Three factors were significantly associated with synchronous 
metastasis: mrEMVI (p=0.001; odds ratio=8.665), histopathological lymphatic 
invasion (p=0.001; odds ratio=12.940) and preoperative CEA (p =0.026; odds 
ratio=4.124). mrEMVI score 4 was more liable for synchronous metastasis 
(p=0.044; odds ratio=9.429) than mrEMVI score 3 in rectal cancer. 
Conclusion: mrEMVI positive is an independent risk factor for synchronous 
distant metastasis in rectal cancer. mrEMVI score 4 is a strong risk factor for 
synchronous metastasis than mrEMVI score 3 in rectal cancer.  
  






B-1271 14:56  
Radiomics analysis for preoperative prediction of synchronous distant 
metastasis in patients with rectal cancer  
H. Liu, C. Zhang, J. Li, D. Wang; Shanghai/CN (liuhuanhuan0117@163.com)  
Purpose: To investigate the value of radiomics analysis for preoperative 
prediction of synchronous distant metastasis in patients with rectal cancer. 
Methods and Materials: A total of 177 patients with histopathologically 
confirmed rectal cancer who underwent high-resolution MR imaging before any 
treatment were divided into the primary cohort (n=123) and the validation 
cohort (n=54). Radiomics features were extracted from oblique axial T2-
weighted images of each patient. The independent two-sample t test, Kruskal-
Wallis test, and Pearson correlation analysis were used for feature selection. A 
radiomics signature was built and multivariable logistic regression analysis was 
used to develop the radiomics model including radiomics features and 
independent clinico-radiologic risk factors. The performance of the radiomics 
model was assessed by its calibration, discrimination, and clinical usefulness. 
Results: A total of 385 radiomic features were extracted from each patient, 
and 9 radiomics features were selected for the radiomics signature. The 
radiomics model included radiomics signature, MR-reported lymph node status, 
and CA199. The model showed good discrimination and moderate calibration 
in the primary cohort and validation cohort, with a C-index of 0.840 (95% 
confidence interval (CI), 0.768-0.912) and 0.782 (95% CI, 0.648-0.916), 
respectively. Decision curve analysis confirmed the clinical utility of the 
radiomics model. 
Conclusion: We developed a radiomics model based on the MR radiomics 
features in combination with independent clinico-radiologic risk factors. The 
model could be used to predict synchronous distant metastasis in patients with 
rectal cancer, which could be helpful for individual treatment strategy.  
B-1272 15:00  
CT-based radiomics for prediction of neoadjuvant chemotherapy 
outcomes in locally advanced gastric cancer: a pilot study  
Z. Li; Kunming/CN (lizhenhui621@qq.com)  
Purpose: To investigate the wealth of radiomics for pretreatment CT in 
prediction of pathological response of locally advanced gastric cancer with 
preoperative chemotherapy. 
Methods and Materials: Thirty consecutive patients with CT-staged II/III 
gastric cancer receiving neoadjuvant chemotherapy were enrolled. All patients 
underwent unenhanced, late arterial phase (AP) and portal venous phase (PP) 
of the abdomen CT scans. In total, 19,985 radiomic features were extracted in 
AP and PP for each patient, respectively. Four methods were adopted in 
feature selection and 6 methods were used in the process of building the 
classifier model. Twenty-four combinations of feature selection and 
classification methods were examined. ROC curves were used to evaluate the 
capability of each combination of feature selection and classification method to 
predict non-good response evaluated with tumour regression grade. 
Results: The mean AUC ranged from 0.760 to 0.954 in AP and from 0.671 to 
0.925 in PP according to different combinations of feature selection and the 
classification method. For both AP and PP, the feature selection method of 
lasso + classifier of lasso achieved the highest prognostic performance (AUC, 
0.954 ± 0.064 and 0.925 ± 0.073, respectively). For the combination of AP and 
PP (AP+PP), the AUC was 0.965. There was no statistical difference between 
AP and PP, AP and AP+PP, PP and AP+PP in the highest prognostic 
performance (all P>0.05). 
Conclusion: It is possible to predict non-GR after neoadjuvant chemotherapy 
in locally advanced gastric cancers based on the radiomics of CT.  
B-1273 15:04  
Can emergency CT reliably detect significant blunt bowel and mesenteric 
injury?  
N. Keller, T. Zingg, F. Agri, J.-F. Knebel, S. Schmidt Kobbe; Lausanne/CH 
(keller.nathalie@chuv.ch)  
Purpose: To evaluate and compare two previously validated imaging-based 
scoring systems for the detection of significant blunt bowel and mesenteric 
injury (sBBMI) by emergency computed tomography (CT). 
Methods and Materials: We consecutively included all our polytrauma 
patients addressed from 2008 to 2015 to our emergency department (trauma 
registry cohort) following a road traffic accident provided that they had 
undergone abdominal CT before surgery. In consensus, two radiologists, 
blinded to patients’ outcome, reviewed all the CT examinations in view of 6 
mesenteric, 4 intestinal and 9 other abdominal trauma CT findings. The latter 
were then correlated with patients’ surgical outcome or clinical follow-up 
(>24h). Furthermore, two previously validated imaging-based bowel-injury 
scoring systems were compared with each other by applying them on our 
cohort (t test, Chi-square test). 
Results: Among 681 analysed patients 21 (3.1%) had sBBMI, confirmed by 
emergency laparotomy. Pneumoperitoneum, small hemoperitoneum, diffuse 
bowel wall thickening, mesenteric or pericolic stranding, vascular 
extravasation, and anterior abdominal wall injury were significantly correlated 
with sBBMI, as were each of the two scoring systems, the Faget and Mc Nutt 
score (p<0.001). 
Conclusion: The prevalence of sBBMI among polytrauma patients is low; 
however, early diagnosis is necessary. Certain CT-features are pathognomic; 
thus, they must not be overlooked. Scoring systems may be helpful, but do not 
seem mandatory for the detection of significant blunt bowel and mesenteric 
injury.  
B-1274 15:08  
MRI vs FDG PET-CT for response assessment after neoadjuvant 
chemoradiotherapy in oesophageal cancer  
S.E. Vollenbrock, F.E.M. Voncken, D.M. Lambregts, M. Maas, E. Vegt, 
L.C. ter Beek, B.M.P. Aleman, R.G.H. Beets-Tan, A. Bartels-Rutten; 
Amsterdam/NL (s.vollenbrock@nki.nl)  
Purpose: The debate nowadays is whether patients with oesophageal cancer 
who show clinical complete response (cCR) after neoadjuvant 
chemoradiotherapy (nCRT) could be deferred from resection. Critical is an 
accurate response assessment tool. FDG-PET-CT is current clinical routine to 
rule out distant metastases, but is suboptimal for local tumour restaging. We 
determined the performance of MRI compared with FDG-PET-CT for response 
assessment after nCRT. 
Methods and Materials: Twenty-three patients with locally advanced 
oesophageal cancer underwent FDG-PET-CT and MRI (1.5T; T2W&DWI;b-
values=0,200,800s/mm2) before and after nCRT with a maximum of 21 days 
between imaging and surgery. One radiologist scored MRIs and one nuclear 
medicine physician scored FDG-PET-CTs, both using a 5-point score 
(1=definite cCR, 3=inconclusive/equivocal, 5=definite residual tumour). 
Histopathology of the resection specimen was the reference standard 
(Mandard tumour regression grade 1=pCR,2-5=residual tumour). Areas under 
the ROC (AUROC), sensitivity and specificity were calculated considering 
imaging scores 3-5 tumour-positive. 
Results: Two patients were excluded due to poor image quality. Six (29%) of 
21 patients achieved a pCR. AUROC was 0.58 on PET-CT versus 0.80 on MRI 
(p = 0.056). Sensitivity for residual tumour was 67% on FDG-PET-CT and 93% 
on MRI, whereas specificity was 50% on FDG-PET-CT versus 57% on MRI. 
The number of equivocal scores was 6 on FDG-PET-CT and 3 on MRI. 
Conclusion: MRI shows a tendency towards higher accuracy than FDG-PET-
CT for the local assessment of tumour response. MRI shows a lower number of 
equivocal scores than FDG-PET-CT which may be because of better 
discrimination between treatment-related effects and residual tumour.  
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B-1275 16:00  
Comparison of double-reading of mammography-2D with single-reading 
of tomosynthesis plus synthesised mammography: is it time to change 
the way we work in breast-screening programme?  
S. Romero, J.L. Raya Povedano, M. Cara Garcia, A.L. Santos, 
M. Pedrosa Garriguet; Cordoba/ES  
Purpose: To evaluate single reading of tomosynthesis plus synthesised 
mammography compared with double-reading of mammography-2D as new 
screening strategy. 
Methods and Materials: Women (50-69) were invited to participate in this 
prospective study between January 2015 and December 2016, written 
informed consent was provided. Those who agreed underwent combined 
mammography plus tomosynthesis at the same time. The reading models 
were: 1) double-reading of mammography-2D (double-2D); 2) single-reading of 
tomosynthesis + synthesised mammography (single-3D). Each participant had 
three blind and independent readings. Five radiologists with exclusive 
dedication to breast imaging participated. 
Results: 16067 women participated. 98 cancers were detected in 97 
participants (one bilateral cancer), because we present data for 16068 
screens. 69 cancers were detected with both techniques (double-2D and 
single-3D), 7 cancers detected only at double-2D (4.7/1000) and 18 cancers 
only at single-3D (5.4/1000), showing a significant increase of 12.6% (95%IC: 
7.2%-21.2%, p=0.043). 1196 women were recalled, 250 recalls occurred with 
both techniques, 560 only at double-2D (5.0%) and 232 only at single-3D 
  






(2.9%), significant decrease of 40.5% (95%IC: 37.2-43.9%, p<.001). Both 
techniques detected similar cancer number in 3341 women baseline screened 
(23 double-2D and 22 single-3D). In 12727 women previously screened, 53 
cancers were detected at double-2D (4.2/1000) and 65 cancers at single-3D 
(5.1/1000), a significant increase in 18.5% (95%IC: 10.9-29.5%, p=.004). 
Conclusion: Single reading of tomosynthesis plus synthesised mammography 
allows a significant increase in cancer detection and decrease in recalls 
compared to double reading of mammography-2D, so it could be considered 
as new screening strategy.  
B-1276 16:04  
Radiomics signature from enhanced T1-weighted MR image helps to 
improve the differential diagnosis performance of sub-1cm breast mass  
L. Wang1, D. Wang1, X. Li2; 1Shanghai/CN, 2Guangzhou/CN 
(wanglijun@xinhuamed.com.cn)  
Purpose: To investigate the value of magnetic resonance imaging (MRI)-
based radiomics signature for differentiation of malignant from benign masses 
that manifest as sub-1cm breast masses. 
Methods and Materials: We enrolled 130 patients with 130 pathologically 
confirmed solitary and solid sub-1cm breast masses (training cohort: n=90; 
validation cohort: n=40) on MRI. The 130 masses included 94 benignities and 
36 malignancies. A total of 388 radiomic features were extracted from the 
second post-contrast enhanced T1-weighted MR image. A model 1 including 
the clinical and conventional MRI features was established. A model 2, which 
incorporated model 1 with radiomic features was constructed. Feature 
selection and model building were performed by logistic regression. 
Results: The radiomics signature, which consisted of seven selected features, 
was a significant diagnostic indicator in the differential diagnosis of the sub-
1cm breast mass in the training cohort (p=0.016). The model 2 yielded a C-
index of 0.885 in the training cohort and 0.862 in the validation cohort. The 
model 2 had a higher accuracy in differential diagnosis of sub-1cm masses 
than the model 1 both in the training cohort (80% vs. 75.6%) and the validation 
cohort( 85% vs. 70% ). Decision curve analysis demonstrated that the model 2 
had a higher overall net benefit than the model 1 with a significant difference 
(p=0.001). 
Conclusion: The radiomics signature is an independent diagnostic factor for 
the differential diagnosis of sub-1cm breast masses. Incorporating radiomics 
signature into clinical and conventional MRI features performed better in the 
differential diagnosis of sub-1cm breast masses.  
B-1277 16:08  
Correlation between optoacoustic imaging and molecular subtypes of 
malignant breast masses  
G. Menezes1, R.M. Pijnappel1, C. Meeuwis2, B. Bisschops3, J. Veltman4, 
P. Lavin5, M. van de Vijver6, R.M. Mann7; 1Utrecht/NL, 2Arnhem/NL, 
3
Dordrecht/NL, 4Almelo/NL, 5Framingham, MA/US, 6Amsterdam/NL, 
7
Nijmegen/NL (giselalgm@gmail.com)  
Purpose: OA/US fuses real time gray-scale ultrasound imaging with 
optoacoustic imaging using laser light. This enables simultaneous functional 
(relative de-oxygenation of hemoglobin) and morphologic imaging of breast 
masses using a hand-held duplex OA/US probe. In this study we assessed the 
correlation between OA/US features and histopathological findings of 
malignant breast lesions. 
Methods and Materials: For OA/US 3 internal and 2 external features were 
scored per lesion. Spearman correlation was used to analyze the relationship 
between these OA/US features and mitotic index. Pearson correlation 
coefficient was used to evaluate the correlation with percentages of ER, PR 
and Ki-67. One-way ANOVA was used to evaluate the correlation between the 
OA/US features and molecular subtypes. 
Results: Of 215 breast masses included in this prospective multicenter study, 
67 were malignant. A significant correlation was observed between the sum of 
3 OA/US internal feature scores and the mitotic index (p= 0.0352). There was a 
significant correlation between summed OA/US internal feature scores and KI-
67 percentages (p= 0.0250), and between summed OA/US internal feature 
scores and ER percentages (p= 0.0307). OA/US Internal Vessel Scores 
significantly distinguished Luminal A from Luminal B masses (p= 0.0221) and 
triple negative from HER-2 positive masses (p= 0.0440). Both summed internal 
and external OA/US Features helped to differentiate between Luminal A and 
triple negative masses (p= 0.0134). 
Conclusion: OA/US features may be used to differentiate among breast 
cancer molecular subtypes. They may also help to identify triple negative 
breast cancers.  
Author Disclosures: 
 P. Lavin: Consultant; Provided study design and analysis services to Seno 
Medical Instruments, Inc. (sponsor of the research project). 
 
 
B-1278 16:12  
Diagnostic values of magnetic resonance imaging in mammography 
detected BI-RADS 4 category calcifications  
Y. Jiang, H.-U. Kauczor; Heidelberg/DE (peggy_jiang@hotmail.com)  
Purpose: To assess the diagnostic value of magnetic resonance imaging 
(MRI) in suspicious calcification which were negative on ultrasound. 
Methods and Materials: A total of 338 suspicious calcification lesions were 
included in the study. Those calcifications were classified above BI-RADS 4 
category and negative on ultrasound between January 2013 and June 2016. 
277 lesions were sent to breast magnetic resonance imaging (MRI). Then 
evaluate mammography (MG) and MRI features of suspicious calcification 
lesions and correlate with pathologic results. 
Results: A total of 338 lesions, benign lesions 284 (84.0%), malignant lesions 
54 (16.0%). Benign calcifications were most presented as amorphous 
calcifications 74.3% (211/284), while malignant calcifications were most 
presented as fine pleomorphic calcifications 40.7% (22/54). In malignant 
calcifications 67.4% lesions were presented as non-mass enhancement, and 
mass enhancement were more common in malignant lesions than in benign 
lesions, (20.9% VS 3.4%, P<0.001). 11.6% lesions were presented as non 
enhancement while 75.2% benign calcifications were presented as non 
enhancement, (P<0.001). Persistent time-signal intensity curve (TIC) suggest 
benign lesions (82.8% VS 34.2%, P<0.001) while wash-out curve suggest 
malignant lesions (57.9% VS 13.8%, P<0.001). The detect sensitivity for 
ultrasound negative calcifications were 60.5% for MG and 88.4% for MRI, 
(P=0.003). The negative predictive value were 92.3% for MG and 97.5% for 
MRI, (P=0.015). 
Conclusion: MRI has higher sensitivity and negative predictive value (NPV) 
than MG. For ultrasound negative suspicious calcifications, the combination of 
MRI could improve the diagnostic efficiency.  
B-1279 16:16  
Characterising mammographic calcification as a prognostic biomarker 
for breast tumour phenotypes  
J. Li, Y. Song, Y. Wu, H. Cai, L. Li; Guangzhou/CN (lijiao@sysucc.org.cn)  
Purpose: To identify the relationship between histological types and 
calcification characteristics on mammography in breast carcinomas. 
Methods and Materials: Between January 2012 and January 2016, 755 
consecutive patients with calcified lesions on mammography were recruited, 
including 160 (21.2%) with ductal carcinoma in situ (DCIS), 272 (36.0%) with 
DCIS with invasion component (DCIS-I), and 323 (42.8%) with pure invasive 
ductal carcinoma (IDC). 568 features were extracted from microcalcification 
clusters. We applied the 10-fold cross-validation as the criterion for feature 
selection and classification. We compared the performance of seven 
classification methods based on clinical features alone. For radiomics alone or 
combined clinical features and radiomics signatures, five feature selection 
methods and the same seven classification methods were evaluated in terms 
of their performance. Probability estimates for the three prediction models in 
test cohort were compared by multivariate analysis of variance (MANOVA). 
Results: The mean age of pure-IDC patients was statistically older than DCIS-I 
and pure-IDC (P < .001); the proportion of dense breast in DCIS-I was higher 
than for other histological types (P < .001); mass prevalence was most 
frequent in pure IDC (P < .001). ROC curve analysis showed that clinical 
variables combined with radiomics signatures (AUC, 0.8463) was superior to 
clinical variables alone (AUC, 0.8161) and to radiomics signatures (AUC, 
0.7060) (P < .001) in discrimination pure-DCIS from pure-IDC. The 
combination methods XGBoost + logistic regression gave the highest 
prognostic performance. 
Conclusion: Microcalcifications on mammograms can help predict 
histopathological phenotypes.  
B-1280 16:20  
Intravoxel incoherent motion diffusion-weighted magnetic resonance 
imaging in characterisation of axillary lymph nodes: preliminary animal 
experience  
Y. Zhu, X. Li, F. Wang, Z. Ye; Tianjin/CN (zhuyueqiang1985@126.com)  
Purpose: To investigate the diagnostic value of intravoxel incoherent motion 
(IVIM) diffusion-weighted imaging (DWI) for discriminating axillary metastatic 
from non-metastatic lymph nodes (LNs) in rabbit models. 
Methods and Materials: The institutional animal care and use committee 
approved this study. Forty New Zealand white rabbits were randomly divided 
into two groups. The axillary LN models were created by inoculating VX2 cell 
suspension and complete Freund’s adjuvant in the mammary glands of 20 
female rabbits of each group, respectively. Conventional MRI and IVIM DWI 
were performed after animal models were successfully established. Images of 
axillary LNs were analysed with regard to long-axis diameter (L), short-axis 
diameter (S), apparent diffusion coefficient (ADC) and IVIM parameters (D, D*, 
  






f). Receiver operating characteristic analyses were conducted to determine the 
diagnostic performance of aforementioned criteria. 
Results: A total of 42 metastatic and 30 non-metastatic LNs were successfully 
isolated. ADC and D of metastatic LNs were significantly lower than those of 
non-metastatic ones (all P < 0.001), whereas D* was statistically higher (P = 
0.033). L, S, and f showed no significant difference between the two groups (P 
= 0.089, 0.058, 0.054, respectively). Optimal cutoff values, area under the 
curve, sensitivity, and specificity for differentiation were as follows: ADC=1.101 
× 10−3 mm2/s, 0.886, 78.6%, 90.0%; D = 0.938 × 10−3 mm2/s, 0.927, 83.3%, 
93.3%; and D* = 12.635 × 10−3 mm2/s, 0.657, 52.4%, 80.0%. 
Conclusion: IVIM DWI is useful to distinguish metastatic from non-metastatic 
LNs in axilla. D was the most discriminative variable for predicting metastatic 
LNs.  
B-1281 16:24  
Radiomics with MRI for early prediction of the response to neo-adjuvant 
chemotherapy in breast cancer patients  
A. Tahmassebi1, A. Meyer-Baese1, G.J. Wengert2, T.H. Helbich2, 
K. Pinker-Domenig2; 1Tallahassee, FL/US, 2Vienna/AT 
(katja.pinker-domenig@meduniwien.ac.at)  
Purpose: In patients undergoing neoadjuvant chemotherapy for breast cancer, 
the achievement of a pathological complete response (pCR) is associated with 
a significantly improved disease-free and overall survival. The aim of this study 
was to assess radiomics with dynamic contrast-enhanced (DCE) MRI for the 
early prediction of pathological complete response (pCR) in breast cancer 
patients undergoing neoadjuvant chemotherapy. 
Methods and Materials: In this IRB-approved prospective study, 41 women 
(median age 50 years; range 25-80 years) with breast cancer scheduled for 
NAC were included and underwent mpMRI using DCE MRI prior to and after 
two cycles of NAC. For each lesion a total of 14 features were extracted 
ranging from morphological, enhancement and ADC parameters. Recursive 
feature elimination method along with five different classifiers including linear 
support vector machine (SVM), linear discriminant analysis (LDA), logistic 
regression (LR), random forest (RF), and stochastic gradient descent (SGD) 
was employed to rank the features. 
Results: Radiomics analysis and classification accuracy of mpMRI achieved 
AUCs for residual cancer burden (RCB) score (AUC 0.85), metastases (AUC 
0.89) based on RF and death (AUC 0.95) based on SVM. The most relevant 
parameters for prediction of RCB score were mass internal enhancement, 
shape and margins with DCE, for metastasis peritumoural oedema, mass 
margins and internal enhancement, and for death high signal intensity on T2-
weighted imaging, mass margins, and internal enhancement. 
Conclusion: Radiomics with DCE-MRI enables prediction of response to NAC 
with high accuracy and thus can provide predictive information and guide 
treatment decisions.  
B-1282 16:28  
The role of arterial spin labelling (ASL) and diffusion tensor Imaging (DTI) 
and to differentiate between malignant and benign breast lesions  
A.N. Kamble1, A. Kamble2, M. Popli1; 1New Delhi/IN, 2Mumbai/IN 
(akshaykumar.kamble92@gmail.com)  
Purpose: Diffusion tensor imaging picks up the architectural distortions. 
Arterial spin labelling give perfusion maps by utilising the water as a contrast 
medium itself. Both of these techniques do not require contrast, therefore, 
clinically significant where contrast is contraindicated. We applied these 
techniques to differentiate between malignant and benign breast lesions. 
Methods and Materials: 44 women with breast lesion detected on 
mammography, USG or MR underwent advanced MR imaging. DTI was 
performed at 3Telsa (Skyra Siemens) in 12 directions using a diffusion-
weighted echo planar sequence. 2D ASL (Arterial Spin Labelling) protocol was 
modified with TI of 1800ms and TR of 4000. Analysis of DTI and ASL data was 
done by dedicated post processing team using MATLAB-2017a, FSL and ASL 
2.0 toolbox. Taking histopathology as Gold Standard, ROC curves were 
plotted. 
Results: Total of 44 lesions were detected on MRI. ROC curve showed ASL 
has 72% sensitivity, 89.5% specificity, 79.5% accuracy, 10% FPR. The blood 
flow to the malignant lesions was significantly higher (350 ml/100gm 
tissue/sec, SD: 100ml) compared to benign lesions (150ml/100gm tissue/sec, 
SD: 90ml) (p value<0.05). ROC curve for DTI showed 80% sensitivity, 78% 
specificity, 79% accuracy, 21 % FPR. Combined DTI and ASL had increased 
sensitivity of 84%. 
Conclusion: This study demonstrates advanced MR imaging using ASL and 
DTI has good specificity for differentiating breast cancer from benign lesions. 
With ASL quantification of blood flow to malignant and benign lesion is 
possible. The sensitivity of combined ASL and DTI method is better that the 
sensitivity of both independently.  
 
B-1283 16:32  
Earlier detection of breast cancer using artificial intelligence  
A. Watanabe1, W. Bradley2, V.D. Lim2, C.Y.R. Chim2; 
1
Manhattan Beach, CA/US, 2San Diego, CA/US (alyssa90266@gmail.com)  
Purpose: It is known that up to 50% of breast cancers may be seen on 
previous mammograms. The purpose of this study was to evaluate the 
potential benefit of using a deep learning based breast CAD in earlier detection 
of breast cancer. 
Methods and Materials: A 3 year retrospective audit was performed of an 
archive of mammograms obtained from a community based practice. 125 
cases of confirmed breast cancers with prior studies were identified. All of the 
mammograms were processed using a deep learning based CAD (cmAssist, 
CureMetrix, La Jolla, CA. The cancer cases were evaluated by 2 radiologists 
who identified retrospective findings and then classified them as actionable vs 
nonactionable. The type of lesion (calcification, density, or mass) was also 
tabulated. The ROC and AUC of the entire data base was calculated as well as 
the false positive per image rate to demonstrate overall accuracy of the CAD. 
Results: The artificial intelligence trained CAD flagged 100% of the breast 
cancers that were detected by the original interpreting radiologists. In addition, 
the CAD flagged actionable findings on prior mammograms in 76% of the 
cases. The true negative rate for the CAD also showed high accuracy. There 
were few false flags. 
Conclusion: This deep learning based CAD flagged a majority (76%) of breast 
cancers on prior studies that showed retrospective findings. This CAD could be 
a powerful tool in enhancing earlier detection of cancer on mammography and 
reducing false negative mammography.  
Author Disclosures: 
  A. Watanabe: Consultant; Curemetrix. W. Bradley: Advisory Board; 
Curemetrix. V.D. Lim: Consultant; Curemetrix. C.Y.R. Chim: Employee; 
Curemetrix. 
B-1284 16:36  
Sensitivity of contrast-enhanced spectral mammography (CESM) versus 
digital mammography (DM) for detecting breast cancer in dense or 
extremely dense breasts  
E. Gioutlaki, C. Tzimas, E. Feida, A.N. Chalazonitis; Athens/GR 
(egiou@hotmail.gr)  
Purpose: Contrast-enhanced spectral mammography (CESM) is a quite new 
imaging method for neo-angiogenesis detection by tracking iodinated contrast 
agent uptake and washout in suspicious breast lesions. Our aim was to 
compare mammography findings of CESM and DM, in dense or extremely 
dense breasts. 
Methods and Materials: From October 2012 to May 2017, 283 women, aged 
from 24 to 88 years, (mean age 54.6 years) with dense or extremely dense 
breasts, underwent CESM examination. Evaluation of CESM examination was 
based on enhancement intensity of the lesion according to a qualitative scale 
categorized into 4 steps as follows: type -1 (negative enhancement), type 0 (no 
enhancement), type 1 (moderate enhancement), type 2 (intense 
enhancement). Histopathology reports were compared with imaging 
assessment. 
Results: Out of 283 women, 20 of them had bilateral lesions. From a total 
sample of 189 breasts positive in CESM, 164 were diagnosed with breast 
cancer at histopathology. According to our study, the sensitivity of this method 
was 91%, specificity 71.4%, and accuracy 82%. On the contrary, conventional 
MMG had a sensitivity of 73%, a specificity of 62%, and diagnostic accuracy 
67%. As a result, sensitivity, specificity and accuracy were significantly higher 
on CESM compared to MMG. 
Conclusion: Many factors may affect the diagnostic accuracy of DM. One of 
them is breast density. Cancer may be occult in dense breast. It seems that 
CESM is superior to DM in detecting breast cancer with high accuracy, 
especially in dense breasts.  
Author Disclosures: 
  E. Gioutlaki: Speaker; E.Gioutlaki. 
B-1285 16:40  
MRI analysis after neoadjuvant chemotherapy on breast cancer: 
correlation between radiological and pathological response  
E.M.S. Negrao, A. Bitencourt, J.A. Souza, E. Ferreira Marques, 
C. Souza Guatelli, L. Graziano, M.L.L. Albuquerque; São Paulo/BR 
(brenda_kika@yahoo.com.br)  
Purpose: Breast cancer is classified into molecular subtypes (MS), which differ 
in clinical presentation, response to treatment and survival. Triple-negative 
(TN) and HER2 expression (HER2+) are known to be more aggressive and 
potentially metastatic. Complete pathological response (pCR) after neo-
adjuvant systemic treatment (NST) is considered predictor of clinical benefit. 
The aim of this study was to compare radiological response at magnetic 
resonance imaging (MRI) and pathological response after NST. 
  






Methods and Materials: 310 breast tumours were analyased retrospectively in 
a cancer centre between October 2014 and July 2017. Radiological response 
(MRI after NST) was compared to the pathological response (surgical 
specimen) and stratified the different MS to define the ability of MRI to predict 
the pCR. 
Results: Patients' age ranged between 27 and 85 years (mean age 47 years). 
The predominant Luminal B in 189 cases (of these, 55 cases hybrid Luminal B: 
HER2+). TN in 90 cases and HER2+ (hormone negative) in 31 cases. There 
were 126 cases (41%) of pCR (10 cases had only residual CDIS). The 
sensitivity, specificity and accuracy of the MRI was 82%, 74% and 79%, 
respectively. Stratifying by MS, the highest indexes were HER2+ (89%, 82% 
and 83%) and the TN subtype (78%, 78% and 70%). The Luminal B subtype 
presented specificity of 56% (Luminal B hybrid obtained 78%). 
Conclusion: MRI has remained a good method to investigate the pCR, 
especially in the HER2+, TN and Luminal B hybrid subtypes, demonstrating 
greater accuracy in the pCR in the more aggressive subtypes.  
B-1286 16:44  
Screen-detected breast cancer: differences in mammographic tumour 
features between agreement and disagreement recall  
M. Orsi, M. Cellina, F. Leone, D. Mariani, A. Presazzi, C. Floridi, G. Oliva; 
Milan/IT (marcello.orsi@asst-fbf-sacco.it)  
Purpose: To analyse how radiological features of breast cancer are correlated 
with agreement and disagreement recall, in a single-centre independent double 
reading population-based screening program. 
Methods and Materials: Between November 2014 and February 2017, 
screening mammograms positive for breast cancer were retrospectively 
evaluated by two radiologists, in consensus, to assess the tumoural imaging 
features (mass, calcifications, asymmetric density or architectural distortion). 
We evaluated two different groups according to agreement recall (AR) or 
disagreement recall (DR). We compared the differences among tumoural 
imaging features between the two groups. 
Results: 113 consecutive screen-detected histologically proved breast cancer 
mammograms were reviewed, there were 76 AR and 37 DR. In the AR group, 
we found, as single or part of multiple features in a suspicious lesion, 51 (67%) 
mass, 24 (32%) calcifications, 24 (32%) architectural distortion and 18 (23%) 
asymmetric density; in the DR group, we depicted 20 (54%) architectural 
distortion, 11 (30%) mass, 9 (24%) calcifications, 7 (19%) asymmetric density. 
Differences in tumour imaging features between the two groups were 
statistically significant (p<0.05). 
Conclusion: Our results show that architectural distortion is the most frequent 
tumour imaging feature in the DR group, which includes a false-negative result; 
the detection of architectural distortion requires a good practice of 
mammography and any technical improvements focused on depicting 
architectural distortion could increase the overall sensitivity of mammographic 
screening.  
B-1287 16:48  
Interpretation of patterns of enhancement on contrast-enhanced digital 
mammography: an approach to a standardised scheme  
S. Gareer, Y. Mounir, M.H. Helal, O. Mokhtar, A. Abdel Aziz, H. Kassas, 
L. Bassam; Cairo/EG (sherihangareer@gmail.com)  
Purpose: Applying the morphological descriptors described in the MRI breast 
imaging and reporting data system (BIRADS) in characterising enhancing 
breast lesions seen on CESM. 
Methods and Materials: Methods: 178 breast lesions in patients with mean 
age 46 years in a prospective study were included. Morphological 
categorisation of the included lesions was presented into focus, mass and non-
mass forms. Furthermore classifications included the margin, enhancement 
intensity for “focus”, the shape, margin and internal enhancement for “mass” 
and the distribution and internal enhancement for “non-mass”. Each 
morphology descriptor was evaluated separately (irrespective of the other 
descriptors) by calculating its sensitivity, specificity, (PPV) and (NPV) 
Results: This study included 104 malignant lesions versus 74 benign. 
Diagnostic accuracy parameters for CEDM were sensitivity 98 % (102/104) and 
specificity 76% (56/74). Irregular margin intense enhancement focus (1/8) was 
diagnosed malignant, (7/8) while regular margin faint enhancing foci were 
benign.Irregular shape, spiculated margin and heterogenous internal 
enhancement descriptors of mass lesion descriptors conformed to malignancy 
(PPV 92.5% of the former and 88.7% of the latter, p value  0.001).Asymmetry 
with segmental distribution, (17/27) (70.8%) heterogeneous and clumped 
internal enhancement patterns were indicative for malignancy in non mass 
enhancement (PPV <0.001) 
Conclusion: MRI lexicon morphology descriptors can be applied (yet with few 
exceptions) in the characterization of enhancing breast lesions on CESM.The 
most sensitive descriptors for malignant lesions regarding masses are 
irregular, margins yet for NME the focal, ductal and segmental distribution with 
heterogeneous or clumped enhancing patterns. Foci are still controversial.  
B-1288 16:52  
Screen-detected breast cancer: an argument for starting screening 
mammography at age 40 in the community-based setting  
R. Benjamin1, M. Aujero1, K.S. Traylor1, M. Gerges2, J. Holt1; 1Newark, DE/US, 
2
Philadelphia, PA/US (Rbenjamin@christianacare.org)  
Purpose: Current screening guidelines are contradicting. An argument for 
starting screening mammography at age 40 is introduced. 
Methods and Materials: A total of 38,393 screening mammograms, additional 
imaging studies, and relevant biopsy results were compiled and analysed at 
our institution from August 2015 to December 2016. 72.5% of the studies were 
performed with tomosynthesis. No stratification was based on imaging 
modality, race, breast density, or risk assessment. 
Results: 38,393 patients were stratified into different age ranges including 40-
49, 50-64, and over 65. 10,267 patients were within the 40-49 age range and 
31 cancers were detected, 20 invasive. 16,735 patients were within the 50-64 
age range and 97 cancers were detected, 64 invasive. 10,680 patients were 
within the greater than 65 age range and 93 cancers were detected, 75 
invasive. 
Conclusion: In our screening populations, 14% of all screen-detected cancers 
were found in women aged 40-49 and 65% of these (21/30) were invasive. 
Although, the USPSTF agrees that there is a “net benefit” to screening women 
age 40-49, it gives a “C” recommendation for screening in this age group. Data 
obtained by the task force come predominantly from randomised and 
observational studies and trials which date as far back as 1963. Furthermore, 
film mammography, not digital mammography or tomosynthesis (DBT), was the 
basis for their recommendations. With growing research on the benefits of 
DBT, the USPSTF recommendations should be updated according to current 
data. This study supports the ACR and ACOG recommendation that annual 
screening mammography begin at age 40.  
B-1289 16:56  
Abbreviated breast MRI: do we still need contrast media?  
A. D'Angelo1, J. Al Mohanna2, P. Clauser3, P. Kapetas3, P. Rinaldi1, C. Zuiani4, 
T.H. Helbich3, K. Preidler3, P.A.T. Baltzer3; 1Rome/IT, 2Riyadh/SA, 3Vienna/AT, 
4
Udine/IT (anna.dangelo05@gmail.com)  
Purpose: To compare the diagnostic performance of two abbreviated breast 
MRI protocols for the characterisation of breast lesions: Diffusion Weighted 
Imaging (Non-contrast MRI, NC-MRI) and early enhanced T1w (first contrast 
enhanced measurement, CE-MRI). 
Methods and Materials: IRB-approved retrospective single-center study. 57 
consecutive patients (median age 55, range 29-84 years) were eligible, who 
underwent biopsy of BI-RADS 4/5 findings after full diagnostic workup including 
mammography, ultrasound and MRI. The MRI protocol (3T Siemens 
Magnetom Skyra; 16-channel coil) included a readout-segmented DWI (b 0, 
800 and calculated b1400 s/mm2) and Dynamic-Contrast-Enhanced (DCE) 
images (T1w VIBE with fatsat; single-dose Gadoteridol (ProHance), temporal 
resolution 72 seconds). Two fellowship-trained breast radiologists (R1, R2) 
independently assigned a BI-RADS and visibility score (ordinal 5-point scale) 
to NC-MRI and CE-MRI using MIP reconstructions and original acquisitions. 
Receiver Operating Characteristics (ROC) and Visual Grading Characteristics 
(VGC) analysis were applied. 
Results: Histopathology revealed 36 malignant and 21 benign lesions. Areas 
under the ROC curves were similar: CE-MRI: 0.825 (95%-CI: 0.702-0.913), R1 
and 0.810 (95%-CI: 0.684-0.901), R2; NC-MRI: 0.721 (95%-CI: 0.573-0.841), 
R1 and 0.730 (95%-CI: 0.582-0.847), R2. The lower AUC in NC-MRI was 
mainly due to a lower sensitivity. In both readers, NC-MRI could not rule-out 
malignancy while CE-MRI could. VGC analysis revealed a superior lesion 
conspicuity by CE-MRI (P<0.001, R1, R2). 
Conclusion: The comparison of abbreviated NC-MRI and CE-MRI revealed a 
superiority of CE-MRI for characterisation of breast lesions. NC-MRI readings 
could not rule-out malignancy, stressing the necessity of contrast media in 
breast MRI for breast cancer diagnosis.  
B-1290 17:00  
Mammography, breast MRI and histopathological features of pure ductal 
carcinoma in situ  
Y. Jiang, H.-U. Kauczor; Heidelberg/DE (peggy_jiang@hotmail.com)  
Purpose: To analyze the imaging and histopathological features of pure ductal 
carcinoma in situ (DCIS). To evaluate the sensitivity of breast MRI and 
mammography (MG) in the detection of pure DCIS. 
Methods and Materials: A total of 131 pure DCIS lesions between January 
2013 and June 2016 were included. According to 2013 BI-RADS to evaluate 
MG and MRI features of calcified and non-calcified DCIS. All lesions were 
divided into different cancer subtypes determined by immunohistochemistry 
(IHC) and fluorescence in situ hybridization (FISH). Correlate molecular 
subtypes and nuclear grade of pure DCIS with MG and MRI features. 
  






Results: Most pure DCIS (68.0%) presented with suspicious calcifications 
(including other abnormal expression: mass, FAD and architectural distortion). 
32.0% presented without suspicious calcifications. For DCIS presented with 
suspicious calcifications on MG, diagnostic accuracy for MRI was 95.1% 
(P=0.001). Diagnostic accuracy of MG and MRI for DCIS without suspicious 
calcifications on MG were 62.2% and 91.9% (P=0.002). On MRI, 69.7% pure 
DCIS presented as non-mass enhancement. HER2 positive DCIS were more 
commonly associated with calcifications than ER positive and triple negative 
DCIS (54.0%, 45.5% VS 81.4%, P-0.002). High nuclear grade DCIS more 
presented with calcification compared to middle and low grade DCIS (42.1%, 
67.2% VS 77.8%, P=0.015). The diagnostic accuracy for MG and MRI were 
80.6% and 94.1% (P=0.002). 
Conclusion: The most typical MG and MRI features of pure DCIS were 
suspicious calcification and non mass-like enhancement. MG was better than 
MRI in diagnosing calcified DCIS, while MRI was better in diagnosing non-
calcified DCIS  
B-1291 17:04  
Molecular subtypes of invasive breast cancer: correlation between 
PET/CT and MRI findings  
M. Akin, I.S. Örgüc, F. Aras, A. Kandiloglu; Manisa/TR (meloakin@gmail.com)  
Purpose: In our study, we investigated the diagnostic value of F18-FDG 
PET/CT and MRI findings in determining molecular subtypes of invasive breast 
cancer. In addition, the relationships between the volume measurements in 
PET/CT and MRI and the pathological volume of the mass were evaluated. 
Methods and Materials: A total of 55 primary invasive breast cancer masses 
in 51 female patients who had histopathological diagnosis and underwent FDG 
PET/CT and MRI before therapy were retrospectively analysed. The 
correlations between molecular subtypes and SUVmax, SUVmean, MImean, 
MTV and HU values from FDG PET/CT findings; shape, margin, intratumoral 
enhancement, kinetic curve type and ADC values (based on 2013 BI-RADS 
MRI classification) from MRI findings were evaluated. In addition, the 
relationships between the pathologic tumor volume and the tumor volume 
measured by MRI and PET/CT were evaluated. 
Results: The SUVmax and SUVmean values of the luminal B subtype of 
invasive breast cancer were higher than the luminal subtype A (p = 0.002, p = 
0.017, respectively); the triple negative subtype had a higher SUVmax value 
than the luminal subtype A (p = 0.028). There were statistically significant 
strong positive correlations between MTV and FTV (p= 0,000; r= 0,857); MTV 
and the pathologic tumor volume (p= 0,006, r= 0,796); FTV and the pathologic 
tumor volume (p= 0,006, r= 0,921). 
Conclusion: Our findings suggested that SUVmax value was superior to MRI 
findings in predicting molecular subtypes. In addition, we determined that MRI 
was superior to PET/CT in predicting the pathologic tumor volume.  
B-1292 17:08  
Focal breast categorisation according to the BI-RADS-US lexicon: role of 
a computer-aided decision-making support  
A. Orlando, F. Amato, M. Di Vittorio, C. Lupo, L. Spatafora, M. Safina, F. Ienzi, 
R. Ienzi, T.V. Bartolotta; Palermo/IT (orlandoalessiamed@hotmail.it)  
Purpose: To assess a computer-guided decision-making software (S-Detect) 
in the sonographic characterisation of focal breast lesions (FBLs). 
Methods and Materials: According to BI-RADS-US lexicon, 300 FBLs (size: 
2.6-47.2mm) in 255 patients were prospectively assessed in consensus by two 
experienced radiologists without and with S-Detect. To evaluate intra and inter-
observer agreement, two residents assessed independently the same 300 
FBLs at baseline and after 3 months. All the FBLs classified as BI-RADS-4 or 5 
underwent core-biopsy, all the lesions classified as BI-RADS-3 were followed-
up. 
Results: 120/300 FBLs were malignant, 2/300 high-risk and 178/300 benign. 
Experts reviewers showed higher Sensitivity, Specificity, PPV and NPV with S-
Detect (97.5%, 86.5%, 83.2%, 98.1%) than without (91.8%, 81.5%, 77.2%, 
93.6%) (p>0.05), as confirmed by ROC curve analysis (0.95 with and 0.92 
without [p=0.0735]. A significant higher area under the ROC curve was found 
for Resident#1 (0.85 without and 0.88 with S-Detect [p=0.0067]) and 
Resident#2 (0.83 without and 0.87 with S-Detect [0.0302]). Intra-observer 
agreement (k score) improved with S-Detect from 0.69 to 0.78 for Resident#1 
(p>0.05) and from 0.69 to 0.81 for Resident#2 (p>0.05). Inter-observer 
agreement improved with S-Detect from 0.67 to 0.7 (baseline; p>0.05) and 
from 0.63 to 0.77 (after 3 months; p>0.05). According to S-Detect-guided re-
classification, 25/64 (39.1%; 95%CI=[25.1;51.0] FBLs underwent no change in 
clinical management (CM), 27/64(42.2%; 95%CI=[30.0;52.3]) and 
12/68(18.7%; 95%CI=[27.1; 51.1]) underwent respectively a positive and a 
negative change in CM. 
Conclusion: S-Detect is an effective tool for the classification of FBLs 
according to BI-RADS-US lexicon, improving cancer detection rate, especially 
for less experienced physicians.  
B-1293 17:12  
Comparison of automated vs bilateral handheld whole-breast US in 
screening patients regarding efficacy and patient preferance  
B. Tutar, G. Esen, H. Kara, N. Guldogan, C. Uras; Istanbul/TR 
(gulesenicten@gmail.com)  
Purpose: To evaluate the efficacy and patient satisfaction for automated 
breast volumetric scanning (ABVS) compared to handheld breast US (HHUS). 
Methods and Materials: From May 2014 to July 2015, 338 screening patients 
underwent bilateral technician performed ABVS followed by physician 
performed HHUS (ACUSON S2000™; Siemens, Germany). Acquisition and 
evaluation time, patient satisfaction,image interpretability, lesion number and 
BIRADS scores were recorded. Chi square test was used for statistical 
analysis. 
Results: Mean examination time was 20 minutes for ABVS and 10 minutes for 
HHUS. Mean interpretation time for ABVS was 8minutes. The ratio of patients 
who experienced severe pain during the procedure was 8% for ABVS and 3% 
for HHUS. With ABVS, 19 patients (5.6%) were recalled because of areas of 
shadowing (BIRADS 0) but were normal on second look US. ABVS detected 
more solid lesions in 10 patients, while HHUS detected more in 4. The 
difference was statistically significant. The final category for ABVS was 
BIRADS 4 in 11 and BIRADS 5 in 1 patient. With HHUS, there were 2 BIRADS 
4 and 2 BIRADS 5 results. US guided biopsy was performed in 4 patients and 
cancer was diagnosed in 2. 
Conclusion: ABVS is superior to HHUS in lesion detection with no false 
negative results. Patient satisfaction is good and physician time is shorter. It 
can be an alternative to HHUS in breast clinics. It should be kept in mind that 
the recall rate is higher and positive predictive value is lower with ABVS as 
stated in previous reports.  
B-1294 17:16  
Breast cancer staging with automated breast volume scanner (ABVS) and 
digital breast tomosynthesis (DBT): a comparison with magnetic 
resonance imaging (MRI)  
R. Girometti, L. Tomkova, M. Zanotel, M. Lorenzon, A. Linda, V. Londero, 
C. Zuiani; Udine/IT (rgirometti@sirm.org)  
Purpose: To investigate whether the combination of ABVS and DBT 
(ABVS+DBT) is comparable to MRI in staging breast cancer. 
Methods and Materials: We retrospectively included seventy-three patients 
with histologically proven breast cancer who underwent preoperative ABVS, 
DBT and 1,5T MRI in the period July 2015-January 2017. Two radiologists in 
consensus recorded the number, site and BI-RADS category of breast findings 
during two independent reading strategies, namely using DBT+ABVS or MRI 
(complemented with hand held ultrasound second look images, if indicated). 
Using histology or 1-year follow up as the standard of reference, we calculated 
sensitivity and specificity for breast cancer of both imaging strategies. 
Results: Patients showed a total of 160 lesions (109 malignant and 51 
benign). Malignant lesions were monofocal, multifocal, multicentric and 
biltateral in 53, 16, 3 and 1 cases, respectively. Sensitivity and specificity of 
ABVS+DBT versus MRI were 88.1% and 86.2% vs. 94.5% and 88.2%, 
respectively, with no significant differences in cancer detection (p>0.05; 
McNemar’s test). Compared to MRI, ABVS+DBT missed 9 lesions, including 
5/9 DCIS or DCI with DCIS, 3 DCI and 1 Paget disease. Compared to 
ABVS+DBT, MRI missed 2 lesions (DCIS). 
Conclusion: ABVS+DBT approaches MRI in staging breast cancer, and might 
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B-1295 08:30  
Clinical value of dynamic contrast-enhanced MRI and diffusion-weighted 
imaging on diagnosis of central gland prostate carcinoma  
W. Jing, X. Zhang; Shenyang/CN  
Purpose: To study the clinical value of dynamic contrast-enhanced MRI (DCE-
MRI) and diffusion-weighted imaging (DWI) on diagnosis of central gland 
prostate cancer(CG-PCa). 
Methods and Materials: A retrospective analysis was performed based on the 
clinical data of 63 patients who were admitted in the Hospital and confirmed to 
have central gland diease through pathological diagnosis.There were 34 cases 
of CG-PCa and 29 of CG-BPH.According to the pathological Gleason 
scores,the 34 patients with PCa were divided into three groups:the low(GS 
3+3),moderate(GS 3+4)and high(GS 4+3,4+4,4+5,5+4,5+5)malignancy 
groups.The DCE-MRI semi-quantitative parameters (TTP, MSI), quantitative 
parameters (Ktrans, Kep and Ve) and ADC of the PCa and the BPH were 
measured and compared.These parameters were used for ROC curve analysis 
to calculate the PCa diagnosis susceptibility and specificity.The correlations 
between the ADC value and Gleason score grouping were assessed. 
Results: The TTP and MSI values of the BPH patients were both higher than 
those of the PCa ones (P<0.05).Meanwhile,statistically significant differences 
were found in the Ktrans,Kep and ADC values between the PCa and the BPH 
whereas the differences in the Ve values showed no statistical significance.The 
largest area of Ktrans under the ROC curve reached 0.82 with the 
susceptibility and specificity of 82.4% and 67.6%.There were significant 
differences in the ADC values among the three groupings(F=14.04, 
P>0.05).The ADC values of the low and the moderate malignancy groups 
showed no significant differences (P>0.05).The results suggested negative 
correlations between the ADC value and the Gleason score grouping. 
Conclusion: Hence,DCE-MRI and DWI have important clinical value on CG-
PCa identification.  
B-1296 08:34  
Development and validation of a low-cost paediatric pelvic phantom for 
digital radiography dose optimisation  
A.H. Mohammed Ali1, P.H. Hogg1, A. England2; 1Salford/UK, 2Manchester/UK 
(p.hogg.@salford.ac.uk)  
Purpose: Imaging phantoms can be cost prohibitive and a need, therefore, 
exists to produce low-cost alternatives which are fit for purpose. Consequently, 
this paper outlines the development and validation of a low-cost dose/image-
quality pelvis phantom for a 5-year-old child. 
Methods and Materials: Tissue equivalent materials representing paediatric 
bone (plaster) and soft tissue (PMMA) were used. PMMA was machined to 
match the bony anatomy identified from a CT scan of a 5-year-old child and 
cavities were created for plaster infusion. Phantom validation comprised 
physical and visual measures. Physical included CT density (HU) comparison 
between a CT scan of a 5-year-old male one of the phantom, a signal to noise 
ratio (SNR) comparative analysis of AP DR phantom X-ray images against a 
commercially anthropomorphic phantom. Visual analysis used a psychometric 
image quality scale. 
Results: For HUs, the percentage difference between cortical bone and soft 
tissue and the equivalent tissue phantom substitutes were 88.4% and 86.1%, 
respectively. For SNR (mAs response) there was a strong positive correlation 
between the two phantoms (r>0.95 for all kVps). For kVp response, there was 
a strong positive correlation (1-8mAs (r>0.85)), this decreased as mAs 
increased (r=-0.21 at 20 mAs). Psychometric scale results produced a 
Cronbach’s alpha of almost 0.8. 
Conclusion: Physical and visual measures suggest the low-cost phantom has 
suitable anatomical characteristics for X-ray imaging. Our method produces a 
low-cost phantom which could have utility in dose and image quality 







B-1297 08:38  
80kV vs 100kV in the CT pulmonary angiography protocol: an evaluation 
of the impact on patient dose and image quality on two CT machines  
A. Rusandu1,2, A. Ødegård1, G.C. Engh1, H.M. Olerud2; 1Trondheim/NO, 
2
Kongsberg/NO (albertina.rusandu@ntnu.no)  
Purpose: The aim of this study was to analyse the dose reduction and image 
quality achieved using 80kV instead of 100kV in CT protocols for pulmonary 
arteries. 
Methods and Materials: 80 examinations of non-obese patients were 
analysed (40 consecutive patients for each protocol, equally distributed on two 
CT scanners). Objective image quality was assessed by measurements of HU 
values (average and standard deviation) in five ROIs in pulmonary arteries and 
calculations of signal-to-noise (SNR) and contrast-to-noise ratio (CNR). 
Subjective image quality was independently evaluated by two radiologists in 
terms of perceived noise, sharp reproduction of pulmonary arteries and overall 
diagnostic quality. Radiation dose parameters (CTDIvol, DLP, SSDE and 
effective dose) were compared. Differences in dose and objective image 
quality for the two protocols were assessed using the independent t test; 
comparison of subjective grading of image quality was performed with Mann-
Whitney U test. 
Results: Use of 80kV significantly increased arterial contrast enhancement. 
Both measured and subjectively rated image noise was higher at 80 kV. 
Differences in SNR, CNR and subjective diagnostic image quality between 
protocols were not statistically significant (p = 0.177, p=0.88, p=0,703). The 
dose reduction achieved by using 80kV was significant on both scanners 
(SSDE reduction 33% and 45%, p<0.001; effective dose reduction 40% and 
52%, p<0.001). 
Conclusion: Use of 80kV protocols for CT examinations of pulmonary arteries 
in non-obese patients with body weight below 80 kg results in significant 
reduction of patient doses without compromising diagnostic image quality.  
B-1298 08:42  
Atypical functional connectivity between cerebral and cerebellar resting 
state networks in autism spectrum disorder  
Y. Wang, W. Zhang, S. Lui; Chengdu/CN (970805975@qq.com)  
Purpose: Motor impairment has been repeatedly documented in autism 
spectrum disorder (ASD). However, it is unclear what brain mechanisms 
contribute to this impairment. Our purpose is to examine the correlation 
between motor data and brain resting-state functional imaging and identify the 
functional connectivity(FC)alteration in ASD individuals using seed-driven 
approach. 
Methods and Materials: We acquired resting-state functional magnetic 
resonance imaging scans from 43 subjects (24 ASD)10-33 years old. ROIs 
were identified by examining the correlations between motor data and whole 
brain ALFF in control and ASD separately. Whatever correlation of motor data 
with brain ALFF showed statistical significance, its specific brain region was 
selected as one of the ROIs and further used for FC analysis. Brain-behaviour 
relationships were assessed by regressing FC measures with social deficit 
severity and repetitive behaviours. 
Results: Relative to typically developing control participants,individuals with 
ASD showed a mixed pattern of both over- and under-connectivity in the 
cerebral-cerebellar network, including increased connectivity of posterior 
cerebellum with left superior parietal ,bilateral superior occipital and left middle 
occipital gyrus but decreased connectivity with prefrontal cortex and superior 
temporal gyrus. Decreased connectivity was also identified within cerebellar 
network, and was negatively correlated with repetitive behaviour score 
(P<0.05, uncorrected). 
Conclusion: Individuals with ASD showed a mixed pattern of over- and under-
connectivity with cerebral-cerebellar network and decreased connectivity within 
cerebellar network, these findings are consistent with emerging evidence of 
disrupted network segregation and integration in ASD. Further, abnormal 
decreased connectivity within cerebellar network implicates relation with 
restricted and repetitive behaviours in ASD.  
B-1299 08:46  
Morphological characteristics of carotid atherosclerotic plaques: 
comparison based on CTA and MRI  
N. Giannotti, J. McNulty, S.J. Foley, P. Kelly; Dublin/IE 
(nicola.giannotti@ucd.ie)  
Purpose: Risk stratification of atherosclerotic plaque is based on the degree of 
stenosis. However, classification of plaque components (fibrous tissue, lipid, 
and calcium) can be associated with plaque vulnerability and may be used as a 
predictor of cerebrovascular events. 
Methods and Materials: CT Angiography (CTA) and High-resolution MRI 
(HRMRI) datasets of 30 patients with confirmed internal carotid artery stenosis 
were analysed by a single observer using two software tools (TeraRecon 
iNtuition™ and MRI-Plaque View2.1) to measure the volume of plaque 
components. Plaque volume was assessed through semi-automatic 
  






segmentation of the vessel wall from the lumen. Three Hounsfield unit ranges 
were defined in the CTA analysis, while an algorithm based on morphology 
enhanced probabilistic plaque segmentation was used for the HRMRI analysis. 
The Wilcoxon signed-ranked test assessed whether statistical differences exist 
between CTA and HRMRI plaque components measurements and Spearman’s 
correlation test investigated their level of agreement. Bland-Altman plots 
assessed proportional bias. 
Results: Although a significant difference was found between fibrous tissue 
measurements; measurements of lipid and calcium did not statistically change 
(Z=-2.026, p=0.43) (Z=-2.448, p=0.14) and Spearman’s tests showed 
moderate agreement rs=0.446 (p=0.013), 0.444 (p=0.014). Bland-Altman plot 
confirmed no proportional bias between lipid and calcium measurements 
(t=0.359, p=0.722) (t=1.354, p=0.187). 
Conclusion: Lipid and calcium measurements did not statistically differ 
between CTA and HRMRI. Although limitations affect these analyses, further 
investigations are necessary in order to validate these approaches since the 
presence of certain components within atherosclerotic lesions can lead to 
plaque vulnerability and cerebrovascular events.  
B-1300 08:50  
The impact of the smartphone application (app) on MR radiographers' 
knowledge and confidence in relation to MR image-quality-related errors  
W. Alsharif, M. Davis, L.A. Rainford, A. McGee; Dublin/IE 
(walaa.alsharif@ucdconnect.ie)  
Purpose: This study aimed to evaluate the impact of a smartphone app 
prototype on the level of MR radiographers’ knowledge and confidence in 
recognising and rectifying MR image-quality-related errors. 
Methods and Materials: The study used the comparison-experimental 
approach (pre- and post-test). Thirty-five MR radiographers independently 
reviewed a prepared series of MR images (n=25). The participants were 
requested to identify image-quality-related errors, to specify error-correction 
strategies and score how confident they were in relation to their responses. 
Participants were then divided into experimental (n=19) and control cohorts 
(n=16). The app was provided to the experimental cohort for three months, 
after this period both cohorts re-reviewed the MR images and retested. 
Results: During pre-test, a low level of MR radiographer knowledge was noted 
in terms of correct identification of the type of image quality error and 
specification of an appropriate error-correction strategy (p<0.05). The 
confidence level of radiographers in their ability to name the types of error 
varied significantly (p<0.05). During post-test, the results showed a statistically 
significant difference between control and experimental cohorts relative to 
participants’ pre- to post-test knowledge level. For the experimental cohort, 
years of experience, qualification and type of hospital were not associated with 
radiographer knowledge level and confidence in recognising the presence of 
an image quality error, naming the error and specifying appropriate correction 
strategies (p>0.05). 
Conclusion: The study identified the potential of the smartphone app as an 
effective educational tool to support MR radiographers’ knowledge in 
recognising and characterising MR image quality errors.  
B-1301 08:54  
Role of renal ultrasound in pelvic imaging: to scan or not to scan?  
K. Cronin, S.J. Foley, S. Simpson, A. Kelly; Dublin/IE (kevin.cronin@ucd.ie)  
Purpose: Ultrasound is a highly sought after imaging tool with consequent 
resource pressures. Kidneys are often routinely scanned when female patients 
present for pelvic imaging. The objective of this audit was to identify the 
frequency of abnormal renal findings when imaged following pelvic 
examinations and determine the clinical significance of the patient. The results 
would be used to inform the local imaging protocol. 
Methods and Materials: A retrospective study was carried out over a four-
month period in a single university teaching hospital. Radiology reports were 
reviewed from the hospital radiology information system. Renal findings were 
recorded as normal/abnormal based on local double reporting system and 
clinical significance recorded according to pre-agreed criteria reached via 
consensus between two sonographers. The average kidney scan time was 
estimated based on all departmental sonographers' input (n=10). 
Results: The results for 286 scans were analysed, and 31 (11%) abnormal 
scans were identified, most of which were benign cysts (n=15). Just 16 (6%) 
were deemed clinically significant (13 complicated cysts, 1 carcinoma, 1 
calculus, 1 mild hydronephrosis). The estimated mean time to scan the kidneys 
was 20 min, which equates to 98 hours and 40 min of scanning kidneys where 
findings were normal during this period. 
Conclusion: Routine scanning of the kidneys with pelvic examinations is not 
recommended and significant time/resources can be saved from an evidence-




B-1302 08:58  
Implementing mobile radiography services: a qualitative study of 
managers' experiences of success criteria and barriers to overcome  
E. Kjelle, K.B. Lysdahl, H.M. Olerud, A. Myklebust; Kongsberg/NO 
(elin.kjelle@usn.no)  
Purpose: The objective of this qualitative study was to evaluate success 
criteria and barriers in the process of implementing mobile radiography 
services, from managers’ point of view. 
Methods and Materials: 11 semi-structured interviews were conducted with 
managers from five hospitals and six municipalities in Norway with mobile 
radiography services. Core issues in the interview guide were barriers and 
facilitators in the different implementation phases. The framework method of 
thematic analysis was used for inductive data analysis. 
Results: Five main categories were developed: national health policy, regional 
and municipal policy and conditions, inter-organizational implementation 
projects, experienced outcome, and professional skills and personal 
characteristics. These categories were allocated into three higher order 
classifications macro-, meso- and micro-level. The main barriers experienced 
by the managers were financial, structural and procedural. In particular, the 
reimbursement system, crossing of healthcare levels and incompatible 
information systems. The main facilitators were external funding, collaboration 
and enthusiastic individuals. 
Conclusion: The main success criteria were external funding and the support 
and engagement from individuals in the collaborating organizations. To 
facilitate mobile services and services across healthcare levels, changes in 
management and the financial system are needed. In addition, there is a need 
for compatible information systems across healthcare levels. This study have 
been submitted to BMC health services research.  
B-1303 09:02  
Paediatric lifetime cancer risk for head CT protocols of a 1-year-old child  
M.R. Benhalim, P.H. Hogg, A. England, L.A. Walton, K. Szczepura; Salford/UK 
(P.Hogg@salford.ac.uk)  
Purpose: To compare effective risk (ER) for a range of paediatric CT brain 
scanning protocols. 
Methods and Materials: An ATOM phantom representing a one-year-old child 
was implanted with MOSFET radiation detectors. Helical CT scans were 
undertaken using 162 protocols. Protocols included changes in rotation times, 
gantry angulation, pitch, mA and detector configuration. Absorbed tissue doses 
were read from MOSFET and used to estimate ER, using BEIR VII report, for 
males and females aged 0-5years. 
Results: ER ranged from 20-102 and 8-46 for females and males, 
respectively. ER increased consistently by approximately 38% for females and 
17% for males when the pitch factor changed from fast to detail (mean ER 102 
versus 64 and 46 versus 29, respectively). Changing mA modulation from high 
to low dose resulted in a 48% risk reduction for both female and male (mean 
ER 102 versus 36 and 46 versus 16, respectively). Changing detector 
configuration from 0.5x16 to 1.0x16 resulted in approximately 33% reduction 
for both female and male, respectively. The gantry angulation and rotation time 
had no effect on ER. When CT gantry angle changed from 0o to 27o and the 
rotation time from 0.5 to 0.75 (S), the percentage change in effective risk was 
0.03% and 0.0% for female and male, respectively. 
Conclusion: CT protocol selection has a significant effect on ER and it is 
important to consider this when implementing protocols. Risks are lower for 
older children and males.  
B-1304 09:06  
How can we improve the patient experience of nuclear medicine hybrid 
imaging procedures? A systematic review of the evidence  
S. King; Bristol/UK (simon5.king@uwe.ac.uk)  
Purpose: Patients attending complex imaging examinations may suffer from 
anxiety and discomfort resulting in reduced satisfaction and perceptions of a 
suboptimal experience. A systematic literature review was performed on the 
patient experience of nuclear medicine hybrid imaging procedures. 
Methods and Materials: A systematic search of relevant databases including 
MEDLINE, EMBASE, AMED and CINAHL was conducted. Articles identified 
during the search process as meeting pre-determined inclusion criteria were 
then subjected to quality appraisal. A process of narrative synthesis followed in 
which key themes were identified and could be used to inform any 
recommendations for practice. 
Results: Five studies were identified that met the predetermined inclusion 
criteria. The studies were evaluated within two separate strands: the 
quantifiable evidence relating to the effectiveness of an intervention in 
improving patient experience, and a thematic analysis of the qualitative 
evidence. Four key themes were identified relating to: prior knowledge of the 
procedure, anxiety levels, standards of care and physical comfort levels. The 
review demonstrates some promising areas for further investigation and early 
  






evidence to show which interventions may have a positive impact on patient 
experience. 
Conclusion: The findings of the review highlight the diverse and challenging 
ways that patients experience nuclear medicine hybrid imaging. All health 
professionals involved in this type of imaging need to be aware of the 
experiences of their patients and provide them with ongoing support. This 
could be through the use of accurate patient information resources and/or 
ensuring that staff-patient communication is able to reduce feelings of isolation 
and anxiety.  
B-1306 09:10  
Air embolism on coronary computed tomography angiography: its 
incidence associated with the preparation of intravenous infusion  
S. Kayano1, K. Ono1, T. Yamaguchi2, H. Ota1; 1Sendai/JP, 2Sapporo/JP 
(skayano.ism@gmail.com)  
Purpose: Air embolism can be observed in the right heart system following 
injection of contrast media with power injector system on coronary CT 
angiography. Although almost all air embolism is asymptomatic, it has potential 
risks of paradoxical embolism. The study aimed was to evaluate whether its 
incidence on coronary CT angiography was associated with the process of 
preparation for intravenous infusion. 
Methods and Materials: We retrospectively evaluated a total of 693 coronary 
CT examinations in three institutions. Trained CT nurses placed an intravenous 
cannula in the forearm. Tubes connected to the cannula were prepared in the 
following ways: A, an interposed three-way cock and 20-ml syringe filled with 
normal saline to collect air contamination in the tube; B, direct connection to 
the power injector system without interposed three-way cock; C, an interposed 
three-way cock and 50-ml normal saline drip infusion bottle system to keep the 
tube patency. The incidence and location of air emboli and preparation of 
intravenous injection were assessed. 
Results: The overall incidence of air embolism was 54.9% (381/693), most 
frequently observed in the right atrium (81.9%, 312/381). Its incidence was 
significantly different among the three methods of preparation (A, 21% 
(34/162), B: 62.9% (237/376) and C, 71% (110/155), respectively, p < 0.05). 
No patient demonstrated any symptom associated with air embolism. 
Conclusion: Using a three-way cock with syringe demonstrated the lowest 
incidence of air embolism on coronary CT angiography. It is recommended to 
reduce the potential risks of complications related to intravenous contrast 
medium injection.  
B-1308 09:14  
Evaluating the roles of CT radiographers in the UK  
M.A. Harris1, M. Hardy2; 1Wakefield/UK, 2Bradford/UK 
(martine.harris@midyorks.nhs.uk)  
Purpose: Computed tomography (CT) technologies have advanced 
significantly over the last decade resulting in faster patient throughput and 
greater utility. However, threshold radiographer competencies, as defined by 
the UK Health and Care Professions Council (HCPC), are limited and no 
certification and registration requirements for operating CT exist. Instead, 
generic person and professional skills and knowledge frameworks have been 
published but these are inconsistent in their role expectations. As a result, a 
unified knowledge and skills analysis tool has been developed. This study 
reports the application of this tool to UK CT radiographer role descriptors to 
compare current clinical roles with theoretical framework standards. 
Methods and Materials: A convenience sample of UK advertised radiographer 
role descriptors requiring participation in CT were surveyed and analysed using 
systematic structured content analysis to determine correlation with themes 
within the unified framework tool. 
Results: A total of 114 radiographer role descriptors were analysed. Role 
grades and experience required, as well as type of recruiting organization, 
were varied. While key knowledge, skills and behaviors were evident across all 
roles, we noted discrepancies in role expectations. Further, the language used 
to describe role characteristics was inconsistent and open to interpretation. 
Conclusion: Small changes in language were identified between recognized 
levels of radiography practice and these have a significant impact on expected 
radiographer decision-making, responsibility and autonomy of clinical practice. 
However, the majority of these competencies reflect generic professional 
standards and CT clinical task competencies remain largely undefined 










B-1309 09:18  
Digital radiography: impact of a lower tube voltages on image quality and 
radiation dose in chest phantom radiography  
I. Hauge1, I.-J. Aandahl1, J.-P. Baranzelli2, P.M. Coelho3, L. Eriksen1, 
N. Hadebe4, G. Kahl5, S. van Schagen6, M. O`Connor7; 1Oslo/NO, 
2
Lausanne/CH, 3Lisbon/PT, 4Bloemfontein, Free State/ZA, 5Santa Catarina/BR, 
6
Groningen/NL, 7Dublin/IE (vs_steven@hotmail.com)  
Purpose: A tube voltage of 120 kVp is the standard in chest radiography. 
However, three studies have found that a lower kVp (e.g. 80 kVp) may provide 
better image quality for visualizing lung tissue and the cardiac silhouette. The 
aim of this study is to investigate the impact of tube voltage reduction on dose 
and image quality of DR chest phantom radiographs. 
Methods and Materials: An anthropomorphic chest phantom, without and with 
additional plates, to simulate a normal and large person, was imaged in PA 
and lateral projections using stepwise increases of 10 kVp, from 60 to 130 kVp. 
Subjective image analysis was conducted by doing visual grading analysis 
(VGA). Six observers rated the image quality score (IQS). In addition, objective 
image analysis was performed by using ImageJ analysis software by finding 
the contrast-to-noise ratio for six and 3 regions of interest (ROI) in the image, 
for the PA and lateral view, respectively. To optimize with regard to both image 
quality and dose, the figure of merit (FOM) = (contrast-to-noise- ratio 
squared/DAP) was estimated at each selected kVp. 
Results: 91 kVp had highest IQS for PA without plates and 110 kVp for the PA 
with plates, lateral without plates and lateral with plates. However, 130 kVp had 
the best FOM. 
Conclusion: The VGA analysis showed that it is possible to reduce the kVp 
and still get good image quality. However, more extensive VGA is needed to 
come to a definite conclusion.  
B-1310 09:22  
Patient doses in plain chest x-ray compared to national DRLs  
A. Henner, K. Paalimäki-Paakki; Oulu/FI (anja.henner@oamk.fi)  
Purpose: Finnish Radiation and Nuclear Safety Authority set updated 
diagnostic reference levels (DRLs) in 2017 (both ESD and DAP) for adult's 
plain chest x-ray. These DRLs are: pa projection 0.12mGy (0.1Gy*cm2) and 
lateral projection 0.5mGy (0.2Gy*cm2). There is also achievable level for DR: 
pa 0.05mGy (0.07Gy*cm2) and lateral 0.14Gy*cm2. Purpose of this study was 
to find out doses of chest examination and compare them to updated national 
DRLs. 
Methods and Materials: The data (526 patients) was collected by student 
radiographers during their clinical practice in spring 2016 and 2017 all over 
Finland. Imaging protocols, equipment and doses/parameters were 
documented. Entrance surface doses were calculated with formula 
ESD=Y(U,F) · (FDD/FSD)2 · Q · BSF. Measurements of radiation output were 
done by vendors or hospital engineers. DAP meter was available only in few 
places and, therefore, is not included in data. 
Results: Source to image distance 200cm, focal spot size 1mm or 1.2mm, grid 
10:1 ; 12:1, 17:1, kV 125 and AEC were used. Added filtration varied according 
to the manufacturer. Mean ESD was 0.08mGy in pa and 0.31mGy in lateral 
projection. 
Conclusion: The mean ESD 0.08mGy in pa projection compared to DRL 
0.12mGy and in lateral ESD 0.31mGy compared to 0.5mGy are below DRLs. 
Both CR and DR detectors are included in the mean. With DR the mean ESD 
in pa was 0.05mGy which is same as the achievable level.  
B-1311 09:26  
Radiography on wheels for nursing home residents may reduce 
healthcare costs  
E. Kjelle1, L. Kleven2, H. Olerud1, H. Melberg2,2; 1Kongsberg/NO, 2Oslo/NO 
(elin.kjelle@usn.no)  
Purpose: To determine whether mobile radiography service for nursing home 
residents reduce cost from a societal perspective. 
Methods and Materials: To do the cost analyses a model was constructed 
based on current knowledge of organization of radiology services for nursing 
home residents. The model included two different organizational alternatives, 
hospital-based services alone and hospital-based services combined with a 
mobile radiography service. In addition to the x-ray examination, the model 
included the immediate treatment given based on the results of the 
examination. The treatment could be given either in the hospital (in or 
outpatient) or at the nursing home. Transition probabilities in the model are 
based on data collected from hospitals in southeast Norway and earlier 
research. Cost data have been collected in reports, Norwegian regulations and 
Statistics Norway. Costs are presented in Euro (annual average of daily rates 
in 2016). 
Results: The preliminary analysis indicates that the mean cost of examining 
and treating one resident in the case of hospital-based services would be 
approximately € 2 116 (95% CI: 1 908 - 2 313). In the case of combination of 
  






hospital-based and mobile services the mean cost would be € 1 378 (95% CI: 
1 342-1 410). 
Conclusion: Mobile radiography services reduce costs by approximately 35% 
when x-ray examining and treating nursing home residents in southeast 
Norway.  
B-1312 09:30  
Evidence-based practice in diagnostic imaging departments - involving 
the patients in procedure-developement  
L. Hammerstrøm; Sarpsborg/NO (linda.hammerstrom@hioa.no)  
Purpose: In an effort to increase patient safety and reduce adverse events in 
health care, there is a strong focus on developing and utilising evidence-based 
clinical guidelines or protocols. The purpose of this study has been to 
investigate radiographers’ views on involving the patients in developing 
procedures in imaging departments. 
Methods and Materials: The study has a qualitative inductive design with 
phenomenological approach. Data collection took place in individual, semi-
structured interviews. Inclusion criteria: Radiographers with experience in 
developing guidelines or protocols in imaging departments. Managers in eight 
imaging departments received information about the study and inclusion 
criteria by email, to help in recruitment by suggesting participants. Fourteen 
suggested participants received information about the study by email. Seven 
radiographers in five different imaging departments who met the inclusion 
criteria choose to participate in the study. The author transcribed and analysed 
all interviews. 
Results: The study suggests that brief encounters with patients and complex 
high-tech equipment are factors that can complicate patient involvement in 
procedure development in imaging diagnostics. The study shows that 
radiographers perceive patient involvement in developing procedures difficult 
and confusing, due to few guidelines on how to involve the patients. 
Conclusion: The findings suggests that further training and research on EBP 
must be a focus in future procedure development. New ways of thinking is in 
order to involve the patients according to the governments’ intentions  
B-1313 09:34  
Relationship between body fat by DEXA and cardiovascular risk factors  
R.A.M. Santos, A.C. Girão, J.P. Figueiredo; Coimbra/PT 
(rutemartinssantos@gmail.com)  
Purpose: To evaluate the relationship between % body fat (%BF) and % 
abdominal fat (%ABDF) evaluated by bone densitometry (DEXA) and risk 
factors for cardiovascular diseases in young adult’s students. 
Methods and Materials: 214 individuals (aged between 18-25 years), were 
submitted to a DEXA for the determination of %BF and android fat (AF) 
classified in four groups 9using the Bray criteria (1998); and submitted to blood 
sampling for biochemical analyses: glycemia, triglycerides, total cholesterol 
and HDL, and insulin resistance. Correlation was assessed by the Pearson 
coefficient. Fat parameters and biochemical analysis were compared by 
Student's t-test. The association between anthropometric variables and 
cardiovascular risk factors was analysed by gender using the 2 test. The 
multivariate linear regression allowed to identify the predictors of %BF and AF. 
Results: The prevalence of obesity was 9.09% in boys and 16.6% in girls, with 
the average of the ABDF (AF) respectively of 17.49% and 29.27% (p=0.000). 
There was a positive correlation of insulin resistance with BF (p=0.023), with 
total cholesterol (p=0.001) and triglycerides (p=0.019) only in girls. Also in girls, 
a positive correlation was observed between TF and triglycerides (p=0.030). 
With the multivariate linear regression, we verified that both predictive models 
of BF and AF expressed a modest explanatory model (R2.0.4) associated to 
predictors gender and BF (p<0.05). 
Conclusion: This study shows that gender and triglycerides are one of the 
predictors for BF and AF, in girls.  
B-1314 09:38  
Exposure to electromagnetic fields during a gradient echo sequence in a 
3T MRI scanner along z-axis  
V.M.F. Silva, I. Ramos, M. Marques, J. Moreira; Porto/PT 
(vitorsoft@gmail.com)  
Purpose: Occupational staff, volunteers and patients' accompanying 
sometimes are exposed to electromagnetic fields (EMF) during magnetic 
resonance imaging (MRI) procedures, inside MRI room. This study aims at 
evaluating the propagation of the electromagnetic field associated with a T2 
gradient echo brain sequence along the z-axis from the magnet entrance up to 
the room limits in a 3T scanner. 
Methods and Materials: A well 200 MHz oscilloscope (Agilent DS01024A), 
that was positioned outside the MRI room, was used with a receiving 
rectangular loop connected through a double-shielded coaxial cable, allowing 
measurements of the induced voltage due to RF-magnetic field. Six 
independent measurements of induced voltage were taken at different fixed 
points in the MRI room along the z-axis from the bore, using a T2 gradient 
echo brain sequence. 
Results: Values obtained ranged from 55 mV to 382 mV and a sinusoidal z-
dependence of the induced voltage was ascertained, due to interference of the 
income and wall reflected RF-wave. Lowest values were reached at the bore 
entrance (0 cm) and at 150 cm from the entrance. Highest values were 
reached at 105, 210, 225, 240 and 255 cm from the bore entrance. Values 
measured on the back of the equipment were at 380 mV range at different 
points. 
Conclusion: Values measured from all six measurements showed a 
"sinusoidal" waveform shape, demonstrating that highest values are not 
located in points closer to the magnet isocenter. Professionals must be aware 
to that for better practices in terms of exposure to EMF in MRI.  
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B-1323 10:30  
Diagnostic performance in the stage of liver fibrosis: comparison of 
magnetic resonance T1 rho and acoustic radiation force impulse  
J. Li, C. Zhang, H. Liu, S. Yang, Y. Wang, W. Chen, D. Wang; Shanghai/CN 
(lijinning117@163.com)  
Purpose: To compare the diagnostic performance of magnetic resonance 
(MR) T1 relaxation time in rotating frame (T1 rho) and ultrasound-based 
elastography (acoustic radiation force impulse imaging, ARFI) for staging liver 
fibrosis in rat models. 
Methods and Materials: Thirty-two rats were injected with carbon tetrachloride 
(CCl4) to induce liver fibrosis and fifteen rats were injected without CCl4 as 
control. Both T1 rho and ARFI imaging were performed for all rats, and T1 rho 
values and ARFI velocities were measured. The stage of liver fibrosis was 
identified based on METAVIR scoring system (F0-4). The Pearson correlation 
coefficient was obtained between the two imaging techniques and pathological 
staging. Diagnostic performance was determined by calculating areas under 
receiver operating characteristic curves (AUCs). 
Results: There is moderate correlation between T1 rho values and ARFI 
velocities (r = 0.624, P < 0.001). T1 rho values showed stronger correlation 
with the stage of liver fibrosis (r = 0.82, P < 0.001) than that of ARFI velocities 
(r = 0.618, P < 0.001). AUCs of diagnosing fibrosis of  F1,  F2,  F3,  F4 for 
T1 rho imaging was 0.923, 0.901, 0.898, 0.961, respectively, which was higher 
than 0.862, 0.825, 0.815, 0.860 of ARFI imaging, and there is significant 
difference of AUCs between two imaging techniques for detecting fibrosis of  
F3 (P = 0.046) and  F4 (P = 0.019). 
Conclusion: MR T1 rho value is a better biomarker than ultrasound ARFI 
velocity for staging liver fibrosis, especially for diagnosing obvious fibrosis (  
F3).  
B-1315 10:38  
Evaluation of T1 measurement methods of the liver in chronic liver 
disease  
A. Yamada, T. Nonaka, M. Nakamura, T. Suzuki, D. Komatsu, S. Fujita, 
Y. Fujinaga, M. Kadoya; Matsumoto/JP (a_yamada@shinshu-u.ac.jp)  
Purpose: The purpose of study is to validate reproducibility and clinical 
usefulness of T1 measurement by variable flip angle method (VFA) and 
saturation recovery method (SR) in chronic liver disease. 
Methods and Materials: Consecutive sixty-four patients with chronic liver 
diseases who underwent MR elastography (MRE) and T1 measurement of the 
liver from April 2015 to April 2016 in our institution were included in this IRB 
approved prospective study. Plastic bottle phantoms filled with various 
concentration of Gd-EOB-DTPA (0, 0.1, 0.2 mmol/mL) were scanned together 
with patients. T1 of the liver and phantoms were measured by VFA in 43 
patients, by SR in 21 patients, before and 20 minutes after contrast media 
administration. Correlation coefficient between Gd-EOB-DTPA concentration 
and measured 1/T1 in phantoms (rC), normalized absolute difference in 
repeated measurement of T1 in phantoms (dT1), correlation coefficient 
between liver stiffness obtained by MRE and native T1 of the liver (rLS) were 
statistically analyzed between VFA and SR. 
Results: Mean and standard deviation (SD) of rC and dT1 were 
0.9084±0.3103 and 0.3058±1.0881 for VFA, 0.9997±0.0006 and 
0.0379±0.0201 for SR, respectively (P = 0.0105 and 0.0262). Mean and 95% 
  






confidence intervals of rLS were 0.0658 (-0.3531, 0.4848) for VFA, -0.7779 (-
0.9461, -0.6098) for SR, respectively. 
Conclusion: T1 measurement by SR is more reproducible and well correlated 
to Gd-EOB-DTPA concentration and liver stiffness than that by VFA.  
B-1317 10:46  
Assessment of histological stage of fibrosis using relative liver 
enhancement in patients with primary sclerosing cholangitis  
J. Yamamura, A. Aigner, C. Schramm, R. Zenouzi, G. Adam, S. Keller; 
Hamburg/DE (j.yamamura@uke.de)  
Purpose: To assess if relative liver enhancement (RLE) of extracellular 
gadolinium-based contrast agent (GBCA) enhanced magnetic resonance 
imaging (MRI) could be used as a marker of hepatic fibrosis and inflammation 
in patients with PSC. 
Methods and Materials: 40 patients (41.2±7.1 years) underwent 3-tesla (T) 
MRI examination of the liver as well as liver biopsies in a mean time of 54±55 
days between liver biopsy and MRI. Ishak modified hepatic activity index 
(mHAI) and Scheuer grading/staging of inflammation/fibrosis were used to 
categorize the specimen. T2wI and multiphase T1wI were performed, where 
T2 signal intensities, contrast enhancement and RLE were assessed. 
Interobserver agreement tests, and mixed effects regression models were 
applied to derive effect estimates for the association between histopathology 
and MRI parameters. 
Results: A fibrosis stage >2/4 was found in n=26/66 of liver histologies. 
Regression models revealed a significant positive correlation of delayed-phase 
RLE and fibrosis staging (e.g. 69.2 times (95%-CI: 45.8-92.8) higher RLE for 
fibrosis 3 or 4 compared to 0. Interobserver agreement for quantification of 
RLE was excellent (portalvenous RLE R=0.93; delayed RLE R=0.97). 
Interobserver agreement was good both for detection of T2 signal alterations 
and contrast enhancement (Cohen´s Kappa T2 >0.77; contrast enhancement 
>0.92). No significant association between portalvenous/delayed RLE and 
mHAI was observed. 
Conclusion: Delayed RLE of multiphase MRI may provide a reproducible and 
accessible evaluation of hepatic fibrosis in patients with PSC.  
B-1318 10:54  
Assessing liver fibrosis with diffusion-weighted MRI: comparison 
between conventional and kurtosis models  
L. Yang, M. Zeng, S. Rao; Shanghai/CN  
Purpose: To assess liver fibrosis in patients with chronic liver disease using 
diffusion kurtosis imaging (DKI), in comparison with conventional diffusion-
weighted Imaging. 
Methods and Materials: This prospective study was conducted with a 1.5T 
MR scanner. DKI with b-values of 0, 200, 500, 1000, 1500 and 2000 sec/mm2 
was performed in 81 patients with chronic liver disease. Mean diffusivity (MD), 
mean kurtosis (MK) and apparent diffusion coefficient (ADC) maps were 
calculated. Correlations of MK and MD with fibrosis stages and ADC were 
computed. The diagnostic efficacy of MD, MK and ADC for predicting stage 2 
fibrosis or greater, and stage 3 fibrosis or greater was compared. 
Results: The MD (rho=-0.475, P<0.001), MK (rho=0.526, P<0.001) and ADC 
(rho=-0.480, P<0.001) correlated significantly with fibrosis stages, and ADC 
exhibited a strong negative correlation with MK (rho=-0.967; P<0.001) and a 
moderate association with MD (rho=0.601, P<0.001). Areas under the curves 
(AUCs) for predicting stage 2 fibrosis or greater were not significantly different 
(P>0.05) between MK (0.809,95%CI: 0.709-0.909) and ADC (0.797,95%CI: 
695-0.899) as well as between MD (0.715,95%CI: 0.598-0.832) and ADC. 
AUCs were also similar for MD (0.710,95%CI: 0.599-0.822), MK (0.768,95%CI: 
0.665-0.870) and ADC (0.747,95%CI: 0.641-0.853) for predicting stage 3 
fibrosis or greater. 
Conclusion: DKI is feasible for predicting liver fibrosis in patients with chronic 
liver disease, but MD and MK offer similar diagnostic performance to ADC 
values.  
B-1319 11:02  
The potential role of Gadoxetate disodium (Gd-EOB-DTPA) and diffusion-
weighted magnetic resonance imaging in primary sclerosing cholangitis  
J. Yamamura1, J. Sedlacik1, T. Schuler1, R. Buchert2, H. Kooijman-Kurfuerst1, 
C. Schramm1, J. Fiehler1, G. Adam1, S. Keller1; 1Hamburg/DE, 2Berlin/DE 
(s.keller@uke.de)  
Purpose: To assess the diagnostic effectiveness of both dynamic contrast-
enhanced (DCE) and diffusion-weighted (DWI) magnetic resonance imaging 
(MRI) in patients with primary sclerosing cholangitis (PSC). 
Methods and Materials: After measuring the hepatic fibrosis classified 
according to METAVIR fibrosis score with ultrasound-elastography within an 
interval of 0±6 months, 47 patients (43.4 ± 14.5 years) with known PSC were 
examined by DCE-MRI using Gd-EOB-DTPA and by DWI on a 3.0-tesla 
scanner. DCE-parameters were calculated using a dual-inlet two-compartment 
uptake model. ROI covering the right liver lobe were drawn by two observers 
independently. Pearson correlation and univariate analysis of variance was 
used to test quantitative ADC and DCE-parameters for differences between the 
fibrosis stages. 
Results: Both ADC and hepatocellular uptake rate (Ki) correlated significantly 
to hepatic fibrosis (r=-0.610; P<0.001 and r=-0.368; P=0.01). Multiple 
comparison testing of ADC confirmed significant difference in discrimination of 
F0/1 from F2 (p=0.02), F3 (p=0.008), and F4 (p=0.001). The optimal cut-off 
value of ADC=1.17 mm2/sx10-3 for discrimination of F0/1 from F3 showed a 
sensitivity 0.1 and specificity of 0.826. The cut-off value ADC=1.13 mm2/sx10-3 
discriminated F0/1 from F4 with a sensitivity of 0.875 and specificity of 0.87. Ki 
only discriminates F0/1 from F4 (p=0.034), but not F2 or F3. The cut-off value 
Ki=0.353/100/min and Ki=0.355/100/min showed a sensitivity of 0.857 and 
specificity of 0.5 to discriminate F0/1 from F3 and F4, respectively. 
Conclusion: DWI showed a higher sensitivity to differentiate several stages of 
fibrosis and might be more preferable than DCE-MRI for diagnosis and staging 
of fibrosis in PSC.  
B-1320 11:10  
Tumour response to preoperative chemotherapy in patients with 
colorectal liver metastases: can ADC values evaluated at 3T MRI replace 
RECIST criteria?  
F. Donati, P. Boraschi, R. Cervelli, F. Pacciardi, G. Tarantini, M. Castagna, 
L. Urbani, D. Caramella, F. Falaschi; Pisa/IT (francescamaria69@gmail.com)  
Purpose: To evaluate tumour treatment response in colorectal liver 
metastases (CRLM) after preoperative chemotherapy (pCT) at 3T MRI, 
focusing on the role of ADC values. 
Methods and Materials: Twenty-five patients with CRLM, who underwent 3T 
MRI before and after fluorouracil-based pCT and subsequently treated by 
parenchymal-sparing liver surgery, were retrospectively included in our study. 
Diffusion weighted-MRI (DW-MRI) was performed using a spin-echo echo-
planar sequence with multiple b-values, obtaining an ADC map. Fitted ADC 
values were calculated by two radiologists in conference for each lesion before 
and after pCT, by drawing on the ADC map a ROI around the tumour burden of 
the lesion. Maximum diameter of each lesion in both examinations was 
recorded. Diameter variations and RECIST 1.1 criteria were assessed. All MRI 
findings were histopathologically related to Tumour Regression Grading (TRG) 
of resected liver metastases. Statistical analysis was performed on a per-lesion 
basis. 
Results: A total of 58 CRLM were analyzed. According to RECIST 1.1, 8 
lesions were classified as CR, 24 as PR and 25 as SD. In only one lesion PD 
was found. In 8 lesions both ADC and TRG was not evaluated due to the 
lesion disappearance. TRG 1, TRG 2, TRG 3, TRG 4 and TRG 5 were 
observed in 6, 12, 12, 13 and 7 lesions, respectively. ADCpost,  ADC values 
(both p<0.0001), RECIST 1.1 criteria (p=0.0009) were significantly different 
based on TRG classes. 
Conclusion: 3T DW-MRI, using ADC values, can be a reliable tool to assess 
tumour treatment response after pCT in CRLM.  
B-1321 11:18  
Liver function estimation using gadoxetic acid-enhanced liver MRI  
J.-H. Yoon1, E. Kim1, T. Okuaki2, J. Lee1; 1Seoul/KR, 2Tokyo/JP  
Purpose: To determine whether hepatocyte fraction derived from gadoxetic 
acid-enhanced liver MRI can estimate liver function. 
Methods and Materials: In this IRB approved prospective study analysed 50 
patients who underwent gadoxetic acid MRI at 3T and ICG R15. T1 maps of the 
liver using Look-Locker sequence were obtained before contrast (preT1 map) 
media injection and 10 minutes (post T1 map) after a standard dose of 
gadoxetic acid (0.025mmol/kg). Hepatocyte fraction and liver volume were 
calculated. The relationships were evaluated between MR parameters and ICG 
R15. The parameters were also compared between patients with different Child-
Pugh class, and with different ICG R15 results (15% or <15%). 
Results: Hepatocyte fraction (r=-0.78) and liver volume (r=-0.42) showed a 
negative correlation with ICG R15. Compared with patients with chronic liver 
disease (CLD) or Child A (88%, 44/50), hepatocyte fraction (238.6±106.3%, 
77.0±34.6%, P<0.0001) was significantly lower in Child B patients (12%, 6/50). 
In 44 patients with CLD or Child A, hepatocyte fraction (298.17±69.81% vs. 
160.12±95.28%, P<0.0001) was significantly higher in patients with ICG 
R15<15% (n=25), compared with patients with ICG R1515% (n=19), whereas 
liver volume did not (1059.7±129.8mL vs. 991.7±207.0mL, P=0.19). Compared 
with liver volume, hepatocyte fraction showed a better performance to detect 
patients with ICG R15> 20%, which is a contraindication of major hepatectomy 
(area under the curves were 0.70, and 0.98). 
Conclusion: Hepatocyte fraction derived from gadoxetic acid-enhanced liver 
MRI showed a significantly negative correlation with ICG R15, and showed a 
better performance to identify contraindicative patients of major hepatectomy 
than liver volumetry.  
Author Disclosures: 
  J. Yoon: Research/Grant Support; Bayer Healthcare. E. Kim: Employee; 
Philips Healthcare Korea. T. Okuaki: Employee; Philips Healthcare Japan. 
  






J. Lee: Advisory Board; Bayer Schering Pharma.. Research/Grant Support; 
Acuzen, Guerbet. 
B-1322 11:26  
Pathologic alterations in hepatic vasculature in primary sclerosing 
cholangitis: correlation with morphologic spectrum and abnormal 
hyperintensity in T2-weighted MR images  
M. Kul, D. Kuru Öz, A. Erden; Ankara/TR (melahatkul@yahoo.com)  
Purpose: To correlate both the spectrum of hepatic morphology and 
abnormally high signal intensity in T2-weighted (T2w) MR images in primary 
sclerosing cholangitis (PSC)with pathologic alterations in major hepatic 
vessels. 
Methods and Materials: A total of 34 patients with PSC were included in this 
study. Two radiologists retrospectively analyzed the image sets in consensus 
regarding the presence of any pathologic finding in portal and hepatic veins, 
abnormally T2-hyperintense areas, and spectrum of hepatic morphologic 
changes. Patients were divided into hepatic vascular pathology group (HPG) 
and control group (CG). Hepatic morphology and T2-hyperintensity were 
correlated between both groups. In HPG, correlation was also made in terms of 
location between affected vessel and both morphologic changes and T2-
hyperintensity. Additionally, time since diagnosis and total bilirubin levels were 
compared between both groups. 
Results: In 12 out of 34 patients (35%) at least in one of the hepatic vessels 
pathologic alteration was present (HPG). No significant difference was 
detected between HPG and CG in terms of abnormal morphologic spectrum 
and T2-hyperintensity (p>0.05). Total bilirubin levels, time since diagnosis did 
not differ between HPG and CG (p>0.05). No significant correlation was found 
between hepatic vascular pathology and both hepatic morphologic changes 
and T2-hyperintensity in terms of location (p>0.05). 
Conclusion: Abnormal hepatic morphology and T2-hyperintensity do not 
appear to be primarily affected by pathologic alterations of hepatic and portal 
veins in PSC. Thus, the heterogenous spectrum of hepatic morphology/T2-
hyperintensity in PSC seems rather to derive from heterogenity in 
microperfusional alterations due to periductal inflammatory and fibrotic 
changes.  
B-1324 11:34  
The possitive effects of bariatric surgery on NAFLD at early postoperative 
period: proof with ideal IQ sequences obtained by 3.0 Tesla MRI  
Y. Metin1, N. Orhan Metin1, S. Kalcan1, O. Ozdemir1, M. Çolako+lu1, A. Küpeli2; 
1
Rize/TR, 2Mus/TR (ymetin53@gmail.com)  
Purpose: To investigate the early effects of bariatric surgery on liver fat 
fraction (LFF), pancreas fat fraction (PFF) and liver length at 3T MRI using 
ideal IQ sequences. 
Methods and Materials: Body mass index (BMI), body weight, liver fat 
fraction, pancreas fat fraction and craniocaudal length of liver were measured 
preoperatively (one week before surgery) and postoperatively (one month after 
surgery) in 39 consecutive patients (25 female, 14 male; age range, 25-60 
years; mean age, 41 years) who underwent bariatric surgery [laparoscopic 
Roux-Y-gastric-bypass (4) or laparoscopic sleeve gastrectomy (35) ] between 
May 2016 and April 2017. 
Results: At the end of first month of bariatric surgery a significant decrease in 
mean values of pancreas and liver fat fraction has been observed along with a 
decrease of body weight and BMI. A moderate positive linear correlation was 
observed between LFF and PFF, liver length while a weak positive linear 
correlation was noticed between LFF, BMI and body weight. 
Conclusion: Ideal IQ MRI sequences enables quantitative analysis of fatty 
infiltration within the liver and pancreas, and thus may be use as a non-
invasive tool to monitor the positive effects of the surgery on fatty infiltration of 
these organs.  
B-1325 11:42  
Contrast-enhanced MR imaging 3D texture analysis as a potential tool for 
preoperative prediction of microvascular invasion in hepatocellular 
carcinoma  
Y. Zhu, X. Ma, X. Zhao; Beijing/CN (zhuyj04@126.com)  
Purpose: To explore the value of contrast-enhanced MR imaging (MRI) texture 
analysis in predicting the microvascular invasion (MVI) status of hepatocellular 
carcinoma (HCC) preoperatively. 
Methods and Materials: A retrospective study of 90 pathologically confirmed 
cases was conducted. Studies were divided into two groups: the MVI-positive 
group (n=45) and MVI-negative group (n=45) based on pathology. 58 texture 
parameters of HCC were extracted using baseline MRI on both arterial phase 
(AP) and portal phase (PP) by a 3D method. The clinical radiological features 
were also included. Univariable logistic regression identified potentially 
predictive parameters, which were tested in multivariable logistic regression 
together with clinical features to predict development of MVI. 
Results: In the clinical features, only max tumour diameter (MTD) showed 
significant difference between the two groups (P=0.001). Multivariable logistic 
regression revealed that MTD, 3 MR texture features in AP model and 3 in PP 
model might be predictors to MVI. AP model showed a better diagnostic 
performance than PP model using ROC analysis, with area under the curve 
(AUC) 0.921 (0.864-0.977) vs 0.815 (0.727-0.904), sensitivity 88.9% vs 80.0%, 
specificity 84.4% vs 71.1%. 
Conclusion: The contrast-enhanced MRI 3D texture analysis can predict MVI 
of HCC preoperatively and noninvasively; the arterial phase showed better 
performance.  
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B-1326 10:39  
Virtual monoenergetic image reconstruction from spectral detector CT 
improves objective image quality and subjective assessment of 
pulmonary emboli  
N. Grosse Hokamp1,2, R. Kessner2, R. Gilkeson2, A. Gupta2; 1Cologne/DE, 
2
Cleveland, OH/US (nils.grosse-hokamp@uk-koeln.de)  
Purpose: To investigate objective and subjective image quality of virtual 
monoenergetic images (VMI) provided by spectral detector computed 
tomography (SDCT) for assessment of pulmonary vessels regarding emboli 
(PE). 
Methods and Materials: 40 consecutive patients that underwent contrast-
enhanced SDCT (IQon, Philips Healthcare) with PE-protocol were included in 
this IRB-approved study. Two regions of interest were placed in each of the 
following regions in conventional images (CI) and copied to VMI (40-200keV; 
10keV increment): pulmonary trunk and arteries, lobar arteries, and segmental 
arteries. Attenuation (HU) and standard deviation (SD) were recorded, 
SDMuscle was considered representative of image noise. Signal- [SNR = 
HU(x) / SD(x)] was calculated. Subjectively, 40keV, 70keV, 110keV and CI 
images were assessed using 5-point Likert scale regarding 
large/intermediate/small vessel assessment and diagnostic confidence. 
ANOVA and Wilcoxon test were used for statistical assessment. 
Results: Attenuation in vessels was higher in low-keV images (p0.05) while 
image noise remained constant throughout all reconstructions (p0.05); this 
resulted in a significant increase of SNR in VMI40-70keV compared to CI (e.g. 
lobar arteries, 40keV/CI: 40.7±14.6/13.9±4.8; p0.05). Segmental arteries’ 
SNR in VMI40keV was equivalent to the SNR of the pulmonary arteries in CI 
(15.1±9.8 and 15.3±5.2, respectively). Subjectively, 40keV images significantly 
improved the assessment of vessels (e.g. intermediate, 4(4-5) vs 4(2-5), 
p0.05) resulting in a higher diagnostic confidence regarding PE (4.5(3-5) vs 
4(2-4), p0.05). 
Conclusion: Low-keV VMI from SDCT yields a significant increase in SNR of 
pulmonary vessels while maintaining low image noise. Accordingly, subjective 
vessel assessment and diagnostic confidence is improved in these 
reconstructions.  
B-1327 10:47  
CT pulmonary angiography at reduced radiation exposure and contrast 
material volume in obese patients using IMR and iDose4 in comparison to 
FBP  
A. Quitzke, J. Schmidt-Holtz, C. Behzadi, G. Adam, M. Regier; Hamburg/DE 
(a.laqmani@uke.de)  
Purpose: To intraindividually assess the image quality of CT pulmonary 
angiography (CTPA) in obese patients at reduced radiation exposure (RD-
CTPA) and contrast medium (CM) volume using two different iterative 
reconstruction (IR) algorithms (iDose4 and iterative model image reconstruction 
(IMR)) in comparison to filtered back projection (FBP). 
Methods and Materials: 17 obese patients (mean BMI: 37.6) with suspected 
pulmonary embolism (PE) underwent RD-CTPA (tube voltage: 100 kV; mean 
CTDIvol: 6.15 mGy; mean effective dose: 2.94 mSv) using 60 ml CM. The raw 
data were reconstructed using FBP and two different IR algorithms, iDose4 
(levels 4 and 6) and IMR (levels 1-3) (Philips Healthcare). Subjective and 
objective image quality, image appearance and conspicuity of PE were 
  






assessed in central, segmental, and subsegmental arteries. The objective 
image noise (OIN) was measured; contrast-to-noise ratio (CNR) was 
calculated. 
Results: Noise reduction of up to 65% was achieved with iDose4 level 3 and of 
85% with IMR level 3. CNR significantly increased with iDose4 and IMR 
compared to FBP (p<0.05). Subjective image quality was rated significantly 
higher at IMR reconstructions in comparison with iDose4 and FBP. Moderate 
blotchy image appearance was observed when the highest strength of IMR 
was obtained, mildly limiting the diagnostic confidence. The conspicuity of 
central and segmental PE improved with the use of IMR. In subsegmental 
arteries, IMR was inferior to iDose4. 
Conclusion: IMR enables CTPA at reduced radiation exposure and contrast 
medium volume in obese patients by the superior reduction of image noise and 
improvement of conspicuity of pulmonary embolism compared to FBP and 
iDose4.  
B-1328 10:55  
Model-based iterative reconstruction on low-dose CT pulmonary 
angiography: image quality and radiation dose saving compared with 
hybrid iterative reconstruction CTPA  
A. de Vito1, D. Ippolito1, C.R. Talei Franzesi2, L. Riva2, S. Drago1, S. Sironi1; 
1
Monza/IT, 2Milan/IT (a.devito@campus.unimib.it)  
Purpose: To evaluate the dose reduction and image quality of low-dose 
pulmonary angiography (CTPA) reconstructed with model-based iterative 
reconstruction (IMR), and compared with standard CTPA with hybrid iterative 
reconstruction (iDose4). 
Methods and Materials: 139 patients were prospectively enrolled and 
investigated for pulmonary embolism; a study group of 75 patients underwent 
low kV setting (80 kV, automated mAs) CTPA study, while a control group of 
64 patients underwent standard CTPA protocol (100 kV; automated mAs); all 
patients were examined on 256 MDCT scanner (Philips iCT elite). In the study 
group, images were reconstructed using IMR technique, while in the control 
group we used iDose4 technique. CTDIvol, DLP and ED were evaluated in 
both groups. Region of interests were drawn in the three main pulmonary 
vessels to evaluate vascular enhancement (HU); signal-to-noise ratio (SNR) 
and contrast-to-noise ratio (CNR) were also calculated. 
Results: Compared to iDose4-CTPA, low kV IMR-CTPA presented lower 
CTDIvol (6.41±0.84 vs 9.68±3.5 mGy) and DLP (248.24±3.2 vs 352.4±3.59 
mGy*cm), with ED of 3.48±1.,2 vs 4.93±1.8 mSv. Moreover, IMR-CTPA 
showed higher attenuation values (670.91±9.09HU vs 292.61±15.5HU) and a 
significantly higher SNR and CNR. The subjective image quality of low kV IMR-
CTPA was also higher compared with iDose4-CTPA. 
Conclusion: Low-dose CTPA (80 kV and automated mAs modulation) 
reconstructed with model-based algorithm represents a feasible protocol for 
the diagnosis of pulmonary embolism in the emergency setting, achieving high 
image quality with extremely low noise and a significant dose reduction within 
adequate reconstruction times (less than 120 seconds).  
B-1329 11:03  
High temporal resolution dynamic CE MRA in detection of reperfused 
pulmonary arteriovenos malformations (PAVMs) in HHT-patients  
G. Schneider, A. Bücker, A. Massmann; Homburg/DE 
(dr.guenther.schneider@uks.eu)  
Purpose: The recommended treatment of PAVMs in HHT patients (Hereditary 
Hemorrhagic Telangiectasia / Osler disease) is catheter embolization. Although 
immediate postinterventional imaging may show complete success of therapy, 
reperfusion may occur. We evaluated time-resolved contrast-enhanced MR-
Angiography for detection of reperfused PAVMs. 
Methods and Materials: 65 patients post embolization of PAVMS with 
platinum-coils or Amplatzer-vascular-plugs underwent follow-up studies for 
detection of reperfused PAVM. First, a time-resolved MRA-study was 
performed with injection of a small contrast medium bolus (0.025 mmol/kg BW 
(Gd-BOPTA) MultiHance, Bracco). The temporal resolution of the sequence 
was 3 sec/dataset with a total number of 72 slices. Thereafter a high resolution 
CE-MRA (0.075 mmol/kg BW MultiHance) with a timing based on the findings 
from the time-resolved study was performed. Images were evaluated regarding 
simultaneous enhancement of feeding artery and draining vein on dynamic CE-
MRA. 
Results: Time-resolved MR-Angiography was technically adequate in 61/65 
cases. In 26/61 patients 32 reperfused PAVMs were detected. In those cases 
in which diagnosis of reperfused PAVM was unclear on high resolution images, 
evaluation of the enhancement kinetics of the draining vein on dynamic CE-
MRA was used for diagnosis and could confirm 14 reperfused PAVM. All 
reperfused PAVM diagnosed on CE-MRA were confirmed by DSA and 
underwent reembolization. 
Conclusion: Time resolved CE-MRA is a helpful adjunct to standard high 
resolution anatomic imaging, allowing for the evaluation of the enhancement 
kinetics of the draining vein as an indicator of recanalization of PAVM. 
Compared with CT imaging of embolized PAVM, this is an important 
advantage of CE-MRA.  
Author Disclosures: 
  G. Schneider: Advisory Board; Bracco. Research/Grant Support; Bracco, 
Siemens, Guerbetracco, Siemens, Guerbet. Speaker; Bracco, Siemens, 
Guerbet. A. Bücker: Research/Grant Support; Bracco, Siemens, Guerbet. 
A. Massmann: Research/Grant Support; Bracco, Siemens, Guerbet. 
B-1330 11:11  
The frequency of coexistence of renal artery and vein variations on 
abdominal CT  
S. Gurel, Ö. Yılmaz, A. Kiyan; Bolu/TR (safiyegurel@gmail.com)  
Purpose: Our aim is to determine the frequency of coexistence of renal artery 
and vein variations. 
Methods and Materials: Abdominal CT examinations of 505 patients(217 
female and 288 male) were evaluated for the presence of renal artery 
variations [early branching, multiple renal arteries (hilar-polar-supplementary 
artery)], right renal vein variations (multiple right renal vein, split of right renal 
vein, gonadal vein connected to right renal vein) and left renal vein variations 
(circumaortic left renal vein, retroaortic left renal vein, multiple left renal vein). 
Presence of accompanying IVC anomaly (duplication and transposition) was 
evaluated as well. The frequency of renal artery and vein variations were 
calculated in percentages. 
Results: The frequency of uni- or bilateral early branching of main renal artery 
were found to be 0.6% and 2.97% whereas uni- or bilateral multiple renal 
arteries were found to be 12.3% and 2.97% respectively. On the right side, the 
frequency of multiple renal veins, split renal vein and gonadal vein draining to 
renal vein were found to be 20.4%, 0.2%, 8.9% respectively. On the left 
side,the frequency of circumaortic renal vein and retroaortic renal vein were 
6% and 3.96% respectively. No left-sided multiple renal veins and 
accompanying IVC anomaly were detected. 
Conclusion: The frequency of coexistence of renal artery and vein variations 
were found to be 7.5%. Within this group, presence of left hilar artery and 
double renal vein on the right side in nine (1.78%) of 38 patients were found to 
be the most frequent coexistent variations.  
B-1331 11:19  
Evaluation of pelvic congestion syndrome with time-resolved MR 
angiography  
S. Wassef, A. Stolpen; Iowa City, IA/US (shafik.wassef@gmail.com)  
Purpose: The purpose of this educational exhibit is to review the role of time-
resolved MR angiography (TR-MRA) in evaluation of pelvic venous congestion. 
Methods and Materials: Although non-invasive imaging techniques, such as 
ultrasound and static CT and MRI, can be helpful, they cannot accurately 
determine the timing and direction of venous blood flow, which is essential for 
accurate diagnosis and treatment planning. Conventional angiography has 
been considered the gold standard for diagnosis and potential embolisation 
therapy. Recently, TR-MRA has proved to be a useful tool for the assessment 
of ovarian vein reflux eliminating the invasiveness and ionising radiation of 
conventional angiography. 
Results: TR-MRA is a useful sequence for the assessment of ovarian vein 
reflux, which may aid the evaluation of pelvic congestion syndrome. Pelvic 
congestion syndrome (PCS), the female counterpart of male varicocele, is 
caused by incompetence of the left ovarian vein, often in combination with left 
renal vein compression. This results in venous reflux, pelvic venous 
engorgement, and chronic pelvic pain. 
Conclusion: TR-MRA has been proven to be a quick and non-invasive 
technique that allows evaluation of the physiological blood flow. It can be 
useful in detecting ovarian vein reflux which help evaluating PCS. MRI also 
provides details of the anatomy and can evaluate for other possible causes of 
pelvic pain in addition to providing dynamic imaging of the pelvic vasculature.  
B-1332 11:27  
Determination of inferior vena caval diameter: is it true on cavography?  
C. Ma; Changsha/CN (mcismc@126.com)  
Purpose: The geometries and the orientations of IVC are various and variable, 
which may lead to an inaccurate diameter measurement. The purpose of this 
study was to (a) type the geometries and the orientations of IVC on cross-
sectional CT imaging; (b)compare the discrepancy between anteroposterior 
projection diameter(PD) on cross-sectional CT imaging and hypothetical 
diameter based on caval circumferences calculation (CD); (c) if difference 
between PD and CD exists, how often it can affect IVC filter selection. 
Methods and Materials: 1619 patients who underwent abdominal contrast-
enhanced CT were included. The following parameters were measured on 
cross-sectional CT: (a) the anteroposterior PD and (b) the caval circumference. 
PD and CD were compared using Mann-Whitney U test. Cohen’s kappa test 
was used to evaluate the agreement of measurement consistency between PD 
  






and CD, where one yielded a diameter of >28mm and the other yielded a 
diameter of <28mm. 
Results: PD was significantly larger than CD (22.3±3.5 vs 20.4±2.8, P<0.05) in 
the entire study population. With the PD rule, the prevalence of megacava was 
5.5% in our study,but only 0.67% patients in our series had an IVC diameter 
greater than 28 mm according to the CD rule. When performing a Cohen’s 
kappa test, an agreement of consistency for the diameter of 28 mm was poor 
with a kappa coefficient of 0.186. 
Conclusion: As the geometry of IVC may not be circular, HD calculation 
based on circumference may be a more appropriate approach for IVC diameter 
determination.  
B-1333 11:35  
Evaluation of radiation dose and image quality of dual-detector spectral 
CT portal venography of swine using a low-concentration iodinated 
contrast agent and low tube current  
C. Chen, X. Lu, H. Liu, Z. Lu; Shenyang/CN (475395751@qq.com)  
Purpose: To investigate image quality and radiation dose of the low-iodine-
load contrast agents for portal venography by dual-detector spectral CT. 
Methods and Materials: Five swines (weighing 42.5± 3.1 kg) underwent portal 
venography by dual-detector spectral CT (120 kVp; current: dose right index 
22) with the following four different contrast media injection protocols: total 
iodine dose 40ml, 50ml, 60ml for 270 mg I/ml and 80ml for 350 mg I/ml (control 
group). The data were reconstructed in monochromatic images at 40, 50, 60, 
70 keV (spectral iterative reconstruction level 3). The image noise (IN) 
(standard deviation, SD) of portal vein (PV) and the contrast-to-noise-ratio 
(CNR) of PV-to-liver parenchyma were measured. Subjective score of the 
sharpness of PV boundaries and the diagnostic acceptability (DA) were 
performed by two radiologists independently using a 5-point scale (1 very poor 
to 5 excellent). 
Results: The radiation dose (CTDIvol) for low-iodine-load contrast groups was 
60% lower than for control group (7.4mGy vs 18.4mGy, P < 0.05) . The IN, 
CNR, DA and sharpness of PV of all groups were statistically different (P < 
0.05). For each low-iodine-load contrast group, the IN decreased and CNR 
increased from 40 keV to 70 keV, respectively. Compared with control group, 
monochromatic images 50 keV + 50 ml contrast dose combination 
demonstrated the acceptance image quality. 
Conclusion: At less than 40% of the conventional radiation dose, by the dual-
layer detector spectral CT, 50ml isotonic iodine contrast agents still clearly 
show the portal vein, at the same time, to meet the diagnostic needs.  
B-1334 11:43  
Treatment of varicose veins with endovenous laser ablation using low 
linear endogenous density  
S. Sangma1, U. Gorsi1, M. Yadav2, T. Yadav1, N. Khandelwal1; 1Chandigarh/IN, 
2
New Delhi/IN (ujjwalgorsi@gmail.com)  
Purpose: To assess the efficacy of EVLA with 1470 nm laser using low linear 
energy density (LEED) less than 80 J/cm 
Methods and Materials: A prospective study was conducted in a total of 58 
limbs with GSV incompetence using low LEED below 80 J/cm. The occlusion 
rate, improvement in CEAP and VCSS, ulcer healing rate, improvement in 
symptoms were assessed . The complication rate and recurrence of disease 
were also assessed 
Results: The occlusion rate was 96.1%; there was up gradation of CEAP 
score by one or two grades by a period of one month in 75 % cases and rest 
by a maximum period of 3 months. Ulcer healing rate was seen in more than 
91 % patients. Over 95 % confirmed improvement of symptoms . The post 
procedure pain was minimal and less than 50 % requiring NSAIDS immediately 
post procedure. DVT was encountered in 2% of patients. No major 
complications like pulmonary embolism and arterio-venous fistula were 
encountered. Two patients had segmental recanalisation of GSV after a period 
of 18 months. One patient had recurrence of symptoms and down gradation of 
CEAP score 
Conclusion: EVLA with 1470 nm using low LEED is an effective mode of 
treatment for varicose veins with lesser complications and similar venous 
occlusion rate with higher LEED>90 J/cm. No significant recanalisation of GSV 
was encountered; however a longer period of follow up will be required to 











B-1335 11:51  
Multiparameter ultrasound in the diagnosis of deep vein thrombosis of 
the lower extremities  
A. Demidova, I. Rychkova, N. Krivosheeva, E.A. Zubareva, A. Kuznecova; 
Moscow/RU 
Purpose: With the advent of the latest visualisation technologies such as 
acoustic structure quantification (ASQ), ultrasound elastography (USEG) and 
superb microvascular imaging (SMI), we get an opportunity to detect 
hypoechoic thrombotic masses in the deep veins of the lower extremities, 
hardly visualised in B-mode and colour duplex or power Doppler imaging 
modes. The combined use of new technologies, based on different variants of 
echo signal processing, allowed us to qualitatively assess the ageing of deep 
vein thrombosis (DVT). 
Methods and Materials: 32 patients aged 43 to 85 years with DVT underwent 
ultrasound examination (B-mode, CD, PD) and additional examination using 
ASQ, USEG and SMI. All examinations were provided with Toshiba Aplio 500 
ultrasound systems with high-frequency linear transducers. 
Results: Visualisation of thrombi with USEG had advantages over B-mode in 
the acute phase of thrombus formation. Thrombi were coded as homogeneous 
hard elastic structure in the vein lumen. Thrombi after the retraction phase 
were coded as soft elastic structure; later, the stiffness of the structure 
increased and the signs of elastic inhomogeneity appeared. Within the zone of 
recanalisation, we detected soft elastic parts. Using SMI allowed us to detect 
early signs of the recanalisation process (before appearance of classic color 
Doppler signs). ASQ technology determines inhomogeneity of thrombi which 
were homogeny hypoechoic structures in the B-mode. 
Conclusion: New ultrasound technologies allow us to reliably assess the echo 
structure of thrombi within different DVT stages and determine early signs of 
the recanalisation processes. Moreover, these technologies are simple to use 
and can be provided within a short time.  
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B-1336 10:39  
Percutaneous combined treatment for lumbar disc herniation: how we do 
it  
G. Galvano1, M. Raciti2, G. Scavone1, S. De Luca1, A. Cannella1, 
C. Di Lorenzo1, G. Tigano1, A. Scavone1; 1Catania/IT, 2Pavia/IT 
(mariavittoria.raciti@libero.it)  
Purpose: To show percutaneous combined treatment, coblation and oxygen-
ozone nucleus pulposus ablation, for lumbar disc decompression under 
fluoroscopic guidance and local anaesthesia. 
Methods and Materials: Retrospective single-centre study has been 
performed. Inclusion criteria included patients with back pain (visual analogue 
scales VAS > 6), unsuccessful conservative treatments at least six weeks and 
protruded disc without calcifications. Main exclusion criteria were extruded disc 
herniation, black disc, spinal stenosis, spondylolisthesis, instability, neoplastic 
disease, metabolic bone disease, infection and haemorrhagic diathesis. Since 
July 2015, 150 patients (82 male, 68 female, from 26 to 69 years) were 
enrolled. Disc disease was studied with MR or TC and electromyography in 
doubt cases. Interventions have been performed with postero-lateral access 
under fluoroscopic guidance in local anaesthesia. All patients were treated with 
coblation and oxygen-ozone nucleus pulposus ablation, and simultaneously 
with transforaminal periganglionic steroid injection. The clinical outcomes were 
evaluated using VAS score at 1, 6 and 12 months of follow-up. 
Results: There was a significant reduction of back pain in 80% of patients. The 
average preoperative VAS score was 7.1±0.3; VAS score was decreased down 
to 2.1±0.3 1 months after the procedure; the final follow-up VAS score was 
2.6±0.1. The treatment showed a complication rate <1%. Only 1 patient 
showed an early complication, extruded disc herniation. 
Conclusion: The advantage of percutaneous combined treatment, coblation 
and oxygen-ozone nucleus pulposus ablation, is that it is a single minimally 
invasive procedure which allows for a double treatment with a synergistic 
effect. Combination treatment is more effective than single procedures without 
increasing complications.  
  






B-1337 10:47  
CT-guided pulsed radiofrequency treatment of the lumbar dorsal root 
ganglion in patients with acute radicular low back pain  
A. Napoli, S. Dababou, H.-P. Erasmus, C. Marrocchio, R. Scipione, 
C. Catalano; Rome/IT (alessandro.napoli@uniroma1.it)  
Purpose: To determine the clinical impact of CT-guided Pulsed 
Radiofrequency (PR) in the management of patients with acute or sub-acute 
neuro-radicular pain from lumbar disc herniation, refractory to usual therapeutic 
strategies. 
Methods and Materials: Patients were eligible for this single-center 
prospective study if they presented acute or sub-acute neuro-radicular low 
back pain (EMG confirmed),refractory to usual treatments(drugs and 
injections),and if they could safely undergo PR-procedures.Treatment was 
performed using a 22-20G needle-electrode with probe tip directed to the 
symptomatic DRG under CT-guidance;E-pulsed radiofrequency(Cosman G4) 
was administered for 10min at 45V with constant local temperature of 
42°C.Clinical evaluation was conducted with Visual Analogue 
Scale(VAS),Owestry Disability Index(ODI) and Roland-Morris score(RM) for 
quality of life assessment; all questionnaires were obtained at baseline and at 
1-week,1-month and 3-month follow-up.Analyses were performed on a per-
protocol basis. 
Results: Over a 3-year period,80 patients were treated with PR.Median VAS 
decreased from 7.8 to 3.5 to 2.6 to 1.3, median ODI from 78.0 to 12.5 to 6.0 to 
5.5 at baseline, 1week, 1month and 3 months,respectively; RM decreased 
from 16 to 3 to 1.5 at baseline, 1month and 3 
months,respectively(p<0.001).Overall,90.0% of patients reached a 0 VAS 
score within the first month after treatment;97.5% had a decrease of 20 points 
in ODI score in the same interval.6 patients were considered partial responders 
requiring a second PR session. 
Conclusion: CT-guided PR has shown to be a minimally invasive, effective 
and repeatable percutaneous treatment option for patients with acute or sub-
acute neuro-radicular low back pain.  
B-1338 10:55  
Clinical outcome of rotational angiography in percutaneous laser disc 
decompression  
D.N. Srivastava, V. Ha, A. Monga, R. Malhotra; Ansari Nagar/IN 
(drdeepsrivastava@gmail.com)  
Purpose: 1. To evaluate the use of 3D rotational angiography technique in the 
percutaneous laser disc decompression (PLDD) treatment. 2. To evaluate the 
role of PLDD in patients with low back pain due to disc herniation. 
Methods and Materials: We performed a prospective study of 46 patients who 
underwent PLDD for chronic discogenic low back pain. The PLDD procedure 
was performed under fluoroscopic guidance using flat panel DSA unit with 3D 
rotational x-ray imaging facility. For PLDD 980-nm diode laser was used. 
Follow-up clinical outcomes were assessed by the modified MacNab criteria. 
Results: Excellent to fair response was seen in 30 out of 46 patients with 
overall success rate of 65%. In a group of patients with disc herniation smaller 
than 1/3 of the spinal canal diameter (34/46), success rate was 73.9% and in 
patients with disc herniation more than 1/3 of the spinal canal diameter (12/46), 
success rate was 26%. 
Conclusion: Preoperative imaging studies and selection of patients with disc 
herniation smaller than 1/3 of the spinal canal diameter predict the clinical 
outcome of PLDD. 3D rotational angiography technique with Dyna CT is useful 
in target selection to maximise the efficacy of the technique. PLDD is a valid 
alternative for those selected patients with contained lumbar disc herniation, 
who do not respond to conservative treatment.  
B-1339 11:03  
Evaluation of magnetic resonance guided focused ultrasound (MRgFUS) 
as a first-line treatment of bone metastases with the intention of local 
treatment and pain palliation  
H.-P. Erasmus, A. Napoli, S. Dababou, C. Marrocchio, R. Scipione, 
C. Catalano; Rome/IT (hansperasmus@gmail.com)  
Purpose: To evaluate MRgFUS as a first-line treatment of metastatic bone 
disease for the purpose of tumor control and pain palliation. 
Methods and Materials: 40 patients with naïve (no previous treatment) 
symptomatic skeletal metastases, suitable for MRgFUS, were enrolled. 
Imaging (CT/MRI) was performed before and 3, 6 and 12 months after 
treatment. The primary endpoint was the number of lesions with partial or 
complete response at 3 months according to MD Anderson criteria. Clinical 
outcomes were evaluated over the same time period using a VAS score. 
Results: Out of 40 patients, 7 were lost and missed the 3-month imaging 
check. 33 patients with 41 lesions were evaluated. The procedure was 
successful in terms of local control at 3 months in 20 lesions (49%) - complete 
in 12, partial in 8. Stable disease was observed in 5 lesions and a progression 
in 2. VAS score dropped from an average of 9 to 6 to 3 to 1,5 to 1 before, 
immediately after and 3, 6 and 12 months after treatment. Results were 
statisticallyindependent of histology (primary cancer). The only element 
influencing the outcome was the size of the lesion (upto 16 cm), with 7 cm as a 
reasonable cutoff for successful ablation - p<0.01. BMI, age and sex did not 
play a role in the final outcome. No major adverse events occurred. 
Conclusion: MRgFUS for painful bone metastases appears to achieve a local 
control of the lesion and satisfactory pain control.  
B-1340 11:11  
Drill-assisted bone tissue sampling: do we need to care about heat?  
S. Niehues, J.L. Vahldiek, B. Geyer, B. Hamm, F. Poch, K.S. Lehmann; 
Berlin/DE  
Purpose: Battery-powered drill-assisted bone tissue sampling has become a 
value alternative to manual drilling. Due to enhanced rotation speed and 
improved material, sampling of bone lesions has become more comfortable in 
lesser time. The question if enhanced drilling results in an increased heating of 
the system and the bone sample, leading to temperature-related sample 
affection, remains unclear. 
Methods and Materials: Eight experimental drillings using a battery-powered 
drilling system (Arrow OnControl, Teleflex, Shavano Park, TX, USA) were 
carried out in an in vivo model using large pigs (15 sec. drilling time) with a 
temperature probe placed adjacent to the drilling canal. Continuous 
temperature measurements during the drilling was recorded to identify possible 
heating of the tissue. 
Results: During the drilling process, we encountered a slight heating effect of 
median 0.65 degrees Celsius (SD 0.33, min. 0.1, max. 1.4 degrees Celsius). 
Initial heating reached a plateau phase during the drilling process. 
Conclusion: Battery-powered drilling causes a slight heating of the tissue not 
exceeding 1.4 degrees Celsius. Initial heating is limited mainly due to the heat-
sink effect preventing from thermal damage of the bone probe.  
B-1341 11:19  
The clinical impact of a novel low-dose protocol for minimal-invasive CT-
guided musculoskeletal interventions  
Z. Alagic, H. Alagic, R. Bujila, M.C. Wick; Stockholm/SE (zlatan.alagic@sll.se)  
Purpose: CT-guided biopsies are important to establish the diagnoses of 
musculoskeletal lesions. They have a low morbidity and high cost-
effectiveness but high levels of radiation. This prospective study compares our 
low-dose protocol for CT-guided musculoskeletal biopsies on a latest 
generation 16-cm detector 258-slice multi-detector CT (MDCT) scanner with 
advanced dose-reduction techniques to a protocol on a 64-slice MDCT 
scanner. 
Methods and Materials: Between October 2016 and April 2017, 115 patients 
met the inclusion criteria and 58 of these underwent a CT-guided intervention 
utilising our novel low-dose protocol on a 258-slice MDCT (group A). The 
remainders underwent CT-guided intervention on a 64-slice MDCT without 
modern radiation-dose reduction (group B). Between-group comparisons 
comprised radiation dose, success rate, image quality parameters and 
workflow. 
Results: In group A, the mean total DLP was 41.2±2.9 mGy*cm and 
statistically significantly lower than of group B (257.4±22.0 mGy*cm), 
corresponding to a mean dose reduction of 84% (p<0.001). For group A, the 
mean CTDIvol for the localizer scan was 1.34±0.08 mGy and for the puncture 
scan 1.88±0.09 mGy. Corresponding values for group B were 5.88±0.14 mGy 
and 13.16±0.40 mGy and statistically significantly higher than for group A 
(p<0.001, respectively). The success rate in group A was 91.2% and in group 
B 87.9% (p=N.S.). No negative effect on quantitative- and qualitative image-
quality parameters, time of intervention and number of biopsy scans was 
found. 
Conclusion: We developed and successfully utilised a low-dose protocol for 
CT-guided musculoskeletal biopsies on a 258-slice MDCT that markedly 
reduces the radiation dose without affecting success rate, image quality and 
workflow.  
B-1342 11:27  
MR-guided high-intensity focused ultrasound (MRgFUS) for the treatment 
of oligometastatic prostate cancer bone metastases: can sound waves 
downstage cancer spread?  
C. Marrocchio, A. Napoli, R. Scipione, S. Dababou, H.-P. Erasmus, 
C. Catalano; Rome/IT (cristinamarrocchio@gmail.com)  
Purpose: With improvements in diagnostic modalities such as functional 
imaging, oligometastatic prostate cancer is being diagnosed with greater 
frequency than ever before. Our aim was to determine MRgFUS ability to 
downstage patients with oligometastatic bone disease with a single session of 
non-invasive metastasis-directed therapy. 
Methods and Materials: The study was designed with intention-to-treat 
metastatic bone lesions. Patients were enrolled if they had accessible bone 
metastasis and could safely undergo MRgFUS (InSightec, Israel). Baseline 
measurable characteristics included dynamic contrast-enhanced MRI study 
  






(Gd-BOPTA, Bracco; GE 750 3T magnet) with semiquantitative perfusion 
analysis, PSA level (ng/ml) and choline PET (SUV). Measurable variables were 
obtained at treatment time, and 3 months, 12 months and 24 months follow-up. 
Results: 18 patients fulfilled the inclusion criteria and safely underwent 
MRgFUS procedure of metastatic bone ablations. Lesions were located in the 
pelvis (11), scapula (3) and long bones (4). At baseline, all lesions showed a 
significant DCE perfusion (highly vascular) with a mean perfusion reduction of 
88% at the 3 months follow-up (CI:100-50; p<0.001) and stable at subsequent 
follow-up scans. Similarly, PSA levels decreased from a mean baseline of 19 
(ng/ml) to 7.1, 2.9 and 2.1, at 3-12 and 24 months, respectively. SUV values 
showed a similar trend with reduction from baseline (mean 8.9 to 3.0, 2.3 and 
1.7; p<0.001). In all patients, a single MRgFUS session was appropriate 
without any major or minor adverse events reported. 
Conclusion: MRgFUS is a totally non-invasive procedure that can obtain 
nearly complete bone ablation in patients with oligometastatic prostate 
disease. The technique features a radiation-free approach that can be of 
incremental value in the long-survivor subset of oncological patients, 
significantly reducing the risk of toxic effects.  
B-1343 11:35  
Focused ultrasounds for the treatment of bone metastases: efficacy and 
feasibility  
A. Iannessi, A.-S. Bertrand, H. Beaumont, R. Natale, G. Baudin, A. Thyss; 
Nice/FR (asbertrand3@hotmail.com)  
Purpose: To evaluate the efficacy and feasibility of high intensity focused 
ultrasounds (HIFU) for the treatment of bone metastases. 
Methods and Materials: A single-centre prospective study involving 11 
consecutive patients with symptomatic bone metastases were done (8 women, 
3 men). Patients were treated by Focused Ultrasounds performed with MR-
guidance applied to bone metastases. Surgical treatment or radiotherapy 
treatment were not indicated for the patients who underwent FUs. The lesions 
were located in the appendicular and axial skeleton, consisting of secondary 
symptomatic lesions resulting from metastatic disease. The clinical course of 
pain was evaluated using the Visual Analog Scale (VAS) before treatment, at 
one week, and one month after treatment. We used Wilcoxon signed rank test 
to assess change in patient’s pain (R CRAN software V 3.1.1). 
Results: Patient follow-ups in our series show supportive results: within 11 
patients, 10 patients were satisfied with a long-lasting result after the 
procedure had been performed, and would recommend the intervention to 
relatives. The average evaluation of pain was 7.9/10 (SD: 1.3) before 
treatment, 2.8/10 (SD: 1.7) one week after treatment, and 2.3/10 (SD: 2.1) one 
month after treatment. Our results show a significant decrease of the pain felt 
by patients between -before procedure and one week after the procedure- (p= 
0.003), -before procedure and one month after the procedure- (p=0.004). 
Conclusion: HIFU under MR-guidance seems to be an effective and safe 
procedure in the treatment of symptomatic bone lesions for patients suffering 
from metastatic disease with a significant decrease of patient’s pain.  
B-1344 11:43  
How to carry out follow-up studies in patients with osteoid osteoma 
treated with minimally invasive procedures (MRgFUS and RFA). 
Evaluation of imaging findings and clinical outcome  
C. Gianneramo1, S. Quarchioni2, P. Palumbo1, F. Arrigoni1, S. Mariani1, 
L. Zugaro1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2Teramo/IT 
(camillagianneramo@gmail.com)  
Purpose: To evaluate the main diagnostic CT and MRI findings after treatment 
of osteoid osteoma (OO) with radiofrequency ablation (RFA) or MRgFUS, and 
their relationship with clinical outcome with a follow-up period that lasted up to 
24 months 
Methods and Materials: We retrospectively evaluated follow-up CT and MRI 
examinations of 35 patients treated with minimally invasive procedures 
(MRgFUS and RFA) (23 and 12 patients respectively).We analysed imaging 
findings that proved the good clinical outcome, in particular bone marrow 
oedema, perilesional flogistic reaction, disappearance of the nidus, “needle 
signs”, periosteal reaction and “ring signs”. We identified the follow-up period 
when this imaging signs disappeared, according to clinical improvement 
(evaluated by VAS score). 
Results: Clinical improvement was exhibited by VAS reduction (from 8 to 1) 
after 6 months from treatment.Imaging analysis showed decrease of bone 
marrow oedema in 65% of patients and decrease of perilesional flogistic 
reaction in 50% of cases in the 6 months follow-up. After one year from 
treatment, resolution of bone marrow oedema and perilesional flogistic 
reaction, was observed in 86% and 70% of cases respectively. We also noted 
significant decrease of periosteal reaction in 60% of patients.Two-years control 
was important to evaluate the disappearance of the nidus (80% of cases). 
Conclusion: According to our results, follow-up CT and MRI examinations 
after treatment of OO should be performed at 6, 12 and 24 months , since in 
this time we have statistically significant correlations between clinical outcome 
and variations in imaging findings.  
B-1345 11:51  
Ablation zones after radiofrequency ablation in 16 patients with atypical 
cartilaginous tumours  
R. Rivas Loya, J. Overbosch, J. Kraeima, R.A.J.O. Dierckx, P.C. Jutte, 
P.M. Van Ooijen; Groningen/NL (r.rivas.loya@umcg.nl)  
Purpose: Local bone tumour treatment using Radiofrequency Ablation (RFA) 
is increasing, but mostly clinical outcomes are reported. There is a lack of 
radiology data regarding ablation zones in bone, needed for reliable planning 
and predictability. The purpose is to report ablation zones in 16 RFA 
procedures in Atypical Cartilaginous Tumours (ACT). 
Methods and Materials: A retrospective study of 16 patients with ACT in long 
bones underwent a single placement CT-guided temperature controlled RFA. 
Tumours <10 mm (n=1) were treated with 10 mm needles; tumours 10-20 mm 
(n=9) with 20 mm needles, and tumours 20-30 mm (n=6) with 30 mm needles. 
The ablation zone was measured three months later in a follow-up MRI scan. 
Results: All ablations were successful and without complications. Mean total 
ablation time was 9.25 minutes (range 8-12 minutes), in which the tip of the 
needle was at 90°C for a mean time of 7.62 minutes (range 6-10 minutes). 
Mean ablation zone diameters and standard deviations (SD) were: 24 mm for 
10 mm needles, 41.37 mm (range 35-48 mm and SD 3.9 mm) for 20 mm 
needles, and 46.66 (range 42-64 mm and SD 7.88 mm) for 30 mm needles. 
Conclusion: Clinical success obtained reaffirm that RFA can be effectively 
performed in the treatment of ACT. Ablation zones are ellipsoids 10-20 mm 
larger than the tip of the needle, with a SD <10 mm. However, there were 
outliers. Thus, stressing the need for better real-time monitoring techniques 
and better planning to develop safe and effective bone tumour ablations.  
10:30 - 12:00 Room O  
Chest  
SS 1804  
Bronchopulmonary diseases: new trends 
in CT and MR  
Moderators:  
J. Ley-Zaporozhan; Munich/DE 
N.N.  
B-1346 10:30  
High-resolution lung MRI: 1.5 or 3 Tesla?  
G. Chassagnon1, C. Martin1, W. Ben Hassen2, A. Stemmer3, S. Bennani1, 
M.-P. Revel-Dubois1; 1Paris/FR, 2Saint-Denis/FR, 3Erlangen/DE 
(gchassagnon@gmail.com)  
Purpose: To compare high-resolution lung MR images acquired at 1.5 and 3 
Tesla. 
Methods and Materials: 3D spiral VIBE sequences were performed in 10 
healthy volunteers on a 1.5 Tesla unit with an isotropic resolution of 1.2 mm3 
and then at 3 Tesla with isotropic resolutions of 1.0 and 1.2 mm3. Assessment 
of bronchi up to the subsegmental level and signal measurements were 
performed. Signal and contrast-to-noise ratios (SNR, CNR) were calculated. 
Images acquired with the 1.2 mm3 resolution at 1.5 and 3 Tesla were 
compared to assess the effect of the magnetic field strength on image quality. 
Images with 1mm3 and 1.2mm3 resolution acquired at 3 Tesla were also 
compared to assess the effect of image resolution. Comparisons were 
performed using paired t-tests. 
Results: Mean acquisition and reconstruction times respectively ranged from 
4.9 ±0.4 to 6.1 ±3.1 minutes and from 9.1 ±2.1 to 14.3 ±7.5 minutes. They were 
significantly longer for the 1mm3 resolution. Ninety-five to 99% and 33 to 45% 
of the segmental and subsegmental bronchi were detected, respectively. The 
number of visible subsegmental bronchi was significantly higher with the 1mm3 
resolution (p=0.04) and significantly lower at 3 Tesla (p=0.04). Mean SNR and 
CNR ranged from 133 to 165% and from 5.7 to 9.6%, respectively. Both were 
significantly lower at 3 Tesla (p=0.016 and 0.003, respectively). 
Conclusion: High-resolution lung MRI is feasible at 1.5 and 3 Tesla. However, 
bronchial visibility as well as SNR and CNR are significantly better at 1.5 Tesla.  
Author Disclosures: 
 W. Ben Hassen: Employee; Siemens Healthineers. A. Stemmer: Employee; 
Siemens Healthineers. 
B-1347 10:38  
Preliminary application of PETRA sequence in lung nodule screening  
H. Feng; Shijiazhuang/CN (hellofh1984@163.com)  
Purpose: To assess lung MRI with a respiratory-gated pointwise encoding 
time reduction with radial acquisition (PETRA) sequence at 3T and compare it 
with computed tomography (CT) on the visibility of lung nodules. 
  






Methods and Materials: Patients were imaged with PETRA sequence,T2-
haste sequence,T2-blade sequence,T1-vibe and CT. Taking the image of CT 
as the gold standard, the total detectable rate of nodules, the detection rate of 
solid nodules, the detection rate of glass nodule and the difference of CNR and 
maximum diameter were compared. SPSS21.0 software was used for 
statistical analysis. Comparisons were made using the Wilcoxon-signed rank 
test for means and the McNemar test for ratios. Agreement between CT and 
MR imaging was assessed using the k test. 
Results: Good agreement was found between CT and PETRA image (k = 
1.0).Compared with other sequences, Petra sequence has a higher detection 
rate, the total detection rate is 85%, the detection rate of solid nodules, glass 
nodules and some solid nodules are 80%, 74% and 100%, respectively. For 
nodules with diameter greater than 5mm, the detection rate was 85%, and the 
CT value was higher than that of 600HU. The detection rate was 83%, and the 
nodules located in the middle and upper lung fields were better than those in 
the lower lung fields. 
Conclusion: PETRA enables free-breathing and submillimeter imaging of lung 
nodules with high CNR and may be an alternative to CT for patients with lung 
nodules .  
B-1348 10:46  
Chemical exchange saturation transfer (CEST) imaging vs diffusion-
weighted imaging vs FDG-PET/CT: single- and multiparametric approach 
for diagnosis of pulmonary nodules  
Y. Ohno1, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1; 1Kobe/JP, 2Otawara/JP 
(yosirad@kobe-u.ac.jp)  
Purpose: To directly and prospectively compare the capability for diagnosis of 
pulmonary nodules between single- and multi-parametric approaches by 
chemical exchange saturation transfer (CEST) imaging, diffusion-weighted 
imaging (DWI), and FDG-PET/CT. 
Methods and Materials: Fifty-six consecutive patients with 65 pulmonary 
nodules underwent CEST imaging and DWI at a 3T MR system, FDG-PET/CT, 
and pathological and/or follow-up examinations. According to final diagnoses, 
all lesions were divided into lung cancer (n=44) and benign nodule (n=21) 
groups. Then, magnetization transfer ratio asymmetry (MTRasym) was 
calculated from z-spectra at 3.5ppm, ADC and SUVmax were assessed by ROI 
measurements. To compare each index between two groups, Student’s t test 
was performed. Multivariate logistic regression analysis was performed to 
investigate the discriminating factors of malignant lesions from benign lesions. 
ROC analysis was performed to compare diagnostic performance among all 
methods. Finally, sensitivity, specificity and accuracy were compared among all 
methods by McNemar’s test. 
Results: Mean MTRasym, ADC and SUVmax of malignant group had significant 
difference with those of benign group (p<0.05). Multivariate regression analysis 
identified MTRasym (odds ratio [OR]: 0.62), ADC (OR: 1.01) and SUVmax (OR: 
0.15) as a significant differentiator of malignancy. ROC analysis showed area 
under the curve (Az) of multiparametric method (Az=0.96) was significantly 
larger than that of SUVmax (Az=0.84, p<0.05). Sensitivity and accuracy of 
multiparametric method were significantly higher than those of SUVmax 
(p<0.05). 
Conclusion: Multiparametric approach by CEST imaging, DWI and PET/CT 
has a potential to improve diagnosis performance of PET/CT for diagnosis of 
pulmonary nodules.  
Author Disclosures: 
  Y. Ohno: Research/Grant Support; Toshiba Medical Systems Corporation. 
M. Yui: Employee; Toshiba Medical Systems Corporation.  S. Seki: 
Research/Grant Support; Toshiba Medical Systems Corporation.  
T. Yoshikawa: Research/Grant Support; Toshiba Medical Systems 
Corporation. 
B-1349 10:54  
Active surveillance of subsoil nodules detected by screening: safe 
strategy to reduce overtreatment  
M. Silva1, C. Jacobs2, G. Capretti1, F. Ciompi2, B. Van Ginneken2, 
C.M. Schaefer-Prokop3,2, A. Marchianò4, U. Pastorino4, N. Sverzellati1; 
1
Parma/IT, 2Nijmegen/NL, 3Amersfoort/NL, 4Milan/IT 
(mariosilvamed@gmail.com)  
Purpose: Lung cancer derived from subsolid nodule (SSN) can show 
extremely slow growth rate having no impact on patient outcome. Active 
surveillance might reduce the rate of overtreatment. The aim of this study was 
to determine long-term evolution of SSN, survival and cause of death of 
screenees with SSN, in a large lung cancer screening trial. 
Methods and Materials: SSNs underwent active surveillance by low-dose 
computed tomography. Risk of developing lung cancer, overall mortality, and 
mortality from lung cancer were calculated by Cox proportional hazards model. 
Rates of potential overdiagnosis and potential overtreatment were calculated 
according to the National Comprehensive Cancer network guidelines for lung 
cancer screening. 
Results: SSNs were found in 16.9% (389/2,303) of screenees. During 9.3±1.2 
years, the hazard ratio (HR) of developing any lung cancer in subjects with 
SSN was 6.77, with more cancers not derived from SSN. HR of overall 
mortality in screenees with SSN was 1.34 and HR of lung cancer mortality was 
3.80; no death was associated with lung cancer derived from SSN. Potential 
overdiagnosis was seen in 28.5% (81/284) and potential overtreatment in 3.5% 
(10/284). Screenees with a high-risk SSN had an increased risk of lethal lung 
cancer not derived from SSN compared with screenees with low-intermediate 
risk (p=0.023). 
Conclusion: Active surveillance of SSN does not increase risk of lung cancer 
mortality due to local progression of the lesion. Active surveillance by long-term 
annual low-dose computed tomography is a safe strategy to reduce 
overdiagnosis and overtreatment in lung cancer screening.  
Author Disclosures: 
 C. Jacobs: Research/Grant Support; MeVis Medical Solutions AG.  
B. Van Ginneken: Grant Recipient; Mevis Medical Solutions. Shareholder; 
Thirona BV.  U. Pastorino: Research/Grant Support; Italian Ministry of Health 
RF 2004, Italian Association for Cancer Research AIRC 2004 IG 1227, Italian 
Association for Cancer Research AIRC 5xmille IG 12162, Fondazione Cariplo 
2004-1560.  
B-1350 11:02  
Lung cancer screening with MRI: characterisation of nodules with 
different non-enhanced MRI sequences  
M. Meier-Schroers, R. Homsi, H. Schild, D. Thomas; Bonn/DE 
(michael.meier@ukbonn.de)  
Purpose: To analyse MRI characteristics of pulmonary nodules in lung cancer 
screening. 
Methods and Materials: 82 participants of a lung cancer screening were 
included for this prospective study. MRI datasets of 32 subjects with 46 
nodules 6 mm were prospectively evaluated together with 50 controls. 
Acquired MRI sequences were T2-STIR, T2, bSSFP, 3D-T1, and DWI. Each 
sequence was randomly and separately viewed blinded to low-dose CT 
(LDCT). Size, shape and contrast of nodules were evaluated on each 
sequence. Findings were correlated with LDCT and with histopathology if 
available. 
Results: There were eight carcinomas with a size of 7-35 mm. Detection rates 
for malignant nodules were 100% for T2-STIR, T2 and bSSFP, and 87.5% for 
3D-T1. Contrast was significantly higher for malignant nodules on all 
sequences. Seven of eight carcinomas showed restricted diffusion, positive 
predictive value of diffusion restriction as an indication of malignancy was 
41.2%. Size measurement by MRI significantly correlated with LDCT. 
Sensitivity/specificity for nodules 6 mm was 89.1%/94.2% for T2-STIR, 
87.0%/94.2% for T2, 69.9%/98.0% for bSSFP, and 67.4%/96.0% for 3D-T1. 
Seven of eight subsolid nodules were visible on T2-sequences with lesion 
contrast being significantly lower compared to solid nodules. Two of eight 
subsolid nodules were detected by bSFFP and none by 3D-T1. All three 
calcified nodules were detected by 3D-T1, one by bSSFP, and none by T2-
sequences. 
Conclusion: Malignant nodules, as well as calcified and subsolid nodules 
seem to have distinctive characteristics on different MRI sequences. T2-
imaging was most suitable for the detection of pulmonary nodules 6 mm.  
B-1351 11:10  
Variation of tube electric current (mA) in lung CT screening for glass 
ground nodules (GGNs) bigger than 3 mm: phantom study  
L. Jin; Shanghai/CN (BrightDK@126.com)  
Purpose: To explore and assess the feasibility analysis and evaluation for lung 
mini-nodule thorax CT screening. 
Methods and Materials: Two kinds of lung nodules with different distance 
(3mm, 5mm) and density (-630HU, -800HU), totally four nodules, were 
randomly placed in phantom. The phantom was scanned under different mA 
and KV setting by both Lightspeed VCT and Discovery HD750. All the images 
were scored by 2 experienced radiologists including detection and diagnosis of 
the lung nodules and image quality. The differences of the inter-observer were 
determined by kappa statistics. 
Results: There was perfect concordance of inter-observers in image quality 
and diagnostic acceptability (kappa=0.819, kappa=0.847). There was no 
statistical difference in CT value of the air (P=0.056>0.05). For (3mm, -630HU), 
under HDCT (120KV, 20mA) for detection, the lowest ED was 0.6mSv; for (120 
KV, 40mA) the lowest ED was 1.21mSv; under VCT (120KV, 80mA), the 
lowest ED was 1.19mSv; for (120 KV, 160 mA), the lowest ED was 3.57mSv. 
For (3mm, -800HU), under HDCT (80KV, 120mA), the lowest ED was 
1.22mSv; for (80 KV, 280mA), the lowest ED was 2.84mSv; under VCT 
(120KV, 120mA), the lowest ED was 2.37mSv; for (120 KV, 240mA), the 
lowest ED was 5.95mSv. 
Conclusion: In this phantom study, using (120KV, 20mA, HDCT) scanning 
parameters could be satisfied with the detection for (3mm, -630HU) or over 
(5mm) lung mini-nodule, but if involving differential diagnosis, the lowest 
  






scanning parameters could be (120KV, 40mA, HDCT). For (3mm, -800HU), 
detection scanning parameters could be (80KV, 120mA, HDCT), diagnosis 
scanning parameters could be (80 KV, 280 mA, HDCT).  
B-1352 11:18  
Semiquantitative visual assessment of sub-solid pulmonary nodules  3 
cm in differentiation of lung adenocarcinoma spectrum  
F.-.Z. Wu; Kaohsiung/TW (cmvwu1029@gmail.com)  
Purpose: We aimed to analyze the CT features of persistent subsolid nodules 
(SSN)  3 cm diagnosed pathologically as adenocarcinoma spectrum to 
investigate whether parameters enable distinction between invasive and 
preinvasive lesions. 
Methods and Materials: A total of 129 patients with 141 SSNs confirmed with 
surgically pathologic proof were retrospectively reviewed. SSNs were classified 
into three categories: pure ground-glass nodules (pure GGNs), heterogeneous 
GGNs, and part-solid nodules. Of 141 SSNs, there were 57 pure GGNs, 22 
heterogeneous GGNs, and 62 part-solid nodules. 
Results: SSN subclassification showed a significant linear trend with the 
invasive degree of the adenocarcinoma spectrum (pure GGNs 7%; 
heterogeneous GGNs 36.4%; part-solid nodules 85.5%, P for trend <0.0001). 
For invasive lesions detection in 141 SSNs, a solid part of  3 mm was the 
most specificity (sensitivity, 76.9%; specificity, 94.7%), followed by air-
bronchogram sign (sensitivity, 53.8%; specificity, 89.5%), SSN 
subclassification (sensitivity, 81.5%; specificity, 88.2%), and a lesion size  12 
mm (sensitivity, 84.6%; specificity, 76.3%). For invasive lesion detection in 79 
pure or heterogeneous GGNs, the heterogeneous GGN sign was the most 
useful finding, with most specificity (sensitivity, 66.7%; specificity, 79.1%), 
followed by CT attenuation (HU) of  -493 (sensitivity, 75%; specificity, 74.6%) 
and a lesion size  10 mm (sensitivity, 83.3%; specificity, 70.1%). 
Conclusion: In conclusion, this simple combined visual and semiquantitative 
analysis of CT features helps distinguish invasive from preinvasive lesions.  
B-1353 11:26  
Analysis of pulmonary fibrosis, using an elastic registration technique in 
a model of fibrosis: systemic sclerosis  
C. Martin1, G. Chassagnon1, R. Marini2, A. Regent1, L. Mouthon1, N. Paragios2, 
M.-P. Revel1; 1Paris/FR, 2Gif-sur-Yvette/FR (chachmartin@hotmail.com)  
Purpose: To evaluate the feasibility of pulmonary fibrosis detection in 
scleroderma patients by using magnetic resonance imaging (MRI) and an 
elastic registration algorithm. 
Methods and Materials: Full inspiratory and expiratory spiral VIBE (Volume 
Interpolated Breath-hold Examination) sequences were performed on a 3T-
MRI unit. Depending on High Resolution Computed Tomography results, 3 
patient groups were considered: no infiltrative lung disease (ILD), ILD without 
fibrosis and ILD with fibrosis. A control group of healthy volunteers was also 
evaluated. An elastic registration algorithm was applied to all examinations in 
order to get Jacobian maps for each subject. Regions with the most important 
volume changes between inspiration and expiration were compared in the 3 
patient groups and healthy volunteers, using Dice coefficients. Pearson 
correlation coefficient was calculated between Dice coefficient and Forced Vital 
Capacity (FVC). 
Results: 33 subjects were prospectively evaluated. Jacobian distributions 
were visually different between subjects with and without ILD. ROC curves 
analysis was performed for the whole cohort and for a subgroup composed by 
healthy volunteers and fibrotic patients. The best Dice coefficient cut-off value 
was 0.44 for both analysis, with sensitivities of 92% and 86% and specificities 
of 75% and 100% for the presence of fibrosis, respectively. No significant 
correlation was found between Dice coefficient and FVC (R= 0.12, p=0.6). 
Conclusion: Elastic registration of inspiratory and expiratory MR images 
shows significant differences between subjects with and without ILD. High 
specificity for the presence of fibrotic changes is reported even though no 
correlation was found with FVC, in this preliminary study.  
Author Disclosures: 
  C. Martin: Research/Grant Support; Société Francaise de Radiologie, Bourse 
CARDIF - L'assistance respiratoire.  
B-1354 11:34  
Finding the right spot: where to measure airway parameters in patients 
with COPD?  
J.F.M. Gawlitza, A.M. Fischer, I. Akin, M. Borggrefe, S.O. Schönberg, 
H. Haubenreisser, T. Henzler, F. Trinkmann; Mannheim/DE 
(joshua_gawlitza@yahoo.de)  
Purpose: The importance of spirometry for diagnosing and treating COPD was 
reduced in the 2017 revision of the GOLD report. While spirometry does not 
reflect the complexity of the disease, quantified computed tomography (qCT) 
may gain further relevance. Airway measurements show strong correlations 
with lung function tests and symptoms. However, these correlations are 
specific to the airway localization, and currently there is no evidence for the 
ideal spot. Therefore, the aim of this prospective study was to systematically 
correlate airway measurements with extensive lung function testing. 
Methods and Materials: 65 patients with diagnosed COPD underwent body 
plethysmography, impulse oscillometry and dose-optimized qCT examination 
(Somatom Force, Healthineers, Germany) in inspiration and expiration. Eight 
airway parameters were acquired for both scans in every lobe for the third- to 
fifth-generation bronchus and correlated with the lung function tests. 
Results: The most significant correlations between airway parameters were 
found for the third-generation bronchus of the upper left lobe during expiration 
(25 out of 48 correlation pairs, mean r = -0.39) and for the third-generation 
bronchus of the upper right lobe during inspiration (9 out of 48 correlation pairs, 
mean r = -0.25). No significant correlations were for example found for the 
upper right lobe in expiration. 
Conclusion: Correlations between airway parameters and lung function tests 
vary widely between lobes, bronchus generations and breathing states. Our 
work suggests that the third-generation bronchus of the upper left lobe in 
expiration could be the preferred localization for airway quantification in future 
studies.  
B-1355 11:42  
Prospective quantification of respiratory mechanics in COPD patients 
before and after lung volume reduction surgery on dynamic MRI  
K. Martini, C. Caviezel, G. Milanese, W. Weder, T. Frauenfelder; Zurich/CH  
Purpose: To prospectively evaluate respiratory mechanics in chronic 
obstructive pulmonary disease (COPD) patients pre- and post-lung volume 
reduction surgery (LVRS) on dynamic magnetic resonance imaging (MRI). 
Methods and Materials: 24 patients (11 female, median age 63y) suffering 
from COPD and scheduled for LVRS were included. MRI was performed on a 
3T MR-scanner and dynamic sequences of the lung were acquired in a sagittal 
plane during two breath-cycles for both lungs the day before and 3 months 
after LVRS, herein termed as pre- and post-LVRS-MRI. Quantitative 
measurements were performed on sagittal planes for left and right lung in pre- 
and post-LVRS-MRI: lung height, anteroposterior (AP) diameter, 
hemidiaphragm height and lung area as well as hemidiaphragm area were 
measured. Additionally, lung areas during one breath cycle were measured. 
Student's t test was used to test for statistically significant differences between 
pre- and post-LVRS-MRIs. A p value<0.05 was considered as statistically 
significant. 
Results: In expiration, mean lung and hemidiaphragmatic area on both sides 
(pright=0.002 and pleft=0.043) as well AP diameter of both lungs (pright=0.003 and 
pleft<0.001) improved significantly in patients undergoing LVRS. Dynamic 
measurements showed significant differences pre- and post-LVRS on the right 
lung, but not on the left (pright=0.032 and pleft=0.606). There were no significant 
changes in lung and hemidiaphragmatic high pre- and post-LVRS. Additionally, 
there was no difference of the measured variables in inspiration. 
Conclusion: By increasing the elastic recoil of the lung LVRS improves 
significantly impaired respiratory mechanics caused by increased airflow 
resistance and reduces pulmonary compliance in patients with COPD.  
B-1356 11:50  
MR-based lung volume segmentation in population-based whole-body 
MR imaging: correlation with clinical characteristics, pulmonary function 
testing and obstructive lung disease  
J. Mueller1, R. Lorbeer2, R. von Krüchten1, A. Pomschar3, H.-U. Kauczor1, 
F. Bamberg4, H. Schulz5, S. Karrasch5, C.L. Schlett1; 1Heidelberg/DE, 
2
Munich/DE, 3München/DE, 4Tuebingen/DE, 5Neuherberg/DE 
(Ricarda.vonKruechten@med.uni-heidelberg.de)  
Purpose: Whole-body magnetic resonance imaging (MRI) is increasingly 
performed as part of clinical service and research. The value of lung volume 
derived from non-dedicated MRI sequences is unknown. 
Methods and Materials: As part of a population-based KORA FF4 study, 400 
subjects aged 56.4 (±9.2) years underwent whole-body MRI. Lung volumes 
were derived semi-automated and related to common predictors, pulmonary 
function tests (PFT, available in n=214) and obstructive lung disease 
(FEV1/FVC<70% or self-reported physician diagnosis of COPD/emphysema). 
Results: The average MRI-based lung volume (MRLV) was 4.0±1.1L, which 
was 64.8±14.9% of the predicted total lung capacity (TLC) and 124.4±27.9% of 
the predicted functional residual capacity. In multivariate analysis, MRLV was 
positively associated with age, male gender, current smoking, and height. 
Among PFT indices, MRLV correlated best with TLC, alveolar volume (VA), 
and residual volume (RV; r=0.57 each), while it was negatively correlated to 
FEV1/FVC (r=-0.36) and lung diffusing capacity (TLCO/VA; r=-0.16). 
Combining the most strongly associated PFT parameters in a multivariate 
model, RV and FEV1/FVC remained independently associated with MRLV 
(=0.50, p=0.04, and =-0.02, p=0.02, respectively) explaining up to 45% of 
the variability of the MRI data. In subjects with obstructive lung disease, higher 
MRLVs were observed yielding an AUC of 0.673 for a FEV1/FVC below 0.7 
and of 0.654 for a diagnosis of COPD/emphysema. 
  






Conclusion: Lung volumes derived from non-dedicated whole-body MRI were 
independently associated with RV and FEV1/FVC after accounting for well-
known predictors and typical risk factors of respiratory function and show 
moderate accuracy for detection of obstructive lung disease.  
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B-1357 10:39  
Learning the language of PI-RADS version 2: correlation between 
prostate MRI lexicon terms and malignancy  
M. Rudolph, A. Baur, M. Haas, S. Mahjoub, H. Cash, P. Asbach, B. Hamm, 
T. Penzkofer; Berlin/DE  
Purpose: To assess the value of PI-RADS 2 lexicon terms for predicting 
prostate cancer using lesion shape, border and diffusion characteristics. 
Methods and Materials: Prostate lesions of 160 patients that received 
multiparametric prostate MRI and subsequent MRI/TRUS-biopsy including 
systematic biopsy were examined in a blinded and randomized setting by two 
experienced radiologists. Every lesion was examined with regard to imaging 
characteristics as defined by PI-RADS v2 lexicon terms. The histopathological 
result of the respective lesion was correlated to the assigned morphological 
features and positive and negative predictive values (PPV and NPV) were 
calculated. 
Results: 174 lesions were identified of which 102 (58.6%) were 
histopathologically confirmed malignant. Predictive values of lexicon terms 
describing lesion characteristics were reported as follows (PPV/NPV): 
“restricted diffusion” (76%/74%), “DWI hyperintensity” (80%/86%), “ADC 
hypointense” (74%/90%), “round” (53%/40%), “oval” (66%/43%), “lenticular” 
(83%/43%), “lobulated” (71%/43%), “water drop shaped” (91%/44%), “wedge 
shaped” (29%/37%), “linear” (7%/37%), “irregular shape” (63%/43%), 
“circumscribed” (57%/40%), “non-circumscribed” (83%/43%), “indistinct” 
(63%/42%), “obscured” (85%/49%), “irregular border” (71%/43%), “spiculated” 
(100%/42%), “encapsulated” (12%/36%), “organized chaos” (31%/30%), 
“erased charcoal sign” (86%/45%). 
Conclusion: Out of 20 examined PI-RADS lexicon items, the terms associated 
with restricted diffusion had a favorable combination of both high PPV and 
NPV to correctly predict and exclude malignant lesions. The shape and border 
terms associated with inflammation or BPH “wedge shaped”, “linear”, 
“encapsulated” and “organized chaos” showed a potential to predict benign 
lesions with low PPV/NPV. The remaining lexicon terms had mediocre 
predictive values indicating potential for refinement in further iterations of the 
PI-RADS lexicon.  
Author Disclosures: 
 A. Baur: Speaker; Bayer.  B. Hamm: Consultant; Toshiba Medical Services 
Corporation. Equipment Support Recipient; Elbit Imaging Ltd. Grant Recipient; 
Toshiba Medical Services Corporation, Koninklijke Philips NV, Siemens AG, 
General Electric Company, Elbit Imaging Ltd, Bayer AG, Guerbet SA, Bracco 
Group, B. Braun Melsungen AG, KRAUTH medical KG, Boston Scientific 
Corporation. Investigator; CMC Contrast AB. Shareholder; Siemens AG, 
General Electric Company.  
B-1358 10:47  
Diagnostic performance of PI-RADS version 2 in detecting prostate 
cancer using whole-mount histology after radical prostatectomy as the 
standard of reference  
R. Girometti1, S. Bednarova1, S. Sioletic1, V. Ficarra2, F. Greco1, A. Crestani1, 
C. Zuiani1; 1Udine/IT, 2Messina/IT (rgirometti@sirm.org)  
Purpose: To assess the accuracy of prostate imaging reporting and data 
system version 2 (PI-RADS v2) in detecting prostate cancer (PCa) on 
multiparametric magnetic resonance imaging (mpMRI). 
Methods and Materials: During May 2016-February 2017 we prospectively 
included patients with PCa undergoing staging 3.0T mpMRI before radical 
prostatectomy. One experienced pathologist performed whole-mount histology 
on prostate specimens. mpMRI images were analysed independently by three 
radiologists (2-8 years of experience) who detected, mapped and scored 
imaging findings following PI-RADS v2. After an mpMRI-to-whole-mount 
histology matching, we calculated sensitivity and specificity in detecting PCa 
and clinical significant PCa (csPCa) using PI-RADS 3 and 4 thresholds. 
Inter-reader agreement in attributing the PI-RADS score was calculated with 
Cohen’s weighted-kappa statistic. 
Results: Included were forty-eight patients (median iPSA 7.2 ng/ml) with 71 
cancers on final histology (median size 16 mm, median Gleason score 6, stage 
T3 in 19/48 cases). On a per-lesion basis, sensitivity was slightly higher with 
PI-RADS 3 vs. 4 threshold (range 0.55-0.62 vs. 0.48-0.60 for all PCas, and 
0.67-0.74 vs. 0.61-0.72 for csPCas, respectively), at expenses of lower 
specificity (range 0.11-0.30 vs. 0.56-0.71 for all PCas, and 0.28-0.30 vs. 0.55-
0.71 for csPCas, respectively). Accuracy improved on a per-patient basis, with 
0.64-0.77 sensitivity and 0.73-0.83 specificity for csPCa with a PI-RADS 4 
threshold. Inter-reader agreement was moderate to substantial (k=0.47-0.72 
vs. 0.51-0.71 for PI-RADs thresholds 3 and 4, respectively). 
Conclusion: PI-RADS v2 showed good diagnostic performance in detecting 
PCa, with acceptable inter-reader agreement. PI-RADS 4 threshold offered a 
better balance between sensitivity and specificity.  
B-1359 10:55  
Diagnostic yield of prostate biopsies and PI RADS version 2 scoring of 
MRI prostates  
G. Chilvers, U. Udeshi; Worcester/UK (geoffreyschilvers@gmail.com)  
Purpose: Current literature assessing the accuracy of PI-RADS v2 scoring of 
MRI prostates demonstrates variable outcomes. This study investigates this 
further with the largest reported population to date. We also determine if the 
addition of cognitive targeted biopsies to systematic biopsies of the prostate 
improves diagnostic yield for prostate cancer. 
Methods and Materials: A retrospective study was performed comparing all 
prostate biopsy results in 2016 with PI-RADS v2 score on the pre-biopsy MRI. 
Two populations were identified: those with PI-RADS v2 score of 4 or 5 
(significant cancer identified) and those with PI-RADS v2 score of 1, 2 or 3. A 
significant cancer was defined histologically as a Gleason score 7. The 
histology results were analysed to determine whether the diagnosis of prostate 
cancer was made via systematic biopsies or cognitively targeted biopsies. 
Results: 464 patients were included. 166 scored PI-RADS 4 or 5. 63% of 
these had histologically proven significant cancer, whilst 90% of 298 patients 
scored 1, 2 or 3 had no histologically proven significant cancer. Overall, 
sensitivity 77%, specificity 81%, positive predictive value 63% and negative 
predictive value 90%. 49.4% of systematic prostate biopsies demonstrated 
prostate cancer, whilst 51.1% of systematic plus cognitively targeted prostate 
biopsies demonstrated prostate cancer. 
Conclusion: This study demonstrates that PI-RADS v2 scoring can help 
identify which patients require further investigation with prostate biopsy. PI-
RADS v2 scores of 1, 2 or 3 correlate well with histologically non-significant 
biopsy results. Cognitively targeted biopsies in addition to systematic prostate 
biopsies slightly improve the diagnostic yield for prostate cancer.  
B-1360 11:03  
Clinical value of the PIRADS score in predicting benign and malignant 
conditions at MRI-guided prostate biopsy: a correlation of 54 patients 
with suspicion of prostate cancer  
K. Engelhard, K. Bogner, F. Schneider; Nürnberg/DE 
(karl.engelhard@martha-maria.de)  
Purpose: To evaluate the sensitivity and positive predictive value of the 
PIRADS score 4 and 5 (version 2) in determining positive histological tumour 
results and the impact of PIRADS score 3 score in differentiating these 
nondistinctive lesions as benign or malignant at MRI-guided prostate biopsy in 
patients with the suspicion of prostate cancer. 
Methods and Materials: 54 patients with an elevated PSA value >4 ng/ml and 
a cancer suspicious region in multiparametric MRI underwent MRI-guided 
biopsy in a standard 1.5T magnet. 34 men were biopsy naïve, 20 patients had 
prior tumour-negative biopsies. A mean of 2.2 cores were taken from each 
tumour-suspected lesion. The PIRADS scores of the tumour-suspected lesions 
were compared with the histological results of the biopsy. 
Results: Applying the PIRADS system 54% of cancers were detected by MRI-
guided biopsy with a rate of 90% significant tumours. The sensitivity of 
PIRADS score 4, 5 was 90%, by a positive predictive value of 70%. In 25 men 
with PIRADS score 3 no cancerous tissue was found at histology. In one of 
these lesions a high-grade PIN was detected. 
Conclusion: In this study the PIRADS score system was highly sensitive and 
shows a fair positive predictive value in detecting significant prostate cancers 
at MRI-guided biopsy. Including PIRADS 3 lesions into the biopsy procedure in 
our population the score can be helpful as a predictive tool in the estimating 











B-1361 11:11  
Audit of diagnostic yields of prostate cancer in biopsy naive patients at 
high risk of cancer on the London Cancer Alliance Best Practice Prostate 
Pathway (LCABPPP)  
H.K. Sokhi1, S. Patel1, A. Padhani2, A. Pope1; 1London/UK, 2Northwood/UK  
Purpose: To document multiparametric MRI (mpMRI) diagnostic yields of the 
2013 LCABPPP involving pre-biopsy mpMRI followed by TRUS biopsies in 
patients at higher risk of prostate cancer (PCa). 
Methods and Materials: 214 pre-biopsy PI-RADS compliant mpMRI studies 
performed between April 2014 & April 2017. 195 (91%) patients had PSA 
>10ng/mL and/or abnormal digital rectal examination. 180 scans evaluated 
with the PI-RADS scoring systems. mpMRI findings were correlated with TRUS 
+/- targeted biopsy histology. 
Results: Prevalence of all PCa and clinically significant cancer (csPCa: 
Gleason>3+3) was 72% and 58% respectively in 199 of 214 patients. Of 180 
PI-RADS assessed mpMRIs, 121 contained focal index lesions (PI-RADS 3-5); 
33 demonstrated non-measurable extensive/diffuse changes (PI-RADS 3-5); 
26 were negative (PI-RADS 1-2). Overall diagnostic yield of all PCa and csPCa 
was 4/26 (15%) & 1/26 (4%) for PI-RADS 1/2; 6/19 (32%) & 3/19 (16%) for PI-
RADS 3; 20/27 (74%) & 14/27 (52%) for PI-RADS 4 and 102/108 (94%) & 
87/108 (81%) for PI-RADS 5 categories respectively. Rule out ability (Sen 
99%, NPV 96%, LR-ve 0.03) was better than rule in performance (Spec 33%, 
PPV 68%, LR+ve 1.49) for csPCa. 
Conclusion: There is a high prevalence of positive mpMRI (PI-RADS 3-5) in 
higher risk biopsy naïve patients. Positive mpMRI (PIRADS 3-5) is associated 
with all PCa and csPCa detection rate of 83% & 68% respectively using TRUS 
+/- targeted biopsy. Systematic TRUS biopsy has negligible yields in mpMRI 
negative patients.  
B-1362 11:19  
PI-RADS version 2-based assessment of prostate in patients with 
borderline-elevated prostate-specific antigen levels: a prospective study  
A. Yadav, M. Bagarhatta, U. Jaipal; Jaipur/IN (arushiy403@gmail.com)  
Purpose: To predict clinically significant prostate cancer (CSPca) in patients 
with borderline-elevated prostate-specific antigen (PSA) levels. 
Methods and Materials: Fifty patients with PSA levels of 4-10 ng/ml were 
prospectively evaluated by 3.0 T multiparametric MRI (mp-MRI). Evaluation 
was done by 2 independent radiologists using PI-RADS v2 scoring system. 
Region-based analysis with sectoral mapping followed by 12 core systematic 
biopsy was done. CSPca was defined as Gleason score  3+4 or tumour 
volume  0.5 ml. Histopathology by expert uropathologist was considered gold 
standard. Statistical analysis was done with SPSS 20 and diagnostic accuracy 
was calculated separately for PI-RADS score 3 and 4 as cutoff. Youden index 
was used for best diagnostic cutoff. Kappa test was used for diagnostic 
concordance among radiologists. 
Results: 95% cores of biopsy specimen were reported satisfactory. Mean age 
was 62 ± 1 years, with mean PSA of 7.86 ± 2.79 ng/ml. The diagnostic 
accuracy (95% CI) of PI-RADS v2 with score of 3 as cutoff in diagnosing 
CSPca was: sensitivity, 0.93 (0.77-0.99); specificity, 0.94 (0.92-0.96); LR+, 
17.40 (12.05-25.13); LR-, 0.07 (0.02-0.28), respectively. The PPV were from 
0.39 to 0.57 and NPV from 0.98 to 0.99. ROC curve showed a score of 3 as 
the best diagnostic cutoff (AUC - 0.949). The diagnostic concordance among 
two radiologists was good (kappa=0.719). 
Conclusion: PI-RADS v2 has very high NPV in predicting CSPca in patients 
with borderline PSA, reducing the number of useless biopsy and morbidity. A 
score of 3 seems to be the best cutoff to diagnose CSPca.  
B-1363 11:27  
When does biopsy make sense in patients with an overall PI-RADS score 
of 3?  
T. Ullrich, L. Schimmöller, M. Quentin, N. Laqua, D. Blondin, C. Arsov, 
R. Rabenalt, P. Albers, G. Antoch; Düsseldorf/DE 
(Tim.Ullrich@med.uni-duesseldorf.de)  
Purpose: To systematically analyse patients with ‘equivocal’ (PI-RADS-3) 
lesions in multiparametric prostate MRI (mp-MRI) and MR-targeted plus 
systematic transrectal ultrasound-guided (TRUS-GB) biopsies as reference 
standard and define conditions under which biopsy is recommended. 
Methods and Materials: One hundred and twenty consecutive patients with a 
PI-RADS overall score of 3 after mp-MRI (T2WI, DWI, DCE-MRI) at 3T and 
subsequent targeted MRI/US fusion-guided (FUS-GB) plus systematic 12-core 
TRUS-GB were retrospectively included in this study. Endpoints were prostate 
cancer (PCa) detection rates, distribution of Gleason scores and location of 
PCa. 
Results: PCa was detected in 13 of 118 patients (detection rate 11%) 
including five patients with a Gleason score (GS) of 3+4=7 (4.2%). 1.4% 
(3/212) of the transitional lesions and 9.4% (6/64) of the peripheral zone 
lesions were positive for PCa. 54% of the PCa patients showed MRI patterns 
of peripheral prostatitis combined with diffuse stromal hyperplasia. Prostate 
volume was significantly lower in PCa patients (p=0.015), whereas differences 
in PSA levels were not statistically significant (p=0.87). PSA density (PSAD) 
was higher in patients with PCa (0.19 vs 0.12ng/ml/ml). 
Conclusion: In patients with PI-RADS overall score of 3 low-grade PCa (GS 
3+3=6) can occur. PCa with a GS 3+4=7 can reliably be detected in mp-MRI. 
GS 4+3=7 PCa is very unlikely in PI-RADS-3-lesions. Therefore, these 
patients primarily should receive follow-up MRI. In patients with a combination 
of MRI aspects of extensive prostatitis and diffuse stromal hyperplasia, low 
prostate volume, and high PSA density a combination of targeted and 
systematic biopsy might be considered.  
B-1364 11:35  
How to prevent patients with a false-positive overall score of PI-RADS 4  
T. Ullrich, L. Schimmöller, M. Quentin, N. Laqua, F. Dietzel, C. Arsov, 
R. Rabenalt, P. Albers, G. Antoch; Düsseldorf/DE 
(Tim.Ullrich@med.uni-duesseldorf.de)  
Purpose: To characterize patients with an overall PI-RADS score of 4 in mp-
MRI of the prostate and negative histology after combined targeted and 
systematic biopsy in a large cohort based on clinical conditions and PI-RADS 
decision rules. 
Methods and Materials: 170 consecutive patients with a PI-RADS v2 overall 
score of 4 after multi-parametric MRI (T2WI, DWI, DCE) at 3T and subsequent 
targeted MR/US fusion-guided plus systematic transrectal ultrasound-guided 
biopsy were retrospectively included in this study. Endpoints were detection 
rates and subgroup analyses. 
Results: PCa detection rate was 62% (106/170) including 87 patients (51%) 
with a Gleason score (GS) of 3+4=7 (csPCA). PSA density (PSAD) was 
significantly higher in PCa patients (0.22±0.12ng/ml/ml; p<0.01). 135/287 
(47%) index lesions in the peripheral zone (PZ) were positive for PCa whereas 
28/143 (20%) transitional lesions revealed PCa. 58/107 (54%) PZ lesions with 
PI-RADS single score of 3 in DWI and upgrade to overall PI-RADS 4 due to 
positive DCE contained PCa. 4/10 (40%) transitional lesions with upgrade to 
overall PI-RADS 4 due to positive DWI (score 4 or 5) contained PCa. 
Conclusion: Patients with an overall PI-RADS score of 4 possess a high 
likelihood of PCa/csPCa and index lesions need (additional) targeted biopsy. In 
case of negative histology results, targeted re-biopsy should be considered in 
patients with high PSAD and index lesion located in the PZ. Existing PI-RADS 
decision rules for upgrading lesions from 3 to 4 reveal PCa in many cases. 
DCE is essential not to miss significant PCa, especially in the peripheral zone.  
B-1365 11:43  
Is it possible to reduce the number of false positive cases of PI-RADS v.2 
classification? Role of quantitative analysis of DCE-MRI in prostate 
lesions' characterisation  
G. Cristel, A. Esposito, A. Damascelli, S. Antunes, G. Brembilla, A. Briganti, 
A. Del Maschio, F. De Cobelli; Milan/IT (cristel.giulia@hsr.it)  
Purpose: To test the potential impact of pharmacokinetic dynamic contrast-
enhanced MRI parameters on the multiparametric MRI (mpMRI) diagnostic 
performance, using PI-RADSv.2 as standard of reference. 
Methods and Materials: From our Data-Base of 666 prostate mpMRI (1.5T) 
acquired between January 2016 and July 2017, we retrospectively evaluated a 
group of 103 patients, with available corresponding histological specimen 
obtained through target biopsies. Perfusion study included multiple flip-angle 
T1W-images (5°,8°,12°,15°) for T1-mapping and contrast enhanced 3D-FFE-
T1W sequence. Images were evaluated using PI-RADS score v.2 and 
pharmacokinetic parameters (Ktrans, Kep, Ve, Vp) were calculated with 
commercially available permeability software (population-based AIF). We 
evaluated the diagnostic performance of MRI for Gleason Score (GS)>=7 
tumours, considering PI-RADS>=3 as pathological. 
Results: The 103 lesions were classified as follow: 8 PI-RADS2, 23 PI-
RADS3, 57 PI-RADS4 and 15 PI-RADS5. 59 lesions presented GS7 at 
histological evaluation. Sensitivity and PPV of mpMRI using PI-RADSv.2, were 
98% and 61%, respectively. GS7 lesions showed higher Ktrans (p<0.01) and 
Kep (p=0.01) compared to GS<7. ROC curve analysis was used to identify a 
Ktrans cut-off value of 191x10-3/min (AUC 0.75) that predicted the presence of 
GS7 with sensitivity of 95% and specificity of 61%. Considering only PI-
RADS3 lesions, the application of Ktrans cut-off shifted 22 false positives to 
true negatives with 3 false negative findings, resulting in an increase of PPV 
(79%) without a significant drop of sensitivity (93%,p=0.25). 
Conclusion: DCE-MRI pharmacokinetic parameters, especially Ktrans, may 
improve PI-RADSv.2 diagnostic performance and its capability in prostate 














B-1366 11:51  
Chronic prostatitis: distinction from prostate cancer and benign prostatic 
hyperplasia by means of PIRADS version-2 descriptors  
U.G. Mueller-Lisse1, M. Kuhn1, M. Scherr2, U.L. Mueller-Lisse1, S. Murer1,  
M.F. Reiser1, J. Scheidler1; 1Munich/DE, 2Murnau a. Staffelsee/DE 
(ullrich.mueller-lisse@med.uni-muenchen.de)  
Purpose: Chronic prostatitis (CP) is common and potentially difficult to 
distinguish from both benign prostatic hyperplasia (BPH) and prostate cancer 
(PCA) in mpMRI of the prostate. We hypothesized that prostate imaging 
reporting and data system-version-2 (PIRADSv2) descriptors for T2-weighted 
magnetic resonance imaging (T2WI) and diffusion-weighted magnetic 
resonance imaging (DWI) would not distinguish CP from BPH or PCA. 
Methods and Materials: With ethics committee approval, consecutive 3.0T-
multi-channel surface coil mpMRIs of 19 CP patients (previous clinical and MRI 
diagnosis, negative prostate biopsy, NBX), 17 BPH patients (NBX), and 16 
patients with high-grade PCA (biopsy Gleason scores 4+3 to 4+5, n=7) or low-
grade PCA (biopsy Gleason scores 3+3 and 3+4, n=9) were independently 
scored by two blinded observers (O1, O2) applying respective PIRADSv2 
descriptors for T2WI and DWI. Two-tailed Fisher's exact tests assessed 
scoring contingency tables and two-tailed Student's T tests potential 
confounders (significance, p<0.05). 
Results: Both observers distinguished BPH and high-grade-PCA. Despite 
significant statistical differences, PIRADSv2 scores implying malignancy 
overlapped between CP patients versus low-grade PCA patients in T2WI (O1: 
1/19 versus 5/9; O2: 4/19 versus 6/9), standard pelvic DWI (O1: 0/19 versus 
3/9; O2: 3/19 versus 5/9), and optimized DWI zoomed to the prostate (O1: 0/19 
versus 4/9; O2: 4/19 versus 6/9), respectively. Between CP and low-grade 
PCA, prostate-specific antigen levels (PSA, 9.4±2.6 versus 8.4±5.2 ng/ml), 
PSA density (0.13±0.06 versus 0.17±0.10 ng/ml/ccm), and age (64±7 versus 
65±9 years) did not differ significantly, while prostate volume differed 
(88.9±60.2 versus 48.4±10.0 ccm, p=0.01). 
Conclusion: PIRADSv2 descriptors for T2WI and DWI of PIRADSv2 
peripheral or central zone regions appear to overlap between CP and low-
grade PCA.  
10:30 - 12:00 Studio 2018  
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B-1367 10:30  
Whole-body tumour staging of cervical cancer patients using 18F-FDG 
PET/MRI: does it change therapeutic decisions when compared to MRI 
alone?  
J. Grueneisen1, T. Sarabhai1, B.M. Schaarschmidt2, A. Wetter1, M. Forsting1, 
K. Herrmann1, L. Umutlu1; 1Essen/DE, 2Dusseldorf/DE 
(johannes.grueneisen@uk-essen.de)  
Purpose: To investigate whether differences in local and whole-body tumour 
staging between integrated PET/MRI and MRI alone lead to different 
therapeutic decisions in patients with primary cervical cancer. 
Methods and Materials: 53 consecutive patients with a primary cervical 
cancer were prospectively enrolled for a whole-body 18F-FDG PET/MRI 
examination. A radiologist and nuclear medicine physician analysed the MRI 
data, in consensus, followed by a second reading session of the PET/MR 
datasets. The readers were asked to perform a dedicated TNM staging (7th 
edition of the AJCC staging manual). Subsequently, the results of MRI and 
PET/MRI were discussed in a simulated interdisciplinary tumour board and 
therapeutic decisions based on both imaging modalities were recorded. 
Results: Staging results of MRI and PET/MRI revealed discrepant findings in 
17/53 (32%) cases, which led to differences in treatment recommendations for 
11 patients (21%). PET/MRI over- (n=1) and underestimated (n=1) the actual 
tumour stage in two patients, which affected therapy decisions. Conversely, 
MR readings led to incorrect staging results in 9 patients (n=3, upstaging; n=6 
downstaging). PET/MRI enabled determination of the correct tumour stage in 7 
of those 9 patients. In the two other cases, false ratings in PET/MRI did not 
result in changes in therapy management. In the remaining 6 patients (11%), 
different imaging findings in MRI and PET/MRI did not lead to changes in 
therapeutic decisions. 
Conclusion: Our results demonstrate the successful application and 
diagnostic advantage of integrated PET/MRI imaging over MRI alone for 
whole-body tumour staging of cervical cancer patients, enabling more accurate 
treatment planning.  
B-1368 10:38  
The prognostic value of pre-treatment FDG-PET/CT metabolic parameters 
in cervical cancer patients  
V. Bollineni1,2, S. Ytre-Hauge2, A. Gulati2, M. Halle2, K. Woie2, Ø. Salvesen3, 
C. Krakstad2, J. Trovik2, I. Haldorsen2; 1Brussels/BE, 2Bergen/NO, 
3
Trondheim/NO (bollinenivr@yahoo.com)  
Purpose: To explore quantitative metabolic and microstructural primary tumour 
parameters at pre-treatment FDG-PET/CT and diffusion-weighted MRI (DW-
MRI) in relation to clinical FIGO stage and outcome in cervical cancer patients. 
Methods and Materials: Fifty-three patients with histopathologically verified 
cervical carcinoma with clinical FIGO stage IB1-IV were subjected to FDG-
PET/CT and for a subgroup also DW-MRI (n=30) prior-to-treatment. Maximum 
standardized uptake value (SUVmax), total lesion glycolysis (TLG) and 
metabolic tumour volume (MTV) were estimated from the entire primary tumour 
at FDG-PET/CT. On MRI, longest tumour diameter (MRI-LD), tumour volume 
(MRI-TV) and mean tumour apparent diffusion coefficient (ADCmean) values 
were measured. FDG-PET/CT-parameters were explored in relation to clinical 
prognostic factors at diagnosis and progression/recurrence-free survival and 
compared to MRI parameters. 
Results: The metabolic tumour parameters TLG and MTV were highly 
positively correlated to MRI-LD and MRI-TV (r=0.72-0.82; p<0.001 for all), 
whereas tumour SUVmax was only moderately correlated (r=0.29-0.36; p0.04). 
High tumour TLG, MTV, MRI-LD and MRI-TV predict advanced-FIGO-stage, 
whereas high tumour-SUVmax does not. No significant correlations were 
observed between tumour-ADCmean and the other imaging parameters or 
FIGO-stage. High primary tumour-MTV (> 56.7 cm3), high-TLG (> 412) and 
large MRI-TV (>36 cm3) as well as advanced FIGO-stage (> IIIA) predicted 
reduced progression/recurrence-free survival yielding corresponding hazard 
ratios [HR]/of 7.8 (P/=/0.002), 6.9 (P/=/0.004), 4.6 (P/=/0.022) and 6.9 (P/=/0.004), 
respectively. In multivariate analysis, advanced FIGO-stage (> IIIA) and high-
MTV (> 56.7 cm3) both had an independent unfavourable impact on 
progression/recurrence-free survival with adjusted HRs of 5.5 (P/=/0.02) and 7.8 
(P/=/0.025), respectively. 
Conclusion: High MTV at pre-treatment FDG-PET/CT and high clinical FIGO 
stage independently predict reduced progression/recurrence-free survival in 
cervical cancer patients.  
B-1369 10:46  
Quantitative MRI analysis of cervical cancer parametrium invasion  
M. Shorikov, E. Tarachkova, V. Panov, I. Tyurin; Moscow/RU 
(vopanov@gmail.com)  
Purpose: It is well known that MRI is a good method for evaluation of cervical 
cancer (CC) extent to parametrium. However, in the literature mostly the 
evaluation was qualitative and it was pointed out that MRI tends to 
overestimate the extent due to peritumoural inflammation. The purpose of the 
study is to correlate quantitatively measured on different MR-images the extent 
of the CC to parametrium to the results of the histological analysis performed 
after surgery. 
Methods and Materials: 40 patients with histologically verified CC were 
enrolled in the study. The parametrium invasion maximal distance was 
measured in mm by two radiologists on different MR images (axial images, 
thickness=3mm): T2w/T2wfs, DWI+ADC-maps, contrast-enhanced T1TWISTfs 
at 90-120sec after i.v. injection of the MRCA (1.0mmol/ml solution of Gd-
DO3A-butrol in standard dose). All the patients underwent surgery and the 
parametrium invasion of the tumour was measured in mm by a histologist. 
Results: The MR measurements were significantly different to the histological 
findings (p<0.05) and tended to overestimate the invasion. The sen/sp for 
actual presence of the invasion and not peritumoural inflammation was 
estimated, the best results were on: T1WI+CE with sen/sp=0.96/0.92 for a 
3mm distance on MRI and DWI sen/sp=0.91/0.92 for 4mm. MR results showed 
high correlation to histological measurements for all images (r2=0.79-0.93, 
p<0.05) with the best results for T1WI+CE and DWI. The actual distance can 
be calculated as: invasion (histology) = 0.8*invasion (T1WI+CE) - 0.8 or 
invasion (histology) = 0.7*invasion (DWI) - 1.0. 
Conclusion: The critical distances to detect the presence of invasion with high 
sen/sp are determined in this study (best results for T1WI+CE and DWI). The 
actual distance can be calculated using our results.  
B-1370 10:54  
MRI findings of post-IGBT-treated cervical tumour  
E. Wong1, T. Chang2, F. Cho1, M. Lai1, S. Soong1, L. Law1, M. Yeung1, 
K. Tang1; 1Chai Wan/HK, 2Pok Fu Lam/HK (esthermfwong@gmail.com)  
Purpose: To study the accuracy of MRI as surveillance tool in locally 
advanced cervical cancer who has received MRI-image-guided brachytherapy 
(IGBT). 
Methods and Materials: Consecutive cases of locally advanced cervical 
tumour receiving concurrent chemoradiation with whole pelvic radiotherapy 
were included. Pelvic MRI was performed 3-6 months post-radiotherapy. 
  






Cervical biopsies were performed near the time of MRI. Images on post-
radiotherapy MRI were retrospectively reviewed by 2 radiologists and scored 
as 1 = frank residual tumour signal, 2 = equivocal residual tumour signal, 3 = 
mainly fibrotic signal, no residual disease. The resulting scores were compared 
with the biopsy findings. 
Results: 29 patients were retrospectively reviewed. The mean time interval 
between the last fraction of brachytherapy and post-treatment MRI was 20 
weeks. Three cases were subsequently proven to have residual/recurrent 
disease at cervix or upper vagina. Out of the 15 cases rated as MRI negative 
(score 1) by both reviewers, none of their respective biopsies were positive. 
The other 14 cases were rated as either indeterminate (score 2) or frank 
residual disease (score 3) by either or both of the two reviewers. Three out of 
these are subsequently proven positive recurrent disease. Overall good 
interobserver agreement was found (k=0.75). Using residual disease detection 
as endpoint, MRI reached 100% for sensitivity and negative predictive value. 
Specificity was 73%. 
Conclusion: MRI is highly sensitive in detection and ruling out of residual 
disease. It guides biopsy in dubious case. 
B-1371 11:02  
Simultaneous multiparametric PET/MRI for the assessment of therapeutic 
response to chemotherapy or concurrent radiochemotherapy of cervical 
cancer patients: preliminary results  
T. Sarabhai, V. Stebner, A. Wetter, R. Kimmig, M. Forsting, L. Umutlu, 
J. Grueneisen; Essen/DE (theresia-catharina.sarabhai@uk-essen.de)  
Purpose: To assess the response to chemotherapy or chemoradiotherapy in 
patients with primary cervical cancer, using simultaneous multiparametric 
PET/MR analysis. 
Methods and Materials: 8 patients with a histopathologically confirmed 
primary cervical cancer were prospectively enrolled for a simultaneous 18F-
FDG PET/MRI examination prior and after initial treatment strategy 
(chemotherapy, n=6; chemoradiotherapy, n=2). For the assessment of 
therapeutic response several morphological, functional and metabolic 
parameters of the primary tumors were determined in pre- and post-treatment 
PET/MR examinations. Histopathological correlation after subsequent tumor 
resection (n=7) or biopsy (n=1) served as the reference standard for the 
determination of therapeutic response. 
Results: In accordance with the RECIST- and PERCIST-criteria, 7 of the 8 
patients were classified as therapy responders (RECIST: CR=1, PR=6; 
PERCIST: CR=2; PR=5), while one patient showed stable disease. The 
responder group showed a significant reduction in tumor size (60%) and 
metabolic activity (SUVmax: 64%; SUVmean: 62%). Furthermore, a valuable 
increase of ADC values (ADCmin: 38%; ADCmean: 39%) and a significant 
decrease of certain perfusion parameters (Ktrans: 39%, Kep: 47%, iAUC: 57%) 
was found. Conversely, the non-responder revealed a slight decrease in tumor 
size (9%) and metabolic activity (SUVmax: 6%; SUVmean: 15%), accompanied 
with an increase of post-treatment perfusion parameters (Ktrans: 15%, Kep: 
22%, iAUC: 22%). In addition, ADC values showed a slight (ADCmean: 24%) 
to moderate (ADCmin: 35%) increase during treatment. 
Conclusion: These preliminary results demonstrate the feasibility of 
simultaneous multiparametric PET/MR analysis, which may function as a 
useful diagnostic tool for response assessment of initial treatment strategies in 
cervical cancer patients.  
B-1372 11:10  
Predicting early response in cervical malignancies to concurrent 
chemoradiation using intravoxel incoherent motion (IVIM) MRI  
R. Balaji; Chennai/IN (ravikanthbalaji@gmail.com)  
Purpose: To evaluate the use of intravoxel incoherent imaging diffusion MRI in 
assessing early response of cervical malignancies treated with concurrent 
chemoradiation. 
Methods and Materials: 36 patients with cervical malignancies decided by the 
tumour board for concurrent chemoradiation were included in the study. 
Patients underwent routine diagnostic pelvic MRI for staging purpose in a 1.5T 
scanner. IVIM imaging was also performed with 11 b values 0 to 1000 s/mm2. 
Follow-up imaging was then performed a week after start of treatment, 3 weeks 
later and within 3 days of completing therapy. The apparent diffusion 
coefficient (ADC) maps were derived from the mono-exponential model, while 
the diffusion coefficient (D), perfusion fraction (f) and pseudo-diffusion 
coefficient (D*) maps were calculated from the bi-exponential model. Changes 
in ADC, D, f and D* in cervical cancers were investigated as bio-imaging 
markers for treatment response. 
Results: ADC and D values showed progressive elevation after commencing 
treatment which persisted after completion. Mean D values after completion of 
therapy were 1.4 ± 0.16 x 10−3 mm2/s. f values, however, increased in the first 
week of treatment, started to decline by third week with significant fall in post-
treatment scans (0.14% ± 0.67). 
Conclusion: IVIM-derived D and f parameter values have significant potential 
in assessing treatment response non-invasively without use of contrast and 
without use of radionuclides.  
B-1373 11:18  
Evaluating the MR scoring system (“ADNEX MR score”) for 
characterisation of sonographically indeterminate adnexal masses  
H. Rajani, S.B. Grover, P. Mittal, G. Khanna; New Delhi/IN 
(heena.rajani@gmail.com)  
Purpose: The critical role of imaging in adnexal masses is to differentiate 
between benign and malignant pathologies, as it has a crucial role in deciding 
the management: radical surgery versus fertility preserving laparoscopic 
surgery. Although ultrasound is the primary modality for evaluation of adnexal 
masses, the results are often inconclusive. The present study aimed to 
evaluate the “ADNEX MR score” for classification of sonographically 
indeterminate adnexal masses as benign or malignant. 
Methods and Materials: MR imaging (1.5 T) was performed in 34 adnexal 
masses in 30 patients, presenting with sonographically indeterminate adnexal 
masses. Routine sequences were followed by Dynamic contrast enhanced 
study.The adnexal masses were assigned an “ADNEX MR score” between 1 to 
5, as devised by Thomassin-Naggara et al. ROC curve analysis was done to 
determine the cut- off ADNEX MR Score for prediction of malignancy. All 
patients underwent laparoscopic or surgical excision. Statistical analysis was 
done using histopathology as gold standard. 
Results: Using ROC analysis, we obtained the optimal “ADNEX MR score” 
cut-off value of 4. The sensitivity, specificity, NPV, PPV and accuracy of 
“ADNEX MR score”, using cut off score 4 for prediction of malignancy was 
100%, 90%, 100% , 87.5% and 94.% respectively with area under curve being 
0.96. 
Conclusion: In the present study, the “ADNEX MR score” value of 4 was 
found to have good sensitivity and specificity for malignancy prediction in 
sonographically indeterminate adnexal masses. Hence, “ADNEX MR score” 
should be included in the standardised MRI reporting format for adnexal 
masses.  
B-1374 11:26  
Adnexal masses: diagnostic value of DCE-MRI  
S. Parviz; Tehran/IR (srparviz@gmail.com)  
Purpose: To evaluate the utility of the dynamic contrast-enhanced magnetic 
resonance imaging (DCE-MRI) parameters in differentiating the malignant 
adnexal masses from the benign ones. 
Methods and Materials: 43 patients with 49 complex adnexal masses (27 
benign, 3 borderline, and 19 malignant) underwent preoperative DCE-MRI 
examinations, on a 3 Tesla MRI. Using extended Tofts’ model, quantitative 
analysis was done in the solid parts of all tumours. Three PK parameters were 
defined as volume transfer coefficient (Ktrans), the rate constant (Kep ) ,and 
the plasma volume (Vp). Semi-quantitative analysis was also performed and 
the values of relative signal intensity (SIrel) , wash-in-rate (WIR) , the initial area 
under the curve ( iAUC60), time-to-peak (TTP) and wash-out-rate (WOR) were 
calculated. Using logistic regression and receiver operating characteristic 
(ROC) curve, we compared the mean values of individual parameters between 
the two groups. 
Results: The mean value of Ktrans and the plasma volume (Vp) were 
significantly higher in malignant adnexal masses (P value<0.0001 and P value 
= 0.001, respectively). Semi-quantitative analysis showed that SIrel (P value 
<0.0001), WIR (P value <0.0001) and iAUC60 (P value = 0.001) had higher 
values in malignant adnexal tumours compared to the benign ones. The 
pairwise comparison among the receiver operating characteristic (ROC) curves 
showed that the area under the curve (AUC) of Ktrans was significantly larger 
than the AUCs of all the other DCE-MRI parameters. 
Conclusion: DCE-MRI is a relevant tool for differentiating benign from 
malignant adnexal masses. Among all pharmacokinetic and semi-quantitative 
parameters, Ktrans is the most accurate discriminator.  
Author Disclosures: 
  S. Parviz: Author; Masoumeh Gity, Hamidreza Saligheh Rad, Anahita 
FathiKazerooni, Madjid Shakiba, Maryam Shirali. 
B-1375 11:34  
MR-imaging of neoplastic and non-neoplastic lesions of the vagina  
S. Aksenova, N. Nudnov, J. Kreynina; Moscow/RU (fabella@mail.ru)  
Purpose: Capabilities of MRI in detecting tumour lesions of the vagina using of 
the whole panel of modern features of MRI: DWI, DCE. Identify difficult 
moments in the diagnostic assessment of the vagina in operated patients with 
gynaecologic cancer. 
Methods and Materials: 196 MRI examinations of pelvic with contrast 
enhancement were done in 137 patients. omplex MRI pelvic examinations 
with contrast enhancement were evaluated in 83 (60.6%) patients aged 34−82 
(mean age 58±4.7) with vagina neoplastic lesion suspicion, consisted of native 
  






scanning, diffusion-weighted imaging, dynamic contrast enhanced examination 
with additional endovaginal MR suitable applicator introduction. 
Results: Neoplastic lesions in vagina were found during MRI in 83 (60.6%) 
patients, at lower third − in 8 (9,7%), as endometrial and vulvar cancer 
progression, at middle third − in 20 (24.1%) patients, at upper third − in 55 
(66.2%), included 30 (36.1%) patients with vaginal cuff relapse. It was revealed 
as a zone with increasing signal in T2WI and contrast accumulation in the 
arterial and venous phases. Non-tumour changes were observed in 54 
patients. The greatest difficulty was to make the differentiation of early 
manifestations vaginal cuff relapse with residual fibrotic changes after radiation 
therapy. Differential diagnosis with post-radiation fibrosis demanded image 
fusion of T2WI fat sat, DWI and DCE with endovaginal MR-suitable applicator, 
which created conditions for better visualisation of vaginal wall structure and 
tumour localisation because of fold smoothing. 
Conclusion: MRI allows a good visualisation of the tumour, as well as the 
differential diagnosis of neoplastic and non-neoplastic lesion.  
B-1376 11:42  
Diagnostic value of imaging for the detection of peritoneal metastases: a 
meta-analysis  
I. van't Sant-Jansen, M. Engbersen, D.M. Lambregts, A.G. Aalbers, 
W. van Driel, R.G.H. Beets-Tan, M.J. Lahaye; Amsterdam/NL 
(M.Lahaye@nki.nl)  
Purpose: To determine the diagnostic value of imaging in detecting peritoneal 
carcinomatosis (PC) in staging cancer patients. 
Methods and Materials: A literature search in Pubmed, Embase (Ovid) and 
Scopus was performed (January 1997- July 2017) to identify studies reporting 
on the accuracy of imaging of PC in newly diagnosed primary gastrointestinal 
or ovarian cancers. Data extraction was performed by two observers in 
consensus. The sensitivity, specificity, and diagnostic odds ratio (DOR) were 
calculated using a bivariate random effects model and hierarchical summary 
operating curves (HSROC) were generated. 
Results: The original search resulted in 4177 articles. Twenty relevant studies 
fulfilled all the required inclusion criteria of > 15 patients and 
surgery/histology/radiological follow-up as reference standard. From these 
articles 30 datasets could be extracted for analysis; 18 for CT, 8 for PET(CT) 
and 4 for MRI. The pooled sensitivity, specificity, DOR for detection of PC were 
71% (CI:58-81%) ; 94% (CI:88-97%); 35.1 (CI:15.7-78.5) for CT. For PET(CT): 
80% (CI:56-93%); 89% (CI:79-94%); 31.7(CI: 16.2-130.4). Due to the limited 
amount of MRI studies these datasets could not be analysed. 
Conclusion: This meta-analysis shows that CT and PET(CT) demonstrate 
almost similar results in detecting peritoneal metastasis. More research is 
needed to investigate the diagnostic performance of MRI for peritoneal 
metastasis.  
B-1377 11:50  
Ovarian cancer staging: prospective comparison among ultrasound, CT 
and whole-body-MRI  
V. Buscarino1, S. Rizzo1, A. Colarieti2, M. Femia1, E. Pagan1, V. Bagnardi1, 
M. Bellomi1; 1Milan/IT, 2Rome/IT (valentinabuscarino@gmail.com)  
Purpose: The standard treatment of OC is primary cytoreductive surgery with 
resection of macroscopic disease; although, according to recent studies, 
interval debulking surgery after neoadjuvant chemotherapy allows comparable 
outcomes in advanced OC. The role of pre-operative staging is to select 
patients who may undergo up-front cytoreduction or may benefit from a 
neoadjuvant treatment. The objective of this study is a prospective comparison 
of diagnostic performance among WB-DW-MRI, US and CT. 
Methods and Materials: All patients included underwent to US, CT and WB-
DW-MRI as pre-surgical imaging evaluation before diagnostic or therapeutic 
surgery. Every imaging reader and the surgeon, reported on a specific report 
site of disease. Diagnostic performance of WB-DW-MRI, TC and US was 
calculated for each site, using the surgical evaluation as gold standard. The 
accuracy of WB-DWI-MR and CT were compared using the McNemar’s test. 
Results: Thirty-eight patients met the inclusion criteria. Imaging studies 
included for evaluation were: 31 CT, 36 US, 38 MRI examinations. WB-DWI-
MR showed higher values of sensitivity, specificity and accuracy for crucial 
sites such as peritoneal carcinosis, mesenteric involvement and retraction, 
lombo-aortic and celiac nodes, although there was no significant statistical 
difference among WB-DWI-MRI and CT. 
Conclusion: WB-DW-MRI is able to assess OC staging in satisfactory 
concordance with surgical findings, especially for sites considered crucial to 
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B-1378 10:39  
Identifying pulmonary consolidation in chest x rays using deep learning  
T.R. Nimmada, P. Putha, M. Tadepalli, S. Jain, P. Rao, P. Warier; Mumbai/IN 
(tarun.raj@qure.ai)  
Purpose: Chest x-rays are widely used to identify pulmonary consolidation 
because they are highly accessible, cheap and sensitive. Automating the 
diagnosis in chest x-rays can reduce diagnostic delay, especially in resource 
limited settings. 
Methods and Materials: Anonymised dataset of 423,218 chest x-rays with 
corresponding reports (collected from 166 centres across India spanning 22 x-
ray machine variants from 9 manufacturers) is used for training and validation. 
x-rays with consolidation are identified from their reports using natural 
language processing techniques. Images are preprocessed to a standard size 
and normalised to remove source dependency. These images are trained 
using deep residual neural networks. Multiple models are trained on various 
selective subsets of the dataset along with one model trained on entire data 
set. Scores yielded by each of these models is passed through a 2-layer neural 
network to generate final probabilities for presence of consolidation in an x-ray. 
Results: The model is validated and tested on a test dataset that is uniformly 
sampled from the parent dataset without any exclusion criteria. Sensitivity and 
specificity for the tag has been observed as 0.81 and 0.80, respectively. Area 
under the Receiver Operating Curve (AUC-ROC) was observed as 0.88. 
Conclusion: Deep learning can be used to diagnose pulmonary consolidation 
in chest x-rays with models trained on a generalised dataset with samples from 
multiple demographics. This model performs better than a model trained on 
controlled dataset and is suited for a real world setting where x-ray quality may 
not be consistent.  
B-1379 10:47  
Efficacy of deep learning for screening pulmonary tuberculosis  
P. Putha, M. Tadepalli, S. Jain, J. Chiramal, T.R. Nimmada, P. Warier; 
Mumbai/IN (preetham.putha@qure.ai)  
Purpose: Chest X-rays(CXR), being highly sensitive, serve as a Screening tool 
in TB diagnosis. Though there are no classical features diagnostic of TB on 
CXR, there are a few patterns that can be used as supportive evidence. In 
Resource limited settings, developing Deep Learning algorithms for CXR 
based TB screening, could reduce diagnostic delay. Our algorithm screens for 
8 abnormal patterns(TB tags)- Pleural effusion, blunted CP, Atelectasis, 
Fibrosis, Opacity, Nodules, Calcification and Cavity. It reports 'No Abnormality 
Detected' if none of these patterns are present on CXR. 
Methods and Materials: An anonymized dataset of 423,218 CXRs with 
matched radiologist reports across (22 models, 9 manufacturers, 166 centres 
in India) was used to generate training data for the deep learning models. 
Natural Language Processing techniques were used to extract TB tags from 
these reports. Deep learning systems were trained to predict the probability of 
the presence/absence of each TB tag along with heat-maps that highlight 
abnormal regions in the CXR for each positive result. 
Results: We validated the screening algorithm on 3 datasets external to our 
training set- two public datasets maintained by NIH(from Montgomery and 
Shenzen) and a third from NIRT, India. The Area under the Receiver Operating 
Curve (AUC-ROC) for TB prediction was 0.91, 0.87 and 0.83 respectively. 
Conclusion: Training on a diversified dataset enabled good performance on 
samples from completely different demographics. After further validation of it's 
robustness against variation, the system can be deployed at scale to improve 
the current systems for TB screening significantly  
Author Disclosures: 
  P. Putha: Employee; qure.ai. M. Tadepalli: Employee; qure.ai.  
S. Jain: Employee; qure.ai. J. Chiramal: Employee; qure.ai. T.R. Nimmada: 











B-1380 10:55  
Automatic localisation and identification of vertebrae in spine CT scans 
by combining Deep Learning with morphological image processing 
techniques  
A. Jiménez-Pastor, A. Alberich-Bayarri, B. Fos Guarinos, F. Garcia-Castro, 
L. Marti-Bonmati; Valencia/ES (anajimenez@quibim.com)  
Purpose: In spine pathologies, the proper detection and identification of 
vertebrae is a need to perform diagnosis. This is a manual task that delays 
radiologists’ workflow. The main goal of this work is to assist radiologists by 
detecting and identifying automatically vertebrae in spine CT scans. 
Methods and Materials: To locate the spine centerline, a detection of the 
spinal canal was done by using a thresholding and a dilation using a cylindrical 
structuring element. Once the spine was located, the position of each vertebral 
body was detected and identified. This procedure was divided into 4 steps. 
First each axial 2D image was classified into 4 different regions: upper-
thoracic, lower-thoracic, lumbar or sacrum. Thereafter, for each region, axial 
2D images were classified into vertebra or non-vertebra. All these classifiers 
were designed using a pre-trained Convolutional Neural Network (CNN) to 
extract characteristics of each image followed by a Support-Vector-Machine 
(SVM) classifier and distribute them into the different groups. Finally, the 
centroid of each vertebra was calculated and identified. 
Results: The mean localization error (distance between the estimated and real 
vertebra position) obtained was 7,37±8,69mm on the thoracic region and 
9,21±8,70mm in the lumbar region; and the identification rate obtained was 
89,20% in the thoracic region and 92,90% in the lumbar zone. 
Conclusion: By combining deep learning with image processing techniques it 
is possible to automatically locate and identify vertebrae in spine CT scans. 
CNN are a good candidate to extract complex characteristics from the images 
in order to classify radiological images.  
B-1381 11:03  
Fully automatically staging of lung cancer using deep neural networks  
K.S. Mader1, A.W. Sauter2, G. Sommer2, T. Weikert2, F. Trolese1, J. Hagger1, 
B. Stieltjes2; 1Zurich/CH, 2Basel/CH (kevinmader@4quant.com)  
Purpose: The standard diagnostic protocol for Lung Cancer involves an FDG-
PET/CT to stage the patient. Both over- and undertreating the stage lead to 
drastic consequences for the patient’s health and comfort. The full examination 
of these images takes up to 90 minutes per patient and requires the expertise 
of both a radiologist and a nuclear medicine physician. We aim to support 
physicians by automatically and quantitatively evaluating this reading and 
interpretation process. 
Methods and Materials: Using a retrospective study with 179 patients, we 
collect the first PET-CT scan, manually annotate the suspicious lesions, and 
record the radiological TNM stage. We train a deep neural network using 
augmentation including transformed versions of the original images to avoid 
overfitting. 
Results: The accuracy of the network was evaluated by using a validation 
group. The accuracy of the network was for very high: over 90% of lesions 
area was overlapping and a misclassification rate of 20%.Once the network 
was trained, detecting the suspicious lesions and computation of stage for a 
new patient can be done in a few seconds. 
Conclusion: Staging and reading PET-CT images is a challenging task with 
large degrees of heterogeneity in both the patients and images. Given this 
heterogeneity, this initial study shows great promise in terms of speed and 
accuracy of the proposed set-up and could make this a valuable asset in the 
clinical environment and clinical trials.  
Author Disclosures: 
  K.S. Mader: Founder; 4Quant AG.  F. Trolese: Founder; 4Quant AG. 
J. Hagger: Founder; 4Quant AG. B. Stieltjes: Founder; HQImaging. 
B-1382 11:11  
Discrimination between distal ureteral stones and pelvic phleboliths in 
CT using a deep neural network: more than local features needed  
M. Lidén, J.K. Jendeberg, M. Längkvist, A. Loutfi, P. Thunberg; Örebro/SE 
(matsliden@yahoo.com)  
Purpose: To develop a deep learning method for assisting radiologists in the 
discrimination between distal ureteral stones and pelvic phleboliths in thin slice 
CT images, and to evaluate whether this differentiation is possible using only 
local features. 
Methods and Materials: A limited field-of-view image data bank was 
retrospectively created, consisting of 5x5x5cm selections from 1-mm-thick 
unenhanced CT images centred around 218 pelvis phleboliths and 267 distal 
ureteral stones in 336 patients. 50 stones and 50 phleboliths formed a 
validation cohort and the remainder a training cohort. Ground truth was 
established by a radiologist using the complete CT examination during 
inclusion. The limited field-of-view CT stacks were independently reviewed and 
classified as containing a distal ureteral stone or a phlebolith by seven 
radiologists. Each cropped stack consisted of 50 slices (5x5cm field-of-view) 
and was displayed in a standard PACS reading environment. A convolutional 
neural network using three perpendicular images (2.5D-CNN) from the limited 
field-of-view CT stacks was trained for classification. 
Results: The 2.5D-CNN obtained 89% accuracy (95% confidence interval 
81%-94%) for the classification in the unseen validation cohort while the 
accuracy of radiologists reviewing the same cohort was 86% (range 76%-
91%). There was no statistically significant difference between 2.5D-CNN and 
radiologists. 
Conclusion: The 2.5D-CNN achieved radiologist level classification accuracy 
between distal ureteral stones and pelvic phleboliths when only using the local 
features. The mean accuracy of 86% for radiologists using limited field-of-view 
indicates that distant anatomical information that helps identifying the ureter’s 
course is needed.  
B-1383 11:19  
Deep learning for liver segmentation and volumetry in late phase MRI  
A. Schenk1, G. Chlebus1, H. Meine1, S. Thoduka2, N. Abolmaali2; 1Bremen/DE, 
2
Dresden/DE (andrea.schenk@mevis.fraunhofer.de)  
Purpose: Radioembolisation in the liver requires the computation of organ and 
tumor volumes for dosimetry planning. The purpose of this study was to 
investigate the accuracy of a new, fully-automated deep learning approach for 
liver segmentation in MRI data. 
Methods and Materials: Images of 70 patients who underwent MRI to 
evaluate liver tumors were retrospectively analyzed. Data was acquired on two 
different scanners (Signa HDxt or Discovery 750, GE) applying a volume 
sequence and Gd-EOB-DTPA as contrast agent. Segmentation was performed 
on late phase images with a slice thickness of 2-3 mm. 
Ground truth liver contours were accurately defined by experienced technicians 
using contouring and interpolation software and checked by a radiologist. 
Additionally, one radiologist and two residents defined routine segmentations 
for 28 patients scheduled for radioembolisation. A deep learning network was 
trained on the remaining 42 data sets and automatic organ boundaries were 
computed for the radioembolisation cases. 
Results: Compared to the ground truth, relative volume error was 
5.37%±4.38%, 3.63%±4.57% and 4.33%±4.62% for the three clinical users, 
and 6.95%±5.73% for the deep learning approach. DICE coefficient was 
0.94±0.02, 0.95±0.02, 0.95±0.02, and 0.92±0.04 for the automatic method. 
Interactive ground truth segmentation took 24±8 minutes compared to 
approximately 10±4 minutes by the clinicians, and 20±7 seconds for the deep 
learning method. 
Conclusion: Automated deep learning based liver segmentation in MRI data 
of radioembolisation patients was much faster with sufficient accuracy 
compared to interactive contouring and interpolation. The new method will 
support automated tumor load computation based on MRI in the future.  
B-1384 11:27  
Evaluation of a multiparametric deep learning model for glioblastoma 
segmentation  
M. Perkuhn1,2, F. Thiele1,2, G. Shakirin1,2, D. Garmpis1, P. Stavrinou1, 
J. Borggrefe1; 1Cologne/DE, 2Aachen/DE (michael.perkuhn@uk-koeln.de)  
Purpose: MRI is commonly used to non-invasively evaluate location, size, 
spread, oedema and the biological status of glioblastoma (GBM). Automatic, 
reliable and reproducible tumour segmentation can enable volumetric response 
assessment and effective integration of volumetric multimodal tumour 
characterization. The objective of this study was to apply a state-of-the-art 
deep learning algorithm for fully automatic GBM-compartment segmentation on 
clinical routine data from multiple centres, and to compare the results to ground 
truth manual expert segmentation. 
Methods and Materials: 64 patients from 15 institutions with newly diagnosed, 
primary GBM were included. T1, T2, FLAIR and contrast-enhanced (CE) T1 
sequences (Philips and Siemens scanners) underwent preprocessing and 
were fed to a deep-learning model based on DeepMedic. This model was 
trained on 220 cases of the BRATS database. Acquired segmentations were 
compared to manual segmentations of whole tumour (WT), necrosis (NC), and 
contrast-enhanced tumour (CET) performed by experienced radiologists as 
part of this study. 
Results: The CET and WT were automatically detected in all patients. The 
automatic/manual segmentation dice similarity coefficients (DSC) were 
0.86±0.09 (WT), 0.78±0.15 (CET), 0.62±0.30 (NC). For NC we found a 
correlation (R=-0.622, p<0.01) between surface-to-volume ratio and DSC. No 
correlation was found between resolution and DSC. 
Conclusion: The proposed approach is robust on routine clinical data and has 
high accuracy comparable to interrater variability. This makes it a suitable 
building block for automatic tumour segmentation reviewed by the radiologist in 
pre-operative characterisation of GBM. Training the network on data with 
small/complex shape tumours might further increase the NC segmentation 
accuracy.  
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B-1385 11:35  
Peering into the darkness: visualising what neural networks learn 
through generative deep learning  
J.C.Y. Seah, J.S.N. Tang, F. Gaillard; Melbourne/AU (J.Seah@alfred.org.au)  
Purpose: To demonstrate the application of generative deep learning in 
visually representing what neural networks learn. The specific example 
explored is the prediction of B-type natriuretic peptide (BNP) levels as a marker 
of heart failure from chest radiographs. 
Methods and Materials: 106,290 chest radiographs from 48,532 unique 
patients were extracted from a PACS database for this ethics approved study. 
7,390 radiographs had a corresponding BNP result within 36 hours.The 
remainder 98,900 did not have a corresponding BNP result and formed the 
unlabelled dataset. The unlabelled dataset was used to create a generative 
model to convert radiographs to and from a low dimensional latent space. 
Simulated reconstructions for chest radiographs with high BNPs were then 
performed to visualise the same radiograph if it had a normal BNP. These were 
used to obtain a visual rationale which represent features the model has 
identified as important in this specific predictive task. 
Results: A linear regression shows that the latent representations are 
logarithmically correlated with the accompanying BNP result. At a cut-off BNP 
value of 100 ng/L, the linear classifier obtained an AUC of 0.82. Qualitative 
assessment of the generated visual rationales confirms that the algorithm 
learns radiographic findings compatible with traditional human teaching. It also 
allows identification of unexpected features. 
Conclusion: Generative learning can be applied to create visual 
representations of features learned by an algorithm. These visual 
representations could improve radiologists’ understanding of deep learning 
algorithms and help enable the safe and appropriate application of deep 
learning in medicine.  
B-1386 11:43  
Automated detection of intra- and extra-axial haemorrhages on CT brain 
images using deep neural networks  
S. Chilamkurthy1, R. Ghosh1, P. Rao1, M. Biviji2; 1Mumbai/IN, 2Nagpur/IN 
(rohit.ghosh@qure.ai)  
Purpose: To develop and validate a deep neural network-based algorithm for 
automated, rapid and accurate detection from head CT for the following 
haemorrhages: intracerebral (ICH), subdural (SDH), extradural (EDH) and 
subarachnoid (SAH). 
Methods and Materials: An anonymised database of head CTs was searched 
for non-contrast scans which were reported with any of ICH, SDH, EDH, SAH 
and those which were reported with neither of these. Each slice of these scans 
is manually tagged with the haemorrhages that are visible in that slice. In all, 
3040 scans (116227 slices) were annotated, of which number of scans(slices) 
with ICH, SDH, EDH, SAH and neither of these are 781(6957), 493(6593), 
742(6880), 561(5609) and 944(92999), respectively. Our deep learning model 
is a modified ResNet18 with 4 parallel final fully connected layers for each of 
the haemorrhages. This model is trained on the slices from the annotated 
dataset to make slice-level decisions. Random forests are trained with 
ResNet's softmax outputs for all the slices in a scan as features to make scan-
level decisions. 
Results: A different set of 2993 scans, uniformly sampled from the database 
without any exclusion criterion, is used for testing the scan-level decisions. 
Number of scans with ICH, SDH, EDH and SAH in this set are 123, 58, 41 and 
62, respectively. Area under the receiver operating curve (AUC) for scan-level 
decisions for ICH, SDH, EDH and SAH are 0.91, 0.90, 0.90 and 0.90, 
respectively. Algorithm takes <1s to produce the decision for a scan. 
Conclusion: Deep learning can accurately detect intra- and extra-axial 
haemorrhages from head CTs.  
Author Disclosures: 
  S. Chilamkurthy: Employee; Qure.ai. R. Ghosh: Employee; Qure.ai. P. Rao: 
Employee; Qure.ai.  
B-1387 11:51  
Automatic detection of generalised cerebral atrophy using deep neural 
networks from head CT scans  
S. Tanamala1, R. Ghosh1, S. Chilamkurthy1, P. Rao1, M. Biviji2; 1Mumbai/IN, 
2
Nagpur/IN (rohit.ghosh@qure.ai)  
Purpose: Features of generalised cerebral atrophy on brain CT images are the 
marker of neurodegenerative diseases of the brain. Our study aims at 
automated diagnosis of generalised cerebral atrophy on brain CT images using 
deep neural networks thereby offering an objective early diagnosis. 
Methods and Materials: An anonymised dataset containing 78 head CT 
scans (1608 slices) was used to train and validate a skull-stripping algorithm. 
The intracranial region was marked out slice by slice in each scan. Then a U-
Net-based deep neural network was trained on these annotations to strip the 
skull from each slice. A second anonymised dataset containing 2189 CT scans 
(231 scans with atrophy) was used to train and validate an atrophy detection 
algorithm. First, an image registration technique was applied on the predicted 
intracranial region to align all scans to a standard head CT scan. The 
parenchymal and CSF volume was calculated by thresholding Hounsfield units 
from the intracranial region. The ratio of CSF volume to parenchymal volume 
from each slice of the aligned CT scan and the age of the patient were used as 
features to train a random forest algorithm that decides if the scan shows 
generalised cerebral atrophy. 
Results: An independent set of 3000 head CT scans (347 scans with atrophy) 
was used to test the algorithm. Area under the receiver operating curve (AUC) 
for scan-level decisions is 0.86. Predictions on each patient takes time < 45s. 
Conclusion: Deep convolutional networks can accurately detect generalised 
cerebral atrophy given a CT scan.  
Author Disclosures: 
  S. Tanamala: Employee; Qure.ai. R. Ghosh: Employee; Qure.ai.  
S. Chilamkurthy: Employee; Qure.ai. P. Rao: Employee; Qure.ai. 
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B-1388 10:30  
Features of MRI after cryoablation of primary breast cancer without 
surgical resection  
Y. Machida1, A. Shimauchi1, T. Igarashi2, H. Okuma2, E. Fukuma3; 1Chuo/JP, 
2
Tokyo/JP, 3Kamogawa/JP (machida.yoichi@kameda.jp)  
Purpose: To retrospectively evaluate the features of serial magnetic 
resonance imaging (MRI) after cryoablation for breast cancer lesions without 
subsequent surgical resection. 
Methods and Materials: This study was approved by the institutional review 
board. Requirement to obtain informed consent was waived. Ductal carcinoma 
in situ or invasive carcinoma  15mm, nuclear grade 1 or 2, estrogen receptor 
positive/human epidermal growth factor 2 negative without lymph node 
metastasis were treated with cryoablation without subsequent excision. Two 
observers independently reviewed the first and second post-cryoablation MRI 
for shape (none, linear, or nodular) and suspicion for residual disease (positive 
or negative). Fisher's exact test or the Mann-Whitney U test was performed for 
variables. Interobserver agreement of findings was evaluated by calculating  
values. 
Results: Fifty-four cases were enrolled. The first and second post-cryoablation 
MRIs were performed 22-171 days and 82-487 days after cryoablation, 
respectively. The interobserver agreement for descriptor ranged fair to 
moderate ( = 0.331 - 0.434). There were 7 cases (13.0%) for which either 
observer 1 or 2 evaluated positive suspicion on the first post-cryoablation MRI. 
There was a significant association between nodular shape compared to non-
nodular (linear or none) and positive suspicion for residual disease or 
recurrence in both two observers’ results (p < 0.001). On the second post-
cryoablation, there were no cases with suspicious findings based on both of 
the two observers. 
Conclusion: There were some cases with suspicious findings within treated 
area at the first post-cryoablation MRI, which can resolve during subsequent 
adjuvant therapies and follow-up management.  
B-1389 10:38  
Combined ultrasound-guided high-intensity focused ultrasound and 
vacuum assisted biopsy for treatment of large sized breast fibroadenoma  
N.M. Abdel Razek, M. Hamed; Cairo/EG (naglaabdelrazek@yahoo.com)  
Purpose: To assess the efficiency of ultrasound guided HIFU & VAB as non 
surgical technique for compete excision of large sized breast fibroadenoma 
Methods and Materials: The study is a prospective one conduced in a single 
center during the period from February 2017 to September 2017.The ethical 
committee approval and patients written consents were obtained. The study 
included 20 patients with large sized breast fibroadenomas in one or both 
breasts were selected for treatment with US guided HIFU followed by VAB 
excision after 2 months. Patients’ age ranged from 16 to 52 years ;mean 32 
years. All patients with FA underwent core needle biopsy with histological 
confirmation. HIFU treatment was performed as an outpatient procedure under 
conscious sedation. After the treatment, follow up US with volume evaluation 
  






was performed at 1 &2 months and then percutaneous ultrasound guided VAB 
was performed to the residual lesion after HIFU 
Results: The FA mean baseline size ranged between 3.5-6 cm diameter. At 1 
month follow up, the mean volume reduction was 33.2%±19.1% and achieved 
significance at 2 month ;49.2%±16.2%, p<0.001 . After 2 months, the residual 
part was then excised using ultrasound guided VAB thus achieving complete 
excision . 
Conclusion: Combined Ultrasound guided HIFU followed by VAB is an 
efficient well tolerated non invasive two step procedure for non-surgical 
complete excision of large fibroadenoma, Preliminary results are encouraging 
and show that the combined HIFU & VAB could be an alternative to surgery for 
large breast fibroadenoma. further work is still on progress .  
B-1390 10:46  
Digital breast tomosynthesis-guided vacuum-assisted biopsy (DBT-
guided VAB): initial experience with patients positioned on a dedicated 
armchair  
E. Venturini, M. Panzeri, C. Losio, M. Rodighiero, S. Tacchini, E. Schiani, 
P. Panizza; Milan/IT (venturini.elena@hsr.it)  
Purpose: To evaluate the success rate and the tolerability of DBT-guided VAB 
with patients positioned on a dedicated armchair. 
Methods and Materials: Sixty-four women with a suspicious breast finding 
(BIRADS 4) detectable only by mammography or DBT underwent DBT-guided 
VAB (Selenia Dimensions, Hologic). Patients were positioned in lateral 
decubitus or in sitting position on a dedicated armchair. DBT was acquired to 
determine lesion coordinates. Pre and post fire images were acquired with 2D-
full field digital mammography to limit artifacts related to the needle (9G 
vacuum device). At least 12 biopsy specimens were obtained. Mammography 
of biopsy specimens was performed to verify the presence of 
microcalcifications. 
Results: From 10/2016 and 09/2017 64 women (mean age 52 years; 39-81 
years) with 66 suspicious (BI-RADS 4) mammographic findings underwent 
DBT-VAB. Overall, 66 DBT-guided biopsies were performed: 37 procedures 
with patient in sitting position, 29 in lateral decubitus. The technical success 
rate was 98.5% (65/66). Twenty-five breast carcinomas were diagnosed (4 
invasive, 21 in situ) and 2 high-risk lesions were found at histological 
examination on biopsy specimens. Fifteen women underwent surgery at our 
Institution. One case of upgrade at final pathology was registered (from DCIS 
to 5 mm CDI with extensive in situ component). No serious complications were 
observed; 4 patients developed a small hematoma and 5 women a slight 
vasovagal reaction, which resolved spontaneously. 
Conclusion: DBT-VAB with patients positioned on a dedicated armchair are a 
procedure with high success rate and well-tolerated.  
Author Disclosures: 
  E. Venturini: Investigator; Philips, Novaura. Research/Grant Support; Philips, 
Novaura.  P. Panizza: Investigator; Philips, Novaura. Research/Grant Support; 
Philips, Novaura. Speaker; Philips, Bayer, Hologic. 
B-1391 10:54  
Impact of MRI/ultrasound fusion-guided biopsy for breast lesions 
detected on MRI alone  
S. Nakano1, K. Fujii2, J. Kousaka2, Y. Mouri2, T. Ando1, M. Ido1, M. Goto1, 
Y. Ito1, T. Ishiguchi1; 1Aichi/JP, 2Nagakute/JP (snakano1@aichi-med-u.ac.jp)  
Purpose: When MRI-detected breast lesion can be identified by second-look 
US, US-guided biopsy is recommended. However, the detection rate of 
second-US is very heterogeneous because of the lack of reproducibility. The 
aim of this study was to examine the safety and outcomes of MRI/ultrasound 
fusion-guided biopsy using real-time virtual sonography (RVS) for breast 
lesions detected on MRI alone. 
Methods and Materials: 39 lesions in 39 consecutive patients who underwent 
second-look US to identify MRI-detected lesions on prone MRI were enrolled in 
this retrospective study. For MRI-detected lesions that were not identified using 
conventional B-mode, second-look US using RVS and RVS-guided biopsy 
were performed after an additional supine MRI. The detection rate, lesion 
characteristics, and complication were assessed. 
Results: The mean lesion size on MRI was 8.0 mm (3-46mm). Of the 39 
lesions, 33 (85%) were detected and subjected to biopsy with second-look US 
using RVS. The MRI morphology types of these lesions were as follows: mass, 
16; non-mass, 5; and focus, 12. 25 (76%) were benign and 8 (24%) were 
malignant. Of the 33 lesions, those with non-circumscribed margins and 
hypoechogenicity were significantly more likely to be malignant (p <0.05). The 
remaining 6 (15%) US-occult lesions could be judged to be benign after 24 
months follow-up under RVS. There were no procedure-related complications. 
Conclusion: Our results suggest that RVS-guided biopsy is a useful modality 
for the tissue sampling of breast lesions detected on MRI alone and may 
contribute to identifying cases in which MRI-guided biopsy is absolutely 
necessary.  
 
B-1392 11:02  
What can affect tomosynthesis-guided vacuum-assisted breast biopsy 
(TVAB) procedures? Clinical and technical challenges  
G. Negro, M. Durando, G. Mariscotti, B. Desana, E. Regini, P. Isoardi, 
M. Garolla, P. Fonio, G. Gandini; Turin/IT (giulietta.negro@gmail.com)  
Purpose: To evaluate clinical and technical performances of tomosynthesis-
guided vacuum-assisted breast biopsy (TVAB), considering different breast 
compositions and mammographic lesion features. 
Methods and Materials: All TVABs performed at our Breast Service between 
June 2016-July 2017 with an upright system and using VAB 9G-needles were 
retrospectively reviewed. We recorded all data about patient age, breast 
density, lesion type, dimension and localization, histhology, breast thickness, 
breast positioning, number of projections, procedure time, average glandular 
dose(AGD), entrance surface dose(ESD). TVAB procedures were classified 
according to the number of performed projections(8 or 9), as less or more 
difficult proceedings. Uni- and multi-varied analyses of data were performed 
(significant p values<0.05). 
Results: 145 TVABs were included. Mammographic findings were: 
microcalcifications(115;79%), architectural distortions(14;10%), focal 
asymmetries(6;4%) and masses(11;7%). At microhistological examination, 
lesions were classified as B1(1;1%), B2(74;51%), B3(38;26%), B4(3;2%), 
B5(29;20%). Average procedure time was 17±4minutes. Average number of 
projections per procedure was 8±2. TVAB with 8 projections were 95(66%) 
and 50(34%) with 9. No associations were observed(p>0.05) between easier 
technical feasibility (procedures 8 projections) and breast density or 
thickness, lesion dimension or localisation. Considering lesion type, 
microcalcifications correlated with a higher number of projections(p=0,01). 
Median total AGD for TVAB with 8 projections was 10.8 mGy and 14.3 mGy 
with 9 (p<0.0001) and correlated with median total ESD (35.6 mGy and 45.2 
mGy respectively; p<0,0001). 
Conclusion: TVAB, in our experience, is a rapid, safe and accurate technique. 
The evaluation of microcalcifications correlated with a greater number of 
projections, as they can represent a more difficult target in tomosynthesis-
images.  
B-1393 11:10  
Digital breast tomosynthesis (DBT) guided biopsy of thin breast patients: 
how tomosynthesis and special maneuvers contribute to the technical 
success  
L.H.Y. Sinn, J.C.M. Sitt, C.Y. Fong, C.Y. Lui; Central/HK 
(lorriesinn@gmail.com)  
Purpose: To evaluate how rapid target depths identification by DBT contribute 
to the improvement in workflow and successful rate in performing biopsies in 
thin breast patients, which minimize the need for open surgical biopsy. 
Methods and Materials: Patients referred to our centre for tomosynthesis 
guided biopsies (core biopsy with 14G needle or vacuum assisted biopsy 
(VAB) with 9G/10G needle) from January 2016 to July 2017 with compressed 
thickness </= 30mm were included. All biopsies were carried out under DBT 
guidance in upright position or with prone table system by dedicated 
radiologists. The compressed breast thicknesses, z value of the target co-
ordinates, microcalcifications retrieval, histological diagnosis, and special 
maneuvers during the procedure were recorded. 
Results: 33 patients (6 VAB, 27 core biopsies) were included, compressed 
breast thickness ranged 17-30mm. All (100%) biopsies were technically 
successful with target lesions (31 microcalcifications group: confirmed by 
specimen radiographs, 2 architectural distortions) removed. Different 
maneuvers including air-gap technique (n=4), lateral approach with lateral arm 
(n=1, VAB), petite needle (n=1, VAB) and application with peripheral pressure 
to increase breast thickness (ring technique, n=1, VAB) were used. No 
significant complications developed. 6 DCIS and 1 invasive ductal carcinoma 
were identified. No pathological discordance with final pathology identified in 
operated cases. Mean time of procedure was 22 (range 8-42) minutes. 
Conclusion: DBT guided biopsies in thin breast patients provided better 
planning of approach before and during the procedures, with known anticipated 
target depths which allowed optimal positioning and special manipulations for 
successful lesion retrieval in short time.  
B-1394 11:18  
Diagnosis and treatment of suspected high-grade lesions using 
ultrasound-guided vacuum-assisted breast biopsy  
J. Vucetic, J. Palao Errando, C. Barber Hueso, J.S. Cárdenas Herrán, 
M. Ortega Millán, R. Garcia Garcia; Valencia/ES (vucetic_jelena@yahoo.com)  
Purpose: The purpose is to share our two-year experience in performing 
vacuum-assisted breast biopsy (VABB) for diagnosis and treatment of benign 
and potentially malignant breast lesions. 
Methods and Materials: We received patients from outpatient clinics (68%), 
primary care (17%) and screening centers (15%). Eligible for VABB are 
considered lesions BI-RADS 4A and higher, high risk histology (B3 and 
  






higher), radio-pathologic discordance (benign histology but suspicious lesion 
on image), and special cases such as patients with confirmed cancer and high 
anesthetic risk or BI-RADS 3 lesions at patient´s request. We use Bard Encord 
vacuum system with 7G and 10 G needles. Biopsies are performed in supine 
position. We do follow up ultrasound and mammogram the next day for 
possible complications. 
Results: A total of 76 lesions were biopsied from March 2015 to September 
2017. The most of the lesions were BI-RADS 4A (63 lesions, 83%). Regarding 
histological classification, there were 35 (46%) of B3 lesions (papillary and/or 
atypical lesions on core needle biopsy). Five cancers were diagnosed (6.6%), 
three of them corresponding to BI-RADS 4A lesions, one 4B lesion and one BI-
RADS 3 lesion BRCA+ patient. 
Conclusion: Although longitudinal studies are still needed, the excision of 
high-risk lesions and lesions with radio-pathologic discordance is possible with 
VABB system. There is generally a very good tolerance among patients with a 
low complication rate. The surgical intervention is avoided in 95% of the cases 
in our series. It is essential to have multidisciplinary collaboration for the 
selection of cases.  
B-1395 11:26  
Design, development and validation of the first 3D PET manual breast-
guided biopsy system  
M. Herranz1, G. Abou-Jaoude2, W. Liang3, P. Aguiar1, A. Ruibal1; 
1
Santiago de Compostela/ES, 2Lausanne/CH, 3Shanghai/CN 
(michel.herranz.carnero@sergas.es)  
Purpose: Some of the problems reported with breast-specific PET imaging 
technology lies in those lesions able to detect but invisible to other techniques, 
or those that, because of their heterogeneity, are difficult to characterize, or 
tumours with functional resistance to chemotherapy. How we can be able to 
validate or demonstrate the correct diagnosis of these lesions? 
Methods and Materials: The PROne BIOpsy Sistem: ProBioS™ consists 1. a 
resistive resin adapter with fixed or mobile grids of 1, 3 or 6 racks. 2. A 
disposable holding system with receptacle for blood and other fluids, sterile 
and detachable. 3. A specific software. The system is adapted to be able to be 
used with any type of manual biopsy system. 
Results: Test with PROBioS: 1. calibration of the 3D positioning. 2. Checking 
the theoretical calibration values. 3. Verification of empirical calibration values 
using point sources. Accuracy definition. 4. Verification of empirical calibration 
values using sources mimicking tumours. 5. Verification of empirical calibration 
values using breast phantoms. 6. Comparison with stereotaxic biopsy. 7.- 
Mathematical study of correlation between the values of biopsy in stereotaxic 
and MAMMI corrections. 8. Compression software studies. 9. Compression 
hardware studies. 10. Viability and sterilization studies. 11. Biopsies on 
patients. 
Conclusion: We present the first 3D manual biopsy system guided by 
dedicated breast PET, its design, and its clinical utility. The development of this 
technique will allow the diagnosis of breast pathology to be much more precise 
and provide image services with an additional tool.  
B-1397 11:34  
Does breast MRI have a high negative predictive value for identifying 
residual axillary metastases in patients treated with neoadjuvant 
chemotherapy  
N. Sharma, S. Rajan, B. Dall; Leeds/UK (Nisha.sharma2@nhs.net)  
Purpose: It has been well documented that Breast MRI has a high negative 
predictive value (95%) for axillary metastases in women being staged for 
breast cancer. The question being asked is how good is breast MRI in 
determining complete pathological response in the malignant axilla in those 
women treated with neoadjuvant chemotherapy (NACT) and monitored with 
breast MRI. The end of treatment MRI T1 and T2 weighted sequences were 
reviewed to assess the axilla. 
Methods and Materials: From October 2013-July 2015 49 patients who had 
breast cancer and biopsy proven malignant axillary lymph nodes treated with 
NACT were identified. All patients had an end of treatment MRI scan prior to 
axillary surgery. The lymph nodes were classified as normal or abnormal based 
on the T1 and T2 W sequences. 
Results: 49 patients had axillary surgery. 57%(28/49) had malignant nodes at 
axillary clearance and 86% were correctly identified by MRI. 43%(21/49) had 
pathological complete response in the axilla and MRI correctly identified 71% 
of the cases. MRI overcalled 6 cases as being positive that were negative at 
surgery - all these lymph nodes showed evidence of tumour regression at 
histology. 
Conclusion: MRI has a lower negative predictive value in assessing the axilla 
in women treated with NACT. This maybe related to the fact that these lymph 
nodes show evidence of tumour regression in the nodes which would account 
for signal and morphological changes seen on MRI which categorises the 
lymph nodes as being equivocal rather than normal.  
 
B-1398 11:42  
Comparison between standard specimen mammography and 
intraoperative specimen mammography (Faxitron®) located in the 
surgical block: has anything changed?  
L.J. Pavan, M. Durando, G. Mariscotti, S. Martinello, G. Cappello, A. Ala, 
I. Castellano, P. Fonio, G. Gandini; Turin/IT  
Purpose: To compare standard specimen mammography (SSM) with remote 
intraoperative specimen mammography (ISM)(FaxitronⓇ), carried out by 
surgeons and remotely interpreted by radiologists, assessing operative times, 
intraoperative additional excision (IAE) and re-intervention rates for breast 
conserving surgery (BCS). 
Methods and Materials: We retrospectively collected 129 consecutive 
patients (mean age 62±11 years, 136 lesions) who had BCS with SSM at our 
centre between 11/2011 and 02/2013 and 138 consecutive patients (mean age 
60±11 years, 144 lesions) who underwent BCS with ISM between 08/2014 and 
02/2015. We excluded patients treated in the first 6 months since ISM 
introduction, to avoid low-experience bias. Mammographic lesions were: 88 
masses, 26 microcalcifications and 22 architectural distortions in SSM group, 
and 95, 23 and 26 in ISM group, respectively. Diagnostic reliability of SMM and 
ISM was evaluated considering pathology as gold standard, using Chi-square 
or Fisher’s tests for categorical variables, and Mann-Whitney test for 
continuous variables. 
Results: The two groups did not statistically differ for age (p=0.2), lesion sizes 
(p=0.29) and tumour histotypes (p=0.75). Intraoperative time was significantly 
(p<0.00001) higher for SSM (132±43min) than for ISM (90±42min). In SSM 
group, 39/136 (29%) lesions required IAE and 53/144 (37%) in ISM group, with 
no significant differences (p=0.16), even at a stratified analysis by each 
mammographic sign. Re-intervention rates were not statistically different 
between the two groups [SSM: 19/136 (14%), ISM: 11/144 (8%); p=0.08]. At 
pathology, 9/39 (23%) IAE specimens were positive for cancer in SSM group 
and 18/53 (34%) in ISM group, not statistically different (p=0.25). 
Conclusion: The introduction of ISM significantly reduced surgical time without 
significant changes in IAE rates and surgical accuracy, corroborating the 
comprehension between surgeons and radiologists.  
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Keynote lecture  
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B-1399 10:39  
Volumetric interpolated breath-hold MRI sequence: value and reliability in 
diagnosis of mesial temporal sclerosis  
N.F. El Ameen, M.F. Amin; El Minia/EG (nadia.elameen@yahoo.com)  
Purpose: To evaluate the role of 3D volumetric interpolated breath-hold 
sequence (VIBE) MRI of the brain in diagnosis of mesial temporal lobe 
sclerosis (MTS). 
Methods and Materials: A prospective study included 45 patients with 
intractable epilepsy and suspected to have MTS. The patients were recruited 
between June 2015 and April 2016. All patients were referred from neurology 
department to radiology department in our institution. They underwent VIBE 
MRI in addition to the routine MRI protocol of the brain. Inter-observer reliability 
was done to the results to evaluate the reliability of VIBE sequence in 
diagnosis of MTS. 
Results: Conventional T2WI was positive and diagnosed MTS in 34/45 
(75.6%) and negative in 11/45 (24.4%) with sensitivity 90%, specificity 70% 
and accuracy 78%, while VIBE sequence was positive and diagnosed MTS in 
39/45 (86.7%) and negative in 6/45 (13.3%) patients with sensitivity 92%, 
specificity 77% and accuracy 82%. 
Conclusion: VIBE is a novel 3D gradient-echo sequence that offers several 
promising advantages if the object moves during the scan. Patients with 
intractable epilepsy could get much benefit from application of this sequence in 
routine imaging practice. It gives more clear images than T2WI and reduces 










B-1400 10:47  
Description of white matter damage in patients with mesial temporal 
sclerosis evaluated by diffusion tensor imaging (DTI)  
L.L. Resende, K. Lyra, C. Lôbo, L. Castro, V. Passarelli, R. Valerio, 
C. Jorge, C.D. Leite, M. Otaduy; São Paulo/BR (carlosfelipetl2@gmail.com)  
Purpose: Mesial temporal sclerosis (MTS) is a common cause of focal 
epilepsy. Although epilepsy is considered a grey-matter disease, white matter 
abnormalities have also been described. Describing white matter abnormality 
extension might help to understand differents surgical outcomes. Our purpose 
is to describe the tracts affected and to evaluate differences in patients with 
right or left MTS. 
Methods and Materials: 51 patients and 30 healthy controls were submitted 
to brain MRI and Diffusion tensor imaging (DTI) sequences with 32 gradient 
encoding direction. DTI images were post-processed with the FSL software 
and mean and median values of fractional anisotropy (FA) were obtained from 
20 tracts. We grouped patients in left and right-sided MTS and compared FA 
between patients and controls for commissural, association and projection 
tracts, grouping tracts in ipsilateral and contralateral, regarding the laterality of 
MTS. We considered a p value <0.05 as statistically significant. 
Results: In the comparison of commissural tracts, MTS patients showed a 
significant lower FA for forceps minor tract. In the comparison of association 
and projection tracts, we observed that right-sided MTS patients had a 
significantly lower FA in 7 of 9 right tracts (ipsilateral) and a lower FA in 6 of 9 
left tracts (contralateral). Left-sided MTS patients had a significant lower FA in 
3 of 9 left tracts (ipsilateral) and 6 of 9 right tracts (contralateral). 
Conclusion: This study revealed diffusional abnormalities in 14 of the 20 tracts 
analysed. Curiously, MTS patients presented more damage on right-sided 
tracts, regardless the laterality of the hippocampal sclerosis.  
B-1401 10:55  
Incomplete hippocampal inversion does not affect the hippocampal 
volume in neurologically healthy subjects  
D. Bajic1, E. Kumlien1, M. Milivojevic2, R. Raininko1; 1Uppsala/SE, 2Uzice/RS 
(drabaj02@yahoo.se)  
Purpose: In cases with incomplete hippocampal inversion (IHI), also called 
hippocampal malrotation, the hippocampus always looks narrow in axial 
images. In coronal images, it is difficult to compare the volumes of the 
hippocampi, which can be important in epilepsy, if there is IHI in one side. The 
aim of the study was to evaluate if IHI affects the hippocampal volume. 
Methods and Materials: Hippocampal volumes were measured 
semiautomatically on MRIs of 99 neurologically healthy subjects aged 1-67 
years. Asymmetry indices (AI) were calculated. AI was considered positive if 
the right hippocampus was larger and negative if the left was larger. 
Results: 25/99 (25%) of the neurologically healthy subjects had IHI: 19 left-
sided, 6 bilateral. The right hippocampus was larger in 63/74 (85%) subjects 
without IHI and in 86 (86%) of all subjects. The volumes of the left 
hippocampus in subjects without and with IHI did not differ statistically 
significantly. AI was 0.042±0.049 (mean±SD) in the 74 subjects without IHI and 
it was not age-dependent. AI was 0.029±0.036 in the 19 subjects with left-sided 
IHI, and 0.061±0.048 in the six subjects with bilateral IHI. Differences were not 
statistically significant. The ±2SD limits for AI were 0.14 and -0.05 in all 
subjects. 
Conclusion: IHI does not seem to affect the hippocampal volume in 
neurologically healthy subjects. Consequently, AI is not affected by IHI. AI is 
not age-dependent and the same criteria for normal asymmetry can be used in 
the evaluation of the patients at all ages.  
B-1402 11:03  
Utility of volumetric assessment of the hippocampal substructures in 
hippocampal sclerosis  
A.M. Granados, J.F. Orejuela; Cali/CO (anamaria.granados@gmail.com)  
Purpose: Pathological classification of hippocampal sclerosis (HS) is based on 
neuronal loss of hippocampal substructures, which has been correlated with 
disease duration, memory function performance, and postoperative prognosis. 
The purpose of this work is to evaluate the usefulness of an automated method 
for the assessment of hippocampal substructures on MRI studies. 
Methods and Materials: Twenty-five patients with unilateral-HS and twenty-
five healthy subjects were included. Volumes of the whole hippocampus and 
hippocampal subfields were obtained using FreeSurfer. A p value less than 
0.05 was considered statistically significant. 
Results: A statistically significant decrease in the ipsilateral hippocampus was 
found in 22 cases (88.0%). With the exception of the fissure, there was a 
decrease in all ipsilateral hippocampal substructures in right-HS (CA1, 
p=0.0223; CA2-CA3, p=0.0066; CA4-DG, p=0.0066; fimbria, p=0.0046; 
presubiculum, p=0.0087; subiculum, p=0.0017), and left-HS (CA1, p<0.0001; 
CA2-CA3, p<0. 0001; CA4-DG, p<0. 0001; fimbria, p=0.0183; presubiculum, 
p<0. 0001; subiculum, p<0. 0001). No decrease in overall volume was 
observed in three patients; however, one case showed a decrease in the 
volume of CA1, CA2-CA3, and CA4-DG, the second case of CA1, CA2-CA3, 
and subiculum; and in the other case, CA4-DG, fimbria, and presubiculum 
volumes were decreased. 
Conclusion: The automated method used in this work could improve the 
predictive values of quantitative MRI analysis in the diagnosis of HS as it 
allows to identify focal alterations before global structural changes occur. 
Moreover, the good correlation found with the last ILAE classification suggests 
that this method could also play an important role as a prognosis tool.  
B-1403 11:11  
Prefrontal lobe cortex-thalamus pathway impairment in intractable 
temporal lobe epilepsy with executive control function abnormal: 
evidence from structural and functional MRI study  
C. Zhang, N. Chen, K. Li, H. Yang; Beijing/CN (chaozhang0328@hotmail.com)  
Purpose: The aim of this study was to investigate structure and functional 
connectivity of prefrontal lobe cortex (PFC)-thalamus pathway in unilateral 
intractable temporal lobe epilepsy (TLE) patients with impaired executive 
control function (ECF). 
Methods and Materials: Thirty-seven intractable left TLE patients and twenty-
three volunteers were recruited for diffusion tensor imaging and resting-state 
fMRI scanning. The patients were divided into two subgroups according to ECF 
performance which judged by Wisconsin card sorting test (WCST): ECF 
decreased group (18 subjects) as G1 and ECF normal group (21 subjects) as 
G2. The healthy control group (HC) included all 23 volunteers. The region of 
interest (ROI) was set in bilateral prefrontal cortex and bilateral thalamus. A 
general linear model (GLM) was employed to analyse fibres and functional 
connectivity (FC) between each pair of ROI among G1, G2 and HC (p<0.05). 
Pearson correlation between FC, fibre number and WCST score was also 
observed through partial correlation analysis (p<0.05). 
Results: Fibre number and FC between left dorsolateral frontal gyrus and left 
thalamus of G1 were increased significantly when compared with G2 and HC 
(p=0.017). Both fibre number and FC had significantly negative correlation with 
WCST score (p<0.05). 
Conclusion: This study demonstrated that decreased ECF was related to 
PFC-thalamus pathway. Furthermore, such alternation may potentially act as 
an important imaging feature for differentiating TLE patients with ECF 
impairment.  
B-1404 11:19  
Comparison between different post-processing techniques in the 
identification of focal cortical dysplasias in children with 
pharmacoresistant epilepsy  
M. Rossi Espagnet, E. Bassanelli, A. Napolitano, N. Pietrafusa, L. De Palma, 
N. Specchio, D. Longo; Rome/IT (camilla.rossiespagnet@gmail.com)  
Purpose: Different techniques have been developed to improve identification 
of malformations of cortical development such as focal cortical dysplasias 
(FCD) in MRI-negative patients affected by pharmacoresistant epilepsy (PRE). 
However, no studies investigated the reliability of these methods for the 
paediatric population so far. The purpose of this prospective on-going study is 
to compare the MAP and the SUPR-FLAIR techniques for the pre-surgical 
evaluation of the paediatric brain in children with PRE. 
Methods and Materials: A group of 90 healthy subjects (age range 8-16 
years) was used as a control group, while 10 patients (4 RMN positive and 6 
RMN negative) with drug-resistant epilepsy, and histological proof of FCD, 
were analysed to compare the two methods. All subjects were scanned with a 
3T Siemens Skyra (Erlangen, Germany). The original Map method has been 
optimised (Opti-MAP) by creating a specific template for paediatric subjects (90 
healthy subjects), and inserting two tools into the algorithm: BET and N4ITK. 
For the SUPR-FLAIR Analysis the original algorithm was followed. 
Results: The Opti-Map approach was successful in the 90% of cases despite 
the fact that most of the FCDs were type I. Conversely, the SUPR-FLAIR 
approach succeeded only in 20% of cases . In no cases, there was any overlap 
between the 2 methods. 
Conclusion: From these preliminary results optimised MAP post-processing 
seems to be a more reliable tool compared to the SUPR-FLAIR technique in 
the pre-surgical evaluation of pharmacoresistant epilepsy in children. Further 
data are necessary to further optimise the template and validate these results.  
B-1405 11:27  
Mesial temporal sclerosis: is standard MRI protocol enough?  
J. Ponnatapura Satyanarayana; Bangalore/IN (psjanardhan@yahoo.com)  
Purpose: Evaluation of the different protocols of MR imaging in MTS and 
correlation with EEG findings. Pearls and pitfalls of MRI. 
Methods and Materials: A prospective study was conducted of 52 mesial 
temporal sclerosis patients who underwent dedicated epilepsy protocol MRI 
and volumetric MRI on 1.5T within 7 days from the onset of seizures. A routine 
EEG from the scalp electrodes was obtained 3 days before or after the MRI. 
  






Results: Thirty-six patients (69%) presented with partial seizure, and 31% 
presented with generalized clonic tonic seizure. 26% had childhood history of 
febrile illness. 62% diagnosed with MTS on MRI showed abnormal EEG 
findings and 10 showed normal EEG findings. The lateralisation of EEG in 
MTS patients was 70-76% (p>0.5). 98% of patients with MTS showed positive 
MR volumetric study (p<0.5), of which 36% showed normal EEG study (p<0.5). 
100% of patients with hippocampal sclerosis were detected using “epilepsy 
protocol” MRI, which would have been missed if only “standard protocol” MRI 
was done. 
Conclusion: Mesial temporal findings on MRI did not always result in 
abnormal EEG findings and hence newer imaging modalities like MR 
volumetric study, functional MRI, MR spectroscopy, SPECT and PET should 
be done in medically refractory seizures, especially before planning surgery.  
B-1406 11:35  
Comparison between BOLD-fMRI and Stereo-EEG in the pre-surgical 
evaluation of language dominance in children affected by 
pharmacoresistant epilepsy  
M. Rossi Espagnet, E. Bassanelli, N. Pietrafusa, L. Figà-Talamanca, 
L. De Palma, D. Longo, A. Napolitano; Rome/IT 
(camilla.rossiespagnet@gmail.com)  
Purpose: The optimal pre-surgical management of patients with 
pharmacoresistant epilepsy (PRE) has the aim to correctly identify the seizure 
onset zone and to verify the localisation of “critical” regions to avoid post-
surgery deficits. Both task-based fMRI and Stereo-EEG demonstrated good 
correlation in the identification of language dominance compared to WADA 
test. The purpose of this preliminary study is to verify the correlation between 
Stereo-EEG and fMRI results in the identification of language dominance in 
children with PRE. 
Methods and Materials: Language Task-based fMRI obtained from a 3T 
scanner (Siemens Skyra, Erlangen, Germany) in 5 patients with PRE were 
retrospectively analysed to calculate lateralisation index (LI) for all the tasks 
applied (semantic task, verb generation and story listening). Stereo-EEG data 
obtained from all patients after electrode stimulation during language-related 
tasks were also reviewed to verify language dominance. 
Results: Language dominance obtained from SEEG and fMRI was concordant 
in all patients. 4/5 patients demonstrated a left language lateralisation whilst 
1/5 patient with a left fronto-temporo-parietal perinatal stroke demonstrated 
right language lateralisation. The location of language-related areas obtained 
from fMRI tasks demonstrated a good correlation with those that determined a 
block in language tests during electrode stimulation. 
Conclusion: task-based fMRI and stereo-EEG provided good correlation in the 
evaluation of language dominance and can be considered reliable tools in the 
pre-surgical evaluation of children affected by PRE.  
B-1407 11:43  
The role of conventional MRI-based scale in distinguishing chronic 
disorders of consciousness  
S. Morozova, E.I. Kremneva, L. Legostaeva, E. Mochalova, D. Sinitsyn, 
D. Sergeev, M. Krotenkova, N. Suponeva, M. Piradov; Moscow/RU 
(kulikovasn@gmail.com)  
Purpose: To evaluate predictive role of new suggested conventional MRI-
based scale in distinguishing chronic disorders of consciousness (DOCDS-
disorders of consciousness distinguishing scale). 
Methods and Materials: Data were acquired from 24 patients with clinically 
assessed chronic disorders of consciousness (12 with minimal consciousness 
state (MCS) and 12 with unresponsive wakefulness syndrome (UWS)) due to 
anoxia or trauma age ranged 21-56. All patients underwent conventional MRI 
on Siemens Verio 3.0 T scanner, scanning protocol included conventional T2 
sequence, T1 multiplanar sequence, which were used for scaling. The 
following parameters were suggested for DOCDS: general cortical atrophy, 
inner and external hydrocephalus, leukoareosis, brainstem degeneration, 
corpus callosum degeneration and lesions. T2WI and T1WI of all patients were 
assessed according to the scale resulting in a total score. Images were 
analysed by two experts blinded to diagnosis and it's cause. Statistical analysis 
was performed using SPSS 20.0.0. 
Results: Total DOCDS score ranged 2-9. ROC-analysis showed threshold 
score 5,5, which means that patients with total DOCDS score 6 and more refer 
to UWS, 5 and less refer to MCS with sensitivity 76,9%, specificity 90,9% (area 
under the curve (AUC) = 82,9%, p=0,006). 
Conclusion: Taking into consideration relatively high sensitivity and specificity, 
DOCDS could be used as an additional instrument in distinguishing chronic 
disorders of consciousness. The study was supported by Russian Science 





B-1408 11:51  
Utility of MRI brain epilepsy protocol in new onset seizures: how is it 
different in developing countries?  
J. Ponnatapura Satyanarayana; Bangalore/IN (psjanardhan@yahoo.com)  
Purpose: To evaluate the diagnostic efficacy of standard MRI brain in patients 
with first-onset seizures and to identify whether there is an increase in the 
diagnostic yield with addition of a dedicated seizure protocol. 
Methods and Materials: 129 cases were studied for a period of 18 months. 
Chi-square test was used to test for the difference in proportion. The 
correlation between MRI brain and EEG was studied using McNemar test. 
Patients underwent both standard protocol and dedicated epilepsy protocol 
MRI brain scanning on 1.5T within 7 days from the onset of seizures. A routine 
EEG from the scalp electrodes obtained 3 days before or after the MRI and 
after presentation with the index seizure, preferably within 48 hours. 
Results: The diagnostic yield of MRI was 47%. Infection and inflammation was 
most common (28%). Of the 59 patients with potential epileptogenic lesions, 
63% were detected using “standard protocol” MRI and remaining 37% lesions 
were detected using “dedicated epilepsy protocol” MRI. Of the epileptogenic 
lesions, all 11 patients (100%) with hippocampal sclerosis were detected using 
“epilepsy protocol” MRI which would have been missed if only “standard 
protocol” MRI was done. Patients with focal-onset seizures had a higher 
proportion of potentially epileptogenic lesions (81%) compared with the 
patients with generalized clonic tonic seizures. 
Conclusion: A dedicated epilepsy protocol MRI should be done in all patients 
who present with first-onset seizures, which allows identification of a lesion and 
earlier consideration of epilepsy surgery especially in patients with focal-onset 
seizures.  
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B-1409 10:30  
Is there a difference in the degree of enhancement in contrast-enhanced 
spectral mammography between invasive lobular carcinomas and 
invasive ductal carcinomas?  
T. van Nijnatten1, M.B. Lobbes1, K. Pinker2, D.M. Keating2, J.S. Sung2, 
M. Morrow2, J.E. Wildberger1, M. Smidt1, M.S. Jochelson2; 1Maastricht/NL, 
2
New York, NY/US (t.vannijnatten@maastrichtuniversity.nl)  
Purpose: To investigate the differences in the degree of lesion enhancement 
of invasive lobular carcinomas (ILC) and invasive ductal carcinomas in 
contrast-enhanced spectral mammography (CESM). 
Methods and Materials: This two-centre HPAA-compliant retrospective study 
included consecutive patients with ILC or IDC who underwent preoperative 
CESM between 2010 and 2017. Three independent readers (one expert CESM 
reader, one reader with greater than 4 years of experience in CESM and one 
inexperienced reader) assessed the degree of lesion enhancement of the 
cancers, blinded to histology. Enhancement was scored as: possible, weak, 
moderate or strong. Interobserver agreement was calculated by using 
quadratic-weighted kappa (including 95% confidence intervals) to compare the 
results of the expert CESM reader with the other readers. 
Results: A total of 44 patients were included: 22 patients with ILC and 22 
patients with IDC. The degree of lesion enhancement was classified 
significantly more often as possible or weak in patients with ILC compared to 
IDC (reader 1: 31.8% versus 4.5%, p=0.045; reader 2: 36.4% versus 18.2%, 
p=0.310; reader 3: 22.7% versus 4.5%, p=0.185). All other lesions were 
considered moderate or strong enhancement. Inter-observer agreement was 
good for the two experienced CESM readers (=0.723 (0.584 - 0.862) as well 
as for the expert CESM reader compared to the non-experienced CESM 
reader (=0.728 (0.598 - 0.858)). 
Conclusion: There is a difference in the degree of enhancement between ILC 
and IDC, with ILC significantly more often presenting with weak enhancement. 
In case of weak lesion enhancement, radiologists should consider ILC for the 
final diagnosis.  
Author Disclosures: 
 M.B. Lobbes: Research/Grant Support; GE.  J.E. Wildberger: 
Research/Grant Support; Bayer, Agfa, BRACCO, GE, Philips, Siemens. 
Speaker; Bayer, Siemens. 
  






B-1410 10:38  
Quantification of enhancement in contrast-enhanced spectral 
mammography using a custom-made quantifier tool: a proof-of-concept 
study  
H.K.P. Mulder, C.R. Jeukens, M. Rousch, J.E. Wildberger, M.B. Lobbes; 
Maastricht/NL (harmen.mulder@mumc.nl)  
Purpose: Contrast-enhanced spectral mammography (CESM) is superior to 
conventional mammography and is able to show contrast agent uptake 
(enhancement) in breast lesions, increasing its diagnostic accuracy. A major 
step forward would be the ability to quantify enhancement, perhaps allowing 
discrimination between malign and benign tumours. In this proof-of-concept 
study, we present a novel quantification method for rating CESM 
enhancement. 
Methods and Materials: We developed a novel, custom-made quantifier tool 
(I-STRIP) filled with different concentrations of contrast agent, which is 
positioned near the breast during acquisition. The measured CESM signal in 
the I-STRIP is used to quantify iodine mass thickness (IMT) in the breast. We 
evaluated the accuracy and precision using a dedicated phantom containing 
lesions with known IMT. Furthermore, we tested its effect on image quality and 
clinical use in five breast cancer patients. 
Results: Phantom experiments showed that measured enhancement scales 
linearly with IMT. Furthermore, enhancement in a medium-thick (4.6 cm) breast 
phantom corresponded within 11.8%, 9.0% and 13.2% to enhancement in the 
I-STRIP for IMT’s of 1.5, 3.0 and 7.5 mg/cm2, respectively. Only for lesions 
near the periphery of the phantom the so-called breast-within-breast artefact 
resulted in overestimation of enhancement. In five clinical experiments, the 
workflow and the image quality were not influenced by the I-STRIP. The mean 
IMT of five invasive breast cancers was 2.1 mg/cm2 (range 1.3-3.4 mg/cm2). 
Conclusion: We showed in both phantom and clinical experiments that we 
could accurately quantify the CESM enhancement on recombined CESM 
images without affecting image quality.  
Author Disclosures: 
 J.E. Wildberger: Research/Grant Support; Siemens, Philips, GE, BRACCO, 
Bayer, Agfa. Speaker; Siemens, Bayer.  
B-1411 10:46  
Contrast-enhanced spectral mammography and diffusion-weighted image 
with backward signal suppression: which is more effective in breast 
cancer detection?  
N.A.E. ElDeib, F.M.E.S. Singer, S.M.M.T. Talaat, M. Anas, M. Rezk; Cairo/EG 
(nohasaid.rad@hotmail.com)  
Purpose: The purpose of this study is to assess diagnostic accuracy of 
diffusion weighted imaging with background signal suppression (DWIBS) 
compared with contrast-enhanced mammography in the diagnosis of breast 
lesions and correlate the findings with the histopathological results. 
Methods and Materials: 52 female patients have enrolled in this prospective 
study their age ranged between 23-77 years old, mean age is about (47.83,+/-
SD=11.55)years. The patients presented with breast lesions by mammography 
were assessed by both contrast-enhanced mammography and DWIBS MR. 
Written consent was taken from the patients. The maximum dimension of the 
lesion or lesions was measured in both studies. Findings assessed by two 
radiologists, one for each modality without knowing pathologic results. 
Results: The primary unit of analysis was the lesion ,54 lesions were detected 
in 52 cases .39/54 of the lesions were histopathologically proven as malignant 
and 15/54 were benign. The calculated sensitivity ,specificity,total accuracy 
,PPV and NPV for CEDM were (100.00%, 73.30%, 92.60%, 90.70% and 
100.00% )respectively The calculated sensitivity, specificity, total accuracy 
PPV and NPV for DWIBS MRI were (94.90%, 93.30%, 94.40%,97.40% and 
87.50% )respectively DWIBS MRI showed the highest diagnostic performance 
and accuracy due to improved specificity by reducing number of false positive 
results, compared to CEDM. 
Conclusion: The DWIBS is a new non-contrast imaging technique with an 
improved specificity when compared to CEDM. DWIBS is superior to CEDM in 
the detection of both malignant and benign lesions. CEDM is less expensive , 
easier and quicker examination compared to MRI.  
B-1412 10:54  
Feasibility of contrast-enhanced spectrum mammography in breast 
cancer diagnosis  
L. Zheng, C. Zhang, K. LI; Shanghai/CN (zhenglinfeng04@aliyun.com)  
Purpose: To study feasibility of contrast-enhanced spectral mammography 
(CESM) in the diagnosis of breast cancer. 
Methods and Materials: Institutional review board approved this study. 
Ninety-one cases clinically diagnosed with breast cancer were underwent 
CESM, mammography (MG) and contrast-enhanced magnetic resonance 
imaging (CE-MRI). Detectable rate of CESM, MG and CE-MRI were compared, 
respectively. Then average maximum dimension of suspicious lesions on 
CESM image was measured and compared with pathological specimen. 
Finally, morphologic features of CESM images were analysed for four different 
molecular subtypes of breast cancer cases. 
Results: CESM has high detectable rate than MG and CE-MRI for breast 
cancer (97.0% vs 83.3% vs 91.0%; P<0.05). For the measurement of mass 
average maximum dimension, no difference was found between CESM and 
pathology (P>0.05). However, CESM image features of the four different 
molecular subtype cases, including average maximum dimension of mass, 
shape, margin, enhancement and enlargement of lymph node, were of 
statistical difference (P<0.05). 
Conclusion: CESM may play an important role in the breast cancer clinical 
practice.  
B-1413 11:02  
Features from computerised texture analysis of breast cancer on 
contrast-enhanced spectral mammography to predict tumour 
aggressiveness  
C. Bassi, L.S. Fournier, M. Bouaboula, C. Rousseau, A.-S. Jannot, C. Ngo, 
H. Roussel, F. Chamming's; Paris/FR (clotilde.bassi@gmail.com)  
Purpose: To evaluate whether heterogeneity as evaluated by texture analysis 
on contrast enhanced spectral mammography (CESM) was associated with 
breast cancer features on pathology. 
Methods and Materials: Institutional review board was obtained. 79 patients 
with 79 breast cancers who underwent CESM between january 2015 and may 
2017 were included in this retrospective monocentric study. 2D texture analysis 
was performed using TexRAD software. Quantitative texture parameters were 
compared with pathological features. Eigen value analysis was used to 
determine the number of independent parameters. Univariate analysis was 
performed to determine texture parameters significantly associated with tumour 
pathology. After Bonferroni correction, P less than 0,0014 was considered 
statistically significant. 
Results: On univariate analysis, Kurtosis for Spatial scale filter (SSF) 0,5 (P = 
0,0015) and 4 (P = 0,0006), skewness for SSF2 (P = 0,003) and mean 
proportion of positive pixels (MPP) for SSF2 (P = 0,004) showed significant 
association with mitotic index. There was also a trend for association between 
MPP SSF2 (P = 0,003) and SSF4 (P = 0,004) and tumour grade. 
Conclusion: On CESM, heterogeneity of breast cancers as measured by 
texture analysis is associated with mitotic index and could be a promising 
biomarker of tumour aggressiveness.  
B-1414 11:10  
Impact of mammogrphic features and level of tumour-infiltrating 
lymphocytes on prognosis of tripple-negative breast cancer  
C. Casella, G. Mariscotti, M. Durando, I. Castellano, E. Vissio, F. Esposito, 
S. Osella Abate, P. Fonio, G. Gandini; Turin/IT (loricri@inwind.it)  
Purpose: Triple-negative breast cancer (TNBC) is known to be associated with 
aggressive clinical behaviour and poor clinical outcomes. Elevated levels of 
tumor-infiltrating lymphocytes (TILs) positively correlate with the pathologic 
complete response and increased survival in patients with TNBC. The purpose 
of this study was to investigate associations between mammographic features, 
TIL levels and prognosis in patients with TNBC. 
Methods and Materials: We conducted a retrospective observer study that 
includes 81 patients (mean age 56,6 years; range:36,6-88,1) with 
pathologically confirmed TNBC, who consecutively underwent preoperative 
digital mammography between January 2010 and March 2017. All 
mammographic lesions were evaluated by radiologists and classified in 
accordance with the BI-RADS lexicon. Tumors were divided into two groups: 
those with a TIL level of less than 10% and those 10%. Univariate and 
multivariate analysis were performed on the data. 
Results: TNBCs were predominantly mass lesions (73/81, 90,1%), 
subgrouped in 16(21,9%) masses associated with microcalcifications, 3(4,1%) 
with architectural distortions and 1 with microcalcifications and architectural 
distortion. Out of 73 masses, 22(30%) had circumscribed margins, statistically 
associated with favourable clinical behaviour (IC 0.02-1.00, p=0.05); 
considering the 20/81(24.7%) cases with recurrence, only in 1 case the TNBC 
was a mass with circumscribed margins. In 36/81(44.5%) TNBC TILs level was 
10% and in 45(55.5%) <10%. TILs  10% proved to be a positive prognostic 
biomarker for disease free-survival (HR 0.30; p=0.05). 
Conclusion: In the TNBCs, circumscribed margins at mammography, as well 
TILs10% could provide added diagnostic benefit for the identification and 
















B-1415 11:18  
Low-dose perfusion CT for quantification of tumour vascularity in breast 
cancer: correlation with prognostic biomarkers  
B.K. Seo1, E.K. Park1, M. Kwon1, C.S. Ko1, J. Cha1, K.R. Cho2, O.H. Woo2; 
1
Ansan/KR, 2Seoul/KR (seoboky@korea.ac.kr)  
Purpose: To investigate the feasibility of low-dose perfusion computed 
tomography (CT) in breast cancers for quantification of tumor vascularity and to 
correlate perfusion indexes with prognostic biomarkers. 
Methods and Materials: Low-dose perfusion CT was performed in 70 patients 
with invasive breast cancers. CT was performed in the prone position with a 
spectral CT (iQon, Philips Healthcare) after contrast media (Xenetix350, 
Guerbet) injection. On CT perfusion maps, perfusion (mL/100g/min), blood 
volume (mL/100g), time to peak (sec) and peak enhancement (HU) were 
measured in the tumor, normal breast glandular tissues and fat. Pathologically, 
tumor grade, estrogen receptor (ER), progesterone receptor (PR), human 
epidermal growth factor receptor 2 (HER2), and Ki67 level were evaluated. 
Statistically, CT perfusion indexes of the tumor and normal glandular tissues or 
fat was compared using the Wilcoxon signed rank test and CT indexes were 
correlated with histological characteristics with the Mann-Whitney or Kruskal-
Wallis test. 
Results: In breast cancers, perfusion, blood volume and peak enhancement 
values were significantly higher and time to peak was shorter than these 
values in normal glandular tissues and fat (P < .05). Perfusion significantly 
increased in breast cancers with high grade, ER- or HER2+ (P < .05). Time to 
peak decreased in cancers with high grade, ER-, HER2+ or high Ki67 level (P 
< .05). Peak enhancement significantly increased in high grade cancers (P < 
.05). 
Conclusion: Low-dose perfusion CT in the prone position is feasible to 
quantify tumor vascularity in breast cancers and CT perfusion indexes may 
predict prognostic biomarkers.  
B-1416 11:26  
A visual grading analysis of propagation-based phase-contrast CT 
mammography  
S. Tavakoli Taba1, P. Baran2, S. Lewis1, R. Heard1, S. Pacile3, Y.I. Nesterets2, 
S.C. Mayo2, C. Dullin4, D. Dreossi3, F. Arfelli3, D. Thompson2, M. McCormack2, 
M. Alakhra1, F. Brun3, M. Pinamonti3, C. Nickson2, C. Hall2, F. Zanconati3, 
D.J. Lockie2, H. Quiney2, G. Tromba3, T.E. Gureyev2, P.C. Brennan1; 
1
Sydney/AU, 2Melbourne/AU, 3Trieste/IT, 4Göttingen/DE  
Purpose: While all current X-ray based breast imaging modalities rely on 
differences in soft tissue X-ray attenuation (absorption contrast), phase-
contrast imaging (PCI) has capacity to also visualise variations in X-ray 
refraction (phase contrast). To successfully translate the preclinical results of 
PCI technology into clinical implementation, the imaging variables of the 
technology must first be optimised through radiological assessments by breast 
radiologists and medical imaging experts. We conducted a series of 
assessments to establish the optimum imaging conditions of X-ray 
propagation-based imaging (PBI), which is experimentally the simplest PCI 
technique for clinical purposes. 
Methods and Materials: We investigated 161 synchrotron-based CT 
reconstructions of one full-size section of a breast specimen produced by 
adjusting the following five imaging parameters: sample-to-detector distance, 
X-ray energy, CT reconstruction method, phase retrieval algorithm applied to 
the CT projection images and maximum intensity projection in image 
reconstruction. A visual grading analysis was conducted in two stages (13 
assessors in stage I and 15 assessors in stage II) by comparing various 
radiological image quality attributes of PBI CT scans with reference images 
approximating conventional CT images. 
Results: The results showed that the application of the longest sample-to-
detector distance (9.31 m in our experiments), the lowest employed X-ray 
energy (32 keV), full application of the phase retrieval algorithm and the use of 
maximum intensity projection could substantially improve the image quality 
compared with conventional imaging. 
Conclusion: The results from this study should provide a strong basis for 
future radiological assessments and clinical testing of this advanced X-ray 
imaging technology.  
Author Disclosures: 
  S. Tavakoli Taba: Research/Grant Support; This research was supported by 
a grant from the National Breast Cancer Foundation (Australia), We 
acknowledge travel funding provided by the International Synchrotron Access 
Program (ISAP) managed by the Australian Synchrotron and funded by the 
Australian Government, This research was undertaken on the SYnchrotron 





B-1417 11:34  
Exploring contrast agents in phase-contrast x-ray mammography: an ex 
vivo pilot study  
K. Lang1, C. Arboleda2, S. Forte3, Z. Wang2, R. Kubik-Huch3, M. Stampanoni4; 
1
Zurich/CH, 2Villigen/CH, 3Baden/CH, 4Zürich/CH (kristina.lang@med.lu.se)  
Purpose: Phase contrast x-ray mammography (PCM) is an experimental 
breast imaging method, at the edge of clinical implementation, that besides 
absorption can measure the refraction and scattering of x-rays resulting in 
differential-phase-contrast (DPC) and dark-field (DF) images. We assessed the 
feasibility of using microbubbles and iodine contrast agents in PCM. 
Methods and Materials: An ex vivo phantom of a fresh chicken breast 
(5x5x3cm) with fragments of eggshells simulating calcification clusters was 
used. Native and post-contrast images were acquired with a clinically 
compatible grating-interferometry-based mammography setup, based on a 
modified Philips MicroDose mammography system, operated at 38 kvP, 14 sec 
acquisition time, with an estimated dose of 1.3 mGy. 2 mL of sulphur 
hexafluoride microbubbles (SonoVue 8 µL/mL, Bracco) used for contrast-
enhanced ultrasound, and iodine (Iopamiro 370 mg/mL, Bayer) were, 
respectively, injected into the phantom. The visibility of the contrast agents in 
the absorption, DPC and DF images were analysed in a side-by-side 
comparison and the contrast-to-noise-ratio (CNR) between the contrast agent 
and surrounding tissue was calculated. 
Results: The microbubbles were clearly visible in the DF image (CNR=2.5), 
but not in the absorption or DPC images. The iodine was visible in the 
absorption image (CNR=15.8) and as noise in both the DF and DPC images. 
Conclusion: This is a first proof-of-principle that microbubbles can be used as 
a contrast agent in clinically compatible PCM, due to their scattering properties, 
which implies a potential use of a contrast agent with a high safety profile in x-
ray-based breast imaging.  
Author Disclosures: 
  K. Lang: Other; Research collaboration with Philips. C. Arboleda: Other; 
Research collaboration with Philips.  Z. Wang: Board Member; GratXray. 
M. Stampanoni: Board Member; GratXray. 
B-1418 11:42  
Effectiveness of superb microvascular imaging (SMI) in differentiating 
intraductal breast lesions  
S. Bakdik, S. Arslan, F. Öncü, M.S. Durmaz, A. Altunkeser, M.A. Eryilmaz, 
Y. Unlu; Konya/TR (oncufatih@gmail.com)  
Purpose: The aim of this study is to compare the diagnostic performance of 
Superb Microvascular Imaging (SMI) and power Doppler imaging (PDI) for 
differentiation of intraductal breast lesions. 
Methods and Materials: A total of 54 intraductal breast lesions (13 solidified 
debris, 26 benign, 10 atypical and 5 malignant) in 53 patients were examined 
with B-mode ultrasonography, PDI and SMI. Vascularity grading, distribution of 
microvessels and penetrating vessels were evaluated with each doppler 
technique. Diagnostic performances of both methods were compared. 
Results: SMI is more efficient in detecting flow signals than PDI. The highest 
diagnostic accuracy rates were achieved with SMI by using vascular grading. 
When hypervascularity was used as a cut-off value to differentiate malign and 
atypical lesions from benign lesions, sensitivity, specificity, positive predictive 
value, negative predictive value, and accuracy were 66.6%, 80.7%, 66.6%, 
80.7%, and 75.6% for PDI, 86.6%, 76.9%, 68.4%, 90.9% and 80.4% for SMI 
respectively. 
Conclusion: SMI is more sensitive than PDI in detecting subtle blood flow of 
intraductal breast lesions. The novel and promising vascular imaging technique 
can be helpful to B-mode ultrasonography to distinguish intraductal breast 
lesions.  
B-1419 11:50  
Usefulness of automated breast volume scanner to evaluate the early 
response to neoadjuvant therapy in breast cancer patients: a prospective 
study  
A. D'angelo1, P. Rinaldi1, R. Rella1, M. Giuliani1, P. Belli1, G. Carlino1, 
C. Grippo1, M. Romani1, R. Manfredi2; 1Rome/IT, 2Verona/IT 
(anna.dangelo05@gmail.com)  
Purpose: To investigate the accuracy of ABVS compared with conventional 
ultrasound (US) to evaluate the early assessment of response to neoadjuvant 
therapy (NADT, chemotherapy/hormone therapy). 
Methods and Materials: IRB-approved prospective single-center study. 35 
consecutive patients (range 25-65 years), eligible for NADT, were enrolled. 
They underwent ABVS, US, MRI and mammography at the beginning of 
NADT, at the mid-therapy and before the surgery. MRI has been considered 
the gold standard. Two breast radiologists independently assigned a BI-RADS 
score to ABVS, MRI, US and MG, and they evaluated tumour response using 
RECIST criteria. Cohen's kappa coefficient was used to assess the agreement 
between ABVS and US.  
  






Results: The comparison of ABVS and US showed that ABVS had a 
sensitivity of 86.7% [26 positive cases at ABVS/30 positive cases at US; 95% 
confidence interval (CI) 70.3%-94.7%], and a specificity of 80.0% (4 negative 
cases at ABVS/5 negative cases at US; 95% CI 37.6%-96.4%). Positive and 
negative predictive values (PPV and NPV) were, respectively, 96.3% (26 
positive cases at ABVS and US/27 total positive cases at ABVS; 95% CI 
81.7%-99.3%) and 50% (4 negative cases at ABVS and US/8 total negative 
cases at ABVS; 95% CI 21.5%-78.5%). The agreement between ABVS and 
US was 53.3% (Cohen's kappa p value=0.001). 
Conclusion: Diagnostic performance of ABVS is high, indicating a potential 
use of it, in addition to MRI, as a useful tool for early prediction of response to 
NADT.  
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B-1420 10:30  
3D printed model based on knee MRI as a new tool in surgical planning of 
anterior cruciate ligament reconstruction  
L.J. Pavan, R. Faletti, L. Nicolet, A. Cosentino, A. Di Chio, M. Gatti, S. Fiore, 
F. Bonino, P. Fonio; Turin/IT (lucajpavan@gmail.com)  
Purpose: The aim of the study was to compare measurement of 
transepicondylar femoral axis (TFA) and planned length of the surgical graft, 
both calculated on 3D printing models and on multiplanar reconstruction (MPR) 
of knee MRI, in view of anterior cruciate ligament (ACL) surgical reconstruction. 
Methods and Materials: Sixteen healthy volunteers with no ACL lesions (6 
females, 10 males, mean age 27 years, range 22-34y) underwent standard 
knee MRI examination on a 1.5T scanner (Philips Achieva 2.6®) with a 
complimentary T1-weighted volumetric gradient echo sequence. Knee bones 
were isolated and elaborated with open source softwares (Osirix®, 
Meshmixer®, Cura®, Slic3r®) to obtain a STL file for a Ultimaker2+® 3D 
extrusion printer. TFA measurement and ACL graft length were blindly 
calculated by an orthopaedic on 3D-printed models and by a radiologist on 
MPR images and compared using Wilcoxon signed-rank test. 
Results: Mean values of TFA were 82,2±7 mm on 3D model and 83,1±7 mm 
on MPR images, with no significant difference (p=0.056). Mean values of graft 
lengths were significantly lower (p<0.001) on 3D printed models (136.6±13 
mm) than on MPR images (146.1±13 mm), with a mean difference of 9.5±4 
mm. Mean printing time was 11±1.8 hours and mean material cost 4.33±0.5 €. 
Conclusion: 3D printing is a reliable, non-expensive technique with good 
anatomical correlation that needs further studies for a better assessment. A 9.5 
mm difference in the planned length of ACL graft may still be acceptable from 
an orthopaedic point of view, on an average 140-160-mm graft.  
B-1421 10:38  
Anterior inferior iliac spine morphology: quantitative and qualitative 
assessment in an asymptomatic population  
F.F. Ergen1, O. Topcuoglu1,2, S. Ardali1, T. Cankurtaran1, A. Dolgun Barak1, 
U. Aydingoz1; 1Ankara/TR, 2Istanbul/TR (omtopcuoglu@gmail.com)  
Purpose: To assess the prevalence of anterior inferior iliac spine (AIIS) types, 
and to investigate the quantitative measurements that characterise AIIS 
morphology in an asymptomatic adult population. 
Methods and Materials: In this prospective study, 358 hips from 179 
consecutive subjects (age range, 19-82 years; 91 males, 88 females), who 
underwent CT examination for reasons other than hip problems and were 
negative for hip impingement test, were analysed. AIIS types were determined 
(1, flat wall of the ilium between distal end of AIIS and acetebular rim; 2, bony 
eminence between distal end of AIIS and acetebular rim; and 3, extension of 
AIIS to the anterior superior acetabular rim) and AIIS tip angle (TA), direct 
distance (DD) of the anterior acetabular rim to AIIS as well as projectional 
distances in vertical (VD) and horizontal (HD) planes were measured. Age- and 
gender-related factors were searched using two-way ANOVA test under three 
age groups (18-39, 40-59, and 60 years). 
Results: There were 238 (66.5%) type 1, 118 (33.0%) type 2, and 2 (0.5%) 
type 3 AIISs, with significant difference between AIIS types among age groups 
and genders (P<0.001). VD and DD showed age- and gender-related 
(P<0.001, P=0.001), and TA demonstrated gender-related differences 
(P=0.001). Inter-observer variability was good for TA and moderate to poor for 
other measurements. 
Conclusion: Type 1 AIIS is the most common shape across all age groups in 
adult females and in young and middle-aged adult males. TA, DD, and VD 
might be reliably used for the evaluation of AIIS morphology.  
B-1422 10:46  
Association between cam type femoroacetabular impingement and 
osteitis pubis on MR images  
A.S. Akgun, M. Agirman; Istanbul/TR (drayserap80@gmail.com)  
Purpose: Retrospectively to search whether there is an increase prevalance of 
osteitis pubis by MR imaging in patients with cam femoroacetabular 
impingement (FAI). 
Methods and Materials: The study included 178 subjects; 90 patients with 
cam-type FAI diagnosed by magnetic resonance imaging and 88 subjects used 
as a control group. Additionally their MR data were analyzed for the 
characteristics of osteitis pubis, with severity graded from minimal to severe (4-
point scale). 
Results: A statistically significant increase in the prevalence of osteitis pubis 
was found in patients with femoroacetabular impingement compared with age-
matched control subjects, with a prevalence of 45.6 % in the femoroacetabular 
impingement group compared with 5.7 % in the control group (p= 0,000). 
Conclusion: Femoroacetabular impingement results in restriction of internal 
rotation of the hip joint. This abnormal biomechanical stress lead to increased 
stresses at the pubis symphysis. 
Keywords: Femoroacetabular impingement, Alpha angle, Osteitis pubis.  
B-1423 10:54  
Gouty knee arthritis: ultrasound findings compared to dual-energy CT  
M.M.H. Abd Ellah1,2, S. Strobl1, S. Rauch1, E.J. Halpern3, C. Kremser1,  
W. Jaschke1, A. Klauser1; 1Innsbruck/AT, 2Assiut/EG, 3Philadelphia, PA/US 
(dr_m_hamdy2006@hotmail.com)  
Purpose: To describe and compare findings of ultrasound (US) and dual-
energy computed tomography (DECT) in patients with gouty knee arthritis. 
Methods and Materials: Sixty-five patients (52 males and 13 females, mean 
age 61.7 years) with gouty knee arthritis underwent DECT examination using 
128-multidetector CT scanner (Somatom Definition Flash, Siemens Healthcare, 
Forchheim, Germany) followed by US examination using a 5-18 MHz linear 
array transducer (Hitachi Aloka Medical, HI Vision Preirus, LTD, Tokyo). Both 
intra- and extra-articular findings of each modality were tabulated and the 
accuracy of imaging was compared to clinical diagnosis. 
Results: The overall diagnosis of gout was positive in 52/65 patients (80%) by 
DECT versus 33/65 patients (50.8%) by US (P=0.0016). Among positive 
exams, DECT demonstrated intra-articular gouty deposits in 43/52 patients 
(cartilage 51.9%, lateral meniscus 65.4% and medial meniscus 42.3%), while 
US demonstrated intra-articular deposits in 31/33 patients (double contour 
69.7%, tophi 51.5%, aggregates 27.3%), P=0.059. DECT demonstrated extra-
articular deposits in 44/52 patients (quadriceps tendon 48.1%, patellar tendon 
42.3%, lateral collateral ligament 15.4% and medial collateral ligament 23.1%), 
while US demonstrated extra-articular deposits in 11/33 patients (P<0.0001). 
Conclusion: Although DECT and US both can detect gouty deposits in the 
knee, DECT is more sensitive than US for detection of gouty deposits. 
However, US still has a role as a cost-effective and widely available imaging 
modality in gout diagnosis especially upon detection of certain findings as 
double contour.  
B-1424 11:02  
Influence of meniscus tears on cartilage T2 relaxation time in subjects 
with and without knee osteoarthritis  
R. Kijowski, K. Woo, F. Liu; Madison, WI/US (rkijowski@uwhealth.org)  
Purpose: To investigate the influence of meniscus tears on cartilage T2 
relaxation time in subjects with and without knee osteoarthritis. 
Methods and Materials: Cartilage T2 was measured in the medial and lateral 
compartments of the knee in 93 subjects with 87 medial and 27 lateral 
meniscus tears and in a control group of 30 subjects without meniscus tears. 
Radiographs were reviewed to determine the Kellgren-Lawrence (KL) grade of 
knee osteoarthritis. Linear regression models adjusted for age and gender 
were used to compare cartilage T2 between groups of subjects and between 
meniscus tear types (vertical, horizontal, complex, and root). 
Results: KL-0 (n=46), KL-1 (n=27), and KL-2 (n=20) subjects with meniscus 
tears had significantly higher (p<0.001) cartilage T2 within the medial 
compartment than KL-0 control subjects without meniscus tears (n=30). KL-1 
and KL-2 subjects with meniscus tears had significantly higher (p<0.01) 
cartilage T2 within the lateral compartment than KL-0 control subjects. KL-0 
subjects with medial meniscus tears (n=44) had significantly higher (p<0.001) 
cartilage T2 in the medial compartment than KL-0 control subjects. There was 
no significant difference (p=0.09-0.84) in cartilage T2 within the medial and 
lateral compartments between KL-0, KL-1, and KL-2 subjects with meniscus 
tears. Cartilage T2 in the same compartment as the meniscus tear was not 
significantly different (p=0.06-0.81) between tear types. 
  






Conclusion: Subjects with meniscus tears had significantly higher cartilage T2 
within the knee than subjects without meniscus tears controlling for age, 
gender, and KL grade which indicates that meniscus tears are an independent 
risk factor for cartilage degeneration.  
B-1425 11:10  
Subchondral bone/cartilage: a functional unit? Bone density and 
cartilage thickness are correlated  
P. Omoumi, H. Babel, B. Jolles, J. Favre; Lausanne/CH 
(patrick.omoumi@chuv.ch)  
Purpose: To test whether subchondral bone mineral density (sBMD) and 
cartilage thickness (CTh) of femoral condyles are correlated in knees without 
and with severe medial femorotibial osteoarthritis (OA), using a subregional 
analysis with CT arthrography. 
Methods and Materials: Knee CT arthrograms of 80 patients, divided into 
groups of non-OA (n=40,13males,61.4±6.2years) and severe medial OA 
(n=40,19males,64.2±10.8years) knees, were retrospectively analyzed. 
Cartilage and subchondral bone contours were segmented on a custom-
designed software, leading to 3D models on which each point of the articular 
surface is given a CTh and sBMD (average signal intensity over the most 
superficial 3mm of subchondral bone) value. 3D property maps were produced 
by calculating average values for the entire weight-bearing regions as well as 
standard subregions of interest. Multiple regression analyses were performed 
to test for relationships between sBMD and CTh (regional and subregional 
values, as well as medial-to-lateral ratios), with covariates of age, gender and 
femoral bone size in any of the groups and regions/subregions (alpha<5%) 
Results: For non-OA knees, sBMD medial-to-lateral ratios were significantly 
positively correlated with CTh medial-to-lateral ratios for the total regions 
(R2=0.23,p<0.01), the external (R2=0.35,p<0.01), and internal (R2=0.12,p<0.03) 
subregions. For OA knees, sBMD medial-to-lateral ratios were significantly 
negatively correlated with CTh ratios for all regions/subregions (all 
R20.33,p<0.01), except for the internal subregion (R2=0.08,p=0.08). 
Conclusion: The positive correlation between sBMD and CTh in non-OA 
knees, and the negative one in OA knees brings support to the theory of a 
subchondral bone/cartilage functional unit, which could help to better 
understand the pathophysiology of OA.  
B-1426 11:18  
Increased perfusion in subchondral bone marrow lesions in knee 
osteoarthritis measured with quantitative DCE-MRI  
B. De Vries, J. Verschueren, D. Poot, E. Oei, G.P. Krestin; Rotterdam/NL 
(b.devries@erasmusmc.nl)  
Purpose: Knee osteoarthritis (OA) on MRI is characterized by articular 
cartilage degeneration, synovial inflammation, and subchondral bone marrow 
lesions (BMLs). Altered blood perfusion in subchondral bone is also considered 
an important OA process which may be associated with altered fluid dynamics, 
inflammation, bone remodeling, and cartilage degeneration. Since it is 
unknown whether BMLs directly represent altered blood perfusion, our aim was 
to quantitatively analyze perfusion in subchondral BMLs with dynamic contrast-
enhanced MRI (DCE-MRI). 
Methods and Materials: 16 patients with unicompartmental knee OA were 
prospectively included. Multisequence MRI including DCE-MRI was performed 
at 3T (GE Discovery MR750) using an 8-channel knee coil. DCE-MRI was 
acquired using a sagittal fat-suppressed 3D SPGR sequence (35 phases of 10 
seconds) after intravenous contrast administration (0.2 mmol/kg gadopentetate 
dimeglumine, 2 ml/s). On fat-saturated T2-weighted images, regions-of-interest 
(ROIs) were defined in tibial or femoral subchondral bone containing BMLs and 
in surrounding subchondral bone without BMLs. Ktrans, a measure of capillary 
permeability, was calculated in each ROI. Mean Ktrans was mapped and 
compared between subchondral bone with and without BMLs using the 
Wilcoxon signed rank test. 
Results: Subchondral BMLs were present in all patients. Perfusion maps and 
analysis of Ktrans consistently showed significantly (p<0.001) higher Ktrans 
values within subchondral BML ROIs compared to surrounding subchondral 
bone without BMLs. 
Conclusion: Subchondral BMLs are associated with increased blood 
perfusion compared to subchondral bone regions without BMLs. This finding 
may aid in the understanding of OA pathogenesis and further research is 











B-1427 11:26  
Who runs further? Intra-articular Platelet Rich Plasma (PRP) vs 
Viscosupplementation (HA) and PRP in the treatment of knee 
osteoartrithis: six-months follow-up study using T2 mapping  
E. Cannizzaro, F. Bruno, S. Quarchioni, I. Capretti, S. Mariani, F. Arrigoni, 
L. Zugaro, A. Barile, C. Masciocchi; L'Aquila/IT (estercannizzaro@hotmail.it)  
Purpose: To evaluate clinical outcomes and the degree of knee cartilage 
repair using T2 mapping sequences in patients with knee condropathy treated 
with intrarticular injection of Platelet Rich Plasma (PRP) or combined 
Viscosupplementation (HA) and PRP. 
Methods and Materials: We analyzed 58 patients (33 males and 25 females; 
mean age 32,6±11,5 years) who underwent to intrarticular injection procedures 
in our center, with diagnosis of knee condropathy. All patients underwent to 
MRI (3T) and were evaluated before and after treatment (6 months) using 
images findings (WORMS score and T2 mapping values) and clinical outcomes 
(WOMAC index). All patients were randomly divided into two groups: Group A 
(29 patients) treated with PRP and Group B (29 patients) treated with PRP and 
HA. 
Results: Group A showed an improvement of WOMAC index of 40%; the 
WORMS score showed improvement with decrease of the mean values (from 
8,6 pre-treatment to 6,9 post-treatment). T2 mapping evaluation showed mean 
values of 46,7ms post-treatment (51,86 ms pre-treatment). Group B showed a 
clinical improvement of WOMAC index of 65%, with a decrease of WORMS 
score from 8,4 to 6,7. Mean T2 mapping values were 51,39 pre-treatment vs 
45,19 post-treatment . All results showed statistical significance (p< 0.005). 
Conclusion: Both treatments showed similar results in terms of morphological 
improvement as showed by T2 mapping evaluation. Combined therapy PRP 
and HA showed higher efficacy in terms of clinical improvement compared to 
PRP therapy.  
B-1428 11:34  
The patella-shape: is it relevant to the analysis of patella malalignment?  
A. Kolb, C. Chiari, R. Windhager; Vienna/AT 
(alexander.kolb@meduniwien.ac.at)  
Purpose: The tibial-tubercle-trochlear-groove-distance (TT-TG) is an 
established risk factor for patellar instability. However, it was criticised that TT-
TG-measurements might be increased due to trochlear dysplasia despite a 
normal tibial tubercle position. To avoid this problem, the tibial-tubercle-
posterior-cruciate-ligament-distance (TT-PCL) was suggested. Our study 
aimed to analyse, whether the patella shape represented as patellar-ridge-
offset (PRO), is suitable to correct the TT-TG-distance in cases of trochlear 
dysplasia. 
Methods and Materials: A retrospective analysis of 20 routine MRIs of 
patients with mixed patellar shapes and history of patellar instability was 
performed (mean age 24yrs). The PRO was defined as distance between the 
patellar-ridge and the patella-midpoint parallel to the inclined patella, measured 
on axial MRI slices. In contrast to the TT-TG-distance the combined PRO-TT-
TG-distance gives information on the position of the knee extensor complex 
relative to the tibial tubercle. 
Results: Mean RPO was 4.0mm (STD=2.00; range -1.5 to 7.6mm). TT-TG 
showed a very strong correlation to TT-PCL and PRO-TT-TG (p=<0.001; r= 
0.847 and r=0.915); TT-PCL and PRO-TT-TG showed a strong correlation 
(p=<0.001; r=0.777). PRO showed no significant correlation to the difference 
between TT-TG and TT-PCL (p= 0.801; r=-0.062. In cases with PRO above 
6mm, trochlear angle tends to be decreased (not significant, p=0.174). 
Conclusion: The PRO is a promising parameter to adjust the TT-TG-distance 
to different trochlear and patellar shapes. Interestingly the effect of PRO is not 
correlated to the difference between TT-TG and TT-PCL, suggesting that TT-
PCL is not only independent from trochlear dysplasia, but moreover influenced 
by other factors.  
B-1429 11:42  
The association of patellar maltracking with infrapatellar fat pad oedema 
and chondromalacia patella: a quantitative morphologic MRI analysis  
M. Gursoy1, B. Dirim Mete1, Y.K. Cetinoglu1, O. Oyar1, N. Erdogan1, M. Uluc1, 
T. Bulut1, G. Safa2; 1Izmir/TR, 2Ankara/TR (kenancetinoglu@hotmail.com)  
Purpose: Oedema in the superolateral portion of infrapatellar fat pad and 
chondromalacia patella (CP) could be related to impingement of fat between 
the patellar tendon or lateral patellar facet and the lateral femoral condyle. Due 
to the lack of extensive literature on the association of patellar maltracking with 
infrapatellar fat pad oedema, the evidence supporting this view remains 
suspicious. The aim of this study is to investigate the relationship of 
patellofemoral joint morphology with infrapatellar fat pad oedema and CP using 
patellar maltracking parameters on MRI. 
Methods and Materials: Fifty patients with oedema in the superolateral 
portion of the infrapatellar fat pad (the study group) and control group (50 
patients) with a normal infrapatellar fat pad were identified on MRI to compare 
with regard to five patellar maltracking parameters retrospectively. These 
  






parameters were trochlear depth, the trochlear sulcus angle (TSA), patellar 
translation, the lateral patellofemoral angle (PFA) and the Insall-Salvati ratio. 
The relationship between patellar maltracking and the CP was also evaluated 
using the same parameters. 
Results: In the study group the Insall-Salvati index and TSA were significantly 
high (p=0.001), the trochlear depth and PFA were low (p=0.001, p=0.01), while 
patellar translation showed no difference (p=0.957). In the CP group the Insall-
Salvati index and TSA were significantly high (p=0.001), the trochlear depth 
was low (p=0.001). No statistically significant difference was found in PFA and 
patellar translation (p=0.292, p=0.446). 
Conclusion: Oedema in the superolateral portion of infrapatellar fat pad and 
CP are associated with patellar maltracking.  
B-1430 11:50  
3D-printed models of the knee for evaluation of trochlear dysplasia in 
comparison to standard radiographs and computed tomography  
B. Fritz1, S. Fucentese1, S. Zimmermann1, P.M. Tscholl2, R. Sutter1, 
C.W. Pfirrmann1; 1Zurich/CH, 2Geneva/CH (benjamin.fritz@gmx.net)  
Purpose: To test the hypothesis that 3D-printed specimens improve diagnosis 
of trochlear dysplasia and Dejour´s classification in comparison to radiographs 
and computed tomography (Rx/CT). 
Methods and Materials: This retrospective study was approved by the local 
ethics committee. 50 patients were included. 3D-models of the distal femur 
were printed after segmentation of CT-datasets. An expert panel consisting of 
a senior musculoskeletal radiologist and a senior knee surgeon classified the 
knees into normal or Dejour grade A-D, which served as the standard of 
reference. Therefore, the experts reviewed radiographs, CT, the 3D-specimens 
and patients’ clinical history. The 3D-specimens and Rx/CT were evaluated by 
two readers independently and separately at the interval of 3 weeks for 
trochlear dysplasia and Dejour A-D. Statistics included general descriptive 
statistics, ROC-analysis and inter-reader reliability. 
Results: The expert panel diagnosed a trochlear dysplasia in 28/50 patients. 
In comparison to the panel’s diagnoses, the diagnostic accuracy for the 
presence/absence of trochlear dysplasia after evaluation of 3D-specimens and 
Rx/CT was for reader1 0.937 and 0.823 (p=0.029) and for reader2 0.982 and 
0.946 (p=0.147). Inter-reader reliability was excellent for 3D-specimens and 
substantial for Rx/CT (Kappa: 0.920 and 0.788). For Dejour-classification, the 
proportion of exact matches for 3D- and Rx/CT-analysis were for reader1 36% 
and 59% and for reader2 48% and 52%. Inter-reader reliability was poor for 
3D-specimens and fair for Rx/CT (Kappa: 0.148 and 0.368). 
Conclusion: 3D-models can improve detection of trochlear dysplasia in 
comparison to radiographs and CT, whereas no additional value for grading 
into Dejour A-D could be demonstrated.  
10:30 - 12:00 Room G  
Physics in Medical Imaging  
SS 1813  
Developments in volumetric imaging  
Moderators:  
K.N. Bolstad; Bergen/NO 
N.N.  
B-1431 10:30  
Task-based radiation dose assessment for paediatric dental CBCT 
imaging  
A. Stratis, G. Zhang, R. Jacobs, R. Bogaerts, H. Bosmans; Leuven/BE 
(andreas.stratis@uzleuven.be)  
Purpose: to calculate organ doses, effective dose-ED and LAR-incidence 
(cases/100,000 persons) for paediatric patients undergoing the most frequently 
applied dental-cone-beam-CT (CBCT) protocols in 5 scanners via Monte Carlo 
(MC) simulations. 
Methods and Materials: An EGSnrc-MC framework and an in-house-built 
voxel-model-database (8 male and 10 female paediatric heads, 3 to 14 y.o) 
were employed. The MC-framework was customized and validated for Promax-
3D-Max (Planmeca, FI), NewTom VGi-evo and NewTom 5G (QR srl, IT), 
CS9300 (Carestream, USA) and Accuitomo 170 (Morita, JP) scanners. Organ 
doses were assessed for single-tooth, upper/lower-jaw, cleft, maxillofacial 
complex, sinus, face and skull imaging by simulating the respective scanner-
specific and age-dependent FOVs-protocols. 
Results: Females were slightly more radiosensitive in all cases (3% to 5% 
depending on the protocol), with organ-dose and radiation-risk increasing with 
decreasing age-at-exposure. The lowest risk protocol was for central-incisor-
tooth imaging (14 y.o male, ED=13µSv, LAR=0.29) whereas the highest one 
was for skull imaging (5 y.o female, ED=323µSv, LAR=13.8). Salivary glands 
and oral mucosa were the highest irradiated organs in all cases, followed by 
the Extra-thoracic-tissue (ET) in protocols where the entire nasal cavity was 
inside the primary field. The dose to thyroid was considerably high for young 
patients (max=1.1 mGy-5y.o-female-skull-protocol). The lowest doses were 
observed in scanners with tube-current-modulation and added-Cu-filtration. 
Conclusion: Thyroid-lead-aprons are recommended for young patients. Small 
FOV-scans reach the dose levels of conventional panoramic acquisitions. The 
unavailability of manual collimation results in dose increase, especially for 
young patients, as the preset FOVs can extend the radiation field beyond the 
clinical volume of interest.  
B-1432 10:38  
Sliding organ motion regularisation for motion-compensated cone-beam 
CT (CBCT) in image-guided radiation therapy (IGRT)  
S. Sauppe1, J. Kuhm1, M. Brehm2, P. Paysan2, D. Seghers2, M. Kachelrieß1; 
1
Heidelberg/DE, 2Baden-Dättwil/CH (marc.kachelriess@dkfz.de)  
Purpose: To improve the accuracy of motion estimation and motion 
compensation in CBCT of the thorax. 
Methods and Materials: Respiratory-gated images minimize the motion 
artefacts, but yield severe sparseness artefacts. We propose a 4D motion-
compensation (MoCo) algorithm with an enhanced underlying motion model 
that handles sliding organ motion. Our MoCo removes both motion artefacts 
and sparse view artefacts and ensures 100% data usage [MedPhys 
40(10):101913,2013]. Image quality depends on the underlying motion model. 
Due to strong streak artefacts, regularization of the motion vector fields (MVFs) 
during motion estimation for continuity is necessary. Our guided regularization 
filter inputs a bone and lung segmentation. The algorithm handles sliding organ 
motion such as it occurs between the diaphragm and the lung wall. The filter 
passes motion perpendicular to the sliding organ boundary. We thus prevent 
non-physiological motion of the rib cage. For validation, we use an artificially 
deformed clinical CT scan and patient data acquired with a TrueBeam™ 4D 
CBCT system (Varian Medical Systems). 
Results: Our guided regularization filter yields realistic high-fidelity thorax 
MVFs. Hereby, we can reconstruct 4D respiratory motion-compensated 
images, almost free of motion artefacts. Moreover, our proposed sliding organ 
motion model prevents unphysiological bone motion in motion-compensated 
images. We significantly improve spatial resolution and noise level by our 4D 
MoCo approach, preserving high temporal resolution for respiratory motion. 
Conclusion: Our patient data demonstrate that good image quality is 
achievable at identical x-ray dose levels and at acquisition times as for today’s 
3D CBCT. Lung tumour treatments may benefit from our motion-compensated 
images.  
B-1433 10:46  
Material-guided scatter correction in cone-beam-computed tomography 
using spectroscopic information  
C. Egan, P. Scott, N. Loxley; Sedgefield/UK (c.egan@ibexinnovations.co.uk)  
Purpose: Scatter is a major problem in cone-beam-computed tomography 
(CBCT), causing reconstruction artefacts and reduced contrast. A material-
guided scatter correction algorithm is introduced using spectral information 
generated from pixel-wise attenuation modulation of the x-ray beam. 
Methods and Materials: A metal plate which is designed to cause a pixel-wise 
attenuation modulation of the x-ray beam is placed directly in front of a flat 
panel detector in a CBCT system. This modulation yields spectroscopic 
information, which is decomposed to give thickness and composition 
information about the sample. These data used to predict scatter using a 
Monte Carlo model, which is subtracted from the x-ray image. The material 
information is updated based upon this new scatter-corrected image. An 
iterative procedure then operates to converge to a solution where the scatter 
estimate and materials estimate no longer changes, leaving the final scatter-
corrected image. This procedure is applied to every projection in a CBCT 
dataset which can be reconstructed using conventional algorithms. 
Results: Applying the material-guided scatter correction algorithm to a water 
phantom removes the cupping artefact leaving a flat cross-sectional profile and 
at the same time improves mean contrast by 18%. Other phantom and cadaver 
samples have been processed, again showing reduced artefacts and 
enhanced contrast. 
Conclusion: The material-guided scatter correction algorithm can accurately 
predict and correct scatter yielding superior quality images without the use of 
anti-scatter grids and no impact on dose.  
Author Disclosures: 
  C. Egan: Employee; IBEX Innovations Ltd. P. Scott: Employee; IBEX 















B-1434 10:54  
Moving metal artifact reduction (MMAR) for cone-beam CT (CBCT) scans 
of the thorax region  
A. Hahn, S. Sauppe, M. Knaup, M. Kachelrieß; Heidelberg/DE 
(andreas.hahn@dkfz.de)  
Purpose: Established metal artifact reduction (MAR) methods are insufficient 
in cone-beam CT (CBCT) scans with moving metal implants such as fiducial 
gold markers. A method for moving metal artifact reduction (MMAR) is 
introduced. 
Methods and Materials: Standard inpainting-based MAR methods do not 
account for respiratory patient motion and fail in cases with strong metal 
motion. MMAR resolves this issue by applying a motion compensation (MoCo) 
algorithm [MedPhys 40(10):101913, 2013]. This results in a 4D volume without 
motion blurring but with metal artifacts. They are corrected using a normalized 
MAR (NMAR) [Med Phys. 2010 Oct;37(10):5482-93]. A simulation was created 
by adding 5 analytical cylindrical gold markers of different sizes to a thorax 
scan that was acquired using a TrueBeam™ 4D CBCT system (Varian Medical 
Systems). Realistic deformation vector fields of different magnitudes were 
applied to simulate cases of different motion. The proposed algorithm was 
compared to standard linear interpolation MAR and was applied to CBCT data 
of a patient with metal markers. 
Results: Using the MMAR algorithm, a 4D volume with a high temporal 
resolution is reconstructed. Remaining metal artifacts are almost completely 
removed in the 4D volume for all motion magnitudes. Simple MAR was able to 
reduce artifacts in cases of small motion but failed for large motion. 
Conclusion: MMAR is able to properly account for motion of moving metal 
markers and is able to remove metal artifacts where classical linear 
interpolation MAR fails. The advantage of MMAR compared to MAR increases 
for larger motion.  
B-1435 11:02  
Focal spot blur correction for cone-beam CT (CBCT)  
N.K. Waltrich, S. Sawall, M. Kachelrieß; Heidelberg/DE 
(nadine.waltrich@dkfz.de)  
Purpose: To correct for the spatial resolution mismatch caused by anode 
angulation in CBCT. 
Methods and Materials: The combination of anode angulation and large fan 
and cone angles causes a position-dependent focal spot blur in CBCT data. 
This results in a variation of spatial resolution along the u- and v-direction of 
the flat detector and a resolution mismatch within the reconstructed volume. To 
assess the spatial resolution, a metal edge was measured at different u-v-
positions close to the focal spot. The full width at half maximum of the line 
spread function is measured for each u-v-position and inter- and extrapolated 
to be available for each detector position. A projection-domain deconvolution 
iteratively achieves a user-prescribed (e.g. uniform) spatial resolution across 
the whole detector. Noise is reduced using a bilateral filter in the image domain 
with a position-dependent domain filter shape. The proposed method is 
validated using data from a line pattern phantom, an anthropomorphic head 
phantom, and patient measurements acquired with a CBCT system in short 
scan mode. This scan mode results in images with higher spatial resolution on 
the right side compared to the left side. 
Results: On the right side, five iterations of the deconvolution algorithm 
increase the line pattern contrast from 198 HU to 442 HU. On the left side, 460 
HU is measured before and after blur correction. This indicates a nearly 
complete spatial resolution restoration. The findings were confirmed in patient 
measurements. 
Conclusion: The proposed method results in a homogeneous resolution 
throughout the complete volume.  
B-1436 11:10  
Spectroscopic cone-beam-computed tomography using pixel-wise 
attenuation modulation  
C. Egan, P. Scott, N. Loxley; Sedgefield/UK (c.egan@ibexinnovations.co.uk)  
Purpose: Quantitative information can be extracted from dual-energy-
computed tomography (DECT) such as precise electron densities and effective 
atomic numbers, which can be used for accurate dose planning in 
radiotherapy, for example. DECT is normally implemented either using dual-
source scanners or via rapid kV switching. Here we introduce a technique for 
obtaining spectroscopic information from a CBCT system using pixel-wise 
attenuation modulation of the x-ray beam, without the need for kV switching or 
dual sources. 
Methods and Materials: A metal plate which is designed to cause a pixel-wise 
attenuation modulation of the x-ray beam is placed directly in front of a flat 
panel detector in a CBCT system. The differential attenuation of the x-ray 
beam over a group of pixels yields spectroscopic information, which can be 
decomposed to give quantitative composition information about the sample. 
This data is then run through a standard iterative reconstruction algorithm. The 
reconstructed materials information is examined in 2D scatter plots, similar to 
standard DECT systems. 
Results: A quantitative phantom containing tissue equivalent material inserts 
was scanned to yield 2D scatter plots in a materials space. Data in this space 
are classified using a Mahalanobis distance measure. The accuracy of this 
approach is quantified, and, compared to the literature values from standard 
DECT systems, yields analogous results. 
Conclusion: Spectroscopic information can be extracted from a CBCT system 
without the need for kV switching or multiple sources, yielding comparable 
results to standard DECT systems.  
Author Disclosures: 
  C. Egan: Employee; IBEX Innovations Ltd. P. Scott: Employee; IBEX 
Innovations Ltd. N. Loxley: CEO; IBEX Innovations Ltd. 
B-1437 11:18  
Stack transition motion compensation in sequential and in cardiac CT  
S. Lebedev1,2, K. Stierstorfer2, M. Kachelrieß1; 1Heidelberg/DE, 2Forchheim/DE 
(marc.kachelriess@dkfz.de)  
Purpose: Sequential CT scans and cardiac CT scans result in image stacks 
whose overlapping regions may be inconsistent due to patient motion. We thus 
propose a motion compensation method for stack transition artefact removal 
(STAR). 
Methods and Materials: To estimate stack-to-stack patient motion, STAR 
uses a novel symmetric deformable image registration algorithm to register 
stack overlap regions of adjacent stacks. The registration algorithm scans the 
surroundings of control points situated within stack overlaps for matching sub-
volume pairs and finds the pair that maximizes a similarity metric. The optimal 
displacement for a control point yields the deformation vector at the respective 
position. To get a densely sampled motion vector field (MVF), a trilinear 
interpolation between the control points is performed within the transition 
areas. The MVFs are then extrapolated across the whole stack to minimise 
distortions. Cardiac CT patient data from a Somatom Definition Flash and a 
Somatom Definition Edge CT system (Siemens Healthineers, Forchheim, 
Germany) were used to validate the STAR algorithm. 
Results: STAR is able to reduce the stacks transition artefacts and 
displace/deform structures in a size range of multiple millimetres and make 
small adjustments in the millimetre range. In all cases, the images become 
sharper and the information in the stack transition regions becomes consistent 
between adjacent stacks. The coronary arteries are much better defined even 
in cases with strong stack-to-stack patient motion. 
Conclusion: Artefacts at stack transitions due to irregular motion can be 
addressed using symmetric registration. STAR was able to considerably 
improve image quality.  
Author Disclosures: 
  S. Lebedev: Employee; Siemens Healthcare GmbH. K. Stierstorfer: 
Employee; Siemens Healthcare GmbH.  
B-1438 11:26  
First evaluation of new photon counting CT technology  
J. Da Silva, M. Yveborg, F. Grönberg, M. Sjölin, S. Holmin, J. Lundberg, 
M. Danielsson; Stockholm/SE (jds@kth.se)  
Purpose: We are developing a new photon-counting edge-on silicon detector 
with 0.2x0.3 mm2 detector elements at the isocenter and 8 energy bins for 
clinical CT applications. The purpose of this work is to present the first images 
using our detector technology, and show significantly improved spectral and 
spatial resolution compared to current state-of-the-art. In addition, we 
demonstrate the feasibility of projection based three-material basis 
decomposition based on the novel technology. 
Methods and Materials: For this work, several objects were imaged using a 
spectrally resolved silicon detector. The reconstructed CT images were 
compared to images using current state-of-the art CT scanners at the 
Karolinska University hospital. Specifically, we compared spatial resolution, 
artefact visibility and identification of iodine. In addition, we performed 
projection based three-material basis decomposition using recent 
developments in forward model calibration. 
Results: The results demonstrate improved spatial and spectral resolution, 
compared to current state-of-the-art. Specifically, we demonstrate improved 
visibility of small details, decreased visibility of artefacts and improved 
identification of iodine. In addition, reconstructed un-biased iodine basis 
images are presented. 
Conclusion: Several objects have successfully been imaged using a novel 
spectrally resolved photon counting silicon detector with sub-millimetre 
resolution. Compared to current state-of-the-art, reconstructed CT images 
demonstrate a potential improvement for clinical CT applications by improved 
spectral and spatial resolution.  
Author Disclosures: 
  J. Da Silva: Other; Finanical interests Prismatic Sensors AB. M. Yveborg: 
Shareholder; Prismatic Sensors AB. F. Grönberg: Shareholder; Prismatic 
Sensors AB. M. Sjölin: Shareholder; Prismatic Sensors AB. S. Holmin: Other; 
  






Medical advisor for Prismatic Sensors AB. J. Lundberg: Other; Financial 
Interest, Smartwise AB. M. Danielsson: Other; Stockholder, Prismatic Sensors 
AB President, Prismatic Sensors AB Stockholder, Innovicum AB President, 
Innovicum AB Stockholder, Biovica International AB Board Member, Biovica 
International AB Researc. 
B-1439 11:34  
Phase-contrast monochromatic breast-CT: a feasibility study  
R. Longo1, M.A. Cova1, P. Delogu2, B. Golosio3, G. Mettivier4, A. Taibi5, 
M. Tonutti1, G. Tromba1, F. Zanconati1; 1Trieste/IT, 2Siena/IT, 3Cagliari/IT, 
4
Naples/IT, 5Ferrara/IT (renata.longo@ts.infn.it)  
Purpose: To develop methods and the facility to perform the first study in 
phase-contrast (PhC) breast computed tomography (breast-CT) exploiting the 
monochromatic beam available at the Elettra synchrotron radiation (SR) 
laboratory. 
Methods and Materials: Images of test objects and large breast specimens 
were acquired at the SR facility used for the first clinical study of PhC 
mammography and up-dated for breast-CT. The CdTe detector was a state-of-
the-art dead-time-free single-photon-counting with a 60 µm pixel size. The 
monochromatic x-ray beam was set in the energy range 32-38 keV and the 
delivered mean glandular dose (MGD) was in the range 5-20 mGy. Since the 
SR provides high energy resolution and spatial coherence, the free-
propagation PhC imaging technique was used and the phase-retrieval 
algorithm was applied on the projections before the image reconstruction. 
Contrast-to-noise ratio (CNR) and resolution performances were evaluated for 
both absorption and phase-retrieved images by considering fat and glandular 
tissue. 
Results: The phase-retrieval approach resulted in a remarkable CNR increase 
with respect to the absorption image (from 0.5 to 3.5), while the resolution loss 
is significantly lower than the one obtained by applying common de-noising 
filters. Furthermore, the full volume reconstructions of a breast lumpectomy 
(about 9 cm diameter and 3 cm thickness) are presented (MGD about 5 mGy). 
Conclusion: This investigation indicates that PhC monochromatic breast-CT, 
evaluated so far in terms of CNR, spatial resolution and scan volume, is 
feasible.  
B-1440 11:42  
Digital breast tomosynthesis: flat panel and photon counting detectors 
comparison  
A. Loria1, P. Signorotto1, M. Campoleoni1, N. Paruccini2, R. Villa2, E. Venturini1, 
P. Panizza1, A. del Vecchio1; 1Milan/IT, 2Monza/IT (loria.alessandro@hsr.it)  
Purpose: In this study three digital breast tomosynthesis (DBT) devices 
equipped with different flat panel detectors (FPD) and a prototype equipped 
with a scan-spectral photon counting detector (PCD) are compared. The aim is 
to evaluate if a PCD device can guarantee comparable or even better image 
quality (IQ) delivering lower radiation doses than FPD devices. 
Methods and Materials: Image quality performances were evaluated exposing 
two IQ DBT phantoms, Tomophan and Agatha, the CDMAM phantom and a 
homemade phantom for low-contrast detectability (LCD). Exposures were 
performed in automatic exposure control mode. Images with the lowest 
achievable post-processing were analysed. Geometric distortion, signal-
difference-to-noise ratio (SDNR), LCD, in-plane resolution as modulation 
transfer function (MTF) in scan and sub-scan directions, slice-sensitivity profile 
(SSP), noise power spectrum (NPS) and artefact spread function (ASF) were 
evaluated. 
Results: Geometric distortion, SDNR and NPS resulted comparable. PCD 
device showed the best LCD. In-plane resolution was higher for PCD device: 
FPD devices exhibit a reduction in MTF0.1 between 38% and 62%, both in scan 
and sub-scan direction. SSP showed comparable results for PCD and one of 
the FPD devices, while it was up to 60% worse for the others. PCD device had 
the worst ASF. Delivered dose with PCD device was 50% lower than doses 
delivered with FPD devices. 
Conclusion: PCD device ensures a comparable or even better IQ than FPD 
devices, especially for spatial resolution and detectability of low-contrast 
objects, delivering much lower radiation dose. Photon counting seems to be 
really an impressive approach to DBT.  
B-1441 11:50  
Digital breast tomosynthesis index (DBTI): a score to evaluate digital 
breast tomosynthesis (DBT) device performance  
A. Loria, P. Signorotto, E. Venturini, P. Panizza, A. del Vecchio; Milan/IT 
(loria.alessandro@hsr.it)  
Purpose: The aim of this study is to combine image quality (IQ) and dosimetric 
parameters into a score to evaluate the goodness of a digital breast 
tomosynthesis (DBT) device. 
Methods and Materials: Digital Breast Tomosynthesis Index (DBTI) is derived 
from two figure of merit (FoM) introduced to evaluate CT devices (Rose and 
ImPACT). These FoMs include parameters as contrast-to-noise ratio (CNR), 
spatial resolution in terms of modulation transfer function (MTF), slice thickness 
and a dosimetric quantity (CTDI). In the same way, DBTI is designed to be 
dependent on signal-difference-to-noise ratio (SDNR), MTF, slice-sensitivity 
profile (SSP) and average glandular dose (AGD). IQ parameters were 
measured using the Tomophan phantom. SDNR was evaluated with the 0.2-
mm-thick aluminum insert. MTF was calculated for scan and sub-scan 
directions from the point spread function of the 0.18mm tungsten bead. SSP 
evaluation was performed with the two reversing angled bead ramps method. 
These parameters were evaluated for two different DBT devices at seven 
different values of AGD, obtained manually setting the tube current time 
product. 
Results: Each DBT device showed a characteristic value of DBTI. These 
values were constant as the tube current time product changes, with a 
standard deviation of 2% and 6% for the two devices. 
Conclusion: Independence of DBTI from exposure parameters could make it a 
good FoM to benchmark DBT devices. Compared to CT, DBT have less clinical 
questions, so a single score could provide a reliable estimation of the 
goodness of the DBT device.  
10:30 - 12:00 Room K  
Radiographers  
SS 1814  
Quality improvement in radiography  
Moderators:  
J. Grehan; Dublin/IE 
N.N.  
B-1442 10:30  
Does the post-processing annotation of images become a standard 
practice in digital radiography today?  
E. Saukko1, M. Wirtanen2, K. Kortelainen2; 1Turku/FI, 2Helsinki/FI 
(ekaterina.saukko@tyks.fi)  
Purpose: Digital radiography allows post-processing annotation of mages, 
which enables radiographers to apply markers electronically onto images post-
exposure. This advancement has led to a decrease in use of lead anatomical 
side markers (ASMs), although the best practice has always been to place 
markers within primary beam. The aim of this study was to assess the 
radiographers' perception on the use of lead ASMs in Finland. 
Methods and Materials: A self-designed questionnaire was sent in April 2017 
to all members of the Society of Radiographers in Finland using the society's e-
mail list (n=1696). In total, 278 responses were received. 
Results: Among all respondents, only 32% reports that there were guidelines 
for lead ASMs use in their radiological department. About 88% of 
radiographers stated that lead ASMs were sufficiently available in the x-ray 
rooms and 18% had personal markers. The preference of ASMs use within 
primary beam over the post-processing annotation varied depending on the 
type of anatomy examined. Radiographers prefer using ASMs pre-exposure in 
radiographs demonstrating both sides of unilateral anatomy (72%, n=199), 
while in examinations performed outside the imaging departments the lead 
ASMs use was very scarce (21%, n=57). Longer work experience was 
associated with increased lead ASMs use in radiography of the skull and face 
(p=0.004), chest (p=0.006), bones and joints (p=0.021), spine (p=0.002) and in 
radiographs showing both sides of unilateral anatomy (p=0.019). 
Conclusion: Overall, the use of ASMs post-exposure is predominated among 
radiographers. Written protocols, regular audits of practice and continuous staff 
education are recommended.  
B-1443 10:38  
Implementation of DR detectors for paediatric chest x-ray in NICU  
D. Pekarovic, U. Zdesar, P.A. Jesih, M. Pungr0ar; Ljubljana/SI 
(dean.pekarovic@kclj.si)  
Purpose: Development of exposure charts when changing image detectors 
from imagining plates (CR) to digital detectors (DR). 
Methods and Materials: After commissioning of a new mobile DR system in 
NICU, a group of radiographers, radiologist and medical physicist were 
established to optimise exposure technique. Patients were divided into seven 
age groups from neonates to the age of 18. Anode voltage (kV) and exposure 
(mAs) were changed in small steps from the factory settings and radiologist 
was consulted about image quality. Exposure index (EI) was used as a 
measure of detector exposure and dose area product (DAP) as a measure of 
patient exposure. As the last step, the DAP values for each group was 
compared to proposed EU diagnostic reference levels (PiDRL-paediatric dose 
reference levels). During the process, the gaps in knowledge regarding DR 
systems were identified and training curriculum for radiographers was 
prepared. 
  






Results: A target exposure index (TEI) of 300 was set and radiographers were 
instructed to follow deviation index (DI). Data from 1816 patients were 
analysed in the period of 11 months. Average DI was 0.35 being largest (0.8) 
at the youngest age group (0-7 days). 5.8% of patients had DI larger than ±3 
(1.6% underexposed and 4.2% overexposed). Measured DAP were compared 
to diagnostic reference levels PiDRL. Third quartile DAP values for all groups 
were far below PiDRLs. 
Conclusion: Introduction of new imaging equipment in radiology department 
often requires adoption of new exposure techniques required for optimised 
imaging. Technique changes should be followed by additional training of 
radiographers operating the equipment. 
B-1444 10:46  
Practitioner variability in collimation and centring for AP shoulder 
projections  
D. Browne1, K. Szczepura2, A. England1; 1Manchester/UK, 2M6 6PU/UK 
(A.England@salford.ac.uk)  
Purpose: Radiographic positioning textbooks recommend AP shoulder 
projections using either a square- or diamond-shaped radiation field. 
Recommendations reflect the likely differences in radiation dose to breast 
tissue but this is unproven. Within these texts there are also variations in the 
centring points proposed. The aim of this study was to assess differences in 
collimation field and centring point, and their effect on breast dose and image 
quality (IQ). 
Methods and Materials: Six volunteers were invited to position and expose a 
PIXY phantom for an AP shoulder projection using both square- and diamond-
shaped field. Entrance surface doses (ESD) were measured at four locations 
around a simulated breast to determine which scenario delivered the lowest 
overall ESD. 
Results: Study findings demonstrated that switching from a square to a 
diamond X-ray field shape increased (24.5%) the total ESD to the breast (55.1 
mGy vs 72.9 mGy; P<0.0001). Positional accuracy results (IQ) indicated that 
practitioners can use either field shape accurately (P>0.05). Evaluation of 
centring points suggests that practitioners showed a tendency to centre more 
medially and inferiorly when compared to textbooks. 
Conclusion: Evidence from this study suggests that the absorbed dose to the 
breast could increase by moving from a square field to a diamond shape. Both 
techniques can be performed with similar accuracy and centring points used by 
participants did differ slightly from positioning texts. Findings from this pilot 
study warrant further investigation.  
B-1445 10:54  
Study of scattered radiation during fluoroscopy in hip surgery  
O. Lesyuk1, L.P. Ribeiro2, A.F. Abrantes2, P. Sousa2, S. Rodrigues2, 
R.P. Almeida2, K.B. Azevedo2, J.P. Pinheiro2; 1São Brás de Alportel/PT, 
2
Faro/PT (oksanalesyuk@gmail.com)  
Purpose: To measure the scattered radiation dose at different positions 
simulating hip surgery. 
Methods and Materials: We simulated fluoroscopy-assisted hip surgery in 
order to study the distribution of scattered radiation in the operating room. To 
simulate the patient, we used an anthropomorphic whole-body phantom and a 
X-ray-specific detector to quantify the scattered radiation. Radiographs were 
obtained with a mobile C-arm X-ray system in continuous scan mode, with the 
tube at 0° (configuration 1) or 90° (configuration 2). The operating parameters 
employed (voltage, current, and exposure time) were determined by a 
statistical analysis based on the observation of orthopedic surgical procedures 
involving the hip. 
Results: For all measurements, higher exposures were observed in 
configuration 2. In the measurements obtained as a function of height, the 
maximum dose rates observed were 1.167 (± 0.023) µ Sv/s and 2.278 (± 
0.023) µ Sv/s in configurations 1 and 2, respectively, corresponding to the 
chest level of health care professionals within the operating room. Near to the 
patient, the maximum values were recorded in the position occupied by the 
surgeon. 
Conclusion: We can conclude that, in the scenario under study, health care 
professionals workers are exposed to low levels of radiation, and that those 
levels can be reduced through the use of personal protective equipment.  
B-1446 11:02  
An investigation of the impact of image viewing parameter settings on 
the performance of 2.4 MP colour monitor in visualising low contrast 
detail using the CDRAD phantom  
S.H. Al-Murshedi, P.H. Hogg, M.M. Benhalim, M. Alrowily, A. England; 
Manchester/UK (p.hogg@salford.ac.uk)  
Purpose: To investigate the relation between the observer performance for 
low contrast details detection and the image viewing settings (magnification, 
window setting) for a wide range of image quality on 2.4 MP colour monitor 
Methods and Materials: Six images of CDRAD phantom were generated, 
using adults chest radiography protocols with different image quality. Five 
observers evaluated the images on 2.4 MP colour monitor. The images were 
assessed in four different ways: firstly, the observers were not free in adjusting 
the contrast, intensity, and magnification of the image; secondly, only the 
magnification was allowed to be adjusted; thirdly, only the contrast and 
intensity were allowed to be adjusted; finally, the observers were free to adjust 
the contrast, intensity and magnification of the image 
Results: Data analysis was conducted via repeated measures of variance 
(ANOVA). For the images with high quality, using magnification only has no 
significant difference on improvement of image scoring p=0.10, whereas 
significant difference was noted between employing windowing solely and 
using both windowing and magnification with p=0.03 and p=0.00 respectively. 
Furthermore, it was found image viewing manipulation has negative influence 
on image scoring for the ones characterised by low quality 
Conclusion: The study demonstrates that adopting both magnification and 
windowing is of a significant impact on improving image scoring; employing 
windowing solely has the second highest impact. Hence, this study 
recommends the utilisation of image viewing manipulation only with the images 
that are of high image quality, while it should be avoided with the images that 
are of low quality  
B-1447 11:10  
The optimised location to assist patient during imaging of scoliosis with 
EOS system device  
H.M.S. Laitinen, H. Niiniviita, E. Saukko, E. Svedström; Turku/FI 
(helena.laitinen@edu.turkuamk.fi)  
Purpose: With challenging scoliosis patients, it is occasionally necessary to 
assist patient in the examination room during exposure for patient safety and 
preventing movement. EOS system is a slot-scanning technique specialised to 
orthopaedic imaging, especially scoliosis. Finland’s first EOS system 
installation was made at Turku University Hospital in 2017. The aim of this 
study was to measure scattered radiation during imaging of scoliosis with this 
new technique and thereby find the optimized place for the assistance. 
Methods and Materials: An anthropomorphic phantom was set at the 
isocenter and scanned using standard scoliosis protocol, with both AP and LAT 
views. The scattered dose rates were measured at seven points from one 
meter above the floor level with ion chamber survey meter. At three points 
measurements were made also with lead shields. For reliability and 
repeatability measurements were repeated three times and average dose rates 
were calculated. 
Results: The dose rate at the closest point (45 cm from isocentre) was 10.5 
mSv/h, but lead apron reduced the dose significantly to 263 µSv/h. At the most 
distant point (175 cm from isocentre) the dose was 0.73 mSv/h and with lead 
shield 8.0 µSv/h. There was more scattered radiation on the lateral side than 
the AP/PA side. 
Conclusion: Assistant should wear lead apron if holding the patient is 
necessary. If only presence in the same room is sufficient, assistant should be 
on the AP/PA side, behind lead shield, wear lead apron, and take distance, but 
keep the eye-contact to patient.  
B-1448 11:18  
A tool for automated assessment of imaging system resolution  
R. Us, A. Matja i, R. Bizjak, T. Hribar, Z. Malinova, N. Mekis; Ljubljana/SI  
Purpose: To develop and deploy a software solution for automatic, consistent 
and quantitative characterisation of an imaging system's spatial resolution. 
Methods and Materials: We used an ETR-1 test plate, a Siemens 
Multix/Vertix system, AGFA CR MD 4.0 general cassettes and an AGFA 25.0 
scanner. The study was conducted in two parts. The first series of exposures 
was done using the small focal spot while the second series utilised the large 
focal spot. All exposures were conducted in line with QC guidelines. 
Parameters including SID, tube voltage as well as the product of exposure time 
and tube current were held constant throughout. 20 exposures were done at 
different z axis positions to record system performance under each set of 
conditions, for a total of 40 images. We moved the test plate by 20 mm toward 
the cathode end of the FOV between successive exposures. An ImageJ macro 
was developed to carry out consistent characterisation of ETR-1's line pair 
segments. This data was used to chart an approximate MTF curve for each 
position along the z axis. 
Results: Our results take the form of 2 spreadsheets containing MTF values 
for 20 different frequencies in the vertical direction and 19 different z axis 
positions in the horizontal direction. The sampling resolution limit was clearly 
visible in the first series at between 3,1 and 3,4 lp/mm which is consistent with 
our scanner specifications. 
Conclusion: Our macro consistently produced a comprehensive quantitative 










B-1449 11:26  
Scattering in dental cone-beam computed tomography  
J. Heikkinen, P. Sepponen, A. Henner; Oulu/FI (anja.henner@oamk.fi)  
Purpose: The aim of this study was to produce information of scattered 
radiation that can be utilized in aforesaid situations and possibly in future 
CBCT applications and radiation protection. The measurement system and the 
presentation of the results can also be commonly utilized for scattering 
measurements. Therefore it’s important to figure out doses, dose rates and 
directions of scattered radiation around the CBCT machine during the 
examination. 
Methods and Materials: The scattering was measured using a RaySafe X2 X-
ray measurement system and its survey-sensor. The studied CBCT machine 
was Scanora 3D (Soredex). CIRS ATOM 711-HN was used as an 
anthropomorphic patient-phantom. Measurements were performed on three 
different heights with normal dental imaging parameters (dental infection) and 
on one height with the largest FOV and highest resolution. 
Results: Four scattering maps that represent the X-ray scattering in the X-ray 
simulation room were obtained. The highest doses were naturally measured in 
the vicinity of the CBCT machine on the height of the isocenter of the x-ray 
beam. Increasing the FOV and resolution led to increased scattered radiation. 
In addition to dose and dose rate measurements the dose rate as a function of 
time during the rotation of the gantry was examined. 
Conclusion: The dose rates in the examination room were significant and 
regarding radiation protection. The scattering maps show the safest areas in 
the examination room  
B-1450 11:34  
Overview of CT throughput in a radiology department: drawbacks and 
solutions  
B. Kara1, A. Toker1, S. Horoz1, M. Onur1, S. Sanje2, D. Akata1; 1Ankara/TR, 
2
Istanbul/TR (tomografi@hotmail.com)  
Purpose: The aim of this study to investigate the productivity of computed 
tomography (CT) units in a radiology department and to draw conclusions on 
how to achieve efficient outcomes. 
Methods and Materials: A total number of 69.865 CT scans performed in four 
different multislice CT scanners (Scanner A, B,C,D) between May 2016 and 
April 2017 were analysed in terms of equipment utilization rate against 
institutional entitlement and industry benchmarks, staff utilization, adoption to 
protocol standardization, patient flow and end to end radiology value stream 
leveraging Lean Six Sigma methodology. 
Results: Utilization rate of overall CT units was found as 61% against industry 
benchmarks (85%, 80%, 120%, 35% for scanners A, B, C and D, respectively). 
Based on data; 57% of CT requests were scanned at the same day whereas 
for 25% of patients it takes more than 5 days. Although CT examinations are 
mostly scheduled in office hours (between 8 am to 6 pm), utilization rates 
decreased significantly during lunch and staff shift change times. Patient 
preparation time was increased when there is single radiographer per scanner. 
Unnecessary activities in scanner room including manual entrance of patient 
information, patient questions, and opening route for intravenous contrast 
agent administration constituted 13% of total observed time in CT rooms. 
Conclusion: Overview of radiology departments in guidance with professional 
partners using bench-markings is helpful for management and improvement of 
CT throughput. Changed behaviours of staff in accordance with innovative 
perspective of radiology departments will be helpful for overcoming drawbacks 
in CT throughput.  
Author Disclosures: 
 S. Sanje: Employee; General Electric.  
B-1451 11:42  
Eye-lens dose in head CT examinations: evaluation of different methods 
through the use of gantry angulation and barium shields  
M.V.C. Reis, S. Rodrigues, A.F. Abrantes, L.P. Ribeiro, R.P.P. Almeida, 
O. Lesyuk; Faro/PT (monica14@live.com.pt)  
Purpose: To evaluate the effect of gantry angulation, scanning techniques 
(spiral vs sequential) and barium eye shielding on radiation dose to the eye 
lens during head CT examinations. 
Methods and Materials: An anthropomorphic phantom was scanned with a 
routine head CT protocol using a 16-slices CT equipment. Three exposures 
were performed for each of the following settings with different combinations: 
(1) spiral and sequential scanning techniques, (2) with and without barium 
shields and (3) gantry angulation at 12º, 0º, -12º and -22º using the 
orbitomeatal line as reference. Thermoluminescent dosimeters (TLD) were 
used to measure the entrance skin dose (ESD) in eye lens. 
Results: An ESD reduction range from 15% to 21% was verified in all 
configurations with barium shields. The lower ESD value was observed in 
configuration with barium shields and gantry angulation at -12º (28,86mGy). In 
terms of effective dose, it was found that the sequential scanning technique at 
0º with no barium shield presents the higher value (0.43mSv), although below 
the dose threshold. The lower effective dose (0.29mSv) was verified with the 
use of barium shield in combination with -12º of gantry angulation. 
Conclusion: These results may be used to provide more adequate procedures 
and to ensure that protocols are operated safely below thresholds. Tilting the 
gantry to avoid the orbits and using the barium eye shielding are effective 
measures for reducing radiation dose to the eye lens in clinical practice. These 
actions should be considered when they are consistent with the clinical task 
and patient anatomy.  
B-1452 11:50  
Patients' experiences in coronary angiography  
A. Henner, A. Lahdenperä, H. Suutari, K. Koivunen, K. Paalimäki-Paakki; 
Oulu/FI (anja.henner@oamk.fi)  
Purpose: The purpose of this study was to find out patient's experiences after 
coronary angiography. 
Methods and Materials: Patients' experiences were studied with group and 
individual theme interviews. 12 persons (aged 59-84 years) were interviewed in 
Autumn 2016. The data were analysed with inductive content analysis. 
Purpose of this study was to describe the patients’ experiences in coronary 
angiography. 
Results: According to the data, the patients felt that they are not encountered 
as individuals, but they still trust on the professionalism of the care team. 
Invasive nature of the coronary angiography affects strongly to the experience. 
Patients felt they have got very good care. On the other hand, the patients felt 
they are on conveyor belt and they are medicated too heavily. The invasive 
examination rises anxiety and fear. Patient's background and personality 
affects to what kind of and how much counselling they require before, during 
and after examination. According to patients, nobody told them about the use 
of radiation. The possibility to discuss and share the experiences with other 
patients is highly valued. 
Conclusion: This study gives additional information about the patient's 
experience in coronary angiography. This study gave to interviewees a 
possibility to participate in the development of the future care pathway and also 
gives them a possibility to share their experiences. Results of our study can be 
used in the development of the coronary angiography procedure, more 
personalized patient counseling and patient profiles.  
10:30 - 12:00 Room M 1  
Cardiac  
SS 1803  
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Moderators:  
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B-1453 10:30  
Computed tomography CT: derived fractional flow reserve improves 
reader confidence for coronary CT angiography  
C. Schabel1, K. Nikolaou1, L. Hurwitz2; 1Tübingen/DE, 2Durham, NC/US 
(christoph.schabel@med.uni-tuebingen.de)  
Purpose: To assess the impact of fractional flow reserve computed 
tomography (FFRCT) on reader confidence and time efficiency for interpretation 
of coronary computed tomography angiography (CCTA). 
Methods and Materials: This IRB-approved, HIPAA-compliant, consent 
waivered, retrospective quality-assessment study included 50 patients (23 
women, age 67±12years, body mass index 28.7±5.3kg/m2). CCTA was 
acquired on 2nd&3rd generation dual-source MDCT with use of beta-blockers 
and nitroglycerin, and FFRCT was calculated (HeartFlow,Redwood City,CA). 
Two readers with experience level COCATS2 (Core-Cardiology-Training-
Symposium) and two with COCATS3 assessed CCTA alone and CCTA plus 
FFRCT. Readers’ confidence to diagnose or exclude coronary artery disease 
(CAD) and hemodynamically significant stenosis (HS) was rated on a 4-point 
Likert-scale (1=high, 2=good, 3=limited, 4=none) for the four major epicardial 
coronary artery vessels (CAV). Time to interpret was recorded. 
Results: The severity of CAD in the cohort population was CAD-RADS1 
(Coronary-Artery-Disease Reporting-and-Data-System) n=15, CAD-RADS2 
n=8, CAD-RADS3 n=11, and CAD-RADS4A n=16. Sixty-four CAV in 33 
patients had FFRCT values <0.8. Readers’ confidence when FFRCT was 
available increased for CAD and HS (p=0.0001) with a reduction of “non-
confident” patient reads (rank 3&4) by 27% and 75%, respectively. The change 
in confidence was not associated with CAD-RADS (p>0.1) but correlated with 
readers’ experience (p=0.0001). The median time-to-read a CCTA study 
decreased by 5 minutes when FFRCT was available (p<0.0001). 
  






Conclusion: Interpretation of CCTA in conjunction with FFRCT improved 
readers’ confidence to identify or exclude CAD and HS with reduction of “non-
confident” reads by 27% and 75%, respectively, and decreased the median 
time-to-interpret a CCTA by 5 minutes.  
Author Disclosures: 
  C. Schabel: Speaker; Siemens Healthcare.  
B-1454 10:38  
Effect of coronary calcium on the diagnostic performance of machine 
learning-based coronary CT angiography-derived fractional flow reserve: 
results from the machine registry  
C. Tesche1, K. Otani2, M. Albrecht3, C.N. De Cecco3, T. duguay3, S. Baumann4, 
M. Renker5, A. Varga-Szemes3, U.J. Schoepf3; 1Munich/DE, 2Tokyo/JP, 
3
Charleston, SC/US, 4Mannheim/DE, 5Bad Nauheim/DE 
(tesche.christian@googlemail.com)  
Purpose: To investigate the effect of coronary artery calcium (CAC) on the 
diagnostic performance of machine learning-based coronary CT angiography 
(cCTA)-derived fractional flow reserve (CT-FFR). 
Methods and Materials: 481 vessels from 314 patients (62.3±9.3 years, 77% 
male) who had undergone cCTA followed by invasive fractional flow reserve 
(FFR) were investigated in this retrospective analysis of the MACHINE registry 
(Machine leArning-based CT angiograpHy-derIved FFR: a Multi-ceNtEr 
Registry) data. CAC was quantified using the Agatston convention. The 
diagnostic performance of CT-FFR to detect lesion-specific ischaemia was 
assessed across all Agatston score quartiles with invasive FFR as the 
reference standard. 
Results: The diagnostic accuracy of CT-FFR vs invasive FFR was superior to 
that of cCTA alone on a per-vessel (78% vs 58%) and per-patient (83% vs 
73%) basis across all Agatston score quartiles. CT-FFR demonstrated high 
discriminatory power in vessels with high Agatston scores (250-2066) and a 
low to intermediate Agatston scores (0-249) without a statistically significant 
difference in the area under the receiver-operating characteristic curve (AUC) 
(AUC: 0.77 [95%CI 0.68-0.86] vs 0.86 [95%CI 0.82-0.90], p=0.76). CT-FFR 
showed incremental diagnostic value over cCTA in vessels with high Agatston 
scores (AUC 0.77 vs 0.55, p<0.001) and low to intermediate Agatston scores 
(AUC 0.86 vs 0.66, p<0.001). 
Conclusion: Machine learning-based CT-FFR demonstrated superior 
diagnostic performance over cCTA alone in calcified coronary arteries on a 
per-lesion and per-patient level with no difference in the performance of CT-
FFR between patients with low to intermediate and patients with high Agatston 
scores.  
Author Disclosures: 
 K. Otani: Employee; Siemens Healthineers.  C.N. De Cecco: Consultant; 
Guerbet. A. Varga-Szemes: Consultant; Guerbet. U.J. Schoepf: Consultant; 
Guerbet. Research/Grant Support; Astellas, Bayer, GE, Bracco, Medrad, 
Siemens. 
B-1455 10:46  
Artificial intelligence deep-learning-based coronary CT fractional flow 
reserve: the impact of iterative and filtered back projection 
reconstruction techniques  
D. Mastrodicasa1, C.N. De Cecco1, A. Moritz2, A. Varga-Szemes1, 
G. Muscogiuri3, M. van Assen4, M. Eid1, F. Lavra5, U.J. Schoepf1; 
1
Charleston, SC/US, 2Horb/DE, 3Milan/IT, 4Groningen/NL, 5Cagliari/IT 
(domenico.mastrodicasa@gmail.com)  
Purpose: To evaluate the influence of CT reconstruction algorithms on 
machine-learning-based computed tomography-derived fractional flow reserve 
(CT-FFRML) results and processing time. 
Methods and Materials: Iterative reconstruction in image space (IRIS) and 
filtered back-projection (FBP) datasets were retrospectively included from 40 
patients who underwent coronary CT angiography (CCTA) on a 3rd-generation 
dual-source scanner. Using a machine-learning software prototype, CT-FFR 
was computed on a per-vessel and per-segment basis, as well as proximal and 
distal to lesions with 50% luminal stenosis according to CCTA. Invasive FFR 
comparison was performed when available. Significant ischaemia was defined 
as invasive FFR and CT-FFR values 0.80. Computational times were 
recorded. Pearson correlation, Wilcoxon, and McNemar testing were used for 
data analysis. 
Results: A total of 320 vessels were analysed to calculate CT-FFR. Per-vessel 
analysis of IRIS and FBP reconstructions showed significantly different CT-
FFR values (p0.05). Correlations between the two algorithms for the left main 
(r=0.74), left anterior descending (r=0.76) and right coronary artery (r=0.70) 
were high. A per-segment analysis revealed significantly different CT-FFR 
values (p0.05) and high correlation for all proximal and middle segments 
(r=0.73 and r=0.70, p0.001, respectively). No difference in diagnostic 
accuracy was observed between algorithms (81.8%, p=1.000). Per-lesion 
correlation with invasive FFR values was moderate for both IRIS (r=0.53, 
p=0.117) and FBP (r=0.49, p=0.142). CT-FFR computational time was 
significantly shorter using IRIS reconstruction (15.9 vs 19.8 minutes, p0.05). 
Conclusion: IRIS improves CT-FFRML post-processing speed, likely owing to 
reduced image noise. However, the reconstruction algorithm influences CT-
FFR results with potential implications on patient management.  
Author Disclosures: 
 C.N. De Cecco: Research/Grant Support; Siemens. A. Varga-Szemes: 
Research/Grant Support; Siemens.  U.J. Schoepf: Consultant; Bayer, 
Guerbet. Research/Grant Support; Astellas, Bayer, GE, Siemens. 
B-1456 10:54  
Gender differences in machine learning-based coronary CT angiography-
derived fractional flow reserve: results from the machine registry  
B.E. Jacobs1, S. Baumann1,2, M. Renker1,3, C. Tesche1,4, T. Duguay1, 
M.H. Albrecht1,5, A. Coenen6, K. Nieman6, U.J. Schoepf1; 1Charleston, SC/US, 
2
Mannheim/DE, 3Bad Nauheim/DE, 4München/DE, 5Frankfurt/DE, 
6
Rotterdam/NL (jacobsbr@musc.edu)  
Purpose: Coronary computed tomography angiography (cCTA)-derived 
fractional flow reserve (cFFR) is a non-invasive FFR approach that improves 
diagnostic accuracy in detecting haemodynamically relevant lesions over cCTA 
alone. An artificial intelligence deep machine-learning method of calculating 
cFFR (ML-cFFR) has recently been introduced. Currently, no data exist 
regarding the influence of patient sex on the accuracy of artificial intelligence 
ML-cFFR. 
Methods and Materials: Five centres enrolled 351 patients (73.5% male) with 
525 vessels in the retrospective MACHINE (Machine leArning Based CT 
angiograpHy derIved FFR: a Multi-ceNtEr) registry (NCT02805621). ML-cFFR 
and invasive FFR 0.80 were considered haemodynamically significant, 
whereas cCTA luminal stenosis 50% was considered obstructive. 
Results: Compared with invasive FFR on a per-lesion basis, ML-cFFR 
reached a pooled sensitivity, specificity, positive predictive value, and negative 
predictive value of 83.0% (95%CI: 76.6-88.2), 73.4% (95%CI: 67.1-79.1), 
71.2% (95%CI: 66.3-75.7), and 84.5% (95%CI: 79.5-88.4) in men vs 69.4% 
(95%CI: 51.9-83.7, p=0.0009), 83.5% (95%CI: 74.3-90.5, p=0.0207), 62.5% 
(95%CI: 50.0-73.5, p=0.0650) and 87.4% (95%CI: 80.7-91.9, p=0.4234) in 
women, respectively. The AUC of ML-cFFR was not significantly superior to 
cCTA alone on a per-vessel basis [0.83 (95%CI: 0.75-0.90) vs 0.79 (95%CI: 
0.70-0.87), p=0.4752] in women, but showed a statistically significant 
improvement in men [0.83 (95%CI: 0.79-0.87) vs 0.74 (95%CI: 0.69-0.79), 
p<0.0001]. 
Conclusion: ML-cFFR significantly improves the diagnostic performance over 
cCTA alone for the detection of haemodynamically relevant lesions, using 
invasive FFR values as the reference standard. The incremental value is 
greater in men than in women.  
Author Disclosures: 
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A. Coenen: Research/Grant Support; Receives financial research support from 
Siemens Healthcare. K. Nieman: Research/Grant Support; Receives 
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B-1457 11:02  
Noninvasive CT-derived FFR based on structural and fluid analysis with 
low radiation dose using a full iterative reconstruction  
H. Takagi, K. Kikuchi, R. Tanaka, K. Yoshioka; Morioka/JP 
(hdnb69tkg@gmail.com)  
Purpose: The purpose of this study was to evaluate the diagnostic 
performance for functional significance of coronary artery stenosis (i.e. 
ischaemia) of CT-derived fractional flow reserve (CT-FFR) at low radiation 
dose using a full iterative reconstruction (IR) technique. 
Methods and Materials: This retrospective study included 19 vessels in 16 
patients with suspected coronary artery disease (CAD) who underwent 
coronary CT angiography (CCTA), followed by invasive fractional flow reserve 
(FFR). All CCTA examinations were performed with a 320-row MDCT scanner, 
and all CT data were reconstructed with a full IR technique. CT-FFR was 
derived using a reduced order model performed with dedicated software on a 
standard desktop computer. Ischaemia was defined as a CT-FFR and FFR 
0.80. The diagnostic performance with 95% confidence interval (95%CI) of 
CT-FFR was assessed with invasive FFR as the reference standard. The 
effective radiation dose of CCTA was calculated by a dose-length product 
(mGy･cm) and a standard conversion factor of 0.014 (mSv/mGy･cm). 
Results: Ischaemia was observed in 58% (11/19) vessels during invasive FFR. 
On a per-vessel basis, sensitivity, specificity, accuracy, and area under the 
curve were 82% (95%CI, 63-89), 88% (95%CI, 62-98), 84% (95%CI, 63-93) 
and 0.85 (95%CI, 0.60-0.95) for CT-FFR. The CT-FFR and FFR were well 
correlated (r=0.79, p<0.01), and there was no significant difference between 
CT-FFR and FFR (-0.01±0.07, p=0.68). The mean effective radiation dose for 
CCTA was 1.9±1.0 mSv. 
  






Conclusion: Noninvasive CT-FFR with low radiation dose using a full IR 
demonstrated a high diagnostic performance for the detection of ischaemia.  
Author Disclosures: 
 K. Yoshioka: Research/Grant Support; Toshiba Medical Systems. 
B-1458 11:10  
Intermodel agreement of myocardial blood flow quantification in dynamic 
myocardial perfusion CT  
M. van Assen1, G. Pelgrim2, M. Stijnen3, S. Van Tuijl3, U.J. Schoepf1, 
R. Vliegenthart2, M. Oudkerk2; 1Charleston, SC/US, 2Groningen/NL, 
3
Eindhoven/NL (m.van.assen@umcg.nl)  
Purpose: To assess intermodel agreement of tracer kinetic models to 
determine myocardial blood flow (MBF) and ischemia in dynamic CT 
myocardial perfusion imaging (CTMPI). 
Methods and Materials: Three porcine hearts perfused in Langendorff mode 
(Physioheart©, LifeTec Group, Eindhoven,The Netherlands) and 8 patients 
with suspected CAD and rest-stress perfusion single photon emission CT 
(SPECT) were included. Dynamic CTMPI was performed in shuttle-mode 
(70kVp, 350mAs/rot, z-range 10.2cm) on 3rd-generation dual-source CT. In 
porcine hearts and patients, myocardial segments were drawn according to the 
AHA-16-segment model. Tissue attenuation curves were calculated per 
segment. The arterial input function was derived from the aorta. True MBF was 
calculated in the porcine model based on input flow and weight of the heart. In 
patients, ischemic segments were defined based on previous SPECT results. 
MBF (ml/g/min) quantification was performed using the upslope, Extended Toft 
(ET), Two-compartment (TC) and Fermi models. 
Results: For the non-ischemic segments in the porcine hearts, the upslope 
method resulted in lower MBF (median 1.23, interquartile range[IQR]:1.07-
1.46) compared to the Fermi, ET and TC model, which had median values of 
1.93 (1.37-2.63), 2.78 (1.56-3.81) and 2.26 (1.64-3.29). True global MBF was 
calculated at median 1.88 (IQR:1.80-2.80). In patients all models showed a 
significant difference between ischemic and non-ischemic segments (p-
value<0.001). Again the upslope model showed the lowest MBF values. 
Conclusion: The most commonly used upslope method yielded lower absolute 
MBF values compared to other models and true MBF in porcine hearts. In 
patients all models were able to discriminate between ischemic and non-
ischemic segments.  
Author Disclosures: 
 M. Stijnen: Employee; LifeTec. S. Van Tuijl: Employee; LifeTec.  
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B-1459 11:18  
Additional diagnostic value of CT perfusion over coronary CT 
angiography in stented patients with suspected in stent restenosis or 
coronary artery disease progression: Advantage study  
D. Andreini1, S. Mushtaq1, J. Sonck2, G. Pontone1, E. Conte1, M. Mancini1, 
A. Baggiano1, A.L. Bartorelli1, M. Pepi1; 1Milan/IT, 2Brussels/BE 
(daniele.andreini@ccfm.it)  
Purpose: Aim of the study is to assess the diagnostic performance of CCTA 
alone, CTP alone and CCTA plus CTP when compared to invasive coronary 
angiography (ICA) in patients with coronary stents. 
Methods and Materials: A cohort of consecutive patients referred to ICA were 
enrolled. The feasibility of CCTA, CTP and the combined evaluation CCTA 
plus CTP were calculated. Sensitivity, specificity, positive predictive value, 
negative predictive value and diagnostic accuracy of CCTA, CTP, combined 
evaluation CCTA-CTP (considered as positive when CCTA indicated a >50% 
stenosis or ISR and/or CTP indicated a perfusion defect) and concordant 
evaluation CCTA-CTP vs. ICA were calculated. Radiation exposure was 
recorded. 
Results: Sixty nine patients were enrolled. CTP feasibility was significantly 
higher than CCTA feasibility in a stent-, territory- and patient-based analysis. 
The feasibility of the combined evaluation CCTA-CTP was significantly higher 
than CCTA feasibility. The diagnostic accuracy of CCTA was 78%, 81%, and 
78%, respectively; the diagnostic accuracy of CTP was 90%, 92% and 84%, 
respectively; the diagnostic accuracy of combined CCTA-CTP was 84%, 88%, 
and 83%, respectively; the diagnostic accuracy of concordant CCTA-CTP was 
95%, 97% and 96%, respectively. The diagnostic accuracy of concordant 
CCTA-CTP was higher than that of CCTA and CTP in a patient-based analysis. 
The mean effective dose of CCTA-CTP was 3.89±1.35 mSv. 
Conclusion: The CTP assessment appears more feasible accurate than the 
anatomical evaluation alone by CCTA in patients with coronary stents. When 
results of CCTA and CTP are concordant the diagnostic accuracy of the 





B-1460 11:26  
Accuracy of CCTA to detect obstructive CAD using stress vs rest dataset 
in patients referred to stress CTP  
M. Guglielmo1, A. Guaricci2, A. Baggiano1, F. Fazzari3, D. Andreini1, 
F. Fabiocchi1, A. Lualdi1, A. Bartorelli1, G. Pontone1; 1Milan/IT, 2Bari/IT, 
3
Palermo/IT (marco.guglielmo@ccfm.it)  
Purpose: We sought to compare diagnostic accuracy of CCTA (coronary 
computed tomographic angiography) to detect obstructive CAD (coronary 
artery disease) between stress versus rest dataset as compared to invasive 
coronary angiography (ICA).  
Methods and Materials: 66 symptomatic patients with intermediate to high 
pre-test probability of CAD and scheduled for clinically indicated ICA were 
prospectively enrolled. All patients underwent rest-CCTA followed by stress-
CTP protocol with adenosine (revolution CT scanner, GE Healthcare, 
Milwaukee, WI) with injection of 70 ml of iodixanol 320 (Visipaque 320 mg/ml, 
GE Healthcare, Oslo, Norway). For both datasets, the image quality was 
evaluated with Likert score.The severity of coronary lesions was quantified by 
identifying the minimum diameter and reference diameter for all stenoses, and 
the percentage of stenosis will be derived according to the following formula: 
(Dref−Dmin)/Dref·100, where Dref is the reference diameter and Dmin is the 
minimum diameter. For CCTA and ICA, the obstructive CAD was defined as 
the presence of coronary artery stenosis 50%. 
Results: Obstructive CAD was found in 61% of patients at ICA. In vessel-
based model, the stress dataset showed a higher heart rate as compared to 
the rest dataset (p<0.001) with similar image quality. Stress dataset showed 
similar sensitivity (95% [CI95%: 89-100)] vs 93% [CI95%: 89-100)] but slightly 
lower specificity (75% [CI95%: 69-82)] vs 80% [CI95%: 74-86), p: 0.05] as 
compared to rest dataset. In both vessel and patient-based model, stress and 
rest dataset showed similar area under the curve (AUC) (0.84 vs 0.82 and 0.84 
vs 0.84). 
Conclusion: In static stress CTP, the new-generation scanner allows to 
perform the coronary artery imaging in the stress dataset with the same 
accuracy of rest dataset.  
B-1461 11:34  
The impact of a tiered cardiac CT protocol compared to functional testing 
on cardiovascular risk management in patients with suspected coronary 
artery disease  
F. Nous1, M.M. Lubbers1, J. Akkerhuis1, T. Bruning1, B. Krenning1, M. Kofflard2, 
B.L. Kietselaer3, R.P. Budde1, K. Nieman1; 1Rotterdam/NL, 2Dordrecht/NL, 
3
Maastricht/NL (f.nous@erasmusmc.nl)  
Purpose: To assess the impact of a tiered cardiac CT protocol, compared to 
functional testing, on cardiovascular risk factors and life style changes in 
patients evaluated for coronary artery disease (CAD). 
Methods and Materials: Patients with suspected CAD, who participated in the 
CRESENT I or CRESENT II trials, who were randomly assigned to cardiac CT 
or functional testing, were assessed. The protocol included a calcium scan and 
when indicated a coronary CT angiography (CCTA) (calcium score >0/high 
pre-test probability) and a CT myocardial perfusion (CRESENT II, CCTA: 
stenosis >50%), or functional-testing according to European guidelines. The 
use of preventive medication was registered at baseline and at 6 months 
(CRESENT I) or 1 year (CRESENT II) and patients were asked to fill out a 
questionnaire about their health status (smoking, diet, exercise, weight change, 
blood pressure and cholesterol level) at follow-up. 
Results: Patients who underwent a cardiac CT (n=372) were more likely to 
improve at least one of the risk factors or life style changes compared to 
patients who underwent functional-testing (n=246) (78% vs. 67%, p<0.01). 
They were more likely to increase their exercise (p<0.05), to gain less weight 
(p<0.001) and to normalise their cholesterol levels (p<0.01). Fewer patients 
used antiplatelet agents and/or statins after diagnostic testing, from 31% to 
24% (p<0.01) after CT, and from 45% to 39% (p<0.05). No differences were 
found between both groups. 
Conclusion: A tiered cardiac CT protocol is associated with more change in 
life style in patients evaluated for CAD compare to functional testing.  
Author Disclosures: 
 B.L. Kietselaer: Research/Grant Support; Astra Zeneca and Bayer. Speaker; 
Astellas and AMGEN.  K. Nieman: Research/Grant Support; Siemens, 
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B-1462 11:42  
Deep learning-based analysis of the left ventricular myocardium in 
coronary CTA images improves specificity for detection of functionally 
significant coronary artery stenosis  
R.W. van Hamersvelt, M. Zreik, M. Voskuil, I. Isgum, T. Leiner; Utrecht/NL 
(R.w.vanhamersvelt-3@umcutrecht.nl)  
Purpose: To evaluate the added value of fully automatic deep learning-based 
analysis of left ventricular myocardium (LVM) in addition to routine stenosis 
  






degree assessment for the detection of functionally significant coronary artery 
stenosis in resting coronary computed tomography angiography (CCTA). 
Methods and Materials: We retrospectively studied 126 consecutive patients 
(76.9% male) who received a CCTA within one year prior to an invasive 
fractional flow reserve (FFR) measurement. An FFR0.80 and/or PCI 
performed was used as a reference to indicate a functionally significant 
stenosis. Resting CCTA scans were performed on a 256-slice CT. Stenosis 
degree was categorised as 0%, 1-30%, 31-49%, 50-69% and 70% by visual 
assessment. Patients with stenosis 70% were considered significant and 
30% non-significant. Patients with intermediate stenosis (31-69%) were 
referred for deep learning analysis of the LVM evaluating presence of 
functionally significant stenosis. LVM was automatically segmented using a 
multiscale convolutional neural network and subsequently characterised using 
a convolutional auto-encoder. Using these encodings, patients with functionally 
significant stenosis were identified using a support vector machine classifier. 
Diagnostic performance of the combined method was compared with stenosis 
degree evaluation on CCTA alone (50% stenosis indicating functional 
significance). 
Results: In 84 patients (66.7%) a functionally significant stenosis was present. 
Sensitivity and specificity of stenosis degree evaluation alone (cut-off50%) 
were 91.7% and 31.0%. The combined method resulted in an increase in 
specificity to 50% with only minor decrease in sensitivity (82.1%). 
Conclusion: Adding deep learning-based analysis of the LVM to stenosis 
grading improves specificity with only minor decrease in sensitivity.  
Author Disclosures: 
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B-1463 11:50  
A meta-analysis on functional CT for diagnosing haemodynamically 
significant coronary artery disease: ready for prime time?  
C. Celeng1, T. Leiner1, P. Maurovich-Horvat2, B. Merkely2, P. de Jong1, 
J.W. Dankbaar1, B. Ghoshhajra3, U. Hoffmann3, R.A. Takx1; 1Utrecht/NL, 
2
Budapest/HU, 3Boston, MA/US  
Purpose: Coronary CT angiography (CCTA) provides excellent anatomical 
albeit limited functional information about coronary artery disease (CAD). 
Various CT techniques have emerged for the assessment of myocardial 
ischemia. We performed a meta-analysis to determine the diagnostic accuracy 
of myocardial perfusion (CTP), CT derived fractional flow reserve (FFRCT) and 
coronary transluminal attenuation gradient (TAG) for the detection of 
hemodynamically significant CAD. 
Methods and Materials: This meta-analysis was performed according to the 
PRISMA guidelines. We systematically searched PubMed, EMBASE and Web 
of Science for studies using invasive FFR as a reference standard for the 
assessment of CAD. Results were pooled to compute summary sensitivity, 
specificity and the diagnostic odds ratio on vessel level. Since stenosis degree 
on CCTA as a standalone technique has an excellent sensitivity, specificity 
was considered most relevant. 
Results: Thirty-four studies reported on CCTA, 12 on CTP, 17 on FFRCT and 6 
on TAG. With CCTA 6225, with CTP 2170, with FFRCT 2372 and with TAG 726 
vessels were analyzed. For the assessment of hemodynamically significant 
stenosis at vessel level the specificity of CCTA was 65% [95% CI: 63-66%], of 
CTP was 79% [95% CI: 77-81%], of FFRCT was 76% [95% CI: 74-79%] and of 
TAG was 64% [95% CI: 60-69%]. Combining CTP with CTA resulted in a slight 
improvement in specificity of 84% [95% CI: 81-86%] compared to CTP alone. 
Conclusion: Functional CT (CTP and FFRCT) yielded a substantial 
improvement in the identification of hemodynamically significant CAD, 
therefore it is ready to be integrated into the clinical routine.  
Author Disclosures: 
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B-1464 10:30  
Updated evidence-based European Society of Urogenital Radiology 
(ESUR) Contrast Media Safety Committee (CMSC) Guidelines for 
prevention of post-contrast acute kidney injury (PC-AKI)  
A.J. Van Der Molen1, P. Reimer2, I. Dekkers1, G. Bongartz3, H.S. Thomsen4; 
1
Leiden/NL, 2Karlsruhe/DE, 3Basle/CH, 4Herlev/DK 
(A.J.van_der_Molen@lumc.nl)  
Purpose: To update current ESUR CMSC guidelines for prevention of PC-AKI 
after administration of iodine-based contrast media (CM). 
Methods and Materials: Ten answerable clinical questions were phrased by 
the writing group. A systematic literature search was performed for each of the 
questions using PubMed, Medline, Embase and Web of Science databases. 
Literature was selected with help of published quality metrics (PRISMA, 
CONSORT, STROBE), and scientific evidence was graded using Oxford 
CEBM levels of evidence. Scientific evidence was combined with logistic and 
economic aspects into practical clinical recommendations. 
Results: CM are much less nephrotoxic than previously defined. PC-AKI is the 
preferred terminology as in most instances the causative relation with CM can’t 
be established. The CKD-EPI and updated Schwarz equations are 
recommended for estimation of glomerular filtration rate (eGFR). Patients are 
at increased risk for PC-AKI if eGFR <30ml/min/1.73m2 if CM is administered 
intravenously or intra-arterially with second pass renal exposure. For maximum 
safety, eGFR <45ml/min/1.73m2 is employed if CM is administered intra-
arterially with first pass renal exposure and in ICU patients. Hydration with 
normal saline or bicarbonate remains the primary preventive measure, using 
shortened protocols. Other measures in addition to hydration have not been 
found sufficiently effective. Metformin should be stopped temporarily if eGFR 
<30ml/min/1.73m2 and prescribing physician should be informed. It is not 
needed to align contrast-enhanced procedures with schedules of chronic renal 
dialysis. 
Conclusion: Updated CMSC guidelines for prevention of PC-AKI lowered the 
cut-off for preventive measures to eGFR <30ml/min/1.73cm2 and shortened 
hydration protocols, resulting in reduced costs.  
Author Disclosures: 
  A.J. Van Der Molen: Speaker; Guerbet, Bayer, Bracco.  
B-1465 10:38  
Intravenous contrast media administration: is there a risk of acute kidney 
injury?  
M.D. Ferrer Puchol, E. Sanz-Rodrigo, P. Montesinos Garcia, 
E. Taberner Lopez, E. Blanco Pérez, M. Forment Navarro; Alzira/ES 
(lolesferrer@ono.com)  
Purpose: To assess whether intravenous contrast media administration 
(IVCMA) is associated with an increase in creatinine levels and risk for acute 
kidney injury. 
Methods and Materials: This is a retrospective cohort analysis that included 
all patients who attended the Emergency Department (ED) during 6-year 
period (2010-2015) with a baseline creatinine (C1) and other creatinine (C2) 
24-72 hours later.The Ethics Committee approved this study. An experienced 
systems analyst extracted all clinical information from the available data-base 
stored in the institution.Exclusion criteria: patients less 18 years, serum 
creatinine less 0.04 mg/dL or more 4.0 mg/dL and IVCMA in the 6 months 
before the study.Our mean annual census in ED was 105,435 visits.There 
were 3 groups: 1. Patients undergoing contrast-enhanced CT (n=6,662), 2. 
Patients undergoing non-contrast-enhanced CT (n=6,193), 3. Not CT received 
patients (n=33,802).We used both criteria for "Contrast-induced Nephropathy" 
(CIN) and for "Acute Kidney Injury Network/Kidney Disease" (AKI).Results 
were presented as odds ratios using Stata 15. 
Results: We analysed 52,411 patients and, after applying exclusion criteria 
46,637.Mean-age 67.95 years. C1 values:1.16 mg/dL (SD:0.61), C2 values: 
1.14 mg/dL (SD:0.66). Multivariable logistic regression revealed:Using AKI and 
CNI criteria: CT with IVCM was not associated with increased incidence of 
acute injury (OR:0.9, 95% CI 0.83-0.99 and OR:0.89, 95% CI 0.81-0.98, 
respectively).The value of baseline creatinine conditioned nephropathy 
(OR:1.41) independently of CT being performed or not. 
  






Conclusion: These findings demonstrate that in our context, contrast media 
administration is not associated with an increase in incidence of acute kidney 
injury.  
B-1466 10:46  
Survey of contrast-induced nephropathy after CT scan in patients who 
stayed in Sari Imam Khomeini Hospital from 2016 to 2017  
H. Majidi, F. Godazandeh, R. Abdi, F. Espahbodi, R. Alimohammadpur, 
M. Tayebi; Sari/IR (farnaz_godazandeh@yahoo.com)  
Purpose: With the growing use of contrast agents in diagnostic imaging 
techniques, the contrast-induced nephropathy (CIN) has become a major 
source of hospital morbidity. The aim of this study was to determine the 
incidence of CIN after a CT scan with contrast and identifying its risk factors. 
Methods and Materials: This cross-sectional study was induced on 100 
patients who had CT scan with contrast. Predictors of CIN were evaluated in 
four general categories: demographic variables, underlying disease, 
concomitant medications, and laboratory findings (level of Cr, BUN and eGFR). 
Cr measurement was performed 24 and 48 hours after receiving contrast agent 
and increment of its baseline level to more than 25% or 0.5mg/dl after 48 hours 
was considered as an indicator of the CIN. 
Results: The incidence of CIN was 7% and it was significantly associated with 
hypertension (P=0.028) and use of ARBs (P=0.019). BUN and eGFR parallel 
to each other were observed as more accurate markers than Cr in prediction of 
CIN incidence. However, BUN showed higher sensitivity (71.4% vs 57.1%), 
eGFR indicated higher specificity (75.3% vs 65.6%). 
Conclusion: Hypertension and use of ARBs are the most important risk 
factors for CIN. BUN has been found to be a better marker compared to eGFR 
and Cr in CIN prediction. Thus, attention to marker BUN in initial assessments 
of the CIN incidence in patients undergoing CT with contrast is highly 
recommended.  
B-1467 10:54  
Multiphase urinary tract imaging with dual contrast using spectral 
photon-counting CT  
S.A. Si-Mohamed1, M. Sigovan2, G. Normand2, P. Coulon3, D. Bar-Ness2, 
L. Boussel1, P. Douek1; 1Bron/FR, 2Lyon/FR, 3Suresne/FR 
(salimaymeric@gmail.com)  
Purpose: To demonstrate the feasibility of dual contrast multiphase imaging of 
urinary tract using a spectral photon-counting computed tomography (SPCCT). 
Methods and Materials: SPCCT with 5 energy bins (Philips Healthcare, Haifa, 
Israel) was used at 120 kVp, 100 mA to acquire the urinary tract in 3 rabbits, 
following approval by an ethics committee. The protocol was to inject at 6 
minutes apart first an iodine contrast agent (Xenetix, 350 mg/ml, 1 mg/kg, 
Guerbet) followed by a macrocyclic gadolinium contrast agent (Dotarem, 0.5 M, 
3 ml/kg, Guerbet) in order to beneficiate from two different phases imaging, i.e. 
urinary for iodine and renal for gadolinium. Acquisitions were made at 10 and 
30 seconds after second injection. SPCCT provided conventional HU and 
quantitative material decomposition iodine and specific K-edge gadolinium 
maps. 
Results: The conventional CT images could not allow to discriminate the 
specific contrast agent pharmacokinetics opposite to the gadolinium and iodine 
maps. We observed a dual-phase imaging with urinary cavity enhancement by 
the first contrast media injected and a cortical and medullar enhancement 
resulting from the second contrast media injected, matching the expected 
pharmacokinetics of the contrast media. Moreover, the water images allowed 
visualisation of a non-enhanced-like image. 
Conclusion: SPCCT allows in vivo dual contrast quantitative multi-phase 
imaging in a single acquisition. This finding pinpoints major clinical applications 
in multiphase imaging with no registration issues and with the additional value 
of reducing radiation dose to patients by reducing the number of acquisitions.  
Author Disclosures: 
 P. Coulon: Employee; Philips employee.  
B-1468 11:02  
Split-bolus vs single-bolus MDCT urography: comparison of urinary tract 
opacification, radiation dose exposure and diagnostic capability  
C. Valle1, P. Bonaffini2, F. Invernizzi3, A. Barletta1, A. Casiraghi2, A. Pappini3, 
S. Sironi1; 1Bergamo/IT, 2Monza/IT, 3Desio/IT (clarissa.valle1987@icloud.com)  
Purpose: To compare urinary tract opacification, radiation dose exposure and 
diagnostic capability of split-bolus MDCT urography (CTU) as compared to 
single-bolus protocol. 
Methods and Materials: Forty-eight patients (18-83 years), undergone CTU 
on a 64-row scanner (Aquilion, Toshiba) after IV administration of 90-110 mL of 
iodinated CM (350 mg/mL), were retrospectively analyzed: 24 (study group) 
performed a split-bolus CTU (combined nephrographic-excretory phase) and 
24 (control group) a single-bolus protocol. Quantitative analysis of intraluminal 
opacification (HU) was achieved by placing ROIs in renal pelvis, ureters and 
bladder. Qualitative analysis was performed by two radiologists (1-
consultant;2-resident) using a 4-point scale (0:none;3:excellent); inter-observer 
agreement was calculated. The radiation dose exposure was calculated as 
DLP (mGy*cm) and CTDIvol (mGy). The diagnostic capability was evaluated 
using a 2-point scale (0:no answer;1: question satisfied) and considering 
histology, further imaging and endoscopy. 
Results: The split-bolus protocol demonstrated significantly lower mean 
urinary attenuation (HU) as compared to the control group (L pelvis 909 vs 
1326, R pelvis 877 vs 1253, L ureter 810 vs 1114, R ureter 655 vs 1127, 
bladder 605 vs 939); no differences were observed in quality of intraluminal 
opacification. The mean DLP was significantly lower (1869 vs 3002 
mGy*cm;p=0.045) in the study group (dose exposure reduction of 37%). Split-
bolus protocol answered to the clinical question in almost all the cases (2 
diagnoses missed). 
Conclusion: With a qualitatively comparable urinary tract opacification as 
compared to single-bolus protocols, split-bolus CTU results in a proper ability 
to answer the clinical question with a significant dose reduction of 37%.  
B-1469 11:10  
Evaluation of parenchymal and vascular enhancement in split-bolus 
MDCT urography compared to standard single-bolus protocol: a 
feasibility study  
M. Balbi1, F. Invernizzi2, P.A. Bonaffini3, G.C. Preziosa1, D. Nicoletta2,  
C. Valle1, A. Pappini2, S. Sironi1; 1Bergamo/IT, 2Desio/IT, 3Monza/IT 
(balbi.m@libero.it)  
Purpose: To evaluate parenchymal and vascular enhancement in split-bolus 
MDCT urography (CTU) studies compared to standard single-bolus protocol. 
Methods and Materials: A total of 20 split-bolus (study group, a) and 20 
single-bolus (control group, b) CTU studies were retrospectively reviewed. All 
examinations were performed in adult patients (19-84 years) following i.v. 
injection of 90-110 mL of iodinated contrast medium (CM; 350 mg/mL), on a 
64-row scanner (Aquilion, Toshiba). Two radiologists (1-consultant, 2-resident) 
independently analyzed parenchymal and vascular enhancement in both 
groups on combined nephro-urographic (a) and portal venous phase (b) 
respectively. ROIs (regions of interest) were placed on: kidneys, liver, spleen, 
abdominal aorta and inferior vena cava (IVC). The corresponding mean HU 
and radiation dose exposure values (CTDIvol and DLP) were compared 
between the groups and statistically analyzed. 
Results: In terms of HU values there were no statistically significant 
differences (p > 0.05) between the study and the control group. The mean 
attenuation values for split-bolus and single-bolus CTU were respectively: 187 
vs 176 HU (R kidney), 188 vs 180 HU (L kidney), 109 vs 105 HU (liver), 114 vs 
106 HU (spleen), 162 vs 152 HU (aorta) and 132 vs 121 HU (IVC). CTDIvol 
and DLP values in the study group were significantly lower (p < 0.05; mean 
values, 54 vs 104 mGy and 1663 vs 3065 mGy*cm, respectively). 
Conclusion: Split-bolus CTU may provide studies potentially useful for the 
evaluation of extra-renal findings due to proper vascular and parenchymal 
enhancement, coupled to an overall dose reduction of about 47%.  
B-1470 11:18  
Diagnostic value of virtual monoenergetic urographic phase images in 
the assessment of urothelial carcinoma  
D. Zopfs, S. Lennartz, D. Maintz, T. Persigehl; Cologne/DE 
(david.zopfs@uk-koeln.de)  
Purpose: To compare virtual monoenergetic images of the urographic phase 
(U-VMI) with polyenergetic images of the venous (V-PI) and the urographic 
phase (U-PI) regarding image quality, organ and vessel contrast as well as 
diagnostic assessment of urothelial carcinoma using a spectral-detector CT 
(SDCT). 
Methods and Materials: Contrast-enhanced SDCT of 13 patients with 
histologically confirmed urothelial carcinoma were included at this retrospective 
study. Attenuation (HU), image noise (SD) as well as signal- and contrast-to-
noise-ratio (SNR, CNR) in V-PI, U-PI and U-VMI (40-200keV) were obtained 
from ROI-based measurements in following regions: liver, pancreas, renal 
cortex and medulla, psoas muscle, subcutaneous fat, renal vein and artery, 
portal vein, wall of urinary bladder, lymph node, prostate and uterus. Moreover, 
subjective assessment of vessel contrast, parenchymal organs, urothelial 
carcinoma and corticomedullar differentiation of the kidneys was rated using a 
5-point Likert scale. 
Results: Attenuation and SNR in U-VMI at 40keV were equivalent or higher 
compared to V-PI (p-range: 0.69 - 0.01). Regarding image noise, no significant 
difference was found between V-PI and U-VMI at 40keV (p0.05 each). CNR of 
urothelial carcinoma was significantly higher in U-VMI at 40keV than in V-PI 
(8.24 vs. 3.80, p0.01). Subjective vessel contrast, assessment of 
parenchymal organs, carcinoma and corticomedullar differentiation received 
equivalent or higher Likert scores in U-VMI at 40keV compared to V-PI (p-
range: 0.06 - 0.6). 
Conclusion: U-VMI at 40keV yield equivalent SNR of parenchymal organs and 
an even increased CNR of malignant lesions in comparison to V-PI, allowing 
for a better delineation of urothelial carcinoma.  
  






B-1471 11:26  
CT urography: dependence of distal ureter opacification on excretory-
phase timing and urinary-bladder volume  
U.L. Mueller-Lisse, R. Ebner, S. Seifert, C. Stief, J. Ricke, M.F. Reiser, 
U.G. Mueller-Lisse; Munich/DE  
Purpose: CT urography (CTU) is challenged by distal ureter opacification in 
the excretory phase (DUO). Potential dependence of DUO on excretory-phase 
timing after venous-phase scanning (EPT) and urinary-bladder volume (UBV) 
were retrospectively analysed. 
Methods and Materials: Ethics committee approval was obtained for an 
institutional picture-archiving-and-communication-system (PACS) search of 
CTU-examinations from 2007 to 2016 (three sites, nine different CT-scanners) 
in patients with extra-urinary abdominal or pelvic tumour or trauma or suspicion 
of tumour and reports of unremarkable native urinary tracts bilaterally. A 
random sample of 147 adult patients (age+/-standard-deviation, 63+/-14 years, 
66 females) was reviewed by two researchers who consented on DUO of each 
pelvic ureter (>80% opacified). EPT-intervals (3-34 minutes) were retrieved 
from PACS. Venous-phase and excretory-phase UBV were estimated in multi-
planar image-reconstructions (ellipsoid formula). Two-tailed statistical tests 
were significant for p<0.05. 
Results: DUO was positive bilaterally in more than 75% and failed bilaterally in 
less than 10% of patients for EPT 8-11 minutes (1/50 failed, versus 19/59 <8 
minutes, and 12/28 12-18 minutes, 3x2-chi-square, 9.51, 0.005<p<0.010). 
DUO frequently failed (5/7) in venous-phase UBV <120 ml and associated 
excretory-phase UBV increase <50 ml after 12-18 minutes (versus 9/32, 
Fisher's exact test, p=0.0442). Technical parameters (tube-charge, CTDI, DLP, 
slice thickness) did not differ significantly (all T tests, p>>0.05). 
Conclusion: DUO appears to be most successful for EPT 8-11 minutes. EPT 
12-18 minutes is likely to fail DUO when venous-phase UBV is <120 ml and 
excretory-phase UBV-increase <50 ml.  
B-1472 11:34  
Kinking of the upper ureter in CT urography: anatomic and clinical 
significance  
M. Kamo, T. Nozaki, K. Yoshida, U. Tateishi, K. Akita; Tokyo/JP 
(kamomino@luke.ac.jp)  
Purpose: Although the course of the ureter is described as a straight descent 
in the retroperitoneum, kinking of the upper ureter is often seen at imaging. 
The aim of this study was to investigate kinking of the ureter and its underlying 
anatomico-clinical significance. 
Methods and Materials: We evaluated 176 computed tomography (CT) 
images and classified kinking into three grades: no/mild kinking as Grade 1, 
moderate as Grade 2, and severe as Grade 3. We defined the ‘‘crossing point’’ 
(CP) as where the ureter crosses over the gonadal vein and assessed its 
relation to the kinking. Fourteen halves from seven cadavers were used for 
examination. Approaching anteriorly, we macroscopically observed the ureter 
and surrounding structures. 
Results: On CT, the rate of the radiologically "significant" kinking classified into 
either Grade 2 or 3 was 18.4% on the right and 21.8% on the left. All kinking 
was either at or above the level of the CP. In cadavers, the ureter was 
relatively mobile in the perirenal fat and then beginning at approximately the 
level of the CP became firmly fixed to the anteromedial aspect of the psoas 
major muscle. 
Conclusion: Kinking of the upper ureter is not a clinically significant finding 
and arises from the ureter having a relatively mobile portion in the perirenal 
space compared to its caudal portion. The fixation boundary can be identified 
by observing the CP.  
B-1473 11:42  
Characterisation of renal stones using spectral detector computed 
tomography using normal and low-dose protocols  
N. Grosse Hokamp1,2, J. Salem1, J. Holz1, G. Dervishi1, M. Ritter3, 
A. Heidenreich1, D. Maintz1, S. Haneder1; 1Cologne/DE, 2Cleveland, OH/US, 
3
Mannheim/DE (nils.grosse-hokamp@uk-koeln.de)  
Purpose: To investigate the feasibility of renal stone composition analysis 
using a spectral detector computed tomography scanner with normal and low-
dose imaging protocols (SDCT). 
Methods and Materials: 180 stones harvested from nephrolithotripsy or 
nephrolithotomy with a known composition as determined by infrared 
spectroscopy were examined in a non-anthropomorphic phantom on a SDCT 
(IQon, Philips Healthcare, The Netherlands), imaging was performed with 
120kVp and a) 40mAs and b) 200mAs, resulting in an CTDIvol of 2mGy and 
10mGy, respectively. Besides conventional CT images (CI), SDCT enables 
reconstruction virtual monoenergetic images (40-200keV). Spectral coefficient 
images (SC) were calculated performing a voxel-by-voxel subtraction of 40keV 
and 200keV images (Matlab R2017b, Mathworks Inc, USA). All stones were 
semi-automatically 3D-segmented on CI using a threshold-based algorithm 
implemented in an offline Dicom-viewer. Statistic assessment was performed 
applying ANOVA with Tukey-HSD post hoc for multiple comparisons. 
Results: Whewellite (n=73), weddellite (n=13), brushite (n=32), cysteine 
(n=19) struvite (n=15) and uric acid stones (n=28) were included in the 
analysis. Stone volume ranged from 10.0 to 599.2mm3. While on CI attenuation 
differed significantly between calcified and non-calcified stones only 
(whewellit/weddellit/brushite vs others: 393HU vs 173HU, p0.05), the spectral 
coefficient differed significantly between (//): whewellite, 
weddellite//brushite//struvite, cysteine//uric acid in 10mGy protocol (all p0.05; 
95% confidence intervals 3.4-4.3//2.6-3.6//1.4-2.2//0.5-0.9). The same results 
were found for the 2mGy protocol, except differentiation of brushite from 
whewellite and weddellite concrements was not possible (p=0.6). 
Conclusion: SDCT allows for differentiation of renal stones using semi-
automatic segmentation and spectral coefficient images, even in low-dose 
imaging protocols.  
B-1474 11:50  
Diagnostic performance of advanced modelled iterative reconstruction-
applied images for detecting urinary stones on submillisievert low-dose 
computed tomography  
J. Ahn, S. Kim, S. Kim, I. Nam, S.-J. Lee; Busan/KR (radiresi@gmail.com)  
Purpose: To compare the sensitivities among the variable advanced modelled 
iterative reconstruction (ADMIRE) strengths applied to submillisievert (sub-
mSv) low-dose CT (LDCT) and standard-dose CT (SDCT) for the detection of 
urinary stones. 
Methods and Materials: A total of 92 consecutive patients (62 men and 30 
women, mean age 50.8 years, range 17-79 years) with urinary stones 
underwent non-enhanced abdomino-pelvic CT that consisted of SDCT (120 
kVp, 200 mAs) and LDCT (80 kVp, 60 mAs). The LDCT images were 
reconstructed separately with 5 different strengths of ADMIRE (hereafter, S1-
S5) and filtered back projection (FBP). Two blinded radiologists independently 
recorded a number of urinary stones in the 6 LDCT data sets and SDCT. The 
sensitivity of each set for detecting urinary stones was compared using the 
McNemar test. 
Results: A total of 309 urinary stones were analysed. The sensitivities of the 6 
LDCT data sets showed no significant difference (FBP, S1-S5, for reader 1: 
61%, 61%, 61%, 62%, 63%, and 62%; for reader 2: 47%, 49%, 50%, 50%, 
51%, and 51%, P > 0.05, respectively), which were lower than those of SDCT 
for both readers (reader 1: 88%; reader 2:f 81%, P < 0.05, respectively). 
Conclusion: The sensitivities for detecting urinary stones showed no 
significant differences among sub-mSv LDCT with variable ADMIRE strengths 
and were lower than those of SDCT.  
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B-1475 10:30  
The value of whole tumour volume-based T2 histogram analysis of 
differential diagnosis in paediatric posterior fossa tumours  
K. Xu, Y. Zhang; Zhengzhou/CN (15188367223@163.com)  
Purpose: To study the value of whole tumour T2 histogram analysis of 
differential diagnosis in three common paediatric posterior fossa tumours 
(ependymoma, astrocytoma, medulloblastoma). 
Methods and Materials: A retrospective analysis was conducted by brain MRI 
examination and pathology diagnosis of 133 cases of posterior fossa tumours 
in children patients in our hospital. Among them, there are 49 cases of 
ependymoma (there are 25 males and 24 females ), 36 cases of astrocytoma 
(there were 19 males and 17 females ), 48 cases of medulloblastoma (there 
were 36 males and 12 females), respectively, to draw the region of interest 
(ROI) in the T2 MR transaxial images of three groups on each layer of tumour 
level using Mazda software and analyse the whole tumour gray histogram, 
performing a statistical analysis on the three sets of parameters obtained from 
histograms to find out statistical significance of each parameter. 
Results: Through histogram analysis of 9 parameters, these 9 parameters 
were statistically significant (all P <0.05), including mean, variance, kurtosis, 
skewness, Perc.01%, Perc.10%, Perc.50%, Perc.90% and Perc.99%. 
Conclusion: The whole tumours T2 grey histogram analysis of three kinds of 
paediatric posterior fossa tumours in the differential diagnosis has certain 
value. It can be used as a new auxiliary method of diagnosis in three paediatric 
posterior fossa tumours.  
  






B-1476 10:38  
Predicting medulloblastoma genomic subtypes by exploiting MRI 
morphologic phenotypes  
M.S. Alahmadi, M. Alharbi, N. Mobark, A.N. Alsaad, A. Daghriri, A.B. Anver, 
M.S.J. Althagafi, S. Raja; Riyadh/SA (mo.alahmadi@gmail.com)  
Purpose: Standard of care mandates classification of medulloblastomas into 4 
genomic subtypes (SHH, WNT, grade III and grade IV) at presentation. 
However, the subtyping is done invasively. Recent work suggests that MRI 
features may classify the subtypes non-invasively. We postulate that a 
combination of morphologic MRI features may be more accurate, for subtype 
prediction. 
Methods and Materials: A retrospective review of baseline MRI of all patients 
already having Medullaobastoma genomic subtyping (no=22) were reviewed 
blindly and the MRI features were categorized by 3 radiologists (expert, 
intermediate, novice), based on modified Vasari criteria for example contrast 
enhancement, morphologic features such as location, hemorrhage, cystic 
component etc. using Access data-sheet, and subsequently exported to SPSS 
modeler for subsequent analysis. 
Results: Out of 22 cases with genomic subtypes of SHH, WNT, Group III and 
Group IV (6,3,3 and 10). We performed a binary classification by combining 
into two separate groups, more aggressive Group III+IV (morAg), and less 
aggressive SHH+WNT (lesAg). The best discriminator was peritumoral 
oedema, and the 2nd best was length of lesion. The classification accuracy of 
the model was 90%, the model classified all lesAg correctly. 
Conclusion: Our results strongly suggest that peritumoral oedema and length 
of lesion on MRI can accurately discriminate medulloblastoma genomic 
subtypes non-invasively. The unique ability of peritumoral oedema to separate 
between the two groups, has not yet been described in the literature. Our 
results show significant peritumoral oedema around lesAG lesions contrary to 
what is expected, we observed that the aggressive medulloblastomas show 
minimal peritumoral oedema.  
B-1477 10:46  
Application of MRI whole-tumour histogram analysis in assessment risk 
of medulloblastoma recurrence  
Q. Lv; Zhengzhou/CN (478071645@qq.com)  
Purpose: To explore the value of MRI whole-tumour histogram in the risk 
assessment of medulloblastoma recurrence. 
Methods and Materials: Retrospective analysis of 26 patients which were 
pathologically confirmed medulloblastoma. These patients were divided into 
two groups, which were defined as the recurrent group and the non-recurrent 
group, each of the groups has 13 cases. Drawing the region of interest (ROI) 
on each slice of enhanced MR sagittal image including and doing the 
histogram analysis, the two steps were both conducted by the software Mazda. 
The histogram parameters were analysed statistically to find out the 
characteristics of the significant differences between the two groups. Next, we 
drew the ROC curve to assess diagnostic efficiency in medulloblastoma 
recurrence. 
Results: As for the 9 parameters extracted from histogram, the differences of 
the variance, the 90th and 99th percentiles between the two groups have 
statistical significance (P<0.05). Areas under the ROC curve were 0.799, 0.728 
and 0.746, respectively. The variance showed the sensitivity and the specificity 
of the risk of medulloblastoma recurrence which were 84.6% and 61.5%, 
respectively; the 90th percentile suggested both the sensitivity and the 
specificity were 69.2%, and by the 99th percentile, they were 69.2% and 
61.5%, respectively. The cutoff of variance, the 90th percentile and 99th 
percentile were 414.66, 128.4, 159.235, respectively. 
Conclusion: MRI whole-tumour histogram analysis can be used as an 
important supplementary method to assess the risk of medulloblastoma 
recurrence.  
B-1478 10:54  
Paediatric astrocytic tumour grading: comparison between ASL and DSC 
MRI perfusion  
S. Staglianò1, D. Tortora2, M. Severino2, C. Martinetti2, M. Garrè2, A. Rossi2, 
G. Morana2; 1Rome/IT, 2Genova/IT (sere.stagliano@gmail.com)  
Purpose: The aim of this study was to compare arterial spin labelling (ASL) 
and dynamic susceptibility contrast (DSC) MRI perfusion with respect to 
diagnostic performance in tumour grading in paediatric patients with low- and 
high-grade astrocytic tumours (AT). 
Methods and Materials: We retrospectively analysed 37 children with 
histologically proven treatment-naïve low- and high-grade AT who underwent 
pre-operative ASL and DSC MRI perfusion. Studies were performed on a 1.5 T 
scanner and a pulsed technique was used for ASL. DSC data were post-
processed with a leakage correction software. Normalisation of tumour 
perfusion parameters was performed with contralateral normal-appearing gray 
matter. Normalised ASL-derived cerebral blood flow (nASL-CBF) values in the 
most perfused area of each neoplasm were compared with normalised DSC-
derived cerebral blood flow (nDSC-CBF) and cerebral blood volume (nCBV) 
data and correlated with WHO tumour grade. Statistics included Pearson’s chi-
square and Mann-Whitney U tests, Spearman’s rank correlation and receiver 
operating characteristic (ROC) analysis. 
Results: A significant correlation was demonstrated between ASL and DSC 
data (p<0.001). Significant differences in terms of ASL and DSC data were 
found between low- and high-grade AT (p<0.001). ROC analysis demonstrated 
similar performances between all parameters in predicting tumour grade 
(nASL-CBF: AUC 0.98, p<0.001; nDSC-CBF: AUC 0.97, p<0.001; nCBV: AUC 
0.97, p<0.001). 
Conclusion: Normalised pulsed ASL performed with a 1.5 T scanner provides 
comparable results to DSC MRI perfusion in paediatric AT and allows 
distinction between high- and low-grade AT.  
B-1479 11:02  
Differentiation of medulloblastoma and astrocytoma in children using 
histogram analysis of enhancement MRI  
W. Wang1, Y. Zhang1, J. Cheng1, Z. Zhang2; 1Zhengzhou/CN, 2Henan/CN 
(252936888@qq.com)  
Purpose: To investigate the diagnostic value of the histogram analysis derived 
from enhancement MR imaging in differentiating medulloblastomas from 
astrocytomas. 
Methods and Materials: Retrospective analysis of 47 patients which were 
pathologically confirmed posterior fossa tumours, including 29 cases of 
medulloblastoma and 18 cases of astrocytoma. Drawing the region of interest 
(ROI) on the maximum level of enhanced MR sagittal image and going on 
histogram analysis, these two steps are all performed on the software named 
Mazda. A statistical analysis was performed on the histogram parameters to 
find out the characteristics of the significant differences between the two 
groups. 
Results: In the 9 parameters which are extracted from histogram, C99 has the 
statistical significance. The maximum area under the ROC curve was 0.85. The 
optimum C99 to distinguish medulloblastomas from astrocytomas was 176.5 
(76% specificity and 61% sensitivity). 
Conclusion: Histogram analysis of enhancement MR imaging can provide 
reliably objective basis for differentiating medulloblastomas from astrocytomas.  
B-1480 11:10  
3D fast spin-echo T1 black-blood imaging for the preoperative detection 
of venous sinus invasion of meningioma: comparison with contrast-
enhanced MRV  
D. Wang; Shanghai/CN (wangddfsk@126.com)  
Purpose: A comprehensive understanding of venous situation is helpful for 
optimised treatment decisions and for managing the severe complications of 
meningiomas adjacent to venous sinuses. To prospectively evaluate the 
diagnostic value of 3D FSE T1 CUBE MR imaging in comparison with contrast-
enhanced MRV in the detection of sinus invasion by meningiomas. 
Methods and Materials: Forty consecutive patients with suspected 
meningiomas adjacent to venous sinus underwent conventional MR imaging, 
CE-MRV and 3D CUBE T1WI scanning. Two neuroradiologists independently 
assessed images for (1) wall invasion and (2) lumen invasion of target venous 
sinus. 
Results: 3D CUBE T1WI imaging was found to afford an easy way to detect 
the venous wall invasion by para-venous lesions. The inter-observer 
agreement was excellent (1=0.851; 95% CI, 0.769-0.933) and the result was 
basically aligned with the surgical findings (sensitivity of 90.91%, specificity of 
94.44%, PPV of 95.23%, NPV of 89.47% and Youden Index of 0.85). In the 
analysis of the lumen invasion, the inter-observer agreement obtained by 3D 
CUBE T1WI sequence was excellent (1=0.958; 95% CI, 0.917-0.999) with a 
diagnostic accuracy of 92.5% based on surgical findings, which surpassed CE-
MRV not only in inter-observer agreement (1=0.717; 95% CI, 0.622-0.812) but 
also in diagnostic value (accuracy=65%). Among all 40 patients, no correlation 
was found between the extent of peritumoural oedema and venous invasion. 
Conclusion: 3D CUBE T1WI sequence is a reliable technique to provide 
accurate assessment about the venous sinus invasion by meningioma. 
Meanwhile, CE-MRV is more suitable in the evaluation of the bypass draining 
veins around the tumour.  
B-1482 11:18  
Quantitative T1rho-weighted magnetic resonance imaging in gliomas: a 
preliminary study of its biochemical mechanism  
Y. Yu, Y. Ren, H. Pang, Z. Yao; Shanghai/CN (yy_0324@126.com)  
Purpose: To evaluate the utility of quantitative T1rho value for differentiating 
between low-grade and high-grade gliomas, and make a preliminary 
exploration of its possible molecular basis. 
Methods and Materials: Thirty-six patients (28 males and 8 females; 43.9 ± 
13.7 years) with pathologically verified gliomas were included in this study. MRI 
was performed for each patient on a 3.0T MRI system. An echo-planar 
  






imaging-based T1rho-weighted MR pulse sequence (spin-lock times 20, 40, 
60, and 80 ms) was employed to obtain single-slice images of maximum 
lesion. T1rho value maps were created using MATLAB software. The T1rho 
value of glioma parenchyma was measured on a manually drawn region of 
interest and correlated with the pathological grade of the gliomas. Furthermore, 
we calculated the hyaluronan intensity of each pathologic sections and 
analysed the correlation between intensity of hyaluronan and T1rho value. 
Results: There were a total of 37 lesions (0, 22, 3 and 12 tumours of grades I, 
II, III, and IV, respectively) in the study. Low-grade (grades I and II) gliomas 
had significantly higher T1rho value than high-grade (grades III and IV) gliomas 
(179.22 ± 44.93 ms vs. 126.24 ± 22.91 ms; P < 0.001). With a cutoff T1rho 
value of 147.68 ms, the sensitivity for glioma grading was 81.8% and the 
specificity was 93.3%. Pathologically, T1rho value has a poor correlation with 
hyaluronan intensity in glioma. 
Conclusion: Quantitative T1rho value can be a reliable imaging biomarker of 
the malignancy of brain gliomas. The cellular and molecular basis of T1rho is 
still unknown.  
B-1483 11:26  
DCE-MRI in human gliomas: a surrogate for assessment of invasive 
hypoxia marker HIF-1 based on MRI-neuronavigation stereotactic 
biopsies  
Q. Xie1, J. Wu2, Y. Ren1, H. Pang1, H. Zhang1, T. Jin1, Y. Wu1, Z. Yao1,  
X. Feng1; 1Shanghai/CN, 2Nantong/CN (xieqianjames@foxmail.com)  
Purpose: The purpose of this study was to correlate dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI) parameters with data from 
a specific marker of hypoxia, hypoxia-inducible factor 1(HIF-1), in human 
gliomas on a point-to-point basis using coregistered MRI and frameless 
stereotactic biopsies. 
Methods and Materials: Thirty-four patients with treatment-naive gliomas 
underwent DCE,axial T1-weighted(T1W),T2-weighted (T2W),T2-weighted fluid 
acquisition of inversion recovery (T2FLAIR),and three-dimensional T1-
weighted brain volume with gadolinium contrast enhancement(3D 
T1BRAVO+C)sequences on a 3.0-T MR scanner before stereotactic surgery. 
Quantitative perfusion indices such as endothelial transfer constant (Ktrans), 
fractional extravascular extracellular space volume (Ve),fractional plasma 
volume (fpV), and reflux rate (kep) were measured at corresponding stereotactic 
biopsy sites.Each sample was considered an independent measurement, and 
its histology grade was diagnosed.HIF-1 expression was quantified from the 
point-to-point biopsy tissues. Analyses of receiver operating characteristic 
(ROC) curves were done for HIF-1 to discriminate different grades of 
glioma.To look for correlations between immunohistochemical (IHC) 
parameters and DCE indices, Spearman’s correlation coefficient was used. 
Results: Seventy biopsy samples from 34 subjects were included in the 
analysis. Mean immunoreactivity scores of HIF-1 were 2.75±1.11 for grade II 
(n=24), 6.20±2.33 for grade III (n=20) and 10.46±2.42 for grade IV(n=26). HIF-
1 showed very good-to-excellent accuracy in discriminating grade II from III,III 
from IV,and II from IV (area under the curve=0.838, 0.862 and 0.994, 
respectively). Ktrans and Ve showed a significantly positive correlation with HIF-
1 expression(r = 0.686, P < 0.001; r = 0.549, P<0.001, respectively). 
Conclusion: Our study demonstrated HIF-1 to be a significant predictor of 
different grades of gliomas with high sensitivity and specificity. DCE-MRI is a 
useful, non-invasive imaging tool for quantitative evaluation of HIF-1, and its 
parameters may be used as a surrogate for HIF-1 expression.  
B-1484 11:34  
3D MRSI biomarkers of glial tumour  
T. Anastasia, I. Pronin, L. Fadeeva, V. Kornienko; Moscow/RU 
(alfa.net@list.ru)  
Purpose: To evaluate metabolite ratio in the whole tumour volume on the base 
of 3D 1H-MP spectroscopy in patients with glial brain tumours. 
Methods and Materials: 20 healthy volunteers (age 26-65 years), 20 patients 
(age 28-65 years) with low-grade gliomas and 20 patients (age 25-60 years) 
with high-grade gliomas were examined in our study. We assessed the 
following metabolites: choline, creatine and N-acetylaspartate. 
Results: In control group of healthy volunteers, we measured the metabolite 
ratio in white and grey brain matter. There were following ratios in white matter: 
Cho/NAA - 1.45±0.30, Cho/Cr - 1.15±0.11, NAA/Cr - 2.70±0.20 and grey 
matter: Cho/NAA - 0.52 ± 0.09, Cho/Cr - 1.14 ± 0.11, NAA/Cr - 2.53 ± 0.19. In 
glial brain tumours the good correlation between an elevation of Cho/Cr ratio, 
decreases of NAA/Cr ratio and degree of malignancy were found. High-grade 
gliomas demonstrated an elevation of Cho/Cr (3.41±0.79) and Cho/NAA 
(2.27±1.3), compared with low-grade tumours Cho/Cr (2.54±1.44) and 
Cho/NAA (2.76±1.2). NAA/Cr ratio was higher in low-grade gliomas 
(1.44±0.57) in comparison with grade III-IV lesions (0.95±0.41). 
Conclusion: 3D MRSI provides the clinicians qualitative and quantitative 
markers of brain biochemistry in normal brain and in gliomas. Precisely to 
evaluate the tumour malignancy.  
B-1485 11:42  
Brain tumour-induced alterations in haemodynamic responses of BOLD 
fMRI  
L. Wang1,2, Y. Zhang3, Z. Liu4, D. Chen5, L. Liu1, H. Mao2; 1Shenzhen/CN, 
2
Atlanta, GA/US, 3ShenZhen/CN, 4Nanchang/CN, 5Suzhou/CN 
(2718377613@qq.com)  
Purpose: To investigate the effect of brain tumours on the haemodynamic 
responses and its impact on BOLD MRI signal time course to better 
understand tumour-induced alterations in haemodynamic responses and for 
accurate mapping in brain tumour patients. 
Methods and Materials: fMRI data from 42 glioma patients who underwent 
presurgical mapping of primary motor cortex (PMC) with a block-designed 
fingertapping paradigm were analysed, retrospectively. Cases were divided 
into high- (n=24) and low- (n=18) grade groups based on pathology. Tumour 
volume and distance to the activated PMCs were measured. BOLD signal time 
courses from selected regions of interest (ROIs) in the PMCs of tumouraffected 
and contralateral unaffected hemispheres were obtained from each patient. 
Tumour-induced changes of BOLD signal intensity and time to peak (TTP) 
were analysed statistically. 
Results: BOLD signal intensity and TTP in the tumour-affected PMCs are 
altered when compared with that in the unaffected hemisphere. The average 
BOLD signal level is statistically significantly lower in the affected PMCs. The 
average TTP in the affected PMCs is shorter in the high-grade group, but 
longer in the low-grade group compared to the contralateral unaffected 
hemisphere. The degrees of alterations in BOLD signal time courses are 
related to both the distance to activated foci and tumour volume, with a 
stronger effect in tumour distance to activated PMC. 
Conclusion: Alterations in BOLD signal time courses are strongly related to 
tumour grade, tumour volume, and distance to the activated foci. Such 
alterations may impair accurate mapping of tumour-affected functional areas 
when using conventional fixed models.  
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B-1486 10:30  
Volumetric histogram-based analysis of SUV and ADC values for the 
assessment of paediatric sarcomas at staging: preliminary results of a 
PET/MR study  
A. Varotto1, G. Orsatti1, F. Crimì1, D. Cecchin1, P. Zucchetta1, M. Weber2, 
R. Stramare1, C. Giraudo1; 1Padua/IT, 2Vienna/AT (ale.varotto86@gmail.com)  
Purpose: Previous studies showed heterogeneous results about the 
correlation between metabolic activity and cell density in sarcomas. Thus, our 
aim was to assess the relationship between ADCs and SUVs in paediatric 
sarcomas at staging, using histograms obtained by volumetric analyses. 
Methods and Materials: Paediatric patients with histologically proven 
sarcoma, referring to our tertiary centre for a whole-body [18F]-FDG-PET/MR 
for staging and including DWI in the MR protocol were investigated. First, TIRM 
and PET images were re-sliced and resampled according to the ADC maps 
(i.e. Osirix Software). Regions of interest were drawn along tumour margins on 
TIRM images and then copied on PET and ADC datasets. Pixel-based SUVs 
and ADCs were collected from the entire volume of each lesion. Mean, 
median, skewness, kurtosis of SUVs and ADCs values were computed and 
Pearson correlation coefficient was applied (i.e. for the entire population and 
separately, for histological subgroups including more than five patients). 
Results: Ten patients met the inclusion criteria (five males; mean age 
8.9±5.7years). Histology revealed six rhabdomyosarcoma (i.e. three alveolar 
and three embryonal), two Ewing-sarcoma, one diffuse myofibromatosis and 
one chondroblastic osteosarcoma. The mean volume of the lesions was 
135.46±172.16cm3. A significant negative correlation between ADCs’ and 
SUVs’ mean (rmean=-0.326, p<0.001), median (rmedian=-0.393, p<0,001) and 
skewness (rskewness=-0.623, p<0.001) emerged for the entire population and for 
rhabdomyosarcomas (rmean=-0.365, p=0.002, rmedian=-0.467, p<0.001, rskewness=-
0.691, p<0.001) whereas a significant positive correlation was found for 
kurtosis (rkurtosis=0.412, p<0.001 and rkurtosis=0.395, p<0.001, respectively, for 
the entire population and for rhabdomyosarcomas). 
Conclusion: Our preliminary results demonstrate that, using volumetric 
histograms, SUVs and ADCs are dependent biomarkers in paediatric 
sarcomas. Further studies, on a larger population, are necessary to confirm 
this evidence and assess its clinical implications after therapeutic treatment.  
  






B-1487 10:34  
Computer-assisted detection of acute pulmonary embolism in children 
and young adults: inter-observer effect  
C. Tang1, C. Zhou1, U.J. Schoepf2, D. Mastrodicasa3, Y. Zhao1, L. Lu1, X. Li1, 
M. Lu1, L. Zhang1; 1Nanjing/CN, 2Charleston, SC/US, 3Chieti/IT 
(522956587@qq.com)  
Purpose: To evaluate the effect of a CAD algorithm on the identification of 
acute PE on CTPA studies in children and young adults by readers with 
varying experience levels. 
Methods and Materials: In this retrospective study, six readers with differing 
levels of experience evaluated 303 patients’ CTPA studies (range, 6-25 years) 
on per-emboli basis. Observers were asked to independently determine the 
presence of PE and rank their diagnostic confidence on a five-point scale with 
and without CAD. Reading time was recorded and sensitivities, specificities, 
accuracies, PPVs and NPVs were calculated. 
Results: For all readers, there was no diagnostic performance difference in 
detecting central PE in the first to the third levels of the pulmonary arteries with 
or without the CAD (all P values >0.05). However, significant differences were 
found in the detection of peripheral PE with CAD versus without CAD. Except 
the most experienced reader, the sensitivities and NPVs differed significantly 
between with CAD and non-CAD readings. Additionally, the accuracies of all 
readers differed significantly between readings done with or without CAD. For 
each reader, the time with CAD was longer than those without CAD. Significant 
differences were found for confidence scores in inter-group measurements with 
CAD (P=0.045) and without CAD (P<0.001), but no difference in the 
confidence scores of any individual readers between CAD and non-CAD 
readings (P>0.05). 
Conclusion: At the expense of longer reading time, the use of CAD improves 
sensitivities and NPVs for most readers and the accuracies of all readers in 
peripheral PE detection.  
Author Disclosures: 
 U.J. Schoepf: Consultant; Bayer, Bracco, GE Healthcare, Medrad, and 
Sieme. Research/Grant Support; Bayer, Bracco, GE Healthcare, Medrad, and 
Sieme.  
B-1488 10:38  
Clinical equivalence assessment of T2 synthetic paediatric brain MRI  
B. Kerleroux1, T. Kober2, T. Hilbert3, D. Sirinelli1, B. Morel1; 1Tours/FR, 
2
Zurich/CH, 3Lausanne/CH (basile.kerleroux@gmail.com)  
Purpose: Automated synthetic MR imaging (SyntMRI) provides different image 
contrasts as well as quantitative information from one scan. It would well suit 
paediatric neuroradiology for various applications such as analysis of white 
matter disorders. However, SyntMRI has been poorly evaluated in this 
population. The purpose of this study was to compare the image quality of 
synthetic T2 with conventional TSE T2 in paediatric brain MRI. 
Methods and Materials: This was a mono-centre prospective study. Synthetic 
and conventional MRI acquisitions at 1.5 Tesla were performed for each 
patient during the same session using a prototype accelerated T2 mapping 
sequence package (TAsynthetic=3:07 min, TAconventional=2:33 min). Image sets 
were blindly and randomly analysed by senior and fellow paediatric 
neuroradiologists. Global image quality, morphologic legibility of standard 
structures and artefacts were assessed using a 4-point Likert scale. Inter-
observer kappa agreements were calculated. The capability of SyntMRI and 
conventional T2 to discern normal and pathological cases was evaluated. 
Results: Sixty patients were enrolled. The diagnostic quality of SyntMRI was 
non-inferior to conventional imaging scale (p=0.06). There was no significant 
difference in the legibility of normal and pathological anatomic structures of 
synthetic and conventional T2 (all p > 0.05) as well as for artefacts except for 
phase encoding (p=0.008). Interobserver agreement was good to almost 
perfect (kappa between 0.66 and 1). 
Conclusion: T2 SyntMRI, which provides quantitative T2 information that 
could be used to build normative databases of healthy subjects, could be 
suggested as an equivalent technique in paediatric neuro-imaging, compared 
to conventional TSE T2.  
Author Disclosures: 
T. Kober: Employee; Siemens.  
B-1489 10:42  
Effect of a child-adjusted method for brain volume quantification on 
group comparisons in dyslexia  
T. Phan, D. Smeets, M. Vandermosten; Leuven/BE (van.phan@icometrix.com)  
Purpose: A child-adjusted method for the quantification of grey matter (GM) 
and white matter (WM) volumes in young children is introduced, and its impact 
on group comparisons between healthy controls and dyslexia is assessed. 
Methods and Materials: T1-weighted images were acquired from children of 
5-6 years old (21 controls, 15 children with dyslexia) and checked for motion 
artefacts. For brain volume quantification, the brain segmentation was adjusted 
to children by the use of an age-specific atlas and probabilistic model-based 
algorithm (referred to as childmetrix). Group comparisons based on GM and 
WM volumes estimated by this method are compared to results obtained with a 
method using the same segmentation algorithm, but based on an adult atlas 
(icobrain) and a method using a surface model-based segmentation based on 
an adult atlas (Freesurfer). 
Results: Subtle differences between healthy controls and children with 
dyslexia were better captured by childmetrix that showed a higher effect size 
(Cohen’s d of 0.40 for GM and 0.45 for WM) compared with icobrain (GM: 0.27, 
WM: 0.40) and Freesurfer (GM: 0.31, WM: 0.38). Compared to the literature, 
the results obtained with childmetrix on children of 5-6 years old were similar to 
differences measured in older populations (GM: 0.40, WM: 0.40). 
Conclusion: The choice of segmentation method has an impact on group 
comparisons. Brain segmentation is adapted to young children (under 6 years 
old) by the use of an age-specific atlas, which enables measuring the subtle 
differences that might not be observed using standard methods based on adult 
atlas.  
Author Disclosures: 
  T. Phan: Employee; employee at icometrix. Research/Grant Support; 
European Union H2020 MSCA-ITN-2014-ETN Programme, ChildBrain, 
#641652. D. Smeets: Employee; employee at icometrix.  
B-1490 10:46  
Enhancement of MRI histogram in the identification of children with 
medulloblastoma and ependymoma  
W. Wang, J. Cheng, Y. Zhang; Zhengzhou/CN (weijianwang520@163.com)  
Purpose: To investigate the diagnostic value of the histogram analysis derived 
from enhancement MR imaging in differentiating medulloblastomas from 
ependymoma. 
Methods and Materials: Retrospective analysis of pathologically confirmed 36 
cases of posterior fossa tumors, including 20 cases of medulloblastoma, 16 
cases of ependymoma. The collection of the two kinds of tumor T1, T2 and 
enhanced T1 weighted magnetic resonance images, extraction of tumor region 
of interest using the software of MaZda (region of interest, ROI), histogram 
analysis for the maximum level of tumor region of interest, using the average 
value, variance, skewness, kurtosis, the 1,10,50,90,99 percentile 
characteristics, find out the significant differences between the two kinds of 
tumors. 
Results: Histogram analysis of ADC including the mean, variance, skewness, 
kurtosis, the 1,10,50,90,99 percentile characteristics.The mean, variance, 
skewness,90th and 99th percentile were detected statistical significance.ROC 
curve analysis of the variance yielded the best area under the ROC curve 
(AUC; 0.90), sensitivity of 92%, and specificity of 90%, with a cutoff value of 
820. 
Conclusion: Histogram analysis can provide more quantitative information 
characteristics, which provides a new method for the differential diagnosis of 
children with medulloblastoma and ependymoma.  
B-1491 10:50  
Prenatal imaging of anorectal malformations  
L. Rohrer, Y. Vial, R. Meuli, L. Alamo-Maestre; Lausanne/CH 
(lysiane.rohrer@gmail.com)  
Purpose: Anorectal malformations (ARM) are usually classified as low, 
intermediate and high type. Most of them are first discovered after birth. The 
purpose of this study is to describe the imaging signs suggesting ARMs at 
prenatal US and MRI exams in order to improve early diagnosis and optimize 
perinatal care. 
Methods and Materials: All available prenatal imaging studies performed on 
children treated for ARM at the University Hospital of Lausanne between 2001-
2016 were retrospectively reviewed and compared with the final diagnosis (low 
or intermediate-high ARM), obtained from postnatal imaging studies, surgery 
and/or autopsy records. 
Results: We identified 54 children treated for ARM. Only 5 cases (9.2%) were 
diagnosed in utero. Prenatal exams were available in 17 cases (15 US, 7 MRI) 
corresponding to 5 low- and 12 intermediate-high type ARM, including 5 
cloaca. Diagnosis was prenatally suspected in 5/17 (29.4%) and associated 
anomalies, mainly vertebral and renal, present in 15/17 cases (88%). 
Retrospectively evaluation identified imaging findings suggesting ARMs in 
11/17 cases (64.7%, 1/5 low and 10/12 intermediate-high type ARMs). 
Findings include small or no anus identification and distal digestive dilatation in 
ARMs without fistula; rectal echogenic fluid and rectal hyperintense signal in 
T2-WI MRI images in ARMs with fistula and genital duplication and pelvic 
cystic masses in cloaca. 
Conclusion: Prenatal diagnosis of ARMs requires a routine and systematic 
examination of the fetal pelvis and perineal area, especially in presence of 
vertebral, renal or genital anomalies. However, low type malformations remain 










B-1492 10:54  
Prognostic value of radiological response assessment after induction 
therapy in paediatric soft tissue sarcomas  
G. Orsatti1, A. Varotto1, F. Crimì2, G. Bisogno1, I. Zanetti1, C. Giraudo1, 
R. Stramare1; 1Padua/IT, 2Vicenza/IT (giovanna_orsatti@hotmail.it)  
Purpose: Previous studies showed controversial results about the correlation 
between the dimensional modification, due to induction therapy, of paediatric 
soft tissue sarcomas (pSTS) and patients’ outcome. Thus, our aims were to 
compare three methods of pSTSs dimensional assessment and evaluate their 
prognostic value. 
Methods and Materials: Forty-five paediatric patients with non-metastatic STS 
(26 rhabdomyosarcomas and 19 non-rhabdomyosarcomas) who underwent 
MR or CT imaging at staging and after three cycles of chemotherapy were 
included.Three observers measured the tumour size using three different 
methods:maximal diameter, estimated volumetric assessment(the product of 
the three-maximal diameters and 2/6) and software-assisted volumetric 
assessment.To investigate the interobserver agreement, the Overall 
Concordance Correlation Coefficient(OCCC) was calculated.Regarding tumour 
response, each patient was classified as “Good responder”(i.e.,including Very 
good and Partial Response) or “Poor responder”(i.e.,including Stable and 
Progressive Disease)according to each radiological method.To assess the 
inter-method agreement,Cohen’s kappa coefficient was calculated.The Kaplan-
Meier method was used to estimate the event-free survival(EFS) 
distribution.Differences between survival curves were analysed by the log-rank 
test. 
Results: Interobserver agreement was very high for each method 
(OCCC>0.9).The three methods showed a poor agreement regarding the 
classification of tumour response (i.e.,highest value, k=0.56 between the two 
volumetric techniques).In rhabdomyosarcomas, the three-years EFS resulted 
to be significantly higher in “Good Responders” than in “Poor responders” 
using the estimated (76.2% vs 40%,p=0.02) and the software-assisted 
volumetric assessment (80% vs 33.3%,p=0.002) whereas no significant 
differences emerged for the “non-rhabdomyosarcomas”(p>0.05,for each 
method). 
Conclusion: The volumetric assessment, especially when software-assisted, 
demonstrated to be a significant prognostic factor for paediatric STSs. Larger 
future studies are necessary to confirm these preliminary results.  
B-1493 10:58  
Central nervous system (CNS) involvement in congenital heart diseases 
(CHD): value of foetal MRI  
R. Petrillo, A. Antonelli, S. Bernardo, S. Satta, V. Vinci, L. Manganaro, 
 C. Catalano; Rome/IT (roberta.petrillo@hotmail.it)  
Purpose: To demonstrate the diagnostic value of foetal MRI in the detection of 
CNS impairment in prenatally echocardiographic diagnosed CHD. 
Methods and Materials: We retrospectively examined 24 fetuses (mean 
gestational age: 19-33), between February 2012 and April 2017, who 
underwent MRI in our institution at 1.5 T (Siemens Magnetom Avanto), without 
maternal sedation, after a foetal echocardiography. Prenatal findings were 
compared to fetopsy results, foetal MRI after 30 GW or postnatal MRI. 
Results: On 24 cases, 7/24 had interatrial septal defect (IASD), interventricular 
septal defect (IVSD), and atrioventricular canal defect (CAVC), 6/24 had 
cardiac rhabdomyomas, 3/24 had hypoplastic left heart syndrome and 
hypoplastic aorta, 2/24 had transposition of the great vessels, 2/24 had Fallot 
tetralogy, 2/24 had aorta coartation and 2/24 had intracardiac masses of 
uncertain significance. Magnetic resonance imaging was able to detect CNS 
impairment: we recognise 11/24 corpus callosum (CC) dysgenesis (4/13 CC 
hypoplasia, 4/13 complete CC agenesis, 3/13 partial CC agenesis), 7/24 
ventriculomegalies or hydrocephalus, 3/24 subtentorial anomalies (Dandy-
Walker, vermian hypoplasia and vermian malrotation), and 3/24 gyration 
anomalies. 
Conclusion: Due to the high risk of CNS involvement in prenatal congenital 
heart diseases, it is essential to suggest an MRI study of the evolving foetal 
brain, especially in complexes forms that suggest a syndromic background. 
Foetal MRI of the CNS is mandatory in the study of congenital heart disease 
due to the high rate of encephalic anomalies associated, particularly in IASD, 
IVSD and CAVC.  
B-1494 11:02  
Vermis-to-Pons ratio in the differential diagnosis of Vermian 
malformations: a foetal MRI study  
A. Antonelli, S. Bernardo, R. Petrillo, S. Satta, S. Ciulla, V. Vinci, 
L. Manganaro, C. Catalano; Rome/IT (amanda.antonelli@hotmail.it)  
Purpose: To assess the feasibility of Vermis-to-Pons Ratio in helping the 
prenatal MR diagnosis of isolated Dandy-Walker Malformation (DWM), in 
fetuses with a Ultrasonographic (US) suspicion of Posterior Cranial Fossa 
(PCF) abnormalities. 
Methods and Materials: A total of 38 fetal MRI, performed in our department 
between April 2013 and June 2017 after a US examination, were 
retrospectively reviewed. All MRI examinations were performed using a 1.5 
Tesla Magnetom Avanto (Siemens, Erlangen, Germany) without maternal 
sedation. Gestational Age (GA) range was 20-31 weeks. The study sample 
included fetuses with a US suspicion of PCF malformations such as DWM, 
vermian hypoplasia/agenesis, vermian malrotation and Walker Warbourg 
Syndrome (WWS); fetuses with Chiari Malformation type II, cerebellar 
hemorrhage and rhomboencephalosynapsis were excluded. Vermis-to-Pons 
Ratio was manually measured in all cases. 
Results: Fetal Magnetic Resonance Imaging found 16/38 cases of DWM, 6/38 
of vermian malrotation, 2/38 of WWS and 4/38 isolated vermian hypoplasia; 
10/38 fetuses had normal PCF anatomy and sub-tentorial morphology. In 
DWM the Vermis-to-Pons ratio was <1, while in normal fetuses was 1. 
Depending on the maternal decision to continue the pregnancy, prenatal MRI 
findings matched with both fetopsy results and postnatal MRI. 
Conclusion: The Vermis-to-Pons Ratio could be an additional parameter and 
a helpful tool in the assessment of PCF malformations, with a special focus on 
the differential diagnosis between DWM and vermian malrotation.  
B-1495 11:06  
Radiation use in paediatric age: are paediatricians updates of the state of 
the art legislation?  
S. Salerno1, C. Tudisca1, C. Granata2, D. Origgi3, L. Moro4, M. Barbagallo5, 
G. Corsello1, A. Villani6; 1Palermo/IT, 2Genoa/IT, 3Milan/IT, 4Pavia/IT, 
5
Catania/IT, 6Rome/IT (ssalerno@sirm.org)  
Purpose: To assess the opinion on use of radiation in paediatric age and 
radiation protection knowledge by paediatricians members of the Italian 
Paediatric Society (SIP) via an online survey. 
Methods and Materials: All members received an email invitation to join the 
survey as an initiative by the "Radiation in Paediatrics" project involving SIP, 
Italian Society of Medical Radiology (SIRM)  and Italian Association of Medical 
Physics (AIFM) Scientific Societies. The survey included 11 questions about 
general knowledge on radiation protection and new legislation on the 
theme/issue of the respondents and eventual criticisms found in radiation 
protection field in the everyday practice. 
Results: 877 SIP members participated in the survey and have entirely fulfilled 
the questionnaire. The most significant results of the survey were: 57.6% of the 
participants ignore the existence of guidelines that can help them in choosing 
the most appropriate diagnostic examination according to patient's symptoms, 
and the 47,1% has difficulties to evaluate the risk related to the use of 
examination using ionizing radiation. 43% do not know the European Directive 
2013/59 Euratom. 98% of the participants believe it is necessary to grow their 
knowledge on the topic of radiation protection, considering useful a specific 
training on practical issues. 
Conclusion: Most paediatricians were interested in radiation protection theme 
and considered their knowledge inadequate for their daily practice. Aim of the 
radiological society should be to organize a large-scale information campaign 
to spread the theme of radiation protection in a paediatric environment.  
B-1496 11:10  
Histogram analysis of apparent diffusion coefficients may predict 
molecular subgroups of medulloblastoma in children  
W. Wang, J. Cheng, Y. Zhang; Zhengzhou/CN (weijianwang520@163.com)  
Purpose: The aim is to verify if ADC histogram is able to predict new 
subgroups of MB. 
Methods and Materials: sixty-five patients with diagnosis of MB(30 classic, 8 
desmoplastic/nodular, 7 extensive nodularity, 20 large cell/anaplastic ), with 
pretreatment MR imaging, histologic, genomic characterisation after surgery, 
were retrospectively selected. ADC maps were coregistered with T1w post-
contrast and T2 images. Drawing the region of interest(ROI) on the maximum 
level of ADC maps and going on histogram analysis,these two steps are all 
performed on the software named Mazda.We used the Mann-Whitney test to 
evaluate the capacity of histogram parameters to discriminate among paired 
MB subgroups. 
Results: Desmoplastic/nodular and extensive nodularity were detected no 
statistical significance. A trend in differences was found between classic and 
large cell/anaplastic. 9 texture parameters using histogram extracted, with 
statistical significance (mean,variance,1 percent,10 percent). ROC curve 
analysis of the 10th percentile yielded the best area under the ROC curve 
(AUC; 0.96), sensitivity of 98%, and specificity of 96%, with a cutoff value of 
90. 
Conclusion: The study shows histograms analysis of apparent diffusion 
coefficient can provide reliably objective basis for molecular subgroups of 










B-1497 11:14  
The role of prenatal diffusion weighted MRI in the evaluation of the fetal 
CNS condition in patients who received intrauterine blood 
hemotransfusion as the hemolytic disease threatment  
A.A. Berman1, A. Ageev1, O. Chernova2, A. Vazhenin2; 1Ekaterinburg/RU, 
2
Chelyabinsk/RU (ageev.artem@gmail.com)  
Purpose: The purpose of the study is to evaluate the apropriateness of 
prenatal MRI using diffusion weighted sequences in the evaluation of fetal 
brain focal lesions in cases of mother`s hemolytic anemia before and after 
treatment of fetuses by intrauterine hemotransfusion. 
Methods and Materials: The focus group included 30 pregnant women with 
presence of haemolytic fetal disease by Rh- factor, which required treatment 
who underwent intrauterine blood hemotransfusion, and further their 30 
newborns with hemolytic disease and perinatal hypoxic-ischemic brain injury. 
The control group included 15 pregnant women without hemolytic disease with 
concomitant pathology of pregnancy comparable in gestational age, and 
further their 15 newborns. Prenatal MRI were performed at 1,5 T scanner. MRI 
protocol included DWI sequences with b0 and b700 s/mm2. The local lesions 
in the fetal brain detected on MRI were defined as focal zones of 
hyperintensive signal at the T2 and DWI sequences accompanied by the signal 
restriction on the ADC maps. 
Results: 45 focal lesions in 30 patients in focus group were revealed before 
therapy and only 12 focal lesions were revealed after therapy before birth. 
Average size of lesions was 1,8x1,9x2,1 mm and 0,4x0,4x0,5 mm respectively. 
No lesions were revealed in control group. 
Conclusion: A statistically significant difference in the MRI data in focus and 
control group and before and after intrauterine blood transfusion was obtained 
thus prenatal MRI with DWI sequences was considered to be apropriate for 
pathomorphological evaluation of fetal focal brain lesions and evaluation of 
effectiveness of intrauterine hemotransfusion.  
B-1498 11:18  
Hepatobiliary ultrasonographic abnormalities and clinical severity score 
of paediatric sickle cell anaemia patients in a resource-poor setting  
D. Ibe; Kaduna/NG (church.donaldo@yahoo.com)  
Purpose: To determine the relationship between hepatobiliary 
ultrasonographic abnormalities and clinical severity score of paediatric sickle 
cell anaemia patients. 
Methods and Materials: A cross-sectional descriptive study of hepatobiliary 
ultrasonographic findings of 420 steady-state paediatric sickle cell anaemia 
patients aged 1-18 years was conducted using Mindray (DC8) ultrasound 
machine. Clinical severity score was assessed based on 3 parameters: (a) the 
present state of the child: splenic (0-2) and hepatic (0-2) enlargement, current 
haematocrit (0-2) and total white blood count (0-2); (b) frequency of significant 
painful episodes (0-3), blood transfusion (0-3), and hospitalization (0-3) in the 
previous 12 months and (c) lifetime cumulative incidence of complications for 
each patient: cerebrovascular accident (5), acute chest syndrome (3), 
pneumococcal meningitis (3), avascular necrosis (2), gallstone (1), chronic leg 
ulcer (1), osteomyelitis (1), or priapism (1). A total score calculated ranged from 
0 to 34 and the disease categorized as: mild (<8), moderate (8-17) and severe 
(>17). Chi-square test and Fisher's exact test were used to test for statistical 
relationship between variables. 
Results: One hundred and forty-seven (35%) patients had hepatobiliary 
abnormalities with hepatomegaly (66.7%), biliary sludge (28.6%) and 
gallstones (17%) as the common findings. Mild and moderate forms of clinical 
severity of sickle cell anaemia were seen in 45.6% and 54.5%, respectively. 
None of the patients had a severe form of clinical severity. There was a 
statistically significant association between hepatobiliary abnormalities and the 
clinical severity of steady-state paediatric sickle cell anaemia patients (p value 
<0.001). 
Conclusion: Hepatobiliary abnormalities have a statistically significant 
association with clinical severity score of paediatric sickle cell anaemia 
patients.  
B-1499 11:22  
Ultrasound diagnostics of the respiratory distress syndrome in 
premature infants  
O. Sorochan; Kharkiv/UA (Sorochanop@gmail.com)  
Purpose: To identify capabilities of lung ultrasound (LUS) in the diagnostics of 
respiratory distress syndrome (RDS) in premature infants. 
Methods and Materials: We studied 54 preterm infants (32 boys, 22 girls) 
gestation age 25-34 weeks with diagnosis of RDS with varying severity grades. 
Ultrasound was performed at the bedside of a patient using the device Logiq E, 
GE Medical Systems, linear transducer with a frequency of 5-12 MHz. Chest x-
ray (CXR) was performed for all patients the same day. 
Results: The basic patterns of the lung tissue changes we found was B-line 
and consolidation ("white lung"). Evaluation was carried out according to the 
number of B-lines in the intercostal spaces. The most serious degree 
manifested pattern of "white lung". On the base of this pattern premature 
infants with RDS were divided into four groups by degree of severity: 1st - 
20.0%, 2nd - 40%, 3rd - 36.1%, and 4th - 13.9%. There was high correlation in 
CXR and LUS severity data that indicates possibility of its using in medical 
practice. 
Conclusion: Ultrasound could not replace CXR to estimate all changes of the 
lungs, but can complement it. Also it can be useful for monitoring already 
established RDS to reduce radiation exposure.  
B-1500 11:26  
Role of MR enterography in evaluation of disease activity and treatment 
response in paediatric Crohn's disease correlation between MRE and 
PCDAI scores  
A. Chellathurai, A. Narasingam, S. Radhakrishnan, S. Sankaranarayanan, 
D. Arun; Chennai/IN (amarrd02@yahoo.co.in)  
Purpose: The aim of the study was to assess the role of MR enterography in 
the diagnosis and follow-up of children with Crohn’s disease and to correlate 
disease activity indices with known MR enterography features of active 
disease. 
Methods and Materials: This was a retrospective study including 24 patients 
(median age 11yrs, male 17) with clinically and histologically proven CD who 
underwent MRE. Two previously validated MRE scores - MR enterography 
global score (MEGS) and CD MRI index( CDMI) were calculated. A correlative 
analysis was made between the PCDAI score and MRE scores as well as 
individually with each MR variable. Comparison of both the MR scores was 
made between patients with different disease activity. 
Results: MEGS and PCDAI scores showed strong positive correlation (r 
equals 0.724, p equal to or less than 0.001) CDMI and PCDAI scores showed 
moderate positive correlation (r equal to 0.661, p equal to 0.0004). There was 
a statistically significant difference in the MR scores between patients grouped 
by clinical activity. Among individual MR variables, mural thickness and 
enhancement best predicted the disease activity. 
Conclusion: MR enterography-based scores and findings correlate with 
clinical activity in paediatric Crohn’s. Thereby, MRE can be considered a 
valuable tool in the management of CD, predicting disease activity and offering 
a potential alternative to endoscopy in monitoring patients during follow-up.  
B-1501 11:30  
Transverse comparisons between ultrasound and radionuclide 
parameters in children with pelviureteric junction obstruction  
N.O. Shwaky; Cairo/EG (norhanmedecine@yahoo.com)  
Purpose: Correlation between ultrasound parameters and dynamic 
scintigraphic parameters in pelviureteric junction obstruction, the importance of 
each factor, and which of the ultrasound parameters most reflect the renal 
function, and if we can predict, on the basis of ultrasound parameters, the 
patient in whom radionuclide renography can be avoided. The role of 
ultrasound and radionuclide parameters in deciding on surgery was studied . 
Methods and Materials: Ultrasound and renographic studies were compared. 
Anteroposterior pelvic diameter (APD) and calyceal size were divided into 
three levels of dilatation. Parenchymal thickness was considered either normal 
or significantly decreased. Acquisition of renograms with quantification of DRF, 
quality of renal drainage and cortical transit was carried out. 
Results: The low DRF and poor drainage were higher among those with major 
hydronephrosis, severe calyceal dilatation or parenchymal thinning. Impaired 
cortical transit, which is a major risk factor for functional decline, was seen 
more frequently among those with very severe calyceal dilatation. However, 
none of the structural ultrasound parameters was able to predict whether the 
level of renal function or the quality of drainage was normal or abnormal. 
Alternatively, an APD <30 mm, a calyceal dilatation of <10 mm and a normal 
parenchymal thickness were associated with a low probability of decreased 
renal function. 
Conclusion: Nuclear medicine examinations may be postponed in those with 
an APD <30 mm, a calyceal dilatation of <10 mm and a normal parenchymal 
thickness. On the contrary, precise estimation of DRF and renal cortical transit 
should be performed in APD >30 mm, major calyceal dilatation and/or 
parenchymal thinning.  
B-1502 11:34  
Spectrum of malformations of cortical development with 
clinicoradiological correlation and analysis of associated abnormalities: 
experience from a tertiary care centre in Egypt  
D.M. El-Mossly, S.A. Mohammad, E.M. Abelhafez, N. Osman, K.A. Ahmad; 
Cairo/EG (dollyelmossly@yahoo.com)  
Purpose: Malformations of cortical development (MCD) usually cause 
developmental disability, focal neurological deficits and seizures in children 
which are frequently resistant to anticonvulsant treatment. The structural 
neuroimaging technique especially MRI is the most important non-invasive 
method in their diagnosis and other associated brain abnormalities, thus 
  






smaller lesions can be identified. So, it is important to exclude MCD in every 
case of developmental delay, congenital neurological signs and intractable 
epilepsy. 
Methods and Materials: All paediatric cases with MCD diagnosed on MRI at 
Ain Shams University Hospital during the period from January 2015 till January 
2017 were retrospectively reviewed with correlation to their presenting 
symptoms. 
Results: Among 4300 paediatric patients referred for MRI brain, 72 cases with 
MCD were identified with prevalence of 1.67%. Epilepsy was the main 
presenting symptom (72%) and focal epilepsy was seen in 19.5% of the cases. 
There was an association between focal cortical dysplasia and focal epilepsy 
(P=0.005), polymicrogyria and global developmental delay (P=0.008) and also 
between tuberous sclerosis and epilepsy (P=0.007). The most common type of 
MCD was polymicrogyria (25%), followed by tuberous sclerosis (21%). MCD 
was seen in association with other neuroimaging findings, or as a part of 
syndromes as congenital muscular dystrophy spectrum especially Walker-
Warburg syndrome and also it was seen in Sturge Weber and chronic infantile 
neurological cutaneous articular (CINCA) syndromes. 
Conclusion: MCD showed relatively high prevalence among Egyptian children 
being associated with epilepsy and developmental delay. MCD was 
infrequently isolated, also occurred in association, or as a part of syndromes.  
B-1503 11:38  
Role of MRI vs CT in staging and decision making in paediatric renal 
masses  
E. Nasr, A. Youssef, W. Zekry, T. Raafat, A. Younis, H.A. Elkiki; Cairo/EG 
(emannasr84@yahoo.com)  
Purpose: To determine whether MRI can replace CT in local staging of newly 
diagnosed renal tumours in paediatric age group renal masses to avoid 
radiation exposure and contrast material administration. 
Methods and Materials: 50 children with newly diagnosed renal masses were 
included. Contrast-enhanced CT and non-contrast MRI were done in all 
patients. Local staging was done in both studies separately. The surgical and 
pathological findings were the reference standard. 
Results: The sensitivity of CT and MRI for detecting capsular penetration was 
68.6% and 62.9%, respectively, while specificity was 86.5% and 83.8%. The 
sensitivity of CT and MRI for detecting lymph node metastasis was 76.5% and 
52.9%, and specificity was 90.4% and 92.3%. Synchronous contra-lateral 
lesions were identified by CT in 4/9 cases and by MRI in 7/9 cases. 
Conclusion: CT and MRI have similar diagnostic performance for detection of 
lymph node metastasis and capsular penetration. MR detected more contra-
lateral synchronous lesions; however, these were present in a very small 
number of cases. Either modality can be used for initial loco-regional staging of 
paediatric renal tumours.  
B-1504 11:42  
Closed spinal dysraphisms: how to improve prenatal diagnosis  
T. Nguyen, V. Houfflin-Debarge, M. Vinchon, N. Boutry, F.E. Avni; Lille/FR 
(nguyentoan5989@gmail.com)  
Purpose: Prenatal diagnosis of closed spinal dysraphisms (CSDs) is difficult 
and not well studied. The purpose was to study the contribution of prenatal 
imaging in the diagnosis of CSD to improve their screening. 
Methods and Materials: Patients with postnatally diagnosed CSD by spinal 
MRI or surgery in Lille University Hospital were included. Ultrasound signs, 
proportion of positive and negative prenatal diagnosis and the contribution of 
prenatal imaging techniques were analysed. 
Results: 38 patients with CSD were included, 17 of whom were diagnosed 
prenatally. Utrasound signs were a posterior soft tissue mass in 9 cases, low 
position of the conus medullaris in 8 cases, vertebral anomalies in 7 cases and 
spinal cord anomalies in 4 cases. Ultrasound was excellent in screening and 
characterizing cystic masses (8 diagnosed on 8 included), unlike fatty masses 
(1 only on 11). It was less successful in screening (7 on 14) and characterizing 
vertebral anomalies. In these cases, foetal CT scan permitted a full diagnosis. 
Foetal MRI was performed in 12 cases, allowing to characterize posterior soft 
tissues mass (100% of concordance between ultrasound and MRI). It was less 
accurate than ultrasound in studying the wall of the mass, the conus medullaris 
level and the spinal cord morphology. 
Conclusion: Ultrasound must remain the first-line imaging technique and its 
study has to contain three parts: vertebral, spinal cord and posterior soft tissue 
study. Foetal MRI seems to be useful in characterizing a posterior soft tissue 
mass when ultrasound is difficult. Foetal CT scan is useful to characterize 







B-1505 11:46  
Radiological appearance and follow up results of diaphragmatic 
mesothelial cysts during childhood  
I. Akdulum1, M. Öztürk2, S. Karatoprak3, A. Sı+ırcı3; 1Ankara/TR, 2Konya/TR, 
3
Malatya/TR (iakdulum@yahoo.com)  
Purpose: Diaphragmatic mesothelial cysts (DMC) are rare congenital benign 
lesions. DMC often cannot be distinguished from liver cystic lesions and cause 
management failure. The aim of this study is to describe radiologic findings of 
DMC and to evaluate our follow-up results. 
Methods and Materials: Ultrasound (US), computed tomography (CT) or 
magnetic resonance imaging (MRI) of DMCs were acquired from 20 children. 
Patients’ age, gender, indication for imaging, size of cyst and follow-up times 
were evaluated prospectively. 
Results: The patients were aged between 4 months to 13 years. Eight of 20 
patients were female and 12 were male. The most common indication for 
imaging was abdominal pain. All patients had US exam. The long diameter of 
the DMC was between 14 and 39 mm. All DMC were located near to liver 
segment 6-7, extraparenchymal and bilobular. In addition, a triangular 
echogenic area of fatty tissue extending between the supra-lateral segment of 
the DMC and the liver parenchyma, which we have described as the ''lateral fat 
sign'', was detected. We confirmed the lateral fat sign in 6 patients with CT and 
in 2 patients with MRI. Patients were monitored for 12-36 months and the size 
of the lesions was stable in 13 patients. The lesion dimensions in 7 patients 
were reduced, but this was not statistically significant. 
Conclusion: Cysts were treated with ablation techniques in the literature. We 
followed asymptomatic patients. With typical localization, bilobular form and 
lateral fat sign, diagnosis is clear. US is useful for diagnosis and follow-up of 
DMC.  
14:00 - 15:30 Room B  
Abdominal Viscera  
SS 1901a  
New development in CT of the liver  
Moderators:  
H. Ringl; Vienna/AT  
G. Tardaguila de la Fuente; Vigo/ES  
B-1506 14:00  
Meta-analysis of spectral CT image analysis tools and multi-phase CT 
enhancement in diagnostic accuracy of hepatic cell carcinoma  
Y. Zhou; Zhengzhou/CN  
Purpose: To assess and compare the overall diagnostic value of spectral CT 
image analysis tools and multi-phase CT enhancement with hepatic cell 
carcinoma using meta-analysis. 
Methods and Materials: Relevant English articles published on PubMed, 
EMBASE, Cochrane library database and Chinese articles published on CNKI 
and Wanfang database were searched. Characteristics of included articles 
were summarised and extracted. Statistical analyses were performed using 
Meta Disc version 1.4 and Review Manager 5.3. Heterogeneities of included 
articles were tested and selected using proper effect model. Pooled sensitivity, 
specificity, 95% CI, summary receiver operating characteristics (SROC) curve 
and area under curve (AUC) were calculated. The heterogeneity and sub-
group analyses were explored. 
Results: 12 of 101 retrieved articles were included, in which 3 articles used 
two methods of imaging modalities at the same time. Spectral CT image 
analysis tools consist of four articles of monochromatic image, three articles of 
spectral curve and four of spectral quantitative parameters, respectively. The 
pooled sensitivity, specificity (95% CI) and AUC of SROC for spectral CT 
image analysis tools and DECT were 0.91 (0.88-0.94), 0.78 (0.73-0.83), 
0.9022 and 0.85 (0.78-0.90), 0.71 (0.60-0.80), 0.874. Sub-group analysis 
showed that category of spectral CT image analysis tools was the essential 
factor for diagnosis of HCC. The pooled sensitivity, specificity (95% CI) and 
AUC of SROC for monochromatic image, spectral curve and spectral 
quantitative parameters were 0.83 (0.74-0.91), 0.75(0.65-0.84), 0.8935; 0.87 
(0.81-0.92), 0.73 (0.65-0.80), 0.9412 and 0.99 (0.96-1.00), 0.94 (0.85-0.98), 
0.9877. 
Conclusion: Spectral CT image analysis tools showed higher sensitivity, 
specificity and better diagnostic performance compared to conventional DECT, 













B-1507 14:08  
Perfusion CT vs triphasic CT in evaluation of hepatic masses  
V. Laxmi, V. Chowdhury, R. Dixit, A. Agarwal; New Delhi/IN 
(drvijaylaxmi25@gmail.com)  
Purpose: Compare the diagnostic accuracy of triphasic and perfusion CT in 
characterisation of focal liver lesions as benign and malignant lesions. 
Correlation of radiological findings with histopathology. 
Methods and Materials: Total of 50 patients with a clinical suspicion of focal 
liver lesions were included. Clinical and lab findings were recorded followed by 
CT examination on 128 slice scanner. Hepatic perfusion CT of entire liver 
volume was performed followed by routine scan of whole abdomen. Perfusion 
maps of the liver were generated using dedicated hepatic CT perfusion 
software. Various perfusion parameters like blood flow, blood volume, time to 
peak, permeability, arterial liver perfusion, portal venous perfusion and hepatic 
perfusion index were evaluated. The data set of perfusion CT was used to 
generate arterial phase images. The whole abdomen scan was taken as portal 
venous phase. Delayed phase scans were obtained wherever indicated. These 
images were analysed for presence of focal lesions and their enhancement 
pattern/perfusion parameters to characterise them. Findings were compared 
with histopathological/operative diagnosis/clinical follow up. 
Results: Sensitivity of both Triple phase CT and perfusion CT for 
characterisation of lesion as malignant was equal at 97 %. Specificity and 
positive predictive value of triple phase was 88.89% and 97% respectively. 
Both specificity and positive predictive value of perfusion CT was 100%. 
Conclusion: Perfusion CT with a high sensitivity, specificity and positive 
predictive value is a useful tool for characterisation of liver lesions  
B-1508 14:16  
Iterative reconstruction in "virtual non-contrast" with dual-energy CT: is it 
an alternative to conventional unenhanced phase?  
S. Jamali, C. Dragean, N. Michoux; Brussels/BE (sanaa.jamali@uclouvain.be)  
Purpose: To compare attenuation values and image quality of virtual non-
contrast (VNC) with conventional true non-enhanced phase (TNC), on dual-
energy double-detector computed tomography (CT) and to assess potential 
radiation dose reduction. 
Methods and Materials: 286 patients with the pre- and post-contrast imaging 
in dual-layer spectral detector CT were retrospectively analysed. Quantitative 
analysis was performed for 247 patients by the measurements of the mean 
attenuation value in different regions of the abdomen for VNC and TNC. 
Qualitative analysis was performed for 48 patients using a graded scale for 
image quality. The radiation dose delivered to patients was compared with 
dose of protocols without TNC. 
Results: Difference of mean attenuation values between TNC and VNC is less 
than 15 UH in 98.3% and less than 10 UH in 92.3%. The higher difference was 
found for perineal fat. VNC overestimated attenuation in fat and 
underestimated it in aorta comparatively to TNC. Image quality was evaluated 
as good or excellent in 77% of TNC and 54% of VNC. VNC was in most cases 
an alternative acceptable for the replacement of TNC. Using VNC, the radiation 
dose can be diminished by 32%. 
Conclusion: VNC reconstructions demonstrate good correlation with TNC 
images in different abdominals tissues. VNC image quality is satisfying and 
acceptable in most cases; technical improvement is needed to correct 
imperfect iodine removal. VNC seems one interesting alternative to TNC with 
reduction in irradiation dose. However, further studies are needed to evaluate 
VNC in the pathological cases.  
B-1509 14:24  
Segmental variation of CT liver attenuation index in living-related liver 
donors: correlation with histopathological findings  
A. Rana1, A. Jang1, M. Jehangir1, M. Asghar1, R. Nazir1, S. Burki2, K. Shakeel1; 
1
Islamabad/PK, 2Rawalpindi/PK (aisha_jang@yahoo.com)  
Purpose: To find out the variation in CT liver attenuation index between 
anterior and posterior liver segments on non-enhanced CT scan and correlate 
it with histological degree of steatosis. 
Methods and Materials: A radiologist blinded to histological grading 
calculated mean anterior and posterior segments CT hepatic attenuation in 74 
potential living-related liver donors.  
Results: Significant association (with p value of 0.00) is found between 
anterior segment liver attenuation index and histopathological findings, 
whereas no significant association is seen between posterior and combined CT 
liver attenuation index with histopathological findings. 
Conclusion: The results of our study suggest that mean liver attenuation index 
of posterior liver segments does not correctly predict the degree of steatosis 
and rather results in significant over estimation of steatosis due to beam 
hardening. Hence, while calculating CT liver attenuation index, only the 
anterior segments of liver should be sampled to quantify steatosis.  
B-1512 14:32  
Evaluation of tumour response in patients with neuroendocrine hepatic 
metastasis treated using transarterial chemoembolisation (TACE) on MRI  
M. Lapteva, M. Shorikov, D. Frantsev, O.N. Sergeeva, E. Virshke, 
B. Dolgushin; Moscow/RU (mglapteva@inbox.ru)  
Purpose: The purpose of the paper is to develop suitable TACE evaluation 
criteria in liver metastatic neuroendocrine tumour (mNET) patients on MRI. 
Methods and Materials: 23 liver mNET patients (G1-9, G2-10, G3-2, unknown 
grade-2) who underwent 36 TACE procedures were enrolled in the study. 68 
MRI studies performed 3-86 days before (median 28 days) and 23-147 days 
(median 61 days) after TACE were analysed retrospectively. Using 1.5T MRI 
scanner, we acquired: 1) 3DT1WIFS in the axial plane before i.v. contrast 
injection and after in the portal and delayed phases; 2) diffusion weighted 
images with ADC maps. We measured before/after TACE: (1) maximum 
necrotic/fibrotic zone diameter and solid component thickness on its periphery 
in the largest targeted lesion; (2) ADC and MR contrast agent accumulation 
dynamics (dSl) in regions of interest in tumour solid component. 
Results: TACE effect according to RECIST (1.1) was evaluated as progressive 
disease in 8.3% cases, stabilised in 83.3% cases and partial response in 8.3% 
cases. The diameter of the fibrosis/necrosis areas before/after TACE 
demonstrated no changes (3=0.614), but solid component thickness on its 
periphery decreased significantly (3=0.003, median 16%). ADC values 
increased significantly in solid portions of mNETs after TACE (3=0.003). MR 
contrast agent accumulation of the lesions in portal phase decreased 
significantly after TACE (p=0.003, median 8.5%). Decrease of MR contrast 
agent accumulation in the solid part of the target lesions by more than 10% 
after TACE is associated with a longer time to progression of the disease 
(p=0.025). There is an increase in MR contrast agent washout time in the solid 
part of the target lesions after TACE (p=0.032). 
Conclusion: Parameters changed in liver mNET after TACE: (1) solid 
component thickness in cases of central necrosis/fibrosis (decrease); (2) ADC 
(increase); (3) SI T1WI in portal phase (decrease) and this is the positive 
prognostic factor; 4) MR contrast agent washout time (increase).  
B-1513 14:40  
Perfusion CT imaging: diagnostic biomarker tool for survival predictor of 
tumour in response to antiangiogenic treatment in patients with 
advanced HCC lesions  
D. Ippolito1, G. Querques1, C.R. Talei Franzesi2, S. Lombardi1, A. Pecorelli3, 
S. Sironi1; 1Monza/IT, 2Milan/IT, 3Bergamo/IT (davide.atena@tiscalinet.it)  
Purpose: To investigate whether perfusion-CT (p-CT) imaging could depict the 
inhibition of tumour neoangiogenesis induced by sorafenib in advanced 
hepatocellular carcinoma (HCC), and whether it could be useful in determining 
the efficacy of anti-angiogenic therapy and predicting survival during treatment. 
Methods and Materials: Ninety-eight p-CT examinations were performed 
among 29 cirrhotic patients, with advanced HCC, before and every 2 months 
after Sorafenib administration. Perfusion-CT protocol was performed on a 256-
slice MDCT scanner, during injection of 50 ml of contrast medium. Perfusion 
parameters were considered (hepatic perfusion; arterial perfusion; hepatic 
perfusion index and time to peak) and statistically compared, at baseline and 
follow-up, between responders (complete response, stable disease or partial 
response) and non-responders (progressive disease). Kaplan-Meier analyses 
estimated the time to survival in overall population, after stratifying patients 
according to mRECIST. 
Results: Percentage variation of perfusion parameters (∆HP and ∆AP), from 
baseline to follow-up study was assessed and correlated with response 
classified according to mRECIST criteria. The group that responded to 
sorafenib showed a significant reduction of values in HCC target lesions after 
anti-angiogenic therapy (HP 29.4±23.7 vs 51.9±16.8; AP 29.8±25.5 vs 
52.2±17.9; p<0.01), in comparison with progressor group that demonstrated an 
increase or no significant variation after treatment. When patients were 
stratified into mRECIST, higher survival rate was observed in the non-
progressor group compared to the progressor (48.6% vs 28.6%), and 
statistically significant correlation was found between mRECIST-∆HP (p=0.04) 
and mRECIST-∆AP (p=0.01) and overall survival rate. 
Conclusion: Quantitative analysis of perfusion parameters represents 
prognostic indicators useful in assessment of response to anti-angiogenic 

















B-1514 14:48  
Diagnostic value and radiation dose reduction of model-based iterative 
reconstruction compared with hybrid iterative reconstruction in 
abdominal CT study  
A. de Vito1, D. Ippolito1, C.R. Talei Franzesi2, L. Riva2, S. Drago1, S. Sironi1; 
1
Monza/IT, 2Milan/IT (a.devito@campus.unimib.it)  
Purpose: To evaluate dose reduction and image quality of routinely abdominal 
CT images reconstructed with model-based iterative reconstruction (IMR) and 
low-kV setting compared with hybrid iterative reconstruction (iDose4) and 
standard kV protocol. 
Methods and Materials: We prospectively enrolled 72 patients who underwent 
entire abdominal CT scan; 36 patients were examined using a low-kV 
setting(100kV) while the other 36 patients were investigated using standard kV 
setting(120 kV), on the same 256-row CT scanner (iCT Elite). In the study 
group images were reconstructed using IMR algorithm while in the control 
group we used iDose4 technique. CTDIvol and DLP were evaluated. Region of 
interests were drawn in three different levels in the liver and in spleen to 
evaluate absolute enhancement values (HU), SNR and CNR. 
Results: Compared to standard dose iDose4-CT study the low kV IMR-CT 
presented lower CTDIvol (9.2 ± 1.2 vs 17.7 ± 2.5 mGy) and DLP (570.5 ± 8.3 
vs 911 ± 10.2 mGy x cm) with ED of 6.3 ±1.8 vs 9.44 ± 1.8 mSv. Low kV IMR 
images yielded higher attenuation values (HU) and higher SNR and CNR in 
liver and spleen, compared with standard dose iDose4 images. The subjective 
image quality of low-kV IMR CT was also higher compared with iDose4-CT. 
Conclusion: Low dose CT scan (100kV and automated mAs modulation) 
reconstructed with IMR algorithm represents a feasible protocol for routinely 
daily examination of the abdomen, achieving excellent image quality with 
extremely low noise, and a significant dose reduction within acceptable 
reconstruction times (mean time of 3 minutes).  
B-1515 14:56  
Dual-energy CT in patients with abdominal malignant lymphoma: impact 
of noise-optimised virtual monoenergetic imaging on objective and 
subjective image quality  
L. Lenga, D. Leithner, M.H. Albrecht, C. Booz, J.L. Wichmann, T.J. Vogl, 
S.S. Martin; Frankfurt a. Main/DE (lukas.lenga@gmail.com)  
Purpose: To evaluate the impact of the noise-optimised virtual monoenergetic 
imaging (VMI+) technique on objective and subjective image quality in patients 
with malignant lymphoma undergoing abdominal dual-energy computed 
tomography (DECT). 
Methods and Materials: 35 consecutive patients (mean age, 53.8±18.6 years; 
range, 21-82 years) with histologically proven malignant lymphoma of the 
abdomen were enrolled in this IRB-approved retrospective study. DECT image 
series were reconstructed using standard linearly blended (M_0.6), as well as 
traditional VMI, and VMI+ reconstructions at 40 to 100 keV in 10-keV intervals. 
Attenuation measurements were performed in lymphoma lesions to calculate 
signal-to-noise (SNR) and contrast-to-noise ratios (CNR). Three independent 
radiologists assessed the overall image quality, lesion delineation, and image 
noise using five-point Likert scales. 
Results: Assessment of objective image parameters showed the highest SNR 
and CNR values for 40-keV VMI+ (SNR, 15.77±7.74; CNR, 18.27±8.04) 
compared to standard linearly blended (SNR, 7.96±3.26; CNR, 13.55±3.47) 
and all traditional VMI series (P<0.001). Regarding the subjective image 
evaluation, overall image quality peaked in the 60-keV VMI+ series (median, 5) 
with significant differences to all other series (P<0.001). Evaluation of lesion 
delineation was superior in 40-keV VMI+ series (median, 5), whereas image 
noise showed best rating scores for 100-keV VMI+ (median, 5). 
Conclusion: Low-keV VMI+ series significantly increase objective image 
quality of malignant lymphoma lesions in abdominal DECT examinations 
compared to standard DECT and VMI series. In addition, the highest lesion 
delineation can be achieved using 40-keV VMI+ reconstructions.  
B-1516 15:04  
Sarcopenic index as a predictor of post-transplant morbidity and 
mortality  
S. Singhal1, B.K. Saranga2, D. Balakrishnan2; 1Bangalore/IN, 2Kochi/IN 
(drsoumilsinghal75@gmail.com)  
Purpose: Nutrition assessment in chronic liver disease is a challenge as the 
common indices such as anthropometric measurements and body mass index 
are inaccurate and overexpressed; hence, the use of sarcopenia index has 
shown to solve this problem. The primary aim of my study is to assess 
morbidity and mortality in post-transplant patient using sarcopenia index. 
Methods and Materials: A cross-sectional prospective study was performed 
between October 2014 and November 2016, at Amrita Institute of Medical 
Sciences. The study was approved by the ethical committee. 60 patients (59 
male, 1 female) were included in the study. Sarcopenia was assessed by 
calculating psoas volume and psoas index using volumetric software Aquarius 
Intuition Terrarecon version 4.4.11 . All statistical analyses were done using 
IBM SPSS version 20.0. 
Results: Among the 60 patients included in the study 6 belonged to class 0, 16 
to class 1 and 38 to class 2, patients who had normal psoas index (class 0 - as 
per European working group on sarcopenia in older people guideline of 2010) 
had nil mortality. Mean comparison analysis showed high risk of mortality in 
patients with sarcopenia. Correlation analysis of psoas index with ICU stay 
showed a negative correlation which was statistically significant. On 
associational analysis, the reintubation was found to have a significant 
correlation with mortality 72% (p value <0.001). 
Conclusion: Sarcopenia index acts as an important prognostic tool in post-
transplant patients.  
14:00 - 15:30 Room C  
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B-1517 14:00  
Carcinoma pancreas: how good is multi-detector-computed tomography: 
a single-centre experience  
S. Singhal1, N.K. Prabhu2; 1Karnataka/IN, 2Kochi/IN 
(drsoumilsinghal75@gmail.com)  
Purpose: To compare the staging of pancreatic carcinoma assessed by MDCT 
with surgery in a tertiary referral centre in Kerala. 
Methods and Materials: A cross-sectional observational study was performed 
between November 2014 and October 2016, 25 patients (12 male and 13 
female patients) were evaluated with a mean age of 54.2 years. CT was 
performed on all patients. The gold standard for diagnosis was operative and 
histopathology data. All statistical analyses were done using IBM SPSS 
version 20.0. Validity parameters like sensitivity, specificity, accuracy, positive 
and negative predictive value were computed for CT with respect to surgery. 
Results: Of the 25 patients who were evaluated for surgery, 15 cases (60%) 
were classified as resectable tumours, 3 (12%) as borderline resectable and 7 
(28%) as unresectable tumours. CT showed a sensitivity of 82.3% with a 
specificity of 87.5%. On assessing vascular invasion CT showed a sensitivity 
and specificity of 100% and 93.3%, respectively. Three patients who were 
classified as having borderline resectable tumour underwent vascular 
reconstruction during the surgery. 
Conclusion: Contrast-enhanced multiphase pancreatic imaging using CT 
plays a pivotal role in diagnosing and assessing the resectability and vascular 
invasion of pancreatic tumours. It is very useful for determining borderline 
resectable tumours pre-operatively, which aids for better treatment planning.  
B-1518 14:08  
The diagnostic role of 256 multidetector-row CT in the detection and 
characterisation of incidental pancreatic cystic lesions: comparison with 
MR colangiopancreatography  
S. Drago, D. Ippolito, C. Talei Franzesi, A. Nasatti, A. Parlati, A. Casiraghi, 
S. Sironi; Monza/IT (silvia.drago@hotmail.it)  
Purpose: To compare the diagnostic accuracy of contrast-enhanced MDCT 
scan with MRI with MRCP sequences, in the detection of pancreatic cystic 
lesions and those features useful for their characterisation. 
Methods and Materials: Fifty patients with no history of pancreatitis, 
neoplasm and prior surgical procedures in pancreas, who underwent both 
MDCT and MRI with MRCP (time interval lower than 90 days) for pancreatic 
cysts characterisation, were evaluated. All CT and MRI examinations were 
performed, respectively, on a 256 slice CT (Brilliance iCT; Philips) and on a 1,5 
T magnet (Achieva, Philips). The reviewer recorded the number of lesions in 
each patient and the main morphologic features of the defined target lesions: 
location (head, uncinate process, neck, body, tail), number, size, 
communication with main pancreatic duct (MPD), maximum MPD diameter, 
presence of septa, mural enhancing nodules and calcifications. Data were 
analysed to compare the diagnostic performance of MDCT and MRI. 
Results: A greater number of pancreatic cysts were identified on MRI than CT 
examinations (227 vs 128); however, the ICC value was 0.76, suggesting a 
good agreement. Very good agreement (ICC 0.98) was found regarding the 
diameter of target lesions (21.4mm on CT vs 21.8mm on MRI), location of 
target lesion (=0.90), detection of MPD dilatation (=1.00) and septa (=0.86). 
Fair agreement on the evaluation of MPD communication (=0.33) and 
calcifications (=0.22) was found. 
  






Conclusion: MDCT can be considered almost equivalent to MRI with MRCP in 
the evaluation of pancreatic cystic lesion, offering detailed morphologic 
features helpful for their characterisation and correlation with a high risk of 
malignancy.  
B-1519 14:16  
CT features of primary pancreatic lymphoma: experience from three 
referral centres for pancreatic diseases  
E. Boninsegna1, G. Zamboni1, D. Facchinelli1, C. Triantopoulou2, 
S. Gourtsoyianni3, M.C. Ambrosetti1, R. Pozzi Mucelli1; 1Verona/IT, 
2
Athens/GR, 3London/UK (boninsegnae@gmail.com)  
Purpose: To describe CT characteristics of primary pancreatic lymphoma 
(PPL), a rare disease with features in common with adenocarcinoma. 
Methods and Materials: Fourteen patients were enrolled. CT: unenhanced 
scan, contrast-enhanced pancreatic and venous phases. Image analysis: 
tumour location; peri-pancreatic vessels encasement; necrosis; enlarged lymph 
nodes; fat stranding; enlarged bile duct and pancreatic duct; neoplasm longest 
dimension, volume and density. 
Results: Histopathological diagnoses: follicular non-Hodgkin lymphoma (5/14), 
diffuse large B-cell lymphoma (6/14), high-grade B-cell lymphoma not 
otherwise specified (3/14). 6/14 PPLs were located in the pancreatic head, 
7/14 in the body-tail and 1/14 involved the whole gland. In 5/14 cases superior 
mesenteric artery and vein were encased; splenic vein and artery encasement 
was depicted in 2 PPLs. Necrosis was present in 2/14. Enlarged 
retroperitoneal lymph nodes were found in 11 cases; fat stranding in all 
patients. Bile duct was dilated in 6 cases, pancreatic duct in 5. Mean neoplasm 
longest diameter and volume were 8.05 cm and 210.8 cm3. Mean tumour 
attenuation values were 39.1 HU at baseline, 60.6 HU in the pancreatic phase 
and 71.4 HU in the venous phase. 
Conclusion: PPL presents as a large lesion with delayed homogeneous 
enhancement; peri-pancreatic fat stranding and vessel encasement are 
present, without vascular infiltration; pancreatic duct dilatation is rare.  
B-1520 14:24  
CT and pathologic correlation in pancreatic cancer after neoadjuvant 
chemoradiotherapy  
J.R. Ayuso, M. Cuatrecasas, J. Maurel, O. Reig, C. Conill, A. Darnell, 
M. Pages, S. Rodríguez, S. Sanchez; Barcelona/ES (JRAYUSO@clinic.cat)  
Purpose: To correlate morphologic changes observed in CT after neoadjuvant 
chemoradiotherapy (CRT) with the pathologic piece in patients with pancreatic 
cancer (PC). 
Methods and Materials: Eleven patients with resectable pancreatic cancer 
(RPC) (Group1) who underwent surgery after CRT and nine with borderline 
pancreatic cancer (BPC) (Group2), selected form those included in the 
GEMCAD1003 trial, who completed the CRT treatment and underwent tumour 
resection were evaluated by CT before and after treatment. CT changes in 
tumour volume were determined by three orthogonal measurements and a 
semiautomatic tool. Tumour density measured in the portal venous phase and 
changes in vascular infiltration (only in group 2) were compared to pathologic 
tumour volume and tumour regression grade (TRG). Spearman coefficient and 
Wilcoxon test were used to compare results. 
Results: The Spearman’s correlation coefficients were 0.92 and 0.95, 
respectively, for manual and semiautomatic tumour volumes measured before 
and after CRT, but only 0.231 for post-CRT CT and pathologic tumour volume 
measurements. It was 0.39 for the correlation between CT volume reduction 
and tumour/fibrosis ratio. No correlation was observed between the CT volume 
reduction and pathologic TRG (p=0.96), or between variations in tumour 
density in the portal venous phase and the percentage of tumoural fibrosis 
(p=0.15). In group 2 patients, the percentage of radial and longitudinal 
tumour/vessel contact remained unchanged in 10/11 patients. 
Conclusion: CT changes in size, density and extension in vascular infiltration 
in PC after CRT do not correlate with pathological tumour response.  
B-1521 14:32  
Lobar distribution of liver metastases based on the site of pancreatic 
neuroendocrine tumours  
C. Fabris, G. Zamboni, M.C. Ambrosetti, R. Negrelli, R. Pozzi Mucelli; 
Verona/IT (cristina.fabris@yahoo.it)  
Purpose: The presence of liver metastases from neuroendocrine tumours 
does not preclude surgery; the distribution of the metastases is important for 
treatment planning. Our purpose was to assess whether the location of the 
primary neuroendocrine tumour (pNET) in the pancreas influences the lobar 
distribution of metastases within the liver. 
Methods and Materials: This is a retrospective review of the CTs performed 
on 49 patients with pNETs (27 males, 22 females) and liver metastases. Of 
these patients, 11 had a primary tumour in the head (group A: mean age 50,3 
years) and 38 in the body-tail (group B: mean age 59,3 years). We evaluated 
tumour site, diameter, vascular invasion and number of metastases within each 
lobe. We used an unpaired t-test to compare the total number of metastases 
between the two groups and Fisher’s test to evaluate the number of 
metastases in the two lobes. 
Results: Group B primary tumours were larger than group A (59,55 vs 39,82 
mm; p 0.043). The number of liver metastases was higher in the right lobe in 
both groups (p=ns). The ratio of metastases in the right-to-left hemi-liver was 
2,5:1 for group A compared with 1,79:1 for group B (p=0,0423). The splenic 
vein was more commonly involved in patients in group B. 
Conclusion: Tumours from all locations in the pancreas will give a higher 
number of metastases in the right lobe. The right-to-left ratio is however 
significantly different based on the site of the primary tumour.  
B-1522 14:40  
MRI and MRCP features of chronic pancreatitis in patients with or without 
pancreas divisum abnormality and their ralationship to patients age  
M. Monti, G. Zamboni, L. Bertuzzo, R. Pozzi Mucelli; Verona/IT 
(marialaura.monti@hotmail.it)  
Purpose: To compare the MRI and MRCP features of chronic pancreatitis 
(CP) in patients with or without pancreas divisum (PD) and to determine their 
relationship to patient age. 
Methods and Materials: We retrospectively reviewed the MRI/MRCPs of 175 
patients (mean age 53years) with symptomatic CP. 86 had CP associated with 
PD, and 89 had CP without PD. Both patients with PD and without PD were 
stratified by age: <40 years (26 PD; 33 non-PD), 41-60 years (27 PD; 28 non-
PD), >60 years (33 PD; 32 non-PD). Two readers reviewed the scans for: 
morphological changes, signal intensity abnormalities, pancreatic ducts 
changes, filling defects. All MRI features were compared between age groups 
by using Chi-square test. 
Results: No difference was observed in mean patient age between PD and 
non-PD patients(p=ns). Parenchymal intensity was significantly more often 
reduced in non-PD than in PD patients(p<0,001). The degree of parenchymal 
thinning, and irregularity of margins were significantly higher in non-PD 
patients in the groups aged <40 and 41-60 (p<0,001). No difference was 
observed between PD and non-PD patients aged >60 for irregularity of 
parenchymal margins (p=0,3). In non-PD patients, main pancreatic duct (MPD) 
and branch-ducts were significantly more often dilated(p=0,0031), and filling 
defects were more common (p<0,0007). A significant association was found 
between parenchymal T1-hypointensity, MPD dilation and filling defects and 
increasing age in non-PD patients compared to PD patients in all the age 
groups(p<0,001). 
Conclusion: Patients with PD show less severe morphological alterations as 
compared with patients affected by other forms of CP.  
B-1523 14:48  
MRI evaluation of pathologically confirmed IPMNs of the pancreas using 
Fukuoka Guidelines: can we differentiate between invasive/high-grade 
IPMNs and low/moderate-grade IPMNs?  
C. Fabris, G. Zamboni, R. Negrelli, E. Boninsegna, R. Pozzi Mucelli; Verona/IT 
(cristina.fabris@yahoo.it)  
Purpose: IPMNs of the pancreas are intraductal mucin-producing cystic 
neoplasms with malignant potential. The Fukuoka criteria are commonly used 
to assess the risk of malignancy. Our purpose was to assess if these criteria 
can differentiate between invasive/high grade IPMNs and low/moderate grade 
IPMNs. 
Methods and Materials: We reviewed the preoperative MRIs from 42 patients 
(25 males, 17 females; mean age 63,62 years) with a confirmed pathologic 
diagnosis of IPMN (invasive= 7; non invasive= 35). Two readers analyzed in 
consensus the MRIs for tumor size (>/< 3 cm), diameter of the main pancreatic 
duct (MPD) (>10 mm, <10 mm), presence of enhancing solid components, 
radiologic signs of pancreatitis, enhancing or nonenhancing nodules, 
thickened/enhancing walls, abrupt change in MPD caliber with distal atrophy, 
lymphadenopathy. MRI and pathology findings were compared using Fisher’s 
test dividing the patients in two groups: invasive/high grade IPMNs vs 
low/moderate dysplasia IPMNs. 
Results: A MPD >10 mm was significantly more common in patients with 
invasive/ high grade dysplasia IPMN than in patients with low/moderate 
dysplasia (p=0,0026). No significant difference was observed between the two 
groups for the tumor diameter, presence of solid nonenhancing or enhancing 
nodules, thickened enhancing walls, pancreatitis, abrupt change in MPD and 
presence of lymphadenopathy. 
Conclusion: Fukuoka criteria are being commonly used to assess the risk of 
malignancy in patients with IPMN. The only criterion that appears to be helpful 
in differentiating between invasive/high grade IPMNs and low/moderate grade 












B-1524 14:56  
Preoperative classification of resectability of pancreatic cancer using 
multi-detector row CT: a study of interobserver reliability  
I. Joo1, J. Lee1, E. Lee1, D. Lee1, J.-Y. Son1, W. Chang2, S. Lee3, H. Yang1; 
1
Seoul/KR, 2Seongnam/KR, 3Anyang/KR (hijijin@gmail.com)  
Purpose: To investigate the interobserver reliability in the preoperative 
classification of resectability of pancreatic cancer using multi-detector row CT 
(MDCT). 
Methods and Materials: In this retrospective study, we included 110 patients 
with pathologically confirmed pancreatic cancer who underwent baseline 
multiphasic contrast-enhanced MDCT. Eight board-certified radiologists with 
different levels of experience (more experienced, n=4; less experienced, n=4) 
reviewed MDCT images to score the likelihood of local resectability using a 5-
point Likert scale based on each reviewer’s impression and to determine 
categories of resectable, borderline resectable, or unresectable based on given 
MDCT criteria. Diagnostic performance and interobserver agreement were 
determined by receiver operating characteristic (ROC) curve analysis and 
Fleiss kappa statistics, respectively. 
Results: Overall interobserver agreements were fair in Likert scale (kappa = 
0.360 [95% confidence interval (CI): 0.344-0.375]) and moderate in categories 
(kappa = 0.477 [95% CI: 0.452-0.502]). More experienced reviewers showed 
higher agreement in the determination of categories than those with less 
experience (kappa = 0.548 [95% CI: 0.495-0.600] vs 0.432 [95% CI: 0.377-
0.487]) while there was no significant difference in Likert scale according to 
experience level (kappa = 0.395 [95% CI: 0.361-0.428] vs 0.347 [95% CI: 
0.312-0.382]). In patients with reference standard for local resectability (n=82), 
area under the ROC curves were 0.845-0.978 on 5-point Likert scale and 
0.833-0.960 on 3 categories. 
Conclusion: In the resectability assessment of pancreatic cancer, MDCT 
shows only fair to moderate interobserver agreement. Radiologists with higher 
experience level would be more likely to make consistent classifications of 
resectability.  
B-1525 15:04  
Application of CT texture analysis in quantification of pancreatic 
cystadenoma phenotype images  
Z. Feng, Z. Hu; Hangzhou/CN (gerxyuan@126.com)  
Purpose: Pancreatic serous cystadenoma and pancreatic mucinous 
cystadenoma differ greatly in biological characteristics, as well as their 
treatment and prognosis. We quantified the special imaging features of 
pancreatic cystadenomas and to provide new parameters for identifying of 
pancreatic cystic tumours using computed tomography texture analysis 
(CTTA). 
Methods and Materials: We retrospectively analysed contrast-enhanced CT 
data from patients who were admitted and had pathologically confirmed 
pancreatic serous cystadenomas (N = 48) and mucinous cystadenomas (n = 
34) in our hospital from January 2009 to December 2016. Regions of interest 
were drawn manually on the parenchymal phase CT images according to the 
border of the tumours. A Laplacian of Gaussian band-pass filter was chosen to 
highlight the characteristics of the image. Mean grey-level intensity (M), 
variance (V), entropy (E), skewness (Ske) and kurtosis (Kur) were derived with 
different spatial scales from fine texture ( =1.0) to coarse texture ( =2.5). 
Results: There were no statistically significant differences (p > 0.05) in value 
M, but statistically significant difference (p < 0.05) in value V2.5, E2.5, Kur2.5 and 
Ske0-2.5 between the two sets of serous cystadenomas and mucinous cystic 
tumours. Areas under the ROC curve for the two sets based on the texture 
parameters above ranged between 0.56 and 0.84. 
Conclusion: CTTA can quantify and extract the specific and abstract texture 
features of medical images, and reveal the inherent heterogeneity between 
tumours, which facilitates objective evaluation of pancreatic cystadenoma 
image, and greatly improve clinical diagnosis and prognostic analysis.  
B-1526 15:12  
Microcystic serous pancreatic cystic neoplasms: the added diagnostic 
value of contrast-enhanced ultrasound  
Y. Dong, F. Mao, J. Cao, P. Fan, W. Wang; Shanghai/CN 
(drdaisydong@hotmail.com)  
Purpose: Preoperative diagnosis of microcystic serous pancreatic cystic 
neoplasms (MPN) is clinical challenges. The purpose of current study is to 
analyse contrast-enhanced ultrasound (CEUS) features of histologically proven 
MPN, in comparison to pancreatic ductal adenocarcinomas (PDA). 
Methods and Materials: The present study was approved by the institutional 
ethics committee and informed consent was waived. Twenty-five patients with 
histologically proved MPN lesions and 30 patients with histologically proved 
PDA lesions were retrospectively analyzed. The CEUS features of pancreatic 
lesions were compared to the surrounding normal pancreatic parenchyma. 
Two radiologists assessed the CEUS enhancement pattern in consensus. 
Results: All MPN and PDA lesions were hypoechoic on B-mode ultrasound. 
Twenty (80 %) MPN present as solitary multilocular microcystic lesion. With 
colour Doppler imaging (CDI), typical ‘spoke wheel’ macrovessels were 
identified in 64 % of lesions. On CEUS, most MPN lesions displayed hyper- (96 
%) or isoenhancement (4 %) in the arterial phase with ‘honeycomb’ 
architectures. In contrast, all PDA lesions showed hypoenhancment in the 
arterial phase (P < 0.01). 
Conclusion: CEUS of the pancreas has the potential to aid differentiation of 
MPN from other neoplastic lesions. The differential diagnosis to the typically 
hypovascularised pancreatic adenocarcinoma was always possible.  
B-1527 15:20  
Assessment of local vascular invasion in pancreatic carcinoma by MDCT 
using the angle measuring tool  
D. Šaponjski, A. Djuric Stefanovic; Belgrade/RS (saponjski.d@gmail.com)  
Purpose: According to the NCCN criteria, resectability of pancreatic carcinoma 
(PC) is commonly assessed by MDCT and depends on tumour’s relation to 
neighbouring blood vessels, such as celiac trunk (CT), hepatic artery (HA), 
superior mesenteric artery (SMA), portal vein (PV) and superior mesenteric 
vein (SMV). The aim of study was to investigate methodology of the 
assessment of local vascular invasion of pancreatic carcinoma by MDCT using 
the angle measuring tool. 
Methods and Materials: Fifty consecutive 64-MDCT scans of patients with the 
PC were retrospectively analysed. Maximal angle of blood vessel’s 
circumference that was in direct contact with the tumour was measured using 
the angle measuring tool on axial section, and length of direct contact on MPR-
reconstructed section. Accordingly, resectability was estimated using the 
NCCN criteria. Frequencies and correlations were statistically analysed using 
Spearman’s (rS) and Pearson’s correlation coefficient (r). 
Results: Average size of tumour was 36 ± 13 mm (10-68 mm). Majority of PCs 
were in advanced stage (60% T3 and 36% T4), located in the head of the 
pancreas (62%). 22% tumours were estimated as resectable, 48% borderline 
resectable, and 30% unresectable. SMV and PV were invaded most frequently 
(50% and 46%), and surrounding arteries in lower percent (SMA in 26%, HA in 
22% and CT in 16%). Location, size and T-stage correlated with the frequency 
of local vascular invasion (rS>0.450). Maximal angle correlated with the length 
of the vascular infiltration (r>0.450). 
Conclusion: Precise estimation of vascular invasion in PC by MDCT is 
possible using the angle measuring tool.  
14:00 - 15:30 Room X  
GI Tract  
SS 1901c  
Inflammatory bowel disease: what next?  
Moderators:  
S. Kinner; Essen/DE 
N.N.  
B-1528 14:00  
7 T MR imaging for fibrosis evaluation in a radiation-induced murine 
model of colitis  
M. Zappa1, S. Doblas2, D. Cazals-Hatem1, F. Milliat3, P. Garteiser2, M. David1, 
V. Vilgrain1, B. Van Beers1, E. Ogier-Denis2; 1Clichy/FR, 2Paris/FR,  
3
Fontenay-aux-Roses/FR (magaly.zappa@netc.fr)  
Purpose: Crohn's disease transmural bowel wall inflammation can lead to 
fibrosis causing luminal narrowing and fistula which are the main indications to 
surgery. The aim of our study was to evaluate MR imaging to distinguish 
submucosal from transmural fibrosis using an original murine model of 
radiation-induced colitis. 
Methods and Materials: Colitis was induced with localised single-dose 
radiation (27 Gy). We included an inflammation group of 24 rats with pathologic 
features of severe acute inflammation associated with minimal submucosal 
fibrosis and a mixed group of 39 rats with pathological features of severe 
inflammation associated with transmural fibrosis, obtained two and twelve 
weeks after irradiation, respectively. Fat suppressed T2- and T1-weighted, 
diffusion-weighted, magnetisation transfer and perfusion using ASL technique 
7 T MR imaging was performed. 
Results: MR imaging showed significant differences between inflammation 
and mixed groups in normalised to muscle signal intensity on T2-weighted 
images (4.2 vs 3.1, P < 0.0001) and T1-weighted images (1.4 vs 1.3, P = 
0.0003), ADC (2.17×10-3 vs 1.69×10-3 mm2/s, P < 0.0001), magnetisation 
transfer ratio (35 vs 42%, P < 0.0001) and perfusion (60 vs 38 mL/min/100g, P 
= 0.0009). Monoparametric analysis with the best AUC to differentiate the two 
groups included T2-weighted signal intensity, ADC and magnetisation transfer 
  






ratio. The combination with the best global predictive value (94%) included all 
parameters but T1-weighted parameter (AUC 0.94). 
Conclusion: MR multiparametric analysis was able to distinguish transmural 
from submucosal fibrosis in our radiation-induced model. This model could be 
used to evaluate antifibrotic treatments currently under development.  
B-1529 14:08  
Accuracy of multi-parametric magnetic resonance imaging in the 
diagnosis and grading of intestinal acute Graft-versus-Host disease after 
allogenic bone marrow transplantation  
D. Vitale, F. Maccioni, V. Buonocore, D. Bencardino, M. Lopez, A. Iori,  
C. Catalano; Rome/IT (davide.vitale@uniroma1.it)  
Purpose: The diagnosis of the intestinal acute Graft-versus-Host disease (a-
GVHD) after allogenic bone marrow transplantation is based on clinical 
symptoms, CT findings and biopsies. We assessed Magnetic Resonance 
Imaging (MRI) diagnostic accuracy. 
Methods and Materials: We performed a prospective study on 35 patients 
(range 9-69 years) with clinical suspicion of intestinal a-GvHD, who underwent 
clinical-endoscopic, histological and multi-parametric MRI evaluation. Inclusion 
criteria: intestinal symptoms within 100 days from transplantation, <2 weeks 
between MRI and clinical-endoscopic evaluation. The following MRI features 
were evaluated: small and large bowel wall thickening, T2 signal and 
Gadolinium-enhancement of the intestinal wall, mesenteric lymph nodes, 
peritoneal effusion, comb-sign and restricted diffusion. Histology, clinical-
endoscopic data and follow-up were considered as gold standard for diagnosis 
and staging. Sensibility, specificity, accuracy and Cohen’s kappa were 
calculated. 
Results: In 21/35 (60%) a-GvHD was confirmed at histology and follow-up. In 
true positive patients, MRI showed significant continuous wall thickening in 
76.2%, stratified wall contrast-enhancement in 90%, comb-sign in 76%, 
increased number of mesenteric lymph nodes in 19%, and free intra-peritoneal 
fluid in 57.2%. A significant correlation was found between number of 
pathological intestinal segments and clinical grade of a-GvHD (r=0.54, 
p=0.009). The distal ileum was the segment most frequently involved (85.7%). 
MRI sensitivity was 90.5%, specificity 78%, the PPV 86%, NPV 84%, accuracy 
85%. Furthermore, MRI detected early disease in 82% of patients without 
intestinal symptoms. 
Conclusion: In patients with intestinal a-GvHD, MRI can diagnose and grade 
the disease with high accuracy, in both early and more advanced or severe 
stages.  
B-1530 14:16  
DWI ADC values are influenced not only by bowel distention degree but 
also the presence of osmotically active agent: results from research in 
healthy subjects  
I. Apine, M.P.M. Angerer, M. Baduna, G. Krumina; Riga/LV 
(dr.ilze.apine@gmail.com)  
Purpose: To assess dependence of bowel distention and presence of mannitol 
in MRE examinations on ADC values. 
Methods and Materials: ADC values of small and large bowel walls with high 
SI in DWI images at b=600 and b=800 grading bowel filling as “distended” and 
“collapsed” were measured before and after oral ingeston of 2.5% mannitol (1-
1.5 l) in 54 patients with no evidence of IBD. ADC differences between bowel 
filling grades and presence of mannitol were assessed with t-test and Wilcoxon 
signed-rank test. 
Results: Statistically significant differences (p<0.05) were gained in jejunum 
after preparation where ADC values were lower in wall of collapsed bowel than 
of distended one (the mean ADC in collapsed bowel at b=600 and b=800 was 
1.76×10-3 mm2/s (SD=0.48) and 1.10 (SD 0.32), respectively, whereas in 
distended bowel at b=600 and b=800 being 2.56×10-3 mm2/s (SD=0.63) and 
1.95 (SD 0.41), respectively). Regarding presence of mannitol, higher ADC 
was achieved in collapsed jejunum for b 600 and 800, respectively, being 1.35 
(SD 0.51) and 1.10 (SD 0.32) before preparation, 1.76 (SD 0.51) and 1.47 (SD 
0.36) after preparation as well as in distended colon ascendens for ADC 600 
and 800, being 1.56 (SD 0.26) and 1.36 (SD 0.27) before preparation and 2.48 
(SD 0.59) and 2.10 (SD 0.44) after preparation. 
Conclusion: ADC is influenced by both bowel distention degree and presence 
of mannitol which has to be considered in diagnosis of IBD.  
B-1531 14:24  
Magnetisation transfer MRI can characterise the degree of intestinal 
fibrosis in patients with Crohn's disease: comparing with contrast-
enhanced and diffusion-weighted MRI  
X. Li, S. Huang, Z. Fang, Z. Li; Guangzhou/CN (lixuehua803@163.com)  
Purpose: To evaluate the role of magnetisation transfer imaging (MTI) for 
characterisation of intestinal fibrosis compared with contrast-enhanced (CE) 
imaging and DWI and its capability for differentiating fibrotic from inflammatory 
strictures in humans with Crohn’s disease (CD). 
Methods and Materials: Abdominal MTI, CE and DWI of 31 consecutive CD 
patients were analysed before elective surgery. Bowel wall MT ratio (MTR) 
normalised to skeletal muscle, ADC and the percentage of enhancement gain 
were calculated and region-by-region correlation with surgical specimen was 
performed for histologic degree of fibrosis and inflammation. The performance 
of MTI was validated on 5 new patients. 
Results: Normalised MTRs correlated with fibrosis scores (r=0.769, P<0.001) 
but did not correlate with inflammation scores (r=-0.034, P=0.740). Significant 
differences in normalised MTRs were found among non-fibrotic, mildly, 
moderately and severely fibrotic walls (all P<0.05). Normalised MTRs of mixed 
fibrotic and inflammatory bowel walls were significantly higher than that of 
purely inflammatory bowel walls (P<0.001). High accuracy of normalised MTRs 
was shown with an AUC of 0.919 (P<0.001) for differentiating moderately-
severely fibrotic from non-fibrotic and mildly fibrotic bowel walls, followed by 
ADC (AUC=0.747, P=0.001) and the percentage of enhancement gain 
(AUC=0.592, P<0.001). Sensitivity, specificity and AUC of MTI for diagnosing 
moderate-severe fibrosis in the validation dataset were 80%, 100% and 0.9 
(P=0.033), respectively. 
Conclusion: MTI outperforms ADC and CE imaging in detecting and 
distinguishing varying degrees of bowel fibrosis with or without coexisting 
inflammation. It could potentially be used as a method to differentiate fibrotic 
from inflammatory intestinal strictures in CD.  
B-1532 14:32  
Biomarkers derived from time-intensity curves in patients with Crohn's 
disease  
E. Quaia1, A. Gennari2, M.A. Cova2, E.J. Van Beek1; 1Edinburgh/UK, 2Trieste/IT 
(equaia@exseed.ed.ac.uk)  
Purpose: To assess the best predictors of response to therapy in patients with 
Crohn’s disease calculated from time - intensity curves after microbubble 
injection. 
Methods and Materials: One-hundred-and-fifteen consecutive patients (66 
male and 49 female; 45.76 years ± 11) with a proven diagnosis of Crohn’s 
disease involving the terminal ileal loop and scheduled to begin or under 
therapy with corticosteroids or biologics (infliximab or adalimumab) and with 
stricture of the terminal ileal loop were scanned after sulphur hexafluoride-filled 
microbubble injection. In each patient the terminal ileal loop was scanned with 
CEUS before the beginning and at the end of week 6 of pharmacologic 
treatment. In each patient the percent change (Post - Pre x 100/Pre) of each 
kinetic parameter - peak enhancement, wash-in and washout rate, mean 
transit time, area under the whole time-intensity curve (AUC), AUC during 
wash-in (AUCWI), and AUC during wash-out (AUCWO) were automatically 
calculated from time intensity curves. Percent changes of responders and non-
responders were compared by Mann Whitney test. Separate univariate logistic 
regressions were conducted to determine the relationship between the percent 
change of each kinetic parameter (independent variables), and the therapeutic 
outcome as responder (dependent outcome variable). 
Results: Responders (n=72 patients) and non-responders (n=43) differed (P 
<0.05) in the percent change of peak enhancement, and area under the curve. 
Percent change of AUC, AUCWI, AUCWO were found predictors of therapeutic 
outcome. 
Conclusion: Area under time-intensity curve obtained after microbubble 
contrast agent injection is predictor of response to therapy in patients with 
Crohn’s disease.  
Author Disclosures: 
  E. Quaia: Advisory Board; Bracco Imaging. Speaker; Bracco imaging.  
B-1533 14:40  
Performance of PET/MR enterography vs MR enterography alone vs PET 
alone in evaluating active inflammation in Crohn's disease  
O.A. Catalano1,1, V. Wu1, U. Mahmood1, A. Soricelli2, A. Signore3, 
M. Salvatore2, D. Gervais1, B.R. Rosen4; 1Boston, MA/US, 2Naples/IT, 
3
Rome/IT, 4Charlestown, MA/US (alberto.signore@uniroma1.it)  
Purpose: To explore the performance of PET/MR enterography (PET-MR-E) 
versus MR enterography (MR-E) alone and PET alone in evaluating active 
inflammation in Crohn's disease patients. 
Methods and Materials: 21 Crohn's disease patients underwent PET/MR-E 
followed by surgery within 8 weeks, and constitute our study population. The 
gastrointestinal tract was divided into 5 segments in each patient. Two readers 
evaluated MR-E alone, PET alone, and PET/MR-E for active inflammation in 
each segment. 
Results: 59/105 bowel segments were positive for active inflammation at 
surgery. Sensitivity of PET (91.5%) and of PET/MR-E (88%) were statistically 
significantly higher than MR-E alone (80%) (p = 0.02 and p=0.08, respectively). 
No statistically significant differences were found between sensitivity of PET 
and PET/MR-E (p = 0.48). Specificity of MR-E (87%) and PET/MR-E (93%) 
were statistically significantly higher than PET (74%) (p=0.01 and 0.04, 
respectively) but no statistically significant difference was found between MR-E 
and PET/MR-E (p=0.37). Accuracy of PET/MR-E (91%) was statistically 
  






significantly higher than PET (84%) and MR-E (83%) (p=0.02 and 0.01, 
respectively). No statistically significant difference was found between PET and 
MR-E (p=1.00). 
Conclusion: PET/MR-E is significantly more accurate than sub-modality alone 
and more specific than PET alone in the detection of active inflammation in 
patients with Crohn's disease.  
B-1534 14:48  
Detection of inflammatory bowel segments with [18F]-FDG PET/MR 
enterography by Crohn's disease: which surrogate marker is better? 
MaRIA, Clermont score or PET?  
Y. Li, K.J. Beiderwellen, F. Nensa, K. Herrmann, L. Jost, L. Umutlu; Essen/DE 
(yan.li@uk-essen.de)  
Purpose: To compare the diagnostic accuracy of magnetic resonance index of 
activity (MaRIA), Clermont score and PET parameter in detecting ileocolonic 
inflammation in Crohn’s disease (CD) with an integrated whole-body PET/MR 
scanner. 
Methods and Materials: 50 patients with known CD and recurrent symptoms 
underwent ileocolonoscopy with biopsy (reference standard) as well as 
PET/MR enterography. The average time interval between endoscopy and 
PET/MR scan was 3 days. The endoscopic activity of inflammation was 
determined by simplified endoscopic activity score for Crohn’s disease (SES-
CD) and categorized in absent, mild to moderate and severe (ulcerative 
inflammation). 
Results: A total of 309 ileocolonic segments could be analysed. To detect 
active inflammatory segments, area under the curve (AUC) of receiver 
operating characteristic (ROC) for MaRIA was 0.93, sensitivity 0.86 and 
specificity 0.92 (cutoff  11.5); for Clermont score 0.89, 0.82 and 0.91 (cutoff  
13); for SUVmax_ratio (SUVmax of the segment divided by SUVmax of liver) 
0.87, 0.77 and 0.89 (cutoff  1.2), respectively. In detecting severe ulcerative 
inflammatory segments, AUC of ROC for MaRIA was 0.97, sensitivity 1.0 and 
specificity 0.89 (cutoff  14); for Clermont score 0.98, 1.0 and 0.93 (cutoff  
17); for SUVmax_ratio 0.95, 0.86 and 0.91 (cutoff  1.5). MaRIA, Clermont 
score and SUVmax_ratio all correlated significantly with global SES-CD (rho = 
0.76, 0.56 and 0.52, p<0.001). 
Conclusion: Both MR parameters were superior to PET in detecting active 
inflammatory segments. All of the three surrogate markers facilitate high 
diagnostic accuracy in detecting severe ulcerative inflammation.  
B-1535 14:56  
Magnetisation transfer and conventional MRI for characterisation of 
intestinal fibrosis and inflammation in patients with Crohn's disease  
Z. Fang1, X. Li1, S. Huang1, Z. Zhang2, C.C. Sun1, S.-T. Feng1, Z. Li1; 
1
Guangzhou/CN, 2Winston-Salam, NC/US (fangzn05@126.com)  
Purpose: An accurate and non-invasive technique to identify inflammation or 
fibrosis predominant strictures in Crohn's disease (CD) patients is crucial for 
treatment strategy. The aim of this study is to evaluate the value of magnetic 
transfer imaging as well as conventional MRI in characterizing types of CD 
strictures, using surgical histopathology as a reference standard. 
Methods and Materials: Seventeen CD patients with 56 specimens who had 
MRI studies within 15 days before surgery were enrolled in this study. MRI 
findings and variables included MTR, normalized MTR, T2WI high signal 
intensity, wall thickness, changes of enhancement pattern over time, 
enhancement pattern and enhancement gain ratio in each phase of the 
dynamic contrast-enhanced study. Correlation analysis, group difference 
analysis and logistic regression analysis were performed to find specific MRI 
variables as predictors for moderate-severe inflammation and fibrosis. 
Results: The severity of inflammation was significantly associated with the 
following MRI variables: T2WI high signal intensity and wall thickness (both 
P<0.05). The degree of fibrosis was significantly associated with the following 
MRI variables: MTR, normalized MTR and wall thickness (all P<0.05). Using 
T2WI high signal intensity as a predictor, MRI is able to differentiate mild and 
moderate-severe inflammation with a sensitivity of 0.913 and a specificity of 
0.800. Using normalized MTR to discriminate mild and moderate-severe 
fibrosis, the sensitivity and specificity were 0.875 and 0.875, respectively. 
Conclusion: T2WI high signal intensity and normalized MTR may serve as 
MRI markers for predicting moderate-severe inflammation and fibrosis, 
respectively, which can provide information for clinical treatment options.  
B-1536 15:04  
A simulated fast magnetic resonance enterography protocol in patients 
with Crohn’s disease: a retrospective, randomised, double-blind study  
G. Cicero, S. Mondello, A. Blandino, G. Ascenti, T. D'Angelo, S. Mazziotti; 
Messina/IT (gcicero87@gmail.com)  
Purpose: Magnetic resonance enterography (MRE) is a radiation-free and 
accurate technique in the assessment of Crohn’s disease, mainly impaired by 
high costs and prolonged scanning times. Our purpose is to compare the 
diagnostic performance of standard MRE vs a “fast” protocol consisting of only 
three sequences. 
Methods and Materials: 73 standard MRE examinations of patients with 
Crohn's disease performed over a 7-month period were retrospectively 
evaluated. The images of the two protocols were separated and evaluated by 
two radiologists with 12 and 2 years of experience in MRE. Statistical analysis 
was performed using the Cohen kappa value, the Lin’s concordance 
correlation, Bland-Altman plot, and the nonparametric Mann-Whitney U test. 
Results: Inter-protocol agreement was excellent for the presence and number 
of lesions, assessment of intestinal complications, and excellent in recognising 
inflammation pattern and extra-intestinal complications (kappa value 0.94-
0.096). The assessment of fibrosis had lower agreement with a kappa value of 
0.84, while an almost perfect concordance (c=0.999) was found in the 
assessment of lesion extension. Inter-observer agreement was excellent for 
the presence and number of lesions, inflammation and intestinal and extra-
intestinal complications; the assessment of fibrosis showed a lower agreement 
(93%; =0.84; 95% CI, 0.69 to 0.96). A concordance coefficient of 0.997 (95% 
CI 0.995-0.999) between the readers was obtained for the lesion extensions. 
Moreover, time spent in the evaluation of the fast protocol was significantly 
lower. 
Conclusion: The fast protocol achieves comparable performance with 
standard MRE. Furthermore, it has potentially enormous benefits in terms of 
patient’s comfort, time and health-care cost savings.  
B-1537 15:12  
Established bowel damage detected on MR enterography in patients with 
Crohn's disease in complete endoscopic remission  
J. Rimola, I. Alfaro, D. Vas, I. Ordás, E. Ricart, J. Panes; Barcelona/ES 
(jrimola@clinic.cat)  
Purpose: To identify the MRE lesions that persist in patients with Crohn’s 
disease (CD) in endoscopic remission as indicators of established damage and 
to determine its relationship with pre-treatment MRE lesions. 
Methods and Materials: Patients with CD who had been included in 
prospective studies on autologous haematopoietic stem cell transplant and/or 
anti-TNF drugs were evaluated for this study. Inclusion criteria were: presence 
of at least one segment with severe inflammatory lesions on endoscopy 
(CDEIS>8.5) or MRE (MaRIA>11) before treatment and achievement of 
endoscopic remission after 1 year of treatment. Baseline and 1-year MRE were 
reviewed. 
Results: 73 intestinal segments with severe inflammatory lesions from 28 
patients achieved endoscopic remission. The prevalence of creeping fat and 
bowel mural fat did not change in association with achievement of endoscopic 
remission (p=0.34 and p=0.35, respectively). Furthermore, luminal stenosis 
persisted in 50% of initial stenosis and mural thickness>3mm remained in 29% 
of segments. At least one of the aforementioned residual lesions was present 
in 30/73 segments with endoscopic remission. Regression analysis showed 
that the predictive factors on MRE for established residual mural lesions after 
achieving endoscopic remission were the presence of bowel fat deposition 
(OR=48.3, p=0.001) and stenosis (OR=15.96, p=0.004), whereas creeping fat 
was the predictive factor for persistent extramural lesions (OR=35.8, p<0.001) 
and for either mural or extramural lesions (OR=16.25, p<0.001). 
Conclusion: Up to 41% of bowel segments in endoscopic long-standing 
remission after treatment had residual lesions at MRE. The presence of bowel 
fat deposition, stenosis and creeping fat may predict the development of 
established damage.  
B-1538 15:20  
Dual-energy CT enterography in evaluation of Crohn's disease: the role 
of virtual monochromatic images  
E. Güler, N.G. Ünal, I. Hekimsoy, T. Köse, M. Harman, Z.N. Elmas; Izmir/TR 
(gulerezgi@yahoo.com)  
Purpose: The purpose of this study is to evaluate the performance of virtual 
monochromatic images (VMI) in differentiating diseased and non-diseased 
bowel segments in Crohn’s disease (CD). The second aim is to compare mural 
enhancement between patients with and without CD by using VMI. 
Methods and Materials: Dual-energy CT enterography (CTE) of 61 
patients(47 with CD and 14 without CD) were retrospectively reviewed. Images 
were reconstructed at VMI energy levels from 40 to 110keV in 10 keV 
increments. Attenuation, signal-to-noise ratio(SNR), and contrast-to-noise 
ratio(CNR) were obtained from diseased and non-diseased bowel segments. 
Subjective analysis of image quality of VMI and polychromatic images(PCI) 
was performed by two radiologists in consensus. Repeated measures ANOVA 
and Wilcoxon tests were used in the assessment of quantitative and subjective 
analyses, respectively. 
Results: Attenuation, SNR, and CNR were found to be higher with a statistical 
significant difference in diseased segments than non-diseased segments in 
patients with CD at each energy level of VMI. In the evaluation of patients with 
and without CD, optimal attenuation, SNR, and CNR values were observed at 
40keV (area under ROC curve (AUC):0.913;95% confidence interval(CI):0.843-
  






0.984), 40keV (AUC:0.807;95%CI:0.679-0.935), and 70keV 
(AUC:0.906;95%CI:0.82-0.987), respectively. For subjective analysis, there 
was a statistically significant difference between the comparison of VMI and 
PCI (p<0.05). 
Conclusion: VMI of dual-energy CTE provide information in differentiating 
diseased bowel segments in CD by assessing mural enhancement 
quantitatively. In the evaluation of CD and controls, VMI at 40keV and 70keV 
allow for the optimal attenuation and CNR of bowel segments, respectively.  
14:00 - 15:30 Room Z  
Interventional Radiology  
SS 1909  
Urogenital interventions  
Moderators:  
S. Bongiovanni; Cuneo/IT  
J. Kettenbach; St. Pölten/AT  
K-30 14:00  
Keynote lecture  
T.J. Kroencke; Augsburg/DE  
B-1539 14:09  
Interventional radiology approach in the treatment of symptomatic 
uterine fibroids: from diagnosis to treatment: our experience  
P. Palumbo, S. Quarchioni, F. Bruno, M.V. Micelli, A. Giordano, M. Varrassi, 
S. Carducci, M. Di Luzio, C. Masciocchi; L'Aquila/IT 
(palumbopierpaolo89@gmail.com)  
Purpose: Uterine fibroids (UF) are the most common benign uterine neoplasm. 
Uterine artery embolization (UAE) and Magnetic Resonance guided Focused 
UltraSound (MRgFUS) have been demonstrated to be safe and effective as 
uterus-sparing therapeutic option. Our purpose is to demonstrate the efficacy 
of both procedures in the treatment of symptomatic UF. 
Methods and Materials: We retrospectively analysed 105 women. 58/105 
were treated with MRgFUS and 47/105 were treated with UAE. They were 
screened by magnetic resonance imaging (MRI) to evaluate Non-Perfused-
Volume (NPV) and Perfused Volume (PV) of remains fibroids. The UFs 
questionnaire (UFS-QOL) is used in order to assesses clinical symptoms 
severity before and after one year post procedure. 
Results: After one year, the NPV mean value was of 95% using UAE and of 
91% using MRgFUS. The post-treatment UFS-QOL has shown a significant 
reduction of score when compared to pre-treatment score. High efficay of 
MRgFUS depends on the correct selection criteria (better efficacy for type 0 
and 1 UFs when compared to other). The UFS-QOL too, show high value in 
case of inappropriate MRgFUS treatment (post-treatment score near to pre-
treatment values, with mean value between 40 to 60), with necessity of 
retreatment or other treatment as UAE or myomectomy. 
Conclusion: UAE is more radical compared to MRgFUS, but it is necessary to 
consider the age of patients and their wishing to conceive; considering 
controversial aspect about pregnancy after UAE, we consider always MRgFUS 
as first treatment option especially in young patients.  
B-1540 14:17  
A comparative study of quantitative T1 perfusion parameters in magnetic 
resonance-guided high-intensity focused ultrasound ablation of uterine 
fibroids  
N.M. Duc1, B. Keserci1, H.Q. Huy1, P.N. Hoa1, P.M. Thong2; 1Ho Chi Minh/VN, 
2
Ha Noi/VN (bsnguyenminhduc@pnt.edu.vn)  
Purpose: To investigate the predictive role of quantitative perfusion 
parameters in magnetic resonance-guided high-intensity focused ultrasound 
(MR-HIFU) ablation of uterine fibroids. 
Methods and Materials: 100 uterine fibroid patients (39.4 ± 5.9 years with a 
range of 22-52 years) underwent MR-HIFU were accessed in this study. The 
population was divided into 2 groups based on dynamic contrast-enhanced MR 
images at screening: group A (n = 75) if the time-intensity curves of uterine 
fibroids is lower than that of myometrium and group B (n = 25) if the time-
intensity curves of uterine fibroids is equal or higher than that of myometrium. 
Ktrans, area under the curve (AUC) of both fibroids and myometrium and the 
ratio Ktrans and AUC of uterine fibroids relative to myometrium were 
investigated. 
Results: Ktrans, AUC, Ktrans ratio and AUC ratio were 83.1 ± 59.0 (30.1-315.2); 
20.7 ± 16.1 (3.2-69.8); 0.56 ± 0.18 (0.2-1.0); 0.6 ± 0.2 (0.3-1.0); for group A 
and 189.1 ± 87.9 (55.2-372.4); 38.4 ± 27.1 (9.2-99.1); 1.8 ± 0.7 (0.7-3.8); 1.8 ± 
0.5 (1.3-2.9) for group B (p < 0.05), respectively. Immediate post-treatment 
non-perfused volume (NPV) ratio of uterine fibroids was 95.71% ± 5.9 (80-
100%) for group A and 54.26% ± 25.77 (4.26-80.17%) for group B (p<0.05). 
Multiple linear regression manifested that there were Ktrans ratio and AUC ratio 
parameters had significant effect on NPV ratio (p < 0.05). 
Conclusion: The Ktrans ratio and AUC ratio parameters could be served as a 
potential criteria in patient selection for an improved NPV ratio.  
B-1541 14:25  
MR-guided focused ultrasound (MRgFUS) compared to the main current 
therapeutic approaches for the treatment of uterine fibroids  
S. Dababou, F. Andrani, A. Napoli, R. Scipione, C. Marrocchio, H.-P. Erasmus, 
C. Catalano; Rome/IT (susy150791@gmail.com)  
Purpose: To prospectively evaluate the clinical outcome of magnetic 
resonance focused ultrasound (MRgFUS), uterine artery embolization (UAE) 
and surgery for symptomatic uterine fibroids. 
Methods and Materials: 585 symptomatic uterine fibroids underwent pre-
treatment MR evaluation to assess myoma characteristics and MRgFUS 
eligibility. 187(32%) were considered eligible for MRgFUS and treated with 
ExAblate-InSightec 2100 system, while 398 were ineligible and directed toward 
other therapeutic strategies. Of these, 137 patients underwent UAE, 143 
myomectomy and 61 hysterectomy. The clinical outcome was evaluated by 
comparing the pre-treatment Symptoms Severity Score (SSS) with post-
treatment SSS at the 3-month and 12-month follow-up. Data concerning the 
number and type of complications, days of hospitalization and days of 
convalescence were also collected and compared. 
Results: The mean SSS reduction at 3 and 12 months was respectively 27,4% 
and 56,3% for the MRgFUS group; 48,7% and 56,9% for the UAE group; 
69,8% and 67,1% for the myomectomy group; 96,6% and 94,5% for the 
hysterectomy group. The MRgFUS group demonstrated fewer complications (4 
patients, 2,3%), while the major adverse events rate was reported in the UAE 
group (33 patients, 25,4%). All MRgFUS patients were treated in an outpatient 
setting, while the mean days for hospitalization and convalescence were, 
respectively, 3,4+/-2 and 11,7+/-9 days for the UAE group; 4,1+/-2 and 16,9+/-
12 days for the myomectomy group; 4,5+/-1 and 24,6+/-14 days for the 
hysterectomy group. 
Conclusion: The clinical efficacy of MRgFUS for uterine fibroids treatment is 
comparable to UAE, but slightly lower than that for myomectomy. However, 
MRgFUS is feasible in an outpatient setting and adverse events rate is 
significantly lower than that of other therapeutic strategies.  
B-1542 14:33  
Follow-up studies of uterine fibroids (UFs) treated with MRgFUS: who are 
the best candidates for treatment?  
I. Capretti, S. Iafrate, E. Cannizzaro, F. Arrigoni, M. Di Luzio, A. Giordano, 
S. Mascaretti, G. Mascaretti, C. Masciocchi; L'Aquila/IT 
(ilaria_capretti@hotmail.it)  
Purpose: To investigate the individual variables that can influence a good 
clinical result in patients affected by symptomatic UFs and treated with 
MRgFUS. 
Methods and Materials: A population of 110 women with symptomatic UFs 
(aged between 27 and 49) and treated with MRgFUS was retrospectively 
analyzed. These women were submitted to c.e.MRI immediately after 
treatment and after twelve months in order to evaluate the Non-Perfused 
Volume (NPV). Clinical outcome was investigated by means of a questionnaire 
about symptoms and health-related quality of life (UFS-QOL). Acoustic 
window, patients’ BMI and distance from skin tissue to fibroid in the anterior or 
posterior uterine wall were considered as individual characteristics. 
Results: All patients presented a mean value of NPV extension ranging 
between 68% and 81% after treatment and a reduction of 50% at twelve 
months. In 94 patients an improvement of symptomatology was observed: 
mean UFS-QOL value of 51.6 before treatment and 16.7 at the follow-up. 
Some women (70) became asymptomatic during the follow-up. Women with 
higher NPV ratio, appropriate and wide acoustic window, lower BMI and less 
distance between skin tissue and fibroid, in particular UFs of anterior uterine 
wall, achieved good clinical success. 
Conclusion: MRgFUS may be considered a valid alternative therapy in 
patients affected by UFs. Some favorable conditions such as appropriate 
acoustic window and lower BMI and distance from the skin may be related to a 
better clinical success.  
B-1543 14:41  
Tips and tricks to treat difficult cases of uterine fibroids (UFs): how to 
increase elegibility in MRgFUS (magnetic resonance-guided focused 
ultrasound surgery)  
S. Iafrate, I. Capretti, E. Cannizzaro, F. Arrigoni, M. Di Luzio, A. Giordano, 
S. Mascaretti, G. Mascaretti, C. Masciocchi; L'Aquila/IT 
(sonia.iafrate87@gmail.com)  
Purpose: To increase eligibility of uterine fibroids(UFs) treatment by 
MRgFUS,via some practical strategies,in order to obtain an adequate acoustic 
window for the ultrasound beam in difficult cases. 
  






Methods and Materials: Fourteen patients affected by UFs,displaying an 
inadequate acoustic window to MRgFUS, were assessed from May 2014 to 
September 2016.Additionally to the common techniques used to obtain an 
adequate acoustic window,we tried to evaluate some strategies to increase the 
eligibility to the procedure.Inversion table together with abdominal massages 
were used to move up the bowel loops with the patients in antigravity position. 
To minimise intestinal bloating and peristalsis a low-fibre diet for a week before 
the MRgFUS was advised.Filling bladder to move-up bowel loops and filling 
rectum to outdistance the UFs from the sacrum were also used.The volume of 
treated UFs and Non perfuse volume(NPV) were calculated,while symptom 
outcome was assessed with a symptom severity score questionnaire (UFS-
QOL). 
Results: Fourteen patients, affected by UFS and with inadequate acoustic 
window, were evaluated.After using inversion table(20%),filling bladder and 
rectum(50%),low-fibre diet(30%) inadequate acoustic window was obtained 
and 10 patients underwent MRgFUS. A mean extension of NPV of 50-65% 
with a good effectiveness of the treatment was observed in all treated UFs. 
Furthermore, patients experienced a reduction of UFS-QOL around 70%,when 
compared with the pre-treatment score.No severe side effects were 
observed.Despite these practical strategies,4 patients were not treated due to 
inadequate acoustic window. 
Conclusion: Some practical strategies may increase eligibility to MRgFUS 
obtaining an adequate acoustic window for the ultrasound beam; in these 
patients, MRgFUS may improve clinical outcome.  
B-1544 14:49  
Combined uterine artery embolisation with intra-arterial chemoinfusion 
as a sole management for scar and cervical ectopic pregnancy  
A. Elmokadem, R. Abdel-Wahab, A.A. El-Zayadi, M. ElRakhawy; Mansoura/EG 
(mokadem83@yahoo.com)  
Purpose: To evaluate the technical and clinical outcomes of uterine artery 
embolization (UAE) along with the chemoinfusion of methotrexate (MTX) for 
cesarean scar (CSP) and cervical pregnancy (CP) as an alternative 
nonsurgical treatment to control bleeding and uterine preservation. 
Methods and Materials: This study included eleven patients (age range 
between 25-40 year, mean; 31.8) with 7 CSP & 4 CP. They presented with 
vaginal bleeding and elevated -HCG levels (mean 31.245 mlU/mL). The 
diagnosis of ectopic pregnancy was confirmed by sonography and magnetic 
resonance imaging. They were treated with UAE using embolic particles (500-
700 microns) and gelatin sponge particles. In all patients, the infusion of MTX 
(50mg/m2) was performed before UAE. Angiographic features as contrast 
extravasation and utero-ovarian anastomosis were reported. Follow-up periods 
after UAE ranged between 6 to 24 months included weekly sonography and -
HCG level assessment with MRI scan after 2 months. 
Results: All patients had prior history of cesarean section. The gestational sac 
age range between 6-11 week. In ten patients, UAE controlled active vaginal 
bleeding and postprocedural HCG levels were reduced significantly by the 
second week . One patient presented with persistent elevated HCG level and 
vaginal rebleeding was encountered. The rebleeding was successfully 
controlled by second UAE procedure. The ectopic pregnancies were 
dramatically resolved & uterus was preserved in all patients. No major 
complications were detected. Normal menses resumed within 2 months after 
UAE. 
Conclusion: UAE along with chemoinfusion of MTX is effective non surgical 
alternative for treating SCP and CP with uterine preservation.  
B-1545 14:57  
Transperineal ultrasound-guided laser ablation for the treatment of 
benign prostatic hyperplasia in interventional radiology: preliminary 
results  
G. Patelli1, A. Ranieri1, G.A. Paganelli1, A. D'Alessio2, F. Besana1, G. Mauri3, 
C.M. Pacella4; 1Seriate/IT, 2Osio Sotto-Zingonia/IT, 3Milan/IT, 
4
Albano Laziale/IT (gianluigi.patelli@asst-bergamoest.it)  
Purpose: To assess the safety and efficacy of ultrasound-guided (US-g) 
transperineal laser ablation (TPLA) in treating benign prostatic hyperplasia 
(BPH). 
Methods and Materials: fifty-five patients (age 72.6±10.4 years, range 58-93) 
suffering from obstructive syndrome secondary to BPH underwent TPLA using 
continuous wave (CW) diode laser source operating at 1064 nm (Echolaser 
SoracteLite, Elesta s.r.l., Calenzano (FI), Italy). Under US-g, depending on 
basal volume, up to two 21 G introducer needles for each lobe were inserted 
via transperineal approach. Each treatment was performed with a fixed power 
protocol (3W) changing the illumination time case by case according to the 
prostate volume. The efficacy of the treatment was evaluated considering the 
changes of International Prostate Symptoms Score (IPSS), Quality of 
Life(QoL), post-void residual (PVR), peak urinary flow rate (Qmax) and 
prostate volume. the mean hospital stay and mean catheterization time were 
measured. 
Results: In all patients, the treatment was successful without intraoperative 
and perioperative complications. The mean operation time was 43.3±8.7 min, 
mean ablation time 15.9±3.9 min, mean energy deployed 11,470.0±3,570.6J, 
mean hospital stay 1.5±0.4 days and mean catheterization time after the 
procedure 14.4±7.7 days. The mean follow-up was 11.5 months (range 4-36). 
IPSS improved from 22.2 to 7.7 (P<0.001), QoL from 4.5 to 1 (P<0.001), Qmax 
from 7.6 to 13.3 ml/s (P=0.001), PVR from 148.0 to 58.2 ml (P<0.001) and 
mean prostate volume from 80.6 to 52.6 ml (P<0.001). No major complications 
occurred. 
Conclusion: TPLA is a novel option to treat patients affected by BPH. The 
study demonstrated that this approach was efficacious and safe with significant 
and durable results.  
B-1546 15:05  
MRI-guided percutaneous transgluteal ablation of unilateral prostate 
carcinoma: initial experiences and results  
J. Figiel, A. Koenig, A. Hegele, A. Mahnken; Marburg/DE 
(figiel@med.uni-marburg.de)  
Purpose: To evaluate safety, periprocedural imaging features and short-term-
outcome of MRI-guided percutaneous transgluteal cryo-ablation of focal 
prostate carcinoma in a 1.5T MR-scanner. 
Methods and Materials: The analysis includes 10 consecutive Patients (age 
46-75, average 60) with 11 interventions performed between 06/2016 and 
07/2017. All patients had histologically proven unilateral prostate carcinoma (5 
low risk, 6 intermediate risk). Pre- and postinterventional PSA-levels were 
measured. MRI-guided semigland-ablation was performed under general 
anesthesia via a transgluteal access. Realtime-imaging was used for 
positioning of the cryo-needle. Periprocedural imaging was used to monitor ice-
ball formation. Rectum, urethral sphincter and bladder-tissue were spared. 
Postprocedural multiparametric MRI was performed to assess results after 1 
day, 6 months and 12 months. 
Results: Average procedure time was 2:41 h (2:07 h - 3:49 h). There were no 
major complications. One patient suffered hematuria for 4 weeks requiring no 
further treatment, one patient had a clinically irrelevant mucosal defect in the 
rectum and one patient had postinterventional urinary retention requiring 
prolonged transurethral catheterization. Peri- and postinterventional MRI 
showed full coverage of 9 lesions. In 1 lesions postinterventional biopsy 
revealed residual tumor and the intervention was repeated 10 months after 
initial procedure. PSA-levels declined by an average of 71,5% (18,2-99,5%). 
During follow-up no death or distant metastasis occurred. 
Conclusion: Initial results show, that percutaneous MRI-guided cryoablation of 
focal prostate carcinoma is a safe and effective minimal-invasive therapy for a 
selected group of patients with prostate carcinoma. It may provide a viable 
alternative in patients under active surveillance.  
B-1547 15:13  
MR-guided focused ultrasound treatment for management of organ-
confined intermediate-risk prostate cancer: evaluation of safety and 
effectiveness  
S. Bednarova, A. Napoli, R. Scipione, S. Dababou, C. Marrocchio, 
H.-P. Erasmus, V. Panebianco, C. Catalano; Rome/IT 
(sandra.bednarova@gmail.com)  
Purpose: To evaluate the safety and effectiveness of MR-guided focused 
ultrasound (MRgFUS) ablation of organ-confined intermediate-risk prostate 
cancer (PCa) in patients seeking urogenital functional preservation while 
controlling tumour growth, postponing or avoiding the need of definitive 
treatment. 
Methods and Materials: This prospective single-arm study was approved by 
the institutional review board, and informed consent was obtained from all 
subjects. Sixteen treatment-naïve patients (age range 50-74 years) with 
histologically proven organ-confined intermediate-risk PCa (Gleason score 
7=3+4/4+3, T1-T2b, N0, M0 stage, PSA20ng/ml) underwent pre-treatment 
3T multiparametric MR imaging (mpMRI) and for MR visible lesions MRgFUS 
treatment with ExAblate (InSightec) was performed. Safety of treatment was 
determined by evaluation of the incidence and severity of device-related 
complications while clinical efficacy was evaluated in terms of prostate MRI 
changes and serum PSA (sPSa) levels at 3, 6 and 12 months follow-up. 
Results: MRgFUS shows low operative morbidity and no systemic side effects: 
one patient reported urinary incontinence and two patients referred erectile 
dysfunction after treatment. Contrast-enhanced MRI (DCE-MRI) at 3, 6 and 12 
months follow-up showed no recurrence/residual disease in treated patients. 
Progressive decrease of sPSA levels was encountered; an average value of 
17.1 ng/ml before treatment dropped to 2.2 ng/ml at 12 months follow-up. Yet 
all patients included in this study are considered free of clinically significant 
PCa with no present need of definitive treatment. 
Conclusion: MRgFUS can reduce the need of surgery or radiation therapy in 
patients with intermediate-risk prostate cancer representing a safe and 
effective treatment.  
  






B-1548 15:21  
MR-guided in-bore prostate biopsy for clinically significant cancer 
detection in patients with negative TRUS biopsies and rising PSA level  
N. Matinyan1, V. Kuplevatsky2, I. Minasyan1, M. Cherkashin2, N. Berezina2, 
D. Sahakyan1; 1Yerevan/AM, 2St. Petersburg/RU (matinyan@doctor.com)  
Purpose: To evaluate the potential of MRI-guided prostate biopsy in 
individuals with negative TRUS biopsy and rising PSA level. 
Methods and Materials: This study covered 91 patients (aged 40-70), with 
negative TRUS biopsy and rising PSA level, who underwent multiparametric 
MRI, with high-field 3T scanner (MAGNETOM Verio) or 1.5T scanners 
(MAGNETOM Aera and Symphony). Quantitative and qualitative assessment 
of changes were carried out in accordance with the recommendations of PI-
RADSv2. MRI-guided in-bore biopsy was performed using a MRI-compatible 
“In vivo” biopsy set, with a 150mm/16g needle gun. To navigate and control the 
location of the needle, T2 WI was used in the sagittal and coronal projection. 
Results: Based on the results of multiparametric MRI, 40 patients were graded 
as PI-RADS 3, 32 patients as PI-RADS 4 and 19 patients as PI-RADS 5. 
Based on the histological data after the MRI-guided biopsy, in the group of 
patients with PI-RADS 3 score, 32 were diagnosed with adenocarcinoma (in 
one case clinically insignificant cancer was diagnosed, in the rest Gleason 
score did not exceed 3+4=7). In the group of patients with PI-RADS 4 score, 
28 were diagnosed with adenocarcinoma (with average Gleason score 4+3=7). 
In the group of patients with PI-RADS 5 score, 19 were diagnosed with 
adenocarcinoma (with average Gleason score 4+3=7). 
Conclusion: The MRI-guided biopsy is an efficient procedure for detecting 
clinically significant prostate cancer in patients with previous negative TRUS 
biopsies results and rising PSA level.  
14:00 - 15:30 Room O  
Chest  
SS 1904a  
Pulmonary vessels  
Moderators:  
F. Pontana; Lille/FR  
J. Vlahos; London/UK  
B-1549 14:00  
Automated volumetry of peripheral pulmonary vessels based on CT 
angiography in suspected pulmonary hypertension  
C. Melzig1, O. Weinheimer1, B. Egenlauf1, M. Messerli2, E. Grünig1, 
H.-U. Kauczor1, C. Heussel1, F. Rengier1; 1Heidelberg/DE, 2Zurich/CH 
(claudius1.melzig@med.uni-heidelberg.de)  
Purpose: To assess automated volumetry of the peripheral lung vasculature 
based on pulmonary CT angiography (CTPA) for the detection of pulmonary 
hypertension (PH). 
Methods and Materials: 74 consecutive patients (mean 66.2 years, 50 
female) who underwent right heart catheterization (RHC) and CTPA for 
suspected PH at our institution were included. Patients with chronic 
thromboembolic PH were excluded. In-house developed software was used for 
automated vessel segmentation. Vascular volumes within 10 mm, 15 mm and 
20 mm of the lung borders were calculated. 
Results: 42 out of 74 patients had PH (mean pulmonary arterial pressure 
(mPAP) 37±11 mmHg, 57%), while 32 had normal mPAP (17±4 mmHg). 
Peripheral vessel volumes were significantly enlarged in patients with PH 
compared to patients without PH: 86±29 vs. 66±23 cm³ within 20 mm, 59±24 
vs. 42±19 cm³ within 15 mm and 31±17 vs. 19±14 cm³ within 10 mm of the 
lung borders (all p < 0.003). ROC analysis showed AUC for the detection of PH 
of 0.73 for 20 mm, 0.74 for 15 mm and 0.75 for 10 mm of the peripheral 
vascular volume. A cutoff value of 19.4 cm³ for the 10 mm peripheral vascular 
volume identified PH with 74% sensitivity, 72% specificity, 78% positive and 
67% negative predictive value. 
Conclusion: Automated volumetry of peripheral pulmonary vasculature is 
feasible and demonstrated significantly enlarged vessel volumes in patients 
with confirmed PH with the highest diagnostic accuracy within 10 mm of the 
lung periphery. The technique may facilitate non-invasive detection of PH.  
B-1550 14:08  
CT evaluation of small pulmonary vessel area in patients with 
bronchiolitis obliterans syndrome after lung transplantation  
Y. Sato, J. Tominaga, N. Mori, Y. Matsuda, Y. Okada, K. Takase; Sendai/JP 
(maroty0507@gmail.com)  
Purpose: To evaluate the cross-sectional area (CSA) of small pulmonary 
vessels measured on CT for detection of bronchiolitis obliterans syndrome 
(BOS) in patients who have undergone bilateral lung transplantation. 
Methods and Materials: The institutional review board approved this study 
and waived informed consent. The study comprised consecutive 26 patients 
who underwent bilateral lung transplantation. The patients were divided into 
two groups: non-BOS and BOS on the basis of spirometry test. We measured 
CSA less than 5 mm2 and calculated the percentage of total CSA for the lung 
area (%CSA<5) using plain chest CT. Three CT slices were selected for the 
measurement of CSA. The upper slice was taken 1 cm above the upper margin 
of the aortic arch, the middle slice was taken 1 cm below the carina, and the 
lower slice was taken 1 cm below the right inferior pulmonary vein. These three 
CT slices were analysed using ImageJ. The values of %CSA<5 were 
compared between the non-BOS and the BOS groups using the Mann-Whitney 
U test. P<0.05 indicated statistical significance. 
Results: Six patients had BOS grade 0-p, two patients had BOS grade 2, and 
two patient had BOS grade 3. The remaining 16 patients had no BOS. Median 
%CSA<5 of the BOS group was significantly lower than that of the non-BOS 
group (0.49 versus 0.66, P=0.047). The ROC curve revealed that the area 
under the curve was 0.74. 
Conclusion: CSA of small pulmonary vessels measured by CT may be useful 
for diagnosis of BOS after lung transplantation.  
B-1551 14:16  
High-resolution computerised tomography (HRCT) features of Group 1 
pulmonary arterial hypertension (PAH): a case series of 21 lung 
transplant patients  
M.S. Juárez-García, E. Pallisa, M. López-Meseguer, D. Varona Porres, 
A.L. Sanchez Martinez, E. Maciag, L. Cabanzo Campos, J. Andreu, 
O. Persiva Morenza; Barcelona/ES (anchante.juarez@gmail.com)  
Purpose: Characterise HRCT features of PAH in a case series of patients who 
posteriorly received a uni-/bilung graft between the years 2010 and 2017. 
Methods and Materials: We retrospectively evaluated a case series of 21 
PAH patients and described the last pre-transplant thoracic/HRCT features. 
These features were analysed by two independent thoracic-radiologists at five 
levels: origin of great vessels; main carina; pulmonary venous confluence; 
halfway between the third and fifth section; above the right hemidiaphragm. We 
defined the disease extension and the extent of the primary and secondary 
radiological features at each level. Primary features were centrilobular nodules, 
ground-glass opacities, and interlobular septal smooth thickening. Secondary 
features were enlargement of mediastinal lymph nodes, pleural/pericardial 
effusion, and egg-banana sign. 
Results: Eight patients had idiopathic/heritable PAH, five had scleroderma, 
four had pulmonary veno-occlusive disease/Group 1´(PVOD), and four had left 
heart disease. Almost all idiopathic/heritable PAH patients had all the primary 
and secondary HRCT features, except interlobular septal thickening, which 
was only described in one patient (12.5%). All scleroderma patients had more 
than 50% of disease extension and positive egg-banana sign; however, no 
patient had interlobular septal thickening. All PVOD patients had centrilobular 
nodules, interlobular septal thickening and mediastinal lymph node 
enlargement, but none had positive egg-banana sign. All left heart disease 
patients had centrilobular nodules and interlobular septal thickening, but none 
had lymph node enlargement or pleural/pericardial effusion. 
Conclusion: In our case series, the scleroderma patients had the greatest 
lung disease extension and the highest positivity of egg-banana sign. All POVD 
patients showed the classical radiological features as described in the 
literature.  
B-1552 14:24  
Dual-energy CT (DECT) lung perfusion in chronic thromboembolic 
pulmonary hypertension (CTEPH): diagnostic accuracy and concordance 
with radionuclide scintigraphy  
M. Masy, J. Giordano, C. Hossein-Foucher, G. Petyt, J. Remy, 
M. Remy-Jardin; Lille/FR (martine.remy@chru-lille.fr)  
Purpose: To evaluate the concordance rate of DECT lung perfusion and 
ventilation/perfusion (V/Q) scintigraphy in diagnosing chronic thromboembolic 
pulmonary hypertension (CTEPH) amongst patients with proven pulmonary 
hypertension (PH). 
Methods and Materials: 80 patients with proven PH underwent V/Q 
scintigraphy and DECT lung perfusion. Diagnosis of CTEPH was established 
by the presence of at least one segmental triangular perfusion defect on DECT 
perfusion images and by characteristic V/Q mismatch on scintigraphic 
examinations. 
Results: The study population comprised 36 patients with CTEPH (“CTEPH 
group”) and 44 patients with other aetiologies of PH (i.e. “non CTEPH group”). 
On DECT perfusion images alone, 35 were true positive, 6 false positive and 1 
false negative (sensitivity: 0.97; specificity: 0.86; positive predictive value: 0.85; 
negative predictive value: 0.97). On V/Q scans, there were 36 true positives 
and 1 false positive (sensitivity: 1; specificity: 0.97; positive predictive value: 
0.97; negative predictive value: 1). There was excellent agreement between 
DECT perfusion and scintigraphy in diagnosing CTEPH (kappa: 0.80). 
Combined information from DECT lung perfusion and CT angiographic images 
  






enabled reclassification of (a) the 6 false-positive cases into the “non CTEPH 
group”, triangular defects being related to small airway disease; (b) the false-
negative case into the “CTEPH group”, based on the finding of mild central and 
extensive peripheral chronic PE. 
Conclusion: There is excellent agreement between DECT perfusion and V/Q 
scintigraphy. The diagnostic accuracy of DECT is reinforced by the morpho-
functional analysis of datasets.  
Author Disclosures: 
 J. Remy: Consultant; Research Consultant, Siemens Healthcare. 
M. Remy-Jardin: Research/Grant Support; Siemens Healthcare. 
B-1554 14:32  
Overdiagnosis of PE in pregnancy? Interpretative discrepancy in the 
diagnosis of pulmonary embolism in pregnant patients undergoing CTPA  
D.P. Mitchell, C.D. Gillespie, H. Moriarty, C.A. Ridge, P.J. MacMahon; 
Dublin/IE (dpmmitchell@gmail.com)  
Purpose: To evaluate the rate of discrepancy in the diagnosis of PE in 
pregnant patients undergoing CTPA. 
Methods and Materials: Retrospective review of all CTPA studies performed 
on pregnant patients referred to a tertiary referral centre over a two-year 
period. CTPA studies reported as positive for PE were matched with negative 
CTPA studies. This mixed subset was blindly reviewed by two subspecialist 
radiologists. CTPA study quality and thrombus volume was recorded. 
Results: 98 CTPA studies were performed on pregnant patients over the two-
year period. 14% (14/98) of studies were initially read as positive for PE. A 
subset of 30 studies (14 PE-positive and 16 PE-negative studies) were blindly 
assessed by two sub-specialist reviewers. There was 97% agreement between 
reviewers (29/30 studies). 1 study was considered nondiagnostic and 3 studies 
were determined to be suboptimal but sufficient for the diagnosis of a large- or 
medium-sized PE. The diagnostic agreement between the reviewers and the 
initial reporting radiologist in 83% (25/30). 36% (5/14) of "PE positive" studies 
were reclassified as false positives. 
Conclusion: There was a higher than expected rate of discrepancy in the 
interpretation of positive CTPA studies. By raising awareness of this issue of 
PE over-diagnosis, the percentage of CTPAs reported as positive for PE 
dropped from 14% to 2% in our institution. We strongly recommend the 
addition of “MDT review” to the diagnostic treatment algorithm for all positive 
PE cases in pregnancy to ensure a subspeciality double read of all positive 
CTPA studies.  
B-1555 14:40  
Indeterminate CT pulmonary angiograms (CTPA) with dual-source CT 
(DSCT): prospective evaluation in 449 patients suspected of acute 
pulmonary embolism (PE)  
J. Hennicaux, A. Hutt, J.-B. Faivre, S. Khung, J. Remy, M. Remy-Jardin; 
Lille/FR (martine.remy@chru-lille.fr)  
Purpose: To evaluate (a) the rate of indeterminate CTPA acquired with a 3rd-
generation DSCT system; and (b) the impact of correcting factors immediately 
applicable. 
Methods and Materials: 449 patients underwent a DSCT angiogram with 
single- (SE) (n=276; 61.5%) or dual-energy (DE) CT (n=173; 38.5%). An 
indeterminate study was defined by (a) a totally nondiagnostic examination; or 
(b) an examination limiting the level of analyzability of pulmonary arteries to 
central vessels. 
Results: Twelve CTPAs (12/449; 2.7%) were deemed indeterminate with a 
proportion that did not differ between examinations acquired with SE (9/276; 
3.2%) and DE (3/173; 1.73%) (p=0.38). The contributing factors comprised (a) 
motion artifacts due to the lack of patient cooperation (1/12) ; (b) a poor level of 
enhancement (6/12); or (c) patient-related limitations (5/12). In the case of 
indeterminate SE examination (n=9): (a) a second acquisition was immediately 
obtained after correction of the presumed contributing factor: (i) repeated 
instructions to maintain apnea (1/9); (ii) selection of a lower kVp, higher iodine 
concentration or both (7/9); (iii) no change in the repeat CTPA (1/9); (b) the 
second acquisition was subsequently diagnostic in all but one patient. In the 
case of DE indeterminate acquisitions (n=3), the reading of low-kVp images 
restored a diagnostic image quality. After correction, the final rate of 
indeterminate CTPA was 0.2% (1/449). 
Conclusion: The rate of indeterminate CTPA decreased from 2.7% to 0.2% 
after a second acquisition (SE) or the reading of low-kVp images of the initial 
acquisition (DE).  
Author Disclosures: 
 J. Remy: Consultant; Research Consultant, Siemens Healthcare. 






B-1556 14:48  
Significant reduction of contrast agent dose for venous phase chest CT 
scans: first experiences using monoenergetic reconstructions from a 
novel spectral detector scanner  
T. Hickethier, J. Kröger, B. Baessler, D. Maintz, D.-H. Chang; Cologne/DE 
(tilman.hickethier@uk-koeln.de)  
Purpose: Monoenergetic reconstructions (MonoE) from Dual-Energy-CT 
systems can elevate iodine attenuation and therefore might permit a significant 
reduction of contrast agent dose. In this study, we investigated the influence of 
MonoE from a novel Spectral-Detector-CT (SDCT) on delineation of 
mediastinal structures and overall image quality in chest CT examinations with 
significantly reduced contrast agent dose (>50%). 
Methods and Materials: 41 patients underwent venous phase CT scans of the 
chest on a SDCT (IQon, Philips) and 35 instead of 75ml contrast agent 
followed by a NaCl flush of 60 ml. Images were calculated conventionally 
(Conv) and with MonoE at 40 keV. Contrast-to-noise-ratio (CNR) was 
measured for a hilar lymph-node (LN) as well as its attenuation difference to 
the adjacent pulmonary artery (LNPA). Image quality (IQ) was evaluated by 2 
readers with respect to overall diagnostic certainty (ODC) and LN delineation 
(LND) using a 5-point-Likert-scale: 1=non-diagnostic; 2=barely diagnostic; 
3=fair; 4=adequate; 5=excellent. 
Results: Both subjective IQ parameters were significantly improved using 
MonoE compared to Conv (ODC 4.2 vs. 2.7; p<.01 / LND: 3.8 vs. 2.3; p<.01). 
The IQ of all MonoE reconstructions was rated at least as adequate without 
any non-diagnostic results. Objectively measured CNR and LNPA were 
superior using MonoE compared to Conv (CNR 14.18 vs. 5.96; p<.01 / LNPA 
111.99 vs. 38.02 HU; p<.01). 
Conclusion: In venous phase chest CT scans with markedly reduced contrast 
agent dose subjective image impression and objective IQ parameters can be 
significantly improved by using monoenergetic reconstructions from a novel 
SDCT.  
B-1557 14:56  
Investigation of a roll pump contrast media injector for individually 
adapted iodine concentrations  
I. Rychina1, T. Rienmüller2, V. Makarenko1, V. Bereznitskiy1, A. Tikhonov1, 
J.A. Oreshkova1, P. Frank3, L. Bockeria1, R. Rienmüller2; 1Moscow/RU, 
2
Graz/AT, 3Ulm/DE (rainer@rienmueller.net)  
Purpose: To investigate the precision of different iodine concentrations 
obtained using an automatic contrast media (CM) injector and commercially 
available CM with higher iodine concentration. 
Methods and Materials: Starting from an initial concentration of 320 
(Iodixanol, blood iso-osmolarity) and 350 mgI/ml (Iohexol, low osmolarity) the 
CM were sequentially mixed with physiological NaCl-solution using the CT 
motion XD 8000 ulrich medical automatic CM injector with an injection speed of 
2, 5, and 8 ml/s. The Iodine concentration was reduced in steps of 10% down 
to 50% of the starting concentrations. Calibration standards were prepared 
diluting the initial solutions with distilled water. High-performance liquid 
chromatography (HPLC) measurements of the probes were performed on Agile 
1290 Infinity instrument equipped with ZORBAX Eclipse Plus C18 column 
maintained at 30°C and UV/Vis detector. The relative deviation of probes from 
the desired concentration was computed. 
Results: For Iodixanol 320 an average relative deviation of 6.91% (min 1.5, 
max 12.63%) at an injection speed of 2 ml/s, 6.03% (min: 0.88, max: 16.89%) 
at 5 ml/s and 3.38% (min: 0.07, max: 9.37%) at 8 ml/s was obtained. Iohexol 
350 showed an average relative error of 4.26% (min 0.3, max 7.8%) at 2 ml/s, 
5.13% (min 1.2, max 9.6%) at 5 ml/s and 2.9% (min 1.1, max 5.1%) at 8 ml/s. 
Conclusion: Our data confirm the feasibility of obtaining the desired iodine 
concentration using the automatic roll pump CM injector under investigation.  
Author Disclosures: 
 P. Frank: Employee; Ulrich Medical.  R. Rienmüller: Consultant; Ulrich 
Medical. 
B-1558 15:04  
Lesion detection on the "all-in-one" window: is it as good as on 
conventional window settings? A feasibility study  
A. Snoeckx1, B. Broeckx2, K. Carpentier1, R. Corthouts1, E. Luyckx1, 
S. Nicolay1, M.J. Spinhoven1, A. Van Hoyweghen1, J. Cant3; 1Edegem/BE, 
2
Merelbeke/BE, 3Mortsel/BE (annemie.snoeckx@uza.be)  
Purpose: Historically, CT studies are always viewed in several window 
settings, optimized to evaluate specific anatomic structures and regions 
(mediastinal, lung, bone and vascular window). A newly developed image 
processing technique fuses these conventional windows into a single "all-in-
one" window. Our purpose was to compare lesion detection on this "all-in-one" 
window versus conventional window settings. 
Methods and Materials: In this study, 50 consecutive thoracic oncology chest 
CT examinations, containing 417 documented lesions and features, were 
reviewed by 6 radiologists, subdivided into 2 groups of 3 radiologists each, with 
  






similar levels of expertise in each group (experienced, junior and radiology 
resident). All scans were reviewed in conventional window settings (as in 
routine daily practice), by one group, and in the "all-in-one" window by the 
other group. Lesions were listed as 'missed' when they were not seen by at 
least two out of three observers and as 'well diagnosed' when seen by at least 
two out of three observers. 
Results: Out of the 417 lesions, 68 lesions were missed: 21 on the "all-in-one" 
window, 30 on conventional views and 17 on both views. Statistical analysis 
with linear mixed model showed that use of the "all-in-one" window did not 
result in an increase of missed lesions (p=1). Conversely, we found a tendency 
towards better lesion detection on the "all-in-one" window, though not strongly 
significant (p=0.07). Inter-observer agreement in both groups was similar 
(p=0.462). 
Conclusion: In chest CT examinations, lesion detection on the "all-in-one" 
window is at least as good as on conventional window settings.  
Author Disclosures: 
 J. Cant: Employee; Agfa Healthcare. 
B-1559 15:12  
The influence of intelligent optimum tube voltage-combined low dose of 
contrast medium injection based on BMI on radiation dose and image 
quality of chest CT enhancement  
Y. Zhou; Zhengzhou/CN (zhouyue779@163.com)  
Purpose: To investigate influence of intelligent optimum tube voltage-
combined low dose of contrast medium based on BMI on radiation dose and 
image quality of chest CT enhancement. 
Methods and Materials: 104 patients who received spectral chest CT 
enhancement were randomly divided into groups A and B: group A with 
conventional 120 kVp, 450mgI/Kg contrast medium injection; group B with 
intelligent optimum tube voltage, 300mgI/Kg contrast medium injection. 
Patients were divided into three sub-groups based on BMI. Subjective image 
quality score, SNR, CNR of descending aorta at different layers and radiation 
dose were compared. 
Results: Image quality scores of A1, A2 were higher than that of B1, B2 during 
arterial phase, while no significant difference during venous phase. A3 and B3 
showed no statistical difference during arterial and venous phase. CNR of 
descending aorta at tracheal bifurcation, right pulmonary artery layer in A1 and 
B1, left/right atrium layer in A2 and B2, left/right atrium layer in A3 and B3 
during venous phase have no statistical difference, other layers in group B 
were higher than that of group A. SNR in group B was superior to that of group 
A. Radiation dose in A1, A2 were lower vs B1, B2, dropped by 16.39% and 
14.50%, respectively; however, there was no significant difference between A3 
and B3. 
Conclusion: Optimal tube voltage can be selected according to BMI using 
intelligent optimum tube voltage technique, which can reduce radiation dose 
and improve CNR. Combined low-contrast medium infection can reduce 
contrast agent injection and maintain image quality.  
14:00 - 15:30 Room N  
Genitourinary  
SS 1907a  
Prostate biopsy and (post-)intervention  
Moderators:  
A. Baur; Berlin/DE  
V. Panebianco; Rome/IT  
B-1560 14:00  
A prospective study to compare the outcomes of MRF-TB and 12-core SB 
in different PSA groups  
J.-M. Xu, Y.Q. Chen; Shanghai/CN (junmei_510@126.com)  
Purpose: To assess and compare the rate of detection of clinically significant 
prostate cancer (csPCa) between magnetic resonance imaging (MRI)-
ultrasound fusion-targeted prostate biopsy (MRF-TB) and 12-core systematic 
biopsy (SB) in the different prostate-specific antigen (PSA) groups. 
Methods and Materials: This prospective study included 156 patients who 
underwent pre-biopsy MRI and 12-core SB between September 2014 and 
August 2016. In the patients with MRI-suspicious lesions (n=123), MRF-TB 
was performed before SB. In the clinically suspicious patients with normal MRI 
(n=33), SB was performed without MRF-TB. The detection rates for any cancer 
and csPCa were compared between MRF-TB and SB. 
Results: Detection rate for any cancer was not significantly different between 
MRF-TB (64/123, 52.0%) and SB (66/156, 42.3%; p=0.106). For csPCa, the 
detection rate of MRF-TB (61/123, 49.6%) was significantly higher than that of 
SB (46/156, 29.5%; p=0.001). In a subset analysis of patients with 
PSA<10ng/ml, csPCa detection rate of MRF-TB (26/67, 38.8%) was 
significantly higher than that of SB (16/83, 19.3%; p=0.008). In 
10PSA<20ng/ml group, csPCa detection rate of MRF-TB (20/38, 52.6%) was 
also significantly higher than that of SB (15/52, 28.8%; p=0.022). In 
PSA20ng/ml group, csPCa detection rate of MRF-TB (15/18, 83.3%) was 
higher than that of SB (15/21, 71.4%), but no significant difference was found 
(p=0.379). 
Conclusion: Our prospective study revealed a similar rate of prostate cancer 
detection between MRF-TB and SB, and MRF-TB could improve the overall 
detection of csPCa compared to SB. We also found that MRF-TB was superior 
to SB for csPCa detection in subset patients with PSA<10ng/ml and 
10PSA<20ng/ml, but was similar in patients with PSA20ng/ml. Therefore, 
the traditional SB may be replaced by MRF-TB for detection of csPCa.  
B-1561 14:08  
The accuracy of MRI/TRUS fusion biopsy in detection of high-risk 
prostate cancer vs random biopsies: advertisement or necessary 
innovation?  
F. Kossov1, I.I. Abdullin1, B. Kamolov1, B. Olimov1, O. Orlov1, V. Panov1, 
I. Tyurin1, E. Fedorenko1, V. Kapustin2; 1Moscow/RU, 2Moscow Oblast/RU 
(fil-doc@yandex.ru)  
Purpose: Systematic biopsies (SB) are an integral part of prostate cancer 
(PCa) diagnostics. SB PCa detection varies from 31% to 42%; however, the 
number of false-negative results is high. MRI/TRUS fusion target biopsy 
(MRI/TRUS FTB) probably would improve the detection of high-risk cancer 
(HRC) both in initial biopsy and in patients with preliminary negative SB results. 
Methods and Materials: 82 patients with suspected PCa were examined. The 
criteria of patients inclusion was the presence of: 1) PSA>4 ng/ml and positive 
results of the digital rectal examination; 2) mpMRI data. The examination 
includes: 1) prostate mpMRI; 2) MRI/TRUS FTB; 3) SB. 
Results: PCa was detected in 66 cases (including 12 cases with previously 
negative SB). MRI/TRUS FTB PCa detection rate includes: 1) 13.3% cases 
with Gleason=6; 2) 33.5% with Gleason=7; 3) 53.2% with Gleason=8-10. SB 
evaluates PCa in: 1) 27.8% patients with Gleason=6; 2) 38.9% with 
Gleason=7; 3) 27.8% with Gleason=8-10. MRI/TRUS FTB data is significantly 
highly competitive in high malignancy potential nodes detection with SB 
(p<0.0001). The HRC detection accuracy using MRI/TRUS FTB appears 
higher in comparison with SB data (p<0.0001). MRI data (estimated by PI-
RADS v.2) showed significant correlation with the MRI/TRUS FTB results 
(3<0.02, correlation coefficient 0.7). 
Conclusion: The MRI/TRUS FTB provides an opportunity to decrease the 
necessary number of punctures in PCa patients for detection of the histological 
material with the highest malignancy rate. MRI/TRUS FTB exposes low 
sensibility to insignificant PCa. It increases the detection of clinically relevant 
forms of PCa.  
B-1562 14:16  
MRI/US fusion prostate biopsy a single-centre experience  
C. Cicero, E. Lievore, A. Casarin, B. De concilio, A. Celia, L. Genesio, 
A. Guarise; Bassano del Grappa/IT (aircalo@yahoo.it)  
Purpose: MRI-US fusion biopsy system is a diagnostic procedure which 
permits the withdrawal of prostate specimens directly from a suspected lesion 
seen at MRI, bypassing random prostate biopsies. We studied the efficacy of 
the method among the patients evaluated in our facility. 
Methods and Materials: 150 patients with findings suspicious for PCa (mean 
age 65,5 years, median PSA 5,533ng/mL and median prostate volume 59cc) 
underwent mpMRI. All the mpMRI were evaluated by a specialised 
uroradiologist. The suspected lesions were classified according to the PI-
RADS and marked. Data were transferred in the Biopsee® system and, with 
superimposition of MRI on real-time transrectal US, three-dimensional biopsy 
planning was conducted and transperineal biopsies were performed according 
to the planning. We conducted statistical evaluation of cancer detection in 
these patients. 
Results: 58 out of 150 patients (39%) were found positive for PCa. The 
correlation between mpMRI findings and histologic evaluation was satisfactory 
for lesion marked as PI-RADS 5 or highly suspicious for PCa (34 over 52 or 
65%) but mild for lesions classified as PI-RADS 4 or moderately suspicious for 
PCa (28 over 106 or 26,5%). Regarding complications, three patients were 
affected by acute urinary retention and one experienced haematuria. 
Conclusion: Transperineal stereotactic prostate biopsy combining US/MR 
enables targeted evaluation of suspected lesions. The method is safe with few 
complications. The correlation between PI-RADS and histologic lesion 
approximates the results of similarly-conducted studies. The procedure is 
overall promising, and opens to other utilisations beyond the detection of PCa, 











B-1563 14:24  
Transrectal ultrasound-guided targeted biopsy of transition zone prostate 
cancer: usefulness of across midline sign  
S. Park, S. Won; Seoul/KR (WSY0622@yuhs.ac)  
Purpose: To retrospectively evaluate diagnostic performance of transrectal 
ultrasound (TRUS)-guided targeted biopsy (TB) of transition zone (TZ) prostate 
cancer (PCa) in patients with prebiopsy magnetic resonance imaging (MRI). 
Methods and Materials: Consecutive series of 38 patients who underwent 
TRUS-guided TB of TZ lesions were evaluated. TB (mean core number, 
2.4±0.6; range, 2-4) was performed by a single experienced radiologist under 
cognitive registration between prebiopsy MRI and TRUS. Across midline sign 
was defined by a focal lesion traversing the midline of prostatic TZ on MRI and 
TRUS, leading to discontinuity of the midline. Prostate Imaging-Reporting and 
Data System version 2 (PI-RADSv2) scoring for targeted TZ lesions was also 
conducted with T2-weighted and diffusion-weighted MRI by the same 
radiologist. 
Results: PI-RADSv2 categories from 2 to 5 for TZ lesions consisted of 4, 14, 
7, and 13. Cancer detection rate of TRUS-guided TB for TZ lesions was 78.9% 
(30/38). Across midline sign was identified in 50.0% (19/38). Cancer detection 
rate of TRUS-guided TB for TZ lesions showing across midline sign on both 
MRI and TRUS was 94.7% (18/19). 
Conclusion: Under cognitive registration, TRUS-guided TB for TZ lesions 
showing across midline sign on both MRI and TRUS may be highly predictive 
of TZ PCa.  
B-1564 14:32  
In-bore biopsies of the prostate assisted by a remote-controlled 
manipulator at 1.5 T  
N.P. Linder, A. Schaudinn, T.-O. Petersen, R. Stange, M. Moche, P. Stumpp, 
T. Kahn, H. Busse; Leipzig/DE (linder@uniklinik-leipzig.de)  
Purpose: To evaluate technical and clinical performance of a fully MRI-
compatible, pneumatically driven remote-controlled manipulator (RCM, "robot") 
for 1.5-T in-bore biopsies of the prostate. 
Methods and Materials: This preliminary prospective study included the first 
15 patients that underwent robotic (Soteria Medical, Arnhem, Netherlands), in-
bore biopsies of the prostate in a wide-bore 1.5 T MRI (Magnetom Aera, 
Siemens Healthcare, Erlangen, Germany). Targeting and control of the 
transrectal needle guide were realized by rapid MR imaging (balanced SSFP 
sequence with acquisition times around 10 s). Biopsies were performed by two 
radiologists, each with 4 years of experience with prostate interventions. 
Analysis involved pre-biopsy MRI reports (PIRADS version 2), procedure times 
(between planning and final control MRI), periprocedural complications and 
histopathologic results of the samples. 
Results: Mean age (range) was 67 (54 - 80) years and mean PSA level was 
11.1 (0.7 - 21.5) ng/dl. Twelve patients (80%) had received prior biopsies 
under transrectal ultrasound guidance. Prebiopsy MRI reports involved 12 
cases with a single suspicious finding (2x PIRADS 3, 5x "P4" and 5x "P5") and 
3 cases with two ones (2x "P3" and 1x "P5"). Histopathologic examination 
revealed prostate cancer in 7 of 15 cases. One patient developed urosepsis 
which was successfully treated with antibiotics. Procedure times ranged 
between 26 and 85 min. 
Conclusion: In-bore, transrectal prostate biopsies could be successfully 
performed with a robotic manipulator at a field strength of 1.5 T. Unlike with 
passive interventional devices, the patient may remain inside the bore for 
needle-guide adjustments.  
B-1565 14:40  
Experience with MRI guided prostate biopsies using the 3D Navigo 
system in an oncologic referral centre  
S. Heijmink, R. van den Bergh, E. Wit, H. van der Poel; Amsterdam/NL 
(swheijmink@live.com)  
Purpose: Multiparametric (mp) MRI has the potential to increase biopsy yield 
of prostate cancer detection. This study presents experiences with the Navigo 
system for MRI-TRUS fusion. 
Methods and Materials: Navigo MRI-TRUS fusion biopsies was performed 
from 2015-2017. All patients received prebiopsy 3TmpMRI. Dependent on 
biopsy indication, random non-guided biopsies were taken in the same 
session. We recorded any encountered problems, compared Navigo and NG 
biopsy cancer detection rates, and explored predictors for positive biopsy 
outcome. 
Results: Navigo biopsies were planned in 228 patients for diverse indications, 
of whom 26 (11%) could not be performed. In 18 (9%) of the remaining 
patients a problem was reported during the procedure. Any of the guided 
biopsies was positive in 24-85%, dependent on indication. Of the 202 Navigo 
procedures, additional non-guided cores were taken in 99 patients. Similar 
results between Navigo and non-guided biopsies were found for any positive 
biopsy rate, %positive cores, and mean Gleason score (all p>0.05), but the 
absolute number of cores taken was almost half for the Navigo biopsies. 
Lowest lesion mean ADC was a persistent predictor in multivariable analysis 
for positive biopsy outcomes. 
Conclusion: The benefit of 3TmpMRI targeted Navigo fusion biopsies was 
seen in the lower number of biopsy cores needed, but not in cancer detection 
rate or mean Gleason score. In patients without primary diagnosis, guided 
biopsies did not obviate the need for additional random biopsies. ADC was the 
main biopsy outcome predictor for guided and non-guided biopsies.  
B-1566 14:48  
Typical MR imaging findings after HIFU-hemiablation of the prostate  
N.P. Linder1, J. Michaelis1, J. Gawlitza1, H. Busse1, P. Ho-Thi1, T. Kahn1, 
P. Stumpp1, R. Ganzer2, A. Schaudinn1; 1Leipzig/DE, 2Bad Tölz/DE 
(linder@uniklinik-leipzig.de)  
Purpose: To evaluate MR imaging features of the prostate after high-intensity 
focused ultrasound (HIFU) treatment of the hemigland. 
Methods and Materials: Eighteen patients with a mean age of 67.1 (48.9-
78.5) years, mean Prostate-specific-Antigen level of 6.35 (4.0-9.8) ng/dl and 
biopsy-proven unilateral Prostate Cancer (PCa) received MRI before and 12 
months after HIFU (Hemiablation, Focal One). MR/ultrasound fusion-guided 
Biopsy was performed after 12 months to exclude recurrent/contralateral 
cancer. MRI (3T) followed PIRADS version 2 guidelines with T2 TSE, diffusion-
weighted imaging (DWI) and dynamic-contrast enhanced-T1 imaging (DCE). 
MR-analysis included quantitative and qualitative imaging characteristics, such 
as T2-volumetry, DCE and DWI signal-intensity measurements. 
Results: Treatment resulted in a mean volume reduction of the target lobe by 
49.1% (27.9-69.5%) and of the whole gland by 28.1% (1.0-45.6%), 
respectively. The typical image patterns of the ablated lobe consisted of a 
centrally positioned, T2-hyperintens, well circumscribed area, defined as 
seroma and/or a T2-hypointens area with heterogeneous DWI signal intensity, 
interpreted as scar, mainly adjacent laterally to the seroma. The combination 
seroma/scar was observed in 16 of 18 patients, whereas only scar was 
observed in 2 cases. In 50% of the cases a rim-like contrast media uptake 
around the ablation area was observed. MRI detected one of four cases of 
biopsy-proven low grade contralateral PCa and none of two cases of ipsilateral 
recurrent PCa (Ø Gleason: 6.5). 
Conclusion: MRI analysis revealed distinct image patterns at 12 months after 
hemiablation, such as seroma, scar and volume reduction. However detection 
rate of recurrent or contralateral prostate cancer was low.  
B-1567 14:56  
Six months follow-up of periprostatic nerve plexus changes after robot-
assisted radical prostatectomy using MRI tractography.  
A. Cybulski, S. Brancato, V. Di Paola, R. Negrelli, E. Boninsegna, M. Catania, 
A. Tafuri, S. Siracusano, R. Pozzi Mucelli; Verona/IT (sarix_89@hotmail.it)  
Purpose: To evaluate early and late modifications of periprostatic nerve plexus 
(PNP) after robot-assisted radical prostatectomy (RARP) with MRI tractography 
and their clinical correlations.  
Methods and Materials: 34 patients (mean age:64,8) candidate to RARP 
performed 3 MRI examinations completed with 32-directions DTI sequences 
respectively before, 1 (mean:39,4 days) and 6 months (mean:201,7 days) after 
RARP. Tractography reconstructions were performed by positioning 6 ROIs of 
PNP, evaluating the following parameters: number of fibers(N), number of 
voxels(V), fractional anisotropy(FA), apparent diffusion coefficient(ADC), fiber 
length(L). Before each MRI, 2 questionnaires were administered to investigate 
urinary continence(ICIQ-SF) and erectile function(IIEF-5). Each tractography 
parameter of the 3 examinations was compared using Student’s T-test and 
was correlated with urinary incontinence and erectile dysfunction using 
Kendall’s-tau test. 
Results: Reduction of N and V was observed 1 month after RARP, without any 
increment at 6 months. 1 month-MRI demonstrates reduction of FA, which 
returns to pre-surgery values at 6 months-control. Reduction of ADC was 
observed at 6 months-MRI compared with the previous examinations 
(p<0,001). No modification of L emerged. Positive correlation has been 
established between N(4=0,297), V(4=0,282), FA(4=-0,249) and potency and 
between N(4=-0,257), V(4=-0,231) and urinary continence(p0,001). 
Conclusion: MRI tractography is able to identify complex changes regarding 
the number of fibers(N and V reduction post-RARP) and fiber patterns of 
PNP(FA reduction at 1 month, growing up back to pre-surgery values at 6 
months). These changes correlate both with potency and urinary continence.  
B-1568 15:04  
Predicting and improving postprostatectomy urinary continence by 
pelvic floor measures on MR  
S. Heijmink, N. Grivas, C. Tillier, R. van der Roest, E. van Muilekom, 
H. van der Poel; Amsterdam/NL (swheijmink@live.com)  
Purpose: Urinary incontinence is a frequent complication of prostatectomy. 
MRI imaging of pelvic floor musculature has learned that several anatomical 
characteristics predict postprostatectomy continence function. We used this 
  






information to attempt reconstruction of the pelvic floor after prostatectomy to 
improve continence outcome. 
Methods and Materials: In 439 patients preprostatectomy MRI images were 
correlated to functional outcome continence scores (ICIQ-SF) for 10 pelvic 
measurements. Based on the obtained measures we changed the pelvic floor 
reconstruction from median fibrous raphe reconstruction only and added 
medialisation of the anterior muscle fibers of the levator ani muscle behind the 
urethra. In a prospective comparative analysis we studied the 6 months 
postoperative ICIQ-SF score in men with median fibrous raphe reconstruction 
with or without levator suspension and standard urethral-bladder anastomosis. 
Results: A longer membranous urethral length (MUL), smaller interlevator 
distance (ILD) and more extpensive fascia preservation score were predictive 
of earlier continence recovery. We developed an algorithm to predict 
continence outcome after prostatectomy based on these predictors. Since we 
hypothesized that narrowing of the pelvic floor exit by medializing anterior 
fibers of the levator ani muscle would artificially decrease ILD and elongate 
MUL and therefore improve postprostatectomy continence we performed this 
procedure in 211 men undergoing RARP. In comparison to standard (n=1375) 
or median fibrous raphe reconstruction (n=271) bladder-urethral anastomosis, 
MALF addition improved early (3w) (p=0.01) but not late (6m) continence 
recovery. 
Conclusion: MRI-based pelvic floor prostatometry individualizes prediction of 
postprostatectomy continence. Increasing pelvic floor support of the urethra 
improves early, but not overall continence.  
B-1569 15:12  
Correlation of short- and long-term urinary continence after radical 
prostatectomy with findings of preoperative multiparametric prostate MRI  
M. Sauer, R. Pompe, P. Tennstedt, L. Budaeus, G. Salomon, G. Adam, 
D. Beyersdorff; Hamburg/DE (m.sauer@uke.de)  
Purpose: To evaluate whether preoperative multiparametric prostate MRI 
(mpMRI) can help to stratify the risk of urinary continence (UC) after radical 
prostatectomy (RP) based on specified image findings. 
Methods and Materials: Our institutional review board approved this 
retrospective study. 233 patients (median age 66.1 years) underwent 
standardized mpMRI at 3T prior to prostatectomy, including high-resolution 
T2w-TSE-imaging in 3 planes, T1w-TSE, DWI with ADC map, PD-TSE and 
Gd-DCE. Membranous urethra length, urethra angle and apex shape were 
measured systematically in T2w sequences in the sagittal plane. Prostate 
volume was determined during transrectal sonography. Image findings and 
clinical data (age, type of surgery) were correlated to UC as evaluated by a 
standardized questionnaire determining the amount of necessary hygiene pads 
one week (response rate 100%) and one year after surgery (response rate 
61.4%; n=143 patients). 
Results: Of all clinical parameters, there was a small yet significant positive 
correlation of age with UC one week (Spearman r=0.27, p=0.0001) and one 
year after surgery (r=0.20, p=0.02). Urethra angle and apex shape as 
measured in mpMRI did not correlate significantly with UC at neither time point. 
Correlation of the membranous urethra length with UC was small negative after 
one week (r=-0.22, p=0.001) and close to medium negative after one year (r=-
0.29, p=0.001). Sonographic prostate volume did not correlate with UC and will 
be complemented by outstanding MRI volumetries. 
Conclusion: Measurements of the membranous urethra length in mpMRI 
correlate with short- and long-term UC after radical prostatectomy and should 
be acknowledged during preoperative risk stratification.  
B-1570 15:20  
Additional value of early imaging of 68Ga-PSMA-11 PET/CT in the 
assessment of local recurrence in prostate cancer patients with 
biochemical relapse  
C. Uprimny, A. Kroiss, C. Decristoforo, J. Fritz, B. Nilica, W. Horninger, 
I. Virgolini; Innsbruck/AT (Christian.UPRIMNY@tirol-kliniken.at)  
Purpose: Evaluation of local recurrence (LR) in prostate cancer patients with 
biochemical recurrence is hampered by high physiologic urinary bladder 
activity present on 68Ga-PSMA-11 PET/CT exams, usually conducted 60 min 
after tracer injection (p.i.). This study aims to investigate whether additional 
early static PET scans could enhance diagnostic performance of 68Ga-PSMA-
11 PET/CT in the evaluation of LR. 
Methods and Materials: 213 prostate cancer patients with biochemical 
recurrence referred to 68Ga-PSMA-11 PET/CT were analysed retrospectively 
(median PSA: 1.47 ng/ml). In all patients an early static scan of the pelvis was 
performed with a median starting time of 281 sec p.i., followed by a whole-body 
PET/CT 60 min p.i. Image interpretation was based on visual analysis. 
Furthermore, calculation of maximum standardized uptake value (SUVmax) of 
pathologic lesions was performed. 
Results: On standard PET images 60 min p.i. a LR-suggestive lesion (median 
SUVmax: 11.0) could be detected in 28 patients (13.1%), whereas an equivocal 
finding was present in 36 patients (16.9%). In contrast, on early PET scans a 
pathologic lesion compatible with LR was revealed in 52 patients (median 
SUVmax: 5.9) and an unclear finding in only nine patients (4.2%). Early PET 
images led to a significant rise in the detection rate (p<0.001) as well as a 
significant reduction of equivocal findings (p<0.001) compared to PET-imaging 
60 min p.i. 
Conclusion: Assessment of local recurrence in prostate cancer patients with 
biochemical relapse referred to 68Ga-PSMA-11 PET/CT is improved by 
additional early PET imaging.  
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B-1571 14:00  
Lung cancer screening with MRI: application of Lung-RADS in the first 
two screening rounds  
M. Meier-Schroers, R. Homsi, H. Schild, D. Thomas; Bonn/DE 
(michael.meier@ukbonn.de)  
Purpose: To evaluate if Lung-RADS can be applied for MRI based on the 
results of the first two rounds of a lung cancer screening. 
Methods and Materials: 224 participants of a lung cancer screening were 
examined with MRI and low-dose CT (LDCT). Acquired sequences were T2-
MVXD, balanced-FFE, 3D-T1, and DWI. MRI was prospectively analysed 
regarding nodules blinded to LDCT (minimum nodule size 4mm). Nodules were 
assigned a Lung-RADS score based on their appearance and size at baseline 
and in follow-up examinations after 3, 6, and 12 months. MRI findings were 
correlated with LDCT. 
Results: The early recall rate dropped from 13.8% at baseline to 1.9% in the 
second round with biopsy rates of 3.6% in the first round and 0.5% in the 
second round. All eight lung cancers were accurately depicted by MRI. The 
following categories were assigned on MRI with results of LDCT in 
parentheses: 4B/4X in 10 (10) cases, 4A in 16 (15) cases, 3 in 13 (12) cases, 2 
in 77 (92) cases, 1 in 140 (126) cases. Lung-RADS scoring significantly 
correlated between MRI and CT (p<0.001). The score was overestimated by 
MRI in one case for category 4A, in two cases for category 3, and in five cases 
for category 2. The MRI-based Lung-RADS score was only underestimated for 
category 1 in 20 cases. 
Conclusion: Lung-RADS might be applied for lung cancer screening with MRI, 
since findings significantly correlated with LDCT. Relevant findings with a 
Lung-RADS score of 3 were never missed or underestimated by MRI.  
B-1572 14:08  
The value of diffusion-weighted imaging based on monoexponential and 
biexponential model in the diagnosis of benign and malignant lung 
nodules and masses  
J. Jiang1, L. Cui2, X. Gu3, Q. Hong1, Y. Fu1, G. Xu1; 1Yancheng/CN, 
2
Nantong/CN, 3Suzhou/CN (1021809719@qq.com)  
Purpose: To compare the value of lesion-to-spinal cord signal-intensity ratio 
(LSR), apparent diffusion coefficient (ADC) and intravoxel incoherent motion 
(IVIM) parameters in the differention of pulmonary nodules and masses, and to 
explore the preferred region-of-interest (ROI) method. 
Methods and Materials: 63 lesions (18 benign cases and 45 malignant cases) 
in forms of pulmonary nodules (n=26) or masses (n=37) were erolled. DWI and 
IVIM scans were performed on a 3T MRI machine. LSR800 was drawn and 
ADCmean, ADCmin, D, D*, f were measured using single-slice ROIs and 
volumetric ROIv. ICCs were assessed. Parameters obtained by these two ROIs 
were compared using paired t-test and indepnedent t-test was adopted to 
compare parameters between benign and malignant lesions. ROC curves were 
generated to identify the best parameters and thresholds to distinguish the 
benign and malignant lung nodules and masses. 
Results: The inter-observer reproducibility of D* was relatively poor. There 
were no significant differences in ADCmean, ADCmin, D and f values obtained by 
different ROI methods (P=0.029). Between benign and malignant lung nodules, 
only ADCmean(ROIs) showed difference while for lung masses, ADCmean, 
ADCmin(ROIv), D and f(ROIs) all had diagnostic value, the highest belonging to 
D(ROIv). 
Conclusion: DWI can better diagnose pulmonary masses than pulmonary 
nodules. For the latter only ADCmean obtained by single-slice ROI has the 
diagnostic value. For the former, ADCmean, ADCmin, D and f all could do, but D 
obtained by volumetric analysis was perferred.  
 
  






B-1573 14:16  
Computed diffusion-weighted image: utility for differentiation of 
malignant from benign pulmonary nodules as compared with actually 
obtained diffusion-weighted image  
Y. Kishida1, S. Shinichiro1, T. Yoshikawa1, M. Yui2, Y. Kassai2, K. Kyotani1, 
Y. Ohno1; 1Kobe/JP, 2tawara/JP (yjk121@med.kobe-u.ac.jp)  
Purpose: To determine the utility of computed diffusion-weighted image (DWI) 
for differentiation of malignant from benign pulmonary nodules as compared 
with actually obtained DWI (aDWI). 
Methods and Materials: 61 consecutive patients with 82 pulmonary nodules 
(41 malignant and 41 benign nodules) underwent 3T MRI. All DWI were 
obtained using fast advanced spin-echo (FASE) sequence with b-values at 0 
and 1000s/mm2 (aDWI0, 1000). Computed DWIs (cDWIs) were generated as 
400, 600, 800, 1000, 1500 and 2000 (cDWI400-2000) s/mm2 by commercially 
available software. Then, signal-to-noise ratio (SNR) and contrast ratio (CR) 
between nodule and thoracic muscles were determined by ROI measurement 
at each nodule. To compare image quality between aDWI1000 and each cDWI, 
SNR and CR were compared among all DWIs by Dunnett multiple comparison 
test. To compare diagnostic performance of pulmonary nodule and determine 
the threshold values of each DWIs, receiver operating characteristic (ROC) 
analyses were performed. Sensitivity, specificity and accuracy were compared 
among all DWIs and aDWI1000 combined with each cDWI by McNemar’s test. 
Results: SNRs of cDWI400 and cDWI600 were significantly higher than that of 
aDWI1000 (p<0.05). AUCs of cDWI800 and cDWI1000 were significantly larger 
than that of cDWI2000 (p<0.05). There were no significant differences of 
diagnostic performance among all DWIs and aDWI1000 with each cDWI 
(p>0.05). However, specificity and accuracy of aDWI1000 were improved, when 
combined with cDWI600. 
Conclusion: Computed DWI is suggested as useful for differentiating 
malignant from benign pulmonary nodules, when added with actual DWI in 
routine clinical practice.  
Author Disclosures: 
 S. Shinichiro: Research/Grant Support; Toshiba Medical Systems Co. 
T. Yoshikawa: Research/Grant Support; Toshiba Medical Systems Co. 
M. Yui: Employee; Toshiba Medical systems Co. Y. Kassai: Employee; 
Toshiba Medical Systems Co.  Y. Ohno: Research/Grant Support; Toshiba 
Medical Systems Co., Bayer Pharma, Guerbet, Daiichi-Sankyo Co., Ltd., Eizai 
Co., Ltd., Fuji Pharma, Philips Electronics Japan. 
B-1574 14:24  
Functional MRI evaluation of b-2000 images improve mediastinal lesion 
characterisation  
J. Coolen, F. De Keyzer, E. Verbeken, A. Dubbeldam, C. Dooms, P. De Leyn, 
W. De Wever, D. Van Raemdonck, J.A. Verschakelen; Leuven/BE 
(johan.coolen@uzleuven.be)  
Purpose: Invasive surgical procedures are at the moment the cornerstone of 
mediastinal staging. We attempted to use a noninvasive MRI approach to 
differentiate benign from malignant mediastinal lesions and at the same time 
attempt to provide an imaging-based preoperative evaluation of lesion 
resectability. 
Methods and Materials: 100 consecutive patients (58 male, 42 female), with a 
suspicious mediastinal lesion on clinical or on imaging-based (CT, PET or 
EBUS) examinations, were inluded. Additional to the anatomical MRI 
sequences on a 3 Tesla scanner DWI-acquisition was performed. All MR 
images were evaluated by visual inspection and by calculating the ADC values 
(mean) of the whole lesion (WL) (based on b-1000) and of the hyperintens b-
1000 zones (based on b-2000). Histological examinations of operative 
specimens served as reference. 
Results: A total of 43 benign and 57 malignant lesions were included. 
Diagnosis based on the mean ADC calculated from the WL (b-1000) was 
rather disappointing (sens.75.4%, spec.60.5% and acc.69.0%) and showed an 
optimal threshold of 1.97x10-3 mm/s2 between benign and malignant lesions. 
The ADC calculation on b-1000 images (b-2000) was much better 
(sens.94.7%, spec.88.4% and acc.92.0%) with an optimal cutt-off value of 
1.79x10-3 mm/s2. Over all patients, a very good correlation was found between 
MR-signs of local invasion and surgical resectability (kappa 0.87, p<0.0001). 
Conclusion: This MR imaging technique with DWI might provide additional 
information for preoperative lesion characterization and assessment of lesion 
resectability. Volume and especially heterogeneity of the WL seem to preclude 
a b-1000 evaluation for diagnosis, but b-2000 rating allow better accuracies.  
B-1575 14:32  
Characterisation of mediastinal anterior masses with magnetic resonance 
imaging (MRI) using diffusion-weighted imaging  
M. Gavrel, E. Auclin, C.S. Balleyguier, C. Caramella; Villejuif/FR 
(gavrelmarie@gmail.com)  
Purpose: To characterise mediastinal anterior masses (MAM) in a qualitative 
and quantitative MRI evaluation using diffusion-weighted imaging (DWI). To 
correlate imaging features of epithelial thymic malignancies with the World 
Health Organization (WHO) and Masaoka-Koga classifications. 
Methods and Materials: A retrospective analysis of patients referred for an 
MAM between 2000 and 2017 was made. Correlation with histopathological 
examinations was performed except for patients with typical thymic hyperplasia 
or rebound. Chi-square, Fisher and Student's tests were used for data 
description. Logistic regression models and areas under the ROC curves were 
estimated. 
Results: Out of 94 patients, 66 were included. 21 patients had a benign MAM 
and 45 had a malignant MAM including 25 thymomas and 10 thymic 
carcinomas. Qualitative assessment demonstrated significant differences for 
contours, shape, septas, capsule, calcifications, cystic or necrotic areas, 
invasiveness, homogeneity and pattern of enhancement (p<0,05). Mean 
chemical shift radio (CSR) differed significantly between benign and malignant 
MAM (0,66 ± 0,26 and 1,45 ± 1,36, respectively, p=0,003). Cutoff point for CSR 
was 0,880 (sensitivity 94%, specificity 84%). Mean apparent diffusion 
coefficient (ADC) differed significantly between benign and malignant MAM 
(2,31 10-3 sec/mm² ± 1,1 and 1,17 10-3 sec/mm² ± 0,64, respectively, p=0,001). 
Cutoff point for ADC was 1,39 10-3 sec/mm² (sensitivity 87%, specificity 68%). 
High-risk thymomas showed stronger enhancement than low-risk thymomas 
(p=0,04). Qualitative assessment demonstrated significant differences between 
thymomas according to the Masaoka-Koga classification for shape, contours, 
capsule, septas, invasiveness, homogeneity and pattern of enhancement 
(p<0,05). 
Conclusion: DWI-MRI is a useful non-invasive technique for the 
characterisation of MAM.  
B-1576 14:40  
Quantitative analysis of diffusion weighted magnetic resonance imaging 
for characterization of mediastinal lymphadenopathy  
A. Sudarkina, A. Dergilev, N. Gorbunov; Novosibirsk/RU (a.sudarkina@mail.ru)  
Purpose: To evaluate the possibilities of diffusion-weighted imaging (DWI) with 
different scan parameters for the characterisation of mediastinal 
lymphadenopathy. 
Methods and Materials: 30 patients with metastases (n=12), lymphoma (n=3), 
sarcoidosis (n=8) and reactive hyperplasia (n=7) of mediastinal lymph nodes 
were underwent DWI of the chest on 1.5T machine. Two series of DWI with 
different types of data acquisition (during free breathing and synchronised with 
breathing) and scan parameters (repetition time, slice thickness, values of 
acquired b-factors et al.) were obtained for all patients. The apparent diffusion 
coefficient (ADC) maps were calculated automatically. Altogether, 371 
measurements of ADC were performed in the solid area of the lymph nodes in 
consecutive slices. 
Results: The mean ADC values in metastases, lymphoma, sarcoidosis and 
reactive hyperplasia of mediastinal lymph nodes were 0.97±0.31×10−3 mm2/s, 
0.89±0.07×10−3 mm2/s, 1.54±0.24×10−3 mm2/s, 1.66±0.32×10−3 mm2/s, 
respectively. The mean ADC value in benign lymphadenopathy 
(1.62±0.28×10−3 mm2/s) was significantly higher (p<0.001) when compared to 
malignant lymphadenopathy (0.95±0.29×10−3 mm2/s). The differences between 
the mean ADC values obtained with different scan parameters were 
insignificant (p>0.05) within all types of the lesions. According to the ROC-
analysis the cut-off value of 1.36×10−3 mm2/s can be used for differentiation of 
benign from malignant lymphadenopathy with a sensitivity of 80% and a 
specificity of 92%. The area under the curve was 0.947. 
Conclusion: Quantitative analysis of ADC maps is a promising tool which can 
be used for noninvasive differentiation of malignant from benign mediastinal 
lymphadenopathy regardless of scan parameters and type of data acquisition 
of DWI.  
B-1577 14:48  
Value of computed tomography perfusion and diffusion-weighted 
imaging inpredicting the efficacy of non-small cell lung cancer 
chemoradiotherapy  
L. Cui; Nantong/CN (cuigeleili@126.com)  
Purpose: To evaluate computed tomography perfusion(CTP) and diffusion-
weighted imaging(DWI) parameters in estimating the efficacy of non-small cell 
lung cancer(NSCLC) chemoradiotherapy in terms of two-year progression-free 
survival (PFS) and overall survival (OS). 
Methods and Materials: This prospective study was approved by our 
institutional review board. All 23 pathologically-confirmed NSCLC patients 
underwent CTP and DWI scans before the standard concurrent 
chemoradiotherapy. A serial of pseudo-color perfusion images were produced, 
such as BF(blood flow), BV(blood volume) and PMB(permeability). DWI scan 
used three b values and generated three ADC images, i.e., ADC1(b=0, 
300s/mm2), ADC2(b=0, 800s/mm
2), and ADC3(b=300, 800s/mm
2). Fixed area 
of ROIf and maximum area of ROIm were drawn. Kaplan-Meier survival curves 
were used to estimate PFS and OS while Cox regression with multiple 
variables was applied to identify independent predictors, significant level being 
0.05. 
  






Results: No significant correlation was found between clinical stages and two-
year PFS and OS(P=0.223 and 0.112). The regression analysis showed that 
parameters with independent predictive value for PFS and OS were BF(ROIm), 
PMB(ROIm), and ADC2(ROIm). A prediction scoring model was established 
accordingly: 0 for BF(ROIm)46.10ml/100ml/min, 
PMB(ROIm)30.95ml/100ml/min or ADC2(ROIm)1.52×10
-3mm2/s whereas 1 for 
the otherwise. Three groups were yielded and the differences in two-year PFS 
and OS between them had statistical significance (Hazard Ratio=6.712 to 
19.921,P<0.001). 
Conclusion: CTP parameters BF(ROIm), PMB(ROIm) and ADC(b=0, 800 
s/mm2, ROIm) had independent predictive value for PFS and OS, and the 
prediction scoring model based on which had higher value in estimating 
treatment efficacy.  
B-1578 14:56  
Multiparametric approach by dynamic contrast-enhanced perfusion MRI 
with FDG-PET/CT: capability for conservative therapeutic response 
prediction in NSCLC patients  
Y. Ohno1, Y. Kishida1, S. Seki1, M. Yui2, S. Ohyu2, T. Yoshikawa1; 1Kobe/JP, 
2
Otawara/JP (yosirad@kobe-u.ac.jp)  
Purpose: To directly compare the capability for quantitative therapeutic 
response prediction among dynamic CE-perfusion MRI, FDG-PET/CT and 
multiparametric approach by both modalities in non-small cell lung cancer 
(NSCLC) patients treated with chemoradiotherapy. 
Methods and Materials: 43 consecutive Stage IIIB NSCLC patients (25 men, 
18 women; mean age 67 years) underwent PET/CT, dynamic CE-perfusion 
MRI, chemoradiotherapy, and follow-up examination. Then, all patients were 
divided into two groups by RECIST guideline as follows: 1) responders 
(CR+PR cases: n=23) and 2) non-responders (SD+PD cases: n=20). In each 
patient, total perfusion (TP) and tumour perfusions from pulmonary (TPP) and 
systemic (TPS) circulations calculated from dynamic CE-perfusion MR data 
and SUVmax on PET/CT were assessed at each targeted lesion, and averaged 
to determine final values. Multivariate logistic regression analysis was 
performed to investigate the discriminating factors of responders. In addition, 
ROC analysis was performed to compare diagnostic performance among all 
methods. Finally, sensitivity, specificity and accuracy were compared among all 
methods by McNemar’s test. 
Results: Multivariate regression analysis identified SUVmax (odds ratio [OR]: 
2.56) and TP (OR: 0.68) as significant differentiator of responder. ROC 
analysis showed area under the curve (Az) of multiparametric approach 
(Az=0.95) was significantly larger than that of TPP (Az=0.72, p=0.001). 
Sensitivity (95.7%) of multiparametric approach was significantly higher than 
that of TP (69.6%, p=0.03) and TPP (65.2%, p=0.02). 
Conclusion: Multiparametric approach by dynamic CE-perfusion MRI and 
PET/CT can improve the capability for therapeutic response prediction as 
compared with each modality alone in NSCLC patients after conservative 
therapy.  
Author Disclosures: 
  Y. Ohno: Research/Grant Support; Toshiba Medical Systems Corporation, 
Guerbet. S. Seki: Research/Grant Support; Toshiba Medical Systems 
Corporation. M. Yui: Employee; Toshiba Medical Systems Corporation. 
S. Ohyu: Employee; Toshiba Medical Systems Corporation. T. Yoshikawa: 
Research/Grant Support; Toshiba Medical Systems Corporation. 
B-1579 15:04  
Blood volume-based MR imaging with ultra-short TE: capability for 
prediction of postoperative lung function in NSCLC patients as compared 
with CT and perfusion SPECT  
Y. Ohno1, M. Yui2, Y. Chen3, S. Ohyu2, Y. Kishida1, S. Seki1, T. Yoshikawa1; 
1
Kobe/JP, 2Otawara/JP, 3Beijing/CN (yosirad@kobe-u.ac.jp)  
Purpose: To directly compare the capability of semi-quantitatively assessed 
blood volume-based pulmonary MR imaging with ultra-short TE (BV-MRI with 
UTE) for prediction of postoperative lung function in non-small cell lung cancer 
(NSCLC) patients as compared with CT and perfusion SPECT. 
Methods and Materials: 29 NSCLC patients underwent unenhanced and 
contrast-enhanced pulmonary MR imaging with UTE at a 3T system, CT, 
perfusion SPECT, and measurements of FEV1% before and after lung 
resection. In each patient, BV MRI was generated as percent signal change 
between unenhanced and CE-MR imaging. On BV-MRI with UTE and 
perfusion SPECT, postoperative FEV1% (poFEV1%) was predicted from semi-
quantitatively assessed blood volumes within total and resected lungs. 
Quantitatively predicted poFEV1% using CT was determined from the 
functional lung volumes within total and resected lungs. Qualitatively predicted 
poFEV1% using CT was determined from the number of segments of total and 
resected lungs. On each method, correlation with actual poFEV1% and the 
limits of agreement between actual and each predicted poFEV1% were 
statistically evaluated. 
Results: BV-MRI with UTE (r=0.82, p<0.0001) and quantitative CT (r=0.86, 
p<0.0001) showed better correlation than qualitatively assessed CT (r=0.79, 
p<0.0001) and SPECT (r=0.78, p<0.0001). The limits of agreement by BV-MRI 
with UTE (4.3±12.7%) and quantitatively assessed CT (3.5±10.8%) were 
smaller than those by qualitatively assessed CT (5.1±13.9%) and SPECT 
(4.2±14.5%). 
Conclusion: BV-MRI with UTE can more accurately predict postoperative lung 
function than qualitatively assessed CT and perfusion SPECT, and is at least 
as valuable as quantitatively assessed CT in NSCLC patients.  
Author Disclosures: 
  Y. Ohno: Research/Grant Support; Toshiba Medical Systems Corporation, 
Guerbet Japan. M. Yui: Employee; Toshiba Medical Systems Corporation.  
Y. Chen: Employee; Toshiba Medical Systems (China) Co., Ltd. S. Ohyu: 
Employee; Toshiba Medical Systems Corporation.  S. Seki: Research/Grant 
Support; Toshiba Medical Systems Corporation. T. Yoshikawa: 
Research/Grant Support; Toshiba Medical Systems Corporation. 
B-1580 15:12  
A 3T MRI with radial T1-weighted 3D spoiled gradient echo sequence can 
clarify pleural invasion classification of primary lung cancer  
H. Lee, W. Kwon, Y. Zhang; Wonju/KR (jeenylee@yonsei.ac.kr)  
Purpose: To clarify the pleural invasion of primary lung cancer by a 3T MRI 
with free-breathing radial T1-weighted 3D spoiled gradient echo sequence. 
Methods and Materials: The study was approved by the institutional review 
board and the local ethics committee. All subjects provided written informed 
consent. Twelve patients (7 men and 5 women, average 73.0 years old) with 
primary non-small cell lung cancer had suspicion for pleural invasion on CT. 
Cases were reviewed by retrospective interpretation of prospectively acquired 
data from January 2016 to August 2017 and confirmed by pathology. A 3T MRI 
was performed with fat suppression and contrast enhancement with 0.9 mm 
slice thickness, TR=3.36 msec, and TE=1.66 msec. It was compared with 64 
MDCT and conventional MRI sequence. Pleural invasion (PL) was graded as 
smooth and irregular margin of pleural enhancement. 
Results: Six adenocarcinoma and six squamous cell carcinoma cases were 
enrolled. Five T3 stage (5 PL0) and six T4 stage (5 PL1 and 1 PL2) were 
involved. All cases with proven PL0 and PL1 had smooth and curvilinear high 
signal intensity of pleura. One case with PL2 had irregular signal intensity of 
tumour interface of pleura against the chest wall suggesting tumour invasion 
beyond the visceral pleural surface. Well-enhancing high signal intensity of 
pleural adhesion is well visible on enhanced radial T1-weighted spoiled 
gradient echo sequence by MRI and can estimate resectable visceral pleural 
invasion of primary lung cancer. 
Conclusion: MRI with radial T1-weighted 3D spoiled gradient echo sequence 
can assess pleural invasion for T classification of lung cancer in routine clinical 
practice.  
B-1581 15:20  
MRI with DWI vs FDG-PET/MRI vs FDG-PET/CT vs conventional 
radiological examination: capability for TNM staging in patients with 
malignant pleural mesothelioma  
Y. Ohno1, Y. Kishida1, S. Seki1, M. Yui2, K. Aoyagi2, S. Kaminaga2, 
T. Yoshikawa1; 1Kobe/JP, 2Otawara/JP (yosirad@kobe-u.ac.jp)  
Purpose: To compare the TNM staging capability among MRI with diffusion-
weighted imaging (DWI), FDG-PET/MRI, FDG-PET/CT and conventional 
radiological examination in patients with malignant pleural mesothelioma 
(MPM). 
Methods and Materials: 23 consecutive and pathologically diagnosed MPM 
patients underwent whole-body MRI including DWI, PET/CT, conventional 
radiological and pathological examinations and surgical reports as well as 
follow-up examinations. TNM staging was evaluated by three different reader 
groups. Kappa statistics were determined for evaluations of agreements of 
each factor and the clinical stage between each method and final diagnosis. 
Finally, the diagnostic accuracy of each factor and of determination of the 
clinical stage was statistically compared with each other using McNemar’s test. 
Results: T factor agreements were determined as substantial (PET/CT and 
conventional examination: kappa value=0.61) or almost perfect (PET/MRI and 
MRI: kappa value=0.86). N factor agreements were also determined as 
substantial (PET/CT: kappa value=0.73, conventional examination: kappa 
value=0.61) or almost perfect (PET/MRI and MRI: kappa value=1.00). M factor 
assessment, agreements were also determined as moderate (conventional 
examination: kappa value=0.47), substantial (MRI: kappa value=0.78) or 
almost perfect (PET/MRI and PET/CT: kappa value=1.00). In addition, clinical 
stage agreements were determined as substantial (PET/CT and conventional 
examination: kappa value=0.70) or almost perfect (PET/MRI and MRI: kappa 
value=0.87). Finally, accuracies of N factor evaluation on PET/MRI and MRI 
were significantly higher than that of conventional examination (p=0.03). 
Conclusion: Whole-body MRI with DWI and PET/MRI are potentially more 
useful than conventional radiological examination, and can be considered at 
least as effective as PET/CT in this setting.  
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B-1582 14:00  
Structured reporting supports junior readers and improves PI-RADS 
conformity of multi-parametric MRI reports of the prostate-based on 
cross-lingual RADLEX annotations  
M.E. Maros1, B. Kämpgen2, A. Förster1, C. Groden1, W.H. Sommer3, 
S.O. Schönberg1, T. Henzler3, H. Wenz1; 1Mannheim/DE, 2Rimpar/DE, 
3
Munich/DE (matt.maros@gmail.com)  
Purpose: Prostate cancer (PC) represents an enormous burden as the second 
most common cancer in men. Therefore, the Prostate Imaging Reporting and 
Data System (PI-RADS v2) was developed to provide imaging and reporting 
standards of multi-parametric prostate MRI (mpMRI) in accordance with 
terminologies of RSNA's Radiologic Lexicon (RADLEX). We present a proof of 
concept study to assess the effect of (1) structured reporting (SR) and (2) to 
use automatic RADLEX content annotation as a quality measure for prostate 
MRI-reports. 
Methods and Materials: A cohort of 294 consecutive patients (02/2017-
08/2017; mean age 66.6, range 34-89yrs) with suspected PC and mpMRI were 
retrieved from local RIS archives and reassessed by two independent blinded 
readers. All reports were generated using an online SR tool (www.smart-
radiology.com). An automatic, cross-lingual annotation of German reports and 
English PI-RADS guideline with RADLEX terms was performed using a 
proprietary information extraction software (www.empolis.com). Structured 
reports of junior (n=110;37.4%) and senior (n=184;62.6%) radiologists were 
compared with the extracted PI-RADS RADLEX terms as a query using a free 
web-tool (radreport-query.com) and Wilcoxon rank-sum test. 
Results: Annotation of PI-RADS guideline identified 394 RADLEX terms. 
Reports of junior and senior radiologists had similar number of key terms 
(W=10700, p=0.416). Comparing PI-RADS guideline confirm RADLEX content 
of both findings (W=10266, p=0.837) and impressions (W=11103, p=0.164) 
sections showed that junior readers achieved comparable scores as senior 
ones. 
Conclusion: Automatic guideline-based RADLEX content extraction could 
serve as an important quality measure of reports of PC MRIs. SR templates 
support junior readers to produce high-quality PI-RADS conform mpMRI 
reports.  
Author Disclosures: 
 B. Kämpgen: Employee; Empolis Information Management GmbH, 
Kaiserslautern, Germany.  W.H. Sommer: Founder; co-founder of Smart 
Reporting GmbH.  T. Henzler: CEO; managing director of Diagnostik 
München.  
B-1583 14:08  
Opportunities in automatically annotating radiology reports with RadLex 
terms  
B. Kämpgen1, M.E. Maros2, T. Stening1, W.H. Sommer3, A. Klüter4; 
1
Rimpar/DE, 2Mannheim/DE, 3Munich/DE, 4Kaiserslautern/DE 
(benedikt.kaempgen@empolis.com)  
Purpose: With the development, subsequent refinement and translation of 
RadLex, there is a trend in radiology towards the use of standardised terms for 
all information resources. As a result, there will be greater opportunities for 
Natural Language Processing (NLP) to automatically collect data with a high 
degree of accuracy. This work investigates the gap in coverage between the 
vocabulary used in non-English radiology reports and the controlled vocabulary 
of RadLex. 
Methods and Materials: 300 MR prostate cancer, 280 CT haemorrhage, and 
75 MR stroke suspected cases were randomly selected from two radiological 
institutions. Findings sections of anonymised German reports were annotated 
with RadLex terms using a proprietary web service that includes stemming, 
compounds, abbreviations and automatic inference of more general terms 
(average no of annotations=71). An ID3 decision tree with (pre-)pruning 
(criterion=gain ratio; maximal depth=20; minimal leaf size=2) was trained, 10-
fold cross-validated, and tested on subsets of the data to automatically classify 
case type (300/280/75) and level of reader experience (unexperienced: yrs>2, 
no=149; experienced: yrs>6,no=225). 
Results: For case type, there is a macro-averaged f-score of 98% (precision: 
97%, recall: 98%). For experience level, there is an f-score of 75% (precision: 
65%, recall: 96%). Each test shows a 95% binomial confidence Wilson score 
interval no wider than 5%. 
Conclusion: Radlex annotations of reports are sufficiently specific for basic 
data analysis and decision support. The more complex the information 
extraction task, the more additional information (e.g., beyond localised 
synonyms) need to be considered, e.g., negation detection, disambiguation 
and relation extraction.  
Author Disclosures: 
  B. Kämpgen: Employee; Empolis Information Management GmbH.  
T. Stening: Employee; Empolis Information Management GmbH.  
W.H. Sommer: Founder; Smart Radiology GmbH. A. Klüter: Employee; 
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B-1584 14:16  
Quality assurance in CT: using automated CT dose monitoring software 
to implement updated national diagnostic reference levels  
E. Appel, P. Kröpil, C. Thomas, J. Aissa, Y. Klosterkemper, N. Heinzler, 
J. Boos; Düsseldorf/DE (elisabeth.appel@med.uni-duesseldorf.de)  
Purpose: To evaluate the implementation of the updated computed 
tomography (CT) diagnostic reference levels (DRLs) from the German Federal 
Office for Radiation Protection into clinical routine using an automatic CT dose 
monitoring system. 
Methods and Materials: CT radiation exposure was analysed before and after 
implementing the updated national DRLs into clinical routine in 2016. After the 
implementation process, institutional CT protocols were mapped to the 
anatomic regions for which DRLs were provided. Systematically exceeded 
protocols were optimised and analysed in detail. Analysed CT radiation output 
parameters were volumetric computed tomography dose index (CTDIvol) and 
dose length product (DLP). Three radiologists evaluated subjective image 
quality using a 3-Point-Likert-Scale. 
Results: 94258 CT series (from 27103 CT examinations) in adult patients 
performed in 2016 were included. Averaged over all body regions with 
available DRL, institutional CTDIvol/DLP were always below the DRLs (65.2 ± 
32.9 %/67.3 ± 41.5 % initially; 59.4 ± 32.0 %/60.5 ± 39.9 % after optimisation). 
Thus, incipiently exceeding protocols were seen for pelvis (CTDIvol 107.7 ± 
65.7 %/DLP 106.3 ± 79.3 %), lumbar spine (160.8 ± 74.7 %/175.2 ± 104.1 %) 
and viscerocranium (108.0 ± 39.0%/152.7 ± 75.7%). After optimisation, 
radiation dose was 87.9 ± 73.0 %/87.8 ± 80.8 % for the pelvis, 67.8 ± 33.2 
%/74.5 ± 50.6 % for the lumbar spine and 95.1 ± 45.8 %/133.3 ± 74.6 % for the 
viscerocranium. 
Conclusion: An automatic CT dose monitoring system enabled not only 
comprehensive monitoring of a DRL implementation process but can also help 
optimising radiation exposure.  
B-1585 14:24  
Investigating potential gadolinium toxicity to gadoterate meglumine 
(Dotarem) in local renally insufficient adult and paediatric populations 
using bioinformatics data linkage  
L.K. Young, S. Matthew, G. Houston; Dundee/UK (lkyoung@dundee.ac.uk)  
Purpose: Although current guidelines restrict the use of some gadolinium-
based contrast agents in patients with renal insufficiency (RI) 
(eGFR<60ml/min/1.73m2), they may be administered when the clinical benefit-
risk ratio is favourable. This study uses routine electronic health records to 
investigate the incidence of potential gadolinium toxicity to the agent 
gadoterate meglumine within a local RI population. 
Methods and Materials: Adult and paediatric patients who underwent 
contrast-enhanced MRI were identified, stratified by renal function and followed 
using health data. The following were identified: confirmed cases of NSF; onset 
of chronic pain, a symptom of NSF and potentially gadolinium deposition 
disease (GDD) (identified by new, regular pain medication prescriptions within 
7 days post-MRI) and contrast-induced nephropathy (CIN) (>25% increase in 
creatinine within 3 days post-MRI). Comparisons were made via chi-square 
tests to non-RI and non-contrast MRI populations. 
Results: From 2004 to 2016, 22,325 and 572 contrast-enhanced scans were 
performed on adult and paediatric patients, respectively. 14% of scans were 
undertaken while the patient had RI (30eGFR<60, n=2,622; 15eGFR<30, 
n=464; eGFR<15, n=123). Zero resulted in NSF diagnosis with an average 
follow-up time of 6.0 ± 2.5years (range, 8months - 15years). For all scans, 
there was no statistically higher rate of chronic pain onset post-MRI (adults: 
p=0.777, paediatrics: p=0.578), nor rate of CIN (adults: p=0.566, paediatrics: 
p=0.841), regardless of renal function or whether contrast was administered. 
Conclusion: These data indicate that gadoterate meglumine administered to 
adult and paediatric RI patients does not result in a higher rate of potential 
gadolinium toxicity symptoms.  
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B-1586 14:32  
Machine learning in radiology operations management  
O. Pianykh; Newton Highlands, MA/US (opiany@gmail.com)  
Purpose: Radiology workflow presents a complex mixture of planned events 
and random deviations. The old management approach was to set certain 
expectations and hope that they would be met. Instead, we propose to employ 
machine learning algorithms for predicting and managing Radiology workflow. 
Methods and Materials: To optimize radiology workflow at Mass5chusetts 
General Hospital, we developed an event-tracking system (“Tempus Fugit”, or 
TF for short), entirely based on RIS, PACS, and reporting data. The system 
was implemented as a real-time process (3-minute updates), querying 
radiology databases for the most recent year of data (nearly 1,000,000 records 
per query), to identify each study status in the current processing chain. 
Capturing this complex data enabled us to build machine-learning models for 
predicting and analyzing radiology operations. 
Results: We applied machine learning algorithms to several major operational 
problems such as predicting patient wait times, predicting facility delays, and 
identifying operational bottlenecks. Decision-based models such as regression 
trees proved efficient for identifying bottlenecking logic - Predictive models 
such as elastic nets achieved high accuracy in forecasting wait/delay times. As 
a result, we achieved: - Accurate prediction of wait/delay times: 80% within a 5-
min error. Ability to objectively identify the real sources of our operational 
bottlenecks. 
Conclusion: Machine learning is only a tool, but it can help when applied to a 
right problem. Large, noisy radiology workflow data, too complex to be 
analyzed manually, presents a perfect target for such applications, and can 
lead to visible improvements in operations management.  
B-1587 14:40  
Automated assessment of Sarcopenia on CT studies  
J.E. Burns1, J. Yao2, J. Chen1, R.M. Summers2; 1Orange, CA/US, 
2
Bethesda, MD/US (jburns@uci.edu)  
Purpose: Central sarcopenia is an adverse risk factor for mortality in cancer, 
liver transplantation, cirrhosis, and older trauma patients. The purpose is to 
validate a fully-automated system to opportunistically analyze lumbar 
paraspinous muscles for sarcopenia on CT. 
Methods and Materials: Watershed, graph cut, and level set algorithms obtain 
initial segmentation of lumbar vertebrae. Paraspinous muscles are localized 
and segmented by holistically nested neural networks through image-to-image 
training and classification. The system is tested on two data sets, CTs from 
PET/CT examinations of 40 patients with metastatic cancer and abdominal 
CTs from an elder cohort of 25 patients, to assess performance variation and 
generalizability of results. Manually segmented paraspinous muscles served as 
reference standard. Sarcopenia is defined through meta-analysis of 
publications as normalized L3 total psoas muscle index (L3TPI) of < 3.62 
cm^2/m^2 for women and <4.92 cm^2/m^2 for men. Segmentation accuracy is 
assessed via Dice Similarity Coefficient. 
Results: Dice coefficients for detecting psoas and posterior paraspinous 
muscle groups were 0.877+/-0.073 and 0.919+/-0.031 for PET/CT, and 
0.886+/-0.089 and 0.948+/-0.018 for abdominal CT, respectively. L3TPI was 
5.6 +/- 2.5 and 4.9 +/- 2.1 cm^2/m^2 (women) and 8.6 +/- 3.2 and 7.9 +/- 3.6 
cm^2/m^2 (men) for automatic and manual measurement respectively. 
Sarcopenia was present in 21.2% (7/33) and 24.2% (8/33) of women, and 
9.3% (3/32) and 15.6% (5/32) of men from automatic and manual 
measurement respectively. 
Conclusion: This fully-automated system accurately determines paraspinous 
muscle volume on CT for sarcopenia detection and monitoring, with potential to 
predict prognosis and guide patient management.  
B-1588 14:48  
COPD phenotyping with parameter response maps based on paired 
inspiratory/expiratory low-dose computed tomography  
O. Weinheimer1, C.J. Galban2, T.E. Robinson3, M. Wielpütz1, C. Heussel1, 
H.-U. Kauczor1, B.J. Jobst1; 1Heidelberg/DE, 2Ann Arbor, MI/US, 
3
Palo Alto, CA/US (weinheimer@uni-heidelberg.de)  
Purpose: Patients suffering from chronic obstructive pulmonary disease 
(COPD) can be subdivided using computed tomography (CT) into an airway-
dominant or emphysema-dominant phenotype. The parametric response map 
(PRM) method, a voxel-wise image analysis technique may detect distinct 
functional differences between these phenotypes. 
Methods and Materials: 169 paired inspiratory/expiratory low-dose CT scans 
(120 kV, 30-35 mAs, ~3.5 mSv) from the multicentre COSYCONET study were 
visually classified as airway-dominant (67%) and emphysema-dominant (33%). 
PRM was computed fully automatically employing a deformable volumetric 
registration and lung segmentation, classifying lung voxels as normal 
parenchyma (PRMNormal), functional small-airway disease (PRMfSAD) and 
emphysema (PRMEmph). For comparison the emphysema index (EI) was 
calculated on the inspiratory scans. 
Results: Average PRMNormal, PRMfSAD, PRMEmph and EI were 66.9%, 26.4%, 
6.9% and 9.2% in the airway-dominant group and 46.9%, 32.3%, 19.8% and 
23.1% in the emphysema-dominant group, respectively. The differences were 
significant between the groups with p=1.8e-07, p=0.006, p=3.6e-08 and 
p=2.8e-08. The Pearson correlation coefficient r between PRMNormal and forced 
expiratory volume in 1s (FEV1) was 0.63 (p<2.2e-16), for PRM
fSAD -0.54 
(p=3.1e-14), for PRMEmph -0.55 (p=5.1e-15) and for EI -0.55 (p<2.2e-16) across 
all patients, which was similar for airway-dominant and emphysema-dominant 
phenotypes. 
Conclusion: PRM identified fSAD regions, which would have been missed by 
emphysema quantification just on inspiratory CT scans. The results show that 
in emphysema-dominant COPD there is a large fraction of fSAD besides 
irreversible emphysema, which may be addressed by therapy. Additionally, the 
combination of PRMfSAD and PRMEmph leads to a higher correlation with FEV1.  
B-1589 14:56  
Model for improved correlation of BMD values between abdominal 
routine dual-energy CT data and DXA scans  
M. Woisetschlager, A. Spångeus; Linköping/SE  
Purpose: In this study, we evaluated a new software solution to calculate 
volume bone mass densities (vBMD) from dual-energy CT studies (DECT) and 
correlated them to DXA. We constructed a model where influencing factors for 
differences between vBMD and aBMD were taken into account. 
Methods and Materials: A total of 20 patients, i.e. 80 vertebrae, were 
examined with abdominal DECT (in three contrast phases) where the L1-L4 
were analysed with a software delivering vBMD. Within 1 months after the 
DECT, a DXA scan was performed. The amount of calcifications in the 
abdominal aorta (ACS) and of spondylarthritis (SAS) was evaluated. 
Results: The median age was 70.5 years (43 - 85) where 60% were women 
and 40% men. A significant correlation was found between DXA BMD and 
vBMD from DECT without contrast (WNC), and with venous contrast (WVC), 
but no significant correlation was found with arterial contrast. After combining 
DECT WNC, ACS and SAS in Model 1, a correlation is achieved with an R2 = 
0.616. The Pearson correlation between Model 1 predictive value and DXA is 
0.785 (p=0.001). The respective values in Model 2 for the DECT WVC are R2 
= 0.612 and predictive value of 0.782 (p=0.001). 
Conclusion: The shortcomings of DXA in predicting true BMD values 
compared to DECT, as being susceptible for confounding factors like 
calcifications in the abdominal aorta and osteoarthritis changes can be 
overcome by quantifying the amount of confounding factors and taking these 
into account in an explanatory model.  
B-1590 15:04  
Computer-aided detection of sonographic features for thyroid nodules 
and its effects on readers’ performance  
A. Chen, C.-N. Chen, H.-C. Tai, M.-H. Wu, K.-Y. Chen, M.-C. Ho, K.-J. Chang; 
Taipei/TW (achen@ntu.edu.tw)  
Purpose: This study is to evaluate the performance of an FDA-cleared 
computer-aided detection (CADe) device for thyroid nodules and its effects on 
readers’ performance. 
Methods and Materials: A total of 130 images of thyroid nodules were 
randomly selected from a case pool of 372 patients with 472 thyroid nodules. 
The ground truth for the presence of each sonographic feature was determined 
by a panel of three specialists. Detection of feature presence was evaluated by 
AUROC’s and t-test p-values. For assessment of the effects on readers’ 
performance, diagnostic decisions were compared to the pathology results (74 
benign and 56 malignant). Seven physicians were recruited to read the 130 
ultrasound images. The reader performance was then evaluated by the 
multiple reader multiple case (MRMC) study design and Dorfman-Berbaum-
Metz method. 
Results: The study first showed that the computed values of the anechoic 
area, echogenic foci, hypoechogenicity, heterogeneity, and ill-defined margin 
were all tested significant in detecting their presence with p-values <0.0001 for 
the first three features, 0.033 and 0.0014 for the last two and the AUC=0.882, 
0.788, 0.817, 0.71 and 0.686, respectively. The MRMC study showed that the 
average AUC (=0.796) with CADe was significantly larger (p-value=0.0077) 
than the average AUC (=0.724) without CADe. 
Conclusion: The tested CADe device was shown significant in detecting 
presence of the five sonographic characteristics. The diagnostic interpretations 
by physicians reading the ultrasound images with the CADe device were also 
shown significantly improved when compared to interpretations without the 
device.  
Author Disclosures: 
  A. Chen: Author; receive research grant from AmCad BioMed. C. Chen: 
Author; receive research grant from AmCad BioMed. H. Tai: Author; receive 
  






research grant from AmCad BioMed. M. Wu: Author; receive research grant 
from AmCad BioMed. K. Chen: Author; receive research grant from AmCad 
BioMed. M. Ho: Author; receive research grant from AmCad BioMed. 
K. Chang: Author; receive research grant from AmCad BioMed. 
B-1591 15:12  
Newly developed curvelet-based noise reduction algorithm for volume CT 
data  
M.S. Usanov, N.S. Kulberg, A.V. Petraikin, S.P. Morozov; Moscow/RU 
(m.usanov@npcmr.ru)  
Purpose: Estimate the effectiveness of newly developed noise reduction 
algorithm by means of analysis of acquired volume CT data, obtained from 
phantoms and patient studies of various anatomical areas. 
Methods and Materials: A new 3D noise reduction algorithm was developed 
based on wavelet curvlet transformation and bilateral filter. Estimation of noise 
reduction quality was made based on volume CT data, obtained from various 
CT scanners and study objects, including phantoms, brain, chest, abdominal 
area. 30 % of analysed studies are low dose CT. Overall, 113 studies were 
analysed. After data processing the results were assessed by radiologists, who 
made valuable notices in the algorithm presets. The following parameters were 
taken into consideration: standard deviation (SD), determination coefficient. 
Special attention was paid to speed of data processing. 
Results: SD is improved in phantom study by 58.08%, and in patient study by 
76.89%. Confidence interval for SD value difference = 0.0003. Determination 
coefficient between mean native and processed values = 0.99 for phantom 
study and = 0.97-0.99 for patient study, which means the data remains 
unspoiled, without any value loss or border deformation. Estimated processing 
time of 500 slices is around 20 seconds. 
Conclusion: Proposed algorithm has shown its effectiveness in the field of 
various CT data processing without data spoilage, comparing to standard 
methods. This method requires only DICOM files, without manipulating raw 
data. High speed processing allows the algorithm to be used both on 
workstations and PC. This new technology will enhance quality of CT 
diagnostic, as well as lowering x ray dose for patients during the study. The 
work is supported by RFBR, project 17-01-00601.  
B-1592 15:20  
Multiparametric magnetic resonance imaging of the prostate with 
computer-aided detection: non-experienced observer performance study  
G. Cappello, V. Giannini, S. Mazzetti, F. Russo, L. Vassallo, V. Doronzio, 
D. Regge; Turin/IT (giovanni.cappello@ircc.it)  
Purpose: To understand how non-experienced readers interacts with 
likelihood map generated by a computer-aided detection (CAD) for prostate 
cancer (PCa) detection and to compare their sensitivity, specificity and reading 
time obtained with and without the color-coded map. 
Methods and Materials: 90 multiparametric magnetic resonance imaging (mp-
MRI) prostate cases (45 negatives and 45 with at least one significant PCa) 
were reviewed twice by three radiology residents. First, suspected PCa were 
detected on the basis of CAD marks observed on a likelihood map 
superimposed to the T2w image, as anatomical reference. After 6 weeks, 
readers reviewed the same cases analyzing mp-MRI unassisted. Sensitivity, 
specificity, and reading time were compared for the two reading paradigms. 
Results: The stand-alone CAD sensitivity was equal to 94.3%. Considering all 
readers, sensitivity was 66.7% (95% CI 58.0-74.5%) and 70.4% (95% CI 61.9-
77.9; p=0.236) for unassisted and CAD paradigm, respectively. Sensitivity was 
higher with CAD for lesions with GS>6 (79.6% vs 
71.0%; p=0.0287), but not for lesion with diameter 10 mm (76.5% vs 79.0%; 
p=0.395). Specificity was not affected by CAD (94.8% for CAD vs 89.6%; 
p=0.071).The average reading time was significantly lower (170s vs 66s; 
p<0.001) when using the CAD system. 
Conclusion: Using the CAD system, non-experienced readers can detect 
more patients with GS>6 PCa than unassisted MRI interpretation; overall 
reporting time is shorter. However, CAD stand-alone sensitivity was 
significantly higher, demonstrating that operators were somewhat 
uncomfortable when using CAD systems. However, other reading paradigms 














14:00 - 15:30 Room E2  
Neuro  
SS 1911a  
Trauma and encephalopathies  
Moderators:  
A.S. Gersing; Munich/DE  
D. Goldsher; Haifa/IL  
B-1593 14:00  
Saliently alteration of hub profiles following acute mTBI  
X. Wang1, C. Sun1, S. Wang1, J. Cao1, H. Xu1, S. Gan1, B. Yin2, G. Bai2, 
L. Bai1; 1Xi'an/CN, 2Whenzhou/CN (lemon124w@outlook.com)  
Purpose: To investigate altered network hubs following acute mild traumatic 
brain injury (mTBI) in a large homogenous sample compared with healthy 
controls. 
Methods and Materials: 74 mTBI patients (46 males, ages of 36.3 ± 12.7 
years) within 7 days post-injury and 51 matched healthy controls (26 males, 
ages of 36.7 ± 12.2 years) were enrolled in this study. Functional brain 
networks were constructed using resting state fMRI. Hub disruption index  
was also calculated across the whole network and for each functional network. 
SVM was applied to test whether participation coefficient can be used as a 
neurobiomarker to identify mTBI patients from controls. 
Results: Our results indicated evidence for a radical reorganization of highly 
efficient hub nodes following mTBI. Specially, hubs for mTBI patients 
distributed in more extensive networks such as the default mode network 
(DMN), ventral attention network (VAN) and frontoparietal network (FPN), 
somatomotor network (SMN) and the visual network (VN), compared with 
healthy controls limited to the first three. Hubs in healthy controls typically 
became non-hubs in patients and vice versa defined by a novel hub disruption 
index. Participation coefficients for mTBI presented significantly decreased in 
the DMN (P=0.015) and FPN (P=0.02), while increased in the VN (P=0.035). 
Additionally, SVM trained with participation coefficient metrics identified mTBI 
patients from controls with 78% accuracy, providing for its diagnostic potential 
in clinical settings. 
Conclusion: These evidence suggested a saliently spatial transition of hub 
profiles even in the very early stage of mTBI, associated with functional 
network reorganization in these patients.  
B-1594 14:08  
Automatic vs human detection of traumatic cerebral microbleeds on 
susceptibility-weighted imaging  
A.W. van der Eerden1,2, T.L.A. van den Heuvel1, B.H. Geurts1, B. Platel1, 
T. Vande Vyvere3,4, L. van den Hauwe3,4, T.M.J.C. Andriessen5, B.M. Góraj1,6, 
R. Manniesing1; 1Nijmegen/NL, 2Venlo/NL, 3Edegem/BE, 4Leuven/BE, 
5
Gorinchem/NL, 6Warsaw/PL (ankevandereerden@gmail.com)  
Purpose: To evaluate the performance of computer-aided traumatic cerebral 
microbleed detection (CAD) with and without human interference. 
Methods and Materials: 33 adult patients admitted to our emergency 
department with moderate or severe TBI (mean age 33 years, 21 males) 
underwent a standardised trauma 3T MRI-protocol at 28 weeks. The 
microbleeds in their SWI-scans were annotated by an expert. A CAD system 
was developed, based on this training set. Six experts, blind to the CAD-
results, annotated a subset of ten patients. In two experiments, we compared 
the performance of the CAD system to each of these six experts, using the 
majority voting results of the other five experts as the reference standard for 
the calculation of performance characteristics (paired t-test). In the first 
experiment, the performance of fully automatic microbleed detection was 
assessed. In the second experiment, one expert removed CAD-annotations 
she considered false positives from the automatically detected microbleeds, 
and briefly screened the CAD-annotated SWI-scans to complete the dataset 
with missed definite microbleeds. 
Results: Fully manual evaluation took one hour per patient with an average 
sensitivity of 77% (SD 12.4%). The sensitivity of fully automatic detection of 
candidate microbleeds was 89% (SD 0.8%). Evaluation of the CAD results by 
an expert took 13 minutes per patient with a sensitivity of 93% (SD 1.0%) (p < 
0.05 versus fully manual evaluation). 
Conclusion: This CAD system allows detecting more microbleeds in a 
reduced reading time. This may facilitate the execution of otherwise too time-
consuming large studies on the clinical relevance of microbleeds.  
Author Disclosures: 











B-1595 14:16  
Looking for association between blood pressure, imaging severity and 
complications - MR imaging study in posterior reversible encephalopathy 
syndrome  
S.B. Hiremath, A.A. Gautam, G. Benjamin; Thiruvalla/IN 
(shivaprakashbh@gmail.com)  
Purpose: To evaluate for significance of association between blood pressure 
and imaging severity with hemorrhage and cytotoxic edema in PRES. 
Methods and Materials: This retro - prospective study included the medical 
records and imaging involving 35 consecutive patients with PRES from 2010 - 
2016. The clinical data was analyzed for blood pressure recorded at the ictus 
with MR imaging including a spin-echo echo planar diffusion weighted imaging 
(DWI) and susceptibility weighted angiography (SWAN) with conventional 
sequences. The presence of haemorrhage and cytotoxic edema was assessed 
for significance of correlation and association with each other and with BP and 
imaging severity (IS). 
Results: Hemorrhage was found in 25.7 % of patients and cytotoxic edema 
was in 20 % of patients. There was no statistically significant association of 
hemorrhage (p = 0.403) and cytotoxic edema (p = 0.162) with BP. There was 
statistically significant association of hemorrhage (p < 0.001) and cytotoxic 
edema (p = 0.011) with IS and with each other (p = 0.002). There was 
significant correlation of hemorrhage (Cramer’s V - 0.672) and cytotoxic edema 
(Cramer’s V - 0.506) with IS and with each other (Cramer’s V - 0.523). 
Conclusion: There is significant association of hemorrhage and cytotoxic 
edema with imaging severity and among each other. The endothelial injury 
secondary to hyperperfusion or hypoperfusion is the basic mechanism of 
changes in PRES. Vasculopathy and decreased perfusion results in ischemia 
and restricted diffusion; rupture of pial vessels due to impaired autoregulation 
causes subarachnoid hemorrhage and post-ischemic reperfusion leads to 
microhemorrhages.  
B-1596 14:24  
Atypical inter-hemispheric communication following subacute mild 
traumatic brain injury  
Z. Wang1, S. Wang1, C. Sun1, B. Yin2, G. Bai2, X. Niu1, Y. Sun1, M. Zhang1, 
L. Bai1; 1Xi'an/CN, 2Wenzhou/CN (wangzhuonan424@stu.xjtu.edu.cn)  
Purpose: To examine the structural integrity of the corpus callosum (CC) in 
subacute phase of mild traumatic brain injury (mTBI) patients and its related 
inter-hemispheric functional connectivity changes. 
Methods and Materials: Forty two patients with mTBI (29 male, ages of 37.8 ± 
11.9 years) and 42 matched healthy controls (male 22, 36.2 ± 9.9 years) 
underwent comprehensive neuropsychological evaluations as well as both 
diffusion tensor imaging (DTI) and resting state scanning. The specific division 
of the CC was conducted by using DTI in combination with a tract-tracing 
algorithm. Fractional anisotropy (FA) for each subsection of the CC was 
generated by the Tract-Based Spatial Statistics (TBSS) and inter-hemispheric 
functional connectivity (FC) was analyzed by using voxel-mirrored homotopic 
connectivity (VMHC) approach. These analysis were also compared between 
patients with mTBI and controls, covarying for age, sex, and education with 
multiple comparison corrections. 
Results: MTBI patients showed significantly decreased FA in the splenium and 
marginally reductions in the mid anterior body part of CC compared with 
controls (P <0.01, corrected for multiple comparisons). The increased FC were 
shown in the pre-supplementary motor area and supplementary motor area, 
while decreased in the default-mode network (DMN) (precuneus/ posterior 
cingulate and inferior parietal lobule), salience network (SN) (fronto-insular 
cortex) and orbitofrontal cortex (OFC) (P < 0.05, FDR corrected). 
Conclusion: As a conduit in mediating inter-hemispheric communications, the 
structural loss in the specific section of the CC may, therefore, influence the 
corresponding projection fibers and its related inter-hemispheric functional 
connectivity following mTBI.  
B-1599 14:32  
Subcortical nuclei and cognitive impairment in sub-acute mild traumatic 
brain injury: a diffusion kurtosis imaging and volumetric study  
M.-L. Wang, W. Li; Shanghai/CN (doctor-mingliang@sjtu.edu.cn)  
Purpose: To investigate the volumetric and diffusional kurtosis imaging (DKI) 
changes of subcortical nuclei in sub-acute mTBI, and to assess the relationship 
between subcortical nuclei volume, DKI parameters and cognitive function. 
Methods and Materials: A total of 23 mTBI patients and 24 control 
participants underwent examinations of neuropsychological tests, MRI-based 
morphological and DKI scans. Volume, mean kurtosis (MK), mean diffusivity 
(MD), and fractional anisotropy (FA) were measured in bilateral hippocampus, 
thalamus, caudate, putamen, pallidum, and amygdala. Neuropsychological 
tests and MRI parameters were compared between mTBI and control group. 
Correlation analysis was performed to examine the relationship between 
subcortical nuclei volume, DKI parameters and cognitive function. 
Results: There were no significant differences in the volume of any subcortical 
nuclei between mTBI and control group. The mTBI group had higher MK value 
in right hippocampus, left thalamus, left caudate, right putamen, and right 
pallidum (P<0.05), and lower MD value in right pallidum (P<0.05).mTBI 
participants had worse performance in the domains of verbal memory, 
attention and executive function. In the mTBI group, the declined verbal 
memory function was correlated with higher MD value in left thalamus (r=-
0.678, P=0.022) and lower FA value in left amygdala (r=0.611, P=0.016). The 
attention deficit was correlated with lower MK value in left amygdala (r=0.625, 
P=0.010), right thalamus (r=0.634, P=0.008), right putamen (r=0.582, 
P=0.018), right hippocampus (r=0.576, P=0.020) and right amygdala (r=0.503, 
P=0.047). 
Conclusion: DKI is more sensitive than conventional DTI for detecting 
subcortical nuclei microstructural changes that might underlie the pathology of 
cognitive impairment in sub-acute mTBI.  
B-1600 14:40  
Resting-state functional connectivity in the visual network: a possible 
predictor of treatment response in chronic migraine  
D. Kies, J.A. Pijpers, M.D. Ferrari, M.C. Kruit, G.M. Terwindt; Leiden/NL 
(d.a.kies@lumc.nl)  
Purpose: Up to 25% of episodic migraine patients progress to chronic 
migraine (headache on more than 15 days per month). The mechanisms 
behind chronification and reversion are still uncertain, although overuse of 
acute headache medication plays an important role. We investigated whether 
resting-state functional connectivity (RS-fc) can predict favourable outcome of 
treatment. 
Methods and Materials: RS-fMRI was conducted in 112 participants with 
chronic migraine and medication overuse before and 3 months after treatment. 
Responders to treatment (greater than 50% reduction in headache days) were 
compared with non-responders, using RS-fc within ten functional networks. 
Data were preprocessed using a standard FSL pipeline with addition of the 
AROMA motion correction tool. Results were corrected for multiple 
comparisons. 
Results: Data of 99 participants was complete and useable for analysis. The 
mean number of headache days at baseline was 21.2 per month. At baseline, 
the lateral visual network showed a higher connectivity in areas in the bilateral 
occipital cortex in responders vs non-responders (p= .015). Only in responders 
this higher functional connectivity decreased after treatment (p= .001). No 
differences in connectivity were detected at baseline or during follow-up in any 
of the other 9 evaluated networks. 
Conclusion: Chronic migraineurs who responded to treatment showed a 
significantly higher RS-fc within the lateral visual network as compared to non-
responders at baseline, as well as a significant decrease of RS-fc in this area 
after treatment. RS-fc might serve as a prognostic tool in selecting responsive 
patients for treatment.  
B-1601 14:48  
Prognostic role of CT imaging in coup and contre coup injuries of brain  
M. Jayakumar, A. Rangari, M.J. Rodriguez; Vaniamkulam/IN 
(meghpsbb@gmail.com)  
Purpose: Coup and contrecoup contusions are a set of focal brain injuries. 
Since the pathogenesis of the two are different, the outcome in the two also 
would be expected to be different. Present study aims to evaluate role of CT in 
predicting prognosis in coup-contrecoup injuries. 
Methods and Materials: 103 consecutive cases presenting with coup and 
contrecoup injuries over a 1-year period were retrospectively analyzed. They 
were divided into three groups: Coup injuries with intraparenchymal injury (n = 
53), contrecoup injuries (n = 25) and coup-contrecoup injuries (n = 25). The 
groups were comparable with respect to age and GCS. Site of primary imapact 
was detrmined clinically.All patients underwent CT scan of brain. The mortality 
rates in each group were compared with respect to age, GCS and CT pattern. 
Significance was calculated using the chi -square test. 
Results: Fractures,extraxial hemorrhage and intraparenchymal hemorrhage 
were the common findings identified on CT brain scan. There was a statistically 
significant difference in mortality between patients with coup injuries and 
patients with contrecoup (p< 0.005) and coup-contrecoup injuries (p<0.001). 
There was no significant difference in mortality between contrecoup and coup-
contrecoup injuries 
Conclusion: CT is able to identify coup and contre coup injuries 
effectively.Presence of a contrecoup component on CT scan predicts a worse 
outcome in head injuries and warrants aggressive management and thus can 













B-1603 14:56  
Vision-related structural and functional reorganisation after incomplete 
acute cervical cord injury  
Q. Chen, N. Chen, W. Zheng, X. Chen, X. Li, K. Li, C. Zhang; Beijing/CN 
(chaozhang0328@hotmail.com)  
Purpose: The aim of this study was to explore possible vision-related 
structural and functional reorganisation of the brain after acute incomplete 
cervical cord injury (ICCI), which often leads to motor dysfunction, using multi-
modal MR imaging study, and to further study their associations with motor and 
other clinical variables. 
Methods and Materials: Eleven patients with ICCI and eleven matched 
healthy controls (HCs) were recruited. All participants underwent structural and 
functional MRI scans. Voxel-based morphometry analysis was carried out to 
investigate the differences in brain structure between ICCI and HCs, the 
fractional amplitude of low-frequency fluctuations (fALFF) was used to 
characterise changes in regional neural activities, and the independent 
component analyses (ICA) were used to explore alterations in resting-state 
network after spinal cord injury (SCI). Finally, we also investigate the 
correlations between brain imaging metrics and clinical variables. 
Results: Compared with HCs, patients with ICCI showed significant grey 
matter (GM) atrophy in the left hippocampus and parahippocampal gyrus, and 
right superior frontal gyrus (SFG) and right middle frontal gyrus (MFG), and 
decreased fALFF in the left OFC. Moreover, ICCI patients exhibited decreased 
intra-network functional connectivity (FC) in the medial vision network (mVN). 
Finally, the mean fALFF value was correlated with the clinic motor scores. 
Conclusion: Our findings provide evidence that acute ICCI can induce 
significant structural and functional alterations in vision-related regions of the 
brain. These reorganisations may suggest a potentially vital role for vision-
related rehabilitation training in SCI patients with sensorimotor dysfunction, 
such as virtual reality (VR)-augmented training, brain-computer interfaces 
(BCI).  
14:00 - 15:30 Room F2  
Breast  
SS 1902a  
Risk-based screening  
Moderators:  
L.A. Carbonaro; San Donato Milanese/IT 
D. Djilas-Ivanovic; Sremska Kamenica/RS  
B-1604 14:00  
Risk-based strategies for supplemental breast cancer screening  
D.L. Miglioretti1, B. Sprague2, C. Gard3, G. Rauscher4, J. Tice5, 
K. Kerlikowske5; 1Davis, CA/US, 2Burlington, VT/US, 3Las Cruces, NM/US, 
4
Chicago, IL/US, 5San Francisco, CA/US (dmiglioretti@ucdavis.edu)  
Purpose: Supplemental screening of women with dense breasts has been 
promoted given the low sensitivity of mammography in these women; however, 
screening ultrasound and MRI are limited by high false-positive rates. We 
evaluated the efficiency of basing supplemental screening decisions on a risk 
model for screening failures versus breast density. 
Methods and Materials: We included 1,808,514 million screening 
mammograms on women 40-74 years in the U.S. Breast Cancer Surveillance 
Consortium. Risk factors were collected at the screen. Screening failures were 
defined as interval invasive cancers (<12 months after a normal mammogram) 
and screen-detected cancers AJCC stage IIb or higher. We used logistic 
regression to develop a risk model to predict the probability of a screening 
failure given a woman’s age, BI-RADS breast density, family history, 
race/ethnicity, and history of benign breast disease. 
Results: Screening failures occurred in 1.36/1000 and 1.71/1,000 screens 
performed on women with heterogeneously and extremely dense breasts, 
respectively. Supplemental screening of women with dense breasts (46% of 
population) would potentially avert 64% of screening failures. To potentially 
avert 64% of failures based on our risk model, only the 41% of women with 
failure risk >1.05/1000 would receive supplemental screening, resulting in 
fewer supplemental screens per failure (601 vs. 705). Supplemental screening 
of the 23% of women with failure risk >1.36/1000 would to potentially avert 
46% of failures, further lowering the supplemental screens per failure to 476. 
Conclusion: A risk model for screening failures more efficiently identifies 
women who might benefit from supplemental imaging than breast density.  
Author Disclosures: 




B-1605 14:08  
Feasibility of risk assessment and personalised breast screening 
recommendations delivery in community radiology practice: a national 
prospective study (NCT02997384)  
C.S. Balleyguier1, E. Bayou1, B. Boyer2, S. Canale1, I. Ewenczyk-Bitton2, 
R. Gilles3, L. Rotenberg4, J. Viala5, S. Delaloge1; 1Villejuif/FR, 2Paris/FR, 
3
Bordeaux/FR, 4Neuilly-Sur-Seine/FR, 5Antony/FR  
Purpose: Stratified breast cancer (BC) prevention is a major option for the 
future but requires adapted and relevant tools to assess BC risk and 
communicate with the women. The prospective "Riviera" trial (NCT02997384) 
aimed to evaluate the feasibility of a BC prevention consultation using a 
dedicated software, in private community practices in France. We report results 
obtained among participating radiologists. 
Methods and Materials: Riviera was conducted from December 2016 to July 
2017 and involved 8 community radiologists. Women aged 40-74 were 
proposed to have their BC risk assessed and a personalized screening 
program (PSP) provided using the Mammorisk™ software. Primary end point 
was the % of women accepting to participate. Secondary objectives were 
women's awareness, anxiety and satisfaction, and physicians' satisfaction. The 
participants filled questionnaires at accrual and 48h later. The radiologists’ 
point of view was evaluated with a standardized questionnaire. 
Results: 189 women were included. Median age was 51 (41% between 40 
and 49). The BC risk assessment acceptance rate was 100%. 31 % of women 
were reclassified at high risk. 70% of women returned the H48 questionnaires. 
93% found that the information and the PSP were clear or very clear. Anxiety 
levels after the consultation were low. The mean score for radiologists’ 
satisfaction was good. 
Conclusion: A BC prevention consultation with risk assessment and delivery 
of a PSP is feasible in community radiology practices. The next step is to 
evaluate the feasibility at a European level taking into consideration the 
different BC screening organizations.  
B-1606 14:16  
Mammographic density, age and family history: a minimally sufficient set 
of parameters to risk stratify average-risk women for follow-up screening  
M. Abdolell, K. Tsuruda, J.I. Payne, P. Brown, J. Caines, P. Barnes, 
M. Rivers-Bowerman, S.E. Iles; Halifax, NS/CA (Sian.Iles@nshealth.ca)  
Purpose: This study evaluated the consistency and discriminatory power of 
several short-term breast cancer risk models within a general screening 
population. 
Methods and Materials: This 3:1 age- and screen-matched case-control study 
sampled all breast cancer cases diagnosed among digitally screened women 
aged 40-75 years (2009-2015) within a provincial breast screening programme. 
Clinical risk factor data and fully automated percent mammographic density 
assessments were obtained for 2,347 cases and 7,041 controls. The data were 
partitioned such that risk models were developed using a training dataset and 
validated using a test dataset. Patient-specific risk estimates were derived from 
models that included density and clinical risk factors alone and in combination. 
Agreement between models was assessed using intraclass correlation 
coefficient (ICC) and kappa; the predictive performance was assessed using 
the area under the receiver operating curve (AUROC). 
Results: The agreement between risk estimates was highly variable 
(ICC=0.016-0.962, kappa=0.025-0.823). The risk model performance varied 
highly (AUROC=0.485-0.602). Agreement was almost perfect between a model 
including density, family history and age versus a model that additionally 
included menopausal status, HRT use and parity (ICC=0.962, kappa=0.823); 
the predictive performance was similar (AUROC =0.594,0.598). 
Conclusion: Risk models can generate significantly different risk estimates for 
the same woman depending on the risk factors included, thus altering follow-up 
recommendations, especially for higher-risk women. A short-term risk model 
incorporating mammographic density, family history and age provides a 
practical solution for risk stratification of the average-risk population.  
Author Disclosures: 
  M. Abdolell: CEO; Densitas Inc. Founder; Densitas Inc. K. Tsuruda: 
Employee; Densitas Inc.  
B-1607 14:24  
Mammographic breast density analysis with automated volumetric breast 
density in a single centre of Taiwan women  
H.-K. Wu, W.-P. Wu; Changhua/TW (139496@cch.org.tw)  
Purpose: Women with increased mammographic breast density are known to 
be at higher risk of developing breast cancer. The changes of breast density 
among diverse age groups in Asian women is still elusive. We aimed to 
investigate the distribution of breast density in Taiwanese women. 
Methods and Materials: A retrospective review of data collected from 130,237 
women who underwent digital mammography from 2011 to 2016 was 
conducted. On the basis of ACR BI-RADS 5th edition breast composition, 
breast density analysis based on fully-automated volumetric breast density 
  






estimates (Volpara) were determined on four density grades (a, b, c, d) and a 
binary classification of fatty (a-b) vs. dense (c-d) breast. 
Results: In Taiwan women, the frequency of dense breast was 94.0% (30-39 
years old), 93.4% (40-49), 82.8% (50-59), 67.5% (60-69), 63.1% (70-79), and 
63.5% (80-89), p-trend <0.001. Taiwanese women has a higher frequency of 
dense breast, but this frequency decreased abruptly between the ages of 50 
and 69. Even in 70-89-year-old women, dense breasts are majority. 
Conclusion: Our results indicate the higher frequency of dense breast among 
Taiwanese women.  
B-1608 14:32  
Assessing the diagnostic accuracy of a 3D functional infrared imaging as 
adjunct screening for women at high risk for breast cancer  
M. Sklair-Levy1, E. Friedman1, O. Halshtok Neiman1, A. Shalmon1, M. Gotlieb1, 
R. Faermann1, J. Oaknin2, D. Izhaky2; 1Ramat Gan/IL, 2Airport City/IL 
(david@realimaging.com)  
Purpose: Three-dimensional functional infrared imaging (3DIRI) has been 
shown before to provide high-accuracy risk assessment for the likelihood of 
breast cancer based on multiparametric evaluation of metabolic imaging 
biomarkers. In this prospective one-arm clinical study, 3DIRI is added twice 
yearly to a screening program which includes annual breast MRI and breast 
ultrasound or mammography surveillance. The aim of this study was to 
determine diagnostic accuracy of 3DIRI. 
Methods and Materials: Following Ethics Approval, 230 females at high risk 
for breast cancer due to genetic predisposition, mainly known carriers of BRCA 
1/2 mutation, signed informed consent for this study. They underwent 465 
screening rounds between January 2015 and June 2016. Screening included 
3DIRI scan (prototype Real Imager 8) and MRI or breast ultrasound or 
mammography. Accuracy of 3DIRI was determined by ROC curve using 
histopathological confirmation for cancer cases and one-year follow-up for non-
cancer. 
Results: Of 230 women who underwent 465 standard care screening 
procedures, 63 women underwent biopsy of which, 55 proved to be benign 
while 8 were malignant on histopathology. In addition, one interval cancer was 
observed during the follow-up. AUC of 3DIRI was 82.32%. 
Conclusion: Three-dimensional functional infrared imaging can provide risk 
assessment for the likelihood of breast cancer with high accuracy in a 
population of women that are at high risk for breast cancer. Additional studies 
are necessary to evaluate its clinical utilisation as adjunct to mammography in 
screening population.  
Author Disclosures: 
 J. Oaknin: Employee; Real Imaging Ltd. D. Izhaky: Employee; Real Imaging 
Ltd.. 
B-1609 14:40  
Correlation of breast MRI screening with 3D functional infrared imaging  
U. Fischer1, F. Baum1, J. Oaknin2, D. Izhaky2; 1Göttingen/DE, 2Air Port City/IL 
(david@realimaging.com)  
Purpose: Three-dimensional functional infrared imaging (3DIRI) has been 
shown before to provide high-accuracy risk assessment for the likelihood of 
breast cancer in women based on multiparametric evaluation of metabolic 
imaging biomarkers. The aim of this study was to investigate the relationship 
between risk assessment score derived from 3DIRI and BI-RADS classification 
result derived from breast MRI. 
Methods and Materials: In this prospective, ethically approved study, written 
informed consent was obtained from 120 women who underwent 3DIRI exam 
and breast MRI between September 2016 and September 2017. 3DIRI risk 
assessment score (on a scale of -100 to 100, with positive score indicating 
likelihood for malignancy) was used to determine area under the receiving 
operating characteristics in which MRI assessment (BI-RADS lexicon 
classification) was used as the gold standard. We used a Fisher's exact test to 
further compare association of MRI BI-RADS classification with 3DIRI scores. 
Results: Seventy-three women (mean age, 58) were enrolled, recruited and 
had bilateral contrast-enhanced MRI screening and valid 3DIRI (Real Imager 
8) imaging scan at day of analysis. Of 73 women, 32 women (44%) had 
positive MRI (BI-RADS>=3). AUC for 3DIRI was 0.70 (U test p<0.005). A 
Fisher's exact test of association between positive/negative MRI and 
positive/negative 3DIRI risk assessment score further corroborated this 
association (p<0.01). 
Conclusion: Three-dimensional functional infrared imaging risk assessment 
score may serve as a predictor of positive breast screening MRI and may be 
utilized for selection of women for breast MRI screening.  
Author Disclosures: 





B-1610 14:48  
Interest of breast MRI surveillance in women with a personal history of 
breast invasive lobular carcinoma  
J. Sanchez, C. de Bazelaire; Paris/FR  
Purpose: Our purpose was to evaluate if breast MRI (BMRI) had an interest in 
the follow-up of patients after pure invasive lobular carcinoma (ILC). 
Methods and Materials: From a retrospective review from Jannuary 2006 to 
February 2016, we recorded patients' and tumours' characteristics at the initial 
and second breast cancer (BC): systemic recurrence, disease-free survival 
(DFS) and overall survival (OS). 
Results: 308 of 727 patients were included with a mean follow-up of 75.5 
months: 217 with a conventional follow-up (mammography and ultrasound) and 
91 with additional BMRI. There was no difference between the groups in 
locoregional recurrence (LR) (13 vs 22, p = 0.561). 306 BMRI were performed 
to detect 12 LR with 4 occult BC. BMRI had 4.2% cancer detection rate, 100% 
sensitivity, 88.7% specificity and 11.8% false positives. The DFS after 
exclusion of patients with distant recurrence was not significantly different: 
184.7 months (IC 95% : 145.6-223.8) without MRI and 156.3 months (125.5-
187.2) with MRI (p = 0.132). The mean OS did not differ significantly between 
the groups, being 318 months with MRI and 301.8 months without MRI (IC 
95% = 275.5 - 328; log rank = 0.087). 
Conclusion: BMRI surveillance did not increase the detection of LR and 
appeared not to be associated with an improvement in OS.  
B-1611 14:56  
How early can MRI diagnosis of breast cancer be in BRCA mutated 
women?  
A. Pecchi, G. Musacchia, M. Verrusio, R. Battista, B. Canossi, L. Cortesi, 
P. Torricelli; Modena/IT (pecchi.annarita@policlinico.mo.it)  
Purpose: Genes mutations increase the risk of developing breast cancer in 
women by approx. 50%. In the literature, evidence has consistently reported 
the importance of MRI screening for early diagnosis of breast cancer in these 
patients. Primary endpoint was to describe morphological and dynamic 
patterns of breast cancer diagnosed by MRI during an intensive surveillance 
multi-imaging protocol. Secondary endpoint was to retrospectively analyse the 
MRI examination obtained during the round prior to diagnosis to identify the 
early signs of cancer. 
Methods and Materials: Our study involves 224 high-risk women studied with 
a multi-imaging screening protocol that includes mammography, ultrasound 
and MRI, differently matched according to woman's age. 
Results: 25/224 women developed breast cancer: 4/25 diagnosed in the 
interval between a round and the next; 21/25 during multi-imaging follow-up. 
Among these, MRI enhancement pattern was non mass-like in 4 cases, mass-
like in 17 cases, 4 of which showed a typical ring enhancement. In 9/21 of 
tumours detected during MRI screening, at the MRI performed one year before 
the diagnosis can be detected 3-6 millimetre neoangiogenetic foci, early sign of 
cancer not visible with the other imaging modality. 
Conclusion: In high-risk women, MRI showed a higher sensibility than 
mammography and ultrasound, confirming as the more efficient screening 
method. Repeated annually, MRI offers the advantage of comparing with 
previous exams from which you can detect the appearance of small 
enhancement foci that may be an early sign of tumour and, therefore, must be 
considered suspicious.  
B-1612 15:04  
Single-centre experience with breast MRI maximum intensity projection 
(MIP) views: sensitivity, specificity and accuracy of the stand-alone 
evaluation  
M. Orsi, M. Cellina, C. Floridi, F. Leone, E. Battaglia, F. Barmettler, G. Oliva; 
Milan/IT (marcello.orsi@asst-fbf-sacco.it)  
Purpose: Breast MRI has been proposed as a reliable screening tool for 
young high-risk patients for breast cancer. MIP reconstruction is a simple, 
reproducible and comparable view. The aim of our study was to test MIP views 
as a stand-alone tool for the detection of suspicious findings. 
Methods and Materials: From September 2013 to February 2017, 159 
consecutive breast MRI scans, performed in a single centre with a 1.5 Tesla 
scanner, were retrospectively evaluated by an expert radiologist that analysed 
the MIP coronal and axial views to assess the presence of suspicious findings 
(SF+ or SF-). The diagnostic accuracy of the MIP views was tested taking as 
gold standard of the complete radiologic evaluation (breast MRI, US and 
mammography), considering BI-RADS 1-2 as true negative and BI-RADS 3-5 
as true positive. 
Results: We analysed 159 breast MRI scans performed in women of a median 
age of 51(+/-24) years. 11 exams were excluded from the study for motion 
artefacts. In 89/148 MIP evaluation result was SF+; in 59/148 SF-. MIP 
evaluation showed sensitivity and specificity of 90.5% and 94.3%, respectively, 
and accuracy of 0.92. False-negative results were 9: 4 BI-RADS3, 2 BI-RADS4 
and 3 BI-RADS5; mean diameter of non-depicted lesions was 8mm (+/-4mm). 
  






Conclusion: MIP reconstruction view showed high sensitivity and specificity in 
assessing the presence of suspicious findings. Single image comparison with 
previous analogues helps the readers to notice the appearance or growing of 
the suspicious findings in the screening setting.  
B-1613 15:12  
Assessment of background parenchymal enhancement on breast MRI: 
which sequence shows the best agreement?  
B. Bignotti1, M. Calabrese1, S. Tosto1, F. Valdora1, M. Durando2, 
A. Tagliafico1,1, G. Mariscotti2; 1Genoa/IT, 2Turin/IT (bignottibianca@gmail.com)  
Purpose: To evaluate inter- and intrareader agreement among different 
sequences for assessment of background parenchymal enhancement (BPE) 
on breast MRI. 
Methods and Materials: Two independent readers qualitatively categorized 
BPE on ninety-eight breast MRI using a four-point scale (minimal, mild, 
moderate or marked) in accordance with the BI-RADS category system. 
According to MR sequence used for the assessment of BPE categorization, 
interreader and intrareader agreement across four reading strategies were 
performed: (1) initial contrast-enhanced fat-suppressed T1-weighted; (2) initial 
contrast-enhanced subtracted images; (3) MIP images; (4) combination of the 
initial contrast-enhanced fat-suppressed T1-weighted, initial contrast-enhanced 
subtracted and MIP images. Readers repeated BPE assessment of twenty-
eight breast MRI four weeks after the initial assessment. K statistics was used 
to calculate the agreement. 
Results: Interreader agreement was moderate (k=0.44) using initial contrast-
enhanced fat-suppressed T1-weighted, substantial (k=0.69) using initial 
contrast-enhanced subtracted images, substantial (k=0.67) using MIP images, 
substantial (k=0.71) using a combination of the initial contrast-enhanced fat-
suppressed T1-weighted, initial contrast-enhanced subtracted and MIP 
images. Mean intra-reader agreement among the two readers was moderate 
(k=0.55) using a combination of contrast-enhanced fat-suppressed T1-
weighted, initial contrast-enhanced subtracted and MIP images. 
Conclusion: Overall, the combination of the initial contrast-enhanced fat-
suppressed T1-weighted, initial contrast-enhanced subtracted and MIP images 
showed the highest inter- and intrareader agreement.  
B-1614 15:20  
Background parenchymal enhancement in MRI, mammographic density 
and risk of breast cancer  
F. Amato1, A. Orlando1, M. Di Vittorio1, M. Safina2, T.V. Bartolotta1, R. Ienzi1; 
1
Palermo/IT, 2Castellammare del Golfo/IT (amaciccio89@gmail.com)  
Purpose: Evaluate the relationship between "background parenchymal 
enhancement" (BPE) on magnetic resonance imaging (MRI), mammographic 
density (MD) and breast cancer (BC). 
Methods and Materials: According to BIRADS, two radiologists have 
classified BPE on MRI (minimal/mild/moderate/marked) and mammographic 
density (A/B/C/D) of 231 patients (age: 29-91 aa)underwent MR and 
Mammography examination. Patients with (111/231; 48 %) and without 
(120/231 ; 52 % ) family history of BC were included, and patients with BRCA 
positivity were excluded. Patients were divided into four groups: Group I:BPE 
minimal/mild and DM A-B; Group II:BPE minimal/mild and DM C-D; Group 
III:BPE moderate/marked and DM A-B; Group IV:BPE moderate/marked DM 
and C-D.Using the chi-square test was calculated the Relative Risk (RR) of BC 
in the various groups. 
Results: 75/231 (32,5%) patients were in Group I, 131/231 (56,7%) in the 
second, 11/231 (4,8%) in the third and 14/231 (6,1%) in the fourth. Diagnosis 
of BC was made in 35/75 (46,7% %) of cases in group I, in 60/131 (45,8%) in 
Group II, in 8/11 (72,7%) in Group III and in 5/14 (35,7%) in group IV. 
Prevalence of BC was significantly greater among the patients of group III, who 
had a moderate/marked BPE and DM Grade A-B (p = 0.0181; RR = 1.60; 95% 
CI: 1.08-2.36 ), regardless of familiarity and age. 
Conclusion: The degree of BPE isn’t directly related to the degree of 
mammographic density or to the relative risk of BC. The association between 
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B-1615 14:00  
Detection of osteitis at the sacroiliac joint in patients with chronic low 
back pain by STIR and T2-weighted fat-suppressed turbo spin echo 
sequences: results from the SIMACT study  
J. Greese, T. Diekhoff, J. Sieper, C. Schwenke, M.R. Makowski,                     
D. Poddubnyy, B. Hamm, K.-G. Hermann; Berlin/DE 
(juliane.greese@charite.de)  
Purpose: To compare short tau inversion recovery (STIR) and T2-weighted 
fat-suppressed turbo spin echo (T2-FS) sequences to detect osteitis lesions at 
sacroiliac joints (SIJ) in patients with chronic low back pain (CLBP). 
Methods and Materials: This prospective study included 110 patients with 
CLBP and suspicion of spondyloarthritis and 18 healthy volunteers. All 128 
participants (age range 19 to 57 years) underwent 3.0 Tesla MRI of the SIJ 
including STIR and T2-FS. Two readers independently evaluated osteitis in 
STIR and T2-FS in separate scoring sessions. Sum score values, signal-to-
noise (SNR) and contrast-to-noise (CNR) ratios were calculated. Images were 
further analysed whether they fulfilled the Assessment of SpondyloArthritis 
international Society (ASAS) criterion of a “positive MRI” (MRI+). Inter-reader 
agreement was calculated by intra-class correlation coefficients (ICC). 
Results: Overall, sum score values for osteitis lesions were significantly higher 
(p=0.02) for T2-FS (reader 1: 3.90±5.67; reader 2: 7.10±8.69) compared to 
STIR (reader 1: 2.55±4.41; reader 2: 3.95±5.79). Mean SNR was measured 
16.54 for STIR and 37.30 for T2-FS (p=0.03). Likewise, mean CNR was 4.14 
for STIR and 20.20 for T2-FS (p=0.02). ASAS MRI+ definition was significantly 
more often fulfilled for T2-FS compared to STIR (p=0.0003) by both readers. 
Inter-reader ICC values were very good both for STIR (0.91) and T2-FS (0.86). 
Conclusion: T2-FS sequences detect more MRI+ patients with superior image 
quality in cohorts with CLBP compared to STIR. Therefore, we recommend T2-
FS as addition to STIR for MRI protocols of the SIJ.  
B-1616 14:08  
T2-mapping of the sacroiliac joints at 1.5T: a reproducibility study  
D. Albano1, V. Chianca2, M. Galia1, R. Cuocolo2, R. Bignone1, C. Messina3, 
L.M. Sconfienza3, A. Brunetti2, R. Lagalla1; 1Palermo/IT, 2Naples/IT, 3Milan/IT 
(vitochianca@gmail.com)  
Purpose: T2-mapping of the sacroiliac joints has shown to be feasible at 3T, 
but feasibility at 1.5T has never been tested. We evaluated the reproducibility 
of T2 relaxation time measurements of the sacroiliac joints at 1.5T. 
Methods and Materials: Healthy volunteers underwent an oblique axial 
multislice multiecho spin-echo T2-weighted sequence of the sacroiliac joints at 
1.5 T. The regions of interest were manually drawn with Olea Sphere® 3.0 
software (Olea Medical®, La Ciotat, France) by two musculoskeletal 
radiologists to include the cartilaginous part of the sacroiliac joints. Intra- and 
inter-observer reproducibility was tested using the Bland-Altman method. 
Association between sex and T2 relaxation times was tested using the Mann-
Whitney U test. Correlation between T2 relaxation times and body mass index 
(BMI) was tested using the Spearman's rho. 
Results: Eighty sacroiliac joints of 40 subjects (mean age: 28±4.8 years, 
range: 20-43; mean BMI: 23.3±3.1, range: 18.9-30) were imaged. The mean 
T2 value calculated by the senior radiologist in the first series of measurements 
was 42±4.4ms, whereas in the second series was 40.7±4.5ms. The mean T2 
value obtained by the radiology resident was 41.1±4.2ms. Intra-observer 
reproducibility was 88% (coefficient of repeatability=3.8; bias=1.28; p<0.001), 
while inter-observer reproducibility was 86% (4.7; -0.88; p<0.001). There was 
significant association between sex and T2 relaxation times (p=0.024) and 
significant inverse correlation between T2 relaxation times and BMI (r=-.340, 
p=0.002). 
Conclusion: The assessment of T2 relaxation time measurements of 
sacroiliac joints seems reproducible to be performed at 1.5T. Further studies 














B-1617 14:16  
MRI findings of sacroiliac joint disorders in SAPHO syndrome  
X. Shao, W. Xu, C. Li, X. Zhao, W. Zhang; Beijing/CN (sxl669594@sina.com)  
Purpose: To retrospectively evaluate the MRI features of sacroiliac joint 
disorders in 38 SAPHO patients, thus increasing the awareness of SAPHO 
syndrome among clinicians. 
Methods and Materials: 38 SAPHO patients (female: male, 26:12; mean±SD 
age, 46.3±10.1 years) were enrolled. The frequency of sacroiliac joint disorders 
was calculated and MRI features were evaluated. 
Results: 23 patients (41 joints) were involved, with a frequency of 
60.5%(23/38). 52.2% (12/23) of these patients were bilaterally involved. 
Among the involved 41 joints, lesions distributed with a predilection on the 
sacrum in 58.5% (24/41). 87.8% (36/41) of the involved sacroiliac joints were 
affected by the cartilaginous portion, and 90.2%(37/41) by the ligamentous 
portion. Inflammatory changes including bone marrow oedema, capsulitis, 
effusion and enthesitis were observed in 80.5% (33/41), 29.3%(12/41), 
24.4%(10/41) and 80.5%(33/41) of the involved sacroiliac joints, respectively. 
While chronic changes including post-inflammatory fatty deposition, erosion 
and sclerosis were observed in 92.7% (38/41), 70.7% (29/41) and 70.7% 
(29/41) of the involved sacroiliac joints, respectively. Joint space was widened 
in 19.5% (8/41) joints, narrowed in 17.1% (7/41) and ankylosis in 14.6% (6/41). 
Soft tissue involvement was observed in 14.6% (6/41) of the involved sacroiliac 
joints. 
Conclusion: Sacroiliac joints were more bilaterally involved in SAPHO 
patients, with predilection on the sacrum. Active lesions and chronic lesions 
usually coexist, with a lower prevalence of ankylosing and soft tissue 
involvement. These MRI features could provide certain information of SAPHO 
syndrome. Consultation of skin lesions should be taken into consideration for a 
comprehensive evaluation and definite diagnosis.  
B-1618 14:24  
Sacroiliitis due to early ankylosing spondylitis, inflammatory bowel 
disease and Behçet's disease: could sacroiliac MRI play a role in 
differentiation?  
Z. Akkaya, E. Peker, F.S. Ozalp Ates, G. Sahin; Ankara/TR 
(zehraakkaya@gmail.com)  
Purpose: The purpose of this study was to investigate whether sacroiliitis due 
to early ankylosing spondylitis (AS), inflammatory bowel disease (IBD)-related 
spondyloarthropathy and Behçet's disease (BD) were distinguishable by MRI. 
Methods and Materials: Sacroiliac MR images of 88 patients (52 with AS, 17 
with BD, 12 with Crohn's disease (CD) and 7 with ulcerative colitis (UC) 
including 65 females and 23 males (mean age: 41.8 ±11.3) were 
retrospectively evaluated by two radiologists who were blind to the diagnoses. 
The evaluation parameters consisted of soft tissue-related changes (thickness 
of perirectal fat, presence of perirectal lymph node or submucosal fatty 
infiltration) and sacroiliac joint changes (joint surface irregularities-erosions, 
bone marrow edema, subchondral sclerosis-fatty change and laterality of 
involvement). Statistical analyses were performed to search for distinguishing 
parameters between the AS and IBD-Behçet’s disease combined group. 
Additionally, the findings for the Behçet's disease group were compared to 
those of the IBD group. 
Results: Marrow edema, chronic subchondral marrow changes, surface 
irregularities-erosions and bilateral involvement of the sacroiliac joints were 
significantly more common in the AS group (p< 0.05). No statistically significant 
results were found for either parameter between the IBD and Behçet's disease 
groups. 
Conclusion: Both active and chronic joint changes were more pronounced in 
the AS group. Behçet's disease is a multisystem disorder but not an IBD-
associated spondyloarthropathy. However, the analyzed Behçet’s disease 
group displayed bowel and joint changes similar to those of the IBD group.  
B-1619 14:32  
Osteitis distribution on MRI of the sacroiliac joints in patients with 
osteitis condensans compared to axial spondyloarthritis  
K.-G. Hermann1, S. Mercan1, K. Ziegeler1, T. Diekhoff1, J. Greese1, B. Hamm1, 
M. Bollow2; 1Berlin/DE, 2Bochum/DE (kghermann@gmail.com)  
Purpose: Osteitis condensans (OC) is a non-inflammatory disorder affecting 
the sacroiliac joints (SIJ) and is attributed mainly to mechanical stress, such as 
pregnancy and delivery or frequent sports activities. In later stages, it can be 
readily diagnosed on conventional X-rays. However, frequently MRI is the sole 
imaging modality and confusion exists whether the distribution and frequency 
of MRI findings. 
Methods and Materials: 119 MRI examinations of the SIJ from a single center 
specialized in MSK imaging were retrospectively analyzed independently by 
two experienced readers. Clinical data was collected prior to MRI acquisition 
via standardized patient questionnaires. A third reader (senior MSK expert) 
made a decision between either OC or SpA as the leading diagnosis, taking all 
available imaging data and clinical data into account. Scoring of osteitis was 
done in a quadrantic scheme and in addition, the predominant site of findings 
in the anterior-posterior orientation was recorded (anterior, middle, and 
posterior positions). 
Results: 71 patients with OC and 48 with SpA were identified. Osteitis was 
evident in 73% and 79% of patients, respectively, with mean osteitis sum 
scores of 1.75±2.55 and 4.13±4.62 (p<0.001). While the distribution of osteitis 
was in the anterior position in 94% of OC patients only 38% of SpA patients 
demonstrated osteitis in the anterior position and 52% in the middle position. 
Conclusion: Different osteitis distribution patterns can be identified to 
distinguish OC and SpA at SIJ, with OC demonstrating the lesser amount of 
osteitis compared to SpA, but most frequently located in the anterior inferior 
position.  
B-1620 14:40  
Relative maximum apparent diffusion coefficient: a potential biomarker of 
disease activity in axial spondyloarthritis  
K. Lee, W. Lau, H. Tsang, C. Lau, H. Chung; Hong Kong/HK 
(viclkh88@gmail.com)  
Purpose: To evaluate the correlation between diffusion-weighted imaging 
(DWI)-derived parameters of disco-vertebral lesions and clinical parameters in 
axial spondyloarthritis (SpA). 
Methods and Materials: Two hundred and seventy-five patients with expert 
diagnosed axial SpA were recruited from 3 rheumatology centres. Clinical, 
biochemical and radiological parameters were collected. All patients underwent 
whole spine and sacroiliac (SI) joints MRI using short tau inversion recovery 
(STIR) sequence and diffusion weighted imaging (DWI). The presence of 
disco-vertebral lesions was defined by positive identification by two 
independent readers. Apparent diffusion coefficients (ADC) of disco-vertebral 
lesions and normal marrow were measured for determination of relative mean 
ADC (rADCmean) and relative maximum ADC (rADCmax) of the disco-vertebral 
lesions. These were then compared with clinical parameters using Spearman 
and Pearson correlation coefficients. 
Results: Twenty-six (9.5%) patients had disco-vertebral lesions. Forty-two (23 
thoracic, 17 lumbar) lesions were identified. Inter-observer agreement was 
excellent (kappa = 0.895). rADCmax correlated positively with intensity of back 
pain (CC=0.46; p=0.02), morning stiffness (CC=0.47; p=0.02), duration of 
stiffness (CC=0.44; p=0.03), and stiffness score (CC=0.49; p=0.01). No 
significant correlations were found between the number of lesions, ADCmean, 
rADCmean, CRP, ESR, and BASDAI score. There were no significant differences 
in the BASDAI score, CRP, and ESR in patients with or without disco-vertebral 
lesions. 
Conclusion: In axial SpA, rADCmax of disco-vertebral lesions correlates 
significantly with degree of back pain and intensity of morning stiffness. This 
parameter could be a potential imaging biomarker.  
B-1621 14:48  
Examination of association of inflammatory activity in psoriatic arthritis 
and vascular calcification metabolism based on integrated 18F PET/MRI  
N. Guberina, A. Körber, M. Forsting, L. Umutlu, A. Bockisch, K. Herrmann, 
T.D. Poeppel; Essen/DE  
Purpose: To examine the association between vascular calcification 
metabolism and musculoskeletal manifestations in patients with active psoriatic 
arthritis. 
Methods and Materials: In a prospective clinical trial 21 patients with psoriatic 
arthritis were included in the study. Participants were examined according to a 
standardized whole-body protocol on the PET/MRI-scanner 
MagnetomBiograph_mMR (Siemens Healthcare, Germany) within a single 
session. Joint inflammation based on 18F-NaF PET/MRI images was assessed 
according to 8 different variables (SUVmax, tenosynovitis, bone and soft tissue 
oedema, bone erosions, joint-space narrowing, joint-subluxation, and 
interphalangeal ankylosis). Vascular calcification metabolism was evaluated 
based on 18F-NaF-PET/MRI images in terms of 18F-NaF-uptake in large (aorta 
ascendens, aortic arch, thoracal and abdominal aorta descendens) and 
medium vessels (supraaortic arteries, a. mesenterica superior, iliac arteries, a. 
femoralis superficialis). SUVmax was normalized for the mediastinal blood pool. 
Furthermore, association with laboratory parameters (CRP, CCP, leukocytes, 
rheuma factor, triglycerides and cholesterol) was examined. 
Results: A total of 21 subjects (71.4% men, 28.6% women, age range 23-77 
years) were evaluated. Vascular calcification metabolism of large and medium 
vessels showed a significant positive correlation with changes observed in 
advanced stage of psoriatic joint manifestation (p<0.05). Moreover, arthritic 
changes were not associated and showed no correlation with laboratory 
markers of inflammation (p>0.05). 
Conclusion: The severity of psoriatic joint manifestations in advanced stage of 
psoriatic arthritis does significantly correlate with vascular calcification 
metabolism. Patients with psoriatic arthritis with clinical mild arthritic changes 
may present severe atherosclerotic changes. Both psoriatic changes and 
vascular inflammation may precede the actual onset of clinical symptoms.  
 
  






B-1622 14:56  
Subclinical psoriatic arthritis detection in patients with psoriatic 
onychopathy  
V. Linovs, M. Radzina, T. Linova, A. Rubins, S. Rubins; Riga/LV 
(dr.viktors.linovs@gmail.com)  
Purpose: Find correlation between psoriatic onychopathy and subclinical 
enthesitis. 
Methods and Materials: The prospective study included 97 patients: 25 
patients with nail psoriasis (clinically confirmed) with no history of previous 
rheumatological disease, 47 patients with psoriasis without onychopathy with 
no history of previous rheumatological disease and 25 control cases (healthy 
individuals). Clinical evaluation and ultrasonographic assessment was 
performed in 12 entheses and 8 nails in each patient by a dermatologist and a 
radiologist (ultrasonographic assessment using modified Madrid Sonographic 
Enthesis Index (MASEI) protocol). Inflammatory activity in enthesis (active 
enthesitis) was defined as the presence of power Doppler signal, tendon 
thickening and/or hypoechogenicity. 
Results: There was correlation between enthesitis and psoriatic nail 
involvement (p<0.05), as well as correlation between psoriasis and enthesitis 
(p<0.05). No correlation between clinical evaluation of the enthesis and 
enthesitis was observed (p>0.05). Nail matrix thickness was significantly 
increased in patients with nail disease (1.89 mm vs. 1.75 mm; p<0.05). The 
loss of the trilaminar nail plate appearance and increased Power Doppler 
signal in the matrix were also significantly associated with nail psoriasis (p< 
0.05). There is correlation between clinical evaluation of the nail and 
ultrasound findings in the nail organ (p<0.05). No pathological findings were 
seen in control group. 
Conclusion: Ultrasound could be a valuable diagnostic tool for detection of 
subclinical enthesitis in patients with psoriatic onychopathy, which is proved to 
be predisposing factor of psoriatic arthritis. Ultrasound screening in psoriatic 
onychopathy patients may be considered as early stratification method for 
early treatment initiation.  
B-1623 15:04  
Hypodermal adipose tissue sonoelastography for monitoring different 
treatment responses in patients with plaque psoriasis  
M. Guazzaroni, S. Altobelli, S. Marsico, A.U. Cavallo, A. Bozzi, R. Floris; 
Rome/IT (salvatore.marsico@hotmail.it)  
Purpose: To evaluate hypodermal adipose tissue inflammation underneath 
psoriasis plaques quantifying tissue elasticity with sonoelastography before 
and after treatment with topic therapy, systemic therapy or with biologic drugs. 
Methods and Materials: From September 2015 to September 2017, we 
enrolled 120 patients with plaque psoriasis with a mean age of 51 years (range 
18-80) (38F, 22M) with plaque psoriasis and a PASI score of >5. They were 
divided into 3 groups of treatment depending on the prescribed drug: topic 
therapy (Group A), systemic therapy with DMARDS (Group B) and biologic 
drugs therapy (Group C). A baseline (T0) ultrasound examination with 
sonoelastography was performed before the beginning of drugs assumption. At 
this time the mean strain ratio was recorded on normal and pathologic skin. A 
follow-up clinical and ultrasonographic examination (T1) was performed after 
one month of treatment to evaluate therapy response. 
Results: At T0 lesional mean strain ratio was significantly higher than non-
lesional one, thus documenting an high grade of stiffness of the hypodermal fat 
underneath psoriasis evaluated plaques. T1 examination data obtained from 
the 3 selected groups of patients documented a significant decrease in 
stiffness when comparing groups B and C together with groups A and group C 
with both groups A and B. Mean strain ratio decrease correlated with clinical 
PASI improvement in all the responder patients in the considered groups. 
Conclusion: Sonoelastography is able to identify hypodermal adipose tissue 
involvement in plaque psoriasis and it represents a valid method to assess 
early therapy response.  
B-1625 15:12  
Correlation between central adiposity distribution measured by DXA and 
inflammatory markers in the Italian cohort of the NU-AGE project  
D. Mercatelli1, A. Santoro1, G. Guidarelli1, M. Aparisi Gomez2, G. Guglielmi3, 
C. Franceschi1, G. Battista1, A. Bazzocchi1; 1Bologna/IT, 2Valencia/ES, 
3
Andria/IT (abazzo@inwind.it)  
Purpose: Adipose tissue is a source of hormones and cytokines, in particular 
visceral adipose tissue(VAT) and subcutaneous adipose tissue(SAT) have 
been linked to systemic inflammation.Both modifications in body 
composition(BC) and a low-grade chronic inflammation characterise human 
ageing.This study evaluates the changes of fat distribution, measured by dual-
energy X-ray absorptiometry(DXA), and the correlation with some inflammatory 
markers in a group of Italian elderly people that increased BMI but reduced fat 
and vice-versa after one-year. 
Methods and Materials: 271 sex-balanced volunteers free of major overt 
diseases, aged 65-79 years, were enrolled in the Italian cohort of the NU-AGE 
study, a one year randomised, single-blind, controlled trial with two parallel 
groups (control vs. diet).Whole-body DXA scans to assess BC, and blood 
samples were taken at T0 and T1. Comparison of variables was performed 
using Wilcoxon rank-sum test. 
Results: In 42 patients showing reduction of SAT but increase or no change in 
BMI, significantly lower levels of pro-inflammatory cytokines leptin(p=0.02801) 
and TGF-(p=0.04676) were found, compared to 28 patients who gained SAT 
with no changes or reduced BMI. In 47 patients showing a reduction of VAT 
but an increase or no changes in BMI, significantly lower levels of leptin 
(p=0.02736) were found compared to 23 patients who gained VAT but reduced 
their BMI. 
Conclusion: DXA scans are useful to monitor BC changes over time, 
especially in patients where changes in BMIdo not reflect changes in central 
adiposity distribution.Both VAT and SAT reduction were positively correlated 
with a decreased inflammatory status, despite an increase or no change in 
BMI.  
14:00 - 15:30 Room G  
Breast  
SS 1902b  
AI and CAD in breast imaging  
Moderators:  
J. van Zelst; Nijmegen/NL 
S.J. Vinnicombe; Dundee/UK 
B-1627 14:00  
Determination of breast parenchymal enhancement (BPE) in breast MRI 
using a deep convolutional neural network  
N. Berger, C. Rossi, A. Ciritsis, M. Marcon, A.S. Becker, A. Boss; Zurich/CH 
(Nicole.Berger@usz.ch)  
Purpose: Breast parenchymal enhancement (BPE) is rated in each breast MRI 
in the categories minimal, mild, moderate and marked. If elevated, BPE may 
hamper the evaluation of the acquired images. The aim of this study was to 
train a deep convolutional neural network (dCNN) for automatic classification of 
BPE according to the American College of Radiology Breast Imaging Reporting 
and Data System (ACR BI-RADS) Atlas. 
Methods and Materials: In this IRB-approved retrospective study, breast-MRI 
data (1200 images) from 106 different patients were downloaded from the 
picture archiving and communications system (PACS) and labelled by a board 
certified radiologist according to the enhancement category. A dCNN with 13 
convolutional layers followed by 4 dense layers and one fully connected layer 
implemented in Keras 2.08 was trained with 70% of the data, whereas 30% 
were used for validation. Minimal, mild and moderate BPE were compared in a 
one-vs-one fashion computing the probability for the suitability of each 
category. The classification was determined from the highest probability. 
Results: Validation accuracy for BPE category minimal vs. mild was 0.63 and 
minimal vs. moderate was 0.69. 
Conclusion: Even with limited training data, dCNN shows promising results for 
distinguishing the first three categories of the BPE in breast-MRI based on the 
ACR BI-RADS system. The proposed technique may in future be useful for 
accurate, standardized, and observer-independent BPE rating.  
B-1628 14:08  
Can the breast cancer screening case-load be reduced by deep-learning 
based identification of normal cases? An international multi-centre 
retrospective analysis  
A. Rodriguez Ruiz1, A. Gubern-Mérida1, G. Gennaro2, M. Chevalier3, 
S. Zackrisson4, I. Andersson4, I. Sechopoulos1, R.M. Mann1; 1Nijmegen/NL, 
2
Padua/IT, 3Madrid/ES, 4Malmö/SE (alejandrorzrz@gmail.com)  
Purpose: To study the feasibility of reducing the screening case load by 
automatically identifying digital mammography (DM) exams without 
abnormalities. 
Methods and Materials: Three datasets used in previously published multi-
reader studies, performed across four countries and using systems from three 
vendors, were collected. Each dataset consisted of DM exams, radiologists’ BI-
RADS© scores and ground truth, yielding 1122 exams (257 malignant) 
interpreted by 15 readers. A deep learning based computer system (Transpara 
1.3.0, ScreenPoint Medical) automatically analyzed each exam, providing a 
cancer suspiciousness score (1-10). For each dataset, a modified set was 
created in which pre-selection was simulated by setting the radiologists’ scores 
to BI-RADS 1 for all cases with cancer suspiciousness score 5. The area 
under the reader-averaged receiver operating characteristic curve (AUC) was 
calculated for the original and modified sets, and compared using 
bootstrapping. 
  






Results: After pre-selection, we observed only non-significant AUC changes; a 
slight increase in two sets: 0.785 (95% CI: 0.671-0.865) to 0.807 (0.696-0.887) 
[P=0.095], and 0.870 (0.819-0.912) to 0.883 (0.836-0.921) [P=0.197]; and a 
slight decrease in one: 0.821 (0.752-0.877) to 0.804 (0.723-0.871) [P=0.473]. 
Averaging among readers on each dataset, 27%, 20%, 8% of false positives 
were excluded; and 1%, 1%, 5% of true positives. Across datasets, pre-
selection discarded 44%, 40%, 51% of non-malignant cases and 8%, 6%, 17% 
of malignant cases. 
Conclusion: Automated identification of mammograms that are most likely 
normal, and therefore might not need to be read, is feasible without 
significantly affecting the reading performance. This may nearly halve the 
workload for screening radiologists.  
Author Disclosures: 
 A. Gubern-Mérida: Employee; Screenpoint Medical BV.  R.M. Mann: 
Consultant; Screenpoint Medical. 
B-1629 14:16  
A novel open-access neural network to evaluate suspicious mass lesions 
detected in breast MRI for direct integration into clinical workflows  
S. Ellmann, E. Wenkel, M. Hammon, R. Janka, P.A. Fasching, 
R. Schulz-Wendtland, A. Maier, M. Uder, T. Bäuerle; Erlangen/DE 
(stephan.ellmann@uk-erlangen.de)  
Purpose: To develop a novel machine learning algorithm for classification of 
suspicious mass lesions detected in breast MRI that can be readily integrated 
into clinical workflows and is based on objective image features only. 
Methods and Materials: This retrospective study included 176 BIRADS 4 and 
5 mass lesions in breast MRI with available histopathology as gold standard. 
138 lesions were used to train a neural network for classification (benign vs 
malignant) using different objective parameters (lesion diameter, diffusion 
restriction, T2w-fs signal intensity, patient age, dynamic contrast enhancement 
curve type and washout ratio and number of lesions in the affected breast). 38 
lesions were randomly selected and retained as a test set. Receiver operating 
characteristic analyses were used to determine the predictive abilities of the 
single predictors, and compared to the diagnostic accuracy of the neural 
network with McNemar tests. The neural network was made available as an 
open-access internet application using Shiny for R. 
Results: The neural network achieved a sensitivity of 90.1% (95% CI 87.8-
92.4) and a specificity of 82.6% (78.8-86.4) during training and validation, 
featuring significantly higher diagnostic accuracy compared to all single 
parameters alone (p < .0001). Regarding the test set lesions, sensitivity and 
specificity of the neural network were within the 95% confidence intervals 
(92.0% and 84.6%, respectively). 
Conclusion: Here we present a machine learning algorithm for evaluation of 
suspicious mass lesions in breast MRI based on objective parameters that can 
only be directly applied in clinical workflows using an open-access online form.  
B-1630 14:24  
Advancements in computer-aided BI-RADS US characterisation of focal 
breast lesions: clinical assessment of a new software release of S-Detect  
M.L. Di Vittorio, A. Orlando, F. Amato, L. Spatafora, M. Safina, A. Taibbi, 
F. Ienzi, R. Ienzi, T.V. Bartolotta; Palermo/IT (marialaura.divittorio@gmail.com)  
Purpose: To compare version 2.0 (V2) to 1.0 (V1) of a computer-guided 
decision-making software (S-Detect) in the sonographic characterisation of 
focal breast lesions (FBLs). 
Methods and Materials: 73 FBLs (mean size 15.9 mm) in 73 women detected 
by high frequency US (RS80A with Prestige, Samsung, Seoul) were 
retrospectively assessed by five independent reviewers with different years of 
experience (YOE) in breast sonography: one experienced radiologist (ER, >20 
YOE), two general radiologists (GR#1 and GR#2, 5-10 YOE) and two radiology 
residents (RR#1 and RR#2). FBLs were randomly evaluated twice according to 
BI-RADS US lexicon with V1 and V2. US-guided core-biopsy was the standard 
of reference for BI-RADS category 4 or 5 FBLs. US follow-up at 6 and 12 
months has been available for BI-RADS 3 category lesions both before and 
after S-detect assessment. 
Results: 33/73 were malignant and 40/73 were benignant. Diagnostic 
accurancy, sensitivity, specificity values for the ER were 0.90, 1.00, 0.83 with 
V1 and 0.89, 1.00, 0.80 with V2 (p>0.05). Corresponding values were: 0.71, 
0.83, 0.64 with V1 and 0.71, 0.79, 0.65 with V2 (p>0.05) for GR#1; 0.74, 0.76, 
0.72 with V1 and 0.74, 0.76, 0.72 with V2 (p>0.05) for GR#2; 0.70, 0.95, 0.60 
with V1 and 0.75, 0.87, 0.67 with V2 (p>0.05) for RR#1; 0.67, 0.77, 0.60 with 
V1 and 0.73, 0.76, 0.69 with V2 (p=0.009) for RR#2. 
Conclusion: S-Detect V2 showed a better performance than V1 in lesion 
boundary segmentation, offering a more accurate tool for decision-making in 





B-1632 14:34  
Selection of parameters for computer model of breast anatomy through 
human observer experiments  
D. Pokrajac1, Z. Radovanovic2,2, T. Milosavljevic2, V. Stokanovic2, 
S. Weinstein3, A. Imran Al-Zubaer1, A.D.A. Maidment3, P.R. Bakic3; 
1
Dover, DE/US, 2Niš/RS, 3Philadelphia, PA/US (dpokrajac@desu.edu)  
Purpose: Human observers have evaluated the influence of software breast 
phantom parameters on the realism of synthetic mammography and 
tomosynthesis images. 
Methods and Materials: Previously, we developed a recursive partitioning 
algorithm to simulate breast anatomy. The simulation parameters were 
selected using a volumetric analysis of reconstructed CT images of a 
mastectomy specimen. To validate selected parameters, we performed an 
observer study with clinical radiologists. Mammography and reconstructed 
tomosynthesis images of phantoms with various simulation parameters were 
synthesised, and used in 2-alternative forced choice experiments. The varied 
parameters included the number of simulated tissue compartments and the 
relative size and shape of compartments. In a preliminary study, we presented 
16 synthetic image pairs (8 mammographic and 8 tomosynthesis) to a clinical 
radiologist. The observer was asked to indicate a more realistic image in each 
pair. We compared the observers' preference with parameters selected from 
the mastectomy specimen images. 
Results: In the preliminary study, consistently for both mammography and 
tomosynthesis images, the observer preferred images of phantoms with the 
larger number of compartments, and with a wider variation in the compartment 
shape and size. While the number of compartments may be relatively easy to 
notice, the visual difference in parenchymal pattern due to the range of speed 
parameters is more subtle. 
Conclusion: Our preliminary study supported the anatomy simulation 
parameters selected from the analysis of mastectomy specimen CT images. A 
full observer study with two additional radiologists and a larger image set is 
ongoing.  
B-1633 14:40  
S-detect as a teaching tool in the characterisation of breast lesions: a 
preliminary study  
M. Di Segni, V. De Soccio, G. Bonito, A. Rubini, V. Magri, V. Cantisani, 
C. De Felice, F. D'Ambrosio, C. Catalano, G. Alagna; Rome/IT 
(gralagna@gmail.com)  
Purpose: To assess the value of S-detect as a teaching tool in the 
characterisation of breast lesions. 
Methods and Materials: One hundred twenty two female patients, aged 21 to 
84 years, with 135 breast lesions were prospectively imaged with baseline US 
by a 32 years experienced radiologist and analysed with S-detect; 4 residents 
with different experience in breast imaging, blinded to clinical and pathological 
results, completed the exam with elastography. Then, the residents 
retrospectively described and categorised lesions according to BIRADS 2013 
lexicon and to the scheme proposed by Jales et al. When lesions were 
categorised as BIRADS 4a by the residents, their readings were compared to 
the readings of S-detect and in case of disagreement, priority was given to S-
detect (Samsung Healthcare, Seoul, South Korea). Diagnostic performance 
was analysed with 2x2 contingency tables and differences were assessed with 
Pearson’s ² test. 
Results: Residents’ sensitivity values varied from 95.5% to 100%, whereas 
specificity values varied from 54.2% to 70.8%; S-detect showed 91.1% 
sensitivity and 70.8% specificity. In case of BIRADS 4a lesions, using S-detect 
for 2 of the residents significantly increased from 54 to 75% and from 50% to 
75%, whereas it was not significant for the most experienced one (from 70.8% 
to 75%, p<0.005) and for the remaining resident with weak performance 
(p>0.05). 
Conclusion: S-detect has a potential as a teaching tool for the less 
experienced operators.  
Author Disclosures: 
 V. Cantisani: Speaker; Bracco, Toshiba Medical Systems, Samsung 
Healthcare.  
B-1636 14:48  
Evaluation of a CAD (computer-aided detection)-enhanced 2D synthetic 
mammogram: comparison with a standard synthetic 2D mammogram and 
conventional 2D digital mammography  
J. James1, E. Giannotti1, Y. Chen2; 1Nottingham/UK, 2Loughborough/UK 
(jonathan.james@nuh.nhs.uk)  
Purpose: CAD-enhanced mammograms utilise an algorithm identifying 
potential abnormalities on tomosynthesis slices blending them onto a synthetic 
image. The aim was to evaluate the diagnostic performance of CAD enhanced 
2D synthetic mammograms in comparison with standard 2D synthetic 
mammograms generated from a tomosynthesis data set and conventional 2D 
digital mammography. 
  






Methods and Materials: A CAD-enhanced synthetic 2D mammogram, a 
standard synthetic 2D mammogram and 2D digital mammogram were available 
in 68 breast screening recall cases. Two radiologists, blinded to image type 
and final assessment outcome, retrospectively read a single-side oblique and 
cranio-caudal projection for each of the three conditions. The resulting 204 
pairs of 2D images were presented in random order and scored on a 1-5 scale 
(1: normal to 5: malignant) without access to the DBT slices. ROC analysis was 
performed with area under the curve (AUC) compared using Hanley's two-
tailed test. 
Results: There were 34 biopsy-proven malignancies and 34 normal/benign 
cases. Diagnostic accuracy was significantly improved for the CAD enhanced 
synthetic mammogram compared to the standard synthetic mammogram 
(AUC=0.846 and AUC=0.683, respectively, p=0.004) and compared to the 
conventional 2D digital mammogram (AUC=0.724, p=0.027). For all 68 cases, 
there was an average of 3.2 areas enhanced per image. For the 34 cancer 
cases, 97.4% of lesions were correctly enhanced, with 2.1 false areas 
enhanced per image. 
Conclusion: CAD enhancement significantly improves performance of 
synthetic 2D mammograms and also exhibits improved diagnostic accuracy 
compared to conventional 2D digital mammography.  
14:00 - 15:30 Room K  
Radiographers  
SS 1914  
Professional issues in radiography  
Moderators:  
S.O. Schönberg; Mannheim/DE  
N.H. Woznitza; London/UK  
B-1637 14:00  
The impact of shift work on life, psychological and physical health of 
radiographers: a comparison between fixed and rotating shifts  
A.F.V. Cardoso1, A.F. Abrantes1, L.P. Ribeiro1, S. Rodrigues1, R.P. Almeida1,1, 
C.A. da Silva2; 1Faro/PT, 2Evora/PT (ana.fv.cardoso@hotmail.com)  
Purpose: Shift work is necessary to ensure continuity of care in healthcare 
facilities where radiographers play an increasingly key role in patient care and 
patient safety. The aim of this study was to analyse the influence of rotating 
shift work on social and domestic life and on the health of radiographers as 
compared to the fixed shift. 
Methods and Materials: This cross-sectional and correlational study was 
conducted in several public and private imaging departments using a 
combination of four instruments (Sleep Questionnaire, General Health 
Questionnaire, Physical Health Questionnaire and Scale of Social and 
Domestic life) consisting of 183 questions. A total sample of 102 radiographers 
was included and the questionnaires were interpreted and statistically analysed 
through descriptive statistics and correlation tests. 
Results: Using Mann-Whitney test it was observed statistically significant 
differences between fixed and rotating shifts regarding the psychological 
disorders, social and domestic life (p<0.05). The rotating shifts have a 
moderate influence on psychological disturbances (X=26,6; p=0,016) as well 
on the social and domestic life (X=9,5; p=0,005). Moderate sleep disturbances 
were found for both groups and no statistically significant differences were 
found regarding the sleep disturbances, gastrointestinal and cardiovascular 
disorders. 
Conclusion: Rotating shifts have consequences on the psychological health 
and social and domestic life of the radiographer. It is important to regulate and 
implement strategies to minimise biological, physical and social impact in the 
radiographer life to allow that these professionals keep working without 
significant health impairment.  
B-1638 14:08  
Patient perceptions of radiographer communication skills in general 
radiology  
L. Soares1, L.P. Ribeiro1, A.F. Abrantes1, A.M. Ribeiro1, K.B. Azevedo1, 
R.P. Almeida1, O. Lesyuk2, C.A. da Silva3; 1Faro/PT, 2São Brás de Alportel/PT, 
3
Evora/PT (oksanalesyuk@gmail.com)  
Purpose: The improvement of results in healthcare through the transmission of 
information to the patient within a relation of empathy and trust is already a 
verified hypothesis. Healthcare professionals should base themselves on 
interpersonal competences throughout their daily work routine, to promote 
quality in medical imaging, patient safety and technical excellence. The aim of 
this study was the exploration of patient’s perceptions regarding the 
performance of radiographer in terms of interpersonal communication skills 
during general radiology procedures. 
Methods and Materials: The instrument used was the questionnaire 
“communication Assessment Tool” (Makoul et al. 2007) adapted to the 
professional reality of the radiographers. A total of 225 valid questionnaires 
(including 14 questions with a five-point Likert scale) from patients aged 
between 24 to 85 years old. The paper-based instrument was delivered and 
filled by the patients after the performance of general radiology procedures in 
two public hospitals 
Results: The internal consistency of the questionnaire was excellent 
(Cronbach's alpha = 0.98). Highest ratings were for radiographer behaviour 
items, such as “greet the patients” (3.88), “respect for the patients” (4.04) and 
“time available to patient-centred care” (3.80). Lowest ratings were 
“encouraged to make questions,” (3.65), “involved patients in decision-making 
process” (3.34) and “talk with patients about the next following steps” (3.49). 
Conclusion: Radiographers communication skills were evaluated with good 
levels of patient confidence with the radiological examinations. Despite the 
overall positive results, this area of health service delivery must be accorded 
the attention it deserves to continually improve on patient satisfaction through 
improved communication.  
B-1639 14:16  
An account of silences in diagnostic radiography: a cultural quilt stitched 
together with the threads of social defences  
T.J. O'Regan1,2, L. Robinsion2, A. Newton-Hughes2, R. Strudwick3; 
1
London/UK, 2Salford/UK, 3Ipswich/UK (Tracyo@sor.org)  
Purpose: Multi-professional disciplines contribute typologies of silence that 
theorize approximately 50-70 different forms, functions and motives for silence. 
This study provides an account of cultures of silence that present at three UK 
clinical imaging departments. 
Methods and Materials: A qualitative methodology of visual ethnography 
produced an account of silence in radiography practice. Main methods of 
creative collage workshops and twelve interviews were supplemented with 
observations of twenty five staff working in accident and emergency and 
general practice radiography. 
Results: Thematic analysis demonstrates five overarching themes grounded in 
the data. Silence in radiography clinical practice is related to 1) Emotional 
labour and social defences; 2) Workload; 3) Avoidance of conflict; 4) Legal and 
ethical dilemma and dichotomy; 5) Hierarchy. Silence strategies were used to 
facilitate the smooth every day running of the imaging departments. Silence 
functioned to reflect and enact empathy towards patients and colleagues, it 
facilitated staff and patient well being and was also a strategy used to keep 
waiting times to the minimum. Silence reduced threats of litigation, promoted 
harmonious teamwork, decreased emotional anxiety and diminished the 
demands of emotional labour. 
Conclusion: The study results in knowledge of silence and silencing strategies 
used in radiography. In particular data in the form of images and words raise 
awareness of the emotional labour and social defences employed within 
radiography. The conclusion is that silence is both help and hindrance to 
services in a clinical setting. The results should be used to inform health 
service development and change in cultures of practice.  
B-1640 14:24  
Job satisfaction of radiographers  
S. Souto1, A.F. Abrantes1, C.A. da Silva2, L.P.V. Ribeiro1, R.P. Almeida1, 
K.B. Azevedo1; 1Faro/PT, 2Evora/PT (lpribeiro@ualg.pt)  
Purpose: The main objective of this study was to determine the relationship 
between job characteristics and job satisfaction among radiographers to 
determine which of the dimensions of the job characteristics model contribute 
most to job satisfaction among radiographers. 
Methods and Materials: A self-applied questionnaire was used based in the 
basic task dimensions tool developed primarily by Hackman e Oldham. This 
paper-based survey was made available to the radiographers (n=63) working 
in two local public hospitals to assess the work content (variety of skills (VS), 
identity (I), Task Meaning (TM), Autonomy (A), Intrinsic feedback (IF), extrinsic 
feedback (EF), interrelationship (IR)) and the work context (satisfaction with the 
social environment (SE), satisfaction with supervision (SS), satisfaction with 
the possibilities of growth (SPG), satisfaction with the physical environment 
(SPE), satisfaction with payment and compensation (SPC), Satisfaction with 
Work Organization (SWO) and Satisfaction with Safety at Work (SSW)). 
Results: The internal consistency of the questionnaire was good (Cronbach's 
alpha = 0.88). The lowest satisfaction scores were identified in IR (61.9%), EF 
(59%), SSW (71%), SPC (31.7%), SS (74.6%) and (77.8%). All the other 
dimensions scored higher than 80%. 
Conclusion: In general, it is possible to say that radiographers are 
professionally satisfied. However, it is of major importance to show to the 
managers that human resources policies and management related problems 
still need major attention and improvement. In order to further strengthen and 
validate the findings of the study, interviews can be carried out in addition to 
the distribution of questionnaires.  
  






B-1641 14:32  
Evaluation of burnout syndrome in radiographers  
V.R. Luiz, L.P.V. Ribeiro, A.F. Abrantes, K.B. Azevedo, R.P. Almeida, 
S. Rodrigues, N.F. Pinto; Faro/PT (lpribeiro@ualg.pt)  
Purpose: Evidence demonstrates that health care professionals are more 
prone to burnout than other professionals due to the emotionally taxing 
interactions they have with their patients on a daily basis. The aim of this study 
was to measure occupational burnout levels among radiographers. 
Methods and Materials: This research used a sample characterisation survey 
in addition to the Maslach Burnout Inventory (MBI), translated and validated to 
the professional’s native language. The evaluated dimensions were emotional 
exhaustion (EE), depersonalisation (D) and reduced personal accomplishment 
(RPA). The MBI survey is composed by 22 questions where the professional 
should mark the answer in a 0 (never) to 6 (daily) Likert scale. A total of 119 
radiographers from 9 different healthcare facilities agreed to participate. 
Results: In this study, 99.2% of radiographers worked in a facility with 
emergency department. The EE, D and RPA dimensions revealed moderate 
levels of burnout. Statistically significant differences were found between 
dimension D and the hospital and between dimension RPA and the work in 
rotational shifts (p<0.05). The variable job satisfaction interferes significantly 
with the three dimensions of the MBI. 
Conclusion: This research allow us to conclude that the burnout may reach 
disturbing levels, since professionals often do not recognise this phenomenon 
and do not seek for help, thus becoming a chronic problem. Therefore, it is vital 
to develop further research in this area to strengthen the demonstration that 
healthcare may be endangered by health professionals in burnout.  
B-1642 14:40  
A survey on the attitude towards research among radiographers  
I. Conceição, A.F. Abrantes, L.P. Ribeiro, S.I. Rodrigues, R.P. Almeida; 
Faro/PT (inesconceicao.ic@gmail.com)  
Purpose: Research is a key component of evidence-based medical imaging 
and good knowledge and attitude towards research is important in 
implementing the paradigm shift from traditional model of practice to evidence-
based practice. Therefore, the aim of this study was to assess the 
radiographers attitudes towards scientific research. 
Methods and Materials: A cross-sectional, non-experimental research design 
was adopted, using a self-applied questionnaire and assigned to 115 
radiographers from public and private imaging departments in order to verify 
important barriers and attitudes regarding research in clinical practice. The 
questionnaire includes 5 main sections with a total of 43 items. Data were 
interpreted and statistically analysed through descriptive statistics. Chi-square, 
Spearman and Mann-Whitney tests were also performed. 
Results: Currently, most radiographers (78,3%) are not involved in research 
activities, but 80% presented interest in this field. It were observed statistically 
significant correlations between the radiographer involvement in research 
activities and the academic degree (p=0.027) as well with the participation in 
research training programs (p=0.046). Also, it were observed statistically 
significant differences between the radiographers involved and not involved in 
research activities, namely in the items: “Radiographer role includes the 
promotion of research activities” (p=0.019), “Radiographer uses the research 
findings in clinical practice” (p=0.016), “The need for research training 
programs” (p=0.001) and all the items related to research competences 
(p<0.05). 
Conclusion: The data suggest positive attitudes among radiographers. 
However, some barriers to participation were identified and institutional support 
and provision of research related courses are needed to increase 
radiographers involvement in research activities.  
B-1643 14:48  
A comparative study about motivations, expectations and professional 
development in four European radiography programmes  
C.S. Reis1, J. Pires Jorge2, S. Mæhle3, H. York4, L. Flaction2, S. Johansen3; 
1
Perth/AU, 2Lausanne/CH, 3Oslo/NO, 4Herts/UK (Jose.JORGE@hesav.ch)  
Purpose: To compare motivations, expectations and work plans of recent 
graduated students and teaching-staff from different European radiography 
programmes. 
Methods and Materials: A survey was performed to collect data about 
motivations, expectations, challenges, potentials of radiography education and 
plans for further professional development addressing students and teaching-
staff. The questions were closed ended and answers were dichotomous, 
multiple choice, five- or nine-point Likert Scale. To explore further perspectives, 
open questions were introduced into the questionnaires. Content analysis was 
performed to analyse the data. 
Results: Response rate varied between 16% to 93%. The motivations referred 
by students to pursue radiography education were the opportunity to work in a 
health-care organisation helping those that need help, performing different 
tasks and combining different areas of knowledge such as physics, patient 
care, physiology and anatomy. 75% of students did not reach all of their own 
expectations for radiography, mainly due to the content and poor 
specialisation. An enlargement of radiographers’ role was expected for the 
future by the teaching-staff. As further professional developments, the 
participants identified also the extension of studies (postgraduations, masters), 
more research and international collaborations. 
Conclusion: In general, the participants have similar motivations, expectations 
and plans for the future even having different curricula. There is a need for 
improvements in education due to the permanent technological developments, 
changes and demands observed in the workplace/job markets. Further studies 
need to be perform to identify an approach that considers, at the same time, 
the specificities of each country and proving strategies to harmonise 
radiography in Europe.  
B-1644 14:56  
Where is the radiography profession heading? Plausible scenarios for 
the profession in Sweden in 2025  
B. Bjorkman1, K. Fridell2, P. Tavakol Olofsson3; 1Jönköping/SE, 2Huddinge/SE, 
3
Stockholm/SE (berit.bjorkman@ju.se)  
Purpose: The aim of the study was to analyse and describe plausible 
scenarios for the radiography profession in 2025. 
Methods and Materials: The study has a qualitative design with an inductive 
approach. Data collection is based on eleven focus group interviews, with 48 
registered radiographers, working in eleven different diagnostic radiology 
departments throughout Sweden. The study builds on the scenario-planning 
method, which has the potential to predict four plausible scenarios for the 
radiography profession in the future. 
Results: Two trends were considered as the most uncertain scenarios for the 
future, hence having the greatest impact on the radiography profession if they 
should occur. These trends were labelled: ”Access to career advancement” 
and ”A sufficient number of radiographers”. Following four plausible scenarios 
unfolded: ”The happy radiographer”, ”The specialist radiographer”, ”The dying 
profession” and ”The assembly line”. 
Conclusion: The direction of the radiography profession within the Swedish 
context can probably be changed in a positive way. Hence, future opportunities 
and threats should be identified and incorporated into the strategic planning. 
Following, appropriate actions should be taken. It is suggested, that ”The dying 
profession” scenario could be turned in the opposite direction by facilitating 
career development opportunities for radiographers. This direction would 
probably lead to a profession composed of ”happy radiographers”, who are 
specialists and competent to carry out advanced tasks. Heading towards this 
scenario, may as well lead to a more visible profession and consequently, 
radiographers being proud of their profession.  
B-1645 15:04  
Radiographers and non-accidental injury in children  
A.F. Abrantes1, D.M. Sobral2, L.P.V. Ribeiro1, K.B. Azevedo1, R.P. Almeida1, 
O. Lesyuk1; 1Faro/PT, 2Cercal do Alentejo/PT (lpribeiro@ualg.pt)  
Purpose: The purpose of this research was to evaluate the capabilities and 
competences of radiographers with regard to situations of non-accidental injury 
in children. 
Methods and Materials: On the medical environment, particularly in two public 
radiology departments from two hospitals, a self-applied questionnaire was 
applied to a total of 42 radiographers in order to study their capabilities and 
competences within the non-accidental injury in children. 
Results: The internal reliability of the questionnaire was good (Cronbach's 
alpha = 0.84). Most of the radiographers (78.6%) referred to have had formal 
formation in paediatrics, during the academic training. The remaining have had 
post-graduated formation. Despite this fact, there was no statistical significance 
correlation (p>0.05). 42.5% of the radiographers declared to have an 
acceptable level of competence to recognise the radiological signs of non-
accidental trauma in children, although 47.6% referred to not know exactly the 
national guidelines on this matter. Most of the radiographers said to have 
excellent capacity to do these examinations, but most of them do not feel 
comfortable in give testimony in the court. 
Conclusion: This research allowed to conclude that during the procedure of 
imaging examinations in cases of non-accidental injury in children, 
radiographers attribute a more significant valuation to clinical practice and 
direct contact with this type of situation, compared to specific training, as a 
means of attain the skills to engage in this area. Further education and training 















B-1646 15:12  
Evaluating the use of detector dose indicators in digital x-ray imaging 
systems  
S. Lewis1, T. Pieterse2, L.A. Rainford3, H. Lawrence1; 1Johannesburg/ZA, 
2
Doornfontein, Johannesburg/ZA, 3Dublin/IE (shantell@uj.ac.za)  
Purpose: Detector dose indicators (DDI) are the only indicator of correct 
exposure technique in digital x-ray imaging systems but the use of such 
indicators remains largely unexplored in a South African setting. The study 
investigated radiographers’ familiarity and use of DDI and compared the actual 
DDI obtained in practice to the manufacturer's recommended standards which 
provided insight into current exposure technique practices in this setting. 
Methods and Materials: An explorative and descriptive quantitative study was 
conducted in two phases at randomly selected radiography clinical training 
facilities (n=10). Phase one of the study investigated the radiographers 
familiarity with and use of DDI (n=105) at selected sites by means of a 
questionnaire. In phase two of the study, actual DDI values were collected 
retrospectively from the same sites and compared to the manufacturer's 
recommended standards (n= 1422). 
Results: 54.3% of respondents had a correct understanding of DDI and 55.7% 
of respondents used the DDI correctly. Of the 1422 retrospectively collected 
actual DDI values only 50% of DDI evaluated were within the manufacturer's 
recommended range and 27% of DDI evaluated indicated overexposure. 
Conclusion: An observable lack of familiarity and the questionable use of DDI 
by radiographers coupled with some evidence of overexposure in the clinical 
setting suggest that improvements could be made to the training 
radiographers’ receive on digital imaging systems. Moreover, retrospective 
auditing of DDI is advocated as a dose optimisation, radiation protection and 
quality improvement strategy in clinical departments in a South African setting.  
B-1647 15:20  
Evaluation of radiation protection knowledge among hospital employees  
T.Ø. Holter1, S. Torp2, A. Martinsen1; 1Oslo/NO, 2Kongsberg/NO 
(uxtaho@ous-hf.no)  
Purpose: Radiation protection regulations emphasize the importance of 
knowledge as a preventive factor in radiation safety. Employees occupationally 
exposed to ionizing radiation in hospitals are required to possess adequate 
competence regarding radiation protection and possible health hazards from 
radiation exposure. Besides, knowledge may prevent unnecessary concern. In 
this study, the reliability of self-assessment was compared to quantitative tests 
to evaluate the different methods for measuring the level of employees’ 
knowledge on radiation protection. 
Methods and Materials: A quantitative cross-sectional survey was performed 
to evaluate self-reported competence compared to quantitative test results. 
The results from the survey were tested for correlations using Cohen’s Kappa. 
All staff members in the hospital carrying dosimeters were invited to participate. 
528 respondents (52% of the invited respondents) answered the electronic 
questionnaire. 
Results: Findings from this study demonstrate that there were discrepancies 
between the respondents tested and self-reported radiation protection 
knowledge (kappa = 0.27). Personnel with a high tested score tended to 
underestimate their knowledge, while personnel with a lower level of tested 
knowledge, tended to overrate themselves. 
Conclusion: To evaluate the level of radiation protection knowledge among 
hospital workers, it is not sufficient to map their personal perception, as a large 
proportion of the informants either overrate or underestimate their level of 
knowledge. Supplementary analyses are needed to give an accurate 
impression of the level of competence, and should be implemented in further 
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B-1648 14:00  
Performance of native T1 and T2 mapping cardiovascular magnetic 
resonance to detect myocardial oedema in patients with dilated 
cardiomyopathy  
W. Peng, Z.-L. Li, C. Xia; Chengdu/CN (yimaerlin@163.com)  
Purpose: To evaluate the performance of nativeT1 and T2 mapping 
techniques to identify myocardial oedema in patients with dilated 
cardiomyopathy (DCM). 
Methods and Materials: Twenty DCM patients and 10 healthy volunteers 
were enrolled in and underwent CMR examination. Modified Look-Locker 
Inversion recovery T1 maps and Balanced Steady-State Free Precession 
(bSSFP) T2 maps were acquired on matching short axis of basal, middle and 
apex segments. The native T1 values of T1 maps and T2 values of T2maps 
were measured and compared. Receiver operating characteristic analysis was 
performed to determine whether T2 values could be used in discriminating 
myocardial oedema between DCM patients and normal subjects. 
Results: In DCM patients, T2 values were significantly increased in 
comparison with normal controls (45.61 ± 4.30 vs. 39.57 ± 5.01, p < 0.05). T1 
values of DCM subjects were increased(1095.21 ± 266.73 vs. 991.99 ± 
229.90), but no statistical significance (P=0.458). For the segmental 
heterogeneity, T2 values of basal, middle and apical segments in DCM 
patients were higher comparing with normal ones(all P<0.05). A cutoff value for 
global myocardial T2 of  42.91 ms provided a sensitivity, specificity, accuracy, 
negative and positive predictive value of 71% (42%-92%), 80% (30%-95%), 
81.4% (57%-95%), 91% (59%-100%), and 50% (16%-84%) for DCM, 
respectively. 
Conclusion: T2 mapping seems to be superior when compared with native 
myocardial T1 values for assessing myocardial oedema in patients with DCM. 
The threshold values of global T2 values may be used as indicators for 
differentiating myocardial oedema between DCM patients and normal subjects.  
B-1649 14:08  
The multidisciplinary “endocarditis team”: results on imaging utilisation 
and diagnostic and therapeutic changes in the first 100 patients  
L.E. Swart, M.M. Henneman, T.W. Galema, J.A. Bekkers, R. Valkema, 
C.A.M. Schurink, N.J. Verkaik, J.W. Roos-Hesselink, R.P.J. Budde; 
Rotterdam/NL (r.budde@erasmusmc.nl)  
Purpose: The most recent European Society of Cardiology guidelines on 
endocarditis strongly advise to set-up a multidisciplinary “endocarditis team” 
including imaging specialists to guide diagnostic and therapeutic decisions. 
These guidelines now also include Cardiac CTA and PET-CT as major 
diagnostic criteria next to blood cultures and echocardiography. We present 
the first 100 patients discussed in our “endocarditis team”. 
Methods and Materials: Starting January 1st 2016, patients with suspected 
endocarditis were discussed in our “endocarditis team”. At least one 
radiologist, nuclear medicine physician, cardiologist, cardiac surgeon and 
infectious diseases specialist/medical microbiologist were present every 
meeting. Data of patients were retrieved from the structured reports of these 
meetings and electronic patient files, including imaging technique utilization as 
well as diagnostic and therapeutic changes. 
Results: One hundred patients (66 males; age 64±19y) with (suspicion of) 
native (n=43) or prosthetic (n=48) heart valve endocarditis or cardiac 
implantable device infection (n=9) were discussed (total amount of discussions: 
143). At the time of initial discussion, the following diagnostics had been 
performed: TTE (n=82), TEE (n=76), cardiac CT (n=22), PET-CT (n=35) and 
MRI (n=10). Additional imaging was advised in 19 patients (19%) (16 cardiac 
CT, 7 PET-CT). During the “endocarditis-team” meetings, diagnosis changed in 
13 patients (13%), and therapy in 53 (53%; surgical intervention recommended 
in 34, change in antimicrobial therapy recommended in 42). 
Conclusion: A multidisciplinary “endocarditis team”-approach to patients with 
(suspected) endocarditis results in increased utilization of additional imaging 
techniques and a change in both diagnosis and treatment in a substantial 
numbers of patients.  
 
  






B-1650 14:16  
Six months follow-up after triple rule-out using second-generation dual-
source CT in patients with acute chest pain  
M. Fusaro1, G. Balestriero1, A. Dorigo2, G. Battistella1, C. Bortolanza1, 
G. Tessarin1, L. Doni1, A. De Leo1, G. Morana1; 1Treviso/IT, 
2
Santa Maria di Sala/IT (fusaro341@gmail.com)  
Purpose: To determine the prognostic value at six months of a low-dose 
protocol triple-rule-out CT using second-generation dual-source CT vs 
standard evaluation in acute chest pain. 
Methods and Materials: A blinded prospective observational cohort study was 
conducted. We enrolled patients with acute chest pain, negative ECG, negative 
troponin test and low-intermediate cardiovascular risk, arriving at ED from 
March 7, 2016 to December 31, 2016. CT was performed in all patients with a 
standardized low-dose prospective ECG-trigger triple rule-out. Patients were 
classified with CAD >50%, <50% or without: all patients were treated by a 
standard protocol of our hospital without knowledge of the CT results. A follow-
up phone call was conducted after 6 months to determine the occurrence of 
MACE (death, ACS, and coronary revascularization). Total DLP and contrast-
enhanced phase DLP were assessed.The analysis of the data was performed 
with SPSSv13 and WinPEPI v11.5. 
Results: 125 consecutive patients (53.2 yo ± 9.7), 83 (66.4%) males, were 
enrolled: 76 (60.8%) were free of CAD, 40 (32%) had <50% CAD and 9 (7.2%) 
had a >50% CAD. No pulmonary embolism or aortic dissection was observed. 
At 6 months, no MACE was observed. 4 patients were not traceable during 
follow-up. The total and the single contrast-enahnced phase DLP were, 
respectively, 250.7±90.8 and 195.2 ±82.5. 
Conclusion: The triple-rule-out protocol with second-generation dual-source 
CT in properly stratified acute chest pain patients allows safe discharge and 
may be an ideal diagnostic tool in all hospitals with the necessary technology 
and experience.  
B-1651 14:24  
The prognostic value of late gadolinium enhancement in non-ischaemic 
dilated cardiomyopathy  
P.M. Cannao', F. Secchi, M. Scarabello, M. Alì, F. Sardanelli; Milan/IT 
(paola.m.cannao@gmail.com)  
Purpose: To evaluate the prognostic value of late gadolinium enhancement 
(LGE) amount for the stratification risk in patients with non-ischaemic dilated 
cardiomyopathy (DCM). 
Methods and Materials: We retrospectively evaluated 58 DCM patients who 
underwent 1.5-T CMR at our Institution from July 2008 to April 2016. Of these, 
only 30 patients followed up for at least 10 months (median follow-up was 46 
months). For each patient, segmentation and volume analysis were performed. 
LGE images were processed, after a semi-automated endocardial and 
epicardial segmentation of the slices, choosing 6 standard deviation threshold. 
Spearman's correlation was used to correlate the EDVi, ESVi, EF and SV of 
both ventricles with the amount of LGE. The ROC analysis was performed 
between the amount of LGE and the ICD implantation. 
Results: There was a positively significant correlation between LV EDVi and 
LGE (r=0.550, P<.001), LV ESVi and LGE (r =0.590, P<.001) and LGE and LV 
SV (r=0.379, P=.004), while there was a negatively significant correlation 
between LVEF and LGE (r =-0.479, P=.002). In 10 patients implanted ICD or 
PM, a receiver-operator characteristic (ROC) curve analysis revealed a cutoff 
value of 20.4 g for the LGE amount and this cutoff was determined to have 
80% sensitivity and 100% specificity. 
Conclusion: An association between myocardial LGE and ICD implantation 
may be possible to identify high-risk patients. The cutoff found of 20.4 g could 
be an innovative method to guide the selection of patients eligible for device 
therapy with a sensitivity 80% and specificity 100%.  
B-1652 14:32  
The feasibility of dual-energy-computed tomography in cardiac contusion 
imaging for mildest blunt cardiac injury  
M. Kantarci, A. Levent, S. Eren; Erzurum/TR (akkanrad@hotmail.com)  
Purpose: The purpose of this study was to evaluate the efficiency and 
feasibility of DECT used in the diagnosis of cardiac contusion with the mildest 
blunt cardiac injury (BCI). 
Methods and Materials: This study was performed between February 2014 
and September 2015, a total of 17 consecutive patients (10 men and 7 women; 
median age 51 years [range: 20-78]) were enrolled in the study. DECT was 
performed within 48 hours of the trauma and a subsequent follow-up DECT 
was performed a little less than one year after the first examination. All 
examinations were analysed on iodine map images by two experienced 
radiologists. Interobserver and intraobserver agreement was calculated. The 
correlation of initial troponin level, age and gender with number of contusion 
areas in the left ventricle and complete recovery of contusion were measured. 
Results: The contusion areas were amorphous, with considerable variation in 
their size, shape, and density. Contusions were primarily located in the left free 
wall of ventricle, the ventricular septum, and the apex, respectively. In 10 
patients, contusion areas disappeared upon follow-up examination. In four 
patients, the contusion areas decreased but were still present in the follow-up 
examination. The interobserver agreements were almost perfect with respect 
to the presence of cardiac contusion, the anatomic location of contusions, and 
the contusion areas. 
Conclusion: DECT can show cardiac contusion and could be useful and 
feasible for the diagnosis and follow-up of BCIs. DECT is a new, user-
independent and valuable imaging technique.  
B-1653 14:40  
Morbus Fabry: new insights from CMR strain imaging  
M.C. Halfmann, S. Benz, J. Eichstädt, A. Lollert, C. Düber, K.-F. Kreitner, 
T. Emrich; Mainz/DE (Moritz.Halfmann@gmx.de)  
Purpose: Although Morbus Fabry is widely acknowledged as a systemic 
disease, the focus of research concerning myocardial involvement has been 
focused on the left ventricle. Through the measurement of strains, we want to 
encourage the close examination of right ventricle (RV) as well. 
Methods and Materials: In our study, 62 healthy volunteers and 10 patients 
with a diagnosis of Morbus Fabry and proven cardiac involvement underwent 
cardiac magnetic resonance (CMR) imaging at 3T. Using a semi-automatic 
tissue tracking software (CVI Circle®), we measured global strains for both 
ventricles from multiple axes. 
Results: The left ventricular strain parameters (radial, circumferential and 
longitudinal strains) showed statistically significant differences between Morbus 
Fabry patients and healthy volunteers (p = .027 and .003). There were also 
significant differences concerning right ventricular strains (p = .012) with mean 
of RV global radial strains for Fabry patients of 19.13% (±6.35) and healthy 
volunteers of 13.47% (±6.46). 
Conclusion: Despite the still limited patient number, we found significant 
evidence for right ventricular involvement of Fabry’s disease. This should be 
the motivation to take a closer look and expand research also on the right 
ventricle in Fabry patients.  
B-1654 14:48  
Late gadolinium enhancement patterns in patients with 
hypereosinophilia: can CMR help identifying the aetiology?  
D. Morgan1, J. Pagniez1, G. Lefevre1, L. Averlant1, J.-E. Kahn2, B. Longere1, 
V. Silvestri1, F. Pontana1; 1Lille/FR, 2Suresnes/FR 
(dubois.morgan.59@gmail.com)  
Purpose: The aim of this study was to assess the prevalence and patterns of 
cardiac abnormalities detected by cardiac magnetic resonance (CMR) in 
patients with hypereosinophilia according to the underlying disease. 
Methods and Materials: Thirty consecutive patients without history of 
coronary artery disease (15 males; mean age = 47.7 ± 21) referred for 
hypereosinophilia were prospectively included. Hypereosinophilia was related 
to: idiopathic hypereosinophilic syndrome (HES) n=13; eosinophilic 
granulomatosis with polyangiitis (EGPA) n=6; parasitic infection n=3; 
hemopathy n=4; and allergy n=4. Cine functional parameters, T1 and T2 
values on parametric mapping and late gadolinium enhancement (LGE) were 
independently assessed by two readers. 
Results: Left ventricle (LV) and right ventricle (RV) ejection fractions were 
impaired in 19 patients (63%) and 7 patients (23%) respectively. LV and RV 
dilatation was observed in 7 patients (23%) and 2 patients (7%) respectively. 
Increased myocardial T1 and T2 values were found respectively in 10/21 
patients (48%) and 4/21 patients (19%). LGE was detected in 13 patients 
(43%). Among them, 5 patients presented a myocarditis enhancement pattern 
(HES n=2, EGPA n=2, parasitic infection n=1), 5 patients presented a vasculitis 
enhancement pattern (EGPA n=3, parasitic infection n=1, hemopathy n=1) and 
3 patients presented an endomyocardial fibrosis pattern (HES n=2, EGPA 
n=1); p = 0.59. 
Conclusion: LGE was observed in almost half of the patients with 
hypereosinophilia with three different patterns (myocarditis, vasculitis and 
endomyocardial fibrosis) independently of the etiological diagnosis, suggesting 
a non-specific myocardial toxicity of the eosinophils.  
B-1655 14:56  
The effect of myocardial bridge on the presence and extent of coronary 
artery disease: case-control study  
S. Papp, J. Karady, M. Kolossvary, Z. Drobni, B. Szilveszter, G. Barczi, 
B. Merkely, P. Maurovich-Horvat; Budapest/HU (papp.sara94@gmail.com)  
Purpose: Previous studies have suggested that the presence of myocardial 
bridge (MB) increases the risk of atherosclerosis proximal to the MB. Our aim 
was to assess the effect of MB on the quantity and composition of plaques 
proximal to MBs. 
Methods and Materials: Patients who underwent coronary CT-angiography 
due to suspected coronary artery disease were enrolled into this retrospective 
case-control study. We selected patients with MB on their left anterior 
  






descending (LAD) coronary artery and a control group matched to age, sex, 
BMI and cardiovascular risk factors such as smoking, hypertension, diabetes 
mellitus and dyslipidaemia. Using semiautomated plaque quantification 
software we segmented the LAD segment proximal to the bridge in the cases 
and an identical length segment of the LAD in each control patient. We 
compared the plaque volume and plaque composition between the case and 
control groups (Wilcoxon signed-rank test). 
Results: In total, we assessed 25 case-control pairs (mean age: 59.0±10.9 
versus 59.0±10.9 years, p=0.946; males: 88%). The average length of the 
analysed segments proximal to MBs were 43.5±9.3mm in the case and 
43.3±9.3mm in the control group (p=0.412). The total plaque volume did not 
differ between the groups (178mm2 [IQR:146.9-198.9] versus 154mm2 
[IQR:124.4-204.9], p=0.638). We found no significant difference in the calcified 
plaque volume (19mm2 [IQR:7.3-37.4] versus 12mm2 [IQR:5.1-24.8], p=0.861), 
and in the non-calcified plaque volume (109mm2 [IQR:66.3-131.7] versus 
107mm2 [IQR:79.0-139.1], p=0.527) between the groups. 
Conclusion: Our results suggest that the MB has no effect on plaque volume 
and composition in coronary segment proximal to the MB.  
B-1656 15:04  
Atrial dysfunction in arrhythmogenic right ventricular cardiomyopathy: 
value of quantitative MR analysis in predicting atrial arrhythmias  
M. Bourfiss1, T. Zghaib2, R.N.W. Hauer1, H. Tandri2, H. Calkins2, S. Nazarian3, 
A.S.J.M. te Riele1, B.K. Velthuis1, S.L. Zimmerman2; 1Utrecht/NL,  
2
Baltimore, MD/US, 3Philadelphia, PA/US (m.bourfiss-2@umcutrecht.nl)  
Purpose: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an 
inherited cardiomyopathy that predominantly affects the ventricles. Evidence 
for direct atrial involvement remains limited and few studies have characterized 
atrial arrhythmias (AA) in ARVC. We aimed to characterize atrial involvement in 
ARVC using Cardiac Magnetic Resonance (CMR) and to identify CMR-based 
predictors of AA in ARVC. 
Methods and Materials: We analyzed cine-CMR images of 66 definite ARVC 
patients without a history of AA or severe heart failure (NYHA3) and 24 
healthy controls. Using tissue-tracking, we evaluated phasic bi-atrial volumes, 
ejection fractions (EF), peak longitudinal-strain (PLAS) and strain rates (SR). 
The primary outcome was the occurrence of AA during 6.8 [3.0-10.8] years of 
follow-up. 
Results: Compared to controls, ARVC patients had higher bi-atrial volumes 
and lower right atrial (RA) passive-EF, RA-PLAS, systolic and early RA-
diastolic SR and systolic left atrial (LA)-SR (p<0.05). Although worsening in 
ventricular size and function was associated with increased bi-atrial volumes 
and decreased function, variation in atrial parameters was only partially 
explained by ventricular changes (r2 5-29%). Using multivariable analysis, 
predictors of increased risk of AA during follow-up were higher atrial volumes 
(10% increased risk of AA per mL, p<0.05), decreased LA reservoir function 
(total LA-EF and LA-PLAS) and decreased RA conduit function (passive RA-
EF and RA early diastolic SR). 
Conclusion: ARVC is characterized by enlarged atria with decreased function, 
which is only partially explained by ventricular changes. Bi-atrial parameters 
predict incident AA after adjusting for clinical and ventricular characteristics, 
which suggests primary atrial involvement in ARVC.  
B-1657 15:12  
The role of cardiac magnetic resonance imaging (MRI) in the diagnostic 
work-up after aborted sudden cardiac death  
L. Szabó, C.L. Czimbalmos, I. Csécs, A. Tóth, F.I. Suhai, K. Heltai, E. Zima, 
L. Gellér, D. Becker, B. Merkely, H. Vágó; Budapest/HU 
(sz.liliana.e@gmail.com)  
Purpose: The aim of our study was to assess the added value of cardiac 
magnetic resonance (CMR) imaging in the diagnostic work-up of aborted SCD 
in absence of coronary artery disease and to determine commonness to the 
myocardial abnormalities in this patient population. 
Methods and Materials: During a 7.5-year period (between 2010 and 2017) at 
the Heart and Vascular Center of the Semmelweis University we performed 
CMR examinations in 78 patients (37.9±13.8 y, 37 male) after aborted SCD 
with normal coronary angiography. Among them, 10 were athletes (28.4±10.3 
y, 8 male). We measured the left and right ventricular parameters and the 
presence of myocardial scar/necrosis. We assessed whether CMR changed 
the provisional diagnosis. 
Results: In 65% of the cases (n=51) the CMR proved structural myocardial 
abnormality as follows: dilated (DCM n=12), arrhythmogenic right ventricular 
(ARVC n=4), hypertrophic (HCM n=4), Tako-tsubo (n=1) and noncompaction 
cardiomyopathy (n=1); myocarditis (n=4), acute myocardial infarction (n=3), 
mitral valve prolapse (n=4), endomyocardial fibrosis (n=1) and aspecific 
structural alterations (n=16). In the last group, myocardial fibrosis with 
nonischaemic pattern could be identified in 7 patients. Age group specific 
incidence rates show that the most common structural heart disease over 35 
years was DCM (n=9), while ARVC occurred more frequently under 35 years in 
our patient population, and was the most common structural disorder in 
athletes (n=3). CMR examination changed the provisional diagnosis in 50% of 
the patients. 
Conclusion: CMR provides an advanced diagnostic yield in the diagnostic 
work-up of the excessively variable aetiology of SCD.  
B-1658 15:20  
Cardiac MRI for a better identification of structural heart disease in 
patients with ventricular arrhythmia  
D. Andreini, S. Mushtaq, G. Pontone, A.D. Annoni, A. Formenti, M.E. Mancini, 
E. Conte, M. Guglielmo, M. Pepi; Milan/IT (daniele.andreini@ccfm.it)  
Purpose: Aim of this study is to evaluate whether in patients with ventricular 
arrhythmia and normal echocardiography, cardiac MRI may identify patients 
with structural heart disease whose risk has been underestimated by 
transthoracic echocardiography 
Methods and Materials: We enrolled a cohort of consecutive patients with VA 
who underwent to cardiac MRI after a negative echocardiography. For every 
patient the presence of cardiovascular symptoms were evaluated. Ventricular 
ectopic beats (VEBs) was graded as follow: >1000 VEBs/24h; >10000 
VEBs/24h; non-sustained ventricular tachycardia (NSVT); sustained ventricular 
tachycardia (SVT) and history of resuscitated cardiac arrest. End-point of the 
study was the presence of structural heart disease at MRI. 
Results: We enrolled 946 patients (age 41±16 years; 609 male 64.4%). 
Among them, 241 patients (25.5%) were found to have structural heart disease 
at cardiac MRI. More specifically, 91 (37.7%) patients had a diagnosis of 
previous myocarditis, 50 (20.7%) of arrhythmogenic right ventricular 
cardiomyopathy, 39 (16.2%) of dilated cardiomyopathy, 22 (9.1%) of previous 
myocardial infarction, 11 (4.6 %) of congenital heart disease, 13 (5.4%) of 
hypertrophic cardiomyopathy, 5 (2.1%) of left-dominant arrhythmogenic 
cardiomyopathy, 5 (2.1%) pericarditis and 5 (2.1%) of left ventricular non-
compaction cardiomyopathy. Among clinical variable at multivariate analysis 
only previous SVT (OR 2.23 95%CI 1.26-3.9) and reported chest pain (OR 
2.38 95%CI 1.55-3.64) are associated with MRI positive for structural heart 
disease. 
Conclusion: Among patient with ventricular arrhythmia and normal 
transthoracic echocardiogram almost 25% had cardiac MRI positive for 
structural heart disease. Among clinical variable previous chest pain and SVT 
were associated to positive cardiac MRI.  
14:00 - 15:30 Room M 4  
Genitourinary  
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B. Ahuja; Agra/IN  
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B-1659 14:00  
"Avascular" hypoechoic testicular lesions on colour Doppler ultrasound: 
can they be considered benign? what is the added value of contrast-
enhanced ultrasound?  
D. Huang, M.R. Alsadiq, M. Sellars, R. Eckersley, P. Sidhu; London/UK 
(m.alsadiq@nhs.net)  
Purpose: Although most avascular hypoechoic testicular lesions on colour 
Doppler US (CDUS) are often considered benign, the diagnosis may be 
unreliable due to inherent limitation of CDUS. The purpose of this study is to 
determine the added value of contrast-enhanced US (CEUS) to conventional 
CDUS in assessing hypoechoic testicular pathology in differentiating benign 
from malignant aetiology detected at scrotal US. 
Methods and Materials: This retrospective study included 102 avascular 
hypoechoic testicular lesions detected at colour Doppler testicular ultrasound. 
The sonographic features recorded include lesion size and presence of 
vascularity on CEUS and CDUS. The reference standard was pathologic 
results or at least 6 months stability documented with serial follow-up 
ultrasound studies. 
Results: 102 lesions with no vascular signal on CDUS were identified. 18 of 
these lesions (17.6%) showed enhancement on CEUS despite lack of signal 
on CDUS. 6 of lesions with CEUS enhancement were malignant (6/18, 33.3%). 
The remaining lesions (12) include pathology such as sarcoidosis, post biopsy 
change, intra-testicular adenomatoid tumour, focal scarring with history of 
previous orchiopexy, and focal atrophy in patient with klinefelter syndrome. All 
lesions with no enhancement on CEUS (84) were of benign nature. 
Conclusion: Although most avascular hypoechoic testicular lesions on CDUS 
are benign, a proportion of these lesions are malignant and demonstrate CEUS 
enhancement. CEUS provides a more definitive characterisation of vascularity 
  






of a focal testicular lesion and would therefore add value to conventional 
CDUS in differentiating malignant from benign lesions.  
Author Disclosures: 
  D. Huang: Speaker; Bracco.  M. Sellars: Speaker; Bracco.  P. Sidhu: 
Speaker; Bracco. 
B-1660 14:08  
A comparison of testicular tissue stiffness using shear wave 
elastography  
M.R.V. Pedersen1, H. Møller2, P. Osther1, P. Vedsted3, R. Holst4, 
S.R. Rafaelsen1; 1Vejle/DK, 2London/UK, 3Aarhus/DK, 4Oslo/NO 
(Malene.Roland.Vils.Pedersen@rsyd.dk)  
Purpose: To compare elastography measurements in different testis tissues. 
Methods and Materials: A total of 248 consecutive patients were included 
during the period between 2013 and 2016 from our department of radiology. All 
patients were outpatients referred by their general practitioner to a clinical US 
scrotal examination due to symptoms such as pain, discomfort, lump or 
testicular mass. Exclusion criteria were patients with torsion, inflammation, 
previously diagnosed with testicular cancer or any linguistic difficulties to 
understand the informed consent. All men provided written informed consent. 
Testicular stiffness was assessed using shear wave elastography (SWE). 
Three SWE velocity measurements were assessed in each testicle. All patients 
underwent B-mode US investigation followed by SWE. The patients were 
divided into three groups: men with normal testicular tissue, men with testicular 
microlithiasis and men with testicular cancer. 
Results: We found a higher mean velocity in the group of patients with 
testicular cancer (1.92 m/s (95% CI 1.82-2.03)) compared to both the group 
with normal tissue (0.76 m/s (95% CI: 0.75-0.78)) (p<0.001) and the group with 
testicular microlithiasis 0.79 m/s (95% CI: 0.77-0.81) (p<0.001). 
Conclusion: The presence of testicular microlithiasis increased stiffness 
slightly, but within the range of variation in normal testicles. Increased stiffness 
may indicate testicular malignancy in testicular lesions. Ultrasound 
elastography may be a very useful tool when investigating scrotum.  
B-1661 14:16  
Diffusion-weighted imaging combined with ADC in the diagnosis of 
testicular lesions  
M. Huang; Zhengzhou/CN (huangmengna1127@163.com)  
Purpose: The purpose of this study is to identify the diagnostic value of ADC 
combined with DWI in benign lesions and malignant lesions of testis. 
Methods and Materials: 35 patients with testicular lesions confirmed by 
operation and pathological examination in our hospital were retrospectively 
analysed, including 18 benign lesions and 17 malignant lesions. The mean 
ADC values of normal tissue and parenchyma of testicular lesions were 
measured and statistically analysed by Kruskal-Wallis test and receiver 
operating characteristic (ROC) curve was delineated. The optimum ADC value 
for differential diagnosis of malignant testicular lesions was analysed and 
determined. 
Results: In 33 cases of normal testicular tissue, DWI showed homogeneous 
high signal, mean ADC was (1.137±0.119)×10-3 mm2/s. 18 cases of benign 
lesions mostly showed unrestricted diffusion, mean ADC was 
(1.104±0.463)×10-3 mm2/s. In 17 cases of malignant lesions, DWI showed high 
signal, mean ADC was (0.778±0.198)×10-3 mm2/s. The comparison of ADC 
mean values between malignant testicular lesions and normal tissue as well as 
benign lesions of testis showed significant difference (P<0.05). The optimum 
ADC to distinguish malignant testicular lesions from benign testicular lesions 
was 0.911×10-3 mm2/s (82.4% sensitivity and 82.4% specificity). 
Conclusion: DWI combined with ADC value is beneficial to the preoperative 
diagnosis and differential diagnosis between malignant testicular lesions and 
benign lesions of testis.  
B-1662 14:24  
Diffusion tensor imaging parameters in the identification of 
spermatogenesis in men with non-obstructive azoospermia  
A. Tsili1, A. Ntorkou1,2, L.G. Astrakas1, A. Goussia1, E. Panopoulou1, 
N. Sofikitis1, M. Argyropoulou1; 1Ioannina/GR, 2Paris/FR (atsili@cc.uoi.gr)  
Purpose: To assess possible differences of testicular apparent diffusion 
coefficient (ADC) and fractional anisotropy (FA) values in different histological 
states of spermatogenesis in men with non-obstructive azoospermia (NOA). 
Methods and Materials: Twenty infertile men with NOA and 21 age-matched 
controls were retrospectively evaluated. All subjects underwent 1.5 T MRI of 
the scrotum, including diffusion tensor imaging (DTI). ADC and FA in NOA and 
normal testes were measured. NOA testes were classified as NOA with highest 
Johnsen score (JS) 8 (group 1) and JS <8 (group 2), based on the presence 
of tubules with spermatozoa at histologic analysis. The same classification was 
used for mean JS (mJS). Parametric and non-parametric statistical tests were 
used to compare ADC and FA between NOA groups and normal testes (group 
3). 
Results: Statistical analysis showed differences in ADC and FA between 
groups 1 and 3 (P=0.047 and P<0.001, respectively) and between groups 2 
and 3 (P=0.003 and P<0.001), but not between groups 1 and 2 (P=0.241 and 
P=0.976), when using the highest JS. When classification was based on mJS, 
ADC (P=0.014) and not FA (P=0.849) enabled the discrimination between 
groups 1 and 2. 
Conclusion: Our preliminary data show promising results in the identification 
of spermatogenesis in NOA testes using DTI parameters. Both ADC and FA 
are increased in NOA testes compared to controls. However, ADC and not FA 
proved useful in differentiating NOA testes, based on histology.  
B-1663 14:32  
High-resolution MR imaging with small surface coil in diagnosis of slight 
penile lesions after penile injury  
J. Guan, Y. Peng, H. Wang, Y. Guo; Guangzhou/CN (py9165@163.com)  
Purpose: To investigate the diagnostic value for micro-penile lesions after 
penile injury using high-resolution MR imaging with small surface coil. 
Methods and Materials: There were 13 patients with history of penile injury 
including intense intercourse or masturbation recently without clinical 
manifestations of penile fracture. In all patients, the complaints were mild and 
the sonographic results were negative. MR scan with both small surface coil 
(loop coil, diameter 11 cm) and body coil was performed in all 13 cases, 
respectively. MR findings were analysed by two experienced radiologists. 
Results: Only 2 cases with suspected lesions were found by MR scan with 
body coil. 10 cases with slight lesions of penis were detected by MR scan with 
small surface coil. 8 out of 10 cases with slight albuginea tear presented as 
focal interruption (about 1~2mm) of the hypointensity tunica albuginea and a 
small amount overlying effusion. Tiny haematomas with diameter 2-3mm 
between tunica albuginea and the buck fascia were seen in the remaining 2 
cases, presenting as a small nodule with hyperintensity on T2WI, hypo- or iso-
intensity on T1WI without enhancement. MR scan with small surface coil 
detected more tiny lesions of penis than routine scan with body coil (P<0.05), 
and showed the MR imaging features for diagnosis. 
Conclusion: MR scan with small surface coil can provide higher diagnostic 
sensitivity for slight penile lesions after penile injury, and avoid misdiagnosis.  
B-1664 14:40  
Neoclitoris size and location: a preliminary pelvic MRI study  
E. Serena, F. Vedovo, S. Bucci, C. Trombetta, M. Bertolotto, M.A. Cova; 
Trieste/IT (elena.serena1986@libero.it)  
Purpose: To evaluate whether MR investigation of neoclitoris size and location 
can help predict sexual function after male-to-female sex reassignment surgery 
(MtF-SRS). 
Methods and Materials: The Female Sexual Function Index (FSFI) was 
calculated in 40 consecutive transsexual women who had postoperative MRI 
after MtF-SRS. An investigator blinded to sexual function data measured the 
distance between the neoclitoris and the neovagina and calculated the coronal 
and sagittal area of the neoclitoris and the volume from the three axes using 
the ellipsoid formula. 
Results: 22 patients completed the study. The mean age was 34±7.44 years. 
The majority were Caucasians (n=20, 91%) and in a relationship (n=13, 51%). 
The volume of the neoclitoris was 1.18±0.43 cm3. Coronal and sagittal areas 
were 6.80±2.4 cm2 and 5.33±1.34 cm2, respectively. There was an inverse 
relationship between the distance of the neoclitoris from the neovagina and the 
FSFI total score (p < 0.0001). Neoclitoris size did not significantly correlate with 
FSFI total score (p=0.76). 
Conclusion: In patients with MtF-SRS MRI allows evaluation of the neoclitoris. 
Our data suggest that neoclitoris localisation affects sexual function, with 
reduction of the distance between the neovagina and the neoclitoris associated 
with greater sexual satisfaction. Conversely, neoclitoris size does not to affect 
sexual function.   
B-1665 14:48  
US-guided sclerotisation of the cavernosal stumps following male-to-
female sex reassignment surgery  
M. Muca, M. Bertolotto, I. Zorzenon, M. Iannelli, C. Sachs, M.A. Cova; 
Trieste/IT (bertolot@units.it)  
Purpose: In early male-to-female sex reassignment surgery (MtF-SRS) 
operations a variable portion of the cavernosal crura was preserved. This 
residual erectile tissue undergoes engorgement during sexual arousal, causing 
dyspareunia and limiting patient's life. Surgical removal is the most commonly 
used treatment. It consists in a wide dissection of the perineum with significant 
morbidity and a high risk of complications. Development of mini-invasive 
techniques is therefore necessary. The aim of this study is to describe US-
guided sclerotherapy of the cavernosal stumps as an alternative to surgery, 
and to illustrate the results obtained in a series of 3 consecutive patients 
treated with this technique. 
  






Methods and Materials: US-guided sclerotherapy was performed in 3 patients 
(mean age 29-38 years) with severe dyspareunia after MtF-SRS caused by 
residual cavernosal stumps. 2.5 micrograms of PGE1 were injected in each 
stump under US guidance to achieve erection. A 3% sodium tetradecyl 
sulphate (Fibrovein®) solution diluted 1/5 with saline was injected bilaterally. A 
variable amount (max.3.5 cc) was injected depending on the volume of the 
erectile tissue. In 2 patients, the treatment was repeated monthly for 7 and 8 
sessions, respectively. The 3rd patient developed an abscess after the 5th 
session with prompt resolution of clinical symptoms after drainage. 
Results: A good aesthetic and functional result was achieved in all patients 
with disappearance of the erections during sexual arousal and improvement of 
the sexual quality of life. 
Conclusion: In patients with MtF-SRS US guided sclerotisation is a suitable 
mini-invasive alternative to surgical excision of the cavernosal stumps.  
B-1666 14:56  
Role of diffusion MR imaging and 3D/4D ultrasound in the assessment of 
placental insufficiency in gestational hypertension  
S.A. Mansour, S.T. Hamed, S. Hosny, S.B. Elsayed; Cairo/EG 
(sohathamed@yahoo.com)  
Purpose: To assess the role of diffusion-weighted MRI and 3D/4D ultrasound 
and power Doppler scanning in the detection of placental insufficiency in high-
risk pregnancies with hypertension. 
Methods and Materials: This prospective analysis included 50 pregnant 
females; 40 hypertensive and 10 control with the gestational age range from 20 
to 34 weeks. All cases had undergone 3D/4D transabdominal ultrasound aided 
by power Doppler scanning and diffusion-weighted MR imaging. No contrast 
administration was used. 
Results: There was a significant relation between right uterine artery RI 
(mean) of both cases and control groups when measured by power Doppler 
ultrasound (P=0.014). There was also a positive correlation between the 
presence of diastolic notch and RI value (P value= 0.012). There was also a 
significant difference between patients with normal and those with the 
abnormal placental signal in diffusion images as P value is significant (0.047). 
The mean of placental volume by MRI was 500.5+223.12 with median (IQR) 
507.08 (311.22-721.85) and by 3D ultrasound was 374.11+251.52 with median 
(IQR) 329.02 (162.66-596.75). There was a significant difference between the 
measurement of placental volume by MRI and US among both cases and 
control groups where P value<0.001 and 0.017, respectively. There was 
significant relation between results of both US and diffusion imaging in cases 
group (P value=0.006 and kappa value=0.318). 
Conclusion: Diffusion-weighted imaging can detect early subtle findings of 
placental dysfunction more than detected with 3D/4D ultrasound, so it can add 
to the diagnostic accuracy of imaging in pregnancies at high risk of placental 
insufficiency.  
B-1667 15:04  
Placenta accreta index: what a radiologist should know about an imaging 
update in detection of morbidly adherent placenta  
A. Agarwal, S. Agarwal, S. Sharma, S. Chandak; Moradabad/IN 
(drarjit26@gmail.com)  
Purpose: To study the role of placenta accreta index (PAI) in detection of 
morbidly adherent placenta and to analyse the inter-observer reliability in its 
calculation. 
Methods and Materials: 42 pregnant females with sonographically confirmed 
placenta previa in their third trimester and history of 1 caesarean section were 
subjected to ultrasonography for calculation of placenta accreta index (PAI). 
The index was calculated on the basis of placental morphology, retro-placental 
zone, uterine-bladder interface, myometrial thickness, bridging vessels and 
previous history of caesarean sections. Each parameter was weighted to 
produce a 9-point score (PAI) which predicted the probability of adherent 
placenta. PAI score of <5 was considered unfavourable and 5 as favourable 
for accreta. Statistical analysis was done to find the sensitivity, specificity and 
predictive values of PAI. The PAI was calculated by two radiologists 
separately, to determine the reproducibility of the technique. Cohen’s Kappa 
and intra-class correlation co-efficient (ICC) were calculated for categorical and 
scale variables, respectively, to determine the inter-rater agreement in 
calculation of scores. 
Results: Among 42 patients, 15 were placenta accreta on caesarean section. 
PAI 5 (favourable for accreta) was found in 17 and 14 patients by the two 
radiologists, respectively. The index showed highest sensitivity of 93.3% and 
specificity of 92.6% with negative predictive value of 96%. A perfect agreement 
was also found in calculation of PAI by the two radiologists with ICC of 0.959; p 
value<0.001. 
Conclusion: PAI can be utilised as a standard criterion for prediction of 
adherent placenta and thus decreasing maternal and foetal morbidity.  
 
 
B-1668 15:12  
Implementing strategies for a better quality fetal MRI by technologist 
training and the effect on radiologist satisfaction  
S. Sefidbakht, L. Mina, R. Ravanfar Haghighi, B. Zeinali, 
M. Saeedi-Moghadam, F. Zarei, S. Haseli; Shiraz/IR (sarahaseli@gmail.com)  
Purpose: To simplify and implement limited strategies for a improving quality 
of performing fetal MRI and to evaluate the effect on exam time and radiologist 
satisfaction 
Methods and Materials: We designed a limited extra education strategy for 
MRI technicians which included a limited fetal brain MRI a±natomy, practical 
solutions for obtaining perfect orthogonal images using a knowledge of the 
anatomy of the corpus callosum and vermis as key sagittal landmarks. We also 
included an extra orientation to motion insensitive MRI protocols tailored to our 
1.5 Seimens Avanto and 8channel body coil. We measured the duration of the 
study with retrospective evaluation of the metadata on our PACS database. In 
addition we measured radiologist satisfaction of the quality of the images on a 
scale of 1 to 10 and recorded the time spent by the radiologist at the scanner 
before and after implementing the strategies. Independent samples T test was 
used to compare results. 
Results: Last 100 patients before implementing the quality measures and first 
100 patients with fetal MRI’s performed immediately after implementing the 
qualities entered the study. Mean exam duration time changed from 
36.57±9.69 minutes to 24.86±5.39 minutes (p=0.002). Mean radiologist 
supervision time was reduced from 9.58±5.76 minutes to 5.43±2.74 minutes 
(p=0.020). Radiologist satisfaction score with the quality of the images 
increased significantly from 7.35±2.65 to 8.98±2.31. 
Conclusion: Implementing a limited extra education strategy for technologists 
involved in fetal MRI can significantly improve the quality of the images and in 
the meantime reduce the exam time.  
B-1669 15:20  
Added value of foetal MRI in evaluation of lung anomalies  
S. Sefidbakht, S. Bagheri, Z. Etemadi, B. Zeinali, M. Saeedi-Moghadam, 
N. Asadi, H. Vafaee; Shiraz/IR (SepidehSefidbakht@yahoo.com)  
Purpose: To retrospectively correlate all foetal MRI’s performed over the last 5 
years in our center with lung anomalies detected either primarily in ultrasound 
or unexpectedly in MRI with post-delivery results. 
Methods and Materials: From a total of 456 foetal MRI’s performed 53 studies 
(GA=30+/-8 wks) were performed either for evaluation of a lung finding 
detected in ultrasound or had an incidental lung finding detected in MRI. In 36 
patients post delivery confirmation in form of phone calls, national registry 
search results or post-delivery CT scans, operation notes or pathology results 
was available. 
Results: Patients included 11 cases of pure CPAM, 3 patients with hybrid 
lesions (two of which were correctly identified by MRI as such), 3 cases of 
bronchopulmonary sequestration (correctly diagnosed both by ultrasound and 
MRI, one fetus with pulmonary blastoma, one case of CHAOS, one case of 
LAM, 3 cases of pleural effusion, including one proven chylothorax. MRI ruled 
out focal lung abnormality suspected in ultrasound in 3 suspected cases, all 
asymptomatic after birth, showed two unsuspected cases of possible CO, both 
of which subsequently resolved spontaneously. Other patients had some form 
of uni or bilateral pulmonary hypoplasia. 
Conclusion: Foetal MRI detected unsuspected non-significant foetal lung 
pathology in a small number of cases and also more accurately characterized 
two lesions. This detailed characterization however did not alter patient 
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B-1670 14:00  
Evaluation of pituitary micro-lesions using 3D space: the large sample 
analysis  
H. Zhang, Y. Tang; Shanghai/CN (wozhanghua@126.com)  
Purpose: To evaluate the diagnostic yield of the 3D-T2 SPACE sequences 
compared to a standard MR protocol concerning the pituitary micro-lesions at 
3.0T with large sample analysis. 
Methods and Materials: Magnetic resonance imaging (MRI) findings of 664 
patients with clinically suspected pituitary lesions were retrospectively analysed 
in this study, some of them confirmed by pathology. Of all patients, post-
contrast coronal 3D-SPACE sequence was performed, besides conventional 
scanning sequences (coronal T1 weighted image (T1WI) and post-contrast 
enhanced T1WI). The images were evaluated by two-experienced 
neuroradiologists independently in a retrospective fashion. The inter-observer 
agreement was analysed with kappa statistics. 
Results: Compared to conventional sequences, there was an increase of 
60.3% in confidence level on diagnosing pituitary micro-lesions with addition of 
3D-SPACE sequence. The scores of combined conventional and 3D-SPACE 
sequences were significantly higher than that of conventional (z=−6.403, 
P<0.01) and 3D-SPACE (z=−4.243, P<0.01) alone. In addition, there was good 
inter-observer agreement for 3D-SPACE sequence (k=0.826). 
Conclusion: Combined with routine sequence, 3D-SPACE sequence is 
reliable in improving the diagnostic confidence for evaluation of pituitary micro-
lesions.  
B-1671 14:08  
Fully automated meningioma detection and segmentation using deep 
learning on routine multiparametric MRI  
K.R. Laukamp, F. Thiele, G. Shakirin, M. Perkuhn, D. Zopfs, A. Faymonville, 
M. Timmer, J. Borggrefe; Cologne/DE (kai.laukamp@uk-koeln.de)  
Purpose: MRI is a key method for meningioma imaging. Clear indications 
regarding detection and tumour volume are needed for primary assessment, 
resection planning and monitoring along therapy. Monitoring meningioma 
volumetrically is superior to conventional diameter methods. We used a 
multiparametric deep learning model (DLM) on routine MR data including 
images from referring institutions to investigate performance in automated 
detection and segmentation. 
Methods and Materials: MRI data (T1-/T2-weighted, T1-weighted contrast-
enhanced [T1CE], FLAIR) of n=38 grade I and n=18 grade II non-treated 
meningioma were available. Nine patients had been excluded earlier due to 
leucoencephalopathy, prevalent secondary tumours or strong artefacts. 
Tumour grade was determined by histopathology. The DLM was trained on an 
independent dataset of 249 cases of glioma and segments different tumour 
classes as defined in the BRATS-benchmark. Preprocessing included 
registration, skull stripping, resampling to isotropic resolution, and 
normalisation. The DLM was based on the DeepMedic-architecture 
(Kamnitsas2016) using a 3D-convolutional neural network for segmentation 
and a 3D-post-processing step to remove false positives. Results were 
compared to manual segmentation by an experienced radiologist in FLAIR and 
T1CE tumour. 
Results: The DLM detected meningioma in 55 of 56 cases. Further, 
automated segmentation correlated strongly with manual segmentation: 
average dice coefficients were 0.81±0.10 (range, 0.46-0.93) for the total 
tumour volume (union of tumour volume in FLAIR and T1CE) and 0.78±0.19 
(range, 0.27-0.95) for contrast-enhancing tumour volume in T1CE. 
Conclusion: The DLM yielded accurate automated detection and 
segmentation of meningioma tissue despite diverse scanner data and thereby 
may improve and facilitate future clinical management of this highly frequent 
tumour entity.  
Author Disclosures: 
 F. Thiele: Employee; Philips employee. G. Shakirin: Employee; Philips 





B-1672 14:16  
23Na-MRI demonstrates a sodium gradient within gliomas as a biomarker 
of tumour heterogeneity  
F. Zaccagna1, F. Riemer1, M.A. McLean1, J.T. Grist1, R. Schulte2, C. Watts1, 
S.J. Price1, M.J. Graves1, F.A. Gallagher1; 1Cambridge/UK, 2Munich/DE 
(f.zaccagna@gmail.com)  
Purpose: The increase in mitotic activity within gliomas is associated with a 
decrease in Na+/K+-ATPase activity and gain in concentration of these ions. 
23Na-MRI quantifies sodium concentration and can probe cell morphology and 
membrane function within the tumour microenvironment, as well as 
heterogeneity. The purpose of this study was to evaluate sodium distribution 
within glioma and in the surrounding tissue. 
Methods and Materials: 33 patients were imaged on a 3T clinical scanner 
(GE Discovery MR750) using a Rapid Biomedical (Rimpar) dual-tuned 23Na/1H 
birdcage head coil. Sodium imaging was performed using an UTE sequence 
with 3D-cones readout (nominal isotropic resolution = 3mm). Intracellular-
weighted sodium imaging was obtained using fluid suppression by inversion 
recovery (adiabatic inversion, TI = 30ms). Differences between tumour, grey 
matter (NAGM) and white matter (NAWM) in total sodium concentration (TSC) 
and intracellular sodium concentration (IW-SC) were tested using the paired 
samples t-test (p<0.05). 
Results: All the patients completed the examination (age 57.8±17.5 yrs). TSC 
in the lesion was 50.2±16.9mM in the high grade gliomas (HGG), 
43.1±28.6mM in the low grade gliomas (LGG) and 52.3±0.5mM in the 
metastases. The IW-SC was 22.4±17.4mM in the HGGs; 12.9±8.8mM in the 
LGGs and 7.5±2.3mM in the metastases. TSC was significantly higher in 
tumours when compared to NAGM (p=0.0001) and NAWM (p=0.0001). 
Conclusion: In all cases, TSC was higher in the entire lesion and in the 
enhancing tumour compared to the NAGM and NAWM. In conclusion, we 
demonstrated a sodium concentration gradient across gliomas that is 
consistent with the expected underlying histopathology.  
Author Disclosures: 
 R. Schulte: Employee; GE Healthcare.  
B-1673 14:24  
Brain aging in chronic HIV infection: a comparative multivoxel MR 
spectroscopy study  
J. Boban1,2, S. Brkic1,1, D. Lendak1,1, J. Ostojic1, M. Bjelan2, D. Kozic2; 
1
Novi Sad/RS, 2Sremska Kamenica/RS (jasmina.konstantinovic@gmail.com)  
Purpose: Studies of cognitive changes during the course of HIV infection 
resulted in hypothesis of accelerated brain aging. The aim of this study was to 
compare age-related changes in chronic neuroasymptomatic HIV+ patients, 
with age-related changes in age, gender and education-level-matched healthy 
subjects using magnetic-resonance spectroscopy (MRS). 
Methods and Materials: Study included 60 chronically-infected HIV+ patients 
on combination antiretroviral therapy and 60 age- and education-matched 
healthy male subjects, who underwent standard magnetic resonance imaging 
and long-echo time multivoxel MRS protocol on 3T unit (Trio Tim, Siemens, 
Germany). Voxels were placed in grey matter of frontal and parietal cortices, 
and in posterior cingulate gyrus. We analyzed N-acetyl aspartate and creatine 
(Cr) peaks, expressed as NAA/Cr ratios. Statistical analysis included 
stratification of the sample according to age (in decades) and comparison of 
correspondent groups of HIV+ and healthy subjects using ANOVA. 
Significance was set at value p<0.05. 
Results: ANOVA with stratified sample revealed significant differences in all 
locations when youngest groups were compared (20-29 years), while there 
were no significant differences between the youngest HIV+ subjects (20-29) 
and the oldest controls (50-59). 
Conclusion: Our results imply an initial rapid decrease in NAA/Cr level early in 
the course of HIV infection, followed by relatively stable level of NAA/Cr over 
time. However, levels of NAA/Cr in healthy subjects were stable at younger 
age, with progressive descrease in the oldest group. Brain aging process in 
chronic, stable HIV infection shows signs of accentuation compared to healthy, 
with early and rapid decrease in neuron marker.  
B-1674 14:32  
Empty sella and inferior sella impression are frequently associated and 
characteristic in patients with growth hormone-secreting pituitary 
adenomas  
G. Bier, J.-M. Hempel, U. Ernemann, B. Bender, J. Honegger; Tübingen/DE 
(georg.bier@med.uni-tuebingen.de)  
Purpose: To assess the prevalence of a sellar floor lowering and empty sella 
phenomenon in patients with GH (growth hormone)-secreting pituitary 
adenoma in comparison to an age-matched control cohort. 
Methods and Materials: 159 acromegalic patients were included in this study 
and compared to a control group (150 patients with non-GH-secreting 
adenomas and 50 patients without pituitary pathology). Magnetic resonance 
images of all patients were evaluated for the presence of an empty sella, 
  






downward tumour extension and maximum superoinferior diameter of the 
mass. 
Results: The empty sella phenomenon was detected significantly more often 
in patients with a GH-secreting adenoma (22% vs 7%; p=0.003). Moreover, 
GH-secreting adenomas presented with a significant rate of downward tumour 
extension (74.8% vs 35.5%; p<0.0001). A comparably decreased 
superoinferior diameter and higher ratio of intrasellar to suprasellar extension 
are predictive for the presence of a GH-secreting adenoma (AUC, 0.712). 
Conclusion: The association of GH-secreting pituitary adenomas and an 
empty sella phenomenon is frequent. Moreover, GH-secreting adenomas are 
frequently accompanied by an enhanced impression of the sellar floor. 
Hypothetically, this is caused by tumour-induced bone remodelling processes.  
B-1675 14:40  
Role of phase contrast MR CSF flowmetry study in the evaluation of 
normal pressure hydrocephalus  
S. Kumari1, M. Mohammad Zakir2, Y. Kirubha1, K. Sudhakar1, P. Chatterjee1, 
R. Ranjan3, J. Kumari4, S. Kumari5, S. Khan2; 1Chennai/IN, 2Nagpur/IN, 
3
Rohtak/IN, 4New Delhi/IN, 5Patna/IN (surbhinmch@gmail.com)  
Purpose: To study role of cerebrospinal fluid (CSF) flowmetry indices in 
patients with symptoms of normal pressure hydrocephalus (NPH) and to 
establish its diagnostic value. 
Methods and Materials: In this prospective case-control study, 44 patients 
(age range = 45-83 years) were evaluated by phase contrast (PC) MR CSF 
flowmetry in a 3T MRI equipment. 22 patients of NPH (with clinical and MRI 
diagnosis) and 22 age-matched control were evaluated. The CSF flow 
parameters studied include aqueductal stroke volume (ASV), peak systolic 
velocity (PSV), mean systolic velocity (MSV), forward flow (FF) and backward 
flow (BF). Statistical significance of these parameters was studied and 
comparisons were made between the parameters. 
Results: CSF flow parameters reliably differentiated NPH patients from 
controls in this study. Cerebral aqueduct in patients with NPH showed 
increased ASV. ASV parameters also showed marked difference in the values 
between NPH and controls. In patients with NPH above 45 years of age, mean 
values of ASV, PSV, MSV, FF and BF flow were 0.190(ml), 9.0(cm/s), 
4.8cm/s,0.098(ml) and 0.091(ml), respectively. In the control group above 45 
years of age, mean values of ASV, PSV, MSV, FF and BF were 0.032(ml), 
5.0(cm/s), 3.3 cm/s, 0.022(ml) and 0.020 (ml). CSF flow parameters including 
ASV, PSV, MSV, FF and BF reliably differentiated NPH patients from controls 
in the above 45 years age group (p values were 0.0001, 0.0001, 0.003, 0.0001 
and 0.0001 ml, respectively). 
Conclusion: Phase-contrast MR CSF flowmetry is a non-invasive means of 
calculating CSF flow in patients with NPH. In patients with clinical and MRI 
evidence of NPH, CSF flow parameters including ASV, PSV, MSV, FF and BF 
can be reliably used as an additional diagnostic tool.  
B-1676 14:48  
Cognitive decline in ageing and cerebrovascular reactivity assessed by 
ASL fMRI of perfusion  
N. Boudiaf, A. Krainik, J. Warnking, J. Pietras, O. Moreaud, M. Baciu; 
Grenoble/FR (akrainik@chu-grenoble.fr)  
Purpose: Cerebral blood flow (CBF) and cerebral vascular reactivity (CVR) 
decrease with age and might affect cognitive functions. This study aimed at 
investigating their correlations with cognitive abilities during normal and 
pathological ageing. 
Methods and Materials: We performed neuropsychological assessments on 
13 healthy younger subjects (44.1±9.5yo), 10 older subjects without cognitive 
complaint (72.1±5.7yo), 11 older subjects with cognitive complaint 
(73.4±7.9yo). We tested cognitive functions (attention, short-term and working 
memories, executive functions, language). We measured basal CBF and CVR 
elicited by hypercapnic challenge (7%CO2) using pCASL (3T Achieva TX, 
Philip, post-label delay=1525ms; voxel=3x3x6mm3; 20 slices; TE 12 ms; 
TR=4s for a total of 180 control and tag volumes acquired in 12 min during 
block-designed hypercapnia; s). Individual end-tidal CO2 pressure was used as 
physiological regressor to conduct linear regression analysis. Post-processing 
was performed using AMIGOv0.9, an in-house software (Python3.6, Matlab8.6, 
SPM12), giving whole-brain and regional basal CBF, CBV, MTT, CVR. We 
tested correlations between global and regional CBF and CVR with cognitive 
scores. 
Results: We found a decrease in attention and inhibition in older participants. 
Impaired-old subjects showed specific decreases in global cognitive 
functioning, executive functions, short-term and working memory. Global CBF 
decreased with age, only. Regional CBF decreased with attention and 
inhibition processes in anterior regions. Global CVR decreased with age and 
executive functions. Regional CVR decreased with lower performances in all 
cognitive tests, especially in posterior regions. 
Conclusion: CBF and CVR decrease with ageing. Unlike CBF, regional CVR 
decrease is specifically associated with cognitive impairment during ageing.  
B-1677 14:56  
Comparative study of activation during color-word Stroop test and new 
suggested counting test performance  
S. Morozova, E.I. Kremneva, Z. Gadzhieva, A.N. Sergeeva, B. Akhmetzianov, 
M. Zabitova, E. Kashina, M. Krotenkova, L. Dobrynina; Moscow/RU 
(kulikovasn@gmail.com)  
Purpose: To explore fMRI-based activation in healthy subjects performing the 
Stroop color-word test, widely used for executive functions mapping, and new 
suggested counting test, which is simpler to explain and perform. 
Methods and Materials: Data were acquired from 12 healthy subjects age 
ranged 45-63. MRI was performed on Siemens Verio 3.0 T scanner, scanning 
protocol included conventional T2-weighted sequence, T1 multiplanar 
sequence and simple block task-fMRI sequences using the Stroop color-word 
test and new suggested counting test as paradigms. Statistical analysis was 
performed using SPM8. 
Results: FMRI-based analysis using modified Stroop test paradigm showed 
activation of constituent regions of executive network (anterior insular and 
anterior cingulate cortex, dorsolateral prefrontal cortex, premotor cortex, 
supplementary motor area and inferior parietal lobules) and also of medial 
parts of lenticular nuclei, of regions in occipital cortex and cerebellar 
hemispheres. FMRI analysis using new suggested counting test paradigm also 
showed activation of constituent regions of executive network, including 
angular gyri, and also activation of cerebellar hemispheres but without 
activation of occipital cortex. Significant differences between the series were 
found in occipital cortex. 
Conclusion: Similar areas of activation during examination with Stroop test 
and counting test allow using new suggested counting test as an alternative 
paradigm for executive functions mapping, especially in patients with vision 
problems.  
B-1678 15:04  
Comparing normative subcortical volume distributions across cohorts  
E.J. Vinke1, W. Huizinga1, M. Bergtholdt2, M.A. Ikram1, W.J. Niessen1, 
F. Wenzel2, M.W. Vernooij1; 1Rotterdam/NL, 2Hamburg/DE 
(e.vinke@erasmusmc.nl)  
Purpose: More and more brain imaging data are publicly accessible and may 
serve as normative data for individual patient comparison. However, different 
normative cohorts differ in field strength, sequence parameters, and 
population. We assessed the differences in subcortical structure volumes 
between population and case-control studies, and the effects of using different 
cohorts for individual patient assessment. 
Methods and Materials: Segmentation of subcortical structures was 
performed using a shape-constrained deformable surface model. Then, 
percentile curves were fitted on the volume distributions using the LMS method 
on healthy subjects from three different studies: (1.) the population-based 
Rotterdam Study (n=1000), (2.) the case-control study, Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) (n=430), and (3.) the United Kingdom Biobank 
population study (UKBB) (n=904), with an overall age range of 40 to 95 years. 
The percentiles for 50 AD and 50 MCI patients (from ADNI) based on the 
distributions of the three datasets served for assessing the impact on individual 
patient classification. Here, differences between these percentiles were tested 
using a Welch’s two-sample T test. 
Results: Overall, LMS percentile curves were highly overlapping between the 
three different datasets: for AD and MCI patients, there were no significant 
differences between percentiles for the putamen, thalamus, hippocampus and 
the nucleus caudate. Globus pallidus and amygdala revealed small 
differences, with mainly the Rotterdam Study data showing slightly lower 
normative values. 
Conclusion: Overall, we found that the subcortical volume normative data 
from these three cohorts is interchangeable, suggesting more flexibility in 
clinical implementation.  
B-1679 15:12  
Are cerebral DTI changes correlated with degree of disability and 
cognitive dysfunction in patients with multiple sclerosis?  
J. Bladowska, A. Pokryszko-Dragan, A. Banaszek, A. Zacharzewska-Gondek, 
M. Nowakowska-Kotas, E. Gruszka, M. Sasiadek; Wroclaw/PL 
(asia.bladowska@gmail.com)  
Purpose: The aim of the study was to evaluate the microstructural changes 
within normal-appearing brain regions in multiple sclerosis (MS) patients using 
diffusion tensor imaging (DTI) as well as their association with disability and 
cognitive dysfunction. 
Methods and Materials: Fifty patients with clinically definite, relapsing-
remitting MS, according to McDonald’s criteria (mean age 36.4 yrs) and 40 
age- and sex-matched control subjects were enrolled in the study. DTI 
examinations were performed on a 1.5T MR scanner. Fractional anisotropy 
(FA) and apparent diffusion coefficient (ADC) values were obtained with a 
small ROI method within: genu (GCC) and splenium of the corpus callosum 
  






(SCC) as well as within right and left thalami. There were no demyelinating 
lesions within the ROIs in any of the patients included in the study. Degree of 
disability was assessed using Expanded Disability Status Scale (EDSS) and 
cognitive function using Paced Auditory Serial Addition Test (PASAT) and 
Symbol Digit Modalities Test (SDMT). 
Results: Significant decrease of FA (p<0.05) and significant increase of ADC 
(p<0.05) values were found in MS patients in GCC, SCC and both thalami 
compared to the normal subjects. There were significant correlations between 
FA values in GCC, SCC and SDMT results in MS subjects. ADC values in SCC 
and right thalamus were also significantly correlated with SDMT score. No 
correlations were found between FA or ADC values and EDSS. 
Conclusion: Microstructural tissue damage assessed with DTI measurements 
within normal-appearing corpus callosum and thalamus shows significant 
relationship with cognitive dysfunction in MS patients.  
B-1680 15:20  
Optimising pre-surgical fMRI language mapping using knowledge derived 
from intrinsic connectivity brain networks for personalised therapy 
planning  
L.R. Kozák1, G. Gyebnár1, A.G. Szabo1, A.L. van Graan2,3, P. Barsi1, 
L. Lemieux2,3, G. Rudas1; 1Budapest/HU, 2London/UK, 3Chalfont St. Peter/UK 
(lrkozak@gmail.com)  
Purpose: Blood-oxygenation level dependent functional MRI (fMRI) became 
an important tool of pre-surgical workup of tumors and/or other epileptogenic 
lesions within or near eloquent brain areas. Still, there are almost as many 
paradigms in use as MRI centers using them. We aimed to investigate whether 
language mapping paradigms can be fine-tuned in a neuropsychologically 
meaningful way using inference based on intrinsic connectivity (also referred 
as resting-state) brain networks (ICNs). 
Methods and Materials: fMRI language mapping results of 40 consecutive 
patients scanned using picture naming, synonym matching, speech 
comprehension, and word/non-word decision tasks in 2016-2017 on a Philips 
Ingenia 3T scanner were re-evaluated using our recently published ICN_Atlas 
framework[1]. Correspondence information between ICNs and pertinent 
cognitive/behavioral domains derived from BrainMap[2,3] were used to infer 
the specific cognitive processes involved by the different paradigms based on 
the fMRI activation maps. 
Results: There were paradigm-dependent differences both in the categorical 
label output of ICN_atlas toolbox (e.g. ‘Perception.Vision.Shape’ and ‘Naming 
(Overt)’ for picture naming; ‘Perception.Audition’, ‘Passive Listening’ and ‘Pitch 
Monitor/Discrimination’ for word/non-word decision), and in the weights 
associated with labels; within-task effects being smaller than between-tasks 
effects (Friedman’s test, p<0.05). These labeling differences reflected those 
expected for paradigms and patients based on prior neuropsychology. 
Conclusion: fMRI-based inference may be used to fine-tune mapping 
paradigms for specific symptoms, lesion loci and/or specific sub-functions 
deemed necessary by neuropsychological evaluation, thus opening 
personalized ways for paradigm optimization and therapy planning. 
[1]Kozák et al., NeuroImage (2017) 163C:319-341, [2]Laird, J Cogn Neurosci 








Wednesday, February 28 
10:30 - 12:00 Sky High Stage 
Interventional Radiology  
CT 2 
Clinical Trials in Radiology 1 
Moderators: 
M. Dewey; Berlin/DE  
R.L. Ehman; Rochester, MN/US 
B-0184 10:30
A two-center phase III, randomised, controlled study of MRgFUS vs EBRT 
in patients with metastatic non-spinal bone disease: palliative strategy 
for cancer-induced bone pain  
A. Napoli, R. Scipione, A. Leonardi, H.-P. Erasmus, S. Dababou, 
C. Marrocchio, C. Catalano; Rome/IT (alessandro.napoli@uniroma1.it)  
10:40  
Discussant  
M. Szczerbo-Trojanowska; Lublin/PL 
B-0185 10:45
Percutaneous microwave thermal ablation (MWA) for patients with 
malignant lung tumors: mid-term results of a prospective multicenter 
study (MALT study)  
A. Posa1, R. Iezzi1, F. Carchesio1, A. Veltri2, R. Cioni3, R. Manfredi1, 
L. Bonomo1; 1Rome/IT, 2Orbassano/IT, 3Pisa/IT (alessandro.posa@gmail.com)
10:55  
Discussant  
F. Gleeson; Oxford/UK 
B-0186 11:00
Use of electromagnetic navigation improves performances in CT-guided 
interventions: a multicentric, prospective and randomised clinical trial  
A. Mounier, R.-C. Rouchy, M. Medici, E. Chipon, A. Moreau-Gaudry, I. Bricault; 
Grenoble/FR (amounier1@chu-grenoble.fr)  
11:10  
Discussant  
T. Penzkofer; Berlin/DE 
B-0187 11:15
Randomised clinical trial of portal vein embolisation using n-butyl-
cyanoacrylate vs polyvinyl alcohol particles plus coils for liver 
hypertrophy before major hepatectomies  
J.H.M. Luz1, E. Coimbra1, T. Bilhim1, F.V. Gomes1, N.V. Costa1, M.T. Correia1, 
P. Luz2, E. Barroso1; 1Lisbon/PT, 2Rio de Janeiro/BR (jhugoluz@gmail.com)  
11:25  
Discussant  
K.A. Hausegger; Klagenfurt/AT  
B-0188 11:30
Paclitaxel-coated balloon angioplasty for the treatment of symptomatic 
central venous stenosis in dialysis access: results from a prospective 
randomised control trial  
P. Papadimatos, P. Kitrou, K. Katsanos, N. Christeas, D. Karnabatidis; 
Patras/GR (pnpapadimatos@yahoo.gr)  
11:40  
Discussant  
H. Portugaller; Graz/AT  
B-0189 11:45
Comparing different thrombectomy techniques in five large-volume 
centres: a ‘real world’ observational study  
A.C. Hesse1, A. Zapf1, J. Liman1, J. Fiehler2, A. Mpotsaris3, P. Schramm4, 
A. Berlis5, M. Knauth1, M.-N. Psychogios1; 1Göttingen/DE, 2Hamburg/DE, 
3




H.A. Deutschmann; Graz/AT  
Clinical Trials will be presented at ECR 2018; the abstracts will be published afterwards 




Thursday, March 1 
10:30 - 12:00 Sky High Stage 
Cardiac 
CT 6 
Clinical Trials in Radiology 2 
Moderators: 
M. Dewey; Berlin/DE  
R.L. Ehman; Rochester, MN/US 
B-0595 10:30
MEDIRAD EARLY-HEART study: early clinical and biological predictors of 
radiotherapy-induced cardiac toxicity in breast cancer  
M.-O. Bernier1, S. Jacob1, A.P.G. Crijns2, J.A. Langendijk2, R. Vliegenhart2, 
S.E. Combs3, M. Mayinger3, A. Eraso4, F. Guedea5, M. Fiuza6, 
S. Constantino Rosa Santos6, E. Mousseaux7, E. Cardis8, G. Frija7; 
1
Fontenay-aux-Roses/FR, 2Groningen/NL, 3Munich/DE, 4Girona/ES, 
5




V.E. Sinitsyn; Moscow/RU 
B-0596 10:45
Low-dose chest CT vs conventional chest x-ray prior to cardiac surgery: 
the CRICKET study  
R.P.J. Budde1, A.M. den Harder2, T. Leiner2, P.A. de Jong2, J. Karady3, 
C. Chun3, A. Bogers1, P. Horvat-Maurovich3, L. de Heer2; 1Rotterdam/NL, 
2
Utrecht/NL, 3Budapest/HU (r.budde@erasmusmc.nl) 
10:55  
Discussant  
J. Bremerich; Basle/CH 
B-0597 11:00
Computed tomography (CTA) vs invasive coronary angiography (ICA) in 
patients with atypical chest pain and suspected coronary artery disease 
(CAD): gender analysis of a randomised study  
M. Bosserdt1, S. Feger1, M. Rief1, D. Preuß1, P. Ibes1, P. Martus2, K. Kofoed3, 
M. Laule1, M. Dewey1; 1Berlin/DE, 2Tübingen/DE, 3Copenhagen/DK  
11:10  
Discussant  
R. Marano; Rome/IT 
B-0598 11:15
Effect of coronary computed tomography vs invasive coronary 
angiography on statin adherence and serum lipid levels in patients with 
atypical chest pain: a randomised controlled trial  
L. Elzenbeck1, S. Feger1, P. Martus2, N. Rieckmann1, K. Stangl1, A. Marek1, 
H. Dreger1, M. Beling1, E. Zimmermann1, M. Rief1, B. Chow3, 
P. Maurovich- Horvat4, M. Laule1, M. Dewey1; 1Berlin/DE, 2Tübingen/DE, 
3
Ottawa, BC/CA, 4Budapest/HU (laura.elzenbeck@charite.de) 
11:25  
Discussant  
R. Vliegenthart; Groningen/NL 
B-0599 11:30
The role of intraprostatic antibiotic injection for reducing infectious 
complications of transrectal ultrasound-guided biopsy  
F. Shobeirian, M. Darabi, S.M. Bagheri, M. Zare Mehrjardi, A. Rezayi; 
Tehran/IR (farzaneh.shobeirian@gmail.com)  
11:39  
Discussant  
R.H. Oyen; Leuven/BE 
B-0600 11:45
The accurate non-invasive staging of liver fibrosis using deep learning 
radiomics of shear wave elastography for a multicenter study  
H. Zhou, K. Wang, J. Tian; Beijing/CN (zhouhui2015@ia.ac.cn)  
11:55 
Discussant 
D. Regge; Turin/IT  
Clinical Trials will be presented at ECR 2018; the abstracts will be published afterwards 




Friday, March 1 
10:30 - 12:00 Sky High Stage 
Breast 
CT 10 
Clinical Trials in Radiology 3 
Moderators: 
M. Dewey; Berlin/DE  
R.L. Ehman; Rochester, MN/US 
B-1006 10:30
Breast cancer screening with tomosynthesis: distribution of cancer 
subtypes in the Malmö Breast Tomosynthesis Screening Trial  
K.S. Johnson1, S. Zackrisson1, A. Rosso1, H. Sartor1, I. Andersson1, L.H. Saal2, 
K. Lang1; 1Malmö/SE, 2Lund/SE (kristin.johnson@med.lu.se)  
10:40  
Discussant  
F.J. Gilbert; Cambridge/UK 
B-1007 10:45
Digital breast tomosynthesis vs digital mammography: recallrate by 
mammographic density, interim analyses  




E.M. Fallenberg; Berlin/DE 
B-1008 11:00
Reduction in infarct volume on CT and functional outcome after 
endovascular treatment for acute ischaemic stroke: a causal mediation 
analysis  
K. Compagne1, M. Boers2, H. Marquering2, C.B. Majoie2, W. Van Zwam3, 
D.W. Dippel1, A. van Es1, A. Van der Lugt1, H. Lingsma1; 1Rotterdam/NL, 
2
Amsterdam/NL, 3Maastricht/NL (c.compagne@erasmusmc.nl) 
Discussant  
I. Szikora; Budapest/HU 
B-1009 11:15
Radiologic follow-up of the NU-AGE trial: body composition changes 
detected by dual-energy x-ray absorptiometry show a correlation with 
laboratory markers of inflammation  
D. Mercatelli1, A. Santoro1, G. Guidarelli1, C. Fabbri1, R. Ostan1,  
A. Berendsen2, B. Pietruszka3, A. jennings4, N. Meunier5, M. Aparisi Gomez6, 
E. Caumon1, S. Fairweather-Tait4, A. Bialecka3, C. de Groot7, G. Guglielmi8, 
G. Battista1, C. franceschi1, A. Bazzocchi1; 1Bologna/IT, 2Wageningen/NL, 
3
Warsaw/PL, 4Norwich/UK, 5Clermont-Ferrand/FR, 6Auckland/NZ, 
7
Wageningen/IT, 8Andria/IT (abazzo@inwind.it) 
Discussant  
F. Bamberg; Tübingen/DE 
B-1010 11:30
An international randomised controlled trial of two interventions for 
reducing doses for computed tomography through audit feedback and 
sharing best practices  
R. Smith-Bindman1, P. Chu1, Y. Wang1, R. Chung1, A. Einstein2, D. Miglioretti3; 
1




A. Trianni; Udine/IT  
B-1011 11:45
Prophylactic hydration to prevent contrast-induced nephropathy 
(AMACING): long-term results of a prospective, randomised, controlled, 
non-inferiority trial  
E.C. Nijssen; Maastricht/NL (estelle.nijssen@mumc.nl)  
11:55  
Discussant  
P. Aspelin; Stockholm/SE 
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Wednesday, February 28 
10:30 - 12:00  Studio 2018  
jointly organised by Siemens Healthineers and Bayer 
HealthCare  
SY 1a  
High-risk screening with breast MRI: today 
and in the future 
Moderator:  
C. Van Ongeval; Leuven/BE  
Phenotype-genotype correlation and radiological screening for breast 
cancer in gene mutation carriers  
C. Van Ongeval; Leuven/BE  
Approximately 5%-10% of breast cancers (BC) are hereditary; the most 
common mutation is BRCA 1, BRCA 2 and CHEK2. It has been shown that 
breast cancer gene mutation carriers (BCGM) have different clinical, 
histological and immune-phenotypic features. In BRCA1 BC presents at 
younger age (<40y) compared to BRCA2 and CHEK2 and is often more 
aggressive, presenting as medullary-like, triple negative breast cancers. 
Notwithstanding some studies reporting different mammographical 
characteristics of BC in BCGM, a study on imaging characteristics of BC in 
BRCA 1/ 2 and CHEK2 performed in University Hospitals Leuven (poster 
EUSOBI 2016) did not prove any difference compared to BC in non-mutation 
carriers. Breast tumour recurrence (first, second and contralateral) risk is 
significantly higher in BCGM carriers compared to non-mutation carriers, with 
CHEK2 most frequently showing an early and contralateral recurrence. Age at 
first breast cancer is also a strong risk factor for cumulative contralateral BC in 
BRCA1/2 carriers. Annual MRI alternating mammography and/or ultrasound is 
probably the most effective screening strategy in BCGM. Screening benefits, 
associated risks, and acceptance of false-positive results should be discussed.  
Learning Objectives: 
1. To learn about the immunohistochemical and radiological characteristics of 
breast cancer in BRCA 1, BRCA 2 and CHEK2 gene mutation carriers. 
2. To understand the radiological follow-up program for breast cancer detection 
in gene mutation carriers. 
Ten-year experience of population-based dynamic breast MR Imaging: 
the Study of Health in Pomerania (SHIP)  
R. Bülow; Greifswald/DE  
Purpose: To present 10-year results of dynamic breast MRI in the population-
based Study of Health in Pomerania (SHIP). 
Methods and Materials: Between 2008 and 2012, 774 women (51±12.9 years 
(range 20 to 83 years) participated in dynamic breast MRI with T1-weighted 
three-dimensional MR images (repetition time msec/echo time msec, 
8.86/4.51; flip angle, 25°) acquired with a 1.5-T MR unit before and 1 to 5 
minutes after a gadobutrol bolus injection of 0.1 mmol per kilogram of body 
weight. Images were analysed by two radiologists independently using the 
American College of Radiology BI-RADS-MRI Classification Form. In case of 
disagreement a consensus reading was performed. BI-RADS IV and V breast 
lesions were disclosed to the women with individual recommendations for 
follow-up. Between 2013 and 2017, MRI follow-up was realised in 275 (35.5%) 
women and 228 women participated additionally. 
Results: At baseline 113/774 women (recall rate 14.6%) had breast lesions of 
category BI-RADS IV (n=106) or BI-RADS V (n=7): 84 mass lesions, 15 foci 
and 29 non-mass lesions. Diagnostic follow-up was completed in 111/113 
(97.3%) women. In 21/113 (18.6%) women breast biopsy was performed 
confirming malignancy in 7/774 (0.9%) women. In the 5-year-follow-up group 
3/275 women with new mass lesions (BI-RADS IV) have been detected (recall 
rate 1.1%) and malignancy was confirmed in 2/275 (0.73%). 
Conclusion: Population-based dynamic breast MRI is feasible and has a recall 
rate of 14.6% at baseline and 1.1% during 5-year-follow-up. Mass lesion was 
the most detected lesion type. Malignancy was confirmed in 0.9% women at 
baseline.  
Gadolinium retention: impact on breast MRI?  
J. Barkhausen; Lübeck/DE  
More than 30 years ago, contrast-enhanced MRI emerged as a new technique 
in clinical breast imaging and over the last three decades numerous clinical 
studies have shown excellent results for the detection and characterisation of 
breast lesions. Despite the most recent improvement of high-resolution and 
diffusion-weighted MRI, dynamic contrast-enhanced sequences are still 
considered as the key component of any breast MRI examination. The applied 
gadolinium-based contrast agents (GBCAs) were considered as very safe 
compounds until the association between nephrogenic systemic fibrosis and 
GBCAs was suspected in 2006. Additionally, in late 2013 Kanda and 
colleagues described increased signal intensity in the dentate nucleus on 
unenhanced T1-weighted MR images as a consequence of repetitive previous 
GBCA administrations. Although no clinically relevant adverse events have yet 
been associated with the detection of gadolinium in the brain, the results of 
these studies must be taken seriously. With respect to breast MRI, these 
issues are especially important for repetitive breast cancer screening in high-
risk patients for example with BRCA mutations. In this lecture the results of the 
most recent clinical trials addressing this topic and the regulatory 
recommendations will be presented and discussed in a comprehensive 
manner.  
Learning Objectives: 
1. To gain knowledge of the pharmacokinetics of different MR contrast agents. 
2. To discuss the potential risks of gadolinium based contrast agents. 
3. To learn about the most recent recommendations and guidelines. 
Radiomics in breast imaging  
L. Umutlu; Essen/DE  
12:15 - 13:45  Studio 2018  
jointly organised by Siemens Healthineers and Bayer 
HealthCare  
SY 1b  
Multimodality Lunch Symposium:  
Reading approaches and protocols 
Moderator: 
R.M. Mann; Nijmegen/NL  
ABVS and personalised breast cancer screening  
A.-R. Grivegnée; Brussels/BE  
Dense fibroglandular tissue has an important impact on breast cancer 
screening. While mammography remains the gold standard in breast cancer 
screening (BCS), the approach has evolved and more personalised programs 
are now emerging. We will present our experience in BCS including ultrasound 
(Hand Held (HH) and/or Automated 3D) for patients having heterogeneously 
and extremely dense breasts. The conclusions of this study conducted in the 
ASSURE PROJECT (EU funded) show a higher cancer detection with an 
acceptable recall rate. The personalised workflow for BCS in our clinic has 
been defined as: Mammography (including DBT) followed by ABVS decided on 
the basis of volumetric density evaluation; then rapid overview by the 
radiologist of the examinations. If any positive or doubtful finding is seen, 
HHUS or dedicated mammogram is immediately performed. In addition, the 
use of CAD for mammography and ABVS is programmed as an evaluation 
process in our clinic.  
Learning Objectives: 
1. Ultrasound examination increases breast cancer detection rate with an 
acceptable recall rate. 
2. ABVS is at least equivalent to HHUS in this application; furthermore it allows 
a quality assurance which is mandatory in BCS. 
3. ABVS can be utilised in personalised breast cancer screening workflow in a 
reasonable cost-effective approach. 
Approaches to accelerating and standardising DBT reading in screening: 
what's new? Final results of the Malmö Breast Tomosynthesis Screening 
Trial  
S. Zackrisson; Malmö/SE  
The superiority of digital breast tomosynthesis (DBT) compared to digital 
mammography (DM) for cancer detection in screening is undoubted, as 
indicated by the results from several large, prospective screening trials. One of 
the challenges for implementation of DBT in screening is that longer reading 
times are reported for DBT, up to twice as long as for DM. In high-volume 
screen reading, ways to improve reading times with sustained sensitivity and 
specificity are warranted. The image protocols vary between trials, from two-
view DM+DBT, two-view synthetic DM+DBT and one-view DBT, although with 
quite similar results on detection and somewhat mixed effects on recalls. This 
presentation will include a discussion on what is the optimal image protocol. 
Further, does the use of narrow- versus wide-angle DBT make a difference? 
Do we need double reading with DBT? Will artificial intelligence systems 
replace one reader? Are thicker slices, slabbing, a way forward? How much 
  




does experience add? Finally, some of the final results from the Malmö Breast 
Tomosynthesis Screening Trial will be presented.  
Learning Objectives: 
1. To be familiar with the different image protocols used in prospective trials. 
2. To acknowledge ways to accelerate and standardise DBT screen-reading. 
Breast elastography: examination protocol and imaging interpretation  
C. Gkali; Athens/GR  
In recent years the use of elastography in addition to sonography has become 
a routine clinical tool for the characterisation of breast masses. Studies have 
investigated the improvement of specificity in differentiating benign from 
malignant breast masses. Therefore, additional use of elastography could help 
to reduce the number of unnecessary biopsies in benign breast lesions 
especially in category IV lesions of the ultrasound breast imaging reporting 
data system (US-BI-RADS). Ultrasound elastography is a cheap, readily 
available, useful, quick, non-invasive method in the diagnosis of breast lesions 
but it needs specific training as well as acknowledging the technical and 
pathological factors which may influence it. Both Strain and ARFI (Shear Wave 
Elastography) methods have been evaluated. Whereas Strain elastography 
results in qualitative imaging of tissue stiffness due to induced compression, 
ARFI (SWE) elastography displays quantitative and qualitative information of 
tissue displacement. A standardised protocol is essential for an adequate and 
effective examination, also helping reducing the dependence from operators. 
Furthermore, knowledge of pitfalls that can be encountered when ultrasound 
elastography is performed may help to avoid erroneous images interpretation. 
Interesting and rare cases will be presented and interpreted.  
Progress on whole-body MRI use for advanced breast cancer  
A.R. Padhani; London/UK  
Learning Objectives: 
1. To learn how WB-MRI addresses limitations of current imaging for bone 
metastatic detection and response. 
2. To understand how the biology of metastatic bone disease affects imaging 
findings. 
3. To enumerate patient care.  
12:30 - 13:30  Room F2  
organised by GE Healthcare 
SY 2  
Clinical impact of GE Healthcare's latest 
innovations 
Moderator:  
O. Adda; Buc/FR  
AIR Coil Technology: the next breakthrough in MRI  
F.J. Robb; Cleveland, OH/US  
Spectral imaging: the future of CT?  
M. Zins; Paris/FR  
Contrast-media considerations during complex MRI examinations 
N.N. 
12:30 - 13:30  Room K  
organised by Canon 
SY 3  
The role of cross-modality imaging in 
oncology diagnostics and treatment 
Moderator:  
A. Denys; Lausanne/CH  
MRI-US fusion for diagnostic assessment of the prostate and treatment 
guidance  
T. Fischer; Berlin/DE  
Published data on TRUS-guided repeat biopsy reveal markedly declining 
detection rates. The combination of high-resolution 3T magnetic resonance 
imaging (MRI) with multi- parametric ultrasound (B-mode, elastography, 
Doppler, CEUS) can be implemented in the form of MRI/US fusion biopsy of 
the prostate. Our studies show this approach to be able to increase the 
detection rate of PCa in general and also of significant PCa ( cT2b and/or  
Gleason score of 7). Since mainly patients with clinically significant PCa benefit 
from prostatectomy, the foremost diagnostic aim should be to identify these 
patients and separate them from patients with non-significant PCa. Our 
working group focuses on prostate cancer treatment by irreversible 
electroporation (IRE) which spares not only the nerves but also the large blood 
vessels and the urethra.  
Learning Objectives: 
1. Understand the basic technique of TRUS-guided prostate biopsy. 
2. Understand the basics of MRI/US image fusion using clinical examples. 
3. Understand the advantages of multi-parametric ultrasound compared with 
MRI. 
4. Understand the benefits of focal treatment of prostate cancer using IRE. 
Improving clinical pathways with angio CT in abdominal IR  
B. Guiu; Daix/FR  
Minimally invasive techniques, such as liver ablation, are recommended for 
almost 50% of primary liver cancer cases. Thermoablation of tumours of the 
liver using multi-modality imaging, combining CT, ultrasound and angiography 
is a promising technique being developed. Almost 40% of liver tumours are not 
detectable with ultrasound and 20% are not identified in CT scanning. The 
combination of these imaging modalities, however, as well as the ability to 
mark the tumours endovascularly, has enabled us to perform three times more 
thermoablation treatments over the last three years with interventional follow-
up.  
Learning Objectives: 
1. Understand the components of a modern Angio CT system. 
2. Learn how Angio CT can change practice in abdominal IR. 
3. Appreciate the benefit of Angio CT in terms of radiation exposure. 
4. Learn about 4D imaging. 
Interventional oncology in a state-of-the-art angio CT environment  
A. Gangi; Strasbourg/FR  
The combination of CT scan and C-arm fluoroscopy has been used since the 
1990s. Expanding this set-up with high-end CT and angiography, a milestone 
in interventional radiology (IR) and oncology, has been shown to provide the 
most precise imaging in liver tumour management. In this presentation we will 
explore further applications in oncology and IR that might benefit from the 
combination of the high-end imaging modalities. We will furthermore discuss 
the minimal requirements for the installation of such a system, including 
technical and financial challenges.  
Learning Objectives: 
1. Identify the best indications for an Angio CT set-up. 
2. Recognise the advantages of Angio CT. 
3. Plan the installation of such a combination, transparency and accuracy in 
treatment decisions.  
12:30 - 13:30  Room M 3  
organised by SuperSonic Imagine 
SY 4  








14:00 - 15:30  Studio 2018  
organised by Siemens Healthineers  
SY 1c  
Digital mammography: from improving 
morphological assessment to functional 
imaging 
Moderator:  
L.J. Pina Insausti; Pamplona/ES  
Impact of tomosynthesis angular range on mass conspicuity in patients 
with dense breasts: experiences from a radiologist's view  
P.R. Fisher; Stony Brook, NY/US  
Purpose: Recent studies have suggested that cancer detection rates for digital 
breast tomosynthesis (DBT) are poor for patients with heterogeneously to 
extremely dense breasts. These studies have been predominantly conducted 
on narrow-angle DBT. Increasing angular range (AR) reduces breast structural 
noise and increases image contrast for masses, potentially improving mass 
detection in dense breasts. We investigate the effect of AR on mass 
detectability using a previously validated cascaded linear system model 
(CLSM) for DBT, and compare theoretical results with clinical findings in an 
IRB-approved study. 
Materials and Methods: Mass conspicuity in DBT was modelled as a function 
of AR using a normalised detectability index d’, incorporating breast structural 
noise and image contrast. DBT images were acquired for 6 patients with 
heterogeneously or extremely dense breasts on both the Hologic Selenia 
Dimensions (AR = 15°) and the Siemens MAMMOMAT Inspiration (AR = 50°). 
Two breast radiologists were presented with both sets of images for each 
patient and compared lesion conspicuity on a five-point scale (-2: lesion much 
more conspicuous on narrow-angle DBT, to +2: lesion much more conspicuous 
on wide-angle DBT). 
Results: Mass detectability was predicted to increase with increasing AR due 
to reduced structural noise and increased contrast in the reconstructed image 
slices. Increasing AR from 15° to 50° would increase detectability of 2, 5 and 
10 mm masses by 85.3%, 87.5% and 87.9%, respectively. Clinical findings 
corroborated simulation results, with mass conspicuity shown to be superior for 
wider-angle DBT, with a mean score of 0.89 (95% CI: 0.44, 1.44). Importantly, 
masses found in areas with high masking risk (defined as high local density as 
characterised by the radiologist) were more conspicuous on wider-angle DBT. 
Conclusion: Using a normalised detectability index d’, mass conspicuity was 
shown to increase with increasing AR. These results were corroborated by a 
pilot clinical study, and motivate an ongoing larger scale study to demonstrate 
whether DBT with wider AR provides superior mass conspicuity for patients 
with heterogeneously to extremely dense breasts.  
Learning Objectives: 
1. To understand the imaging science of the impact of AR in DBT image 
quality. 
2. To compare the mass conspicuity in DBT with wide and narrow AR for 
patients with dense breast. 
Impact of tomosynthesis angular range on mass conspicuity in patients 
with dense breasts: experiences from a physicist's view  
W. Zhao; Stony Brook, NY/US  
Purpose: Recent studies have suggested that cancer detection rates for digital 
breast tomosynthesis (DBT) are poor for patients with heterogeneously to 
extremely dense breasts. These studies have been predominantly conducted 
on narrow-angle DBT. Increasing angular range (AR) reduces breast structural 
noise and increases image contrast for masses, potentially improving mass 
detection in dense breasts. We investigate the effect of AR on mass 
detectability using a previously validated cascaded linear system model 
(CLSM) for DBT, and compare theoretical results with clinical findings in an 
IRB-approved study. 
Materials and Methods: Mass conspicuity in DBT was modelled as a function 
of AR using a normalised detectability index d’, incorporating breast structural 
noise and image contrast. DBT images were acquired for 6 patients with 
heterogeneously or extremely dense breasts on both the Hologic Selenia 
Dimensions (AR = 15°) and the Siemens MAMMOMAT Inspiration (AR = 50°). 
Two breast radiologists were presented with both sets of images for each 
patient and compared lesion conspicuity on a five-point scale (-2: lesion much 
more conspicuous on narrow-angle DBT, to +2: lesion much more conspicuous 
on wide-angle DBT). 
Results: Mass detectability was predicted to increase with increasing AR due 
to reduced structural noise and increased contrast in the reconstructed image 
slices. Increasing AR from 15° to 50° would increase detectability of 2, 5 and 
10 mm masses by 85.3%, 87.5% and 87.9%, respectively. Clinical findings 
corroborated simulation results, with mass conspicuity shown to be superior for 
wider-angle DBT, with a mean score of 0.89 (95% CI: 0.44, 1.44). Importantly, 
masses found in areas with high masking risk (defined as high local density as 
characterised by the radiologist) were more conspicuous on wider-angle DBT. 
Conclusion: Using a normalised detectability index d’, mass conspicuity was 
shown to increase with increasing AR. These results were corroborated by a 
pilot clinical study, and motivate an ongoing larger scale study to demonstrate 
whether DBT with wider AR provides superior mass conspicuity for patients 
with heterogeneously to extremely dense breasts.  
Learning Objectives: 
1. To understand the imaging science of the impact of AR in DBT image 
quality. 
2. To compare the mass conspicuity in DBT with wide and narrow AR for 
patients with dense breast. 
Synthetic 2D mammography with digital breast tomosynthesis: the new 
mammography  
P. Clauser; Vienna/AT  
The introduction of digital breast tomosynthesis (DBT) in conjunction with 
digital mammography (DM) is rapidly changing clinical practice. DBT is 
becoming the new mammography, and therefore the new first-line examination 
- in conjunction with DM - for women in the screening and assessment setting. 
The need to perform two examinations (DM and DBT) has raised concerns 
regarding the increased radiation exposure. Synthetic 2D mammography (SM) 
is a 2D image reconstructed from the DBT projections. SM is similar to DM and 
it could be used instead of DM to avoid the need for two examinations.  
Learning Objectives: 
1. Radiation dose of DM and DBT. 
2. What is synthetic 2D mammography? 
3. Current evidence in favor of the introduction of SM mammography to replace 
DM as an adjunct to DBT in clinical practice. 
Clinical utility of contrast-enhanced dual energy mammography (CEDEM)  
L.J. Pina-Insausti; Pamplona/ES  
Contrast-enhanced dual energy mammography (CEDEM) is a development of 
digital mammography. By using dual energy (conventional low energy 
mammography plus high energy mammography) after the administration of a 
bolus of intravenous iodinated contrast medium, a morpho-functional image of 
the breast is acquired. This technique joins the high spatial resolution of 
conventional digital mammography with functional information based on 
neoangiogenesis. The indications of this technique for clinical use include: 
Problem-solving technique after inconclusive mammography, preoperative 
assessment of breast cancer, follow-up of scars after conservative treatment, 
follow-up of intermediate risk patients (borderline histological lesions, such as 
lobular carcinoma in situ, atypical ductal or lobular hyperplasia, as well as 
positive family history of breast cancer). In fact, the majority of indications are 
those of MRI, including the contraindications for MRI (pacemakers, 
claustrophobic patients, etc.). Furthermore, CEDEM has fewer false negative 
results than MRI. Nevertheless CEDEM has some limitations: The sensitivity is 
lower for ductal carcinomas in situ, lesions out of the field of view of the 
detector are missed and some benign lesions can enhance after contrast 
administration. CEDEM is contraindicated for patients allergic to iodine as well 
as for patients with renal insufficiency.  
Learning Objectives: 
1. To become familiar with contrast-enhanced dual energy mammography 
(CEDEM). 
2. To learn the main indications for this technique. 
3. To learn the main limitations of CEDEM. 
Comparison of contrast-enhanced dual energy mammography and 
contrast-enhanced digital breast tomosynthesis for lesion assessment 
and radiation dose  
P.R. Fisher; Stony Brook, NY/US  
Purpose: Digital breast tomosynthesis combined with contrast-enhanced dual 
energy mammography (DBT+CEDEM) is being investigated for diagnostic 
accuracy. Contrast-enhanced digital breast tomosynthesis (CEDBT) provides 
coregistered low energy DBT and 3D contrast enhancement map. Synthetic 
CEDEM may also be generated and paired with synthetic mammogram. This 
study compares CEDBT with CEDEM for lesion assessment and dose 
efficiency. 
Method and materials: A Siemens MAMMOMAT Inspiration DBT system 
modified for dual energy contrast-enhanced imaging is used. Patients with 
BIRAD 4 and 5 lesions and scheduled for biopsy were recruited for an IRB-
approved CE imaging study. CEDEM images were acquired 120 seconds after 
injection of iodine contrast agent, followed by CEDBT acquisition under the 
same breast compression. Eleven malignant lesions from 12 patients were 
confirmed by pathology result. A reader study of side-by-side comparison 
between CEDEM and CEDBT is performed to assess lesions on 1) Contrast 
  




enhancement level and 2) Margin identification, using a 5-point scale from -2 
(CEDEM much better) to 2 (CEDBT much better). The radiation dose recorded 
by the DBT system is reviewed for DBT+CEDEM and CEDBT. 
Synthetic CEDEM is created with dual-energy subtracted projections from 
CEDBT using software developed by Siemens Healthineers. 
Results: For malignant lesions, CEDEM shows higher enhancement level than 
CEDBT slices (mean score=-0.64; 95% CI: -1.09, -0.18). CEDBT shows lesion 
margin better than CEDEM (mean score=0.78; 95% CI: 0.11, 1.44). In CEDBT 
slices, background parenchymal enhancement is less intense, and motion 
artifact is less severe than that in CEDEM. On average, CEDBT reduces dose 
by 32.8% ± 9.9% compared to DBT+CEDEM (average dose 1.91 ± 0.74 mGy 
vs. 2.86 ± 1.04 mGy). Synthetic CEDEM has similar mammographic 
appearance to CEDEM, and shows the same enhanced lesions. 
Conclusion: CEDBT provides better lesion margin identification and reduces 
structural noise due to background parenchymal enhancement and motion 
compared to CEDEM, while the intensity of lesion enhancement is lower. 
CEDBT uses lower dose than DBT+CEDEM. Synthetic CEDEM can be created 
from CEDBT to quickly identify lesion enhancement. Clinical 
relevance/application: With the advent of DBT replacing FFDM, contrast 
imaging can potentially be done in full 3D setting (CEDBT) facilitated by 
synthetic 2D images (synthetic mammogram and synthetic CEDEM).  
16:00 - 17:00  Studio 2018  
organised by Siemens Healthineers  
SY 1d  
Big data and precision medicine in breast 
care 
Moderator:  
T. Manoharan; Forchheim/DE  
Integrated decision support for improved patient outcome  
T. Manoharan; Forchheim/DE  
In this segment we’ll focus on value-based healthcare, exploring how 
Integrated Decision Support (IDS) can help make more precise diagnosis and 
therapy decisions in multi-disciplinary teams, improving patient health 
outcome, while keeping the clinical pathway cost-efficient. Emphasis will be 
placed on multi-modal data integration, including imaging, pathology, lab, 
genomics and other relevant clinical information.  
Improving the clinical utility of digital breast tomosynthesis using novel 
software applications  
R.M. Mann; Nijmegen/NL  
Digital breast tomosynthesis (DBT) is rapidly replacing mammography as 
standard of care due to its higher sensitivity and specificity. In clinical practice, 
in contrast to the screening situation, images are scrutinised in depth. 
Furthermore, the availability of ultrasound and MRI, if needed, require the DBT 
findings to be appreciated in a multimodality context. To deal with the large 
amount of data and the demanding requirements, software applications are 
indispensable to aid reading. To ensure detection of all lesions within the DBT 
dataset, novel CAD applications may help, not only localising abnormalities on 
synthetic 2D slices, but also navigating directly to the most relevant slice in the 
tomosynthesis volume. For the rapid evaluation of findings within the tomo 
dataset, synthetic 3D images offer unique possibilities; showing tissue 
composition of possibly abnormal areas and clearly locating suspicious lesions 
in the breast. Novel tools that automatically segment and measure relevant 
findings further aid in reporting and in addition may reduce inter-reader 
variability. Finally, coupling studies from one modality to the next integrates the 
findings and allows for multimodal assessment of lesions. Consequently, 
current software developments have a powerful impact on the usefulness of 
DBT and multimodality imaging.  
The future of MR mammography: radiomics?  
C.G.N. Kaiser; Mannheim/DE  
Recently, terms like big data, radiogenomics and radiomics as a basis for 
precision-based medicine are an increasingly common topic for discussion. In 
MR mammography there is also more information to be retrieved from the 
images than the sole question of whether invasive carcinoma is present. 
However, MR mammography presents more challenges than the "optimisation 
of the diagnostic return on investment" as the indications for MR 
mammography are still limited.  
 
Personalised therapy through optimisation of diagnostic data in multi-
disciplinary team decisions  
R.M. Mann; Nijmegen/NL  
How can the use of diagnostic data in multi-disciplinary team decisions be 
optimised to enable more personalised therapy? Dr. Mann will walk us through 
this, using a specific breast cancer case as an example, covering everything 
from the complexity of preparation and patient empowerment to data Thursday, 
March 1 
  




Thursday, March 3 
12:30 - 13:30  Room O  
organised by Philips 
SY 5  
The next MR wave 
Welcome to MR with a new point of view: new perspective, bigger impact  
A. Radder; Best/NL  
Philips next generation wide-bore 3.0T: body oncology imaging  
R. Braren; Munich/DE  
Advanced and accelerated neuro imaging on a next generation wide-bore 
3.0T MRI to simultaneously address clinical and research needs  
J.S. Kirschke; Munich/DE  
Philips Prodiva 1.5T: bringing performance and productivity together  
H. Mahajan; New Delhi/IN  
12:30 - 13:30  Room N  
organised by Samsung 
SY 6  
Multiparametric ultrasound imaging 
Moderator:  
P.S. Sidhu; London/UK  
CEUS and 3D US for assessment of carotid plaque morphology  
V. Cantisani; Rome/IT  
Diagnosis and treatment of hepatocellular carcinoma by CEUS  
D.A. Clevert; Munich/DE  
Comparison of US strain elastography and entero-MRI to typify the 
mesenteric and bowel wall changes during Crohn’s disease  
T.V. Bartolotta; Palermo/IT  
12:30 - 13:30  Studio 2018  
organised by Siemens Healthineers 
SY 7  
Paving the way for MRI in precision 
medicine 
Programme not available by date of publication 
12:30 - 13:30  Room E 1  
organised by Bracco 
SY 8  
Programme not available by date of publication  
12:30 - 13:30  Room G  
organised by Bayer HealthCare  
SY 9  
Time to look at the bigger picture …   
Presence of gadolinium in the brain and 
body being put into context, including NSF 
Moderator:  
V. Runge; Berne/CH  
Clinical perspective: what to consider and to know when interpreting the 
clinical literature on Gd presence in the brain and body  
A. Radbruch; Heidelberg/DE  
Latest pre-clinical findings and potential consequences of gadolinium 
presence in brain  
H. Pietsch; Berlin/DE  
10 years of NSF: a critical review in the context of gadolinium in brain 
and body  
T. Balzer; Whippany, NJ/US  
Clinical recommendations in context to current health authority 
regulations  
V. Runge; Berne/CH  
12:30 - 13:30  Room K  
organised by Hologic 
SY 10  
Transforming breast biopsy with real time 
imaging: impact on clinical practice 
Moderator:  
L. Fontaine; Marlborough, MA/US  
Changing the breast biopsy approach in a national cancer institute: 
impact on clinical routine  
G. Scaperrotta; Milan/IT  
How much is enough? Quantity vs quality: our initial experience with a 
new vacuum assisted breast biopsy device in the UK  
W. Teh; London/UK  
A new biopsy technology combined with tomosynthesis guidance: our 
experience and initial results  
A. Tejerina; Madrid/ES  
  




12:30 - 13:30  Room M 3  
organised by Siemens Healthineers  
SY 11  
Personalised ultrasound: advanced 
applications for customised patient care 
Moderator:  
G.T. Yusuf; London/UK  
A paediatric cost and safety analysis of contrast-enhanced ultrasound  
G.T. Yusuf; London/UK  
Because of concern over medical ionising radiation exposure of children, 
contrast-enhanced ultrasound (CEUS) has generated interest as an 
inexpensive, ionising radiation-free alternative to CT and MRI. CEUS has 
received approval for paediatric hepatic use but remains off-label for a range of 
other applications. A retrospective study was performed to analyse adverse 
incidents encountered in paediatric CEUS and to assess the financial benefits 
of reducing the number of CT and MRI examinations performed. The records 
of 305 paediatric patients (187 boys, 118 girls; age range, 1 month-18 years) 
undergoing CEUS were reviewed. Most of the studies were for characterising 
liver lesions (147/305 [48.2%]) and trauma (113/305 [37.1%]); the others were 
for renal, vascular, and intracavitary assessment (45/305 [14.8%]). No 
immediate adverse reactions occurred. Delayed adverse reactions occurred in 
two patients (2/305 [0.7%]). These reactions were transient hypertension and 
transient tachycardia. Neither was symptomatic, and both were deemed not 
due to the underlying disorder. The potential cost savings of CEUS were $74 
per examination over CT and $180 over MRI. Paediatric CEUS is a safe and 
potentially cost-effective imaging modality. Using it allows reduction in the 
ionising radiation associated with CT and in the gadolinium contrast 
administration, sedation, and anesthesia sometimes required for MRI.  
Learning Objectives: 
1. To acknowledge that paediatric CEUS is off label, but safe and useful in a 
wide variety of scenarios without exposure to radiation, iodinated contrast or 
the need for anaesthetic drugs. 
2. To understand that the use of paediatric CEUS over conventional imaging 
pathways can result in significant cost reduction. 
3. To learn about the characterisation of focal liver lesions and follow up post 
trauma represent two of the commonest reasons for paediatric CEUS usage. 
The benefits of Shear Wave elastography in the liver  
N.N. 
The clinical advantages of advanced applications in the abdomen  
M. D'Onofrio; Verona/IT  
Shear Wave Elastography (SWE/ARFI) allows the assessment of the tissue 
stiffness. It is very important to consider that ARFI is implemented in the 
ultrasound scanner. Strength of the ARFI Virtual Touch Quantification 
technique relies in obtaining a number (meter/second or kilopascals) for the 
shear wave velocity generated in the explored tissue: the stiffer a tissue, the 
greater the numeric value. Several non-invasive methods are used for 
assessing liver fibrosis in order to avoid biopsy. Liver function tests and 
transient elastography are other non-invasive, sensitive and accurate tools. 
Many published studies analyse ARFI performance and feasibility in studying 
diffuse liver diseases and compare them to other diagnostic imaging modalities 
such as conventional US and transient elastography. Fewer papers describe 
the application of ARFI technology in the study of solid focal liver or pancreatic 
lesions, with different results. Contrast enhanced ultrasound can enhance the 
diagnosis of lesions and the use of SWE/ARFI can then improve the 
characterisation of these ultrasound detected pancreatic masses. Image fusion 
(CT/MRI & US) using eSieFusion can then be used in follow up and treatment 
to aid in more successful interventional exams, such as ablation procedures 
and response to therapies.  
Learning Objectives: 
1. To understand where using SWE can help in assessing tissue stiffness. 
2. To understand the benefits of contrast enhanced ultrasound imaging and 
where it is useful in clinical practice. 
3. To understand how the combination of SWE, CEUS and CT/MRI image 
fusion can be used to improve both detection and ablation of abdominal 
malignancies. 
  




Friday, March 2 
12:30 - 13:30  Room O  
organised by Philips 
SY 12  
Advances in iterative reconstruction and 
spectral CT: transforming the use of CT in 
routine practice 
Moderator:  
A. Vlassenbroek; Anderlecht/BE  
Iterative model-based reconstruction: basis of new imaging era  
D. Ippolito; Monza/IT  
Model-based iterative reconstruction is a new image reconstruction method 
which models the acquisition process, leading to image optimisation acting not 
only in the image domain but also in the projection domain (i.e. during the 
acquisition process). As a result, this algorithm can better deal with low signal 
levels in the setting of modern low dose acquisitions; in fact IMR can provide a 
significant reduction in image noise and streak artifacts, an increment of 
contrast-to-noise ratio and a significant improvement in spatial resolution, 
creating virtual “noise free” diagnostic images. Therefore the use of IMR may 
further improve the sensitivity and specificity of lesion’s detection also in follow-
up CT studies in different clinical setting (i.e. angiographic study, oncologic 
fields, emergency examinations), due to the increase of small details evidence. 
In summary, the main advantages of IMR in clinical practice are represented 
by high contrast resolution, subtle attenuation differences, applications in no 
compliant patients or patients with limited IV access or suboptimal acquisition 
timing, use of reduced radiation and contrast dose. 
Spectral CT for emergency imaging: luxury or necessity  
E. Danse; Brussels/BE  
This lecture is focused on the interest of dual layer spectral scanner detectors 
for its routine use in the visceral emergency spectrum, including severe 
traumatised patient, bowel obstruction and ischemic disorders, genitourinary, 
pancreatic and hepatobiliary situations. Spectral CT for acute aortic and 
peripheral arteries disorders will be also presented. Additionally, we propose to 
share our way of process for the analysis and the report of CT examinations 
done with the spectral system, compared to the conventional CT.  
The clinical validation of spectral benefits  
D. Maintz; Cologne/DE  
Spectral Detector CT offers new possibilities regarding image quality, dose 
reduction and diagnostic performance in clinical computed tomography. Using 
virtual monoenergetic images the contrast-to-noise ratio can be significantly 
increased and using material decomposition maps, such as e.g. iodine-maps, 
quantitative measurements of tissue components can be obtained. Over the 
last years systematic studies have been performed to evaluate the benefits in 
image quality, lesion detection and lesion characterisation. This lecture 
presents the scientific state-of-the-art and also gives an outlook on future 
spectral benefits.  
12:30 - 13:30  Room N  
organised by Hitachi 
SY 13  
Diverse and innovative imaging solutions, 
creating new value through innovation and 
digital technologies 
Moderator:  
P.S. Sidhu; London/UK  
Clinical usefulness of new fusion imaging for interventional kidney/liver 
procedures  
J.-M. Correas; Paris/FR  
The role of combi-elasto and attenuation measurement in the assessment 
of diffuse liver disease  
G. Ferraioli; Pavia/IT  
Value of high-field open MRI and ultrasound image fusion for the 
detection of prostate cancer  
C. Figge; Paderborn/DE  
12:30 - 13:30  Studio 2018  
organised by Samsung  
SY 14  
Innovations in Samsung's Digital 
Radiography Technologies 
Experiences with Samsung's Digital Radiography at Freiburg University 
Hospital  
E. Kotter; Freiburg/DE  
Initial experiences with Samsung's Digital Radiography (DR) technology at 
Freiburg University Hospital will be presented. Two specific DR technology 
utilising the deep-learning (DL) algorithms and their preliminary results will be 
introduced - bone suppression imaging (BS) and computer-aided detection 
(CAD) for lung cancer nodules. First, application of bone suppression imaging 
(BS) for various subtle lung lesions will be shown. Second, computer-aided 
detection (CAD) technology for lung cancer nodule detection will be introduced. 
The detection accuracies of CAD system, radiologists, and radiologists with 
CAD assistance in reading chest PA digital radiography images will be 
compared.  
Value of x-ray in the diagnosis and follow-up of rheumatic diseases  
K.-G.A. Hermann; Berlin/DE  
Initial experiences with Samsung's low-dose Digital Radiography technology 
will be presented. The speaker will share preliminary impressions from 
applying S-vue (TM) technology to diagnosis and follow-up of patients with 
rheumatic diseases of hands and feet.  
Innovations in digital radiography dose reduction by Samsung  
N.N. 
12:30 - 13:30  Room E1  
jointly organised by Bayer HealthCare and Siemens 
Healthineers 
SY 15  
Clear direction in CT: new standards for 
better patient care 
Moderator:  
J.E. Wildberger; Maastricht/NL  
The China CT standardisation initiative  
Z.Y. Jin; Beijing/CN  
CT imaging on the edge: kV adapted contrast administration  
U.J. Schoepf; Charleston, SC/US  
12:30 - 13:30  Room G  
organised by Bracco 
SY 16  
Programme not available by date of publication  
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12:30 - 13:30  Room K  
organised by Guerbet 
SY 17  
From Gd contrast-media stability to 
recommendations of the European 
Medicines Agency 
Moderator:  
O. Clément; Paris/FR  
Gd retention: back to basics  
R.E. Lenkinski; Dallas, TX/US  
Methodological approach for a correct interpretation of the gadolinium 
retention studies  
J.-S. Raynaud; Roissy/FR  
From evidence to the new recommendations of the European Medicines 
Agency  
O. Clément; Paris/FR  
12:30 - 13:30  Room M 1  
organised by Bayer Russia  
SY 18  
MR-perfusion in neuro-oncology: survival 
guide for daily practice 
Moderators: 
I.E. Tyurin; Moscow/RU  
S. Morozov; Moscow/RU  
I.N. Pronin; Moscow/RU  
DSC and DCE: what does it mean and how to cook it?  
H.R. Jäger; London/UK  
Primary diagnosis: when and why to use perfusion?  
E.I. Shults; Moscow/RU  
Evaluation after treatment: Q&A  
I. Trofimenko; St. Petersburg/RU  
12:30 - 13:30  Room M 2  
organised by Philips 
SY 19  
First impressions of new ultrasound 
developments 
Moderators:  
M. Claudon; Vandoeuvre-les-Nancy/FR  
R.G. Barr; Campbell, OH/US  
New eL18-4 PureWave transducer with shear wave elastography for 
breast exams  
R.G. Barr; Campbell, OH/US  
New Philips anatomical intelligent breast ultrasound solution  
K. Kinkel; Chêne-Bougeries/CH  
Potential of micro-flow imaging in bowel application  
P.-J. Valette; Pierre-Bénite/FR  
eL18-4 in small parts, musculoskeletal and abdominal exams  
A. McNeill; Newcastle Upon Tyne/UK  
12:30 - 13:30  Room M 3  
organised by Siemens Healthineers 
SY 20  
Medical image interpretation in the age of 
artificial intelligence 
Programme not available by date of publication  
14:00 - 15:30  Room X  
organised by GE Healthcare Russia 
SY 21  
Programme not available by date of publication  
14:00 - 15:30  Room Z  
organised by Carestream  
SY 25  
Carestream OnSight 3D Extremity System 
- Point Of Care CBCT 
Moderator:  
J.A. Carrino; Baltimore, MD/US  
Evolution of CBCT  
J.A. Carrino; Baltimore, MD/US  
The use of CBCT in clinical settings: the experience of Geneva University 
Hospital  
X. Montet; Geneva/CH  
Use of OnSight 3D in emergency settings  
T. Jacques; Lille/FR  
Clinical indications for weight-bearing CBCT  
M. Boesen; Copenhagen/DK  
Different generations of metal artefact reduction algorithms  
M. Kortesniemi; Helsinki/FI  
OnSight 3D workflow and usability  
R. Dobbin-Stacey; Cheltenham/UK  
  




Saturday, March 3 
12:30 - 13:30  Room X  
organised by Nocimed, Inc. 
SY 27  
The future is now: advancing lumbar spine 
diagnostics for better outcomes 
Advanced MR in the spine: a radiologist's view of the advanced 
techniques you need to know  
L. Tanenbaum; New York, NY/US  
Lumbar Disc MRS: can it help my daily practice? An integrated spine 
surgeon's perspective and experience with NOCISCAN-LS exams using a 
Siemens 1.5T scanner  
S. Becker; Vienna/AT  
12:30 - 13:30 Room Z  
organised by Kheiron Medical Technologies  
SY 26  
How new technology can support 
radiologists: the benefits and challenges 
of advanced machine learning in 
mammography 
Moderator:  
S. Tan; London/UK  
How learnings and best practices from digital health can help radiology  
V. Gulati; London/UK  
Perspectives on the challenges in developing ML for radiology: how ML 
can save breast screening  
H. Harvey; London/UK  
Deep learning in mammography  
P. Kecskemethy; London/UK  
12:30 - 13:30  Room L 8  
organised by Philips 
SY 22  
Enhanced diagnostic confidence with 
digital fluoroscopy 
Moderator:  
S. Mintert; Hamburg/DE  
Together with clinical experts we will outline, how a fully digital workflow and 
our innovations in image quality contribute to meet the day-to-day challenges 
in your radiology department.  
Real-time dose control, real-time image processing  
A. Gooßen; Hamburg/DE  
12:30 - 13:30  Room G  
organised by Bracco 
SY 23  
CEUS: evolving roles and uses 
Moderator:  
V. Cantisani; Rome/IT  
Vesicouretral reflux: the role of contrast ultrasound  
F. Papadopoulou; Ioannina/GR  
Update on the EFSUMB guidelines for the use of CEUS  
P.S. Sidhu; London/UK  
CEUS, a powerful diagnostic tool in daily practice: clinical case 
presentation  
D.A. Clevert; Munich/DE  
12:30 - 13:30  Room O  
organised by Siemens Healthineers 
SY 24  
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A 
Aadnevik D.  
Dose reduction: tips and tricks: A. Dose 
reduction in paediatric CT (RC 912), A-389  
Abd El Bagi M., Alshehre O., Alfaleh H., 
Ahmed S., Alorfi F., Ashraf N., Thomas A., 
Reutener M.  
Knee derangement in the era of total knee 
replacement epidemic (SS 310), B-0306  
Abd Ellah M.M.H., Strobl S., Rauch S., 
Halpern E.J., Kremser C., Jaschke W., 
Klauser A.  
Gouty knee arthritis: ultrasound findings 
compared to dual-energy CT (SS 1810), B-1423  
Abdel Aal A.M.K., Mahmoud K., Kim S., 
Heeke B., Moawad S., Massoud M., 
Saddekni S., A. Aboueldahab N., Gunn A.  
Outcomes of transjugular intrahepatic 
portosystemic shunt using 12-mm-diameter stent 
for portal hypertension with refractory ascites 
(SS 209), B-0034 
Abdel Aal A.M.K., Tatum S., Mahmoud K., 
Moawad S., Ertel N., Oser R., Saddekni S.,  
A. Aboueldahab N., Gunn A.  
Safety and efficacy of transarterial 
chemoembolization using very small drug-eluting 
beads for advanced stage hepatocellular 
carcinoma (SS 1409), B-1055  
Abdel Hamid W.R.A.  
MRI in endometriosis: a new platform  
(SS 607), B-0474  
Abdel Hamid W.R.A.  
DTI of the breast: is it worth the hassle? 
(SS 1402b), B-1113  
Abdel Razek N.M., Hamed M.  
Combined ultrasound-guided high-intensity 
focused ultrasound and vacuum assisted biopsy 
for treatment of large sized breast fibroadenoma 
(SS 1802a), B-1389  
Abdolell M., Brown P., Caines J., Payne J.I., 
Tsuruda K., Barnes P., Rivers-Bowerman M., 
Iles S.E.  
The impact of image quality and mammographic 
breast density on missed cancers in organised 
screening (SS 702), B-0684  
Abdolell M., Tsuruda K., Payne J.I., Brown P., 
Caines J., Barnes P., Rivers-Bowerman M., 
Iles S.E.  
Mammographic density, age and family history: 
a minimally sufficient set of parameters to risk 
stratify average-risk women for follow-up 
screening (SS 1902a), B-1606  
Abdullayev N., Neuhaus V., Le Blanc M., 
Grosse Hokamp N., Maus V., Lennartz S., 
Maintz D., Borggrefe J.  
Spectral detector-computed tomography iodine 
density thresholds for the detection of vertebral 
metastases (MY 13), B-1012  
Abeyakoon O., Woitek R.A., Wallis M., 
Moyle P.L., Morscher S., Malchus N., 
Manavaki R., Mendichovszky I.A., Joseph J., 
Quiros-Gonzales I., Bohndiek S., Gilbert F.J.  
Optoacoustic imaging increases the sensitivity of 
mammography and specificity of US: 
implications for practice (SS 1402a), B-1094  
Abidi Z., Faeghi F., Mardanshahi Z., 
Abdolmohammadi J., Haghighikaboudkola M.  
Comparison between grey matter-only and white 
matter-only imaging in the detection of brain 
multiple sclerosis lesions (SS 311), B-0287  
Abihanna M., Melodelima C., Moldovan P., 
Souchon R., Ruffion A., Colombel M., 
Crouzet S., Rouviere O.  
Impact of upfront risk stratification on the 
negative predictive value of multiparametric MRI 
in patients with no history of prostate cancer  
(SS 307), B-0245  
Abihanna M., Melodelima C., Moldovan P., 
Souchon R., Ruffion A., Colombel M., 
Crouzet S., Rouviere O.  
Impact of upfront risk stratification on the 
negative predictive value of multiparametric MRI 
in patients under active surveillance  
(SS 1407), B-1074  
Abrantes A.F., Gaspar V.L., Ribeiro L.P., 
Lesyuk O., Ribeiro A.M., Almeida R.P.,  
da Silva C.A.  
Internship supervisors' perception of the 
radiography students in clinical environment 
(SS 1414), B-1149  
Abrantes A.F., Sobral D.M., Ribeiro L.P.V., 
Azevedo K.B., Almeida R.P., Lesyuk O.  
Radiographers and non-accidental injury in 
children (SS 1914), B-1645  
Adam E.J.  
Euratom Basic Safety Standards Directive:  
a comprehensive approach for radiation 
protection: Panel discussion: Is the Basic Safety 
Standards Directive a step forward for patients, 
clinical professionals and regulators? (part 4) 
(EU 1)  
Adam E.J.  
Value-based radiology: Panel discussion:  
A European - US debate on the value of "value-
based radiology" (part 5) (PI 3)  
Adam E.J.  
Euratom Basic Safety Standards Directive:  
a comprehensive approach for radiation 
protection: The clinical audit: the missing link 
(EU 1), A-148  
Adam G.G.A., Cognard C., Bonneville F.  
Standard diffusion-weighted imaging on the 
brain detects cervical internal carotid artery 
dissections (SS 711b), B-0692  
Adams L., Ralla B., Engel G., Diederichs G., 
Busch J., Fuller F., Hamm B., Makowski M.R.  
Assessing venous thrombus in renal cell 
carcinoma: preliminary results for non-contrast 
enhanced magnetic-resonance 3D-SSFP  
(SS 207), B-0061  
Adriaensen M.  
ESR and UEMS: a united European voice: 
Chairpersons' introduction (part 2) 
(ESR/UEMS 1), A-179  
Agarwal A., Agarwal S., Sharma S.,  
Chandak S.  
Placenta accreta index: what a radiologist 
should know about an imaging update in 
detection of morbidly adherent placenta 
(SS 1907b), B-1667  
Aghaghazvini L., Hashemi F., Sharifian H., 
Rasuli B., Yazdani N.  
Cervical adenopathies: diagnostic efficacy of 
DCMR (SS 1508), B-1215  
Agten C.A., Dennler C., Rosskopf A.B., 
Jaberg L., Pfirrmann C.W., Farshad M.  
Augmented reality-guided lumbar facet joint 
injections (SS 1410), B-1123  
Ahmad M.  
The effect of oesophageal varices on the 
outcome of RF ablation in patients with HCC 
(SS 1509), B-1207  
Ahn H., Hwang S.I., Lee H.J.  
How to predict anterolateral extracapsular 
tumour extension in patients with prostate 
cancer (SS 1407), B-1066  
Ahn J., Kim S., Kim S., Nam I., Lee S.  
Diagnostic performance of advanced modelled 
iterative reconstruction-applied images for 
detecting urinary stones on submillisievert low-
dose computed tomography (SS 1807b), B-1474  
Ahuja B.  
MRI for gynaecologic imaging: how I do it: 
Chairperson's introduction (RC 1207), A-544  
Akata D.  
Imaging of HCC: C. Mimickers and pitfalls 
(E³ 520), A-244  
Akbas T., Ulus S., Karagun B.S., Arpaci T.  
Fast magnetic resonance imaging (MRI) of 
invasive lung aspergillosis in 
immunocompromised children: comparison with 
HRCT (SS 712), B-0763  
Akdulum I., Öztürk M., Karatoprak S.,  
Sıırcı A.  
Radiological appearance and follow up results of 
diaphragmatic mesothelial cysts during 
childhood (MY 18), B-1505  
Akgun A.S., Agirman M.  
Association between cam type femoroacetabular 
impingement and osteitis pubis on MR images 
(SS 1810), B-1422  
Akhan O.  
Image-guided therapies in oncology: Kidney 
(BS 6), A-411  
Akin M., Örgüc I.S., Aras F., Kandiloglu A.  
Molecular subtypes of invasive breast cancer: 
correlation between PET/CT and MRI findings 
(MY 16), B-1291 
Akinci D.  
Percutaneous interventional procedures:  
a practical guide: A. How to safely perform  
US-guided procedures (RC 809), A-365  
Akinci D'Antonoli T., Farchione A., 
Lenkowicz J., Chiappetta M., Cicchetti G., 
Larici A.R., Valentini V., Bonomo L.,  
Manfredi R.  
Radiomics signature for non-small cell lung 
cancer recurrence risk prediction after surgery: 
quantitative analysis of the tumour and 
peritumoural lung parenchyma on presurgical 
MDCT (SS 1004), B-0874  
Akkaya Z., Bas H., Oztuna D., sahin G.  
Imaging of aponeurotic expansion of 
supraspinatus tendon by 3.0 T MRI and its 
association with biceps brachii long head, 
supraspinatus and subscapularis tendon 
pathologies (SS 1010), B-0952  
Akkaya Z., Peker E., Ozalp Ates F.S., Sahin G.  
Sacroiliitis due to early ankylosing spondylitis, 
inflammatory bowel disease and Behçet's 
disease: could sacroiliac MRI play a role in 
differentiation? (SS 1910), B-1618  
Aksakal M., Ozhan Oktar S.,  
Esendaglı Yılmaz G., Özenirler S., Cindoruk 
M., Hızel K., Baran Aksakal F.N., Yucel C.  
Use of 2D shear-wave elastography in predicting 
different stages of liver fibrosis according to 
METAVIR scoring system: a histopathological 
correlation study (SS 301b), B-0205  
Aksenova S., Nudnov N., Kreynina J.  
MR-imaging of neoplastic and non-neoplastic 
lesions of the vagina (SS 1816), B-1375  
Al Dahery S., Rainford L.A., McGee A.  
A multi-centre study: qualitative and quantitative 
comparison of liver MR image quality  
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Al Mohanna J., Pipan F., Clauser P., 
Bumberger A., Stöttinger A., Kapetas P., 
Zuiani C., Helbich T.H., Baltzer P.A.T.  
A formalised clinical decision rule applied to 
breast MRI: can we rule-out malignancy in 
lesions presenting as suspicious mammographic 
microcalcifications? (SS 1002), B-0912  
Al-Murshedi S.H., Hogg P.H., Benhalim M.M., 
Alrowily M., England A.  
An investigation of the impact of image viewing 
parameter settings on the performance of 2.4 
MP colour monitor in visualising low contrast 
detail using the CDRAD phantom  
(SS 1814), B-1446  
Alagic Z., Alagic H., Bujila R., Wick M.C.  
The clinical impact of a novel low-dose protocol 
for minimal-invasive CT-guided musculoskeletal 
interventions (SS 1809), B-1341  
Alagna G., Cantisani V., Forte V.,  
De Soccio V., Di Leo N., Rubini A.,  
Di Segni M., D'Ambrosio F., Catalano C.  
Can S-detect provide accurate differentiation of 
thyroid nodules? - assessing the impact on the 
assessment made by operators with different 
experience (SS 708), B-0668  
Alahmadi M.S., Alharbi M., Mobark N.,  
Alsaad A.N., Daghriri A., Anver A.B., 
Althagafi M.S.J., Raja S.  
Predicting medulloblastoma genomic subtypes 
by exploiting MRI morphologic phenotypes 
(SS 1811b), B-1476  
Albano D., Messina C., Tagliafico A., 
Sconfienza L.M.  
How, when, why in magnetic resonance 
arthrography: an international survey by the 
European Society of Musculoskeletal Radiology 
(SS 1010), B-0955  
Albano D., Chianca V., Galia M., Cuocolo R., 
Bignone R., Messina C., Sconfienza L.M., 
Brunetti A., Lagalla R.  
T2-mapping of the sacroiliac joints at 1.5T:  
a reproducibility study (SS 1910), B-1616  
Alberich-Bayarri A.  
Everything you need to know about 3D  
post-processing: A. 3D post-processing in 2018  
(RC 105), A-047  
Alberich-Bayarri A.  
Artificial intelligence and big data in medical 
imaging: IT infrastructure, data sharing methods 
and data analysis aspects (PC 15), A-734  
Albrecht M., De Cecco C.N., Otani K.,  
Nance J.W., Varga-Szemes A., De Santis D., 
von Knebel Doeberitz P., Vogl T.J.,  
Schoepf U.J.  
Diagnostic accuracy between low and high tube 
voltage third-generation dual-source coronary 
CT angiography using tailored contrast medium 
injection protocols (SS 703), B-0752  
Albrecht M., Baumann S., Nance J.W.,  
De Cecco C.N., Varga-Szemes A., 
Vliegenthart R., Schwemmer C., Vogl T.J., 
Schoepf U.J., Martin S.S.  
Machine-learning on-site CT-derived fractional 
flow reserve (FFR) compared to invasive FFR: 
influence of myocardial mass on accuracy 
(MY 7), B-0776  
Albrecht M., Varga-Szemes A., De Cecco 
C.N., Vogl T.J., Nance J.W., De Santis D.,  
Eid M., Piccini D., Schoepf U.J.  
Diagnostic accuracy of non-contrast self-
navigated free-breathing MRA in paediatric 
patients with coronary anomalies using CTA as 
reference standard (SS 1503), B-1232  
Albweady A.A., Raja S., George S.,  
Alharbi M., Aldossari K.  
Myocardial textural analysis and machine 
learning for differentiating normal myocardium vs 
chronic infarct on non-contrast CT scan 
(SS 1003), B-0982  
Alcalá-Galiano A.  
MR imaging of the knee: A. Cruciate ligaments: 
what to know and do (RC 1710), A-920  
Alfaqih M., Soni S., Flacke S., Andrabi Y., 
Elentuck D., French R.  
Inferior glenohumeral vertical distance: a novel 
radiographic marker better suited for detection of 
rotator cuff tears involving the infraspinatus 
tendon (SS 1010), B-0951  
Alfayate Sáez E., de la Cámara Egea M.A., 
Vega de Andrea N.I.  
Making the most of social media: The value of 
social media to professional societies 
(EFRS WS), A-789  
Alì M., Monti C.B., Carbone F.S., Secchi F., 
Cannao' P.M., Sardanelli F.  
Quantitative oedema and late gadolinium 
enhancement thresholds for the diagnosis of 
myocarditis in suspect cases (MY 7), B-0786  
Ali R.M.K.M., England A., Mercer C.E.,  
Tootell A.K., Hogg P.H. 
Impact of contralateral breast shielding on the 
risk of developing radiation-induced cancer from 
full field digital mammography (FFDM) screening 
(SS 214), B-0135  
Ali T.F.T.  
Diffusion-weighted MRI in prostatic lesions: 
diagnostic performance of normalised ADC 
using normal peripheral prostatic zone as a 
reference (SS 307), B-0247  
Alison M.  
Paediatric MRI: can we make gadolinium 
superfluous?: Chairperson's introduction 
(SF 13b), A-648  
Alkadhi H.  
Emergency radiology I: A. Acute aortic 
syndrome (E³ 121), A-001  
Alkadhi H.  
Dose reduction and image quality implications of 
iterative image reconstruction in CT: B. Iterative 
image reconstruction in clinical practice (dos and 
don'ts) (RC 1513), A-784  
Allard P., Bridoux A., Longere B., Silvestri V., 
Schmidt M., Forman C., Pontana F.  
Compressed sensing real-time cine imaging in 
patients with cardiac arrhythmia: does it help to 
reduce mistriggering artefacts?  
(SS 1403),  B-1156  
Allen C.  
Focal treatment of prostate cancer: Imaging of 
prostate cancer: how accurately can prostate 
cancer be localised? (SF 9a), A-397  
Allimant C., Kafrouni M., Delicque J.,  
Ilonca A., Fourcade M., Mariano-Goulard D., 
Cassinotto C., Piron L., Guiu B.  
Tumour targeting and 3D voxel-based dosimetry 
to predict tumour response, toxicity and survival 
after Y-90 resin microsphere radioembolisation 
in HCC (SS 1409), B-1057  
Almehmi A., Narasimha Krishna V.,  
Abdel Aal A.M.  
Cumulative patency rate of forearm vs upper 
arm arteriovenous dialysis fistulae  
(SS 1009), B-0866  
Alqahtani F., Messina F., Offiah A.C.  
Assessment of a 33-point software programme 
for the identification of vertebral fractures in 
children (SS 212), B-0158  
Alqahtani S.J.M., Knapp K., Palfrey R.M., 
Meakin J.R.  
Construction of obese phantoms for dose 
optimisation and image quality purposes  
(SS 714), B-0746  
Alqahtani S.J.M., Knapp K., Palfrey R.M., 
Meakin J.R.  
Fabrication of fat tissue-equivalent substitutes 
(FTES) and lean tissue-equivalent substitute 
(LTES) to underpin obese phantom construction 
(SS 714), B-0751  
Alsharif W., Davis M., Rainford L.A.,  
McGee A.  
The impact of the smartphone application (app) 
on MR radiographers' knowledge and 
confidence in relation to MR image-quality-
related errors (MY 17), B-1300  
Alster T., Carmon E., Maly B., Sella T.  
The incremental value of preoperative MRI for 
evaluation of extent of disease in IDC vs ILC  
(SS 1002), B-0916  
Altamash M., Grover S.B., Suman S.,  
Katyan A., Kumar A., Mandal A.K.  
Contrast-enhanced ultrasound in evaluation of 
renal masses: a preliminary experience  
(SS 207), B-0054  
Altay Ç.M., Düsünceli Atman E., Uzun C., 
Arslan M.F.  
Should breast artery calcifications be graded? 
(SS 202b), B-0098  
Altman A.  
Single-dual-multi-energy CT:  
B. Photon counting detectors in diagnostic CT 
(RC 113), A-035  
Alukic E., Škrk D., Mekis N.  
Dose reduction with PA projection in lumbar 
spine radiography (SS 714), B-0745  
Alves E.D., Zorzenon C.d.F., Bienes G.H.A.A., 
Ferraz H.B., Carrete Jr H.  
MR imaging of the Parkinson's syndrome: a 
pictorial essay (SS 1511), B-1233  
Amarnath C.  
State-of-the-art paediatric neuroradiology: 
Chairperson's introduction (RC 811), A-335  
Amato F., Orlando A., Di Vittorio M.,  
Safina M., Bartolotta T.V., Ienzi R.  
Background parenchymal enhancement in MRI, 
mammographic density and risk of breast cancer 
(SS 1902a), B-1614  
Amaxopoulou C., Geiger J., Grehten P., 
Gnannt R., Bode P., Moehrlen U.  
Magnetic resonance imaging of congenital lung 
lesions (SS 1412), B-1166  
Amini N., Fomekong E., Raftopoulos C., 
Vande Berg B.  
Disc and vertebral changes after spinal fusion at 
serial CT imaging: correlation with discstability 
(SS 610a), B-0438  
Amodeo E., Contegiacomo A., Attempati N., 
Paladini A., Di Stasi C., Manfredi R.  
Renal artery embolisation for vascular lesions 
following Nephron-sparing surgery: a five-year 
experience (SS 1009), B-0861  
Anastasia T., Pronin I., Fadeeva L., 
Kornienko V.  
3D MRSI biomarkers of glial tumour  
(SS 1811b), B-1484  
Andersson B.  
Radiography research: a how to guide:  
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Andersson B.T.  
Patient-doctor relationship and interdisciplinary 
communication in the radiology department:  
A radiographer's point of view (PA 1), A-695  
Ando S.M., Coelho F.M., Viana P.C.,  
Gomes L.G., Fragoso M.B.V., Yamauchi F.I.  
Diagnostic accuracy of primary macronodular 
adrenal hyperplasia on CT: a quantitative and 
qualitative study (SS 1007), B-0877  
Andrade S., Velasco S., Bermúdez S.,  
Useche N., Morillo A.J.  
Scannographic density of intracranial venous 
sinuses in healthly patients and diagnosed with 
venous thrombosis at 2600 meters above sea 
level from 2008 to 2016 (SS 711b), B-0694  
André A., Pinto J., Oliveira D., Aguiar C., 
De Francesco S., Oliveira A., Marques A., 
Martins P.  
Development and reliability of an ultrasound 
protocol to evaluate quadriceps muscle mass 
and diaphragm structure: a pilot study 
(SS 1014), B-0963  
Andreani O., Gendre P., Dekimpe C., 
Rudel A., Amoretti N., Boileau P.  
Postoperative evaluation of a arthroscopic 
coracoid bone block surgery with CT-Scan. 
(MY 13), B-1025  
Andreani O., Dekimpe C., Raffaelli C., 
Amoretti N.  
Learning curve of an ultrasound-guided 
percutaneous release of carpal tunnel:  
a cadaveric study (MY 13), B-1027  
Andreini D., Mushtaq S., Pontone G.,  
Annoni A.D., Formenti A., Mancini M.E., 
Guglielmo M., Bartorelli A.L., Pepi M.  
Diagnostic accuracy of coronary CT angiography 
performed with a novel whole-heart coverage 
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know: C. Practical MRI: a toolkit of standard MR 
pulse sequences (RC 1613), A-846  
Hahn A., Sauppe S., Knaup M., Kachelrieß M.  
Moving metal artifact reduction (MMAR) for 
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competencies through simulation  
(SS 1414), B-1143  
Harris E.  
New imaging approaches for radiotherapy: 
Ultrasound imaging in radiotherapy: "old" 
technology with new applications in RT? 
(ESR/ESTRO), A-886  
Harris M.A., Hardy M.  
Evaluating the roles of CT radiographers in the 
UK (MY 17), B-1308  
Hartmann I.  
Pneumonia: A. Community-acquired pneumonia 
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a population-based screening programme 
(SS 202a), B-0076  
Hovda T., Holen Å.S., Bjørndal H., 
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enhanced computed tomography scans of 
polytraumatised patients (SS 317), B-0294  
Kim D., Kang B., Ko Y.  
Can we diagnose T1 stage UB (urinary bladder) 
cancer from T2 stage with an inchworm/stalk 
sign on 3T-MRI? (SS 207), B-0062  
Kim D., Kim C., Lee K., Choo J., Kang E.,  
Oh Y.  
Impact of iterative model reconstruction on the 
correlation between CT quantification of 
emphysema and airway measurements and 
pulmonary function test in the normal study 
cohort (SS 704), B-0639  
Kim D., Kim C., Lee K., Kang E., Oh Y.,  
Kim H., Cha J.  
The optimal energy level of virtual 
monochromatic images from spectral CT for 
reducing beam-hardening artefacts due to 
contrast media in the thorax (SS 1413), B-1132  
Kim D., Park S.  
Percutaneous cryoablation for renal cell 
carcinoma using US-guided targeting and CT-
guided ice-ball monitoring: procedure time, 
radiation dose and mid-term outcomes  
(SS 207), B-0058  
Kim H., Yoon S.H., Hong H., Hahn S.,  
Goo J.M.  
A meta-analysis of a UIP pattern on CT: is 
surgical lung biopsy necessary in patients with a 
possible UIP pattern? (SS 204), B-0044  
Kim H., Kim H., Jang S.  
Value of structured report form for appendix 
ultrasound in paediatric patients: can we reduce 
negative appendectomy and additional CT?  
(SS 612), B-0577  
Kim J., Chung W.S., Jang H.Y., Kim H.C., 
Kang T.S., Lee H.J., Sohn J.S.  
Perivascular infiltration and histologic difference: 
is it helpful to determine T stage of advanced 
gastric cancer in CT? (SS 701b), B-0718  
Kim M., Hwang J., Choo K., Ryu H., Kim Y.  
Comparison of image quality of the 
abdominopelvic computed tomography in 
paediatric patients: low-osmolar contrast media 
vs less iodine-containing iso-osmolar contrast 
media (SS 612), B-0575  
Kim M., Park J., Kim H.  
Building an apparent diffusion coefficient 
radiomics to yield high diagnostic performance in 
identifying atypical primary CNS lymphoma 
mimicking glioblastoma (SS 211), B-0087  
Kim S.W., Ryu H., Kim Y.R., Lee Y.H., Yoon K.  
Quantitative evaluation of liver function using 
coefficient of variation value and contrast 
enhancement index (CEI) on gadoxetic acid-
enhanced MR imaging in preoperative 
evaluation (SS 201a), B-0005  
Kim T.M., Kim S., Cho J., Kim S.  
Clinical value of low-kiloelectron volt 
monoenergetic images of dual energy computed 
tomography for evaluation of peritoneal seeding 
of ovarian cancer (SS 707), B-0645  
Kim W.  
The new horizon for radiology: What will the 
radiologist’s job look like in 2025?  
(NH 14), A-723  
Kim W.  
Deep learning: Keynote lecture (SS 1805), K-28  
Kim Y.W., Debray M.P., Fetita C., Fouque O., 
Aubier M., Brillet P.-Y.  
Bronchial wall changes after thermoplasty in the 
treatment of severe asthma: CT scan 
assessment at 3 months (MY 5), B-0414  
King A.D.  
Post-treatment imaging of the head and neck:  
C. Treatment monitoring for early detection of 
recurrence (RC 1308), A-624  
King A.D.  
Distant metastases of head and neck cancer: A. 
Incidence and prognosis of synchronous cancer 
or distant metastases from head and neck 
tumours (E³ 926), A-434  
King S.  
How can we improve the patient experience of 
nuclear medicine hybrid imaging procedures?  
A systematic review of the evidence  
(MY 17), B-1304  
Kinkel K.  
New Philips anatomical intelligent breast 
ultrasound solution (SY 19)  
Kinkel K.  
Gynaecological and obstetrics: Chairperson's 
introduction (E³ 1523), A-767  
Kintzelé L., Rehnitz C., Kauczor H.-U.,  
Weber M.-A. 
Oblique sagittal images prevent underestimation 
of neuroforaminal stenosis grade caused by disc 
herniation in cervical spine MRI  
(SS 610a), B-0437  
Kirchner J., Sawicki L.M., Tschischka A.F., 
Umutlu L., Herrmann K., Schaarschmidt B.M., 
Antoch G., Heusch P.  
Comparison of 18FDG PET/CT and 18FDG 
PET/MRI for thoracic staging in lung cancer 
patients (SS 616), B-0584  
Kirkbride T.E., Anderson N., Raja A.Y.  
Use of calcium chloride as a calibration phantom 
material to aid identification of clinically 
significant compounds with spectral CT 
(SS 713), B-0731  
Kirschke J. 
Advanced and accelerated neuro imaging on a 
next generation wide-bore 3.0T MRI to 
simultaneously address clinical and research 
needs (SY 5) 
Kishida Y., Shinichiro S., Yoshikawa T.,  
Yui M., Kassai Y., Kyotani K., Ohno Y.  
Computed diffusion-weighted image: utility for 
differentiation of malignant from benign 
pulmonary nodules as compared with actually 
obtained diffusion-weighted image  
(SS 1904b), B-1573  
Kitao A., Matsui O., Yoneda N., Kita R., 
Kozaka K., Kobayashi S., Minami T., Koda W., 
Gabata T.  
Differentiation between hepatocellular carcinoma 
showing uptake of gadoxetic acid and focal 
nodular hyperplasia (SS 301a), B-0198  
Kitrou P., Papadimatos P., Katsanos K., 
Spiliopoulos S.C., Christeas N.,  
Karnabatidis D.  
Lysis-assisted balloon (LAB) thrombectomy - a 
method for declotting thrombosed arteriovenous 
dialysis grafts: results from a retrospective 
analysis of 241 endovascular procedures 
(SS 1009), B-0865  
Kjaer A.  
Molecular imaging in oncology: B. Imaging of 
proliferation (RC 406), A-157  
Kjelle E., Lysdahl K.B., Olerud H.M., 
Myklebust A.  
Implementing mobile radiography services: a 
qualitative study of managers' experiences of 
success criteria and barriers to overcome 
(MY 17), B-1302  
Kjelle E., Kleven L., Olerud H., Melberg H.  
Radiography on wheels for nursing home 
residents may reduce healthcare costs  
(MY 17), B-1311  
Klang E., Frid M., Diamant I., Ben Cohen A., 
Di Segni M., Konen E., Greenspan H.,  
Amitai M.M.  
Automatic liver metastases detection on CT 
using multi-class patch based convolutional 
neural networks (SS 605), B-0486  
Klauser A.  
Elastography of superficial structures: where are 
we now?: Is there any value in tendon and nerve 
assessment? (WG/EFSUMB 1), A-105  
Klauser A.  
Musculoskeletal ultrasound in the management 
of sports injuries: B. Ultrasound of the hip and 
knee: what is it good for and what are its 
limitations? (RC 810), A-347  
Kleber F.  
Drug elution or drug illusion in vascular disease: 
Drug-eluting balloons and stents, technology 
and biological interaction: lessons learned from 
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Klompenhouwer E., Beets-Tan R.G.H.,  
De Boer M., Trebeschi S., Prevoo W., 
Lambregts D.M., Beets G.L., Maas M.  
CT texture parameters to evaluate outcome after 
thermal ablation for colorectal liver metastases 
(SS 1509), B-1204  
Klontzas M.  
Radiologic anatomy: lower extremities: Knee 
(ESR/ESOR 1), A-254  
Knopp M.V., Briley-Saebo K., Menendez M.I., 
Siva A., Binzel K., Zhang J.  
Small animal imaging using a clinical PET/CT 
system: high throughput imaging enabled by 
next-generation digital PET (SS 1006), B-0993  
Knopp M.I., Wright C.L., Binzel K., 
Giesel F.L., Zhang J., Maniawski P.,  
Knopp M.V.  
A 2 minute, ultra-fast wholebody PET/CT 
enabled by digital photon counting PET detector 
technology (SS 1016a), B-0888  
Kocak B., Zeynalova A., Kizilkilic O.,  
Kocer N., Islak C.  
Added value of c-arm contrast-enhanced cone-
beam CT to routine contrast-enhanced MRI in 
evaluation of sporadic intracranial cavernous 
malformations for detecting associated DVAs 
(SS 711b), B-0687  
Köcher M.  
Peripheral vascular malformations: what every 
radiologist should know: A. The diagnostic 
assessment (RC 115), A-043  
Koh D.-M. 
Advanced MR techniques and imaging 
biomarkers: Chairperson's introduction  
(E³ 420), A-164  
Koh D.-M. 
Immunotherapy: a revolution in cancer care?: 
The MR armoury in follow-up (NH 9), A-387  
Kohler R.  
Head and neck emergencies: Chairperson's 
introduction (SF 12c), A-540  
Kohler R.  
Pathways for tumour spread: C. Pathway for 
laryngeal and hypopharyngeal tumour spread 
(RC 408), A-112  
Kolb A., Chiari C., Windhager R.  
The patella-shape: is it relevant to the analysis 
of patella malalignment? (SS 1810), B-1428  
Kolbitsch C.  
Motion artefacts and their management in 
medical imaging: C. Motion compensation in MR 
and PET imaging (RC 1313), A-656  
Kolossvary M., Karady J., Szilveszter B., 
Kitslaar P., Merkely B., Maurovich- Horvat P.  
Napkin-ring plaques can be identified on 
coronary CT angiography images using radiomic 
analysis (SS 703), B-0754  
Kolossvary M., Szilveszter B., Karady J., 
Merkely B., Maurovich-Horvat P.  
Effect of image reconstruction algorithms on 
cardiovascular radiomic features using coronary 
CT angiography (SS 703), B-0761  
Konietzke P., Weinheimer O., Wielpütz M., 
Wagner W., Heussel P., Heussel C.,  
Kauczor H.-U., Herth F.J., Schuhmann M.  
Use of quantitative computed tomography to 
assess post-interventional long-term changes 
after bronchial thermoplasty in patients with 
severe asthma (SS 304), B-0240  
Koo A., Smith J.T.  
Learning from our errors: what are the common 
clinically important errors that radiologists 
repeatedly make in the UK’s largest teaching 
hospital and how can we best address them? 
(SS 1001a), B-0844  
Kool D.R.  
Emergencies following tumour therapy: 
Chairperson's introduction: The role of imaging 
in the early detection of complications in 
oncologic treated patients (E³ 1726b), A-940  
Kool D.R.  
Non-traumatic emergencies: Keynote lecture 
(SS 1017), K-18  
Kopp C.W.  
How can radiologists expand their role in 
peripheral vascular intervention?: How to 
improve your clinical knowledge (PC 9), A-429  
Kopp F.K., Bippus R., Mei K., Sauter A., 
Schwaiger B.J., Gersing A., Dangelmaier J., 
Rummeny E.J., Noel P.B.  
Endoleak detection with ultra-low radiation 
exposure CT based on sparse sampling and 
reduced tube current (SS 1413), B-1136  
Kortesniemi M.  
CT examination of pregnant patients: a dilemma 
for the radiologist and the mother: How to 
reduce radiation dose and keep CT diagnostics 
(SF 8a), A-310  
Kortesniemi M. 
Different generations of metal artefact reduction 
algorithms (SY 25) 
Kortesniemi M.  
Dose reduction and image quality implications of 
iterative image reconstruction in CT: A. Basics of 
iterative image reconstruction in CT  
(RC 1513), A-783  
Koryukova K., Bezzi M., Di Martino M., 
Ginanni Corradini S.G., Rossi M., Catalano C.  
Up to seven criteria for liver transplantation: a 
single-centre experience (SS 601a), B-0429  
Koryukova K., Rossi M., Di Martino M.,  
Saba L., Ginanni Corradini S.G., Catalano C.  
High-field-strength MR imaging of the liver at 
3.0T: comparative study with 1.5 T in cirrhotic 
population (SS 701a), B-0608  
Koryukova K., Saba L., Di Martino M., 
Catalano C.  
Respiratory motion artefact affecting hepatic 
arterial phase MR imaging: comparison between 
gadoxetate disodium and gadobenate 
dimeglumine (SS 701a), B-0611  
Kossov F., Bulychkin P., Romanov D., 
Shorikov M.A., Tarachkova E., Panov V., 
Tkachev S., Dolgushin B.,  
Hagverdiyeva G.  
Could mpMRI really improve the detection of 
clinical recurrence of prostate cancer with low 
PSA value and efficacy of radiation treatment? 
(SS 1516), B-1248  
Kossov F., Abdullin I.I., Kamolov B.,  
Olimov B., Orlov O., Panov V., Tyurin I., 
Fedorenko E., Kapustin V.  
The accuracy of MRI/TRUS fusion biopsy in 
detection of high-risk prostate cancer vs random 
biopsies: advertisement or necessary 
innovation? (SS 1907a), B-1561  
Kotter E.  
Daily use of mobile devices in radiology: A. What 
did mobile devices change in radiology 
education? (RC 805), A-361  
Kotter E. 
Experiences with Samsung's Digital 
Radiography at Freiburg University Hospital  
(SY 14) 
Kottlors J., Kabbasch C., Maus V.,  
Mpotsaris A., Borggrefe J.  
Combined measurements of clot density in 
unenhanced and enhanced CT of acute 
ischaemic stroke in complete vessel occlusions 
of the medial cerebral artery predict 90 day 
patient outcome (SS 611), B-0515  
Koutsouleris N.  
Psychoradiology: a blend of molecular, 
functional and structural imaging with a taste of 
psychology: Can images predict psychiatric 
diagnosis and treatment response?  
(MS 16), A-830  
Kovacevic D., Papageorgiou I., Chelaru R.L., 
Winzler S., Malich A.  
Whole-body MRI for bone metastasis detection 
in prostate cancer: the roles of static field 
intensity and contrast media in focus  
(SS 1407), B-1069  
Kozák L.R., Gyebnár G., Szabo A.G.,  
van Graan A.L., Barsi P., Lemieux L.,  
Rudas G.  
Optimising pre-surgical fMRI language mapping 
using knowledge derived from intrinsic 
connectivity brain networks for personalised 
therapy planning (SS 1911b), B-1680  
Krainik A.  
Altered mental state: C. MRI in the diagnosis of 
Alzheimer's disease (RC 1311), A-639  
Krajina A.  
Portal hypertension and interventional radiology 
(IR): C. Transjugular intrahepatic portosystemic 
shunt (TIPS): critical appraisal of techniques and 
guidelines for treatment (RC 109), A-053  
Kramer J.  
Knee: Chairperson's introduction  
(E³ 1019), A-466  
Kraus B.  
Radiography research: a how to guide: How to 
critically appraise a research article  
(BR 1), A-550  
Kraus M.S., Esser M., Teufel M., Fleischer S., 
Riethmueller J., Ruff C., Tsiflikas I.,  
Schäfer J.F.  
Pulmonary MRI: diagnostic performance and 
detection of structural abnormality using 
ultrashort echo time in cystic fibrosis patients 
(SS 712), B-0764  
Kräuter C., Reiter U., Reiter C., Schmidt A., 
Fuchsjäger M.H., Stollberger R., Reiter G.  
Impact of local native T1 times on pixel-wise 
quantification of myocardial blood flow  
(SS 1403), B-1151  
Kreitner K.-F. 
Shoulder: A. Post-traumatic (E³ 719), A-289  
Kreitner K.-F. 
Shoulder MRI: mastering technique and making 
my report relevant: B. Rotator cuff tears: what 
are they and what do they look like?  
(RC 1210), A-570  
Krestin G.P.  
EIBIR Research Session: European imaging 
researchers united in diversity: Chairperson's 
introduction (EIBIR 1), A-319  
Kriachok I., Novovsad O., Skrypets T., 
Gorbach A., Kmetyuk Y., Kozlova O.,  
Novikov M., Mikhalska L., Kozlov V.  
Quantitative PET parameters in predicting event 
free survival in patients with hodgkin lymphoma 
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Kroencke T.J.  
Urogenital interventions: Keynote lecture  
(SS 1909), K-30  
Kroll J.  
Forensic imaging: A. Disaster victim 
identification (RC 114), A-039  
Krombach G.A.  
Peritoneum and mesentery: C. From misty 
mesentery to mesenteritis (E³ 1622), A-869  
Kromrey M., Schäfer S., Ittermann T.,  
Mensel B., Kühn J.  
Impact of personality and experience of 
interventional radiologists in outcome of CT-
guided percutaneous lung biopsies  
(SS 609), B-0447  
Kröpil P., Thomas C., Bethge O.T., 
Klosterkemper Y., Aissa J., Appel E., 
Schleich C., Antoch G., Boos J.  
Implementation of updated ACR size-specific CT 
diagnostic reference levels based on water-
equivalent diameter and SSDE using automated 
dose monitoring software (SS 313), B-0319  
Kubik-Huch R.A.  
MRI for gynaecologic imaging: how I do it:  
B. Contrast agents (RC 1207), A-546  
Kubik-Huch R.A.  
Gynaecological and obstetrics: A. Imaging of the 
uterus (E³ 1523), A-768  
Kuchcinski G., Jacquiez C., Baroncini M., 
Dumont J., Delmaire C., Defebvre L.,  
Pruvo J.-P., Leclerc X.  
Sulcal-based morphometry for the diagnosis of 
normal-pressure hydrocephalus in patients with 
ventriculomegaly (SS 1411a), B-1040  
Kuhl C.K.  
MRI for early detection, staging and 
management of breast cancer: C. Screening 
with abbreviated protocols (RC 1202), A-556  
Kuhl C.K.  
Breast MRI: Keynote lecture (SS 1002), K-16  
Kul M., Kuru Öz D., Erden A.  
Pathologic alterations in hepatic vasculature in 
primary sclerosing cholangitis: correlation with 
morphologic spectrum and abnormal 
hyperintensity in T2-weighted MR images  
(SS 1801), B-1322  
Kumar S.  
My three top tips for neuroimaging: 
Hydrocephalus (SF 15c), A-758  
Kumari S., Mohammad Zakir M., Kirubha Y., 
Sudhakar K., Chatterjee P., Ranjan R., 
Kumari J., Kumari S., Khan S.  
Role of phase contrast MR CSF flowmetry study 
in the evaluation of normal pressure 
hydrocephalus (SS 1911b), B-1675  
Kuplevatskaya D.I., Babiy A., Vorobyov N., 
Kuplevatsky V.I., Berezina N., Cherkashin M.  
MRI-based treatment response assessment for 
liver metastasis stereotactic radiotherapy 
(SS 1416), B-1078  
Kural Rahatli F., Yildirim Donmez F.,  
Kesim Ç., Haberal k., Turnaoglu H.,  
Agildere A.  
Can unenhanced brain magnetic resonance 
imaging be used in routine follow-up of 
meningiomas to avoid gadolinium deposition in 
the brain? (SS 1011b), B-1004  
Kurochkina N., Moroz A., Konovalov R., 
Krotenkova M., Illarioshkin S.  
Neuroimaging signs and features of brain 
lesions in patients with CADASIL  
(SS 711b), B-0696  
Kuru Öz D., Peker E., Kul M., Erden A.  
Comparison of stiffness values of peripheral and 
central liver tissues with MR elastography in 
patients with primary sclerosing cholangitis 
(SS 1001a), B-0842  
Kurz K.D.  
Inflammatory and infectious CNS pathology:  
B. Infectious encephalitis (RC 1211), A-559  
Kwon Y., Moon W., Park M., Kim H., Choi J.  
3D neuromelanin imaging for differential 
diagnosis between Parkinson disease and 
essential tremor: a multicenter retrospective 
study (MY 8), B-0801  
L 
La Grutta L., Clemente A., Maffei E., 
Privitera G., Rengo M., Toia P., Francone M., 
Midiri M., Cademartiri F.  
Results from the Italian Registry of Contrast 
Material use in Cardiac Computed Tomography 
(IRCM-CCT) (SS 603), B-0565  
Lacey S., Mulholland K., Fancourt N.,  
O'Brien K., de Campo J., de Campo M.  
World Health Organization guidelines for 
achieving high-quality paediatric chest 
radiographs for use in epidemiological studies 
(SS 712), B-0765  
Lahaye M.J.  
Tumour response assessment in abdominal 
imaging: B. Rectal carcinoma (RC 1601), A-808  
Laitinen H.M.S., Niiniviita H., Saukko E., 
Svedström E.  
The optimised location to assist patient during 
imaging of scoliosis with EOS system device 
(SS 1814), B-1447  
Lamb H.J.  
Cardiac MRI: from sequence to bedside:  
B. Spectroscopy: implications of myocardial 
metabolism? (E³ 1326a), A-619  
Lang K., Arboleda C., Forte S., Wang Z., 
Kubik-Huch R., Stampanoni M.  
Exploring contrast agents in phase-contrast x-
ray mammography: an ex vivo pilot study  
(SS 1802b), B-1417  
Langenbach M.C., Kaup M., Beeres M., 
Scholz J., Park C., Frellesen C., Vogl T.J., 
Gruber-Rouh T.  
Use of conventional defecography or dynamic 
MRI defecography in patients with symptomatic 
pelvic floor dysfunction: a retrospective 
intraindividual trial (SS 601b), B-0528  
Laniado M.  
Gastrointestinal: 'the gut': Stomach  
(BS 2), A-064  
Lansier A., Bourillon C., Jantzen R., Ragot E., 
Follin A., Berger A., Clement O., Halimi P., 
Cuenod C.A.  
Evaluation of CT and clinical features of bowel 
and/or mesenteric injury in blunt abdominal 
trauma: a case-control study (SS 317), B-0293  
Lapteva M., Shorikov M., Frantsev D., 
Sergeeva O.N., Virshke E., Dolgushin B.  
Evaluation of tumour response in patients with 
neuroendocrine hepatic metastasis treated using 
transarterial chemoembolisation (TACE) on MRI 
(SS 1901a), B-1512  
Lara Nuñez D., Gonzalez Balboa P., Chapa 
Ibargüengoitia M., Fuentes Corona R.E., 
Candanedo González F., Licano Zubiate M., 
Castro German K.P.  
Imaging findings of papillary lesions of the breast 
with histopathologic correlation: a five-year study 
from Instituto Nacional de Ciencias Médicas y 
Nutrición "Salvador Zubirán"  
(SS 1402a), B-1092  
Larici A.R.  
Updates on lung cancer management: 
Chairperson's introduction (E³ 918), A-446  
Larici A.R.  
Oncologic imaging: A. Lung cancer: key signs in 
the new TNM (E³ 1321), A-603  
Larsen V., Traply C.T., Mussmann B.R.  
Improved image quality and reduced radiation 
dose in trauma CT using a custom arm rest 
pillow (SS 317), B-0288  
Larsson E.-M.B.  
When to use hybrid imaging: Differentiating 
radiation necrosis from tumour recurrence: do 
we need hybrid imaging? (ESR/ESHI), A-202  
Lassalle L., Eminian S., Buisson A.,  
Pessis E., Campagna R., Regnard N.E., 
Khaled W., Moya L., Drape J.L.  
MRI characteristics of 26 onychomatricomas  
(SS 210), B-0117  
Lassalle L., Lapegue F., Guerini H., 
Campagna R., Vuillemin V., Regnard N.E., 
Buisson A., Drape J.L.  
MRI patterns of locked metacarpophalangeal 
joints of the long fingers (SS 310), B-0302  
Lauenstein T.C.  
The ten-minute abdominal MRI: make the dream 
come true!: Liver (SF 8c), A-350  
Lauenstein T.C.  
Pancreatic tumours: C. Tough clinical cases  
(E³ 1422), A-706  
Laukamp K.R., Lennartz S., Neuhaus V., 
Grosse Hokamp N., Rau R., Le Blanc M., 
Abdullayev N., Maintz D., Borggrefe J.  
Complementary metal artefact reduction of total 
hip replacements by monoenergetic and O-MAR 
reconstructions in spectral-detector computed 
tomography (MY 13), B-1023  
Laukamp K.R., Thiele F., Shakirin G., 
Perkuhn M., Zopfs D., Faymonville A., 
Timmer M., Borggrefe J.  
Fully automated meningioma detection and 
segmentation using deep learning on routine 
multiparametric MRI (SS 1911b), B-1671  
Laverman P.  
Contrast media in imaging: B. Radiotracers in 
PET/RNI (RC 814), A-354  
Laxmi V., Chowdhury V., Dixit R., Agarwal A.  
Perfusion CT vs triphasic CT in evaluation of 
hepatic masses (SS 1901a), B-1507  
Le Roy J., Vernhet Kovacsik H., Zarqane H., 
Vincenti M., Lacampagne A., Amedro P.  
Sub-millisievertmultiphasic acquisitions for 
coronary CT angiography of congenital 
coronaryanomalies in paediatric patients  
(SS 1413), B-1133  
Leander P.  
Radiology will survive, but will the radiologist still 
be there?: The landscape in radiology is 
changing: the radiologists need to adapt  
(PI 2), A-507  
Lebedev S., Stierstorfer K., Kachelrieß M.  
Stack transition motion compensation in 
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Lecouvet F.E.  
Whole-body MRI: ready for prime time?: 
Chairperson's introduction (SA 5a), A-196  
Lecouvet F.E.  
Advances in musculoskeletal techniques: whole-
body MR: A. Oncologic application  
(E³ 1821), A-944  
Lederlin M.  
Lung cancer in the era of molecular oncology 
and immune therapy: A. Lung adenocarcinomas 
with EGFR mutations (E³ 118), A-055  
Lee H., An C., Kim M.  
Diagnostic accuracy of LR-M criteria for 
differentiating combined hepatocellular 
cholangiocarcinoma on gadoxetate-enhanced 
MRI (SS 301a), B-0192  
Lee H., Kwon W., Zhang Y.  
A 3T MRI with radial T1-weighted 3D spoiled 
gradient echo sequence can clarify pleural 
invasion classification of primary lung cancer 
(SS 1904b), B-1580  
Lee J.M.  
Hepatocellular carcinoma: diagnosis, staging 
and current guidelines: Atypical appearance of 
HCC and mimics: how to solve the challenging 
cases (SF 1), A-019  
Lee J., Kim C., Gu K.  
Blood oxygenation level-dependent MRI for 
prediction of clinical outcome in uterine cervical 
cancer treated with radiotherapy  
(SS 707), B-0650  
Lee J., Bruni S., Kennedy S., Swami V.,  
Chen E., Menezes R., Borrego D., Lee C., 
Rogalla P.  
Comparing diagnostic performance of ultra-low-
dose CT compared to abdominal plain films 
(SS 1017), B-0947  
Lee K.H., Tse M.L.D., Cheng A.K.C.,  
Wong H.Y.F., Yu M.L., Li Y.L., Chien P.Y.C., 
Ho Y.C., Chu F.  
An imaging and clinical scoring system to predict 
early mortality in spontaneous ruptured 
hepatocellular carcinoma treated with 
transarterial embolisation (SS 301a), B-0193  
Lee K., Lau W., Tsang H., Lau C., Chung H.  
Relative maximum apparent diffusion coefficient: 
a potential biomarker of disease activity in axial 
spondyloarthritis (SS 1910), B-1620  
Lee K., Baik J.  
Proposal of imaging reporting and data system 
for cervical lymph node based on computed 
tomography (SS 1508), B-1212  
Lee S.  
Making the most of social media: Social media 
at ECR (part 1) (EFRS WS), A-790  
Lee S.  
Audit across Europe: directive and perspective: 
Quality improvement and change management: 
Audit in industry (ESR Audit), A-856  
Leen E.  
Ultrasound-guided interventional procedures: 
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(SS 1003), B-0980  
Mannil M., von Spiczak J., Manka R.,  
Alkadhi H.  
Texture analysis and machine learning for 
detecting myocardial infarction in non-contrast 
low-dose CT (SS 1003), B-0981  
Manoharan T.  
Integrated decision support for improved patient 
outcome (SY 1d)  
Mansour O., Jafarinosar G.  
The diagnostic accuracy of diffusion-weighted 
imaging for the detection of partial-thickness 
rotator cuff tears (SS 1010), B-0956  
Mansour S.A., Hamed S.T., Hosny S.,  
Elsayed S.B.  
Role of diffusion MR imaging and 3D/4D 
ultrasound in the assessment of placental 
insufficiency in gestational hypertension  
(SS 1907b), B-1666  
Maravi P.  
Role of ureteric jet angle as measured by colour 
Doppler ultrasound in evaluating severity 
(grading) of VUR in patients presenting with 
urinary complaints (MY 4), B-0385  
Marcello R., Assegnati G., Di Blasi A., 
Cortese F., Vitale S.  
Evaluations of outcomes for drop in pain and 
analgesic use for kyphoplasty in the treatment of 
249 patients with vertebral compression 
fractures: a single centre results  
(SS 610b), B-0532  
Marcon M., Becker A., Berger N., Wurnig M., 
Wagner M., Frauenfelder T., Boss A.  
Texture feature analysis can support breast 
lesions identification and characterisation in 
images acquired by automated breast 
ultrasound systems (SS 302), B-0273  
Marcu M., Hedesiu M.  
Estimation of the irradiation dose of children 
exposed to CBCT for various dental pathologies 
(MY 14), B-1184  
Marcy P.-Y. 
Distant metastases of head and neck cancer: 
Chairperson's introduction (E³ 926), A-433  
Mariani S., Bruno F., Quarchioni S., 
Cannizzaro E., Gianneramo C., Arrigoni F., 
Zugaro L., Barile A., Masciocchi C.  
Another breach in the wall: efficacy of sodium 
hexametaphosphate (SHMP) solution vs simple 
saline in percutaneous treatment of calcific 
tendonitis of the shoulder: 6-months follow-up 
(SS 1010), B-0960  
Marie G., Po eg P., Son Forget J.,  
Maeder J.P., Meuli R.  
Quantitative assessment of spatial and temporal 
gadolinium deposition within the deep brain 
nuclei (SS 1011b), B-0996  
Maroldi R.  
Head and neck: inflammation, tumour or 
something else?: Sinuses (BS 1), A-023  
Maroldi R.  
Distant metastases of head and neck cancer: C. 
Is functional imaging necessary to detect distant 
metastases in head and neck cancers?  
(E³ 926), A-436  
Maros M.E., Kämpgen B., Förster A.,  
Groden C., Sommer W.H., Schönberg S.O., 
Henzler T., Wenz H.  
Structured reporting supports junior readers and 
improves PI-RADS conformity of multi-
parametric MRI reports of the prostate-based on 
cross-lingual RADLEX annotations  
(SS 1905), B-1582  
Marques H.  
Discovering Portuguese radiology: past, present, 
future: Cardiac CT from anatomy to functional 
information: comprehensive CAD evaluation  
(EM 2), A-687  
Marra P., Venturini M., Colombo M.,  
Brembilla G., Panzeri M.M., Salvioni M., 
Gusmini S., De Cobelli F., Del Maschio A.  
Endovascular repair of 40 Visceral Artery 
Aneurysms (VAAs) and 
Pseudoaneurysms(VAPAs) with the Viabahn 
Stent-Graft: technical aspsects, clinical outcome 
and mid-term patency (SS 309), B-0230  
Marra P., Diana P., Ratti F., Partelli S., 
Salvioni M., Gusmini S., Venturini M., 
Aldrighetti L., De Cobelli F.  
Microwaveablation (MWA) of liver metastases 
from pancreatic neuroendocrine tumour (pNET): 
preliminary results with a new generation system 
(SS 709), B-0629  
Marra P., Diana P., Ratti F., Cipriani F., 
Salvioni M., Gusmini S., Venturini M., 
Aldrighetti L., De Cobelli F.  
Microwave ablation (MWA) of liver malignancies: 
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progression (LTP) with a new generation system 
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MR-guided high-intensity focused ultrasound 
(MRgFUS) for the treatment of oligometastatic 
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Chairperson's introduction (RC 901), A-381  
Martí-Bonmatí L.  
Diffuse liver disease: C. Diagnosis and staging 
of liver fibrosis (E³ 320), A-090  
Martí-Bonmatí L.  
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Integration of big data in radiological education 
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Martí-Bonmatí L.  
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articles (ESR Publication), A-934  
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Case-Based Diagnosis Training - Part 1: Liver 
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Marticorena Garcia S.R., Guo J., Tzschätzsch 
H., Althoff C.E., Dürr M., Halleck F., Hamm B., 
Fischer T., Sack I.  
Long-term follow-up magnetic resonance 
elastography after novel direct antiviral therapy 
in chronic hepatitis C virus induced liver fibrosis 
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Regent A., Mouthon L., Paragios N.,  
Revel M.-P.  
Analysis of pulmonary fibrosis, using an elastic 
registration technique in a model of fibrosis: 
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Musculoskeletal radiology: inflammation:  
A. Inflammatory and infections in the soft tissues 
(E³ 221), A-061  
Martin S., Hofmeister J., Burgermeister S., 
Becker C.D., Montet X.  
Artificial intelligence applied on the national lung 
screening trial dataset: a radiomics study  
(SS 1004), B-0867  
Martinelli M., Chincarini M., Zamboni G., 
Fabris C., Conti C., Pedrazzani C.,  
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Prognostic value of bodycomposition parameters 
assessed at the preoperative CT in patients 
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Prospective quantification of respiratory 
mechanics in COPD patients before and after 
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Musculoskeletal ultrasound in the management 
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technique and diagnosis (RC 810), A-346  
Martynova N., Vorobyov N., Mikhailov A., 
Gutsalo J., Smirnova E., Kalesnik A., 
Andreev G., Kubasov A., Lyubinskij A.  
Primary and metastatic lung tumours treated 
with stereotactic body radiation therapy (SBRT): 
own experience (MY 5), B-0406  
Mascagni L., Tipaldi M., Pignatelli M., 
Cappucci M., Krokidis M., Orgera G.,  
Rossi M.  
Endovascular treatment of visceral artery 
aneurysms and pseudoaneurysms: 
extravascular stent graft migration as a possible 
long-term complication (SS 309), B-0231  
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Use of ultrasound for diagnosis of 
schistosomiasis mansoni (SS 1014), B-0968  
Masselli G.  
Emergency radiology II: B. Non-traumatic urinary 
tract emergencies (E³ 921), A-380  
Masselli G.  
Placental imaging: how, when and why?: 
Placental abnormalities, timing of imaging, 
methods and diagnosis (SF 16), A-815  
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Ricci F., Gallina S., Messalli G.,  
Cademartiri F., Cotroneo A.R.  
Prevalence and clinical relevance of extra-
cardiac findings in CMR imaging  
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Mastrodicasa D., De Cecco C.N., Moritz A., 
Varga-Szemes A., Muscogiuri G.,  
van Assen M., Eid M., Lavra F., Schoepf U.J.  
Artificial intelligence deep-learning-based 
coronary CT fractional flow reserve: the impact 
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reconstruction techniques (SS 1803), B-1455  
Masy M., Giordano J., Hossein-Foucher C., 
Petyt G., Remy J., Remy-Jardin M.  
Dual-energy CT (DECT) lung perfusion in 
chronic thromboembolic pulmonary hypertension 
(CTEPH): diagnostic accuracy and concordance 
with radionuclide scintigraphy  
(SS 1904a), B-1552  
Mathilakath R.V.  
Diagnostic efficacy of dynamic manoeuvres in 
computed tomographic evaluation of oral cavity 
lesions (MY 14), B-1198  
Matinyan N., Kuplevatsky V., Minasyan I., 
Cherkashin M., Berezina N., Sahakyan D.  
MR-guided in-bore prostate biopsy for clinically 
significant cancer detection in patients with 
negative TRUS biopsies and rising PSA level 
(SS 1909), B-1548  
Matos C.  
Cystic pancreatic lesions: how to differentiate, 
how to manage?: Chairperson's introduction  
(SF 5), A-219  
Matos C.  
Liver and bile duct pathologies:  
B. Cholangiocarcinoma: diagnosing and staging 
(E³ 820), A-374  
Matos C.  
Imaging of abdominal tumours: B. Pancreatic 
tumours (E³ 1921), A-968  
Mauri G.  
Ultrasound-guided interventional procedures: 
new techniques and applications: Thyroid  
(WG 1), A-826  
Maus V., Kalkan A., Kabbasch C.,  
Abdullayev N., Barnikol U.B., Liebig T., 
Dohmen C., Fink G.R., Mpotsaris A.  
Mechanical thrombectomy in basilar artery 
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favorable clinical outcome. (SS 611), B-0511  
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Molecular imaging in oncology: D. Biomarker 
imaging with MR (RC 406), A-159  
Mayerhöfer M.E.  
Whole-body MRI: ready for prime time?:  
The case of lymphoma (SA 5a), A-199  
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Hybrid imaging in oncology: Chairperson's 
introduction (SF 15a), A-740  
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Comparison of cardiovascular magnetic 
resonance imaging and computed tomography 
to guide transcatheter aortic valve replacement: 
a pilot study (SS 203), B-0148  
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Linking imaging biobanks to -omics: the role of 
BBMRI and ESR: Secondary use of existing 
data: ethical issues, sharing and data protection 
(ESR/BBMRI-ERIC), A-613  
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CT - patterns in chest radiology: back to basics 
and beyond: Chairperson's introduction  
(RC 404), A-099  
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Highlighted Lectures: Non-occlusive mesenteric 
ischaemia: CT diagnosis and signs of 
reperfusion (TF 1), A-690  
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Bergin D., Bruzzi J.F., Voisin B., Sheppard D.  
A novel mobile phone app to minimise bias and 
aid the FNAC decision-making process  
(SS 708), B-0670  
McDermott A., Navin P., Weir A., Tarmey T., 
Bruzzi J.F., Voisin B., Sheppard D.  
Comparison of the clinical utility of international 
guidelines to aid the decision on when to 
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(SS 708), B-0671  
McDonald R.J.  
Gadolinium deposition: is it harmful?: 
Gadolinium deposition in the brain: from 
preclinical studies to clinical implications  
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McGill M., Paterson A.  
A pain in the neck: imaging of the paediatric 
cervical spine (c-spine) in isolated neck trauma 
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McGinty G.  
Value-based radiology: Panel discussion:  
A European - US debate on the value of "value-
based radiology" (part 3) (PI 3)  
McGinty G.  
Value-based radiology: New metrics are 
required for value-based radiology (PI 3), A-586  
McKay C., Maguire S., Gilligan P., Walsh C., 
Matthews J., Eustace S.J. 
Optimisation of contrast delivery using 
quantitative and qualitative analysis in a clinical 
based CTPA setting (SS 1014), B-0972  
McLenachan S.L., Williams M., Camilleri F., 
Newby D.E.  
Vascular calcification on mammography and 
coronary artery disease identified by computed 
tomography (SS 202b), B-0097  
McNeill A.  
eL18-4 in small parts, musculoskeletal and 
abdominal exams (SY 19)  
McNulty J.  
Forensic imaging: Chairpersons' introduction 
(part 1) (RC 114), A-037  
McNulty J.  
How to foster clinical research in imaging 
departments: An overview of the roles of 
radiographers in research  
(ESR Research), A-401  
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EFRS meets Switzerland and Portugal: 
Introduction (EM 4), A-493  
McNulty J.  
Making the most of social media: Chairperson's 
introduction: Social media in healthcare  
(EFRS WS), A-786  
Mdletshe S., Nel A., Rainford L.,  
Lawrence H.A.  
The development of a CAD tool employing 
TELTA, designed to support the training of 
radiographers in chest pattern recognition  
(SS 1414), B-1148  
Medina-Ornelas S.S., Garcia-Perez F.  
Influence of Trigger-PSA and molecularactive 
tumour volume evaluated with 68Ga-PSMA 
PET/CT on detection rate and localisation of 
recurrence in patients with prostate cancer  
(MY 3), B-0376  
Medina-Ornelas S.S., Garcia-Perez F.  
Clinical utility of 18F-NaFand 68Ga-PSMA PET-
CT as prognostic marker in patients with 
metastatic prostate cancer treated with Radium-
223 (SS 1516), B-1253  
Mehana S.M.  
Can renal artery resistive index predict disease 
activity in lupus nephritis? (SS 1007), B-0885  
Meier-Schroers M., Homsi R., Schild H., 
Thomas D.  
Lung cancer screening with MRI: 
characterisation of nodules with different non-
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Meier-Schroers M., Homsi R., Schild H., 
Thomas D.  
Lung cancer screening with MRI: application of 
Lung-RADS in the first two screening rounds 
(SS 1904b), B-1571  
Meijer F.J.A.  
The polytrauma patient: The neuroradiologist's 
perspective (MS 17), A-939  
Melendez F.J., Rosati S., Aixut Lorenzo S., 
Remollo Friedemann S., Werner Reyes M.F., 
Ribó Jacobí M., Hernández Morales D., 
Martínez M., Tomasello Weitz A.  
Stent retriever single shot study (4S): 
multivariable analysis for first-pass 
recanalization in acute stroke (MY 9), B-0827  
Melzig C., Weinheimer O., Egenlauf B., 
Messerli M., Grünig E., Kauczor H.-U., 
Heussel C., Rengier F.  
Automated volumetry of peripheral pulmonary 
vessels based on CT angiography in suspected 
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Bisschops B., Veltman J., Lavin P.,  
van de Vijver M., Mann R.M.  
Correlation between optoacoustic imaging and 
molecular subtypes of malignant breast masses 
(MY 16), B-1277  
Meng-Na H., Jiang T.  
Preliminary exploration of the application of 
super microvascular imaging in focal liver 
lesions (SS 301b), B-0206  
Menshchikov P.E., Ublinskiy M.,  
Manzhurtsev A., Akhadov T., Semenova N.  
Simultaneous decrease of aspartate and NAA 
levels in the brain after severe TBI: 1H MRS 
study (SS 212), B-0156  
Menshchikov P.E., Semenova N., Melnikov I., 
Ublinskiy M., Akhadov T.  
Increased cerebral GABA concentration 
measured using 1H MRS in the acute paediatric 
mTBI (MY 8), B-0806  
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Trends in quality education in radiology: The 
beauty of face-to-face teaching (ESOR), A-285  
Menu Y.  
My three top tips for abdominal imaging: Liver 
metastases follow-up (SF 12a), A-528  
Menu Y.  
How to write a scientific paper and how to get it 
published: The review process in radiology  
(ESR Publication), A-932  
Mercatelli D., Santoro A., Guidarelli G., 
Aparisi Gomez M., Guglielmi G.,  
Franceschi C., Battista G., Bazzocchi A.  
Correlation between central adiposity distribution 
measured by DXA and inflammatory markers in 
the Italian cohort of the NU-AGE project  
(SS 1910), B-1625  
Merhemic Z.  
Neurologic emergencies: Ischaemic stroke  
(BS 3), A-082  
Mershin K.  
The heart team: coronary imaging and 
treatment: The role of coronary imaging in the 
coronary artery bypass and valve surgery 
(MS 4), A-131 
Mershina E.  
The heart team: coronary imaging and 
treatment: Chairperson's introduction  
(MS 4), A-128  
Messina C., Albano D., Corazza A., 
Rapisarda S., Martinelli N., Bianchi A., 
Sconfienza L.M.  
Posterior tibial tendon dysfunction: clinical and 
magnetic resonance imaging findings having 
histology as reference standard  
(SS 710b), B-0719  
Messiou C.  
New treatments for musculoskeletal tumours: 
Multimodality imaging in treatment and 
surveillance of soft tissue sarcoma  
(SF 17a), A-895  
Metin Y., Orhan Metin N., Kalcan S.,  
Ozdemir O., Çolakolu M., Küpeli A.  
The possitive effects of bariatric surgery on 
NAFLD at early postoperative period: proof with 
ideal IQ sequences obtained by 3.0 Tesla MRI 
(SS 1801), B-1324  
Meyer H., Schob S., Münch B.,  
Frydrychowicz C., Quäschling U.,  
Hoffmann K., Surov A.  
Histogram analysis of T1-weighted, T2-
weighted, and postcontrast T1-weighted images 
in primary CNS lymphoma: correlations with 
histopathological findings (SS 316), B-0359  
Miglioretti D.L., Sprague B., Gard C., 
Rauscher G., Tice J., Kerlikowske K.  
Risk-based strategies for supplemental breast 
cancer screening (SS 1902a), B-1604  
Milanese G., Silva M., Seletti V., Galeone C., 
Bartholmai B., Palmucci S., Piciucchi S., 
Karwoski R., Sverzellati N.  
Follow-up of idiopathic pulmonary fibrosis: 
computed tomography vs functional metrics  
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Milanese G., Mannil M., Martini K., Maurer B., 
Alkadhi H., Frauenfelder T.  
Effect of different radiation doses and 
reconstruction kernels of HRCT on texture 
analysis-based artificial neural network 
classification of patients with systemic sclerosis 
(SS 204), B-0047  
Milanese G., Silva M., Bruno L., Goldoni M., 
Maffei E., Cademartiri F., Sverzellati N.  
Epicardial fat volume as a potential imaging 
biomarker for coronary artery disease in 
symptomatic patients (SS 303), B-0333  
Milani A., Trimboli R.M., Carbonaro L.A., 
Codari M., Di Leo G., Sardanelli F.  
MRI of invasive mass breast cancer: correlation 
of global vascularity and ADC with pathological 
features (SS 602), B-0503  
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Lower extremity sports injuries: A. Sports-related 
injuries of the knee: what does the orthopaedic 
surgeon need to know? (TC 1428), A-707  
Miller T.T.  
Lower extremity sports injuries: C. Interactive 
case discussion (part 1) (TC 1428), A-709  
Min L.A., Ackermans L.L.G.C., Nowee M.E., 
van Griethuysen J.J., Trebeschi S., Vogel W., 
Maas M., Beets-Tan R.G.H., Lambregts D.M. 
Multiparametric MRI to predict response to 
external beam radiotherapy in locally advanced 
cervical cancer: comparison of MRI volumetry, 
diffusion-weighted MRI and MR texture analysis 
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Min L.A., Vogel W., Lahaye M.J., Maas M., 
Donswijk M., Vegt E., Beets-Tan R.G.H., 
Lambregts D.M. 
Integrated versus separate reporting of FDG-
PET/CT and MRI for abdominal malignancies: 
effect on diagnostic confidence and staging 
outcomes (SS 1016a), B-0893  
Mirafzal S., Lahaye C., Mulliez A., Morin P., 
Vaz Touret M.A., Boirie Y., Boyer L., 
Cassagnes L.  
CT dose reduction for epicardial fat 
measurement in obese patients: effects of low-
dose cardiac CT and adaptive statistical iterative 
reconstruction (SS 303), B-0331  
Miraglia R., Maruzzelli L., Petridis I.,  
Marrone G., Luca A.  
Preliminary experience of TIPS creation using 
the new controlled expansion e-PTFE covered 
stent (SS 209), B-0033  
Mishra A., AlSaady R., Patel S., 
Mahemood S.A., Abdulla T.S., Hussain 
A.A.W.  
How accurate are we and how can we get better 
in diagnosing acute appendicitis by unenhanced 
multidetector computed tomography: a large 
meta-analysis and literature review (SS 1017), 
B-0946  
Mitchell D.P., Gillespie C.D., Moriarty H., 
Ridge C.A., MacMahon P.J. 
Overdiagnosis of PE in pregnancy? 
Interpretative discrepancy in the diagnosis of 
pulmonary embolism in pregnant patients 
undergoing CTPA (SS 1904a), B-1554  
Mitreska N.  
Successful paediatric imaging: Chairpersons' 
introduction: Paediatrics: more than just 'small 
adults' (part 2) (RC 514), A-224  
Mizandari M., Azrumelashvili T., Habib N.  
VesOpen procedure: the new percutaneous 
image-guided treatment option of HCC-induced 
portal vein thrombosis (SS 209), B-0037  
Mizandari M., Azrumelashvili T., Habib N.  
Image-guided percutaneous drainage of 
pancreatic duct: what for and how  
(SS 209), B-0040  
Mizandari M., Azrumelashvili T., Habib N.  
Fluoroscopy-guided percutaneous interventions 
via pancreatic duct percutaneous drainage track 
for diagnosis and treatment: feasibility and 
technique (SS 209), B-0041  
Mizzi A.  
Portal hypertension and interventional radiology 
(IR): Chairperson's introduction (RC 109), A-050  
Mohammadzadeh A., Mohammadzadeh M., 
Shahkarami V., Shakiba M., Sabetrasekh P.  
Association of non-alcoholic fatty liver disease 
with increased carotid intima-media thickness 
considering other cardiovascular risk factors  
(SS 315), B-0212  
Mohammadzadeh M., Mohammadzadeh A., 
Haghighi Z., Sharifian H.,  
Mohammadzadeh V., Kadivar S.  
Perineural spread of fungal sinonasal infections: 
CT scan and MRI findings (SS 1508), B-1221  
Mohammed N.-E.A.N., Naguib N.N.N.,  
Gruber-Rouh T., Burck I., Vogl T.J.  
Ablation therapy of non-colorectal cancer lung 
metastases: retrospective analysis of tumour 
response post LITT, RFA and MWA  
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Mohammed Ali A.H., Hogg P.H., England A.  
Relationships between image quality and 
radiation dose during paediatric pelvis 
radiography: a factorial phantom study  
(SS 714), B-0741  
Mohammed Ali A.H., Hogg P.H., England A.  
Development and validation of a low-cost 
paediatric pelvic phantom for digital radiography 





 E A 
 
C B D F G S585  
Molinari F.  
CT - patterns in chest radiology: back to basics 
and beyond: B. Linear and reticular pattern 
(RC 404), A-101  
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Imaging of the chest: A. Fibrosing lung diseases 
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Scaramuzza D.  
Evaluation of diagnostic accuracy of diffusion 
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The use of CBCT in clinical settings: the 
experience of Geneva University Hospital  
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Monti M., Zamboni G., Bertuzzo L.,  
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MRI and MRCP features of chronic pancreatitis 
in patients with or without pancreas divisum 
abnormality and their ralationship to patients age 
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Moorthy I., Iliadis K., Diacon T., Moon L.,  
Vitta L.  
Optimising imaging in suspected child abuse: a 
five-year prospective study in a tertiary referral 
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Moraes P.H.D., Chammas M., Schelini M.  
Elastography shear wave contribution when 
evaluating thyroid follicular nodules comparing to 
histological findings (MY 14), B-1186  
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EFRS meets Switzerland and Portugal: 
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Rodrigues P.P.  
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assessment within a breast imaging eLearning 
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Averlant L., Kahn J., Longere B., Silvestri V., 
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Late gadolinium enhancement patterns in 
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Mochalova E., Sinitsyn D., Sergeev D., 
Krotenkova M., Suponeva N., Piradov M.  
The role of conventional MRI-based scale in 
distinguishing chronic disorders of 
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Zabitova M., Kashina E., Krotenkova M., 
Dobrynina L.  
Comparative study of activation during color-
word Stroop test and new suggested counting 
test performance (SS 1911b), B-1677  
Morris E.A.  
MRI for early detection, staging and 
management of breast cancer: B. MR imaging 
biomarkers for the clinical setting  
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Mostbeck G.H.  
GI bleeding: how to solve the problem?:  
A. Acute GI bleeding (RC 101), A-004  
Motosugi U., Hori M., Goshima S., Kozaka K., 
Hyodo T., Nakamura Y., Nishie A., Tamada T., 
Kanki A.  
How to avoid gadoxetic acid-related artefacts? 
Prospective multi-institutional study in 1994 
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Mottet N.  
A multidisciplinary approach to prostate cancer: 
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evidence-based clinical decision making  
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Motyer R., Kok H., Asadi H., O'Hare A., 
Brennan P., Sarah P., Looby S., Nicholson P., 
Thornton J.  
Outcomes of endovascular treatment for acute 
large vessel ischaemic stroke more than 6 hours 
after symptom onset (SS 1009), B-0856  
Motyer R., Thornton J., Power S., Brennan P., 
O'Hare A., Looby S., Williams D.,  
Moynihan B., Murphy S.  
Endovascular thrombectomy beyond 12 hours of 
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Vasco Aragão M.: SS 1411a 
Vassallo E.: SS 1008 
Vázquez E.: RC 1712 
Verbist B.: BS 1, MY 14 
Vernooij M.: MY 8, SS 1511 
Vilanova J.C.: SS 1807a 
Vilar J.: MY 5, RTF Quiz 
Vilela P.: SS 711b 
Villa R.: SS 313 
Vinnicombe S.J.: SS 1902b 
Vlahos J.: SS 1904a 
Vlassenbroek A.: SY 12 
Vock P.: E³ 1226, S 1 
Vourtsis A.: SS 1802b 
 
W 
Weishaupt D.: EM 1 
Wildberger J.E.: SY 15 
Willemink M.J.: SS 713 
Woitek R.: SS 311 
Woznitza N.H.: SS 1914 
 
Y 
Yalynska T.A.: E³ 24E, SS 1503 
Yousry T.A.: SS 711a 
Yusuf G.T.: SY 11 
 
Z 
Zackrisson S.: SS 202a 
Zanetti M.: SS 710b 
Zech C.J.: E³ 126 
Zins M.: MY 7, MY 15 
Zlatareva D.: S 2 
 
